data_2l2a_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 2l2a _Structure_validation_residue.Date_analyzed 2016-10-07 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A 1515 ' ' ASP . . . . . . . . . . . . . 22.8 t0 . . . . . 0 N--CA 1.434 -1.26 0 N-CA-C 106.874 -1.528 . . . . 2.54 106.874 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A 1516 ' ' CYS . . . . . . . . . . . . . 29.8 m -75.99 67.92 2.41 Favored 'General case' 0 C--N 1.288 -2.081 0 CA-C-O 121.948 0.88 . . . . 1.25 110.862 -176.008 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A 1517 ' ' GLN . . . . . . . . . . . . . 4.0 pt20 -148.56 151.31 34.85 Favored 'General case' 0 N--CA 1.417 -2.119 0 N-CA-C 108.578 -0.897 . . . . 2.36 108.578 -179.494 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A 1518 ' ' VAL . . . . . 0.8 HG21 HD11 ' A' 1588 ' ' LEU . 44.6 t -127.08 134.07 66.89 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.459 0 N-CA-C 108.87 -0.789 . . . . 2.34 108.87 -179.169 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A 1519 ' ' THR . . . . . . . . . . . . . 27.7 m -107.71 125.33 51.25 Favored 'General case' 0 C--N 1.296 -1.727 0 N-CA-C 110.063 -0.347 . . . . 2.04 110.063 177.14 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A 1520 ' ' ASN . . . . . . . . . . . . . 30.3 t-20 -97.33 100.37 7.81 Favored Pre-proline 0 C--N 1.309 -1.16 0 N-CA-C 106.802 -1.555 . . . . 2.12 106.802 172.063 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A 1521 ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -73.83 -0.12 9.01 Favored 'Trans proline' 0 C--N 1.353 0.784 0 C-N-CA 122.713 2.275 . . . . 2.59 113.495 -175.633 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A 1522 ' ' SER . . . . . . . . . . . . . 50.8 m -91.44 -14.96 29.62 Favored 'General case' 0 N--CA 1.433 -1.279 0 CA-C-N 116.641 -0.254 . . . . 2.65 110.917 178.384 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A 1523 ' ' THR . . . . . . . . . . . . . 14.3 t -139.12 0.67 1.95 Allowed 'General case' 0 CA--C 1.555 1.135 0 CA-C-O 121.271 0.557 . . . . 2.33 111.247 177.427 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A 1524 ' ' GLY . . . . . . . . . . . . . . . 66.8 30.61 76.45 Favored Glycine 0 C--N 1.339 0.708 0 CA-C-N 116.217 -0.447 . . . . 1.96 112.535 178.466 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A 1525 ' ' HIS . . . . . 0.614 ' HE1' ' HB2' ' A' 1647 ' ' GLU . 23.8 t-160 -101.53 122.75 44.38 Favored 'General case' 0 C--N 1.303 -1.438 0 O-C-N 122.616 -0.343 . . . . 2.44 111.021 -176.729 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A 1526 ' ' LEU . . . . . . . . . . . . . 42.6 tp -97.97 133.55 42.29 Favored 'General case' 0 C--N 1.307 -1.249 0 N-CA-C 108.86 -0.793 . . . . 2.19 108.86 176.383 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A 1527 ' ' PHE . . . . . 0.416 ' CE1' ' HA ' ' A' 1646 ' ' CYS . 94.8 m-85 -102.87 132.67 48.92 Favored 'General case' 0 C--N 1.292 -1.917 0 N-CA-C 108.529 -0.915 . . . . 1.61 108.529 176.822 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A 1528 ' ' ASP . . . . . . . . . . . . . 28.7 t70 -110.98 114.76 28.32 Favored 'General case' 0 CA--C 1.487 -1.45 0 CA-C-O 122.103 0.954 . . . . 2.18 112.425 -179.245 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A 1529 ' ' LEU . . . . . . . . . . . . . 87.0 mt -119.63 3.53 11.16 Favored 'General case' 0 C--N 1.294 -1.818 0 CA-C-N 114.055 -1.429 . . . . 2.04 107.427 174.623 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A 1530 ' ' SER . . . . . . . . . . . . . 14.5 t -80.36 -31.6 37.89 Favored 'General case' 0 N--CA 1.441 -0.898 0 CA-C-N 115.74 -0.664 . . . . 1.44 110.428 -175.443 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A 1531 ' ' SER . . . . . . . . . . . . . 25.9 m -70.4 -10.9 60.35 Favored 'General case' 0 C--O 1.236 0.379 0 CA-C-O 121.133 0.492 . . . . 1.63 110.204 177.234 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A 1532 ' ' LEU . . . . . . . . . . . . . 97.1 mt -80.39 10.01 5.15 Favored 'General case' 0 CA--C 1.546 0.811 0 N-CA-C 112.787 0.662 . . . . 2.32 112.787 178.666 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A 1533 ' ' SER . . . . . . . . . . . . . 31.7 m -72.7 145.02 47.47 Favored 'General case' 0 C--O 1.247 0.964 0 N-CA-C 108.495 -0.928 . . . . 2.57 108.495 174.924 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A 1534 ' ' GLY . . . . . . . . . . . . . . . -162.66 169.28 37.86 Favored Glycine 0 N--CA 1.441 -0.995 0 C-N-CA 120.319 -0.944 . . . . 1.89 112.277 -177.419 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A 1535 ' ' ARG . . . . . 0.801 ' HD3' ' HG3' ' A' 1557 ' ' GLU . 21.8 tpp180 -80.67 -51.59 8.53 Favored 'General case' 0 C--N 1.312 -1.028 0 N-CA-C 108.676 -0.861 . . . . 4.44 108.676 179.459 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A 1536 ' ' ALA . . . . . . . . . . . . . . . -79.61 -37.44 36.17 Favored 'General case' 0 C--N 1.309 -1.193 0 C-N-CA 120.033 -0.667 . . . . 2.07 110.261 179.291 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A 1537 ' ' GLY . . . . . . . . . . . . . . . 79.68 -151.17 33.77 Favored Glycine 0 N--CA 1.426 -1.972 0 N-CA-C 109.962 -1.255 . . . . 1.2 109.962 -179.953 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A 1538 ' ' PHE . . . . . 0.605 ' CD1' HD13 ' A' 1552 ' ' ILE . 65.7 m-85 -107.95 135.91 48.53 Favored 'General case' 0 C--N 1.288 -2.09 0 N-CA-C 107.6 -1.259 . . . . 1.98 107.6 177.598 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A 1539 ' ' THR . . . . . 0.441 ' O ' ' HD2' ' A' 1623 ' ' ARG . 2.7 p -112.45 137.02 51.24 Favored 'General case' 0 C--N 1.296 -1.75 0 N-CA-C 113.135 0.791 . . . . 1.97 113.135 -175.676 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A 1540 ' ' ALA . . . . . . . . . . . . . . . -117.02 108.81 16.21 Favored 'General case' 0 C--N 1.308 -1.203 0 N-CA-C 109.687 -0.486 . . . . 1.39 109.687 178.302 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A 1541 ' ' ALA . . . . . . . . . . . . . . . -74.19 113.75 11.76 Favored 'General case' 0 C--N 1.313 -0.98 0 CA-C-N 115.36 -0.836 . . . . 1.86 109.396 178.998 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A 1542 ' ' TYR . . . . . 0.431 ' CE2' ' HB2' ' A' 1545 ' ' SER . 80.0 t80 -130.72 157.64 42.25 Favored 'General case' 0 N--CA 1.418 -2.065 0 CA-C-N 115.852 -0.613 . . . . 2.4 109.734 -176.587 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A 1543 ' ' SER . . . . . . . . . . . . . 5.3 m -40.85 -153.6 0.0 OUTLIER 'General case' 0 CA--C 1.592 2.561 0 C-N-CA 129.709 3.204 . . . . 2.58 117.111 -174.716 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A 1544 ' ' LYS . . . . . . . . . . . . . 25.0 ttmm -54.86 -24.71 24.41 Favored 'General case' 0 CA--C 1.556 1.188 0 O-C-N 120.863 -1.148 . . . . 4.24 112.385 -179.343 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A 1545 ' ' SER . . . . . 0.431 ' HB2' ' CE2' ' A' 1542 ' ' TYR . 22.6 m -64.69 -30.69 71.71 Favored 'General case' 0 CA--C 1.547 0.827 0 O-C-N 121.759 -0.588 . . . . 3.6 110.717 175.452 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A 1546 ' ' GLY . . . . . 0.408 ' O ' ' HB3' ' A' 1542 ' ' TYR . . . 116.85 174.26 17.12 Favored Glycine 0 N--CA 1.436 -1.34 0 C-N-CA 119.489 -1.339 . . . . 1.66 114.974 174.174 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A 1547 ' ' VAL . . . . . . . . . . . . . 3.1 p -92.92 129.21 43.79 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.343 0 C-N-CA 123.991 0.916 . . . . 2.23 110.398 179.915 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A 1548 ' ' VAL . . . . . 0.487 ' HA ' ' HA ' ' A' 1567 ' ' PHE . 3.0 t -97.47 143.29 12.87 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.86 0 CA-C-N 115.55 -0.75 . . . . 1.59 109.957 -174.763 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A 1549 ' ' TYR . . . . . 0.672 ' HB3' HD22 ' A' 1556 ' ' ASN . 37.3 m-85 -102.49 145.41 29.62 Favored 'General case' 0 C--N 1.307 -1.243 0 N-CA-C 105.915 -1.883 . . . . 1.58 105.915 169.341 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A 1550 ' ' MET . . . . . . . . . . . . . 37.1 ttm -143.52 127.72 17.64 Favored 'General case' 0 C--N 1.292 -1.929 0 C-N-CA 120.49 -0.484 . . . . 2.08 110.833 -175.615 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A 1551 ' ' SER . . . . . . . . . . . . . 41.0 p -99.52 115.76 30.08 Favored 'General case' 0 N--CA 1.418 -2.04 0 N-CA-C 108.047 -1.094 . . . . 1.9 108.047 174.572 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A 1552 ' ' ILE . . . . . 0.605 HD13 ' CD1' ' A' 1538 ' ' PHE . 1.7 mp -75.53 -7.84 10.73 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.017 0 CA-C-O 122.474 1.131 . . . . 2.04 110.586 179.228 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A 1553 ' ' CYS . . . . . . . . . . . . . 33.9 t -161.48 148.83 14.78 Favored 'General case' 0 N--CA 1.425 -1.691 0 N-CA-C 107.516 -1.29 . . . . 1.43 107.516 177.56 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A 1554 ' ' GLY . . . . . 0.415 ' O ' ' HB3' ' A' 1577 ' ' ALA . . . 82.93 -120.15 5.07 Favored Glycine 0 C--N 1.318 -0.462 0 C-N-CA 121.227 -0.511 . . . . 1.23 113.129 176.228 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A 1555 ' ' GLU . . . . . . . . . . . . . 9.3 pt-20 -145.81 145.51 30.81 Favored 'General case' 0 C--N 1.315 -0.91 0 C-N-CA 123.347 0.659 . . . . 1.8 110.812 -179.885 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A 1556 ' ' ASN . . . . . 0.672 HD22 ' HB3' ' A' 1549 ' ' TYR . 3.4 t-20 -85.13 132.3 34.32 Favored 'General case' 0 C--N 1.295 -1.773 0 CA-C-N 114.644 -1.162 . . . . 2.63 110.821 -175.183 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A 1557 ' ' GLU . . . . . 0.801 ' HG3' ' HD3' ' A' 1535 ' ' ARG . 33.2 mm-40 -98.48 177.87 5.2 Favored 'General case' 0 C--N 1.289 -2.044 0 CA-C-N 113.837 -1.529 . . . . 3.79 109.116 179.937 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A 1558 ' ' ASN . . . . . . . . . . . . . 37.8 m-80 75.53 5.71 4.03 Favored 'General case' 0 N--CA 1.504 2.258 0 C-N-CA 124.471 1.109 . . . . 1.59 111.119 -178.727 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A 1559 ' ' CYS . . . . . 0.445 ' HB3' ' HD2' ' A' 1560 ' ' PRO . 97.7 m -148.28 169.35 9.38 Favored Pre-proline 0 C--N 1.291 -1.938 0 N-CA-C 103.413 -2.81 . . . . 0.94 103.413 176.34 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A 1560 ' ' PRO . . . . . 0.445 ' HD2' ' HB3' ' A' 1559 ' ' CYS . 9.4 Cg_endo -52.18 109.21 0.31 Allowed 'Trans proline' 0 C--N 1.359 1.115 0 C-N-CA 122.37 2.046 . . . . 1.53 111.244 176.624 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A 1561 ' ' PRO . . . . . . . . . . . . . 75.4 Cg_exo -50.85 120.61 6.83 Favored 'Trans proline' 0 C--N 1.359 1.088 0 C-N-CA 123.884 3.056 . . . . 1.82 112.502 -175.523 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A 1562 ' ' GLY . . . . . . . . . . . . . . . 134.19 -6.04 4.66 Favored Glycine 0 N--CA 1.435 -1.433 0 CA-C-N 115.081 -0.963 . . . . 0.81 110.987 -177.608 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A 1563 ' ' VAL . . . . . 0.572 HG22 ' HB3' ' A' 1556 ' ' ASN . 13.9 m -90.43 161.06 2.67 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.182 0 N-CA-C 105.937 -1.875 . . . . 1.73 105.937 172.944 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A 1564 ' ' GLY . . . . . . . . . . . . . . . -112.18 -21.88 6.1 Favored Glycine 0 C--N 1.309 -0.923 0 C-N-CA 120.395 -0.907 . . . . 0.72 111.964 -179.816 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A 1565 ' ' ALA . . . . . . . . . . . . . . . -150.13 127.63 11.52 Favored 'General case' 0 C--N 1.311 -1.081 0 N-CA-C 107.511 -1.292 . . . . 1.14 107.511 179.048 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A 1566 ' ' CYS . . . . . . . . . . . . . 34.2 t -155.75 141.57 18.06 Favored 'General case' 0 C--N 1.297 -1.681 0 N-CA-C 110.33 -0.248 . . . . 0.51 110.33 -174.62 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A 1567 ' ' PHE . . . . . 0.487 ' HA ' ' HA ' ' A' 1548 ' ' VAL . 87.6 m-85 -71.2 121.69 18.84 Favored 'General case' 0 C--O 1.216 -0.662 0 N-CA-C 105.365 -2.087 . . . . 1.22 105.365 171.678 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A 1568 ' ' GLY . . . . . 0.627 ' HA3' ' CD1' ' A' 1549 ' ' TYR . . . -83.21 -16.23 69.91 Favored Glycine 0 C--N 1.296 -1.672 0 C-N-CA 119.314 -1.422 . . . . 1.08 114.009 -171.141 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A 1569 ' ' GLN . . . . . . . . . . . . . 4.1 pt20 -82.31 -21.71 35.97 Favored 'General case' 0 C--N 1.301 -1.521 0 C-N-CA 120.565 -0.454 . . . . 3.05 111.408 -178.164 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A 1570 ' ' THR . . . . . . . . . . . . . 9.7 p -121.54 -12.36 8.55 Favored 'General case' 0 C--O 1.239 0.505 0 N-CA-C 112.347 0.499 . . . . 2.44 112.347 178.303 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A 1571 ' ' ARG . . . . . 0.428 ' HA ' ' SG ' ' A' 1559 ' ' CYS . 96.4 mtt180 62.81 42.57 7.79 Favored 'General case' 0 CA--C 1.511 -0.552 0 C-N-CA 125.1 1.36 . . . . 4.48 112.693 178.922 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A 1572 ' ' ILE . . . . . . . . . . . . . 25.2 mm -99.95 116.26 42.85 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.19 0 N-CA-C 108.139 -1.06 . . . . 1.94 108.139 179.942 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A 1573 ' ' SER . . . . . . . . . . . . . 35.0 t -69.15 133.33 47.87 Favored 'General case' 0 C--N 1.306 -1.284 0 CA-C-N 115.311 -0.859 . . . . 1.25 111.084 -176.402 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A 1574 ' ' VAL . . . . . . . . . . . . . 13.8 m -130.6 28.42 1.51 Allowed 'Isoleucine or valine' 0 C--N 1.315 -0.929 0 CA-C-O 122.205 1.002 . . . . 1.61 110.857 174.903 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A 1575 ' ' GLY . . . . . . . . . . . . . . . 163.04 126.97 0.85 Allowed Glycine 0 N--CA 1.421 -2.342 0 CA-C-N 113.835 -1.53 . . . . 0.65 110.439 176.854 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A 1576 ' ' LYS . . . . . 0.464 ' HA ' ' HA ' ' A' 1563 ' ' VAL . 68.3 mttm -85.79 151.24 23.98 Favored 'General case' 0 C--N 1.31 -1.133 0 N-CA-C 108.781 -0.822 . . . . 3.33 108.781 177.969 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A 1577 ' ' ALA . . . . . 0.415 ' HB3' ' O ' ' A' 1554 ' ' GLY . . . -74.34 91.84 2.23 Favored 'General case' 0 C--N 1.315 -0.928 0 CA-C-O 121.736 0.779 . . . . 1.31 111.641 -175.48 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A 1578 ' ' ASN . . . . . . . . . . . . . 41.4 m-80 -117.22 115.18 24.8 Favored 'General case' 0 C--N 1.284 -2.243 0 N-CA-C 104.747 -2.316 . . . . 2.24 104.747 171.724 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A 1579 ' ' LYS . . . . . . . . . . . . . 54.1 mtmt -77.29 90.41 3.75 Favored 'General case' 0 CA--C 1.493 -1.244 0 N-CA-C 108.654 -0.869 . . . . 2.34 108.654 -177.037 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A 1580 ' ' ARG . . . . . . . . . . . . . 27.4 ttm180 -134.79 99.09 4.21 Favored 'General case' 0 N--CA 1.402 -2.861 0 CA-C-N 114.341 -1.3 . . . . 4.19 108.869 -176.481 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A 1581 ' ' LEU . . . . . 0.429 ' HA ' ' HA ' ' A' 1590 ' ' LEU . 4.6 pp -103.61 168.03 9.41 Favored 'General case' 0 C--N 1.297 -1.7 0 C-N-CA 120.4 -0.52 . . . . 2.39 110.189 177.518 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A 1582 ' ' ARG . . . . . 0.659 ' HB3' ' HB3' ' A' 1589 ' ' GLN . 61.5 ttt180 -135.21 125.5 26.36 Favored 'General case' 0 C--N 1.297 -1.688 0 C-N-CA 123.158 0.583 . . . . 4.48 109.766 -174.046 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A 1583 ' ' TYR . . . . . . . . . . . . . 40.2 t80 -119.09 104.11 10.16 Favored 'General case' 0 C--N 1.308 -1.202 0 CA-C-N 116.256 -0.429 . . . . 1.57 110.131 176.075 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A 1584 ' ' VAL . . . . . . . . . . . . . 12.5 p -148.62 142.82 18.85 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.953 0 N-CA-C 108.76 -0.83 . . . . 2.29 108.76 178.981 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A 1585 ' ' ASP . . . . . . . . . . . . . 31.6 t70 49.65 38.7 15.71 Favored 'General case' 0 N--CA 1.501 2.092 0 CA-C-O 122.559 1.171 . . . . 2.06 112.503 177.226 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A 1586 ' ' GLN . . . . . . . . . . . . . 27.4 mt-30 53.84 34.57 19.59 Favored 'General case' 0 C--O 1.241 0.638 0 CA-C-N 114.581 -1.191 . . . . 2.61 113.151 -179.426 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A 1587 ' ' VAL . . . . . . . . . . . . . 7.1 p -135.08 117.5 22.13 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.386 0 CA-C-O 121.826 0.822 . . . . 1.33 109.427 174.724 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A 1588 ' ' LEU . . . . . 0.8 HD11 HG21 ' A' 1518 ' ' VAL . 2.3 mm? -81.57 152.72 27.09 Favored 'General case' 0 C--N 1.297 -1.706 0 CA-C-N 114.784 -1.098 . . . . 2.03 111.588 -178.167 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A 1589 ' ' GLN . . . . . 0.659 ' HB3' ' HB3' ' A' 1582 ' ' ARG . 35.3 tt0 -152.47 156.99 40.52 Favored 'General case' 0 C--N 1.294 -1.837 0 N-CA-C 107.493 -1.299 . . . . 1.73 107.493 -179.534 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A 1590 ' ' LEU . . . . . 0.456 ' HB2' ' HE2' ' A' 1612 ' ' PHE . 5.3 tt -147.83 143.35 27.39 Favored 'General case' 0 C--N 1.303 -1.448 0 N-CA-C 105.685 -1.968 . . . . 1.76 105.685 175.06 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A 1591 ' ' VAL . . . . . 0.459 HG22 HG21 ' A' 1609 ' ' VAL . 11.5 p -130.93 135.26 60.42 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.178 0 N-CA-C 112.805 0.668 . . . . 2.14 112.805 -173.843 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A 1592 ' ' TYR . . . . . . . . . . . . . 63.3 m-85 -122.35 106.11 10.78 Favored 'General case' 0 C--N 1.315 -0.904 0 N-CA-C 107.857 -1.164 . . . . 1.53 107.857 172.912 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A 1593 ' ' LYS . . . . . . . . . . . . . 20.0 pttp -104.37 178.4 4.57 Favored 'General case' 0 C--N 1.293 -1.854 0 CA-C-N 115.982 -0.553 . . . . 2.72 112.07 -176.173 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A 1594 ' ' ASP . . . . . 0.562 ' HA ' ' CB ' ' A' 1605 ' ' SER . 55.8 m-20 49.05 47.83 21.44 Favored 'General case' 0 CA--C 1.514 -0.423 0 C-N-CA 126.101 1.76 . . . . 1.45 115.701 172.407 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A 1595 ' ' GLY . . . . . . . . . . . . . . . -78.66 -80.48 0.73 Allowed Glycine 0 N--CA 1.445 -0.724 0 C-N-CA 120.298 -0.953 . . . . 0.83 111.226 177.758 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A 1596 ' ' SER . . . . . 0.421 ' HA ' ' HD3' ' A' 1597 ' ' PRO . 4.2 p -107.47 143.38 27.11 Favored Pre-proline 0 C--N 1.299 -1.618 0 N-CA-C 109.963 -0.384 . . . . 1.96 109.963 177.588 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A 1597 ' ' PRO . . . . . 0.421 ' HD3' ' HA ' ' A' 1596 ' ' SER . 21.5 Cg_exo -67.24 130.13 21.95 Favored 'Trans proline' 0 N--CA 1.46 -0.475 0 C-N-CA 123.039 2.493 . . . . 1.34 110.29 177.099 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A 1598 ' ' CYS . . . . . 0.416 ' HA ' ' HD3' ' A' 1599 ' ' PRO . 33.7 t -101.25 121.42 51.92 Favored Pre-proline 0 C--N 1.296 -1.736 0 N-CA-C 109.924 -0.398 . . . . 1.19 109.924 -177.157 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A 1599 ' ' PRO . . . . . 0.416 ' HD3' ' HA ' ' A' 1598 ' ' CYS . 94.3 Cg_endo -98.34 22.4 0.29 Allowed 'Trans proline' 0 N--CA 1.449 -1.114 0 C-N-CA 123.127 2.551 . . . . 1.88 112.097 178.344 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A 1600 ' ' SER . . . . . . . . . . . . . 17.9 m -79.61 -74.24 0.3 Allowed 'General case' 0 C--N 1.315 -0.931 0 CA-C-N 116.466 -0.333 . . . . 2.19 111.788 -177.899 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A 1601 ' ' LYS . . . . . . . . . . . . . 23.2 tptm -98.13 -87.11 0.34 Allowed 'General case' 0 C--N 1.317 -0.822 0 C-N-CA 120.317 -0.553 . . . . 4.21 110.42 -178.949 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A 1602 ' ' SER . . . . . . . . . . . . . 16.7 m -96.21 174.98 6.62 Favored 'General case' 0 C--N 1.298 -1.672 0 N-CA-C 107.942 -1.133 . . . . 3.82 107.942 178.718 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A 1603 ' ' GLY . . . . . . . . . . . . . . . -81.57 65.64 3.98 Favored Glycine 0 N--CA 1.439 -1.126 0 N-CA-C 110.382 -1.087 . . . . 2.45 110.382 178.025 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A 1604 ' ' LEU . . . . . . . . . . . . . 1.7 pt? -117.02 165.18 13.66 Favored 'General case' 0 C--N 1.296 -1.724 0 N-CA-C 108.025 -1.102 . . . . 2.06 108.025 -178.111 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A 1605 ' ' SER . . . . . 0.562 ' CB ' ' HA ' ' A' 1594 ' ' ASP . 19.3 m -92.31 178.49 5.83 Favored 'General case' 0 C--N 1.298 -1.641 0 CA-C-O 120.967 0.413 . . . . 1.75 110.389 179.616 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A 1606 ' ' TYR . . . . . 0.497 ' HA ' ' O ' ' A' 1634 ' ' CYS . 76.7 m-85 -95.91 133.74 39.73 Favored 'General case' 0 CA--C 1.468 -2.21 0 N-CA-C 104.658 -2.349 . . . . 1.59 104.658 176.321 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A 1607 ' ' LYS . . . . . . . . . . . . . 10.3 ptpp? -128.36 153.95 46.5 Favored 'General case' 0 N--CA 1.403 -2.802 0 C-N-CA 118.452 -1.299 . . . . 2.21 109.133 178.53 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A 1608 ' ' SER . . . . . . . . . . . . . 45.3 m -117.64 124.29 48.23 Favored 'General case' 0 C--N 1.296 -1.727 0 N-CA-C 109.784 -0.45 . . . . 1.48 109.784 178.063 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A 1609 ' ' VAL . . . . . 0.459 HG21 HG22 ' A' 1591 ' ' VAL . 78.4 t -114.65 124.48 71.35 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.868 0 N-CA-C 109.002 -0.74 . . . . 1.57 109.002 178.956 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A 1610 ' ' ILE . . . . . 0.722 HG13 ' HB2' ' A' 1638 ' ' PHE . 3.2 mp -108.21 119.14 57.26 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.202 0 N-CA-C 109.166 -0.679 . . . . 1.47 109.166 178.683 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A 1611 ' ' SER . . . . . 0.401 ' O ' ' HA ' ' A' 1639 ' ' SER . 8.6 t -96.35 118.37 32.75 Favored 'General case' 0 N--CA 1.412 -2.348 0 N-CA-C 107.732 -1.21 . . . . 1.84 107.732 178.558 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A 1612 ' ' PHE . . . . . 0.456 ' HE2' ' HB2' ' A' 1590 ' ' LEU . 92.8 m-85 -97.06 102.12 13.83 Favored 'General case' 0 N--CA 1.428 -1.556 0 N-CA-C 107.858 -1.164 . . . . 0.86 107.858 178.664 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A 1613 ' ' VAL . . . . . . . . . . . . . 85.0 t -84.29 120.03 34.36 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.952 0 N-CA-C 107.51 -1.293 . . . . 1.32 107.51 179.911 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A 1614 ' ' CYS . . . . . 0.515 ' HB3' ' HB2' ' A' 1646 ' ' CYS . 56.8 m -75.06 91.61 2.56 Favored 'General case' 0 C--N 1.295 -1.795 0 CA-C-O 121.653 0.74 . . . . 1.39 109.036 -178.334 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A 1615 ' ' ARG . . . . . 0.466 ' NE ' ' HA ' ' A' 1615 ' ' ARG . 0.0 OUTLIER -140.08 123.19 10.3 Favored Pre-proline 0 N--CA 1.414 -2.274 0 CA-C-N 115.748 -0.66 . . . . 4.34 109.893 178.358 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A 1616 ' ' PRO . . . . . . . . . . . . . 56.9 Cg_endo -73.04 68.53 3.98 Favored 'Trans proline' 0 CA--C 1.546 1.083 0 C-N-CA 122.261 1.974 . . . . 1.5 110.82 173.908 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A 1617 ' ' GLU . . . . . . . . . . . . . 7.5 tp10 . . . . . 0 C--N 1.314 -0.978 0 N-CA-C 108.878 -0.786 . . . . 3.21 108.878 -177.933 . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A 1622 ' ' ASN . . . . . . . . . . . . . 20.3 t-20 . . . . . 0 C--O 1.231 0.099 0 N-CA-C 107.944 -1.132 . . . . 3.58 107.944 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A 1623 ' ' ARG . . . . . 0.441 ' HD2' ' O ' ' A' 1539 ' ' THR . 32.9 ptt180 -155.32 156.48 31.05 Favored Pre-proline 0 C--N 1.305 -1.361 0 C-N-CA 119.752 -0.779 . . . . 4.09 112.144 -169.786 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A 1624 ' ' PRO . . . . . 0.407 ' HD3' ' HA ' ' A' 1623 ' ' ARG . 12.0 Cg_exo -70.76 106.67 1.89 Allowed 'Trans proline' 0 C--N 1.356 0.964 0 C-N-CA 123.426 2.751 . . . . 2.86 112.068 179.69 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A 1625 ' ' MET . . . . . . . . . . . . . 25.4 ptm -90.3 164.21 14.45 Favored 'General case' 0 C--N 1.303 -1.423 0 CA-C-N 115.698 -0.683 . . . . 2.73 109.304 179.252 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A 1626 ' ' LEU . . . . . . . . . . . . . 41.2 tp -89.58 112.87 24.2 Favored 'General case' 0 C--N 1.303 -1.421 0 N-CA-C 108.69 -0.856 . . . . 1.94 108.69 -178.944 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A 1627 ' ' ILE . . . . . . . . . . . . . 44.0 pt -94.43 -27.71 4.29 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.768 0 C-N-CA 120.585 -0.446 . . . . 1.75 111.662 -177.35 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A 1628 ' ' SER . . . . . . . . . . . . . 15.6 p -162.19 151.8 16.13 Favored 'General case' 0 N--CA 1.44 -0.969 0 N-CA-C 109.951 -0.388 . . . . 1.85 109.951 -178.485 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A 1629 ' ' LEU . . . . . 0.878 ' HG ' ' HG ' ' A' 1636 ' ' LEU . 2.7 tt -138.82 117.43 12.17 Favored 'General case' 0 C--N 1.293 -1.857 0 N-CA-C 106.84 -1.541 . . . . 2.12 106.84 -178.753 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A 1630 ' ' ASP . . . . . . . . . . . . . 12.6 t70 -94.72 103.38 15.29 Favored 'General case' 0 C--N 1.299 -1.621 0 N-CA-C 106.483 -1.673 . . . . 0.87 106.483 178.847 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A 1631 ' ' LYS . . . . . 0.566 ' HG2' HD23 ' A' 1629 ' ' LEU . 90.9 mttt -83.13 -5.35 59.08 Favored 'General case' 0 C--N 1.291 -1.946 0 CA-C-N 115.984 -0.553 . . . . 2.76 111.662 -172.35 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A 1632 ' ' GLN . . . . . . . . . . . . . 1.9 mp0 -87.0 -46.15 10.1 Favored 'General case' 0 C--N 1.312 -1.055 0 N-CA-C 108.437 -0.949 . . . . 2.55 108.437 -179.524 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A 1633 ' ' THR . . . . . . . . . . . . . 2.3 m -89.83 -2.93 58.33 Favored 'General case' 0 C--N 1.312 -1.022 0 CA-C-O 122.241 1.02 . . . . 1.92 108.769 178.01 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A 1634 ' ' CYS . . . . . 0.497 ' O ' ' HA ' ' A' 1606 ' ' TYR . 28.7 m 59.94 43.72 14.43 Favored 'General case' 0 C--O 1.219 -0.529 0 CA-C-N 114.263 -1.335 . . . . 0.89 109.976 176.95 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A 1635 ' ' THR . . . . . . . . . . . . . 16.7 m -120.15 127.68 52.72 Favored 'General case' 0 N--CA 1.428 -1.548 0 CA-C-N 115.228 -0.896 . . . . 1.31 110.847 -173.643 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A 1636 ' ' LEU . . . . . 0.878 ' HG ' ' HG ' ' A' 1629 ' ' LEU . 5.9 mp -101.05 132.43 46.48 Favored 'General case' 0 C--N 1.312 -1.059 0 N-CA-C 109.475 -0.565 . . . . 1.97 109.475 177.346 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A 1637 ' ' PHE . . . . . . . . . . . . . 95.5 m-85 -113.4 107.86 16.42 Favored 'General case' 0 C--O 1.25 1.089 0 CA-C-O 121.26 0.552 . . . . 0.92 111.122 -177.762 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A 1638 ' ' PHE . . . . . 0.722 ' HB2' HG13 ' A' 1610 ' ' ILE . 95.7 m-85 -101.01 154.55 18.61 Favored 'General case' 0 C--N 1.299 -1.587 0 N-CA-C 108.866 -0.79 . . . . 0.7 108.866 178.944 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A 1639 ' ' SER . . . . . 0.401 ' HA ' ' O ' ' A' 1611 ' ' SER . 66.2 m -143.85 130.52 20.19 Favored 'General case' 0 C--N 1.296 -1.726 0 CA-C-O 120.992 0.425 . . . . 1.46 111.682 178.892 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A 1640 ' ' TRP . . . . . . . . . . . . . 12.2 t90 -124.71 105.95 9.7 Favored 'General case' 0 N--CA 1.434 -1.262 0 CA-C-N 115.488 -0.778 . . . . 0.92 109.117 178.008 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A 1641 ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -76.16 100.32 4.98 Favored 'General case' 0 C--N 1.305 -1.346 0 CA-C-O 121.547 0.689 . . . . 3.18 109.479 175.309 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A 1642 ' ' THR . . . . . 0.406 ' O ' ' HA ' ' A' 1614 ' ' CYS . 14.9 t -142.08 139.01 17.37 Favored Pre-proline 0 C--N 1.291 -1.936 0 C-N-CA 120.016 -0.674 . . . . 1.48 112.447 -173.493 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A 1643 ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -80.86 -0.32 10.52 Favored 'Trans proline' 0 N--CA 1.453 -0.893 0 C-N-CA 123.296 2.664 . . . . 1.09 110.611 175.487 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A 1644 ' ' LEU . . . . . . . . . . . . . 88.9 mt -77.04 -27.57 54.51 Favored 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 108.405 -0.961 . . . . 2.08 108.405 175.345 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A 1645 ' ' ALA . . . . . . . . . . . . . . . -71.11 -42.37 69.36 Favored 'General case' 0 N--CA 1.441 -0.887 0 CA-C-N 114.596 -1.184 . . . . 1.37 110.022 -179.368 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A 1646 ' ' CYS . . . . . 0.515 ' HB2' ' HB3' ' A' 1614 ' ' CYS . 65.5 m -139.94 115.97 10.37 Favored 'General case' 0 C--O 1.244 0.808 0 N-CA-C 106.931 -1.507 . . . . 1.7 106.931 173.656 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A 1647 ' ' GLU . . . . . 0.614 ' HB2' ' HE1' ' A' 1525 ' ' HIS . 35.8 mt-10 . . . . . 0 C--N 1.309 -1.18 0 O-C-N 123.802 0.689 . . . . 2.92 110.226 -174.882 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A 1515 ' ' ASP . . . . . 0.425 ' HA ' ' HG3' ' A' 1579 ' ' LYS . 10.4 m-20 . . . . . 0 N--CA 1.48 1.073 0 N-CA-C 114.274 1.212 . . . . 2.54 114.274 . . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A 1516 ' ' CYS . . . . . 0.712 ' HA ' HD23 ' A' 1581 ' ' LEU . 57.0 m -135.79 40.75 2.74 Favored 'General case' 0 C--N 1.324 -0.536 0 C-N-CA 123.933 0.893 . . . . 1.25 111.37 -178.801 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A 1517 ' ' GLN . . . . . 0.452 ' HB2' HD21 ' A' 1526 ' ' LEU . 25.0 pt20 -139.09 124.19 18.96 Favored 'General case' 0 C--N 1.3 -1.571 0 N-CA-C 109.662 -0.496 . . . . 2.36 109.662 176.131 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A 1518 ' ' VAL . . . . . . . . . . . . . 7.5 p -124.78 128.94 73.64 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.849 0 CA-C-O 121.044 0.449 . . . . 2.34 110.324 -179.799 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A 1519 ' ' THR . . . . . 0.401 ' HA ' ' HA ' ' A' 1526 ' ' LEU . 50.3 m -100.7 126.33 47.22 Favored 'General case' 0 C--N 1.284 -2.274 0 N-CA-C 108.879 -0.786 . . . . 2.04 108.879 175.369 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A 1520 ' ' ASN . . . . . . . . . . . . . 38.1 t-20 -88.96 110.53 38.6 Favored Pre-proline 0 C--N 1.303 -1.434 0 N-CA-C 107.453 -1.314 . . . . 2.12 107.453 176.942 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A 1521 ' ' PRO . . . . . . . . . . . . . 58.9 Cg_endo -70.4 -14.18 33.79 Favored 'Trans proline' 0 C--N 1.356 0.928 0 C-N-CA 122.585 2.19 . . . . 2.59 113.19 -175.487 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A 1522 ' ' SER . . . . . . . . . . . . . 6.9 m -80.29 -17.01 53.35 Favored 'General case' 0 N--CA 1.43 -1.442 0 CA-C-N 116.281 -0.418 . . . . 2.65 110.581 -178.795 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A 1523 ' ' THR . . . . . . . . . . . . . 10.1 t -131.51 -18.16 2.85 Favored 'General case' 0 CA--C 1.556 1.203 0 C-N-CA 120.312 -0.555 . . . . 2.33 112.492 179.45 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A 1524 ' ' GLY . . . . . . . . . . . . . . . 80.38 16.66 75.57 Favored Glycine 0 C--N 1.338 0.683 0 C-N-CA 121.186 -0.53 . . . . 1.96 111.93 179.471 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A 1525 ' ' HIS . . . . . . . . . . . . . 21.1 t-160 -102.06 134.71 44.86 Favored 'General case' 0 C--N 1.305 -1.343 0 N-CA-C 109.425 -0.583 . . . . 2.44 109.425 -178.795 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A 1526 ' ' LEU . . . . . 0.452 HD21 ' HB2' ' A' 1517 ' ' GLN . 6.7 tt -102.73 138.11 40.06 Favored 'General case' 0 C--N 1.305 -1.357 0 N-CA-C 107.838 -1.171 . . . . 2.19 107.838 178.651 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A 1527 ' ' PHE . . . . . 0.539 ' CE2' ' HA ' ' A' 1646 ' ' CYS . 57.9 m-85 -114.03 111.96 22.5 Favored 'General case' 0 C--N 1.299 -1.594 0 N-CA-C 107.71 -1.218 . . . . 1.61 107.71 177.489 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A 1528 ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -102.06 139.0 38.27 Favored 'General case' 0 CA--C 1.471 -2.077 0 N-CA-C 108.514 -0.921 . . . . 2.18 108.514 178.999 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A 1529 ' ' LEU . . . . . 0.561 ' HB2' ' HB3' ' A' 1516 ' ' CYS . 43.3 mt -111.73 2.82 17.38 Favored 'General case' 0 C--N 1.292 -1.908 0 N-CA-C 107.756 -1.201 . . . . 2.04 107.756 176.871 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A 1530 ' ' SER . . . . . . . . . . . . . 8.4 m -65.81 -45.02 83.87 Favored 'General case' 0 N--CA 1.441 -0.893 0 CA-C-N 114.895 -1.048 . . . . 1.44 110.538 -177.708 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A 1531 ' ' SER . . . . . . . . . . . . . 37.6 m -77.12 -12.54 59.96 Favored 'General case' 0 C--O 1.24 0.565 0 CA-C-O 121.304 0.573 . . . . 1.63 110.296 177.533 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A 1532 ' ' LEU . . . . . 0.529 HD12 ' HA ' ' A' 1529 ' ' LEU . 8.5 mp -80.22 -31.28 38.62 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 116.033 -0.53 . . . . 2.32 112.362 -179.493 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A 1533 ' ' SER . . . . . 0.606 ' HB2' HG22 ' A' 1552 ' ' ILE . 19.2 t -85.7 173.28 10.22 Favored 'General case' 0 C--N 1.306 -1.32 0 CA-C-O 120.914 0.388 . . . . 2.57 110.304 -178.439 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A 1534 ' ' GLY . . . . . . . . . . . . . . . -153.99 167.1 32.17 Favored Glycine 0 N--CA 1.429 -1.821 0 N-CA-C 109.549 -1.42 . . . . 1.89 109.549 -179.256 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A 1535 ' ' ARG . . . . . 0.494 ' CG ' ' HG3' ' A' 1557 ' ' GLU . 13.4 ttp180 -69.29 -47.75 63.66 Favored 'General case' 0 C--N 1.318 -0.789 0 CA-C-O 121.016 0.436 . . . . 4.44 111.132 -177.274 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A 1536 ' ' ALA . . . . . . . . . . . . . . . -77.45 -29.67 52.92 Favored 'General case' 0 C--O 1.245 0.823 0 CA-C-O 121.262 0.554 . . . . 2.07 110.361 -179.409 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A 1537 ' ' GLY . . . . . . . . . . . . . . . 86.3 -164.58 36.71 Favored Glycine 0 N--CA 1.427 -1.962 0 CA-C-N 115.296 -0.865 . . . . 1.2 112.377 175.574 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A 1538 ' ' PHE . . . . . 0.449 ' CD1' HD11 ' A' 1552 ' ' ILE . 84.2 m-85 -106.6 156.63 18.4 Favored 'General case' 0 C--N 1.293 -1.877 0 N-CA-C 108.081 -1.081 . . . . 1.98 108.081 179.439 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A 1539 ' ' THR . . . . . . . . . . . . . 18.8 m -116.13 111.57 20.45 Favored 'General case' 0 C--N 1.291 -1.946 0 CA-C-O 121.51 0.671 . . . . 1.97 109.82 -176.879 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A 1540 ' ' ALA . . . . . . . . . . . . . . . -93.87 151.61 19.46 Favored 'General case' 0 C--N 1.3 -1.583 0 N-CA-C 109.314 -0.624 . . . . 1.39 109.314 -179.743 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A 1541 ' ' ALA . . . . . . . . . . . . . . . -88.02 132.61 34.21 Favored 'General case' 0 C--N 1.305 -1.361 0 N-CA-C 109.45 -0.574 . . . . 1.86 109.45 -179.065 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A 1542 ' ' TYR . . . . . 0.506 ' HD2' ' HB2' ' A' 1545 ' ' SER . 72.5 t80 -139.96 164.51 29.8 Favored 'General case' 0 N--CA 1.437 -1.094 0 C-N-CA 120.628 -0.429 . . . . 2.4 111.143 -177.426 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A 1543 ' ' SER . . . . . . . . . . . . . 5.6 m -47.47 -151.14 0.0 OUTLIER 'General case' 0 CA--C 1.573 1.833 0 C-N-CA 129.106 2.962 . . . . 2.58 113.619 175.154 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A 1544 ' ' LYS . . . . . . . . . . . . . 18.5 ptpt -39.69 -26.42 0.03 OUTLIER 'General case' 0 CA--C 1.574 1.882 0 N-CA-C 115.004 1.483 . . . . 4.24 115.004 178.604 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A 1545 ' ' SER . . . . . 0.506 ' HB2' ' HD2' ' A' 1542 ' ' TYR . 8.4 m -79.12 -8.09 58.7 Favored 'General case' 0 CA--C 1.566 1.591 0 O-C-N 121.501 -0.749 . . . . 3.6 111.775 178.717 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A 1546 ' ' GLY . . . . . . . . . . . . . . . 86.09 -80.35 1.79 Allowed Glycine 0 C--N 1.339 0.706 0 C-N-CA 121.488 -0.387 . . . . 1.66 113.991 174.108 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A 1547 ' ' VAL . . . . . . . . . . . . . 8.2 m -141.53 157.96 21.59 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.694 0 C-N-CA 122.99 0.516 . . . . 2.23 110.031 -176.987 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A 1548 ' ' VAL . . . . . 0.429 HG11 ' HD1' ' A' 1567 ' ' PHE . 1.3 t -122.79 137.69 55.43 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.37 0 N-CA-C 107.895 -1.15 . . . . 1.59 107.895 -178.922 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A 1549 ' ' TYR . . . . . . . . . . . . . 71.3 m-85 -96.02 118.64 33.02 Favored 'General case' 0 C--N 1.306 -1.298 0 N-CA-C 108.771 -0.826 . . . . 1.58 108.771 175.263 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A 1550 ' ' MET . . . . . . . . . . . . . 74.0 mmm -118.55 121.74 40.97 Favored 'General case' 0 C--N 1.3 -1.549 0 CA-C-N 115.286 -0.87 . . . . 2.08 109.8 -173.412 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A 1551 ' ' SER . . . . . . . . . . . . . 75.5 m -106.58 114.63 28.85 Favored 'General case' 0 C--N 1.296 -1.759 0 N-CA-C 108.672 -0.862 . . . . 1.9 108.672 174.127 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A 1552 ' ' ILE . . . . . 0.606 HG22 ' HB2' ' A' 1533 ' ' SER . 1.5 mp -57.46 -34.02 45.63 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.873 0 CA-C-N 114.957 -1.02 . . . . 2.04 113.261 -176.576 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A 1553 ' ' CYS . . . . . 0.548 ' HB3' ' HE3' ' A' 1579 ' ' LYS . 73.6 m -140.68 137.98 33.94 Favored 'General case' 0 C--N 1.304 -1.396 0 N-CA-C 108.978 -0.749 . . . . 1.43 108.978 174.977 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A 1554 ' ' GLY . . . . . . . . . . . . . . . 94.89 -125.52 8.37 Favored Glycine 0 N--CA 1.433 -1.547 0 C-N-CA 120.937 -0.649 . . . . 1.23 114.043 172.252 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A 1555 ' ' GLU . . . . . . . . . . . . . 7.5 pt-20 -138.45 150.74 46.77 Favored 'General case' 0 C--N 1.31 -1.12 0 C-N-CA 123.432 0.693 . . . . 1.8 111.175 -175.464 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A 1556 ' ' ASN . . . . . . . . . . . . . 17.5 t-20 -101.23 138.96 37.57 Favored 'General case' 0 N--CA 1.433 -1.301 0 CA-C-N 115.503 -0.771 . . . . 2.63 108.944 -177.194 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A 1557 ' ' GLU . . . . . 0.494 ' HG3' ' CG ' ' A' 1535 ' ' ARG . 54.7 mm-40 -99.77 -0.42 39.96 Favored 'General case' 0 C--N 1.298 -1.645 0 N-CA-C 113.088 0.773 . . . . 3.79 113.088 -172.528 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A 1558 ' ' ASN . . . . . . . . . . . . . 33.5 m-80 -87.66 -1.82 58.2 Favored 'General case' 0 N--CA 1.483 1.187 0 CA-C-O 122.09 0.948 . . . . 1.59 110.144 -176.812 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A 1559 ' ' CYS . . . . . 0.778 ' HB3' ' HD2' ' A' 1560 ' ' PRO . 94.0 m -142.21 -175.95 0.52 Allowed Pre-proline 0 C--N 1.288 -2.066 0 N-CA-C 104.821 -2.289 . . . . 0.94 104.821 177.27 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A 1560 ' ' PRO . . . . . 0.778 ' HD2' ' HB3' ' A' 1559 ' ' CYS . 1.0 OUTLIER -45.72 124.16 6.64 Favored 'Trans proline' 0 C--N 1.364 1.374 0 C-N-CA 122.556 2.171 . . . . 1.53 112.882 175.677 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A 1561 ' ' PRO . . . . . . . . . . . . . 33.5 Cg_exo -62.66 103.33 0.32 Allowed 'Trans proline' 0 C--O 1.242 0.688 0 C-N-CA 122.913 2.408 . . . . 1.82 110.688 179.053 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A 1562 ' ' GLY . . . . . . . . . . . . . . . 146.85 -9.46 1.35 Allowed Glycine 0 N--CA 1.423 -2.197 0 CA-C-N 115.103 -0.953 . . . . 0.81 110.805 -177.206 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A 1563 ' ' VAL . . . . . . . . . . . . . 3.6 m -98.29 150.82 4.67 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.345 0 N-CA-C 106.646 -1.613 . . . . 1.73 106.646 174.174 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A 1564 ' ' GLY . . . . . . . . . . . . . . . -103.21 -21.75 9.77 Favored Glycine 0 C--N 1.306 -1.089 0 C-N-CA 120.179 -1.01 . . . . 0.72 112.286 -176.483 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A 1565 ' ' ALA . . . . . . . . . . . . . . . -148.34 132.38 17.23 Favored 'General case' 0 C--N 1.31 -1.113 0 N-CA-C 109.063 -0.717 . . . . 1.14 109.063 -179.283 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A 1566 ' ' CYS . . . . . . . . . . . . . 35.9 t -153.5 138.95 17.66 Favored 'General case' 0 C--N 1.309 -1.158 0 CA-C-N 116.69 -0.232 . . . . 0.51 110.818 -173.821 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A 1567 ' ' PHE . . . . . 0.429 ' HD1' HG11 ' A' 1548 ' ' VAL . 21.0 m-85 -68.73 123.34 20.65 Favored 'General case' 0 CA--C 1.514 -0.436 0 N-CA-C 108.2 -1.037 . . . . 1.22 108.2 175.489 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A 1568 ' ' GLY . . . . . . . . . . . . . . . -55.06 -64.36 4.43 Favored Glycine 0 C--N 1.31 -0.908 0 N-CA-C 116.861 1.505 . . . . 1.08 116.861 -167.76 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A 1569 ' ' GLN . . . . . . . . . . . . . 13.7 pt20 -85.15 -23.58 28.33 Favored 'General case' 0 C--N 1.312 -1.064 0 N-CA-C 113.208 0.818 . . . . 3.05 113.208 -172.057 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A 1570 ' ' THR . . . . . . . . . . . . . 19.7 p -88.32 -17.56 30.37 Favored 'General case' 0 C--N 1.308 -1.222 0 CA-C-O 121.719 0.771 . . . . 2.44 111.191 -179.625 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A 1571 ' ' ARG . . . . . . . . . . . . . 67.9 mtm180 59.12 47.75 11.45 Favored 'General case' 0 CA--C 1.508 -0.67 0 C-N-CA 125.817 1.647 . . . . 4.48 112.253 175.272 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A 1572 ' ' ILE . . . . . . . . . . . . . 32.7 mm -112.0 120.28 61.98 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.26 0 N-CA-C 108.062 -1.088 . . . . 1.94 108.062 179.434 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A 1573 ' ' SER . . . . . 0.491 ' HG ' ' HB2' ' A' 1596 ' ' SER . 60.4 p -73.63 127.45 32.8 Favored 'General case' 0 C--N 1.309 -1.195 0 CA-C-N 115.857 -0.611 . . . . 1.25 111.092 -177.06 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A 1574 ' ' VAL . . . . . 0.449 ' HA ' ' HB2' ' A' 1606 ' ' TYR . 23.5 m -118.22 15.05 7.19 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.307 0 CA-C-O 121.936 0.874 . . . . 1.61 110.782 -179.339 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A 1575 ' ' GLY . . . . . . . . . . . . . . . -179.29 125.28 0.96 Allowed Glycine 0 N--CA 1.429 -1.775 0 CA-C-N 114.466 -1.243 . . . . 0.65 110.54 176.531 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A 1576 ' ' LYS . . . . . . . . . . . . . 55.2 tptt -85.68 156.4 20.68 Favored 'General case' 0 C--N 1.313 -0.981 0 N-CA-C 106.423 -1.695 . . . . 3.33 106.423 177.955 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A 1577 ' ' ALA . . . . . . . . . . . . . . . -55.88 115.28 2.29 Favored 'General case' 0 N--CA 1.468 0.465 0 CA-C-O 121.447 0.641 . . . . 1.31 110.586 179.738 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A 1578 ' ' ASN . . . . . . . . . . . . . 1.1 m-80 -125.11 169.72 11.91 Favored 'General case' 0 C--N 1.283 -2.285 0 N-CA-C 106.061 -1.829 . . . . 2.24 106.061 178.265 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A 1579 ' ' LYS . . . . . 0.548 ' HE3' ' HB3' ' A' 1553 ' ' CYS . 17.9 tptm -163.87 89.99 0.59 Allowed 'General case' 0 C--N 1.306 -1.283 0 C-N-CA 119.88 -0.728 . . . . 2.34 109.418 -176.956 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A 1580 ' ' ARG . . . . . . . . . . . . . 52.0 ttp180 -149.43 106.83 3.62 Favored 'General case' 0 C--N 1.297 -1.691 0 N-CA-C 108.811 -0.811 . . . . 4.19 108.811 -178.881 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A 1581 ' ' LEU . . . . . 0.712 HD23 ' HA ' ' A' 1516 ' ' CYS . 0.8 OUTLIER -73.17 133.26 44.0 Favored 'General case' 0 C--N 1.311 -1.098 0 N-CA-C 107.714 -1.217 . . . . 2.39 107.714 -179.494 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A 1582 ' ' ARG . . . . . . . . . . . . . 61.5 ttt180 -132.14 108.32 9.2 Favored 'General case' 0 C--N 1.303 -1.417 0 N-CA-C 109.876 -0.416 . . . . 4.48 109.876 178.634 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A 1583 ' ' TYR . . . . . 0.48 ' HD1' HD21 ' A' 1588 ' ' LEU . 49.2 t80 -101.33 92.95 5.17 Favored 'General case' 0 C--N 1.307 -1.24 0 N-CA-C 108.896 -0.779 . . . . 1.57 108.896 177.676 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A 1584 ' ' VAL . . . . . . . . . . . . . 15.4 m -123.7 111.12 27.86 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.77 0 N-CA-C 113.14 0.793 . . . . 2.29 113.14 -176.113 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A 1585 ' ' ASP . . . . . . . . . . . . . 36.5 t70 56.33 53.62 8.59 Favored 'General case' 0 N--CA 1.478 0.973 0 CA-C-O 122.463 1.125 . . . . 2.06 111.194 176.041 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A 1586 ' ' GLN . . . . . . . . . . . . . 18.4 mp0 64.63 -1.63 0.76 Allowed 'General case' 0 C--N 1.324 -0.512 0 C-N-CA 125.743 1.617 . . . . 2.61 115.088 178.734 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A 1587 ' ' VAL . . . . . . . . . . . . . 12.7 p -107.84 120.94 60.07 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.887 0 CA-C-O 121.973 0.892 . . . . 1.33 109.459 175.978 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A 1588 ' ' LEU . . . . . 0.807 ' HB2' ' HB2' ' A' 1612 ' ' PHE . 2.5 mm? -79.2 137.99 37.65 Favored 'General case' 0 C--N 1.29 -1.983 0 CA-C-N 114.339 -1.3 . . . . 2.03 108.357 179.053 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A 1589 ' ' GLN . . . . . 0.409 ' HA ' ' O ' ' A' 1610 ' ' ILE . 6.0 tt0 -140.43 141.08 35.52 Favored 'General case' 0 C--N 1.286 -2.175 0 CA-C-O 120.75 0.309 . . . . 1.73 111.254 -178.017 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A 1590 ' ' LEU . . . . . . . . . . . . . 7.0 tt -142.48 124.59 15.37 Favored 'General case' 0 C--N 1.305 -1.359 0 N-CA-C 105.957 -1.868 . . . . 1.76 105.957 175.633 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A 1591 ' ' VAL . . . . . . . . . . . . . 46.4 t -112.48 129.7 67.56 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.067 0 O-C-N 122.381 -0.199 . . . . 2.14 111.508 -175.379 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A 1592 ' ' TYR . . . . . . . . . . . . . 79.4 m-85 -105.3 106.67 17.28 Favored 'General case' 0 C--N 1.313 -0.992 0 N-CA-C 108.8 -0.815 . . . . 1.53 108.8 174.647 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A 1593 ' ' LYS . . . . . . . . . . . . . 8.1 ptpp? -108.67 -178.99 3.74 Favored 'General case' 0 C--N 1.311 -1.066 0 C-N-CA 120.31 -0.556 . . . . 2.72 112.119 -179.067 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A 1594 ' ' ASP . . . . . . . . . . . . . 5.0 m-20 54.13 44.88 28.54 Favored 'General case' 0 N--CA 1.487 1.376 0 C-N-CA 124.798 1.239 . . . . 1.45 113.831 177.67 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A 1595 ' ' GLY . . . . . . . . . . . . . . . -73.2 -90.54 0.13 Allowed Glycine 0 N--CA 1.445 -0.72 0 C-N-CA 120.45 -0.881 . . . . 0.83 111.522 177.176 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A 1596 ' ' SER . . . . . 0.491 ' HB2' ' HG ' ' A' 1573 ' ' SER . 33.7 t -114.49 149.46 42.23 Favored Pre-proline 0 C--N 1.297 -1.691 0 N-CA-C 107.101 -1.444 . . . . 1.96 107.101 176.977 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A 1597 ' ' PRO . . . . . . . . . . . . . 33.7 Cg_exo -64.95 133.55 36.39 Favored 'Trans proline' 0 C--N 1.347 0.493 0 C-N-CA 123.074 2.516 . . . . 1.34 110.911 176.999 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A 1598 ' ' CYS . . . . . 0.434 ' HA ' ' HD3' ' A' 1599 ' ' PRO . 37.6 t -95.65 126.89 43.62 Favored Pre-proline 0 C--N 1.3 -1.553 0 N-CA-C 108.12 -1.067 . . . . 1.19 108.12 -179.13 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A 1599 ' ' PRO . . . . . 0.434 ' HD3' ' HA ' ' A' 1598 ' ' CYS . 25.6 Cg_exo -65.61 -25.52 54.59 Favored 'Trans proline' 0 C--N 1.353 0.784 0 C-N-CA 123.472 2.781 . . . . 1.88 112.113 -178.476 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A 1600 ' ' SER . . . . . . . . . . . . . 23.0 m -86.17 123.51 31.53 Favored 'General case' 0 N--CA 1.421 -1.883 0 N-CA-C 108.367 -0.975 . . . . 2.19 108.367 177.338 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A 1601 ' ' LYS . . . . . 0.823 ' HB3' HD11 ' A' 1604 ' ' LEU . 4.3 tmtm? 68.49 81.58 0.18 Allowed 'General case' 0 C--O 1.239 0.523 0 N-CA-C 107.747 -1.205 . . . . 4.21 107.747 -179.678 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A 1602 ' ' SER . . . . . . . . . . . . . 20.9 m -50.82 111.45 0.55 Allowed 'General case' 0 N--CA 1.441 -0.915 0 CA-C-N 114.025 -1.443 . . . . 3.82 112.651 -176.695 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A 1603 ' ' GLY . . . . . . . . . . . . . . . 128.78 -19.04 5.59 Favored Glycine 0 N--CA 1.433 -1.524 0 CA-C-N 114.747 -1.115 . . . . 2.45 110.315 -177.929 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A 1604 ' ' LEU . . . . . 0.823 HD11 ' HB3' ' A' 1601 ' ' LYS . 12.6 mt -74.91 159.35 31.95 Favored 'General case' 0 CA--C 1.506 -0.732 0 CA-C-O 122.69 1.233 . . . . 2.06 114.291 -179.99 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A 1605 ' ' SER . . . . . . . . . . . . . 16.6 m -137.19 175.8 9.29 Favored 'General case' 0 C--N 1.288 -2.077 0 N-CA-C 104.897 -2.26 . . . . 1.75 104.897 177.217 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A 1606 ' ' TYR . . . . . 0.449 ' HB2' ' HA ' ' A' 1574 ' ' VAL . 56.9 m-85 -102.54 134.58 45.64 Favored 'General case' 0 CA--C 1.462 -2.406 0 N-CA-C 105.249 -2.13 . . . . 1.59 105.249 -179.292 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A 1607 ' ' LYS . . . . . 0.47 ' HG3' HG21 ' A' 1635 ' ' THR . 26.6 pttm -131.18 142.79 50.25 Favored 'General case' 0 N--CA 1.401 -2.889 0 C-N-CA 119.338 -0.945 . . . . 2.21 108.9 177.8 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A 1608 ' ' SER . . . . . . . . . . . . . 44.3 m -114.59 118.76 34.62 Favored 'General case' 0 C--N 1.295 -1.796 0 CA-C-O 120.666 0.27 . . . . 1.48 110.96 -178.849 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A 1609 ' ' VAL . . . . . . . . . . . . . 69.3 t -94.62 115.6 33.85 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.76 0 N-CA-C 108.782 -0.822 . . . . 1.57 108.782 176.851 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A 1610 ' ' ILE . . . . . 0.409 ' O ' ' HA ' ' A' 1589 ' ' GLN . 17.6 mm -98.66 112.19 30.15 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.191 0 N-CA-C 108.77 -0.826 . . . . 1.47 108.77 179.189 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A 1611 ' ' SER . . . . . 0.487 ' O ' ' HA ' ' A' 1639 ' ' SER . 36.5 m -101.05 128.62 47.01 Favored 'General case' 0 C--N 1.304 -1.375 0 N-CA-C 109.518 -0.549 . . . . 1.84 109.518 177.005 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A 1612 ' ' PHE . . . . . 0.807 ' HB2' ' HB2' ' A' 1588 ' ' LEU . 97.9 m-85 -100.88 115.37 30.24 Favored 'General case' 0 C--N 1.292 -1.894 0 CA-C-O 121.003 0.43 . . . . 0.86 110.494 -179.429 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A 1613 ' ' VAL . . . . . . . . . . . . . 58.9 t -100.01 111.54 29.95 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.161 0 N-CA-C 108.486 -0.931 . . . . 1.32 108.486 -178.613 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A 1614 ' ' CYS . . . . . 0.486 ' HA ' ' O ' ' A' 1642 ' ' THR . 3.0 p -85.57 94.22 8.99 Favored 'General case' 0 C--N 1.301 -1.535 0 CA-C-O 121.715 0.769 . . . . 1.39 112.999 -178.605 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A 1615 ' ' ARG . . . . . 0.516 ' HD3' ' HD2' ' A' 1616 ' ' PRO . 19.7 tpp180 -138.2 113.48 8.89 Favored Pre-proline 0 N--CA 1.428 -1.539 0 CA-C-N 115.37 -0.832 . . . . 4.34 109.93 177.318 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A 1616 ' ' PRO . . . . . 0.516 ' HD2' ' HD3' ' A' 1615 ' ' ARG . 57.8 Cg_endo -71.34 53.69 1.72 Allowed 'Trans proline' 0 CA--C 1.548 1.223 0 C-N-CA 123.414 2.742 . . . . 1.5 112.495 176.488 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A 1617 ' ' GLU . . . . . . . . . . . . . 30.6 tt0 . . . . . 0 C--N 1.306 -1.312 0 N-CA-C 106.29 -1.744 . . . . 3.21 106.29 176.624 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A 1622 ' ' ASN . . . . . . . . . . . . . 28.1 t-20 . . . . . 0 C--O 1.242 0.665 0 N-CA-C 107.872 -1.158 . . . . 3.58 107.872 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A 1623 ' ' ARG . . . . . . . . . . . . . 5.7 ptm180 -121.82 146.69 46.56 Favored Pre-proline 0 C--N 1.281 -2.385 0 N-CA-C 109.083 -0.71 . . . . 4.09 109.083 -177.228 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A 1624 ' ' PRO . . . . . . . . . . . . . 11.0 Cg_endo -55.25 117.52 4.12 Favored 'Trans proline' 0 C--N 1.348 0.551 0 C-N-CA 123.192 2.595 . . . . 2.86 111.621 178.536 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A 1625 ' ' MET . . . . . . . . . . . . . 26.5 ptm -96.79 143.16 27.98 Favored 'General case' 0 C--N 1.296 -1.748 0 CA-C-N 115.49 -0.777 . . . . 2.73 109.603 -178.573 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A 1626 ' ' LEU . . . . . . . . . . . . . 38.5 tp -80.48 123.07 27.76 Favored 'General case' 0 C--N 1.303 -1.425 0 N-CA-C 107.396 -1.335 . . . . 1.94 107.396 176.192 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A 1627 ' ' ILE . . . . . . . . . . . . . 41.4 pt -100.98 -32.43 3.42 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.548 0 C-N-CA 120.252 -0.579 . . . . 1.75 111.116 -179.907 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A 1628 ' ' SER . . . . . . . . . . . . . 20.4 m -152.64 148.71 27.63 Favored 'General case' 0 C--N 1.318 -0.802 0 N-CA-C 109.696 -0.483 . . . . 1.85 109.696 -178.099 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A 1629 ' ' LEU . . . . . . . . . . . . . 25.8 tp -136.1 99.65 4.19 Favored 'General case' 0 C--N 1.304 -1.407 0 N-CA-C 109.132 -0.692 . . . . 2.12 109.132 178.581 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A 1630 ' ' ASP . . . . . . . . . . . . . 11.8 t70 -90.95 107.85 19.47 Favored 'General case' 0 C--N 1.305 -1.331 0 N-CA-C 108.628 -0.879 . . . . 0.87 108.628 -178.1 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A 1631 ' ' LYS . . . . . . . . . . . . . 68.2 mttm -81.44 -15.15 55.96 Favored 'General case' 0 C--N 1.304 -1.381 0 N-CA-C 112.386 0.513 . . . . 2.76 112.386 -175.448 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A 1632 ' ' GLN . . . . . . . . . . . . . 1.5 mp0 -84.98 -40.74 16.57 Favored 'General case' 0 C--N 1.313 -1.005 0 CA-C-O 120.937 0.399 . . . . 2.55 110.58 -178.771 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A 1633 ' ' THR . . . . . . . . . . . . . 2.7 m -95.95 -4.15 43.88 Favored 'General case' 0 C--N 1.301 -1.511 0 CA-C-O 121.55 0.691 . . . . 1.92 110.278 -178.873 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A 1634 ' ' CYS . . . . . . . . . . . . . 56.6 m 59.47 41.41 19.35 Favored 'General case' 0 C--N 1.35 0.59 0 C-N-CA 124.105 0.962 . . . . 0.89 110.081 176.923 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A 1635 ' ' THR . . . . . 0.47 HG21 ' HG3' ' A' 1607 ' ' LYS . 33.4 m -112.83 132.61 55.2 Favored 'General case' 0 N--CA 1.431 -1.408 0 CA-C-N 115.179 -0.919 . . . . 1.31 111.467 -174.223 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A 1636 ' ' LEU . . . . . 0.405 ' HB3' ' CE2' ' A' 1638 ' ' PHE . 2.4 mm? -100.95 127.71 47.32 Favored 'General case' 0 C--N 1.316 -0.877 0 N-CA-C 108.561 -0.904 . . . . 1.97 108.561 -179.489 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A 1637 ' ' PHE . . . . . . . . . . . . . 97.6 m-85 -115.94 111.28 20.17 Favored 'General case' 0 C--N 1.305 -1.34 0 N-CA-C 109.931 -0.396 . . . . 0.92 109.931 179.38 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A 1638 ' ' PHE . . . . . 0.405 ' CE2' ' HB3' ' A' 1636 ' ' LEU . 87.8 m-85 -118.81 154.42 32.89 Favored 'General case' 0 C--N 1.309 -1.16 0 CA-C-O 121.191 0.52 . . . . 0.7 110.703 -179.094 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A 1639 ' ' SER . . . . . 0.487 ' HA ' ' O ' ' A' 1611 ' ' SER . 46.8 m -141.51 136.91 31.66 Favored 'General case' 0 C--N 1.294 -1.841 0 CA-C-N 116.171 -0.468 . . . . 1.46 110.46 176.827 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A 1640 ' ' TRP . . . . . . . . . . . . . 22.0 t90 -113.32 132.27 55.63 Favored 'General case' 0 C--N 1.298 -1.635 0 N-CA-C 107.924 -1.139 . . . . 0.92 107.924 178.066 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A 1641 ' ' HIS . . . . . . . . . . . . . 11.8 m170 -96.93 110.28 22.84 Favored 'General case' 0 CA--C 1.493 -1.22 0 N-CA-C 107.129 -1.434 . . . . 3.18 107.129 179.424 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A 1642 ' ' THR . . . . . 0.554 HG21 ' HB3' ' A' 1645 ' ' ALA . 2.9 t -142.92 137.95 15.46 Favored Pre-proline 0 C--N 1.283 -2.309 0 CA-C-N 115.989 -0.551 . . . . 1.48 111.69 -170.604 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A 1643 ' ' PRO . . . . . . . . . . . . . 95.8 Cg_endo -83.31 -0.39 9.86 Favored 'Trans proline' 0 CA--C 1.535 0.527 0 C-N-CA 123.35 2.7 . . . . 1.09 111.655 178.455 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A 1644 ' ' LEU . . . . . . . . . . . . . 47.4 mt -98.33 1.64 47.24 Favored 'General case' 0 C--N 1.315 -0.894 0 CA-C-N 115.765 -0.652 . . . . 2.08 110.9 179.624 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A 1645 ' ' ALA . . . . . 0.554 ' HB3' HG21 ' A' 1642 ' ' THR . . . -91.8 -18.18 24.24 Favored 'General case' 0 C--N 1.301 -1.537 0 CA-C-N 115.756 -0.656 . . . . 1.37 111.612 -176.274 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A 1646 ' ' CYS . . . . . 0.539 ' HA ' ' CE2' ' A' 1527 ' ' PHE . 72.0 m -154.25 174.26 15.03 Favored 'General case' 0 C--N 1.313 -0.991 0 N-CA-C 105.267 -2.123 . . . . 1.7 105.267 175.452 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A 1647 ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--N 1.298 -1.658 0 N-CA-C 109.526 -0.546 . . . . 2.92 109.526 175.819 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A 1515 ' ' ASP . . . . . 0.435 ' HB2' ' NE2' ' A' 1517 ' ' GLN . 8.8 m-20 . . . . . 0 CA--C 1.494 -1.175 0 N-CA-C 108.447 -0.945 . . . . 2.54 108.447 . . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A 1516 ' ' CYS . . . . . 0.506 ' HB3' ' HB2' ' A' 1529 ' ' LEU . 74.4 m -79.01 60.34 2.9 Favored 'General case' 0 C--N 1.306 -1.299 0 CA-C-O 120.981 0.42 . . . . 1.25 112.069 -176.895 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A 1517 ' ' GLN . . . . . 0.461 ' HB2' HD21 ' A' 1526 ' ' LEU . 0.4 OUTLIER -157.29 122.6 4.58 Favored 'General case' 0 N--CA 1.437 -1.105 0 CA-C-O 121.618 0.723 . . . . 2.36 111.885 177.754 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A 1518 ' ' VAL . . . . . . . . . . . . . 10.6 p -129.6 142.32 44.22 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.683 0 CA-C-N 115.454 -0.794 . . . . 2.34 109.657 -177.736 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A 1519 ' ' THR . . . . . 0.571 ' HA ' ' HA ' ' A' 1526 ' ' LEU . 12.7 m -100.74 135.94 41.39 Favored 'General case' 0 C--N 1.3 -1.549 0 CA-C-O 120.67 0.271 . . . . 2.04 110.83 -178.025 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A 1520 ' ' ASN . . . . . 0.469 ' OD1' HG21 ' A' 1523 ' ' THR . 17.1 t-20 -86.61 113.8 54.67 Favored Pre-proline 0 C--N 1.308 -1.226 0 N-CA-C 106.915 -1.513 . . . . 2.12 106.915 171.399 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A 1521 ' ' PRO . . . . . . . . . . . . . 51.9 Cg_endo -67.88 -21.52 43.91 Favored 'Trans proline' 0 C--O 1.234 0.276 0 C-N-CA 122.232 1.955 . . . . 2.59 113.512 -174.164 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A 1522 ' ' SER . . . . . . . . . . . . . 13.1 m -68.48 -54.88 14.01 Favored 'General case' 0 N--CA 1.438 -1.047 0 C-N-CA 122.265 0.226 . . . . 2.65 111.02 -178.715 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A 1523 ' ' THR . . . . . 0.514 HG22 ' HB2' ' A' 1647 ' ' GLU . 15.0 t -94.94 -15.74 23.36 Favored 'General case' 0 CA--C 1.554 1.11 0 CA-C-O 121.097 0.475 . . . . 2.33 111.483 -177.949 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A 1524 ' ' GLY . . . . . . . . . . . . . . . 81.17 17.38 72.01 Favored Glycine 0 C--N 1.334 0.434 0 C-N-CA 121.139 -0.553 . . . . 1.96 112.984 178.89 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A 1525 ' ' HIS . . . . . . . . . . . . . 18.4 t60 -101.25 137.48 39.54 Favored 'General case' 0 C--N 1.313 -0.982 0 N-CA-C 109.556 -0.535 . . . . 2.44 109.556 -177.279 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A 1526 ' ' LEU . . . . . 0.571 ' HA ' ' HA ' ' A' 1519 ' ' THR . 6.1 tt -99.94 132.39 45.32 Favored 'General case' 0 C--N 1.3 -1.548 0 N-CA-C 109.36 -0.608 . . . . 2.19 109.36 178.712 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A 1527 ' ' PHE . . . . . 0.408 ' O ' ' HA ' ' A' 1517 ' ' GLN . 28.4 m-85 -99.84 104.87 16.57 Favored 'General case' 0 C--N 1.299 -1.611 0 N-CA-C 108.781 -0.822 . . . . 1.61 108.781 -178.952 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A 1528 ' ' ASP . . . . . . . . . . . . . 35.6 t70 -95.01 124.66 39.18 Favored 'General case' 0 CA--C 1.495 -1.165 0 CA-C-O 121.473 0.654 . . . . 2.18 111.753 -179.749 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A 1529 ' ' LEU . . . . . 0.506 ' HB2' ' HB3' ' A' 1516 ' ' CYS . 80.1 mt -109.76 -3.0 17.02 Favored 'General case' 0 C--N 1.296 -1.735 0 CA-C-N 114.285 -1.325 . . . . 2.04 109.076 178.863 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A 1530 ' ' SER . . . . . . . . . . . . . 4.5 m -70.33 -38.8 74.95 Favored 'General case' 0 C--O 1.223 -0.315 0 CA-C-N 115.749 -0.66 . . . . 1.44 109.597 -179.306 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A 1531 ' ' SER . . . . . . . . . . . . . 24.2 m -63.81 -26.26 68.55 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 121.665 0.745 . . . . 1.63 109.878 177.113 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A 1532 ' ' LEU . . . . . 0.549 HD11 ' CZ3' ' A' 1640 ' ' TRP . 66.2 mt -83.51 -4.4 58.49 Favored 'General case' 0 C--N 1.317 -0.838 0 CA-C-N 115.254 -0.884 . . . . 2.32 111.506 -178.687 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A 1533 ' ' SER . . . . . 0.508 ' OG ' ' HB2' ' A' 1553 ' ' CYS . 10.2 m -87.28 151.89 22.75 Favored 'General case' 0 C--O 1.249 1.049 0 N-CA-C 108.419 -0.956 . . . . 2.57 108.419 179.115 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A 1534 ' ' GLY . . . . . . . . . . . . . . . -171.18 -160.13 18.96 Favored Glycine 0 N--CA 1.435 -1.431 0 C-N-CA 119.532 -1.318 . . . . 1.89 112.907 -179.666 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A 1535 ' ' ARG . . . . . 0.469 ' HG3' ' HB2' ' A' 1557 ' ' GLU . 38.3 ttm180 -75.53 -56.1 5.03 Favored 'General case' 0 C--N 1.307 -1.253 0 C-N-CA 123.989 0.916 . . . . 4.44 110.957 -179.132 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A 1536 ' ' ALA . . . . . . . . . . . . . . . -95.65 -29.68 14.18 Favored 'General case' 0 C--N 1.303 -1.452 0 CA-C-N 116.002 -0.545 . . . . 2.07 110.544 178.583 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A 1537 ' ' GLY . . . . . . . . . . . . . . . 85.02 -118.46 4.76 Favored Glycine 0 N--CA 1.431 -1.693 0 N-CA-C 110.343 -1.103 . . . . 1.2 110.343 -177.998 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A 1538 ' ' PHE . . . . . . . . . . . . . 69.1 m-85 -130.79 165.2 23.48 Favored 'General case' 0 C--N 1.308 -1.233 0 C-N-CA 123.085 0.554 . . . . 1.98 109.507 178.292 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A 1539 ' ' THR . . . . . . . . . . . . . 3.1 p -115.15 120.5 39.98 Favored 'General case' 0 C--N 1.311 -1.105 0 N-CA-C 113.16 0.8 . . . . 1.97 113.16 -174.76 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A 1540 ' ' ALA . . . . . . . . . . . . . . . -117.27 127.52 54.16 Favored 'General case' 0 C--N 1.312 -1.063 0 N-CA-C 108.251 -1.018 . . . . 1.39 108.251 173.886 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A 1541 ' ' ALA . . . . . . . . . . . . . . . -88.28 153.22 21.38 Favored 'General case' 0 C--N 1.31 -1.127 0 N-CA-C 110.03 -0.359 . . . . 1.86 110.03 -178.492 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A 1542 ' ' TYR . . . . . . . . . . . . . 52.9 t80 -157.42 175.31 14.15 Favored 'General case' 0 C--N 1.318 -0.79 0 N-CA-C 109.015 -0.735 . . . . 2.4 109.015 -178.416 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A 1543 ' ' SER . . . . . . . . . . . . . 14.1 m -46.62 -151.0 0.0 OUTLIER 'General case' 0 CA--C 1.57 1.725 0 C-N-CA 129.245 3.018 . . . . 2.58 114.306 177.572 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A 1544 ' ' LYS . . . . . . . . . . . . . 65.0 mttp -42.35 -23.06 0.03 OUTLIER 'General case' 0 CA--C 1.572 1.807 0 N-CA-C 115.47 1.656 . . . . 4.24 115.47 -178.574 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A 1545 ' ' SER . . . . . . . . . . . . . 32.4 m -71.62 -15.84 62.26 Favored 'General case' 0 CA--C 1.564 1.517 0 C-N-CA 123.295 0.638 . . . . 3.6 111.813 175.277 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A 1546 ' ' GLY . . . . . . . . . . . . . . . 84.04 -75.25 2.39 Favored Glycine 0 C--O 1.241 0.571 0 N-CA-C 114.298 0.479 . . . . 1.66 114.298 174.033 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A 1547 ' ' VAL . . . . . . . . . . . . . 11.7 p -156.32 148.01 11.62 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.853 0 N-CA-C 108.115 -1.069 . . . . 2.23 108.115 -175.872 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A 1548 ' ' VAL . . . . . . . . . . . . . 2.4 t -106.25 133.34 50.99 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.81 0 N-CA-C 108.327 -0.99 . . . . 1.59 108.327 -179.356 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A 1549 ' ' TYR . . . . . 0.539 ' HB3' HD22 ' A' 1556 ' ' ASN . 12.6 m-85 -100.39 117.32 34.32 Favored 'General case' 0 C--N 1.301 -1.524 0 N-CA-C 107.672 -1.233 . . . . 1.58 107.672 172.867 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A 1550 ' ' MET . . . . . . . . . . . . . 52.4 ttp -140.45 122.78 15.94 Favored 'General case' 0 C--N 1.292 -1.896 0 C-N-CA 120.515 -0.474 . . . . 2.08 111.021 -177.544 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A 1551 ' ' SER . . . . . . . . . . . . . 33.9 t -93.98 137.75 32.85 Favored 'General case' 0 N--CA 1.43 -1.472 0 N-CA-C 104.999 -2.223 . . . . 1.9 104.999 173.483 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A 1552 ' ' ILE . . . . . . . . . . . . . 47.5 mm -63.26 -33.29 60.21 Favored 'Isoleucine or valine' 0 C--O 1.207 -1.158 0 CA-C-N 115.325 -0.852 . . . . 2.04 110.639 -175.856 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A 1553 ' ' CYS . . . . . 0.508 ' HB2' ' OG ' ' A' 1533 ' ' SER . 79.6 m -144.77 141.19 29.02 Favored 'General case' 0 C--O 1.252 1.236 0 N-CA-C 108.363 -0.977 . . . . 1.43 108.363 172.553 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A 1554 ' ' GLY . . . . . . . . . . . . . . . 99.99 -157.93 19.62 Favored Glycine 0 N--CA 1.427 -1.926 0 C-N-CA 120.805 -0.712 . . . . 1.23 112.701 174.196 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A 1555 ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 -103.31 147.97 26.43 Favored 'General case' 0 C--N 1.302 -1.469 0 CA-C-O 121.407 0.622 . . . . 1.8 111.549 -178.007 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A 1556 ' ' ASN . . . . . 0.539 HD22 ' HB3' ' A' 1549 ' ' TYR . 25.5 t-20 -95.7 123.44 39.27 Favored 'General case' 0 C--N 1.293 -1.863 0 CA-C-N 115.029 -0.987 . . . . 2.63 108.553 179.636 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A 1557 ' ' GLU . . . . . 0.469 ' HB2' ' HG3' ' A' 1535 ' ' ARG . 5.4 mt-10 -91.87 39.57 1.02 Allowed 'General case' 0 C--N 1.303 -1.419 0 N-CA-C 112.09 0.404 . . . . 3.79 112.09 -173.746 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A 1558 ' ' ASN . . . . . . . . . . . . . 32.1 m-80 -125.89 -0.52 7.28 Favored 'General case' 0 C--N 1.311 -1.083 0 CA-C-O 121.971 0.891 . . . . 1.59 109.764 178.931 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A 1559 ' ' CYS . . . . . 0.817 ' HB3' ' HD2' ' A' 1560 ' ' PRO . 84.0 m -144.24 -175.83 0.5 Allowed Pre-proline 0 C--N 1.295 -1.802 0 N-CA-C 106.263 -1.754 . . . . 0.94 106.263 -179.664 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A 1560 ' ' PRO . . . . . 0.817 ' HD2' ' HB3' ' A' 1559 ' ' CYS . 4.5 Cg_exo -41.96 123.28 2.39 Favored 'Trans proline' 0 C--N 1.379 2.176 0 C-N-CA 122.702 2.268 . . . . 1.53 112.959 175.658 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A 1561 ' ' PRO . . . . . . . . . . . . . 31.6 Cg_exo -60.75 105.45 0.31 Allowed 'Trans proline' 0 C--O 1.244 0.805 0 C-N-CA 123.082 2.521 . . . . 1.82 110.793 -179.532 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A 1562 ' ' GLY . . . . . . . . . . . . . . . 141.68 -14.7 2.67 Favored Glycine 0 N--CA 1.431 -1.654 0 N-CA-C 111.25 -0.74 . . . . 0.81 111.25 -177.368 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A 1563 ' ' VAL . . . . . 0.547 ' HA ' ' HA ' ' A' 1576 ' ' LYS . 3.2 m -98.46 146.85 7.46 Favored 'Isoleucine or valine' 0 C--O 1.207 -1.181 0 N-CA-C 107.465 -1.309 . . . . 1.73 107.465 177.15 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A 1564 ' ' GLY . . . . . . . . . . . . . . . -105.67 -25.1 6.71 Favored Glycine 0 C--O 1.241 0.538 0 C-N-CA 120.611 -0.804 . . . . 0.72 113.539 -174.229 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A 1565 ' ' ALA . . . . . . . . . . . . . . . -134.91 128.72 33.11 Favored 'General case' 0 C--N 1.315 -0.91 0 N-CA-C 108.996 -0.742 . . . . 1.14 108.996 -179.988 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A 1566 ' ' CYS . . . . . . . . . . . . . 42.1 t -156.54 145.87 20.57 Favored 'General case' 0 C--N 1.307 -1.258 0 CA-C-N 116.671 -0.24 . . . . 0.51 110.538 -173.857 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A 1567 ' ' PHE . . . . . . . . . . . . . 24.7 m-85 -71.13 125.58 27.29 Favored 'General case' 0 C--O 1.207 -1.137 0 N-CA-C 107.387 -1.338 . . . . 1.22 107.387 175.018 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A 1568 ' ' GLY . . . . . . . . . . . . . . . -75.22 -24.93 69.86 Favored Glycine 0 C--N 1.307 -1.047 0 C-N-CA 120.801 -0.714 . . . . 1.08 114.027 -173.648 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A 1569 ' ' GLN . . . . . . . . . . . . . 65.5 tt0 -85.13 -53.03 5.53 Favored 'General case' 0 C--N 1.317 -0.814 0 C-N-CA 120.088 -0.645 . . . . 3.05 111.071 -179.757 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A 1570 ' ' THR . . . . . . . . . . . . . 22.8 p -84.19 -16.95 41.53 Favored 'General case' 0 C--N 1.312 -1.053 0 N-CA-C 112.852 0.686 . . . . 2.44 112.852 -176.696 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A 1571 ' ' ARG . . . . . . . . . . . . . 66.0 mtm180 60.78 41.87 14.17 Favored 'General case' 0 CA--C 1.508 -0.661 0 C-N-CA 125.382 1.473 . . . . 4.48 112.85 177.463 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A 1572 ' ' ILE . . . . . . . . . . . . . 36.9 mm -103.83 122.8 56.99 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.222 0 N-CA-C 107.404 -1.332 . . . . 1.94 107.404 178.134 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A 1573 ' ' SER . . . . . . . . . . . . . 71.5 p -78.43 121.94 25.17 Favored 'General case' 0 N--CA 1.436 -1.137 0 N-CA-C 113.129 0.788 . . . . 1.25 113.129 -176.46 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A 1574 ' ' VAL . . . . . . . . . . . . . 22.4 m -106.51 11.39 8.88 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.426 0 CA-C-O 121.875 0.845 . . . . 1.61 110.402 -177.126 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A 1575 ' ' GLY . . . . . . . . . . . . . . . -177.27 118.93 0.66 Allowed Glycine 0 N--CA 1.421 -2.333 0 CA-C-N 114.718 -1.128 . . . . 0.65 111.673 177.398 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A 1576 ' ' LYS . . . . . 0.547 ' HA ' ' HA ' ' A' 1563 ' ' VAL . 55.7 tttm -79.85 152.17 29.83 Favored 'General case' 0 C--N 1.306 -1.315 0 N-CA-C 105.799 -1.926 . . . . 3.33 105.799 174.888 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A 1577 ' ' ALA . . . . . . . . . . . . . . . -56.22 102.33 0.07 Allowed 'General case' 0 N--CA 1.468 0.434 0 O-C-N 123.983 0.802 . . . . 1.31 110.277 -178.537 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A 1578 ' ' ASN . . . . . 0.571 ' HB3' ' HA ' ' A' 1592 ' ' TYR . 8.0 t30 -135.61 130.22 34.07 Favored 'General case' 0 C--N 1.29 -2.001 0 N-CA-C 105.683 -1.969 . . . . 2.24 105.683 -179.094 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A 1579 ' ' LYS . . . . . . . . . . . . . 36.9 ttpt -115.54 90.24 3.29 Favored 'General case' 0 C--N 1.269 -2.926 0 CA-C-O 121.631 0.729 . . . . 2.34 109.211 -173.507 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A 1580 ' ' ARG . . . . . 0.522 ' O ' ' HA ' ' A' 1590 ' ' LEU . 44.3 ttm180 -109.93 109.59 20.25 Favored 'General case' 0 C--N 1.286 -2.163 0 N-CA-C 107.902 -1.147 . . . . 4.19 107.902 177.332 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A 1581 ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -100.21 138.38 37.35 Favored 'General case' 0 C--N 1.298 -1.665 0 N-CA-C 106.273 -1.751 . . . . 2.39 106.273 -177.682 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A 1582 ' ' ARG . . . . . 0.415 ' HB3' ' HB3' ' A' 1589 ' ' GLN . 38.5 ttm180 -144.66 128.46 17.31 Favored 'General case' 0 C--N 1.305 -1.36 0 CA-C-O 121.137 0.494 . . . . 4.48 111.043 178.958 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A 1583 ' ' TYR . . . . . 0.461 ' HD1' ' CD2' ' A' 1588 ' ' LEU . 84.9 t80 -117.9 105.02 11.49 Favored 'General case' 0 C--N 1.297 -1.702 0 N-CA-C 105.946 -1.872 . . . . 1.57 105.946 176.996 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A 1584 ' ' VAL . . . . . . . . . . . . . 6.6 p -136.79 97.77 1.59 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.343 0 C-N-CA 119.594 -0.842 . . . . 2.29 112.501 -177.058 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A 1585 ' ' ASP . . . . . . . . . . . . . 35.7 t70 56.87 69.07 0.78 Allowed 'General case' 0 N--CA 1.476 0.874 0 C-N-CA 124.188 0.995 . . . . 2.06 111.814 178.211 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A 1586 ' ' GLN . . . . . . . . . . . . . 53.3 mt-30 52.51 25.5 3.64 Favored 'General case' 0 N--CA 1.478 0.945 0 N-CA-C 114.767 1.395 . . . . 2.61 114.767 178.657 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A 1587 ' ' VAL . . . . . 0.416 HG23 ' O ' ' A' 1612 ' ' PHE . 11.5 p -139.52 122.29 17.47 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.772 0 N-CA-C 108.571 -0.9 . . . . 1.33 108.571 173.352 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A 1588 ' ' LEU . . . . . 0.557 ' HB2' ' HB2' ' A' 1612 ' ' PHE . 18.5 mt -89.09 158.28 18.02 Favored 'General case' 0 C--N 1.3 -1.556 0 CA-C-N 115.284 -0.871 . . . . 2.03 109.963 -178.493 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A 1589 ' ' GLN . . . . . 0.415 ' HB3' ' HB3' ' A' 1582 ' ' ARG . 6.8 tt0 -146.46 136.99 23.97 Favored 'General case' 0 C--N 1.292 -1.935 0 N-CA-C 108.667 -0.864 . . . . 1.73 108.667 176.918 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A 1590 ' ' LEU . . . . . 0.522 ' HA ' ' O ' ' A' 1580 ' ' ARG . 6.1 tt -133.04 135.45 45.38 Favored 'General case' 0 C--N 1.302 -1.47 0 N-CA-C 106.443 -1.688 . . . . 1.76 106.443 176.927 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A 1591 ' ' VAL . . . . . 0.42 HG23 HG23 ' A' 1609 ' ' VAL . 57.9 t -130.3 134.58 62.29 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.76 0 N-CA-C 112.761 0.652 . . . . 2.14 112.761 -171.769 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A 1592 ' ' TYR . . . . . 0.571 ' HA ' ' HB3' ' A' 1578 ' ' ASN . 67.3 m-85 -111.09 152.01 27.43 Favored 'General case' 0 C--N 1.318 -0.802 0 N-CA-C 107.405 -1.331 . . . . 1.53 107.405 171.53 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A 1593 ' ' LYS . . . . . . . . . . . . . 21.2 pttp -152.48 -177.16 6.05 Favored 'General case' 0 C--N 1.301 -1.539 0 N-CA-C 109.753 -0.462 . . . . 2.72 109.753 -178.767 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A 1594 ' ' ASP . . . . . . . . . . . . . 1.7 m-20 53.36 41.83 32.09 Favored 'General case' 0 N--CA 1.485 1.291 0 N-CA-C 115.238 1.57 . . . . 1.45 115.238 173.614 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A 1595 ' ' GLY . . . . . . . . . . . . . . . -82.65 -121.78 0.7 Allowed Glycine 0 N--CA 1.435 -1.429 0 C-N-CA 119.816 -1.183 . . . . 0.83 110.816 175.696 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A 1596 ' ' SER . . . . . . . . . . . . . 49.0 m -83.44 153.0 65.1 Favored Pre-proline 0 C--N 1.284 -2.282 0 N-CA-C 109.934 -0.395 . . . . 1.96 109.934 -179.606 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A 1597 ' ' PRO . . . . . . . . . . . . . 33.2 Cg_exo -63.67 139.33 68.9 Favored 'Trans proline' 0 C--O 1.253 1.243 0 C-N-CA 122.689 2.26 . . . . 1.34 109.723 172.369 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A 1598 ' ' CYS . . . . . . . . . . . . . 34.8 t -95.05 130.16 33.5 Favored Pre-proline 0 C--N 1.287 -2.139 0 N-CA-C 108.97 -0.752 . . . . 1.19 108.97 -177.318 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A 1599 ' ' PRO . . . . . 0.456 ' HD2' ' OH ' ' A' 1606 ' ' TYR . 89.2 Cg_endo -82.33 4.57 6.97 Favored 'Trans proline' 0 CA--C 1.536 0.577 0 C-N-CA 122.879 2.386 . . . . 1.88 112.697 179.319 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A 1600 ' ' SER . . . . . . . . . . . . . 15.9 m -107.81 123.0 47.91 Favored 'General case' 0 N--CA 1.431 -1.388 0 N-CA-C 109.957 -0.386 . . . . 2.19 109.957 -177.468 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A 1601 ' ' LYS . . . . . . . . . . . . . 26.5 mtpp 66.02 -97.93 0.05 Allowed 'General case' 0 N--CA 1.454 -0.27 0 N-CA-C 114.565 1.32 . . . . 4.21 114.565 -179.372 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A 1602 ' ' SER . . . . . 0.472 ' HB3' ' HG ' ' A' 1604 ' ' LEU . 10.4 t -97.59 153.61 18.08 Favored 'General case' 0 C--N 1.301 -1.505 0 N-CA-C 109.202 -0.666 . . . . 3.82 109.202 -178.247 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A 1603 ' ' GLY . . . . . . . . . . . . . . . -80.63 56.87 4.76 Favored Glycine 0 N--CA 1.447 -0.622 0 N-CA-C 110.835 -0.906 . . . . 2.45 110.835 177.625 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A 1604 ' ' LEU . . . . . 0.472 ' HG ' ' HB3' ' A' 1602 ' ' SER . 0.7 OUTLIER -99.28 -172.01 2.19 Favored 'General case' 0 C--N 1.307 -1.259 0 C-N-CA 123.817 0.847 . . . . 2.06 110.633 -179.69 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A 1605 ' ' SER . . . . . . . . . . . . . 8.7 m -97.78 -178.72 4.2 Favored 'General case' 0 C--N 1.301 -1.543 0 CA-C-N 118.206 0.457 . . . . 1.75 110.102 -176.749 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A 1606 ' ' TYR . . . . . 0.456 ' OH ' ' HD2' ' A' 1599 ' ' PRO . 68.2 m-85 -106.39 137.69 43.92 Favored 'General case' 0 N--CA 1.417 -2.091 0 N-CA-C 104.424 -2.436 . . . . 1.59 104.424 174.902 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A 1607 ' ' LYS . . . . . 0.525 ' HG3' HG22 ' A' 1635 ' ' THR . 21.9 ptmt -130.05 142.7 50.58 Favored 'General case' 0 C--N 1.282 -2.35 0 C-N-CA 119.955 -0.698 . . . . 2.21 109.216 179.383 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A 1608 ' ' SER . . . . . . . . . . . . . 46.7 m -119.0 126.84 52.67 Favored 'General case' 0 C--N 1.3 -1.553 0 CA-C-O 120.413 0.149 . . . . 1.48 110.653 -176.806 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A 1609 ' ' VAL . . . . . 0.42 HG23 HG23 ' A' 1591 ' ' VAL . 74.2 t -116.2 124.45 72.48 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.839 0 N-CA-C 109.321 -0.622 . . . . 1.57 109.321 178.205 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A 1610 ' ' ILE . . . . . 0.807 HG13 ' HB2' ' A' 1638 ' ' PHE . 3.0 mp -108.07 120.06 58.76 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.966 0 N-CA-C 109.072 -0.714 . . . . 1.47 109.072 176.68 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A 1611 ' ' SER . . . . . . . . . . . . . 24.2 p -94.89 123.63 38.47 Favored 'General case' 0 N--CA 1.432 -1.372 0 N-CA-C 109.049 -0.723 . . . . 1.84 109.049 175.317 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A 1612 ' ' PHE . . . . . 0.557 ' HB2' ' HB2' ' A' 1588 ' ' LEU . 93.0 m-85 -97.11 108.89 21.71 Favored 'General case' 0 C--N 1.298 -1.638 0 CA-C-O 121.123 0.487 . . . . 0.86 110.657 -177.914 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A 1613 ' ' VAL . . . . . 0.426 ' O ' ' HA ' ' A' 1641 ' ' HIS . 49.0 t -103.72 120.74 54.26 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.531 0 N-CA-C 109.246 -0.65 . . . . 1.32 109.246 -178.154 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A 1614 ' ' CYS . . . . . 0.581 ' HA ' ' O ' ' A' 1642 ' ' THR . 0.8 OUTLIER -77.7 93.94 4.35 Favored 'General case' 0 C--N 1.302 -1.476 0 N-CA-C 114.201 1.185 . . . . 1.39 114.201 -179.15 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A 1615 ' ' ARG . . . . . . . . . . . . . 71.8 ttt180 -115.74 107.05 49.13 Favored Pre-proline 0 C--N 1.312 -1.063 0 N-CA-C 108.163 -1.051 . . . . 4.34 108.163 175.755 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A 1616 ' ' PRO . . . . . 0.41 ' HA ' ' HB3' ' A' 1643 ' ' PRO . 27.0 Cg_endo -63.95 -38.1 39.94 Favored 'Trans proline' 0 CA--C 1.531 0.328 0 C-N-CA 122.753 2.302 . . . . 1.5 112.191 -179.922 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A 1617 ' ' GLU . . . . . . . . . . . . . 20.4 mm-40 . . . . . 0 C--N 1.312 -1.028 0 CA-C-N 115.976 -0.556 . . . . 3.21 110.937 -179.153 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A 1622 ' ' ASN . . . . . 0.474 ' HA ' ' O ' ' A' 1641 ' ' HIS . 48.8 t-20 . . . . . 0 C--O 1.243 0.722 0 N-CA-C 106.941 -1.503 . . . . 3.58 106.941 . . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A 1623 ' ' ARG . . . . . . . . . . . . . 16.5 ptm180 -149.71 150.26 30.2 Favored Pre-proline 0 C--N 1.308 -1.236 0 N-CA-C 107.677 -1.231 . . . . 4.09 107.677 -176.606 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A 1624 ' ' PRO . . . . . . . . . . . . . 11.9 Cg_exo -71.63 94.81 0.69 Allowed 'Trans proline' 0 N--CA 1.456 -0.691 0 C-N-CA 122.148 1.899 . . . . 2.86 109.104 175.909 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A 1625 ' ' MET . . . . . . . . . . . . . 57.7 ttp -101.64 141.41 34.54 Favored 'General case' 0 C--N 1.299 -1.588 0 CA-C-N 115.662 -0.699 . . . . 2.73 109.779 -175.17 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A 1626 ' ' LEU . . . . . . . . . . . . . 56.2 tp -80.61 110.7 16.34 Favored 'General case' 0 C--N 1.313 -1.005 0 N-CA-C 108.446 -0.946 . . . . 1.94 108.446 178.334 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A 1627 ' ' ILE . . . . . . . . . . . . . 26.5 pt -88.16 -41.76 14.48 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.919 0 C-N-CA 120.339 -0.545 . . . . 1.75 112.196 -177.893 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A 1628 ' ' SER . . . . . . . . . . . . . 26.7 t -147.21 148.45 31.52 Favored 'General case' 0 N--CA 1.434 -1.242 0 N-CA-C 109.933 -0.395 . . . . 1.85 109.933 -175.489 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A 1629 ' ' LEU . . . . . 0.639 ' HG ' HD13 ' A' 1636 ' ' LEU . 5.1 tt -125.51 112.13 15.87 Favored 'General case' 0 C--N 1.304 -1.411 0 N-CA-C 106.496 -1.668 . . . . 2.12 106.496 176.798 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A 1630 ' ' ASP . . . . . 0.412 ' HB2' ' HE2' ' A' 1637 ' ' PHE . 19.5 t70 -83.22 117.46 22.95 Favored 'General case' 0 C--N 1.303 -1.444 0 N-CA-C 108.479 -0.934 . . . . 0.87 108.479 177.704 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A 1631 ' ' LYS . . . . . . . . . . . . . 98.3 mttt -92.26 -7.18 48.83 Favored 'General case' 0 C--N 1.29 -2.021 0 CA-C-N 115.932 -0.576 . . . . 2.76 111.179 -174.948 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A 1632 ' ' GLN . . . . . . . . . . . . . 36.5 mt-30 -80.25 -47.52 14.47 Favored 'General case' 0 C--N 1.317 -0.817 0 CA-C-O 121.456 0.646 . . . . 2.55 110.295 -177.338 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A 1633 ' ' THR . . . . . . . . . . . . . 41.0 p -107.25 -1.34 21.87 Favored 'General case' 0 C--N 1.298 -1.66 0 CA-C-N 116.034 -0.53 . . . . 1.92 111.306 179.858 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A 1634 ' ' CYS . . . . . . . . . . . . . 60.3 m 64.62 52.05 1.81 Allowed 'General case' 0 N--CA 1.472 0.644 0 CA-C-O 122.171 0.986 . . . . 0.89 110.538 -179.682 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A 1635 ' ' THR . . . . . 0.525 HG22 ' HG3' ' A' 1607 ' ' LYS . 32.1 m -114.16 126.65 55.31 Favored 'General case' 0 N--CA 1.431 -1.381 0 CA-C-N 114.567 -1.197 . . . . 1.31 110.186 -175.485 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A 1636 ' ' LEU . . . . . 0.639 HD13 ' HG ' ' A' 1629 ' ' LEU . 2.1 mm? -95.45 132.99 39.93 Favored 'General case' 0 C--N 1.308 -1.205 0 N-CA-C 108.971 -0.751 . . . . 1.97 108.971 -179.423 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A 1637 ' ' PHE . . . . . 0.412 ' HE2' ' HB2' ' A' 1630 ' ' ASP . 99.8 m-85 -116.42 106.38 13.55 Favored 'General case' 0 C--O 1.247 0.969 0 CA-C-O 121.21 0.528 . . . . 0.92 110.702 179.555 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A 1638 ' ' PHE . . . . . 0.807 ' HB2' HG13 ' A' 1610 ' ' ILE . 99.0 m-85 -103.77 149.52 24.94 Favored 'General case' 0 C--N 1.301 -1.533 0 N-CA-C 108.619 -0.882 . . . . 0.7 108.619 178.684 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A 1639 ' ' SER . . . . . . . . . . . . . 33.6 t -135.59 132.11 36.73 Favored 'General case' 0 C--N 1.285 -2.229 0 N-CA-C 109.216 -0.661 . . . . 1.46 109.216 179.496 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A 1640 ' ' TRP . . . . . 0.549 ' CZ3' HD11 ' A' 1532 ' ' LEU . 7.2 t90 -120.82 118.96 31.33 Favored 'General case' 0 N--CA 1.423 -1.806 0 N-CA-C 107.472 -1.307 . . . . 0.92 107.472 177.642 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A 1641 ' ' HIS . . . . . 0.474 ' O ' ' HA ' ' A' 1622 ' ' ASN . 31.7 m-70 -96.96 103.46 15.39 Favored 'General case' 0 C--N 1.294 -1.812 0 N-CA-C 106.734 -1.58 . . . . 3.18 106.734 177.354 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A 1642 ' ' THR . . . . . 0.581 ' O ' ' HA ' ' A' 1614 ' ' CYS . 8.9 t -142.24 139.54 17.95 Favored Pre-proline 0 C--N 1.303 -1.45 0 CA-C-N 115.7 -0.682 . . . . 1.48 111.807 -170.536 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A 1643 ' ' PRO . . . . . 0.41 ' HB3' ' HA ' ' A' 1616 ' ' PRO . 4.3 Cg_exo -74.84 -3.64 14.21 Favored 'Trans proline' 0 N--CA 1.456 -0.718 0 C-N-CA 123.499 2.8 . . . . 1.09 111.639 175.573 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A 1644 ' ' LEU . . . . . . . . . . . . . 83.4 mt -82.03 -8.62 59.67 Favored 'General case' 0 C--N 1.315 -0.929 0 CA-C-N 116.447 -0.342 . . . . 2.08 110.635 177.282 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A 1645 ' ' ALA . . . . . . . . . . . . . . . -88.31 -21.0 24.65 Favored 'General case' 0 C--N 1.32 -0.713 0 N-CA-C 113.092 0.775 . . . . 1.37 113.092 -176.196 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A 1646 ' ' CYS . . . . . . . . . . . . . 61.1 m -155.15 172.45 18.12 Favored 'General case' 0 N--CA 1.475 0.781 0 N-CA-C 107.243 -1.391 . . . . 1.7 107.243 -179.761 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A 1647 ' ' GLU . . . . . 0.514 ' HB2' HG22 ' A' 1523 ' ' THR . 37.7 mm-40 . . . . . 0 C--N 1.309 -1.179 0 N-CA-C 109.815 -0.439 . . . . 2.92 109.815 174.694 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A 1515 ' ' ASP . . . . . . . . . . . . . 13.6 t70 . . . . . 0 CA--C 1.54 0.573 0 N-CA-C 105.58 -2.007 . . . . 2.54 105.58 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A 1516 ' ' CYS . . . . . 0.446 ' HB3' ' HB2' ' A' 1529 ' ' LEU . 74.0 m -128.32 43.11 3.2 Favored 'General case' 0 C--N 1.298 -1.637 0 CA-C-N 118.561 0.618 . . . . 1.25 110.135 -176.417 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A 1517 ' ' GLN . . . . . . . . . . . . . 3.8 pt20 -124.52 129.28 50.33 Favored 'General case' 0 C--N 1.295 -1.762 0 C-N-CA 119.866 -0.734 . . . . 2.36 110.702 178.238 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A 1518 ' ' VAL . . . . . . . . . . . . . 15.9 m -133.28 139.51 49.07 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.641 0 CA-C-N 115.715 -0.675 . . . . 2.34 110.4 -179.058 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A 1519 ' ' THR . . . . . . . . . . . . . 23.1 m -90.55 123.57 34.32 Favored 'General case' 0 C--N 1.284 -2.251 0 N-CA-C 108.832 -0.803 . . . . 2.04 108.832 176.478 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A 1520 ' ' ASN . . . . . . . . . . . . . 48.6 t-20 -84.63 112.25 40.87 Favored Pre-proline 0 C--N 1.311 -1.08 0 N-CA-C 107.746 -1.205 . . . . 2.12 107.746 178.083 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A 1521 ' ' PRO . . . . . . . . . . . . . 42.6 Cg_endo -65.38 -16.46 54.42 Favored 'Trans proline' 0 C--N 1.353 0.766 0 C-N-CA 122.897 2.398 . . . . 2.59 113.992 -174.299 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A 1522 ' ' SER . . . . . . . . . . . . . 38.0 m -81.21 -9.8 59.72 Favored 'General case' 0 C--N 1.312 -1.031 0 CA-C-O 120.779 0.323 . . . . 2.65 111.869 -178.976 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A 1523 ' ' THR . . . . . . . . . . . . . 13.7 t -136.55 -13.82 1.72 Allowed 'General case' 0 CA--C 1.552 1.041 0 CA-C-O 121.349 0.595 . . . . 2.33 111.371 176.761 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A 1524 ' ' GLY . . . . . . . . . . . . . . . 73.33 16.26 78.8 Favored Glycine 0 C--N 1.341 0.845 0 O-C-N 122.134 -0.354 . . . . 1.96 112.362 179.481 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A 1525 ' ' HIS . . . . . . . . . . . . . 58.3 t60 -101.93 136.72 41.28 Favored 'General case' 0 C--N 1.306 -1.31 0 C-N-CA 122.623 0.369 . . . . 2.44 110.091 -176.135 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A 1526 ' ' LEU . . . . . . . . . . . . . 26.4 tp -83.45 124.49 30.75 Favored 'General case' 0 C--N 1.306 -1.289 0 N-CA-C 108.579 -0.897 . . . . 2.19 108.579 176.914 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A 1527 ' ' PHE . . . . . . . . . . . . . 80.8 m-85 -98.53 114.11 26.4 Favored 'General case' 0 C--N 1.296 -1.731 0 CA-C-O 121.671 0.748 . . . . 1.61 110.06 176.145 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A 1528 ' ' ASP . . . . . . . . . . . . . 4.6 t70 -90.41 105.75 18.03 Favored 'General case' 0 C--N 1.298 -1.642 0 CA-C-N 114.205 -1.361 . . . . 2.18 111.02 -177.636 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A 1529 ' ' LEU . . . . . 0.789 ' HA ' HD12 ' A' 1532 ' ' LEU . 79.6 mt -104.19 5.99 35.31 Favored 'General case' 0 C--N 1.297 -1.69 0 N-CA-C 106.089 -1.819 . . . . 2.04 106.089 170.861 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A 1530 ' ' SER . . . . . . . . . . . . . 3.1 m -65.47 -36.72 84.74 Favored 'General case' 0 N--CA 1.438 -1.059 0 CA-C-N 114.531 -1.213 . . . . 1.44 109.694 -179.279 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A 1531 ' ' SER . . . . . . . . . . . . . 15.6 m -73.62 -9.75 58.99 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 121.308 0.575 . . . . 1.63 109.908 178.114 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A 1532 ' ' LEU . . . . . 0.789 HD12 ' HA ' ' A' 1529 ' ' LEU . 6.6 mp -92.97 15.27 15.35 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.788 -0.642 . . . . 2.32 111.049 -179.724 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A 1533 ' ' SER . . . . . . . . . . . . . 50.4 m -74.16 127.9 34.13 Favored 'General case' 0 N--CA 1.435 -1.212 0 N-CA-C 108.132 -1.062 . . . . 2.57 108.132 174.353 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A 1534 ' ' GLY . . . . . . . . . . . . . . . -127.45 137.36 9.81 Favored Glycine 0 CA--C 1.478 -2.249 0 N-CA-C 109.823 -1.311 . . . . 1.89 109.823 -177.905 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A 1535 ' ' ARG . . . . . . . . . . . . . 3.6 tpp180 -90.33 -44.3 9.77 Favored 'General case' 0 C--N 1.302 -1.471 0 N-CA-C 109.131 -0.692 . . . . 4.44 109.131 -179.845 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A 1536 ' ' ALA . . . . . . . . . . . . . . . -95.32 -6.84 40.31 Favored 'General case' 0 C--N 1.314 -0.961 0 N-CA-C 108.15 -1.056 . . . . 2.07 108.15 175.125 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A 1537 ' ' GLY . . . . . . . . . . . . . . . 78.73 -174.12 55.23 Favored Glycine 0 N--CA 1.429 -1.828 0 CA-C-N 113.887 -1.506 . . . . 1.2 113.67 177.322 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A 1538 ' ' PHE . . . . . . . . . . . . . 90.3 m-85 -113.97 175.14 5.6 Favored 'General case' 0 C--N 1.292 -1.899 0 N-CA-C 105.457 -2.053 . . . . 1.98 105.457 176.263 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A 1539 ' ' THR . . . . . . . . . . . . . 11.9 t -136.47 152.88 51.04 Favored 'General case' 0 C--N 1.282 -2.352 0 C-N-CA 119.02 -1.072 . . . . 1.97 110.21 -178.626 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A 1540 ' ' ALA . . . . . 0.632 ' HA ' ' HD3' ' A' 1623 ' ' ARG . . . -133.38 130.9 39.4 Favored 'General case' 0 C--N 1.319 -0.754 0 N-CA-C 109.062 -0.718 . . . . 1.39 109.062 179.067 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A 1541 ' ' ALA . . . . . . . . . . . . . . . -78.57 147.52 33.7 Favored 'General case' 0 C--O 1.247 0.929 0 CA-C-N 116.189 -0.459 . . . . 1.86 110.761 -178.331 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A 1542 ' ' TYR . . . . . 0.463 ' HB3' ' O ' ' A' 1546 ' ' GLY . 89.2 t80 -160.46 160.3 31.92 Favored 'General case' 0 CA--C 1.552 1.058 0 CA-C-O 119.599 -0.239 . . . . 2.4 111.549 -177.591 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A 1543 ' ' SER . . . . . . . . . . . . . 17.9 t -37.58 -152.2 0.0 OUTLIER 'General case' 0 CA--C 1.591 2.538 0 C-N-CA 130.626 3.57 . . . . 2.58 115.562 176.331 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A 1544 ' ' LYS . . . . . . . . . . . . . 97.6 mttt -46.7 -35.61 6.26 Favored 'General case' 0 N--CA 1.479 0.98 0 C-N-CA 124.497 1.119 . . . . 4.24 113.496 -177.707 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A 1545 ' ' SER . . . . . . . . . . . . . 37.2 m -71.15 -8.12 51.32 Favored 'General case' 0 CA--C 1.551 0.993 0 N-CA-C 112.96 0.726 . . . . 3.6 112.96 177.582 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A 1546 ' ' GLY . . . . . 0.463 ' O ' ' HB3' ' A' 1542 ' ' TYR . . . 83.06 -160.71 38.92 Favored Glycine 0 N--CA 1.432 -1.586 0 C-N-CA 121.239 -0.505 . . . . 1.66 114.255 173.05 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A 1547 ' ' VAL . . . . . . . . . . . . . 14.9 p -91.23 134.25 30.36 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.938 0 N-CA-C 108.742 -0.836 . . . . 2.23 108.742 -177.019 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A 1548 ' ' VAL . . . . . . . . . . . . . 4.9 t -110.52 147.72 14.49 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.518 0 N-CA-C 108.44 -0.948 . . . . 1.59 108.44 -175.03 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A 1549 ' ' TYR . . . . . 0.514 ' HB3' HD22 ' A' 1556 ' ' ASN . 99.8 m-85 -106.0 129.13 54.18 Favored 'General case' 0 C--N 1.313 -0.992 0 N-CA-C 108.185 -1.043 . . . . 1.58 108.185 176.762 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A 1550 ' ' MET . . . . . . . . . . . . . 87.7 mmm -134.29 122.35 22.56 Favored 'General case' 0 C--N 1.299 -1.614 0 CA-C-N 115.792 -0.64 . . . . 2.08 109.845 -173.708 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A 1551 ' ' SER . . . . . 0.482 ' OG ' ' HA ' ' A' 1556 ' ' ASN . 74.9 m -97.35 115.63 28.06 Favored 'General case' 0 C--N 1.286 -2.178 0 N-CA-C 107.058 -1.46 . . . . 1.9 107.058 171.79 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A 1552 ' ' ILE . . . . . 0.482 ' HB ' ' O ' ' A' 1532 ' ' LEU . 41.9 mm -57.37 -49.55 79.75 Favored 'Isoleucine or valine' 0 C--O 1.21 -0.989 0 CA-C-N 114.811 -1.086 . . . . 2.04 108.139 179.421 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A 1553 ' ' CYS . . . . . 0.484 ' HA ' ' OH ' ' A' 1592 ' ' TYR . 81.3 m -131.48 137.45 48.58 Favored 'General case' 0 N--CA 1.425 -1.724 0 N-CA-C 109.371 -0.603 . . . . 1.43 109.371 173.96 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A 1554 ' ' GLY . . . . . . . . . . . . . . . 105.56 -143.05 15.64 Favored Glycine 0 N--CA 1.435 -1.42 0 O-C-N 123.785 0.678 . . . . 1.23 112.745 174.802 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A 1555 ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -117.91 157.49 26.59 Favored 'General case' 0 C--N 1.303 -1.418 0 N-CA-C 108.473 -0.936 . . . . 1.8 108.473 179.754 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A 1556 ' ' ASN . . . . . 0.514 HD22 ' HB3' ' A' 1549 ' ' TYR . 4.0 t-20 -100.38 -23.4 14.77 Favored 'General case' 0 C--N 1.301 -1.533 0 CA-C-N 116.281 -0.418 . . . . 2.63 111.977 -172.816 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A 1557 ' ' GLU . . . . . 0.477 ' C ' ' H ' ' A' 1559 ' ' CYS . 37.7 mt-10 54.82 -158.99 0.19 Allowed 'General case' 0 N--CA 1.449 -0.477 0 CA-C-N 114.92 -1.036 . . . . 3.79 109.577 -174.709 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A 1558 ' ' ASN . . . . . . . . . . . . . 39.8 m-80 69.93 -8.95 0.75 Allowed 'General case' 0 N--CA 1.495 1.801 0 C-N-CA 124.078 0.951 . . . . 1.59 112.192 175.683 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A 1559 ' ' CYS . . . . . 0.731 ' HB3' ' HD2' ' A' 1560 ' ' PRO . 63.4 m -145.04 -173.55 0.36 Allowed Pre-proline 0 C--N 1.283 -2.323 0 N-CA-C 103.683 -2.71 . . . . 0.94 103.683 -178.675 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A 1560 ' ' PRO . . . . . 0.731 ' HD2' ' HB3' ' A' 1559 ' ' CYS . 2.8 Cg_exo -37.8 137.3 0.43 Allowed 'Trans proline' 0 C--N 1.373 1.82 0 C-N-CA 123.621 2.88 . . . . 1.53 113.727 175.624 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A 1561 ' ' PRO . . . . . . . . . . . . . 39.8 Cg_endo -68.04 125.33 12.91 Favored 'Trans proline' 0 N--CA 1.456 -0.678 0 C-N-CA 122.482 2.121 . . . . 1.82 112.265 -177.839 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A 1562 ' ' GLY . . . . . . . . . . . . . . . 101.68 17.48 21.22 Favored Glycine 0 N--CA 1.434 -1.481 0 C-N-CA 121.029 -0.605 . . . . 0.81 112.79 177.341 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A 1563 ' ' VAL . . . . . 0.518 ' HA ' ' HA ' ' A' 1576 ' ' LYS . 10.4 m -103.68 150.75 6.83 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.868 0 N-CA-C 106.746 -1.576 . . . . 1.73 106.746 174.631 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A 1564 ' ' GLY . . . . . . . . . . . . . . . -112.26 -5.62 24.66 Favored Glycine 0 C--N 1.317 -0.473 0 C-N-CA 120.233 -0.984 . . . . 0.72 113.305 -174.352 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A 1565 ' ' ALA . . . . . . . . . . . . . . . -150.75 133.43 15.75 Favored 'General case' 0 C--O 1.254 1.314 0 N-CA-C 109.414 -0.587 . . . . 1.14 109.414 -179.014 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A 1566 ' ' CYS . . . . . . . . . . . . . 34.7 t -154.06 142.32 20.49 Favored 'General case' 0 C--N 1.312 -1.043 0 CA-C-O 121.234 0.54 . . . . 0.51 111.042 -177.186 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A 1567 ' ' PHE . . . . . 0.662 ' O ' ' HA ' ' A' 1571 ' ' ARG . 13.2 m-85 -67.6 150.99 48.06 Favored 'General case' 0 N--CA 1.452 -0.339 0 CA-C-N 115.742 -0.663 . . . . 1.22 109.756 176.322 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A 1568 ' ' GLY . . . . . . . . . . . . . . . -108.78 -10.56 24.59 Favored Glycine 0 N--CA 1.432 -1.633 0 C-N-CA 120.337 -0.935 . . . . 1.08 111.751 178.831 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A 1569 ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -89.81 -62.34 1.49 Allowed 'General case' 0 C--N 1.317 -0.822 0 N-CA-C 108.217 -1.031 . . . . 3.05 108.217 178.374 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A 1570 ' ' THR . . . . . . . . . . . . . 19.3 p -89.24 -11.99 42.03 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 121.135 0.493 . . . . 2.44 111.819 178.718 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A 1571 ' ' ARG . . . . . 0.662 ' HA ' ' O ' ' A' 1567 ' ' PHE . 83.6 mtm180 61.43 37.03 17.01 Favored 'General case' 0 N--CA 1.473 0.709 0 C-N-CA 124.607 1.163 . . . . 4.48 113.434 175.748 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A 1572 ' ' ILE . . . . . . . . . . . . . 33.2 mm -99.43 132.9 43.99 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.205 0 N-CA-C 108.655 -0.868 . . . . 1.94 108.655 179.907 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A 1573 ' ' SER . . . . . . . . . . . . . 29.5 p -74.73 120.88 20.89 Favored 'General case' 0 N--CA 1.441 -0.89 0 CA-C-O 121.134 0.492 . . . . 1.25 111.892 -179.239 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A 1574 ' ' VAL . . . . . . . . . . . . . 35.3 m -113.25 21.8 5.96 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.233 0 CA-C-O 121.672 0.749 . . . . 1.61 112.311 -173.911 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A 1575 ' ' GLY . . . . . . . . . . . . . . . 179.97 127.36 1.11 Allowed Glycine 0 N--CA 1.431 -1.641 0 CA-C-N 115.128 -0.942 . . . . 0.65 111.297 176.544 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A 1576 ' ' LYS . . . . . 0.518 ' HA ' ' HA ' ' A' 1563 ' ' VAL . 54.7 tttp -89.91 151.6 21.64 Favored 'General case' 0 C--N 1.313 -0.991 0 N-CA-C 106.794 -1.558 . . . . 3.33 106.794 178.499 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A 1577 ' ' ALA . . . . . 0.405 ' HA ' ' CD1' ' A' 1592 ' ' TYR . . . -67.1 88.67 0.17 Allowed 'General case' 0 C--O 1.239 0.508 0 CA-C-O 121.939 0.875 . . . . 1.31 112.286 -174.708 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A 1578 ' ' ASN . . . . . . . . . . . . . 49.8 m-80 -117.87 113.29 21.54 Favored 'General case' 0 C--N 1.288 -2.087 0 N-CA-C 104.178 -2.527 . . . . 2.24 104.178 172.714 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A 1579 ' ' LYS . . . . . . . . . . . . . 37.4 ttpt -101.07 91.01 4.36 Favored 'General case' 0 C--N 1.274 -2.681 0 C-N-CA 119.24 -0.984 . . . . 2.34 109.306 -173.783 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A 1580 ' ' ARG . . . . . . . . . . . . . 49.1 ttp180 -129.7 100.62 5.57 Favored 'General case' 0 N--CA 1.42 -1.968 0 CA-C-N 114.391 -1.277 . . . . 4.19 109.576 -178.398 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A 1581 ' ' LEU . . . . . . . . . . . . . 64.3 tp -96.08 147.63 23.52 Favored 'General case' 0 C--N 1.303 -1.43 0 N-CA-C 107.175 -1.417 . . . . 2.39 107.175 177.459 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A 1582 ' ' ARG . . . . . 0.534 ' HG2' HG12 ' A' 1584 ' ' VAL . 40.8 ttp180 -146.36 138.52 25.03 Favored 'General case' 0 C--N 1.304 -1.397 0 C-N-CA 120.559 -0.456 . . . . 4.48 111.64 178.782 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A 1583 ' ' TYR . . . . . 0.554 ' HD2' HD21 ' A' 1588 ' ' LEU . 55.7 t80 -98.71 108.14 20.75 Favored 'General case' 0 C--O 1.24 0.586 0 N-CA-C 108.114 -1.069 . . . . 1.57 108.114 176.438 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A 1584 ' ' VAL . . . . . 0.534 HG12 ' HG2' ' A' 1582 ' ' ARG . 5.1 m -130.34 108.35 15.67 Favored 'Isoleucine or valine' 0 C--O 1.207 -1.147 0 CA-C-O 120.905 0.383 . . . . 2.29 111.847 179.228 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A 1585 ' ' ASP . . . . . . . . . . . . . 38.8 t70 57.37 48.11 15.39 Favored 'General case' 0 N--CA 1.479 0.985 0 CA-C-O 122.423 1.106 . . . . 2.06 110.796 175.656 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A 1586 ' ' GLN . . . . . . . . . . . . . 22.8 mt-30 68.56 -7.1 0.74 Allowed 'General case' 0 N--CA 1.477 0.886 0 N-CA-C 114.905 1.446 . . . . 2.61 114.905 -179.11 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A 1587 ' ' VAL . . . . . . . . . . . . . 9.6 p -99.67 126.37 53.08 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.189 0 C-N-CA 119.73 -0.788 . . . . 1.33 108.907 176.554 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A 1588 ' ' LEU . . . . . 0.558 ' HB2' ' HB2' ' A' 1612 ' ' PHE . 36.0 mt -88.23 143.09 27.24 Favored 'General case' 0 C--N 1.292 -1.902 0 CA-C-N 115.593 -0.731 . . . . 2.03 109.082 179.596 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A 1589 ' ' GLN . . . . . . . . . . . . . 9.8 tt0 -135.56 134.45 39.41 Favored 'General case' 0 C--N 1.279 -2.473 0 N-CA-C 108.609 -0.886 . . . . 1.73 108.609 179.089 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A 1590 ' ' LEU . . . . . . . . . . . . . 2.2 tt -134.4 133.11 40.19 Favored 'General case' 0 C--N 1.293 -1.877 0 N-CA-C 104.982 -2.229 . . . . 1.76 104.982 177.156 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A 1591 ' ' VAL . . . . . . . . . . . . . 29.6 m -128.53 144.26 38.51 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.848 0 N-CA-C 113.039 0.755 . . . . 2.14 113.039 -173.585 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A 1592 ' ' TYR . . . . . 0.484 ' OH ' ' HA ' ' A' 1553 ' ' CYS . 86.8 m-85 -127.95 97.1 4.69 Favored 'General case' 0 C--N 1.312 -1.061 0 N-CA-C 107.3 -1.37 . . . . 1.53 107.3 173.423 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A 1593 ' ' LYS . . . . . 0.441 ' HA ' ' HA ' ' A' 1607 ' ' LYS . 14.4 ptmm? -109.19 165.03 11.92 Favored 'General case' 0 C--N 1.296 -1.755 0 CA-C-N 115.852 -0.613 . . . . 2.72 111.361 -174.196 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A 1594 ' ' ASP . . . . . . . . . . . . . 2.1 m-20 58.08 59.91 2.91 Favored 'General case' 0 CA--C 1.507 -0.688 0 C-N-CA 125.34 1.456 . . . . 1.45 114.195 172.802 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A 1595 ' ' GLY . . . . . . . . . . . . . . . -86.65 -77.38 1.24 Allowed Glycine 0 N--CA 1.435 -1.381 0 N-CA-C 109.911 -1.276 . . . . 0.83 109.911 174.461 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A 1596 ' ' SER . . . . . . . . . . . . . 51.1 m -114.04 145.79 34.32 Favored Pre-proline 0 C--N 1.299 -1.613 0 N-CA-C 109.824 -0.436 . . . . 1.96 109.824 178.147 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A 1597 ' ' PRO . . . . . . . . . . . . . 52.2 Cg_exo -59.83 133.37 50.49 Favored 'Trans proline' 0 C--N 1.351 0.709 0 C-N-CA 123.173 2.582 . . . . 1.34 110.41 175.284 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A 1598 ' ' CYS . . . . . . . . . . . . . 47.9 t -95.78 130.28 32.08 Favored Pre-proline 0 C--N 1.292 -1.892 0 CA-C-N 115.628 -0.714 . . . . 1.19 110.136 -176.124 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A 1599 ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -75.11 -9.64 20.71 Favored 'Trans proline' 0 C--N 1.35 0.63 0 C-N-CA 123.31 2.673 . . . . 1.88 113.551 -177.502 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A 1600 ' ' SER . . . . . 0.416 ' HB2' ' SG ' ' A' 1634 ' ' CYS . 48.6 m -69.11 -26.46 64.92 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 120.75 0.31 . . . . 2.19 111.312 179.873 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A 1601 ' ' LYS . . . . . 0.619 ' HB3' HD12 ' A' 1604 ' ' LEU . 6.0 tmtm? -156.65 114.58 3.25 Favored 'General case' 0 C--N 1.314 -0.972 0 N-CA-C 107.11 -1.441 . . . . 4.21 107.11 -179.003 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A 1602 ' ' SER . . . . . . . . . . . . . 18.5 m -64.27 105.53 0.92 Allowed 'General case' 0 C--N 1.304 -1.37 0 CA-C-O 121.271 0.558 . . . . 3.82 110.26 179.811 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A 1603 ' ' GLY . . . . . . . . . . . . . . . 125.06 -7.5 8.13 Favored Glycine 0 N--CA 1.441 -1.026 0 N-CA-C 110.617 -0.993 . . . . 2.45 110.617 -176.357 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A 1604 ' ' LEU . . . . . 0.619 HD12 ' HB3' ' A' 1601 ' ' LYS . 1.4 mt -100.88 160.76 14.1 Favored 'General case' 0 C--N 1.318 -0.781 0 C-N-CA 122.808 0.443 . . . . 2.06 110.563 177.227 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A 1605 ' ' SER . . . . . . . . . . . . . 28.8 m -131.57 -169.37 2.18 Favored 'General case' 0 C--N 1.294 -1.828 0 N-CA-C 106.319 -1.734 . . . . 1.75 106.319 177.445 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A 1606 ' ' TYR . . . . . . . . . . . . . 85.1 m-85 -108.67 131.68 54.67 Favored 'General case' 0 N--CA 1.412 -2.337 0 N-CA-C 106.257 -1.757 . . . . 1.59 106.257 -179.884 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A 1607 ' ' LYS . . . . . 0.441 ' HA ' ' HA ' ' A' 1593 ' ' LYS . 20.5 ptmt -125.63 125.13 42.62 Favored 'General case' 0 N--CA 1.409 -2.484 0 O-C-N 124.145 0.903 . . . . 2.21 110.918 -177.798 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A 1608 ' ' SER . . . . . 0.658 ' HA ' ' HB2' ' A' 1636 ' ' LEU . 49.7 m -98.87 122.86 42.66 Favored 'General case' 0 C--N 1.301 -1.528 0 N-CA-C 110.205 -0.295 . . . . 1.48 110.205 178.616 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A 1609 ' ' VAL . . . . . . . . . . . . . 84.0 t -119.8 126.37 75.23 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.846 0 C-N-CA 123.381 0.672 . . . . 1.57 109.261 179.908 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A 1610 ' ' ILE . . . . . 0.472 HG13 ' HB2' ' A' 1638 ' ' PHE . 3.4 mp -115.67 118.03 57.49 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.832 0 N-CA-C 109.123 -0.695 . . . . 1.47 109.123 177.328 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A 1611 ' ' SER . . . . . . . . . . . . . 44.8 p -100.95 120.99 40.97 Favored 'General case' 0 N--CA 1.436 -1.139 0 CA-C-O 120.946 0.403 . . . . 1.84 110.095 176.505 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A 1612 ' ' PHE . . . . . 0.558 ' HB2' ' HB2' ' A' 1588 ' ' LEU . 36.2 m-85 -97.68 104.11 16.1 Favored 'General case' 0 C--N 1.302 -1.476 0 C-N-CA 123.404 0.682 . . . . 0.86 109.607 -177.351 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A 1613 ' ' VAL . . . . . 0.55 ' O ' ' HA ' ' A' 1641 ' ' HIS . 46.1 t -103.5 131.88 51.05 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.502 0 N-CA-C 108.534 -0.913 . . . . 1.32 108.534 -178.801 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A 1614 ' ' CYS . . . . . 0.574 ' HA ' ' O ' ' A' 1642 ' ' THR . 0.8 OUTLIER -70.06 101.64 1.86 Allowed 'General case' 0 C--N 1.305 -1.355 0 N-CA-C 115.518 1.673 . . . . 1.39 115.518 -178.167 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A 1615 ' ' ARG . . . . . 0.584 ' HB3' ' HB3' ' A' 1641 ' ' HIS . 75.9 ttt180 -137.81 107.07 8.25 Favored Pre-proline 0 C--N 1.323 -0.545 0 C-N-CA 124.221 1.009 . . . . 4.34 108.304 173.84 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A 1616 ' ' PRO . . . . . 0.434 ' HA ' ' HB3' ' A' 1643 ' ' PRO . 58.9 Cg_endo -69.75 64.45 1.79 Allowed 'Trans proline' 0 CA--C 1.546 1.087 0 C-N-CA 123.562 2.841 . . . . 1.5 115.194 -177.288 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A 1617 ' ' GLU . . . . . . . . . . . . . 29.5 mm-40 . . . . . 0 C--N 1.311 -1.081 0 N-CA-C 109.025 -0.731 . . . . 3.21 109.025 176.403 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A 1622 ' ' ASN . . . . . . . . . . . . . 27.5 t-20 . . . . . 0 CA--C 1.494 -1.176 0 CA-C-O 122.438 1.113 . . . . 3.58 110.23 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A 1623 ' ' ARG . . . . . 0.632 ' HD3' ' HA ' ' A' 1540 ' ' ALA . 3.5 ptp180 -75.78 149.38 83.15 Favored Pre-proline 0 C--N 1.283 -2.299 0 CA-C-N 112.456 -2.156 . . . . 4.09 111.537 -177.509 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A 1624 ' ' PRO . . . . . 0.654 ' HB3' ' HB2' ' A' 1640 ' ' TRP . 18.6 Cg_endo -60.2 159.7 25.54 Favored 'Trans proline' 0 C--N 1.364 1.357 0 C-N-CA 124.274 3.316 . . . . 2.86 112.427 177.824 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A 1625 ' ' MET . . . . . . . . . . . . . 72.2 mtm -119.81 150.46 40.39 Favored 'General case' 0 CA--C 1.494 -1.189 0 CA-C-O 121.226 0.536 . . . . 2.73 111.347 -178.313 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A 1626 ' ' LEU . . . . . 0.419 HD11 ' O ' ' A' 1637 ' ' PHE . 34.4 tp -83.27 108.98 16.85 Favored 'General case' 0 N--CA 1.43 -1.447 0 N-CA-C 106.632 -1.618 . . . . 1.94 106.632 172.572 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A 1627 ' ' ILE . . . . . . . . . . . . . 21.2 pt -85.48 -26.04 6.6 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.965 0 N-CA-C 112.346 0.499 . . . . 1.75 112.346 -173.992 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A 1628 ' ' SER . . . . . 0.521 ' HG ' ' HB2' ' A' 1637 ' ' PHE . 23.5 p -167.73 149.98 5.7 Favored 'General case' 0 N--CA 1.438 -1.042 0 CA-C-N 116.699 -0.228 . . . . 1.85 110.591 -177.711 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A 1629 ' ' LEU . . . . . 0.751 HD12 HD11 ' A' 1636 ' ' LEU . 33.1 tp -128.35 108.58 10.69 Favored 'General case' 0 N--CA 1.42 -1.956 0 O-C-N 123.812 0.695 . . . . 2.12 109.128 177.612 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A 1630 ' ' ASP . . . . . . . . . . . . . 10.0 t70 -83.94 98.44 9.8 Favored 'General case' 0 C--N 1.301 -1.52 0 N-CA-C 106.459 -1.682 . . . . 0.87 106.459 176.936 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A 1631 ' ' LYS . . . . . . . . . . . . . 96.8 mttt -71.65 -20.87 61.89 Favored 'General case' 0 C--N 1.312 -1.054 0 N-CA-C 113.489 0.922 . . . . 2.76 113.489 -173.024 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A 1632 ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -85.91 -39.31 17.1 Favored 'General case' 0 C--N 1.324 -0.529 0 N-CA-C 113.413 0.894 . . . . 2.55 113.413 -179.908 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A 1633 ' ' THR . . . . . . . . . . . . . 42.2 p -101.21 10.13 41.13 Favored 'General case' 0 C--N 1.315 -0.913 0 C-N-CA 119.459 -0.896 . . . . 1.92 111.547 177.877 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A 1634 ' ' CYS . . . . . 0.416 ' SG ' ' HB2' ' A' 1600 ' ' SER . 10.9 m 54.98 43.92 29.08 Favored 'General case' 0 C--O 1.245 0.833 0 C-N-CA 124.772 1.229 . . . . 0.89 111.714 170.177 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A 1635 ' ' THR . . . . . . . . . . . . . 20.9 m -108.16 122.1 46.21 Favored 'General case' 0 N--CA 1.422 -1.861 0 CA-C-N 115.338 -0.846 . . . . 1.31 110.72 -176.178 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A 1636 ' ' LEU . . . . . 0.751 HD11 HD12 ' A' 1629 ' ' LEU . 3.0 mm? -93.07 110.15 21.63 Favored 'General case' 0 C--N 1.312 -1.057 0 CA-C-N 115.296 -0.865 . . . . 1.97 108.925 179.986 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A 1637 ' ' PHE . . . . . 0.521 ' HB2' ' HG ' ' A' 1628 ' ' SER . 99.1 m-85 -100.51 99.21 9.78 Favored 'General case' 0 C--O 1.246 0.918 0 CA-C-O 120.797 0.332 . . . . 0.92 111.024 -179.132 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A 1638 ' ' PHE . . . . . 0.472 ' HB2' HG13 ' A' 1610 ' ' ILE . 94.9 m-85 -101.7 141.9 33.86 Favored 'General case' 0 C--N 1.299 -1.588 0 N-CA-C 108.72 -0.844 . . . . 0.7 108.72 176.759 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A 1639 ' ' SER . . . . . . . . . . . . . 16.7 t -134.84 137.87 43.68 Favored 'General case' 0 N--CA 1.412 -2.364 0 N-CA-C 109.083 -0.71 . . . . 1.46 109.083 -178.913 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A 1640 ' ' TRP . . . . . 0.654 ' HB2' ' HB3' ' A' 1624 ' ' PRO . 7.0 t90 -129.17 99.17 5.15 Favored 'General case' 0 N--CA 1.415 -2.188 0 N-CA-C 108.268 -1.012 . . . . 0.92 108.268 179.905 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A 1641 ' ' HIS . . . . . 0.584 ' HB3' ' HB3' ' A' 1615 ' ' ARG . 17.9 m-70 -81.24 95.45 6.95 Favored 'General case' 0 C--N 1.302 -1.463 0 N-CA-C 107.785 -1.191 . . . . 3.18 107.785 174.719 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A 1642 ' ' THR . . . . . 0.574 ' O ' ' HA ' ' A' 1614 ' ' CYS . 13.4 t -138.82 149.52 62.25 Favored Pre-proline 0 C--N 1.305 -1.354 0 CA-C-N 114.895 -1.048 . . . . 1.48 109.506 -169.375 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A 1643 ' ' PRO . . . . . 0.434 ' HB3' ' HA ' ' A' 1616 ' ' PRO . 58.6 Cg_endo -72.12 0.06 7.83 Favored 'Trans proline' 0 C--N 1.36 1.134 0 C-N-CA 123.833 3.022 . . . . 1.09 112.8 179.211 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A 1644 ' ' LEU . . . . . . . . . . . . . 62.5 mt -79.85 4.69 15.82 Favored 'General case' 0 C--N 1.315 -0.892 0 C-N-CA 123.214 0.606 . . . . 2.08 111.171 -178.987 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A 1645 ' ' ALA . . . . . . . . . . . . . . . -106.66 -42.22 5.03 Favored 'General case' 0 C--N 1.316 -0.879 0 CA-C-N 116.221 -0.445 . . . . 1.37 110.721 176.923 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A 1646 ' ' CYS . . . . . 0.423 ' N ' ' HB3' ' A' 1614 ' ' CYS . 10.7 m -143.23 144.64 32.23 Favored 'General case' 0 C--N 1.32 -0.684 0 N-CA-C 106.858 -1.534 . . . . 1.7 106.858 -179.303 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A 1647 ' ' GLU . . . . . . . . . . . . . 47.1 mt-10 . . . . . 0 C--N 1.3 -1.565 0 N-CA-C 109.988 -0.375 . . . . 2.92 109.988 178.816 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A 1515 ' ' ASP . . . . . . . . . . . . . 24.7 t0 . . . . . 0 N--CA 1.436 -1.149 0 N-CA-C 108.782 -0.821 . . . . 2.54 108.782 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A 1516 ' ' CYS . . . . . . . . . . . . . 9.6 m -78.2 54.03 1.31 Allowed 'General case' 0 C--N 1.31 -1.128 0 C-N-CA 123.828 0.851 . . . . 1.25 111.362 -175.249 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A 1517 ' ' GLN . . . . . . . . . . . . . 11.0 pt20 -132.62 122.78 25.23 Favored 'General case' 0 C--N 1.296 -1.724 0 N-CA-C 108.605 -0.887 . . . . 2.36 108.605 178.779 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A 1518 ' ' VAL . . . . . 0.409 ' HB ' ' CB ' ' A' 1581 ' ' LEU . 7.4 p -109.11 127.25 65.95 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.967 0 CA-C-O 121.621 0.724 . . . . 2.34 111.536 -175.364 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A 1519 ' ' THR . . . . . . . . . . . . . 5.2 m -92.43 118.65 31.17 Favored 'General case' 0 N--CA 1.421 -1.902 0 CA-C-N 115.569 -0.741 . . . . 2.04 109.168 178.312 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A 1520 ' ' ASN . . . . . 0.42 ' CG ' HG23 ' A' 1523 ' ' THR . 32.8 t-20 -84.11 113.83 50.59 Favored Pre-proline 0 C--N 1.31 -1.119 0 N-CA-C 107.513 -1.292 . . . . 2.12 107.513 175.918 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A 1521 ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -73.82 -9.58 22.53 Favored 'Trans proline' 0 C--N 1.354 0.834 0 C-N-CA 122.63 2.22 . . . . 2.59 113.475 -173.27 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A 1522 ' ' SER . . . . . . . . . . . . . 19.5 m -94.32 -50.96 5.01 Favored 'General case' 0 N--CA 1.427 -1.615 0 C-N-CA 120.825 -0.35 . . . . 2.65 111.365 -179.022 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A 1523 ' ' THR . . . . . 0.42 HG23 ' CG ' ' A' 1520 ' ' ASN . 13.8 t -89.79 -12.86 38.01 Favored 'General case' 0 CA--C 1.552 1.041 0 C-N-CA 119.805 -0.758 . . . . 2.33 111.184 -178.888 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A 1524 ' ' GLY . . . . . . . . . . . . . . . 73.41 20.36 79.85 Favored Glycine 0 C--O 1.222 -0.619 0 CA-C-N 116.062 -0.517 . . . . 1.96 113.634 177.698 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A 1525 ' ' HIS . . . . . . . . . . . . . 9.8 t60 -101.23 136.99 40.16 Favored 'General case' 0 C--N 1.31 -1.126 0 O-C-N 122.222 -0.575 . . . . 2.44 109.466 -177.801 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A 1526 ' ' LEU . . . . . . . . . . . . . 65.1 tp -95.3 106.25 18.27 Favored 'General case' 0 C--N 1.303 -1.449 0 N-CA-C 108.346 -0.983 . . . . 2.19 108.346 177.906 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A 1527 ' ' PHE . . . . . 0.495 ' CE1' ' HA ' ' A' 1646 ' ' CYS . 93.9 m-85 -89.53 104.94 17.45 Favored 'General case' 0 C--N 1.302 -1.476 0 CA-C-O 121.417 0.627 . . . . 1.61 109.441 -179.055 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A 1528 ' ' ASP . . . . . . . . . . . . . 10.9 t70 -89.9 114.67 26.49 Favored 'General case' 0 C--N 1.296 -1.735 0 CA-C-N 115.55 -0.75 . . . . 2.18 109.247 -179.843 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A 1529 ' ' LEU . . . . . 0.446 ' HA ' ' HG ' ' A' 1532 ' ' LEU . 37.6 mt -111.04 8.38 21.86 Favored 'General case' 0 C--N 1.295 -1.764 0 N-CA-C 107.918 -1.141 . . . . 2.04 107.918 178.983 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A 1530 ' ' SER . . . . . 0.424 ' HA ' ' SG ' ' A' 1553 ' ' CYS . 22.9 t -80.31 -45.75 17.31 Favored 'General case' 0 N--CA 1.439 -0.996 0 CA-C-N 114.597 -1.183 . . . . 1.44 109.307 -175.482 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A 1531 ' ' SER . . . . . . . . . . . . . 14.1 p -74.2 -16.86 60.96 Favored 'General case' 0 N--CA 1.438 -1.062 0 CA-C-N 115.514 -0.766 . . . . 1.63 111.589 -179.329 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A 1532 ' ' LEU . . . . . 0.485 HD12 HD12 ' A' 1644 ' ' LEU . 71.6 mt -65.96 -57.21 8.34 Favored 'General case' 0 CA--C 1.508 -0.651 0 CA-C-O 121.116 0.484 . . . . 2.32 111.398 -179.506 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A 1533 ' ' SER . . . . . . . . . . . . . 28.1 t -81.23 139.05 35.71 Favored 'General case' 0 N--CA 1.427 -1.583 0 CA-C-N 115.066 -0.97 . . . . 2.57 111.24 -173.037 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A 1534 ' ' GLY . . . . . . . . . . . . . . . -85.06 171.68 46.73 Favored Glycine 0 N--CA 1.416 -2.641 0 N-CA-C 107.65 -2.18 . . . . 1.89 107.65 170.652 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A 1535 ' ' ARG . . . . . . . . . . . . . 38.5 ttm180 -77.7 -15.68 58.99 Favored 'General case' 0 C--N 1.3 -1.569 0 CA-C-O 121.91 0.862 . . . . 4.44 110.764 -176.33 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A 1536 ' ' ALA . . . . . . . . . . . . . . . -84.23 -11.4 56.55 Favored 'General case' 0 C--O 1.242 0.668 0 N-CA-C 108.881 -0.785 . . . . 2.07 108.881 174.411 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A 1537 ' ' GLY . . . . . . . . . . . . . . . 74.92 -150.3 40.88 Favored Glycine 0 N--CA 1.426 -1.991 0 CA-C-N 114.701 -1.136 . . . . 1.2 113.459 178.17 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A 1538 ' ' PHE . . . . . 0.466 ' CD1' HD11 ' A' 1552 ' ' ILE . 95.5 m-85 -120.98 146.77 46.32 Favored 'General case' 0 C--N 1.295 -1.803 0 N-CA-C 107.765 -1.198 . . . . 1.98 107.765 177.746 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A 1539 ' ' THR . . . . . . . . . . . . . 30.2 p -99.38 113.53 25.91 Favored 'General case' 0 C--N 1.283 -2.298 0 CA-C-O 121.323 0.582 . . . . 1.97 109.993 179.591 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A 1540 ' ' ALA . . . . . 0.686 ' HB3' HG11 ' A' 1548 ' ' VAL . . . -93.84 148.56 22.02 Favored 'General case' 0 C--N 1.296 -1.726 0 CA-C-N 115.724 -0.671 . . . . 1.39 109.899 -177.575 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A 1541 ' ' ALA . . . . . . . . . . . . . . . -85.7 128.38 34.77 Favored 'General case' 0 N--CA 1.439 -0.982 0 N-CA-C 109.025 -0.731 . . . . 1.86 109.025 178.51 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A 1542 ' ' TYR . . . . . 0.538 ' HD2' ' HB2' ' A' 1545 ' ' SER . 72.9 t80 -136.54 171.79 13.97 Favored 'General case' 0 C--N 1.296 -1.758 0 CA-C-N 116.007 -0.542 . . . . 2.4 109.826 -177.667 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A 1543 ' ' SER . . . . . . . . . . . . . 3.6 m -45.67 -150.79 0.0 OUTLIER 'General case' 0 CA--C 1.573 1.855 0 C-N-CA 130.466 3.507 . . . . 2.58 114.147 177.537 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A 1544 ' ' LYS . . . . . . . . . . . . . 22.6 tptm -39.55 -37.22 0.46 Allowed 'General case' 0 N--CA 1.495 1.799 0 N-CA-C 113.531 0.937 . . . . 4.24 113.531 178.842 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A 1545 ' ' SER . . . . . 0.538 ' HB2' ' HD2' ' A' 1542 ' ' TYR . 15.7 m -65.08 -21.22 66.78 Favored 'General case' 0 CA--C 1.557 1.246 0 N-CA-C 112.023 0.379 . . . . 3.6 112.023 178.401 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A 1546 ' ' GLY . . . . . . . . . . . . . . . 82.45 -67.18 3.76 Favored Glycine 0 N--CA 1.443 -0.839 0 N-CA-C 113.866 0.307 . . . . 1.66 113.866 176.154 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A 1547 ' ' VAL . . . . . . . . . . . . . 72.0 t -128.67 144.48 37.88 Favored 'Isoleucine or valine' 0 N--CA 1.419 -1.997 0 C-N-CA 122.985 0.514 . . . . 2.23 110.228 -175.031 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A 1548 ' ' VAL . . . . . 0.686 HG11 ' HB3' ' A' 1540 ' ' ALA . 2.6 p -133.69 127.58 52.99 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.219 0 N-CA-C 108.309 -0.997 . . . . 1.59 108.309 173.285 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A 1549 ' ' TYR . . . . . 0.507 ' CZ ' ' HA2' ' A' 1568 ' ' GLY . 0.6 OUTLIER -101.49 133.23 46.46 Favored 'General case' 0 C--N 1.303 -1.43 0 CA-C-O 121.756 0.789 . . . . 1.58 112.296 -179.188 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A 1550 ' ' MET . . . . . . . . . . . . . 43.2 ttp -144.51 129.33 18.32 Favored 'General case' 0 C--N 1.296 -1.751 0 CA-C-N 114.666 -1.152 . . . . 2.08 109.704 -176.37 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A 1551 ' ' SER . . . . . . . . . . . . . 50.5 m -88.16 139.8 30.13 Favored 'General case' 0 C--N 1.289 -2.035 0 N-CA-C 108.671 -0.863 . . . . 1.9 108.671 178.207 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A 1552 ' ' ILE . . . . . 0.472 HD13 ' HG3' ' A' 1624 ' ' PRO . 1.4 mp -87.13 -6.61 10.7 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.2 0 CA-C-O 122.773 1.273 . . . . 2.04 109.462 178.876 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A 1553 ' ' CYS . . . . . 0.424 ' SG ' ' HA ' ' A' 1530 ' ' SER . 54.1 t -157.8 138.28 12.84 Favored 'General case' 0 N--CA 1.416 -2.132 0 CA-C-N 114.179 -1.373 . . . . 1.43 108.843 174.501 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A 1554 ' ' GLY . . . . . . . . . . . . . . . 74.09 -169.35 53.89 Favored Glycine 0 N--CA 1.434 -1.497 0 O-C-N 123.958 0.786 . . . . 1.23 113.816 174.635 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A 1555 ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -72.91 153.44 41.0 Favored 'General case' 0 C--N 1.311 -1.068 0 CA-C-N 114.805 -0.697 . . . . 1.8 111.362 179.412 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A 1556 ' ' ASN . . . . . . . . . . . . . 25.4 t-20 -105.4 139.31 40.23 Favored 'General case' 0 N--CA 1.414 -2.227 0 CA-C-N 114.509 -1.223 . . . . 2.63 108.01 177.494 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A 1557 ' ' GLU . . . . . . . . . . . . . 45.9 mt-10 -102.53 174.9 5.69 Favored 'General case' 0 C--N 1.29 -2.013 0 CA-C-N 115.864 -0.607 . . . . 3.79 110.856 -178.251 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A 1558 ' ' ASN . . . . . . . . . . . . . 46.5 m-80 72.44 12.17 5.64 Favored 'General case' 0 N--CA 1.486 1.355 0 C-N-CA 124.685 1.194 . . . . 1.59 110.597 -176.026 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A 1559 ' ' CYS . . . . . 0.627 ' SG ' ' HD2' ' A' 1560 ' ' PRO . 22.5 t -160.69 152.45 16.49 Favored Pre-proline 0 C--N 1.295 -1.784 0 N-CA-C 103.856 -2.646 . . . . 0.94 103.856 179.168 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A 1560 ' ' PRO . . . . . 0.627 ' HD2' ' SG ' ' A' 1559 ' ' CYS . 39.2 Cg_exo -24.24 112.59 0.02 OUTLIER 'Trans proline' 0 C--N 1.368 1.591 0 C-N-CA 125.253 3.968 . . . . 1.53 115.472 179.075 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A 1561 ' ' PRO . . . . . 0.411 ' HD2' ' HA ' ' A' 1560 ' ' PRO . 9.6 Cg_endo -53.76 110.63 0.52 Allowed 'Trans proline' 0 C--O 1.237 0.475 0 C-N-CA 123.685 2.923 . . . . 1.82 112.58 179.846 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A 1562 ' ' GLY . . . . . . . . . . . . . . . 133.78 -16.26 4.53 Favored Glycine 0 N--CA 1.439 -1.121 0 C-N-CA 120.528 -0.844 . . . . 0.81 111.84 179.254 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A 1563 ' ' VAL . . . . . 0.406 ' HA ' ' HA ' ' A' 1576 ' ' LYS . 4.3 m -86.83 157.35 3.25 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.264 0 N-CA-C 107.586 -1.264 . . . . 1.73 107.586 178.834 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A 1564 ' ' GLY . . . . . . . . . . . . . . . -111.44 -22.93 5.91 Favored Glycine 0 N--CA 1.444 -0.791 0 C-N-CA 120.459 -0.877 . . . . 0.72 112.545 -177.904 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A 1565 ' ' ALA . . . . . . . . . . . . . . . -141.51 125.45 17.15 Favored 'General case' 0 C--O 1.247 0.957 0 N-CA-C 109.553 -0.536 . . . . 1.14 109.553 -179.437 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A 1566 ' ' CYS . . . . . . . . . . . . . 53.9 t -148.94 132.91 17.14 Favored 'General case' 0 C--N 1.314 -0.946 0 CA-C-N 116.324 -0.398 . . . . 0.51 109.999 -176.476 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A 1567 ' ' PHE . . . . . . . . . . . . . 35.0 m-85 -63.82 134.82 55.94 Favored 'General case' 0 N--CA 1.474 0.742 0 N-CA-C 108.106 -1.072 . . . . 1.22 108.106 177.205 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A 1568 ' ' GLY . . . . . 0.507 ' HA2' ' CZ ' ' A' 1549 ' ' TYR . . . -73.67 -30.74 61.46 Favored Glycine 0 CA--C 1.498 -0.989 0 CA-C-N 116.42 -0.354 . . . . 1.08 113.727 -173.199 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A 1569 ' ' GLN . . . . . . . . . . . . . 8.5 tp-100 -82.45 -56.83 3.64 Favored 'General case' 0 C--N 1.304 -1.376 0 CA-C-O 121.359 0.6 . . . . 3.05 110.511 -179.725 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A 1570 ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -72.06 -27.29 62.59 Favored 'General case' 0 N--CA 1.426 -1.654 0 CA-C-N 114.963 -1.017 . . . . 2.44 111.33 -174.974 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A 1571 ' ' ARG . . . . . . . . . . . . . 42.7 ttp180 52.87 60.75 3.58 Favored 'General case' 0 C--O 1.235 0.315 0 CA-C-O 121.85 0.833 . . . . 4.48 109.687 -176.781 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A 1572 ' ' ILE . . . . . . . . . . . . . 40.4 mm -131.58 129.55 61.78 Favored 'Isoleucine or valine' 0 C--O 1.251 1.165 0 N-CA-C 106.915 -1.513 . . . . 1.94 106.915 179.405 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A 1573 ' ' SER . . . . . . . . . . . . . 35.7 t -73.04 140.04 46.99 Favored 'General case' 0 C--N 1.303 -1.437 0 O-C-N 124.126 0.891 . . . . 1.25 111.357 -178.373 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A 1574 ' ' VAL . . . . . . . . . . . . . 18.0 m -133.06 19.77 1.44 Allowed 'Isoleucine or valine' 0 C--N 1.314 -0.937 0 CA-C-N 115.815 -0.63 . . . . 1.61 110.828 174.587 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A 1575 ' ' GLY . . . . . . . . . . . . . . . 173.73 126.58 0.92 Allowed Glycine 0 N--CA 1.44 -1.058 0 C-N-CA 120.627 -0.797 . . . . 0.65 111.869 178.336 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A 1576 ' ' LYS . . . . . 0.406 ' HA ' ' HA ' ' A' 1563 ' ' VAL . 59.0 tttp -82.98 147.45 28.19 Favored 'General case' 0 C--O 1.239 0.552 0 N-CA-C 107.57 -1.271 . . . . 3.33 107.57 179.263 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A 1577 ' ' ALA . . . . . . . . . . . . . . . -68.92 79.16 0.31 Allowed 'General case' 0 N--CA 1.475 0.804 0 N-CA-C 113.041 0.756 . . . . 1.31 113.041 -174.151 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A 1578 ' ' ASN . . . . . . . . . . . . . 32.0 m-80 -96.67 113.41 24.97 Favored 'General case' 0 C--N 1.297 -1.716 0 N-CA-C 108.107 -1.071 . . . . 2.24 108.107 175.519 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A 1579 ' ' LYS . . . . . . . . . . . . . 52.8 pttt -96.92 109.2 21.98 Favored 'General case' 0 C--N 1.291 -1.972 0 CA-C-O 121.311 0.577 . . . . 2.34 109.712 -178.859 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A 1580 ' ' ARG . . . . . . . . . . . . . 32.7 ttm180 -158.43 94.18 1.26 Allowed 'General case' 0 N--CA 1.43 -1.445 0 CA-C-N 115.033 -0.985 . . . . 4.19 109.435 -177.36 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A 1581 ' ' LEU . . . . . 0.409 ' CB ' ' HB ' ' A' 1518 ' ' VAL . 4.4 mm? -85.52 124.5 32.16 Favored 'General case' 0 C--N 1.302 -1.491 0 CA-C-N 116.275 -0.421 . . . . 2.39 110.554 178.011 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A 1582 ' ' ARG . . . . . . . . . . . . . 89.0 mtm180 -120.29 134.32 55.29 Favored 'General case' 0 C--N 1.29 -1.98 0 CA-C-O 121.112 0.482 . . . . 4.48 110.863 177.076 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A 1583 ' ' TYR . . . . . 0.442 ' HD1' HD21 ' A' 1588 ' ' LEU . 80.1 t80 -94.9 96.84 9.58 Favored 'General case' 0 C--N 1.292 -1.904 0 N-CA-C 107.485 -1.302 . . . . 1.57 107.485 176.908 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A 1584 ' ' VAL . . . . . . . . . . . . . 36.5 t -112.3 95.16 3.6 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.287 0 CA-C-N 115.653 -0.703 . . . . 2.29 109.528 -176.176 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A 1585 ' ' ASP . . . . . . . . . . . . . 35.1 t70 54.72 75.57 0.29 Allowed 'General case' 0 C--N 1.32 -0.708 0 C-N-CA 124.308 1.043 . . . . 2.06 112.472 177.775 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A 1586 ' ' GLN . . . . . . . . . . . . . 34.1 tt0 68.16 -14.67 0.24 Allowed 'General case' 0 CA--C 1.574 1.888 0 C-N-CA 124.868 1.267 . . . . 2.61 114.398 176.403 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A 1587 ' ' VAL . . . . . . . . . . . . . 7.5 p -118.4 129.62 74.43 Favored 'Isoleucine or valine' 0 C--O 1.25 1.09 0 O-C-N 121.273 -0.892 . . . . 1.33 111.484 -179.4 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A 1588 ' ' LEU . . . . . 0.718 ' HB2' ' HB2' ' A' 1612 ' ' PHE . 3.8 mm? -81.26 157.53 25.13 Favored 'General case' 0 N--CA 1.435 -1.189 0 CA-C-N 115.23 -0.896 . . . . 2.03 110.415 179.001 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A 1589 ' ' GLN . . . . . . . . . . . . . 34.6 tt0 -148.05 134.96 20.14 Favored 'General case' 0 C--N 1.31 -1.148 0 C-N-CA 121.154 -0.218 . . . . 1.73 110.643 -174.715 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A 1590 ' ' LEU . . . . . 0.452 ' HB3' ' HB ' ' A' 1610 ' ' ILE . 51.0 tp -119.39 133.39 55.74 Favored 'General case' 0 C--N 1.301 -1.507 0 N-CA-C 106.95 -1.5 . . . . 1.76 106.95 175.396 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A 1591 ' ' VAL . . . . . . . . . . . . . 52.8 t -126.99 111.63 26.31 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.537 0 CA-C-O 121.022 0.439 . . . . 2.14 111.969 -174.884 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A 1592 ' ' TYR . . . . . . . . . . . . . 20.6 m-85 -101.37 93.05 5.21 Favored 'General case' 0 C--N 1.308 -1.205 0 N-CA-C 108.512 -0.921 . . . . 1.53 108.512 173.87 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A 1593 ' ' LYS . . . . . . . . . . . . . 61.4 pttt -103.36 177.21 4.91 Favored 'General case' 0 C--N 1.283 -2.321 0 CA-C-N 115.569 -0.741 . . . . 2.72 109.926 -178.754 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A 1594 ' ' ASP . . . . . . . . . . . . . 8.3 m-20 53.96 42.04 31.81 Favored 'General case' 0 N--CA 1.475 0.8 0 N-CA-C 113.923 1.083 . . . . 1.45 113.923 175.74 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A 1595 ' ' GLY . . . . . . . . . . . . . . . -74.58 -87.49 0.24 Allowed Glycine 0 N--CA 1.445 -0.704 0 C-N-CA 120.356 -0.926 . . . . 0.83 111.069 176.477 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A 1596 ' ' SER . . . . . . . . . . . . . 32.4 m -114.43 154.33 46.5 Favored Pre-proline 0 C--N 1.294 -1.807 0 N-CA-C 108.258 -1.016 . . . . 1.96 108.258 177.599 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A 1597 ' ' PRO . . . . . . . . . . . . . 23.1 Cg_exo -67.03 133.32 30.65 Favored 'Trans proline' 0 C--N 1.351 0.672 0 C-N-CA 122.849 2.366 . . . . 1.34 109.997 177.153 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A 1598 ' ' CYS . . . . . 0.427 ' HA ' ' HD3' ' A' 1599 ' ' PRO . 42.4 t -97.68 121.14 58.9 Favored Pre-proline 0 C--N 1.289 -2.055 0 CA-C-O 120.533 0.206 . . . . 1.19 110.768 -175.939 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A 1599 ' ' PRO . . . . . 0.427 ' HD3' ' HA ' ' A' 1598 ' ' CYS . 2.8 Cg_exo -77.52 -7.83 16.95 Favored 'Trans proline' 0 C--O 1.238 0.494 0 C-N-CA 123.23 2.62 . . . . 1.88 112.227 179.992 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A 1600 ' ' SER . . . . . 0.419 ' HB3' ' SG ' ' A' 1598 ' ' CYS . 22.8 t -75.32 -19.7 59.49 Favored 'General case' 0 C--N 1.317 -0.811 0 CA-C-N 115.831 -0.622 . . . . 2.19 110.313 -177.563 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A 1601 ' ' LYS . . . . . 0.546 ' HB3' HD12 ' A' 1604 ' ' LEU . 24.5 tptm -162.33 116.64 1.82 Allowed 'General case' 0 N--CA 1.443 -0.82 0 N-CA-C 108.556 -0.905 . . . . 4.21 108.556 178.915 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A 1602 ' ' SER . . . . . . . . . . . . . 51.4 m -61.3 123.2 17.09 Favored 'General case' 0 C--N 1.313 -1.01 0 CA-C-O 121.393 0.616 . . . . 3.82 111.588 179.202 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A 1603 ' ' GLY . . . . . . . . . . . . . . . 104.94 -1.45 41.33 Favored Glycine 0 N--CA 1.439 -1.1 0 CA-C-N 115.067 -0.969 . . . . 2.45 111.004 -179.895 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A 1604 ' ' LEU . . . . . 0.546 HD12 ' HB3' ' A' 1601 ' ' LYS . 3.0 mt -107.05 145.3 32.53 Favored 'General case' 0 C--N 1.31 -1.111 0 CA-C-O 121.692 0.758 . . . . 2.06 111.859 179.62 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A 1605 ' ' SER . . . . . . . . . . . . . 25.6 m -111.27 -173.94 2.35 Favored 'General case' 0 C--N 1.29 -1.987 0 N-CA-C 105.824 -1.917 . . . . 1.75 105.824 172.929 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A 1606 ' ' TYR . . . . . . . . . . . . . 62.1 m-85 -101.59 128.67 47.75 Favored 'General case' 0 CA--C 1.453 -2.78 0 N-CA-C 105.792 -1.929 . . . . 1.59 105.792 178.014 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A 1607 ' ' LYS . . . . . 0.493 ' O ' ' HA ' ' A' 1635 ' ' THR . 4.3 ptmm? -128.05 135.06 49.33 Favored 'General case' 0 N--CA 1.397 -3.075 0 O-C-N 124.506 1.129 . . . . 2.21 111.152 -176.813 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A 1608 ' ' SER . . . . . . . . . . . . . 35.1 t -114.98 125.89 54.13 Favored 'General case' 0 C--N 1.292 -1.921 0 N-CA-C 109.339 -0.615 . . . . 1.48 109.339 -178.753 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A 1609 ' ' VAL . . . . . . . . . . . . . 41.3 t -115.14 115.39 49.31 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.814 0 CA-C-O 121.237 0.541 . . . . 1.57 110.439 178.854 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A 1610 ' ' ILE . . . . . 0.66 HG13 ' HB2' ' A' 1638 ' ' PHE . 2.9 mp -102.16 113.67 39.3 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.338 0 N-CA-C 108.717 -0.845 . . . . 1.47 108.717 178.962 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A 1611 ' ' SER . . . . . . . . . . . . . 42.7 m -95.17 123.36 38.63 Favored 'General case' 0 C--N 1.284 -2.26 0 N-CA-C 109.012 -0.736 . . . . 1.84 109.012 177.367 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A 1612 ' ' PHE . . . . . 0.718 ' HB2' ' HB2' ' A' 1588 ' ' LEU . 98.2 m-85 -92.62 103.51 15.9 Favored 'General case' 0 C--N 1.305 -1.353 0 N-CA-C 108.831 -0.803 . . . . 0.86 108.831 178.835 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A 1613 ' ' VAL . . . . . 0.619 ' O ' ' HA ' ' A' 1641 ' ' HIS . 24.0 t -100.2 109.23 24.51 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.883 0 N-CA-C 107.224 -1.399 . . . . 1.32 107.224 -174.918 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A 1614 ' ' CYS . . . . . 0.553 ' HA ' ' O ' ' A' 1642 ' ' THR . 31.8 m -70.23 100.47 1.7 Allowed 'General case' 0 C--N 1.279 -2.458 0 CA-C-N 115.963 -0.562 . . . . 1.39 111.516 -174.362 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A 1615 ' ' ARG . . . . . 0.414 ' HB3' ' HB3' ' A' 1641 ' ' HIS . 56.9 ttt180 -126.77 99.07 29.99 Favored Pre-proline 0 N--CA 1.439 -0.993 0 CA-C-N 115.479 -0.782 . . . . 4.34 109.412 -179.152 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A 1616 ' ' PRO . . . . . 0.435 ' HA ' ' HB3' ' A' 1643 ' ' PRO . 76.7 Cg_exo -52.43 -34.42 61.37 Favored 'Trans proline' 0 CA--C 1.534 0.489 0 C-N-CA 123.993 3.129 . . . . 1.5 113.834 177.781 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A 1617 ' ' GLU . . . . . . . . . . . . . 48.2 mt-10 . . . . . 0 CA--C 1.545 0.753 0 N-CA-C 112.611 0.597 . . . . 3.21 112.611 -177.938 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A 1622 ' ' ASN . . . . . . . . . . . . . 27.6 t-20 . . . . . 0 N--CA 1.433 -1.29 0 CA-C-O 121.785 0.803 . . . . 3.58 111.885 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A 1623 ' ' ARG . . . . . . . . . . . . . 19.8 ptp180 -151.89 156.95 34.47 Favored Pre-proline 0 C--N 1.3 -1.583 0 N-CA-C 105.048 -2.204 . . . . 4.09 105.048 175.229 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A 1624 ' ' PRO . . . . . 0.472 ' HG3' HD13 ' A' 1552 ' ' ILE . 13.6 Cg_endo -56.22 115.76 2.7 Favored 'Trans proline' 0 C--O 1.237 0.433 0 C-N-CA 122.669 2.246 . . . . 2.86 112.154 -179.313 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A 1625 ' ' MET . . . . . . . . . . . . . 1.3 pmm? -106.48 147.7 29.05 Favored 'General case' 0 C--O 1.245 0.845 0 CA-C-O 120.999 0.428 . . . . 2.73 110.485 -179.216 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A 1626 ' ' LEU . . . . . . . . . . . . . 52.1 tp -77.6 122.02 24.72 Favored 'General case' 0 C--N 1.317 -0.842 0 N-CA-C 107.855 -1.165 . . . . 1.94 107.855 176.837 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A 1627 ' ' ILE . . . . . . . . . . . . . 39.1 pt -100.88 -32.81 3.5 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.214 0 C-N-CA 120.48 -0.488 . . . . 1.75 111.286 -179.021 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A 1628 ' ' SER . . . . . . . . . . . . . 49.5 m -151.11 153.28 34.73 Favored 'General case' 0 C--N 1.314 -0.97 0 CA-C-O 120.789 0.328 . . . . 1.85 110.283 -177.589 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A 1629 ' ' LEU . . . . . 0.93 HD12 ' HG ' ' A' 1636 ' ' LEU . 17.7 tp -139.12 120.39 14.79 Favored 'General case' 0 C--N 1.294 -1.809 0 N-CA-C 108.522 -0.918 . . . . 2.12 108.522 177.47 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A 1630 ' ' ASP . . . . . . . . . . . . . 23.0 t70 -118.29 107.33 13.76 Favored 'General case' 0 C--N 1.299 -1.624 0 N-CA-C 109.658 -0.497 . . . . 0.87 109.658 176.855 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A 1631 ' ' LYS . . . . . . . . . . . . . 34.8 mtmm -78.74 -13.13 59.98 Favored 'General case' 0 C--N 1.303 -1.416 0 CA-C-N 115.514 -0.766 . . . . 2.76 111.07 -176.997 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A 1632 ' ' GLN . . . . . . . . . . . . . 40.2 mt-30 -70.35 -42.63 71.58 Favored 'General case' 0 C--N 1.323 -0.544 0 N-CA-C 109.587 -0.523 . . . . 2.55 109.587 178.254 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A 1633 ' ' THR . . . . . . . . . . . . . 35.9 p -98.27 4.2 48.77 Favored 'General case' 0 C--N 1.318 -0.765 0 CA-C-O 121.047 0.451 . . . . 1.92 110.821 175.747 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A 1634 ' ' CYS . . . . . . . . . . . . . 59.1 m 56.55 38.8 29.91 Favored 'General case' 0 C--O 1.236 0.394 0 C-N-CA 124.195 0.998 . . . . 0.89 110.461 177.361 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A 1635 ' ' THR . . . . . 0.493 ' HA ' ' O ' ' A' 1607 ' ' LYS . 44.2 m -119.73 131.45 55.38 Favored 'General case' 0 N--CA 1.422 -1.841 0 CA-C-N 114.945 -1.025 . . . . 1.31 111.597 -174.223 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A 1636 ' ' LEU . . . . . 0.93 ' HG ' HD12 ' A' 1629 ' ' LEU . 5.2 mp -104.12 134.89 46.61 Favored 'General case' 0 N--CA 1.434 -1.25 0 N-CA-C 108.04 -1.096 . . . . 1.97 108.04 174.838 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A 1637 ' ' PHE . . . . . . . . . . . . . 93.9 m-85 -111.42 105.83 14.57 Favored 'General case' 0 C--N 1.307 -1.279 0 CA-C-O 120.919 0.39 . . . . 0.92 111.008 -176.844 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A 1638 ' ' PHE . . . . . 0.66 ' HB2' HG13 ' A' 1610 ' ' ILE . 96.4 m-85 -103.11 151.87 22.06 Favored 'General case' 0 C--N 1.306 -1.304 0 N-CA-C 109.03 -0.73 . . . . 0.7 109.03 177.398 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A 1639 ' ' SER . . . . . . . . . . . . . 49.0 m -137.08 133.82 35.82 Favored 'General case' 0 C--N 1.276 -2.598 0 N-CA-C 109.705 -0.48 . . . . 1.46 109.705 176.656 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A 1640 ' ' TRP . . . . . 0.585 ' HE3' ' HE1' ' A' 1612 ' ' PHE . 12.3 t90 -115.58 120.93 41.07 Favored 'General case' 0 N--CA 1.413 -2.306 0 N-CA-C 106.274 -1.75 . . . . 0.92 106.274 174.164 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A 1641 ' ' HIS . . . . . 0.619 ' HA ' ' O ' ' A' 1613 ' ' VAL . 39.1 m-70 -93.89 92.34 7.36 Favored 'General case' 0 C--N 1.304 -1.378 0 N-CA-C 107.517 -1.29 . . . . 3.18 107.517 -177.922 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A 1642 ' ' THR . . . . . 0.724 HG23 ' HG ' ' A' 1644 ' ' LEU . 1.5 m -119.91 123.62 28.34 Favored Pre-proline 0 C--N 1.289 -2.053 0 CA-C-N 114.947 -1.024 . . . . 1.48 111.884 -167.96 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A 1643 ' ' PRO . . . . . 0.435 ' HB3' ' HA ' ' A' 1616 ' ' PRO . 31.7 Cg_exo -65.24 -29.7 55.1 Favored 'Trans proline' 0 CA--C 1.539 0.745 0 C-N-CA 123.443 2.762 . . . . 1.09 112.861 177.001 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A 1644 ' ' LEU . . . . . 0.724 ' HG ' HG23 ' A' 1642 ' ' THR . 4.4 pp -84.07 -6.76 59.46 Favored 'General case' 0 C--N 1.323 -0.562 0 N-CA-C 112.104 0.409 . . . . 2.08 112.104 -176.969 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A 1645 ' ' ALA . . . . . 0.601 ' HB1' ' HB ' ' A' 1642 ' ' THR . . . -74.14 -30.92 62.51 Favored 'General case' 0 C--N 1.306 -1.3 0 CA-C-N 116.022 -0.536 . . . . 1.37 112.165 -174.941 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A 1646 ' ' CYS . . . . . 0.495 ' HA ' ' CE1' ' A' 1527 ' ' PHE . 17.0 p -177.38 175.29 1.48 Allowed 'General case' 0 C--O 1.246 0.871 0 N-CA-C 106.999 -1.482 . . . . 1.7 106.999 175.288 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A 1647 ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 . . . . . 0 C--N 1.299 -1.608 0 N-CA-C 108.54 -0.911 . . . . 2.92 108.54 175.871 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A 1515 ' ' ASP . . . . . . . . . . . . . 17.3 t70 . . . . . 0 CA--C 1.551 0.991 0 N-CA-C 109.958 -0.386 . . . . 2.54 109.958 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A 1516 ' ' CYS . . . . . 0.457 ' SG ' ' HD2' ' A' 1579 ' ' LYS . 97.1 m -137.09 18.96 2.98 Favored 'General case' 0 C--N 1.316 -0.874 0 CA-C-O 121.194 0.521 . . . . 1.25 110.456 175.104 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A 1517 ' ' GLN . . . . . 0.478 ' HB2' HD22 ' A' 1526 ' ' LEU . 11.2 pt20 -132.54 137.47 47.14 Favored 'General case' 0 C--N 1.302 -1.469 0 O-C-N 121.809 -0.557 . . . . 2.36 109.7 178.92 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A 1518 ' ' VAL . . . . . . . . . . . . . 10.2 p -143.55 134.87 22.83 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.664 0 CA-C-O 121.025 0.441 . . . . 2.34 110.288 -178.402 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A 1519 ' ' THR . . . . . 0.763 ' HA ' ' HA ' ' A' 1526 ' ' LEU . 23.3 m -85.3 120.84 27.22 Favored 'General case' 0 C--N 1.3 -1.549 0 N-CA-C 109.327 -0.62 . . . . 2.04 109.327 178.781 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A 1520 ' ' ASN . . . . . 0.402 ' OD1' HG21 ' A' 1523 ' ' THR . 24.0 t-20 -71.98 119.71 76.02 Favored Pre-proline 0 C--N 1.314 -0.937 0 N-CA-C 109.327 -0.62 . . . . 2.12 109.327 179.131 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A 1521 ' ' PRO . . . . . . . . . . . . . 86.5 Cg_endo -75.09 -2.95 13.22 Favored 'Trans proline' 0 CA--C 1.539 0.749 0 C-N-CA 122.64 2.227 . . . . 2.59 113.953 -175.31 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A 1522 ' ' SER . . . . . . . . . . . . . 32.8 m -94.11 -49.75 5.61 Favored 'General case' 0 C--N 1.305 -1.341 0 O-C-N 122.104 -0.373 . . . . 2.65 111.101 -179.375 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A 1523 ' ' THR . . . . . 0.402 HG21 ' OD1' ' A' 1520 ' ' ASN . 12.0 t -96.53 -16.99 20.8 Favored 'General case' 0 CA--C 1.553 1.07 0 CA-C-O 121.255 0.55 . . . . 2.33 111.097 -179.901 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A 1524 ' ' GLY . . . . . . . . . . . . . . . 81.84 8.16 87.08 Favored Glycine 0 C--O 1.222 -0.601 0 C-N-CA 121.507 -0.378 . . . . 1.96 112.918 178.83 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A 1525 ' ' HIS . . . . . . . . . . . . . 16.0 t-160 -101.69 134.97 44.01 Favored 'General case' 0 C--N 1.302 -1.47 0 N-CA-C 109.432 -0.581 . . . . 2.44 109.432 -178.306 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A 1526 ' ' LEU . . . . . 0.763 ' HA ' ' HA ' ' A' 1519 ' ' THR . 6.7 tt -84.98 135.21 34.13 Favored 'General case' 0 C--N 1.303 -1.43 0 CA-C-N 116.387 -0.369 . . . . 2.19 110.735 177.819 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A 1527 ' ' PHE . . . . . . . . . . . . . 80.7 m-85 -99.8 113.03 25.27 Favored 'General case' 0 C--N 1.309 -1.195 0 N-CA-C 108.078 -1.082 . . . . 1.61 108.078 174.546 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A 1528 ' ' ASP . . . . . . . . . . . . . 11.8 t70 -100.59 103.55 14.86 Favored 'General case' 0 C--N 1.302 -1.495 0 N-CA-C 108.927 -0.768 . . . . 2.18 108.927 -179.455 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A 1529 ' ' LEU . . . . . 0.45 ' HA ' ' HG ' ' A' 1532 ' ' LEU . 78.7 mt -89.5 -13.81 36.63 Favored 'General case' 0 C--N 1.298 -1.65 0 N-CA-C 108.234 -1.024 . . . . 2.04 108.234 -176.145 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A 1530 ' ' SER . . . . . 0.427 ' OG ' ' HB2' ' A' 1516 ' ' CYS . 3.2 m -58.03 -54.83 42.56 Favored 'General case' 0 N--CA 1.438 -1.065 0 C-N-CA 124.788 1.235 . . . . 1.44 110.742 -179.58 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A 1531 ' ' SER . . . . . . . . . . . . . 5.6 m -81.23 1.43 32.29 Favored 'General case' 0 C--N 1.317 -0.829 0 CA-C-N 115.886 -0.597 . . . . 1.63 111.592 -175.722 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A 1532 ' ' LEU . . . . . 0.45 ' HG ' ' HA ' ' A' 1529 ' ' LEU . 32.3 mt -82.41 -18.34 42.28 Favored 'General case' 0 C--N 1.319 -0.757 0 C-N-CA 120.036 -0.666 . . . . 2.32 110.661 179.507 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A 1533 ' ' SER . . . . . 0.856 ' HB2' HG22 ' A' 1552 ' ' ILE . 22.7 t -114.2 134.13 55.13 Favored 'General case' 0 N--CA 1.432 -1.341 0 N-CA-C 108.523 -0.917 . . . . 2.57 108.523 178.417 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A 1534 ' ' GLY . . . . . . . . . . . . . . . -81.93 173.46 53.53 Favored Glycine 0 N--CA 1.429 -1.768 0 N-CA-C 107.724 -2.15 . . . . 1.89 107.724 172.148 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A 1535 ' ' ARG . . . . . . . . . . . . . 14.8 ttp180 -72.3 -17.8 61.84 Favored 'General case' 0 C--N 1.31 -1.151 0 CA-C-N 118.254 1.027 . . . . 4.44 110.55 -178.842 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A 1536 ' ' ALA . . . . . . . . . . . . . . . -84.86 -6.92 59.35 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 116.109 -0.496 . . . . 2.07 110.198 176.423 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A 1537 ' ' GLY . . . . . . . . . . . . . . . 59.84 -153.81 33.06 Favored Glycine 0 N--CA 1.447 -0.569 0 CA-C-N 115.321 -0.854 . . . . 1.2 114.126 177.366 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A 1538 ' ' PHE . . . . . . . . . . . . . 96.2 m-85 -113.55 163.72 14.57 Favored 'General case' 0 C--N 1.294 -1.819 0 N-CA-C 108.027 -1.101 . . . . 1.98 108.027 178.441 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A 1539 ' ' THR . . . . . . . . . . . . . 9.5 t -143.99 130.64 20.14 Favored 'General case' 0 C--N 1.287 -2.128 0 N-CA-C 108.991 -0.744 . . . . 1.97 108.991 177.88 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A 1540 ' ' ALA . . . . . . . . . . . . . . . -131.96 143.72 50.3 Favored 'General case' 0 C--N 1.306 -1.307 0 N-CA-C 109.054 -0.721 . . . . 1.39 109.054 -177.374 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A 1541 ' ' ALA . . . . . . . . . . . . . . . -82.14 151.46 26.95 Favored 'General case' 0 C--N 1.31 -1.124 0 CA-C-N 116.167 -0.47 . . . . 1.86 110.386 -178.991 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A 1542 ' ' TYR . . . . . . . . . . . . . 26.1 t80 -152.54 175.06 13.16 Favored 'General case' 0 C--N 1.312 -1.031 0 N-CA-C 107.864 -1.162 . . . . 2.4 107.864 -177.162 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A 1543 ' ' SER . . . . . . . . . . . . . 8.3 p -49.57 -150.46 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.797 0 C-N-CA 127.922 2.489 . . . . 2.58 114.853 -179.941 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A 1544 ' ' LYS . . . . . . . . . . . . . 9.7 ptpp? -39.81 -28.12 0.04 OUTLIER 'General case' 0 N--CA 1.506 2.353 0 N-CA-C 114.53 1.307 . . . . 4.24 114.53 -178.245 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A 1545 ' ' SER . . . . . . . . . . . . . 25.0 t -73.01 -8.55 56.22 Favored 'General case' 0 CA--C 1.555 1.146 0 N-CA-C 112.204 0.446 . . . . 3.6 112.204 177.571 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A 1546 ' ' GLY . . . . . . . . . . . . . . . 81.08 -75.31 2.3 Favored Glycine 0 N--CA 1.44 -1.088 0 N-CA-C 114.643 0.617 . . . . 1.66 114.643 172.624 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A 1547 ' ' VAL . . . . . . . . . . . . . 9.3 p -153.26 150.26 12.67 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.446 0 N-CA-C 109.32 -0.622 . . . . 2.23 109.32 -175.158 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A 1548 ' ' VAL . . . . . . . . . . . . . 5.7 t -111.21 145.06 17.93 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.547 0 N-CA-C 108.536 -0.912 . . . . 1.59 108.536 -178.699 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A 1549 ' ' TYR . . . . . . . . . . . . . 39.4 m-85 -114.54 125.27 53.6 Favored 'General case' 0 CA--C 1.501 -0.928 0 N-CA-C 107.31 -1.367 . . . . 1.58 107.31 172.926 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A 1550 ' ' MET . . . . . . . . . . . . . 18.3 ptm -153.15 124.58 7.63 Favored 'General case' 0 C--N 1.298 -1.658 0 CA-C-O 121.396 0.617 . . . . 2.08 112.008 -172.672 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A 1551 ' ' SER . . . . . . . . . . . . . 25.4 m -93.57 133.46 36.86 Favored 'General case' 0 C--N 1.282 -2.34 0 N-CA-C 106.88 -1.526 . . . . 1.9 106.88 176.175 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A 1552 ' ' ILE . . . . . 0.856 HG22 ' HB2' ' A' 1533 ' ' SER . 1.1 tp -73.17 -18.63 18.18 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.114 0 CA-C-O 121.816 0.817 . . . . 2.04 109.629 -176.374 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A 1553 ' ' CYS . . . . . . . . . . . . . 38.4 t -161.27 138.44 8.84 Favored 'General case' 0 N--CA 1.416 -2.144 0 N-CA-C 105.923 -1.88 . . . . 1.43 105.923 173.532 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A 1554 ' ' GLY . . . . . . . . . . . . . . . 101.38 -174.87 25.34 Favored Glycine 0 N--CA 1.433 -1.529 0 N-CA-C 111.17 -0.772 . . . . 1.23 111.17 178.538 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A 1555 ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -103.31 151.7 22.41 Favored 'General case' 0 C--N 1.302 -1.459 0 CA-C-O 121.439 0.638 . . . . 1.8 111.776 -179.17 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A 1556 ' ' ASN . . . . . . . . . . . . . 8.6 t-20 -100.67 139.11 36.82 Favored 'General case' 0 N--CA 1.42 -1.94 0 CA-C-N 114.52 -1.218 . . . . 2.63 108.3 -177.241 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A 1557 ' ' GLU . . . . . . . . . . . . . 54.2 mm-40 -102.65 -7.07 22.06 Favored 'General case' 0 C--N 1.293 -1.875 0 CA-C-N 115.443 -0.799 . . . . 3.79 112.156 -172.404 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A 1558 ' ' ASN . . . . . . . . . . . . . 39.6 m-80 -75.52 -31.36 60.09 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-O 121.803 0.811 . . . . 1.59 109.901 -178.655 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A 1559 ' ' CYS . . . . . 0.656 ' HB3' ' HD2' ' A' 1560 ' ' PRO . 95.5 m -113.25 176.47 1.47 Allowed Pre-proline 0 C--N 1.294 -1.841 0 CA-C-O 117.471 -1.252 . . . . 0.94 108.027 176.474 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A 1560 ' ' PRO . . . . . 0.656 ' HD2' ' HB3' ' A' 1559 ' ' CYS . 99.2 Cg_exo -29.88 122.16 0.06 OUTLIER 'Trans proline' 0 C--N 1.375 1.957 0 C-N-CA 124.358 3.372 . . . . 1.53 113.909 173.693 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A 1561 ' ' PRO . . . . . . . . . . . . . 32.1 Cg_exo -58.57 110.25 0.63 Allowed 'Trans proline' 0 C--O 1.245 0.85 0 C-N-CA 123.243 2.629 . . . . 1.82 111.66 -176.776 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A 1562 ' ' GLY . . . . . . . . . . . . . . . 132.94 -15.24 4.86 Favored Glycine 0 N--CA 1.44 -1.085 0 C-N-CA 120.23 -0.986 . . . . 0.81 112.507 -179.792 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A 1563 ' ' VAL . . . . . . . . . . . . . 13.8 m -86.49 149.82 4.04 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.957 0 N-CA-C 108.02 -1.104 . . . . 1.73 108.02 177.326 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A 1564 ' ' GLY . . . . . . . . . . . . . . . -102.0 -30.77 5.62 Favored Glycine 0 C--N 1.307 -1.059 0 N-CA-C 111.188 -0.765 . . . . 0.72 111.188 -178.019 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A 1565 ' ' ALA . . . . . . . . . . . . . . . -140.3 136.3 33.11 Favored 'General case' 0 N--CA 1.44 -0.927 0 N-CA-C 109.04 -0.726 . . . . 1.14 109.04 178.773 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A 1566 ' ' CYS . . . . . . . . . . . . . 16.5 t -156.32 146.36 21.26 Favored 'General case' 0 C--N 1.298 -1.668 0 CA-C-N 116.243 -0.435 . . . . 0.51 109.933 -175.324 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A 1567 ' ' PHE . . . . . . . . . . . . . 21.5 m-85 -73.88 123.32 24.01 Favored 'General case' 0 C--O 1.211 -0.921 0 N-CA-C 107.239 -1.393 . . . . 1.22 107.239 174.467 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A 1568 ' ' GLY . . . . . . . . . . . . . . . -75.36 -18.64 79.89 Favored Glycine 0 C--N 1.309 -0.92 0 C-N-CA 120.472 -0.871 . . . . 1.08 114.655 -171.732 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A 1569 ' ' GLN . . . . . . . . . . . . . 58.9 tp60 -80.66 -60.0 2.47 Favored 'General case' 0 C--N 1.302 -1.496 0 CA-C-O 121.059 0.457 . . . . 3.05 110.498 -179.586 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A 1570 ' ' THR . . . . . . . . . . . . . 12.3 p -88.14 -11.16 47.74 Favored 'General case' 0 C--N 1.31 -1.146 0 N-CA-C 112.817 0.673 . . . . 2.44 112.817 -175.289 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A 1571 ' ' ARG . . . . . . . . . . . . . 51.0 mtm180 58.04 45.16 18.33 Favored 'General case' 0 CA--C 1.515 -0.372 0 C-N-CA 125.363 1.465 . . . . 4.48 112.853 179.248 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A 1572 ' ' ILE . . . . . . . . . . . . . 36.3 mt -100.61 122.82 53.07 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.192 0 N-CA-C 108.788 -0.819 . . . . 1.94 108.788 179.112 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A 1573 ' ' SER . . . . . . . . . . . . . 33.2 t -61.88 122.57 15.76 Favored 'General case' 0 C--N 1.31 -1.133 0 C-N-CA 124.644 1.178 . . . . 1.25 110.855 -179.033 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A 1574 ' ' VAL . . . . . . . . . . . . . 30.0 m -127.83 33.93 1.36 Allowed 'Isoleucine or valine' 0 C--N 1.315 -0.895 0 CA-C-O 122.238 1.018 . . . . 1.61 110.234 178.973 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A 1575 ' ' GLY . . . . . . . . . . . . . . . 155.69 115.61 0.52 Allowed Glycine 0 N--CA 1.419 -2.442 0 CA-C-N 114.248 -1.342 . . . . 0.65 111.341 177.979 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A 1576 ' ' LYS . . . . . . . . . . . . . 3.3 tppp? -82.13 145.33 30.19 Favored 'General case' 0 C--N 1.307 -1.253 0 N-CA-C 106.77 -1.567 . . . . 3.33 106.77 178.201 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A 1577 ' ' ALA . . . . . . . . . . . . . . . -63.81 112.92 3.1 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 121.343 0.592 . . . . 1.31 109.516 -179.024 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A 1578 ' ' ASN . . . . . . . . . . . . . 50.4 t-20 -135.77 139.13 43.3 Favored 'General case' 0 C--N 1.295 -1.802 0 N-CA-C 107.687 -1.227 . . . . 2.24 107.687 -173.493 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A 1579 ' ' LYS . . . . . 0.457 ' HD2' ' SG ' ' A' 1516 ' ' CYS . 43.2 mmtm -100.9 89.85 3.99 Favored 'General case' 0 C--N 1.3 -1.562 0 N-CA-C 108.043 -1.095 . . . . 2.34 108.043 178.957 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A 1580 ' ' ARG . . . . . . . . . . . . . 18.7 tpp180 -146.79 84.87 1.61 Allowed 'General case' 0 N--CA 1.429 -1.514 0 CA-C-O 121.33 0.586 . . . . 4.19 110.593 -177.627 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A 1581 ' ' LEU . . . . . . . . . . . . . 3.8 pp -104.37 153.71 20.73 Favored 'General case' 0 N--CA 1.427 -1.595 0 CA-C-N 115.55 -0.75 . . . . 2.39 110.112 176.117 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A 1582 ' ' ARG . . . . . 0.416 ' CG ' ' HB3' ' A' 1589 ' ' GLN . 14.7 ptp180 -131.62 139.89 49.25 Favored 'General case' 0 C--N 1.283 -2.296 0 N-CA-C 108.937 -0.764 . . . . 4.48 108.937 177.427 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A 1583 ' ' TYR . . . . . 0.43 ' CE1' ' HA ' ' A' 1586 ' ' GLN . 67.5 t80 -102.84 91.85 4.34 Favored 'General case' 0 N--CA 1.432 -1.367 0 N-CA-C 107.448 -1.315 . . . . 1.57 107.448 176.819 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A 1584 ' ' VAL . . . . . . . . . . . . . 1.6 m -120.27 110.46 28.86 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.607 0 CA-C-N 115.421 -0.809 . . . . 2.29 112.53 -176.553 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A 1585 ' ' ASP . . . . . . . . . . . . . 16.0 t70 65.45 38.8 5.46 Favored 'General case' 0 C--N 1.313 -1.019 0 CA-C-O 122.481 1.134 . . . . 2.06 109.619 173.409 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A 1586 ' ' GLN . . . . . 0.43 ' HA ' ' CE1' ' A' 1583 ' ' TYR . 47.8 mt-30 73.78 -14.43 0.66 Allowed 'General case' 0 N--CA 1.484 1.234 0 C-N-CA 126.049 1.739 . . . . 2.61 114.042 -179.729 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A 1587 ' ' VAL . . . . . . . . . . . . . 7.6 p -94.53 121.68 45.33 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.026 0 CA-C-O 121.361 0.601 . . . . 1.33 110.055 178.461 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A 1588 ' ' LEU . . . . . 0.65 ' HB2' ' HB2' ' A' 1612 ' ' PHE . 3.8 mm? -78.75 138.76 38.38 Favored 'General case' 0 N--CA 1.433 -1.301 0 CA-C-N 115.658 -0.701 . . . . 2.03 109.67 178.736 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A 1589 ' ' GLN . . . . . 0.416 ' HB3' ' CG ' ' A' 1582 ' ' ARG . 34.6 tt0 -133.58 126.92 31.99 Favored 'General case' 0 C--N 1.292 -1.91 0 N-CA-C 108.63 -0.878 . . . . 1.73 108.63 179.479 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A 1590 ' ' LEU . . . . . . . . . . . . . 8.9 tt -124.59 126.21 45.42 Favored 'General case' 0 C--N 1.295 -1.794 0 N-CA-C 107.438 -1.319 . . . . 1.76 107.438 179.911 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A 1591 ' ' VAL . . . . . . . . . . . . . 67.8 t -117.75 123.03 71.14 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.798 0 CA-C-O 121.237 0.541 . . . . 2.14 112.454 -174.488 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A 1592 ' ' TYR . . . . . . . . . . . . . 49.4 m-85 -97.29 101.59 13.17 Favored 'General case' 0 C--N 1.309 -1.153 0 CA-C-N 115.041 -0.981 . . . . 1.53 108.383 175.114 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A 1593 ' ' LYS . . . . . . . . . . . . . 19.0 ptpt -99.74 -173.68 2.52 Favored 'General case' 0 C--N 1.3 -1.547 0 N-CA-C 109.756 -0.461 . . . . 2.72 109.756 179.849 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A 1594 ' ' ASP . . . . . . . . . . . . . 6.7 m-20 50.07 53.96 11.93 Favored 'General case' 0 N--CA 1.478 0.925 0 N-CA-C 114.84 1.422 . . . . 1.45 114.84 175.951 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A 1595 ' ' GLY . . . . . . . . . . . . . . . -90.02 -92.45 1.22 Allowed Glycine 0 N--CA 1.425 -2.052 0 N-CA-C 108.001 -2.04 . . . . 0.83 108.001 174.367 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A 1596 ' ' SER . . . . . . . . . . . . . 20.0 m -114.16 135.95 22.19 Favored Pre-proline 0 C--N 1.291 -1.936 0 N-CA-C 107.475 -1.306 . . . . 1.96 107.475 175.404 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A 1597 ' ' PRO . . . . . . . . . . . . . 32.0 Cg_exo -60.87 128.23 24.88 Favored 'Trans proline' 0 C--O 1.243 0.754 0 C-N-CA 122.513 2.142 . . . . 1.34 109.422 178.254 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A 1598 ' ' CYS . . . . . 0.552 ' HB3' HD12 ' A' 1604 ' ' LEU . 9.0 t -95.7 125.27 49.78 Favored Pre-proline 0 C--N 1.293 -1.861 0 N-CA-C 109.021 -0.733 . . . . 1.19 109.021 -174.35 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A 1599 ' ' PRO . . . . . 0.435 ' HD3' ' HA ' ' A' 1598 ' ' CYS . 1.0 OUTLIER -84.04 -0.29 9.52 Favored 'Trans proline' 0 CA--C 1.536 0.591 0 C-N-CA 122.86 2.373 . . . . 1.88 113.18 -177.296 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A 1600 ' ' SER . . . . . . . . . . . . . 20.3 m -67.41 -31.3 71.41 Favored 'General case' 0 C--O 1.241 0.645 0 CA-C-O 121.095 0.474 . . . . 2.19 111.122 179.594 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A 1601 ' ' LYS . . . . . 0.432 ' HB3' HD21 ' A' 1604 ' ' LEU . 13.1 tmtt? -152.63 130.47 11.69 Favored 'General case' 0 C--N 1.31 -1.151 0 N-CA-C 105.96 -1.867 . . . . 4.21 105.96 178.731 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A 1602 ' ' SER . . . . . . . . . . . . . 23.9 t -71.88 117.39 13.42 Favored 'General case' 0 C--N 1.305 -1.333 0 CA-C-O 121.207 0.527 . . . . 3.82 111.255 -177.103 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A 1603 ' ' GLY . . . . . . . . . . . . . . . 116.66 15.71 6.76 Favored Glycine 0 N--CA 1.43 -1.762 0 CA-C-N 115.625 -0.716 . . . . 2.45 112.79 175.988 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A 1604 ' ' LEU . . . . . 0.552 HD12 ' HB3' ' A' 1598 ' ' CYS . 2.3 pp -140.3 161.3 38.0 Favored 'General case' 0 C--N 1.316 -0.864 0 N-CA-C 113.462 0.912 . . . . 2.06 113.462 179.711 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A 1605 ' ' SER . . . . . . . . . . . . . 9.3 t -121.38 170.93 9.15 Favored 'General case' 0 C--N 1.295 -1.765 0 N-CA-C 108.078 -1.082 . . . . 1.75 108.078 -175.314 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A 1606 ' ' TYR . . . . . . . . . . . . . 90.8 m-85 -85.54 111.91 20.45 Favored 'General case' 0 CA--C 1.461 -2.465 0 N-CA-C 102.783 -3.043 . . . . 1.59 102.783 176.078 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A 1607 ' ' LYS . . . . . . . . . . . . . 22.3 pttm -126.93 148.63 50.04 Favored 'General case' 0 N--CA 1.399 -2.99 0 C-N-CA 119.006 -1.077 . . . . 2.21 112.111 -172.877 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A 1608 ' ' SER . . . . . . . . . . . . . 23.8 t -104.65 128.2 52.63 Favored 'General case' 0 C--N 1.298 -1.663 0 CA-C-N 115.674 -0.694 . . . . 1.48 109.598 -177.429 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A 1609 ' ' VAL . . . . . . . . . . . . . 53.4 t -114.42 111.01 34.14 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.969 0 N-CA-C 108.507 -0.923 . . . . 1.57 108.507 178.874 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A 1610 ' ' ILE . . . . . . . . . . . . . 26.3 mm -94.03 117.26 37.24 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.348 0 CA-C-N 116.117 -0.492 . . . . 1.47 109.697 -179.139 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A 1611 ' ' SER . . . . . . . . . . . . . 35.9 p -104.58 113.75 27.53 Favored 'General case' 0 N--CA 1.429 -1.493 0 CA-C-O 121.33 0.586 . . . . 1.84 109.614 175.861 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A 1612 ' ' PHE . . . . . 0.65 ' HB2' ' HB2' ' A' 1588 ' ' LEU . 96.9 m-85 -87.7 102.51 14.71 Favored 'General case' 0 C--N 1.306 -1.295 0 CA-C-N 115.518 -0.765 . . . . 0.86 109.139 -179.256 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A 1613 ' ' VAL . . . . . . . . . . . . . 42.2 t -106.35 122.18 59.83 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.877 0 N-CA-C 109.303 -0.628 . . . . 1.32 109.303 -175.914 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A 1614 ' ' CYS . . . . . 0.578 ' HA ' ' O ' ' A' 1642 ' ' THR . 0.5 OUTLIER -75.34 93.81 2.95 Favored 'General case' 0 C--N 1.298 -1.65 0 N-CA-C 114.632 1.345 . . . . 1.39 114.632 -178.988 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A 1615 ' ' ARG . . . . . 0.467 ' HB3' ' HB3' ' A' 1641 ' ' HIS . 23.3 tpt180 -131.64 96.84 20.04 Favored Pre-proline 0 N--CA 1.423 -1.78 0 N-CA-C 107.881 -1.155 . . . . 4.34 107.881 174.306 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A 1616 ' ' PRO . . . . . 0.609 ' HB3' ' HB3' ' A' 1643 ' ' PRO . 7.6 Cg_exo -75.66 64.34 6.6 Favored 'Trans proline' 0 CA--C 1.532 0.42 0 C-N-CA 123.817 3.011 . . . . 1.5 113.643 -175.854 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A 1617 ' ' GLU . . . . . . . . . . . . . 44.0 mt-10 . . . . . 0 C--N 1.312 -1.024 0 O-C-N 122.201 -0.312 . . . . 3.21 111.337 179.013 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A 1622 ' ' ASN . . . . . . . . . . . . . 59.6 t30 . . . . . 0 C--O 1.239 0.53 0 CA-C-O 120.762 0.315 . . . . 3.58 110.991 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A 1623 ' ' ARG . . . . . . . . . . . . . 7.7 ptp180 -135.2 147.93 64.36 Favored Pre-proline 0 C--N 1.309 -1.186 0 N-CA-C 109.622 -0.51 . . . . 4.09 109.622 -177.393 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A 1624 ' ' PRO . . . . . . . . . . . . . 18.7 Cg_endo -58.97 124.38 15.56 Favored 'Trans proline' 0 C--N 1.349 0.565 0 C-N-CA 123.436 2.757 . . . . 2.86 112.109 179.762 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A 1625 ' ' MET . . . . . . . . . . . . . 54.9 ttp -94.6 125.08 39.02 Favored 'General case' 0 C--N 1.301 -1.503 0 CA-C-N 115.863 -0.608 . . . . 2.73 110.809 -176.84 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A 1626 ' ' LEU . . . . . 0.487 ' HB2' ' CE1' ' A' 1638 ' ' PHE . 31.8 tp -73.66 103.73 4.34 Favored 'General case' 0 C--N 1.306 -1.299 0 N-CA-C 108.729 -0.841 . . . . 1.94 108.729 175.979 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A 1627 ' ' ILE . . . . . . . . . . . . . 27.9 pt -91.56 -36.58 8.1 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.381 0 CA-C-N 115.751 -0.659 . . . . 1.75 112.485 -176.649 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A 1628 ' ' SER . . . . . . . . . . . . . 6.2 p -153.66 135.42 14.5 Favored 'General case' 0 N--CA 1.43 -1.448 0 CA-C-O 120.883 0.373 . . . . 1.85 111.567 -177.396 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A 1629 ' ' LEU . . . . . 0.966 ' HG ' ' HG ' ' A' 1636 ' ' LEU . 4.4 tt -125.31 114.76 19.34 Favored 'General case' 0 C--N 1.3 -1.552 0 N-CA-C 105.757 -1.942 . . . . 2.12 105.757 177.825 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A 1630 ' ' ASP . . . . . . . . . . . . . 25.0 t70 -91.87 121.99 33.98 Favored 'General case' 0 C--N 1.301 -1.502 0 N-CA-C 107.962 -1.125 . . . . 0.87 107.962 178.279 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A 1631 ' ' LYS . . . . . . . . . . . . . 96.8 mttt -86.48 -2.97 58.92 Favored 'General case' 0 C--N 1.301 -1.511 0 N-CA-C 112.642 0.608 . . . . 2.76 112.642 -172.252 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A 1632 ' ' GLN . . . . . . . . . . . . . 1.9 mp0 -95.59 -42.63 8.32 Favored 'General case' 0 C--N 1.318 -0.773 0 C-N-CA 120.463 -0.495 . . . . 2.55 110.665 177.424 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A 1633 ' ' THR . . . . . 0.459 ' HA ' HD23 ' A' 1604 ' ' LEU . 31.7 p -90.97 -8.15 50.03 Favored 'General case' 0 C--O 1.251 1.137 0 CA-C-O 121.621 0.724 . . . . 1.92 110.902 177.581 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A 1634 ' ' CYS . . . . . . . . . . . . . 33.3 m 59.29 44.64 15.15 Favored 'General case' 0 C--N 1.34 0.161 0 CA-C-N 113.905 -1.498 . . . . 0.89 110.379 176.588 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A 1635 ' ' THR . . . . . . . . . . . . . 7.5 p -108.32 126.21 52.58 Favored 'General case' 0 N--CA 1.428 -1.549 0 CA-C-N 114.339 -1.3 . . . . 1.31 111.173 -176.198 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A 1636 ' ' LEU . . . . . 0.966 ' HG ' ' HG ' ' A' 1629 ' ' LEU . 5.9 mp -105.47 111.04 23.6 Favored 'General case' 0 N--CA 1.431 -1.423 0 N-CA-C 109.621 -0.511 . . . . 1.97 109.621 175.596 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A 1637 ' ' PHE . . . . . . . . . . . . . 97.5 m-85 -92.03 112.75 24.81 Favored 'General case' 0 C--O 1.249 1.06 0 CA-C-N 116.202 -0.453 . . . . 0.92 110.6 -178.573 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A 1638 ' ' PHE . . . . . 0.487 ' CE1' ' HB2' ' A' 1626 ' ' LEU . 97.1 m-85 -109.12 132.13 54.41 Favored 'General case' 0 C--N 1.304 -1.385 0 CA-C-N 115.892 -0.595 . . . . 0.7 109.448 177.709 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A 1639 ' ' SER . . . . . . . . . . . . . 29.4 p -111.19 117.23 32.64 Favored 'General case' 0 C--N 1.285 -2.223 0 CA-C-O 121.628 0.728 . . . . 1.46 110.34 176.652 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A 1640 ' ' TRP . . . . . . . . . . . . . 13.9 t90 -101.8 102.57 13.21 Favored 'General case' 0 N--CA 1.419 -1.978 0 N-CA-C 107.42 -1.326 . . . . 0.92 107.42 177.565 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A 1641 ' ' HIS . . . . . 0.467 ' HB3' ' HB3' ' A' 1615 ' ' ARG . 62.9 m80 -82.35 93.19 7.12 Favored 'General case' 0 C--N 1.311 -1.096 0 N-CA-C 107.604 -1.258 . . . . 3.18 107.604 -179.885 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A 1642 ' ' THR . . . . . 0.578 ' O ' ' HA ' ' A' 1614 ' ' CYS . 9.7 t -134.84 141.52 38.81 Favored Pre-proline 0 C--N 1.288 -2.103 0 CA-C-O 121.384 0.612 . . . . 1.48 112.13 -170.421 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A 1643 ' ' PRO . . . . . 0.609 ' HB3' ' HB3' ' A' 1616 ' ' PRO . 38.2 Cg_endo -70.65 -10.15 27.26 Favored 'Trans proline' 0 C--N 1.352 0.742 0 C-N-CA 123.396 2.73 . . . . 1.09 111.024 173.628 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A 1644 ' ' LEU . . . . . . . . . . . . . 31.7 mt -83.28 -2.52 55.85 Favored 'General case' 0 C--N 1.312 -1.023 0 C-N-CA 123.945 0.898 . . . . 2.08 111.215 -179.464 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A 1645 ' ' ALA . . . . . . . . . . . . . . . -92.23 -34.0 14.45 Favored 'General case' 0 C--N 1.323 -0.564 0 N-CA-C 112.765 0.654 . . . . 1.37 112.765 -176.96 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A 1646 ' ' CYS . . . . . . . . . . . . . 5.9 m -152.55 172.19 16.97 Favored 'General case' 0 CA--C 1.506 -0.721 0 N-CA-C 106.94 -1.504 . . . . 1.7 106.94 -179.205 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A 1647 ' ' GLU . . . . . . . . . . . . . 8.0 pt-20 . . . . . 0 C--N 1.302 -1.49 0 CA-C-O 121.586 0.708 . . . . 2.92 109.956 173.494 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A 1515 ' ' ASP . . . . . . . . . . . . . 35.5 t70 . . . . . 0 CA--C 1.502 -0.903 0 N-CA-C 110.761 -0.088 . . . . 2.54 110.761 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A 1516 ' ' CYS . . . . . . . . . . . . . 74.1 m -76.25 77.4 3.04 Favored 'General case' 0 CA--C 1.508 -0.673 0 CA-C-O 122.326 1.06 . . . . 1.25 110.65 179.786 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A 1517 ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -147.01 172.54 13.56 Favored 'General case' 0 N--CA 1.402 -2.86 0 CA-C-N 114.324 -1.307 . . . . 2.36 109.22 -179.622 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A 1518 ' ' VAL . . . . . 0.5 HG21 ' HB2' ' A' 1583 ' ' TYR . 10.4 p -159.0 126.01 0.57 Allowed 'Isoleucine or valine' 0 C--N 1.279 -2.466 0 CA-C-O 121.46 0.648 . . . . 2.34 109.551 173.035 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A 1519 ' ' THR . . . . . . . . . . . . . 7.3 m -90.57 121.52 32.58 Favored 'General case' 0 C--N 1.282 -2.351 0 CA-C-N 114.548 -1.205 . . . . 2.04 108.202 177.635 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A 1520 ' ' ASN . . . . . . . . . . . . . 38.9 t30 -99.79 103.33 21.21 Favored Pre-proline 0 C--N 1.311 -1.09 0 N-CA-C 109.59 -0.522 . . . . 2.12 109.59 177.35 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A 1521 ' ' PRO . . . . . . . . . . . . . 41.4 Cg_endo -69.28 -3.35 11.52 Favored 'Trans proline' 0 CA--C 1.54 0.797 0 C-N-CA 122.624 2.216 . . . . 2.59 113.954 -175.778 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A 1522 ' ' SER . . . . . . . . . . . . . 11.4 m -69.34 -28.84 66.58 Favored 'General case' 0 CA--C 1.545 0.776 0 CA-C-O 120.984 0.421 . . . . 2.65 109.883 176.805 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A 1523 ' ' THR . . . . . . . . . . . . . 12.9 t -139.21 -16.62 1.06 Allowed 'General case' 0 CA--C 1.551 0.999 0 CA-C-O 120.903 0.383 . . . . 2.33 111.827 178.771 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A 1524 ' ' GLY . . . . . . . . . . . . . . . 94.16 7.92 60.54 Favored Glycine 0 N--CA 1.446 -0.658 0 C-N-CA 120.597 -0.811 . . . . 1.96 113.08 179.017 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A 1525 ' ' HIS . . . . . . . . . . . . . 24.5 t60 -77.06 134.11 38.87 Favored 'General case' 0 C--O 1.245 0.838 0 CA-C-O 120.866 0.365 . . . . 2.44 110.023 -177.927 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A 1526 ' ' LEU . . . . . . . . . . . . . 3.4 tm? -104.51 114.73 29.14 Favored 'General case' 0 N--CA 1.43 -1.426 0 N-CA-C 108.157 -1.053 . . . . 2.19 108.157 178.324 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A 1527 ' ' PHE . . . . . . . . . . . . . 97.6 m-85 -88.32 129.33 35.41 Favored 'General case' 0 C--N 1.291 -1.942 0 N-CA-C 108.071 -1.085 . . . . 1.61 108.071 178.267 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A 1528 ' ' ASP . . . . . . . . . . . . . 3.4 p-10 -117.82 126.9 53.28 Favored 'General case' 0 CA--C 1.476 -1.866 0 CA-C-O 121.964 0.887 . . . . 2.18 110.322 179.073 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A 1529 ' ' LEU . . . . . . . . . . . . . 71.7 mt -117.68 7.45 12.56 Favored 'General case' 0 C--N 1.292 -1.919 0 N-CA-C 106.231 -1.766 . . . . 2.04 106.231 175.738 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A 1530 ' ' SER . . . . . . . . . . . . . 1.6 m -70.99 -24.95 62.49 Favored 'General case' 0 N--CA 1.438 -1.026 0 CA-C-N 113.853 -1.521 . . . . 1.44 110.219 -179.152 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A 1531 ' ' SER . . . . . . . . . . . . . 14.5 m -88.07 -16.15 34.34 Favored 'General case' 0 N--CA 1.433 -1.309 0 N-CA-C 108.582 -0.896 . . . . 1.63 108.582 178.814 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A 1532 ' ' LEU . . . . . . . . . . . . . 90.8 mt -82.05 -8.28 59.66 Favored 'General case' 0 C--O 1.244 0.804 0 CA-C-N 115.509 -0.769 . . . . 2.32 111.72 177.631 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A 1533 ' ' SER . . . . . . . . . . . . . 22.5 m -57.67 125.84 24.73 Favored 'General case' 0 N--CA 1.445 -0.702 0 C-N-CA 123.155 0.582 . . . . 2.57 110.424 177.146 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A 1534 ' ' GLY . . . . . . . . . . . . . . . -121.16 169.53 14.38 Favored Glycine 0 N--CA 1.427 -1.943 0 N-CA-C 109.976 -1.25 . . . . 1.89 109.976 179.698 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A 1535 ' ' ARG . . . . . . . . . . . . . 45.8 ttt180 -95.37 -54.27 3.46 Favored 'General case' 0 C--N 1.303 -1.452 0 N-CA-C 108.524 -0.917 . . . . 4.44 108.524 179.123 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A 1536 ' ' ALA . . . . . . . . . . . . . . . -86.14 -24.19 26.3 Favored 'General case' 0 N--CA 1.438 -1.047 0 CA-C-N 115.505 -0.771 . . . . 2.07 109.463 178.68 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A 1537 ' ' GLY . . . . . . . . . . . . . . . 81.76 -140.66 21.16 Favored Glycine 0 N--CA 1.434 -1.473 0 CA-C-N 115.177 -0.919 . . . . 1.2 112.344 176.664 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A 1538 ' ' PHE . . . . . . . . . . . . . 98.7 m-85 -134.16 156.83 47.62 Favored 'General case' 0 C--N 1.299 -1.617 0 N-CA-C 108.72 -0.844 . . . . 1.98 108.72 179.881 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A 1539 ' ' THR . . . . . . . . . . . . . 23.5 p -104.93 111.63 24.47 Favored 'General case' 0 N--CA 1.425 -1.709 0 CA-C-N 115.929 -0.578 . . . . 1.97 110.046 177.114 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A 1540 ' ' ALA . . . . . . . . . . . . . . . -102.72 116.59 32.87 Favored 'General case' 0 C--N 1.295 -1.784 0 N-CA-C 108.865 -0.791 . . . . 1.39 108.865 178.618 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A 1541 ' ' ALA . . . . . . . . . . . . . . . -61.68 128.34 35.8 Favored 'General case' 0 C--N 1.308 -1.222 0 CA-C-O 121.428 0.632 . . . . 1.86 110.943 178.021 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A 1542 ' ' TYR . . . . . 0.611 ' HD2' ' HB2' ' A' 1545 ' ' SER . 66.7 t80 -125.0 174.84 7.73 Favored 'General case' 0 C--N 1.293 -1.875 0 N-CA-C 107.296 -1.372 . . . . 2.4 107.296 -178.426 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A 1543 ' ' SER . . . . . . . . . . . . . 1.7 m -46.5 -152.15 0.0 OUTLIER 'General case' 0 CA--C 1.596 2.721 0 C-N-CA 128.741 2.816 . . . . 2.58 114.404 -179.865 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A 1544 ' ' LYS . . . . . . . . . . . . . 63.6 mttp -55.07 -15.39 2.1 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 119.621 -1.924 . . . . 4.24 113.556 -177.012 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A 1545 ' ' SER . . . . . 0.611 ' HB2' ' HD2' ' A' 1542 ' ' TYR . 36.0 m -70.62 -19.63 62.81 Favored 'General case' 0 CA--C 1.552 1.023 0 N-CA-C 111.976 0.361 . . . . 3.6 111.976 174.707 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A 1546 ' ' GLY . . . . . . . . . . . . . . . 102.63 -98.55 1.7 Allowed Glycine 0 CA--C 1.493 -1.289 0 C-N-CA 119.224 -1.465 . . . . 1.66 113.187 174.822 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A 1547 ' ' VAL . . . . . . . . . . . . . 16.6 m -131.39 166.29 29.23 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.616 0 CA-C-N 117.26 0.53 . . . . 2.23 109.913 177.567 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A 1548 ' ' VAL . . . . . . . . . . . . . 3.6 t -118.83 128.7 75.66 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.724 0 N-CA-C 106.627 -1.62 . . . . 1.59 106.627 175.983 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A 1549 ' ' TYR . . . . . 0.552 ' HD2' ' HA2' ' A' 1568 ' ' GLY . 50.8 m-85 -87.64 114.57 24.37 Favored 'General case' 0 C--N 1.3 -1.57 0 N-CA-C 106.233 -1.765 . . . . 1.58 106.233 171.223 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A 1550 ' ' MET . . . . . . . . . . . . . 3.0 ppp? -141.87 149.8 40.73 Favored 'General case' 0 C--N 1.284 -2.247 0 CA-C-N 116.435 -0.348 . . . . 2.08 111.304 -176.357 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A 1551 ' ' SER . . . . . . . . . . . . . 22.6 t -116.55 145.05 43.63 Favored 'General case' 0 C--N 1.294 -1.819 0 N-CA-C 107.83 -1.174 . . . . 1.9 107.83 177.834 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A 1552 ' ' ILE . . . . . . . . . . . . . 32.6 mm -68.07 -27.31 36.88 Favored 'Isoleucine or valine' 0 C--O 1.213 -0.849 0 CA-C-N 114.856 -1.066 . . . . 2.04 109.406 -178.132 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A 1553 ' ' CYS . . . . . 0.421 ' SG ' ' HE2' ' A' 1579 ' ' LYS . 51.4 t -161.64 138.65 8.52 Favored 'General case' 0 N--CA 1.421 -1.914 0 N-CA-C 108.282 -1.007 . . . . 1.43 108.282 178.142 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A 1554 ' ' GLY . . . . . . . . . . . . . . . 95.47 -177.63 34.84 Favored Glycine 0 N--CA 1.438 -1.227 0 C-N-CA 120.689 -0.767 . . . . 1.23 112.472 176.493 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A 1555 ' ' GLU . . . . . . . . . . . . . 10.1 pt-20 -81.37 144.25 31.59 Favored 'General case' 0 C--N 1.309 -1.194 0 CA-C-O 121.392 0.615 . . . . 1.8 111.522 -178.962 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A 1556 ' ' ASN . . . . . . . . . . . . . 27.8 t-20 -96.91 105.62 17.79 Favored 'General case' 0 C--N 1.293 -1.849 0 CA-C-N 115.225 -0.898 . . . . 2.63 109.229 -179.408 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A 1557 ' ' GLU . . . . . . . . . . . . . 13.0 mt-10 -86.31 76.7 9.64 Favored 'General case' 0 C--N 1.313 -0.978 0 CA-C-O 122.035 0.922 . . . . 3.79 111.918 -177.028 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A 1558 ' ' ASN . . . . . . . . . . . . . 31.7 m-80 -146.82 -43.94 0.18 Allowed 'General case' 0 C--N 1.297 -1.705 0 N-CA-C 106.143 -1.799 . . . . 1.59 106.143 178.892 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A 1559 ' ' CYS . . . . . 0.616 ' HB3' ' HD2' ' A' 1560 ' ' PRO . 78.2 m -108.63 175.92 1.78 Allowed Pre-proline 0 N--CA 1.425 -1.69 0 N-CA-C 105.532 -2.025 . . . . 0.94 105.532 170.675 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A 1560 ' ' PRO . . . . . 0.616 ' HD2' ' HB3' ' A' 1559 ' ' CYS . 20.8 Cg_exo -32.95 113.11 0.06 OUTLIER 'Trans proline' 0 C--N 1.375 1.943 0 C-N-CA 123.641 2.894 . . . . 1.53 113.962 176.879 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A 1561 ' ' PRO . . . . . . . . . . . . . 39.7 Cg_exo -59.07 102.79 0.16 Allowed 'Trans proline' 0 C--O 1.242 0.702 0 C-N-CA 123.335 2.69 . . . . 1.82 111.31 -179.026 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A 1562 ' ' GLY . . . . . . . . . . . . . . . 152.17 -19.74 0.84 Allowed Glycine 0 N--CA 1.432 -1.618 0 N-CA-C 108.582 -1.807 . . . . 0.81 108.582 -175.081 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A 1563 ' ' VAL . . . . . 0.483 ' HA ' ' HA ' ' A' 1576 ' ' LYS . 4.6 m -93.06 151.56 3.61 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.109 0 N-CA-C 107.118 -1.438 . . . . 1.73 107.118 174.013 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A 1564 ' ' GLY . . . . . . . . . . . . . . . -113.16 -15.35 9.13 Favored Glycine 0 C--N 1.308 -0.986 0 C-N-CA 120.664 -0.779 . . . . 0.72 112.451 -176.79 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A 1565 ' ' ALA . . . . . . . . . . . . . . . -142.92 125.61 15.93 Favored 'General case' 0 C--O 1.244 0.8 0 N-CA-C 108.871 -0.789 . . . . 1.14 108.871 179.524 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A 1566 ' ' CYS . . . . . . . . . . . . . 41.7 t -150.41 144.33 25.38 Favored 'General case' 0 C--N 1.302 -1.498 0 N-CA-C 109.524 -0.547 . . . . 0.51 109.524 -176.729 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A 1567 ' ' PHE . . . . . . . . . . . . . 18.1 m-85 -67.59 145.26 55.05 Favored 'General case' 0 C--N 1.319 -0.724 0 N-CA-C 112.181 0.438 . . . . 1.22 112.181 179.91 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A 1568 ' ' GLY . . . . . 0.552 ' HA2' ' HD2' ' A' 1549 ' ' TYR . . . -63.8 -73.48 0.54 Allowed Glycine 0 C--N 1.304 -1.225 0 N-CA-C 115.004 0.761 . . . . 1.08 115.004 -175.437 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A 1569 ' ' GLN . . . . . . . . . . . . . 11.2 pt20 -83.03 -34.29 26.3 Favored 'General case' 0 C--N 1.316 -0.849 0 N-CA-C 112.379 0.511 . . . . 3.05 112.379 -173.344 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A 1570 ' ' THR . . . . . . . . . . . . . 21.3 p -81.51 -18.05 46.46 Favored 'General case' 0 C--N 1.312 -1.063 0 CA-C-O 121.32 0.581 . . . . 2.44 110.682 -178.162 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A 1571 ' ' ARG . . . . . . . . . . . . . 64.6 mtp180 56.21 37.9 29.29 Favored 'General case' 0 C--N 1.344 0.354 0 C-N-CA 125.132 1.373 . . . . 4.48 113.063 172.774 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A 1572 ' ' ILE . . . . . . . . . . . . . 25.5 mt -101.81 128.12 54.61 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.121 0 N-CA-C 108.27 -1.011 . . . . 1.94 108.27 179.838 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A 1573 ' ' SER . . . . . . . . . . . . . 62.3 p -75.79 128.59 35.47 Favored 'General case' 0 C--N 1.314 -0.956 0 C-N-CA 122.364 0.266 . . . . 1.25 111.478 -177.106 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A 1574 ' ' VAL . . . . . . . . . . . . . 27.7 m -126.3 26.44 2.62 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.75 0 CA-C-O 121.608 0.718 . . . . 1.61 112.299 -177.937 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A 1575 ' ' GLY . . . . . . . . . . . . . . . 174.12 117.06 0.45 Allowed Glycine 0 N--CA 1.434 -1.47 0 CA-C-N 115.277 -0.874 . . . . 0.65 111.897 176.769 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A 1576 ' ' LYS . . . . . 0.483 ' HA ' ' HA ' ' A' 1563 ' ' VAL . 63.8 tttp -79.2 135.83 36.91 Favored 'General case' 0 C--N 1.314 -0.962 0 N-CA-C 107.628 -1.249 . . . . 3.33 107.628 176.045 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A 1577 ' ' ALA . . . . . . . . . . . . . . . -70.42 130.7 42.61 Favored 'General case' 0 C--N 1.313 -0.993 0 O-C-N 123.647 0.592 . . . . 1.31 110.504 -174.431 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A 1578 ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -157.83 148.41 20.81 Favored 'General case' 0 C--N 1.291 -1.942 0 N-CA-C 105.686 -1.968 . . . . 2.24 105.686 176.715 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A 1579 ' ' LYS . . . . . 0.421 ' HE2' ' SG ' ' A' 1553 ' ' CYS . 96.9 mttt -101.47 89.34 3.7 Favored 'General case' 0 C--N 1.284 -2.257 0 CA-C-O 121.845 0.831 . . . . 2.34 108.761 -177.508 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A 1580 ' ' ARG . . . . . . . . . . . . . 30.4 ttm180 -138.67 109.1 6.51 Favored 'General case' 0 N--CA 1.422 -1.862 0 CA-C-N 114.156 -1.383 . . . . 4.19 110.117 -175.587 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A 1581 ' ' LEU . . . . . . . . . . . . . 2.0 pt? -138.92 142.16 38.48 Favored 'General case' 0 N--CA 1.419 -1.992 0 N-CA-C 109.288 -0.634 . . . . 2.39 109.288 173.408 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A 1582 ' ' ARG . . . . . 0.504 ' HB3' HG13 ' A' 1584 ' ' VAL . 37.4 mmt180 -124.76 128.77 49.28 Favored 'General case' 0 C--N 1.276 -2.623 0 CA-C-N 114.972 -1.013 . . . . 4.48 110.585 -177.71 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A 1583 ' ' TYR . . . . . 0.5 ' HB2' HG21 ' A' 1518 ' ' VAL . 62.0 t80 -89.08 90.15 8.27 Favored 'General case' 0 N--CA 1.427 -1.585 0 N-CA-C 106.234 -1.765 . . . . 1.57 106.234 174.452 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A 1584 ' ' VAL . . . . . 0.504 HG13 ' HB3' ' A' 1582 ' ' ARG . 26.6 m -124.53 142.4 41.48 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.167 0 CA-C-N 114.435 -1.257 . . . . 2.29 107.896 -176.21 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A 1585 ' ' ASP . . . . . . . . . . . . . 22.8 t70 61.05 22.63 12.87 Favored 'General case' 0 N--CA 1.483 1.178 0 CA-C-O 122.44 1.114 . . . . 2.06 109.79 178.565 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A 1586 ' ' GLN . . . . . . . . . . . . . 50.1 mt-30 59.98 38.88 20.63 Favored 'General case' 0 C--O 1.241 0.634 0 C-N-CA 125.278 1.431 . . . . 2.61 113.254 -176.255 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A 1587 ' ' VAL . . . . . 0.472 HG11 ' O ' ' A' 1584 ' ' VAL . 12.5 p -134.52 145.77 32.12 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.895 0 N-CA-C 108.495 -0.928 . . . . 1.33 108.495 174.904 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A 1588 ' ' LEU . . . . . 0.842 ' HB2' ' HB2' ' A' 1612 ' ' PHE . 0.7 OUTLIER -84.31 133.08 34.56 Favored 'General case' 0 C--N 1.312 -1.041 0 N-CA-C 108.306 -0.998 . . . . 2.03 108.306 177.831 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A 1589 ' ' GLN . . . . . . . . . . . . . 7.3 tt0 -146.05 106.85 4.11 Favored 'General case' 0 C--N 1.307 -1.268 0 C-N-CA 120.456 -0.498 . . . . 1.73 110.132 -176.611 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A 1590 ' ' LEU . . . . . . . . . . . . . 6.2 tt -104.39 127.97 52.15 Favored 'General case' 0 C--N 1.307 -1.259 0 N-CA-C 106.245 -1.761 . . . . 1.76 106.245 179.319 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A 1591 ' ' VAL . . . . . 0.444 HG13 HG23 ' A' 1609 ' ' VAL . 15.6 m -123.69 124.37 69.22 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.245 0 N-CA-C 115.031 1.493 . . . . 2.14 115.031 -170.704 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A 1592 ' ' TYR . . . . . . . . . . . . . 94.5 m-85 -105.2 144.56 31.83 Favored 'General case' 0 C--N 1.317 -0.836 0 N-CA-C 107.267 -1.383 . . . . 1.53 107.267 173.813 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A 1593 ' ' LYS . . . . . . . . . . . . . 23.0 pttm -149.89 179.57 7.94 Favored 'General case' 0 C--N 1.302 -1.493 0 N-CA-C 109.249 -0.648 . . . . 2.72 109.249 -177.642 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A 1594 ' ' ASP . . . . . . . . . . . . . 1.4 m-20 47.05 43.19 13.77 Favored 'General case' 0 N--CA 1.482 1.128 0 N-CA-C 115.123 1.527 . . . . 1.45 115.123 173.367 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A 1595 ' ' GLY . . . . . . . . . . . . . . . -73.14 -75.57 0.72 Allowed Glycine 0 N--CA 1.443 -0.838 0 N-CA-C 109.816 -1.313 . . . . 0.83 109.816 175.978 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A 1596 ' ' SER . . . . . . . . . . . . . 21.7 t -115.39 142.36 28.63 Favored Pre-proline 0 C--N 1.29 -1.994 0 N-CA-C 105.867 -1.901 . . . . 1.96 105.867 173.42 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A 1597 ' ' PRO . . . . . . . . . . . . . 25.9 Cg_exo -65.75 143.15 72.96 Favored 'Trans proline' 0 N--CA 1.451 -0.99 0 C-N-CA 122.68 2.253 . . . . 1.34 109.533 175.571 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A 1598 ' ' CYS . . . . . . . . . . . . . 37.1 t -99.56 131.79 24.23 Favored Pre-proline 0 C--N 1.283 -2.325 0 N-CA-C 109.102 -0.703 . . . . 1.19 109.102 -176.37 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A 1599 ' ' PRO . . . . . . . . . . . . . 55.3 Cg_endo -69.44 -11.72 31.88 Favored 'Trans proline' 0 C--N 1.351 0.663 0 C-N-CA 123.165 2.577 . . . . 1.88 112.352 179.604 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A 1600 ' ' SER . . . . . . . . . . . . . 10.9 m -90.26 112.82 24.49 Favored 'General case' 0 N--CA 1.423 -1.795 0 N-CA-C 107.612 -1.255 . . . . 2.19 107.612 176.326 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A 1601 ' ' LYS . . . . . 0.708 ' HB3' HD12 ' A' 1604 ' ' LEU . 55.7 tptt 71.03 114.31 0.05 Allowed 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 124.155 0.982 . . . . 4.21 110.98 179.054 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A 1602 ' ' SER . . . . . . . . . . . . . 47.4 t -63.61 108.96 1.52 Allowed 'General case' 0 C--N 1.316 -0.862 0 CA-C-N 116.075 -0.511 . . . . 3.82 109.949 179.757 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A 1603 ' ' GLY . . . . . . . . . . . . . . . 129.99 -15.83 5.59 Favored Glycine 0 N--CA 1.434 -1.498 0 N-CA-C 110.724 -0.95 . . . . 2.45 110.724 -179.924 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A 1604 ' ' LEU . . . . . 0.708 HD12 ' HB3' ' A' 1601 ' ' LYS . 12.6 mt -83.21 156.92 22.92 Favored 'General case' 0 N--CA 1.434 -1.263 0 CA-C-O 122.172 0.987 . . . . 2.06 113.6 179.805 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A 1605 ' ' SER . . . . . . . . . . . . . 14.9 m -143.15 -173.12 3.83 Favored 'General case' 0 C--N 1.296 -1.727 0 N-CA-C 104.752 -2.314 . . . . 1.75 104.752 176.749 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A 1606 ' ' TYR . . . . . 0.469 ' CD1' ' HB3' ' A' 1634 ' ' CYS . 84.3 m-85 -107.38 132.49 53.1 Favored 'General case' 0 CA--C 1.462 -2.438 0 N-CA-C 105.77 -1.937 . . . . 1.59 105.77 179.863 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A 1607 ' ' LYS . . . . . 0.528 ' HG3' HG21 ' A' 1635 ' ' THR . 21.6 ptmt -128.04 153.31 46.93 Favored 'General case' 0 N--CA 1.407 -2.59 0 O-C-N 124.234 0.959 . . . . 2.21 109.505 -177.777 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A 1608 ' ' SER . . . . . . . . . . . . . 51.0 m -126.31 115.36 19.56 Favored 'General case' 0 C--N 1.303 -1.44 0 N-CA-C 109.393 -0.595 . . . . 1.48 109.393 -178.541 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A 1609 ' ' VAL . . . . . 0.444 HG23 HG13 ' A' 1591 ' ' VAL . 76.6 t -104.12 116.15 47.37 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.064 0 CA-C-O 120.663 0.268 . . . . 1.57 110.647 -179.407 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A 1610 ' ' ILE . . . . . . . . . . . . . 19.3 mm -95.22 106.55 18.36 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.127 0 N-CA-C 108.448 -0.945 . . . . 1.47 108.448 177.969 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A 1611 ' ' SER . . . . . 0.472 ' O ' ' HA ' ' A' 1639 ' ' SER . 21.8 m -98.05 123.19 41.96 Favored 'General case' 0 C--N 1.297 -1.7 0 N-CA-C 108.914 -0.773 . . . . 1.84 108.914 176.246 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A 1612 ' ' PHE . . . . . 0.842 ' HB2' ' HB2' ' A' 1588 ' ' LEU . 80.5 m-85 -100.39 123.16 44.26 Favored 'General case' 0 C--N 1.305 -1.364 0 N-CA-C 109.242 -0.651 . . . . 0.86 109.242 -179.066 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A 1613 ' ' VAL . . . . . 0.576 ' O ' ' HA ' ' A' 1641 ' ' HIS . 44.6 t -115.75 136.99 50.85 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.703 0 N-CA-C 106.697 -1.594 . . . . 1.32 106.697 179.281 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A 1614 ' ' CYS . . . . . 0.455 ' HA ' ' O ' ' A' 1642 ' ' THR . 42.3 t -86.69 108.88 18.85 Favored 'General case' 0 C--N 1.281 -2.409 0 CA-C-O 121.6 0.714 . . . . 1.39 111.748 -177.588 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A 1615 ' ' ARG . . . . . 0.677 ' HB3' ' HB2' ' A' 1641 ' ' HIS . 80.4 ttt180 -135.94 94.1 14.85 Favored Pre-proline 0 N--CA 1.43 -1.473 0 N-CA-C 108.009 -1.108 . . . . 4.34 108.009 176.544 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A 1616 ' ' PRO . . . . . . . . . . . . . 68.7 Cg_endo -72.04 50.0 1.4 Allowed 'Trans proline' 0 N--CA 1.481 0.773 0 C-N-CA 123.829 3.019 . . . . 1.5 113.156 -178.466 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A 1617 ' ' GLU . . . . . . . . . . . . . 42.4 mt-10 . . . . . 0 C--N 1.305 -1.352 0 N-CA-C 108.316 -0.994 . . . . 3.21 108.316 177.789 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A 1622 ' ' ASN . . . . . . . . . . . . . 25.4 t-20 . . . . . 0 N--CA 1.464 0.274 0 N-CA-C 107.521 -1.289 . . . . 3.58 107.521 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A 1623 ' ' ARG . . . . . . . . . . . . . 7.2 ptp180 -122.13 162.44 37.44 Favored Pre-proline 0 C--N 1.299 -1.602 0 CA-C-O 119.381 -0.342 . . . . 4.09 110.153 -178.725 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A 1624 ' ' PRO . . . . . . . . . . . . . 50.0 Cg_exo -55.61 144.68 73.86 Favored 'Trans proline' 0 C--N 1.364 1.348 0 C-N-CA 122.914 2.41 . . . . 2.86 113.404 -179.777 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A 1625 ' ' MET . . . . . 0.515 ' HE3' HG22 ' A' 1627 ' ' ILE . 55.4 ttp -118.35 136.03 53.97 Favored 'General case' 0 C--N 1.301 -1.533 0 CA-C-N 115.272 -0.876 . . . . 2.73 109.517 -179.929 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A 1626 ' ' LEU . . . . . 0.56 ' HG ' ' HD1' ' A' 1542 ' ' TYR . 3.2 tm? -73.71 113.69 11.13 Favored 'General case' 0 C--N 1.31 -1.137 0 N-CA-C 106.79 -1.559 . . . . 1.94 106.79 175.071 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A 1627 ' ' ILE . . . . . 0.515 HG22 ' HE3' ' A' 1625 ' ' MET . 31.6 pt -99.95 -30.95 3.35 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.957 0 C-N-CA 120.675 -0.41 . . . . 1.75 111.758 -176.758 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A 1628 ' ' SER . . . . . 0.403 ' HB3' ' HB2' ' A' 1637 ' ' PHE . 32.2 t -148.84 165.77 30.5 Favored 'General case' 0 N--CA 1.425 -1.679 0 CA-C-O 121.575 0.702 . . . . 1.85 111.253 -175.116 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A 1629 ' ' LEU . . . . . . . . . . . . . 14.2 tp -146.15 130.23 17.41 Favored 'General case' 0 C--N 1.292 -1.898 0 C-N-CA 125.153 1.381 . . . . 2.12 108.37 -177.682 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A 1630 ' ' ASP . . . . . 0.423 ' HB2' ' HE2' ' A' 1637 ' ' PHE . 21.2 t70 -119.36 106.63 12.47 Favored 'General case' 0 C--N 1.308 -1.222 0 N-CA-C 108.452 -0.944 . . . . 0.87 108.452 175.139 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A 1631 ' ' LYS . . . . . . . . . . . . . 67.9 mttm -69.41 -35.02 75.34 Favored 'General case' 0 C--N 1.304 -1.411 0 CA-C-N 115.528 -0.76 . . . . 2.76 112.707 -176.031 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A 1632 ' ' GLN . . . . . . . . . . . . . 39.4 mt-30 -74.19 -23.15 59.18 Favored 'General case' 0 C--N 1.323 -0.57 0 N-CA-C 112.938 0.718 . . . . 2.55 112.938 -176.12 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A 1633 ' ' THR . . . . . . . . . . . . . 2.0 m -112.5 3.69 16.97 Favored 'General case' 0 C--N 1.314 -0.942 0 CA-C-O 121.875 0.845 . . . . 1.92 110.217 178.528 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A 1634 ' ' CYS . . . . . 0.469 ' HB3' ' CD1' ' A' 1606 ' ' TYR . 33.4 m 54.36 43.36 30.58 Favored 'General case' 0 C--N 1.349 0.569 0 CA-C-N 114.673 -1.149 . . . . 0.89 110.32 177.099 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A 1635 ' ' THR . . . . . 0.528 HG21 ' HG3' ' A' 1607 ' ' LYS . 26.8 m -112.57 133.6 54.54 Favored 'General case' 0 N--CA 1.436 -1.156 0 CA-C-N 114.934 -1.03 . . . . 1.31 111.255 -173.128 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A 1636 ' ' LEU . . . . . . . . . . . . . 14.0 mt -104.72 130.45 52.77 Favored 'General case' 0 C--O 1.246 0.887 0 N-CA-C 107.894 -1.15 . . . . 1.97 107.894 174.118 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A 1637 ' ' PHE . . . . . 0.423 ' HE2' ' HB2' ' A' 1630 ' ' ASP . 96.1 m-85 -107.87 110.01 21.67 Favored 'General case' 0 C--N 1.313 -1.015 0 CA-C-O 120.832 0.349 . . . . 0.92 110.809 -178.073 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A 1638 ' ' PHE . . . . . . . . . . . . . 97.9 m-85 -105.44 150.39 25.32 Favored 'General case' 0 C--N 1.307 -1.255 0 N-CA-C 109.219 -0.66 . . . . 0.7 109.219 178.457 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A 1639 ' ' SER . . . . . 0.472 ' HA ' ' O ' ' A' 1611 ' ' SER . 69.1 m -141.61 138.05 32.31 Favored 'General case' 0 C--N 1.281 -2.391 0 N-CA-C 109.868 -0.419 . . . . 1.46 109.868 175.147 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A 1640 ' ' TRP . . . . . 0.49 ' HE3' ' HE2' ' A' 1612 ' ' PHE . 12.8 t90 -127.6 118.93 24.84 Favored 'General case' 0 C--N 1.29 -2.017 0 N-CA-C 107.561 -1.274 . . . . 0.92 107.561 178.537 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A 1641 ' ' HIS . . . . . 0.677 ' HB2' ' HB3' ' A' 1615 ' ' ARG . 6.2 p-80 -91.11 90.95 8.05 Favored 'General case' 0 N--CA 1.43 -1.461 0 CA-C-O 122.425 1.107 . . . . 3.18 110.045 176.465 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A 1642 ' ' THR . . . . . 0.455 ' O ' ' HA ' ' A' 1614 ' ' CYS . 1.6 m -103.3 133.81 20.11 Favored Pre-proline 0 C--N 1.281 -2.411 0 CA-C-N 113.629 -1.623 . . . . 1.48 109.688 -172.93 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A 1643 ' ' PRO . . . . . . . . . . . . . 23.7 Cg_exo -69.46 -18.91 38.19 Favored 'Trans proline' 0 CA--C 1.533 0.43 0 C-N-CA 122.669 2.246 . . . . 1.09 110.482 174.036 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A 1644 ' ' LEU . . . . . . . . . . . . . 84.2 mt -76.55 -13.69 60.06 Favored 'General case' 0 N--CA 1.471 0.616 0 CA-C-N 115.036 -0.984 . . . . 2.08 110.958 178.491 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A 1645 ' ' ALA . . . . . . . . . . . . . . . -79.73 2.91 21.02 Favored 'General case' 0 CA--C 1.539 0.548 0 N-CA-C 113.436 0.902 . . . . 1.37 113.436 -172.392 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A 1646 ' ' CYS . . . . . . . . . . . . . 12.0 p -168.06 177.03 5.78 Favored 'General case' 0 C--O 1.25 1.094 0 N-CA-C 107.092 -1.447 . . . . 1.7 107.092 177.102 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A 1647 ' ' GLU . . . . . . . . . . . . . 6.7 mp0 . . . . . 0 C--N 1.309 -1.188 0 N-CA-C 107.089 -1.448 . . . . 2.92 107.089 172.145 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A 1515 ' ' ASP . . . . . . . . . . . . . 16.3 t70 . . . . . 0 C--O 1.239 0.55 0 N-CA-C 109.102 -0.703 . . . . 2.54 109.102 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A 1516 ' ' CYS . . . . . 0.553 ' HB2' ' HD2' ' A' 1579 ' ' LYS . 8.0 t -79.63 74.07 6.31 Favored 'General case' 0 C--N 1.31 -1.152 0 CA-C-O 122.019 0.914 . . . . 1.25 110.181 -176.194 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A 1517 ' ' GLN . . . . . 0.474 ' HB2' HD21 ' A' 1526 ' ' LEU . 10.3 pt20 -151.12 159.28 44.57 Favored 'General case' 0 C--N 1.306 -1.29 0 CA-C-N 116.014 -0.539 . . . . 2.36 109.827 -179.397 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A 1518 ' ' VAL . . . . . . . . . . . . . 7.5 p -151.5 139.69 14.29 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.496 0 N-CA-C 108.829 -0.804 . . . . 2.34 108.829 177.207 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A 1519 ' ' THR . . . . . 0.595 ' HA ' ' HA ' ' A' 1526 ' ' LEU . 15.2 m -87.14 122.67 31.27 Favored 'General case' 0 N--CA 1.42 -1.94 0 N-CA-C 107.482 -1.303 . . . . 2.04 107.482 176.88 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A 1520 ' ' ASN . . . . . . . . . . . . . 25.2 t-20 -78.74 115.34 51.15 Favored Pre-proline 0 C--N 1.318 -0.794 0 N-CA-C 108.612 -0.885 . . . . 2.12 108.612 179.393 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A 1521 ' ' PRO . . . . . . . . . . . . . 71.4 Cg_endo -72.27 -20.29 24.67 Favored 'Trans proline' 0 CA--C 1.533 0.437 0 C-N-CA 122.185 1.924 . . . . 2.59 113.715 -175.144 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A 1522 ' ' SER . . . . . . . . . . . . . 37.6 m -81.96 -37.44 26.67 Favored 'General case' 0 N--CA 1.436 -1.155 0 N-CA-C 112.648 0.61 . . . . 2.65 112.648 -175.642 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A 1523 ' ' THR . . . . . . . . . . . . . 8.8 t -103.63 -17.58 15.09 Favored 'General case' 0 CA--C 1.551 0.984 0 C-N-CA 120.005 -0.678 . . . . 2.33 111.35 176.987 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A 1524 ' ' GLY . . . . . . . . . . . . . . . 81.48 11.38 83.27 Favored Glycine 0 C--O 1.226 -0.391 0 C-N-CA 121.168 -0.539 . . . . 1.96 112.181 179.209 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A 1525 ' ' HIS . . . . . . . . . . . . . 57.1 t-80 -101.89 136.12 42.28 Favored 'General case' 0 C--N 1.304 -1.37 0 N-CA-C 108.182 -1.044 . . . . 2.44 108.182 -179.237 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A 1526 ' ' LEU . . . . . 0.595 ' HA ' ' HA ' ' A' 1519 ' ' THR . 5.1 tt -82.31 134.56 35.27 Favored 'General case' 0 C--N 1.293 -1.855 0 N-CA-C 106.512 -1.662 . . . . 2.19 106.512 177.621 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A 1527 ' ' PHE . . . . . 0.41 ' N ' HD22 ' A' 1526 ' ' LEU . 65.7 m-85 -110.85 112.34 24.12 Favored 'General case' 0 C--N 1.294 -1.834 0 CA-C-O 121.424 0.631 . . . . 1.61 111.072 177.889 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A 1528 ' ' ASP . . . . . . . . . . . . . 11.3 t70 -85.63 124.09 31.77 Favored 'General case' 0 C--N 1.312 -1.051 0 CA-C-N 114.525 -1.216 . . . . 2.18 111.092 179.453 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A 1529 ' ' LEU . . . . . . . . . . . . . 9.9 mp -116.62 18.45 14.98 Favored 'General case' 0 C--N 1.313 -0.986 0 CA-C-N 115.801 -0.636 . . . . 2.04 109.285 175.006 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A 1530 ' ' SER . . . . . . . . . . . . . 47.9 m -98.38 -29.08 13.34 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-O 121.246 0.546 . . . . 1.44 111.419 -178.404 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A 1531 ' ' SER . . . . . . . . . . . . . 3.4 m -96.02 -9.71 30.32 Favored 'General case' 0 C--N 1.302 -1.493 0 CA-C-O 121.148 0.499 . . . . 1.63 110.421 -178.556 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A 1532 ' ' LEU . . . . . . . . . . . . . 78.5 mt -65.64 -40.92 93.03 Favored 'General case' 0 CA--C 1.543 0.695 0 N-CA-C 114.169 1.174 . . . . 2.32 114.169 -178.686 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A 1533 ' ' SER . . . . . 0.699 ' HB2' ' HB ' ' A' 1552 ' ' ILE . 7.2 t -101.01 126.78 47.7 Favored 'General case' 0 C--N 1.302 -1.477 0 N-CA-C 108.861 -0.792 . . . . 2.57 108.861 -178.137 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A 1534 ' ' GLY . . . . . . . . . . . . . . . -104.57 -122.53 5.1 Favored Glycine 0 N--CA 1.425 -2.037 0 CA-C-N 115.883 -0.599 . . . . 1.89 112.466 -179.957 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A 1535 ' ' ARG . . . . . . . . . . . . . 20.5 tpt180 -81.79 -56.98 3.64 Favored 'General case' 0 C--N 1.302 -1.48 0 CA-C-O 120.875 0.369 . . . . 4.44 111.178 -176.446 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A 1536 ' ' ALA . . . . . . . . . . . . . . . -91.49 -45.45 8.52 Favored 'General case' 0 C--N 1.307 -1.25 0 C-N-CA 120.456 -0.497 . . . . 2.07 111.65 -174.258 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A 1537 ' ' GLY . . . . . . . . . . . . . . . 100.15 -138.22 13.73 Favored Glycine 0 N--CA 1.429 -1.794 0 N-CA-C 110.894 -0.882 . . . . 1.2 110.894 -179.212 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A 1538 ' ' PHE . . . . . . . . . . . . . 74.6 m-85 -138.1 172.99 12.11 Favored 'General case' 0 C--N 1.316 -0.88 0 N-CA-C 107.705 -1.22 . . . . 1.98 107.705 -178.821 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A 1539 ' ' THR . . . . . . . . . . . . . 6.6 t -147.41 151.71 36.92 Favored 'General case' 0 C--N 1.299 -1.59 0 C-N-CA 119.384 -0.926 . . . . 1.97 111.21 -177.072 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A 1540 ' ' ALA . . . . . . . . . . . . . . . -132.19 135.47 46.36 Favored 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 108.543 -0.91 . . . . 1.39 108.543 177.945 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A 1541 ' ' ALA . . . . . . . . . . . . . . . -80.45 152.2 28.89 Favored 'General case' 0 C--N 1.317 -0.827 0 CA-C-O 121.033 0.444 . . . . 1.86 110.855 -179.086 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A 1542 ' ' TYR . . . . . . . . . . . . . 30.3 t80 -149.36 177.62 9.51 Favored 'General case' 0 N--CA 1.425 -1.689 0 N-CA-C 108.48 -0.933 . . . . 2.4 108.48 -177.903 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A 1543 ' ' SER . . . . . . . . . . . . . 4.5 m -48.69 -151.16 0.0 OUTLIER 'General case' 0 CA--C 1.58 2.132 0 C-N-CA 128.71 2.804 . . . . 2.58 113.28 178.173 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A 1544 ' ' LYS . . . . . . . . . . . . . 27.5 ttpp -43.18 -26.26 0.16 Allowed 'General case' 0 N--CA 1.495 1.8 0 O-C-N 120.607 -1.308 . . . . 4.24 113.322 178.365 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A 1545 ' ' SER . . . . . . . . . . . . . 7.1 m -64.68 -22.02 66.88 Favored 'General case' 0 CA--C 1.569 1.677 0 C-N-CA 123.134 0.574 . . . . 3.6 111.541 175.633 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A 1546 ' ' GLY . . . . . . . . . . . . . . . 91.45 -78.68 1.33 Allowed Glycine 0 N--CA 1.438 -1.174 0 N-CA-C 114.127 0.411 . . . . 1.66 114.127 173.518 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A 1547 ' ' VAL . . . . . . . . . . . . . 10.0 p -159.37 147.42 7.19 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.043 0 N-CA-C 107.057 -1.46 . . . . 2.23 107.057 -176.071 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A 1548 ' ' VAL . . . . . . . . . . . . . 1.6 t -116.57 129.22 73.42 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.946 0 N-CA-C 108.319 -0.993 . . . . 1.59 108.319 -177.338 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A 1549 ' ' TYR . . . . . 0.511 ' CE2' ' HA3' ' A' 1568 ' ' GLY . 79.3 m-85 -85.44 120.38 26.84 Favored 'General case' 0 CA--C 1.494 -1.184 0 N-CA-C 107.315 -1.365 . . . . 1.58 107.315 174.839 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A 1550 ' ' MET . . . . . . . . . . . . . 88.7 mmm -124.76 121.29 34.19 Favored 'General case' 0 C--N 1.298 -1.654 0 N-CA-C 109.707 -0.479 . . . . 2.08 109.707 -173.579 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A 1551 ' ' SER . . . . . . . . . . . . . 50.4 m -89.96 158.62 17.3 Favored 'General case' 0 C--N 1.286 -2.158 0 N-CA-C 108.41 -0.959 . . . . 1.9 108.41 175.622 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A 1552 ' ' ILE . . . . . 0.699 ' HB ' ' HB2' ' A' 1533 ' ' SER . 38.8 mm -74.14 -60.57 2.26 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.299 0 C-N-CA 119.228 -0.989 . . . . 2.04 108.507 -179.871 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A 1553 ' ' CYS . . . . . 0.408 ' SG ' ' HG3' ' A' 1579 ' ' LYS . 34.9 t -151.16 141.99 22.86 Favored 'General case' 0 N--CA 1.421 -1.92 0 N-CA-C 104.402 -2.444 . . . . 1.43 104.402 178.663 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A 1554 ' ' GLY . . . . . . . . . . . . . . . 104.81 -172.34 19.93 Favored Glycine 0 C--N 1.291 -1.951 0 C-N-CA 119.666 -1.254 . . . . 1.23 111.073 -177.504 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A 1555 ' ' GLU . . . . . . . . . . . . . 8.9 pt-20 -98.67 142.4 30.28 Favored 'General case' 0 C--N 1.308 -1.219 0 N-CA-C 113.656 0.984 . . . . 1.8 113.656 -173.009 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A 1556 ' ' ASN . . . . . 0.409 ' O ' ' HA ' ' A' 1561 ' ' PRO . 19.3 t-20 -94.15 145.68 24.52 Favored 'General case' 0 C--N 1.309 -1.168 0 CA-C-N 113.707 -1.588 . . . . 2.63 108.216 -179.398 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A 1557 ' ' GLU . . . . . . . . . . . . . 58.1 mm-40 -112.39 -9.47 13.84 Favored 'General case' 0 C--N 1.305 -1.35 0 O-C-N 123.464 0.478 . . . . 3.79 111.525 -174.618 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A 1558 ' ' ASN . . . . . . . . . . . . . 18.4 m-80 -85.49 2.58 44.11 Favored 'General case' 0 N--CA 1.489 1.488 0 CA-C-O 121.91 0.862 . . . . 1.59 111.519 -177.972 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A 1559 ' ' CYS . . . . . 0.798 ' HB3' ' HD2' ' A' 1560 ' ' PRO . 47.3 m -145.46 -175.93 0.51 Allowed Pre-proline 0 C--N 1.288 -2.097 0 N-CA-C 105.192 -2.151 . . . . 0.94 105.192 175.51 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A 1560 ' ' PRO . . . . . 0.798 ' HD2' ' HB3' ' A' 1559 ' ' CYS . 1.6 Cg_endo -44.48 112.84 0.38 Allowed 'Trans proline' 0 C--N 1.376 2.01 0 C-N-CA 122.312 2.008 . . . . 1.53 112.255 177.285 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A 1561 ' ' PRO . . . . . 0.409 ' HA ' ' O ' ' A' 1556 ' ' ASN . 53.0 Cg_exo -57.67 110.62 0.65 Allowed 'Trans proline' 0 C--O 1.244 0.82 0 C-N-CA 122.97 2.447 . . . . 1.82 111.229 -177.233 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A 1562 ' ' GLY . . . . . . . . . . . . . . . 135.96 -16.4 3.96 Favored Glycine 0 C--N 1.299 -1.483 0 N-CA-C 110.756 -0.938 . . . . 0.81 110.756 -176.544 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A 1563 ' ' VAL . . . . . 0.565 ' HA ' ' HA ' ' A' 1576 ' ' LYS . 4.9 m -94.02 160.96 2.64 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.236 0 N-CA-C 107.029 -1.471 . . . . 1.73 107.029 176.659 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A 1564 ' ' GLY . . . . . 0.486 ' HA3' ' CE2' ' A' 1592 ' ' TYR . . . -124.18 -5.08 7.5 Favored Glycine 0 C--O 1.238 0.403 0 C-N-CA 119.125 -1.512 . . . . 0.72 113.162 -177.06 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A 1565 ' ' ALA . . . . . . . . . . . . . . . -150.18 127.24 11.2 Favored 'General case' 0 C--O 1.251 1.14 0 N-CA-C 108.808 -0.812 . . . . 1.14 108.808 179.867 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A 1566 ' ' CYS . . . . . . . . . . . . . 9.8 t -159.13 142.92 15.04 Favored 'General case' 0 C--N 1.308 -1.201 0 CA-C-N 116.258 -0.428 . . . . 0.51 111.062 -172.755 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A 1567 ' ' PHE . . . . . . . . . . . . . 24.9 m-85 -73.31 123.24 23.37 Favored 'General case' 0 CA--C 1.508 -0.668 0 N-CA-C 107.224 -1.398 . . . . 1.22 107.224 175.789 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A 1568 ' ' GLY . . . . . 0.511 ' HA3' ' CE2' ' A' 1549 ' ' TYR . . . -79.26 -25.47 59.28 Favored Glycine 0 C--N 1.3 -1.426 0 C-N-CA 120.052 -1.07 . . . . 1.08 114.785 -171.688 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A 1569 ' ' GLN . . . . . . . . . . . . . 8.1 tp-100 -71.08 -46.03 62.62 Favored 'General case' 0 C--N 1.306 -1.303 0 C-N-CA 119.937 -0.705 . . . . 3.05 110.934 -179.179 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A 1570 ' ' THR . . . . . . . . . . . . . 38.3 p -95.83 -13.14 24.27 Favored 'General case' 0 C--N 1.306 -1.309 0 N-CA-C 112.333 0.494 . . . . 2.44 112.333 -177.154 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A 1571 ' ' ARG . . . . . . . . . . . . . 79.4 mtm180 60.63 37.39 19.29 Favored 'General case' 0 C--O 1.246 0.869 0 C-N-CA 124.753 1.221 . . . . 4.48 112.798 -177.303 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A 1572 ' ' ILE . . . . . . . . . . . . . 39.9 mm -101.03 110.69 28.55 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.378 0 CA-C-N 114.458 -1.246 . . . . 1.94 108.2 177.941 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A 1573 ' ' SER . . . . . . . . . . . . . 29.1 t -67.68 133.73 49.85 Favored 'General case' 0 C--N 1.294 -1.836 0 CA-C-N 114.548 -1.206 . . . . 1.25 111.016 -179.971 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A 1574 ' ' VAL . . . . . 0.506 ' HB ' ' HB2' ' A' 1606 ' ' TYR . 34.8 m -108.23 -33.39 2.55 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.309 0 C-N-CA 120.602 -0.439 . . . . 1.61 111.009 -179.815 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A 1575 ' ' GLY . . . . . . . . . . . . . . . -140.11 130.88 4.83 Favored Glycine 0 N--CA 1.433 -1.512 0 C-N-CA 120.364 -0.922 . . . . 0.65 112.67 -177.692 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A 1576 ' ' LYS . . . . . 0.565 ' HA ' ' HA ' ' A' 1563 ' ' VAL . 88.4 tttt -79.75 151.15 30.54 Favored 'General case' 0 C--N 1.313 -1.009 0 N-CA-C 108.32 -0.993 . . . . 3.33 108.32 178.698 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A 1577 ' ' ALA . . . . . . . . . . . . . . . -70.71 98.17 1.48 Allowed 'General case' 0 CA--C 1.508 -0.662 0 CA-C-O 121.245 0.545 . . . . 1.31 111.119 -175.988 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A 1578 ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -101.66 115.93 31.62 Favored 'General case' 0 C--N 1.296 -1.753 0 N-CA-C 107.118 -1.438 . . . . 2.24 107.118 175.97 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A 1579 ' ' LYS . . . . . 0.553 ' HD2' ' HB2' ' A' 1516 ' ' CYS . 38.4 ttpt -91.34 89.72 7.4 Favored 'General case' 0 C--N 1.3 -1.578 0 N-CA-C 108.085 -1.08 . . . . 2.34 108.085 179.532 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A 1580 ' ' ARG . . . . . . . . . . . . . 14.4 tpp180 -156.43 116.93 3.67 Favored 'General case' 0 N--CA 1.419 -1.976 0 CA-C-N 114.459 -1.246 . . . . 4.19 108.556 -176.11 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A 1581 ' ' LEU . . . . . . . . . . . . . 2.9 pp -113.37 150.65 32.33 Favored 'General case' 0 C--N 1.297 -1.688 0 C-N-CA 120.515 -0.474 . . . . 2.39 111.236 178.145 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A 1582 ' ' ARG . . . . . . . . . . . . . 41.2 ttm180 -130.12 109.75 11.07 Favored 'General case' 0 C--N 1.295 -1.781 0 CA-C-N 115.603 -0.726 . . . . 4.48 109.912 -178.625 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A 1583 ' ' TYR . . . . . . . . . . . . . 79.6 t80 -94.84 104.12 16.02 Favored 'General case' 0 C--N 1.296 -1.746 0 N-CA-C 108.443 -0.947 . . . . 1.57 108.443 178.801 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A 1584 ' ' VAL . . . . . 0.486 ' O ' HG11 ' A' 1587 ' ' VAL . 7.0 p -130.78 111.2 19.76 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.403 0 C-N-CA 120.358 -0.537 . . . . 2.29 112.0 -177.584 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A 1585 ' ' ASP . . . . . . . . . . . . . 18.7 t70 59.98 59.16 2.5 Favored 'General case' 0 N--CA 1.481 1.078 0 CA-C-O 122.584 1.183 . . . . 2.06 110.976 177.171 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A 1586 ' ' GLN . . . . . . . . . . . . . 41.8 mt-30 57.35 23.53 9.01 Favored 'General case' 0 C--N 1.315 -0.916 0 N-CA-C 115.186 1.55 . . . . 2.61 115.186 179.087 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A 1587 ' ' VAL . . . . . 0.486 HG11 ' O ' ' A' 1584 ' ' VAL . 9.5 p -130.85 128.32 62.63 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.512 0 N-CA-C 108.757 -0.831 . . . . 1.33 108.757 173.482 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A 1588 ' ' LEU . . . . . 0.598 ' HB2' ' HB2' ' A' 1612 ' ' PHE . 8.1 mp -89.15 143.98 26.45 Favored 'General case' 0 N--CA 1.427 -1.58 0 CA-C-N 115.609 -0.723 . . . . 2.03 109.636 179.689 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A 1589 ' ' GLN . . . . . . . . . . . . . 7.7 tt0 -136.05 142.8 44.43 Favored 'General case' 0 C--N 1.28 -2.454 0 N-CA-C 108.872 -0.788 . . . . 1.73 108.872 178.136 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A 1590 ' ' LEU . . . . . . . . . . . . . 5.7 tt -139.19 133.83 31.94 Favored 'General case' 0 C--N 1.293 -1.861 0 N-CA-C 103.611 -2.737 . . . . 1.76 103.611 173.463 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A 1591 ' ' VAL . . . . . . . . . . . . . 7.3 p -130.9 127.61 61.59 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.496 0 N-CA-C 113.792 1.034 . . . . 2.14 113.792 -172.808 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A 1592 ' ' TYR . . . . . 0.486 ' CE2' ' HA3' ' A' 1564 ' ' GLY . 96.4 m-85 -101.33 139.9 36.37 Favored 'General case' 0 CA--C 1.495 -1.162 0 CA-C-N 114.581 -1.19 . . . . 1.53 107.86 177.412 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A 1593 ' ' LYS . . . . . . . . . . . . . 14.1 ptmm? -158.93 170.12 22.81 Favored 'General case' 0 C--N 1.299 -1.595 0 C-N-CA 120.601 -0.44 . . . . 2.72 110.084 -179.125 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A 1594 ' ' ASP . . . . . . . . . . . . . 48.1 m-20 61.8 41.98 11.11 Favored 'General case' 0 C--N 1.312 -1.025 0 N-CA-C 114.774 1.398 . . . . 1.45 114.774 175.127 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A 1595 ' ' GLY . . . . . . . . . . . . . . . -77.49 -86.88 0.41 Allowed Glycine 0 N--CA 1.437 -1.258 0 N-CA-C 109.13 -1.588 . . . . 0.83 109.13 171.241 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A 1596 ' ' SER . . . . . . . . . . . . . 15.5 m -114.47 152.37 46.06 Favored Pre-proline 0 C--N 1.298 -1.635 0 N-CA-C 107.921 -1.14 . . . . 1.96 107.921 176.059 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A 1597 ' ' PRO . . . . . . . . . . . . . 28.1 Cg_exo -63.74 146.35 91.99 Favored 'Trans proline' 0 C--O 1.247 0.97 0 C-N-CA 122.929 2.42 . . . . 1.34 111.45 178.103 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A 1598 ' ' CYS . . . . . 0.446 ' HA ' ' HD3' ' A' 1599 ' ' PRO . 27.4 t -98.76 133.3 22.56 Favored Pre-proline 0 C--N 1.297 -1.696 0 N-CA-C 108.894 -0.78 . . . . 1.19 108.894 -178.486 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A 1599 ' ' PRO . . . . . 0.446 ' HD3' ' HA ' ' A' 1598 ' ' CYS . 32.1 Cg_exo -62.82 -21.62 73.22 Favored 'Trans proline' 0 C--N 1.359 1.129 0 C-N-CA 123.759 2.973 . . . . 1.88 112.941 179.801 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A 1600 ' ' SER . . . . . 0.551 ' HB3' ' SG ' ' A' 1634 ' ' CYS . 47.9 t -85.89 117.74 24.93 Favored 'General case' 0 N--CA 1.427 -1.606 0 N-CA-C 106.704 -1.591 . . . . 2.19 106.704 175.242 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A 1601 ' ' LYS . . . . . . . . . . . . . 48.4 mmtm 58.82 60.63 2.42 Favored 'General case' 0 C--O 1.245 0.865 0 O-C-N 123.988 0.805 . . . . 4.21 108.994 -176.484 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A 1602 ' ' SER . . . . . . . . . . . . . 23.3 t -53.37 112.27 0.86 Allowed 'General case' 0 C--O 1.247 0.969 0 CA-C-N 114.786 -1.097 . . . . 3.82 111.542 -174.846 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A 1603 ' ' GLY . . . . . . . . . . . . . . . 150.99 -33.84 0.94 Allowed Glycine 0 N--CA 1.43 -1.743 0 N-CA-C 108.137 -1.985 . . . . 2.45 108.137 -177.912 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A 1604 ' ' LEU . . . . . . . . . . . . . 2.5 pp -94.59 164.16 13.09 Favored 'General case' 0 N--CA 1.427 -1.585 0 CA-C-N 114.644 -0.778 . . . . 2.06 109.567 175.87 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A 1605 ' ' SER . . . . . . . . . . . . . 19.0 p -109.42 -167.08 1.16 Allowed 'General case' 0 C--N 1.286 -2.19 0 N-CA-C 109.371 -0.603 . . . . 1.75 109.371 -178.82 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A 1606 ' ' TYR . . . . . 0.506 ' HB2' ' HB ' ' A' 1574 ' ' VAL . 61.1 m-85 -97.45 144.79 26.83 Favored 'General case' 0 N--CA 1.413 -2.32 0 N-CA-C 104.466 -2.42 . . . . 1.59 104.466 179.07 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A 1607 ' ' LYS . . . . . 0.45 ' HG3' HG21 ' A' 1635 ' ' THR . 19.2 ptmt -132.38 132.98 43.4 Favored 'General case' 0 C--N 1.268 -2.968 0 C-N-CA 118.655 -1.218 . . . . 2.21 109.422 177.283 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A 1608 ' ' SER . . . . . . . . . . . . . 20.2 m -115.69 111.72 21.02 Favored 'General case' 0 C--N 1.291 -1.945 0 C-N-CA 122.848 0.459 . . . . 1.48 110.694 -175.724 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A 1609 ' ' VAL . . . . . . . . . . . . . 96.5 t -92.34 121.38 42.87 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.069 0 N-CA-C 109.151 -0.685 . . . . 1.57 109.151 178.17 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A 1610 ' ' ILE . . . . . . . . . . . . . 17.0 mm -99.62 104.44 16.07 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.552 0 N-CA-C 107.871 -1.159 . . . . 1.47 107.871 177.11 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A 1611 ' ' SER . . . . . 0.459 ' O ' ' HA ' ' A' 1639 ' ' SER . 22.8 t -91.8 119.87 32.01 Favored 'General case' 0 N--CA 1.42 -1.957 0 N-CA-C 108.612 -0.884 . . . . 1.84 108.612 178.667 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A 1612 ' ' PHE . . . . . 0.598 ' HB2' ' HB2' ' A' 1588 ' ' LEU . 97.4 m-85 -95.85 108.73 21.11 Favored 'General case' 0 C--N 1.297 -1.696 0 CA-C-N 115.548 -0.751 . . . . 0.86 109.678 -178.776 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A 1613 ' ' VAL . . . . . . . . . . . . . 48.0 t -100.56 122.14 52.19 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.012 0 CA-C-N 115.409 -0.814 . . . . 1.32 109.544 -176.891 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A 1614 ' ' CYS . . . . . 0.659 ' HA ' ' O ' ' A' 1642 ' ' THR . 0.8 OUTLIER -76.68 100.6 5.45 Favored 'General case' 0 CA--C 1.5 -0.977 0 N-CA-C 113.178 0.807 . . . . 1.39 113.178 177.289 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A 1615 ' ' ARG . . . . . 0.503 ' HD3' ' HD2' ' A' 1616 ' ' PRO . 14.0 tpp180 -137.71 116.77 9.96 Favored Pre-proline 0 N--CA 1.414 -2.27 0 CA-C-N 114.851 -1.068 . . . . 4.34 108.411 177.103 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A 1616 ' ' PRO . . . . . 0.503 ' HD2' ' HD3' ' A' 1615 ' ' ARG . 56.6 Cg_exo -58.16 52.13 0.05 OUTLIER 'Trans proline' 0 CA--C 1.553 1.463 0 C-N-CA 124.788 3.659 . . . . 1.5 114.717 174.636 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A 1617 ' ' GLU . . . . . . . . . . . . . 44.0 tt0 . . . . . 0 C--N 1.31 -1.143 0 N-CA-C 108.2 -1.037 . . . . 3.21 108.2 176.628 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A 1622 ' ' ASN . . . . . 0.45 ' C ' ' HD3' ' A' 1624 ' ' PRO . 61.0 t30 . . . . . 0 C--O 1.247 0.934 0 CA-C-O 121.894 0.854 . . . . 3.58 112.578 . . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A 1623 ' ' ARG . . . . . 0.504 ' HB3' ' CD1' ' A' 1640 ' ' TRP . 9.2 ptm180 -123.72 69.6 45.63 Favored Pre-proline 0 N--CA 1.434 -1.237 0 C-N-CA 119.572 -0.851 . . . . 4.09 112.043 178.62 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A 1624 ' ' PRO . . . . . 0.45 ' HD3' ' C ' ' A' 1622 ' ' ASN . 64.4 Cg_endo -114.41 91.18 0.01 OUTLIER 'Trans proline' 0 N--CA 1.426 -2.491 0 C-N-CA 122.446 2.098 . . . . 2.86 110.09 167.61 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A 1625 ' ' MET . . . . . 0.475 ' HG3' HG23 ' A' 1627 ' ' ILE . 12.9 tpt -151.78 98.77 2.51 Favored 'General case' 0 C--N 1.297 -1.714 0 C-N-CA 116.939 -1.905 . . . . 2.73 112.236 -179.389 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A 1626 ' ' LEU . . . . . . . . . . . . . 4.4 mm? -87.85 88.99 7.82 Favored 'General case' 0 C--N 1.302 -1.494 0 N-CA-C 108.518 -0.919 . . . . 1.94 108.518 171.321 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A 1627 ' ' ILE . . . . . 0.475 HG23 ' HG3' ' A' 1625 ' ' MET . 37.0 pt -73.42 -35.18 45.11 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.872 0 CA-C-N 115.875 -0.602 . . . . 1.75 110.956 -178.293 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A 1628 ' ' SER . . . . . . . . . . . . . 22.9 t -161.67 152.43 17.87 Favored 'General case' 0 N--CA 1.414 -2.268 0 N-CA-C 107.628 -1.249 . . . . 1.85 107.628 -178.242 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A 1629 ' ' LEU . . . . . 0.58 ' HG ' ' HG ' ' A' 1636 ' ' LEU . 5.1 tt -146.72 111.99 5.49 Favored 'General case' 0 C--N 1.286 -2.166 0 N-CA-C 106.041 -1.837 . . . . 2.12 106.041 175.843 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A 1630 ' ' ASP . . . . . 0.408 ' HB3' ' HB ' ' A' 1635 ' ' THR . 14.0 t70 -84.81 99.66 11.04 Favored 'General case' 0 C--N 1.292 -1.915 0 N-CA-C 106.741 -1.577 . . . . 0.87 106.741 -179.544 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A 1631 ' ' LYS . . . . . . . . . . . . . 47.1 mtmt -72.79 -19.17 61.39 Favored 'General case' 0 C--N 1.306 -1.324 0 CA-C-N 115.941 -0.572 . . . . 2.76 112.373 -173.304 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A 1632 ' ' GLN . . . . . . . . . . . . . 2.8 mp0 -73.68 -51.45 16.64 Favored 'General case' 0 C--N 1.313 -0.985 0 C-N-CA 121.01 -0.276 . . . . 2.55 110.719 179.616 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A 1633 ' ' THR . . . . . . . . . . . . . 35.7 p -97.36 14.03 27.62 Favored 'General case' 0 C--N 1.316 -0.858 0 CA-C-O 121.357 0.599 . . . . 1.92 111.917 -179.706 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A 1634 ' ' CYS . . . . . 0.551 ' SG ' ' HB3' ' A' 1600 ' ' SER . 65.9 m 50.01 45.58 25.18 Favored 'General case' 0 N--CA 1.475 0.813 0 C-N-CA 124.966 1.307 . . . . 0.89 112.244 177.744 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A 1635 ' ' THR . . . . . 0.45 HG21 ' HG3' ' A' 1607 ' ' LYS . 25.5 m -107.14 107.51 18.52 Favored 'General case' 0 N--CA 1.428 -1.574 0 CA-C-N 114.89 -1.05 . . . . 1.31 109.831 -176.609 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A 1636 ' ' LEU . . . . . 0.58 ' HG ' ' HG ' ' A' 1629 ' ' LEU . 4.9 mp -95.11 127.88 41.51 Favored 'General case' 0 C--N 1.309 -1.182 0 N-CA-C 109.434 -0.58 . . . . 1.97 109.434 -177.505 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A 1637 ' ' PHE . . . . . . . . . . . . . 95.6 m-85 -109.36 110.85 22.11 Favored 'General case' 0 C--N 1.314 -0.939 0 CA-C-O 120.941 0.401 . . . . 0.92 110.305 -179.12 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A 1638 ' ' PHE . . . . . 0.429 ' HA ' ' O ' ' A' 1625 ' ' MET . 92.6 m-85 -105.41 159.32 16.01 Favored 'General case' 0 C--N 1.315 -0.933 0 N-CA-C 109.393 -0.595 . . . . 0.7 109.393 179.583 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A 1639 ' ' SER . . . . . 0.459 ' HA ' ' O ' ' A' 1611 ' ' SER . 50.1 m -142.09 144.85 33.74 Favored 'General case' 0 C--N 1.299 -1.599 0 CA-C-O 120.841 0.353 . . . . 1.46 110.885 175.713 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A 1640 ' ' TRP . . . . . 0.504 ' CD1' ' HB3' ' A' 1623 ' ' ARG . 12.4 t90 -118.95 137.79 53.25 Favored 'General case' 0 C--N 1.323 -0.551 0 N-CA-C 106.939 -1.504 . . . . 0.92 106.939 176.871 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A 1641 ' ' HIS . . . . . . . . . . . . . 38.9 m-70 -98.87 98.09 9.21 Favored 'General case' 0 C--N 1.314 -0.937 0 N-CA-C 105.966 -1.864 . . . . 3.18 105.966 179.075 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A 1642 ' ' THR . . . . . 0.659 ' O ' ' HA ' ' A' 1614 ' ' CYS . 9.8 t -142.24 139.21 17.47 Favored Pre-proline 0 C--N 1.305 -1.359 0 N-CA-C 113.459 0.911 . . . . 1.48 113.459 -171.686 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A 1643 ' ' PRO . . . . . 0.48 ' HD3' ' HA ' ' A' 1642 ' ' THR . 4.4 Cg_exo -79.42 -6.77 14.77 Favored 'Trans proline' 0 C--N 1.355 0.894 0 C-N-CA 123.462 2.775 . . . . 1.09 110.385 173.574 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A 1644 ' ' LEU . . . . . . . . . . . . . 65.8 mt -89.13 5.32 45.14 Favored 'General case' 0 N--CA 1.443 -0.797 0 CA-C-N 115.229 -0.896 . . . . 2.08 110.249 -177.693 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A 1645 ' ' ALA . . . . . . . . . . . . . . . -97.18 -44.36 6.98 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-O 121.619 0.724 . . . . 1.37 109.642 176.46 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A 1646 ' ' CYS . . . . . . . . . . . . . 0.6 OUTLIER -171.41 173.91 4.64 Favored 'General case' 0 C--N 1.303 -1.441 0 N-CA-C 107.69 -1.226 . . . . 1.7 107.69 -178.063 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A 1647 ' ' GLU . . . . . . . . . . . . . 51.8 mt-10 . . . . . 0 C--N 1.303 -1.432 0 N-CA-C 108.519 -0.919 . . . . 2.92 108.519 -178.787 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A 1515 ' ' ASP . . . . . 0.553 ' HB3' ' HG2' ' A' 1517 ' ' GLN . 7.5 t70 . . . . . 0 N--CA 1.442 -0.852 0 N-CA-C 105.781 -1.933 . . . . 2.54 105.781 . . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A 1516 ' ' CYS . . . . . . . . . . . . . 72.8 m -104.34 51.5 0.77 Allowed 'General case' 0 C--N 1.27 -2.865 0 N-CA-C 108.196 -1.039 . . . . 1.25 108.196 -179.8 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A 1517 ' ' GLN . . . . . 0.553 ' HG2' ' HB3' ' A' 1515 ' ' ASP . 3.9 pt20 -151.64 171.38 17.72 Favored 'General case' 0 C--N 1.304 -1.377 0 N-CA-C 109.407 -0.59 . . . . 2.36 109.407 -177.316 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A 1518 ' ' VAL . . . . . . . . . . . . . 8.5 p -154.23 140.6 11.91 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.404 0 N-CA-C 109.404 -0.591 . . . . 2.34 109.404 -179.414 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A 1519 ' ' THR . . . . . . . . . . . . . 19.1 m -100.76 130.74 46.83 Favored 'General case' 0 N--CA 1.423 -1.783 0 N-CA-C 107.895 -1.15 . . . . 2.04 107.895 177.097 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A 1520 ' ' ASN . . . . . 0.434 ' OD1' HG21 ' A' 1523 ' ' THR . 27.9 t-20 -90.03 121.35 68.88 Favored Pre-proline 0 C--N 1.3 -1.567 0 C-N-CA 120.236 -0.585 . . . . 2.12 109.868 178.295 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A 1521 ' ' PRO . . . . . . . . . . . . . 60.0 Cg_endo -73.09 -20.28 21.89 Favored 'Trans proline' 0 C--N 1.352 0.754 0 C-N-CA 122.089 1.86 . . . . 2.59 113.642 -175.797 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A 1522 ' ' SER . . . . . . . . . . . . . 48.1 m -77.0 -57.9 3.58 Favored 'General case' 0 C--N 1.316 -0.851 0 N-CA-C 111.981 0.363 . . . . 2.65 111.981 -177.95 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A 1523 ' ' THR . . . . . 0.434 HG21 ' OD1' ' A' 1520 ' ' ASN . 8.9 t -90.71 -14.81 31.45 Favored 'General case' 0 C--N 1.317 -0.835 0 CA-C-O 121.053 0.454 . . . . 2.33 111.134 -178.601 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A 1524 ' ' GLY . . . . . . . . . . . . . . . 76.13 14.32 82.39 Favored Glycine 0 C--O 1.226 -0.393 0 C-N-CA 120.873 -0.679 . . . . 1.96 112.478 178.932 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A 1525 ' ' HIS . . . . . . . . . . . . . 22.7 t60 -100.75 137.65 38.85 Favored 'General case' 0 C--N 1.309 -1.183 0 N-CA-C 108.143 -1.058 . . . . 2.44 108.143 -177.57 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A 1526 ' ' LEU . . . . . . . . . . . . . 7.7 tt -100.0 136.37 40.01 Favored 'General case' 0 C--N 1.297 -1.707 0 N-CA-C 108.604 -0.887 . . . . 2.19 108.604 -178.451 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A 1527 ' ' PHE . . . . . . . . . . . . . 88.2 m-85 -110.46 126.16 54.04 Favored 'General case' 0 C--N 1.3 -1.554 0 N-CA-C 107.792 -1.188 . . . . 1.61 107.792 178.618 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A 1528 ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -114.71 143.64 44.74 Favored 'General case' 0 C--N 1.309 -1.179 0 CA-C-O 122.021 0.915 . . . . 2.18 112.104 -178.932 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A 1529 ' ' LEU . . . . . . . . . . . . . 3.1 mm? -122.33 16.68 10.59 Favored 'General case' 0 C--N 1.292 -1.896 0 N-CA-C 105.047 -2.205 . . . . 2.04 105.047 168.963 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A 1530 ' ' SER . . . . . . . . . . . . . 12.7 m -74.04 -37.48 64.29 Favored 'General case' 0 N--CA 1.435 -1.219 0 CA-C-N 113.727 -1.579 . . . . 1.44 108.681 -179.157 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A 1531 ' ' SER . . . . . . . . . . . . . 9.6 m -75.0 -21.61 59.03 Favored 'General case' 0 N--CA 1.433 -1.32 0 N-CA-C 108.801 -0.814 . . . . 1.63 108.801 176.515 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A 1532 ' ' LEU . . . . . 0.472 HD13 HD23 ' A' 1644 ' ' LEU . 90.2 mt -96.29 11.23 35.36 Favored 'General case' 0 CA--C 1.52 -0.21 0 CA-C-N 115.638 -0.71 . . . . 2.32 112.238 178.239 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A 1533 ' ' SER . . . . . . . . . . . . . 34.0 m -69.47 114.46 7.72 Favored 'General case' 0 N--CA 1.435 -1.212 0 N-CA-C 107.622 -1.251 . . . . 2.57 107.622 176.479 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A 1534 ' ' GLY . . . . . . . . . . . . . . . -82.47 151.11 29.18 Favored Glycine 0 N--CA 1.426 -2.005 0 CA-C-N 115.615 -0.721 . . . . 1.89 113.993 -170.209 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A 1535 ' ' ARG . . . . . 0.465 ' C ' ' HD3' ' A' 1535 ' ' ARG . 1.2 tmt_? -95.88 -61.57 1.43 Allowed 'General case' 0 N--CA 1.426 -1.644 0 N-CA-C 106.885 -1.524 . . . . 4.44 106.885 174.821 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A 1536 ' ' ALA . . . . . . . . . . . . . . . -94.87 -23.01 17.65 Favored 'General case' 0 C--N 1.312 -1.056 0 CA-C-N 115.458 -0.792 . . . . 2.07 109.023 177.195 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A 1537 ' ' GLY . . . . . . . . . . . . . . . 91.25 -167.75 31.75 Favored Glycine 0 N--CA 1.427 -1.962 0 CA-C-N 115.623 -0.717 . . . . 1.2 113.862 174.492 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A 1538 ' ' PHE . . . . . . . . . . . . . 81.6 m-85 -108.46 168.3 9.42 Favored 'General case' 0 C--N 1.298 -1.661 0 C-N-CA 125.574 1.55 . . . . 1.98 107.661 -179.321 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A 1539 ' ' THR . . . . . . . . . . . . . 14.5 p -117.05 112.7 21.3 Favored 'General case' 0 C--N 1.297 -1.714 0 CA-C-O 120.925 0.393 . . . . 1.97 110.273 179.809 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A 1540 ' ' ALA . . . . . . . . . . . . . . . -102.17 143.96 31.32 Favored 'General case' 0 C--N 1.303 -1.435 0 N-CA-C 108.05 -1.093 . . . . 1.39 108.05 178.741 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A 1541 ' ' ALA . . . . . . . . . . . . . . . -91.01 156.64 17.8 Favored 'General case' 0 C--N 1.294 -1.826 0 CA-C-O 121.982 0.896 . . . . 1.86 112.844 -173.819 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A 1542 ' ' TYR . . . . . 0.723 ' HB3' ' HA3' ' A' 1546 ' ' GLY . 68.5 t80 -147.44 171.69 15.11 Favored 'General case' 0 C--N 1.296 -1.761 0 N-CA-C 102.746 -3.057 . . . . 2.4 102.746 175.006 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A 1543 ' ' SER . . . . . . . . . . . . . 6.8 m -43.09 -161.88 0.0 OUTLIER 'General case' 0 CA--C 1.603 2.983 0 N-CA-C 117.119 2.266 . . . . 2.58 117.119 -173.769 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A 1544 ' ' LYS . . . . . . . . . . . . . 57.7 tttm -46.12 -38.05 7.65 Favored 'General case' 0 N--CA 1.479 0.997 0 O-C-N 120.669 -1.27 . . . . 4.24 113.24 -178.493 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A 1545 ' ' SER . . . . . . . . . . . . . 19.4 m -111.29 26.12 11.01 Favored 'General case' 0 C--N 1.3 -1.56 0 O-C-N 122.27 -0.269 . . . . 3.6 110.583 179.18 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A 1546 ' ' GLY . . . . . 0.723 ' HA3' ' HB3' ' A' 1542 ' ' TYR . . . -112.84 131.28 10.0 Favored Glycine 0 N--CA 1.412 -2.912 0 C-N-CA 117.879 -2.105 . . . . 1.66 116.311 -173.836 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A 1547 ' ' VAL . . . . . . . . . . . . . 9.1 p -162.07 119.46 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.567 0 N-CA-C 107.821 -1.177 . . . . 2.23 107.821 171.808 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A 1548 ' ' VAL . . . . . . . . . . . . . 2.1 t -115.29 129.23 71.88 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.814 0 N-CA-C 107.923 -1.14 . . . . 1.59 107.923 -175.599 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A 1549 ' ' TYR . . . . . 0.423 ' HB3' HD22 ' A' 1556 ' ' ASN . 96.3 m-85 -84.61 116.57 23.24 Favored 'General case' 0 N--CA 1.423 -1.783 0 N-CA-C 107.552 -1.277 . . . . 1.58 107.552 176.002 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A 1550 ' ' MET . . . . . . . . . . . . . 54.9 tpp -119.1 122.53 42.28 Favored 'General case' 0 C--N 1.29 -1.986 0 CA-C-N 115.379 -0.828 . . . . 2.08 110.551 -174.014 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A 1551 ' ' SER . . . . . . . . . . . . . 8.2 t -96.57 121.7 38.68 Favored 'General case' 0 C--N 1.285 -2.202 0 N-CA-C 103.527 -2.768 . . . . 1.9 103.527 171.263 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A 1552 ' ' ILE . . . . . . . . . . . . . 1.8 tp -62.14 -27.57 42.77 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.666 0 CA-C-O 121.38 0.609 . . . . 2.04 110.344 -172.166 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A 1553 ' ' CYS . . . . . 0.521 ' HA ' ' OH ' ' A' 1592 ' ' TYR . 23.0 t -162.39 138.39 7.48 Favored 'General case' 0 N--CA 1.415 -2.215 0 N-CA-C 105.479 -2.045 . . . . 1.43 105.479 167.494 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A 1554 ' ' GLY . . . . . . . . . . . . . . . 110.45 -166.85 12.46 Favored Glycine 0 C--N 1.292 -1.913 0 N-CA-C 110.018 -1.233 . . . . 1.23 110.018 -179.011 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A 1555 ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -99.69 156.93 16.82 Favored 'General case' 0 C--N 1.303 -1.448 0 CA-C-N 117.48 0.64 . . . . 1.8 111.109 -178.221 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A 1556 ' ' ASN . . . . . 0.423 HD22 ' HB3' ' A' 1549 ' ' TYR . 23.0 t-20 -111.47 109.37 19.28 Favored 'General case' 0 N--CA 1.423 -1.815 0 CA-C-N 115.34 -0.845 . . . . 2.63 109.269 -178.409 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A 1557 ' ' GLU . . . . . . . . . . . . . 25.6 mt-10 -87.91 54.42 3.09 Favored 'General case' 0 C--N 1.301 -1.525 0 N-CA-C 113.307 0.854 . . . . 3.79 113.307 -174.022 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A 1558 ' ' ASN . . . . . . . . . . . . . 32.9 m-80 -129.22 3.45 5.2 Favored 'General case' 0 C--N 1.306 -1.298 0 N-CA-C 107.94 -1.133 . . . . 1.59 107.94 174.615 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A 1559 ' ' CYS . . . . . 0.761 ' HB3' ' HD2' ' A' 1560 ' ' PRO . 69.3 m -153.98 177.84 1.84 Allowed Pre-proline 0 C--N 1.31 -1.146 0 N-CA-C 106.995 -1.483 . . . . 0.94 106.995 -177.911 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A 1560 ' ' PRO . . . . . 0.761 ' HD2' ' HB3' ' A' 1559 ' ' CYS . 15.9 Cg_exo -32.82 132.74 0.09 OUTLIER 'Trans proline' 0 C--N 1.381 2.246 0 C-N-CA 124.363 3.375 . . . . 1.53 114.955 177.615 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A 1561 ' ' PRO . . . . . . . . . . . . . 35.9 Cg_exo -58.25 123.49 13.75 Favored 'Trans proline' 0 C--O 1.245 0.826 0 C-N-CA 122.916 2.411 . . . . 1.82 111.568 179.814 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A 1562 ' ' GLY . . . . . 0.409 ' O ' ' HD3' ' A' 1576 ' ' LYS . . . 109.48 -8.08 32.38 Favored Glycine 0 N--CA 1.436 -1.364 0 C-N-CA 120.288 -0.958 . . . . 0.81 114.163 178.247 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A 1563 ' ' VAL . . . . . . . . . . . . . 3.4 m -89.17 148.21 4.69 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.874 0 N-CA-C 107.962 -1.125 . . . . 1.73 107.962 178.286 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A 1564 ' ' GLY . . . . . . . . . . . . . . . -97.63 -23.14 14.44 Favored Glycine 0 CA--C 1.505 -0.573 0 C-N-CA 120.137 -1.03 . . . . 0.72 113.162 -174.441 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A 1565 ' ' ALA . . . . . . . . . . . . . . . -151.65 140.46 20.92 Favored 'General case' 0 C--N 1.31 -1.13 0 N-CA-C 109.137 -0.69 . . . . 1.14 109.137 -177.909 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A 1566 ' ' CYS . . . . . . . . . . . . . 48.0 t -161.77 147.65 13.64 Favored 'General case' 0 C--N 1.315 -0.92 0 CA-C-N 116.398 -0.365 . . . . 0.51 110.016 -175.526 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A 1567 ' ' PHE . . . . . 0.412 ' O ' ' HA ' ' A' 1571 ' ' ARG . 50.3 m-85 -74.73 152.16 39.11 Favored 'General case' 0 N--CA 1.471 0.583 0 N-CA-C 108.609 -0.885 . . . . 1.22 108.609 178.424 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A 1568 ' ' GLY . . . . . . . . . . . . . . . -89.07 -31.75 11.61 Favored Glycine 0 N--CA 1.447 -0.61 0 C-N-CA 120.499 -0.857 . . . . 1.08 114.125 -176.744 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A 1569 ' ' GLN . . . . . . . . . . . . . 8.9 tt0 -89.9 -56.93 3.04 Favored 'General case' 0 C--N 1.309 -1.183 0 N-CA-C 108.361 -0.977 . . . . 3.05 108.361 178.363 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A 1570 ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -68.79 -32.6 72.45 Favored 'General case' 0 N--CA 1.421 -1.88 0 CA-C-N 113.684 -1.598 . . . . 2.44 110.579 -175.921 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A 1571 ' ' ARG . . . . . 0.412 ' HA ' ' O ' ' A' 1567 ' ' PHE . 67.7 mtm180 46.29 55.76 7.01 Favored 'General case' 0 C--O 1.246 0.871 0 N-CA-C 113.176 0.806 . . . . 4.48 113.176 -179.252 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A 1572 ' ' ILE . . . . . . . . . . . . . 47.9 mm -109.7 126.05 66.86 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.384 0 N-CA-C 106.394 -1.706 . . . . 1.94 106.394 175.066 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A 1573 ' ' SER . . . . . . . . . . . . . 42.1 t -75.76 120.46 21.16 Favored 'General case' 0 C--N 1.298 -1.634 0 N-CA-C 108.973 -0.751 . . . . 1.25 108.973 179.496 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A 1574 ' ' VAL . . . . . 0.625 ' HB ' ' HB2' ' A' 1606 ' ' TYR . 34.5 m -90.88 -33.9 6.1 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.81 0 C-N-CA 119.401 -0.919 . . . . 1.61 110.827 179.948 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A 1575 ' ' GLY . . . . . . . . . . . . . . . -161.31 155.63 26.87 Favored Glycine 0 N--CA 1.424 -2.144 0 C-N-CA 120.047 -1.073 . . . . 0.65 113.747 -177.761 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A 1576 ' ' LYS . . . . . 0.409 ' HD3' ' O ' ' A' 1562 ' ' GLY . 17.0 tppt? -71.47 153.11 42.47 Favored 'General case' 0 C--N 1.311 -1.108 0 C-N-CA 125.814 1.646 . . . . 3.33 108.512 178.17 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A 1577 ' ' ALA . . . . . . . . . . . . . . . -65.16 74.9 0.05 Allowed 'General case' 0 N--CA 1.482 1.152 0 C-N-CA 123.629 0.771 . . . . 1.31 109.578 174.425 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A 1578 ' ' ASN . . . . . . . . . . . . . 61.8 t30 -89.81 131.67 35.64 Favored 'General case' 0 C--N 1.293 -1.878 0 C-N-CA 124.092 0.957 . . . . 2.24 111.303 -173.211 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A 1579 ' ' LYS . . . . . . . . . . . . . 2.4 mppt? -100.2 92.12 5.07 Favored 'General case' 0 C--N 1.292 -1.914 0 N-CA-C 108.771 -0.826 . . . . 2.34 108.771 175.56 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A 1580 ' ' ARG . . . . . 0.492 ' O ' ' HA ' ' A' 1590 ' ' LEU . 61.7 ttt180 -140.16 86.49 2.08 Favored 'General case' 0 C--N 1.289 -2.056 0 N-CA-C 107.536 -1.283 . . . . 4.19 107.536 176.735 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A 1581 ' ' LEU . . . . . 0.573 HD12 ' HB2' ' A' 1590 ' ' LEU . 20.6 tp -110.85 135.79 50.87 Favored 'General case' 0 C--N 1.297 -1.69 0 N-CA-C 108.672 -0.862 . . . . 2.39 108.672 -177.238 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A 1582 ' ' ARG . . . . . . . . . . . . . 57.5 ttp180 -136.79 140.4 42.49 Favored 'General case' 0 C--N 1.304 -1.384 0 N-CA-C 109.535 -0.542 . . . . 4.48 109.535 179.854 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A 1583 ' ' TYR . . . . . . . . . . . . . 74.2 t80 -112.17 92.89 4.19 Favored 'General case' 0 C--O 1.245 0.843 0 C-N-CA 122.896 0.478 . . . . 1.57 110.174 179.83 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A 1584 ' ' VAL . . . . . . . . . . . . . 28.5 m -137.51 147.22 26.63 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.293 0 N-CA-C 107.261 -1.385 . . . . 2.29 107.261 175.346 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A 1585 ' ' ASP . . . . . . . . . . . . . 19.0 t70 61.96 28.08 17.06 Favored 'General case' 0 N--CA 1.483 1.22 0 C-N-CA 124.246 1.018 . . . . 2.06 109.702 -179.672 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A 1586 ' ' GLN . . . . . . . . . . . . . 46.2 mt-30 53.98 34.16 19.05 Favored 'General case' 0 N--CA 1.466 0.354 0 C-N-CA 125.243 1.417 . . . . 2.61 113.474 -176.147 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A 1587 ' ' VAL . . . . . . . . . . . . . 8.1 p -132.13 123.56 50.98 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.692 0 CA-C-O 121.24 0.543 . . . . 1.33 110.021 176.266 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A 1588 ' ' LEU . . . . . 0.71 ' HB2' ' HB2' ' A' 1612 ' ' PHE . 80.1 mt -78.75 116.72 19.28 Favored 'General case' 0 C--N 1.312 -1.026 0 N-CA-C 107.392 -1.336 . . . . 2.03 107.392 174.695 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A 1589 ' ' GLN . . . . . . . . . . . . . 8.6 tt0 -118.2 124.78 48.76 Favored 'General case' 0 C--N 1.28 -2.432 0 CA-C-N 115.863 -0.608 . . . . 1.73 109.935 -177.316 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A 1590 ' ' LEU . . . . . 0.573 ' HB2' HD12 ' A' 1581 ' ' LEU . 7.5 tt -122.55 126.14 47.16 Favored 'General case' 0 C--N 1.302 -1.475 0 N-CA-C 106.876 -1.527 . . . . 1.76 106.876 178.761 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A 1591 ' ' VAL . . . . . . . . . . . . . 19.3 m -114.38 117.76 56.52 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.235 0 N-CA-C 113.864 1.061 . . . . 2.14 113.864 -175.665 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A 1592 ' ' TYR . . . . . 0.521 ' OH ' ' HA ' ' A' 1553 ' ' CYS . 56.4 m-85 -90.9 133.5 35.19 Favored 'General case' 0 C--N 1.311 -1.067 0 CA-C-N 115.316 -0.856 . . . . 1.53 110.584 177.16 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A 1593 ' ' LYS . . . . . . . . . . . . . 63.4 pttt -159.02 -177.95 6.88 Favored 'General case' 0 C--N 1.314 -0.958 0 N-CA-C 108.396 -0.964 . . . . 2.72 108.396 177.304 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A 1594 ' ' ASP . . . . . . . . . . . . . 62.2 m-20 72.1 59.04 0.14 Allowed 'General case' 0 N--CA 1.476 0.846 0 C-N-CA 124.379 1.072 . . . . 1.45 111.865 179.158 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A 1595 ' ' GLY . . . . . . . . . . . . . . . -131.32 -109.91 1.28 Allowed Glycine 0 N--CA 1.433 -1.541 0 N-CA-C 109.343 -1.503 . . . . 0.83 109.343 177.35 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A 1596 ' ' SER . . . . . 0.418 ' HA ' ' HD3' ' A' 1597 ' ' PRO . 14.1 m -97.67 134.98 21.83 Favored Pre-proline 0 C--N 1.299 -1.591 0 N-CA-C 108.801 -0.814 . . . . 1.96 108.801 177.719 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A 1597 ' ' PRO . . . . . 0.418 ' HD3' ' HA ' ' A' 1596 ' ' SER . 23.5 Cg_exo -67.14 152.27 80.06 Favored 'Trans proline' 0 N--CA 1.458 -0.574 0 C-N-CA 123.074 2.516 . . . . 1.34 112.133 177.908 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A 1598 ' ' CYS . . . . . . . . . . . . . 43.1 t -94.77 135.67 23.62 Favored Pre-proline 0 C--N 1.293 -1.881 0 N-CA-C 107.932 -1.136 . . . . 1.19 107.932 179.563 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A 1599 ' ' PRO . . . . . . . . . . . . . 89.4 Cg_endo -79.49 3.21 7.7 Favored 'Trans proline' 0 C--O 1.243 0.746 0 C-N-CA 123.383 2.722 . . . . 1.88 113.707 -177.395 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A 1600 ' ' SER . . . . . . . . . . . . . 14.6 m -120.94 145.83 47.29 Favored 'General case' 0 C--N 1.297 -1.68 0 N-CA-C 108.055 -1.091 . . . . 2.19 108.055 178.837 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A 1601 ' ' LYS . . . . . 0.614 ' HG3' HG23 ' A' 1633 ' ' THR . 29.7 mmmt 67.63 -146.14 0.14 Allowed 'General case' 0 CA--C 1.537 0.453 0 O-C-N 124.006 0.816 . . . . 4.21 110.61 177.925 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A 1602 ' ' SER . . . . . . . . . . . . . 33.5 t -68.76 163.43 24.08 Favored 'General case' 0 CA--C 1.551 0.998 0 N-CA-C 109.66 -0.496 . . . . 3.82 109.66 178.862 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A 1603 ' ' GLY . . . . . . . . . . . . . . . -77.36 58.0 3.7 Favored Glycine 0 C--N 1.332 0.324 0 N-CA-C 111.685 -0.566 . . . . 2.45 111.685 179.015 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A 1604 ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -101.2 159.43 15.25 Favored 'General case' 0 C--N 1.297 -1.715 0 C-N-CA 124.773 1.229 . . . . 2.06 110.146 -179.278 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A 1605 ' ' SER . . . . . . . . . . . . . 38.6 m -75.74 -170.9 1.42 Allowed 'General case' 0 C--N 1.315 -0.91 0 CA-C-O 121.586 0.708 . . . . 1.75 110.737 177.837 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A 1606 ' ' TYR . . . . . 0.625 ' HB2' ' HB ' ' A' 1574 ' ' VAL . 14.7 m-85 -96.57 117.07 30.17 Favored 'General case' 0 N--CA 1.422 -1.858 0 N-CA-C 103.513 -2.773 . . . . 1.59 103.513 174.582 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A 1607 ' ' LYS . . . . . . . . . . . . . 22.0 ptmt -102.88 124.07 47.7 Favored 'General case' 0 C--N 1.276 -2.597 0 C-N-CA 118.613 -1.235 . . . . 2.21 111.404 -170.083 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A 1608 ' ' SER . . . . . 0.508 ' HB2' ' HB2' ' A' 1592 ' ' TYR . 21.7 m -101.46 110.16 22.11 Favored 'General case' 0 C--N 1.299 -1.629 0 CA-C-N 114.928 -1.033 . . . . 1.48 109.626 -178.98 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A 1609 ' ' VAL . . . . . . . . . . . . . 65.8 t -94.3 106.44 18.1 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.351 0 N-CA-C 109.31 -0.626 . . . . 1.57 109.31 178.729 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A 1610 ' ' ILE . . . . . . . . . . . . . 38.2 mm -89.49 109.21 20.12 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.701 0 N-CA-C 108.471 -0.937 . . . . 1.47 108.471 178.831 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A 1611 ' ' SER . . . . . . . . . . . . . 18.2 m -104.98 116.59 32.22 Favored 'General case' 0 C--N 1.301 -1.51 0 CA-C-O 121.286 0.565 . . . . 1.84 110.398 178.923 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A 1612 ' ' PHE . . . . . 0.71 ' HB2' ' HB2' ' A' 1588 ' ' LEU . 93.3 m-85 -87.74 108.61 19.2 Favored 'General case' 0 C--N 1.301 -1.509 0 N-CA-C 108.36 -0.978 . . . . 0.86 108.36 177.143 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A 1613 ' ' VAL . . . . . . . . . . . . . 78.9 t -102.61 130.62 52.29 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.084 0 CA-C-O 120.889 0.376 . . . . 1.32 110.312 -178.227 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A 1614 ' ' CYS . . . . . . . . . . . . . 32.5 m -75.02 92.28 2.6 Favored 'General case' 0 C--N 1.303 -1.415 0 CA-C-N 115.257 -0.883 . . . . 1.39 111.586 -176.169 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A 1615 ' ' ARG . . . . . 0.786 ' HB3' ' HB3' ' A' 1641 ' ' HIS . 2.9 tpm_? -138.93 85.46 16.2 Favored Pre-proline 0 C--N 1.314 -0.975 0 N-CA-C 108.861 -0.792 . . . . 4.34 108.861 176.789 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A 1616 ' ' PRO . . . . . . . . . . . . . 52.6 Cg_exo -59.29 -18.54 45.75 Favored 'Trans proline' 0 N--CA 1.492 1.439 0 C-N-CA 123.07 2.513 . . . . 1.5 113.554 179.019 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A 1617 ' ' GLU . . . . . . . . . . . . . 33.0 tt0 . . . . . 0 C--N 1.321 -0.634 0 C-N-CA 123.473 0.709 . . . . 3.21 112.312 -178.351 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A 1622 ' ' ASN . . . . . . . . . . . . . 50.6 t-20 . . . . . 0 C--O 1.239 0.527 0 N-CA-C 107.574 -1.269 . . . . 3.58 107.574 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A 1623 ' ' ARG . . . . . . . . . . . . . 8.1 ptm180 -150.97 153.77 33.5 Favored Pre-proline 0 C--N 1.31 -1.11 0 CA-C-N 115.095 -0.957 . . . . 4.09 108.468 -177.44 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A 1624 ' ' PRO . . . . . . . . . . . . . 11.6 Cg_exo -71.43 120.63 7.09 Favored 'Trans proline' 0 C--O 1.236 0.403 0 C-N-CA 122.631 2.22 . . . . 2.86 110.896 178.279 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A 1625 ' ' MET . . . . . . . . . . . . . 44.4 ttm -109.94 140.84 43.49 Favored 'General case' 0 C--N 1.306 -1.294 0 C-N-CA 122.777 0.431 . . . . 2.73 110.082 -177.621 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A 1626 ' ' LEU . . . . . . . . . . . . . 59.9 tp -81.38 117.3 21.72 Favored 'General case' 0 C--N 1.308 -1.237 0 N-CA-C 107.768 -1.197 . . . . 1.94 107.768 175.337 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A 1627 ' ' ILE . . . . . . . . . . . . . 41.0 pt -99.33 -33.1 3.86 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.204 0 C-N-CA 119.778 -0.769 . . . . 1.75 111.547 -177.209 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A 1628 ' ' SER . . . . . 0.523 ' HB3' ' HB2' ' A' 1637 ' ' PHE . 44.9 t -141.28 143.65 34.21 Favored 'General case' 0 N--CA 1.431 -1.4 0 N-CA-C 109.287 -0.634 . . . . 1.85 109.287 -176.99 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A 1629 ' ' LEU . . . . . 0.735 HD12 ' HG ' ' A' 1636 ' ' LEU . 22.4 tp -146.07 116.21 7.42 Favored 'General case' 0 C--N 1.303 -1.42 0 CA-C-N 116.057 -0.52 . . . . 2.12 110.312 -177.941 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A 1630 ' ' ASP . . . . . . . . . . . . . 12.3 t70 -109.51 107.97 18.28 Favored 'General case' 0 C--N 1.298 -1.659 0 N-CA-C 107.801 -1.185 . . . . 0.87 107.801 176.416 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A 1631 ' ' LYS . . . . . . . . . . . . . 95.3 mttt -85.27 3.54 39.05 Favored 'General case' 0 C--N 1.307 -1.281 0 CA-C-N 116.241 -0.436 . . . . 2.76 111.979 -176.202 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A 1632 ' ' GLN . . . . . . . . . . . . . 1.4 mp0 -91.11 -49.21 6.52 Favored 'General case' 0 C--N 1.316 -0.863 0 N-CA-C 109.102 -0.703 . . . . 2.55 109.102 178.875 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A 1633 ' ' THR . . . . . 0.614 HG23 ' HG3' ' A' 1601 ' ' LYS . 22.2 p -97.48 2.78 50.63 Favored 'General case' 0 C--N 1.308 -1.234 0 CA-C-N 115.772 -0.649 . . . . 1.92 111.455 179.013 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A 1634 ' ' CYS . . . . . . . . . . . . . 98.3 m 56.6 47.49 18.39 Favored 'General case' 0 C--N 1.347 0.467 0 CA-C-N 114.879 -1.055 . . . . 0.89 111.758 178.692 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A 1635 ' ' THR . . . . . . . . . . . . . 26.7 m -112.44 118.38 35.02 Favored 'General case' 0 N--CA 1.43 -1.434 0 CA-C-N 115.006 -0.997 . . . . 1.31 109.246 -178.21 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A 1636 ' ' LEU . . . . . 0.735 ' HG ' HD12 ' A' 1629 ' ' LEU . 4.0 mp -112.1 130.17 55.98 Favored 'General case' 0 N--CA 1.441 -0.884 0 N-CA-C 109.626 -0.509 . . . . 1.97 109.626 -177.816 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A 1637 ' ' PHE . . . . . 0.523 ' HB2' ' HB3' ' A' 1628 ' ' SER . 91.0 m-85 -111.15 113.09 25.35 Favored 'General case' 0 C--N 1.315 -0.931 0 CA-C-O 120.9 0.381 . . . . 0.92 110.509 -178.712 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A 1638 ' ' PHE . . . . . . . . . . . . . 97.4 m-85 -108.25 145.53 34.18 Favored 'General case' 0 C--N 1.306 -1.298 0 CA-C-N 116.103 -0.499 . . . . 0.7 109.766 -179.087 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A 1639 ' ' SER . . . . . . . . . . . . . 65.6 m -136.98 127.89 27.47 Favored 'General case' 0 C--N 1.29 -2.018 0 CA-C-O 121.226 0.536 . . . . 1.46 111.381 178.848 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A 1640 ' ' TRP . . . . . . . . . . . . . 16.4 t90 -115.72 125.49 52.87 Favored 'General case' 0 C--N 1.294 -1.843 0 N-CA-C 107.022 -1.473 . . . . 0.92 107.022 175.188 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A 1641 ' ' HIS . . . . . 0.786 ' HB3' ' HB3' ' A' 1615 ' ' ARG . 69.9 m-70 -89.39 103.3 15.94 Favored 'General case' 0 C--N 1.306 -1.297 0 N-CA-C 107.054 -1.461 . . . . 3.18 107.054 -179.848 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A 1642 ' ' THR . . . . . . . . . . . . . 10.2 t -143.0 142.02 20.98 Favored Pre-proline 0 C--N 1.302 -1.476 0 CA-C-O 121.013 0.435 . . . . 1.48 110.96 -173.618 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A 1643 ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo -73.64 -12.13 24.42 Favored 'Trans proline' 0 C--N 1.359 1.08 0 C-N-CA 123.211 2.608 . . . . 1.09 113.118 179.93 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A 1644 ' ' LEU . . . . . 0.472 HD23 HD13 ' A' 1532 ' ' LEU . 2.4 pp -90.66 4.48 51.3 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 121.685 0.755 . . . . 2.08 112.799 -179.221 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A 1645 ' ' ALA . . . . . . . . . . . . . . . -72.66 -38.4 67.65 Favored 'General case' 0 C--N 1.302 -1.482 0 CA-C-N 114.476 -1.238 . . . . 1.37 108.086 173.461 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A 1646 ' ' CYS . . . . . . . . . . . . . 18.6 p -175.4 135.29 0.32 Allowed 'General case' 0 C--N 1.312 -1.037 0 N-CA-C 105.004 -2.221 . . . . 1.7 105.004 175.402 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A 1647 ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 . . . . . 0 C--N 1.312 -1.039 0 N-CA-C 108.801 -0.814 . . . . 2.92 108.801 -179.568 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A 1515 ' ' ASP . . . . . . . . . . . . . 62.7 m-20 . . . . . 0 CA--C 1.49 -1.346 0 N-CA-C 108.238 -1.023 . . . . 2.54 108.238 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A 1516 ' ' CYS . . . . . . . . . . . . . 58.3 m -120.39 73.19 0.98 Allowed 'General case' 0 C--N 1.305 -1.359 0 CA-C-O 121.436 0.636 . . . . 1.25 110.664 -175.796 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A 1517 ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -139.59 136.14 34.08 Favored 'General case' 0 C--N 1.297 -1.7 0 CA-C-N 115.527 -0.76 . . . . 2.36 111.014 174.067 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A 1518 ' ' VAL . . . . . . . . . . . . . 94.8 t -121.23 121.59 65.23 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.449 0 CA-C-N 115.673 -0.694 . . . . 2.34 109.269 176.497 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A 1519 ' ' THR . . . . . 0.498 ' HA ' ' HA ' ' A' 1526 ' ' LEU . 20.5 m -90.62 108.23 19.68 Favored 'General case' 0 C--N 1.295 -1.763 0 CA-C-O 120.865 0.364 . . . . 2.04 110.914 179.651 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A 1520 ' ' ASN . . . . . 0.722 HD21 ' HH ' ' A' 1583 ' ' TYR . 15.1 t-20 -67.43 122.3 82.55 Favored Pre-proline 0 N--CA 1.47 0.566 0 CA-C-N 116.033 -0.531 . . . . 2.12 110.98 179.416 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A 1521 ' ' PRO . . . . . . . . . . . . . 94.9 Cg_endo -83.4 -1.5 10.25 Favored 'Trans proline' 0 CA--C 1.533 0.442 0 C-N-CA 122.347 2.031 . . . . 2.59 113.756 -178.236 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A 1522 ' ' SER . . . . . . . . . . . . . 6.8 m -83.62 -58.18 2.92 Favored 'General case' 0 C--N 1.308 -1.201 0 C-N-CA 120.773 -0.371 . . . . 2.65 110.57 -179.071 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A 1523 ' ' THR . . . . . . . . . . . . . 11.3 t -108.85 -5.98 15.98 Favored 'General case' 0 N--CA 1.443 -0.815 0 CA-C-O 120.972 0.415 . . . . 2.33 110.844 -177.045 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A 1524 ' ' GLY . . . . . . . . . . . . . . . 80.01 28.76 48.9 Favored Glycine 0 CA--C 1.507 -0.445 0 C-N-CA 120.62 -0.8 . . . . 1.96 112.91 176.899 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A 1525 ' ' HIS . . . . . . . . . . . . . 22.1 t-160 -97.41 118.59 34.23 Favored 'General case' 0 C--N 1.312 -1.032 0 N-CA-C 109.414 -0.587 . . . . 2.44 109.414 -179.885 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A 1526 ' ' LEU . . . . . 0.498 ' HA ' ' HA ' ' A' 1519 ' ' THR . 5.0 tt -82.9 111.0 18.38 Favored 'General case' 0 C--N 1.295 -1.79 0 N-CA-C 107.095 -1.446 . . . . 2.19 107.095 178.087 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A 1527 ' ' PHE . . . . . 0.541 ' CE2' ' HB2' ' A' 1520 ' ' ASN . 32.6 m-85 -87.9 102.62 14.89 Favored 'General case' 0 C--N 1.305 -1.351 0 N-CA-C 108.498 -0.927 . . . . 1.61 108.498 179.395 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A 1528 ' ' ASP . . . . . . . . . . . . . 23.4 t70 -105.71 133.44 50.45 Favored 'General case' 0 C--N 1.298 -1.632 0 C-N-CA 120.467 -0.493 . . . . 2.18 110.106 179.347 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A 1529 ' ' LEU . . . . . . . . . . . . . 89.0 mt -113.3 -7.98 13.5 Favored 'General case' 0 C--N 1.299 -1.614 0 CA-C-N 115.146 -0.934 . . . . 2.04 110.001 179.248 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A 1530 ' ' SER . . . . . . . . . . . . . 2.3 m -69.1 -37.41 78.37 Favored 'General case' 0 CA--C 1.543 0.696 0 CA-C-O 121.878 0.846 . . . . 1.44 109.154 -177.92 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A 1531 ' ' SER . . . . . . . . . . . . . 14.0 m -70.85 -24.13 62.47 Favored 'General case' 0 C--N 1.317 -0.844 0 CA-C-N 115.199 -0.91 . . . . 1.63 109.926 177.895 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A 1532 ' ' LEU . . . . . . . . . . . . . 8.0 mp -84.7 4.58 31.97 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.414 -0.812 . . . . 2.32 110.502 179.317 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A 1533 ' ' SER . . . . . . . . . . . . . 32.5 m -113.87 119.08 36.06 Favored 'General case' 0 N--CA 1.425 -1.709 0 N-CA-C 113.337 0.866 . . . . 2.57 113.337 -175.303 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A 1534 ' ' GLY . . . . . . . . . . . . . . . -89.65 -162.84 38.76 Favored Glycine 0 N--CA 1.431 -1.677 0 N-CA-C 109.221 -1.552 . . . . 1.89 109.221 172.398 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A 1535 ' ' ARG . . . . . 0.427 ' HE ' ' CD ' ' A' 1557 ' ' GLU . 62.4 ttt180 -81.39 -47.76 12.81 Favored 'General case' 0 C--N 1.304 -1.409 0 CA-C-N 117.395 0.597 . . . . 4.44 110.633 -179.08 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A 1536 ' ' ALA . . . . . . . . . . . . . . . -95.56 -13.53 24.36 Favored 'General case' 0 C--N 1.316 -0.863 0 N-CA-C 108.752 -0.833 . . . . 2.07 108.752 177.74 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A 1537 ' ' GLY . . . . . . . . . . . . . . . 73.53 -139.94 27.37 Favored Glycine 0 N--CA 1.436 -1.355 0 CA-C-N 114.581 -1.191 . . . . 1.2 112.371 177.244 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A 1538 ' ' PHE . . . . . . . . . . . . . 78.0 m-85 -101.42 152.08 21.16 Favored 'General case' 0 C--N 1.296 -1.734 0 N-CA-C 109.188 -0.671 . . . . 1.98 109.188 179.456 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A 1539 ' ' THR . . . . . . . . . . . . . 25.8 m -103.66 115.19 30.04 Favored 'General case' 0 C--N 1.288 -2.09 0 N-CA-C 108.495 -0.928 . . . . 1.97 108.495 179.37 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A 1540 ' ' ALA . . . . . 0.758 ' HB2' HG12 ' A' 1548 ' ' VAL . . . -94.65 149.95 20.72 Favored 'General case' 0 C--N 1.309 -1.177 0 N-CA-C 109.223 -0.658 . . . . 1.39 109.223 -177.935 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A 1541 ' ' ALA . . . . . . . . . . . . . . . -87.01 139.07 30.95 Favored 'General case' 0 C--N 1.311 -1.078 0 N-CA-C 109.358 -0.608 . . . . 1.86 109.358 -179.407 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A 1542 ' ' TYR . . . . . 0.544 ' HD2' ' HB2' ' A' 1545 ' ' SER . 42.1 t80 -141.47 173.52 11.42 Favored 'General case' 0 N--CA 1.437 -1.091 0 CA-C-O 119.288 -0.387 . . . . 2.4 110.413 -176.813 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A 1543 ' ' SER . . . . . . . . . . . . . 9.5 m -46.92 -152.6 0.0 OUTLIER 'General case' 0 CA--C 1.577 1.995 0 C-N-CA 129.084 2.954 . . . . 2.58 114.07 178.619 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A 1544 ' ' LYS . . . . . . . . . . . . . 57.8 mtpt -45.03 -31.79 1.45 Allowed 'General case' 0 N--CA 1.487 1.389 0 O-C-N 121.088 -1.007 . . . . 4.24 112.902 177.121 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A 1545 ' ' SER . . . . . 0.544 ' HB2' ' HD2' ' A' 1542 ' ' TYR . 33.2 m -65.83 -12.68 56.19 Favored 'General case' 0 CA--C 1.562 1.409 0 N-CA-C 112.719 0.637 . . . . 3.6 112.719 176.425 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A 1546 ' ' GLY . . . . . . . . . . . . . . . 85.09 -74.2 2.52 Favored Glycine 0 CA--C 1.495 -1.216 0 C-N-CA 121.037 -0.601 . . . . 1.66 113.723 172.812 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A 1547 ' ' VAL . . . . . . . . . . . . . 10.7 m -139.01 156.99 28.52 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.445 0 CA-C-O 121.652 0.739 . . . . 2.23 112.145 -176.663 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A 1548 ' ' VAL . . . . . 0.758 HG12 ' HB2' ' A' 1540 ' ' ALA . 2.0 p -134.1 136.24 53.71 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.917 0 CA-C-N 114.766 -1.106 . . . . 1.59 108.114 178.924 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A 1549 ' ' TYR . . . . . . . . . . . . . 97.5 m-85 -93.51 141.29 28.63 Favored 'General case' 0 C--N 1.294 -1.835 0 N-CA-C 109.287 -0.634 . . . . 1.58 109.287 -179.085 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A 1550 ' ' MET . . . . . . . . . . . . . 42.2 ttm -138.37 121.64 17.01 Favored 'General case' 0 C--N 1.288 -2.083 0 CA-C-N 115.852 -0.613 . . . . 2.08 110.54 -179.261 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A 1551 ' ' SER . . . . . 0.45 ' OG ' ' HA ' ' A' 1556 ' ' ASN . 59.3 m -91.98 122.76 34.79 Favored 'General case' 0 N--CA 1.409 -2.517 0 N-CA-C 105.692 -1.966 . . . . 1.9 105.692 172.057 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A 1552 ' ' ILE . . . . . . . . . . . . . 38.6 mm -62.94 -21.53 28.26 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.804 0 CA-C-O 121.777 0.798 . . . . 2.04 110.716 -175.323 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A 1553 ' ' CYS . . . . . . . . . . . . . 43.7 t -161.55 138.33 8.45 Favored 'General case' 0 N--CA 1.412 -2.366 0 N-CA-C 106.65 -1.611 . . . . 1.43 106.65 175.063 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A 1554 ' ' GLY . . . . . 0.848 ' HA2' ' HE2' ' A' 1579 ' ' LYS . . . 104.71 -150.33 17.13 Favored Glycine 0 N--CA 1.426 -2.026 0 C-N-CA 119.957 -1.116 . . . . 1.23 112.305 175.489 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A 1555 ' ' GLU . . . . . . . . . . . . . 7.6 pt-20 -106.96 147.81 29.41 Favored 'General case' 0 C--N 1.293 -1.875 0 C-N-CA 123.088 0.555 . . . . 1.8 109.976 -177.612 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A 1556 ' ' ASN . . . . . 0.45 ' HA ' ' OG ' ' A' 1551 ' ' SER . 5.3 t-20 -98.54 88.88 4.22 Favored 'General case' 0 C--N 1.286 -2.159 0 CA-C-O 121.641 0.734 . . . . 2.63 109.07 -175.594 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A 1557 ' ' GLU . . . . . 0.427 ' CD ' ' HE ' ' A' 1535 ' ' ARG . 22.2 mt-10 -79.72 111.47 16.04 Favored 'General case' 0 C--N 1.303 -1.448 0 CA-C-N 115.409 -0.814 . . . . 3.79 111.567 -175.573 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A 1558 ' ' ASN . . . . . . . . . . . . . 6.9 p30 160.21 -25.1 0.0 OUTLIER 'General case' 0 N--CA 1.475 0.781 0 C-N-CA 127.501 2.32 . . . . 1.59 105.789 -176.556 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A 1559 ' ' CYS . . . . . 0.609 ' HB3' ' HD2' ' A' 1560 ' ' PRO . 93.2 m -118.2 173.86 3.03 Favored Pre-proline 0 N--CA 1.439 -0.992 0 CA-C-O 117.353 -1.308 . . . . 0.94 107.605 174.204 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A 1560 ' ' PRO . . . . . 0.609 ' HD2' ' HB3' ' A' 1559 ' ' CYS . 21.3 Cg_exo -35.8 132.14 0.29 Allowed 'Trans proline' 0 C--N 1.378 2.109 0 C-N-CA 123.567 2.844 . . . . 1.53 113.88 176.603 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A 1561 ' ' PRO . . . . . . . . . . . . . 19.8 Cg_endo -62.82 120.2 7.61 Favored 'Trans proline' 0 C--O 1.243 0.759 0 C-N-CA 122.792 2.328 . . . . 1.82 113.146 -177.634 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A 1562 ' ' GLY . . . . . . . . . . . . . . . 117.14 7.87 12.14 Favored Glycine 0 N--CA 1.434 -1.458 0 CA-C-N 115.833 -0.621 . . . . 0.81 112.669 176.972 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A 1563 ' ' VAL . . . . . . . . . . . . . 6.4 m -101.23 156.74 4.38 Favored 'Isoleucine or valine' 0 C--O 1.205 -1.263 0 N-CA-C 106.885 -1.524 . . . . 1.73 106.885 178.118 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A 1564 ' ' GLY . . . . . . . . . . . . . . . -108.71 -23.61 6.45 Favored Glycine 0 C--N 1.311 -0.81 0 C-N-CA 120.213 -0.994 . . . . 0.72 112.645 -177.713 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A 1565 ' ' ALA . . . . . . . . . . . . . . . -149.28 137.7 20.87 Favored 'General case' 0 C--N 1.311 -1.088 0 N-CA-C 108.572 -0.899 . . . . 1.14 108.572 -179.721 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A 1566 ' ' CYS . . . . . 0.512 ' SG ' ' HA ' ' A' 1571 ' ' ARG . 35.6 t -157.68 138.05 12.78 Favored 'General case' 0 C--N 1.312 -1.048 0 C-N-CA 121.229 -0.188 . . . . 0.51 111.492 -173.9 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A 1567 ' ' PHE . . . . . 0.55 ' HD1' ' HB ' ' A' 1548 ' ' VAL . 22.0 m-85 -67.19 125.27 25.53 Favored 'General case' 0 N--CA 1.471 0.607 0 N-CA-C 108.313 -0.995 . . . . 1.22 108.313 177.602 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A 1568 ' ' GLY . . . . . . . . . . . . . . . -58.36 -43.51 95.66 Favored Glycine 0 C--N 1.315 -0.606 0 N-CA-C 117.119 1.608 . . . . 1.08 117.119 -168.434 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A 1569 ' ' GLN . . . . . . . . . . . . . 4.0 pt20 -87.51 -34.35 18.66 Favored 'General case' 0 C--N 1.307 -1.274 0 CA-C-N 118.367 1.083 . . . . 3.05 113.748 -175.368 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A 1570 ' ' THR . . . . . . . . . . . . . 11.5 p -89.63 -22.36 22.35 Favored 'General case' 0 C--N 1.312 -1.063 0 CA-C-O 121.597 0.713 . . . . 2.44 112.321 -176.447 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A 1571 ' ' ARG . . . . . 0.512 ' HA ' ' SG ' ' A' 1566 ' ' CYS . 94.7 mtt180 59.88 38.89 20.98 Favored 'General case' 0 CA--C 1.515 -0.401 0 CA-C-N 114.523 -1.217 . . . . 4.48 113.755 175.295 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A 1572 ' ' ILE . . . . . . . . . . . . . 75.8 mt -98.35 123.44 50.88 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.971 0 CA-C-N 114.416 -1.266 . . . . 1.94 107.797 178.201 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A 1573 ' ' SER . . . . . . . . . . . . . 27.3 t -62.91 130.39 44.57 Favored 'General case' 0 C--N 1.318 -0.804 0 O-C-N 123.669 0.606 . . . . 1.25 111.446 -178.213 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A 1574 ' ' VAL . . . . . . . . . . . . . 27.7 m -122.87 25.36 3.72 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.402 0 CA-C-O 122.047 0.927 . . . . 1.61 109.898 176.17 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A 1575 ' ' GLY . . . . . . . . . . . . . . . 163.58 128.59 0.96 Allowed Glycine 0 N--CA 1.426 -1.974 0 CA-C-N 114.138 -1.392 . . . . 0.65 111.202 177.043 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A 1576 ' ' LYS . . . . . . . . . . . . . 50.5 tptt -77.77 151.19 34.18 Favored 'General case' 0 C--N 1.317 -0.81 0 N-CA-C 106.772 -1.566 . . . . 3.33 106.772 178.336 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A 1577 ' ' ALA . . . . . . . . . . . . . . . -67.66 99.79 0.83 Allowed 'General case' 0 C--N 1.321 -0.646 0 CA-C-O 120.963 0.411 . . . . 1.31 110.503 -178.705 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A 1578 ' ' ASN . . . . . 0.426 ' H ' ' HD1' ' A' 1592 ' ' TYR . 15.6 m120 -117.44 130.07 56.23 Favored 'General case' 0 C--N 1.302 -1.498 0 N-CA-C 108.736 -0.838 . . . . 2.24 108.736 -179.886 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A 1579 ' ' LYS . . . . . 0.848 ' HE2' ' HA2' ' A' 1554 ' ' GLY . 33.5 mmtp -93.44 89.79 6.46 Favored 'General case' 0 C--N 1.292 -1.901 0 N-CA-C 104.545 -2.391 . . . . 2.34 104.545 174.745 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A 1580 ' ' ARG . . . . . . . . . . . . . 22.0 ttm180 -148.27 103.52 3.45 Favored 'General case' 0 C--N 1.313 -0.986 0 C-N-CA 119.147 -1.021 . . . . 4.19 113.259 -170.219 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A 1581 ' ' LEU . . . . . . . . . . . . . 3.9 mm? -100.75 141.25 33.89 Favored 'General case' 0 C--N 1.31 -1.135 0 CA-C-N 115.691 -0.686 . . . . 2.39 110.285 172.99 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A 1582 ' ' ARG . . . . . 0.778 ' HB2' ' HB3' ' A' 1589 ' ' GLN . 93.4 mtt180 -116.55 98.44 6.55 Favored 'General case' 0 C--N 1.285 -2.205 0 N-CA-C 107.055 -1.461 . . . . 4.48 107.055 170.923 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A 1583 ' ' TYR . . . . . 0.722 ' HH ' HD21 ' A' 1520 ' ' ASN . 45.6 t80 -79.18 91.64 4.98 Favored 'General case' 0 C--N 1.295 -1.769 0 N-CA-C 107.522 -1.288 . . . . 1.57 107.522 178.697 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A 1584 ' ' VAL . . . . . 0.532 ' O ' HG12 ' A' 1587 ' ' VAL . 11.5 m -117.55 98.29 6.44 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.26 0 CA-C-O 121.547 0.689 . . . . 2.29 111.68 -177.346 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A 1585 ' ' ASP . . . . . . . . . . . . . 34.7 t70 53.46 70.38 0.6 Allowed 'General case' 0 C--N 1.313 -1.016 0 C-N-CA 124.348 1.059 . . . . 2.06 111.804 -178.021 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A 1586 ' ' GLN . . . . . . . . . . . . . 14.9 mm100 68.72 -14.23 0.29 Allowed 'General case' 0 N--CA 1.481 1.088 0 N-CA-C 115.615 1.709 . . . . 2.61 115.615 177.247 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A 1587 ' ' VAL . . . . . 0.532 HG12 ' O ' ' A' 1584 ' ' VAL . 7.5 p -94.84 128.64 45.88 Favored 'Isoleucine or valine' 0 C--O 1.243 0.752 0 C-N-CA 119.159 -1.016 . . . . 1.33 110.197 178.837 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A 1588 ' ' LEU . . . . . 0.735 ' HB2' ' HB2' ' A' 1612 ' ' PHE . 3.0 mm? -84.58 124.11 31.07 Favored 'General case' 0 N--CA 1.418 -2.035 0 N-CA-C 106.568 -1.641 . . . . 2.03 106.568 173.013 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A 1589 ' ' GLN . . . . . 0.778 ' HB3' ' HB2' ' A' 1582 ' ' ARG . 7.5 tp60 -119.26 107.0 12.88 Favored 'General case' 0 C--N 1.277 -2.556 0 N-CA-C 107.806 -1.183 . . . . 1.73 107.806 -173.874 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A 1590 ' ' LEU . . . . . . . . . . . . . 7.1 tt -105.61 128.59 53.71 Favored 'General case' 0 C--N 1.297 -1.708 0 N-CA-C 108.382 -0.97 . . . . 1.76 108.382 -178.215 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A 1591 ' ' VAL . . . . . 0.605 HG13 HG23 ' A' 1609 ' ' VAL . 19.7 m -124.41 122.23 63.52 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.258 0 N-CA-C 112.868 0.692 . . . . 2.14 112.868 -175.409 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A 1592 ' ' TYR . . . . . 0.426 ' HD1' ' H ' ' A' 1578 ' ' ASN . 39.1 m-85 -103.07 98.38 8.33 Favored 'General case' 0 C--N 1.306 -1.3 0 N-CA-C 107.644 -1.243 . . . . 1.53 107.644 171.47 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A 1593 ' ' LYS . . . . . . . . . . . . . 21.4 ptmt -102.75 175.67 5.41 Favored 'General case' 0 C--N 1.3 -1.576 0 N-CA-C 109.751 -0.463 . . . . 2.72 109.751 -177.323 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A 1594 ' ' ASP . . . . . . . . . . . . . 22.0 m-20 61.22 50.07 5.09 Favored 'General case' 0 N--CA 1.494 1.75 0 N-CA-C 113.792 1.034 . . . . 1.45 113.792 178.68 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A 1595 ' ' GLY . . . . . . . . . . . . . . . -85.85 -106.72 0.73 Allowed Glycine 0 N--CA 1.436 -1.304 0 N-CA-C 110.36 -1.096 . . . . 0.83 110.36 175.637 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A 1596 ' ' SER . . . . . . . . . . . . . 69.6 m -99.87 151.87 37.63 Favored Pre-proline 0 C--N 1.297 -1.684 0 N-CA-C 109.364 -0.606 . . . . 1.96 109.364 177.438 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A 1597 ' ' PRO . . . . . . . . . . . . . 26.5 Cg_exo -65.28 131.49 28.49 Favored 'Trans proline' 0 C--O 1.24 0.588 0 C-N-CA 123.096 2.531 . . . . 1.34 111.416 178.287 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A 1598 ' ' CYS . . . . . 0.42 ' HB3' ' HB3' ' A' 1604 ' ' LEU . 43.2 t -100.24 109.9 58.12 Favored Pre-proline 0 C--N 1.301 -1.532 0 CA-C-N 116.018 -0.537 . . . . 1.19 109.779 -178.354 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A 1599 ' ' PRO . . . . . . . . . . . . . 38.6 Cg_endo -98.02 21.85 0.32 Allowed 'Trans proline' 0 N--CA 1.445 -1.377 0 C-N-CA 123.308 2.672 . . . . 1.88 112.527 -179.191 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A 1600 ' ' SER . . . . . . . . . . . . . 16.9 m -73.73 -41.02 63.11 Favored 'General case' 0 C--N 1.313 -0.982 0 CA-C-N 116.571 -0.286 . . . . 2.19 111.627 -179.155 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A 1601 ' ' LYS . . . . . . . . . . . . . 87.3 tttt -142.39 -77.64 0.25 Allowed 'General case' 0 C--N 1.318 -0.765 0 CA-C-O 121.259 0.552 . . . . 4.21 111.258 -177.632 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A 1602 ' ' SER . . . . . . . . . . . . . 21.1 m -96.07 175.59 6.41 Favored 'General case' 0 C--N 1.3 -1.584 0 CA-C-N 115.294 -0.866 . . . . 3.82 109.055 -177.194 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A 1603 ' ' GLY . . . . . . . . . . . . . . . -75.81 63.62 2.73 Favored Glycine 0 CA--C 1.505 -0.533 0 N-CA-C 109.78 -1.328 . . . . 2.45 109.78 175.276 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A 1604 ' ' LEU . . . . . 0.453 HD13 ' HA ' ' A' 1633 ' ' THR . 2.2 mt -93.52 -174.41 3.48 Favored 'General case' 0 C--N 1.293 -1.883 0 C-N-CA 125.55 1.54 . . . . 2.06 112.184 -173.809 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A 1605 ' ' SER . . . . . . . . . . . . . 34.5 t -140.93 -179.22 5.95 Favored 'General case' 0 N--CA 1.419 -2.017 0 N-CA-C 105.667 -1.975 . . . . 1.75 105.667 179.348 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A 1606 ' ' TYR . . . . . . . . . . . . . 7.1 m-85 -110.06 129.23 55.72 Favored 'General case' 0 CA--C 1.47 -2.101 0 N-CA-C 105.253 -2.129 . . . . 1.59 105.253 -179.561 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A 1607 ' ' LYS . . . . . . . . . . . . . 10.0 ptpp? -131.8 138.12 48.41 Favored 'General case' 0 N--CA 1.411 -2.41 0 C-N-CA 118.495 -1.282 . . . . 2.21 110.437 179.867 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A 1608 ' ' SER . . . . . 0.762 ' HA ' ' HB2' ' A' 1636 ' ' LEU . 50.1 m -98.83 114.32 26.83 Favored 'General case' 0 C--N 1.295 -1.79 0 N-CA-C 109.158 -0.682 . . . . 1.48 109.158 177.71 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A 1609 ' ' VAL . . . . . 0.605 HG23 HG13 ' A' 1591 ' ' VAL . 85.9 t -109.3 118.28 56.3 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.054 0 N-CA-C 108.884 -0.784 . . . . 1.57 108.884 -179.677 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A 1610 ' ' ILE . . . . . 0.596 HG13 ' HB2' ' A' 1638 ' ' PHE . 3.3 mp -111.29 116.66 53.1 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.318 0 N-CA-C 109.261 -0.644 . . . . 1.47 109.261 179.58 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A 1611 ' ' SER . . . . . . . . . . . . . 30.3 p -92.46 117.14 29.63 Favored 'General case' 0 N--CA 1.423 -1.8 0 CA-C-N 115.706 -0.679 . . . . 1.84 109.447 177.076 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A 1612 ' ' PHE . . . . . 0.735 ' HB2' ' HB2' ' A' 1588 ' ' LEU . 96.0 m-85 -89.78 103.7 16.33 Favored 'General case' 0 C--N 1.299 -1.629 0 CA-C-N 116.05 -0.523 . . . . 0.86 110.563 -179.393 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A 1613 ' ' VAL . . . . . 0.595 ' O ' ' HA ' ' A' 1641 ' ' HIS . 11.9 t -107.6 145.12 15.28 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.452 0 N-CA-C 106.871 -1.529 . . . . 1.32 106.871 -179.011 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A 1614 ' ' CYS . . . . . . . . . . . . . 34.2 m -89.65 93.75 9.59 Favored 'General case' 0 C--N 1.294 -1.836 0 N-CA-C 113.536 0.939 . . . . 1.39 113.536 -169.977 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A 1615 ' ' ARG . . . . . 0.874 ' HB3' ' HB3' ' A' 1641 ' ' HIS . 21.3 tpp180 -138.09 112.33 8.77 Favored Pre-proline 0 C--N 1.316 -0.87 0 N-CA-C 109.368 -0.604 . . . . 4.34 109.368 176.195 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A 1616 ' ' PRO . . . . . 0.512 ' HA ' ' HD3' ' A' 1643 ' ' PRO . 11.4 Cg_endo -55.07 -20.36 23.39 Favored 'Trans proline' 0 CA--C 1.562 1.876 0 C-N-CA 123.927 3.085 . . . . 1.5 116.259 -178.352 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A 1617 ' ' GLU . . . . . 0.697 ' HG2' ' HG3' ' A' 1615 ' ' ARG . 11.4 pt-20 . . . . . 0 N--CA 1.478 0.939 0 N-CA-C 113.82 1.045 . . . . 3.21 113.82 -177.812 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A 1622 ' ' ASN . . . . . . . . . . . . . 23.6 t-20 . . . . . 0 CA--C 1.501 -0.906 0 N-CA-C 112.925 0.713 . . . . 3.58 112.925 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A 1623 ' ' ARG . . . . . 0.556 ' HB2' ' HD2' ' A' 1624 ' ' PRO . 0.0 OUTLIER -61.18 167.69 3.61 Favored Pre-proline 0 C--N 1.292 -1.924 0 CA-C-N 113.412 -1.722 . . . . 4.09 113.236 -173.478 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A 1624 ' ' PRO . . . . . 0.66 ' HB3' ' HB2' ' A' 1640 ' ' TRP . 11.6 Cg_endo -57.46 159.3 16.68 Favored 'Trans proline' 0 C--N 1.369 1.606 0 C-N-CA 123.02 2.48 . . . . 2.86 113.209 175.867 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A 1625 ' ' MET . . . . . . . . . . . . . 26.5 ptt? -125.41 148.42 48.81 Favored 'General case' 0 C--N 1.311 -1.093 0 CA-C-N 116.094 -0.503 . . . . 2.73 110.003 -179.766 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A 1626 ' ' LEU . . . . . 0.4 HD21 ' HB2' ' A' 1629 ' ' LEU . 38.2 tp -77.68 116.11 17.96 Favored 'General case' 0 C--N 1.309 -1.173 0 N-CA-C 107.794 -1.187 . . . . 1.94 107.794 175.513 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A 1627 ' ' ILE . . . . . . . . . . . . . 25.0 pt -93.02 -30.05 4.46 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.22 0 C-N-CA 120.45 -0.5 . . . . 1.75 111.178 -179.107 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A 1628 ' ' SER . . . . . . . . . . . . . 37.4 m -155.18 154.07 31.71 Favored 'General case' 0 C--N 1.313 -0.988 0 N-CA-C 109.015 -0.735 . . . . 1.85 109.015 -178.317 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A 1629 ' ' LEU . . . . . 0.504 HD13 HD11 ' A' 1636 ' ' LEU . 45.2 tp -145.95 114.43 6.74 Favored 'General case' 0 C--N 1.301 -1.52 0 CA-C-O 121.24 0.543 . . . . 2.12 109.946 178.892 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A 1630 ' ' ASP . . . . . . . . . . . . . 27.6 t70 -112.75 102.07 10.13 Favored 'General case' 0 C--N 1.298 -1.633 0 N-CA-C 108.408 -0.96 . . . . 0.87 108.408 179.447 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A 1631 ' ' LYS . . . . . . . . . . . . . 60.1 mttp -73.58 -18.01 61.11 Favored 'General case' 0 C--N 1.316 -0.853 0 N-CA-C 112.182 0.438 . . . . 2.76 112.182 -177.52 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A 1632 ' ' GLN . . . . . . . . . . . . . 7.6 tp-100 -64.65 -45.14 88.04 Favored 'General case' 0 N--CA 1.451 -0.39 0 CA-C-O 120.885 0.374 . . . . 2.55 110.668 178.632 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A 1633 ' ' THR . . . . . 0.453 ' HA ' HD13 ' A' 1604 ' ' LEU . 40.9 p -99.23 -2.02 37.7 Favored 'General case' 0 C--N 1.316 -0.849 0 CA-C-O 121.467 0.651 . . . . 1.92 111.226 177.858 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A 1634 ' ' CYS . . . . . . . . . . . . . 82.8 m 56.68 40.29 29.31 Favored 'General case' 0 C--O 1.235 0.298 0 CA-C-N 114.539 -1.21 . . . . 0.89 111.362 -179.853 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A 1635 ' ' THR . . . . . . . . . . . . . 25.1 m -99.03 119.56 38.0 Favored 'General case' 0 N--CA 1.423 -1.8 0 CA-C-N 114.921 -1.036 . . . . 1.31 109.826 -177.583 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A 1636 ' ' LEU . . . . . 0.762 ' HB2' ' HA ' ' A' 1608 ' ' SER . 2.7 mm? -90.85 107.94 19.52 Favored 'General case' 0 C--N 1.311 -1.086 0 N-CA-C 108.454 -0.943 . . . . 1.97 108.454 178.648 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A 1637 ' ' PHE . . . . . . . . . . . . . 96.5 m-85 -95.88 100.16 11.88 Favored 'General case' 0 C--O 1.244 0.815 0 CA-C-O 120.853 0.359 . . . . 0.92 110.611 -178.79 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A 1638 ' ' PHE . . . . . 0.596 ' HB2' HG13 ' A' 1610 ' ' ILE . 96.7 m-85 -108.76 156.19 19.89 Favored 'General case' 0 C--N 1.298 -1.634 0 CA-C-O 121.364 0.602 . . . . 0.7 109.987 177.852 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A 1639 ' ' SER . . . . . . . . . . . . . 32.9 t -143.34 130.84 21.12 Favored 'General case' 0 C--N 1.285 -2.218 0 N-CA-C 108.593 -0.892 . . . . 1.46 108.593 176.172 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A 1640 ' ' TRP . . . . . 0.735 ' HE3' ' HE1' ' A' 1612 ' ' PHE . 9.5 t90 -115.92 111.46 20.45 Favored 'General case' 0 N--CA 1.409 -2.485 0 N-CA-C 107.635 -1.246 . . . . 0.92 107.635 175.696 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A 1641 ' ' HIS . . . . . 0.874 ' HB3' ' HB3' ' A' 1615 ' ' ARG . 47.3 m-70 -89.76 105.3 17.71 Favored 'General case' 0 N--CA 1.422 -1.869 0 N-CA-C 107.167 -1.42 . . . . 3.18 107.167 175.88 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A 1642 ' ' THR . . . . . . . . . . . . . 6.1 t -142.8 146.12 36.56 Favored Pre-proline 0 C--N 1.287 -2.127 0 CA-C-N 115.846 -0.616 . . . . 1.48 109.914 -175.322 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A 1643 ' ' PRO . . . . . 0.512 ' HD3' ' HA ' ' A' 1616 ' ' PRO . 71.6 Cg_endo -76.65 -4.69 15.28 Favored 'Trans proline' 0 C--N 1.352 0.725 0 C-N-CA 122.694 2.263 . . . . 1.09 110.495 175.775 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A 1644 ' ' LEU . . . . . . . . . . . . . 81.9 mt -86.67 -7.63 58.14 Favored 'General case' 0 N--CA 1.447 -0.621 0 CA-C-N 115.234 -0.894 . . . . 2.08 109.489 177.217 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A 1645 ' ' ALA . . . . . . . . . . . . . . . -78.97 -42.58 26.42 Favored 'General case' 0 C--O 1.222 -0.366 0 N-CA-C 107.996 -1.112 . . . . 1.37 107.996 176.716 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A 1646 ' ' CYS . . . . . . . . . . . . . 13.5 p -176.11 154.83 1.47 Allowed 'General case' 0 N--CA 1.432 -1.344 0 N-CA-C 104.362 -2.459 . . . . 1.7 104.362 172.639 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A 1647 ' ' GLU . . . . . . . . . . . . . 42.8 mt-10 . . . . . 0 C--N 1.288 -2.108 0 N-CA-C 108.506 -0.924 . . . . 2.92 108.506 -179.685 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A 1515 ' ' ASP . . . . . 0.461 ' HA ' ' HD2' ' A' 1579 ' ' LYS . 31.4 t70 . . . . . 0 N--CA 1.427 -1.605 0 N-CA-C 105.991 -1.855 . . . . 2.54 105.991 . . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A 1516 ' ' CYS . . . . . . . . . . . . . 61.1 m -75.14 51.04 0.51 Allowed 'General case' 0 C--N 1.318 -0.769 0 CA-C-O 121.489 0.661 . . . . 1.25 111.455 -178.301 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A 1517 ' ' GLN . . . . . . . . . . . . . 11.3 pt20 -137.9 154.69 49.41 Favored 'General case' 0 N--CA 1.413 -2.307 0 N-CA-C 106.949 -1.5 . . . . 2.36 106.949 178.55 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A 1518 ' ' VAL . . . . . . . . . . . . . 7.7 p -148.58 137.94 15.81 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.741 0 O-C-N 123.178 0.299 . . . . 2.34 110.913 -174.893 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A 1519 ' ' THR . . . . . . . . . . . . . 8.4 m -103.66 102.76 12.62 Favored 'General case' 0 N--CA 1.429 -1.523 0 N-CA-C 107.901 -1.148 . . . . 2.04 107.901 178.713 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A 1520 ' ' ASN . . . . . . . . . . . . . 24.7 t30 -71.61 114.65 30.09 Favored Pre-proline 0 C--N 1.319 -0.72 0 C-N-CA 121.021 -0.272 . . . . 2.12 110.281 -179.049 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A 1521 ' ' PRO . . . . . . . . . . . . . 55.9 Cg_endo -68.27 -9.63 26.47 Favored 'Trans proline' 0 C--N 1.357 1.018 0 C-N-CA 122.688 2.259 . . . . 2.59 113.486 -174.797 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A 1522 ' ' SER . . . . . . . . . . . . . 15.1 m -79.21 -23.59 43.7 Favored 'General case' 0 N--CA 1.435 -1.18 0 CA-C-N 116.694 -0.23 . . . . 2.65 111.249 178.991 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A 1523 ' ' THR . . . . . . . . . . . . . 7.0 t -137.5 -15.93 1.39 Allowed 'General case' 0 CA--C 1.549 0.913 0 N-CA-C 112.712 0.634 . . . . 2.33 112.712 -177.893 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A 1524 ' ' GLY . . . . . . . . . . . . . . . 84.6 -5.38 81.74 Favored Glycine 0 N--CA 1.45 -0.417 0 O-C-N 121.982 -0.449 . . . . 1.96 113.182 179.024 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A 1525 ' ' HIS . . . . . . . . . . . . . 11.7 t60 -73.01 135.71 44.97 Favored 'General case' 0 C--N 1.311 -1.081 0 CA-C-O 121.113 0.482 . . . . 2.44 110.091 -177.403 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A 1526 ' ' LEU . . . . . . . . . . . . . 3.5 tm? -95.34 121.65 37.22 Favored 'General case' 0 C--N 1.306 -1.285 0 CA-C-N 114.905 -1.043 . . . . 2.19 108.407 -179.918 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A 1527 ' ' PHE . . . . . 0.578 ' CE1' ' HA ' ' A' 1646 ' ' CYS . 78.7 m-85 -106.6 149.23 27.4 Favored 'General case' 0 C--N 1.292 -1.914 0 N-CA-C 107.352 -1.351 . . . . 1.61 107.352 177.574 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A 1528 ' ' ASP . . . . . . . . . . . . . 1.2 p30 -143.29 148.21 35.99 Favored 'General case' 0 CA--C 1.484 -1.566 0 CA-C-O 121.371 0.605 . . . . 2.18 109.82 177.287 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A 1529 ' ' LEU . . . . . . . . . . . . . 88.7 mt -117.07 -6.05 11.39 Favored 'General case' 0 C--N 1.284 -2.255 0 CA-C-N 114.002 -1.454 . . . . 2.04 107.371 175.338 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A 1530 ' ' SER . . . . . . . . . . . . . 11.5 m -66.42 -41.67 88.87 Favored 'General case' 0 N--CA 1.432 -1.33 0 CA-C-N 114.315 -1.311 . . . . 1.44 111.624 -175.556 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A 1531 ' ' SER . . . . . . . . . . . . . 13.6 t -87.35 -16.18 35.76 Favored 'General case' 0 N--CA 1.438 -1.067 0 N-CA-C 109.027 -0.731 . . . . 1.63 109.027 -178.77 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A 1532 ' ' LEU . . . . . 0.446 HD11 HD12 ' A' 1644 ' ' LEU . 80.2 mt -76.15 -36.26 58.84 Favored 'General case' 0 CA--C 1.521 -0.173 0 CA-C-N 115.854 -0.612 . . . . 2.32 111.068 179.362 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A 1533 ' ' SER . . . . . 0.565 ' HB2' ' HB ' ' A' 1552 ' ' ILE . 25.7 t -80.29 133.74 36.0 Favored 'General case' 0 C--N 1.304 -1.41 0 CA-C-N 115.914 -0.585 . . . . 2.57 110.349 -178.041 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A 1534 ' ' GLY . . . . . . . . . . . . . . . -91.47 160.01 26.47 Favored Glycine 0 N--CA 1.441 -1.022 0 N-CA-C 109.092 -1.603 . . . . 1.89 109.092 174.797 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A 1535 ' ' ARG . . . . . . . . . . . . . 29.0 ttp180 -70.82 -19.77 62.63 Favored 'General case' 0 C--N 1.318 -0.761 0 CA-C-N 117.961 0.88 . . . . 4.44 110.927 -175.911 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A 1536 ' ' ALA . . . . . . . . . . . . . . . -90.26 -9.7 46.97 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-O 121.375 0.607 . . . . 2.07 109.666 177.302 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A 1537 ' ' GLY . . . . . . . . . . . . . . . 80.61 -169.44 52.36 Favored Glycine 0 N--CA 1.422 -2.277 0 CA-C-N 115.123 -0.944 . . . . 1.2 110.962 -177.09 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A 1538 ' ' PHE . . . . . . . . . . . . . 17.3 m-85 -120.33 170.16 9.62 Favored 'General case' 0 C--N 1.285 -2.233 0 N-CA-C 108.286 -1.005 . . . . 1.98 108.286 177.517 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A 1539 ' ' THR . . . . . 0.497 ' HA ' ' O ' ' A' 1548 ' ' VAL . 23.5 p -120.98 118.3 29.49 Favored 'General case' 0 C--N 1.289 -2.028 0 CA-C-N 116.223 -0.444 . . . . 1.97 110.454 -179.433 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A 1540 ' ' ALA . . . . . . . . . . . . . . . -93.24 143.66 26.05 Favored 'General case' 0 C--N 1.305 -1.333 0 N-CA-C 107.323 -1.362 . . . . 1.39 107.323 175.449 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A 1541 ' ' ALA . . . . . . . . . . . . . . . -84.68 70.08 10.73 Favored 'General case' 0 C--N 1.298 -1.633 0 N-CA-C 112.658 0.614 . . . . 1.86 112.658 -173.282 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A 1542 ' ' TYR . . . . . . . . . . . . . 16.4 t80 -157.06 112.76 2.89 Favored 'General case' 0 C--O 1.208 -1.079 0 N-CA-C 113.386 0.884 . . . . 2.4 113.386 176.511 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A 1543 ' ' SER . . . . . 0.572 ' HB3' ' N ' ' A' 1546 ' ' GLY . 43.4 t -138.42 -153.61 0.48 Allowed 'General case' 0 C--N 1.263 -3.159 0 N-CA-C 103.467 -2.79 . . . . 2.58 103.467 162.03 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A 1544 ' ' LYS . . . . . . . . . . . . . 96.1 mttt -66.22 -50.34 64.14 Favored 'General case' 0 C--N 1.303 -1.44 0 N-CA-C 106.354 -1.721 . . . . 4.24 106.354 170.275 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A 1545 ' ' SER . . . . . . . . . . . . . 17.6 t -134.41 25.98 3.79 Favored 'General case' 0 CA--C 1.562 1.442 0 CA-C-N 115.166 -0.925 . . . . 3.6 110.013 175.597 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A 1546 ' ' GLY . . . . . 0.572 ' N ' ' HB3' ' A' 1543 ' ' SER . . . -138.09 -118.05 1.62 Allowed Glycine 0 CA--C 1.529 0.96 0 C-N-CA 118.027 -2.035 . . . . 1.66 117.316 -170.524 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A 1547 ' ' VAL . . . . . . . . . . . . . 14.0 m -159.21 169.34 0.53 Allowed 'Isoleucine or valine' 0 C--O 1.255 1.382 0 C-N-CA 124.256 1.022 . . . . 2.23 110.876 -165.581 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A 1548 ' ' VAL . . . . . 0.497 ' O ' ' HA ' ' A' 1539 ' ' THR . 3.5 t -124.87 135.57 63.58 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.628 0 N-CA-C 107.787 -1.19 . . . . 1.59 107.787 178.625 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A 1549 ' ' TYR . . . . . . . . . . . . . 22.7 m-85 -92.16 114.92 27.59 Favored 'General case' 0 CA--C 1.502 -0.869 0 N-CA-C 105.711 -1.959 . . . . 1.58 105.711 172.52 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A 1550 ' ' MET . . . . . . . . . . . . . 19.8 ptm -144.66 127.8 16.64 Favored 'General case' 0 C--N 1.283 -2.294 0 C-N-CA 119.601 -0.84 . . . . 2.08 111.653 -176.744 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A 1551 ' ' SER . . . . . . . . . . . . . 51.0 m -86.68 135.3 33.44 Favored 'General case' 0 C--N 1.285 -2.236 0 N-CA-C 107.805 -1.183 . . . . 1.9 107.805 177.812 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A 1552 ' ' ILE . . . . . 0.565 ' HB ' ' HB2' ' A' 1533 ' ' SER . 27.8 mm -75.97 -13.16 14.82 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.959 0 CA-C-O 122.363 1.078 . . . . 2.04 108.471 -175.181 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A 1553 ' ' CYS . . . . . . . . . . . . . 33.1 t -161.33 137.95 8.46 Favored 'General case' 0 N--CA 1.421 -1.918 0 N-CA-C 106.957 -1.497 . . . . 1.43 106.957 174.54 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A 1554 ' ' GLY . . . . . . . . . . . . . . . 86.99 -166.56 37.19 Favored Glycine 0 N--CA 1.435 -1.371 0 C-N-CA 120.857 -0.687 . . . . 1.23 114.015 174.18 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A 1555 ' ' GLU . . . . . . . . . . . . . 13.5 pt-20 -86.74 154.57 20.85 Favored 'General case' 0 C--N 1.313 -1.01 0 CA-C-O 121.384 0.612 . . . . 1.8 111.129 -178.192 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A 1556 ' ' ASN . . . . . . . . . . . . . 20.4 t-20 -108.91 112.5 24.76 Favored 'General case' 0 C--N 1.301 -1.524 0 N-CA-C 109.259 -0.645 . . . . 2.63 109.259 178.341 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A 1557 ' ' GLU . . . . . . . . . . . . . 7.9 mt-10 -83.21 40.41 0.71 Allowed 'General case' 0 C--N 1.309 -1.176 0 CA-C-O 121.066 0.46 . . . . 3.79 112.198 -173.017 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A 1558 ' ' ASN . . . . . . . . . . . . . 34.6 m-80 -126.89 -0.78 6.62 Favored 'General case' 0 C--N 1.307 -1.249 0 CA-C-O 121.291 0.567 . . . . 1.59 110.079 179.648 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A 1559 ' ' CYS . . . . . 0.748 ' HB3' ' HD2' ' A' 1560 ' ' PRO . 67.5 m -147.11 177.8 1.65 Allowed Pre-proline 0 C--N 1.309 -1.172 0 CA-C-O 116.884 -1.532 . . . . 0.94 107.162 179.594 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A 1560 ' ' PRO . . . . . 0.748 ' HD2' ' HB3' ' A' 1559 ' ' CYS . 3.4 Cg_exo -36.13 122.84 0.29 Allowed 'Trans proline' 0 C--N 1.385 2.469 0 C-N-CA 124.107 3.205 . . . . 1.53 114.038 178.917 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A 1561 ' ' PRO . . . . . . . . . . . . . 56.4 Cg_exo -53.82 107.64 0.22 Allowed 'Trans proline' 0 C--O 1.254 1.31 0 C-N-CA 123.482 2.788 . . . . 1.82 112.698 -179.053 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A 1562 ' ' GLY . . . . . . . . . . . . . . . 134.12 -11.56 4.75 Favored Glycine 0 N--CA 1.43 -1.707 0 CA-C-N 115.306 -0.861 . . . . 0.81 111.84 179.263 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A 1563 ' ' VAL . . . . . 0.542 ' HA ' ' HA ' ' A' 1576 ' ' LYS . 15.1 m -88.17 144.11 9.85 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.247 0 CA-C-O 120.965 0.412 . . . . 1.73 109.922 179.739 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A 1564 ' ' GLY . . . . . . . . . . . . . . . -100.74 -26.43 8.03 Favored Glycine 0 C--N 1.306 -1.106 0 N-CA-C 110.725 -0.95 . . . . 0.72 110.725 179.796 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A 1565 ' ' ALA . . . . . . . . . . . . . . . -138.59 141.18 39.2 Favored 'General case' 0 N--CA 1.439 -0.986 0 N-CA-C 109.045 -0.724 . . . . 1.14 109.045 179.533 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A 1566 ' ' CYS . . . . . . . . . . . . . 39.8 t -158.7 133.04 7.92 Favored 'General case' 0 C--N 1.3 -1.546 0 N-CA-C 108.106 -1.072 . . . . 0.51 108.106 -176.955 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A 1567 ' ' PHE . . . . . . . . . . . . . 86.3 m-85 -63.63 123.62 19.3 Favored 'General case' 0 C--O 1.208 -1.126 0 N-CA-C 107.508 -1.293 . . . . 1.22 107.508 178.305 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A 1568 ' ' GLY . . . . . 0.412 ' H ' ' HA ' ' A' 1548 ' ' VAL . . . -82.91 -24.85 51.6 Favored Glycine 0 CA--C 1.487 -1.676 0 C-N-CA 120.244 -0.979 . . . . 1.08 112.986 -171.654 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A 1569 ' ' GLN . . . . . . . . . . . . . 22.0 tp60 -81.89 -38.29 25.56 Favored 'General case' 0 C--N 1.298 -1.648 0 CA-C-O 122.096 0.95 . . . . 3.05 108.736 179.391 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A 1570 ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -93.13 -22.28 19.18 Favored 'General case' 0 C--N 1.295 -1.77 0 CA-C-N 114.354 -1.294 . . . . 2.44 112.157 -171.727 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A 1571 ' ' ARG . . . . . . . . . . . . . 50.9 mtt180 63.31 38.01 10.58 Favored 'General case' 0 N--CA 1.47 0.547 0 C-N-CA 125.54 1.536 . . . . 4.48 112.411 -179.256 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A 1572 ' ' ILE . . . . . . . . . . . . . 48.1 mm -118.08 126.05 74.66 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.934 0 CA-C-N 114.849 -1.069 . . . . 1.94 108.864 -177.028 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A 1573 ' ' SER . . . . . . . . . . . . . 45.8 t -62.17 134.63 56.81 Favored 'General case' 0 C--N 1.307 -1.277 0 C-N-CA 123.87 0.868 . . . . 1.25 111.782 -177.578 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A 1574 ' ' VAL . . . . . . . . . . . . . 92.6 t -97.69 -50.61 11.14 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.426 0 CA-C-N 115.313 -0.858 . . . . 1.61 109.174 -179.622 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A 1575 ' ' GLY . . . . . . . . . . . . . . . -160.55 150.38 20.35 Favored Glycine 0 N--CA 1.432 -1.616 0 C-N-CA 120.38 -0.914 . . . . 0.65 112.117 -176.895 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A 1576 ' ' LYS . . . . . 0.542 ' HA ' ' HA ' ' A' 1563 ' ' VAL . 64.8 tttm -78.7 146.54 33.9 Favored 'General case' 0 C--N 1.311 -1.084 0 N-CA-C 108.714 -0.847 . . . . 3.33 108.714 -179.47 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A 1577 ' ' ALA . . . . . . . . . . . . . . . -69.09 90.81 0.47 Allowed 'General case' 0 C--N 1.319 -0.73 0 C-N-CA 123.783 0.833 . . . . 1.31 112.047 -176.03 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A 1578 ' ' ASN . . . . . . . . . . . . . 43.6 m-80 -103.73 113.75 27.5 Favored 'General case' 0 C--N 1.303 -1.42 0 N-CA-C 108.549 -0.908 . . . . 2.24 108.549 176.9 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A 1579 ' ' LYS . . . . . 0.461 ' HD2' ' HA ' ' A' 1515 ' ' ASP . 35.9 ttpt -89.7 89.99 8.03 Favored 'General case' 0 C--N 1.295 -1.764 0 CA-C-O 122.223 1.011 . . . . 2.34 109.152 -176.713 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A 1580 ' ' ARG . . . . . . . . . . . . . 27.4 tpt180 -161.3 111.84 1.7 Allowed 'General case' 0 N--CA 1.424 -1.766 0 CA-C-N 113.747 -1.57 . . . . 4.19 109.236 -178.007 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A 1581 ' ' LEU . . . . . . . . . . . . . 3.6 pp -117.75 160.94 20.51 Favored 'General case' 0 N--CA 1.413 -2.295 0 CA-C-N 114.991 -1.004 . . . . 2.39 108.647 176.56 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A 1582 ' ' ARG . . . . . . . . . . . . . 18.0 ttp85 -140.78 138.02 33.81 Favored 'General case' 0 C--N 1.291 -1.95 0 N-CA-C 108.519 -0.919 . . . . 4.48 108.519 176.059 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A 1583 ' ' TYR . . . . . . . . . . . . . 70.0 t80 -102.65 96.6 6.99 Favored 'General case' 0 C--N 1.303 -1.429 0 N-CA-C 107.694 -1.224 . . . . 1.57 107.694 179.788 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A 1584 ' ' VAL . . . . . 0.501 ' O ' HG13 ' A' 1587 ' ' VAL . 6.0 p -121.85 105.8 17.0 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.505 0 CA-C-N 116.123 -0.49 . . . . 2.29 111.802 -175.581 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A 1585 ' ' ASP . . . . . . . . . . . . . 37.0 t70 61.46 61.19 1.54 Allowed 'General case' 0 C--N 1.319 -0.739 0 CA-C-O 122.356 1.074 . . . . 2.06 111.115 178.38 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A 1586 ' ' GLN . . . . . . . . . . . . . 47.8 mt-30 62.62 8.75 3.11 Favored 'General case' 0 N--CA 1.478 0.941 0 CA-C-N 114.244 -1.344 . . . . 2.61 114.258 178.322 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A 1587 ' ' VAL . . . . . 0.501 HG13 ' O ' ' A' 1584 ' ' VAL . 11.7 p -122.07 125.43 73.04 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.242 0 C-N-CA 119.204 -0.998 . . . . 1.33 110.548 178.496 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A 1588 ' ' LEU . . . . . 0.675 ' HB2' ' HB2' ' A' 1612 ' ' PHE . 57.6 mt -83.22 126.24 32.43 Favored 'General case' 0 C--N 1.3 -1.552 0 CA-C-N 114.919 -1.037 . . . . 2.03 109.061 173.826 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A 1589 ' ' GLN . . . . . . . . . . . . . 36.0 tt0 -118.85 117.44 28.86 Favored 'General case' 0 C--N 1.284 -2.248 0 CA-C-N 115.736 -0.666 . . . . 1.73 109.291 -178.475 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A 1590 ' ' LEU . . . . . . . . . . . . . 7.3 tt -124.6 132.83 53.41 Favored 'General case' 0 C--N 1.307 -1.248 0 N-CA-C 106.847 -1.538 . . . . 1.76 106.847 176.611 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A 1591 ' ' VAL . . . . . 0.416 HG21 HG21 ' A' 1609 ' ' VAL . 39.0 t -127.42 137.68 57.01 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.704 0 CA-C-O 120.69 0.281 . . . . 2.14 111.309 -174.092 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A 1592 ' ' TYR . . . . . . . . . . . . . 57.9 m-85 -115.07 124.64 52.11 Favored 'General case' 0 C--N 1.314 -0.962 0 N-CA-C 107.262 -1.384 . . . . 1.53 107.262 171.231 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A 1593 ' ' LYS . . . . . . . . . . . . . 13.3 ptmm? -137.98 172.86 12.3 Favored 'General case' 0 C--N 1.302 -1.484 0 C-N-CA 121.149 -0.22 . . . . 2.72 111.263 -177.111 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A 1594 ' ' ASP . . . . . . . . . . . . . 17.3 m-20 66.37 48.0 1.65 Allowed 'General case' 0 C--O 1.247 0.935 0 C-N-CA 125.313 1.445 . . . . 1.45 111.875 179.082 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A 1595 ' ' GLY . . . . . . . . . . . . . . . -89.93 -106.98 1.23 Allowed Glycine 0 N--CA 1.44 -1.04 0 N-CA-C 110.877 -0.889 . . . . 0.83 110.877 175.832 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A 1596 ' ' SER . . . . . . . . . . . . . 19.9 m -101.89 152.08 38.09 Favored Pre-proline 0 C--N 1.296 -1.741 0 N-CA-C 109.732 -0.47 . . . . 1.96 109.732 179.214 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A 1597 ' ' PRO . . . . . . . . . . . . . 22.6 Cg_exo -66.79 141.35 59.07 Favored 'Trans proline' 0 C--N 1.353 0.797 0 C-N-CA 123.203 2.602 . . . . 1.34 112.018 178.88 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A 1598 ' ' CYS . . . . . 0.642 ' O ' ' HA ' ' A' 1602 ' ' SER . 42.2 t -95.86 136.39 22.27 Favored Pre-proline 0 C--N 1.287 -2.136 0 CA-C-N 115.505 -0.771 . . . . 1.19 109.011 179.993 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A 1599 ' ' PRO . . . . . . . . . . . . . 63.3 Cg_endo -75.08 -18.01 18.91 Favored 'Trans proline' 0 C--N 1.36 1.149 0 C-N-CA 123.11 2.54 . . . . 1.88 112.198 177.751 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A 1600 ' ' SER . . . . . . . . . . . . . 34.2 m -86.63 112.54 21.7 Favored 'General case' 0 N--CA 1.425 -1.721 0 N-CA-C 107.037 -1.468 . . . . 2.19 107.037 176.592 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A 1601 ' ' LYS . . . . . . . . . . . . . 42.9 mmtm 56.23 55.79 6.4 Favored 'General case' 0 C--O 1.242 0.694 0 CA-C-O 122.477 1.132 . . . . 4.21 108.542 -173.215 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A 1602 ' ' SER . . . . . 0.642 ' HA ' ' O ' ' A' 1598 ' ' CYS . 15.0 t -49.11 122.77 6.28 Favored 'General case' 0 N--CA 1.442 -0.865 0 CA-C-N 112.781 -2.009 . . . . 3.82 112.108 -172.693 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A 1603 ' ' GLY . . . . . . . . . . . . . . . 140.02 -23.58 2.74 Favored Glycine 0 N--CA 1.43 -1.726 0 N-CA-C 109.131 -1.588 . . . . 2.45 109.131 -176.61 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A 1604 ' ' LEU . . . . . . . . . . . . . 72.3 mt -85.33 152.45 23.27 Favored 'General case' 0 C--N 1.309 -1.183 0 CA-C-N 114.733 -0.734 . . . . 2.06 109.473 177.502 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A 1605 ' ' SER . . . . . . . . . . . . . 49.1 m -101.7 175.54 5.52 Favored 'General case' 0 C--N 1.282 -2.341 0 N-CA-C 105.933 -1.877 . . . . 1.75 105.933 169.094 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A 1606 ' ' TYR . . . . . . . . . . . . . 78.5 m-85 -94.76 149.69 20.98 Favored 'General case' 0 CA--C 1.466 -2.28 0 N-CA-C 106.133 -1.803 . . . . 1.59 106.133 -177.583 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A 1607 ' ' LYS . . . . . 0.41 ' HG3' HG23 ' A' 1635 ' ' THR . 23.2 pttm -135.67 132.18 36.64 Favored 'General case' 0 N--CA 1.401 -2.915 0 C-N-CA 118.377 -1.329 . . . . 2.21 110.123 175.243 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A 1608 ' ' SER . . . . . . . . . . . . . 29.3 p -106.9 112.15 24.98 Favored 'General case' 0 C--N 1.288 -2.08 0 CA-C-N 116.277 -0.419 . . . . 1.48 110.376 -179.232 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A 1609 ' ' VAL . . . . . 0.416 HG21 HG21 ' A' 1591 ' ' VAL . 92.6 t -100.3 117.4 45.44 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.961 0 N-CA-C 108.719 -0.845 . . . . 1.57 108.719 177.622 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A 1610 ' ' ILE . . . . . 0.667 HG13 ' HB2' ' A' 1638 ' ' PHE . 3.5 mp -101.94 118.34 48.61 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.567 0 N-CA-C 108.22 -1.03 . . . . 1.47 108.22 177.133 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A 1611 ' ' SER . . . . . . . . . . . . . 14.1 m -104.22 117.02 33.22 Favored 'General case' 0 N--CA 1.416 -2.131 0 CA-C-N 115.357 -0.838 . . . . 1.84 108.966 178.834 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A 1612 ' ' PHE . . . . . 0.675 ' HB2' ' HB2' ' A' 1588 ' ' LEU . 95.2 m-85 -90.18 107.32 19.06 Favored 'General case' 0 C--N 1.298 -1.648 0 CA-C-N 115.458 -0.792 . . . . 0.86 109.251 179.98 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A 1613 ' ' VAL . . . . . . . . . . . . . 71.9 t -100.38 131.31 48.15 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.108 0 CA-C-N 116.152 -0.477 . . . . 1.32 109.922 -177.02 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A 1614 ' ' CYS . . . . . . . . . . . . . 59.6 m -67.98 101.76 1.17 Allowed 'General case' 0 C--N 1.317 -0.848 0 C-N-CA 123.787 0.835 . . . . 1.39 110.925 -179.425 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A 1615 ' ' ARG . . . . . 0.533 ' HD2' ' OE2' ' A' 1617 ' ' GLU . 21.4 mmt180 -137.07 95.76 11.77 Favored Pre-proline 0 C--N 1.306 -1.294 0 CA-C-N 115.594 -0.73 . . . . 4.34 110.927 178.692 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A 1616 ' ' PRO . . . . . 0.422 ' HA ' ' HB3' ' A' 1643 ' ' PRO . 11.4 Cg_exo -74.1 58.53 4.26 Favored 'Trans proline' 0 CA--C 1.541 0.857 0 C-N-CA 123.636 2.891 . . . . 1.5 111.371 176.587 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A 1617 ' ' GLU . . . . . 0.533 ' OE2' ' HD2' ' A' 1615 ' ' ARG . 38.3 mt-10 . . . . . 0 C--N 1.31 -1.121 0 C-N-CA 124.659 1.183 . . . . 3.21 108.471 179.503 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A 1622 ' ' ASN . . . . . . . . . . . . . 25.2 t-20 . . . . . 0 C--O 1.233 0.226 0 N-CA-C 108.864 -0.791 . . . . 3.58 108.864 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A 1623 ' ' ARG . . . . . . . . . . . . . 8.6 ptm180 -133.67 158.17 76.17 Favored Pre-proline 0 C--N 1.311 -1.089 0 CA-C-N 115.378 -0.828 . . . . 4.09 109.714 -173.866 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A 1624 ' ' PRO . . . . . . . . . . . . . 12.2 Cg_exo -69.86 127.21 14.2 Favored 'Trans proline' 0 C--O 1.246 0.905 0 C-N-CA 122.792 2.328 . . . . 2.86 110.834 176.942 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A 1625 ' ' MET . . . . . . . . . . . . . 22.1 ptp -126.34 151.47 47.53 Favored 'General case' 0 C--N 1.303 -1.438 0 CA-C-N 116.131 -0.486 . . . . 2.73 110.396 -178.561 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A 1626 ' ' LEU . . . . . 0.409 HD13 ' O ' ' A' 1637 ' ' PHE . 39.0 tp -85.55 118.35 25.01 Favored 'General case' 0 C--N 1.306 -1.293 0 N-CA-C 108.436 -0.95 . . . . 1.94 108.436 -179.666 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A 1627 ' ' ILE . . . . . . . . . . . . . 45.8 pt -93.17 -28.33 4.45 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.331 0 C-N-CA 120.345 -0.542 . . . . 1.75 111.47 -177.993 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A 1628 ' ' SER . . . . . . . . . . . . . 21.1 t -160.57 142.0 12.22 Favored 'General case' 0 N--CA 1.432 -1.371 0 C-N-CA 120.341 -0.543 . . . . 1.85 110.565 -177.482 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A 1629 ' ' LEU . . . . . 0.815 HD11 ' HG ' ' A' 1636 ' ' LEU . 29.5 tp -119.76 128.02 53.36 Favored 'General case' 0 C--N 1.304 -1.37 0 N-CA-C 108.065 -1.087 . . . . 2.12 108.065 174.055 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A 1630 ' ' ASP . . . . . . . . . . . . . 25.1 t70 -102.07 127.41 48.98 Favored 'General case' 0 C--N 1.295 -1.761 0 CA-C-N 116.737 -0.211 . . . . 0.87 110.623 179.269 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A 1631 ' ' LYS . . . . . . . . . . . . . 53.0 mttm -95.14 0.97 54.72 Favored 'General case' 0 C--N 1.317 -0.808 0 N-CA-C 111.872 0.323 . . . . 2.76 111.872 -178.495 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A 1632 ' ' GLN . . . . . . . . . . . . . 36.5 mt-30 -87.19 -52.47 5.39 Favored 'General case' 0 C--N 1.315 -0.926 0 C-N-CA 120.218 -0.593 . . . . 2.55 109.969 178.917 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A 1633 ' ' THR . . . . . . . . . . . . . 69.1 p -106.51 -1.44 23.05 Favored 'General case' 0 N--CA 1.432 -1.374 0 CA-C-N 115.761 -0.654 . . . . 1.92 111.927 -178.833 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A 1634 ' ' CYS . . . . . . . . . . . . . 60.3 m 62.61 42.91 7.99 Favored 'General case' 0 C--O 1.237 0.399 0 CA-C-O 122.464 1.126 . . . . 0.89 111.26 177.409 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A 1635 ' ' THR . . . . . 0.41 HG23 ' HG3' ' A' 1607 ' ' LYS . 28.2 m -102.57 133.09 48.13 Favored 'General case' 0 N--CA 1.416 -2.145 0 CA-C-N 114.168 -1.378 . . . . 1.31 109.245 -178.547 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A 1636 ' ' LEU . . . . . 0.815 ' HG ' HD11 ' A' 1629 ' ' LEU . 5.2 mp -109.79 129.69 55.6 Favored 'General case' 0 N--CA 1.435 -1.213 0 N-CA-C 108.994 -0.743 . . . . 1.97 108.994 179.806 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A 1637 ' ' PHE . . . . . 0.409 ' O ' HD13 ' A' 1626 ' ' LEU . 88.7 m-85 -110.32 108.0 17.93 Favored 'General case' 0 C--N 1.308 -1.223 0 CA-C-O 121.049 0.452 . . . . 0.92 110.979 -177.121 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A 1638 ' ' PHE . . . . . 0.667 ' HB2' HG13 ' A' 1610 ' ' ILE . 97.0 m-85 -101.78 146.95 27.08 Favored 'General case' 0 C--N 1.305 -1.359 0 N-CA-C 109.228 -0.656 . . . . 0.7 109.228 177.706 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A 1639 ' ' SER . . . . . . . . . . . . . 50.0 m -132.64 133.66 43.89 Favored 'General case' 0 C--N 1.278 -2.529 0 N-CA-C 109.788 -0.449 . . . . 1.46 109.788 176.967 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A 1640 ' ' TRP . . . . . 0.404 ' CE3' ' HE2' ' A' 1612 ' ' PHE . 6.7 t90 -121.43 92.54 3.77 Favored 'General case' 0 N--CA 1.413 -2.32 0 N-CA-C 106.761 -1.57 . . . . 0.92 106.761 173.517 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A 1641 ' ' HIS . . . . . . . . . . . . . 4.4 p-80 -71.64 98.75 1.96 Allowed 'General case' 0 C--N 1.308 -1.209 0 CA-C-N 114.867 -1.061 . . . . 3.18 108.555 175.154 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A 1642 ' ' THR . . . . . . . . . . . . . 10.0 t -143.55 147.81 40.97 Favored Pre-proline 0 C--N 1.279 -2.49 0 CA-C-N 115.831 -0.622 . . . . 1.48 110.483 -170.963 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A 1643 ' ' PRO . . . . . 0.422 ' HB3' ' HA ' ' A' 1616 ' ' PRO . 34.6 Cg_endo -75.68 0.18 9.47 Favored 'Trans proline' 0 C--O 1.215 -0.651 0 C-N-CA 122.853 2.369 . . . . 1.09 111.114 174.768 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A 1644 ' ' LEU . . . . . 0.446 HD12 HD11 ' A' 1532 ' ' LEU . 45.5 mt -85.04 -11.81 54.52 Favored 'General case' 0 C--N 1.32 -0.683 0 C-N-CA 123.927 0.891 . . . . 2.08 110.782 176.679 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A 1645 ' ' ALA . . . . . . . . . . . . . . . -73.09 -43.44 61.82 Favored 'General case' 0 N--CA 1.471 0.592 0 CA-C-O 121.563 0.696 . . . . 1.37 110.118 -178.604 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A 1646 ' ' CYS . . . . . 0.578 ' HA ' ' CE1' ' A' 1527 ' ' PHE . 18.8 p -155.61 142.26 18.79 Favored 'General case' 0 N--CA 1.417 -2.084 0 N-CA-C 104.666 -2.346 . . . . 1.7 104.666 172.389 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A 1647 ' ' GLU . . . . . . . . . . . . . 39.9 mt-10 . . . . . 0 C--N 1.283 -2.323 0 O-C-N 123.199 0.312 . . . . 2.92 110.414 -171.249 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A 1515 ' ' ASP . . . . . 0.454 ' HB3' ' HB3' ' A' 1579 ' ' LYS . 38.7 m-20 . . . . . 0 N--CA 1.466 0.348 0 N-CA-C 111.936 0.347 . . . . 2.54 111.936 . . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A 1516 ' ' CYS . . . . . . . . . . . . . 85.7 m -124.4 41.38 3.51 Favored 'General case' 0 C--N 1.311 -1.069 0 CA-C-O 121.432 0.634 . . . . 1.25 110.99 -177.266 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A 1517 ' ' GLN . . . . . . . . . . . . . 9.6 pt20 -161.21 168.62 23.82 Favored 'General case' 0 C--N 1.287 -2.132 0 N-CA-C 109.42 -0.585 . . . . 2.36 109.42 -179.562 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A 1518 ' ' VAL . . . . . . . . . . . . . 80.7 t -131.37 105.96 11.27 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.081 0 N-CA-C 108.497 -0.927 . . . . 2.34 108.497 176.111 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A 1519 ' ' THR . . . . . . . . . . . . . 20.4 m -86.16 102.14 13.62 Favored 'General case' 0 C--N 1.281 -2.376 0 N-CA-C 107.596 -1.261 . . . . 2.04 107.596 175.048 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A 1520 ' ' ASN . . . . . . . . . . . . . 31.4 t30 -92.0 105.41 13.57 Favored Pre-proline 0 C--N 1.322 -0.614 0 N-CA-C 109.859 -0.423 . . . . 2.12 109.859 179.809 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A 1521 ' ' PRO . . . . . . . . . . . . . 59.1 Cg_endo -72.72 -18.98 24.63 Favored 'Trans proline' 0 N--CA 1.458 -0.593 0 C-N-CA 122.383 2.055 . . . . 2.59 113.376 -175.123 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A 1522 ' ' SER . . . . . . . . . . . . . 32.6 m -61.27 -35.75 78.15 Favored 'General case' 0 CA--C 1.54 0.565 0 CA-C-O 120.818 0.342 . . . . 2.65 111.832 -178.393 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A 1523 ' ' THR . . . . . . . . . . . . . 12.3 t -120.21 -5.24 9.95 Favored 'General case' 0 CA--C 1.554 1.096 0 CA-C-O 122.074 0.94 . . . . 2.33 109.543 178.809 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A 1524 ' ' GLY . . . . . . . . . . . . . . . 73.97 20.18 79.73 Favored Glycine 0 C--N 1.335 0.526 0 CA-C-N 115.44 -0.8 . . . . 1.96 112.345 179.666 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A 1525 ' ' HIS . . . . . . . . . . . . . 12.9 t-80 -101.65 128.16 48.07 Favored 'General case' 0 C--N 1.314 -0.951 0 CA-C-O 120.797 0.332 . . . . 2.44 110.745 -177.869 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A 1526 ' ' LEU . . . . . . . . . . . . . 6.9 tt -100.34 130.71 46.48 Favored 'General case' 0 C--N 1.3 -1.579 0 N-CA-C 108.43 -0.952 . . . . 2.19 108.43 178.208 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A 1527 ' ' PHE . . . . . 0.677 ' HE1' ' HA ' ' A' 1646 ' ' CYS . 97.7 m-85 -95.78 102.95 14.81 Favored 'General case' 0 C--N 1.308 -1.199 0 N-CA-C 109.183 -0.673 . . . . 1.61 109.183 177.243 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A 1528 ' ' ASP . . . . . . . . . . . . . 4.9 p-10 -85.17 106.68 16.79 Favored 'General case' 0 C--N 1.314 -0.936 0 CA-C-O 122.389 1.09 . . . . 2.18 113.437 -178.285 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A 1529 ' ' LEU . . . . . 0.731 ' HG ' HD11 ' A' 1532 ' ' LEU . 7.4 mp -105.5 0.22 26.48 Favored 'General case' 0 C--N 1.312 -1.06 0 CA-C-N 114.78 -1.1 . . . . 2.04 108.148 172.398 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A 1530 ' ' SER . . . . . . . . . . . . . 2.6 p -68.3 -31.32 70.68 Favored 'General case' 0 N--CA 1.426 -1.641 0 CA-C-N 114.248 -1.342 . . . . 1.44 109.356 177.406 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A 1531 ' ' SER . . . . . . . . . . . . . 9.9 m -76.11 -7.91 55.8 Favored 'General case' 0 N--CA 1.443 -0.793 0 CA-C-N 115.03 -0.987 . . . . 1.63 110.358 177.759 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A 1532 ' ' LEU . . . . . 0.731 HD11 ' HG ' ' A' 1529 ' ' LEU . 81.7 mt -90.72 15.8 10.43 Favored 'General case' 0 C--O 1.238 0.485 0 CA-C-O 121.544 0.688 . . . . 2.32 111.676 -179.792 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A 1533 ' ' SER . . . . . . . . . . . . . 17.0 m -78.74 173.23 12.69 Favored 'General case' 0 N--CA 1.44 -0.955 0 N-CA-C 108.558 -0.904 . . . . 2.57 108.558 176.143 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A 1534 ' ' GLY . . . . . . . . . . . . . . . 165.5 147.44 5.16 Favored Glycine 0 N--CA 1.428 -1.897 0 C-N-CA 120.038 -1.077 . . . . 1.89 111.848 -178.997 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A 1535 ' ' ARG . . . . . 0.833 ' HG3' ' HG3' ' A' 1557 ' ' GLU . 43.6 ttm180 -60.35 -49.29 78.17 Favored 'General case' 0 C--O 1.246 0.907 0 C-N-CA 124.513 1.125 . . . . 4.44 110.301 179.562 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A 1536 ' ' ALA . . . . . . . . . . . . . . . -95.68 -33.65 12.25 Favored 'General case' 0 N--CA 1.434 -1.266 0 N-CA-C 109.044 -0.724 . . . . 2.07 109.044 177.858 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A 1537 ' ' GLY . . . . . . . . . . . . . . . 84.19 -136.37 14.7 Favored Glycine 0 N--CA 1.428 -1.873 0 CA-C-N 114.496 -1.229 . . . . 1.2 111.963 177.73 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A 1538 ' ' PHE . . . . . 0.473 ' CD1' HD13 ' A' 1552 ' ' ILE . 54.2 m-85 -106.34 135.94 46.94 Favored 'General case' 0 C--N 1.295 -1.802 0 N-CA-C 108.207 -1.034 . . . . 1.98 108.207 177.88 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A 1539 ' ' THR . . . . . . . . . . . . . 19.2 p -113.35 117.99 33.33 Favored 'General case' 0 C--N 1.292 -1.927 0 CA-C-N 116.128 -0.487 . . . . 1.97 111.352 -178.509 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A 1540 ' ' ALA . . . . . . . . . . . . . . . -122.43 124.33 43.39 Favored 'General case' 0 C--N 1.313 -1.015 0 N-CA-C 109.932 -0.396 . . . . 1.39 109.932 179.77 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A 1541 ' ' ALA . . . . . . . . . . . . . . . -74.18 144.63 44.72 Favored 'General case' 0 C--O 1.251 1.156 0 CA-C-O 120.654 0.264 . . . . 1.86 110.521 179.247 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A 1542 ' ' TYR . . . . . . . . . . . . . 27.4 t80 -149.16 -173.64 4.43 Favored 'General case' 0 N--CA 1.437 -1.114 0 N-CA-C 109.148 -0.686 . . . . 2.4 109.148 -176.276 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A 1543 ' ' SER . . . . . . . . . . . . . 13.9 m -45.99 -152.78 0.0 OUTLIER 'General case' 0 CA--C 1.569 1.7 0 C-N-CA 129.707 3.203 . . . . 2.58 115.063 -178.799 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A 1544 ' ' LYS . . . . . . . . . . . . . 55.9 tptt -47.24 -29.52 2.46 Favored 'General case' 0 N--CA 1.486 1.336 0 O-C-N 121.266 -0.897 . . . . 4.24 112.774 178.677 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A 1545 ' ' SER . . . . . . . . . . . . . 4.3 p -61.74 -22.64 65.55 Favored 'General case' 0 CA--C 1.556 1.207 0 C-N-CA 123.053 0.541 . . . . 3.6 112.202 175.048 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A 1546 ' ' GLY . . . . . . . . . . . . . . . 89.49 -69.72 2.49 Favored Glycine 0 N--CA 1.431 -1.666 0 N-CA-C 113.867 0.307 . . . . 1.66 113.867 173.664 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A 1547 ' ' VAL . . . . . . . . . . . . . 7.2 p -158.79 138.61 3.73 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.925 0 N-CA-C 109.787 -0.449 . . . . 2.23 109.787 -173.606 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A 1548 ' ' VAL . . . . . . . . . . . . . 2.4 t -103.0 134.88 42.89 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.601 0 N-CA-C 108.548 -0.908 . . . . 1.59 108.548 -177.563 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A 1549 ' ' TYR . . . . . . . . . . . . . 97.9 m-85 -104.02 121.89 44.11 Favored 'General case' 0 C--N 1.311 -1.096 0 N-CA-C 107.112 -1.44 . . . . 1.58 107.112 173.717 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A 1550 ' ' MET . . . . . 0.49 ' HE3' ' HB2' ' A' 1624 ' ' PRO . 71.5 mtm -131.07 122.17 26.27 Favored 'General case' 0 CA--C 1.488 -1.43 0 C-N-CA 120.217 -0.593 . . . . 2.08 112.195 177.913 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A 1551 ' ' SER . . . . . . . . . . . . . 53.2 m -103.03 105.17 15.44 Favored 'General case' 0 C--N 1.272 -2.803 0 N-CA-C 105.45 -2.056 . . . . 1.9 105.45 171.457 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A 1552 ' ' ILE . . . . . 0.491 ' O ' ' OH ' ' A' 1592 ' ' TYR . 1.7 mp -52.48 -35.34 20.22 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.813 0 O-C-N 124.112 0.883 . . . . 2.04 112.133 -176.456 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A 1553 ' ' CYS . . . . . . . . . . . . . 93.9 m -145.7 155.66 43.13 Favored 'General case' 0 C--N 1.307 -1.249 0 N-CA-C 109.152 -0.685 . . . . 1.43 109.152 174.924 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A 1554 ' ' GLY . . . . . . . . . . . . . . . 102.66 -118.32 6.07 Favored Glycine 0 N--CA 1.441 -1.031 0 N-CA-C 110.366 -1.094 . . . . 1.23 110.366 -179.917 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A 1555 ' ' GLU . . . . . . . . . . . . . 17.0 pt-20 -157.9 148.32 20.6 Favored 'General case' 0 C--N 1.311 -1.107 0 N-CA-C 107.741 -1.207 . . . . 1.8 107.741 176.769 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A 1556 ' ' ASN . . . . . . . . . . . . . 21.0 t-20 -97.05 118.86 34.4 Favored 'General case' 0 C--N 1.305 -1.329 0 CA-C-O 121.543 0.687 . . . . 2.63 110.277 -178.609 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A 1557 ' ' GLU . . . . . 0.833 ' HG3' ' HG3' ' A' 1535 ' ' ARG . 12.0 mm-40 -82.53 11.97 5.11 Favored 'General case' 0 C--N 1.298 -1.644 0 CA-C-N 114.65 -1.159 . . . . 3.79 112.956 -172.429 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A 1558 ' ' ASN . . . . . . . . . . . . . 39.2 m-80 -104.24 -9.02 18.92 Favored 'General case' 0 C--N 1.301 -1.528 0 O-C-N 121.726 -0.609 . . . . 1.59 110.662 -178.886 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A 1559 ' ' CYS . . . . . 0.695 ' HB3' ' HD2' ' A' 1560 ' ' PRO . 88.1 m -144.29 178.46 1.45 Allowed Pre-proline 0 C--N 1.302 -1.466 0 CA-C-O 117.199 -1.381 . . . . 0.94 108.154 -178.521 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A 1560 ' ' PRO . . . . . 0.695 ' HD2' ' HB3' ' A' 1559 ' ' CYS . 24.2 Cg_exo -29.4 125.69 0.05 OUTLIER 'Trans proline' 0 C--N 1.383 2.356 0 C-N-CA 124.772 3.648 . . . . 1.53 114.94 176.422 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A 1561 ' ' PRO . . . . . . . . . . . . . 51.2 Cg_exo -55.52 115.99 2.84 Favored 'Trans proline' 0 C--O 1.244 0.782 0 C-N-CA 123.445 2.764 . . . . 1.82 112.964 -177.126 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A 1562 ' ' GLY . . . . . . . . . . . . . . . 114.11 -10.34 22.65 Favored Glycine 0 N--CA 1.439 -1.122 0 C-N-CA 120.455 -0.878 . . . . 0.81 113.275 177.187 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A 1563 ' ' VAL . . . . . 0.549 ' HA ' ' HA ' ' A' 1576 ' ' LYS . 5.1 m -90.65 152.37 3.35 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.183 0 N-CA-C 107.189 -1.411 . . . . 1.73 107.189 176.635 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A 1564 ' ' GLY . . . . . . . . . . . . . . . -117.23 -19.06 5.24 Favored Glycine 0 C--N 1.306 -1.127 0 C-N-CA 119.451 -1.357 . . . . 0.72 113.74 -176.25 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A 1565 ' ' ALA . . . . . . . . . . . . . . . -126.37 123.23 37.49 Favored 'General case' 0 C--O 1.25 1.095 0 N-CA-C 109.385 -0.598 . . . . 1.14 109.385 -179.851 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A 1566 ' ' CYS . . . . . . . . . . . . . 49.3 t -151.69 146.78 26.03 Favored 'General case' 0 C--N 1.312 -1.035 0 C-N-CA 121.056 -0.258 . . . . 0.51 111.126 -177.096 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A 1567 ' ' PHE . . . . . . . . . . . . . 31.4 m-85 -94.05 123.68 37.57 Favored 'General case' 0 C--O 1.247 0.965 0 CA-C-N 116.101 -0.5 . . . . 1.22 109.677 177.836 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A 1568 ' ' GLY . . . . . . . . . . . . . . . 50.62 -140.82 19.74 Favored Glycine 0 C--N 1.321 -0.289 0 O-C-N 123.893 0.745 . . . . 1.08 114.719 175.517 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A 1569 ' ' GLN . . . . . . . . . . . . . 49.0 tt0 -90.87 -58.23 2.55 Favored 'General case' 0 N--CA 1.43 -1.444 0 N-CA-C 109.558 -0.534 . . . . 3.05 109.558 179.993 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A 1570 ' ' THR . . . . . . . . . . . . . 14.8 p -123.01 34.13 5.21 Favored 'General case' 0 C--N 1.312 -1.043 0 CA-C-N 115.892 -0.594 . . . . 2.44 112.473 -176.668 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A 1571 ' ' ARG . . . . . . . . . . . . . 7.5 mpt_? -97.5 12.03 34.76 Favored 'General case' 0 N--CA 1.432 -1.328 0 C-N-CA 119.388 -0.925 . . . . 4.48 110.765 175.691 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A 1572 ' ' ILE . . . . . 0.423 HG21 ' HB2' ' A' 1596 ' ' SER . 75.9 mt 80.97 144.51 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.548 0.894 0 CA-C-N 114.112 -1.404 . . . . 1.94 114.371 165.581 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A 1573 ' ' SER . . . . . . . . . . . . . 36.3 p -82.01 134.89 35.4 Favored 'General case' 0 N--CA 1.438 -1.072 0 CA-C-N 114.582 -1.19 . . . . 1.25 111.113 -179.242 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A 1574 ' ' VAL . . . . . . . . . . . . . 19.0 m -123.22 30.43 2.24 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.228 0 N-CA-C 112.611 0.597 . . . . 1.61 112.611 -177.553 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A 1575 ' ' GLY . . . . . . . . . . . . . . . 173.56 122.68 0.68 Allowed Glycine 0 N--CA 1.434 -1.434 0 C-N-CA 119.989 -1.1 . . . . 0.65 112.799 177.753 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A 1576 ' ' LYS . . . . . 0.549 ' HA ' ' HA ' ' A' 1563 ' ' VAL . 66.6 tttm -76.8 143.09 40.05 Favored 'General case' 0 C--O 1.246 0.914 0 N-CA-C 106.835 -1.543 . . . . 3.33 106.835 175.787 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A 1577 ' ' ALA . . . . . . . . . . . . . . . -77.04 82.63 3.55 Favored 'General case' 0 C--N 1.304 -1.412 0 CA-C-O 121.642 0.734 . . . . 1.31 111.7 -175.23 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A 1578 ' ' ASN . . . . . . . . . . . . . 41.6 m-80 -89.47 147.44 24.0 Favored 'General case' 0 C--N 1.306 -1.3 0 N-CA-C 108.058 -1.09 . . . . 2.24 108.058 175.243 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A 1579 ' ' LYS . . . . . 0.454 ' HB3' ' HB3' ' A' 1515 ' ' ASP . 58.7 mttp -95.14 89.67 5.62 Favored 'General case' 0 C--N 1.283 -2.299 0 N-CA-C 105.746 -1.946 . . . . 2.34 105.746 175.331 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A 1580 ' ' ARG . . . . . . . . . . . . . 42.1 ttm180 -140.32 101.14 4.06 Favored 'General case' 0 C--N 1.297 -1.703 0 CA-C-N 115.346 -0.843 . . . . 4.19 110.003 -173.607 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A 1581 ' ' LEU . . . . . . . . . . . . . 41.0 tp -117.4 145.02 44.38 Favored 'General case' 0 C--N 1.289 -2.054 0 CA-C-N 115.151 -0.931 . . . . 2.39 109.462 -177.39 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A 1582 ' ' ARG . . . . . . . . . . . . . 97.0 mtt180 -119.44 125.27 48.54 Favored 'General case' 0 C--N 1.297 -1.713 0 CA-C-N 115.656 -0.702 . . . . 4.48 109.984 -179.729 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A 1583 ' ' TYR . . . . . 0.414 ' HD1' ' CD2' ' A' 1588 ' ' LEU . 22.6 t80 -108.09 97.89 7.52 Favored 'General case' 0 C--N 1.296 -1.727 0 N-CA-C 108.547 -0.909 . . . . 1.57 108.547 174.49 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A 1584 ' ' VAL . . . . . . . . . . . . . 1.1 m -140.07 121.28 14.91 Favored 'Isoleucine or valine' 0 CA--C 1.499 -0.981 0 N-CA-C 112.697 0.628 . . . . 2.29 112.697 -178.079 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A 1585 ' ' ASP . . . . . . . . . . . . . 30.9 t70 56.67 45.04 22.73 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-O 122.334 1.064 . . . . 2.06 111.082 171.613 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A 1586 ' ' GLN . . . . . . . . . . . . . 21.5 mt-30 58.82 18.25 5.92 Favored 'General case' 0 C--N 1.323 -0.548 0 N-CA-C 115.068 1.507 . . . . 2.61 115.068 -178.871 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A 1587 ' ' VAL . . . . . . . . . . . . . 12.4 p -120.69 133.37 67.6 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.331 0 N-CA-C 107.619 -1.252 . . . . 1.33 107.619 172.86 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A 1588 ' ' LEU . . . . . 0.414 ' CD2' ' HD1' ' A' 1583 ' ' TYR . 16.6 mt -103.24 133.09 48.91 Favored 'General case' 0 C--N 1.296 -1.746 0 N-CA-C 108.277 -1.008 . . . . 2.03 108.277 -177.104 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A 1589 ' ' GLN . . . . . . . . . . . . . 35.0 tt0 -134.31 115.78 14.49 Favored 'General case' 0 C--N 1.275 -2.639 0 C-N-CA 120.39 -0.524 . . . . 1.73 110.442 -175.496 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A 1590 ' ' LEU . . . . . . . . . . . . . 8.7 tt -106.74 128.96 54.66 Favored 'General case' 0 C--N 1.293 -1.849 0 N-CA-C 107.411 -1.329 . . . . 1.76 107.411 -179.25 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A 1591 ' ' VAL . . . . . . . . . . . . . 61.4 t -119.26 126.89 75.76 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.808 0 N-CA-C 112.792 0.664 . . . . 2.14 112.792 -170.355 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A 1592 ' ' TYR . . . . . 0.604 ' HB2' ' HB3' ' A' 1608 ' ' SER . 9.7 m-30 -108.53 149.23 29.13 Favored 'General case' 0 C--N 1.31 -1.135 0 CA-C-N 114.986 -1.006 . . . . 1.53 109.44 174.487 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A 1593 ' ' LYS . . . . . . . . . . . . . 18.4 ptpt -159.47 177.37 11.02 Favored 'General case' 0 C--N 1.296 -1.741 0 N-CA-C 107.371 -1.344 . . . . 2.72 107.371 178.578 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A 1594 ' ' ASP . . . . . 0.406 ' O ' ' HB2' ' A' 1576 ' ' LYS . 3.8 m-20 65.62 76.76 0.32 Allowed 'General case' 0 N--CA 1.483 1.206 0 O-C-N 124.038 0.837 . . . . 1.45 112.399 179.046 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A 1595 ' ' GLY . . . . . . . . . . . . . . . -143.08 -73.4 0.03 OUTLIER Glycine 0 N--CA 1.432 -1.57 0 N-CA-C 110.879 -0.889 . . . . 0.83 110.879 176.865 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A 1596 ' ' SER . . . . . 0.423 ' HB2' HG21 ' A' 1572 ' ' ILE . 31.1 t -114.86 139.6 24.4 Favored Pre-proline 0 C--N 1.288 -2.077 0 N-CA-C 109.534 -0.543 . . . . 1.96 109.534 179.621 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A 1597 ' ' PRO . . . . . . . . . . . . . 23.2 Cg_exo -68.39 144.28 61.13 Favored 'Trans proline' 0 N--CA 1.445 -1.361 0 N-CA-C 106.435 -2.179 . . . . 1.34 106.435 168.527 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A 1598 ' ' CYS . . . . . . . . . . . . . 19.1 t -95.17 125.26 51.03 Favored Pre-proline 0 C--N 1.286 -2.173 0 C-N-CA 120.065 -0.654 . . . . 1.19 110.287 -175.795 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A 1599 ' ' PRO . . . . . . . . . . . . . 84.6 Cg_endo -88.38 -4.04 6.69 Favored 'Trans proline' 0 N--CA 1.456 -0.73 0 C-N-CA 122.807 2.338 . . . . 1.88 111.698 177.079 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A 1600 ' ' SER . . . . . . . . . . . . . 16.3 m -86.35 109.11 18.77 Favored 'General case' 0 N--CA 1.425 -1.68 0 CA-C-N 115.865 -0.607 . . . . 2.19 109.994 -178.874 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A 1601 ' ' LYS . . . . . 0.799 ' HD2' ' HA ' ' A' 1632 ' ' GLN . 67.0 mttm 67.67 -86.71 0.03 OUTLIER 'General case' 0 C--O 1.242 0.684 0 C-N-CA 124.067 0.947 . . . . 4.21 113.358 178.571 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A 1602 ' ' SER . . . . . 0.787 ' HB3' HD22 ' A' 1604 ' ' LEU . 29.1 t -96.66 150.47 20.63 Favored 'General case' 0 N--CA 1.422 -1.867 0 N-CA-C 108.781 -0.822 . . . . 3.82 108.781 -175.5 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A 1603 ' ' GLY . . . . . . . . . . . . . . . -83.64 59.61 4.95 Favored Glycine 0 N--CA 1.435 -1.43 0 N-CA-C 110.331 -1.108 . . . . 2.45 110.331 176.425 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A 1604 ' ' LEU . . . . . 0.787 HD22 ' HB3' ' A' 1602 ' ' SER . 2.0 pt? -105.32 -175.35 2.77 Favored 'General case' 0 C--N 1.302 -1.494 0 CA-C-N 115.704 -0.248 . . . . 2.06 110.82 -176.982 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A 1605 ' ' SER . . . . . . . . . . . . . 5.0 p -83.81 -176.19 6.17 Favored 'General case' 0 C--N 1.294 -1.829 0 CA-C-O 121.249 0.547 . . . . 1.75 111.25 -178.568 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A 1606 ' ' TYR . . . . . . . . . . . . . 5.1 m-85 -116.76 128.5 55.37 Favored 'General case' 0 CA--C 1.469 -2.144 0 N-CA-C 106.882 -1.525 . . . . 1.59 106.882 177.426 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A 1607 ' ' LYS . . . . . . . . . . . . . 20.6 ptmt -119.32 118.93 32.53 Favored 'General case' 0 N--CA 1.407 -2.618 0 CA-C-O 121.536 0.684 . . . . 2.21 110.204 -178.535 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A 1608 ' ' SER . . . . . 0.604 ' HB3' ' HB2' ' A' 1592 ' ' TYR . 33.4 t -103.5 106.8 17.41 Favored 'General case' 0 C--N 1.288 -2.083 0 N-CA-C 108.056 -1.09 . . . . 1.48 108.056 -177.277 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A 1609 ' ' VAL . . . . . . . . . . . . . 66.2 t -107.49 115.44 48.74 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.5 0 CA-C-O 121.012 0.434 . . . . 1.57 110.862 -176.597 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A 1610 ' ' ILE . . . . . 0.523 ' HA ' ' HB2' ' A' 1638 ' ' PHE . 3.3 mp -103.78 111.17 32.42 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.21 0 N-CA-C 108.074 -1.084 . . . . 1.47 108.074 178.095 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A 1611 ' ' SER . . . . . 0.527 ' O ' ' HA ' ' A' 1639 ' ' SER . 18.8 m -104.43 129.83 52.37 Favored 'General case' 0 C--N 1.303 -1.451 0 CA-C-O 121.368 0.604 . . . . 1.84 110.706 -179.858 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A 1612 ' ' PHE . . . . . 0.411 ' HB2' ' HB2' ' A' 1588 ' ' LEU . 92.2 m-85 -101.55 113.18 26.07 Favored 'General case' 0 C--N 1.292 -1.899 0 N-CA-C 108.342 -0.984 . . . . 0.86 108.342 -179.524 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A 1613 ' ' VAL . . . . . . . . . . . . . 92.2 t -106.43 132.18 54.28 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.176 0 N-CA-C 109.538 -0.541 . . . . 1.32 109.538 -176.594 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A 1614 ' ' CYS . . . . . . . . . . . . . 62.6 m -67.48 99.51 0.76 Allowed 'General case' 0 C--N 1.322 -0.611 0 CA-C-O 121.573 0.701 . . . . 1.39 112.526 -177.559 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A 1615 ' ' ARG . . . . . 0.453 ' HB3' ' HB3' ' A' 1641 ' ' HIS . 20.3 tpp180 -137.28 85.45 21.75 Favored Pre-proline 0 N--CA 1.429 -1.479 0 CA-C-N 114.851 -1.068 . . . . 4.34 108.164 176.352 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A 1616 ' ' PRO . . . . . 0.433 ' HA ' ' HB3' ' A' 1643 ' ' PRO . 16.4 Cg_exo -71.68 -13.22 29.66 Favored 'Trans proline' 0 C--N 1.357 0.984 0 C-N-CA 123.327 2.684 . . . . 1.5 110.227 178.153 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A 1617 ' ' GLU . . . . . 0.425 ' HB3' ' CD ' ' A' 1615 ' ' ARG . 43.7 tt0 . . . . . 0 C--N 1.304 -1.388 0 C-N-CA 126.067 1.747 . . . . 3.21 107.963 176.459 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A 1622 ' ' ASN . . . . . . . . . . . . . 29.1 t-20 . . . . . 0 N--CA 1.45 -0.455 0 N-CA-C 107.058 -1.46 . . . . 3.58 107.058 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A 1623 ' ' ARG . . . . . . . . . . . . . 4.9 ptp180 -153.12 164.49 20.2 Favored Pre-proline 0 C--N 1.301 -1.538 0 N-CA-C 108.887 -0.783 . . . . 4.09 108.887 -176.34 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A 1624 ' ' PRO . . . . . 0.49 ' HB2' ' HE3' ' A' 1550 ' ' MET . 22.7 Cg_exo -65.34 100.05 0.38 Allowed 'Trans proline' 0 C--N 1.361 1.234 0 C-N-CA 122.588 2.192 . . . . 2.86 110.813 177.059 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A 1625 ' ' MET . . . . . . . . . . . . . 23.4 ptp -108.72 148.65 30.14 Favored 'General case' 0 C--N 1.302 -1.457 0 CA-C-N 115.443 -0.798 . . . . 2.73 109.694 -177.17 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A 1626 ' ' LEU . . . . . 0.507 HD21 ' HB3' ' A' 1636 ' ' LEU . 38.1 mt -71.01 109.74 5.29 Favored 'General case' 0 C--N 1.309 -1.184 0 CA-C-N 115.978 -0.556 . . . . 1.94 110.369 174.667 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A 1627 ' ' ILE . . . . . . . . . . . . . 40.8 pt -92.4 -23.74 5.55 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.306 0 CA-C-N 115.115 -0.948 . . . . 1.75 109.185 177.321 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A 1628 ' ' SER . . . . . . . . . . . . . 51.1 m -154.53 149.84 27.13 Favored 'General case' 0 N--CA 1.428 -1.574 0 CA-C-N 115.452 -0.795 . . . . 1.85 109.403 -179.088 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A 1629 ' ' LEU . . . . . 0.728 HD13 ' HG ' ' A' 1636 ' ' LEU . 20.2 tp -143.28 112.25 6.59 Favored 'General case' 0 C--N 1.297 -1.701 0 N-CA-C 108.697 -0.853 . . . . 2.12 108.697 177.984 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A 1630 ' ' ASP . . . . . . . . . . . . . 13.4 t70 -100.26 108.15 20.15 Favored 'General case' 0 C--N 1.296 -1.728 0 N-CA-C 108.605 -0.887 . . . . 0.87 108.605 -178.26 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A 1631 ' ' LYS . . . . . . . . . . . . . 92.1 mttt -92.51 5.44 50.82 Favored 'General case' 0 C--N 1.293 -1.871 0 CA-C-O 120.947 0.403 . . . . 2.76 111.43 -177.293 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A 1632 ' ' GLN . . . . . 0.799 ' HA ' ' HD2' ' A' 1601 ' ' LYS . 33.5 mt-30 -85.55 -41.2 15.5 Favored 'General case' 0 N--CA 1.437 -1.098 0 N-CA-C 108.491 -0.929 . . . . 2.55 108.491 178.53 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A 1633 ' ' THR . . . . . . . . . . . . . 32.6 m -106.9 -2.44 21.3 Favored 'General case' 0 CA--C 1.564 1.516 0 CA-C-O 122.111 0.957 . . . . 1.92 110.256 176.917 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A 1634 ' ' CYS . . . . . . . . . . . . . 51.2 m 63.78 47.59 3.54 Favored 'General case' 0 N--CA 1.471 0.592 0 CA-C-O 122.675 1.226 . . . . 0.89 110.007 176.852 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A 1635 ' ' THR . . . . . . . . . . . . . 24.2 m -112.43 121.63 45.38 Favored 'General case' 0 N--CA 1.423 -1.824 0 CA-C-N 113.836 -1.529 . . . . 1.31 109.887 -175.774 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A 1636 ' ' LEU . . . . . 0.728 ' HG ' HD13 ' A' 1629 ' ' LEU . 5.5 mp -99.4 126.18 45.24 Favored 'General case' 0 C--N 1.305 -1.35 0 N-CA-C 108.812 -0.81 . . . . 1.97 108.812 179.061 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A 1637 ' ' PHE . . . . . . . . . . . . . 94.1 m-85 -108.08 94.82 5.28 Favored 'General case' 0 C--O 1.249 1.078 0 CA-C-O 121.012 0.434 . . . . 0.92 111.193 -177.774 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A 1638 ' ' PHE . . . . . 0.523 ' HB2' ' HA ' ' A' 1610 ' ' ILE . 99.7 m-85 -90.94 144.62 25.48 Favored 'General case' 0 CA--C 1.487 -1.458 0 N-CA-C 107.917 -1.142 . . . . 0.7 107.917 175.751 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A 1639 ' ' SER . . . . . 0.527 ' HA ' ' O ' ' A' 1611 ' ' SER . 66.8 m -141.7 133.08 26.62 Favored 'General case' 0 C--N 1.273 -2.737 0 CA-C-O 120.852 0.358 . . . . 1.46 111.187 177.267 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A 1640 ' ' TRP . . . . . 0.429 ' HZ3' HD13 ' A' 1532 ' ' LEU . 8.3 t90 -118.93 112.56 19.79 Favored 'General case' 0 N--CA 1.426 -1.674 0 N-CA-C 107.799 -1.186 . . . . 0.92 107.799 175.688 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A 1641 ' ' HIS . . . . . 0.453 ' HB3' ' HB3' ' A' 1615 ' ' ARG . 13.4 m170 -82.43 98.42 8.88 Favored 'General case' 0 C--N 1.297 -1.704 0 N-CA-C 107.315 -1.365 . . . . 3.18 107.315 175.311 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A 1642 ' ' THR . . . . . . . . . . . . . 9.2 t -143.1 147.81 42.49 Favored Pre-proline 0 C--N 1.305 -1.335 0 CA-C-N 115.406 -0.815 . . . . 1.48 111.394 -170.414 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A 1643 ' ' PRO . . . . . 0.433 ' HB3' ' HA ' ' A' 1616 ' ' PRO . 34.6 Cg_endo -70.11 -12.04 31.49 Favored 'Trans proline' 0 C--N 1.353 0.778 0 C-N-CA 123.067 2.511 . . . . 1.09 111.106 171.837 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A 1644 ' ' LEU . . . . . . . . . . . . . 94.1 mt -75.55 -6.32 49.66 Favored 'General case' 0 N--CA 1.465 0.291 0 CA-C-N 116.241 -0.436 . . . . 2.08 111.699 178.74 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A 1645 ' ' ALA . . . . . . . . . . . . . . . -81.11 -42.52 20.83 Favored 'General case' 0 C--N 1.318 -0.778 0 N-CA-C 108.745 -0.835 . . . . 1.37 108.745 175.791 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A 1646 ' ' CYS . . . . . 0.677 ' HA ' ' HE1' ' A' 1527 ' ' PHE . 19.3 p -169.44 116.45 0.59 Allowed 'General case' 0 N--CA 1.432 -1.348 0 N-CA-C 107.717 -1.216 . . . . 1.7 107.717 173.645 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A 1647 ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 . . . . . 0 C--N 1.309 -1.194 0 CA-C-N 116.088 -0.506 . . . . 2.92 109.779 179.17 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A 1515 ' ' ASP . . . . . . . . . . . . . 16.5 t70 . . . . . 0 CA--C 1.513 -0.478 0 N-CA-C 107.057 -1.46 . . . . 2.54 107.057 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A 1516 ' ' CYS . . . . . 0.637 ' HB3' ' HB2' ' A' 1529 ' ' LEU . 34.3 m -87.5 59.7 5.63 Favored 'General case' 0 C--N 1.305 -1.356 0 N-CA-C 109.556 -0.535 . . . . 1.25 109.556 -177.283 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A 1517 ' ' GLN . . . . . 0.482 ' HA ' ' O ' ' A' 1527 ' ' PHE . 11.3 pt20 -148.41 138.54 22.49 Favored 'General case' 0 C--N 1.306 -1.292 0 N-CA-C 109.211 -0.662 . . . . 2.36 109.211 -179.785 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A 1518 ' ' VAL . . . . . . . . . . . . . 10.1 p -144.57 133.31 18.17 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.889 0 CA-C-O 120.921 0.391 . . . . 2.34 110.258 179.326 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A 1519 ' ' THR . . . . . 0.488 ' O ' ' HD3' ' A' 1521 ' ' PRO . 21.4 m -93.8 128.98 40.34 Favored 'General case' 0 C--N 1.292 -1.926 0 N-CA-C 108.926 -0.768 . . . . 2.04 108.926 179.158 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A 1520 ' ' ASN . . . . . . . . . . . . . 22.8 t30 -101.71 94.84 4.68 Favored Pre-proline 0 C--N 1.314 -0.974 0 N-CA-C 108.722 -0.844 . . . . 2.12 108.722 172.501 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A 1521 ' ' PRO . . . . . 0.488 ' HD3' ' O ' ' A' 1519 ' ' THR . 52.8 Cg_exo -55.27 -20.87 26.6 Favored 'Trans proline' 0 C--N 1.365 1.399 0 C-N-CA 123.68 2.92 . . . . 2.59 114.242 -177.257 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A 1522 ' ' SER . . . . . . . . . . . . . 19.9 t -64.47 -30.01 71.05 Favored 'General case' 0 CA--C 1.549 0.927 0 CA-C-O 120.834 0.349 . . . . 2.65 111.099 178.573 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A 1523 ' ' THR . . . . . . . . . . . . . 8.8 t -122.82 -14.84 7.59 Favored 'General case' 0 CA--C 1.545 0.753 0 C-N-CA 120.484 -0.487 . . . . 2.33 110.611 178.257 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A 1524 ' ' GLY . . . . . . . . . . . . . . . 89.22 -13.96 62.12 Favored Glycine 0 C--O 1.22 -0.744 0 CA-C-N 116.394 -0.366 . . . . 1.96 113.805 177.202 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A 1525 ' ' HIS . . . . . . . . . . . . . 13.7 t-160 -79.31 127.62 32.3 Favored 'General case' 0 C--N 1.311 -1.068 0 CA-C-O 121.289 0.566 . . . . 2.44 111.862 -175.616 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A 1526 ' ' LEU . . . . . 0.456 HD11 ' HB2' ' A' 1517 ' ' GLN . 41.9 tp -84.67 127.61 34.18 Favored 'General case' 0 C--N 1.315 -0.927 0 CA-C-N 114.685 -1.143 . . . . 2.19 107.969 173.084 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A 1527 ' ' PHE . . . . . 0.482 ' O ' ' HA ' ' A' 1517 ' ' GLN . 70.9 m-85 -99.01 119.02 37.09 Favored 'General case' 0 C--N 1.288 -2.073 0 N-CA-C 108.831 -0.803 . . . . 1.61 108.831 178.398 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A 1528 ' ' ASP . . . . . . . . . . . . . 10.9 t70 -105.24 124.18 49.11 Favored 'General case' 0 CA--C 1.487 -1.469 0 CA-C-O 121.189 0.518 . . . . 2.18 110.316 179.314 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A 1529 ' ' LEU . . . . . 0.637 ' HB2' ' HB3' ' A' 1516 ' ' CYS . 69.8 mt -108.59 -19.8 13.31 Favored 'General case' 0 C--N 1.294 -1.831 0 CA-C-N 114.922 -1.036 . . . . 2.04 108.914 177.213 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A 1530 ' ' SER . . . . . 0.415 ' OG ' ' HB2' ' A' 1516 ' ' CYS . 24.9 m -57.85 -37.87 74.65 Favored 'General case' 0 C--O 1.24 0.566 0 C-N-CA 123.626 0.77 . . . . 1.44 112.763 -176.634 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A 1531 ' ' SER . . . . . . . . . . . . . 50.5 p -87.43 1.07 54.49 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-O 120.906 0.384 . . . . 1.63 111.625 178.948 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A 1532 ' ' LEU . . . . . . . . . . . . . 96.1 mt -88.13 14.76 8.54 Favored 'General case' 0 CA--C 1.544 0.726 0 N-CA-C 113.12 0.785 . . . . 2.32 113.12 179.394 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A 1533 ' ' SER . . . . . . . . . . . . . 46.1 m -113.38 108.78 17.69 Favored 'General case' 0 C--N 1.314 -0.964 0 O-C-N 121.591 -0.693 . . . . 2.57 110.898 178.84 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A 1534 ' ' GLY . . . . . . . . . . . . . . . -86.08 -127.29 2.01 Favored Glycine 0 C--O 1.22 -0.743 0 C-N-CA 120.69 -0.767 . . . . 1.89 111.499 176.714 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A 1535 ' ' ARG . . . . . . . . . . . . . 19.4 tpt180 -83.18 -52.8 6.29 Favored 'General case' 0 C--N 1.311 -1.081 0 CA-C-N 117.108 0.454 . . . . 4.44 109.958 178.36 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A 1536 ' ' ALA . . . . . 0.418 ' HB3' ' HD1' ' A' 1549 ' ' TYR . . . -96.12 -21.48 17.9 Favored 'General case' 0 C--N 1.312 -1.064 0 CA-C-O 121.216 0.531 . . . . 2.07 109.623 178.944 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A 1537 ' ' GLY . . . . . . . . . . . . . . . 90.66 -92.16 1.74 Allowed Glycine 0 N--CA 1.425 -2.058 0 N-CA-C 108.057 -2.017 . . . . 1.2 108.057 -175.925 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A 1538 ' ' PHE . . . . . . . . . . . . . 47.2 m-85 -136.85 158.32 44.73 Favored 'General case' 0 C--N 1.295 -1.799 0 N-CA-C 109.151 -0.685 . . . . 1.98 109.151 174.17 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A 1539 ' ' THR . . . . . . . . . . . . . 5.8 p -127.99 142.97 51.09 Favored 'General case' 0 C--N 1.296 -1.737 0 CA-C-N 116.506 -0.315 . . . . 1.97 111.295 -176.878 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A 1540 ' ' ALA . . . . . . . . . . . . . . . -131.21 140.12 49.82 Favored 'General case' 0 C--N 1.302 -1.479 0 N-CA-C 109.416 -0.587 . . . . 1.39 109.416 176.796 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A 1541 ' ' ALA . . . . . . . . . . . . . . . -86.21 133.43 33.85 Favored 'General case' 0 C--N 1.312 -1.034 0 N-CA-C 108.107 -1.071 . . . . 1.86 108.107 178.642 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A 1542 ' ' TYR . . . . . 0.613 ' HD2' ' HB2' ' A' 1545 ' ' SER . 76.6 t80 -136.12 166.56 23.11 Favored 'General case' 0 C--N 1.301 -1.531 0 N-CA-C 109.448 -0.575 . . . . 2.4 109.448 -175.747 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A 1543 ' ' SER . . . . . . . . . . . . . 16.0 t -48.67 -150.32 0.0 OUTLIER 'General case' 0 CA--C 1.577 1.997 0 C-N-CA 127.916 2.486 . . . . 2.58 112.886 176.229 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A 1544 ' ' LYS . . . . . . . . . . . . . 95.7 mttt -38.92 -30.75 0.05 Allowed 'General case' 0 CA--C 1.567 1.62 0 C-N-CA 124.986 1.314 . . . . 4.24 114.442 -178.619 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A 1545 ' ' SER . . . . . 0.613 ' HB2' ' HD2' ' A' 1542 ' ' TYR . 15.3 m -72.59 -10.69 60.1 Favored 'General case' 0 CA--C 1.579 2.076 0 N-CA-C 112.617 0.599 . . . . 3.6 112.617 177.254 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A 1546 ' ' GLY . . . . . . . . . . . . . . . 85.2 -80.15 1.84 Allowed Glycine 0 C--O 1.244 0.725 0 N-CA-C 115.049 0.78 . . . . 1.66 115.049 171.965 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A 1547 ' ' VAL . . . . . . . . . . . . . 7.8 p -146.39 143.09 21.06 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.475 0 CA-C-O 120.997 0.427 . . . . 2.23 109.914 -174.126 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A 1548 ' ' VAL . . . . . . . . . . . . . 2.1 t -109.86 135.1 49.9 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.414 0 N-CA-C 107.979 -1.119 . . . . 1.59 107.979 -179.058 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A 1549 ' ' TYR . . . . . 0.418 ' CE2' ' HA3' ' A' 1568 ' ' GLY . 80.1 m-85 -100.63 131.19 46.67 Favored 'General case' 0 C--N 1.313 -1.006 0 N-CA-C 106.522 -1.659 . . . . 1.58 106.522 173.266 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A 1550 ' ' MET . . . . . . . . . . . . . 68.1 mtp -126.08 122.44 35.8 Favored 'General case' 0 C--N 1.298 -1.647 0 CA-C-N 116.569 -0.287 . . . . 2.08 110.242 -171.436 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A 1551 ' ' SER . . . . . 0.619 ' CB ' ' HB3' ' A' 1556 ' ' ASN . 19.6 p -105.83 133.37 50.67 Favored 'General case' 0 N--CA 1.419 -1.997 0 CA-C-O 122.082 0.944 . . . . 1.9 111.1 -179.514 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A 1552 ' ' ILE . . . . . 0.438 HG22 ' SG ' ' A' 1553 ' ' CYS . 1.7 mp -76.38 -42.88 36.46 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.023 0 CA-C-N 114.355 -1.293 . . . . 2.04 111.499 -176.943 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A 1553 ' ' CYS . . . . . 0.438 ' SG ' HG22 ' A' 1552 ' ' ILE . 46.5 m -130.92 135.99 48.18 Favored 'General case' 0 C--N 1.307 -1.243 0 N-CA-C 108.636 -0.876 . . . . 1.43 108.636 174.626 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A 1554 ' ' GLY . . . . . 0.422 ' HA2' ' HB3' ' A' 1577 ' ' ALA . . . 54.57 -155.74 7.88 Favored Glycine 0 C--O 1.247 0.928 0 O-C-N 124.46 1.1 . . . . 1.23 111.981 179.371 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A 1555 ' ' GLU . . . . . 0.442 ' HG2' ' HA ' ' A' 1561 ' ' PRO . 0.4 OUTLIER -89.9 146.66 24.25 Favored 'General case' 0 N--CA 1.413 -2.295 0 C-N-CA 119.056 -1.058 . . . . 1.8 108.945 170.924 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A 1556 ' ' ASN . . . . . 0.619 ' HB3' ' CB ' ' A' 1551 ' ' SER . 4.3 t30 -170.37 61.41 0.04 OUTLIER 'General case' 0 C--N 1.282 -2.347 0 N-CA-C 107.388 -1.338 . . . . 2.63 107.388 -171.65 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A 1557 ' ' GLU . . . . . 0.569 ' CD ' ' H ' ' A' 1558 ' ' ASN 0.388 0.3 OUTLIER -157.58 -119.92 0.02 OUTLIER 'General case' 0 CA--C 1.553 1.09 0 N-CA-C 116.101 1.889 . . . . 3.79 116.101 -177.402 . . . . . . . . 4 4 . 1 . 013 nuclear orig core ' A' A 1558 ' ' ASN . . . . . 0.569 ' H ' ' CD ' ' A' 1557 ' ' GLU . 40.4 m-80 -139.6 -5.68 1.36 Allowed 'General case' 0 CA--C 1.55 0.96 0 N-CA-C 113.029 0.752 . . . . 1.59 113.029 -175.849 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A 1559 ' ' CYS . . . . . 0.474 ' HB3' ' HD2' ' A' 1560 ' ' PRO . 43.7 m -91.36 170.22 10.03 Favored Pre-proline 0 C--N 1.317 -0.809 0 CA-C-O 119.161 -0.447 . . . . 0.94 109.937 179.015 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A 1560 ' ' PRO . . . . . 0.474 ' HD2' ' HB3' ' A' 1559 ' ' CYS . 91.6 Cg_exo -45.83 129.01 11.66 Favored 'Trans proline' 0 C--N 1.364 1.374 0 C-N-CA 122.853 2.369 . . . . 1.53 111.348 174.633 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A 1561 ' ' PRO . . . . . 0.442 ' HA ' ' HG2' ' A' 1555 ' ' GLU . 53.3 Cg_exo -56.21 115.65 2.62 Favored 'Trans proline' 0 C--O 1.241 0.642 0 C-N-CA 123.268 2.646 . . . . 1.82 112.505 -178.133 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A 1562 ' ' GLY . . . . . . . . . . . . . . . 155.05 -21.43 0.58 Allowed Glycine 0 N--CA 1.443 -0.881 0 N-CA-C 111.619 -0.593 . . . . 0.81 111.619 -179.08 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A 1563 ' ' VAL . . . . . 0.42 ' HA ' ' HA ' ' A' 1576 ' ' LYS . 25.6 m -80.68 161.21 3.92 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.121 0 CA-C-O 121.486 0.66 . . . . 1.73 111.885 178.004 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A 1564 ' ' GLY . . . . . 0.588 ' HA3' ' CD2' ' A' 1592 ' ' TYR . . . -119.98 0.14 13.28 Favored Glycine 0 N--CA 1.424 -2.142 0 N-CA-C 108.845 -1.702 . . . . 0.72 108.845 166.718 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A 1565 ' ' ALA . . . . . . . . . . . . . . . -170.22 125.54 0.77 Allowed 'General case' 0 C--O 1.246 0.911 0 N-CA-C 108.511 -0.922 . . . . 1.14 108.511 178.312 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A 1566 ' ' CYS . . . . . . . . . . . . . 48.8 t -149.98 145.01 26.2 Favored 'General case' 0 C--N 1.309 -1.159 0 C-N-CA 121.141 -0.224 . . . . 0.51 110.45 -175.513 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A 1567 ' ' PHE . . . . . . . . . . . . . 26.8 m-85 -69.87 124.17 23.35 Favored 'General case' 0 C--O 1.217 -0.656 0 N-CA-C 107.548 -1.279 . . . . 1.22 107.548 174.179 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A 1568 ' ' GLY . . . . . 0.418 ' HA3' ' CE2' ' A' 1549 ' ' TYR . . . -70.06 -31.53 69.45 Favored Glycine 0 CA--C 1.498 -1.001 0 C-N-CA 121.02 -0.609 . . . . 1.08 114.032 -173.667 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A 1569 ' ' GLN . . . . . . . . . . . . . 34.5 tt0 -84.57 -53.24 5.53 Favored 'General case' 0 C--N 1.304 -1.394 0 CA-C-O 121.444 0.64 . . . . 3.05 109.853 -179.219 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A 1570 ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -77.19 -23.73 51.45 Favored 'General case' 0 C--N 1.307 -1.25 0 CA-C-N 115.133 -0.939 . . . . 2.44 113.019 -173.177 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A 1571 ' ' ARG . . . . . . . . . . . . . 91.5 mtt180 60.97 36.57 18.64 Favored 'General case' 0 CA--C 1.511 -0.548 0 C-N-CA 125.02 1.328 . . . . 4.48 113.39 179.101 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A 1572 ' ' ILE . . . . . . . . . . . . . 44.0 mm -106.0 122.62 59.86 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.131 0 N-CA-C 108.462 -0.94 . . . . 1.94 108.462 179.473 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A 1573 ' ' SER . . . . . . . . . . . . . 41.5 t -66.86 128.54 36.71 Favored 'General case' 0 C--N 1.308 -1.239 0 C-N-CA 124.231 1.012 . . . . 1.25 111.201 179.562 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A 1574 ' ' VAL . . . . . 0.513 ' HA ' ' HB2' ' A' 1606 ' ' TYR . 35.4 m -118.8 18.01 6.8 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.236 0 CA-C-O 122.023 0.916 . . . . 1.61 110.335 178.004 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A 1575 ' ' GLY . . . . . . . . . . . . . . . 167.25 123.64 0.67 Allowed Glycine 0 N--CA 1.43 -1.725 0 CA-C-N 114.299 -1.319 . . . . 0.65 109.941 178.339 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A 1576 ' ' LYS . . . . . 0.42 ' HA ' ' HA ' ' A' 1563 ' ' VAL . 62.0 mttp -84.32 153.72 23.34 Favored 'General case' 0 CA--C 1.498 -1.021 0 CA-C-O 121.201 0.524 . . . . 3.33 110.427 179.478 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A 1577 ' ' ALA . . . . . 0.471 ' HA ' ' CE2' ' A' 1592 ' ' TYR . . . -59.65 104.23 0.26 Allowed 'General case' 0 C--N 1.307 -1.244 0 CA-C-N 114.025 -1.443 . . . . 1.31 111.287 178.028 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A 1578 ' ' ASN . . . . . . . . . . . . . 45.7 m-80 -135.32 123.05 22.33 Favored 'General case' 0 C--N 1.301 -1.502 0 N-CA-C 105.974 -1.862 . . . . 2.24 105.974 177.027 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A 1579 ' ' LYS . . . . . . . . . . . . . 36.6 ttpt -94.34 89.8 6.03 Favored 'General case' 0 C--N 1.285 -2.227 0 N-CA-C 108.388 -0.967 . . . . 2.34 108.388 -174.583 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A 1580 ' ' ARG . . . . . . . . . . . . . 72.8 ttt180 -127.64 109.86 12.1 Favored 'General case' 0 N--CA 1.419 -1.991 0 CA-C-N 114.631 -1.168 . . . . 4.19 109.128 -179.095 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A 1581 ' ' LEU . . . . . 0.449 HD11 ' N ' ' A' 1582 ' ' ARG . 2.3 tm? -96.25 141.94 29.0 Favored 'General case' 0 C--N 1.3 -1.563 0 CA-C-N 114.649 -1.16 . . . . 2.39 108.143 -177.868 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A 1582 ' ' ARG . . . . . 0.449 ' N ' HD11 ' A' 1581 ' ' LEU . 4.7 tpt180 -145.84 141.79 28.22 Favored 'General case' 0 C--N 1.304 -1.376 0 N-CA-C 108.638 -0.875 . . . . 4.48 108.638 173.274 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A 1583 ' ' TYR . . . . . . . . . . . . . 46.9 t80 -137.05 103.58 5.18 Favored 'General case' 0 C--N 1.321 -0.645 0 N-CA-C 109.206 -0.665 . . . . 1.57 109.206 179.051 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A 1584 ' ' VAL . . . . . . . . . . . . . 26.9 m -134.69 140.26 45.97 Favored 'Isoleucine or valine' 0 C--O 1.201 -1.453 0 N-CA-C 109.64 -0.504 . . . . 2.29 109.64 -178.484 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A 1585 ' ' ASP . . . . . . . . . . . . . 8.9 t70 43.98 52.46 6.73 Favored 'General case' 0 N--CA 1.492 1.646 0 C-N-CA 125.06 1.344 . . . . 2.06 113.088 175.184 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A 1586 ' ' GLN . . . . . . . . . . . . . 19.0 mm-40 61.93 22.39 13.02 Favored 'General case' 0 CA--C 1.553 1.091 0 C-N-CA 123.89 0.876 . . . . 2.61 112.853 178.815 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A 1587 ' ' VAL . . . . . 0.499 HG23 ' O ' ' A' 1612 ' ' PHE . 9.4 p -134.06 125.02 47.71 Favored 'Isoleucine or valine' 0 C--O 1.245 0.833 0 O-C-N 121.455 -0.778 . . . . 1.33 111.785 177.451 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A 1588 ' ' LEU . . . . . 0.698 ' HB2' ' HB2' ' A' 1612 ' ' PHE . 79.3 mt -85.99 155.31 20.92 Favored 'General case' 0 C--N 1.313 -1.0 0 CA-C-N 114.942 -1.026 . . . . 2.03 110.731 177.314 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A 1589 ' ' GLN . . . . . 0.488 ' HA ' ' O ' ' A' 1610 ' ' ILE . 6.9 tt0 -150.4 133.36 16.06 Favored 'General case' 0 C--N 1.318 -0.795 0 N-CA-C 112.33 0.493 . . . . 1.73 112.33 -179.447 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A 1590 ' ' LEU . . . . . 0.616 ' HG ' ' HE1' ' A' 1612 ' ' PHE . 96.0 mt -104.0 125.52 50.43 Favored 'General case' 0 C--O 1.248 1.006 0 N-CA-C 106.982 -1.488 . . . . 1.76 106.982 172.068 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A 1591 ' ' VAL . . . . . . . . . . . . . 40.4 t -105.72 102.56 14.05 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.498 0 C-N-CA 120.757 -0.377 . . . . 2.14 110.119 179.827 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A 1592 ' ' TYR . . . . . 0.588 ' CD2' ' HA3' ' A' 1564 ' ' GLY . 27.7 m-85 -117.55 92.96 3.98 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-O 121.379 0.609 . . . . 1.53 109.422 177.788 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A 1593 ' ' LYS . . . . . . . . . . . . . 21.3 pttp -110.85 -177.55 3.25 Favored 'General case' 0 C--N 1.305 -1.358 0 N-CA-C 112.569 0.581 . . . . 2.72 112.569 -175.901 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A 1594 ' ' ASP . . . . . . . . . . . . . 18.2 m-20 52.77 59.43 4.48 Favored 'General case' 0 N--CA 1.466 0.355 0 C-N-CA 124.931 1.292 . . . . 1.45 113.598 175.212 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A 1595 ' ' GLY . . . . . 0.404 ' HA2' ' HG3' ' A' 1576 ' ' LYS . . . -83.34 -107.35 0.51 Allowed Glycine 0 N--CA 1.438 -1.167 0 C-N-CA 120.517 -0.849 . . . . 0.83 111.719 177.631 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A 1596 ' ' SER . . . . . . . . . . . . . 23.0 t -106.23 145.47 31.04 Favored Pre-proline 0 C--N 1.291 -1.94 0 N-CA-C 107.545 -1.279 . . . . 1.96 107.545 -179.839 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A 1597 ' ' PRO . . . . . . . . . . . . . 77.3 Cg_exo -53.29 134.21 55.95 Favored 'Trans proline' 0 C--N 1.362 1.286 0 C-N-CA 123.558 2.839 . . . . 1.34 111.523 178.654 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A 1598 ' ' CYS . . . . . . . . . . . . . 50.6 t -95.05 125.66 49.75 Favored Pre-proline 0 C--N 1.289 -2.042 0 CA-C-N 115.41 -0.814 . . . . 1.19 109.883 -173.569 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A 1599 ' ' PRO . . . . . . . . . . . . . 58.4 Cg_endo -71.86 -13.91 29.45 Favored 'Trans proline' 0 C--N 1.346 0.395 0 C-N-CA 122.971 2.447 . . . . 1.88 112.497 -179.375 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A 1600 ' ' SER . . . . . . . . . . . . . 19.3 m -74.3 -20.46 60.11 Favored 'General case' 0 N--CA 1.439 -1.002 0 CA-C-N 116.019 -0.537 . . . . 2.19 111.06 179.984 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A 1601 ' ' LYS . . . . . . . . . . . . . 20.9 tptm -156.68 104.13 2.14 Favored 'General case' 0 N--CA 1.433 -1.314 0 N-CA-C 109.052 -0.721 . . . . 4.21 109.052 177.109 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A 1602 ' ' SER . . . . . . . . . . . . . 7.4 p -61.27 107.41 0.75 Allowed 'General case' 0 C--N 1.303 -1.432 0 CA-C-N 115.294 -0.866 . . . . 3.82 112.086 -178.654 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A 1603 ' ' GLY . . . . . . . . . . . . . . . 136.13 -5.38 3.93 Favored Glycine 0 N--CA 1.434 -1.498 0 C-N-CA 120.576 -0.821 . . . . 2.45 113.367 177.91 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A 1604 ' ' LEU . . . . . . . . . . . . . 3.0 pp -140.27 161.81 36.77 Favored 'General case' 0 C--N 1.311 -1.092 0 CA-C-N 117.586 0.693 . . . . 2.06 112.067 -178.727 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A 1605 ' ' SER . . . . . . . . . . . . . 21.7 m -102.78 -174.99 2.69 Favored 'General case' 0 C--N 1.307 -1.259 0 N-CA-C 109.062 -0.718 . . . . 1.75 109.062 178.016 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A 1606 ' ' TYR . . . . . 0.513 ' HB2' ' HA ' ' A' 1574 ' ' VAL . 96.1 m-85 -95.34 153.36 17.72 Favored 'General case' 0 CA--C 1.472 -2.036 0 N-CA-C 105.768 -1.938 . . . . 1.59 105.768 179.495 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A 1607 ' ' LYS . . . . . 0.461 ' HG3' HG22 ' A' 1635 ' ' THR . 25.2 pttm -137.63 146.44 43.93 Favored 'General case' 0 N--CA 1.403 -2.783 0 C-N-CA 118.634 -1.226 . . . . 2.21 110.202 173.054 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A 1608 ' ' SER . . . . . . . . . . . . . 49.9 m -118.69 126.7 52.48 Favored 'General case' 0 C--N 1.305 -1.336 0 CA-C-O 121.235 0.541 . . . . 1.48 110.845 -179.174 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A 1609 ' ' VAL . . . . . . . . . . . . . 56.2 t -111.23 116.91 53.79 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.932 0 N-CA-C 109.565 -0.531 . . . . 1.57 109.565 177.798 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A 1610 ' ' ILE . . . . . 0.56 ' HB ' ' HB2' ' A' 1590 ' ' LEU . 29.3 mm -92.52 111.65 24.72 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.989 0 N-CA-C 108.652 -0.87 . . . . 1.47 108.652 177.349 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A 1611 ' ' SER . . . . . . . . . . . . . 6.3 m -102.67 119.54 39.01 Favored 'General case' 0 C--N 1.29 -2.015 0 N-CA-C 108.146 -1.057 . . . . 1.84 108.146 179.386 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A 1612 ' ' PHE . . . . . 0.698 ' HB2' ' HB2' ' A' 1588 ' ' LEU . 69.5 m-85 -91.47 105.3 17.66 Favored 'General case' 0 C--N 1.297 -1.699 0 N-CA-C 109.196 -0.668 . . . . 0.86 109.196 -178.833 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A 1613 ' ' VAL . . . . . 0.512 ' O ' ' HA ' ' A' 1641 ' ' HIS . 56.6 t -99.09 124.96 52.66 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.164 0 CA-C-N 115.868 -0.605 . . . . 1.32 109.587 -175.672 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A 1614 ' ' CYS . . . . . 0.441 ' SG ' ' HB2' ' A' 1645 ' ' ALA . 34.5 m -71.14 93.97 1.1 Allowed 'General case' 0 C--N 1.304 -1.401 0 CA-C-O 121.505 0.669 . . . . 1.39 112.711 -178.192 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A 1615 ' ' ARG . . . . . 0.689 ' HB3' ' HB2' ' A' 1641 ' ' HIS . 28.5 ttm180 -136.15 92.61 15.81 Favored Pre-proline 0 C--N 1.307 -1.264 0 CA-C-N 115.361 -0.836 . . . . 4.34 110.562 176.607 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A 1616 ' ' PRO . . . . . 0.472 ' HB3' ' HB3' ' A' 1643 ' ' PRO . 12.0 Cg_exo -75.42 18.59 0.57 Allowed 'Trans proline' 0 CA--C 1.535 0.574 0 C-N-CA 123.558 2.839 . . . . 1.5 112.895 176.925 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A 1617 ' ' GLU . . . . . . . . . . . . . 42.3 mt-10 . . . . . 0 C--N 1.312 -1.026 0 CA-C-O 120.971 0.415 . . . . 3.21 110.285 -178.613 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A 1622 ' ' ASN . . . . . . . . . . . . . 49.5 t-20 . . . . . 0 C--O 1.243 0.711 0 N-CA-C 107.231 -1.396 . . . . 3.58 107.231 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A 1623 ' ' ARG . . . . . . . . . . . . . 16.2 ptm180 -147.89 153.64 42.58 Favored Pre-proline 0 N--CA 1.437 -1.089 0 CA-C-N 114.996 -1.002 . . . . 4.09 108.805 -174.943 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A 1624 ' ' PRO . . . . . 0.498 ' HA ' ' HA ' ' A' 1640 ' ' TRP . 8.1 Cg_exo -73.77 111.01 3.19 Favored 'Trans proline' 0 C--O 1.238 0.519 0 C-N-CA 122.705 2.27 . . . . 2.86 110.75 178.581 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A 1625 ' ' MET . . . . . 0.462 ' HE1' HG23 ' A' 1627 ' ' ILE . 26.7 ptt? -100.15 154.3 18.55 Favored 'General case' 0 C--N 1.303 -1.418 0 CA-C-N 116.026 -0.534 . . . . 2.73 109.846 -178.041 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A 1626 ' ' LEU . . . . . . . . . . . . . 56.4 tp -87.4 106.92 18.29 Favored 'General case' 0 C--N 1.301 -1.51 0 N-CA-C 108.747 -0.835 . . . . 1.94 108.747 -179.036 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A 1627 ' ' ILE . . . . . 0.462 HG23 ' HE1' ' A' 1625 ' ' MET . 2.8 pp -85.83 -36.02 10.16 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.205 0 C-N-CA 119.921 -0.712 . . . . 1.75 112.758 -177.272 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A 1628 ' ' SER . . . . . . . . . . . . . 49.3 m -157.67 143.92 17.65 Favored 'General case' 0 C--N 1.316 -0.86 0 N-CA-C 110.155 -0.313 . . . . 1.85 110.155 179.428 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A 1629 ' ' LEU . . . . . 0.907 ' HG ' ' HG ' ' A' 1636 ' ' LEU . 5.1 tt -130.33 118.53 21.41 Favored 'General case' 0 C--N 1.301 -1.506 0 N-CA-C 106.343 -1.725 . . . . 2.12 106.343 176.183 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A 1630 ' ' ASP . . . . . . . . . . . . . 20.1 t70 -93.36 117.25 29.86 Favored 'General case' 0 C--N 1.29 -2.005 0 N-CA-C 108.541 -0.911 . . . . 0.87 108.541 178.82 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A 1631 ' ' LYS . . . . . . . . . . . . . 95.7 mttt -83.37 1.52 40.94 Favored 'General case' 0 C--N 1.314 -0.937 0 N-CA-C 112.445 0.535 . . . . 2.76 112.445 -174.983 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A 1632 ' ' GLN . . . . . . . . . . . . . 1.5 mp0 -96.68 -45.7 6.59 Favored 'General case' 0 C--N 1.315 -0.905 0 CA-C-O 121.359 0.6 . . . . 2.55 110.318 -178.424 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A 1633 ' ' THR . . . . . . . . . . . . . 41.6 p -95.39 -5.99 41.97 Favored 'General case' 0 C--N 1.305 -1.348 0 CA-C-O 121.793 0.806 . . . . 1.92 110.286 177.87 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A 1634 ' ' CYS . . . . . . . . . . . . . 83.4 m 56.69 51.33 11.17 Favored 'General case' 0 C--N 1.347 0.475 0 CA-C-N 113.569 -1.65 . . . . 0.89 110.789 -179.394 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A 1635 ' ' THR . . . . . 0.461 HG22 ' HG3' ' A' 1607 ' ' LYS . 24.8 m -111.54 124.36 52.13 Favored 'General case' 0 N--CA 1.425 -1.723 0 CA-C-N 114.109 -1.405 . . . . 1.31 109.651 -176.093 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A 1636 ' ' LEU . . . . . 0.907 ' HG ' ' HG ' ' A' 1629 ' ' LEU . 5.1 mp -105.83 126.72 52.5 Favored 'General case' 0 C--N 1.309 -1.186 0 N-CA-C 109.481 -0.563 . . . . 1.97 109.481 178.519 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A 1637 ' ' PHE . . . . . . . . . . . . . 91.0 m-85 -105.91 111.46 24.11 Favored 'General case' 0 C--N 1.31 -1.139 0 CA-C-N 116.135 -0.484 . . . . 0.92 110.232 -178.831 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A 1638 ' ' PHE . . . . . . . . . . . . . 94.8 m-85 -106.42 128.25 53.91 Favored 'General case' 0 C--N 1.303 -1.436 0 N-CA-C 109.432 -0.581 . . . . 0.7 109.432 178.988 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A 1639 ' ' SER . . . . . . . . . . . . . 67.2 m -112.75 114.64 27.3 Favored 'General case' 0 C--N 1.278 -2.538 0 CA-C-O 121.132 0.491 . . . . 1.46 110.288 179.663 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A 1640 ' ' TRP . . . . . 0.498 ' HA ' ' HA ' ' A' 1624 ' ' PRO . 14.8 t90 -96.26 90.8 5.6 Favored 'General case' 0 N--CA 1.425 -1.699 0 N-CA-C 107.755 -1.202 . . . . 0.92 107.755 176.955 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A 1641 ' ' HIS . . . . . 0.689 ' HB2' ' HB3' ' A' 1615 ' ' ARG . 0.8 OUTLIER -71.87 99.13 2.14 Favored 'General case' 0 C--N 1.311 -1.097 0 CA-C-N 115.223 -0.898 . . . . 3.18 110.072 175.093 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A 1642 ' ' THR . . . . . . . . . . . . . 5.6 t -142.89 149.59 50.15 Favored Pre-proline 0 C--N 1.295 -1.77 0 CA-C-N 114.741 -1.118 . . . . 1.48 109.009 -172.655 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A 1643 ' ' PRO . . . . . 0.472 ' HB3' ' HB3' ' A' 1616 ' ' PRO . 45.6 Cg_endo -73.07 -9.85 23.89 Favored 'Trans proline' 0 C--O 1.215 -0.675 0 C-N-CA 122.858 2.372 . . . . 1.09 112.301 176.187 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A 1644 ' ' LEU . . . . . . . . . . . . . 81.9 mt -87.69 3.83 46.4 Favored 'General case' 0 C--N 1.318 -0.801 0 C-N-CA 122.713 0.405 . . . . 2.08 111.292 -177.748 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A 1645 ' ' ALA . . . . . 0.441 ' HB2' ' SG ' ' A' 1614 ' ' CYS . . . -80.45 -30.13 37.55 Favored 'General case' 0 C--N 1.317 -0.822 0 N-CA-C 112.383 0.512 . . . . 1.37 112.383 -176.61 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A 1646 ' ' CYS . . . . . . . . . . . . . 21.1 p -172.06 -179.57 2.4 Favored 'General case' 0 C--N 1.306 -1.297 0 N-CA-C 105.667 -1.975 . . . . 1.7 105.667 179.594 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A 1647 ' ' GLU . . . . . . . . . . . . . 56.3 mm-40 . . . . . 0 C--N 1.312 -1.024 0 N-CA-C 107.747 -1.205 . . . . 2.92 107.747 174.479 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A 1515 ' ' ASP . . . . . . . . . . . . . 23.6 t70 . . . . . 0 N--CA 1.443 -0.818 0 N-CA-C 107.158 -1.423 . . . . 2.54 107.158 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A 1516 ' ' CYS . . . . . . . . . . . . . 71.0 m -83.98 77.24 9.96 Favored 'General case' 0 C--N 1.303 -1.425 0 CA-C-O 121.048 0.451 . . . . 1.25 110.363 179.427 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A 1517 ' ' GLN . . . . . . . . . . . . . 3.5 pt20 -142.54 152.98 43.17 Favored 'General case' 0 C--N 1.306 -1.283 0 O-C-N 121.977 -0.452 . . . . 2.36 111.375 -178.56 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A 1518 ' ' VAL . . . . . 0.564 ' HB ' ' HD2' ' A' 1527 ' ' PHE . 59.2 t -138.59 130.51 37.49 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.86 0 N-CA-C 109.315 -0.624 . . . . 2.34 109.315 -179.759 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A 1519 ' ' THR . . . . . . . . . . . . . 26.6 m -102.67 115.33 30.36 Favored 'General case' 0 C--N 1.306 -1.303 0 N-CA-C 108.217 -1.031 . . . . 2.04 108.217 173.982 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A 1520 ' ' ASN . . . . . . . . . . . . . 25.9 t-20 -74.17 130.43 82.62 Favored Pre-proline 0 C--N 1.313 -0.98 0 N-CA-C 110.122 -0.325 . . . . 2.12 110.122 178.934 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A 1521 ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -74.75 -16.92 20.63 Favored 'Trans proline' 0 CA--C 1.543 0.947 0 C-N-CA 122.744 2.296 . . . . 2.59 114.749 -176.375 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A 1522 ' ' SER . . . . . . . . . . . . . 16.5 m -91.93 -60.86 1.75 Allowed 'General case' 0 C--N 1.314 -0.942 0 N-CA-C 112.044 0.387 . . . . 2.65 112.044 -176.32 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A 1523 ' ' THR . . . . . . . . . . . . . 8.8 t -94.71 -10.06 32.85 Favored 'General case' 0 C--N 1.316 -0.861 0 CA-C-O 121.474 0.654 . . . . 2.33 111.202 -176.153 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A 1524 ' ' GLY . . . . . . . . . . . . . . . 75.0 18.46 80.2 Favored Glycine 0 C--O 1.223 -0.559 0 CA-C-N 115.871 -0.604 . . . . 1.96 112.61 179.093 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A 1525 ' ' HIS . . . . . . . . . . . . . 17.6 t60 -75.65 128.07 34.43 Favored 'General case' 0 C--N 1.308 -1.212 0 N-CA-C 109.751 -0.463 . . . . 2.44 109.751 -176.95 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A 1526 ' ' LEU . . . . . . . . . . . . . 3.5 tm? -94.39 120.15 34.2 Favored 'General case' 0 C--N 1.299 -1.603 0 N-CA-C 106.626 -1.62 . . . . 2.19 106.626 177.451 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A 1527 ' ' PHE . . . . . 0.564 ' HD2' ' HB ' ' A' 1518 ' ' VAL . 86.1 m-85 -89.03 109.94 20.71 Favored 'General case' 0 C--N 1.297 -1.679 0 CA-C-N 116.525 -0.307 . . . . 1.61 110.28 -178.574 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A 1528 ' ' ASP . . . . . . . . . . . . . 13.5 m-20 -81.8 87.3 6.36 Favored 'General case' 0 CA--C 1.494 -1.198 0 CA-C-N 115.913 -0.585 . . . . 2.18 110.484 179.556 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A 1529 ' ' LEU . . . . . 0.678 ' HA ' HD23 ' A' 1532 ' ' LEU . 85.7 mt -99.09 -9.61 23.62 Favored 'General case' 0 C--N 1.302 -1.493 0 N-CA-C 108.95 -0.759 . . . . 2.04 108.95 178.269 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A 1530 ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -62.98 -25.4 68.36 Favored 'General case' 0 C--N 1.318 -0.781 0 C-N-CA 125.166 1.386 . . . . 1.44 109.314 175.623 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A 1531 ' ' SER . . . . . . . . . . . . . 34.3 t -77.34 -9.21 58.7 Favored 'General case' 0 N--CA 1.427 -1.582 0 CA-C-N 114.279 -1.328 . . . . 1.63 109.654 -179.699 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A 1532 ' ' LEU . . . . . 0.678 HD23 ' HA ' ' A' 1529 ' ' LEU . 3.5 mm? -95.87 10.03 38.55 Favored 'General case' 0 C--O 1.245 0.855 0 CA-C-N 115.898 -0.592 . . . . 2.32 111.356 177.805 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A 1533 ' ' SER . . . . . 0.537 ' HA ' ' O ' ' A' 1553 ' ' CYS . 42.3 m -76.58 107.79 9.12 Favored 'General case' 0 N--CA 1.436 -1.15 0 N-CA-C 107.745 -1.206 . . . . 2.57 107.745 172.894 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A 1534 ' ' GLY . . . . . . . . . . . . . . . -110.19 151.33 17.49 Favored Glycine 0 N--CA 1.436 -1.366 0 C-N-CA 120.655 -0.783 . . . . 1.89 112.957 -174.343 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A 1535 ' ' ARG . . . . . . . . . . . . . 40.7 ttm180 -72.36 -62.53 1.41 Allowed 'General case' 0 C--N 1.314 -0.942 0 CA-C-O 121.149 0.499 . . . . 4.44 110.38 178.451 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A 1536 ' ' ALA . . . . . . . . . . . . . . . -93.57 -6.38 46.75 Favored 'General case' 0 C--N 1.309 -1.19 0 C-N-CA 120.028 -0.669 . . . . 2.07 109.484 179.386 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A 1537 ' ' GLY . . . . . . . . . . . . . . . 79.49 -152.85 36.26 Favored Glycine 0 N--CA 1.436 -1.359 0 CA-C-N 115.454 -0.794 . . . . 1.2 112.671 176.397 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A 1538 ' ' PHE . . . . . . . . . . . . . 87.1 m-85 -120.18 155.07 33.86 Favored 'General case' 0 C--N 1.29 -2.003 0 N-CA-C 107.754 -1.202 . . . . 1.98 107.754 179.885 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A 1539 ' ' THR . . . . . . . . . . . . . 24.1 p -112.14 111.93 23.18 Favored 'General case' 0 C--N 1.293 -1.865 0 CA-C-O 121.359 0.599 . . . . 1.97 111.068 -179.409 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A 1540 ' ' ALA . . . . . . . . . . . . . . . -96.8 139.26 33.12 Favored 'General case' 0 C--N 1.3 -1.568 0 N-CA-C 109.075 -0.713 . . . . 1.39 109.075 -179.618 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A 1541 ' ' ALA . . . . . . . . . . . . . . . -80.69 132.87 35.62 Favored 'General case' 0 C--N 1.311 -1.107 0 CA-C-N 115.862 -0.608 . . . . 1.86 110.159 -177.79 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A 1542 ' ' TYR . . . . . 0.469 ' HB3' ' O ' ' A' 1546 ' ' GLY . 45.6 t80 -145.75 156.25 43.48 Favored 'General case' 0 C--N 1.313 -0.999 0 CA-C-N 116.402 -0.363 . . . . 2.4 110.499 -179.134 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A 1543 ' ' SER . . . . . . . . . . . . . 5.5 m -41.25 -153.07 0.0 OUTLIER 'General case' 0 CA--C 1.585 2.305 0 C-N-CA 129.921 3.288 . . . . 2.58 116.58 -176.426 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A 1544 ' ' LYS . . . . . . . . . . . . . 61.2 mttp -51.7 -24.77 6.13 Favored 'General case' 0 N--CA 1.484 1.274 0 O-C-N 120.627 -1.296 . . . . 4.24 113.773 -179.655 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A 1545 ' ' SER . . . . . . . . . . . . . 22.7 t -71.98 -14.71 61.97 Favored 'General case' 0 CA--C 1.553 1.076 0 N-CA-C 111.87 0.322 . . . . 3.6 111.87 178.239 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A 1546 ' ' GLY . . . . . 0.469 ' O ' ' HB3' ' A' 1542 ' ' TYR . . . 96.07 -153.36 20.53 Favored Glycine 0 C--O 1.216 -1.031 0 C-N-CA 119.707 -1.235 . . . . 1.66 113.763 173.491 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A 1547 ' ' VAL . . . . . . . . . . . . . 95.6 t -91.96 139.87 17.11 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.653 0 C-N-CA 123.11 0.564 . . . . 2.23 110.47 -173.751 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A 1548 ' ' VAL . . . . . . . . . . . . . 2.4 t -103.27 131.32 51.96 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.971 0 N-CA-C 107.679 -1.23 . . . . 1.59 107.679 179.211 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A 1549 ' ' TYR . . . . . 0.408 ' CE1' ' HA3' ' A' 1568 ' ' GLY . 75.9 m-85 -97.1 115.19 27.06 Favored 'General case' 0 C--N 1.295 -1.789 0 N-CA-C 107.17 -1.418 . . . . 1.58 107.17 175.129 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A 1550 ' ' MET . . . . . . . . . . . . . 2.7 ppp? -138.34 142.5 39.71 Favored 'General case' 0 C--N 1.291 -1.957 0 CA-C-O 121.172 0.511 . . . . 2.08 111.829 -177.611 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A 1551 ' ' SER . . . . . . . . . . . . . 47.3 m -109.04 149.59 29.04 Favored 'General case' 0 C--N 1.279 -2.463 0 N-CA-C 108.084 -1.08 . . . . 1.9 108.084 177.417 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A 1552 ' ' ILE . . . . . . . . . . . . . 41.6 mm -74.49 -51.64 22.25 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.627 0 N-CA-C 107.385 -1.339 . . . . 2.04 107.385 176.188 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A 1553 ' ' CYS . . . . . 0.537 ' O ' ' HA ' ' A' 1533 ' ' SER . 80.9 m -134.27 147.53 50.65 Favored 'General case' 0 C--N 1.29 -2.01 0 N-CA-C 107.346 -1.353 . . . . 1.43 107.346 175.141 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A 1554 ' ' GLY . . . . . . . . . . . . . . . 97.99 176.05 33.45 Favored Glycine 0 N--CA 1.427 -1.952 0 C-N-CA 120.591 -0.814 . . . . 1.23 111.433 178.294 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A 1555 ' ' GLU . . . . . . . . . . . . . 10.9 pt-20 -89.84 145.74 24.94 Favored 'General case' 0 C--N 1.303 -1.451 0 N-CA-C 109.823 -0.436 . . . . 1.8 109.823 -179.828 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A 1556 ' ' ASN . . . . . . . . . . . . . 20.9 t-20 -93.02 114.24 26.74 Favored 'General case' 0 C--N 1.305 -1.343 0 N-CA-C 108.543 -0.91 . . . . 2.63 108.543 -178.608 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A 1557 ' ' GLU . . . . . . . . . . . . . 51.2 mt-10 -87.23 51.34 2.21 Favored 'General case' 0 C--N 1.294 -1.832 0 N-CA-C 113.178 0.807 . . . . 3.79 113.178 -172.505 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A 1558 ' ' ASN . . . . . . . . . . . . . 36.6 m-80 -133.99 -0.12 3.12 Favored 'General case' 0 C--N 1.311 -1.105 0 CA-C-N 115.781 -0.645 . . . . 1.59 109.79 175.839 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A 1559 ' ' CYS . . . . . 0.625 ' HB3' ' HD2' ' A' 1560 ' ' PRO . 87.4 m -150.86 171.87 5.96 Favored Pre-proline 0 C--N 1.311 -1.08 0 N-CA-C 106.959 -1.497 . . . . 0.94 106.959 -178.764 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A 1560 ' ' PRO . . . . . 0.625 ' HD2' ' HB3' ' A' 1559 ' ' CYS . 44.2 Cg_exo -27.63 129.61 0.03 OUTLIER 'Trans proline' 0 C--N 1.384 2.435 0 C-N-CA 124.948 3.765 . . . . 1.53 114.526 177.454 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A 1561 ' ' PRO . . . . . 0.404 ' HD3' ' HA ' ' A' 1560 ' ' PRO . 37.3 Cg_exo -58.36 116.33 3.17 Favored 'Trans proline' 0 C--O 1.241 0.663 0 C-N-CA 123.277 2.651 . . . . 1.82 112.365 -178.188 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A 1562 ' ' GLY . . . . . . . . . . . . . . . 122.33 -9.94 9.38 Favored Glycine 0 N--CA 1.442 -0.9 0 C-N-CA 120.798 -0.715 . . . . 0.81 112.905 177.858 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A 1563 ' ' VAL . . . . . . . . . . . . . 2.4 m -92.64 153.72 3.27 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.093 0 N-CA-C 107.85 -1.167 . . . . 1.73 107.85 179.242 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A 1564 ' ' GLY . . . . . . . . . . . . . . . -118.68 -18.73 4.71 Favored Glycine 0 C--N 1.297 -1.585 0 C-N-CA 120.284 -0.96 . . . . 0.72 112.656 -177.21 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A 1565 ' ' ALA . . . . . . . . . . . . . . . -139.5 122.35 16.56 Favored 'General case' 0 C--N 1.314 -0.941 0 N-CA-C 108.862 -0.792 . . . . 1.14 108.862 178.994 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A 1566 ' ' CYS . . . . . . . . . . . . . 39.6 t -150.28 144.44 25.56 Favored 'General case' 0 C--N 1.306 -1.297 0 CA-C-N 116.599 -0.273 . . . . 0.51 110.586 -174.812 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A 1567 ' ' PHE . . . . . . . . . . . . . 26.1 m-85 -76.89 123.85 26.88 Favored 'General case' 0 C--O 1.211 -0.96 0 N-CA-C 107.599 -1.259 . . . . 1.22 107.599 175.38 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A 1568 ' ' GLY . . . . . 0.408 ' HA3' ' CE1' ' A' 1549 ' ' TYR . . . -69.16 -27.84 73.39 Favored Glycine 0 C--N 1.315 -0.59 0 N-CA-C 114.561 0.584 . . . . 1.08 114.561 -175.445 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A 1569 ' ' GLN . . . . . . . . . . . . . 35.3 tt0 -77.44 -47.33 19.99 Favored 'General case' 0 C--N 1.315 -0.906 0 O-C-N 122.47 -0.429 . . . . 3.05 111.481 -178.248 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A 1570 ' ' THR . . . . . . . . . . . . . 18.6 p -96.31 -13.36 23.38 Favored 'General case' 0 C--N 1.308 -1.221 0 N-CA-C 113.034 0.753 . . . . 2.44 113.034 -176.21 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A 1571 ' ' ARG . . . . . . . . . . . . . 21.7 mtp180 57.6 40.72 26.54 Favored 'General case' 0 CA--C 1.51 -0.573 0 C-N-CA 124.924 1.29 . . . . 4.48 113.007 -179.456 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A 1572 ' ' ILE . . . . . . . . . . . . . 66.0 mt -106.4 126.45 62.11 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.18 0 CA-C-N 114.733 -1.121 . . . . 1.94 108.327 178.981 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A 1573 ' ' SER . . . . . . . . . . . . . 37.7 t -75.6 136.88 40.48 Favored 'General case' 0 C--N 1.309 -1.186 0 CA-C-N 115.449 -0.796 . . . . 1.25 111.383 -176.95 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A 1574 ' ' VAL . . . . . . . . . . . . . 22.8 m -129.81 21.14 2.2 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.395 0 CA-C-O 121.995 0.903 . . . . 1.61 110.196 177.778 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A 1575 ' ' GLY . . . . . . . . . . . . . . . 176.87 119.04 0.56 Allowed Glycine 0 N--CA 1.422 -2.243 0 CA-C-N 114.576 -1.193 . . . . 0.65 111.274 177.117 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A 1576 ' ' LYS . . . . . . . . . . . . . 46.9 tptt -75.45 151.54 38.06 Favored 'General case' 0 C--N 1.31 -1.147 0 N-CA-C 106.001 -1.852 . . . . 3.33 106.001 175.52 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A 1577 ' ' ALA . . . . . . . . . . . . . . . -70.94 95.08 1.13 Allowed 'General case' 0 C--N 1.314 -0.942 0 N-CA-C 109.273 -0.64 . . . . 1.31 109.273 -179.126 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A 1578 ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -104.66 142.4 34.75 Favored 'General case' 0 C--N 1.3 -1.553 0 CA-C-N 115.439 -0.8 . . . . 2.24 111.117 -178.337 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A 1579 ' ' LYS . . . . . . . . . . . . . 9.9 mmmm -105.89 89.03 2.95 Favored 'General case' 0 C--N 1.287 -2.148 0 N-CA-C 106.079 -1.823 . . . . 2.34 106.079 173.792 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A 1580 ' ' ARG . . . . . 0.509 ' HD3' ' HB ' ' A' 1591 ' ' VAL . 70.0 ttt180 -146.62 97.76 2.96 Favored 'General case' 0 C--N 1.303 -1.435 0 CA-C-N 115.183 -0.917 . . . . 4.19 109.457 -173.023 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A 1581 ' ' LEU . . . . . . . . . . . . . 54.3 tp -118.93 144.57 46.36 Favored 'General case' 0 C--N 1.299 -1.627 0 CA-C-N 115.9 -0.591 . . . . 2.39 109.941 -176.622 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A 1582 ' ' ARG . . . . . . . . . . . . . 49.5 mtp180 -132.96 136.41 46.08 Favored 'General case' 0 C--N 1.309 -1.155 0 C-N-CA 123.416 0.686 . . . . 4.48 109.907 179.185 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A 1583 ' ' TYR . . . . . . . . . . . . . 7.8 t80 -92.9 104.77 16.98 Favored 'General case' 0 C--N 1.311 -1.09 0 CA-C-O 121.56 0.695 . . . . 1.57 109.894 174.184 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A 1584 ' ' VAL . . . . . 0.544 ' HB ' HG11 ' A' 1587 ' ' VAL . 35.0 t -109.69 149.26 12.85 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.648 0 N-CA-C 105.245 -2.131 . . . . 2.29 105.245 175.301 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A 1585 ' ' ASP . . . . . . . . . . . . . 35.8 t70 -46.34 102.68 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.376 0 C-N-CA 124.473 1.109 . . . . 2.06 113.713 -177.968 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A 1586 ' ' GLN . . . . . . . . . . . . . 49.8 mt-30 58.41 35.25 24.63 Favored 'General case' 0 C--O 1.249 1.033 0 C-N-CA 124.828 1.251 . . . . 2.61 112.477 179.911 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A 1587 ' ' VAL . . . . . 0.544 HG11 ' HB ' ' A' 1584 ' ' VAL . 7.7 p -164.69 104.54 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.436 -1.158 0 CA-C-O 122.06 0.933 . . . . 1.33 110.616 175.433 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A 1588 ' ' LEU . . . . . 0.512 ' HB2' ' HB2' ' A' 1612 ' ' PHE . 44.2 mt -78.62 141.25 38.17 Favored 'General case' 0 C--N 1.294 -1.845 0 N-CA-C 107.71 -1.218 . . . . 2.03 107.71 176.295 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A 1589 ' ' GLN . . . . . . . . . . . . . 36.0 tt0 -125.27 117.62 24.21 Favored 'General case' 0 C--N 1.284 -2.253 0 N-CA-C 109.642 -0.503 . . . . 1.73 109.642 -177.835 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A 1590 ' ' LEU . . . . . . . . . . . . . 4.9 tt -116.16 123.25 47.35 Favored 'General case' 0 C--N 1.304 -1.381 0 N-CA-C 106.72 -1.585 . . . . 1.76 106.72 178.354 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A 1591 ' ' VAL . . . . . 0.509 ' HB ' ' HD3' ' A' 1580 ' ' ARG . 60.9 t -110.94 127.76 67.82 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.131 0 N-CA-C 113.633 0.975 . . . . 2.14 113.633 -171.05 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A 1592 ' ' TYR . . . . . . . . . . . . . 5.6 m-30 -109.08 143.49 38.37 Favored 'General case' 0 C--N 1.32 -0.677 0 N-CA-C 107.783 -1.192 . . . . 1.53 107.783 171.378 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A 1593 ' ' LYS . . . . . 0.409 ' HA ' ' HA ' ' A' 1607 ' ' LYS . 13.4 ptmm? -158.96 -177.24 6.37 Favored 'General case' 0 C--N 1.3 -1.58 0 N-CA-C 108.601 -0.889 . . . . 2.72 108.601 179.82 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A 1594 ' ' ASP . . . . . . . . . . . . . 22.0 m-20 64.57 43.31 4.45 Favored 'General case' 0 C--O 1.247 0.936 0 O-C-N 124.147 0.904 . . . . 1.45 112.107 177.724 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A 1595 ' ' GLY . . . . . . . . . . . . . . . -80.83 -104.34 0.31 Allowed Glycine 0 N--CA 1.437 -1.29 0 N-CA-C 111.088 -0.805 . . . . 0.83 111.088 176.309 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A 1596 ' ' SER . . . . . . . . . . . . . 17.7 m -114.11 152.34 45.74 Favored Pre-proline 0 C--N 1.29 -2.013 0 N-CA-C 107.958 -1.127 . . . . 1.96 107.958 177.558 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A 1597 ' ' PRO . . . . . . . . . . . . . 24.7 Cg_exo -62.37 143.39 93.55 Favored 'Trans proline' 0 C--O 1.248 0.99 0 C-N-CA 122.663 2.242 . . . . 1.34 111.193 179.143 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A 1598 ' ' CYS . . . . . . . . . . . . . 45.9 t -96.25 133.15 25.39 Favored Pre-proline 0 C--N 1.29 -2.005 0 CA-C-N 115.844 -0.616 . . . . 1.19 110.41 -177.071 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A 1599 ' ' PRO . . . . . . . . . . . . . 88.2 Cg_endo -88.3 -7.43 5.91 Favored 'Trans proline' 0 CA--C 1.537 0.659 0 C-N-CA 122.68 2.253 . . . . 1.88 112.141 178.013 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A 1600 ' ' SER . . . . . . . . . . . . . 16.5 m -84.27 -34.04 23.88 Favored 'General case' 0 N--CA 1.446 -0.645 0 CA-C-O 121.25 0.548 . . . . 2.19 110.075 -179.87 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A 1601 ' ' LYS . . . . . 0.524 ' HG2' HD11 ' A' 1604 ' ' LEU . 15.8 tppt? -139.64 118.68 12.61 Favored 'General case' 0 N--CA 1.431 -1.379 0 N-CA-C 107.653 -1.24 . . . . 4.21 107.653 178.185 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A 1602 ' ' SER . . . . . . . . . . . . . 22.9 m -72.85 134.39 44.84 Favored 'General case' 0 C--N 1.297 -1.705 0 CA-C-O 121.28 0.562 . . . . 3.82 110.481 -177.587 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A 1603 ' ' GLY . . . . . . . . . . . . . . . 97.61 -7.45 63.43 Favored Glycine 0 N--CA 1.439 -1.125 0 N-CA-C 110.876 -0.89 . . . . 2.45 110.876 -179.756 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A 1604 ' ' LEU . . . . . 0.524 HD11 ' HG2' ' A' 1601 ' ' LYS . 2.2 mt -105.72 148.88 26.94 Favored 'General case' 0 C--N 1.303 -1.424 0 C-N-CA 123.107 0.563 . . . . 2.06 110.873 179.658 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A 1605 ' ' SER . . . . . . . . . . . . . 52.3 m -113.2 -167.45 1.19 Allowed 'General case' 0 C--N 1.287 -2.114 0 N-CA-C 106.356 -1.72 . . . . 1.75 106.356 173.286 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A 1606 ' ' TYR . . . . . . . . . . . . . 44.0 m-85 -108.07 128.24 54.5 Favored 'General case' 0 N--CA 1.399 -2.992 0 N-CA-C 107.223 -1.399 . . . . 1.59 107.223 -179.963 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A 1607 ' ' LYS . . . . . 0.537 ' HG3' HG22 ' A' 1635 ' ' THR . 21.7 ptmt -125.4 154.38 42.01 Favored 'General case' 0 N--CA 1.397 -3.097 0 O-C-N 124.56 1.163 . . . . 2.21 109.407 -177.68 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A 1608 ' ' SER . . . . . 0.483 ' HB3' ' HE2' ' A' 1638 ' ' PHE . 51.1 m -132.38 118.36 19.29 Favored 'General case' 0 C--N 1.296 -1.735 0 N-CA-C 109.598 -0.519 . . . . 1.48 109.598 -178.53 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A 1609 ' ' VAL . . . . . 0.409 HG23 HG13 ' A' 1591 ' ' VAL . 88.1 t -104.12 124.68 58.7 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.558 0 N-CA-C 109.224 -0.658 . . . . 1.57 109.224 178.882 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A 1610 ' ' ILE . . . . . . . . . . . . . 3.1 mp -99.51 117.81 45.2 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.41 0 N-CA-C 108.473 -0.936 . . . . 1.47 108.473 178.156 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A 1611 ' ' SER . . . . . . . . . . . . . 62.9 p -103.45 125.75 50.21 Favored 'General case' 0 N--CA 1.42 -1.928 0 N-CA-C 109.48 -0.563 . . . . 1.84 109.48 177.342 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A 1612 ' ' PHE . . . . . 0.512 ' HB2' ' HB2' ' A' 1588 ' ' LEU . 15.3 m-85 -94.51 107.47 19.45 Favored 'General case' 0 C--N 1.296 -1.735 0 N-CA-C 107.708 -1.219 . . . . 0.86 107.708 179.544 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A 1613 ' ' VAL . . . . . 0.598 HG12 ' HG2' ' A' 1615 ' ' ARG . 97.2 t -103.73 134.41 45.02 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.958 0 N-CA-C 109.86 -0.422 . . . . 1.32 109.86 -177.018 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A 1614 ' ' CYS . . . . . . . . . . . . . 62.6 m -77.1 91.8 3.72 Favored 'General case' 0 N--CA 1.436 -1.166 0 CA-C-O 121.984 0.897 . . . . 1.39 109.879 -178.384 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A 1615 ' ' ARG . . . . . 0.719 ' HB2' ' HB2' ' A' 1641 ' ' HIS . 12.9 mmt180 -137.52 103.04 8.62 Favored Pre-proline 0 C--N 1.293 -1.865 0 N-CA-C 106.336 -1.727 . . . . 4.34 106.336 176.662 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A 1616 ' ' PRO . . . . . . . . . . . . . 32.6 Cg_endo -68.03 73.22 0.75 Allowed 'Trans proline' 0 C--O 1.245 0.857 0 C-N-CA 122.441 2.094 . . . . 1.5 111.956 177.843 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A 1617 ' ' GLU . . . . . . . . . . . . . 48.8 mt-10 . . . . . 0 N--CA 1.431 -1.404 0 CA-C-N 114.653 -1.158 . . . . 3.21 109.816 176.659 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A 1622 ' ' ASN . . . . . . . . . . . . . 58.0 t30 . . . . . 0 CA--C 1.535 0.37 0 CA-C-O 122.056 0.931 . . . . 3.58 109.079 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A 1623 ' ' ARG . . . . . . . . . . . . . 19.7 ptp180 -155.17 154.71 29.1 Favored Pre-proline 0 C--N 1.3 -1.585 0 N-CA-C 106.998 -1.482 . . . . 4.09 106.998 179.69 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A 1624 ' ' PRO . . . . . . . . . . . . . 23.0 Cg_exo -66.1 117.47 4.7 Favored 'Trans proline' 0 N--CA 1.459 -0.522 0 C-N-CA 122.789 2.326 . . . . 2.86 112.339 -179.648 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A 1625 ' ' MET . . . . . . . . . . . . . 48.3 ttm -90.9 133.16 35.47 Favored 'General case' 0 C--N 1.306 -1.289 0 N-CA-C 108.46 -0.941 . . . . 2.73 108.46 -179.785 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A 1626 ' ' LEU . . . . . 0.419 HD23 HD21 ' A' 1629 ' ' LEU . 29.0 tp -85.22 91.8 8.24 Favored 'General case' 0 C--N 1.294 -1.806 0 N-CA-C 108.715 -0.846 . . . . 1.94 108.715 179.272 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A 1627 ' ' ILE . . . . . . . . . . . . . 32.6 pt -86.05 -27.64 6.18 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.611 0 CA-C-N 115.851 -0.613 . . . . 1.75 111.893 -175.118 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A 1628 ' ' SER . . . . . 0.792 ' HB2' ' HB2' ' A' 1637 ' ' PHE . 18.2 m -132.1 129.04 39.4 Favored 'General case' 0 N--CA 1.427 -1.578 0 CA-C-O 121.087 0.47 . . . . 1.85 110.825 -175.594 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A 1629 ' ' LEU . . . . . 0.569 HD22 ' HG ' ' A' 1636 ' ' LEU . 1.5 tm? -129.77 109.27 10.81 Favored 'General case' 0 C--N 1.296 -1.756 0 N-CA-C 105.393 -2.077 . . . . 2.12 105.393 177.094 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A 1630 ' ' ASP . . . . . . . . . . . . . 22.9 t70 -105.45 112.59 25.75 Favored 'General case' 0 C--N 1.297 -1.682 0 C-N-CA 118.95 -1.1 . . . . 0.87 110.135 179.35 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A 1631 ' ' LYS . . . . . . . . . . . . . 28.7 mtpp -71.77 -37.65 70.44 Favored 'General case' 0 C--N 1.306 -1.308 0 CA-C-N 114.621 -1.172 . . . . 2.76 112.946 -175.923 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A 1632 ' ' GLN . . . . . . . . . . . . . 8.7 pt20 -75.02 -31.26 61.31 Favored 'General case' 0 CA--C 1.535 0.394 0 N-CA-C 112.906 0.706 . . . . 2.55 112.906 -174.444 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A 1633 ' ' THR . . . . . . . . . . . . . 54.7 p -99.46 -1.55 38.23 Favored 'General case' 0 C--O 1.245 0.83 0 C-N-CA 120.073 -0.651 . . . . 1.92 111.198 177.8 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A 1634 ' ' CYS . . . . . . . . . . . . . 18.4 m 60.74 40.28 16.35 Favored 'General case' 0 C--N 1.352 0.699 0 CA-C-O 122.114 0.959 . . . . 0.89 110.466 174.366 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A 1635 ' ' THR . . . . . 0.537 HG22 ' HG3' ' A' 1607 ' ' LYS . 27.5 m -124.04 132.5 53.69 Favored 'General case' 0 N--CA 1.435 -1.202 0 CA-C-N 115.207 -0.906 . . . . 1.31 111.512 -173.802 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A 1636 ' ' LEU . . . . . 0.569 ' HG ' HD22 ' A' 1629 ' ' LEU . 6.2 mp -102.87 141.32 35.88 Favored 'General case' 0 C--N 1.313 -1.0 0 N-CA-C 109.113 -0.699 . . . . 1.97 109.113 175.93 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A 1637 ' ' PHE . . . . . 0.792 ' HB2' ' HB2' ' A' 1628 ' ' SER . 90.9 m-85 -124.22 106.85 10.62 Favored 'General case' 0 C--O 1.25 1.119 0 CA-C-O 121.362 0.601 . . . . 0.92 111.448 177.928 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A 1638 ' ' PHE . . . . . 0.483 ' HE2' ' HB3' ' A' 1608 ' ' SER . 86.3 m-85 -91.75 144.51 25.43 Favored 'General case' 0 C--N 1.31 -1.14 0 CA-C-N 115.508 -0.769 . . . . 0.7 109.223 178.317 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A 1639 ' ' SER . . . . . . . . . . . . . 28.8 m -129.42 114.89 16.72 Favored 'General case' 0 C--N 1.292 -1.92 0 CA-C-O 120.924 0.393 . . . . 1.46 110.136 178.777 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A 1640 ' ' TRP . . . . . . . . . . . . . 19.3 t90 -108.52 113.36 26.33 Favored 'General case' 0 C--N 1.296 -1.73 0 N-CA-C 109.248 -0.649 . . . . 0.92 109.248 177.777 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A 1641 ' ' HIS . . . . . 0.719 ' HB2' ' HB2' ' A' 1615 ' ' ARG . 7.3 p-80 -79.81 104.47 10.41 Favored 'General case' 0 C--N 1.317 -0.846 0 CA-C-N 115.305 -0.861 . . . . 3.18 108.936 176.253 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A 1642 ' ' THR . . . . . 0.467 ' HA ' ' HD3' ' A' 1643 ' ' PRO . 8.9 t -143.08 144.35 28.48 Favored Pre-proline 0 C--N 1.285 -2.198 0 C-N-CA 120.069 -0.652 . . . . 1.48 112.046 -173.366 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A 1643 ' ' PRO . . . . . 0.467 ' HD3' ' HA ' ' A' 1642 ' ' THR . 4.9 Cg_exo -79.1 -0.74 11.0 Favored 'Trans proline' 0 N--CA 1.451 -1.013 0 C-N-CA 123.298 2.665 . . . . 1.09 110.328 171.831 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A 1644 ' ' LEU . . . . . . . . . . . . . 89.6 mt -91.07 3.87 53.61 Favored 'General case' 0 C--O 1.225 -0.207 0 CA-C-N 115.771 -0.65 . . . . 2.08 109.73 176.268 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A 1645 ' ' ALA . . . . . . . . . . . . . . . -86.51 -42.43 13.55 Favored 'General case' 0 C--N 1.317 -0.805 0 N-CA-C 108.14 -1.059 . . . . 1.37 108.14 175.988 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A 1646 ' ' CYS . . . . . . . . . . . . . 16.0 p -176.82 161.46 2.01 Favored 'General case' 0 N--CA 1.43 -1.471 0 N-CA-C 102.993 -2.966 . . . . 1.7 102.993 174.453 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A 1647 ' ' GLU . . . . . . . . . . . . . 41.7 mt-10 . . . . . 0 C--N 1.309 -1.155 0 CA-C-N 118.624 0.647 . . . . 2.92 110.784 -179.684 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A 1515 ' ' ASP . . . . . . . . . . . . . 11.3 t70 . . . . . 0 N--CA 1.437 -1.118 0 N-CA-C 106.836 -1.542 . . . . 2.54 106.836 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A 1516 ' ' CYS . . . . . 0.65 ' SG ' ' HE3' ' A' 1579 ' ' LYS . 11.6 m -82.64 81.93 8.22 Favored 'General case' 0 C--N 1.299 -1.629 0 N-CA-C 109.381 -0.6 . . . . 1.25 109.381 -176.812 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A 1517 ' ' GLN . . . . . . . . . . . . . 3.9 pt20 -165.39 176.69 8.07 Favored 'General case' 0 C--N 1.32 -0.68 0 N-CA-C 110.147 -0.316 . . . . 2.36 110.147 179.39 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A 1518 ' ' VAL . . . . . 0.696 ' HB ' HD12 ' A' 1581 ' ' LEU . 4.5 p -148.76 131.32 6.61 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.863 0 CA-C-N 116.068 -0.515 . . . . 2.34 110.131 176.454 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A 1519 ' ' THR . . . . . . . . . . . . . 4.8 m -105.97 123.97 48.83 Favored 'General case' 0 C--N 1.312 -1.039 0 N-CA-C 109.775 -0.454 . . . . 2.04 109.775 179.181 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A 1520 ' ' ASN . . . . . . . . . . . . . 24.8 t-20 -83.86 113.29 46.58 Favored Pre-proline 0 C--N 1.314 -0.971 0 N-CA-C 108.966 -0.753 . . . . 2.12 108.966 175.661 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A 1521 ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -75.55 -15.83 19.36 Favored 'Trans proline' 0 C--N 1.344 0.326 0 C-N-CA 122.221 1.947 . . . . 2.59 113.552 -174.958 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A 1522 ' ' SER . . . . . . . . . . . . . 12.2 m -68.25 -54.75 15.5 Favored 'General case' 0 N--CA 1.432 -1.344 0 CA-C-N 116.494 -0.321 . . . . 2.65 110.785 -177.925 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A 1523 ' ' THR . . . . . 0.435 HG21 ' HB2' ' A' 1525 ' ' HIS . 14.5 t -109.02 -7.8 15.3 Favored 'General case' 0 C--N 1.315 -0.895 0 C-N-CA 119.654 -0.818 . . . . 2.33 111.966 -179.465 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A 1524 ' ' GLY . . . . . . . . . . . . . . . 80.45 37.38 20.87 Favored Glycine 0 CA--C 1.503 -0.658 0 C-N-CA 120.511 -0.852 . . . . 1.96 111.18 -179.487 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A 1525 ' ' HIS . . . . . 0.435 ' HB2' HG21 ' A' 1523 ' ' THR . 22.3 t-160 -100.97 115.71 31.11 Favored 'General case' 0 C--N 1.308 -1.205 0 N-CA-C 109.284 -0.636 . . . . 2.44 109.284 -176.545 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A 1526 ' ' LEU . . . . . . . . . . . . . 3.5 tm? -88.41 120.65 29.98 Favored 'General case' 0 C--N 1.295 -1.766 0 N-CA-C 107.799 -1.185 . . . . 2.19 107.799 178.762 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A 1527 ' ' PHE . . . . . . . . . . . . . 95.0 m-85 -92.86 112.95 25.09 Favored 'General case' 0 C--N 1.3 -1.555 0 N-CA-C 107.646 -1.242 . . . . 1.61 107.646 176.975 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A 1528 ' ' ASP . . . . . . . . . . . . . 10.8 t70 -77.84 105.6 9.13 Favored 'General case' 0 CA--C 1.495 -1.143 0 CA-C-O 121.533 0.682 . . . . 2.18 109.678 -178.356 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A 1529 ' ' LEU . . . . . . . . . . . . . 89.2 mt -106.55 -3.0 21.28 Favored 'General case' 0 C--N 1.281 -2.412 0 N-CA-C 107.207 -1.405 . . . . 2.04 107.207 176.458 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A 1530 ' ' SER . . . . . . . . . . . . . 8.1 m -69.72 -37.05 76.4 Favored 'General case' 0 N--CA 1.419 -1.985 0 CA-C-N 114.027 -1.442 . . . . 1.44 110.73 -174.013 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A 1531 ' ' SER . . . . . . . . . . . . . 14.8 m -74.94 -21.97 58.86 Favored 'General case' 0 C--N 1.316 -0.853 0 CA-C-O 121.344 0.592 . . . . 1.63 110.026 177.72 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A 1532 ' ' LEU . . . . . 0.583 HD21 ' HH2' ' A' 1640 ' ' TRP . 82.1 mt -85.83 -5.72 59.2 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.549 -0.751 . . . . 2.32 109.643 179.711 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A 1533 ' ' SER . . . . . 0.405 ' OG ' ' HB3' ' A' 1553 ' ' CYS . 22.6 m -92.18 107.36 19.16 Favored 'General case' 0 N--CA 1.415 -2.199 0 N-CA-C 108.631 -0.878 . . . . 2.57 108.631 178.584 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A 1534 ' ' GLY . . . . . . . . . . . . . . . -126.58 -150.33 7.54 Favored Glycine 0 N--CA 1.422 -2.296 0 N-CA-C 109.768 -1.333 . . . . 1.89 109.768 179.551 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A 1535 ' ' ARG . . . . . . . . . . . . . 9.5 tpt180 -96.82 -70.11 0.73 Allowed 'General case' 0 N--CA 1.419 -1.979 0 C-N-CA 120.242 -0.583 . . . . 4.44 109.58 179.214 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A 1536 ' ' ALA . . . . . . . . . . . . . . . -86.93 -18.28 31.17 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 121.047 0.451 . . . . 2.07 110.994 -177.831 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A 1537 ' ' GLY . . . . . . . . . . . . . . . 73.44 -112.9 4.04 Favored Glycine 0 N--CA 1.435 -1.383 0 CA-C-N 115.941 -0.572 . . . . 1.2 113.317 176.15 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A 1538 ' ' PHE . . . . . . . . . . . . . 64.9 m-85 -127.23 159.0 35.64 Favored 'General case' 0 C--N 1.307 -1.27 0 N-CA-C 109.837 -0.431 . . . . 1.98 109.837 -176.55 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A 1539 ' ' THR . . . . . . . . . . . . . 6.8 p -112.76 119.99 39.95 Favored 'General case' 0 C--N 1.306 -1.3 0 CA-C-N 116.288 -0.415 . . . . 1.97 111.138 -178.886 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A 1540 ' ' ALA . . . . . . . . . . . . . . . -100.51 116.0 31.43 Favored 'General case' 0 C--N 1.307 -1.253 0 N-CA-C 109.46 -0.57 . . . . 1.39 109.46 177.976 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A 1541 ' ' ALA . . . . . . . . . . . . . . . -80.48 89.05 5.61 Favored 'General case' 0 C--N 1.313 -0.979 0 CA-C-N 115.541 -0.754 . . . . 1.86 109.134 -179.161 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A 1542 ' ' TYR . . . . . . . . . . . . . 64.3 t80 -100.13 157.2 16.74 Favored 'General case' 0 C--N 1.293 -1.856 0 CA-C-N 115.861 -0.609 . . . . 2.4 111.483 -176.486 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A 1543 ' ' SER . . . . . . . . . . . . . 2.8 m -40.46 -153.07 0.0 OUTLIER 'General case' 0 CA--C 1.578 2.043 0 C-N-CA 130.179 3.391 . . . . 2.58 116.893 -177.15 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A 1544 ' ' LYS . . . . . 0.637 ' HZ1' ' HB3' ' A' 1544 ' ' LYS . 4.9 ttpm? -49.4 -31.7 10.15 Favored 'General case' 0 N--CA 1.481 1.082 0 O-C-N 121.3 -0.875 . . . . 4.24 112.262 -179.197 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A 1545 ' ' SER . . . . . . . . . . . . . 13.1 m -63.82 -27.18 69.0 Favored 'General case' 0 CA--C 1.559 1.291 0 N-CA-C 112.375 0.509 . . . . 3.6 112.375 178.261 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A 1546 ' ' GLY . . . . . . . . . . . . . . . 109.02 -165.21 12.48 Favored Glycine 0 N--CA 1.43 -1.764 0 C-N-CA 119.363 -1.398 . . . . 1.66 114.034 174.869 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A 1547 ' ' VAL . . . . . . . . . . . . . 7.2 p -92.35 133.51 33.48 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.608 0 CA-C-O 121.596 0.712 . . . . 2.23 111.151 -176.297 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A 1548 ' ' VAL . . . . . . . . . . . . . 4.1 t -111.37 135.83 49.36 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.442 0 N-CA-C 106.682 -1.599 . . . . 1.59 106.682 179.202 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A 1549 ' ' TYR . . . . . 0.649 ' HE1' ' HA3' ' A' 1568 ' ' GLY . 95.7 m-85 -93.74 151.38 19.67 Favored 'General case' 0 C--N 1.3 -1.547 0 N-CA-C 106.565 -1.642 . . . . 1.58 106.565 174.129 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A 1550 ' ' MET . . . . . . . . . . . . . 46.0 ttm -144.16 122.38 12.24 Favored 'General case' 0 C--N 1.301 -1.514 0 C-N-CA 120.255 -0.578 . . . . 2.08 111.113 -178.686 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A 1551 ' ' SER . . . . . . . . . . . . . 28.8 p -111.36 122.06 46.86 Favored 'General case' 0 N--CA 1.418 -2.07 0 N-CA-C 108.7 -0.852 . . . . 1.9 108.7 174.932 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A 1552 ' ' ILE . . . . . . . . . . . . . 1.7 mp -62.04 -29.33 46.24 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.342 0 CA-C-N 115.134 -0.939 . . . . 2.04 110.621 179.058 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A 1553 ' ' CYS . . . . . 0.702 ' SG ' ' HE3' ' A' 1579 ' ' LYS . 37.2 t -160.63 141.0 11.45 Favored 'General case' 0 N--CA 1.426 -1.629 0 N-CA-C 108.354 -0.98 . . . . 1.43 108.354 174.797 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A 1554 ' ' GLY . . . . . . . . . . . . . . . 97.43 160.29 31.17 Favored Glycine 0 N--CA 1.443 -0.85 0 O-C-N 123.652 0.595 . . . . 1.23 111.678 -179.003 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A 1555 ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -67.54 127.25 32.04 Favored 'General case' 0 N--CA 1.447 -0.578 0 CA-C-O 121.729 0.776 . . . . 1.8 111.334 178.474 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A 1556 ' ' ASN . . . . . 0.521 HD22 ' HB3' ' A' 1549 ' ' TYR . 3.4 t-20 -75.05 -14.47 60.6 Favored 'General case' 0 C--N 1.299 -1.603 0 C-N-CA 126.328 1.851 . . . . 2.63 114.023 -170.069 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A 1557 ' ' GLU . . . . . 0.488 ' C ' ' H ' ' A' 1559 ' ' CYS . 50.6 mm-40 66.45 -173.61 0.19 Allowed 'General case' 0 N--CA 1.481 1.084 0 C-N-CA 123.237 0.615 . . . . 3.79 110.282 -176.112 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A 1558 ' ' ASN . . . . . . . . . . . . . 42.2 m-80 76.31 -20.9 0.34 Allowed 'General case' 0 N--CA 1.496 1.855 0 C-N-CA 125.659 1.584 . . . . 1.59 111.972 173.467 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A 1559 ' ' CYS . . . . . 0.572 ' HB3' ' HD2' ' A' 1560 ' ' PRO . 63.8 m -142.12 169.63 10.66 Favored Pre-proline 0 C--N 1.282 -2.355 0 N-CA-C 106.491 -1.67 . . . . 0.94 106.491 179.732 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A 1560 ' ' PRO . . . . . 0.572 ' HD2' ' HB3' ' A' 1559 ' ' CYS . 26.8 Cg_exo -32.26 130.26 0.09 OUTLIER 'Trans proline' 0 C--N 1.369 1.608 0 C-N-CA 124.984 3.789 . . . . 1.53 114.983 178.098 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A 1561 ' ' PRO . . . . . . . . . . . . . 50.5 Cg_exo -56.09 110.83 0.62 Allowed 'Trans proline' 0 C--O 1.242 0.723 0 C-N-CA 123.583 2.855 . . . . 1.82 112.551 179.71 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A 1562 ' ' GLY . . . . . . . . . . . . . . . 141.05 -14.05 2.83 Favored Glycine 0 N--CA 1.442 -0.953 0 C-N-CA 120.526 -0.845 . . . . 0.81 112.519 178.875 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A 1563 ' ' VAL . . . . . 0.485 HG23 ' O ' ' A' 1560 ' ' PRO . 7.3 m -85.24 151.47 3.74 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.309 0 O-C-N 122.488 -0.419 . . . . 1.73 111.617 179.031 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A 1564 ' ' GLY . . . . . 0.407 ' HA3' ' CE2' ' A' 1592 ' ' TYR . . . -117.81 -1.23 17.35 Favored Glycine 0 N--CA 1.433 -1.547 0 N-CA-C 110.911 -0.876 . . . . 0.72 110.911 176.201 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A 1565 ' ' ALA . . . . . . . . . . . . . . . -158.43 119.56 3.43 Favored 'General case' 0 C--O 1.247 0.952 0 N-CA-C 109.552 -0.536 . . . . 1.14 109.552 179.158 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A 1566 ' ' CYS . . . . . . . . . . . . . 48.7 t -154.33 145.77 23.09 Favored 'General case' 0 C--N 1.304 -1.373 0 N-CA-C 109.956 -0.387 . . . . 0.51 109.956 -177.343 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A 1567 ' ' PHE . . . . . . . . . . . . . 66.9 m-85 -71.07 123.26 21.7 Favored 'General case' 0 CA--C 1.511 -0.546 0 N-CA-C 107.412 -1.329 . . . . 1.22 107.412 172.951 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A 1568 ' ' GLY . . . . . 0.649 ' HA3' ' HE1' ' A' 1549 ' ' TYR . . . -73.62 -22.52 78.31 Favored Glycine 0 C--N 1.308 -1.01 0 C-N-CA 120.788 -0.72 . . . . 1.08 114.735 -172.021 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A 1569 ' ' GLN . . . . . . . . . . . . . 10.0 mt-30 -90.53 -55.52 3.55 Favored 'General case' 0 C--N 1.305 -1.349 0 CA-C-O 121.125 0.488 . . . . 3.05 109.98 -177.13 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A 1570 ' ' THR . . . . . . . . . . . . . 21.2 p -81.93 -12.98 58.13 Favored 'General case' 0 CA--C 1.546 0.821 0 N-CA-C 113.691 0.997 . . . . 2.44 113.691 -176.487 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A 1571 ' ' ARG . . . . . . . . . . . . . 37.0 mtp85 62.91 42.44 7.66 Favored 'General case' 0 N--CA 1.476 0.872 0 C-N-CA 124.263 1.025 . . . . 4.48 112.262 -179.883 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A 1572 ' ' ILE . . . . . . . . . . . . . 30.8 mm -104.49 122.24 57.22 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.241 0 N-CA-C 109.237 -0.653 . . . . 1.94 109.237 -179.149 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A 1573 ' ' SER . . . . . . . . . . . . . 31.9 t -83.24 137.11 34.15 Favored 'General case' 0 C--N 1.303 -1.453 0 C-N-CA 124.364 1.066 . . . . 1.25 111.821 -175.593 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A 1574 ' ' VAL . . . . . . . . . . . . . 11.5 m -140.01 27.48 0.5 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 115.982 -0.553 . . . . 1.61 110.72 175.224 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A 1575 ' ' GLY . . . . . . . . . . . . . . . 178.71 119.54 0.61 Allowed Glycine 0 N--CA 1.434 -1.489 0 C-N-CA 120.016 -1.088 . . . . 0.65 112.921 178.976 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A 1576 ' ' LYS . . . . . . . . . . . . . 22.9 tptm -89.56 137.15 32.57 Favored 'General case' 0 C--N 1.304 -1.409 0 N-CA-C 107.047 -1.464 . . . . 3.33 107.047 176.044 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A 1577 ' ' ALA . . . . . 0.662 ' HA ' ' CE2' ' A' 1592 ' ' TYR . . . -67.56 119.86 13.03 Favored 'General case' 0 C--N 1.322 -0.629 0 N-CA-C 109.379 -0.6 . . . . 1.31 109.379 -178.772 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A 1578 ' ' ASN . . . . . . . . . . . . . 5.7 p30 -157.61 166.83 31.85 Favored 'General case' 0 C--N 1.31 -1.126 0 N-CA-C 107.071 -1.455 . . . . 2.24 107.071 -176.468 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A 1579 ' ' LYS . . . . . 0.702 ' HE3' ' SG ' ' A' 1553 ' ' CYS . 50.9 mttp -122.1 90.07 3.24 Favored 'General case' 0 C--N 1.306 -1.317 0 N-CA-C 109.789 -0.448 . . . . 2.34 109.789 178.179 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A 1580 ' ' ARG . . . . . . . . . . . . . 47.2 ttp180 -138.39 92.46 2.64 Favored 'General case' 0 C--N 1.309 -1.188 0 N-CA-C 106.969 -1.493 . . . . 4.19 106.969 175.178 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A 1581 ' ' LEU . . . . . 0.696 HD12 ' HB ' ' A' 1518 ' ' VAL . 4.6 pp -127.5 158.9 36.18 Favored 'General case' 0 C--N 1.294 -1.826 0 CA-C-N 115.7 -0.682 . . . . 2.39 110.147 -177.675 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A 1582 ' ' ARG . . . . . 0.468 ' HB3' HG13 ' A' 1584 ' ' VAL . 80.4 mtm-85 -139.96 139.09 36.02 Favored 'General case' 0 C--N 1.301 -1.539 0 O-C-N 123.449 0.468 . . . . 4.48 109.885 178.378 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A 1583 ' ' TYR . . . . . 0.465 ' CD1' ' HG ' ' A' 1588 ' ' LEU . 25.4 t80 -99.73 90.44 4.46 Favored 'General case' 0 C--N 1.309 -1.175 0 N-CA-C 106.547 -1.649 . . . . 1.57 106.547 174.256 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A 1584 ' ' VAL . . . . . 0.468 HG13 ' HB3' ' A' 1582 ' ' ARG . 18.3 m -115.89 124.38 72.19 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.948 0 CA-C-N 115.83 -0.623 . . . . 2.29 111.701 -172.475 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A 1585 ' ' ASP . . . . . . . . . . . . . 38.8 t70 56.06 50.51 13.56 Favored 'General case' 0 C--N 1.31 -1.123 0 C-N-CA 123.98 0.912 . . . . 2.06 111.701 177.901 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A 1586 ' ' GLN . . . . . . . . . . . . . 49.2 mt-30 69.75 10.71 7.66 Favored 'General case' 0 N--CA 1.481 1.105 0 CA-C-N 114.8 -1.091 . . . . 2.61 113.853 176.253 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A 1587 ' ' VAL . . . . . 0.485 HG23 ' O ' ' A' 1612 ' ' PHE . 7.4 p -135.61 133.01 51.83 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.517 0 CA-C-O 121.49 0.662 . . . . 1.33 110.895 -179.735 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A 1588 ' ' LEU . . . . . 0.8 ' HB2' ' HB2' ' A' 1612 ' ' PHE . 20.4 mt -80.15 142.74 34.49 Favored 'General case' 0 C--N 1.312 -1.037 0 CA-C-N 115.303 -0.862 . . . . 2.03 110.749 178.037 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A 1589 ' ' GLN . . . . . . . . . . . . . 6.5 tt0 -128.24 106.86 9.32 Favored 'General case' 0 C--N 1.289 -2.051 0 CA-C-N 115.434 -0.803 . . . . 1.73 109.475 -179.481 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A 1590 ' ' LEU . . . . . 0.713 ' HB2' ' HE1' ' A' 1612 ' ' PHE . 21.1 tp -101.54 112.99 25.72 Favored 'General case' 0 C--N 1.314 -0.974 0 N-CA-C 107.022 -1.473 . . . . 1.76 107.022 178.636 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A 1591 ' ' VAL . . . . . 0.527 HG22 HG23 ' A' 1609 ' ' VAL . 61.1 t -105.96 107.84 23.63 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.381 0 C-N-CA 120.107 -0.637 . . . . 2.14 112.248 -175.824 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A 1592 ' ' TYR . . . . . 0.662 ' CE2' ' HA ' ' A' 1577 ' ' ALA . 5.0 m-85 -102.89 92.84 4.75 Favored 'General case' 0 C--N 1.297 -1.691 0 CA-C-O 121.907 0.86 . . . . 1.53 108.74 173.587 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A 1593 ' ' LYS . . . . . 0.503 ' HA ' ' HA ' ' A' 1607 ' ' LYS . 18.0 pttp -104.5 -175.44 2.8 Favored 'General case' 0 C--N 1.291 -1.948 0 CA-C-N 114.152 -1.385 . . . . 2.72 108.285 -178.433 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A 1594 ' ' ASP . . . . . . . . . . . . . 1.6 m-20 63.67 72.5 0.47 Allowed 'General case' 0 CA--C 1.512 -0.501 0 O-C-N 124.072 0.857 . . . . 1.45 112.17 177.969 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A 1595 ' ' GLY . . . . . . . . . . . . . . . -110.11 -113.56 3.52 Favored Glycine 0 N--CA 1.425 -2.04 0 N-CA-C 109.659 -1.376 . . . . 0.83 109.659 176.159 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A 1596 ' ' SER . . . . . . . . . . . . . 33.4 p -104.53 158.03 32.84 Favored Pre-proline 0 C--N 1.29 -1.988 0 N-CA-C 108.866 -0.79 . . . . 1.96 108.866 177.915 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A 1597 ' ' PRO . . . . . . . . . . . . . 36.9 Cg_exo -59.45 137.2 76.59 Favored 'Trans proline' 0 C--N 1.353 0.815 0 C-N-CA 122.757 2.305 . . . . 1.34 112.004 178.869 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A 1598 ' ' CYS . . . . . . . . . . . . . 42.7 t -95.82 115.16 65.33 Favored Pre-proline 0 C--N 1.299 -1.621 0 CA-C-N 115.899 -0.591 . . . . 1.19 110.034 -178.711 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A 1599 ' ' PRO . . . . . 0.517 ' HD2' ' OH ' ' A' 1606 ' ' TYR . 44.2 Cg_endo -69.36 -15.63 38.73 Favored 'Trans proline' 0 CA--C 1.535 0.525 0 C-N-CA 122.591 2.194 . . . . 1.88 112.625 -179.119 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A 1600 ' ' SER . . . . . . . . . . . . . 21.0 m -80.16 -13.16 59.47 Favored 'General case' 0 C--O 1.249 1.058 0 CA-C-N 116.157 -0.474 . . . . 2.19 111.876 -178.261 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A 1601 ' ' LYS . . . . . 0.81 ' HG2' HD12 ' A' 1604 ' ' LEU . 16.1 tppt? -156.2 110.65 2.82 Favored 'General case' 0 N--CA 1.442 -0.83 0 N-CA-C 108.83 -0.804 . . . . 4.21 108.83 179.405 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A 1602 ' ' SER . . . . . . . . . . . . . 8.4 m -59.61 109.84 1.0 Allowed 'General case' 0 C--N 1.296 -1.73 0 C-N-CA 124.185 0.994 . . . . 3.82 111.1 -176.991 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A 1603 ' ' GLY . . . . . . . . . . . . . . . 108.22 -17.84 34.07 Favored Glycine 0 N--CA 1.441 -0.971 0 C-N-CA 120.701 -0.762 . . . . 2.45 112.495 177.584 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A 1604 ' ' LEU . . . . . 0.81 HD12 ' HG2' ' A' 1601 ' ' LYS . 1.1 mt -86.89 146.02 26.35 Favored 'General case' 0 C--N 1.308 -1.23 0 CA-C-O 121.15 0.5 . . . . 2.06 110.838 -178.849 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A 1605 ' ' SER . . . . . . . . . . . . . 22.8 t -108.21 -175.05 2.67 Favored 'General case' 0 N--CA 1.424 -1.747 0 N-CA-C 106.336 -1.728 . . . . 1.75 106.336 173.378 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A 1606 ' ' TYR . . . . . 0.517 ' OH ' ' HD2' ' A' 1599 ' ' PRO . 78.6 m-85 -107.46 135.7 48.49 Favored 'General case' 0 CA--C 1.46 -2.485 0 N-CA-C 107.705 -1.22 . . . . 1.59 107.705 -176.452 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A 1607 ' ' LYS . . . . . 0.503 ' HA ' ' HA ' ' A' 1593 ' ' LYS . 24.6 pttm -122.31 134.54 54.66 Favored 'General case' 0 N--CA 1.398 -3.062 0 C-N-CA 118.592 -1.243 . . . . 2.21 110.433 176.835 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A 1608 ' ' SER . . . . . . . . . . . . . 47.1 m -101.56 111.15 23.3 Favored 'General case' 0 C--N 1.28 -2.452 0 CA-C-N 115.17 -0.923 . . . . 1.48 108.543 176.857 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A 1609 ' ' VAL . . . . . 0.527 HG23 HG22 ' A' 1591 ' ' VAL . 56.4 t -98.09 112.56 30.45 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.107 0 N-CA-C 109.48 -0.563 . . . . 1.57 109.48 177.568 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A 1610 ' ' ILE . . . . . 0.581 ' HB ' ' HB3' ' A' 1590 ' ' LEU . 2.5 mp -93.46 104.72 16.04 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.649 0 N-CA-C 107.521 -1.289 . . . . 1.47 107.521 177.353 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A 1611 ' ' SER . . . . . . . . . . . . . 22.8 t -90.72 117.41 29.34 Favored 'General case' 0 C--N 1.293 -1.864 0 N-CA-C 108.387 -0.968 . . . . 1.84 108.387 -179.735 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A 1612 ' ' PHE . . . . . 0.8 ' HB2' ' HB2' ' A' 1588 ' ' LEU . 50.7 m-85 -92.15 102.22 14.74 Favored 'General case' 0 C--N 1.31 -1.126 0 N-CA-C 108.985 -0.746 . . . . 0.86 108.985 -179.651 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A 1613 ' ' VAL . . . . . . . . . . . . . 47.8 t -100.53 127.59 53.44 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.51 0 N-CA-C 107.821 -1.177 . . . . 1.32 107.821 -177.881 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A 1614 ' ' CYS . . . . . 0.648 ' HA ' ' O ' ' A' 1642 ' ' THR . 8.3 t -71.45 106.4 3.93 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-O 121.28 0.562 . . . . 1.39 111.618 -176.657 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A 1615 ' ' ARG . . . . . 0.758 ' HB2' ' HB3' ' A' 1641 ' ' HIS . 37.2 mmt180 -137.09 85.2 22.91 Favored Pre-proline 0 N--CA 1.433 -1.306 0 CA-C-N 115.228 -0.896 . . . . 4.34 110.462 177.048 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A 1616 ' ' PRO . . . . . 0.416 ' HA ' ' HB3' ' A' 1643 ' ' PRO . 48.5 Cg_exo -61.22 -16.61 47.59 Favored 'Trans proline' 0 N--CA 1.482 0.801 0 C-N-CA 122.942 2.428 . . . . 1.5 111.481 174.444 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A 1617 ' ' GLU . . . . . . . . . . . . . 8.6 pt-20 . . . . . 0 C--N 1.318 -0.765 0 C-N-CA 123.886 0.874 . . . . 3.21 112.345 178.328 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A 1622 ' ' ASN . . . . . . . . . . . . . 50.0 t-20 . . . . . 0 C--O 1.245 0.856 0 N-CA-C 108.878 -0.786 . . . . 3.58 108.878 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A 1623 ' ' ARG . . . . . . . . . . . . . 19.0 ptp180 -155.42 161.38 29.58 Favored Pre-proline 0 C--O 1.247 0.94 0 N-CA-C 108.131 -1.063 . . . . 4.09 108.131 -179.67 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A 1624 ' ' PRO . . . . . . . . . . . . . 7.7 Cg_exo -73.42 94.7 0.84 Allowed 'Trans proline' 0 N--CA 1.458 -0.595 0 C-N-CA 122.747 2.298 . . . . 2.86 111.566 177.476 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A 1625 ' ' MET . . . . . . . . . . . . . 20.5 ptp -81.64 150.12 28.24 Favored 'General case' 0 C--N 1.313 -1.011 0 CA-C-N 115.646 -0.706 . . . . 2.73 109.797 179.735 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A 1626 ' ' LEU . . . . . . . . . . . . . 47.3 tp -90.35 105.25 17.69 Favored 'General case' 0 C--N 1.304 -1.389 0 N-CA-C 108.194 -1.039 . . . . 1.94 108.194 179.101 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A 1627 ' ' ILE . . . . . . . . . . . . . 44.7 pt -85.7 -38.07 12.52 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.331 0 N-CA-C 112.119 0.414 . . . . 1.75 112.119 -175.428 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A 1628 ' ' SER . . . . . . . . . . . . . 19.4 t -148.95 150.91 33.69 Favored 'General case' 0 N--CA 1.432 -1.34 0 N-CA-C 109.036 -0.727 . . . . 1.85 109.036 -177.426 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A 1629 ' ' LEU . . . . . 0.961 ' HG ' ' HG ' ' A' 1636 ' ' LEU . 3.1 tt -141.83 116.19 9.53 Favored 'General case' 0 C--N 1.303 -1.446 0 N-CA-C 106.682 -1.599 . . . . 2.12 106.682 179.798 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A 1630 ' ' ASP . . . . . . . . . . . . . 33.2 t70 -109.27 119.84 40.7 Favored 'General case' 0 C--N 1.294 -1.833 0 N-CA-C 109.444 -0.576 . . . . 0.87 109.444 176.723 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A 1631 ' ' LYS . . . . . . . . . . . . . 30.1 mtpp -77.35 -24.93 50.63 Favored 'General case' 0 C--N 1.3 -1.564 0 CA-C-N 115.592 -0.731 . . . . 2.76 111.272 -175.913 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A 1632 ' ' GLN . . . . . . . . . . . . . 39.6 mt-30 -68.57 -44.52 74.26 Favored 'General case' 0 CA--C 1.515 -0.381 0 CA-C-O 121.397 0.618 . . . . 2.55 110.519 -176.317 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A 1633 ' ' THR . . . . . . . . . . . . . 25.1 p -90.42 -4.4 57.04 Favored 'General case' 0 C--N 1.31 -1.146 0 CA-C-N 115.516 -0.765 . . . . 1.92 110.797 177.347 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A 1634 ' ' CYS . . . . . 0.49 ' O ' ' HA ' ' A' 1606 ' ' TYR . 29.3 m 56.98 41.97 26.9 Favored 'General case' 0 C--O 1.221 -0.41 0 CA-C-N 114.288 -1.324 . . . . 0.89 109.503 179.061 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A 1635 ' ' THR . . . . . . . . . . . . . 89.3 m -124.11 131.32 53.53 Favored 'General case' 0 N--CA 1.428 -1.537 0 CA-C-N 115.226 -0.897 . . . . 1.31 111.389 -173.217 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A 1636 ' ' LEU . . . . . 0.961 ' HG ' ' HG ' ' A' 1629 ' ' LEU . 5.2 mp -108.66 130.74 55.33 Favored 'General case' 0 N--CA 1.432 -1.353 0 N-CA-C 108.567 -0.901 . . . . 1.97 108.567 177.626 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A 1637 ' ' PHE . . . . . . . . . . . . . 94.3 m-85 -105.76 105.95 16.23 Favored 'General case' 0 C--N 1.308 -1.204 0 CA-C-O 121.069 0.461 . . . . 0.92 110.953 -177.489 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A 1638 ' ' PHE . . . . . . . . . . . . . 99.6 m-85 -100.79 148.0 25.42 Favored 'General case' 0 C--N 1.303 -1.416 0 N-CA-C 108.4 -0.963 . . . . 0.7 108.4 177.681 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A 1639 ' ' SER . . . . . . . . . . . . . 66.2 m -137.33 115.1 11.34 Favored 'General case' 0 C--N 1.281 -2.382 0 CA-C-O 121.445 0.64 . . . . 1.46 110.703 176.984 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A 1640 ' ' TRP . . . . . 0.583 ' HH2' HD21 ' A' 1532 ' ' LEU . 7.9 t90 -95.93 122.14 38.42 Favored 'General case' 0 N--CA 1.418 -2.05 0 N-CA-C 106.569 -1.641 . . . . 0.92 106.569 178.434 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A 1641 ' ' HIS . . . . . 0.758 ' HB3' ' HB2' ' A' 1615 ' ' ARG . 40.6 m80 -95.09 102.99 14.83 Favored 'General case' 0 C--N 1.285 -2.206 0 N-CA-C 107.633 -1.247 . . . . 3.18 107.633 178.206 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A 1642 ' ' THR . . . . . 0.648 ' O ' ' HA ' ' A' 1614 ' ' CYS . 8.9 t -142.42 140.2 18.62 Favored Pre-proline 0 C--N 1.297 -1.678 0 CA-C-N 115.45 -0.795 . . . . 1.48 111.21 -173.134 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A 1643 ' ' PRO . . . . . 0.416 ' HB3' ' HA ' ' A' 1616 ' ' PRO . 57.4 Cg_endo -71.46 -0.82 8.78 Favored 'Trans proline' 0 CA--C 1.534 0.494 0 C-N-CA 123.621 2.881 . . . . 1.09 112.451 176.865 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A 1644 ' ' LEU . . . . . . . . . . . . . 77.5 mt -85.4 -4.33 59.13 Favored 'General case' 0 C--N 1.322 -0.613 0 C-N-CA 122.62 0.368 . . . . 2.08 111.113 -179.085 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A 1645 ' ' ALA . . . . . . . . . . . . . . . -88.84 -13.87 38.26 Favored 'General case' 0 C--N 1.319 -0.725 0 N-CA-C 111.984 0.364 . . . . 1.37 111.984 -178.129 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A 1646 ' ' CYS . . . . . . . . . . . . . 14.3 p -148.02 -177.04 5.52 Favored 'General case' 0 C--N 1.304 -1.386 0 N-CA-C 107.137 -1.431 . . . . 1.7 107.137 -179.27 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A 1647 ' ' GLU . . . . . . . . . . . . . 9.8 tp10 . . . . . 0 N--CA 1.428 -1.526 0 N-CA-C 107.891 -1.151 . . . . 2.92 107.891 174.643 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A 1515 ' ' ASP . . . . . . . . . . . . . 4.1 t70 . . . . . 0 N--CA 1.445 -0.7 0 N-CA-C 108.548 -0.908 . . . . 2.54 108.548 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A 1516 ' ' CYS . . . . . . . . . . . . . 52.0 m -115.67 44.56 1.86 Allowed 'General case' 0 C--N 1.29 -2.007 0 N-CA-C 108.35 -0.982 . . . . 1.25 108.35 -176.811 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A 1517 ' ' GLN . . . . . . . . . . . . . 10.6 pt20 -148.47 138.07 22.12 Favored 'General case' 0 N--CA 1.433 -1.282 0 C-N-CA 120.79 -0.364 . . . . 2.36 111.054 -176.948 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A 1518 ' ' VAL . . . . . . . . . . . . . 29.4 m -113.87 154.06 15.31 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.668 0 CA-C-N 115.744 -0.662 . . . . 2.34 109.945 179.551 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A 1519 ' ' THR . . . . . 0.511 ' HA ' ' HA ' ' A' 1526 ' ' LEU . 32.0 m -119.61 137.76 53.66 Favored 'General case' 0 C--N 1.277 -2.544 0 N-CA-C 109.037 -0.727 . . . . 2.04 109.037 177.354 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A 1520 ' ' ASN . . . . . . . . . . . . . 38.3 t-20 -93.78 101.61 6.41 Favored Pre-proline 0 C--N 1.315 -0.895 0 N-CA-C 107.416 -1.327 . . . . 2.12 107.416 175.139 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A 1521 ' ' PRO . . . . . 0.455 ' HD3' ' O ' ' A' 1519 ' ' THR . 23.4 Cg_exo -65.71 -14.07 42.91 Favored 'Trans proline' 0 C--N 1.36 1.165 0 C-N-CA 123.205 2.603 . . . . 2.59 113.802 -176.772 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A 1522 ' ' SER . . . . . . . . . . . . . 33.3 t -71.24 -38.39 71.95 Favored 'General case' 0 N--CA 1.439 -0.977 0 N-CA-C 109.746 -0.464 . . . . 2.65 109.746 178.759 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A 1523 ' ' THR . . . . . . . . . . . . . 7.2 t -112.37 -16.53 12.91 Favored 'General case' 0 C--N 1.317 -0.827 0 N-CA-C 112.766 0.654 . . . . 2.33 112.766 -177.116 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A 1524 ' ' GLY . . . . . . . . . . . . . . . 81.66 14.54 77.77 Favored Glycine 0 C--O 1.229 -0.172 0 C-N-CA 120.984 -0.627 . . . . 1.96 111.591 -178.764 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A 1525 ' ' HIS . . . . . . . . . . . . . 32.5 t-80 -101.45 131.99 47.28 Favored 'General case' 0 C--N 1.306 -1.318 0 CA-C-O 121.077 0.465 . . . . 2.44 110.187 -178.925 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A 1526 ' ' LEU . . . . . 0.511 ' HA ' ' HA ' ' A' 1519 ' ' THR . 7.8 tt -101.52 143.37 31.6 Favored 'General case' 0 C--N 1.289 -2.038 0 CA-C-N 115.329 -0.851 . . . . 2.19 110.211 -178.166 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A 1527 ' ' PHE . . . . . 0.402 ' HE1' ' HG3' ' A' 1647 ' ' GLU . 80.0 m-85 -118.09 113.08 21.07 Favored 'General case' 0 C--N 1.312 -1.032 0 N-CA-C 107.291 -1.374 . . . . 1.61 107.291 176.524 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A 1528 ' ' ASP . . . . . . . . . . . . . 1.3 p-10 -104.79 141.61 36.19 Favored 'General case' 0 C--N 1.297 -1.714 0 CA-C-O 121.955 0.883 . . . . 2.18 110.938 -178.441 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A 1529 ' ' LEU . . . . . . . . . . . . . 75.7 mt -114.16 11.19 17.48 Favored 'General case' 0 C--N 1.287 -2.13 0 N-CA-C 105.7 -1.963 . . . . 2.04 105.7 173.253 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A 1530 ' ' SER . . . . . . . . . . . . . 5.5 m -73.44 -37.32 65.88 Favored 'General case' 0 N--CA 1.43 -1.435 0 CA-C-N 114.166 -1.379 . . . . 1.44 109.323 -178.977 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A 1531 ' ' SER . . . . . . . . . . . . . 12.8 m -79.85 -7.95 59.01 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-O 121.466 0.651 . . . . 1.63 109.33 175.324 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A 1532 ' ' LEU . . . . . . . . . . . . . 92.8 mt -106.83 9.15 31.01 Favored 'General case' 0 N--CA 1.448 -0.565 0 CA-C-N 115.669 -0.696 . . . . 2.32 110.514 177.017 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A 1533 ' ' SER . . . . . . . . . . . . . 66.0 m -70.94 107.52 4.1 Favored 'General case' 0 N--CA 1.437 -1.081 0 CA-C-O 121.733 0.778 . . . . 2.57 111.577 -175.447 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A 1534 ' ' GLY . . . . . . . . . . . . . . . -103.23 103.0 2.3 Favored Glycine 0 N--CA 1.423 -2.202 0 N-CA-C 109.632 -1.387 . . . . 1.89 109.632 176.607 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A 1535 ' ' ARG . . . . . . . . . . . . . 71.4 ttt180 -79.27 -20.66 47.55 Favored 'General case' 0 C--O 1.205 -1.257 0 O-C-N 124.205 0.591 . . . . 4.44 111.114 -176.732 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A 1536 ' ' ALA . . . . . . . . . . . . . . . -90.59 -3.21 57.72 Favored 'General case' 0 C--N 1.309 -1.166 0 C-N-CA 119.643 -0.823 . . . . 2.07 109.39 178.979 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A 1537 ' ' GLY . . . . . 0.439 ' HA2' ' HA ' ' A' 1551 ' ' SER . . . 79.13 166.07 30.85 Favored Glycine 0 N--CA 1.423 -2.214 0 CA-C-N 114.855 -1.066 . . . . 1.2 113.123 177.932 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A 1538 ' ' PHE . . . . . . . . . . . . . 97.1 m-85 -133.73 163.43 29.48 Favored 'General case' 0 C--N 1.297 -1.678 0 N-CA-C 107.472 -1.307 . . . . 1.98 107.472 176.507 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A 1539 ' ' THR . . . . . 0.521 ' HA ' ' O ' ' A' 1548 ' ' VAL . 59.4 p -118.06 157.73 26.31 Favored 'General case' 0 C--N 1.303 -1.422 0 N-CA-C 113.335 0.865 . . . . 1.97 113.335 -172.315 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A 1540 ' ' ALA . . . . . . . . . . . . . . . -142.55 146.13 34.32 Favored 'General case' 0 C--O 1.25 1.131 0 N-CA-C 106.685 -1.598 . . . . 1.39 106.685 173.628 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A 1541 ' ' ALA . . . . . . . . . . . . . . . -65.05 131.65 47.14 Favored 'General case' 0 C--O 1.247 0.952 0 O-C-N 124.222 0.951 . . . . 1.86 110.611 -178.571 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A 1542 ' ' TYR . . . . . . . . . . . . . 81.0 t80 -143.34 171.14 14.52 Favored 'General case' 0 C--N 1.3 -1.585 0 CA-C-N 115.427 -0.806 . . . . 2.4 109.343 -177.264 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A 1543 ' ' SER . . . . . . . . . . . . . 14.0 m -44.28 -151.62 0.0 OUTLIER 'General case' 0 CA--C 1.581 2.165 0 C-N-CA 129.728 3.211 . . . . 2.58 114.961 176.327 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A 1544 ' ' LYS . . . . . . . . . . . . . 39.9 ttmt -36.03 -39.24 0.16 Allowed 'General case' 0 CA--C 1.568 1.665 0 C-N-CA 125.217 1.407 . . . . 4.24 114.143 178.149 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A 1545 ' ' SER . . . . . . . . . . . . . 48.3 t -66.45 -21.73 66.2 Favored 'General case' 0 CA--C 1.56 1.332 0 N-CA-C 112.329 0.492 . . . . 3.6 112.329 177.462 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A 1546 ' ' GLY . . . . . . . . . . . . . . . 88.75 -63.8 3.51 Favored Glycine 0 CA--C 1.492 -1.345 0 N-CA-C 111.455 -0.658 . . . . 1.66 111.455 179.999 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A 1547 ' ' VAL . . . . . . . . . . . . . 13.3 m -140.58 157.87 24.22 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.416 0 C-N-CA 123.205 0.602 . . . . 2.23 109.874 178.318 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A 1548 ' ' VAL . . . . . 0.521 ' O ' ' HA ' ' A' 1539 ' ' THR . 5.7 t -111.98 142.7 23.55 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.28 0 N-CA-C 106.598 -1.63 . . . . 1.59 106.598 176.388 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A 1549 ' ' TYR . . . . . 0.496 ' CD2' ' HA2' ' A' 1568 ' ' GLY . 62.2 m-85 -98.4 114.91 27.43 Favored 'General case' 0 C--N 1.31 -1.152 0 N-CA-C 108.08 -1.082 . . . . 1.58 108.08 173.509 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A 1550 ' ' MET . . . . . . . . . . . . . 65.4 mtm -128.6 133.15 48.23 Favored 'General case' 0 C--N 1.299 -1.603 0 N-CA-C 109.448 -0.575 . . . . 2.08 109.448 176.543 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A 1551 ' ' SER . . . . . 0.439 ' HA ' ' HA2' ' A' 1537 ' ' GLY . 23.8 p -86.3 147.8 25.9 Favored 'General case' 0 C--N 1.289 -2.048 0 N-CA-C 106.658 -1.608 . . . . 1.9 106.658 175.983 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A 1552 ' ' ILE . . . . . . . . . . . . . 35.7 mm -76.41 -29.72 19.0 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.978 0 N-CA-C 108.77 -0.826 . . . . 2.04 108.77 -178.706 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A 1553 ' ' CYS . . . . . 0.475 ' HA ' ' HH ' ' A' 1592 ' ' TYR . 38.2 t -162.94 138.38 6.82 Favored 'General case' 0 N--CA 1.432 -1.344 0 N-CA-C 107.519 -1.289 . . . . 1.43 107.519 169.398 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A 1554 ' ' GLY . . . . . . . . . . . . . . . 96.13 -164.93 23.81 Favored Glycine 0 N--CA 1.438 -1.205 0 C-N-CA 120.781 -0.724 . . . . 1.23 112.802 176.05 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A 1555 ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -76.43 156.17 33.34 Favored 'General case' 0 C--N 1.312 -1.046 0 C-N-CA 122.622 0.369 . . . . 1.8 110.028 -179.734 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A 1556 ' ' ASN . . . . . 0.437 HD22 ' HB3' ' A' 1549 ' ' TYR . 27.5 t-20 -98.31 -17.66 18.77 Favored 'General case' 0 CA--C 1.548 0.874 0 N-CA-C 113.413 0.894 . . . . 2.63 113.413 -173.719 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A 1557 ' ' GLU . . . . . . . . . . . . . 30.1 mt-10 65.66 -24.04 0.09 Allowed 'General case' 0 N--CA 1.492 1.656 0 N-CA-C 115.376 1.621 . . . . 3.79 115.376 179.738 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A 1558 ' ' ASN . . . . . . . . . . . . . 38.6 m-80 -75.64 -21.4 57.75 Favored 'General case' 0 CA--C 1.503 -0.834 0 CA-C-O 121.731 0.777 . . . . 1.59 109.11 177.133 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A 1559 ' ' CYS . . . . . . . . . . . . . 73.4 m -135.05 158.38 74.98 Favored Pre-proline 0 N--CA 1.423 -1.802 0 N-CA-C 106.66 -1.608 . . . . 0.94 106.66 176.731 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A 1560 ' ' PRO . . . . . 0.423 ' HA ' ' HD3' ' A' 1561 ' ' PRO . 3.0 Cg_exo -32.82 145.52 0.03 OUTLIER 'Trans proline' 0 CA--C 1.561 1.832 1 C-N-CA 125.859 4.373 . . . . 1.53 117.014 -176.186 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A 1561 ' ' PRO . . . . . 0.423 ' HD3' ' HA ' ' A' 1560 ' ' PRO . 42.5 Cg_exo -59.37 115.08 2.34 Favored 'Trans proline' 0 C--O 1.245 0.834 0 C-N-CA 123.43 2.753 . . . . 1.82 110.421 176.827 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A 1562 ' ' GLY . . . . . . . . . . . . . . . 121.79 -11.42 9.49 Favored Glycine 0 N--CA 1.426 -1.974 0 N-CA-C 110.174 -1.17 . . . . 0.81 110.174 -176.086 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A 1563 ' ' VAL . . . . . . . . . . . . . 66.2 t -99.29 133.88 40.42 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.275 0 N-CA-C 108.005 -1.109 . . . . 1.73 108.005 176.224 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A 1564 ' ' GLY . . . . . . . . . . . . . . . -114.54 -34.53 1.56 Allowed Glycine 0 N--CA 1.443 -0.89 0 C-N-CA 120.916 -0.659 . . . . 0.72 111.78 -179.319 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A 1565 ' ' ALA . . . . . . . . . . . . . . . -123.09 121.08 35.14 Favored 'General case' 0 C--O 1.249 1.043 0 N-CA-C 108.871 -0.789 . . . . 1.14 108.871 -179.753 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A 1566 ' ' CYS . . . . . . . . . . . . . 38.6 t -146.45 140.88 26.58 Favored 'General case' 0 C--N 1.297 -1.709 0 N-CA-C 108.964 -0.754 . . . . 0.51 108.964 -173.953 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A 1567 ' ' PHE . . . . . 0.462 ' O ' ' HA ' ' A' 1571 ' ' ARG . 16.3 m-85 -63.23 132.76 52.75 Favored 'General case' 0 C--O 1.21 -1.01 0 N-CA-C 108.518 -0.919 . . . . 1.22 108.518 177.174 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A 1568 ' ' GLY . . . . . 0.496 ' HA2' ' CD2' ' A' 1549 ' ' TYR . . . -68.99 -36.0 80.21 Favored Glycine 0 N--CA 1.435 -1.387 0 CA-C-N 115.752 -0.658 . . . . 1.08 114.622 -174.164 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A 1569 ' ' GLN . . . . . . . . . . . . . 36.1 tt0 -90.44 -53.89 4.24 Favored 'General case' 0 C--N 1.303 -1.43 0 CA-C-O 121.671 0.748 . . . . 3.05 110.261 -179.393 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A 1570 ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -74.96 -20.06 59.84 Favored 'General case' 0 C--N 1.298 -1.641 0 CA-C-N 114.836 -1.075 . . . . 2.44 112.783 -172.971 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A 1571 ' ' ARG . . . . . 0.462 ' HA ' ' O ' ' A' 1567 ' ' PHE . 50.8 mtp180 54.36 36.37 25.22 Favored 'General case' 0 CA--C 1.51 -0.58 0 C-N-CA 125.814 1.646 . . . . 4.48 113.589 179.633 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A 1572 ' ' ILE . . . . . . . . . . . . . 43.6 mm -94.96 123.89 47.26 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.286 0 N-CA-C 108.893 -0.78 . . . . 1.94 108.893 178.079 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A 1573 ' ' SER . . . . . . . . . . . . . 31.5 t -65.44 95.71 0.22 Allowed 'General case' 0 C--N 1.307 -1.266 0 C-N-CA 125.309 1.444 . . . . 1.25 111.207 179.94 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A 1574 ' ' VAL . . . . . 0.492 ' O ' ' HA3' ' A' 1595 ' ' GLY . 27.6 m -88.17 -30.94 5.55 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.871 0 N-CA-C 112.327 0.491 . . . . 1.61 112.327 179.099 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A 1575 ' ' GLY . . . . . . . . . . . . . . . -136.58 132.25 5.98 Favored Glycine 0 C--O 1.246 0.85 0 C-N-CA 120.858 -0.687 . . . . 0.65 112.177 179.816 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A 1576 ' ' LYS . . . . . 0.586 ' HG2' ' HA2' ' A' 1595 ' ' GLY . 75.5 mmtt -88.77 149.37 23.47 Favored 'General case' 0 C--N 1.312 -1.049 0 N-CA-C 109.859 -0.423 . . . . 3.33 109.859 -179.894 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A 1577 ' ' ALA . . . . . . . . . . . . . . . -67.07 98.87 0.61 Allowed 'General case' 0 C--N 1.307 -1.278 0 C-N-CA 123.976 0.91 . . . . 1.31 110.913 -178.195 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A 1578 ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -113.49 120.34 40.67 Favored 'General case' 0 C--N 1.306 -1.299 0 N-CA-C 108.504 -0.925 . . . . 2.24 108.504 177.261 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A 1579 ' ' LYS . . . . . . . . . . . . . 48.9 mtmt -90.96 90.55 7.93 Favored 'General case' 0 C--N 1.307 -1.254 0 N-CA-C 107.294 -1.372 . . . . 2.34 107.294 177.621 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A 1580 ' ' ARG . . . . . . . . . . . . . 17.7 ttp180 -165.84 110.98 0.85 Allowed 'General case' 0 C--N 1.309 -1.192 0 CA-C-N 115.309 -0.859 . . . . 4.19 110.246 -175.216 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A 1581 ' ' LEU . . . . . . . . . . . . . 3.9 mm? -101.77 137.28 40.29 Favored 'General case' 0 C--N 1.316 -0.877 0 CA-C-N 115.888 -0.596 . . . . 2.39 109.563 178.592 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A 1582 ' ' ARG . . . . . . . . . . . . . 90.4 mtt180 -108.68 98.31 7.83 Favored 'General case' 0 C--N 1.291 -1.957 0 CA-C-N 116.374 -0.375 . . . . 4.48 110.254 177.057 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A 1583 ' ' TYR . . . . . . . . . . . . . 92.8 t80 -79.84 110.13 14.92 Favored 'General case' 0 C--N 1.311 -1.098 0 CA-C-N 115.477 -0.783 . . . . 1.57 109.153 -179.615 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A 1584 ' ' VAL . . . . . 0.595 ' O ' HG13 ' A' 1587 ' ' VAL . 3.9 p -148.36 126.4 3.24 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.419 0 CA-C-N 116.17 -0.468 . . . . 2.29 110.076 179.703 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A 1585 ' ' ASP . . . . . . . . . . . . . 38.4 t70 54.34 44.65 28.64 Favored 'General case' 0 N--CA 1.484 1.244 0 CA-C-O 122.748 1.261 . . . . 2.06 109.951 -177.894 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A 1586 ' ' GLN . . . . . . . . . . . . . 48.4 mt-30 59.79 18.41 7.29 Favored 'General case' 0 CA--C 1.539 0.545 0 CA-C-N 113.632 -1.622 . . . . 2.61 114.32 179.141 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A 1587 ' ' VAL . . . . . 0.595 HG13 ' O ' ' A' 1584 ' ' VAL . 4.0 p -103.78 139.64 24.16 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.146 0 N-CA-C 108.568 -0.901 . . . . 1.33 108.568 176.733 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A 1588 ' ' LEU . . . . . 0.72 ' HB2' ' HB2' ' A' 1612 ' ' PHE . 41.1 mt -94.27 123.83 37.91 Favored 'General case' 0 C--N 1.296 -1.732 0 N-CA-C 106.187 -1.783 . . . . 2.03 106.187 174.179 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A 1589 ' ' GLN . . . . . . . . . . . . . 9.8 tt0 -122.4 112.96 18.72 Favored 'General case' 0 C--N 1.281 -2.398 0 CA-C-N 116.398 -0.365 . . . . 1.73 110.094 -173.864 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A 1590 ' ' LEU . . . . . 0.412 ' HB3' ' HB ' ' A' 1610 ' ' ILE . 32.8 tp -100.7 116.48 32.71 Favored 'General case' 0 C--N 1.299 -1.59 0 N-CA-C 107.078 -1.452 . . . . 1.76 107.078 -179.659 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A 1591 ' ' VAL . . . . . . . . . . . . . 15.4 m -106.94 94.82 3.33 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.565 0 N-CA-C 113.803 1.038 . . . . 2.14 113.803 -174.884 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A 1592 ' ' TYR . . . . . 0.475 ' HH ' ' HA ' ' A' 1553 ' ' CYS . 14.7 m-30 -86.5 92.92 9.02 Favored 'General case' 0 C--N 1.312 -1.035 0 N-CA-C 107.811 -1.181 . . . . 1.53 107.811 173.435 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A 1593 ' ' LYS . . . . . . . . . . . . . 14.6 ptmm? -115.43 175.08 5.68 Favored 'General case' 0 C--N 1.293 -1.868 0 CA-C-N 115.951 -0.568 . . . . 2.72 111.588 -174.874 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A 1594 ' ' ASP . . . . . . . . . . . . . 8.9 m-20 62.86 31.32 16.41 Favored 'General case' 0 CA--C 1.509 -0.613 0 O-C-N 124.17 0.919 . . . . 1.45 112.154 -178.799 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A 1595 ' ' GLY . . . . . 0.586 ' HA2' ' HG2' ' A' 1576 ' ' LYS . . . -78.58 -84.93 0.54 Allowed Glycine 0 N--CA 1.435 -1.402 0 C-N-CA 120.855 -0.688 . . . . 0.83 112.624 -178.004 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A 1596 ' ' SER . . . . . . . . . . . . . 14.4 t -101.58 145.17 29.98 Favored Pre-proline 0 C--N 1.293 -1.87 0 N-CA-C 108.498 -0.927 . . . . 1.96 108.498 -177.75 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A 1597 ' ' PRO . . . . . . . . . . . . . 24.2 Cg_exo -67.99 131.78 24.73 Favored 'Trans proline' 0 C--O 1.238 0.5 0 C-N-CA 122.785 2.323 . . . . 1.34 110.371 175.252 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A 1598 ' ' CYS . . . . . 0.687 ' HA ' ' HE1' ' A' 1606 ' ' TYR . 40.6 t -95.09 123.09 58.35 Favored Pre-proline 0 C--N 1.304 -1.392 0 CA-C-O 120.767 0.318 . . . . 1.19 110.476 -176.634 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A 1599 ' ' PRO . . . . . . . . . . . . . 91.2 Cg_endo -88.44 -9.36 5.02 Favored 'Trans proline' 0 N--CA 1.454 -0.851 0 C-N-CA 122.798 2.332 . . . . 1.88 112.913 179.799 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A 1600 ' ' SER . . . . . . . . . . . . . 14.9 m -70.31 -21.87 62.88 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-O 121.101 0.477 . . . . 2.19 110.77 -177.795 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A 1601 ' ' LYS . . . . . 0.909 ' HB3' HD12 ' A' 1604 ' ' LEU . 25.7 tptp -161.0 132.08 5.43 Favored 'General case' 0 N--CA 1.43 -1.444 0 N-CA-C 106.257 -1.757 . . . . 4.21 106.257 178.429 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A 1602 ' ' SER . . . . . . . . . . . . . 16.4 m -73.34 126.82 31.02 Favored 'General case' 0 C--N 1.307 -1.249 0 CA-C-O 120.884 0.373 . . . . 3.82 110.268 -176.763 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A 1603 ' ' GLY . . . . . . . . . . . . . . . 102.87 22.0 9.78 Favored Glycine 0 C--N 1.303 -1.256 0 N-CA-C 110.301 -1.12 . . . . 2.45 110.301 -179.358 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A 1604 ' ' LEU . . . . . 0.909 HD12 ' HB3' ' A' 1601 ' ' LYS . 6.1 mt -124.83 152.54 43.8 Favored 'General case' 0 C--N 1.3 -1.548 0 CA-C-O 121.801 0.81 . . . . 2.06 112.259 -179.554 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A 1605 ' ' SER . . . . . . . . . . . . . 50.1 m -128.29 177.67 6.79 Favored 'General case' 0 C--N 1.281 -2.399 0 N-CA-C 106.313 -1.736 . . . . 1.75 106.313 174.613 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A 1606 ' ' TYR . . . . . 0.687 ' HE1' ' HA ' ' A' 1598 ' ' CYS . 7.0 m-85 -98.9 140.36 33.19 Favored 'General case' 0 CA--C 1.459 -2.557 0 N-CA-C 105.682 -1.97 . . . . 1.59 105.682 -179.115 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A 1607 ' ' LYS . . . . . . . . . . . . . 23.3 pttm -133.09 137.45 46.36 Favored 'General case' 0 N--CA 1.391 -3.382 0 C-N-CA 119.21 -0.996 . . . . 2.21 110.127 176.718 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A 1608 ' ' SER . . . . . . . . . . . . . 14.6 m -107.08 110.02 22.03 Favored 'General case' 0 C--N 1.29 -2.02 0 N-CA-C 108.11 -1.07 . . . . 1.48 108.11 178.612 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A 1609 ' ' VAL . . . . . . . . . . . . . 98.3 t -102.04 102.82 14.08 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.256 0 CA-C-O 121.118 0.485 . . . . 1.57 110.481 -177.923 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A 1610 ' ' ILE . . . . . 0.412 ' HB ' ' HB3' ' A' 1590 ' ' LEU . 2.6 mp -90.78 115.31 29.77 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.361 0 N-CA-C 108.252 -1.018 . . . . 1.47 108.252 179.243 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A 1611 ' ' SER . . . . . 0.501 ' O ' ' HA ' ' A' 1639 ' ' SER . 16.9 m -107.13 122.4 46.42 Favored 'General case' 0 C--N 1.295 -1.789 0 CA-C-O 121.26 0.552 . . . . 1.84 110.666 -178.152 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A 1612 ' ' PHE . . . . . 0.72 ' HB2' ' HB2' ' A' 1588 ' ' LEU . 84.5 m-85 -88.38 109.78 20.27 Favored 'General case' 0 C--N 1.298 -1.666 0 N-CA-C 108.134 -1.062 . . . . 0.86 108.134 177.391 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A 1613 ' ' VAL . . . . . . . . . . . . . 58.2 t -102.01 126.2 56.06 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.414 0 CA-C-N 115.632 -0.713 . . . . 1.32 110.216 -173.781 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A 1614 ' ' CYS . . . . . . . . . . . . . 57.9 m -59.63 95.68 0.03 OUTLIER 'General case' 0 C--O 1.244 0.764 0 C-N-CA 124.427 1.091 . . . . 1.39 111.302 179.771 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A 1615 ' ' ARG . . . . . 0.433 ' C ' ' H ' ' A' 1617 ' ' GLU . 17.0 mmt180 -137.28 102.17 9.0 Favored Pre-proline 0 C--N 1.294 -1.824 0 CA-C-N 115.112 -0.949 . . . . 4.34 108.744 177.725 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A 1616 ' ' PRO . . . . . 0.444 ' HA ' ' HB3' ' A' 1643 ' ' PRO . 52.6 Cg_exo -61.2 10.36 0.07 OUTLIER 'Trans proline' 0 N--CA 1.493 1.479 0 C-N-CA 124.707 3.605 . . . . 1.5 115.137 -179.189 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A 1617 ' ' GLU . . . . . 0.433 ' H ' ' C ' ' A' 1615 ' ' ARG . 34.0 mt-10 . . . . . 0 C--O 1.243 0.726 0 C-N-CA 123.501 0.72 . . . . 3.21 109.647 178.209 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A 1622 ' ' ASN . . . . . . . . . . . . . 54.9 t30 . . . . . 0 C--O 1.248 0.989 0 CA-C-O 122.441 1.115 . . . . 3.58 111.935 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A 1623 ' ' ARG . . . . . 0.509 ' HB3' ' CG ' ' A' 1640 ' ' TRP . 6.0 ptt180 -130.14 74.11 80.74 Favored Pre-proline 0 C--N 1.306 -1.321 0 CA-C-N 115.082 -0.963 . . . . 4.09 112.765 -177.326 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A 1624 ' ' PRO . . . . . . . . . . . . . 54.9 Cg_endo -111.01 90.9 0.02 OUTLIER 'Trans proline' 0 N--CA 1.42 -2.843 0 C-N-CA 121.306 1.338 . . . . 2.86 109.519 169.177 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A 1625 ' ' MET . . . . . 0.492 ' HB2' ' O ' ' A' 1639 ' ' SER . 10.7 mmt -151.54 98.27 2.49 Favored 'General case' 0 CA--C 1.491 -1.303 0 C-N-CA 120.022 -0.671 . . . . 2.73 112.695 178.02 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A 1626 ' ' LEU . . . . . . . . . . . . . 63.1 tp -92.02 101.04 13.58 Favored 'General case' 0 C--N 1.292 -1.919 0 N-CA-C 103.402 -2.814 . . . . 1.94 103.402 163.82 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A 1627 ' ' ILE . . . . . 0.458 HD12 ' HB3' ' A' 1637 ' ' PHE . 5.0 mt -68.64 -44.65 82.4 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.602 0 N-CA-C 108.499 -0.926 . . . . 1.75 108.499 -171.211 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A 1628 ' ' SER . . . . . . . . . . . . . 46.5 t -171.12 148.09 2.67 Favored 'General case' 0 N--CA 1.412 -2.373 0 N-CA-C 106.245 -1.761 . . . . 1.85 106.245 -179.572 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A 1629 ' ' LEU . . . . . 0.842 ' HG ' ' HG ' ' A' 1636 ' ' LEU . 5.1 tt -126.02 111.02 14.24 Favored 'General case' 0 C--N 1.281 -2.381 0 N-CA-C 105.238 -2.134 . . . . 2.12 105.238 173.916 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A 1630 ' ' ASP . . . . . . . . . . . . . 29.8 t70 -94.83 108.68 20.7 Favored 'General case' 0 C--N 1.283 -2.318 0 N-CA-C 108.954 -0.758 . . . . 0.87 108.954 -178.894 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A 1631 ' ' LYS . . . . . . . . . . . . . 65.6 mttp -71.26 -32.96 69.35 Favored 'General case' 0 C--N 1.309 -1.177 0 CA-C-N 115.586 -0.733 . . . . 2.76 112.656 -174.486 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A 1632 ' ' GLN . . . . . . . . . . . . . 9.1 pt20 -71.25 -28.74 64.38 Favored 'General case' 0 N--CA 1.467 0.419 0 N-CA-C 113.226 0.825 . . . . 2.55 113.226 -176.38 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A 1633 ' ' THR . . . . . 0.427 ' HA ' HD11 ' A' 1604 ' ' LEU . 71.8 p -106.31 -4.3 20.21 Favored 'General case' 0 C--N 1.319 -0.756 0 C-N-CA 119.908 -0.717 . . . . 1.92 110.674 175.08 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A 1634 ' ' CYS . . . . . . . . . . . . . 72.6 m 61.16 40.07 15.21 Favored 'General case' 0 C--O 1.237 0.412 0 CA-C-N 115.063 -0.972 . . . . 0.89 111.278 -178.455 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A 1635 ' ' THR . . . . . . . . . . . . . 30.9 m -105.69 122.42 46.03 Favored 'General case' 0 N--CA 1.433 -1.278 0 CA-C-N 115.387 -0.824 . . . . 1.31 110.028 -177.446 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A 1636 ' ' LEU . . . . . 0.842 ' HG ' ' HG ' ' A' 1629 ' ' LEU . 5.8 mp -108.44 124.87 51.08 Favored 'General case' 0 C--N 1.313 -0.982 0 N-CA-C 109.378 -0.601 . . . . 1.97 109.378 179.303 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A 1637 ' ' PHE . . . . . 0.458 ' HB3' HD12 ' A' 1627 ' ' ILE . 84.3 m-85 -107.55 126.72 52.89 Favored 'General case' 0 C--N 1.311 -1.092 0 N-CA-C 110.121 -0.326 . . . . 0.92 110.121 -178.674 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A 1638 ' ' PHE . . . . . 0.474 ' HA ' ' O ' ' A' 1625 ' ' MET . 93.4 m-85 -124.05 155.31 38.55 Favored 'General case' 0 C--N 1.32 -0.71 0 C-N-CA 122.6 0.36 . . . . 0.7 110.634 -179.495 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A 1639 ' ' SER . . . . . 0.501 ' HA ' ' O ' ' A' 1611 ' ' SER . 65.1 m -142.61 148.82 38.1 Favored 'General case' 0 C--O 1.249 1.063 0 N-CA-C 113.486 0.921 . . . . 1.46 113.486 174.621 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A 1640 ' ' TRP . . . . . 0.509 ' CG ' ' HB3' ' A' 1623 ' ' ARG . 8.1 t90 -122.05 135.4 54.82 Favored 'General case' 0 C--O 1.243 0.754 0 N-CA-C 106.859 -1.534 . . . . 0.92 106.859 176.053 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A 1641 ' ' HIS . . . . . . . . . . . . . 15.3 m-70 -80.51 92.78 5.94 Favored 'General case' 0 CA--C 1.509 -0.613 0 N-CA-C 107.818 -1.178 . . . . 3.18 107.818 177.596 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A 1642 ' ' THR . . . . . 0.473 ' HA ' ' HD3' ' A' 1643 ' ' PRO . 0.0 OUTLIER -128.63 130.5 23.5 Favored Pre-proline 0 C--N 1.304 -1.372 0 N-CA-C 112.852 0.686 . . . . 1.48 112.852 -174.248 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A 1643 ' ' PRO . . . . . 0.473 ' HD3' ' HA ' ' A' 1642 ' ' THR . 2.5 Cg_endo -81.66 -7.1 12.58 Favored 'Trans proline' 0 C--N 1.332 -0.302 0 C-N-CA 123.026 2.484 . . . . 1.09 111.323 177.008 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A 1644 ' ' LEU . . . . . . . . . . . . . 4.0 pp -89.14 3.94 50.19 Favored 'General case' 0 C--N 1.312 -1.046 0 CA-C-N 115.155 -0.93 . . . . 2.08 112.084 -179.369 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A 1645 ' ' ALA . . . . . . . . . . . . . . . -78.22 -43.07 29.41 Favored 'General case' 0 C--N 1.314 -0.967 0 CA-C-O 122.031 0.919 . . . . 1.37 108.791 175.56 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A 1646 ' ' CYS . . . . . . . . . . . . . 24.0 p -159.29 129.87 5.87 Favored 'General case' 0 N--CA 1.428 -1.557 0 N-CA-C 104.163 -2.532 . . . . 1.7 104.163 173.658 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A 1647 ' ' GLU . . . . . 0.402 ' HG3' ' HE1' ' A' 1527 ' ' PHE . 35.9 mt-10 . . . . . 0 C--N 1.285 -2.196 0 C-N-CA 120.198 -0.601 . . . . 2.92 110.968 -169.298 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A 1515 ' ' ASP . . . . . . . . . . . . . 5.3 t70 . . . . . 0 C--O 1.223 -0.29 0 N-CA-C 109.807 -0.442 . . . . 2.54 109.807 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A 1516 ' ' CYS . . . . . 0.582 ' SG ' ' HE3' ' A' 1579 ' ' LYS . 86.8 m -116.86 20.81 13.72 Favored 'General case' 0 C--N 1.302 -1.495 0 C-N-CA 124.088 0.955 . . . . 1.25 110.536 -176.116 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A 1517 ' ' GLN . . . . . . . . . . . . . 4.0 pt20 -109.69 126.24 53.48 Favored 'General case' 0 N--CA 1.422 -1.87 0 CA-C-N 115.523 -0.762 . . . . 2.36 109.169 177.737 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A 1518 ' ' VAL . . . . . 0.639 ' HB ' ' HB2' ' A' 1527 ' ' PHE . 59.3 t -93.45 127.82 45.27 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.233 0 N-CA-C 107.982 -1.118 . . . . 2.34 107.982 -179.962 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A 1519 ' ' THR . . . . . . . . . . . . . 11.3 m -115.02 117.83 31.69 Favored 'General case' 0 N--CA 1.417 -2.109 0 C-N-CA 120.369 -0.533 . . . . 2.04 109.917 -179.165 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A 1520 ' ' ASN . . . . . . . . . . . . . 41.8 t-20 -94.25 105.57 18.35 Favored Pre-proline 0 C--N 1.318 -0.794 0 N-CA-C 107.044 -1.465 . . . . 2.12 107.044 174.666 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A 1521 ' ' PRO . . . . . . . . . . . . . 21.2 Cg_exo -67.26 -21.78 47.42 Favored 'Trans proline' 0 C--N 1.351 0.672 0 C-N-CA 122.528 2.152 . . . . 2.59 113.663 -176.802 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A 1522 ' ' SER . . . . . . . . . . . . . 19.5 m -76.16 -40.1 53.34 Favored 'General case' 0 C--N 1.311 -1.108 0 N-CA-C 111.955 0.354 . . . . 2.65 111.955 -176.323 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A 1523 ' ' THR . . . . . 0.407 HG21 ' HB2' ' A' 1525 ' ' HIS . 14.4 t -107.01 -17.55 14.15 Favored 'General case' 0 CA--C 1.551 0.997 0 C-N-CA 119.525 -0.87 . . . . 2.33 111.268 179.418 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A 1524 ' ' GLY . . . . . . . . . . . . . . . 82.0 17.06 70.72 Favored Glycine 0 N--CA 1.45 -0.4 0 C-N-CA 121.171 -0.538 . . . . 1.96 112.093 -179.713 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A 1525 ' ' HIS . . . . . 0.407 ' HB2' HG21 ' A' 1523 ' ' THR . 7.3 t60 -84.19 135.08 34.51 Favored 'General case' 0 C--N 1.313 -0.999 0 N-CA-C 108.994 -0.743 . . . . 2.44 108.994 -177.672 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A 1526 ' ' LEU . . . . . . . . . . . . . 3.3 tm? -113.87 121.42 43.93 Favored 'General case' 0 C--N 1.3 -1.56 0 N-CA-C 108.415 -0.957 . . . . 2.19 108.415 -176.349 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A 1527 ' ' PHE . . . . . 0.639 ' HB2' ' HB ' ' A' 1518 ' ' VAL . 69.9 m-85 -104.2 116.12 31.61 Favored 'General case' 0 C--N 1.304 -1.395 0 N-CA-C 109.641 -0.503 . . . . 1.61 109.641 -178.601 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A 1528 ' ' ASP . . . . . 0.473 ' O ' HD11 ' A' 1532 ' ' LEU . 11.6 t70 -95.69 102.52 14.32 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-N 117.576 0.171 . . . . 2.18 110.782 -179.977 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A 1529 ' ' LEU . . . . . . . . . . . . . 6.4 mp -89.77 -7.58 54.11 Favored 'General case' 0 C--N 1.318 -0.785 0 CA-C-O 120.8 0.333 . . . . 2.04 111.777 179.305 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A 1530 ' ' SER . . . . . 0.441 ' OG ' ' HB2' ' A' 1516 ' ' CYS . 50.2 m -72.51 -48.54 39.7 Favored 'General case' 0 C--N 1.313 -0.993 0 CA-C-N 116.369 -0.378 . . . . 1.44 111.265 -178.108 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A 1531 ' ' SER . . . . . . . . . . . . . 8.2 m -70.4 -17.17 63.02 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 116.173 -0.467 . . . . 1.63 111.672 -175.993 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A 1532 ' ' LEU . . . . . 0.493 ' HB3' HG13 ' A' 1552 ' ' ILE . 9.8 mp -68.19 -13.72 62.44 Favored 'General case' 0 N--CA 1.466 0.35 0 CA-C-N 116.255 -0.429 . . . . 2.32 112.042 177.52 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A 1533 ' ' SER . . . . . . . . . . . . . 10.9 m -110.24 106.42 15.83 Favored 'General case' 0 N--CA 1.437 -1.105 0 N-CA-C 109.162 -0.681 . . . . 2.57 109.162 178.952 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A 1534 ' ' GLY . . . . . . . . . . . . . . . -92.21 -110.67 1.82 Allowed Glycine 0 N--CA 1.436 -1.312 0 C-N-CA 121.179 -0.534 . . . . 1.89 111.813 178.065 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A 1535 ' ' ARG . . . . . . . . . . . . . 42.8 ttm180 -95.61 -53.85 3.58 Favored 'General case' 0 C--N 1.31 -1.129 0 CA-C-O 121.081 0.467 . . . . 4.44 110.612 178.369 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A 1536 ' ' ALA . . . . . . . . . . . . . . . -96.64 -29.95 13.54 Favored 'General case' 0 C--N 1.316 -0.877 0 CA-C-O 121.044 0.449 . . . . 2.07 110.459 177.745 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A 1537 ' ' GLY . . . . . . . . . . . . . . . 70.69 -128.17 17.25 Favored Glycine 0 CA--C 1.499 -0.922 0 CA-C-N 115.515 -0.766 . . . . 1.2 112.166 178.278 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A 1538 ' ' PHE . . . . . 0.477 ' CD1' HD13 ' A' 1552 ' ' ILE . 29.8 m-85 -114.26 122.96 48.36 Favored 'General case' 0 CA--C 1.497 -1.074 0 N-CA-C 109.639 -0.504 . . . . 1.98 109.639 179.122 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A 1539 ' ' THR . . . . . . . . . . . . . 38.0 p -102.38 141.78 34.66 Favored 'General case' 0 C--N 1.286 -2.161 0 CA-C-N 115.454 -0.793 . . . . 1.97 111.329 -175.581 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A 1540 ' ' ALA . . . . . . . . . . . . . . . -118.79 159.03 24.46 Favored 'General case' 0 C--N 1.308 -1.213 0 N-CA-C 108.643 -0.873 . . . . 1.39 108.643 179.356 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A 1541 ' ' ALA . . . . . . . . . . . . . . . -99.48 141.5 32.19 Favored 'General case' 0 C--N 1.306 -1.313 0 CA-C-O 120.887 0.375 . . . . 1.86 111.231 -177.618 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A 1542 ' ' TYR . . . . . . . . . . . . . 76.7 t80 -141.68 177.57 8.06 Favored 'General case' 0 C--N 1.314 -0.95 0 N-CA-C 108.442 -0.947 . . . . 2.4 108.442 -178.415 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A 1543 ' ' SER . . . . . . . . . . . . . 5.3 m -45.91 -151.35 0.0 OUTLIER 'General case' 0 CA--C 1.578 2.034 0 C-N-CA 129.52 3.128 . . . . 2.58 114.259 177.14 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A 1544 ' ' LYS . . . . . . . . . . . . . 64.6 mttp -41.93 -32.87 0.47 Allowed 'General case' 0 N--CA 1.492 1.666 0 N-CA-C 115.064 1.505 . . . . 4.24 115.064 -177.678 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A 1545 ' ' SER . . . . . . . . . . . . . 6.0 t -67.29 -22.83 65.63 Favored 'General case' 0 CA--C 1.56 1.334 0 CA-C-N 117.877 0.308 . . . . 3.6 110.919 178.148 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A 1546 ' ' GLY . . . . . . . . . . . . . . . 88.6 -76.13 1.92 Allowed Glycine 0 N--CA 1.439 -1.105 0 C-N-CA 121.046 -0.597 . . . . 1.66 114.193 174.689 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A 1547 ' ' VAL . . . . . . . . . . . . . 88.2 t -122.87 144.3 32.82 Favored 'Isoleucine or valine' 0 N--CA 1.417 -2.098 0 C-N-CA 122.748 0.419 . . . . 2.23 110.108 -174.272 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A 1548 ' ' VAL . . . . . . . . . . . . . 10.7 t -113.09 136.06 50.62 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.308 0 N-CA-C 106.456 -1.683 . . . . 1.59 106.456 175.573 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A 1549 ' ' TYR . . . . . 0.522 ' CE2' ' HA2' ' A' 1568 ' ' GLY . 31.2 m-85 -91.63 146.91 23.4 Favored 'General case' 0 C--N 1.301 -1.508 0 N-CA-C 105.316 -2.105 . . . . 1.58 105.316 172.75 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A 1550 ' ' MET . . . . . . . . . . . . . 46.7 ttp -156.69 141.09 16.67 Favored 'General case' 0 C--N 1.292 -1.917 0 N-CA-C 109.12 -0.696 . . . . 2.08 109.12 -179.221 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A 1551 ' ' SER . . . . . . . . . . . . . 64.0 p -89.54 153.48 20.75 Favored 'General case' 0 N--CA 1.414 -2.274 0 N-CA-C 107.937 -1.134 . . . . 1.9 107.937 177.114 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A 1552 ' ' ILE . . . . . 0.493 HG13 ' HB3' ' A' 1532 ' ' LEU . 46.2 mm -83.97 -32.29 8.47 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.708 0 N-CA-C 107.595 -1.261 . . . . 2.04 107.595 178.627 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A 1553 ' ' CYS . . . . . 0.516 ' HA ' ' HH ' ' A' 1592 ' ' TYR . 36.6 t -162.44 137.62 7.01 Favored 'General case' 0 N--CA 1.43 -1.472 0 CA-C-N 115.547 -0.751 . . . . 1.43 109.125 165.836 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A 1554 ' ' GLY . . . . . . . . . . . . . . . 85.91 -124.39 6.84 Favored Glycine 0 CA--C 1.473 -2.549 0 N-CA-C 110.201 -1.16 . . . . 1.23 110.201 -178.641 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A 1555 ' ' GLU . . . . . 0.403 ' H ' ' CD ' ' A' 1555 ' ' GLU . 0.1 OUTLIER -117.93 -177.53 3.28 Favored 'General case' 0 C--N 1.258 -3.401 0 CA-C-N 113.538 -1.331 . . . . 1.8 108.516 -176.522 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A 1556 ' ' ASN . . . . . . . . . . . . . 41.3 t30 165.31 -158.91 0.0 OUTLIER 'General case' 0 C--O 1.255 1.365 0 N-CA-C 103.096 -2.927 . . . . 2.63 103.096 -174.209 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A 1557 ' ' GLU . . . . . 0.416 ' HG2' ' HB3' ' A' 1549 ' ' TYR . 26.0 mt-10 83.49 178.72 0.05 Allowed 'General case' 0 CA--C 1.497 -1.058 0 N-CA-C 115.814 1.783 . . . . 3.79 115.814 159.713 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A 1558 ' ' ASN . . . . . . . . . . . . . 33.2 m-80 -127.97 43.06 3.21 Favored 'General case' 0 C--N 1.307 -1.273 0 CA-C-N 113.358 -1.747 . . . . 1.59 107.948 -173.541 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A 1559 ' ' CYS . . . . . . . . . . . . . 84.2 m -131.85 172.37 7.48 Favored Pre-proline 0 C--N 1.293 -1.889 0 CA-C-N 113.666 -1.607 . . . . 0.94 106.885 -179.609 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A 1560 ' ' PRO . . . . . . . . . . . . . 99.7 Cg_exo -48.73 116.21 2.02 Favored 'Trans proline' 0 C--N 1.361 1.209 0 C-N-CA 122.177 1.918 . . . . 1.53 110.591 172.756 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A 1561 ' ' PRO . . . . . . . . . . . . . 12.4 Cg_endo -53.63 142.51 60.51 Favored 'Trans proline' 0 C--N 1.354 0.828 0 C-N-CA 124.35 3.367 . . . . 1.82 113.988 -172.854 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A 1562 ' ' GLY . . . . . . . . . . . . . . . 112.28 9.24 20.27 Favored Glycine 0 N--CA 1.437 -1.277 0 N-CA-C 110.687 -0.965 . . . . 0.81 110.687 -179.71 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A 1563 ' ' VAL . . . . . . . . . . . . . 4.8 m -99.66 154.23 4.27 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.838 0 N-CA-C 109.357 -0.609 . . . . 1.73 109.357 176.049 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A 1564 ' ' GLY . . . . . . . . . . . . . . . -115.94 -6.43 16.5 Favored Glycine 0 N--CA 1.421 -2.324 0 N-CA-C 110.36 -1.096 . . . . 0.72 110.36 175.408 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A 1565 ' ' ALA . . . . . . . . . . . . . . . -168.78 119.2 0.74 Allowed 'General case' 0 C--O 1.259 1.577 0 N-CA-C 108.969 -0.752 . . . . 1.14 108.969 -179.347 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A 1566 ' ' CYS . . . . . . . . . . . . . 35.8 t -141.72 141.29 33.27 Favored 'General case' 0 C--N 1.297 -1.686 0 CA-C-N 115.368 -0.833 . . . . 0.51 111.2 -174.064 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A 1567 ' ' PHE . . . . . . . . . . . . . 15.7 m-85 -66.6 126.94 30.49 Favored 'General case' 0 C--O 1.219 -0.51 0 N-CA-C 109.723 -0.473 . . . . 1.22 109.723 176.197 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A 1568 ' ' GLY . . . . . 0.522 ' HA2' ' CE2' ' A' 1549 ' ' TYR . . . -66.86 -33.22 83.38 Favored Glycine 0 N--CA 1.444 -0.83 0 CA-C-N 115.748 -0.66 . . . . 1.08 114.167 -175.109 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A 1569 ' ' GLN . . . . . . . . . . . . . 8.8 tt0 -84.45 -52.86 5.84 Favored 'General case' 0 C--N 1.303 -1.436 0 CA-C-O 121.686 0.755 . . . . 3.05 110.707 -179.576 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A 1570 ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -83.29 -14.68 52.53 Favored 'General case' 0 C--N 1.296 -1.721 0 CA-C-N 114.884 -1.053 . . . . 2.44 112.463 -169.745 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A 1571 ' ' ARG . . . . . . . . . . . . . 49.3 mtp180 54.97 37.23 28.51 Favored 'General case' 0 N--CA 1.476 0.855 0 C-N-CA 125.864 1.666 . . . . 4.48 111.95 -179.644 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A 1572 ' ' ILE . . . . . . . . . . . . . 45.9 mm -107.01 132.78 53.49 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.126 0 CA-C-N 115.347 -0.842 . . . . 1.94 109.359 -178.349 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A 1573 ' ' SER . . . . . . . . . . . . . 33.0 t -73.83 131.58 41.67 Favored 'General case' 0 N--CA 1.428 -1.528 0 CA-C-N 114.997 -1.001 . . . . 1.25 110.607 179.858 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A 1574 ' ' VAL . . . . . 1.004 ' HA ' ' HB3' ' A' 1596 ' ' SER . 34.0 m -109.85 -32.69 2.34 Favored 'Isoleucine or valine' 0 N--CA 1.419 -1.978 0 C-N-CA 119.976 -0.69 . . . . 1.61 109.864 171.984 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A 1575 ' ' GLY . . . . . . . . . . . . . . . -133.51 121.8 2.91 Favored Glycine 0 N--CA 1.425 -2.088 0 N-CA-C 110.372 -1.091 . . . . 0.65 110.372 178.762 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A 1576 ' ' LYS . . . . . . . . . . . . . 88.0 tttt -80.49 149.15 30.16 Favored 'General case' 0 C--N 1.311 -1.1 0 N-CA-C 108.578 -0.897 . . . . 3.33 108.578 179.637 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A 1577 ' ' ALA . . . . . . . . . . . . . . . -61.88 102.35 0.27 Allowed 'General case' 0 CA--C 1.516 -0.357 0 O-C-N 123.928 0.768 . . . . 1.31 111.141 -177.81 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A 1578 ' ' ASN . . . . . . . . . . . . . 73.4 m-20 -120.87 115.19 22.75 Favored 'General case' 0 C--N 1.297 -1.699 0 N-CA-C 106.487 -1.672 . . . . 2.24 106.487 175.638 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A 1579 ' ' LYS . . . . . 0.582 ' HE3' ' SG ' ' A' 1516 ' ' CYS . 55.6 mtpt -83.35 90.17 7.12 Favored 'General case' 0 C--N 1.295 -1.781 0 N-CA-C 107.724 -1.213 . . . . 2.34 107.724 -179.047 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A 1580 ' ' ARG . . . . . 0.402 HH11 ' HD2' ' A' 1580 ' ' ARG . 26.0 ttt85 -150.96 113.91 4.75 Favored 'General case' 0 N--CA 1.424 -1.734 0 CA-C-N 114.847 -1.07 . . . . 4.19 109.667 -175.579 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A 1581 ' ' LEU . . . . . . . . . . . . . 3.5 pp -134.04 161.73 34.03 Favored 'General case' 0 C--N 1.292 -1.915 0 CA-C-N 115.776 -0.647 . . . . 2.39 109.721 179.425 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A 1582 ' ' ARG . . . . . . . . . . . . . 79.1 ttt180 -138.15 129.39 27.45 Favored 'General case' 0 C--N 1.292 -1.892 0 C-N-CA 121.134 -0.227 . . . . 4.48 110.444 176.999 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A 1583 ' ' TYR . . . . . . . . . . . . . 36.7 t80 -93.07 102.6 14.93 Favored 'General case' 0 C--N 1.3 -1.583 0 N-CA-C 107.185 -1.413 . . . . 1.57 107.185 173.662 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A 1584 ' ' VAL . . . . . . . . . . . . . 7.5 p -135.87 120.93 27.85 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.949 0 C-N-CA 120.875 -0.33 . . . . 2.29 111.463 -177.293 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A 1585 ' ' ASP . . . . . . . . . . . . . 35.3 t70 53.08 45.73 28.14 Favored 'General case' 0 N--CA 1.488 1.435 0 C-N-CA 124.453 1.101 . . . . 2.06 111.12 178.367 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A 1586 ' ' GLN . . . . . . . . . . . . . 47.0 mt-30 58.13 25.83 12.94 Favored 'General case' 0 C--O 1.242 0.685 0 C-N-CA 125.377 1.471 . . . . 2.61 114.587 179.675 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A 1587 ' ' VAL . . . . . . . . . . . . . 8.1 p -128.45 126.17 65.12 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.314 0 N-CA-C 107.895 -1.15 . . . . 1.33 107.895 171.737 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A 1588 ' ' LEU . . . . . 0.562 ' HB2' ' HB2' ' A' 1612 ' ' PHE . 34.6 mt -86.22 138.99 31.45 Favored 'General case' 0 C--N 1.304 -1.396 0 N-CA-C 108.991 -0.744 . . . . 2.03 108.991 -179.918 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A 1589 ' ' GLN . . . . . . . . . . . . . 34.6 tt0 -130.59 107.0 8.87 Favored 'General case' 0 C--N 1.292 -1.929 0 N-CA-C 109.397 -0.594 . . . . 1.73 109.397 -177.278 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A 1590 ' ' LEU . . . . . . . . . . . . . 9.1 tt -111.82 137.16 50.15 Favored 'General case' 0 C--N 1.288 -2.07 0 N-CA-C 107.744 -1.206 . . . . 1.76 107.744 179.031 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A 1591 ' ' VAL . . . . . 0.505 HG11 HG21 ' A' 1609 ' ' VAL . 28.8 m -130.55 140.58 48.44 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.937 0 N-CA-C 112.233 0.457 . . . . 2.14 112.233 -175.431 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A 1592 ' ' TYR . . . . . 0.516 ' HH ' ' HA ' ' A' 1553 ' ' CYS . 39.6 m-85 -122.09 138.69 54.36 Favored 'General case' 0 C--N 1.313 -1.01 0 N-CA-C 108.128 -1.064 . . . . 1.53 108.128 172.948 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A 1593 ' ' LYS . . . . . . . . . . . . . 62.5 pttt -159.25 174.85 14.17 Favored 'General case' 0 C--O 1.251 1.133 0 N-CA-C 109.899 -0.408 . . . . 2.72 109.899 178.8 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A 1594 ' ' ASP . . . . . . . . . . . . . 31.6 m-20 67.54 56.93 0.57 Allowed 'General case' 0 N--CA 1.48 1.03 0 C-N-CA 124.376 1.07 . . . . 1.45 110.888 179.592 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A 1595 ' ' GLY . . . . . . . . . . . . . . . -142.1 -47.92 0.05 OUTLIER Glycine 0 C--N 1.308 -1.026 0 CA-C-N 115.054 -0.976 . . . . 0.83 111.362 -179.578 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A 1596 ' ' SER . . . . . 1.004 ' HB3' ' HA ' ' A' 1574 ' ' VAL . 15.8 p -96.69 134.21 23.51 Favored Pre-proline 0 C--N 1.298 -1.638 0 CA-C-N 115.526 -0.337 . . . . 1.96 111.545 179.031 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A 1597 ' ' PRO . . . . . 0.432 ' HD3' ' HA ' ' A' 1596 ' ' SER . 3.0 Cg_exo -79.77 113.56 3.07 Favored 'Trans proline' 0 N--CA 1.445 -1.373 0 C-N-CA 122.176 1.917 . . . . 1.34 108.593 170.863 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A 1598 ' ' CYS . . . . . . . . . . . . . 48.6 t -94.87 122.66 59.86 Favored Pre-proline 0 C--N 1.306 -1.326 0 N-CA-C 109.727 -0.471 . . . . 1.19 109.727 -176.3 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A 1599 ' ' PRO . . . . . . . . . . . . . 87.9 Cg_endo -77.97 0.6 9.7 Favored 'Trans proline' 0 CA--C 1.537 0.67 0 C-N-CA 123.384 2.723 . . . . 1.88 114.267 -175.463 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A 1600 ' ' SER . . . . . . . . . . . . . 19.9 m -77.9 -32.18 51.65 Favored 'General case' 0 C--N 1.308 -1.223 0 CA-C-O 120.677 0.275 . . . . 2.19 111.288 -179.679 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A 1601 ' ' LYS . . . . . 0.89 ' HB3' HD12 ' A' 1604 ' ' LEU . 11.2 tmtt? -158.92 129.98 6.19 Favored 'General case' 0 C--N 1.313 -0.993 0 N-CA-C 105.691 -1.966 . . . . 4.21 105.691 -177.13 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A 1602 ' ' SER . . . . . . . . . . . . . 16.4 m -67.36 125.41 26.02 Favored 'General case' 0 C--N 1.316 -0.852 0 CA-C-O 120.886 0.374 . . . . 3.82 110.591 -175.222 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A 1603 ' ' GLY . . . . . . . . . . . . . . . 103.83 -6.27 47.9 Favored Glycine 0 N--CA 1.435 -1.382 0 N-CA-C 110.918 -0.873 . . . . 2.45 110.918 -179.937 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A 1604 ' ' LEU . . . . . 0.89 HD12 ' HB3' ' A' 1601 ' ' LYS . 6.8 mt -89.19 148.26 23.73 Favored 'General case' 0 N--CA 1.43 -1.463 0 CA-C-O 121.425 0.631 . . . . 2.06 111.851 178.209 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A 1605 ' ' SER . . . . . 0.415 ' HA ' ' O ' ' A' 1596 ' ' SER . 8.3 t -130.45 163.58 26.64 Favored 'General case' 0 N--CA 1.413 -2.287 0 N-CA-C 104.673 -2.344 . . . . 1.75 104.673 176.561 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A 1606 ' ' TYR . . . . . 0.562 ' HA ' ' O ' ' A' 1634 ' ' CYS . 67.6 m-85 -90.22 116.01 27.88 Favored 'General case' 0 CA--C 1.458 -2.563 0 N-CA-C 106.331 -1.729 . . . . 1.59 106.331 -179.852 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A 1607 ' ' LYS . . . . . 0.512 ' HZ2' HG22 ' A' 1635 ' ' THR . 23.3 pttp -103.23 127.41 50.55 Favored 'General case' 0 N--CA 1.394 -3.226 0 C-N-CA 118.196 -1.401 . . . . 2.21 109.496 -176.738 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A 1608 ' ' SER . . . . . 0.517 ' HA ' ' HB2' ' A' 1636 ' ' LEU . 12.0 p -97.43 111.31 23.62 Favored 'General case' 0 N--CA 1.407 -2.62 0 CA-C-N 115.118 -0.946 . . . . 1.48 109.287 -177.186 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A 1609 ' ' VAL . . . . . 0.505 HG21 HG11 ' A' 1591 ' ' VAL . 85.5 t -101.35 107.84 22.24 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.523 0 N-CA-C 108.166 -1.049 . . . . 1.57 108.166 179.747 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A 1610 ' ' ILE . . . . . 0.432 HD12 ' N ' ' A' 1610 ' ' ILE . 2.5 mp -93.28 108.7 20.77 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.561 0 N-CA-C 108.274 -1.01 . . . . 1.47 108.274 179.023 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A 1611 ' ' SER . . . . . . . . . . . . . 21.8 m -94.52 113.92 25.83 Favored 'General case' 0 N--CA 1.409 -2.509 0 N-CA-C 108.232 -1.025 . . . . 1.84 108.232 177.346 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A 1612 ' ' PHE . . . . . 0.562 ' HB2' ' HB2' ' A' 1588 ' ' LEU . 79.8 m-85 -84.89 106.84 16.71 Favored 'General case' 0 C--N 1.291 -1.941 0 CA-C-N 115.067 -0.97 . . . . 0.86 110.57 -178.24 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A 1613 ' ' VAL . . . . . . . . . . . . . 41.9 t -94.92 119.68 43.3 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.52 0 CA-C-N 115.279 -0.873 . . . . 1.32 109.067 -177.051 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A 1614 ' ' CYS . . . . . 0.501 ' HB3' ' HB2' ' A' 1646 ' ' CYS . 56.2 m -71.45 92.33 1.09 Allowed 'General case' 0 C--N 1.314 -0.958 0 CA-C-O 121.377 0.608 . . . . 1.39 109.381 178.241 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A 1615 ' ' ARG . . . . . 0.505 ' HB3' ' HB3' ' A' 1641 ' ' HIS . 0.6 OUTLIER -137.97 87.46 16.58 Favored Pre-proline 0 C--N 1.305 -1.36 0 N-CA-C 107.109 -1.441 . . . . 4.34 107.109 -178.904 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A 1616 ' ' PRO . . . . . 0.437 ' HA ' ' HB3' ' A' 1643 ' ' PRO . 6.6 Cg_exo -76.34 44.79 1.43 Allowed 'Trans proline' 0 N--CA 1.479 0.635 0 C-N-CA 123.459 2.772 . . . . 1.5 112.768 -177.449 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A 1617 ' ' GLU . . . . . . . . . . . . . 41.8 mt-10 . . . . . 0 C--N 1.303 -1.44 0 N-CA-C 108.201 -1.036 . . . . 3.21 108.201 -179.276 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A 1622 ' ' ASN . . . . . . . . . . . . . 60.6 t30 . . . . . 0 N--CA 1.472 0.65 0 CA-C-O 121.81 0.814 . . . . 3.58 110.761 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A 1623 ' ' ARG . . . . . . . . . . . . . 9.2 ptm180 -154.0 153.49 28.61 Favored Pre-proline 0 C--N 1.3 -1.566 0 N-CA-C 107.28 -1.378 . . . . 4.09 107.28 -178.922 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A 1624 ' ' PRO . . . . . . . . . . . . . 32.5 Cg_exo -61.29 119.82 7.16 Favored 'Trans proline' 0 C--O 1.245 0.87 0 C-N-CA 122.761 2.307 . . . . 2.86 111.751 179.246 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A 1625 ' ' MET . . . . . . . . . . . . . 56.3 ttp -95.99 130.7 42.92 Favored 'General case' 0 C--N 1.301 -1.522 0 CA-C-N 115.082 -0.963 . . . . 2.73 109.688 -177.228 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A 1626 ' ' LEU . . . . . 0.699 HD21 HD21 ' A' 1629 ' ' LEU . 56.8 tp -83.53 105.73 14.7 Favored 'General case' 0 C--N 1.306 -1.304 0 N-CA-C 107.8 -1.185 . . . . 1.94 107.8 178.001 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A 1627 ' ' ILE . . . . . . . . . . . . . 45.4 pt -83.19 -33.61 10.36 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.268 0 N-CA-C 112.303 0.483 . . . . 1.75 112.303 -175.1 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A 1628 ' ' SER . . . . . . . . . . . . . 45.7 m -149.75 147.49 28.08 Favored 'General case' 0 C--N 1.313 -1.001 0 CA-C-O 120.673 0.273 . . . . 1.85 110.475 -178.077 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A 1629 ' ' LEU . . . . . 0.699 HD21 HD21 ' A' 1626 ' ' LEU . 1.2 tm? -127.76 108.41 10.72 Favored 'General case' 0 C--N 1.307 -1.255 0 N-CA-C 106.61 -1.626 . . . . 2.12 106.61 -179.216 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A 1630 ' ' ASP . . . . . . . . . . . . . 15.3 t70 -107.7 112.08 24.59 Favored 'General case' 0 C--N 1.304 -1.399 0 N-CA-C 109.056 -0.72 . . . . 0.87 109.056 178.771 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A 1631 ' ' LYS . . . . . . . . . . . . . 63.4 mttm -80.0 -22.5 42.41 Favored 'General case' 0 C--N 1.303 -1.426 0 N-CA-C 112.674 0.62 . . . . 2.76 112.674 -177.186 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A 1632 ' ' GLN . . . . . . . . . . . . . 1.7 mp0 -78.77 -49.96 12.14 Favored 'General case' 0 CA--C 1.509 -0.61 0 CA-C-O 121.029 0.442 . . . . 2.55 111.467 -173.277 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A 1633 ' ' THR . . . . . . . . . . . . . 60.4 p -86.57 -4.52 59.18 Favored 'General case' 0 C--N 1.313 -1.011 0 CA-C-O 121.875 0.845 . . . . 1.92 110.004 179.764 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A 1634 ' ' CYS . . . . . 0.562 ' O ' ' HA ' ' A' 1606 ' ' TYR . 29.4 m 59.62 51.05 6.65 Favored 'General case' 0 N--CA 1.441 -0.907 0 CA-C-N 113.442 -1.708 . . . . 0.89 108.768 179.712 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A 1635 ' ' THR . . . . . 0.512 HG22 ' HZ2' ' A' 1607 ' ' LYS . 39.7 m -114.94 130.26 56.88 Favored 'General case' 0 N--CA 1.425 -1.699 0 CA-C-N 114.999 -1.001 . . . . 1.31 110.087 -175.831 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A 1636 ' ' LEU . . . . . 0.517 ' HB2' ' HA ' ' A' 1608 ' ' SER . 40.6 mt -112.62 116.06 29.59 Favored 'General case' 0 N--CA 1.435 -1.223 0 N-CA-C 107.58 -1.267 . . . . 1.97 107.58 -178.479 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A 1637 ' ' PHE . . . . . . . . . . . . . 89.1 m-85 -98.68 100.92 12.19 Favored 'General case' 0 C--N 1.307 -1.282 0 N-CA-C 111.777 0.288 . . . . 0.92 111.777 -175.298 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A 1638 ' ' PHE . . . . . . . . . . . . . 68.0 m-85 -100.74 138.84 37.26 Favored 'General case' 0 C--N 1.307 -1.258 0 N-CA-C 109.169 -0.678 . . . . 0.7 109.169 176.165 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A 1639 ' ' SER . . . . . . . . . . . . . 50.8 m -136.79 120.75 17.61 Favored 'General case' 0 C--N 1.279 -2.467 0 N-CA-C 108.464 -0.939 . . . . 1.46 108.464 174.883 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A 1640 ' ' TRP . . . . . . . . . . . . . 19.7 t90 -111.76 119.89 40.16 Favored 'General case' 0 C--N 1.292 -1.898 0 CA-C-N 115.942 -0.572 . . . . 0.92 109.501 -178.131 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A 1641 ' ' HIS . . . . . 0.505 ' HB3' ' HB3' ' A' 1615 ' ' ARG . 39.8 m170 -77.06 107.46 9.44 Favored 'General case' 0 C--N 1.31 -1.138 0 N-CA-C 106.347 -1.723 . . . . 3.18 106.347 174.718 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A 1642 ' ' THR . . . . . . . . . . . . . 8.8 t -140.92 136.93 16.56 Favored Pre-proline 0 C--N 1.291 -1.952 0 N-CA-C 113.126 0.787 . . . . 1.48 113.126 -173.711 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A 1643 ' ' PRO . . . . . 0.437 ' HB3' ' HA ' ' A' 1616 ' ' PRO . 64.4 Cg_endo -76.97 -2.93 13.2 Favored 'Trans proline' 0 C--O 1.199 -1.462 0 C-N-CA 123.475 2.783 . . . . 1.09 111.006 173.735 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A 1644 ' ' LEU . . . . . . . . . . . . . 83.6 mt -91.84 -9.67 42.56 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 116.608 -0.269 . . . . 2.08 111.417 -177.968 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A 1645 ' ' ALA . . . . . . . . . . . . . . . -81.67 -35.98 29.29 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 121.805 0.812 . . . . 1.37 109.128 177.45 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A 1646 ' ' CYS . . . . . 0.501 ' HB2' ' HB3' ' A' 1614 ' ' CYS . 71.2 m -142.19 114.76 8.48 Favored 'General case' 0 N--CA 1.426 -1.645 0 N-CA-C 105.499 -2.037 . . . . 1.7 105.499 174.786 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A 1647 ' ' GLU . . . . . . . . . . . . . 42.2 mt-10 . . . . . 0 C--N 1.3 -1.56 0 N-CA-C 109.137 -0.69 . . . . 2.92 109.137 -178.413 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A 1515 ' ' ASP . . . . . . . . . . . . . 7.0 t0 . . . . . 0 N--CA 1.449 -0.491 0 N-CA-C 107.061 -1.459 . . . . 2.54 107.061 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A 1516 ' ' CYS . . . . . . . . . . . . . 81.3 m -90.65 61.53 4.87 Favored 'General case' 0 C--N 1.28 -2.422 0 C-N-CA 123.599 0.76 . . . . 1.25 109.183 -179.761 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A 1517 ' ' GLN . . . . . . . . . . . . . 9.8 pt20 -160.97 131.9 5.39 Favored 'General case' 0 C--N 1.308 -1.211 0 CA-C-O 120.803 0.335 . . . . 2.36 110.695 179.219 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A 1518 ' ' VAL . . . . . . . . . . . . . 14.1 p -131.88 137.32 55.19 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.804 0 N-CA-C 109.053 -0.721 . . . . 2.34 109.053 178.429 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A 1519 ' ' THR . . . . . 0.623 ' HA ' ' HA ' ' A' 1526 ' ' LEU . 40.0 m -89.37 128.65 35.93 Favored 'General case' 0 C--N 1.29 -1.98 0 CA-C-N 116.182 -0.463 . . . . 2.04 109.758 177.891 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A 1520 ' ' ASN . . . . . . . . . . . . . 17.7 t-20 -80.1 114.3 45.6 Favored Pre-proline 0 C--N 1.308 -1.228 0 N-CA-C 108.473 -0.936 . . . . 2.12 108.473 174.758 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A 1521 ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -74.63 0.2 9.0 Favored 'Trans proline' 0 CA--C 1.539 0.767 0 C-N-CA 122.541 2.16 . . . . 2.59 113.926 -176.371 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A 1522 ' ' SER . . . . . . . . . . . . . 49.3 m -88.79 -62.34 1.51 Allowed 'General case' 0 N--CA 1.432 -1.375 0 O-C-N 122.13 -0.356 . . . . 2.65 110.895 178.784 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A 1523 ' ' THR . . . . . . . . . . . . . 8.8 t -92.98 -11.89 32.09 Favored 'General case' 0 CA--C 1.547 0.858 0 CA-C-O 120.952 0.406 . . . . 2.33 111.253 -179.821 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A 1524 ' ' GLY . . . . . . . . . . . . . . . 80.33 27.79 50.81 Favored Glycine 0 C--N 1.332 0.329 0 C-N-CA 121.059 -0.591 . . . . 1.96 112.119 179.244 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A 1525 ' ' HIS . . . . . . . . . . . . . 16.1 t60 -101.22 119.18 38.36 Favored 'General case' 0 C--N 1.309 -1.169 0 N-CA-C 110.184 -0.302 . . . . 2.44 110.184 -176.802 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A 1526 ' ' LEU . . . . . 0.623 ' HA ' ' HA ' ' A' 1519 ' ' THR . 7.0 tt -82.72 124.73 30.5 Favored 'General case' 0 C--N 1.301 -1.533 0 N-CA-C 108.174 -1.047 . . . . 2.19 108.174 175.651 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A 1527 ' ' PHE . . . . . . . . . . . . . 76.4 m-85 -90.32 102.41 15.14 Favored 'General case' 0 C--N 1.309 -1.194 0 N-CA-C 109.183 -0.673 . . . . 1.61 109.183 178.233 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A 1528 ' ' ASP . . . . . . . . . . . . . 8.8 t70 -80.76 118.13 22.03 Favored 'General case' 0 C--N 1.309 -1.154 0 CA-C-O 121.336 0.588 . . . . 2.18 111.633 178.306 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A 1529 ' ' LEU . . . . . . . . . . . . . 6.2 mp -121.05 11.47 10.96 Favored 'General case' 0 C--N 1.307 -1.28 0 N-CA-C 106.496 -1.668 . . . . 2.04 106.496 168.149 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A 1530 ' ' SER . . . . . . . . . . . . . 42.9 m -76.18 -29.1 57.54 Favored 'General case' 0 N--CA 1.442 -0.867 0 CA-C-N 115.376 -0.829 . . . . 1.44 110.06 -178.615 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A 1531 ' ' SER . . . . . . . . . . . . . 29.0 t -75.32 -6.35 49.44 Favored 'General case' 0 CA--C 1.548 0.903 0 CA-C-O 122.303 1.049 . . . . 1.63 108.806 174.518 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A 1532 ' ' LEU . . . . . . . . . . . . . 98.1 mt -91.89 15.24 13.49 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.807 -0.633 . . . . 2.32 110.616 175.243 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A 1533 ' ' SER . . . . . 0.412 ' HA ' ' O ' ' A' 1553 ' ' CYS . 18.8 m -84.56 122.11 28.57 Favored 'General case' 0 N--CA 1.432 -1.35 0 N-CA-C 108.619 -0.882 . . . . 2.57 108.619 175.668 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A 1534 ' ' GLY . . . . . . . . . . . . . . . -135.92 152.77 21.15 Favored Glycine 0 N--CA 1.419 -2.448 0 N-CA-C 110.594 -1.002 . . . . 1.89 110.594 -179.255 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A 1535 ' ' ARG . . . . . 0.564 ' HG3' ' HG3' ' A' 1555 ' ' GLU . 51.2 ttt180 -96.44 -25.13 15.8 Favored 'General case' 0 C--N 1.306 -1.283 0 CA-C-O 121.669 0.747 . . . . 4.44 109.886 179.049 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A 1536 ' ' ALA . . . . . . . . . . . . . . . -89.72 -41.03 12.14 Favored 'General case' 0 C--O 1.243 0.732 0 CA-C-N 115.587 -0.733 . . . . 2.07 110.849 -179.043 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A 1537 ' ' GLY . . . . . . . . . . . . . . . 97.7 -175.95 30.62 Favored Glycine 0 N--CA 1.435 -1.382 0 CA-C-N 115.761 -0.654 . . . . 1.2 112.477 176.75 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A 1538 ' ' PHE . . . . . . . . . . . . . 92.1 m-85 -111.64 155.09 23.94 Favored 'General case' 0 C--N 1.302 -1.49 0 N-CA-C 108.212 -1.033 . . . . 1.98 108.212 176.687 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A 1539 ' ' THR . . . . . . . . . . . . . 5.2 p -106.27 111.08 23.52 Favored 'General case' 0 C--N 1.295 -1.761 0 CA-C-N 116.016 -0.538 . . . . 1.97 111.538 -179.704 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A 1540 ' ' ALA . . . . . . . . . . . . . . . -112.32 107.63 16.53 Favored 'General case' 0 C--N 1.313 -0.988 0 N-CA-C 109.027 -0.731 . . . . 1.39 109.027 176.014 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A 1541 ' ' ALA . . . . . . . . . . . . . . . -71.75 155.23 40.69 Favored 'General case' 0 C--N 1.312 -1.037 0 CA-C-N 116.261 -0.427 . . . . 1.86 110.644 178.705 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A 1542 ' ' TYR . . . . . 0.418 ' HD2' ' HB2' ' A' 1545 ' ' SER . 32.4 t80 -156.23 179.92 8.77 Favored 'General case' 0 C--N 1.302 -1.491 0 N-CA-C 107.708 -1.219 . . . . 2.4 107.708 -178.926 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A 1543 ' ' SER . . . . . . . . . . . . . 5.5 m -44.98 -151.67 0.0 OUTLIER 'General case' 0 CA--C 1.57 1.728 0 C-N-CA 129.181 2.993 . . . . 2.58 114.616 178.101 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A 1544 ' ' LYS . . . . . 0.404 ' HB2' ' HE3' ' A' 1544 ' ' LYS . 19.4 ptmt -54.7 -6.9 0.13 Allowed 'General case' 0 CA--C 1.575 1.931 0 O-C-N 120.251 -1.531 . . . . 4.24 114.021 176.511 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A 1545 ' ' SER . . . . . 0.418 ' HB2' ' HD2' ' A' 1542 ' ' TYR . 20.4 m -73.03 -17.4 61.44 Favored 'General case' 0 CA--C 1.554 1.132 0 C-N-CA 123.332 0.653 . . . . 3.6 109.693 170.668 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A 1546 ' ' GLY . . . . . . . . . . . . . . . 83.75 -80.38 1.83 Allowed Glycine 0 N--CA 1.436 -1.316 0 CA-C-O 121.43 0.461 . . . . 1.66 114.009 174.093 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A 1547 ' ' VAL . . . . . . . . . . . . . 7.1 p -160.16 140.77 3.78 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.169 0 N-CA-C 109.235 -0.654 . . . . 2.23 109.235 -174.738 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A 1548 ' ' VAL . . . . . . . . . . . . . 4.0 t -108.29 131.9 57.52 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.726 0 N-CA-C 107.399 -1.334 . . . . 1.59 107.399 179.398 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A 1549 ' ' TYR . . . . . . . . . . . . . 68.4 m-85 -93.15 114.64 27.2 Favored 'General case' 0 C--N 1.308 -1.207 0 N-CA-C 106.858 -1.534 . . . . 1.58 106.858 174.077 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A 1550 ' ' MET . . . . . . . . . . . . . 56.3 ttp -135.93 121.6 19.64 Favored 'General case' 0 C--N 1.299 -1.614 0 C-N-CA 119.706 -0.798 . . . . 2.08 111.388 -177.774 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A 1551 ' ' SER . . . . . 0.431 ' O ' ' OH ' ' A' 1592 ' ' TYR . 19.9 m -95.97 124.1 39.84 Favored 'General case' 0 C--N 1.277 -2.568 0 N-CA-C 104.801 -2.296 . . . . 1.9 104.801 173.017 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A 1552 ' ' ILE . . . . . . . . . . . . . 50.6 mm -60.86 -43.2 95.12 Favored 'Isoleucine or valine' 0 C--O 1.213 -0.854 0 N-CA-C 109.404 -0.591 . . . . 2.04 109.404 -179.037 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A 1553 ' ' CYS . . . . . 0.412 ' O ' ' HA ' ' A' 1533 ' ' SER . 76.1 m -144.71 155.87 43.79 Favored 'General case' 0 C--N 1.295 -1.782 0 N-CA-C 106.491 -1.67 . . . . 1.43 106.491 173.411 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A 1554 ' ' GLY . . . . . . . . . . . . . . . 118.26 -110.92 2.05 Favored Glycine 0 N--CA 1.434 -1.489 0 C-N-CA 120.342 -0.932 . . . . 1.23 112.763 176.427 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A 1555 ' ' GLU . . . . . 0.564 ' HG3' ' HG3' ' A' 1535 ' ' ARG . 9.5 pt-20 -165.34 161.94 19.33 Favored 'General case' 0 C--N 1.305 -1.33 0 N-CA-C 106.724 -1.584 . . . . 1.8 106.724 -178.207 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A 1556 ' ' ASN . . . . . . . . . . . . . 17.9 t-20 -131.34 103.65 6.57 Favored 'General case' 0 C--N 1.287 -2.136 0 N-CA-C 109.332 -0.618 . . . . 2.63 109.332 -179.209 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A 1557 ' ' GLU . . . . . . . . . . . . . 9.1 mm-40 -83.13 36.65 0.52 Allowed 'General case' 0 C--N 1.3 -1.576 0 N-CA-C 113.782 1.03 . . . . 3.79 113.782 -173.2 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A 1558 ' ' ASN . . . . . . . . . . . . . 33.0 m-80 -111.78 -19.35 12.47 Favored 'General case' 0 C--N 1.295 -1.802 0 N-CA-C 107.846 -1.168 . . . . 1.59 107.846 176.244 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A 1559 ' ' CYS . . . . . 0.778 ' HB3' ' HD2' ' A' 1560 ' ' PRO . 70.8 m -138.51 176.48 2.63 Favored Pre-proline 0 N--CA 1.436 -1.156 0 CA-C-O 116.866 -1.54 . . . . 0.94 107.088 -178.103 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A 1560 ' ' PRO . . . . . 0.778 ' HD2' ' HB3' ' A' 1559 ' ' CYS . 2.9 Cg_exo -33.2 126.93 0.13 Allowed 'Trans proline' 0 C--N 1.386 2.538 0 C-N-CA 124.578 3.518 . . . . 1.53 115.149 -177.412 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A 1561 ' ' PRO . . . . . 0.432 ' HD2' ' HA ' ' A' 1560 ' ' PRO . 9.5 Cg_endo -51.37 111.86 0.67 Allowed 'Trans proline' 0 C--O 1.246 0.898 0 C-N-CA 123.675 2.917 . . . . 1.82 112.98 -179.294 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A 1562 ' ' GLY . . . . . . . . . . . . . . . 111.39 2.94 27.63 Favored Glycine 0 N--CA 1.437 -1.255 0 CA-C-N 115.436 -0.802 . . . . 0.81 113.018 177.937 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A 1563 ' ' VAL . . . . . 0.544 ' HA ' ' HA ' ' A' 1576 ' ' LYS . 14.9 m -94.06 152.0 3.64 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.055 0 N-CA-C 106.288 -1.745 . . . . 1.73 106.288 172.723 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A 1564 ' ' GLY . . . . . 0.603 ' HA3' ' CE2' ' A' 1592 ' ' TYR . . . -113.86 -26.41 3.86 Favored Glycine 0 C--N 1.307 -1.059 0 C-N-CA 119.28 -1.438 . . . . 0.72 113.139 -175.986 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A 1565 ' ' ALA . . . . . . . . . . . . . . . -132.59 126.11 32.01 Favored 'General case' 0 C--O 1.251 1.181 0 N-CA-C 109.63 -0.507 . . . . 1.14 109.63 -178.779 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A 1566 ' ' CYS . . . . . . . . . . . . . 43.2 t -150.4 139.7 21.31 Favored 'General case' 0 C--N 1.311 -1.075 0 CA-C-N 115.728 -0.669 . . . . 0.51 110.064 -174.774 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A 1567 ' ' PHE . . . . . . . . . . . . . 26.5 m-85 -69.84 123.13 20.68 Favored 'General case' 0 CA--C 1.508 -0.665 0 N-CA-C 107.396 -1.335 . . . . 1.22 107.396 175.755 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A 1568 ' ' GLY . . . . . . . . . . . . . . . -74.66 -37.27 46.15 Favored Glycine 0 N--CA 1.441 -1.023 0 C-N-CA 120.677 -0.773 . . . . 1.08 113.769 -173.627 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A 1569 ' ' GLN . . . . . . . . . . . . . 50.1 tp60 -69.35 -48.61 60.82 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-O 121.976 0.893 . . . . 3.05 109.44 -178.947 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A 1570 ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -80.71 -23.08 39.75 Favored 'General case' 0 C--N 1.301 -1.537 0 CA-C-N 114.387 -1.279 . . . . 2.44 112.397 -173.498 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A 1571 ' ' ARG . . . . . . . . . . . . . 40.5 mtp-105 64.32 32.15 12.38 Favored 'General case' 0 N--CA 1.472 0.64 0 C-N-CA 125.035 1.334 . . . . 4.48 111.864 -178.833 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A 1572 ' ' ILE . . . . . . . . . . . . . 49.8 mm -109.66 118.98 58.02 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.227 0 N-CA-C 108.972 -0.751 . . . . 1.94 108.972 -178.361 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A 1573 ' ' SER . . . . . . . . . . . . . 36.7 t -67.28 140.08 57.32 Favored 'General case' 0 N--CA 1.435 -1.205 0 CA-C-N 115.064 -0.971 . . . . 1.25 109.453 178.379 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A 1574 ' ' VAL . . . . . 0.536 ' HB ' ' HB2' ' A' 1606 ' ' TYR . 23.0 m -116.01 -38.96 2.48 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.653 0 C-N-CA 119.978 -0.689 . . . . 1.61 110.663 178.606 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A 1575 ' ' GLY . . . . . 0.771 ' HA3' ' HB3' ' A' 1592 ' ' TYR . . . -135.87 133.1 6.45 Favored Glycine 0 N--CA 1.428 -1.836 0 C-N-CA 120.376 -0.916 . . . . 0.65 112.729 -177.592 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A 1576 ' ' LYS . . . . . 0.544 ' HA ' ' HA ' ' A' 1563 ' ' VAL . 24.4 ttpp -85.89 149.37 25.27 Favored 'General case' 0 C--N 1.309 -1.191 0 N-CA-C 107.307 -1.368 . . . . 3.33 107.307 178.608 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A 1577 ' ' ALA . . . . . . . . . . . . . . . -63.44 133.91 54.77 Favored 'General case' 0 CA--C 1.501 -0.924 0 O-C-N 123.793 0.683 . . . . 1.31 109.503 179.128 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A 1578 ' ' ASN . . . . . . . . . . . . . 7.8 p30 -153.27 144.96 23.42 Favored 'General case' 0 C--N 1.282 -2.369 0 N-CA-C 105.638 -1.986 . . . . 2.24 105.638 179.867 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A 1579 ' ' LYS . . . . . . . . . . . . . 67.9 mttm -114.48 89.3 3.06 Favored 'General case' 0 C--N 1.29 -2.019 0 C-N-CA 118.631 -1.228 . . . . 2.34 110.791 -176.703 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A 1580 ' ' ARG . . . . . . . . . . . . . 53.1 ttt180 -156.72 131.07 8.63 Favored 'General case' 0 N--CA 1.415 -2.207 0 CA-C-N 115.288 -0.869 . . . . 4.19 109.42 172.712 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A 1581 ' ' LEU . . . . . 0.405 HD13 HD11 ' A' 1588 ' ' LEU . 2.3 pp -124.88 150.66 46.26 Favored 'General case' 0 C--N 1.284 -2.282 0 N-CA-C 108.784 -0.821 . . . . 2.39 108.784 175.857 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A 1582 ' ' ARG . . . . . . . . . . . . . 90.0 mtt180 -115.82 125.7 53.03 Favored 'General case' 0 C--N 1.288 -2.082 0 CA-C-O 121.0 0.429 . . . . 4.48 110.052 -176.592 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A 1583 ' ' TYR . . . . . 0.446 ' CE1' ' HA ' ' A' 1586 ' ' GLN . 58.8 t80 -94.0 91.25 6.78 Favored 'General case' 0 C--N 1.289 -2.031 0 N-CA-C 107.714 -1.217 . . . . 1.57 107.714 179.115 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A 1584 ' ' VAL . . . . . . . . . . . . . 4.4 p -107.21 95.37 3.74 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.85 0 CA-C-O 121.824 0.821 . . . . 2.29 111.4 -176.909 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A 1585 ' ' ASP . . . . . . . . . . . . . 27.9 t70 52.69 67.89 0.92 Allowed 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 114.695 -1.139 . . . . 2.06 111.359 -177.954 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A 1586 ' ' GLN . . . . . 0.446 ' HA ' ' CE1' ' A' 1583 ' ' TYR . 49.6 mt-30 66.31 -15.23 0.13 Allowed 'General case' 0 C--N 1.315 -0.905 0 N-CA-C 115.873 1.805 . . . . 2.61 115.873 177.73 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A 1587 ' ' VAL . . . . . . . . . . . . . 10.9 p -99.38 123.21 51.94 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.028 0 CA-C-N 119.119 0.872 . . . . 1.33 109.684 178.301 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A 1588 ' ' LEU . . . . . 0.521 ' HB2' ' HB2' ' A' 1612 ' ' PHE . 4.1 mm? -81.96 140.18 34.16 Favored 'General case' 0 N--CA 1.43 -1.472 0 CA-C-N 115.581 -0.736 . . . . 2.03 111.885 -178.848 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A 1589 ' ' GLN . . . . . . . . . . . . . 35.1 tt0 -129.78 122.1 28.13 Favored 'General case' 0 C--N 1.303 -1.454 0 CA-C-N 115.573 -0.74 . . . . 1.73 109.926 179.073 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A 1590 ' ' LEU . . . . . . . . . . . . . 6.8 tt -119.16 132.94 56.02 Favored 'General case' 0 C--N 1.304 -1.393 0 N-CA-C 106.569 -1.641 . . . . 1.76 106.569 176.583 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A 1591 ' ' VAL . . . . . 0.554 HG11 HG23 ' A' 1609 ' ' VAL . 35.3 m -124.29 144.7 33.21 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.837 0 CA-C-O 121.688 0.756 . . . . 2.14 112.956 -173.509 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A 1592 ' ' TYR . . . . . 0.771 ' HB3' ' HA3' ' A' 1575 ' ' GLY . 22.5 m-85 -106.66 123.49 48.2 Favored 'General case' 0 C--N 1.298 -1.664 0 CA-C-N 115.078 -0.964 . . . . 1.53 110.298 172.249 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A 1593 ' ' LYS . . . . . . . . . . . . . 20.5 ptmt -142.59 -178.64 5.87 Favored 'General case' 0 C--N 1.298 -1.67 0 CA-C-N 114.364 -1.289 . . . . 2.72 108.072 -173.59 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A 1594 ' ' ASP . . . . . 0.495 ' HB2' ' HE3' ' A' 1576 ' ' LYS . 57.9 m-20 67.05 14.88 9.98 Favored 'General case' 0 N--CA 1.491 1.618 0 C-N-CA 124.098 0.959 . . . . 1.45 113.265 175.253 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A 1595 ' ' GLY . . . . . . . . . . . . . . . -90.54 -105.89 1.29 Allowed Glycine 0 N--CA 1.432 -1.587 0 N-CA-C 111.212 -0.755 . . . . 0.83 111.212 179.106 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A 1596 ' ' SER . . . . . 0.42 ' HA ' ' HD3' ' A' 1597 ' ' PRO . 23.0 m -106.65 128.05 26.93 Favored Pre-proline 0 C--N 1.295 -1.795 0 N-CA-C 109.679 -0.489 . . . . 1.96 109.679 179.9 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A 1597 ' ' PRO . . . . . 0.42 ' HD3' ' HA ' ' A' 1596 ' ' SER . 32.3 Cg_exo -63.07 150.95 87.16 Favored 'Trans proline' 0 C--O 1.238 0.516 0 C-N-CA 123.289 2.659 . . . . 1.34 110.866 176.554 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A 1598 ' ' CYS . . . . . 0.455 ' HA ' ' HD3' ' A' 1599 ' ' PRO . 50.2 t -94.93 132.63 27.85 Favored Pre-proline 0 C--N 1.293 -1.851 0 N-CA-C 109.961 -0.385 . . . . 1.19 109.961 -177.675 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A 1599 ' ' PRO . . . . . 0.455 ' HD3' ' HA ' ' A' 1598 ' ' CYS . 11.8 Cg_exo -72.29 -7.5 21.05 Favored 'Trans proline' 0 C--N 1.362 1.24 0 C-N-CA 123.392 2.728 . . . . 1.88 112.165 -179.97 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A 1600 ' ' SER . . . . . . . . . . . . . 44.9 t -113.14 123.67 50.79 Favored 'General case' 0 N--CA 1.421 -1.906 0 N-CA-C 107.757 -1.201 . . . . 2.19 107.757 177.603 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A 1601 ' ' LYS . . . . . . . . . . . . . 34.9 mmtp 57.13 50.92 11.06 Favored 'General case' 0 C--O 1.241 0.633 0 O-C-N 123.64 0.587 . . . . 4.21 109.814 -179.623 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A 1602 ' ' SER . . . . . . . . . . . . . 50.9 m -54.04 140.56 31.15 Favored 'General case' 0 N--CA 1.439 -0.992 0 CA-C-N 114.964 -1.016 . . . . 3.82 113.254 -175.988 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A 1603 ' ' GLY . . . . . . . . . . . . . . . 135.75 -10.9 4.27 Favored Glycine 0 N--CA 1.434 -1.466 0 N-CA-C 108.954 -1.659 . . . . 2.45 108.954 -173.327 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A 1604 ' ' LEU . . . . . . . . . . . . . 1.3 pp -135.42 162.4 32.72 Favored 'General case' 0 N--CA 1.437 -1.075 0 C-N-CA 123.897 0.879 . . . . 2.06 110.449 179.834 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A 1605 ' ' SER . . . . . . . . . . . . . 11.4 m -99.71 -176.04 3.15 Favored 'General case' 0 C--N 1.302 -1.46 0 N-CA-C 109.012 -0.736 . . . . 1.75 109.012 -178.611 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A 1606 ' ' TYR . . . . . 0.544 ' HA ' ' HB3' ' A' 1634 ' ' CYS . 78.5 m-85 -81.71 97.12 7.78 Favored 'General case' 0 CA--C 1.477 -1.837 0 N-CA-C 103.325 -2.843 . . . . 1.59 103.325 171.508 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A 1607 ' ' LYS . . . . . . . . . . . . . 17.3 ptmt -103.53 125.52 50.13 Favored 'General case' 0 C--N 1.26 -3.285 0 C-N-CA 119.695 -0.802 . . . . 2.21 112.041 -165.57 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A 1608 ' ' SER . . . . . 0.42 ' HB2' ' HB2' ' A' 1592 ' ' TYR . 16.5 m -98.62 117.29 32.73 Favored 'General case' 0 C--N 1.296 -1.73 0 CA-C-N 114.796 -1.093 . . . . 1.48 108.95 -179.102 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A 1609 ' ' VAL . . . . . 0.554 HG23 HG11 ' A' 1591 ' ' VAL . 98.1 t -112.12 117.19 54.59 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.22 0 N-CA-C 109.194 -0.669 . . . . 1.57 109.194 179.775 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A 1610 ' ' ILE . . . . . 0.691 HG13 ' HB2' ' A' 1638 ' ' PHE . 2.9 mp -105.36 114.53 45.1 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.178 0 N-CA-C 108.695 -0.854 . . . . 1.47 108.695 178.108 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A 1611 ' ' SER . . . . . . . . . . . . . 63.5 p -90.66 124.19 34.87 Favored 'General case' 0 N--CA 1.43 -1.465 0 N-CA-C 108.324 -0.991 . . . . 1.84 108.324 175.541 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A 1612 ' ' PHE . . . . . 0.521 ' HB2' ' HB2' ' A' 1588 ' ' LEU . 96.2 m-85 -93.23 107.74 19.49 Favored 'General case' 0 C--N 1.297 -1.71 0 CA-C-N 116.209 -0.45 . . . . 0.86 109.914 -179.125 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A 1613 ' ' VAL . . . . . . . . . . . . . 66.7 t -104.8 132.59 51.14 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.137 0 O-C-N 124.723 1.265 . . . . 1.32 108.895 -178.787 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A 1614 ' ' CYS . . . . . 0.407 ' HA ' ' O ' ' A' 1642 ' ' THR . 55.8 m -76.88 103.78 7.02 Favored 'General case' 0 C--N 1.295 -1.797 0 CA-C-N 114.973 -1.012 . . . . 1.39 111.433 -175.092 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A 1615 ' ' ARG . . . . . . . . . . . . . 38.3 mmt180 -123.7 86.7 52.83 Favored Pre-proline 0 C--N 1.306 -1.312 0 CA-C-N 115.541 -0.754 . . . . 4.34 110.067 179.041 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A 1616 ' ' PRO . . . . . 0.408 ' HA ' ' HB3' ' A' 1643 ' ' PRO . 42.7 Cg_endo -66.25 -28.78 47.44 Favored 'Trans proline' 0 C--N 1.348 0.511 0 C-N-CA 122.919 2.412 . . . . 1.5 113.392 -177.44 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A 1617 ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 . . . . . 0 C--N 1.319 -0.721 0 CA-C-O 121.408 0.623 . . . . 3.21 111.117 -178.065 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A 1622 ' ' ASN . . . . . 0.426 ' HA ' ' O ' ' A' 1641 ' ' HIS . 53.8 t-20 . . . . . 0 N--CA 1.479 0.999 0 CA-C-O 121.576 0.703 . . . . 3.58 109.564 . . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A 1623 ' ' ARG . . . . . . . . . . . . . 15.5 ptm180 -155.15 151.0 21.88 Favored Pre-proline 0 C--N 1.31 -1.114 0 CA-C-N 115.8 -0.637 . . . . 4.09 109.467 179.781 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A 1624 ' ' PRO . . . . . 0.482 ' HA ' ' O ' ' A' 1639 ' ' SER . 39.5 Cg_endo -87.14 101.17 0.52 Allowed 'Trans proline' 0 N--CA 1.443 -1.452 0 C-N-CA 122.777 2.318 . . . . 2.86 111.112 174.931 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A 1625 ' ' MET . . . . . . . . . . . . . 1.5 pmm? -96.17 153.3 17.87 Favored 'General case' 0 C--N 1.301 -1.505 0 N-CA-C 109.701 -0.481 . . . . 2.73 109.701 179.696 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A 1626 ' ' LEU . . . . . . . . . . . . . 40.6 tp -81.91 105.25 12.88 Favored 'General case' 0 C--N 1.31 -1.145 0 N-CA-C 108.687 -0.857 . . . . 1.94 108.687 177.919 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A 1627 ' ' ILE . . . . . . . . . . . . . 46.2 pt -87.21 -26.39 5.94 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.988 0 CA-C-N 116.083 -0.508 . . . . 1.75 112.134 -175.187 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A 1628 ' ' SER . . . . . . . . . . . . . 13.0 t -160.8 144.49 13.46 Favored 'General case' 0 N--CA 1.437 -1.09 0 N-CA-C 109.496 -0.557 . . . . 1.85 109.496 -178.3 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A 1629 ' ' LEU . . . . . 1.004 ' HG ' ' HG ' ' A' 1636 ' ' LEU . 4.4 tt -133.96 112.27 11.11 Favored 'General case' 0 C--N 1.306 -1.319 0 N-CA-C 107.023 -1.473 . . . . 2.12 107.023 177.572 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A 1630 ' ' ASP . . . . . . . . . . . . . 29.4 t70 -92.23 117.56 30.0 Favored 'General case' 0 C--N 1.307 -1.248 0 N-CA-C 108.84 -0.8 . . . . 0.87 108.84 177.553 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A 1631 ' ' LYS . . . . . . . . . . . . . 94.8 mttt -86.48 -5.77 59.07 Favored 'General case' 0 C--N 1.303 -1.422 0 CA-C-N 116.454 -0.339 . . . . 2.76 111.572 -176.253 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A 1632 ' ' GLN . . . . . . . . . . . . . 39.2 mt-30 -81.43 -45.67 15.71 Favored 'General case' 0 N--CA 1.447 -0.588 0 N-CA-C 109.961 -0.385 . . . . 2.55 109.961 -178.981 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A 1633 ' ' THR . . . . . . . . . . . . . 11.4 p -109.82 13.21 23.68 Favored 'General case' 0 C--N 1.305 -1.353 0 CA-C-N 115.799 -0.637 . . . . 1.92 111.639 178.495 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A 1634 ' ' CYS . . . . . 0.544 ' HB3' ' HA ' ' A' 1606 ' ' TYR . 65.4 m 47.52 41.89 13.81 Favored 'General case' 0 N--CA 1.474 0.728 0 C-N-CA 123.943 0.897 . . . . 0.89 112.976 179.879 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A 1635 ' ' THR . . . . . . . . . . . . . 33.4 m -105.33 117.07 33.08 Favored 'General case' 0 N--CA 1.417 -2.079 0 CA-C-N 115.368 -0.833 . . . . 1.31 109.596 -177.542 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A 1636 ' ' LEU . . . . . 1.004 ' HG ' ' HG ' ' A' 1629 ' ' LEU . 5.4 mp -101.84 129.73 48.13 Favored 'General case' 0 C--N 1.311 -1.09 0 N-CA-C 109.15 -0.685 . . . . 1.97 109.15 179.966 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A 1637 ' ' PHE . . . . . . . . . . . . . 80.6 m-85 -108.1 109.92 21.47 Favored 'General case' 0 C--N 1.308 -1.237 0 CA-C-N 116.27 -0.423 . . . . 0.92 111.123 -175.874 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A 1638 ' ' PHE . . . . . 0.691 ' HB2' HG13 ' A' 1610 ' ' ILE . 97.1 m-85 -107.68 149.01 28.64 Favored 'General case' 0 C--N 1.304 -1.391 0 N-CA-C 108.454 -0.943 . . . . 0.7 108.454 176.151 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A 1639 ' ' SER . . . . . 0.482 ' O ' ' HA ' ' A' 1624 ' ' PRO . 43.5 m -137.58 121.18 17.3 Favored 'General case' 0 C--N 1.294 -1.825 0 N-CA-C 109.795 -0.446 . . . . 1.46 109.795 178.051 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A 1640 ' ' TRP . . . . . 0.43 ' CD1' ' HB ' ' A' 1642 ' ' THR . 3.8 t90 -100.61 125.13 46.97 Favored 'General case' 0 C--N 1.314 -0.966 0 N-CA-C 108.445 -0.946 . . . . 0.92 108.445 -179.828 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A 1641 ' ' HIS . . . . . 0.426 ' O ' ' HA ' ' A' 1622 ' ' ASN . 11.4 m-70 -89.67 94.79 9.98 Favored 'General case' 0 C--N 1.307 -1.277 0 N-CA-C 105.63 -1.989 . . . . 3.18 105.63 175.093 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A 1642 ' ' THR . . . . . 0.652 ' OG1' ' HG ' ' A' 1644 ' ' LEU . 12.2 t -142.12 138.39 16.73 Favored Pre-proline 0 C--N 1.303 -1.419 0 C-N-CA 119.663 -0.815 . . . . 1.48 112.867 -171.886 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A 1643 ' ' PRO . . . . . 0.446 ' HD3' ' HA ' ' A' 1642 ' ' THR . 15.1 Cg_exo -71.96 -25.14 20.01 Favored 'Trans proline' 0 N--CA 1.456 -0.733 0 C-N-CA 123.34 2.694 . . . . 1.09 112.027 175.969 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A 1644 ' ' LEU . . . . . 0.652 ' HG ' ' OG1' ' A' 1642 ' ' THR . 4.0 pp -70.55 -17.17 62.93 Favored 'General case' 0 N--CA 1.478 0.932 0 N-CA-C 112.348 0.499 . . . . 2.08 112.348 -176.636 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A 1645 ' ' ALA . . . . . 0.422 ' HB1' HG21 ' A' 1642 ' ' THR . . . -64.0 -41.52 97.47 Favored 'General case' 0 N--CA 1.448 -0.543 0 CA-C-N 115.495 -0.775 . . . . 1.37 109.24 178.948 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A 1646 ' ' CYS . . . . . . . . . . . . . 19.2 p -177.11 116.02 0.1 Allowed 'General case' 0 C--O 1.244 0.791 0 C-N-CA 124.473 1.109 . . . . 1.7 108.342 171.903 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A 1647 ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 C--N 1.294 -1.834 0 O-C-N 121.961 -0.462 . . . . 2.92 110.212 179.164 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A 1515 ' ' ASP . . . . . . . . . . . . . 3.4 p-10 . . . . . 0 N--CA 1.437 -1.081 0 N-CA-C 103.536 -2.765 . . . . 2.54 103.536 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A 1516 ' ' CYS . . . . . 0.465 ' HB3' ' HB2' ' A' 1529 ' ' LEU . 58.1 m -79.37 61.75 3.52 Favored 'General case' 0 C--N 1.301 -1.541 0 N-CA-C 113.924 1.083 . . . . 1.25 113.924 -172.375 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A 1517 ' ' GLN . . . . . 0.52 ' HA ' ' O ' ' A' 1527 ' ' PHE . 11.1 pt20 -145.22 122.14 11.31 Favored 'General case' 0 N--CA 1.425 -1.702 0 N-CA-C 107.41 -1.329 . . . . 2.36 107.41 172.351 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A 1518 ' ' VAL . . . . . . . . . . . . . 84.9 t -109.23 106.21 20.26 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.941 0 N-CA-C 109.059 -0.719 . . . . 2.34 109.059 179.98 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A 1519 ' ' THR . . . . . . . . . . . . . 19.0 m -86.36 113.19 22.13 Favored 'General case' 0 C--N 1.287 -2.111 0 N-CA-C 107.066 -1.457 . . . . 2.04 107.066 175.772 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A 1520 ' ' ASN . . . . . . . . . . . . . 49.8 t-20 -87.52 104.81 7.1 Favored Pre-proline 0 C--N 1.308 -1.216 0 N-CA-C 107.766 -1.198 . . . . 2.12 107.766 179.437 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A 1521 ' ' PRO . . . . . . . . . . . . . 63.3 Cg_endo -71.48 -12.17 29.13 Favored 'Trans proline' 0 C--N 1.353 0.803 0 C-N-CA 122.505 2.137 . . . . 2.59 112.831 -174.613 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A 1522 ' ' SER . . . . . . . . . . . . . 5.8 m -76.95 -23.32 52.39 Favored 'General case' 0 N--CA 1.431 -1.421 0 CA-C-N 115.988 -0.551 . . . . 2.65 110.242 -178.953 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A 1523 ' ' THR . . . . . . . . . . . . . 5.0 t -127.44 -23.52 3.48 Favored 'General case' 0 CA--C 1.545 0.756 0 N-CA-C 112.46 0.541 . . . . 2.33 112.46 179.319 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A 1524 ' ' GLY . . . . . . . . . . . . . . . 100.1 -17.7 56.73 Favored Glycine 0 N--CA 1.447 -0.568 0 C-N-CA 120.566 -0.826 . . . . 1.96 112.168 -179.002 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A 1525 ' ' HIS . . . . . . . . . . . . . 17.4 t-80 -75.3 134.64 41.01 Favored 'General case' 0 C--N 1.312 -1.048 0 C-N-CA 123.009 0.524 . . . . 2.44 111.244 -177.379 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A 1526 ' ' LEU . . . . . 0.505 HD22 ' HB2' ' A' 1517 ' ' GLN . 7.1 tt -111.27 135.79 51.3 Favored 'General case' 0 C--N 1.313 -0.988 0 CA-C-N 115.666 -0.697 . . . . 2.19 109.271 -178.586 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A 1527 ' ' PHE . . . . . 0.52 ' O ' ' HA ' ' A' 1517 ' ' GLN . 85.2 m-85 -102.14 106.36 17.2 Favored 'General case' 0 C--N 1.312 -1.028 0 N-CA-C 108.893 -0.78 . . . . 1.61 108.893 177.334 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A 1528 ' ' ASP . . . . . . . . . . . . . 9.9 t70 -97.82 115.58 28.32 Favored 'General case' 0 C--N 1.319 -0.737 0 N-CA-C 109.654 -0.499 . . . . 2.18 109.654 179.76 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A 1529 ' ' LEU . . . . . 0.465 ' HB2' ' HB3' ' A' 1516 ' ' CYS . 84.6 mt -106.69 -12.99 15.4 Favored 'General case' 0 C--N 1.308 -1.21 0 CA-C-N 116.166 -0.47 . . . . 2.04 111.157 -178.398 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A 1530 ' ' SER . . . . . 0.481 ' HA ' ' HB3' ' A' 1553 ' ' CYS . 17.1 m -71.65 -47.38 54.75 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-O 121.036 0.446 . . . . 1.44 109.903 -178.102 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A 1531 ' ' SER . . . . . . . . . . . . . 13.3 m -70.01 -9.7 56.15 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.366 -0.833 . . . . 1.63 111.515 -175.936 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A 1532 ' ' LEU . . . . . . . . . . . . . 58.9 mt -76.55 -18.69 58.55 Favored 'General case' 0 C--N 1.313 -1.004 0 CA-C-N 116.382 -0.372 . . . . 2.32 110.446 178.142 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A 1533 ' ' SER . . . . . 0.464 ' OG ' ' HB ' ' A' 1552 ' ' ILE . 19.6 m -100.91 143.13 31.43 Favored 'General case' 0 C--N 1.315 -0.895 0 CA-C-N 116.226 -0.443 . . . . 2.57 110.848 -176.38 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A 1534 ' ' GLY . . . . . . . . . . . . . . . -102.18 -174.64 27.61 Favored Glycine 0 N--CA 1.42 -2.375 0 N-CA-C 109.512 -1.435 . . . . 1.89 109.512 175.401 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A 1535 ' ' ARG . . . . . . . . . . . . . 36.3 ttm180 -69.48 -50.05 48.99 Favored 'General case' 0 C--N 1.294 -1.815 0 N-CA-C 112.035 0.383 . . . . 4.44 112.035 -177.822 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A 1536 ' ' ALA . . . . . 0.526 ' HB2' HD22 ' A' 1558 ' ' ASN . . . -69.77 -48.89 57.57 Favored 'General case' 0 C--N 1.313 -0.979 0 CA-C-N 116.038 -0.528 . . . . 2.07 111.772 -175.82 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A 1537 ' ' GLY . . . . . 0.555 ' HA3' ' ND2' ' A' 1556 ' ' ASN . . . 119.66 -173.84 15.27 Favored Glycine 0 N--CA 1.444 -0.806 0 C-N-CA 121.289 -0.481 . . . . 1.2 112.914 175.535 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A 1538 ' ' PHE . . . . . 0.461 ' HE2' ' HA ' ' A' 1533 ' ' SER . 97.4 m-85 -116.51 170.37 8.62 Favored 'General case' 0 C--N 1.313 -1.013 0 C-N-CA 123.29 0.636 . . . . 1.98 109.917 -179.953 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A 1539 ' ' THR . . . . . 0.544 ' HA ' ' O ' ' A' 1548 ' ' VAL . 16.9 p -129.85 130.28 45.03 Favored 'General case' 0 N--CA 1.438 -1.042 0 CA-C-N 116.028 -0.533 . . . . 1.97 111.528 177.988 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A 1540 ' ' ALA . . . . . . . . . . . . . . . -103.36 146.98 27.67 Favored 'General case' 0 C--N 1.301 -1.52 0 N-CA-C 107.745 -1.206 . . . . 1.39 107.745 173.348 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A 1541 ' ' ALA . . . . . . . . . . . . . . . -77.88 130.89 37.16 Favored 'General case' 0 C--O 1.246 0.89 0 N-CA-C 109.815 -0.439 . . . . 1.86 109.815 -177.98 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A 1542 ' ' TYR . . . . . 0.679 ' HD2' ' HB2' ' A' 1545 ' ' SER . 70.0 t80 -139.88 168.09 20.61 Favored 'General case' 0 N--CA 1.437 -1.087 0 CA-C-O 119.425 -0.321 . . . . 2.4 110.245 -176.237 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A 1543 ' ' SER . . . . . . . . . . . . . 12.0 m -49.09 -151.99 0.0 OUTLIER 'General case' 0 CA--C 1.576 1.979 0 C-N-CA 128.796 2.838 . . . . 2.58 113.754 178.224 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A 1544 ' ' LYS . . . . . . . . . . . . . 39.7 ttmt -40.29 -35.48 0.42 Allowed 'General case' 0 N--CA 1.486 1.366 0 O-C-N 121.041 -1.037 . . . . 4.24 113.547 177.886 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A 1545 ' ' SER . . . . . 0.679 ' HB2' ' HD2' ' A' 1542 ' ' TYR . 19.3 m -66.55 -12.07 55.97 Favored 'General case' 0 CA--C 1.568 1.639 0 N-CA-C 112.856 0.688 . . . . 3.6 112.856 176.469 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A 1546 ' ' GLY . . . . . . . . . . . . . . . 82.24 -74.09 2.54 Favored Glycine 0 N--CA 1.446 -0.641 0 N-CA-C 114.6 0.6 . . . . 1.66 114.6 172.151 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A 1547 ' ' VAL . . . . . . . . . . . . . 15.4 m -138.41 146.52 26.56 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.244 0 CA-C-O 121.185 0.517 . . . . 2.23 111.272 -176.506 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A 1548 ' ' VAL . . . . . 0.544 ' O ' ' HA ' ' A' 1539 ' ' THR . 2.3 t -108.04 126.45 64.59 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.52 0 N-CA-C 106.675 -1.602 . . . . 1.59 106.675 176.573 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A 1549 ' ' TYR . . . . . 0.612 ' HD2' ' HA3' ' A' 1568 ' ' GLY . 6.4 m-85 -84.87 120.67 26.73 Favored 'General case' 0 C--N 1.301 -1.516 0 N-CA-C 108.452 -0.944 . . . . 1.58 108.452 174.906 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A 1550 ' ' MET . . . . . . . . . . . . . 60.7 mtp -135.87 164.96 26.74 Favored 'General case' 0 C--N 1.292 -1.924 0 CA-C-N 115.002 -0.999 . . . . 2.08 110.518 -173.489 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A 1551 ' ' SER . . . . . . . . . . . . . 13.9 p -129.7 144.57 51.35 Favored 'General case' 0 C--N 1.283 -2.31 0 N-CA-C 106.495 -1.668 . . . . 1.9 106.495 175.002 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A 1552 ' ' ILE . . . . . 0.464 ' HB ' ' OG ' ' A' 1533 ' ' SER . 46.0 mm -74.25 -29.44 24.71 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.483 0 N-CA-C 107.525 -1.287 . . . . 2.04 107.525 179.871 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A 1553 ' ' CYS . . . . . 0.484 ' HA ' ' HH ' ' A' 1592 ' ' TYR . 46.7 t -161.79 149.96 15.08 Favored 'General case' 0 N--CA 1.419 -1.986 0 N-CA-C 105.93 -1.878 . . . . 1.43 105.93 171.661 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A 1554 ' ' GLY . . . . . . . . . . . . . . . 94.22 -153.42 21.07 Favored Glycine 0 N--CA 1.427 -1.919 0 C-N-CA 120.304 -0.95 . . . . 1.23 111.103 178.752 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A 1555 ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -122.73 145.0 48.79 Favored 'General case' 0 C--N 1.294 -1.825 0 CA-C-O 121.471 0.653 . . . . 1.8 110.963 -176.675 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A 1556 ' ' ASN . . . . . 0.555 ' ND2' ' HA3' ' A' 1537 ' ' GLY . 24.9 t-20 -87.59 138.25 31.63 Favored 'General case' 0 C--N 1.299 -1.605 0 N-CA-C 108.39 -0.967 . . . . 2.63 108.39 179.464 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A 1557 ' ' GLU . . . . . . . . . . . . . 42.9 mt-10 -114.45 34.1 4.93 Favored 'General case' 0 C--N 1.317 -0.806 0 N-CA-C 113.557 0.947 . . . . 3.79 113.557 -175.83 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A 1558 ' ' ASN . . . . . 0.526 HD22 ' HB2' ' A' 1536 ' ' ALA . 25.2 m-80 -128.65 26.13 5.63 Favored 'General case' 0 C--N 1.313 -0.981 0 CA-C-O 122.839 1.304 . . . . 1.59 108.389 173.039 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A 1559 ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -161.84 173.17 4.81 Favored Pre-proline 0 C--N 1.29 -1.999 0 N-CA-C 104.621 -2.362 . . . . 0.94 104.621 179.009 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A 1560 ' ' PRO . . . . . 0.6 ' O ' HG21 ' A' 1563 ' ' VAL . 2.4 Cg_endo -40.7 117.45 0.5 Allowed 'Trans proline' 0 C--N 1.365 1.397 0 C-N-CA 123.538 2.826 . . . . 1.53 113.0 178.187 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A 1561 ' ' PRO . . . . . . . . . . . . . 36.8 Cg_exo -57.84 111.85 0.97 Allowed 'Trans proline' 0 C--O 1.248 0.996 0 C-N-CA 122.428 2.085 . . . . 1.82 110.546 -179.398 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A 1562 ' ' GLY . . . . . . . . . . . . . . . 129.17 -0.22 6.01 Favored Glycine 0 N--CA 1.431 -1.687 0 CA-C-N 115.534 -0.757 . . . . 0.81 112.596 -177.646 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A 1563 ' ' VAL . . . . . 0.6 HG21 ' O ' ' A' 1560 ' ' PRO . 25.2 m -105.98 146.96 12.11 Favored 'Isoleucine or valine' 0 CA--C 1.493 -1.238 0 O-C-N 122.151 -0.617 . . . . 1.73 111.048 175.325 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A 1564 ' ' GLY . . . . . . . . . . . . . . . -103.7 -8.07 40.75 Favored Glycine 0 N--CA 1.418 -2.526 0 N-CA-C 109.83 -1.308 . . . . 0.72 109.83 175.477 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A 1565 ' ' ALA . . . . . . . . . . . . . . . -152.58 119.39 5.74 Favored 'General case' 0 N--CA 1.441 -0.911 0 CA-C-O 121.303 0.573 . . . . 1.14 110.381 -179.838 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A 1566 ' ' CYS . . . . . . . . . . . . . 6.7 t -154.76 136.07 14.07 Favored 'General case' 0 C--N 1.297 -1.686 0 N-CA-C 108.816 -0.809 . . . . 0.51 108.816 -178.279 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A 1567 ' ' PHE . . . . . . . . . . . . . 26.1 m-85 -67.11 122.76 18.52 Favored 'General case' 0 C--O 1.208 -1.1 0 N-CA-C 106.334 -1.728 . . . . 1.22 106.334 176.322 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A 1568 ' ' GLY . . . . . 0.612 ' HA3' ' HD2' ' A' 1549 ' ' TYR . . . -72.57 -36.89 58.45 Favored Glycine 0 CA--C 1.489 -1.569 0 C-N-CA 121.035 -0.602 . . . . 1.08 114.453 -169.136 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A 1569 ' ' GLN . . . . . . . . . . . . . 30.1 tt0 -74.57 -43.97 53.1 Favored 'General case' 0 C--N 1.302 -1.469 0 CA-C-O 121.767 0.794 . . . . 3.05 109.662 -179.931 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A 1570 ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -81.27 -26.23 35.92 Favored 'General case' 0 C--N 1.286 -2.154 0 CA-C-N 114.497 -1.229 . . . . 2.44 112.138 -173.092 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A 1571 ' ' ARG . . . . . . . . . . . . . 66.1 mtt180 60.65 47.33 8.34 Favored 'General case' 0 C--O 1.234 0.26 0 C-N-CA 125.947 1.699 . . . . 4.48 111.653 -178.493 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A 1572 ' ' ILE . . . . . . . . . . . . . 40.8 mm -121.77 128.61 75.76 Favored 'Isoleucine or valine' 0 C--O 1.24 0.579 0 N-CA-C 108.228 -1.027 . . . . 1.94 108.228 -179.616 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A 1573 ' ' SER . . . . . . . . . . . . . 28.2 t -79.03 138.61 38.08 Favored 'General case' 0 C--N 1.312 -1.057 0 C-N-CA 124.014 0.926 . . . . 1.25 112.447 -175.972 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A 1574 ' ' VAL . . . . . . . . . . . . . 15.4 m -136.31 24.03 0.86 Allowed 'Isoleucine or valine' 0 C--N 1.318 -0.771 0 CA-C-O 121.581 0.705 . . . . 1.61 110.342 174.731 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A 1575 ' ' GLY . . . . . . . . . . . . . . . 169.03 115.21 0.32 Allowed Glycine 0 N--CA 1.442 -0.958 0 CA-C-N 115.301 -0.863 . . . . 0.65 111.997 178.043 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A 1576 ' ' LYS . . . . . 0.691 ' HG3' ' HA2' ' A' 1595 ' ' GLY . 98.6 mttt -86.25 154.33 21.36 Favored 'General case' 0 C--N 1.315 -0.934 0 O-C-N 122.599 -0.354 . . . . 3.33 110.074 179.297 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A 1577 ' ' ALA . . . . . . . . . . . . . . . -69.79 119.52 14.14 Favored 'General case' 0 C--O 1.244 0.803 0 CA-C-N 115.453 -0.794 . . . . 1.31 110.241 -178.19 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A 1578 ' ' ASN . . . . . . . . . . . . . 40.0 m-80 -141.98 162.4 35.56 Favored 'General case' 0 C--N 1.305 -1.355 0 N-CA-C 107.123 -1.436 . . . . 2.24 107.123 -179.427 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A 1579 ' ' LYS . . . . . . . . . . . . . 75.2 mmtt -102.76 88.8 3.3 Favored 'General case' 0 C--N 1.307 -1.264 0 N-CA-C 107.77 -1.196 . . . . 2.34 107.77 175.842 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A 1580 ' ' ARG . . . . . . . . . . . . . 17.2 ttm180 -136.08 84.77 2.1 Favored 'General case' 0 C--N 1.293 -1.854 0 CA-C-O 121.926 0.87 . . . . 4.19 109.159 -179.238 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A 1581 ' ' LEU . . . . . . . . . . . . . 49.1 tp -113.6 147.78 37.41 Favored 'General case' 0 C--N 1.294 -1.818 0 CA-C-N 114.053 -1.43 . . . . 2.39 107.302 -179.41 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A 1582 ' ' ARG . . . . . . . . . . . . . 55.3 ttp180 -141.97 144.06 33.52 Favored 'General case' 0 C--N 1.295 -1.802 0 N-CA-C 109.99 -0.374 . . . . 4.48 109.99 -175.492 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A 1583 ' ' TYR . . . . . . . . . . . . . 74.2 t80 -128.09 104.59 7.85 Favored 'General case' 0 C--N 1.299 -1.604 0 N-CA-C 108.368 -0.975 . . . . 1.57 108.368 176.704 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A 1584 ' ' VAL . . . . . . . . . . . . . 13.6 p -148.25 131.88 8.48 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.164 0 N-CA-C 109.117 -0.697 . . . . 2.29 109.117 178.529 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A 1585 ' ' ASP . . . . . . . . . . . . . 37.5 t70 65.7 32.45 9.01 Favored 'General case' 0 N--CA 1.482 1.13 0 CA-C-O 122.622 1.201 . . . . 2.06 109.621 -177.721 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A 1586 ' ' GLN . . . . . . . . . . . . . 51.1 mt-30 65.05 4.89 2.7 Favored 'General case' 0 N--CA 1.473 0.707 0 C-N-CA 125.642 1.577 . . . . 2.61 114.674 178.606 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A 1587 ' ' VAL . . . . . . . . . . . . . 7.1 p -108.32 130.09 61.54 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.394 0 CA-C-O 121.087 0.47 . . . . 1.33 109.876 178.944 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A 1588 ' ' LEU . . . . . 0.555 ' HB2' ' HB2' ' A' 1612 ' ' PHE . 3.8 mm? -84.18 146.5 27.8 Favored 'General case' 0 N--CA 1.439 -0.991 0 CA-C-N 116.047 -0.524 . . . . 2.03 110.838 -178.523 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A 1589 ' ' GLN . . . . . . . . . . . . . 35.2 tt0 -147.13 127.61 14.08 Favored 'General case' 0 C--N 1.302 -1.49 0 N-CA-C 109.819 -0.438 . . . . 1.73 109.819 178.475 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A 1590 ' ' LEU . . . . . . . . . . . . . 6.7 tt -125.59 138.39 53.94 Favored 'General case' 0 C--N 1.308 -1.217 0 N-CA-C 107.016 -1.476 . . . . 1.76 107.016 179.895 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A 1591 ' ' VAL . . . . . 0.496 ' HB ' HG21 ' A' 1609 ' ' VAL . 5.0 p -137.54 134.16 46.24 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.292 0 CA-C-O 121.312 0.577 . . . . 2.14 112.132 -176.459 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A 1592 ' ' TYR . . . . . 0.484 ' HH ' ' HA ' ' A' 1553 ' ' CYS . 77.5 m-85 -97.63 96.36 8.22 Favored 'General case' 0 N--CA 1.431 -1.402 0 N-CA-C 107.347 -1.353 . . . . 1.53 107.347 174.079 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A 1593 ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -88.52 157.81 18.52 Favored 'General case' 0 C--N 1.295 -1.78 0 CA-C-N 115.058 -0.973 . . . . 2.72 111.932 -177.107 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A 1594 ' ' ASP . . . . . . . . . . . . . 5.6 m-20 48.77 79.27 0.08 Allowed 'General case' 0 N--CA 1.475 0.78 0 N-CA-C 115.453 1.649 . . . . 1.45 115.453 -179.664 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A 1595 ' ' GLY . . . . . 0.691 ' HA2' ' HG3' ' A' 1576 ' ' LYS . . . -96.5 -107.94 2.43 Favored Glycine 0 N--CA 1.441 -0.985 0 N-CA-C 109.312 -1.515 . . . . 0.83 109.312 171.245 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A 1596 ' ' SER . . . . . . . . . . . . . 34.2 t -82.8 142.57 45.44 Favored Pre-proline 0 C--N 1.309 -1.166 0 N-CA-C 107.245 -1.391 . . . . 1.96 107.245 175.451 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A 1597 ' ' PRO . . . . . . . . . . . . . 22.0 Cg_exo -65.13 142.21 73.05 Favored 'Trans proline' 0 N--CA 1.457 -0.65 0 C-N-CA 122.646 2.231 . . . . 1.34 110.248 177.219 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A 1598 ' ' CYS . . . . . . . . . . . . . 49.8 t -95.45 112.85 60.27 Favored Pre-proline 0 C--N 1.306 -1.31 0 N-CA-C 108.972 -0.751 . . . . 1.19 108.972 -178.178 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A 1599 ' ' PRO . . . . . . . . . . . . . 71.5 Cg_endo -76.91 -19.9 13.63 Favored 'Trans proline' 0 N--CA 1.464 -0.236 0 C-N-CA 122.395 2.064 . . . . 1.88 112.453 -176.939 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A 1600 ' ' SER . . . . . . . . . . . . . 4.1 m -76.4 -26.33 55.45 Favored 'General case' 0 C--N 1.314 -0.967 0 CA-C-O 121.818 0.818 . . . . 2.19 109.955 -177.931 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A 1601 ' ' LYS . . . . . 0.525 ' HG3' ' O ' ' A' 1632 ' ' GLN . 12.9 mmmm -134.71 72.01 1.45 Allowed 'General case' 0 N--CA 1.434 -1.256 0 CA-C-N 114.971 -1.013 . . . . 4.21 108.933 178.387 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A 1602 ' ' SER . . . . . . . . . . . . . 3.2 p -49.86 116.37 1.78 Allowed 'General case' 0 N--CA 1.441 -0.905 0 CA-C-N 113.871 -1.513 . . . . 3.82 112.66 -179.304 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A 1603 ' ' GLY . . . . . . . . . . . . . . . 135.94 -29.79 2.81 Favored Glycine 0 N--CA 1.431 -1.671 0 N-CA-C 111.062 -0.815 . . . . 2.45 111.062 -179.595 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A 1604 ' ' LEU . . . . . . . . . . . . . 2.3 pp -127.11 166.72 17.11 Favored 'General case' 0 C--N 1.317 -0.83 0 CA-C-O 121.105 0.478 . . . . 2.06 111.59 179.844 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A 1605 ' ' SER . . . . . . . . . . . . . 21.0 m -109.13 -172.03 1.97 Allowed 'General case' 0 C--N 1.296 -1.719 0 C-N-CA 123.326 0.65 . . . . 1.75 109.367 -177.817 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A 1606 ' ' TYR . . . . . 0.511 ' HA ' ' O ' ' A' 1634 ' ' CYS . 79.0 m-85 -95.83 136.68 35.93 Favored 'General case' 0 N--CA 1.405 -2.704 0 N-CA-C 104.897 -2.26 . . . . 1.59 104.897 177.614 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A 1607 ' ' LYS . . . . . 0.521 ' HG3' HG21 ' A' 1635 ' ' THR . 21.6 ptmt -137.56 147.84 45.44 Favored 'General case' 0 C--N 1.262 -3.209 0 N-CA-C 108.625 -0.88 . . . . 2.21 108.625 -179.206 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A 1608 ' ' SER . . . . . . . . . . . . . 47.1 m -125.33 122.25 36.28 Favored 'General case' 0 C--N 1.303 -1.454 0 C-N-CA 120.886 -0.326 . . . . 1.48 111.05 -178.635 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A 1609 ' ' VAL . . . . . 0.496 HG21 ' HB ' ' A' 1591 ' ' VAL . 7.2 p -110.69 139.79 32.77 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 CA-C-O 120.69 0.281 . . . . 1.57 110.357 -179.91 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A 1610 ' ' ILE . . . . . 0.723 HG13 ' HB2' ' A' 1638 ' ' PHE . 3.7 mp -118.05 118.33 57.85 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.357 0 N-CA-C 108.072 -1.084 . . . . 1.47 108.072 174.871 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A 1611 ' ' SER . . . . . . . . . . . . . 48.0 m -98.19 133.02 43.2 Favored 'General case' 0 C--N 1.286 -2.191 0 N-CA-C 108.949 -0.759 . . . . 1.84 108.949 177.745 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A 1612 ' ' PHE . . . . . 0.563 ' HE1' ' HE3' ' A' 1640 ' ' TRP . 91.3 m-85 -99.58 106.68 18.68 Favored 'General case' 0 C--N 1.3 -1.585 0 CA-C-N 116.144 -0.48 . . . . 0.86 111.653 -173.713 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A 1613 ' ' VAL . . . . . 0.495 ' O ' ' HA ' ' A' 1641 ' ' HIS . 84.5 t -107.44 129.03 62.01 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.552 0 CA-C-N 114.921 -1.036 . . . . 1.32 109.302 -178.895 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A 1614 ' ' CYS . . . . . 0.451 ' HA ' ' O ' ' A' 1642 ' ' THR . 0.5 OUTLIER -81.32 106.89 13.65 Favored 'General case' 0 C--N 1.297 -1.704 0 N-CA-C 113.856 1.058 . . . . 1.39 113.856 -177.683 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A 1615 ' ' ARG . . . . . 0.405 ' HB3' ' HB3' ' A' 1641 ' ' HIS . 12.0 tpp180 -138.06 106.41 8.05 Favored Pre-proline 0 N--CA 1.428 -1.559 0 N-CA-C 107.897 -1.149 . . . . 4.34 107.897 175.493 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A 1616 ' ' PRO . . . . . 0.409 ' HA ' ' HB3' ' A' 1643 ' ' PRO . 97.4 Cg_endo -79.08 5.57 5.65 Favored 'Trans proline' 0 CA--C 1.534 0.485 0 C-N-CA 122.649 2.233 . . . . 1.5 113.059 -176.231 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A 1617 ' ' GLU . . . . . . . . . . . . . 39.0 mt-10 . . . . . 0 C--N 1.307 -1.28 0 CA-C-O 121.419 0.628 . . . . 3.21 110.771 -178.04 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A 1622 ' ' ASN . . . . . . . . . . . . . 45.6 t30 . . . . . 0 N--CA 1.464 0.26 0 N-CA-C 107.721 -1.214 . . . . 3.58 107.721 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A 1623 ' ' ARG . . . . . . . . . . . . . 12.2 ptm180 -147.13 145.59 22.66 Favored Pre-proline 0 C--N 1.302 -1.498 0 N-CA-C 108.123 -1.065 . . . . 4.09 108.123 -178.233 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A 1624 ' ' PRO . . . . . 0.429 ' HA ' ' O ' ' A' 1639 ' ' SER . 15.9 Cg_exo -69.23 123.47 10.31 Favored 'Trans proline' 0 N--CA 1.457 -0.664 0 C-N-CA 122.569 2.179 . . . . 2.86 111.361 179.193 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A 1625 ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -119.03 149.04 42.33 Favored 'General case' 0 C--N 1.303 -1.414 0 N-CA-C 109.067 -0.716 . . . . 2.73 109.067 179.277 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A 1626 ' ' LEU . . . . . . . . . . . . . 34.7 tp -76.48 122.49 24.63 Favored 'General case' 0 C--N 1.306 -1.303 0 N-CA-C 108.083 -1.08 . . . . 1.94 108.083 177.516 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A 1627 ' ' ILE . . . . . . . . . . . . . 24.4 pt -100.19 -28.26 3.38 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.312 0 C-N-CA 120.654 -0.418 . . . . 1.75 111.158 -178.876 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A 1628 ' ' SER . . . . . . . . . . . . . 35.8 t -157.86 159.08 36.26 Favored 'General case' 0 N--CA 1.43 -1.425 0 N-CA-C 108.237 -1.023 . . . . 1.85 108.237 -175.868 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A 1629 ' ' LEU . . . . . 0.761 ' HG ' ' HG ' ' A' 1636 ' ' LEU . 4.1 tt -145.9 134.05 21.6 Favored 'General case' 0 C--N 1.293 -1.89 0 N-CA-C 105.512 -2.033 . . . . 2.12 105.512 177.579 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A 1630 ' ' ASP . . . . . . . . . . . . . 20.1 t70 -121.0 109.93 15.66 Favored 'General case' 0 C--N 1.29 -2.0 0 N-CA-C 108.812 -0.81 . . . . 0.87 108.812 177.957 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A 1631 ' ' LYS . . . . . 0.431 ' HE3' ' HB2' ' A' 1631 ' ' LYS . 49.7 mtmt -81.07 1.16 32.75 Favored 'General case' 0 C--N 1.303 -1.435 0 N-CA-C 112.553 0.575 . . . . 2.76 112.553 -175.991 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A 1632 ' ' GLN . . . . . 0.525 ' O ' ' HG3' ' A' 1601 ' ' LYS . 2.1 mp0 -94.56 -34.3 12.71 Favored 'General case' 0 CA--C 1.509 -0.626 0 CA-C-O 121.336 0.588 . . . . 2.55 110.398 -179.226 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A 1633 ' ' THR . . . . . . . . . . . . . 24.9 p -101.32 1.87 39.11 Favored 'General case' 0 C--N 1.289 -2.055 0 CA-C-O 121.947 0.88 . . . . 1.92 108.908 172.255 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A 1634 ' ' CYS . . . . . 0.511 ' O ' ' HA ' ' A' 1606 ' ' TYR . 47.8 m 52.15 42.37 30.59 Favored 'General case' 0 C--N 1.346 0.443 0 CA-C-N 113.714 -1.584 . . . . 0.89 110.377 178.478 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A 1635 ' ' THR . . . . . 0.521 HG21 ' HG3' ' A' 1607 ' ' LYS . 55.8 m -114.9 132.55 56.5 Favored 'General case' 0 N--CA 1.425 -1.691 0 CA-C-N 114.386 -1.279 . . . . 1.31 110.048 -175.143 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A 1636 ' ' LEU . . . . . 0.761 ' HG ' ' HG ' ' A' 1629 ' ' LEU . 5.8 mp -102.94 132.55 49.1 Favored 'General case' 0 C--N 1.306 -1.293 0 N-CA-C 108.989 -0.745 . . . . 1.97 108.989 176.991 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A 1637 ' ' PHE . . . . . . . . . . . . . 72.7 m-85 -107.47 101.54 10.88 Favored 'General case' 0 C--N 1.318 -0.792 0 CA-C-N 116.242 -0.436 . . . . 0.92 111.673 -175.874 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A 1638 ' ' PHE . . . . . 0.723 ' HB2' HG13 ' A' 1610 ' ' ILE . 96.6 m-85 -100.29 160.19 14.53 Favored 'General case' 0 C--N 1.306 -1.284 0 N-CA-C 108.743 -0.836 . . . . 0.7 108.743 177.21 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A 1639 ' ' SER . . . . . 0.429 ' O ' ' HA ' ' A' 1624 ' ' PRO . 31.9 t -143.37 147.74 35.14 Favored 'General case' 0 C--N 1.283 -2.285 0 N-CA-C 107.823 -1.177 . . . . 1.46 107.823 177.204 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A 1640 ' ' TRP . . . . . 0.563 ' HE3' ' HE1' ' A' 1612 ' ' PHE . 12.4 t90 -127.75 112.26 14.6 Favored 'General case' 0 C--N 1.291 -1.942 0 N-CA-C 108.069 -1.086 . . . . 0.92 108.069 176.746 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A 1641 ' ' HIS . . . . . 0.495 ' HA ' ' O ' ' A' 1613 ' ' VAL . 25.4 m170 -88.15 102.95 15.29 Favored 'General case' 0 CA--C 1.487 -1.454 0 N-CA-C 106.953 -1.499 . . . . 3.18 106.953 176.318 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A 1642 ' ' THR . . . . . 0.451 ' O ' ' HA ' ' A' 1614 ' ' CYS . 12.5 t -142.83 141.2 19.43 Favored Pre-proline 0 N--CA 1.414 -2.231 0 CA-C-N 115.451 -0.795 . . . . 1.48 111.021 -173.149 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A 1643 ' ' PRO . . . . . 0.409 ' HB3' ' HA ' ' A' 1616 ' ' PRO . 42.4 Cg_endo -70.25 -1.68 9.27 Favored 'Trans proline' 0 C--N 1.349 0.592 0 C-N-CA 123.34 2.693 . . . . 1.09 111.567 175.942 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A 1644 ' ' LEU . . . . . . . . . . . . . 67.5 mt -86.66 -18.61 30.87 Favored 'General case' 0 C--N 1.317 -0.823 0 CA-C-N 115.692 -0.686 . . . . 2.08 110.089 178.122 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A 1645 ' ' ALA . . . . . . . . . . . . . . . -73.77 -32.91 64.03 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-O 121.648 0.737 . . . . 1.37 110.033 -179.032 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A 1646 ' ' CYS . . . . . . . . . . . . . 4.1 m -159.04 117.31 2.88 Favored 'General case' 0 C--N 1.311 -1.093 0 N-CA-C 103.558 -2.756 . . . . 1.7 103.558 175.784 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A 1647 ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 . . . . . 0 C--N 1.3 -1.583 0 C-N-CA 118.832 -1.147 . . . . 2.92 109.708 179.458 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A 1515 ' ' ASP . . . . . 0.661 ' HB3' ' HG2' ' A' 1517 ' ' GLN . 22.5 m-20 . . . . . 0 N--CA 1.433 -1.284 0 N-CA-C 109.0 -0.741 . . . . 2.54 109.0 . . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A 1516 ' ' CYS . . . . . . . . . . . . . 11.0 t -118.08 39.88 3.29 Favored 'General case' 0 C--N 1.292 -1.896 0 N-CA-C 105.777 -1.935 . . . . 1.25 105.777 175.259 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A 1517 ' ' GLN . . . . . 0.661 ' HG2' ' HB3' ' A' 1515 ' ' ASP . 3.3 pt20 -151.95 127.98 10.39 Favored 'General case' 0 N--CA 1.417 -2.077 0 CA-C-N 113.792 -1.549 . . . . 2.36 107.35 -175.769 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A 1518 ' ' VAL . . . . . 0.419 HG11 ' HB2' ' A' 1583 ' ' TYR . 7.4 m -111.57 156.86 12.6 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.979 0 N-CA-C 108.747 -0.835 . . . . 2.34 108.747 -174.716 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A 1519 ' ' THR . . . . . 0.62 ' HA ' ' HA ' ' A' 1526 ' ' LEU . 28.4 m -101.84 103.06 13.74 Favored 'General case' 0 N--CA 1.404 -2.727 0 N-CA-C 106.204 -1.776 . . . . 2.04 106.204 174.1 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A 1520 ' ' ASN . . . . . . . . . . . . . 25.4 t-20 -60.02 110.31 2.72 Favored Pre-proline 0 C--O 1.22 -0.498 0 O-C-N 123.779 0.674 . . . . 2.12 110.006 -176.759 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A 1521 ' ' PRO . . . . . . . . . . . . . 21.1 Cg_exo -68.33 -14.79 41.12 Favored 'Trans proline' 0 N--CA 1.478 0.585 0 C-N-CA 122.539 2.159 . . . . 2.59 114.14 -177.419 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A 1522 ' ' SER . . . . . . . . . . . . . 15.8 m -78.49 -45.62 21.59 Favored 'General case' 0 C--N 1.308 -1.209 0 CA-C-O 120.563 0.221 . . . . 2.65 110.941 -178.353 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A 1523 ' ' THR . . . . . . . . . . . . . 15.1 t -104.96 -18.57 14.13 Favored 'General case' 0 CA--C 1.55 0.948 0 C-N-CA 120.438 -0.505 . . . . 2.33 111.832 -179.408 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A 1524 ' ' GLY . . . . . . . . . . . . . . . 87.0 5.14 81.18 Favored Glycine 0 C--N 1.331 0.269 0 C-N-CA 121.365 -0.445 . . . . 1.96 112.763 179.505 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A 1525 ' ' HIS . . . . . . . . . . . . . 23.2 t-160 -100.66 128.79 46.58 Favored 'General case' 0 C--N 1.303 -1.42 0 N-CA-C 109.691 -0.485 . . . . 2.44 109.691 -176.614 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A 1526 ' ' LEU . . . . . 0.62 ' HA ' ' HA ' ' A' 1519 ' ' THR . 5.5 tt -73.48 135.33 44.07 Favored 'General case' 0 C--N 1.305 -1.347 0 N-CA-C 107.638 -1.245 . . . . 2.19 107.638 176.057 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A 1527 ' ' PHE . . . . . 0.426 ' N ' HD22 ' A' 1526 ' ' LEU . 82.5 m-85 -112.81 110.25 20.24 Favored 'General case' 0 C--N 1.303 -1.426 0 CA-C-O 120.972 0.415 . . . . 1.61 110.873 178.052 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A 1528 ' ' ASP . . . . . . . . . . . . . 10.0 t70 -83.38 109.41 17.28 Favored 'General case' 0 CA--C 1.5 -0.955 0 CA-C-N 115.1 -0.955 . . . . 2.18 110.646 178.775 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A 1529 ' ' LEU . . . . . 0.652 ' HA ' HD13 ' A' 1532 ' ' LEU . 3.7 mm? -98.7 -18.12 18.2 Favored 'General case' 0 C--N 1.307 -1.279 0 CA-C-N 114.766 -1.107 . . . . 2.04 108.179 173.154 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A 1530 ' ' SER . . . . . . . . . . . . . 1.9 m -53.26 -47.1 69.37 Favored 'General case' 0 CA--C 1.544 0.724 0 C-N-CA 125.592 1.557 . . . . 1.44 112.741 -176.998 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A 1531 ' ' SER . . . . . . . . . . . . . 5.1 m -78.24 -3.79 44.55 Favored 'General case' 0 C--N 1.321 -0.652 0 N-CA-C 112.086 0.402 . . . . 1.63 112.086 -174.652 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A 1532 ' ' LEU . . . . . 0.652 HD13 ' HA ' ' A' 1529 ' ' LEU . 11.0 mp -62.41 -25.94 68.21 Favored 'General case' 0 N--CA 1.48 1.032 0 N-CA-C 113.066 0.765 . . . . 2.32 113.066 177.685 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A 1533 ' ' SER . . . . . . . . . . . . . 52.4 m -90.82 142.48 27.72 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-O 120.511 0.196 . . . . 2.57 110.477 177.464 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A 1534 ' ' GLY . . . . . . . . . . . . . . . -151.65 -116.81 0.73 Allowed Glycine 0 N--CA 1.441 -1.005 0 N-CA-C 109.649 -1.381 . . . . 1.89 109.649 179.158 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A 1535 ' ' ARG . . . . . . . . . . . . . 27.3 tpt180 -90.0 -59.05 2.3 Favored 'General case' 0 C--N 1.309 -1.186 0 N-CA-C 109.063 -0.717 . . . . 4.44 109.063 176.92 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A 1536 ' ' ALA . . . . . . . . . . . . . . . -95.07 -32.51 13.08 Favored 'General case' 0 N--CA 1.441 -0.89 0 CA-C-N 116.035 -0.529 . . . . 2.07 110.2 -179.228 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A 1537 ' ' GLY . . . . . . . . . . . . . . . 69.11 -127.14 21.2 Favored Glycine 0 CA--C 1.491 -1.455 0 N-CA-C 109.854 -1.299 . . . . 1.2 109.854 -178.524 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A 1538 ' ' PHE . . . . . . . . . . . . . 53.0 m-85 -106.42 141.43 37.74 Favored 'General case' 0 C--N 1.294 -1.822 0 C-N-CA 120.281 -0.568 . . . . 1.98 109.563 174.608 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A 1539 ' ' THR . . . . . . . . . . . . . 3.0 p -123.52 138.36 54.58 Favored 'General case' 0 C--N 1.293 -1.879 0 CA-C-N 116.017 -0.538 . . . . 1.97 111.081 -176.0 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A 1540 ' ' ALA . . . . . . . . . . . . . . . -128.87 116.03 18.79 Favored 'General case' 0 C--N 1.305 -1.364 0 CA-C-O 120.52 0.2 . . . . 1.39 110.48 178.387 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A 1541 ' ' ALA . . . . . . . . . . . . . . . -75.4 131.2 40.04 Favored 'General case' 0 C--N 1.313 -1.017 0 N-CA-C 108.397 -0.964 . . . . 1.86 108.397 177.316 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A 1542 ' ' TYR . . . . . . . . . . . . . 36.4 t80 -144.48 -179.27 6.44 Favored 'General case' 0 C--N 1.301 -1.524 0 N-CA-C 109.439 -0.578 . . . . 2.4 109.439 -173.776 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A 1543 ' ' SER . . . . . . . . . . . . . 5.9 m -43.86 -151.3 0.0 OUTLIER 'General case' 0 CA--C 1.584 2.25 0 C-N-CA 129.773 3.229 . . . . 2.58 114.669 177.91 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A 1544 ' ' LYS . . . . . . . . . . . . . 98.4 mttt -43.99 -29.12 0.54 Allowed 'General case' 0 N--CA 1.5 2.058 0 O-C-N 120.38 -1.45 . . . . 4.24 112.824 175.052 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A 1545 ' ' SER . . . . . . . . . . . . . 16.5 m -61.97 -17.29 56.52 Favored 'General case' 0 CA--C 1.562 1.44 0 C-N-CA 123.566 0.746 . . . . 3.6 111.463 175.091 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A 1546 ' ' GLY . . . . . . . . . . . . . . . 79.5 -77.85 1.82 Allowed Glycine 0 CA--C 1.496 -1.136 0 CA-C-O 121.457 0.476 . . . . 1.66 113.67 173.244 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A 1547 ' ' VAL . . . . . . . . . . . . . 7.4 p -157.64 131.73 1.38 Allowed 'Isoleucine or valine' 0 C--N 1.284 -2.249 0 N-CA-C 108.204 -1.036 . . . . 2.23 108.204 -175.788 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A 1548 ' ' VAL . . . . . . . . . . . . . 2.3 t -103.17 139.73 23.32 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.043 0 N-CA-C 108.346 -0.983 . . . . 1.59 108.346 -177.287 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A 1549 ' ' TYR . . . . . 0.445 ' HB3' ' HG2' ' A' 1557 ' ' GLU . 77.3 m-85 -98.29 148.23 23.84 Favored 'General case' 0 C--N 1.303 -1.418 0 N-CA-C 106.586 -1.635 . . . . 1.58 106.586 170.969 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A 1550 ' ' MET . . . . . . . . . . . . . 42.2 ttm -138.9 125.52 20.68 Favored 'General case' 0 C--N 1.291 -1.965 0 C-N-CA 120.685 -0.406 . . . . 2.08 110.704 -178.113 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A 1551 ' ' SER . . . . . 0.663 ' HB2' ' HB3' ' A' 1556 ' ' ASN . 43.1 t -99.23 138.91 35.65 Favored 'General case' 0 N--CA 1.411 -2.403 0 N-CA-C 105.938 -1.875 . . . . 1.9 105.938 172.551 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A 1552 ' ' ILE . . . . . 0.416 HG22 ' SG ' ' A' 1553 ' ' CYS . 1.8 mp -92.91 -55.17 6.41 Favored 'Isoleucine or valine' 0 N--CA 1.416 -2.174 0 N-CA-C 108.713 -0.847 . . . . 2.04 108.713 179.117 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A 1553 ' ' CYS . . . . . 0.416 ' SG ' HG22 ' A' 1552 ' ' ILE . 84.5 m -127.07 136.64 52.45 Favored 'General case' 0 C--N 1.303 -1.415 0 N-CA-C 109.162 -0.681 . . . . 1.43 109.162 177.202 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A 1554 ' ' GLY . . . . . . . . . . . . . . . 69.92 -141.46 34.65 Favored Glycine 0 N--CA 1.435 -1.4 0 N-CA-C 111.031 -0.827 . . . . 1.23 111.031 179.806 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A 1555 ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -109.35 177.41 4.75 Favored 'General case' 0 C--N 1.3 -1.569 0 N-CA-C 108.91 -0.774 . . . . 1.8 108.91 -178.79 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A 1556 ' ' ASN . . . . . 0.663 ' HB3' ' HB2' ' A' 1551 ' ' SER . 8.9 t30 -177.73 -165.03 0.1 Allowed 'General case' 0 C--N 1.297 -1.705 0 N-CA-C 103.427 -2.805 . . . . 2.63 103.427 -174.616 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A 1557 ' ' GLU . . . . . 0.445 ' HG2' ' HB3' ' A' 1549 ' ' TYR . 25.3 mt-10 79.57 -176.8 0.08 Allowed 'General case' 0 C--N 1.321 -0.636 0 N-CA-C 115.404 1.631 . . . . 3.79 115.404 163.519 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A 1558 ' ' ASN . . . . . . . . . . . . . 26.9 m-80 -125.21 43.93 2.93 Favored 'General case' 0 C--N 1.313 -0.991 0 CA-C-N 112.6 -2.091 . . . . 1.59 107.373 -174.612 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A 1559 ' ' CYS . . . . . . . . . . . . . 77.1 m -141.17 152.56 64.95 Favored Pre-proline 0 C--N 1.285 -2.214 0 N-CA-C 106.105 -1.813 . . . . 0.94 106.105 -176.029 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A 1560 ' ' PRO . . . . . . . . . . . . . 24.6 Cg_exo -36.23 112.32 0.09 OUTLIER 'Trans proline' 0 C--N 1.376 2.023 0 C-N-CA 124.667 3.578 . . . . 1.53 113.339 -178.811 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A 1561 ' ' PRO . . . . . . . . . . . . . 88.7 Cg_exo -48.89 153.52 3.74 Favored 'Trans proline' 0 C--N 1.365 1.407 0 C-N-CA 124.93 3.753 . . . . 1.82 114.486 -174.956 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A 1562 ' ' GLY . . . . . . . . . . . . . . . 93.67 7.78 61.32 Favored Glycine 0 N--CA 1.447 -0.589 0 N-CA-C 111.092 -0.803 . . . . 0.81 111.092 -177.545 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A 1563 ' ' VAL . . . . . 0.462 ' HA ' ' HA ' ' A' 1576 ' ' LYS . 8.3 p -111.25 156.96 12.28 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.588 0 N-CA-C 107.297 -1.372 . . . . 1.73 107.297 -179.355 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A 1564 ' ' GLY . . . . . . . . . . . . . . . -124.82 9.08 8.09 Favored Glycine 0 CA--C 1.528 0.852 0 C-N-CA 120.056 -1.069 . . . . 0.72 114.555 -176.417 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A 1565 ' ' ALA . . . . . . . . . . . . . . . -170.22 141.62 2.1 Favored 'General case' 0 C--N 1.302 -1.494 0 N-CA-C 107.917 -1.142 . . . . 1.14 107.917 178.956 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A 1566 ' ' CYS . . . . . 0.447 ' HA ' HG23 ' A' 1574 ' ' VAL . 51.6 t -164.22 139.23 5.83 Favored 'General case' 0 C--N 1.309 -1.165 0 CA-C-O 120.896 0.379 . . . . 0.51 110.184 -175.7 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A 1567 ' ' PHE . . . . . . . . . . . . . 35.2 m-85 -80.57 122.9 27.62 Favored 'General case' 0 CA--C 1.512 -0.501 0 N-CA-C 106.535 -1.654 . . . . 1.22 106.535 174.416 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A 1568 ' ' GLY . . . . . . . . . . . . . . . -75.97 -26.75 63.8 Favored Glycine 0 C--N 1.314 -0.656 0 C-N-CA 120.7 -0.762 . . . . 1.08 113.274 -173.879 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A 1569 ' ' GLN . . . . . . . . . . . . . 25.9 tp60 -71.42 -57.0 4.84 Favored 'General case' 0 C--N 1.311 -1.102 0 CA-C-O 121.798 0.809 . . . . 3.05 109.211 178.991 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A 1570 ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -83.42 -16.65 45.02 Favored 'General case' 0 C--N 1.301 -1.515 0 CA-C-N 114.634 -1.166 . . . . 2.44 113.089 -172.141 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A 1571 ' ' ARG . . . . . . . . . . . . . 11.1 tpp180 63.94 43.93 5.02 Favored 'General case' 0 N--CA 1.479 0.989 0 C-N-CA 125.59 1.556 . . . . 4.48 109.878 178.758 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A 1572 ' ' ILE . . . . . . . . . . . . . 31.9 mm -115.53 128.82 72.61 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.258 0 CA-C-N 115.447 -0.797 . . . . 1.94 109.819 -174.939 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A 1573 ' ' SER . . . . . . . . . . . . . 57.2 p -72.53 134.83 45.45 Favored 'General case' 0 C--O 1.247 0.951 0 CA-C-O 121.367 0.603 . . . . 1.25 111.869 -178.038 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A 1574 ' ' VAL . . . . . 0.447 HG23 ' HA ' ' A' 1566 ' ' CYS . 13.4 t -119.18 39.7 0.77 Allowed 'Isoleucine or valine' 0 CA--C 1.565 1.533 0 CA-C-O 122.597 1.189 . . . . 1.61 109.084 -174.926 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A 1575 ' ' GLY . . . . . . . . . . . . . . . 125.79 133.65 3.96 Favored Glycine 0 CA--C 1.53 1.017 0 CA-C-N 115.043 -0.98 . . . . 0.65 113.451 179.708 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A 1576 ' ' LYS . . . . . 0.465 ' O ' ' HD1' ' A' 1592 ' ' TYR . 64.4 mttp -84.31 153.99 23.19 Favored 'General case' 0 N--CA 1.469 0.491 0 N-CA-C 109.496 -0.557 . . . . 3.33 109.496 178.455 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A 1577 ' ' ALA . . . . . 0.553 ' HA ' ' CE1' ' A' 1592 ' ' TYR . . . -72.34 92.23 1.4 Allowed 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 113.042 0.756 . . . . 1.31 113.042 -173.028 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A 1578 ' ' ASN . . . . . 0.413 ' N ' HD21 ' A' 1578 ' ' ASN . 0.8 OUTLIER -98.92 117.64 33.88 Favored 'General case' 0 C--N 1.311 -1.08 0 N-CA-C 107.879 -1.156 . . . . 2.24 107.879 174.019 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A 1579 ' ' LYS . . . . . . . . . . . . . 55.7 mtmt -90.37 90.77 8.19 Favored 'General case' 0 C--N 1.3 -1.582 0 CA-C-O 121.882 0.849 . . . . 2.34 109.477 -177.479 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A 1580 ' ' ARG . . . . . . . . . . . . . 9.3 ttp180 -153.99 131.65 11.46 Favored 'General case' 0 C--N 1.288 -2.091 0 N-CA-C 107.068 -1.456 . . . . 4.19 107.068 179.925 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A 1581 ' ' LEU . . . . . 0.479 HD12 HD11 ' A' 1590 ' ' LEU . 28.9 tp -119.05 167.5 11.71 Favored 'General case' 0 C--N 1.296 -1.755 0 N-CA-C 108.299 -1.0 . . . . 2.39 108.299 -178.102 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A 1582 ' ' ARG . . . . . . . . . . . . . 69.2 ttt180 -145.18 103.04 3.82 Favored 'General case' 0 C--N 1.304 -1.408 0 N-CA-C 109.637 -0.505 . . . . 4.48 109.637 -179.81 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A 1583 ' ' TYR . . . . . 0.419 ' HB2' HG11 ' A' 1518 ' ' VAL . 42.2 t80 -88.6 111.46 21.92 Favored 'General case' 0 C--N 1.3 -1.567 0 CA-C-O 121.401 0.619 . . . . 1.57 111.141 179.087 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A 1584 ' ' VAL . . . . . 0.518 ' HB ' HG13 ' A' 1587 ' ' VAL . 48.9 t -112.94 150.68 15.01 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.744 0 N-CA-C 105.043 -2.206 . . . . 2.29 105.043 173.849 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A 1585 ' ' ASP . . . . . . . . . . . . . 33.9 t70 -47.4 108.32 0.15 Allowed 'General case' 0 C--N 1.33 -0.258 0 C-N-CA 123.843 0.857 . . . . 2.06 112.569 -179.563 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A 1586 ' ' GLN . . . . . . . . . . . . . 93.7 mt-30 63.76 24.29 13.76 Favored 'General case' 0 C--O 1.251 1.132 0 C-N-CA 125.155 1.382 . . . . 2.61 114.488 -178.966 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A 1587 ' ' VAL . . . . . 0.518 HG13 ' HB ' ' A' 1584 ' ' VAL . 7.1 p -161.13 105.71 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.439 -1.003 0 CA-C-O 122.35 1.072 . . . . 1.33 112.236 176.202 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A 1588 ' ' LEU . . . . . . . . . . . . . 7.3 mp -91.39 120.58 32.37 Favored 'General case' 0 C--N 1.299 -1.595 0 CA-C-N 115.075 -0.966 . . . . 2.03 108.842 179.934 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A 1589 ' ' GLN . . . . . . . . . . . . . 35.2 tt0 -105.89 134.21 49.38 Favored 'General case' 0 C--N 1.297 -1.689 0 N-CA-C 110.196 -0.298 . . . . 1.73 110.196 -177.768 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A 1590 ' ' LEU . . . . . 0.479 HD11 HD12 ' A' 1581 ' ' LEU . 2.0 tt -136.8 138.0 40.4 Favored 'General case' 0 C--N 1.304 -1.406 0 N-CA-C 106.222 -1.77 . . . . 1.76 106.222 175.925 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A 1591 ' ' VAL . . . . . . . . . . . . . 8.4 p -137.98 140.76 40.1 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.222 0 CA-C-O 120.967 0.413 . . . . 2.14 111.869 -174.171 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A 1592 ' ' TYR . . . . . 0.553 ' CE1' ' HA ' ' A' 1577 ' ' ALA . 88.1 m-85 -125.56 128.75 48.43 Favored 'General case' 0 C--N 1.317 -0.805 0 N-CA-C 108.094 -1.076 . . . . 1.53 108.094 176.117 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A 1593 ' ' LYS . . . . . . . . . . . . . 20.9 pttp -137.54 -174.21 3.7 Favored 'General case' 0 C--N 1.306 -1.313 0 N-CA-C 109.496 -0.557 . . . . 2.72 109.496 -176.925 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A 1594 ' ' ASP . . . . . . . . . . . . . 13.6 m-20 60.79 44.27 11.2 Favored 'General case' 0 N--CA 1.482 1.13 0 C-N-CA 123.281 0.632 . . . . 1.45 112.312 -179.603 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A 1595 ' ' GLY . . . . . . . . . . . . . . . -86.03 -92.76 0.86 Allowed Glycine 0 N--CA 1.437 -1.285 0 C-N-CA 119.477 -1.344 . . . . 0.83 111.76 177.685 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A 1596 ' ' SER . . . . . . . . . . . . . 37.1 m -113.47 151.69 44.68 Favored Pre-proline 0 C--N 1.287 -2.142 0 N-CA-C 108.678 -0.86 . . . . 1.96 108.678 179.377 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A 1597 ' ' PRO . . . . . . . . . . . . . 24.4 Cg_exo -65.3 133.03 33.48 Favored 'Trans proline' 0 C--O 1.24 0.607 0 C-N-CA 123.248 2.632 . . . . 1.34 110.976 178.798 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A 1598 ' ' CYS . . . . . . . . . . . . . 22.0 t -95.9 113.89 63.0 Favored Pre-proline 0 C--N 1.296 -1.76 0 CA-C-N 116.093 -0.503 . . . . 1.19 109.682 -177.463 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A 1599 ' ' PRO . . . . . . . . . . . . . 60.6 Cg_endo -88.8 18.18 1.52 Allowed 'Trans proline' 0 C--O 1.24 0.594 0 C-N-CA 122.904 2.402 . . . . 1.88 111.726 178.696 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A 1600 ' ' SER . . . . . . . . . . . . . 35.8 t -75.85 -55.92 5.16 Favored 'General case' 0 N--CA 1.427 -1.616 0 CA-C-N 115.715 -0.675 . . . . 2.19 110.59 -178.572 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A 1601 ' ' LYS . . . . . . . . . . . . . 53.2 tttp -142.42 -71.87 0.32 Allowed 'General case' 0 N--CA 1.445 -0.693 0 C-N-CA 119.926 -0.709 . . . . 4.21 112.486 -175.955 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A 1602 ' ' SER . . . . . 0.564 ' HB3' ' HG ' ' A' 1604 ' ' LEU . 23.0 t -96.37 157.11 16.05 Favored 'General case' 0 N--CA 1.427 -1.575 0 N-CA-C 108.47 -0.937 . . . . 3.82 108.47 -175.957 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A 1603 ' ' GLY . . . . . . . . . . . . . . . -77.74 58.21 3.84 Favored Glycine 0 C--O 1.236 0.27 0 N-CA-C 111.942 -0.463 . . . . 2.45 111.942 -179.824 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A 1604 ' ' LEU . . . . . 0.564 ' HG ' ' HB3' ' A' 1602 ' ' SER . 0.6 OUTLIER -120.97 -175.27 3.01 Favored 'General case' 0 C--N 1.298 -1.668 0 C-N-CA 124.581 1.152 . . . . 2.06 110.364 -178.516 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A 1605 ' ' SER . . . . . . . . . . . . . 15.0 m -104.58 -170.04 1.71 Allowed 'General case' 0 C--N 1.297 -1.712 0 N-CA-C 109.929 -0.397 . . . . 1.75 109.929 -178.879 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A 1606 ' ' TYR . . . . . . . . . . . . . 97.5 m-85 -103.37 126.65 50.64 Favored 'General case' 0 CA--C 1.482 -1.662 0 N-CA-C 104.328 -2.471 . . . . 1.59 104.328 177.274 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A 1607 ' ' LYS . . . . . . . . . . . . . 21.3 ptmt -119.15 132.15 55.95 Favored 'General case' 0 C--N 1.285 -2.219 0 C-N-CA 119.528 -0.869 . . . . 2.21 111.654 -176.071 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A 1608 ' ' SER . . . . . . . . . . . . . 33.1 m -103.15 118.31 36.51 Favored 'General case' 0 C--N 1.309 -1.177 0 C-N-CA 123.024 0.53 . . . . 1.48 110.731 -177.301 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A 1609 ' ' VAL . . . . . . . . . . . . . 58.7 t -110.98 114.57 47.48 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.778 0 N-CA-C 108.687 -0.857 . . . . 1.57 108.687 177.363 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A 1610 ' ' ILE . . . . . 0.642 HG13 ' HB2' ' A' 1638 ' ' PHE . 2.9 mp -105.04 114.67 45.22 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.214 0 N-CA-C 108.675 -0.861 . . . . 1.47 108.675 178.345 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A 1611 ' ' SER . . . . . . . . . . . . . 19.4 m -104.42 107.76 18.85 Favored 'General case' 0 C--N 1.296 -1.753 0 CA-C-N 115.474 -0.784 . . . . 1.84 109.486 179.535 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A 1612 ' ' PHE . . . . . 0.518 ' O ' ' HA ' ' A' 1587 ' ' VAL . 97.7 m-85 -83.8 102.55 12.4 Favored 'General case' 0 C--N 1.306 -1.319 0 CA-C-N 115.882 -0.599 . . . . 0.86 109.472 179.089 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A 1613 ' ' VAL . . . . . . . . . . . . . 94.4 t -86.52 124.9 40.7 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.485 0 N-CA-C 107.857 -1.164 . . . . 1.32 107.857 179.345 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A 1614 ' ' CYS . . . . . 0.457 ' HB3' ' HB2' ' A' 1646 ' ' CYS . 61.8 m -75.73 92.78 3.03 Favored 'General case' 0 C--N 1.295 -1.797 0 CA-C-O 121.614 0.721 . . . . 1.39 111.018 -177.12 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A 1615 ' ' ARG . . . . . 0.504 ' HB3' ' HB3' ' A' 1641 ' ' HIS . 43.6 ttm180 -138.45 131.79 16.35 Favored Pre-proline 0 N--CA 1.43 -1.464 0 CA-C-N 115.155 -0.929 . . . . 4.34 109.467 -179.742 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A 1616 ' ' PRO . . . . . . . . . . . . . 38.4 Cg_endo -70.7 67.37 2.29 Favored 'Trans proline' 0 CA--C 1.55 1.309 0 C-N-CA 123.142 2.562 . . . . 1.5 111.351 175.764 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A 1617 ' ' GLU . . . . . . . . . . . . . 10.9 tp10 . . . . . 0 CA--C 1.555 1.169 0 CA-C-O 121.982 0.896 . . . . 3.21 109.354 -177.52 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A 1622 ' ' ASN . . . . . . . . . . . . . 40.3 t30 . . . . . 0 C--O 1.242 0.71 0 N-CA-C 108.77 -0.826 . . . . 3.58 108.77 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A 1623 ' ' ARG . . . . . . . . . . . . . 20.2 ptp180 -148.78 169.22 9.51 Favored Pre-proline 0 C--N 1.302 -1.497 0 N-CA-C 108.474 -0.935 . . . . 4.09 108.474 -174.364 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A 1624 ' ' PRO . . . . . . . . . . . . . 33.6 Cg_exo -61.41 114.89 2.42 Favored 'Trans proline' 0 C--N 1.36 1.161 0 C-N-CA 121.825 1.684 . . . . 2.86 109.51 175.69 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A 1625 ' ' MET . . . . . . . . . . . . . 22.7 ptt? -109.81 146.1 35.6 Favored 'General case' 0 C--N 1.292 -1.892 0 CA-C-N 115.891 -0.595 . . . . 2.73 111.495 -175.301 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A 1626 ' ' LEU . . . . . . . . . . . . . 43.0 tp -76.0 111.07 11.0 Favored 'General case' 0 N--CA 1.441 -0.904 0 CA-C-N 114.773 -1.103 . . . . 1.94 109.179 179.521 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A 1627 ' ' ILE . . . . . . . . . . . . . 39.0 mm -81.69 -49.58 17.51 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.745 0 CA-C-N 115.03 -0.986 . . . . 1.75 110.41 -175.727 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A 1628 ' ' SER . . . . . . . . . . . . . 48.3 m -157.26 154.09 28.56 Favored 'General case' 0 C--N 1.301 -1.52 0 CA-C-N 116.259 -0.428 . . . . 1.85 109.913 -178.064 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A 1629 ' ' LEU . . . . . 0.437 HD13 ' HG ' ' A' 1636 ' ' LEU . 56.7 tp -113.36 118.41 34.5 Favored 'General case' 0 N--CA 1.428 -1.56 0 N-CA-C 108.039 -1.096 . . . . 2.12 108.039 175.251 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A 1630 ' ' ASP . . . . . 0.481 ' HB3' ' HB ' ' A' 1635 ' ' THR . 12.6 t70 -95.09 117.62 30.49 Favored 'General case' 0 C--N 1.293 -1.864 0 N-CA-C 107.653 -1.24 . . . . 0.87 107.653 177.121 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A 1631 ' ' LYS . . . . . 0.541 ' HZ1' ' HB3' ' A' 1631 ' ' LYS . 8.5 mtpm? -94.22 4.87 53.29 Favored 'General case' 0 C--N 1.298 -1.673 0 N-CA-C 112.402 0.519 . . . . 2.76 112.402 -176.116 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A 1632 ' ' GLN . . . . . . . . . . . . . 2.2 mp0 -89.99 -51.97 5.2 Favored 'General case' 0 C--N 1.307 -1.245 0 CA-C-O 121.208 0.528 . . . . 2.55 109.686 -179.608 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A 1633 ' ' THR . . . . . . . . . . . . . 7.2 m -105.15 4.46 31.36 Favored 'General case' 0 C--N 1.306 -1.314 0 CA-C-O 122.309 1.052 . . . . 1.92 109.261 179.815 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A 1634 ' ' CYS . . . . . 0.412 ' HA ' ' O ' ' A' 1630 ' ' ASP . 61.3 m 55.24 52.8 10.95 Favored 'General case' 0 N--CA 1.469 0.505 0 CA-C-N 114.092 -1.413 . . . . 0.89 110.739 179.199 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A 1635 ' ' THR . . . . . 0.481 ' HB ' ' HB3' ' A' 1630 ' ' ASP . 21.1 m -103.87 125.23 50.14 Favored 'General case' 0 N--CA 1.421 -1.92 0 CA-C-N 113.458 -1.701 . . . . 1.31 109.924 -175.059 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A 1636 ' ' LEU . . . . . 0.437 ' HG ' HD13 ' A' 1629 ' ' LEU . 5.8 mp -106.49 122.58 46.58 Favored 'General case' 0 C--N 1.313 -0.981 0 N-CA-C 109.362 -0.607 . . . . 1.97 109.362 178.921 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A 1637 ' ' PHE . . . . . . . . . . . . . 96.9 m-85 -98.85 112.51 24.58 Favored 'General case' 0 C--N 1.313 -1.0 0 CA-C-N 115.983 -0.553 . . . . 0.92 111.783 -176.275 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A 1638 ' ' PHE . . . . . 0.642 ' HB2' HG13 ' A' 1610 ' ' ILE . 87.6 m-85 -115.09 133.81 55.71 Favored 'General case' 0 C--N 1.294 -1.832 0 N-CA-C 108.484 -0.932 . . . . 0.7 108.484 175.303 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A 1639 ' ' SER . . . . . . . . . . . . . 28.2 t -140.47 141.5 35.41 Favored 'General case' 0 C--N 1.276 -2.606 0 C-N-CA 120.099 -0.641 . . . . 1.46 109.308 177.49 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A 1640 ' ' TRP . . . . . 0.495 ' HE3' ' HE1' ' A' 1612 ' ' PHE . 10.5 t90 -128.0 127.88 44.01 Favored 'General case' 0 N--CA 1.43 -1.429 0 N-CA-C 107.849 -1.167 . . . . 0.92 107.849 178.659 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A 1641 ' ' HIS . . . . . 0.504 ' HB3' ' HB3' ' A' 1615 ' ' ARG . 34.9 m80 -91.25 97.79 11.33 Favored 'General case' 0 C--N 1.301 -1.513 0 N-CA-C 105.983 -1.858 . . . . 3.18 105.983 175.276 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A 1642 ' ' THR . . . . . 0.56 ' OG1' ' HG ' ' A' 1644 ' ' LEU . 7.8 t -135.12 140.85 35.97 Favored Pre-proline 0 C--N 1.296 -1.719 0 N-CA-C 113.63 0.974 . . . . 1.48 113.63 -170.737 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A 1643 ' ' PRO . . . . . . . . . . . . . 87.3 Cg_endo -80.66 -0.84 10.9 Favored 'Trans proline' 0 N--CA 1.447 -1.219 0 C-N-CA 123.475 2.783 . . . . 1.09 112.451 175.903 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A 1644 ' ' LEU . . . . . 0.56 ' HG ' ' OG1' ' A' 1642 ' ' THR . 2.8 pp -92.94 4.03 54.68 Favored 'General case' 0 CA--C 1.502 -0.885 0 CA-C-O 121.969 0.89 . . . . 2.08 110.386 174.613 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A 1645 ' ' ALA . . . . . . . . . . . . . . . -95.78 -43.47 7.86 Favored 'General case' 0 C--N 1.3 -1.552 0 CA-C-N 113.818 -1.537 . . . . 1.37 108.421 175.992 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A 1646 ' ' CYS . . . . . 0.457 ' HB2' ' HB3' ' A' 1614 ' ' CYS . 38.2 m -156.44 158.36 37.16 Favored 'General case' 0 CA--C 1.498 -1.05 0 N-CA-C 105.585 -2.005 . . . . 1.7 105.585 174.71 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A 1647 ' ' GLU . . . . . . . . . . . . . 53.9 mt-10 . . . . . 0 C--N 1.305 -1.368 0 N-CA-C 110.215 -0.291 . . . . 2.92 110.215 -179.624 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A 1508 ' ' MET . . . . . . . . . . . . . 70.3 mtm . . . . . 0 C--O 1.238 0.481 0 N-CA-C 111.826 0.306 . . . . 8.58 111.826 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A 1509 ' ' LYS . . . . . . . . . . . . . 61.7 tttp -71.83 -58.56 3.36 Favored 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 111.7 0.259 . . . . 6.8 111.7 -177.745 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 1510 ' ' SER . . . . . . . . . . . . . 66.0 m -112.1 119.89 39.98 Favored 'General case' 0 C--N 1.303 -1.45 0 N-CA-C 109.002 -0.74 . . . . 4.48 109.002 178.145 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 1511 ' ' ASN . . . . . . . . . . . . . 21.8 m-80 -121.88 -24.2 5.28 Favored 'General case' 0 C--N 1.298 -1.662 0 CA-C-N 116.143 -0.48 . . . . 3.08 111.019 -174.334 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 1512 ' ' GLU . . . . . . . . . . . . . 1.4 mp0 -51.32 -25.87 6.63 Favored 'General case' 0 N--CA 1.475 0.798 0 C-N-CA 126.214 1.806 . . . . 4.46 114.608 -173.921 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 1513 ' ' HIS . . . . . 0.5 ' CE1' ' HG3' ' A' 1580 ' ' ARG . 49.1 m-70 -113.3 0.66 14.9 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-O 121.359 0.6 . . . . 6.25 110.476 -179.177 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A 1514 ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -104.82 -55.85 2.27 Favored 'General case' 0 C--N 1.295 -1.774 0 CA-C-N 115.657 -0.701 . . . . 3.7 110.722 -175.413 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 1515 ' ' ASP . . . . . . . . . . . . . 22.8 t0 -145.04 152.77 40.64 Favored 'General case' 0 C--N 1.291 -1.969 0 N-CA-C 106.874 -1.528 . . . . 2.54 106.874 -177.712 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 1516 ' ' CYS . . . . . . . . . . . . . 29.8 m -75.99 67.92 2.41 Favored 'General case' 0 C--N 1.288 -2.081 0 CA-C-O 121.948 0.88 . . . . 1.25 110.862 -176.008 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 1517 ' ' GLN . . . . . . . . . . . . . 4.0 pt20 -148.56 151.31 34.85 Favored 'General case' 0 N--CA 1.417 -2.119 0 N-CA-C 108.578 -0.897 . . . . 2.36 108.578 -179.494 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 1518 ' ' VAL . . . . . 0.8 HG21 HD11 ' A' 1588 ' ' LEU . 44.6 t -127.08 134.07 66.89 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.459 0 N-CA-C 108.87 -0.789 . . . . 2.34 108.87 -179.169 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A 1519 ' ' THR . . . . . . . . . . . . . 27.7 m -107.71 125.33 51.25 Favored 'General case' 0 C--N 1.296 -1.727 0 N-CA-C 110.063 -0.347 . . . . 2.04 110.063 177.14 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 1520 ' ' ASN . . . . . . . . . . . . . 30.3 t-20 -97.33 100.37 7.81 Favored Pre-proline 0 C--N 1.309 -1.16 0 N-CA-C 106.802 -1.555 . . . . 2.12 106.802 172.063 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 1521 ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -73.83 -0.12 9.01 Favored 'Trans proline' 0 C--N 1.353 0.784 0 C-N-CA 122.713 2.275 . . . . 2.59 113.495 -175.633 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 1522 ' ' SER . . . . . . . . . . . . . 50.8 m -91.44 -14.96 29.62 Favored 'General case' 0 N--CA 1.433 -1.279 0 CA-C-N 116.641 -0.254 . . . . 2.65 110.917 178.384 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 1523 ' ' THR . . . . . . . . . . . . . 14.3 t -139.12 0.67 1.95 Allowed 'General case' 0 CA--C 1.555 1.135 0 CA-C-O 121.271 0.557 . . . . 2.33 111.247 177.427 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 1524 ' ' GLY . . . . . . . . . . . . . . . 66.8 30.61 76.45 Favored Glycine 0 C--N 1.339 0.708 0 CA-C-N 116.217 -0.447 . . . . 1.96 112.535 178.466 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 1525 ' ' HIS . . . . . 0.614 ' HE1' ' HB2' ' A' 1647 ' ' GLU . 23.8 t-160 -101.53 122.75 44.38 Favored 'General case' 0 C--N 1.303 -1.438 0 O-C-N 122.616 -0.343 . . . . 2.44 111.021 -176.729 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A 1526 ' ' LEU . . . . . . . . . . . . . 42.6 tp -97.97 133.55 42.29 Favored 'General case' 0 C--N 1.307 -1.249 0 N-CA-C 108.86 -0.793 . . . . 2.19 108.86 176.383 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 1527 ' ' PHE . . . . . 0.416 ' CE1' ' HA ' ' A' 1646 ' ' CYS . 94.8 m-85 -102.87 132.67 48.92 Favored 'General case' 0 C--N 1.292 -1.917 0 N-CA-C 108.529 -0.915 . . . . 1.61 108.529 176.822 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A 1528 ' ' ASP . . . . . . . . . . . . . 28.7 t70 -110.98 114.76 28.32 Favored 'General case' 0 CA--C 1.487 -1.45 0 CA-C-O 122.103 0.954 . . . . 2.18 112.425 -179.245 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 1529 ' ' LEU . . . . . . . . . . . . . 87.0 mt -119.63 3.53 11.16 Favored 'General case' 0 C--N 1.294 -1.818 0 CA-C-N 114.055 -1.429 . . . . 2.04 107.427 174.623 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 1530 ' ' SER . . . . . . . . . . . . . 14.5 t -80.36 -31.6 37.89 Favored 'General case' 0 N--CA 1.441 -0.898 0 CA-C-N 115.74 -0.664 . . . . 1.44 110.428 -175.443 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 1531 ' ' SER . . . . . . . . . . . . . 25.9 m -70.4 -10.9 60.35 Favored 'General case' 0 C--O 1.236 0.379 0 CA-C-O 121.133 0.492 . . . . 1.63 110.204 177.234 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 1532 ' ' LEU . . . . . . . . . . . . . 97.1 mt -80.39 10.01 5.15 Favored 'General case' 0 CA--C 1.546 0.811 0 N-CA-C 112.787 0.662 . . . . 2.32 112.787 178.666 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 1533 ' ' SER . . . . . . . . . . . . . 31.7 m -72.7 145.02 47.47 Favored 'General case' 0 C--O 1.247 0.964 0 N-CA-C 108.495 -0.928 . . . . 2.57 108.495 174.924 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 1534 ' ' GLY . . . . . . . . . . . . . . . -162.66 169.28 37.86 Favored Glycine 0 N--CA 1.441 -0.995 0 C-N-CA 120.319 -0.944 . . . . 1.89 112.277 -177.419 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 1535 ' ' ARG . . . . . 0.801 ' HD3' ' HG3' ' A' 1557 ' ' GLU . 21.8 tpp180 -80.67 -51.59 8.53 Favored 'General case' 0 C--N 1.312 -1.028 0 N-CA-C 108.676 -0.861 . . . . 4.44 108.676 179.459 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A 1536 ' ' ALA . . . . . . . . . . . . . . . -79.61 -37.44 36.17 Favored 'General case' 0 C--N 1.309 -1.193 0 C-N-CA 120.033 -0.667 . . . . 2.07 110.261 179.291 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 1537 ' ' GLY . . . . . . . . . . . . . . . 79.68 -151.17 33.77 Favored Glycine 0 N--CA 1.426 -1.972 0 N-CA-C 109.962 -1.255 . . . . 1.2 109.962 -179.953 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 1538 ' ' PHE . . . . . 0.605 ' CD1' HD13 ' A' 1552 ' ' ILE . 65.7 m-85 -107.95 135.91 48.53 Favored 'General case' 0 C--N 1.288 -2.09 0 N-CA-C 107.6 -1.259 . . . . 1.98 107.6 177.598 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A 1539 ' ' THR . . . . . 0.441 ' O ' ' HD2' ' A' 1623 ' ' ARG . 2.7 p -112.45 137.02 51.24 Favored 'General case' 0 C--N 1.296 -1.75 0 N-CA-C 113.135 0.791 . . . . 1.97 113.135 -175.676 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A 1540 ' ' ALA . . . . . . . . . . . . . . . -117.02 108.81 16.21 Favored 'General case' 0 C--N 1.308 -1.203 0 N-CA-C 109.687 -0.486 . . . . 1.39 109.687 178.302 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 1541 ' ' ALA . . . . . . . . . . . . . . . -74.19 113.75 11.76 Favored 'General case' 0 C--N 1.313 -0.98 0 CA-C-N 115.36 -0.836 . . . . 1.86 109.396 178.998 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 1542 ' ' TYR . . . . . 0.431 ' CE2' ' HB2' ' A' 1545 ' ' SER . 80.0 t80 -130.72 157.64 42.25 Favored 'General case' 0 N--CA 1.418 -2.065 0 CA-C-N 115.852 -0.613 . . . . 2.4 109.734 -176.587 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A 1543 ' ' SER . . . . . . . . . . . . . 5.3 m -40.85 -153.6 0.0 OUTLIER 'General case' 0 CA--C 1.592 2.561 0 C-N-CA 129.709 3.204 . . . . 2.58 117.111 -174.716 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 1544 ' ' LYS . . . . . . . . . . . . . 25.0 ttmm -54.86 -24.71 24.41 Favored 'General case' 0 CA--C 1.556 1.188 0 O-C-N 120.863 -1.148 . . . . 4.24 112.385 -179.343 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 1545 ' ' SER . . . . . 0.431 ' HB2' ' CE2' ' A' 1542 ' ' TYR . 22.6 m -64.69 -30.69 71.71 Favored 'General case' 0 CA--C 1.547 0.827 0 O-C-N 121.759 -0.588 . . . . 3.6 110.717 175.452 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A 1546 ' ' GLY . . . . . 0.408 ' O ' ' HB3' ' A' 1542 ' ' TYR . . . 116.85 174.26 17.12 Favored Glycine 0 N--CA 1.436 -1.34 0 C-N-CA 119.489 -1.339 . . . . 1.66 114.974 174.174 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A 1547 ' ' VAL . . . . . . . . . . . . . 3.1 p -92.92 129.21 43.79 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.343 0 C-N-CA 123.991 0.916 . . . . 2.23 110.398 179.915 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 1548 ' ' VAL . . . . . 0.487 ' HA ' ' HA ' ' A' 1567 ' ' PHE . 3.0 t -97.47 143.29 12.87 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.86 0 CA-C-N 115.55 -0.75 . . . . 1.59 109.957 -174.763 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A 1549 ' ' TYR . . . . . 0.672 ' HB3' HD22 ' A' 1556 ' ' ASN . 37.3 m-85 -102.49 145.41 29.62 Favored 'General case' 0 C--N 1.307 -1.243 0 N-CA-C 105.915 -1.883 . . . . 1.58 105.915 169.341 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A 1550 ' ' MET . . . . . . . . . . . . . 37.1 ttm -143.52 127.72 17.64 Favored 'General case' 0 C--N 1.292 -1.929 0 C-N-CA 120.49 -0.484 . . . . 2.08 110.833 -175.615 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 1551 ' ' SER . . . . . . . . . . . . . 41.0 p -99.52 115.76 30.08 Favored 'General case' 0 N--CA 1.418 -2.04 0 N-CA-C 108.047 -1.094 . . . . 1.9 108.047 174.572 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 1552 ' ' ILE . . . . . 0.605 HD13 ' CD1' ' A' 1538 ' ' PHE . 1.7 mp -75.53 -7.84 10.73 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.017 0 CA-C-O 122.474 1.131 . . . . 2.04 110.586 179.228 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A 1553 ' ' CYS . . . . . . . . . . . . . 33.9 t -161.48 148.83 14.78 Favored 'General case' 0 N--CA 1.425 -1.691 0 N-CA-C 107.516 -1.29 . . . . 1.43 107.516 177.56 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 1554 ' ' GLY . . . . . 0.415 ' O ' ' HB3' ' A' 1577 ' ' ALA . . . 82.93 -120.15 5.07 Favored Glycine 0 C--N 1.318 -0.462 0 C-N-CA 121.227 -0.511 . . . . 1.23 113.129 176.228 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A 1555 ' ' GLU . . . . . . . . . . . . . 9.3 pt-20 -145.81 145.51 30.81 Favored 'General case' 0 C--N 1.315 -0.91 0 C-N-CA 123.347 0.659 . . . . 1.8 110.812 -179.885 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 1556 ' ' ASN . . . . . 0.672 HD22 ' HB3' ' A' 1549 ' ' TYR . 3.4 t-20 -85.13 132.3 34.32 Favored 'General case' 0 C--N 1.295 -1.773 0 CA-C-N 114.644 -1.162 . . . . 2.63 110.821 -175.183 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A 1557 ' ' GLU . . . . . 0.801 ' HG3' ' HD3' ' A' 1535 ' ' ARG . 33.2 mm-40 -98.48 177.87 5.2 Favored 'General case' 0 C--N 1.289 -2.044 0 CA-C-N 113.837 -1.529 . . . . 3.79 109.116 179.937 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A 1558 ' ' ASN . . . . . . . . . . . . . 37.8 m-80 75.53 5.71 4.03 Favored 'General case' 0 N--CA 1.504 2.258 0 C-N-CA 124.471 1.109 . . . . 1.59 111.119 -178.727 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 1559 ' ' CYS . . . . . 0.445 ' HB3' ' HD2' ' A' 1560 ' ' PRO . 97.7 m -148.28 169.35 9.38 Favored Pre-proline 0 C--N 1.291 -1.938 0 N-CA-C 103.413 -2.81 . . . . 0.94 103.413 176.34 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A 1560 ' ' PRO . . . . . 0.445 ' HD2' ' HB3' ' A' 1559 ' ' CYS . 9.4 Cg_endo -52.18 109.21 0.31 Allowed 'Trans proline' 0 C--N 1.359 1.115 0 C-N-CA 122.37 2.046 . . . . 1.53 111.244 176.624 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A 1561 ' ' PRO . . . . . . . . . . . . . 75.4 Cg_exo -50.85 120.61 6.83 Favored 'Trans proline' 0 C--N 1.359 1.088 0 C-N-CA 123.884 3.056 . . . . 1.82 112.502 -175.523 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 1562 ' ' GLY . . . . . . . . . . . . . . . 134.19 -6.04 4.66 Favored Glycine 0 N--CA 1.435 -1.433 0 CA-C-N 115.081 -0.963 . . . . 0.81 110.987 -177.608 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 1563 ' ' VAL . . . . . 0.572 HG22 ' HB3' ' A' 1556 ' ' ASN . 13.9 m -90.43 161.06 2.67 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.182 0 N-CA-C 105.937 -1.875 . . . . 1.73 105.937 172.944 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A 1564 ' ' GLY . . . . . . . . . . . . . . . -112.18 -21.88 6.1 Favored Glycine 0 C--N 1.309 -0.923 0 C-N-CA 120.395 -0.907 . . . . 0.72 111.964 -179.816 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 1565 ' ' ALA . . . . . . . . . . . . . . . -150.13 127.63 11.52 Favored 'General case' 0 C--N 1.311 -1.081 0 N-CA-C 107.511 -1.292 . . . . 1.14 107.511 179.048 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 1566 ' ' CYS . . . . . . . . . . . . . 34.2 t -155.75 141.57 18.06 Favored 'General case' 0 C--N 1.297 -1.681 0 N-CA-C 110.33 -0.248 . . . . 0.51 110.33 -174.62 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 1567 ' ' PHE . . . . . 0.487 ' HA ' ' HA ' ' A' 1548 ' ' VAL . 87.6 m-85 -71.2 121.69 18.84 Favored 'General case' 0 C--O 1.216 -0.662 0 N-CA-C 105.365 -2.087 . . . . 1.22 105.365 171.678 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A 1568 ' ' GLY . . . . . 0.627 ' HA3' ' CD1' ' A' 1549 ' ' TYR . . . -83.21 -16.23 69.91 Favored Glycine 0 C--N 1.296 -1.672 0 C-N-CA 119.314 -1.422 . . . . 1.08 114.009 -171.141 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A 1569 ' ' GLN . . . . . . . . . . . . . 4.1 pt20 -82.31 -21.71 35.97 Favored 'General case' 0 C--N 1.301 -1.521 0 C-N-CA 120.565 -0.454 . . . . 3.05 111.408 -178.164 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 1570 ' ' THR . . . . . . . . . . . . . 9.7 p -121.54 -12.36 8.55 Favored 'General case' 0 C--O 1.239 0.505 0 N-CA-C 112.347 0.499 . . . . 2.44 112.347 178.303 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 1571 ' ' ARG . . . . . 0.428 ' HA ' ' SG ' ' A' 1559 ' ' CYS . 96.4 mtt180 62.81 42.57 7.79 Favored 'General case' 0 CA--C 1.511 -0.552 0 C-N-CA 125.1 1.36 . . . . 4.48 112.693 178.922 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A 1572 ' ' ILE . . . . . . . . . . . . . 25.2 mm -99.95 116.26 42.85 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.19 0 N-CA-C 108.139 -1.06 . . . . 1.94 108.139 179.942 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 1573 ' ' SER . . . . . . . . . . . . . 35.0 t -69.15 133.33 47.87 Favored 'General case' 0 C--N 1.306 -1.284 0 CA-C-N 115.311 -0.859 . . . . 1.25 111.084 -176.402 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 1574 ' ' VAL . . . . . . . . . . . . . 13.8 m -130.6 28.42 1.51 Allowed 'Isoleucine or valine' 0 C--N 1.315 -0.929 0 CA-C-O 122.205 1.002 . . . . 1.61 110.857 174.903 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 1575 ' ' GLY . . . . . . . . . . . . . . . 163.04 126.97 0.85 Allowed Glycine 0 N--CA 1.421 -2.342 0 CA-C-N 113.835 -1.53 . . . . 0.65 110.439 176.854 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 1576 ' ' LYS . . . . . 0.464 ' HA ' ' HA ' ' A' 1563 ' ' VAL . 68.3 mttm -85.79 151.24 23.98 Favored 'General case' 0 C--N 1.31 -1.133 0 N-CA-C 108.781 -0.822 . . . . 3.33 108.781 177.969 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A 1577 ' ' ALA . . . . . 0.415 ' HB3' ' O ' ' A' 1554 ' ' GLY . . . -74.34 91.84 2.23 Favored 'General case' 0 C--N 1.315 -0.928 0 CA-C-O 121.736 0.779 . . . . 1.31 111.641 -175.48 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A 1578 ' ' ASN . . . . . . . . . . . . . 41.4 m-80 -117.22 115.18 24.8 Favored 'General case' 0 C--N 1.284 -2.243 0 N-CA-C 104.747 -2.316 . . . . 2.24 104.747 171.724 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 1579 ' ' LYS . . . . . . . . . . . . . 54.1 mtmt -77.29 90.41 3.75 Favored 'General case' 0 CA--C 1.493 -1.244 0 N-CA-C 108.654 -0.869 . . . . 2.34 108.654 -177.037 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 1580 ' ' ARG . . . . . 0.5 ' HG3' ' CE1' ' A' 1513 ' ' HIS . 27.4 ttm180 -134.79 99.09 4.21 Favored 'General case' 0 N--CA 1.402 -2.861 0 CA-C-N 114.341 -1.3 . . . . 4.19 108.869 -176.481 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A 1581 ' ' LEU . . . . . 0.429 ' HA ' ' HA ' ' A' 1590 ' ' LEU . 4.6 pp -103.61 168.03 9.41 Favored 'General case' 0 C--N 1.297 -1.7 0 C-N-CA 120.4 -0.52 . . . . 2.39 110.189 177.518 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A 1582 ' ' ARG . . . . . 0.659 ' HB3' ' HB3' ' A' 1589 ' ' GLN . 61.5 ttt180 -135.21 125.5 26.36 Favored 'General case' 0 C--N 1.297 -1.688 0 C-N-CA 123.158 0.583 . . . . 4.48 109.766 -174.046 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A 1583 ' ' TYR . . . . . . . . . . . . . 40.2 t80 -119.09 104.11 10.16 Favored 'General case' 0 C--N 1.308 -1.202 0 CA-C-N 116.256 -0.429 . . . . 1.57 110.131 176.075 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 1584 ' ' VAL . . . . . . . . . . . . . 12.5 p -148.62 142.82 18.85 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.953 0 N-CA-C 108.76 -0.83 . . . . 2.29 108.76 178.981 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 1585 ' ' ASP . . . . . . . . . . . . . 31.6 t70 49.65 38.7 15.71 Favored 'General case' 0 N--CA 1.501 2.092 0 CA-C-O 122.559 1.171 . . . . 2.06 112.503 177.226 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 1586 ' ' GLN . . . . . . . . . . . . . 27.4 mt-30 53.84 34.57 19.59 Favored 'General case' 0 C--O 1.241 0.638 0 CA-C-N 114.581 -1.191 . . . . 2.61 113.151 -179.426 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 1587 ' ' VAL . . . . . . . . . . . . . 7.1 p -135.08 117.5 22.13 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.386 0 CA-C-O 121.826 0.822 . . . . 1.33 109.427 174.724 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 1588 ' ' LEU . . . . . 0.8 HD11 HG21 ' A' 1518 ' ' VAL . 2.3 mm? -81.57 152.72 27.09 Favored 'General case' 0 C--N 1.297 -1.706 0 CA-C-N 114.784 -1.098 . . . . 2.03 111.588 -178.167 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A 1589 ' ' GLN . . . . . 0.659 ' HB3' ' HB3' ' A' 1582 ' ' ARG . 35.3 tt0 -152.47 156.99 40.52 Favored 'General case' 0 C--N 1.294 -1.837 0 N-CA-C 107.493 -1.299 . . . . 1.73 107.493 -179.534 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A 1590 ' ' LEU . . . . . 0.456 ' HB2' ' HE2' ' A' 1612 ' ' PHE . 5.3 tt -147.83 143.35 27.39 Favored 'General case' 0 C--N 1.303 -1.448 0 N-CA-C 105.685 -1.968 . . . . 1.76 105.685 175.06 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A 1591 ' ' VAL . . . . . 0.459 HG22 HG21 ' A' 1609 ' ' VAL . 11.5 p -130.93 135.26 60.42 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.178 0 N-CA-C 112.805 0.668 . . . . 2.14 112.805 -173.843 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A 1592 ' ' TYR . . . . . . . . . . . . . 63.3 m-85 -122.35 106.11 10.78 Favored 'General case' 0 C--N 1.315 -0.904 0 N-CA-C 107.857 -1.164 . . . . 1.53 107.857 172.912 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 1593 ' ' LYS . . . . . . . . . . . . . 20.0 pttp -104.37 178.4 4.57 Favored 'General case' 0 C--N 1.293 -1.854 0 CA-C-N 115.982 -0.553 . . . . 2.72 112.07 -176.173 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 1594 ' ' ASP . . . . . 0.562 ' HA ' ' CB ' ' A' 1605 ' ' SER . 55.8 m-20 49.05 47.83 21.44 Favored 'General case' 0 CA--C 1.514 -0.423 0 C-N-CA 126.101 1.76 . . . . 1.45 115.701 172.407 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A 1595 ' ' GLY . . . . . . . . . . . . . . . -78.66 -80.48 0.73 Allowed Glycine 0 N--CA 1.445 -0.724 0 C-N-CA 120.298 -0.953 . . . . 0.83 111.226 177.758 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 1596 ' ' SER . . . . . 0.421 ' HA ' ' HD3' ' A' 1597 ' ' PRO . 4.2 p -107.47 143.38 27.11 Favored Pre-proline 0 C--N 1.299 -1.618 0 N-CA-C 109.963 -0.384 . . . . 1.96 109.963 177.588 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A 1597 ' ' PRO . . . . . 0.421 ' HD3' ' HA ' ' A' 1596 ' ' SER . 21.5 Cg_exo -67.24 130.13 21.95 Favored 'Trans proline' 0 N--CA 1.46 -0.475 0 C-N-CA 123.039 2.493 . . . . 1.34 110.29 177.099 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A 1598 ' ' CYS . . . . . 0.416 ' HA ' ' HD3' ' A' 1599 ' ' PRO . 33.7 t -101.25 121.42 51.92 Favored Pre-proline 0 C--N 1.296 -1.736 0 N-CA-C 109.924 -0.398 . . . . 1.19 109.924 -177.157 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A 1599 ' ' PRO . . . . . 0.416 ' HD3' ' HA ' ' A' 1598 ' ' CYS . 94.3 Cg_endo -98.34 22.4 0.29 Allowed 'Trans proline' 0 N--CA 1.449 -1.114 0 C-N-CA 123.127 2.551 . . . . 1.88 112.097 178.344 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A 1600 ' ' SER . . . . . . . . . . . . . 17.9 m -79.61 -74.24 0.3 Allowed 'General case' 0 C--N 1.315 -0.931 0 CA-C-N 116.466 -0.333 . . . . 2.19 111.788 -177.899 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 1601 ' ' LYS . . . . . . . . . . . . . 23.2 tptm -98.13 -87.11 0.34 Allowed 'General case' 0 C--N 1.317 -0.822 0 C-N-CA 120.317 -0.553 . . . . 4.21 110.42 -178.949 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 1602 ' ' SER . . . . . . . . . . . . . 16.7 m -96.21 174.98 6.62 Favored 'General case' 0 C--N 1.298 -1.672 0 N-CA-C 107.942 -1.133 . . . . 3.82 107.942 178.718 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 1603 ' ' GLY . . . . . . . . . . . . . . . -81.57 65.64 3.98 Favored Glycine 0 N--CA 1.439 -1.126 0 N-CA-C 110.382 -1.087 . . . . 2.45 110.382 178.025 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 1604 ' ' LEU . . . . . . . . . . . . . 1.7 pt? -117.02 165.18 13.66 Favored 'General case' 0 C--N 1.296 -1.724 0 N-CA-C 108.025 -1.102 . . . . 2.06 108.025 -178.111 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 1605 ' ' SER . . . . . 0.562 ' CB ' ' HA ' ' A' 1594 ' ' ASP . 19.3 m -92.31 178.49 5.83 Favored 'General case' 0 C--N 1.298 -1.641 0 CA-C-O 120.967 0.413 . . . . 1.75 110.389 179.616 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A 1606 ' ' TYR . . . . . 0.497 ' HA ' ' O ' ' A' 1634 ' ' CYS . 76.7 m-85 -95.91 133.74 39.73 Favored 'General case' 0 CA--C 1.468 -2.21 0 N-CA-C 104.658 -2.349 . . . . 1.59 104.658 176.321 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A 1607 ' ' LYS . . . . . . . . . . . . . 10.3 ptpp? -128.36 153.95 46.5 Favored 'General case' 0 N--CA 1.403 -2.802 0 C-N-CA 118.452 -1.299 . . . . 2.21 109.133 178.53 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 1608 ' ' SER . . . . . . . . . . . . . 45.3 m -117.64 124.29 48.23 Favored 'General case' 0 C--N 1.296 -1.727 0 N-CA-C 109.784 -0.45 . . . . 1.48 109.784 178.063 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 1609 ' ' VAL . . . . . 0.459 HG21 HG22 ' A' 1591 ' ' VAL . 78.4 t -114.65 124.48 71.35 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.868 0 N-CA-C 109.002 -0.74 . . . . 1.57 109.002 178.956 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A 1610 ' ' ILE . . . . . 0.722 HG13 ' HB2' ' A' 1638 ' ' PHE . 3.2 mp -108.21 119.14 57.26 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.202 0 N-CA-C 109.166 -0.679 . . . . 1.47 109.166 178.683 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A 1611 ' ' SER . . . . . 0.401 ' O ' ' HA ' ' A' 1639 ' ' SER . 8.6 t -96.35 118.37 32.75 Favored 'General case' 0 N--CA 1.412 -2.348 0 N-CA-C 107.732 -1.21 . . . . 1.84 107.732 178.558 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A 1612 ' ' PHE . . . . . 0.456 ' HE2' ' HB2' ' A' 1590 ' ' LEU . 92.8 m-85 -97.06 102.12 13.83 Favored 'General case' 0 N--CA 1.428 -1.556 0 N-CA-C 107.858 -1.164 . . . . 0.86 107.858 178.664 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A 1613 ' ' VAL . . . . . . . . . . . . . 85.0 t -84.29 120.03 34.36 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.952 0 N-CA-C 107.51 -1.293 . . . . 1.32 107.51 179.911 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 1614 ' ' CYS . . . . . 0.515 ' HB3' ' HB2' ' A' 1646 ' ' CYS . 56.8 m -75.06 91.61 2.56 Favored 'General case' 0 C--N 1.295 -1.795 0 CA-C-O 121.653 0.74 . . . . 1.39 109.036 -178.334 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A 1615 ' ' ARG . . . . . 0.466 ' NE ' ' HA ' ' A' 1615 ' ' ARG . 0.0 OUTLIER -140.08 123.19 10.3 Favored Pre-proline 0 N--CA 1.414 -2.274 0 CA-C-N 115.748 -0.66 . . . . 4.34 109.893 178.358 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A 1616 ' ' PRO . . . . . . . . . . . . . 56.9 Cg_endo -73.04 68.53 3.98 Favored 'Trans proline' 0 CA--C 1.546 1.083 0 C-N-CA 122.261 1.974 . . . . 1.5 110.82 173.908 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 1617 ' ' GLU . . . . . . . . . . . . . 7.5 tp10 -130.2 16.43 5.58 Favored 'General case' 0 C--N 1.314 -0.978 0 N-CA-C 108.878 -0.786 . . . . 3.21 108.878 -177.933 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 1618 ' ' ALA . . . . . . . . . . . . . . . -173.88 162.62 3.97 Favored 'General case' 0 CA--C 1.506 -0.733 0 N-CA-C 108.423 -0.955 . . . . 2.91 108.423 -177.026 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 1619 ' ' GLY . . . . . . . . . . . . . . . -113.13 -175.69 19.36 Favored Glycine 0 N--CA 1.44 -1.093 0 N-CA-C 111.685 -0.566 . . . . 3.35 111.685 177.878 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 1620 ' ' PRO . . . . . 0.45 ' HB3' HD12 ' A' 1644 ' ' LEU . 19.6 Cg_endo -59.61 -18.02 45.25 Favored 'Trans proline' 0 CA--C 1.546 1.105 0 C-N-CA 123.568 2.845 . . . . 6.61 115.304 -178.122 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A 1621 ' ' THR . . . . . . . . . . . . . 4.5 t -77.09 -18.59 57.88 Favored 'General case' 0 C--O 1.247 0.939 0 C-N-CA 120.077 -0.649 . . . . 5.03 109.958 179.274 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 1622 ' ' ASN . . . . . . . . . . . . . 20.3 t-20 -73.06 172.23 11.42 Favored 'General case' 0 C--N 1.34 0.191 0 N-CA-C 107.944 -1.132 . . . . 3.58 107.944 -179.238 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 1623 ' ' ARG . . . . . 0.441 ' HD2' ' O ' ' A' 1539 ' ' THR . 32.9 ptt180 -155.32 156.48 31.05 Favored Pre-proline 0 C--N 1.305 -1.361 0 C-N-CA 119.752 -0.779 . . . . 4.09 112.144 -169.786 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A 1624 ' ' PRO . . . . . 0.407 ' HD3' ' HA ' ' A' 1623 ' ' ARG . 12.0 Cg_exo -70.76 106.67 1.89 Allowed 'Trans proline' 0 C--N 1.356 0.964 0 C-N-CA 123.426 2.751 . . . . 2.86 112.068 179.69 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A 1625 ' ' MET . . . . . . . . . . . . . 25.4 ptm -90.3 164.21 14.45 Favored 'General case' 0 C--N 1.303 -1.423 0 CA-C-N 115.698 -0.683 . . . . 2.73 109.304 179.252 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 1626 ' ' LEU . . . . . . . . . . . . . 41.2 tp -89.58 112.87 24.2 Favored 'General case' 0 C--N 1.303 -1.421 0 N-CA-C 108.69 -0.856 . . . . 1.94 108.69 -178.944 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 1627 ' ' ILE . . . . . . . . . . . . . 44.0 pt -94.43 -27.71 4.29 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.768 0 C-N-CA 120.585 -0.446 . . . . 1.75 111.662 -177.35 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 1628 ' ' SER . . . . . . . . . . . . . 15.6 p -162.19 151.8 16.13 Favored 'General case' 0 N--CA 1.44 -0.969 0 N-CA-C 109.951 -0.388 . . . . 1.85 109.951 -178.485 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 1629 ' ' LEU . . . . . 0.878 ' HG ' ' HG ' ' A' 1636 ' ' LEU . 2.7 tt -138.82 117.43 12.17 Favored 'General case' 0 C--N 1.293 -1.857 0 N-CA-C 106.84 -1.541 . . . . 2.12 106.84 -178.753 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A 1630 ' ' ASP . . . . . . . . . . . . . 12.6 t70 -94.72 103.38 15.29 Favored 'General case' 0 C--N 1.299 -1.621 0 N-CA-C 106.483 -1.673 . . . . 0.87 106.483 178.847 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 1631 ' ' LYS . . . . . 0.566 ' HG2' HD23 ' A' 1629 ' ' LEU . 90.9 mttt -83.13 -5.35 59.08 Favored 'General case' 0 C--N 1.291 -1.946 0 CA-C-N 115.984 -0.553 . . . . 2.76 111.662 -172.35 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A 1632 ' ' GLN . . . . . . . . . . . . . 1.9 mp0 -87.0 -46.15 10.1 Favored 'General case' 0 C--N 1.312 -1.055 0 N-CA-C 108.437 -0.949 . . . . 2.55 108.437 -179.524 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 1633 ' ' THR . . . . . . . . . . . . . 2.3 m -89.83 -2.93 58.33 Favored 'General case' 0 C--N 1.312 -1.022 0 CA-C-O 122.241 1.02 . . . . 1.92 108.769 178.01 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 1634 ' ' CYS . . . . . 0.497 ' O ' ' HA ' ' A' 1606 ' ' TYR . 28.7 m 59.94 43.72 14.43 Favored 'General case' 0 C--O 1.219 -0.529 0 CA-C-N 114.263 -1.335 . . . . 0.89 109.976 176.95 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A 1635 ' ' THR . . . . . . . . . . . . . 16.7 m -120.15 127.68 52.72 Favored 'General case' 0 N--CA 1.428 -1.548 0 CA-C-N 115.228 -0.896 . . . . 1.31 110.847 -173.643 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 1636 ' ' LEU . . . . . 0.878 ' HG ' ' HG ' ' A' 1629 ' ' LEU . 5.9 mp -101.05 132.43 46.48 Favored 'General case' 0 C--N 1.312 -1.059 0 N-CA-C 109.475 -0.565 . . . . 1.97 109.475 177.346 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A 1637 ' ' PHE . . . . . . . . . . . . . 95.5 m-85 -113.4 107.86 16.42 Favored 'General case' 0 C--O 1.25 1.089 0 CA-C-O 121.26 0.552 . . . . 0.92 111.122 -177.762 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 1638 ' ' PHE . . . . . 0.722 ' HB2' HG13 ' A' 1610 ' ' ILE . 95.7 m-85 -101.01 154.55 18.61 Favored 'General case' 0 C--N 1.299 -1.587 0 N-CA-C 108.866 -0.79 . . . . 0.7 108.866 178.944 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A 1639 ' ' SER . . . . . 0.401 ' HA ' ' O ' ' A' 1611 ' ' SER . 66.2 m -143.85 130.52 20.19 Favored 'General case' 0 C--N 1.296 -1.726 0 CA-C-O 120.992 0.425 . . . . 1.46 111.682 178.892 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A 1640 ' ' TRP . . . . . . . . . . . . . 12.2 t90 -124.71 105.95 9.7 Favored 'General case' 0 N--CA 1.434 -1.262 0 CA-C-N 115.488 -0.778 . . . . 0.92 109.117 178.008 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 1641 ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -76.16 100.32 4.98 Favored 'General case' 0 C--N 1.305 -1.346 0 CA-C-O 121.547 0.689 . . . . 3.18 109.479 175.309 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A 1642 ' ' THR . . . . . 0.406 ' O ' ' HA ' ' A' 1614 ' ' CYS . 14.9 t -142.08 139.01 17.37 Favored Pre-proline 0 C--N 1.291 -1.936 0 C-N-CA 120.016 -0.674 . . . . 1.48 112.447 -173.493 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A 1643 ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -80.86 -0.32 10.52 Favored 'Trans proline' 0 N--CA 1.453 -0.893 0 C-N-CA 123.296 2.664 . . . . 1.09 110.611 175.487 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 1644 ' ' LEU . . . . . 0.45 HD12 ' HB3' ' A' 1620 ' ' PRO . 88.9 mt -77.04 -27.57 54.51 Favored 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 108.405 -0.961 . . . . 2.08 108.405 175.345 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A 1645 ' ' ALA . . . . . . . . . . . . . . . -71.11 -42.37 69.36 Favored 'General case' 0 N--CA 1.441 -0.887 0 CA-C-N 114.596 -1.184 . . . . 1.37 110.022 -179.368 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 1646 ' ' CYS . . . . . 0.515 ' HB2' ' HB3' ' A' 1614 ' ' CYS . 65.5 m -139.94 115.97 10.37 Favored 'General case' 0 C--O 1.244 0.808 0 N-CA-C 106.931 -1.507 . . . . 1.7 106.931 173.656 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A 1647 ' ' GLU . . . . . 0.614 ' HB2' ' HE1' ' A' 1525 ' ' HIS . 35.8 mt-10 -90.69 114.05 59.97 Favored Pre-proline 0 C--N 1.309 -1.18 0 O-C-N 123.802 0.689 . . . . 2.92 110.226 -174.882 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A 1648 ' ' PRO . . . . . . . . . . . . . 20.5 Cg_exo -66.69 101.74 0.57 Allowed 'Trans proline' 0 C--O 1.25 1.083 0 C-N-CA 122.748 2.298 . . . . 3.19 112.218 178.973 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 1649 ' ' GLU . . . . . . . . . . . . . 12.8 tp10 . . . . . 0 C--O 1.264 1.839 0 N-CA-C 107.371 -1.344 . . . . 5.06 107.371 179.67 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A 1508 ' ' MET . . . . . . . . . . . . . 88.8 mtp . . . . . 0 CA--C 1.499 -1.003 0 N-CA-C 108.869 -0.789 . . . . 8.58 108.869 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A 1509 ' ' LYS . . . . . . . . . . . . . 36.2 mtmm -82.02 117.33 22.14 Favored 'General case' 0 C--N 1.302 -1.498 0 N-CA-C 108.742 -0.836 . . . . 6.8 108.742 178.054 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 1510 ' ' SER . . . . . . . . . . . . . 1.7 p -88.62 -18.83 27.17 Favored 'General case' 0 N--CA 1.418 -2.052 0 CA-C-O 121.647 0.737 . . . . 4.48 109.632 -176.945 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 1511 ' ' ASN . . . . . 0.537 HD22 ' HA ' ' A' 1518 ' ' VAL . 20.6 m120 -86.88 15.74 5.57 Favored 'General case' 0 N--CA 1.437 -1.123 0 CA-C-N 115.417 -0.811 . . . . 3.08 112.255 -177.257 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A 1512 ' ' GLU . . . . . . . . . . . . . 43.8 mt-10 -82.13 -16.77 48.74 Favored 'General case' 0 CA--C 1.521 -0.148 0 N-CA-C 107.063 -1.458 . . . . 4.46 107.063 169.337 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 1513 ' ' HIS . . . . . . . . . . . . . 69.7 m80 -130.16 48.2 2.42 Favored 'General case' 0 C--N 1.315 -0.907 0 N-CA-C 105.26 -2.126 . . . . 6.25 105.26 176.678 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 1514 ' ' ASP . . . . . . . . . . . . . 35.6 t70 -45.53 -72.3 0.06 Allowed 'General case' 0 N--CA 1.476 0.862 0 CA-C-N 113.012 -1.904 . . . . 3.7 113.264 -172.323 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 1515 ' ' ASP . . . . . 0.425 ' HA ' ' HG3' ' A' 1579 ' ' LYS . 10.4 m-20 45.73 -94.19 0.02 OUTLIER 'General case' 0 N--CA 1.48 1.073 0 N-CA-C 114.274 1.212 . . . . 2.54 114.274 -179.189 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A 1516 ' ' CYS . . . . . 0.712 ' HA ' HD23 ' A' 1581 ' ' LEU . 57.0 m -135.79 40.75 2.74 Favored 'General case' 0 C--N 1.324 -0.536 0 C-N-CA 123.933 0.893 . . . . 1.25 111.37 -178.801 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A 1517 ' ' GLN . . . . . 0.452 ' HB2' HD21 ' A' 1526 ' ' LEU . 25.0 pt20 -139.09 124.19 18.96 Favored 'General case' 0 C--N 1.3 -1.571 0 N-CA-C 109.662 -0.496 . . . . 2.36 109.662 176.131 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A 1518 ' ' VAL . . . . . 0.537 ' HA ' HD22 ' A' 1511 ' ' ASN . 7.5 p -124.78 128.94 73.64 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.849 0 CA-C-O 121.044 0.449 . . . . 2.34 110.324 -179.799 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A 1519 ' ' THR . . . . . 0.401 ' HA ' ' HA ' ' A' 1526 ' ' LEU . 50.3 m -100.7 126.33 47.22 Favored 'General case' 0 C--N 1.284 -2.274 0 N-CA-C 108.879 -0.786 . . . . 2.04 108.879 175.369 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A 1520 ' ' ASN . . . . . . . . . . . . . 38.1 t-20 -88.96 110.53 38.6 Favored Pre-proline 0 C--N 1.303 -1.434 0 N-CA-C 107.453 -1.314 . . . . 2.12 107.453 176.942 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 1521 ' ' PRO . . . . . . . . . . . . . 58.9 Cg_endo -70.4 -14.18 33.79 Favored 'Trans proline' 0 C--N 1.356 0.928 0 C-N-CA 122.585 2.19 . . . . 2.59 113.19 -175.487 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 1522 ' ' SER . . . . . . . . . . . . . 6.9 m -80.29 -17.01 53.35 Favored 'General case' 0 N--CA 1.43 -1.442 0 CA-C-N 116.281 -0.418 . . . . 2.65 110.581 -178.795 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 1523 ' ' THR . . . . . . . . . . . . . 10.1 t -131.51 -18.16 2.85 Favored 'General case' 0 CA--C 1.556 1.203 0 C-N-CA 120.312 -0.555 . . . . 2.33 112.492 179.45 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 1524 ' ' GLY . . . . . . . . . . . . . . . 80.38 16.66 75.57 Favored Glycine 0 C--N 1.338 0.683 0 C-N-CA 121.186 -0.53 . . . . 1.96 111.93 179.471 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 1525 ' ' HIS . . . . . . . . . . . . . 21.1 t-160 -102.06 134.71 44.86 Favored 'General case' 0 C--N 1.305 -1.343 0 N-CA-C 109.425 -0.583 . . . . 2.44 109.425 -178.795 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 1526 ' ' LEU . . . . . 0.452 HD21 ' HB2' ' A' 1517 ' ' GLN . 6.7 tt -102.73 138.11 40.06 Favored 'General case' 0 C--N 1.305 -1.357 0 N-CA-C 107.838 -1.171 . . . . 2.19 107.838 178.651 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A 1527 ' ' PHE . . . . . 0.539 ' CE2' ' HA ' ' A' 1646 ' ' CYS . 57.9 m-85 -114.03 111.96 22.5 Favored 'General case' 0 C--N 1.299 -1.594 0 N-CA-C 107.71 -1.218 . . . . 1.61 107.71 177.489 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A 1528 ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -102.06 139.0 38.27 Favored 'General case' 0 CA--C 1.471 -2.077 0 N-CA-C 108.514 -0.921 . . . . 2.18 108.514 178.999 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A 1529 ' ' LEU . . . . . 0.561 ' HB2' ' HB3' ' A' 1516 ' ' CYS . 43.3 mt -111.73 2.82 17.38 Favored 'General case' 0 C--N 1.292 -1.908 0 N-CA-C 107.756 -1.201 . . . . 2.04 107.756 176.871 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A 1530 ' ' SER . . . . . . . . . . . . . 8.4 m -65.81 -45.02 83.87 Favored 'General case' 0 N--CA 1.441 -0.893 0 CA-C-N 114.895 -1.048 . . . . 1.44 110.538 -177.708 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 1531 ' ' SER . . . . . . . . . . . . . 37.6 m -77.12 -12.54 59.96 Favored 'General case' 0 C--O 1.24 0.565 0 CA-C-O 121.304 0.573 . . . . 1.63 110.296 177.533 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 1532 ' ' LEU . . . . . 0.529 HD12 ' HA ' ' A' 1529 ' ' LEU . 8.5 mp -80.22 -31.28 38.62 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 116.033 -0.53 . . . . 2.32 112.362 -179.493 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A 1533 ' ' SER . . . . . 0.606 ' HB2' HG22 ' A' 1552 ' ' ILE . 19.2 t -85.7 173.28 10.22 Favored 'General case' 0 C--N 1.306 -1.32 0 CA-C-O 120.914 0.388 . . . . 2.57 110.304 -178.439 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A 1534 ' ' GLY . . . . . . . . . . . . . . . -153.99 167.1 32.17 Favored Glycine 0 N--CA 1.429 -1.821 0 N-CA-C 109.549 -1.42 . . . . 1.89 109.549 -179.256 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 1535 ' ' ARG . . . . . 0.494 ' CG ' ' HG3' ' A' 1557 ' ' GLU . 13.4 ttp180 -69.29 -47.75 63.66 Favored 'General case' 0 C--N 1.318 -0.789 0 CA-C-O 121.016 0.436 . . . . 4.44 111.132 -177.274 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A 1536 ' ' ALA . . . . . . . . . . . . . . . -77.45 -29.67 52.92 Favored 'General case' 0 C--O 1.245 0.823 0 CA-C-O 121.262 0.554 . . . . 2.07 110.361 -179.409 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 1537 ' ' GLY . . . . . . . . . . . . . . . 86.3 -164.58 36.71 Favored Glycine 0 N--CA 1.427 -1.962 0 CA-C-N 115.296 -0.865 . . . . 1.2 112.377 175.574 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 1538 ' ' PHE . . . . . 0.449 ' CD1' HD11 ' A' 1552 ' ' ILE . 84.2 m-85 -106.6 156.63 18.4 Favored 'General case' 0 C--N 1.293 -1.877 0 N-CA-C 108.081 -1.081 . . . . 1.98 108.081 179.439 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A 1539 ' ' THR . . . . . . . . . . . . . 18.8 m -116.13 111.57 20.45 Favored 'General case' 0 C--N 1.291 -1.946 0 CA-C-O 121.51 0.671 . . . . 1.97 109.82 -176.879 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 1540 ' ' ALA . . . . . . . . . . . . . . . -93.87 151.61 19.46 Favored 'General case' 0 C--N 1.3 -1.583 0 N-CA-C 109.314 -0.624 . . . . 1.39 109.314 -179.743 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 1541 ' ' ALA . . . . . . . . . . . . . . . -88.02 132.61 34.21 Favored 'General case' 0 C--N 1.305 -1.361 0 N-CA-C 109.45 -0.574 . . . . 1.86 109.45 -179.065 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 1542 ' ' TYR . . . . . 0.506 ' HD2' ' HB2' ' A' 1545 ' ' SER . 72.5 t80 -139.96 164.51 29.8 Favored 'General case' 0 N--CA 1.437 -1.094 0 C-N-CA 120.628 -0.429 . . . . 2.4 111.143 -177.426 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A 1543 ' ' SER . . . . . . . . . . . . . 5.6 m -47.47 -151.14 0.0 OUTLIER 'General case' 0 CA--C 1.573 1.833 0 C-N-CA 129.106 2.962 . . . . 2.58 113.619 175.154 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 1544 ' ' LYS . . . . . . . . . . . . . 18.5 ptpt -39.69 -26.42 0.03 OUTLIER 'General case' 0 CA--C 1.574 1.882 0 N-CA-C 115.004 1.483 . . . . 4.24 115.004 178.604 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 1545 ' ' SER . . . . . 0.506 ' HB2' ' HD2' ' A' 1542 ' ' TYR . 8.4 m -79.12 -8.09 58.7 Favored 'General case' 0 CA--C 1.566 1.591 0 O-C-N 121.501 -0.749 . . . . 3.6 111.775 178.717 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A 1546 ' ' GLY . . . . . . . . . . . . . . . 86.09 -80.35 1.79 Allowed Glycine 0 C--N 1.339 0.706 0 C-N-CA 121.488 -0.387 . . . . 1.66 113.991 174.108 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 1547 ' ' VAL . . . . . . . . . . . . . 8.2 m -141.53 157.96 21.59 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.694 0 C-N-CA 122.99 0.516 . . . . 2.23 110.031 -176.987 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 1548 ' ' VAL . . . . . 0.429 HG11 ' HD1' ' A' 1567 ' ' PHE . 1.3 t -122.79 137.69 55.43 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.37 0 N-CA-C 107.895 -1.15 . . . . 1.59 107.895 -178.922 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A 1549 ' ' TYR . . . . . . . . . . . . . 71.3 m-85 -96.02 118.64 33.02 Favored 'General case' 0 C--N 1.306 -1.298 0 N-CA-C 108.771 -0.826 . . . . 1.58 108.771 175.263 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 1550 ' ' MET . . . . . . . . . . . . . 74.0 mmm -118.55 121.74 40.97 Favored 'General case' 0 C--N 1.3 -1.549 0 CA-C-N 115.286 -0.87 . . . . 2.08 109.8 -173.412 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 1551 ' ' SER . . . . . . . . . . . . . 75.5 m -106.58 114.63 28.85 Favored 'General case' 0 C--N 1.296 -1.759 0 N-CA-C 108.672 -0.862 . . . . 1.9 108.672 174.127 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 1552 ' ' ILE . . . . . 0.606 HG22 ' HB2' ' A' 1533 ' ' SER . 1.5 mp -57.46 -34.02 45.63 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.873 0 CA-C-N 114.957 -1.02 . . . . 2.04 113.261 -176.576 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A 1553 ' ' CYS . . . . . 0.548 ' HB3' ' HE3' ' A' 1579 ' ' LYS . 73.6 m -140.68 137.98 33.94 Favored 'General case' 0 C--N 1.304 -1.396 0 N-CA-C 108.978 -0.749 . . . . 1.43 108.978 174.977 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A 1554 ' ' GLY . . . . . . . . . . . . . . . 94.89 -125.52 8.37 Favored Glycine 0 N--CA 1.433 -1.547 0 C-N-CA 120.937 -0.649 . . . . 1.23 114.043 172.252 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 1555 ' ' GLU . . . . . . . . . . . . . 7.5 pt-20 -138.45 150.74 46.77 Favored 'General case' 0 C--N 1.31 -1.12 0 C-N-CA 123.432 0.693 . . . . 1.8 111.175 -175.464 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 1556 ' ' ASN . . . . . . . . . . . . . 17.5 t-20 -101.23 138.96 37.57 Favored 'General case' 0 N--CA 1.433 -1.301 0 CA-C-N 115.503 -0.771 . . . . 2.63 108.944 -177.194 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 1557 ' ' GLU . . . . . 0.494 ' HG3' ' CG ' ' A' 1535 ' ' ARG . 54.7 mm-40 -99.77 -0.42 39.96 Favored 'General case' 0 C--N 1.298 -1.645 0 N-CA-C 113.088 0.773 . . . . 3.79 113.088 -172.528 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A 1558 ' ' ASN . . . . . . . . . . . . . 33.5 m-80 -87.66 -1.82 58.2 Favored 'General case' 0 N--CA 1.483 1.187 0 CA-C-O 122.09 0.948 . . . . 1.59 110.144 -176.812 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 1559 ' ' CYS . . . . . 0.778 ' HB3' ' HD2' ' A' 1560 ' ' PRO . 94.0 m -142.21 -175.95 0.52 Allowed Pre-proline 0 C--N 1.288 -2.066 0 N-CA-C 104.821 -2.289 . . . . 0.94 104.821 177.27 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A 1560 ' ' PRO . . . . . 0.778 ' HD2' ' HB3' ' A' 1559 ' ' CYS . 1.0 OUTLIER -45.72 124.16 6.64 Favored 'Trans proline' 0 C--N 1.364 1.374 0 C-N-CA 122.556 2.171 . . . . 1.53 112.882 175.677 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A 1561 ' ' PRO . . . . . . . . . . . . . 33.5 Cg_exo -62.66 103.33 0.32 Allowed 'Trans proline' 0 C--O 1.242 0.688 0 C-N-CA 122.913 2.408 . . . . 1.82 110.688 179.053 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 1562 ' ' GLY . . . . . . . . . . . . . . . 146.85 -9.46 1.35 Allowed Glycine 0 N--CA 1.423 -2.197 0 CA-C-N 115.103 -0.953 . . . . 0.81 110.805 -177.206 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 1563 ' ' VAL . . . . . . . . . . . . . 3.6 m -98.29 150.82 4.67 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.345 0 N-CA-C 106.646 -1.613 . . . . 1.73 106.646 174.174 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 1564 ' ' GLY . . . . . . . . . . . . . . . -103.21 -21.75 9.77 Favored Glycine 0 C--N 1.306 -1.089 0 C-N-CA 120.179 -1.01 . . . . 0.72 112.286 -176.483 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 1565 ' ' ALA . . . . . . . . . . . . . . . -148.34 132.38 17.23 Favored 'General case' 0 C--N 1.31 -1.113 0 N-CA-C 109.063 -0.717 . . . . 1.14 109.063 -179.283 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 1566 ' ' CYS . . . . . . . . . . . . . 35.9 t -153.5 138.95 17.66 Favored 'General case' 0 C--N 1.309 -1.158 0 CA-C-N 116.69 -0.232 . . . . 0.51 110.818 -173.821 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 1567 ' ' PHE . . . . . 0.429 ' HD1' HG11 ' A' 1548 ' ' VAL . 21.0 m-85 -68.73 123.34 20.65 Favored 'General case' 0 CA--C 1.514 -0.436 0 N-CA-C 108.2 -1.037 . . . . 1.22 108.2 175.489 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A 1568 ' ' GLY . . . . . . . . . . . . . . . -55.06 -64.36 4.43 Favored Glycine 0 C--N 1.31 -0.908 0 N-CA-C 116.861 1.505 . . . . 1.08 116.861 -167.76 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 1569 ' ' GLN . . . . . . . . . . . . . 13.7 pt20 -85.15 -23.58 28.33 Favored 'General case' 0 C--N 1.312 -1.064 0 N-CA-C 113.208 0.818 . . . . 3.05 113.208 -172.057 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 1570 ' ' THR . . . . . . . . . . . . . 19.7 p -88.32 -17.56 30.37 Favored 'General case' 0 C--N 1.308 -1.222 0 CA-C-O 121.719 0.771 . . . . 2.44 111.191 -179.625 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 1571 ' ' ARG . . . . . . . . . . . . . 67.9 mtm180 59.12 47.75 11.45 Favored 'General case' 0 CA--C 1.508 -0.67 0 C-N-CA 125.817 1.647 . . . . 4.48 112.253 175.272 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 1572 ' ' ILE . . . . . . . . . . . . . 32.7 mm -112.0 120.28 61.98 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.26 0 N-CA-C 108.062 -1.088 . . . . 1.94 108.062 179.434 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 1573 ' ' SER . . . . . 0.491 ' HG ' ' HB2' ' A' 1596 ' ' SER . 60.4 p -73.63 127.45 32.8 Favored 'General case' 0 C--N 1.309 -1.195 0 CA-C-N 115.857 -0.611 . . . . 1.25 111.092 -177.06 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A 1574 ' ' VAL . . . . . 0.449 ' HA ' ' HB2' ' A' 1606 ' ' TYR . 23.5 m -118.22 15.05 7.19 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.307 0 CA-C-O 121.936 0.874 . . . . 1.61 110.782 -179.339 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A 1575 ' ' GLY . . . . . . . . . . . . . . . -179.29 125.28 0.96 Allowed Glycine 0 N--CA 1.429 -1.775 0 CA-C-N 114.466 -1.243 . . . . 0.65 110.54 176.531 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 1576 ' ' LYS . . . . . . . . . . . . . 55.2 tptt -85.68 156.4 20.68 Favored 'General case' 0 C--N 1.313 -0.981 0 N-CA-C 106.423 -1.695 . . . . 3.33 106.423 177.955 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 1577 ' ' ALA . . . . . . . . . . . . . . . -55.88 115.28 2.29 Favored 'General case' 0 N--CA 1.468 0.465 0 CA-C-O 121.447 0.641 . . . . 1.31 110.586 179.738 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 1578 ' ' ASN . . . . . . . . . . . . . 1.1 m-80 -125.11 169.72 11.91 Favored 'General case' 0 C--N 1.283 -2.285 0 N-CA-C 106.061 -1.829 . . . . 2.24 106.061 178.265 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 1579 ' ' LYS . . . . . 0.548 ' HE3' ' HB3' ' A' 1553 ' ' CYS . 17.9 tptm -163.87 89.99 0.59 Allowed 'General case' 0 C--N 1.306 -1.283 0 C-N-CA 119.88 -0.728 . . . . 2.34 109.418 -176.956 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A 1580 ' ' ARG . . . . . . . . . . . . . 52.0 ttp180 -149.43 106.83 3.62 Favored 'General case' 0 C--N 1.297 -1.691 0 N-CA-C 108.811 -0.811 . . . . 4.19 108.811 -178.881 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 1581 ' ' LEU . . . . . 0.712 HD23 ' HA ' ' A' 1516 ' ' CYS . 0.8 OUTLIER -73.17 133.26 44.0 Favored 'General case' 0 C--N 1.311 -1.098 0 N-CA-C 107.714 -1.217 . . . . 2.39 107.714 -179.494 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A 1582 ' ' ARG . . . . . . . . . . . . . 61.5 ttt180 -132.14 108.32 9.2 Favored 'General case' 0 C--N 1.303 -1.417 0 N-CA-C 109.876 -0.416 . . . . 4.48 109.876 178.634 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 1583 ' ' TYR . . . . . 0.48 ' HD1' HD21 ' A' 1588 ' ' LEU . 49.2 t80 -101.33 92.95 5.17 Favored 'General case' 0 C--N 1.307 -1.24 0 N-CA-C 108.896 -0.779 . . . . 1.57 108.896 177.676 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A 1584 ' ' VAL . . . . . . . . . . . . . 15.4 m -123.7 111.12 27.86 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.77 0 N-CA-C 113.14 0.793 . . . . 2.29 113.14 -176.113 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 1585 ' ' ASP . . . . . . . . . . . . . 36.5 t70 56.33 53.62 8.59 Favored 'General case' 0 N--CA 1.478 0.973 0 CA-C-O 122.463 1.125 . . . . 2.06 111.194 176.041 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 1586 ' ' GLN . . . . . . . . . . . . . 18.4 mp0 64.63 -1.63 0.76 Allowed 'General case' 0 C--N 1.324 -0.512 0 C-N-CA 125.743 1.617 . . . . 2.61 115.088 178.734 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 1587 ' ' VAL . . . . . . . . . . . . . 12.7 p -107.84 120.94 60.07 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.887 0 CA-C-O 121.973 0.892 . . . . 1.33 109.459 175.978 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 1588 ' ' LEU . . . . . 0.807 ' HB2' ' HB2' ' A' 1612 ' ' PHE . 2.5 mm? -79.2 137.99 37.65 Favored 'General case' 0 C--N 1.29 -1.983 0 CA-C-N 114.339 -1.3 . . . . 2.03 108.357 179.053 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A 1589 ' ' GLN . . . . . 0.409 ' HA ' ' O ' ' A' 1610 ' ' ILE . 6.0 tt0 -140.43 141.08 35.52 Favored 'General case' 0 C--N 1.286 -2.175 0 CA-C-O 120.75 0.309 . . . . 1.73 111.254 -178.017 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A 1590 ' ' LEU . . . . . . . . . . . . . 7.0 tt -142.48 124.59 15.37 Favored 'General case' 0 C--N 1.305 -1.359 0 N-CA-C 105.957 -1.868 . . . . 1.76 105.957 175.633 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 1591 ' ' VAL . . . . . . . . . . . . . 46.4 t -112.48 129.7 67.56 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.067 0 O-C-N 122.381 -0.199 . . . . 2.14 111.508 -175.379 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 1592 ' ' TYR . . . . . . . . . . . . . 79.4 m-85 -105.3 106.67 17.28 Favored 'General case' 0 C--N 1.313 -0.992 0 N-CA-C 108.8 -0.815 . . . . 1.53 108.8 174.647 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 1593 ' ' LYS . . . . . . . . . . . . . 8.1 ptpp? -108.67 -178.99 3.74 Favored 'General case' 0 C--N 1.311 -1.066 0 C-N-CA 120.31 -0.556 . . . . 2.72 112.119 -179.067 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 1594 ' ' ASP . . . . . . . . . . . . . 5.0 m-20 54.13 44.88 28.54 Favored 'General case' 0 N--CA 1.487 1.376 0 C-N-CA 124.798 1.239 . . . . 1.45 113.831 177.67 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 1595 ' ' GLY . . . . . . . . . . . . . . . -73.2 -90.54 0.13 Allowed Glycine 0 N--CA 1.445 -0.72 0 C-N-CA 120.45 -0.881 . . . . 0.83 111.522 177.176 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 1596 ' ' SER . . . . . 0.491 ' HB2' ' HG ' ' A' 1573 ' ' SER . 33.7 t -114.49 149.46 42.23 Favored Pre-proline 0 C--N 1.297 -1.691 0 N-CA-C 107.101 -1.444 . . . . 1.96 107.101 176.977 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A 1597 ' ' PRO . . . . . . . . . . . . . 33.7 Cg_exo -64.95 133.55 36.39 Favored 'Trans proline' 0 C--N 1.347 0.493 0 C-N-CA 123.074 2.516 . . . . 1.34 110.911 176.999 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 1598 ' ' CYS . . . . . 0.434 ' HA ' ' HD3' ' A' 1599 ' ' PRO . 37.6 t -95.65 126.89 43.62 Favored Pre-proline 0 C--N 1.3 -1.553 0 N-CA-C 108.12 -1.067 . . . . 1.19 108.12 -179.13 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A 1599 ' ' PRO . . . . . 0.434 ' HD3' ' HA ' ' A' 1598 ' ' CYS . 25.6 Cg_exo -65.61 -25.52 54.59 Favored 'Trans proline' 0 C--N 1.353 0.784 0 C-N-CA 123.472 2.781 . . . . 1.88 112.113 -178.476 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A 1600 ' ' SER . . . . . . . . . . . . . 23.0 m -86.17 123.51 31.53 Favored 'General case' 0 N--CA 1.421 -1.883 0 N-CA-C 108.367 -0.975 . . . . 2.19 108.367 177.338 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 1601 ' ' LYS . . . . . 0.823 ' HB3' HD11 ' A' 1604 ' ' LEU . 4.3 tmtm? 68.49 81.58 0.18 Allowed 'General case' 0 C--O 1.239 0.523 0 N-CA-C 107.747 -1.205 . . . . 4.21 107.747 -179.678 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A 1602 ' ' SER . . . . . . . . . . . . . 20.9 m -50.82 111.45 0.55 Allowed 'General case' 0 N--CA 1.441 -0.915 0 CA-C-N 114.025 -1.443 . . . . 3.82 112.651 -176.695 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 1603 ' ' GLY . . . . . . . . . . . . . . . 128.78 -19.04 5.59 Favored Glycine 0 N--CA 1.433 -1.524 0 CA-C-N 114.747 -1.115 . . . . 2.45 110.315 -177.929 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 1604 ' ' LEU . . . . . 0.823 HD11 ' HB3' ' A' 1601 ' ' LYS . 12.6 mt -74.91 159.35 31.95 Favored 'General case' 0 CA--C 1.506 -0.732 0 CA-C-O 122.69 1.233 . . . . 2.06 114.291 -179.99 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A 1605 ' ' SER . . . . . . . . . . . . . 16.6 m -137.19 175.8 9.29 Favored 'General case' 0 C--N 1.288 -2.077 0 N-CA-C 104.897 -2.26 . . . . 1.75 104.897 177.217 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 1606 ' ' TYR . . . . . 0.449 ' HB2' ' HA ' ' A' 1574 ' ' VAL . 56.9 m-85 -102.54 134.58 45.64 Favored 'General case' 0 CA--C 1.462 -2.406 0 N-CA-C 105.249 -2.13 . . . . 1.59 105.249 -179.292 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A 1607 ' ' LYS . . . . . 0.47 ' HG3' HG21 ' A' 1635 ' ' THR . 26.6 pttm -131.18 142.79 50.25 Favored 'General case' 0 N--CA 1.401 -2.889 0 C-N-CA 119.338 -0.945 . . . . 2.21 108.9 177.8 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A 1608 ' ' SER . . . . . . . . . . . . . 44.3 m -114.59 118.76 34.62 Favored 'General case' 0 C--N 1.295 -1.796 0 CA-C-O 120.666 0.27 . . . . 1.48 110.96 -178.849 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 1609 ' ' VAL . . . . . . . . . . . . . 69.3 t -94.62 115.6 33.85 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.76 0 N-CA-C 108.782 -0.822 . . . . 1.57 108.782 176.851 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 1610 ' ' ILE . . . . . 0.409 ' O ' ' HA ' ' A' 1589 ' ' GLN . 17.6 mm -98.66 112.19 30.15 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.191 0 N-CA-C 108.77 -0.826 . . . . 1.47 108.77 179.189 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A 1611 ' ' SER . . . . . 0.487 ' O ' ' HA ' ' A' 1639 ' ' SER . 36.5 m -101.05 128.62 47.01 Favored 'General case' 0 C--N 1.304 -1.375 0 N-CA-C 109.518 -0.549 . . . . 1.84 109.518 177.005 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A 1612 ' ' PHE . . . . . 0.807 ' HB2' ' HB2' ' A' 1588 ' ' LEU . 97.9 m-85 -100.88 115.37 30.24 Favored 'General case' 0 C--N 1.292 -1.894 0 CA-C-O 121.003 0.43 . . . . 0.86 110.494 -179.429 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A 1613 ' ' VAL . . . . . . . . . . . . . 58.9 t -100.01 111.54 29.95 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.161 0 N-CA-C 108.486 -0.931 . . . . 1.32 108.486 -178.613 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 1614 ' ' CYS . . . . . 0.486 ' HA ' ' O ' ' A' 1642 ' ' THR . 3.0 p -85.57 94.22 8.99 Favored 'General case' 0 C--N 1.301 -1.535 0 CA-C-O 121.715 0.769 . . . . 1.39 112.999 -178.605 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A 1615 ' ' ARG . . . . . 0.516 ' HD3' ' HD2' ' A' 1616 ' ' PRO . 19.7 tpp180 -138.2 113.48 8.89 Favored Pre-proline 0 N--CA 1.428 -1.539 0 CA-C-N 115.37 -0.832 . . . . 4.34 109.93 177.318 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A 1616 ' ' PRO . . . . . 0.516 ' HD2' ' HD3' ' A' 1615 ' ' ARG . 57.8 Cg_endo -71.34 53.69 1.72 Allowed 'Trans proline' 0 CA--C 1.548 1.223 0 C-N-CA 123.414 2.742 . . . . 1.5 112.495 176.488 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A 1617 ' ' GLU . . . . . . . . . . . . . 30.6 tt0 -124.75 2.13 8.17 Favored 'General case' 0 C--N 1.306 -1.312 0 N-CA-C 106.29 -1.744 . . . . 3.21 106.29 176.624 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 1618 ' ' ALA . . . . . . . . . . . . . . . -148.16 165.67 30.19 Favored 'General case' 0 N--CA 1.427 -1.594 0 N-CA-C 106.192 -1.781 . . . . 2.91 106.192 -177.92 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 1619 ' ' GLY . . . . . . . . . . . . . . . -134.26 -160.0 9.06 Favored Glycine 0 C--N 1.302 -1.308 0 N-CA-C 110.744 -0.942 . . . . 3.35 110.744 178.971 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 1620 ' ' PRO . . . . . 0.413 ' HA ' ' HZ2' ' A' 1640 ' ' TRP . 22.7 Cg_exo -68.15 -4.29 12.36 Favored 'Trans proline' 0 CA--C 1.54 0.8 0 C-N-CA 123.078 2.519 . . . . 6.61 112.51 178.817 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A 1621 ' ' THR . . . . . . . . . . . . . 15.6 m -86.07 -12.47 50.03 Favored 'General case' 0 CA--C 1.552 1.03 0 CA-C-O 121.458 0.646 . . . . 5.03 109.326 178.212 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 1622 ' ' ASN . . . . . . . . . . . . . 28.1 t-20 -70.14 151.04 45.88 Favored 'General case' 0 C--O 1.242 0.665 0 N-CA-C 107.872 -1.158 . . . . 3.58 107.872 175.445 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 1623 ' ' ARG . . . . . . . . . . . . . 5.7 ptm180 -121.82 146.69 46.56 Favored Pre-proline 0 C--N 1.281 -2.385 0 N-CA-C 109.083 -0.71 . . . . 4.09 109.083 -177.228 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 1624 ' ' PRO . . . . . . . . . . . . . 11.0 Cg_endo -55.25 117.52 4.12 Favored 'Trans proline' 0 C--N 1.348 0.551 0 C-N-CA 123.192 2.595 . . . . 2.86 111.621 178.536 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 1625 ' ' MET . . . . . . . . . . . . . 26.5 ptm -96.79 143.16 27.98 Favored 'General case' 0 C--N 1.296 -1.748 0 CA-C-N 115.49 -0.777 . . . . 2.73 109.603 -178.573 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 1626 ' ' LEU . . . . . . . . . . . . . 38.5 tp -80.48 123.07 27.76 Favored 'General case' 0 C--N 1.303 -1.425 0 N-CA-C 107.396 -1.335 . . . . 1.94 107.396 176.192 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 1627 ' ' ILE . . . . . . . . . . . . . 41.4 pt -100.98 -32.43 3.42 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.548 0 C-N-CA 120.252 -0.579 . . . . 1.75 111.116 -179.907 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 1628 ' ' SER . . . . . . . . . . . . . 20.4 m -152.64 148.71 27.63 Favored 'General case' 0 C--N 1.318 -0.802 0 N-CA-C 109.696 -0.483 . . . . 1.85 109.696 -178.099 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 1629 ' ' LEU . . . . . . . . . . . . . 25.8 tp -136.1 99.65 4.19 Favored 'General case' 0 C--N 1.304 -1.407 0 N-CA-C 109.132 -0.692 . . . . 2.12 109.132 178.581 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 1630 ' ' ASP . . . . . . . . . . . . . 11.8 t70 -90.95 107.85 19.47 Favored 'General case' 0 C--N 1.305 -1.331 0 N-CA-C 108.628 -0.879 . . . . 0.87 108.628 -178.1 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 1631 ' ' LYS . . . . . . . . . . . . . 68.2 mttm -81.44 -15.15 55.96 Favored 'General case' 0 C--N 1.304 -1.381 0 N-CA-C 112.386 0.513 . . . . 2.76 112.386 -175.448 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 1632 ' ' GLN . . . . . . . . . . . . . 1.5 mp0 -84.98 -40.74 16.57 Favored 'General case' 0 C--N 1.313 -1.005 0 CA-C-O 120.937 0.399 . . . . 2.55 110.58 -178.771 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 1633 ' ' THR . . . . . . . . . . . . . 2.7 m -95.95 -4.15 43.88 Favored 'General case' 0 C--N 1.301 -1.511 0 CA-C-O 121.55 0.691 . . . . 1.92 110.278 -178.873 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 1634 ' ' CYS . . . . . . . . . . . . . 56.6 m 59.47 41.41 19.35 Favored 'General case' 0 C--N 1.35 0.59 0 C-N-CA 124.105 0.962 . . . . 0.89 110.081 176.923 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 1635 ' ' THR . . . . . 0.47 HG21 ' HG3' ' A' 1607 ' ' LYS . 33.4 m -112.83 132.61 55.2 Favored 'General case' 0 N--CA 1.431 -1.408 0 CA-C-N 115.179 -0.919 . . . . 1.31 111.467 -174.223 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A 1636 ' ' LEU . . . . . 0.405 ' HB3' ' CE2' ' A' 1638 ' ' PHE . 2.4 mm? -100.95 127.71 47.32 Favored 'General case' 0 C--N 1.316 -0.877 0 N-CA-C 108.561 -0.904 . . . . 1.97 108.561 -179.489 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A 1637 ' ' PHE . . . . . . . . . . . . . 97.6 m-85 -115.94 111.28 20.17 Favored 'General case' 0 C--N 1.305 -1.34 0 N-CA-C 109.931 -0.396 . . . . 0.92 109.931 179.38 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 1638 ' ' PHE . . . . . 0.405 ' CE2' ' HB3' ' A' 1636 ' ' LEU . 87.8 m-85 -118.81 154.42 32.89 Favored 'General case' 0 C--N 1.309 -1.16 0 CA-C-O 121.191 0.52 . . . . 0.7 110.703 -179.094 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A 1639 ' ' SER . . . . . 0.487 ' HA ' ' O ' ' A' 1611 ' ' SER . 46.8 m -141.51 136.91 31.66 Favored 'General case' 0 C--N 1.294 -1.841 0 CA-C-N 116.171 -0.468 . . . . 1.46 110.46 176.827 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A 1640 ' ' TRP . . . . . 0.413 ' HZ2' ' HA ' ' A' 1620 ' ' PRO . 22.0 t90 -113.32 132.27 55.63 Favored 'General case' 0 C--N 1.298 -1.635 0 N-CA-C 107.924 -1.139 . . . . 0.92 107.924 178.066 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A 1641 ' ' HIS . . . . . . . . . . . . . 11.8 m170 -96.93 110.28 22.84 Favored 'General case' 0 CA--C 1.493 -1.22 0 N-CA-C 107.129 -1.434 . . . . 3.18 107.129 179.424 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 1642 ' ' THR . . . . . 0.554 HG21 ' HB3' ' A' 1645 ' ' ALA . 2.9 t -142.92 137.95 15.46 Favored Pre-proline 0 C--N 1.283 -2.309 0 CA-C-N 115.989 -0.551 . . . . 1.48 111.69 -170.604 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A 1643 ' ' PRO . . . . . . . . . . . . . 95.8 Cg_endo -83.31 -0.39 9.86 Favored 'Trans proline' 0 CA--C 1.535 0.527 0 C-N-CA 123.35 2.7 . . . . 1.09 111.655 178.455 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 1644 ' ' LEU . . . . . . . . . . . . . 47.4 mt -98.33 1.64 47.24 Favored 'General case' 0 C--N 1.315 -0.894 0 CA-C-N 115.765 -0.652 . . . . 2.08 110.9 179.624 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 1645 ' ' ALA . . . . . 0.554 ' HB3' HG21 ' A' 1642 ' ' THR . . . -91.8 -18.18 24.24 Favored 'General case' 0 C--N 1.301 -1.537 0 CA-C-N 115.756 -0.656 . . . . 1.37 111.612 -176.274 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A 1646 ' ' CYS . . . . . 0.539 ' HA ' ' CE2' ' A' 1527 ' ' PHE . 72.0 m -154.25 174.26 15.03 Favored 'General case' 0 C--N 1.313 -0.991 0 N-CA-C 105.267 -2.123 . . . . 1.7 105.267 175.452 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A 1647 ' ' GLU . . . . . 0.464 ' HA ' ' HD3' ' A' 1648 ' ' PRO . 0.5 OUTLIER -85.99 123.5 71.88 Favored Pre-proline 0 C--N 1.298 -1.658 0 N-CA-C 109.526 -0.546 . . . . 2.92 109.526 175.819 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A 1648 ' ' PRO . . . . . 0.464 ' HD3' ' HA ' ' A' 1647 ' ' GLU . 39.0 Cg_exo -66.12 101.85 0.52 Allowed 'Trans proline' 0 C--O 1.243 0.753 0 C-N-CA 122.775 2.317 . . . . 3.19 110.532 176.423 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A 1649 ' ' GLU . . . . . . . . . . . . . 42.4 mt-10 . . . . . 0 C--N 1.302 -1.486 0 N-CA-C 108.638 -0.875 . . . . 5.06 108.638 -179.504 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A 1508 ' ' MET . . . . . 0.458 ' HA ' ' OD1' ' A' 1511 ' ' ASN . 43.5 tpp . . . . . 0 C--O 1.238 0.467 0 N-CA-C 108.362 -0.977 . . . . 8.58 108.362 . . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 1509 ' ' LYS . . . . . . . . . . . . . 61.7 tttm 79.37 -29.87 0.14 Allowed 'General case' 0 N--CA 1.484 1.242 0 C-N-CA 124.826 1.25 . . . . 6.8 112.212 176.289 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 1510 ' ' SER . . . . . . . . . . . . . 22.8 t -148.33 73.09 1.23 Allowed 'General case' 0 C--N 1.301 -1.528 0 N-CA-C 106.877 -1.527 . . . . 4.48 106.877 176.303 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 1511 ' ' ASN . . . . . 0.768 ' HB2' HE22 ' A' 1517 ' ' GLN . 4.3 p-10 -141.09 -28.39 0.68 Allowed 'General case' 0 C--N 1.302 -1.46 0 CA-C-N 115.269 -0.878 . . . . 3.08 112.551 -177.4 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A 1512 ' ' GLU . . . . . 0.54 ' HG2' HG23 ' A' 1518 ' ' VAL . 50.6 mt-10 -55.56 -29.05 58.31 Favored 'General case' 0 N--CA 1.483 1.201 0 N-CA-C 113.903 1.075 . . . . 4.46 113.903 -173.608 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A 1513 ' ' HIS . . . . . . . . . . . . . 89.8 m-70 -129.52 6.6 5.24 Favored 'General case' 0 C--N 1.311 -1.109 0 CA-C-O 121.113 0.483 . . . . 6.25 110.51 178.405 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 1514 ' ' ASP . . . . . 0.437 ' HB2' ' HA ' ' A' 1511 ' ' ASN . 2.0 m-20 -89.22 -44.67 10.11 Favored 'General case' 0 C--N 1.31 -1.127 0 CA-C-N 115.709 -0.678 . . . . 3.7 110.349 179.579 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A 1515 ' ' ASP . . . . . 0.435 ' HB2' ' NE2' ' A' 1517 ' ' GLN . 8.8 m-20 -137.78 168.56 19.43 Favored 'General case' 0 C--N 1.307 -1.279 0 N-CA-C 108.447 -0.945 . . . . 2.54 108.447 -178.946 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A 1516 ' ' CYS . . . . . 0.506 ' HB3' ' HB2' ' A' 1529 ' ' LEU . 74.4 m -79.01 60.34 2.9 Favored 'General case' 0 C--N 1.306 -1.299 0 CA-C-O 120.981 0.42 . . . . 1.25 112.069 -176.895 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A 1517 ' ' GLN . . . . . 0.768 HE22 ' HB2' ' A' 1511 ' ' ASN . 0.4 OUTLIER -157.29 122.6 4.58 Favored 'General case' 0 N--CA 1.437 -1.105 0 CA-C-O 121.618 0.723 . . . . 2.36 111.885 177.754 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A 1518 ' ' VAL . . . . . 0.54 HG23 ' HG2' ' A' 1512 ' ' GLU . 10.6 p -129.6 142.32 44.22 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.683 0 CA-C-N 115.454 -0.794 . . . . 2.34 109.657 -177.736 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A 1519 ' ' THR . . . . . 0.571 ' HA ' ' HA ' ' A' 1526 ' ' LEU . 12.7 m -100.74 135.94 41.39 Favored 'General case' 0 C--N 1.3 -1.549 0 CA-C-O 120.67 0.271 . . . . 2.04 110.83 -178.025 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A 1520 ' ' ASN . . . . . 0.469 ' OD1' HG21 ' A' 1523 ' ' THR . 17.1 t-20 -86.61 113.8 54.67 Favored Pre-proline 0 C--N 1.308 -1.226 0 N-CA-C 106.915 -1.513 . . . . 2.12 106.915 171.399 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A 1521 ' ' PRO . . . . . . . . . . . . . 51.9 Cg_endo -67.88 -21.52 43.91 Favored 'Trans proline' 0 C--O 1.234 0.276 0 C-N-CA 122.232 1.955 . . . . 2.59 113.512 -174.164 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 1522 ' ' SER . . . . . . . . . . . . . 13.1 m -68.48 -54.88 14.01 Favored 'General case' 0 N--CA 1.438 -1.047 0 C-N-CA 122.265 0.226 . . . . 2.65 111.02 -178.715 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 1523 ' ' THR . . . . . 0.514 HG22 ' HB2' ' A' 1647 ' ' GLU . 15.0 t -94.94 -15.74 23.36 Favored 'General case' 0 CA--C 1.554 1.11 0 CA-C-O 121.097 0.475 . . . . 2.33 111.483 -177.949 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A 1524 ' ' GLY . . . . . . . . . . . . . . . 81.17 17.38 72.01 Favored Glycine 0 C--N 1.334 0.434 0 C-N-CA 121.139 -0.553 . . . . 1.96 112.984 178.89 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 1525 ' ' HIS . . . . . . . . . . . . . 18.4 t60 -101.25 137.48 39.54 Favored 'General case' 0 C--N 1.313 -0.982 0 N-CA-C 109.556 -0.535 . . . . 2.44 109.556 -177.279 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 1526 ' ' LEU . . . . . 0.571 ' HA ' ' HA ' ' A' 1519 ' ' THR . 6.1 tt -99.94 132.39 45.32 Favored 'General case' 0 C--N 1.3 -1.548 0 N-CA-C 109.36 -0.608 . . . . 2.19 109.36 178.712 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A 1527 ' ' PHE . . . . . 0.408 ' O ' ' HA ' ' A' 1517 ' ' GLN . 28.4 m-85 -99.84 104.87 16.57 Favored 'General case' 0 C--N 1.299 -1.611 0 N-CA-C 108.781 -0.822 . . . . 1.61 108.781 -178.952 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A 1528 ' ' ASP . . . . . . . . . . . . . 35.6 t70 -95.01 124.66 39.18 Favored 'General case' 0 CA--C 1.495 -1.165 0 CA-C-O 121.473 0.654 . . . . 2.18 111.753 -179.749 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 1529 ' ' LEU . . . . . 0.506 ' HB2' ' HB3' ' A' 1516 ' ' CYS . 80.1 mt -109.76 -3.0 17.02 Favored 'General case' 0 C--N 1.296 -1.735 0 CA-C-N 114.285 -1.325 . . . . 2.04 109.076 178.863 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A 1530 ' ' SER . . . . . . . . . . . . . 4.5 m -70.33 -38.8 74.95 Favored 'General case' 0 C--O 1.223 -0.315 0 CA-C-N 115.749 -0.66 . . . . 1.44 109.597 -179.306 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 1531 ' ' SER . . . . . . . . . . . . . 24.2 m -63.81 -26.26 68.55 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 121.665 0.745 . . . . 1.63 109.878 177.113 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 1532 ' ' LEU . . . . . 0.549 HD11 ' CZ3' ' A' 1640 ' ' TRP . 66.2 mt -83.51 -4.4 58.49 Favored 'General case' 0 C--N 1.317 -0.838 0 CA-C-N 115.254 -0.884 . . . . 2.32 111.506 -178.687 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A 1533 ' ' SER . . . . . 0.508 ' OG ' ' HB2' ' A' 1553 ' ' CYS . 10.2 m -87.28 151.89 22.75 Favored 'General case' 0 C--O 1.249 1.049 0 N-CA-C 108.419 -0.956 . . . . 2.57 108.419 179.115 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A 1534 ' ' GLY . . . . . . . . . . . . . . . -171.18 -160.13 18.96 Favored Glycine 0 N--CA 1.435 -1.431 0 C-N-CA 119.532 -1.318 . . . . 1.89 112.907 -179.666 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 1535 ' ' ARG . . . . . 0.469 ' HG3' ' HB2' ' A' 1557 ' ' GLU . 38.3 ttm180 -75.53 -56.1 5.03 Favored 'General case' 0 C--N 1.307 -1.253 0 C-N-CA 123.989 0.916 . . . . 4.44 110.957 -179.132 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A 1536 ' ' ALA . . . . . . . . . . . . . . . -95.65 -29.68 14.18 Favored 'General case' 0 C--N 1.303 -1.452 0 CA-C-N 116.002 -0.545 . . . . 2.07 110.544 178.583 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 1537 ' ' GLY . . . . . . . . . . . . . . . 85.02 -118.46 4.76 Favored Glycine 0 N--CA 1.431 -1.693 0 N-CA-C 110.343 -1.103 . . . . 1.2 110.343 -177.998 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 1538 ' ' PHE . . . . . . . . . . . . . 69.1 m-85 -130.79 165.2 23.48 Favored 'General case' 0 C--N 1.308 -1.233 0 C-N-CA 123.085 0.554 . . . . 1.98 109.507 178.292 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 1539 ' ' THR . . . . . . . . . . . . . 3.1 p -115.15 120.5 39.98 Favored 'General case' 0 C--N 1.311 -1.105 0 N-CA-C 113.16 0.8 . . . . 1.97 113.16 -174.76 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 1540 ' ' ALA . . . . . . . . . . . . . . . -117.27 127.52 54.16 Favored 'General case' 0 C--N 1.312 -1.063 0 N-CA-C 108.251 -1.018 . . . . 1.39 108.251 173.886 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 1541 ' ' ALA . . . . . . . . . . . . . . . -88.28 153.22 21.38 Favored 'General case' 0 C--N 1.31 -1.127 0 N-CA-C 110.03 -0.359 . . . . 1.86 110.03 -178.492 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 1542 ' ' TYR . . . . . . . . . . . . . 52.9 t80 -157.42 175.31 14.15 Favored 'General case' 0 C--N 1.318 -0.79 0 N-CA-C 109.015 -0.735 . . . . 2.4 109.015 -178.416 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 1543 ' ' SER . . . . . . . . . . . . . 14.1 m -46.62 -151.0 0.0 OUTLIER 'General case' 0 CA--C 1.57 1.725 0 C-N-CA 129.245 3.018 . . . . 2.58 114.306 177.572 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 1544 ' ' LYS . . . . . . . . . . . . . 65.0 mttp -42.35 -23.06 0.03 OUTLIER 'General case' 0 CA--C 1.572 1.807 0 N-CA-C 115.47 1.656 . . . . 4.24 115.47 -178.574 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 1545 ' ' SER . . . . . . . . . . . . . 32.4 m -71.62 -15.84 62.26 Favored 'General case' 0 CA--C 1.564 1.517 0 C-N-CA 123.295 0.638 . . . . 3.6 111.813 175.277 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 1546 ' ' GLY . . . . . . . . . . . . . . . 84.04 -75.25 2.39 Favored Glycine 0 C--O 1.241 0.571 0 N-CA-C 114.298 0.479 . . . . 1.66 114.298 174.033 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 1547 ' ' VAL . . . . . . . . . . . . . 11.7 p -156.32 148.01 11.62 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.853 0 N-CA-C 108.115 -1.069 . . . . 2.23 108.115 -175.872 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 1548 ' ' VAL . . . . . . . . . . . . . 2.4 t -106.25 133.34 50.99 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.81 0 N-CA-C 108.327 -0.99 . . . . 1.59 108.327 -179.356 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 1549 ' ' TYR . . . . . 0.539 ' HB3' HD22 ' A' 1556 ' ' ASN . 12.6 m-85 -100.39 117.32 34.32 Favored 'General case' 0 C--N 1.301 -1.524 0 N-CA-C 107.672 -1.233 . . . . 1.58 107.672 172.867 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A 1550 ' ' MET . . . . . . . . . . . . . 52.4 ttp -140.45 122.78 15.94 Favored 'General case' 0 C--N 1.292 -1.896 0 C-N-CA 120.515 -0.474 . . . . 2.08 111.021 -177.544 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 1551 ' ' SER . . . . . . . . . . . . . 33.9 t -93.98 137.75 32.85 Favored 'General case' 0 N--CA 1.43 -1.472 0 N-CA-C 104.999 -2.223 . . . . 1.9 104.999 173.483 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 1552 ' ' ILE . . . . . . . . . . . . . 47.5 mm -63.26 -33.29 60.21 Favored 'Isoleucine or valine' 0 C--O 1.207 -1.158 0 CA-C-N 115.325 -0.852 . . . . 2.04 110.639 -175.856 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 1553 ' ' CYS . . . . . 0.508 ' HB2' ' OG ' ' A' 1533 ' ' SER . 79.6 m -144.77 141.19 29.02 Favored 'General case' 0 C--O 1.252 1.236 0 N-CA-C 108.363 -0.977 . . . . 1.43 108.363 172.553 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A 1554 ' ' GLY . . . . . . . . . . . . . . . 99.99 -157.93 19.62 Favored Glycine 0 N--CA 1.427 -1.926 0 C-N-CA 120.805 -0.712 . . . . 1.23 112.701 174.196 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 1555 ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 -103.31 147.97 26.43 Favored 'General case' 0 C--N 1.302 -1.469 0 CA-C-O 121.407 0.622 . . . . 1.8 111.549 -178.007 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 1556 ' ' ASN . . . . . 0.539 HD22 ' HB3' ' A' 1549 ' ' TYR . 25.5 t-20 -95.7 123.44 39.27 Favored 'General case' 0 C--N 1.293 -1.863 0 CA-C-N 115.029 -0.987 . . . . 2.63 108.553 179.636 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A 1557 ' ' GLU . . . . . 0.469 ' HB2' ' HG3' ' A' 1535 ' ' ARG . 5.4 mt-10 -91.87 39.57 1.02 Allowed 'General case' 0 C--N 1.303 -1.419 0 N-CA-C 112.09 0.404 . . . . 3.79 112.09 -173.746 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A 1558 ' ' ASN . . . . . . . . . . . . . 32.1 m-80 -125.89 -0.52 7.28 Favored 'General case' 0 C--N 1.311 -1.083 0 CA-C-O 121.971 0.891 . . . . 1.59 109.764 178.931 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 1559 ' ' CYS . . . . . 0.817 ' HB3' ' HD2' ' A' 1560 ' ' PRO . 84.0 m -144.24 -175.83 0.5 Allowed Pre-proline 0 C--N 1.295 -1.802 0 N-CA-C 106.263 -1.754 . . . . 0.94 106.263 -179.664 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A 1560 ' ' PRO . . . . . 0.817 ' HD2' ' HB3' ' A' 1559 ' ' CYS . 4.5 Cg_exo -41.96 123.28 2.39 Favored 'Trans proline' 0 C--N 1.379 2.176 0 C-N-CA 122.702 2.268 . . . . 1.53 112.959 175.658 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A 1561 ' ' PRO . . . . . . . . . . . . . 31.6 Cg_exo -60.75 105.45 0.31 Allowed 'Trans proline' 0 C--O 1.244 0.805 0 C-N-CA 123.082 2.521 . . . . 1.82 110.793 -179.532 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 1562 ' ' GLY . . . . . . . . . . . . . . . 141.68 -14.7 2.67 Favored Glycine 0 N--CA 1.431 -1.654 0 N-CA-C 111.25 -0.74 . . . . 0.81 111.25 -177.368 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 1563 ' ' VAL . . . . . 0.547 ' HA ' ' HA ' ' A' 1576 ' ' LYS . 3.2 m -98.46 146.85 7.46 Favored 'Isoleucine or valine' 0 C--O 1.207 -1.181 0 N-CA-C 107.465 -1.309 . . . . 1.73 107.465 177.15 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A 1564 ' ' GLY . . . . . . . . . . . . . . . -105.67 -25.1 6.71 Favored Glycine 0 C--O 1.241 0.538 0 C-N-CA 120.611 -0.804 . . . . 0.72 113.539 -174.229 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 1565 ' ' ALA . . . . . . . . . . . . . . . -134.91 128.72 33.11 Favored 'General case' 0 C--N 1.315 -0.91 0 N-CA-C 108.996 -0.742 . . . . 1.14 108.996 -179.988 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 1566 ' ' CYS . . . . . . . . . . . . . 42.1 t -156.54 145.87 20.57 Favored 'General case' 0 C--N 1.307 -1.258 0 CA-C-N 116.671 -0.24 . . . . 0.51 110.538 -173.857 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 1567 ' ' PHE . . . . . . . . . . . . . 24.7 m-85 -71.13 125.58 27.29 Favored 'General case' 0 C--O 1.207 -1.137 0 N-CA-C 107.387 -1.338 . . . . 1.22 107.387 175.018 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 1568 ' ' GLY . . . . . . . . . . . . . . . -75.22 -24.93 69.86 Favored Glycine 0 C--N 1.307 -1.047 0 C-N-CA 120.801 -0.714 . . . . 1.08 114.027 -173.648 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 1569 ' ' GLN . . . . . . . . . . . . . 65.5 tt0 -85.13 -53.03 5.53 Favored 'General case' 0 C--N 1.317 -0.814 0 C-N-CA 120.088 -0.645 . . . . 3.05 111.071 -179.757 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 1570 ' ' THR . . . . . . . . . . . . . 22.8 p -84.19 -16.95 41.53 Favored 'General case' 0 C--N 1.312 -1.053 0 N-CA-C 112.852 0.686 . . . . 2.44 112.852 -176.696 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 1571 ' ' ARG . . . . . . . . . . . . . 66.0 mtm180 60.78 41.87 14.17 Favored 'General case' 0 CA--C 1.508 -0.661 0 C-N-CA 125.382 1.473 . . . . 4.48 112.85 177.463 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 1572 ' ' ILE . . . . . . . . . . . . . 36.9 mm -103.83 122.8 56.99 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.222 0 N-CA-C 107.404 -1.332 . . . . 1.94 107.404 178.134 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 1573 ' ' SER . . . . . . . . . . . . . 71.5 p -78.43 121.94 25.17 Favored 'General case' 0 N--CA 1.436 -1.137 0 N-CA-C 113.129 0.788 . . . . 1.25 113.129 -176.46 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 1574 ' ' VAL . . . . . . . . . . . . . 22.4 m -106.51 11.39 8.88 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.426 0 CA-C-O 121.875 0.845 . . . . 1.61 110.402 -177.126 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 1575 ' ' GLY . . . . . . . . . . . . . . . -177.27 118.93 0.66 Allowed Glycine 0 N--CA 1.421 -2.333 0 CA-C-N 114.718 -1.128 . . . . 0.65 111.673 177.398 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 1576 ' ' LYS . . . . . 0.547 ' HA ' ' HA ' ' A' 1563 ' ' VAL . 55.7 tttm -79.85 152.17 29.83 Favored 'General case' 0 C--N 1.306 -1.315 0 N-CA-C 105.799 -1.926 . . . . 3.33 105.799 174.888 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A 1577 ' ' ALA . . . . . . . . . . . . . . . -56.22 102.33 0.07 Allowed 'General case' 0 N--CA 1.468 0.434 0 O-C-N 123.983 0.802 . . . . 1.31 110.277 -178.537 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 1578 ' ' ASN . . . . . 0.571 ' HB3' ' HA ' ' A' 1592 ' ' TYR . 8.0 t30 -135.61 130.22 34.07 Favored 'General case' 0 C--N 1.29 -2.001 0 N-CA-C 105.683 -1.969 . . . . 2.24 105.683 -179.094 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A 1579 ' ' LYS . . . . . . . . . . . . . 36.9 ttpt -115.54 90.24 3.29 Favored 'General case' 0 C--N 1.269 -2.926 0 CA-C-O 121.631 0.729 . . . . 2.34 109.211 -173.507 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 1580 ' ' ARG . . . . . 0.522 ' O ' ' HA ' ' A' 1590 ' ' LEU . 44.3 ttm180 -109.93 109.59 20.25 Favored 'General case' 0 C--N 1.286 -2.163 0 N-CA-C 107.902 -1.147 . . . . 4.19 107.902 177.332 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A 1581 ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -100.21 138.38 37.35 Favored 'General case' 0 C--N 1.298 -1.665 0 N-CA-C 106.273 -1.751 . . . . 2.39 106.273 -177.682 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A 1582 ' ' ARG . . . . . 0.415 ' HB3' ' HB3' ' A' 1589 ' ' GLN . 38.5 ttm180 -144.66 128.46 17.31 Favored 'General case' 0 C--N 1.305 -1.36 0 CA-C-O 121.137 0.494 . . . . 4.48 111.043 178.958 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A 1583 ' ' TYR . . . . . 0.461 ' HD1' ' CD2' ' A' 1588 ' ' LEU . 84.9 t80 -117.9 105.02 11.49 Favored 'General case' 0 C--N 1.297 -1.702 0 N-CA-C 105.946 -1.872 . . . . 1.57 105.946 176.996 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A 1584 ' ' VAL . . . . . . . . . . . . . 6.6 p -136.79 97.77 1.59 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.343 0 C-N-CA 119.594 -0.842 . . . . 2.29 112.501 -177.058 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 1585 ' ' ASP . . . . . . . . . . . . . 35.7 t70 56.87 69.07 0.78 Allowed 'General case' 0 N--CA 1.476 0.874 0 C-N-CA 124.188 0.995 . . . . 2.06 111.814 178.211 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 1586 ' ' GLN . . . . . . . . . . . . . 53.3 mt-30 52.51 25.5 3.64 Favored 'General case' 0 N--CA 1.478 0.945 0 N-CA-C 114.767 1.395 . . . . 2.61 114.767 178.657 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 1587 ' ' VAL . . . . . 0.416 HG23 ' O ' ' A' 1612 ' ' PHE . 11.5 p -139.52 122.29 17.47 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.772 0 N-CA-C 108.571 -0.9 . . . . 1.33 108.571 173.352 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A 1588 ' ' LEU . . . . . 0.557 ' HB2' ' HB2' ' A' 1612 ' ' PHE . 18.5 mt -89.09 158.28 18.02 Favored 'General case' 0 C--N 1.3 -1.556 0 CA-C-N 115.284 -0.871 . . . . 2.03 109.963 -178.493 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A 1589 ' ' GLN . . . . . 0.415 ' HB3' ' HB3' ' A' 1582 ' ' ARG . 6.8 tt0 -146.46 136.99 23.97 Favored 'General case' 0 C--N 1.292 -1.935 0 N-CA-C 108.667 -0.864 . . . . 1.73 108.667 176.918 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A 1590 ' ' LEU . . . . . 0.522 ' HA ' ' O ' ' A' 1580 ' ' ARG . 6.1 tt -133.04 135.45 45.38 Favored 'General case' 0 C--N 1.302 -1.47 0 N-CA-C 106.443 -1.688 . . . . 1.76 106.443 176.927 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A 1591 ' ' VAL . . . . . 0.42 HG23 HG23 ' A' 1609 ' ' VAL . 57.9 t -130.3 134.58 62.29 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.76 0 N-CA-C 112.761 0.652 . . . . 2.14 112.761 -171.769 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A 1592 ' ' TYR . . . . . 0.571 ' HA ' ' HB3' ' A' 1578 ' ' ASN . 67.3 m-85 -111.09 152.01 27.43 Favored 'General case' 0 C--N 1.318 -0.802 0 N-CA-C 107.405 -1.331 . . . . 1.53 107.405 171.53 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A 1593 ' ' LYS . . . . . . . . . . . . . 21.2 pttp -152.48 -177.16 6.05 Favored 'General case' 0 C--N 1.301 -1.539 0 N-CA-C 109.753 -0.462 . . . . 2.72 109.753 -178.767 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 1594 ' ' ASP . . . . . . . . . . . . . 1.7 m-20 53.36 41.83 32.09 Favored 'General case' 0 N--CA 1.485 1.291 0 N-CA-C 115.238 1.57 . . . . 1.45 115.238 173.614 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 1595 ' ' GLY . . . . . . . . . . . . . . . -82.65 -121.78 0.7 Allowed Glycine 0 N--CA 1.435 -1.429 0 C-N-CA 119.816 -1.183 . . . . 0.83 110.816 175.696 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 1596 ' ' SER . . . . . . . . . . . . . 49.0 m -83.44 153.0 65.1 Favored Pre-proline 0 C--N 1.284 -2.282 0 N-CA-C 109.934 -0.395 . . . . 1.96 109.934 -179.606 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 1597 ' ' PRO . . . . . . . . . . . . . 33.2 Cg_exo -63.67 139.33 68.9 Favored 'Trans proline' 0 C--O 1.253 1.243 0 C-N-CA 122.689 2.26 . . . . 1.34 109.723 172.369 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 1598 ' ' CYS . . . . . . . . . . . . . 34.8 t -95.05 130.16 33.5 Favored Pre-proline 0 C--N 1.287 -2.139 0 N-CA-C 108.97 -0.752 . . . . 1.19 108.97 -177.318 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 1599 ' ' PRO . . . . . 0.456 ' HD2' ' OH ' ' A' 1606 ' ' TYR . 89.2 Cg_endo -82.33 4.57 6.97 Favored 'Trans proline' 0 CA--C 1.536 0.577 0 C-N-CA 122.879 2.386 . . . . 1.88 112.697 179.319 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A 1600 ' ' SER . . . . . . . . . . . . . 15.9 m -107.81 123.0 47.91 Favored 'General case' 0 N--CA 1.431 -1.388 0 N-CA-C 109.957 -0.386 . . . . 2.19 109.957 -177.468 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 1601 ' ' LYS . . . . . . . . . . . . . 26.5 mtpp 66.02 -97.93 0.05 Allowed 'General case' 0 N--CA 1.454 -0.27 0 N-CA-C 114.565 1.32 . . . . 4.21 114.565 -179.372 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 1602 ' ' SER . . . . . 0.472 ' HB3' ' HG ' ' A' 1604 ' ' LEU . 10.4 t -97.59 153.61 18.08 Favored 'General case' 0 C--N 1.301 -1.505 0 N-CA-C 109.202 -0.666 . . . . 3.82 109.202 -178.247 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A 1603 ' ' GLY . . . . . . . . . . . . . . . -80.63 56.87 4.76 Favored Glycine 0 N--CA 1.447 -0.622 0 N-CA-C 110.835 -0.906 . . . . 2.45 110.835 177.625 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 1604 ' ' LEU . . . . . 0.472 ' HG ' ' HB3' ' A' 1602 ' ' SER . 0.7 OUTLIER -99.28 -172.01 2.19 Favored 'General case' 0 C--N 1.307 -1.259 0 C-N-CA 123.817 0.847 . . . . 2.06 110.633 -179.69 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A 1605 ' ' SER . . . . . . . . . . . . . 8.7 m -97.78 -178.72 4.2 Favored 'General case' 0 C--N 1.301 -1.543 0 CA-C-N 118.206 0.457 . . . . 1.75 110.102 -176.749 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 1606 ' ' TYR . . . . . 0.456 ' OH ' ' HD2' ' A' 1599 ' ' PRO . 68.2 m-85 -106.39 137.69 43.92 Favored 'General case' 0 N--CA 1.417 -2.091 0 N-CA-C 104.424 -2.436 . . . . 1.59 104.424 174.902 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A 1607 ' ' LYS . . . . . 0.525 ' HG3' HG22 ' A' 1635 ' ' THR . 21.9 ptmt -130.05 142.7 50.58 Favored 'General case' 0 C--N 1.282 -2.35 0 C-N-CA 119.955 -0.698 . . . . 2.21 109.216 179.383 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A 1608 ' ' SER . . . . . . . . . . . . . 46.7 m -119.0 126.84 52.67 Favored 'General case' 0 C--N 1.3 -1.553 0 CA-C-O 120.413 0.149 . . . . 1.48 110.653 -176.806 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 1609 ' ' VAL . . . . . 0.42 HG23 HG23 ' A' 1591 ' ' VAL . 74.2 t -116.2 124.45 72.48 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.839 0 N-CA-C 109.321 -0.622 . . . . 1.57 109.321 178.205 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A 1610 ' ' ILE . . . . . 0.807 HG13 ' HB2' ' A' 1638 ' ' PHE . 3.0 mp -108.07 120.06 58.76 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.966 0 N-CA-C 109.072 -0.714 . . . . 1.47 109.072 176.68 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A 1611 ' ' SER . . . . . . . . . . . . . 24.2 p -94.89 123.63 38.47 Favored 'General case' 0 N--CA 1.432 -1.372 0 N-CA-C 109.049 -0.723 . . . . 1.84 109.049 175.317 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 1612 ' ' PHE . . . . . 0.557 ' HB2' ' HB2' ' A' 1588 ' ' LEU . 93.0 m-85 -97.11 108.89 21.71 Favored 'General case' 0 C--N 1.298 -1.638 0 CA-C-O 121.123 0.487 . . . . 0.86 110.657 -177.914 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A 1613 ' ' VAL . . . . . 0.426 ' O ' ' HA ' ' A' 1641 ' ' HIS . 49.0 t -103.72 120.74 54.26 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.531 0 N-CA-C 109.246 -0.65 . . . . 1.32 109.246 -178.154 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A 1614 ' ' CYS . . . . . 0.581 ' HA ' ' O ' ' A' 1642 ' ' THR . 0.8 OUTLIER -77.7 93.94 4.35 Favored 'General case' 0 C--N 1.302 -1.476 0 N-CA-C 114.201 1.185 . . . . 1.39 114.201 -179.15 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A 1615 ' ' ARG . . . . . . . . . . . . . 71.8 ttt180 -115.74 107.05 49.13 Favored Pre-proline 0 C--N 1.312 -1.063 0 N-CA-C 108.163 -1.051 . . . . 4.34 108.163 175.755 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 1616 ' ' PRO . . . . . 0.41 ' HA ' ' HB3' ' A' 1643 ' ' PRO . 27.0 Cg_endo -63.95 -38.1 39.94 Favored 'Trans proline' 0 CA--C 1.531 0.328 0 C-N-CA 122.753 2.302 . . . . 1.5 112.191 -179.922 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A 1617 ' ' GLU . . . . . . . . . . . . . 20.4 mm-40 -94.01 40.48 1.08 Allowed 'General case' 0 C--N 1.312 -1.028 0 CA-C-N 115.976 -0.556 . . . . 3.21 110.937 -179.153 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 1618 ' ' ALA . . . . . . . . . . . . . . . -92.75 128.54 38.65 Favored 'General case' 0 C--N 1.307 -1.256 0 N-CA-C 109.1 -0.704 . . . . 2.91 109.1 177.584 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 1619 ' ' GLY . . . . . . . . . . . . . . . -122.98 -85.91 0.75 Allowed Glycine 0 C--N 1.297 -1.587 0 N-CA-C 110.455 -1.058 . . . . 3.35 110.455 179.036 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 1620 ' ' PRO . . . . . . . . . . . . . 53.4 Cg_exo -56.45 -40.2 86.17 Favored 'Trans proline' 0 CA--C 1.542 0.886 0 C-N-CA 123.155 2.57 . . . . 6.61 112.814 177.143 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 1621 ' ' THR . . . . . . . . . . . . . 19.6 m -95.49 21.59 8.01 Favored 'General case' 0 CA--C 1.56 1.357 0 CA-C-O 122.428 1.109 . . . . 5.03 110.782 -178.131 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 1622 ' ' ASN . . . . . 0.474 ' HA ' ' O ' ' A' 1641 ' ' HIS . 48.8 t-20 -91.46 53.14 2.21 Favored 'General case' 0 C--O 1.243 0.722 0 N-CA-C 106.941 -1.503 . . . . 3.58 106.941 176.854 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A 1623 ' ' ARG . . . . . . . . . . . . . 16.5 ptm180 -149.71 150.26 30.2 Favored Pre-proline 0 C--N 1.308 -1.236 0 N-CA-C 107.677 -1.231 . . . . 4.09 107.677 -176.606 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 1624 ' ' PRO . . . . . . . . . . . . . 11.9 Cg_exo -71.63 94.81 0.69 Allowed 'Trans proline' 0 N--CA 1.456 -0.691 0 C-N-CA 122.148 1.899 . . . . 2.86 109.104 175.909 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 1625 ' ' MET . . . . . . . . . . . . . 57.7 ttp -101.64 141.41 34.54 Favored 'General case' 0 C--N 1.299 -1.588 0 CA-C-N 115.662 -0.699 . . . . 2.73 109.779 -175.17 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 1626 ' ' LEU . . . . . . . . . . . . . 56.2 tp -80.61 110.7 16.34 Favored 'General case' 0 C--N 1.313 -1.005 0 N-CA-C 108.446 -0.946 . . . . 1.94 108.446 178.334 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 1627 ' ' ILE . . . . . . . . . . . . . 26.5 pt -88.16 -41.76 14.48 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.919 0 C-N-CA 120.339 -0.545 . . . . 1.75 112.196 -177.893 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 1628 ' ' SER . . . . . . . . . . . . . 26.7 t -147.21 148.45 31.52 Favored 'General case' 0 N--CA 1.434 -1.242 0 N-CA-C 109.933 -0.395 . . . . 1.85 109.933 -175.489 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 1629 ' ' LEU . . . . . 0.639 ' HG ' HD13 ' A' 1636 ' ' LEU . 5.1 tt -125.51 112.13 15.87 Favored 'General case' 0 C--N 1.304 -1.411 0 N-CA-C 106.496 -1.668 . . . . 2.12 106.496 176.798 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A 1630 ' ' ASP . . . . . 0.412 ' HB2' ' HE2' ' A' 1637 ' ' PHE . 19.5 t70 -83.22 117.46 22.95 Favored 'General case' 0 C--N 1.303 -1.444 0 N-CA-C 108.479 -0.934 . . . . 0.87 108.479 177.704 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A 1631 ' ' LYS . . . . . . . . . . . . . 98.3 mttt -92.26 -7.18 48.83 Favored 'General case' 0 C--N 1.29 -2.021 0 CA-C-N 115.932 -0.576 . . . . 2.76 111.179 -174.948 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 1632 ' ' GLN . . . . . . . . . . . . . 36.5 mt-30 -80.25 -47.52 14.47 Favored 'General case' 0 C--N 1.317 -0.817 0 CA-C-O 121.456 0.646 . . . . 2.55 110.295 -177.338 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 1633 ' ' THR . . . . . . . . . . . . . 41.0 p -107.25 -1.34 21.87 Favored 'General case' 0 C--N 1.298 -1.66 0 CA-C-N 116.034 -0.53 . . . . 1.92 111.306 179.858 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 1634 ' ' CYS . . . . . . . . . . . . . 60.3 m 64.62 52.05 1.81 Allowed 'General case' 0 N--CA 1.472 0.644 0 CA-C-O 122.171 0.986 . . . . 0.89 110.538 -179.682 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 1635 ' ' THR . . . . . 0.525 HG22 ' HG3' ' A' 1607 ' ' LYS . 32.1 m -114.16 126.65 55.31 Favored 'General case' 0 N--CA 1.431 -1.381 0 CA-C-N 114.567 -1.197 . . . . 1.31 110.186 -175.485 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A 1636 ' ' LEU . . . . . 0.639 HD13 ' HG ' ' A' 1629 ' ' LEU . 2.1 mm? -95.45 132.99 39.93 Favored 'General case' 0 C--N 1.308 -1.205 0 N-CA-C 108.971 -0.751 . . . . 1.97 108.971 -179.423 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A 1637 ' ' PHE . . . . . 0.412 ' HE2' ' HB2' ' A' 1630 ' ' ASP . 99.8 m-85 -116.42 106.38 13.55 Favored 'General case' 0 C--O 1.247 0.969 0 CA-C-O 121.21 0.528 . . . . 0.92 110.702 179.555 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A 1638 ' ' PHE . . . . . 0.807 ' HB2' HG13 ' A' 1610 ' ' ILE . 99.0 m-85 -103.77 149.52 24.94 Favored 'General case' 0 C--N 1.301 -1.533 0 N-CA-C 108.619 -0.882 . . . . 0.7 108.619 178.684 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A 1639 ' ' SER . . . . . . . . . . . . . 33.6 t -135.59 132.11 36.73 Favored 'General case' 0 C--N 1.285 -2.229 0 N-CA-C 109.216 -0.661 . . . . 1.46 109.216 179.496 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 1640 ' ' TRP . . . . . 0.549 ' CZ3' HD11 ' A' 1532 ' ' LEU . 7.2 t90 -120.82 118.96 31.33 Favored 'General case' 0 N--CA 1.423 -1.806 0 N-CA-C 107.472 -1.307 . . . . 0.92 107.472 177.642 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A 1641 ' ' HIS . . . . . 0.474 ' O ' ' HA ' ' A' 1622 ' ' ASN . 31.7 m-70 -96.96 103.46 15.39 Favored 'General case' 0 C--N 1.294 -1.812 0 N-CA-C 106.734 -1.58 . . . . 3.18 106.734 177.354 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A 1642 ' ' THR . . . . . 0.581 ' O ' ' HA ' ' A' 1614 ' ' CYS . 8.9 t -142.24 139.54 17.95 Favored Pre-proline 0 C--N 1.303 -1.45 0 CA-C-N 115.7 -0.682 . . . . 1.48 111.807 -170.536 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A 1643 ' ' PRO . . . . . 0.41 ' HB3' ' HA ' ' A' 1616 ' ' PRO . 4.3 Cg_exo -74.84 -3.64 14.21 Favored 'Trans proline' 0 N--CA 1.456 -0.718 0 C-N-CA 123.499 2.8 . . . . 1.09 111.639 175.573 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A 1644 ' ' LEU . . . . . . . . . . . . . 83.4 mt -82.03 -8.62 59.67 Favored 'General case' 0 C--N 1.315 -0.929 0 CA-C-N 116.447 -0.342 . . . . 2.08 110.635 177.282 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 1645 ' ' ALA . . . . . . . . . . . . . . . -88.31 -21.0 24.65 Favored 'General case' 0 C--N 1.32 -0.713 0 N-CA-C 113.092 0.775 . . . . 1.37 113.092 -176.196 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 1646 ' ' CYS . . . . . 0.428 ' O ' ' HD3' ' A' 1648 ' ' PRO . 61.1 m -155.15 172.45 18.12 Favored 'General case' 0 N--CA 1.475 0.781 0 N-CA-C 107.243 -1.391 . . . . 1.7 107.243 -179.761 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A 1647 ' ' GLU . . . . . 0.514 ' HB2' HG22 ' A' 1523 ' ' THR . 37.7 mm-40 -113.09 85.1 7.71 Favored Pre-proline 0 C--N 1.309 -1.179 0 N-CA-C 109.815 -0.439 . . . . 2.92 109.815 174.694 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A 1648 ' ' PRO . . . . . 0.428 ' HD3' ' O ' ' A' 1646 ' ' CYS . 4.0 Cg_exo -80.78 156.5 20.95 Favored 'Trans proline' 0 C--O 1.253 1.275 0 C-N-CA 123.125 2.55 . . . . 3.19 110.966 -178.001 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A 1649 ' ' GLU . . . . . . . . . . . . . 7.6 tp10 . . . . . 0 N--CA 1.425 -1.698 0 N-CA-C 108.53 -0.915 . . . . 5.06 108.53 179.902 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A 1508 ' ' MET . . . . . 0.41 ' HB2' ' OD1' ' A' 1511 ' ' ASN . 3.7 mpp? . . . . . 0 CA--C 1.51 -0.578 0 N-CA-C 109.01 -0.737 . . . . 8.58 109.01 . . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 1509 ' ' LYS . . . . . . . . . . . . . 59.5 pttt -107.28 -19.99 13.42 Favored 'General case' 0 C--N 1.312 -1.036 0 CA-C-O 120.975 0.417 . . . . 6.8 111.197 178.46 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 1510 ' ' SER . . . . . . . . . . . . . 15.2 m -116.43 80.8 1.52 Allowed 'General case' 0 N--CA 1.429 -1.48 0 N-CA-C 106.143 -1.799 . . . . 4.48 106.143 174.538 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 1511 ' ' ASN . . . . . 0.411 ' HB2' ' O ' ' A' 1517 ' ' GLN . 13.1 m-80 -93.2 -18.37 22.6 Favored 'General case' 0 C--N 1.306 -1.29 0 CA-C-N 115.502 -0.772 . . . . 3.08 111.315 -171.855 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A 1512 ' ' GLU . . . . . 0.484 ' HB2' ' HB3' ' A' 1581 ' ' LEU . 0.3 OUTLIER -64.52 1.11 0.87 Allowed 'General case' 0 N--CA 1.483 1.214 0 N-CA-C 115.847 1.795 . . . . 4.46 115.847 -169.857 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A 1513 ' ' HIS . . . . . . . . . . . . . 18.5 p80 -113.17 3.18 15.92 Favored 'General case' 0 C--N 1.308 -1.237 0 CA-C-O 121.002 0.43 . . . . 6.25 110.119 177.144 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 1514 ' ' ASP . . . . . . . . . . . . . 34.2 t70 -140.37 -42.16 0.41 Allowed 'General case' 0 N--CA 1.468 0.46 0 CA-C-O 121.613 0.721 . . . . 3.7 111.187 -174.057 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 1515 ' ' ASP . . . . . . . . . . . . . 13.6 t70 -125.58 -168.41 1.84 Allowed 'General case' 0 C--N 1.303 -1.418 0 N-CA-C 105.58 -2.007 . . . . 2.54 105.58 179.711 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 1516 ' ' CYS . . . . . 0.446 ' HB3' ' HB2' ' A' 1529 ' ' LEU . 74.0 m -128.32 43.11 3.2 Favored 'General case' 0 C--N 1.298 -1.637 0 CA-C-N 118.561 0.618 . . . . 1.25 110.135 -176.417 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A 1517 ' ' GLN . . . . . 0.411 ' O ' ' HB2' ' A' 1511 ' ' ASN . 3.8 pt20 -124.52 129.28 50.33 Favored 'General case' 0 C--N 1.295 -1.762 0 C-N-CA 119.866 -0.734 . . . . 2.36 110.702 178.238 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A 1518 ' ' VAL . . . . . . . . . . . . . 15.9 m -133.28 139.51 49.07 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.641 0 CA-C-N 115.715 -0.675 . . . . 2.34 110.4 -179.058 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 1519 ' ' THR . . . . . . . . . . . . . 23.1 m -90.55 123.57 34.32 Favored 'General case' 0 C--N 1.284 -2.251 0 N-CA-C 108.832 -0.803 . . . . 2.04 108.832 176.478 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 1520 ' ' ASN . . . . . . . . . . . . . 48.6 t-20 -84.63 112.25 40.87 Favored Pre-proline 0 C--N 1.311 -1.08 0 N-CA-C 107.746 -1.205 . . . . 2.12 107.746 178.083 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 1521 ' ' PRO . . . . . . . . . . . . . 42.6 Cg_endo -65.38 -16.46 54.42 Favored 'Trans proline' 0 C--N 1.353 0.766 0 C-N-CA 122.897 2.398 . . . . 2.59 113.992 -174.299 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 1522 ' ' SER . . . . . . . . . . . . . 38.0 m -81.21 -9.8 59.72 Favored 'General case' 0 C--N 1.312 -1.031 0 CA-C-O 120.779 0.323 . . . . 2.65 111.869 -178.976 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 1523 ' ' THR . . . . . . . . . . . . . 13.7 t -136.55 -13.82 1.72 Allowed 'General case' 0 CA--C 1.552 1.041 0 CA-C-O 121.349 0.595 . . . . 2.33 111.371 176.761 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 1524 ' ' GLY . . . . . . . . . . . . . . . 73.33 16.26 78.8 Favored Glycine 0 C--N 1.341 0.845 0 O-C-N 122.134 -0.354 . . . . 1.96 112.362 179.481 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 1525 ' ' HIS . . . . . . . . . . . . . 58.3 t60 -101.93 136.72 41.28 Favored 'General case' 0 C--N 1.306 -1.31 0 C-N-CA 122.623 0.369 . . . . 2.44 110.091 -176.135 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 1526 ' ' LEU . . . . . . . . . . . . . 26.4 tp -83.45 124.49 30.75 Favored 'General case' 0 C--N 1.306 -1.289 0 N-CA-C 108.579 -0.897 . . . . 2.19 108.579 176.914 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 1527 ' ' PHE . . . . . . . . . . . . . 80.8 m-85 -98.53 114.11 26.4 Favored 'General case' 0 C--N 1.296 -1.731 0 CA-C-O 121.671 0.748 . . . . 1.61 110.06 176.145 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 1528 ' ' ASP . . . . . . . . . . . . . 4.6 t70 -90.41 105.75 18.03 Favored 'General case' 0 C--N 1.298 -1.642 0 CA-C-N 114.205 -1.361 . . . . 2.18 111.02 -177.636 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 1529 ' ' LEU . . . . . 0.789 ' HA ' HD12 ' A' 1532 ' ' LEU . 79.6 mt -104.19 5.99 35.31 Favored 'General case' 0 C--N 1.297 -1.69 0 N-CA-C 106.089 -1.819 . . . . 2.04 106.089 170.861 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A 1530 ' ' SER . . . . . . . . . . . . . 3.1 m -65.47 -36.72 84.74 Favored 'General case' 0 N--CA 1.438 -1.059 0 CA-C-N 114.531 -1.213 . . . . 1.44 109.694 -179.279 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 1531 ' ' SER . . . . . . . . . . . . . 15.6 m -73.62 -9.75 58.99 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 121.308 0.575 . . . . 1.63 109.908 178.114 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 1532 ' ' LEU . . . . . 0.789 HD12 ' HA ' ' A' 1529 ' ' LEU . 6.6 mp -92.97 15.27 15.35 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.788 -0.642 . . . . 2.32 111.049 -179.724 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A 1533 ' ' SER . . . . . . . . . . . . . 50.4 m -74.16 127.9 34.13 Favored 'General case' 0 N--CA 1.435 -1.212 0 N-CA-C 108.132 -1.062 . . . . 2.57 108.132 174.353 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 1534 ' ' GLY . . . . . . . . . . . . . . . -127.45 137.36 9.81 Favored Glycine 0 CA--C 1.478 -2.249 0 N-CA-C 109.823 -1.311 . . . . 1.89 109.823 -177.905 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 1535 ' ' ARG . . . . . . . . . . . . . 3.6 tpp180 -90.33 -44.3 9.77 Favored 'General case' 0 C--N 1.302 -1.471 0 N-CA-C 109.131 -0.692 . . . . 4.44 109.131 -179.845 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 1536 ' ' ALA . . . . . . . . . . . . . . . -95.32 -6.84 40.31 Favored 'General case' 0 C--N 1.314 -0.961 0 N-CA-C 108.15 -1.056 . . . . 2.07 108.15 175.125 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 1537 ' ' GLY . . . . . . . . . . . . . . . 78.73 -174.12 55.23 Favored Glycine 0 N--CA 1.429 -1.828 0 CA-C-N 113.887 -1.506 . . . . 1.2 113.67 177.322 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 1538 ' ' PHE . . . . . . . . . . . . . 90.3 m-85 -113.97 175.14 5.6 Favored 'General case' 0 C--N 1.292 -1.899 0 N-CA-C 105.457 -2.053 . . . . 1.98 105.457 176.263 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 1539 ' ' THR . . . . . . . . . . . . . 11.9 t -136.47 152.88 51.04 Favored 'General case' 0 C--N 1.282 -2.352 0 C-N-CA 119.02 -1.072 . . . . 1.97 110.21 -178.626 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 1540 ' ' ALA . . . . . 0.632 ' HA ' ' HD3' ' A' 1623 ' ' ARG . . . -133.38 130.9 39.4 Favored 'General case' 0 C--N 1.319 -0.754 0 N-CA-C 109.062 -0.718 . . . . 1.39 109.062 179.067 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A 1541 ' ' ALA . . . . . . . . . . . . . . . -78.57 147.52 33.7 Favored 'General case' 0 C--O 1.247 0.929 0 CA-C-N 116.189 -0.459 . . . . 1.86 110.761 -178.331 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 1542 ' ' TYR . . . . . 0.463 ' HB3' ' O ' ' A' 1546 ' ' GLY . 89.2 t80 -160.46 160.3 31.92 Favored 'General case' 0 CA--C 1.552 1.058 0 CA-C-O 119.599 -0.239 . . . . 2.4 111.549 -177.591 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A 1543 ' ' SER . . . . . . . . . . . . . 17.9 t -37.58 -152.2 0.0 OUTLIER 'General case' 0 CA--C 1.591 2.538 0 C-N-CA 130.626 3.57 . . . . 2.58 115.562 176.331 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 1544 ' ' LYS . . . . . . . . . . . . . 97.6 mttt -46.7 -35.61 6.26 Favored 'General case' 0 N--CA 1.479 0.98 0 C-N-CA 124.497 1.119 . . . . 4.24 113.496 -177.707 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 1545 ' ' SER . . . . . . . . . . . . . 37.2 m -71.15 -8.12 51.32 Favored 'General case' 0 CA--C 1.551 0.993 0 N-CA-C 112.96 0.726 . . . . 3.6 112.96 177.582 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 1546 ' ' GLY . . . . . 0.463 ' O ' ' HB3' ' A' 1542 ' ' TYR . . . 83.06 -160.71 38.92 Favored Glycine 0 N--CA 1.432 -1.586 0 C-N-CA 121.239 -0.505 . . . . 1.66 114.255 173.05 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A 1547 ' ' VAL . . . . . . . . . . . . . 14.9 p -91.23 134.25 30.36 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.938 0 N-CA-C 108.742 -0.836 . . . . 2.23 108.742 -177.019 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 1548 ' ' VAL . . . . . . . . . . . . . 4.9 t -110.52 147.72 14.49 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.518 0 N-CA-C 108.44 -0.948 . . . . 1.59 108.44 -175.03 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 1549 ' ' TYR . . . . . 0.514 ' HB3' HD22 ' A' 1556 ' ' ASN . 99.8 m-85 -106.0 129.13 54.18 Favored 'General case' 0 C--N 1.313 -0.992 0 N-CA-C 108.185 -1.043 . . . . 1.58 108.185 176.762 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A 1550 ' ' MET . . . . . . . . . . . . . 87.7 mmm -134.29 122.35 22.56 Favored 'General case' 0 C--N 1.299 -1.614 0 CA-C-N 115.792 -0.64 . . . . 2.08 109.845 -173.708 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 1551 ' ' SER . . . . . 0.482 ' OG ' ' HA ' ' A' 1556 ' ' ASN . 74.9 m -97.35 115.63 28.06 Favored 'General case' 0 C--N 1.286 -2.178 0 N-CA-C 107.058 -1.46 . . . . 1.9 107.058 171.79 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A 1552 ' ' ILE . . . . . 0.482 ' HB ' ' O ' ' A' 1532 ' ' LEU . 41.9 mm -57.37 -49.55 79.75 Favored 'Isoleucine or valine' 0 C--O 1.21 -0.989 0 CA-C-N 114.811 -1.086 . . . . 2.04 108.139 179.421 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A 1553 ' ' CYS . . . . . 0.484 ' HA ' ' OH ' ' A' 1592 ' ' TYR . 81.3 m -131.48 137.45 48.58 Favored 'General case' 0 N--CA 1.425 -1.724 0 N-CA-C 109.371 -0.603 . . . . 1.43 109.371 173.96 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A 1554 ' ' GLY . . . . . . . . . . . . . . . 105.56 -143.05 15.64 Favored Glycine 0 N--CA 1.435 -1.42 0 O-C-N 123.785 0.678 . . . . 1.23 112.745 174.802 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 1555 ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -117.91 157.49 26.59 Favored 'General case' 0 C--N 1.303 -1.418 0 N-CA-C 108.473 -0.936 . . . . 1.8 108.473 179.754 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 1556 ' ' ASN . . . . . 0.514 HD22 ' HB3' ' A' 1549 ' ' TYR . 4.0 t-20 -100.38 -23.4 14.77 Favored 'General case' 0 C--N 1.301 -1.533 0 CA-C-N 116.281 -0.418 . . . . 2.63 111.977 -172.816 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A 1557 ' ' GLU . . . . . 0.477 ' C ' ' H ' ' A' 1559 ' ' CYS . 37.7 mt-10 54.82 -158.99 0.19 Allowed 'General case' 0 N--CA 1.449 -0.477 0 CA-C-N 114.92 -1.036 . . . . 3.79 109.577 -174.709 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A 1558 ' ' ASN . . . . . . . . . . . . . 39.8 m-80 69.93 -8.95 0.75 Allowed 'General case' 0 N--CA 1.495 1.801 0 C-N-CA 124.078 0.951 . . . . 1.59 112.192 175.683 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 1559 ' ' CYS . . . . . 0.731 ' HB3' ' HD2' ' A' 1560 ' ' PRO . 63.4 m -145.04 -173.55 0.36 Allowed Pre-proline 0 C--N 1.283 -2.323 0 N-CA-C 103.683 -2.71 . . . . 0.94 103.683 -178.675 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A 1560 ' ' PRO . . . . . 0.731 ' HD2' ' HB3' ' A' 1559 ' ' CYS . 2.8 Cg_exo -37.8 137.3 0.43 Allowed 'Trans proline' 0 C--N 1.373 1.82 0 C-N-CA 123.621 2.88 . . . . 1.53 113.727 175.624 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A 1561 ' ' PRO . . . . . . . . . . . . . 39.8 Cg_endo -68.04 125.33 12.91 Favored 'Trans proline' 0 N--CA 1.456 -0.678 0 C-N-CA 122.482 2.121 . . . . 1.82 112.265 -177.839 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 1562 ' ' GLY . . . . . . . . . . . . . . . 101.68 17.48 21.22 Favored Glycine 0 N--CA 1.434 -1.481 0 C-N-CA 121.029 -0.605 . . . . 0.81 112.79 177.341 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 1563 ' ' VAL . . . . . 0.518 ' HA ' ' HA ' ' A' 1576 ' ' LYS . 10.4 m -103.68 150.75 6.83 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.868 0 N-CA-C 106.746 -1.576 . . . . 1.73 106.746 174.631 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A 1564 ' ' GLY . . . . . . . . . . . . . . . -112.26 -5.62 24.66 Favored Glycine 0 C--N 1.317 -0.473 0 C-N-CA 120.233 -0.984 . . . . 0.72 113.305 -174.352 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 1565 ' ' ALA . . . . . . . . . . . . . . . -150.75 133.43 15.75 Favored 'General case' 0 C--O 1.254 1.314 0 N-CA-C 109.414 -0.587 . . . . 1.14 109.414 -179.014 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 1566 ' ' CYS . . . . . . . . . . . . . 34.7 t -154.06 142.32 20.49 Favored 'General case' 0 C--N 1.312 -1.043 0 CA-C-O 121.234 0.54 . . . . 0.51 111.042 -177.186 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 1567 ' ' PHE . . . . . 0.662 ' O ' ' HA ' ' A' 1571 ' ' ARG . 13.2 m-85 -67.6 150.99 48.06 Favored 'General case' 0 N--CA 1.452 -0.339 0 CA-C-N 115.742 -0.663 . . . . 1.22 109.756 176.322 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A 1568 ' ' GLY . . . . . . . . . . . . . . . -108.78 -10.56 24.59 Favored Glycine 0 N--CA 1.432 -1.633 0 C-N-CA 120.337 -0.935 . . . . 1.08 111.751 178.831 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 1569 ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -89.81 -62.34 1.49 Allowed 'General case' 0 C--N 1.317 -0.822 0 N-CA-C 108.217 -1.031 . . . . 3.05 108.217 178.374 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A 1570 ' ' THR . . . . . . . . . . . . . 19.3 p -89.24 -11.99 42.03 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 121.135 0.493 . . . . 2.44 111.819 178.718 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 1571 ' ' ARG . . . . . 0.662 ' HA ' ' O ' ' A' 1567 ' ' PHE . 83.6 mtm180 61.43 37.03 17.01 Favored 'General case' 0 N--CA 1.473 0.709 0 C-N-CA 124.607 1.163 . . . . 4.48 113.434 175.748 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A 1572 ' ' ILE . . . . . . . . . . . . . 33.2 mm -99.43 132.9 43.99 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.205 0 N-CA-C 108.655 -0.868 . . . . 1.94 108.655 179.907 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 1573 ' ' SER . . . . . . . . . . . . . 29.5 p -74.73 120.88 20.89 Favored 'General case' 0 N--CA 1.441 -0.89 0 CA-C-O 121.134 0.492 . . . . 1.25 111.892 -179.239 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 1574 ' ' VAL . . . . . . . . . . . . . 35.3 m -113.25 21.8 5.96 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.233 0 CA-C-O 121.672 0.749 . . . . 1.61 112.311 -173.911 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 1575 ' ' GLY . . . . . . . . . . . . . . . 179.97 127.36 1.11 Allowed Glycine 0 N--CA 1.431 -1.641 0 CA-C-N 115.128 -0.942 . . . . 0.65 111.297 176.544 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 1576 ' ' LYS . . . . . 0.518 ' HA ' ' HA ' ' A' 1563 ' ' VAL . 54.7 tttp -89.91 151.6 21.64 Favored 'General case' 0 C--N 1.313 -0.991 0 N-CA-C 106.794 -1.558 . . . . 3.33 106.794 178.499 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A 1577 ' ' ALA . . . . . 0.405 ' HA ' ' CD1' ' A' 1592 ' ' TYR . . . -67.1 88.67 0.17 Allowed 'General case' 0 C--O 1.239 0.508 0 CA-C-O 121.939 0.875 . . . . 1.31 112.286 -174.708 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A 1578 ' ' ASN . . . . . . . . . . . . . 49.8 m-80 -117.87 113.29 21.54 Favored 'General case' 0 C--N 1.288 -2.087 0 N-CA-C 104.178 -2.527 . . . . 2.24 104.178 172.714 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 1579 ' ' LYS . . . . . . . . . . . . . 37.4 ttpt -101.07 91.01 4.36 Favored 'General case' 0 C--N 1.274 -2.681 0 C-N-CA 119.24 -0.984 . . . . 2.34 109.306 -173.783 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 1580 ' ' ARG . . . . . . . . . . . . . 49.1 ttp180 -129.7 100.62 5.57 Favored 'General case' 0 N--CA 1.42 -1.968 0 CA-C-N 114.391 -1.277 . . . . 4.19 109.576 -178.398 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 1581 ' ' LEU . . . . . 0.484 ' HB3' ' HB2' ' A' 1512 ' ' GLU . 64.3 tp -96.08 147.63 23.52 Favored 'General case' 0 C--N 1.303 -1.43 0 N-CA-C 107.175 -1.417 . . . . 2.39 107.175 177.459 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A 1582 ' ' ARG . . . . . 0.534 ' HG2' HG12 ' A' 1584 ' ' VAL . 40.8 ttp180 -146.36 138.52 25.03 Favored 'General case' 0 C--N 1.304 -1.397 0 C-N-CA 120.559 -0.456 . . . . 4.48 111.64 178.782 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A 1583 ' ' TYR . . . . . 0.554 ' HD2' HD21 ' A' 1588 ' ' LEU . 55.7 t80 -98.71 108.14 20.75 Favored 'General case' 0 C--O 1.24 0.586 0 N-CA-C 108.114 -1.069 . . . . 1.57 108.114 176.438 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A 1584 ' ' VAL . . . . . 0.534 HG12 ' HG2' ' A' 1582 ' ' ARG . 5.1 m -130.34 108.35 15.67 Favored 'Isoleucine or valine' 0 C--O 1.207 -1.147 0 CA-C-O 120.905 0.383 . . . . 2.29 111.847 179.228 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A 1585 ' ' ASP . . . . . . . . . . . . . 38.8 t70 57.37 48.11 15.39 Favored 'General case' 0 N--CA 1.479 0.985 0 CA-C-O 122.423 1.106 . . . . 2.06 110.796 175.656 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 1586 ' ' GLN . . . . . . . . . . . . . 22.8 mt-30 68.56 -7.1 0.74 Allowed 'General case' 0 N--CA 1.477 0.886 0 N-CA-C 114.905 1.446 . . . . 2.61 114.905 -179.11 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 1587 ' ' VAL . . . . . . . . . . . . . 9.6 p -99.67 126.37 53.08 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.189 0 C-N-CA 119.73 -0.788 . . . . 1.33 108.907 176.554 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 1588 ' ' LEU . . . . . 0.558 ' HB2' ' HB2' ' A' 1612 ' ' PHE . 36.0 mt -88.23 143.09 27.24 Favored 'General case' 0 C--N 1.292 -1.902 0 CA-C-N 115.593 -0.731 . . . . 2.03 109.082 179.596 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A 1589 ' ' GLN . . . . . . . . . . . . . 9.8 tt0 -135.56 134.45 39.41 Favored 'General case' 0 C--N 1.279 -2.473 0 N-CA-C 108.609 -0.886 . . . . 1.73 108.609 179.089 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 1590 ' ' LEU . . . . . . . . . . . . . 2.2 tt -134.4 133.11 40.19 Favored 'General case' 0 C--N 1.293 -1.877 0 N-CA-C 104.982 -2.229 . . . . 1.76 104.982 177.156 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 1591 ' ' VAL . . . . . . . . . . . . . 29.6 m -128.53 144.26 38.51 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.848 0 N-CA-C 113.039 0.755 . . . . 2.14 113.039 -173.585 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 1592 ' ' TYR . . . . . 0.484 ' OH ' ' HA ' ' A' 1553 ' ' CYS . 86.8 m-85 -127.95 97.1 4.69 Favored 'General case' 0 C--N 1.312 -1.061 0 N-CA-C 107.3 -1.37 . . . . 1.53 107.3 173.423 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A 1593 ' ' LYS . . . . . 0.441 ' HA ' ' HA ' ' A' 1607 ' ' LYS . 14.4 ptmm? -109.19 165.03 11.92 Favored 'General case' 0 C--N 1.296 -1.755 0 CA-C-N 115.852 -0.613 . . . . 2.72 111.361 -174.196 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A 1594 ' ' ASP . . . . . . . . . . . . . 2.1 m-20 58.08 59.91 2.91 Favored 'General case' 0 CA--C 1.507 -0.688 0 C-N-CA 125.34 1.456 . . . . 1.45 114.195 172.802 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 1595 ' ' GLY . . . . . . . . . . . . . . . -86.65 -77.38 1.24 Allowed Glycine 0 N--CA 1.435 -1.381 0 N-CA-C 109.911 -1.276 . . . . 0.83 109.911 174.461 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 1596 ' ' SER . . . . . . . . . . . . . 51.1 m -114.04 145.79 34.32 Favored Pre-proline 0 C--N 1.299 -1.613 0 N-CA-C 109.824 -0.436 . . . . 1.96 109.824 178.147 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 1597 ' ' PRO . . . . . . . . . . . . . 52.2 Cg_exo -59.83 133.37 50.49 Favored 'Trans proline' 0 C--N 1.351 0.709 0 C-N-CA 123.173 2.582 . . . . 1.34 110.41 175.284 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 1598 ' ' CYS . . . . . . . . . . . . . 47.9 t -95.78 130.28 32.08 Favored Pre-proline 0 C--N 1.292 -1.892 0 CA-C-N 115.628 -0.714 . . . . 1.19 110.136 -176.124 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 1599 ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -75.11 -9.64 20.71 Favored 'Trans proline' 0 C--N 1.35 0.63 0 C-N-CA 123.31 2.673 . . . . 1.88 113.551 -177.502 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 1600 ' ' SER . . . . . 0.416 ' HB2' ' SG ' ' A' 1634 ' ' CYS . 48.6 m -69.11 -26.46 64.92 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 120.75 0.31 . . . . 2.19 111.312 179.873 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A 1601 ' ' LYS . . . . . 0.619 ' HB3' HD12 ' A' 1604 ' ' LEU . 6.0 tmtm? -156.65 114.58 3.25 Favored 'General case' 0 C--N 1.314 -0.972 0 N-CA-C 107.11 -1.441 . . . . 4.21 107.11 -179.003 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A 1602 ' ' SER . . . . . . . . . . . . . 18.5 m -64.27 105.53 0.92 Allowed 'General case' 0 C--N 1.304 -1.37 0 CA-C-O 121.271 0.558 . . . . 3.82 110.26 179.811 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 1603 ' ' GLY . . . . . . . . . . . . . . . 125.06 -7.5 8.13 Favored Glycine 0 N--CA 1.441 -1.026 0 N-CA-C 110.617 -0.993 . . . . 2.45 110.617 -176.357 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 1604 ' ' LEU . . . . . 0.619 HD12 ' HB3' ' A' 1601 ' ' LYS . 1.4 mt -100.88 160.76 14.1 Favored 'General case' 0 C--N 1.318 -0.781 0 C-N-CA 122.808 0.443 . . . . 2.06 110.563 177.227 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A 1605 ' ' SER . . . . . . . . . . . . . 28.8 m -131.57 -169.37 2.18 Favored 'General case' 0 C--N 1.294 -1.828 0 N-CA-C 106.319 -1.734 . . . . 1.75 106.319 177.445 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 1606 ' ' TYR . . . . . . . . . . . . . 85.1 m-85 -108.67 131.68 54.67 Favored 'General case' 0 N--CA 1.412 -2.337 0 N-CA-C 106.257 -1.757 . . . . 1.59 106.257 -179.884 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 1607 ' ' LYS . . . . . 0.441 ' HA ' ' HA ' ' A' 1593 ' ' LYS . 20.5 ptmt -125.63 125.13 42.62 Favored 'General case' 0 N--CA 1.409 -2.484 0 O-C-N 124.145 0.903 . . . . 2.21 110.918 -177.798 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A 1608 ' ' SER . . . . . 0.658 ' HA ' ' HB2' ' A' 1636 ' ' LEU . 49.7 m -98.87 122.86 42.66 Favored 'General case' 0 C--N 1.301 -1.528 0 N-CA-C 110.205 -0.295 . . . . 1.48 110.205 178.616 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A 1609 ' ' VAL . . . . . . . . . . . . . 84.0 t -119.8 126.37 75.23 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.846 0 C-N-CA 123.381 0.672 . . . . 1.57 109.261 179.908 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 1610 ' ' ILE . . . . . 0.472 HG13 ' HB2' ' A' 1638 ' ' PHE . 3.4 mp -115.67 118.03 57.49 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.832 0 N-CA-C 109.123 -0.695 . . . . 1.47 109.123 177.328 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A 1611 ' ' SER . . . . . . . . . . . . . 44.8 p -100.95 120.99 40.97 Favored 'General case' 0 N--CA 1.436 -1.139 0 CA-C-O 120.946 0.403 . . . . 1.84 110.095 176.505 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 1612 ' ' PHE . . . . . 0.558 ' HB2' ' HB2' ' A' 1588 ' ' LEU . 36.2 m-85 -97.68 104.11 16.1 Favored 'General case' 0 C--N 1.302 -1.476 0 C-N-CA 123.404 0.682 . . . . 0.86 109.607 -177.351 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A 1613 ' ' VAL . . . . . 0.55 ' O ' ' HA ' ' A' 1641 ' ' HIS . 46.1 t -103.5 131.88 51.05 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.502 0 N-CA-C 108.534 -0.913 . . . . 1.32 108.534 -178.801 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A 1614 ' ' CYS . . . . . 0.574 ' HA ' ' O ' ' A' 1642 ' ' THR . 0.8 OUTLIER -70.06 101.64 1.86 Allowed 'General case' 0 C--N 1.305 -1.355 0 N-CA-C 115.518 1.673 . . . . 1.39 115.518 -178.167 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A 1615 ' ' ARG . . . . . 0.584 ' HB3' ' HB3' ' A' 1641 ' ' HIS . 75.9 ttt180 -137.81 107.07 8.25 Favored Pre-proline 0 C--N 1.323 -0.545 0 C-N-CA 124.221 1.009 . . . . 4.34 108.304 173.84 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A 1616 ' ' PRO . . . . . 0.473 ' HB3' ' HG3' ' A' 1648 ' ' PRO . 58.9 Cg_endo -69.75 64.45 1.79 Allowed 'Trans proline' 0 CA--C 1.546 1.087 0 C-N-CA 123.562 2.841 . . . . 1.5 115.194 -177.288 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A 1617 ' ' GLU . . . . . . . . . . . . . 29.5 mm-40 -129.96 27.66 5.13 Favored 'General case' 0 C--N 1.311 -1.081 0 N-CA-C 109.025 -0.731 . . . . 3.21 109.025 176.403 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 1618 ' ' ALA . . . . . . . . . . . . . . . 70.34 -43.14 0.54 Allowed 'General case' 0 N--CA 1.496 1.862 0 C-N-CA 125.51 1.524 . . . . 2.91 111.213 -173.048 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 1619 ' ' GLY . . . . . . . . . . . . . . . 175.62 -156.02 21.05 Favored Glycine 0 N--CA 1.419 -2.498 0 N-CA-C 106.984 -2.447 . . . . 3.35 106.984 178.093 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 1620 ' ' PRO . . . . . 0.525 ' HD3' ' HD1' ' A' 1640 ' ' TRP . 75.4 Cg_exo -54.85 -52.61 7.62 Favored 'Trans proline' 0 N--CA 1.474 0.37 0 C-N-CA 122.326 2.017 . . . . 6.61 108.489 172.642 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A 1621 ' ' THR . . . . . 0.439 HG23 ' H ' ' A' 1622 ' ' ASN . 3.0 t -132.0 -52.45 0.97 Allowed 'General case' 0 N--CA 1.416 -2.129 0 N-CA-C 106.162 -1.792 . . . . 5.03 106.162 166.678 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A 1622 ' ' ASN . . . . . 0.439 ' H ' HG23 ' A' 1621 ' ' THR . 27.5 t-20 -138.03 -68.92 0.45 Allowed 'General case' 0 CA--C 1.494 -1.176 0 CA-C-O 122.438 1.113 . . . . 3.58 110.23 163.322 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A 1623 ' ' ARG . . . . . 0.632 ' HD3' ' HA ' ' A' 1540 ' ' ALA . 3.5 ptp180 -75.78 149.38 83.15 Favored Pre-proline 0 C--N 1.283 -2.299 0 CA-C-N 112.456 -2.156 . . . . 4.09 111.537 -177.509 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A 1624 ' ' PRO . . . . . 0.654 ' HB3' ' HB2' ' A' 1640 ' ' TRP . 18.6 Cg_endo -60.2 159.7 25.54 Favored 'Trans proline' 0 C--N 1.364 1.357 0 C-N-CA 124.274 3.316 . . . . 2.86 112.427 177.824 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A 1625 ' ' MET . . . . . 0.513 ' HE2' ' HB3' ' A' 1620 ' ' PRO . 72.2 mtm -119.81 150.46 40.39 Favored 'General case' 0 CA--C 1.494 -1.189 0 CA-C-O 121.226 0.536 . . . . 2.73 111.347 -178.313 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A 1626 ' ' LEU . . . . . 0.419 HD11 ' O ' ' A' 1637 ' ' PHE . 34.4 tp -83.27 108.98 16.85 Favored 'General case' 0 N--CA 1.43 -1.447 0 N-CA-C 106.632 -1.618 . . . . 1.94 106.632 172.572 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A 1627 ' ' ILE . . . . . . . . . . . . . 21.2 pt -85.48 -26.04 6.6 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.965 0 N-CA-C 112.346 0.499 . . . . 1.75 112.346 -173.992 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 1628 ' ' SER . . . . . 0.521 ' HG ' ' HB2' ' A' 1637 ' ' PHE . 23.5 p -167.73 149.98 5.7 Favored 'General case' 0 N--CA 1.438 -1.042 0 CA-C-N 116.699 -0.228 . . . . 1.85 110.591 -177.711 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A 1629 ' ' LEU . . . . . 0.751 HD12 HD11 ' A' 1636 ' ' LEU . 33.1 tp -128.35 108.58 10.69 Favored 'General case' 0 N--CA 1.42 -1.956 0 O-C-N 123.812 0.695 . . . . 2.12 109.128 177.612 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A 1630 ' ' ASP . . . . . . . . . . . . . 10.0 t70 -83.94 98.44 9.8 Favored 'General case' 0 C--N 1.301 -1.52 0 N-CA-C 106.459 -1.682 . . . . 0.87 106.459 176.936 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 1631 ' ' LYS . . . . . . . . . . . . . 96.8 mttt -71.65 -20.87 61.89 Favored 'General case' 0 C--N 1.312 -1.054 0 N-CA-C 113.489 0.922 . . . . 2.76 113.489 -173.024 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 1632 ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -85.91 -39.31 17.1 Favored 'General case' 0 C--N 1.324 -0.529 0 N-CA-C 113.413 0.894 . . . . 2.55 113.413 -179.908 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A 1633 ' ' THR . . . . . . . . . . . . . 42.2 p -101.21 10.13 41.13 Favored 'General case' 0 C--N 1.315 -0.913 0 C-N-CA 119.459 -0.896 . . . . 1.92 111.547 177.877 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 1634 ' ' CYS . . . . . 0.416 ' SG ' ' HB2' ' A' 1600 ' ' SER . 10.9 m 54.98 43.92 29.08 Favored 'General case' 0 C--O 1.245 0.833 0 C-N-CA 124.772 1.229 . . . . 0.89 111.714 170.177 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A 1635 ' ' THR . . . . . . . . . . . . . 20.9 m -108.16 122.1 46.21 Favored 'General case' 0 N--CA 1.422 -1.861 0 CA-C-N 115.338 -0.846 . . . . 1.31 110.72 -176.178 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 1636 ' ' LEU . . . . . 0.751 HD11 HD12 ' A' 1629 ' ' LEU . 3.0 mm? -93.07 110.15 21.63 Favored 'General case' 0 C--N 1.312 -1.057 0 CA-C-N 115.296 -0.865 . . . . 1.97 108.925 179.986 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A 1637 ' ' PHE . . . . . 0.521 ' HB2' ' HG ' ' A' 1628 ' ' SER . 99.1 m-85 -100.51 99.21 9.78 Favored 'General case' 0 C--O 1.246 0.918 0 CA-C-O 120.797 0.332 . . . . 0.92 111.024 -179.132 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A 1638 ' ' PHE . . . . . 0.472 ' HB2' HG13 ' A' 1610 ' ' ILE . 94.9 m-85 -101.7 141.9 33.86 Favored 'General case' 0 C--N 1.299 -1.588 0 N-CA-C 108.72 -0.844 . . . . 0.7 108.72 176.759 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A 1639 ' ' SER . . . . . . . . . . . . . 16.7 t -134.84 137.87 43.68 Favored 'General case' 0 N--CA 1.412 -2.364 0 N-CA-C 109.083 -0.71 . . . . 1.46 109.083 -178.913 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 1640 ' ' TRP . . . . . 0.654 ' HB2' ' HB3' ' A' 1624 ' ' PRO . 7.0 t90 -129.17 99.17 5.15 Favored 'General case' 0 N--CA 1.415 -2.188 0 N-CA-C 108.268 -1.012 . . . . 0.92 108.268 179.905 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A 1641 ' ' HIS . . . . . 0.584 ' HB3' ' HB3' ' A' 1615 ' ' ARG . 17.9 m-70 -81.24 95.45 6.95 Favored 'General case' 0 C--N 1.302 -1.463 0 N-CA-C 107.785 -1.191 . . . . 3.18 107.785 174.719 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A 1642 ' ' THR . . . . . 0.574 ' O ' ' HA ' ' A' 1614 ' ' CYS . 13.4 t -138.82 149.52 62.25 Favored Pre-proline 0 C--N 1.305 -1.354 0 CA-C-N 114.895 -1.048 . . . . 1.48 109.506 -169.375 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A 1643 ' ' PRO . . . . . 0.434 ' HB3' ' HA ' ' A' 1616 ' ' PRO . 58.6 Cg_endo -72.12 0.06 7.83 Favored 'Trans proline' 0 C--N 1.36 1.134 0 C-N-CA 123.833 3.022 . . . . 1.09 112.8 179.211 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A 1644 ' ' LEU . . . . . . . . . . . . . 62.5 mt -79.85 4.69 15.82 Favored 'General case' 0 C--N 1.315 -0.892 0 C-N-CA 123.214 0.606 . . . . 2.08 111.171 -178.987 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 1645 ' ' ALA . . . . . . . . . . . . . . . -106.66 -42.22 5.03 Favored 'General case' 0 C--N 1.316 -0.879 0 CA-C-N 116.221 -0.445 . . . . 1.37 110.721 176.923 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 1646 ' ' CYS . . . . . 0.423 ' N ' ' HB3' ' A' 1614 ' ' CYS . 10.7 m -143.23 144.64 32.23 Favored 'General case' 0 C--N 1.32 -0.684 0 N-CA-C 106.858 -1.534 . . . . 1.7 106.858 -179.303 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A 1647 ' ' GLU . . . . . . . . . . . . . 47.1 mt-10 -87.07 127.33 59.79 Favored Pre-proline 0 C--N 1.3 -1.565 0 N-CA-C 109.988 -0.375 . . . . 2.92 109.988 178.816 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 1648 ' ' PRO . . . . . 0.473 ' HG3' ' HB3' ' A' 1616 ' ' PRO . 36.5 Cg_endo -67.28 129.11 19.67 Favored 'Trans proline' 0 N--CA 1.453 -0.885 0 C-N-CA 122.158 1.905 . . . . 3.19 109.987 172.731 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A 1649 ' ' GLU . . . . . . . . . . . . . 13.5 pt-20 . . . . . 0 C--N 1.3 -1.574 0 CA-C-O 117.904 -1.046 . . . . 5.06 110.58 177.945 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A 1508 ' ' MET . . . . . . . . . . . . . 26.3 ptm . . . . . 0 C--O 1.242 0.666 0 N-CA-C 112.071 0.397 . . . . 8.58 112.071 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A 1509 ' ' LYS . . . . . . . . . . . . . 13.7 ptmm? -120.79 152.19 38.65 Favored 'General case' 0 C--N 1.315 -0.904 0 O-C-N 121.754 -0.591 . . . . 6.8 109.578 179.764 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 1510 ' ' SER . . . . . . . . . . . . . 8.4 m -137.77 112.11 8.64 Favored 'General case' 0 C--N 1.304 -1.381 0 N-CA-C 109.627 -0.509 . . . . 4.48 109.627 -179.292 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 1511 ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -115.54 1.97 13.72 Favored 'General case' 0 C--N 1.308 -1.199 0 CA-C-O 122.201 1.0 . . . . 3.08 109.266 178.745 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A 1512 ' ' GLU . . . . . 0.741 ' HG3' ' HA ' ' A' 1518 ' ' VAL . 2.9 mp0 -75.73 -6.5 50.89 Favored 'General case' 0 C--N 1.318 -0.793 0 CA-C-N 113.985 -1.462 . . . . 4.46 111.465 -175.544 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A 1513 ' ' HIS . . . . . . . . . . . . . 18.6 m-70 -97.2 -18.7 19.09 Favored 'General case' 0 C--N 1.318 -0.765 0 N-CA-C 108.223 -1.029 . . . . 6.25 108.223 -179.41 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 1514 ' ' ASP . . . . . 0.455 ' O ' ' HE3' ' A' 1579 ' ' LYS . 24.3 t70 -87.65 -42.86 12.37 Favored 'General case' 0 CA--C 1.496 -1.101 0 CA-C-N 114.792 -1.094 . . . . 3.7 109.661 -178.356 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A 1515 ' ' ASP . . . . . . . . . . . . . 24.7 t0 -147.16 162.61 38.52 Favored 'General case' 0 C--N 1.306 -1.303 0 N-CA-C 108.782 -0.821 . . . . 2.54 108.782 -179.526 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 1516 ' ' CYS . . . . . . . . . . . . . 9.6 m -78.2 54.03 1.31 Allowed 'General case' 0 C--N 1.31 -1.128 0 C-N-CA 123.828 0.851 . . . . 1.25 111.362 -175.249 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 1517 ' ' GLN . . . . . . . . . . . . . 11.0 pt20 -132.62 122.78 25.23 Favored 'General case' 0 C--N 1.296 -1.724 0 N-CA-C 108.605 -0.887 . . . . 2.36 108.605 178.779 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 1518 ' ' VAL . . . . . 0.741 ' HA ' ' HG3' ' A' 1512 ' ' GLU . 7.4 p -109.11 127.25 65.95 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.967 0 CA-C-O 121.621 0.724 . . . . 2.34 111.536 -175.364 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A 1519 ' ' THR . . . . . . . . . . . . . 5.2 m -92.43 118.65 31.17 Favored 'General case' 0 N--CA 1.421 -1.902 0 CA-C-N 115.569 -0.741 . . . . 2.04 109.168 178.312 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 1520 ' ' ASN . . . . . 0.42 ' CG ' HG23 ' A' 1523 ' ' THR . 32.8 t-20 -84.11 113.83 50.59 Favored Pre-proline 0 C--N 1.31 -1.119 0 N-CA-C 107.513 -1.292 . . . . 2.12 107.513 175.918 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A 1521 ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -73.82 -9.58 22.53 Favored 'Trans proline' 0 C--N 1.354 0.834 0 C-N-CA 122.63 2.22 . . . . 2.59 113.475 -173.27 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 1522 ' ' SER . . . . . . . . . . . . . 19.5 m -94.32 -50.96 5.01 Favored 'General case' 0 N--CA 1.427 -1.615 0 C-N-CA 120.825 -0.35 . . . . 2.65 111.365 -179.022 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 1523 ' ' THR . . . . . 0.42 HG23 ' CG ' ' A' 1520 ' ' ASN . 13.8 t -89.79 -12.86 38.01 Favored 'General case' 0 CA--C 1.552 1.041 0 C-N-CA 119.805 -0.758 . . . . 2.33 111.184 -178.888 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A 1524 ' ' GLY . . . . . . . . . . . . . . . 73.41 20.36 79.85 Favored Glycine 0 C--O 1.222 -0.619 0 CA-C-N 116.062 -0.517 . . . . 1.96 113.634 177.698 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 1525 ' ' HIS . . . . . . . . . . . . . 9.8 t60 -101.23 136.99 40.16 Favored 'General case' 0 C--N 1.31 -1.126 0 O-C-N 122.222 -0.575 . . . . 2.44 109.466 -177.801 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 1526 ' ' LEU . . . . . . . . . . . . . 65.1 tp -95.3 106.25 18.27 Favored 'General case' 0 C--N 1.303 -1.449 0 N-CA-C 108.346 -0.983 . . . . 2.19 108.346 177.906 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 1527 ' ' PHE . . . . . 0.495 ' CE1' ' HA ' ' A' 1646 ' ' CYS . 93.9 m-85 -89.53 104.94 17.45 Favored 'General case' 0 C--N 1.302 -1.476 0 CA-C-O 121.417 0.627 . . . . 1.61 109.441 -179.055 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A 1528 ' ' ASP . . . . . . . . . . . . . 10.9 t70 -89.9 114.67 26.49 Favored 'General case' 0 C--N 1.296 -1.735 0 CA-C-N 115.55 -0.75 . . . . 2.18 109.247 -179.843 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 1529 ' ' LEU . . . . . 0.446 ' HA ' ' HG ' ' A' 1532 ' ' LEU . 37.6 mt -111.04 8.38 21.86 Favored 'General case' 0 C--N 1.295 -1.764 0 N-CA-C 107.918 -1.141 . . . . 2.04 107.918 178.983 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A 1530 ' ' SER . . . . . 0.424 ' HA ' ' SG ' ' A' 1553 ' ' CYS . 22.9 t -80.31 -45.75 17.31 Favored 'General case' 0 N--CA 1.439 -0.996 0 CA-C-N 114.597 -1.183 . . . . 1.44 109.307 -175.482 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A 1531 ' ' SER . . . . . . . . . . . . . 14.1 p -74.2 -16.86 60.96 Favored 'General case' 0 N--CA 1.438 -1.062 0 CA-C-N 115.514 -0.766 . . . . 1.63 111.589 -179.329 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 1532 ' ' LEU . . . . . 0.485 HD12 HD12 ' A' 1644 ' ' LEU . 71.6 mt -65.96 -57.21 8.34 Favored 'General case' 0 CA--C 1.508 -0.651 0 CA-C-O 121.116 0.484 . . . . 2.32 111.398 -179.506 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A 1533 ' ' SER . . . . . . . . . . . . . 28.1 t -81.23 139.05 35.71 Favored 'General case' 0 N--CA 1.427 -1.583 0 CA-C-N 115.066 -0.97 . . . . 2.57 111.24 -173.037 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 1534 ' ' GLY . . . . . . . . . . . . . . . -85.06 171.68 46.73 Favored Glycine 0 N--CA 1.416 -2.641 0 N-CA-C 107.65 -2.18 . . . . 1.89 107.65 170.652 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 1535 ' ' ARG . . . . . . . . . . . . . 38.5 ttm180 -77.7 -15.68 58.99 Favored 'General case' 0 C--N 1.3 -1.569 0 CA-C-O 121.91 0.862 . . . . 4.44 110.764 -176.33 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 1536 ' ' ALA . . . . . . . . . . . . . . . -84.23 -11.4 56.55 Favored 'General case' 0 C--O 1.242 0.668 0 N-CA-C 108.881 -0.785 . . . . 2.07 108.881 174.411 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 1537 ' ' GLY . . . . . . . . . . . . . . . 74.92 -150.3 40.88 Favored Glycine 0 N--CA 1.426 -1.991 0 CA-C-N 114.701 -1.136 . . . . 1.2 113.459 178.17 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 1538 ' ' PHE . . . . . 0.466 ' CD1' HD11 ' A' 1552 ' ' ILE . 95.5 m-85 -120.98 146.77 46.32 Favored 'General case' 0 C--N 1.295 -1.803 0 N-CA-C 107.765 -1.198 . . . . 1.98 107.765 177.746 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A 1539 ' ' THR . . . . . . . . . . . . . 30.2 p -99.38 113.53 25.91 Favored 'General case' 0 C--N 1.283 -2.298 0 CA-C-O 121.323 0.582 . . . . 1.97 109.993 179.591 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 1540 ' ' ALA . . . . . 0.686 ' HB3' HG11 ' A' 1548 ' ' VAL . . . -93.84 148.56 22.02 Favored 'General case' 0 C--N 1.296 -1.726 0 CA-C-N 115.724 -0.671 . . . . 1.39 109.899 -177.575 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A 1541 ' ' ALA . . . . . . . . . . . . . . . -85.7 128.38 34.77 Favored 'General case' 0 N--CA 1.439 -0.982 0 N-CA-C 109.025 -0.731 . . . . 1.86 109.025 178.51 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 1542 ' ' TYR . . . . . 0.538 ' HD2' ' HB2' ' A' 1545 ' ' SER . 72.9 t80 -136.54 171.79 13.97 Favored 'General case' 0 C--N 1.296 -1.758 0 CA-C-N 116.007 -0.542 . . . . 2.4 109.826 -177.667 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A 1543 ' ' SER . . . . . . . . . . . . . 3.6 m -45.67 -150.79 0.0 OUTLIER 'General case' 0 CA--C 1.573 1.855 0 C-N-CA 130.466 3.507 . . . . 2.58 114.147 177.537 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 1544 ' ' LYS . . . . . . . . . . . . . 22.6 tptm -39.55 -37.22 0.46 Allowed 'General case' 0 N--CA 1.495 1.799 0 N-CA-C 113.531 0.937 . . . . 4.24 113.531 178.842 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 1545 ' ' SER . . . . . 0.538 ' HB2' ' HD2' ' A' 1542 ' ' TYR . 15.7 m -65.08 -21.22 66.78 Favored 'General case' 0 CA--C 1.557 1.246 0 N-CA-C 112.023 0.379 . . . . 3.6 112.023 178.401 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A 1546 ' ' GLY . . . . . . . . . . . . . . . 82.45 -67.18 3.76 Favored Glycine 0 N--CA 1.443 -0.839 0 N-CA-C 113.866 0.307 . . . . 1.66 113.866 176.154 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 1547 ' ' VAL . . . . . . . . . . . . . 72.0 t -128.67 144.48 37.88 Favored 'Isoleucine or valine' 0 N--CA 1.419 -1.997 0 C-N-CA 122.985 0.514 . . . . 2.23 110.228 -175.031 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 1548 ' ' VAL . . . . . 0.686 HG11 ' HB3' ' A' 1540 ' ' ALA . 2.6 p -133.69 127.58 52.99 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.219 0 N-CA-C 108.309 -0.997 . . . . 1.59 108.309 173.285 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A 1549 ' ' TYR . . . . . 0.507 ' CZ ' ' HA2' ' A' 1568 ' ' GLY . 0.6 OUTLIER -101.49 133.23 46.46 Favored 'General case' 0 C--N 1.303 -1.43 0 CA-C-O 121.756 0.789 . . . . 1.58 112.296 -179.188 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A 1550 ' ' MET . . . . . . . . . . . . . 43.2 ttp -144.51 129.33 18.32 Favored 'General case' 0 C--N 1.296 -1.751 0 CA-C-N 114.666 -1.152 . . . . 2.08 109.704 -176.37 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 1551 ' ' SER . . . . . . . . . . . . . 50.5 m -88.16 139.8 30.13 Favored 'General case' 0 C--N 1.289 -2.035 0 N-CA-C 108.671 -0.863 . . . . 1.9 108.671 178.207 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 1552 ' ' ILE . . . . . 0.472 HD13 ' HG3' ' A' 1624 ' ' PRO . 1.4 mp -87.13 -6.61 10.7 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.2 0 CA-C-O 122.773 1.273 . . . . 2.04 109.462 178.876 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A 1553 ' ' CYS . . . . . 0.424 ' SG ' ' HA ' ' A' 1530 ' ' SER . 54.1 t -157.8 138.28 12.84 Favored 'General case' 0 N--CA 1.416 -2.132 0 CA-C-N 114.179 -1.373 . . . . 1.43 108.843 174.501 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A 1554 ' ' GLY . . . . . . . . . . . . . . . 74.09 -169.35 53.89 Favored Glycine 0 N--CA 1.434 -1.497 0 O-C-N 123.958 0.786 . . . . 1.23 113.816 174.635 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 1555 ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -72.91 153.44 41.0 Favored 'General case' 0 C--N 1.311 -1.068 0 CA-C-N 114.805 -0.697 . . . . 1.8 111.362 179.412 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 1556 ' ' ASN . . . . . . . . . . . . . 25.4 t-20 -105.4 139.31 40.23 Favored 'General case' 0 N--CA 1.414 -2.227 0 CA-C-N 114.509 -1.223 . . . . 2.63 108.01 177.494 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 1557 ' ' GLU . . . . . . . . . . . . . 45.9 mt-10 -102.53 174.9 5.69 Favored 'General case' 0 C--N 1.29 -2.013 0 CA-C-N 115.864 -0.607 . . . . 3.79 110.856 -178.251 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 1558 ' ' ASN . . . . . . . . . . . . . 46.5 m-80 72.44 12.17 5.64 Favored 'General case' 0 N--CA 1.486 1.355 0 C-N-CA 124.685 1.194 . . . . 1.59 110.597 -176.026 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 1559 ' ' CYS . . . . . 0.627 ' SG ' ' HD2' ' A' 1560 ' ' PRO . 22.5 t -160.69 152.45 16.49 Favored Pre-proline 0 C--N 1.295 -1.784 0 N-CA-C 103.856 -2.646 . . . . 0.94 103.856 179.168 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A 1560 ' ' PRO . . . . . 0.627 ' HD2' ' SG ' ' A' 1559 ' ' CYS . 39.2 Cg_exo -24.24 112.59 0.02 OUTLIER 'Trans proline' 0 C--N 1.368 1.591 0 C-N-CA 125.253 3.968 . . . . 1.53 115.472 179.075 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A 1561 ' ' PRO . . . . . 0.411 ' HD2' ' HA ' ' A' 1560 ' ' PRO . 9.6 Cg_endo -53.76 110.63 0.52 Allowed 'Trans proline' 0 C--O 1.237 0.475 0 C-N-CA 123.685 2.923 . . . . 1.82 112.58 179.846 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A 1562 ' ' GLY . . . . . . . . . . . . . . . 133.78 -16.26 4.53 Favored Glycine 0 N--CA 1.439 -1.121 0 C-N-CA 120.528 -0.844 . . . . 0.81 111.84 179.254 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 1563 ' ' VAL . . . . . 0.406 ' HA ' ' HA ' ' A' 1576 ' ' LYS . 4.3 m -86.83 157.35 3.25 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.264 0 N-CA-C 107.586 -1.264 . . . . 1.73 107.586 178.834 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A 1564 ' ' GLY . . . . . . . . . . . . . . . -111.44 -22.93 5.91 Favored Glycine 0 N--CA 1.444 -0.791 0 C-N-CA 120.459 -0.877 . . . . 0.72 112.545 -177.904 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 1565 ' ' ALA . . . . . . . . . . . . . . . -141.51 125.45 17.15 Favored 'General case' 0 C--O 1.247 0.957 0 N-CA-C 109.553 -0.536 . . . . 1.14 109.553 -179.437 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 1566 ' ' CYS . . . . . . . . . . . . . 53.9 t -148.94 132.91 17.14 Favored 'General case' 0 C--N 1.314 -0.946 0 CA-C-N 116.324 -0.398 . . . . 0.51 109.999 -176.476 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 1567 ' ' PHE . . . . . . . . . . . . . 35.0 m-85 -63.82 134.82 55.94 Favored 'General case' 0 N--CA 1.474 0.742 0 N-CA-C 108.106 -1.072 . . . . 1.22 108.106 177.205 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 1568 ' ' GLY . . . . . 0.507 ' HA2' ' CZ ' ' A' 1549 ' ' TYR . . . -73.67 -30.74 61.46 Favored Glycine 0 CA--C 1.498 -0.989 0 CA-C-N 116.42 -0.354 . . . . 1.08 113.727 -173.199 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A 1569 ' ' GLN . . . . . . . . . . . . . 8.5 tp-100 -82.45 -56.83 3.64 Favored 'General case' 0 C--N 1.304 -1.376 0 CA-C-O 121.359 0.6 . . . . 3.05 110.511 -179.725 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 1570 ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -72.06 -27.29 62.59 Favored 'General case' 0 N--CA 1.426 -1.654 0 CA-C-N 114.963 -1.017 . . . . 2.44 111.33 -174.974 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A 1571 ' ' ARG . . . . . . . . . . . . . 42.7 ttp180 52.87 60.75 3.58 Favored 'General case' 0 C--O 1.235 0.315 0 CA-C-O 121.85 0.833 . . . . 4.48 109.687 -176.781 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 1572 ' ' ILE . . . . . . . . . . . . . 40.4 mm -131.58 129.55 61.78 Favored 'Isoleucine or valine' 0 C--O 1.251 1.165 0 N-CA-C 106.915 -1.513 . . . . 1.94 106.915 179.405 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 1573 ' ' SER . . . . . . . . . . . . . 35.7 t -73.04 140.04 46.99 Favored 'General case' 0 C--N 1.303 -1.437 0 O-C-N 124.126 0.891 . . . . 1.25 111.357 -178.373 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 1574 ' ' VAL . . . . . . . . . . . . . 18.0 m -133.06 19.77 1.44 Allowed 'Isoleucine or valine' 0 C--N 1.314 -0.937 0 CA-C-N 115.815 -0.63 . . . . 1.61 110.828 174.587 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 1575 ' ' GLY . . . . . . . . . . . . . . . 173.73 126.58 0.92 Allowed Glycine 0 N--CA 1.44 -1.058 0 C-N-CA 120.627 -0.797 . . . . 0.65 111.869 178.336 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 1576 ' ' LYS . . . . . 0.406 ' HA ' ' HA ' ' A' 1563 ' ' VAL . 59.0 tttp -82.98 147.45 28.19 Favored 'General case' 0 C--O 1.239 0.552 0 N-CA-C 107.57 -1.271 . . . . 3.33 107.57 179.263 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A 1577 ' ' ALA . . . . . . . . . . . . . . . -68.92 79.16 0.31 Allowed 'General case' 0 N--CA 1.475 0.804 0 N-CA-C 113.041 0.756 . . . . 1.31 113.041 -174.151 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 1578 ' ' ASN . . . . . . . . . . . . . 32.0 m-80 -96.67 113.41 24.97 Favored 'General case' 0 C--N 1.297 -1.716 0 N-CA-C 108.107 -1.071 . . . . 2.24 108.107 175.519 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 1579 ' ' LYS . . . . . 0.455 ' HE3' ' O ' ' A' 1514 ' ' ASP . 52.8 pttt -96.92 109.2 21.98 Favored 'General case' 0 C--N 1.291 -1.972 0 CA-C-O 121.311 0.577 . . . . 2.34 109.712 -178.859 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A 1580 ' ' ARG . . . . . 0.419 ' HA ' ' O ' ' A' 1512 ' ' GLU . 32.7 ttm180 -158.43 94.18 1.26 Allowed 'General case' 0 N--CA 1.43 -1.445 0 CA-C-N 115.033 -0.985 . . . . 4.19 109.435 -177.36 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A 1581 ' ' LEU . . . . . 0.409 ' CB ' ' HB ' ' A' 1518 ' ' VAL . 4.4 mm? -85.52 124.5 32.16 Favored 'General case' 0 C--N 1.302 -1.491 0 CA-C-N 116.275 -0.421 . . . . 2.39 110.554 178.011 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A 1582 ' ' ARG . . . . . . . . . . . . . 89.0 mtm180 -120.29 134.32 55.29 Favored 'General case' 0 C--N 1.29 -1.98 0 CA-C-O 121.112 0.482 . . . . 4.48 110.863 177.076 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 1583 ' ' TYR . . . . . 0.442 ' HD1' HD21 ' A' 1588 ' ' LEU . 80.1 t80 -94.9 96.84 9.58 Favored 'General case' 0 C--N 1.292 -1.904 0 N-CA-C 107.485 -1.302 . . . . 1.57 107.485 176.908 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A 1584 ' ' VAL . . . . . . . . . . . . . 36.5 t -112.3 95.16 3.6 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.287 0 CA-C-N 115.653 -0.703 . . . . 2.29 109.528 -176.176 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 1585 ' ' ASP . . . . . . . . . . . . . 35.1 t70 54.72 75.57 0.29 Allowed 'General case' 0 C--N 1.32 -0.708 0 C-N-CA 124.308 1.043 . . . . 2.06 112.472 177.775 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 1586 ' ' GLN . . . . . . . . . . . . . 34.1 tt0 68.16 -14.67 0.24 Allowed 'General case' 0 CA--C 1.574 1.888 0 C-N-CA 124.868 1.267 . . . . 2.61 114.398 176.403 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 1587 ' ' VAL . . . . . . . . . . . . . 7.5 p -118.4 129.62 74.43 Favored 'Isoleucine or valine' 0 C--O 1.25 1.09 0 O-C-N 121.273 -0.892 . . . . 1.33 111.484 -179.4 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 1588 ' ' LEU . . . . . 0.718 ' HB2' ' HB2' ' A' 1612 ' ' PHE . 3.8 mm? -81.26 157.53 25.13 Favored 'General case' 0 N--CA 1.435 -1.189 0 CA-C-N 115.23 -0.896 . . . . 2.03 110.415 179.001 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A 1589 ' ' GLN . . . . . . . . . . . . . 34.6 tt0 -148.05 134.96 20.14 Favored 'General case' 0 C--N 1.31 -1.148 0 C-N-CA 121.154 -0.218 . . . . 1.73 110.643 -174.715 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 1590 ' ' LEU . . . . . 0.452 ' HB3' ' HB ' ' A' 1610 ' ' ILE . 51.0 tp -119.39 133.39 55.74 Favored 'General case' 0 C--N 1.301 -1.507 0 N-CA-C 106.95 -1.5 . . . . 1.76 106.95 175.396 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A 1591 ' ' VAL . . . . . . . . . . . . . 52.8 t -126.99 111.63 26.31 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.537 0 CA-C-O 121.022 0.439 . . . . 2.14 111.969 -174.884 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 1592 ' ' TYR . . . . . . . . . . . . . 20.6 m-85 -101.37 93.05 5.21 Favored 'General case' 0 C--N 1.308 -1.205 0 N-CA-C 108.512 -0.921 . . . . 1.53 108.512 173.87 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 1593 ' ' LYS . . . . . . . . . . . . . 61.4 pttt -103.36 177.21 4.91 Favored 'General case' 0 C--N 1.283 -2.321 0 CA-C-N 115.569 -0.741 . . . . 2.72 109.926 -178.754 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 1594 ' ' ASP . . . . . . . . . . . . . 8.3 m-20 53.96 42.04 31.81 Favored 'General case' 0 N--CA 1.475 0.8 0 N-CA-C 113.923 1.083 . . . . 1.45 113.923 175.74 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 1595 ' ' GLY . . . . . . . . . . . . . . . -74.58 -87.49 0.24 Allowed Glycine 0 N--CA 1.445 -0.704 0 C-N-CA 120.356 -0.926 . . . . 0.83 111.069 176.477 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 1596 ' ' SER . . . . . . . . . . . . . 32.4 m -114.43 154.33 46.5 Favored Pre-proline 0 C--N 1.294 -1.807 0 N-CA-C 108.258 -1.016 . . . . 1.96 108.258 177.599 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 1597 ' ' PRO . . . . . . . . . . . . . 23.1 Cg_exo -67.03 133.32 30.65 Favored 'Trans proline' 0 C--N 1.351 0.672 0 C-N-CA 122.849 2.366 . . . . 1.34 109.997 177.153 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 1598 ' ' CYS . . . . . 0.427 ' HA ' ' HD3' ' A' 1599 ' ' PRO . 42.4 t -97.68 121.14 58.9 Favored Pre-proline 0 C--N 1.289 -2.055 0 CA-C-O 120.533 0.206 . . . . 1.19 110.768 -175.939 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A 1599 ' ' PRO . . . . . 0.427 ' HD3' ' HA ' ' A' 1598 ' ' CYS . 2.8 Cg_exo -77.52 -7.83 16.95 Favored 'Trans proline' 0 C--O 1.238 0.494 0 C-N-CA 123.23 2.62 . . . . 1.88 112.227 179.992 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A 1600 ' ' SER . . . . . 0.419 ' HB3' ' SG ' ' A' 1598 ' ' CYS . 22.8 t -75.32 -19.7 59.49 Favored 'General case' 0 C--N 1.317 -0.811 0 CA-C-N 115.831 -0.622 . . . . 2.19 110.313 -177.563 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A 1601 ' ' LYS . . . . . 0.546 ' HB3' HD12 ' A' 1604 ' ' LEU . 24.5 tptm -162.33 116.64 1.82 Allowed 'General case' 0 N--CA 1.443 -0.82 0 N-CA-C 108.556 -0.905 . . . . 4.21 108.556 178.915 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A 1602 ' ' SER . . . . . . . . . . . . . 51.4 m -61.3 123.2 17.09 Favored 'General case' 0 C--N 1.313 -1.01 0 CA-C-O 121.393 0.616 . . . . 3.82 111.588 179.202 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 1603 ' ' GLY . . . . . . . . . . . . . . . 104.94 -1.45 41.33 Favored Glycine 0 N--CA 1.439 -1.1 0 CA-C-N 115.067 -0.969 . . . . 2.45 111.004 -179.895 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 1604 ' ' LEU . . . . . 0.546 HD12 ' HB3' ' A' 1601 ' ' LYS . 3.0 mt -107.05 145.3 32.53 Favored 'General case' 0 C--N 1.31 -1.111 0 CA-C-O 121.692 0.758 . . . . 2.06 111.859 179.62 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A 1605 ' ' SER . . . . . . . . . . . . . 25.6 m -111.27 -173.94 2.35 Favored 'General case' 0 C--N 1.29 -1.987 0 N-CA-C 105.824 -1.917 . . . . 1.75 105.824 172.929 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 1606 ' ' TYR . . . . . . . . . . . . . 62.1 m-85 -101.59 128.67 47.75 Favored 'General case' 0 CA--C 1.453 -2.78 0 N-CA-C 105.792 -1.929 . . . . 1.59 105.792 178.014 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 1607 ' ' LYS . . . . . 0.493 ' O ' ' HA ' ' A' 1635 ' ' THR . 4.3 ptmm? -128.05 135.06 49.33 Favored 'General case' 0 N--CA 1.397 -3.075 0 O-C-N 124.506 1.129 . . . . 2.21 111.152 -176.813 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A 1608 ' ' SER . . . . . . . . . . . . . 35.1 t -114.98 125.89 54.13 Favored 'General case' 0 C--N 1.292 -1.921 0 N-CA-C 109.339 -0.615 . . . . 1.48 109.339 -178.753 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 1609 ' ' VAL . . . . . . . . . . . . . 41.3 t -115.14 115.39 49.31 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.814 0 CA-C-O 121.237 0.541 . . . . 1.57 110.439 178.854 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 1610 ' ' ILE . . . . . 0.66 HG13 ' HB2' ' A' 1638 ' ' PHE . 2.9 mp -102.16 113.67 39.3 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.338 0 N-CA-C 108.717 -0.845 . . . . 1.47 108.717 178.962 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A 1611 ' ' SER . . . . . . . . . . . . . 42.7 m -95.17 123.36 38.63 Favored 'General case' 0 C--N 1.284 -2.26 0 N-CA-C 109.012 -0.736 . . . . 1.84 109.012 177.367 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 1612 ' ' PHE . . . . . 0.718 ' HB2' ' HB2' ' A' 1588 ' ' LEU . 98.2 m-85 -92.62 103.51 15.9 Favored 'General case' 0 C--N 1.305 -1.353 0 N-CA-C 108.831 -0.803 . . . . 0.86 108.831 178.835 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A 1613 ' ' VAL . . . . . 0.619 ' O ' ' HA ' ' A' 1641 ' ' HIS . 24.0 t -100.2 109.23 24.51 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.883 0 N-CA-C 107.224 -1.399 . . . . 1.32 107.224 -174.918 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A 1614 ' ' CYS . . . . . 0.553 ' HA ' ' O ' ' A' 1642 ' ' THR . 31.8 m -70.23 100.47 1.7 Allowed 'General case' 0 C--N 1.279 -2.458 0 CA-C-N 115.963 -0.562 . . . . 1.39 111.516 -174.362 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A 1615 ' ' ARG . . . . . 0.414 ' HB3' ' HB3' ' A' 1641 ' ' HIS . 56.9 ttt180 -126.77 99.07 29.99 Favored Pre-proline 0 N--CA 1.439 -0.993 0 CA-C-N 115.479 -0.782 . . . . 4.34 109.412 -179.152 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A 1616 ' ' PRO . . . . . 0.435 ' HA ' ' HB3' ' A' 1643 ' ' PRO . 76.7 Cg_exo -52.43 -34.42 61.37 Favored 'Trans proline' 0 CA--C 1.534 0.489 0 C-N-CA 123.993 3.129 . . . . 1.5 113.834 177.781 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A 1617 ' ' GLU . . . . . . . . . . . . . 48.2 mt-10 -81.01 40.77 0.55 Allowed 'General case' 0 CA--C 1.545 0.753 0 N-CA-C 112.611 0.597 . . . . 3.21 112.611 -177.938 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 1618 ' ' ALA . . . . . . . . . . . . . . . -81.4 124.82 29.73 Favored 'General case' 0 C--N 1.308 -1.231 0 N-CA-C 109.079 -0.711 . . . . 2.91 109.079 178.523 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 1619 ' ' GLY . . . . . . . . . . . . . . . -84.41 -161.4 33.02 Favored Glycine 0 CA--C 1.527 0.802 0 CA-C-N 116.182 -0.463 . . . . 3.35 113.93 -177.368 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 1620 ' ' PRO . . . . . . . . . . . . . 90.8 Cg_endo -85.21 3.92 7.04 Favored 'Trans proline' 0 CA--C 1.54 0.809 0 C-N-CA 123.352 2.701 . . . . 6.61 113.928 -176.545 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 1621 ' ' THR . . . . . . . . . . . . . 14.9 m -120.33 42.79 2.88 Favored 'General case' 0 C--N 1.303 -1.439 0 N-CA-C 107.044 -1.465 . . . . 5.03 107.044 178.743 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 1622 ' ' ASN . . . . . . . . . . . . . 27.6 t-20 -102.66 109.09 20.58 Favored 'General case' 0 C--N 1.305 -1.365 0 CA-C-N 114.322 -1.308 . . . . 3.58 111.885 -174.732 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 1623 ' ' ARG . . . . . . . . . . . . . 19.8 ptp180 -151.89 156.95 34.47 Favored Pre-proline 0 C--N 1.3 -1.583 0 N-CA-C 105.048 -2.204 . . . . 4.09 105.048 175.229 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 1624 ' ' PRO . . . . . 0.472 ' HG3' HD13 ' A' 1552 ' ' ILE . 13.6 Cg_endo -56.22 115.76 2.7 Favored 'Trans proline' 0 C--O 1.237 0.433 0 C-N-CA 122.669 2.246 . . . . 2.86 112.154 -179.313 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A 1625 ' ' MET . . . . . . . . . . . . . 1.3 pmm? -106.48 147.7 29.05 Favored 'General case' 0 C--O 1.245 0.845 0 CA-C-O 120.999 0.428 . . . . 2.73 110.485 -179.216 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 1626 ' ' LEU . . . . . . . . . . . . . 52.1 tp -77.6 122.02 24.72 Favored 'General case' 0 C--N 1.317 -0.842 0 N-CA-C 107.855 -1.165 . . . . 1.94 107.855 176.837 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 1627 ' ' ILE . . . . . . . . . . . . . 39.1 pt -100.88 -32.81 3.5 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.214 0 C-N-CA 120.48 -0.488 . . . . 1.75 111.286 -179.021 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 1628 ' ' SER . . . . . . . . . . . . . 49.5 m -151.11 153.28 34.73 Favored 'General case' 0 C--N 1.314 -0.97 0 CA-C-O 120.789 0.328 . . . . 1.85 110.283 -177.589 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 1629 ' ' LEU . . . . . 0.93 HD12 ' HG ' ' A' 1636 ' ' LEU . 17.7 tp -139.12 120.39 14.79 Favored 'General case' 0 C--N 1.294 -1.809 0 N-CA-C 108.522 -0.918 . . . . 2.12 108.522 177.47 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A 1630 ' ' ASP . . . . . . . . . . . . . 23.0 t70 -118.29 107.33 13.76 Favored 'General case' 0 C--N 1.299 -1.624 0 N-CA-C 109.658 -0.497 . . . . 0.87 109.658 176.855 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 1631 ' ' LYS . . . . . . . . . . . . . 34.8 mtmm -78.74 -13.13 59.98 Favored 'General case' 0 C--N 1.303 -1.416 0 CA-C-N 115.514 -0.766 . . . . 2.76 111.07 -176.997 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 1632 ' ' GLN . . . . . . . . . . . . . 40.2 mt-30 -70.35 -42.63 71.58 Favored 'General case' 0 C--N 1.323 -0.544 0 N-CA-C 109.587 -0.523 . . . . 2.55 109.587 178.254 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 1633 ' ' THR . . . . . . . . . . . . . 35.9 p -98.27 4.2 48.77 Favored 'General case' 0 C--N 1.318 -0.765 0 CA-C-O 121.047 0.451 . . . . 1.92 110.821 175.747 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 1634 ' ' CYS . . . . . . . . . . . . . 59.1 m 56.55 38.8 29.91 Favored 'General case' 0 C--O 1.236 0.394 0 C-N-CA 124.195 0.998 . . . . 0.89 110.461 177.361 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 1635 ' ' THR . . . . . 0.493 ' HA ' ' O ' ' A' 1607 ' ' LYS . 44.2 m -119.73 131.45 55.38 Favored 'General case' 0 N--CA 1.422 -1.841 0 CA-C-N 114.945 -1.025 . . . . 1.31 111.597 -174.223 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A 1636 ' ' LEU . . . . . 0.93 ' HG ' HD12 ' A' 1629 ' ' LEU . 5.2 mp -104.12 134.89 46.61 Favored 'General case' 0 N--CA 1.434 -1.25 0 N-CA-C 108.04 -1.096 . . . . 1.97 108.04 174.838 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A 1637 ' ' PHE . . . . . . . . . . . . . 93.9 m-85 -111.42 105.83 14.57 Favored 'General case' 0 C--N 1.307 -1.279 0 CA-C-O 120.919 0.39 . . . . 0.92 111.008 -176.844 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 1638 ' ' PHE . . . . . 0.66 ' HB2' HG13 ' A' 1610 ' ' ILE . 96.4 m-85 -103.11 151.87 22.06 Favored 'General case' 0 C--N 1.306 -1.304 0 N-CA-C 109.03 -0.73 . . . . 0.7 109.03 177.398 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A 1639 ' ' SER . . . . . . . . . . . . . 49.0 m -137.08 133.82 35.82 Favored 'General case' 0 C--N 1.276 -2.598 0 N-CA-C 109.705 -0.48 . . . . 1.46 109.705 176.656 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 1640 ' ' TRP . . . . . 0.585 ' HE3' ' HE1' ' A' 1612 ' ' PHE . 12.3 t90 -115.58 120.93 41.07 Favored 'General case' 0 N--CA 1.413 -2.306 0 N-CA-C 106.274 -1.75 . . . . 0.92 106.274 174.164 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A 1641 ' ' HIS . . . . . 0.619 ' HA ' ' O ' ' A' 1613 ' ' VAL . 39.1 m-70 -93.89 92.34 7.36 Favored 'General case' 0 C--N 1.304 -1.378 0 N-CA-C 107.517 -1.29 . . . . 3.18 107.517 -177.922 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A 1642 ' ' THR . . . . . 0.724 HG23 ' HG ' ' A' 1644 ' ' LEU . 1.5 m -119.91 123.62 28.34 Favored Pre-proline 0 C--N 1.289 -2.053 0 CA-C-N 114.947 -1.024 . . . . 1.48 111.884 -167.96 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A 1643 ' ' PRO . . . . . 0.435 ' HB3' ' HA ' ' A' 1616 ' ' PRO . 31.7 Cg_exo -65.24 -29.7 55.1 Favored 'Trans proline' 0 CA--C 1.539 0.745 0 C-N-CA 123.443 2.762 . . . . 1.09 112.861 177.001 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A 1644 ' ' LEU . . . . . 0.724 ' HG ' HG23 ' A' 1642 ' ' THR . 4.4 pp -84.07 -6.76 59.46 Favored 'General case' 0 C--N 1.323 -0.562 0 N-CA-C 112.104 0.409 . . . . 2.08 112.104 -176.969 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A 1645 ' ' ALA . . . . . 0.601 ' HB1' ' HB ' ' A' 1642 ' ' THR . . . -74.14 -30.92 62.51 Favored 'General case' 0 C--N 1.306 -1.3 0 CA-C-N 116.022 -0.536 . . . . 1.37 112.165 -174.941 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A 1646 ' ' CYS . . . . . 0.495 ' HA ' ' CE1' ' A' 1527 ' ' PHE . 17.0 p -177.38 175.29 1.48 Allowed 'General case' 0 C--O 1.246 0.871 0 N-CA-C 106.999 -1.482 . . . . 1.7 106.999 175.288 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A 1647 ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 -121.19 90.98 47.85 Favored Pre-proline 0 C--N 1.299 -1.608 0 N-CA-C 108.54 -0.911 . . . . 2.92 108.54 175.871 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 1648 ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -74.62 115.53 4.33 Favored 'Trans proline' 0 C--O 1.24 0.581 0 C-N-CA 123.292 2.661 . . . . 3.19 114.158 -170.655 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 1649 ' ' GLU . . . . . . . . . . . . . 35.2 tt0 . . . . . 0 C--N 1.309 -1.154 0 N-CA-C 108.171 -1.048 . . . . 5.06 108.171 176.497 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A 1508 ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.531 0.22 0 N-CA-C 113.129 0.788 . . . . 8.58 113.129 . . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 1509 ' ' LYS . . . . . . . . . . . . . 25.6 pttm -120.3 -24.8 5.81 Favored 'General case' 0 C--O 1.232 0.148 0 C-N-CA 119.591 -0.844 . . . . 6.8 112.254 -179.295 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 1510 ' ' SER . . . . . . . . . . . . . 4.3 m -121.39 36.24 4.66 Favored 'General case' 0 C--N 1.309 -1.16 0 N-CA-C 109.286 -0.635 . . . . 4.48 109.286 -178.653 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 1511 ' ' ASN . . . . . . . . . . . . . 15.8 m120 -120.24 2.59 10.86 Favored 'General case' 0 C--N 1.312 -1.052 0 O-C-N 122.197 -0.314 . . . . 3.08 111.552 -173.681 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 1512 ' ' GLU . . . . . . . . . . . . . 7.2 mm-40 -83.51 -4.18 58.29 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 121.26 0.552 . . . . 4.46 111.371 -178.735 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 1513 ' ' HIS . . . . . . . . . . . . . 62.6 m80 -113.35 39.82 2.51 Favored 'General case' 0 C--N 1.305 -1.348 0 N-CA-C 107.664 -1.235 . . . . 6.25 107.664 172.782 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 1514 ' ' ASP . . . . . . . . . . . . . 3.3 p-10 -49.47 -79.73 0.01 OUTLIER 'General case' 0 C--O 1.232 0.181 0 CA-C-N 114.043 -1.435 . . . . 3.7 113.051 179.635 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 1515 ' ' ASP . . . . . . . . . . . . . 17.3 t70 62.16 -88.31 0.02 OUTLIER 'General case' 0 CA--C 1.551 0.991 0 C-N-CA 123.268 0.627 . . . . 2.54 109.958 -177.995 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 1516 ' ' CYS . . . . . 0.457 ' SG ' ' HD2' ' A' 1579 ' ' LYS . 97.1 m -137.09 18.96 2.98 Favored 'General case' 0 C--N 1.316 -0.874 0 CA-C-O 121.194 0.521 . . . . 1.25 110.456 175.104 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A 1517 ' ' GLN . . . . . 0.478 ' HB2' HD22 ' A' 1526 ' ' LEU . 11.2 pt20 -132.54 137.47 47.14 Favored 'General case' 0 C--N 1.302 -1.469 0 O-C-N 121.809 -0.557 . . . . 2.36 109.7 178.92 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A 1518 ' ' VAL . . . . . . . . . . . . . 10.2 p -143.55 134.87 22.83 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.664 0 CA-C-O 121.025 0.441 . . . . 2.34 110.288 -178.402 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 1519 ' ' THR . . . . . 0.763 ' HA ' ' HA ' ' A' 1526 ' ' LEU . 23.3 m -85.3 120.84 27.22 Favored 'General case' 0 C--N 1.3 -1.549 0 N-CA-C 109.327 -0.62 . . . . 2.04 109.327 178.781 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A 1520 ' ' ASN . . . . . 0.402 ' OD1' HG21 ' A' 1523 ' ' THR . 24.0 t-20 -71.98 119.71 76.02 Favored Pre-proline 0 C--N 1.314 -0.937 0 N-CA-C 109.327 -0.62 . . . . 2.12 109.327 179.131 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A 1521 ' ' PRO . . . . . . . . . . . . . 86.5 Cg_endo -75.09 -2.95 13.22 Favored 'Trans proline' 0 CA--C 1.539 0.749 0 C-N-CA 122.64 2.227 . . . . 2.59 113.953 -175.31 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 1522 ' ' SER . . . . . . . . . . . . . 32.8 m -94.11 -49.75 5.61 Favored 'General case' 0 C--N 1.305 -1.341 0 O-C-N 122.104 -0.373 . . . . 2.65 111.101 -179.375 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 1523 ' ' THR . . . . . 0.402 HG21 ' OD1' ' A' 1520 ' ' ASN . 12.0 t -96.53 -16.99 20.8 Favored 'General case' 0 CA--C 1.553 1.07 0 CA-C-O 121.255 0.55 . . . . 2.33 111.097 -179.901 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A 1524 ' ' GLY . . . . . . . . . . . . . . . 81.84 8.16 87.08 Favored Glycine 0 C--O 1.222 -0.601 0 C-N-CA 121.507 -0.378 . . . . 1.96 112.918 178.83 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 1525 ' ' HIS . . . . . . . . . . . . . 16.0 t-160 -101.69 134.97 44.01 Favored 'General case' 0 C--N 1.302 -1.47 0 N-CA-C 109.432 -0.581 . . . . 2.44 109.432 -178.306 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 1526 ' ' LEU . . . . . 0.763 ' HA ' ' HA ' ' A' 1519 ' ' THR . 6.7 tt -84.98 135.21 34.13 Favored 'General case' 0 C--N 1.303 -1.43 0 CA-C-N 116.387 -0.369 . . . . 2.19 110.735 177.819 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A 1527 ' ' PHE . . . . . . . . . . . . . 80.7 m-85 -99.8 113.03 25.27 Favored 'General case' 0 C--N 1.309 -1.195 0 N-CA-C 108.078 -1.082 . . . . 1.61 108.078 174.546 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 1528 ' ' ASP . . . . . . . . . . . . . 11.8 t70 -100.59 103.55 14.86 Favored 'General case' 0 C--N 1.302 -1.495 0 N-CA-C 108.927 -0.768 . . . . 2.18 108.927 -179.455 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 1529 ' ' LEU . . . . . 0.45 ' HA ' ' HG ' ' A' 1532 ' ' LEU . 78.7 mt -89.5 -13.81 36.63 Favored 'General case' 0 C--N 1.298 -1.65 0 N-CA-C 108.234 -1.024 . . . . 2.04 108.234 -176.145 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A 1530 ' ' SER . . . . . 0.427 ' OG ' ' HB2' ' A' 1516 ' ' CYS . 3.2 m -58.03 -54.83 42.56 Favored 'General case' 0 N--CA 1.438 -1.065 0 C-N-CA 124.788 1.235 . . . . 1.44 110.742 -179.58 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A 1531 ' ' SER . . . . . . . . . . . . . 5.6 m -81.23 1.43 32.29 Favored 'General case' 0 C--N 1.317 -0.829 0 CA-C-N 115.886 -0.597 . . . . 1.63 111.592 -175.722 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 1532 ' ' LEU . . . . . 0.45 ' HG ' ' HA ' ' A' 1529 ' ' LEU . 32.3 mt -82.41 -18.34 42.28 Favored 'General case' 0 C--N 1.319 -0.757 0 C-N-CA 120.036 -0.666 . . . . 2.32 110.661 179.507 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A 1533 ' ' SER . . . . . 0.856 ' HB2' HG22 ' A' 1552 ' ' ILE . 22.7 t -114.2 134.13 55.13 Favored 'General case' 0 N--CA 1.432 -1.341 0 N-CA-C 108.523 -0.917 . . . . 2.57 108.523 178.417 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A 1534 ' ' GLY . . . . . . . . . . . . . . . -81.93 173.46 53.53 Favored Glycine 0 N--CA 1.429 -1.768 0 N-CA-C 107.724 -2.15 . . . . 1.89 107.724 172.148 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 1535 ' ' ARG . . . . . . . . . . . . . 14.8 ttp180 -72.3 -17.8 61.84 Favored 'General case' 0 C--N 1.31 -1.151 0 CA-C-N 118.254 1.027 . . . . 4.44 110.55 -178.842 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 1536 ' ' ALA . . . . . . . . . . . . . . . -84.86 -6.92 59.35 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 116.109 -0.496 . . . . 2.07 110.198 176.423 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 1537 ' ' GLY . . . . . . . . . . . . . . . 59.84 -153.81 33.06 Favored Glycine 0 N--CA 1.447 -0.569 0 CA-C-N 115.321 -0.854 . . . . 1.2 114.126 177.366 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 1538 ' ' PHE . . . . . . . . . . . . . 96.2 m-85 -113.55 163.72 14.57 Favored 'General case' 0 C--N 1.294 -1.819 0 N-CA-C 108.027 -1.101 . . . . 1.98 108.027 178.441 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 1539 ' ' THR . . . . . . . . . . . . . 9.5 t -143.99 130.64 20.14 Favored 'General case' 0 C--N 1.287 -2.128 0 N-CA-C 108.991 -0.744 . . . . 1.97 108.991 177.88 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 1540 ' ' ALA . . . . . . . . . . . . . . . -131.96 143.72 50.3 Favored 'General case' 0 C--N 1.306 -1.307 0 N-CA-C 109.054 -0.721 . . . . 1.39 109.054 -177.374 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 1541 ' ' ALA . . . . . . . . . . . . . . . -82.14 151.46 26.95 Favored 'General case' 0 C--N 1.31 -1.124 0 CA-C-N 116.167 -0.47 . . . . 1.86 110.386 -178.991 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 1542 ' ' TYR . . . . . . . . . . . . . 26.1 t80 -152.54 175.06 13.16 Favored 'General case' 0 C--N 1.312 -1.031 0 N-CA-C 107.864 -1.162 . . . . 2.4 107.864 -177.162 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 1543 ' ' SER . . . . . . . . . . . . . 8.3 p -49.57 -150.46 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.797 0 C-N-CA 127.922 2.489 . . . . 2.58 114.853 -179.941 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 1544 ' ' LYS . . . . . . . . . . . . . 9.7 ptpp? -39.81 -28.12 0.04 OUTLIER 'General case' 0 N--CA 1.506 2.353 0 N-CA-C 114.53 1.307 . . . . 4.24 114.53 -178.245 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 1545 ' ' SER . . . . . . . . . . . . . 25.0 t -73.01 -8.55 56.22 Favored 'General case' 0 CA--C 1.555 1.146 0 N-CA-C 112.204 0.446 . . . . 3.6 112.204 177.571 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 1546 ' ' GLY . . . . . . . . . . . . . . . 81.08 -75.31 2.3 Favored Glycine 0 N--CA 1.44 -1.088 0 N-CA-C 114.643 0.617 . . . . 1.66 114.643 172.624 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 1547 ' ' VAL . . . . . . . . . . . . . 9.3 p -153.26 150.26 12.67 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.446 0 N-CA-C 109.32 -0.622 . . . . 2.23 109.32 -175.158 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 1548 ' ' VAL . . . . . . . . . . . . . 5.7 t -111.21 145.06 17.93 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.547 0 N-CA-C 108.536 -0.912 . . . . 1.59 108.536 -178.699 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 1549 ' ' TYR . . . . . . . . . . . . . 39.4 m-85 -114.54 125.27 53.6 Favored 'General case' 0 CA--C 1.501 -0.928 0 N-CA-C 107.31 -1.367 . . . . 1.58 107.31 172.926 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 1550 ' ' MET . . . . . . . . . . . . . 18.3 ptm -153.15 124.58 7.63 Favored 'General case' 0 C--N 1.298 -1.658 0 CA-C-O 121.396 0.617 . . . . 2.08 112.008 -172.672 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 1551 ' ' SER . . . . . . . . . . . . . 25.4 m -93.57 133.46 36.86 Favored 'General case' 0 C--N 1.282 -2.34 0 N-CA-C 106.88 -1.526 . . . . 1.9 106.88 176.175 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 1552 ' ' ILE . . . . . 0.856 HG22 ' HB2' ' A' 1533 ' ' SER . 1.1 tp -73.17 -18.63 18.18 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.114 0 CA-C-O 121.816 0.817 . . . . 2.04 109.629 -176.374 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A 1553 ' ' CYS . . . . . . . . . . . . . 38.4 t -161.27 138.44 8.84 Favored 'General case' 0 N--CA 1.416 -2.144 0 N-CA-C 105.923 -1.88 . . . . 1.43 105.923 173.532 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 1554 ' ' GLY . . . . . . . . . . . . . . . 101.38 -174.87 25.34 Favored Glycine 0 N--CA 1.433 -1.529 0 N-CA-C 111.17 -0.772 . . . . 1.23 111.17 178.538 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 1555 ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -103.31 151.7 22.41 Favored 'General case' 0 C--N 1.302 -1.459 0 CA-C-O 121.439 0.638 . . . . 1.8 111.776 -179.17 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 1556 ' ' ASN . . . . . . . . . . . . . 8.6 t-20 -100.67 139.11 36.82 Favored 'General case' 0 N--CA 1.42 -1.94 0 CA-C-N 114.52 -1.218 . . . . 2.63 108.3 -177.241 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 1557 ' ' GLU . . . . . . . . . . . . . 54.2 mm-40 -102.65 -7.07 22.06 Favored 'General case' 0 C--N 1.293 -1.875 0 CA-C-N 115.443 -0.799 . . . . 3.79 112.156 -172.404 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 1558 ' ' ASN . . . . . . . . . . . . . 39.6 m-80 -75.52 -31.36 60.09 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-O 121.803 0.811 . . . . 1.59 109.901 -178.655 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 1559 ' ' CYS . . . . . 0.656 ' HB3' ' HD2' ' A' 1560 ' ' PRO . 95.5 m -113.25 176.47 1.47 Allowed Pre-proline 0 C--N 1.294 -1.841 0 CA-C-O 117.471 -1.252 . . . . 0.94 108.027 176.474 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A 1560 ' ' PRO . . . . . 0.656 ' HD2' ' HB3' ' A' 1559 ' ' CYS . 99.2 Cg_exo -29.88 122.16 0.06 OUTLIER 'Trans proline' 0 C--N 1.375 1.957 0 C-N-CA 124.358 3.372 . . . . 1.53 113.909 173.693 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A 1561 ' ' PRO . . . . . . . . . . . . . 32.1 Cg_exo -58.57 110.25 0.63 Allowed 'Trans proline' 0 C--O 1.245 0.85 0 C-N-CA 123.243 2.629 . . . . 1.82 111.66 -176.776 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 1562 ' ' GLY . . . . . . . . . . . . . . . 132.94 -15.24 4.86 Favored Glycine 0 N--CA 1.44 -1.085 0 C-N-CA 120.23 -0.986 . . . . 0.81 112.507 -179.792 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 1563 ' ' VAL . . . . . . . . . . . . . 13.8 m -86.49 149.82 4.04 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.957 0 N-CA-C 108.02 -1.104 . . . . 1.73 108.02 177.326 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 1564 ' ' GLY . . . . . . . . . . . . . . . -102.0 -30.77 5.62 Favored Glycine 0 C--N 1.307 -1.059 0 N-CA-C 111.188 -0.765 . . . . 0.72 111.188 -178.019 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 1565 ' ' ALA . . . . . . . . . . . . . . . -140.3 136.3 33.11 Favored 'General case' 0 N--CA 1.44 -0.927 0 N-CA-C 109.04 -0.726 . . . . 1.14 109.04 178.773 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 1566 ' ' CYS . . . . . . . . . . . . . 16.5 t -156.32 146.36 21.26 Favored 'General case' 0 C--N 1.298 -1.668 0 CA-C-N 116.243 -0.435 . . . . 0.51 109.933 -175.324 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 1567 ' ' PHE . . . . . . . . . . . . . 21.5 m-85 -73.88 123.32 24.01 Favored 'General case' 0 C--O 1.211 -0.921 0 N-CA-C 107.239 -1.393 . . . . 1.22 107.239 174.467 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 1568 ' ' GLY . . . . . . . . . . . . . . . -75.36 -18.64 79.89 Favored Glycine 0 C--N 1.309 -0.92 0 C-N-CA 120.472 -0.871 . . . . 1.08 114.655 -171.732 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 1569 ' ' GLN . . . . . . . . . . . . . 58.9 tp60 -80.66 -60.0 2.47 Favored 'General case' 0 C--N 1.302 -1.496 0 CA-C-O 121.059 0.457 . . . . 3.05 110.498 -179.586 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 1570 ' ' THR . . . . . . . . . . . . . 12.3 p -88.14 -11.16 47.74 Favored 'General case' 0 C--N 1.31 -1.146 0 N-CA-C 112.817 0.673 . . . . 2.44 112.817 -175.289 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 1571 ' ' ARG . . . . . . . . . . . . . 51.0 mtm180 58.04 45.16 18.33 Favored 'General case' 0 CA--C 1.515 -0.372 0 C-N-CA 125.363 1.465 . . . . 4.48 112.853 179.248 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 1572 ' ' ILE . . . . . . . . . . . . . 36.3 mt -100.61 122.82 53.07 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.192 0 N-CA-C 108.788 -0.819 . . . . 1.94 108.788 179.112 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 1573 ' ' SER . . . . . . . . . . . . . 33.2 t -61.88 122.57 15.76 Favored 'General case' 0 C--N 1.31 -1.133 0 C-N-CA 124.644 1.178 . . . . 1.25 110.855 -179.033 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 1574 ' ' VAL . . . . . . . . . . . . . 30.0 m -127.83 33.93 1.36 Allowed 'Isoleucine or valine' 0 C--N 1.315 -0.895 0 CA-C-O 122.238 1.018 . . . . 1.61 110.234 178.973 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 1575 ' ' GLY . . . . . . . . . . . . . . . 155.69 115.61 0.52 Allowed Glycine 0 N--CA 1.419 -2.442 0 CA-C-N 114.248 -1.342 . . . . 0.65 111.341 177.979 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 1576 ' ' LYS . . . . . . . . . . . . . 3.3 tppp? -82.13 145.33 30.19 Favored 'General case' 0 C--N 1.307 -1.253 0 N-CA-C 106.77 -1.567 . . . . 3.33 106.77 178.201 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 1577 ' ' ALA . . . . . . . . . . . . . . . -63.81 112.92 3.1 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 121.343 0.592 . . . . 1.31 109.516 -179.024 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 1578 ' ' ASN . . . . . . . . . . . . . 50.4 t-20 -135.77 139.13 43.3 Favored 'General case' 0 C--N 1.295 -1.802 0 N-CA-C 107.687 -1.227 . . . . 2.24 107.687 -173.493 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 1579 ' ' LYS . . . . . 0.457 ' HD2' ' SG ' ' A' 1516 ' ' CYS . 43.2 mmtm -100.9 89.85 3.99 Favored 'General case' 0 C--N 1.3 -1.562 0 N-CA-C 108.043 -1.095 . . . . 2.34 108.043 178.957 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A 1580 ' ' ARG . . . . . . . . . . . . . 18.7 tpp180 -146.79 84.87 1.61 Allowed 'General case' 0 N--CA 1.429 -1.514 0 CA-C-O 121.33 0.586 . . . . 4.19 110.593 -177.627 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 1581 ' ' LEU . . . . . . . . . . . . . 3.8 pp -104.37 153.71 20.73 Favored 'General case' 0 N--CA 1.427 -1.595 0 CA-C-N 115.55 -0.75 . . . . 2.39 110.112 176.117 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 1582 ' ' ARG . . . . . 0.416 ' CG ' ' HB3' ' A' 1589 ' ' GLN . 14.7 ptp180 -131.62 139.89 49.25 Favored 'General case' 0 C--N 1.283 -2.296 0 N-CA-C 108.937 -0.764 . . . . 4.48 108.937 177.427 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A 1583 ' ' TYR . . . . . 0.43 ' CE1' ' HA ' ' A' 1586 ' ' GLN . 67.5 t80 -102.84 91.85 4.34 Favored 'General case' 0 N--CA 1.432 -1.367 0 N-CA-C 107.448 -1.315 . . . . 1.57 107.448 176.819 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A 1584 ' ' VAL . . . . . . . . . . . . . 1.6 m -120.27 110.46 28.86 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.607 0 CA-C-N 115.421 -0.809 . . . . 2.29 112.53 -176.553 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 1585 ' ' ASP . . . . . . . . . . . . . 16.0 t70 65.45 38.8 5.46 Favored 'General case' 0 C--N 1.313 -1.019 0 CA-C-O 122.481 1.134 . . . . 2.06 109.619 173.409 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 1586 ' ' GLN . . . . . 0.43 ' HA ' ' CE1' ' A' 1583 ' ' TYR . 47.8 mt-30 73.78 -14.43 0.66 Allowed 'General case' 0 N--CA 1.484 1.234 0 C-N-CA 126.049 1.739 . . . . 2.61 114.042 -179.729 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A 1587 ' ' VAL . . . . . . . . . . . . . 7.6 p -94.53 121.68 45.33 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.026 0 CA-C-O 121.361 0.601 . . . . 1.33 110.055 178.461 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 1588 ' ' LEU . . . . . 0.65 ' HB2' ' HB2' ' A' 1612 ' ' PHE . 3.8 mm? -78.75 138.76 38.38 Favored 'General case' 0 N--CA 1.433 -1.301 0 CA-C-N 115.658 -0.701 . . . . 2.03 109.67 178.736 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A 1589 ' ' GLN . . . . . 0.416 ' HB3' ' CG ' ' A' 1582 ' ' ARG . 34.6 tt0 -133.58 126.92 31.99 Favored 'General case' 0 C--N 1.292 -1.91 0 N-CA-C 108.63 -0.878 . . . . 1.73 108.63 179.479 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A 1590 ' ' LEU . . . . . . . . . . . . . 8.9 tt -124.59 126.21 45.42 Favored 'General case' 0 C--N 1.295 -1.794 0 N-CA-C 107.438 -1.319 . . . . 1.76 107.438 179.911 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 1591 ' ' VAL . . . . . . . . . . . . . 67.8 t -117.75 123.03 71.14 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.798 0 CA-C-O 121.237 0.541 . . . . 2.14 112.454 -174.488 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 1592 ' ' TYR . . . . . . . . . . . . . 49.4 m-85 -97.29 101.59 13.17 Favored 'General case' 0 C--N 1.309 -1.153 0 CA-C-N 115.041 -0.981 . . . . 1.53 108.383 175.114 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 1593 ' ' LYS . . . . . . . . . . . . . 19.0 ptpt -99.74 -173.68 2.52 Favored 'General case' 0 C--N 1.3 -1.547 0 N-CA-C 109.756 -0.461 . . . . 2.72 109.756 179.849 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 1594 ' ' ASP . . . . . . . . . . . . . 6.7 m-20 50.07 53.96 11.93 Favored 'General case' 0 N--CA 1.478 0.925 0 N-CA-C 114.84 1.422 . . . . 1.45 114.84 175.951 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 1595 ' ' GLY . . . . . . . . . . . . . . . -90.02 -92.45 1.22 Allowed Glycine 0 N--CA 1.425 -2.052 0 N-CA-C 108.001 -2.04 . . . . 0.83 108.001 174.367 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 1596 ' ' SER . . . . . . . . . . . . . 20.0 m -114.16 135.95 22.19 Favored Pre-proline 0 C--N 1.291 -1.936 0 N-CA-C 107.475 -1.306 . . . . 1.96 107.475 175.404 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 1597 ' ' PRO . . . . . . . . . . . . . 32.0 Cg_exo -60.87 128.23 24.88 Favored 'Trans proline' 0 C--O 1.243 0.754 0 C-N-CA 122.513 2.142 . . . . 1.34 109.422 178.254 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 1598 ' ' CYS . . . . . 0.552 ' HB3' HD12 ' A' 1604 ' ' LEU . 9.0 t -95.7 125.27 49.78 Favored Pre-proline 0 C--N 1.293 -1.861 0 N-CA-C 109.021 -0.733 . . . . 1.19 109.021 -174.35 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A 1599 ' ' PRO . . . . . 0.435 ' HD3' ' HA ' ' A' 1598 ' ' CYS . 1.0 OUTLIER -84.04 -0.29 9.52 Favored 'Trans proline' 0 CA--C 1.536 0.591 0 C-N-CA 122.86 2.373 . . . . 1.88 113.18 -177.296 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A 1600 ' ' SER . . . . . . . . . . . . . 20.3 m -67.41 -31.3 71.41 Favored 'General case' 0 C--O 1.241 0.645 0 CA-C-O 121.095 0.474 . . . . 2.19 111.122 179.594 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 1601 ' ' LYS . . . . . 0.432 ' HB3' HD21 ' A' 1604 ' ' LEU . 13.1 tmtt? -152.63 130.47 11.69 Favored 'General case' 0 C--N 1.31 -1.151 0 N-CA-C 105.96 -1.867 . . . . 4.21 105.96 178.731 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A 1602 ' ' SER . . . . . . . . . . . . . 23.9 t -71.88 117.39 13.42 Favored 'General case' 0 C--N 1.305 -1.333 0 CA-C-O 121.207 0.527 . . . . 3.82 111.255 -177.103 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 1603 ' ' GLY . . . . . . . . . . . . . . . 116.66 15.71 6.76 Favored Glycine 0 N--CA 1.43 -1.762 0 CA-C-N 115.625 -0.716 . . . . 2.45 112.79 175.988 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 1604 ' ' LEU . . . . . 0.552 HD12 ' HB3' ' A' 1598 ' ' CYS . 2.3 pp -140.3 161.3 38.0 Favored 'General case' 0 C--N 1.316 -0.864 0 N-CA-C 113.462 0.912 . . . . 2.06 113.462 179.711 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A 1605 ' ' SER . . . . . . . . . . . . . 9.3 t -121.38 170.93 9.15 Favored 'General case' 0 C--N 1.295 -1.765 0 N-CA-C 108.078 -1.082 . . . . 1.75 108.078 -175.314 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 1606 ' ' TYR . . . . . . . . . . . . . 90.8 m-85 -85.54 111.91 20.45 Favored 'General case' 0 CA--C 1.461 -2.465 0 N-CA-C 102.783 -3.043 . . . . 1.59 102.783 176.078 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 1607 ' ' LYS . . . . . . . . . . . . . 22.3 pttm -126.93 148.63 50.04 Favored 'General case' 0 N--CA 1.399 -2.99 0 C-N-CA 119.006 -1.077 . . . . 2.21 112.111 -172.877 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 1608 ' ' SER . . . . . . . . . . . . . 23.8 t -104.65 128.2 52.63 Favored 'General case' 0 C--N 1.298 -1.663 0 CA-C-N 115.674 -0.694 . . . . 1.48 109.598 -177.429 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 1609 ' ' VAL . . . . . . . . . . . . . 53.4 t -114.42 111.01 34.14 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.969 0 N-CA-C 108.507 -0.923 . . . . 1.57 108.507 178.874 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 1610 ' ' ILE . . . . . . . . . . . . . 26.3 mm -94.03 117.26 37.24 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.348 0 CA-C-N 116.117 -0.492 . . . . 1.47 109.697 -179.139 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 1611 ' ' SER . . . . . . . . . . . . . 35.9 p -104.58 113.75 27.53 Favored 'General case' 0 N--CA 1.429 -1.493 0 CA-C-O 121.33 0.586 . . . . 1.84 109.614 175.861 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 1612 ' ' PHE . . . . . 0.65 ' HB2' ' HB2' ' A' 1588 ' ' LEU . 96.9 m-85 -87.7 102.51 14.71 Favored 'General case' 0 C--N 1.306 -1.295 0 CA-C-N 115.518 -0.765 . . . . 0.86 109.139 -179.256 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A 1613 ' ' VAL . . . . . . . . . . . . . 42.2 t -106.35 122.18 59.83 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.877 0 N-CA-C 109.303 -0.628 . . . . 1.32 109.303 -175.914 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 1614 ' ' CYS . . . . . 0.578 ' HA ' ' O ' ' A' 1642 ' ' THR . 0.5 OUTLIER -75.34 93.81 2.95 Favored 'General case' 0 C--N 1.298 -1.65 0 N-CA-C 114.632 1.345 . . . . 1.39 114.632 -178.988 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A 1615 ' ' ARG . . . . . 0.467 ' HB3' ' HB3' ' A' 1641 ' ' HIS . 23.3 tpt180 -131.64 96.84 20.04 Favored Pre-proline 0 N--CA 1.423 -1.78 0 N-CA-C 107.881 -1.155 . . . . 4.34 107.881 174.306 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A 1616 ' ' PRO . . . . . 0.609 ' HB3' ' HB3' ' A' 1643 ' ' PRO . 7.6 Cg_exo -75.66 64.34 6.6 Favored 'Trans proline' 0 CA--C 1.532 0.42 0 C-N-CA 123.817 3.011 . . . . 1.5 113.643 -175.854 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A 1617 ' ' GLU . . . . . . . . . . . . . 44.0 mt-10 -130.47 25.03 5.13 Favored 'General case' 0 C--N 1.312 -1.024 0 O-C-N 122.201 -0.312 . . . . 3.21 111.337 179.013 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 1618 ' ' ALA . . . . . 0.415 ' HB1' ' HB2' ' A' 1622 ' ' ASN . . . -158.51 152.45 23.71 Favored 'General case' 0 C--O 1.242 0.707 0 CA-C-O 120.778 0.323 . . . . 2.91 110.848 -176.135 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A 1619 ' ' GLY . . . . . 0.421 ' HA3' ' HD2' ' A' 1620 ' ' PRO . . . -121.44 -137.37 5.23 Favored Glycine 0 N--CA 1.437 -1.29 0 CA-C-N 115.581 -0.736 . . . . 3.35 112.262 -178.999 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A 1620 ' ' PRO . . . . . 0.421 ' HD2' ' HA3' ' A' 1619 ' ' GLY . 1.5 Cg_endo -44.79 -37.41 11.78 Favored 'Trans proline' 0 CA--C 1.56 1.785 0 C-N-CA 124.717 3.611 . . . . 6.61 117.136 -176.608 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A 1621 ' ' THR . . . . . . . . . . . . . 13.7 t -80.94 -7.08 59.42 Favored 'General case' 0 CA--C 1.539 0.523 0 O-C-N 121.399 -0.813 . . . . 5.03 112.54 -177.064 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 1622 ' ' ASN . . . . . 0.415 ' HB2' ' HB1' ' A' 1618 ' ' ALA . 59.6 t30 -64.54 124.05 20.85 Favored 'General case' 0 C--N 1.313 -0.987 0 C-N-CA 122.731 0.412 . . . . 3.58 110.991 -176.061 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A 1623 ' ' ARG . . . . . . . . . . . . . 7.7 ptp180 -135.2 147.93 64.36 Favored Pre-proline 0 C--N 1.309 -1.186 0 N-CA-C 109.622 -0.51 . . . . 4.09 109.622 -177.393 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 1624 ' ' PRO . . . . . . . . . . . . . 18.7 Cg_endo -58.97 124.38 15.56 Favored 'Trans proline' 0 C--N 1.349 0.565 0 C-N-CA 123.436 2.757 . . . . 2.86 112.109 179.762 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 1625 ' ' MET . . . . . . . . . . . . . 54.9 ttp -94.6 125.08 39.02 Favored 'General case' 0 C--N 1.301 -1.503 0 CA-C-N 115.863 -0.608 . . . . 2.73 110.809 -176.84 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 1626 ' ' LEU . . . . . 0.487 ' HB2' ' CE1' ' A' 1638 ' ' PHE . 31.8 tp -73.66 103.73 4.34 Favored 'General case' 0 C--N 1.306 -1.299 0 N-CA-C 108.729 -0.841 . . . . 1.94 108.729 175.979 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A 1627 ' ' ILE . . . . . . . . . . . . . 27.9 pt -91.56 -36.58 8.1 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.381 0 CA-C-N 115.751 -0.659 . . . . 1.75 112.485 -176.649 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 1628 ' ' SER . . . . . . . . . . . . . 6.2 p -153.66 135.42 14.5 Favored 'General case' 0 N--CA 1.43 -1.448 0 CA-C-O 120.883 0.373 . . . . 1.85 111.567 -177.396 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 1629 ' ' LEU . . . . . 0.966 ' HG ' ' HG ' ' A' 1636 ' ' LEU . 4.4 tt -125.31 114.76 19.34 Favored 'General case' 0 C--N 1.3 -1.552 0 N-CA-C 105.757 -1.942 . . . . 2.12 105.757 177.825 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A 1630 ' ' ASP . . . . . . . . . . . . . 25.0 t70 -91.87 121.99 33.98 Favored 'General case' 0 C--N 1.301 -1.502 0 N-CA-C 107.962 -1.125 . . . . 0.87 107.962 178.279 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 1631 ' ' LYS . . . . . . . . . . . . . 96.8 mttt -86.48 -2.97 58.92 Favored 'General case' 0 C--N 1.301 -1.511 0 N-CA-C 112.642 0.608 . . . . 2.76 112.642 -172.252 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 1632 ' ' GLN . . . . . . . . . . . . . 1.9 mp0 -95.59 -42.63 8.32 Favored 'General case' 0 C--N 1.318 -0.773 0 C-N-CA 120.463 -0.495 . . . . 2.55 110.665 177.424 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 1633 ' ' THR . . . . . 0.459 ' HA ' HD23 ' A' 1604 ' ' LEU . 31.7 p -90.97 -8.15 50.03 Favored 'General case' 0 C--O 1.251 1.137 0 CA-C-O 121.621 0.724 . . . . 1.92 110.902 177.581 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A 1634 ' ' CYS . . . . . . . . . . . . . 33.3 m 59.29 44.64 15.15 Favored 'General case' 0 C--N 1.34 0.161 0 CA-C-N 113.905 -1.498 . . . . 0.89 110.379 176.588 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 1635 ' ' THR . . . . . . . . . . . . . 7.5 p -108.32 126.21 52.58 Favored 'General case' 0 N--CA 1.428 -1.549 0 CA-C-N 114.339 -1.3 . . . . 1.31 111.173 -176.198 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 1636 ' ' LEU . . . . . 0.966 ' HG ' ' HG ' ' A' 1629 ' ' LEU . 5.9 mp -105.47 111.04 23.6 Favored 'General case' 0 N--CA 1.431 -1.423 0 N-CA-C 109.621 -0.511 . . . . 1.97 109.621 175.596 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A 1637 ' ' PHE . . . . . . . . . . . . . 97.5 m-85 -92.03 112.75 24.81 Favored 'General case' 0 C--O 1.249 1.06 0 CA-C-N 116.202 -0.453 . . . . 0.92 110.6 -178.573 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 1638 ' ' PHE . . . . . 0.487 ' CE1' ' HB2' ' A' 1626 ' ' LEU . 97.1 m-85 -109.12 132.13 54.41 Favored 'General case' 0 C--N 1.304 -1.385 0 CA-C-N 115.892 -0.595 . . . . 0.7 109.448 177.709 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A 1639 ' ' SER . . . . . . . . . . . . . 29.4 p -111.19 117.23 32.64 Favored 'General case' 0 C--N 1.285 -2.223 0 CA-C-O 121.628 0.728 . . . . 1.46 110.34 176.652 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 1640 ' ' TRP . . . . . . . . . . . . . 13.9 t90 -101.8 102.57 13.21 Favored 'General case' 0 N--CA 1.419 -1.978 0 N-CA-C 107.42 -1.326 . . . . 0.92 107.42 177.565 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 1641 ' ' HIS . . . . . 0.467 ' HB3' ' HB3' ' A' 1615 ' ' ARG . 62.9 m80 -82.35 93.19 7.12 Favored 'General case' 0 C--N 1.311 -1.096 0 N-CA-C 107.604 -1.258 . . . . 3.18 107.604 -179.885 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A 1642 ' ' THR . . . . . 0.578 ' O ' ' HA ' ' A' 1614 ' ' CYS . 9.7 t -134.84 141.52 38.81 Favored Pre-proline 0 C--N 1.288 -2.103 0 CA-C-O 121.384 0.612 . . . . 1.48 112.13 -170.421 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A 1643 ' ' PRO . . . . . 0.609 ' HB3' ' HB3' ' A' 1616 ' ' PRO . 38.2 Cg_endo -70.65 -10.15 27.26 Favored 'Trans proline' 0 C--N 1.352 0.742 0 C-N-CA 123.396 2.73 . . . . 1.09 111.024 173.628 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A 1644 ' ' LEU . . . . . . . . . . . . . 31.7 mt -83.28 -2.52 55.85 Favored 'General case' 0 C--N 1.312 -1.023 0 C-N-CA 123.945 0.898 . . . . 2.08 111.215 -179.464 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 1645 ' ' ALA . . . . . . . . . . . . . . . -92.23 -34.0 14.45 Favored 'General case' 0 C--N 1.323 -0.564 0 N-CA-C 112.765 0.654 . . . . 1.37 112.765 -176.96 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 1646 ' ' CYS . . . . . . . . . . . . . 5.9 m -152.55 172.19 16.97 Favored 'General case' 0 CA--C 1.506 -0.721 0 N-CA-C 106.94 -1.504 . . . . 1.7 106.94 -179.205 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 1647 ' ' GLU . . . . . . . . . . . . . 8.0 pt-20 -126.74 84.13 63.62 Favored Pre-proline 0 C--N 1.302 -1.49 0 CA-C-O 121.586 0.708 . . . . 2.92 109.956 173.494 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 1648 ' ' PRO . . . . . . . . . . . . . 6.1 Cg_exo -78.25 165.9 25.14 Favored 'Trans proline' 0 C--O 1.243 0.771 0 C-N-CA 123.054 2.503 . . . . 3.19 110.739 -178.573 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 1649 ' ' GLU . . . . . . . . . . . . . 39.8 tt0 . . . . . 0 C--O 1.254 1.336 0 O-C-N 124.098 0.874 . . . . 5.06 109.237 -178.443 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A 1508 ' ' MET . . . . . . . . . . . . . 48.9 ttm . . . . . 0 CA--C 1.518 -0.283 0 N-CA-C 108.55 -0.907 . . . . 8.58 108.55 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A 1509 ' ' LYS . . . . . . . . . . . . . 23.0 tptm 69.29 117.68 0.04 OUTLIER 'General case' 0 N--CA 1.468 0.46 0 C-N-CA 125.189 1.396 . . . . 6.8 111.518 -178.85 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 1510 ' ' SER . . . . . . . . . . . . . 58.8 m 62.38 46.84 5.6 Favored 'General case' 0 C--O 1.234 0.264 0 CA-C-O 122.197 0.999 . . . . 4.48 109.893 -176.107 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 1511 ' ' ASN . . . . . . . . . . . . . 2.8 p-10 -111.24 -20.44 12.31 Favored 'General case' 0 C--N 1.303 -1.416 0 CA-C-N 114.72 -1.127 . . . . 3.08 111.805 -177.073 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 1512 ' ' GLU . . . . . . . . . . . . . 7.9 mm-40 -50.67 -44.6 57.7 Favored 'General case' 0 N--CA 1.476 0.863 0 C-N-CA 123.672 0.789 . . . . 4.46 112.925 -176.906 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 1513 ' ' HIS . . . . . . . . . . . . . 23.1 p80 -121.25 27.1 8.55 Favored 'General case' 0 C--N 1.312 -1.036 0 C-N-CA 119.48 -0.888 . . . . 6.25 111.154 179.569 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 1514 ' ' ASP . . . . . . . . . . . . . 31.2 t70 -123.59 -39.6 2.41 Favored 'General case' 0 C--N 1.308 -1.221 0 N-CA-C 114.431 1.271 . . . . 3.7 114.431 -174.861 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 1515 ' ' ASP . . . . . . . . . . . . . 35.5 t70 -130.18 145.0 51.68 Favored 'General case' 0 C--N 1.294 -1.835 0 C-N-CA 118.979 -1.088 . . . . 2.54 110.761 -174.115 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 1516 ' ' CYS . . . . . . . . . . . . . 74.1 m -76.25 77.4 3.04 Favored 'General case' 0 CA--C 1.508 -0.673 0 CA-C-O 122.326 1.06 . . . . 1.25 110.65 179.786 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 1517 ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -147.01 172.54 13.56 Favored 'General case' 0 N--CA 1.402 -2.86 0 CA-C-N 114.324 -1.307 . . . . 2.36 109.22 -179.622 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A 1518 ' ' VAL . . . . . 0.5 HG21 ' HB2' ' A' 1583 ' ' TYR . 10.4 p -159.0 126.01 0.57 Allowed 'Isoleucine or valine' 0 C--N 1.279 -2.466 0 CA-C-O 121.46 0.648 . . . . 2.34 109.551 173.035 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A 1519 ' ' THR . . . . . . . . . . . . . 7.3 m -90.57 121.52 32.58 Favored 'General case' 0 C--N 1.282 -2.351 0 CA-C-N 114.548 -1.205 . . . . 2.04 108.202 177.635 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 1520 ' ' ASN . . . . . . . . . . . . . 38.9 t30 -99.79 103.33 21.21 Favored Pre-proline 0 C--N 1.311 -1.09 0 N-CA-C 109.59 -0.522 . . . . 2.12 109.59 177.35 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 1521 ' ' PRO . . . . . . . . . . . . . 41.4 Cg_endo -69.28 -3.35 11.52 Favored 'Trans proline' 0 CA--C 1.54 0.797 0 C-N-CA 122.624 2.216 . . . . 2.59 113.954 -175.778 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 1522 ' ' SER . . . . . . . . . . . . . 11.4 m -69.34 -28.84 66.58 Favored 'General case' 0 CA--C 1.545 0.776 0 CA-C-O 120.984 0.421 . . . . 2.65 109.883 176.805 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 1523 ' ' THR . . . . . . . . . . . . . 12.9 t -139.21 -16.62 1.06 Allowed 'General case' 0 CA--C 1.551 0.999 0 CA-C-O 120.903 0.383 . . . . 2.33 111.827 178.771 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 1524 ' ' GLY . . . . . . . . . . . . . . . 94.16 7.92 60.54 Favored Glycine 0 N--CA 1.446 -0.658 0 C-N-CA 120.597 -0.811 . . . . 1.96 113.08 179.017 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 1525 ' ' HIS . . . . . . . . . . . . . 24.5 t60 -77.06 134.11 38.87 Favored 'General case' 0 C--O 1.245 0.838 0 CA-C-O 120.866 0.365 . . . . 2.44 110.023 -177.927 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 1526 ' ' LEU . . . . . . . . . . . . . 3.4 tm? -104.51 114.73 29.14 Favored 'General case' 0 N--CA 1.43 -1.426 0 N-CA-C 108.157 -1.053 . . . . 2.19 108.157 178.324 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 1527 ' ' PHE . . . . . . . . . . . . . 97.6 m-85 -88.32 129.33 35.41 Favored 'General case' 0 C--N 1.291 -1.942 0 N-CA-C 108.071 -1.085 . . . . 1.61 108.071 178.267 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 1528 ' ' ASP . . . . . . . . . . . . . 3.4 p-10 -117.82 126.9 53.28 Favored 'General case' 0 CA--C 1.476 -1.866 0 CA-C-O 121.964 0.887 . . . . 2.18 110.322 179.073 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 1529 ' ' LEU . . . . . . . . . . . . . 71.7 mt -117.68 7.45 12.56 Favored 'General case' 0 C--N 1.292 -1.919 0 N-CA-C 106.231 -1.766 . . . . 2.04 106.231 175.738 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 1530 ' ' SER . . . . . . . . . . . . . 1.6 m -70.99 -24.95 62.49 Favored 'General case' 0 N--CA 1.438 -1.026 0 CA-C-N 113.853 -1.521 . . . . 1.44 110.219 -179.152 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 1531 ' ' SER . . . . . . . . . . . . . 14.5 m -88.07 -16.15 34.34 Favored 'General case' 0 N--CA 1.433 -1.309 0 N-CA-C 108.582 -0.896 . . . . 1.63 108.582 178.814 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 1532 ' ' LEU . . . . . . . . . . . . . 90.8 mt -82.05 -8.28 59.66 Favored 'General case' 0 C--O 1.244 0.804 0 CA-C-N 115.509 -0.769 . . . . 2.32 111.72 177.631 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 1533 ' ' SER . . . . . . . . . . . . . 22.5 m -57.67 125.84 24.73 Favored 'General case' 0 N--CA 1.445 -0.702 0 C-N-CA 123.155 0.582 . . . . 2.57 110.424 177.146 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 1534 ' ' GLY . . . . . . . . . . . . . . . -121.16 169.53 14.38 Favored Glycine 0 N--CA 1.427 -1.943 0 N-CA-C 109.976 -1.25 . . . . 1.89 109.976 179.698 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 1535 ' ' ARG . . . . . . . . . . . . . 45.8 ttt180 -95.37 -54.27 3.46 Favored 'General case' 0 C--N 1.303 -1.452 0 N-CA-C 108.524 -0.917 . . . . 4.44 108.524 179.123 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 1536 ' ' ALA . . . . . . . . . . . . . . . -86.14 -24.19 26.3 Favored 'General case' 0 N--CA 1.438 -1.047 0 CA-C-N 115.505 -0.771 . . . . 2.07 109.463 178.68 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 1537 ' ' GLY . . . . . . . . . . . . . . . 81.76 -140.66 21.16 Favored Glycine 0 N--CA 1.434 -1.473 0 CA-C-N 115.177 -0.919 . . . . 1.2 112.344 176.664 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 1538 ' ' PHE . . . . . . . . . . . . . 98.7 m-85 -134.16 156.83 47.62 Favored 'General case' 0 C--N 1.299 -1.617 0 N-CA-C 108.72 -0.844 . . . . 1.98 108.72 179.881 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 1539 ' ' THR . . . . . . . . . . . . . 23.5 p -104.93 111.63 24.47 Favored 'General case' 0 N--CA 1.425 -1.709 0 CA-C-N 115.929 -0.578 . . . . 1.97 110.046 177.114 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 1540 ' ' ALA . . . . . . . . . . . . . . . -102.72 116.59 32.87 Favored 'General case' 0 C--N 1.295 -1.784 0 N-CA-C 108.865 -0.791 . . . . 1.39 108.865 178.618 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 1541 ' ' ALA . . . . . . . . . . . . . . . -61.68 128.34 35.8 Favored 'General case' 0 C--N 1.308 -1.222 0 CA-C-O 121.428 0.632 . . . . 1.86 110.943 178.021 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 1542 ' ' TYR . . . . . 0.611 ' HD2' ' HB2' ' A' 1545 ' ' SER . 66.7 t80 -125.0 174.84 7.73 Favored 'General case' 0 C--N 1.293 -1.875 0 N-CA-C 107.296 -1.372 . . . . 2.4 107.296 -178.426 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A 1543 ' ' SER . . . . . . . . . . . . . 1.7 m -46.5 -152.15 0.0 OUTLIER 'General case' 0 CA--C 1.596 2.721 0 C-N-CA 128.741 2.816 . . . . 2.58 114.404 -179.865 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 1544 ' ' LYS . . . . . . . . . . . . . 63.6 mttp -55.07 -15.39 2.1 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 119.621 -1.924 . . . . 4.24 113.556 -177.012 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 1545 ' ' SER . . . . . 0.611 ' HB2' ' HD2' ' A' 1542 ' ' TYR . 36.0 m -70.62 -19.63 62.81 Favored 'General case' 0 CA--C 1.552 1.023 0 N-CA-C 111.976 0.361 . . . . 3.6 111.976 174.707 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A 1546 ' ' GLY . . . . . . . . . . . . . . . 102.63 -98.55 1.7 Allowed Glycine 0 CA--C 1.493 -1.289 0 C-N-CA 119.224 -1.465 . . . . 1.66 113.187 174.822 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 1547 ' ' VAL . . . . . . . . . . . . . 16.6 m -131.39 166.29 29.23 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.616 0 CA-C-N 117.26 0.53 . . . . 2.23 109.913 177.567 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 1548 ' ' VAL . . . . . . . . . . . . . 3.6 t -118.83 128.7 75.66 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.724 0 N-CA-C 106.627 -1.62 . . . . 1.59 106.627 175.983 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 1549 ' ' TYR . . . . . 0.552 ' HD2' ' HA2' ' A' 1568 ' ' GLY . 50.8 m-85 -87.64 114.57 24.37 Favored 'General case' 0 C--N 1.3 -1.57 0 N-CA-C 106.233 -1.765 . . . . 1.58 106.233 171.223 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A 1550 ' ' MET . . . . . . . . . . . . . 3.0 ppp? -141.87 149.8 40.73 Favored 'General case' 0 C--N 1.284 -2.247 0 CA-C-N 116.435 -0.348 . . . . 2.08 111.304 -176.357 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 1551 ' ' SER . . . . . . . . . . . . . 22.6 t -116.55 145.05 43.63 Favored 'General case' 0 C--N 1.294 -1.819 0 N-CA-C 107.83 -1.174 . . . . 1.9 107.83 177.834 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 1552 ' ' ILE . . . . . . . . . . . . . 32.6 mm -68.07 -27.31 36.88 Favored 'Isoleucine or valine' 0 C--O 1.213 -0.849 0 CA-C-N 114.856 -1.066 . . . . 2.04 109.406 -178.132 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 1553 ' ' CYS . . . . . 0.421 ' SG ' ' HE2' ' A' 1579 ' ' LYS . 51.4 t -161.64 138.65 8.52 Favored 'General case' 0 N--CA 1.421 -1.914 0 N-CA-C 108.282 -1.007 . . . . 1.43 108.282 178.142 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A 1554 ' ' GLY . . . . . . . . . . . . . . . 95.47 -177.63 34.84 Favored Glycine 0 N--CA 1.438 -1.227 0 C-N-CA 120.689 -0.767 . . . . 1.23 112.472 176.493 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 1555 ' ' GLU . . . . . . . . . . . . . 10.1 pt-20 -81.37 144.25 31.59 Favored 'General case' 0 C--N 1.309 -1.194 0 CA-C-O 121.392 0.615 . . . . 1.8 111.522 -178.962 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 1556 ' ' ASN . . . . . . . . . . . . . 27.8 t-20 -96.91 105.62 17.79 Favored 'General case' 0 C--N 1.293 -1.849 0 CA-C-N 115.225 -0.898 . . . . 2.63 109.229 -179.408 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 1557 ' ' GLU . . . . . . . . . . . . . 13.0 mt-10 -86.31 76.7 9.64 Favored 'General case' 0 C--N 1.313 -0.978 0 CA-C-O 122.035 0.922 . . . . 3.79 111.918 -177.028 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 1558 ' ' ASN . . . . . . . . . . . . . 31.7 m-80 -146.82 -43.94 0.18 Allowed 'General case' 0 C--N 1.297 -1.705 0 N-CA-C 106.143 -1.799 . . . . 1.59 106.143 178.892 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 1559 ' ' CYS . . . . . 0.616 ' HB3' ' HD2' ' A' 1560 ' ' PRO . 78.2 m -108.63 175.92 1.78 Allowed Pre-proline 0 N--CA 1.425 -1.69 0 N-CA-C 105.532 -2.025 . . . . 0.94 105.532 170.675 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A 1560 ' ' PRO . . . . . 0.616 ' HD2' ' HB3' ' A' 1559 ' ' CYS . 20.8 Cg_exo -32.95 113.11 0.06 OUTLIER 'Trans proline' 0 C--N 1.375 1.943 0 C-N-CA 123.641 2.894 . . . . 1.53 113.962 176.879 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A 1561 ' ' PRO . . . . . . . . . . . . . 39.7 Cg_exo -59.07 102.79 0.16 Allowed 'Trans proline' 0 C--O 1.242 0.702 0 C-N-CA 123.335 2.69 . . . . 1.82 111.31 -179.026 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 1562 ' ' GLY . . . . . . . . . . . . . . . 152.17 -19.74 0.84 Allowed Glycine 0 N--CA 1.432 -1.618 0 N-CA-C 108.582 -1.807 . . . . 0.81 108.582 -175.081 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 1563 ' ' VAL . . . . . 0.483 ' HA ' ' HA ' ' A' 1576 ' ' LYS . 4.6 m -93.06 151.56 3.61 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.109 0 N-CA-C 107.118 -1.438 . . . . 1.73 107.118 174.013 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A 1564 ' ' GLY . . . . . . . . . . . . . . . -113.16 -15.35 9.13 Favored Glycine 0 C--N 1.308 -0.986 0 C-N-CA 120.664 -0.779 . . . . 0.72 112.451 -176.79 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 1565 ' ' ALA . . . . . . . . . . . . . . . -142.92 125.61 15.93 Favored 'General case' 0 C--O 1.244 0.8 0 N-CA-C 108.871 -0.789 . . . . 1.14 108.871 179.524 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 1566 ' ' CYS . . . . . . . . . . . . . 41.7 t -150.41 144.33 25.38 Favored 'General case' 0 C--N 1.302 -1.498 0 N-CA-C 109.524 -0.547 . . . . 0.51 109.524 -176.729 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 1567 ' ' PHE . . . . . . . . . . . . . 18.1 m-85 -67.59 145.26 55.05 Favored 'General case' 0 C--N 1.319 -0.724 0 N-CA-C 112.181 0.438 . . . . 1.22 112.181 179.91 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 1568 ' ' GLY . . . . . 0.552 ' HA2' ' HD2' ' A' 1549 ' ' TYR . . . -63.8 -73.48 0.54 Allowed Glycine 0 C--N 1.304 -1.225 0 N-CA-C 115.004 0.761 . . . . 1.08 115.004 -175.437 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A 1569 ' ' GLN . . . . . . . . . . . . . 11.2 pt20 -83.03 -34.29 26.3 Favored 'General case' 0 C--N 1.316 -0.849 0 N-CA-C 112.379 0.511 . . . . 3.05 112.379 -173.344 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 1570 ' ' THR . . . . . . . . . . . . . 21.3 p -81.51 -18.05 46.46 Favored 'General case' 0 C--N 1.312 -1.063 0 CA-C-O 121.32 0.581 . . . . 2.44 110.682 -178.162 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 1571 ' ' ARG . . . . . . . . . . . . . 64.6 mtp180 56.21 37.9 29.29 Favored 'General case' 0 C--N 1.344 0.354 0 C-N-CA 125.132 1.373 . . . . 4.48 113.063 172.774 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 1572 ' ' ILE . . . . . . . . . . . . . 25.5 mt -101.81 128.12 54.61 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.121 0 N-CA-C 108.27 -1.011 . . . . 1.94 108.27 179.838 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 1573 ' ' SER . . . . . . . . . . . . . 62.3 p -75.79 128.59 35.47 Favored 'General case' 0 C--N 1.314 -0.956 0 C-N-CA 122.364 0.266 . . . . 1.25 111.478 -177.106 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 1574 ' ' VAL . . . . . . . . . . . . . 27.7 m -126.3 26.44 2.62 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.75 0 CA-C-O 121.608 0.718 . . . . 1.61 112.299 -177.937 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 1575 ' ' GLY . . . . . . . . . . . . . . . 174.12 117.06 0.45 Allowed Glycine 0 N--CA 1.434 -1.47 0 CA-C-N 115.277 -0.874 . . . . 0.65 111.897 176.769 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 1576 ' ' LYS . . . . . 0.483 ' HA ' ' HA ' ' A' 1563 ' ' VAL . 63.8 tttp -79.2 135.83 36.91 Favored 'General case' 0 C--N 1.314 -0.962 0 N-CA-C 107.628 -1.249 . . . . 3.33 107.628 176.045 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A 1577 ' ' ALA . . . . . . . . . . . . . . . -70.42 130.7 42.61 Favored 'General case' 0 C--N 1.313 -0.993 0 O-C-N 123.647 0.592 . . . . 1.31 110.504 -174.431 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 1578 ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -157.83 148.41 20.81 Favored 'General case' 0 C--N 1.291 -1.942 0 N-CA-C 105.686 -1.968 . . . . 2.24 105.686 176.715 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A 1579 ' ' LYS . . . . . 0.421 ' HE2' ' SG ' ' A' 1553 ' ' CYS . 96.9 mttt -101.47 89.34 3.7 Favored 'General case' 0 C--N 1.284 -2.257 0 CA-C-O 121.845 0.831 . . . . 2.34 108.761 -177.508 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A 1580 ' ' ARG . . . . . . . . . . . . . 30.4 ttm180 -138.67 109.1 6.51 Favored 'General case' 0 N--CA 1.422 -1.862 0 CA-C-N 114.156 -1.383 . . . . 4.19 110.117 -175.587 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 1581 ' ' LEU . . . . . . . . . . . . . 2.0 pt? -138.92 142.16 38.48 Favored 'General case' 0 N--CA 1.419 -1.992 0 N-CA-C 109.288 -0.634 . . . . 2.39 109.288 173.408 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 1582 ' ' ARG . . . . . 0.504 ' HB3' HG13 ' A' 1584 ' ' VAL . 37.4 mmt180 -124.76 128.77 49.28 Favored 'General case' 0 C--N 1.276 -2.623 0 CA-C-N 114.972 -1.013 . . . . 4.48 110.585 -177.71 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A 1583 ' ' TYR . . . . . 0.5 ' HB2' HG21 ' A' 1518 ' ' VAL . 62.0 t80 -89.08 90.15 8.27 Favored 'General case' 0 N--CA 1.427 -1.585 0 N-CA-C 106.234 -1.765 . . . . 1.57 106.234 174.452 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A 1584 ' ' VAL . . . . . 0.504 HG13 ' HB3' ' A' 1582 ' ' ARG . 26.6 m -124.53 142.4 41.48 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.167 0 CA-C-N 114.435 -1.257 . . . . 2.29 107.896 -176.21 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A 1585 ' ' ASP . . . . . . . . . . . . . 22.8 t70 61.05 22.63 12.87 Favored 'General case' 0 N--CA 1.483 1.178 0 CA-C-O 122.44 1.114 . . . . 2.06 109.79 178.565 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 1586 ' ' GLN . . . . . . . . . . . . . 50.1 mt-30 59.98 38.88 20.63 Favored 'General case' 0 C--O 1.241 0.634 0 C-N-CA 125.278 1.431 . . . . 2.61 113.254 -176.255 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 1587 ' ' VAL . . . . . 0.472 HG11 ' O ' ' A' 1584 ' ' VAL . 12.5 p -134.52 145.77 32.12 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.895 0 N-CA-C 108.495 -0.928 . . . . 1.33 108.495 174.904 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A 1588 ' ' LEU . . . . . 0.842 ' HB2' ' HB2' ' A' 1612 ' ' PHE . 0.7 OUTLIER -84.31 133.08 34.56 Favored 'General case' 0 C--N 1.312 -1.041 0 N-CA-C 108.306 -0.998 . . . . 2.03 108.306 177.831 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A 1589 ' ' GLN . . . . . . . . . . . . . 7.3 tt0 -146.05 106.85 4.11 Favored 'General case' 0 C--N 1.307 -1.268 0 C-N-CA 120.456 -0.498 . . . . 1.73 110.132 -176.611 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 1590 ' ' LEU . . . . . . . . . . . . . 6.2 tt -104.39 127.97 52.15 Favored 'General case' 0 C--N 1.307 -1.259 0 N-CA-C 106.245 -1.761 . . . . 1.76 106.245 179.319 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 1591 ' ' VAL . . . . . 0.444 HG13 HG23 ' A' 1609 ' ' VAL . 15.6 m -123.69 124.37 69.22 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.245 0 N-CA-C 115.031 1.493 . . . . 2.14 115.031 -170.704 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A 1592 ' ' TYR . . . . . . . . . . . . . 94.5 m-85 -105.2 144.56 31.83 Favored 'General case' 0 C--N 1.317 -0.836 0 N-CA-C 107.267 -1.383 . . . . 1.53 107.267 173.813 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 1593 ' ' LYS . . . . . . . . . . . . . 23.0 pttm -149.89 179.57 7.94 Favored 'General case' 0 C--N 1.302 -1.493 0 N-CA-C 109.249 -0.648 . . . . 2.72 109.249 -177.642 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 1594 ' ' ASP . . . . . . . . . . . . . 1.4 m-20 47.05 43.19 13.77 Favored 'General case' 0 N--CA 1.482 1.128 0 N-CA-C 115.123 1.527 . . . . 1.45 115.123 173.367 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 1595 ' ' GLY . . . . . . . . . . . . . . . -73.14 -75.57 0.72 Allowed Glycine 0 N--CA 1.443 -0.838 0 N-CA-C 109.816 -1.313 . . . . 0.83 109.816 175.978 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 1596 ' ' SER . . . . . . . . . . . . . 21.7 t -115.39 142.36 28.63 Favored Pre-proline 0 C--N 1.29 -1.994 0 N-CA-C 105.867 -1.901 . . . . 1.96 105.867 173.42 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 1597 ' ' PRO . . . . . . . . . . . . . 25.9 Cg_exo -65.75 143.15 72.96 Favored 'Trans proline' 0 N--CA 1.451 -0.99 0 C-N-CA 122.68 2.253 . . . . 1.34 109.533 175.571 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 1598 ' ' CYS . . . . . . . . . . . . . 37.1 t -99.56 131.79 24.23 Favored Pre-proline 0 C--N 1.283 -2.325 0 N-CA-C 109.102 -0.703 . . . . 1.19 109.102 -176.37 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 1599 ' ' PRO . . . . . . . . . . . . . 55.3 Cg_endo -69.44 -11.72 31.88 Favored 'Trans proline' 0 C--N 1.351 0.663 0 C-N-CA 123.165 2.577 . . . . 1.88 112.352 179.604 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 1600 ' ' SER . . . . . . . . . . . . . 10.9 m -90.26 112.82 24.49 Favored 'General case' 0 N--CA 1.423 -1.795 0 N-CA-C 107.612 -1.255 . . . . 2.19 107.612 176.326 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 1601 ' ' LYS . . . . . 0.708 ' HB3' HD12 ' A' 1604 ' ' LEU . 55.7 tptt 71.03 114.31 0.05 Allowed 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 124.155 0.982 . . . . 4.21 110.98 179.054 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A 1602 ' ' SER . . . . . . . . . . . . . 47.4 t -63.61 108.96 1.52 Allowed 'General case' 0 C--N 1.316 -0.862 0 CA-C-N 116.075 -0.511 . . . . 3.82 109.949 179.757 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 1603 ' ' GLY . . . . . . . . . . . . . . . 129.99 -15.83 5.59 Favored Glycine 0 N--CA 1.434 -1.498 0 N-CA-C 110.724 -0.95 . . . . 2.45 110.724 -179.924 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 1604 ' ' LEU . . . . . 0.708 HD12 ' HB3' ' A' 1601 ' ' LYS . 12.6 mt -83.21 156.92 22.92 Favored 'General case' 0 N--CA 1.434 -1.263 0 CA-C-O 122.172 0.987 . . . . 2.06 113.6 179.805 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A 1605 ' ' SER . . . . . . . . . . . . . 14.9 m -143.15 -173.12 3.83 Favored 'General case' 0 C--N 1.296 -1.727 0 N-CA-C 104.752 -2.314 . . . . 1.75 104.752 176.749 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 1606 ' ' TYR . . . . . 0.469 ' CD1' ' HB3' ' A' 1634 ' ' CYS . 84.3 m-85 -107.38 132.49 53.1 Favored 'General case' 0 CA--C 1.462 -2.438 0 N-CA-C 105.77 -1.937 . . . . 1.59 105.77 179.863 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A 1607 ' ' LYS . . . . . 0.528 ' HG3' HG21 ' A' 1635 ' ' THR . 21.6 ptmt -128.04 153.31 46.93 Favored 'General case' 0 N--CA 1.407 -2.59 0 O-C-N 124.234 0.959 . . . . 2.21 109.505 -177.777 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A 1608 ' ' SER . . . . . . . . . . . . . 51.0 m -126.31 115.36 19.56 Favored 'General case' 0 C--N 1.303 -1.44 0 N-CA-C 109.393 -0.595 . . . . 1.48 109.393 -178.541 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 1609 ' ' VAL . . . . . 0.444 HG23 HG13 ' A' 1591 ' ' VAL . 76.6 t -104.12 116.15 47.37 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.064 0 CA-C-O 120.663 0.268 . . . . 1.57 110.647 -179.407 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A 1610 ' ' ILE . . . . . . . . . . . . . 19.3 mm -95.22 106.55 18.36 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.127 0 N-CA-C 108.448 -0.945 . . . . 1.47 108.448 177.969 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 1611 ' ' SER . . . . . 0.472 ' O ' ' HA ' ' A' 1639 ' ' SER . 21.8 m -98.05 123.19 41.96 Favored 'General case' 0 C--N 1.297 -1.7 0 N-CA-C 108.914 -0.773 . . . . 1.84 108.914 176.246 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A 1612 ' ' PHE . . . . . 0.842 ' HB2' ' HB2' ' A' 1588 ' ' LEU . 80.5 m-85 -100.39 123.16 44.26 Favored 'General case' 0 C--N 1.305 -1.364 0 N-CA-C 109.242 -0.651 . . . . 0.86 109.242 -179.066 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A 1613 ' ' VAL . . . . . 0.576 ' O ' ' HA ' ' A' 1641 ' ' HIS . 44.6 t -115.75 136.99 50.85 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.703 0 N-CA-C 106.697 -1.594 . . . . 1.32 106.697 179.281 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A 1614 ' ' CYS . . . . . 0.455 ' HA ' ' O ' ' A' 1642 ' ' THR . 42.3 t -86.69 108.88 18.85 Favored 'General case' 0 C--N 1.281 -2.409 0 CA-C-O 121.6 0.714 . . . . 1.39 111.748 -177.588 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A 1615 ' ' ARG . . . . . 0.677 ' HB3' ' HB2' ' A' 1641 ' ' HIS . 80.4 ttt180 -135.94 94.1 14.85 Favored Pre-proline 0 N--CA 1.43 -1.473 0 N-CA-C 108.009 -1.108 . . . . 4.34 108.009 176.544 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A 1616 ' ' PRO . . . . . . . . . . . . . 68.7 Cg_endo -72.04 50.0 1.4 Allowed 'Trans proline' 0 N--CA 1.481 0.773 0 C-N-CA 123.829 3.019 . . . . 1.5 113.156 -178.466 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 1617 ' ' GLU . . . . . . . . . . . . . 42.4 mt-10 -126.95 2.37 6.58 Favored 'General case' 0 C--N 1.305 -1.352 0 N-CA-C 108.316 -0.994 . . . . 3.21 108.316 177.789 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 1618 ' ' ALA . . . . . 0.402 ' HB2' ' HD2' ' A' 1641 ' ' HIS . . . -107.23 148.69 28.61 Favored 'General case' 0 C--N 1.315 -0.925 0 CA-C-N 115.19 -0.913 . . . . 2.91 109.111 -176.96 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A 1619 ' ' GLY . . . . . . . . . . . . . . . -88.76 165.95 33.8 Favored Glycine 0 N--CA 1.427 -1.906 0 N-CA-C 111.068 -0.813 . . . . 3.35 111.068 -179.798 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 1620 ' ' PRO . . . . . . . . . . . . . 49.3 Cg_exo -59.61 -22.78 68.55 Favored 'Trans proline' 0 CA--C 1.544 0.992 0 C-N-CA 123.335 2.69 . . . . 6.61 114.851 -178.087 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 1621 ' ' THR . . . . . . . . . . . . . 4.2 t -93.92 8.11 42.51 Favored 'General case' 0 CA--C 1.555 1.136 0 C-N-CA 119.836 -0.746 . . . . 5.03 111.019 -178.497 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 1622 ' ' ASN . . . . . . . . . . . . . 25.4 t-20 -70.89 137.38 49.28 Favored 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 107.521 -1.289 . . . . 3.58 107.521 176.363 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 1623 ' ' ARG . . . . . . . . . . . . . 7.2 ptp180 -122.13 162.44 37.44 Favored Pre-proline 0 C--N 1.299 -1.602 0 CA-C-O 119.381 -0.342 . . . . 4.09 110.153 -178.725 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 1624 ' ' PRO . . . . . . . . . . . . . 50.0 Cg_exo -55.61 144.68 73.86 Favored 'Trans proline' 0 C--N 1.364 1.348 0 C-N-CA 122.914 2.41 . . . . 2.86 113.404 -179.777 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 1625 ' ' MET . . . . . 0.515 ' HE3' HG22 ' A' 1627 ' ' ILE . 55.4 ttp -118.35 136.03 53.97 Favored 'General case' 0 C--N 1.301 -1.533 0 CA-C-N 115.272 -0.876 . . . . 2.73 109.517 -179.929 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A 1626 ' ' LEU . . . . . 0.56 ' HG ' ' HD1' ' A' 1542 ' ' TYR . 3.2 tm? -73.71 113.69 11.13 Favored 'General case' 0 C--N 1.31 -1.137 0 N-CA-C 106.79 -1.559 . . . . 1.94 106.79 175.071 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A 1627 ' ' ILE . . . . . 0.515 HG22 ' HE3' ' A' 1625 ' ' MET . 31.6 pt -99.95 -30.95 3.35 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.957 0 C-N-CA 120.675 -0.41 . . . . 1.75 111.758 -176.758 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A 1628 ' ' SER . . . . . 0.403 ' HB3' ' HB2' ' A' 1637 ' ' PHE . 32.2 t -148.84 165.77 30.5 Favored 'General case' 0 N--CA 1.425 -1.679 0 CA-C-O 121.575 0.702 . . . . 1.85 111.253 -175.116 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A 1629 ' ' LEU . . . . . . . . . . . . . 14.2 tp -146.15 130.23 17.41 Favored 'General case' 0 C--N 1.292 -1.898 0 C-N-CA 125.153 1.381 . . . . 2.12 108.37 -177.682 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 1630 ' ' ASP . . . . . 0.423 ' HB2' ' HE2' ' A' 1637 ' ' PHE . 21.2 t70 -119.36 106.63 12.47 Favored 'General case' 0 C--N 1.308 -1.222 0 N-CA-C 108.452 -0.944 . . . . 0.87 108.452 175.139 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A 1631 ' ' LYS . . . . . . . . . . . . . 67.9 mttm -69.41 -35.02 75.34 Favored 'General case' 0 C--N 1.304 -1.411 0 CA-C-N 115.528 -0.76 . . . . 2.76 112.707 -176.031 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 1632 ' ' GLN . . . . . . . . . . . . . 39.4 mt-30 -74.19 -23.15 59.18 Favored 'General case' 0 C--N 1.323 -0.57 0 N-CA-C 112.938 0.718 . . . . 2.55 112.938 -176.12 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 1633 ' ' THR . . . . . . . . . . . . . 2.0 m -112.5 3.69 16.97 Favored 'General case' 0 C--N 1.314 -0.942 0 CA-C-O 121.875 0.845 . . . . 1.92 110.217 178.528 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 1634 ' ' CYS . . . . . 0.469 ' HB3' ' CD1' ' A' 1606 ' ' TYR . 33.4 m 54.36 43.36 30.58 Favored 'General case' 0 C--N 1.349 0.569 0 CA-C-N 114.673 -1.149 . . . . 0.89 110.32 177.099 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A 1635 ' ' THR . . . . . 0.528 HG21 ' HG3' ' A' 1607 ' ' LYS . 26.8 m -112.57 133.6 54.54 Favored 'General case' 0 N--CA 1.436 -1.156 0 CA-C-N 114.934 -1.03 . . . . 1.31 111.255 -173.128 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A 1636 ' ' LEU . . . . . . . . . . . . . 14.0 mt -104.72 130.45 52.77 Favored 'General case' 0 C--O 1.246 0.887 0 N-CA-C 107.894 -1.15 . . . . 1.97 107.894 174.118 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 1637 ' ' PHE . . . . . 0.423 ' HE2' ' HB2' ' A' 1630 ' ' ASP . 96.1 m-85 -107.87 110.01 21.67 Favored 'General case' 0 C--N 1.313 -1.015 0 CA-C-O 120.832 0.349 . . . . 0.92 110.809 -178.073 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A 1638 ' ' PHE . . . . . . . . . . . . . 97.9 m-85 -105.44 150.39 25.32 Favored 'General case' 0 C--N 1.307 -1.255 0 N-CA-C 109.219 -0.66 . . . . 0.7 109.219 178.457 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 1639 ' ' SER . . . . . 0.472 ' HA ' ' O ' ' A' 1611 ' ' SER . 69.1 m -141.61 138.05 32.31 Favored 'General case' 0 C--N 1.281 -2.391 0 N-CA-C 109.868 -0.419 . . . . 1.46 109.868 175.147 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A 1640 ' ' TRP . . . . . 0.49 ' HE3' ' HE2' ' A' 1612 ' ' PHE . 12.8 t90 -127.6 118.93 24.84 Favored 'General case' 0 C--N 1.29 -2.017 0 N-CA-C 107.561 -1.274 . . . . 0.92 107.561 178.537 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A 1641 ' ' HIS . . . . . 0.677 ' HB2' ' HB3' ' A' 1615 ' ' ARG . 6.2 p-80 -91.11 90.95 8.05 Favored 'General case' 0 N--CA 1.43 -1.461 0 CA-C-O 122.425 1.107 . . . . 3.18 110.045 176.465 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A 1642 ' ' THR . . . . . 0.455 ' O ' ' HA ' ' A' 1614 ' ' CYS . 1.6 m -103.3 133.81 20.11 Favored Pre-proline 0 C--N 1.281 -2.411 0 CA-C-N 113.629 -1.623 . . . . 1.48 109.688 -172.93 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A 1643 ' ' PRO . . . . . . . . . . . . . 23.7 Cg_exo -69.46 -18.91 38.19 Favored 'Trans proline' 0 CA--C 1.533 0.43 0 C-N-CA 122.669 2.246 . . . . 1.09 110.482 174.036 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 1644 ' ' LEU . . . . . . . . . . . . . 84.2 mt -76.55 -13.69 60.06 Favored 'General case' 0 N--CA 1.471 0.616 0 CA-C-N 115.036 -0.984 . . . . 2.08 110.958 178.491 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 1645 ' ' ALA . . . . . . . . . . . . . . . -79.73 2.91 21.02 Favored 'General case' 0 CA--C 1.539 0.548 0 N-CA-C 113.436 0.902 . . . . 1.37 113.436 -172.392 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 1646 ' ' CYS . . . . . . . . . . . . . 12.0 p -168.06 177.03 5.78 Favored 'General case' 0 C--O 1.25 1.094 0 N-CA-C 107.092 -1.447 . . . . 1.7 107.092 177.102 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 1647 ' ' GLU . . . . . . . . . . . . . 6.7 mp0 -103.0 106.64 51.75 Favored Pre-proline 0 C--N 1.309 -1.188 0 N-CA-C 107.089 -1.448 . . . . 2.92 107.089 172.145 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 1648 ' ' PRO . . . . . . . . . . . . . 67.0 Cg_exo -55.46 116.6 3.27 Favored 'Trans proline' 0 C--O 1.245 0.853 0 C-N-CA 122.521 2.147 . . . . 3.19 109.722 176.201 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 1649 ' ' GLU . . . . . . . . . . . . . 42.5 tt0 . . . . . 0 N--CA 1.426 -1.662 0 N-CA-C 107.962 -1.125 . . . . 5.06 107.962 -176.185 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A 1508 ' ' MET . . . . . . . . . . . . . 26.4 mmt . . . . . 0 CA--C 1.508 -0.664 0 N-CA-C 108.75 -0.833 . . . . 8.58 108.75 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A 1509 ' ' LYS . . . . . . . . . . . . . 57.7 mtpt -129.8 24.75 5.35 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 120.927 0.394 . . . . 6.8 111.538 -175.438 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 1510 ' ' SER . . . . . . . . . . . . . 15.2 m -83.18 -9.17 59.32 Favored 'General case' 0 C--N 1.309 -1.157 0 CA-C-O 122.131 0.967 . . . . 4.48 109.042 -179.667 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 1511 ' ' ASN . . . . . 0.464 ' ND2' ' HA ' ' A' 1518 ' ' VAL . 23.1 p-10 -100.46 20.87 14.12 Favored 'General case' 0 C--N 1.307 -1.257 0 CA-C-N 114.347 -1.297 . . . . 3.08 110.497 -178.97 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A 1512 ' ' GLU . . . . . . . . . . . . . 32.7 tt0 -56.8 -52.09 66.41 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-N 115.914 -0.585 . . . . 4.46 110.733 179.895 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 1513 ' ' HIS . . . . . . . . . . . . . 31.7 t-80 -140.54 -16.76 0.9 Allowed 'General case' 0 C--N 1.313 -0.982 0 CA-C-N 115.796 -0.638 . . . . 6.25 112.257 -179.767 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 1514 ' ' ASP . . . . . . . . . . . . . 18.4 t70 -59.12 -62.01 2.2 Favored 'General case' 0 N--CA 1.47 0.542 0 N-CA-C 112.363 0.505 . . . . 3.7 112.363 -176.4 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 1515 ' ' ASP . . . . . . . . . . . . . 16.3 t70 -120.81 146.71 46.25 Favored 'General case' 0 C--N 1.312 -1.022 0 N-CA-C 109.102 -0.703 . . . . 2.54 109.102 -177.495 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 1516 ' ' CYS . . . . . 0.553 ' HB2' ' HD2' ' A' 1579 ' ' LYS . 8.0 t -79.63 74.07 6.31 Favored 'General case' 0 C--N 1.31 -1.152 0 CA-C-O 122.019 0.914 . . . . 1.25 110.181 -176.194 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A 1517 ' ' GLN . . . . . 0.474 ' HB2' HD21 ' A' 1526 ' ' LEU . 10.3 pt20 -151.12 159.28 44.57 Favored 'General case' 0 C--N 1.306 -1.29 0 CA-C-N 116.014 -0.539 . . . . 2.36 109.827 -179.397 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A 1518 ' ' VAL . . . . . 0.464 ' HA ' ' ND2' ' A' 1511 ' ' ASN . 7.5 p -151.5 139.69 14.29 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.496 0 N-CA-C 108.829 -0.804 . . . . 2.34 108.829 177.207 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A 1519 ' ' THR . . . . . 0.595 ' HA ' ' HA ' ' A' 1526 ' ' LEU . 15.2 m -87.14 122.67 31.27 Favored 'General case' 0 N--CA 1.42 -1.94 0 N-CA-C 107.482 -1.303 . . . . 2.04 107.482 176.88 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A 1520 ' ' ASN . . . . . . . . . . . . . 25.2 t-20 -78.74 115.34 51.15 Favored Pre-proline 0 C--N 1.318 -0.794 0 N-CA-C 108.612 -0.885 . . . . 2.12 108.612 179.393 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 1521 ' ' PRO . . . . . . . . . . . . . 71.4 Cg_endo -72.27 -20.29 24.67 Favored 'Trans proline' 0 CA--C 1.533 0.437 0 C-N-CA 122.185 1.924 . . . . 2.59 113.715 -175.144 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 1522 ' ' SER . . . . . . . . . . . . . 37.6 m -81.96 -37.44 26.67 Favored 'General case' 0 N--CA 1.436 -1.155 0 N-CA-C 112.648 0.61 . . . . 2.65 112.648 -175.642 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 1523 ' ' THR . . . . . . . . . . . . . 8.8 t -103.63 -17.58 15.09 Favored 'General case' 0 CA--C 1.551 0.984 0 C-N-CA 120.005 -0.678 . . . . 2.33 111.35 176.987 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 1524 ' ' GLY . . . . . . . . . . . . . . . 81.48 11.38 83.27 Favored Glycine 0 C--O 1.226 -0.391 0 C-N-CA 121.168 -0.539 . . . . 1.96 112.181 179.209 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 1525 ' ' HIS . . . . . . . . . . . . . 57.1 t-80 -101.89 136.12 42.28 Favored 'General case' 0 C--N 1.304 -1.37 0 N-CA-C 108.182 -1.044 . . . . 2.44 108.182 -179.237 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 1526 ' ' LEU . . . . . 0.595 ' HA ' ' HA ' ' A' 1519 ' ' THR . 5.1 tt -82.31 134.56 35.27 Favored 'General case' 0 C--N 1.293 -1.855 0 N-CA-C 106.512 -1.662 . . . . 2.19 106.512 177.621 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A 1527 ' ' PHE . . . . . 0.41 ' N ' HD22 ' A' 1526 ' ' LEU . 65.7 m-85 -110.85 112.34 24.12 Favored 'General case' 0 C--N 1.294 -1.834 0 CA-C-O 121.424 0.631 . . . . 1.61 111.072 177.889 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A 1528 ' ' ASP . . . . . . . . . . . . . 11.3 t70 -85.63 124.09 31.77 Favored 'General case' 0 C--N 1.312 -1.051 0 CA-C-N 114.525 -1.216 . . . . 2.18 111.092 179.453 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 1529 ' ' LEU . . . . . . . . . . . . . 9.9 mp -116.62 18.45 14.98 Favored 'General case' 0 C--N 1.313 -0.986 0 CA-C-N 115.801 -0.636 . . . . 2.04 109.285 175.006 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 1530 ' ' SER . . . . . . . . . . . . . 47.9 m -98.38 -29.08 13.34 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-O 121.246 0.546 . . . . 1.44 111.419 -178.404 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 1531 ' ' SER . . . . . . . . . . . . . 3.4 m -96.02 -9.71 30.32 Favored 'General case' 0 C--N 1.302 -1.493 0 CA-C-O 121.148 0.499 . . . . 1.63 110.421 -178.556 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 1532 ' ' LEU . . . . . . . . . . . . . 78.5 mt -65.64 -40.92 93.03 Favored 'General case' 0 CA--C 1.543 0.695 0 N-CA-C 114.169 1.174 . . . . 2.32 114.169 -178.686 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 1533 ' ' SER . . . . . 0.699 ' HB2' ' HB ' ' A' 1552 ' ' ILE . 7.2 t -101.01 126.78 47.7 Favored 'General case' 0 C--N 1.302 -1.477 0 N-CA-C 108.861 -0.792 . . . . 2.57 108.861 -178.137 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A 1534 ' ' GLY . . . . . . . . . . . . . . . -104.57 -122.53 5.1 Favored Glycine 0 N--CA 1.425 -2.037 0 CA-C-N 115.883 -0.599 . . . . 1.89 112.466 -179.957 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 1535 ' ' ARG . . . . . . . . . . . . . 20.5 tpt180 -81.79 -56.98 3.64 Favored 'General case' 0 C--N 1.302 -1.48 0 CA-C-O 120.875 0.369 . . . . 4.44 111.178 -176.446 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 1536 ' ' ALA . . . . . . . . . . . . . . . -91.49 -45.45 8.52 Favored 'General case' 0 C--N 1.307 -1.25 0 C-N-CA 120.456 -0.497 . . . . 2.07 111.65 -174.258 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 1537 ' ' GLY . . . . . . . . . . . . . . . 100.15 -138.22 13.73 Favored Glycine 0 N--CA 1.429 -1.794 0 N-CA-C 110.894 -0.882 . . . . 1.2 110.894 -179.212 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 1538 ' ' PHE . . . . . . . . . . . . . 74.6 m-85 -138.1 172.99 12.11 Favored 'General case' 0 C--N 1.316 -0.88 0 N-CA-C 107.705 -1.22 . . . . 1.98 107.705 -178.821 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 1539 ' ' THR . . . . . . . . . . . . . 6.6 t -147.41 151.71 36.92 Favored 'General case' 0 C--N 1.299 -1.59 0 C-N-CA 119.384 -0.926 . . . . 1.97 111.21 -177.072 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 1540 ' ' ALA . . . . . . . . . . . . . . . -132.19 135.47 46.36 Favored 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 108.543 -0.91 . . . . 1.39 108.543 177.945 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 1541 ' ' ALA . . . . . . . . . . . . . . . -80.45 152.2 28.89 Favored 'General case' 0 C--N 1.317 -0.827 0 CA-C-O 121.033 0.444 . . . . 1.86 110.855 -179.086 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 1542 ' ' TYR . . . . . . . . . . . . . 30.3 t80 -149.36 177.62 9.51 Favored 'General case' 0 N--CA 1.425 -1.689 0 N-CA-C 108.48 -0.933 . . . . 2.4 108.48 -177.903 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 1543 ' ' SER . . . . . . . . . . . . . 4.5 m -48.69 -151.16 0.0 OUTLIER 'General case' 0 CA--C 1.58 2.132 0 C-N-CA 128.71 2.804 . . . . 2.58 113.28 178.173 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 1544 ' ' LYS . . . . . . . . . . . . . 27.5 ttpp -43.18 -26.26 0.16 Allowed 'General case' 0 N--CA 1.495 1.8 0 O-C-N 120.607 -1.308 . . . . 4.24 113.322 178.365 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 1545 ' ' SER . . . . . . . . . . . . . 7.1 m -64.68 -22.02 66.88 Favored 'General case' 0 CA--C 1.569 1.677 0 C-N-CA 123.134 0.574 . . . . 3.6 111.541 175.633 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 1546 ' ' GLY . . . . . . . . . . . . . . . 91.45 -78.68 1.33 Allowed Glycine 0 N--CA 1.438 -1.174 0 N-CA-C 114.127 0.411 . . . . 1.66 114.127 173.518 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 1547 ' ' VAL . . . . . . . . . . . . . 10.0 p -159.37 147.42 7.19 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.043 0 N-CA-C 107.057 -1.46 . . . . 2.23 107.057 -176.071 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 1548 ' ' VAL . . . . . . . . . . . . . 1.6 t -116.57 129.22 73.42 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.946 0 N-CA-C 108.319 -0.993 . . . . 1.59 108.319 -177.338 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 1549 ' ' TYR . . . . . 0.511 ' CE2' ' HA3' ' A' 1568 ' ' GLY . 79.3 m-85 -85.44 120.38 26.84 Favored 'General case' 0 CA--C 1.494 -1.184 0 N-CA-C 107.315 -1.365 . . . . 1.58 107.315 174.839 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A 1550 ' ' MET . . . . . . . . . . . . . 88.7 mmm -124.76 121.29 34.19 Favored 'General case' 0 C--N 1.298 -1.654 0 N-CA-C 109.707 -0.479 . . . . 2.08 109.707 -173.579 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 1551 ' ' SER . . . . . . . . . . . . . 50.4 m -89.96 158.62 17.3 Favored 'General case' 0 C--N 1.286 -2.158 0 N-CA-C 108.41 -0.959 . . . . 1.9 108.41 175.622 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 1552 ' ' ILE . . . . . 0.699 ' HB ' ' HB2' ' A' 1533 ' ' SER . 38.8 mm -74.14 -60.57 2.26 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.299 0 C-N-CA 119.228 -0.989 . . . . 2.04 108.507 -179.871 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A 1553 ' ' CYS . . . . . 0.408 ' SG ' ' HG3' ' A' 1579 ' ' LYS . 34.9 t -151.16 141.99 22.86 Favored 'General case' 0 N--CA 1.421 -1.92 0 N-CA-C 104.402 -2.444 . . . . 1.43 104.402 178.663 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A 1554 ' ' GLY . . . . . . . . . . . . . . . 104.81 -172.34 19.93 Favored Glycine 0 C--N 1.291 -1.951 0 C-N-CA 119.666 -1.254 . . . . 1.23 111.073 -177.504 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 1555 ' ' GLU . . . . . . . . . . . . . 8.9 pt-20 -98.67 142.4 30.28 Favored 'General case' 0 C--N 1.308 -1.219 0 N-CA-C 113.656 0.984 . . . . 1.8 113.656 -173.009 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 1556 ' ' ASN . . . . . 0.409 ' O ' ' HA ' ' A' 1561 ' ' PRO . 19.3 t-20 -94.15 145.68 24.52 Favored 'General case' 0 C--N 1.309 -1.168 0 CA-C-N 113.707 -1.588 . . . . 2.63 108.216 -179.398 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A 1557 ' ' GLU . . . . . . . . . . . . . 58.1 mm-40 -112.39 -9.47 13.84 Favored 'General case' 0 C--N 1.305 -1.35 0 O-C-N 123.464 0.478 . . . . 3.79 111.525 -174.618 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 1558 ' ' ASN . . . . . . . . . . . . . 18.4 m-80 -85.49 2.58 44.11 Favored 'General case' 0 N--CA 1.489 1.488 0 CA-C-O 121.91 0.862 . . . . 1.59 111.519 -177.972 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 1559 ' ' CYS . . . . . 0.798 ' HB3' ' HD2' ' A' 1560 ' ' PRO . 47.3 m -145.46 -175.93 0.51 Allowed Pre-proline 0 C--N 1.288 -2.097 0 N-CA-C 105.192 -2.151 . . . . 0.94 105.192 175.51 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A 1560 ' ' PRO . . . . . 0.798 ' HD2' ' HB3' ' A' 1559 ' ' CYS . 1.6 Cg_endo -44.48 112.84 0.38 Allowed 'Trans proline' 0 C--N 1.376 2.01 0 C-N-CA 122.312 2.008 . . . . 1.53 112.255 177.285 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A 1561 ' ' PRO . . . . . 0.409 ' HA ' ' O ' ' A' 1556 ' ' ASN . 53.0 Cg_exo -57.67 110.62 0.65 Allowed 'Trans proline' 0 C--O 1.244 0.82 0 C-N-CA 122.97 2.447 . . . . 1.82 111.229 -177.233 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A 1562 ' ' GLY . . . . . . . . . . . . . . . 135.96 -16.4 3.96 Favored Glycine 0 C--N 1.299 -1.483 0 N-CA-C 110.756 -0.938 . . . . 0.81 110.756 -176.544 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 1563 ' ' VAL . . . . . 0.565 ' HA ' ' HA ' ' A' 1576 ' ' LYS . 4.9 m -94.02 160.96 2.64 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.236 0 N-CA-C 107.029 -1.471 . . . . 1.73 107.029 176.659 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A 1564 ' ' GLY . . . . . 0.486 ' HA3' ' CE2' ' A' 1592 ' ' TYR . . . -124.18 -5.08 7.5 Favored Glycine 0 C--O 1.238 0.403 0 C-N-CA 119.125 -1.512 . . . . 0.72 113.162 -177.06 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A 1565 ' ' ALA . . . . . . . . . . . . . . . -150.18 127.24 11.2 Favored 'General case' 0 C--O 1.251 1.14 0 N-CA-C 108.808 -0.812 . . . . 1.14 108.808 179.867 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 1566 ' ' CYS . . . . . . . . . . . . . 9.8 t -159.13 142.92 15.04 Favored 'General case' 0 C--N 1.308 -1.201 0 CA-C-N 116.258 -0.428 . . . . 0.51 111.062 -172.755 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 1567 ' ' PHE . . . . . . . . . . . . . 24.9 m-85 -73.31 123.24 23.37 Favored 'General case' 0 CA--C 1.508 -0.668 0 N-CA-C 107.224 -1.398 . . . . 1.22 107.224 175.789 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 1568 ' ' GLY . . . . . 0.511 ' HA3' ' CE2' ' A' 1549 ' ' TYR . . . -79.26 -25.47 59.28 Favored Glycine 0 C--N 1.3 -1.426 0 C-N-CA 120.052 -1.07 . . . . 1.08 114.785 -171.688 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A 1569 ' ' GLN . . . . . . . . . . . . . 8.1 tp-100 -71.08 -46.03 62.62 Favored 'General case' 0 C--N 1.306 -1.303 0 C-N-CA 119.937 -0.705 . . . . 3.05 110.934 -179.179 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 1570 ' ' THR . . . . . . . . . . . . . 38.3 p -95.83 -13.14 24.27 Favored 'General case' 0 C--N 1.306 -1.309 0 N-CA-C 112.333 0.494 . . . . 2.44 112.333 -177.154 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 1571 ' ' ARG . . . . . . . . . . . . . 79.4 mtm180 60.63 37.39 19.29 Favored 'General case' 0 C--O 1.246 0.869 0 C-N-CA 124.753 1.221 . . . . 4.48 112.798 -177.303 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 1572 ' ' ILE . . . . . . . . . . . . . 39.9 mm -101.03 110.69 28.55 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.378 0 CA-C-N 114.458 -1.246 . . . . 1.94 108.2 177.941 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 1573 ' ' SER . . . . . . . . . . . . . 29.1 t -67.68 133.73 49.85 Favored 'General case' 0 C--N 1.294 -1.836 0 CA-C-N 114.548 -1.206 . . . . 1.25 111.016 -179.971 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 1574 ' ' VAL . . . . . 0.506 ' HB ' ' HB2' ' A' 1606 ' ' TYR . 34.8 m -108.23 -33.39 2.55 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.309 0 C-N-CA 120.602 -0.439 . . . . 1.61 111.009 -179.815 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A 1575 ' ' GLY . . . . . . . . . . . . . . . -140.11 130.88 4.83 Favored Glycine 0 N--CA 1.433 -1.512 0 C-N-CA 120.364 -0.922 . . . . 0.65 112.67 -177.692 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 1576 ' ' LYS . . . . . 0.565 ' HA ' ' HA ' ' A' 1563 ' ' VAL . 88.4 tttt -79.75 151.15 30.54 Favored 'General case' 0 C--N 1.313 -1.009 0 N-CA-C 108.32 -0.993 . . . . 3.33 108.32 178.698 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A 1577 ' ' ALA . . . . . . . . . . . . . . . -70.71 98.17 1.48 Allowed 'General case' 0 CA--C 1.508 -0.662 0 CA-C-O 121.245 0.545 . . . . 1.31 111.119 -175.988 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 1578 ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -101.66 115.93 31.62 Favored 'General case' 0 C--N 1.296 -1.753 0 N-CA-C 107.118 -1.438 . . . . 2.24 107.118 175.97 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A 1579 ' ' LYS . . . . . 0.553 ' HD2' ' HB2' ' A' 1516 ' ' CYS . 38.4 ttpt -91.34 89.72 7.4 Favored 'General case' 0 C--N 1.3 -1.578 0 N-CA-C 108.085 -1.08 . . . . 2.34 108.085 179.532 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A 1580 ' ' ARG . . . . . . . . . . . . . 14.4 tpp180 -156.43 116.93 3.67 Favored 'General case' 0 N--CA 1.419 -1.976 0 CA-C-N 114.459 -1.246 . . . . 4.19 108.556 -176.11 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 1581 ' ' LEU . . . . . . . . . . . . . 2.9 pp -113.37 150.65 32.33 Favored 'General case' 0 C--N 1.297 -1.688 0 C-N-CA 120.515 -0.474 . . . . 2.39 111.236 178.145 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 1582 ' ' ARG . . . . . . . . . . . . . 41.2 ttm180 -130.12 109.75 11.07 Favored 'General case' 0 C--N 1.295 -1.781 0 CA-C-N 115.603 -0.726 . . . . 4.48 109.912 -178.625 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 1583 ' ' TYR . . . . . . . . . . . . . 79.6 t80 -94.84 104.12 16.02 Favored 'General case' 0 C--N 1.296 -1.746 0 N-CA-C 108.443 -0.947 . . . . 1.57 108.443 178.801 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 1584 ' ' VAL . . . . . 0.486 ' O ' HG11 ' A' 1587 ' ' VAL . 7.0 p -130.78 111.2 19.76 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.403 0 C-N-CA 120.358 -0.537 . . . . 2.29 112.0 -177.584 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A 1585 ' ' ASP . . . . . . . . . . . . . 18.7 t70 59.98 59.16 2.5 Favored 'General case' 0 N--CA 1.481 1.078 0 CA-C-O 122.584 1.183 . . . . 2.06 110.976 177.171 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 1586 ' ' GLN . . . . . . . . . . . . . 41.8 mt-30 57.35 23.53 9.01 Favored 'General case' 0 C--N 1.315 -0.916 0 N-CA-C 115.186 1.55 . . . . 2.61 115.186 179.087 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 1587 ' ' VAL . . . . . 0.486 HG11 ' O ' ' A' 1584 ' ' VAL . 9.5 p -130.85 128.32 62.63 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.512 0 N-CA-C 108.757 -0.831 . . . . 1.33 108.757 173.482 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A 1588 ' ' LEU . . . . . 0.598 ' HB2' ' HB2' ' A' 1612 ' ' PHE . 8.1 mp -89.15 143.98 26.45 Favored 'General case' 0 N--CA 1.427 -1.58 0 CA-C-N 115.609 -0.723 . . . . 2.03 109.636 179.689 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A 1589 ' ' GLN . . . . . . . . . . . . . 7.7 tt0 -136.05 142.8 44.43 Favored 'General case' 0 C--N 1.28 -2.454 0 N-CA-C 108.872 -0.788 . . . . 1.73 108.872 178.136 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 1590 ' ' LEU . . . . . . . . . . . . . 5.7 tt -139.19 133.83 31.94 Favored 'General case' 0 C--N 1.293 -1.861 0 N-CA-C 103.611 -2.737 . . . . 1.76 103.611 173.463 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 1591 ' ' VAL . . . . . . . . . . . . . 7.3 p -130.9 127.61 61.59 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.496 0 N-CA-C 113.792 1.034 . . . . 2.14 113.792 -172.808 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 1592 ' ' TYR . . . . . 0.486 ' CE2' ' HA3' ' A' 1564 ' ' GLY . 96.4 m-85 -101.33 139.9 36.37 Favored 'General case' 0 CA--C 1.495 -1.162 0 CA-C-N 114.581 -1.19 . . . . 1.53 107.86 177.412 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A 1593 ' ' LYS . . . . . . . . . . . . . 14.1 ptmm? -158.93 170.12 22.81 Favored 'General case' 0 C--N 1.299 -1.595 0 C-N-CA 120.601 -0.44 . . . . 2.72 110.084 -179.125 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 1594 ' ' ASP . . . . . . . . . . . . . 48.1 m-20 61.8 41.98 11.11 Favored 'General case' 0 C--N 1.312 -1.025 0 N-CA-C 114.774 1.398 . . . . 1.45 114.774 175.127 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 1595 ' ' GLY . . . . . . . . . . . . . . . -77.49 -86.88 0.41 Allowed Glycine 0 N--CA 1.437 -1.258 0 N-CA-C 109.13 -1.588 . . . . 0.83 109.13 171.241 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 1596 ' ' SER . . . . . . . . . . . . . 15.5 m -114.47 152.37 46.06 Favored Pre-proline 0 C--N 1.298 -1.635 0 N-CA-C 107.921 -1.14 . . . . 1.96 107.921 176.059 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 1597 ' ' PRO . . . . . . . . . . . . . 28.1 Cg_exo -63.74 146.35 91.99 Favored 'Trans proline' 0 C--O 1.247 0.97 0 C-N-CA 122.929 2.42 . . . . 1.34 111.45 178.103 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 1598 ' ' CYS . . . . . 0.446 ' HA ' ' HD3' ' A' 1599 ' ' PRO . 27.4 t -98.76 133.3 22.56 Favored Pre-proline 0 C--N 1.297 -1.696 0 N-CA-C 108.894 -0.78 . . . . 1.19 108.894 -178.486 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A 1599 ' ' PRO . . . . . 0.446 ' HD3' ' HA ' ' A' 1598 ' ' CYS . 32.1 Cg_exo -62.82 -21.62 73.22 Favored 'Trans proline' 0 C--N 1.359 1.129 0 C-N-CA 123.759 2.973 . . . . 1.88 112.941 179.801 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A 1600 ' ' SER . . . . . 0.551 ' HB3' ' SG ' ' A' 1634 ' ' CYS . 47.9 t -85.89 117.74 24.93 Favored 'General case' 0 N--CA 1.427 -1.606 0 N-CA-C 106.704 -1.591 . . . . 2.19 106.704 175.242 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A 1601 ' ' LYS . . . . . . . . . . . . . 48.4 mmtm 58.82 60.63 2.42 Favored 'General case' 0 C--O 1.245 0.865 0 O-C-N 123.988 0.805 . . . . 4.21 108.994 -176.484 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 1602 ' ' SER . . . . . . . . . . . . . 23.3 t -53.37 112.27 0.86 Allowed 'General case' 0 C--O 1.247 0.969 0 CA-C-N 114.786 -1.097 . . . . 3.82 111.542 -174.846 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 1603 ' ' GLY . . . . . . . . . . . . . . . 150.99 -33.84 0.94 Allowed Glycine 0 N--CA 1.43 -1.743 0 N-CA-C 108.137 -1.985 . . . . 2.45 108.137 -177.912 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 1604 ' ' LEU . . . . . . . . . . . . . 2.5 pp -94.59 164.16 13.09 Favored 'General case' 0 N--CA 1.427 -1.585 0 CA-C-N 114.644 -0.778 . . . . 2.06 109.567 175.87 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 1605 ' ' SER . . . . . . . . . . . . . 19.0 p -109.42 -167.08 1.16 Allowed 'General case' 0 C--N 1.286 -2.19 0 N-CA-C 109.371 -0.603 . . . . 1.75 109.371 -178.82 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 1606 ' ' TYR . . . . . 0.506 ' HB2' ' HB ' ' A' 1574 ' ' VAL . 61.1 m-85 -97.45 144.79 26.83 Favored 'General case' 0 N--CA 1.413 -2.32 0 N-CA-C 104.466 -2.42 . . . . 1.59 104.466 179.07 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A 1607 ' ' LYS . . . . . 0.45 ' HG3' HG21 ' A' 1635 ' ' THR . 19.2 ptmt -132.38 132.98 43.4 Favored 'General case' 0 C--N 1.268 -2.968 0 C-N-CA 118.655 -1.218 . . . . 2.21 109.422 177.283 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A 1608 ' ' SER . . . . . . . . . . . . . 20.2 m -115.69 111.72 21.02 Favored 'General case' 0 C--N 1.291 -1.945 0 C-N-CA 122.848 0.459 . . . . 1.48 110.694 -175.724 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 1609 ' ' VAL . . . . . . . . . . . . . 96.5 t -92.34 121.38 42.87 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.069 0 N-CA-C 109.151 -0.685 . . . . 1.57 109.151 178.17 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 1610 ' ' ILE . . . . . . . . . . . . . 17.0 mm -99.62 104.44 16.07 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.552 0 N-CA-C 107.871 -1.159 . . . . 1.47 107.871 177.11 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 1611 ' ' SER . . . . . 0.459 ' O ' ' HA ' ' A' 1639 ' ' SER . 22.8 t -91.8 119.87 32.01 Favored 'General case' 0 N--CA 1.42 -1.957 0 N-CA-C 108.612 -0.884 . . . . 1.84 108.612 178.667 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A 1612 ' ' PHE . . . . . 0.598 ' HB2' ' HB2' ' A' 1588 ' ' LEU . 97.4 m-85 -95.85 108.73 21.11 Favored 'General case' 0 C--N 1.297 -1.696 0 CA-C-N 115.548 -0.751 . . . . 0.86 109.678 -178.776 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A 1613 ' ' VAL . . . . . . . . . . . . . 48.0 t -100.56 122.14 52.19 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.012 0 CA-C-N 115.409 -0.814 . . . . 1.32 109.544 -176.891 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 1614 ' ' CYS . . . . . 0.659 ' HA ' ' O ' ' A' 1642 ' ' THR . 0.8 OUTLIER -76.68 100.6 5.45 Favored 'General case' 0 CA--C 1.5 -0.977 0 N-CA-C 113.178 0.807 . . . . 1.39 113.178 177.289 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A 1615 ' ' ARG . . . . . 0.503 ' HD3' ' HD2' ' A' 1616 ' ' PRO . 14.0 tpp180 -137.71 116.77 9.96 Favored Pre-proline 0 N--CA 1.414 -2.27 0 CA-C-N 114.851 -1.068 . . . . 4.34 108.411 177.103 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A 1616 ' ' PRO . . . . . 0.503 ' HD2' ' HD3' ' A' 1615 ' ' ARG . 56.6 Cg_exo -58.16 52.13 0.05 OUTLIER 'Trans proline' 0 CA--C 1.553 1.463 0 C-N-CA 124.788 3.659 . . . . 1.5 114.717 174.636 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A 1617 ' ' GLU . . . . . . . . . . . . . 44.0 tt0 -104.26 -13.87 16.01 Favored 'General case' 0 C--N 1.31 -1.143 0 N-CA-C 108.2 -1.037 . . . . 3.21 108.2 176.628 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 1618 ' ' ALA . . . . . . . . . . . . . . . 59.73 -173.07 0.11 Allowed 'General case' 0 N--CA 1.47 0.532 0 CA-C-N 113.719 -1.582 . . . . 2.91 112.548 177.225 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 1619 ' ' GLY . . . . . . . . . . . . . . . 98.6 103.93 2.41 Favored Glycine 0 N--CA 1.434 -1.458 0 C-N-CA 120.938 -0.649 . . . . 3.35 112.367 177.45 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 1620 ' ' PRO . . . . . 0.834 ' HA ' ' HZ2' ' A' 1640 ' ' TRP . 18.4 Cg_exo -69.75 -17.78 37.41 Favored 'Trans proline' 0 CA--C 1.539 0.771 0 C-N-CA 122.531 2.154 . . . . 6.61 111.993 178.292 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A 1621 ' ' THR . . . . . . . . . . . . . 31.2 m -102.52 -0.31 32.41 Favored 'General case' 0 C--N 1.314 -0.955 0 N-CA-C 108.663 -0.866 . . . . 5.03 108.663 178.044 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 1622 ' ' ASN . . . . . 0.45 ' C ' ' HD3' ' A' 1624 ' ' PRO . 61.0 t30 -77.16 47.79 0.57 Allowed 'General case' 0 C--O 1.247 0.934 0 CA-C-O 121.894 0.854 . . . . 3.58 112.578 -174.592 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A 1623 ' ' ARG . . . . . 0.504 ' HB3' ' CD1' ' A' 1640 ' ' TRP . 9.2 ptm180 -123.72 69.6 45.63 Favored Pre-proline 0 N--CA 1.434 -1.237 0 C-N-CA 119.572 -0.851 . . . . 4.09 112.043 178.62 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A 1624 ' ' PRO . . . . . 0.45 ' HD3' ' C ' ' A' 1622 ' ' ASN . 64.4 Cg_endo -114.41 91.18 0.01 OUTLIER 'Trans proline' 0 N--CA 1.426 -2.491 0 C-N-CA 122.446 2.098 . . . . 2.86 110.09 167.61 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A 1625 ' ' MET . . . . . 0.475 ' HG3' HG23 ' A' 1627 ' ' ILE . 12.9 tpt -151.78 98.77 2.51 Favored 'General case' 0 C--N 1.297 -1.714 0 C-N-CA 116.939 -1.905 . . . . 2.73 112.236 -179.389 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A 1626 ' ' LEU . . . . . . . . . . . . . 4.4 mm? -87.85 88.99 7.82 Favored 'General case' 0 C--N 1.302 -1.494 0 N-CA-C 108.518 -0.919 . . . . 1.94 108.518 171.321 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 1627 ' ' ILE . . . . . 0.475 HG23 ' HG3' ' A' 1625 ' ' MET . 37.0 pt -73.42 -35.18 45.11 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.872 0 CA-C-N 115.875 -0.602 . . . . 1.75 110.956 -178.293 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A 1628 ' ' SER . . . . . . . . . . . . . 22.9 t -161.67 152.43 17.87 Favored 'General case' 0 N--CA 1.414 -2.268 0 N-CA-C 107.628 -1.249 . . . . 1.85 107.628 -178.242 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 1629 ' ' LEU . . . . . 0.58 ' HG ' ' HG ' ' A' 1636 ' ' LEU . 5.1 tt -146.72 111.99 5.49 Favored 'General case' 0 C--N 1.286 -2.166 0 N-CA-C 106.041 -1.837 . . . . 2.12 106.041 175.843 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A 1630 ' ' ASP . . . . . 0.408 ' HB3' ' HB ' ' A' 1635 ' ' THR . 14.0 t70 -84.81 99.66 11.04 Favored 'General case' 0 C--N 1.292 -1.915 0 N-CA-C 106.741 -1.577 . . . . 0.87 106.741 -179.544 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A 1631 ' ' LYS . . . . . . . . . . . . . 47.1 mtmt -72.79 -19.17 61.39 Favored 'General case' 0 C--N 1.306 -1.324 0 CA-C-N 115.941 -0.572 . . . . 2.76 112.373 -173.304 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 1632 ' ' GLN . . . . . . . . . . . . . 2.8 mp0 -73.68 -51.45 16.64 Favored 'General case' 0 C--N 1.313 -0.985 0 C-N-CA 121.01 -0.276 . . . . 2.55 110.719 179.616 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 1633 ' ' THR . . . . . . . . . . . . . 35.7 p -97.36 14.03 27.62 Favored 'General case' 0 C--N 1.316 -0.858 0 CA-C-O 121.357 0.599 . . . . 1.92 111.917 -179.706 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 1634 ' ' CYS . . . . . 0.551 ' SG ' ' HB3' ' A' 1600 ' ' SER . 65.9 m 50.01 45.58 25.18 Favored 'General case' 0 N--CA 1.475 0.813 0 C-N-CA 124.966 1.307 . . . . 0.89 112.244 177.744 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A 1635 ' ' THR . . . . . 0.45 HG21 ' HG3' ' A' 1607 ' ' LYS . 25.5 m -107.14 107.51 18.52 Favored 'General case' 0 N--CA 1.428 -1.574 0 CA-C-N 114.89 -1.05 . . . . 1.31 109.831 -176.609 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A 1636 ' ' LEU . . . . . 0.58 ' HG ' ' HG ' ' A' 1629 ' ' LEU . 4.9 mp -95.11 127.88 41.51 Favored 'General case' 0 C--N 1.309 -1.182 0 N-CA-C 109.434 -0.58 . . . . 1.97 109.434 -177.505 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A 1637 ' ' PHE . . . . . . . . . . . . . 95.6 m-85 -109.36 110.85 22.11 Favored 'General case' 0 C--N 1.314 -0.939 0 CA-C-O 120.941 0.401 . . . . 0.92 110.305 -179.12 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 1638 ' ' PHE . . . . . 0.429 ' HA ' ' O ' ' A' 1625 ' ' MET . 92.6 m-85 -105.41 159.32 16.01 Favored 'General case' 0 C--N 1.315 -0.933 0 N-CA-C 109.393 -0.595 . . . . 0.7 109.393 179.583 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A 1639 ' ' SER . . . . . 0.459 ' HA ' ' O ' ' A' 1611 ' ' SER . 50.1 m -142.09 144.85 33.74 Favored 'General case' 0 C--N 1.299 -1.599 0 CA-C-O 120.841 0.353 . . . . 1.46 110.885 175.713 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A 1640 ' ' TRP . . . . . 0.834 ' HZ2' ' HA ' ' A' 1620 ' ' PRO . 12.4 t90 -118.95 137.79 53.25 Favored 'General case' 0 C--N 1.323 -0.551 0 N-CA-C 106.939 -1.504 . . . . 0.92 106.939 176.871 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A 1641 ' ' HIS . . . . . . . . . . . . . 38.9 m-70 -98.87 98.09 9.21 Favored 'General case' 0 C--N 1.314 -0.937 0 N-CA-C 105.966 -1.864 . . . . 3.18 105.966 179.075 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 1642 ' ' THR . . . . . 0.659 ' O ' ' HA ' ' A' 1614 ' ' CYS . 9.8 t -142.24 139.21 17.47 Favored Pre-proline 0 C--N 1.305 -1.359 0 N-CA-C 113.459 0.911 . . . . 1.48 113.459 -171.686 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A 1643 ' ' PRO . . . . . 0.48 ' HD3' ' HA ' ' A' 1642 ' ' THR . 4.4 Cg_exo -79.42 -6.77 14.77 Favored 'Trans proline' 0 C--N 1.355 0.894 0 C-N-CA 123.462 2.775 . . . . 1.09 110.385 173.574 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A 1644 ' ' LEU . . . . . . . . . . . . . 65.8 mt -89.13 5.32 45.14 Favored 'General case' 0 N--CA 1.443 -0.797 0 CA-C-N 115.229 -0.896 . . . . 2.08 110.249 -177.693 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 1645 ' ' ALA . . . . . . . . . . . . . . . -97.18 -44.36 6.98 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-O 121.619 0.724 . . . . 1.37 109.642 176.46 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 1646 ' ' CYS . . . . . . . . . . . . . 0.6 OUTLIER -171.41 173.91 4.64 Favored 'General case' 0 C--N 1.303 -1.441 0 N-CA-C 107.69 -1.226 . . . . 1.7 107.69 -178.063 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A 1647 ' ' GLU . . . . . . . . . . . . . 51.8 mt-10 -132.47 111.63 13.91 Favored Pre-proline 0 C--N 1.303 -1.432 0 N-CA-C 108.519 -0.919 . . . . 2.92 108.519 -178.787 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 1648 ' ' PRO . . . . . . . . . . . . . 23.9 Cg_exo -67.47 101.03 0.6 Allowed 'Trans proline' 0 C--O 1.245 0.828 0 C-N-CA 122.211 1.941 . . . . 3.19 110.51 178.875 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 1649 ' ' GLU . . . . . . . . . . . . . 14.1 tp10 . . . . . 0 N--CA 1.427 -1.62 0 N-CA-C 108.012 -1.107 . . . . 5.06 108.012 -178.341 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A 1508 ' ' MET . . . . . . . . . . . . . 23.8 ptp . . . . . 0 CA--C 1.533 0.292 0 N-CA-C 112.027 0.38 . . . . 8.58 112.027 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A 1509 ' ' LYS . . . . . . . . . . . . . 22.3 pttp -139.15 27.31 2.36 Favored 'General case' 0 C--N 1.327 -0.41 0 O-C-N 121.711 -0.618 . . . . 6.8 110.607 -177.356 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 1510 ' ' SER . . . . . . . . . . . . . 26.0 p -144.51 144.15 31.2 Favored 'General case' 0 C--N 1.299 -1.62 0 N-CA-C 108.97 -0.752 . . . . 4.48 108.97 -176.753 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 1511 ' ' ASN . . . . . 0.428 ' HB2' ' HG3' ' A' 1517 ' ' GLN . 28.4 p30 -140.75 -19.77 0.82 Allowed 'General case' 0 C--N 1.307 -1.246 0 N-CA-C 114.103 1.149 . . . . 3.08 114.103 -177.458 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A 1512 ' ' GLU . . . . . 0.446 ' HG2' HG21 ' A' 1518 ' ' VAL . 47.2 mt-10 -61.38 -28.28 69.13 Favored 'General case' 0 N--CA 1.486 1.373 0 CA-C-O 121.312 0.577 . . . . 4.46 112.491 -176.429 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A 1513 ' ' HIS . . . . . 0.469 ' HA ' ' O ' ' A' 1579 ' ' LYS . 35.4 m-70 -122.38 -9.06 8.59 Favored 'General case' 0 C--N 1.315 -0.92 0 CA-C-O 121.053 0.454 . . . . 6.25 110.611 176.793 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A 1514 ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -92.06 -31.53 15.52 Favored 'General case' 0 C--N 1.307 -1.27 0 N-CA-C 112.416 0.524 . . . . 3.7 112.416 -175.721 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 1515 ' ' ASP . . . . . 0.553 ' HB3' ' HG2' ' A' 1517 ' ' GLN . 7.5 t70 -141.15 -171.77 3.35 Favored 'General case' 0 C--N 1.295 -1.799 0 N-CA-C 105.781 -1.933 . . . . 2.54 105.781 -177.347 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A 1516 ' ' CYS . . . . . . . . . . . . . 72.8 m -104.34 51.5 0.77 Allowed 'General case' 0 C--N 1.27 -2.865 0 N-CA-C 108.196 -1.039 . . . . 1.25 108.196 -179.8 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 1517 ' ' GLN . . . . . 0.553 ' HG2' ' HB3' ' A' 1515 ' ' ASP . 3.9 pt20 -151.64 171.38 17.72 Favored 'General case' 0 C--N 1.304 -1.377 0 N-CA-C 109.407 -0.59 . . . . 2.36 109.407 -177.316 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A 1518 ' ' VAL . . . . . 0.446 HG21 ' HG2' ' A' 1512 ' ' GLU . 8.5 p -154.23 140.6 11.91 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.404 0 N-CA-C 109.404 -0.591 . . . . 2.34 109.404 -179.414 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A 1519 ' ' THR . . . . . . . . . . . . . 19.1 m -100.76 130.74 46.83 Favored 'General case' 0 N--CA 1.423 -1.783 0 N-CA-C 107.895 -1.15 . . . . 2.04 107.895 177.097 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 1520 ' ' ASN . . . . . 0.434 ' OD1' HG21 ' A' 1523 ' ' THR . 27.9 t-20 -90.03 121.35 68.88 Favored Pre-proline 0 C--N 1.3 -1.567 0 C-N-CA 120.236 -0.585 . . . . 2.12 109.868 178.295 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A 1521 ' ' PRO . . . . . . . . . . . . . 60.0 Cg_endo -73.09 -20.28 21.89 Favored 'Trans proline' 0 C--N 1.352 0.754 0 C-N-CA 122.089 1.86 . . . . 2.59 113.642 -175.797 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 1522 ' ' SER . . . . . . . . . . . . . 48.1 m -77.0 -57.9 3.58 Favored 'General case' 0 C--N 1.316 -0.851 0 N-CA-C 111.981 0.363 . . . . 2.65 111.981 -177.95 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 1523 ' ' THR . . . . . 0.434 HG21 ' OD1' ' A' 1520 ' ' ASN . 8.9 t -90.71 -14.81 31.45 Favored 'General case' 0 C--N 1.317 -0.835 0 CA-C-O 121.053 0.454 . . . . 2.33 111.134 -178.601 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A 1524 ' ' GLY . . . . . . . . . . . . . . . 76.13 14.32 82.39 Favored Glycine 0 C--O 1.226 -0.393 0 C-N-CA 120.873 -0.679 . . . . 1.96 112.478 178.932 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 1525 ' ' HIS . . . . . . . . . . . . . 22.7 t60 -100.75 137.65 38.85 Favored 'General case' 0 C--N 1.309 -1.183 0 N-CA-C 108.143 -1.058 . . . . 2.44 108.143 -177.57 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 1526 ' ' LEU . . . . . . . . . . . . . 7.7 tt -100.0 136.37 40.01 Favored 'General case' 0 C--N 1.297 -1.707 0 N-CA-C 108.604 -0.887 . . . . 2.19 108.604 -178.451 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 1527 ' ' PHE . . . . . . . . . . . . . 88.2 m-85 -110.46 126.16 54.04 Favored 'General case' 0 C--N 1.3 -1.554 0 N-CA-C 107.792 -1.188 . . . . 1.61 107.792 178.618 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 1528 ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -114.71 143.64 44.74 Favored 'General case' 0 C--N 1.309 -1.179 0 CA-C-O 122.021 0.915 . . . . 2.18 112.104 -178.932 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A 1529 ' ' LEU . . . . . . . . . . . . . 3.1 mm? -122.33 16.68 10.59 Favored 'General case' 0 C--N 1.292 -1.896 0 N-CA-C 105.047 -2.205 . . . . 2.04 105.047 168.963 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 1530 ' ' SER . . . . . . . . . . . . . 12.7 m -74.04 -37.48 64.29 Favored 'General case' 0 N--CA 1.435 -1.219 0 CA-C-N 113.727 -1.579 . . . . 1.44 108.681 -179.157 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 1531 ' ' SER . . . . . . . . . . . . . 9.6 m -75.0 -21.61 59.03 Favored 'General case' 0 N--CA 1.433 -1.32 0 N-CA-C 108.801 -0.814 . . . . 1.63 108.801 176.515 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 1532 ' ' LEU . . . . . 0.472 HD13 HD23 ' A' 1644 ' ' LEU . 90.2 mt -96.29 11.23 35.36 Favored 'General case' 0 CA--C 1.52 -0.21 0 CA-C-N 115.638 -0.71 . . . . 2.32 112.238 178.239 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A 1533 ' ' SER . . . . . . . . . . . . . 34.0 m -69.47 114.46 7.72 Favored 'General case' 0 N--CA 1.435 -1.212 0 N-CA-C 107.622 -1.251 . . . . 2.57 107.622 176.479 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 1534 ' ' GLY . . . . . . . . . . . . . . . -82.47 151.11 29.18 Favored Glycine 0 N--CA 1.426 -2.005 0 CA-C-N 115.615 -0.721 . . . . 1.89 113.993 -170.209 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 1535 ' ' ARG . . . . . 0.465 ' C ' ' HD3' ' A' 1535 ' ' ARG . 1.2 tmt_? -95.88 -61.57 1.43 Allowed 'General case' 0 N--CA 1.426 -1.644 0 N-CA-C 106.885 -1.524 . . . . 4.44 106.885 174.821 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A 1536 ' ' ALA . . . . . . . . . . . . . . . -94.87 -23.01 17.65 Favored 'General case' 0 C--N 1.312 -1.056 0 CA-C-N 115.458 -0.792 . . . . 2.07 109.023 177.195 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 1537 ' ' GLY . . . . . . . . . . . . . . . 91.25 -167.75 31.75 Favored Glycine 0 N--CA 1.427 -1.962 0 CA-C-N 115.623 -0.717 . . . . 1.2 113.862 174.492 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 1538 ' ' PHE . . . . . . . . . . . . . 81.6 m-85 -108.46 168.3 9.42 Favored 'General case' 0 C--N 1.298 -1.661 0 C-N-CA 125.574 1.55 . . . . 1.98 107.661 -179.321 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 1539 ' ' THR . . . . . . . . . . . . . 14.5 p -117.05 112.7 21.3 Favored 'General case' 0 C--N 1.297 -1.714 0 CA-C-O 120.925 0.393 . . . . 1.97 110.273 179.809 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 1540 ' ' ALA . . . . . . . . . . . . . . . -102.17 143.96 31.32 Favored 'General case' 0 C--N 1.303 -1.435 0 N-CA-C 108.05 -1.093 . . . . 1.39 108.05 178.741 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 1541 ' ' ALA . . . . . . . . . . . . . . . -91.01 156.64 17.8 Favored 'General case' 0 C--N 1.294 -1.826 0 CA-C-O 121.982 0.896 . . . . 1.86 112.844 -173.819 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 1542 ' ' TYR . . . . . 0.723 ' HB3' ' HA3' ' A' 1546 ' ' GLY . 68.5 t80 -147.44 171.69 15.11 Favored 'General case' 0 C--N 1.296 -1.761 0 N-CA-C 102.746 -3.057 . . . . 2.4 102.746 175.006 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A 1543 ' ' SER . . . . . . . . . . . . . 6.8 m -43.09 -161.88 0.0 OUTLIER 'General case' 0 CA--C 1.603 2.983 0 N-CA-C 117.119 2.266 . . . . 2.58 117.119 -173.769 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 1544 ' ' LYS . . . . . . . . . . . . . 57.7 tttm -46.12 -38.05 7.65 Favored 'General case' 0 N--CA 1.479 0.997 0 O-C-N 120.669 -1.27 . . . . 4.24 113.24 -178.493 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 1545 ' ' SER . . . . . . . . . . . . . 19.4 m -111.29 26.12 11.01 Favored 'General case' 0 C--N 1.3 -1.56 0 O-C-N 122.27 -0.269 . . . . 3.6 110.583 179.18 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 1546 ' ' GLY . . . . . 0.723 ' HA3' ' HB3' ' A' 1542 ' ' TYR . . . -112.84 131.28 10.0 Favored Glycine 0 N--CA 1.412 -2.912 0 C-N-CA 117.879 -2.105 . . . . 1.66 116.311 -173.836 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A 1547 ' ' VAL . . . . . . . . . . . . . 9.1 p -162.07 119.46 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.567 0 N-CA-C 107.821 -1.177 . . . . 2.23 107.821 171.808 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 1548 ' ' VAL . . . . . . . . . . . . . 2.1 t -115.29 129.23 71.88 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.814 0 N-CA-C 107.923 -1.14 . . . . 1.59 107.923 -175.599 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 1549 ' ' TYR . . . . . 0.423 ' HB3' HD22 ' A' 1556 ' ' ASN . 96.3 m-85 -84.61 116.57 23.24 Favored 'General case' 0 N--CA 1.423 -1.783 0 N-CA-C 107.552 -1.277 . . . . 1.58 107.552 176.002 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A 1550 ' ' MET . . . . . . . . . . . . . 54.9 tpp -119.1 122.53 42.28 Favored 'General case' 0 C--N 1.29 -1.986 0 CA-C-N 115.379 -0.828 . . . . 2.08 110.551 -174.014 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 1551 ' ' SER . . . . . . . . . . . . . 8.2 t -96.57 121.7 38.68 Favored 'General case' 0 C--N 1.285 -2.202 0 N-CA-C 103.527 -2.768 . . . . 1.9 103.527 171.263 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 1552 ' ' ILE . . . . . . . . . . . . . 1.8 tp -62.14 -27.57 42.77 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.666 0 CA-C-O 121.38 0.609 . . . . 2.04 110.344 -172.166 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 1553 ' ' CYS . . . . . 0.521 ' HA ' ' OH ' ' A' 1592 ' ' TYR . 23.0 t -162.39 138.39 7.48 Favored 'General case' 0 N--CA 1.415 -2.215 0 N-CA-C 105.479 -2.045 . . . . 1.43 105.479 167.494 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A 1554 ' ' GLY . . . . . . . . . . . . . . . 110.45 -166.85 12.46 Favored Glycine 0 C--N 1.292 -1.913 0 N-CA-C 110.018 -1.233 . . . . 1.23 110.018 -179.011 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 1555 ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -99.69 156.93 16.82 Favored 'General case' 0 C--N 1.303 -1.448 0 CA-C-N 117.48 0.64 . . . . 1.8 111.109 -178.221 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 1556 ' ' ASN . . . . . 0.423 HD22 ' HB3' ' A' 1549 ' ' TYR . 23.0 t-20 -111.47 109.37 19.28 Favored 'General case' 0 N--CA 1.423 -1.815 0 CA-C-N 115.34 -0.845 . . . . 2.63 109.269 -178.409 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A 1557 ' ' GLU . . . . . . . . . . . . . 25.6 mt-10 -87.91 54.42 3.09 Favored 'General case' 0 C--N 1.301 -1.525 0 N-CA-C 113.307 0.854 . . . . 3.79 113.307 -174.022 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 1558 ' ' ASN . . . . . . . . . . . . . 32.9 m-80 -129.22 3.45 5.2 Favored 'General case' 0 C--N 1.306 -1.298 0 N-CA-C 107.94 -1.133 . . . . 1.59 107.94 174.615 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 1559 ' ' CYS . . . . . 0.761 ' HB3' ' HD2' ' A' 1560 ' ' PRO . 69.3 m -153.98 177.84 1.84 Allowed Pre-proline 0 C--N 1.31 -1.146 0 N-CA-C 106.995 -1.483 . . . . 0.94 106.995 -177.911 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A 1560 ' ' PRO . . . . . 0.761 ' HD2' ' HB3' ' A' 1559 ' ' CYS . 15.9 Cg_exo -32.82 132.74 0.09 OUTLIER 'Trans proline' 0 C--N 1.381 2.246 0 C-N-CA 124.363 3.375 . . . . 1.53 114.955 177.615 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A 1561 ' ' PRO . . . . . . . . . . . . . 35.9 Cg_exo -58.25 123.49 13.75 Favored 'Trans proline' 0 C--O 1.245 0.826 0 C-N-CA 122.916 2.411 . . . . 1.82 111.568 179.814 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 1562 ' ' GLY . . . . . 0.409 ' O ' ' HD3' ' A' 1576 ' ' LYS . . . 109.48 -8.08 32.38 Favored Glycine 0 N--CA 1.436 -1.364 0 C-N-CA 120.288 -0.958 . . . . 0.81 114.163 178.247 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A 1563 ' ' VAL . . . . . . . . . . . . . 3.4 m -89.17 148.21 4.69 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.874 0 N-CA-C 107.962 -1.125 . . . . 1.73 107.962 178.286 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 1564 ' ' GLY . . . . . . . . . . . . . . . -97.63 -23.14 14.44 Favored Glycine 0 CA--C 1.505 -0.573 0 C-N-CA 120.137 -1.03 . . . . 0.72 113.162 -174.441 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 1565 ' ' ALA . . . . . . . . . . . . . . . -151.65 140.46 20.92 Favored 'General case' 0 C--N 1.31 -1.13 0 N-CA-C 109.137 -0.69 . . . . 1.14 109.137 -177.909 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 1566 ' ' CYS . . . . . . . . . . . . . 48.0 t -161.77 147.65 13.64 Favored 'General case' 0 C--N 1.315 -0.92 0 CA-C-N 116.398 -0.365 . . . . 0.51 110.016 -175.526 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 1567 ' ' PHE . . . . . 0.412 ' O ' ' HA ' ' A' 1571 ' ' ARG . 50.3 m-85 -74.73 152.16 39.11 Favored 'General case' 0 N--CA 1.471 0.583 0 N-CA-C 108.609 -0.885 . . . . 1.22 108.609 178.424 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A 1568 ' ' GLY . . . . . . . . . . . . . . . -89.07 -31.75 11.61 Favored Glycine 0 N--CA 1.447 -0.61 0 C-N-CA 120.499 -0.857 . . . . 1.08 114.125 -176.744 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 1569 ' ' GLN . . . . . . . . . . . . . 8.9 tt0 -89.9 -56.93 3.04 Favored 'General case' 0 C--N 1.309 -1.183 0 N-CA-C 108.361 -0.977 . . . . 3.05 108.361 178.363 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 1570 ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -68.79 -32.6 72.45 Favored 'General case' 0 N--CA 1.421 -1.88 0 CA-C-N 113.684 -1.598 . . . . 2.44 110.579 -175.921 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A 1571 ' ' ARG . . . . . 0.412 ' HA ' ' O ' ' A' 1567 ' ' PHE . 67.7 mtm180 46.29 55.76 7.01 Favored 'General case' 0 C--O 1.246 0.871 0 N-CA-C 113.176 0.806 . . . . 4.48 113.176 -179.252 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A 1572 ' ' ILE . . . . . . . . . . . . . 47.9 mm -109.7 126.05 66.86 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.384 0 N-CA-C 106.394 -1.706 . . . . 1.94 106.394 175.066 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 1573 ' ' SER . . . . . . . . . . . . . 42.1 t -75.76 120.46 21.16 Favored 'General case' 0 C--N 1.298 -1.634 0 N-CA-C 108.973 -0.751 . . . . 1.25 108.973 179.496 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 1574 ' ' VAL . . . . . 0.625 ' HB ' ' HB2' ' A' 1606 ' ' TYR . 34.5 m -90.88 -33.9 6.1 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.81 0 C-N-CA 119.401 -0.919 . . . . 1.61 110.827 179.948 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A 1575 ' ' GLY . . . . . . . . . . . . . . . -161.31 155.63 26.87 Favored Glycine 0 N--CA 1.424 -2.144 0 C-N-CA 120.047 -1.073 . . . . 0.65 113.747 -177.761 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 1576 ' ' LYS . . . . . 0.409 ' HD3' ' O ' ' A' 1562 ' ' GLY . 17.0 tppt? -71.47 153.11 42.47 Favored 'General case' 0 C--N 1.311 -1.108 0 C-N-CA 125.814 1.646 . . . . 3.33 108.512 178.17 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A 1577 ' ' ALA . . . . . . . . . . . . . . . -65.16 74.9 0.05 Allowed 'General case' 0 N--CA 1.482 1.152 0 C-N-CA 123.629 0.771 . . . . 1.31 109.578 174.425 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 1578 ' ' ASN . . . . . . . . . . . . . 61.8 t30 -89.81 131.67 35.64 Favored 'General case' 0 C--N 1.293 -1.878 0 C-N-CA 124.092 0.957 . . . . 2.24 111.303 -173.211 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 1579 ' ' LYS . . . . . 0.469 ' O ' ' HA ' ' A' 1513 ' ' HIS . 2.4 mppt? -100.2 92.12 5.07 Favored 'General case' 0 C--N 1.292 -1.914 0 N-CA-C 108.771 -0.826 . . . . 2.34 108.771 175.56 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A 1580 ' ' ARG . . . . . 0.492 ' O ' ' HA ' ' A' 1590 ' ' LEU . 61.7 ttt180 -140.16 86.49 2.08 Favored 'General case' 0 C--N 1.289 -2.056 0 N-CA-C 107.536 -1.283 . . . . 4.19 107.536 176.735 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A 1581 ' ' LEU . . . . . 0.573 HD12 ' HB2' ' A' 1590 ' ' LEU . 20.6 tp -110.85 135.79 50.87 Favored 'General case' 0 C--N 1.297 -1.69 0 N-CA-C 108.672 -0.862 . . . . 2.39 108.672 -177.238 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A 1582 ' ' ARG . . . . . . . . . . . . . 57.5 ttp180 -136.79 140.4 42.49 Favored 'General case' 0 C--N 1.304 -1.384 0 N-CA-C 109.535 -0.542 . . . . 4.48 109.535 179.854 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 1583 ' ' TYR . . . . . . . . . . . . . 74.2 t80 -112.17 92.89 4.19 Favored 'General case' 0 C--O 1.245 0.843 0 C-N-CA 122.896 0.478 . . . . 1.57 110.174 179.83 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 1584 ' ' VAL . . . . . . . . . . . . . 28.5 m -137.51 147.22 26.63 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.293 0 N-CA-C 107.261 -1.385 . . . . 2.29 107.261 175.346 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 1585 ' ' ASP . . . . . . . . . . . . . 19.0 t70 61.96 28.08 17.06 Favored 'General case' 0 N--CA 1.483 1.22 0 C-N-CA 124.246 1.018 . . . . 2.06 109.702 -179.672 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 1586 ' ' GLN . . . . . . . . . . . . . 46.2 mt-30 53.98 34.16 19.05 Favored 'General case' 0 N--CA 1.466 0.354 0 C-N-CA 125.243 1.417 . . . . 2.61 113.474 -176.147 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 1587 ' ' VAL . . . . . . . . . . . . . 8.1 p -132.13 123.56 50.98 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.692 0 CA-C-O 121.24 0.543 . . . . 1.33 110.021 176.266 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 1588 ' ' LEU . . . . . 0.71 ' HB2' ' HB2' ' A' 1612 ' ' PHE . 80.1 mt -78.75 116.72 19.28 Favored 'General case' 0 C--N 1.312 -1.026 0 N-CA-C 107.392 -1.336 . . . . 2.03 107.392 174.695 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A 1589 ' ' GLN . . . . . . . . . . . . . 8.6 tt0 -118.2 124.78 48.76 Favored 'General case' 0 C--N 1.28 -2.432 0 CA-C-N 115.863 -0.608 . . . . 1.73 109.935 -177.316 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 1590 ' ' LEU . . . . . 0.573 ' HB2' HD12 ' A' 1581 ' ' LEU . 7.5 tt -122.55 126.14 47.16 Favored 'General case' 0 C--N 1.302 -1.475 0 N-CA-C 106.876 -1.527 . . . . 1.76 106.876 178.761 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A 1591 ' ' VAL . . . . . . . . . . . . . 19.3 m -114.38 117.76 56.52 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.235 0 N-CA-C 113.864 1.061 . . . . 2.14 113.864 -175.665 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 1592 ' ' TYR . . . . . 0.521 ' OH ' ' HA ' ' A' 1553 ' ' CYS . 56.4 m-85 -90.9 133.5 35.19 Favored 'General case' 0 C--N 1.311 -1.067 0 CA-C-N 115.316 -0.856 . . . . 1.53 110.584 177.16 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A 1593 ' ' LYS . . . . . . . . . . . . . 63.4 pttt -159.02 -177.95 6.88 Favored 'General case' 0 C--N 1.314 -0.958 0 N-CA-C 108.396 -0.964 . . . . 2.72 108.396 177.304 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 1594 ' ' ASP . . . . . . . . . . . . . 62.2 m-20 72.1 59.04 0.14 Allowed 'General case' 0 N--CA 1.476 0.846 0 C-N-CA 124.379 1.072 . . . . 1.45 111.865 179.158 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 1595 ' ' GLY . . . . . . . . . . . . . . . -131.32 -109.91 1.28 Allowed Glycine 0 N--CA 1.433 -1.541 0 N-CA-C 109.343 -1.503 . . . . 0.83 109.343 177.35 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 1596 ' ' SER . . . . . 0.418 ' HA ' ' HD3' ' A' 1597 ' ' PRO . 14.1 m -97.67 134.98 21.83 Favored Pre-proline 0 C--N 1.299 -1.591 0 N-CA-C 108.801 -0.814 . . . . 1.96 108.801 177.719 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A 1597 ' ' PRO . . . . . 0.418 ' HD3' ' HA ' ' A' 1596 ' ' SER . 23.5 Cg_exo -67.14 152.27 80.06 Favored 'Trans proline' 0 N--CA 1.458 -0.574 0 C-N-CA 123.074 2.516 . . . . 1.34 112.133 177.908 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A 1598 ' ' CYS . . . . . . . . . . . . . 43.1 t -94.77 135.67 23.62 Favored Pre-proline 0 C--N 1.293 -1.881 0 N-CA-C 107.932 -1.136 . . . . 1.19 107.932 179.563 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 1599 ' ' PRO . . . . . . . . . . . . . 89.4 Cg_endo -79.49 3.21 7.7 Favored 'Trans proline' 0 C--O 1.243 0.746 0 C-N-CA 123.383 2.722 . . . . 1.88 113.707 -177.395 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 1600 ' ' SER . . . . . . . . . . . . . 14.6 m -120.94 145.83 47.29 Favored 'General case' 0 C--N 1.297 -1.68 0 N-CA-C 108.055 -1.091 . . . . 2.19 108.055 178.837 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 1601 ' ' LYS . . . . . 0.614 ' HG3' HG23 ' A' 1633 ' ' THR . 29.7 mmmt 67.63 -146.14 0.14 Allowed 'General case' 0 CA--C 1.537 0.453 0 O-C-N 124.006 0.816 . . . . 4.21 110.61 177.925 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A 1602 ' ' SER . . . . . . . . . . . . . 33.5 t -68.76 163.43 24.08 Favored 'General case' 0 CA--C 1.551 0.998 0 N-CA-C 109.66 -0.496 . . . . 3.82 109.66 178.862 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 1603 ' ' GLY . . . . . . . . . . . . . . . -77.36 58.0 3.7 Favored Glycine 0 C--N 1.332 0.324 0 N-CA-C 111.685 -0.566 . . . . 2.45 111.685 179.015 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 1604 ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -101.2 159.43 15.25 Favored 'General case' 0 C--N 1.297 -1.715 0 C-N-CA 124.773 1.229 . . . . 2.06 110.146 -179.278 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A 1605 ' ' SER . . . . . . . . . . . . . 38.6 m -75.74 -170.9 1.42 Allowed 'General case' 0 C--N 1.315 -0.91 0 CA-C-O 121.586 0.708 . . . . 1.75 110.737 177.837 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 1606 ' ' TYR . . . . . 0.625 ' HB2' ' HB ' ' A' 1574 ' ' VAL . 14.7 m-85 -96.57 117.07 30.17 Favored 'General case' 0 N--CA 1.422 -1.858 0 N-CA-C 103.513 -2.773 . . . . 1.59 103.513 174.582 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A 1607 ' ' LYS . . . . . . . . . . . . . 22.0 ptmt -102.88 124.07 47.7 Favored 'General case' 0 C--N 1.276 -2.597 0 C-N-CA 118.613 -1.235 . . . . 2.21 111.404 -170.083 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 1608 ' ' SER . . . . . 0.508 ' HB2' ' HB2' ' A' 1592 ' ' TYR . 21.7 m -101.46 110.16 22.11 Favored 'General case' 0 C--N 1.299 -1.629 0 CA-C-N 114.928 -1.033 . . . . 1.48 109.626 -178.98 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A 1609 ' ' VAL . . . . . . . . . . . . . 65.8 t -94.3 106.44 18.1 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.351 0 N-CA-C 109.31 -0.626 . . . . 1.57 109.31 178.729 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 1610 ' ' ILE . . . . . . . . . . . . . 38.2 mm -89.49 109.21 20.12 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.701 0 N-CA-C 108.471 -0.937 . . . . 1.47 108.471 178.831 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 1611 ' ' SER . . . . . . . . . . . . . 18.2 m -104.98 116.59 32.22 Favored 'General case' 0 C--N 1.301 -1.51 0 CA-C-O 121.286 0.565 . . . . 1.84 110.398 178.923 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 1612 ' ' PHE . . . . . 0.71 ' HB2' ' HB2' ' A' 1588 ' ' LEU . 93.3 m-85 -87.74 108.61 19.2 Favored 'General case' 0 C--N 1.301 -1.509 0 N-CA-C 108.36 -0.978 . . . . 0.86 108.36 177.143 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A 1613 ' ' VAL . . . . . . . . . . . . . 78.9 t -102.61 130.62 52.29 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.084 0 CA-C-O 120.889 0.376 . . . . 1.32 110.312 -178.227 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 1614 ' ' CYS . . . . . . . . . . . . . 32.5 m -75.02 92.28 2.6 Favored 'General case' 0 C--N 1.303 -1.415 0 CA-C-N 115.257 -0.883 . . . . 1.39 111.586 -176.169 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 1615 ' ' ARG . . . . . 0.786 ' HB3' ' HB3' ' A' 1641 ' ' HIS . 2.9 tpm_? -138.93 85.46 16.2 Favored Pre-proline 0 C--N 1.314 -0.975 0 N-CA-C 108.861 -0.792 . . . . 4.34 108.861 176.789 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A 1616 ' ' PRO . . . . . 0.611 ' HG2' ' HG3' ' A' 1648 ' ' PRO . 52.6 Cg_exo -59.29 -18.54 45.75 Favored 'Trans proline' 0 N--CA 1.492 1.439 0 C-N-CA 123.07 2.513 . . . . 1.5 113.554 179.019 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A 1617 ' ' GLU . . . . . . . . . . . . . 33.0 tt0 -66.3 -20.71 66.17 Favored 'General case' 0 C--N 1.321 -0.634 0 C-N-CA 123.473 0.709 . . . . 3.21 112.312 -178.351 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 1618 ' ' ALA . . . . . . . . . . . . . . . -58.39 116.28 3.52 Favored 'General case' 0 C--N 1.316 -0.859 0 C-N-CA 122.993 0.517 . . . . 2.91 111.625 -176.279 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 1619 ' ' GLY . . . . . . . . . . . . . . . -119.27 -84.77 0.92 Allowed Glycine 0 N--CA 1.437 -1.295 0 CA-C-N 115.881 -0.6 . . . . 3.35 112.117 -178.455 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 1620 ' ' PRO . . . . . . . . . . . . . 27.6 Cg_endo -64.21 -25.92 64.85 Favored 'Trans proline' 0 CA--C 1.535 0.548 0 C-N-CA 122.855 2.37 . . . . 6.61 113.315 -179.348 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 1621 ' ' THR . . . . . . . . . . . . . 5.7 m -108.84 43.1 1.29 Allowed 'General case' 0 N--CA 1.436 -1.159 0 CA-C-O 122.137 0.97 . . . . 5.03 110.086 -179.179 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 1622 ' ' ASN . . . . . . . . . . . . . 50.6 t-20 -82.93 67.97 9.23 Favored 'General case' 0 C--N 1.319 -0.75 0 N-CA-C 107.574 -1.269 . . . . 3.58 107.574 178.369 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 1623 ' ' ARG . . . . . . . . . . . . . 8.1 ptm180 -150.97 153.77 33.5 Favored Pre-proline 0 C--N 1.31 -1.11 0 CA-C-N 115.095 -0.957 . . . . 4.09 108.468 -177.44 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 1624 ' ' PRO . . . . . . . . . . . . . 11.6 Cg_exo -71.43 120.63 7.09 Favored 'Trans proline' 0 C--O 1.236 0.403 0 C-N-CA 122.631 2.22 . . . . 2.86 110.896 178.279 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 1625 ' ' MET . . . . . . . . . . . . . 44.4 ttm -109.94 140.84 43.49 Favored 'General case' 0 C--N 1.306 -1.294 0 C-N-CA 122.777 0.431 . . . . 2.73 110.082 -177.621 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 1626 ' ' LEU . . . . . . . . . . . . . 59.9 tp -81.38 117.3 21.72 Favored 'General case' 0 C--N 1.308 -1.237 0 N-CA-C 107.768 -1.197 . . . . 1.94 107.768 175.337 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 1627 ' ' ILE . . . . . . . . . . . . . 41.0 pt -99.33 -33.1 3.86 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.204 0 C-N-CA 119.778 -0.769 . . . . 1.75 111.547 -177.209 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 1628 ' ' SER . . . . . 0.523 ' HB3' ' HB2' ' A' 1637 ' ' PHE . 44.9 t -141.28 143.65 34.21 Favored 'General case' 0 N--CA 1.431 -1.4 0 N-CA-C 109.287 -0.634 . . . . 1.85 109.287 -176.99 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A 1629 ' ' LEU . . . . . 0.735 HD12 ' HG ' ' A' 1636 ' ' LEU . 22.4 tp -146.07 116.21 7.42 Favored 'General case' 0 C--N 1.303 -1.42 0 CA-C-N 116.057 -0.52 . . . . 2.12 110.312 -177.941 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A 1630 ' ' ASP . . . . . . . . . . . . . 12.3 t70 -109.51 107.97 18.28 Favored 'General case' 0 C--N 1.298 -1.659 0 N-CA-C 107.801 -1.185 . . . . 0.87 107.801 176.416 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 1631 ' ' LYS . . . . . . . . . . . . . 95.3 mttt -85.27 3.54 39.05 Favored 'General case' 0 C--N 1.307 -1.281 0 CA-C-N 116.241 -0.436 . . . . 2.76 111.979 -176.202 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 1632 ' ' GLN . . . . . . . . . . . . . 1.4 mp0 -91.11 -49.21 6.52 Favored 'General case' 0 C--N 1.316 -0.863 0 N-CA-C 109.102 -0.703 . . . . 2.55 109.102 178.875 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 1633 ' ' THR . . . . . 0.614 HG23 ' HG3' ' A' 1601 ' ' LYS . 22.2 p -97.48 2.78 50.63 Favored 'General case' 0 C--N 1.308 -1.234 0 CA-C-N 115.772 -0.649 . . . . 1.92 111.455 179.013 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A 1634 ' ' CYS . . . . . . . . . . . . . 98.3 m 56.6 47.49 18.39 Favored 'General case' 0 C--N 1.347 0.467 0 CA-C-N 114.879 -1.055 . . . . 0.89 111.758 178.692 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 1635 ' ' THR . . . . . . . . . . . . . 26.7 m -112.44 118.38 35.02 Favored 'General case' 0 N--CA 1.43 -1.434 0 CA-C-N 115.006 -0.997 . . . . 1.31 109.246 -178.21 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 1636 ' ' LEU . . . . . 0.735 ' HG ' HD12 ' A' 1629 ' ' LEU . 4.0 mp -112.1 130.17 55.98 Favored 'General case' 0 N--CA 1.441 -0.884 0 N-CA-C 109.626 -0.509 . . . . 1.97 109.626 -177.816 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A 1637 ' ' PHE . . . . . 0.523 ' HB2' ' HB3' ' A' 1628 ' ' SER . 91.0 m-85 -111.15 113.09 25.35 Favored 'General case' 0 C--N 1.315 -0.931 0 CA-C-O 120.9 0.381 . . . . 0.92 110.509 -178.712 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A 1638 ' ' PHE . . . . . . . . . . . . . 97.4 m-85 -108.25 145.53 34.18 Favored 'General case' 0 C--N 1.306 -1.298 0 CA-C-N 116.103 -0.499 . . . . 0.7 109.766 -179.087 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 1639 ' ' SER . . . . . . . . . . . . . 65.6 m -136.98 127.89 27.47 Favored 'General case' 0 C--N 1.29 -2.018 0 CA-C-O 121.226 0.536 . . . . 1.46 111.381 178.848 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 1640 ' ' TRP . . . . . . . . . . . . . 16.4 t90 -115.72 125.49 52.87 Favored 'General case' 0 C--N 1.294 -1.843 0 N-CA-C 107.022 -1.473 . . . . 0.92 107.022 175.188 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 1641 ' ' HIS . . . . . 0.786 ' HB3' ' HB3' ' A' 1615 ' ' ARG . 69.9 m-70 -89.39 103.3 15.94 Favored 'General case' 0 C--N 1.306 -1.297 0 N-CA-C 107.054 -1.461 . . . . 3.18 107.054 -179.848 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A 1642 ' ' THR . . . . . . . . . . . . . 10.2 t -143.0 142.02 20.98 Favored Pre-proline 0 C--N 1.302 -1.476 0 CA-C-O 121.013 0.435 . . . . 1.48 110.96 -173.618 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 1643 ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo -73.64 -12.13 24.42 Favored 'Trans proline' 0 C--N 1.359 1.08 0 C-N-CA 123.211 2.608 . . . . 1.09 113.118 179.93 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 1644 ' ' LEU . . . . . 0.472 HD23 HD13 ' A' 1532 ' ' LEU . 2.4 pp -90.66 4.48 51.3 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 121.685 0.755 . . . . 2.08 112.799 -179.221 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A 1645 ' ' ALA . . . . . . . . . . . . . . . -72.66 -38.4 67.65 Favored 'General case' 0 C--N 1.302 -1.482 0 CA-C-N 114.476 -1.238 . . . . 1.37 108.086 173.461 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 1646 ' ' CYS . . . . . . . . . . . . . 18.6 p -175.4 135.29 0.32 Allowed 'General case' 0 C--N 1.312 -1.037 0 N-CA-C 105.004 -2.221 . . . . 1.7 105.004 175.402 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 1647 ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 -71.81 136.42 82.84 Favored Pre-proline 0 C--N 1.312 -1.039 0 N-CA-C 108.801 -0.814 . . . . 2.92 108.801 -179.568 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 1648 ' ' PRO . . . . . 0.611 ' HG3' ' HG2' ' A' 1616 ' ' PRO . 51.4 Cg_endo -68.99 100.48 0.73 Allowed 'Trans proline' 0 C--O 1.249 1.033 0 C-N-CA 122.265 1.977 . . . . 3.19 112.733 -174.672 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A 1649 ' ' GLU . . . . . . . . . . . . . 19.7 mm-40 . . . . . 0 C--N 1.296 -1.724 0 CA-C-N 114.787 -1.097 . . . . 5.06 108.509 179.415 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A 1508 ' ' MET . . . . . . . . . . . . . 24.9 mmt . . . . . 0 CA--C 1.495 -1.139 0 N-CA-C 109.937 -0.394 . . . . 8.58 109.937 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A 1509 ' ' LYS . . . . . . . . . . . . . 12.8 mptt -78.09 99.34 6.1 Favored 'General case' 0 C--N 1.304 -1.4 0 CA-C-O 121.539 0.685 . . . . 6.8 111.013 179.811 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 1510 ' ' SER . . . . . . . . . . . . . 10.3 p -91.64 -1.26 57.52 Favored 'General case' 0 C--N 1.31 -1.151 0 CA-C-O 122.446 1.117 . . . . 4.48 109.611 177.91 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 1511 ' ' ASN . . . . . 0.402 HD21 ' HG2' ' A' 1517 ' ' GLN . 32.0 p-10 -108.72 29.12 7.73 Favored 'General case' 0 C--N 1.308 -1.229 0 CA-C-N 114.04 -1.436 . . . . 3.08 108.12 178.499 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A 1512 ' ' GLU . . . . . . . . . . . . . 39.6 tt0 -89.11 -58.57 2.49 Favored 'General case' 0 C--N 1.311 -1.087 0 CA-C-N 114.783 -1.098 . . . . 4.46 111.629 -175.689 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 1513 ' ' HIS . . . . . . . . . . . . . 6.5 t60 -110.46 47.77 0.95 Allowed 'General case' 0 C--N 1.306 -1.306 0 N-CA-C 108.415 -0.957 . . . . 6.25 108.415 -175.214 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 1514 ' ' ASP . . . . . . . . . . . . . 15.1 t70 -140.46 -59.01 0.53 Allowed 'General case' 0 C--N 1.31 -1.149 0 C-N-CA 120.042 -0.663 . . . . 3.7 109.835 178.953 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 1515 ' ' ASP . . . . . . . . . . . . . 62.7 m-20 -123.36 -173.19 2.67 Favored 'General case' 0 CA--C 1.49 -1.346 0 N-CA-C 108.238 -1.023 . . . . 2.54 108.238 175.845 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 1516 ' ' CYS . . . . . . . . . . . . . 58.3 m -120.39 73.19 0.98 Allowed 'General case' 0 C--N 1.305 -1.359 0 CA-C-O 121.436 0.636 . . . . 1.25 110.664 -175.796 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 1517 ' ' GLN . . . . . 0.402 ' HG2' HD21 ' A' 1511 ' ' ASN . 0.0 OUTLIER -139.59 136.14 34.08 Favored 'General case' 0 C--N 1.297 -1.7 0 CA-C-N 115.527 -0.76 . . . . 2.36 111.014 174.067 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A 1518 ' ' VAL . . . . . . . . . . . . . 94.8 t -121.23 121.59 65.23 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.449 0 CA-C-N 115.673 -0.694 . . . . 2.34 109.269 176.497 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 1519 ' ' THR . . . . . 0.498 ' HA ' ' HA ' ' A' 1526 ' ' LEU . 20.5 m -90.62 108.23 19.68 Favored 'General case' 0 C--N 1.295 -1.763 0 CA-C-O 120.865 0.364 . . . . 2.04 110.914 179.651 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A 1520 ' ' ASN . . . . . 0.722 HD21 ' HH ' ' A' 1583 ' ' TYR . 15.1 t-20 -67.43 122.3 82.55 Favored Pre-proline 0 N--CA 1.47 0.566 0 CA-C-N 116.033 -0.531 . . . . 2.12 110.98 179.416 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A 1521 ' ' PRO . . . . . . . . . . . . . 94.9 Cg_endo -83.4 -1.5 10.25 Favored 'Trans proline' 0 CA--C 1.533 0.442 0 C-N-CA 122.347 2.031 . . . . 2.59 113.756 -178.236 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 1522 ' ' SER . . . . . . . . . . . . . 6.8 m -83.62 -58.18 2.92 Favored 'General case' 0 C--N 1.308 -1.201 0 C-N-CA 120.773 -0.371 . . . . 2.65 110.57 -179.071 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 1523 ' ' THR . . . . . . . . . . . . . 11.3 t -108.85 -5.98 15.98 Favored 'General case' 0 N--CA 1.443 -0.815 0 CA-C-O 120.972 0.415 . . . . 2.33 110.844 -177.045 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 1524 ' ' GLY . . . . . . . . . . . . . . . 80.01 28.76 48.9 Favored Glycine 0 CA--C 1.507 -0.445 0 C-N-CA 120.62 -0.8 . . . . 1.96 112.91 176.899 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 1525 ' ' HIS . . . . . . . . . . . . . 22.1 t-160 -97.41 118.59 34.23 Favored 'General case' 0 C--N 1.312 -1.032 0 N-CA-C 109.414 -0.587 . . . . 2.44 109.414 -179.885 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 1526 ' ' LEU . . . . . 0.498 ' HA ' ' HA ' ' A' 1519 ' ' THR . 5.0 tt -82.9 111.0 18.38 Favored 'General case' 0 C--N 1.295 -1.79 0 N-CA-C 107.095 -1.446 . . . . 2.19 107.095 178.087 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A 1527 ' ' PHE . . . . . 0.541 ' CE2' ' HB2' ' A' 1520 ' ' ASN . 32.6 m-85 -87.9 102.62 14.89 Favored 'General case' 0 C--N 1.305 -1.351 0 N-CA-C 108.498 -0.927 . . . . 1.61 108.498 179.395 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A 1528 ' ' ASP . . . . . . . . . . . . . 23.4 t70 -105.71 133.44 50.45 Favored 'General case' 0 C--N 1.298 -1.632 0 C-N-CA 120.467 -0.493 . . . . 2.18 110.106 179.347 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 1529 ' ' LEU . . . . . . . . . . . . . 89.0 mt -113.3 -7.98 13.5 Favored 'General case' 0 C--N 1.299 -1.614 0 CA-C-N 115.146 -0.934 . . . . 2.04 110.001 179.248 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 1530 ' ' SER . . . . . . . . . . . . . 2.3 m -69.1 -37.41 78.37 Favored 'General case' 0 CA--C 1.543 0.696 0 CA-C-O 121.878 0.846 . . . . 1.44 109.154 -177.92 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 1531 ' ' SER . . . . . . . . . . . . . 14.0 m -70.85 -24.13 62.47 Favored 'General case' 0 C--N 1.317 -0.844 0 CA-C-N 115.199 -0.91 . . . . 1.63 109.926 177.895 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 1532 ' ' LEU . . . . . . . . . . . . . 8.0 mp -84.7 4.58 31.97 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.414 -0.812 . . . . 2.32 110.502 179.317 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 1533 ' ' SER . . . . . . . . . . . . . 32.5 m -113.87 119.08 36.06 Favored 'General case' 0 N--CA 1.425 -1.709 0 N-CA-C 113.337 0.866 . . . . 2.57 113.337 -175.303 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 1534 ' ' GLY . . . . . . . . . . . . . . . -89.65 -162.84 38.76 Favored Glycine 0 N--CA 1.431 -1.677 0 N-CA-C 109.221 -1.552 . . . . 1.89 109.221 172.398 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 1535 ' ' ARG . . . . . 0.427 ' HE ' ' CD ' ' A' 1557 ' ' GLU . 62.4 ttt180 -81.39 -47.76 12.81 Favored 'General case' 0 C--N 1.304 -1.409 0 CA-C-N 117.395 0.597 . . . . 4.44 110.633 -179.08 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A 1536 ' ' ALA . . . . . . . . . . . . . . . -95.56 -13.53 24.36 Favored 'General case' 0 C--N 1.316 -0.863 0 N-CA-C 108.752 -0.833 . . . . 2.07 108.752 177.74 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 1537 ' ' GLY . . . . . . . . . . . . . . . 73.53 -139.94 27.37 Favored Glycine 0 N--CA 1.436 -1.355 0 CA-C-N 114.581 -1.191 . . . . 1.2 112.371 177.244 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 1538 ' ' PHE . . . . . . . . . . . . . 78.0 m-85 -101.42 152.08 21.16 Favored 'General case' 0 C--N 1.296 -1.734 0 N-CA-C 109.188 -0.671 . . . . 1.98 109.188 179.456 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 1539 ' ' THR . . . . . . . . . . . . . 25.8 m -103.66 115.19 30.04 Favored 'General case' 0 C--N 1.288 -2.09 0 N-CA-C 108.495 -0.928 . . . . 1.97 108.495 179.37 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 1540 ' ' ALA . . . . . 0.758 ' HB2' HG12 ' A' 1548 ' ' VAL . . . -94.65 149.95 20.72 Favored 'General case' 0 C--N 1.309 -1.177 0 N-CA-C 109.223 -0.658 . . . . 1.39 109.223 -177.935 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A 1541 ' ' ALA . . . . . . . . . . . . . . . -87.01 139.07 30.95 Favored 'General case' 0 C--N 1.311 -1.078 0 N-CA-C 109.358 -0.608 . . . . 1.86 109.358 -179.407 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 1542 ' ' TYR . . . . . 0.544 ' HD2' ' HB2' ' A' 1545 ' ' SER . 42.1 t80 -141.47 173.52 11.42 Favored 'General case' 0 N--CA 1.437 -1.091 0 CA-C-O 119.288 -0.387 . . . . 2.4 110.413 -176.813 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A 1543 ' ' SER . . . . . . . . . . . . . 9.5 m -46.92 -152.6 0.0 OUTLIER 'General case' 0 CA--C 1.577 1.995 0 C-N-CA 129.084 2.954 . . . . 2.58 114.07 178.619 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 1544 ' ' LYS . . . . . . . . . . . . . 57.8 mtpt -45.03 -31.79 1.45 Allowed 'General case' 0 N--CA 1.487 1.389 0 O-C-N 121.088 -1.007 . . . . 4.24 112.902 177.121 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 1545 ' ' SER . . . . . 0.544 ' HB2' ' HD2' ' A' 1542 ' ' TYR . 33.2 m -65.83 -12.68 56.19 Favored 'General case' 0 CA--C 1.562 1.409 0 N-CA-C 112.719 0.637 . . . . 3.6 112.719 176.425 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A 1546 ' ' GLY . . . . . . . . . . . . . . . 85.09 -74.2 2.52 Favored Glycine 0 CA--C 1.495 -1.216 0 C-N-CA 121.037 -0.601 . . . . 1.66 113.723 172.812 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 1547 ' ' VAL . . . . . . . . . . . . . 10.7 m -139.01 156.99 28.52 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.445 0 CA-C-O 121.652 0.739 . . . . 2.23 112.145 -176.663 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 1548 ' ' VAL . . . . . 0.758 HG12 ' HB2' ' A' 1540 ' ' ALA . 2.0 p -134.1 136.24 53.71 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.917 0 CA-C-N 114.766 -1.106 . . . . 1.59 108.114 178.924 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A 1549 ' ' TYR . . . . . . . . . . . . . 97.5 m-85 -93.51 141.29 28.63 Favored 'General case' 0 C--N 1.294 -1.835 0 N-CA-C 109.287 -0.634 . . . . 1.58 109.287 -179.085 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 1550 ' ' MET . . . . . . . . . . . . . 42.2 ttm -138.37 121.64 17.01 Favored 'General case' 0 C--N 1.288 -2.083 0 CA-C-N 115.852 -0.613 . . . . 2.08 110.54 -179.261 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 1551 ' ' SER . . . . . 0.45 ' OG ' ' HA ' ' A' 1556 ' ' ASN . 59.3 m -91.98 122.76 34.79 Favored 'General case' 0 N--CA 1.409 -2.517 0 N-CA-C 105.692 -1.966 . . . . 1.9 105.692 172.057 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A 1552 ' ' ILE . . . . . . . . . . . . . 38.6 mm -62.94 -21.53 28.26 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.804 0 CA-C-O 121.777 0.798 . . . . 2.04 110.716 -175.323 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 1553 ' ' CYS . . . . . . . . . . . . . 43.7 t -161.55 138.33 8.45 Favored 'General case' 0 N--CA 1.412 -2.366 0 N-CA-C 106.65 -1.611 . . . . 1.43 106.65 175.063 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 1554 ' ' GLY . . . . . 0.848 ' HA2' ' HE2' ' A' 1579 ' ' LYS . . . 104.71 -150.33 17.13 Favored Glycine 0 N--CA 1.426 -2.026 0 C-N-CA 119.957 -1.116 . . . . 1.23 112.305 175.489 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A 1555 ' ' GLU . . . . . . . . . . . . . 7.6 pt-20 -106.96 147.81 29.41 Favored 'General case' 0 C--N 1.293 -1.875 0 C-N-CA 123.088 0.555 . . . . 1.8 109.976 -177.612 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 1556 ' ' ASN . . . . . 0.45 ' HA ' ' OG ' ' A' 1551 ' ' SER . 5.3 t-20 -98.54 88.88 4.22 Favored 'General case' 0 C--N 1.286 -2.159 0 CA-C-O 121.641 0.734 . . . . 2.63 109.07 -175.594 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A 1557 ' ' GLU . . . . . 0.427 ' CD ' ' HE ' ' A' 1535 ' ' ARG . 22.2 mt-10 -79.72 111.47 16.04 Favored 'General case' 0 C--N 1.303 -1.448 0 CA-C-N 115.409 -0.814 . . . . 3.79 111.567 -175.573 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A 1558 ' ' ASN . . . . . . . . . . . . . 6.9 p30 160.21 -25.1 0.0 OUTLIER 'General case' 0 N--CA 1.475 0.781 0 C-N-CA 127.501 2.32 . . . . 1.59 105.789 -176.556 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 1559 ' ' CYS . . . . . 0.609 ' HB3' ' HD2' ' A' 1560 ' ' PRO . 93.2 m -118.2 173.86 3.03 Favored Pre-proline 0 N--CA 1.439 -0.992 0 CA-C-O 117.353 -1.308 . . . . 0.94 107.605 174.204 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A 1560 ' ' PRO . . . . . 0.609 ' HD2' ' HB3' ' A' 1559 ' ' CYS . 21.3 Cg_exo -35.8 132.14 0.29 Allowed 'Trans proline' 0 C--N 1.378 2.109 0 C-N-CA 123.567 2.844 . . . . 1.53 113.88 176.603 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A 1561 ' ' PRO . . . . . . . . . . . . . 19.8 Cg_endo -62.82 120.2 7.61 Favored 'Trans proline' 0 C--O 1.243 0.759 0 C-N-CA 122.792 2.328 . . . . 1.82 113.146 -177.634 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 1562 ' ' GLY . . . . . . . . . . . . . . . 117.14 7.87 12.14 Favored Glycine 0 N--CA 1.434 -1.458 0 CA-C-N 115.833 -0.621 . . . . 0.81 112.669 176.972 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 1563 ' ' VAL . . . . . . . . . . . . . 6.4 m -101.23 156.74 4.38 Favored 'Isoleucine or valine' 0 C--O 1.205 -1.263 0 N-CA-C 106.885 -1.524 . . . . 1.73 106.885 178.118 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 1564 ' ' GLY . . . . . . . . . . . . . . . -108.71 -23.61 6.45 Favored Glycine 0 C--N 1.311 -0.81 0 C-N-CA 120.213 -0.994 . . . . 0.72 112.645 -177.713 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 1565 ' ' ALA . . . . . . . . . . . . . . . -149.28 137.7 20.87 Favored 'General case' 0 C--N 1.311 -1.088 0 N-CA-C 108.572 -0.899 . . . . 1.14 108.572 -179.721 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 1566 ' ' CYS . . . . . 0.512 ' SG ' ' HA ' ' A' 1571 ' ' ARG . 35.6 t -157.68 138.05 12.78 Favored 'General case' 0 C--N 1.312 -1.048 0 C-N-CA 121.229 -0.188 . . . . 0.51 111.492 -173.9 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A 1567 ' ' PHE . . . . . 0.55 ' HD1' ' HB ' ' A' 1548 ' ' VAL . 22.0 m-85 -67.19 125.27 25.53 Favored 'General case' 0 N--CA 1.471 0.607 0 N-CA-C 108.313 -0.995 . . . . 1.22 108.313 177.602 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A 1568 ' ' GLY . . . . . . . . . . . . . . . -58.36 -43.51 95.66 Favored Glycine 0 C--N 1.315 -0.606 0 N-CA-C 117.119 1.608 . . . . 1.08 117.119 -168.434 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 1569 ' ' GLN . . . . . . . . . . . . . 4.0 pt20 -87.51 -34.35 18.66 Favored 'General case' 0 C--N 1.307 -1.274 0 CA-C-N 118.367 1.083 . . . . 3.05 113.748 -175.368 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 1570 ' ' THR . . . . . . . . . . . . . 11.5 p -89.63 -22.36 22.35 Favored 'General case' 0 C--N 1.312 -1.063 0 CA-C-O 121.597 0.713 . . . . 2.44 112.321 -176.447 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 1571 ' ' ARG . . . . . 0.512 ' HA ' ' SG ' ' A' 1566 ' ' CYS . 94.7 mtt180 59.88 38.89 20.98 Favored 'General case' 0 CA--C 1.515 -0.401 0 CA-C-N 114.523 -1.217 . . . . 4.48 113.755 175.295 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A 1572 ' ' ILE . . . . . . . . . . . . . 75.8 mt -98.35 123.44 50.88 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.971 0 CA-C-N 114.416 -1.266 . . . . 1.94 107.797 178.201 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 1573 ' ' SER . . . . . . . . . . . . . 27.3 t -62.91 130.39 44.57 Favored 'General case' 0 C--N 1.318 -0.804 0 O-C-N 123.669 0.606 . . . . 1.25 111.446 -178.213 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 1574 ' ' VAL . . . . . . . . . . . . . 27.7 m -122.87 25.36 3.72 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.402 0 CA-C-O 122.047 0.927 . . . . 1.61 109.898 176.17 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 1575 ' ' GLY . . . . . . . . . . . . . . . 163.58 128.59 0.96 Allowed Glycine 0 N--CA 1.426 -1.974 0 CA-C-N 114.138 -1.392 . . . . 0.65 111.202 177.043 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 1576 ' ' LYS . . . . . . . . . . . . . 50.5 tptt -77.77 151.19 34.18 Favored 'General case' 0 C--N 1.317 -0.81 0 N-CA-C 106.772 -1.566 . . . . 3.33 106.772 178.336 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 1577 ' ' ALA . . . . . . . . . . . . . . . -67.66 99.79 0.83 Allowed 'General case' 0 C--N 1.321 -0.646 0 CA-C-O 120.963 0.411 . . . . 1.31 110.503 -178.705 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 1578 ' ' ASN . . . . . 0.426 ' H ' ' HD1' ' A' 1592 ' ' TYR . 15.6 m120 -117.44 130.07 56.23 Favored 'General case' 0 C--N 1.302 -1.498 0 N-CA-C 108.736 -0.838 . . . . 2.24 108.736 -179.886 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A 1579 ' ' LYS . . . . . 0.848 ' HE2' ' HA2' ' A' 1554 ' ' GLY . 33.5 mmtp -93.44 89.79 6.46 Favored 'General case' 0 C--N 1.292 -1.901 0 N-CA-C 104.545 -2.391 . . . . 2.34 104.545 174.745 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A 1580 ' ' ARG . . . . . . . . . . . . . 22.0 ttm180 -148.27 103.52 3.45 Favored 'General case' 0 C--N 1.313 -0.986 0 C-N-CA 119.147 -1.021 . . . . 4.19 113.259 -170.219 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 1581 ' ' LEU . . . . . . . . . . . . . 3.9 mm? -100.75 141.25 33.89 Favored 'General case' 0 C--N 1.31 -1.135 0 CA-C-N 115.691 -0.686 . . . . 2.39 110.285 172.99 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 1582 ' ' ARG . . . . . 0.778 ' HB2' ' HB3' ' A' 1589 ' ' GLN . 93.4 mtt180 -116.55 98.44 6.55 Favored 'General case' 0 C--N 1.285 -2.205 0 N-CA-C 107.055 -1.461 . . . . 4.48 107.055 170.923 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A 1583 ' ' TYR . . . . . 0.722 ' HH ' HD21 ' A' 1520 ' ' ASN . 45.6 t80 -79.18 91.64 4.98 Favored 'General case' 0 C--N 1.295 -1.769 0 N-CA-C 107.522 -1.288 . . . . 1.57 107.522 178.697 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A 1584 ' ' VAL . . . . . 0.532 ' O ' HG12 ' A' 1587 ' ' VAL . 11.5 m -117.55 98.29 6.44 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.26 0 CA-C-O 121.547 0.689 . . . . 2.29 111.68 -177.346 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A 1585 ' ' ASP . . . . . . . . . . . . . 34.7 t70 53.46 70.38 0.6 Allowed 'General case' 0 C--N 1.313 -1.016 0 C-N-CA 124.348 1.059 . . . . 2.06 111.804 -178.021 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 1586 ' ' GLN . . . . . . . . . . . . . 14.9 mm100 68.72 -14.23 0.29 Allowed 'General case' 0 N--CA 1.481 1.088 0 N-CA-C 115.615 1.709 . . . . 2.61 115.615 177.247 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 1587 ' ' VAL . . . . . 0.532 HG12 ' O ' ' A' 1584 ' ' VAL . 7.5 p -94.84 128.64 45.88 Favored 'Isoleucine or valine' 0 C--O 1.243 0.752 0 C-N-CA 119.159 -1.016 . . . . 1.33 110.197 178.837 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A 1588 ' ' LEU . . . . . 0.735 ' HB2' ' HB2' ' A' 1612 ' ' PHE . 3.0 mm? -84.58 124.11 31.07 Favored 'General case' 0 N--CA 1.418 -2.035 0 N-CA-C 106.568 -1.641 . . . . 2.03 106.568 173.013 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A 1589 ' ' GLN . . . . . 0.778 ' HB3' ' HB2' ' A' 1582 ' ' ARG . 7.5 tp60 -119.26 107.0 12.88 Favored 'General case' 0 C--N 1.277 -2.556 0 N-CA-C 107.806 -1.183 . . . . 1.73 107.806 -173.874 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A 1590 ' ' LEU . . . . . . . . . . . . . 7.1 tt -105.61 128.59 53.71 Favored 'General case' 0 C--N 1.297 -1.708 0 N-CA-C 108.382 -0.97 . . . . 1.76 108.382 -178.215 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 1591 ' ' VAL . . . . . 0.605 HG13 HG23 ' A' 1609 ' ' VAL . 19.7 m -124.41 122.23 63.52 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.258 0 N-CA-C 112.868 0.692 . . . . 2.14 112.868 -175.409 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A 1592 ' ' TYR . . . . . 0.426 ' HD1' ' H ' ' A' 1578 ' ' ASN . 39.1 m-85 -103.07 98.38 8.33 Favored 'General case' 0 C--N 1.306 -1.3 0 N-CA-C 107.644 -1.243 . . . . 1.53 107.644 171.47 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A 1593 ' ' LYS . . . . . . . . . . . . . 21.4 ptmt -102.75 175.67 5.41 Favored 'General case' 0 C--N 1.3 -1.576 0 N-CA-C 109.751 -0.463 . . . . 2.72 109.751 -177.323 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 1594 ' ' ASP . . . . . . . . . . . . . 22.0 m-20 61.22 50.07 5.09 Favored 'General case' 0 N--CA 1.494 1.75 0 N-CA-C 113.792 1.034 . . . . 1.45 113.792 178.68 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 1595 ' ' GLY . . . . . . . . . . . . . . . -85.85 -106.72 0.73 Allowed Glycine 0 N--CA 1.436 -1.304 0 N-CA-C 110.36 -1.096 . . . . 0.83 110.36 175.637 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 1596 ' ' SER . . . . . . . . . . . . . 69.6 m -99.87 151.87 37.63 Favored Pre-proline 0 C--N 1.297 -1.684 0 N-CA-C 109.364 -0.606 . . . . 1.96 109.364 177.438 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 1597 ' ' PRO . . . . . . . . . . . . . 26.5 Cg_exo -65.28 131.49 28.49 Favored 'Trans proline' 0 C--O 1.24 0.588 0 C-N-CA 123.096 2.531 . . . . 1.34 111.416 178.287 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 1598 ' ' CYS . . . . . 0.42 ' HB3' ' HB3' ' A' 1604 ' ' LEU . 43.2 t -100.24 109.9 58.12 Favored Pre-proline 0 C--N 1.301 -1.532 0 CA-C-N 116.018 -0.537 . . . . 1.19 109.779 -178.354 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A 1599 ' ' PRO . . . . . . . . . . . . . 38.6 Cg_endo -98.02 21.85 0.32 Allowed 'Trans proline' 0 N--CA 1.445 -1.377 0 C-N-CA 123.308 2.672 . . . . 1.88 112.527 -179.191 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 1600 ' ' SER . . . . . . . . . . . . . 16.9 m -73.73 -41.02 63.11 Favored 'General case' 0 C--N 1.313 -0.982 0 CA-C-N 116.571 -0.286 . . . . 2.19 111.627 -179.155 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 1601 ' ' LYS . . . . . . . . . . . . . 87.3 tttt -142.39 -77.64 0.25 Allowed 'General case' 0 C--N 1.318 -0.765 0 CA-C-O 121.259 0.552 . . . . 4.21 111.258 -177.632 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 1602 ' ' SER . . . . . . . . . . . . . 21.1 m -96.07 175.59 6.41 Favored 'General case' 0 C--N 1.3 -1.584 0 CA-C-N 115.294 -0.866 . . . . 3.82 109.055 -177.194 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 1603 ' ' GLY . . . . . . . . . . . . . . . -75.81 63.62 2.73 Favored Glycine 0 CA--C 1.505 -0.533 0 N-CA-C 109.78 -1.328 . . . . 2.45 109.78 175.276 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 1604 ' ' LEU . . . . . 0.453 HD13 ' HA ' ' A' 1633 ' ' THR . 2.2 mt -93.52 -174.41 3.48 Favored 'General case' 0 C--N 1.293 -1.883 0 C-N-CA 125.55 1.54 . . . . 2.06 112.184 -173.809 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A 1605 ' ' SER . . . . . . . . . . . . . 34.5 t -140.93 -179.22 5.95 Favored 'General case' 0 N--CA 1.419 -2.017 0 N-CA-C 105.667 -1.975 . . . . 1.75 105.667 179.348 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 1606 ' ' TYR . . . . . . . . . . . . . 7.1 m-85 -110.06 129.23 55.72 Favored 'General case' 0 CA--C 1.47 -2.101 0 N-CA-C 105.253 -2.129 . . . . 1.59 105.253 -179.561 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 1607 ' ' LYS . . . . . . . . . . . . . 10.0 ptpp? -131.8 138.12 48.41 Favored 'General case' 0 N--CA 1.411 -2.41 0 C-N-CA 118.495 -1.282 . . . . 2.21 110.437 179.867 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 1608 ' ' SER . . . . . 0.762 ' HA ' ' HB2' ' A' 1636 ' ' LEU . 50.1 m -98.83 114.32 26.83 Favored 'General case' 0 C--N 1.295 -1.79 0 N-CA-C 109.158 -0.682 . . . . 1.48 109.158 177.71 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A 1609 ' ' VAL . . . . . 0.605 HG23 HG13 ' A' 1591 ' ' VAL . 85.9 t -109.3 118.28 56.3 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.054 0 N-CA-C 108.884 -0.784 . . . . 1.57 108.884 -179.677 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A 1610 ' ' ILE . . . . . 0.596 HG13 ' HB2' ' A' 1638 ' ' PHE . 3.3 mp -111.29 116.66 53.1 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.318 0 N-CA-C 109.261 -0.644 . . . . 1.47 109.261 179.58 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A 1611 ' ' SER . . . . . . . . . . . . . 30.3 p -92.46 117.14 29.63 Favored 'General case' 0 N--CA 1.423 -1.8 0 CA-C-N 115.706 -0.679 . . . . 1.84 109.447 177.076 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 1612 ' ' PHE . . . . . 0.735 ' HB2' ' HB2' ' A' 1588 ' ' LEU . 96.0 m-85 -89.78 103.7 16.33 Favored 'General case' 0 C--N 1.299 -1.629 0 CA-C-N 116.05 -0.523 . . . . 0.86 110.563 -179.393 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A 1613 ' ' VAL . . . . . 0.595 ' O ' ' HA ' ' A' 1641 ' ' HIS . 11.9 t -107.6 145.12 15.28 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.452 0 N-CA-C 106.871 -1.529 . . . . 1.32 106.871 -179.011 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A 1614 ' ' CYS . . . . . . . . . . . . . 34.2 m -89.65 93.75 9.59 Favored 'General case' 0 C--N 1.294 -1.836 0 N-CA-C 113.536 0.939 . . . . 1.39 113.536 -169.977 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 1615 ' ' ARG . . . . . 0.874 ' HB3' ' HB3' ' A' 1641 ' ' HIS . 21.3 tpp180 -138.09 112.33 8.77 Favored Pre-proline 0 C--N 1.316 -0.87 0 N-CA-C 109.368 -0.604 . . . . 4.34 109.368 176.195 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A 1616 ' ' PRO . . . . . 0.512 ' HA ' ' HD3' ' A' 1643 ' ' PRO . 11.4 Cg_endo -55.07 -20.36 23.39 Favored 'Trans proline' 0 CA--C 1.562 1.876 0 C-N-CA 123.927 3.085 . . . . 1.5 116.259 -178.352 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A 1617 ' ' GLU . . . . . 0.697 ' HG2' ' HG3' ' A' 1615 ' ' ARG . 11.4 pt-20 -75.48 -6.75 51.72 Favored 'General case' 0 N--CA 1.478 0.939 0 N-CA-C 113.82 1.045 . . . . 3.21 113.82 -177.812 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A 1618 ' ' ALA . . . . . 0.547 ' HA ' ' O ' ' A' 1641 ' ' HIS . . . 72.59 -170.42 0.14 Allowed 'General case' 0 N--CA 1.482 1.167 0 C-N-CA 124.513 1.125 . . . . 2.91 112.398 177.018 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A 1619 ' ' GLY . . . . . . . . . . . . . . . -80.92 -141.88 3.11 Favored Glycine 0 CA--C 1.528 0.845 0 CA-C-O 119.539 -0.589 . . . . 3.35 112.349 -179.765 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 1620 ' ' PRO . . . . . 0.726 ' HD3' ' HB3' ' A' 1625 ' ' MET . 95.2 Cg_exo -48.45 -51.84 9.52 Favored 'Trans proline' 0 C--N 1.365 1.439 0 C-N-CA 124.109 3.206 . . . . 6.61 111.152 179.883 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A 1621 ' ' THR . . . . . . . . . . . . . 2.3 t -131.11 -50.68 1.02 Allowed 'General case' 0 N--CA 1.418 -2.057 0 N-CA-C 107.933 -1.136 . . . . 5.03 107.933 172.23 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 1622 ' ' ASN . . . . . . . . . . . . . 23.6 t-20 -136.34 -60.6 0.71 Allowed 'General case' 0 CA--C 1.501 -0.906 0 N-CA-C 112.925 0.713 . . . . 3.58 112.925 169.672 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 1623 ' ' ARG . . . . . 0.556 ' HB2' ' HD2' ' A' 1624 ' ' PRO . 0.0 OUTLIER -61.18 167.69 3.61 Favored Pre-proline 0 C--N 1.292 -1.924 0 CA-C-N 113.412 -1.722 . . . . 4.09 113.236 -173.478 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A 1624 ' ' PRO . . . . . 0.66 ' HB3' ' HB2' ' A' 1640 ' ' TRP . 11.6 Cg_endo -57.46 159.3 16.68 Favored 'Trans proline' 0 C--N 1.369 1.606 0 C-N-CA 123.02 2.48 . . . . 2.86 113.209 175.867 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A 1625 ' ' MET . . . . . 0.726 ' HB3' ' HD3' ' A' 1620 ' ' PRO . 26.5 ptt? -125.41 148.42 48.81 Favored 'General case' 0 C--N 1.311 -1.093 0 CA-C-N 116.094 -0.503 . . . . 2.73 110.003 -179.766 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A 1626 ' ' LEU . . . . . 0.4 HD21 ' HB2' ' A' 1629 ' ' LEU . 38.2 tp -77.68 116.11 17.96 Favored 'General case' 0 C--N 1.309 -1.173 0 N-CA-C 107.794 -1.187 . . . . 1.94 107.794 175.513 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A 1627 ' ' ILE . . . . . . . . . . . . . 25.0 pt -93.02 -30.05 4.46 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.22 0 C-N-CA 120.45 -0.5 . . . . 1.75 111.178 -179.107 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 1628 ' ' SER . . . . . . . . . . . . . 37.4 m -155.18 154.07 31.71 Favored 'General case' 0 C--N 1.313 -0.988 0 N-CA-C 109.015 -0.735 . . . . 1.85 109.015 -178.317 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 1629 ' ' LEU . . . . . 0.504 HD13 HD11 ' A' 1636 ' ' LEU . 45.2 tp -145.95 114.43 6.74 Favored 'General case' 0 C--N 1.301 -1.52 0 CA-C-O 121.24 0.543 . . . . 2.12 109.946 178.892 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A 1630 ' ' ASP . . . . . . . . . . . . . 27.6 t70 -112.75 102.07 10.13 Favored 'General case' 0 C--N 1.298 -1.633 0 N-CA-C 108.408 -0.96 . . . . 0.87 108.408 179.447 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 1631 ' ' LYS . . . . . . . . . . . . . 60.1 mttp -73.58 -18.01 61.11 Favored 'General case' 0 C--N 1.316 -0.853 0 N-CA-C 112.182 0.438 . . . . 2.76 112.182 -177.52 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 1632 ' ' GLN . . . . . . . . . . . . . 7.6 tp-100 -64.65 -45.14 88.04 Favored 'General case' 0 N--CA 1.451 -0.39 0 CA-C-O 120.885 0.374 . . . . 2.55 110.668 178.632 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 1633 ' ' THR . . . . . 0.453 ' HA ' HD13 ' A' 1604 ' ' LEU . 40.9 p -99.23 -2.02 37.7 Favored 'General case' 0 C--N 1.316 -0.849 0 CA-C-O 121.467 0.651 . . . . 1.92 111.226 177.858 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A 1634 ' ' CYS . . . . . . . . . . . . . 82.8 m 56.68 40.29 29.31 Favored 'General case' 0 C--O 1.235 0.298 0 CA-C-N 114.539 -1.21 . . . . 0.89 111.362 -179.853 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 1635 ' ' THR . . . . . . . . . . . . . 25.1 m -99.03 119.56 38.0 Favored 'General case' 0 N--CA 1.423 -1.8 0 CA-C-N 114.921 -1.036 . . . . 1.31 109.826 -177.583 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 1636 ' ' LEU . . . . . 0.762 ' HB2' ' HA ' ' A' 1608 ' ' SER . 2.7 mm? -90.85 107.94 19.52 Favored 'General case' 0 C--N 1.311 -1.086 0 N-CA-C 108.454 -0.943 . . . . 1.97 108.454 178.648 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A 1637 ' ' PHE . . . . . . . . . . . . . 96.5 m-85 -95.88 100.16 11.88 Favored 'General case' 0 C--O 1.244 0.815 0 CA-C-O 120.853 0.359 . . . . 0.92 110.611 -178.79 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 1638 ' ' PHE . . . . . 0.596 ' HB2' HG13 ' A' 1610 ' ' ILE . 96.7 m-85 -108.76 156.19 19.89 Favored 'General case' 0 C--N 1.298 -1.634 0 CA-C-O 121.364 0.602 . . . . 0.7 109.987 177.852 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A 1639 ' ' SER . . . . . . . . . . . . . 32.9 t -143.34 130.84 21.12 Favored 'General case' 0 C--N 1.285 -2.218 0 N-CA-C 108.593 -0.892 . . . . 1.46 108.593 176.172 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 1640 ' ' TRP . . . . . 0.735 ' HE3' ' HE1' ' A' 1612 ' ' PHE . 9.5 t90 -115.92 111.46 20.45 Favored 'General case' 0 N--CA 1.409 -2.485 0 N-CA-C 107.635 -1.246 . . . . 0.92 107.635 175.696 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A 1641 ' ' HIS . . . . . 0.874 ' HB3' ' HB3' ' A' 1615 ' ' ARG . 47.3 m-70 -89.76 105.3 17.71 Favored 'General case' 0 N--CA 1.422 -1.869 0 N-CA-C 107.167 -1.42 . . . . 3.18 107.167 175.88 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A 1642 ' ' THR . . . . . . . . . . . . . 6.1 t -142.8 146.12 36.56 Favored Pre-proline 0 C--N 1.287 -2.127 0 CA-C-N 115.846 -0.616 . . . . 1.48 109.914 -175.322 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 1643 ' ' PRO . . . . . 0.512 ' HD3' ' HA ' ' A' 1616 ' ' PRO . 71.6 Cg_endo -76.65 -4.69 15.28 Favored 'Trans proline' 0 C--N 1.352 0.725 0 C-N-CA 122.694 2.263 . . . . 1.09 110.495 175.775 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A 1644 ' ' LEU . . . . . . . . . . . . . 81.9 mt -86.67 -7.63 58.14 Favored 'General case' 0 N--CA 1.447 -0.621 0 CA-C-N 115.234 -0.894 . . . . 2.08 109.489 177.217 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 1645 ' ' ALA . . . . . . . . . . . . . . . -78.97 -42.58 26.42 Favored 'General case' 0 C--O 1.222 -0.366 0 N-CA-C 107.996 -1.112 . . . . 1.37 107.996 176.716 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 1646 ' ' CYS . . . . . . . . . . . . . 13.5 p -176.11 154.83 1.47 Allowed 'General case' 0 N--CA 1.432 -1.344 0 N-CA-C 104.362 -2.459 . . . . 1.7 104.362 172.639 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 1647 ' ' GLU . . . . . . . . . . . . . 42.8 mt-10 -103.14 124.78 37.22 Favored Pre-proline 0 C--N 1.288 -2.108 0 N-CA-C 108.506 -0.924 . . . . 2.92 108.506 -179.685 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 1648 ' ' PRO . . . . . . . . . . . . . 31.4 Cg_exo -60.9 101.37 0.18 Allowed 'Trans proline' 0 C--O 1.251 1.142 0 C-N-CA 122.632 2.221 . . . . 3.19 111.552 177.075 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 1649 ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 . . . . . 0 N--CA 1.434 -1.259 0 C-N-CA 125.167 1.387 . . . . 5.06 108.25 179.227 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A 1508 ' ' MET . . . . . . . . . . . . . 26.9 ttt . . . . . 0 CA--C 1.506 -0.721 0 N-CA-C 107.994 -1.114 . . . . 8.58 107.994 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A 1509 ' ' LYS . . . . . . . . . . . . . 60.6 pttt -80.35 170.04 16.93 Favored 'General case' 0 C--N 1.305 -1.335 0 N-CA-C 108.696 -0.853 . . . . 6.8 108.696 178.274 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A 1510 ' ' SER . . . . . . . . . . . . . 51.0 m -151.8 178.14 9.69 Favored 'General case' 0 C--N 1.28 -2.419 0 N-CA-C 107.32 -1.363 . . . . 4.48 107.32 -179.7 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A 1511 ' ' ASN . . . . . 0.446 ' HB3' ' O ' ' A' 1517 ' ' GLN . 85.3 m-20 68.35 30.37 5.5 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 121.784 0.802 . . . . 3.08 111.152 173.307 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A 1512 ' ' GLU . . . . . . . . . . . . . 8.9 tp10 -93.71 -47.04 6.97 Favored 'General case' 0 C--N 1.317 -0.839 0 CA-C-N 115.115 -0.948 . . . . 4.46 108.706 178.891 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A 1513 ' ' HIS . . . . . . . . . . . . . 56.9 t-80 -139.91 15.23 2.48 Favored 'General case' 0 CA--C 1.549 0.932 0 CA-C-O 121.901 0.857 . . . . 6.25 108.891 176.635 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A 1514 ' ' ASP . . . . . . . . . . . . . 12.5 m-20 -71.34 -70.26 0.33 Allowed 'General case' 0 CA--C 1.499 -1.014 0 CA-C-O 121.817 0.818 . . . . 3.7 111.463 -177.902 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A 1515 ' ' ASP . . . . . 0.461 ' HA ' ' HD2' ' A' 1579 ' ' LYS . 31.4 t70 -141.22 170.04 16.48 Favored 'General case' 0 C--N 1.284 -2.255 0 N-CA-C 105.991 -1.855 . . . . 2.54 105.991 -175.216 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A 1516 ' ' CYS . . . . . . . . . . . . . 61.1 m -75.14 51.04 0.51 Allowed 'General case' 0 C--N 1.318 -0.769 0 CA-C-O 121.489 0.661 . . . . 1.25 111.455 -178.301 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A 1517 ' ' GLN . . . . . 0.446 ' O ' ' HB3' ' A' 1511 ' ' ASN . 11.3 pt20 -137.9 154.69 49.41 Favored 'General case' 0 N--CA 1.413 -2.307 0 N-CA-C 106.949 -1.5 . . . . 2.36 106.949 178.55 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A 1518 ' ' VAL . . . . . . . . . . . . . 7.7 p -148.58 137.94 15.81 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.741 0 O-C-N 123.178 0.299 . . . . 2.34 110.913 -174.893 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A 1519 ' ' THR . . . . . . . . . . . . . 8.4 m -103.66 102.76 12.62 Favored 'General case' 0 N--CA 1.429 -1.523 0 N-CA-C 107.901 -1.148 . . . . 2.04 107.901 178.713 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A 1520 ' ' ASN . . . . . . . . . . . . . 24.7 t30 -71.61 114.65 30.09 Favored Pre-proline 0 C--N 1.319 -0.72 0 C-N-CA 121.021 -0.272 . . . . 2.12 110.281 -179.049 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A 1521 ' ' PRO . . . . . . . . . . . . . 55.9 Cg_endo -68.27 -9.63 26.47 Favored 'Trans proline' 0 C--N 1.357 1.018 0 C-N-CA 122.688 2.259 . . . . 2.59 113.486 -174.797 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A 1522 ' ' SER . . . . . . . . . . . . . 15.1 m -79.21 -23.59 43.7 Favored 'General case' 0 N--CA 1.435 -1.18 0 CA-C-N 116.694 -0.23 . . . . 2.65 111.249 178.991 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A 1523 ' ' THR . . . . . . . . . . . . . 7.0 t -137.5 -15.93 1.39 Allowed 'General case' 0 CA--C 1.549 0.913 0 N-CA-C 112.712 0.634 . . . . 2.33 112.712 -177.893 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A 1524 ' ' GLY . . . . . . . . . . . . . . . 84.6 -5.38 81.74 Favored Glycine 0 N--CA 1.45 -0.417 0 O-C-N 121.982 -0.449 . . . . 1.96 113.182 179.024 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A 1525 ' ' HIS . . . . . . . . . . . . . 11.7 t60 -73.01 135.71 44.97 Favored 'General case' 0 C--N 1.311 -1.081 0 CA-C-O 121.113 0.482 . . . . 2.44 110.091 -177.403 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A 1526 ' ' LEU . . . . . . . . . . . . . 3.5 tm? -95.34 121.65 37.22 Favored 'General case' 0 C--N 1.306 -1.285 0 CA-C-N 114.905 -1.043 . . . . 2.19 108.407 -179.918 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A 1527 ' ' PHE . . . . . 0.578 ' CE1' ' HA ' ' A' 1646 ' ' CYS . 78.7 m-85 -106.6 149.23 27.4 Favored 'General case' 0 C--N 1.292 -1.914 0 N-CA-C 107.352 -1.351 . . . . 1.61 107.352 177.574 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A 1528 ' ' ASP . . . . . . . . . . . . . 1.2 p30 -143.29 148.21 35.99 Favored 'General case' 0 CA--C 1.484 -1.566 0 CA-C-O 121.371 0.605 . . . . 2.18 109.82 177.287 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A 1529 ' ' LEU . . . . . . . . . . . . . 88.7 mt -117.07 -6.05 11.39 Favored 'General case' 0 C--N 1.284 -2.255 0 CA-C-N 114.002 -1.454 . . . . 2.04 107.371 175.338 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A 1530 ' ' SER . . . . . . . . . . . . . 11.5 m -66.42 -41.67 88.87 Favored 'General case' 0 N--CA 1.432 -1.33 0 CA-C-N 114.315 -1.311 . . . . 1.44 111.624 -175.556 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A 1531 ' ' SER . . . . . . . . . . . . . 13.6 t -87.35 -16.18 35.76 Favored 'General case' 0 N--CA 1.438 -1.067 0 N-CA-C 109.027 -0.731 . . . . 1.63 109.027 -178.77 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A 1532 ' ' LEU . . . . . 0.446 HD11 HD12 ' A' 1644 ' ' LEU . 80.2 mt -76.15 -36.26 58.84 Favored 'General case' 0 CA--C 1.521 -0.173 0 CA-C-N 115.854 -0.612 . . . . 2.32 111.068 179.362 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A 1533 ' ' SER . . . . . 0.565 ' HB2' ' HB ' ' A' 1552 ' ' ILE . 25.7 t -80.29 133.74 36.0 Favored 'General case' 0 C--N 1.304 -1.41 0 CA-C-N 115.914 -0.585 . . . . 2.57 110.349 -178.041 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A 1534 ' ' GLY . . . . . . . . . . . . . . . -91.47 160.01 26.47 Favored Glycine 0 N--CA 1.441 -1.022 0 N-CA-C 109.092 -1.603 . . . . 1.89 109.092 174.797 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A 1535 ' ' ARG . . . . . . . . . . . . . 29.0 ttp180 -70.82 -19.77 62.63 Favored 'General case' 0 C--N 1.318 -0.761 0 CA-C-N 117.961 0.88 . . . . 4.44 110.927 -175.911 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A 1536 ' ' ALA . . . . . . . . . . . . . . . -90.26 -9.7 46.97 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-O 121.375 0.607 . . . . 2.07 109.666 177.302 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A 1537 ' ' GLY . . . . . . . . . . . . . . . 80.61 -169.44 52.36 Favored Glycine 0 N--CA 1.422 -2.277 0 CA-C-N 115.123 -0.944 . . . . 1.2 110.962 -177.09 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A 1538 ' ' PHE . . . . . . . . . . . . . 17.3 m-85 -120.33 170.16 9.62 Favored 'General case' 0 C--N 1.285 -2.233 0 N-CA-C 108.286 -1.005 . . . . 1.98 108.286 177.517 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A 1539 ' ' THR . . . . . 0.497 ' HA ' ' O ' ' A' 1548 ' ' VAL . 23.5 p -120.98 118.3 29.49 Favored 'General case' 0 C--N 1.289 -2.028 0 CA-C-N 116.223 -0.444 . . . . 1.97 110.454 -179.433 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A 1540 ' ' ALA . . . . . . . . . . . . . . . -93.24 143.66 26.05 Favored 'General case' 0 C--N 1.305 -1.333 0 N-CA-C 107.323 -1.362 . . . . 1.39 107.323 175.449 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A 1541 ' ' ALA . . . . . . . . . . . . . . . -84.68 70.08 10.73 Favored 'General case' 0 C--N 1.298 -1.633 0 N-CA-C 112.658 0.614 . . . . 1.86 112.658 -173.282 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A 1542 ' ' TYR . . . . . . . . . . . . . 16.4 t80 -157.06 112.76 2.89 Favored 'General case' 0 C--O 1.208 -1.079 0 N-CA-C 113.386 0.884 . . . . 2.4 113.386 176.511 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A 1543 ' ' SER . . . . . 0.572 ' HB3' ' N ' ' A' 1546 ' ' GLY . 43.4 t -138.42 -153.61 0.48 Allowed 'General case' 0 C--N 1.263 -3.159 0 N-CA-C 103.467 -2.79 . . . . 2.58 103.467 162.03 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A 1544 ' ' LYS . . . . . . . . . . . . . 96.1 mttt -66.22 -50.34 64.14 Favored 'General case' 0 C--N 1.303 -1.44 0 N-CA-C 106.354 -1.721 . . . . 4.24 106.354 170.275 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A 1545 ' ' SER . . . . . . . . . . . . . 17.6 t -134.41 25.98 3.79 Favored 'General case' 0 CA--C 1.562 1.442 0 CA-C-N 115.166 -0.925 . . . . 3.6 110.013 175.597 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A 1546 ' ' GLY . . . . . 0.572 ' N ' ' HB3' ' A' 1543 ' ' SER . . . -138.09 -118.05 1.62 Allowed Glycine 0 CA--C 1.529 0.96 0 C-N-CA 118.027 -2.035 . . . . 1.66 117.316 -170.524 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A 1547 ' ' VAL . . . . . . . . . . . . . 14.0 m -159.21 169.34 0.53 Allowed 'Isoleucine or valine' 0 C--O 1.255 1.382 0 C-N-CA 124.256 1.022 . . . . 2.23 110.876 -165.581 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A 1548 ' ' VAL . . . . . 0.497 ' O ' ' HA ' ' A' 1539 ' ' THR . 3.5 t -124.87 135.57 63.58 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.628 0 N-CA-C 107.787 -1.19 . . . . 1.59 107.787 178.625 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A 1549 ' ' TYR . . . . . . . . . . . . . 22.7 m-85 -92.16 114.92 27.59 Favored 'General case' 0 CA--C 1.502 -0.869 0 N-CA-C 105.711 -1.959 . . . . 1.58 105.711 172.52 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A 1550 ' ' MET . . . . . . . . . . . . . 19.8 ptm -144.66 127.8 16.64 Favored 'General case' 0 C--N 1.283 -2.294 0 C-N-CA 119.601 -0.84 . . . . 2.08 111.653 -176.744 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A 1551 ' ' SER . . . . . . . . . . . . . 51.0 m -86.68 135.3 33.44 Favored 'General case' 0 C--N 1.285 -2.236 0 N-CA-C 107.805 -1.183 . . . . 1.9 107.805 177.812 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A 1552 ' ' ILE . . . . . 0.565 ' HB ' ' HB2' ' A' 1533 ' ' SER . 27.8 mm -75.97 -13.16 14.82 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.959 0 CA-C-O 122.363 1.078 . . . . 2.04 108.471 -175.181 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A 1553 ' ' CYS . . . . . . . . . . . . . 33.1 t -161.33 137.95 8.46 Favored 'General case' 0 N--CA 1.421 -1.918 0 N-CA-C 106.957 -1.497 . . . . 1.43 106.957 174.54 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A 1554 ' ' GLY . . . . . . . . . . . . . . . 86.99 -166.56 37.19 Favored Glycine 0 N--CA 1.435 -1.371 0 C-N-CA 120.857 -0.687 . . . . 1.23 114.015 174.18 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A 1555 ' ' GLU . . . . . . . . . . . . . 13.5 pt-20 -86.74 154.57 20.85 Favored 'General case' 0 C--N 1.313 -1.01 0 CA-C-O 121.384 0.612 . . . . 1.8 111.129 -178.192 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A 1556 ' ' ASN . . . . . . . . . . . . . 20.4 t-20 -108.91 112.5 24.76 Favored 'General case' 0 C--N 1.301 -1.524 0 N-CA-C 109.259 -0.645 . . . . 2.63 109.259 178.341 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A 1557 ' ' GLU . . . . . . . . . . . . . 7.9 mt-10 -83.21 40.41 0.71 Allowed 'General case' 0 C--N 1.309 -1.176 0 CA-C-O 121.066 0.46 . . . . 3.79 112.198 -173.017 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A 1558 ' ' ASN . . . . . . . . . . . . . 34.6 m-80 -126.89 -0.78 6.62 Favored 'General case' 0 C--N 1.307 -1.249 0 CA-C-O 121.291 0.567 . . . . 1.59 110.079 179.648 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A 1559 ' ' CYS . . . . . 0.748 ' HB3' ' HD2' ' A' 1560 ' ' PRO . 67.5 m -147.11 177.8 1.65 Allowed Pre-proline 0 C--N 1.309 -1.172 0 CA-C-O 116.884 -1.532 . . . . 0.94 107.162 179.594 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A 1560 ' ' PRO . . . . . 0.748 ' HD2' ' HB3' ' A' 1559 ' ' CYS . 3.4 Cg_exo -36.13 122.84 0.29 Allowed 'Trans proline' 0 C--N 1.385 2.469 0 C-N-CA 124.107 3.205 . . . . 1.53 114.038 178.917 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A 1561 ' ' PRO . . . . . . . . . . . . . 56.4 Cg_exo -53.82 107.64 0.22 Allowed 'Trans proline' 0 C--O 1.254 1.31 0 C-N-CA 123.482 2.788 . . . . 1.82 112.698 -179.053 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A 1562 ' ' GLY . . . . . . . . . . . . . . . 134.12 -11.56 4.75 Favored Glycine 0 N--CA 1.43 -1.707 0 CA-C-N 115.306 -0.861 . . . . 0.81 111.84 179.263 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A 1563 ' ' VAL . . . . . 0.542 ' HA ' ' HA ' ' A' 1576 ' ' LYS . 15.1 m -88.17 144.11 9.85 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.247 0 CA-C-O 120.965 0.412 . . . . 1.73 109.922 179.739 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A 1564 ' ' GLY . . . . . . . . . . . . . . . -100.74 -26.43 8.03 Favored Glycine 0 C--N 1.306 -1.106 0 N-CA-C 110.725 -0.95 . . . . 0.72 110.725 179.796 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A 1565 ' ' ALA . . . . . . . . . . . . . . . -138.59 141.18 39.2 Favored 'General case' 0 N--CA 1.439 -0.986 0 N-CA-C 109.045 -0.724 . . . . 1.14 109.045 179.533 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A 1566 ' ' CYS . . . . . . . . . . . . . 39.8 t -158.7 133.04 7.92 Favored 'General case' 0 C--N 1.3 -1.546 0 N-CA-C 108.106 -1.072 . . . . 0.51 108.106 -176.955 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A 1567 ' ' PHE . . . . . . . . . . . . . 86.3 m-85 -63.63 123.62 19.3 Favored 'General case' 0 C--O 1.208 -1.126 0 N-CA-C 107.508 -1.293 . . . . 1.22 107.508 178.305 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A 1568 ' ' GLY . . . . . 0.412 ' H ' ' HA ' ' A' 1548 ' ' VAL . . . -82.91 -24.85 51.6 Favored Glycine 0 CA--C 1.487 -1.676 0 C-N-CA 120.244 -0.979 . . . . 1.08 112.986 -171.654 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A 1569 ' ' GLN . . . . . . . . . . . . . 22.0 tp60 -81.89 -38.29 25.56 Favored 'General case' 0 C--N 1.298 -1.648 0 CA-C-O 122.096 0.95 . . . . 3.05 108.736 179.391 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A 1570 ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -93.13 -22.28 19.18 Favored 'General case' 0 C--N 1.295 -1.77 0 CA-C-N 114.354 -1.294 . . . . 2.44 112.157 -171.727 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A 1571 ' ' ARG . . . . . . . . . . . . . 50.9 mtt180 63.31 38.01 10.58 Favored 'General case' 0 N--CA 1.47 0.547 0 C-N-CA 125.54 1.536 . . . . 4.48 112.411 -179.256 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A 1572 ' ' ILE . . . . . . . . . . . . . 48.1 mm -118.08 126.05 74.66 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.934 0 CA-C-N 114.849 -1.069 . . . . 1.94 108.864 -177.028 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A 1573 ' ' SER . . . . . . . . . . . . . 45.8 t -62.17 134.63 56.81 Favored 'General case' 0 C--N 1.307 -1.277 0 C-N-CA 123.87 0.868 . . . . 1.25 111.782 -177.578 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A 1574 ' ' VAL . . . . . . . . . . . . . 92.6 t -97.69 -50.61 11.14 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.426 0 CA-C-N 115.313 -0.858 . . . . 1.61 109.174 -179.622 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A 1575 ' ' GLY . . . . . . . . . . . . . . . -160.55 150.38 20.35 Favored Glycine 0 N--CA 1.432 -1.616 0 C-N-CA 120.38 -0.914 . . . . 0.65 112.117 -176.895 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A 1576 ' ' LYS . . . . . 0.542 ' HA ' ' HA ' ' A' 1563 ' ' VAL . 64.8 tttm -78.7 146.54 33.9 Favored 'General case' 0 C--N 1.311 -1.084 0 N-CA-C 108.714 -0.847 . . . . 3.33 108.714 -179.47 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A 1577 ' ' ALA . . . . . . . . . . . . . . . -69.09 90.81 0.47 Allowed 'General case' 0 C--N 1.319 -0.73 0 C-N-CA 123.783 0.833 . . . . 1.31 112.047 -176.03 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A 1578 ' ' ASN . . . . . . . . . . . . . 43.6 m-80 -103.73 113.75 27.5 Favored 'General case' 0 C--N 1.303 -1.42 0 N-CA-C 108.549 -0.908 . . . . 2.24 108.549 176.9 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A 1579 ' ' LYS . . . . . 0.461 ' HD2' ' HA ' ' A' 1515 ' ' ASP . 35.9 ttpt -89.7 89.99 8.03 Favored 'General case' 0 C--N 1.295 -1.764 0 CA-C-O 122.223 1.011 . . . . 2.34 109.152 -176.713 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A 1580 ' ' ARG . . . . . . . . . . . . . 27.4 tpt180 -161.3 111.84 1.7 Allowed 'General case' 0 N--CA 1.424 -1.766 0 CA-C-N 113.747 -1.57 . . . . 4.19 109.236 -178.007 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A 1581 ' ' LEU . . . . . . . . . . . . . 3.6 pp -117.75 160.94 20.51 Favored 'General case' 0 N--CA 1.413 -2.295 0 CA-C-N 114.991 -1.004 . . . . 2.39 108.647 176.56 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A 1582 ' ' ARG . . . . . . . . . . . . . 18.0 ttp85 -140.78 138.02 33.81 Favored 'General case' 0 C--N 1.291 -1.95 0 N-CA-C 108.519 -0.919 . . . . 4.48 108.519 176.059 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A 1583 ' ' TYR . . . . . . . . . . . . . 70.0 t80 -102.65 96.6 6.99 Favored 'General case' 0 C--N 1.303 -1.429 0 N-CA-C 107.694 -1.224 . . . . 1.57 107.694 179.788 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A 1584 ' ' VAL . . . . . 0.501 ' O ' HG13 ' A' 1587 ' ' VAL . 6.0 p -121.85 105.8 17.0 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.505 0 CA-C-N 116.123 -0.49 . . . . 2.29 111.802 -175.581 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A 1585 ' ' ASP . . . . . . . . . . . . . 37.0 t70 61.46 61.19 1.54 Allowed 'General case' 0 C--N 1.319 -0.739 0 CA-C-O 122.356 1.074 . . . . 2.06 111.115 178.38 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A 1586 ' ' GLN . . . . . . . . . . . . . 47.8 mt-30 62.62 8.75 3.11 Favored 'General case' 0 N--CA 1.478 0.941 0 CA-C-N 114.244 -1.344 . . . . 2.61 114.258 178.322 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A 1587 ' ' VAL . . . . . 0.501 HG13 ' O ' ' A' 1584 ' ' VAL . 11.7 p -122.07 125.43 73.04 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.242 0 C-N-CA 119.204 -0.998 . . . . 1.33 110.548 178.496 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A 1588 ' ' LEU . . . . . 0.675 ' HB2' ' HB2' ' A' 1612 ' ' PHE . 57.6 mt -83.22 126.24 32.43 Favored 'General case' 0 C--N 1.3 -1.552 0 CA-C-N 114.919 -1.037 . . . . 2.03 109.061 173.826 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A 1589 ' ' GLN . . . . . . . . . . . . . 36.0 tt0 -118.85 117.44 28.86 Favored 'General case' 0 C--N 1.284 -2.248 0 CA-C-N 115.736 -0.666 . . . . 1.73 109.291 -178.475 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A 1590 ' ' LEU . . . . . . . . . . . . . 7.3 tt -124.6 132.83 53.41 Favored 'General case' 0 C--N 1.307 -1.248 0 N-CA-C 106.847 -1.538 . . . . 1.76 106.847 176.611 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A 1591 ' ' VAL . . . . . 0.416 HG21 HG21 ' A' 1609 ' ' VAL . 39.0 t -127.42 137.68 57.01 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.704 0 CA-C-O 120.69 0.281 . . . . 2.14 111.309 -174.092 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A 1592 ' ' TYR . . . . . . . . . . . . . 57.9 m-85 -115.07 124.64 52.11 Favored 'General case' 0 C--N 1.314 -0.962 0 N-CA-C 107.262 -1.384 . . . . 1.53 107.262 171.231 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A 1593 ' ' LYS . . . . . . . . . . . . . 13.3 ptmm? -137.98 172.86 12.3 Favored 'General case' 0 C--N 1.302 -1.484 0 C-N-CA 121.149 -0.22 . . . . 2.72 111.263 -177.111 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A 1594 ' ' ASP . . . . . . . . . . . . . 17.3 m-20 66.37 48.0 1.65 Allowed 'General case' 0 C--O 1.247 0.935 0 C-N-CA 125.313 1.445 . . . . 1.45 111.875 179.082 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A 1595 ' ' GLY . . . . . . . . . . . . . . . -89.93 -106.98 1.23 Allowed Glycine 0 N--CA 1.44 -1.04 0 N-CA-C 110.877 -0.889 . . . . 0.83 110.877 175.832 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A 1596 ' ' SER . . . . . . . . . . . . . 19.9 m -101.89 152.08 38.09 Favored Pre-proline 0 C--N 1.296 -1.741 0 N-CA-C 109.732 -0.47 . . . . 1.96 109.732 179.214 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A 1597 ' ' PRO . . . . . . . . . . . . . 22.6 Cg_exo -66.79 141.35 59.07 Favored 'Trans proline' 0 C--N 1.353 0.797 0 C-N-CA 123.203 2.602 . . . . 1.34 112.018 178.88 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A 1598 ' ' CYS . . . . . 0.642 ' O ' ' HA ' ' A' 1602 ' ' SER . 42.2 t -95.86 136.39 22.27 Favored Pre-proline 0 C--N 1.287 -2.136 0 CA-C-N 115.505 -0.771 . . . . 1.19 109.011 179.993 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A 1599 ' ' PRO . . . . . . . . . . . . . 63.3 Cg_endo -75.08 -18.01 18.91 Favored 'Trans proline' 0 C--N 1.36 1.149 0 C-N-CA 123.11 2.54 . . . . 1.88 112.198 177.751 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A 1600 ' ' SER . . . . . . . . . . . . . 34.2 m -86.63 112.54 21.7 Favored 'General case' 0 N--CA 1.425 -1.721 0 N-CA-C 107.037 -1.468 . . . . 2.19 107.037 176.592 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A 1601 ' ' LYS . . . . . . . . . . . . . 42.9 mmtm 56.23 55.79 6.4 Favored 'General case' 0 C--O 1.242 0.694 0 CA-C-O 122.477 1.132 . . . . 4.21 108.542 -173.215 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A 1602 ' ' SER . . . . . 0.642 ' HA ' ' O ' ' A' 1598 ' ' CYS . 15.0 t -49.11 122.77 6.28 Favored 'General case' 0 N--CA 1.442 -0.865 0 CA-C-N 112.781 -2.009 . . . . 3.82 112.108 -172.693 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A 1603 ' ' GLY . . . . . . . . . . . . . . . 140.02 -23.58 2.74 Favored Glycine 0 N--CA 1.43 -1.726 0 N-CA-C 109.131 -1.588 . . . . 2.45 109.131 -176.61 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A 1604 ' ' LEU . . . . . . . . . . . . . 72.3 mt -85.33 152.45 23.27 Favored 'General case' 0 C--N 1.309 -1.183 0 CA-C-N 114.733 -0.734 . . . . 2.06 109.473 177.502 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A 1605 ' ' SER . . . . . . . . . . . . . 49.1 m -101.7 175.54 5.52 Favored 'General case' 0 C--N 1.282 -2.341 0 N-CA-C 105.933 -1.877 . . . . 1.75 105.933 169.094 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A 1606 ' ' TYR . . . . . . . . . . . . . 78.5 m-85 -94.76 149.69 20.98 Favored 'General case' 0 CA--C 1.466 -2.28 0 N-CA-C 106.133 -1.803 . . . . 1.59 106.133 -177.583 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A 1607 ' ' LYS . . . . . 0.41 ' HG3' HG23 ' A' 1635 ' ' THR . 23.2 pttm -135.67 132.18 36.64 Favored 'General case' 0 N--CA 1.401 -2.915 0 C-N-CA 118.377 -1.329 . . . . 2.21 110.123 175.243 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A 1608 ' ' SER . . . . . . . . . . . . . 29.3 p -106.9 112.15 24.98 Favored 'General case' 0 C--N 1.288 -2.08 0 CA-C-N 116.277 -0.419 . . . . 1.48 110.376 -179.232 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A 1609 ' ' VAL . . . . . 0.416 HG21 HG21 ' A' 1591 ' ' VAL . 92.6 t -100.3 117.4 45.44 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.961 0 N-CA-C 108.719 -0.845 . . . . 1.57 108.719 177.622 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A 1610 ' ' ILE . . . . . 0.667 HG13 ' HB2' ' A' 1638 ' ' PHE . 3.5 mp -101.94 118.34 48.61 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.567 0 N-CA-C 108.22 -1.03 . . . . 1.47 108.22 177.133 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A 1611 ' ' SER . . . . . . . . . . . . . 14.1 m -104.22 117.02 33.22 Favored 'General case' 0 N--CA 1.416 -2.131 0 CA-C-N 115.357 -0.838 . . . . 1.84 108.966 178.834 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A 1612 ' ' PHE . . . . . 0.675 ' HB2' ' HB2' ' A' 1588 ' ' LEU . 95.2 m-85 -90.18 107.32 19.06 Favored 'General case' 0 C--N 1.298 -1.648 0 CA-C-N 115.458 -0.792 . . . . 0.86 109.251 179.98 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A 1613 ' ' VAL . . . . . . . . . . . . . 71.9 t -100.38 131.31 48.15 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.108 0 CA-C-N 116.152 -0.477 . . . . 1.32 109.922 -177.02 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A 1614 ' ' CYS . . . . . . . . . . . . . 59.6 m -67.98 101.76 1.17 Allowed 'General case' 0 C--N 1.317 -0.848 0 C-N-CA 123.787 0.835 . . . . 1.39 110.925 -179.425 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A 1615 ' ' ARG . . . . . 0.533 ' HD2' ' OE2' ' A' 1617 ' ' GLU . 21.4 mmt180 -137.07 95.76 11.77 Favored Pre-proline 0 C--N 1.306 -1.294 0 CA-C-N 115.594 -0.73 . . . . 4.34 110.927 178.692 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A 1616 ' ' PRO . . . . . 0.422 ' HA ' ' HB3' ' A' 1643 ' ' PRO . 11.4 Cg_exo -74.1 58.53 4.26 Favored 'Trans proline' 0 CA--C 1.541 0.857 0 C-N-CA 123.636 2.891 . . . . 1.5 111.371 176.587 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A 1617 ' ' GLU . . . . . 0.533 ' OE2' ' HD2' ' A' 1615 ' ' ARG . 38.3 mt-10 -131.38 37.02 3.74 Favored 'General case' 0 C--N 1.31 -1.121 0 C-N-CA 124.659 1.183 . . . . 3.21 108.471 179.503 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A 1618 ' ' ALA . . . . . . . . . . . . . . . -63.96 140.38 58.86 Favored 'General case' 0 C--O 1.243 0.734 0 CA-C-N 115.709 -0.678 . . . . 2.91 111.856 -173.929 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A 1619 ' ' GLY . . . . . . . . . . . . . . . -148.92 -165.1 11.98 Favored Glycine 0 N--CA 1.426 -1.985 0 N-CA-C 110.185 -1.166 . . . . 3.35 110.185 179.89 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A 1620 ' ' PRO . . . . . . . . . . . . . 5.9 Cg_exo -78.69 4.91 6.0 Favored 'Trans proline' 0 CA--C 1.532 0.401 0 C-N-CA 123.068 2.512 . . . . 6.61 112.89 -176.823 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A 1621 ' ' THR . . . . . . . . . . . . . 15.0 t -131.55 33.22 4.06 Favored 'General case' 0 N--CA 1.426 -1.635 0 CA-C-O 122.249 1.023 . . . . 5.03 109.664 179.61 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A 1622 ' ' ASN . . . . . . . . . . . . . 25.2 t-20 -85.4 82.44 8.32 Favored 'General case' 0 C--N 1.321 -0.645 0 N-CA-C 108.864 -0.791 . . . . 3.58 108.864 -178.759 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A 1623 ' ' ARG . . . . . . . . . . . . . 8.6 ptm180 -133.67 158.17 76.17 Favored Pre-proline 0 C--N 1.311 -1.089 0 CA-C-N 115.378 -0.828 . . . . 4.09 109.714 -173.866 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A 1624 ' ' PRO . . . . . . . . . . . . . 12.2 Cg_exo -69.86 127.21 14.2 Favored 'Trans proline' 0 C--O 1.246 0.905 0 C-N-CA 122.792 2.328 . . . . 2.86 110.834 176.942 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A 1625 ' ' MET . . . . . . . . . . . . . 22.1 ptp -126.34 151.47 47.53 Favored 'General case' 0 C--N 1.303 -1.438 0 CA-C-N 116.131 -0.486 . . . . 2.73 110.396 -178.561 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A 1626 ' ' LEU . . . . . 0.409 HD13 ' O ' ' A' 1637 ' ' PHE . 39.0 tp -85.55 118.35 25.01 Favored 'General case' 0 C--N 1.306 -1.293 0 N-CA-C 108.436 -0.95 . . . . 1.94 108.436 -179.666 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A 1627 ' ' ILE . . . . . . . . . . . . . 45.8 pt -93.17 -28.33 4.45 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.331 0 C-N-CA 120.345 -0.542 . . . . 1.75 111.47 -177.993 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A 1628 ' ' SER . . . . . . . . . . . . . 21.1 t -160.57 142.0 12.22 Favored 'General case' 0 N--CA 1.432 -1.371 0 C-N-CA 120.341 -0.543 . . . . 1.85 110.565 -177.482 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A 1629 ' ' LEU . . . . . 0.815 HD11 ' HG ' ' A' 1636 ' ' LEU . 29.5 tp -119.76 128.02 53.36 Favored 'General case' 0 C--N 1.304 -1.37 0 N-CA-C 108.065 -1.087 . . . . 2.12 108.065 174.055 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A 1630 ' ' ASP . . . . . . . . . . . . . 25.1 t70 -102.07 127.41 48.98 Favored 'General case' 0 C--N 1.295 -1.761 0 CA-C-N 116.737 -0.211 . . . . 0.87 110.623 179.269 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A 1631 ' ' LYS . . . . . . . . . . . . . 53.0 mttm -95.14 0.97 54.72 Favored 'General case' 0 C--N 1.317 -0.808 0 N-CA-C 111.872 0.323 . . . . 2.76 111.872 -178.495 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A 1632 ' ' GLN . . . . . . . . . . . . . 36.5 mt-30 -87.19 -52.47 5.39 Favored 'General case' 0 C--N 1.315 -0.926 0 C-N-CA 120.218 -0.593 . . . . 2.55 109.969 178.917 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A 1633 ' ' THR . . . . . . . . . . . . . 69.1 p -106.51 -1.44 23.05 Favored 'General case' 0 N--CA 1.432 -1.374 0 CA-C-N 115.761 -0.654 . . . . 1.92 111.927 -178.833 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A 1634 ' ' CYS . . . . . . . . . . . . . 60.3 m 62.61 42.91 7.99 Favored 'General case' 0 C--O 1.237 0.399 0 CA-C-O 122.464 1.126 . . . . 0.89 111.26 177.409 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A 1635 ' ' THR . . . . . 0.41 HG23 ' HG3' ' A' 1607 ' ' LYS . 28.2 m -102.57 133.09 48.13 Favored 'General case' 0 N--CA 1.416 -2.145 0 CA-C-N 114.168 -1.378 . . . . 1.31 109.245 -178.547 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A 1636 ' ' LEU . . . . . 0.815 ' HG ' HD11 ' A' 1629 ' ' LEU . 5.2 mp -109.79 129.69 55.6 Favored 'General case' 0 N--CA 1.435 -1.213 0 N-CA-C 108.994 -0.743 . . . . 1.97 108.994 179.806 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A 1637 ' ' PHE . . . . . 0.409 ' O ' HD13 ' A' 1626 ' ' LEU . 88.7 m-85 -110.32 108.0 17.93 Favored 'General case' 0 C--N 1.308 -1.223 0 CA-C-O 121.049 0.452 . . . . 0.92 110.979 -177.121 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A 1638 ' ' PHE . . . . . 0.667 ' HB2' HG13 ' A' 1610 ' ' ILE . 97.0 m-85 -101.78 146.95 27.08 Favored 'General case' 0 C--N 1.305 -1.359 0 N-CA-C 109.228 -0.656 . . . . 0.7 109.228 177.706 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A 1639 ' ' SER . . . . . . . . . . . . . 50.0 m -132.64 133.66 43.89 Favored 'General case' 0 C--N 1.278 -2.529 0 N-CA-C 109.788 -0.449 . . . . 1.46 109.788 176.967 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A 1640 ' ' TRP . . . . . 0.404 ' CE3' ' HE2' ' A' 1612 ' ' PHE . 6.7 t90 -121.43 92.54 3.77 Favored 'General case' 0 N--CA 1.413 -2.32 0 N-CA-C 106.761 -1.57 . . . . 0.92 106.761 173.517 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A 1641 ' ' HIS . . . . . . . . . . . . . 4.4 p-80 -71.64 98.75 1.96 Allowed 'General case' 0 C--N 1.308 -1.209 0 CA-C-N 114.867 -1.061 . . . . 3.18 108.555 175.154 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A 1642 ' ' THR . . . . . . . . . . . . . 10.0 t -143.55 147.81 40.97 Favored Pre-proline 0 C--N 1.279 -2.49 0 CA-C-N 115.831 -0.622 . . . . 1.48 110.483 -170.963 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A 1643 ' ' PRO . . . . . 0.422 ' HB3' ' HA ' ' A' 1616 ' ' PRO . 34.6 Cg_endo -75.68 0.18 9.47 Favored 'Trans proline' 0 C--O 1.215 -0.651 0 C-N-CA 122.853 2.369 . . . . 1.09 111.114 174.768 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A 1644 ' ' LEU . . . . . 0.446 HD12 HD11 ' A' 1532 ' ' LEU . 45.5 mt -85.04 -11.81 54.52 Favored 'General case' 0 C--N 1.32 -0.683 0 C-N-CA 123.927 0.891 . . . . 2.08 110.782 176.679 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A 1645 ' ' ALA . . . . . . . . . . . . . . . -73.09 -43.44 61.82 Favored 'General case' 0 N--CA 1.471 0.592 0 CA-C-O 121.563 0.696 . . . . 1.37 110.118 -178.604 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A 1646 ' ' CYS . . . . . 0.578 ' HA ' ' CE1' ' A' 1527 ' ' PHE . 18.8 p -155.61 142.26 18.79 Favored 'General case' 0 N--CA 1.417 -2.084 0 N-CA-C 104.666 -2.346 . . . . 1.7 104.666 172.389 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A 1647 ' ' GLU . . . . . . . . . . . . . 39.9 mt-10 -113.62 116.19 46.01 Favored Pre-proline 0 C--N 1.283 -2.323 0 O-C-N 123.199 0.312 . . . . 2.92 110.414 -171.249 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A 1648 ' ' PRO . . . . . . . . . . . . . 37.2 Cg_exo -64.16 114.89 2.84 Favored 'Trans proline' 0 N--CA 1.452 -0.916 0 C-N-CA 122.745 2.297 . . . . 3.19 110.772 178.089 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A 1649 ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--N 1.298 -1.656 0 N-CA-C 108.827 -0.805 . . . . 5.06 108.827 177.867 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A 1508 ' ' MET . . . . . . . . . . . . . 61.3 mtt . . . . . 0 CA--C 1.501 -0.914 0 N-CA-C 107.538 -1.282 . . . . 8.58 107.538 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A 1509 ' ' LYS . . . . . . . . . . . . . 20.7 ptmt -112.72 -34.81 5.69 Favored 'General case' 0 C--N 1.3 -1.554 0 N-CA-C 111.631 0.234 . . . . 6.8 111.631 -177.587 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A 1510 ' ' SER . . . . . . . . . . . . . 16.9 t -175.02 106.76 0.1 Allowed 'General case' 0 CA--C 1.542 0.67 0 N-CA-C 110.12 -0.326 . . . . 4.48 110.12 -178.053 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A 1511 ' ' ASN . . . . . . . . . . . . . 12.5 m120 -135.17 -6.33 2.33 Favored 'General case' 0 N--CA 1.482 1.169 0 CA-C-O 120.772 0.32 . . . . 3.08 111.534 178.153 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A 1512 ' ' GLU . . . . . . . . . . . . . 39.8 tt0 -78.28 -42.91 29.56 Favored 'General case' 0 C--N 1.32 -0.712 0 N-CA-C 112.167 0.432 . . . . 4.46 112.167 -174.234 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A 1513 ' ' HIS . . . . . . . . . . . . . 20.8 p80 -68.17 -21.75 64.88 Favored 'General case' 0 N--CA 1.485 1.313 0 CA-C-O 121.555 0.693 . . . . 6.25 109.941 -178.704 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A 1514 ' ' ASP . . . . . . . . . . . . . 6.4 m-20 -76.23 -43.17 43.28 Favored 'General case' 0 N--CA 1.433 -1.283 0 CA-C-N 114.495 -1.23 . . . . 3.7 110.814 -177.017 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A 1515 ' ' ASP . . . . . 0.454 ' HB3' ' HB3' ' A' 1579 ' ' LYS . 38.7 m-20 71.67 -72.18 0.12 Allowed 'General case' 0 C--N 1.323 -0.565 0 C-N-CA 124.644 1.178 . . . . 2.54 111.936 -178.696 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A 1516 ' ' CYS . . . . . . . . . . . . . 85.7 m -124.4 41.38 3.51 Favored 'General case' 0 C--N 1.311 -1.069 0 CA-C-O 121.432 0.634 . . . . 1.25 110.99 -177.266 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A 1517 ' ' GLN . . . . . . . . . . . . . 9.6 pt20 -161.21 168.62 23.82 Favored 'General case' 0 C--N 1.287 -2.132 0 N-CA-C 109.42 -0.585 . . . . 2.36 109.42 -179.562 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A 1518 ' ' VAL . . . . . . . . . . . . . 80.7 t -131.37 105.96 11.27 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.081 0 N-CA-C 108.497 -0.927 . . . . 2.34 108.497 176.111 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A 1519 ' ' THR . . . . . . . . . . . . . 20.4 m -86.16 102.14 13.62 Favored 'General case' 0 C--N 1.281 -2.376 0 N-CA-C 107.596 -1.261 . . . . 2.04 107.596 175.048 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A 1520 ' ' ASN . . . . . . . . . . . . . 31.4 t30 -92.0 105.41 13.57 Favored Pre-proline 0 C--N 1.322 -0.614 0 N-CA-C 109.859 -0.423 . . . . 2.12 109.859 179.809 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A 1521 ' ' PRO . . . . . . . . . . . . . 59.1 Cg_endo -72.72 -18.98 24.63 Favored 'Trans proline' 0 N--CA 1.458 -0.593 0 C-N-CA 122.383 2.055 . . . . 2.59 113.376 -175.123 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A 1522 ' ' SER . . . . . . . . . . . . . 32.6 m -61.27 -35.75 78.15 Favored 'General case' 0 CA--C 1.54 0.565 0 CA-C-O 120.818 0.342 . . . . 2.65 111.832 -178.393 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A 1523 ' ' THR . . . . . . . . . . . . . 12.3 t -120.21 -5.24 9.95 Favored 'General case' 0 CA--C 1.554 1.096 0 CA-C-O 122.074 0.94 . . . . 2.33 109.543 178.809 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A 1524 ' ' GLY . . . . . . . . . . . . . . . 73.97 20.18 79.73 Favored Glycine 0 C--N 1.335 0.526 0 CA-C-N 115.44 -0.8 . . . . 1.96 112.345 179.666 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A 1525 ' ' HIS . . . . . . . . . . . . . 12.9 t-80 -101.65 128.16 48.07 Favored 'General case' 0 C--N 1.314 -0.951 0 CA-C-O 120.797 0.332 . . . . 2.44 110.745 -177.869 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A 1526 ' ' LEU . . . . . . . . . . . . . 6.9 tt -100.34 130.71 46.48 Favored 'General case' 0 C--N 1.3 -1.579 0 N-CA-C 108.43 -0.952 . . . . 2.19 108.43 178.208 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A 1527 ' ' PHE . . . . . 0.677 ' HE1' ' HA ' ' A' 1646 ' ' CYS . 97.7 m-85 -95.78 102.95 14.81 Favored 'General case' 0 C--N 1.308 -1.199 0 N-CA-C 109.183 -0.673 . . . . 1.61 109.183 177.243 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A 1528 ' ' ASP . . . . . . . . . . . . . 4.9 p-10 -85.17 106.68 16.79 Favored 'General case' 0 C--N 1.314 -0.936 0 CA-C-O 122.389 1.09 . . . . 2.18 113.437 -178.285 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A 1529 ' ' LEU . . . . . 0.731 ' HG ' HD11 ' A' 1532 ' ' LEU . 7.4 mp -105.5 0.22 26.48 Favored 'General case' 0 C--N 1.312 -1.06 0 CA-C-N 114.78 -1.1 . . . . 2.04 108.148 172.398 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A 1530 ' ' SER . . . . . . . . . . . . . 2.6 p -68.3 -31.32 70.68 Favored 'General case' 0 N--CA 1.426 -1.641 0 CA-C-N 114.248 -1.342 . . . . 1.44 109.356 177.406 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A 1531 ' ' SER . . . . . . . . . . . . . 9.9 m -76.11 -7.91 55.8 Favored 'General case' 0 N--CA 1.443 -0.793 0 CA-C-N 115.03 -0.987 . . . . 1.63 110.358 177.759 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A 1532 ' ' LEU . . . . . 0.731 HD11 ' HG ' ' A' 1529 ' ' LEU . 81.7 mt -90.72 15.8 10.43 Favored 'General case' 0 C--O 1.238 0.485 0 CA-C-O 121.544 0.688 . . . . 2.32 111.676 -179.792 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A 1533 ' ' SER . . . . . . . . . . . . . 17.0 m -78.74 173.23 12.69 Favored 'General case' 0 N--CA 1.44 -0.955 0 N-CA-C 108.558 -0.904 . . . . 2.57 108.558 176.143 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A 1534 ' ' GLY . . . . . . . . . . . . . . . 165.5 147.44 5.16 Favored Glycine 0 N--CA 1.428 -1.897 0 C-N-CA 120.038 -1.077 . . . . 1.89 111.848 -178.997 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A 1535 ' ' ARG . . . . . 0.833 ' HG3' ' HG3' ' A' 1557 ' ' GLU . 43.6 ttm180 -60.35 -49.29 78.17 Favored 'General case' 0 C--O 1.246 0.907 0 C-N-CA 124.513 1.125 . . . . 4.44 110.301 179.562 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A 1536 ' ' ALA . . . . . . . . . . . . . . . -95.68 -33.65 12.25 Favored 'General case' 0 N--CA 1.434 -1.266 0 N-CA-C 109.044 -0.724 . . . . 2.07 109.044 177.858 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A 1537 ' ' GLY . . . . . . . . . . . . . . . 84.19 -136.37 14.7 Favored Glycine 0 N--CA 1.428 -1.873 0 CA-C-N 114.496 -1.229 . . . . 1.2 111.963 177.73 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A 1538 ' ' PHE . . . . . 0.473 ' CD1' HD13 ' A' 1552 ' ' ILE . 54.2 m-85 -106.34 135.94 46.94 Favored 'General case' 0 C--N 1.295 -1.802 0 N-CA-C 108.207 -1.034 . . . . 1.98 108.207 177.88 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A 1539 ' ' THR . . . . . . . . . . . . . 19.2 p -113.35 117.99 33.33 Favored 'General case' 0 C--N 1.292 -1.927 0 CA-C-N 116.128 -0.487 . . . . 1.97 111.352 -178.509 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A 1540 ' ' ALA . . . . . . . . . . . . . . . -122.43 124.33 43.39 Favored 'General case' 0 C--N 1.313 -1.015 0 N-CA-C 109.932 -0.396 . . . . 1.39 109.932 179.77 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A 1541 ' ' ALA . . . . . . . . . . . . . . . -74.18 144.63 44.72 Favored 'General case' 0 C--O 1.251 1.156 0 CA-C-O 120.654 0.264 . . . . 1.86 110.521 179.247 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A 1542 ' ' TYR . . . . . . . . . . . . . 27.4 t80 -149.16 -173.64 4.43 Favored 'General case' 0 N--CA 1.437 -1.114 0 N-CA-C 109.148 -0.686 . . . . 2.4 109.148 -176.276 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A 1543 ' ' SER . . . . . . . . . . . . . 13.9 m -45.99 -152.78 0.0 OUTLIER 'General case' 0 CA--C 1.569 1.7 0 C-N-CA 129.707 3.203 . . . . 2.58 115.063 -178.799 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A 1544 ' ' LYS . . . . . . . . . . . . . 55.9 tptt -47.24 -29.52 2.46 Favored 'General case' 0 N--CA 1.486 1.336 0 O-C-N 121.266 -0.897 . . . . 4.24 112.774 178.677 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A 1545 ' ' SER . . . . . . . . . . . . . 4.3 p -61.74 -22.64 65.55 Favored 'General case' 0 CA--C 1.556 1.207 0 C-N-CA 123.053 0.541 . . . . 3.6 112.202 175.048 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A 1546 ' ' GLY . . . . . . . . . . . . . . . 89.49 -69.72 2.49 Favored Glycine 0 N--CA 1.431 -1.666 0 N-CA-C 113.867 0.307 . . . . 1.66 113.867 173.664 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A 1547 ' ' VAL . . . . . . . . . . . . . 7.2 p -158.79 138.61 3.73 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.925 0 N-CA-C 109.787 -0.449 . . . . 2.23 109.787 -173.606 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A 1548 ' ' VAL . . . . . . . . . . . . . 2.4 t -103.0 134.88 42.89 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.601 0 N-CA-C 108.548 -0.908 . . . . 1.59 108.548 -177.563 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A 1549 ' ' TYR . . . . . . . . . . . . . 97.9 m-85 -104.02 121.89 44.11 Favored 'General case' 0 C--N 1.311 -1.096 0 N-CA-C 107.112 -1.44 . . . . 1.58 107.112 173.717 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A 1550 ' ' MET . . . . . 0.49 ' HE3' ' HB2' ' A' 1624 ' ' PRO . 71.5 mtm -131.07 122.17 26.27 Favored 'General case' 0 CA--C 1.488 -1.43 0 C-N-CA 120.217 -0.593 . . . . 2.08 112.195 177.913 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A 1551 ' ' SER . . . . . . . . . . . . . 53.2 m -103.03 105.17 15.44 Favored 'General case' 0 C--N 1.272 -2.803 0 N-CA-C 105.45 -2.056 . . . . 1.9 105.45 171.457 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A 1552 ' ' ILE . . . . . 0.491 ' O ' ' OH ' ' A' 1592 ' ' TYR . 1.7 mp -52.48 -35.34 20.22 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.813 0 O-C-N 124.112 0.883 . . . . 2.04 112.133 -176.456 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A 1553 ' ' CYS . . . . . . . . . . . . . 93.9 m -145.7 155.66 43.13 Favored 'General case' 0 C--N 1.307 -1.249 0 N-CA-C 109.152 -0.685 . . . . 1.43 109.152 174.924 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A 1554 ' ' GLY . . . . . . . . . . . . . . . 102.66 -118.32 6.07 Favored Glycine 0 N--CA 1.441 -1.031 0 N-CA-C 110.366 -1.094 . . . . 1.23 110.366 -179.917 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A 1555 ' ' GLU . . . . . . . . . . . . . 17.0 pt-20 -157.9 148.32 20.6 Favored 'General case' 0 C--N 1.311 -1.107 0 N-CA-C 107.741 -1.207 . . . . 1.8 107.741 176.769 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A 1556 ' ' ASN . . . . . . . . . . . . . 21.0 t-20 -97.05 118.86 34.4 Favored 'General case' 0 C--N 1.305 -1.329 0 CA-C-O 121.543 0.687 . . . . 2.63 110.277 -178.609 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A 1557 ' ' GLU . . . . . 0.833 ' HG3' ' HG3' ' A' 1535 ' ' ARG . 12.0 mm-40 -82.53 11.97 5.11 Favored 'General case' 0 C--N 1.298 -1.644 0 CA-C-N 114.65 -1.159 . . . . 3.79 112.956 -172.429 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A 1558 ' ' ASN . . . . . . . . . . . . . 39.2 m-80 -104.24 -9.02 18.92 Favored 'General case' 0 C--N 1.301 -1.528 0 O-C-N 121.726 -0.609 . . . . 1.59 110.662 -178.886 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A 1559 ' ' CYS . . . . . 0.695 ' HB3' ' HD2' ' A' 1560 ' ' PRO . 88.1 m -144.29 178.46 1.45 Allowed Pre-proline 0 C--N 1.302 -1.466 0 CA-C-O 117.199 -1.381 . . . . 0.94 108.154 -178.521 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A 1560 ' ' PRO . . . . . 0.695 ' HD2' ' HB3' ' A' 1559 ' ' CYS . 24.2 Cg_exo -29.4 125.69 0.05 OUTLIER 'Trans proline' 0 C--N 1.383 2.356 0 C-N-CA 124.772 3.648 . . . . 1.53 114.94 176.422 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A 1561 ' ' PRO . . . . . . . . . . . . . 51.2 Cg_exo -55.52 115.99 2.84 Favored 'Trans proline' 0 C--O 1.244 0.782 0 C-N-CA 123.445 2.764 . . . . 1.82 112.964 -177.126 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A 1562 ' ' GLY . . . . . . . . . . . . . . . 114.11 -10.34 22.65 Favored Glycine 0 N--CA 1.439 -1.122 0 C-N-CA 120.455 -0.878 . . . . 0.81 113.275 177.187 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A 1563 ' ' VAL . . . . . 0.549 ' HA ' ' HA ' ' A' 1576 ' ' LYS . 5.1 m -90.65 152.37 3.35 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.183 0 N-CA-C 107.189 -1.411 . . . . 1.73 107.189 176.635 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A 1564 ' ' GLY . . . . . . . . . . . . . . . -117.23 -19.06 5.24 Favored Glycine 0 C--N 1.306 -1.127 0 C-N-CA 119.451 -1.357 . . . . 0.72 113.74 -176.25 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A 1565 ' ' ALA . . . . . . . . . . . . . . . -126.37 123.23 37.49 Favored 'General case' 0 C--O 1.25 1.095 0 N-CA-C 109.385 -0.598 . . . . 1.14 109.385 -179.851 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A 1566 ' ' CYS . . . . . . . . . . . . . 49.3 t -151.69 146.78 26.03 Favored 'General case' 0 C--N 1.312 -1.035 0 C-N-CA 121.056 -0.258 . . . . 0.51 111.126 -177.096 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A 1567 ' ' PHE . . . . . . . . . . . . . 31.4 m-85 -94.05 123.68 37.57 Favored 'General case' 0 C--O 1.247 0.965 0 CA-C-N 116.101 -0.5 . . . . 1.22 109.677 177.836 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A 1568 ' ' GLY . . . . . . . . . . . . . . . 50.62 -140.82 19.74 Favored Glycine 0 C--N 1.321 -0.289 0 O-C-N 123.893 0.745 . . . . 1.08 114.719 175.517 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A 1569 ' ' GLN . . . . . . . . . . . . . 49.0 tt0 -90.87 -58.23 2.55 Favored 'General case' 0 N--CA 1.43 -1.444 0 N-CA-C 109.558 -0.534 . . . . 3.05 109.558 179.993 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A 1570 ' ' THR . . . . . . . . . . . . . 14.8 p -123.01 34.13 5.21 Favored 'General case' 0 C--N 1.312 -1.043 0 CA-C-N 115.892 -0.594 . . . . 2.44 112.473 -176.668 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A 1571 ' ' ARG . . . . . . . . . . . . . 7.5 mpt_? -97.5 12.03 34.76 Favored 'General case' 0 N--CA 1.432 -1.328 0 C-N-CA 119.388 -0.925 . . . . 4.48 110.765 175.691 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A 1572 ' ' ILE . . . . . 0.423 HG21 ' HB2' ' A' 1596 ' ' SER . 75.9 mt 80.97 144.51 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.548 0.894 0 CA-C-N 114.112 -1.404 . . . . 1.94 114.371 165.581 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A 1573 ' ' SER . . . . . . . . . . . . . 36.3 p -82.01 134.89 35.4 Favored 'General case' 0 N--CA 1.438 -1.072 0 CA-C-N 114.582 -1.19 . . . . 1.25 111.113 -179.242 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A 1574 ' ' VAL . . . . . . . . . . . . . 19.0 m -123.22 30.43 2.24 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.228 0 N-CA-C 112.611 0.597 . . . . 1.61 112.611 -177.553 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A 1575 ' ' GLY . . . . . . . . . . . . . . . 173.56 122.68 0.68 Allowed Glycine 0 N--CA 1.434 -1.434 0 C-N-CA 119.989 -1.1 . . . . 0.65 112.799 177.753 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A 1576 ' ' LYS . . . . . 0.549 ' HA ' ' HA ' ' A' 1563 ' ' VAL . 66.6 tttm -76.8 143.09 40.05 Favored 'General case' 0 C--O 1.246 0.914 0 N-CA-C 106.835 -1.543 . . . . 3.33 106.835 175.787 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A 1577 ' ' ALA . . . . . . . . . . . . . . . -77.04 82.63 3.55 Favored 'General case' 0 C--N 1.304 -1.412 0 CA-C-O 121.642 0.734 . . . . 1.31 111.7 -175.23 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A 1578 ' ' ASN . . . . . . . . . . . . . 41.6 m-80 -89.47 147.44 24.0 Favored 'General case' 0 C--N 1.306 -1.3 0 N-CA-C 108.058 -1.09 . . . . 2.24 108.058 175.243 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A 1579 ' ' LYS . . . . . 0.454 ' HB3' ' HB3' ' A' 1515 ' ' ASP . 58.7 mttp -95.14 89.67 5.62 Favored 'General case' 0 C--N 1.283 -2.299 0 N-CA-C 105.746 -1.946 . . . . 2.34 105.746 175.331 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A 1580 ' ' ARG . . . . . . . . . . . . . 42.1 ttm180 -140.32 101.14 4.06 Favored 'General case' 0 C--N 1.297 -1.703 0 CA-C-N 115.346 -0.843 . . . . 4.19 110.003 -173.607 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A 1581 ' ' LEU . . . . . . . . . . . . . 41.0 tp -117.4 145.02 44.38 Favored 'General case' 0 C--N 1.289 -2.054 0 CA-C-N 115.151 -0.931 . . . . 2.39 109.462 -177.39 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A 1582 ' ' ARG . . . . . . . . . . . . . 97.0 mtt180 -119.44 125.27 48.54 Favored 'General case' 0 C--N 1.297 -1.713 0 CA-C-N 115.656 -0.702 . . . . 4.48 109.984 -179.729 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A 1583 ' ' TYR . . . . . 0.414 ' HD1' ' CD2' ' A' 1588 ' ' LEU . 22.6 t80 -108.09 97.89 7.52 Favored 'General case' 0 C--N 1.296 -1.727 0 N-CA-C 108.547 -0.909 . . . . 1.57 108.547 174.49 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A 1584 ' ' VAL . . . . . . . . . . . . . 1.1 m -140.07 121.28 14.91 Favored 'Isoleucine or valine' 0 CA--C 1.499 -0.981 0 N-CA-C 112.697 0.628 . . . . 2.29 112.697 -178.079 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A 1585 ' ' ASP . . . . . . . . . . . . . 30.9 t70 56.67 45.04 22.73 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-O 122.334 1.064 . . . . 2.06 111.082 171.613 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A 1586 ' ' GLN . . . . . . . . . . . . . 21.5 mt-30 58.82 18.25 5.92 Favored 'General case' 0 C--N 1.323 -0.548 0 N-CA-C 115.068 1.507 . . . . 2.61 115.068 -178.871 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A 1587 ' ' VAL . . . . . . . . . . . . . 12.4 p -120.69 133.37 67.6 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.331 0 N-CA-C 107.619 -1.252 . . . . 1.33 107.619 172.86 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A 1588 ' ' LEU . . . . . 0.414 ' CD2' ' HD1' ' A' 1583 ' ' TYR . 16.6 mt -103.24 133.09 48.91 Favored 'General case' 0 C--N 1.296 -1.746 0 N-CA-C 108.277 -1.008 . . . . 2.03 108.277 -177.104 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A 1589 ' ' GLN . . . . . . . . . . . . . 35.0 tt0 -134.31 115.78 14.49 Favored 'General case' 0 C--N 1.275 -2.639 0 C-N-CA 120.39 -0.524 . . . . 1.73 110.442 -175.496 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A 1590 ' ' LEU . . . . . . . . . . . . . 8.7 tt -106.74 128.96 54.66 Favored 'General case' 0 C--N 1.293 -1.849 0 N-CA-C 107.411 -1.329 . . . . 1.76 107.411 -179.25 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A 1591 ' ' VAL . . . . . . . . . . . . . 61.4 t -119.26 126.89 75.76 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.808 0 N-CA-C 112.792 0.664 . . . . 2.14 112.792 -170.355 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A 1592 ' ' TYR . . . . . 0.604 ' HB2' ' HB3' ' A' 1608 ' ' SER . 9.7 m-30 -108.53 149.23 29.13 Favored 'General case' 0 C--N 1.31 -1.135 0 CA-C-N 114.986 -1.006 . . . . 1.53 109.44 174.487 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A 1593 ' ' LYS . . . . . . . . . . . . . 18.4 ptpt -159.47 177.37 11.02 Favored 'General case' 0 C--N 1.296 -1.741 0 N-CA-C 107.371 -1.344 . . . . 2.72 107.371 178.578 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A 1594 ' ' ASP . . . . . 0.406 ' O ' ' HB2' ' A' 1576 ' ' LYS . 3.8 m-20 65.62 76.76 0.32 Allowed 'General case' 0 N--CA 1.483 1.206 0 O-C-N 124.038 0.837 . . . . 1.45 112.399 179.046 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A 1595 ' ' GLY . . . . . . . . . . . . . . . -143.08 -73.4 0.03 OUTLIER Glycine 0 N--CA 1.432 -1.57 0 N-CA-C 110.879 -0.889 . . . . 0.83 110.879 176.865 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A 1596 ' ' SER . . . . . 0.423 ' HB2' HG21 ' A' 1572 ' ' ILE . 31.1 t -114.86 139.6 24.4 Favored Pre-proline 0 C--N 1.288 -2.077 0 N-CA-C 109.534 -0.543 . . . . 1.96 109.534 179.621 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A 1597 ' ' PRO . . . . . . . . . . . . . 23.2 Cg_exo -68.39 144.28 61.13 Favored 'Trans proline' 0 N--CA 1.445 -1.361 0 N-CA-C 106.435 -2.179 . . . . 1.34 106.435 168.527 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A 1598 ' ' CYS . . . . . . . . . . . . . 19.1 t -95.17 125.26 51.03 Favored Pre-proline 0 C--N 1.286 -2.173 0 C-N-CA 120.065 -0.654 . . . . 1.19 110.287 -175.795 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A 1599 ' ' PRO . . . . . . . . . . . . . 84.6 Cg_endo -88.38 -4.04 6.69 Favored 'Trans proline' 0 N--CA 1.456 -0.73 0 C-N-CA 122.807 2.338 . . . . 1.88 111.698 177.079 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A 1600 ' ' SER . . . . . . . . . . . . . 16.3 m -86.35 109.11 18.77 Favored 'General case' 0 N--CA 1.425 -1.68 0 CA-C-N 115.865 -0.607 . . . . 2.19 109.994 -178.874 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A 1601 ' ' LYS . . . . . 0.799 ' HD2' ' HA ' ' A' 1632 ' ' GLN . 67.0 mttm 67.67 -86.71 0.03 OUTLIER 'General case' 0 C--O 1.242 0.684 0 C-N-CA 124.067 0.947 . . . . 4.21 113.358 178.571 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A 1602 ' ' SER . . . . . 0.787 ' HB3' HD22 ' A' 1604 ' ' LEU . 29.1 t -96.66 150.47 20.63 Favored 'General case' 0 N--CA 1.422 -1.867 0 N-CA-C 108.781 -0.822 . . . . 3.82 108.781 -175.5 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A 1603 ' ' GLY . . . . . . . . . . . . . . . -83.64 59.61 4.95 Favored Glycine 0 N--CA 1.435 -1.43 0 N-CA-C 110.331 -1.108 . . . . 2.45 110.331 176.425 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A 1604 ' ' LEU . . . . . 0.787 HD22 ' HB3' ' A' 1602 ' ' SER . 2.0 pt? -105.32 -175.35 2.77 Favored 'General case' 0 C--N 1.302 -1.494 0 CA-C-N 115.704 -0.248 . . . . 2.06 110.82 -176.982 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A 1605 ' ' SER . . . . . . . . . . . . . 5.0 p -83.81 -176.19 6.17 Favored 'General case' 0 C--N 1.294 -1.829 0 CA-C-O 121.249 0.547 . . . . 1.75 111.25 -178.568 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A 1606 ' ' TYR . . . . . . . . . . . . . 5.1 m-85 -116.76 128.5 55.37 Favored 'General case' 0 CA--C 1.469 -2.144 0 N-CA-C 106.882 -1.525 . . . . 1.59 106.882 177.426 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A 1607 ' ' LYS . . . . . . . . . . . . . 20.6 ptmt -119.32 118.93 32.53 Favored 'General case' 0 N--CA 1.407 -2.618 0 CA-C-O 121.536 0.684 . . . . 2.21 110.204 -178.535 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A 1608 ' ' SER . . . . . 0.604 ' HB3' ' HB2' ' A' 1592 ' ' TYR . 33.4 t -103.5 106.8 17.41 Favored 'General case' 0 C--N 1.288 -2.083 0 N-CA-C 108.056 -1.09 . . . . 1.48 108.056 -177.277 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A 1609 ' ' VAL . . . . . . . . . . . . . 66.2 t -107.49 115.44 48.74 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.5 0 CA-C-O 121.012 0.434 . . . . 1.57 110.862 -176.597 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A 1610 ' ' ILE . . . . . 0.523 ' HA ' ' HB2' ' A' 1638 ' ' PHE . 3.3 mp -103.78 111.17 32.42 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.21 0 N-CA-C 108.074 -1.084 . . . . 1.47 108.074 178.095 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A 1611 ' ' SER . . . . . 0.527 ' O ' ' HA ' ' A' 1639 ' ' SER . 18.8 m -104.43 129.83 52.37 Favored 'General case' 0 C--N 1.303 -1.451 0 CA-C-O 121.368 0.604 . . . . 1.84 110.706 -179.858 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A 1612 ' ' PHE . . . . . 0.411 ' HB2' ' HB2' ' A' 1588 ' ' LEU . 92.2 m-85 -101.55 113.18 26.07 Favored 'General case' 0 C--N 1.292 -1.899 0 N-CA-C 108.342 -0.984 . . . . 0.86 108.342 -179.524 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A 1613 ' ' VAL . . . . . . . . . . . . . 92.2 t -106.43 132.18 54.28 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.176 0 N-CA-C 109.538 -0.541 . . . . 1.32 109.538 -176.594 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A 1614 ' ' CYS . . . . . . . . . . . . . 62.6 m -67.48 99.51 0.76 Allowed 'General case' 0 C--N 1.322 -0.611 0 CA-C-O 121.573 0.701 . . . . 1.39 112.526 -177.559 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A 1615 ' ' ARG . . . . . 0.453 ' HB3' ' HB3' ' A' 1641 ' ' HIS . 20.3 tpp180 -137.28 85.45 21.75 Favored Pre-proline 0 N--CA 1.429 -1.479 0 CA-C-N 114.851 -1.068 . . . . 4.34 108.164 176.352 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A 1616 ' ' PRO . . . . . 0.433 ' HA ' ' HB3' ' A' 1643 ' ' PRO . 16.4 Cg_exo -71.68 -13.22 29.66 Favored 'Trans proline' 0 C--N 1.357 0.984 0 C-N-CA 123.327 2.684 . . . . 1.5 110.227 178.153 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A 1617 ' ' GLU . . . . . 0.425 ' HB3' ' CD ' ' A' 1615 ' ' ARG . 43.7 tt0 -82.54 41.16 0.7 Allowed 'General case' 0 C--N 1.304 -1.388 0 C-N-CA 126.067 1.747 . . . . 3.21 107.963 176.459 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A 1618 ' ' ALA . . . . . . . . . . . . . . . -160.51 179.05 8.93 Favored 'General case' 0 C--N 1.305 -1.364 0 N-CA-C 105.127 -2.175 . . . . 2.91 105.127 -179.017 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A 1619 ' ' GLY . . . . . . . . . . . . . . . -147.42 -160.54 8.94 Favored Glycine 0 N--CA 1.433 -1.549 0 C-N-CA 119.054 -1.546 . . . . 3.35 112.802 -178.045 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A 1620 ' ' PRO . . . . . . . . . . . . . 56.2 Cg_endo -70.61 -4.98 15.69 Favored 'Trans proline' 0 C--O 1.24 0.606 0 C-N-CA 123.283 2.656 . . . . 6.61 112.803 -177.722 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A 1621 ' ' THR . . . . . . . . . . . . . 15.6 m -79.75 -21.63 44.23 Favored 'General case' 0 N--CA 1.439 -1.023 0 CA-C-O 121.174 0.511 . . . . 5.03 109.901 179.169 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A 1622 ' ' ASN . . . . . . . . . . . . . 29.1 t-20 -82.61 159.27 22.75 Favored 'General case' 0 N--CA 1.45 -0.455 0 N-CA-C 107.058 -1.46 . . . . 3.58 107.058 178.849 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A 1623 ' ' ARG . . . . . . . . . . . . . 4.9 ptp180 -153.12 164.49 20.2 Favored Pre-proline 0 C--N 1.301 -1.538 0 N-CA-C 108.887 -0.783 . . . . 4.09 108.887 -176.34 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A 1624 ' ' PRO . . . . . 0.49 ' HB2' ' HE3' ' A' 1550 ' ' MET . 22.7 Cg_exo -65.34 100.05 0.38 Allowed 'Trans proline' 0 C--N 1.361 1.234 0 C-N-CA 122.588 2.192 . . . . 2.86 110.813 177.059 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A 1625 ' ' MET . . . . . . . . . . . . . 23.4 ptp -108.72 148.65 30.14 Favored 'General case' 0 C--N 1.302 -1.457 0 CA-C-N 115.443 -0.798 . . . . 2.73 109.694 -177.17 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A 1626 ' ' LEU . . . . . 0.507 HD21 ' HB3' ' A' 1636 ' ' LEU . 38.1 mt -71.01 109.74 5.29 Favored 'General case' 0 C--N 1.309 -1.184 0 CA-C-N 115.978 -0.556 . . . . 1.94 110.369 174.667 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A 1627 ' ' ILE . . . . . . . . . . . . . 40.8 pt -92.4 -23.74 5.55 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.306 0 CA-C-N 115.115 -0.948 . . . . 1.75 109.185 177.321 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A 1628 ' ' SER . . . . . . . . . . . . . 51.1 m -154.53 149.84 27.13 Favored 'General case' 0 N--CA 1.428 -1.574 0 CA-C-N 115.452 -0.795 . . . . 1.85 109.403 -179.088 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A 1629 ' ' LEU . . . . . 0.728 HD13 ' HG ' ' A' 1636 ' ' LEU . 20.2 tp -143.28 112.25 6.59 Favored 'General case' 0 C--N 1.297 -1.701 0 N-CA-C 108.697 -0.853 . . . . 2.12 108.697 177.984 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A 1630 ' ' ASP . . . . . . . . . . . . . 13.4 t70 -100.26 108.15 20.15 Favored 'General case' 0 C--N 1.296 -1.728 0 N-CA-C 108.605 -0.887 . . . . 0.87 108.605 -178.26 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A 1631 ' ' LYS . . . . . . . . . . . . . 92.1 mttt -92.51 5.44 50.82 Favored 'General case' 0 C--N 1.293 -1.871 0 CA-C-O 120.947 0.403 . . . . 2.76 111.43 -177.293 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A 1632 ' ' GLN . . . . . 0.799 ' HA ' ' HD2' ' A' 1601 ' ' LYS . 33.5 mt-30 -85.55 -41.2 15.5 Favored 'General case' 0 N--CA 1.437 -1.098 0 N-CA-C 108.491 -0.929 . . . . 2.55 108.491 178.53 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A 1633 ' ' THR . . . . . . . . . . . . . 32.6 m -106.9 -2.44 21.3 Favored 'General case' 0 CA--C 1.564 1.516 0 CA-C-O 122.111 0.957 . . . . 1.92 110.256 176.917 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A 1634 ' ' CYS . . . . . . . . . . . . . 51.2 m 63.78 47.59 3.54 Favored 'General case' 0 N--CA 1.471 0.592 0 CA-C-O 122.675 1.226 . . . . 0.89 110.007 176.852 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A 1635 ' ' THR . . . . . . . . . . . . . 24.2 m -112.43 121.63 45.38 Favored 'General case' 0 N--CA 1.423 -1.824 0 CA-C-N 113.836 -1.529 . . . . 1.31 109.887 -175.774 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A 1636 ' ' LEU . . . . . 0.728 ' HG ' HD13 ' A' 1629 ' ' LEU . 5.5 mp -99.4 126.18 45.24 Favored 'General case' 0 C--N 1.305 -1.35 0 N-CA-C 108.812 -0.81 . . . . 1.97 108.812 179.061 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A 1637 ' ' PHE . . . . . . . . . . . . . 94.1 m-85 -108.08 94.82 5.28 Favored 'General case' 0 C--O 1.249 1.078 0 CA-C-O 121.012 0.434 . . . . 0.92 111.193 -177.774 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A 1638 ' ' PHE . . . . . 0.523 ' HB2' ' HA ' ' A' 1610 ' ' ILE . 99.7 m-85 -90.94 144.62 25.48 Favored 'General case' 0 CA--C 1.487 -1.458 0 N-CA-C 107.917 -1.142 . . . . 0.7 107.917 175.751 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A 1639 ' ' SER . . . . . 0.527 ' HA ' ' O ' ' A' 1611 ' ' SER . 66.8 m -141.7 133.08 26.62 Favored 'General case' 0 C--N 1.273 -2.737 0 CA-C-O 120.852 0.358 . . . . 1.46 111.187 177.267 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A 1640 ' ' TRP . . . . . 0.429 ' HZ3' HD13 ' A' 1532 ' ' LEU . 8.3 t90 -118.93 112.56 19.79 Favored 'General case' 0 N--CA 1.426 -1.674 0 N-CA-C 107.799 -1.186 . . . . 0.92 107.799 175.688 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A 1641 ' ' HIS . . . . . 0.453 ' HB3' ' HB3' ' A' 1615 ' ' ARG . 13.4 m170 -82.43 98.42 8.88 Favored 'General case' 0 C--N 1.297 -1.704 0 N-CA-C 107.315 -1.365 . . . . 3.18 107.315 175.311 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A 1642 ' ' THR . . . . . . . . . . . . . 9.2 t -143.1 147.81 42.49 Favored Pre-proline 0 C--N 1.305 -1.335 0 CA-C-N 115.406 -0.815 . . . . 1.48 111.394 -170.414 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A 1643 ' ' PRO . . . . . 0.433 ' HB3' ' HA ' ' A' 1616 ' ' PRO . 34.6 Cg_endo -70.11 -12.04 31.49 Favored 'Trans proline' 0 C--N 1.353 0.778 0 C-N-CA 123.067 2.511 . . . . 1.09 111.106 171.837 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A 1644 ' ' LEU . . . . . . . . . . . . . 94.1 mt -75.55 -6.32 49.66 Favored 'General case' 0 N--CA 1.465 0.291 0 CA-C-N 116.241 -0.436 . . . . 2.08 111.699 178.74 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A 1645 ' ' ALA . . . . . . . . . . . . . . . -81.11 -42.52 20.83 Favored 'General case' 0 C--N 1.318 -0.778 0 N-CA-C 108.745 -0.835 . . . . 1.37 108.745 175.791 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A 1646 ' ' CYS . . . . . 0.677 ' HA ' ' HE1' ' A' 1527 ' ' PHE . 19.3 p -169.44 116.45 0.59 Allowed 'General case' 0 N--CA 1.432 -1.348 0 N-CA-C 107.717 -1.216 . . . . 1.7 107.717 173.645 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A 1647 ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -74.31 148.15 85.89 Favored Pre-proline 0 C--N 1.309 -1.194 0 CA-C-N 116.088 -0.506 . . . . 2.92 109.779 179.17 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A 1648 ' ' PRO . . . . . . . . . . . . . 12.6 Cg_endo -52.97 109.46 0.36 Allowed 'Trans proline' 0 C--N 1.353 0.801 0 C-N-CA 124.559 3.506 . . . . 3.19 114.446 -175.051 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A 1649 ' ' GLU . . . . . . . . . . . . . 42.5 tt0 . . . . . 0 N--CA 1.422 -1.833 0 N-CA-C 106.98 -1.489 . . . . 5.06 106.98 175.78 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A 1508 ' ' MET . . . . . . . . . . . . . 27.1 ttt . . . . . 0 C--O 1.235 0.324 0 N-CA-C 109.958 -0.386 . . . . 8.58 109.958 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A 1509 ' ' LYS . . . . . . . . . . . . . 64.9 tttp -113.74 131.09 56.32 Favored 'General case' 0 N--CA 1.441 -0.918 0 N-CA-C 109.293 -0.632 . . . . 6.8 109.293 179.819 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A 1510 ' ' SER . . . . . . . . . . . . . 32.1 m 62.76 59.46 1.42 Allowed 'General case' 0 C--O 1.253 1.252 0 O-C-N 124.377 1.048 . . . . 4.48 110.45 179.904 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A 1511 ' ' ASN . . . . . . . . . . . . . 76.1 m-20 -79.03 0.25 28.5 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 115.082 -0.963 . . . . 3.08 110.659 -178.48 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A 1512 ' ' GLU . . . . . 0.922 ' HA ' ' HB3' ' A' 1581 ' ' LEU . 1.8 mp0 -47.15 -29.68 2.42 Favored 'General case' 0 N--CA 1.472 0.658 0 C-N-CA 124.604 1.162 . . . . 4.46 112.359 178.104 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A 1513 ' ' HIS . . . . . . . . . . . . . 5.7 p80 -133.65 42.55 2.96 Favored 'General case' 0 C--N 1.309 -1.17 0 CA-C-O 121.824 0.821 . . . . 6.25 109.666 179.692 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A 1514 ' ' ASP . . . . . . . . . . . . . 14.4 t70 -131.28 -62.3 0.89 Allowed 'General case' 0 C--N 1.317 -0.829 0 CA-C-N 115.287 -0.869 . . . . 3.7 110.319 -179.61 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A 1515 ' ' ASP . . . . . . . . . . . . . 16.5 t70 -154.92 168.06 28.23 Favored 'General case' 0 C--N 1.317 -0.835 0 N-CA-C 107.057 -1.46 . . . . 2.54 107.057 -174.583 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A 1516 ' ' CYS . . . . . 0.637 ' HB3' ' HB2' ' A' 1529 ' ' LEU . 34.3 m -87.5 59.7 5.63 Favored 'General case' 0 C--N 1.305 -1.356 0 N-CA-C 109.556 -0.535 . . . . 1.25 109.556 -177.283 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A 1517 ' ' GLN . . . . . 0.482 ' HA ' ' O ' ' A' 1527 ' ' PHE . 11.3 pt20 -148.41 138.54 22.49 Favored 'General case' 0 C--N 1.306 -1.292 0 N-CA-C 109.211 -0.662 . . . . 2.36 109.211 -179.785 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A 1518 ' ' VAL . . . . . . . . . . . . . 10.1 p -144.57 133.31 18.17 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.889 0 CA-C-O 120.921 0.391 . . . . 2.34 110.258 179.326 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A 1519 ' ' THR . . . . . 0.488 ' O ' ' HD3' ' A' 1521 ' ' PRO . 21.4 m -93.8 128.98 40.34 Favored 'General case' 0 C--N 1.292 -1.926 0 N-CA-C 108.926 -0.768 . . . . 2.04 108.926 179.158 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A 1520 ' ' ASN . . . . . . . . . . . . . 22.8 t30 -101.71 94.84 4.68 Favored Pre-proline 0 C--N 1.314 -0.974 0 N-CA-C 108.722 -0.844 . . . . 2.12 108.722 172.501 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A 1521 ' ' PRO . . . . . 0.488 ' HD3' ' O ' ' A' 1519 ' ' THR . 52.8 Cg_exo -55.27 -20.87 26.6 Favored 'Trans proline' 0 C--N 1.365 1.399 0 C-N-CA 123.68 2.92 . . . . 2.59 114.242 -177.257 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A 1522 ' ' SER . . . . . . . . . . . . . 19.9 t -64.47 -30.01 71.05 Favored 'General case' 0 CA--C 1.549 0.927 0 CA-C-O 120.834 0.349 . . . . 2.65 111.099 178.573 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A 1523 ' ' THR . . . . . . . . . . . . . 8.8 t -122.82 -14.84 7.59 Favored 'General case' 0 CA--C 1.545 0.753 0 C-N-CA 120.484 -0.487 . . . . 2.33 110.611 178.257 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A 1524 ' ' GLY . . . . . . . . . . . . . . . 89.22 -13.96 62.12 Favored Glycine 0 C--O 1.22 -0.744 0 CA-C-N 116.394 -0.366 . . . . 1.96 113.805 177.202 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A 1525 ' ' HIS . . . . . . . . . . . . . 13.7 t-160 -79.31 127.62 32.3 Favored 'General case' 0 C--N 1.311 -1.068 0 CA-C-O 121.289 0.566 . . . . 2.44 111.862 -175.616 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A 1526 ' ' LEU . . . . . 0.456 HD11 ' HB2' ' A' 1517 ' ' GLN . 41.9 tp -84.67 127.61 34.18 Favored 'General case' 0 C--N 1.315 -0.927 0 CA-C-N 114.685 -1.143 . . . . 2.19 107.969 173.084 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A 1527 ' ' PHE . . . . . 0.482 ' O ' ' HA ' ' A' 1517 ' ' GLN . 70.9 m-85 -99.01 119.02 37.09 Favored 'General case' 0 C--N 1.288 -2.073 0 N-CA-C 108.831 -0.803 . . . . 1.61 108.831 178.398 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A 1528 ' ' ASP . . . . . . . . . . . . . 10.9 t70 -105.24 124.18 49.11 Favored 'General case' 0 CA--C 1.487 -1.469 0 CA-C-O 121.189 0.518 . . . . 2.18 110.316 179.314 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A 1529 ' ' LEU . . . . . 0.637 ' HB2' ' HB3' ' A' 1516 ' ' CYS . 69.8 mt -108.59 -19.8 13.31 Favored 'General case' 0 C--N 1.294 -1.831 0 CA-C-N 114.922 -1.036 . . . . 2.04 108.914 177.213 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A 1530 ' ' SER . . . . . 0.415 ' OG ' ' HB2' ' A' 1516 ' ' CYS . 24.9 m -57.85 -37.87 74.65 Favored 'General case' 0 C--O 1.24 0.566 0 C-N-CA 123.626 0.77 . . . . 1.44 112.763 -176.634 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A 1531 ' ' SER . . . . . . . . . . . . . 50.5 p -87.43 1.07 54.49 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-O 120.906 0.384 . . . . 1.63 111.625 178.948 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A 1532 ' ' LEU . . . . . . . . . . . . . 96.1 mt -88.13 14.76 8.54 Favored 'General case' 0 CA--C 1.544 0.726 0 N-CA-C 113.12 0.785 . . . . 2.32 113.12 179.394 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A 1533 ' ' SER . . . . . . . . . . . . . 46.1 m -113.38 108.78 17.69 Favored 'General case' 0 C--N 1.314 -0.964 0 O-C-N 121.591 -0.693 . . . . 2.57 110.898 178.84 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A 1534 ' ' GLY . . . . . . . . . . . . . . . -86.08 -127.29 2.01 Favored Glycine 0 C--O 1.22 -0.743 0 C-N-CA 120.69 -0.767 . . . . 1.89 111.499 176.714 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A 1535 ' ' ARG . . . . . . . . . . . . . 19.4 tpt180 -83.18 -52.8 6.29 Favored 'General case' 0 C--N 1.311 -1.081 0 CA-C-N 117.108 0.454 . . . . 4.44 109.958 178.36 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A 1536 ' ' ALA . . . . . 0.418 ' HB3' ' HD1' ' A' 1549 ' ' TYR . . . -96.12 -21.48 17.9 Favored 'General case' 0 C--N 1.312 -1.064 0 CA-C-O 121.216 0.531 . . . . 2.07 109.623 178.944 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A 1537 ' ' GLY . . . . . . . . . . . . . . . 90.66 -92.16 1.74 Allowed Glycine 0 N--CA 1.425 -2.058 0 N-CA-C 108.057 -2.017 . . . . 1.2 108.057 -175.925 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A 1538 ' ' PHE . . . . . . . . . . . . . 47.2 m-85 -136.85 158.32 44.73 Favored 'General case' 0 C--N 1.295 -1.799 0 N-CA-C 109.151 -0.685 . . . . 1.98 109.151 174.17 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A 1539 ' ' THR . . . . . . . . . . . . . 5.8 p -127.99 142.97 51.09 Favored 'General case' 0 C--N 1.296 -1.737 0 CA-C-N 116.506 -0.315 . . . . 1.97 111.295 -176.878 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A 1540 ' ' ALA . . . . . . . . . . . . . . . -131.21 140.12 49.82 Favored 'General case' 0 C--N 1.302 -1.479 0 N-CA-C 109.416 -0.587 . . . . 1.39 109.416 176.796 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A 1541 ' ' ALA . . . . . . . . . . . . . . . -86.21 133.43 33.85 Favored 'General case' 0 C--N 1.312 -1.034 0 N-CA-C 108.107 -1.071 . . . . 1.86 108.107 178.642 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A 1542 ' ' TYR . . . . . 0.613 ' HD2' ' HB2' ' A' 1545 ' ' SER . 76.6 t80 -136.12 166.56 23.11 Favored 'General case' 0 C--N 1.301 -1.531 0 N-CA-C 109.448 -0.575 . . . . 2.4 109.448 -175.747 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A 1543 ' ' SER . . . . . . . . . . . . . 16.0 t -48.67 -150.32 0.0 OUTLIER 'General case' 0 CA--C 1.577 1.997 0 C-N-CA 127.916 2.486 . . . . 2.58 112.886 176.229 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A 1544 ' ' LYS . . . . . . . . . . . . . 95.7 mttt -38.92 -30.75 0.05 Allowed 'General case' 0 CA--C 1.567 1.62 0 C-N-CA 124.986 1.314 . . . . 4.24 114.442 -178.619 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A 1545 ' ' SER . . . . . 0.613 ' HB2' ' HD2' ' A' 1542 ' ' TYR . 15.3 m -72.59 -10.69 60.1 Favored 'General case' 0 CA--C 1.579 2.076 0 N-CA-C 112.617 0.599 . . . . 3.6 112.617 177.254 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A 1546 ' ' GLY . . . . . . . . . . . . . . . 85.2 -80.15 1.84 Allowed Glycine 0 C--O 1.244 0.725 0 N-CA-C 115.049 0.78 . . . . 1.66 115.049 171.965 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A 1547 ' ' VAL . . . . . . . . . . . . . 7.8 p -146.39 143.09 21.06 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.475 0 CA-C-O 120.997 0.427 . . . . 2.23 109.914 -174.126 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A 1548 ' ' VAL . . . . . . . . . . . . . 2.1 t -109.86 135.1 49.9 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.414 0 N-CA-C 107.979 -1.119 . . . . 1.59 107.979 -179.058 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A 1549 ' ' TYR . . . . . 0.418 ' CE2' ' HA3' ' A' 1568 ' ' GLY . 80.1 m-85 -100.63 131.19 46.67 Favored 'General case' 0 C--N 1.313 -1.006 0 N-CA-C 106.522 -1.659 . . . . 1.58 106.522 173.266 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A 1550 ' ' MET . . . . . . . . . . . . . 68.1 mtp -126.08 122.44 35.8 Favored 'General case' 0 C--N 1.298 -1.647 0 CA-C-N 116.569 -0.287 . . . . 2.08 110.242 -171.436 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A 1551 ' ' SER . . . . . 0.619 ' CB ' ' HB3' ' A' 1556 ' ' ASN . 19.6 p -105.83 133.37 50.67 Favored 'General case' 0 N--CA 1.419 -1.997 0 CA-C-O 122.082 0.944 . . . . 1.9 111.1 -179.514 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A 1552 ' ' ILE . . . . . 0.438 HG22 ' SG ' ' A' 1553 ' ' CYS . 1.7 mp -76.38 -42.88 36.46 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.023 0 CA-C-N 114.355 -1.293 . . . . 2.04 111.499 -176.943 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A 1553 ' ' CYS . . . . . 0.438 ' SG ' HG22 ' A' 1552 ' ' ILE . 46.5 m -130.92 135.99 48.18 Favored 'General case' 0 C--N 1.307 -1.243 0 N-CA-C 108.636 -0.876 . . . . 1.43 108.636 174.626 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A 1554 ' ' GLY . . . . . 0.422 ' HA2' ' HB3' ' A' 1577 ' ' ALA . . . 54.57 -155.74 7.88 Favored Glycine 0 C--O 1.247 0.928 0 O-C-N 124.46 1.1 . . . . 1.23 111.981 179.371 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A 1555 ' ' GLU . . . . . 0.442 ' HG2' ' HA ' ' A' 1561 ' ' PRO . 0.4 OUTLIER -89.9 146.66 24.25 Favored 'General case' 0 N--CA 1.413 -2.295 0 C-N-CA 119.056 -1.058 . . . . 1.8 108.945 170.924 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A 1556 ' ' ASN . . . . . 0.619 ' HB3' ' CB ' ' A' 1551 ' ' SER . 4.3 t30 -170.37 61.41 0.04 OUTLIER 'General case' 0 C--N 1.282 -2.347 0 N-CA-C 107.388 -1.338 . . . . 2.63 107.388 -171.65 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A 1557 ' ' GLU . . . . . 0.569 ' CD ' ' H ' ' A' 1558 ' ' ASN 0.388 0.3 OUTLIER -157.58 -119.92 0.02 OUTLIER 'General case' 0 CA--C 1.553 1.09 0 N-CA-C 116.101 1.889 . . . . 3.79 116.101 -177.402 . . . . . . . . 4 4 . 1 . 013 nuclear orig full ' A' A 1558 ' ' ASN . . . . . 0.569 ' H ' ' CD ' ' A' 1557 ' ' GLU . 40.4 m-80 -139.6 -5.68 1.36 Allowed 'General case' 0 CA--C 1.55 0.96 0 N-CA-C 113.029 0.752 . . . . 1.59 113.029 -175.849 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A 1559 ' ' CYS . . . . . 0.474 ' HB3' ' HD2' ' A' 1560 ' ' PRO . 43.7 m -91.36 170.22 10.03 Favored Pre-proline 0 C--N 1.317 -0.809 0 CA-C-O 119.161 -0.447 . . . . 0.94 109.937 179.015 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A 1560 ' ' PRO . . . . . 0.474 ' HD2' ' HB3' ' A' 1559 ' ' CYS . 91.6 Cg_exo -45.83 129.01 11.66 Favored 'Trans proline' 0 C--N 1.364 1.374 0 C-N-CA 122.853 2.369 . . . . 1.53 111.348 174.633 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A 1561 ' ' PRO . . . . . 0.442 ' HA ' ' HG2' ' A' 1555 ' ' GLU . 53.3 Cg_exo -56.21 115.65 2.62 Favored 'Trans proline' 0 C--O 1.241 0.642 0 C-N-CA 123.268 2.646 . . . . 1.82 112.505 -178.133 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A 1562 ' ' GLY . . . . . . . . . . . . . . . 155.05 -21.43 0.58 Allowed Glycine 0 N--CA 1.443 -0.881 0 N-CA-C 111.619 -0.593 . . . . 0.81 111.619 -179.08 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A 1563 ' ' VAL . . . . . 0.42 ' HA ' ' HA ' ' A' 1576 ' ' LYS . 25.6 m -80.68 161.21 3.92 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.121 0 CA-C-O 121.486 0.66 . . . . 1.73 111.885 178.004 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A 1564 ' ' GLY . . . . . 0.588 ' HA3' ' CD2' ' A' 1592 ' ' TYR . . . -119.98 0.14 13.28 Favored Glycine 0 N--CA 1.424 -2.142 0 N-CA-C 108.845 -1.702 . . . . 0.72 108.845 166.718 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A 1565 ' ' ALA . . . . . . . . . . . . . . . -170.22 125.54 0.77 Allowed 'General case' 0 C--O 1.246 0.911 0 N-CA-C 108.511 -0.922 . . . . 1.14 108.511 178.312 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A 1566 ' ' CYS . . . . . . . . . . . . . 48.8 t -149.98 145.01 26.2 Favored 'General case' 0 C--N 1.309 -1.159 0 C-N-CA 121.141 -0.224 . . . . 0.51 110.45 -175.513 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A 1567 ' ' PHE . . . . . . . . . . . . . 26.8 m-85 -69.87 124.17 23.35 Favored 'General case' 0 C--O 1.217 -0.656 0 N-CA-C 107.548 -1.279 . . . . 1.22 107.548 174.179 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A 1568 ' ' GLY . . . . . 0.418 ' HA3' ' CE2' ' A' 1549 ' ' TYR . . . -70.06 -31.53 69.45 Favored Glycine 0 CA--C 1.498 -1.001 0 C-N-CA 121.02 -0.609 . . . . 1.08 114.032 -173.667 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A 1569 ' ' GLN . . . . . . . . . . . . . 34.5 tt0 -84.57 -53.24 5.53 Favored 'General case' 0 C--N 1.304 -1.394 0 CA-C-O 121.444 0.64 . . . . 3.05 109.853 -179.219 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A 1570 ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -77.19 -23.73 51.45 Favored 'General case' 0 C--N 1.307 -1.25 0 CA-C-N 115.133 -0.939 . . . . 2.44 113.019 -173.177 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A 1571 ' ' ARG . . . . . . . . . . . . . 91.5 mtt180 60.97 36.57 18.64 Favored 'General case' 0 CA--C 1.511 -0.548 0 C-N-CA 125.02 1.328 . . . . 4.48 113.39 179.101 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A 1572 ' ' ILE . . . . . . . . . . . . . 44.0 mm -106.0 122.62 59.86 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.131 0 N-CA-C 108.462 -0.94 . . . . 1.94 108.462 179.473 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A 1573 ' ' SER . . . . . . . . . . . . . 41.5 t -66.86 128.54 36.71 Favored 'General case' 0 C--N 1.308 -1.239 0 C-N-CA 124.231 1.012 . . . . 1.25 111.201 179.562 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A 1574 ' ' VAL . . . . . 0.513 ' HA ' ' HB2' ' A' 1606 ' ' TYR . 35.4 m -118.8 18.01 6.8 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.236 0 CA-C-O 122.023 0.916 . . . . 1.61 110.335 178.004 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A 1575 ' ' GLY . . . . . . . . . . . . . . . 167.25 123.64 0.67 Allowed Glycine 0 N--CA 1.43 -1.725 0 CA-C-N 114.299 -1.319 . . . . 0.65 109.941 178.339 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A 1576 ' ' LYS . . . . . 0.42 ' HA ' ' HA ' ' A' 1563 ' ' VAL . 62.0 mttp -84.32 153.72 23.34 Favored 'General case' 0 CA--C 1.498 -1.021 0 CA-C-O 121.201 0.524 . . . . 3.33 110.427 179.478 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A 1577 ' ' ALA . . . . . 0.471 ' HA ' ' CE2' ' A' 1592 ' ' TYR . . . -59.65 104.23 0.26 Allowed 'General case' 0 C--N 1.307 -1.244 0 CA-C-N 114.025 -1.443 . . . . 1.31 111.287 178.028 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A 1578 ' ' ASN . . . . . . . . . . . . . 45.7 m-80 -135.32 123.05 22.33 Favored 'General case' 0 C--N 1.301 -1.502 0 N-CA-C 105.974 -1.862 . . . . 2.24 105.974 177.027 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A 1579 ' ' LYS . . . . . . . . . . . . . 36.6 ttpt -94.34 89.8 6.03 Favored 'General case' 0 C--N 1.285 -2.227 0 N-CA-C 108.388 -0.967 . . . . 2.34 108.388 -174.583 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A 1580 ' ' ARG . . . . . . . . . . . . . 72.8 ttt180 -127.64 109.86 12.1 Favored 'General case' 0 N--CA 1.419 -1.991 0 CA-C-N 114.631 -1.168 . . . . 4.19 109.128 -179.095 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A 1581 ' ' LEU . . . . . 0.922 ' HB3' ' HA ' ' A' 1512 ' ' GLU . 2.3 tm? -96.25 141.94 29.0 Favored 'General case' 0 C--N 1.3 -1.563 0 CA-C-N 114.649 -1.16 . . . . 2.39 108.143 -177.868 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A 1582 ' ' ARG . . . . . 0.449 ' N ' HD11 ' A' 1581 ' ' LEU . 4.7 tpt180 -145.84 141.79 28.22 Favored 'General case' 0 C--N 1.304 -1.376 0 N-CA-C 108.638 -0.875 . . . . 4.48 108.638 173.274 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A 1583 ' ' TYR . . . . . . . . . . . . . 46.9 t80 -137.05 103.58 5.18 Favored 'General case' 0 C--N 1.321 -0.645 0 N-CA-C 109.206 -0.665 . . . . 1.57 109.206 179.051 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A 1584 ' ' VAL . . . . . . . . . . . . . 26.9 m -134.69 140.26 45.97 Favored 'Isoleucine or valine' 0 C--O 1.201 -1.453 0 N-CA-C 109.64 -0.504 . . . . 2.29 109.64 -178.484 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A 1585 ' ' ASP . . . . . . . . . . . . . 8.9 t70 43.98 52.46 6.73 Favored 'General case' 0 N--CA 1.492 1.646 0 C-N-CA 125.06 1.344 . . . . 2.06 113.088 175.184 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A 1586 ' ' GLN . . . . . . . . . . . . . 19.0 mm-40 61.93 22.39 13.02 Favored 'General case' 0 CA--C 1.553 1.091 0 C-N-CA 123.89 0.876 . . . . 2.61 112.853 178.815 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A 1587 ' ' VAL . . . . . 0.499 HG23 ' O ' ' A' 1612 ' ' PHE . 9.4 p -134.06 125.02 47.71 Favored 'Isoleucine or valine' 0 C--O 1.245 0.833 0 O-C-N 121.455 -0.778 . . . . 1.33 111.785 177.451 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A 1588 ' ' LEU . . . . . 0.698 ' HB2' ' HB2' ' A' 1612 ' ' PHE . 79.3 mt -85.99 155.31 20.92 Favored 'General case' 0 C--N 1.313 -1.0 0 CA-C-N 114.942 -1.026 . . . . 2.03 110.731 177.314 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A 1589 ' ' GLN . . . . . 0.488 ' HA ' ' O ' ' A' 1610 ' ' ILE . 6.9 tt0 -150.4 133.36 16.06 Favored 'General case' 0 C--N 1.318 -0.795 0 N-CA-C 112.33 0.493 . . . . 1.73 112.33 -179.447 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A 1590 ' ' LEU . . . . . 0.616 ' HG ' ' HE1' ' A' 1612 ' ' PHE . 96.0 mt -104.0 125.52 50.43 Favored 'General case' 0 C--O 1.248 1.006 0 N-CA-C 106.982 -1.488 . . . . 1.76 106.982 172.068 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A 1591 ' ' VAL . . . . . . . . . . . . . 40.4 t -105.72 102.56 14.05 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.498 0 C-N-CA 120.757 -0.377 . . . . 2.14 110.119 179.827 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A 1592 ' ' TYR . . . . . 0.588 ' CD2' ' HA3' ' A' 1564 ' ' GLY . 27.7 m-85 -117.55 92.96 3.98 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-O 121.379 0.609 . . . . 1.53 109.422 177.788 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A 1593 ' ' LYS . . . . . . . . . . . . . 21.3 pttp -110.85 -177.55 3.25 Favored 'General case' 0 C--N 1.305 -1.358 0 N-CA-C 112.569 0.581 . . . . 2.72 112.569 -175.901 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A 1594 ' ' ASP . . . . . . . . . . . . . 18.2 m-20 52.77 59.43 4.48 Favored 'General case' 0 N--CA 1.466 0.355 0 C-N-CA 124.931 1.292 . . . . 1.45 113.598 175.212 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A 1595 ' ' GLY . . . . . 0.404 ' HA2' ' HG3' ' A' 1576 ' ' LYS . . . -83.34 -107.35 0.51 Allowed Glycine 0 N--CA 1.438 -1.167 0 C-N-CA 120.517 -0.849 . . . . 0.83 111.719 177.631 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A 1596 ' ' SER . . . . . . . . . . . . . 23.0 t -106.23 145.47 31.04 Favored Pre-proline 0 C--N 1.291 -1.94 0 N-CA-C 107.545 -1.279 . . . . 1.96 107.545 -179.839 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A 1597 ' ' PRO . . . . . . . . . . . . . 77.3 Cg_exo -53.29 134.21 55.95 Favored 'Trans proline' 0 C--N 1.362 1.286 0 C-N-CA 123.558 2.839 . . . . 1.34 111.523 178.654 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A 1598 ' ' CYS . . . . . . . . . . . . . 50.6 t -95.05 125.66 49.75 Favored Pre-proline 0 C--N 1.289 -2.042 0 CA-C-N 115.41 -0.814 . . . . 1.19 109.883 -173.569 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A 1599 ' ' PRO . . . . . . . . . . . . . 58.4 Cg_endo -71.86 -13.91 29.45 Favored 'Trans proline' 0 C--N 1.346 0.395 0 C-N-CA 122.971 2.447 . . . . 1.88 112.497 -179.375 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A 1600 ' ' SER . . . . . . . . . . . . . 19.3 m -74.3 -20.46 60.11 Favored 'General case' 0 N--CA 1.439 -1.002 0 CA-C-N 116.019 -0.537 . . . . 2.19 111.06 179.984 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A 1601 ' ' LYS . . . . . . . . . . . . . 20.9 tptm -156.68 104.13 2.14 Favored 'General case' 0 N--CA 1.433 -1.314 0 N-CA-C 109.052 -0.721 . . . . 4.21 109.052 177.109 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A 1602 ' ' SER . . . . . . . . . . . . . 7.4 p -61.27 107.41 0.75 Allowed 'General case' 0 C--N 1.303 -1.432 0 CA-C-N 115.294 -0.866 . . . . 3.82 112.086 -178.654 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A 1603 ' ' GLY . . . . . . . . . . . . . . . 136.13 -5.38 3.93 Favored Glycine 0 N--CA 1.434 -1.498 0 C-N-CA 120.576 -0.821 . . . . 2.45 113.367 177.91 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A 1604 ' ' LEU . . . . . . . . . . . . . 3.0 pp -140.27 161.81 36.77 Favored 'General case' 0 C--N 1.311 -1.092 0 CA-C-N 117.586 0.693 . . . . 2.06 112.067 -178.727 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A 1605 ' ' SER . . . . . . . . . . . . . 21.7 m -102.78 -174.99 2.69 Favored 'General case' 0 C--N 1.307 -1.259 0 N-CA-C 109.062 -0.718 . . . . 1.75 109.062 178.016 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A 1606 ' ' TYR . . . . . 0.513 ' HB2' ' HA ' ' A' 1574 ' ' VAL . 96.1 m-85 -95.34 153.36 17.72 Favored 'General case' 0 CA--C 1.472 -2.036 0 N-CA-C 105.768 -1.938 . . . . 1.59 105.768 179.495 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A 1607 ' ' LYS . . . . . 0.461 ' HG3' HG22 ' A' 1635 ' ' THR . 25.2 pttm -137.63 146.44 43.93 Favored 'General case' 0 N--CA 1.403 -2.783 0 C-N-CA 118.634 -1.226 . . . . 2.21 110.202 173.054 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A 1608 ' ' SER . . . . . . . . . . . . . 49.9 m -118.69 126.7 52.48 Favored 'General case' 0 C--N 1.305 -1.336 0 CA-C-O 121.235 0.541 . . . . 1.48 110.845 -179.174 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A 1609 ' ' VAL . . . . . . . . . . . . . 56.2 t -111.23 116.91 53.79 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.932 0 N-CA-C 109.565 -0.531 . . . . 1.57 109.565 177.798 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A 1610 ' ' ILE . . . . . 0.56 ' HB ' ' HB2' ' A' 1590 ' ' LEU . 29.3 mm -92.52 111.65 24.72 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.989 0 N-CA-C 108.652 -0.87 . . . . 1.47 108.652 177.349 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A 1611 ' ' SER . . . . . . . . . . . . . 6.3 m -102.67 119.54 39.01 Favored 'General case' 0 C--N 1.29 -2.015 0 N-CA-C 108.146 -1.057 . . . . 1.84 108.146 179.386 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A 1612 ' ' PHE . . . . . 0.698 ' HB2' ' HB2' ' A' 1588 ' ' LEU . 69.5 m-85 -91.47 105.3 17.66 Favored 'General case' 0 C--N 1.297 -1.699 0 N-CA-C 109.196 -0.668 . . . . 0.86 109.196 -178.833 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A 1613 ' ' VAL . . . . . 0.512 ' O ' ' HA ' ' A' 1641 ' ' HIS . 56.6 t -99.09 124.96 52.66 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.164 0 CA-C-N 115.868 -0.605 . . . . 1.32 109.587 -175.672 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A 1614 ' ' CYS . . . . . 0.595 ' HB3' ' HG3' ' A' 1648 ' ' PRO . 34.5 m -71.14 93.97 1.1 Allowed 'General case' 0 C--N 1.304 -1.401 0 CA-C-O 121.505 0.669 . . . . 1.39 112.711 -178.192 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A 1615 ' ' ARG . . . . . 0.689 ' HB3' ' HB2' ' A' 1641 ' ' HIS . 28.5 ttm180 -136.15 92.61 15.81 Favored Pre-proline 0 C--N 1.307 -1.264 0 CA-C-N 115.361 -0.836 . . . . 4.34 110.562 176.607 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A 1616 ' ' PRO . . . . . 0.472 ' HB3' ' HB3' ' A' 1643 ' ' PRO . 12.0 Cg_exo -75.42 18.59 0.57 Allowed 'Trans proline' 0 CA--C 1.535 0.574 0 C-N-CA 123.558 2.839 . . . . 1.5 112.895 176.925 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A 1617 ' ' GLU . . . . . . . . . . . . . 42.3 mt-10 -126.69 23.95 6.66 Favored 'General case' 0 C--N 1.312 -1.026 0 CA-C-O 120.971 0.415 . . . . 3.21 110.285 -178.613 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A 1618 ' ' ALA . . . . . . . . . . . . . . . -77.5 -32.58 54.27 Favored 'General case' 0 C--N 1.315 -0.928 0 CA-C-O 121.066 0.46 . . . . 2.91 110.504 -176.726 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A 1619 ' ' GLY . . . . . . . . . . . . . . . 60.39 -118.77 15.9 Favored Glycine 0 N--CA 1.44 -1.095 0 CA-C-N 114.903 -1.044 . . . . 3.35 112.668 176.188 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A 1620 ' ' PRO . . . . . . . . . . . . . 49.5 Cg_endo -69.04 -22.64 35.08 Favored 'Trans proline' 0 CA--C 1.529 0.236 0 C-N-CA 123.008 2.472 . . . . 6.61 112.755 -179.508 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A 1621 ' ' THR . . . . . . . . . . . . . 7.5 t -104.4 34.76 2.96 Favored 'General case' 0 N--CA 1.428 -1.57 0 CA-C-O 122.471 1.129 . . . . 5.03 109.946 -177.444 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A 1622 ' ' ASN . . . . . . . . . . . . . 49.5 t-20 -75.91 70.93 2.69 Favored 'General case' 0 C--O 1.243 0.711 0 N-CA-C 107.231 -1.396 . . . . 3.58 107.231 174.774 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A 1623 ' ' ARG . . . . . . . . . . . . . 16.2 ptm180 -147.89 153.64 42.58 Favored Pre-proline 0 N--CA 1.437 -1.089 0 CA-C-N 114.996 -1.002 . . . . 4.09 108.805 -174.943 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A 1624 ' ' PRO . . . . . 0.498 ' HA ' ' HA ' ' A' 1640 ' ' TRP . 8.1 Cg_exo -73.77 111.01 3.19 Favored 'Trans proline' 0 C--O 1.238 0.519 0 C-N-CA 122.705 2.27 . . . . 2.86 110.75 178.581 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A 1625 ' ' MET . . . . . 0.462 ' HE1' HG23 ' A' 1627 ' ' ILE . 26.7 ptt? -100.15 154.3 18.55 Favored 'General case' 0 C--N 1.303 -1.418 0 CA-C-N 116.026 -0.534 . . . . 2.73 109.846 -178.041 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A 1626 ' ' LEU . . . . . . . . . . . . . 56.4 tp -87.4 106.92 18.29 Favored 'General case' 0 C--N 1.301 -1.51 0 N-CA-C 108.747 -0.835 . . . . 1.94 108.747 -179.036 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A 1627 ' ' ILE . . . . . 0.462 HG23 ' HE1' ' A' 1625 ' ' MET . 2.8 pp -85.83 -36.02 10.16 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.205 0 C-N-CA 119.921 -0.712 . . . . 1.75 112.758 -177.272 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A 1628 ' ' SER . . . . . . . . . . . . . 49.3 m -157.67 143.92 17.65 Favored 'General case' 0 C--N 1.316 -0.86 0 N-CA-C 110.155 -0.313 . . . . 1.85 110.155 179.428 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A 1629 ' ' LEU . . . . . 0.907 ' HG ' ' HG ' ' A' 1636 ' ' LEU . 5.1 tt -130.33 118.53 21.41 Favored 'General case' 0 C--N 1.301 -1.506 0 N-CA-C 106.343 -1.725 . . . . 2.12 106.343 176.183 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A 1630 ' ' ASP . . . . . . . . . . . . . 20.1 t70 -93.36 117.25 29.86 Favored 'General case' 0 C--N 1.29 -2.005 0 N-CA-C 108.541 -0.911 . . . . 0.87 108.541 178.82 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A 1631 ' ' LYS . . . . . . . . . . . . . 95.7 mttt -83.37 1.52 40.94 Favored 'General case' 0 C--N 1.314 -0.937 0 N-CA-C 112.445 0.535 . . . . 2.76 112.445 -174.983 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A 1632 ' ' GLN . . . . . . . . . . . . . 1.5 mp0 -96.68 -45.7 6.59 Favored 'General case' 0 C--N 1.315 -0.905 0 CA-C-O 121.359 0.6 . . . . 2.55 110.318 -178.424 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A 1633 ' ' THR . . . . . . . . . . . . . 41.6 p -95.39 -5.99 41.97 Favored 'General case' 0 C--N 1.305 -1.348 0 CA-C-O 121.793 0.806 . . . . 1.92 110.286 177.87 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A 1634 ' ' CYS . . . . . . . . . . . . . 83.4 m 56.69 51.33 11.17 Favored 'General case' 0 C--N 1.347 0.475 0 CA-C-N 113.569 -1.65 . . . . 0.89 110.789 -179.394 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A 1635 ' ' THR . . . . . 0.461 HG22 ' HG3' ' A' 1607 ' ' LYS . 24.8 m -111.54 124.36 52.13 Favored 'General case' 0 N--CA 1.425 -1.723 0 CA-C-N 114.109 -1.405 . . . . 1.31 109.651 -176.093 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A 1636 ' ' LEU . . . . . 0.907 ' HG ' ' HG ' ' A' 1629 ' ' LEU . 5.1 mp -105.83 126.72 52.5 Favored 'General case' 0 C--N 1.309 -1.186 0 N-CA-C 109.481 -0.563 . . . . 1.97 109.481 178.519 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A 1637 ' ' PHE . . . . . . . . . . . . . 91.0 m-85 -105.91 111.46 24.11 Favored 'General case' 0 C--N 1.31 -1.139 0 CA-C-N 116.135 -0.484 . . . . 0.92 110.232 -178.831 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A 1638 ' ' PHE . . . . . . . . . . . . . 94.8 m-85 -106.42 128.25 53.91 Favored 'General case' 0 C--N 1.303 -1.436 0 N-CA-C 109.432 -0.581 . . . . 0.7 109.432 178.988 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A 1639 ' ' SER . . . . . . . . . . . . . 67.2 m -112.75 114.64 27.3 Favored 'General case' 0 C--N 1.278 -2.538 0 CA-C-O 121.132 0.491 . . . . 1.46 110.288 179.663 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A 1640 ' ' TRP . . . . . 0.498 ' HA ' ' HA ' ' A' 1624 ' ' PRO . 14.8 t90 -96.26 90.8 5.6 Favored 'General case' 0 N--CA 1.425 -1.699 0 N-CA-C 107.755 -1.202 . . . . 0.92 107.755 176.955 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A 1641 ' ' HIS . . . . . 0.689 ' HB2' ' HB3' ' A' 1615 ' ' ARG . 0.8 OUTLIER -71.87 99.13 2.14 Favored 'General case' 0 C--N 1.311 -1.097 0 CA-C-N 115.223 -0.898 . . . . 3.18 110.072 175.093 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A 1642 ' ' THR . . . . . . . . . . . . . 5.6 t -142.89 149.59 50.15 Favored Pre-proline 0 C--N 1.295 -1.77 0 CA-C-N 114.741 -1.118 . . . . 1.48 109.009 -172.655 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A 1643 ' ' PRO . . . . . 0.472 ' HB3' ' HB3' ' A' 1616 ' ' PRO . 45.6 Cg_endo -73.07 -9.85 23.89 Favored 'Trans proline' 0 C--O 1.215 -0.675 0 C-N-CA 122.858 2.372 . . . . 1.09 112.301 176.187 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A 1644 ' ' LEU . . . . . . . . . . . . . 81.9 mt -87.69 3.83 46.4 Favored 'General case' 0 C--N 1.318 -0.801 0 C-N-CA 122.713 0.405 . . . . 2.08 111.292 -177.748 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A 1645 ' ' ALA . . . . . 0.441 ' HB2' ' SG ' ' A' 1614 ' ' CYS . . . -80.45 -30.13 37.55 Favored 'General case' 0 C--N 1.317 -0.822 0 N-CA-C 112.383 0.512 . . . . 1.37 112.383 -176.61 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A 1646 ' ' CYS . . . . . 0.564 ' O ' ' HD3' ' A' 1648 ' ' PRO . 21.1 p -172.06 -179.57 2.4 Favored 'General case' 0 C--N 1.306 -1.297 0 N-CA-C 105.667 -1.975 . . . . 1.7 105.667 179.594 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A 1647 ' ' GLU . . . . . . . . . . . . . 56.3 mm-40 -100.02 97.17 5.67 Favored Pre-proline 0 C--N 1.312 -1.024 0 N-CA-C 107.747 -1.205 . . . . 2.92 107.747 174.479 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A 1648 ' ' PRO . . . . . 0.595 ' HG3' ' HB3' ' A' 1614 ' ' CYS . 46.5 Cg_endo -95.78 126.87 0.35 Allowed 'Trans proline' 0 N--CA 1.44 -1.666 0 C-N-CA 123.077 2.518 . . . . 3.19 112.647 -177.452 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A 1649 ' ' GLU . . . . . . . . . . . . . 2.9 mp0 . . . . . 0 C--N 1.301 -1.526 0 N-CA-C 109.021 -0.733 . . . . 5.06 109.021 176.428 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A 1508 ' ' MET . . . . . . . . . . . . . 50.6 ttm . . . . . 0 C--O 1.232 0.168 0 N-CA-C 109.073 -0.714 . . . . 8.58 109.073 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A 1509 ' ' LYS . . . . . . . . . . . . . 13.2 ptmm? -153.82 148.08 25.88 Favored 'General case' 0 C--N 1.31 -1.113 0 N-CA-C 107.832 -1.173 . . . . 6.8 107.832 179.186 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A 1510 ' ' SER . . . . . . . . . . . . . 20.8 t -125.31 -7.93 7.0 Favored 'General case' 0 C--N 1.305 -1.35 0 C-N-CA 120.509 -0.476 . . . . 4.48 111.045 -174.845 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A 1511 ' ' ASN . . . . . . . . . . . . . 27.8 p-10 -65.78 -6.9 13.23 Favored 'General case' 0 C--O 1.202 -1.439 0 C-N-CA 123.435 0.694 . . . . 3.08 112.588 -179.412 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A 1512 ' ' GLU . . . . . . . . . . . . . 9.6 pt-20 -102.83 5.82 38.87 Favored 'General case' 0 C--N 1.308 -1.232 0 CA-C-O 121.33 0.586 . . . . 4.46 110.347 178.294 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A 1513 ' ' HIS . . . . . 0.576 ' HD2' ' HA ' ' A' 1580 ' ' ARG . 36.0 m80 -138.67 -41.23 0.49 Allowed 'General case' 0 N--CA 1.471 0.596 0 CA-C-N 115.98 -0.555 . . . . 6.25 111.628 -177.796 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A 1514 ' ' ASP . . . . . . . . . . . . . 13.7 t70 -64.07 -45.75 87.37 Favored 'General case' 0 N--CA 1.469 0.513 0 N-CA-C 108.914 -0.773 . . . . 3.7 108.914 179.507 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A 1515 ' ' ASP . . . . . . . . . . . . . 23.6 t70 -140.7 157.24 45.72 Favored 'General case' 0 C--N 1.311 -1.085 0 N-CA-C 107.158 -1.423 . . . . 2.54 107.158 179.507 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A 1516 ' ' CYS . . . . . . . . . . . . . 71.0 m -83.98 77.24 9.96 Favored 'General case' 0 C--N 1.303 -1.425 0 CA-C-O 121.048 0.451 . . . . 1.25 110.363 179.427 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A 1517 ' ' GLN . . . . . . . . . . . . . 3.5 pt20 -142.54 152.98 43.17 Favored 'General case' 0 C--N 1.306 -1.283 0 O-C-N 121.977 -0.452 . . . . 2.36 111.375 -178.56 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A 1518 ' ' VAL . . . . . 0.564 ' HB ' ' HD2' ' A' 1527 ' ' PHE . 59.2 t -138.59 130.51 37.49 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.86 0 N-CA-C 109.315 -0.624 . . . . 2.34 109.315 -179.759 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A 1519 ' ' THR . . . . . . . . . . . . . 26.6 m -102.67 115.33 30.36 Favored 'General case' 0 C--N 1.306 -1.303 0 N-CA-C 108.217 -1.031 . . . . 2.04 108.217 173.982 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A 1520 ' ' ASN . . . . . . . . . . . . . 25.9 t-20 -74.17 130.43 82.62 Favored Pre-proline 0 C--N 1.313 -0.98 0 N-CA-C 110.122 -0.325 . . . . 2.12 110.122 178.934 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A 1521 ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -74.75 -16.92 20.63 Favored 'Trans proline' 0 CA--C 1.543 0.947 0 C-N-CA 122.744 2.296 . . . . 2.59 114.749 -176.375 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A 1522 ' ' SER . . . . . . . . . . . . . 16.5 m -91.93 -60.86 1.75 Allowed 'General case' 0 C--N 1.314 -0.942 0 N-CA-C 112.044 0.387 . . . . 2.65 112.044 -176.32 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A 1523 ' ' THR . . . . . . . . . . . . . 8.8 t -94.71 -10.06 32.85 Favored 'General case' 0 C--N 1.316 -0.861 0 CA-C-O 121.474 0.654 . . . . 2.33 111.202 -176.153 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A 1524 ' ' GLY . . . . . . . . . . . . . . . 75.0 18.46 80.2 Favored Glycine 0 C--O 1.223 -0.559 0 CA-C-N 115.871 -0.604 . . . . 1.96 112.61 179.093 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A 1525 ' ' HIS . . . . . . . . . . . . . 17.6 t60 -75.65 128.07 34.43 Favored 'General case' 0 C--N 1.308 -1.212 0 N-CA-C 109.751 -0.463 . . . . 2.44 109.751 -176.95 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A 1526 ' ' LEU . . . . . . . . . . . . . 3.5 tm? -94.39 120.15 34.2 Favored 'General case' 0 C--N 1.299 -1.603 0 N-CA-C 106.626 -1.62 . . . . 2.19 106.626 177.451 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A 1527 ' ' PHE . . . . . 0.564 ' HD2' ' HB ' ' A' 1518 ' ' VAL . 86.1 m-85 -89.03 109.94 20.71 Favored 'General case' 0 C--N 1.297 -1.679 0 CA-C-N 116.525 -0.307 . . . . 1.61 110.28 -178.574 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A 1528 ' ' ASP . . . . . . . . . . . . . 13.5 m-20 -81.8 87.3 6.36 Favored 'General case' 0 CA--C 1.494 -1.198 0 CA-C-N 115.913 -0.585 . . . . 2.18 110.484 179.556 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A 1529 ' ' LEU . . . . . 0.678 ' HA ' HD23 ' A' 1532 ' ' LEU . 85.7 mt -99.09 -9.61 23.62 Favored 'General case' 0 C--N 1.302 -1.493 0 N-CA-C 108.95 -0.759 . . . . 2.04 108.95 178.269 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A 1530 ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -62.98 -25.4 68.36 Favored 'General case' 0 C--N 1.318 -0.781 0 C-N-CA 125.166 1.386 . . . . 1.44 109.314 175.623 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A 1531 ' ' SER . . . . . . . . . . . . . 34.3 t -77.34 -9.21 58.7 Favored 'General case' 0 N--CA 1.427 -1.582 0 CA-C-N 114.279 -1.328 . . . . 1.63 109.654 -179.699 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A 1532 ' ' LEU . . . . . 0.678 HD23 ' HA ' ' A' 1529 ' ' LEU . 3.5 mm? -95.87 10.03 38.55 Favored 'General case' 0 C--O 1.245 0.855 0 CA-C-N 115.898 -0.592 . . . . 2.32 111.356 177.805 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A 1533 ' ' SER . . . . . 0.537 ' HA ' ' O ' ' A' 1553 ' ' CYS . 42.3 m -76.58 107.79 9.12 Favored 'General case' 0 N--CA 1.436 -1.15 0 N-CA-C 107.745 -1.206 . . . . 2.57 107.745 172.894 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A 1534 ' ' GLY . . . . . . . . . . . . . . . -110.19 151.33 17.49 Favored Glycine 0 N--CA 1.436 -1.366 0 C-N-CA 120.655 -0.783 . . . . 1.89 112.957 -174.343 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A 1535 ' ' ARG . . . . . . . . . . . . . 40.7 ttm180 -72.36 -62.53 1.41 Allowed 'General case' 0 C--N 1.314 -0.942 0 CA-C-O 121.149 0.499 . . . . 4.44 110.38 178.451 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A 1536 ' ' ALA . . . . . . . . . . . . . . . -93.57 -6.38 46.75 Favored 'General case' 0 C--N 1.309 -1.19 0 C-N-CA 120.028 -0.669 . . . . 2.07 109.484 179.386 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A 1537 ' ' GLY . . . . . . . . . . . . . . . 79.49 -152.85 36.26 Favored Glycine 0 N--CA 1.436 -1.359 0 CA-C-N 115.454 -0.794 . . . . 1.2 112.671 176.397 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A 1538 ' ' PHE . . . . . . . . . . . . . 87.1 m-85 -120.18 155.07 33.86 Favored 'General case' 0 C--N 1.29 -2.003 0 N-CA-C 107.754 -1.202 . . . . 1.98 107.754 179.885 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A 1539 ' ' THR . . . . . . . . . . . . . 24.1 p -112.14 111.93 23.18 Favored 'General case' 0 C--N 1.293 -1.865 0 CA-C-O 121.359 0.599 . . . . 1.97 111.068 -179.409 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A 1540 ' ' ALA . . . . . . . . . . . . . . . -96.8 139.26 33.12 Favored 'General case' 0 C--N 1.3 -1.568 0 N-CA-C 109.075 -0.713 . . . . 1.39 109.075 -179.618 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A 1541 ' ' ALA . . . . . . . . . . . . . . . -80.69 132.87 35.62 Favored 'General case' 0 C--N 1.311 -1.107 0 CA-C-N 115.862 -0.608 . . . . 1.86 110.159 -177.79 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A 1542 ' ' TYR . . . . . 0.469 ' HB3' ' O ' ' A' 1546 ' ' GLY . 45.6 t80 -145.75 156.25 43.48 Favored 'General case' 0 C--N 1.313 -0.999 0 CA-C-N 116.402 -0.363 . . . . 2.4 110.499 -179.134 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A 1543 ' ' SER . . . . . . . . . . . . . 5.5 m -41.25 -153.07 0.0 OUTLIER 'General case' 0 CA--C 1.585 2.305 0 C-N-CA 129.921 3.288 . . . . 2.58 116.58 -176.426 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A 1544 ' ' LYS . . . . . . . . . . . . . 61.2 mttp -51.7 -24.77 6.13 Favored 'General case' 0 N--CA 1.484 1.274 0 O-C-N 120.627 -1.296 . . . . 4.24 113.773 -179.655 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A 1545 ' ' SER . . . . . . . . . . . . . 22.7 t -71.98 -14.71 61.97 Favored 'General case' 0 CA--C 1.553 1.076 0 N-CA-C 111.87 0.322 . . . . 3.6 111.87 178.239 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A 1546 ' ' GLY . . . . . 0.469 ' O ' ' HB3' ' A' 1542 ' ' TYR . . . 96.07 -153.36 20.53 Favored Glycine 0 C--O 1.216 -1.031 0 C-N-CA 119.707 -1.235 . . . . 1.66 113.763 173.491 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A 1547 ' ' VAL . . . . . . . . . . . . . 95.6 t -91.96 139.87 17.11 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.653 0 C-N-CA 123.11 0.564 . . . . 2.23 110.47 -173.751 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A 1548 ' ' VAL . . . . . . . . . . . . . 2.4 t -103.27 131.32 51.96 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.971 0 N-CA-C 107.679 -1.23 . . . . 1.59 107.679 179.211 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A 1549 ' ' TYR . . . . . 0.408 ' CE1' ' HA3' ' A' 1568 ' ' GLY . 75.9 m-85 -97.1 115.19 27.06 Favored 'General case' 0 C--N 1.295 -1.789 0 N-CA-C 107.17 -1.418 . . . . 1.58 107.17 175.129 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A 1550 ' ' MET . . . . . . . . . . . . . 2.7 ppp? -138.34 142.5 39.71 Favored 'General case' 0 C--N 1.291 -1.957 0 CA-C-O 121.172 0.511 . . . . 2.08 111.829 -177.611 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A 1551 ' ' SER . . . . . . . . . . . . . 47.3 m -109.04 149.59 29.04 Favored 'General case' 0 C--N 1.279 -2.463 0 N-CA-C 108.084 -1.08 . . . . 1.9 108.084 177.417 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A 1552 ' ' ILE . . . . . . . . . . . . . 41.6 mm -74.49 -51.64 22.25 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.627 0 N-CA-C 107.385 -1.339 . . . . 2.04 107.385 176.188 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A 1553 ' ' CYS . . . . . 0.537 ' O ' ' HA ' ' A' 1533 ' ' SER . 80.9 m -134.27 147.53 50.65 Favored 'General case' 0 C--N 1.29 -2.01 0 N-CA-C 107.346 -1.353 . . . . 1.43 107.346 175.141 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A 1554 ' ' GLY . . . . . . . . . . . . . . . 97.99 176.05 33.45 Favored Glycine 0 N--CA 1.427 -1.952 0 C-N-CA 120.591 -0.814 . . . . 1.23 111.433 178.294 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A 1555 ' ' GLU . . . . . . . . . . . . . 10.9 pt-20 -89.84 145.74 24.94 Favored 'General case' 0 C--N 1.303 -1.451 0 N-CA-C 109.823 -0.436 . . . . 1.8 109.823 -179.828 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A 1556 ' ' ASN . . . . . . . . . . . . . 20.9 t-20 -93.02 114.24 26.74 Favored 'General case' 0 C--N 1.305 -1.343 0 N-CA-C 108.543 -0.91 . . . . 2.63 108.543 -178.608 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A 1557 ' ' GLU . . . . . . . . . . . . . 51.2 mt-10 -87.23 51.34 2.21 Favored 'General case' 0 C--N 1.294 -1.832 0 N-CA-C 113.178 0.807 . . . . 3.79 113.178 -172.505 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A 1558 ' ' ASN . . . . . . . . . . . . . 36.6 m-80 -133.99 -0.12 3.12 Favored 'General case' 0 C--N 1.311 -1.105 0 CA-C-N 115.781 -0.645 . . . . 1.59 109.79 175.839 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A 1559 ' ' CYS . . . . . 0.625 ' HB3' ' HD2' ' A' 1560 ' ' PRO . 87.4 m -150.86 171.87 5.96 Favored Pre-proline 0 C--N 1.311 -1.08 0 N-CA-C 106.959 -1.497 . . . . 0.94 106.959 -178.764 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A 1560 ' ' PRO . . . . . 0.625 ' HD2' ' HB3' ' A' 1559 ' ' CYS . 44.2 Cg_exo -27.63 129.61 0.03 OUTLIER 'Trans proline' 0 C--N 1.384 2.435 0 C-N-CA 124.948 3.765 . . . . 1.53 114.526 177.454 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A 1561 ' ' PRO . . . . . 0.404 ' HD3' ' HA ' ' A' 1560 ' ' PRO . 37.3 Cg_exo -58.36 116.33 3.17 Favored 'Trans proline' 0 C--O 1.241 0.663 0 C-N-CA 123.277 2.651 . . . . 1.82 112.365 -178.188 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A 1562 ' ' GLY . . . . . . . . . . . . . . . 122.33 -9.94 9.38 Favored Glycine 0 N--CA 1.442 -0.9 0 C-N-CA 120.798 -0.715 . . . . 0.81 112.905 177.858 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A 1563 ' ' VAL . . . . . . . . . . . . . 2.4 m -92.64 153.72 3.27 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.093 0 N-CA-C 107.85 -1.167 . . . . 1.73 107.85 179.242 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A 1564 ' ' GLY . . . . . . . . . . . . . . . -118.68 -18.73 4.71 Favored Glycine 0 C--N 1.297 -1.585 0 C-N-CA 120.284 -0.96 . . . . 0.72 112.656 -177.21 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A 1565 ' ' ALA . . . . . . . . . . . . . . . -139.5 122.35 16.56 Favored 'General case' 0 C--N 1.314 -0.941 0 N-CA-C 108.862 -0.792 . . . . 1.14 108.862 178.994 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A 1566 ' ' CYS . . . . . . . . . . . . . 39.6 t -150.28 144.44 25.56 Favored 'General case' 0 C--N 1.306 -1.297 0 CA-C-N 116.599 -0.273 . . . . 0.51 110.586 -174.812 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A 1567 ' ' PHE . . . . . . . . . . . . . 26.1 m-85 -76.89 123.85 26.88 Favored 'General case' 0 C--O 1.211 -0.96 0 N-CA-C 107.599 -1.259 . . . . 1.22 107.599 175.38 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A 1568 ' ' GLY . . . . . 0.408 ' HA3' ' CE1' ' A' 1549 ' ' TYR . . . -69.16 -27.84 73.39 Favored Glycine 0 C--N 1.315 -0.59 0 N-CA-C 114.561 0.584 . . . . 1.08 114.561 -175.445 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A 1569 ' ' GLN . . . . . . . . . . . . . 35.3 tt0 -77.44 -47.33 19.99 Favored 'General case' 0 C--N 1.315 -0.906 0 O-C-N 122.47 -0.429 . . . . 3.05 111.481 -178.248 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A 1570 ' ' THR . . . . . . . . . . . . . 18.6 p -96.31 -13.36 23.38 Favored 'General case' 0 C--N 1.308 -1.221 0 N-CA-C 113.034 0.753 . . . . 2.44 113.034 -176.21 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A 1571 ' ' ARG . . . . . . . . . . . . . 21.7 mtp180 57.6 40.72 26.54 Favored 'General case' 0 CA--C 1.51 -0.573 0 C-N-CA 124.924 1.29 . . . . 4.48 113.007 -179.456 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A 1572 ' ' ILE . . . . . . . . . . . . . 66.0 mt -106.4 126.45 62.11 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.18 0 CA-C-N 114.733 -1.121 . . . . 1.94 108.327 178.981 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A 1573 ' ' SER . . . . . . . . . . . . . 37.7 t -75.6 136.88 40.48 Favored 'General case' 0 C--N 1.309 -1.186 0 CA-C-N 115.449 -0.796 . . . . 1.25 111.383 -176.95 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A 1574 ' ' VAL . . . . . . . . . . . . . 22.8 m -129.81 21.14 2.2 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.395 0 CA-C-O 121.995 0.903 . . . . 1.61 110.196 177.778 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A 1575 ' ' GLY . . . . . . . . . . . . . . . 176.87 119.04 0.56 Allowed Glycine 0 N--CA 1.422 -2.243 0 CA-C-N 114.576 -1.193 . . . . 0.65 111.274 177.117 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A 1576 ' ' LYS . . . . . . . . . . . . . 46.9 tptt -75.45 151.54 38.06 Favored 'General case' 0 C--N 1.31 -1.147 0 N-CA-C 106.001 -1.852 . . . . 3.33 106.001 175.52 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A 1577 ' ' ALA . . . . . . . . . . . . . . . -70.94 95.08 1.13 Allowed 'General case' 0 C--N 1.314 -0.942 0 N-CA-C 109.273 -0.64 . . . . 1.31 109.273 -179.126 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A 1578 ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -104.66 142.4 34.75 Favored 'General case' 0 C--N 1.3 -1.553 0 CA-C-N 115.439 -0.8 . . . . 2.24 111.117 -178.337 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A 1579 ' ' LYS . . . . . . . . . . . . . 9.9 mmmm -105.89 89.03 2.95 Favored 'General case' 0 C--N 1.287 -2.148 0 N-CA-C 106.079 -1.823 . . . . 2.34 106.079 173.792 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A 1580 ' ' ARG . . . . . 0.576 ' HA ' ' HD2' ' A' 1513 ' ' HIS . 70.0 ttt180 -146.62 97.76 2.96 Favored 'General case' 0 C--N 1.303 -1.435 0 CA-C-N 115.183 -0.917 . . . . 4.19 109.457 -173.023 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A 1581 ' ' LEU . . . . . . . . . . . . . 54.3 tp -118.93 144.57 46.36 Favored 'General case' 0 C--N 1.299 -1.627 0 CA-C-N 115.9 -0.591 . . . . 2.39 109.941 -176.622 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A 1582 ' ' ARG . . . . . . . . . . . . . 49.5 mtp180 -132.96 136.41 46.08 Favored 'General case' 0 C--N 1.309 -1.155 0 C-N-CA 123.416 0.686 . . . . 4.48 109.907 179.185 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A 1583 ' ' TYR . . . . . . . . . . . . . 7.8 t80 -92.9 104.77 16.98 Favored 'General case' 0 C--N 1.311 -1.09 0 CA-C-O 121.56 0.695 . . . . 1.57 109.894 174.184 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A 1584 ' ' VAL . . . . . 0.544 ' HB ' HG11 ' A' 1587 ' ' VAL . 35.0 t -109.69 149.26 12.85 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.648 0 N-CA-C 105.245 -2.131 . . . . 2.29 105.245 175.301 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A 1585 ' ' ASP . . . . . . . . . . . . . 35.8 t70 -46.34 102.68 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.376 0 C-N-CA 124.473 1.109 . . . . 2.06 113.713 -177.968 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A 1586 ' ' GLN . . . . . . . . . . . . . 49.8 mt-30 58.41 35.25 24.63 Favored 'General case' 0 C--O 1.249 1.033 0 C-N-CA 124.828 1.251 . . . . 2.61 112.477 179.911 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A 1587 ' ' VAL . . . . . 0.544 HG11 ' HB ' ' A' 1584 ' ' VAL . 7.7 p -164.69 104.54 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.436 -1.158 0 CA-C-O 122.06 0.933 . . . . 1.33 110.616 175.433 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A 1588 ' ' LEU . . . . . 0.512 ' HB2' ' HB2' ' A' 1612 ' ' PHE . 44.2 mt -78.62 141.25 38.17 Favored 'General case' 0 C--N 1.294 -1.845 0 N-CA-C 107.71 -1.218 . . . . 2.03 107.71 176.295 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A 1589 ' ' GLN . . . . . . . . . . . . . 36.0 tt0 -125.27 117.62 24.21 Favored 'General case' 0 C--N 1.284 -2.253 0 N-CA-C 109.642 -0.503 . . . . 1.73 109.642 -177.835 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A 1590 ' ' LEU . . . . . . . . . . . . . 4.9 tt -116.16 123.25 47.35 Favored 'General case' 0 C--N 1.304 -1.381 0 N-CA-C 106.72 -1.585 . . . . 1.76 106.72 178.354 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A 1591 ' ' VAL . . . . . 0.509 ' HB ' ' HD3' ' A' 1580 ' ' ARG . 60.9 t -110.94 127.76 67.82 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.131 0 N-CA-C 113.633 0.975 . . . . 2.14 113.633 -171.05 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A 1592 ' ' TYR . . . . . . . . . . . . . 5.6 m-30 -109.08 143.49 38.37 Favored 'General case' 0 C--N 1.32 -0.677 0 N-CA-C 107.783 -1.192 . . . . 1.53 107.783 171.378 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A 1593 ' ' LYS . . . . . 0.409 ' HA ' ' HA ' ' A' 1607 ' ' LYS . 13.4 ptmm? -158.96 -177.24 6.37 Favored 'General case' 0 C--N 1.3 -1.58 0 N-CA-C 108.601 -0.889 . . . . 2.72 108.601 179.82 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A 1594 ' ' ASP . . . . . . . . . . . . . 22.0 m-20 64.57 43.31 4.45 Favored 'General case' 0 C--O 1.247 0.936 0 O-C-N 124.147 0.904 . . . . 1.45 112.107 177.724 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A 1595 ' ' GLY . . . . . . . . . . . . . . . -80.83 -104.34 0.31 Allowed Glycine 0 N--CA 1.437 -1.29 0 N-CA-C 111.088 -0.805 . . . . 0.83 111.088 176.309 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A 1596 ' ' SER . . . . . . . . . . . . . 17.7 m -114.11 152.34 45.74 Favored Pre-proline 0 C--N 1.29 -2.013 0 N-CA-C 107.958 -1.127 . . . . 1.96 107.958 177.558 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A 1597 ' ' PRO . . . . . . . . . . . . . 24.7 Cg_exo -62.37 143.39 93.55 Favored 'Trans proline' 0 C--O 1.248 0.99 0 C-N-CA 122.663 2.242 . . . . 1.34 111.193 179.143 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A 1598 ' ' CYS . . . . . . . . . . . . . 45.9 t -96.25 133.15 25.39 Favored Pre-proline 0 C--N 1.29 -2.005 0 CA-C-N 115.844 -0.616 . . . . 1.19 110.41 -177.071 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A 1599 ' ' PRO . . . . . . . . . . . . . 88.2 Cg_endo -88.3 -7.43 5.91 Favored 'Trans proline' 0 CA--C 1.537 0.659 0 C-N-CA 122.68 2.253 . . . . 1.88 112.141 178.013 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A 1600 ' ' SER . . . . . . . . . . . . . 16.5 m -84.27 -34.04 23.88 Favored 'General case' 0 N--CA 1.446 -0.645 0 CA-C-O 121.25 0.548 . . . . 2.19 110.075 -179.87 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A 1601 ' ' LYS . . . . . 0.524 ' HG2' HD11 ' A' 1604 ' ' LEU . 15.8 tppt? -139.64 118.68 12.61 Favored 'General case' 0 N--CA 1.431 -1.379 0 N-CA-C 107.653 -1.24 . . . . 4.21 107.653 178.185 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A 1602 ' ' SER . . . . . . . . . . . . . 22.9 m -72.85 134.39 44.84 Favored 'General case' 0 C--N 1.297 -1.705 0 CA-C-O 121.28 0.562 . . . . 3.82 110.481 -177.587 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A 1603 ' ' GLY . . . . . . . . . . . . . . . 97.61 -7.45 63.43 Favored Glycine 0 N--CA 1.439 -1.125 0 N-CA-C 110.876 -0.89 . . . . 2.45 110.876 -179.756 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A 1604 ' ' LEU . . . . . 0.524 HD11 ' HG2' ' A' 1601 ' ' LYS . 2.2 mt -105.72 148.88 26.94 Favored 'General case' 0 C--N 1.303 -1.424 0 C-N-CA 123.107 0.563 . . . . 2.06 110.873 179.658 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A 1605 ' ' SER . . . . . . . . . . . . . 52.3 m -113.2 -167.45 1.19 Allowed 'General case' 0 C--N 1.287 -2.114 0 N-CA-C 106.356 -1.72 . . . . 1.75 106.356 173.286 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A 1606 ' ' TYR . . . . . . . . . . . . . 44.0 m-85 -108.07 128.24 54.5 Favored 'General case' 0 N--CA 1.399 -2.992 0 N-CA-C 107.223 -1.399 . . . . 1.59 107.223 -179.963 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A 1607 ' ' LYS . . . . . 0.537 ' HG3' HG22 ' A' 1635 ' ' THR . 21.7 ptmt -125.4 154.38 42.01 Favored 'General case' 0 N--CA 1.397 -3.097 0 O-C-N 124.56 1.163 . . . . 2.21 109.407 -177.68 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A 1608 ' ' SER . . . . . 0.483 ' HB3' ' HE2' ' A' 1638 ' ' PHE . 51.1 m -132.38 118.36 19.29 Favored 'General case' 0 C--N 1.296 -1.735 0 N-CA-C 109.598 -0.519 . . . . 1.48 109.598 -178.53 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A 1609 ' ' VAL . . . . . 0.409 HG23 HG13 ' A' 1591 ' ' VAL . 88.1 t -104.12 124.68 58.7 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.558 0 N-CA-C 109.224 -0.658 . . . . 1.57 109.224 178.882 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A 1610 ' ' ILE . . . . . . . . . . . . . 3.1 mp -99.51 117.81 45.2 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.41 0 N-CA-C 108.473 -0.936 . . . . 1.47 108.473 178.156 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A 1611 ' ' SER . . . . . . . . . . . . . 62.9 p -103.45 125.75 50.21 Favored 'General case' 0 N--CA 1.42 -1.928 0 N-CA-C 109.48 -0.563 . . . . 1.84 109.48 177.342 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A 1612 ' ' PHE . . . . . 0.512 ' HB2' ' HB2' ' A' 1588 ' ' LEU . 15.3 m-85 -94.51 107.47 19.45 Favored 'General case' 0 C--N 1.296 -1.735 0 N-CA-C 107.708 -1.219 . . . . 0.86 107.708 179.544 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A 1613 ' ' VAL . . . . . 0.598 HG12 ' HG2' ' A' 1615 ' ' ARG . 97.2 t -103.73 134.41 45.02 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.958 0 N-CA-C 109.86 -0.422 . . . . 1.32 109.86 -177.018 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A 1614 ' ' CYS . . . . . 0.808 ' HB3' ' HG3' ' A' 1648 ' ' PRO . 62.6 m -77.1 91.8 3.72 Favored 'General case' 0 N--CA 1.436 -1.166 0 CA-C-O 121.984 0.897 . . . . 1.39 109.879 -178.384 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A 1615 ' ' ARG . . . . . 0.719 ' HB2' ' HB2' ' A' 1641 ' ' HIS . 12.9 mmt180 -137.52 103.04 8.62 Favored Pre-proline 0 C--N 1.293 -1.865 0 N-CA-C 106.336 -1.727 . . . . 4.34 106.336 176.662 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A 1616 ' ' PRO . . . . . 0.853 ' HD3' ' HG2' ' A' 1648 ' ' PRO . 32.6 Cg_endo -68.03 73.22 0.75 Allowed 'Trans proline' 0 C--O 1.245 0.857 0 C-N-CA 122.441 2.094 . . . . 1.5 111.956 177.843 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A 1617 ' ' GLU . . . . . . . . . . . . . 48.8 mt-10 -131.11 39.98 3.5 Favored 'General case' 0 N--CA 1.431 -1.404 0 CA-C-N 114.653 -1.158 . . . . 3.21 109.816 176.659 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A 1618 ' ' ALA . . . . . . . . . . . . . . . -69.62 128.58 36.95 Favored 'General case' 0 N--CA 1.444 -0.745 0 N-CA-C 108.376 -0.972 . . . . 2.91 108.376 177.685 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A 1619 ' ' GLY . . . . . 0.666 ' H ' ' HB2' ' A' 1622 ' ' ASN . . . 169.02 -126.86 1.43 Allowed Glycine 0 N--CA 1.427 -1.906 0 C-N-CA 120.669 -0.776 . . . . 3.35 111.711 -177.946 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A 1620 ' ' PRO . . . . . . . . . . . . . 53.5 Cg_exo -55.35 -41.7 75.64 Favored 'Trans proline' 0 N--CA 1.478 0.584 0 C-N-CA 123.84 3.027 . . . . 6.61 114.211 -176.356 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A 1621 ' ' THR . . . . . . . . . . . . . 8.9 m -112.65 42.31 1.87 Allowed 'General case' 0 C--N 1.307 -1.253 0 CA-C-O 122.511 1.148 . . . . 5.03 109.378 -176.814 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A 1622 ' ' ASN . . . . . 0.666 ' HB2' ' H ' ' A' 1619 ' ' GLY . 58.0 t30 -80.56 65.13 5.59 Favored 'General case' 0 C--N 1.318 -0.799 0 CA-C-N 114.929 -1.032 . . . . 3.58 109.079 178.025 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A 1623 ' ' ARG . . . . . . . . . . . . . 19.7 ptp180 -155.17 154.71 29.1 Favored Pre-proline 0 C--N 1.3 -1.585 0 N-CA-C 106.998 -1.482 . . . . 4.09 106.998 179.69 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A 1624 ' ' PRO . . . . . . . . . . . . . 23.0 Cg_exo -66.1 117.47 4.7 Favored 'Trans proline' 0 N--CA 1.459 -0.522 0 C-N-CA 122.789 2.326 . . . . 2.86 112.339 -179.648 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A 1625 ' ' MET . . . . . . . . . . . . . 48.3 ttm -90.9 133.16 35.47 Favored 'General case' 0 C--N 1.306 -1.289 0 N-CA-C 108.46 -0.941 . . . . 2.73 108.46 -179.785 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A 1626 ' ' LEU . . . . . 0.419 HD23 HD21 ' A' 1629 ' ' LEU . 29.0 tp -85.22 91.8 8.24 Favored 'General case' 0 C--N 1.294 -1.806 0 N-CA-C 108.715 -0.846 . . . . 1.94 108.715 179.272 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A 1627 ' ' ILE . . . . . . . . . . . . . 32.6 pt -86.05 -27.64 6.18 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.611 0 CA-C-N 115.851 -0.613 . . . . 1.75 111.893 -175.118 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A 1628 ' ' SER . . . . . 0.792 ' HB2' ' HB2' ' A' 1637 ' ' PHE . 18.2 m -132.1 129.04 39.4 Favored 'General case' 0 N--CA 1.427 -1.578 0 CA-C-O 121.087 0.47 . . . . 1.85 110.825 -175.594 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A 1629 ' ' LEU . . . . . 0.569 HD22 ' HG ' ' A' 1636 ' ' LEU . 1.5 tm? -129.77 109.27 10.81 Favored 'General case' 0 C--N 1.296 -1.756 0 N-CA-C 105.393 -2.077 . . . . 2.12 105.393 177.094 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A 1630 ' ' ASP . . . . . . . . . . . . . 22.9 t70 -105.45 112.59 25.75 Favored 'General case' 0 C--N 1.297 -1.682 0 C-N-CA 118.95 -1.1 . . . . 0.87 110.135 179.35 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A 1631 ' ' LYS . . . . . . . . . . . . . 28.7 mtpp -71.77 -37.65 70.44 Favored 'General case' 0 C--N 1.306 -1.308 0 CA-C-N 114.621 -1.172 . . . . 2.76 112.946 -175.923 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A 1632 ' ' GLN . . . . . . . . . . . . . 8.7 pt20 -75.02 -31.26 61.31 Favored 'General case' 0 CA--C 1.535 0.394 0 N-CA-C 112.906 0.706 . . . . 2.55 112.906 -174.444 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A 1633 ' ' THR . . . . . . . . . . . . . 54.7 p -99.46 -1.55 38.23 Favored 'General case' 0 C--O 1.245 0.83 0 C-N-CA 120.073 -0.651 . . . . 1.92 111.198 177.8 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A 1634 ' ' CYS . . . . . . . . . . . . . 18.4 m 60.74 40.28 16.35 Favored 'General case' 0 C--N 1.352 0.699 0 CA-C-O 122.114 0.959 . . . . 0.89 110.466 174.366 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A 1635 ' ' THR . . . . . 0.537 HG22 ' HG3' ' A' 1607 ' ' LYS . 27.5 m -124.04 132.5 53.69 Favored 'General case' 0 N--CA 1.435 -1.202 0 CA-C-N 115.207 -0.906 . . . . 1.31 111.512 -173.802 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A 1636 ' ' LEU . . . . . 0.569 ' HG ' HD22 ' A' 1629 ' ' LEU . 6.2 mp -102.87 141.32 35.88 Favored 'General case' 0 C--N 1.313 -1.0 0 N-CA-C 109.113 -0.699 . . . . 1.97 109.113 175.93 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A 1637 ' ' PHE . . . . . 0.792 ' HB2' ' HB2' ' A' 1628 ' ' SER . 90.9 m-85 -124.22 106.85 10.62 Favored 'General case' 0 C--O 1.25 1.119 0 CA-C-O 121.362 0.601 . . . . 0.92 111.448 177.928 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A 1638 ' ' PHE . . . . . 0.483 ' HE2' ' HB3' ' A' 1608 ' ' SER . 86.3 m-85 -91.75 144.51 25.43 Favored 'General case' 0 C--N 1.31 -1.14 0 CA-C-N 115.508 -0.769 . . . . 0.7 109.223 178.317 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A 1639 ' ' SER . . . . . . . . . . . . . 28.8 m -129.42 114.89 16.72 Favored 'General case' 0 C--N 1.292 -1.92 0 CA-C-O 120.924 0.393 . . . . 1.46 110.136 178.777 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A 1640 ' ' TRP . . . . . . . . . . . . . 19.3 t90 -108.52 113.36 26.33 Favored 'General case' 0 C--N 1.296 -1.73 0 N-CA-C 109.248 -0.649 . . . . 0.92 109.248 177.777 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A 1641 ' ' HIS . . . . . 0.719 ' HB2' ' HB2' ' A' 1615 ' ' ARG . 7.3 p-80 -79.81 104.47 10.41 Favored 'General case' 0 C--N 1.317 -0.846 0 CA-C-N 115.305 -0.861 . . . . 3.18 108.936 176.253 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A 1642 ' ' THR . . . . . 0.467 ' HA ' ' HD3' ' A' 1643 ' ' PRO . 8.9 t -143.08 144.35 28.48 Favored Pre-proline 0 C--N 1.285 -2.198 0 C-N-CA 120.069 -0.652 . . . . 1.48 112.046 -173.366 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A 1643 ' ' PRO . . . . . 0.467 ' HD3' ' HA ' ' A' 1642 ' ' THR . 4.9 Cg_exo -79.1 -0.74 11.0 Favored 'Trans proline' 0 N--CA 1.451 -1.013 0 C-N-CA 123.298 2.665 . . . . 1.09 110.328 171.831 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A 1644 ' ' LEU . . . . . . . . . . . . . 89.6 mt -91.07 3.87 53.61 Favored 'General case' 0 C--O 1.225 -0.207 0 CA-C-N 115.771 -0.65 . . . . 2.08 109.73 176.268 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A 1645 ' ' ALA . . . . . . . . . . . . . . . -86.51 -42.43 13.55 Favored 'General case' 0 C--N 1.317 -0.805 0 N-CA-C 108.14 -1.059 . . . . 1.37 108.14 175.988 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A 1646 ' ' CYS . . . . . 0.64 ' O ' ' HD3' ' A' 1648 ' ' PRO . 16.0 p -176.82 161.46 2.01 Favored 'General case' 0 N--CA 1.43 -1.471 0 N-CA-C 102.993 -2.966 . . . . 1.7 102.993 174.453 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A 1647 ' ' GLU . . . . . . . . . . . . . 41.7 mt-10 -96.65 98.53 4.48 Favored Pre-proline 0 C--N 1.309 -1.155 0 CA-C-N 118.624 0.647 . . . . 2.92 110.784 -179.684 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A 1648 ' ' PRO . . . . . 0.853 ' HG2' ' HD3' ' A' 1616 ' ' PRO . 86.1 Cg_endo -96.29 172.44 0.98 Allowed 'Trans proline' 0 N--CA 1.442 -1.501 0 C-N-CA 123.29 2.66 . . . . 3.19 110.957 -179.49 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A 1649 ' ' GLU . . . . . . . . . . . . . 11.5 tp10 . . . . . 0 C--N 1.285 -2.216 0 N-CA-C 107.889 -1.152 . . . . 5.06 107.889 179.557 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A 1508 ' ' MET . . . . . 0.498 ' HG3' ' OD1' ' A' 1511 ' ' ASN . 50.7 ttp . . . . . 0 N--CA 1.454 -0.256 0 N-CA-C 107.83 -1.174 . . . . 8.58 107.83 . . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A 1509 ' ' LYS . . . . . . . . . . . . . 47.5 pttt -101.79 -64.99 1.01 Allowed 'General case' 0 C--N 1.315 -0.908 0 N-CA-C 114.83 1.419 . . . . 6.8 114.83 -173.3 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A 1510 ' ' SER . . . . . . . . . . . . . 39.1 m -121.59 32.15 6.0 Favored 'General case' 0 C--N 1.309 -1.174 0 CA-C-O 121.231 0.539 . . . . 4.48 111.838 -173.279 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A 1511 ' ' ASN . . . . . 0.498 ' OD1' ' HG3' ' A' 1508 ' ' MET . 23.0 p-10 -128.44 29.13 5.36 Favored 'General case' 0 C--N 1.296 -1.737 0 CA-C-O 121.297 0.57 . . . . 3.08 110.117 177.942 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A 1512 ' ' GLU . . . . . . . . . . . . . 37.4 mt-10 -90.52 -40.96 11.68 Favored 'General case' 0 C--N 1.317 -0.816 0 CA-C-N 115.552 -0.749 . . . . 4.46 110.228 -178.36 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A 1513 ' ' HIS . . . . . 0.543 ' HA ' ' HB2' ' A' 1579 ' ' LYS . 15.1 p-80 -136.3 25.03 3.23 Favored 'General case' 0 C--N 1.314 -0.969 0 CA-C-O 121.7 0.762 . . . . 6.25 110.053 -179.543 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A 1514 ' ' ASP . . . . . . . . . . . . . 34.2 t70 -111.06 -61.06 1.75 Allowed 'General case' 0 C--N 1.305 -1.352 0 CA-C-N 114.846 -1.07 . . . . 3.7 108.946 179.526 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A 1515 ' ' ASP . . . . . . . . . . . . . 11.3 t70 -107.86 153.14 23.44 Favored 'General case' 0 C--N 1.306 -1.3 0 N-CA-C 106.836 -1.542 . . . . 2.54 106.836 177.127 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A 1516 ' ' CYS . . . . . 0.65 ' SG ' ' HE3' ' A' 1579 ' ' LYS . 11.6 m -82.64 81.93 8.22 Favored 'General case' 0 C--N 1.299 -1.629 0 N-CA-C 109.381 -0.6 . . . . 1.25 109.381 -176.812 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A 1517 ' ' GLN . . . . . . . . . . . . . 3.9 pt20 -165.39 176.69 8.07 Favored 'General case' 0 C--N 1.32 -0.68 0 N-CA-C 110.147 -0.316 . . . . 2.36 110.147 179.39 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A 1518 ' ' VAL . . . . . 0.696 ' HB ' HD12 ' A' 1581 ' ' LEU . 4.5 p -148.76 131.32 6.61 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.863 0 CA-C-N 116.068 -0.515 . . . . 2.34 110.131 176.454 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A 1519 ' ' THR . . . . . . . . . . . . . 4.8 m -105.97 123.97 48.83 Favored 'General case' 0 C--N 1.312 -1.039 0 N-CA-C 109.775 -0.454 . . . . 2.04 109.775 179.181 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A 1520 ' ' ASN . . . . . . . . . . . . . 24.8 t-20 -83.86 113.29 46.58 Favored Pre-proline 0 C--N 1.314 -0.971 0 N-CA-C 108.966 -0.753 . . . . 2.12 108.966 175.661 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A 1521 ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -75.55 -15.83 19.36 Favored 'Trans proline' 0 C--N 1.344 0.326 0 C-N-CA 122.221 1.947 . . . . 2.59 113.552 -174.958 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A 1522 ' ' SER . . . . . . . . . . . . . 12.2 m -68.25 -54.75 15.5 Favored 'General case' 0 N--CA 1.432 -1.344 0 CA-C-N 116.494 -0.321 . . . . 2.65 110.785 -177.925 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A 1523 ' ' THR . . . . . 0.435 HG21 ' HB2' ' A' 1525 ' ' HIS . 14.5 t -109.02 -7.8 15.3 Favored 'General case' 0 C--N 1.315 -0.895 0 C-N-CA 119.654 -0.818 . . . . 2.33 111.966 -179.465 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A 1524 ' ' GLY . . . . . . . . . . . . . . . 80.45 37.38 20.87 Favored Glycine 0 CA--C 1.503 -0.658 0 C-N-CA 120.511 -0.852 . . . . 1.96 111.18 -179.487 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A 1525 ' ' HIS . . . . . 0.435 ' HB2' HG21 ' A' 1523 ' ' THR . 22.3 t-160 -100.97 115.71 31.11 Favored 'General case' 0 C--N 1.308 -1.205 0 N-CA-C 109.284 -0.636 . . . . 2.44 109.284 -176.545 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A 1526 ' ' LEU . . . . . . . . . . . . . 3.5 tm? -88.41 120.65 29.98 Favored 'General case' 0 C--N 1.295 -1.766 0 N-CA-C 107.799 -1.185 . . . . 2.19 107.799 178.762 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A 1527 ' ' PHE . . . . . . . . . . . . . 95.0 m-85 -92.86 112.95 25.09 Favored 'General case' 0 C--N 1.3 -1.555 0 N-CA-C 107.646 -1.242 . . . . 1.61 107.646 176.975 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A 1528 ' ' ASP . . . . . . . . . . . . . 10.8 t70 -77.84 105.6 9.13 Favored 'General case' 0 CA--C 1.495 -1.143 0 CA-C-O 121.533 0.682 . . . . 2.18 109.678 -178.356 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A 1529 ' ' LEU . . . . . . . . . . . . . 89.2 mt -106.55 -3.0 21.28 Favored 'General case' 0 C--N 1.281 -2.412 0 N-CA-C 107.207 -1.405 . . . . 2.04 107.207 176.458 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A 1530 ' ' SER . . . . . . . . . . . . . 8.1 m -69.72 -37.05 76.4 Favored 'General case' 0 N--CA 1.419 -1.985 0 CA-C-N 114.027 -1.442 . . . . 1.44 110.73 -174.013 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A 1531 ' ' SER . . . . . . . . . . . . . 14.8 m -74.94 -21.97 58.86 Favored 'General case' 0 C--N 1.316 -0.853 0 CA-C-O 121.344 0.592 . . . . 1.63 110.026 177.72 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A 1532 ' ' LEU . . . . . 0.583 HD21 ' HH2' ' A' 1640 ' ' TRP . 82.1 mt -85.83 -5.72 59.2 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.549 -0.751 . . . . 2.32 109.643 179.711 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A 1533 ' ' SER . . . . . 0.405 ' OG ' ' HB3' ' A' 1553 ' ' CYS . 22.6 m -92.18 107.36 19.16 Favored 'General case' 0 N--CA 1.415 -2.199 0 N-CA-C 108.631 -0.878 . . . . 2.57 108.631 178.584 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A 1534 ' ' GLY . . . . . . . . . . . . . . . -126.58 -150.33 7.54 Favored Glycine 0 N--CA 1.422 -2.296 0 N-CA-C 109.768 -1.333 . . . . 1.89 109.768 179.551 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A 1535 ' ' ARG . . . . . . . . . . . . . 9.5 tpt180 -96.82 -70.11 0.73 Allowed 'General case' 0 N--CA 1.419 -1.979 0 C-N-CA 120.242 -0.583 . . . . 4.44 109.58 179.214 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A 1536 ' ' ALA . . . . . . . . . . . . . . . -86.93 -18.28 31.17 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 121.047 0.451 . . . . 2.07 110.994 -177.831 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A 1537 ' ' GLY . . . . . . . . . . . . . . . 73.44 -112.9 4.04 Favored Glycine 0 N--CA 1.435 -1.383 0 CA-C-N 115.941 -0.572 . . . . 1.2 113.317 176.15 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A 1538 ' ' PHE . . . . . . . . . . . . . 64.9 m-85 -127.23 159.0 35.64 Favored 'General case' 0 C--N 1.307 -1.27 0 N-CA-C 109.837 -0.431 . . . . 1.98 109.837 -176.55 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A 1539 ' ' THR . . . . . . . . . . . . . 6.8 p -112.76 119.99 39.95 Favored 'General case' 0 C--N 1.306 -1.3 0 CA-C-N 116.288 -0.415 . . . . 1.97 111.138 -178.886 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A 1540 ' ' ALA . . . . . . . . . . . . . . . -100.51 116.0 31.43 Favored 'General case' 0 C--N 1.307 -1.253 0 N-CA-C 109.46 -0.57 . . . . 1.39 109.46 177.976 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A 1541 ' ' ALA . . . . . . . . . . . . . . . -80.48 89.05 5.61 Favored 'General case' 0 C--N 1.313 -0.979 0 CA-C-N 115.541 -0.754 . . . . 1.86 109.134 -179.161 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A 1542 ' ' TYR . . . . . . . . . . . . . 64.3 t80 -100.13 157.2 16.74 Favored 'General case' 0 C--N 1.293 -1.856 0 CA-C-N 115.861 -0.609 . . . . 2.4 111.483 -176.486 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A 1543 ' ' SER . . . . . . . . . . . . . 2.8 m -40.46 -153.07 0.0 OUTLIER 'General case' 0 CA--C 1.578 2.043 0 C-N-CA 130.179 3.391 . . . . 2.58 116.893 -177.15 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A 1544 ' ' LYS . . . . . 0.637 ' HZ1' ' HB3' ' A' 1544 ' ' LYS . 4.9 ttpm? -49.4 -31.7 10.15 Favored 'General case' 0 N--CA 1.481 1.082 0 O-C-N 121.3 -0.875 . . . . 4.24 112.262 -179.197 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A 1545 ' ' SER . . . . . . . . . . . . . 13.1 m -63.82 -27.18 69.0 Favored 'General case' 0 CA--C 1.559 1.291 0 N-CA-C 112.375 0.509 . . . . 3.6 112.375 178.261 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A 1546 ' ' GLY . . . . . . . . . . . . . . . 109.02 -165.21 12.48 Favored Glycine 0 N--CA 1.43 -1.764 0 C-N-CA 119.363 -1.398 . . . . 1.66 114.034 174.869 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A 1547 ' ' VAL . . . . . . . . . . . . . 7.2 p -92.35 133.51 33.48 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.608 0 CA-C-O 121.596 0.712 . . . . 2.23 111.151 -176.297 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A 1548 ' ' VAL . . . . . . . . . . . . . 4.1 t -111.37 135.83 49.36 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.442 0 N-CA-C 106.682 -1.599 . . . . 1.59 106.682 179.202 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A 1549 ' ' TYR . . . . . 0.649 ' HE1' ' HA3' ' A' 1568 ' ' GLY . 95.7 m-85 -93.74 151.38 19.67 Favored 'General case' 0 C--N 1.3 -1.547 0 N-CA-C 106.565 -1.642 . . . . 1.58 106.565 174.129 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A 1550 ' ' MET . . . . . . . . . . . . . 46.0 ttm -144.16 122.38 12.24 Favored 'General case' 0 C--N 1.301 -1.514 0 C-N-CA 120.255 -0.578 . . . . 2.08 111.113 -178.686 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A 1551 ' ' SER . . . . . . . . . . . . . 28.8 p -111.36 122.06 46.86 Favored 'General case' 0 N--CA 1.418 -2.07 0 N-CA-C 108.7 -0.852 . . . . 1.9 108.7 174.932 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A 1552 ' ' ILE . . . . . . . . . . . . . 1.7 mp -62.04 -29.33 46.24 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.342 0 CA-C-N 115.134 -0.939 . . . . 2.04 110.621 179.058 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A 1553 ' ' CYS . . . . . 0.702 ' SG ' ' HE3' ' A' 1579 ' ' LYS . 37.2 t -160.63 141.0 11.45 Favored 'General case' 0 N--CA 1.426 -1.629 0 N-CA-C 108.354 -0.98 . . . . 1.43 108.354 174.797 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A 1554 ' ' GLY . . . . . . . . . . . . . . . 97.43 160.29 31.17 Favored Glycine 0 N--CA 1.443 -0.85 0 O-C-N 123.652 0.595 . . . . 1.23 111.678 -179.003 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A 1555 ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -67.54 127.25 32.04 Favored 'General case' 0 N--CA 1.447 -0.578 0 CA-C-O 121.729 0.776 . . . . 1.8 111.334 178.474 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A 1556 ' ' ASN . . . . . 0.521 HD22 ' HB3' ' A' 1549 ' ' TYR . 3.4 t-20 -75.05 -14.47 60.6 Favored 'General case' 0 C--N 1.299 -1.603 0 C-N-CA 126.328 1.851 . . . . 2.63 114.023 -170.069 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A 1557 ' ' GLU . . . . . 0.488 ' C ' ' H ' ' A' 1559 ' ' CYS . 50.6 mm-40 66.45 -173.61 0.19 Allowed 'General case' 0 N--CA 1.481 1.084 0 C-N-CA 123.237 0.615 . . . . 3.79 110.282 -176.112 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A 1558 ' ' ASN . . . . . . . . . . . . . 42.2 m-80 76.31 -20.9 0.34 Allowed 'General case' 0 N--CA 1.496 1.855 0 C-N-CA 125.659 1.584 . . . . 1.59 111.972 173.467 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A 1559 ' ' CYS . . . . . 0.572 ' HB3' ' HD2' ' A' 1560 ' ' PRO . 63.8 m -142.12 169.63 10.66 Favored Pre-proline 0 C--N 1.282 -2.355 0 N-CA-C 106.491 -1.67 . . . . 0.94 106.491 179.732 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A 1560 ' ' PRO . . . . . 0.572 ' HD2' ' HB3' ' A' 1559 ' ' CYS . 26.8 Cg_exo -32.26 130.26 0.09 OUTLIER 'Trans proline' 0 C--N 1.369 1.608 0 C-N-CA 124.984 3.789 . . . . 1.53 114.983 178.098 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A 1561 ' ' PRO . . . . . . . . . . . . . 50.5 Cg_exo -56.09 110.83 0.62 Allowed 'Trans proline' 0 C--O 1.242 0.723 0 C-N-CA 123.583 2.855 . . . . 1.82 112.551 179.71 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A 1562 ' ' GLY . . . . . . . . . . . . . . . 141.05 -14.05 2.83 Favored Glycine 0 N--CA 1.442 -0.953 0 C-N-CA 120.526 -0.845 . . . . 0.81 112.519 178.875 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A 1563 ' ' VAL . . . . . 0.485 HG23 ' O ' ' A' 1560 ' ' PRO . 7.3 m -85.24 151.47 3.74 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.309 0 O-C-N 122.488 -0.419 . . . . 1.73 111.617 179.031 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A 1564 ' ' GLY . . . . . 0.407 ' HA3' ' CE2' ' A' 1592 ' ' TYR . . . -117.81 -1.23 17.35 Favored Glycine 0 N--CA 1.433 -1.547 0 N-CA-C 110.911 -0.876 . . . . 0.72 110.911 176.201 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A 1565 ' ' ALA . . . . . . . . . . . . . . . -158.43 119.56 3.43 Favored 'General case' 0 C--O 1.247 0.952 0 N-CA-C 109.552 -0.536 . . . . 1.14 109.552 179.158 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A 1566 ' ' CYS . . . . . . . . . . . . . 48.7 t -154.33 145.77 23.09 Favored 'General case' 0 C--N 1.304 -1.373 0 N-CA-C 109.956 -0.387 . . . . 0.51 109.956 -177.343 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A 1567 ' ' PHE . . . . . . . . . . . . . 66.9 m-85 -71.07 123.26 21.7 Favored 'General case' 0 CA--C 1.511 -0.546 0 N-CA-C 107.412 -1.329 . . . . 1.22 107.412 172.951 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A 1568 ' ' GLY . . . . . 0.649 ' HA3' ' HE1' ' A' 1549 ' ' TYR . . . -73.62 -22.52 78.31 Favored Glycine 0 C--N 1.308 -1.01 0 C-N-CA 120.788 -0.72 . . . . 1.08 114.735 -172.021 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A 1569 ' ' GLN . . . . . . . . . . . . . 10.0 mt-30 -90.53 -55.52 3.55 Favored 'General case' 0 C--N 1.305 -1.349 0 CA-C-O 121.125 0.488 . . . . 3.05 109.98 -177.13 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A 1570 ' ' THR . . . . . . . . . . . . . 21.2 p -81.93 -12.98 58.13 Favored 'General case' 0 CA--C 1.546 0.821 0 N-CA-C 113.691 0.997 . . . . 2.44 113.691 -176.487 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A 1571 ' ' ARG . . . . . . . . . . . . . 37.0 mtp85 62.91 42.44 7.66 Favored 'General case' 0 N--CA 1.476 0.872 0 C-N-CA 124.263 1.025 . . . . 4.48 112.262 -179.883 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A 1572 ' ' ILE . . . . . . . . . . . . . 30.8 mm -104.49 122.24 57.22 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.241 0 N-CA-C 109.237 -0.653 . . . . 1.94 109.237 -179.149 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A 1573 ' ' SER . . . . . . . . . . . . . 31.9 t -83.24 137.11 34.15 Favored 'General case' 0 C--N 1.303 -1.453 0 C-N-CA 124.364 1.066 . . . . 1.25 111.821 -175.593 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A 1574 ' ' VAL . . . . . . . . . . . . . 11.5 m -140.01 27.48 0.5 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 115.982 -0.553 . . . . 1.61 110.72 175.224 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A 1575 ' ' GLY . . . . . . . . . . . . . . . 178.71 119.54 0.61 Allowed Glycine 0 N--CA 1.434 -1.489 0 C-N-CA 120.016 -1.088 . . . . 0.65 112.921 178.976 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A 1576 ' ' LYS . . . . . . . . . . . . . 22.9 tptm -89.56 137.15 32.57 Favored 'General case' 0 C--N 1.304 -1.409 0 N-CA-C 107.047 -1.464 . . . . 3.33 107.047 176.044 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A 1577 ' ' ALA . . . . . 0.662 ' HA ' ' CE2' ' A' 1592 ' ' TYR . . . -67.56 119.86 13.03 Favored 'General case' 0 C--N 1.322 -0.629 0 N-CA-C 109.379 -0.6 . . . . 1.31 109.379 -178.772 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A 1578 ' ' ASN . . . . . . . . . . . . . 5.7 p30 -157.61 166.83 31.85 Favored 'General case' 0 C--N 1.31 -1.126 0 N-CA-C 107.071 -1.455 . . . . 2.24 107.071 -176.468 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A 1579 ' ' LYS . . . . . 0.702 ' HE3' ' SG ' ' A' 1553 ' ' CYS . 50.9 mttp -122.1 90.07 3.24 Favored 'General case' 0 C--N 1.306 -1.317 0 N-CA-C 109.789 -0.448 . . . . 2.34 109.789 178.179 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A 1580 ' ' ARG . . . . . . . . . . . . . 47.2 ttp180 -138.39 92.46 2.64 Favored 'General case' 0 C--N 1.309 -1.188 0 N-CA-C 106.969 -1.493 . . . . 4.19 106.969 175.178 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A 1581 ' ' LEU . . . . . 0.696 HD12 ' HB ' ' A' 1518 ' ' VAL . 4.6 pp -127.5 158.9 36.18 Favored 'General case' 0 C--N 1.294 -1.826 0 CA-C-N 115.7 -0.682 . . . . 2.39 110.147 -177.675 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A 1582 ' ' ARG . . . . . 0.468 ' HB3' HG13 ' A' 1584 ' ' VAL . 80.4 mtm-85 -139.96 139.09 36.02 Favored 'General case' 0 C--N 1.301 -1.539 0 O-C-N 123.449 0.468 . . . . 4.48 109.885 178.378 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A 1583 ' ' TYR . . . . . 0.465 ' CD1' ' HG ' ' A' 1588 ' ' LEU . 25.4 t80 -99.73 90.44 4.46 Favored 'General case' 0 C--N 1.309 -1.175 0 N-CA-C 106.547 -1.649 . . . . 1.57 106.547 174.256 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A 1584 ' ' VAL . . . . . 0.468 HG13 ' HB3' ' A' 1582 ' ' ARG . 18.3 m -115.89 124.38 72.19 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.948 0 CA-C-N 115.83 -0.623 . . . . 2.29 111.701 -172.475 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A 1585 ' ' ASP . . . . . . . . . . . . . 38.8 t70 56.06 50.51 13.56 Favored 'General case' 0 C--N 1.31 -1.123 0 C-N-CA 123.98 0.912 . . . . 2.06 111.701 177.901 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A 1586 ' ' GLN . . . . . . . . . . . . . 49.2 mt-30 69.75 10.71 7.66 Favored 'General case' 0 N--CA 1.481 1.105 0 CA-C-N 114.8 -1.091 . . . . 2.61 113.853 176.253 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A 1587 ' ' VAL . . . . . 0.485 HG23 ' O ' ' A' 1612 ' ' PHE . 7.4 p -135.61 133.01 51.83 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.517 0 CA-C-O 121.49 0.662 . . . . 1.33 110.895 -179.735 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A 1588 ' ' LEU . . . . . 0.8 ' HB2' ' HB2' ' A' 1612 ' ' PHE . 20.4 mt -80.15 142.74 34.49 Favored 'General case' 0 C--N 1.312 -1.037 0 CA-C-N 115.303 -0.862 . . . . 2.03 110.749 178.037 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A 1589 ' ' GLN . . . . . . . . . . . . . 6.5 tt0 -128.24 106.86 9.32 Favored 'General case' 0 C--N 1.289 -2.051 0 CA-C-N 115.434 -0.803 . . . . 1.73 109.475 -179.481 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A 1590 ' ' LEU . . . . . 0.713 ' HB2' ' HE1' ' A' 1612 ' ' PHE . 21.1 tp -101.54 112.99 25.72 Favored 'General case' 0 C--N 1.314 -0.974 0 N-CA-C 107.022 -1.473 . . . . 1.76 107.022 178.636 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A 1591 ' ' VAL . . . . . 0.527 HG22 HG23 ' A' 1609 ' ' VAL . 61.1 t -105.96 107.84 23.63 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.381 0 C-N-CA 120.107 -0.637 . . . . 2.14 112.248 -175.824 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A 1592 ' ' TYR . . . . . 0.662 ' CE2' ' HA ' ' A' 1577 ' ' ALA . 5.0 m-85 -102.89 92.84 4.75 Favored 'General case' 0 C--N 1.297 -1.691 0 CA-C-O 121.907 0.86 . . . . 1.53 108.74 173.587 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A 1593 ' ' LYS . . . . . 0.503 ' HA ' ' HA ' ' A' 1607 ' ' LYS . 18.0 pttp -104.5 -175.44 2.8 Favored 'General case' 0 C--N 1.291 -1.948 0 CA-C-N 114.152 -1.385 . . . . 2.72 108.285 -178.433 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A 1594 ' ' ASP . . . . . . . . . . . . . 1.6 m-20 63.67 72.5 0.47 Allowed 'General case' 0 CA--C 1.512 -0.501 0 O-C-N 124.072 0.857 . . . . 1.45 112.17 177.969 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A 1595 ' ' GLY . . . . . . . . . . . . . . . -110.11 -113.56 3.52 Favored Glycine 0 N--CA 1.425 -2.04 0 N-CA-C 109.659 -1.376 . . . . 0.83 109.659 176.159 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A 1596 ' ' SER . . . . . . . . . . . . . 33.4 p -104.53 158.03 32.84 Favored Pre-proline 0 C--N 1.29 -1.988 0 N-CA-C 108.866 -0.79 . . . . 1.96 108.866 177.915 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A 1597 ' ' PRO . . . . . . . . . . . . . 36.9 Cg_exo -59.45 137.2 76.59 Favored 'Trans proline' 0 C--N 1.353 0.815 0 C-N-CA 122.757 2.305 . . . . 1.34 112.004 178.869 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A 1598 ' ' CYS . . . . . . . . . . . . . 42.7 t -95.82 115.16 65.33 Favored Pre-proline 0 C--N 1.299 -1.621 0 CA-C-N 115.899 -0.591 . . . . 1.19 110.034 -178.711 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A 1599 ' ' PRO . . . . . 0.517 ' HD2' ' OH ' ' A' 1606 ' ' TYR . 44.2 Cg_endo -69.36 -15.63 38.73 Favored 'Trans proline' 0 CA--C 1.535 0.525 0 C-N-CA 122.591 2.194 . . . . 1.88 112.625 -179.119 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A 1600 ' ' SER . . . . . . . . . . . . . 21.0 m -80.16 -13.16 59.47 Favored 'General case' 0 C--O 1.249 1.058 0 CA-C-N 116.157 -0.474 . . . . 2.19 111.876 -178.261 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A 1601 ' ' LYS . . . . . 0.81 ' HG2' HD12 ' A' 1604 ' ' LEU . 16.1 tppt? -156.2 110.65 2.82 Favored 'General case' 0 N--CA 1.442 -0.83 0 N-CA-C 108.83 -0.804 . . . . 4.21 108.83 179.405 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A 1602 ' ' SER . . . . . . . . . . . . . 8.4 m -59.61 109.84 1.0 Allowed 'General case' 0 C--N 1.296 -1.73 0 C-N-CA 124.185 0.994 . . . . 3.82 111.1 -176.991 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A 1603 ' ' GLY . . . . . . . . . . . . . . . 108.22 -17.84 34.07 Favored Glycine 0 N--CA 1.441 -0.971 0 C-N-CA 120.701 -0.762 . . . . 2.45 112.495 177.584 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A 1604 ' ' LEU . . . . . 0.81 HD12 ' HG2' ' A' 1601 ' ' LYS . 1.1 mt -86.89 146.02 26.35 Favored 'General case' 0 C--N 1.308 -1.23 0 CA-C-O 121.15 0.5 . . . . 2.06 110.838 -178.849 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A 1605 ' ' SER . . . . . . . . . . . . . 22.8 t -108.21 -175.05 2.67 Favored 'General case' 0 N--CA 1.424 -1.747 0 N-CA-C 106.336 -1.728 . . . . 1.75 106.336 173.378 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A 1606 ' ' TYR . . . . . 0.517 ' OH ' ' HD2' ' A' 1599 ' ' PRO . 78.6 m-85 -107.46 135.7 48.49 Favored 'General case' 0 CA--C 1.46 -2.485 0 N-CA-C 107.705 -1.22 . . . . 1.59 107.705 -176.452 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A 1607 ' ' LYS . . . . . 0.503 ' HA ' ' HA ' ' A' 1593 ' ' LYS . 24.6 pttm -122.31 134.54 54.66 Favored 'General case' 0 N--CA 1.398 -3.062 0 C-N-CA 118.592 -1.243 . . . . 2.21 110.433 176.835 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A 1608 ' ' SER . . . . . . . . . . . . . 47.1 m -101.56 111.15 23.3 Favored 'General case' 0 C--N 1.28 -2.452 0 CA-C-N 115.17 -0.923 . . . . 1.48 108.543 176.857 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A 1609 ' ' VAL . . . . . 0.527 HG23 HG22 ' A' 1591 ' ' VAL . 56.4 t -98.09 112.56 30.45 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.107 0 N-CA-C 109.48 -0.563 . . . . 1.57 109.48 177.568 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A 1610 ' ' ILE . . . . . 0.581 ' HB ' ' HB3' ' A' 1590 ' ' LEU . 2.5 mp -93.46 104.72 16.04 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.649 0 N-CA-C 107.521 -1.289 . . . . 1.47 107.521 177.353 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A 1611 ' ' SER . . . . . . . . . . . . . 22.8 t -90.72 117.41 29.34 Favored 'General case' 0 C--N 1.293 -1.864 0 N-CA-C 108.387 -0.968 . . . . 1.84 108.387 -179.735 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A 1612 ' ' PHE . . . . . 0.8 ' HB2' ' HB2' ' A' 1588 ' ' LEU . 50.7 m-85 -92.15 102.22 14.74 Favored 'General case' 0 C--N 1.31 -1.126 0 N-CA-C 108.985 -0.746 . . . . 0.86 108.985 -179.651 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A 1613 ' ' VAL . . . . . . . . . . . . . 47.8 t -100.53 127.59 53.44 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.51 0 N-CA-C 107.821 -1.177 . . . . 1.32 107.821 -177.881 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A 1614 ' ' CYS . . . . . 0.648 ' HA ' ' O ' ' A' 1642 ' ' THR . 8.3 t -71.45 106.4 3.93 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-O 121.28 0.562 . . . . 1.39 111.618 -176.657 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A 1615 ' ' ARG . . . . . 0.758 ' HB2' ' HB3' ' A' 1641 ' ' HIS . 37.2 mmt180 -137.09 85.2 22.91 Favored Pre-proline 0 N--CA 1.433 -1.306 0 CA-C-N 115.228 -0.896 . . . . 4.34 110.462 177.048 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A 1616 ' ' PRO . . . . . 0.416 ' HA ' ' HB3' ' A' 1643 ' ' PRO . 48.5 Cg_exo -61.22 -16.61 47.59 Favored 'Trans proline' 0 N--CA 1.482 0.801 0 C-N-CA 122.942 2.428 . . . . 1.5 111.481 174.444 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A 1617 ' ' GLU . . . . . . . . . . . . . 8.6 pt-20 -69.99 -17.66 63.3 Favored 'General case' 0 C--N 1.318 -0.765 0 C-N-CA 123.886 0.874 . . . . 3.21 112.345 178.328 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A 1618 ' ' ALA . . . . . . . . . . . . . . . -76.67 141.55 40.91 Favored 'General case' 0 C--N 1.312 -1.057 0 CA-C-O 120.794 0.33 . . . . 2.91 110.673 -176.596 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A 1619 ' ' GLY . . . . . . . . . . . . . . . -145.3 -80.52 0.04 OUTLIER Glycine 0 N--CA 1.436 -1.339 0 N-CA-C 111.465 -0.654 . . . . 3.35 111.465 -178.24 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A 1620 ' ' PRO . . . . . . . . . . . . . 31.5 Cg_endo -65.12 -32.62 52.4 Favored 'Trans proline' 0 C--O 1.236 0.399 0 C-N-CA 122.58 2.187 . . . . 6.61 112.59 -179.603 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A 1621 ' ' THR . . . . . . . . . . . . . 2.8 m -110.18 29.38 7.72 Favored 'General case' 0 N--CA 1.435 -1.183 0 CA-C-O 121.683 0.754 . . . . 5.03 109.345 -178.188 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A 1622 ' ' ASN . . . . . . . . . . . . . 50.0 t-20 -77.65 75.98 4.19 Favored 'General case' 0 C--O 1.245 0.856 0 N-CA-C 108.878 -0.786 . . . . 3.58 108.878 179.015 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A 1623 ' ' ARG . . . . . . . . . . . . . 19.0 ptp180 -155.42 161.38 29.58 Favored Pre-proline 0 C--O 1.247 0.94 0 N-CA-C 108.131 -1.063 . . . . 4.09 108.131 -179.67 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A 1624 ' ' PRO . . . . . . . . . . . . . 7.7 Cg_exo -73.42 94.7 0.84 Allowed 'Trans proline' 0 N--CA 1.458 -0.595 0 C-N-CA 122.747 2.298 . . . . 2.86 111.566 177.476 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A 1625 ' ' MET . . . . . . . . . . . . . 20.5 ptp -81.64 150.12 28.24 Favored 'General case' 0 C--N 1.313 -1.011 0 CA-C-N 115.646 -0.706 . . . . 2.73 109.797 179.735 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A 1626 ' ' LEU . . . . . . . . . . . . . 47.3 tp -90.35 105.25 17.69 Favored 'General case' 0 C--N 1.304 -1.389 0 N-CA-C 108.194 -1.039 . . . . 1.94 108.194 179.101 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A 1627 ' ' ILE . . . . . . . . . . . . . 44.7 pt -85.7 -38.07 12.52 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.331 0 N-CA-C 112.119 0.414 . . . . 1.75 112.119 -175.428 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A 1628 ' ' SER . . . . . . . . . . . . . 19.4 t -148.95 150.91 33.69 Favored 'General case' 0 N--CA 1.432 -1.34 0 N-CA-C 109.036 -0.727 . . . . 1.85 109.036 -177.426 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A 1629 ' ' LEU . . . . . 0.961 ' HG ' ' HG ' ' A' 1636 ' ' LEU . 3.1 tt -141.83 116.19 9.53 Favored 'General case' 0 C--N 1.303 -1.446 0 N-CA-C 106.682 -1.599 . . . . 2.12 106.682 179.798 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A 1630 ' ' ASP . . . . . . . . . . . . . 33.2 t70 -109.27 119.84 40.7 Favored 'General case' 0 C--N 1.294 -1.833 0 N-CA-C 109.444 -0.576 . . . . 0.87 109.444 176.723 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A 1631 ' ' LYS . . . . . . . . . . . . . 30.1 mtpp -77.35 -24.93 50.63 Favored 'General case' 0 C--N 1.3 -1.564 0 CA-C-N 115.592 -0.731 . . . . 2.76 111.272 -175.913 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A 1632 ' ' GLN . . . . . . . . . . . . . 39.6 mt-30 -68.57 -44.52 74.26 Favored 'General case' 0 CA--C 1.515 -0.381 0 CA-C-O 121.397 0.618 . . . . 2.55 110.519 -176.317 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A 1633 ' ' THR . . . . . . . . . . . . . 25.1 p -90.42 -4.4 57.04 Favored 'General case' 0 C--N 1.31 -1.146 0 CA-C-N 115.516 -0.765 . . . . 1.92 110.797 177.347 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A 1634 ' ' CYS . . . . . 0.49 ' O ' ' HA ' ' A' 1606 ' ' TYR . 29.3 m 56.98 41.97 26.9 Favored 'General case' 0 C--O 1.221 -0.41 0 CA-C-N 114.288 -1.324 . . . . 0.89 109.503 179.061 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A 1635 ' ' THR . . . . . . . . . . . . . 89.3 m -124.11 131.32 53.53 Favored 'General case' 0 N--CA 1.428 -1.537 0 CA-C-N 115.226 -0.897 . . . . 1.31 111.389 -173.217 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A 1636 ' ' LEU . . . . . 0.961 ' HG ' ' HG ' ' A' 1629 ' ' LEU . 5.2 mp -108.66 130.74 55.33 Favored 'General case' 0 N--CA 1.432 -1.353 0 N-CA-C 108.567 -0.901 . . . . 1.97 108.567 177.626 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A 1637 ' ' PHE . . . . . . . . . . . . . 94.3 m-85 -105.76 105.95 16.23 Favored 'General case' 0 C--N 1.308 -1.204 0 CA-C-O 121.069 0.461 . . . . 0.92 110.953 -177.489 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A 1638 ' ' PHE . . . . . . . . . . . . . 99.6 m-85 -100.79 148.0 25.42 Favored 'General case' 0 C--N 1.303 -1.416 0 N-CA-C 108.4 -0.963 . . . . 0.7 108.4 177.681 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A 1639 ' ' SER . . . . . . . . . . . . . 66.2 m -137.33 115.1 11.34 Favored 'General case' 0 C--N 1.281 -2.382 0 CA-C-O 121.445 0.64 . . . . 1.46 110.703 176.984 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A 1640 ' ' TRP . . . . . 0.583 ' HH2' HD21 ' A' 1532 ' ' LEU . 7.9 t90 -95.93 122.14 38.42 Favored 'General case' 0 N--CA 1.418 -2.05 0 N-CA-C 106.569 -1.641 . . . . 0.92 106.569 178.434 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A 1641 ' ' HIS . . . . . 0.758 ' HB3' ' HB2' ' A' 1615 ' ' ARG . 40.6 m80 -95.09 102.99 14.83 Favored 'General case' 0 C--N 1.285 -2.206 0 N-CA-C 107.633 -1.247 . . . . 3.18 107.633 178.206 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A 1642 ' ' THR . . . . . 0.648 ' O ' ' HA ' ' A' 1614 ' ' CYS . 8.9 t -142.42 140.2 18.62 Favored Pre-proline 0 C--N 1.297 -1.678 0 CA-C-N 115.45 -0.795 . . . . 1.48 111.21 -173.134 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A 1643 ' ' PRO . . . . . 0.416 ' HB3' ' HA ' ' A' 1616 ' ' PRO . 57.4 Cg_endo -71.46 -0.82 8.78 Favored 'Trans proline' 0 CA--C 1.534 0.494 0 C-N-CA 123.621 2.881 . . . . 1.09 112.451 176.865 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A 1644 ' ' LEU . . . . . . . . . . . . . 77.5 mt -85.4 -4.33 59.13 Favored 'General case' 0 C--N 1.322 -0.613 0 C-N-CA 122.62 0.368 . . . . 2.08 111.113 -179.085 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A 1645 ' ' ALA . . . . . . . . . . . . . . . -88.84 -13.87 38.26 Favored 'General case' 0 C--N 1.319 -0.725 0 N-CA-C 111.984 0.364 . . . . 1.37 111.984 -178.129 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A 1646 ' ' CYS . . . . . . . . . . . . . 14.3 p -148.02 -177.04 5.52 Favored 'General case' 0 C--N 1.304 -1.386 0 N-CA-C 107.137 -1.431 . . . . 1.7 107.137 -179.27 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A 1647 ' ' GLU . . . . . . . . . . . . . 9.8 tp10 -113.77 99.52 50.22 Favored Pre-proline 0 N--CA 1.428 -1.526 0 N-CA-C 107.891 -1.151 . . . . 2.92 107.891 174.643 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A 1648 ' ' PRO . . . . . . . . . . . . . 97.4 Cg_exo -47.78 112.45 0.57 Allowed 'Trans proline' 0 C--N 1.354 0.827 0 C-N-CA 124.014 3.143 . . . . 3.19 112.776 179.293 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A 1649 ' ' GLU . . . . . . . . . . . . . 44.3 tt0 . . . . . 0 C--N 1.292 -1.925 0 N-CA-C 107.927 -1.138 . . . . 5.06 107.927 -179.661 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A 1508 ' ' MET . . . . . . . . . . . . . 72.4 mtm . . . . . 0 C--O 1.24 0.581 0 CA-C-O 120.962 0.411 . . . . 8.58 110.515 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A 1509 ' ' LYS . . . . . . . . . . . . . 95.5 mttt -128.18 124.76 37.6 Favored 'General case' 0 N--CA 1.441 -0.888 0 N-CA-C 109.685 -0.487 . . . . 6.8 109.685 178.351 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A 1510 ' ' SER . . . . . . . . . . . . . 32.1 m -99.62 104.1 15.85 Favored 'General case' 0 C--N 1.294 -1.843 0 N-CA-C 108.345 -0.983 . . . . 4.48 108.345 178.702 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A 1511 ' ' ASN . . . . . . . . . . . . . 31.8 p30 -142.76 6.45 1.61 Allowed 'General case' 0 C--N 1.306 -1.285 0 CA-C-N 116.262 -0.426 . . . . 3.08 112.137 -177.615 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A 1512 ' ' GLU . . . . . . . . . . . . . 9.3 tp10 -67.45 -45.69 75.27 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 109.171 -0.677 . . . . 4.46 109.171 179.679 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A 1513 ' ' HIS . . . . . 0.416 ' HA ' ' O ' ' A' 1579 ' ' LYS . 51.4 m80 -121.91 -8.55 8.87 Favored 'General case' 0 C--N 1.313 -0.986 0 CA-C-N 115.885 -0.598 . . . . 6.25 111.017 176.952 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A 1514 ' ' ASP . . . . . . . . . . . . . 4.8 m-20 -92.28 -20.01 21.57 Favored 'General case' 0 C--N 1.311 -1.099 0 N-CA-C 114.028 1.122 . . . . 3.7 114.028 -173.197 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A 1515 ' ' ASP . . . . . . . . . . . . . 4.1 t70 -143.99 -174.97 4.42 Favored 'General case' 0 C--N 1.301 -1.535 0 C-N-CA 119.189 -1.004 . . . . 2.54 108.548 -176.208 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A 1516 ' ' CYS . . . . . . . . . . . . . 52.0 m -115.67 44.56 1.86 Allowed 'General case' 0 C--N 1.29 -2.007 0 N-CA-C 108.35 -0.982 . . . . 1.25 108.35 -176.811 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A 1517 ' ' GLN . . . . . . . . . . . . . 10.6 pt20 -148.47 138.07 22.12 Favored 'General case' 0 N--CA 1.433 -1.282 0 C-N-CA 120.79 -0.364 . . . . 2.36 111.054 -176.948 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A 1518 ' ' VAL . . . . . . . . . . . . . 29.4 m -113.87 154.06 15.31 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.668 0 CA-C-N 115.744 -0.662 . . . . 2.34 109.945 179.551 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A 1519 ' ' THR . . . . . 0.511 ' HA ' ' HA ' ' A' 1526 ' ' LEU . 32.0 m -119.61 137.76 53.66 Favored 'General case' 0 C--N 1.277 -2.544 0 N-CA-C 109.037 -0.727 . . . . 2.04 109.037 177.354 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A 1520 ' ' ASN . . . . . . . . . . . . . 38.3 t-20 -93.78 101.61 6.41 Favored Pre-proline 0 C--N 1.315 -0.895 0 N-CA-C 107.416 -1.327 . . . . 2.12 107.416 175.139 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A 1521 ' ' PRO . . . . . 0.455 ' HD3' ' O ' ' A' 1519 ' ' THR . 23.4 Cg_exo -65.71 -14.07 42.91 Favored 'Trans proline' 0 C--N 1.36 1.165 0 C-N-CA 123.205 2.603 . . . . 2.59 113.802 -176.772 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A 1522 ' ' SER . . . . . . . . . . . . . 33.3 t -71.24 -38.39 71.95 Favored 'General case' 0 N--CA 1.439 -0.977 0 N-CA-C 109.746 -0.464 . . . . 2.65 109.746 178.759 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A 1523 ' ' THR . . . . . . . . . . . . . 7.2 t -112.37 -16.53 12.91 Favored 'General case' 0 C--N 1.317 -0.827 0 N-CA-C 112.766 0.654 . . . . 2.33 112.766 -177.116 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A 1524 ' ' GLY . . . . . . . . . . . . . . . 81.66 14.54 77.77 Favored Glycine 0 C--O 1.229 -0.172 0 C-N-CA 120.984 -0.627 . . . . 1.96 111.591 -178.764 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A 1525 ' ' HIS . . . . . . . . . . . . . 32.5 t-80 -101.45 131.99 47.28 Favored 'General case' 0 C--N 1.306 -1.318 0 CA-C-O 121.077 0.465 . . . . 2.44 110.187 -178.925 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A 1526 ' ' LEU . . . . . 0.511 ' HA ' ' HA ' ' A' 1519 ' ' THR . 7.8 tt -101.52 143.37 31.6 Favored 'General case' 0 C--N 1.289 -2.038 0 CA-C-N 115.329 -0.851 . . . . 2.19 110.211 -178.166 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A 1527 ' ' PHE . . . . . 0.402 ' HE1' ' HG3' ' A' 1647 ' ' GLU . 80.0 m-85 -118.09 113.08 21.07 Favored 'General case' 0 C--N 1.312 -1.032 0 N-CA-C 107.291 -1.374 . . . . 1.61 107.291 176.524 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A 1528 ' ' ASP . . . . . . . . . . . . . 1.3 p-10 -104.79 141.61 36.19 Favored 'General case' 0 C--N 1.297 -1.714 0 CA-C-O 121.955 0.883 . . . . 2.18 110.938 -178.441 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A 1529 ' ' LEU . . . . . . . . . . . . . 75.7 mt -114.16 11.19 17.48 Favored 'General case' 0 C--N 1.287 -2.13 0 N-CA-C 105.7 -1.963 . . . . 2.04 105.7 173.253 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A 1530 ' ' SER . . . . . . . . . . . . . 5.5 m -73.44 -37.32 65.88 Favored 'General case' 0 N--CA 1.43 -1.435 0 CA-C-N 114.166 -1.379 . . . . 1.44 109.323 -178.977 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A 1531 ' ' SER . . . . . . . . . . . . . 12.8 m -79.85 -7.95 59.01 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-O 121.466 0.651 . . . . 1.63 109.33 175.324 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A 1532 ' ' LEU . . . . . . . . . . . . . 92.8 mt -106.83 9.15 31.01 Favored 'General case' 0 N--CA 1.448 -0.565 0 CA-C-N 115.669 -0.696 . . . . 2.32 110.514 177.017 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A 1533 ' ' SER . . . . . . . . . . . . . 66.0 m -70.94 107.52 4.1 Favored 'General case' 0 N--CA 1.437 -1.081 0 CA-C-O 121.733 0.778 . . . . 2.57 111.577 -175.447 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A 1534 ' ' GLY . . . . . . . . . . . . . . . -103.23 103.0 2.3 Favored Glycine 0 N--CA 1.423 -2.202 0 N-CA-C 109.632 -1.387 . . . . 1.89 109.632 176.607 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A 1535 ' ' ARG . . . . . . . . . . . . . 71.4 ttt180 -79.27 -20.66 47.55 Favored 'General case' 0 C--O 1.205 -1.257 0 O-C-N 124.205 0.591 . . . . 4.44 111.114 -176.732 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A 1536 ' ' ALA . . . . . . . . . . . . . . . -90.59 -3.21 57.72 Favored 'General case' 0 C--N 1.309 -1.166 0 C-N-CA 119.643 -0.823 . . . . 2.07 109.39 178.979 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A 1537 ' ' GLY . . . . . 0.439 ' HA2' ' HA ' ' A' 1551 ' ' SER . . . 79.13 166.07 30.85 Favored Glycine 0 N--CA 1.423 -2.214 0 CA-C-N 114.855 -1.066 . . . . 1.2 113.123 177.932 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A 1538 ' ' PHE . . . . . . . . . . . . . 97.1 m-85 -133.73 163.43 29.48 Favored 'General case' 0 C--N 1.297 -1.678 0 N-CA-C 107.472 -1.307 . . . . 1.98 107.472 176.507 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A 1539 ' ' THR . . . . . 0.521 ' HA ' ' O ' ' A' 1548 ' ' VAL . 59.4 p -118.06 157.73 26.31 Favored 'General case' 0 C--N 1.303 -1.422 0 N-CA-C 113.335 0.865 . . . . 1.97 113.335 -172.315 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A 1540 ' ' ALA . . . . . . . . . . . . . . . -142.55 146.13 34.32 Favored 'General case' 0 C--O 1.25 1.131 0 N-CA-C 106.685 -1.598 . . . . 1.39 106.685 173.628 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A 1541 ' ' ALA . . . . . . . . . . . . . . . -65.05 131.65 47.14 Favored 'General case' 0 C--O 1.247 0.952 0 O-C-N 124.222 0.951 . . . . 1.86 110.611 -178.571 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A 1542 ' ' TYR . . . . . . . . . . . . . 81.0 t80 -143.34 171.14 14.52 Favored 'General case' 0 C--N 1.3 -1.585 0 CA-C-N 115.427 -0.806 . . . . 2.4 109.343 -177.264 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A 1543 ' ' SER . . . . . . . . . . . . . 14.0 m -44.28 -151.62 0.0 OUTLIER 'General case' 0 CA--C 1.581 2.165 0 C-N-CA 129.728 3.211 . . . . 2.58 114.961 176.327 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A 1544 ' ' LYS . . . . . . . . . . . . . 39.9 ttmt -36.03 -39.24 0.16 Allowed 'General case' 0 CA--C 1.568 1.665 0 C-N-CA 125.217 1.407 . . . . 4.24 114.143 178.149 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A 1545 ' ' SER . . . . . . . . . . . . . 48.3 t -66.45 -21.73 66.2 Favored 'General case' 0 CA--C 1.56 1.332 0 N-CA-C 112.329 0.492 . . . . 3.6 112.329 177.462 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A 1546 ' ' GLY . . . . . . . . . . . . . . . 88.75 -63.8 3.51 Favored Glycine 0 CA--C 1.492 -1.345 0 N-CA-C 111.455 -0.658 . . . . 1.66 111.455 179.999 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A 1547 ' ' VAL . . . . . . . . . . . . . 13.3 m -140.58 157.87 24.22 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.416 0 C-N-CA 123.205 0.602 . . . . 2.23 109.874 178.318 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A 1548 ' ' VAL . . . . . 0.521 ' O ' ' HA ' ' A' 1539 ' ' THR . 5.7 t -111.98 142.7 23.55 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.28 0 N-CA-C 106.598 -1.63 . . . . 1.59 106.598 176.388 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A 1549 ' ' TYR . . . . . 0.496 ' CD2' ' HA2' ' A' 1568 ' ' GLY . 62.2 m-85 -98.4 114.91 27.43 Favored 'General case' 0 C--N 1.31 -1.152 0 N-CA-C 108.08 -1.082 . . . . 1.58 108.08 173.509 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A 1550 ' ' MET . . . . . . . . . . . . . 65.4 mtm -128.6 133.15 48.23 Favored 'General case' 0 C--N 1.299 -1.603 0 N-CA-C 109.448 -0.575 . . . . 2.08 109.448 176.543 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A 1551 ' ' SER . . . . . 0.439 ' HA ' ' HA2' ' A' 1537 ' ' GLY . 23.8 p -86.3 147.8 25.9 Favored 'General case' 0 C--N 1.289 -2.048 0 N-CA-C 106.658 -1.608 . . . . 1.9 106.658 175.983 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A 1552 ' ' ILE . . . . . . . . . . . . . 35.7 mm -76.41 -29.72 19.0 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.978 0 N-CA-C 108.77 -0.826 . . . . 2.04 108.77 -178.706 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A 1553 ' ' CYS . . . . . 0.475 ' HA ' ' HH ' ' A' 1592 ' ' TYR . 38.2 t -162.94 138.38 6.82 Favored 'General case' 0 N--CA 1.432 -1.344 0 N-CA-C 107.519 -1.289 . . . . 1.43 107.519 169.398 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A 1554 ' ' GLY . . . . . . . . . . . . . . . 96.13 -164.93 23.81 Favored Glycine 0 N--CA 1.438 -1.205 0 C-N-CA 120.781 -0.724 . . . . 1.23 112.802 176.05 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A 1555 ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -76.43 156.17 33.34 Favored 'General case' 0 C--N 1.312 -1.046 0 C-N-CA 122.622 0.369 . . . . 1.8 110.028 -179.734 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A 1556 ' ' ASN . . . . . 0.437 HD22 ' HB3' ' A' 1549 ' ' TYR . 27.5 t-20 -98.31 -17.66 18.77 Favored 'General case' 0 CA--C 1.548 0.874 0 N-CA-C 113.413 0.894 . . . . 2.63 113.413 -173.719 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A 1557 ' ' GLU . . . . . . . . . . . . . 30.1 mt-10 65.66 -24.04 0.09 Allowed 'General case' 0 N--CA 1.492 1.656 0 N-CA-C 115.376 1.621 . . . . 3.79 115.376 179.738 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A 1558 ' ' ASN . . . . . . . . . . . . . 38.6 m-80 -75.64 -21.4 57.75 Favored 'General case' 0 CA--C 1.503 -0.834 0 CA-C-O 121.731 0.777 . . . . 1.59 109.11 177.133 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A 1559 ' ' CYS . . . . . . . . . . . . . 73.4 m -135.05 158.38 74.98 Favored Pre-proline 0 N--CA 1.423 -1.802 0 N-CA-C 106.66 -1.608 . . . . 0.94 106.66 176.731 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A 1560 ' ' PRO . . . . . 0.423 ' HA ' ' HD3' ' A' 1561 ' ' PRO . 3.0 Cg_exo -32.82 145.52 0.03 OUTLIER 'Trans proline' 0 CA--C 1.561 1.832 1 C-N-CA 125.859 4.373 . . . . 1.53 117.014 -176.186 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A 1561 ' ' PRO . . . . . 0.423 ' HD3' ' HA ' ' A' 1560 ' ' PRO . 42.5 Cg_exo -59.37 115.08 2.34 Favored 'Trans proline' 0 C--O 1.245 0.834 0 C-N-CA 123.43 2.753 . . . . 1.82 110.421 176.827 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A 1562 ' ' GLY . . . . . . . . . . . . . . . 121.79 -11.42 9.49 Favored Glycine 0 N--CA 1.426 -1.974 0 N-CA-C 110.174 -1.17 . . . . 0.81 110.174 -176.086 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A 1563 ' ' VAL . . . . . . . . . . . . . 66.2 t -99.29 133.88 40.42 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.275 0 N-CA-C 108.005 -1.109 . . . . 1.73 108.005 176.224 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A 1564 ' ' GLY . . . . . . . . . . . . . . . -114.54 -34.53 1.56 Allowed Glycine 0 N--CA 1.443 -0.89 0 C-N-CA 120.916 -0.659 . . . . 0.72 111.78 -179.319 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A 1565 ' ' ALA . . . . . . . . . . . . . . . -123.09 121.08 35.14 Favored 'General case' 0 C--O 1.249 1.043 0 N-CA-C 108.871 -0.789 . . . . 1.14 108.871 -179.753 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A 1566 ' ' CYS . . . . . . . . . . . . . 38.6 t -146.45 140.88 26.58 Favored 'General case' 0 C--N 1.297 -1.709 0 N-CA-C 108.964 -0.754 . . . . 0.51 108.964 -173.953 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A 1567 ' ' PHE . . . . . 0.462 ' O ' ' HA ' ' A' 1571 ' ' ARG . 16.3 m-85 -63.23 132.76 52.75 Favored 'General case' 0 C--O 1.21 -1.01 0 N-CA-C 108.518 -0.919 . . . . 1.22 108.518 177.174 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A 1568 ' ' GLY . . . . . 0.496 ' HA2' ' CD2' ' A' 1549 ' ' TYR . . . -68.99 -36.0 80.21 Favored Glycine 0 N--CA 1.435 -1.387 0 CA-C-N 115.752 -0.658 . . . . 1.08 114.622 -174.164 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A 1569 ' ' GLN . . . . . . . . . . . . . 36.1 tt0 -90.44 -53.89 4.24 Favored 'General case' 0 C--N 1.303 -1.43 0 CA-C-O 121.671 0.748 . . . . 3.05 110.261 -179.393 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A 1570 ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -74.96 -20.06 59.84 Favored 'General case' 0 C--N 1.298 -1.641 0 CA-C-N 114.836 -1.075 . . . . 2.44 112.783 -172.971 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A 1571 ' ' ARG . . . . . 0.462 ' HA ' ' O ' ' A' 1567 ' ' PHE . 50.8 mtp180 54.36 36.37 25.22 Favored 'General case' 0 CA--C 1.51 -0.58 0 C-N-CA 125.814 1.646 . . . . 4.48 113.589 179.633 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A 1572 ' ' ILE . . . . . . . . . . . . . 43.6 mm -94.96 123.89 47.26 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.286 0 N-CA-C 108.893 -0.78 . . . . 1.94 108.893 178.079 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A 1573 ' ' SER . . . . . . . . . . . . . 31.5 t -65.44 95.71 0.22 Allowed 'General case' 0 C--N 1.307 -1.266 0 C-N-CA 125.309 1.444 . . . . 1.25 111.207 179.94 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A 1574 ' ' VAL . . . . . 0.492 ' O ' ' HA3' ' A' 1595 ' ' GLY . 27.6 m -88.17 -30.94 5.55 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.871 0 N-CA-C 112.327 0.491 . . . . 1.61 112.327 179.099 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A 1575 ' ' GLY . . . . . . . . . . . . . . . -136.58 132.25 5.98 Favored Glycine 0 C--O 1.246 0.85 0 C-N-CA 120.858 -0.687 . . . . 0.65 112.177 179.816 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A 1576 ' ' LYS . . . . . 0.586 ' HG2' ' HA2' ' A' 1595 ' ' GLY . 75.5 mmtt -88.77 149.37 23.47 Favored 'General case' 0 C--N 1.312 -1.049 0 N-CA-C 109.859 -0.423 . . . . 3.33 109.859 -179.894 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A 1577 ' ' ALA . . . . . . . . . . . . . . . -67.07 98.87 0.61 Allowed 'General case' 0 C--N 1.307 -1.278 0 C-N-CA 123.976 0.91 . . . . 1.31 110.913 -178.195 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A 1578 ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -113.49 120.34 40.67 Favored 'General case' 0 C--N 1.306 -1.299 0 N-CA-C 108.504 -0.925 . . . . 2.24 108.504 177.261 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A 1579 ' ' LYS . . . . . 0.416 ' O ' ' HA ' ' A' 1513 ' ' HIS . 48.9 mtmt -90.96 90.55 7.93 Favored 'General case' 0 C--N 1.307 -1.254 0 N-CA-C 107.294 -1.372 . . . . 2.34 107.294 177.621 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A 1580 ' ' ARG . . . . . . . . . . . . . 17.7 ttp180 -165.84 110.98 0.85 Allowed 'General case' 0 C--N 1.309 -1.192 0 CA-C-N 115.309 -0.859 . . . . 4.19 110.246 -175.216 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A 1581 ' ' LEU . . . . . . . . . . . . . 3.9 mm? -101.77 137.28 40.29 Favored 'General case' 0 C--N 1.316 -0.877 0 CA-C-N 115.888 -0.596 . . . . 2.39 109.563 178.592 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A 1582 ' ' ARG . . . . . . . . . . . . . 90.4 mtt180 -108.68 98.31 7.83 Favored 'General case' 0 C--N 1.291 -1.957 0 CA-C-N 116.374 -0.375 . . . . 4.48 110.254 177.057 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A 1583 ' ' TYR . . . . . . . . . . . . . 92.8 t80 -79.84 110.13 14.92 Favored 'General case' 0 C--N 1.311 -1.098 0 CA-C-N 115.477 -0.783 . . . . 1.57 109.153 -179.615 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A 1584 ' ' VAL . . . . . 0.595 ' O ' HG13 ' A' 1587 ' ' VAL . 3.9 p -148.36 126.4 3.24 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.419 0 CA-C-N 116.17 -0.468 . . . . 2.29 110.076 179.703 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A 1585 ' ' ASP . . . . . . . . . . . . . 38.4 t70 54.34 44.65 28.64 Favored 'General case' 0 N--CA 1.484 1.244 0 CA-C-O 122.748 1.261 . . . . 2.06 109.951 -177.894 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A 1586 ' ' GLN . . . . . . . . . . . . . 48.4 mt-30 59.79 18.41 7.29 Favored 'General case' 0 CA--C 1.539 0.545 0 CA-C-N 113.632 -1.622 . . . . 2.61 114.32 179.141 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A 1587 ' ' VAL . . . . . 0.595 HG13 ' O ' ' A' 1584 ' ' VAL . 4.0 p -103.78 139.64 24.16 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.146 0 N-CA-C 108.568 -0.901 . . . . 1.33 108.568 176.733 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A 1588 ' ' LEU . . . . . 0.72 ' HB2' ' HB2' ' A' 1612 ' ' PHE . 41.1 mt -94.27 123.83 37.91 Favored 'General case' 0 C--N 1.296 -1.732 0 N-CA-C 106.187 -1.783 . . . . 2.03 106.187 174.179 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A 1589 ' ' GLN . . . . . . . . . . . . . 9.8 tt0 -122.4 112.96 18.72 Favored 'General case' 0 C--N 1.281 -2.398 0 CA-C-N 116.398 -0.365 . . . . 1.73 110.094 -173.864 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A 1590 ' ' LEU . . . . . 0.412 ' HB3' ' HB ' ' A' 1610 ' ' ILE . 32.8 tp -100.7 116.48 32.71 Favored 'General case' 0 C--N 1.299 -1.59 0 N-CA-C 107.078 -1.452 . . . . 1.76 107.078 -179.659 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A 1591 ' ' VAL . . . . . . . . . . . . . 15.4 m -106.94 94.82 3.33 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.565 0 N-CA-C 113.803 1.038 . . . . 2.14 113.803 -174.884 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A 1592 ' ' TYR . . . . . 0.475 ' HH ' ' HA ' ' A' 1553 ' ' CYS . 14.7 m-30 -86.5 92.92 9.02 Favored 'General case' 0 C--N 1.312 -1.035 0 N-CA-C 107.811 -1.181 . . . . 1.53 107.811 173.435 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A 1593 ' ' LYS . . . . . . . . . . . . . 14.6 ptmm? -115.43 175.08 5.68 Favored 'General case' 0 C--N 1.293 -1.868 0 CA-C-N 115.951 -0.568 . . . . 2.72 111.588 -174.874 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A 1594 ' ' ASP . . . . . . . . . . . . . 8.9 m-20 62.86 31.32 16.41 Favored 'General case' 0 CA--C 1.509 -0.613 0 O-C-N 124.17 0.919 . . . . 1.45 112.154 -178.799 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A 1595 ' ' GLY . . . . . 0.586 ' HA2' ' HG2' ' A' 1576 ' ' LYS . . . -78.58 -84.93 0.54 Allowed Glycine 0 N--CA 1.435 -1.402 0 C-N-CA 120.855 -0.688 . . . . 0.83 112.624 -178.004 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A 1596 ' ' SER . . . . . . . . . . . . . 14.4 t -101.58 145.17 29.98 Favored Pre-proline 0 C--N 1.293 -1.87 0 N-CA-C 108.498 -0.927 . . . . 1.96 108.498 -177.75 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A 1597 ' ' PRO . . . . . . . . . . . . . 24.2 Cg_exo -67.99 131.78 24.73 Favored 'Trans proline' 0 C--O 1.238 0.5 0 C-N-CA 122.785 2.323 . . . . 1.34 110.371 175.252 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A 1598 ' ' CYS . . . . . 0.687 ' HA ' ' HE1' ' A' 1606 ' ' TYR . 40.6 t -95.09 123.09 58.35 Favored Pre-proline 0 C--N 1.304 -1.392 0 CA-C-O 120.767 0.318 . . . . 1.19 110.476 -176.634 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A 1599 ' ' PRO . . . . . . . . . . . . . 91.2 Cg_endo -88.44 -9.36 5.02 Favored 'Trans proline' 0 N--CA 1.454 -0.851 0 C-N-CA 122.798 2.332 . . . . 1.88 112.913 179.799 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A 1600 ' ' SER . . . . . . . . . . . . . 14.9 m -70.31 -21.87 62.88 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-O 121.101 0.477 . . . . 2.19 110.77 -177.795 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A 1601 ' ' LYS . . . . . 0.909 ' HB3' HD12 ' A' 1604 ' ' LEU . 25.7 tptp -161.0 132.08 5.43 Favored 'General case' 0 N--CA 1.43 -1.444 0 N-CA-C 106.257 -1.757 . . . . 4.21 106.257 178.429 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A 1602 ' ' SER . . . . . . . . . . . . . 16.4 m -73.34 126.82 31.02 Favored 'General case' 0 C--N 1.307 -1.249 0 CA-C-O 120.884 0.373 . . . . 3.82 110.268 -176.763 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A 1603 ' ' GLY . . . . . . . . . . . . . . . 102.87 22.0 9.78 Favored Glycine 0 C--N 1.303 -1.256 0 N-CA-C 110.301 -1.12 . . . . 2.45 110.301 -179.358 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A 1604 ' ' LEU . . . . . 0.909 HD12 ' HB3' ' A' 1601 ' ' LYS . 6.1 mt -124.83 152.54 43.8 Favored 'General case' 0 C--N 1.3 -1.548 0 CA-C-O 121.801 0.81 . . . . 2.06 112.259 -179.554 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A 1605 ' ' SER . . . . . . . . . . . . . 50.1 m -128.29 177.67 6.79 Favored 'General case' 0 C--N 1.281 -2.399 0 N-CA-C 106.313 -1.736 . . . . 1.75 106.313 174.613 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A 1606 ' ' TYR . . . . . 0.687 ' HE1' ' HA ' ' A' 1598 ' ' CYS . 7.0 m-85 -98.9 140.36 33.19 Favored 'General case' 0 CA--C 1.459 -2.557 0 N-CA-C 105.682 -1.97 . . . . 1.59 105.682 -179.115 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A 1607 ' ' LYS . . . . . . . . . . . . . 23.3 pttm -133.09 137.45 46.36 Favored 'General case' 0 N--CA 1.391 -3.382 0 C-N-CA 119.21 -0.996 . . . . 2.21 110.127 176.718 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A 1608 ' ' SER . . . . . . . . . . . . . 14.6 m -107.08 110.02 22.03 Favored 'General case' 0 C--N 1.29 -2.02 0 N-CA-C 108.11 -1.07 . . . . 1.48 108.11 178.612 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A 1609 ' ' VAL . . . . . . . . . . . . . 98.3 t -102.04 102.82 14.08 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.256 0 CA-C-O 121.118 0.485 . . . . 1.57 110.481 -177.923 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A 1610 ' ' ILE . . . . . 0.412 ' HB ' ' HB3' ' A' 1590 ' ' LEU . 2.6 mp -90.78 115.31 29.77 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.361 0 N-CA-C 108.252 -1.018 . . . . 1.47 108.252 179.243 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A 1611 ' ' SER . . . . . 0.501 ' O ' ' HA ' ' A' 1639 ' ' SER . 16.9 m -107.13 122.4 46.42 Favored 'General case' 0 C--N 1.295 -1.789 0 CA-C-O 121.26 0.552 . . . . 1.84 110.666 -178.152 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A 1612 ' ' PHE . . . . . 0.72 ' HB2' ' HB2' ' A' 1588 ' ' LEU . 84.5 m-85 -88.38 109.78 20.27 Favored 'General case' 0 C--N 1.298 -1.666 0 N-CA-C 108.134 -1.062 . . . . 0.86 108.134 177.391 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A 1613 ' ' VAL . . . . . . . . . . . . . 58.2 t -102.01 126.2 56.06 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.414 0 CA-C-N 115.632 -0.713 . . . . 1.32 110.216 -173.781 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A 1614 ' ' CYS . . . . . . . . . . . . . 57.9 m -59.63 95.68 0.03 OUTLIER 'General case' 0 C--O 1.244 0.764 0 C-N-CA 124.427 1.091 . . . . 1.39 111.302 179.771 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A 1615 ' ' ARG . . . . . 0.433 ' C ' ' H ' ' A' 1617 ' ' GLU . 17.0 mmt180 -137.28 102.17 9.0 Favored Pre-proline 0 C--N 1.294 -1.824 0 CA-C-N 115.112 -0.949 . . . . 4.34 108.744 177.725 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A 1616 ' ' PRO . . . . . 0.444 ' HA ' ' HB3' ' A' 1643 ' ' PRO . 52.6 Cg_exo -61.2 10.36 0.07 OUTLIER 'Trans proline' 0 N--CA 1.493 1.479 0 C-N-CA 124.707 3.605 . . . . 1.5 115.137 -179.189 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A 1617 ' ' GLU . . . . . 0.433 ' H ' ' C ' ' A' 1615 ' ' ARG . 34.0 mt-10 -68.35 -25.67 65.21 Favored 'General case' 0 C--O 1.243 0.726 0 C-N-CA 123.501 0.72 . . . . 3.21 109.647 178.209 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A 1618 ' ' ALA . . . . . . . . . . . . . . . 64.64 -172.94 0.18 Allowed 'General case' 0 C--O 1.239 0.5 0 CA-C-N 113.44 -1.709 . . . . 2.91 111.328 178.385 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A 1619 ' ' GLY . . . . . . . . . . . . . . . 122.31 103.52 1.75 Allowed Glycine 0 N--CA 1.422 -2.297 0 N-CA-C 110.874 -0.89 . . . . 3.35 110.874 179.446 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A 1620 ' ' PRO . . . . . 0.405 ' HA ' ' HZ2' ' A' 1640 ' ' TRP . 34.3 Cg_endo -65.12 -10.74 26.85 Favored 'Trans proline' 0 CA--C 1.539 0.737 0 C-N-CA 123.03 2.487 . . . . 6.61 113.276 -177.976 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A 1621 ' ' THR . . . . . . . . . . . . . 12.8 m -130.97 16.67 5.15 Favored 'General case' 0 CA--C 1.558 1.258 0 N-CA-C 108.072 -1.084 . . . . 5.03 108.072 177.083 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A 1622 ' ' ASN . . . . . . . . . . . . . 54.9 t30 -86.11 60.34 6.17 Favored 'General case' 0 C--O 1.248 0.989 0 CA-C-O 122.441 1.115 . . . . 3.58 111.935 -175.686 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A 1623 ' ' ARG . . . . . 0.509 ' HB3' ' CG ' ' A' 1640 ' ' TRP . 6.0 ptt180 -130.14 74.11 80.74 Favored Pre-proline 0 C--N 1.306 -1.321 0 CA-C-N 115.082 -0.963 . . . . 4.09 112.765 -177.326 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A 1624 ' ' PRO . . . . . . . . . . . . . 54.9 Cg_endo -111.01 90.9 0.02 OUTLIER 'Trans proline' 0 N--CA 1.42 -2.843 0 C-N-CA 121.306 1.338 . . . . 2.86 109.519 169.177 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A 1625 ' ' MET . . . . . 0.492 ' HB2' ' O ' ' A' 1639 ' ' SER . 10.7 mmt -151.54 98.27 2.49 Favored 'General case' 0 CA--C 1.491 -1.303 0 C-N-CA 120.022 -0.671 . . . . 2.73 112.695 178.02 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A 1626 ' ' LEU . . . . . . . . . . . . . 63.1 tp -92.02 101.04 13.58 Favored 'General case' 0 C--N 1.292 -1.919 0 N-CA-C 103.402 -2.814 . . . . 1.94 103.402 163.82 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A 1627 ' ' ILE . . . . . 0.458 HD12 ' HB3' ' A' 1637 ' ' PHE . 5.0 mt -68.64 -44.65 82.4 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.602 0 N-CA-C 108.499 -0.926 . . . . 1.75 108.499 -171.211 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A 1628 ' ' SER . . . . . . . . . . . . . 46.5 t -171.12 148.09 2.67 Favored 'General case' 0 N--CA 1.412 -2.373 0 N-CA-C 106.245 -1.761 . . . . 1.85 106.245 -179.572 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A 1629 ' ' LEU . . . . . 0.842 ' HG ' ' HG ' ' A' 1636 ' ' LEU . 5.1 tt -126.02 111.02 14.24 Favored 'General case' 0 C--N 1.281 -2.381 0 N-CA-C 105.238 -2.134 . . . . 2.12 105.238 173.916 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A 1630 ' ' ASP . . . . . . . . . . . . . 29.8 t70 -94.83 108.68 20.7 Favored 'General case' 0 C--N 1.283 -2.318 0 N-CA-C 108.954 -0.758 . . . . 0.87 108.954 -178.894 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A 1631 ' ' LYS . . . . . . . . . . . . . 65.6 mttp -71.26 -32.96 69.35 Favored 'General case' 0 C--N 1.309 -1.177 0 CA-C-N 115.586 -0.733 . . . . 2.76 112.656 -174.486 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A 1632 ' ' GLN . . . . . . . . . . . . . 9.1 pt20 -71.25 -28.74 64.38 Favored 'General case' 0 N--CA 1.467 0.419 0 N-CA-C 113.226 0.825 . . . . 2.55 113.226 -176.38 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A 1633 ' ' THR . . . . . 0.427 ' HA ' HD11 ' A' 1604 ' ' LEU . 71.8 p -106.31 -4.3 20.21 Favored 'General case' 0 C--N 1.319 -0.756 0 C-N-CA 119.908 -0.717 . . . . 1.92 110.674 175.08 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A 1634 ' ' CYS . . . . . . . . . . . . . 72.6 m 61.16 40.07 15.21 Favored 'General case' 0 C--O 1.237 0.412 0 CA-C-N 115.063 -0.972 . . . . 0.89 111.278 -178.455 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A 1635 ' ' THR . . . . . . . . . . . . . 30.9 m -105.69 122.42 46.03 Favored 'General case' 0 N--CA 1.433 -1.278 0 CA-C-N 115.387 -0.824 . . . . 1.31 110.028 -177.446 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A 1636 ' ' LEU . . . . . 0.842 ' HG ' ' HG ' ' A' 1629 ' ' LEU . 5.8 mp -108.44 124.87 51.08 Favored 'General case' 0 C--N 1.313 -0.982 0 N-CA-C 109.378 -0.601 . . . . 1.97 109.378 179.303 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A 1637 ' ' PHE . . . . . 0.458 ' HB3' HD12 ' A' 1627 ' ' ILE . 84.3 m-85 -107.55 126.72 52.89 Favored 'General case' 0 C--N 1.311 -1.092 0 N-CA-C 110.121 -0.326 . . . . 0.92 110.121 -178.674 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A 1638 ' ' PHE . . . . . 0.474 ' HA ' ' O ' ' A' 1625 ' ' MET . 93.4 m-85 -124.05 155.31 38.55 Favored 'General case' 0 C--N 1.32 -0.71 0 C-N-CA 122.6 0.36 . . . . 0.7 110.634 -179.495 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A 1639 ' ' SER . . . . . 0.501 ' HA ' ' O ' ' A' 1611 ' ' SER . 65.1 m -142.61 148.82 38.1 Favored 'General case' 0 C--O 1.249 1.063 0 N-CA-C 113.486 0.921 . . . . 1.46 113.486 174.621 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A 1640 ' ' TRP . . . . . 0.509 ' CG ' ' HB3' ' A' 1623 ' ' ARG . 8.1 t90 -122.05 135.4 54.82 Favored 'General case' 0 C--O 1.243 0.754 0 N-CA-C 106.859 -1.534 . . . . 0.92 106.859 176.053 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A 1641 ' ' HIS . . . . . . . . . . . . . 15.3 m-70 -80.51 92.78 5.94 Favored 'General case' 0 CA--C 1.509 -0.613 0 N-CA-C 107.818 -1.178 . . . . 3.18 107.818 177.596 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A 1642 ' ' THR . . . . . 0.473 ' HA ' ' HD3' ' A' 1643 ' ' PRO . 0.0 OUTLIER -128.63 130.5 23.5 Favored Pre-proline 0 C--N 1.304 -1.372 0 N-CA-C 112.852 0.686 . . . . 1.48 112.852 -174.248 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A 1643 ' ' PRO . . . . . 0.473 ' HD3' ' HA ' ' A' 1642 ' ' THR . 2.5 Cg_endo -81.66 -7.1 12.58 Favored 'Trans proline' 0 C--N 1.332 -0.302 0 C-N-CA 123.026 2.484 . . . . 1.09 111.323 177.008 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A 1644 ' ' LEU . . . . . . . . . . . . . 4.0 pp -89.14 3.94 50.19 Favored 'General case' 0 C--N 1.312 -1.046 0 CA-C-N 115.155 -0.93 . . . . 2.08 112.084 -179.369 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A 1645 ' ' ALA . . . . . . . . . . . . . . . -78.22 -43.07 29.41 Favored 'General case' 0 C--N 1.314 -0.967 0 CA-C-O 122.031 0.919 . . . . 1.37 108.791 175.56 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A 1646 ' ' CYS . . . . . . . . . . . . . 24.0 p -159.29 129.87 5.87 Favored 'General case' 0 N--CA 1.428 -1.557 0 N-CA-C 104.163 -2.532 . . . . 1.7 104.163 173.658 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A 1647 ' ' GLU . . . . . 0.402 ' HG3' ' HE1' ' A' 1527 ' ' PHE . 35.9 mt-10 -93.36 140.48 23.24 Favored Pre-proline 0 C--N 1.285 -2.196 0 C-N-CA 120.198 -0.601 . . . . 2.92 110.968 -169.298 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A 1648 ' ' PRO . . . . . . . . . . . . . 35.4 Cg_endo -68.09 101.92 0.74 Allowed 'Trans proline' 0 C--O 1.246 0.879 0 C-N-CA 122.682 2.255 . . . . 3.19 110.989 177.195 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A 1649 ' ' GLU . . . . . . . . . . . . . 42.9 mt-10 . . . . . 0 C--N 1.298 -1.669 0 CA-C-O 118.311 -0.852 . . . . 5.06 109.415 -178.212 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A 1508 ' ' MET . . . . . . . . . . . . . 25.7 ptt? . . . . . 0 CA--C 1.52 -0.195 0 CA-C-O 120.706 0.289 . . . . 8.58 110.639 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A 1509 ' ' LYS . . . . . . . . . . . . . 69.0 mttm -93.09 55.21 2.29 Favored 'General case' 0 N--CA 1.449 -0.494 0 O-C-N 121.909 -0.495 . . . . 6.8 111.765 -177.486 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A 1510 ' ' SER . . . . . . . . . . . . . 4.5 p -87.67 58.66 5.02 Favored 'General case' 0 C--N 1.303 -1.443 0 N-CA-C 106.892 -1.521 . . . . 4.48 106.892 176.216 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A 1511 ' ' ASN . . . . . . . . . . . . . 27.3 t-20 -140.78 -48.92 0.43 Allowed 'General case' 0 N--CA 1.425 -1.694 0 CA-C-N 113.888 -1.505 . . . . 3.08 111.527 -167.689 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A 1512 ' ' GLU . . . . . . . . . . . . . 45.0 mt-10 -47.12 -37.4 9.75 Favored 'General case' 0 N--CA 1.483 1.211 0 C-N-CA 125.135 1.374 . . . . 4.46 113.169 -174.225 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A 1513 ' ' HIS . . . . . . . . . . . . . 8.8 p-80 -134.77 25.41 3.67 Favored 'General case' 0 C--N 1.312 -1.045 0 CA-C-O 121.157 0.503 . . . . 6.25 110.119 177.03 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A 1514 ' ' ASP . . . . . . . . . . . . . 6.4 m-20 -124.18 -35.84 2.75 Favored 'General case' 0 C--N 1.305 -1.344 0 N-CA-C 112.564 0.579 . . . . 3.7 112.564 -176.561 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A 1515 ' ' ASP . . . . . . . . . . . . . 5.3 t70 -130.32 177.02 7.64 Favored 'General case' 0 C--N 1.323 -0.581 0 C-N-CA 119.791 -0.764 . . . . 2.54 109.807 -174.827 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A 1516 ' ' CYS . . . . . 0.582 ' SG ' ' HE3' ' A' 1579 ' ' LYS . 86.8 m -116.86 20.81 13.72 Favored 'General case' 0 C--N 1.302 -1.495 0 C-N-CA 124.088 0.955 . . . . 1.25 110.536 -176.116 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A 1517 ' ' GLN . . . . . . . . . . . . . 4.0 pt20 -109.69 126.24 53.48 Favored 'General case' 0 N--CA 1.422 -1.87 0 CA-C-N 115.523 -0.762 . . . . 2.36 109.169 177.737 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A 1518 ' ' VAL . . . . . 0.639 ' HB ' ' HB2' ' A' 1527 ' ' PHE . 59.3 t -93.45 127.82 45.27 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.233 0 N-CA-C 107.982 -1.118 . . . . 2.34 107.982 -179.962 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A 1519 ' ' THR . . . . . . . . . . . . . 11.3 m -115.02 117.83 31.69 Favored 'General case' 0 N--CA 1.417 -2.109 0 C-N-CA 120.369 -0.533 . . . . 2.04 109.917 -179.165 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A 1520 ' ' ASN . . . . . . . . . . . . . 41.8 t-20 -94.25 105.57 18.35 Favored Pre-proline 0 C--N 1.318 -0.794 0 N-CA-C 107.044 -1.465 . . . . 2.12 107.044 174.666 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A 1521 ' ' PRO . . . . . . . . . . . . . 21.2 Cg_exo -67.26 -21.78 47.42 Favored 'Trans proline' 0 C--N 1.351 0.672 0 C-N-CA 122.528 2.152 . . . . 2.59 113.663 -176.802 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A 1522 ' ' SER . . . . . . . . . . . . . 19.5 m -76.16 -40.1 53.34 Favored 'General case' 0 C--N 1.311 -1.108 0 N-CA-C 111.955 0.354 . . . . 2.65 111.955 -176.323 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A 1523 ' ' THR . . . . . 0.407 HG21 ' HB2' ' A' 1525 ' ' HIS . 14.4 t -107.01 -17.55 14.15 Favored 'General case' 0 CA--C 1.551 0.997 0 C-N-CA 119.525 -0.87 . . . . 2.33 111.268 179.418 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A 1524 ' ' GLY . . . . . . . . . . . . . . . 82.0 17.06 70.72 Favored Glycine 0 N--CA 1.45 -0.4 0 C-N-CA 121.171 -0.538 . . . . 1.96 112.093 -179.713 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A 1525 ' ' HIS . . . . . 0.407 ' HB2' HG21 ' A' 1523 ' ' THR . 7.3 t60 -84.19 135.08 34.51 Favored 'General case' 0 C--N 1.313 -0.999 0 N-CA-C 108.994 -0.743 . . . . 2.44 108.994 -177.672 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A 1526 ' ' LEU . . . . . . . . . . . . . 3.3 tm? -113.87 121.42 43.93 Favored 'General case' 0 C--N 1.3 -1.56 0 N-CA-C 108.415 -0.957 . . . . 2.19 108.415 -176.349 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A 1527 ' ' PHE . . . . . 0.639 ' HB2' ' HB ' ' A' 1518 ' ' VAL . 69.9 m-85 -104.2 116.12 31.61 Favored 'General case' 0 C--N 1.304 -1.395 0 N-CA-C 109.641 -0.503 . . . . 1.61 109.641 -178.601 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A 1528 ' ' ASP . . . . . 0.473 ' O ' HD11 ' A' 1532 ' ' LEU . 11.6 t70 -95.69 102.52 14.32 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-N 117.576 0.171 . . . . 2.18 110.782 -179.977 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A 1529 ' ' LEU . . . . . . . . . . . . . 6.4 mp -89.77 -7.58 54.11 Favored 'General case' 0 C--N 1.318 -0.785 0 CA-C-O 120.8 0.333 . . . . 2.04 111.777 179.305 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A 1530 ' ' SER . . . . . 0.441 ' OG ' ' HB2' ' A' 1516 ' ' CYS . 50.2 m -72.51 -48.54 39.7 Favored 'General case' 0 C--N 1.313 -0.993 0 CA-C-N 116.369 -0.378 . . . . 1.44 111.265 -178.108 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A 1531 ' ' SER . . . . . . . . . . . . . 8.2 m -70.4 -17.17 63.02 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 116.173 -0.467 . . . . 1.63 111.672 -175.993 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A 1532 ' ' LEU . . . . . 0.493 ' HB3' HG13 ' A' 1552 ' ' ILE . 9.8 mp -68.19 -13.72 62.44 Favored 'General case' 0 N--CA 1.466 0.35 0 CA-C-N 116.255 -0.429 . . . . 2.32 112.042 177.52 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A 1533 ' ' SER . . . . . . . . . . . . . 10.9 m -110.24 106.42 15.83 Favored 'General case' 0 N--CA 1.437 -1.105 0 N-CA-C 109.162 -0.681 . . . . 2.57 109.162 178.952 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A 1534 ' ' GLY . . . . . . . . . . . . . . . -92.21 -110.67 1.82 Allowed Glycine 0 N--CA 1.436 -1.312 0 C-N-CA 121.179 -0.534 . . . . 1.89 111.813 178.065 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A 1535 ' ' ARG . . . . . . . . . . . . . 42.8 ttm180 -95.61 -53.85 3.58 Favored 'General case' 0 C--N 1.31 -1.129 0 CA-C-O 121.081 0.467 . . . . 4.44 110.612 178.369 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A 1536 ' ' ALA . . . . . . . . . . . . . . . -96.64 -29.95 13.54 Favored 'General case' 0 C--N 1.316 -0.877 0 CA-C-O 121.044 0.449 . . . . 2.07 110.459 177.745 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A 1537 ' ' GLY . . . . . . . . . . . . . . . 70.69 -128.17 17.25 Favored Glycine 0 CA--C 1.499 -0.922 0 CA-C-N 115.515 -0.766 . . . . 1.2 112.166 178.278 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A 1538 ' ' PHE . . . . . 0.477 ' CD1' HD13 ' A' 1552 ' ' ILE . 29.8 m-85 -114.26 122.96 48.36 Favored 'General case' 0 CA--C 1.497 -1.074 0 N-CA-C 109.639 -0.504 . . . . 1.98 109.639 179.122 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A 1539 ' ' THR . . . . . . . . . . . . . 38.0 p -102.38 141.78 34.66 Favored 'General case' 0 C--N 1.286 -2.161 0 CA-C-N 115.454 -0.793 . . . . 1.97 111.329 -175.581 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A 1540 ' ' ALA . . . . . . . . . . . . . . . -118.79 159.03 24.46 Favored 'General case' 0 C--N 1.308 -1.213 0 N-CA-C 108.643 -0.873 . . . . 1.39 108.643 179.356 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A 1541 ' ' ALA . . . . . . . . . . . . . . . -99.48 141.5 32.19 Favored 'General case' 0 C--N 1.306 -1.313 0 CA-C-O 120.887 0.375 . . . . 1.86 111.231 -177.618 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A 1542 ' ' TYR . . . . . . . . . . . . . 76.7 t80 -141.68 177.57 8.06 Favored 'General case' 0 C--N 1.314 -0.95 0 N-CA-C 108.442 -0.947 . . . . 2.4 108.442 -178.415 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A 1543 ' ' SER . . . . . . . . . . . . . 5.3 m -45.91 -151.35 0.0 OUTLIER 'General case' 0 CA--C 1.578 2.034 0 C-N-CA 129.52 3.128 . . . . 2.58 114.259 177.14 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A 1544 ' ' LYS . . . . . . . . . . . . . 64.6 mttp -41.93 -32.87 0.47 Allowed 'General case' 0 N--CA 1.492 1.666 0 N-CA-C 115.064 1.505 . . . . 4.24 115.064 -177.678 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A 1545 ' ' SER . . . . . . . . . . . . . 6.0 t -67.29 -22.83 65.63 Favored 'General case' 0 CA--C 1.56 1.334 0 CA-C-N 117.877 0.308 . . . . 3.6 110.919 178.148 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A 1546 ' ' GLY . . . . . . . . . . . . . . . 88.6 -76.13 1.92 Allowed Glycine 0 N--CA 1.439 -1.105 0 C-N-CA 121.046 -0.597 . . . . 1.66 114.193 174.689 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A 1547 ' ' VAL . . . . . . . . . . . . . 88.2 t -122.87 144.3 32.82 Favored 'Isoleucine or valine' 0 N--CA 1.417 -2.098 0 C-N-CA 122.748 0.419 . . . . 2.23 110.108 -174.272 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A 1548 ' ' VAL . . . . . . . . . . . . . 10.7 t -113.09 136.06 50.62 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.308 0 N-CA-C 106.456 -1.683 . . . . 1.59 106.456 175.573 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A 1549 ' ' TYR . . . . . 0.522 ' CE2' ' HA2' ' A' 1568 ' ' GLY . 31.2 m-85 -91.63 146.91 23.4 Favored 'General case' 0 C--N 1.301 -1.508 0 N-CA-C 105.316 -2.105 . . . . 1.58 105.316 172.75 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A 1550 ' ' MET . . . . . . . . . . . . . 46.7 ttp -156.69 141.09 16.67 Favored 'General case' 0 C--N 1.292 -1.917 0 N-CA-C 109.12 -0.696 . . . . 2.08 109.12 -179.221 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A 1551 ' ' SER . . . . . . . . . . . . . 64.0 p -89.54 153.48 20.75 Favored 'General case' 0 N--CA 1.414 -2.274 0 N-CA-C 107.937 -1.134 . . . . 1.9 107.937 177.114 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A 1552 ' ' ILE . . . . . 0.493 HG13 ' HB3' ' A' 1532 ' ' LEU . 46.2 mm -83.97 -32.29 8.47 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.708 0 N-CA-C 107.595 -1.261 . . . . 2.04 107.595 178.627 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A 1553 ' ' CYS . . . . . 0.516 ' HA ' ' HH ' ' A' 1592 ' ' TYR . 36.6 t -162.44 137.62 7.01 Favored 'General case' 0 N--CA 1.43 -1.472 0 CA-C-N 115.547 -0.751 . . . . 1.43 109.125 165.836 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A 1554 ' ' GLY . . . . . . . . . . . . . . . 85.91 -124.39 6.84 Favored Glycine 0 CA--C 1.473 -2.549 0 N-CA-C 110.201 -1.16 . . . . 1.23 110.201 -178.641 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A 1555 ' ' GLU . . . . . 0.403 ' H ' ' CD ' ' A' 1555 ' ' GLU . 0.1 OUTLIER -117.93 -177.53 3.28 Favored 'General case' 0 C--N 1.258 -3.401 0 CA-C-N 113.538 -1.331 . . . . 1.8 108.516 -176.522 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A 1556 ' ' ASN . . . . . . . . . . . . . 41.3 t30 165.31 -158.91 0.0 OUTLIER 'General case' 0 C--O 1.255 1.365 0 N-CA-C 103.096 -2.927 . . . . 2.63 103.096 -174.209 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A 1557 ' ' GLU . . . . . 0.416 ' HG2' ' HB3' ' A' 1549 ' ' TYR . 26.0 mt-10 83.49 178.72 0.05 Allowed 'General case' 0 CA--C 1.497 -1.058 0 N-CA-C 115.814 1.783 . . . . 3.79 115.814 159.713 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A 1558 ' ' ASN . . . . . . . . . . . . . 33.2 m-80 -127.97 43.06 3.21 Favored 'General case' 0 C--N 1.307 -1.273 0 CA-C-N 113.358 -1.747 . . . . 1.59 107.948 -173.541 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A 1559 ' ' CYS . . . . . . . . . . . . . 84.2 m -131.85 172.37 7.48 Favored Pre-proline 0 C--N 1.293 -1.889 0 CA-C-N 113.666 -1.607 . . . . 0.94 106.885 -179.609 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A 1560 ' ' PRO . . . . . . . . . . . . . 99.7 Cg_exo -48.73 116.21 2.02 Favored 'Trans proline' 0 C--N 1.361 1.209 0 C-N-CA 122.177 1.918 . . . . 1.53 110.591 172.756 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A 1561 ' ' PRO . . . . . . . . . . . . . 12.4 Cg_endo -53.63 142.51 60.51 Favored 'Trans proline' 0 C--N 1.354 0.828 0 C-N-CA 124.35 3.367 . . . . 1.82 113.988 -172.854 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A 1562 ' ' GLY . . . . . . . . . . . . . . . 112.28 9.24 20.27 Favored Glycine 0 N--CA 1.437 -1.277 0 N-CA-C 110.687 -0.965 . . . . 0.81 110.687 -179.71 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A 1563 ' ' VAL . . . . . . . . . . . . . 4.8 m -99.66 154.23 4.27 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.838 0 N-CA-C 109.357 -0.609 . . . . 1.73 109.357 176.049 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A 1564 ' ' GLY . . . . . . . . . . . . . . . -115.94 -6.43 16.5 Favored Glycine 0 N--CA 1.421 -2.324 0 N-CA-C 110.36 -1.096 . . . . 0.72 110.36 175.408 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A 1565 ' ' ALA . . . . . . . . . . . . . . . -168.78 119.2 0.74 Allowed 'General case' 0 C--O 1.259 1.577 0 N-CA-C 108.969 -0.752 . . . . 1.14 108.969 -179.347 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A 1566 ' ' CYS . . . . . . . . . . . . . 35.8 t -141.72 141.29 33.27 Favored 'General case' 0 C--N 1.297 -1.686 0 CA-C-N 115.368 -0.833 . . . . 0.51 111.2 -174.064 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A 1567 ' ' PHE . . . . . . . . . . . . . 15.7 m-85 -66.6 126.94 30.49 Favored 'General case' 0 C--O 1.219 -0.51 0 N-CA-C 109.723 -0.473 . . . . 1.22 109.723 176.197 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A 1568 ' ' GLY . . . . . 0.522 ' HA2' ' CE2' ' A' 1549 ' ' TYR . . . -66.86 -33.22 83.38 Favored Glycine 0 N--CA 1.444 -0.83 0 CA-C-N 115.748 -0.66 . . . . 1.08 114.167 -175.109 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A 1569 ' ' GLN . . . . . . . . . . . . . 8.8 tt0 -84.45 -52.86 5.84 Favored 'General case' 0 C--N 1.303 -1.436 0 CA-C-O 121.686 0.755 . . . . 3.05 110.707 -179.576 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A 1570 ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -83.29 -14.68 52.53 Favored 'General case' 0 C--N 1.296 -1.721 0 CA-C-N 114.884 -1.053 . . . . 2.44 112.463 -169.745 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A 1571 ' ' ARG . . . . . . . . . . . . . 49.3 mtp180 54.97 37.23 28.51 Favored 'General case' 0 N--CA 1.476 0.855 0 C-N-CA 125.864 1.666 . . . . 4.48 111.95 -179.644 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A 1572 ' ' ILE . . . . . . . . . . . . . 45.9 mm -107.01 132.78 53.49 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.126 0 CA-C-N 115.347 -0.842 . . . . 1.94 109.359 -178.349 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A 1573 ' ' SER . . . . . . . . . . . . . 33.0 t -73.83 131.58 41.67 Favored 'General case' 0 N--CA 1.428 -1.528 0 CA-C-N 114.997 -1.001 . . . . 1.25 110.607 179.858 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A 1574 ' ' VAL . . . . . 1.004 ' HA ' ' HB3' ' A' 1596 ' ' SER . 34.0 m -109.85 -32.69 2.34 Favored 'Isoleucine or valine' 0 N--CA 1.419 -1.978 0 C-N-CA 119.976 -0.69 . . . . 1.61 109.864 171.984 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A 1575 ' ' GLY . . . . . . . . . . . . . . . -133.51 121.8 2.91 Favored Glycine 0 N--CA 1.425 -2.088 0 N-CA-C 110.372 -1.091 . . . . 0.65 110.372 178.762 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A 1576 ' ' LYS . . . . . . . . . . . . . 88.0 tttt -80.49 149.15 30.16 Favored 'General case' 0 C--N 1.311 -1.1 0 N-CA-C 108.578 -0.897 . . . . 3.33 108.578 179.637 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A 1577 ' ' ALA . . . . . . . . . . . . . . . -61.88 102.35 0.27 Allowed 'General case' 0 CA--C 1.516 -0.357 0 O-C-N 123.928 0.768 . . . . 1.31 111.141 -177.81 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A 1578 ' ' ASN . . . . . . . . . . . . . 73.4 m-20 -120.87 115.19 22.75 Favored 'General case' 0 C--N 1.297 -1.699 0 N-CA-C 106.487 -1.672 . . . . 2.24 106.487 175.638 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A 1579 ' ' LYS . . . . . 0.582 ' HE3' ' SG ' ' A' 1516 ' ' CYS . 55.6 mtpt -83.35 90.17 7.12 Favored 'General case' 0 C--N 1.295 -1.781 0 N-CA-C 107.724 -1.213 . . . . 2.34 107.724 -179.047 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A 1580 ' ' ARG . . . . . 0.402 HH11 ' HD2' ' A' 1580 ' ' ARG . 26.0 ttt85 -150.96 113.91 4.75 Favored 'General case' 0 N--CA 1.424 -1.734 0 CA-C-N 114.847 -1.07 . . . . 4.19 109.667 -175.579 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A 1581 ' ' LEU . . . . . . . . . . . . . 3.5 pp -134.04 161.73 34.03 Favored 'General case' 0 C--N 1.292 -1.915 0 CA-C-N 115.776 -0.647 . . . . 2.39 109.721 179.425 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A 1582 ' ' ARG . . . . . . . . . . . . . 79.1 ttt180 -138.15 129.39 27.45 Favored 'General case' 0 C--N 1.292 -1.892 0 C-N-CA 121.134 -0.227 . . . . 4.48 110.444 176.999 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A 1583 ' ' TYR . . . . . . . . . . . . . 36.7 t80 -93.07 102.6 14.93 Favored 'General case' 0 C--N 1.3 -1.583 0 N-CA-C 107.185 -1.413 . . . . 1.57 107.185 173.662 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A 1584 ' ' VAL . . . . . . . . . . . . . 7.5 p -135.87 120.93 27.85 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.949 0 C-N-CA 120.875 -0.33 . . . . 2.29 111.463 -177.293 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A 1585 ' ' ASP . . . . . . . . . . . . . 35.3 t70 53.08 45.73 28.14 Favored 'General case' 0 N--CA 1.488 1.435 0 C-N-CA 124.453 1.101 . . . . 2.06 111.12 178.367 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A 1586 ' ' GLN . . . . . . . . . . . . . 47.0 mt-30 58.13 25.83 12.94 Favored 'General case' 0 C--O 1.242 0.685 0 C-N-CA 125.377 1.471 . . . . 2.61 114.587 179.675 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A 1587 ' ' VAL . . . . . . . . . . . . . 8.1 p -128.45 126.17 65.12 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.314 0 N-CA-C 107.895 -1.15 . . . . 1.33 107.895 171.737 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A 1588 ' ' LEU . . . . . 0.562 ' HB2' ' HB2' ' A' 1612 ' ' PHE . 34.6 mt -86.22 138.99 31.45 Favored 'General case' 0 C--N 1.304 -1.396 0 N-CA-C 108.991 -0.744 . . . . 2.03 108.991 -179.918 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A 1589 ' ' GLN . . . . . . . . . . . . . 34.6 tt0 -130.59 107.0 8.87 Favored 'General case' 0 C--N 1.292 -1.929 0 N-CA-C 109.397 -0.594 . . . . 1.73 109.397 -177.278 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A 1590 ' ' LEU . . . . . . . . . . . . . 9.1 tt -111.82 137.16 50.15 Favored 'General case' 0 C--N 1.288 -2.07 0 N-CA-C 107.744 -1.206 . . . . 1.76 107.744 179.031 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A 1591 ' ' VAL . . . . . 0.505 HG11 HG21 ' A' 1609 ' ' VAL . 28.8 m -130.55 140.58 48.44 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.937 0 N-CA-C 112.233 0.457 . . . . 2.14 112.233 -175.431 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A 1592 ' ' TYR . . . . . 0.516 ' HH ' ' HA ' ' A' 1553 ' ' CYS . 39.6 m-85 -122.09 138.69 54.36 Favored 'General case' 0 C--N 1.313 -1.01 0 N-CA-C 108.128 -1.064 . . . . 1.53 108.128 172.948 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A 1593 ' ' LYS . . . . . . . . . . . . . 62.5 pttt -159.25 174.85 14.17 Favored 'General case' 0 C--O 1.251 1.133 0 N-CA-C 109.899 -0.408 . . . . 2.72 109.899 178.8 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A 1594 ' ' ASP . . . . . . . . . . . . . 31.6 m-20 67.54 56.93 0.57 Allowed 'General case' 0 N--CA 1.48 1.03 0 C-N-CA 124.376 1.07 . . . . 1.45 110.888 179.592 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A 1595 ' ' GLY . . . . . . . . . . . . . . . -142.1 -47.92 0.05 OUTLIER Glycine 0 C--N 1.308 -1.026 0 CA-C-N 115.054 -0.976 . . . . 0.83 111.362 -179.578 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A 1596 ' ' SER . . . . . 1.004 ' HB3' ' HA ' ' A' 1574 ' ' VAL . 15.8 p -96.69 134.21 23.51 Favored Pre-proline 0 C--N 1.298 -1.638 0 CA-C-N 115.526 -0.337 . . . . 1.96 111.545 179.031 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A 1597 ' ' PRO . . . . . 0.432 ' HD3' ' HA ' ' A' 1596 ' ' SER . 3.0 Cg_exo -79.77 113.56 3.07 Favored 'Trans proline' 0 N--CA 1.445 -1.373 0 C-N-CA 122.176 1.917 . . . . 1.34 108.593 170.863 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A 1598 ' ' CYS . . . . . . . . . . . . . 48.6 t -94.87 122.66 59.86 Favored Pre-proline 0 C--N 1.306 -1.326 0 N-CA-C 109.727 -0.471 . . . . 1.19 109.727 -176.3 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A 1599 ' ' PRO . . . . . . . . . . . . . 87.9 Cg_endo -77.97 0.6 9.7 Favored 'Trans proline' 0 CA--C 1.537 0.67 0 C-N-CA 123.384 2.723 . . . . 1.88 114.267 -175.463 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A 1600 ' ' SER . . . . . . . . . . . . . 19.9 m -77.9 -32.18 51.65 Favored 'General case' 0 C--N 1.308 -1.223 0 CA-C-O 120.677 0.275 . . . . 2.19 111.288 -179.679 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A 1601 ' ' LYS . . . . . 0.89 ' HB3' HD12 ' A' 1604 ' ' LEU . 11.2 tmtt? -158.92 129.98 6.19 Favored 'General case' 0 C--N 1.313 -0.993 0 N-CA-C 105.691 -1.966 . . . . 4.21 105.691 -177.13 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A 1602 ' ' SER . . . . . . . . . . . . . 16.4 m -67.36 125.41 26.02 Favored 'General case' 0 C--N 1.316 -0.852 0 CA-C-O 120.886 0.374 . . . . 3.82 110.591 -175.222 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A 1603 ' ' GLY . . . . . . . . . . . . . . . 103.83 -6.27 47.9 Favored Glycine 0 N--CA 1.435 -1.382 0 N-CA-C 110.918 -0.873 . . . . 2.45 110.918 -179.937 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A 1604 ' ' LEU . . . . . 0.89 HD12 ' HB3' ' A' 1601 ' ' LYS . 6.8 mt -89.19 148.26 23.73 Favored 'General case' 0 N--CA 1.43 -1.463 0 CA-C-O 121.425 0.631 . . . . 2.06 111.851 178.209 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A 1605 ' ' SER . . . . . 0.415 ' HA ' ' O ' ' A' 1596 ' ' SER . 8.3 t -130.45 163.58 26.64 Favored 'General case' 0 N--CA 1.413 -2.287 0 N-CA-C 104.673 -2.344 . . . . 1.75 104.673 176.561 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A 1606 ' ' TYR . . . . . 0.562 ' HA ' ' O ' ' A' 1634 ' ' CYS . 67.6 m-85 -90.22 116.01 27.88 Favored 'General case' 0 CA--C 1.458 -2.563 0 N-CA-C 106.331 -1.729 . . . . 1.59 106.331 -179.852 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A 1607 ' ' LYS . . . . . 0.512 ' HZ2' HG22 ' A' 1635 ' ' THR . 23.3 pttp -103.23 127.41 50.55 Favored 'General case' 0 N--CA 1.394 -3.226 0 C-N-CA 118.196 -1.401 . . . . 2.21 109.496 -176.738 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A 1608 ' ' SER . . . . . 0.517 ' HA ' ' HB2' ' A' 1636 ' ' LEU . 12.0 p -97.43 111.31 23.62 Favored 'General case' 0 N--CA 1.407 -2.62 0 CA-C-N 115.118 -0.946 . . . . 1.48 109.287 -177.186 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A 1609 ' ' VAL . . . . . 0.505 HG21 HG11 ' A' 1591 ' ' VAL . 85.5 t -101.35 107.84 22.24 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.523 0 N-CA-C 108.166 -1.049 . . . . 1.57 108.166 179.747 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A 1610 ' ' ILE . . . . . 0.432 HD12 ' N ' ' A' 1610 ' ' ILE . 2.5 mp -93.28 108.7 20.77 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.561 0 N-CA-C 108.274 -1.01 . . . . 1.47 108.274 179.023 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A 1611 ' ' SER . . . . . . . . . . . . . 21.8 m -94.52 113.92 25.83 Favored 'General case' 0 N--CA 1.409 -2.509 0 N-CA-C 108.232 -1.025 . . . . 1.84 108.232 177.346 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A 1612 ' ' PHE . . . . . 0.562 ' HB2' ' HB2' ' A' 1588 ' ' LEU . 79.8 m-85 -84.89 106.84 16.71 Favored 'General case' 0 C--N 1.291 -1.941 0 CA-C-N 115.067 -0.97 . . . . 0.86 110.57 -178.24 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A 1613 ' ' VAL . . . . . . . . . . . . . 41.9 t -94.92 119.68 43.3 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.52 0 CA-C-N 115.279 -0.873 . . . . 1.32 109.067 -177.051 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A 1614 ' ' CYS . . . . . 0.501 ' HB3' ' HB2' ' A' 1646 ' ' CYS . 56.2 m -71.45 92.33 1.09 Allowed 'General case' 0 C--N 1.314 -0.958 0 CA-C-O 121.377 0.608 . . . . 1.39 109.381 178.241 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A 1615 ' ' ARG . . . . . 0.505 ' HB3' ' HB3' ' A' 1641 ' ' HIS . 0.6 OUTLIER -137.97 87.46 16.58 Favored Pre-proline 0 C--N 1.305 -1.36 0 N-CA-C 107.109 -1.441 . . . . 4.34 107.109 -178.904 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A 1616 ' ' PRO . . . . . 0.437 ' HA ' ' HB3' ' A' 1643 ' ' PRO . 6.6 Cg_exo -76.34 44.79 1.43 Allowed 'Trans proline' 0 N--CA 1.479 0.635 0 C-N-CA 123.459 2.772 . . . . 1.5 112.768 -177.449 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A 1617 ' ' GLU . . . . . . . . . . . . . 41.8 mt-10 -131.15 40.82 3.41 Favored 'General case' 0 C--N 1.303 -1.44 0 N-CA-C 108.201 -1.036 . . . . 3.21 108.201 -179.276 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A 1618 ' ' ALA . . . . . . . . . . . . . . . -114.09 134.89 54.58 Favored 'General case' 0 C--N 1.308 -1.21 0 CA-C-N 115.538 -0.756 . . . . 2.91 110.963 -175.795 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A 1619 ' ' GLY . . . . . . . . . . . . . . . -151.64 -86.76 0.06 OUTLIER Glycine 0 N--CA 1.436 -1.308 0 N-CA-C 110.954 -0.858 . . . . 3.35 110.954 179.168 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A 1620 ' ' PRO . . . . . . . . . . . . . 18.8 Cg_endo -60.53 -31.34 92.26 Favored 'Trans proline' 0 CA--C 1.539 0.731 0 C-N-CA 122.972 2.448 . . . . 6.61 113.463 -179.402 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A 1621 ' ' THR . . . . . . . . . . . . . 4.4 m -114.42 31.23 6.75 Favored 'General case' 0 C--N 1.317 -0.839 0 N-CA-C 109.429 -0.582 . . . . 5.03 109.429 -178.928 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A 1622 ' ' ASN . . . . . . . . . . . . . 60.6 t30 -76.93 74.73 3.53 Favored 'General case' 0 N--CA 1.472 0.65 0 CA-C-O 121.81 0.814 . . . . 3.58 110.761 -178.649 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A 1623 ' ' ARG . . . . . . . . . . . . . 9.2 ptm180 -154.0 153.49 28.61 Favored Pre-proline 0 C--N 1.3 -1.566 0 N-CA-C 107.28 -1.378 . . . . 4.09 107.28 -178.922 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A 1624 ' ' PRO . . . . . . . . . . . . . 32.5 Cg_exo -61.29 119.82 7.16 Favored 'Trans proline' 0 C--O 1.245 0.87 0 C-N-CA 122.761 2.307 . . . . 2.86 111.751 179.246 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A 1625 ' ' MET . . . . . . . . . . . . . 56.3 ttp -95.99 130.7 42.92 Favored 'General case' 0 C--N 1.301 -1.522 0 CA-C-N 115.082 -0.963 . . . . 2.73 109.688 -177.228 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A 1626 ' ' LEU . . . . . 0.699 HD21 HD21 ' A' 1629 ' ' LEU . 56.8 tp -83.53 105.73 14.7 Favored 'General case' 0 C--N 1.306 -1.304 0 N-CA-C 107.8 -1.185 . . . . 1.94 107.8 178.001 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A 1627 ' ' ILE . . . . . . . . . . . . . 45.4 pt -83.19 -33.61 10.36 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.268 0 N-CA-C 112.303 0.483 . . . . 1.75 112.303 -175.1 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A 1628 ' ' SER . . . . . . . . . . . . . 45.7 m -149.75 147.49 28.08 Favored 'General case' 0 C--N 1.313 -1.001 0 CA-C-O 120.673 0.273 . . . . 1.85 110.475 -178.077 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A 1629 ' ' LEU . . . . . 0.699 HD21 HD21 ' A' 1626 ' ' LEU . 1.2 tm? -127.76 108.41 10.72 Favored 'General case' 0 C--N 1.307 -1.255 0 N-CA-C 106.61 -1.626 . . . . 2.12 106.61 -179.216 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A 1630 ' ' ASP . . . . . . . . . . . . . 15.3 t70 -107.7 112.08 24.59 Favored 'General case' 0 C--N 1.304 -1.399 0 N-CA-C 109.056 -0.72 . . . . 0.87 109.056 178.771 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A 1631 ' ' LYS . . . . . . . . . . . . . 63.4 mttm -80.0 -22.5 42.41 Favored 'General case' 0 C--N 1.303 -1.426 0 N-CA-C 112.674 0.62 . . . . 2.76 112.674 -177.186 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A 1632 ' ' GLN . . . . . . . . . . . . . 1.7 mp0 -78.77 -49.96 12.14 Favored 'General case' 0 CA--C 1.509 -0.61 0 CA-C-O 121.029 0.442 . . . . 2.55 111.467 -173.277 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A 1633 ' ' THR . . . . . . . . . . . . . 60.4 p -86.57 -4.52 59.18 Favored 'General case' 0 C--N 1.313 -1.011 0 CA-C-O 121.875 0.845 . . . . 1.92 110.004 179.764 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A 1634 ' ' CYS . . . . . 0.562 ' O ' ' HA ' ' A' 1606 ' ' TYR . 29.4 m 59.62 51.05 6.65 Favored 'General case' 0 N--CA 1.441 -0.907 0 CA-C-N 113.442 -1.708 . . . . 0.89 108.768 179.712 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A 1635 ' ' THR . . . . . 0.512 HG22 ' HZ2' ' A' 1607 ' ' LYS . 39.7 m -114.94 130.26 56.88 Favored 'General case' 0 N--CA 1.425 -1.699 0 CA-C-N 114.999 -1.001 . . . . 1.31 110.087 -175.831 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A 1636 ' ' LEU . . . . . 0.517 ' HB2' ' HA ' ' A' 1608 ' ' SER . 40.6 mt -112.62 116.06 29.59 Favored 'General case' 0 N--CA 1.435 -1.223 0 N-CA-C 107.58 -1.267 . . . . 1.97 107.58 -178.479 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A 1637 ' ' PHE . . . . . . . . . . . . . 89.1 m-85 -98.68 100.92 12.19 Favored 'General case' 0 C--N 1.307 -1.282 0 N-CA-C 111.777 0.288 . . . . 0.92 111.777 -175.298 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A 1638 ' ' PHE . . . . . . . . . . . . . 68.0 m-85 -100.74 138.84 37.26 Favored 'General case' 0 C--N 1.307 -1.258 0 N-CA-C 109.169 -0.678 . . . . 0.7 109.169 176.165 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A 1639 ' ' SER . . . . . . . . . . . . . 50.8 m -136.79 120.75 17.61 Favored 'General case' 0 C--N 1.279 -2.467 0 N-CA-C 108.464 -0.939 . . . . 1.46 108.464 174.883 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A 1640 ' ' TRP . . . . . . . . . . . . . 19.7 t90 -111.76 119.89 40.16 Favored 'General case' 0 C--N 1.292 -1.898 0 CA-C-N 115.942 -0.572 . . . . 0.92 109.501 -178.131 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A 1641 ' ' HIS . . . . . 0.505 ' HB3' ' HB3' ' A' 1615 ' ' ARG . 39.8 m170 -77.06 107.46 9.44 Favored 'General case' 0 C--N 1.31 -1.138 0 N-CA-C 106.347 -1.723 . . . . 3.18 106.347 174.718 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A 1642 ' ' THR . . . . . . . . . . . . . 8.8 t -140.92 136.93 16.56 Favored Pre-proline 0 C--N 1.291 -1.952 0 N-CA-C 113.126 0.787 . . . . 1.48 113.126 -173.711 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A 1643 ' ' PRO . . . . . 0.437 ' HB3' ' HA ' ' A' 1616 ' ' PRO . 64.4 Cg_endo -76.97 -2.93 13.2 Favored 'Trans proline' 0 C--O 1.199 -1.462 0 C-N-CA 123.475 2.783 . . . . 1.09 111.006 173.735 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A 1644 ' ' LEU . . . . . . . . . . . . . 83.6 mt -91.84 -9.67 42.56 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 116.608 -0.269 . . . . 2.08 111.417 -177.968 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A 1645 ' ' ALA . . . . . . . . . . . . . . . -81.67 -35.98 29.29 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 121.805 0.812 . . . . 1.37 109.128 177.45 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A 1646 ' ' CYS . . . . . 0.501 ' HB2' ' HB3' ' A' 1614 ' ' CYS . 71.2 m -142.19 114.76 8.48 Favored 'General case' 0 N--CA 1.426 -1.645 0 N-CA-C 105.499 -2.037 . . . . 1.7 105.499 174.786 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A 1647 ' ' GLU . . . . . . . . . . . . . 42.2 mt-10 -103.74 129.59 25.04 Favored Pre-proline 0 C--N 1.3 -1.56 0 N-CA-C 109.137 -0.69 . . . . 2.92 109.137 -178.413 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A 1648 ' ' PRO . . . . . . . . . . . . . 18.6 Cg_endo -63.96 101.52 0.33 Allowed 'Trans proline' 0 C--O 1.245 0.861 0 C-N-CA 122.193 1.929 . . . . 3.19 109.506 175.025 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A 1649 ' ' GLU . . . . . . . . . . . . . 44.1 mt-10 . . . . . 0 C--N 1.305 -1.357 0 CA-C-N 115.533 -0.758 . . . . 5.06 109.227 -176.313 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A 1508 ' ' MET . . . . . . . . . . . . . 67.6 mtt . . . . . 0 C--O 1.24 0.586 0 CA-C-O 120.94 0.4 . . . . 8.58 110.933 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A 1509 ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER 59.7 80.24 0.21 Allowed 'General case' 0 N--CA 1.466 0.368 0 N-CA-C 113.555 0.946 . . . . 6.8 113.555 177.643 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A 1510 ' ' SER . . . . . . . . . . . . . 71.0 m -107.9 41.15 1.58 Allowed 'General case' 0 C--N 1.294 -1.838 0 CA-C-O 121.785 0.802 . . . . 4.48 108.943 173.074 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A 1511 ' ' ASN . . . . . . . . . . . . . 38.2 m-80 -67.59 -19.02 65.2 Favored 'General case' 0 CA--C 1.51 -0.58 0 CA-C-N 114.9 -1.045 . . . . 3.08 112.632 -174.405 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A 1512 ' ' GLU . . . . . 0.501 ' O ' ' HG3' ' A' 1580 ' ' ARG . 0.0 OUTLIER -66.82 -23.18 66.01 Favored 'General case' 0 C--O 1.212 -0.903 0 C-N-CA 120.403 -0.519 . . . . 4.46 110.604 179.79 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A 1513 ' ' HIS . . . . . . . . . . . . . 88.7 m-70 -91.64 1.89 56.84 Favored 'General case' 0 N--CA 1.464 0.251 0 CA-C-N 115.743 -0.662 . . . . 6.25 109.941 178.478 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A 1514 ' ' ASP . . . . . . . . . . . . . 26.8 t70 -119.24 -53.61 2.24 Favored 'General case' 0 C--N 1.316 -0.863 0 N-CA-C 112.712 0.634 . . . . 3.7 112.712 -172.231 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A 1515 ' ' ASP . . . . . . . . . . . . . 7.0 t0 -138.76 -174.31 3.8 Favored 'General case' 0 C--N 1.305 -1.361 0 N-CA-C 107.061 -1.459 . . . . 2.54 107.061 -174.186 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A 1516 ' ' CYS . . . . . . . . . . . . . 81.3 m -90.65 61.53 4.87 Favored 'General case' 0 C--N 1.28 -2.422 0 C-N-CA 123.599 0.76 . . . . 1.25 109.183 -179.761 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A 1517 ' ' GLN . . . . . . . . . . . . . 9.8 pt20 -160.97 131.9 5.39 Favored 'General case' 0 C--N 1.308 -1.211 0 CA-C-O 120.803 0.335 . . . . 2.36 110.695 179.219 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A 1518 ' ' VAL . . . . . . . . . . . . . 14.1 p -131.88 137.32 55.19 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.804 0 N-CA-C 109.053 -0.721 . . . . 2.34 109.053 178.429 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A 1519 ' ' THR . . . . . 0.623 ' HA ' ' HA ' ' A' 1526 ' ' LEU . 40.0 m -89.37 128.65 35.93 Favored 'General case' 0 C--N 1.29 -1.98 0 CA-C-N 116.182 -0.463 . . . . 2.04 109.758 177.891 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A 1520 ' ' ASN . . . . . . . . . . . . . 17.7 t-20 -80.1 114.3 45.6 Favored Pre-proline 0 C--N 1.308 -1.228 0 N-CA-C 108.473 -0.936 . . . . 2.12 108.473 174.758 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A 1521 ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -74.63 0.2 9.0 Favored 'Trans proline' 0 CA--C 1.539 0.767 0 C-N-CA 122.541 2.16 . . . . 2.59 113.926 -176.371 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A 1522 ' ' SER . . . . . . . . . . . . . 49.3 m -88.79 -62.34 1.51 Allowed 'General case' 0 N--CA 1.432 -1.375 0 O-C-N 122.13 -0.356 . . . . 2.65 110.895 178.784 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A 1523 ' ' THR . . . . . . . . . . . . . 8.8 t -92.98 -11.89 32.09 Favored 'General case' 0 CA--C 1.547 0.858 0 CA-C-O 120.952 0.406 . . . . 2.33 111.253 -179.821 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A 1524 ' ' GLY . . . . . . . . . . . . . . . 80.33 27.79 50.81 Favored Glycine 0 C--N 1.332 0.329 0 C-N-CA 121.059 -0.591 . . . . 1.96 112.119 179.244 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A 1525 ' ' HIS . . . . . . . . . . . . . 16.1 t60 -101.22 119.18 38.36 Favored 'General case' 0 C--N 1.309 -1.169 0 N-CA-C 110.184 -0.302 . . . . 2.44 110.184 -176.802 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A 1526 ' ' LEU . . . . . 0.623 ' HA ' ' HA ' ' A' 1519 ' ' THR . 7.0 tt -82.72 124.73 30.5 Favored 'General case' 0 C--N 1.301 -1.533 0 N-CA-C 108.174 -1.047 . . . . 2.19 108.174 175.651 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A 1527 ' ' PHE . . . . . . . . . . . . . 76.4 m-85 -90.32 102.41 15.14 Favored 'General case' 0 C--N 1.309 -1.194 0 N-CA-C 109.183 -0.673 . . . . 1.61 109.183 178.233 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A 1528 ' ' ASP . . . . . . . . . . . . . 8.8 t70 -80.76 118.13 22.03 Favored 'General case' 0 C--N 1.309 -1.154 0 CA-C-O 121.336 0.588 . . . . 2.18 111.633 178.306 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A 1529 ' ' LEU . . . . . . . . . . . . . 6.2 mp -121.05 11.47 10.96 Favored 'General case' 0 C--N 1.307 -1.28 0 N-CA-C 106.496 -1.668 . . . . 2.04 106.496 168.149 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A 1530 ' ' SER . . . . . . . . . . . . . 42.9 m -76.18 -29.1 57.54 Favored 'General case' 0 N--CA 1.442 -0.867 0 CA-C-N 115.376 -0.829 . . . . 1.44 110.06 -178.615 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A 1531 ' ' SER . . . . . . . . . . . . . 29.0 t -75.32 -6.35 49.44 Favored 'General case' 0 CA--C 1.548 0.903 0 CA-C-O 122.303 1.049 . . . . 1.63 108.806 174.518 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A 1532 ' ' LEU . . . . . . . . . . . . . 98.1 mt -91.89 15.24 13.49 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.807 -0.633 . . . . 2.32 110.616 175.243 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A 1533 ' ' SER . . . . . 0.412 ' HA ' ' O ' ' A' 1553 ' ' CYS . 18.8 m -84.56 122.11 28.57 Favored 'General case' 0 N--CA 1.432 -1.35 0 N-CA-C 108.619 -0.882 . . . . 2.57 108.619 175.668 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A 1534 ' ' GLY . . . . . . . . . . . . . . . -135.92 152.77 21.15 Favored Glycine 0 N--CA 1.419 -2.448 0 N-CA-C 110.594 -1.002 . . . . 1.89 110.594 -179.255 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A 1535 ' ' ARG . . . . . 0.564 ' HG3' ' HG3' ' A' 1555 ' ' GLU . 51.2 ttt180 -96.44 -25.13 15.8 Favored 'General case' 0 C--N 1.306 -1.283 0 CA-C-O 121.669 0.747 . . . . 4.44 109.886 179.049 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A 1536 ' ' ALA . . . . . . . . . . . . . . . -89.72 -41.03 12.14 Favored 'General case' 0 C--O 1.243 0.732 0 CA-C-N 115.587 -0.733 . . . . 2.07 110.849 -179.043 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A 1537 ' ' GLY . . . . . . . . . . . . . . . 97.7 -175.95 30.62 Favored Glycine 0 N--CA 1.435 -1.382 0 CA-C-N 115.761 -0.654 . . . . 1.2 112.477 176.75 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A 1538 ' ' PHE . . . . . . . . . . . . . 92.1 m-85 -111.64 155.09 23.94 Favored 'General case' 0 C--N 1.302 -1.49 0 N-CA-C 108.212 -1.033 . . . . 1.98 108.212 176.687 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A 1539 ' ' THR . . . . . . . . . . . . . 5.2 p -106.27 111.08 23.52 Favored 'General case' 0 C--N 1.295 -1.761 0 CA-C-N 116.016 -0.538 . . . . 1.97 111.538 -179.704 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A 1540 ' ' ALA . . . . . . . . . . . . . . . -112.32 107.63 16.53 Favored 'General case' 0 C--N 1.313 -0.988 0 N-CA-C 109.027 -0.731 . . . . 1.39 109.027 176.014 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A 1541 ' ' ALA . . . . . . . . . . . . . . . -71.75 155.23 40.69 Favored 'General case' 0 C--N 1.312 -1.037 0 CA-C-N 116.261 -0.427 . . . . 1.86 110.644 178.705 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A 1542 ' ' TYR . . . . . 0.418 ' HD2' ' HB2' ' A' 1545 ' ' SER . 32.4 t80 -156.23 179.92 8.77 Favored 'General case' 0 C--N 1.302 -1.491 0 N-CA-C 107.708 -1.219 . . . . 2.4 107.708 -178.926 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A 1543 ' ' SER . . . . . . . . . . . . . 5.5 m -44.98 -151.67 0.0 OUTLIER 'General case' 0 CA--C 1.57 1.728 0 C-N-CA 129.181 2.993 . . . . 2.58 114.616 178.101 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A 1544 ' ' LYS . . . . . 0.404 ' HB2' ' HE3' ' A' 1544 ' ' LYS . 19.4 ptmt -54.7 -6.9 0.13 Allowed 'General case' 0 CA--C 1.575 1.931 0 O-C-N 120.251 -1.531 . . . . 4.24 114.021 176.511 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A 1545 ' ' SER . . . . . 0.418 ' HB2' ' HD2' ' A' 1542 ' ' TYR . 20.4 m -73.03 -17.4 61.44 Favored 'General case' 0 CA--C 1.554 1.132 0 C-N-CA 123.332 0.653 . . . . 3.6 109.693 170.668 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A 1546 ' ' GLY . . . . . . . . . . . . . . . 83.75 -80.38 1.83 Allowed Glycine 0 N--CA 1.436 -1.316 0 CA-C-O 121.43 0.461 . . . . 1.66 114.009 174.093 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A 1547 ' ' VAL . . . . . . . . . . . . . 7.1 p -160.16 140.77 3.78 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.169 0 N-CA-C 109.235 -0.654 . . . . 2.23 109.235 -174.738 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A 1548 ' ' VAL . . . . . . . . . . . . . 4.0 t -108.29 131.9 57.52 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.726 0 N-CA-C 107.399 -1.334 . . . . 1.59 107.399 179.398 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A 1549 ' ' TYR . . . . . . . . . . . . . 68.4 m-85 -93.15 114.64 27.2 Favored 'General case' 0 C--N 1.308 -1.207 0 N-CA-C 106.858 -1.534 . . . . 1.58 106.858 174.077 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A 1550 ' ' MET . . . . . . . . . . . . . 56.3 ttp -135.93 121.6 19.64 Favored 'General case' 0 C--N 1.299 -1.614 0 C-N-CA 119.706 -0.798 . . . . 2.08 111.388 -177.774 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A 1551 ' ' SER . . . . . 0.431 ' O ' ' OH ' ' A' 1592 ' ' TYR . 19.9 m -95.97 124.1 39.84 Favored 'General case' 0 C--N 1.277 -2.568 0 N-CA-C 104.801 -2.296 . . . . 1.9 104.801 173.017 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A 1552 ' ' ILE . . . . . . . . . . . . . 50.6 mm -60.86 -43.2 95.12 Favored 'Isoleucine or valine' 0 C--O 1.213 -0.854 0 N-CA-C 109.404 -0.591 . . . . 2.04 109.404 -179.037 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A 1553 ' ' CYS . . . . . 0.412 ' O ' ' HA ' ' A' 1533 ' ' SER . 76.1 m -144.71 155.87 43.79 Favored 'General case' 0 C--N 1.295 -1.782 0 N-CA-C 106.491 -1.67 . . . . 1.43 106.491 173.411 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A 1554 ' ' GLY . . . . . . . . . . . . . . . 118.26 -110.92 2.05 Favored Glycine 0 N--CA 1.434 -1.489 0 C-N-CA 120.342 -0.932 . . . . 1.23 112.763 176.427 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A 1555 ' ' GLU . . . . . 0.564 ' HG3' ' HG3' ' A' 1535 ' ' ARG . 9.5 pt-20 -165.34 161.94 19.33 Favored 'General case' 0 C--N 1.305 -1.33 0 N-CA-C 106.724 -1.584 . . . . 1.8 106.724 -178.207 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A 1556 ' ' ASN . . . . . . . . . . . . . 17.9 t-20 -131.34 103.65 6.57 Favored 'General case' 0 C--N 1.287 -2.136 0 N-CA-C 109.332 -0.618 . . . . 2.63 109.332 -179.209 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A 1557 ' ' GLU . . . . . . . . . . . . . 9.1 mm-40 -83.13 36.65 0.52 Allowed 'General case' 0 C--N 1.3 -1.576 0 N-CA-C 113.782 1.03 . . . . 3.79 113.782 -173.2 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A 1558 ' ' ASN . . . . . . . . . . . . . 33.0 m-80 -111.78 -19.35 12.47 Favored 'General case' 0 C--N 1.295 -1.802 0 N-CA-C 107.846 -1.168 . . . . 1.59 107.846 176.244 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A 1559 ' ' CYS . . . . . 0.778 ' HB3' ' HD2' ' A' 1560 ' ' PRO . 70.8 m -138.51 176.48 2.63 Favored Pre-proline 0 N--CA 1.436 -1.156 0 CA-C-O 116.866 -1.54 . . . . 0.94 107.088 -178.103 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A 1560 ' ' PRO . . . . . 0.778 ' HD2' ' HB3' ' A' 1559 ' ' CYS . 2.9 Cg_exo -33.2 126.93 0.13 Allowed 'Trans proline' 0 C--N 1.386 2.538 0 C-N-CA 124.578 3.518 . . . . 1.53 115.149 -177.412 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A 1561 ' ' PRO . . . . . 0.432 ' HD2' ' HA ' ' A' 1560 ' ' PRO . 9.5 Cg_endo -51.37 111.86 0.67 Allowed 'Trans proline' 0 C--O 1.246 0.898 0 C-N-CA 123.675 2.917 . . . . 1.82 112.98 -179.294 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A 1562 ' ' GLY . . . . . . . . . . . . . . . 111.39 2.94 27.63 Favored Glycine 0 N--CA 1.437 -1.255 0 CA-C-N 115.436 -0.802 . . . . 0.81 113.018 177.937 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A 1563 ' ' VAL . . . . . 0.544 ' HA ' ' HA ' ' A' 1576 ' ' LYS . 14.9 m -94.06 152.0 3.64 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.055 0 N-CA-C 106.288 -1.745 . . . . 1.73 106.288 172.723 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A 1564 ' ' GLY . . . . . 0.603 ' HA3' ' CE2' ' A' 1592 ' ' TYR . . . -113.86 -26.41 3.86 Favored Glycine 0 C--N 1.307 -1.059 0 C-N-CA 119.28 -1.438 . . . . 0.72 113.139 -175.986 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A 1565 ' ' ALA . . . . . . . . . . . . . . . -132.59 126.11 32.01 Favored 'General case' 0 C--O 1.251 1.181 0 N-CA-C 109.63 -0.507 . . . . 1.14 109.63 -178.779 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A 1566 ' ' CYS . . . . . . . . . . . . . 43.2 t -150.4 139.7 21.31 Favored 'General case' 0 C--N 1.311 -1.075 0 CA-C-N 115.728 -0.669 . . . . 0.51 110.064 -174.774 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A 1567 ' ' PHE . . . . . . . . . . . . . 26.5 m-85 -69.84 123.13 20.68 Favored 'General case' 0 CA--C 1.508 -0.665 0 N-CA-C 107.396 -1.335 . . . . 1.22 107.396 175.755 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A 1568 ' ' GLY . . . . . . . . . . . . . . . -74.66 -37.27 46.15 Favored Glycine 0 N--CA 1.441 -1.023 0 C-N-CA 120.677 -0.773 . . . . 1.08 113.769 -173.627 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A 1569 ' ' GLN . . . . . . . . . . . . . 50.1 tp60 -69.35 -48.61 60.82 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-O 121.976 0.893 . . . . 3.05 109.44 -178.947 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A 1570 ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -80.71 -23.08 39.75 Favored 'General case' 0 C--N 1.301 -1.537 0 CA-C-N 114.387 -1.279 . . . . 2.44 112.397 -173.498 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A 1571 ' ' ARG . . . . . . . . . . . . . 40.5 mtp-105 64.32 32.15 12.38 Favored 'General case' 0 N--CA 1.472 0.64 0 C-N-CA 125.035 1.334 . . . . 4.48 111.864 -178.833 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A 1572 ' ' ILE . . . . . . . . . . . . . 49.8 mm -109.66 118.98 58.02 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.227 0 N-CA-C 108.972 -0.751 . . . . 1.94 108.972 -178.361 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A 1573 ' ' SER . . . . . . . . . . . . . 36.7 t -67.28 140.08 57.32 Favored 'General case' 0 N--CA 1.435 -1.205 0 CA-C-N 115.064 -0.971 . . . . 1.25 109.453 178.379 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A 1574 ' ' VAL . . . . . 0.536 ' HB ' ' HB2' ' A' 1606 ' ' TYR . 23.0 m -116.01 -38.96 2.48 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.653 0 C-N-CA 119.978 -0.689 . . . . 1.61 110.663 178.606 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A 1575 ' ' GLY . . . . . 0.771 ' HA3' ' HB3' ' A' 1592 ' ' TYR . . . -135.87 133.1 6.45 Favored Glycine 0 N--CA 1.428 -1.836 0 C-N-CA 120.376 -0.916 . . . . 0.65 112.729 -177.592 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A 1576 ' ' LYS . . . . . 0.544 ' HA ' ' HA ' ' A' 1563 ' ' VAL . 24.4 ttpp -85.89 149.37 25.27 Favored 'General case' 0 C--N 1.309 -1.191 0 N-CA-C 107.307 -1.368 . . . . 3.33 107.307 178.608 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A 1577 ' ' ALA . . . . . . . . . . . . . . . -63.44 133.91 54.77 Favored 'General case' 0 CA--C 1.501 -0.924 0 O-C-N 123.793 0.683 . . . . 1.31 109.503 179.128 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A 1578 ' ' ASN . . . . . . . . . . . . . 7.8 p30 -153.27 144.96 23.42 Favored 'General case' 0 C--N 1.282 -2.369 0 N-CA-C 105.638 -1.986 . . . . 2.24 105.638 179.867 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A 1579 ' ' LYS . . . . . . . . . . . . . 67.9 mttm -114.48 89.3 3.06 Favored 'General case' 0 C--N 1.29 -2.019 0 C-N-CA 118.631 -1.228 . . . . 2.34 110.791 -176.703 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A 1580 ' ' ARG . . . . . 0.501 ' HG3' ' O ' ' A' 1512 ' ' GLU . 53.1 ttt180 -156.72 131.07 8.63 Favored 'General case' 0 N--CA 1.415 -2.207 0 CA-C-N 115.288 -0.869 . . . . 4.19 109.42 172.712 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A 1581 ' ' LEU . . . . . 0.405 HD13 HD11 ' A' 1588 ' ' LEU . 2.3 pp -124.88 150.66 46.26 Favored 'General case' 0 C--N 1.284 -2.282 0 N-CA-C 108.784 -0.821 . . . . 2.39 108.784 175.857 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A 1582 ' ' ARG . . . . . . . . . . . . . 90.0 mtt180 -115.82 125.7 53.03 Favored 'General case' 0 C--N 1.288 -2.082 0 CA-C-O 121.0 0.429 . . . . 4.48 110.052 -176.592 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A 1583 ' ' TYR . . . . . 0.446 ' CE1' ' HA ' ' A' 1586 ' ' GLN . 58.8 t80 -94.0 91.25 6.78 Favored 'General case' 0 C--N 1.289 -2.031 0 N-CA-C 107.714 -1.217 . . . . 1.57 107.714 179.115 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A 1584 ' ' VAL . . . . . . . . . . . . . 4.4 p -107.21 95.37 3.74 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.85 0 CA-C-O 121.824 0.821 . . . . 2.29 111.4 -176.909 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A 1585 ' ' ASP . . . . . . . . . . . . . 27.9 t70 52.69 67.89 0.92 Allowed 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 114.695 -1.139 . . . . 2.06 111.359 -177.954 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A 1586 ' ' GLN . . . . . 0.446 ' HA ' ' CE1' ' A' 1583 ' ' TYR . 49.6 mt-30 66.31 -15.23 0.13 Allowed 'General case' 0 C--N 1.315 -0.905 0 N-CA-C 115.873 1.805 . . . . 2.61 115.873 177.73 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A 1587 ' ' VAL . . . . . . . . . . . . . 10.9 p -99.38 123.21 51.94 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.028 0 CA-C-N 119.119 0.872 . . . . 1.33 109.684 178.301 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A 1588 ' ' LEU . . . . . 0.521 ' HB2' ' HB2' ' A' 1612 ' ' PHE . 4.1 mm? -81.96 140.18 34.16 Favored 'General case' 0 N--CA 1.43 -1.472 0 CA-C-N 115.581 -0.736 . . . . 2.03 111.885 -178.848 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A 1589 ' ' GLN . . . . . . . . . . . . . 35.1 tt0 -129.78 122.1 28.13 Favored 'General case' 0 C--N 1.303 -1.454 0 CA-C-N 115.573 -0.74 . . . . 1.73 109.926 179.073 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A 1590 ' ' LEU . . . . . . . . . . . . . 6.8 tt -119.16 132.94 56.02 Favored 'General case' 0 C--N 1.304 -1.393 0 N-CA-C 106.569 -1.641 . . . . 1.76 106.569 176.583 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A 1591 ' ' VAL . . . . . 0.554 HG11 HG23 ' A' 1609 ' ' VAL . 35.3 m -124.29 144.7 33.21 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.837 0 CA-C-O 121.688 0.756 . . . . 2.14 112.956 -173.509 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A 1592 ' ' TYR . . . . . 0.771 ' HB3' ' HA3' ' A' 1575 ' ' GLY . 22.5 m-85 -106.66 123.49 48.2 Favored 'General case' 0 C--N 1.298 -1.664 0 CA-C-N 115.078 -0.964 . . . . 1.53 110.298 172.249 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A 1593 ' ' LYS . . . . . . . . . . . . . 20.5 ptmt -142.59 -178.64 5.87 Favored 'General case' 0 C--N 1.298 -1.67 0 CA-C-N 114.364 -1.289 . . . . 2.72 108.072 -173.59 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A 1594 ' ' ASP . . . . . 0.495 ' HB2' ' HE3' ' A' 1576 ' ' LYS . 57.9 m-20 67.05 14.88 9.98 Favored 'General case' 0 N--CA 1.491 1.618 0 C-N-CA 124.098 0.959 . . . . 1.45 113.265 175.253 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A 1595 ' ' GLY . . . . . . . . . . . . . . . -90.54 -105.89 1.29 Allowed Glycine 0 N--CA 1.432 -1.587 0 N-CA-C 111.212 -0.755 . . . . 0.83 111.212 179.106 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A 1596 ' ' SER . . . . . 0.42 ' HA ' ' HD3' ' A' 1597 ' ' PRO . 23.0 m -106.65 128.05 26.93 Favored Pre-proline 0 C--N 1.295 -1.795 0 N-CA-C 109.679 -0.489 . . . . 1.96 109.679 179.9 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A 1597 ' ' PRO . . . . . 0.42 ' HD3' ' HA ' ' A' 1596 ' ' SER . 32.3 Cg_exo -63.07 150.95 87.16 Favored 'Trans proline' 0 C--O 1.238 0.516 0 C-N-CA 123.289 2.659 . . . . 1.34 110.866 176.554 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A 1598 ' ' CYS . . . . . 0.455 ' HA ' ' HD3' ' A' 1599 ' ' PRO . 50.2 t -94.93 132.63 27.85 Favored Pre-proline 0 C--N 1.293 -1.851 0 N-CA-C 109.961 -0.385 . . . . 1.19 109.961 -177.675 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A 1599 ' ' PRO . . . . . 0.455 ' HD3' ' HA ' ' A' 1598 ' ' CYS . 11.8 Cg_exo -72.29 -7.5 21.05 Favored 'Trans proline' 0 C--N 1.362 1.24 0 C-N-CA 123.392 2.728 . . . . 1.88 112.165 -179.97 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A 1600 ' ' SER . . . . . . . . . . . . . 44.9 t -113.14 123.67 50.79 Favored 'General case' 0 N--CA 1.421 -1.906 0 N-CA-C 107.757 -1.201 . . . . 2.19 107.757 177.603 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A 1601 ' ' LYS . . . . . . . . . . . . . 34.9 mmtp 57.13 50.92 11.06 Favored 'General case' 0 C--O 1.241 0.633 0 O-C-N 123.64 0.587 . . . . 4.21 109.814 -179.623 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A 1602 ' ' SER . . . . . . . . . . . . . 50.9 m -54.04 140.56 31.15 Favored 'General case' 0 N--CA 1.439 -0.992 0 CA-C-N 114.964 -1.016 . . . . 3.82 113.254 -175.988 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A 1603 ' ' GLY . . . . . . . . . . . . . . . 135.75 -10.9 4.27 Favored Glycine 0 N--CA 1.434 -1.466 0 N-CA-C 108.954 -1.659 . . . . 2.45 108.954 -173.327 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A 1604 ' ' LEU . . . . . . . . . . . . . 1.3 pp -135.42 162.4 32.72 Favored 'General case' 0 N--CA 1.437 -1.075 0 C-N-CA 123.897 0.879 . . . . 2.06 110.449 179.834 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A 1605 ' ' SER . . . . . . . . . . . . . 11.4 m -99.71 -176.04 3.15 Favored 'General case' 0 C--N 1.302 -1.46 0 N-CA-C 109.012 -0.736 . . . . 1.75 109.012 -178.611 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A 1606 ' ' TYR . . . . . 0.544 ' HA ' ' HB3' ' A' 1634 ' ' CYS . 78.5 m-85 -81.71 97.12 7.78 Favored 'General case' 0 CA--C 1.477 -1.837 0 N-CA-C 103.325 -2.843 . . . . 1.59 103.325 171.508 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A 1607 ' ' LYS . . . . . . . . . . . . . 17.3 ptmt -103.53 125.52 50.13 Favored 'General case' 0 C--N 1.26 -3.285 0 C-N-CA 119.695 -0.802 . . . . 2.21 112.041 -165.57 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A 1608 ' ' SER . . . . . 0.42 ' HB2' ' HB2' ' A' 1592 ' ' TYR . 16.5 m -98.62 117.29 32.73 Favored 'General case' 0 C--N 1.296 -1.73 0 CA-C-N 114.796 -1.093 . . . . 1.48 108.95 -179.102 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A 1609 ' ' VAL . . . . . 0.554 HG23 HG11 ' A' 1591 ' ' VAL . 98.1 t -112.12 117.19 54.59 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.22 0 N-CA-C 109.194 -0.669 . . . . 1.57 109.194 179.775 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A 1610 ' ' ILE . . . . . 0.691 HG13 ' HB2' ' A' 1638 ' ' PHE . 2.9 mp -105.36 114.53 45.1 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.178 0 N-CA-C 108.695 -0.854 . . . . 1.47 108.695 178.108 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A 1611 ' ' SER . . . . . . . . . . . . . 63.5 p -90.66 124.19 34.87 Favored 'General case' 0 N--CA 1.43 -1.465 0 N-CA-C 108.324 -0.991 . . . . 1.84 108.324 175.541 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A 1612 ' ' PHE . . . . . 0.521 ' HB2' ' HB2' ' A' 1588 ' ' LEU . 96.2 m-85 -93.23 107.74 19.49 Favored 'General case' 0 C--N 1.297 -1.71 0 CA-C-N 116.209 -0.45 . . . . 0.86 109.914 -179.125 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A 1613 ' ' VAL . . . . . . . . . . . . . 66.7 t -104.8 132.59 51.14 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.137 0 O-C-N 124.723 1.265 . . . . 1.32 108.895 -178.787 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A 1614 ' ' CYS . . . . . 0.407 ' HA ' ' O ' ' A' 1642 ' ' THR . 55.8 m -76.88 103.78 7.02 Favored 'General case' 0 C--N 1.295 -1.797 0 CA-C-N 114.973 -1.012 . . . . 1.39 111.433 -175.092 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A 1615 ' ' ARG . . . . . . . . . . . . . 38.3 mmt180 -123.7 86.7 52.83 Favored Pre-proline 0 C--N 1.306 -1.312 0 CA-C-N 115.541 -0.754 . . . . 4.34 110.067 179.041 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A 1616 ' ' PRO . . . . . 0.408 ' HA ' ' HB3' ' A' 1643 ' ' PRO . 42.7 Cg_endo -66.25 -28.78 47.44 Favored 'Trans proline' 0 C--N 1.348 0.511 0 C-N-CA 122.919 2.412 . . . . 1.5 113.392 -177.44 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A 1617 ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -99.32 22.61 10.35 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-O 121.408 0.623 . . . . 3.21 111.117 -178.065 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A 1618 ' ' ALA . . . . . . . . . . . . . . . -84.73 147.2 27.01 Favored 'General case' 0 N--CA 1.439 -1.023 0 N-CA-C 109.136 -0.69 . . . . 2.91 109.136 177.672 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A 1619 ' ' GLY . . . . . . . . . . . . . . . -139.41 -88.48 0.17 Allowed Glycine 0 C--N 1.292 -1.902 0 N-CA-C 109.671 -1.371 . . . . 3.35 109.671 178.023 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A 1620 ' ' PRO . . . . . . . . . . . . . 22.3 Cg_endo -63.17 -23.93 72.87 Favored 'Trans proline' 0 CA--C 1.543 0.933 0 C-N-CA 122.52 2.146 . . . . 6.61 112.749 178.633 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A 1621 ' ' THR . . . . . 0.407 ' O ' ' HB2' ' A' 1641 ' ' HIS . 13.0 m -96.44 13.95 26.14 Favored 'General case' 0 CA--C 1.566 1.584 0 CA-C-O 121.49 0.662 . . . . 5.03 110.868 -179.454 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A 1622 ' ' ASN . . . . . 0.426 ' HA ' ' O ' ' A' 1641 ' ' HIS . 53.8 t-20 -78.6 68.29 4.55 Favored 'General case' 0 N--CA 1.479 0.999 0 CA-C-O 121.576 0.703 . . . . 3.58 109.564 178.847 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A 1623 ' ' ARG . . . . . . . . . . . . . 15.5 ptm180 -155.15 151.0 21.88 Favored Pre-proline 0 C--N 1.31 -1.114 0 CA-C-N 115.8 -0.637 . . . . 4.09 109.467 179.781 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A 1624 ' ' PRO . . . . . 0.482 ' HA ' ' O ' ' A' 1639 ' ' SER . 39.5 Cg_endo -87.14 101.17 0.52 Allowed 'Trans proline' 0 N--CA 1.443 -1.452 0 C-N-CA 122.777 2.318 . . . . 2.86 111.112 174.931 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A 1625 ' ' MET . . . . . . . . . . . . . 1.5 pmm? -96.17 153.3 17.87 Favored 'General case' 0 C--N 1.301 -1.505 0 N-CA-C 109.701 -0.481 . . . . 2.73 109.701 179.696 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A 1626 ' ' LEU . . . . . . . . . . . . . 40.6 tp -81.91 105.25 12.88 Favored 'General case' 0 C--N 1.31 -1.145 0 N-CA-C 108.687 -0.857 . . . . 1.94 108.687 177.919 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A 1627 ' ' ILE . . . . . . . . . . . . . 46.2 pt -87.21 -26.39 5.94 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.988 0 CA-C-N 116.083 -0.508 . . . . 1.75 112.134 -175.187 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A 1628 ' ' SER . . . . . . . . . . . . . 13.0 t -160.8 144.49 13.46 Favored 'General case' 0 N--CA 1.437 -1.09 0 N-CA-C 109.496 -0.557 . . . . 1.85 109.496 -178.3 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A 1629 ' ' LEU . . . . . 1.004 ' HG ' ' HG ' ' A' 1636 ' ' LEU . 4.4 tt -133.96 112.27 11.11 Favored 'General case' 0 C--N 1.306 -1.319 0 N-CA-C 107.023 -1.473 . . . . 2.12 107.023 177.572 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A 1630 ' ' ASP . . . . . . . . . . . . . 29.4 t70 -92.23 117.56 30.0 Favored 'General case' 0 C--N 1.307 -1.248 0 N-CA-C 108.84 -0.8 . . . . 0.87 108.84 177.553 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A 1631 ' ' LYS . . . . . . . . . . . . . 94.8 mttt -86.48 -5.77 59.07 Favored 'General case' 0 C--N 1.303 -1.422 0 CA-C-N 116.454 -0.339 . . . . 2.76 111.572 -176.253 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A 1632 ' ' GLN . . . . . . . . . . . . . 39.2 mt-30 -81.43 -45.67 15.71 Favored 'General case' 0 N--CA 1.447 -0.588 0 N-CA-C 109.961 -0.385 . . . . 2.55 109.961 -178.981 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A 1633 ' ' THR . . . . . . . . . . . . . 11.4 p -109.82 13.21 23.68 Favored 'General case' 0 C--N 1.305 -1.353 0 CA-C-N 115.799 -0.637 . . . . 1.92 111.639 178.495 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A 1634 ' ' CYS . . . . . 0.544 ' HB3' ' HA ' ' A' 1606 ' ' TYR . 65.4 m 47.52 41.89 13.81 Favored 'General case' 0 N--CA 1.474 0.728 0 C-N-CA 123.943 0.897 . . . . 0.89 112.976 179.879 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A 1635 ' ' THR . . . . . . . . . . . . . 33.4 m -105.33 117.07 33.08 Favored 'General case' 0 N--CA 1.417 -2.079 0 CA-C-N 115.368 -0.833 . . . . 1.31 109.596 -177.542 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A 1636 ' ' LEU . . . . . 1.004 ' HG ' ' HG ' ' A' 1629 ' ' LEU . 5.4 mp -101.84 129.73 48.13 Favored 'General case' 0 C--N 1.311 -1.09 0 N-CA-C 109.15 -0.685 . . . . 1.97 109.15 179.966 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A 1637 ' ' PHE . . . . . . . . . . . . . 80.6 m-85 -108.1 109.92 21.47 Favored 'General case' 0 C--N 1.308 -1.237 0 CA-C-N 116.27 -0.423 . . . . 0.92 111.123 -175.874 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A 1638 ' ' PHE . . . . . 0.691 ' HB2' HG13 ' A' 1610 ' ' ILE . 97.1 m-85 -107.68 149.01 28.64 Favored 'General case' 0 C--N 1.304 -1.391 0 N-CA-C 108.454 -0.943 . . . . 0.7 108.454 176.151 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A 1639 ' ' SER . . . . . 0.482 ' O ' ' HA ' ' A' 1624 ' ' PRO . 43.5 m -137.58 121.18 17.3 Favored 'General case' 0 C--N 1.294 -1.825 0 N-CA-C 109.795 -0.446 . . . . 1.46 109.795 178.051 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A 1640 ' ' TRP . . . . . 0.43 ' CD1' ' HB ' ' A' 1642 ' ' THR . 3.8 t90 -100.61 125.13 46.97 Favored 'General case' 0 C--N 1.314 -0.966 0 N-CA-C 108.445 -0.946 . . . . 0.92 108.445 -179.828 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A 1641 ' ' HIS . . . . . 0.426 ' O ' ' HA ' ' A' 1622 ' ' ASN . 11.4 m-70 -89.67 94.79 9.98 Favored 'General case' 0 C--N 1.307 -1.277 0 N-CA-C 105.63 -1.989 . . . . 3.18 105.63 175.093 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A 1642 ' ' THR . . . . . 0.652 ' OG1' ' HG ' ' A' 1644 ' ' LEU . 12.2 t -142.12 138.39 16.73 Favored Pre-proline 0 C--N 1.303 -1.419 0 C-N-CA 119.663 -0.815 . . . . 1.48 112.867 -171.886 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A 1643 ' ' PRO . . . . . 0.446 ' HD3' ' HA ' ' A' 1642 ' ' THR . 15.1 Cg_exo -71.96 -25.14 20.01 Favored 'Trans proline' 0 N--CA 1.456 -0.733 0 C-N-CA 123.34 2.694 . . . . 1.09 112.027 175.969 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A 1644 ' ' LEU . . . . . 0.652 ' HG ' ' OG1' ' A' 1642 ' ' THR . 4.0 pp -70.55 -17.17 62.93 Favored 'General case' 0 N--CA 1.478 0.932 0 N-CA-C 112.348 0.499 . . . . 2.08 112.348 -176.636 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A 1645 ' ' ALA . . . . . 0.422 ' HB1' HG21 ' A' 1642 ' ' THR . . . -64.0 -41.52 97.47 Favored 'General case' 0 N--CA 1.448 -0.543 0 CA-C-N 115.495 -0.775 . . . . 1.37 109.24 178.948 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A 1646 ' ' CYS . . . . . . . . . . . . . 19.2 p -177.11 116.02 0.1 Allowed 'General case' 0 C--O 1.244 0.791 0 C-N-CA 124.473 1.109 . . . . 1.7 108.342 171.903 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A 1647 ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -93.58 135.27 25.39 Favored Pre-proline 0 C--N 1.294 -1.834 0 O-C-N 121.961 -0.462 . . . . 2.92 110.212 179.164 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A 1648 ' ' PRO . . . . . . . . . . . . . 19.0 Cg_endo -61.6 102.44 0.24 Allowed 'Trans proline' 0 C--O 1.245 0.872 0 C-N-CA 122.857 2.371 . . . . 3.19 111.2 178.858 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A 1649 ' ' GLU . . . . . . . . . . . . . 7.6 pt-20 . . . . . 0 C--N 1.303 -1.454 0 CA-C-O 118.455 -0.783 . . . . 5.06 110.597 -179.316 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A 1508 ' ' MET . . . . . . . . . . . . . 26.3 mmt . . . . . 0 CA--C 1.517 -0.312 0 CA-C-O 120.41 0.147 . . . . 8.58 110.829 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A 1509 ' ' LYS . . . . . . . . . . . . . 68.3 mttm -135.37 52.23 2.03 Favored 'General case' 0 N--CA 1.45 -0.451 0 O-C-N 122.088 -0.382 . . . . 6.8 111.988 -178.162 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A 1510 ' ' SER . . . . . . . . . . . . . 19.7 m -80.23 50.37 1.24 Allowed 'General case' 0 C--N 1.317 -0.841 0 CA-C-O 121.752 0.787 . . . . 4.48 110.145 -179.369 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A 1511 ' ' ASN . . . . . . . . . . . . . 13.8 t30 -170.5 -59.45 0.02 OUTLIER 'General case' 0 C--N 1.307 -1.247 0 N-CA-C 108.31 -0.996 . . . . 3.08 108.31 -173.457 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A 1512 ' ' GLU . . . . . . . . . . . . . 31.6 tt0 -53.49 -41.79 66.63 Favored 'General case' 0 CA--C 1.543 0.676 0 C-N-CA 124.307 1.043 . . . . 4.46 112.719 -175.952 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A 1513 ' ' HIS . . . . . 0.508 ' HB3' ' O ' ' A' 1581 ' ' LEU . 9.6 p80 -132.87 31.83 3.87 Favored 'General case' 0 CA--C 1.511 -0.528 0 C-N-CA 120.003 -0.679 . . . . 6.25 111.383 179.315 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A 1514 ' ' ASP . . . . . . . . . . . . . 20.3 t70 -82.03 -47.83 12.16 Favored 'General case' 0 C--N 1.312 -1.027 0 N-CA-C 107.304 -1.369 . . . . 3.7 107.304 179.259 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A 1515 ' ' ASP . . . . . . . . . . . . . 3.4 p-10 -155.84 172.54 18.18 Favored 'General case' 0 C--N 1.3 -1.57 0 N-CA-C 103.536 -2.765 . . . . 2.54 103.536 174.852 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A 1516 ' ' CYS . . . . . 0.465 ' HB3' ' HB2' ' A' 1529 ' ' LEU . 58.1 m -79.37 61.75 3.52 Favored 'General case' 0 C--N 1.301 -1.541 0 N-CA-C 113.924 1.083 . . . . 1.25 113.924 -172.375 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A 1517 ' ' GLN . . . . . 0.52 ' HA ' ' O ' ' A' 1527 ' ' PHE . 11.1 pt20 -145.22 122.14 11.31 Favored 'General case' 0 N--CA 1.425 -1.702 0 N-CA-C 107.41 -1.329 . . . . 2.36 107.41 172.351 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A 1518 ' ' VAL . . . . . . . . . . . . . 84.9 t -109.23 106.21 20.26 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.941 0 N-CA-C 109.059 -0.719 . . . . 2.34 109.059 179.98 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A 1519 ' ' THR . . . . . . . . . . . . . 19.0 m -86.36 113.19 22.13 Favored 'General case' 0 C--N 1.287 -2.111 0 N-CA-C 107.066 -1.457 . . . . 2.04 107.066 175.772 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A 1520 ' ' ASN . . . . . . . . . . . . . 49.8 t-20 -87.52 104.81 7.1 Favored Pre-proline 0 C--N 1.308 -1.216 0 N-CA-C 107.766 -1.198 . . . . 2.12 107.766 179.437 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A 1521 ' ' PRO . . . . . . . . . . . . . 63.3 Cg_endo -71.48 -12.17 29.13 Favored 'Trans proline' 0 C--N 1.353 0.803 0 C-N-CA 122.505 2.137 . . . . 2.59 112.831 -174.613 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A 1522 ' ' SER . . . . . . . . . . . . . 5.8 m -76.95 -23.32 52.39 Favored 'General case' 0 N--CA 1.431 -1.421 0 CA-C-N 115.988 -0.551 . . . . 2.65 110.242 -178.953 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A 1523 ' ' THR . . . . . . . . . . . . . 5.0 t -127.44 -23.52 3.48 Favored 'General case' 0 CA--C 1.545 0.756 0 N-CA-C 112.46 0.541 . . . . 2.33 112.46 179.319 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A 1524 ' ' GLY . . . . . . . . . . . . . . . 100.1 -17.7 56.73 Favored Glycine 0 N--CA 1.447 -0.568 0 C-N-CA 120.566 -0.826 . . . . 1.96 112.168 -179.002 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A 1525 ' ' HIS . . . . . . . . . . . . . 17.4 t-80 -75.3 134.64 41.01 Favored 'General case' 0 C--N 1.312 -1.048 0 C-N-CA 123.009 0.524 . . . . 2.44 111.244 -177.379 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A 1526 ' ' LEU . . . . . 0.505 HD22 ' HB2' ' A' 1517 ' ' GLN . 7.1 tt -111.27 135.79 51.3 Favored 'General case' 0 C--N 1.313 -0.988 0 CA-C-N 115.666 -0.697 . . . . 2.19 109.271 -178.586 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A 1527 ' ' PHE . . . . . 0.52 ' O ' ' HA ' ' A' 1517 ' ' GLN . 85.2 m-85 -102.14 106.36 17.2 Favored 'General case' 0 C--N 1.312 -1.028 0 N-CA-C 108.893 -0.78 . . . . 1.61 108.893 177.334 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A 1528 ' ' ASP . . . . . . . . . . . . . 9.9 t70 -97.82 115.58 28.32 Favored 'General case' 0 C--N 1.319 -0.737 0 N-CA-C 109.654 -0.499 . . . . 2.18 109.654 179.76 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A 1529 ' ' LEU . . . . . 0.465 ' HB2' ' HB3' ' A' 1516 ' ' CYS . 84.6 mt -106.69 -12.99 15.4 Favored 'General case' 0 C--N 1.308 -1.21 0 CA-C-N 116.166 -0.47 . . . . 2.04 111.157 -178.398 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A 1530 ' ' SER . . . . . 0.481 ' HA ' ' HB3' ' A' 1553 ' ' CYS . 17.1 m -71.65 -47.38 54.75 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-O 121.036 0.446 . . . . 1.44 109.903 -178.102 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A 1531 ' ' SER . . . . . . . . . . . . . 13.3 m -70.01 -9.7 56.15 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.366 -0.833 . . . . 1.63 111.515 -175.936 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A 1532 ' ' LEU . . . . . . . . . . . . . 58.9 mt -76.55 -18.69 58.55 Favored 'General case' 0 C--N 1.313 -1.004 0 CA-C-N 116.382 -0.372 . . . . 2.32 110.446 178.142 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A 1533 ' ' SER . . . . . 0.464 ' OG ' ' HB ' ' A' 1552 ' ' ILE . 19.6 m -100.91 143.13 31.43 Favored 'General case' 0 C--N 1.315 -0.895 0 CA-C-N 116.226 -0.443 . . . . 2.57 110.848 -176.38 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A 1534 ' ' GLY . . . . . . . . . . . . . . . -102.18 -174.64 27.61 Favored Glycine 0 N--CA 1.42 -2.375 0 N-CA-C 109.512 -1.435 . . . . 1.89 109.512 175.401 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A 1535 ' ' ARG . . . . . . . . . . . . . 36.3 ttm180 -69.48 -50.05 48.99 Favored 'General case' 0 C--N 1.294 -1.815 0 N-CA-C 112.035 0.383 . . . . 4.44 112.035 -177.822 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A 1536 ' ' ALA . . . . . 0.526 ' HB2' HD22 ' A' 1558 ' ' ASN . . . -69.77 -48.89 57.57 Favored 'General case' 0 C--N 1.313 -0.979 0 CA-C-N 116.038 -0.528 . . . . 2.07 111.772 -175.82 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A 1537 ' ' GLY . . . . . 0.555 ' HA3' ' ND2' ' A' 1556 ' ' ASN . . . 119.66 -173.84 15.27 Favored Glycine 0 N--CA 1.444 -0.806 0 C-N-CA 121.289 -0.481 . . . . 1.2 112.914 175.535 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A 1538 ' ' PHE . . . . . 0.461 ' HE2' ' HA ' ' A' 1533 ' ' SER . 97.4 m-85 -116.51 170.37 8.62 Favored 'General case' 0 C--N 1.313 -1.013 0 C-N-CA 123.29 0.636 . . . . 1.98 109.917 -179.953 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A 1539 ' ' THR . . . . . 0.544 ' HA ' ' O ' ' A' 1548 ' ' VAL . 16.9 p -129.85 130.28 45.03 Favored 'General case' 0 N--CA 1.438 -1.042 0 CA-C-N 116.028 -0.533 . . . . 1.97 111.528 177.988 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A 1540 ' ' ALA . . . . . . . . . . . . . . . -103.36 146.98 27.67 Favored 'General case' 0 C--N 1.301 -1.52 0 N-CA-C 107.745 -1.206 . . . . 1.39 107.745 173.348 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A 1541 ' ' ALA . . . . . . . . . . . . . . . -77.88 130.89 37.16 Favored 'General case' 0 C--O 1.246 0.89 0 N-CA-C 109.815 -0.439 . . . . 1.86 109.815 -177.98 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A 1542 ' ' TYR . . . . . 0.679 ' HD2' ' HB2' ' A' 1545 ' ' SER . 70.0 t80 -139.88 168.09 20.61 Favored 'General case' 0 N--CA 1.437 -1.087 0 CA-C-O 119.425 -0.321 . . . . 2.4 110.245 -176.237 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A 1543 ' ' SER . . . . . . . . . . . . . 12.0 m -49.09 -151.99 0.0 OUTLIER 'General case' 0 CA--C 1.576 1.979 0 C-N-CA 128.796 2.838 . . . . 2.58 113.754 178.224 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A 1544 ' ' LYS . . . . . . . . . . . . . 39.7 ttmt -40.29 -35.48 0.42 Allowed 'General case' 0 N--CA 1.486 1.366 0 O-C-N 121.041 -1.037 . . . . 4.24 113.547 177.886 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A 1545 ' ' SER . . . . . 0.679 ' HB2' ' HD2' ' A' 1542 ' ' TYR . 19.3 m -66.55 -12.07 55.97 Favored 'General case' 0 CA--C 1.568 1.639 0 N-CA-C 112.856 0.688 . . . . 3.6 112.856 176.469 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A 1546 ' ' GLY . . . . . . . . . . . . . . . 82.24 -74.09 2.54 Favored Glycine 0 N--CA 1.446 -0.641 0 N-CA-C 114.6 0.6 . . . . 1.66 114.6 172.151 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A 1547 ' ' VAL . . . . . . . . . . . . . 15.4 m -138.41 146.52 26.56 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.244 0 CA-C-O 121.185 0.517 . . . . 2.23 111.272 -176.506 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A 1548 ' ' VAL . . . . . 0.544 ' O ' ' HA ' ' A' 1539 ' ' THR . 2.3 t -108.04 126.45 64.59 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.52 0 N-CA-C 106.675 -1.602 . . . . 1.59 106.675 176.573 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A 1549 ' ' TYR . . . . . 0.612 ' HD2' ' HA3' ' A' 1568 ' ' GLY . 6.4 m-85 -84.87 120.67 26.73 Favored 'General case' 0 C--N 1.301 -1.516 0 N-CA-C 108.452 -0.944 . . . . 1.58 108.452 174.906 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A 1550 ' ' MET . . . . . . . . . . . . . 60.7 mtp -135.87 164.96 26.74 Favored 'General case' 0 C--N 1.292 -1.924 0 CA-C-N 115.002 -0.999 . . . . 2.08 110.518 -173.489 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A 1551 ' ' SER . . . . . . . . . . . . . 13.9 p -129.7 144.57 51.35 Favored 'General case' 0 C--N 1.283 -2.31 0 N-CA-C 106.495 -1.668 . . . . 1.9 106.495 175.002 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A 1552 ' ' ILE . . . . . 0.464 ' HB ' ' OG ' ' A' 1533 ' ' SER . 46.0 mm -74.25 -29.44 24.71 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.483 0 N-CA-C 107.525 -1.287 . . . . 2.04 107.525 179.871 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A 1553 ' ' CYS . . . . . 0.484 ' HA ' ' HH ' ' A' 1592 ' ' TYR . 46.7 t -161.79 149.96 15.08 Favored 'General case' 0 N--CA 1.419 -1.986 0 N-CA-C 105.93 -1.878 . . . . 1.43 105.93 171.661 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A 1554 ' ' GLY . . . . . . . . . . . . . . . 94.22 -153.42 21.07 Favored Glycine 0 N--CA 1.427 -1.919 0 C-N-CA 120.304 -0.95 . . . . 1.23 111.103 178.752 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A 1555 ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -122.73 145.0 48.79 Favored 'General case' 0 C--N 1.294 -1.825 0 CA-C-O 121.471 0.653 . . . . 1.8 110.963 -176.675 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A 1556 ' ' ASN . . . . . 0.555 ' ND2' ' HA3' ' A' 1537 ' ' GLY . 24.9 t-20 -87.59 138.25 31.63 Favored 'General case' 0 C--N 1.299 -1.605 0 N-CA-C 108.39 -0.967 . . . . 2.63 108.39 179.464 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A 1557 ' ' GLU . . . . . . . . . . . . . 42.9 mt-10 -114.45 34.1 4.93 Favored 'General case' 0 C--N 1.317 -0.806 0 N-CA-C 113.557 0.947 . . . . 3.79 113.557 -175.83 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A 1558 ' ' ASN . . . . . 0.526 HD22 ' HB2' ' A' 1536 ' ' ALA . 25.2 m-80 -128.65 26.13 5.63 Favored 'General case' 0 C--N 1.313 -0.981 0 CA-C-O 122.839 1.304 . . . . 1.59 108.389 173.039 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A 1559 ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -161.84 173.17 4.81 Favored Pre-proline 0 C--N 1.29 -1.999 0 N-CA-C 104.621 -2.362 . . . . 0.94 104.621 179.009 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A 1560 ' ' PRO . . . . . 0.6 ' O ' HG21 ' A' 1563 ' ' VAL . 2.4 Cg_endo -40.7 117.45 0.5 Allowed 'Trans proline' 0 C--N 1.365 1.397 0 C-N-CA 123.538 2.826 . . . . 1.53 113.0 178.187 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A 1561 ' ' PRO . . . . . . . . . . . . . 36.8 Cg_exo -57.84 111.85 0.97 Allowed 'Trans proline' 0 C--O 1.248 0.996 0 C-N-CA 122.428 2.085 . . . . 1.82 110.546 -179.398 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A 1562 ' ' GLY . . . . . . . . . . . . . . . 129.17 -0.22 6.01 Favored Glycine 0 N--CA 1.431 -1.687 0 CA-C-N 115.534 -0.757 . . . . 0.81 112.596 -177.646 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A 1563 ' ' VAL . . . . . 0.6 HG21 ' O ' ' A' 1560 ' ' PRO . 25.2 m -105.98 146.96 12.11 Favored 'Isoleucine or valine' 0 CA--C 1.493 -1.238 0 O-C-N 122.151 -0.617 . . . . 1.73 111.048 175.325 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A 1564 ' ' GLY . . . . . . . . . . . . . . . -103.7 -8.07 40.75 Favored Glycine 0 N--CA 1.418 -2.526 0 N-CA-C 109.83 -1.308 . . . . 0.72 109.83 175.477 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A 1565 ' ' ALA . . . . . . . . . . . . . . . -152.58 119.39 5.74 Favored 'General case' 0 N--CA 1.441 -0.911 0 CA-C-O 121.303 0.573 . . . . 1.14 110.381 -179.838 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A 1566 ' ' CYS . . . . . . . . . . . . . 6.7 t -154.76 136.07 14.07 Favored 'General case' 0 C--N 1.297 -1.686 0 N-CA-C 108.816 -0.809 . . . . 0.51 108.816 -178.279 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A 1567 ' ' PHE . . . . . . . . . . . . . 26.1 m-85 -67.11 122.76 18.52 Favored 'General case' 0 C--O 1.208 -1.1 0 N-CA-C 106.334 -1.728 . . . . 1.22 106.334 176.322 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A 1568 ' ' GLY . . . . . 0.612 ' HA3' ' HD2' ' A' 1549 ' ' TYR . . . -72.57 -36.89 58.45 Favored Glycine 0 CA--C 1.489 -1.569 0 C-N-CA 121.035 -0.602 . . . . 1.08 114.453 -169.136 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A 1569 ' ' GLN . . . . . . . . . . . . . 30.1 tt0 -74.57 -43.97 53.1 Favored 'General case' 0 C--N 1.302 -1.469 0 CA-C-O 121.767 0.794 . . . . 3.05 109.662 -179.931 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A 1570 ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -81.27 -26.23 35.92 Favored 'General case' 0 C--N 1.286 -2.154 0 CA-C-N 114.497 -1.229 . . . . 2.44 112.138 -173.092 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A 1571 ' ' ARG . . . . . . . . . . . . . 66.1 mtt180 60.65 47.33 8.34 Favored 'General case' 0 C--O 1.234 0.26 0 C-N-CA 125.947 1.699 . . . . 4.48 111.653 -178.493 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A 1572 ' ' ILE . . . . . . . . . . . . . 40.8 mm -121.77 128.61 75.76 Favored 'Isoleucine or valine' 0 C--O 1.24 0.579 0 N-CA-C 108.228 -1.027 . . . . 1.94 108.228 -179.616 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A 1573 ' ' SER . . . . . . . . . . . . . 28.2 t -79.03 138.61 38.08 Favored 'General case' 0 C--N 1.312 -1.057 0 C-N-CA 124.014 0.926 . . . . 1.25 112.447 -175.972 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A 1574 ' ' VAL . . . . . . . . . . . . . 15.4 m -136.31 24.03 0.86 Allowed 'Isoleucine or valine' 0 C--N 1.318 -0.771 0 CA-C-O 121.581 0.705 . . . . 1.61 110.342 174.731 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A 1575 ' ' GLY . . . . . . . . . . . . . . . 169.03 115.21 0.32 Allowed Glycine 0 N--CA 1.442 -0.958 0 CA-C-N 115.301 -0.863 . . . . 0.65 111.997 178.043 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A 1576 ' ' LYS . . . . . 0.691 ' HG3' ' HA2' ' A' 1595 ' ' GLY . 98.6 mttt -86.25 154.33 21.36 Favored 'General case' 0 C--N 1.315 -0.934 0 O-C-N 122.599 -0.354 . . . . 3.33 110.074 179.297 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A 1577 ' ' ALA . . . . . . . . . . . . . . . -69.79 119.52 14.14 Favored 'General case' 0 C--O 1.244 0.803 0 CA-C-N 115.453 -0.794 . . . . 1.31 110.241 -178.19 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A 1578 ' ' ASN . . . . . . . . . . . . . 40.0 m-80 -141.98 162.4 35.56 Favored 'General case' 0 C--N 1.305 -1.355 0 N-CA-C 107.123 -1.436 . . . . 2.24 107.123 -179.427 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A 1579 ' ' LYS . . . . . . . . . . . . . 75.2 mmtt -102.76 88.8 3.3 Favored 'General case' 0 C--N 1.307 -1.264 0 N-CA-C 107.77 -1.196 . . . . 2.34 107.77 175.842 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A 1580 ' ' ARG . . . . . . . . . . . . . 17.2 ttm180 -136.08 84.77 2.1 Favored 'General case' 0 C--N 1.293 -1.854 0 CA-C-O 121.926 0.87 . . . . 4.19 109.159 -179.238 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A 1581 ' ' LEU . . . . . 0.508 ' O ' ' HB3' ' A' 1513 ' ' HIS . 49.1 tp -113.6 147.78 37.41 Favored 'General case' 0 C--N 1.294 -1.818 0 CA-C-N 114.053 -1.43 . . . . 2.39 107.302 -179.41 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A 1582 ' ' ARG . . . . . . . . . . . . . 55.3 ttp180 -141.97 144.06 33.52 Favored 'General case' 0 C--N 1.295 -1.802 0 N-CA-C 109.99 -0.374 . . . . 4.48 109.99 -175.492 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A 1583 ' ' TYR . . . . . . . . . . . . . 74.2 t80 -128.09 104.59 7.85 Favored 'General case' 0 C--N 1.299 -1.604 0 N-CA-C 108.368 -0.975 . . . . 1.57 108.368 176.704 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A 1584 ' ' VAL . . . . . . . . . . . . . 13.6 p -148.25 131.88 8.48 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.164 0 N-CA-C 109.117 -0.697 . . . . 2.29 109.117 178.529 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A 1585 ' ' ASP . . . . . . . . . . . . . 37.5 t70 65.7 32.45 9.01 Favored 'General case' 0 N--CA 1.482 1.13 0 CA-C-O 122.622 1.201 . . . . 2.06 109.621 -177.721 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A 1586 ' ' GLN . . . . . . . . . . . . . 51.1 mt-30 65.05 4.89 2.7 Favored 'General case' 0 N--CA 1.473 0.707 0 C-N-CA 125.642 1.577 . . . . 2.61 114.674 178.606 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A 1587 ' ' VAL . . . . . . . . . . . . . 7.1 p -108.32 130.09 61.54 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.394 0 CA-C-O 121.087 0.47 . . . . 1.33 109.876 178.944 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A 1588 ' ' LEU . . . . . 0.555 ' HB2' ' HB2' ' A' 1612 ' ' PHE . 3.8 mm? -84.18 146.5 27.8 Favored 'General case' 0 N--CA 1.439 -0.991 0 CA-C-N 116.047 -0.524 . . . . 2.03 110.838 -178.523 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A 1589 ' ' GLN . . . . . . . . . . . . . 35.2 tt0 -147.13 127.61 14.08 Favored 'General case' 0 C--N 1.302 -1.49 0 N-CA-C 109.819 -0.438 . . . . 1.73 109.819 178.475 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A 1590 ' ' LEU . . . . . . . . . . . . . 6.7 tt -125.59 138.39 53.94 Favored 'General case' 0 C--N 1.308 -1.217 0 N-CA-C 107.016 -1.476 . . . . 1.76 107.016 179.895 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A 1591 ' ' VAL . . . . . 0.496 ' HB ' HG21 ' A' 1609 ' ' VAL . 5.0 p -137.54 134.16 46.24 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.292 0 CA-C-O 121.312 0.577 . . . . 2.14 112.132 -176.459 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A 1592 ' ' TYR . . . . . 0.484 ' HH ' ' HA ' ' A' 1553 ' ' CYS . 77.5 m-85 -97.63 96.36 8.22 Favored 'General case' 0 N--CA 1.431 -1.402 0 N-CA-C 107.347 -1.353 . . . . 1.53 107.347 174.079 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A 1593 ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -88.52 157.81 18.52 Favored 'General case' 0 C--N 1.295 -1.78 0 CA-C-N 115.058 -0.973 . . . . 2.72 111.932 -177.107 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A 1594 ' ' ASP . . . . . . . . . . . . . 5.6 m-20 48.77 79.27 0.08 Allowed 'General case' 0 N--CA 1.475 0.78 0 N-CA-C 115.453 1.649 . . . . 1.45 115.453 -179.664 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A 1595 ' ' GLY . . . . . 0.691 ' HA2' ' HG3' ' A' 1576 ' ' LYS . . . -96.5 -107.94 2.43 Favored Glycine 0 N--CA 1.441 -0.985 0 N-CA-C 109.312 -1.515 . . . . 0.83 109.312 171.245 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A 1596 ' ' SER . . . . . . . . . . . . . 34.2 t -82.8 142.57 45.44 Favored Pre-proline 0 C--N 1.309 -1.166 0 N-CA-C 107.245 -1.391 . . . . 1.96 107.245 175.451 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A 1597 ' ' PRO . . . . . . . . . . . . . 22.0 Cg_exo -65.13 142.21 73.05 Favored 'Trans proline' 0 N--CA 1.457 -0.65 0 C-N-CA 122.646 2.231 . . . . 1.34 110.248 177.219 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A 1598 ' ' CYS . . . . . . . . . . . . . 49.8 t -95.45 112.85 60.27 Favored Pre-proline 0 C--N 1.306 -1.31 0 N-CA-C 108.972 -0.751 . . . . 1.19 108.972 -178.178 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A 1599 ' ' PRO . . . . . . . . . . . . . 71.5 Cg_endo -76.91 -19.9 13.63 Favored 'Trans proline' 0 N--CA 1.464 -0.236 0 C-N-CA 122.395 2.064 . . . . 1.88 112.453 -176.939 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A 1600 ' ' SER . . . . . . . . . . . . . 4.1 m -76.4 -26.33 55.45 Favored 'General case' 0 C--N 1.314 -0.967 0 CA-C-O 121.818 0.818 . . . . 2.19 109.955 -177.931 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A 1601 ' ' LYS . . . . . 0.525 ' HG3' ' O ' ' A' 1632 ' ' GLN . 12.9 mmmm -134.71 72.01 1.45 Allowed 'General case' 0 N--CA 1.434 -1.256 0 CA-C-N 114.971 -1.013 . . . . 4.21 108.933 178.387 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A 1602 ' ' SER . . . . . . . . . . . . . 3.2 p -49.86 116.37 1.78 Allowed 'General case' 0 N--CA 1.441 -0.905 0 CA-C-N 113.871 -1.513 . . . . 3.82 112.66 -179.304 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A 1603 ' ' GLY . . . . . . . . . . . . . . . 135.94 -29.79 2.81 Favored Glycine 0 N--CA 1.431 -1.671 0 N-CA-C 111.062 -0.815 . . . . 2.45 111.062 -179.595 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A 1604 ' ' LEU . . . . . . . . . . . . . 2.3 pp -127.11 166.72 17.11 Favored 'General case' 0 C--N 1.317 -0.83 0 CA-C-O 121.105 0.478 . . . . 2.06 111.59 179.844 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A 1605 ' ' SER . . . . . . . . . . . . . 21.0 m -109.13 -172.03 1.97 Allowed 'General case' 0 C--N 1.296 -1.719 0 C-N-CA 123.326 0.65 . . . . 1.75 109.367 -177.817 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A 1606 ' ' TYR . . . . . 0.511 ' HA ' ' O ' ' A' 1634 ' ' CYS . 79.0 m-85 -95.83 136.68 35.93 Favored 'General case' 0 N--CA 1.405 -2.704 0 N-CA-C 104.897 -2.26 . . . . 1.59 104.897 177.614 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A 1607 ' ' LYS . . . . . 0.521 ' HG3' HG21 ' A' 1635 ' ' THR . 21.6 ptmt -137.56 147.84 45.44 Favored 'General case' 0 C--N 1.262 -3.209 0 N-CA-C 108.625 -0.88 . . . . 2.21 108.625 -179.206 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A 1608 ' ' SER . . . . . . . . . . . . . 47.1 m -125.33 122.25 36.28 Favored 'General case' 0 C--N 1.303 -1.454 0 C-N-CA 120.886 -0.326 . . . . 1.48 111.05 -178.635 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A 1609 ' ' VAL . . . . . 0.496 HG21 ' HB ' ' A' 1591 ' ' VAL . 7.2 p -110.69 139.79 32.77 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 CA-C-O 120.69 0.281 . . . . 1.57 110.357 -179.91 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A 1610 ' ' ILE . . . . . 0.723 HG13 ' HB2' ' A' 1638 ' ' PHE . 3.7 mp -118.05 118.33 57.85 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.357 0 N-CA-C 108.072 -1.084 . . . . 1.47 108.072 174.871 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A 1611 ' ' SER . . . . . . . . . . . . . 48.0 m -98.19 133.02 43.2 Favored 'General case' 0 C--N 1.286 -2.191 0 N-CA-C 108.949 -0.759 . . . . 1.84 108.949 177.745 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A 1612 ' ' PHE . . . . . 0.563 ' HE1' ' HE3' ' A' 1640 ' ' TRP . 91.3 m-85 -99.58 106.68 18.68 Favored 'General case' 0 C--N 1.3 -1.585 0 CA-C-N 116.144 -0.48 . . . . 0.86 111.653 -173.713 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A 1613 ' ' VAL . . . . . 0.495 ' O ' ' HA ' ' A' 1641 ' ' HIS . 84.5 t -107.44 129.03 62.01 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.552 0 CA-C-N 114.921 -1.036 . . . . 1.32 109.302 -178.895 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A 1614 ' ' CYS . . . . . 0.451 ' HA ' ' O ' ' A' 1642 ' ' THR . 0.5 OUTLIER -81.32 106.89 13.65 Favored 'General case' 0 C--N 1.297 -1.704 0 N-CA-C 113.856 1.058 . . . . 1.39 113.856 -177.683 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A 1615 ' ' ARG . . . . . 0.405 ' HB3' ' HB3' ' A' 1641 ' ' HIS . 12.0 tpp180 -138.06 106.41 8.05 Favored Pre-proline 0 N--CA 1.428 -1.559 0 N-CA-C 107.897 -1.149 . . . . 4.34 107.897 175.493 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A 1616 ' ' PRO . . . . . 0.409 ' HA ' ' HB3' ' A' 1643 ' ' PRO . 97.4 Cg_endo -79.08 5.57 5.65 Favored 'Trans proline' 0 CA--C 1.534 0.485 0 C-N-CA 122.649 2.233 . . . . 1.5 113.059 -176.231 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A 1617 ' ' GLU . . . . . . . . . . . . . 39.0 mt-10 -98.54 7.38 46.22 Favored 'General case' 0 C--N 1.307 -1.28 0 CA-C-O 121.419 0.628 . . . . 3.21 110.771 -178.04 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A 1618 ' ' ALA . . . . . . . . . . . . . . . -91.12 108.12 19.66 Favored 'General case' 0 C--N 1.303 -1.42 0 CA-C-N 115.999 -0.546 . . . . 2.91 109.862 179.467 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A 1619 ' ' GLY . . . . . . . . . . . . . . . -95.39 -94.62 1.72 Allowed Glycine 0 N--CA 1.436 -1.318 0 N-CA-C 109.486 -1.446 . . . . 3.35 109.486 178.474 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A 1620 ' ' PRO . . . . . . . . . . . . . 32.5 Cg_endo -67.95 -17.38 46.42 Favored 'Trans proline' 0 CA--C 1.54 0.782 0 C-N-CA 122.245 1.963 . . . . 6.61 111.232 174.815 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A 1621 ' ' THR . . . . . . . . . . . . . 4.7 m -91.21 13.07 18.17 Favored 'General case' 0 CA--C 1.561 1.37 0 CA-C-O 122.208 1.004 . . . . 5.03 109.951 -179.356 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A 1622 ' ' ASN . . . . . . . . . . . . . 45.6 t30 -81.59 63.52 5.91 Favored 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 107.721 -1.214 . . . . 3.58 107.721 175.76 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A 1623 ' ' ARG . . . . . . . . . . . . . 12.2 ptm180 -147.13 145.59 22.66 Favored Pre-proline 0 C--N 1.302 -1.498 0 N-CA-C 108.123 -1.065 . . . . 4.09 108.123 -178.233 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A 1624 ' ' PRO . . . . . 0.429 ' HA ' ' O ' ' A' 1639 ' ' SER . 15.9 Cg_exo -69.23 123.47 10.31 Favored 'Trans proline' 0 N--CA 1.457 -0.664 0 C-N-CA 122.569 2.179 . . . . 2.86 111.361 179.193 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A 1625 ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -119.03 149.04 42.33 Favored 'General case' 0 C--N 1.303 -1.414 0 N-CA-C 109.067 -0.716 . . . . 2.73 109.067 179.277 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A 1626 ' ' LEU . . . . . . . . . . . . . 34.7 tp -76.48 122.49 24.63 Favored 'General case' 0 C--N 1.306 -1.303 0 N-CA-C 108.083 -1.08 . . . . 1.94 108.083 177.516 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A 1627 ' ' ILE . . . . . . . . . . . . . 24.4 pt -100.19 -28.26 3.38 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.312 0 C-N-CA 120.654 -0.418 . . . . 1.75 111.158 -178.876 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A 1628 ' ' SER . . . . . . . . . . . . . 35.8 t -157.86 159.08 36.26 Favored 'General case' 0 N--CA 1.43 -1.425 0 N-CA-C 108.237 -1.023 . . . . 1.85 108.237 -175.868 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A 1629 ' ' LEU . . . . . 0.761 ' HG ' ' HG ' ' A' 1636 ' ' LEU . 4.1 tt -145.9 134.05 21.6 Favored 'General case' 0 C--N 1.293 -1.89 0 N-CA-C 105.512 -2.033 . . . . 2.12 105.512 177.579 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A 1630 ' ' ASP . . . . . . . . . . . . . 20.1 t70 -121.0 109.93 15.66 Favored 'General case' 0 C--N 1.29 -2.0 0 N-CA-C 108.812 -0.81 . . . . 0.87 108.812 177.957 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A 1631 ' ' LYS . . . . . 0.431 ' HE3' ' HB2' ' A' 1631 ' ' LYS . 49.7 mtmt -81.07 1.16 32.75 Favored 'General case' 0 C--N 1.303 -1.435 0 N-CA-C 112.553 0.575 . . . . 2.76 112.553 -175.991 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A 1632 ' ' GLN . . . . . 0.525 ' O ' ' HG3' ' A' 1601 ' ' LYS . 2.1 mp0 -94.56 -34.3 12.71 Favored 'General case' 0 CA--C 1.509 -0.626 0 CA-C-O 121.336 0.588 . . . . 2.55 110.398 -179.226 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A 1633 ' ' THR . . . . . . . . . . . . . 24.9 p -101.32 1.87 39.11 Favored 'General case' 0 C--N 1.289 -2.055 0 CA-C-O 121.947 0.88 . . . . 1.92 108.908 172.255 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A 1634 ' ' CYS . . . . . 0.511 ' O ' ' HA ' ' A' 1606 ' ' TYR . 47.8 m 52.15 42.37 30.59 Favored 'General case' 0 C--N 1.346 0.443 0 CA-C-N 113.714 -1.584 . . . . 0.89 110.377 178.478 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A 1635 ' ' THR . . . . . 0.521 HG21 ' HG3' ' A' 1607 ' ' LYS . 55.8 m -114.9 132.55 56.5 Favored 'General case' 0 N--CA 1.425 -1.691 0 CA-C-N 114.386 -1.279 . . . . 1.31 110.048 -175.143 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A 1636 ' ' LEU . . . . . 0.761 ' HG ' ' HG ' ' A' 1629 ' ' LEU . 5.8 mp -102.94 132.55 49.1 Favored 'General case' 0 C--N 1.306 -1.293 0 N-CA-C 108.989 -0.745 . . . . 1.97 108.989 176.991 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A 1637 ' ' PHE . . . . . . . . . . . . . 72.7 m-85 -107.47 101.54 10.88 Favored 'General case' 0 C--N 1.318 -0.792 0 CA-C-N 116.242 -0.436 . . . . 0.92 111.673 -175.874 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A 1638 ' ' PHE . . . . . 0.723 ' HB2' HG13 ' A' 1610 ' ' ILE . 96.6 m-85 -100.29 160.19 14.53 Favored 'General case' 0 C--N 1.306 -1.284 0 N-CA-C 108.743 -0.836 . . . . 0.7 108.743 177.21 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A 1639 ' ' SER . . . . . 0.429 ' O ' ' HA ' ' A' 1624 ' ' PRO . 31.9 t -143.37 147.74 35.14 Favored 'General case' 0 C--N 1.283 -2.285 0 N-CA-C 107.823 -1.177 . . . . 1.46 107.823 177.204 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A 1640 ' ' TRP . . . . . 0.563 ' HE3' ' HE1' ' A' 1612 ' ' PHE . 12.4 t90 -127.75 112.26 14.6 Favored 'General case' 0 C--N 1.291 -1.942 0 N-CA-C 108.069 -1.086 . . . . 0.92 108.069 176.746 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A 1641 ' ' HIS . . . . . 0.495 ' HA ' ' O ' ' A' 1613 ' ' VAL . 25.4 m170 -88.15 102.95 15.29 Favored 'General case' 0 CA--C 1.487 -1.454 0 N-CA-C 106.953 -1.499 . . . . 3.18 106.953 176.318 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A 1642 ' ' THR . . . . . 0.451 ' O ' ' HA ' ' A' 1614 ' ' CYS . 12.5 t -142.83 141.2 19.43 Favored Pre-proline 0 N--CA 1.414 -2.231 0 CA-C-N 115.451 -0.795 . . . . 1.48 111.021 -173.149 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A 1643 ' ' PRO . . . . . 0.409 ' HB3' ' HA ' ' A' 1616 ' ' PRO . 42.4 Cg_endo -70.25 -1.68 9.27 Favored 'Trans proline' 0 C--N 1.349 0.592 0 C-N-CA 123.34 2.693 . . . . 1.09 111.567 175.942 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A 1644 ' ' LEU . . . . . . . . . . . . . 67.5 mt -86.66 -18.61 30.87 Favored 'General case' 0 C--N 1.317 -0.823 0 CA-C-N 115.692 -0.686 . . . . 2.08 110.089 178.122 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A 1645 ' ' ALA . . . . . . . . . . . . . . . -73.77 -32.91 64.03 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-O 121.648 0.737 . . . . 1.37 110.033 -179.032 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A 1646 ' ' CYS . . . . . . . . . . . . . 4.1 m -159.04 117.31 2.88 Favored 'General case' 0 C--N 1.311 -1.093 0 N-CA-C 103.558 -2.756 . . . . 1.7 103.558 175.784 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A 1647 ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -93.0 117.82 67.65 Favored Pre-proline 0 C--N 1.3 -1.583 0 C-N-CA 118.832 -1.147 . . . . 2.92 109.708 179.458 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A 1648 ' ' PRO . . . . . . . . . . . . . 38.4 Cg_exo -58.29 104.29 0.17 Allowed 'Trans proline' 0 C--O 1.239 0.544 0 C-N-CA 123.274 2.649 . . . . 3.19 113.12 -178.894 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A 1649 ' ' GLU . . . . . . . . . . . . . 42.6 mt-10 . . . . . 0 C--N 1.302 -1.481 0 N-CA-C 108.809 -0.811 . . . . 5.06 108.809 177.109 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A 1508 ' ' MET . . . . . . . . . . . . . 68.4 mtt . . . . . 0 N--CA 1.467 0.402 0 N-CA-C 109.327 -0.62 . . . . 8.58 109.327 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A 1509 ' ' LYS . . . . . . . . . . . . . 66.0 mttm -96.61 24.19 6.21 Favored 'General case' 0 C--N 1.31 -1.148 0 N-CA-C 113.134 0.791 . . . . 6.8 113.134 -176.851 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A 1510 ' ' SER . . . . . . . . . . . . . 22.8 t -76.54 -24.68 53.64 Favored 'General case' 0 N--CA 1.441 -0.883 0 N-CA-C 107.191 -1.411 . . . . 4.48 107.191 175.503 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A 1511 ' ' ASN . . . . . 0.563 ' HA ' ' HB2' ' A' 1515 ' ' ASP . 10.8 m120 -79.01 -2.23 39.29 Favored 'General case' 0 C--O 1.221 -0.444 0 CA-C-N 113.994 -1.457 . . . . 3.08 108.739 178.965 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A 1512 ' ' GLU . . . . . 0.42 ' HA ' ' HB3' ' A' 1581 ' ' LEU . 42.5 mt-10 -121.96 23.49 9.98 Favored 'General case' 0 C--N 1.319 -0.732 0 C-N-CA 124.789 1.235 . . . . 4.46 108.435 178.881 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A 1513 ' ' HIS . . . . . . . . . . . . . 28.4 t-80 -147.08 -60.72 0.28 Allowed 'General case' 0 C--N 1.314 -0.956 0 CA-C-N 115.672 -0.695 . . . . 6.25 110.478 -176.714 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A 1514 ' ' ASP . . . . . . . . . . . . . 33.2 t70 -81.67 -49.79 10.07 Favored 'General case' 0 CA--C 1.484 -1.58 0 N-CA-C 107.357 -1.349 . . . . 3.7 107.357 177.732 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A 1515 ' ' ASP . . . . . 0.661 ' HB3' ' HG2' ' A' 1517 ' ' GLN . 22.5 m-20 -89.74 156.61 18.42 Favored 'General case' 0 C--N 1.302 -1.473 0 CA-C-N 114.244 -1.344 . . . . 2.54 109.0 177.788 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A 1516 ' ' CYS . . . . . . . . . . . . . 11.0 t -118.08 39.88 3.29 Favored 'General case' 0 C--N 1.292 -1.896 0 N-CA-C 105.777 -1.935 . . . . 1.25 105.777 175.259 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A 1517 ' ' GLN . . . . . 0.661 ' HG2' ' HB3' ' A' 1515 ' ' ASP . 3.3 pt20 -151.95 127.98 10.39 Favored 'General case' 0 N--CA 1.417 -2.077 0 CA-C-N 113.792 -1.549 . . . . 2.36 107.35 -175.769 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A 1518 ' ' VAL . . . . . 0.419 HG11 ' HB2' ' A' 1583 ' ' TYR . 7.4 m -111.57 156.86 12.6 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.979 0 N-CA-C 108.747 -0.835 . . . . 2.34 108.747 -174.716 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A 1519 ' ' THR . . . . . 0.62 ' HA ' ' HA ' ' A' 1526 ' ' LEU . 28.4 m -101.84 103.06 13.74 Favored 'General case' 0 N--CA 1.404 -2.727 0 N-CA-C 106.204 -1.776 . . . . 2.04 106.204 174.1 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A 1520 ' ' ASN . . . . . . . . . . . . . 25.4 t-20 -60.02 110.31 2.72 Favored Pre-proline 0 C--O 1.22 -0.498 0 O-C-N 123.779 0.674 . . . . 2.12 110.006 -176.759 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A 1521 ' ' PRO . . . . . . . . . . . . . 21.1 Cg_exo -68.33 -14.79 41.12 Favored 'Trans proline' 0 N--CA 1.478 0.585 0 C-N-CA 122.539 2.159 . . . . 2.59 114.14 -177.419 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A 1522 ' ' SER . . . . . . . . . . . . . 15.8 m -78.49 -45.62 21.59 Favored 'General case' 0 C--N 1.308 -1.209 0 CA-C-O 120.563 0.221 . . . . 2.65 110.941 -178.353 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A 1523 ' ' THR . . . . . . . . . . . . . 15.1 t -104.96 -18.57 14.13 Favored 'General case' 0 CA--C 1.55 0.948 0 C-N-CA 120.438 -0.505 . . . . 2.33 111.832 -179.408 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A 1524 ' ' GLY . . . . . . . . . . . . . . . 87.0 5.14 81.18 Favored Glycine 0 C--N 1.331 0.269 0 C-N-CA 121.365 -0.445 . . . . 1.96 112.763 179.505 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A 1525 ' ' HIS . . . . . . . . . . . . . 23.2 t-160 -100.66 128.79 46.58 Favored 'General case' 0 C--N 1.303 -1.42 0 N-CA-C 109.691 -0.485 . . . . 2.44 109.691 -176.614 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A 1526 ' ' LEU . . . . . 0.62 ' HA ' ' HA ' ' A' 1519 ' ' THR . 5.5 tt -73.48 135.33 44.07 Favored 'General case' 0 C--N 1.305 -1.347 0 N-CA-C 107.638 -1.245 . . . . 2.19 107.638 176.057 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A 1527 ' ' PHE . . . . . 0.426 ' N ' HD22 ' A' 1526 ' ' LEU . 82.5 m-85 -112.81 110.25 20.24 Favored 'General case' 0 C--N 1.303 -1.426 0 CA-C-O 120.972 0.415 . . . . 1.61 110.873 178.052 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A 1528 ' ' ASP . . . . . . . . . . . . . 10.0 t70 -83.38 109.41 17.28 Favored 'General case' 0 CA--C 1.5 -0.955 0 CA-C-N 115.1 -0.955 . . . . 2.18 110.646 178.775 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A 1529 ' ' LEU . . . . . 0.652 ' HA ' HD13 ' A' 1532 ' ' LEU . 3.7 mm? -98.7 -18.12 18.2 Favored 'General case' 0 C--N 1.307 -1.279 0 CA-C-N 114.766 -1.107 . . . . 2.04 108.179 173.154 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A 1530 ' ' SER . . . . . . . . . . . . . 1.9 m -53.26 -47.1 69.37 Favored 'General case' 0 CA--C 1.544 0.724 0 C-N-CA 125.592 1.557 . . . . 1.44 112.741 -176.998 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A 1531 ' ' SER . . . . . . . . . . . . . 5.1 m -78.24 -3.79 44.55 Favored 'General case' 0 C--N 1.321 -0.652 0 N-CA-C 112.086 0.402 . . . . 1.63 112.086 -174.652 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A 1532 ' ' LEU . . . . . 0.652 HD13 ' HA ' ' A' 1529 ' ' LEU . 11.0 mp -62.41 -25.94 68.21 Favored 'General case' 0 N--CA 1.48 1.032 0 N-CA-C 113.066 0.765 . . . . 2.32 113.066 177.685 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A 1533 ' ' SER . . . . . . . . . . . . . 52.4 m -90.82 142.48 27.72 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-O 120.511 0.196 . . . . 2.57 110.477 177.464 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A 1534 ' ' GLY . . . . . . . . . . . . . . . -151.65 -116.81 0.73 Allowed Glycine 0 N--CA 1.441 -1.005 0 N-CA-C 109.649 -1.381 . . . . 1.89 109.649 179.158 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A 1535 ' ' ARG . . . . . . . . . . . . . 27.3 tpt180 -90.0 -59.05 2.3 Favored 'General case' 0 C--N 1.309 -1.186 0 N-CA-C 109.063 -0.717 . . . . 4.44 109.063 176.92 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A 1536 ' ' ALA . . . . . . . . . . . . . . . -95.07 -32.51 13.08 Favored 'General case' 0 N--CA 1.441 -0.89 0 CA-C-N 116.035 -0.529 . . . . 2.07 110.2 -179.228 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A 1537 ' ' GLY . . . . . . . . . . . . . . . 69.11 -127.14 21.2 Favored Glycine 0 CA--C 1.491 -1.455 0 N-CA-C 109.854 -1.299 . . . . 1.2 109.854 -178.524 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A 1538 ' ' PHE . . . . . . . . . . . . . 53.0 m-85 -106.42 141.43 37.74 Favored 'General case' 0 C--N 1.294 -1.822 0 C-N-CA 120.281 -0.568 . . . . 1.98 109.563 174.608 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A 1539 ' ' THR . . . . . . . . . . . . . 3.0 p -123.52 138.36 54.58 Favored 'General case' 0 C--N 1.293 -1.879 0 CA-C-N 116.017 -0.538 . . . . 1.97 111.081 -176.0 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A 1540 ' ' ALA . . . . . . . . . . . . . . . -128.87 116.03 18.79 Favored 'General case' 0 C--N 1.305 -1.364 0 CA-C-O 120.52 0.2 . . . . 1.39 110.48 178.387 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A 1541 ' ' ALA . . . . . . . . . . . . . . . -75.4 131.2 40.04 Favored 'General case' 0 C--N 1.313 -1.017 0 N-CA-C 108.397 -0.964 . . . . 1.86 108.397 177.316 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A 1542 ' ' TYR . . . . . . . . . . . . . 36.4 t80 -144.48 -179.27 6.44 Favored 'General case' 0 C--N 1.301 -1.524 0 N-CA-C 109.439 -0.578 . . . . 2.4 109.439 -173.776 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A 1543 ' ' SER . . . . . . . . . . . . . 5.9 m -43.86 -151.3 0.0 OUTLIER 'General case' 0 CA--C 1.584 2.25 0 C-N-CA 129.773 3.229 . . . . 2.58 114.669 177.91 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A 1544 ' ' LYS . . . . . . . . . . . . . 98.4 mttt -43.99 -29.12 0.54 Allowed 'General case' 0 N--CA 1.5 2.058 0 O-C-N 120.38 -1.45 . . . . 4.24 112.824 175.052 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A 1545 ' ' SER . . . . . . . . . . . . . 16.5 m -61.97 -17.29 56.52 Favored 'General case' 0 CA--C 1.562 1.44 0 C-N-CA 123.566 0.746 . . . . 3.6 111.463 175.091 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A 1546 ' ' GLY . . . . . . . . . . . . . . . 79.5 -77.85 1.82 Allowed Glycine 0 CA--C 1.496 -1.136 0 CA-C-O 121.457 0.476 . . . . 1.66 113.67 173.244 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A 1547 ' ' VAL . . . . . . . . . . . . . 7.4 p -157.64 131.73 1.38 Allowed 'Isoleucine or valine' 0 C--N 1.284 -2.249 0 N-CA-C 108.204 -1.036 . . . . 2.23 108.204 -175.788 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A 1548 ' ' VAL . . . . . . . . . . . . . 2.3 t -103.17 139.73 23.32 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.043 0 N-CA-C 108.346 -0.983 . . . . 1.59 108.346 -177.287 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A 1549 ' ' TYR . . . . . 0.445 ' HB3' ' HG2' ' A' 1557 ' ' GLU . 77.3 m-85 -98.29 148.23 23.84 Favored 'General case' 0 C--N 1.303 -1.418 0 N-CA-C 106.586 -1.635 . . . . 1.58 106.586 170.969 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A 1550 ' ' MET . . . . . . . . . . . . . 42.2 ttm -138.9 125.52 20.68 Favored 'General case' 0 C--N 1.291 -1.965 0 C-N-CA 120.685 -0.406 . . . . 2.08 110.704 -178.113 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A 1551 ' ' SER . . . . . 0.663 ' HB2' ' HB3' ' A' 1556 ' ' ASN . 43.1 t -99.23 138.91 35.65 Favored 'General case' 0 N--CA 1.411 -2.403 0 N-CA-C 105.938 -1.875 . . . . 1.9 105.938 172.551 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A 1552 ' ' ILE . . . . . 0.416 HG22 ' SG ' ' A' 1553 ' ' CYS . 1.8 mp -92.91 -55.17 6.41 Favored 'Isoleucine or valine' 0 N--CA 1.416 -2.174 0 N-CA-C 108.713 -0.847 . . . . 2.04 108.713 179.117 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A 1553 ' ' CYS . . . . . 0.416 ' SG ' HG22 ' A' 1552 ' ' ILE . 84.5 m -127.07 136.64 52.45 Favored 'General case' 0 C--N 1.303 -1.415 0 N-CA-C 109.162 -0.681 . . . . 1.43 109.162 177.202 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A 1554 ' ' GLY . . . . . . . . . . . . . . . 69.92 -141.46 34.65 Favored Glycine 0 N--CA 1.435 -1.4 0 N-CA-C 111.031 -0.827 . . . . 1.23 111.031 179.806 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A 1555 ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -109.35 177.41 4.75 Favored 'General case' 0 C--N 1.3 -1.569 0 N-CA-C 108.91 -0.774 . . . . 1.8 108.91 -178.79 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A 1556 ' ' ASN . . . . . 0.663 ' HB3' ' HB2' ' A' 1551 ' ' SER . 8.9 t30 -177.73 -165.03 0.1 Allowed 'General case' 0 C--N 1.297 -1.705 0 N-CA-C 103.427 -2.805 . . . . 2.63 103.427 -174.616 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A 1557 ' ' GLU . . . . . 0.445 ' HG2' ' HB3' ' A' 1549 ' ' TYR . 25.3 mt-10 79.57 -176.8 0.08 Allowed 'General case' 0 C--N 1.321 -0.636 0 N-CA-C 115.404 1.631 . . . . 3.79 115.404 163.519 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A 1558 ' ' ASN . . . . . . . . . . . . . 26.9 m-80 -125.21 43.93 2.93 Favored 'General case' 0 C--N 1.313 -0.991 0 CA-C-N 112.6 -2.091 . . . . 1.59 107.373 -174.612 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A 1559 ' ' CYS . . . . . . . . . . . . . 77.1 m -141.17 152.56 64.95 Favored Pre-proline 0 C--N 1.285 -2.214 0 N-CA-C 106.105 -1.813 . . . . 0.94 106.105 -176.029 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A 1560 ' ' PRO . . . . . . . . . . . . . 24.6 Cg_exo -36.23 112.32 0.09 OUTLIER 'Trans proline' 0 C--N 1.376 2.023 0 C-N-CA 124.667 3.578 . . . . 1.53 113.339 -178.811 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A 1561 ' ' PRO . . . . . . . . . . . . . 88.7 Cg_exo -48.89 153.52 3.74 Favored 'Trans proline' 0 C--N 1.365 1.407 0 C-N-CA 124.93 3.753 . . . . 1.82 114.486 -174.956 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A 1562 ' ' GLY . . . . . . . . . . . . . . . 93.67 7.78 61.32 Favored Glycine 0 N--CA 1.447 -0.589 0 N-CA-C 111.092 -0.803 . . . . 0.81 111.092 -177.545 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A 1563 ' ' VAL . . . . . 0.462 ' HA ' ' HA ' ' A' 1576 ' ' LYS . 8.3 p -111.25 156.96 12.28 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.588 0 N-CA-C 107.297 -1.372 . . . . 1.73 107.297 -179.355 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A 1564 ' ' GLY . . . . . . . . . . . . . . . -124.82 9.08 8.09 Favored Glycine 0 CA--C 1.528 0.852 0 C-N-CA 120.056 -1.069 . . . . 0.72 114.555 -176.417 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A 1565 ' ' ALA . . . . . . . . . . . . . . . -170.22 141.62 2.1 Favored 'General case' 0 C--N 1.302 -1.494 0 N-CA-C 107.917 -1.142 . . . . 1.14 107.917 178.956 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A 1566 ' ' CYS . . . . . 0.447 ' HA ' HG23 ' A' 1574 ' ' VAL . 51.6 t -164.22 139.23 5.83 Favored 'General case' 0 C--N 1.309 -1.165 0 CA-C-O 120.896 0.379 . . . . 0.51 110.184 -175.7 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A 1567 ' ' PHE . . . . . . . . . . . . . 35.2 m-85 -80.57 122.9 27.62 Favored 'General case' 0 CA--C 1.512 -0.501 0 N-CA-C 106.535 -1.654 . . . . 1.22 106.535 174.416 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A 1568 ' ' GLY . . . . . . . . . . . . . . . -75.97 -26.75 63.8 Favored Glycine 0 C--N 1.314 -0.656 0 C-N-CA 120.7 -0.762 . . . . 1.08 113.274 -173.879 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A 1569 ' ' GLN . . . . . . . . . . . . . 25.9 tp60 -71.42 -57.0 4.84 Favored 'General case' 0 C--N 1.311 -1.102 0 CA-C-O 121.798 0.809 . . . . 3.05 109.211 178.991 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A 1570 ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -83.42 -16.65 45.02 Favored 'General case' 0 C--N 1.301 -1.515 0 CA-C-N 114.634 -1.166 . . . . 2.44 113.089 -172.141 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A 1571 ' ' ARG . . . . . . . . . . . . . 11.1 tpp180 63.94 43.93 5.02 Favored 'General case' 0 N--CA 1.479 0.989 0 C-N-CA 125.59 1.556 . . . . 4.48 109.878 178.758 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A 1572 ' ' ILE . . . . . . . . . . . . . 31.9 mm -115.53 128.82 72.61 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.258 0 CA-C-N 115.447 -0.797 . . . . 1.94 109.819 -174.939 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A 1573 ' ' SER . . . . . . . . . . . . . 57.2 p -72.53 134.83 45.45 Favored 'General case' 0 C--O 1.247 0.951 0 CA-C-O 121.367 0.603 . . . . 1.25 111.869 -178.038 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A 1574 ' ' VAL . . . . . 0.447 HG23 ' HA ' ' A' 1566 ' ' CYS . 13.4 t -119.18 39.7 0.77 Allowed 'Isoleucine or valine' 0 CA--C 1.565 1.533 0 CA-C-O 122.597 1.189 . . . . 1.61 109.084 -174.926 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A 1575 ' ' GLY . . . . . . . . . . . . . . . 125.79 133.65 3.96 Favored Glycine 0 CA--C 1.53 1.017 0 CA-C-N 115.043 -0.98 . . . . 0.65 113.451 179.708 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A 1576 ' ' LYS . . . . . 0.465 ' O ' ' HD1' ' A' 1592 ' ' TYR . 64.4 mttp -84.31 153.99 23.19 Favored 'General case' 0 N--CA 1.469 0.491 0 N-CA-C 109.496 -0.557 . . . . 3.33 109.496 178.455 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A 1577 ' ' ALA . . . . . 0.553 ' HA ' ' CE1' ' A' 1592 ' ' TYR . . . -72.34 92.23 1.4 Allowed 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 113.042 0.756 . . . . 1.31 113.042 -173.028 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A 1578 ' ' ASN . . . . . 0.413 ' N ' HD21 ' A' 1578 ' ' ASN . 0.8 OUTLIER -98.92 117.64 33.88 Favored 'General case' 0 C--N 1.311 -1.08 0 N-CA-C 107.879 -1.156 . . . . 2.24 107.879 174.019 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A 1579 ' ' LYS . . . . . . . . . . . . . 55.7 mtmt -90.37 90.77 8.19 Favored 'General case' 0 C--N 1.3 -1.582 0 CA-C-O 121.882 0.849 . . . . 2.34 109.477 -177.479 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A 1580 ' ' ARG . . . . . . . . . . . . . 9.3 ttp180 -153.99 131.65 11.46 Favored 'General case' 0 C--N 1.288 -2.091 0 N-CA-C 107.068 -1.456 . . . . 4.19 107.068 179.925 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A 1581 ' ' LEU . . . . . 0.479 HD12 HD11 ' A' 1590 ' ' LEU . 28.9 tp -119.05 167.5 11.71 Favored 'General case' 0 C--N 1.296 -1.755 0 N-CA-C 108.299 -1.0 . . . . 2.39 108.299 -178.102 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A 1582 ' ' ARG . . . . . . . . . . . . . 69.2 ttt180 -145.18 103.04 3.82 Favored 'General case' 0 C--N 1.304 -1.408 0 N-CA-C 109.637 -0.505 . . . . 4.48 109.637 -179.81 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A 1583 ' ' TYR . . . . . 0.419 ' HB2' HG11 ' A' 1518 ' ' VAL . 42.2 t80 -88.6 111.46 21.92 Favored 'General case' 0 C--N 1.3 -1.567 0 CA-C-O 121.401 0.619 . . . . 1.57 111.141 179.087 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A 1584 ' ' VAL . . . . . 0.518 ' HB ' HG13 ' A' 1587 ' ' VAL . 48.9 t -112.94 150.68 15.01 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.744 0 N-CA-C 105.043 -2.206 . . . . 2.29 105.043 173.849 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A 1585 ' ' ASP . . . . . . . . . . . . . 33.9 t70 -47.4 108.32 0.15 Allowed 'General case' 0 C--N 1.33 -0.258 0 C-N-CA 123.843 0.857 . . . . 2.06 112.569 -179.563 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A 1586 ' ' GLN . . . . . . . . . . . . . 93.7 mt-30 63.76 24.29 13.76 Favored 'General case' 0 C--O 1.251 1.132 0 C-N-CA 125.155 1.382 . . . . 2.61 114.488 -178.966 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A 1587 ' ' VAL . . . . . 0.518 HG13 ' HB ' ' A' 1584 ' ' VAL . 7.1 p -161.13 105.71 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.439 -1.003 0 CA-C-O 122.35 1.072 . . . . 1.33 112.236 176.202 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A 1588 ' ' LEU . . . . . . . . . . . . . 7.3 mp -91.39 120.58 32.37 Favored 'General case' 0 C--N 1.299 -1.595 0 CA-C-N 115.075 -0.966 . . . . 2.03 108.842 179.934 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A 1589 ' ' GLN . . . . . . . . . . . . . 35.2 tt0 -105.89 134.21 49.38 Favored 'General case' 0 C--N 1.297 -1.689 0 N-CA-C 110.196 -0.298 . . . . 1.73 110.196 -177.768 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A 1590 ' ' LEU . . . . . 0.479 HD11 HD12 ' A' 1581 ' ' LEU . 2.0 tt -136.8 138.0 40.4 Favored 'General case' 0 C--N 1.304 -1.406 0 N-CA-C 106.222 -1.77 . . . . 1.76 106.222 175.925 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A 1591 ' ' VAL . . . . . . . . . . . . . 8.4 p -137.98 140.76 40.1 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.222 0 CA-C-O 120.967 0.413 . . . . 2.14 111.869 -174.171 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A 1592 ' ' TYR . . . . . 0.553 ' CE1' ' HA ' ' A' 1577 ' ' ALA . 88.1 m-85 -125.56 128.75 48.43 Favored 'General case' 0 C--N 1.317 -0.805 0 N-CA-C 108.094 -1.076 . . . . 1.53 108.094 176.117 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A 1593 ' ' LYS . . . . . . . . . . . . . 20.9 pttp -137.54 -174.21 3.7 Favored 'General case' 0 C--N 1.306 -1.313 0 N-CA-C 109.496 -0.557 . . . . 2.72 109.496 -176.925 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A 1594 ' ' ASP . . . . . . . . . . . . . 13.6 m-20 60.79 44.27 11.2 Favored 'General case' 0 N--CA 1.482 1.13 0 C-N-CA 123.281 0.632 . . . . 1.45 112.312 -179.603 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A 1595 ' ' GLY . . . . . . . . . . . . . . . -86.03 -92.76 0.86 Allowed Glycine 0 N--CA 1.437 -1.285 0 C-N-CA 119.477 -1.344 . . . . 0.83 111.76 177.685 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A 1596 ' ' SER . . . . . . . . . . . . . 37.1 m -113.47 151.69 44.68 Favored Pre-proline 0 C--N 1.287 -2.142 0 N-CA-C 108.678 -0.86 . . . . 1.96 108.678 179.377 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A 1597 ' ' PRO . . . . . . . . . . . . . 24.4 Cg_exo -65.3 133.03 33.48 Favored 'Trans proline' 0 C--O 1.24 0.607 0 C-N-CA 123.248 2.632 . . . . 1.34 110.976 178.798 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A 1598 ' ' CYS . . . . . . . . . . . . . 22.0 t -95.9 113.89 63.0 Favored Pre-proline 0 C--N 1.296 -1.76 0 CA-C-N 116.093 -0.503 . . . . 1.19 109.682 -177.463 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A 1599 ' ' PRO . . . . . . . . . . . . . 60.6 Cg_endo -88.8 18.18 1.52 Allowed 'Trans proline' 0 C--O 1.24 0.594 0 C-N-CA 122.904 2.402 . . . . 1.88 111.726 178.696 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A 1600 ' ' SER . . . . . . . . . . . . . 35.8 t -75.85 -55.92 5.16 Favored 'General case' 0 N--CA 1.427 -1.616 0 CA-C-N 115.715 -0.675 . . . . 2.19 110.59 -178.572 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A 1601 ' ' LYS . . . . . . . . . . . . . 53.2 tttp -142.42 -71.87 0.32 Allowed 'General case' 0 N--CA 1.445 -0.693 0 C-N-CA 119.926 -0.709 . . . . 4.21 112.486 -175.955 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A 1602 ' ' SER . . . . . 0.564 ' HB3' ' HG ' ' A' 1604 ' ' LEU . 23.0 t -96.37 157.11 16.05 Favored 'General case' 0 N--CA 1.427 -1.575 0 N-CA-C 108.47 -0.937 . . . . 3.82 108.47 -175.957 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A 1603 ' ' GLY . . . . . . . . . . . . . . . -77.74 58.21 3.84 Favored Glycine 0 C--O 1.236 0.27 0 N-CA-C 111.942 -0.463 . . . . 2.45 111.942 -179.824 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A 1604 ' ' LEU . . . . . 0.564 ' HG ' ' HB3' ' A' 1602 ' ' SER . 0.6 OUTLIER -120.97 -175.27 3.01 Favored 'General case' 0 C--N 1.298 -1.668 0 C-N-CA 124.581 1.152 . . . . 2.06 110.364 -178.516 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A 1605 ' ' SER . . . . . . . . . . . . . 15.0 m -104.58 -170.04 1.71 Allowed 'General case' 0 C--N 1.297 -1.712 0 N-CA-C 109.929 -0.397 . . . . 1.75 109.929 -178.879 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A 1606 ' ' TYR . . . . . . . . . . . . . 97.5 m-85 -103.37 126.65 50.64 Favored 'General case' 0 CA--C 1.482 -1.662 0 N-CA-C 104.328 -2.471 . . . . 1.59 104.328 177.274 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A 1607 ' ' LYS . . . . . . . . . . . . . 21.3 ptmt -119.15 132.15 55.95 Favored 'General case' 0 C--N 1.285 -2.219 0 C-N-CA 119.528 -0.869 . . . . 2.21 111.654 -176.071 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A 1608 ' ' SER . . . . . . . . . . . . . 33.1 m -103.15 118.31 36.51 Favored 'General case' 0 C--N 1.309 -1.177 0 C-N-CA 123.024 0.53 . . . . 1.48 110.731 -177.301 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A 1609 ' ' VAL . . . . . . . . . . . . . 58.7 t -110.98 114.57 47.48 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.778 0 N-CA-C 108.687 -0.857 . . . . 1.57 108.687 177.363 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A 1610 ' ' ILE . . . . . 0.642 HG13 ' HB2' ' A' 1638 ' ' PHE . 2.9 mp -105.04 114.67 45.22 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.214 0 N-CA-C 108.675 -0.861 . . . . 1.47 108.675 178.345 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A 1611 ' ' SER . . . . . . . . . . . . . 19.4 m -104.42 107.76 18.85 Favored 'General case' 0 C--N 1.296 -1.753 0 CA-C-N 115.474 -0.784 . . . . 1.84 109.486 179.535 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A 1612 ' ' PHE . . . . . 0.518 ' O ' ' HA ' ' A' 1587 ' ' VAL . 97.7 m-85 -83.8 102.55 12.4 Favored 'General case' 0 C--N 1.306 -1.319 0 CA-C-N 115.882 -0.599 . . . . 0.86 109.472 179.089 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A 1613 ' ' VAL . . . . . . . . . . . . . 94.4 t -86.52 124.9 40.7 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.485 0 N-CA-C 107.857 -1.164 . . . . 1.32 107.857 179.345 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A 1614 ' ' CYS . . . . . 0.457 ' HB3' ' HB2' ' A' 1646 ' ' CYS . 61.8 m -75.73 92.78 3.03 Favored 'General case' 0 C--N 1.295 -1.797 0 CA-C-O 121.614 0.721 . . . . 1.39 111.018 -177.12 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A 1615 ' ' ARG . . . . . 0.504 ' HB3' ' HB3' ' A' 1641 ' ' HIS . 43.6 ttm180 -138.45 131.79 16.35 Favored Pre-proline 0 N--CA 1.43 -1.464 0 CA-C-N 115.155 -0.929 . . . . 4.34 109.467 -179.742 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A 1616 ' ' PRO . . . . . 0.567 ' HD3' ' HG2' ' A' 1648 ' ' PRO . 38.4 Cg_endo -70.7 67.37 2.29 Favored 'Trans proline' 0 CA--C 1.55 1.309 0 C-N-CA 123.142 2.562 . . . . 1.5 111.351 175.764 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A 1617 ' ' GLU . . . . . . . . . . . . . 10.9 tp10 -108.27 32.5 4.76 Favored 'General case' 0 CA--C 1.555 1.169 0 CA-C-O 121.982 0.896 . . . . 3.21 109.354 -177.52 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A 1618 ' ' ALA . . . . . . . . . . . . . . . -83.47 152.88 24.74 Favored 'General case' 0 C--N 1.321 -0.631 0 O-C-N 121.782 -0.574 . . . . 2.91 109.867 179.527 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A 1619 ' ' GLY . . . . . 0.419 ' HA3' ' HD3' ' A' 1620 ' ' PRO . . . 148.6 -87.79 0.15 Allowed Glycine 0 C--N 1.3 -1.419 0 N-CA-C 110.149 -1.18 . . . . 3.35 110.149 -177.028 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A 1620 ' ' PRO . . . . . 0.419 ' HD3' ' HA3' ' A' 1619 ' ' GLY . 18.6 Cg_exo -64.92 -175.94 0.41 Allowed 'Trans proline' 0 CA--C 1.539 0.755 0 C-N-CA 124.059 3.173 . . . . 6.61 110.889 173.818 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A 1621 ' ' THR . . . . . . . . . . . . . 14.6 t -79.94 42.17 0.54 Allowed 'General case' 0 CA--C 1.565 1.526 0 CA-C-O 122.846 1.308 . . . . 5.03 111.366 -177.431 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A 1622 ' ' ASN . . . . . 0.411 ' H ' ' C ' ' A' 1620 ' ' PRO . 40.3 t30 -56.04 127.52 30.89 Favored 'General case' 0 C--O 1.242 0.71 0 C-N-CA 126.107 1.763 . . . . 3.58 108.77 178.423 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A 1623 ' ' ARG . . . . . . . . . . . . . 20.2 ptp180 -148.78 169.22 9.51 Favored Pre-proline 0 C--N 1.302 -1.497 0 N-CA-C 108.474 -0.935 . . . . 4.09 108.474 -174.364 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A 1624 ' ' PRO . . . . . . . . . . . . . 33.6 Cg_exo -61.41 114.89 2.42 Favored 'Trans proline' 0 C--N 1.36 1.161 0 C-N-CA 121.825 1.684 . . . . 2.86 109.51 175.69 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A 1625 ' ' MET . . . . . . . . . . . . . 22.7 ptt? -109.81 146.1 35.6 Favored 'General case' 0 C--N 1.292 -1.892 0 CA-C-N 115.891 -0.595 . . . . 2.73 111.495 -175.301 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A 1626 ' ' LEU . . . . . . . . . . . . . 43.0 tp -76.0 111.07 11.0 Favored 'General case' 0 N--CA 1.441 -0.904 0 CA-C-N 114.773 -1.103 . . . . 1.94 109.179 179.521 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A 1627 ' ' ILE . . . . . . . . . . . . . 39.0 mm -81.69 -49.58 17.51 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.745 0 CA-C-N 115.03 -0.986 . . . . 1.75 110.41 -175.727 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A 1628 ' ' SER . . . . . . . . . . . . . 48.3 m -157.26 154.09 28.56 Favored 'General case' 0 C--N 1.301 -1.52 0 CA-C-N 116.259 -0.428 . . . . 1.85 109.913 -178.064 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A 1629 ' ' LEU . . . . . 0.437 HD13 ' HG ' ' A' 1636 ' ' LEU . 56.7 tp -113.36 118.41 34.5 Favored 'General case' 0 N--CA 1.428 -1.56 0 N-CA-C 108.039 -1.096 . . . . 2.12 108.039 175.251 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A 1630 ' ' ASP . . . . . 0.481 ' HB3' ' HB ' ' A' 1635 ' ' THR . 12.6 t70 -95.09 117.62 30.49 Favored 'General case' 0 C--N 1.293 -1.864 0 N-CA-C 107.653 -1.24 . . . . 0.87 107.653 177.121 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A 1631 ' ' LYS . . . . . 0.541 ' HZ1' ' HB3' ' A' 1631 ' ' LYS . 8.5 mtpm? -94.22 4.87 53.29 Favored 'General case' 0 C--N 1.298 -1.673 0 N-CA-C 112.402 0.519 . . . . 2.76 112.402 -176.116 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A 1632 ' ' GLN . . . . . . . . . . . . . 2.2 mp0 -89.99 -51.97 5.2 Favored 'General case' 0 C--N 1.307 -1.245 0 CA-C-O 121.208 0.528 . . . . 2.55 109.686 -179.608 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A 1633 ' ' THR . . . . . . . . . . . . . 7.2 m -105.15 4.46 31.36 Favored 'General case' 0 C--N 1.306 -1.314 0 CA-C-O 122.309 1.052 . . . . 1.92 109.261 179.815 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A 1634 ' ' CYS . . . . . 0.412 ' HA ' ' O ' ' A' 1630 ' ' ASP . 61.3 m 55.24 52.8 10.95 Favored 'General case' 0 N--CA 1.469 0.505 0 CA-C-N 114.092 -1.413 . . . . 0.89 110.739 179.199 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A 1635 ' ' THR . . . . . 0.481 ' HB ' ' HB3' ' A' 1630 ' ' ASP . 21.1 m -103.87 125.23 50.14 Favored 'General case' 0 N--CA 1.421 -1.92 0 CA-C-N 113.458 -1.701 . . . . 1.31 109.924 -175.059 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A 1636 ' ' LEU . . . . . 0.437 ' HG ' HD13 ' A' 1629 ' ' LEU . 5.8 mp -106.49 122.58 46.58 Favored 'General case' 0 C--N 1.313 -0.981 0 N-CA-C 109.362 -0.607 . . . . 1.97 109.362 178.921 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A 1637 ' ' PHE . . . . . . . . . . . . . 96.9 m-85 -98.85 112.51 24.58 Favored 'General case' 0 C--N 1.313 -1.0 0 CA-C-N 115.983 -0.553 . . . . 0.92 111.783 -176.275 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A 1638 ' ' PHE . . . . . 0.642 ' HB2' HG13 ' A' 1610 ' ' ILE . 87.6 m-85 -115.09 133.81 55.71 Favored 'General case' 0 C--N 1.294 -1.832 0 N-CA-C 108.484 -0.932 . . . . 0.7 108.484 175.303 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A 1639 ' ' SER . . . . . . . . . . . . . 28.2 t -140.47 141.5 35.41 Favored 'General case' 0 C--N 1.276 -2.606 0 C-N-CA 120.099 -0.641 . . . . 1.46 109.308 177.49 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A 1640 ' ' TRP . . . . . 0.495 ' HE3' ' HE1' ' A' 1612 ' ' PHE . 10.5 t90 -128.0 127.88 44.01 Favored 'General case' 0 N--CA 1.43 -1.429 0 N-CA-C 107.849 -1.167 . . . . 0.92 107.849 178.659 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A 1641 ' ' HIS . . . . . 0.504 ' HB3' ' HB3' ' A' 1615 ' ' ARG . 34.9 m80 -91.25 97.79 11.33 Favored 'General case' 0 C--N 1.301 -1.513 0 N-CA-C 105.983 -1.858 . . . . 3.18 105.983 175.276 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A 1642 ' ' THR . . . . . 0.56 ' OG1' ' HG ' ' A' 1644 ' ' LEU . 7.8 t -135.12 140.85 35.97 Favored Pre-proline 0 C--N 1.296 -1.719 0 N-CA-C 113.63 0.974 . . . . 1.48 113.63 -170.737 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A 1643 ' ' PRO . . . . . . . . . . . . . 87.3 Cg_endo -80.66 -0.84 10.9 Favored 'Trans proline' 0 N--CA 1.447 -1.219 0 C-N-CA 123.475 2.783 . . . . 1.09 112.451 175.903 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A 1644 ' ' LEU . . . . . 0.56 ' HG ' ' OG1' ' A' 1642 ' ' THR . 2.8 pp -92.94 4.03 54.68 Favored 'General case' 0 CA--C 1.502 -0.885 0 CA-C-O 121.969 0.89 . . . . 2.08 110.386 174.613 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A 1645 ' ' ALA . . . . . . . . . . . . . . . -95.78 -43.47 7.86 Favored 'General case' 0 C--N 1.3 -1.552 0 CA-C-N 113.818 -1.537 . . . . 1.37 108.421 175.992 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A 1646 ' ' CYS . . . . . 0.457 ' HB2' ' HB3' ' A' 1614 ' ' CYS . 38.2 m -156.44 158.36 37.16 Favored 'General case' 0 CA--C 1.498 -1.05 0 N-CA-C 105.585 -2.005 . . . . 1.7 105.585 174.71 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A 1647 ' ' GLU . . . . . . . . . . . . . 53.9 mt-10 -123.01 93.77 47.96 Favored Pre-proline 0 C--N 1.305 -1.368 0 N-CA-C 110.215 -0.291 . . . . 2.92 110.215 -179.624 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A 1648 ' ' PRO . . . . . 0.567 ' HG2' ' HD3' ' A' 1616 ' ' PRO . 6.5 Cg_exo -73.34 101.53 1.36 Allowed 'Trans proline' 0 N--CA 1.452 -0.949 0 C-N-CA 122.554 2.169 . . . . 3.19 107.104 174.056 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A 1649 ' ' GLU . . . . . . . . . . . . . 8.7 tp10 . . . . . 0 N--CA 1.416 -2.163 0 N-CA-C 109.57 -0.53 . . . . 5.06 109.57 -171.509 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A 1515 ' ' ASP . . . . . . . . . . . . . 22.8 t0 . . . . . 0 N--CA 1.434 -1.26 0 N-CA-C 106.874 -1.528 . . . . 2.54 106.874 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A 1516 ' ' CYS . . . . . . . . . . . . . 29.8 m -75.99 67.92 2.41 Favored 'General case' 0 C--N 1.288 -2.081 0 CA-C-O 121.948 0.88 . . . . 1.25 110.862 -176.008 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A 1517 ' ' GLN . . . . . 0.409 ' HA ' ' O ' ' A' 1527 ' ' PHE . 13.5 pt20 -148.56 151.31 34.85 Favored 'General case' 0 N--CA 1.417 -2.119 0 N-CA-C 108.578 -0.897 . . . . 1.8799999999999999 108.578 -179.494 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A 1518 ' ' VAL . . . . . 0.812 HG21 HD11 ' A' 1588 ' ' LEU . 44.6 t -127.08 134.07 66.89 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.459 0 N-CA-C 108.87 -0.789 . . . . 1.73 108.87 -179.169 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A 1519 ' ' THR . . . . . . . . . . . . . 27.7 m -107.71 125.33 51.25 Favored 'General case' 0 C--N 1.296 -1.727 0 N-CA-C 110.063 -0.347 . . . . 1.7 110.063 177.14 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A 1520 ' ' ASN . . . . . . . . . . . . . 30.3 t-20 -97.33 100.37 7.81 Favored Pre-proline 0 C--N 1.309 -1.16 0 N-CA-C 106.802 -1.555 . . . . 2.1200000000000001 106.802 172.063 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A 1521 ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -73.83 -0.12 9.01 Favored 'Trans proline' 0 C--N 1.353 0.784 0 C-N-CA 122.713 2.275 . . . . 2.4700000000000002 113.495 -175.633 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A 1522 ' ' SER . . . . . . . . . . . . . 50.8 m -91.44 -14.96 29.62 Favored 'General case' 0 N--CA 1.433 -1.279 0 CA-C-N 116.641 -0.254 . . . . 2.5699999999999998 110.917 178.384 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A 1523 ' ' THR . . . . . . . . . . . . . 14.3 t -139.12 0.67 1.95 Allowed 'General case' 0 CA--C 1.555 1.135 0 CA-C-O 121.271 0.557 . . . . 2.1499999999999999 111.247 177.427 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A 1524 ' ' GLY . . . . . . . . . . . . . . . 66.8 30.61 76.45 Favored Glycine 0 C--N 1.339 0.708 0 CA-C-N 116.217 -0.447 . . . . 1.8899999999999999 112.535 178.466 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A 1525 ' ' HIS . . . . . 0.623 ' HE1' ' HB2' ' A' 1647 ' ' GLU . 23.8 t-160 -101.53 122.75 44.38 Favored 'General case' 0 C--N 1.303 -1.438 0 O-C-N 122.616 -0.343 . . . . 1.8999999999999999 111.021 -176.729 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A 1526 ' ' LEU . . . . . . . . . . . . . 42.6 tp -97.97 133.55 42.29 Favored 'General case' 0 C--N 1.307 -1.249 0 N-CA-C 108.86 -0.793 . . . . 1.6100000000000001 108.86 176.383 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A 1527 ' ' PHE . . . . . 0.416 ' CE1' ' HA ' ' A' 1646 ' ' CYS . 94.8 m-85 -102.87 132.67 48.92 Favored 'General case' 0 C--N 1.292 -1.917 0 N-CA-C 108.529 -0.915 . . . . 1.4199999999999999 108.529 176.822 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A 1528 ' ' ASP . . . . . . . . . . . . . 28.7 t70 -110.98 114.76 28.32 Favored 'General case' 0 CA--C 1.487 -1.45 0 CA-C-O 122.103 0.954 . . . . 2.1800000000000002 112.425 -179.245 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A 1529 ' ' LEU . . . . . . . . . . . . . 87.0 mt -119.63 3.53 11.16 Favored 'General case' 0 C--N 1.294 -1.818 0 CA-C-N 114.055 -1.429 . . . . 1.4399999999999999 107.427 174.623 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A 1530 ' ' SER . . . . . . . . . . . . . 14.5 t -80.36 -31.6 37.89 Favored 'General case' 0 N--CA 1.441 -0.898 0 CA-C-N 115.74 -0.664 . . . . 1.4399999999999999 110.428 -175.443 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A 1531 ' ' SER . . . . . . . . . . . . . 25.9 m -70.4 -10.9 60.35 Favored 'General case' 0 C--O 1.236 0.379 0 CA-C-O 121.133 0.492 . . . . 1.5 110.204 177.234 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A 1532 ' ' LEU . . . . . . . . . . . . . 97.1 mt -80.39 10.01 5.15 Favored 'General case' 0 CA--C 1.546 0.811 0 N-CA-C 112.787 0.662 . . . . 1.77 112.787 178.666 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A 1533 ' ' SER . . . . . . . . . . . . . 31.7 m -72.7 145.02 47.47 Favored 'General case' 0 C--O 1.247 0.964 0 N-CA-C 108.495 -0.928 . . . . 2.3799999999999999 108.495 174.924 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A 1534 ' ' GLY . . . . . . . . . . . . . . . -162.66 169.28 37.86 Favored Glycine 0 N--CA 1.441 -0.995 0 C-N-CA 120.319 -0.944 . . . . 1.55 112.277 -177.419 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A 1535 ' ' ARG . . . . . 0.816 ' HD3' ' HG3' ' A' 1557 ' ' GLU . 21.8 tpp180 -80.67 -51.59 8.53 Favored 'General case' 0 C--N 1.312 -1.028 0 N-CA-C 108.676 -0.861 . . . . 3.96 108.676 179.459 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A 1536 ' ' ALA . . . . . . . . . . . . . . . -79.61 -37.44 36.17 Favored 'General case' 0 C--N 1.309 -1.193 0 C-N-CA 120.033 -0.667 . . . . 1.6499999999999999 110.261 179.291 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A 1537 ' ' GLY . . . . . . . . . . . . . . . 79.68 -151.17 33.77 Favored Glycine 0 N--CA 1.426 -1.972 0 N-CA-C 109.962 -1.255 . . . . 1.1899999999999999 109.962 -179.953 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A 1538 ' ' PHE . . . . . 0.614 ' CD1' HD13 ' A' 1552 ' ' ILE . 65.7 m-85 -107.95 135.91 48.53 Favored 'General case' 0 C--N 1.288 -2.09 0 N-CA-C 107.6 -1.259 . . . . 1.6899999999999999 107.6 177.598 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A 1539 ' ' THR . . . . . 0.443 ' O ' ' HD2' ' A' 1623 ' ' ARG . 2.7 p -112.45 137.02 51.24 Favored 'General case' 0 C--N 1.296 -1.75 0 N-CA-C 113.135 0.791 . . . . 1.48 113.135 -175.676 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A 1540 ' ' ALA . . . . . . . . . . . . . . . -117.02 108.81 16.21 Favored 'General case' 0 C--N 1.308 -1.203 0 N-CA-C 109.687 -0.486 . . . . 0.82999999999999996 109.687 178.302 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A 1541 ' ' ALA . . . . . . . . . . . . . . . -74.19 113.75 11.76 Favored 'General case' 0 C--N 1.313 -0.98 0 CA-C-N 115.36 -0.836 . . . . 1.27 109.396 178.998 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A 1542 ' ' TYR . . . . . 0.434 ' CE2' ' HB2' ' A' 1545 ' ' SER . 80.0 t80 -130.72 157.64 42.25 Favored 'General case' 0 N--CA 1.418 -2.065 0 CA-C-N 115.852 -0.613 . . . . 2.1499999999999999 109.734 -176.587 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A 1543 ' ' SER . . . . . . . . . . . . . 5.3 m -40.85 -153.6 0.0 OUTLIER 'General case' 0 CA--C 1.592 2.561 0 C-N-CA 129.709 3.204 . . . . 2.29 117.111 -174.716 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A 1544 ' ' LYS . . . . . . . . . . . . . 25.0 ttmm -54.86 -24.71 24.41 Favored 'General case' 0 CA--C 1.556 1.188 0 O-C-N 120.863 -1.148 . . . . 3.9100000000000001 112.385 -179.343 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A 1545 ' ' SER . . . . . 0.434 ' HB2' ' CE2' ' A' 1542 ' ' TYR . 22.6 m -64.69 -30.69 71.71 Favored 'General case' 0 CA--C 1.547 0.827 0 O-C-N 121.759 -0.588 . . . . 3.2999999999999998 110.717 175.452 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A 1546 ' ' GLY . . . . . 0.417 ' O ' ' HB3' ' A' 1542 ' ' TYR . . . 116.85 174.26 17.12 Favored Glycine 0 N--CA 1.436 -1.34 0 C-N-CA 119.489 -1.339 . . . . 1.24 114.974 174.174 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A 1547 ' ' VAL . . . . . . . . . . . . . 3.1 p -92.92 129.21 43.79 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.343 0 C-N-CA 123.991 0.916 . . . . 1.6299999999999999 110.398 179.915 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A 1548 ' ' VAL . . . . . 0.515 ' HA ' ' HA ' ' A' 1567 ' ' PHE . 3.0 t -97.47 143.29 12.87 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.86 0 CA-C-N 115.55 -0.75 . . . . 0.92000000000000004 109.957 -174.763 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A 1549 ' ' TYR . . . . . 0.63 ' CD1' ' HA3' ' A' 1568 ' ' GLY . 37.3 m-85 -102.49 145.41 29.62 Favored 'General case' 0 C--N 1.307 -1.243 0 N-CA-C 105.915 -1.883 . . . . 1.4399999999999999 105.915 169.341 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A 1550 ' ' MET . . . . . 0.429 ' SD ' HG12 ' A' 1610 ' ' ILE . 37.1 ttm -143.52 127.72 17.64 Favored 'General case' 0 C--N 1.292 -1.929 0 C-N-CA 120.49 -0.484 . . . . 1.74 110.833 -175.615 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A 1551 ' ' SER . . . . . . . . . . . . . 41.0 p -99.52 115.76 30.08 Favored 'General case' 0 N--CA 1.418 -2.04 0 N-CA-C 108.047 -1.094 . . . . 1.6399999999999999 108.047 174.572 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A 1552 ' ' ILE . . . . . 0.614 HD13 ' CD1' ' A' 1538 ' ' PHE . 1.7 mp -75.53 -7.84 10.73 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.017 0 CA-C-O 122.474 1.131 . . . . 1.3300000000000001 110.586 179.228 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A 1553 ' ' CYS . . . . . . . . . . . . . 33.9 t -161.48 148.83 14.78 Favored 'General case' 0 N--CA 1.425 -1.691 0 N-CA-C 107.516 -1.29 . . . . 1.4299999999999999 107.516 177.56 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A 1554 ' ' GLY . . . . . . . . . . . . . . . 82.93 -120.15 5.07 Favored Glycine 0 C--N 1.318 -0.462 0 C-N-CA 121.227 -0.511 . . . . 1.1200000000000001 113.129 176.228 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A 1555 ' ' GLU . . . . . . . . . . . . . 9.3 pt-20 -145.81 145.51 30.81 Favored 'General case' 0 C--N 1.315 -0.91 0 C-N-CA 123.347 0.659 . . . . 1.8 110.812 -179.885 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A 1556 ' ' ASN . . . . . 0.576 ' HB3' HG23 ' A' 1563 ' ' VAL . 57.2 t30 -85.13 132.3 34.32 Favored 'General case' 0 C--N 1.295 -1.773 0 CA-C-N 114.644 -1.162 . . . . 2.6299999999999999 110.821 -175.183 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A 1557 ' ' GLU . . . . . 0.816 ' HG3' ' HD3' ' A' 1535 ' ' ARG . 33.2 mm-40 -98.48 177.87 5.2 Favored 'General case' 0 C--N 1.289 -2.044 0 CA-C-N 113.837 -1.529 . . . . 3.79 109.116 179.937 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A 1558 ' ' ASN . . . . . . . . . . . . . 37.8 m-80 75.53 5.71 4.03 Favored 'General case' 0 N--CA 1.504 2.258 0 C-N-CA 124.471 1.109 . . . . 1.52 111.119 -178.727 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A 1559 ' ' CYS . . . . . 0.447 ' SG ' ' HA ' ' A' 1571 ' ' ARG . 97.7 m -148.28 169.35 9.38 Favored Pre-proline 0 C--N 1.291 -1.938 0 N-CA-C 103.413 -2.81 . . . . 0.83999999999999997 103.413 176.34 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A 1560 ' ' PRO . . . . . 0.438 ' HD2' ' HB3' ' A' 1559 ' ' CYS . 9.4 Cg_endo -52.18 109.21 0.31 Allowed 'Trans proline' 0 C--N 1.359 1.115 0 C-N-CA 122.37 2.046 . . . . 1.1799999999999999 111.244 176.624 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A 1561 ' ' PRO . . . . . . . . . . . . . 75.4 Cg_exo -50.85 120.61 6.83 Favored 'Trans proline' 0 C--N 1.359 1.088 0 C-N-CA 123.884 3.056 . . . . 1.51 112.502 -175.523 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A 1562 ' ' GLY . . . . . . . . . . . . . . . 134.19 -6.04 4.66 Favored Glycine 0 N--CA 1.435 -1.433 0 CA-C-N 115.081 -0.963 . . . . 0.71999999999999997 110.987 -177.608 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A 1563 ' ' VAL . . . . . 0.576 HG23 ' HB3' ' A' 1556 ' ' ASN . 13.9 m -90.43 161.06 2.67 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.182 0 N-CA-C 105.937 -1.875 . . . . 0.96999999999999997 105.937 172.944 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A 1564 ' ' GLY . . . . . . . . . . . . . . . -112.18 -21.88 6.1 Favored Glycine 0 C--N 1.309 -0.923 0 C-N-CA 120.395 -0.907 . . . . 0.71999999999999997 111.964 -179.816 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A 1565 ' ' ALA . . . . . . . . . . . . . . . -150.13 127.63 11.52 Favored 'General case' 0 C--N 1.311 -1.081 0 N-CA-C 107.511 -1.292 . . . . 0.37 107.511 179.048 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A 1566 ' ' CYS . . . . . . . . . . . . . 34.2 t -155.75 141.57 18.06 Favored 'General case' 0 C--N 1.297 -1.681 0 N-CA-C 110.33 -0.248 . . . . 0.51000000000000001 110.33 -174.62 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A 1567 ' ' PHE . . . . . 0.515 ' HA ' ' HA ' ' A' 1548 ' ' VAL . 87.6 m-85 -71.2 121.69 18.84 Favored 'General case' 0 C--O 1.216 -0.662 0 N-CA-C 105.365 -2.087 . . . . 0.96999999999999997 105.365 171.678 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A 1568 ' ' GLY . . . . . 0.63 ' HA3' ' CD1' ' A' 1549 ' ' TYR . . . -83.21 -16.23 69.91 Favored Glycine 0 C--N 1.296 -1.672 0 C-N-CA 119.314 -1.422 . . . . 1.0800000000000001 114.009 -171.141 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A 1569 ' ' GLN . . . . . . . . . . . . . 4.1 pt20 -82.31 -21.71 35.97 Favored 'General case' 0 C--N 1.301 -1.521 0 C-N-CA 120.565 -0.454 . . . . 2.7400000000000002 111.408 -178.164 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A 1570 ' ' THR . . . . . . . . . . . . . 9.7 p -121.54 -12.36 8.55 Favored 'General case' 0 C--O 1.239 0.505 0 N-CA-C 112.347 0.499 . . . . 1.96 112.347 178.303 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A 1571 ' ' ARG . . . . . 0.447 ' HA ' ' SG ' ' A' 1559 ' ' CYS . 96.4 mtt180 62.81 42.57 7.79 Favored 'General case' 0 CA--C 1.511 -0.552 0 C-N-CA 125.1 1.36 . . . . 3.9500000000000002 112.693 178.922 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A 1572 ' ' ILE . . . . . . . . . . . . . 25.2 mm -99.95 116.26 42.85 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.19 0 N-CA-C 108.139 -1.06 . . . . 1.3700000000000001 108.139 179.942 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A 1573 ' ' SER . . . . . . . . . . . . . 35.0 t -69.15 133.33 47.87 Favored 'General case' 0 C--N 1.306 -1.284 0 CA-C-N 115.311 -0.859 . . . . 1.0800000000000001 111.084 -176.402 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A 1574 ' ' VAL . . . . . . . . . . . . . 13.8 m -130.6 28.42 1.51 Allowed 'Isoleucine or valine' 0 C--N 1.315 -0.929 0 CA-C-O 122.205 1.002 . . . . 1.3 110.857 174.903 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A 1575 ' ' GLY . . . . . . . . . . . . . . . 163.04 126.97 0.85 Allowed Glycine 0 N--CA 1.421 -2.342 0 CA-C-N 113.835 -1.53 . . . . 0.51000000000000001 110.439 176.854 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A 1576 ' ' LYS . . . . . 0.479 ' HA ' ' HA ' ' A' 1563 ' ' VAL . 68.3 mttm -85.79 151.24 23.98 Favored 'General case' 0 C--N 1.31 -1.133 0 N-CA-C 108.781 -0.822 . . . . 2.8999999999999999 108.781 177.969 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A 1577 ' ' ALA . . . . . . . . . . . . . . . -74.34 91.84 2.23 Favored 'General case' 0 C--N 1.315 -0.928 0 CA-C-O 121.736 0.779 . . . . 0.82999999999999996 111.641 -175.48 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A 1578 ' ' ASN . . . . . . . . . . . . . 41.4 m-80 -117.22 115.18 24.8 Favored 'General case' 0 C--N 1.284 -2.243 0 N-CA-C 104.747 -2.316 . . . . 1.8500000000000001 104.747 171.724 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A 1579 ' ' LYS . . . . . . . . . . . . . 54.1 mtmt -77.29 90.41 3.75 Favored 'General case' 0 CA--C 1.493 -1.244 0 N-CA-C 108.654 -0.869 . . . . 1.8999999999999999 108.654 -177.037 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A 1580 ' ' ARG . . . . . . . . . . . . . 27.4 ttm180 -134.79 99.09 4.21 Favored 'General case' 0 N--CA 1.402 -2.861 0 CA-C-N 114.341 -1.3 . . . . 3.6299999999999999 108.869 -176.481 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A 1581 ' ' LEU . . . . . 0.477 ' HA ' ' HA ' ' A' 1590 ' ' LEU . 4.6 pp -103.61 168.03 9.41 Favored 'General case' 0 C--N 1.297 -1.7 0 C-N-CA 120.4 -0.52 . . . . 1.8700000000000001 110.189 177.518 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A 1582 ' ' ARG . . . . . 0.673 ' HB3' ' HB3' ' A' 1589 ' ' GLN . 61.5 ttt180 -135.21 125.5 26.36 Favored 'General case' 0 C--N 1.297 -1.688 0 C-N-CA 123.158 0.583 . . . . 3.9700000000000002 109.766 -174.046 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A 1583 ' ' TYR . . . . . . . . . . . . . 40.2 t80 -119.09 104.11 10.16 Favored 'General case' 0 C--N 1.308 -1.202 0 CA-C-N 116.256 -0.429 . . . . 1.4099999999999999 110.131 176.075 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A 1584 ' ' VAL . . . . . . . . . . . . . 12.5 p -148.62 142.82 18.85 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.953 0 N-CA-C 108.76 -0.83 . . . . 1.6899999999999999 108.76 178.981 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A 1585 ' ' ASP . . . . . . . . . . . . . 31.6 t70 49.65 38.7 15.71 Favored 'General case' 0 N--CA 1.501 2.092 0 CA-C-O 122.559 1.171 . . . . 2.0600000000000001 112.503 177.226 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A 1586 ' ' GLN . . . . . . . . . . . . . 97.5 mt-30 53.84 34.57 19.59 Favored 'General case' 0 C--O 1.241 0.638 0 CA-C-N 114.581 -1.191 . . . . 2.3300000000000001 113.151 -179.426 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A 1587 ' ' VAL . . . . . . . . . . . . . 7.1 p -135.08 117.5 22.13 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.386 0 CA-C-O 121.826 0.822 . . . . 0.78000000000000003 109.427 174.724 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A 1588 ' ' LEU . . . . . 0.812 HD11 HG21 ' A' 1518 ' ' VAL . 2.3 mm? -81.57 152.72 27.09 Favored 'General case' 0 C--N 1.297 -1.706 0 CA-C-N 114.784 -1.098 . . . . 1.4099999999999999 111.588 -178.167 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A 1589 ' ' GLN . . . . . 0.673 ' HB3' ' HB3' ' A' 1582 ' ' ARG . 35.3 tt0 -152.47 156.99 40.52 Favored 'General case' 0 C--N 1.294 -1.837 0 N-CA-C 107.493 -1.299 . . . . 1.24 107.493 -179.534 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A 1590 ' ' LEU . . . . . 0.477 ' HA ' ' HA ' ' A' 1581 ' ' LEU . 5.3 tt -147.83 143.35 27.39 Favored 'General case' 0 C--N 1.303 -1.448 0 N-CA-C 105.685 -1.968 . . . . 1.1499999999999999 105.685 175.06 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A 1591 ' ' VAL . . . . . 0.503 HG23 HG22 ' A' 1609 ' ' VAL . 11.5 p -130.93 135.26 60.42 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.178 0 N-CA-C 112.805 0.668 . . . . 1.51 112.805 -173.843 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A 1592 ' ' TYR . . . . . . . . . . . . . 63.3 m-85 -122.35 106.11 10.78 Favored 'General case' 0 C--N 1.315 -0.904 0 N-CA-C 107.857 -1.164 . . . . 1.0600000000000001 107.857 172.912 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A 1593 ' ' LYS . . . . . . . . . . . . . 20.0 pttp -104.37 178.4 4.57 Favored 'General case' 0 C--N 1.293 -1.854 0 CA-C-N 115.982 -0.553 . . . . 2.1800000000000002 112.07 -176.173 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A 1594 ' ' ASP . . . . . 0.576 ' HA ' ' CB ' ' A' 1605 ' ' SER . 55.8 m-20 49.05 47.83 21.44 Favored 'General case' 0 CA--C 1.514 -0.423 0 C-N-CA 126.101 1.76 . . . . 1.45 115.701 172.407 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A 1595 ' ' GLY . . . . . . . . . . . . . . . -78.66 -80.48 0.73 Allowed Glycine 0 N--CA 1.445 -0.724 0 C-N-CA 120.298 -0.953 . . . . 0.78000000000000003 111.226 177.758 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A 1596 ' ' SER . . . . . 0.446 ' HA ' ' HD3' ' A' 1597 ' ' PRO . 4.2 p -107.47 143.38 27.11 Favored Pre-proline 0 C--N 1.299 -1.618 0 N-CA-C 109.963 -0.384 . . . . 1.6799999999999999 109.963 177.588 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A 1597 ' ' PRO . . . . . 0.446 ' HD3' ' HA ' ' A' 1596 ' ' SER . 21.5 Cg_exo -67.24 130.13 21.95 Favored 'Trans proline' 0 N--CA 1.46 -0.475 0 C-N-CA 123.039 2.493 . . . . 1.1699999999999999 110.29 177.099 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A 1598 ' ' CYS . . . . . 0.43 ' HA ' ' HD3' ' A' 1599 ' ' PRO . 33.7 t -101.25 121.42 51.92 Favored Pre-proline 0 C--N 1.296 -1.736 0 N-CA-C 109.924 -0.398 . . . . 1.1899999999999999 109.924 -177.157 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A 1599 ' ' PRO . . . . . 0.43 ' HD3' ' HA ' ' A' 1598 ' ' CYS . 94.3 Cg_endo -98.34 22.4 0.29 Allowed 'Trans proline' 0 N--CA 1.449 -1.114 0 C-N-CA 123.127 2.551 . . . . 1.5900000000000001 112.097 178.344 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A 1600 ' ' SER . . . . . . . . . . . . . 17.9 m -79.61 -74.24 0.3 Allowed 'General case' 0 C--N 1.315 -0.931 0 CA-C-N 116.466 -0.333 . . . . 2.1200000000000001 111.788 -177.899 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A 1601 ' ' LYS . . . . . . . . . . . . . 23.2 tptm -98.13 -87.11 0.34 Allowed 'General case' 0 C--N 1.317 -0.822 0 C-N-CA 120.317 -0.553 . . . . 3.7400000000000002 110.42 -178.949 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A 1602 ' ' SER . . . . . . . . . . . . . 16.7 m -96.21 174.98 6.62 Favored 'General case' 0 C--N 1.298 -1.672 0 N-CA-C 107.942 -1.133 . . . . 3.79 107.942 178.718 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A 1603 ' ' GLY . . . . . . . . . . . . . . . -81.57 65.64 3.98 Favored Glycine 0 N--CA 1.439 -1.126 0 N-CA-C 110.382 -1.087 . . . . 2.0 110.382 178.025 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A 1604 ' ' LEU . . . . . . . . . . . . . 1.7 pt? -117.02 165.18 13.66 Favored 'General case' 0 C--N 1.296 -1.724 0 N-CA-C 108.025 -1.102 . . . . 1.48 108.025 -178.111 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A 1605 ' ' SER . . . . . 0.576 ' CB ' ' HA ' ' A' 1594 ' ' ASP . 19.3 m -92.31 178.49 5.83 Favored 'General case' 0 C--N 1.298 -1.641 0 CA-C-O 120.967 0.413 . . . . 1.51 110.389 179.616 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A 1606 ' ' TYR . . . . . 0.489 ' HA ' ' O ' ' A' 1634 ' ' CYS . 76.7 m-85 -95.91 133.74 39.73 Favored 'General case' 0 CA--C 1.468 -2.21 0 N-CA-C 104.658 -2.349 . . . . 1.1799999999999999 104.658 176.321 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A 1607 ' ' LYS . . . . . 0.411 ' HG3' HG23 ' A' 1635 ' ' THR . 10.3 ptpp? -128.36 153.95 46.5 Favored 'General case' 0 N--CA 1.403 -2.802 0 C-N-CA 118.452 -1.299 . . . . 1.6699999999999999 109.133 178.53 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A 1608 ' ' SER . . . . . . . . . . . . . 45.3 m -117.64 124.29 48.23 Favored 'General case' 0 C--N 1.296 -1.727 0 N-CA-C 109.784 -0.45 . . . . 1.0 109.784 178.063 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A 1609 ' ' VAL . . . . . 0.503 HG22 HG23 ' A' 1591 ' ' VAL . 78.4 t -114.65 124.48 71.35 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.868 0 N-CA-C 109.002 -0.74 . . . . 0.93000000000000005 109.002 178.956 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A 1610 ' ' ILE . . . . . 0.705 HG13 ' HB2' ' A' 1638 ' ' PHE . 3.2 mp -108.21 119.14 57.26 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.202 0 N-CA-C 109.166 -0.679 . . . . 0.78000000000000003 109.166 178.683 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A 1611 ' ' SER . . . . . 0.42 ' O ' ' HA ' ' A' 1639 ' ' SER . 8.6 t -96.35 118.37 32.75 Favored 'General case' 0 N--CA 1.412 -2.348 0 N-CA-C 107.732 -1.21 . . . . 1.29 107.732 178.558 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A 1612 ' ' PHE . . . . . 0.436 ' HE2' ' HB2' ' A' 1590 ' ' LEU . 92.8 m-85 -97.06 102.12 13.83 Favored 'General case' 0 N--CA 1.428 -1.556 0 N-CA-C 107.858 -1.164 . . . . 0.69999999999999996 107.858 178.664 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A 1613 ' ' VAL . . . . . . . . . . . . . 85.0 t -84.29 120.03 34.36 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.952 0 N-CA-C 107.51 -1.293 . . . . 0.75 107.51 179.911 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A 1614 ' ' CYS . . . . . 0.522 ' HB3' ' HB2' ' A' 1646 ' ' CYS . 56.8 m -75.06 91.61 2.56 Favored 'General case' 0 C--N 1.295 -1.795 0 CA-C-O 121.653 0.74 . . . . 1.3899999999999999 109.036 -178.334 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A 1615 ' ' ARG . . . . . 0.503 ' HE ' ' HA ' ' A' 1615 ' ' ARG . 0.0 OUTLIER -140.08 123.19 10.3 Favored Pre-proline 0 N--CA 1.414 -2.274 0 CA-C-N 115.748 -0.66 . . . . 3.75 109.893 178.358 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A 1616 ' ' PRO . . . . . . . . . . . . . 56.9 Cg_endo -73.04 68.53 3.98 Favored 'Trans proline' 0 CA--C 1.546 1.083 0 C-N-CA 122.261 1.974 . . . . 1.3200000000000001 110.82 173.908 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A 1617 ' ' GLU . . . . . . . . . . . . . 7.5 tp10 . . . . . 0 C--N 1.314 -0.978 0 N-CA-C 108.878 -0.786 . . . . 3.21 108.878 -177.933 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A 1622 ' ' ASN . . . . . 0.422 ' HB3' ' HE1' ' A' 1640 ' ' TRP . 7.6 t30 . . . . . 0 C--O 1.231 0.099 0 N-CA-C 107.944 -1.132 . . . . 2.9199999999999999 107.944 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A 1623 ' ' ARG . . . . . 0.444 ' HA ' ' HD3' ' A' 1624 ' ' PRO . 32.9 ptt180 -155.32 156.48 31.05 Favored Pre-proline 0 C--N 1.305 -1.361 0 C-N-CA 119.752 -0.779 . . . . 3.6099999999999999 112.144 -169.786 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A 1624 ' ' PRO . . . . . 0.444 ' HD3' ' HA ' ' A' 1623 ' ' ARG . 12.0 Cg_exo -70.76 106.67 1.89 Allowed 'Trans proline' 0 C--N 1.356 0.964 0 C-N-CA 123.426 2.751 . . . . 2.3700000000000001 112.068 179.69 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A 1625 ' ' MET . . . . . . . . . . . . . 25.4 ptm -90.3 164.21 14.45 Favored 'General case' 0 C--N 1.303 -1.423 0 CA-C-N 115.698 -0.683 . . . . 2.1600000000000001 109.304 179.252 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A 1626 ' ' LEU . . . . . . . . . . . . . 41.2 tp -89.58 112.87 24.2 Favored 'General case' 0 C--N 1.303 -1.421 0 N-CA-C 108.69 -0.856 . . . . 1.3500000000000001 108.69 -178.944 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A 1627 ' ' ILE . . . . . . . . . . . . . 44.0 pt -94.43 -27.71 4.29 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.768 0 C-N-CA 120.585 -0.446 . . . . 1.21 111.662 -177.35 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A 1628 ' ' SER . . . . . . . . . . . . . 15.6 p -162.19 151.8 16.13 Favored 'General case' 0 N--CA 1.44 -0.969 0 N-CA-C 109.951 -0.388 . . . . 1.3999999999999999 109.951 -178.485 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A 1629 ' ' LEU . . . . . 0.87 ' HG ' ' HG ' ' A' 1636 ' ' LEU . 2.7 tt -138.82 117.43 12.17 Favored 'General case' 0 C--N 1.293 -1.857 0 N-CA-C 106.84 -1.541 . . . . 1.5600000000000001 106.84 -178.753 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A 1630 ' ' ASP . . . . . . . . . . . . . 12.6 t70 -94.72 103.38 15.29 Favored 'General case' 0 C--N 1.299 -1.621 0 N-CA-C 106.483 -1.673 . . . . 0.87 106.483 178.847 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A 1631 ' ' LYS . . . . . 0.602 ' HG2' HD22 ' A' 1629 ' ' LEU . 90.9 mttt -83.13 -5.35 59.08 Favored 'General case' 0 C--N 1.291 -1.946 0 CA-C-N 115.984 -0.553 . . . . 2.3500000000000001 111.662 -172.35 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A 1632 ' ' GLN . . . . . . . . . . . . . 1.9 mp0 -87.0 -46.15 10.1 Favored 'General case' 0 C--N 1.312 -1.055 0 N-CA-C 108.437 -0.949 . . . . 2.5499999999999998 108.437 -179.524 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A 1633 ' ' THR . . . . . . . . . . . . . 2.3 m -89.83 -2.93 58.33 Favored 'General case' 0 C--N 1.312 -1.022 0 CA-C-O 122.241 1.02 . . . . 1.24 108.769 178.01 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A 1634 ' ' CYS . . . . . 0.489 ' O ' ' HA ' ' A' 1606 ' ' TYR . 28.7 m 59.94 43.72 14.43 Favored 'General case' 0 C--O 1.219 -0.529 0 CA-C-N 114.263 -1.335 . . . . 0.89000000000000001 109.976 176.95 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A 1635 ' ' THR . . . . . 0.411 HG23 ' HG3' ' A' 1607 ' ' LYS . 16.7 m -120.15 127.68 52.72 Favored 'General case' 0 N--CA 1.428 -1.548 0 CA-C-N 115.228 -0.896 . . . . 0.75 110.847 -173.643 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A 1636 ' ' LEU . . . . . 0.87 ' HG ' ' HG ' ' A' 1629 ' ' LEU . 5.9 mp -101.05 132.43 46.48 Favored 'General case' 0 C--N 1.312 -1.059 0 N-CA-C 109.475 -0.565 . . . . 1.3300000000000001 109.475 177.346 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A 1637 ' ' PHE . . . . . . . . . . . . . 95.5 m-85 -113.4 107.86 16.42 Favored 'General case' 0 C--O 1.25 1.089 0 CA-C-O 121.26 0.552 . . . . 0.82999999999999996 111.122 -177.762 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A 1638 ' ' PHE . . . . . 0.705 ' HB2' HG13 ' A' 1610 ' ' ILE . 95.7 m-85 -101.01 154.55 18.61 Favored 'General case' 0 C--N 1.299 -1.587 0 N-CA-C 108.866 -0.79 . . . . 0.59999999999999998 108.866 178.944 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A 1639 ' ' SER . . . . . 0.42 ' HA ' ' O ' ' A' 1611 ' ' SER . 66.2 m -143.85 130.52 20.19 Favored 'General case' 0 C--N 1.296 -1.726 0 CA-C-O 120.992 0.425 . . . . 1.0800000000000001 111.682 178.892 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A 1640 ' ' TRP . . . . . 0.422 ' HE1' ' HB3' ' A' 1622 ' ' ASN . 12.2 t90 -124.71 105.95 9.7 Favored 'General case' 0 N--CA 1.434 -1.262 0 CA-C-N 115.488 -0.778 . . . . 0.80000000000000004 109.117 178.008 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A 1641 ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -76.16 100.32 4.98 Favored 'General case' 0 C--N 1.305 -1.346 0 CA-C-O 121.547 0.689 . . . . 2.54 109.479 175.309 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A 1642 ' ' THR . . . . . 0.422 ' O ' ' HA ' ' A' 1614 ' ' CYS . 14.9 t -142.08 139.01 17.37 Favored Pre-proline 0 C--N 1.291 -1.936 0 C-N-CA 120.016 -0.674 . . . . 1.1499999999999999 112.447 -173.493 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A 1643 ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -80.86 -0.32 10.52 Favored 'Trans proline' 0 N--CA 1.453 -0.893 0 C-N-CA 123.296 2.664 . . . . 0.80000000000000004 110.611 175.487 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A 1644 ' ' LEU . . . . . . . . . . . . . 88.9 mt -77.04 -27.57 54.51 Favored 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 108.405 -0.961 . . . . 1.54 108.405 175.345 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A 1645 ' ' ALA . . . . . . . . . . . . . . . -71.11 -42.37 69.36 Favored 'General case' 0 N--CA 1.441 -0.887 0 CA-C-N 114.596 -1.184 . . . . 0.94999999999999996 110.022 -179.368 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A 1646 ' ' CYS . . . . . 0.522 ' HB2' ' HB3' ' A' 1614 ' ' CYS . 65.5 m -139.94 115.97 10.37 Favored 'General case' 0 C--O 1.244 0.808 0 N-CA-C 106.931 -1.507 . . . . 1.4099999999999999 106.931 173.656 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A 1647 ' ' GLU . . . . . 0.623 ' HB2' ' HE1' ' A' 1525 ' ' HIS . 35.8 mt-10 . . . . . 0 C--N 1.309 -1.18 0 O-C-N 123.802 0.689 . . . . 2.9199999999999999 110.226 -174.882 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A 1515 ' ' ASP . . . . . 0.441 ' HA ' ' HG3' ' A' 1579 ' ' LYS . 10.4 m-20 . . . . . 0 N--CA 1.48 1.073 0 N-CA-C 114.274 1.212 . . . . 2.54 114.274 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A 1516 ' ' CYS . . . . . 0.742 ' HA ' HD23 ' A' 1581 ' ' LEU . 57.0 m -135.79 40.75 2.74 Favored 'General case' 0 C--N 1.324 -0.536 0 C-N-CA 123.933 0.893 . . . . 1.25 111.37 -178.801 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A 1517 ' ' GLN . . . . . 0.497 ' HB2' HD21 ' A' 1526 ' ' LEU . 25.0 pt20 -139.09 124.19 18.96 Favored 'General case' 0 C--N 1.3 -1.571 0 N-CA-C 109.662 -0.496 . . . . 1.8799999999999999 109.662 176.131 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A 1518 ' ' VAL . . . . . . . . . . . . . 7.5 p -124.78 128.94 73.64 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.849 0 CA-C-O 121.044 0.449 . . . . 1.73 110.324 -179.799 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A 1519 ' ' THR . . . . . 0.409 ' HA ' ' HA ' ' A' 1526 ' ' LEU . 50.3 m -100.7 126.33 47.22 Favored 'General case' 0 C--N 1.284 -2.274 0 N-CA-C 108.879 -0.786 . . . . 1.7 108.879 175.369 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A 1520 ' ' ASN . . . . . . . . . . . . . 38.1 t-20 -88.96 110.53 38.6 Favored Pre-proline 0 C--N 1.303 -1.434 0 N-CA-C 107.453 -1.314 . . . . 2.1200000000000001 107.453 176.942 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A 1521 ' ' PRO . . . . . . . . . . . . . 58.9 Cg_endo -70.4 -14.18 33.79 Favored 'Trans proline' 0 C--N 1.356 0.928 0 C-N-CA 122.585 2.19 . . . . 2.4700000000000002 113.19 -175.487 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A 1522 ' ' SER . . . . . . . . . . . . . 6.9 m -80.29 -17.01 53.35 Favored 'General case' 0 N--CA 1.43 -1.442 0 CA-C-N 116.281 -0.418 . . . . 2.5699999999999998 110.581 -178.795 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A 1523 ' ' THR . . . . . . . . . . . . . 10.1 t -131.51 -18.16 2.85 Favored 'General case' 0 CA--C 1.556 1.203 0 C-N-CA 120.312 -0.555 . . . . 2.1499999999999999 112.492 179.45 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A 1524 ' ' GLY . . . . . . . . . . . . . . . 80.38 16.66 75.57 Favored Glycine 0 C--N 1.338 0.683 0 C-N-CA 121.186 -0.53 . . . . 1.8899999999999999 111.93 179.471 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A 1525 ' ' HIS . . . . . . . . . . . . . 21.1 t-160 -102.06 134.71 44.86 Favored 'General case' 0 C--N 1.305 -1.343 0 N-CA-C 109.425 -0.583 . . . . 1.8999999999999999 109.425 -178.795 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A 1526 ' ' LEU . . . . . 0.497 HD21 ' HB2' ' A' 1517 ' ' GLN . 6.7 tt -102.73 138.11 40.06 Favored 'General case' 0 C--N 1.305 -1.357 0 N-CA-C 107.838 -1.171 . . . . 1.6100000000000001 107.838 178.651 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A 1527 ' ' PHE . . . . . 0.513 ' CE2' ' HA ' ' A' 1646 ' ' CYS . 57.9 m-85 -114.03 111.96 22.5 Favored 'General case' 0 C--N 1.299 -1.594 0 N-CA-C 107.71 -1.218 . . . . 1.4199999999999999 107.71 177.489 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A 1528 ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -102.06 139.0 38.27 Favored 'General case' 0 CA--C 1.471 -2.077 0 N-CA-C 108.514 -0.921 . . . . 2.1800000000000002 108.514 178.999 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A 1529 ' ' LEU . . . . . 0.609 ' HB2' ' HB3' ' A' 1516 ' ' CYS . 43.3 mt -111.73 2.82 17.38 Favored 'General case' 0 C--N 1.292 -1.908 0 N-CA-C 107.756 -1.201 . . . . 1.4399999999999999 107.756 176.871 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A 1530 ' ' SER . . . . . . . . . . . . . 8.4 m -65.81 -45.02 83.87 Favored 'General case' 0 N--CA 1.441 -0.893 0 CA-C-N 114.895 -1.048 . . . . 1.4399999999999999 110.538 -177.708 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A 1531 ' ' SER . . . . . . . . . . . . . 37.6 m -77.12 -12.54 59.96 Favored 'General case' 0 C--O 1.24 0.565 0 CA-C-O 121.304 0.573 . . . . 1.5 110.296 177.533 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A 1532 ' ' LEU . . . . . 0.508 HD13 ' HA ' ' A' 1529 ' ' LEU . 8.5 mp -80.22 -31.28 38.62 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 116.033 -0.53 . . . . 1.77 112.362 -179.493 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A 1533 ' ' SER . . . . . 0.588 ' HB2' HG22 ' A' 1552 ' ' ILE . 19.2 t -85.7 173.28 10.22 Favored 'General case' 0 C--N 1.306 -1.32 0 CA-C-O 120.914 0.388 . . . . 2.3799999999999999 110.304 -178.439 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A 1534 ' ' GLY . . . . . . . . . . . . . . . -153.99 167.1 32.17 Favored Glycine 0 N--CA 1.429 -1.821 0 N-CA-C 109.549 -1.42 . . . . 1.55 109.549 -179.256 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A 1535 ' ' ARG . . . . . 0.491 ' CG ' ' HG3' ' A' 1557 ' ' GLU . 13.4 ttp180 -69.29 -47.75 63.66 Favored 'General case' 0 C--N 1.318 -0.789 0 CA-C-O 121.016 0.436 . . . . 3.96 111.132 -177.274 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A 1536 ' ' ALA . . . . . . . . . . . . . . . -77.45 -29.67 52.92 Favored 'General case' 0 C--O 1.245 0.823 0 CA-C-O 121.262 0.554 . . . . 1.6499999999999999 110.361 -179.409 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A 1537 ' ' GLY . . . . . . . . . . . . . . . 86.3 -164.58 36.71 Favored Glycine 0 N--CA 1.427 -1.962 0 CA-C-N 115.296 -0.865 . . . . 1.1899999999999999 112.377 175.574 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A 1538 ' ' PHE . . . . . 0.464 ' CD1' HD13 ' A' 1552 ' ' ILE . 84.2 m-85 -106.6 156.63 18.4 Favored 'General case' 0 C--N 1.293 -1.877 0 N-CA-C 108.081 -1.081 . . . . 1.6899999999999999 108.081 179.439 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A 1539 ' ' THR . . . . . . . . . . . . . 18.8 m -116.13 111.57 20.45 Favored 'General case' 0 C--N 1.291 -1.946 0 CA-C-O 121.51 0.671 . . . . 1.48 109.82 -176.879 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A 1540 ' ' ALA . . . . . . . . . . . . . . . -93.87 151.61 19.46 Favored 'General case' 0 C--N 1.3 -1.583 0 N-CA-C 109.314 -0.624 . . . . 0.82999999999999996 109.314 -179.743 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A 1541 ' ' ALA . . . . . . . . . . . . . . . -88.02 132.61 34.21 Favored 'General case' 0 C--N 1.305 -1.361 0 N-CA-C 109.45 -0.574 . . . . 1.27 109.45 -179.065 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A 1542 ' ' TYR . . . . . 0.505 ' HD2' ' HB2' ' A' 1545 ' ' SER . 72.5 t80 -139.96 164.51 29.8 Favored 'General case' 0 N--CA 1.437 -1.094 0 C-N-CA 120.628 -0.429 . . . . 2.1499999999999999 111.143 -177.426 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A 1543 ' ' SER . . . . . . . . . . . . . 5.6 m -47.47 -151.14 0.0 OUTLIER 'General case' 0 CA--C 1.573 1.833 0 C-N-CA 129.106 2.962 . . . . 2.29 113.619 175.154 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A 1544 ' ' LYS . . . . . . . . . . . . . 18.5 ptpt -39.69 -26.42 0.03 OUTLIER 'General case' 0 CA--C 1.574 1.882 0 N-CA-C 115.004 1.483 . . . . 3.9100000000000001 115.004 178.604 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A 1545 ' ' SER . . . . . 0.505 ' HB2' ' HD2' ' A' 1542 ' ' TYR . 8.4 m -79.12 -8.09 58.7 Favored 'General case' 0 CA--C 1.566 1.591 0 O-C-N 121.501 -0.749 . . . . 3.2999999999999998 111.775 178.717 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A 1546 ' ' GLY . . . . . . . . . . . . . . . 86.09 -80.35 1.79 Allowed Glycine 0 C--N 1.339 0.706 0 C-N-CA 121.488 -0.387 . . . . 1.24 113.991 174.108 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A 1547 ' ' VAL . . . . . . . . . . . . . 8.2 m -141.53 157.96 21.59 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.694 0 C-N-CA 122.99 0.516 . . . . 1.6299999999999999 110.031 -176.987 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A 1548 ' ' VAL . . . . . 0.417 HG13 ' HD1' ' A' 1567 ' ' PHE . 1.3 t -122.79 137.69 55.43 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.37 0 N-CA-C 107.895 -1.15 . . . . 0.92000000000000004 107.895 -178.922 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A 1549 ' ' TYR . . . . . . . . . . . . . 71.3 m-85 -96.02 118.64 33.02 Favored 'General case' 0 C--N 1.306 -1.298 0 N-CA-C 108.771 -0.826 . . . . 1.4399999999999999 108.771 175.263 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A 1550 ' ' MET . . . . . . . . . . . . . 74.0 mmm -118.55 121.74 40.97 Favored 'General case' 0 C--N 1.3 -1.549 0 CA-C-N 115.286 -0.87 . . . . 1.74 109.8 -173.412 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A 1551 ' ' SER . . . . . . . . . . . . . 75.5 m -106.58 114.63 28.85 Favored 'General case' 0 C--N 1.296 -1.759 0 N-CA-C 108.672 -0.862 . . . . 1.6399999999999999 108.672 174.127 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A 1552 ' ' ILE . . . . . 0.588 HG22 ' HB2' ' A' 1533 ' ' SER . 1.5 mp -57.46 -34.02 45.63 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.873 0 CA-C-N 114.957 -1.02 . . . . 1.3300000000000001 113.261 -176.576 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A 1553 ' ' CYS . . . . . 0.559 ' HB3' ' HE3' ' A' 1579 ' ' LYS . 73.6 m -140.68 137.98 33.94 Favored 'General case' 0 C--N 1.304 -1.396 0 N-CA-C 108.978 -0.749 . . . . 1.4299999999999999 108.978 174.977 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A 1554 ' ' GLY . . . . . . . . . . . . . . . 94.89 -125.52 8.37 Favored Glycine 0 N--CA 1.433 -1.547 0 C-N-CA 120.937 -0.649 . . . . 1.1200000000000001 114.043 172.252 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A 1555 ' ' GLU . . . . . . . . . . . . . 7.5 pt-20 -138.45 150.74 46.77 Favored 'General case' 0 C--N 1.31 -1.12 0 C-N-CA 123.432 0.693 . . . . 1.8 111.175 -175.464 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A 1556 ' ' ASN . . . . . . . . . . . . . 17.5 t-20 -101.23 138.96 37.57 Favored 'General case' 0 N--CA 1.433 -1.301 0 CA-C-N 115.503 -0.771 . . . . 2.6299999999999999 108.944 -177.194 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A 1557 ' ' GLU . . . . . 0.491 ' HG3' ' CG ' ' A' 1535 ' ' ARG . 54.7 mm-40 -99.77 -0.42 39.96 Favored 'General case' 0 C--N 1.298 -1.645 0 N-CA-C 113.088 0.773 . . . . 3.79 113.088 -172.528 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A 1558 ' ' ASN . . . . . . . . . . . . . 33.5 m-80 -87.66 -1.82 58.2 Favored 'General case' 0 N--CA 1.483 1.187 0 CA-C-O 122.09 0.948 . . . . 1.52 110.144 -176.812 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A 1559 ' ' CYS . . . . . 0.782 ' HB3' ' HD2' ' A' 1560 ' ' PRO . 94.0 m -142.21 -175.95 0.52 Allowed Pre-proline 0 C--N 1.288 -2.066 0 N-CA-C 104.821 -2.289 . . . . 0.83999999999999997 104.821 177.27 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A 1560 ' ' PRO . . . . . 0.782 ' HD2' ' HB3' ' A' 1559 ' ' CYS . 1.0 OUTLIER -45.72 124.16 6.64 Favored 'Trans proline' 0 C--N 1.364 1.374 0 C-N-CA 122.556 2.171 . . . . 1.1799999999999999 112.882 175.677 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A 1561 ' ' PRO . . . . . 0.44 ' HD3' ' HA ' ' A' 1560 ' ' PRO . 33.5 Cg_exo -62.66 103.33 0.32 Allowed 'Trans proline' 0 C--O 1.242 0.688 0 C-N-CA 122.913 2.408 . . . . 1.51 110.688 179.053 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A 1562 ' ' GLY . . . . . . . . . . . . . . . 146.85 -9.46 1.35 Allowed Glycine 0 N--CA 1.423 -2.197 0 CA-C-N 115.103 -0.953 . . . . 0.71999999999999997 110.805 -177.206 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A 1563 ' ' VAL . . . . . . . . . . . . . 3.6 m -98.29 150.82 4.67 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.345 0 N-CA-C 106.646 -1.613 . . . . 0.96999999999999997 106.646 174.174 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A 1564 ' ' GLY . . . . . . . . . . . . . . . -103.21 -21.75 9.77 Favored Glycine 0 C--N 1.306 -1.089 0 C-N-CA 120.179 -1.01 . . . . 0.71999999999999997 112.286 -176.483 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A 1565 ' ' ALA . . . . . . . . . . . . . . . -148.34 132.38 17.23 Favored 'General case' 0 C--N 1.31 -1.113 0 N-CA-C 109.063 -0.717 . . . . 0.37 109.063 -179.283 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A 1566 ' ' CYS . . . . . . . . . . . . . 35.9 t -153.5 138.95 17.66 Favored 'General case' 0 C--N 1.309 -1.158 0 CA-C-N 116.69 -0.232 . . . . 0.51000000000000001 110.818 -173.821 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A 1567 ' ' PHE . . . . . 0.417 ' HD1' HG13 ' A' 1548 ' ' VAL . 21.0 m-85 -68.73 123.34 20.65 Favored 'General case' 0 CA--C 1.514 -0.436 0 N-CA-C 108.2 -1.037 . . . . 0.96999999999999997 108.2 175.489 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A 1568 ' ' GLY . . . . . . . . . . . . . . . -55.06 -64.36 4.43 Favored Glycine 0 C--N 1.31 -0.908 0 N-CA-C 116.861 1.505 . . . . 1.0800000000000001 116.861 -167.76 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A 1569 ' ' GLN . . . . . . . . . . . . . 13.7 pt20 -85.15 -23.58 28.33 Favored 'General case' 0 C--N 1.312 -1.064 0 N-CA-C 113.208 0.818 . . . . 2.7400000000000002 113.208 -172.057 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A 1570 ' ' THR . . . . . . . . . . . . . 19.7 p -88.32 -17.56 30.37 Favored 'General case' 0 C--N 1.308 -1.222 0 CA-C-O 121.719 0.771 . . . . 1.96 111.191 -179.625 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A 1571 ' ' ARG . . . . . . . . . . . . . 67.9 mtm180 59.12 47.75 11.45 Favored 'General case' 0 CA--C 1.508 -0.67 0 C-N-CA 125.817 1.647 . . . . 3.9500000000000002 112.253 175.272 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A 1572 ' ' ILE . . . . . . . . . . . . . 32.7 mm -112.0 120.28 61.98 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.26 0 N-CA-C 108.062 -1.088 . . . . 1.3700000000000001 108.062 179.434 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A 1573 ' ' SER . . . . . . . . . . . . . 60.4 p -73.63 127.45 32.8 Favored 'General case' 0 C--N 1.309 -1.195 0 CA-C-N 115.857 -0.611 . . . . 1.0800000000000001 111.092 -177.06 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A 1574 ' ' VAL . . . . . 0.479 ' HA ' ' HB2' ' A' 1606 ' ' TYR . 23.5 m -118.22 15.05 7.19 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.307 0 CA-C-O 121.936 0.874 . . . . 1.3 110.782 -179.339 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A 1575 ' ' GLY . . . . . . . . . . . . . . . -179.29 125.28 0.96 Allowed Glycine 0 N--CA 1.429 -1.775 0 CA-C-N 114.466 -1.243 . . . . 0.51000000000000001 110.54 176.531 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A 1576 ' ' LYS . . . . . . . . . . . . . 55.2 tptt -85.68 156.4 20.68 Favored 'General case' 0 C--N 1.313 -0.981 0 N-CA-C 106.423 -1.695 . . . . 2.8999999999999999 106.423 177.955 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A 1577 ' ' ALA . . . . . 0.442 ' C ' HD22 ' A' 1578 ' ' ASN . . . -55.88 115.28 2.29 Favored 'General case' 0 N--CA 1.468 0.465 0 CA-C-O 121.447 0.641 . . . . 0.82999999999999996 110.586 179.738 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A 1578 ' ' ASN . . . . . 0.442 HD22 ' C ' ' A' 1577 ' ' ALA . 1.1 m-80 -125.11 169.72 11.91 Favored 'General case' 0 C--N 1.283 -2.285 0 N-CA-C 106.061 -1.829 . . . . 1.8500000000000001 106.061 178.265 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A 1579 ' ' LYS . . . . . 0.559 ' HE3' ' HB3' ' A' 1553 ' ' CYS . 17.9 tptm -163.87 89.99 0.59 Allowed 'General case' 0 C--N 1.306 -1.283 0 C-N-CA 119.88 -0.728 . . . . 1.8999999999999999 109.418 -176.956 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A 1580 ' ' ARG . . . . . . . . . . . . . 52.0 ttp180 -149.43 106.83 3.62 Favored 'General case' 0 C--N 1.297 -1.691 0 N-CA-C 108.811 -0.811 . . . . 3.6299999999999999 108.811 -178.881 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A 1581 ' ' LEU . . . . . 0.742 HD23 ' HA ' ' A' 1516 ' ' CYS . 0.8 OUTLIER -73.17 133.26 44.0 Favored 'General case' 0 C--N 1.311 -1.098 0 N-CA-C 107.714 -1.217 . . . . 1.8700000000000001 107.714 -179.494 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A 1582 ' ' ARG . . . . . . . . . . . . . 61.5 ttt180 -132.14 108.32 9.2 Favored 'General case' 0 C--N 1.303 -1.417 0 N-CA-C 109.876 -0.416 . . . . 3.9700000000000002 109.876 178.634 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A 1583 ' ' TYR . . . . . . . . . . . . . 49.2 t80 -101.33 92.95 5.17 Favored 'General case' 0 C--N 1.307 -1.24 0 N-CA-C 108.896 -0.779 . . . . 1.4099999999999999 108.896 177.676 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A 1584 ' ' VAL . . . . . . . . . . . . . 15.4 m -123.7 111.12 27.86 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.77 0 N-CA-C 113.14 0.793 . . . . 1.6899999999999999 113.14 -176.113 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A 1585 ' ' ASP . . . . . . . . . . . . . 36.5 t70 56.33 53.62 8.59 Favored 'General case' 0 N--CA 1.478 0.973 0 CA-C-O 122.463 1.125 . . . . 2.0600000000000001 111.194 176.041 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A 1586 ' ' GLN . . . . . . . . . . . . . 18.4 mp0 64.63 -1.63 0.76 Allowed 'General case' 0 C--N 1.324 -0.512 0 C-N-CA 125.743 1.617 . . . . 2.3300000000000001 115.088 178.734 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A 1587 ' ' VAL . . . . . . . . . . . . . 12.7 p -107.84 120.94 60.07 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.887 0 CA-C-O 121.973 0.892 . . . . 0.78000000000000003 109.459 175.978 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A 1588 ' ' LEU . . . . . 0.822 ' HB2' ' HB2' ' A' 1612 ' ' PHE . 2.5 mm? -79.2 137.99 37.65 Favored 'General case' 0 C--N 1.29 -1.983 0 CA-C-N 114.339 -1.3 . . . . 1.4099999999999999 108.357 179.053 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A 1589 ' ' GLN . . . . . 0.437 ' HA ' ' O ' ' A' 1610 ' ' ILE . 6.0 tt0 -140.43 141.08 35.52 Favored 'General case' 0 C--N 1.286 -2.175 0 CA-C-O 120.75 0.309 . . . . 1.24 111.254 -178.017 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A 1590 ' ' LEU . . . . . . . . . . . . . 7.0 tt -142.48 124.59 15.37 Favored 'General case' 0 C--N 1.305 -1.359 0 N-CA-C 105.957 -1.868 . . . . 1.1499999999999999 105.957 175.633 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A 1591 ' ' VAL . . . . . . . . . . . . . 46.4 t -112.48 129.7 67.56 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.067 0 O-C-N 122.381 -0.199 . . . . 1.51 111.508 -175.379 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A 1592 ' ' TYR . . . . . . . . . . . . . 79.4 m-85 -105.3 106.67 17.28 Favored 'General case' 0 C--N 1.313 -0.992 0 N-CA-C 108.8 -0.815 . . . . 1.0600000000000001 108.8 174.647 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A 1593 ' ' LYS . . . . . . . . . . . . . 8.1 ptpp? -108.67 -178.99 3.74 Favored 'General case' 0 C--N 1.311 -1.066 0 C-N-CA 120.31 -0.556 . . . . 2.1800000000000002 112.119 -179.067 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A 1594 ' ' ASP . . . . . . . . . . . . . 5.0 m-20 54.13 44.88 28.54 Favored 'General case' 0 N--CA 1.487 1.376 0 C-N-CA 124.798 1.239 . . . . 1.45 113.831 177.67 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A 1595 ' ' GLY . . . . . . . . . . . . . . . -73.2 -90.54 0.13 Allowed Glycine 0 N--CA 1.445 -0.72 0 C-N-CA 120.45 -0.881 . . . . 0.78000000000000003 111.522 177.176 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A 1596 ' ' SER . . . . . . . . . . . . . 33.7 t -114.49 149.46 42.23 Favored Pre-proline 0 C--N 1.297 -1.691 0 N-CA-C 107.101 -1.444 . . . . 1.6799999999999999 107.101 176.977 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A 1597 ' ' PRO . . . . . . . . . . . . . 33.7 Cg_exo -64.95 133.55 36.39 Favored 'Trans proline' 0 C--N 1.347 0.493 0 C-N-CA 123.074 2.516 . . . . 1.1699999999999999 110.911 176.999 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A 1598 ' ' CYS . . . . . 0.439 ' HA ' ' HD3' ' A' 1599 ' ' PRO . 37.6 t -95.65 126.89 43.62 Favored Pre-proline 0 C--N 1.3 -1.553 0 N-CA-C 108.12 -1.067 . . . . 1.1899999999999999 108.12 -179.13 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A 1599 ' ' PRO . . . . . 0.439 ' HD3' ' HA ' ' A' 1598 ' ' CYS . 25.6 Cg_exo -65.61 -25.52 54.59 Favored 'Trans proline' 0 C--N 1.353 0.784 0 C-N-CA 123.472 2.781 . . . . 1.5900000000000001 112.113 -178.476 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A 1600 ' ' SER . . . . . . . . . . . . . 23.0 m -86.17 123.51 31.53 Favored 'General case' 0 N--CA 1.421 -1.883 0 N-CA-C 108.367 -0.975 . . . . 2.1200000000000001 108.367 177.338 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A 1601 ' ' LYS . . . . . 0.845 ' HB3' HD12 ' A' 1604 ' ' LEU . 4.3 tmtm? 68.49 81.58 0.18 Allowed 'General case' 0 C--O 1.239 0.523 0 N-CA-C 107.747 -1.205 . . . . 3.7400000000000002 107.747 -179.678 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A 1602 ' ' SER . . . . . . . . . . . . . 20.9 m -50.82 111.45 0.55 Allowed 'General case' 0 N--CA 1.441 -0.915 0 CA-C-N 114.025 -1.443 . . . . 3.79 112.651 -176.695 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A 1603 ' ' GLY . . . . . . . . . . . . . . . 128.78 -19.04 5.59 Favored Glycine 0 N--CA 1.433 -1.524 0 CA-C-N 114.747 -1.115 . . . . 2.0 110.315 -177.929 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A 1604 ' ' LEU . . . . . 0.845 HD12 ' HB3' ' A' 1601 ' ' LYS . 12.6 mt -74.91 159.35 31.95 Favored 'General case' 0 CA--C 1.506 -0.732 0 CA-C-O 122.69 1.233 . . . . 1.48 114.291 -179.99 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A 1605 ' ' SER . . . . . . . . . . . . . 16.6 m -137.19 175.8 9.29 Favored 'General case' 0 C--N 1.288 -2.077 0 N-CA-C 104.897 -2.26 . . . . 1.51 104.897 177.217 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A 1606 ' ' TYR . . . . . 0.479 ' HB2' ' HA ' ' A' 1574 ' ' VAL . 56.9 m-85 -102.54 134.58 45.64 Favored 'General case' 0 CA--C 1.462 -2.406 0 N-CA-C 105.249 -2.13 . . . . 1.1799999999999999 105.249 -179.292 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A 1607 ' ' LYS . . . . . 0.515 ' HG3' HG23 ' A' 1635 ' ' THR . 26.6 pttm -131.18 142.79 50.25 Favored 'General case' 0 N--CA 1.401 -2.889 0 C-N-CA 119.338 -0.945 . . . . 1.6699999999999999 108.9 177.8 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A 1608 ' ' SER . . . . . . . . . . . . . 44.3 m -114.59 118.76 34.62 Favored 'General case' 0 C--N 1.295 -1.796 0 CA-C-O 120.666 0.27 . . . . 1.0 110.96 -178.849 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A 1609 ' ' VAL . . . . . . . . . . . . . 69.3 t -94.62 115.6 33.85 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.76 0 N-CA-C 108.782 -0.822 . . . . 0.93000000000000005 108.782 176.851 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A 1610 ' ' ILE . . . . . 0.437 ' O ' ' HA ' ' A' 1589 ' ' GLN . 17.6 mm -98.66 112.19 30.15 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.191 0 N-CA-C 108.77 -0.826 . . . . 0.78000000000000003 108.77 179.189 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A 1611 ' ' SER . . . . . 0.504 ' O ' ' HA ' ' A' 1639 ' ' SER . 36.5 m -101.05 128.62 47.01 Favored 'General case' 0 C--N 1.304 -1.375 0 N-CA-C 109.518 -0.549 . . . . 1.29 109.518 177.005 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A 1612 ' ' PHE . . . . . 0.822 ' HB2' ' HB2' ' A' 1588 ' ' LEU . 97.9 m-85 -100.88 115.37 30.24 Favored 'General case' 0 C--N 1.292 -1.894 0 CA-C-O 121.003 0.43 . . . . 0.69999999999999996 110.494 -179.429 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A 1613 ' ' VAL . . . . . . . . . . . . . 58.9 t -100.01 111.54 29.95 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.161 0 N-CA-C 108.486 -0.931 . . . . 0.75 108.486 -178.613 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A 1614 ' ' CYS . . . . . 0.498 ' HA ' ' O ' ' A' 1642 ' ' THR . 3.0 p -85.57 94.22 8.99 Favored 'General case' 0 C--N 1.301 -1.535 0 CA-C-O 121.715 0.769 . . . . 1.3899999999999999 112.999 -178.605 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A 1615 ' ' ARG . . . . . 0.516 ' HD3' ' HD2' ' A' 1616 ' ' PRO . 19.7 tpp180 -138.2 113.48 8.89 Favored Pre-proline 0 N--CA 1.428 -1.539 0 CA-C-N 115.37 -0.832 . . . . 3.75 109.93 177.318 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A 1616 ' ' PRO . . . . . 0.516 ' HD2' ' HD3' ' A' 1615 ' ' ARG . 57.8 Cg_endo -71.34 53.69 1.72 Allowed 'Trans proline' 0 CA--C 1.548 1.223 0 C-N-CA 123.414 2.742 . . . . 1.3200000000000001 112.495 176.488 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A 1617 ' ' GLU . . . . . . . . . . . . . 30.6 tt0 . . . . . 0 C--N 1.306 -1.312 0 N-CA-C 106.29 -1.744 . . . . 3.21 106.29 176.624 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A 1622 ' ' ASN . . . . . . . . . . . . . 28.1 t-20 . . . . . 0 C--O 1.242 0.665 0 N-CA-C 107.872 -1.158 . . . . 2.9199999999999999 107.872 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A 1623 ' ' ARG . . . . . . . . . . . . . 5.7 ptm180 -121.82 146.69 46.56 Favored Pre-proline 0 C--N 1.281 -2.385 0 N-CA-C 109.083 -0.71 . . . . 3.6099999999999999 109.083 -177.228 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A 1624 ' ' PRO . . . . . . . . . . . . . 11.0 Cg_endo -55.25 117.52 4.12 Favored 'Trans proline' 0 C--N 1.348 0.551 0 C-N-CA 123.192 2.595 . . . . 2.3700000000000001 111.621 178.536 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A 1625 ' ' MET . . . . . . . . . . . . . 26.5 ptm -96.79 143.16 27.98 Favored 'General case' 0 C--N 1.296 -1.748 0 CA-C-N 115.49 -0.777 . . . . 2.1600000000000001 109.603 -178.573 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A 1626 ' ' LEU . . . . . . . . . . . . . 38.5 tp -80.48 123.07 27.76 Favored 'General case' 0 C--N 1.303 -1.425 0 N-CA-C 107.396 -1.335 . . . . 1.3500000000000001 107.396 176.192 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A 1627 ' ' ILE . . . . . . . . . . . . . 41.4 pt -100.98 -32.43 3.42 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.548 0 C-N-CA 120.252 -0.579 . . . . 1.21 111.116 -179.907 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A 1628 ' ' SER . . . . . . . . . . . . . 20.4 m -152.64 148.71 27.63 Favored 'General case' 0 C--N 1.318 -0.802 0 N-CA-C 109.696 -0.483 . . . . 1.3999999999999999 109.696 -178.099 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A 1629 ' ' LEU . . . . . . . . . . . . . 25.8 tp -136.1 99.65 4.19 Favored 'General case' 0 C--N 1.304 -1.407 0 N-CA-C 109.132 -0.692 . . . . 1.5600000000000001 109.132 178.581 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A 1630 ' ' ASP . . . . . . . . . . . . . 11.8 t70 -90.95 107.85 19.47 Favored 'General case' 0 C--N 1.305 -1.331 0 N-CA-C 108.628 -0.879 . . . . 0.87 108.628 -178.1 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A 1631 ' ' LYS . . . . . . . . . . . . . 68.2 mttm -81.44 -15.15 55.96 Favored 'General case' 0 C--N 1.304 -1.381 0 N-CA-C 112.386 0.513 . . . . 2.3500000000000001 112.386 -175.448 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A 1632 ' ' GLN . . . . . . . . . . . . . 1.5 mp0 -84.98 -40.74 16.57 Favored 'General case' 0 C--N 1.313 -1.005 0 CA-C-O 120.937 0.399 . . . . 2.5499999999999998 110.58 -178.771 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A 1633 ' ' THR . . . . . . . . . . . . . 2.7 m -95.95 -4.15 43.88 Favored 'General case' 0 C--N 1.301 -1.511 0 CA-C-O 121.55 0.691 . . . . 1.24 110.278 -178.873 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A 1634 ' ' CYS . . . . . . . . . . . . . 56.6 m 59.47 41.41 19.35 Favored 'General case' 0 C--N 1.35 0.59 0 C-N-CA 124.105 0.962 . . . . 0.89000000000000001 110.081 176.923 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A 1635 ' ' THR . . . . . 0.515 HG23 ' HG3' ' A' 1607 ' ' LYS . 33.4 m -112.83 132.61 55.2 Favored 'General case' 0 N--CA 1.431 -1.408 0 CA-C-N 115.179 -0.919 . . . . 0.75 111.467 -174.223 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A 1636 ' ' LEU . . . . . 0.415 ' HB3' ' CE2' ' A' 1638 ' ' PHE . 2.4 mm? -100.95 127.71 47.32 Favored 'General case' 0 C--N 1.316 -0.877 0 N-CA-C 108.561 -0.904 . . . . 1.3300000000000001 108.561 -179.489 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A 1637 ' ' PHE . . . . . . . . . . . . . 97.6 m-85 -115.94 111.28 20.17 Favored 'General case' 0 C--N 1.305 -1.34 0 N-CA-C 109.931 -0.396 . . . . 0.82999999999999996 109.931 179.38 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A 1638 ' ' PHE . . . . . 0.415 ' CE2' ' HB3' ' A' 1636 ' ' LEU . 87.8 m-85 -118.81 154.42 32.89 Favored 'General case' 0 C--N 1.309 -1.16 0 CA-C-O 121.191 0.52 . . . . 0.59999999999999998 110.703 -179.094 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A 1639 ' ' SER . . . . . 0.504 ' HA ' ' O ' ' A' 1611 ' ' SER . 46.8 m -141.51 136.91 31.66 Favored 'General case' 0 C--N 1.294 -1.841 0 CA-C-N 116.171 -0.468 . . . . 1.0800000000000001 110.46 176.827 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A 1640 ' ' TRP . . . . . . . . . . . . . 22.0 t90 -113.32 132.27 55.63 Favored 'General case' 0 C--N 1.298 -1.635 0 N-CA-C 107.924 -1.139 . . . . 0.80000000000000004 107.924 178.066 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A 1641 ' ' HIS . . . . . . . . . . . . . 11.8 m170 -96.93 110.28 22.84 Favored 'General case' 0 CA--C 1.493 -1.22 0 N-CA-C 107.129 -1.434 . . . . 2.54 107.129 179.424 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A 1642 ' ' THR . . . . . 0.708 HG23 ' HB2' ' A' 1645 ' ' ALA . 2.9 t -142.92 137.95 15.46 Favored Pre-proline 0 C--N 1.283 -2.309 0 CA-C-N 115.989 -0.551 . . . . 1.1499999999999999 111.69 -170.604 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A 1643 ' ' PRO . . . . . . . . . . . . . 95.8 Cg_endo -83.31 -0.39 9.86 Favored 'Trans proline' 0 CA--C 1.535 0.527 0 C-N-CA 123.35 2.7 . . . . 0.80000000000000004 111.655 178.455 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A 1644 ' ' LEU . . . . . . . . . . . . . 47.4 mt -98.33 1.64 47.24 Favored 'General case' 0 C--N 1.315 -0.894 0 CA-C-N 115.765 -0.652 . . . . 1.54 110.9 179.624 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A 1645 ' ' ALA . . . . . 0.708 ' HB2' HG23 ' A' 1642 ' ' THR . . . -91.8 -18.18 24.24 Favored 'General case' 0 C--N 1.301 -1.537 0 CA-C-N 115.756 -0.656 . . . . 0.94999999999999996 111.612 -176.274 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A 1646 ' ' CYS . . . . . 0.513 ' HA ' ' CE2' ' A' 1527 ' ' PHE . 72.0 m -154.25 174.26 15.03 Favored 'General case' 0 C--N 1.313 -0.991 0 N-CA-C 105.267 -2.123 . . . . 1.4099999999999999 105.267 175.452 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A 1647 ' ' GLU . . . . . 0.404 ' H ' ' CD ' ' A' 1647 ' ' GLU . 0.5 OUTLIER . . . . . 0 C--N 1.298 -1.658 0 N-CA-C 109.526 -0.546 . . . . 2.9199999999999999 109.526 175.819 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A 1515 ' ' ASP . . . . . . . . . . . . . 8.8 m-20 . . . . . 0 CA--C 1.494 -1.175 0 N-CA-C 108.447 -0.945 . . . . 2.54 108.447 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A 1516 ' ' CYS . . . . . 0.542 ' HB3' ' HB2' ' A' 1529 ' ' LEU . 74.4 m -79.01 60.34 2.9 Favored 'General case' 0 C--N 1.306 -1.299 0 CA-C-O 120.981 0.42 . . . . 1.25 112.069 -176.895 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A 1517 ' ' GLN . . . . . 0.533 ' HB2' HD21 ' A' 1526 ' ' LEU . 0.0 OUTLIER -157.29 122.6 4.58 Favored 'General case' 0 N--CA 1.437 -1.105 0 CA-C-O 121.618 0.723 . . . . 1.8799999999999999 111.885 177.754 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A 1518 ' ' VAL . . . . . . . . . . . . . 10.6 p -129.6 142.32 44.22 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.683 0 CA-C-N 115.454 -0.794 . . . . 1.73 109.657 -177.736 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A 1519 ' ' THR . . . . . 0.571 ' HA ' ' HA ' ' A' 1526 ' ' LEU . 12.7 m -100.74 135.94 41.39 Favored 'General case' 0 C--N 1.3 -1.549 0 CA-C-O 120.67 0.271 . . . . 1.7 110.83 -178.025 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A 1520 ' ' ASN . . . . . 0.482 ' OD1' HG22 ' A' 1523 ' ' THR . 17.1 t-20 -86.61 113.8 54.67 Favored Pre-proline 0 C--N 1.308 -1.226 0 N-CA-C 106.915 -1.513 . . . . 2.1200000000000001 106.915 171.399 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A 1521 ' ' PRO . . . . . . . . . . . . . 51.9 Cg_endo -67.88 -21.52 43.91 Favored 'Trans proline' 0 C--O 1.234 0.276 0 C-N-CA 122.232 1.955 . . . . 2.4700000000000002 113.512 -174.164 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A 1522 ' ' SER . . . . . . . . . . . . . 13.1 m -68.48 -54.88 14.01 Favored 'General case' 0 N--CA 1.438 -1.047 0 C-N-CA 122.265 0.226 . . . . 2.5699999999999998 111.02 -178.715 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A 1523 ' ' THR . . . . . 0.52 HG21 ' HB2' ' A' 1647 ' ' GLU . 15.0 t -94.94 -15.74 23.36 Favored 'General case' 0 CA--C 1.554 1.11 0 CA-C-O 121.097 0.475 . . . . 2.1499999999999999 111.483 -177.949 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A 1524 ' ' GLY . . . . . . . . . . . . . . . 81.17 17.38 72.01 Favored Glycine 0 C--N 1.334 0.434 0 C-N-CA 121.139 -0.553 . . . . 1.8899999999999999 112.984 178.89 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A 1525 ' ' HIS . . . . . . . . . . . . . 18.4 t60 -101.25 137.48 39.54 Favored 'General case' 0 C--N 1.313 -0.982 0 N-CA-C 109.556 -0.535 . . . . 1.8999999999999999 109.556 -177.279 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A 1526 ' ' LEU . . . . . 0.571 ' HA ' ' HA ' ' A' 1519 ' ' THR . 6.1 tt -99.94 132.39 45.32 Favored 'General case' 0 C--N 1.3 -1.548 0 N-CA-C 109.36 -0.608 . . . . 1.6100000000000001 109.36 178.712 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A 1527 ' ' PHE . . . . . 0.446 ' O ' ' HA ' ' A' 1517 ' ' GLN . 28.4 m-85 -99.84 104.87 16.57 Favored 'General case' 0 C--N 1.299 -1.611 0 N-CA-C 108.781 -0.822 . . . . 1.4199999999999999 108.781 -178.952 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A 1528 ' ' ASP . . . . . 0.424 ' HA ' ' HB3' ' A' 1517 ' ' GLN . 35.6 t70 -95.01 124.66 39.18 Favored 'General case' 0 CA--C 1.495 -1.165 0 CA-C-O 121.473 0.654 . . . . 2.1800000000000002 111.753 -179.749 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A 1529 ' ' LEU . . . . . 0.542 ' HB2' ' HB3' ' A' 1516 ' ' CYS . 80.1 mt -109.76 -3.0 17.02 Favored 'General case' 0 C--N 1.296 -1.735 0 CA-C-N 114.285 -1.325 . . . . 1.4399999999999999 109.076 178.863 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A 1530 ' ' SER . . . . . . . . . . . . . 4.5 m -70.33 -38.8 74.95 Favored 'General case' 0 C--O 1.223 -0.315 0 CA-C-N 115.749 -0.66 . . . . 1.4399999999999999 109.597 -179.306 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A 1531 ' ' SER . . . . . . . . . . . . . 24.2 m -63.81 -26.26 68.55 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 121.665 0.745 . . . . 1.5 109.878 177.113 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A 1532 ' ' LEU . . . . . 0.559 HD13 ' CZ3' ' A' 1640 ' ' TRP . 66.2 mt -83.51 -4.4 58.49 Favored 'General case' 0 C--N 1.317 -0.838 0 CA-C-N 115.254 -0.884 . . . . 1.77 111.506 -178.687 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A 1533 ' ' SER . . . . . 0.503 ' OG ' ' HB2' ' A' 1553 ' ' CYS . 10.2 m -87.28 151.89 22.75 Favored 'General case' 0 C--O 1.249 1.049 0 N-CA-C 108.419 -0.956 . . . . 2.3799999999999999 108.419 179.115 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A 1534 ' ' GLY . . . . . . . . . . . . . . . -171.18 -160.13 18.96 Favored Glycine 0 N--CA 1.435 -1.431 0 C-N-CA 119.532 -1.318 . . . . 1.55 112.907 -179.666 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A 1535 ' ' ARG . . . . . 0.492 ' HG3' ' HB2' ' A' 1557 ' ' GLU . 38.3 ttm180 -75.53 -56.1 5.03 Favored 'General case' 0 C--N 1.307 -1.253 0 C-N-CA 123.989 0.916 . . . . 3.96 110.957 -179.132 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A 1536 ' ' ALA . . . . . . . . . . . . . . . -95.65 -29.68 14.18 Favored 'General case' 0 C--N 1.303 -1.452 0 CA-C-N 116.002 -0.545 . . . . 1.6499999999999999 110.544 178.583 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A 1537 ' ' GLY . . . . . 0.442 ' HA3' ' HA ' ' A' 1551 ' ' SER . . . 85.02 -118.46 4.76 Favored Glycine 0 N--CA 1.431 -1.693 0 N-CA-C 110.343 -1.103 . . . . 1.1899999999999999 110.343 -177.998 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A 1538 ' ' PHE . . . . . . . . . . . . . 69.1 m-85 -130.79 165.2 23.48 Favored 'General case' 0 C--N 1.308 -1.233 0 C-N-CA 123.085 0.554 . . . . 1.6899999999999999 109.507 178.292 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A 1539 ' ' THR . . . . . . . . . . . . . 3.1 p -115.15 120.5 39.98 Favored 'General case' 0 C--N 1.311 -1.105 0 N-CA-C 113.16 0.8 . . . . 1.48 113.16 -174.76 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A 1540 ' ' ALA . . . . . . . . . . . . . . . -117.27 127.52 54.16 Favored 'General case' 0 C--N 1.312 -1.063 0 N-CA-C 108.251 -1.018 . . . . 0.82999999999999996 108.251 173.886 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A 1541 ' ' ALA . . . . . . . . . . . . . . . -88.28 153.22 21.38 Favored 'General case' 0 C--N 1.31 -1.127 0 N-CA-C 110.03 -0.359 . . . . 1.27 110.03 -178.492 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A 1542 ' ' TYR . . . . . . . . . . . . . 52.9 t80 -157.42 175.31 14.15 Favored 'General case' 0 C--N 1.318 -0.79 0 N-CA-C 109.015 -0.735 . . . . 2.1499999999999999 109.015 -178.416 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A 1543 ' ' SER . . . . . . . . . . . . . 14.1 m -46.62 -151.0 0.0 OUTLIER 'General case' 0 CA--C 1.57 1.725 0 C-N-CA 129.245 3.018 . . . . 2.29 114.306 177.572 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A 1544 ' ' LYS . . . . . . . . . . . . . 65.0 mttp -42.35 -23.06 0.03 OUTLIER 'General case' 0 CA--C 1.572 1.807 0 N-CA-C 115.47 1.656 . . . . 3.9100000000000001 115.47 -178.574 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A 1545 ' ' SER . . . . . . . . . . . . . 32.4 m -71.62 -15.84 62.26 Favored 'General case' 0 CA--C 1.564 1.517 0 C-N-CA 123.295 0.638 . . . . 3.2999999999999998 111.813 175.277 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A 1546 ' ' GLY . . . . . . . . . . . . . . . 84.04 -75.25 2.39 Favored Glycine 0 C--O 1.241 0.571 0 N-CA-C 114.298 0.479 . . . . 1.24 114.298 174.033 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A 1547 ' ' VAL . . . . . . . . . . . . . 11.7 p -156.32 148.01 11.62 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.853 0 N-CA-C 108.115 -1.069 . . . . 1.6299999999999999 108.115 -175.872 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A 1548 ' ' VAL . . . . . . . . . . . . . 2.4 t -106.25 133.34 50.99 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.81 0 N-CA-C 108.327 -0.99 . . . . 0.92000000000000004 108.327 -179.356 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A 1549 ' ' TYR . . . . . 0.535 ' HB3' HD21 ' A' 1556 ' ' ASN . 12.6 m-85 -100.39 117.32 34.32 Favored 'General case' 0 C--N 1.301 -1.524 0 N-CA-C 107.672 -1.233 . . . . 1.4399999999999999 107.672 172.867 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A 1550 ' ' MET . . . . . . . . . . . . . 52.4 ttp -140.45 122.78 15.94 Favored 'General case' 0 C--N 1.292 -1.896 0 C-N-CA 120.515 -0.474 . . . . 1.74 111.021 -177.544 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A 1551 ' ' SER . . . . . 0.442 ' HA ' ' HA3' ' A' 1537 ' ' GLY . 33.9 t -93.98 137.75 32.85 Favored 'General case' 0 N--CA 1.43 -1.472 0 N-CA-C 104.999 -2.223 . . . . 1.6399999999999999 104.999 173.483 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A 1552 ' ' ILE . . . . . . . . . . . . . 47.5 mm -63.26 -33.29 60.21 Favored 'Isoleucine or valine' 0 C--O 1.207 -1.158 0 CA-C-N 115.325 -0.852 . . . . 1.3300000000000001 110.639 -175.856 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A 1553 ' ' CYS . . . . . 0.503 ' HB2' ' OG ' ' A' 1533 ' ' SER . 79.6 m -144.77 141.19 29.02 Favored 'General case' 0 C--O 1.252 1.236 0 N-CA-C 108.363 -0.977 . . . . 1.4299999999999999 108.363 172.553 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A 1554 ' ' GLY . . . . . . . . . . . . . . . 99.99 -157.93 19.62 Favored Glycine 0 N--CA 1.427 -1.926 0 C-N-CA 120.805 -0.712 . . . . 1.1200000000000001 112.701 174.196 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A 1555 ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 -103.31 147.97 26.43 Favored 'General case' 0 C--N 1.302 -1.469 0 CA-C-O 121.407 0.622 . . . . 1.8 111.549 -178.007 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A 1556 ' ' ASN . . . . . 0.535 HD21 ' HB3' ' A' 1549 ' ' TYR . 25.5 t-20 -95.7 123.44 39.27 Favored 'General case' 0 C--N 1.293 -1.863 0 CA-C-N 115.029 -0.987 . . . . 2.6299999999999999 108.553 179.636 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A 1557 ' ' GLU . . . . . 0.492 ' HB2' ' HG3' ' A' 1535 ' ' ARG . 5.4 mt-10 -91.87 39.57 1.02 Allowed 'General case' 0 C--N 1.303 -1.419 0 N-CA-C 112.09 0.404 . . . . 3.79 112.09 -173.746 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A 1558 ' ' ASN . . . . . . . . . . . . . 32.1 m-80 -125.89 -0.52 7.28 Favored 'General case' 0 C--N 1.311 -1.083 0 CA-C-O 121.971 0.891 . . . . 1.52 109.764 178.931 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A 1559 ' ' CYS . . . . . 0.812 ' HB3' ' HD2' ' A' 1560 ' ' PRO . 84.0 m -144.24 -175.83 0.5 Allowed Pre-proline 0 C--N 1.295 -1.802 0 N-CA-C 106.263 -1.754 . . . . 0.83999999999999997 106.263 -179.664 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A 1560 ' ' PRO . . . . . 0.812 ' HD2' ' HB3' ' A' 1559 ' ' CYS . 4.5 Cg_exo -41.96 123.28 2.39 Favored 'Trans proline' 0 C--N 1.379 2.176 0 C-N-CA 122.702 2.268 . . . . 1.1799999999999999 112.959 175.658 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A 1561 ' ' PRO . . . . . 0.445 ' HD3' ' HA ' ' A' 1560 ' ' PRO . 31.6 Cg_exo -60.75 105.45 0.31 Allowed 'Trans proline' 0 C--O 1.244 0.805 0 C-N-CA 123.082 2.521 . . . . 1.51 110.793 -179.532 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A 1562 ' ' GLY . . . . . . . . . . . . . . . 141.68 -14.7 2.67 Favored Glycine 0 N--CA 1.431 -1.654 0 N-CA-C 111.25 -0.74 . . . . 0.71999999999999997 111.25 -177.368 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A 1563 ' ' VAL . . . . . 0.632 ' HA ' ' HA ' ' A' 1576 ' ' LYS . 3.2 m -98.46 146.85 7.46 Favored 'Isoleucine or valine' 0 C--O 1.207 -1.181 0 N-CA-C 107.465 -1.309 . . . . 0.96999999999999997 107.465 177.15 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A 1564 ' ' GLY . . . . . . . . . . . . . . . -105.67 -25.1 6.71 Favored Glycine 0 C--O 1.241 0.538 0 C-N-CA 120.611 -0.804 . . . . 0.71999999999999997 113.539 -174.229 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A 1565 ' ' ALA . . . . . . . . . . . . . . . -134.91 128.72 33.11 Favored 'General case' 0 C--N 1.315 -0.91 0 N-CA-C 108.996 -0.742 . . . . 0.37 108.996 -179.988 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A 1566 ' ' CYS . . . . . . . . . . . . . 42.1 t -156.54 145.87 20.57 Favored 'General case' 0 C--N 1.307 -1.258 0 CA-C-N 116.671 -0.24 . . . . 0.51000000000000001 110.538 -173.857 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A 1567 ' ' PHE . . . . . . . . . . . . . 24.7 m-85 -71.13 125.58 27.29 Favored 'General case' 0 C--O 1.207 -1.137 0 N-CA-C 107.387 -1.338 . . . . 0.96999999999999997 107.387 175.018 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A 1568 ' ' GLY . . . . . . . . . . . . . . . -75.22 -24.93 69.86 Favored Glycine 0 C--N 1.307 -1.047 0 C-N-CA 120.801 -0.714 . . . . 1.0800000000000001 114.027 -173.648 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A 1569 ' ' GLN . . . . . . . . . . . . . 65.5 tt0 -85.13 -53.03 5.53 Favored 'General case' 0 C--N 1.317 -0.814 0 C-N-CA 120.088 -0.645 . . . . 2.7400000000000002 111.071 -179.757 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A 1570 ' ' THR . . . . . . . . . . . . . 22.8 p -84.19 -16.95 41.53 Favored 'General case' 0 C--N 1.312 -1.053 0 N-CA-C 112.852 0.686 . . . . 1.96 112.852 -176.696 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A 1571 ' ' ARG . . . . . . . . . . . . . 66.0 mtm180 60.78 41.87 14.17 Favored 'General case' 0 CA--C 1.508 -0.661 0 C-N-CA 125.382 1.473 . . . . 3.9500000000000002 112.85 177.463 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A 1572 ' ' ILE . . . . . . . . . . . . . 36.9 mm -103.83 122.8 56.99 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.222 0 N-CA-C 107.404 -1.332 . . . . 1.3700000000000001 107.404 178.134 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A 1573 ' ' SER . . . . . . . . . . . . . 71.5 p -78.43 121.94 25.17 Favored 'General case' 0 N--CA 1.436 -1.137 0 N-CA-C 113.129 0.788 . . . . 1.0800000000000001 113.129 -176.46 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A 1574 ' ' VAL . . . . . . . . . . . . . 22.4 m -106.51 11.39 8.88 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.426 0 CA-C-O 121.875 0.845 . . . . 1.3 110.402 -177.126 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A 1575 ' ' GLY . . . . . . . . . . . . . . . -177.27 118.93 0.66 Allowed Glycine 0 N--CA 1.421 -2.333 0 CA-C-N 114.718 -1.128 . . . . 0.51000000000000001 111.673 177.398 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A 1576 ' ' LYS . . . . . 0.632 ' HA ' ' HA ' ' A' 1563 ' ' VAL . 55.7 tttm -79.85 152.17 29.83 Favored 'General case' 0 C--N 1.306 -1.315 0 N-CA-C 105.799 -1.926 . . . . 2.8999999999999999 105.799 174.888 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A 1577 ' ' ALA . . . . . . . . . . . . . . . -56.22 102.33 0.07 Allowed 'General case' 0 N--CA 1.468 0.434 0 O-C-N 123.983 0.802 . . . . 0.82999999999999996 110.277 -178.537 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A 1578 ' ' ASN . . . . . 0.592 ' HB3' ' HA ' ' A' 1592 ' ' TYR . 8.0 t30 -135.61 130.22 34.07 Favored 'General case' 0 C--N 1.29 -2.001 0 N-CA-C 105.683 -1.969 . . . . 1.8500000000000001 105.683 -179.094 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A 1579 ' ' LYS . . . . . 0.411 ' HE2' ' HB3' ' A' 1579 ' ' LYS . 36.9 ttpt -115.54 90.24 3.29 Favored 'General case' 0 C--N 1.269 -2.926 0 CA-C-O 121.631 0.729 . . . . 1.8999999999999999 109.211 -173.507 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A 1580 ' ' ARG . . . . . 0.556 ' O ' ' HA ' ' A' 1590 ' ' LEU . 44.3 ttm180 -109.93 109.59 20.25 Favored 'General case' 0 C--N 1.286 -2.163 0 N-CA-C 107.902 -1.147 . . . . 3.6299999999999999 107.902 177.332 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A 1581 ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -100.21 138.38 37.35 Favored 'General case' 0 C--N 1.298 -1.665 0 N-CA-C 106.273 -1.751 . . . . 1.8700000000000001 106.273 -177.682 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A 1582 ' ' ARG . . . . . 0.42 ' HB3' ' HB3' ' A' 1589 ' ' GLN . 38.5 ttm180 -144.66 128.46 17.31 Favored 'General case' 0 C--N 1.305 -1.36 0 CA-C-O 121.137 0.494 . . . . 3.9700000000000002 111.043 178.958 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A 1583 ' ' TYR . . . . . 0.458 ' HD1' ' CD2' ' A' 1588 ' ' LEU . 84.9 t80 -117.9 105.02 11.49 Favored 'General case' 0 C--N 1.297 -1.702 0 N-CA-C 105.946 -1.872 . . . . 1.4099999999999999 105.946 176.996 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A 1584 ' ' VAL . . . . . . . . . . . . . 6.6 p -136.79 97.77 1.59 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.343 0 C-N-CA 119.594 -0.842 . . . . 1.6899999999999999 112.501 -177.058 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A 1585 ' ' ASP . . . . . . . . . . . . . 35.7 t70 56.87 69.07 0.78 Allowed 'General case' 0 N--CA 1.476 0.874 0 C-N-CA 124.188 0.995 . . . . 2.0600000000000001 111.814 178.211 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A 1586 ' ' GLN . . . . . . . . . . . . . 53.3 mt-30 52.51 25.5 3.64 Favored 'General case' 0 N--CA 1.478 0.945 0 N-CA-C 114.767 1.395 . . . . 2.3300000000000001 114.767 178.657 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A 1587 ' ' VAL . . . . . 0.414 HG23 ' O ' ' A' 1612 ' ' PHE . 11.5 p -139.52 122.29 17.47 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.772 0 N-CA-C 108.571 -0.9 . . . . 0.78000000000000003 108.571 173.352 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A 1588 ' ' LEU . . . . . 0.579 ' HB2' ' HB2' ' A' 1612 ' ' PHE . 18.5 mt -89.09 158.28 18.02 Favored 'General case' 0 C--N 1.3 -1.556 0 CA-C-N 115.284 -0.871 . . . . 1.4099999999999999 109.963 -178.493 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A 1589 ' ' GLN . . . . . 0.42 ' HB3' ' HB3' ' A' 1582 ' ' ARG . 6.8 tt0 -146.46 136.99 23.97 Favored 'General case' 0 C--N 1.292 -1.935 0 N-CA-C 108.667 -0.864 . . . . 1.24 108.667 176.918 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A 1590 ' ' LEU . . . . . 0.556 ' HA ' ' O ' ' A' 1580 ' ' ARG . 6.1 tt -133.04 135.45 45.38 Favored 'General case' 0 C--N 1.302 -1.47 0 N-CA-C 106.443 -1.688 . . . . 1.1499999999999999 106.443 176.927 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A 1591 ' ' VAL . . . . . 0.424 HG22 HG22 ' A' 1609 ' ' VAL . 57.9 t -130.3 134.58 62.29 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.76 0 N-CA-C 112.761 0.652 . . . . 1.51 112.761 -171.769 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A 1592 ' ' TYR . . . . . 0.592 ' HA ' ' HB3' ' A' 1578 ' ' ASN . 67.3 m-85 -111.09 152.01 27.43 Favored 'General case' 0 C--N 1.318 -0.802 0 N-CA-C 107.405 -1.331 . . . . 1.0600000000000001 107.405 171.53 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A 1593 ' ' LYS . . . . . . . . . . . . . 21.2 pttp -152.48 -177.16 6.05 Favored 'General case' 0 C--N 1.301 -1.539 0 N-CA-C 109.753 -0.462 . . . . 2.1800000000000002 109.753 -178.767 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A 1594 ' ' ASP . . . . . . . . . . . . . 1.7 m-20 53.36 41.83 32.09 Favored 'General case' 0 N--CA 1.485 1.291 0 N-CA-C 115.238 1.57 . . . . 1.45 115.238 173.614 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A 1595 ' ' GLY . . . . . . . . . . . . . . . -82.65 -121.78 0.7 Allowed Glycine 0 N--CA 1.435 -1.429 0 C-N-CA 119.816 -1.183 . . . . 0.78000000000000003 110.816 175.696 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A 1596 ' ' SER . . . . . . . . . . . . . 49.0 m -83.44 153.0 65.1 Favored Pre-proline 0 C--N 1.284 -2.282 0 N-CA-C 109.934 -0.395 . . . . 1.6799999999999999 109.934 -179.606 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A 1597 ' ' PRO . . . . . . . . . . . . . 33.2 Cg_exo -63.67 139.33 68.9 Favored 'Trans proline' 0 C--O 1.253 1.243 0 C-N-CA 122.689 2.26 . . . . 1.1699999999999999 109.723 172.369 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A 1598 ' ' CYS . . . . . . . . . . . . . 34.8 t -95.05 130.16 33.5 Favored Pre-proline 0 C--N 1.287 -2.139 0 N-CA-C 108.97 -0.752 . . . . 1.1899999999999999 108.97 -177.318 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A 1599 ' ' PRO . . . . . 0.485 ' HD2' ' OH ' ' A' 1606 ' ' TYR . 89.2 Cg_endo -82.33 4.57 6.97 Favored 'Trans proline' 0 CA--C 1.536 0.577 0 C-N-CA 122.879 2.386 . . . . 1.5900000000000001 112.697 179.319 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A 1600 ' ' SER . . . . . . . . . . . . . 15.9 m -107.81 123.0 47.91 Favored 'General case' 0 N--CA 1.431 -1.388 0 N-CA-C 109.957 -0.386 . . . . 2.1200000000000001 109.957 -177.468 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A 1601 ' ' LYS . . . . . 0.543 ' HD3' ' HA ' ' A' 1632 ' ' GLN . 26.5 mtpp 66.02 -97.93 0.05 Allowed 'General case' 0 N--CA 1.454 -0.27 0 N-CA-C 114.565 1.32 . . . . 3.7400000000000002 114.565 -179.372 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A 1602 ' ' SER . . . . . 0.441 ' HB3' ' HG ' ' A' 1604 ' ' LEU . 10.4 t -97.59 153.61 18.08 Favored 'General case' 0 C--N 1.301 -1.505 0 N-CA-C 109.202 -0.666 . . . . 3.79 109.202 -178.247 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A 1603 ' ' GLY . . . . . . . . . . . . . . . -80.63 56.87 4.76 Favored Glycine 0 N--CA 1.447 -0.622 0 N-CA-C 110.835 -0.906 . . . . 2.0 110.835 177.625 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A 1604 ' ' LEU . . . . . 0.441 ' HG ' ' HB3' ' A' 1602 ' ' SER . 0.7 OUTLIER -99.28 -172.01 2.19 Favored 'General case' 0 C--N 1.307 -1.259 0 C-N-CA 123.817 0.847 . . . . 1.48 110.633 -179.69 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A 1605 ' ' SER . . . . . . . . . . . . . 8.7 m -97.78 -178.72 4.2 Favored 'General case' 0 C--N 1.301 -1.543 0 CA-C-N 118.206 0.457 . . . . 1.51 110.102 -176.749 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A 1606 ' ' TYR . . . . . 0.485 ' OH ' ' HD2' ' A' 1599 ' ' PRO . 68.2 m-85 -106.39 137.69 43.92 Favored 'General case' 0 N--CA 1.417 -2.091 0 N-CA-C 104.424 -2.436 . . . . 1.1799999999999999 104.424 174.902 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A 1607 ' ' LYS . . . . . 0.541 ' HG3' HG23 ' A' 1635 ' ' THR . 21.9 ptmt -130.05 142.7 50.58 Favored 'General case' 0 C--N 1.282 -2.35 0 C-N-CA 119.955 -0.698 . . . . 1.6699999999999999 109.216 179.383 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A 1608 ' ' SER . . . . . . . . . . . . . 46.7 m -119.0 126.84 52.67 Favored 'General case' 0 C--N 1.3 -1.553 0 CA-C-O 120.413 0.149 . . . . 1.0 110.653 -176.806 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A 1609 ' ' VAL . . . . . 0.424 HG22 HG22 ' A' 1591 ' ' VAL . 74.2 t -116.2 124.45 72.48 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.839 0 N-CA-C 109.321 -0.622 . . . . 0.93000000000000005 109.321 178.205 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A 1610 ' ' ILE . . . . . 0.827 HG13 ' HB2' ' A' 1638 ' ' PHE . 3.0 mp -108.07 120.06 58.76 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.966 0 N-CA-C 109.072 -0.714 . . . . 0.78000000000000003 109.072 176.68 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A 1611 ' ' SER . . . . . . . . . . . . . 24.2 p -94.89 123.63 38.47 Favored 'General case' 0 N--CA 1.432 -1.372 0 N-CA-C 109.049 -0.723 . . . . 1.29 109.049 175.317 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A 1612 ' ' PHE . . . . . 0.579 ' HB2' ' HB2' ' A' 1588 ' ' LEU . 93.0 m-85 -97.11 108.89 21.71 Favored 'General case' 0 C--N 1.298 -1.638 0 CA-C-O 121.123 0.487 . . . . 0.69999999999999996 110.657 -177.914 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A 1613 ' ' VAL . . . . . 0.45 ' O ' ' HA ' ' A' 1641 ' ' HIS . 49.0 t -103.72 120.74 54.26 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.531 0 N-CA-C 109.246 -0.65 . . . . 0.75 109.246 -178.154 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A 1614 ' ' CYS . . . . . 0.59 ' HA ' ' O ' ' A' 1642 ' ' THR . 0.8 OUTLIER -77.7 93.94 4.35 Favored 'General case' 0 C--N 1.302 -1.476 0 N-CA-C 114.201 1.185 . . . . 1.3899999999999999 114.201 -179.15 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A 1615 ' ' ARG . . . . . . . . . . . . . 71.8 ttt180 -115.74 107.05 49.13 Favored Pre-proline 0 C--N 1.312 -1.063 0 N-CA-C 108.163 -1.051 . . . . 3.75 108.163 175.755 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A 1616 ' ' PRO . . . . . . . . . . . . . 27.0 Cg_endo -63.95 -38.1 39.94 Favored 'Trans proline' 0 CA--C 1.531 0.328 0 C-N-CA 122.753 2.302 . . . . 1.3200000000000001 112.191 -179.922 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A 1617 ' ' GLU . . . . . . . . . . . . . 20.4 mm-40 . . . . . 0 C--N 1.312 -1.028 0 CA-C-N 115.976 -0.556 . . . . 3.21 110.937 -179.153 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A 1622 ' ' ASN . . . . . 0.5 ' HA ' ' O ' ' A' 1641 ' ' HIS . 48.8 t-20 . . . . . 0 C--O 1.243 0.722 0 N-CA-C 106.941 -1.503 . . . . 2.9199999999999999 106.941 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A 1623 ' ' ARG . . . . . . . . . . . . . 16.5 ptm180 -149.71 150.26 30.2 Favored Pre-proline 0 C--N 1.308 -1.236 0 N-CA-C 107.677 -1.231 . . . . 3.6099999999999999 107.677 -176.606 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A 1624 ' ' PRO . . . . . . . . . . . . . 11.9 Cg_exo -71.63 94.81 0.69 Allowed 'Trans proline' 0 N--CA 1.456 -0.691 0 C-N-CA 122.148 1.899 . . . . 2.3700000000000001 109.104 175.909 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A 1625 ' ' MET . . . . . . . . . . . . . 57.7 ttp -101.64 141.41 34.54 Favored 'General case' 0 C--N 1.299 -1.588 0 CA-C-N 115.662 -0.699 . . . . 2.1600000000000001 109.779 -175.17 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A 1626 ' ' LEU . . . . . . . . . . . . . 56.2 tp -80.61 110.7 16.34 Favored 'General case' 0 C--N 1.313 -1.005 0 N-CA-C 108.446 -0.946 . . . . 1.3500000000000001 108.446 178.334 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A 1627 ' ' ILE . . . . . . . . . . . . . 26.5 pt -88.16 -41.76 14.48 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.919 0 C-N-CA 120.339 -0.545 . . . . 1.21 112.196 -177.893 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A 1628 ' ' SER . . . . . . . . . . . . . 26.7 t -147.21 148.45 31.52 Favored 'General case' 0 N--CA 1.434 -1.242 0 N-CA-C 109.933 -0.395 . . . . 1.3999999999999999 109.933 -175.489 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A 1629 ' ' LEU . . . . . 0.644 ' HG ' HD13 ' A' 1636 ' ' LEU . 5.1 tt -125.51 112.13 15.87 Favored 'General case' 0 C--N 1.304 -1.411 0 N-CA-C 106.496 -1.668 . . . . 1.5600000000000001 106.496 176.798 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A 1630 ' ' ASP . . . . . 0.436 ' HB2' ' HE2' ' A' 1637 ' ' PHE . 19.5 t70 -83.22 117.46 22.95 Favored 'General case' 0 C--N 1.303 -1.444 0 N-CA-C 108.479 -0.934 . . . . 0.87 108.479 177.704 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A 1631 ' ' LYS . . . . . . . . . . . . . 98.3 mttt -92.26 -7.18 48.83 Favored 'General case' 0 C--N 1.29 -2.021 0 CA-C-N 115.932 -0.576 . . . . 2.3500000000000001 111.179 -174.948 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A 1632 ' ' GLN . . . . . 0.543 ' HA ' ' HD3' ' A' 1601 ' ' LYS . 36.5 mt-30 -80.25 -47.52 14.47 Favored 'General case' 0 C--N 1.317 -0.817 0 CA-C-O 121.456 0.646 . . . . 2.5499999999999998 110.295 -177.338 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A 1633 ' ' THR . . . . . . . . . . . . . 41.0 p -107.25 -1.34 21.87 Favored 'General case' 0 C--N 1.298 -1.66 0 CA-C-N 116.034 -0.53 . . . . 1.24 111.306 179.858 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A 1634 ' ' CYS . . . . . . . . . . . . . 60.3 m 64.62 52.05 1.81 Allowed 'General case' 0 N--CA 1.472 0.644 0 CA-C-O 122.171 0.986 . . . . 0.89000000000000001 110.538 -179.682 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A 1635 ' ' THR . . . . . 0.541 HG23 ' HG3' ' A' 1607 ' ' LYS . 32.1 m -114.16 126.65 55.31 Favored 'General case' 0 N--CA 1.431 -1.381 0 CA-C-N 114.567 -1.197 . . . . 0.75 110.186 -175.485 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A 1636 ' ' LEU . . . . . 0.644 HD13 ' HG ' ' A' 1629 ' ' LEU . 2.1 mm? -95.45 132.99 39.93 Favored 'General case' 0 C--N 1.308 -1.205 0 N-CA-C 108.971 -0.751 . . . . 1.3300000000000001 108.971 -179.423 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A 1637 ' ' PHE . . . . . 0.436 ' HE2' ' HB2' ' A' 1630 ' ' ASP . 99.8 m-85 -116.42 106.38 13.55 Favored 'General case' 0 C--O 1.247 0.969 0 CA-C-O 121.21 0.528 . . . . 0.82999999999999996 110.702 179.555 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A 1638 ' ' PHE . . . . . 0.827 ' HB2' HG13 ' A' 1610 ' ' ILE . 99.0 m-85 -103.77 149.52 24.94 Favored 'General case' 0 C--N 1.301 -1.533 0 N-CA-C 108.619 -0.882 . . . . 0.59999999999999998 108.619 178.684 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A 1639 ' ' SER . . . . . . . . . . . . . 33.6 t -135.59 132.11 36.73 Favored 'General case' 0 C--N 1.285 -2.229 0 N-CA-C 109.216 -0.661 . . . . 1.0800000000000001 109.216 179.496 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A 1640 ' ' TRP . . . . . 0.559 ' CZ3' HD13 ' A' 1532 ' ' LEU . 7.2 t90 -120.82 118.96 31.33 Favored 'General case' 0 N--CA 1.423 -1.806 0 N-CA-C 107.472 -1.307 . . . . 0.80000000000000004 107.472 177.642 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A 1641 ' ' HIS . . . . . 0.5 ' O ' ' HA ' ' A' 1622 ' ' ASN . 31.7 m-70 -96.96 103.46 15.39 Favored 'General case' 0 C--N 1.294 -1.812 0 N-CA-C 106.734 -1.58 . . . . 2.54 106.734 177.354 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A 1642 ' ' THR . . . . . 0.59 ' O ' ' HA ' ' A' 1614 ' ' CYS . 8.9 t -142.24 139.54 17.95 Favored Pre-proline 0 C--N 1.303 -1.45 0 CA-C-N 115.7 -0.682 . . . . 1.1499999999999999 111.807 -170.536 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A 1643 ' ' PRO . . . . . 0.402 ' HD3' ' HA ' ' A' 1642 ' ' THR . 4.3 Cg_exo -74.84 -3.64 14.21 Favored 'Trans proline' 0 N--CA 1.456 -0.718 0 C-N-CA 123.499 2.8 . . . . 0.80000000000000004 111.639 175.573 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A 1644 ' ' LEU . . . . . . . . . . . . . 83.4 mt -82.03 -8.62 59.67 Favored 'General case' 0 C--N 1.315 -0.929 0 CA-C-N 116.447 -0.342 . . . . 1.54 110.635 177.282 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A 1645 ' ' ALA . . . . . . . . . . . . . . . -88.31 -21.0 24.65 Favored 'General case' 0 C--N 1.32 -0.713 0 N-CA-C 113.092 0.775 . . . . 0.94999999999999996 113.092 -176.196 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A 1646 ' ' CYS . . . . . . . . . . . . . 61.1 m -155.15 172.45 18.12 Favored 'General case' 0 N--CA 1.475 0.781 0 N-CA-C 107.243 -1.391 . . . . 1.4099999999999999 107.243 -179.761 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A 1647 ' ' GLU . . . . . 0.52 ' HB2' HG21 ' A' 1523 ' ' THR . 37.7 mm-40 . . . . . 0 C--N 1.309 -1.179 0 N-CA-C 109.815 -0.439 . . . . 2.9199999999999999 109.815 174.694 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A 1515 ' ' ASP . . . . . . . . . . . . . 13.6 t70 . . . . . 0 CA--C 1.54 0.573 0 N-CA-C 105.58 -2.007 . . . . 2.54 105.58 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A 1516 ' ' CYS . . . . . 0.476 ' HB3' ' HB2' ' A' 1529 ' ' LEU . 74.0 m -128.32 43.11 3.2 Favored 'General case' 0 C--N 1.298 -1.637 0 CA-C-N 118.561 0.618 . . . . 1.25 110.135 -176.417 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A 1517 ' ' GLN . . . . . . . . . . . . . 13.2 pt20 -124.52 129.28 50.33 Favored 'General case' 0 C--N 1.295 -1.762 0 C-N-CA 119.866 -0.734 . . . . 1.8799999999999999 110.702 178.238 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A 1518 ' ' VAL . . . . . . . . . . . . . 15.9 m -133.28 139.51 49.07 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.641 0 CA-C-N 115.715 -0.675 . . . . 1.73 110.4 -179.058 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A 1519 ' ' THR . . . . . . . . . . . . . 23.1 m -90.55 123.57 34.32 Favored 'General case' 0 C--N 1.284 -2.251 0 N-CA-C 108.832 -0.803 . . . . 1.7 108.832 176.478 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A 1520 ' ' ASN . . . . . . . . . . . . . 48.6 t-20 -84.63 112.25 40.87 Favored Pre-proline 0 C--N 1.311 -1.08 0 N-CA-C 107.746 -1.205 . . . . 2.1200000000000001 107.746 178.083 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A 1521 ' ' PRO . . . . . . . . . . . . . 42.6 Cg_endo -65.38 -16.46 54.42 Favored 'Trans proline' 0 C--N 1.353 0.766 0 C-N-CA 122.897 2.398 . . . . 2.4700000000000002 113.992 -174.299 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A 1522 ' ' SER . . . . . . . . . . . . . 38.0 m -81.21 -9.8 59.72 Favored 'General case' 0 C--N 1.312 -1.031 0 CA-C-O 120.779 0.323 . . . . 2.5699999999999998 111.869 -178.976 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A 1523 ' ' THR . . . . . . . . . . . . . 13.7 t -136.55 -13.82 1.72 Allowed 'General case' 0 CA--C 1.552 1.041 0 CA-C-O 121.349 0.595 . . . . 2.1499999999999999 111.371 176.761 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A 1524 ' ' GLY . . . . . . . . . . . . . . . 73.33 16.26 78.8 Favored Glycine 0 C--N 1.341 0.845 0 O-C-N 122.134 -0.354 . . . . 1.8899999999999999 112.362 179.481 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A 1525 ' ' HIS . . . . . . . . . . . . . 58.3 t60 -101.93 136.72 41.28 Favored 'General case' 0 C--N 1.306 -1.31 0 C-N-CA 122.623 0.369 . . . . 1.8999999999999999 110.091 -176.135 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A 1526 ' ' LEU . . . . . . . . . . . . . 26.4 tp -83.45 124.49 30.75 Favored 'General case' 0 C--N 1.306 -1.289 0 N-CA-C 108.579 -0.897 . . . . 1.6100000000000001 108.579 176.914 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A 1527 ' ' PHE . . . . . 0.407 ' HZ ' ' HG3' ' A' 1647 ' ' GLU . 80.8 m-85 -98.53 114.11 26.4 Favored 'General case' 0 C--N 1.296 -1.731 0 CA-C-O 121.671 0.748 . . . . 1.4199999999999999 110.06 176.145 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A 1528 ' ' ASP . . . . . . . . . . . . . 4.6 t70 -90.41 105.75 18.03 Favored 'General case' 0 C--N 1.298 -1.642 0 CA-C-N 114.205 -1.361 . . . . 2.1800000000000002 111.02 -177.636 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A 1529 ' ' LEU . . . . . 0.795 ' HA ' HD13 ' A' 1532 ' ' LEU . 79.6 mt -104.19 5.99 35.31 Favored 'General case' 0 C--N 1.297 -1.69 0 N-CA-C 106.089 -1.819 . . . . 1.4399999999999999 106.089 170.861 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A 1530 ' ' SER . . . . . . . . . . . . . 3.1 m -65.47 -36.72 84.74 Favored 'General case' 0 N--CA 1.438 -1.059 0 CA-C-N 114.531 -1.213 . . . . 1.4399999999999999 109.694 -179.279 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A 1531 ' ' SER . . . . . . . . . . . . . 15.6 m -73.62 -9.75 58.99 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 121.308 0.575 . . . . 1.5 109.908 178.114 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A 1532 ' ' LEU . . . . . 0.795 HD13 ' HA ' ' A' 1529 ' ' LEU . 6.6 mp -92.97 15.27 15.35 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.788 -0.642 . . . . 1.77 111.049 -179.724 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A 1533 ' ' SER . . . . . 0.429 ' HA ' ' HB2' ' A' 1553 ' ' CYS . 50.4 m -74.16 127.9 34.13 Favored 'General case' 0 N--CA 1.435 -1.212 0 N-CA-C 108.132 -1.062 . . . . 2.3799999999999999 108.132 174.353 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A 1534 ' ' GLY . . . . . . . . . . . . . . . -127.45 137.36 9.81 Favored Glycine 0 CA--C 1.478 -2.249 0 N-CA-C 109.823 -1.311 . . . . 1.55 109.823 -177.905 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A 1535 ' ' ARG . . . . . . . . . . . . . 3.6 tpp180 -90.33 -44.3 9.77 Favored 'General case' 0 C--N 1.302 -1.471 0 N-CA-C 109.131 -0.692 . . . . 3.96 109.131 -179.845 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A 1536 ' ' ALA . . . . . . . . . . . . . . . -95.32 -6.84 40.31 Favored 'General case' 0 C--N 1.314 -0.961 0 N-CA-C 108.15 -1.056 . . . . 1.6499999999999999 108.15 175.125 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A 1537 ' ' GLY . . . . . . . . . . . . . . . 78.73 -174.12 55.23 Favored Glycine 0 N--CA 1.429 -1.828 0 CA-C-N 113.887 -1.506 . . . . 1.1899999999999999 113.67 177.322 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A 1538 ' ' PHE . . . . . . . . . . . . . 90.3 m-85 -113.97 175.14 5.6 Favored 'General case' 0 C--N 1.292 -1.899 0 N-CA-C 105.457 -2.053 . . . . 1.6899999999999999 105.457 176.263 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A 1539 ' ' THR . . . . . . . . . . . . . 11.9 t -136.47 152.88 51.04 Favored 'General case' 0 C--N 1.282 -2.352 0 C-N-CA 119.02 -1.072 . . . . 1.48 110.21 -178.626 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A 1540 ' ' ALA . . . . . 0.669 ' HA ' ' HD3' ' A' 1623 ' ' ARG . . . -133.38 130.9 39.4 Favored 'General case' 0 C--N 1.319 -0.754 0 N-CA-C 109.062 -0.718 . . . . 0.82999999999999996 109.062 179.067 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A 1541 ' ' ALA . . . . . . . . . . . . . . . -78.57 147.52 33.7 Favored 'General case' 0 C--O 1.247 0.929 0 CA-C-N 116.189 -0.459 . . . . 1.27 110.761 -178.331 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A 1542 ' ' TYR . . . . . 0.472 ' HB3' ' O ' ' A' 1546 ' ' GLY . 89.2 t80 -160.46 160.3 31.92 Favored 'General case' 0 CA--C 1.552 1.058 0 CA-C-O 119.599 -0.239 . . . . 2.1499999999999999 111.549 -177.591 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A 1543 ' ' SER . . . . . . . . . . . . . 17.9 t -37.58 -152.2 0.0 OUTLIER 'General case' 0 CA--C 1.591 2.538 0 C-N-CA 130.626 3.57 . . . . 2.29 115.562 176.331 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A 1544 ' ' LYS . . . . . . . . . . . . . 97.6 mttt -46.7 -35.61 6.26 Favored 'General case' 0 N--CA 1.479 0.98 0 C-N-CA 124.497 1.119 . . . . 3.9100000000000001 113.496 -177.707 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A 1545 ' ' SER . . . . . . . . . . . . . 37.2 m -71.15 -8.12 51.32 Favored 'General case' 0 CA--C 1.551 0.993 0 N-CA-C 112.96 0.726 . . . . 3.2999999999999998 112.96 177.582 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A 1546 ' ' GLY . . . . . 0.472 ' O ' ' HB3' ' A' 1542 ' ' TYR . . . 83.06 -160.71 38.92 Favored Glycine 0 N--CA 1.432 -1.586 0 C-N-CA 121.239 -0.505 . . . . 1.24 114.255 173.05 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A 1547 ' ' VAL . . . . . . . . . . . . . 14.9 p -91.23 134.25 30.36 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.938 0 N-CA-C 108.742 -0.836 . . . . 1.6299999999999999 108.742 -177.019 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A 1548 ' ' VAL . . . . . . . . . . . . . 4.9 t -110.52 147.72 14.49 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.518 0 N-CA-C 108.44 -0.948 . . . . 0.92000000000000004 108.44 -175.03 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A 1549 ' ' TYR . . . . . 0.59 ' HB3' HD21 ' A' 1556 ' ' ASN . 99.8 m-85 -106.0 129.13 54.18 Favored 'General case' 0 C--N 1.313 -0.992 0 N-CA-C 108.185 -1.043 . . . . 1.4399999999999999 108.185 176.762 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A 1550 ' ' MET . . . . . . . . . . . . . 87.7 mmm -134.29 122.35 22.56 Favored 'General case' 0 C--N 1.299 -1.614 0 CA-C-N 115.792 -0.64 . . . . 1.74 109.845 -173.708 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A 1551 ' ' SER . . . . . 0.457 ' OG ' ' HA ' ' A' 1556 ' ' ASN . 74.9 m -97.35 115.63 28.06 Favored 'General case' 0 C--N 1.286 -2.178 0 N-CA-C 107.058 -1.46 . . . . 1.6399999999999999 107.058 171.79 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A 1552 ' ' ILE . . . . . 0.496 ' HB ' ' O ' ' A' 1532 ' ' LEU . 41.9 mm -57.37 -49.55 79.75 Favored 'Isoleucine or valine' 0 C--O 1.21 -0.989 0 CA-C-N 114.811 -1.086 . . . . 1.3300000000000001 108.139 179.421 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A 1553 ' ' CYS . . . . . 0.491 ' HA ' ' HH ' ' A' 1592 ' ' TYR . 81.3 m -131.48 137.45 48.58 Favored 'General case' 0 N--CA 1.425 -1.724 0 N-CA-C 109.371 -0.603 . . . . 1.4299999999999999 109.371 173.96 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A 1554 ' ' GLY . . . . . . . . . . . . . . . 105.56 -143.05 15.64 Favored Glycine 0 N--CA 1.435 -1.42 0 O-C-N 123.785 0.678 . . . . 1.1200000000000001 112.745 174.802 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A 1555 ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -117.91 157.49 26.59 Favored 'General case' 0 C--N 1.303 -1.418 0 N-CA-C 108.473 -0.936 . . . . 1.8 108.473 179.754 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A 1556 ' ' ASN . . . . . 0.59 HD21 ' HB3' ' A' 1549 ' ' TYR . 4.0 t-20 -100.38 -23.4 14.77 Favored 'General case' 0 C--N 1.301 -1.533 0 CA-C-N 116.281 -0.418 . . . . 2.6299999999999999 111.977 -172.816 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A 1557 ' ' GLU . . . . . 0.469 ' C ' ' H ' ' A' 1559 ' ' CYS . 37.7 mt-10 54.82 -158.99 0.19 Allowed 'General case' 0 N--CA 1.449 -0.477 0 CA-C-N 114.92 -1.036 . . . . 3.79 109.577 -174.709 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A 1558 ' ' ASN . . . . . . . . . . . . . 39.8 m-80 69.93 -8.95 0.75 Allowed 'General case' 0 N--CA 1.495 1.801 0 C-N-CA 124.078 0.951 . . . . 1.52 112.192 175.683 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A 1559 ' ' CYS . . . . . 0.739 ' HB3' ' HD2' ' A' 1560 ' ' PRO . 63.4 m -145.04 -173.55 0.36 Allowed Pre-proline 0 C--N 1.283 -2.323 0 N-CA-C 103.683 -2.71 . . . . 0.83999999999999997 103.683 -178.675 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A 1560 ' ' PRO . . . . . 0.739 ' HD2' ' HB3' ' A' 1559 ' ' CYS . 2.8 Cg_exo -37.8 137.3 0.43 Allowed 'Trans proline' 0 C--N 1.373 1.82 0 C-N-CA 123.621 2.88 . . . . 1.1799999999999999 113.727 175.624 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A 1561 ' ' PRO . . . . . . . . . . . . . 39.8 Cg_endo -68.04 125.33 12.91 Favored 'Trans proline' 0 N--CA 1.456 -0.678 0 C-N-CA 122.482 2.121 . . . . 1.51 112.265 -177.839 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A 1562 ' ' GLY . . . . . . . . . . . . . . . 101.68 17.48 21.22 Favored Glycine 0 N--CA 1.434 -1.481 0 C-N-CA 121.029 -0.605 . . . . 0.71999999999999997 112.79 177.341 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A 1563 ' ' VAL . . . . . 0.588 ' HA ' ' HA ' ' A' 1576 ' ' LYS . 10.4 m -103.68 150.75 6.83 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.868 0 N-CA-C 106.746 -1.576 . . . . 0.96999999999999997 106.746 174.631 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A 1564 ' ' GLY . . . . . . . . . . . . . . . -112.26 -5.62 24.66 Favored Glycine 0 C--N 1.317 -0.473 0 C-N-CA 120.233 -0.984 . . . . 0.71999999999999997 113.305 -174.352 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A 1565 ' ' ALA . . . . . . . . . . . . . . . -150.75 133.43 15.75 Favored 'General case' 0 C--O 1.254 1.314 0 N-CA-C 109.414 -0.587 . . . . 0.37 109.414 -179.014 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A 1566 ' ' CYS . . . . . . . . . . . . . 34.7 t -154.06 142.32 20.49 Favored 'General case' 0 C--N 1.312 -1.043 0 CA-C-O 121.234 0.54 . . . . 0.51000000000000001 111.042 -177.186 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A 1567 ' ' PHE . . . . . 0.668 ' O ' ' HA ' ' A' 1571 ' ' ARG . 13.2 m-85 -67.6 150.99 48.06 Favored 'General case' 0 N--CA 1.452 -0.339 0 CA-C-N 115.742 -0.663 . . . . 0.96999999999999997 109.756 176.322 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A 1568 ' ' GLY . . . . . . . . . . . . . . . -108.78 -10.56 24.59 Favored Glycine 0 N--CA 1.432 -1.633 0 C-N-CA 120.337 -0.935 . . . . 1.0800000000000001 111.751 178.831 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A 1569 ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -89.81 -62.34 1.49 Allowed 'General case' 0 C--N 1.317 -0.822 0 N-CA-C 108.217 -1.031 . . . . 2.7400000000000002 108.217 178.374 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A 1570 ' ' THR . . . . . . . . . . . . . 19.3 p -89.24 -11.99 42.03 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 121.135 0.493 . . . . 1.96 111.819 178.718 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A 1571 ' ' ARG . . . . . 0.668 ' HA ' ' O ' ' A' 1567 ' ' PHE . 83.6 mtm180 61.43 37.03 17.01 Favored 'General case' 0 N--CA 1.473 0.709 0 C-N-CA 124.607 1.163 . . . . 3.9500000000000002 113.434 175.748 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A 1572 ' ' ILE . . . . . 0.404 ' H ' ' HB2' ' A' 1567 ' ' PHE . 33.2 mm -99.43 132.9 43.99 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.205 0 N-CA-C 108.655 -0.868 . . . . 1.3700000000000001 108.655 179.907 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A 1573 ' ' SER . . . . . . . . . . . . . 29.5 p -74.73 120.88 20.89 Favored 'General case' 0 N--CA 1.441 -0.89 0 CA-C-O 121.134 0.492 . . . . 1.0800000000000001 111.892 -179.239 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A 1574 ' ' VAL . . . . . . . . . . . . . 35.3 m -113.25 21.8 5.96 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.233 0 CA-C-O 121.672 0.749 . . . . 1.3 112.311 -173.911 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A 1575 ' ' GLY . . . . . . . . . . . . . . . 179.97 127.36 1.11 Allowed Glycine 0 N--CA 1.431 -1.641 0 CA-C-N 115.128 -0.942 . . . . 0.51000000000000001 111.297 176.544 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A 1576 ' ' LYS . . . . . 0.588 ' HA ' ' HA ' ' A' 1563 ' ' VAL . 54.7 tttp -89.91 151.6 21.64 Favored 'General case' 0 C--N 1.313 -0.991 0 N-CA-C 106.794 -1.558 . . . . 2.8999999999999999 106.794 178.499 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A 1577 ' ' ALA . . . . . 0.407 ' HA ' ' CD1' ' A' 1592 ' ' TYR . . . -67.1 88.67 0.17 Allowed 'General case' 0 C--O 1.239 0.508 0 CA-C-O 121.939 0.875 . . . . 0.82999999999999996 112.286 -174.708 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A 1578 ' ' ASN . . . . . . . . . . . . . 49.8 m-80 -117.87 113.29 21.54 Favored 'General case' 0 C--N 1.288 -2.087 0 N-CA-C 104.178 -2.527 . . . . 1.8500000000000001 104.178 172.714 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A 1579 ' ' LYS . . . . . . . . . . . . . 37.4 ttpt -101.07 91.01 4.36 Favored 'General case' 0 C--N 1.274 -2.681 0 C-N-CA 119.24 -0.984 . . . . 1.8999999999999999 109.306 -173.783 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A 1580 ' ' ARG . . . . . . . . . . . . . 49.1 ttp180 -129.7 100.62 5.57 Favored 'General case' 0 N--CA 1.42 -1.968 0 CA-C-N 114.391 -1.277 . . . . 3.6299999999999999 109.576 -178.398 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A 1581 ' ' LEU . . . . . 0.416 HD13 HD12 ' A' 1590 ' ' LEU . 64.3 tp -96.08 147.63 23.52 Favored 'General case' 0 C--N 1.303 -1.43 0 N-CA-C 107.175 -1.417 . . . . 1.8700000000000001 107.175 177.459 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A 1582 ' ' ARG . . . . . 0.589 ' HG2' HG13 ' A' 1584 ' ' VAL . 40.8 ttp180 -146.36 138.52 25.03 Favored 'General case' 0 C--N 1.304 -1.397 0 C-N-CA 120.559 -0.456 . . . . 3.9700000000000002 111.64 178.782 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A 1583 ' ' TYR . . . . . 0.561 ' HD2' HD21 ' A' 1588 ' ' LEU . 55.7 t80 -98.71 108.14 20.75 Favored 'General case' 0 C--O 1.24 0.586 0 N-CA-C 108.114 -1.069 . . . . 1.4099999999999999 108.114 176.438 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A 1584 ' ' VAL . . . . . 0.589 HG13 ' HG2' ' A' 1582 ' ' ARG . 5.1 m -130.34 108.35 15.67 Favored 'Isoleucine or valine' 0 C--O 1.207 -1.147 0 CA-C-O 120.905 0.383 . . . . 1.6899999999999999 111.847 179.228 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A 1585 ' ' ASP . . . . . . . . . . . . . 38.8 t70 57.37 48.11 15.39 Favored 'General case' 0 N--CA 1.479 0.985 0 CA-C-O 122.423 1.106 . . . . 2.0600000000000001 110.796 175.656 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A 1586 ' ' GLN . . . . . . . . . . . . . 22.8 mt-30 68.56 -7.1 0.74 Allowed 'General case' 0 N--CA 1.477 0.886 0 N-CA-C 114.905 1.446 . . . . 2.3300000000000001 114.905 -179.11 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A 1587 ' ' VAL . . . . . . . . . . . . . 9.6 p -99.67 126.37 53.08 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.189 0 C-N-CA 119.73 -0.788 . . . . 0.78000000000000003 108.907 176.554 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A 1588 ' ' LEU . . . . . 0.582 ' HB2' ' HB2' ' A' 1612 ' ' PHE . 36.0 mt -88.23 143.09 27.24 Favored 'General case' 0 C--N 1.292 -1.902 0 CA-C-N 115.593 -0.731 . . . . 1.4099999999999999 109.082 179.596 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A 1589 ' ' GLN . . . . . . . . . . . . . 9.8 tt0 -135.56 134.45 39.41 Favored 'General case' 0 C--N 1.279 -2.473 0 N-CA-C 108.609 -0.886 . . . . 1.24 108.609 179.089 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A 1590 ' ' LEU . . . . . 0.416 HD12 HD13 ' A' 1581 ' ' LEU . 2.2 tt -134.4 133.11 40.19 Favored 'General case' 0 C--N 1.293 -1.877 0 N-CA-C 104.982 -2.229 . . . . 1.1499999999999999 104.982 177.156 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A 1591 ' ' VAL . . . . . . . . . . . . . 29.6 m -128.53 144.26 38.51 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.848 0 N-CA-C 113.039 0.755 . . . . 1.51 113.039 -173.585 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A 1592 ' ' TYR . . . . . 0.491 ' HH ' ' HA ' ' A' 1553 ' ' CYS . 86.8 m-85 -127.95 97.1 4.69 Favored 'General case' 0 C--N 1.312 -1.061 0 N-CA-C 107.3 -1.37 . . . . 1.0600000000000001 107.3 173.423 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A 1593 ' ' LYS . . . . . 0.502 ' HA ' ' HA ' ' A' 1607 ' ' LYS . 14.4 ptmm? -109.19 165.03 11.92 Favored 'General case' 0 C--N 1.296 -1.755 0 CA-C-N 115.852 -0.613 . . . . 2.1800000000000002 111.361 -174.196 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A 1594 ' ' ASP . . . . . 0.401 ' HA ' ' CB ' ' A' 1605 ' ' SER . 2.1 m-20 58.08 59.91 2.91 Favored 'General case' 0 CA--C 1.507 -0.688 0 C-N-CA 125.34 1.456 . . . . 1.45 114.195 172.802 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A 1595 ' ' GLY . . . . . . . . . . . . . . . -86.65 -77.38 1.24 Allowed Glycine 0 N--CA 1.435 -1.381 0 N-CA-C 109.911 -1.276 . . . . 0.78000000000000003 109.911 174.461 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A 1596 ' ' SER . . . . . . . . . . . . . 51.1 m -114.04 145.79 34.32 Favored Pre-proline 0 C--N 1.299 -1.613 0 N-CA-C 109.824 -0.436 . . . . 1.6799999999999999 109.824 178.147 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A 1597 ' ' PRO . . . . . . . . . . . . . 52.2 Cg_exo -59.83 133.37 50.49 Favored 'Trans proline' 0 C--N 1.351 0.709 0 C-N-CA 123.173 2.582 . . . . 1.1699999999999999 110.41 175.284 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A 1598 ' ' CYS . . . . . . . . . . . . . 47.9 t -95.78 130.28 32.08 Favored Pre-proline 0 C--N 1.292 -1.892 0 CA-C-N 115.628 -0.714 . . . . 1.1899999999999999 110.136 -176.124 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A 1599 ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -75.11 -9.64 20.71 Favored 'Trans proline' 0 C--N 1.35 0.63 0 C-N-CA 123.31 2.673 . . . . 1.5900000000000001 113.551 -177.502 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A 1600 ' ' SER . . . . . 0.418 ' HB2' ' SG ' ' A' 1634 ' ' CYS . 48.6 m -69.11 -26.46 64.92 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 120.75 0.31 . . . . 2.1200000000000001 111.312 179.873 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A 1601 ' ' LYS . . . . . 0.631 ' HB3' HD12 ' A' 1604 ' ' LEU . 6.0 tmtm? -156.65 114.58 3.25 Favored 'General case' 0 C--N 1.314 -0.972 0 N-CA-C 107.11 -1.441 . . . . 3.7400000000000002 107.11 -179.003 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A 1602 ' ' SER . . . . . . . . . . . . . 18.5 m -64.27 105.53 0.92 Allowed 'General case' 0 C--N 1.304 -1.37 0 CA-C-O 121.271 0.558 . . . . 3.79 110.26 179.811 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A 1603 ' ' GLY . . . . . . . . . . . . . . . 125.06 -7.5 8.13 Favored Glycine 0 N--CA 1.441 -1.026 0 N-CA-C 110.617 -0.993 . . . . 2.0 110.617 -176.357 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A 1604 ' ' LEU . . . . . 0.631 HD12 ' HB3' ' A' 1601 ' ' LYS . 1.4 mt -100.88 160.76 14.1 Favored 'General case' 0 C--N 1.318 -0.781 0 C-N-CA 122.808 0.443 . . . . 1.48 110.563 177.227 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A 1605 ' ' SER . . . . . 0.401 ' CB ' ' HA ' ' A' 1594 ' ' ASP . 28.8 m -131.57 -169.37 2.18 Favored 'General case' 0 C--N 1.294 -1.828 0 N-CA-C 106.319 -1.734 . . . . 1.51 106.319 177.445 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A 1606 ' ' TYR . . . . . . . . . . . . . 85.1 m-85 -108.67 131.68 54.67 Favored 'General case' 0 N--CA 1.412 -2.337 0 N-CA-C 106.257 -1.757 . . . . 1.1799999999999999 106.257 -179.884 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A 1607 ' ' LYS . . . . . 0.502 ' HA ' ' HA ' ' A' 1593 ' ' LYS . 20.5 ptmt -125.63 125.13 42.62 Favored 'General case' 0 N--CA 1.409 -2.484 0 O-C-N 124.145 0.903 . . . . 1.6699999999999999 110.918 -177.798 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A 1608 ' ' SER . . . . . 0.678 ' HA ' ' HB2' ' A' 1636 ' ' LEU . 49.7 m -98.87 122.86 42.66 Favored 'General case' 0 C--N 1.301 -1.528 0 N-CA-C 110.205 -0.295 . . . . 1.0 110.205 178.616 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A 1609 ' ' VAL . . . . . . . . . . . . . 84.0 t -119.8 126.37 75.23 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.846 0 C-N-CA 123.381 0.672 . . . . 0.93000000000000005 109.261 179.908 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A 1610 ' ' ILE . . . . . 0.475 HG13 ' HB2' ' A' 1638 ' ' PHE . 3.4 mp -115.67 118.03 57.49 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.832 0 N-CA-C 109.123 -0.695 . . . . 0.78000000000000003 109.123 177.328 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A 1611 ' ' SER . . . . . . . . . . . . . 44.8 p -100.95 120.99 40.97 Favored 'General case' 0 N--CA 1.436 -1.139 0 CA-C-O 120.946 0.403 . . . . 1.29 110.095 176.505 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A 1612 ' ' PHE . . . . . 0.582 ' HB2' ' HB2' ' A' 1588 ' ' LEU . 36.2 m-85 -97.68 104.11 16.1 Favored 'General case' 0 C--N 1.302 -1.476 0 C-N-CA 123.404 0.682 . . . . 0.69999999999999996 109.607 -177.351 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A 1613 ' ' VAL . . . . . 0.552 ' O ' ' HA ' ' A' 1641 ' ' HIS . 46.1 t -103.5 131.88 51.05 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.502 0 N-CA-C 108.534 -0.913 . . . . 0.75 108.534 -178.801 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A 1614 ' ' CYS . . . . . 0.588 ' HA ' ' O ' ' A' 1642 ' ' THR . 0.8 OUTLIER -70.06 101.64 1.86 Allowed 'General case' 0 C--N 1.305 -1.355 0 N-CA-C 115.518 1.673 . . . . 1.3899999999999999 115.518 -178.167 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A 1615 ' ' ARG . . . . . 0.611 ' HB3' ' HB3' ' A' 1641 ' ' HIS . 75.9 ttt180 -137.81 107.07 8.25 Favored Pre-proline 0 C--N 1.323 -0.545 0 C-N-CA 124.221 1.009 . . . . 3.75 108.304 173.84 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A 1616 ' ' PRO . . . . . . . . . . . . . 58.9 Cg_endo -69.75 64.45 1.79 Allowed 'Trans proline' 0 CA--C 1.546 1.087 0 C-N-CA 123.562 2.841 . . . . 1.3200000000000001 115.194 -177.288 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A 1617 ' ' GLU . . . . . . . . . . . . . 29.5 mm-40 . . . . . 0 C--N 1.311 -1.081 0 N-CA-C 109.025 -0.731 . . . . 3.21 109.025 176.403 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A 1622 ' ' ASN . . . . . . . . . . . . . 27.5 t-20 . . . . . 0 CA--C 1.494 -1.176 0 CA-C-O 122.438 1.113 . . . . 2.9199999999999999 110.23 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A 1623 ' ' ARG . . . . . 0.669 ' HD3' ' HA ' ' A' 1540 ' ' ALA . 3.5 ptp180 -75.78 149.38 83.15 Favored Pre-proline 0 C--N 1.283 -2.299 0 CA-C-N 112.456 -2.156 . . . . 3.6099999999999999 111.537 -177.509 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A 1624 ' ' PRO . . . . . 0.657 ' HB3' ' HB2' ' A' 1640 ' ' TRP . 18.6 Cg_endo -60.2 159.7 25.54 Favored 'Trans proline' 0 C--N 1.364 1.357 0 C-N-CA 124.274 3.316 . . . . 2.3700000000000001 112.427 177.824 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A 1625 ' ' MET . . . . . . . . . . . . . 72.2 mtm -119.81 150.46 40.39 Favored 'General case' 0 CA--C 1.494 -1.189 0 CA-C-O 121.226 0.536 . . . . 2.1600000000000001 111.347 -178.313 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A 1626 ' ' LEU . . . . . 0.426 HD12 ' O ' ' A' 1637 ' ' PHE . 34.4 tp -83.27 108.98 16.85 Favored 'General case' 0 N--CA 1.43 -1.447 0 N-CA-C 106.632 -1.618 . . . . 1.3500000000000001 106.632 172.572 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A 1627 ' ' ILE . . . . . . . . . . . . . 21.2 pt -85.48 -26.04 6.6 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.965 0 N-CA-C 112.346 0.499 . . . . 1.21 112.346 -173.992 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A 1628 ' ' SER . . . . . . . . . . . . . 23.5 p -167.73 149.98 5.7 Favored 'General case' 0 N--CA 1.438 -1.042 0 CA-C-N 116.699 -0.228 . . . . 1.3999999999999999 110.591 -177.711 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A 1629 ' ' LEU . . . . . 0.748 HD13 HD13 ' A' 1636 ' ' LEU . 33.1 tp -128.35 108.58 10.69 Favored 'General case' 0 N--CA 1.42 -1.956 0 O-C-N 123.812 0.695 . . . . 1.5600000000000001 109.128 177.612 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A 1630 ' ' ASP . . . . . . . . . . . . . 10.0 t70 -83.94 98.44 9.8 Favored 'General case' 0 C--N 1.301 -1.52 0 N-CA-C 106.459 -1.682 . . . . 0.87 106.459 176.936 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A 1631 ' ' LYS . . . . . . . . . . . . . 96.8 mttt -71.65 -20.87 61.89 Favored 'General case' 0 C--N 1.312 -1.054 0 N-CA-C 113.489 0.922 . . . . 2.3500000000000001 113.489 -173.024 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A 1632 ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -85.91 -39.31 17.1 Favored 'General case' 0 C--N 1.324 -0.529 0 N-CA-C 113.413 0.894 . . . . 2.5499999999999998 113.413 -179.908 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A 1633 ' ' THR . . . . . . . . . . . . . 42.2 p -101.21 10.13 41.13 Favored 'General case' 0 C--N 1.315 -0.913 0 C-N-CA 119.459 -0.896 . . . . 1.24 111.547 177.877 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A 1634 ' ' CYS . . . . . 0.418 ' SG ' ' HB2' ' A' 1600 ' ' SER . 10.9 m 54.98 43.92 29.08 Favored 'General case' 0 C--O 1.245 0.833 0 C-N-CA 124.772 1.229 . . . . 0.89000000000000001 111.714 170.177 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A 1635 ' ' THR . . . . . . . . . . . . . 20.9 m -108.16 122.1 46.21 Favored 'General case' 0 N--CA 1.422 -1.861 0 CA-C-N 115.338 -0.846 . . . . 0.75 110.72 -176.178 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A 1636 ' ' LEU . . . . . 0.748 HD13 HD13 ' A' 1629 ' ' LEU . 3.0 mm? -93.07 110.15 21.63 Favored 'General case' 0 C--N 1.312 -1.057 0 CA-C-N 115.296 -0.865 . . . . 1.3300000000000001 108.925 179.986 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A 1637 ' ' PHE . . . . . 0.426 ' O ' HD12 ' A' 1626 ' ' LEU . 99.1 m-85 -100.51 99.21 9.78 Favored 'General case' 0 C--O 1.246 0.918 0 CA-C-O 120.797 0.332 . . . . 0.82999999999999996 111.024 -179.132 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A 1638 ' ' PHE . . . . . 0.475 ' HB2' HG13 ' A' 1610 ' ' ILE . 94.9 m-85 -101.7 141.9 33.86 Favored 'General case' 0 C--N 1.299 -1.588 0 N-CA-C 108.72 -0.844 . . . . 0.59999999999999998 108.72 176.759 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A 1639 ' ' SER . . . . . . . . . . . . . 16.7 t -134.84 137.87 43.68 Favored 'General case' 0 N--CA 1.412 -2.364 0 N-CA-C 109.083 -0.71 . . . . 1.0800000000000001 109.083 -178.913 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A 1640 ' ' TRP . . . . . 0.657 ' HB2' ' HB3' ' A' 1624 ' ' PRO . 7.0 t90 -129.17 99.17 5.15 Favored 'General case' 0 N--CA 1.415 -2.188 0 N-CA-C 108.268 -1.012 . . . . 0.80000000000000004 108.268 179.905 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A 1641 ' ' HIS . . . . . 0.611 ' HB3' ' HB3' ' A' 1615 ' ' ARG . 17.9 m-70 -81.24 95.45 6.95 Favored 'General case' 0 C--N 1.302 -1.463 0 N-CA-C 107.785 -1.191 . . . . 2.54 107.785 174.719 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A 1642 ' ' THR . . . . . 0.588 ' O ' ' HA ' ' A' 1614 ' ' CYS . 13.4 t -138.82 149.52 62.25 Favored Pre-proline 0 C--N 1.305 -1.354 0 CA-C-N 114.895 -1.048 . . . . 1.1499999999999999 109.506 -169.375 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A 1643 ' ' PRO . . . . . . . . . . . . . 58.6 Cg_endo -72.12 0.06 7.83 Favored 'Trans proline' 0 C--N 1.36 1.134 0 C-N-CA 123.833 3.022 . . . . 0.80000000000000004 112.8 179.211 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A 1644 ' ' LEU . . . . . . . . . . . . . 62.5 mt -79.85 4.69 15.82 Favored 'General case' 0 C--N 1.315 -0.892 0 C-N-CA 123.214 0.606 . . . . 1.54 111.171 -178.987 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A 1645 ' ' ALA . . . . . . . . . . . . . . . -106.66 -42.22 5.03 Favored 'General case' 0 C--N 1.316 -0.879 0 CA-C-N 116.221 -0.445 . . . . 0.94999999999999996 110.721 176.923 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A 1646 ' ' CYS . . . . . 0.412 ' N ' ' HB3' ' A' 1614 ' ' CYS . 10.7 m -143.23 144.64 32.23 Favored 'General case' 0 C--N 1.32 -0.684 0 N-CA-C 106.858 -1.534 . . . . 1.4099999999999999 106.858 -179.303 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A 1647 ' ' GLU . . . . . 0.407 ' HG3' ' HZ ' ' A' 1527 ' ' PHE . 47.1 mt-10 . . . . . 0 C--N 1.3 -1.565 0 N-CA-C 109.988 -0.375 . . . . 2.9199999999999999 109.988 178.816 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A 1515 ' ' ASP . . . . . . . . . . . . . 24.7 t0 . . . . . 0 N--CA 1.436 -1.149 0 N-CA-C 108.782 -0.821 . . . . 2.54 108.782 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A 1516 ' ' CYS . . . . . . . . . . . . . 9.6 m -78.2 54.03 1.31 Allowed 'General case' 0 C--N 1.31 -1.128 0 C-N-CA 123.828 0.851 . . . . 1.25 111.362 -175.249 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A 1517 ' ' GLN . . . . . . . . . . . . . 11.0 pt20 -132.62 122.78 25.23 Favored 'General case' 0 C--N 1.296 -1.724 0 N-CA-C 108.605 -0.887 . . . . 1.8799999999999999 108.605 178.779 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A 1518 ' ' VAL . . . . . 0.415 ' HB ' ' CB ' ' A' 1581 ' ' LEU . 7.4 p -109.11 127.25 65.95 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.967 0 CA-C-O 121.621 0.724 . . . . 1.73 111.536 -175.364 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A 1519 ' ' THR . . . . . . . . . . . . . 5.2 m -92.43 118.65 31.17 Favored 'General case' 0 N--CA 1.421 -1.902 0 CA-C-N 115.569 -0.741 . . . . 1.7 109.168 178.312 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A 1520 ' ' ASN . . . . . 0.428 ' CG ' HG22 ' A' 1523 ' ' THR . 32.8 t-20 -84.11 113.83 50.59 Favored Pre-proline 0 C--N 1.31 -1.119 0 N-CA-C 107.513 -1.292 . . . . 2.1200000000000001 107.513 175.918 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A 1521 ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -73.82 -9.58 22.53 Favored 'Trans proline' 0 C--N 1.354 0.834 0 C-N-CA 122.63 2.22 . . . . 2.4700000000000002 113.475 -173.27 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A 1522 ' ' SER . . . . . . . . . . . . . 19.5 m -94.32 -50.96 5.01 Favored 'General case' 0 N--CA 1.427 -1.615 0 C-N-CA 120.825 -0.35 . . . . 2.5699999999999998 111.365 -179.022 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A 1523 ' ' THR . . . . . 0.428 HG22 ' CG ' ' A' 1520 ' ' ASN . 13.8 t -89.79 -12.86 38.01 Favored 'General case' 0 CA--C 1.552 1.041 0 C-N-CA 119.805 -0.758 . . . . 2.1499999999999999 111.184 -178.888 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A 1524 ' ' GLY . . . . . . . . . . . . . . . 73.41 20.36 79.85 Favored Glycine 0 C--O 1.222 -0.619 0 CA-C-N 116.062 -0.517 . . . . 1.8899999999999999 113.634 177.698 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A 1525 ' ' HIS . . . . . . . . . . . . . 9.8 t60 -101.23 136.99 40.16 Favored 'General case' 0 C--N 1.31 -1.126 0 O-C-N 122.222 -0.575 . . . . 1.8999999999999999 109.466 -177.801 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A 1526 ' ' LEU . . . . . . . . . . . . . 65.1 tp -95.3 106.25 18.27 Favored 'General case' 0 C--N 1.303 -1.449 0 N-CA-C 108.346 -0.983 . . . . 1.6100000000000001 108.346 177.906 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A 1527 ' ' PHE . . . . . 0.493 ' CE1' ' HA ' ' A' 1646 ' ' CYS . 93.9 m-85 -89.53 104.94 17.45 Favored 'General case' 0 C--N 1.302 -1.476 0 CA-C-O 121.417 0.627 . . . . 1.4199999999999999 109.441 -179.055 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A 1528 ' ' ASP . . . . . . . . . . . . . 10.9 t70 -89.9 114.67 26.49 Favored 'General case' 0 C--N 1.296 -1.735 0 CA-C-N 115.55 -0.75 . . . . 2.1800000000000002 109.247 -179.843 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A 1529 ' ' LEU . . . . . 0.434 ' HA ' ' HG ' ' A' 1532 ' ' LEU . 37.6 mt -111.04 8.38 21.86 Favored 'General case' 0 C--N 1.295 -1.764 0 N-CA-C 107.918 -1.141 . . . . 1.4399999999999999 107.918 178.983 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A 1530 ' ' SER . . . . . 0.442 ' HA ' ' SG ' ' A' 1553 ' ' CYS . 22.9 t -80.31 -45.75 17.31 Favored 'General case' 0 N--CA 1.439 -0.996 0 CA-C-N 114.597 -1.183 . . . . 1.4399999999999999 109.307 -175.482 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A 1531 ' ' SER . . . . . . . . . . . . . 14.1 p -74.2 -16.86 60.96 Favored 'General case' 0 N--CA 1.438 -1.062 0 CA-C-N 115.514 -0.766 . . . . 1.5 111.589 -179.329 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A 1532 ' ' LEU . . . . . 0.446 HD11 HD11 ' A' 1644 ' ' LEU . 71.6 mt -65.96 -57.21 8.34 Favored 'General case' 0 CA--C 1.508 -0.651 0 CA-C-O 121.116 0.484 . . . . 1.77 111.398 -179.506 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A 1533 ' ' SER . . . . . . . . . . . . . 28.1 t -81.23 139.05 35.71 Favored 'General case' 0 N--CA 1.427 -1.583 0 CA-C-N 115.066 -0.97 . . . . 2.3799999999999999 111.24 -173.037 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A 1534 ' ' GLY . . . . . . . . . . . . . . . -85.06 171.68 46.73 Favored Glycine 0 N--CA 1.416 -2.641 0 N-CA-C 107.65 -2.18 . . . . 1.55 107.65 170.652 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A 1535 ' ' ARG . . . . . . . . . . . . . 38.5 ttm180 -77.7 -15.68 58.99 Favored 'General case' 0 C--N 1.3 -1.569 0 CA-C-O 121.91 0.862 . . . . 3.96 110.764 -176.33 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A 1536 ' ' ALA . . . . . . . . . . . . . . . -84.23 -11.4 56.55 Favored 'General case' 0 C--O 1.242 0.668 0 N-CA-C 108.881 -0.785 . . . . 1.6499999999999999 108.881 174.411 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A 1537 ' ' GLY . . . . . . . . . . . . . . . 74.92 -150.3 40.88 Favored Glycine 0 N--CA 1.426 -1.991 0 CA-C-N 114.701 -1.136 . . . . 1.1899999999999999 113.459 178.17 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A 1538 ' ' PHE . . . . . 0.473 ' CD1' HD13 ' A' 1552 ' ' ILE . 95.5 m-85 -120.98 146.77 46.32 Favored 'General case' 0 C--N 1.295 -1.803 0 N-CA-C 107.765 -1.198 . . . . 1.6899999999999999 107.765 177.746 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A 1539 ' ' THR . . . . . . . . . . . . . 30.2 p -99.38 113.53 25.91 Favored 'General case' 0 C--N 1.283 -2.298 0 CA-C-O 121.323 0.582 . . . . 1.48 109.993 179.591 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A 1540 ' ' ALA . . . . . 0.719 ' HB3' HG13 ' A' 1548 ' ' VAL . . . -93.84 148.56 22.02 Favored 'General case' 0 C--N 1.296 -1.726 0 CA-C-N 115.724 -0.671 . . . . 0.82999999999999996 109.899 -177.575 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A 1541 ' ' ALA . . . . . . . . . . . . . . . -85.7 128.38 34.77 Favored 'General case' 0 N--CA 1.439 -0.982 0 N-CA-C 109.025 -0.731 . . . . 1.27 109.025 178.51 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A 1542 ' ' TYR . . . . . 0.546 ' HD2' ' HB2' ' A' 1545 ' ' SER . 72.9 t80 -136.54 171.79 13.97 Favored 'General case' 0 C--N 1.296 -1.758 0 CA-C-N 116.007 -0.542 . . . . 2.1499999999999999 109.826 -177.667 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A 1543 ' ' SER . . . . . . . . . . . . . 3.6 m -45.67 -150.79 0.0 OUTLIER 'General case' 0 CA--C 1.573 1.855 0 C-N-CA 130.466 3.507 . . . . 2.29 114.147 177.537 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A 1544 ' ' LYS . . . . . . . . . . . . . 22.6 tptm -39.55 -37.22 0.46 Allowed 'General case' 0 N--CA 1.495 1.799 0 N-CA-C 113.531 0.937 . . . . 3.9100000000000001 113.531 178.842 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A 1545 ' ' SER . . . . . 0.546 ' HB2' ' HD2' ' A' 1542 ' ' TYR . 15.7 m -65.08 -21.22 66.78 Favored 'General case' 0 CA--C 1.557 1.246 0 N-CA-C 112.023 0.379 . . . . 3.2999999999999998 112.023 178.401 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A 1546 ' ' GLY . . . . . . . . . . . . . . . 82.45 -67.18 3.76 Favored Glycine 0 N--CA 1.443 -0.839 0 N-CA-C 113.866 0.307 . . . . 1.24 113.866 176.154 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A 1547 ' ' VAL . . . . . . . . . . . . . 72.0 t -128.67 144.48 37.88 Favored 'Isoleucine or valine' 0 N--CA 1.419 -1.997 0 C-N-CA 122.985 0.514 . . . . 1.6299999999999999 110.228 -175.031 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A 1548 ' ' VAL . . . . . 0.719 HG13 ' HB3' ' A' 1540 ' ' ALA . 2.6 p -133.69 127.58 52.99 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.219 0 N-CA-C 108.309 -0.997 . . . . 0.92000000000000004 108.309 173.285 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A 1549 ' ' TYR . . . . . 0.521 ' CZ ' ' HA2' ' A' 1568 ' ' GLY . 0.6 OUTLIER -101.49 133.23 46.46 Favored 'General case' 0 C--N 1.303 -1.43 0 CA-C-O 121.756 0.789 . . . . 1.4399999999999999 112.296 -179.188 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A 1550 ' ' MET . . . . . . . . . . . . . 43.2 ttp -144.51 129.33 18.32 Favored 'General case' 0 C--N 1.296 -1.751 0 CA-C-N 114.666 -1.152 . . . . 1.74 109.704 -176.37 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A 1551 ' ' SER . . . . . . . . . . . . . 50.5 m -88.16 139.8 30.13 Favored 'General case' 0 C--N 1.289 -2.035 0 N-CA-C 108.671 -0.863 . . . . 1.6399999999999999 108.671 178.207 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A 1552 ' ' ILE . . . . . 0.473 HD13 ' CD1' ' A' 1538 ' ' PHE . 1.4 mp -87.13 -6.61 10.7 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.2 0 CA-C-O 122.773 1.273 . . . . 1.3300000000000001 109.462 178.876 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A 1553 ' ' CYS . . . . . 0.442 ' SG ' ' HA ' ' A' 1530 ' ' SER . 54.1 t -157.8 138.28 12.84 Favored 'General case' 0 N--CA 1.416 -2.132 0 CA-C-N 114.179 -1.373 . . . . 1.4299999999999999 108.843 174.501 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A 1554 ' ' GLY . . . . . . . . . . . . . . . 74.09 -169.35 53.89 Favored Glycine 0 N--CA 1.434 -1.497 0 O-C-N 123.958 0.786 . . . . 1.1200000000000001 113.816 174.635 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A 1555 ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -72.91 153.44 41.0 Favored 'General case' 0 C--N 1.311 -1.068 0 CA-C-N 114.805 -0.697 . . . . 1.8 111.362 179.412 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A 1556 ' ' ASN . . . . . . . . . . . . . 25.4 t-20 -105.4 139.31 40.23 Favored 'General case' 0 N--CA 1.414 -2.227 0 CA-C-N 114.509 -1.223 . . . . 2.6299999999999999 108.01 177.494 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A 1557 ' ' GLU . . . . . . . . . . . . . 45.9 mt-10 -102.53 174.9 5.69 Favored 'General case' 0 C--N 1.29 -2.013 0 CA-C-N 115.864 -0.607 . . . . 3.79 110.856 -178.251 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A 1558 ' ' ASN . . . . . . . . . . . . . 46.5 m-80 72.44 12.17 5.64 Favored 'General case' 0 N--CA 1.486 1.355 0 C-N-CA 124.685 1.194 . . . . 1.52 110.597 -176.026 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A 1559 ' ' CYS . . . . . 0.62 ' SG ' ' HD2' ' A' 1560 ' ' PRO . 22.5 t -160.69 152.45 16.49 Favored Pre-proline 0 C--N 1.295 -1.784 0 N-CA-C 103.856 -2.646 . . . . 0.83999999999999997 103.856 179.168 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A 1560 ' ' PRO . . . . . 0.62 ' HD2' ' SG ' ' A' 1559 ' ' CYS . 39.2 Cg_exo -24.24 112.59 0.02 OUTLIER 'Trans proline' 0 C--N 1.368 1.591 0 C-N-CA 125.253 3.968 . . . . 1.1799999999999999 115.472 179.075 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A 1561 ' ' PRO . . . . . 0.505 ' HD2' ' HA ' ' A' 1560 ' ' PRO . 9.6 Cg_endo -53.76 110.63 0.52 Allowed 'Trans proline' 0 C--O 1.237 0.475 0 C-N-CA 123.685 2.923 . . . . 1.51 112.58 179.846 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A 1562 ' ' GLY . . . . . . . . . . . . . . . 133.78 -16.26 4.53 Favored Glycine 0 N--CA 1.439 -1.121 0 C-N-CA 120.528 -0.844 . . . . 0.71999999999999997 111.84 179.254 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A 1563 ' ' VAL . . . . . 0.431 ' HA ' ' HA ' ' A' 1576 ' ' LYS . 4.3 m -86.83 157.35 3.25 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.264 0 N-CA-C 107.586 -1.264 . . . . 0.96999999999999997 107.586 178.834 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A 1564 ' ' GLY . . . . . . . . . . . . . . . -111.44 -22.93 5.91 Favored Glycine 0 N--CA 1.444 -0.791 0 C-N-CA 120.459 -0.877 . . . . 0.71999999999999997 112.545 -177.904 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A 1565 ' ' ALA . . . . . . . . . . . . . . . -141.51 125.45 17.15 Favored 'General case' 0 C--O 1.247 0.957 0 N-CA-C 109.553 -0.536 . . . . 0.37 109.553 -179.437 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A 1566 ' ' CYS . . . . . . . . . . . . . 53.9 t -148.94 132.91 17.14 Favored 'General case' 0 C--N 1.314 -0.946 0 CA-C-N 116.324 -0.398 . . . . 0.51000000000000001 109.999 -176.476 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A 1567 ' ' PHE . . . . . 0.427 ' HA ' HG23 ' A' 1548 ' ' VAL . 35.0 m-85 -63.82 134.82 55.94 Favored 'General case' 0 N--CA 1.474 0.742 0 N-CA-C 108.106 -1.072 . . . . 0.96999999999999997 108.106 177.205 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A 1568 ' ' GLY . . . . . 0.521 ' HA2' ' CZ ' ' A' 1549 ' ' TYR . . . -73.67 -30.74 61.46 Favored Glycine 0 CA--C 1.498 -0.989 0 CA-C-N 116.42 -0.354 . . . . 1.0800000000000001 113.727 -173.199 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A 1569 ' ' GLN . . . . . . . . . . . . . 55.1 tp60 -82.45 -56.83 3.64 Favored 'General case' 0 C--N 1.304 -1.376 0 CA-C-O 121.359 0.6 . . . . 2.7400000000000002 110.511 -179.725 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A 1570 ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -72.06 -27.29 62.59 Favored 'General case' 0 N--CA 1.426 -1.654 0 CA-C-N 114.963 -1.017 . . . . 1.96 111.33 -174.974 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A 1571 ' ' ARG . . . . . . . . . . . . . 42.7 ttp180 52.87 60.75 3.58 Favored 'General case' 0 C--O 1.235 0.315 0 CA-C-O 121.85 0.833 . . . . 3.9500000000000002 109.687 -176.781 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A 1572 ' ' ILE . . . . . . . . . . . . . 40.4 mm -131.58 129.55 61.78 Favored 'Isoleucine or valine' 0 C--O 1.251 1.165 0 N-CA-C 106.915 -1.513 . . . . 1.3700000000000001 106.915 179.405 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A 1573 ' ' SER . . . . . . . . . . . . . 35.7 t -73.04 140.04 46.99 Favored 'General case' 0 C--N 1.303 -1.437 0 O-C-N 124.126 0.891 . . . . 1.0800000000000001 111.357 -178.373 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A 1574 ' ' VAL . . . . . . . . . . . . . 18.0 m -133.06 19.77 1.44 Allowed 'Isoleucine or valine' 0 C--N 1.314 -0.937 0 CA-C-N 115.815 -0.63 . . . . 1.3 110.828 174.587 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A 1575 ' ' GLY . . . . . . . . . . . . . . . 173.73 126.58 0.92 Allowed Glycine 0 N--CA 1.44 -1.058 0 C-N-CA 120.627 -0.797 . . . . 0.51000000000000001 111.869 178.336 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A 1576 ' ' LYS . . . . . 0.431 ' HA ' ' HA ' ' A' 1563 ' ' VAL . 59.0 tttp -82.98 147.45 28.19 Favored 'General case' 0 C--O 1.239 0.552 0 N-CA-C 107.57 -1.271 . . . . 2.8999999999999999 107.57 179.263 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A 1577 ' ' ALA . . . . . . . . . . . . . . . -68.92 79.16 0.31 Allowed 'General case' 0 N--CA 1.475 0.804 0 N-CA-C 113.041 0.756 . . . . 0.82999999999999996 113.041 -174.151 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A 1578 ' ' ASN . . . . . 0.465 ' H ' ' HD1' ' A' 1592 ' ' TYR . 32.0 m-80 -96.67 113.41 24.97 Favored 'General case' 0 C--N 1.297 -1.716 0 N-CA-C 108.107 -1.071 . . . . 1.8500000000000001 108.107 175.519 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A 1579 ' ' LYS . . . . . . . . . . . . . 52.8 pttt -96.92 109.2 21.98 Favored 'General case' 0 C--N 1.291 -1.972 0 CA-C-O 121.311 0.577 . . . . 1.8999999999999999 109.712 -178.859 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A 1580 ' ' ARG . . . . . . . . . . . . . 32.7 ttm180 -158.43 94.18 1.26 Allowed 'General case' 0 N--CA 1.43 -1.445 0 CA-C-N 115.033 -0.985 . . . . 3.6299999999999999 109.435 -177.36 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A 1581 ' ' LEU . . . . . 0.415 ' CB ' ' HB ' ' A' 1518 ' ' VAL . 4.4 mm? -85.52 124.5 32.16 Favored 'General case' 0 C--N 1.302 -1.491 0 CA-C-N 116.275 -0.421 . . . . 1.8700000000000001 110.554 178.011 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A 1582 ' ' ARG . . . . . . . . . . . . . 89.0 mtm180 -120.29 134.32 55.29 Favored 'General case' 0 C--N 1.29 -1.98 0 CA-C-O 121.112 0.482 . . . . 3.9700000000000002 110.863 177.076 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A 1583 ' ' TYR . . . . . . . . . . . . . 80.1 t80 -94.9 96.84 9.58 Favored 'General case' 0 C--N 1.292 -1.904 0 N-CA-C 107.485 -1.302 . . . . 1.4099999999999999 107.485 176.908 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A 1584 ' ' VAL . . . . . . . . . . . . . 36.5 t -112.3 95.16 3.6 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.287 0 CA-C-N 115.653 -0.703 . . . . 1.6899999999999999 109.528 -176.176 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A 1585 ' ' ASP . . . . . . . . . . . . . 35.1 t70 54.72 75.57 0.29 Allowed 'General case' 0 C--N 1.32 -0.708 0 C-N-CA 124.308 1.043 . . . . 2.0600000000000001 112.472 177.775 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A 1586 ' ' GLN . . . . . . . . . . . . . 34.1 tt0 68.16 -14.67 0.24 Allowed 'General case' 0 CA--C 1.574 1.888 0 C-N-CA 124.868 1.267 . . . . 2.3300000000000001 114.398 176.403 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A 1587 ' ' VAL . . . . . . . . . . . . . 7.5 p -118.4 129.62 74.43 Favored 'Isoleucine or valine' 0 C--O 1.25 1.09 0 O-C-N 121.273 -0.892 . . . . 0.78000000000000003 111.484 -179.4 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A 1588 ' ' LEU . . . . . 0.749 ' HB2' ' HB2' ' A' 1612 ' ' PHE . 3.8 mm? -81.26 157.53 25.13 Favored 'General case' 0 N--CA 1.435 -1.189 0 CA-C-N 115.23 -0.896 . . . . 1.4099999999999999 110.415 179.001 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A 1589 ' ' GLN . . . . . . . . . . . . . 34.6 tt0 -148.05 134.96 20.14 Favored 'General case' 0 C--N 1.31 -1.148 0 C-N-CA 121.154 -0.218 . . . . 1.24 110.643 -174.715 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A 1590 ' ' LEU . . . . . 0.468 ' HB3' ' HB ' ' A' 1610 ' ' ILE . 51.0 tp -119.39 133.39 55.74 Favored 'General case' 0 C--N 1.301 -1.507 0 N-CA-C 106.95 -1.5 . . . . 1.1499999999999999 106.95 175.396 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A 1591 ' ' VAL . . . . . . . . . . . . . 52.8 t -126.99 111.63 26.31 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.537 0 CA-C-O 121.022 0.439 . . . . 1.51 111.969 -174.884 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A 1592 ' ' TYR . . . . . 0.465 ' HD1' ' H ' ' A' 1578 ' ' ASN . 20.6 m-85 -101.37 93.05 5.21 Favored 'General case' 0 C--N 1.308 -1.205 0 N-CA-C 108.512 -0.921 . . . . 1.0600000000000001 108.512 173.87 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A 1593 ' ' LYS . . . . . . . . . . . . . 61.4 pttt -103.36 177.21 4.91 Favored 'General case' 0 C--N 1.283 -2.321 0 CA-C-N 115.569 -0.741 . . . . 2.1800000000000002 109.926 -178.754 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A 1594 ' ' ASP . . . . . . . . . . . . . 8.3 m-20 53.96 42.04 31.81 Favored 'General case' 0 N--CA 1.475 0.8 0 N-CA-C 113.923 1.083 . . . . 1.45 113.923 175.74 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A 1595 ' ' GLY . . . . . . . . . . . . . . . -74.58 -87.49 0.24 Allowed Glycine 0 N--CA 1.445 -0.704 0 C-N-CA 120.356 -0.926 . . . . 0.78000000000000003 111.069 176.477 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A 1596 ' ' SER . . . . . . . . . . . . . 32.4 m -114.43 154.33 46.5 Favored Pre-proline 0 C--N 1.294 -1.807 0 N-CA-C 108.258 -1.016 . . . . 1.6799999999999999 108.258 177.599 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A 1597 ' ' PRO . . . . . . . . . . . . . 23.1 Cg_exo -67.03 133.32 30.65 Favored 'Trans proline' 0 C--N 1.351 0.672 0 C-N-CA 122.849 2.366 . . . . 1.1699999999999999 109.997 177.153 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A 1598 ' ' CYS . . . . . 0.445 ' HA ' ' HD3' ' A' 1599 ' ' PRO . 42.4 t -97.68 121.14 58.9 Favored Pre-proline 0 C--N 1.289 -2.055 0 CA-C-O 120.533 0.206 . . . . 1.1899999999999999 110.768 -175.939 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A 1599 ' ' PRO . . . . . 0.445 ' HD3' ' HA ' ' A' 1598 ' ' CYS . 2.8 Cg_exo -77.52 -7.83 16.95 Favored 'Trans proline' 0 C--O 1.238 0.494 0 C-N-CA 123.23 2.62 . . . . 1.5900000000000001 112.227 179.992 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A 1600 ' ' SER . . . . . 0.433 ' HB3' ' SG ' ' A' 1598 ' ' CYS . 22.8 t -75.32 -19.7 59.49 Favored 'General case' 0 C--N 1.317 -0.811 0 CA-C-N 115.831 -0.622 . . . . 2.1200000000000001 110.313 -177.563 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A 1601 ' ' LYS . . . . . 0.565 ' HB3' HD12 ' A' 1604 ' ' LEU . 24.5 tptm -162.33 116.64 1.82 Allowed 'General case' 0 N--CA 1.443 -0.82 0 N-CA-C 108.556 -0.905 . . . . 3.7400000000000002 108.556 178.915 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A 1602 ' ' SER . . . . . . . . . . . . . 51.4 m -61.3 123.2 17.09 Favored 'General case' 0 C--N 1.313 -1.01 0 CA-C-O 121.393 0.616 . . . . 3.79 111.588 179.202 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A 1603 ' ' GLY . . . . . . . . . . . . . . . 104.94 -1.45 41.33 Favored Glycine 0 N--CA 1.439 -1.1 0 CA-C-N 115.067 -0.969 . . . . 2.0 111.004 -179.895 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A 1604 ' ' LEU . . . . . 0.565 HD12 ' HB3' ' A' 1601 ' ' LYS . 3.0 mt -107.05 145.3 32.53 Favored 'General case' 0 C--N 1.31 -1.111 0 CA-C-O 121.692 0.758 . . . . 1.48 111.859 179.62 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A 1605 ' ' SER . . . . . . . . . . . . . 25.6 m -111.27 -173.94 2.35 Favored 'General case' 0 C--N 1.29 -1.987 0 N-CA-C 105.824 -1.917 . . . . 1.51 105.824 172.929 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A 1606 ' ' TYR . . . . . . . . . . . . . 62.1 m-85 -101.59 128.67 47.75 Favored 'General case' 0 CA--C 1.453 -2.78 0 N-CA-C 105.792 -1.929 . . . . 1.1799999999999999 105.792 178.014 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A 1607 ' ' LYS . . . . . 0.496 ' O ' ' HA ' ' A' 1635 ' ' THR . 4.3 ptmm? -128.05 135.06 49.33 Favored 'General case' 0 N--CA 1.397 -3.075 0 O-C-N 124.506 1.129 . . . . 1.6699999999999999 111.152 -176.813 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A 1608 ' ' SER . . . . . . . . . . . . . 35.1 t -114.98 125.89 54.13 Favored 'General case' 0 C--N 1.292 -1.921 0 N-CA-C 109.339 -0.615 . . . . 1.0 109.339 -178.753 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A 1609 ' ' VAL . . . . . . . . . . . . . 41.3 t -115.14 115.39 49.31 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.814 0 CA-C-O 121.237 0.541 . . . . 0.93000000000000005 110.439 178.854 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A 1610 ' ' ILE . . . . . 0.678 HG13 ' HB2' ' A' 1638 ' ' PHE . 2.9 mp -102.16 113.67 39.3 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.338 0 N-CA-C 108.717 -0.845 . . . . 0.78000000000000003 108.717 178.962 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A 1611 ' ' SER . . . . . . . . . . . . . 42.7 m -95.17 123.36 38.63 Favored 'General case' 0 C--N 1.284 -2.26 0 N-CA-C 109.012 -0.736 . . . . 1.29 109.012 177.367 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A 1612 ' ' PHE . . . . . 0.749 ' HB2' ' HB2' ' A' 1588 ' ' LEU . 98.2 m-85 -92.62 103.51 15.9 Favored 'General case' 0 C--N 1.305 -1.353 0 N-CA-C 108.831 -0.803 . . . . 0.69999999999999996 108.831 178.835 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A 1613 ' ' VAL . . . . . 0.645 ' O ' ' HA ' ' A' 1641 ' ' HIS . 24.0 t -100.2 109.23 24.51 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.883 0 N-CA-C 107.224 -1.399 . . . . 0.75 107.224 -174.918 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A 1614 ' ' CYS . . . . . 0.574 ' HA ' ' O ' ' A' 1642 ' ' THR . 31.8 m -70.23 100.47 1.7 Allowed 'General case' 0 C--N 1.279 -2.458 0 CA-C-N 115.963 -0.562 . . . . 1.3899999999999999 111.516 -174.362 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A 1615 ' ' ARG . . . . . 0.45 ' HB3' ' HB3' ' A' 1641 ' ' HIS . 56.9 ttt180 -126.77 99.07 29.99 Favored Pre-proline 0 N--CA 1.439 -0.993 0 CA-C-N 115.479 -0.782 . . . . 3.75 109.412 -179.152 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A 1616 ' ' PRO . . . . . 0.419 ' HA ' ' HB3' ' A' 1643 ' ' PRO . 76.7 Cg_exo -52.43 -34.42 61.37 Favored 'Trans proline' 0 CA--C 1.534 0.489 0 C-N-CA 123.993 3.129 . . . . 1.3200000000000001 113.834 177.781 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A 1617 ' ' GLU . . . . . . . . . . . . . 48.2 mt-10 . . . . . 0 CA--C 1.545 0.753 0 N-CA-C 112.611 0.597 . . . . 3.21 112.611 -177.938 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A 1622 ' ' ASN . . . . . . . . . . . . . 27.6 t-20 . . . . . 0 N--CA 1.433 -1.29 0 CA-C-O 121.785 0.803 . . . . 2.9199999999999999 111.885 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A 1623 ' ' ARG . . . . . . . . . . . . . 19.8 ptp180 -151.89 156.95 34.47 Favored Pre-proline 0 C--N 1.3 -1.583 0 N-CA-C 105.048 -2.204 . . . . 3.6099999999999999 105.048 175.229 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A 1624 ' ' PRO . . . . . 0.463 ' HG3' HD11 ' A' 1552 ' ' ILE . 13.6 Cg_endo -56.22 115.76 2.7 Favored 'Trans proline' 0 C--O 1.237 0.433 0 C-N-CA 122.669 2.246 . . . . 2.3700000000000001 112.154 -179.313 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A 1625 ' ' MET . . . . . . . . . . . . . 1.3 pmm? -106.48 147.7 29.05 Favored 'General case' 0 C--O 1.245 0.845 0 CA-C-O 120.999 0.428 . . . . 2.1600000000000001 110.485 -179.216 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A 1626 ' ' LEU . . . . . . . . . . . . . 52.1 tp -77.6 122.02 24.72 Favored 'General case' 0 C--N 1.317 -0.842 0 N-CA-C 107.855 -1.165 . . . . 1.3500000000000001 107.855 176.837 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A 1627 ' ' ILE . . . . . . . . . . . . . 39.1 pt -100.88 -32.81 3.5 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.214 0 C-N-CA 120.48 -0.488 . . . . 1.21 111.286 -179.021 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A 1628 ' ' SER . . . . . . . . . . . . . 49.5 m -151.11 153.28 34.73 Favored 'General case' 0 C--N 1.314 -0.97 0 CA-C-O 120.789 0.328 . . . . 1.3999999999999999 110.283 -177.589 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A 1629 ' ' LEU . . . . . 0.946 HD13 ' HG ' ' A' 1636 ' ' LEU . 17.7 tp -139.12 120.39 14.79 Favored 'General case' 0 C--N 1.294 -1.809 0 N-CA-C 108.522 -0.918 . . . . 1.5600000000000001 108.522 177.47 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A 1630 ' ' ASP . . . . . . . . . . . . . 23.0 t70 -118.29 107.33 13.76 Favored 'General case' 0 C--N 1.299 -1.624 0 N-CA-C 109.658 -0.497 . . . . 0.87 109.658 176.855 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A 1631 ' ' LYS . . . . . . . . . . . . . 34.8 mtmm -78.74 -13.13 59.98 Favored 'General case' 0 C--N 1.303 -1.416 0 CA-C-N 115.514 -0.766 . . . . 2.3500000000000001 111.07 -176.997 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A 1632 ' ' GLN . . . . . . . . . . . . . 40.2 mt-30 -70.35 -42.63 71.58 Favored 'General case' 0 C--N 1.323 -0.544 0 N-CA-C 109.587 -0.523 . . . . 2.5499999999999998 109.587 178.254 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A 1633 ' ' THR . . . . . . . . . . . . . 35.9 p -98.27 4.2 48.77 Favored 'General case' 0 C--N 1.318 -0.765 0 CA-C-O 121.047 0.451 . . . . 1.24 110.821 175.747 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A 1634 ' ' CYS . . . . . . . . . . . . . 59.1 m 56.55 38.8 29.91 Favored 'General case' 0 C--O 1.236 0.394 0 C-N-CA 124.195 0.998 . . . . 0.89000000000000001 110.461 177.361 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A 1635 ' ' THR . . . . . 0.496 ' HA ' ' O ' ' A' 1607 ' ' LYS . 44.2 m -119.73 131.45 55.38 Favored 'General case' 0 N--CA 1.422 -1.841 0 CA-C-N 114.945 -1.025 . . . . 0.75 111.597 -174.223 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A 1636 ' ' LEU . . . . . 0.946 ' HG ' HD13 ' A' 1629 ' ' LEU . 5.2 mp -104.12 134.89 46.61 Favored 'General case' 0 N--CA 1.434 -1.25 0 N-CA-C 108.04 -1.096 . . . . 1.3300000000000001 108.04 174.838 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A 1637 ' ' PHE . . . . . . . . . . . . . 93.9 m-85 -111.42 105.83 14.57 Favored 'General case' 0 C--N 1.307 -1.279 0 CA-C-O 120.919 0.39 . . . . 0.82999999999999996 111.008 -176.844 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A 1638 ' ' PHE . . . . . 0.678 ' HB2' HG13 ' A' 1610 ' ' ILE . 96.4 m-85 -103.11 151.87 22.06 Favored 'General case' 0 C--N 1.306 -1.304 0 N-CA-C 109.03 -0.73 . . . . 0.59999999999999998 109.03 177.398 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A 1639 ' ' SER . . . . . . . . . . . . . 49.0 m -137.08 133.82 35.82 Favored 'General case' 0 C--N 1.276 -2.598 0 N-CA-C 109.705 -0.48 . . . . 1.0800000000000001 109.705 176.656 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A 1640 ' ' TRP . . . . . 0.584 ' HE3' ' HE1' ' A' 1612 ' ' PHE . 12.3 t90 -115.58 120.93 41.07 Favored 'General case' 0 N--CA 1.413 -2.306 0 N-CA-C 106.274 -1.75 . . . . 0.80000000000000004 106.274 174.164 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A 1641 ' ' HIS . . . . . 0.645 ' HA ' ' O ' ' A' 1613 ' ' VAL . 39.1 m-70 -93.89 92.34 7.36 Favored 'General case' 0 C--N 1.304 -1.378 0 N-CA-C 107.517 -1.29 . . . . 2.54 107.517 -177.922 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A 1642 ' ' THR . . . . . 0.73 HG22 ' HG ' ' A' 1644 ' ' LEU . 1.5 m -119.91 123.62 28.34 Favored Pre-proline 0 C--N 1.289 -2.053 0 CA-C-N 114.947 -1.024 . . . . 1.1499999999999999 111.884 -167.96 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A 1643 ' ' PRO . . . . . 0.419 ' HB3' ' HA ' ' A' 1616 ' ' PRO . 31.7 Cg_exo -65.24 -29.7 55.1 Favored 'Trans proline' 0 CA--C 1.539 0.745 0 C-N-CA 123.443 2.762 . . . . 0.80000000000000004 112.861 177.001 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A 1644 ' ' LEU . . . . . 0.73 ' HG ' HG22 ' A' 1642 ' ' THR . 4.4 pp -84.07 -6.76 59.46 Favored 'General case' 0 C--N 1.323 -0.562 0 N-CA-C 112.104 0.409 . . . . 1.54 112.104 -176.969 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A 1645 ' ' ALA . . . . . 0.485 ' HB2' ' HB ' ' A' 1642 ' ' THR . . . -74.14 -30.92 62.51 Favored 'General case' 0 C--N 1.306 -1.3 0 CA-C-N 116.022 -0.536 . . . . 0.94999999999999996 112.165 -174.941 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A 1646 ' ' CYS . . . . . 0.493 ' HA ' ' CE1' ' A' 1527 ' ' PHE . 17.0 p -177.38 175.29 1.48 Allowed 'General case' 0 C--O 1.246 0.871 0 N-CA-C 106.999 -1.482 . . . . 1.4099999999999999 106.999 175.288 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A 1647 ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 . . . . . 0 C--N 1.299 -1.608 0 N-CA-C 108.54 -0.911 . . . . 2.9199999999999999 108.54 175.871 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A 1515 ' ' ASP . . . . . . . . . . . . . 17.3 t70 . . . . . 0 CA--C 1.551 0.991 0 N-CA-C 109.958 -0.386 . . . . 2.54 109.958 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A 1516 ' ' CYS . . . . . 0.472 ' SG ' ' HD2' ' A' 1579 ' ' LYS . 97.1 m -137.09 18.96 2.98 Favored 'General case' 0 C--N 1.316 -0.874 0 CA-C-O 121.194 0.521 . . . . 1.25 110.456 175.104 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A 1517 ' ' GLN . . . . . 0.539 ' HB2' HD21 ' A' 1526 ' ' LEU . 11.2 pt20 -132.54 137.47 47.14 Favored 'General case' 0 C--N 1.302 -1.469 0 O-C-N 121.809 -0.557 . . . . 1.8799999999999999 109.7 178.92 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A 1518 ' ' VAL . . . . . . . . . . . . . 10.2 p -143.55 134.87 22.83 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.664 0 CA-C-O 121.025 0.441 . . . . 1.73 110.288 -178.402 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A 1519 ' ' THR . . . . . 0.773 ' HA ' ' HA ' ' A' 1526 ' ' LEU . 23.3 m -85.3 120.84 27.22 Favored 'General case' 0 C--N 1.3 -1.549 0 N-CA-C 109.327 -0.62 . . . . 1.7 109.327 178.781 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A 1520 ' ' ASN . . . . . 0.407 ' OD1' HG22 ' A' 1523 ' ' THR . 24.0 t-20 -71.98 119.71 76.02 Favored Pre-proline 0 C--N 1.314 -0.937 0 N-CA-C 109.327 -0.62 . . . . 2.1200000000000001 109.327 179.131 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A 1521 ' ' PRO . . . . . . . . . . . . . 86.5 Cg_endo -75.09 -2.95 13.22 Favored 'Trans proline' 0 CA--C 1.539 0.749 0 C-N-CA 122.64 2.227 . . . . 2.4700000000000002 113.953 -175.31 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A 1522 ' ' SER . . . . . . . . . . . . . 32.8 m -94.11 -49.75 5.61 Favored 'General case' 0 C--N 1.305 -1.341 0 O-C-N 122.104 -0.373 . . . . 2.5699999999999998 111.101 -179.375 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A 1523 ' ' THR . . . . . 0.409 HG23 ' H ' ' A' 1525 ' ' HIS . 12.0 t -96.53 -16.99 20.8 Favored 'General case' 0 CA--C 1.553 1.07 0 CA-C-O 121.255 0.55 . . . . 2.1499999999999999 111.097 -179.901 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A 1524 ' ' GLY . . . . . . . . . . . . . . . 81.84 8.16 87.08 Favored Glycine 0 C--O 1.222 -0.601 0 C-N-CA 121.507 -0.378 . . . . 1.8899999999999999 112.918 178.83 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A 1525 ' ' HIS . . . . . 0.409 ' H ' HG23 ' A' 1523 ' ' THR . 16.0 t-160 -101.69 134.97 44.01 Favored 'General case' 0 C--N 1.302 -1.47 0 N-CA-C 109.432 -0.581 . . . . 1.8999999999999999 109.432 -178.306 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A 1526 ' ' LEU . . . . . 0.773 ' HA ' ' HA ' ' A' 1519 ' ' THR . 6.7 tt -84.98 135.21 34.13 Favored 'General case' 0 C--N 1.303 -1.43 0 CA-C-N 116.387 -0.369 . . . . 1.6100000000000001 110.735 177.819 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A 1527 ' ' PHE . . . . . . . . . . . . . 80.7 m-85 -99.8 113.03 25.27 Favored 'General case' 0 C--N 1.309 -1.195 0 N-CA-C 108.078 -1.082 . . . . 1.4199999999999999 108.078 174.546 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A 1528 ' ' ASP . . . . . . . . . . . . . 11.8 t70 -100.59 103.55 14.86 Favored 'General case' 0 C--N 1.302 -1.495 0 N-CA-C 108.927 -0.768 . . . . 2.1800000000000002 108.927 -179.455 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A 1529 ' ' LEU . . . . . 0.457 HD13 ' CZ ' ' A' 1612 ' ' PHE . 78.7 mt -89.5 -13.81 36.63 Favored 'General case' 0 C--N 1.298 -1.65 0 N-CA-C 108.234 -1.024 . . . . 1.4399999999999999 108.234 -176.145 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A 1530 ' ' SER . . . . . 0.458 ' OG ' ' HB2' ' A' 1516 ' ' CYS . 3.2 m -58.03 -54.83 42.56 Favored 'General case' 0 N--CA 1.438 -1.065 0 C-N-CA 124.788 1.235 . . . . 1.4399999999999999 110.742 -179.58 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A 1531 ' ' SER . . . . . . . . . . . . . 5.6 m -81.23 1.43 32.29 Favored 'General case' 0 C--N 1.317 -0.829 0 CA-C-N 115.886 -0.597 . . . . 1.5 111.592 -175.722 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A 1532 ' ' LEU . . . . . 0.414 ' HG ' ' HA ' ' A' 1529 ' ' LEU . 32.3 mt -82.41 -18.34 42.28 Favored 'General case' 0 C--N 1.319 -0.757 0 C-N-CA 120.036 -0.666 . . . . 1.77 110.661 179.507 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A 1533 ' ' SER . . . . . 0.89 ' HB2' HG22 ' A' 1552 ' ' ILE . 22.7 t -114.2 134.13 55.13 Favored 'General case' 0 N--CA 1.432 -1.341 0 N-CA-C 108.523 -0.917 . . . . 2.3799999999999999 108.523 178.417 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A 1534 ' ' GLY . . . . . . . . . . . . . . . -81.93 173.46 53.53 Favored Glycine 0 N--CA 1.429 -1.768 0 N-CA-C 107.724 -2.15 . . . . 1.55 107.724 172.148 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A 1535 ' ' ARG . . . . . 0.428 HH11 ' HD2' ' A' 1535 ' ' ARG . 14.8 ttp180 -72.3 -17.8 61.84 Favored 'General case' 0 C--N 1.31 -1.151 0 CA-C-N 118.254 1.027 . . . . 3.96 110.55 -178.842 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A 1536 ' ' ALA . . . . . . . . . . . . . . . -84.86 -6.92 59.35 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 116.109 -0.496 . . . . 1.6499999999999999 110.198 176.423 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A 1537 ' ' GLY . . . . . . . . . . . . . . . 59.84 -153.81 33.06 Favored Glycine 0 N--CA 1.447 -0.569 0 CA-C-N 115.321 -0.854 . . . . 1.1899999999999999 114.126 177.366 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A 1538 ' ' PHE . . . . . . . . . . . . . 96.2 m-85 -113.55 163.72 14.57 Favored 'General case' 0 C--N 1.294 -1.819 0 N-CA-C 108.027 -1.101 . . . . 1.6899999999999999 108.027 178.441 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A 1539 ' ' THR . . . . . . . . . . . . . 9.5 t -143.99 130.64 20.14 Favored 'General case' 0 C--N 1.287 -2.128 0 N-CA-C 108.991 -0.744 . . . . 1.48 108.991 177.88 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A 1540 ' ' ALA . . . . . . . . . . . . . . . -131.96 143.72 50.3 Favored 'General case' 0 C--N 1.306 -1.307 0 N-CA-C 109.054 -0.721 . . . . 0.82999999999999996 109.054 -177.374 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A 1541 ' ' ALA . . . . . . . . . . . . . . . -82.14 151.46 26.95 Favored 'General case' 0 C--N 1.31 -1.124 0 CA-C-N 116.167 -0.47 . . . . 1.27 110.386 -178.991 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A 1542 ' ' TYR . . . . . . . . . . . . . 26.1 t80 -152.54 175.06 13.16 Favored 'General case' 0 C--N 1.312 -1.031 0 N-CA-C 107.864 -1.162 . . . . 2.1499999999999999 107.864 -177.162 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A 1543 ' ' SER . . . . . . . . . . . . . 8.3 p -49.57 -150.46 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.797 0 C-N-CA 127.922 2.489 . . . . 2.29 114.853 -179.941 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A 1544 ' ' LYS . . . . . . . . . . . . . 9.7 ptpp? -39.81 -28.12 0.04 OUTLIER 'General case' 0 N--CA 1.506 2.353 0 N-CA-C 114.53 1.307 . . . . 3.9100000000000001 114.53 -178.245 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A 1545 ' ' SER . . . . . . . . . . . . . 25.0 t -73.01 -8.55 56.22 Favored 'General case' 0 CA--C 1.555 1.146 0 N-CA-C 112.204 0.446 . . . . 3.2999999999999998 112.204 177.571 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A 1546 ' ' GLY . . . . . . . . . . . . . . . 81.08 -75.31 2.3 Favored Glycine 0 N--CA 1.44 -1.088 0 N-CA-C 114.643 0.617 . . . . 1.24 114.643 172.624 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A 1547 ' ' VAL . . . . . . . . . . . . . 9.3 p -153.26 150.26 12.67 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.446 0 N-CA-C 109.32 -0.622 . . . . 1.6299999999999999 109.32 -175.158 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A 1548 ' ' VAL . . . . . . . . . . . . . 5.7 t -111.21 145.06 17.93 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.547 0 N-CA-C 108.536 -0.912 . . . . 0.92000000000000004 108.536 -178.699 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A 1549 ' ' TYR . . . . . . . . . . . . . 39.4 m-85 -114.54 125.27 53.6 Favored 'General case' 0 CA--C 1.501 -0.928 0 N-CA-C 107.31 -1.367 . . . . 1.4399999999999999 107.31 172.926 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A 1550 ' ' MET . . . . . . . . . . . . . 18.3 ptm -153.15 124.58 7.63 Favored 'General case' 0 C--N 1.298 -1.658 0 CA-C-O 121.396 0.617 . . . . 1.74 112.008 -172.672 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A 1551 ' ' SER . . . . . . . . . . . . . 25.4 m -93.57 133.46 36.86 Favored 'General case' 0 C--N 1.282 -2.34 0 N-CA-C 106.88 -1.526 . . . . 1.6399999999999999 106.88 176.175 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A 1552 ' ' ILE . . . . . 0.89 HG22 ' HB2' ' A' 1533 ' ' SER . 1.1 tp -73.17 -18.63 18.18 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.114 0 CA-C-O 121.816 0.817 . . . . 1.3300000000000001 109.629 -176.374 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A 1553 ' ' CYS . . . . . . . . . . . . . 38.4 t -161.27 138.44 8.84 Favored 'General case' 0 N--CA 1.416 -2.144 0 N-CA-C 105.923 -1.88 . . . . 1.4299999999999999 105.923 173.532 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A 1554 ' ' GLY . . . . . . . . . . . . . . . 101.38 -174.87 25.34 Favored Glycine 0 N--CA 1.433 -1.529 0 N-CA-C 111.17 -0.772 . . . . 1.1200000000000001 111.17 178.538 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A 1555 ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -103.31 151.7 22.41 Favored 'General case' 0 C--N 1.302 -1.459 0 CA-C-O 121.439 0.638 . . . . 1.8 111.776 -179.17 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A 1556 ' ' ASN . . . . . . . . . . . . . 8.6 t-20 -100.67 139.11 36.82 Favored 'General case' 0 N--CA 1.42 -1.94 0 CA-C-N 114.52 -1.218 . . . . 2.6299999999999999 108.3 -177.241 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A 1557 ' ' GLU . . . . . . . . . . . . . 54.2 mm-40 -102.65 -7.07 22.06 Favored 'General case' 0 C--N 1.293 -1.875 0 CA-C-N 115.443 -0.799 . . . . 3.79 112.156 -172.404 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A 1558 ' ' ASN . . . . . . . . . . . . . 39.6 m-80 -75.52 -31.36 60.09 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-O 121.803 0.811 . . . . 1.52 109.901 -178.655 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A 1559 ' ' CYS . . . . . 0.645 ' HB3' ' HD2' ' A' 1560 ' ' PRO . 95.5 m -113.25 176.47 1.47 Allowed Pre-proline 0 C--N 1.294 -1.841 0 CA-C-O 117.471 -1.252 . . . . 0.83999999999999997 108.027 176.474 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A 1560 ' ' PRO . . . . . 0.645 ' HD2' ' HB3' ' A' 1559 ' ' CYS . 99.2 Cg_exo -29.88 122.16 0.06 OUTLIER 'Trans proline' 0 C--N 1.375 1.957 0 C-N-CA 124.358 3.372 . . . . 1.1799999999999999 113.909 173.693 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A 1561 ' ' PRO . . . . . 0.432 ' HD3' ' HA ' ' A' 1560 ' ' PRO . 32.1 Cg_exo -58.57 110.25 0.63 Allowed 'Trans proline' 0 C--O 1.245 0.85 0 C-N-CA 123.243 2.629 . . . . 1.51 111.66 -176.776 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A 1562 ' ' GLY . . . . . . . . . . . . . . . 132.94 -15.24 4.86 Favored Glycine 0 N--CA 1.44 -1.085 0 C-N-CA 120.23 -0.986 . . . . 0.71999999999999997 112.507 -179.792 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A 1563 ' ' VAL . . . . . 0.426 ' HA ' ' HA ' ' A' 1576 ' ' LYS . 13.8 m -86.49 149.82 4.04 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.957 0 N-CA-C 108.02 -1.104 . . . . 0.96999999999999997 108.02 177.326 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A 1564 ' ' GLY . . . . . . . . . . . . . . . -102.0 -30.77 5.62 Favored Glycine 0 C--N 1.307 -1.059 0 N-CA-C 111.188 -0.765 . . . . 0.71999999999999997 111.188 -178.019 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A 1565 ' ' ALA . . . . . . . . . . . . . . . -140.3 136.3 33.11 Favored 'General case' 0 N--CA 1.44 -0.927 0 N-CA-C 109.04 -0.726 . . . . 0.37 109.04 178.773 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A 1566 ' ' CYS . . . . . . . . . . . . . 16.5 t -156.32 146.36 21.26 Favored 'General case' 0 C--N 1.298 -1.668 0 CA-C-N 116.243 -0.435 . . . . 0.51000000000000001 109.933 -175.324 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A 1567 ' ' PHE . . . . . . . . . . . . . 21.5 m-85 -73.88 123.32 24.01 Favored 'General case' 0 C--O 1.211 -0.921 0 N-CA-C 107.239 -1.393 . . . . 0.96999999999999997 107.239 174.467 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A 1568 ' ' GLY . . . . . . . . . . . . . . . -75.36 -18.64 79.89 Favored Glycine 0 C--N 1.309 -0.92 0 C-N-CA 120.472 -0.871 . . . . 1.0800000000000001 114.655 -171.732 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A 1569 ' ' GLN . . . . . . . . . . . . . 58.9 tp60 -80.66 -60.0 2.47 Favored 'General case' 0 C--N 1.302 -1.496 0 CA-C-O 121.059 0.457 . . . . 2.7400000000000002 110.498 -179.586 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A 1570 ' ' THR . . . . . . . . . . . . . 12.3 p -88.14 -11.16 47.74 Favored 'General case' 0 C--N 1.31 -1.146 0 N-CA-C 112.817 0.673 . . . . 1.96 112.817 -175.289 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A 1571 ' ' ARG . . . . . . . . . . . . . 51.0 mtm180 58.04 45.16 18.33 Favored 'General case' 0 CA--C 1.515 -0.372 0 C-N-CA 125.363 1.465 . . . . 3.9500000000000002 112.853 179.248 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A 1572 ' ' ILE . . . . . . . . . . . . . 36.3 mt -100.61 122.82 53.07 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.192 0 N-CA-C 108.788 -0.819 . . . . 1.3700000000000001 108.788 179.112 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A 1573 ' ' SER . . . . . . . . . . . . . 33.2 t -61.88 122.57 15.76 Favored 'General case' 0 C--N 1.31 -1.133 0 C-N-CA 124.644 1.178 . . . . 1.0800000000000001 110.855 -179.033 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A 1574 ' ' VAL . . . . . . . . . . . . . 30.0 m -127.83 33.93 1.36 Allowed 'Isoleucine or valine' 0 C--N 1.315 -0.895 0 CA-C-O 122.238 1.018 . . . . 1.3 110.234 178.973 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A 1575 ' ' GLY . . . . . . . . . . . . . . . 155.69 115.61 0.52 Allowed Glycine 0 N--CA 1.419 -2.442 0 CA-C-N 114.248 -1.342 . . . . 0.51000000000000001 111.341 177.979 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A 1576 ' ' LYS . . . . . 0.426 ' HA ' ' HA ' ' A' 1563 ' ' VAL . 3.3 tppp? -82.13 145.33 30.19 Favored 'General case' 0 C--N 1.307 -1.253 0 N-CA-C 106.77 -1.567 . . . . 2.8999999999999999 106.77 178.201 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A 1577 ' ' ALA . . . . . . . . . . . . . . . -63.81 112.92 3.1 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 121.343 0.592 . . . . 0.82999999999999996 109.516 -179.024 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A 1578 ' ' ASN . . . . . . . . . . . . . 50.4 t-20 -135.77 139.13 43.3 Favored 'General case' 0 C--N 1.295 -1.802 0 N-CA-C 107.687 -1.227 . . . . 1.8500000000000001 107.687 -173.493 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A 1579 ' ' LYS . . . . . 0.472 ' HD2' ' SG ' ' A' 1516 ' ' CYS . 43.2 mmtm -100.9 89.85 3.99 Favored 'General case' 0 C--N 1.3 -1.562 0 N-CA-C 108.043 -1.095 . . . . 1.8999999999999999 108.043 178.957 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A 1580 ' ' ARG . . . . . . . . . . . . . 18.7 tpp180 -146.79 84.87 1.61 Allowed 'General case' 0 N--CA 1.429 -1.514 0 CA-C-O 121.33 0.586 . . . . 3.6299999999999999 110.593 -177.627 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A 1581 ' ' LEU . . . . . 0.4 ' HA ' ' O ' ' A' 1589 ' ' GLN . 3.8 pp -104.37 153.71 20.73 Favored 'General case' 0 N--CA 1.427 -1.595 0 CA-C-N 115.55 -0.75 . . . . 1.8700000000000001 110.112 176.117 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A 1582 ' ' ARG . . . . . 0.43 ' CG ' ' HB3' ' A' 1589 ' ' GLN . 14.7 ptp180 -131.62 139.89 49.25 Favored 'General case' 0 C--N 1.283 -2.296 0 N-CA-C 108.937 -0.764 . . . . 3.9700000000000002 108.937 177.427 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A 1583 ' ' TYR . . . . . 0.43 ' CE1' ' HA ' ' A' 1586 ' ' GLN . 67.5 t80 -102.84 91.85 4.34 Favored 'General case' 0 N--CA 1.432 -1.367 0 N-CA-C 107.448 -1.315 . . . . 1.4099999999999999 107.448 176.819 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A 1584 ' ' VAL . . . . . . . . . . . . . 1.6 m -120.27 110.46 28.86 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.607 0 CA-C-N 115.421 -0.809 . . . . 1.6899999999999999 112.53 -176.553 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A 1585 ' ' ASP . . . . . . . . . . . . . 16.0 t70 65.45 38.8 5.46 Favored 'General case' 0 C--N 1.313 -1.019 0 CA-C-O 122.481 1.134 . . . . 2.0600000000000001 109.619 173.409 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A 1586 ' ' GLN . . . . . 0.43 ' HA ' ' CE1' ' A' 1583 ' ' TYR . 47.8 mt-30 73.78 -14.43 0.66 Allowed 'General case' 0 N--CA 1.484 1.234 0 C-N-CA 126.049 1.739 . . . . 2.3300000000000001 114.042 -179.729 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A 1587 ' ' VAL . . . . . . . . . . . . . 7.6 p -94.53 121.68 45.33 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.026 0 CA-C-O 121.361 0.601 . . . . 0.78000000000000003 110.055 178.461 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A 1588 ' ' LEU . . . . . 0.663 ' HB2' ' HB2' ' A' 1612 ' ' PHE . 3.8 mm? -78.75 138.76 38.38 Favored 'General case' 0 N--CA 1.433 -1.301 0 CA-C-N 115.658 -0.701 . . . . 1.4099999999999999 109.67 178.736 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A 1589 ' ' GLN . . . . . 0.43 ' HB3' ' CG ' ' A' 1582 ' ' ARG . 34.6 tt0 -133.58 126.92 31.99 Favored 'General case' 0 C--N 1.292 -1.91 0 N-CA-C 108.63 -0.878 . . . . 1.24 108.63 179.479 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A 1590 ' ' LEU . . . . . . . . . . . . . 8.9 tt -124.59 126.21 45.42 Favored 'General case' 0 C--N 1.295 -1.794 0 N-CA-C 107.438 -1.319 . . . . 1.1499999999999999 107.438 179.911 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A 1591 ' ' VAL . . . . . 0.436 HG22 HG13 ' A' 1609 ' ' VAL . 67.8 t -117.75 123.03 71.14 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.798 0 CA-C-O 121.237 0.541 . . . . 1.51 112.454 -174.488 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A 1592 ' ' TYR . . . . . . . . . . . . . 49.4 m-85 -97.29 101.59 13.17 Favored 'General case' 0 C--N 1.309 -1.153 0 CA-C-N 115.041 -0.981 . . . . 1.0600000000000001 108.383 175.114 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A 1593 ' ' LYS . . . . . . . . . . . . . 19.0 ptpt -99.74 -173.68 2.52 Favored 'General case' 0 C--N 1.3 -1.547 0 N-CA-C 109.756 -0.461 . . . . 2.1800000000000002 109.756 179.849 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A 1594 ' ' ASP . . . . . . . . . . . . . 6.7 m-20 50.07 53.96 11.93 Favored 'General case' 0 N--CA 1.478 0.925 0 N-CA-C 114.84 1.422 . . . . 1.45 114.84 175.951 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A 1595 ' ' GLY . . . . . . . . . . . . . . . -90.02 -92.45 1.22 Allowed Glycine 0 N--CA 1.425 -2.052 0 N-CA-C 108.001 -2.04 . . . . 0.78000000000000003 108.001 174.367 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A 1596 ' ' SER . . . . . 0.407 ' HB2' ' HD2' ' A' 1606 ' ' TYR . 20.0 m -114.16 135.95 22.19 Favored Pre-proline 0 C--N 1.291 -1.936 0 N-CA-C 107.475 -1.306 . . . . 1.6799999999999999 107.475 175.404 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A 1597 ' ' PRO . . . . . . . . . . . . . 32.0 Cg_exo -60.87 128.23 24.88 Favored 'Trans proline' 0 C--O 1.243 0.754 0 C-N-CA 122.513 2.142 . . . . 1.1699999999999999 109.422 178.254 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A 1598 ' ' CYS . . . . . 0.566 ' HB3' HD12 ' A' 1604 ' ' LEU . 9.0 t -95.7 125.27 49.78 Favored Pre-proline 0 C--N 1.293 -1.861 0 N-CA-C 109.021 -0.733 . . . . 1.1899999999999999 109.021 -174.35 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A 1599 ' ' PRO . . . . . 0.461 ' HD3' ' HA ' ' A' 1598 ' ' CYS . 1.0 OUTLIER -84.04 -0.29 9.52 Favored 'Trans proline' 0 CA--C 1.536 0.591 0 C-N-CA 122.86 2.373 . . . . 1.5900000000000001 113.18 -177.296 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A 1600 ' ' SER . . . . . . . . . . . . . 20.3 m -67.41 -31.3 71.41 Favored 'General case' 0 C--O 1.241 0.645 0 CA-C-O 121.095 0.474 . . . . 2.1200000000000001 111.122 179.594 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A 1601 ' ' LYS . . . . . 0.444 ' HB3' HD21 ' A' 1604 ' ' LEU . 13.1 tmtt? -152.63 130.47 11.69 Favored 'General case' 0 C--N 1.31 -1.151 0 N-CA-C 105.96 -1.867 . . . . 3.7400000000000002 105.96 178.731 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A 1602 ' ' SER . . . . . . . . . . . . . 23.9 t -71.88 117.39 13.42 Favored 'General case' 0 C--N 1.305 -1.333 0 CA-C-O 121.207 0.527 . . . . 3.79 111.255 -177.103 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A 1603 ' ' GLY . . . . . . . . . . . . . . . 116.66 15.71 6.76 Favored Glycine 0 N--CA 1.43 -1.762 0 CA-C-N 115.625 -0.716 . . . . 2.0 112.79 175.988 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A 1604 ' ' LEU . . . . . 0.566 HD12 ' HB3' ' A' 1598 ' ' CYS . 2.3 pp -140.3 161.3 38.0 Favored 'General case' 0 C--N 1.316 -0.864 0 N-CA-C 113.462 0.912 . . . . 1.48 113.462 179.711 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A 1605 ' ' SER . . . . . . . . . . . . . 9.3 t -121.38 170.93 9.15 Favored 'General case' 0 C--N 1.295 -1.765 0 N-CA-C 108.078 -1.082 . . . . 1.51 108.078 -175.314 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A 1606 ' ' TYR . . . . . 0.407 ' HD2' ' HB2' ' A' 1596 ' ' SER . 90.8 m-85 -85.54 111.91 20.45 Favored 'General case' 0 CA--C 1.461 -2.465 0 N-CA-C 102.783 -3.043 . . . . 1.1799999999999999 102.783 176.078 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A 1607 ' ' LYS . . . . . . . . . . . . . 22.3 pttm -126.93 148.63 50.04 Favored 'General case' 0 N--CA 1.399 -2.99 0 C-N-CA 119.006 -1.077 . . . . 1.6699999999999999 112.111 -172.877 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A 1608 ' ' SER . . . . . . . . . . . . . 23.8 t -104.65 128.2 52.63 Favored 'General case' 0 C--N 1.298 -1.663 0 CA-C-N 115.674 -0.694 . . . . 1.0 109.598 -177.429 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A 1609 ' ' VAL . . . . . 0.436 HG13 HG22 ' A' 1591 ' ' VAL . 53.4 t -114.42 111.01 34.14 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.969 0 N-CA-C 108.507 -0.923 . . . . 0.93000000000000005 108.507 178.874 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A 1610 ' ' ILE . . . . . . . . . . . . . 26.3 mm -94.03 117.26 37.24 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.348 0 CA-C-N 116.117 -0.492 . . . . 0.78000000000000003 109.697 -179.139 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A 1611 ' ' SER . . . . . . . . . . . . . 35.9 p -104.58 113.75 27.53 Favored 'General case' 0 N--CA 1.429 -1.493 0 CA-C-O 121.33 0.586 . . . . 1.29 109.614 175.861 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A 1612 ' ' PHE . . . . . 0.663 ' HB2' ' HB2' ' A' 1588 ' ' LEU . 96.9 m-85 -87.7 102.51 14.71 Favored 'General case' 0 C--N 1.306 -1.295 0 CA-C-N 115.518 -0.765 . . . . 0.69999999999999996 109.139 -179.256 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A 1613 ' ' VAL . . . . . . . . . . . . . 42.2 t -106.35 122.18 59.83 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.877 0 N-CA-C 109.303 -0.628 . . . . 0.75 109.303 -175.914 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A 1614 ' ' CYS . . . . . 0.589 ' HA ' ' O ' ' A' 1642 ' ' THR . 0.5 OUTLIER -75.34 93.81 2.95 Favored 'General case' 0 C--N 1.298 -1.65 0 N-CA-C 114.632 1.345 . . . . 1.3899999999999999 114.632 -178.988 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A 1615 ' ' ARG . . . . . 0.49 ' HB3' ' HB3' ' A' 1641 ' ' HIS . 23.3 tpt180 -131.64 96.84 20.04 Favored Pre-proline 0 N--CA 1.423 -1.78 0 N-CA-C 107.881 -1.155 . . . . 3.75 107.881 174.306 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A 1616 ' ' PRO . . . . . 0.595 ' HB3' ' HB3' ' A' 1643 ' ' PRO . 7.6 Cg_exo -75.66 64.34 6.6 Favored 'Trans proline' 0 CA--C 1.532 0.42 0 C-N-CA 123.817 3.011 . . . . 1.3200000000000001 113.643 -175.854 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A 1617 ' ' GLU . . . . . . . . . . . . . 44.0 mt-10 . . . . . 0 C--N 1.312 -1.024 0 O-C-N 122.201 -0.312 . . . . 3.21 111.337 179.013 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A 1622 ' ' ASN . . . . . . . . . . . . . 59.6 t30 . . . . . 0 C--O 1.239 0.53 0 CA-C-O 120.762 0.315 . . . . 2.9199999999999999 110.991 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A 1623 ' ' ARG . . . . . . . . . . . . . 7.7 ptp180 -135.2 147.93 64.36 Favored Pre-proline 0 C--N 1.309 -1.186 0 N-CA-C 109.622 -0.51 . . . . 3.6099999999999999 109.622 -177.393 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A 1624 ' ' PRO . . . . . . . . . . . . . 18.7 Cg_endo -58.97 124.38 15.56 Favored 'Trans proline' 0 C--N 1.349 0.565 0 C-N-CA 123.436 2.757 . . . . 2.3700000000000001 112.109 179.762 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A 1625 ' ' MET . . . . . . . . . . . . . 54.9 ttp -94.6 125.08 39.02 Favored 'General case' 0 C--N 1.301 -1.503 0 CA-C-N 115.863 -0.608 . . . . 2.1600000000000001 110.809 -176.84 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A 1626 ' ' LEU . . . . . 0.494 ' HB2' ' CE1' ' A' 1638 ' ' PHE . 31.8 tp -73.66 103.73 4.34 Favored 'General case' 0 C--N 1.306 -1.299 0 N-CA-C 108.729 -0.841 . . . . 1.3500000000000001 108.729 175.979 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A 1627 ' ' ILE . . . . . . . . . . . . . 27.9 pt -91.56 -36.58 8.1 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.381 0 CA-C-N 115.751 -0.659 . . . . 1.21 112.485 -176.649 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A 1628 ' ' SER . . . . . . . . . . . . . 6.2 p -153.66 135.42 14.5 Favored 'General case' 0 N--CA 1.43 -1.448 0 CA-C-O 120.883 0.373 . . . . 1.3999999999999999 111.567 -177.396 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A 1629 ' ' LEU . . . . . 0.926 ' HG ' ' HG ' ' A' 1636 ' ' LEU . 4.4 tt -125.31 114.76 19.34 Favored 'General case' 0 C--N 1.3 -1.552 0 N-CA-C 105.757 -1.942 . . . . 1.5600000000000001 105.757 177.825 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A 1630 ' ' ASP . . . . . . . . . . . . . 25.0 t70 -91.87 121.99 33.98 Favored 'General case' 0 C--N 1.301 -1.502 0 N-CA-C 107.962 -1.125 . . . . 0.87 107.962 178.279 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A 1631 ' ' LYS . . . . . . . . . . . . . 96.8 mttt -86.48 -2.97 58.92 Favored 'General case' 0 C--N 1.301 -1.511 0 N-CA-C 112.642 0.608 . . . . 2.3500000000000001 112.642 -172.252 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A 1632 ' ' GLN . . . . . . . . . . . . . 1.9 mp0 -95.59 -42.63 8.32 Favored 'General case' 0 C--N 1.318 -0.773 0 C-N-CA 120.463 -0.495 . . . . 2.5499999999999998 110.665 177.424 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A 1633 ' ' THR . . . . . 0.459 ' HA ' HD22 ' A' 1604 ' ' LEU . 31.7 p -90.97 -8.15 50.03 Favored 'General case' 0 C--O 1.251 1.137 0 CA-C-O 121.621 0.724 . . . . 1.24 110.902 177.581 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A 1634 ' ' CYS . . . . . . . . . . . . . 33.3 m 59.29 44.64 15.15 Favored 'General case' 0 C--N 1.34 0.161 0 CA-C-N 113.905 -1.498 . . . . 0.89000000000000001 110.379 176.588 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A 1635 ' ' THR . . . . . . . . . . . . . 7.5 p -108.32 126.21 52.58 Favored 'General case' 0 N--CA 1.428 -1.549 0 CA-C-N 114.339 -1.3 . . . . 0.75 111.173 -176.198 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A 1636 ' ' LEU . . . . . 0.926 ' HG ' ' HG ' ' A' 1629 ' ' LEU . 5.9 mp -105.47 111.04 23.6 Favored 'General case' 0 N--CA 1.431 -1.423 0 N-CA-C 109.621 -0.511 . . . . 1.3300000000000001 109.621 175.596 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A 1637 ' ' PHE . . . . . . . . . . . . . 97.5 m-85 -92.03 112.75 24.81 Favored 'General case' 0 C--O 1.249 1.06 0 CA-C-N 116.202 -0.453 . . . . 0.82999999999999996 110.6 -178.573 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A 1638 ' ' PHE . . . . . 0.494 ' CE1' ' HB2' ' A' 1626 ' ' LEU . 97.1 m-85 -109.12 132.13 54.41 Favored 'General case' 0 C--N 1.304 -1.385 0 CA-C-N 115.892 -0.595 . . . . 0.59999999999999998 109.448 177.709 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A 1639 ' ' SER . . . . . . . . . . . . . 29.4 p -111.19 117.23 32.64 Favored 'General case' 0 C--N 1.285 -2.223 0 CA-C-O 121.628 0.728 . . . . 1.0800000000000001 110.34 176.652 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A 1640 ' ' TRP . . . . . . . . . . . . . 13.9 t90 -101.8 102.57 13.21 Favored 'General case' 0 N--CA 1.419 -1.978 0 N-CA-C 107.42 -1.326 . . . . 0.80000000000000004 107.42 177.565 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A 1641 ' ' HIS . . . . . 0.49 ' HB3' ' HB3' ' A' 1615 ' ' ARG . 62.9 m80 -82.35 93.19 7.12 Favored 'General case' 0 C--N 1.311 -1.096 0 N-CA-C 107.604 -1.258 . . . . 2.54 107.604 -179.885 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A 1642 ' ' THR . . . . . 0.589 ' O ' ' HA ' ' A' 1614 ' ' CYS . 9.7 t -134.84 141.52 38.81 Favored Pre-proline 0 C--N 1.288 -2.103 0 CA-C-O 121.384 0.612 . . . . 1.1499999999999999 112.13 -170.421 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A 1643 ' ' PRO . . . . . 0.595 ' HB3' ' HB3' ' A' 1616 ' ' PRO . 38.2 Cg_endo -70.65 -10.15 27.26 Favored 'Trans proline' 0 C--N 1.352 0.742 0 C-N-CA 123.396 2.73 . . . . 0.80000000000000004 111.024 173.628 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A 1644 ' ' LEU . . . . . . . . . . . . . 31.7 mt -83.28 -2.52 55.85 Favored 'General case' 0 C--N 1.312 -1.023 0 C-N-CA 123.945 0.898 . . . . 1.54 111.215 -179.464 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A 1645 ' ' ALA . . . . . . . . . . . . . . . -92.23 -34.0 14.45 Favored 'General case' 0 C--N 1.323 -0.564 0 N-CA-C 112.765 0.654 . . . . 0.94999999999999996 112.765 -176.96 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A 1646 ' ' CYS . . . . . . . . . . . . . 5.9 m -152.55 172.19 16.97 Favored 'General case' 0 CA--C 1.506 -0.721 0 N-CA-C 106.94 -1.504 . . . . 1.4099999999999999 106.94 -179.205 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A 1647 ' ' GLU . . . . . . . . . . . . . 8.0 pt-20 . . . . . 0 C--N 1.302 -1.49 0 CA-C-O 121.586 0.708 . . . . 2.9199999999999999 109.956 173.494 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A 1515 ' ' ASP . . . . . . . . . . . . . 35.5 t70 . . . . . 0 CA--C 1.502 -0.903 0 N-CA-C 110.761 -0.088 . . . . 2.54 110.761 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A 1516 ' ' CYS . . . . . . . . . . . . . 74.1 m -76.25 77.4 3.04 Favored 'General case' 0 CA--C 1.508 -0.673 0 CA-C-O 122.326 1.06 . . . . 1.25 110.65 179.786 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A 1517 ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -147.01 172.54 13.56 Favored 'General case' 0 N--CA 1.402 -2.86 0 CA-C-N 114.324 -1.307 . . . . 1.8799999999999999 109.22 -179.622 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A 1518 ' ' VAL . . . . . 0.533 HG21 ' HB2' ' A' 1583 ' ' TYR . 10.4 p -159.0 126.01 0.57 Allowed 'Isoleucine or valine' 0 C--N 1.279 -2.466 0 CA-C-O 121.46 0.648 . . . . 1.73 109.551 173.035 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A 1519 ' ' THR . . . . . . . . . . . . . 7.3 m -90.57 121.52 32.58 Favored 'General case' 0 C--N 1.282 -2.351 0 CA-C-N 114.548 -1.205 . . . . 1.7 108.202 177.635 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A 1520 ' ' ASN . . . . . . . . . . . . . 38.9 t30 -99.79 103.33 21.21 Favored Pre-proline 0 C--N 1.311 -1.09 0 N-CA-C 109.59 -0.522 . . . . 2.1200000000000001 109.59 177.35 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A 1521 ' ' PRO . . . . . . . . . . . . . 41.4 Cg_endo -69.28 -3.35 11.52 Favored 'Trans proline' 0 CA--C 1.54 0.797 0 C-N-CA 122.624 2.216 . . . . 2.4700000000000002 113.954 -175.778 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A 1522 ' ' SER . . . . . . . . . . . . . 11.4 m -69.34 -28.84 66.58 Favored 'General case' 0 CA--C 1.545 0.776 0 CA-C-O 120.984 0.421 . . . . 2.5699999999999998 109.883 176.805 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A 1523 ' ' THR . . . . . . . . . . . . . 12.9 t -139.21 -16.62 1.06 Allowed 'General case' 0 CA--C 1.551 0.999 0 CA-C-O 120.903 0.383 . . . . 2.1499999999999999 111.827 178.771 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A 1524 ' ' GLY . . . . . . . . . . . . . . . 94.16 7.92 60.54 Favored Glycine 0 N--CA 1.446 -0.658 0 C-N-CA 120.597 -0.811 . . . . 1.8899999999999999 113.08 179.017 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A 1525 ' ' HIS . . . . . . . . . . . . . 24.5 t60 -77.06 134.11 38.87 Favored 'General case' 0 C--O 1.245 0.838 0 CA-C-O 120.866 0.365 . . . . 1.8999999999999999 110.023 -177.927 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A 1526 ' ' LEU . . . . . . . . . . . . . 3.4 tm? -104.51 114.73 29.14 Favored 'General case' 0 N--CA 1.43 -1.426 0 N-CA-C 108.157 -1.053 . . . . 1.6100000000000001 108.157 178.324 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A 1527 ' ' PHE . . . . . . . . . . . . . 97.6 m-85 -88.32 129.33 35.41 Favored 'General case' 0 C--N 1.291 -1.942 0 N-CA-C 108.071 -1.085 . . . . 1.4199999999999999 108.071 178.267 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A 1528 ' ' ASP . . . . . . . . . . . . . 3.4 p-10 -117.82 126.9 53.28 Favored 'General case' 0 CA--C 1.476 -1.866 0 CA-C-O 121.964 0.887 . . . . 2.1800000000000002 110.322 179.073 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A 1529 ' ' LEU . . . . . . . . . . . . . 71.7 mt -117.68 7.45 12.56 Favored 'General case' 0 C--N 1.292 -1.919 0 N-CA-C 106.231 -1.766 . . . . 1.4399999999999999 106.231 175.738 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A 1530 ' ' SER . . . . . . . . . . . . . 1.6 m -70.99 -24.95 62.49 Favored 'General case' 0 N--CA 1.438 -1.026 0 CA-C-N 113.853 -1.521 . . . . 1.4399999999999999 110.219 -179.152 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A 1531 ' ' SER . . . . . . . . . . . . . 14.5 m -88.07 -16.15 34.34 Favored 'General case' 0 N--CA 1.433 -1.309 0 N-CA-C 108.582 -0.896 . . . . 1.5 108.582 178.814 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A 1532 ' ' LEU . . . . . . . . . . . . . 90.8 mt -82.05 -8.28 59.66 Favored 'General case' 0 C--O 1.244 0.804 0 CA-C-N 115.509 -0.769 . . . . 1.77 111.72 177.631 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A 1533 ' ' SER . . . . . . . . . . . . . 22.5 m -57.67 125.84 24.73 Favored 'General case' 0 N--CA 1.445 -0.702 0 C-N-CA 123.155 0.582 . . . . 2.3799999999999999 110.424 177.146 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A 1534 ' ' GLY . . . . . . . . . . . . . . . -121.16 169.53 14.38 Favored Glycine 0 N--CA 1.427 -1.943 0 N-CA-C 109.976 -1.25 . . . . 1.55 109.976 179.698 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A 1535 ' ' ARG . . . . . . . . . . . . . 45.8 ttt180 -95.37 -54.27 3.46 Favored 'General case' 0 C--N 1.303 -1.452 0 N-CA-C 108.524 -0.917 . . . . 3.96 108.524 179.123 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A 1536 ' ' ALA . . . . . . . . . . . . . . . -86.14 -24.19 26.3 Favored 'General case' 0 N--CA 1.438 -1.047 0 CA-C-N 115.505 -0.771 . . . . 1.6499999999999999 109.463 178.68 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A 1537 ' ' GLY . . . . . . . . . . . . . . . 81.76 -140.66 21.16 Favored Glycine 0 N--CA 1.434 -1.473 0 CA-C-N 115.177 -0.919 . . . . 1.1899999999999999 112.344 176.664 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A 1538 ' ' PHE . . . . . . . . . . . . . 98.7 m-85 -134.16 156.83 47.62 Favored 'General case' 0 C--N 1.299 -1.617 0 N-CA-C 108.72 -0.844 . . . . 1.6899999999999999 108.72 179.881 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A 1539 ' ' THR . . . . . . . . . . . . . 23.5 p -104.93 111.63 24.47 Favored 'General case' 0 N--CA 1.425 -1.709 0 CA-C-N 115.929 -0.578 . . . . 1.48 110.046 177.114 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A 1540 ' ' ALA . . . . . . . . . . . . . . . -102.72 116.59 32.87 Favored 'General case' 0 C--N 1.295 -1.784 0 N-CA-C 108.865 -0.791 . . . . 0.82999999999999996 108.865 178.618 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A 1541 ' ' ALA . . . . . . . . . . . . . . . -61.68 128.34 35.8 Favored 'General case' 0 C--N 1.308 -1.222 0 CA-C-O 121.428 0.632 . . . . 1.27 110.943 178.021 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A 1542 ' ' TYR . . . . . 0.625 ' HD2' ' HB2' ' A' 1545 ' ' SER . 66.7 t80 -125.0 174.84 7.73 Favored 'General case' 0 C--N 1.293 -1.875 0 N-CA-C 107.296 -1.372 . . . . 2.1499999999999999 107.296 -178.426 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A 1543 ' ' SER . . . . . . . . . . . . . 1.7 m -46.5 -152.15 0.0 OUTLIER 'General case' 0 CA--C 1.596 2.721 0 C-N-CA 128.741 2.816 . . . . 2.29 114.404 -179.865 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A 1544 ' ' LYS . . . . . . . . . . . . . 63.6 mttp -55.07 -15.39 2.1 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 119.621 -1.924 . . . . 3.9100000000000001 113.556 -177.012 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A 1545 ' ' SER . . . . . 0.625 ' HB2' ' HD2' ' A' 1542 ' ' TYR . 36.0 m -70.62 -19.63 62.81 Favored 'General case' 0 CA--C 1.552 1.023 0 N-CA-C 111.976 0.361 . . . . 3.2999999999999998 111.976 174.707 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A 1546 ' ' GLY . . . . . . . . . . . . . . . 102.63 -98.55 1.7 Allowed Glycine 0 CA--C 1.493 -1.289 0 C-N-CA 119.224 -1.465 . . . . 1.24 113.187 174.822 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A 1547 ' ' VAL . . . . . . . . . . . . . 16.6 m -131.39 166.29 29.23 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.616 0 CA-C-N 117.26 0.53 . . . . 1.6299999999999999 109.913 177.567 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A 1548 ' ' VAL . . . . . . . . . . . . . 3.6 t -118.83 128.7 75.66 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.724 0 N-CA-C 106.627 -1.62 . . . . 0.92000000000000004 106.627 175.983 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A 1549 ' ' TYR . . . . . 0.566 ' CD2' ' HA2' ' A' 1568 ' ' GLY . 50.8 m-85 -87.64 114.57 24.37 Favored 'General case' 0 C--N 1.3 -1.57 0 N-CA-C 106.233 -1.765 . . . . 1.4399999999999999 106.233 171.223 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A 1550 ' ' MET . . . . . . . . . . . . . 3.0 ppp? -141.87 149.8 40.73 Favored 'General case' 0 C--N 1.284 -2.247 0 CA-C-N 116.435 -0.348 . . . . 1.74 111.304 -176.357 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A 1551 ' ' SER . . . . . . . . . . . . . 22.6 t -116.55 145.05 43.63 Favored 'General case' 0 C--N 1.294 -1.819 0 N-CA-C 107.83 -1.174 . . . . 1.6399999999999999 107.83 177.834 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A 1552 ' ' ILE . . . . . . . . . . . . . 32.6 mm -68.07 -27.31 36.88 Favored 'Isoleucine or valine' 0 C--O 1.213 -0.849 0 CA-C-N 114.856 -1.066 . . . . 1.3300000000000001 109.406 -178.132 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A 1553 ' ' CYS . . . . . 0.418 ' SG ' ' HE2' ' A' 1579 ' ' LYS . 51.4 t -161.64 138.65 8.52 Favored 'General case' 0 N--CA 1.421 -1.914 0 N-CA-C 108.282 -1.007 . . . . 1.4299999999999999 108.282 178.142 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A 1554 ' ' GLY . . . . . . . . . . . . . . . 95.47 -177.63 34.84 Favored Glycine 0 N--CA 1.438 -1.227 0 C-N-CA 120.689 -0.767 . . . . 1.1200000000000001 112.472 176.493 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A 1555 ' ' GLU . . . . . . . . . . . . . 10.1 pt-20 -81.37 144.25 31.59 Favored 'General case' 0 C--N 1.309 -1.194 0 CA-C-O 121.392 0.615 . . . . 1.8 111.522 -178.962 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A 1556 ' ' ASN . . . . . . . . . . . . . 27.8 t-20 -96.91 105.62 17.79 Favored 'General case' 0 C--N 1.293 -1.849 0 CA-C-N 115.225 -0.898 . . . . 2.6299999999999999 109.229 -179.408 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A 1557 ' ' GLU . . . . . . . . . . . . . 13.0 mt-10 -86.31 76.7 9.64 Favored 'General case' 0 C--N 1.313 -0.978 0 CA-C-O 122.035 0.922 . . . . 3.79 111.918 -177.028 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A 1558 ' ' ASN . . . . . . . . . . . . . 14.2 m120 -146.82 -43.94 0.18 Allowed 'General case' 0 C--N 1.297 -1.705 0 N-CA-C 106.143 -1.799 . . . . 1.52 106.143 178.892 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A 1559 ' ' CYS . . . . . 0.626 ' HB3' ' HD2' ' A' 1560 ' ' PRO . 78.2 m -108.63 175.92 1.78 Allowed Pre-proline 0 N--CA 1.425 -1.69 0 N-CA-C 105.532 -2.025 . . . . 0.83999999999999997 105.532 170.675 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A 1560 ' ' PRO . . . . . 0.626 ' HD2' ' HB3' ' A' 1559 ' ' CYS . 20.8 Cg_exo -32.95 113.11 0.06 OUTLIER 'Trans proline' 0 C--N 1.375 1.943 0 C-N-CA 123.641 2.894 . . . . 1.1799999999999999 113.962 176.879 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A 1561 ' ' PRO . . . . . . . . . . . . . 39.7 Cg_exo -59.07 102.79 0.16 Allowed 'Trans proline' 0 C--O 1.242 0.702 0 C-N-CA 123.335 2.69 . . . . 1.51 111.31 -179.026 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A 1562 ' ' GLY . . . . . . . . . . . . . . . 152.17 -19.74 0.84 Allowed Glycine 0 N--CA 1.432 -1.618 0 N-CA-C 108.582 -1.807 . . . . 0.71999999999999997 108.582 -175.081 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A 1563 ' ' VAL . . . . . 0.519 ' HA ' ' HA ' ' A' 1576 ' ' LYS . 4.6 m -93.06 151.56 3.61 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.109 0 N-CA-C 107.118 -1.438 . . . . 0.96999999999999997 107.118 174.013 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A 1564 ' ' GLY . . . . . . . . . . . . . . . -113.16 -15.35 9.13 Favored Glycine 0 C--N 1.308 -0.986 0 C-N-CA 120.664 -0.779 . . . . 0.71999999999999997 112.451 -176.79 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A 1565 ' ' ALA . . . . . . . . . . . . . . . -142.92 125.61 15.93 Favored 'General case' 0 C--O 1.244 0.8 0 N-CA-C 108.871 -0.789 . . . . 0.37 108.871 179.524 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A 1566 ' ' CYS . . . . . . . . . . . . . 41.7 t -150.41 144.33 25.38 Favored 'General case' 0 C--N 1.302 -1.498 0 N-CA-C 109.524 -0.547 . . . . 0.51000000000000001 109.524 -176.729 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A 1567 ' ' PHE . . . . . . . . . . . . . 18.1 m-85 -67.59 145.26 55.05 Favored 'General case' 0 C--N 1.319 -0.724 0 N-CA-C 112.181 0.438 . . . . 0.96999999999999997 112.181 179.91 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A 1568 ' ' GLY . . . . . 0.566 ' HA2' ' CD2' ' A' 1549 ' ' TYR . . . -63.8 -73.48 0.54 Allowed Glycine 0 C--N 1.304 -1.225 0 N-CA-C 115.004 0.761 . . . . 1.0800000000000001 115.004 -175.437 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A 1569 ' ' GLN . . . . . . . . . . . . . 11.2 pt20 -83.03 -34.29 26.3 Favored 'General case' 0 C--N 1.316 -0.849 0 N-CA-C 112.379 0.511 . . . . 2.7400000000000002 112.379 -173.344 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A 1570 ' ' THR . . . . . . . . . . . . . 21.3 p -81.51 -18.05 46.46 Favored 'General case' 0 C--N 1.312 -1.063 0 CA-C-O 121.32 0.581 . . . . 1.96 110.682 -178.162 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A 1571 ' ' ARG . . . . . . . . . . . . . 64.6 mtp180 56.21 37.9 29.29 Favored 'General case' 0 C--N 1.344 0.354 0 C-N-CA 125.132 1.373 . . . . 3.9500000000000002 113.063 172.774 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A 1572 ' ' ILE . . . . . . . . . . . . . 25.5 mt -101.81 128.12 54.61 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.121 0 N-CA-C 108.27 -1.011 . . . . 1.3700000000000001 108.27 179.838 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A 1573 ' ' SER . . . . . . . . . . . . . 62.3 p -75.79 128.59 35.47 Favored 'General case' 0 C--N 1.314 -0.956 0 C-N-CA 122.364 0.266 . . . . 1.0800000000000001 111.478 -177.106 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A 1574 ' ' VAL . . . . . . . . . . . . . 27.7 m -126.3 26.44 2.62 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.75 0 CA-C-O 121.608 0.718 . . . . 1.3 112.299 -177.937 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A 1575 ' ' GLY . . . . . . . . . . . . . . . 174.12 117.06 0.45 Allowed Glycine 0 N--CA 1.434 -1.47 0 CA-C-N 115.277 -0.874 . . . . 0.51000000000000001 111.897 176.769 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A 1576 ' ' LYS . . . . . 0.519 ' HA ' ' HA ' ' A' 1563 ' ' VAL . 63.8 tttp -79.2 135.83 36.91 Favored 'General case' 0 C--N 1.314 -0.962 0 N-CA-C 107.628 -1.249 . . . . 2.8999999999999999 107.628 176.045 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A 1577 ' ' ALA . . . . . . . . . . . . . . . -70.42 130.7 42.61 Favored 'General case' 0 C--N 1.313 -0.993 0 O-C-N 123.647 0.592 . . . . 0.82999999999999996 110.504 -174.431 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A 1578 ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -157.83 148.41 20.81 Favored 'General case' 0 C--N 1.291 -1.942 0 N-CA-C 105.686 -1.968 . . . . 1.8500000000000001 105.686 176.715 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A 1579 ' ' LYS . . . . . 0.418 ' HE2' ' SG ' ' A' 1553 ' ' CYS . 96.9 mttt -101.47 89.34 3.7 Favored 'General case' 0 C--N 1.284 -2.257 0 CA-C-O 121.845 0.831 . . . . 1.8999999999999999 108.761 -177.508 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A 1580 ' ' ARG . . . . . . . . . . . . . 30.4 ttm180 -138.67 109.1 6.51 Favored 'General case' 0 N--CA 1.422 -1.862 0 CA-C-N 114.156 -1.383 . . . . 3.6299999999999999 110.117 -175.587 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A 1581 ' ' LEU . . . . . . . . . . . . . 2.0 pt? -138.92 142.16 38.48 Favored 'General case' 0 N--CA 1.419 -1.992 0 N-CA-C 109.288 -0.634 . . . . 1.8700000000000001 109.288 173.408 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A 1582 ' ' ARG . . . . . 0.532 ' HB3' HG13 ' A' 1584 ' ' VAL . 37.4 mmt180 -124.76 128.77 49.28 Favored 'General case' 0 C--N 1.276 -2.623 0 CA-C-N 114.972 -1.013 . . . . 3.9700000000000002 110.585 -177.71 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A 1583 ' ' TYR . . . . . 0.533 ' HB2' HG21 ' A' 1518 ' ' VAL . 62.0 t80 -89.08 90.15 8.27 Favored 'General case' 0 N--CA 1.427 -1.585 0 N-CA-C 106.234 -1.765 . . . . 1.4099999999999999 106.234 174.452 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A 1584 ' ' VAL . . . . . 0.532 HG13 ' HB3' ' A' 1582 ' ' ARG . 26.6 m -124.53 142.4 41.48 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.167 0 CA-C-N 114.435 -1.257 . . . . 1.6899999999999999 107.896 -176.21 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A 1585 ' ' ASP . . . . . . . . . . . . . 22.8 t70 61.05 22.63 12.87 Favored 'General case' 0 N--CA 1.483 1.178 0 CA-C-O 122.44 1.114 . . . . 2.0600000000000001 109.79 178.565 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A 1586 ' ' GLN . . . . . . . . . . . . . 50.1 mt-30 59.98 38.88 20.63 Favored 'General case' 0 C--O 1.241 0.634 0 C-N-CA 125.278 1.431 . . . . 2.3300000000000001 113.254 -176.255 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A 1587 ' ' VAL . . . . . 0.471 HG12 ' O ' ' A' 1584 ' ' VAL . 12.5 p -134.52 145.77 32.12 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.895 0 N-CA-C 108.495 -0.928 . . . . 0.78000000000000003 108.495 174.904 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A 1588 ' ' LEU . . . . . 0.86 ' HB2' ' HB2' ' A' 1612 ' ' PHE . 0.7 OUTLIER -84.31 133.08 34.56 Favored 'General case' 0 C--N 1.312 -1.041 0 N-CA-C 108.306 -0.998 . . . . 1.4099999999999999 108.306 177.831 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A 1589 ' ' GLN . . . . . 0.419 ' HG2' HG13 ' A' 1591 ' ' VAL . 7.3 tt0 -146.05 106.85 4.11 Favored 'General case' 0 C--N 1.307 -1.268 0 C-N-CA 120.456 -0.498 . . . . 1.24 110.132 -176.611 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A 1590 ' ' LEU . . . . . . . . . . . . . 6.2 tt -104.39 127.97 52.15 Favored 'General case' 0 C--N 1.307 -1.259 0 N-CA-C 106.245 -1.761 . . . . 1.1499999999999999 106.245 179.319 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A 1591 ' ' VAL . . . . . 0.47 HG12 HG22 ' A' 1609 ' ' VAL . 15.6 m -123.69 124.37 69.22 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.245 0 N-CA-C 115.031 1.493 . . . . 1.51 115.031 -170.704 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A 1592 ' ' TYR . . . . . . . . . . . . . 94.5 m-85 -105.2 144.56 31.83 Favored 'General case' 0 C--N 1.317 -0.836 0 N-CA-C 107.267 -1.383 . . . . 1.0600000000000001 107.267 173.813 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A 1593 ' ' LYS . . . . . . . . . . . . . 23.0 pttm -149.89 179.57 7.94 Favored 'General case' 0 C--N 1.302 -1.493 0 N-CA-C 109.249 -0.648 . . . . 2.1800000000000002 109.249 -177.642 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A 1594 ' ' ASP . . . . . . . . . . . . . 1.4 m-20 47.05 43.19 13.77 Favored 'General case' 0 N--CA 1.482 1.128 0 N-CA-C 115.123 1.527 . . . . 1.45 115.123 173.367 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A 1595 ' ' GLY . . . . . . . . . . . . . . . -73.14 -75.57 0.72 Allowed Glycine 0 N--CA 1.443 -0.838 0 N-CA-C 109.816 -1.313 . . . . 0.78000000000000003 109.816 175.978 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A 1596 ' ' SER . . . . . . . . . . . . . 21.7 t -115.39 142.36 28.63 Favored Pre-proline 0 C--N 1.29 -1.994 0 N-CA-C 105.867 -1.901 . . . . 1.6799999999999999 105.867 173.42 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A 1597 ' ' PRO . . . . . . . . . . . . . 25.9 Cg_exo -65.75 143.15 72.96 Favored 'Trans proline' 0 N--CA 1.451 -0.99 0 C-N-CA 122.68 2.253 . . . . 1.1699999999999999 109.533 175.571 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A 1598 ' ' CYS . . . . . . . . . . . . . 37.1 t -99.56 131.79 24.23 Favored Pre-proline 0 C--N 1.283 -2.325 0 N-CA-C 109.102 -0.703 . . . . 1.1899999999999999 109.102 -176.37 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A 1599 ' ' PRO . . . . . . . . . . . . . 55.3 Cg_endo -69.44 -11.72 31.88 Favored 'Trans proline' 0 C--N 1.351 0.663 0 C-N-CA 123.165 2.577 . . . . 1.5900000000000001 112.352 179.604 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A 1600 ' ' SER . . . . . . . . . . . . . 10.9 m -90.26 112.82 24.49 Favored 'General case' 0 N--CA 1.423 -1.795 0 N-CA-C 107.612 -1.255 . . . . 2.1200000000000001 107.612 176.326 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A 1601 ' ' LYS . . . . . 0.74 ' HB3' HD12 ' A' 1604 ' ' LEU . 55.7 tptt 71.03 114.31 0.05 Allowed 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 124.155 0.982 . . . . 3.7400000000000002 110.98 179.054 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A 1602 ' ' SER . . . . . . . . . . . . . 47.4 t -63.61 108.96 1.52 Allowed 'General case' 0 C--N 1.316 -0.862 0 CA-C-N 116.075 -0.511 . . . . 3.79 109.949 179.757 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A 1603 ' ' GLY . . . . . . . . . . . . . . . 129.99 -15.83 5.59 Favored Glycine 0 N--CA 1.434 -1.498 0 N-CA-C 110.724 -0.95 . . . . 2.0 110.724 -179.924 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A 1604 ' ' LEU . . . . . 0.74 HD12 ' HB3' ' A' 1601 ' ' LYS . 12.6 mt -83.21 156.92 22.92 Favored 'General case' 0 N--CA 1.434 -1.263 0 CA-C-O 122.172 0.987 . . . . 1.48 113.6 179.805 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A 1605 ' ' SER . . . . . . . . . . . . . 14.9 m -143.15 -173.12 3.83 Favored 'General case' 0 C--N 1.296 -1.727 0 N-CA-C 104.752 -2.314 . . . . 1.51 104.752 176.749 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A 1606 ' ' TYR . . . . . 0.477 ' CD1' ' HB3' ' A' 1634 ' ' CYS . 84.3 m-85 -107.38 132.49 53.1 Favored 'General case' 0 CA--C 1.462 -2.438 0 N-CA-C 105.77 -1.937 . . . . 1.1799999999999999 105.77 179.863 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A 1607 ' ' LYS . . . . . 0.557 ' HG3' HG23 ' A' 1635 ' ' THR . 21.6 ptmt -128.04 153.31 46.93 Favored 'General case' 0 N--CA 1.407 -2.59 0 O-C-N 124.234 0.959 . . . . 1.6699999999999999 109.505 -177.777 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A 1608 ' ' SER . . . . . . . . . . . . . 51.0 m -126.31 115.36 19.56 Favored 'General case' 0 C--N 1.303 -1.44 0 N-CA-C 109.393 -0.595 . . . . 1.0 109.393 -178.541 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A 1609 ' ' VAL . . . . . 0.47 HG22 HG12 ' A' 1591 ' ' VAL . 76.6 t -104.12 116.15 47.37 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.064 0 CA-C-O 120.663 0.268 . . . . 0.93000000000000005 110.647 -179.407 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A 1610 ' ' ILE . . . . . . . . . . . . . 19.3 mm -95.22 106.55 18.36 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.127 0 N-CA-C 108.448 -0.945 . . . . 0.78000000000000003 108.448 177.969 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A 1611 ' ' SER . . . . . 0.494 ' O ' ' HA ' ' A' 1639 ' ' SER . 21.8 m -98.05 123.19 41.96 Favored 'General case' 0 C--N 1.297 -1.7 0 N-CA-C 108.914 -0.773 . . . . 1.29 108.914 176.246 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A 1612 ' ' PHE . . . . . 0.86 ' HB2' ' HB2' ' A' 1588 ' ' LEU . 80.5 m-85 -100.39 123.16 44.26 Favored 'General case' 0 C--N 1.305 -1.364 0 N-CA-C 109.242 -0.651 . . . . 0.69999999999999996 109.242 -179.066 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A 1613 ' ' VAL . . . . . 0.588 ' O ' ' HA ' ' A' 1641 ' ' HIS . 44.6 t -115.75 136.99 50.85 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.703 0 N-CA-C 106.697 -1.594 . . . . 0.75 106.697 179.281 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A 1614 ' ' CYS . . . . . 0.466 ' HA ' ' O ' ' A' 1642 ' ' THR . 42.3 t -86.69 108.88 18.85 Favored 'General case' 0 C--N 1.281 -2.409 0 CA-C-O 121.6 0.714 . . . . 1.3899999999999999 111.748 -177.588 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A 1615 ' ' ARG . . . . . 0.7 ' HB3' ' HB2' ' A' 1641 ' ' HIS . 80.4 ttt180 -135.94 94.1 14.85 Favored Pre-proline 0 N--CA 1.43 -1.473 0 N-CA-C 108.009 -1.108 . . . . 3.75 108.009 176.544 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A 1616 ' ' PRO . . . . . . . . . . . . . 68.7 Cg_endo -72.04 50.0 1.4 Allowed 'Trans proline' 0 N--CA 1.481 0.773 0 C-N-CA 123.829 3.019 . . . . 1.3200000000000001 113.156 -178.466 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A 1617 ' ' GLU . . . . . . . . . . . . . 42.4 mt-10 . . . . . 0 C--N 1.305 -1.352 0 N-CA-C 108.316 -0.994 . . . . 3.21 108.316 177.789 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A 1622 ' ' ASN . . . . . . . . . . . . . 25.4 t-20 . . . . . 0 N--CA 1.464 0.274 0 N-CA-C 107.521 -1.289 . . . . 2.9199999999999999 107.521 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A 1623 ' ' ARG . . . . . . . . . . . . . 7.2 ptp180 -122.13 162.44 37.44 Favored Pre-proline 0 C--N 1.299 -1.602 0 CA-C-O 119.381 -0.342 . . . . 3.6099999999999999 110.153 -178.725 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A 1624 ' ' PRO . . . . . . . . . . . . . 50.0 Cg_exo -55.61 144.68 73.86 Favored 'Trans proline' 0 C--N 1.364 1.348 0 C-N-CA 122.914 2.41 . . . . 2.3700000000000001 113.404 -179.777 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A 1625 ' ' MET . . . . . . . . . . . . . 55.4 ttp -118.35 136.03 53.97 Favored 'General case' 0 C--N 1.301 -1.533 0 CA-C-N 115.272 -0.876 . . . . 2.1600000000000001 109.517 -179.929 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A 1626 ' ' LEU . . . . . 0.575 ' HG ' ' HD1' ' A' 1542 ' ' TYR . 3.2 tm? -73.71 113.69 11.13 Favored 'General case' 0 C--N 1.31 -1.137 0 N-CA-C 106.79 -1.559 . . . . 1.3500000000000001 106.79 175.071 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A 1627 ' ' ILE . . . . . . . . . . . . . 31.6 pt -99.95 -30.95 3.35 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.957 0 C-N-CA 120.675 -0.41 . . . . 1.21 111.758 -176.758 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A 1628 ' ' SER . . . . . 0.408 ' HB3' ' HB2' ' A' 1637 ' ' PHE . 32.2 t -148.84 165.77 30.5 Favored 'General case' 0 N--CA 1.425 -1.679 0 CA-C-O 121.575 0.702 . . . . 1.3999999999999999 111.253 -175.116 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A 1629 ' ' LEU . . . . . . . . . . . . . 14.2 tp -146.15 130.23 17.41 Favored 'General case' 0 C--N 1.292 -1.898 0 C-N-CA 125.153 1.381 . . . . 1.5600000000000001 108.37 -177.682 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A 1630 ' ' ASP . . . . . 0.435 ' HB2' ' HE2' ' A' 1637 ' ' PHE . 21.2 t70 -119.36 106.63 12.47 Favored 'General case' 0 C--N 1.308 -1.222 0 N-CA-C 108.452 -0.944 . . . . 0.87 108.452 175.139 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A 1631 ' ' LYS . . . . . . . . . . . . . 67.9 mttm -69.41 -35.02 75.34 Favored 'General case' 0 C--N 1.304 -1.411 0 CA-C-N 115.528 -0.76 . . . . 2.3500000000000001 112.707 -176.031 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A 1632 ' ' GLN . . . . . . . . . . . . . 39.4 mt-30 -74.19 -23.15 59.18 Favored 'General case' 0 C--N 1.323 -0.57 0 N-CA-C 112.938 0.718 . . . . 2.5499999999999998 112.938 -176.12 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A 1633 ' ' THR . . . . . . . . . . . . . 2.0 m -112.5 3.69 16.97 Favored 'General case' 0 C--N 1.314 -0.942 0 CA-C-O 121.875 0.845 . . . . 1.24 110.217 178.528 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A 1634 ' ' CYS . . . . . 0.477 ' HB3' ' CD1' ' A' 1606 ' ' TYR . 33.4 m 54.36 43.36 30.58 Favored 'General case' 0 C--N 1.349 0.569 0 CA-C-N 114.673 -1.149 . . . . 0.89000000000000001 110.32 177.099 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A 1635 ' ' THR . . . . . 0.557 HG23 ' HG3' ' A' 1607 ' ' LYS . 26.8 m -112.57 133.6 54.54 Favored 'General case' 0 N--CA 1.436 -1.156 0 CA-C-N 114.934 -1.03 . . . . 0.75 111.255 -173.128 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A 1636 ' ' LEU . . . . . . . . . . . . . 14.0 mt -104.72 130.45 52.77 Favored 'General case' 0 C--O 1.246 0.887 0 N-CA-C 107.894 -1.15 . . . . 1.3300000000000001 107.894 174.118 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A 1637 ' ' PHE . . . . . 0.435 ' HE2' ' HB2' ' A' 1630 ' ' ASP . 96.1 m-85 -107.87 110.01 21.67 Favored 'General case' 0 C--N 1.313 -1.015 0 CA-C-O 120.832 0.349 . . . . 0.82999999999999996 110.809 -178.073 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A 1638 ' ' PHE . . . . . . . . . . . . . 97.9 m-85 -105.44 150.39 25.32 Favored 'General case' 0 C--N 1.307 -1.255 0 N-CA-C 109.219 -0.66 . . . . 0.59999999999999998 109.219 178.457 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A 1639 ' ' SER . . . . . 0.494 ' HA ' ' O ' ' A' 1611 ' ' SER . 69.1 m -141.61 138.05 32.31 Favored 'General case' 0 C--N 1.281 -2.391 0 N-CA-C 109.868 -0.419 . . . . 1.0800000000000001 109.868 175.147 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A 1640 ' ' TRP . . . . . 0.55 ' HE3' ' HE2' ' A' 1612 ' ' PHE . 12.8 t90 -127.6 118.93 24.84 Favored 'General case' 0 C--N 1.29 -2.017 0 N-CA-C 107.561 -1.274 . . . . 0.80000000000000004 107.561 178.537 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A 1641 ' ' HIS . . . . . 0.7 ' HB2' ' HB3' ' A' 1615 ' ' ARG . 6.2 p-80 -91.11 90.95 8.05 Favored 'General case' 0 N--CA 1.43 -1.461 0 CA-C-O 122.425 1.107 . . . . 2.54 110.045 176.465 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A 1642 ' ' THR . . . . . 0.466 ' O ' ' HA ' ' A' 1614 ' ' CYS . 1.6 m -103.3 133.81 20.11 Favored Pre-proline 0 C--N 1.281 -2.411 0 CA-C-N 113.629 -1.623 . . . . 1.1499999999999999 109.688 -172.93 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A 1643 ' ' PRO . . . . . 0.409 ' HD3' ' HA ' ' A' 1642 ' ' THR . 23.7 Cg_exo -69.46 -18.91 38.19 Favored 'Trans proline' 0 CA--C 1.533 0.43 0 C-N-CA 122.669 2.246 . . . . 0.80000000000000004 110.482 174.036 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A 1644 ' ' LEU . . . . . 0.411 ' H ' HG22 ' A' 1642 ' ' THR . 84.2 mt -76.55 -13.69 60.06 Favored 'General case' 0 N--CA 1.471 0.616 0 CA-C-N 115.036 -0.984 . . . . 1.54 110.958 178.491 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A 1645 ' ' ALA . . . . . . . . . . . . . . . -79.73 2.91 21.02 Favored 'General case' 0 CA--C 1.539 0.548 0 N-CA-C 113.436 0.902 . . . . 0.94999999999999996 113.436 -172.392 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A 1646 ' ' CYS . . . . . . . . . . . . . 12.0 p -168.06 177.03 5.78 Favored 'General case' 0 C--O 1.25 1.094 0 N-CA-C 107.092 -1.447 . . . . 1.4099999999999999 107.092 177.102 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A 1647 ' ' GLU . . . . . . . . . . . . . 6.7 mp0 . . . . . 0 C--N 1.309 -1.188 0 N-CA-C 107.089 -1.448 . . . . 2.9199999999999999 107.089 172.145 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A 1515 ' ' ASP . . . . . . . . . . . . . 16.3 t70 . . . . . 0 C--O 1.239 0.55 0 N-CA-C 109.102 -0.703 . . . . 2.54 109.102 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A 1516 ' ' CYS . . . . . 0.579 ' HB2' ' HD2' ' A' 1579 ' ' LYS . 8.0 t -79.63 74.07 6.31 Favored 'General case' 0 C--N 1.31 -1.152 0 CA-C-O 122.019 0.914 . . . . 1.25 110.181 -176.194 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A 1517 ' ' GLN . . . . . 0.471 ' HB2' HD21 ' A' 1526 ' ' LEU . 10.3 pt20 -151.12 159.28 44.57 Favored 'General case' 0 C--N 1.306 -1.29 0 CA-C-N 116.014 -0.539 . . . . 1.8799999999999999 109.827 -179.397 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A 1518 ' ' VAL . . . . . . . . . . . . . 7.5 p -151.5 139.69 14.29 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.496 0 N-CA-C 108.829 -0.804 . . . . 1.73 108.829 177.207 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A 1519 ' ' THR . . . . . 0.633 ' HA ' ' HA ' ' A' 1526 ' ' LEU . 15.2 m -87.14 122.67 31.27 Favored 'General case' 0 N--CA 1.42 -1.94 0 N-CA-C 107.482 -1.303 . . . . 1.7 107.482 176.88 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A 1520 ' ' ASN . . . . . . . . . . . . . 25.2 t-20 -78.74 115.34 51.15 Favored Pre-proline 0 C--N 1.318 -0.794 0 N-CA-C 108.612 -0.885 . . . . 2.1200000000000001 108.612 179.393 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A 1521 ' ' PRO . . . . . . . . . . . . . 71.4 Cg_endo -72.27 -20.29 24.67 Favored 'Trans proline' 0 CA--C 1.533 0.437 0 C-N-CA 122.185 1.924 . . . . 2.4700000000000002 113.715 -175.144 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A 1522 ' ' SER . . . . . . . . . . . . . 37.6 m -81.96 -37.44 26.67 Favored 'General case' 0 N--CA 1.436 -1.155 0 N-CA-C 112.648 0.61 . . . . 2.5699999999999998 112.648 -175.642 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A 1523 ' ' THR . . . . . . . . . . . . . 8.8 t -103.63 -17.58 15.09 Favored 'General case' 0 CA--C 1.551 0.984 0 C-N-CA 120.005 -0.678 . . . . 2.1499999999999999 111.35 176.987 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A 1524 ' ' GLY . . . . . . . . . . . . . . . 81.48 11.38 83.27 Favored Glycine 0 C--O 1.226 -0.391 0 C-N-CA 121.168 -0.539 . . . . 1.8899999999999999 112.181 179.209 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A 1525 ' ' HIS . . . . . . . . . . . . . 57.1 t-80 -101.89 136.12 42.28 Favored 'General case' 0 C--N 1.304 -1.37 0 N-CA-C 108.182 -1.044 . . . . 1.8999999999999999 108.182 -179.237 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A 1526 ' ' LEU . . . . . 0.633 ' HA ' ' HA ' ' A' 1519 ' ' THR . 5.1 tt -82.31 134.56 35.27 Favored 'General case' 0 C--N 1.293 -1.855 0 N-CA-C 106.512 -1.662 . . . . 1.6100000000000001 106.512 177.621 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A 1527 ' ' PHE . . . . . 0.419 ' N ' HD23 ' A' 1526 ' ' LEU . 65.7 m-85 -110.85 112.34 24.12 Favored 'General case' 0 C--N 1.294 -1.834 0 CA-C-O 121.424 0.631 . . . . 1.4199999999999999 111.072 177.889 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A 1528 ' ' ASP . . . . . . . . . . . . . 11.3 t70 -85.63 124.09 31.77 Favored 'General case' 0 C--N 1.312 -1.051 0 CA-C-N 114.525 -1.216 . . . . 2.1800000000000002 111.092 179.453 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A 1529 ' ' LEU . . . . . . . . . . . . . 9.9 mp -116.62 18.45 14.98 Favored 'General case' 0 C--N 1.313 -0.986 0 CA-C-N 115.801 -0.636 . . . . 1.4399999999999999 109.285 175.006 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A 1530 ' ' SER . . . . . . . . . . . . . 47.9 m -98.38 -29.08 13.34 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-O 121.246 0.546 . . . . 1.4399999999999999 111.419 -178.404 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A 1531 ' ' SER . . . . . . . . . . . . . 3.4 m -96.02 -9.71 30.32 Favored 'General case' 0 C--N 1.302 -1.493 0 CA-C-O 121.148 0.499 . . . . 1.5 110.421 -178.556 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A 1532 ' ' LEU . . . . . . . . . . . . . 78.5 mt -65.64 -40.92 93.03 Favored 'General case' 0 CA--C 1.543 0.695 0 N-CA-C 114.169 1.174 . . . . 1.77 114.169 -178.686 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A 1533 ' ' SER . . . . . 0.759 ' HB2' ' HB ' ' A' 1552 ' ' ILE . 7.2 t -101.01 126.78 47.7 Favored 'General case' 0 C--N 1.302 -1.477 0 N-CA-C 108.861 -0.792 . . . . 2.3799999999999999 108.861 -178.137 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A 1534 ' ' GLY . . . . . . . . . . . . . . . -104.57 -122.53 5.1 Favored Glycine 0 N--CA 1.425 -2.037 0 CA-C-N 115.883 -0.599 . . . . 1.55 112.466 -179.957 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A 1535 ' ' ARG . . . . . . . . . . . . . 20.5 tpt180 -81.79 -56.98 3.64 Favored 'General case' 0 C--N 1.302 -1.48 0 CA-C-O 120.875 0.369 . . . . 3.96 111.178 -176.446 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A 1536 ' ' ALA . . . . . . . . . . . . . . . -91.49 -45.45 8.52 Favored 'General case' 0 C--N 1.307 -1.25 0 C-N-CA 120.456 -0.497 . . . . 1.6499999999999999 111.65 -174.258 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A 1537 ' ' GLY . . . . . . . . . . . . . . . 100.15 -138.22 13.73 Favored Glycine 0 N--CA 1.429 -1.794 0 N-CA-C 110.894 -0.882 . . . . 1.1899999999999999 110.894 -179.212 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A 1538 ' ' PHE . . . . . . . . . . . . . 74.6 m-85 -138.1 172.99 12.11 Favored 'General case' 0 C--N 1.316 -0.88 0 N-CA-C 107.705 -1.22 . . . . 1.6899999999999999 107.705 -178.821 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A 1539 ' ' THR . . . . . . . . . . . . . 6.6 t -147.41 151.71 36.92 Favored 'General case' 0 C--N 1.299 -1.59 0 C-N-CA 119.384 -0.926 . . . . 1.48 111.21 -177.072 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A 1540 ' ' ALA . . . . . . . . . . . . . . . -132.19 135.47 46.36 Favored 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 108.543 -0.91 . . . . 0.82999999999999996 108.543 177.945 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A 1541 ' ' ALA . . . . . . . . . . . . . . . -80.45 152.2 28.89 Favored 'General case' 0 C--N 1.317 -0.827 0 CA-C-O 121.033 0.444 . . . . 1.27 110.855 -179.086 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A 1542 ' ' TYR . . . . . . . . . . . . . 30.3 t80 -149.36 177.62 9.51 Favored 'General case' 0 N--CA 1.425 -1.689 0 N-CA-C 108.48 -0.933 . . . . 2.1499999999999999 108.48 -177.903 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A 1543 ' ' SER . . . . . . . . . . . . . 4.5 m -48.69 -151.16 0.0 OUTLIER 'General case' 0 CA--C 1.58 2.132 0 C-N-CA 128.71 2.804 . . . . 2.29 113.28 178.173 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A 1544 ' ' LYS . . . . . . . . . . . . . 27.5 ttpp -43.18 -26.26 0.16 Allowed 'General case' 0 N--CA 1.495 1.8 0 O-C-N 120.607 -1.308 . . . . 3.9100000000000001 113.322 178.365 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A 1545 ' ' SER . . . . . . . . . . . . . 7.1 m -64.68 -22.02 66.88 Favored 'General case' 0 CA--C 1.569 1.677 0 C-N-CA 123.134 0.574 . . . . 3.2999999999999998 111.541 175.633 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A 1546 ' ' GLY . . . . . . . . . . . . . . . 91.45 -78.68 1.33 Allowed Glycine 0 N--CA 1.438 -1.174 0 N-CA-C 114.127 0.411 . . . . 1.24 114.127 173.518 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A 1547 ' ' VAL . . . . . . . . . . . . . 10.0 p -159.37 147.42 7.19 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.043 0 N-CA-C 107.057 -1.46 . . . . 1.6299999999999999 107.057 -176.071 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A 1548 ' ' VAL . . . . . . . . . . . . . 1.6 t -116.57 129.22 73.42 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.946 0 N-CA-C 108.319 -0.993 . . . . 0.92000000000000004 108.319 -177.338 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A 1549 ' ' TYR . . . . . 0.494 ' CE2' ' HA3' ' A' 1568 ' ' GLY . 79.3 m-85 -85.44 120.38 26.84 Favored 'General case' 0 CA--C 1.494 -1.184 0 N-CA-C 107.315 -1.365 . . . . 1.4399999999999999 107.315 174.839 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A 1550 ' ' MET . . . . . . . . . . . . . 88.7 mmm -124.76 121.29 34.19 Favored 'General case' 0 C--N 1.298 -1.654 0 N-CA-C 109.707 -0.479 . . . . 1.74 109.707 -173.579 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A 1551 ' ' SER . . . . . . . . . . . . . 50.4 m -89.96 158.62 17.3 Favored 'General case' 0 C--N 1.286 -2.158 0 N-CA-C 108.41 -0.959 . . . . 1.6399999999999999 108.41 175.622 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A 1552 ' ' ILE . . . . . 0.759 ' HB ' ' HB2' ' A' 1533 ' ' SER . 38.8 mm -74.14 -60.57 2.26 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.299 0 C-N-CA 119.228 -0.989 . . . . 1.3300000000000001 108.507 -179.871 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A 1553 ' ' CYS . . . . . 0.406 ' SG ' ' HG3' ' A' 1579 ' ' LYS . 34.9 t -151.16 141.99 22.86 Favored 'General case' 0 N--CA 1.421 -1.92 0 N-CA-C 104.402 -2.444 . . . . 1.4299999999999999 104.402 178.663 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A 1554 ' ' GLY . . . . . . . . . . . . . . . 104.81 -172.34 19.93 Favored Glycine 0 C--N 1.291 -1.951 0 C-N-CA 119.666 -1.254 . . . . 1.1200000000000001 111.073 -177.504 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A 1555 ' ' GLU . . . . . . . . . . . . . 8.9 pt-20 -98.67 142.4 30.28 Favored 'General case' 0 C--N 1.308 -1.219 0 N-CA-C 113.656 0.984 . . . . 1.8 113.656 -173.009 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A 1556 ' ' ASN . . . . . 0.419 ' O ' ' HA ' ' A' 1561 ' ' PRO . 19.3 t-20 -94.15 145.68 24.52 Favored 'General case' 0 C--N 1.309 -1.168 0 CA-C-N 113.707 -1.588 . . . . 2.6299999999999999 108.216 -179.398 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A 1557 ' ' GLU . . . . . . . . . . . . . 58.1 mm-40 -112.39 -9.47 13.84 Favored 'General case' 0 C--N 1.305 -1.35 0 O-C-N 123.464 0.478 . . . . 3.79 111.525 -174.618 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A 1558 ' ' ASN . . . . . . . . . . . . . 18.4 m-80 -85.49 2.58 44.11 Favored 'General case' 0 N--CA 1.489 1.488 0 CA-C-O 121.91 0.862 . . . . 1.52 111.519 -177.972 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A 1559 ' ' CYS . . . . . 0.802 ' HB3' ' HD2' ' A' 1560 ' ' PRO . 47.3 m -145.46 -175.93 0.51 Allowed Pre-proline 0 C--N 1.288 -2.097 0 N-CA-C 105.192 -2.151 . . . . 0.83999999999999997 105.192 175.51 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A 1560 ' ' PRO . . . . . 0.802 ' HD2' ' HB3' ' A' 1559 ' ' CYS . 1.6 Cg_endo -44.48 112.84 0.38 Allowed 'Trans proline' 0 C--N 1.376 2.01 0 C-N-CA 122.312 2.008 . . . . 1.1799999999999999 112.255 177.285 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A 1561 ' ' PRO . . . . . 0.419 ' HA ' ' O ' ' A' 1556 ' ' ASN . 53.0 Cg_exo -57.67 110.62 0.65 Allowed 'Trans proline' 0 C--O 1.244 0.82 0 C-N-CA 122.97 2.447 . . . . 1.51 111.229 -177.233 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A 1562 ' ' GLY . . . . . . . . . . . . . . . 135.96 -16.4 3.96 Favored Glycine 0 C--N 1.299 -1.483 0 N-CA-C 110.756 -0.938 . . . . 0.71999999999999997 110.756 -176.544 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A 1563 ' ' VAL . . . . . 0.648 ' HA ' ' HA ' ' A' 1576 ' ' LYS . 4.9 m -94.02 160.96 2.64 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.236 0 N-CA-C 107.029 -1.471 . . . . 0.96999999999999997 107.029 176.659 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A 1564 ' ' GLY . . . . . 0.489 ' HA3' ' CE2' ' A' 1592 ' ' TYR . . . -124.18 -5.08 7.5 Favored Glycine 0 C--O 1.238 0.403 0 C-N-CA 119.125 -1.512 . . . . 0.71999999999999997 113.162 -177.06 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A 1565 ' ' ALA . . . . . . . . . . . . . . . -150.18 127.24 11.2 Favored 'General case' 0 C--O 1.251 1.14 0 N-CA-C 108.808 -0.812 . . . . 0.37 108.808 179.867 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A 1566 ' ' CYS . . . . . . . . . . . . . 9.8 t -159.13 142.92 15.04 Favored 'General case' 0 C--N 1.308 -1.201 0 CA-C-N 116.258 -0.428 . . . . 0.51000000000000001 111.062 -172.755 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A 1567 ' ' PHE . . . . . . . . . . . . . 24.9 m-85 -73.31 123.24 23.37 Favored 'General case' 0 CA--C 1.508 -0.668 0 N-CA-C 107.224 -1.398 . . . . 0.96999999999999997 107.224 175.789 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A 1568 ' ' GLY . . . . . 0.494 ' HA3' ' CE2' ' A' 1549 ' ' TYR . . . -79.26 -25.47 59.28 Favored Glycine 0 C--N 1.3 -1.426 0 C-N-CA 120.052 -1.07 . . . . 1.0800000000000001 114.785 -171.688 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A 1569 ' ' GLN . . . . . . . . . . . . . 59.5 tp60 -71.08 -46.03 62.62 Favored 'General case' 0 C--N 1.306 -1.303 0 C-N-CA 119.937 -0.705 . . . . 2.7400000000000002 110.934 -179.179 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A 1570 ' ' THR . . . . . . . . . . . . . 38.3 p -95.83 -13.14 24.27 Favored 'General case' 0 C--N 1.306 -1.309 0 N-CA-C 112.333 0.494 . . . . 1.96 112.333 -177.154 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A 1571 ' ' ARG . . . . . . . . . . . . . 79.4 mtm180 60.63 37.39 19.29 Favored 'General case' 0 C--O 1.246 0.869 0 C-N-CA 124.753 1.221 . . . . 3.9500000000000002 112.798 -177.303 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A 1572 ' ' ILE . . . . . . . . . . . . . 39.9 mm -101.03 110.69 28.55 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.378 0 CA-C-N 114.458 -1.246 . . . . 1.3700000000000001 108.2 177.941 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A 1573 ' ' SER . . . . . . . . . . . . . 29.1 t -67.68 133.73 49.85 Favored 'General case' 0 C--N 1.294 -1.836 0 CA-C-N 114.548 -1.206 . . . . 1.0800000000000001 111.016 -179.971 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A 1574 ' ' VAL . . . . . 0.511 ' HB ' ' HB2' ' A' 1606 ' ' TYR . 34.8 m -108.23 -33.39 2.55 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.309 0 C-N-CA 120.602 -0.439 . . . . 1.3 111.009 -179.815 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A 1575 ' ' GLY . . . . . . . . . . . . . . . -140.11 130.88 4.83 Favored Glycine 0 N--CA 1.433 -1.512 0 C-N-CA 120.364 -0.922 . . . . 0.51000000000000001 112.67 -177.692 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A 1576 ' ' LYS . . . . . 0.648 ' HA ' ' HA ' ' A' 1563 ' ' VAL . 88.4 tttt -79.75 151.15 30.54 Favored 'General case' 0 C--N 1.313 -1.009 0 N-CA-C 108.32 -0.993 . . . . 2.8999999999999999 108.32 178.698 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A 1577 ' ' ALA . . . . . . . . . . . . . . . -70.71 98.17 1.48 Allowed 'General case' 0 CA--C 1.508 -0.662 0 CA-C-O 121.245 0.545 . . . . 0.82999999999999996 111.119 -175.988 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A 1578 ' ' ASN . . . . . . . . . . . . . 3.8 m-20 -101.66 115.93 31.62 Favored 'General case' 0 C--N 1.296 -1.753 0 N-CA-C 107.118 -1.438 . . . . 1.8500000000000001 107.118 175.97 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A 1579 ' ' LYS . . . . . 0.579 ' HD2' ' HB2' ' A' 1516 ' ' CYS . 38.4 ttpt -91.34 89.72 7.4 Favored 'General case' 0 C--N 1.3 -1.578 0 N-CA-C 108.085 -1.08 . . . . 1.8999999999999999 108.085 179.532 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A 1580 ' ' ARG . . . . . . . . . . . . . 14.4 tpp180 -156.43 116.93 3.67 Favored 'General case' 0 N--CA 1.419 -1.976 0 CA-C-N 114.459 -1.246 . . . . 3.6299999999999999 108.556 -176.11 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A 1581 ' ' LEU . . . . . . . . . . . . . 2.9 pp -113.37 150.65 32.33 Favored 'General case' 0 C--N 1.297 -1.688 0 C-N-CA 120.515 -0.474 . . . . 1.8700000000000001 111.236 178.145 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A 1582 ' ' ARG . . . . . . . . . . . . . 41.2 ttm180 -130.12 109.75 11.07 Favored 'General case' 0 C--N 1.295 -1.781 0 CA-C-N 115.603 -0.726 . . . . 3.9700000000000002 109.912 -178.625 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A 1583 ' ' TYR . . . . . . . . . . . . . 79.6 t80 -94.84 104.12 16.02 Favored 'General case' 0 C--N 1.296 -1.746 0 N-CA-C 108.443 -0.947 . . . . 1.4099999999999999 108.443 178.801 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A 1584 ' ' VAL . . . . . 0.482 ' O ' HG12 ' A' 1587 ' ' VAL . 7.0 p -130.78 111.2 19.76 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.403 0 C-N-CA 120.358 -0.537 . . . . 1.6899999999999999 112.0 -177.584 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A 1585 ' ' ASP . . . . . . . . . . . . . 18.7 t70 59.98 59.16 2.5 Favored 'General case' 0 N--CA 1.481 1.078 0 CA-C-O 122.584 1.183 . . . . 2.0600000000000001 110.976 177.171 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A 1586 ' ' GLN . . . . . . . . . . . . . 41.8 mt-30 57.35 23.53 9.01 Favored 'General case' 0 C--N 1.315 -0.916 0 N-CA-C 115.186 1.55 . . . . 2.3300000000000001 115.186 179.087 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A 1587 ' ' VAL . . . . . 0.482 HG12 ' O ' ' A' 1584 ' ' VAL . 9.5 p -130.85 128.32 62.63 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.512 0 N-CA-C 108.757 -0.831 . . . . 0.78000000000000003 108.757 173.482 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A 1588 ' ' LEU . . . . . 0.633 ' HB2' ' HB2' ' A' 1612 ' ' PHE . 8.1 mp -89.15 143.98 26.45 Favored 'General case' 0 N--CA 1.427 -1.58 0 CA-C-N 115.609 -0.723 . . . . 1.4099999999999999 109.636 179.689 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A 1589 ' ' GLN . . . . . . . . . . . . . 7.7 tt0 -136.05 142.8 44.43 Favored 'General case' 0 C--N 1.28 -2.454 0 N-CA-C 108.872 -0.788 . . . . 1.24 108.872 178.136 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A 1590 ' ' LEU . . . . . . . . . . . . . 5.7 tt -139.19 133.83 31.94 Favored 'General case' 0 C--N 1.293 -1.861 0 N-CA-C 103.611 -2.737 . . . . 1.1499999999999999 103.611 173.463 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A 1591 ' ' VAL . . . . . . . . . . . . . 7.3 p -130.9 127.61 61.59 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.496 0 N-CA-C 113.792 1.034 . . . . 1.51 113.792 -172.808 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A 1592 ' ' TYR . . . . . 0.489 ' CE2' ' HA3' ' A' 1564 ' ' GLY . 96.4 m-85 -101.33 139.9 36.37 Favored 'General case' 0 CA--C 1.495 -1.162 0 CA-C-N 114.581 -1.19 . . . . 1.0600000000000001 107.86 177.412 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A 1593 ' ' LYS . . . . . . . . . . . . . 14.1 ptmm? -158.93 170.12 22.81 Favored 'General case' 0 C--N 1.299 -1.595 0 C-N-CA 120.601 -0.44 . . . . 2.1800000000000002 110.084 -179.125 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A 1594 ' ' ASP . . . . . . . . . . . . . 48.1 m-20 61.8 41.98 11.11 Favored 'General case' 0 C--N 1.312 -1.025 0 N-CA-C 114.774 1.398 . . . . 1.45 114.774 175.127 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A 1595 ' ' GLY . . . . . . . . . . . . . . . -77.49 -86.88 0.41 Allowed Glycine 0 N--CA 1.437 -1.258 0 N-CA-C 109.13 -1.588 . . . . 0.78000000000000003 109.13 171.241 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A 1596 ' ' SER . . . . . . . . . . . . . 15.5 m -114.47 152.37 46.06 Favored Pre-proline 0 C--N 1.298 -1.635 0 N-CA-C 107.921 -1.14 . . . . 1.6799999999999999 107.921 176.059 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A 1597 ' ' PRO . . . . . . . . . . . . . 28.1 Cg_exo -63.74 146.35 91.99 Favored 'Trans proline' 0 C--O 1.247 0.97 0 C-N-CA 122.929 2.42 . . . . 1.1699999999999999 111.45 178.103 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A 1598 ' ' CYS . . . . . 0.469 ' HA ' ' HD3' ' A' 1599 ' ' PRO . 27.4 t -98.76 133.3 22.56 Favored Pre-proline 0 C--N 1.297 -1.696 0 N-CA-C 108.894 -0.78 . . . . 1.1899999999999999 108.894 -178.486 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A 1599 ' ' PRO . . . . . 0.469 ' HD3' ' HA ' ' A' 1598 ' ' CYS . 32.1 Cg_exo -62.82 -21.62 73.22 Favored 'Trans proline' 0 C--N 1.359 1.129 0 C-N-CA 123.759 2.973 . . . . 1.5900000000000001 112.941 179.801 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A 1600 ' ' SER . . . . . 0.56 ' HB3' ' SG ' ' A' 1634 ' ' CYS . 47.9 t -85.89 117.74 24.93 Favored 'General case' 0 N--CA 1.427 -1.606 0 N-CA-C 106.704 -1.591 . . . . 2.1200000000000001 106.704 175.242 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A 1601 ' ' LYS . . . . . . . . . . . . . 48.4 mmtm 58.82 60.63 2.42 Favored 'General case' 0 C--O 1.245 0.865 0 O-C-N 123.988 0.805 . . . . 3.7400000000000002 108.994 -176.484 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A 1602 ' ' SER . . . . . . . . . . . . . 23.3 t -53.37 112.27 0.86 Allowed 'General case' 0 C--O 1.247 0.969 0 CA-C-N 114.786 -1.097 . . . . 3.79 111.542 -174.846 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A 1603 ' ' GLY . . . . . . . . . . . . . . . 150.99 -33.84 0.94 Allowed Glycine 0 N--CA 1.43 -1.743 0 N-CA-C 108.137 -1.985 . . . . 2.0 108.137 -177.912 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A 1604 ' ' LEU . . . . . . . . . . . . . 2.5 pp -94.59 164.16 13.09 Favored 'General case' 0 N--CA 1.427 -1.585 0 CA-C-N 114.644 -0.778 . . . . 1.48 109.567 175.87 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A 1605 ' ' SER . . . . . . . . . . . . . 19.0 p -109.42 -167.08 1.16 Allowed 'General case' 0 C--N 1.286 -2.19 0 N-CA-C 109.371 -0.603 . . . . 1.51 109.371 -178.82 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A 1606 ' ' TYR . . . . . 0.511 ' HB2' ' HB ' ' A' 1574 ' ' VAL . 61.1 m-85 -97.45 144.79 26.83 Favored 'General case' 0 N--CA 1.413 -2.32 0 N-CA-C 104.466 -2.42 . . . . 1.1799999999999999 104.466 179.07 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A 1607 ' ' LYS . . . . . 0.471 ' HG3' HG23 ' A' 1635 ' ' THR . 19.2 ptmt -132.38 132.98 43.4 Favored 'General case' 0 C--N 1.268 -2.968 0 C-N-CA 118.655 -1.218 . . . . 1.6699999999999999 109.422 177.283 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A 1608 ' ' SER . . . . . . . . . . . . . 20.2 m -115.69 111.72 21.02 Favored 'General case' 0 C--N 1.291 -1.945 0 C-N-CA 122.848 0.459 . . . . 1.0 110.694 -175.724 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A 1609 ' ' VAL . . . . . . . . . . . . . 96.5 t -92.34 121.38 42.87 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.069 0 N-CA-C 109.151 -0.685 . . . . 0.93000000000000005 109.151 178.17 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A 1610 ' ' ILE . . . . . . . . . . . . . 17.0 mm -99.62 104.44 16.07 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.552 0 N-CA-C 107.871 -1.159 . . . . 0.78000000000000003 107.871 177.11 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A 1611 ' ' SER . . . . . 0.478 ' O ' ' HA ' ' A' 1639 ' ' SER . 22.8 t -91.8 119.87 32.01 Favored 'General case' 0 N--CA 1.42 -1.957 0 N-CA-C 108.612 -0.884 . . . . 1.29 108.612 178.667 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A 1612 ' ' PHE . . . . . 0.633 ' HB2' ' HB2' ' A' 1588 ' ' LEU . 97.4 m-85 -95.85 108.73 21.11 Favored 'General case' 0 C--N 1.297 -1.696 0 CA-C-N 115.548 -0.751 . . . . 0.69999999999999996 109.678 -178.776 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A 1613 ' ' VAL . . . . . . . . . . . . . 48.0 t -100.56 122.14 52.19 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.012 0 CA-C-N 115.409 -0.814 . . . . 0.75 109.544 -176.891 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A 1614 ' ' CYS . . . . . 0.671 ' HA ' ' O ' ' A' 1642 ' ' THR . 0.8 OUTLIER -76.68 100.6 5.45 Favored 'General case' 0 CA--C 1.5 -0.977 0 N-CA-C 113.178 0.807 . . . . 1.3899999999999999 113.178 177.289 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A 1615 ' ' ARG . . . . . 0.497 ' HD3' ' HD2' ' A' 1616 ' ' PRO . 14.0 tpp180 -137.71 116.77 9.96 Favored Pre-proline 0 N--CA 1.414 -2.27 0 CA-C-N 114.851 -1.068 . . . . 3.75 108.411 177.103 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A 1616 ' ' PRO . . . . . 0.497 ' HD2' ' HD3' ' A' 1615 ' ' ARG . 56.6 Cg_exo -58.16 52.13 0.05 OUTLIER 'Trans proline' 0 CA--C 1.553 1.463 0 C-N-CA 124.788 3.659 . . . . 1.3200000000000001 114.717 174.636 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A 1617 ' ' GLU . . . . . . . . . . . . . 44.0 tt0 . . . . . 0 C--N 1.31 -1.143 0 N-CA-C 108.2 -1.037 . . . . 3.21 108.2 176.628 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A 1622 ' ' ASN . . . . . 0.464 ' C ' ' HD3' ' A' 1624 ' ' PRO . 61.0 t30 . . . . . 0 C--O 1.247 0.934 0 CA-C-O 121.894 0.854 . . . . 2.9199999999999999 112.578 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A 1623 ' ' ARG . . . . . 0.5 ' HB3' ' CD1' ' A' 1640 ' ' TRP . 9.2 ptm180 -123.72 69.6 45.63 Favored Pre-proline 0 N--CA 1.434 -1.237 0 C-N-CA 119.572 -0.851 . . . . 3.6099999999999999 112.043 178.62 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A 1624 ' ' PRO . . . . . 0.464 ' HD3' ' C ' ' A' 1622 ' ' ASN . 64.4 Cg_endo -114.41 91.18 0.01 OUTLIER 'Trans proline' 0 N--CA 1.426 -2.491 0 C-N-CA 122.446 2.098 . . . . 2.3700000000000001 110.09 167.61 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A 1625 ' ' MET . . . . . 0.563 ' HG3' HG23 ' A' 1627 ' ' ILE . 12.9 tpt -151.78 98.77 2.51 Favored 'General case' 0 C--N 1.297 -1.714 0 C-N-CA 116.939 -1.905 . . . . 2.1600000000000001 112.236 -179.389 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A 1626 ' ' LEU . . . . . . . . . . . . . 4.4 mm? -87.85 88.99 7.82 Favored 'General case' 0 C--N 1.302 -1.494 0 N-CA-C 108.518 -0.919 . . . . 1.3500000000000001 108.518 171.321 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A 1627 ' ' ILE . . . . . 0.563 HG23 ' HG3' ' A' 1625 ' ' MET . 37.0 pt -73.42 -35.18 45.11 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.872 0 CA-C-N 115.875 -0.602 . . . . 1.21 110.956 -178.293 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A 1628 ' ' SER . . . . . . . . . . . . . 22.9 t -161.67 152.43 17.87 Favored 'General case' 0 N--CA 1.414 -2.268 0 N-CA-C 107.628 -1.249 . . . . 1.3999999999999999 107.628 -178.242 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A 1629 ' ' LEU . . . . . 0.573 ' HG ' ' HG ' ' A' 1636 ' ' LEU . 5.1 tt -146.72 111.99 5.49 Favored 'General case' 0 C--N 1.286 -2.166 0 N-CA-C 106.041 -1.837 . . . . 1.5600000000000001 106.041 175.843 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A 1630 ' ' ASP . . . . . 0.418 ' HB3' ' HB ' ' A' 1635 ' ' THR . 14.0 t70 -84.81 99.66 11.04 Favored 'General case' 0 C--N 1.292 -1.915 0 N-CA-C 106.741 -1.577 . . . . 0.87 106.741 -179.544 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A 1631 ' ' LYS . . . . . 0.429 ' HG2' HD22 ' A' 1629 ' ' LEU . 47.1 mtmt -72.79 -19.17 61.39 Favored 'General case' 0 C--N 1.306 -1.324 0 CA-C-N 115.941 -0.572 . . . . 2.3500000000000001 112.373 -173.304 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A 1632 ' ' GLN . . . . . . . . . . . . . 2.8 mp0 -73.68 -51.45 16.64 Favored 'General case' 0 C--N 1.313 -0.985 0 C-N-CA 121.01 -0.276 . . . . 2.5499999999999998 110.719 179.616 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A 1633 ' ' THR . . . . . . . . . . . . . 35.7 p -97.36 14.03 27.62 Favored 'General case' 0 C--N 1.316 -0.858 0 CA-C-O 121.357 0.599 . . . . 1.24 111.917 -179.706 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A 1634 ' ' CYS . . . . . 0.56 ' SG ' ' HB3' ' A' 1600 ' ' SER . 65.9 m 50.01 45.58 25.18 Favored 'General case' 0 N--CA 1.475 0.813 0 C-N-CA 124.966 1.307 . . . . 0.89000000000000001 112.244 177.744 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A 1635 ' ' THR . . . . . 0.471 HG23 ' HG3' ' A' 1607 ' ' LYS . 25.5 m -107.14 107.51 18.52 Favored 'General case' 0 N--CA 1.428 -1.574 0 CA-C-N 114.89 -1.05 . . . . 0.75 109.831 -176.609 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A 1636 ' ' LEU . . . . . 0.573 ' HG ' ' HG ' ' A' 1629 ' ' LEU . 4.9 mp -95.11 127.88 41.51 Favored 'General case' 0 C--N 1.309 -1.182 0 N-CA-C 109.434 -0.58 . . . . 1.3300000000000001 109.434 -177.505 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A 1637 ' ' PHE . . . . . . . . . . . . . 95.6 m-85 -109.36 110.85 22.11 Favored 'General case' 0 C--N 1.314 -0.939 0 CA-C-O 120.941 0.401 . . . . 0.82999999999999996 110.305 -179.12 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A 1638 ' ' PHE . . . . . 0.424 ' HA ' ' O ' ' A' 1625 ' ' MET . 92.6 m-85 -105.41 159.32 16.01 Favored 'General case' 0 C--N 1.315 -0.933 0 N-CA-C 109.393 -0.595 . . . . 0.59999999999999998 109.393 179.583 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A 1639 ' ' SER . . . . . 0.478 ' HA ' ' O ' ' A' 1611 ' ' SER . 50.1 m -142.09 144.85 33.74 Favored 'General case' 0 C--N 1.299 -1.599 0 CA-C-O 120.841 0.353 . . . . 1.0800000000000001 110.885 175.713 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A 1640 ' ' TRP . . . . . 0.5 ' CD1' ' HB3' ' A' 1623 ' ' ARG . 12.4 t90 -118.95 137.79 53.25 Favored 'General case' 0 C--N 1.323 -0.551 0 N-CA-C 106.939 -1.504 . . . . 0.80000000000000004 106.939 176.871 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A 1641 ' ' HIS . . . . . . . . . . . . . 38.9 m-70 -98.87 98.09 9.21 Favored 'General case' 0 C--N 1.314 -0.937 0 N-CA-C 105.966 -1.864 . . . . 2.54 105.966 179.075 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A 1642 ' ' THR . . . . . 0.671 ' O ' ' HA ' ' A' 1614 ' ' CYS . 9.8 t -142.24 139.21 17.47 Favored Pre-proline 0 C--N 1.305 -1.359 0 N-CA-C 113.459 0.911 . . . . 1.1499999999999999 113.459 -171.686 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A 1643 ' ' PRO . . . . . 0.512 ' HD3' ' HA ' ' A' 1642 ' ' THR . 4.4 Cg_exo -79.42 -6.77 14.77 Favored 'Trans proline' 0 C--N 1.355 0.894 0 C-N-CA 123.462 2.775 . . . . 0.80000000000000004 110.385 173.574 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A 1644 ' ' LEU . . . . . . . . . . . . . 65.8 mt -89.13 5.32 45.14 Favored 'General case' 0 N--CA 1.443 -0.797 0 CA-C-N 115.229 -0.896 . . . . 1.54 110.249 -177.693 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A 1645 ' ' ALA . . . . . . . . . . . . . . . -97.18 -44.36 6.98 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-O 121.619 0.724 . . . . 0.94999999999999996 109.642 176.46 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A 1646 ' ' CYS . . . . . . . . . . . . . 0.6 OUTLIER -171.41 173.91 4.64 Favored 'General case' 0 C--N 1.303 -1.441 0 N-CA-C 107.69 -1.226 . . . . 1.4099999999999999 107.69 -178.063 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A 1647 ' ' GLU . . . . . . . . . . . . . 51.8 mt-10 . . . . . 0 C--N 1.303 -1.432 0 N-CA-C 108.519 -0.919 . . . . 2.9199999999999999 108.519 -178.787 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A 1515 ' ' ASP . . . . . 0.57 ' HB3' ' HG2' ' A' 1517 ' ' GLN . 7.5 t70 . . . . . 0 N--CA 1.442 -0.852 0 N-CA-C 105.781 -1.933 . . . . 2.54 105.781 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A 1516 ' ' CYS . . . . . . . . . . . . . 72.8 m -104.34 51.5 0.77 Allowed 'General case' 0 C--N 1.27 -2.865 0 N-CA-C 108.196 -1.039 . . . . 1.25 108.196 -179.8 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A 1517 ' ' GLN . . . . . 0.57 ' HG2' ' HB3' ' A' 1515 ' ' ASP . 3.9 pt20 -151.64 171.38 17.72 Favored 'General case' 0 C--N 1.304 -1.377 0 N-CA-C 109.407 -0.59 . . . . 1.8799999999999999 109.407 -177.316 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A 1518 ' ' VAL . . . . . . . . . . . . . 8.5 p -154.23 140.6 11.91 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.404 0 N-CA-C 109.404 -0.591 . . . . 1.73 109.404 -179.414 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A 1519 ' ' THR . . . . . . . . . . . . . 19.1 m -100.76 130.74 46.83 Favored 'General case' 0 N--CA 1.423 -1.783 0 N-CA-C 107.895 -1.15 . . . . 1.7 107.895 177.097 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A 1520 ' ' ASN . . . . . 0.434 ' OD1' HG22 ' A' 1523 ' ' THR . 27.9 t-20 -90.03 121.35 68.88 Favored Pre-proline 0 C--N 1.3 -1.567 0 C-N-CA 120.236 -0.585 . . . . 2.1200000000000001 109.868 178.295 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A 1521 ' ' PRO . . . . . . . . . . . . . 60.0 Cg_endo -73.09 -20.28 21.89 Favored 'Trans proline' 0 C--N 1.352 0.754 0 C-N-CA 122.089 1.86 . . . . 2.4700000000000002 113.642 -175.797 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A 1522 ' ' SER . . . . . . . . . . . . . 48.1 m -77.0 -57.9 3.58 Favored 'General case' 0 C--N 1.316 -0.851 0 N-CA-C 111.981 0.363 . . . . 2.5699999999999998 111.981 -177.95 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A 1523 ' ' THR . . . . . 0.434 HG22 ' OD1' ' A' 1520 ' ' ASN . 8.9 t -90.71 -14.81 31.45 Favored 'General case' 0 C--N 1.317 -0.835 0 CA-C-O 121.053 0.454 . . . . 2.1499999999999999 111.134 -178.601 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A 1524 ' ' GLY . . . . . . . . . . . . . . . 76.13 14.32 82.39 Favored Glycine 0 C--O 1.226 -0.393 0 C-N-CA 120.873 -0.679 . . . . 1.8899999999999999 112.478 178.932 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A 1525 ' ' HIS . . . . . . . . . . . . . 22.7 t60 -100.75 137.65 38.85 Favored 'General case' 0 C--N 1.309 -1.183 0 N-CA-C 108.143 -1.058 . . . . 1.8999999999999999 108.143 -177.57 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A 1526 ' ' LEU . . . . . . . . . . . . . 7.7 tt -100.0 136.37 40.01 Favored 'General case' 0 C--N 1.297 -1.707 0 N-CA-C 108.604 -0.887 . . . . 1.6100000000000001 108.604 -178.451 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A 1527 ' ' PHE . . . . . . . . . . . . . 88.2 m-85 -110.46 126.16 54.04 Favored 'General case' 0 C--N 1.3 -1.554 0 N-CA-C 107.792 -1.188 . . . . 1.4199999999999999 107.792 178.618 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A 1528 ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -114.71 143.64 44.74 Favored 'General case' 0 C--N 1.309 -1.179 0 CA-C-O 122.021 0.915 . . . . 2.1800000000000002 112.104 -178.932 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A 1529 ' ' LEU . . . . . . . . . . . . . 3.1 mm? -122.33 16.68 10.59 Favored 'General case' 0 C--N 1.292 -1.896 0 N-CA-C 105.047 -2.205 . . . . 1.4399999999999999 105.047 168.963 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A 1530 ' ' SER . . . . . . . . . . . . . 12.7 m -74.04 -37.48 64.29 Favored 'General case' 0 N--CA 1.435 -1.219 0 CA-C-N 113.727 -1.579 . . . . 1.4399999999999999 108.681 -179.157 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A 1531 ' ' SER . . . . . . . . . . . . . 9.6 m -75.0 -21.61 59.03 Favored 'General case' 0 N--CA 1.433 -1.32 0 N-CA-C 108.801 -0.814 . . . . 1.5 108.801 176.515 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A 1532 ' ' LEU . . . . . 0.488 HD11 HD21 ' A' 1644 ' ' LEU . 90.2 mt -96.29 11.23 35.36 Favored 'General case' 0 CA--C 1.52 -0.21 0 CA-C-N 115.638 -0.71 . . . . 1.77 112.238 178.239 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A 1533 ' ' SER . . . . . . . . . . . . . 34.0 m -69.47 114.46 7.72 Favored 'General case' 0 N--CA 1.435 -1.212 0 N-CA-C 107.622 -1.251 . . . . 2.3799999999999999 107.622 176.479 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A 1534 ' ' GLY . . . . . . . . . . . . . . . -82.47 151.11 29.18 Favored Glycine 0 N--CA 1.426 -2.005 0 CA-C-N 115.615 -0.721 . . . . 1.55 113.993 -170.209 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A 1535 ' ' ARG . . . . . 0.465 ' C ' ' HD3' ' A' 1535 ' ' ARG . 1.2 tmt_? -95.88 -61.57 1.43 Allowed 'General case' 0 N--CA 1.426 -1.644 0 N-CA-C 106.885 -1.524 . . . . 3.96 106.885 174.821 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A 1536 ' ' ALA . . . . . . . . . . . . . . . -94.87 -23.01 17.65 Favored 'General case' 0 C--N 1.312 -1.056 0 CA-C-N 115.458 -0.792 . . . . 1.6499999999999999 109.023 177.195 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A 1537 ' ' GLY . . . . . . . . . . . . . . . 91.25 -167.75 31.75 Favored Glycine 0 N--CA 1.427 -1.962 0 CA-C-N 115.623 -0.717 . . . . 1.1899999999999999 113.862 174.492 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A 1538 ' ' PHE . . . . . . . . . . . . . 81.6 m-85 -108.46 168.3 9.42 Favored 'General case' 0 C--N 1.298 -1.661 0 C-N-CA 125.574 1.55 . . . . 1.6899999999999999 107.661 -179.321 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A 1539 ' ' THR . . . . . . . . . . . . . 14.5 p -117.05 112.7 21.3 Favored 'General case' 0 C--N 1.297 -1.714 0 CA-C-O 120.925 0.393 . . . . 1.48 110.273 179.809 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A 1540 ' ' ALA . . . . . . . . . . . . . . . -102.17 143.96 31.32 Favored 'General case' 0 C--N 1.303 -1.435 0 N-CA-C 108.05 -1.093 . . . . 0.82999999999999996 108.05 178.741 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A 1541 ' ' ALA . . . . . . . . . . . . . . . -91.01 156.64 17.8 Favored 'General case' 0 C--N 1.294 -1.826 0 CA-C-O 121.982 0.896 . . . . 1.27 112.844 -173.819 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A 1542 ' ' TYR . . . . . 0.73 ' HB3' ' HA3' ' A' 1546 ' ' GLY . 68.5 t80 -147.44 171.69 15.11 Favored 'General case' 0 C--N 1.296 -1.761 0 N-CA-C 102.746 -3.057 . . . . 2.1499999999999999 102.746 175.006 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A 1543 ' ' SER . . . . . . . . . . . . . 6.8 m -43.09 -161.88 0.0 OUTLIER 'General case' 0 CA--C 1.603 2.983 0 N-CA-C 117.119 2.266 . . . . 2.29 117.119 -173.769 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A 1544 ' ' LYS . . . . . . . . . . . . . 57.7 tttm -46.12 -38.05 7.65 Favored 'General case' 0 N--CA 1.479 0.997 0 O-C-N 120.669 -1.27 . . . . 3.9100000000000001 113.24 -178.493 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A 1545 ' ' SER . . . . . . . . . . . . . 19.4 m -111.29 26.12 11.01 Favored 'General case' 0 C--N 1.3 -1.56 0 O-C-N 122.27 -0.269 . . . . 3.2999999999999998 110.583 179.18 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A 1546 ' ' GLY . . . . . 0.73 ' HA3' ' HB3' ' A' 1542 ' ' TYR . . . -112.84 131.28 10.0 Favored Glycine 0 N--CA 1.412 -2.912 0 C-N-CA 117.879 -2.105 . . . . 1.24 116.311 -173.836 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A 1547 ' ' VAL . . . . . . . . . . . . . 9.1 p -162.07 119.46 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.567 0 N-CA-C 107.821 -1.177 . . . . 1.6299999999999999 107.821 171.808 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A 1548 ' ' VAL . . . . . . . . . . . . . 2.1 t -115.29 129.23 71.88 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.814 0 N-CA-C 107.923 -1.14 . . . . 0.92000000000000004 107.923 -175.599 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A 1549 ' ' TYR . . . . . 0.447 ' HB3' HD21 ' A' 1556 ' ' ASN . 96.3 m-85 -84.61 116.57 23.24 Favored 'General case' 0 N--CA 1.423 -1.783 0 N-CA-C 107.552 -1.277 . . . . 1.4399999999999999 107.552 176.002 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A 1550 ' ' MET . . . . . . . . . . . . . 54.9 tpp -119.1 122.53 42.28 Favored 'General case' 0 C--N 1.29 -1.986 0 CA-C-N 115.379 -0.828 . . . . 1.74 110.551 -174.014 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A 1551 ' ' SER . . . . . . . . . . . . . 8.2 t -96.57 121.7 38.68 Favored 'General case' 0 C--N 1.285 -2.202 0 N-CA-C 103.527 -2.768 . . . . 1.6399999999999999 103.527 171.263 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A 1552 ' ' ILE . . . . . . . . . . . . . 1.8 tp -62.14 -27.57 42.77 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.666 0 CA-C-O 121.38 0.609 . . . . 1.3300000000000001 110.344 -172.166 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A 1553 ' ' CYS . . . . . 0.466 ' HA ' ' OH ' ' A' 1592 ' ' TYR . 23.0 t -162.39 138.39 7.48 Favored 'General case' 0 N--CA 1.415 -2.215 0 N-CA-C 105.479 -2.045 . . . . 1.4299999999999999 105.479 167.494 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A 1554 ' ' GLY . . . . . . . . . . . . . . . 110.45 -166.85 12.46 Favored Glycine 0 C--N 1.292 -1.913 0 N-CA-C 110.018 -1.233 . . . . 1.1200000000000001 110.018 -179.011 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A 1555 ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -99.69 156.93 16.82 Favored 'General case' 0 C--N 1.303 -1.448 0 CA-C-N 117.48 0.64 . . . . 1.8 111.109 -178.221 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A 1556 ' ' ASN . . . . . 0.447 HD21 ' HB3' ' A' 1549 ' ' TYR . 23.0 t-20 -111.47 109.37 19.28 Favored 'General case' 0 N--CA 1.423 -1.815 0 CA-C-N 115.34 -0.845 . . . . 2.6299999999999999 109.269 -178.409 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A 1557 ' ' GLU . . . . . . . . . . . . . 25.6 mt-10 -87.91 54.42 3.09 Favored 'General case' 0 C--N 1.301 -1.525 0 N-CA-C 113.307 0.854 . . . . 3.79 113.307 -174.022 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A 1558 ' ' ASN . . . . . . . . . . . . . 32.9 m-80 -129.22 3.45 5.2 Favored 'General case' 0 C--N 1.306 -1.298 0 N-CA-C 107.94 -1.133 . . . . 1.52 107.94 174.615 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A 1559 ' ' CYS . . . . . 0.774 ' HB3' ' HD2' ' A' 1560 ' ' PRO . 69.3 m -153.98 177.84 1.84 Allowed Pre-proline 0 C--N 1.31 -1.146 0 N-CA-C 106.995 -1.483 . . . . 0.83999999999999997 106.995 -177.911 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A 1560 ' ' PRO . . . . . 0.774 ' HD2' ' HB3' ' A' 1559 ' ' CYS . 15.9 Cg_exo -32.82 132.74 0.09 OUTLIER 'Trans proline' 0 C--N 1.381 2.246 0 C-N-CA 124.363 3.375 . . . . 1.1799999999999999 114.955 177.615 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A 1561 ' ' PRO . . . . . 0.496 ' HD3' ' HA ' ' A' 1560 ' ' PRO . 35.9 Cg_exo -58.25 123.49 13.75 Favored 'Trans proline' 0 C--O 1.245 0.826 0 C-N-CA 122.916 2.411 . . . . 1.51 111.568 179.814 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A 1562 ' ' GLY . . . . . 0.428 ' O ' ' HD3' ' A' 1576 ' ' LYS . . . 109.48 -8.08 32.38 Favored Glycine 0 N--CA 1.436 -1.364 0 C-N-CA 120.288 -0.958 . . . . 0.71999999999999997 114.163 178.247 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A 1563 ' ' VAL . . . . . . . . . . . . . 3.4 m -89.17 148.21 4.69 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.874 0 N-CA-C 107.962 -1.125 . . . . 0.96999999999999997 107.962 178.286 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A 1564 ' ' GLY . . . . . . . . . . . . . . . -97.63 -23.14 14.44 Favored Glycine 0 CA--C 1.505 -0.573 0 C-N-CA 120.137 -1.03 . . . . 0.71999999999999997 113.162 -174.441 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A 1565 ' ' ALA . . . . . . . . . . . . . . . -151.65 140.46 20.92 Favored 'General case' 0 C--N 1.31 -1.13 0 N-CA-C 109.137 -0.69 . . . . 0.37 109.137 -177.909 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A 1566 ' ' CYS . . . . . . . . . . . . . 48.0 t -161.77 147.65 13.64 Favored 'General case' 0 C--N 1.315 -0.92 0 CA-C-N 116.398 -0.365 . . . . 0.51000000000000001 110.016 -175.526 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A 1567 ' ' PHE . . . . . 0.421 ' O ' ' HA ' ' A' 1571 ' ' ARG . 50.3 m-85 -74.73 152.16 39.11 Favored 'General case' 0 N--CA 1.471 0.583 0 N-CA-C 108.609 -0.885 . . . . 0.96999999999999997 108.609 178.424 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A 1568 ' ' GLY . . . . . . . . . . . . . . . -89.07 -31.75 11.61 Favored Glycine 0 N--CA 1.447 -0.61 0 C-N-CA 120.499 -0.857 . . . . 1.0800000000000001 114.125 -176.744 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A 1569 ' ' GLN . . . . . . . . . . . . . 52.7 tt0 -89.9 -56.93 3.04 Favored 'General case' 0 C--N 1.309 -1.183 0 N-CA-C 108.361 -0.977 . . . . 2.7400000000000002 108.361 178.363 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A 1570 ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -68.79 -32.6 72.45 Favored 'General case' 0 N--CA 1.421 -1.88 0 CA-C-N 113.684 -1.598 . . . . 1.96 110.579 -175.921 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A 1571 ' ' ARG . . . . . 0.421 ' HA ' ' O ' ' A' 1567 ' ' PHE . 67.7 mtm180 46.29 55.76 7.01 Favored 'General case' 0 C--O 1.246 0.871 0 N-CA-C 113.176 0.806 . . . . 3.9500000000000002 113.176 -179.252 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A 1572 ' ' ILE . . . . . . . . . . . . . 47.9 mm -109.7 126.05 66.86 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.384 0 N-CA-C 106.394 -1.706 . . . . 1.3700000000000001 106.394 175.066 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A 1573 ' ' SER . . . . . . . . . . . . . 42.1 t -75.76 120.46 21.16 Favored 'General case' 0 C--N 1.298 -1.634 0 N-CA-C 108.973 -0.751 . . . . 1.0800000000000001 108.973 179.496 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A 1574 ' ' VAL . . . . . 0.629 ' HB ' ' HB2' ' A' 1606 ' ' TYR . 34.5 m -90.88 -33.9 6.1 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.81 0 C-N-CA 119.401 -0.919 . . . . 1.3 110.827 179.948 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A 1575 ' ' GLY . . . . . . . . . . . . . . . -161.31 155.63 26.87 Favored Glycine 0 N--CA 1.424 -2.144 0 C-N-CA 120.047 -1.073 . . . . 0.51000000000000001 113.747 -177.761 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A 1576 ' ' LYS . . . . . 0.428 ' HD3' ' O ' ' A' 1562 ' ' GLY . 17.0 tppt? -71.47 153.11 42.47 Favored 'General case' 0 C--N 1.311 -1.108 0 C-N-CA 125.814 1.646 . . . . 2.8999999999999999 108.512 178.17 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A 1577 ' ' ALA . . . . . . . . . . . . . . . -65.16 74.9 0.05 Allowed 'General case' 0 N--CA 1.482 1.152 0 C-N-CA 123.629 0.771 . . . . 0.82999999999999996 109.578 174.425 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A 1578 ' ' ASN . . . . . . . . . . . . . 61.8 t30 -89.81 131.67 35.64 Favored 'General case' 0 C--N 1.293 -1.878 0 C-N-CA 124.092 0.957 . . . . 1.8500000000000001 111.303 -173.211 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A 1579 ' ' LYS . . . . . . . . . . . . . 2.4 mppt? -100.2 92.12 5.07 Favored 'General case' 0 C--N 1.292 -1.914 0 N-CA-C 108.771 -0.826 . . . . 1.8999999999999999 108.771 175.56 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A 1580 ' ' ARG . . . . . 0.515 ' O ' ' HA ' ' A' 1590 ' ' LEU . 61.7 ttt180 -140.16 86.49 2.08 Favored 'General case' 0 C--N 1.289 -2.056 0 N-CA-C 107.536 -1.283 . . . . 3.6299999999999999 107.536 176.735 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A 1581 ' ' LEU . . . . . 0.605 HD13 ' HB2' ' A' 1590 ' ' LEU . 20.6 tp -110.85 135.79 50.87 Favored 'General case' 0 C--N 1.297 -1.69 0 N-CA-C 108.672 -0.862 . . . . 1.8700000000000001 108.672 -177.238 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A 1582 ' ' ARG . . . . . . . . . . . . . 57.5 ttp180 -136.79 140.4 42.49 Favored 'General case' 0 C--N 1.304 -1.384 0 N-CA-C 109.535 -0.542 . . . . 3.9700000000000002 109.535 179.854 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A 1583 ' ' TYR . . . . . . . . . . . . . 74.2 t80 -112.17 92.89 4.19 Favored 'General case' 0 C--O 1.245 0.843 0 C-N-CA 122.896 0.478 . . . . 1.4099999999999999 110.174 179.83 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A 1584 ' ' VAL . . . . . . . . . . . . . 28.5 m -137.51 147.22 26.63 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.293 0 N-CA-C 107.261 -1.385 . . . . 1.6899999999999999 107.261 175.346 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A 1585 ' ' ASP . . . . . . . . . . . . . 19.0 t70 61.96 28.08 17.06 Favored 'General case' 0 N--CA 1.483 1.22 0 C-N-CA 124.246 1.018 . . . . 2.0600000000000001 109.702 -179.672 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A 1586 ' ' GLN . . . . . . . . . . . . . 46.2 mt-30 53.98 34.16 19.05 Favored 'General case' 0 N--CA 1.466 0.354 0 C-N-CA 125.243 1.417 . . . . 2.3300000000000001 113.474 -176.147 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A 1587 ' ' VAL . . . . . . . . . . . . . 8.1 p -132.13 123.56 50.98 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.692 0 CA-C-O 121.24 0.543 . . . . 0.78000000000000003 110.021 176.266 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A 1588 ' ' LEU . . . . . 0.71 ' HB2' ' HB2' ' A' 1612 ' ' PHE . 80.1 mt -78.75 116.72 19.28 Favored 'General case' 0 C--N 1.312 -1.026 0 N-CA-C 107.392 -1.336 . . . . 1.4099999999999999 107.392 174.695 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A 1589 ' ' GLN . . . . . . . . . . . . . 8.6 tt0 -118.2 124.78 48.76 Favored 'General case' 0 C--N 1.28 -2.432 0 CA-C-N 115.863 -0.608 . . . . 1.24 109.935 -177.316 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A 1590 ' ' LEU . . . . . 0.605 ' HB2' HD13 ' A' 1581 ' ' LEU . 7.5 tt -122.55 126.14 47.16 Favored 'General case' 0 C--N 1.302 -1.475 0 N-CA-C 106.876 -1.527 . . . . 1.1499999999999999 106.876 178.761 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A 1591 ' ' VAL . . . . . 0.422 HG12 HG22 ' A' 1609 ' ' VAL . 19.3 m -114.38 117.76 56.52 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.235 0 N-CA-C 113.864 1.061 . . . . 1.51 113.864 -175.665 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A 1592 ' ' TYR . . . . . 0.521 ' HB2' ' HB2' ' A' 1608 ' ' SER . 56.4 m-85 -90.9 133.5 35.19 Favored 'General case' 0 C--N 1.311 -1.067 0 CA-C-N 115.316 -0.856 . . . . 1.0600000000000001 110.584 177.16 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A 1593 ' ' LYS . . . . . . . . . . . . . 63.4 pttt -159.02 -177.95 6.88 Favored 'General case' 0 C--N 1.314 -0.958 0 N-CA-C 108.396 -0.964 . . . . 2.1800000000000002 108.396 177.304 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A 1594 ' ' ASP . . . . . . . . . . . . . 62.2 m-20 72.1 59.04 0.14 Allowed 'General case' 0 N--CA 1.476 0.846 0 C-N-CA 124.379 1.072 . . . . 1.45 111.865 179.158 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A 1595 ' ' GLY . . . . . . . . . . . . . . . -131.32 -109.91 1.28 Allowed Glycine 0 N--CA 1.433 -1.541 0 N-CA-C 109.343 -1.503 . . . . 0.78000000000000003 109.343 177.35 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A 1596 ' ' SER . . . . . 0.43 ' HA ' ' HD3' ' A' 1597 ' ' PRO . 14.1 m -97.67 134.98 21.83 Favored Pre-proline 0 C--N 1.299 -1.591 0 N-CA-C 108.801 -0.814 . . . . 1.6799999999999999 108.801 177.719 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A 1597 ' ' PRO . . . . . 0.43 ' HD3' ' HA ' ' A' 1596 ' ' SER . 23.5 Cg_exo -67.14 152.27 80.06 Favored 'Trans proline' 0 N--CA 1.458 -0.574 0 C-N-CA 123.074 2.516 . . . . 1.1699999999999999 112.133 177.908 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A 1598 ' ' CYS . . . . . . . . . . . . . 43.1 t -94.77 135.67 23.62 Favored Pre-proline 0 C--N 1.293 -1.881 0 N-CA-C 107.932 -1.136 . . . . 1.1899999999999999 107.932 179.563 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A 1599 ' ' PRO . . . . . . . . . . . . . 89.4 Cg_endo -79.49 3.21 7.7 Favored 'Trans proline' 0 C--O 1.243 0.746 0 C-N-CA 123.383 2.722 . . . . 1.5900000000000001 113.707 -177.395 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A 1600 ' ' SER . . . . . . . . . . . . . 14.6 m -120.94 145.83 47.29 Favored 'General case' 0 C--N 1.297 -1.68 0 N-CA-C 108.055 -1.091 . . . . 2.1200000000000001 108.055 178.837 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A 1601 ' ' LYS . . . . . 0.61 ' HG3' HG22 ' A' 1633 ' ' THR . 29.7 mmmt 67.63 -146.14 0.14 Allowed 'General case' 0 CA--C 1.537 0.453 0 O-C-N 124.006 0.816 . . . . 3.7400000000000002 110.61 177.925 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A 1602 ' ' SER . . . . . . . . . . . . . 33.5 t -68.76 163.43 24.08 Favored 'General case' 0 CA--C 1.551 0.998 0 N-CA-C 109.66 -0.496 . . . . 3.79 109.66 178.862 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A 1603 ' ' GLY . . . . . . . . . . . . . . . -77.36 58.0 3.7 Favored Glycine 0 C--N 1.332 0.324 0 N-CA-C 111.685 -0.566 . . . . 2.0 111.685 179.015 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A 1604 ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -101.2 159.43 15.25 Favored 'General case' 0 C--N 1.297 -1.715 0 C-N-CA 124.773 1.229 . . . . 1.48 110.146 -179.278 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A 1605 ' ' SER . . . . . . . . . . . . . 38.6 m -75.74 -170.9 1.42 Allowed 'General case' 0 C--N 1.315 -0.91 0 CA-C-O 121.586 0.708 . . . . 1.51 110.737 177.837 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A 1606 ' ' TYR . . . . . 0.629 ' HB2' ' HB ' ' A' 1574 ' ' VAL . 14.7 m-85 -96.57 117.07 30.17 Favored 'General case' 0 N--CA 1.422 -1.858 0 N-CA-C 103.513 -2.773 . . . . 1.1799999999999999 103.513 174.582 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A 1607 ' ' LYS . . . . . . . . . . . . . 22.0 ptmt -102.88 124.07 47.7 Favored 'General case' 0 C--N 1.276 -2.597 0 C-N-CA 118.613 -1.235 . . . . 1.6699999999999999 111.404 -170.083 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A 1608 ' ' SER . . . . . 0.521 ' HB2' ' HB2' ' A' 1592 ' ' TYR . 21.7 m -101.46 110.16 22.11 Favored 'General case' 0 C--N 1.299 -1.629 0 CA-C-N 114.928 -1.033 . . . . 1.0 109.626 -178.98 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A 1609 ' ' VAL . . . . . 0.422 HG22 HG12 ' A' 1591 ' ' VAL . 65.8 t -94.3 106.44 18.1 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.351 0 N-CA-C 109.31 -0.626 . . . . 0.93000000000000005 109.31 178.729 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A 1610 ' ' ILE . . . . . . . . . . . . . 38.2 mm -89.49 109.21 20.12 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.701 0 N-CA-C 108.471 -0.937 . . . . 0.78000000000000003 108.471 178.831 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A 1611 ' ' SER . . . . . . . . . . . . . 18.2 m -104.98 116.59 32.22 Favored 'General case' 0 C--N 1.301 -1.51 0 CA-C-O 121.286 0.565 . . . . 1.29 110.398 178.923 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A 1612 ' ' PHE . . . . . 0.71 ' HB2' ' HB2' ' A' 1588 ' ' LEU . 93.3 m-85 -87.74 108.61 19.2 Favored 'General case' 0 C--N 1.301 -1.509 0 N-CA-C 108.36 -0.978 . . . . 0.69999999999999996 108.36 177.143 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A 1613 ' ' VAL . . . . . . . . . . . . . 78.9 t -102.61 130.62 52.29 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.084 0 CA-C-O 120.889 0.376 . . . . 0.75 110.312 -178.227 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A 1614 ' ' CYS . . . . . . . . . . . . . 32.5 m -75.02 92.28 2.6 Favored 'General case' 0 C--N 1.303 -1.415 0 CA-C-N 115.257 -0.883 . . . . 1.3899999999999999 111.586 -176.169 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A 1615 ' ' ARG . . . . . 0.806 ' HB3' ' HB3' ' A' 1641 ' ' HIS . 2.9 tpm_? -138.93 85.46 16.2 Favored Pre-proline 0 C--N 1.314 -0.975 0 N-CA-C 108.861 -0.792 . . . . 3.75 108.861 176.789 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A 1616 ' ' PRO . . . . . . . . . . . . . 52.6 Cg_exo -59.29 -18.54 45.75 Favored 'Trans proline' 0 N--CA 1.492 1.439 0 C-N-CA 123.07 2.513 . . . . 1.3200000000000001 113.554 179.019 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A 1617 ' ' GLU . . . . . . . . . . . . . 33.0 tt0 . . . . . 0 C--N 1.321 -0.634 0 C-N-CA 123.473 0.709 . . . . 3.21 112.312 -178.351 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A 1622 ' ' ASN . . . . . . . . . . . . . 50.6 t-20 . . . . . 0 C--O 1.239 0.527 0 N-CA-C 107.574 -1.269 . . . . 2.9199999999999999 107.574 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A 1623 ' ' ARG . . . . . . . . . . . . . 8.1 ptm180 -150.97 153.77 33.5 Favored Pre-proline 0 C--N 1.31 -1.11 0 CA-C-N 115.095 -0.957 . . . . 3.6099999999999999 108.468 -177.44 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A 1624 ' ' PRO . . . . . . . . . . . . . 11.6 Cg_exo -71.43 120.63 7.09 Favored 'Trans proline' 0 C--O 1.236 0.403 0 C-N-CA 122.631 2.22 . . . . 2.3700000000000001 110.896 178.279 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A 1625 ' ' MET . . . . . . . . . . . . . 44.4 ttm -109.94 140.84 43.49 Favored 'General case' 0 C--N 1.306 -1.294 0 C-N-CA 122.777 0.431 . . . . 2.1600000000000001 110.082 -177.621 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A 1626 ' ' LEU . . . . . . . . . . . . . 59.9 tp -81.38 117.3 21.72 Favored 'General case' 0 C--N 1.308 -1.237 0 N-CA-C 107.768 -1.197 . . . . 1.3500000000000001 107.768 175.337 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A 1627 ' ' ILE . . . . . . . . . . . . . 41.0 pt -99.33 -33.1 3.86 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.204 0 C-N-CA 119.778 -0.769 . . . . 1.21 111.547 -177.209 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A 1628 ' ' SER . . . . . 0.536 ' HB3' ' HB2' ' A' 1637 ' ' PHE . 44.9 t -141.28 143.65 34.21 Favored 'General case' 0 N--CA 1.431 -1.4 0 N-CA-C 109.287 -0.634 . . . . 1.3999999999999999 109.287 -176.99 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A 1629 ' ' LEU . . . . . 0.747 HD13 ' HG ' ' A' 1636 ' ' LEU . 22.4 tp -146.07 116.21 7.42 Favored 'General case' 0 C--N 1.303 -1.42 0 CA-C-N 116.057 -0.52 . . . . 1.5600000000000001 110.312 -177.941 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A 1630 ' ' ASP . . . . . . . . . . . . . 12.3 t70 -109.51 107.97 18.28 Favored 'General case' 0 C--N 1.298 -1.659 0 N-CA-C 107.801 -1.185 . . . . 0.87 107.801 176.416 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A 1631 ' ' LYS . . . . . . . . . . . . . 95.3 mttt -85.27 3.54 39.05 Favored 'General case' 0 C--N 1.307 -1.281 0 CA-C-N 116.241 -0.436 . . . . 2.3500000000000001 111.979 -176.202 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A 1632 ' ' GLN . . . . . . . . . . . . . 1.4 mp0 -91.11 -49.21 6.52 Favored 'General case' 0 C--N 1.316 -0.863 0 N-CA-C 109.102 -0.703 . . . . 2.5499999999999998 109.102 178.875 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A 1633 ' ' THR . . . . . 0.61 HG22 ' HG3' ' A' 1601 ' ' LYS . 22.2 p -97.48 2.78 50.63 Favored 'General case' 0 C--N 1.308 -1.234 0 CA-C-N 115.772 -0.649 . . . . 1.24 111.455 179.013 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A 1634 ' ' CYS . . . . . . . . . . . . . 98.3 m 56.6 47.49 18.39 Favored 'General case' 0 C--N 1.347 0.467 0 CA-C-N 114.879 -1.055 . . . . 0.89000000000000001 111.758 178.692 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A 1635 ' ' THR . . . . . . . . . . . . . 26.7 m -112.44 118.38 35.02 Favored 'General case' 0 N--CA 1.43 -1.434 0 CA-C-N 115.006 -0.997 . . . . 0.75 109.246 -178.21 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A 1636 ' ' LEU . . . . . 0.747 ' HG ' HD13 ' A' 1629 ' ' LEU . 4.0 mp -112.1 130.17 55.98 Favored 'General case' 0 N--CA 1.441 -0.884 0 N-CA-C 109.626 -0.509 . . . . 1.3300000000000001 109.626 -177.816 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A 1637 ' ' PHE . . . . . 0.536 ' HB2' ' HB3' ' A' 1628 ' ' SER . 91.0 m-85 -111.15 113.09 25.35 Favored 'General case' 0 C--N 1.315 -0.931 0 CA-C-O 120.9 0.381 . . . . 0.82999999999999996 110.509 -178.712 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A 1638 ' ' PHE . . . . . . . . . . . . . 97.4 m-85 -108.25 145.53 34.18 Favored 'General case' 0 C--N 1.306 -1.298 0 CA-C-N 116.103 -0.499 . . . . 0.59999999999999998 109.766 -179.087 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A 1639 ' ' SER . . . . . . . . . . . . . 65.6 m -136.98 127.89 27.47 Favored 'General case' 0 C--N 1.29 -2.018 0 CA-C-O 121.226 0.536 . . . . 1.0800000000000001 111.381 178.848 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A 1640 ' ' TRP . . . . . . . . . . . . . 16.4 t90 -115.72 125.49 52.87 Favored 'General case' 0 C--N 1.294 -1.843 0 N-CA-C 107.022 -1.473 . . . . 0.80000000000000004 107.022 175.188 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A 1641 ' ' HIS . . . . . 0.806 ' HB3' ' HB3' ' A' 1615 ' ' ARG . 69.9 m-70 -89.39 103.3 15.94 Favored 'General case' 0 C--N 1.306 -1.297 0 N-CA-C 107.054 -1.461 . . . . 2.54 107.054 -179.848 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A 1642 ' ' THR . . . . . . . . . . . . . 10.2 t -143.0 142.02 20.98 Favored Pre-proline 0 C--N 1.302 -1.476 0 CA-C-O 121.013 0.435 . . . . 1.1499999999999999 110.96 -173.618 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A 1643 ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo -73.64 -12.13 24.42 Favored 'Trans proline' 0 C--N 1.359 1.08 0 C-N-CA 123.211 2.608 . . . . 0.80000000000000004 113.118 179.93 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A 1644 ' ' LEU . . . . . 0.488 HD21 HD11 ' A' 1532 ' ' LEU . 2.4 pp -90.66 4.48 51.3 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 121.685 0.755 . . . . 1.54 112.799 -179.221 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A 1645 ' ' ALA . . . . . . . . . . . . . . . -72.66 -38.4 67.65 Favored 'General case' 0 C--N 1.302 -1.482 0 CA-C-N 114.476 -1.238 . . . . 0.94999999999999996 108.086 173.461 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A 1646 ' ' CYS . . . . . . . . . . . . . 18.6 p -175.4 135.29 0.32 Allowed 'General case' 0 C--N 1.312 -1.037 0 N-CA-C 105.004 -2.221 . . . . 1.4099999999999999 105.004 175.402 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A 1647 ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 . . . . . 0 C--N 1.312 -1.039 0 N-CA-C 108.801 -0.814 . . . . 2.9199999999999999 108.801 -179.568 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A 1515 ' ' ASP . . . . . . . . . . . . . 62.7 m-20 . . . . . 0 CA--C 1.49 -1.346 0 N-CA-C 108.238 -1.023 . . . . 2.54 108.238 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A 1516 ' ' CYS . . . . . . . . . . . . . 58.3 m -120.39 73.19 0.98 Allowed 'General case' 0 C--N 1.305 -1.359 0 CA-C-O 121.436 0.636 . . . . 1.25 110.664 -175.796 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A 1517 ' ' GLN . . . . . 0.43 HE21 ' HB3' ' A' 1517 ' ' GLN . 0.0 OUTLIER -139.59 136.14 34.08 Favored 'General case' 0 C--N 1.297 -1.7 0 CA-C-N 115.527 -0.76 . . . . 1.8799999999999999 111.014 174.067 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A 1518 ' ' VAL . . . . . . . . . . . . . 94.8 t -121.23 121.59 65.23 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.449 0 CA-C-N 115.673 -0.694 . . . . 1.73 109.269 176.497 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A 1519 ' ' THR . . . . . 0.513 ' HA ' ' HA ' ' A' 1526 ' ' LEU . 20.5 m -90.62 108.23 19.68 Favored 'General case' 0 C--N 1.295 -1.763 0 CA-C-O 120.865 0.364 . . . . 1.7 110.914 179.651 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A 1520 ' ' ASN . . . . . 0.559 ' HB2' ' CE2' ' A' 1527 ' ' PHE . 15.1 t-20 -67.43 122.3 82.55 Favored Pre-proline 0 N--CA 1.47 0.566 0 CA-C-N 116.033 -0.531 . . . . 2.1200000000000001 110.98 179.416 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A 1521 ' ' PRO . . . . . . . . . . . . . 94.9 Cg_endo -83.4 -1.5 10.25 Favored 'Trans proline' 0 CA--C 1.533 0.442 0 C-N-CA 122.347 2.031 . . . . 2.4700000000000002 113.756 -178.236 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A 1522 ' ' SER . . . . . . . . . . . . . 6.8 m -83.62 -58.18 2.92 Favored 'General case' 0 C--N 1.308 -1.201 0 C-N-CA 120.773 -0.371 . . . . 2.5699999999999998 110.57 -179.071 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A 1523 ' ' THR . . . . . . . . . . . . . 11.3 t -108.85 -5.98 15.98 Favored 'General case' 0 N--CA 1.443 -0.815 0 CA-C-O 120.972 0.415 . . . . 2.1499999999999999 110.844 -177.045 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A 1524 ' ' GLY . . . . . . . . . . . . . . . 80.01 28.76 48.9 Favored Glycine 0 CA--C 1.507 -0.445 0 C-N-CA 120.62 -0.8 . . . . 1.8899999999999999 112.91 176.899 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A 1525 ' ' HIS . . . . . . . . . . . . . 22.1 t-160 -97.41 118.59 34.23 Favored 'General case' 0 C--N 1.312 -1.032 0 N-CA-C 109.414 -0.587 . . . . 1.8999999999999999 109.414 -179.885 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A 1526 ' ' LEU . . . . . 0.513 ' HA ' ' HA ' ' A' 1519 ' ' THR . 5.0 tt -82.9 111.0 18.38 Favored 'General case' 0 C--N 1.295 -1.79 0 N-CA-C 107.095 -1.446 . . . . 1.6100000000000001 107.095 178.087 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A 1527 ' ' PHE . . . . . 0.559 ' CE2' ' HB2' ' A' 1520 ' ' ASN . 32.6 m-85 -87.9 102.62 14.89 Favored 'General case' 0 C--N 1.305 -1.351 0 N-CA-C 108.498 -0.927 . . . . 1.4199999999999999 108.498 179.395 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A 1528 ' ' ASP . . . . . . . . . . . . . 23.4 t70 -105.71 133.44 50.45 Favored 'General case' 0 C--N 1.298 -1.632 0 C-N-CA 120.467 -0.493 . . . . 2.1800000000000002 110.106 179.347 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A 1529 ' ' LEU . . . . . . . . . . . . . 89.0 mt -113.3 -7.98 13.5 Favored 'General case' 0 C--N 1.299 -1.614 0 CA-C-N 115.146 -0.934 . . . . 1.4399999999999999 110.001 179.248 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A 1530 ' ' SER . . . . . . . . . . . . . 2.3 m -69.1 -37.41 78.37 Favored 'General case' 0 CA--C 1.543 0.696 0 CA-C-O 121.878 0.846 . . . . 1.4399999999999999 109.154 -177.92 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A 1531 ' ' SER . . . . . . . . . . . . . 14.0 m -70.85 -24.13 62.47 Favored 'General case' 0 C--N 1.317 -0.844 0 CA-C-N 115.199 -0.91 . . . . 1.5 109.926 177.895 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A 1532 ' ' LEU . . . . . . . . . . . . . 8.0 mp -84.7 4.58 31.97 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.414 -0.812 . . . . 1.77 110.502 179.317 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A 1533 ' ' SER . . . . . . . . . . . . . 32.5 m -113.87 119.08 36.06 Favored 'General case' 0 N--CA 1.425 -1.709 0 N-CA-C 113.337 0.866 . . . . 2.3799999999999999 113.337 -175.303 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A 1534 ' ' GLY . . . . . . . . . . . . . . . -89.65 -162.84 38.76 Favored Glycine 0 N--CA 1.431 -1.677 0 N-CA-C 109.221 -1.552 . . . . 1.55 109.221 172.398 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A 1535 ' ' ARG . . . . . 0.46 ' HE ' ' CD ' ' A' 1557 ' ' GLU . 62.4 ttt180 -81.39 -47.76 12.81 Favored 'General case' 0 C--N 1.304 -1.409 0 CA-C-N 117.395 0.597 . . . . 3.96 110.633 -179.08 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A 1536 ' ' ALA . . . . . . . . . . . . . . . -95.56 -13.53 24.36 Favored 'General case' 0 C--N 1.316 -0.863 0 N-CA-C 108.752 -0.833 . . . . 1.6499999999999999 108.752 177.74 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A 1537 ' ' GLY . . . . . . . . . . . . . . . 73.53 -139.94 27.37 Favored Glycine 0 N--CA 1.436 -1.355 0 CA-C-N 114.581 -1.191 . . . . 1.1899999999999999 112.371 177.244 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A 1538 ' ' PHE . . . . . . . . . . . . . 78.0 m-85 -101.42 152.08 21.16 Favored 'General case' 0 C--N 1.296 -1.734 0 N-CA-C 109.188 -0.671 . . . . 1.6899999999999999 109.188 179.456 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A 1539 ' ' THR . . . . . . . . . . . . . 25.8 m -103.66 115.19 30.04 Favored 'General case' 0 C--N 1.288 -2.09 0 N-CA-C 108.495 -0.928 . . . . 1.48 108.495 179.37 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A 1540 ' ' ALA . . . . . 0.783 ' HB3' HG13 ' A' 1548 ' ' VAL . . . -94.65 149.95 20.72 Favored 'General case' 0 C--N 1.309 -1.177 0 N-CA-C 109.223 -0.658 . . . . 0.82999999999999996 109.223 -177.935 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A 1541 ' ' ALA . . . . . . . . . . . . . . . -87.01 139.07 30.95 Favored 'General case' 0 C--N 1.311 -1.078 0 N-CA-C 109.358 -0.608 . . . . 1.27 109.358 -179.407 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A 1542 ' ' TYR . . . . . 0.556 ' HD2' ' HB2' ' A' 1545 ' ' SER . 42.1 t80 -141.47 173.52 11.42 Favored 'General case' 0 N--CA 1.437 -1.091 0 CA-C-O 119.288 -0.387 . . . . 2.1499999999999999 110.413 -176.813 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A 1543 ' ' SER . . . . . . . . . . . . . 9.5 m -46.92 -152.6 0.0 OUTLIER 'General case' 0 CA--C 1.577 1.995 0 C-N-CA 129.084 2.954 . . . . 2.29 114.07 178.619 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A 1544 ' ' LYS . . . . . . . . . . . . . 57.8 mtpt -45.03 -31.79 1.45 Allowed 'General case' 0 N--CA 1.487 1.389 0 O-C-N 121.088 -1.007 . . . . 3.9100000000000001 112.902 177.121 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A 1545 ' ' SER . . . . . 0.556 ' HB2' ' HD2' ' A' 1542 ' ' TYR . 33.2 m -65.83 -12.68 56.19 Favored 'General case' 0 CA--C 1.562 1.409 0 N-CA-C 112.719 0.637 . . . . 3.2999999999999998 112.719 176.425 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A 1546 ' ' GLY . . . . . . . . . . . . . . . 85.09 -74.2 2.52 Favored Glycine 0 CA--C 1.495 -1.216 0 C-N-CA 121.037 -0.601 . . . . 1.24 113.723 172.812 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A 1547 ' ' VAL . . . . . . . . . . . . . 10.7 m -139.01 156.99 28.52 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.445 0 CA-C-O 121.652 0.739 . . . . 1.6299999999999999 112.145 -176.663 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A 1548 ' ' VAL . . . . . 0.783 HG13 ' HB3' ' A' 1540 ' ' ALA . 2.0 p -134.1 136.24 53.71 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.917 0 CA-C-N 114.766 -1.106 . . . . 0.92000000000000004 108.114 178.924 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A 1549 ' ' TYR . . . . . . . . . . . . . 97.5 m-85 -93.51 141.29 28.63 Favored 'General case' 0 C--N 1.294 -1.835 0 N-CA-C 109.287 -0.634 . . . . 1.4399999999999999 109.287 -179.085 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A 1550 ' ' MET . . . . . . . . . . . . . 42.2 ttm -138.37 121.64 17.01 Favored 'General case' 0 C--N 1.288 -2.083 0 CA-C-N 115.852 -0.613 . . . . 1.74 110.54 -179.261 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A 1551 ' ' SER . . . . . 0.455 ' OG ' ' HA ' ' A' 1556 ' ' ASN . 59.3 m -91.98 122.76 34.79 Favored 'General case' 0 N--CA 1.409 -2.517 0 N-CA-C 105.692 -1.966 . . . . 1.6399999999999999 105.692 172.057 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A 1552 ' ' ILE . . . . . . . . . . . . . 38.6 mm -62.94 -21.53 28.26 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.804 0 CA-C-O 121.777 0.798 . . . . 1.3300000000000001 110.716 -175.323 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A 1553 ' ' CYS . . . . . . . . . . . . . 43.7 t -161.55 138.33 8.45 Favored 'General case' 0 N--CA 1.412 -2.366 0 N-CA-C 106.65 -1.611 . . . . 1.4299999999999999 106.65 175.063 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A 1554 ' ' GLY . . . . . 0.87 ' HA2' ' HE2' ' A' 1579 ' ' LYS . . . 104.71 -150.33 17.13 Favored Glycine 0 N--CA 1.426 -2.026 0 C-N-CA 119.957 -1.116 . . . . 1.1200000000000001 112.305 175.489 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A 1555 ' ' GLU . . . . . . . . . . . . . 7.6 pt-20 -106.96 147.81 29.41 Favored 'General case' 0 C--N 1.293 -1.875 0 C-N-CA 123.088 0.555 . . . . 1.8 109.976 -177.612 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A 1556 ' ' ASN . . . . . 0.455 ' HA ' ' OG ' ' A' 1551 ' ' SER . 5.3 t-20 -98.54 88.88 4.22 Favored 'General case' 0 C--N 1.286 -2.159 0 CA-C-O 121.641 0.734 . . . . 2.6299999999999999 109.07 -175.594 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A 1557 ' ' GLU . . . . . 0.46 ' CD ' ' HE ' ' A' 1535 ' ' ARG . 22.2 mt-10 -79.72 111.47 16.04 Favored 'General case' 0 C--N 1.303 -1.448 0 CA-C-N 115.409 -0.814 . . . . 3.79 111.567 -175.573 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A 1558 ' ' ASN . . . . . . . . . . . . . 5.8 p-10 160.21 -25.1 0.0 OUTLIER 'General case' 0 N--CA 1.475 0.781 0 C-N-CA 127.501 2.32 . . . . 1.52 105.789 -176.556 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A 1559 ' ' CYS . . . . . 0.62 ' HB3' ' HD2' ' A' 1560 ' ' PRO . 93.2 m -118.2 173.86 3.03 Favored Pre-proline 0 N--CA 1.439 -0.992 0 CA-C-O 117.353 -1.308 . . . . 0.83999999999999997 107.605 174.204 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A 1560 ' ' PRO . . . . . 0.62 ' HD2' ' HB3' ' A' 1559 ' ' CYS . 21.3 Cg_exo -35.8 132.14 0.29 Allowed 'Trans proline' 0 C--N 1.378 2.109 0 C-N-CA 123.567 2.844 . . . . 1.1799999999999999 113.88 176.603 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A 1561 ' ' PRO . . . . . . . . . . . . . 19.8 Cg_endo -62.82 120.2 7.61 Favored 'Trans proline' 0 C--O 1.243 0.759 0 C-N-CA 122.792 2.328 . . . . 1.51 113.146 -177.634 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A 1562 ' ' GLY . . . . . . . . . . . . . . . 117.14 7.87 12.14 Favored Glycine 0 N--CA 1.434 -1.458 0 CA-C-N 115.833 -0.621 . . . . 0.71999999999999997 112.669 176.972 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A 1563 ' ' VAL . . . . . . . . . . . . . 6.4 m -101.23 156.74 4.38 Favored 'Isoleucine or valine' 0 C--O 1.205 -1.263 0 N-CA-C 106.885 -1.524 . . . . 0.96999999999999997 106.885 178.118 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A 1564 ' ' GLY . . . . . . . . . . . . . . . -108.71 -23.61 6.45 Favored Glycine 0 C--N 1.311 -0.81 0 C-N-CA 120.213 -0.994 . . . . 0.71999999999999997 112.645 -177.713 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A 1565 ' ' ALA . . . . . . . . . . . . . . . -149.28 137.7 20.87 Favored 'General case' 0 C--N 1.311 -1.088 0 N-CA-C 108.572 -0.899 . . . . 0.37 108.572 -179.721 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A 1566 ' ' CYS . . . . . 0.544 ' SG ' ' HA ' ' A' 1571 ' ' ARG . 35.6 t -157.68 138.05 12.78 Favored 'General case' 0 C--N 1.312 -1.048 0 C-N-CA 121.229 -0.188 . . . . 0.51000000000000001 111.492 -173.9 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A 1567 ' ' PHE . . . . . 0.561 ' HD1' ' HB ' ' A' 1548 ' ' VAL . 22.0 m-85 -67.19 125.27 25.53 Favored 'General case' 0 N--CA 1.471 0.607 0 N-CA-C 108.313 -0.995 . . . . 0.96999999999999997 108.313 177.602 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A 1568 ' ' GLY . . . . . . . . . . . . . . . -58.36 -43.51 95.66 Favored Glycine 0 C--N 1.315 -0.606 0 N-CA-C 117.119 1.608 . . . . 1.0800000000000001 117.119 -168.434 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A 1569 ' ' GLN . . . . . . . . . . . . . 4.0 pt20 -87.51 -34.35 18.66 Favored 'General case' 0 C--N 1.307 -1.274 0 CA-C-N 118.367 1.083 . . . . 2.7400000000000002 113.748 -175.368 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A 1570 ' ' THR . . . . . . . . . . . . . 11.5 p -89.63 -22.36 22.35 Favored 'General case' 0 C--N 1.312 -1.063 0 CA-C-O 121.597 0.713 . . . . 1.96 112.321 -176.447 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A 1571 ' ' ARG . . . . . 0.544 ' HA ' ' SG ' ' A' 1566 ' ' CYS . 94.7 mtt180 59.88 38.89 20.98 Favored 'General case' 0 CA--C 1.515 -0.401 0 CA-C-N 114.523 -1.217 . . . . 3.9500000000000002 113.755 175.295 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A 1572 ' ' ILE . . . . . . . . . . . . . 75.8 mt -98.35 123.44 50.88 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.971 0 CA-C-N 114.416 -1.266 . . . . 1.3700000000000001 107.797 178.201 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A 1573 ' ' SER . . . . . . . . . . . . . 27.3 t -62.91 130.39 44.57 Favored 'General case' 0 C--N 1.318 -0.804 0 O-C-N 123.669 0.606 . . . . 1.0800000000000001 111.446 -178.213 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A 1574 ' ' VAL . . . . . . . . . . . . . 27.7 m -122.87 25.36 3.72 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.402 0 CA-C-O 122.047 0.927 . . . . 1.3 109.898 176.17 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A 1575 ' ' GLY . . . . . . . . . . . . . . . 163.58 128.59 0.96 Allowed Glycine 0 N--CA 1.426 -1.974 0 CA-C-N 114.138 -1.392 . . . . 0.51000000000000001 111.202 177.043 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A 1576 ' ' LYS . . . . . . . . . . . . . 50.5 tptt -77.77 151.19 34.18 Favored 'General case' 0 C--N 1.317 -0.81 0 N-CA-C 106.772 -1.566 . . . . 2.8999999999999999 106.772 178.336 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A 1577 ' ' ALA . . . . . . . . . . . . . . . -67.66 99.79 0.83 Allowed 'General case' 0 C--N 1.321 -0.646 0 CA-C-O 120.963 0.411 . . . . 0.82999999999999996 110.503 -178.705 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A 1578 ' ' ASN . . . . . 0.498 ' H ' ' HD1' ' A' 1592 ' ' TYR . 15.6 m120 -117.44 130.07 56.23 Favored 'General case' 0 C--N 1.302 -1.498 0 N-CA-C 108.736 -0.838 . . . . 1.8500000000000001 108.736 -179.886 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A 1579 ' ' LYS . . . . . 0.87 ' HE2' ' HA2' ' A' 1554 ' ' GLY . 33.5 mmtp -93.44 89.79 6.46 Favored 'General case' 0 C--N 1.292 -1.901 0 N-CA-C 104.545 -2.391 . . . . 1.8999999999999999 104.545 174.745 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A 1580 ' ' ARG . . . . . 0.403 ' O ' ' HA ' ' A' 1590 ' ' LEU . 22.0 ttm180 -148.27 103.52 3.45 Favored 'General case' 0 C--N 1.313 -0.986 0 C-N-CA 119.147 -1.021 . . . . 3.6299999999999999 113.259 -170.219 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A 1581 ' ' LEU . . . . . . . . . . . . . 3.9 mm? -100.75 141.25 33.89 Favored 'General case' 0 C--N 1.31 -1.135 0 CA-C-N 115.691 -0.686 . . . . 1.8700000000000001 110.285 172.99 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A 1582 ' ' ARG . . . . . 0.786 ' HB2' ' HB3' ' A' 1589 ' ' GLN . 93.4 mtt180 -116.55 98.44 6.55 Favored 'General case' 0 C--N 1.285 -2.205 0 N-CA-C 107.055 -1.461 . . . . 3.9700000000000002 107.055 170.923 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A 1583 ' ' TYR . . . . . . . . . . . . . 45.6 t80 -79.18 91.64 4.98 Favored 'General case' 0 C--N 1.295 -1.769 0 N-CA-C 107.522 -1.288 . . . . 1.4099999999999999 107.522 178.697 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A 1584 ' ' VAL . . . . . 0.529 ' O ' HG12 ' A' 1587 ' ' VAL . 11.5 m -117.55 98.29 6.44 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.26 0 CA-C-O 121.547 0.689 . . . . 1.6899999999999999 111.68 -177.346 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A 1585 ' ' ASP . . . . . . . . . . . . . 34.7 t70 53.46 70.38 0.6 Allowed 'General case' 0 C--N 1.313 -1.016 0 C-N-CA 124.348 1.059 . . . . 2.0600000000000001 111.804 -178.021 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A 1586 ' ' GLN . . . . . . . . . . . . . 14.9 mm100 68.72 -14.23 0.29 Allowed 'General case' 0 N--CA 1.481 1.088 0 N-CA-C 115.615 1.709 . . . . 2.3300000000000001 115.615 177.247 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A 1587 ' ' VAL . . . . . 0.529 HG12 ' O ' ' A' 1584 ' ' VAL . 7.5 p -94.84 128.64 45.88 Favored 'Isoleucine or valine' 0 C--O 1.243 0.752 0 C-N-CA 119.159 -1.016 . . . . 0.78000000000000003 110.197 178.837 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A 1588 ' ' LEU . . . . . 0.751 ' HB2' ' HB2' ' A' 1612 ' ' PHE . 3.0 mm? -84.58 124.11 31.07 Favored 'General case' 0 N--CA 1.418 -2.035 0 N-CA-C 106.568 -1.641 . . . . 1.4099999999999999 106.568 173.013 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A 1589 ' ' GLN . . . . . 0.786 ' HB3' ' HB2' ' A' 1582 ' ' ARG . 7.5 tp60 -119.26 107.0 12.88 Favored 'General case' 0 C--N 1.277 -2.556 0 N-CA-C 107.806 -1.183 . . . . 1.24 107.806 -173.874 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A 1590 ' ' LEU . . . . . 0.403 ' HA ' ' O ' ' A' 1580 ' ' ARG . 7.1 tt -105.61 128.59 53.71 Favored 'General case' 0 C--N 1.297 -1.708 0 N-CA-C 108.382 -0.97 . . . . 1.1499999999999999 108.382 -178.215 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A 1591 ' ' VAL . . . . . 0.629 HG12 HG22 ' A' 1609 ' ' VAL . 19.7 m -124.41 122.23 63.52 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.258 0 N-CA-C 112.868 0.692 . . . . 1.51 112.868 -175.409 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A 1592 ' ' TYR . . . . . 0.498 ' HD1' ' H ' ' A' 1578 ' ' ASN . 39.1 m-85 -103.07 98.38 8.33 Favored 'General case' 0 C--N 1.306 -1.3 0 N-CA-C 107.644 -1.243 . . . . 1.0600000000000001 107.644 171.47 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A 1593 ' ' LYS . . . . . . . . . . . . . 21.4 ptmt -102.75 175.67 5.41 Favored 'General case' 0 C--N 1.3 -1.576 0 N-CA-C 109.751 -0.463 . . . . 2.1800000000000002 109.751 -177.323 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A 1594 ' ' ASP . . . . . . . . . . . . . 22.0 m-20 61.22 50.07 5.09 Favored 'General case' 0 N--CA 1.494 1.75 0 N-CA-C 113.792 1.034 . . . . 1.45 113.792 178.68 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A 1595 ' ' GLY . . . . . . . . . . . . . . . -85.85 -106.72 0.73 Allowed Glycine 0 N--CA 1.436 -1.304 0 N-CA-C 110.36 -1.096 . . . . 0.78000000000000003 110.36 175.637 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A 1596 ' ' SER . . . . . . . . . . . . . 69.6 m -99.87 151.87 37.63 Favored Pre-proline 0 C--N 1.297 -1.684 0 N-CA-C 109.364 -0.606 . . . . 1.6799999999999999 109.364 177.438 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A 1597 ' ' PRO . . . . . . . . . . . . . 26.5 Cg_exo -65.28 131.49 28.49 Favored 'Trans proline' 0 C--O 1.24 0.588 0 C-N-CA 123.096 2.531 . . . . 1.1699999999999999 111.416 178.287 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A 1598 ' ' CYS . . . . . 0.453 ' HA ' ' HD3' ' A' 1599 ' ' PRO . 43.2 t -100.24 109.9 58.12 Favored Pre-proline 0 C--N 1.301 -1.532 0 CA-C-N 116.018 -0.537 . . . . 1.1899999999999999 109.779 -178.354 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A 1599 ' ' PRO . . . . . 0.453 ' HD3' ' HA ' ' A' 1598 ' ' CYS . 38.6 Cg_endo -98.02 21.85 0.32 Allowed 'Trans proline' 0 N--CA 1.445 -1.377 0 C-N-CA 123.308 2.672 . . . . 1.5900000000000001 112.527 -179.191 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A 1600 ' ' SER . . . . . . . . . . . . . 16.9 m -73.73 -41.02 63.11 Favored 'General case' 0 C--N 1.313 -0.982 0 CA-C-N 116.571 -0.286 . . . . 2.1200000000000001 111.627 -179.155 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A 1601 ' ' LYS . . . . . . . . . . . . . 87.3 tttt -142.39 -77.64 0.25 Allowed 'General case' 0 C--N 1.318 -0.765 0 CA-C-O 121.259 0.552 . . . . 3.7400000000000002 111.258 -177.632 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A 1602 ' ' SER . . . . . . . . . . . . . 21.1 m -96.07 175.59 6.41 Favored 'General case' 0 C--N 1.3 -1.584 0 CA-C-N 115.294 -0.866 . . . . 3.79 109.055 -177.194 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A 1603 ' ' GLY . . . . . . . . . . . . . . . -75.81 63.62 2.73 Favored Glycine 0 CA--C 1.505 -0.533 0 N-CA-C 109.78 -1.328 . . . . 2.0 109.78 175.276 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A 1604 ' ' LEU . . . . . 0.461 HD13 ' HA ' ' A' 1633 ' ' THR . 2.2 mt -93.52 -174.41 3.48 Favored 'General case' 0 C--N 1.293 -1.883 0 C-N-CA 125.55 1.54 . . . . 1.48 112.184 -173.809 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A 1605 ' ' SER . . . . . . . . . . . . . 34.5 t -140.93 -179.22 5.95 Favored 'General case' 0 N--CA 1.419 -2.017 0 N-CA-C 105.667 -1.975 . . . . 1.51 105.667 179.348 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A 1606 ' ' TYR . . . . . . . . . . . . . 7.1 m-85 -110.06 129.23 55.72 Favored 'General case' 0 CA--C 1.47 -2.101 0 N-CA-C 105.253 -2.129 . . . . 1.1799999999999999 105.253 -179.561 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A 1607 ' ' LYS . . . . . . . . . . . . . 10.0 ptpp? -131.8 138.12 48.41 Favored 'General case' 0 N--CA 1.411 -2.41 0 C-N-CA 118.495 -1.282 . . . . 1.6699999999999999 110.437 179.867 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A 1608 ' ' SER . . . . . 0.77 ' HA ' ' HB2' ' A' 1636 ' ' LEU . 50.1 m -98.83 114.32 26.83 Favored 'General case' 0 C--N 1.295 -1.79 0 N-CA-C 109.158 -0.682 . . . . 1.0 109.158 177.71 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A 1609 ' ' VAL . . . . . 0.629 HG22 HG12 ' A' 1591 ' ' VAL . 85.9 t -109.3 118.28 56.3 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.054 0 N-CA-C 108.884 -0.784 . . . . 0.93000000000000005 108.884 -179.677 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A 1610 ' ' ILE . . . . . 0.593 HG13 ' HB2' ' A' 1638 ' ' PHE . 3.3 mp -111.29 116.66 53.1 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.318 0 N-CA-C 109.261 -0.644 . . . . 0.78000000000000003 109.261 179.58 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A 1611 ' ' SER . . . . . . . . . . . . . 30.3 p -92.46 117.14 29.63 Favored 'General case' 0 N--CA 1.423 -1.8 0 CA-C-N 115.706 -0.679 . . . . 1.29 109.447 177.076 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A 1612 ' ' PHE . . . . . 0.751 ' HB2' ' HB2' ' A' 1588 ' ' LEU . 96.0 m-85 -89.78 103.7 16.33 Favored 'General case' 0 C--N 1.299 -1.629 0 CA-C-N 116.05 -0.523 . . . . 0.69999999999999996 110.563 -179.393 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A 1613 ' ' VAL . . . . . 0.602 ' O ' ' HA ' ' A' 1641 ' ' HIS . 11.9 t -107.6 145.12 15.28 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.452 0 N-CA-C 106.871 -1.529 . . . . 0.75 106.871 -179.011 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A 1614 ' ' CYS . . . . . . . . . . . . . 34.2 m -89.65 93.75 9.59 Favored 'General case' 0 C--N 1.294 -1.836 0 N-CA-C 113.536 0.939 . . . . 1.3899999999999999 113.536 -169.977 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A 1615 ' ' ARG . . . . . 0.896 ' HB3' ' HB3' ' A' 1641 ' ' HIS . 21.3 tpp180 -138.09 112.33 8.77 Favored Pre-proline 0 C--N 1.316 -0.87 0 N-CA-C 109.368 -0.604 . . . . 3.75 109.368 176.195 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A 1616 ' ' PRO . . . . . 0.589 ' HA ' ' HD3' ' A' 1643 ' ' PRO . 11.4 Cg_endo -55.07 -20.36 23.39 Favored 'Trans proline' 0 CA--C 1.562 1.876 0 C-N-CA 123.927 3.085 . . . . 1.3200000000000001 116.259 -178.352 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A 1617 ' ' GLU . . . . . 0.728 ' HG2' ' HG3' ' A' 1615 ' ' ARG . 11.4 pt-20 . . . . . 0 N--CA 1.478 0.939 0 N-CA-C 113.82 1.045 . . . . 3.21 113.82 -177.812 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A 1622 ' ' ASN . . . . . . . . . . . . . 23.6 t-20 . . . . . 0 CA--C 1.501 -0.906 0 N-CA-C 112.925 0.713 . . . . 2.9199999999999999 112.925 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A 1623 ' ' ARG . . . . . 0.559 ' HB2' ' HD2' ' A' 1624 ' ' PRO . 0.0 OUTLIER -61.18 167.69 3.61 Favored Pre-proline 0 C--N 1.292 -1.924 0 CA-C-N 113.412 -1.722 . . . . 3.6099999999999999 113.236 -173.478 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A 1624 ' ' PRO . . . . . 0.652 ' HB3' ' HB2' ' A' 1640 ' ' TRP . 11.6 Cg_endo -57.46 159.3 16.68 Favored 'Trans proline' 0 C--N 1.369 1.606 0 C-N-CA 123.02 2.48 . . . . 2.3700000000000001 113.209 175.867 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A 1625 ' ' MET . . . . . . . . . . . . . 26.5 ptt? -125.41 148.42 48.81 Favored 'General case' 0 C--N 1.311 -1.093 0 CA-C-N 116.094 -0.503 . . . . 2.1600000000000001 110.003 -179.766 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A 1626 ' ' LEU . . . . . 0.436 HD21 ' HB2' ' A' 1629 ' ' LEU . 38.2 tp -77.68 116.11 17.96 Favored 'General case' 0 C--N 1.309 -1.173 0 N-CA-C 107.794 -1.187 . . . . 1.3500000000000001 107.794 175.513 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A 1627 ' ' ILE . . . . . . . . . . . . . 25.0 pt -93.02 -30.05 4.46 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.22 0 C-N-CA 120.45 -0.5 . . . . 1.21 111.178 -179.107 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A 1628 ' ' SER . . . . . . . . . . . . . 37.4 m -155.18 154.07 31.71 Favored 'General case' 0 C--N 1.313 -0.988 0 N-CA-C 109.015 -0.735 . . . . 1.3999999999999999 109.015 -178.317 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A 1629 ' ' LEU . . . . . 0.539 HD13 HD13 ' A' 1636 ' ' LEU . 45.2 tp -145.95 114.43 6.74 Favored 'General case' 0 C--N 1.301 -1.52 0 CA-C-O 121.24 0.543 . . . . 1.5600000000000001 109.946 178.892 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A 1630 ' ' ASP . . . . . . . . . . . . . 27.6 t70 -112.75 102.07 10.13 Favored 'General case' 0 C--N 1.298 -1.633 0 N-CA-C 108.408 -0.96 . . . . 0.87 108.408 179.447 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A 1631 ' ' LYS . . . . . . . . . . . . . 60.1 mttp -73.58 -18.01 61.11 Favored 'General case' 0 C--N 1.316 -0.853 0 N-CA-C 112.182 0.438 . . . . 2.3500000000000001 112.182 -177.52 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A 1632 ' ' GLN . . . . . . . . . . . . . 7.6 tp-100 -64.65 -45.14 88.04 Favored 'General case' 0 N--CA 1.451 -0.39 0 CA-C-O 120.885 0.374 . . . . 2.5499999999999998 110.668 178.632 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A 1633 ' ' THR . . . . . 0.461 ' HA ' HD13 ' A' 1604 ' ' LEU . 40.9 p -99.23 -2.02 37.7 Favored 'General case' 0 C--N 1.316 -0.849 0 CA-C-O 121.467 0.651 . . . . 1.24 111.226 177.858 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A 1634 ' ' CYS . . . . . . . . . . . . . 82.8 m 56.68 40.29 29.31 Favored 'General case' 0 C--O 1.235 0.298 0 CA-C-N 114.539 -1.21 . . . . 0.89000000000000001 111.362 -179.853 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A 1635 ' ' THR . . . . . . . . . . . . . 25.1 m -99.03 119.56 38.0 Favored 'General case' 0 N--CA 1.423 -1.8 0 CA-C-N 114.921 -1.036 . . . . 0.75 109.826 -177.583 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A 1636 ' ' LEU . . . . . 0.77 ' HB2' ' HA ' ' A' 1608 ' ' SER . 2.7 mm? -90.85 107.94 19.52 Favored 'General case' 0 C--N 1.311 -1.086 0 N-CA-C 108.454 -0.943 . . . . 1.3300000000000001 108.454 178.648 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A 1637 ' ' PHE . . . . . . . . . . . . . 96.5 m-85 -95.88 100.16 11.88 Favored 'General case' 0 C--O 1.244 0.815 0 CA-C-O 120.853 0.359 . . . . 0.82999999999999996 110.611 -178.79 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A 1638 ' ' PHE . . . . . 0.593 ' HB2' HG13 ' A' 1610 ' ' ILE . 96.7 m-85 -108.76 156.19 19.89 Favored 'General case' 0 C--N 1.298 -1.634 0 CA-C-O 121.364 0.602 . . . . 0.59999999999999998 109.987 177.852 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A 1639 ' ' SER . . . . . . . . . . . . . 32.9 t -143.34 130.84 21.12 Favored 'General case' 0 C--N 1.285 -2.218 0 N-CA-C 108.593 -0.892 . . . . 1.0800000000000001 108.593 176.172 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A 1640 ' ' TRP . . . . . 0.724 ' HE3' ' HE1' ' A' 1612 ' ' PHE . 9.5 t90 -115.92 111.46 20.45 Favored 'General case' 0 N--CA 1.409 -2.485 0 N-CA-C 107.635 -1.246 . . . . 0.80000000000000004 107.635 175.696 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A 1641 ' ' HIS . . . . . 0.896 ' HB3' ' HB3' ' A' 1615 ' ' ARG . 47.3 m-70 -89.76 105.3 17.71 Favored 'General case' 0 N--CA 1.422 -1.869 0 N-CA-C 107.167 -1.42 . . . . 2.54 107.167 175.88 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A 1642 ' ' THR . . . . . . . . . . . . . 6.1 t -142.8 146.12 36.56 Favored Pre-proline 0 C--N 1.287 -2.127 0 CA-C-N 115.846 -0.616 . . . . 1.1499999999999999 109.914 -175.322 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A 1643 ' ' PRO . . . . . 0.589 ' HD3' ' HA ' ' A' 1616 ' ' PRO . 71.6 Cg_endo -76.65 -4.69 15.28 Favored 'Trans proline' 0 C--N 1.352 0.725 0 C-N-CA 122.694 2.263 . . . . 0.80000000000000004 110.495 175.775 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A 1644 ' ' LEU . . . . . . . . . . . . . 81.9 mt -86.67 -7.63 58.14 Favored 'General case' 0 N--CA 1.447 -0.621 0 CA-C-N 115.234 -0.894 . . . . 1.54 109.489 177.217 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A 1645 ' ' ALA . . . . . . . . . . . . . . . -78.97 -42.58 26.42 Favored 'General case' 0 C--O 1.222 -0.366 0 N-CA-C 107.996 -1.112 . . . . 0.94999999999999996 107.996 176.716 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A 1646 ' ' CYS . . . . . . . . . . . . . 13.5 p -176.11 154.83 1.47 Allowed 'General case' 0 N--CA 1.432 -1.344 0 N-CA-C 104.362 -2.459 . . . . 1.4099999999999999 104.362 172.639 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A 1647 ' ' GLU . . . . . . . . . . . . . 42.8 mt-10 . . . . . 0 C--N 1.288 -2.108 0 N-CA-C 108.506 -0.924 . . . . 2.9199999999999999 108.506 -179.685 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A 1515 ' ' ASP . . . . . 0.477 ' HA ' ' HD2' ' A' 1579 ' ' LYS . 31.4 t70 . . . . . 0 N--CA 1.427 -1.605 0 N-CA-C 105.991 -1.855 . . . . 2.54 105.991 . . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A 1516 ' ' CYS . . . . . . . . . . . . . 61.1 m -75.14 51.04 0.51 Allowed 'General case' 0 C--N 1.318 -0.769 0 CA-C-O 121.489 0.661 . . . . 1.25 111.455 -178.301 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A 1517 ' ' GLN . . . . . 0.464 ' HA ' ' HA ' ' A' 1528 ' ' ASP . 11.3 pt20 -137.9 154.69 49.41 Favored 'General case' 0 N--CA 1.413 -2.307 0 N-CA-C 106.949 -1.5 . . . . 1.8799999999999999 106.949 178.55 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A 1518 ' ' VAL . . . . . . . . . . . . . 7.7 p -148.58 137.94 15.81 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.741 0 O-C-N 123.178 0.299 . . . . 1.73 110.913 -174.893 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A 1519 ' ' THR . . . . . . . . . . . . . 8.4 m -103.66 102.76 12.62 Favored 'General case' 0 N--CA 1.429 -1.523 0 N-CA-C 107.901 -1.148 . . . . 1.7 107.901 178.713 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A 1520 ' ' ASN . . . . . . . . . . . . . 24.7 t30 -71.61 114.65 30.09 Favored Pre-proline 0 C--N 1.319 -0.72 0 C-N-CA 121.021 -0.272 . . . . 2.1200000000000001 110.281 -179.049 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A 1521 ' ' PRO . . . . . . . . . . . . . 55.9 Cg_endo -68.27 -9.63 26.47 Favored 'Trans proline' 0 C--N 1.357 1.018 0 C-N-CA 122.688 2.259 . . . . 2.4700000000000002 113.486 -174.797 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A 1522 ' ' SER . . . . . . . . . . . . . 15.1 m -79.21 -23.59 43.7 Favored 'General case' 0 N--CA 1.435 -1.18 0 CA-C-N 116.694 -0.23 . . . . 2.5699999999999998 111.249 178.991 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A 1523 ' ' THR . . . . . . . . . . . . . 7.0 t -137.5 -15.93 1.39 Allowed 'General case' 0 CA--C 1.549 0.913 0 N-CA-C 112.712 0.634 . . . . 2.1499999999999999 112.712 -177.893 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A 1524 ' ' GLY . . . . . . . . . . . . . . . 84.6 -5.38 81.74 Favored Glycine 0 N--CA 1.45 -0.417 0 O-C-N 121.982 -0.449 . . . . 1.8899999999999999 113.182 179.024 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A 1525 ' ' HIS . . . . . . . . . . . . . 11.7 t60 -73.01 135.71 44.97 Favored 'General case' 0 C--N 1.311 -1.081 0 CA-C-O 121.113 0.482 . . . . 1.8999999999999999 110.091 -177.403 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A 1526 ' ' LEU . . . . . . . . . . . . . 3.5 tm? -95.34 121.65 37.22 Favored 'General case' 0 C--N 1.306 -1.285 0 CA-C-N 114.905 -1.043 . . . . 1.6100000000000001 108.407 -179.918 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A 1527 ' ' PHE . . . . . 0.551 ' CE1' ' HA ' ' A' 1646 ' ' CYS . 78.7 m-85 -106.6 149.23 27.4 Favored 'General case' 0 C--N 1.292 -1.914 0 N-CA-C 107.352 -1.351 . . . . 1.4199999999999999 107.352 177.574 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A 1528 ' ' ASP . . . . . 0.464 ' HA ' ' HA ' ' A' 1517 ' ' GLN . 1.2 p30 -143.29 148.21 35.99 Favored 'General case' 0 CA--C 1.484 -1.566 0 CA-C-O 121.371 0.605 . . . . 2.1800000000000002 109.82 177.287 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A 1529 ' ' LEU . . . . . . . . . . . . . 88.7 mt -117.07 -6.05 11.39 Favored 'General case' 0 C--N 1.284 -2.255 0 CA-C-N 114.002 -1.454 . . . . 1.4399999999999999 107.371 175.338 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A 1530 ' ' SER . . . . . . . . . . . . . 11.5 m -66.42 -41.67 88.87 Favored 'General case' 0 N--CA 1.432 -1.33 0 CA-C-N 114.315 -1.311 . . . . 1.4399999999999999 111.624 -175.556 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A 1531 ' ' SER . . . . . . . . . . . . . 13.6 t -87.35 -16.18 35.76 Favored 'General case' 0 N--CA 1.438 -1.067 0 N-CA-C 109.027 -0.731 . . . . 1.5 109.027 -178.77 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A 1532 ' ' LEU . . . . . 0.437 HD13 HD13 ' A' 1644 ' ' LEU . 80.2 mt -76.15 -36.26 58.84 Favored 'General case' 0 CA--C 1.521 -0.173 0 CA-C-N 115.854 -0.612 . . . . 1.77 111.068 179.362 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A 1533 ' ' SER . . . . . 0.572 ' HB2' ' HB ' ' A' 1552 ' ' ILE . 25.7 t -80.29 133.74 36.0 Favored 'General case' 0 C--N 1.304 -1.41 0 CA-C-N 115.914 -0.585 . . . . 2.3799999999999999 110.349 -178.041 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A 1534 ' ' GLY . . . . . . . . . . . . . . . -91.47 160.01 26.47 Favored Glycine 0 N--CA 1.441 -1.022 0 N-CA-C 109.092 -1.603 . . . . 1.55 109.092 174.797 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A 1535 ' ' ARG . . . . . . . . . . . . . 29.0 ttp180 -70.82 -19.77 62.63 Favored 'General case' 0 C--N 1.318 -0.761 0 CA-C-N 117.961 0.88 . . . . 3.96 110.927 -175.911 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A 1536 ' ' ALA . . . . . . . . . . . . . . . -90.26 -9.7 46.97 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-O 121.375 0.607 . . . . 1.6499999999999999 109.666 177.302 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A 1537 ' ' GLY . . . . . . . . . . . . . . . 80.61 -169.44 52.36 Favored Glycine 0 N--CA 1.422 -2.277 0 CA-C-N 115.123 -0.944 . . . . 1.1899999999999999 110.962 -177.09 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A 1538 ' ' PHE . . . . . . . . . . . . . 17.3 m-85 -120.33 170.16 9.62 Favored 'General case' 0 C--N 1.285 -2.233 0 N-CA-C 108.286 -1.005 . . . . 1.6899999999999999 108.286 177.517 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A 1539 ' ' THR . . . . . 0.506 ' HA ' ' O ' ' A' 1548 ' ' VAL . 23.5 p -120.98 118.3 29.49 Favored 'General case' 0 C--N 1.289 -2.028 0 CA-C-N 116.223 -0.444 . . . . 1.48 110.454 -179.433 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A 1540 ' ' ALA . . . . . . . . . . . . . . . -93.24 143.66 26.05 Favored 'General case' 0 C--N 1.305 -1.333 0 N-CA-C 107.323 -1.362 . . . . 0.82999999999999996 107.323 175.449 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A 1541 ' ' ALA . . . . . . . . . . . . . . . -84.68 70.08 10.73 Favored 'General case' 0 C--N 1.298 -1.633 0 N-CA-C 112.658 0.614 . . . . 1.27 112.658 -173.282 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A 1542 ' ' TYR . . . . . . . . . . . . . 16.4 t80 -157.06 112.76 2.89 Favored 'General case' 0 C--O 1.208 -1.079 0 N-CA-C 113.386 0.884 . . . . 2.1499999999999999 113.386 176.511 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A 1543 ' ' SER . . . . . 0.582 ' HB3' ' N ' ' A' 1546 ' ' GLY . 43.4 t -138.42 -153.61 0.48 Allowed 'General case' 0 C--N 1.263 -3.159 0 N-CA-C 103.467 -2.79 . . . . 2.29 103.467 162.03 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A 1544 ' ' LYS . . . . . . . . . . . . . 96.1 mttt -66.22 -50.34 64.14 Favored 'General case' 0 C--N 1.303 -1.44 0 N-CA-C 106.354 -1.721 . . . . 3.9100000000000001 106.354 170.275 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A 1545 ' ' SER . . . . . . . . . . . . . 17.6 t -134.41 25.98 3.79 Favored 'General case' 0 CA--C 1.562 1.442 0 CA-C-N 115.166 -0.925 . . . . 3.2999999999999998 110.013 175.597 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A 1546 ' ' GLY . . . . . 0.582 ' N ' ' HB3' ' A' 1543 ' ' SER . . . -138.09 -118.05 1.62 Allowed Glycine 0 CA--C 1.529 0.96 0 C-N-CA 118.027 -2.035 . . . . 1.24 117.316 -170.524 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A 1547 ' ' VAL . . . . . . . . . . . . . 14.0 m -159.21 169.34 0.53 Allowed 'Isoleucine or valine' 0 C--O 1.255 1.382 0 C-N-CA 124.256 1.022 . . . . 1.6299999999999999 110.876 -165.581 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A 1548 ' ' VAL . . . . . 0.506 ' O ' ' HA ' ' A' 1539 ' ' THR . 3.5 t -124.87 135.57 63.58 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.628 0 N-CA-C 107.787 -1.19 . . . . 0.92000000000000004 107.787 178.625 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A 1549 ' ' TYR . . . . . . . . . . . . . 22.7 m-85 -92.16 114.92 27.59 Favored 'General case' 0 CA--C 1.502 -0.869 0 N-CA-C 105.711 -1.959 . . . . 1.4399999999999999 105.711 172.52 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A 1550 ' ' MET . . . . . . . . . . . . . 19.8 ptm -144.66 127.8 16.64 Favored 'General case' 0 C--N 1.283 -2.294 0 C-N-CA 119.601 -0.84 . . . . 1.74 111.653 -176.744 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A 1551 ' ' SER . . . . . . . . . . . . . 51.0 m -86.68 135.3 33.44 Favored 'General case' 0 C--N 1.285 -2.236 0 N-CA-C 107.805 -1.183 . . . . 1.6399999999999999 107.805 177.812 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A 1552 ' ' ILE . . . . . 0.572 ' HB ' ' HB2' ' A' 1533 ' ' SER . 27.8 mm -75.97 -13.16 14.82 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.959 0 CA-C-O 122.363 1.078 . . . . 1.3300000000000001 108.471 -175.181 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A 1553 ' ' CYS . . . . . . . . . . . . . 33.1 t -161.33 137.95 8.46 Favored 'General case' 0 N--CA 1.421 -1.918 0 N-CA-C 106.957 -1.497 . . . . 1.4299999999999999 106.957 174.54 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A 1554 ' ' GLY . . . . . . . . . . . . . . . 86.99 -166.56 37.19 Favored Glycine 0 N--CA 1.435 -1.371 0 C-N-CA 120.857 -0.687 . . . . 1.1200000000000001 114.015 174.18 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A 1555 ' ' GLU . . . . . . . . . . . . . 13.5 pt-20 -86.74 154.57 20.85 Favored 'General case' 0 C--N 1.313 -1.01 0 CA-C-O 121.384 0.612 . . . . 1.8 111.129 -178.192 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A 1556 ' ' ASN . . . . . . . . . . . . . 20.4 t-20 -108.91 112.5 24.76 Favored 'General case' 0 C--N 1.301 -1.524 0 N-CA-C 109.259 -0.645 . . . . 2.6299999999999999 109.259 178.341 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A 1557 ' ' GLU . . . . . . . . . . . . . 7.9 mt-10 -83.21 40.41 0.71 Allowed 'General case' 0 C--N 1.309 -1.176 0 CA-C-O 121.066 0.46 . . . . 3.79 112.198 -173.017 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A 1558 ' ' ASN . . . . . . . . . . . . . 34.6 m-80 -126.89 -0.78 6.62 Favored 'General case' 0 C--N 1.307 -1.249 0 CA-C-O 121.291 0.567 . . . . 1.52 110.079 179.648 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A 1559 ' ' CYS . . . . . 0.738 ' HB3' ' HD2' ' A' 1560 ' ' PRO . 67.5 m -147.11 177.8 1.65 Allowed Pre-proline 0 C--N 1.309 -1.172 0 CA-C-O 116.884 -1.532 . . . . 0.83999999999999997 107.162 179.594 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A 1560 ' ' PRO . . . . . 0.738 ' HD2' ' HB3' ' A' 1559 ' ' CYS . 3.4 Cg_exo -36.13 122.84 0.29 Allowed 'Trans proline' 0 C--N 1.385 2.469 0 C-N-CA 124.107 3.205 . . . . 1.1799999999999999 114.038 178.917 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A 1561 ' ' PRO . . . . . . . . . . . . . 56.4 Cg_exo -53.82 107.64 0.22 Allowed 'Trans proline' 0 C--O 1.254 1.31 0 C-N-CA 123.482 2.788 . . . . 1.51 112.698 -179.053 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A 1562 ' ' GLY . . . . . . . . . . . . . . . 134.12 -11.56 4.75 Favored Glycine 0 N--CA 1.43 -1.707 0 CA-C-N 115.306 -0.861 . . . . 0.71999999999999997 111.84 179.263 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A 1563 ' ' VAL . . . . . 0.553 ' HA ' ' HA ' ' A' 1576 ' ' LYS . 15.1 m -88.17 144.11 9.85 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.247 0 CA-C-O 120.965 0.412 . . . . 0.96999999999999997 109.922 179.739 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A 1564 ' ' GLY . . . . . . . . . . . . . . . -100.74 -26.43 8.03 Favored Glycine 0 C--N 1.306 -1.106 0 N-CA-C 110.725 -0.95 . . . . 0.71999999999999997 110.725 179.796 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A 1565 ' ' ALA . . . . . . . . . . . . . . . -138.59 141.18 39.2 Favored 'General case' 0 N--CA 1.439 -0.986 0 N-CA-C 109.045 -0.724 . . . . 0.37 109.045 179.533 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A 1566 ' ' CYS . . . . . . . . . . . . . 39.8 t -158.7 133.04 7.92 Favored 'General case' 0 C--N 1.3 -1.546 0 N-CA-C 108.106 -1.072 . . . . 0.51000000000000001 108.106 -176.955 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A 1567 ' ' PHE . . . . . . . . . . . . . 86.3 m-85 -63.63 123.62 19.3 Favored 'General case' 0 C--O 1.208 -1.126 0 N-CA-C 107.508 -1.293 . . . . 0.96999999999999997 107.508 178.305 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A 1568 ' ' GLY . . . . . 0.436 ' H ' ' HA ' ' A' 1548 ' ' VAL . . . -82.91 -24.85 51.6 Favored Glycine 0 CA--C 1.487 -1.676 0 C-N-CA 120.244 -0.979 . . . . 1.0800000000000001 112.986 -171.654 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A 1569 ' ' GLN . . . . . . . . . . . . . 22.0 tp60 -81.89 -38.29 25.56 Favored 'General case' 0 C--N 1.298 -1.648 0 CA-C-O 122.096 0.95 . . . . 2.7400000000000002 108.736 179.391 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A 1570 ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -93.13 -22.28 19.18 Favored 'General case' 0 C--N 1.295 -1.77 0 CA-C-N 114.354 -1.294 . . . . 1.96 112.157 -171.727 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A 1571 ' ' ARG . . . . . . . . . . . . . 50.9 mtt180 63.31 38.01 10.58 Favored 'General case' 0 N--CA 1.47 0.547 0 C-N-CA 125.54 1.536 . . . . 3.9500000000000002 112.411 -179.256 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A 1572 ' ' ILE . . . . . . . . . . . . . 48.1 mm -118.08 126.05 74.66 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.934 0 CA-C-N 114.849 -1.069 . . . . 1.3700000000000001 108.864 -177.028 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A 1573 ' ' SER . . . . . . . . . . . . . 45.8 t -62.17 134.63 56.81 Favored 'General case' 0 C--N 1.307 -1.277 0 C-N-CA 123.87 0.868 . . . . 1.0800000000000001 111.782 -177.578 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A 1574 ' ' VAL . . . . . . . . . . . . . 92.6 t -97.69 -50.61 11.14 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.426 0 CA-C-N 115.313 -0.858 . . . . 1.3 109.174 -179.622 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A 1575 ' ' GLY . . . . . . . . . . . . . . . -160.55 150.38 20.35 Favored Glycine 0 N--CA 1.432 -1.616 0 C-N-CA 120.38 -0.914 . . . . 0.51000000000000001 112.117 -176.895 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A 1576 ' ' LYS . . . . . 0.553 ' HA ' ' HA ' ' A' 1563 ' ' VAL . 64.8 tttm -78.7 146.54 33.9 Favored 'General case' 0 C--N 1.311 -1.084 0 N-CA-C 108.714 -0.847 . . . . 2.8999999999999999 108.714 -179.47 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A 1577 ' ' ALA . . . . . . . . . . . . . . . -69.09 90.81 0.47 Allowed 'General case' 0 C--N 1.319 -0.73 0 C-N-CA 123.783 0.833 . . . . 0.82999999999999996 112.047 -176.03 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A 1578 ' ' ASN . . . . . . . . . . . . . 43.6 m-80 -103.73 113.75 27.5 Favored 'General case' 0 C--N 1.303 -1.42 0 N-CA-C 108.549 -0.908 . . . . 1.8500000000000001 108.549 176.9 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A 1579 ' ' LYS . . . . . 0.477 ' HD2' ' HA ' ' A' 1515 ' ' ASP . 35.9 ttpt -89.7 89.99 8.03 Favored 'General case' 0 C--N 1.295 -1.764 0 CA-C-O 122.223 1.011 . . . . 1.8999999999999999 109.152 -176.713 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A 1580 ' ' ARG . . . . . . . . . . . . . 27.4 tpt180 -161.3 111.84 1.7 Allowed 'General case' 0 N--CA 1.424 -1.766 0 CA-C-N 113.747 -1.57 . . . . 3.6299999999999999 109.236 -178.007 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A 1581 ' ' LEU . . . . . . . . . . . . . 3.6 pp -117.75 160.94 20.51 Favored 'General case' 0 N--CA 1.413 -2.295 0 CA-C-N 114.991 -1.004 . . . . 1.8700000000000001 108.647 176.56 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A 1582 ' ' ARG . . . . . . . . . . . . . 18.0 ttp85 -140.78 138.02 33.81 Favored 'General case' 0 C--N 1.291 -1.95 0 N-CA-C 108.519 -0.919 . . . . 3.9700000000000002 108.519 176.059 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A 1583 ' ' TYR . . . . . . . . . . . . . 70.0 t80 -102.65 96.6 6.99 Favored 'General case' 0 C--N 1.303 -1.429 0 N-CA-C 107.694 -1.224 . . . . 1.4099999999999999 107.694 179.788 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A 1584 ' ' VAL . . . . . 0.472 ' O ' HG12 ' A' 1587 ' ' VAL . 6.0 p -121.85 105.8 17.0 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.505 0 CA-C-N 116.123 -0.49 . . . . 1.6899999999999999 111.802 -175.581 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A 1585 ' ' ASP . . . . . . . . . . . . . 37.0 t70 61.46 61.19 1.54 Allowed 'General case' 0 C--N 1.319 -0.739 0 CA-C-O 122.356 1.074 . . . . 2.0600000000000001 111.115 178.38 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A 1586 ' ' GLN . . . . . . . . . . . . . 47.8 mt-30 62.62 8.75 3.11 Favored 'General case' 0 N--CA 1.478 0.941 0 CA-C-N 114.244 -1.344 . . . . 2.3300000000000001 114.258 178.322 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A 1587 ' ' VAL . . . . . 0.472 HG12 ' O ' ' A' 1584 ' ' VAL . 11.7 p -122.07 125.43 73.04 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.242 0 C-N-CA 119.204 -0.998 . . . . 0.78000000000000003 110.548 178.496 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A 1588 ' ' LEU . . . . . 0.675 ' HB2' ' HB2' ' A' 1612 ' ' PHE . 57.6 mt -83.22 126.24 32.43 Favored 'General case' 0 C--N 1.3 -1.552 0 CA-C-N 114.919 -1.037 . . . . 1.4099999999999999 109.061 173.826 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A 1589 ' ' GLN . . . . . . . . . . . . . 36.0 tt0 -118.85 117.44 28.86 Favored 'General case' 0 C--N 1.284 -2.248 0 CA-C-N 115.736 -0.666 . . . . 1.24 109.291 -178.475 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A 1590 ' ' LEU . . . . . . . . . . . . . 7.3 tt -124.6 132.83 53.41 Favored 'General case' 0 C--N 1.307 -1.248 0 N-CA-C 106.847 -1.538 . . . . 1.1499999999999999 106.847 176.611 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A 1591 ' ' VAL . . . . . 0.432 HG22 HG22 ' A' 1609 ' ' VAL . 39.0 t -127.42 137.68 57.01 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.704 0 CA-C-O 120.69 0.281 . . . . 1.51 111.309 -174.092 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A 1592 ' ' TYR . . . . . . . . . . . . . 57.9 m-85 -115.07 124.64 52.11 Favored 'General case' 0 C--N 1.314 -0.962 0 N-CA-C 107.262 -1.384 . . . . 1.0600000000000001 107.262 171.231 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A 1593 ' ' LYS . . . . . . . . . . . . . 13.3 ptmm? -137.98 172.86 12.3 Favored 'General case' 0 C--N 1.302 -1.484 0 C-N-CA 121.149 -0.22 . . . . 2.1800000000000002 111.263 -177.111 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A 1594 ' ' ASP . . . . . . . . . . . . . 17.3 m-20 66.37 48.0 1.65 Allowed 'General case' 0 C--O 1.247 0.935 0 C-N-CA 125.313 1.445 . . . . 1.45 111.875 179.082 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A 1595 ' ' GLY . . . . . . . . . . . . . . . -89.93 -106.98 1.23 Allowed Glycine 0 N--CA 1.44 -1.04 0 N-CA-C 110.877 -0.889 . . . . 0.78000000000000003 110.877 175.832 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A 1596 ' ' SER . . . . . 0.421 ' HA ' ' HD3' ' A' 1597 ' ' PRO . 19.9 m -101.89 152.08 38.09 Favored Pre-proline 0 C--N 1.296 -1.741 0 N-CA-C 109.732 -0.47 . . . . 1.6799999999999999 109.732 179.214 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A 1597 ' ' PRO . . . . . 0.421 ' HD3' ' HA ' ' A' 1596 ' ' SER . 22.6 Cg_exo -66.79 141.35 59.07 Favored 'Trans proline' 0 C--N 1.353 0.797 0 C-N-CA 123.203 2.602 . . . . 1.1699999999999999 112.018 178.88 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A 1598 ' ' CYS . . . . . 0.635 ' O ' ' HA ' ' A' 1602 ' ' SER . 42.2 t -95.86 136.39 22.27 Favored Pre-proline 0 C--N 1.287 -2.136 0 CA-C-N 115.505 -0.771 . . . . 1.1899999999999999 109.011 179.993 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A 1599 ' ' PRO . . . . . . . . . . . . . 63.3 Cg_endo -75.08 -18.01 18.91 Favored 'Trans proline' 0 C--N 1.36 1.149 0 C-N-CA 123.11 2.54 . . . . 1.5900000000000001 112.198 177.751 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A 1600 ' ' SER . . . . . . . . . . . . . 34.2 m -86.63 112.54 21.7 Favored 'General case' 0 N--CA 1.425 -1.721 0 N-CA-C 107.037 -1.468 . . . . 2.1200000000000001 107.037 176.592 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A 1601 ' ' LYS . . . . . 0.435 ' HD3' ' HA ' ' A' 1601 ' ' LYS . 42.9 mmtm 56.23 55.79 6.4 Favored 'General case' 0 C--O 1.242 0.694 0 CA-C-O 122.477 1.132 . . . . 3.7400000000000002 108.542 -173.215 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A 1602 ' ' SER . . . . . 0.635 ' HA ' ' O ' ' A' 1598 ' ' CYS . 15.0 t -49.11 122.77 6.28 Favored 'General case' 0 N--CA 1.442 -0.865 0 CA-C-N 112.781 -2.009 . . . . 3.79 112.108 -172.693 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A 1603 ' ' GLY . . . . . . . . . . . . . . . 140.02 -23.58 2.74 Favored Glycine 0 N--CA 1.43 -1.726 0 N-CA-C 109.131 -1.588 . . . . 2.0 109.131 -176.61 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A 1604 ' ' LEU . . . . . . . . . . . . . 72.3 mt -85.33 152.45 23.27 Favored 'General case' 0 C--N 1.309 -1.183 0 CA-C-N 114.733 -0.734 . . . . 1.48 109.473 177.502 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A 1605 ' ' SER . . . . . . . . . . . . . 49.1 m -101.7 175.54 5.52 Favored 'General case' 0 C--N 1.282 -2.341 0 N-CA-C 105.933 -1.877 . . . . 1.51 105.933 169.094 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A 1606 ' ' TYR . . . . . . . . . . . . . 78.5 m-85 -94.76 149.69 20.98 Favored 'General case' 0 CA--C 1.466 -2.28 0 N-CA-C 106.133 -1.803 . . . . 1.1799999999999999 106.133 -177.583 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A 1607 ' ' LYS . . . . . 0.436 ' HG3' HG23 ' A' 1635 ' ' THR . 23.2 pttm -135.67 132.18 36.64 Favored 'General case' 0 N--CA 1.401 -2.915 0 C-N-CA 118.377 -1.329 . . . . 1.6699999999999999 110.123 175.243 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A 1608 ' ' SER . . . . . . . . . . . . . 29.3 p -106.9 112.15 24.98 Favored 'General case' 0 C--N 1.288 -2.08 0 CA-C-N 116.277 -0.419 . . . . 1.0 110.376 -179.232 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A 1609 ' ' VAL . . . . . 0.432 HG22 HG22 ' A' 1591 ' ' VAL . 92.6 t -100.3 117.4 45.44 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.961 0 N-CA-C 108.719 -0.845 . . . . 0.93000000000000005 108.719 177.622 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A 1610 ' ' ILE . . . . . 0.638 HG13 ' HB2' ' A' 1638 ' ' PHE . 3.5 mp -101.94 118.34 48.61 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.567 0 N-CA-C 108.22 -1.03 . . . . 0.78000000000000003 108.22 177.133 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A 1611 ' ' SER . . . . . . . . . . . . . 14.1 m -104.22 117.02 33.22 Favored 'General case' 0 N--CA 1.416 -2.131 0 CA-C-N 115.357 -0.838 . . . . 1.29 108.966 178.834 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A 1612 ' ' PHE . . . . . 0.675 ' HB2' ' HB2' ' A' 1588 ' ' LEU . 95.2 m-85 -90.18 107.32 19.06 Favored 'General case' 0 C--N 1.298 -1.648 0 CA-C-N 115.458 -0.792 . . . . 0.69999999999999996 109.251 179.98 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A 1613 ' ' VAL . . . . . . . . . . . . . 71.9 t -100.38 131.31 48.15 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.108 0 CA-C-N 116.152 -0.477 . . . . 0.75 109.922 -177.02 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A 1614 ' ' CYS . . . . . . . . . . . . . 59.6 m -67.98 101.76 1.17 Allowed 'General case' 0 C--N 1.317 -0.848 0 C-N-CA 123.787 0.835 . . . . 1.3899999999999999 110.925 -179.425 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A 1615 ' ' ARG . . . . . 0.549 ' HD2' ' OE2' ' A' 1617 ' ' GLU . 21.4 mmt180 -137.07 95.76 11.77 Favored Pre-proline 0 C--N 1.306 -1.294 0 CA-C-N 115.594 -0.73 . . . . 3.75 110.927 178.692 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A 1616 ' ' PRO . . . . . . . . . . . . . 11.4 Cg_exo -74.1 58.53 4.26 Favored 'Trans proline' 0 CA--C 1.541 0.857 0 C-N-CA 123.636 2.891 . . . . 1.3200000000000001 111.371 176.587 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A 1617 ' ' GLU . . . . . 0.549 ' OE2' ' HD2' ' A' 1615 ' ' ARG . 38.3 mt-10 . . . . . 0 C--N 1.31 -1.121 0 C-N-CA 124.659 1.183 . . . . 3.21 108.471 179.503 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A 1622 ' ' ASN . . . . . . . . . . . . . 25.2 t-20 . . . . . 0 C--O 1.233 0.226 0 N-CA-C 108.864 -0.791 . . . . 2.9199999999999999 108.864 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A 1623 ' ' ARG . . . . . . . . . . . . . 8.6 ptm180 -133.67 158.17 76.17 Favored Pre-proline 0 C--N 1.311 -1.089 0 CA-C-N 115.378 -0.828 . . . . 3.6099999999999999 109.714 -173.866 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A 1624 ' ' PRO . . . . . . . . . . . . . 12.2 Cg_exo -69.86 127.21 14.2 Favored 'Trans proline' 0 C--O 1.246 0.905 0 C-N-CA 122.792 2.328 . . . . 2.3700000000000001 110.834 176.942 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A 1625 ' ' MET . . . . . . . . . . . . . 22.1 ptp -126.34 151.47 47.53 Favored 'General case' 0 C--N 1.303 -1.438 0 CA-C-N 116.131 -0.486 . . . . 2.1600000000000001 110.396 -178.561 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A 1626 ' ' LEU . . . . . 0.407 HD12 ' O ' ' A' 1637 ' ' PHE . 39.0 tp -85.55 118.35 25.01 Favored 'General case' 0 C--N 1.306 -1.293 0 N-CA-C 108.436 -0.95 . . . . 1.3500000000000001 108.436 -179.666 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A 1627 ' ' ILE . . . . . . . . . . . . . 45.8 pt -93.17 -28.33 4.45 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.331 0 C-N-CA 120.345 -0.542 . . . . 1.21 111.47 -177.993 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A 1628 ' ' SER . . . . . . . . . . . . . 21.1 t -160.57 142.0 12.22 Favored 'General case' 0 N--CA 1.432 -1.371 0 C-N-CA 120.341 -0.543 . . . . 1.3999999999999999 110.565 -177.482 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A 1629 ' ' LEU . . . . . 0.83 HD13 ' HG ' ' A' 1636 ' ' LEU . 29.5 tp -119.76 128.02 53.36 Favored 'General case' 0 C--N 1.304 -1.37 0 N-CA-C 108.065 -1.087 . . . . 1.5600000000000001 108.065 174.055 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A 1630 ' ' ASP . . . . . . . . . . . . . 25.1 t70 -102.07 127.41 48.98 Favored 'General case' 0 C--N 1.295 -1.761 0 CA-C-N 116.737 -0.211 . . . . 0.87 110.623 179.269 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A 1631 ' ' LYS . . . . . . . . . . . . . 53.0 mttm -95.14 0.97 54.72 Favored 'General case' 0 C--N 1.317 -0.808 0 N-CA-C 111.872 0.323 . . . . 2.3500000000000001 111.872 -178.495 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A 1632 ' ' GLN . . . . . . . . . . . . . 36.5 mt-30 -87.19 -52.47 5.39 Favored 'General case' 0 C--N 1.315 -0.926 0 C-N-CA 120.218 -0.593 . . . . 2.5499999999999998 109.969 178.917 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A 1633 ' ' THR . . . . . . . . . . . . . 69.1 p -106.51 -1.44 23.05 Favored 'General case' 0 N--CA 1.432 -1.374 0 CA-C-N 115.761 -0.654 . . . . 1.24 111.927 -178.833 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A 1634 ' ' CYS . . . . . . . . . . . . . 60.3 m 62.61 42.91 7.99 Favored 'General case' 0 C--O 1.237 0.399 0 CA-C-O 122.464 1.126 . . . . 0.89000000000000001 111.26 177.409 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A 1635 ' ' THR . . . . . 0.436 HG23 ' HG3' ' A' 1607 ' ' LYS . 28.2 m -102.57 133.09 48.13 Favored 'General case' 0 N--CA 1.416 -2.145 0 CA-C-N 114.168 -1.378 . . . . 0.75 109.245 -178.547 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A 1636 ' ' LEU . . . . . 0.83 ' HG ' HD13 ' A' 1629 ' ' LEU . 5.2 mp -109.79 129.69 55.6 Favored 'General case' 0 N--CA 1.435 -1.213 0 N-CA-C 108.994 -0.743 . . . . 1.3300000000000001 108.994 179.806 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A 1637 ' ' PHE . . . . . 0.407 ' O ' HD12 ' A' 1626 ' ' LEU . 88.7 m-85 -110.32 108.0 17.93 Favored 'General case' 0 C--N 1.308 -1.223 0 CA-C-O 121.049 0.452 . . . . 0.82999999999999996 110.979 -177.121 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A 1638 ' ' PHE . . . . . 0.638 ' HB2' HG13 ' A' 1610 ' ' ILE . 97.0 m-85 -101.78 146.95 27.08 Favored 'General case' 0 C--N 1.305 -1.359 0 N-CA-C 109.228 -0.656 . . . . 0.59999999999999998 109.228 177.706 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A 1639 ' ' SER . . . . . . . . . . . . . 50.0 m -132.64 133.66 43.89 Favored 'General case' 0 C--N 1.278 -2.529 0 N-CA-C 109.788 -0.449 . . . . 1.0800000000000001 109.788 176.967 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A 1640 ' ' TRP . . . . . 0.403 ' CE3' ' HE2' ' A' 1612 ' ' PHE . 6.7 t90 -121.43 92.54 3.77 Favored 'General case' 0 N--CA 1.413 -2.32 0 N-CA-C 106.761 -1.57 . . . . 0.80000000000000004 106.761 173.517 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A 1641 ' ' HIS . . . . . . . . . . . . . 4.4 p-80 -71.64 98.75 1.96 Allowed 'General case' 0 C--N 1.308 -1.209 0 CA-C-N 114.867 -1.061 . . . . 2.54 108.555 175.154 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A 1642 ' ' THR . . . . . . . . . . . . . 10.0 t -143.55 147.81 40.97 Favored Pre-proline 0 C--N 1.279 -2.49 0 CA-C-N 115.831 -0.622 . . . . 1.1499999999999999 110.483 -170.963 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A 1643 ' ' PRO . . . . . 0.417 ' O ' ' HG2' ' A' 1647 ' ' GLU . 34.6 Cg_endo -75.68 0.18 9.47 Favored 'Trans proline' 0 C--O 1.215 -0.651 0 C-N-CA 122.853 2.369 . . . . 0.80000000000000004 111.114 174.768 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A 1644 ' ' LEU . . . . . 0.437 HD13 HD13 ' A' 1532 ' ' LEU . 45.5 mt -85.04 -11.81 54.52 Favored 'General case' 0 C--N 1.32 -0.683 0 C-N-CA 123.927 0.891 . . . . 1.54 110.782 176.679 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A 1645 ' ' ALA . . . . . . . . . . . . . . . -73.09 -43.44 61.82 Favored 'General case' 0 N--CA 1.471 0.592 0 CA-C-O 121.563 0.696 . . . . 0.94999999999999996 110.118 -178.604 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A 1646 ' ' CYS . . . . . 0.551 ' HA ' ' CE1' ' A' 1527 ' ' PHE . 18.8 p -155.61 142.26 18.79 Favored 'General case' 0 N--CA 1.417 -2.084 0 N-CA-C 104.666 -2.346 . . . . 1.4099999999999999 104.666 172.389 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A 1647 ' ' GLU . . . . . 0.417 ' HG2' ' O ' ' A' 1643 ' ' PRO . 39.9 mt-10 . . . . . 0 C--N 1.283 -2.323 0 O-C-N 123.199 0.312 . . . . 2.9199999999999999 110.414 -171.249 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A 1515 ' ' ASP . . . . . 0.451 ' HB3' ' HB3' ' A' 1579 ' ' LYS . 38.7 m-20 . . . . . 0 N--CA 1.466 0.348 0 N-CA-C 111.936 0.347 . . . . 2.54 111.936 . . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A 1516 ' ' CYS . . . . . . . . . . . . . 85.7 m -124.4 41.38 3.51 Favored 'General case' 0 C--N 1.311 -1.069 0 CA-C-O 121.432 0.634 . . . . 1.25 110.99 -177.266 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A 1517 ' ' GLN . . . . . . . . . . . . . 9.6 pt20 -161.21 168.62 23.82 Favored 'General case' 0 C--N 1.287 -2.132 0 N-CA-C 109.42 -0.585 . . . . 1.8799999999999999 109.42 -179.562 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A 1518 ' ' VAL . . . . . . . . . . . . . 80.7 t -131.37 105.96 11.27 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.081 0 N-CA-C 108.497 -0.927 . . . . 1.73 108.497 176.111 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A 1519 ' ' THR . . . . . . . . . . . . . 20.4 m -86.16 102.14 13.62 Favored 'General case' 0 C--N 1.281 -2.376 0 N-CA-C 107.596 -1.261 . . . . 1.7 107.596 175.048 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A 1520 ' ' ASN . . . . . . . . . . . . . 31.4 t30 -92.0 105.41 13.57 Favored Pre-proline 0 C--N 1.322 -0.614 0 N-CA-C 109.859 -0.423 . . . . 2.1200000000000001 109.859 179.809 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A 1521 ' ' PRO . . . . . . . . . . . . . 59.1 Cg_endo -72.72 -18.98 24.63 Favored 'Trans proline' 0 N--CA 1.458 -0.593 0 C-N-CA 122.383 2.055 . . . . 2.4700000000000002 113.376 -175.123 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A 1522 ' ' SER . . . . . . . . . . . . . 32.6 m -61.27 -35.75 78.15 Favored 'General case' 0 CA--C 1.54 0.565 0 CA-C-O 120.818 0.342 . . . . 2.5699999999999998 111.832 -178.393 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A 1523 ' ' THR . . . . . . . . . . . . . 12.3 t -120.21 -5.24 9.95 Favored 'General case' 0 CA--C 1.554 1.096 0 CA-C-O 122.074 0.94 . . . . 2.1499999999999999 109.543 178.809 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A 1524 ' ' GLY . . . . . . . . . . . . . . . 73.97 20.18 79.73 Favored Glycine 0 C--N 1.335 0.526 0 CA-C-N 115.44 -0.8 . . . . 1.8899999999999999 112.345 179.666 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A 1525 ' ' HIS . . . . . . . . . . . . . 12.9 t-80 -101.65 128.16 48.07 Favored 'General case' 0 C--N 1.314 -0.951 0 CA-C-O 120.797 0.332 . . . . 1.8999999999999999 110.745 -177.869 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A 1526 ' ' LEU . . . . . . . . . . . . . 6.9 tt -100.34 130.71 46.48 Favored 'General case' 0 C--N 1.3 -1.579 0 N-CA-C 108.43 -0.952 . . . . 1.6100000000000001 108.43 178.208 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A 1527 ' ' PHE . . . . . 0.675 ' HE1' ' HA ' ' A' 1646 ' ' CYS . 97.7 m-85 -95.78 102.95 14.81 Favored 'General case' 0 C--N 1.308 -1.199 0 N-CA-C 109.183 -0.673 . . . . 1.4199999999999999 109.183 177.243 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A 1528 ' ' ASP . . . . . . . . . . . . . 4.9 p-10 -85.17 106.68 16.79 Favored 'General case' 0 C--N 1.314 -0.936 0 CA-C-O 122.389 1.09 . . . . 2.1800000000000002 113.437 -178.285 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A 1529 ' ' LEU . . . . . 0.747 ' HG ' HD12 ' A' 1532 ' ' LEU . 7.4 mp -105.5 0.22 26.48 Favored 'General case' 0 C--N 1.312 -1.06 0 CA-C-N 114.78 -1.1 . . . . 1.4399999999999999 108.148 172.398 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A 1530 ' ' SER . . . . . . . . . . . . . 2.6 p -68.3 -31.32 70.68 Favored 'General case' 0 N--CA 1.426 -1.641 0 CA-C-N 114.248 -1.342 . . . . 1.4399999999999999 109.356 177.406 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A 1531 ' ' SER . . . . . . . . . . . . . 9.9 m -76.11 -7.91 55.8 Favored 'General case' 0 N--CA 1.443 -0.793 0 CA-C-N 115.03 -0.987 . . . . 1.5 110.358 177.759 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A 1532 ' ' LEU . . . . . 0.747 HD12 ' HG ' ' A' 1529 ' ' LEU . 81.7 mt -90.72 15.8 10.43 Favored 'General case' 0 C--O 1.238 0.485 0 CA-C-O 121.544 0.688 . . . . 1.77 111.676 -179.792 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A 1533 ' ' SER . . . . . . . . . . . . . 17.0 m -78.74 173.23 12.69 Favored 'General case' 0 N--CA 1.44 -0.955 0 N-CA-C 108.558 -0.904 . . . . 2.3799999999999999 108.558 176.143 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A 1534 ' ' GLY . . . . . . . . . . . . . . . 165.5 147.44 5.16 Favored Glycine 0 N--CA 1.428 -1.897 0 C-N-CA 120.038 -1.077 . . . . 1.55 111.848 -178.997 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A 1535 ' ' ARG . . . . . 0.855 ' HG3' ' HG3' ' A' 1557 ' ' GLU . 43.6 ttm180 -60.35 -49.29 78.17 Favored 'General case' 0 C--O 1.246 0.907 0 C-N-CA 124.513 1.125 . . . . 3.96 110.301 179.562 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A 1536 ' ' ALA . . . . . . . . . . . . . . . -95.68 -33.65 12.25 Favored 'General case' 0 N--CA 1.434 -1.266 0 N-CA-C 109.044 -0.724 . . . . 1.6499999999999999 109.044 177.858 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A 1537 ' ' GLY . . . . . . . . . . . . . . . 84.19 -136.37 14.7 Favored Glycine 0 N--CA 1.428 -1.873 0 CA-C-N 114.496 -1.229 . . . . 1.1899999999999999 111.963 177.73 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A 1538 ' ' PHE . . . . . 0.479 ' CD1' HD13 ' A' 1552 ' ' ILE . 54.2 m-85 -106.34 135.94 46.94 Favored 'General case' 0 C--N 1.295 -1.802 0 N-CA-C 108.207 -1.034 . . . . 1.6899999999999999 108.207 177.88 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A 1539 ' ' THR . . . . . . . . . . . . . 19.2 p -113.35 117.99 33.33 Favored 'General case' 0 C--N 1.292 -1.927 0 CA-C-N 116.128 -0.487 . . . . 1.48 111.352 -178.509 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A 1540 ' ' ALA . . . . . . . . . . . . . . . -122.43 124.33 43.39 Favored 'General case' 0 C--N 1.313 -1.015 0 N-CA-C 109.932 -0.396 . . . . 0.82999999999999996 109.932 179.77 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A 1541 ' ' ALA . . . . . . . . . . . . . . . -74.18 144.63 44.72 Favored 'General case' 0 C--O 1.251 1.156 0 CA-C-O 120.654 0.264 . . . . 1.27 110.521 179.247 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A 1542 ' ' TYR . . . . . . . . . . . . . 27.4 t80 -149.16 -173.64 4.43 Favored 'General case' 0 N--CA 1.437 -1.114 0 N-CA-C 109.148 -0.686 . . . . 2.1499999999999999 109.148 -176.276 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A 1543 ' ' SER . . . . . . . . . . . . . 13.9 m -45.99 -152.78 0.0 OUTLIER 'General case' 0 CA--C 1.569 1.7 0 C-N-CA 129.707 3.203 . . . . 2.29 115.063 -178.799 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A 1544 ' ' LYS . . . . . . . . . . . . . 55.9 tptt -47.24 -29.52 2.46 Favored 'General case' 0 N--CA 1.486 1.336 0 O-C-N 121.266 -0.897 . . . . 3.9100000000000001 112.774 178.677 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A 1545 ' ' SER . . . . . . . . . . . . . 4.3 p -61.74 -22.64 65.55 Favored 'General case' 0 CA--C 1.556 1.207 0 C-N-CA 123.053 0.541 . . . . 3.2999999999999998 112.202 175.048 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A 1546 ' ' GLY . . . . . . . . . . . . . . . 89.49 -69.72 2.49 Favored Glycine 0 N--CA 1.431 -1.666 0 N-CA-C 113.867 0.307 . . . . 1.24 113.867 173.664 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A 1547 ' ' VAL . . . . . . . . . . . . . 7.2 p -158.79 138.61 3.73 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.925 0 N-CA-C 109.787 -0.449 . . . . 1.6299999999999999 109.787 -173.606 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A 1548 ' ' VAL . . . . . . . . . . . . . 2.4 t -103.0 134.88 42.89 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.601 0 N-CA-C 108.548 -0.908 . . . . 0.92000000000000004 108.548 -177.563 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A 1549 ' ' TYR . . . . . . . . . . . . . 97.9 m-85 -104.02 121.89 44.11 Favored 'General case' 0 C--N 1.311 -1.096 0 N-CA-C 107.112 -1.44 . . . . 1.4399999999999999 107.112 173.717 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A 1550 ' ' MET . . . . . . . . . . . . . 71.5 mtm -131.07 122.17 26.27 Favored 'General case' 0 CA--C 1.488 -1.43 0 C-N-CA 120.217 -0.593 . . . . 1.74 112.195 177.913 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A 1551 ' ' SER . . . . . . . . . . . . . 53.2 m -103.03 105.17 15.44 Favored 'General case' 0 C--N 1.272 -2.803 0 N-CA-C 105.45 -2.056 . . . . 1.6399999999999999 105.45 171.457 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A 1552 ' ' ILE . . . . . 0.479 HD13 ' CD1' ' A' 1538 ' ' PHE . 1.7 mp -52.48 -35.34 20.22 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.813 0 O-C-N 124.112 0.883 . . . . 1.3300000000000001 112.133 -176.456 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A 1553 ' ' CYS . . . . . . . . . . . . . 93.9 m -145.7 155.66 43.13 Favored 'General case' 0 C--N 1.307 -1.249 0 N-CA-C 109.152 -0.685 . . . . 1.4299999999999999 109.152 174.924 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A 1554 ' ' GLY . . . . . . . . . . . . . . . 102.66 -118.32 6.07 Favored Glycine 0 N--CA 1.441 -1.031 0 N-CA-C 110.366 -1.094 . . . . 1.1200000000000001 110.366 -179.917 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A 1555 ' ' GLU . . . . . . . . . . . . . 17.0 pt-20 -157.9 148.32 20.6 Favored 'General case' 0 C--N 1.311 -1.107 0 N-CA-C 107.741 -1.207 . . . . 1.8 107.741 176.769 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A 1556 ' ' ASN . . . . . . . . . . . . . 21.0 t-20 -97.05 118.86 34.4 Favored 'General case' 0 C--N 1.305 -1.329 0 CA-C-O 121.543 0.687 . . . . 2.6299999999999999 110.277 -178.609 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A 1557 ' ' GLU . . . . . 0.855 ' HG3' ' HG3' ' A' 1535 ' ' ARG . 12.0 mm-40 -82.53 11.97 5.11 Favored 'General case' 0 C--N 1.298 -1.644 0 CA-C-N 114.65 -1.159 . . . . 3.79 112.956 -172.429 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A 1558 ' ' ASN . . . . . . . . . . . . . 18.9 m120 -104.24 -9.02 18.92 Favored 'General case' 0 C--N 1.301 -1.528 0 O-C-N 121.726 -0.609 . . . . 1.52 110.662 -178.886 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A 1559 ' ' CYS . . . . . 0.685 ' HB3' ' HD2' ' A' 1560 ' ' PRO . 88.1 m -144.29 178.46 1.45 Allowed Pre-proline 0 C--N 1.302 -1.466 0 CA-C-O 117.199 -1.381 . . . . 0.83999999999999997 108.154 -178.521 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A 1560 ' ' PRO . . . . . 0.685 ' HD2' ' HB3' ' A' 1559 ' ' CYS . 24.2 Cg_exo -29.4 125.69 0.05 OUTLIER 'Trans proline' 0 C--N 1.383 2.356 0 C-N-CA 124.772 3.648 . . . . 1.1799999999999999 114.94 176.422 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A 1561 ' ' PRO . . . . . 0.465 ' HD3' ' HA ' ' A' 1560 ' ' PRO . 51.2 Cg_exo -55.52 115.99 2.84 Favored 'Trans proline' 0 C--O 1.244 0.782 0 C-N-CA 123.445 2.764 . . . . 1.51 112.964 -177.126 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A 1562 ' ' GLY . . . . . . . . . . . . . . . 114.11 -10.34 22.65 Favored Glycine 0 N--CA 1.439 -1.122 0 C-N-CA 120.455 -0.878 . . . . 0.71999999999999997 113.275 177.187 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A 1563 ' ' VAL . . . . . 0.571 ' HA ' ' HA ' ' A' 1576 ' ' LYS . 5.1 m -90.65 152.37 3.35 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.183 0 N-CA-C 107.189 -1.411 . . . . 0.96999999999999997 107.189 176.635 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A 1564 ' ' GLY . . . . . . . . . . . . . . . -117.23 -19.06 5.24 Favored Glycine 0 C--N 1.306 -1.127 0 C-N-CA 119.451 -1.357 . . . . 0.71999999999999997 113.74 -176.25 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A 1565 ' ' ALA . . . . . . . . . . . . . . . -126.37 123.23 37.49 Favored 'General case' 0 C--O 1.25 1.095 0 N-CA-C 109.385 -0.598 . . . . 0.37 109.385 -179.851 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A 1566 ' ' CYS . . . . . . . . . . . . . 49.3 t -151.69 146.78 26.03 Favored 'General case' 0 C--N 1.312 -1.035 0 C-N-CA 121.056 -0.258 . . . . 0.51000000000000001 111.126 -177.096 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A 1567 ' ' PHE . . . . . . . . . . . . . 31.4 m-85 -94.05 123.68 37.57 Favored 'General case' 0 C--O 1.247 0.965 0 CA-C-N 116.101 -0.5 . . . . 0.96999999999999997 109.677 177.836 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A 1568 ' ' GLY . . . . . . . . . . . . . . . 50.62 -140.82 19.74 Favored Glycine 0 C--N 1.321 -0.289 0 O-C-N 123.893 0.745 . . . . 1.0800000000000001 114.719 175.517 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A 1569 ' ' GLN . . . . . . . . . . . . . 49.0 tt0 -90.87 -58.23 2.55 Favored 'General case' 0 N--CA 1.43 -1.444 0 N-CA-C 109.558 -0.534 . . . . 2.7400000000000002 109.558 179.993 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A 1570 ' ' THR . . . . . . . . . . . . . 14.8 p -123.01 34.13 5.21 Favored 'General case' 0 C--N 1.312 -1.043 0 CA-C-N 115.892 -0.594 . . . . 1.96 112.473 -176.668 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A 1571 ' ' ARG . . . . . . . . . . . . . 7.5 mpt_? -97.5 12.03 34.76 Favored 'General case' 0 N--CA 1.432 -1.328 0 C-N-CA 119.388 -0.925 . . . . 3.9500000000000002 110.765 175.691 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A 1572 ' ' ILE . . . . . 0.446 HG22 ' HB2' ' A' 1596 ' ' SER . 75.9 mt 80.97 144.51 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.548 0.894 0 CA-C-N 114.112 -1.404 . . . . 1.3700000000000001 114.371 165.581 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A 1573 ' ' SER . . . . . . . . . . . . . 36.3 p -82.01 134.89 35.4 Favored 'General case' 0 N--CA 1.438 -1.072 0 CA-C-N 114.582 -1.19 . . . . 1.0800000000000001 111.113 -179.242 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A 1574 ' ' VAL . . . . . . . . . . . . . 19.0 m -123.22 30.43 2.24 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.228 0 N-CA-C 112.611 0.597 . . . . 1.3 112.611 -177.553 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A 1575 ' ' GLY . . . . . . . . . . . . . . . 173.56 122.68 0.68 Allowed Glycine 0 N--CA 1.434 -1.434 0 C-N-CA 119.989 -1.1 . . . . 0.51000000000000001 112.799 177.753 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A 1576 ' ' LYS . . . . . 0.571 ' HA ' ' HA ' ' A' 1563 ' ' VAL . 66.6 tttm -76.8 143.09 40.05 Favored 'General case' 0 C--O 1.246 0.914 0 N-CA-C 106.835 -1.543 . . . . 2.8999999999999999 106.835 175.787 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A 1577 ' ' ALA . . . . . . . . . . . . . . . -77.04 82.63 3.55 Favored 'General case' 0 C--N 1.304 -1.412 0 CA-C-O 121.642 0.734 . . . . 0.82999999999999996 111.7 -175.23 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A 1578 ' ' ASN . . . . . . . . . . . . . 41.6 m-80 -89.47 147.44 24.0 Favored 'General case' 0 C--N 1.306 -1.3 0 N-CA-C 108.058 -1.09 . . . . 1.8500000000000001 108.058 175.243 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A 1579 ' ' LYS . . . . . 0.451 ' HB3' ' HB3' ' A' 1515 ' ' ASP . 58.7 mttp -95.14 89.67 5.62 Favored 'General case' 0 C--N 1.283 -2.299 0 N-CA-C 105.746 -1.946 . . . . 1.8999999999999999 105.746 175.331 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A 1580 ' ' ARG . . . . . 0.401 ' O ' ' HG ' ' A' 1590 ' ' LEU . 42.1 ttm180 -140.32 101.14 4.06 Favored 'General case' 0 C--N 1.297 -1.703 0 CA-C-N 115.346 -0.843 . . . . 3.6299999999999999 110.003 -173.607 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A 1581 ' ' LEU . . . . . . . . . . . . . 41.0 tp -117.4 145.02 44.38 Favored 'General case' 0 C--N 1.289 -2.054 0 CA-C-N 115.151 -0.931 . . . . 1.8700000000000001 109.462 -177.39 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A 1582 ' ' ARG . . . . . . . . . . . . . 97.0 mtt180 -119.44 125.27 48.54 Favored 'General case' 0 C--N 1.297 -1.713 0 CA-C-N 115.656 -0.702 . . . . 3.9700000000000002 109.984 -179.729 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A 1583 ' ' TYR . . . . . 0.416 ' HD1' ' CD2' ' A' 1588 ' ' LEU . 22.6 t80 -108.09 97.89 7.52 Favored 'General case' 0 C--N 1.296 -1.727 0 N-CA-C 108.547 -0.909 . . . . 1.4099999999999999 108.547 174.49 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A 1584 ' ' VAL . . . . . . . . . . . . . 1.1 m -140.07 121.28 14.91 Favored 'Isoleucine or valine' 0 CA--C 1.499 -0.981 0 N-CA-C 112.697 0.628 . . . . 1.6899999999999999 112.697 -178.079 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A 1585 ' ' ASP . . . . . . . . . . . . . 30.9 t70 56.67 45.04 22.73 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-O 122.334 1.064 . . . . 2.0600000000000001 111.082 171.613 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A 1586 ' ' GLN . . . . . . . . . . . . . 73.9 mt-30 58.82 18.25 5.92 Favored 'General case' 0 C--N 1.323 -0.548 0 N-CA-C 115.068 1.507 . . . . 2.3300000000000001 115.068 -178.871 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A 1587 ' ' VAL . . . . . . . . . . . . . 12.4 p -120.69 133.37 67.6 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.331 0 N-CA-C 107.619 -1.252 . . . . 0.78000000000000003 107.619 172.86 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A 1588 ' ' LEU . . . . . 0.426 ' HB2' ' HB2' ' A' 1612 ' ' PHE . 16.6 mt -103.24 133.09 48.91 Favored 'General case' 0 C--N 1.296 -1.746 0 N-CA-C 108.277 -1.008 . . . . 1.4099999999999999 108.277 -177.104 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A 1589 ' ' GLN . . . . . . . . . . . . . 35.0 tt0 -134.31 115.78 14.49 Favored 'General case' 0 C--N 1.275 -2.639 0 C-N-CA 120.39 -0.524 . . . . 1.24 110.442 -175.496 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A 1590 ' ' LEU . . . . . 0.401 ' HG ' ' O ' ' A' 1580 ' ' ARG . 8.7 tt -106.74 128.96 54.66 Favored 'General case' 0 C--N 1.293 -1.849 0 N-CA-C 107.411 -1.329 . . . . 1.1499999999999999 107.411 -179.25 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A 1591 ' ' VAL . . . . . . . . . . . . . 61.4 t -119.26 126.89 75.76 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.808 0 N-CA-C 112.792 0.664 . . . . 1.51 112.792 -170.355 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A 1592 ' ' TYR . . . . . 0.631 ' HB2' ' HB3' ' A' 1608 ' ' SER . 9.7 m-30 -108.53 149.23 29.13 Favored 'General case' 0 C--N 1.31 -1.135 0 CA-C-N 114.986 -1.006 . . . . 1.0600000000000001 109.44 174.487 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A 1593 ' ' LYS . . . . . . . . . . . . . 18.4 ptpt -159.47 177.37 11.02 Favored 'General case' 0 C--N 1.296 -1.741 0 N-CA-C 107.371 -1.344 . . . . 2.1800000000000002 107.371 178.578 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A 1594 ' ' ASP . . . . . 0.421 ' O ' ' HB2' ' A' 1576 ' ' LYS . 3.8 m-20 65.62 76.76 0.32 Allowed 'General case' 0 N--CA 1.483 1.206 0 O-C-N 124.038 0.837 . . . . 1.45 112.399 179.046 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A 1595 ' ' GLY . . . . . . . . . . . . . . . -143.08 -73.4 0.03 OUTLIER Glycine 0 N--CA 1.432 -1.57 0 N-CA-C 110.879 -0.889 . . . . 0.78000000000000003 110.879 176.865 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A 1596 ' ' SER . . . . . 0.446 ' HB2' HG22 ' A' 1572 ' ' ILE . 31.1 t -114.86 139.6 24.4 Favored Pre-proline 0 C--N 1.288 -2.077 0 N-CA-C 109.534 -0.543 . . . . 1.6799999999999999 109.534 179.621 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A 1597 ' ' PRO . . . . . . . . . . . . . 23.2 Cg_exo -68.39 144.28 61.13 Favored 'Trans proline' 0 N--CA 1.445 -1.361 0 N-CA-C 106.435 -2.179 . . . . 1.1699999999999999 106.435 168.527 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A 1598 ' ' CYS . . . . . . . . . . . . . 19.1 t -95.17 125.26 51.03 Favored Pre-proline 0 C--N 1.286 -2.173 0 C-N-CA 120.065 -0.654 . . . . 1.1899999999999999 110.287 -175.795 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A 1599 ' ' PRO . . . . . . . . . . . . . 84.6 Cg_endo -88.38 -4.04 6.69 Favored 'Trans proline' 0 N--CA 1.456 -0.73 0 C-N-CA 122.807 2.338 . . . . 1.5900000000000001 111.698 177.079 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A 1600 ' ' SER . . . . . . . . . . . . . 16.3 m -86.35 109.11 18.77 Favored 'General case' 0 N--CA 1.425 -1.68 0 CA-C-N 115.865 -0.607 . . . . 2.1200000000000001 109.994 -178.874 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A 1601 ' ' LYS . . . . . 0.813 ' HD2' ' HA ' ' A' 1632 ' ' GLN . 67.0 mttm 67.67 -86.71 0.03 OUTLIER 'General case' 0 C--O 1.242 0.684 0 C-N-CA 124.067 0.947 . . . . 3.7400000000000002 113.358 178.571 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A 1602 ' ' SER . . . . . 0.837 ' HB3' HD22 ' A' 1604 ' ' LEU . 29.1 t -96.66 150.47 20.63 Favored 'General case' 0 N--CA 1.422 -1.867 0 N-CA-C 108.781 -0.822 . . . . 3.79 108.781 -175.5 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A 1603 ' ' GLY . . . . . . . . . . . . . . . -83.64 59.61 4.95 Favored Glycine 0 N--CA 1.435 -1.43 0 N-CA-C 110.331 -1.108 . . . . 2.0 110.331 176.425 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A 1604 ' ' LEU . . . . . 0.837 HD22 ' HB3' ' A' 1602 ' ' SER . 2.0 pt? -105.32 -175.35 2.77 Favored 'General case' 0 C--N 1.302 -1.494 0 CA-C-N 115.704 -0.248 . . . . 1.48 110.82 -176.982 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A 1605 ' ' SER . . . . . . . . . . . . . 5.0 p -83.81 -176.19 6.17 Favored 'General case' 0 C--N 1.294 -1.829 0 CA-C-O 121.249 0.547 . . . . 1.51 111.25 -178.568 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A 1606 ' ' TYR . . . . . . . . . . . . . 5.1 m-85 -116.76 128.5 55.37 Favored 'General case' 0 CA--C 1.469 -2.144 0 N-CA-C 106.882 -1.525 . . . . 1.1799999999999999 106.882 177.426 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A 1607 ' ' LYS . . . . . . . . . . . . . 20.6 ptmt -119.32 118.93 32.53 Favored 'General case' 0 N--CA 1.407 -2.618 0 CA-C-O 121.536 0.684 . . . . 1.6699999999999999 110.204 -178.535 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A 1608 ' ' SER . . . . . 0.631 ' HB3' ' HB2' ' A' 1592 ' ' TYR . 33.4 t -103.5 106.8 17.41 Favored 'General case' 0 C--N 1.288 -2.083 0 N-CA-C 108.056 -1.09 . . . . 1.0 108.056 -177.277 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A 1609 ' ' VAL . . . . . . . . . . . . . 66.2 t -107.49 115.44 48.74 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.5 0 CA-C-O 121.012 0.434 . . . . 0.93000000000000005 110.862 -176.597 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A 1610 ' ' ILE . . . . . 0.6 ' HA ' ' HB2' ' A' 1638 ' ' PHE . 3.3 mp -103.78 111.17 32.42 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.21 0 N-CA-C 108.074 -1.084 . . . . 0.78000000000000003 108.074 178.095 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A 1611 ' ' SER . . . . . 0.55 ' O ' ' HA ' ' A' 1639 ' ' SER . 18.8 m -104.43 129.83 52.37 Favored 'General case' 0 C--N 1.303 -1.451 0 CA-C-O 121.368 0.604 . . . . 1.29 110.706 -179.858 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A 1612 ' ' PHE . . . . . 0.426 ' HB2' ' HB2' ' A' 1588 ' ' LEU . 92.2 m-85 -101.55 113.18 26.07 Favored 'General case' 0 C--N 1.292 -1.899 0 N-CA-C 108.342 -0.984 . . . . 0.69999999999999996 108.342 -179.524 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A 1613 ' ' VAL . . . . . . . . . . . . . 92.2 t -106.43 132.18 54.28 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.176 0 N-CA-C 109.538 -0.541 . . . . 0.75 109.538 -176.594 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A 1614 ' ' CYS . . . . . . . . . . . . . 62.6 m -67.48 99.51 0.76 Allowed 'General case' 0 C--N 1.322 -0.611 0 CA-C-O 121.573 0.701 . . . . 1.3899999999999999 112.526 -177.559 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A 1615 ' ' ARG . . . . . 0.472 ' HB3' ' HB3' ' A' 1641 ' ' HIS . 20.3 tpp180 -137.28 85.45 21.75 Favored Pre-proline 0 N--CA 1.429 -1.479 0 CA-C-N 114.851 -1.068 . . . . 3.75 108.164 176.352 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A 1616 ' ' PRO . . . . . . . . . . . . . 16.4 Cg_exo -71.68 -13.22 29.66 Favored 'Trans proline' 0 C--N 1.357 0.984 0 C-N-CA 123.327 2.684 . . . . 1.3200000000000001 110.227 178.153 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A 1617 ' ' GLU . . . . . 0.433 ' HB3' ' CD ' ' A' 1615 ' ' ARG . 43.7 tt0 . . . . . 0 C--N 1.304 -1.388 0 C-N-CA 126.067 1.747 . . . . 3.21 107.963 176.459 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A 1622 ' ' ASN . . . . . . . . . . . . . 29.1 t-20 . . . . . 0 N--CA 1.45 -0.455 0 N-CA-C 107.058 -1.46 . . . . 2.9199999999999999 107.058 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A 1623 ' ' ARG . . . . . . . . . . . . . 4.9 ptp180 -153.12 164.49 20.2 Favored Pre-proline 0 C--N 1.301 -1.538 0 N-CA-C 108.887 -0.783 . . . . 3.6099999999999999 108.887 -176.34 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A 1624 ' ' PRO . . . . . . . . . . . . . 22.7 Cg_exo -65.34 100.05 0.38 Allowed 'Trans proline' 0 C--N 1.361 1.234 0 C-N-CA 122.588 2.192 . . . . 2.3700000000000001 110.813 177.059 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A 1625 ' ' MET . . . . . . . . . . . . . 23.4 ptp -108.72 148.65 30.14 Favored 'General case' 0 C--N 1.302 -1.457 0 CA-C-N 115.443 -0.798 . . . . 2.1600000000000001 109.694 -177.17 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A 1626 ' ' LEU . . . . . 0.497 ' HG ' ' CE1' ' A' 1638 ' ' PHE . 38.1 mt -71.01 109.74 5.29 Favored 'General case' 0 C--N 1.309 -1.184 0 CA-C-N 115.978 -0.556 . . . . 1.3500000000000001 110.369 174.667 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A 1627 ' ' ILE . . . . . . . . . . . . . 40.8 pt -92.4 -23.74 5.55 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.306 0 CA-C-N 115.115 -0.948 . . . . 1.21 109.185 177.321 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A 1628 ' ' SER . . . . . . . . . . . . . 51.1 m -154.53 149.84 27.13 Favored 'General case' 0 N--CA 1.428 -1.574 0 CA-C-N 115.452 -0.795 . . . . 1.3999999999999999 109.403 -179.088 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A 1629 ' ' LEU . . . . . 0.746 HD13 ' HG ' ' A' 1636 ' ' LEU . 20.2 tp -143.28 112.25 6.59 Favored 'General case' 0 C--N 1.297 -1.701 0 N-CA-C 108.697 -0.853 . . . . 1.5600000000000001 108.697 177.984 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A 1630 ' ' ASP . . . . . . . . . . . . . 13.4 t70 -100.26 108.15 20.15 Favored 'General case' 0 C--N 1.296 -1.728 0 N-CA-C 108.605 -0.887 . . . . 0.87 108.605 -178.26 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A 1631 ' ' LYS . . . . . . . . . . . . . 92.1 mttt -92.51 5.44 50.82 Favored 'General case' 0 C--N 1.293 -1.871 0 CA-C-O 120.947 0.403 . . . . 2.3500000000000001 111.43 -177.293 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A 1632 ' ' GLN . . . . . 0.813 ' HA ' ' HD2' ' A' 1601 ' ' LYS . 33.5 mt-30 -85.55 -41.2 15.5 Favored 'General case' 0 N--CA 1.437 -1.098 0 N-CA-C 108.491 -0.929 . . . . 2.5499999999999998 108.491 178.53 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A 1633 ' ' THR . . . . . . . . . . . . . 32.6 m -106.9 -2.44 21.3 Favored 'General case' 0 CA--C 1.564 1.516 0 CA-C-O 122.111 0.957 . . . . 1.24 110.256 176.917 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A 1634 ' ' CYS . . . . . . . . . . . . . 51.2 m 63.78 47.59 3.54 Favored 'General case' 0 N--CA 1.471 0.592 0 CA-C-O 122.675 1.226 . . . . 0.89000000000000001 110.007 176.852 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A 1635 ' ' THR . . . . . . . . . . . . . 24.2 m -112.43 121.63 45.38 Favored 'General case' 0 N--CA 1.423 -1.824 0 CA-C-N 113.836 -1.529 . . . . 0.75 109.887 -175.774 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A 1636 ' ' LEU . . . . . 0.746 ' HG ' HD13 ' A' 1629 ' ' LEU . 5.5 mp -99.4 126.18 45.24 Favored 'General case' 0 C--N 1.305 -1.35 0 N-CA-C 108.812 -0.81 . . . . 1.3300000000000001 108.812 179.061 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A 1637 ' ' PHE . . . . . . . . . . . . . 94.1 m-85 -108.08 94.82 5.28 Favored 'General case' 0 C--O 1.249 1.078 0 CA-C-O 121.012 0.434 . . . . 0.82999999999999996 111.193 -177.774 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A 1638 ' ' PHE . . . . . 0.6 ' HB2' ' HA ' ' A' 1610 ' ' ILE . 99.7 m-85 -90.94 144.62 25.48 Favored 'General case' 0 CA--C 1.487 -1.458 0 N-CA-C 107.917 -1.142 . . . . 0.59999999999999998 107.917 175.751 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A 1639 ' ' SER . . . . . 0.55 ' HA ' ' O ' ' A' 1611 ' ' SER . 66.8 m -141.7 133.08 26.62 Favored 'General case' 0 C--N 1.273 -2.737 0 CA-C-O 120.852 0.358 . . . . 1.0800000000000001 111.187 177.267 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A 1640 ' ' TRP . . . . . 0.435 ' HZ3' HD13 ' A' 1532 ' ' LEU . 8.3 t90 -118.93 112.56 19.79 Favored 'General case' 0 N--CA 1.426 -1.674 0 N-CA-C 107.799 -1.186 . . . . 0.80000000000000004 107.799 175.688 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A 1641 ' ' HIS . . . . . 0.472 ' HB3' ' HB3' ' A' 1615 ' ' ARG . 13.4 m170 -82.43 98.42 8.88 Favored 'General case' 0 C--N 1.297 -1.704 0 N-CA-C 107.315 -1.365 . . . . 2.54 107.315 175.311 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A 1642 ' ' THR . . . . . . . . . . . . . 9.2 t -143.1 147.81 42.49 Favored Pre-proline 0 C--N 1.305 -1.335 0 CA-C-N 115.406 -0.815 . . . . 1.1499999999999999 111.394 -170.414 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A 1643 ' ' PRO . . . . . . . . . . . . . 34.6 Cg_endo -70.11 -12.04 31.49 Favored 'Trans proline' 0 C--N 1.353 0.778 0 C-N-CA 123.067 2.511 . . . . 0.80000000000000004 111.106 171.837 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A 1644 ' ' LEU . . . . . . . . . . . . . 94.1 mt -75.55 -6.32 49.66 Favored 'General case' 0 N--CA 1.465 0.291 0 CA-C-N 116.241 -0.436 . . . . 1.54 111.699 178.74 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A 1645 ' ' ALA . . . . . . . . . . . . . . . -81.11 -42.52 20.83 Favored 'General case' 0 C--N 1.318 -0.778 0 N-CA-C 108.745 -0.835 . . . . 0.94999999999999996 108.745 175.791 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A 1646 ' ' CYS . . . . . 0.675 ' HA ' ' HE1' ' A' 1527 ' ' PHE . 19.3 p -169.44 116.45 0.59 Allowed 'General case' 0 N--CA 1.432 -1.348 0 N-CA-C 107.717 -1.216 . . . . 1.4099999999999999 107.717 173.645 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A 1647 ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 . . . . . 0 C--N 1.309 -1.194 0 CA-C-N 116.088 -0.506 . . . . 2.9199999999999999 109.779 179.17 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A 1515 ' ' ASP . . . . . . . . . . . . . 16.5 t70 . . . . . 0 CA--C 1.513 -0.478 0 N-CA-C 107.057 -1.46 . . . . 2.54 107.057 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A 1516 ' ' CYS . . . . . 0.669 ' HB3' ' HB2' ' A' 1529 ' ' LEU . 34.3 m -87.5 59.7 5.63 Favored 'General case' 0 C--N 1.305 -1.356 0 N-CA-C 109.556 -0.535 . . . . 1.25 109.556 -177.283 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A 1517 ' ' GLN . . . . . 0.502 ' HA ' ' O ' ' A' 1527 ' ' PHE . 11.3 pt20 -148.41 138.54 22.49 Favored 'General case' 0 C--N 1.306 -1.292 0 N-CA-C 109.211 -0.662 . . . . 1.8799999999999999 109.211 -179.785 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A 1518 ' ' VAL . . . . . . . . . . . . . 10.1 p -144.57 133.31 18.17 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.889 0 CA-C-O 120.921 0.391 . . . . 1.73 110.258 179.326 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A 1519 ' ' THR . . . . . 0.501 ' O ' ' HD3' ' A' 1521 ' ' PRO . 21.4 m -93.8 128.98 40.34 Favored 'General case' 0 C--N 1.292 -1.926 0 N-CA-C 108.926 -0.768 . . . . 1.7 108.926 179.158 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A 1520 ' ' ASN . . . . . . . . . . . . . 22.8 t30 -101.71 94.84 4.68 Favored Pre-proline 0 C--N 1.314 -0.974 0 N-CA-C 108.722 -0.844 . . . . 2.1200000000000001 108.722 172.501 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A 1521 ' ' PRO . . . . . 0.501 ' HD3' ' O ' ' A' 1519 ' ' THR . 52.8 Cg_exo -55.27 -20.87 26.6 Favored 'Trans proline' 0 C--N 1.365 1.399 0 C-N-CA 123.68 2.92 . . . . 2.4700000000000002 114.242 -177.257 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A 1522 ' ' SER . . . . . . . . . . . . . 19.9 t -64.47 -30.01 71.05 Favored 'General case' 0 CA--C 1.549 0.927 0 CA-C-O 120.834 0.349 . . . . 2.5699999999999998 111.099 178.573 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A 1523 ' ' THR . . . . . . . . . . . . . 8.8 t -122.82 -14.84 7.59 Favored 'General case' 0 CA--C 1.545 0.753 0 C-N-CA 120.484 -0.487 . . . . 2.1499999999999999 110.611 178.257 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A 1524 ' ' GLY . . . . . . . . . . . . . . . 89.22 -13.96 62.12 Favored Glycine 0 C--O 1.22 -0.744 0 CA-C-N 116.394 -0.366 . . . . 1.8899999999999999 113.805 177.202 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A 1525 ' ' HIS . . . . . . . . . . . . . 13.7 t-160 -79.31 127.62 32.3 Favored 'General case' 0 C--N 1.311 -1.068 0 CA-C-O 121.289 0.566 . . . . 1.8999999999999999 111.862 -175.616 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A 1526 ' ' LEU . . . . . 0.47 HD11 ' HB2' ' A' 1517 ' ' GLN . 41.9 tp -84.67 127.61 34.18 Favored 'General case' 0 C--N 1.315 -0.927 0 CA-C-N 114.685 -1.143 . . . . 1.6100000000000001 107.969 173.084 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A 1527 ' ' PHE . . . . . 0.502 ' O ' ' HA ' ' A' 1517 ' ' GLN . 70.9 m-85 -99.01 119.02 37.09 Favored 'General case' 0 C--N 1.288 -2.073 0 N-CA-C 108.831 -0.803 . . . . 1.4199999999999999 108.831 178.398 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A 1528 ' ' ASP . . . . . . . . . . . . . 10.9 t70 -105.24 124.18 49.11 Favored 'General case' 0 CA--C 1.487 -1.469 0 CA-C-O 121.189 0.518 . . . . 2.1800000000000002 110.316 179.314 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A 1529 ' ' LEU . . . . . 0.669 ' HB2' ' HB3' ' A' 1516 ' ' CYS . 69.8 mt -108.59 -19.8 13.31 Favored 'General case' 0 C--N 1.294 -1.831 0 CA-C-N 114.922 -1.036 . . . . 1.4399999999999999 108.914 177.213 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A 1530 ' ' SER . . . . . 0.404 ' OG ' ' HB2' ' A' 1516 ' ' CYS . 24.9 m -57.85 -37.87 74.65 Favored 'General case' 0 C--O 1.24 0.566 0 C-N-CA 123.626 0.77 . . . . 1.4399999999999999 112.763 -176.634 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A 1531 ' ' SER . . . . . . . . . . . . . 50.5 p -87.43 1.07 54.49 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-O 120.906 0.384 . . . . 1.5 111.625 178.948 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A 1532 ' ' LEU . . . . . . . . . . . . . 96.1 mt -88.13 14.76 8.54 Favored 'General case' 0 CA--C 1.544 0.726 0 N-CA-C 113.12 0.785 . . . . 1.77 113.12 179.394 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A 1533 ' ' SER . . . . . 0.408 ' OG ' ' HB ' ' A' 1552 ' ' ILE . 46.1 m -113.38 108.78 17.69 Favored 'General case' 0 C--N 1.314 -0.964 0 O-C-N 121.591 -0.693 . . . . 2.3799999999999999 110.898 178.84 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A 1534 ' ' GLY . . . . . . . . . . . . . . . -86.08 -127.29 2.01 Favored Glycine 0 C--O 1.22 -0.743 0 C-N-CA 120.69 -0.767 . . . . 1.55 111.499 176.714 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A 1535 ' ' ARG . . . . . . . . . . . . . 19.4 tpt180 -83.18 -52.8 6.29 Favored 'General case' 0 C--N 1.311 -1.081 0 CA-C-N 117.108 0.454 . . . . 3.96 109.958 178.36 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A 1536 ' ' ALA . . . . . 0.426 ' HB1' ' HD1' ' A' 1549 ' ' TYR . . . -96.12 -21.48 17.9 Favored 'General case' 0 C--N 1.312 -1.064 0 CA-C-O 121.216 0.531 . . . . 1.6499999999999999 109.623 178.944 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A 1537 ' ' GLY . . . . . . . . . . . . . . . 90.66 -92.16 1.74 Allowed Glycine 0 N--CA 1.425 -2.058 0 N-CA-C 108.057 -2.017 . . . . 1.1899999999999999 108.057 -175.925 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A 1538 ' ' PHE . . . . . . . . . . . . . 47.2 m-85 -136.85 158.32 44.73 Favored 'General case' 0 C--N 1.295 -1.799 0 N-CA-C 109.151 -0.685 . . . . 1.6899999999999999 109.151 174.17 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A 1539 ' ' THR . . . . . . . . . . . . . 5.8 p -127.99 142.97 51.09 Favored 'General case' 0 C--N 1.296 -1.737 0 CA-C-N 116.506 -0.315 . . . . 1.48 111.295 -176.878 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A 1540 ' ' ALA . . . . . . . . . . . . . . . -131.21 140.12 49.82 Favored 'General case' 0 C--N 1.302 -1.479 0 N-CA-C 109.416 -0.587 . . . . 0.82999999999999996 109.416 176.796 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A 1541 ' ' ALA . . . . . . . . . . . . . . . -86.21 133.43 33.85 Favored 'General case' 0 C--N 1.312 -1.034 0 N-CA-C 108.107 -1.071 . . . . 1.27 108.107 178.642 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A 1542 ' ' TYR . . . . . 0.602 ' HD2' ' HB2' ' A' 1545 ' ' SER . 76.6 t80 -136.12 166.56 23.11 Favored 'General case' 0 C--N 1.301 -1.531 0 N-CA-C 109.448 -0.575 . . . . 2.1499999999999999 109.448 -175.747 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A 1543 ' ' SER . . . . . . . . . . . . . 16.0 t -48.67 -150.32 0.0 OUTLIER 'General case' 0 CA--C 1.577 1.997 0 C-N-CA 127.916 2.486 . . . . 2.29 112.886 176.229 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A 1544 ' ' LYS . . . . . . . . . . . . . 95.7 mttt -38.92 -30.75 0.05 Allowed 'General case' 0 CA--C 1.567 1.62 0 C-N-CA 124.986 1.314 . . . . 3.9100000000000001 114.442 -178.619 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A 1545 ' ' SER . . . . . 0.602 ' HB2' ' HD2' ' A' 1542 ' ' TYR . 15.3 m -72.59 -10.69 60.1 Favored 'General case' 0 CA--C 1.579 2.076 0 N-CA-C 112.617 0.599 . . . . 3.2999999999999998 112.617 177.254 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A 1546 ' ' GLY . . . . . . . . . . . . . . . 85.2 -80.15 1.84 Allowed Glycine 0 C--O 1.244 0.725 0 N-CA-C 115.049 0.78 . . . . 1.24 115.049 171.965 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A 1547 ' ' VAL . . . . . . . . . . . . . 7.8 p -146.39 143.09 21.06 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.475 0 CA-C-O 120.997 0.427 . . . . 1.6299999999999999 109.914 -174.126 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A 1548 ' ' VAL . . . . . . . . . . . . . 2.1 t -109.86 135.1 49.9 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.414 0 N-CA-C 107.979 -1.119 . . . . 0.92000000000000004 107.979 -179.058 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A 1549 ' ' TYR . . . . . 0.426 ' HD1' ' HB1' ' A' 1536 ' ' ALA . 80.1 m-85 -100.63 131.19 46.67 Favored 'General case' 0 C--N 1.313 -1.006 0 N-CA-C 106.522 -1.659 . . . . 1.4399999999999999 106.522 173.266 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A 1550 ' ' MET . . . . . . . . . . . . . 68.1 mtp -126.08 122.44 35.8 Favored 'General case' 0 C--N 1.298 -1.647 0 CA-C-N 116.569 -0.287 . . . . 1.74 110.242 -171.436 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A 1551 ' ' SER . . . . . 0.618 ' CB ' ' HB3' ' A' 1556 ' ' ASN . 19.6 p -105.83 133.37 50.67 Favored 'General case' 0 N--CA 1.419 -1.997 0 CA-C-O 122.082 0.944 . . . . 1.6399999999999999 111.1 -179.514 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A 1552 ' ' ILE . . . . . 0.451 HG22 ' SG ' ' A' 1553 ' ' CYS . 1.7 mp -76.38 -42.88 36.46 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.023 0 CA-C-N 114.355 -1.293 . . . . 1.3300000000000001 111.499 -176.943 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A 1553 ' ' CYS . . . . . 0.451 ' SG ' HG22 ' A' 1552 ' ' ILE . 46.5 m -130.92 135.99 48.18 Favored 'General case' 0 C--N 1.307 -1.243 0 N-CA-C 108.636 -0.876 . . . . 1.4299999999999999 108.636 174.626 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A 1554 ' ' GLY . . . . . 0.427 ' HA2' ' HB1' ' A' 1577 ' ' ALA . . . 54.57 -155.74 7.88 Favored Glycine 0 C--O 1.247 0.928 0 O-C-N 124.46 1.1 . . . . 1.1200000000000001 111.981 179.371 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A 1555 ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -89.9 146.66 24.25 Favored 'General case' 0 N--CA 1.413 -2.295 0 C-N-CA 119.056 -1.058 . . . . 1.8 108.945 170.924 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A 1556 ' ' ASN . . . . . 0.618 ' HB3' ' CB ' ' A' 1551 ' ' SER . 4.3 t30 -170.37 61.41 0.04 OUTLIER 'General case' 0 C--N 1.282 -2.347 0 N-CA-C 107.388 -1.338 . . . . 2.6299999999999999 107.388 -171.65 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A 1557 ' ' GLU . . . . . 0.558 ' CD ' ' H ' ' A' 1558 ' ' ASN 0.388 0.3 OUTLIER -157.58 -119.92 0.02 OUTLIER 'General case' 0 CA--C 1.553 1.09 0 N-CA-C 116.101 1.889 . . . . 3.79 116.101 -177.402 . . . . . . . . 4 4 . 1 . 013 nuclear build core ' A' A 1558 ' ' ASN . . . . . 0.558 ' H ' ' CD ' ' A' 1557 ' ' GLU . 40.4 m-80 -139.6 -5.68 1.36 Allowed 'General case' 0 CA--C 1.55 0.96 0 N-CA-C 113.029 0.752 . . . . 1.52 113.029 -175.849 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A 1559 ' ' CYS . . . . . 0.481 ' HB3' ' HD2' ' A' 1560 ' ' PRO . 43.7 m -91.36 170.22 10.03 Favored Pre-proline 0 C--N 1.317 -0.809 0 CA-C-O 119.161 -0.447 . . . . 0.83999999999999997 109.937 179.015 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A 1560 ' ' PRO . . . . . 0.481 ' HD2' ' HB3' ' A' 1559 ' ' CYS . 91.6 Cg_exo -45.83 129.01 11.66 Favored 'Trans proline' 0 C--N 1.364 1.374 0 C-N-CA 122.853 2.369 . . . . 1.1799999999999999 111.348 174.633 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A 1561 ' ' PRO . . . . . 0.452 ' HD3' ' HA ' ' A' 1560 ' ' PRO . 53.3 Cg_exo -56.21 115.65 2.62 Favored 'Trans proline' 0 C--O 1.241 0.642 0 C-N-CA 123.268 2.646 . . . . 1.51 112.505 -178.133 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A 1562 ' ' GLY . . . . . . . . . . . . . . . 155.05 -21.43 0.58 Allowed Glycine 0 N--CA 1.443 -0.881 0 N-CA-C 111.619 -0.593 . . . . 0.71999999999999997 111.619 -179.08 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A 1563 ' ' VAL . . . . . 0.437 ' HA ' ' HA ' ' A' 1576 ' ' LYS . 25.6 m -80.68 161.21 3.92 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.121 0 CA-C-O 121.486 0.66 . . . . 0.96999999999999997 111.885 178.004 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A 1564 ' ' GLY . . . . . 0.601 ' HA3' ' CD2' ' A' 1592 ' ' TYR . . . -119.98 0.14 13.28 Favored Glycine 0 N--CA 1.424 -2.142 0 N-CA-C 108.845 -1.702 . . . . 0.71999999999999997 108.845 166.718 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A 1565 ' ' ALA . . . . . . . . . . . . . . . -170.22 125.54 0.77 Allowed 'General case' 0 C--O 1.246 0.911 0 N-CA-C 108.511 -0.922 . . . . 0.37 108.511 178.312 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A 1566 ' ' CYS . . . . . . . . . . . . . 48.8 t -149.98 145.01 26.2 Favored 'General case' 0 C--N 1.309 -1.159 0 C-N-CA 121.141 -0.224 . . . . 0.51000000000000001 110.45 -175.513 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A 1567 ' ' PHE . . . . . . . . . . . . . 26.8 m-85 -69.87 124.17 23.35 Favored 'General case' 0 C--O 1.217 -0.656 0 N-CA-C 107.548 -1.279 . . . . 0.96999999999999997 107.548 174.179 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A 1568 ' ' GLY . . . . . 0.425 ' HA3' ' CE2' ' A' 1549 ' ' TYR . . . -70.06 -31.53 69.45 Favored Glycine 0 CA--C 1.498 -1.001 0 C-N-CA 121.02 -0.609 . . . . 1.0800000000000001 114.032 -173.667 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A 1569 ' ' GLN . . . . . . . . . . . . . 34.5 tt0 -84.57 -53.24 5.53 Favored 'General case' 0 C--N 1.304 -1.394 0 CA-C-O 121.444 0.64 . . . . 2.7400000000000002 109.853 -179.219 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A 1570 ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -77.19 -23.73 51.45 Favored 'General case' 0 C--N 1.307 -1.25 0 CA-C-N 115.133 -0.939 . . . . 1.96 113.019 -173.177 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A 1571 ' ' ARG . . . . . 0.403 ' HA ' ' SG ' ' A' 1559 ' ' CYS . 91.5 mtt180 60.97 36.57 18.64 Favored 'General case' 0 CA--C 1.511 -0.548 0 C-N-CA 125.02 1.328 . . . . 3.9500000000000002 113.39 179.101 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A 1572 ' ' ILE . . . . . . . . . . . . . 44.0 mm -106.0 122.62 59.86 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.131 0 N-CA-C 108.462 -0.94 . . . . 1.3700000000000001 108.462 179.473 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A 1573 ' ' SER . . . . . . . . . . . . . 41.5 t -66.86 128.54 36.71 Favored 'General case' 0 C--N 1.308 -1.239 0 C-N-CA 124.231 1.012 . . . . 1.0800000000000001 111.201 179.562 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A 1574 ' ' VAL . . . . . 0.542 ' HA ' ' HB2' ' A' 1606 ' ' TYR . 35.4 m -118.8 18.01 6.8 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.236 0 CA-C-O 122.023 0.916 . . . . 1.3 110.335 178.004 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A 1575 ' ' GLY . . . . . . . . . . . . . . . 167.25 123.64 0.67 Allowed Glycine 0 N--CA 1.43 -1.725 0 CA-C-N 114.299 -1.319 . . . . 0.51000000000000001 109.941 178.339 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A 1576 ' ' LYS . . . . . 0.437 ' HA ' ' HA ' ' A' 1563 ' ' VAL . 62.0 mttp -84.32 153.72 23.34 Favored 'General case' 0 CA--C 1.498 -1.021 0 CA-C-O 121.201 0.524 . . . . 2.8999999999999999 110.427 179.478 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A 1577 ' ' ALA . . . . . 0.478 ' HA ' ' CE2' ' A' 1592 ' ' TYR . . . -59.65 104.23 0.26 Allowed 'General case' 0 C--N 1.307 -1.244 0 CA-C-N 114.025 -1.443 . . . . 0.82999999999999996 111.287 178.028 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A 1578 ' ' ASN . . . . . . . . . . . . . 45.7 m-80 -135.32 123.05 22.33 Favored 'General case' 0 C--N 1.301 -1.502 0 N-CA-C 105.974 -1.862 . . . . 1.8500000000000001 105.974 177.027 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A 1579 ' ' LYS . . . . . . . . . . . . . 36.6 ttpt -94.34 89.8 6.03 Favored 'General case' 0 C--N 1.285 -2.227 0 N-CA-C 108.388 -0.967 . . . . 1.8999999999999999 108.388 -174.583 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A 1580 ' ' ARG . . . . . . . . . . . . . 72.8 ttt180 -127.64 109.86 12.1 Favored 'General case' 0 N--CA 1.419 -1.991 0 CA-C-N 114.631 -1.168 . . . . 3.6299999999999999 109.128 -179.095 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A 1581 ' ' LEU . . . . . 0.458 HD13 ' N ' ' A' 1582 ' ' ARG . 2.3 tm? -96.25 141.94 29.0 Favored 'General case' 0 C--N 1.3 -1.563 0 CA-C-N 114.649 -1.16 . . . . 1.8700000000000001 108.143 -177.868 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A 1582 ' ' ARG . . . . . 0.458 ' N ' HD13 ' A' 1581 ' ' LEU . 4.7 tpt180 -145.84 141.79 28.22 Favored 'General case' 0 C--N 1.304 -1.376 0 N-CA-C 108.638 -0.875 . . . . 3.9700000000000002 108.638 173.274 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A 1583 ' ' TYR . . . . . . . . . . . . . 46.9 t80 -137.05 103.58 5.18 Favored 'General case' 0 C--N 1.321 -0.645 0 N-CA-C 109.206 -0.665 . . . . 1.4099999999999999 109.206 179.051 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A 1584 ' ' VAL . . . . . . . . . . . . . 26.9 m -134.69 140.26 45.97 Favored 'Isoleucine or valine' 0 C--O 1.201 -1.453 0 N-CA-C 109.64 -0.504 . . . . 1.6899999999999999 109.64 -178.484 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A 1585 ' ' ASP . . . . . . . . . . . . . 8.9 t70 43.98 52.46 6.73 Favored 'General case' 0 N--CA 1.492 1.646 0 C-N-CA 125.06 1.344 . . . . 2.0600000000000001 113.088 175.184 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A 1586 ' ' GLN . . . . . . . . . . . . . 19.0 mm-40 61.93 22.39 13.02 Favored 'General case' 0 CA--C 1.553 1.091 0 C-N-CA 123.89 0.876 . . . . 2.3300000000000001 112.853 178.815 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A 1587 ' ' VAL . . . . . 0.5 HG23 ' O ' ' A' 1612 ' ' PHE . 9.4 p -134.06 125.02 47.71 Favored 'Isoleucine or valine' 0 C--O 1.245 0.833 0 O-C-N 121.455 -0.778 . . . . 0.78000000000000003 111.785 177.451 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A 1588 ' ' LEU . . . . . 0.696 ' HB2' ' HB2' ' A' 1612 ' ' PHE . 79.3 mt -85.99 155.31 20.92 Favored 'General case' 0 C--N 1.313 -1.0 0 CA-C-N 114.942 -1.026 . . . . 1.4099999999999999 110.731 177.314 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A 1589 ' ' GLN . . . . . 0.514 ' HA ' ' O ' ' A' 1610 ' ' ILE . 6.9 tt0 -150.4 133.36 16.06 Favored 'General case' 0 C--N 1.318 -0.795 0 N-CA-C 112.33 0.493 . . . . 1.24 112.33 -179.447 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A 1590 ' ' LEU . . . . . 0.621 ' HG ' ' HE1' ' A' 1612 ' ' PHE . 96.0 mt -104.0 125.52 50.43 Favored 'General case' 0 C--O 1.248 1.006 0 N-CA-C 106.982 -1.488 . . . . 1.1499999999999999 106.982 172.068 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A 1591 ' ' VAL . . . . . . . . . . . . . 40.4 t -105.72 102.56 14.05 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.498 0 C-N-CA 120.757 -0.377 . . . . 1.51 110.119 179.827 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A 1592 ' ' TYR . . . . . 0.601 ' CD2' ' HA3' ' A' 1564 ' ' GLY . 27.7 m-85 -117.55 92.96 3.98 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-O 121.379 0.609 . . . . 1.0600000000000001 109.422 177.788 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A 1593 ' ' LYS . . . . . . . . . . . . . 21.3 pttp -110.85 -177.55 3.25 Favored 'General case' 0 C--N 1.305 -1.358 0 N-CA-C 112.569 0.581 . . . . 2.1800000000000002 112.569 -175.901 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A 1594 ' ' ASP . . . . . 0.408 ' HA ' ' HB2' ' A' 1605 ' ' SER . 18.2 m-20 52.77 59.43 4.48 Favored 'General case' 0 N--CA 1.466 0.355 0 C-N-CA 124.931 1.292 . . . . 1.45 113.598 175.212 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A 1595 ' ' GLY . . . . . 0.424 ' HA2' ' HG3' ' A' 1576 ' ' LYS . . . -83.34 -107.35 0.51 Allowed Glycine 0 N--CA 1.438 -1.167 0 C-N-CA 120.517 -0.849 . . . . 0.78000000000000003 111.719 177.631 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A 1596 ' ' SER . . . . . . . . . . . . . 23.0 t -106.23 145.47 31.04 Favored Pre-proline 0 C--N 1.291 -1.94 0 N-CA-C 107.545 -1.279 . . . . 1.6799999999999999 107.545 -179.839 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A 1597 ' ' PRO . . . . . . . . . . . . . 77.3 Cg_exo -53.29 134.21 55.95 Favored 'Trans proline' 0 C--N 1.362 1.286 0 C-N-CA 123.558 2.839 . . . . 1.1699999999999999 111.523 178.654 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A 1598 ' ' CYS . . . . . . . . . . . . . 50.6 t -95.05 125.66 49.75 Favored Pre-proline 0 C--N 1.289 -2.042 0 CA-C-N 115.41 -0.814 . . . . 1.1899999999999999 109.883 -173.569 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A 1599 ' ' PRO . . . . . . . . . . . . . 58.4 Cg_endo -71.86 -13.91 29.45 Favored 'Trans proline' 0 C--N 1.346 0.395 0 C-N-CA 122.971 2.447 . . . . 1.5900000000000001 112.497 -179.375 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A 1600 ' ' SER . . . . . . . . . . . . . 19.3 m -74.3 -20.46 60.11 Favored 'General case' 0 N--CA 1.439 -1.002 0 CA-C-N 116.019 -0.537 . . . . 2.1200000000000001 111.06 179.984 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A 1601 ' ' LYS . . . . . 0.414 ' HA ' ' HD2' ' A' 1601 ' ' LYS . 20.9 tptm -156.68 104.13 2.14 Favored 'General case' 0 N--CA 1.433 -1.314 0 N-CA-C 109.052 -0.721 . . . . 3.7400000000000002 109.052 177.109 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A 1602 ' ' SER . . . . . . . . . . . . . 7.4 p -61.27 107.41 0.75 Allowed 'General case' 0 C--N 1.303 -1.432 0 CA-C-N 115.294 -0.866 . . . . 3.79 112.086 -178.654 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A 1603 ' ' GLY . . . . . . . . . . . . . . . 136.13 -5.38 3.93 Favored Glycine 0 N--CA 1.434 -1.498 0 C-N-CA 120.576 -0.821 . . . . 2.0 113.367 177.91 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A 1604 ' ' LEU . . . . . . . . . . . . . 3.0 pp -140.27 161.81 36.77 Favored 'General case' 0 C--N 1.311 -1.092 0 CA-C-N 117.586 0.693 . . . . 1.48 112.067 -178.727 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A 1605 ' ' SER . . . . . 0.408 ' HB2' ' HA ' ' A' 1594 ' ' ASP . 21.7 m -102.78 -174.99 2.69 Favored 'General case' 0 C--N 1.307 -1.259 0 N-CA-C 109.062 -0.718 . . . . 1.51 109.062 178.016 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A 1606 ' ' TYR . . . . . 0.542 ' HB2' ' HA ' ' A' 1574 ' ' VAL . 96.1 m-85 -95.34 153.36 17.72 Favored 'General case' 0 CA--C 1.472 -2.036 0 N-CA-C 105.768 -1.938 . . . . 1.1799999999999999 105.768 179.495 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A 1607 ' ' LYS . . . . . 0.5 ' HG3' HG23 ' A' 1635 ' ' THR . 25.2 pttm -137.63 146.44 43.93 Favored 'General case' 0 N--CA 1.403 -2.783 0 C-N-CA 118.634 -1.226 . . . . 1.6699999999999999 110.202 173.054 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A 1608 ' ' SER . . . . . . . . . . . . . 49.9 m -118.69 126.7 52.48 Favored 'General case' 0 C--N 1.305 -1.336 0 CA-C-O 121.235 0.541 . . . . 1.0 110.845 -179.174 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A 1609 ' ' VAL . . . . . . . . . . . . . 56.2 t -111.23 116.91 53.79 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.932 0 N-CA-C 109.565 -0.531 . . . . 0.93000000000000005 109.565 177.798 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A 1610 ' ' ILE . . . . . 0.595 ' HB ' ' HB2' ' A' 1590 ' ' LEU . 29.3 mm -92.52 111.65 24.72 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.989 0 N-CA-C 108.652 -0.87 . . . . 0.78000000000000003 108.652 177.349 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A 1611 ' ' SER . . . . . . . . . . . . . 6.3 m -102.67 119.54 39.01 Favored 'General case' 0 C--N 1.29 -2.015 0 N-CA-C 108.146 -1.057 . . . . 1.29 108.146 179.386 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A 1612 ' ' PHE . . . . . 0.696 ' HB2' ' HB2' ' A' 1588 ' ' LEU . 69.5 m-85 -91.47 105.3 17.66 Favored 'General case' 0 C--N 1.297 -1.699 0 N-CA-C 109.196 -0.668 . . . . 0.69999999999999996 109.196 -178.833 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A 1613 ' ' VAL . . . . . 0.506 ' O ' ' HA ' ' A' 1641 ' ' HIS . 56.6 t -99.09 124.96 52.66 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.164 0 CA-C-N 115.868 -0.605 . . . . 0.75 109.587 -175.672 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A 1614 ' ' CYS . . . . . . . . . . . . . 34.5 m -71.14 93.97 1.1 Allowed 'General case' 0 C--N 1.304 -1.401 0 CA-C-O 121.505 0.669 . . . . 1.3899999999999999 112.711 -178.192 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A 1615 ' ' ARG . . . . . 0.721 ' HB3' ' HB2' ' A' 1641 ' ' HIS . 28.5 ttm180 -136.15 92.61 15.81 Favored Pre-proline 0 C--N 1.307 -1.264 0 CA-C-N 115.361 -0.836 . . . . 3.75 110.562 176.607 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A 1616 ' ' PRO . . . . . 0.468 ' HB3' ' HB3' ' A' 1643 ' ' PRO . 12.0 Cg_exo -75.42 18.59 0.57 Allowed 'Trans proline' 0 CA--C 1.535 0.574 0 C-N-CA 123.558 2.839 . . . . 1.3200000000000001 112.895 176.925 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A 1617 ' ' GLU . . . . . . . . . . . . . 42.3 mt-10 . . . . . 0 C--N 1.312 -1.026 0 CA-C-O 120.971 0.415 . . . . 3.21 110.285 -178.613 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A 1622 ' ' ASN . . . . . . . . . . . . . 49.5 t-20 . . . . . 0 C--O 1.243 0.711 0 N-CA-C 107.231 -1.396 . . . . 2.9199999999999999 107.231 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A 1623 ' ' ARG . . . . . . . . . . . . . 16.2 ptm180 -147.89 153.64 42.58 Favored Pre-proline 0 N--CA 1.437 -1.089 0 CA-C-N 114.996 -1.002 . . . . 3.6099999999999999 108.805 -174.943 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A 1624 ' ' PRO . . . . . 0.497 ' HA ' ' HA ' ' A' 1640 ' ' TRP . 8.1 Cg_exo -73.77 111.01 3.19 Favored 'Trans proline' 0 C--O 1.238 0.519 0 C-N-CA 122.705 2.27 . . . . 2.3700000000000001 110.75 178.581 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A 1625 ' ' MET . . . . . . . . . . . . . 26.7 ptt? -100.15 154.3 18.55 Favored 'General case' 0 C--N 1.303 -1.418 0 CA-C-N 116.026 -0.534 . . . . 2.1600000000000001 109.846 -178.041 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A 1626 ' ' LEU . . . . . . . . . . . . . 56.4 tp -87.4 106.92 18.29 Favored 'General case' 0 C--N 1.301 -1.51 0 N-CA-C 108.747 -0.835 . . . . 1.3500000000000001 108.747 -179.036 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A 1627 ' ' ILE . . . . . . . . . . . . . 2.8 pp -85.83 -36.02 10.16 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.205 0 C-N-CA 119.921 -0.712 . . . . 1.21 112.758 -177.272 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A 1628 ' ' SER . . . . . . . . . . . . . 49.3 m -157.67 143.92 17.65 Favored 'General case' 0 C--N 1.316 -0.86 0 N-CA-C 110.155 -0.313 . . . . 1.3999999999999999 110.155 179.428 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A 1629 ' ' LEU . . . . . 0.887 ' HG ' ' HG ' ' A' 1636 ' ' LEU . 5.1 tt -130.33 118.53 21.41 Favored 'General case' 0 C--N 1.301 -1.506 0 N-CA-C 106.343 -1.725 . . . . 1.5600000000000001 106.343 176.183 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A 1630 ' ' ASP . . . . . . . . . . . . . 20.1 t70 -93.36 117.25 29.86 Favored 'General case' 0 C--N 1.29 -2.005 0 N-CA-C 108.541 -0.911 . . . . 0.87 108.541 178.82 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A 1631 ' ' LYS . . . . . . . . . . . . . 95.7 mttt -83.37 1.52 40.94 Favored 'General case' 0 C--N 1.314 -0.937 0 N-CA-C 112.445 0.535 . . . . 2.3500000000000001 112.445 -174.983 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A 1632 ' ' GLN . . . . . . . . . . . . . 1.5 mp0 -96.68 -45.7 6.59 Favored 'General case' 0 C--N 1.315 -0.905 0 CA-C-O 121.359 0.6 . . . . 2.5499999999999998 110.318 -178.424 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A 1633 ' ' THR . . . . . . . . . . . . . 41.6 p -95.39 -5.99 41.97 Favored 'General case' 0 C--N 1.305 -1.348 0 CA-C-O 121.793 0.806 . . . . 1.24 110.286 177.87 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A 1634 ' ' CYS . . . . . . . . . . . . . 83.4 m 56.69 51.33 11.17 Favored 'General case' 0 C--N 1.347 0.475 0 CA-C-N 113.569 -1.65 . . . . 0.89000000000000001 110.789 -179.394 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A 1635 ' ' THR . . . . . 0.5 HG23 ' HG3' ' A' 1607 ' ' LYS . 24.8 m -111.54 124.36 52.13 Favored 'General case' 0 N--CA 1.425 -1.723 0 CA-C-N 114.109 -1.405 . . . . 0.75 109.651 -176.093 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A 1636 ' ' LEU . . . . . 0.887 ' HG ' ' HG ' ' A' 1629 ' ' LEU . 5.1 mp -105.83 126.72 52.5 Favored 'General case' 0 C--N 1.309 -1.186 0 N-CA-C 109.481 -0.563 . . . . 1.3300000000000001 109.481 178.519 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A 1637 ' ' PHE . . . . . . . . . . . . . 91.0 m-85 -105.91 111.46 24.11 Favored 'General case' 0 C--N 1.31 -1.139 0 CA-C-N 116.135 -0.484 . . . . 0.82999999999999996 110.232 -178.831 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A 1638 ' ' PHE . . . . . . . . . . . . . 94.8 m-85 -106.42 128.25 53.91 Favored 'General case' 0 C--N 1.303 -1.436 0 N-CA-C 109.432 -0.581 . . . . 0.59999999999999998 109.432 178.988 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A 1639 ' ' SER . . . . . . . . . . . . . 67.2 m -112.75 114.64 27.3 Favored 'General case' 0 C--N 1.278 -2.538 0 CA-C-O 121.132 0.491 . . . . 1.0800000000000001 110.288 179.663 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A 1640 ' ' TRP . . . . . 0.497 ' HA ' ' HA ' ' A' 1624 ' ' PRO . 14.8 t90 -96.26 90.8 5.6 Favored 'General case' 0 N--CA 1.425 -1.699 0 N-CA-C 107.755 -1.202 . . . . 0.80000000000000004 107.755 176.955 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A 1641 ' ' HIS . . . . . 0.721 ' HB2' ' HB3' ' A' 1615 ' ' ARG . 0.8 OUTLIER -71.87 99.13 2.14 Favored 'General case' 0 C--N 1.311 -1.097 0 CA-C-N 115.223 -0.898 . . . . 2.54 110.072 175.093 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A 1642 ' ' THR . . . . . . . . . . . . . 5.6 t -142.89 149.59 50.15 Favored Pre-proline 0 C--N 1.295 -1.77 0 CA-C-N 114.741 -1.118 . . . . 1.1499999999999999 109.009 -172.655 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A 1643 ' ' PRO . . . . . 0.468 ' HB3' ' HB3' ' A' 1616 ' ' PRO . 45.6 Cg_endo -73.07 -9.85 23.89 Favored 'Trans proline' 0 C--O 1.215 -0.675 0 C-N-CA 122.858 2.372 . . . . 0.80000000000000004 112.301 176.187 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A 1644 ' ' LEU . . . . . . . . . . . . . 81.9 mt -87.69 3.83 46.4 Favored 'General case' 0 C--N 1.318 -0.801 0 C-N-CA 122.713 0.405 . . . . 1.54 111.292 -177.748 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A 1645 ' ' ALA . . . . . . . . . . . . . . . -80.45 -30.13 37.55 Favored 'General case' 0 C--N 1.317 -0.822 0 N-CA-C 112.383 0.512 . . . . 0.94999999999999996 112.383 -176.61 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A 1646 ' ' CYS . . . . . . . . . . . . . 21.1 p -172.06 -179.57 2.4 Favored 'General case' 0 C--N 1.306 -1.297 0 N-CA-C 105.667 -1.975 . . . . 1.4099999999999999 105.667 179.594 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A 1647 ' ' GLU . . . . . . . . . . . . . 56.3 mm-40 . . . . . 0 C--N 1.312 -1.024 0 N-CA-C 107.747 -1.205 . . . . 2.9199999999999999 107.747 174.479 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A 1515 ' ' ASP . . . . . . . . . . . . . 23.6 t70 . . . . . 0 N--CA 1.443 -0.818 0 N-CA-C 107.158 -1.423 . . . . 2.54 107.158 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A 1516 ' ' CYS . . . . . . . . . . . . . 71.0 m -83.98 77.24 9.96 Favored 'General case' 0 C--N 1.303 -1.425 0 CA-C-O 121.048 0.451 . . . . 1.25 110.363 179.427 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A 1517 ' ' GLN . . . . . . . . . . . . . 12.9 pt20 -142.54 152.98 43.17 Favored 'General case' 0 C--N 1.306 -1.283 0 O-C-N 121.977 -0.452 . . . . 1.8799999999999999 111.375 -178.56 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A 1518 ' ' VAL . . . . . 0.561 ' HB ' ' HD2' ' A' 1527 ' ' PHE . 59.2 t -138.59 130.51 37.49 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.86 0 N-CA-C 109.315 -0.624 . . . . 1.73 109.315 -179.759 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A 1519 ' ' THR . . . . . . . . . . . . . 26.6 m -102.67 115.33 30.36 Favored 'General case' 0 C--N 1.306 -1.303 0 N-CA-C 108.217 -1.031 . . . . 1.7 108.217 173.982 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A 1520 ' ' ASN . . . . . . . . . . . . . 25.9 t-20 -74.17 130.43 82.62 Favored Pre-proline 0 C--N 1.313 -0.98 0 N-CA-C 110.122 -0.325 . . . . 2.1200000000000001 110.122 178.934 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A 1521 ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -74.75 -16.92 20.63 Favored 'Trans proline' 0 CA--C 1.543 0.947 0 C-N-CA 122.744 2.296 . . . . 2.4700000000000002 114.749 -176.375 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A 1522 ' ' SER . . . . . . . . . . . . . 16.5 m -91.93 -60.86 1.75 Allowed 'General case' 0 C--N 1.314 -0.942 0 N-CA-C 112.044 0.387 . . . . 2.5699999999999998 112.044 -176.32 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A 1523 ' ' THR . . . . . . . . . . . . . 8.8 t -94.71 -10.06 32.85 Favored 'General case' 0 C--N 1.316 -0.861 0 CA-C-O 121.474 0.654 . . . . 2.1499999999999999 111.202 -176.153 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A 1524 ' ' GLY . . . . . . . . . . . . . . . 75.0 18.46 80.2 Favored Glycine 0 C--O 1.223 -0.559 0 CA-C-N 115.871 -0.604 . . . . 1.8899999999999999 112.61 179.093 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A 1525 ' ' HIS . . . . . . . . . . . . . 17.6 t60 -75.65 128.07 34.43 Favored 'General case' 0 C--N 1.308 -1.212 0 N-CA-C 109.751 -0.463 . . . . 1.8999999999999999 109.751 -176.95 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A 1526 ' ' LEU . . . . . . . . . . . . . 3.5 tm? -94.39 120.15 34.2 Favored 'General case' 0 C--N 1.299 -1.603 0 N-CA-C 106.626 -1.62 . . . . 1.6100000000000001 106.626 177.451 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A 1527 ' ' PHE . . . . . 0.561 ' HD2' ' HB ' ' A' 1518 ' ' VAL . 86.1 m-85 -89.03 109.94 20.71 Favored 'General case' 0 C--N 1.297 -1.679 0 CA-C-N 116.525 -0.307 . . . . 1.4199999999999999 110.28 -178.574 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A 1528 ' ' ASP . . . . . . . . . . . . . 13.5 m-20 -81.8 87.3 6.36 Favored 'General case' 0 CA--C 1.494 -1.198 0 CA-C-N 115.913 -0.585 . . . . 2.1800000000000002 110.484 179.556 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A 1529 ' ' LEU . . . . . 0.702 ' HA ' HD23 ' A' 1532 ' ' LEU . 85.7 mt -99.09 -9.61 23.62 Favored 'General case' 0 C--N 1.302 -1.493 0 N-CA-C 108.95 -0.759 . . . . 1.4399999999999999 108.95 178.269 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A 1530 ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -62.98 -25.4 68.36 Favored 'General case' 0 C--N 1.318 -0.781 0 C-N-CA 125.166 1.386 . . . . 1.4399999999999999 109.314 175.623 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A 1531 ' ' SER . . . . . . . . . . . . . 34.3 t -77.34 -9.21 58.7 Favored 'General case' 0 N--CA 1.427 -1.582 0 CA-C-N 114.279 -1.328 . . . . 1.5 109.654 -179.699 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A 1532 ' ' LEU . . . . . 0.702 HD23 ' HA ' ' A' 1529 ' ' LEU . 3.5 mm? -95.87 10.03 38.55 Favored 'General case' 0 C--O 1.245 0.855 0 CA-C-N 115.898 -0.592 . . . . 1.77 111.356 177.805 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A 1533 ' ' SER . . . . . 0.565 ' HA ' ' O ' ' A' 1553 ' ' CYS . 42.3 m -76.58 107.79 9.12 Favored 'General case' 0 N--CA 1.436 -1.15 0 N-CA-C 107.745 -1.206 . . . . 2.3799999999999999 107.745 172.894 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A 1534 ' ' GLY . . . . . . . . . . . . . . . -110.19 151.33 17.49 Favored Glycine 0 N--CA 1.436 -1.366 0 C-N-CA 120.655 -0.783 . . . . 1.55 112.957 -174.343 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A 1535 ' ' ARG . . . . . . . . . . . . . 40.7 ttm180 -72.36 -62.53 1.41 Allowed 'General case' 0 C--N 1.314 -0.942 0 CA-C-O 121.149 0.499 . . . . 3.96 110.38 178.451 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A 1536 ' ' ALA . . . . . . . . . . . . . . . -93.57 -6.38 46.75 Favored 'General case' 0 C--N 1.309 -1.19 0 C-N-CA 120.028 -0.669 . . . . 1.6499999999999999 109.484 179.386 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A 1537 ' ' GLY . . . . . . . . . . . . . . . 79.49 -152.85 36.26 Favored Glycine 0 N--CA 1.436 -1.359 0 CA-C-N 115.454 -0.794 . . . . 1.1899999999999999 112.671 176.397 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A 1538 ' ' PHE . . . . . . . . . . . . . 87.1 m-85 -120.18 155.07 33.86 Favored 'General case' 0 C--N 1.29 -2.003 0 N-CA-C 107.754 -1.202 . . . . 1.6899999999999999 107.754 179.885 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A 1539 ' ' THR . . . . . . . . . . . . . 24.1 p -112.14 111.93 23.18 Favored 'General case' 0 C--N 1.293 -1.865 0 CA-C-O 121.359 0.599 . . . . 1.48 111.068 -179.409 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A 1540 ' ' ALA . . . . . . . . . . . . . . . -96.8 139.26 33.12 Favored 'General case' 0 C--N 1.3 -1.568 0 N-CA-C 109.075 -0.713 . . . . 0.82999999999999996 109.075 -179.618 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A 1541 ' ' ALA . . . . . . . . . . . . . . . -80.69 132.87 35.62 Favored 'General case' 0 C--N 1.311 -1.107 0 CA-C-N 115.862 -0.608 . . . . 1.27 110.159 -177.79 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A 1542 ' ' TYR . . . . . 0.477 ' HB3' ' O ' ' A' 1546 ' ' GLY . 45.6 t80 -145.75 156.25 43.48 Favored 'General case' 0 C--N 1.313 -0.999 0 CA-C-N 116.402 -0.363 . . . . 2.1499999999999999 110.499 -179.134 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A 1543 ' ' SER . . . . . . . . . . . . . 5.5 m -41.25 -153.07 0.0 OUTLIER 'General case' 0 CA--C 1.585 2.305 0 C-N-CA 129.921 3.288 . . . . 2.29 116.58 -176.426 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A 1544 ' ' LYS . . . . . . . . . . . . . 61.2 mttp -51.7 -24.77 6.13 Favored 'General case' 0 N--CA 1.484 1.274 0 O-C-N 120.627 -1.296 . . . . 3.9100000000000001 113.773 -179.655 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A 1545 ' ' SER . . . . . . . . . . . . . 22.7 t -71.98 -14.71 61.97 Favored 'General case' 0 CA--C 1.553 1.076 0 N-CA-C 111.87 0.322 . . . . 3.2999999999999998 111.87 178.239 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A 1546 ' ' GLY . . . . . 0.477 ' O ' ' HB3' ' A' 1542 ' ' TYR . . . 96.07 -153.36 20.53 Favored Glycine 0 C--O 1.216 -1.031 0 C-N-CA 119.707 -1.235 . . . . 1.24 113.763 173.491 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A 1547 ' ' VAL . . . . . . . . . . . . . 95.6 t -91.96 139.87 17.11 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.653 0 C-N-CA 123.11 0.564 . . . . 1.6299999999999999 110.47 -173.751 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A 1548 ' ' VAL . . . . . . . . . . . . . 2.4 t -103.27 131.32 51.96 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.971 0 N-CA-C 107.679 -1.23 . . . . 0.92000000000000004 107.679 179.211 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A 1549 ' ' TYR . . . . . 0.419 ' CE1' ' HA3' ' A' 1568 ' ' GLY . 75.9 m-85 -97.1 115.19 27.06 Favored 'General case' 0 C--N 1.295 -1.789 0 N-CA-C 107.17 -1.418 . . . . 1.4399999999999999 107.17 175.129 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A 1550 ' ' MET . . . . . . . . . . . . . 2.7 ppp? -138.34 142.5 39.71 Favored 'General case' 0 C--N 1.291 -1.957 0 CA-C-O 121.172 0.511 . . . . 1.74 111.829 -177.611 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A 1551 ' ' SER . . . . . . . . . . . . . 47.3 m -109.04 149.59 29.04 Favored 'General case' 0 C--N 1.279 -2.463 0 N-CA-C 108.084 -1.08 . . . . 1.6399999999999999 108.084 177.417 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A 1552 ' ' ILE . . . . . . . . . . . . . 41.6 mm -74.49 -51.64 22.25 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.627 0 N-CA-C 107.385 -1.339 . . . . 1.3300000000000001 107.385 176.188 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A 1553 ' ' CYS . . . . . 0.565 ' O ' ' HA ' ' A' 1533 ' ' SER . 80.9 m -134.27 147.53 50.65 Favored 'General case' 0 C--N 1.29 -2.01 0 N-CA-C 107.346 -1.353 . . . . 1.4299999999999999 107.346 175.141 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A 1554 ' ' GLY . . . . . . . . . . . . . . . 97.99 176.05 33.45 Favored Glycine 0 N--CA 1.427 -1.952 0 C-N-CA 120.591 -0.814 . . . . 1.1200000000000001 111.433 178.294 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A 1555 ' ' GLU . . . . . . . . . . . . . 10.9 pt-20 -89.84 145.74 24.94 Favored 'General case' 0 C--N 1.303 -1.451 0 N-CA-C 109.823 -0.436 . . . . 1.8 109.823 -179.828 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A 1556 ' ' ASN . . . . . . . . . . . . . 20.9 t-20 -93.02 114.24 26.74 Favored 'General case' 0 C--N 1.305 -1.343 0 N-CA-C 108.543 -0.91 . . . . 2.6299999999999999 108.543 -178.608 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A 1557 ' ' GLU . . . . . . . . . . . . . 51.2 mt-10 -87.23 51.34 2.21 Favored 'General case' 0 C--N 1.294 -1.832 0 N-CA-C 113.178 0.807 . . . . 3.79 113.178 -172.505 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A 1558 ' ' ASN . . . . . . . . . . . . . 36.6 m-80 -133.99 -0.12 3.12 Favored 'General case' 0 C--N 1.311 -1.105 0 CA-C-N 115.781 -0.645 . . . . 1.52 109.79 175.839 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A 1559 ' ' CYS . . . . . 0.63 ' HB3' ' HD2' ' A' 1560 ' ' PRO . 87.4 m -150.86 171.87 5.96 Favored Pre-proline 0 C--N 1.311 -1.08 0 N-CA-C 106.959 -1.497 . . . . 0.83999999999999997 106.959 -178.764 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A 1560 ' ' PRO . . . . . 0.63 ' HD2' ' HB3' ' A' 1559 ' ' CYS . 44.2 Cg_exo -27.63 129.61 0.03 OUTLIER 'Trans proline' 0 C--N 1.384 2.435 0 C-N-CA 124.948 3.765 . . . . 1.1799999999999999 114.526 177.454 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A 1561 ' ' PRO . . . . . 0.509 ' HD3' ' HA ' ' A' 1560 ' ' PRO . 37.3 Cg_exo -58.36 116.33 3.17 Favored 'Trans proline' 0 C--O 1.241 0.663 0 C-N-CA 123.277 2.651 . . . . 1.51 112.365 -178.188 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A 1562 ' ' GLY . . . . . . . . . . . . . . . 122.33 -9.94 9.38 Favored Glycine 0 N--CA 1.442 -0.9 0 C-N-CA 120.798 -0.715 . . . . 0.71999999999999997 112.905 177.858 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A 1563 ' ' VAL . . . . . 0.421 ' HA ' ' HA ' ' A' 1576 ' ' LYS . 2.4 m -92.64 153.72 3.27 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.093 0 N-CA-C 107.85 -1.167 . . . . 0.96999999999999997 107.85 179.242 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A 1564 ' ' GLY . . . . . . . . . . . . . . . -118.68 -18.73 4.71 Favored Glycine 0 C--N 1.297 -1.585 0 C-N-CA 120.284 -0.96 . . . . 0.71999999999999997 112.656 -177.21 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A 1565 ' ' ALA . . . . . . . . . . . . . . . -139.5 122.35 16.56 Favored 'General case' 0 C--N 1.314 -0.941 0 N-CA-C 108.862 -0.792 . . . . 0.37 108.862 178.994 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A 1566 ' ' CYS . . . . . . . . . . . . . 39.6 t -150.28 144.44 25.56 Favored 'General case' 0 C--N 1.306 -1.297 0 CA-C-N 116.599 -0.273 . . . . 0.51000000000000001 110.586 -174.812 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A 1567 ' ' PHE . . . . . . . . . . . . . 26.1 m-85 -76.89 123.85 26.88 Favored 'General case' 0 C--O 1.211 -0.96 0 N-CA-C 107.599 -1.259 . . . . 0.96999999999999997 107.599 175.38 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A 1568 ' ' GLY . . . . . 0.419 ' HA3' ' CE1' ' A' 1549 ' ' TYR . . . -69.16 -27.84 73.39 Favored Glycine 0 C--N 1.315 -0.59 0 N-CA-C 114.561 0.584 . . . . 1.0800000000000001 114.561 -175.445 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A 1569 ' ' GLN . . . . . . . . . . . . . 35.3 tt0 -77.44 -47.33 19.99 Favored 'General case' 0 C--N 1.315 -0.906 0 O-C-N 122.47 -0.429 . . . . 2.7400000000000002 111.481 -178.248 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A 1570 ' ' THR . . . . . . . . . . . . . 18.6 p -96.31 -13.36 23.38 Favored 'General case' 0 C--N 1.308 -1.221 0 N-CA-C 113.034 0.753 . . . . 1.96 113.034 -176.21 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A 1571 ' ' ARG . . . . . . . . . . . . . 21.7 mtp180 57.6 40.72 26.54 Favored 'General case' 0 CA--C 1.51 -0.573 0 C-N-CA 124.924 1.29 . . . . 3.9500000000000002 113.007 -179.456 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A 1572 ' ' ILE . . . . . . . . . . . . . 66.0 mt -106.4 126.45 62.11 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.18 0 CA-C-N 114.733 -1.121 . . . . 1.3700000000000001 108.327 178.981 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A 1573 ' ' SER . . . . . . . . . . . . . 37.7 t -75.6 136.88 40.48 Favored 'General case' 0 C--N 1.309 -1.186 0 CA-C-N 115.449 -0.796 . . . . 1.0800000000000001 111.383 -176.95 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A 1574 ' ' VAL . . . . . . . . . . . . . 22.8 m -129.81 21.14 2.2 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.395 0 CA-C-O 121.995 0.903 . . . . 1.3 110.196 177.778 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A 1575 ' ' GLY . . . . . . . . . . . . . . . 176.87 119.04 0.56 Allowed Glycine 0 N--CA 1.422 -2.243 0 CA-C-N 114.576 -1.193 . . . . 0.51000000000000001 111.274 177.117 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A 1576 ' ' LYS . . . . . 0.421 ' HA ' ' HA ' ' A' 1563 ' ' VAL . 46.9 tptt -75.45 151.54 38.06 Favored 'General case' 0 C--N 1.31 -1.147 0 N-CA-C 106.001 -1.852 . . . . 2.8999999999999999 106.001 175.52 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A 1577 ' ' ALA . . . . . . . . . . . . . . . -70.94 95.08 1.13 Allowed 'General case' 0 C--N 1.314 -0.942 0 N-CA-C 109.273 -0.64 . . . . 0.82999999999999996 109.273 -179.126 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A 1578 ' ' ASN . . . . . . . . . . . . . 6.9 m-20 -104.66 142.4 34.75 Favored 'General case' 0 C--N 1.3 -1.553 0 CA-C-N 115.439 -0.8 . . . . 1.8500000000000001 111.117 -178.337 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A 1579 ' ' LYS . . . . . . . . . . . . . 9.9 mmmm -105.89 89.03 2.95 Favored 'General case' 0 C--N 1.287 -2.148 0 N-CA-C 106.079 -1.823 . . . . 1.8999999999999999 106.079 173.792 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A 1580 ' ' ARG . . . . . 0.518 ' HD3' ' HB ' ' A' 1591 ' ' VAL . 70.0 ttt180 -146.62 97.76 2.96 Favored 'General case' 0 C--N 1.303 -1.435 0 CA-C-N 115.183 -0.917 . . . . 3.6299999999999999 109.457 -173.023 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A 1581 ' ' LEU . . . . . . . . . . . . . 54.3 tp -118.93 144.57 46.36 Favored 'General case' 0 C--N 1.299 -1.627 0 CA-C-N 115.9 -0.591 . . . . 1.8700000000000001 109.941 -176.622 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A 1582 ' ' ARG . . . . . . . . . . . . . 49.5 mtp180 -132.96 136.41 46.08 Favored 'General case' 0 C--N 1.309 -1.155 0 C-N-CA 123.416 0.686 . . . . 3.9700000000000002 109.907 179.185 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A 1583 ' ' TYR . . . . . . . . . . . . . 7.8 t80 -92.9 104.77 16.98 Favored 'General case' 0 C--N 1.311 -1.09 0 CA-C-O 121.56 0.695 . . . . 1.4099999999999999 109.894 174.184 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A 1584 ' ' VAL . . . . . 0.555 ' HB ' HG13 ' A' 1587 ' ' VAL . 35.0 t -109.69 149.26 12.85 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.648 0 N-CA-C 105.245 -2.131 . . . . 1.6899999999999999 105.245 175.301 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A 1585 ' ' ASP . . . . . . . . . . . . . 35.8 t70 -46.34 102.68 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.376 0 C-N-CA 124.473 1.109 . . . . 2.0600000000000001 113.713 -177.968 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A 1586 ' ' GLN . . . . . . . . . . . . . 49.8 mt-30 58.41 35.25 24.63 Favored 'General case' 0 C--O 1.249 1.033 0 C-N-CA 124.828 1.251 . . . . 2.3300000000000001 112.477 179.911 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A 1587 ' ' VAL . . . . . 0.555 HG13 ' HB ' ' A' 1584 ' ' VAL . 7.7 p -164.69 104.54 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.436 -1.158 0 CA-C-O 122.06 0.933 . . . . 0.78000000000000003 110.616 175.433 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A 1588 ' ' LEU . . . . . 0.52 ' HB2' ' HB2' ' A' 1612 ' ' PHE . 44.2 mt -78.62 141.25 38.17 Favored 'General case' 0 C--N 1.294 -1.845 0 N-CA-C 107.71 -1.218 . . . . 1.4099999999999999 107.71 176.295 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A 1589 ' ' GLN . . . . . . . . . . . . . 36.0 tt0 -125.27 117.62 24.21 Favored 'General case' 0 C--N 1.284 -2.253 0 N-CA-C 109.642 -0.503 . . . . 1.24 109.642 -177.835 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A 1590 ' ' LEU . . . . . 0.431 ' HA ' ' O ' ' A' 1580 ' ' ARG . 4.9 tt -116.16 123.25 47.35 Favored 'General case' 0 C--N 1.304 -1.381 0 N-CA-C 106.72 -1.585 . . . . 1.1499999999999999 106.72 178.354 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A 1591 ' ' VAL . . . . . 0.518 ' HB ' ' HD3' ' A' 1580 ' ' ARG . 60.9 t -110.94 127.76 67.82 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.131 0 N-CA-C 113.633 0.975 . . . . 1.51 113.633 -171.05 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A 1592 ' ' TYR . . . . . . . . . . . . . 5.6 m-30 -109.08 143.49 38.37 Favored 'General case' 0 C--N 1.32 -0.677 0 N-CA-C 107.783 -1.192 . . . . 1.0600000000000001 107.783 171.378 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A 1593 ' ' LYS . . . . . 0.454 ' HA ' ' HA ' ' A' 1607 ' ' LYS . 13.4 ptmm? -158.96 -177.24 6.37 Favored 'General case' 0 C--N 1.3 -1.58 0 N-CA-C 108.601 -0.889 . . . . 2.1800000000000002 108.601 179.82 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A 1594 ' ' ASP . . . . . . . . . . . . . 22.0 m-20 64.57 43.31 4.45 Favored 'General case' 0 C--O 1.247 0.936 0 O-C-N 124.147 0.904 . . . . 1.45 112.107 177.724 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A 1595 ' ' GLY . . . . . . . . . . . . . . . -80.83 -104.34 0.31 Allowed Glycine 0 N--CA 1.437 -1.29 0 N-CA-C 111.088 -0.805 . . . . 0.78000000000000003 111.088 176.309 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A 1596 ' ' SER . . . . . . . . . . . . . 17.7 m -114.11 152.34 45.74 Favored Pre-proline 0 C--N 1.29 -2.013 0 N-CA-C 107.958 -1.127 . . . . 1.6799999999999999 107.958 177.558 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A 1597 ' ' PRO . . . . . . . . . . . . . 24.7 Cg_exo -62.37 143.39 93.55 Favored 'Trans proline' 0 C--O 1.248 0.99 0 C-N-CA 122.663 2.242 . . . . 1.1699999999999999 111.193 179.143 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A 1598 ' ' CYS . . . . . . . . . . . . . 45.9 t -96.25 133.15 25.39 Favored Pre-proline 0 C--N 1.29 -2.005 0 CA-C-N 115.844 -0.616 . . . . 1.1899999999999999 110.41 -177.071 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A 1599 ' ' PRO . . . . . . . . . . . . . 88.2 Cg_endo -88.3 -7.43 5.91 Favored 'Trans proline' 0 CA--C 1.537 0.659 0 C-N-CA 122.68 2.253 . . . . 1.5900000000000001 112.141 178.013 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A 1600 ' ' SER . . . . . . . . . . . . . 16.5 m -84.27 -34.04 23.88 Favored 'General case' 0 N--CA 1.446 -0.645 0 CA-C-O 121.25 0.548 . . . . 2.1200000000000001 110.075 -179.87 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A 1601 ' ' LYS . . . . . 0.548 ' HG2' HD12 ' A' 1604 ' ' LEU . 15.8 tppt? -139.64 118.68 12.61 Favored 'General case' 0 N--CA 1.431 -1.379 0 N-CA-C 107.653 -1.24 . . . . 3.7400000000000002 107.653 178.185 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A 1602 ' ' SER . . . . . . . . . . . . . 22.9 m -72.85 134.39 44.84 Favored 'General case' 0 C--N 1.297 -1.705 0 CA-C-O 121.28 0.562 . . . . 3.79 110.481 -177.587 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A 1603 ' ' GLY . . . . . . . . . . . . . . . 97.61 -7.45 63.43 Favored Glycine 0 N--CA 1.439 -1.125 0 N-CA-C 110.876 -0.89 . . . . 2.0 110.876 -179.756 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A 1604 ' ' LEU . . . . . 0.548 HD12 ' HG2' ' A' 1601 ' ' LYS . 2.2 mt -105.72 148.88 26.94 Favored 'General case' 0 C--N 1.303 -1.424 0 C-N-CA 123.107 0.563 . . . . 1.48 110.873 179.658 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A 1605 ' ' SER . . . . . . . . . . . . . 52.3 m -113.2 -167.45 1.19 Allowed 'General case' 0 C--N 1.287 -2.114 0 N-CA-C 106.356 -1.72 . . . . 1.51 106.356 173.286 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A 1606 ' ' TYR . . . . . . . . . . . . . 44.0 m-85 -108.07 128.24 54.5 Favored 'General case' 0 N--CA 1.399 -2.992 0 N-CA-C 107.223 -1.399 . . . . 1.1799999999999999 107.223 -179.963 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A 1607 ' ' LYS . . . . . 0.556 ' HG3' HG23 ' A' 1635 ' ' THR . 21.7 ptmt -125.4 154.38 42.01 Favored 'General case' 0 N--CA 1.397 -3.097 0 O-C-N 124.56 1.163 . . . . 1.6699999999999999 109.407 -177.68 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A 1608 ' ' SER . . . . . 0.494 ' HB3' ' HE2' ' A' 1638 ' ' PHE . 51.1 m -132.38 118.36 19.29 Favored 'General case' 0 C--N 1.296 -1.735 0 N-CA-C 109.598 -0.519 . . . . 1.0 109.598 -178.53 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A 1609 ' ' VAL . . . . . 0.436 HG22 HG13 ' A' 1591 ' ' VAL . 88.1 t -104.12 124.68 58.7 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.558 0 N-CA-C 109.224 -0.658 . . . . 0.93000000000000005 109.224 178.882 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A 1610 ' ' ILE . . . . . . . . . . . . . 3.1 mp -99.51 117.81 45.2 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.41 0 N-CA-C 108.473 -0.936 . . . . 0.78000000000000003 108.473 178.156 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A 1611 ' ' SER . . . . . . . . . . . . . 62.9 p -103.45 125.75 50.21 Favored 'General case' 0 N--CA 1.42 -1.928 0 N-CA-C 109.48 -0.563 . . . . 1.29 109.48 177.342 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A 1612 ' ' PHE . . . . . 0.52 ' HB2' ' HB2' ' A' 1588 ' ' LEU . 15.3 m-85 -94.51 107.47 19.45 Favored 'General case' 0 C--N 1.296 -1.735 0 N-CA-C 107.708 -1.219 . . . . 0.69999999999999996 107.708 179.544 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A 1613 ' ' VAL . . . . . 0.652 HG12 ' HG2' ' A' 1615 ' ' ARG . 97.2 t -103.73 134.41 45.02 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.958 0 N-CA-C 109.86 -0.422 . . . . 0.75 109.86 -177.018 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A 1614 ' ' CYS . . . . . . . . . . . . . 62.6 m -77.1 91.8 3.72 Favored 'General case' 0 N--CA 1.436 -1.166 0 CA-C-O 121.984 0.897 . . . . 1.3899999999999999 109.879 -178.384 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A 1615 ' ' ARG . . . . . 0.761 ' HB2' ' HB2' ' A' 1641 ' ' HIS . 12.9 mmt180 -137.52 103.04 8.62 Favored Pre-proline 0 C--N 1.293 -1.865 0 N-CA-C 106.336 -1.727 . . . . 3.75 106.336 176.662 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A 1616 ' ' PRO . . . . . . . . . . . . . 32.6 Cg_endo -68.03 73.22 0.75 Allowed 'Trans proline' 0 C--O 1.245 0.857 0 C-N-CA 122.441 2.094 . . . . 1.3200000000000001 111.956 177.843 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A 1617 ' ' GLU . . . . . . . . . . . . . 48.8 mt-10 . . . . . 0 N--CA 1.431 -1.404 0 CA-C-N 114.653 -1.158 . . . . 3.21 109.816 176.659 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A 1622 ' ' ASN . . . . . . . . . . . . . 58.0 t30 . . . . . 0 CA--C 1.535 0.37 0 CA-C-O 122.056 0.931 . . . . 2.9199999999999999 109.079 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A 1623 ' ' ARG . . . . . . . . . . . . . 19.7 ptp180 -155.17 154.71 29.1 Favored Pre-proline 0 C--N 1.3 -1.585 0 N-CA-C 106.998 -1.482 . . . . 3.6099999999999999 106.998 179.69 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A 1624 ' ' PRO . . . . . . . . . . . . . 23.0 Cg_exo -66.1 117.47 4.7 Favored 'Trans proline' 0 N--CA 1.459 -0.522 0 C-N-CA 122.789 2.326 . . . . 2.3700000000000001 112.339 -179.648 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A 1625 ' ' MET . . . . . . . . . . . . . 48.3 ttm -90.9 133.16 35.47 Favored 'General case' 0 C--N 1.306 -1.289 0 N-CA-C 108.46 -0.941 . . . . 2.1600000000000001 108.46 -179.785 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A 1626 ' ' LEU . . . . . 0.434 HD21 HD23 ' A' 1629 ' ' LEU . 29.0 tp -85.22 91.8 8.24 Favored 'General case' 0 C--N 1.294 -1.806 0 N-CA-C 108.715 -0.846 . . . . 1.3500000000000001 108.715 179.272 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A 1627 ' ' ILE . . . . . . . . . . . . . 32.6 pt -86.05 -27.64 6.18 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.611 0 CA-C-N 115.851 -0.613 . . . . 1.21 111.893 -175.118 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A 1628 ' ' SER . . . . . 0.803 ' HB2' ' HB2' ' A' 1637 ' ' PHE . 18.2 m -132.1 129.04 39.4 Favored 'General case' 0 N--CA 1.427 -1.578 0 CA-C-O 121.087 0.47 . . . . 1.3999999999999999 110.825 -175.594 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A 1629 ' ' LEU . . . . . 0.59 HD22 ' HG ' ' A' 1636 ' ' LEU . 1.5 tm? -129.77 109.27 10.81 Favored 'General case' 0 C--N 1.296 -1.756 0 N-CA-C 105.393 -2.077 . . . . 1.5600000000000001 105.393 177.094 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A 1630 ' ' ASP . . . . . . . . . . . . . 22.9 t70 -105.45 112.59 25.75 Favored 'General case' 0 C--N 1.297 -1.682 0 C-N-CA 118.95 -1.1 . . . . 0.87 110.135 179.35 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A 1631 ' ' LYS . . . . . . . . . . . . . 28.7 mtpp -71.77 -37.65 70.44 Favored 'General case' 0 C--N 1.306 -1.308 0 CA-C-N 114.621 -1.172 . . . . 2.3500000000000001 112.946 -175.923 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A 1632 ' ' GLN . . . . . . . . . . . . . 8.7 pt20 -75.02 -31.26 61.31 Favored 'General case' 0 CA--C 1.535 0.394 0 N-CA-C 112.906 0.706 . . . . 2.5499999999999998 112.906 -174.444 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A 1633 ' ' THR . . . . . . . . . . . . . 54.7 p -99.46 -1.55 38.23 Favored 'General case' 0 C--O 1.245 0.83 0 C-N-CA 120.073 -0.651 . . . . 1.24 111.198 177.8 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A 1634 ' ' CYS . . . . . . . . . . . . . 18.4 m 60.74 40.28 16.35 Favored 'General case' 0 C--N 1.352 0.699 0 CA-C-O 122.114 0.959 . . . . 0.89000000000000001 110.466 174.366 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A 1635 ' ' THR . . . . . 0.556 HG23 ' HG3' ' A' 1607 ' ' LYS . 27.5 m -124.04 132.5 53.69 Favored 'General case' 0 N--CA 1.435 -1.202 0 CA-C-N 115.207 -0.906 . . . . 0.75 111.512 -173.802 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A 1636 ' ' LEU . . . . . 0.59 ' HG ' HD22 ' A' 1629 ' ' LEU . 6.2 mp -102.87 141.32 35.88 Favored 'General case' 0 C--N 1.313 -1.0 0 N-CA-C 109.113 -0.699 . . . . 1.3300000000000001 109.113 175.93 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A 1637 ' ' PHE . . . . . 0.803 ' HB2' ' HB2' ' A' 1628 ' ' SER . 90.9 m-85 -124.22 106.85 10.62 Favored 'General case' 0 C--O 1.25 1.119 0 CA-C-O 121.362 0.601 . . . . 0.82999999999999996 111.448 177.928 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A 1638 ' ' PHE . . . . . 0.494 ' HE2' ' HB3' ' A' 1608 ' ' SER . 86.3 m-85 -91.75 144.51 25.43 Favored 'General case' 0 C--N 1.31 -1.14 0 CA-C-N 115.508 -0.769 . . . . 0.59999999999999998 109.223 178.317 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A 1639 ' ' SER . . . . . . . . . . . . . 28.8 m -129.42 114.89 16.72 Favored 'General case' 0 C--N 1.292 -1.92 0 CA-C-O 120.924 0.393 . . . . 1.0800000000000001 110.136 178.777 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A 1640 ' ' TRP . . . . . . . . . . . . . 19.3 t90 -108.52 113.36 26.33 Favored 'General case' 0 C--N 1.296 -1.73 0 N-CA-C 109.248 -0.649 . . . . 0.80000000000000004 109.248 177.777 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A 1641 ' ' HIS . . . . . 0.761 ' HB2' ' HB2' ' A' 1615 ' ' ARG . 7.3 p-80 -79.81 104.47 10.41 Favored 'General case' 0 C--N 1.317 -0.846 0 CA-C-N 115.305 -0.861 . . . . 2.54 108.936 176.253 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A 1642 ' ' THR . . . . . 0.492 ' HA ' ' HD3' ' A' 1643 ' ' PRO . 8.9 t -143.08 144.35 28.48 Favored Pre-proline 0 C--N 1.285 -2.198 0 C-N-CA 120.069 -0.652 . . . . 1.1499999999999999 112.046 -173.366 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A 1643 ' ' PRO . . . . . 0.492 ' HD3' ' HA ' ' A' 1642 ' ' THR . 4.9 Cg_exo -79.1 -0.74 11.0 Favored 'Trans proline' 0 N--CA 1.451 -1.013 0 C-N-CA 123.298 2.665 . . . . 0.80000000000000004 110.328 171.831 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A 1644 ' ' LEU . . . . . . . . . . . . . 89.6 mt -91.07 3.87 53.61 Favored 'General case' 0 C--O 1.225 -0.207 0 CA-C-N 115.771 -0.65 . . . . 1.54 109.73 176.268 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A 1645 ' ' ALA . . . . . . . . . . . . . . . -86.51 -42.43 13.55 Favored 'General case' 0 C--N 1.317 -0.805 0 N-CA-C 108.14 -1.059 . . . . 0.94999999999999996 108.14 175.988 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A 1646 ' ' CYS . . . . . . . . . . . . . 16.0 p -176.82 161.46 2.01 Favored 'General case' 0 N--CA 1.43 -1.471 0 N-CA-C 102.993 -2.966 . . . . 1.4099999999999999 102.993 174.453 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A 1647 ' ' GLU . . . . . . . . . . . . . 41.7 mt-10 . . . . . 0 C--N 1.309 -1.155 0 CA-C-N 118.624 0.647 . . . . 2.9199999999999999 110.784 -179.684 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A 1515 ' ' ASP . . . . . . . . . . . . . 11.3 t70 . . . . . 0 N--CA 1.437 -1.118 0 N-CA-C 106.836 -1.542 . . . . 2.54 106.836 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A 1516 ' ' CYS . . . . . 0.664 ' SG ' ' HE3' ' A' 1579 ' ' LYS . 11.6 m -82.64 81.93 8.22 Favored 'General case' 0 C--N 1.299 -1.629 0 N-CA-C 109.381 -0.6 . . . . 1.25 109.381 -176.812 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A 1517 ' ' GLN . . . . . . . . . . . . . 14.2 pt20 -165.39 176.69 8.07 Favored 'General case' 0 C--N 1.32 -0.68 0 N-CA-C 110.147 -0.316 . . . . 1.8799999999999999 110.147 179.39 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A 1518 ' ' VAL . . . . . 0.704 ' HB ' HD11 ' A' 1581 ' ' LEU . 4.5 p -148.76 131.32 6.61 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.863 0 CA-C-N 116.068 -0.515 . . . . 1.73 110.131 176.454 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A 1519 ' ' THR . . . . . . . . . . . . . 4.8 m -105.97 123.97 48.83 Favored 'General case' 0 C--N 1.312 -1.039 0 N-CA-C 109.775 -0.454 . . . . 1.7 109.775 179.181 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A 1520 ' ' ASN . . . . . . . . . . . . . 24.8 t-20 -83.86 113.29 46.58 Favored Pre-proline 0 C--N 1.314 -0.971 0 N-CA-C 108.966 -0.753 . . . . 2.1200000000000001 108.966 175.661 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A 1521 ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -75.55 -15.83 19.36 Favored 'Trans proline' 0 C--N 1.344 0.326 0 C-N-CA 122.221 1.947 . . . . 2.4700000000000002 113.552 -174.958 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A 1522 ' ' SER . . . . . . . . . . . . . 12.2 m -68.25 -54.75 15.5 Favored 'General case' 0 N--CA 1.432 -1.344 0 CA-C-N 116.494 -0.321 . . . . 2.5699999999999998 110.785 -177.925 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A 1523 ' ' THR . . . . . 0.465 HG23 ' HB2' ' A' 1525 ' ' HIS . 14.5 t -109.02 -7.8 15.3 Favored 'General case' 0 C--N 1.315 -0.895 0 C-N-CA 119.654 -0.818 . . . . 2.1499999999999999 111.966 -179.465 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A 1524 ' ' GLY . . . . . . . . . . . . . . . 80.45 37.38 20.87 Favored Glycine 0 CA--C 1.503 -0.658 0 C-N-CA 120.511 -0.852 . . . . 1.8899999999999999 111.18 -179.487 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A 1525 ' ' HIS . . . . . 0.465 ' HB2' HG23 ' A' 1523 ' ' THR . 22.3 t-160 -100.97 115.71 31.11 Favored 'General case' 0 C--N 1.308 -1.205 0 N-CA-C 109.284 -0.636 . . . . 1.8999999999999999 109.284 -176.545 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A 1526 ' ' LEU . . . . . . . . . . . . . 3.5 tm? -88.41 120.65 29.98 Favored 'General case' 0 C--N 1.295 -1.766 0 N-CA-C 107.799 -1.185 . . . . 1.6100000000000001 107.799 178.762 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A 1527 ' ' PHE . . . . . . . . . . . . . 95.0 m-85 -92.86 112.95 25.09 Favored 'General case' 0 C--N 1.3 -1.555 0 N-CA-C 107.646 -1.242 . . . . 1.4199999999999999 107.646 176.975 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A 1528 ' ' ASP . . . . . . . . . . . . . 10.8 t70 -77.84 105.6 9.13 Favored 'General case' 0 CA--C 1.495 -1.143 0 CA-C-O 121.533 0.682 . . . . 2.1800000000000002 109.678 -178.356 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A 1529 ' ' LEU . . . . . . . . . . . . . 89.2 mt -106.55 -3.0 21.28 Favored 'General case' 0 C--N 1.281 -2.412 0 N-CA-C 107.207 -1.405 . . . . 1.4399999999999999 107.207 176.458 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A 1530 ' ' SER . . . . . . . . . . . . . 8.1 m -69.72 -37.05 76.4 Favored 'General case' 0 N--CA 1.419 -1.985 0 CA-C-N 114.027 -1.442 . . . . 1.4399999999999999 110.73 -174.013 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A 1531 ' ' SER . . . . . . . . . . . . . 14.8 m -74.94 -21.97 58.86 Favored 'General case' 0 C--N 1.316 -0.853 0 CA-C-O 121.344 0.592 . . . . 1.5 110.026 177.72 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A 1532 ' ' LEU . . . . . 0.575 HD22 ' HH2' ' A' 1640 ' ' TRP . 82.1 mt -85.83 -5.72 59.2 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.549 -0.751 . . . . 1.77 109.643 179.711 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A 1533 ' ' SER . . . . . 0.419 ' OG ' ' HB3' ' A' 1553 ' ' CYS . 22.6 m -92.18 107.36 19.16 Favored 'General case' 0 N--CA 1.415 -2.199 0 N-CA-C 108.631 -0.878 . . . . 2.3799999999999999 108.631 178.584 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A 1534 ' ' GLY . . . . . . . . . . . . . . . -126.58 -150.33 7.54 Favored Glycine 0 N--CA 1.422 -2.296 0 N-CA-C 109.768 -1.333 . . . . 1.55 109.768 179.551 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A 1535 ' ' ARG . . . . . 0.433 ' HD2' ' HA ' ' A' 1535 ' ' ARG . 9.5 tpt180 -96.82 -70.11 0.73 Allowed 'General case' 0 N--CA 1.419 -1.979 0 C-N-CA 120.242 -0.583 . . . . 3.96 109.58 179.214 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A 1536 ' ' ALA . . . . . . . . . . . . . . . -86.93 -18.28 31.17 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 121.047 0.451 . . . . 1.6499999999999999 110.994 -177.831 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A 1537 ' ' GLY . . . . . . . . . . . . . . . 73.44 -112.9 4.04 Favored Glycine 0 N--CA 1.435 -1.383 0 CA-C-N 115.941 -0.572 . . . . 1.1899999999999999 113.317 176.15 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A 1538 ' ' PHE . . . . . . . . . . . . . 64.9 m-85 -127.23 159.0 35.64 Favored 'General case' 0 C--N 1.307 -1.27 0 N-CA-C 109.837 -0.431 . . . . 1.6899999999999999 109.837 -176.55 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A 1539 ' ' THR . . . . . . . . . . . . . 6.8 p -112.76 119.99 39.95 Favored 'General case' 0 C--N 1.306 -1.3 0 CA-C-N 116.288 -0.415 . . . . 1.48 111.138 -178.886 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A 1540 ' ' ALA . . . . . . . . . . . . . . . -100.51 116.0 31.43 Favored 'General case' 0 C--N 1.307 -1.253 0 N-CA-C 109.46 -0.57 . . . . 0.82999999999999996 109.46 177.976 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A 1541 ' ' ALA . . . . . . . . . . . . . . . -80.48 89.05 5.61 Favored 'General case' 0 C--N 1.313 -0.979 0 CA-C-N 115.541 -0.754 . . . . 1.27 109.134 -179.161 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A 1542 ' ' TYR . . . . . . . . . . . . . 64.3 t80 -100.13 157.2 16.74 Favored 'General case' 0 C--N 1.293 -1.856 0 CA-C-N 115.861 -0.609 . . . . 2.1499999999999999 111.483 -176.486 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A 1543 ' ' SER . . . . . . . . . . . . . 2.8 m -40.46 -153.07 0.0 OUTLIER 'General case' 0 CA--C 1.578 2.043 0 C-N-CA 130.179 3.391 . . . . 2.29 116.893 -177.15 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A 1544 ' ' LYS . . . . . 0.472 ' NZ ' ' HB3' ' A' 1544 ' ' LYS . 4.9 ttpm? -49.4 -31.7 10.15 Favored 'General case' 0 N--CA 1.481 1.082 0 O-C-N 121.3 -0.875 . . . . 3.9100000000000001 112.262 -179.197 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A 1545 ' ' SER . . . . . . . . . . . . . 13.1 m -63.82 -27.18 69.0 Favored 'General case' 0 CA--C 1.559 1.291 0 N-CA-C 112.375 0.509 . . . . 3.2999999999999998 112.375 178.261 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A 1546 ' ' GLY . . . . . . . . . . . . . . . 109.02 -165.21 12.48 Favored Glycine 0 N--CA 1.43 -1.764 0 C-N-CA 119.363 -1.398 . . . . 1.24 114.034 174.869 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A 1547 ' ' VAL . . . . . . . . . . . . . 7.2 p -92.35 133.51 33.48 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.608 0 CA-C-O 121.596 0.712 . . . . 1.6299999999999999 111.151 -176.297 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A 1548 ' ' VAL . . . . . . . . . . . . . 4.1 t -111.37 135.83 49.36 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.442 0 N-CA-C 106.682 -1.599 . . . . 0.92000000000000004 106.682 179.202 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A 1549 ' ' TYR . . . . . 0.68 ' HE1' ' HA3' ' A' 1568 ' ' GLY . 95.7 m-85 -93.74 151.38 19.67 Favored 'General case' 0 C--N 1.3 -1.547 0 N-CA-C 106.565 -1.642 . . . . 1.4399999999999999 106.565 174.129 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A 1550 ' ' MET . . . . . . . . . . . . . 46.0 ttm -144.16 122.38 12.24 Favored 'General case' 0 C--N 1.301 -1.514 0 C-N-CA 120.255 -0.578 . . . . 1.74 111.113 -178.686 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A 1551 ' ' SER . . . . . . . . . . . . . 28.8 p -111.36 122.06 46.86 Favored 'General case' 0 N--CA 1.418 -2.07 0 N-CA-C 108.7 -0.852 . . . . 1.6399999999999999 108.7 174.932 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A 1552 ' ' ILE . . . . . . . . . . . . . 1.7 mp -62.04 -29.33 46.24 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.342 0 CA-C-N 115.134 -0.939 . . . . 1.3300000000000001 110.621 179.058 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A 1553 ' ' CYS . . . . . 0.7 ' SG ' ' HE3' ' A' 1579 ' ' LYS . 37.2 t -160.63 141.0 11.45 Favored 'General case' 0 N--CA 1.426 -1.629 0 N-CA-C 108.354 -0.98 . . . . 1.4299999999999999 108.354 174.797 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A 1554 ' ' GLY . . . . . . . . . . . . . . . 97.43 160.29 31.17 Favored Glycine 0 N--CA 1.443 -0.85 0 O-C-N 123.652 0.595 . . . . 1.1200000000000001 111.678 -179.003 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A 1555 ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -67.54 127.25 32.04 Favored 'General case' 0 N--CA 1.447 -0.578 0 CA-C-O 121.729 0.776 . . . . 1.8 111.334 178.474 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A 1556 ' ' ASN . . . . . 0.54 HD21 ' HB3' ' A' 1549 ' ' TYR . 3.4 t-20 -75.05 -14.47 60.6 Favored 'General case' 0 C--N 1.299 -1.603 0 C-N-CA 126.328 1.851 . . . . 2.6299999999999999 114.023 -170.069 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A 1557 ' ' GLU . . . . . 0.456 ' C ' ' H ' ' A' 1559 ' ' CYS . 50.6 mm-40 66.45 -173.61 0.19 Allowed 'General case' 0 N--CA 1.481 1.084 0 C-N-CA 123.237 0.615 . . . . 3.79 110.282 -176.112 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A 1558 ' ' ASN . . . . . . . . . . . . . 42.2 m-80 76.31 -20.9 0.34 Allowed 'General case' 0 N--CA 1.496 1.855 0 C-N-CA 125.659 1.584 . . . . 1.52 111.972 173.467 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A 1559 ' ' CYS . . . . . 0.585 ' HB3' ' HD2' ' A' 1560 ' ' PRO . 63.8 m -142.12 169.63 10.66 Favored Pre-proline 0 C--N 1.282 -2.355 0 N-CA-C 106.491 -1.67 . . . . 0.83999999999999997 106.491 179.732 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A 1560 ' ' PRO . . . . . 0.585 ' HD2' ' HB3' ' A' 1559 ' ' CYS . 26.8 Cg_exo -32.26 130.26 0.09 OUTLIER 'Trans proline' 0 C--N 1.369 1.608 0 C-N-CA 124.984 3.789 . . . . 1.1799999999999999 114.983 178.098 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A 1561 ' ' PRO . . . . . 0.427 ' HD3' ' HA ' ' A' 1560 ' ' PRO . 50.5 Cg_exo -56.09 110.83 0.62 Allowed 'Trans proline' 0 C--O 1.242 0.723 0 C-N-CA 123.583 2.855 . . . . 1.51 112.551 179.71 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A 1562 ' ' GLY . . . . . . . . . . . . . . . 141.05 -14.05 2.83 Favored Glycine 0 N--CA 1.442 -0.953 0 C-N-CA 120.526 -0.845 . . . . 0.71999999999999997 112.519 178.875 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A 1563 ' ' VAL . . . . . 0.489 HG22 ' O ' ' A' 1560 ' ' PRO . 7.3 m -85.24 151.47 3.74 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.309 0 O-C-N 122.488 -0.419 . . . . 0.96999999999999997 111.617 179.031 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A 1564 ' ' GLY . . . . . 0.421 ' HA3' ' CE2' ' A' 1592 ' ' TYR . . . -117.81 -1.23 17.35 Favored Glycine 0 N--CA 1.433 -1.547 0 N-CA-C 110.911 -0.876 . . . . 0.71999999999999997 110.911 176.201 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A 1565 ' ' ALA . . . . . . . . . . . . . . . -158.43 119.56 3.43 Favored 'General case' 0 C--O 1.247 0.952 0 N-CA-C 109.552 -0.536 . . . . 0.37 109.552 179.158 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A 1566 ' ' CYS . . . . . . . . . . . . . 48.7 t -154.33 145.77 23.09 Favored 'General case' 0 C--N 1.304 -1.373 0 N-CA-C 109.956 -0.387 . . . . 0.51000000000000001 109.956 -177.343 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A 1567 ' ' PHE . . . . . . . . . . . . . 66.9 m-85 -71.07 123.26 21.7 Favored 'General case' 0 CA--C 1.511 -0.546 0 N-CA-C 107.412 -1.329 . . . . 0.96999999999999997 107.412 172.951 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A 1568 ' ' GLY . . . . . 0.68 ' HA3' ' HE1' ' A' 1549 ' ' TYR . . . -73.62 -22.52 78.31 Favored Glycine 0 C--N 1.308 -1.01 0 C-N-CA 120.788 -0.72 . . . . 1.0800000000000001 114.735 -172.021 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A 1569 ' ' GLN . . . . . . . . . . . . . 10.0 mt-30 -90.53 -55.52 3.55 Favored 'General case' 0 C--N 1.305 -1.349 0 CA-C-O 121.125 0.488 . . . . 2.7400000000000002 109.98 -177.13 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A 1570 ' ' THR . . . . . . . . . . . . . 21.2 p -81.93 -12.98 58.13 Favored 'General case' 0 CA--C 1.546 0.821 0 N-CA-C 113.691 0.997 . . . . 1.96 113.691 -176.487 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A 1571 ' ' ARG . . . . . 0.405 ' NH2' ' HD3' ' A' 1560 ' ' PRO . 37.0 mtp85 62.91 42.44 7.66 Favored 'General case' 0 N--CA 1.476 0.872 0 C-N-CA 124.263 1.025 . . . . 3.9500000000000002 112.262 -179.883 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A 1572 ' ' ILE . . . . . . . . . . . . . 30.8 mm -104.49 122.24 57.22 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.241 0 N-CA-C 109.237 -0.653 . . . . 1.3700000000000001 109.237 -179.149 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A 1573 ' ' SER . . . . . . . . . . . . . 31.9 t -83.24 137.11 34.15 Favored 'General case' 0 C--N 1.303 -1.453 0 C-N-CA 124.364 1.066 . . . . 1.0800000000000001 111.821 -175.593 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A 1574 ' ' VAL . . . . . . . . . . . . . 11.5 m -140.01 27.48 0.5 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 115.982 -0.553 . . . . 1.3 110.72 175.224 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A 1575 ' ' GLY . . . . . . . . . . . . . . . 178.71 119.54 0.61 Allowed Glycine 0 N--CA 1.434 -1.489 0 C-N-CA 120.016 -1.088 . . . . 0.51000000000000001 112.921 178.976 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A 1576 ' ' LYS . . . . . . . . . . . . . 22.9 tptm -89.56 137.15 32.57 Favored 'General case' 0 C--N 1.304 -1.409 0 N-CA-C 107.047 -1.464 . . . . 2.8999999999999999 107.047 176.044 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A 1577 ' ' ALA . . . . . 0.677 ' HA ' ' CE2' ' A' 1592 ' ' TYR . . . -67.56 119.86 13.03 Favored 'General case' 0 C--N 1.322 -0.629 0 N-CA-C 109.379 -0.6 . . . . 0.82999999999999996 109.379 -178.772 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A 1578 ' ' ASN . . . . . . . . . . . . . 5.7 p30 -157.61 166.83 31.85 Favored 'General case' 0 C--N 1.31 -1.126 0 N-CA-C 107.071 -1.455 . . . . 1.8500000000000001 107.071 -176.468 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A 1579 ' ' LYS . . . . . 0.7 ' HE3' ' SG ' ' A' 1553 ' ' CYS . 50.9 mttp -122.1 90.07 3.24 Favored 'General case' 0 C--N 1.306 -1.317 0 N-CA-C 109.789 -0.448 . . . . 1.8999999999999999 109.789 178.179 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A 1580 ' ' ARG . . . . . . . . . . . . . 47.2 ttp180 -138.39 92.46 2.64 Favored 'General case' 0 C--N 1.309 -1.188 0 N-CA-C 106.969 -1.493 . . . . 3.6299999999999999 106.969 175.178 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A 1581 ' ' LEU . . . . . 0.704 HD11 ' HB ' ' A' 1518 ' ' VAL . 4.6 pp -127.5 158.9 36.18 Favored 'General case' 0 C--N 1.294 -1.826 0 CA-C-N 115.7 -0.682 . . . . 1.8700000000000001 110.147 -177.675 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A 1582 ' ' ARG . . . . . 0.494 ' HB3' HG13 ' A' 1584 ' ' VAL . 80.4 mtm-85 -139.96 139.09 36.02 Favored 'General case' 0 C--N 1.301 -1.539 0 O-C-N 123.449 0.468 . . . . 3.9700000000000002 109.885 178.378 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A 1583 ' ' TYR . . . . . 0.444 ' CD1' ' HG ' ' A' 1588 ' ' LEU . 25.4 t80 -99.73 90.44 4.46 Favored 'General case' 0 C--N 1.309 -1.175 0 N-CA-C 106.547 -1.649 . . . . 1.4099999999999999 106.547 174.256 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A 1584 ' ' VAL . . . . . 0.494 HG13 ' HB3' ' A' 1582 ' ' ARG . 18.3 m -115.89 124.38 72.19 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.948 0 CA-C-N 115.83 -0.623 . . . . 1.6899999999999999 111.701 -172.475 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A 1585 ' ' ASP . . . . . . . . . . . . . 38.8 t70 56.06 50.51 13.56 Favored 'General case' 0 C--N 1.31 -1.123 0 C-N-CA 123.98 0.912 . . . . 2.0600000000000001 111.701 177.901 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A 1586 ' ' GLN . . . . . . . . . . . . . 49.2 mt-30 69.75 10.71 7.66 Favored 'General case' 0 N--CA 1.481 1.105 0 CA-C-N 114.8 -1.091 . . . . 2.3300000000000001 113.853 176.253 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A 1587 ' ' VAL . . . . . 0.489 HG23 ' O ' ' A' 1612 ' ' PHE . 7.4 p -135.61 133.01 51.83 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.517 0 CA-C-O 121.49 0.662 . . . . 0.78000000000000003 110.895 -179.735 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A 1588 ' ' LEU . . . . . 0.811 ' HB2' ' HB2' ' A' 1612 ' ' PHE . 20.4 mt -80.15 142.74 34.49 Favored 'General case' 0 C--N 1.312 -1.037 0 CA-C-N 115.303 -0.862 . . . . 1.4099999999999999 110.749 178.037 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A 1589 ' ' GLN . . . . . . . . . . . . . 43.7 tt0 -128.24 106.86 9.32 Favored 'General case' 0 C--N 1.289 -2.051 0 CA-C-N 115.434 -0.803 . . . . 1.24 109.475 -179.481 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A 1590 ' ' LEU . . . . . 0.74 ' HB2' ' HE1' ' A' 1612 ' ' PHE . 21.1 tp -101.54 112.99 25.72 Favored 'General case' 0 C--N 1.314 -0.974 0 N-CA-C 107.022 -1.473 . . . . 1.1499999999999999 107.022 178.636 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A 1591 ' ' VAL . . . . . 0.522 HG22 HG22 ' A' 1609 ' ' VAL . 61.1 t -105.96 107.84 23.63 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.381 0 C-N-CA 120.107 -0.637 . . . . 1.51 112.248 -175.824 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A 1592 ' ' TYR . . . . . 0.677 ' CE2' ' HA ' ' A' 1577 ' ' ALA . 5.0 m-85 -102.89 92.84 4.75 Favored 'General case' 0 C--N 1.297 -1.691 0 CA-C-O 121.907 0.86 . . . . 1.0600000000000001 108.74 173.587 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A 1593 ' ' LYS . . . . . 0.54 ' HA ' ' HA ' ' A' 1607 ' ' LYS . 18.0 pttp -104.5 -175.44 2.8 Favored 'General case' 0 C--N 1.291 -1.948 0 CA-C-N 114.152 -1.385 . . . . 2.1800000000000002 108.285 -178.433 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A 1594 ' ' ASP . . . . . . . . . . . . . 1.6 m-20 63.67 72.5 0.47 Allowed 'General case' 0 CA--C 1.512 -0.501 0 O-C-N 124.072 0.857 . . . . 1.45 112.17 177.969 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A 1595 ' ' GLY . . . . . . . . . . . . . . . -110.11 -113.56 3.52 Favored Glycine 0 N--CA 1.425 -2.04 0 N-CA-C 109.659 -1.376 . . . . 0.78000000000000003 109.659 176.159 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A 1596 ' ' SER . . . . . . . . . . . . . 33.4 p -104.53 158.03 32.84 Favored Pre-proline 0 C--N 1.29 -1.988 0 N-CA-C 108.866 -0.79 . . . . 1.6799999999999999 108.866 177.915 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A 1597 ' ' PRO . . . . . . . . . . . . . 36.9 Cg_exo -59.45 137.2 76.59 Favored 'Trans proline' 0 C--N 1.353 0.815 0 C-N-CA 122.757 2.305 . . . . 1.1699999999999999 112.004 178.869 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A 1598 ' ' CYS . . . . . . . . . . . . . 42.7 t -95.82 115.16 65.33 Favored Pre-proline 0 C--N 1.299 -1.621 0 CA-C-N 115.899 -0.591 . . . . 1.1899999999999999 110.034 -178.711 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A 1599 ' ' PRO . . . . . 0.528 ' HD2' ' OH ' ' A' 1606 ' ' TYR . 44.2 Cg_endo -69.36 -15.63 38.73 Favored 'Trans proline' 0 CA--C 1.535 0.525 0 C-N-CA 122.591 2.194 . . . . 1.5900000000000001 112.625 -179.119 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A 1600 ' ' SER . . . . . . . . . . . . . 21.0 m -80.16 -13.16 59.47 Favored 'General case' 0 C--O 1.249 1.058 0 CA-C-N 116.157 -0.474 . . . . 2.1200000000000001 111.876 -178.261 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A 1601 ' ' LYS . . . . . 0.825 ' HG2' HD12 ' A' 1604 ' ' LEU . 16.1 tppt? -156.2 110.65 2.82 Favored 'General case' 0 N--CA 1.442 -0.83 0 N-CA-C 108.83 -0.804 . . . . 3.7400000000000002 108.83 179.405 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A 1602 ' ' SER . . . . . . . . . . . . . 8.4 m -59.61 109.84 1.0 Allowed 'General case' 0 C--N 1.296 -1.73 0 C-N-CA 124.185 0.994 . . . . 3.79 111.1 -176.991 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A 1603 ' ' GLY . . . . . . . . . . . . . . . 108.22 -17.84 34.07 Favored Glycine 0 N--CA 1.441 -0.971 0 C-N-CA 120.701 -0.762 . . . . 2.0 112.495 177.584 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A 1604 ' ' LEU . . . . . 0.825 HD12 ' HG2' ' A' 1601 ' ' LYS . 1.1 mt -86.89 146.02 26.35 Favored 'General case' 0 C--N 1.308 -1.23 0 CA-C-O 121.15 0.5 . . . . 1.48 110.838 -178.849 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A 1605 ' ' SER . . . . . . . . . . . . . 22.8 t -108.21 -175.05 2.67 Favored 'General case' 0 N--CA 1.424 -1.747 0 N-CA-C 106.336 -1.728 . . . . 1.51 106.336 173.378 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A 1606 ' ' TYR . . . . . 0.528 ' OH ' ' HD2' ' A' 1599 ' ' PRO . 78.6 m-85 -107.46 135.7 48.49 Favored 'General case' 0 CA--C 1.46 -2.485 0 N-CA-C 107.705 -1.22 . . . . 1.1799999999999999 107.705 -176.452 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A 1607 ' ' LYS . . . . . 0.54 ' HA ' ' HA ' ' A' 1593 ' ' LYS . 24.6 pttm -122.31 134.54 54.66 Favored 'General case' 0 N--CA 1.398 -3.062 0 C-N-CA 118.592 -1.243 . . . . 1.6699999999999999 110.433 176.835 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A 1608 ' ' SER . . . . . . . . . . . . . 47.1 m -101.56 111.15 23.3 Favored 'General case' 0 C--N 1.28 -2.452 0 CA-C-N 115.17 -0.923 . . . . 1.0 108.543 176.857 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A 1609 ' ' VAL . . . . . 0.522 HG22 HG22 ' A' 1591 ' ' VAL . 56.4 t -98.09 112.56 30.45 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.107 0 N-CA-C 109.48 -0.563 . . . . 0.93000000000000005 109.48 177.568 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A 1610 ' ' ILE . . . . . 0.593 ' HB ' ' HB3' ' A' 1590 ' ' LEU . 2.5 mp -93.46 104.72 16.04 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.649 0 N-CA-C 107.521 -1.289 . . . . 0.78000000000000003 107.521 177.353 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A 1611 ' ' SER . . . . . 0.402 ' O ' ' HA ' ' A' 1639 ' ' SER . 22.8 t -90.72 117.41 29.34 Favored 'General case' 0 C--N 1.293 -1.864 0 N-CA-C 108.387 -0.968 . . . . 1.29 108.387 -179.735 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A 1612 ' ' PHE . . . . . 0.811 ' HB2' ' HB2' ' A' 1588 ' ' LEU . 50.7 m-85 -92.15 102.22 14.74 Favored 'General case' 0 C--N 1.31 -1.126 0 N-CA-C 108.985 -0.746 . . . . 0.69999999999999996 108.985 -179.651 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A 1613 ' ' VAL . . . . . . . . . . . . . 47.8 t -100.53 127.59 53.44 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.51 0 N-CA-C 107.821 -1.177 . . . . 0.75 107.821 -177.881 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A 1614 ' ' CYS . . . . . 0.648 ' HA ' ' O ' ' A' 1642 ' ' THR . 8.3 t -71.45 106.4 3.93 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-O 121.28 0.562 . . . . 1.3899999999999999 111.618 -176.657 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A 1615 ' ' ARG . . . . . 0.775 ' HB2' ' HB3' ' A' 1641 ' ' HIS . 37.2 mmt180 -137.09 85.2 22.91 Favored Pre-proline 0 N--CA 1.433 -1.306 0 CA-C-N 115.228 -0.896 . . . . 3.75 110.462 177.048 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A 1616 ' ' PRO . . . . . . . . . . . . . 48.5 Cg_exo -61.22 -16.61 47.59 Favored 'Trans proline' 0 N--CA 1.482 0.801 0 C-N-CA 122.942 2.428 . . . . 1.3200000000000001 111.481 174.444 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A 1617 ' ' GLU . . . . . 0.405 ' CD ' ' HD2' ' A' 1615 ' ' ARG . 8.6 pt-20 . . . . . 0 C--N 1.318 -0.765 0 C-N-CA 123.886 0.874 . . . . 3.21 112.345 178.328 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A 1622 ' ' ASN . . . . . . . . . . . . . 50.0 t-20 . . . . . 0 C--O 1.245 0.856 0 N-CA-C 108.878 -0.786 . . . . 2.9199999999999999 108.878 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A 1623 ' ' ARG . . . . . . . . . . . . . 19.0 ptp180 -155.42 161.38 29.58 Favored Pre-proline 0 C--O 1.247 0.94 0 N-CA-C 108.131 -1.063 . . . . 3.6099999999999999 108.131 -179.67 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A 1624 ' ' PRO . . . . . . . . . . . . . 7.7 Cg_exo -73.42 94.7 0.84 Allowed 'Trans proline' 0 N--CA 1.458 -0.595 0 C-N-CA 122.747 2.298 . . . . 2.3700000000000001 111.566 177.476 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A 1625 ' ' MET . . . . . . . . . . . . . 20.5 ptp -81.64 150.12 28.24 Favored 'General case' 0 C--N 1.313 -1.011 0 CA-C-N 115.646 -0.706 . . . . 2.1600000000000001 109.797 179.735 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A 1626 ' ' LEU . . . . . . . . . . . . . 47.3 tp -90.35 105.25 17.69 Favored 'General case' 0 C--N 1.304 -1.389 0 N-CA-C 108.194 -1.039 . . . . 1.3500000000000001 108.194 179.101 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A 1627 ' ' ILE . . . . . . . . . . . . . 44.7 pt -85.7 -38.07 12.52 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.331 0 N-CA-C 112.119 0.414 . . . . 1.21 112.119 -175.428 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A 1628 ' ' SER . . . . . . . . . . . . . 19.4 t -148.95 150.91 33.69 Favored 'General case' 0 N--CA 1.432 -1.34 0 N-CA-C 109.036 -0.727 . . . . 1.3999999999999999 109.036 -177.426 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A 1629 ' ' LEU . . . . . 1.0 ' HG ' ' HG ' ' A' 1636 ' ' LEU . 3.1 tt -141.83 116.19 9.53 Favored 'General case' 0 C--N 1.303 -1.446 0 N-CA-C 106.682 -1.599 . . . . 1.5600000000000001 106.682 179.798 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A 1630 ' ' ASP . . . . . . . . . . . . . 33.2 t70 -109.27 119.84 40.7 Favored 'General case' 0 C--N 1.294 -1.833 0 N-CA-C 109.444 -0.576 . . . . 0.87 109.444 176.723 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A 1631 ' ' LYS . . . . . . . . . . . . . 30.1 mtpp -77.35 -24.93 50.63 Favored 'General case' 0 C--N 1.3 -1.564 0 CA-C-N 115.592 -0.731 . . . . 2.3500000000000001 111.272 -175.913 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A 1632 ' ' GLN . . . . . . . . . . . . . 39.6 mt-30 -68.57 -44.52 74.26 Favored 'General case' 0 CA--C 1.515 -0.381 0 CA-C-O 121.397 0.618 . . . . 2.5499999999999998 110.519 -176.317 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A 1633 ' ' THR . . . . . . . . . . . . . 25.1 p -90.42 -4.4 57.04 Favored 'General case' 0 C--N 1.31 -1.146 0 CA-C-N 115.516 -0.765 . . . . 1.24 110.797 177.347 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A 1634 ' ' CYS . . . . . 0.491 ' O ' ' HA ' ' A' 1606 ' ' TYR . 29.3 m 56.98 41.97 26.9 Favored 'General case' 0 C--O 1.221 -0.41 0 CA-C-N 114.288 -1.324 . . . . 0.89000000000000001 109.503 179.061 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A 1635 ' ' THR . . . . . . . . . . . . . 89.3 m -124.11 131.32 53.53 Favored 'General case' 0 N--CA 1.428 -1.537 0 CA-C-N 115.226 -0.897 . . . . 0.75 111.389 -173.217 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A 1636 ' ' LEU . . . . . 1.0 ' HG ' ' HG ' ' A' 1629 ' ' LEU . 5.2 mp -108.66 130.74 55.33 Favored 'General case' 0 N--CA 1.432 -1.353 0 N-CA-C 108.567 -0.901 . . . . 1.3300000000000001 108.567 177.626 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A 1637 ' ' PHE . . . . . . . . . . . . . 94.3 m-85 -105.76 105.95 16.23 Favored 'General case' 0 C--N 1.308 -1.204 0 CA-C-O 121.069 0.461 . . . . 0.82999999999999996 110.953 -177.489 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A 1638 ' ' PHE . . . . . 0.4 ' HB2' ' HA ' ' A' 1610 ' ' ILE . 99.6 m-85 -100.79 148.0 25.42 Favored 'General case' 0 C--N 1.303 -1.416 0 N-CA-C 108.4 -0.963 . . . . 0.59999999999999998 108.4 177.681 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A 1639 ' ' SER . . . . . 0.402 ' HA ' ' O ' ' A' 1611 ' ' SER . 66.2 m -137.33 115.1 11.34 Favored 'General case' 0 C--N 1.281 -2.382 0 CA-C-O 121.445 0.64 . . . . 1.0800000000000001 110.703 176.984 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A 1640 ' ' TRP . . . . . 0.575 ' HH2' HD22 ' A' 1532 ' ' LEU . 7.9 t90 -95.93 122.14 38.42 Favored 'General case' 0 N--CA 1.418 -2.05 0 N-CA-C 106.569 -1.641 . . . . 0.80000000000000004 106.569 178.434 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A 1641 ' ' HIS . . . . . 0.775 ' HB3' ' HB2' ' A' 1615 ' ' ARG . 90.5 m-70 -95.09 102.99 14.83 Favored 'General case' 0 C--N 1.285 -2.206 0 N-CA-C 107.633 -1.247 . . . . 2.54 107.633 178.206 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A 1642 ' ' THR . . . . . 0.648 ' O ' ' HA ' ' A' 1614 ' ' CYS . 8.9 t -142.42 140.2 18.62 Favored Pre-proline 0 C--N 1.297 -1.678 0 CA-C-N 115.45 -0.795 . . . . 1.1499999999999999 111.21 -173.134 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A 1643 ' ' PRO . . . . . . . . . . . . . 57.4 Cg_endo -71.46 -0.82 8.78 Favored 'Trans proline' 0 CA--C 1.534 0.494 0 C-N-CA 123.621 2.881 . . . . 0.80000000000000004 112.451 176.865 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A 1644 ' ' LEU . . . . . . . . . . . . . 77.5 mt -85.4 -4.33 59.13 Favored 'General case' 0 C--N 1.322 -0.613 0 C-N-CA 122.62 0.368 . . . . 1.54 111.113 -179.085 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A 1645 ' ' ALA . . . . . . . . . . . . . . . -88.84 -13.87 38.26 Favored 'General case' 0 C--N 1.319 -0.725 0 N-CA-C 111.984 0.364 . . . . 0.94999999999999996 111.984 -178.129 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A 1646 ' ' CYS . . . . . . . . . . . . . 14.3 p -148.02 -177.04 5.52 Favored 'General case' 0 C--N 1.304 -1.386 0 N-CA-C 107.137 -1.431 . . . . 1.4099999999999999 107.137 -179.27 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A 1647 ' ' GLU . . . . . . . . . . . . . 9.8 tp10 . . . . . 0 N--CA 1.428 -1.526 0 N-CA-C 107.891 -1.151 . . . . 2.9199999999999999 107.891 174.643 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A 1515 ' ' ASP . . . . . . . . . . . . . 4.1 t70 . . . . . 0 N--CA 1.445 -0.7 0 N-CA-C 108.548 -0.908 . . . . 2.54 108.548 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A 1516 ' ' CYS . . . . . . . . . . . . . 52.0 m -115.67 44.56 1.86 Allowed 'General case' 0 C--N 1.29 -2.007 0 N-CA-C 108.35 -0.982 . . . . 1.25 108.35 -176.811 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A 1517 ' ' GLN . . . . . . . . . . . . . 10.6 pt20 -148.47 138.07 22.12 Favored 'General case' 0 N--CA 1.433 -1.282 0 C-N-CA 120.79 -0.364 . . . . 1.8799999999999999 111.054 -176.948 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A 1518 ' ' VAL . . . . . . . . . . . . . 29.4 m -113.87 154.06 15.31 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.668 0 CA-C-N 115.744 -0.662 . . . . 1.73 109.945 179.551 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A 1519 ' ' THR . . . . . 0.521 ' HA ' ' HA ' ' A' 1526 ' ' LEU . 32.0 m -119.61 137.76 53.66 Favored 'General case' 0 C--N 1.277 -2.544 0 N-CA-C 109.037 -0.727 . . . . 1.7 109.037 177.354 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A 1520 ' ' ASN . . . . . . . . . . . . . 38.3 t-20 -93.78 101.61 6.41 Favored Pre-proline 0 C--N 1.315 -0.895 0 N-CA-C 107.416 -1.327 . . . . 2.1200000000000001 107.416 175.139 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A 1521 ' ' PRO . . . . . 0.466 ' HD3' ' O ' ' A' 1519 ' ' THR . 23.4 Cg_exo -65.71 -14.07 42.91 Favored 'Trans proline' 0 C--N 1.36 1.165 0 C-N-CA 123.205 2.603 . . . . 2.4700000000000002 113.802 -176.772 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A 1522 ' ' SER . . . . . . . . . . . . . 33.3 t -71.24 -38.39 71.95 Favored 'General case' 0 N--CA 1.439 -0.977 0 N-CA-C 109.746 -0.464 . . . . 2.5699999999999998 109.746 178.759 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A 1523 ' ' THR . . . . . . . . . . . . . 7.2 t -112.37 -16.53 12.91 Favored 'General case' 0 C--N 1.317 -0.827 0 N-CA-C 112.766 0.654 . . . . 2.1499999999999999 112.766 -177.116 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A 1524 ' ' GLY . . . . . . . . . . . . . . . 81.66 14.54 77.77 Favored Glycine 0 C--O 1.229 -0.172 0 C-N-CA 120.984 -0.627 . . . . 1.8899999999999999 111.591 -178.764 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A 1525 ' ' HIS . . . . . . . . . . . . . 32.5 t-80 -101.45 131.99 47.28 Favored 'General case' 0 C--N 1.306 -1.318 0 CA-C-O 121.077 0.465 . . . . 1.8999999999999999 110.187 -178.925 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A 1526 ' ' LEU . . . . . 0.521 ' HA ' ' HA ' ' A' 1519 ' ' THR . 7.8 tt -101.52 143.37 31.6 Favored 'General case' 0 C--N 1.289 -2.038 0 CA-C-N 115.329 -0.851 . . . . 1.6100000000000001 110.211 -178.166 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A 1527 ' ' PHE . . . . . 0.416 ' HE1' ' HG3' ' A' 1647 ' ' GLU . 80.0 m-85 -118.09 113.08 21.07 Favored 'General case' 0 C--N 1.312 -1.032 0 N-CA-C 107.291 -1.374 . . . . 1.4199999999999999 107.291 176.524 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A 1528 ' ' ASP . . . . . . . . . . . . . 1.3 p-10 -104.79 141.61 36.19 Favored 'General case' 0 C--N 1.297 -1.714 0 CA-C-O 121.955 0.883 . . . . 2.1800000000000002 110.938 -178.441 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A 1529 ' ' LEU . . . . . . . . . . . . . 75.7 mt -114.16 11.19 17.48 Favored 'General case' 0 C--N 1.287 -2.13 0 N-CA-C 105.7 -1.963 . . . . 1.4399999999999999 105.7 173.253 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A 1530 ' ' SER . . . . . . . . . . . . . 5.5 m -73.44 -37.32 65.88 Favored 'General case' 0 N--CA 1.43 -1.435 0 CA-C-N 114.166 -1.379 . . . . 1.4399999999999999 109.323 -178.977 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A 1531 ' ' SER . . . . . . . . . . . . . 12.8 m -79.85 -7.95 59.01 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-O 121.466 0.651 . . . . 1.5 109.33 175.324 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A 1532 ' ' LEU . . . . . . . . . . . . . 92.8 mt -106.83 9.15 31.01 Favored 'General case' 0 N--CA 1.448 -0.565 0 CA-C-N 115.669 -0.696 . . . . 1.77 110.514 177.017 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A 1533 ' ' SER . . . . . . . . . . . . . 66.0 m -70.94 107.52 4.1 Favored 'General case' 0 N--CA 1.437 -1.081 0 CA-C-O 121.733 0.778 . . . . 2.3799999999999999 111.577 -175.447 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A 1534 ' ' GLY . . . . . 0.402 ' HA3' ' CE2' ' A' 1538 ' ' PHE . . . -103.23 103.0 2.3 Favored Glycine 0 N--CA 1.423 -2.202 0 N-CA-C 109.632 -1.387 . . . . 1.55 109.632 176.607 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A 1535 ' ' ARG . . . . . . . . . . . . . 71.4 ttt180 -79.27 -20.66 47.55 Favored 'General case' 0 C--O 1.205 -1.257 0 O-C-N 124.205 0.591 . . . . 3.96 111.114 -176.732 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A 1536 ' ' ALA . . . . . . . . . . . . . . . -90.59 -3.21 57.72 Favored 'General case' 0 C--N 1.309 -1.166 0 C-N-CA 119.643 -0.823 . . . . 1.6499999999999999 109.39 178.979 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A 1537 ' ' GLY . . . . . 0.434 ' HA2' ' HA ' ' A' 1551 ' ' SER . . . 79.13 166.07 30.85 Favored Glycine 0 N--CA 1.423 -2.214 0 CA-C-N 114.855 -1.066 . . . . 1.1899999999999999 113.123 177.932 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A 1538 ' ' PHE . . . . . 0.402 ' CE2' ' HA3' ' A' 1534 ' ' GLY . 97.1 m-85 -133.73 163.43 29.48 Favored 'General case' 0 C--N 1.297 -1.678 0 N-CA-C 107.472 -1.307 . . . . 1.6899999999999999 107.472 176.507 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A 1539 ' ' THR . . . . . 0.512 ' HA ' ' O ' ' A' 1548 ' ' VAL . 59.4 p -118.06 157.73 26.31 Favored 'General case' 0 C--N 1.303 -1.422 0 N-CA-C 113.335 0.865 . . . . 1.48 113.335 -172.315 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A 1540 ' ' ALA . . . . . . . . . . . . . . . -142.55 146.13 34.32 Favored 'General case' 0 C--O 1.25 1.131 0 N-CA-C 106.685 -1.598 . . . . 0.82999999999999996 106.685 173.628 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A 1541 ' ' ALA . . . . . . . . . . . . . . . -65.05 131.65 47.14 Favored 'General case' 0 C--O 1.247 0.952 0 O-C-N 124.222 0.951 . . . . 1.27 110.611 -178.571 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A 1542 ' ' TYR . . . . . . . . . . . . . 81.0 t80 -143.34 171.14 14.52 Favored 'General case' 0 C--N 1.3 -1.585 0 CA-C-N 115.427 -0.806 . . . . 2.1499999999999999 109.343 -177.264 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A 1543 ' ' SER . . . . . . . . . . . . . 14.0 m -44.28 -151.62 0.0 OUTLIER 'General case' 0 CA--C 1.581 2.165 0 C-N-CA 129.728 3.211 . . . . 2.29 114.961 176.327 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A 1544 ' ' LYS . . . . . . . . . . . . . 39.9 ttmt -36.03 -39.24 0.16 Allowed 'General case' 0 CA--C 1.568 1.665 0 C-N-CA 125.217 1.407 . . . . 3.9100000000000001 114.143 178.149 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A 1545 ' ' SER . . . . . . . . . . . . . 48.3 t -66.45 -21.73 66.2 Favored 'General case' 0 CA--C 1.56 1.332 0 N-CA-C 112.329 0.492 . . . . 3.2999999999999998 112.329 177.462 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A 1546 ' ' GLY . . . . . . . . . . . . . . . 88.75 -63.8 3.51 Favored Glycine 0 CA--C 1.492 -1.345 0 N-CA-C 111.455 -0.658 . . . . 1.24 111.455 179.999 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A 1547 ' ' VAL . . . . . . . . . . . . . 13.3 m -140.58 157.87 24.22 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.416 0 C-N-CA 123.205 0.602 . . . . 1.6299999999999999 109.874 178.318 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A 1548 ' ' VAL . . . . . 0.512 ' O ' ' HA ' ' A' 1539 ' ' THR . 5.7 t -111.98 142.7 23.55 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.28 0 N-CA-C 106.598 -1.63 . . . . 0.92000000000000004 106.598 176.388 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A 1549 ' ' TYR . . . . . 0.515 ' CD2' ' HA2' ' A' 1568 ' ' GLY . 62.2 m-85 -98.4 114.91 27.43 Favored 'General case' 0 C--N 1.31 -1.152 0 N-CA-C 108.08 -1.082 . . . . 1.4399999999999999 108.08 173.509 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A 1550 ' ' MET . . . . . . . . . . . . . 65.4 mtm -128.6 133.15 48.23 Favored 'General case' 0 C--N 1.299 -1.603 0 N-CA-C 109.448 -0.575 . . . . 1.74 109.448 176.543 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A 1551 ' ' SER . . . . . 0.434 ' HA ' ' HA2' ' A' 1537 ' ' GLY . 23.8 p -86.3 147.8 25.9 Favored 'General case' 0 C--N 1.289 -2.048 0 N-CA-C 106.658 -1.608 . . . . 1.6399999999999999 106.658 175.983 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A 1552 ' ' ILE . . . . . . . . . . . . . 35.7 mm -76.41 -29.72 19.0 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.978 0 N-CA-C 108.77 -0.826 . . . . 1.3300000000000001 108.77 -178.706 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A 1553 ' ' CYS . . . . . . . . . . . . . 38.2 t -162.94 138.38 6.82 Favored 'General case' 0 N--CA 1.432 -1.344 0 N-CA-C 107.519 -1.289 . . . . 1.4299999999999999 107.519 169.398 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A 1554 ' ' GLY . . . . . . . . . . . . . . . 96.13 -164.93 23.81 Favored Glycine 0 N--CA 1.438 -1.205 0 C-N-CA 120.781 -0.724 . . . . 1.1200000000000001 112.802 176.05 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A 1555 ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -76.43 156.17 33.34 Favored 'General case' 0 C--N 1.312 -1.046 0 C-N-CA 122.622 0.369 . . . . 1.8 110.028 -179.734 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A 1556 ' ' ASN . . . . . 0.431 HD21 ' HB3' ' A' 1549 ' ' TYR . 27.5 t-20 -98.31 -17.66 18.77 Favored 'General case' 0 CA--C 1.548 0.874 0 N-CA-C 113.413 0.894 . . . . 2.6299999999999999 113.413 -173.719 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A 1557 ' ' GLU . . . . . . . . . . . . . 30.1 mt-10 65.66 -24.04 0.09 Allowed 'General case' 0 N--CA 1.492 1.656 0 N-CA-C 115.376 1.621 . . . . 3.79 115.376 179.738 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A 1558 ' ' ASN . . . . . . . . . . . . . 38.6 m-80 -75.64 -21.4 57.75 Favored 'General case' 0 CA--C 1.503 -0.834 0 CA-C-O 121.731 0.777 . . . . 1.52 109.11 177.133 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A 1559 ' ' CYS . . . . . . . . . . . . . 73.4 m -135.05 158.38 74.98 Favored Pre-proline 0 N--CA 1.423 -1.802 0 N-CA-C 106.66 -1.608 . . . . 0.83999999999999997 106.66 176.731 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A 1560 ' ' PRO . . . . . 0.487 ' HA ' ' HD3' ' A' 1561 ' ' PRO . 3.0 Cg_exo -32.82 145.52 0.03 OUTLIER 'Trans proline' 0 CA--C 1.561 1.832 1 C-N-CA 125.859 4.373 . . . . 1.1799999999999999 117.014 -176.186 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A 1561 ' ' PRO . . . . . 0.487 ' HD3' ' HA ' ' A' 1560 ' ' PRO . 42.5 Cg_exo -59.37 115.08 2.34 Favored 'Trans proline' 0 C--O 1.245 0.834 0 C-N-CA 123.43 2.753 . . . . 1.51 110.421 176.827 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A 1562 ' ' GLY . . . . . . . . . . . . . . . 121.79 -11.42 9.49 Favored Glycine 0 N--CA 1.426 -1.974 0 N-CA-C 110.174 -1.17 . . . . 0.71999999999999997 110.174 -176.086 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A 1563 ' ' VAL . . . . . . . . . . . . . 66.2 t -99.29 133.88 40.42 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.275 0 N-CA-C 108.005 -1.109 . . . . 0.96999999999999997 108.005 176.224 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A 1564 ' ' GLY . . . . . . . . . . . . . . . -114.54 -34.53 1.56 Allowed Glycine 0 N--CA 1.443 -0.89 0 C-N-CA 120.916 -0.659 . . . . 0.71999999999999997 111.78 -179.319 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A 1565 ' ' ALA . . . . . . . . . . . . . . . -123.09 121.08 35.14 Favored 'General case' 0 C--O 1.249 1.043 0 N-CA-C 108.871 -0.789 . . . . 0.37 108.871 -179.753 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A 1566 ' ' CYS . . . . . . . . . . . . . 38.6 t -146.45 140.88 26.58 Favored 'General case' 0 C--N 1.297 -1.709 0 N-CA-C 108.964 -0.754 . . . . 0.51000000000000001 108.964 -173.953 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A 1567 ' ' PHE . . . . . 0.459 ' O ' ' HA ' ' A' 1571 ' ' ARG . 16.3 m-85 -63.23 132.76 52.75 Favored 'General case' 0 C--O 1.21 -1.01 0 N-CA-C 108.518 -0.919 . . . . 0.96999999999999997 108.518 177.174 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A 1568 ' ' GLY . . . . . 0.515 ' HA2' ' CD2' ' A' 1549 ' ' TYR . . . -68.99 -36.0 80.21 Favored Glycine 0 N--CA 1.435 -1.387 0 CA-C-N 115.752 -0.658 . . . . 1.0800000000000001 114.622 -174.164 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A 1569 ' ' GLN . . . . . . . . . . . . . 36.1 tt0 -90.44 -53.89 4.24 Favored 'General case' 0 C--N 1.303 -1.43 0 CA-C-O 121.671 0.748 . . . . 2.7400000000000002 110.261 -179.393 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A 1570 ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -74.96 -20.06 59.84 Favored 'General case' 0 C--N 1.298 -1.641 0 CA-C-N 114.836 -1.075 . . . . 1.96 112.783 -172.971 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A 1571 ' ' ARG . . . . . 0.459 ' HA ' ' O ' ' A' 1567 ' ' PHE . 50.8 mtp180 54.36 36.37 25.22 Favored 'General case' 0 CA--C 1.51 -0.58 0 C-N-CA 125.814 1.646 . . . . 3.9500000000000002 113.589 179.633 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A 1572 ' ' ILE . . . . . . . . . . . . . 43.6 mm -94.96 123.89 47.26 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.286 0 N-CA-C 108.893 -0.78 . . . . 1.3700000000000001 108.893 178.079 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A 1573 ' ' SER . . . . . . . . . . . . . 31.5 t -65.44 95.71 0.22 Allowed 'General case' 0 C--N 1.307 -1.266 0 C-N-CA 125.309 1.444 . . . . 1.0800000000000001 111.207 179.94 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A 1574 ' ' VAL . . . . . 0.482 ' O ' ' HA3' ' A' 1595 ' ' GLY . 27.6 m -88.17 -30.94 5.55 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.871 0 N-CA-C 112.327 0.491 . . . . 1.3 112.327 179.099 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A 1575 ' ' GLY . . . . . . . . . . . . . . . -136.58 132.25 5.98 Favored Glycine 0 C--O 1.246 0.85 0 C-N-CA 120.858 -0.687 . . . . 0.51000000000000001 112.177 179.816 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A 1576 ' ' LYS . . . . . 0.603 ' HG2' ' HA2' ' A' 1595 ' ' GLY . 75.5 mmtt -88.77 149.37 23.47 Favored 'General case' 0 C--N 1.312 -1.049 0 N-CA-C 109.859 -0.423 . . . . 2.8999999999999999 109.859 -179.894 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A 1577 ' ' ALA . . . . . . . . . . . . . . . -67.07 98.87 0.61 Allowed 'General case' 0 C--N 1.307 -1.278 0 C-N-CA 123.976 0.91 . . . . 0.82999999999999996 110.913 -178.195 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A 1578 ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -113.49 120.34 40.67 Favored 'General case' 0 C--N 1.306 -1.299 0 N-CA-C 108.504 -0.925 . . . . 1.8500000000000001 108.504 177.261 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A 1579 ' ' LYS . . . . . . . . . . . . . 48.9 mtmt -90.96 90.55 7.93 Favored 'General case' 0 C--N 1.307 -1.254 0 N-CA-C 107.294 -1.372 . . . . 1.8999999999999999 107.294 177.621 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A 1580 ' ' ARG . . . . . . . . . . . . . 17.7 ttp180 -165.84 110.98 0.85 Allowed 'General case' 0 C--N 1.309 -1.192 0 CA-C-N 115.309 -0.859 . . . . 3.6299999999999999 110.246 -175.216 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A 1581 ' ' LEU . . . . . . . . . . . . . 3.9 mm? -101.77 137.28 40.29 Favored 'General case' 0 C--N 1.316 -0.877 0 CA-C-N 115.888 -0.596 . . . . 1.8700000000000001 109.563 178.592 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A 1582 ' ' ARG . . . . . . . . . . . . . 90.4 mtt180 -108.68 98.31 7.83 Favored 'General case' 0 C--N 1.291 -1.957 0 CA-C-N 116.374 -0.375 . . . . 3.9700000000000002 110.254 177.057 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A 1583 ' ' TYR . . . . . . . . . . . . . 92.8 t80 -79.84 110.13 14.92 Favored 'General case' 0 C--N 1.311 -1.098 0 CA-C-N 115.477 -0.783 . . . . 1.4099999999999999 109.153 -179.615 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A 1584 ' ' VAL . . . . . 0.62 ' O ' HG12 ' A' 1587 ' ' VAL . 3.9 p -148.36 126.4 3.24 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.419 0 CA-C-N 116.17 -0.468 . . . . 1.6899999999999999 110.076 179.703 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A 1585 ' ' ASP . . . . . . . . . . . . . 38.4 t70 54.34 44.65 28.64 Favored 'General case' 0 N--CA 1.484 1.244 0 CA-C-O 122.748 1.261 . . . . 2.0600000000000001 109.951 -177.894 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A 1586 ' ' GLN . . . . . . . . . . . . . 48.4 mt-30 59.79 18.41 7.29 Favored 'General case' 0 CA--C 1.539 0.545 0 CA-C-N 113.632 -1.622 . . . . 2.3300000000000001 114.32 179.141 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A 1587 ' ' VAL . . . . . 0.62 HG12 ' O ' ' A' 1584 ' ' VAL . 4.0 p -103.78 139.64 24.16 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.146 0 N-CA-C 108.568 -0.901 . . . . 0.78000000000000003 108.568 176.733 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A 1588 ' ' LEU . . . . . 0.725 ' HB2' ' HB2' ' A' 1612 ' ' PHE . 41.1 mt -94.27 123.83 37.91 Favored 'General case' 0 C--N 1.296 -1.732 0 N-CA-C 106.187 -1.783 . . . . 1.4099999999999999 106.187 174.179 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A 1589 ' ' GLN . . . . . . . . . . . . . 9.8 tt0 -122.4 112.96 18.72 Favored 'General case' 0 C--N 1.281 -2.398 0 CA-C-N 116.398 -0.365 . . . . 1.24 110.094 -173.864 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A 1590 ' ' LEU . . . . . 0.433 ' HB3' ' HB ' ' A' 1610 ' ' ILE . 32.8 tp -100.7 116.48 32.71 Favored 'General case' 0 C--N 1.299 -1.59 0 N-CA-C 107.078 -1.452 . . . . 1.1499999999999999 107.078 -179.659 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A 1591 ' ' VAL . . . . . . . . . . . . . 15.4 m -106.94 94.82 3.33 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.565 0 N-CA-C 113.803 1.038 . . . . 1.51 113.803 -174.884 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A 1592 ' ' TYR . . . . . . . . . . . . . 14.7 m-30 -86.5 92.92 9.02 Favored 'General case' 0 C--N 1.312 -1.035 0 N-CA-C 107.811 -1.181 . . . . 1.0600000000000001 107.811 173.435 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A 1593 ' ' LYS . . . . . . . . . . . . . 14.6 ptmm? -115.43 175.08 5.68 Favored 'General case' 0 C--N 1.293 -1.868 0 CA-C-N 115.951 -0.568 . . . . 2.1800000000000002 111.588 -174.874 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A 1594 ' ' ASP . . . . . . . . . . . . . 8.9 m-20 62.86 31.32 16.41 Favored 'General case' 0 CA--C 1.509 -0.613 0 O-C-N 124.17 0.919 . . . . 1.45 112.154 -178.799 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A 1595 ' ' GLY . . . . . 0.603 ' HA2' ' HG2' ' A' 1576 ' ' LYS . . . -78.58 -84.93 0.54 Allowed Glycine 0 N--CA 1.435 -1.402 0 C-N-CA 120.855 -0.688 . . . . 0.78000000000000003 112.624 -178.004 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A 1596 ' ' SER . . . . . . . . . . . . . 14.4 t -101.58 145.17 29.98 Favored Pre-proline 0 C--N 1.293 -1.87 0 N-CA-C 108.498 -0.927 . . . . 1.6799999999999999 108.498 -177.75 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A 1597 ' ' PRO . . . . . . . . . . . . . 24.2 Cg_exo -67.99 131.78 24.73 Favored 'Trans proline' 0 C--O 1.238 0.5 0 C-N-CA 122.785 2.323 . . . . 1.1699999999999999 110.371 175.252 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A 1598 ' ' CYS . . . . . 0.738 ' HA ' ' HE1' ' A' 1606 ' ' TYR . 40.6 t -95.09 123.09 58.35 Favored Pre-proline 0 C--N 1.304 -1.392 0 CA-C-O 120.767 0.318 . . . . 1.1899999999999999 110.476 -176.634 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A 1599 ' ' PRO . . . . . . . . . . . . . 91.2 Cg_endo -88.44 -9.36 5.02 Favored 'Trans proline' 0 N--CA 1.454 -0.851 0 C-N-CA 122.798 2.332 . . . . 1.5900000000000001 112.913 179.799 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A 1600 ' ' SER . . . . . . . . . . . . . 14.9 m -70.31 -21.87 62.88 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-O 121.101 0.477 . . . . 2.1200000000000001 110.77 -177.795 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A 1601 ' ' LYS . . . . . 0.942 ' HB3' HD12 ' A' 1604 ' ' LEU . 25.7 tptp -161.0 132.08 5.43 Favored 'General case' 0 N--CA 1.43 -1.444 0 N-CA-C 106.257 -1.757 . . . . 3.7400000000000002 106.257 178.429 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A 1602 ' ' SER . . . . . . . . . . . . . 16.4 m -73.34 126.82 31.02 Favored 'General case' 0 C--N 1.307 -1.249 0 CA-C-O 120.884 0.373 . . . . 3.79 110.268 -176.763 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A 1603 ' ' GLY . . . . . . . . . . . . . . . 102.87 22.0 9.78 Favored Glycine 0 C--N 1.303 -1.256 0 N-CA-C 110.301 -1.12 . . . . 2.0 110.301 -179.358 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A 1604 ' ' LEU . . . . . 0.942 HD12 ' HB3' ' A' 1601 ' ' LYS . 6.1 mt -124.83 152.54 43.8 Favored 'General case' 0 C--N 1.3 -1.548 0 CA-C-O 121.801 0.81 . . . . 1.48 112.259 -179.554 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A 1605 ' ' SER . . . . . . . . . . . . . 50.1 m -128.29 177.67 6.79 Favored 'General case' 0 C--N 1.281 -2.399 0 N-CA-C 106.313 -1.736 . . . . 1.51 106.313 174.613 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A 1606 ' ' TYR . . . . . 0.738 ' HE1' ' HA ' ' A' 1598 ' ' CYS . 7.0 m-85 -98.9 140.36 33.19 Favored 'General case' 0 CA--C 1.459 -2.557 0 N-CA-C 105.682 -1.97 . . . . 1.1799999999999999 105.682 -179.115 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A 1607 ' ' LYS . . . . . . . . . . . . . 23.3 pttm -133.09 137.45 46.36 Favored 'General case' 0 N--CA 1.391 -3.382 0 C-N-CA 119.21 -0.996 . . . . 1.6699999999999999 110.127 176.718 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A 1608 ' ' SER . . . . . . . . . . . . . 14.6 m -107.08 110.02 22.03 Favored 'General case' 0 C--N 1.29 -2.02 0 N-CA-C 108.11 -1.07 . . . . 1.0 108.11 178.612 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A 1609 ' ' VAL . . . . . . . . . . . . . 98.3 t -102.04 102.82 14.08 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.256 0 CA-C-O 121.118 0.485 . . . . 0.93000000000000005 110.481 -177.923 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A 1610 ' ' ILE . . . . . 0.433 ' HB ' ' HB3' ' A' 1590 ' ' LEU . 2.6 mp -90.78 115.31 29.77 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.361 0 N-CA-C 108.252 -1.018 . . . . 0.78000000000000003 108.252 179.243 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A 1611 ' ' SER . . . . . 0.508 ' O ' ' HA ' ' A' 1639 ' ' SER . 16.9 m -107.13 122.4 46.42 Favored 'General case' 0 C--N 1.295 -1.789 0 CA-C-O 121.26 0.552 . . . . 1.29 110.666 -178.152 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A 1612 ' ' PHE . . . . . 0.725 ' HB2' ' HB2' ' A' 1588 ' ' LEU . 84.5 m-85 -88.38 109.78 20.27 Favored 'General case' 0 C--N 1.298 -1.666 0 N-CA-C 108.134 -1.062 . . . . 0.69999999999999996 108.134 177.391 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A 1613 ' ' VAL . . . . . . . . . . . . . 58.2 t -102.01 126.2 56.06 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.414 0 CA-C-N 115.632 -0.713 . . . . 0.75 110.216 -173.781 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A 1614 ' ' CYS . . . . . 0.403 ' HA ' ' O ' ' A' 1642 ' ' THR . 57.9 m -59.63 95.68 0.03 OUTLIER 'General case' 0 C--O 1.244 0.764 0 C-N-CA 124.427 1.091 . . . . 1.3899999999999999 111.302 179.771 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A 1615 ' ' ARG . . . . . . . . . . . . . 17.0 mmt180 -137.28 102.17 9.0 Favored Pre-proline 0 C--N 1.294 -1.824 0 CA-C-N 115.112 -0.949 . . . . 3.75 108.744 177.725 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A 1616 ' ' PRO . . . . . 0.417 ' HA ' ' HB3' ' A' 1643 ' ' PRO . 52.6 Cg_exo -61.2 10.36 0.07 OUTLIER 'Trans proline' 0 N--CA 1.493 1.479 0 C-N-CA 124.707 3.605 . . . . 1.3200000000000001 115.137 -179.189 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A 1617 ' ' GLU . . . . . . . . . . . . . 34.0 mt-10 . . . . . 0 C--O 1.243 0.726 0 C-N-CA 123.501 0.72 . . . . 3.21 109.647 178.209 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A 1622 ' ' ASN . . . . . . . . . . . . . 54.9 t30 . . . . . 0 C--O 1.248 0.989 0 CA-C-O 122.441 1.115 . . . . 2.9199999999999999 111.935 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A 1623 ' ' ARG . . . . . 0.522 ' HB3' ' CG ' ' A' 1640 ' ' TRP . 6.0 ptt180 -130.14 74.11 80.74 Favored Pre-proline 0 C--N 1.306 -1.321 0 CA-C-N 115.082 -0.963 . . . . 3.6099999999999999 112.765 -177.326 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A 1624 ' ' PRO . . . . . . . . . . . . . 54.9 Cg_endo -111.01 90.9 0.02 OUTLIER 'Trans proline' 0 N--CA 1.42 -2.843 0 C-N-CA 121.306 1.338 . . . . 2.3700000000000001 109.519 169.177 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A 1625 ' ' MET . . . . . 0.501 ' HB2' ' O ' ' A' 1639 ' ' SER . 10.7 mmt -151.54 98.27 2.49 Favored 'General case' 0 CA--C 1.491 -1.303 0 C-N-CA 120.022 -0.671 . . . . 2.1600000000000001 112.695 178.02 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A 1626 ' ' LEU . . . . . . . . . . . . . 63.1 tp -92.02 101.04 13.58 Favored 'General case' 0 C--N 1.292 -1.919 0 N-CA-C 103.402 -2.814 . . . . 1.3500000000000001 103.402 163.82 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A 1627 ' ' ILE . . . . . 0.586 HD12 ' HB3' ' A' 1637 ' ' PHE . 5.0 mt -68.64 -44.65 82.4 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.602 0 N-CA-C 108.499 -0.926 . . . . 1.21 108.499 -171.211 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A 1628 ' ' SER . . . . . . . . . . . . . 46.5 t -171.12 148.09 2.67 Favored 'General case' 0 N--CA 1.412 -2.373 0 N-CA-C 106.245 -1.761 . . . . 1.3999999999999999 106.245 -179.572 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A 1629 ' ' LEU . . . . . 0.839 ' HG ' ' HG ' ' A' 1636 ' ' LEU . 5.1 tt -126.02 111.02 14.24 Favored 'General case' 0 C--N 1.281 -2.381 0 N-CA-C 105.238 -2.134 . . . . 1.5600000000000001 105.238 173.916 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A 1630 ' ' ASP . . . . . . . . . . . . . 29.8 t70 -94.83 108.68 20.7 Favored 'General case' 0 C--N 1.283 -2.318 0 N-CA-C 108.954 -0.758 . . . . 0.87 108.954 -178.894 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A 1631 ' ' LYS . . . . . . . . . . . . . 65.6 mttp -71.26 -32.96 69.35 Favored 'General case' 0 C--N 1.309 -1.177 0 CA-C-N 115.586 -0.733 . . . . 2.3500000000000001 112.656 -174.486 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A 1632 ' ' GLN . . . . . . . . . . . . . 9.1 pt20 -71.25 -28.74 64.38 Favored 'General case' 0 N--CA 1.467 0.419 0 N-CA-C 113.226 0.825 . . . . 2.5499999999999998 113.226 -176.38 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A 1633 ' ' THR . . . . . 0.403 ' HA ' HD13 ' A' 1604 ' ' LEU . 71.8 p -106.31 -4.3 20.21 Favored 'General case' 0 C--N 1.319 -0.756 0 C-N-CA 119.908 -0.717 . . . . 1.24 110.674 175.08 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A 1634 ' ' CYS . . . . . . . . . . . . . 72.6 m 61.16 40.07 15.21 Favored 'General case' 0 C--O 1.237 0.412 0 CA-C-N 115.063 -0.972 . . . . 0.89000000000000001 111.278 -178.455 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A 1635 ' ' THR . . . . . . . . . . . . . 30.9 m -105.69 122.42 46.03 Favored 'General case' 0 N--CA 1.433 -1.278 0 CA-C-N 115.387 -0.824 . . . . 0.75 110.028 -177.446 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A 1636 ' ' LEU . . . . . 0.839 ' HG ' ' HG ' ' A' 1629 ' ' LEU . 5.8 mp -108.44 124.87 51.08 Favored 'General case' 0 C--N 1.313 -0.982 0 N-CA-C 109.378 -0.601 . . . . 1.3300000000000001 109.378 179.303 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A 1637 ' ' PHE . . . . . 0.586 ' HB3' HD12 ' A' 1627 ' ' ILE . 84.3 m-85 -107.55 126.72 52.89 Favored 'General case' 0 C--N 1.311 -1.092 0 N-CA-C 110.121 -0.326 . . . . 0.82999999999999996 110.121 -178.674 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A 1638 ' ' PHE . . . . . 0.474 ' HA ' ' O ' ' A' 1625 ' ' MET . 93.4 m-85 -124.05 155.31 38.55 Favored 'General case' 0 C--N 1.32 -0.71 0 C-N-CA 122.6 0.36 . . . . 0.59999999999999998 110.634 -179.495 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A 1639 ' ' SER . . . . . 0.508 ' HA ' ' O ' ' A' 1611 ' ' SER . 65.1 m -142.61 148.82 38.1 Favored 'General case' 0 C--O 1.249 1.063 0 N-CA-C 113.486 0.921 . . . . 1.0800000000000001 113.486 174.621 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A 1640 ' ' TRP . . . . . 0.522 ' CG ' ' HB3' ' A' 1623 ' ' ARG . 8.1 t90 -122.05 135.4 54.82 Favored 'General case' 0 C--O 1.243 0.754 0 N-CA-C 106.859 -1.534 . . . . 0.80000000000000004 106.859 176.053 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A 1641 ' ' HIS . . . . . . . . . . . . . 15.3 m-70 -80.51 92.78 5.94 Favored 'General case' 0 CA--C 1.509 -0.613 0 N-CA-C 107.818 -1.178 . . . . 2.54 107.818 177.596 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A 1642 ' ' THR . . . . . 0.51 ' HA ' ' HD3' ' A' 1643 ' ' PRO . 0.0 OUTLIER -128.63 130.5 23.5 Favored Pre-proline 0 C--N 1.304 -1.372 0 N-CA-C 112.852 0.686 . . . . 1.1499999999999999 112.852 -174.248 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A 1643 ' ' PRO . . . . . 0.51 ' HD3' ' HA ' ' A' 1642 ' ' THR . 2.5 Cg_endo -81.66 -7.1 12.58 Favored 'Trans proline' 0 C--N 1.332 -0.302 0 C-N-CA 123.026 2.484 . . . . 0.80000000000000004 111.323 177.008 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A 1644 ' ' LEU . . . . . . . . . . . . . 4.0 pp -89.14 3.94 50.19 Favored 'General case' 0 C--N 1.312 -1.046 0 CA-C-N 115.155 -0.93 . . . . 1.54 112.084 -179.369 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A 1645 ' ' ALA . . . . . . . . . . . . . . . -78.22 -43.07 29.41 Favored 'General case' 0 C--N 1.314 -0.967 0 CA-C-O 122.031 0.919 . . . . 0.94999999999999996 108.791 175.56 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A 1646 ' ' CYS . . . . . . . . . . . . . 24.0 p -159.29 129.87 5.87 Favored 'General case' 0 N--CA 1.428 -1.557 0 N-CA-C 104.163 -2.532 . . . . 1.4099999999999999 104.163 173.658 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A 1647 ' ' GLU . . . . . 0.416 ' HG3' ' HE1' ' A' 1527 ' ' PHE . 35.9 mt-10 . . . . . 0 C--N 1.285 -2.196 0 C-N-CA 120.198 -0.601 . . . . 2.9199999999999999 110.968 -169.298 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A 1515 ' ' ASP . . . . . . . . . . . . . 5.3 t70 . . . . . 0 C--O 1.223 -0.29 0 N-CA-C 109.807 -0.442 . . . . 2.54 109.807 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A 1516 ' ' CYS . . . . . 0.594 ' SG ' ' HE3' ' A' 1579 ' ' LYS . 86.8 m -116.86 20.81 13.72 Favored 'General case' 0 C--N 1.302 -1.495 0 C-N-CA 124.088 0.955 . . . . 1.25 110.536 -176.116 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A 1517 ' ' GLN . . . . . 0.435 ' HA ' ' O ' ' A' 1527 ' ' PHE . 14.0 pt20 -109.69 126.24 53.48 Favored 'General case' 0 N--CA 1.422 -1.87 0 CA-C-N 115.523 -0.762 . . . . 1.8799999999999999 109.169 177.737 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A 1518 ' ' VAL . . . . . 0.61 ' HB ' ' HB2' ' A' 1527 ' ' PHE . 59.3 t -93.45 127.82 45.27 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.233 0 N-CA-C 107.982 -1.118 . . . . 1.73 107.982 -179.962 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A 1519 ' ' THR . . . . . . . . . . . . . 11.3 m -115.02 117.83 31.69 Favored 'General case' 0 N--CA 1.417 -2.109 0 C-N-CA 120.369 -0.533 . . . . 1.7 109.917 -179.165 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A 1520 ' ' ASN . . . . . . . . . . . . . 41.8 t-20 -94.25 105.57 18.35 Favored Pre-proline 0 C--N 1.318 -0.794 0 N-CA-C 107.044 -1.465 . . . . 2.1200000000000001 107.044 174.666 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A 1521 ' ' PRO . . . . . . . . . . . . . 21.2 Cg_exo -67.26 -21.78 47.42 Favored 'Trans proline' 0 C--N 1.351 0.672 0 C-N-CA 122.528 2.152 . . . . 2.4700000000000002 113.663 -176.802 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A 1522 ' ' SER . . . . . . . . . . . . . 19.5 m -76.16 -40.1 53.34 Favored 'General case' 0 C--N 1.311 -1.108 0 N-CA-C 111.955 0.354 . . . . 2.5699999999999998 111.955 -176.323 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A 1523 ' ' THR . . . . . 0.432 HG23 ' HB2' ' A' 1525 ' ' HIS . 14.4 t -107.01 -17.55 14.15 Favored 'General case' 0 CA--C 1.551 0.997 0 C-N-CA 119.525 -0.87 . . . . 2.1499999999999999 111.268 179.418 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A 1524 ' ' GLY . . . . . . . . . . . . . . . 82.0 17.06 70.72 Favored Glycine 0 N--CA 1.45 -0.4 0 C-N-CA 121.171 -0.538 . . . . 1.8899999999999999 112.093 -179.713 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A 1525 ' ' HIS . . . . . 0.432 ' HB2' HG23 ' A' 1523 ' ' THR . 7.3 t60 -84.19 135.08 34.51 Favored 'General case' 0 C--N 1.313 -0.999 0 N-CA-C 108.994 -0.743 . . . . 1.8999999999999999 108.994 -177.672 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A 1526 ' ' LEU . . . . . . . . . . . . . 3.3 tm? -113.87 121.42 43.93 Favored 'General case' 0 C--N 1.3 -1.56 0 N-CA-C 108.415 -0.957 . . . . 1.6100000000000001 108.415 -176.349 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A 1527 ' ' PHE . . . . . 0.61 ' HB2' ' HB ' ' A' 1518 ' ' VAL . 69.9 m-85 -104.2 116.12 31.61 Favored 'General case' 0 C--N 1.304 -1.395 0 N-CA-C 109.641 -0.503 . . . . 1.4199999999999999 109.641 -178.601 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A 1528 ' ' ASP . . . . . 0.48 ' O ' HD13 ' A' 1532 ' ' LEU . 11.6 t70 -95.69 102.52 14.32 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-N 117.576 0.171 . . . . 2.1800000000000002 110.782 -179.977 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A 1529 ' ' LEU . . . . . . . . . . . . . 6.4 mp -89.77 -7.58 54.11 Favored 'General case' 0 C--N 1.318 -0.785 0 CA-C-O 120.8 0.333 . . . . 1.4399999999999999 111.777 179.305 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A 1530 ' ' SER . . . . . 0.477 ' OG ' ' HB2' ' A' 1516 ' ' CYS . 50.2 m -72.51 -48.54 39.7 Favored 'General case' 0 C--N 1.313 -0.993 0 CA-C-N 116.369 -0.378 . . . . 1.4399999999999999 111.265 -178.108 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A 1531 ' ' SER . . . . . . . . . . . . . 8.2 m -70.4 -17.17 63.02 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 116.173 -0.467 . . . . 1.5 111.672 -175.993 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A 1532 ' ' LEU . . . . . 0.517 ' HB3' HG13 ' A' 1552 ' ' ILE . 9.8 mp -68.19 -13.72 62.44 Favored 'General case' 0 N--CA 1.466 0.35 0 CA-C-N 116.255 -0.429 . . . . 1.77 112.042 177.52 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A 1533 ' ' SER . . . . . . . . . . . . . 10.9 m -110.24 106.42 15.83 Favored 'General case' 0 N--CA 1.437 -1.105 0 N-CA-C 109.162 -0.681 . . . . 2.3799999999999999 109.162 178.952 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A 1534 ' ' GLY . . . . . . . . . . . . . . . -92.21 -110.67 1.82 Allowed Glycine 0 N--CA 1.436 -1.312 0 C-N-CA 121.179 -0.534 . . . . 1.55 111.813 178.065 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A 1535 ' ' ARG . . . . . . . . . . . . . 42.8 ttm180 -95.61 -53.85 3.58 Favored 'General case' 0 C--N 1.31 -1.129 0 CA-C-O 121.081 0.467 . . . . 3.96 110.612 178.369 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A 1536 ' ' ALA . . . . . . . . . . . . . . . -96.64 -29.95 13.54 Favored 'General case' 0 C--N 1.316 -0.877 0 CA-C-O 121.044 0.449 . . . . 1.6499999999999999 110.459 177.745 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A 1537 ' ' GLY . . . . . . . . . . . . . . . 70.69 -128.17 17.25 Favored Glycine 0 CA--C 1.499 -0.922 0 CA-C-N 115.515 -0.766 . . . . 1.1899999999999999 112.166 178.278 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A 1538 ' ' PHE . . . . . 0.54 ' HB2' HD11 ' A' 1552 ' ' ILE . 29.8 m-85 -114.26 122.96 48.36 Favored 'General case' 0 CA--C 1.497 -1.074 0 N-CA-C 109.639 -0.504 . . . . 1.6899999999999999 109.639 179.122 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A 1539 ' ' THR . . . . . . . . . . . . . 38.0 p -102.38 141.78 34.66 Favored 'General case' 0 C--N 1.286 -2.161 0 CA-C-N 115.454 -0.793 . . . . 1.48 111.329 -175.581 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A 1540 ' ' ALA . . . . . . . . . . . . . . . -118.79 159.03 24.46 Favored 'General case' 0 C--N 1.308 -1.213 0 N-CA-C 108.643 -0.873 . . . . 0.82999999999999996 108.643 179.356 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A 1541 ' ' ALA . . . . . . . . . . . . . . . -99.48 141.5 32.19 Favored 'General case' 0 C--N 1.306 -1.313 0 CA-C-O 120.887 0.375 . . . . 1.27 111.231 -177.618 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A 1542 ' ' TYR . . . . . . . . . . . . . 76.7 t80 -141.68 177.57 8.06 Favored 'General case' 0 C--N 1.314 -0.95 0 N-CA-C 108.442 -0.947 . . . . 2.1499999999999999 108.442 -178.415 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A 1543 ' ' SER . . . . . . . . . . . . . 5.3 m -45.91 -151.35 0.0 OUTLIER 'General case' 0 CA--C 1.578 2.034 0 C-N-CA 129.52 3.128 . . . . 2.29 114.259 177.14 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A 1544 ' ' LYS . . . . . . . . . . . . . 64.6 mttp -41.93 -32.87 0.47 Allowed 'General case' 0 N--CA 1.492 1.666 0 N-CA-C 115.064 1.505 . . . . 3.9100000000000001 115.064 -177.678 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A 1545 ' ' SER . . . . . 0.4 ' OG ' ' HB3' ' A' 1567 ' ' PHE . 6.0 t -67.29 -22.83 65.63 Favored 'General case' 0 CA--C 1.56 1.334 0 CA-C-N 117.877 0.308 . . . . 3.2999999999999998 110.919 178.148 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A 1546 ' ' GLY . . . . . . . . . . . . . . . 88.6 -76.13 1.92 Allowed Glycine 0 N--CA 1.439 -1.105 0 C-N-CA 121.046 -0.597 . . . . 1.24 114.193 174.689 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A 1547 ' ' VAL . . . . . . . . . . . . . 88.2 t -122.87 144.3 32.82 Favored 'Isoleucine or valine' 0 N--CA 1.417 -2.098 0 C-N-CA 122.748 0.419 . . . . 1.6299999999999999 110.108 -174.272 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A 1548 ' ' VAL . . . . . . . . . . . . . 10.7 t -113.09 136.06 50.62 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.308 0 N-CA-C 106.456 -1.683 . . . . 0.92000000000000004 106.456 175.573 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A 1549 ' ' TYR . . . . . 0.541 ' CE2' ' HA2' ' A' 1568 ' ' GLY . 31.2 m-85 -91.63 146.91 23.4 Favored 'General case' 0 C--N 1.301 -1.508 0 N-CA-C 105.316 -2.105 . . . . 1.4399999999999999 105.316 172.75 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A 1550 ' ' MET . . . . . . . . . . . . . 46.7 ttp -156.69 141.09 16.67 Favored 'General case' 0 C--N 1.292 -1.917 0 N-CA-C 109.12 -0.696 . . . . 1.74 109.12 -179.221 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A 1551 ' ' SER . . . . . . . . . . . . . 64.0 p -89.54 153.48 20.75 Favored 'General case' 0 N--CA 1.414 -2.274 0 N-CA-C 107.937 -1.134 . . . . 1.6399999999999999 107.937 177.114 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A 1552 ' ' ILE . . . . . 0.54 HD11 ' HB2' ' A' 1538 ' ' PHE . 46.2 mm -83.97 -32.29 8.47 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.708 0 N-CA-C 107.595 -1.261 . . . . 1.3300000000000001 107.595 178.627 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A 1553 ' ' CYS . . . . . 0.454 ' HA ' ' OH ' ' A' 1592 ' ' TYR . 36.6 t -162.44 137.62 7.01 Favored 'General case' 0 N--CA 1.43 -1.472 0 CA-C-N 115.547 -0.751 . . . . 1.4299999999999999 109.125 165.836 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A 1554 ' ' GLY . . . . . . . . . . . . . . . 85.91 -124.39 6.84 Favored Glycine 0 CA--C 1.473 -2.549 0 N-CA-C 110.201 -1.16 . . . . 1.1200000000000001 110.201 -178.641 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A 1555 ' ' GLU . . . . . 0.457 ' H ' ' CD ' ' A' 1555 ' ' GLU . 0.1 OUTLIER -117.93 -177.53 3.28 Favored 'General case' 0 C--N 1.258 -3.401 0 CA-C-N 113.538 -1.331 . . . . 1.8 108.516 -176.522 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A 1556 ' ' ASN . . . . . 0.465 ' HB3' ' HG3' ' A' 1557 ' ' GLU . 3.6 t-20 165.31 -158.91 0.0 OUTLIER 'General case' 0 C--O 1.255 1.365 0 N-CA-C 103.096 -2.927 . . . . 2.6299999999999999 103.096 -174.209 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A 1557 ' ' GLU . . . . . 0.465 ' HG3' ' HB3' ' A' 1556 ' ' ASN . 26.0 mt-10 83.49 178.72 0.05 Allowed 'General case' 0 CA--C 1.497 -1.058 0 N-CA-C 115.814 1.783 . . . . 3.79 115.814 159.713 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A 1558 ' ' ASN . . . . . . . . . . . . . 33.2 m-80 -127.97 43.06 3.21 Favored 'General case' 0 C--N 1.307 -1.273 0 CA-C-N 113.358 -1.747 . . . . 1.52 107.948 -173.541 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A 1559 ' ' CYS . . . . . 0.408 ' HB3' ' HD2' ' A' 1560 ' ' PRO . 84.2 m -131.85 172.37 7.48 Favored Pre-proline 0 C--N 1.293 -1.889 0 CA-C-N 113.666 -1.607 . . . . 0.83999999999999997 106.885 -179.609 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A 1560 ' ' PRO . . . . . 0.437 ' HA ' ' HD2' ' A' 1561 ' ' PRO . 99.7 Cg_exo -48.73 116.21 2.02 Favored 'Trans proline' 0 C--N 1.361 1.209 0 C-N-CA 122.177 1.918 . . . . 1.1799999999999999 110.591 172.756 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A 1561 ' ' PRO . . . . . 0.437 ' HD2' ' HA ' ' A' 1560 ' ' PRO . 12.4 Cg_endo -53.63 142.51 60.51 Favored 'Trans proline' 0 C--N 1.354 0.828 0 C-N-CA 124.35 3.367 . . . . 1.51 113.988 -172.854 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A 1562 ' ' GLY . . . . . . . . . . . . . . . 112.28 9.24 20.27 Favored Glycine 0 N--CA 1.437 -1.277 0 N-CA-C 110.687 -0.965 . . . . 0.71999999999999997 110.687 -179.71 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A 1563 ' ' VAL . . . . . . . . . . . . . 4.8 m -99.66 154.23 4.27 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.838 0 N-CA-C 109.357 -0.609 . . . . 0.96999999999999997 109.357 176.049 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A 1564 ' ' GLY . . . . . . . . . . . . . . . -115.94 -6.43 16.5 Favored Glycine 0 N--CA 1.421 -2.324 0 N-CA-C 110.36 -1.096 . . . . 0.71999999999999997 110.36 175.408 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A 1565 ' ' ALA . . . . . . . . . . . . . . . -168.78 119.2 0.74 Allowed 'General case' 0 C--O 1.259 1.577 0 N-CA-C 108.969 -0.752 . . . . 0.37 108.969 -179.347 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A 1566 ' ' CYS . . . . . . . . . . . . . 35.8 t -141.72 141.29 33.27 Favored 'General case' 0 C--N 1.297 -1.686 0 CA-C-N 115.368 -0.833 . . . . 0.51000000000000001 111.2 -174.064 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A 1567 ' ' PHE . . . . . 0.4 ' HB3' ' OG ' ' A' 1545 ' ' SER . 15.7 m-85 -66.6 126.94 30.49 Favored 'General case' 0 C--O 1.219 -0.51 0 N-CA-C 109.723 -0.473 . . . . 0.96999999999999997 109.723 176.197 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A 1568 ' ' GLY . . . . . 0.541 ' HA2' ' CE2' ' A' 1549 ' ' TYR . . . -66.86 -33.22 83.38 Favored Glycine 0 N--CA 1.444 -0.83 0 CA-C-N 115.748 -0.66 . . . . 1.0800000000000001 114.167 -175.109 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A 1569 ' ' GLN . . . . . . . . . . . . . 52.3 tt0 -84.45 -52.86 5.84 Favored 'General case' 0 C--N 1.303 -1.436 0 CA-C-O 121.686 0.755 . . . . 2.7400000000000002 110.707 -179.576 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A 1570 ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -83.29 -14.68 52.53 Favored 'General case' 0 C--N 1.296 -1.721 0 CA-C-N 114.884 -1.053 . . . . 1.96 112.463 -169.745 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A 1571 ' ' ARG . . . . . . . . . . . . . 49.3 mtp180 54.97 37.23 28.51 Favored 'General case' 0 N--CA 1.476 0.855 0 C-N-CA 125.864 1.666 . . . . 3.9500000000000002 111.95 -179.644 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A 1572 ' ' ILE . . . . . . . . . . . . . 45.9 mm -107.01 132.78 53.49 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.126 0 CA-C-N 115.347 -0.842 . . . . 1.3700000000000001 109.359 -178.349 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A 1573 ' ' SER . . . . . . . . . . . . . 33.0 t -73.83 131.58 41.67 Favored 'General case' 0 N--CA 1.428 -1.528 0 CA-C-N 114.997 -1.001 . . . . 1.0800000000000001 110.607 179.858 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A 1574 ' ' VAL . . . . . 0.988 ' HA ' ' HB3' ' A' 1596 ' ' SER . 34.0 m -109.85 -32.69 2.34 Favored 'Isoleucine or valine' 0 N--CA 1.419 -1.978 0 C-N-CA 119.976 -0.69 . . . . 1.3 109.864 171.984 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A 1575 ' ' GLY . . . . . . . . . . . . . . . -133.51 121.8 2.91 Favored Glycine 0 N--CA 1.425 -2.088 0 N-CA-C 110.372 -1.091 . . . . 0.51000000000000001 110.372 178.762 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A 1576 ' ' LYS . . . . . . . . . . . . . 88.0 tttt -80.49 149.15 30.16 Favored 'General case' 0 C--N 1.311 -1.1 0 N-CA-C 108.578 -0.897 . . . . 2.8999999999999999 108.578 179.637 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A 1577 ' ' ALA . . . . . . . . . . . . . . . -61.88 102.35 0.27 Allowed 'General case' 0 CA--C 1.516 -0.357 0 O-C-N 123.928 0.768 . . . . 0.82999999999999996 111.141 -177.81 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A 1578 ' ' ASN . . . . . . . . . . . . . 73.4 m-20 -120.87 115.19 22.75 Favored 'General case' 0 C--N 1.297 -1.699 0 N-CA-C 106.487 -1.672 . . . . 1.8500000000000001 106.487 175.638 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A 1579 ' ' LYS . . . . . 0.594 ' HE3' ' SG ' ' A' 1516 ' ' CYS . 55.6 mtpt -83.35 90.17 7.12 Favored 'General case' 0 C--N 1.295 -1.781 0 N-CA-C 107.724 -1.213 . . . . 1.8999999999999999 107.724 -179.047 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A 1580 ' ' ARG . . . . . . . . . . . . . 26.0 ttt85 -150.96 113.91 4.75 Favored 'General case' 0 N--CA 1.424 -1.734 0 CA-C-N 114.847 -1.07 . . . . 3.6299999999999999 109.667 -175.579 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A 1581 ' ' LEU . . . . . . . . . . . . . 3.5 pp -134.04 161.73 34.03 Favored 'General case' 0 C--N 1.292 -1.915 0 CA-C-N 115.776 -0.647 . . . . 1.8700000000000001 109.721 179.425 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A 1582 ' ' ARG . . . . . . . . . . . . . 79.1 ttt180 -138.15 129.39 27.45 Favored 'General case' 0 C--N 1.292 -1.892 0 C-N-CA 121.134 -0.227 . . . . 3.9700000000000002 110.444 176.999 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A 1583 ' ' TYR . . . . . . . . . . . . . 36.7 t80 -93.07 102.6 14.93 Favored 'General case' 0 C--N 1.3 -1.583 0 N-CA-C 107.185 -1.413 . . . . 1.4099999999999999 107.185 173.662 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A 1584 ' ' VAL . . . . . . . . . . . . . 7.5 p -135.87 120.93 27.85 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.949 0 C-N-CA 120.875 -0.33 . . . . 1.6899999999999999 111.463 -177.293 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A 1585 ' ' ASP . . . . . . . . . . . . . 35.3 t70 53.08 45.73 28.14 Favored 'General case' 0 N--CA 1.488 1.435 0 C-N-CA 124.453 1.101 . . . . 2.0600000000000001 111.12 178.367 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A 1586 ' ' GLN . . . . . . . . . . . . . 47.0 mt-30 58.13 25.83 12.94 Favored 'General case' 0 C--O 1.242 0.685 0 C-N-CA 125.377 1.471 . . . . 2.3300000000000001 114.587 179.675 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A 1587 ' ' VAL . . . . . . . . . . . . . 8.1 p -128.45 126.17 65.12 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.314 0 N-CA-C 107.895 -1.15 . . . . 0.78000000000000003 107.895 171.737 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A 1588 ' ' LEU . . . . . 0.623 ' HB2' ' HB2' ' A' 1612 ' ' PHE . 34.6 mt -86.22 138.99 31.45 Favored 'General case' 0 C--N 1.304 -1.396 0 N-CA-C 108.991 -0.744 . . . . 1.4099999999999999 108.991 -179.918 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A 1589 ' ' GLN . . . . . . . . . . . . . 34.6 tt0 -130.59 107.0 8.87 Favored 'General case' 0 C--N 1.292 -1.929 0 N-CA-C 109.397 -0.594 . . . . 1.24 109.397 -177.278 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A 1590 ' ' LEU . . . . . . . . . . . . . 9.1 tt -111.82 137.16 50.15 Favored 'General case' 0 C--N 1.288 -2.07 0 N-CA-C 107.744 -1.206 . . . . 1.1499999999999999 107.744 179.031 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A 1591 ' ' VAL . . . . . 0.543 HG12 HG22 ' A' 1609 ' ' VAL . 28.8 m -130.55 140.58 48.44 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.937 0 N-CA-C 112.233 0.457 . . . . 1.51 112.233 -175.431 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A 1592 ' ' TYR . . . . . 0.454 ' OH ' ' HA ' ' A' 1553 ' ' CYS . 39.6 m-85 -122.09 138.69 54.36 Favored 'General case' 0 C--N 1.313 -1.01 0 N-CA-C 108.128 -1.064 . . . . 1.0600000000000001 108.128 172.948 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A 1593 ' ' LYS . . . . . . . . . . . . . 62.5 pttt -159.25 174.85 14.17 Favored 'General case' 0 C--O 1.251 1.133 0 N-CA-C 109.899 -0.408 . . . . 2.1800000000000002 109.899 178.8 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A 1594 ' ' ASP . . . . . . . . . . . . . 31.6 m-20 67.54 56.93 0.57 Allowed 'General case' 0 N--CA 1.48 1.03 0 C-N-CA 124.376 1.07 . . . . 1.45 110.888 179.592 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A 1595 ' ' GLY . . . . . . . . . . . . . . . -142.1 -47.92 0.05 OUTLIER Glycine 0 C--N 1.308 -1.026 0 CA-C-N 115.054 -0.976 . . . . 0.78000000000000003 111.362 -179.578 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A 1596 ' ' SER . . . . . 0.988 ' HB3' ' HA ' ' A' 1574 ' ' VAL . 15.8 p -96.69 134.21 23.51 Favored Pre-proline 0 C--N 1.298 -1.638 0 CA-C-N 115.526 -0.337 . . . . 1.6799999999999999 111.545 179.031 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A 1597 ' ' PRO . . . . . 0.455 ' HD3' ' HA ' ' A' 1596 ' ' SER . 3.0 Cg_exo -79.77 113.56 3.07 Favored 'Trans proline' 0 N--CA 1.445 -1.373 0 C-N-CA 122.176 1.917 . . . . 1.1699999999999999 108.593 170.863 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A 1598 ' ' CYS . . . . . . . . . . . . . 48.6 t -94.87 122.66 59.86 Favored Pre-proline 0 C--N 1.306 -1.326 0 N-CA-C 109.727 -0.471 . . . . 1.1899999999999999 109.727 -176.3 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A 1599 ' ' PRO . . . . . . . . . . . . . 87.9 Cg_endo -77.97 0.6 9.7 Favored 'Trans proline' 0 CA--C 1.537 0.67 0 C-N-CA 123.384 2.723 . . . . 1.5900000000000001 114.267 -175.463 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A 1600 ' ' SER . . . . . . . . . . . . . 19.9 m -77.9 -32.18 51.65 Favored 'General case' 0 C--N 1.308 -1.223 0 CA-C-O 120.677 0.275 . . . . 2.1200000000000001 111.288 -179.679 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A 1601 ' ' LYS . . . . . 0.905 ' HB3' HD12 ' A' 1604 ' ' LEU . 11.2 tmtt? -158.92 129.98 6.19 Favored 'General case' 0 C--N 1.313 -0.993 0 N-CA-C 105.691 -1.966 . . . . 3.7400000000000002 105.691 -177.13 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A 1602 ' ' SER . . . . . . . . . . . . . 16.4 m -67.36 125.41 26.02 Favored 'General case' 0 C--N 1.316 -0.852 0 CA-C-O 120.886 0.374 . . . . 3.79 110.591 -175.222 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A 1603 ' ' GLY . . . . . . . . . . . . . . . 103.83 -6.27 47.9 Favored Glycine 0 N--CA 1.435 -1.382 0 N-CA-C 110.918 -0.873 . . . . 2.0 110.918 -179.937 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A 1604 ' ' LEU . . . . . 0.905 HD12 ' HB3' ' A' 1601 ' ' LYS . 6.8 mt -89.19 148.26 23.73 Favored 'General case' 0 N--CA 1.43 -1.463 0 CA-C-O 121.425 0.631 . . . . 1.48 111.851 178.209 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A 1605 ' ' SER . . . . . 0.465 ' HA ' ' O ' ' A' 1596 ' ' SER . 8.3 t -130.45 163.58 26.64 Favored 'General case' 0 N--CA 1.413 -2.287 0 N-CA-C 104.673 -2.344 . . . . 1.51 104.673 176.561 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A 1606 ' ' TYR . . . . . 0.548 ' HA ' ' O ' ' A' 1634 ' ' CYS . 67.6 m-85 -90.22 116.01 27.88 Favored 'General case' 0 CA--C 1.458 -2.563 0 N-CA-C 106.331 -1.729 . . . . 1.1799999999999999 106.331 -179.852 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A 1607 ' ' LYS . . . . . . . . . . . . . 23.3 pttp -103.23 127.41 50.55 Favored 'General case' 0 N--CA 1.394 -3.226 0 C-N-CA 118.196 -1.401 . . . . 1.6699999999999999 109.496 -176.738 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A 1608 ' ' SER . . . . . 0.505 ' HA ' ' HB2' ' A' 1636 ' ' LEU . 12.0 p -97.43 111.31 23.62 Favored 'General case' 0 N--CA 1.407 -2.62 0 CA-C-N 115.118 -0.946 . . . . 1.0 109.287 -177.186 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A 1609 ' ' VAL . . . . . 0.543 HG22 HG12 ' A' 1591 ' ' VAL . 85.5 t -101.35 107.84 22.24 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.523 0 N-CA-C 108.166 -1.049 . . . . 0.93000000000000005 108.166 179.747 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A 1610 ' ' ILE . . . . . . . . . . . . . 2.5 mp -93.28 108.7 20.77 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.561 0 N-CA-C 108.274 -1.01 . . . . 0.78000000000000003 108.274 179.023 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A 1611 ' ' SER . . . . . 0.401 ' O ' ' HA ' ' A' 1639 ' ' SER . 21.8 m -94.52 113.92 25.83 Favored 'General case' 0 N--CA 1.409 -2.509 0 N-CA-C 108.232 -1.025 . . . . 1.29 108.232 177.346 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A 1612 ' ' PHE . . . . . 0.623 ' HB2' ' HB2' ' A' 1588 ' ' LEU . 79.8 m-85 -84.89 106.84 16.71 Favored 'General case' 0 C--N 1.291 -1.941 0 CA-C-N 115.067 -0.97 . . . . 0.69999999999999996 110.57 -178.24 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A 1613 ' ' VAL . . . . . . . . . . . . . 41.9 t -94.92 119.68 43.3 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.52 0 CA-C-N 115.279 -0.873 . . . . 0.75 109.067 -177.051 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A 1614 ' ' CYS . . . . . 0.523 ' HB3' ' HB2' ' A' 1646 ' ' CYS . 56.2 m -71.45 92.33 1.09 Allowed 'General case' 0 C--N 1.314 -0.958 0 CA-C-O 121.377 0.608 . . . . 1.3899999999999999 109.381 178.241 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A 1615 ' ' ARG . . . . . 0.515 ' HB3' ' HB3' ' A' 1641 ' ' HIS . 0.6 OUTLIER -137.97 87.46 16.58 Favored Pre-proline 0 C--N 1.305 -1.36 0 N-CA-C 107.109 -1.441 . . . . 3.75 107.109 -178.904 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A 1616 ' ' PRO . . . . . . . . . . . . . 6.6 Cg_exo -76.34 44.79 1.43 Allowed 'Trans proline' 0 N--CA 1.479 0.635 0 C-N-CA 123.459 2.772 . . . . 1.3200000000000001 112.768 -177.449 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A 1617 ' ' GLU . . . . . . . . . . . . . 41.8 mt-10 . . . . . 0 C--N 1.303 -1.44 0 N-CA-C 108.201 -1.036 . . . . 3.21 108.201 -179.276 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A 1622 ' ' ASN . . . . . . . . . . . . . 60.6 t30 . . . . . 0 N--CA 1.472 0.65 0 CA-C-O 121.81 0.814 . . . . 2.9199999999999999 110.761 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A 1623 ' ' ARG . . . . . . . . . . . . . 9.2 ptm180 -154.0 153.49 28.61 Favored Pre-proline 0 C--N 1.3 -1.566 0 N-CA-C 107.28 -1.378 . . . . 3.6099999999999999 107.28 -178.922 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A 1624 ' ' PRO . . . . . . . . . . . . . 32.5 Cg_exo -61.29 119.82 7.16 Favored 'Trans proline' 0 C--O 1.245 0.87 0 C-N-CA 122.761 2.307 . . . . 2.3700000000000001 111.751 179.246 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A 1625 ' ' MET . . . . . . . . . . . . . 56.3 ttp -95.99 130.7 42.92 Favored 'General case' 0 C--N 1.301 -1.522 0 CA-C-N 115.082 -0.963 . . . . 2.1600000000000001 109.688 -177.228 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A 1626 ' ' LEU . . . . . 0.708 HD21 HD23 ' A' 1629 ' ' LEU . 56.8 tp -83.53 105.73 14.7 Favored 'General case' 0 C--N 1.306 -1.304 0 N-CA-C 107.8 -1.185 . . . . 1.3500000000000001 107.8 178.001 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A 1627 ' ' ILE . . . . . . . . . . . . . 45.4 pt -83.19 -33.61 10.36 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.268 0 N-CA-C 112.303 0.483 . . . . 1.21 112.303 -175.1 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A 1628 ' ' SER . . . . . . . . . . . . . 45.7 m -149.75 147.49 28.08 Favored 'General case' 0 C--N 1.313 -1.001 0 CA-C-O 120.673 0.273 . . . . 1.3999999999999999 110.475 -178.077 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A 1629 ' ' LEU . . . . . 0.708 HD23 HD21 ' A' 1626 ' ' LEU . 1.2 tm? -127.76 108.41 10.72 Favored 'General case' 0 C--N 1.307 -1.255 0 N-CA-C 106.61 -1.626 . . . . 1.5600000000000001 106.61 -179.216 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A 1630 ' ' ASP . . . . . . . . . . . . . 15.3 t70 -107.7 112.08 24.59 Favored 'General case' 0 C--N 1.304 -1.399 0 N-CA-C 109.056 -0.72 . . . . 0.87 109.056 178.771 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A 1631 ' ' LYS . . . . . . . . . . . . . 63.4 mttm -80.0 -22.5 42.41 Favored 'General case' 0 C--N 1.303 -1.426 0 N-CA-C 112.674 0.62 . . . . 2.3500000000000001 112.674 -177.186 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A 1632 ' ' GLN . . . . . . . . . . . . . 1.7 mp0 -78.77 -49.96 12.14 Favored 'General case' 0 CA--C 1.509 -0.61 0 CA-C-O 121.029 0.442 . . . . 2.5499999999999998 111.467 -173.277 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A 1633 ' ' THR . . . . . . . . . . . . . 60.4 p -86.57 -4.52 59.18 Favored 'General case' 0 C--N 1.313 -1.011 0 CA-C-O 121.875 0.845 . . . . 1.24 110.004 179.764 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A 1634 ' ' CYS . . . . . 0.548 ' O ' ' HA ' ' A' 1606 ' ' TYR . 29.4 m 59.62 51.05 6.65 Favored 'General case' 0 N--CA 1.441 -0.907 0 CA-C-N 113.442 -1.708 . . . . 0.89000000000000001 108.768 179.712 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A 1635 ' ' THR . . . . . . . . . . . . . 39.7 m -114.94 130.26 56.88 Favored 'General case' 0 N--CA 1.425 -1.699 0 CA-C-N 114.999 -1.001 . . . . 0.75 110.087 -175.831 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A 1636 ' ' LEU . . . . . 0.505 ' HB2' ' HA ' ' A' 1608 ' ' SER . 40.6 mt -112.62 116.06 29.59 Favored 'General case' 0 N--CA 1.435 -1.223 0 N-CA-C 107.58 -1.267 . . . . 1.3300000000000001 107.58 -178.479 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A 1637 ' ' PHE . . . . . . . . . . . . . 89.1 m-85 -98.68 100.92 12.19 Favored 'General case' 0 C--N 1.307 -1.282 0 N-CA-C 111.777 0.288 . . . . 0.82999999999999996 111.777 -175.298 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A 1638 ' ' PHE . . . . . . . . . . . . . 68.0 m-85 -100.74 138.84 37.26 Favored 'General case' 0 C--N 1.307 -1.258 0 N-CA-C 109.169 -0.678 . . . . 0.59999999999999998 109.169 176.165 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A 1639 ' ' SER . . . . . 0.401 ' HA ' ' O ' ' A' 1611 ' ' SER . 50.8 m -136.79 120.75 17.61 Favored 'General case' 0 C--N 1.279 -2.467 0 N-CA-C 108.464 -0.939 . . . . 1.0800000000000001 108.464 174.883 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A 1640 ' ' TRP . . . . . . . . . . . . . 19.7 t90 -111.76 119.89 40.16 Favored 'General case' 0 C--N 1.292 -1.898 0 CA-C-N 115.942 -0.572 . . . . 0.80000000000000004 109.501 -178.131 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A 1641 ' ' HIS . . . . . 0.515 ' HB3' ' HB3' ' A' 1615 ' ' ARG . 39.8 m170 -77.06 107.46 9.44 Favored 'General case' 0 C--N 1.31 -1.138 0 N-CA-C 106.347 -1.723 . . . . 2.54 106.347 174.718 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A 1642 ' ' THR . . . . . . . . . . . . . 8.8 t -140.92 136.93 16.56 Favored Pre-proline 0 C--N 1.291 -1.952 0 N-CA-C 113.126 0.787 . . . . 1.1499999999999999 113.126 -173.711 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A 1643 ' ' PRO . . . . . 0.422 ' O ' ' HG2' ' A' 1647 ' ' GLU . 64.4 Cg_endo -76.97 -2.93 13.2 Favored 'Trans proline' 0 C--O 1.199 -1.462 0 C-N-CA 123.475 2.783 . . . . 0.80000000000000004 111.006 173.735 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A 1644 ' ' LEU . . . . . . . . . . . . . 83.6 mt -91.84 -9.67 42.56 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 116.608 -0.269 . . . . 1.54 111.417 -177.968 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A 1645 ' ' ALA . . . . . . . . . . . . . . . -81.67 -35.98 29.29 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 121.805 0.812 . . . . 0.94999999999999996 109.128 177.45 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A 1646 ' ' CYS . . . . . 0.523 ' HB2' ' HB3' ' A' 1614 ' ' CYS . 71.2 m -142.19 114.76 8.48 Favored 'General case' 0 N--CA 1.426 -1.645 0 N-CA-C 105.499 -2.037 . . . . 1.4099999999999999 105.499 174.786 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A 1647 ' ' GLU . . . . . 0.422 ' HG2' ' O ' ' A' 1643 ' ' PRO . 42.2 mt-10 . . . . . 0 C--N 1.3 -1.56 0 N-CA-C 109.137 -0.69 . . . . 2.9199999999999999 109.137 -178.413 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A 1515 ' ' ASP . . . . . . . . . . . . . 7.0 t0 . . . . . 0 N--CA 1.449 -0.491 0 N-CA-C 107.061 -1.459 . . . . 2.54 107.061 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A 1516 ' ' CYS . . . . . . . . . . . . . 81.3 m -90.65 61.53 4.87 Favored 'General case' 0 C--N 1.28 -2.422 0 C-N-CA 123.599 0.76 . . . . 1.25 109.183 -179.761 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A 1517 ' ' GLN . . . . . 0.415 ' HB2' HD21 ' A' 1526 ' ' LEU . 9.8 pt20 -160.97 131.9 5.39 Favored 'General case' 0 C--N 1.308 -1.211 0 CA-C-O 120.803 0.335 . . . . 1.8799999999999999 110.695 179.219 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A 1518 ' ' VAL . . . . . . . . . . . . . 14.1 p -131.88 137.32 55.19 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.804 0 N-CA-C 109.053 -0.721 . . . . 1.73 109.053 178.429 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A 1519 ' ' THR . . . . . 0.62 ' HA ' ' HA ' ' A' 1526 ' ' LEU . 40.0 m -89.37 128.65 35.93 Favored 'General case' 0 C--N 1.29 -1.98 0 CA-C-N 116.182 -0.463 . . . . 1.7 109.758 177.891 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A 1520 ' ' ASN . . . . . . . . . . . . . 17.7 t-20 -80.1 114.3 45.6 Favored Pre-proline 0 C--N 1.308 -1.228 0 N-CA-C 108.473 -0.936 . . . . 2.1200000000000001 108.473 174.758 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A 1521 ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -74.63 0.2 9.0 Favored 'Trans proline' 0 CA--C 1.539 0.767 0 C-N-CA 122.541 2.16 . . . . 2.4700000000000002 113.926 -176.371 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A 1522 ' ' SER . . . . . . . . . . . . . 49.3 m -88.79 -62.34 1.51 Allowed 'General case' 0 N--CA 1.432 -1.375 0 O-C-N 122.13 -0.356 . . . . 2.5699999999999998 110.895 178.784 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A 1523 ' ' THR . . . . . . . . . . . . . 8.8 t -92.98 -11.89 32.09 Favored 'General case' 0 CA--C 1.547 0.858 0 CA-C-O 120.952 0.406 . . . . 2.1499999999999999 111.253 -179.821 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A 1524 ' ' GLY . . . . . . . . . . . . . . . 80.33 27.79 50.81 Favored Glycine 0 C--N 1.332 0.329 0 C-N-CA 121.059 -0.591 . . . . 1.8899999999999999 112.119 179.244 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A 1525 ' ' HIS . . . . . . . . . . . . . 16.1 t60 -101.22 119.18 38.36 Favored 'General case' 0 C--N 1.309 -1.169 0 N-CA-C 110.184 -0.302 . . . . 1.8999999999999999 110.184 -176.802 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A 1526 ' ' LEU . . . . . 0.62 ' HA ' ' HA ' ' A' 1519 ' ' THR . 7.0 tt -82.72 124.73 30.5 Favored 'General case' 0 C--N 1.301 -1.533 0 N-CA-C 108.174 -1.047 . . . . 1.6100000000000001 108.174 175.651 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A 1527 ' ' PHE . . . . . 0.408 ' O ' ' HA ' ' A' 1517 ' ' GLN . 76.4 m-85 -90.32 102.41 15.14 Favored 'General case' 0 C--N 1.309 -1.194 0 N-CA-C 109.183 -0.673 . . . . 1.4199999999999999 109.183 178.233 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A 1528 ' ' ASP . . . . . . . . . . . . . 8.8 t70 -80.76 118.13 22.03 Favored 'General case' 0 C--N 1.309 -1.154 0 CA-C-O 121.336 0.588 . . . . 2.1800000000000002 111.633 178.306 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A 1529 ' ' LEU . . . . . . . . . . . . . 6.2 mp -121.05 11.47 10.96 Favored 'General case' 0 C--N 1.307 -1.28 0 N-CA-C 106.496 -1.668 . . . . 1.4399999999999999 106.496 168.149 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A 1530 ' ' SER . . . . . . . . . . . . . 42.9 m -76.18 -29.1 57.54 Favored 'General case' 0 N--CA 1.442 -0.867 0 CA-C-N 115.376 -0.829 . . . . 1.4399999999999999 110.06 -178.615 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A 1531 ' ' SER . . . . . . . . . . . . . 29.0 t -75.32 -6.35 49.44 Favored 'General case' 0 CA--C 1.548 0.903 0 CA-C-O 122.303 1.049 . . . . 1.5 108.806 174.518 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A 1532 ' ' LEU . . . . . . . . . . . . . 98.1 mt -91.89 15.24 13.49 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.807 -0.633 . . . . 1.77 110.616 175.243 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A 1533 ' ' SER . . . . . 0.425 ' HA ' ' O ' ' A' 1553 ' ' CYS . 18.8 m -84.56 122.11 28.57 Favored 'General case' 0 N--CA 1.432 -1.35 0 N-CA-C 108.619 -0.882 . . . . 2.3799999999999999 108.619 175.668 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A 1534 ' ' GLY . . . . . . . . . . . . . . . -135.92 152.77 21.15 Favored Glycine 0 N--CA 1.419 -2.448 0 N-CA-C 110.594 -1.002 . . . . 1.55 110.594 -179.255 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A 1535 ' ' ARG . . . . . 0.584 ' HG3' ' HG3' ' A' 1555 ' ' GLU . 51.2 ttt180 -96.44 -25.13 15.8 Favored 'General case' 0 C--N 1.306 -1.283 0 CA-C-O 121.669 0.747 . . . . 3.96 109.886 179.049 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A 1536 ' ' ALA . . . . . . . . . . . . . . . -89.72 -41.03 12.14 Favored 'General case' 0 C--O 1.243 0.732 0 CA-C-N 115.587 -0.733 . . . . 1.6499999999999999 110.849 -179.043 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A 1537 ' ' GLY . . . . . . . . . . . . . . . 97.7 -175.95 30.62 Favored Glycine 0 N--CA 1.435 -1.382 0 CA-C-N 115.761 -0.654 . . . . 1.1899999999999999 112.477 176.75 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A 1538 ' ' PHE . . . . . . . . . . . . . 92.1 m-85 -111.64 155.09 23.94 Favored 'General case' 0 C--N 1.302 -1.49 0 N-CA-C 108.212 -1.033 . . . . 1.6899999999999999 108.212 176.687 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A 1539 ' ' THR . . . . . . . . . . . . . 5.2 p -106.27 111.08 23.52 Favored 'General case' 0 C--N 1.295 -1.761 0 CA-C-N 116.016 -0.538 . . . . 1.48 111.538 -179.704 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A 1540 ' ' ALA . . . . . . . . . . . . . . . -112.32 107.63 16.53 Favored 'General case' 0 C--N 1.313 -0.988 0 N-CA-C 109.027 -0.731 . . . . 0.82999999999999996 109.027 176.014 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A 1541 ' ' ALA . . . . . . . . . . . . . . . -71.75 155.23 40.69 Favored 'General case' 0 C--N 1.312 -1.037 0 CA-C-N 116.261 -0.427 . . . . 1.27 110.644 178.705 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A 1542 ' ' TYR . . . . . 0.414 ' HD2' ' HB2' ' A' 1545 ' ' SER . 32.4 t80 -156.23 179.92 8.77 Favored 'General case' 0 C--N 1.302 -1.491 0 N-CA-C 107.708 -1.219 . . . . 2.1499999999999999 107.708 -178.926 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A 1543 ' ' SER . . . . . . . . . . . . . 5.5 m -44.98 -151.67 0.0 OUTLIER 'General case' 0 CA--C 1.57 1.728 0 C-N-CA 129.181 2.993 . . . . 2.29 114.616 178.101 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A 1544 ' ' LYS . . . . . 0.414 ' HB2' ' HE3' ' A' 1544 ' ' LYS . 19.4 ptmt -54.7 -6.9 0.13 Allowed 'General case' 0 CA--C 1.575 1.931 0 O-C-N 120.251 -1.531 . . . . 3.9100000000000001 114.021 176.511 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A 1545 ' ' SER . . . . . 0.414 ' HB2' ' HD2' ' A' 1542 ' ' TYR . 20.4 m -73.03 -17.4 61.44 Favored 'General case' 0 CA--C 1.554 1.132 0 C-N-CA 123.332 0.653 . . . . 3.2999999999999998 109.693 170.668 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A 1546 ' ' GLY . . . . . . . . . . . . . . . 83.75 -80.38 1.83 Allowed Glycine 0 N--CA 1.436 -1.316 0 CA-C-O 121.43 0.461 . . . . 1.24 114.009 174.093 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A 1547 ' ' VAL . . . . . . . . . . . . . 7.1 p -160.16 140.77 3.78 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.169 0 N-CA-C 109.235 -0.654 . . . . 1.6299999999999999 109.235 -174.738 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A 1548 ' ' VAL . . . . . . . . . . . . . 4.0 t -108.29 131.9 57.52 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.726 0 N-CA-C 107.399 -1.334 . . . . 0.92000000000000004 107.399 179.398 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A 1549 ' ' TYR . . . . . . . . . . . . . 68.4 m-85 -93.15 114.64 27.2 Favored 'General case' 0 C--N 1.308 -1.207 0 N-CA-C 106.858 -1.534 . . . . 1.4399999999999999 106.858 174.077 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A 1550 ' ' MET . . . . . . . . . . . . . 56.3 ttp -135.93 121.6 19.64 Favored 'General case' 0 C--N 1.299 -1.614 0 C-N-CA 119.706 -0.798 . . . . 1.74 111.388 -177.774 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A 1551 ' ' SER . . . . . . . . . . . . . 19.9 m -95.97 124.1 39.84 Favored 'General case' 0 C--N 1.277 -2.568 0 N-CA-C 104.801 -2.296 . . . . 1.6399999999999999 104.801 173.017 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A 1552 ' ' ILE . . . . . . . . . . . . . 50.6 mm -60.86 -43.2 95.12 Favored 'Isoleucine or valine' 0 C--O 1.213 -0.854 0 N-CA-C 109.404 -0.591 . . . . 1.3300000000000001 109.404 -179.037 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A 1553 ' ' CYS . . . . . 0.425 ' O ' ' HA ' ' A' 1533 ' ' SER . 76.1 m -144.71 155.87 43.79 Favored 'General case' 0 C--N 1.295 -1.782 0 N-CA-C 106.491 -1.67 . . . . 1.4299999999999999 106.491 173.411 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A 1554 ' ' GLY . . . . . . . . . . . . . . . 118.26 -110.92 2.05 Favored Glycine 0 N--CA 1.434 -1.489 0 C-N-CA 120.342 -0.932 . . . . 1.1200000000000001 112.763 176.427 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A 1555 ' ' GLU . . . . . 0.584 ' HG3' ' HG3' ' A' 1535 ' ' ARG . 9.5 pt-20 -165.34 161.94 19.33 Favored 'General case' 0 C--N 1.305 -1.33 0 N-CA-C 106.724 -1.584 . . . . 1.8 106.724 -178.207 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A 1556 ' ' ASN . . . . . . . . . . . . . 17.9 t-20 -131.34 103.65 6.57 Favored 'General case' 0 C--N 1.287 -2.136 0 N-CA-C 109.332 -0.618 . . . . 2.6299999999999999 109.332 -179.209 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A 1557 ' ' GLU . . . . . . . . . . . . . 9.1 mm-40 -83.13 36.65 0.52 Allowed 'General case' 0 C--N 1.3 -1.576 0 N-CA-C 113.782 1.03 . . . . 3.79 113.782 -173.2 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A 1558 ' ' ASN . . . . . . . . . . . . . 33.0 m-80 -111.78 -19.35 12.47 Favored 'General case' 0 C--N 1.295 -1.802 0 N-CA-C 107.846 -1.168 . . . . 1.52 107.846 176.244 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A 1559 ' ' CYS . . . . . 0.778 ' HB3' ' HD2' ' A' 1560 ' ' PRO . 70.8 m -138.51 176.48 2.63 Favored Pre-proline 0 N--CA 1.436 -1.156 0 CA-C-O 116.866 -1.54 . . . . 0.83999999999999997 107.088 -178.103 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A 1560 ' ' PRO . . . . . 0.778 ' HD2' ' HB3' ' A' 1559 ' ' CYS . 2.9 Cg_exo -33.2 126.93 0.13 Allowed 'Trans proline' 0 C--N 1.386 2.538 0 C-N-CA 124.578 3.518 . . . . 1.1799999999999999 115.149 -177.412 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A 1561 ' ' PRO . . . . . 0.473 ' HD2' ' HA ' ' A' 1560 ' ' PRO . 9.5 Cg_endo -51.37 111.86 0.67 Allowed 'Trans proline' 0 C--O 1.246 0.898 0 C-N-CA 123.675 2.917 . . . . 1.51 112.98 -179.294 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A 1562 ' ' GLY . . . . . . . . . . . . . . . 111.39 2.94 27.63 Favored Glycine 0 N--CA 1.437 -1.255 0 CA-C-N 115.436 -0.802 . . . . 0.71999999999999997 113.018 177.937 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A 1563 ' ' VAL . . . . . 0.601 ' HA ' ' HA ' ' A' 1576 ' ' LYS . 14.9 m -94.06 152.0 3.64 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.055 0 N-CA-C 106.288 -1.745 . . . . 0.96999999999999997 106.288 172.723 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A 1564 ' ' GLY . . . . . 0.601 ' HA3' ' CE2' ' A' 1592 ' ' TYR . . . -113.86 -26.41 3.86 Favored Glycine 0 C--N 1.307 -1.059 0 C-N-CA 119.28 -1.438 . . . . 0.71999999999999997 113.139 -175.986 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A 1565 ' ' ALA . . . . . . . . . . . . . . . -132.59 126.11 32.01 Favored 'General case' 0 C--O 1.251 1.181 0 N-CA-C 109.63 -0.507 . . . . 0.37 109.63 -178.779 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A 1566 ' ' CYS . . . . . . . . . . . . . 43.2 t -150.4 139.7 21.31 Favored 'General case' 0 C--N 1.311 -1.075 0 CA-C-N 115.728 -0.669 . . . . 0.51000000000000001 110.064 -174.774 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A 1567 ' ' PHE . . . . . . . . . . . . . 26.5 m-85 -69.84 123.13 20.68 Favored 'General case' 0 CA--C 1.508 -0.665 0 N-CA-C 107.396 -1.335 . . . . 0.96999999999999997 107.396 175.755 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A 1568 ' ' GLY . . . . . . . . . . . . . . . -74.66 -37.27 46.15 Favored Glycine 0 N--CA 1.441 -1.023 0 C-N-CA 120.677 -0.773 . . . . 1.0800000000000001 113.769 -173.627 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A 1569 ' ' GLN . . . . . . . . . . . . . 50.1 tp60 -69.35 -48.61 60.82 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-O 121.976 0.893 . . . . 2.7400000000000002 109.44 -178.947 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A 1570 ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -80.71 -23.08 39.75 Favored 'General case' 0 C--N 1.301 -1.537 0 CA-C-N 114.387 -1.279 . . . . 1.96 112.397 -173.498 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A 1571 ' ' ARG . . . . . . . . . . . . . 40.5 mtp-105 64.32 32.15 12.38 Favored 'General case' 0 N--CA 1.472 0.64 0 C-N-CA 125.035 1.334 . . . . 3.9500000000000002 111.864 -178.833 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A 1572 ' ' ILE . . . . . . . . . . . . . 49.8 mm -109.66 118.98 58.02 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.227 0 N-CA-C 108.972 -0.751 . . . . 1.3700000000000001 108.972 -178.361 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A 1573 ' ' SER . . . . . . . . . . . . . 36.7 t -67.28 140.08 57.32 Favored 'General case' 0 N--CA 1.435 -1.205 0 CA-C-N 115.064 -0.971 . . . . 1.0800000000000001 109.453 178.379 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A 1574 ' ' VAL . . . . . 0.523 ' HB ' ' HB2' ' A' 1606 ' ' TYR . 23.0 m -116.01 -38.96 2.48 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.653 0 C-N-CA 119.978 -0.689 . . . . 1.3 110.663 178.606 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A 1575 ' ' GLY . . . . . 0.798 ' HA3' ' HB3' ' A' 1592 ' ' TYR . . . -135.87 133.1 6.45 Favored Glycine 0 N--CA 1.428 -1.836 0 C-N-CA 120.376 -0.916 . . . . 0.51000000000000001 112.729 -177.592 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A 1576 ' ' LYS . . . . . 0.601 ' HA ' ' HA ' ' A' 1563 ' ' VAL . 24.4 ttpp -85.89 149.37 25.27 Favored 'General case' 0 C--N 1.309 -1.191 0 N-CA-C 107.307 -1.368 . . . . 2.8999999999999999 107.307 178.608 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A 1577 ' ' ALA . . . . . . . . . . . . . . . -63.44 133.91 54.77 Favored 'General case' 0 CA--C 1.501 -0.924 0 O-C-N 123.793 0.683 . . . . 0.82999999999999996 109.503 179.128 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A 1578 ' ' ASN . . . . . . . . . . . . . 7.8 p30 -153.27 144.96 23.42 Favored 'General case' 0 C--N 1.282 -2.369 0 N-CA-C 105.638 -1.986 . . . . 1.8500000000000001 105.638 179.867 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A 1579 ' ' LYS . . . . . . . . . . . . . 67.9 mttm -114.48 89.3 3.06 Favored 'General case' 0 C--N 1.29 -2.019 0 C-N-CA 118.631 -1.228 . . . . 1.8999999999999999 110.791 -176.703 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A 1580 ' ' ARG . . . . . . . . . . . . . 53.1 ttt180 -156.72 131.07 8.63 Favored 'General case' 0 N--CA 1.415 -2.207 0 CA-C-N 115.288 -0.869 . . . . 3.6299999999999999 109.42 172.712 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A 1581 ' ' LEU . . . . . 0.415 HD13 HD12 ' A' 1588 ' ' LEU . 2.3 pp -124.88 150.66 46.26 Favored 'General case' 0 C--N 1.284 -2.282 0 N-CA-C 108.784 -0.821 . . . . 1.8700000000000001 108.784 175.857 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A 1582 ' ' ARG . . . . . . . . . . . . . 90.0 mtt180 -115.82 125.7 53.03 Favored 'General case' 0 C--N 1.288 -2.082 0 CA-C-O 121.0 0.429 . . . . 3.9700000000000002 110.052 -176.592 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A 1583 ' ' TYR . . . . . 0.481 ' CE1' ' HA ' ' A' 1586 ' ' GLN . 58.8 t80 -94.0 91.25 6.78 Favored 'General case' 0 C--N 1.289 -2.031 0 N-CA-C 107.714 -1.217 . . . . 1.4099999999999999 107.714 179.115 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A 1584 ' ' VAL . . . . . . . . . . . . . 4.4 p -107.21 95.37 3.74 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.85 0 CA-C-O 121.824 0.821 . . . . 1.6899999999999999 111.4 -176.909 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A 1585 ' ' ASP . . . . . . . . . . . . . 27.9 t70 52.69 67.89 0.92 Allowed 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 114.695 -1.139 . . . . 2.0600000000000001 111.359 -177.954 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A 1586 ' ' GLN . . . . . 0.481 ' HA ' ' CE1' ' A' 1583 ' ' TYR . 49.6 mt-30 66.31 -15.23 0.13 Allowed 'General case' 0 C--N 1.315 -0.905 0 N-CA-C 115.873 1.805 . . . . 2.3300000000000001 115.873 177.73 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A 1587 ' ' VAL . . . . . . . . . . . . . 10.9 p -99.38 123.21 51.94 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.028 0 CA-C-N 119.119 0.872 . . . . 0.78000000000000003 109.684 178.301 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A 1588 ' ' LEU . . . . . 0.541 ' HB2' ' HB2' ' A' 1612 ' ' PHE . 4.1 mm? -81.96 140.18 34.16 Favored 'General case' 0 N--CA 1.43 -1.472 0 CA-C-N 115.581 -0.736 . . . . 1.4099999999999999 111.885 -178.848 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A 1589 ' ' GLN . . . . . . . . . . . . . 35.1 tt0 -129.78 122.1 28.13 Favored 'General case' 0 C--N 1.303 -1.454 0 CA-C-N 115.573 -0.74 . . . . 1.24 109.926 179.073 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A 1590 ' ' LEU . . . . . . . . . . . . . 6.8 tt -119.16 132.94 56.02 Favored 'General case' 0 C--N 1.304 -1.393 0 N-CA-C 106.569 -1.641 . . . . 1.1499999999999999 106.569 176.583 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A 1591 ' ' VAL . . . . . 0.579 HG12 HG22 ' A' 1609 ' ' VAL . 35.3 m -124.29 144.7 33.21 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.837 0 CA-C-O 121.688 0.756 . . . . 1.51 112.956 -173.509 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A 1592 ' ' TYR . . . . . 0.798 ' HB3' ' HA3' ' A' 1575 ' ' GLY . 22.5 m-85 -106.66 123.49 48.2 Favored 'General case' 0 C--N 1.298 -1.664 0 CA-C-N 115.078 -0.964 . . . . 1.0600000000000001 110.298 172.249 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A 1593 ' ' LYS . . . . . . . . . . . . . 20.5 ptmt -142.59 -178.64 5.87 Favored 'General case' 0 C--N 1.298 -1.67 0 CA-C-N 114.364 -1.289 . . . . 2.1800000000000002 108.072 -173.59 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A 1594 ' ' ASP . . . . . 0.523 ' HB2' ' HE3' ' A' 1576 ' ' LYS . 57.9 m-20 67.05 14.88 9.98 Favored 'General case' 0 N--CA 1.491 1.618 0 C-N-CA 124.098 0.959 . . . . 1.45 113.265 175.253 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A 1595 ' ' GLY . . . . . . . . . . . . . . . -90.54 -105.89 1.29 Allowed Glycine 0 N--CA 1.432 -1.587 0 N-CA-C 111.212 -0.755 . . . . 0.78000000000000003 111.212 179.106 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A 1596 ' ' SER . . . . . 0.438 ' HA ' ' HD3' ' A' 1597 ' ' PRO . 23.0 m -106.65 128.05 26.93 Favored Pre-proline 0 C--N 1.295 -1.795 0 N-CA-C 109.679 -0.489 . . . . 1.6799999999999999 109.679 179.9 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A 1597 ' ' PRO . . . . . 0.438 ' HD3' ' HA ' ' A' 1596 ' ' SER . 32.3 Cg_exo -63.07 150.95 87.16 Favored 'Trans proline' 0 C--O 1.238 0.516 0 C-N-CA 123.289 2.659 . . . . 1.1699999999999999 110.866 176.554 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A 1598 ' ' CYS . . . . . 0.481 ' HA ' ' HD3' ' A' 1599 ' ' PRO . 50.2 t -94.93 132.63 27.85 Favored Pre-proline 0 C--N 1.293 -1.851 0 N-CA-C 109.961 -0.385 . . . . 1.1899999999999999 109.961 -177.675 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A 1599 ' ' PRO . . . . . 0.481 ' HD3' ' HA ' ' A' 1598 ' ' CYS . 11.8 Cg_exo -72.29 -7.5 21.05 Favored 'Trans proline' 0 C--N 1.362 1.24 0 C-N-CA 123.392 2.728 . . . . 1.5900000000000001 112.165 -179.97 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A 1600 ' ' SER . . . . . . . . . . . . . 44.9 t -113.14 123.67 50.79 Favored 'General case' 0 N--CA 1.421 -1.906 0 N-CA-C 107.757 -1.201 . . . . 2.1200000000000001 107.757 177.603 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A 1601 ' ' LYS . . . . . . . . . . . . . 34.9 mmtp 57.13 50.92 11.06 Favored 'General case' 0 C--O 1.241 0.633 0 O-C-N 123.64 0.587 . . . . 3.7400000000000002 109.814 -179.623 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A 1602 ' ' SER . . . . . . . . . . . . . 50.9 m -54.04 140.56 31.15 Favored 'General case' 0 N--CA 1.439 -0.992 0 CA-C-N 114.964 -1.016 . . . . 3.79 113.254 -175.988 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A 1603 ' ' GLY . . . . . . . . . . . . . . . 135.75 -10.9 4.27 Favored Glycine 0 N--CA 1.434 -1.466 0 N-CA-C 108.954 -1.659 . . . . 2.0 108.954 -173.327 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A 1604 ' ' LEU . . . . . . . . . . . . . 1.3 pp -135.42 162.4 32.72 Favored 'General case' 0 N--CA 1.437 -1.075 0 C-N-CA 123.897 0.879 . . . . 1.48 110.449 179.834 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A 1605 ' ' SER . . . . . . . . . . . . . 11.4 m -99.71 -176.04 3.15 Favored 'General case' 0 C--N 1.302 -1.46 0 N-CA-C 109.012 -0.736 . . . . 1.51 109.012 -178.611 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A 1606 ' ' TYR . . . . . 0.62 ' HA ' ' HB3' ' A' 1634 ' ' CYS . 78.5 m-85 -81.71 97.12 7.78 Favored 'General case' 0 CA--C 1.477 -1.837 0 N-CA-C 103.325 -2.843 . . . . 1.1799999999999999 103.325 171.508 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A 1607 ' ' LYS . . . . . . . . . . . . . 17.3 ptmt -103.53 125.52 50.13 Favored 'General case' 0 C--N 1.26 -3.285 0 C-N-CA 119.695 -0.802 . . . . 1.6699999999999999 112.041 -165.57 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A 1608 ' ' SER . . . . . 0.422 ' HB2' ' HB2' ' A' 1592 ' ' TYR . 16.5 m -98.62 117.29 32.73 Favored 'General case' 0 C--N 1.296 -1.73 0 CA-C-N 114.796 -1.093 . . . . 1.0 108.95 -179.102 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A 1609 ' ' VAL . . . . . 0.579 HG22 HG12 ' A' 1591 ' ' VAL . 98.1 t -112.12 117.19 54.59 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.22 0 N-CA-C 109.194 -0.669 . . . . 0.93000000000000005 109.194 179.775 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A 1610 ' ' ILE . . . . . 0.717 HG13 ' HB2' ' A' 1638 ' ' PHE . 2.9 mp -105.36 114.53 45.1 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.178 0 N-CA-C 108.695 -0.854 . . . . 0.78000000000000003 108.695 178.108 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A 1611 ' ' SER . . . . . . . . . . . . . 63.5 p -90.66 124.19 34.87 Favored 'General case' 0 N--CA 1.43 -1.465 0 N-CA-C 108.324 -0.991 . . . . 1.29 108.324 175.541 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A 1612 ' ' PHE . . . . . 0.541 ' HB2' ' HB2' ' A' 1588 ' ' LEU . 96.2 m-85 -93.23 107.74 19.49 Favored 'General case' 0 C--N 1.297 -1.71 0 CA-C-N 116.209 -0.45 . . . . 0.69999999999999996 109.914 -179.125 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A 1613 ' ' VAL . . . . . . . . . . . . . 66.7 t -104.8 132.59 51.14 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.137 0 O-C-N 124.723 1.265 . . . . 0.75 108.895 -178.787 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A 1614 ' ' CYS . . . . . 0.427 ' HA ' ' O ' ' A' 1642 ' ' THR . 55.8 m -76.88 103.78 7.02 Favored 'General case' 0 C--N 1.295 -1.797 0 CA-C-N 114.973 -1.012 . . . . 1.3899999999999999 111.433 -175.092 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A 1615 ' ' ARG . . . . . . . . . . . . . 38.3 mmt180 -123.7 86.7 52.83 Favored Pre-proline 0 C--N 1.306 -1.312 0 CA-C-N 115.541 -0.754 . . . . 3.75 110.067 179.041 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A 1616 ' ' PRO . . . . . . . . . . . . . 42.7 Cg_endo -66.25 -28.78 47.44 Favored 'Trans proline' 0 C--N 1.348 0.511 0 C-N-CA 122.919 2.412 . . . . 1.3200000000000001 113.392 -177.44 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A 1617 ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 . . . . . 0 C--N 1.319 -0.721 0 CA-C-O 121.408 0.623 . . . . 3.21 111.117 -178.065 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A 1622 ' ' ASN . . . . . 0.452 ' HA ' ' O ' ' A' 1641 ' ' HIS . 53.8 t-20 . . . . . 0 N--CA 1.479 0.999 0 CA-C-O 121.576 0.703 . . . . 2.9199999999999999 109.564 . . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A 1623 ' ' ARG . . . . . . . . . . . . . 15.5 ptm180 -155.15 151.0 21.88 Favored Pre-proline 0 C--N 1.31 -1.114 0 CA-C-N 115.8 -0.637 . . . . 3.6099999999999999 109.467 179.781 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A 1624 ' ' PRO . . . . . 0.511 ' HA ' ' O ' ' A' 1639 ' ' SER . 39.5 Cg_endo -87.14 101.17 0.52 Allowed 'Trans proline' 0 N--CA 1.443 -1.452 0 C-N-CA 122.777 2.318 . . . . 2.3700000000000001 111.112 174.931 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A 1625 ' ' MET . . . . . . . . . . . . . 1.5 pmm? -96.17 153.3 17.87 Favored 'General case' 0 C--N 1.301 -1.505 0 N-CA-C 109.701 -0.481 . . . . 2.1600000000000001 109.701 179.696 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A 1626 ' ' LEU . . . . . . . . . . . . . 40.6 tp -81.91 105.25 12.88 Favored 'General case' 0 C--N 1.31 -1.145 0 N-CA-C 108.687 -0.857 . . . . 1.3500000000000001 108.687 177.919 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A 1627 ' ' ILE . . . . . . . . . . . . . 46.2 pt -87.21 -26.39 5.94 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.988 0 CA-C-N 116.083 -0.508 . . . . 1.21 112.134 -175.187 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A 1628 ' ' SER . . . . . . . . . . . . . 13.0 t -160.8 144.49 13.46 Favored 'General case' 0 N--CA 1.437 -1.09 0 N-CA-C 109.496 -0.557 . . . . 1.3999999999999999 109.496 -178.3 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A 1629 ' ' LEU . . . . . 1.006 ' HG ' ' HG ' ' A' 1636 ' ' LEU . 4.4 tt -133.96 112.27 11.11 Favored 'General case' 0 C--N 1.306 -1.319 0 N-CA-C 107.023 -1.473 . . . . 1.5600000000000001 107.023 177.572 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A 1630 ' ' ASP . . . . . . . . . . . . . 29.4 t70 -92.23 117.56 30.0 Favored 'General case' 0 C--N 1.307 -1.248 0 N-CA-C 108.84 -0.8 . . . . 0.87 108.84 177.553 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A 1631 ' ' LYS . . . . . . . . . . . . . 94.8 mttt -86.48 -5.77 59.07 Favored 'General case' 0 C--N 1.303 -1.422 0 CA-C-N 116.454 -0.339 . . . . 2.3500000000000001 111.572 -176.253 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A 1632 ' ' GLN . . . . . . . . . . . . . 39.2 mt-30 -81.43 -45.67 15.71 Favored 'General case' 0 N--CA 1.447 -0.588 0 N-CA-C 109.961 -0.385 . . . . 2.5499999999999998 109.961 -178.981 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A 1633 ' ' THR . . . . . . . . . . . . . 11.4 p -109.82 13.21 23.68 Favored 'General case' 0 C--N 1.305 -1.353 0 CA-C-N 115.799 -0.637 . . . . 1.24 111.639 178.495 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A 1634 ' ' CYS . . . . . 0.62 ' HB3' ' HA ' ' A' 1606 ' ' TYR . 65.4 m 47.52 41.89 13.81 Favored 'General case' 0 N--CA 1.474 0.728 0 C-N-CA 123.943 0.897 . . . . 0.89000000000000001 112.976 179.879 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A 1635 ' ' THR . . . . . . . . . . . . . 33.4 m -105.33 117.07 33.08 Favored 'General case' 0 N--CA 1.417 -2.079 0 CA-C-N 115.368 -0.833 . . . . 0.75 109.596 -177.542 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A 1636 ' ' LEU . . . . . 1.006 ' HG ' ' HG ' ' A' 1629 ' ' LEU . 5.4 mp -101.84 129.73 48.13 Favored 'General case' 0 C--N 1.311 -1.09 0 N-CA-C 109.15 -0.685 . . . . 1.3300000000000001 109.15 179.966 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A 1637 ' ' PHE . . . . . . . . . . . . . 80.6 m-85 -108.1 109.92 21.47 Favored 'General case' 0 C--N 1.308 -1.237 0 CA-C-N 116.27 -0.423 . . . . 0.82999999999999996 111.123 -175.874 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A 1638 ' ' PHE . . . . . 0.717 ' HB2' HG13 ' A' 1610 ' ' ILE . 97.1 m-85 -107.68 149.01 28.64 Favored 'General case' 0 C--N 1.304 -1.391 0 N-CA-C 108.454 -0.943 . . . . 0.59999999999999998 108.454 176.151 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A 1639 ' ' SER . . . . . 0.511 ' O ' ' HA ' ' A' 1624 ' ' PRO . 43.5 m -137.58 121.18 17.3 Favored 'General case' 0 C--N 1.294 -1.825 0 N-CA-C 109.795 -0.446 . . . . 1.0800000000000001 109.795 178.051 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A 1640 ' ' TRP . . . . . 0.449 ' CD1' ' HB ' ' A' 1642 ' ' THR . 3.8 t90 -100.61 125.13 46.97 Favored 'General case' 0 C--N 1.314 -0.966 0 N-CA-C 108.445 -0.946 . . . . 0.80000000000000004 108.445 -179.828 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A 1641 ' ' HIS . . . . . 0.452 ' O ' ' HA ' ' A' 1622 ' ' ASN . 11.4 m-70 -89.67 94.79 9.98 Favored 'General case' 0 C--N 1.307 -1.277 0 N-CA-C 105.63 -1.989 . . . . 2.54 105.63 175.093 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A 1642 ' ' THR . . . . . 0.655 ' OG1' ' HG ' ' A' 1644 ' ' LEU . 12.2 t -142.12 138.39 16.73 Favored Pre-proline 0 C--N 1.303 -1.419 0 C-N-CA 119.663 -0.815 . . . . 1.1499999999999999 112.867 -171.886 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A 1643 ' ' PRO . . . . . 0.477 ' HD3' ' HA ' ' A' 1642 ' ' THR . 15.1 Cg_exo -71.96 -25.14 20.01 Favored 'Trans proline' 0 N--CA 1.456 -0.733 0 C-N-CA 123.34 2.694 . . . . 0.80000000000000004 112.027 175.969 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A 1644 ' ' LEU . . . . . 0.655 ' HG ' ' OG1' ' A' 1642 ' ' THR . 4.0 pp -70.55 -17.17 62.93 Favored 'General case' 0 N--CA 1.478 0.932 0 N-CA-C 112.348 0.499 . . . . 1.54 112.348 -176.636 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A 1645 ' ' ALA . . . . . . . . . . . . . . . -64.0 -41.52 97.47 Favored 'General case' 0 N--CA 1.448 -0.543 0 CA-C-N 115.495 -0.775 . . . . 0.94999999999999996 109.24 178.948 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A 1646 ' ' CYS . . . . . . . . . . . . . 19.2 p -177.11 116.02 0.1 Allowed 'General case' 0 C--O 1.244 0.791 0 C-N-CA 124.473 1.109 . . . . 1.4099999999999999 108.342 171.903 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A 1647 ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 C--N 1.294 -1.834 0 O-C-N 121.961 -0.462 . . . . 2.9199999999999999 110.212 179.164 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A 1515 ' ' ASP . . . . . . . . . . . . . 3.4 p-10 . . . . . 0 N--CA 1.437 -1.081 0 N-CA-C 103.536 -2.765 . . . . 2.54 103.536 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A 1516 ' ' CYS . . . . . 0.509 ' HB3' ' HB2' ' A' 1529 ' ' LEU . 58.1 m -79.37 61.75 3.52 Favored 'General case' 0 C--N 1.301 -1.541 0 N-CA-C 113.924 1.083 . . . . 1.25 113.924 -172.375 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A 1517 ' ' GLN . . . . . 0.549 ' HB2' HD21 ' A' 1526 ' ' LEU . 11.1 pt20 -145.22 122.14 11.31 Favored 'General case' 0 N--CA 1.425 -1.702 0 N-CA-C 107.41 -1.329 . . . . 1.8799999999999999 107.41 172.351 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A 1518 ' ' VAL . . . . . . . . . . . . . 84.9 t -109.23 106.21 20.26 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.941 0 N-CA-C 109.059 -0.719 . . . . 1.73 109.059 179.98 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A 1519 ' ' THR . . . . . . . . . . . . . 19.0 m -86.36 113.19 22.13 Favored 'General case' 0 C--N 1.287 -2.111 0 N-CA-C 107.066 -1.457 . . . . 1.7 107.066 175.772 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A 1520 ' ' ASN . . . . . . . . . . . . . 49.8 t-20 -87.52 104.81 7.1 Favored Pre-proline 0 C--N 1.308 -1.216 0 N-CA-C 107.766 -1.198 . . . . 2.1200000000000001 107.766 179.437 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A 1521 ' ' PRO . . . . . . . . . . . . . 63.3 Cg_endo -71.48 -12.17 29.13 Favored 'Trans proline' 0 C--N 1.353 0.803 0 C-N-CA 122.505 2.137 . . . . 2.4700000000000002 112.831 -174.613 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A 1522 ' ' SER . . . . . . . . . . . . . 5.8 m -76.95 -23.32 52.39 Favored 'General case' 0 N--CA 1.431 -1.421 0 CA-C-N 115.988 -0.551 . . . . 2.5699999999999998 110.242 -178.953 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A 1523 ' ' THR . . . . . . . . . . . . . 5.0 t -127.44 -23.52 3.48 Favored 'General case' 0 CA--C 1.545 0.756 0 N-CA-C 112.46 0.541 . . . . 2.1499999999999999 112.46 179.319 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A 1524 ' ' GLY . . . . . . . . . . . . . . . 100.1 -17.7 56.73 Favored Glycine 0 N--CA 1.447 -0.568 0 C-N-CA 120.566 -0.826 . . . . 1.8899999999999999 112.168 -179.002 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A 1525 ' ' HIS . . . . . . . . . . . . . 17.4 t-80 -75.3 134.64 41.01 Favored 'General case' 0 C--N 1.312 -1.048 0 C-N-CA 123.009 0.524 . . . . 1.8999999999999999 111.244 -177.379 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A 1526 ' ' LEU . . . . . 0.549 HD21 ' HB2' ' A' 1517 ' ' GLN . 7.1 tt -111.27 135.79 51.3 Favored 'General case' 0 C--N 1.313 -0.988 0 CA-C-N 115.666 -0.697 . . . . 1.6100000000000001 109.271 -178.586 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A 1527 ' ' PHE . . . . . 0.529 ' O ' ' HA ' ' A' 1517 ' ' GLN . 85.2 m-85 -102.14 106.36 17.2 Favored 'General case' 0 C--N 1.312 -1.028 0 N-CA-C 108.893 -0.78 . . . . 1.4199999999999999 108.893 177.334 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A 1528 ' ' ASP . . . . . . . . . . . . . 9.9 t70 -97.82 115.58 28.32 Favored 'General case' 0 C--N 1.319 -0.737 0 N-CA-C 109.654 -0.499 . . . . 2.1800000000000002 109.654 179.76 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A 1529 ' ' LEU . . . . . 0.509 ' HB2' ' HB3' ' A' 1516 ' ' CYS . 84.6 mt -106.69 -12.99 15.4 Favored 'General case' 0 C--N 1.308 -1.21 0 CA-C-N 116.166 -0.47 . . . . 1.4399999999999999 111.157 -178.398 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A 1530 ' ' SER . . . . . 0.492 ' HA ' ' HB3' ' A' 1553 ' ' CYS . 17.1 m -71.65 -47.38 54.75 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-O 121.036 0.446 . . . . 1.4399999999999999 109.903 -178.102 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A 1531 ' ' SER . . . . . . . . . . . . . 13.3 m -70.01 -9.7 56.15 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.366 -0.833 . . . . 1.5 111.515 -175.936 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A 1532 ' ' LEU . . . . . . . . . . . . . 58.9 mt -76.55 -18.69 58.55 Favored 'General case' 0 C--N 1.313 -1.004 0 CA-C-N 116.382 -0.372 . . . . 1.77 110.446 178.142 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A 1533 ' ' SER . . . . . 0.486 ' OG ' ' HB ' ' A' 1552 ' ' ILE . 19.6 m -100.91 143.13 31.43 Favored 'General case' 0 C--N 1.315 -0.895 0 CA-C-N 116.226 -0.443 . . . . 2.3799999999999999 110.848 -176.38 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A 1534 ' ' GLY . . . . . . . . . . . . . . . -102.18 -174.64 27.61 Favored Glycine 0 N--CA 1.42 -2.375 0 N-CA-C 109.512 -1.435 . . . . 1.55 109.512 175.401 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A 1535 ' ' ARG . . . . . . . . . . . . . 36.3 ttm180 -69.48 -50.05 48.99 Favored 'General case' 0 C--N 1.294 -1.815 0 N-CA-C 112.035 0.383 . . . . 3.96 112.035 -177.822 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A 1536 ' ' ALA . . . . . . . . . . . . . . . -69.77 -48.89 57.57 Favored 'General case' 0 C--N 1.313 -0.979 0 CA-C-N 116.038 -0.528 . . . . 1.6499999999999999 111.772 -175.82 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A 1537 ' ' GLY . . . . . 0.564 ' HA3' ' ND2' ' A' 1556 ' ' ASN . . . 119.66 -173.84 15.27 Favored Glycine 0 N--CA 1.444 -0.806 0 C-N-CA 121.289 -0.481 . . . . 1.1899999999999999 112.914 175.535 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A 1538 ' ' PHE . . . . . 0.475 ' HE2' ' HA ' ' A' 1533 ' ' SER . 97.4 m-85 -116.51 170.37 8.62 Favored 'General case' 0 C--N 1.313 -1.013 0 C-N-CA 123.29 0.636 . . . . 1.6899999999999999 109.917 -179.953 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A 1539 ' ' THR . . . . . 0.544 ' HA ' ' O ' ' A' 1548 ' ' VAL . 16.9 p -129.85 130.28 45.03 Favored 'General case' 0 N--CA 1.438 -1.042 0 CA-C-N 116.028 -0.533 . . . . 1.48 111.528 177.988 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A 1540 ' ' ALA . . . . . . . . . . . . . . . -103.36 146.98 27.67 Favored 'General case' 0 C--N 1.301 -1.52 0 N-CA-C 107.745 -1.206 . . . . 0.82999999999999996 107.745 173.348 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A 1541 ' ' ALA . . . . . . . . . . . . . . . -77.88 130.89 37.16 Favored 'General case' 0 C--O 1.246 0.89 0 N-CA-C 109.815 -0.439 . . . . 1.27 109.815 -177.98 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A 1542 ' ' TYR . . . . . 0.698 ' HD2' ' HB2' ' A' 1545 ' ' SER . 70.0 t80 -139.88 168.09 20.61 Favored 'General case' 0 N--CA 1.437 -1.087 0 CA-C-O 119.425 -0.321 . . . . 2.1499999999999999 110.245 -176.237 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A 1543 ' ' SER . . . . . . . . . . . . . 12.0 m -49.09 -151.99 0.0 OUTLIER 'General case' 0 CA--C 1.576 1.979 0 C-N-CA 128.796 2.838 . . . . 2.29 113.754 178.224 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A 1544 ' ' LYS . . . . . . . . . . . . . 39.7 ttmt -40.29 -35.48 0.42 Allowed 'General case' 0 N--CA 1.486 1.366 0 O-C-N 121.041 -1.037 . . . . 3.9100000000000001 113.547 177.886 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A 1545 ' ' SER . . . . . 0.698 ' HB2' ' HD2' ' A' 1542 ' ' TYR . 19.3 m -66.55 -12.07 55.97 Favored 'General case' 0 CA--C 1.568 1.639 0 N-CA-C 112.856 0.688 . . . . 3.2999999999999998 112.856 176.469 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A 1546 ' ' GLY . . . . . . . . . . . . . . . 82.24 -74.09 2.54 Favored Glycine 0 N--CA 1.446 -0.641 0 N-CA-C 114.6 0.6 . . . . 1.24 114.6 172.151 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A 1547 ' ' VAL . . . . . . . . . . . . . 15.4 m -138.41 146.52 26.56 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.244 0 CA-C-O 121.185 0.517 . . . . 1.6299999999999999 111.272 -176.506 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A 1548 ' ' VAL . . . . . 0.544 ' O ' ' HA ' ' A' 1539 ' ' THR . 2.3 t -108.04 126.45 64.59 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.52 0 N-CA-C 106.675 -1.602 . . . . 0.92000000000000004 106.675 176.573 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A 1549 ' ' TYR . . . . . 0.614 ' HD2' ' HA3' ' A' 1568 ' ' GLY . 6.4 m-85 -84.87 120.67 26.73 Favored 'General case' 0 C--N 1.301 -1.516 0 N-CA-C 108.452 -0.944 . . . . 1.4399999999999999 108.452 174.906 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A 1550 ' ' MET . . . . . . . . . . . . . 60.7 mtp -135.87 164.96 26.74 Favored 'General case' 0 C--N 1.292 -1.924 0 CA-C-N 115.002 -0.999 . . . . 1.74 110.518 -173.489 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A 1551 ' ' SER . . . . . . . . . . . . . 13.9 p -129.7 144.57 51.35 Favored 'General case' 0 C--N 1.283 -2.31 0 N-CA-C 106.495 -1.668 . . . . 1.6399999999999999 106.495 175.002 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A 1552 ' ' ILE . . . . . 0.486 ' HB ' ' OG ' ' A' 1533 ' ' SER . 46.0 mm -74.25 -29.44 24.71 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.483 0 N-CA-C 107.525 -1.287 . . . . 1.3300000000000001 107.525 179.871 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A 1553 ' ' CYS . . . . . 0.492 ' HB3' ' HA ' ' A' 1530 ' ' SER . 46.7 t -161.79 149.96 15.08 Favored 'General case' 0 N--CA 1.419 -1.986 0 N-CA-C 105.93 -1.878 . . . . 1.4299999999999999 105.93 171.661 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A 1554 ' ' GLY . . . . . . . . . . . . . . . 94.22 -153.42 21.07 Favored Glycine 0 N--CA 1.427 -1.919 0 C-N-CA 120.304 -0.95 . . . . 1.1200000000000001 111.103 178.752 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A 1555 ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -122.73 145.0 48.79 Favored 'General case' 0 C--N 1.294 -1.825 0 CA-C-O 121.471 0.653 . . . . 1.8 110.963 -176.675 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A 1556 ' ' ASN . . . . . 0.564 ' ND2' ' HA3' ' A' 1537 ' ' GLY . 24.9 t-20 -87.59 138.25 31.63 Favored 'General case' 0 C--N 1.299 -1.605 0 N-CA-C 108.39 -0.967 . . . . 2.6299999999999999 108.39 179.464 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A 1557 ' ' GLU . . . . . . . . . . . . . 42.9 mt-10 -114.45 34.1 4.93 Favored 'General case' 0 C--N 1.317 -0.806 0 N-CA-C 113.557 0.947 . . . . 3.79 113.557 -175.83 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A 1558 ' ' ASN . . . . . . . . . . . . . 10.6 m120 -128.65 26.13 5.63 Favored 'General case' 0 C--N 1.313 -0.981 0 CA-C-O 122.839 1.304 . . . . 1.52 108.389 173.039 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A 1559 ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -161.84 173.17 4.81 Favored Pre-proline 0 C--N 1.29 -1.999 0 N-CA-C 104.621 -2.362 . . . . 0.83999999999999997 104.621 179.009 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A 1560 ' ' PRO . . . . . 0.627 ' O ' HG22 ' A' 1563 ' ' VAL . 2.4 Cg_endo -40.7 117.45 0.5 Allowed 'Trans proline' 0 C--N 1.365 1.397 0 C-N-CA 123.538 2.826 . . . . 1.1799999999999999 113.0 178.187 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A 1561 ' ' PRO . . . . . . . . . . . . . 36.8 Cg_exo -57.84 111.85 0.97 Allowed 'Trans proline' 0 C--O 1.248 0.996 0 C-N-CA 122.428 2.085 . . . . 1.51 110.546 -179.398 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A 1562 ' ' GLY . . . . . . . . . . . . . . . 129.17 -0.22 6.01 Favored Glycine 0 N--CA 1.431 -1.687 0 CA-C-N 115.534 -0.757 . . . . 0.71999999999999997 112.596 -177.646 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A 1563 ' ' VAL . . . . . 0.627 HG22 ' O ' ' A' 1560 ' ' PRO . 25.2 m -105.98 146.96 12.11 Favored 'Isoleucine or valine' 0 CA--C 1.493 -1.238 0 O-C-N 122.151 -0.617 . . . . 0.96999999999999997 111.048 175.325 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A 1564 ' ' GLY . . . . . . . . . . . . . . . -103.7 -8.07 40.75 Favored Glycine 0 N--CA 1.418 -2.526 0 N-CA-C 109.83 -1.308 . . . . 0.71999999999999997 109.83 175.477 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A 1565 ' ' ALA . . . . . . . . . . . . . . . -152.58 119.39 5.74 Favored 'General case' 0 N--CA 1.441 -0.911 0 CA-C-O 121.303 0.573 . . . . 0.37 110.381 -179.838 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A 1566 ' ' CYS . . . . . . . . . . . . . 6.7 t -154.76 136.07 14.07 Favored 'General case' 0 C--N 1.297 -1.686 0 N-CA-C 108.816 -0.809 . . . . 0.51000000000000001 108.816 -178.279 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A 1567 ' ' PHE . . . . . . . . . . . . . 26.1 m-85 -67.11 122.76 18.52 Favored 'General case' 0 C--O 1.208 -1.1 0 N-CA-C 106.334 -1.728 . . . . 0.96999999999999997 106.334 176.322 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A 1568 ' ' GLY . . . . . 0.614 ' HA3' ' HD2' ' A' 1549 ' ' TYR . . . -72.57 -36.89 58.45 Favored Glycine 0 CA--C 1.489 -1.569 0 C-N-CA 121.035 -0.602 . . . . 1.0800000000000001 114.453 -169.136 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A 1569 ' ' GLN . . . . . . . . . . . . . 30.1 tt0 -74.57 -43.97 53.1 Favored 'General case' 0 C--N 1.302 -1.469 0 CA-C-O 121.767 0.794 . . . . 2.7400000000000002 109.662 -179.931 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A 1570 ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -81.27 -26.23 35.92 Favored 'General case' 0 C--N 1.286 -2.154 0 CA-C-N 114.497 -1.229 . . . . 1.96 112.138 -173.092 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A 1571 ' ' ARG . . . . . . . . . . . . . 66.1 mtt180 60.65 47.33 8.34 Favored 'General case' 0 C--O 1.234 0.26 0 C-N-CA 125.947 1.699 . . . . 3.9500000000000002 111.653 -178.493 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A 1572 ' ' ILE . . . . . . . . . . . . . 40.8 mm -121.77 128.61 75.76 Favored 'Isoleucine or valine' 0 C--O 1.24 0.579 0 N-CA-C 108.228 -1.027 . . . . 1.3700000000000001 108.228 -179.616 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A 1573 ' ' SER . . . . . . . . . . . . . 28.2 t -79.03 138.61 38.08 Favored 'General case' 0 C--N 1.312 -1.057 0 C-N-CA 124.014 0.926 . . . . 1.0800000000000001 112.447 -175.972 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A 1574 ' ' VAL . . . . . . . . . . . . . 15.4 m -136.31 24.03 0.86 Allowed 'Isoleucine or valine' 0 C--N 1.318 -0.771 0 CA-C-O 121.581 0.705 . . . . 1.3 110.342 174.731 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A 1575 ' ' GLY . . . . . . . . . . . . . . . 169.03 115.21 0.32 Allowed Glycine 0 N--CA 1.442 -0.958 0 CA-C-N 115.301 -0.863 . . . . 0.51000000000000001 111.997 178.043 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A 1576 ' ' LYS . . . . . 0.712 ' HG3' ' HA2' ' A' 1595 ' ' GLY . 98.6 mttt -86.25 154.33 21.36 Favored 'General case' 0 C--N 1.315 -0.934 0 O-C-N 122.599 -0.354 . . . . 2.8999999999999999 110.074 179.297 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A 1577 ' ' ALA . . . . . . . . . . . . . . . -69.79 119.52 14.14 Favored 'General case' 0 C--O 1.244 0.803 0 CA-C-N 115.453 -0.794 . . . . 0.82999999999999996 110.241 -178.19 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A 1578 ' ' ASN . . . . . . . . . . . . . 40.0 m-80 -141.98 162.4 35.56 Favored 'General case' 0 C--N 1.305 -1.355 0 N-CA-C 107.123 -1.436 . . . . 1.8500000000000001 107.123 -179.427 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A 1579 ' ' LYS . . . . . . . . . . . . . 75.2 mmtt -102.76 88.8 3.3 Favored 'General case' 0 C--N 1.307 -1.264 0 N-CA-C 107.77 -1.196 . . . . 1.8999999999999999 107.77 175.842 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A 1580 ' ' ARG . . . . . . . . . . . . . 17.2 ttm180 -136.08 84.77 2.1 Favored 'General case' 0 C--N 1.293 -1.854 0 CA-C-O 121.926 0.87 . . . . 3.6299999999999999 109.159 -179.238 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A 1581 ' ' LEU . . . . . . . . . . . . . 49.1 tp -113.6 147.78 37.41 Favored 'General case' 0 C--N 1.294 -1.818 0 CA-C-N 114.053 -1.43 . . . . 1.8700000000000001 107.302 -179.41 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A 1582 ' ' ARG . . . . . . . . . . . . . 55.3 ttp180 -141.97 144.06 33.52 Favored 'General case' 0 C--N 1.295 -1.802 0 N-CA-C 109.99 -0.374 . . . . 3.9700000000000002 109.99 -175.492 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A 1583 ' ' TYR . . . . . 0.416 ' CE1' ' HA ' ' A' 1586 ' ' GLN . 74.2 t80 -128.09 104.59 7.85 Favored 'General case' 0 C--N 1.299 -1.604 0 N-CA-C 108.368 -0.975 . . . . 1.4099999999999999 108.368 176.704 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A 1584 ' ' VAL . . . . . . . . . . . . . 13.6 p -148.25 131.88 8.48 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.164 0 N-CA-C 109.117 -0.697 . . . . 1.6899999999999999 109.117 178.529 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A 1585 ' ' ASP . . . . . . . . . . . . . 37.5 t70 65.7 32.45 9.01 Favored 'General case' 0 N--CA 1.482 1.13 0 CA-C-O 122.622 1.201 . . . . 2.0600000000000001 109.621 -177.721 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A 1586 ' ' GLN . . . . . 0.416 ' HA ' ' CE1' ' A' 1583 ' ' TYR . 51.1 mt-30 65.05 4.89 2.7 Favored 'General case' 0 N--CA 1.473 0.707 0 C-N-CA 125.642 1.577 . . . . 2.3300000000000001 114.674 178.606 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A 1587 ' ' VAL . . . . . . . . . . . . . 7.1 p -108.32 130.09 61.54 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.394 0 CA-C-O 121.087 0.47 . . . . 0.78000000000000003 109.876 178.944 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A 1588 ' ' LEU . . . . . 0.566 ' HB2' ' HB2' ' A' 1612 ' ' PHE . 3.8 mm? -84.18 146.5 27.8 Favored 'General case' 0 N--CA 1.439 -0.991 0 CA-C-N 116.047 -0.524 . . . . 1.4099999999999999 110.838 -178.523 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A 1589 ' ' GLN . . . . . . . . . . . . . 35.2 tt0 -147.13 127.61 14.08 Favored 'General case' 0 C--N 1.302 -1.49 0 N-CA-C 109.819 -0.438 . . . . 1.24 109.819 178.475 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A 1590 ' ' LEU . . . . . . . . . . . . . 6.7 tt -125.59 138.39 53.94 Favored 'General case' 0 C--N 1.308 -1.217 0 N-CA-C 107.016 -1.476 . . . . 1.1499999999999999 107.016 179.895 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A 1591 ' ' VAL . . . . . 0.553 ' HB ' HG23 ' A' 1609 ' ' VAL . 5.0 p -137.54 134.16 46.24 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.292 0 CA-C-O 121.312 0.577 . . . . 1.51 112.132 -176.459 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A 1592 ' ' TYR . . . . . . . . . . . . . 77.5 m-85 -97.63 96.36 8.22 Favored 'General case' 0 N--CA 1.431 -1.402 0 N-CA-C 107.347 -1.353 . . . . 1.0600000000000001 107.347 174.079 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A 1593 ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -88.52 157.81 18.52 Favored 'General case' 0 C--N 1.295 -1.78 0 CA-C-N 115.058 -0.973 . . . . 2.1800000000000002 111.932 -177.107 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A 1594 ' ' ASP . . . . . 0.439 ' HA ' ' HB2' ' A' 1605 ' ' SER . 5.6 m-20 48.77 79.27 0.08 Allowed 'General case' 0 N--CA 1.475 0.78 0 N-CA-C 115.453 1.649 . . . . 1.45 115.453 -179.664 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A 1595 ' ' GLY . . . . . 0.712 ' HA2' ' HG3' ' A' 1576 ' ' LYS . . . -96.5 -107.94 2.43 Favored Glycine 0 N--CA 1.441 -0.985 0 N-CA-C 109.312 -1.515 . . . . 0.78000000000000003 109.312 171.245 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A 1596 ' ' SER . . . . . 0.408 ' HA ' ' HD3' ' A' 1597 ' ' PRO . 34.2 t -82.8 142.57 45.44 Favored Pre-proline 0 C--N 1.309 -1.166 0 N-CA-C 107.245 -1.391 . . . . 1.6799999999999999 107.245 175.451 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A 1597 ' ' PRO . . . . . 0.408 ' HD3' ' HA ' ' A' 1596 ' ' SER . 22.0 Cg_exo -65.13 142.21 73.05 Favored 'Trans proline' 0 N--CA 1.457 -0.65 0 C-N-CA 122.646 2.231 . . . . 1.1699999999999999 110.248 177.219 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A 1598 ' ' CYS . . . . . . . . . . . . . 49.8 t -95.45 112.85 60.27 Favored Pre-proline 0 C--N 1.306 -1.31 0 N-CA-C 108.972 -0.751 . . . . 1.1899999999999999 108.972 -178.178 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A 1599 ' ' PRO . . . . . . . . . . . . . 71.5 Cg_endo -76.91 -19.9 13.63 Favored 'Trans proline' 0 N--CA 1.464 -0.236 0 C-N-CA 122.395 2.064 . . . . 1.5900000000000001 112.453 -176.939 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A 1600 ' ' SER . . . . . . . . . . . . . 4.1 m -76.4 -26.33 55.45 Favored 'General case' 0 C--N 1.314 -0.967 0 CA-C-O 121.818 0.818 . . . . 2.1200000000000001 109.955 -177.931 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A 1601 ' ' LYS . . . . . 0.528 ' HG3' ' O ' ' A' 1632 ' ' GLN . 12.9 mmmm -134.71 72.01 1.45 Allowed 'General case' 0 N--CA 1.434 -1.256 0 CA-C-N 114.971 -1.013 . . . . 3.7400000000000002 108.933 178.387 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A 1602 ' ' SER . . . . . . . . . . . . . 3.2 p -49.86 116.37 1.78 Allowed 'General case' 0 N--CA 1.441 -0.905 0 CA-C-N 113.871 -1.513 . . . . 3.79 112.66 -179.304 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A 1603 ' ' GLY . . . . . . . . . . . . . . . 135.94 -29.79 2.81 Favored Glycine 0 N--CA 1.431 -1.671 0 N-CA-C 111.062 -0.815 . . . . 2.0 111.062 -179.595 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A 1604 ' ' LEU . . . . . . . . . . . . . 2.3 pp -127.11 166.72 17.11 Favored 'General case' 0 C--N 1.317 -0.83 0 CA-C-O 121.105 0.478 . . . . 1.48 111.59 179.844 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A 1605 ' ' SER . . . . . 0.439 ' HB2' ' HA ' ' A' 1594 ' ' ASP . 21.0 m -109.13 -172.03 1.97 Allowed 'General case' 0 C--N 1.296 -1.719 0 C-N-CA 123.326 0.65 . . . . 1.51 109.367 -177.817 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A 1606 ' ' TYR . . . . . 0.508 ' HA ' ' O ' ' A' 1634 ' ' CYS . 79.0 m-85 -95.83 136.68 35.93 Favored 'General case' 0 N--CA 1.405 -2.704 0 N-CA-C 104.897 -2.26 . . . . 1.1799999999999999 104.897 177.614 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A 1607 ' ' LYS . . . . . 0.548 ' HG3' HG23 ' A' 1635 ' ' THR . 21.6 ptmt -137.56 147.84 45.44 Favored 'General case' 0 C--N 1.262 -3.209 0 N-CA-C 108.625 -0.88 . . . . 1.6699999999999999 108.625 -179.206 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A 1608 ' ' SER . . . . . . . . . . . . . 47.1 m -125.33 122.25 36.28 Favored 'General case' 0 C--N 1.303 -1.454 0 C-N-CA 120.886 -0.326 . . . . 1.0 111.05 -178.635 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A 1609 ' ' VAL . . . . . 0.553 HG23 ' HB ' ' A' 1591 ' ' VAL . 7.2 p -110.69 139.79 32.77 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 CA-C-O 120.69 0.281 . . . . 0.93000000000000005 110.357 -179.91 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A 1610 ' ' ILE . . . . . 0.71 HG13 ' HB2' ' A' 1638 ' ' PHE . 3.7 mp -118.05 118.33 57.85 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.357 0 N-CA-C 108.072 -1.084 . . . . 0.78000000000000003 108.072 174.871 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A 1611 ' ' SER . . . . . . . . . . . . . 48.0 m -98.19 133.02 43.2 Favored 'General case' 0 C--N 1.286 -2.191 0 N-CA-C 108.949 -0.759 . . . . 1.29 108.949 177.745 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A 1612 ' ' PHE . . . . . 0.576 ' HE1' ' HE3' ' A' 1640 ' ' TRP . 91.3 m-85 -99.58 106.68 18.68 Favored 'General case' 0 C--N 1.3 -1.585 0 CA-C-N 116.144 -0.48 . . . . 0.69999999999999996 111.653 -173.713 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A 1613 ' ' VAL . . . . . 0.477 ' O ' ' HA ' ' A' 1641 ' ' HIS . 84.5 t -107.44 129.03 62.01 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.552 0 CA-C-N 114.921 -1.036 . . . . 0.75 109.302 -178.895 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A 1614 ' ' CYS . . . . . 0.457 ' HA ' ' O ' ' A' 1642 ' ' THR . 0.5 OUTLIER -81.32 106.89 13.65 Favored 'General case' 0 C--N 1.297 -1.704 0 N-CA-C 113.856 1.058 . . . . 1.3899999999999999 113.856 -177.683 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A 1615 ' ' ARG . . . . . 0.43 ' HB3' ' HB3' ' A' 1641 ' ' HIS . 12.0 tpp180 -138.06 106.41 8.05 Favored Pre-proline 0 N--CA 1.428 -1.559 0 N-CA-C 107.897 -1.149 . . . . 3.75 107.897 175.493 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A 1616 ' ' PRO . . . . . . . . . . . . . 97.4 Cg_endo -79.08 5.57 5.65 Favored 'Trans proline' 0 CA--C 1.534 0.485 0 C-N-CA 122.649 2.233 . . . . 1.3200000000000001 113.059 -176.231 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A 1617 ' ' GLU . . . . . . . . . . . . . 39.0 mt-10 . . . . . 0 C--N 1.307 -1.28 0 CA-C-O 121.419 0.628 . . . . 3.21 110.771 -178.04 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A 1622 ' ' ASN . . . . . . . . . . . . . 45.6 t30 . . . . . 0 N--CA 1.464 0.26 0 N-CA-C 107.721 -1.214 . . . . 2.9199999999999999 107.721 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A 1623 ' ' ARG . . . . . . . . . . . . . 12.2 ptm180 -147.13 145.59 22.66 Favored Pre-proline 0 C--N 1.302 -1.498 0 N-CA-C 108.123 -1.065 . . . . 3.6099999999999999 108.123 -178.233 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A 1624 ' ' PRO . . . . . 0.453 ' HA ' ' O ' ' A' 1639 ' ' SER . 15.9 Cg_exo -69.23 123.47 10.31 Favored 'Trans proline' 0 N--CA 1.457 -0.664 0 C-N-CA 122.569 2.179 . . . . 2.3700000000000001 111.361 179.193 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A 1625 ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -119.03 149.04 42.33 Favored 'General case' 0 C--N 1.303 -1.414 0 N-CA-C 109.067 -0.716 . . . . 2.1600000000000001 109.067 179.277 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A 1626 ' ' LEU . . . . . . . . . . . . . 34.7 tp -76.48 122.49 24.63 Favored 'General case' 0 C--N 1.306 -1.303 0 N-CA-C 108.083 -1.08 . . . . 1.3500000000000001 108.083 177.516 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A 1627 ' ' ILE . . . . . . . . . . . . . 24.4 pt -100.19 -28.26 3.38 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.312 0 C-N-CA 120.654 -0.418 . . . . 1.21 111.158 -178.876 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A 1628 ' ' SER . . . . . . . . . . . . . 35.8 t -157.86 159.08 36.26 Favored 'General case' 0 N--CA 1.43 -1.425 0 N-CA-C 108.237 -1.023 . . . . 1.3999999999999999 108.237 -175.868 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A 1629 ' ' LEU . . . . . 0.746 ' HG ' ' HG ' ' A' 1636 ' ' LEU . 4.1 tt -145.9 134.05 21.6 Favored 'General case' 0 C--N 1.293 -1.89 0 N-CA-C 105.512 -2.033 . . . . 1.5600000000000001 105.512 177.579 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A 1630 ' ' ASP . . . . . . . . . . . . . 20.1 t70 -121.0 109.93 15.66 Favored 'General case' 0 C--N 1.29 -2.0 0 N-CA-C 108.812 -0.81 . . . . 0.87 108.812 177.957 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A 1631 ' ' LYS . . . . . 0.434 ' HE3' ' HB2' ' A' 1631 ' ' LYS . 49.7 mtmt -81.07 1.16 32.75 Favored 'General case' 0 C--N 1.303 -1.435 0 N-CA-C 112.553 0.575 . . . . 2.3500000000000001 112.553 -175.991 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A 1632 ' ' GLN . . . . . 0.528 ' O ' ' HG3' ' A' 1601 ' ' LYS . 2.1 mp0 -94.56 -34.3 12.71 Favored 'General case' 0 CA--C 1.509 -0.626 0 CA-C-O 121.336 0.588 . . . . 2.5499999999999998 110.398 -179.226 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A 1633 ' ' THR . . . . . . . . . . . . . 24.9 p -101.32 1.87 39.11 Favored 'General case' 0 C--N 1.289 -2.055 0 CA-C-O 121.947 0.88 . . . . 1.24 108.908 172.255 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A 1634 ' ' CYS . . . . . 0.508 ' O ' ' HA ' ' A' 1606 ' ' TYR . 47.8 m 52.15 42.37 30.59 Favored 'General case' 0 C--N 1.346 0.443 0 CA-C-N 113.714 -1.584 . . . . 0.89000000000000001 110.377 178.478 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A 1635 ' ' THR . . . . . 0.548 HG23 ' HG3' ' A' 1607 ' ' LYS . 55.8 m -114.9 132.55 56.5 Favored 'General case' 0 N--CA 1.425 -1.691 0 CA-C-N 114.386 -1.279 . . . . 0.75 110.048 -175.143 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A 1636 ' ' LEU . . . . . 0.746 ' HG ' ' HG ' ' A' 1629 ' ' LEU . 5.8 mp -102.94 132.55 49.1 Favored 'General case' 0 C--N 1.306 -1.293 0 N-CA-C 108.989 -0.745 . . . . 1.3300000000000001 108.989 176.991 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A 1637 ' ' PHE . . . . . . . . . . . . . 72.7 m-85 -107.47 101.54 10.88 Favored 'General case' 0 C--N 1.318 -0.792 0 CA-C-N 116.242 -0.436 . . . . 0.82999999999999996 111.673 -175.874 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A 1638 ' ' PHE . . . . . 0.71 ' HB2' HG13 ' A' 1610 ' ' ILE . 96.6 m-85 -100.29 160.19 14.53 Favored 'General case' 0 C--N 1.306 -1.284 0 N-CA-C 108.743 -0.836 . . . . 0.59999999999999998 108.743 177.21 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A 1639 ' ' SER . . . . . 0.453 ' O ' ' HA ' ' A' 1624 ' ' PRO . 31.9 t -143.37 147.74 35.14 Favored 'General case' 0 C--N 1.283 -2.285 0 N-CA-C 107.823 -1.177 . . . . 1.0800000000000001 107.823 177.204 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A 1640 ' ' TRP . . . . . 0.576 ' HE3' ' HE1' ' A' 1612 ' ' PHE . 12.4 t90 -127.75 112.26 14.6 Favored 'General case' 0 C--N 1.291 -1.942 0 N-CA-C 108.069 -1.086 . . . . 0.80000000000000004 108.069 176.746 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A 1641 ' ' HIS . . . . . 0.477 ' HA ' ' O ' ' A' 1613 ' ' VAL . 0.6 OUTLIER -88.15 102.95 15.29 Favored 'General case' 0 CA--C 1.487 -1.454 0 N-CA-C 106.953 -1.499 . . . . 2.54 106.953 176.318 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A 1642 ' ' THR . . . . . 0.457 ' O ' ' HA ' ' A' 1614 ' ' CYS . 12.5 t -142.83 141.2 19.43 Favored Pre-proline 0 N--CA 1.414 -2.231 0 CA-C-N 115.451 -0.795 . . . . 1.1499999999999999 111.021 -173.149 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A 1643 ' ' PRO . . . . . . . . . . . . . 42.4 Cg_endo -70.25 -1.68 9.27 Favored 'Trans proline' 0 C--N 1.349 0.592 0 C-N-CA 123.34 2.693 . . . . 0.80000000000000004 111.567 175.942 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A 1644 ' ' LEU . . . . . . . . . . . . . 67.5 mt -86.66 -18.61 30.87 Favored 'General case' 0 C--N 1.317 -0.823 0 CA-C-N 115.692 -0.686 . . . . 1.54 110.089 178.122 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A 1645 ' ' ALA . . . . . . . . . . . . . . . -73.77 -32.91 64.03 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-O 121.648 0.737 . . . . 0.94999999999999996 110.033 -179.032 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A 1646 ' ' CYS . . . . . . . . . . . . . 4.1 m -159.04 117.31 2.88 Favored 'General case' 0 C--N 1.311 -1.093 0 N-CA-C 103.558 -2.756 . . . . 1.4099999999999999 103.558 175.784 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A 1647 ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 . . . . . 0 C--N 1.3 -1.583 0 C-N-CA 118.832 -1.147 . . . . 2.9199999999999999 109.708 179.458 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A 1515 ' ' ASP . . . . . 0.69 ' HB3' ' HG2' ' A' 1517 ' ' GLN . 22.5 m-20 . . . . . 0 N--CA 1.433 -1.284 0 N-CA-C 109.0 -0.741 . . . . 2.54 109.0 . . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A 1516 ' ' CYS . . . . . . . . . . . . . 11.0 t -118.08 39.88 3.29 Favored 'General case' 0 C--N 1.292 -1.896 0 N-CA-C 105.777 -1.935 . . . . 1.25 105.777 175.259 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A 1517 ' ' GLN . . . . . 0.69 ' HG2' ' HB3' ' A' 1515 ' ' ASP . 14.8 pt20 -151.95 127.98 10.39 Favored 'General case' 0 N--CA 1.417 -2.077 0 CA-C-N 113.792 -1.549 . . . . 1.8799999999999999 107.35 -175.769 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A 1518 ' ' VAL . . . . . 0.447 HG11 ' HB2' ' A' 1583 ' ' TYR . 7.4 m -111.57 156.86 12.6 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.979 0 N-CA-C 108.747 -0.835 . . . . 1.73 108.747 -174.716 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A 1519 ' ' THR . . . . . 0.624 ' HA ' ' HA ' ' A' 1526 ' ' LEU . 28.4 m -101.84 103.06 13.74 Favored 'General case' 0 N--CA 1.404 -2.727 0 N-CA-C 106.204 -1.776 . . . . 1.7 106.204 174.1 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A 1520 ' ' ASN . . . . . . . . . . . . . 25.4 t-20 -60.02 110.31 2.72 Favored Pre-proline 0 C--O 1.22 -0.498 0 O-C-N 123.779 0.674 . . . . 2.1200000000000001 110.006 -176.759 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A 1521 ' ' PRO . . . . . . . . . . . . . 21.1 Cg_exo -68.33 -14.79 41.12 Favored 'Trans proline' 0 N--CA 1.478 0.585 0 C-N-CA 122.539 2.159 . . . . 2.4700000000000002 114.14 -177.419 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A 1522 ' ' SER . . . . . . . . . . . . . 15.8 m -78.49 -45.62 21.59 Favored 'General case' 0 C--N 1.308 -1.209 0 CA-C-O 120.563 0.221 . . . . 2.5699999999999998 110.941 -178.353 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A 1523 ' ' THR . . . . . 0.417 HG23 ' H ' ' A' 1525 ' ' HIS . 15.1 t -104.96 -18.57 14.13 Favored 'General case' 0 CA--C 1.55 0.948 0 C-N-CA 120.438 -0.505 . . . . 2.1499999999999999 111.832 -179.408 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A 1524 ' ' GLY . . . . . . . . . . . . . . . 87.0 5.14 81.18 Favored Glycine 0 C--N 1.331 0.269 0 C-N-CA 121.365 -0.445 . . . . 1.8899999999999999 112.763 179.505 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A 1525 ' ' HIS . . . . . 0.417 ' H ' HG23 ' A' 1523 ' ' THR . 23.2 t-160 -100.66 128.79 46.58 Favored 'General case' 0 C--N 1.303 -1.42 0 N-CA-C 109.691 -0.485 . . . . 1.8999999999999999 109.691 -176.614 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A 1526 ' ' LEU . . . . . 0.624 ' HA ' ' HA ' ' A' 1519 ' ' THR . 5.5 tt -73.48 135.33 44.07 Favored 'General case' 0 C--N 1.305 -1.347 0 N-CA-C 107.638 -1.245 . . . . 1.6100000000000001 107.638 176.057 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A 1527 ' ' PHE . . . . . 0.432 ' N ' HD23 ' A' 1526 ' ' LEU . 82.5 m-85 -112.81 110.25 20.24 Favored 'General case' 0 C--N 1.303 -1.426 0 CA-C-O 120.972 0.415 . . . . 1.4199999999999999 110.873 178.052 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A 1528 ' ' ASP . . . . . . . . . . . . . 10.0 t70 -83.38 109.41 17.28 Favored 'General case' 0 CA--C 1.5 -0.955 0 CA-C-N 115.1 -0.955 . . . . 2.1800000000000002 110.646 178.775 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A 1529 ' ' LEU . . . . . 0.664 ' HA ' HD13 ' A' 1532 ' ' LEU . 3.7 mm? -98.7 -18.12 18.2 Favored 'General case' 0 C--N 1.307 -1.279 0 CA-C-N 114.766 -1.107 . . . . 1.4399999999999999 108.179 173.154 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A 1530 ' ' SER . . . . . . . . . . . . . 1.9 m -53.26 -47.1 69.37 Favored 'General case' 0 CA--C 1.544 0.724 0 C-N-CA 125.592 1.557 . . . . 1.4399999999999999 112.741 -176.998 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A 1531 ' ' SER . . . . . . . . . . . . . 5.1 m -78.24 -3.79 44.55 Favored 'General case' 0 C--N 1.321 -0.652 0 N-CA-C 112.086 0.402 . . . . 1.5 112.086 -174.652 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A 1532 ' ' LEU . . . . . 0.664 HD13 ' HA ' ' A' 1529 ' ' LEU . 11.0 mp -62.41 -25.94 68.21 Favored 'General case' 0 N--CA 1.48 1.032 0 N-CA-C 113.066 0.765 . . . . 1.77 113.066 177.685 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A 1533 ' ' SER . . . . . . . . . . . . . 52.4 m -90.82 142.48 27.72 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-O 120.511 0.196 . . . . 2.3799999999999999 110.477 177.464 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A 1534 ' ' GLY . . . . . . . . . . . . . . . -151.65 -116.81 0.73 Allowed Glycine 0 N--CA 1.441 -1.005 0 N-CA-C 109.649 -1.381 . . . . 1.55 109.649 179.158 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A 1535 ' ' ARG . . . . . . . . . . . . . 27.3 tpt180 -90.0 -59.05 2.3 Favored 'General case' 0 C--N 1.309 -1.186 0 N-CA-C 109.063 -0.717 . . . . 3.96 109.063 176.92 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A 1536 ' ' ALA . . . . . . . . . . . . . . . -95.07 -32.51 13.08 Favored 'General case' 0 N--CA 1.441 -0.89 0 CA-C-N 116.035 -0.529 . . . . 1.6499999999999999 110.2 -179.228 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A 1537 ' ' GLY . . . . . . . . . . . . . . . 69.11 -127.14 21.2 Favored Glycine 0 CA--C 1.491 -1.455 0 N-CA-C 109.854 -1.299 . . . . 1.1899999999999999 109.854 -178.524 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A 1538 ' ' PHE . . . . . . . . . . . . . 53.0 m-85 -106.42 141.43 37.74 Favored 'General case' 0 C--N 1.294 -1.822 0 C-N-CA 120.281 -0.568 . . . . 1.6899999999999999 109.563 174.608 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A 1539 ' ' THR . . . . . . . . . . . . . 3.0 p -123.52 138.36 54.58 Favored 'General case' 0 C--N 1.293 -1.879 0 CA-C-N 116.017 -0.538 . . . . 1.48 111.081 -176.0 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A 1540 ' ' ALA . . . . . . . . . . . . . . . -128.87 116.03 18.79 Favored 'General case' 0 C--N 1.305 -1.364 0 CA-C-O 120.52 0.2 . . . . 0.82999999999999996 110.48 178.387 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A 1541 ' ' ALA . . . . . . . . . . . . . . . -75.4 131.2 40.04 Favored 'General case' 0 C--N 1.313 -1.017 0 N-CA-C 108.397 -0.964 . . . . 1.27 108.397 177.316 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A 1542 ' ' TYR . . . . . . . . . . . . . 36.4 t80 -144.48 -179.27 6.44 Favored 'General case' 0 C--N 1.301 -1.524 0 N-CA-C 109.439 -0.578 . . . . 2.1499999999999999 109.439 -173.776 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A 1543 ' ' SER . . . . . . . . . . . . . 5.9 m -43.86 -151.3 0.0 OUTLIER 'General case' 0 CA--C 1.584 2.25 0 C-N-CA 129.773 3.229 . . . . 2.29 114.669 177.91 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A 1544 ' ' LYS . . . . . . . . . . . . . 98.4 mttt -43.99 -29.12 0.54 Allowed 'General case' 0 N--CA 1.5 2.058 0 O-C-N 120.38 -1.45 . . . . 3.9100000000000001 112.824 175.052 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A 1545 ' ' SER . . . . . . . . . . . . . 16.5 m -61.97 -17.29 56.52 Favored 'General case' 0 CA--C 1.562 1.44 0 C-N-CA 123.566 0.746 . . . . 3.2999999999999998 111.463 175.091 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A 1546 ' ' GLY . . . . . . . . . . . . . . . 79.5 -77.85 1.82 Allowed Glycine 0 CA--C 1.496 -1.136 0 CA-C-O 121.457 0.476 . . . . 1.24 113.67 173.244 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A 1547 ' ' VAL . . . . . . . . . . . . . 7.4 p -157.64 131.73 1.38 Allowed 'Isoleucine or valine' 0 C--N 1.284 -2.249 0 N-CA-C 108.204 -1.036 . . . . 1.6299999999999999 108.204 -175.788 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A 1548 ' ' VAL . . . . . . . . . . . . . 2.3 t -103.17 139.73 23.32 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.043 0 N-CA-C 108.346 -0.983 . . . . 0.92000000000000004 108.346 -177.287 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A 1549 ' ' TYR . . . . . 0.492 ' HB3' ' HG2' ' A' 1557 ' ' GLU . 77.3 m-85 -98.29 148.23 23.84 Favored 'General case' 0 C--N 1.303 -1.418 0 N-CA-C 106.586 -1.635 . . . . 1.4399999999999999 106.586 170.969 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A 1550 ' ' MET . . . . . . . . . . . . . 42.2 ttm -138.9 125.52 20.68 Favored 'General case' 0 C--N 1.291 -1.965 0 C-N-CA 120.685 -0.406 . . . . 1.74 110.704 -178.113 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A 1551 ' ' SER . . . . . 0.654 ' HB2' ' HB3' ' A' 1556 ' ' ASN . 43.1 t -99.23 138.91 35.65 Favored 'General case' 0 N--CA 1.411 -2.403 0 N-CA-C 105.938 -1.875 . . . . 1.6399999999999999 105.938 172.551 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A 1552 ' ' ILE . . . . . 0.429 HG22 ' SG ' ' A' 1553 ' ' CYS . 1.8 mp -92.91 -55.17 6.41 Favored 'Isoleucine or valine' 0 N--CA 1.416 -2.174 0 N-CA-C 108.713 -0.847 . . . . 1.3300000000000001 108.713 179.117 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A 1553 ' ' CYS . . . . . 0.429 ' SG ' HG22 ' A' 1552 ' ' ILE . 84.5 m -127.07 136.64 52.45 Favored 'General case' 0 C--N 1.303 -1.415 0 N-CA-C 109.162 -0.681 . . . . 1.4299999999999999 109.162 177.202 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A 1554 ' ' GLY . . . . . . . . . . . . . . . 69.92 -141.46 34.65 Favored Glycine 0 N--CA 1.435 -1.4 0 N-CA-C 111.031 -0.827 . . . . 1.1200000000000001 111.031 179.806 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A 1555 ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -109.35 177.41 4.75 Favored 'General case' 0 C--N 1.3 -1.569 0 N-CA-C 108.91 -0.774 . . . . 1.8 108.91 -178.79 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A 1556 ' ' ASN . . . . . 0.654 ' HB3' ' HB2' ' A' 1551 ' ' SER . 8.9 t30 -177.73 -165.03 0.1 Allowed 'General case' 0 C--N 1.297 -1.705 0 N-CA-C 103.427 -2.805 . . . . 2.6299999999999999 103.427 -174.616 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A 1557 ' ' GLU . . . . . 0.492 ' HG2' ' HB3' ' A' 1549 ' ' TYR . 25.3 mt-10 79.57 -176.8 0.08 Allowed 'General case' 0 C--N 1.321 -0.636 0 N-CA-C 115.404 1.631 . . . . 3.79 115.404 163.519 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A 1558 ' ' ASN . . . . . . . . . . . . . 26.9 m-80 -125.21 43.93 2.93 Favored 'General case' 0 C--N 1.313 -0.991 0 CA-C-N 112.6 -2.091 . . . . 1.52 107.373 -174.612 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A 1559 ' ' CYS . . . . . . . . . . . . . 77.1 m -141.17 152.56 64.95 Favored Pre-proline 0 C--N 1.285 -2.214 0 N-CA-C 106.105 -1.813 . . . . 0.83999999999999997 106.105 -176.029 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A 1560 ' ' PRO . . . . . . . . . . . . . 24.6 Cg_exo -36.23 112.32 0.09 OUTLIER 'Trans proline' 0 C--N 1.376 2.023 0 C-N-CA 124.667 3.578 . . . . 1.1799999999999999 113.339 -178.811 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A 1561 ' ' PRO . . . . . . . . . . . . . 88.7 Cg_exo -48.89 153.52 3.74 Favored 'Trans proline' 0 C--N 1.365 1.407 0 C-N-CA 124.93 3.753 . . . . 1.51 114.486 -174.956 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A 1562 ' ' GLY . . . . . . . . . . . . . . . 93.67 7.78 61.32 Favored Glycine 0 N--CA 1.447 -0.589 0 N-CA-C 111.092 -0.803 . . . . 0.71999999999999997 111.092 -177.545 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A 1563 ' ' VAL . . . . . 0.499 ' HA ' ' HA ' ' A' 1576 ' ' LYS . 8.3 p -111.25 156.96 12.28 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.588 0 N-CA-C 107.297 -1.372 . . . . 0.96999999999999997 107.297 -179.355 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A 1564 ' ' GLY . . . . . . . . . . . . . . . -124.82 9.08 8.09 Favored Glycine 0 CA--C 1.528 0.852 0 C-N-CA 120.056 -1.069 . . . . 0.71999999999999997 114.555 -176.417 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A 1565 ' ' ALA . . . . . . . . . . . . . . . -170.22 141.62 2.1 Favored 'General case' 0 C--N 1.302 -1.494 0 N-CA-C 107.917 -1.142 . . . . 0.37 107.917 178.956 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A 1566 ' ' CYS . . . . . 0.484 ' HA ' HG23 ' A' 1574 ' ' VAL . 51.6 t -164.22 139.23 5.83 Favored 'General case' 0 C--N 1.309 -1.165 0 CA-C-O 120.896 0.379 . . . . 0.51000000000000001 110.184 -175.7 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A 1567 ' ' PHE . . . . . . . . . . . . . 35.2 m-85 -80.57 122.9 27.62 Favored 'General case' 0 CA--C 1.512 -0.501 0 N-CA-C 106.535 -1.654 . . . . 0.96999999999999997 106.535 174.416 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A 1568 ' ' GLY . . . . . . . . . . . . . . . -75.97 -26.75 63.8 Favored Glycine 0 C--N 1.314 -0.656 0 C-N-CA 120.7 -0.762 . . . . 1.0800000000000001 113.274 -173.879 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A 1569 ' ' GLN . . . . . . . . . . . . . 25.9 tp60 -71.42 -57.0 4.84 Favored 'General case' 0 C--N 1.311 -1.102 0 CA-C-O 121.798 0.809 . . . . 2.7400000000000002 109.211 178.991 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A 1570 ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -83.42 -16.65 45.02 Favored 'General case' 0 C--N 1.301 -1.515 0 CA-C-N 114.634 -1.166 . . . . 1.96 113.089 -172.141 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A 1571 ' ' ARG . . . . . . . . . . . . . 11.1 tpp180 63.94 43.93 5.02 Favored 'General case' 0 N--CA 1.479 0.989 0 C-N-CA 125.59 1.556 . . . . 3.9500000000000002 109.878 178.758 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A 1572 ' ' ILE . . . . . . . . . . . . . 31.9 mm -115.53 128.82 72.61 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.258 0 CA-C-N 115.447 -0.797 . . . . 1.3700000000000001 109.819 -174.939 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A 1573 ' ' SER . . . . . . . . . . . . . 57.2 p -72.53 134.83 45.45 Favored 'General case' 0 C--O 1.247 0.951 0 CA-C-O 121.367 0.603 . . . . 1.0800000000000001 111.869 -178.038 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A 1574 ' ' VAL . . . . . 0.484 HG23 ' HA ' ' A' 1566 ' ' CYS . 13.4 t -119.18 39.7 0.77 Allowed 'Isoleucine or valine' 0 CA--C 1.565 1.533 0 CA-C-O 122.597 1.189 . . . . 1.3 109.084 -174.926 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A 1575 ' ' GLY . . . . . . . . . . . . . . . 125.79 133.65 3.96 Favored Glycine 0 CA--C 1.53 1.017 0 CA-C-N 115.043 -0.98 . . . . 0.51000000000000001 113.451 179.708 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A 1576 ' ' LYS . . . . . 0.499 ' HA ' ' HA ' ' A' 1563 ' ' VAL . 64.4 mttp -84.31 153.99 23.19 Favored 'General case' 0 N--CA 1.469 0.491 0 N-CA-C 109.496 -0.557 . . . . 2.8999999999999999 109.496 178.455 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A 1577 ' ' ALA . . . . . 0.561 ' HA ' ' CE1' ' A' 1592 ' ' TYR . . . -72.34 92.23 1.4 Allowed 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 113.042 0.756 . . . . 0.82999999999999996 113.042 -173.028 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A 1578 ' ' ASN . . . . . . . . . . . . . 2.8 m-20 -98.92 117.64 33.88 Favored 'General case' 0 C--N 1.311 -1.08 0 N-CA-C 107.879 -1.156 . . . . 1.8500000000000001 107.879 174.019 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A 1579 ' ' LYS . . . . . . . . . . . . . 55.7 mtmt -90.37 90.77 8.19 Favored 'General case' 0 C--N 1.3 -1.582 0 CA-C-O 121.882 0.849 . . . . 1.8999999999999999 109.477 -177.479 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A 1580 ' ' ARG . . . . . . . . . . . . . 9.3 ttp180 -153.99 131.65 11.46 Favored 'General case' 0 C--N 1.288 -2.091 0 N-CA-C 107.068 -1.456 . . . . 3.6299999999999999 107.068 179.925 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A 1581 ' ' LEU . . . . . 0.502 HD13 HD12 ' A' 1590 ' ' LEU . 28.9 tp -119.05 167.5 11.71 Favored 'General case' 0 C--N 1.296 -1.755 0 N-CA-C 108.299 -1.0 . . . . 1.8700000000000001 108.299 -178.102 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A 1582 ' ' ARG . . . . . . . . . . . . . 69.2 ttt180 -145.18 103.04 3.82 Favored 'General case' 0 C--N 1.304 -1.408 0 N-CA-C 109.637 -0.505 . . . . 3.9700000000000002 109.637 -179.81 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A 1583 ' ' TYR . . . . . 0.447 ' HB2' HG11 ' A' 1518 ' ' VAL . 42.2 t80 -88.6 111.46 21.92 Favored 'General case' 0 C--N 1.3 -1.567 0 CA-C-O 121.401 0.619 . . . . 1.4099999999999999 111.141 179.087 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A 1584 ' ' VAL . . . . . 0.531 ' HB ' HG13 ' A' 1587 ' ' VAL . 48.9 t -112.94 150.68 15.01 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.744 0 N-CA-C 105.043 -2.206 . . . . 1.6899999999999999 105.043 173.849 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A 1585 ' ' ASP . . . . . . . . . . . . . 33.9 t70 -47.4 108.32 0.15 Allowed 'General case' 0 C--N 1.33 -0.258 0 C-N-CA 123.843 0.857 . . . . 2.0600000000000001 112.569 -179.563 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A 1586 ' ' GLN . . . . . . . . . . . . . 93.7 mt-30 63.76 24.29 13.76 Favored 'General case' 0 C--O 1.251 1.132 0 C-N-CA 125.155 1.382 . . . . 2.3300000000000001 114.488 -178.966 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A 1587 ' ' VAL . . . . . 0.531 HG13 ' HB ' ' A' 1584 ' ' VAL . 7.1 p -161.13 105.71 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.439 -1.003 0 CA-C-O 122.35 1.072 . . . . 0.78000000000000003 112.236 176.202 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A 1588 ' ' LEU . . . . . . . . . . . . . 7.3 mp -91.39 120.58 32.37 Favored 'General case' 0 C--N 1.299 -1.595 0 CA-C-N 115.075 -0.966 . . . . 1.4099999999999999 108.842 179.934 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A 1589 ' ' GLN . . . . . . . . . . . . . 35.2 tt0 -105.89 134.21 49.38 Favored 'General case' 0 C--N 1.297 -1.689 0 N-CA-C 110.196 -0.298 . . . . 1.24 110.196 -177.768 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A 1590 ' ' LEU . . . . . 0.502 HD12 HD13 ' A' 1581 ' ' LEU . 2.0 tt -136.8 138.0 40.4 Favored 'General case' 0 C--N 1.304 -1.406 0 N-CA-C 106.222 -1.77 . . . . 1.1499999999999999 106.222 175.925 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A 1591 ' ' VAL . . . . . . . . . . . . . 8.4 p -137.98 140.76 40.1 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.222 0 CA-C-O 120.967 0.413 . . . . 1.51 111.869 -174.171 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A 1592 ' ' TYR . . . . . 0.561 ' CE1' ' HA ' ' A' 1577 ' ' ALA . 88.1 m-85 -125.56 128.75 48.43 Favored 'General case' 0 C--N 1.317 -0.805 0 N-CA-C 108.094 -1.076 . . . . 1.0600000000000001 108.094 176.117 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A 1593 ' ' LYS . . . . . . . . . . . . . 20.9 pttp -137.54 -174.21 3.7 Favored 'General case' 0 C--N 1.306 -1.313 0 N-CA-C 109.496 -0.557 . . . . 2.1800000000000002 109.496 -176.925 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A 1594 ' ' ASP . . . . . . . . . . . . . 13.6 m-20 60.79 44.27 11.2 Favored 'General case' 0 N--CA 1.482 1.13 0 C-N-CA 123.281 0.632 . . . . 1.45 112.312 -179.603 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A 1595 ' ' GLY . . . . . . . . . . . . . . . -86.03 -92.76 0.86 Allowed Glycine 0 N--CA 1.437 -1.285 0 C-N-CA 119.477 -1.344 . . . . 0.78000000000000003 111.76 177.685 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A 1596 ' ' SER . . . . . 0.401 ' HA ' ' HD3' ' A' 1597 ' ' PRO . 37.1 m -113.47 151.69 44.68 Favored Pre-proline 0 C--N 1.287 -2.142 0 N-CA-C 108.678 -0.86 . . . . 1.6799999999999999 108.678 179.377 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A 1597 ' ' PRO . . . . . 0.401 ' HD3' ' HA ' ' A' 1596 ' ' SER . 24.4 Cg_exo -65.3 133.03 33.48 Favored 'Trans proline' 0 C--O 1.24 0.607 0 C-N-CA 123.248 2.632 . . . . 1.1699999999999999 110.976 178.798 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A 1598 ' ' CYS . . . . . . . . . . . . . 22.0 t -95.9 113.89 63.0 Favored Pre-proline 0 C--N 1.296 -1.76 0 CA-C-N 116.093 -0.503 . . . . 1.1899999999999999 109.682 -177.463 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A 1599 ' ' PRO . . . . . . . . . . . . . 60.6 Cg_endo -88.8 18.18 1.52 Allowed 'Trans proline' 0 C--O 1.24 0.594 0 C-N-CA 122.904 2.402 . . . . 1.5900000000000001 111.726 178.696 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A 1600 ' ' SER . . . . . . . . . . . . . 35.8 t -75.85 -55.92 5.16 Favored 'General case' 0 N--CA 1.427 -1.616 0 CA-C-N 115.715 -0.675 . . . . 2.1200000000000001 110.59 -178.572 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A 1601 ' ' LYS . . . . . . . . . . . . . 53.2 tttp -142.42 -71.87 0.32 Allowed 'General case' 0 N--CA 1.445 -0.693 0 C-N-CA 119.926 -0.709 . . . . 3.7400000000000002 112.486 -175.955 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A 1602 ' ' SER . . . . . 0.52 ' HB3' ' HG ' ' A' 1604 ' ' LEU . 23.0 t -96.37 157.11 16.05 Favored 'General case' 0 N--CA 1.427 -1.575 0 N-CA-C 108.47 -0.937 . . . . 3.79 108.47 -175.957 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A 1603 ' ' GLY . . . . . . . . . . . . . . . -77.74 58.21 3.84 Favored Glycine 0 C--O 1.236 0.27 0 N-CA-C 111.942 -0.463 . . . . 2.0 111.942 -179.824 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A 1604 ' ' LEU . . . . . 0.52 ' HG ' ' HB3' ' A' 1602 ' ' SER . 0.6 OUTLIER -120.97 -175.27 3.01 Favored 'General case' 0 C--N 1.298 -1.668 0 C-N-CA 124.581 1.152 . . . . 1.48 110.364 -178.516 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A 1605 ' ' SER . . . . . . . . . . . . . 15.0 m -104.58 -170.04 1.71 Allowed 'General case' 0 C--N 1.297 -1.712 0 N-CA-C 109.929 -0.397 . . . . 1.51 109.929 -178.879 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A 1606 ' ' TYR . . . . . . . . . . . . . 97.5 m-85 -103.37 126.65 50.64 Favored 'General case' 0 CA--C 1.482 -1.662 0 N-CA-C 104.328 -2.471 . . . . 1.1799999999999999 104.328 177.274 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A 1607 ' ' LYS . . . . . . . . . . . . . 21.3 ptmt -119.15 132.15 55.95 Favored 'General case' 0 C--N 1.285 -2.219 0 C-N-CA 119.528 -0.869 . . . . 1.6699999999999999 111.654 -176.071 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A 1608 ' ' SER . . . . . 0.439 ' OG ' HG12 ' A' 1574 ' ' VAL . 33.1 m -103.15 118.31 36.51 Favored 'General case' 0 C--N 1.309 -1.177 0 C-N-CA 123.024 0.53 . . . . 1.0 110.731 -177.301 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A 1609 ' ' VAL . . . . . . . . . . . . . 58.7 t -110.98 114.57 47.48 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.778 0 N-CA-C 108.687 -0.857 . . . . 0.93000000000000005 108.687 177.363 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A 1610 ' ' ILE . . . . . 0.655 HG13 ' HB2' ' A' 1638 ' ' PHE . 2.9 mp -105.04 114.67 45.22 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.214 0 N-CA-C 108.675 -0.861 . . . . 0.78000000000000003 108.675 178.345 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A 1611 ' ' SER . . . . . . . . . . . . . 19.4 m -104.42 107.76 18.85 Favored 'General case' 0 C--N 1.296 -1.753 0 CA-C-N 115.474 -0.784 . . . . 1.29 109.486 179.535 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A 1612 ' ' PHE . . . . . 0.53 ' O ' ' HA ' ' A' 1587 ' ' VAL . 97.7 m-85 -83.8 102.55 12.4 Favored 'General case' 0 C--N 1.306 -1.319 0 CA-C-N 115.882 -0.599 . . . . 0.69999999999999996 109.472 179.089 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A 1613 ' ' VAL . . . . . . . . . . . . . 94.4 t -86.52 124.9 40.7 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.485 0 N-CA-C 107.857 -1.164 . . . . 0.75 107.857 179.345 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A 1614 ' ' CYS . . . . . 0.499 ' HB3' ' HB2' ' A' 1646 ' ' CYS . 61.8 m -75.73 92.78 3.03 Favored 'General case' 0 C--N 1.295 -1.797 0 CA-C-O 121.614 0.721 . . . . 1.3899999999999999 111.018 -177.12 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A 1615 ' ' ARG . . . . . 0.521 ' HB3' ' HB3' ' A' 1641 ' ' HIS . 43.6 ttm180 -138.45 131.79 16.35 Favored Pre-proline 0 N--CA 1.43 -1.464 0 CA-C-N 115.155 -0.929 . . . . 3.75 109.467 -179.742 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A 1616 ' ' PRO . . . . . . . . . . . . . 38.4 Cg_endo -70.7 67.37 2.29 Favored 'Trans proline' 0 CA--C 1.55 1.309 0 C-N-CA 123.142 2.562 . . . . 1.3200000000000001 111.351 175.764 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A 1617 ' ' GLU . . . . . . . . . . . . . 10.9 tp10 . . . . . 0 CA--C 1.555 1.169 0 CA-C-O 121.982 0.896 . . . . 3.21 109.354 -177.52 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A 1622 ' ' ASN . . . . . . . . . . . . . 40.3 t30 . . . . . 0 C--O 1.242 0.71 0 N-CA-C 108.77 -0.826 . . . . 2.9199999999999999 108.77 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A 1623 ' ' ARG . . . . . . . . . . . . . 20.2 ptp180 -148.78 169.22 9.51 Favored Pre-proline 0 C--N 1.302 -1.497 0 N-CA-C 108.474 -0.935 . . . . 3.6099999999999999 108.474 -174.364 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A 1624 ' ' PRO . . . . . . . . . . . . . 33.6 Cg_exo -61.41 114.89 2.42 Favored 'Trans proline' 0 C--N 1.36 1.161 0 C-N-CA 121.825 1.684 . . . . 2.3700000000000001 109.51 175.69 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A 1625 ' ' MET . . . . . . . . . . . . . 22.7 ptt? -109.81 146.1 35.6 Favored 'General case' 0 C--N 1.292 -1.892 0 CA-C-N 115.891 -0.595 . . . . 2.1600000000000001 111.495 -175.301 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A 1626 ' ' LEU . . . . . . . . . . . . . 43.0 tp -76.0 111.07 11.0 Favored 'General case' 0 N--CA 1.441 -0.904 0 CA-C-N 114.773 -1.103 . . . . 1.3500000000000001 109.179 179.521 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A 1627 ' ' ILE . . . . . . . . . . . . . 39.0 mm -81.69 -49.58 17.51 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.745 0 CA-C-N 115.03 -0.986 . . . . 1.21 110.41 -175.727 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A 1628 ' ' SER . . . . . . . . . . . . . 48.3 m -157.26 154.09 28.56 Favored 'General case' 0 C--N 1.301 -1.52 0 CA-C-N 116.259 -0.428 . . . . 1.3999999999999999 109.913 -178.064 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A 1629 ' ' LEU . . . . . 0.46 HD13 ' HG ' ' A' 1636 ' ' LEU . 56.7 tp -113.36 118.41 34.5 Favored 'General case' 0 N--CA 1.428 -1.56 0 N-CA-C 108.039 -1.096 . . . . 1.5600000000000001 108.039 175.251 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A 1630 ' ' ASP . . . . . 0.488 ' HB3' ' HB ' ' A' 1635 ' ' THR . 12.6 t70 -95.09 117.62 30.49 Favored 'General case' 0 C--N 1.293 -1.864 0 N-CA-C 107.653 -1.24 . . . . 0.87 107.653 177.121 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A 1631 ' ' LYS . . . . . . . . . . . . . 8.5 mtpm? -94.22 4.87 53.29 Favored 'General case' 0 C--N 1.298 -1.673 0 N-CA-C 112.402 0.519 . . . . 2.3500000000000001 112.402 -176.116 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A 1632 ' ' GLN . . . . . . . . . . . . . 2.2 mp0 -89.99 -51.97 5.2 Favored 'General case' 0 C--N 1.307 -1.245 0 CA-C-O 121.208 0.528 . . . . 2.5499999999999998 109.686 -179.608 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A 1633 ' ' THR . . . . . . . . . . . . . 7.2 m -105.15 4.46 31.36 Favored 'General case' 0 C--N 1.306 -1.314 0 CA-C-O 122.309 1.052 . . . . 1.24 109.261 179.815 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A 1634 ' ' CYS . . . . . . . . . . . . . 61.3 m 55.24 52.8 10.95 Favored 'General case' 0 N--CA 1.469 0.505 0 CA-C-N 114.092 -1.413 . . . . 0.89000000000000001 110.739 179.199 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A 1635 ' ' THR . . . . . 0.488 ' HB ' ' HB3' ' A' 1630 ' ' ASP . 21.1 m -103.87 125.23 50.14 Favored 'General case' 0 N--CA 1.421 -1.92 0 CA-C-N 113.458 -1.701 . . . . 0.75 109.924 -175.059 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A 1636 ' ' LEU . . . . . 0.46 ' HG ' HD13 ' A' 1629 ' ' LEU . 5.8 mp -106.49 122.58 46.58 Favored 'General case' 0 C--N 1.313 -0.981 0 N-CA-C 109.362 -0.607 . . . . 1.3300000000000001 109.362 178.921 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A 1637 ' ' PHE . . . . . . . . . . . . . 96.9 m-85 -98.85 112.51 24.58 Favored 'General case' 0 C--N 1.313 -1.0 0 CA-C-N 115.983 -0.553 . . . . 0.82999999999999996 111.783 -176.275 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A 1638 ' ' PHE . . . . . 0.655 ' HB2' HG13 ' A' 1610 ' ' ILE . 87.6 m-85 -115.09 133.81 55.71 Favored 'General case' 0 C--N 1.294 -1.832 0 N-CA-C 108.484 -0.932 . . . . 0.59999999999999998 108.484 175.303 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A 1639 ' ' SER . . . . . . . . . . . . . 28.2 t -140.47 141.5 35.41 Favored 'General case' 0 C--N 1.276 -2.606 0 C-N-CA 120.099 -0.641 . . . . 1.0800000000000001 109.308 177.49 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A 1640 ' ' TRP . . . . . 0.495 ' HE3' ' HE1' ' A' 1612 ' ' PHE . 10.5 t90 -128.0 127.88 44.01 Favored 'General case' 0 N--CA 1.43 -1.429 0 N-CA-C 107.849 -1.167 . . . . 0.80000000000000004 107.849 178.659 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A 1641 ' ' HIS . . . . . 0.521 ' HB3' ' HB3' ' A' 1615 ' ' ARG . 34.9 m80 -91.25 97.79 11.33 Favored 'General case' 0 C--N 1.301 -1.513 0 N-CA-C 105.983 -1.858 . . . . 2.54 105.983 175.276 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A 1642 ' ' THR . . . . . 0.584 ' OG1' ' HG ' ' A' 1644 ' ' LEU . 7.8 t -135.12 140.85 35.97 Favored Pre-proline 0 C--N 1.296 -1.719 0 N-CA-C 113.63 0.974 . . . . 1.1499999999999999 113.63 -170.737 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A 1643 ' ' PRO . . . . . . . . . . . . . 87.3 Cg_endo -80.66 -0.84 10.9 Favored 'Trans proline' 0 N--CA 1.447 -1.219 0 C-N-CA 123.475 2.783 . . . . 0.80000000000000004 112.451 175.903 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A 1644 ' ' LEU . . . . . 0.584 ' HG ' ' OG1' ' A' 1642 ' ' THR . 2.8 pp -92.94 4.03 54.68 Favored 'General case' 0 CA--C 1.502 -0.885 0 CA-C-O 121.969 0.89 . . . . 1.54 110.386 174.613 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A 1645 ' ' ALA . . . . . . . . . . . . . . . -95.78 -43.47 7.86 Favored 'General case' 0 C--N 1.3 -1.552 0 CA-C-N 113.818 -1.537 . . . . 0.94999999999999996 108.421 175.992 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A 1646 ' ' CYS . . . . . 0.499 ' HB2' ' HB3' ' A' 1614 ' ' CYS . 38.2 m -156.44 158.36 37.16 Favored 'General case' 0 CA--C 1.498 -1.05 0 N-CA-C 105.585 -2.005 . . . . 1.4099999999999999 105.585 174.71 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A 1647 ' ' GLU . . . . . 0.4 ' HG3' ' CZ ' ' A' 1527 ' ' PHE . 53.9 mt-10 . . . . . 0 C--N 1.305 -1.368 0 N-CA-C 110.215 -0.291 . . . . 2.9199999999999999 110.215 -179.624 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A 1508 ' ' MET . . . . . . . . . . . . . 70.3 mtm . . . . . 0 C--O 1.238 0.481 0 N-CA-C 111.826 0.306 . . . . 8.2699999999999996 111.826 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A 1509 ' ' LYS . . . . . . . . . . . . . 61.7 tttp -71.83 -58.56 3.36 Favored 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 111.7 0.259 . . . . 6.4800000000000004 111.7 -177.745 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A 1510 ' ' SER . . . . . . . . . . . . . 66.0 m -112.1 119.89 39.98 Favored 'General case' 0 C--N 1.303 -1.45 0 N-CA-C 109.002 -0.74 . . . . 4.2199999999999998 109.002 178.145 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A 1511 ' ' ASN . . . . . . . . . . . . . 21.8 m-80 -121.88 -24.2 5.28 Favored 'General case' 0 C--N 1.298 -1.662 0 CA-C-N 116.143 -0.48 . . . . 3.0800000000000001 111.019 -174.334 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A 1512 ' ' GLU . . . . . 0.45 ' H ' ' CD ' ' A' 1512 ' ' GLU . 1.4 mp0 -51.32 -25.87 6.63 Favored 'General case' 0 N--CA 1.475 0.798 0 C-N-CA 126.214 1.806 . . . . 4.46 114.608 -173.921 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A 1513 ' ' HIS . . . . . . . . . . . . . 65.6 m80 -113.3 0.66 14.9 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-O 121.359 0.6 . . . . 5.5700000000000003 110.476 -179.177 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A 1514 ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -104.82 -55.85 2.27 Favored 'General case' 0 C--N 1.295 -1.774 0 CA-C-N 115.657 -0.701 . . . . 3.7000000000000002 110.722 -175.413 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A 1515 ' ' ASP . . . . . . . . . . . . . 22.8 t0 -145.04 152.77 40.64 Favored 'General case' 0 C--N 1.291 -1.969 0 N-CA-C 106.874 -1.528 . . . . 2.54 106.874 -177.712 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A 1516 ' ' CYS . . . . . . . . . . . . . 29.8 m -75.99 67.92 2.41 Favored 'General case' 0 C--N 1.288 -2.081 0 CA-C-O 121.948 0.88 . . . . 1.25 110.862 -176.008 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A 1517 ' ' GLN . . . . . 0.409 ' HA ' ' O ' ' A' 1527 ' ' PHE . 13.5 pt20 -148.56 151.31 34.85 Favored 'General case' 0 N--CA 1.417 -2.119 0 N-CA-C 108.578 -0.897 . . . . 1.8799999999999999 108.578 -179.494 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A 1518 ' ' VAL . . . . . 0.812 HG21 HD11 ' A' 1588 ' ' LEU . 44.6 t -127.08 134.07 66.89 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.459 0 N-CA-C 108.87 -0.789 . . . . 1.73 108.87 -179.169 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A 1519 ' ' THR . . . . . . . . . . . . . 27.7 m -107.71 125.33 51.25 Favored 'General case' 0 C--N 1.296 -1.727 0 N-CA-C 110.063 -0.347 . . . . 1.7 110.063 177.14 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A 1520 ' ' ASN . . . . . . . . . . . . . 30.3 t-20 -97.33 100.37 7.81 Favored Pre-proline 0 C--N 1.309 -1.16 0 N-CA-C 106.802 -1.555 . . . . 2.1200000000000001 106.802 172.063 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A 1521 ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -73.83 -0.12 9.01 Favored 'Trans proline' 0 C--N 1.353 0.784 0 C-N-CA 122.713 2.275 . . . . 2.4700000000000002 113.495 -175.633 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A 1522 ' ' SER . . . . . . . . . . . . . 50.8 m -91.44 -14.96 29.62 Favored 'General case' 0 N--CA 1.433 -1.279 0 CA-C-N 116.641 -0.254 . . . . 2.5699999999999998 110.917 178.384 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A 1523 ' ' THR . . . . . . . . . . . . . 14.3 t -139.12 0.67 1.95 Allowed 'General case' 0 CA--C 1.555 1.135 0 CA-C-O 121.271 0.557 . . . . 2.1499999999999999 111.247 177.427 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A 1524 ' ' GLY . . . . . . . . . . . . . . . 66.8 30.61 76.45 Favored Glycine 0 C--N 1.339 0.708 0 CA-C-N 116.217 -0.447 . . . . 1.8899999999999999 112.535 178.466 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A 1525 ' ' HIS . . . . . 0.623 ' HE1' ' HB2' ' A' 1647 ' ' GLU . 23.8 t-160 -101.53 122.75 44.38 Favored 'General case' 0 C--N 1.303 -1.438 0 O-C-N 122.616 -0.343 . . . . 1.8999999999999999 111.021 -176.729 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A 1526 ' ' LEU . . . . . . . . . . . . . 42.6 tp -97.97 133.55 42.29 Favored 'General case' 0 C--N 1.307 -1.249 0 N-CA-C 108.86 -0.793 . . . . 1.6100000000000001 108.86 176.383 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A 1527 ' ' PHE . . . . . 0.416 ' CE1' ' HA ' ' A' 1646 ' ' CYS . 94.8 m-85 -102.87 132.67 48.92 Favored 'General case' 0 C--N 1.292 -1.917 0 N-CA-C 108.529 -0.915 . . . . 1.4199999999999999 108.529 176.822 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A 1528 ' ' ASP . . . . . . . . . . . . . 28.7 t70 -110.98 114.76 28.32 Favored 'General case' 0 CA--C 1.487 -1.45 0 CA-C-O 122.103 0.954 . . . . 2.1800000000000002 112.425 -179.245 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A 1529 ' ' LEU . . . . . . . . . . . . . 87.0 mt -119.63 3.53 11.16 Favored 'General case' 0 C--N 1.294 -1.818 0 CA-C-N 114.055 -1.429 . . . . 1.4399999999999999 107.427 174.623 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A 1530 ' ' SER . . . . . . . . . . . . . 14.5 t -80.36 -31.6 37.89 Favored 'General case' 0 N--CA 1.441 -0.898 0 CA-C-N 115.74 -0.664 . . . . 1.4399999999999999 110.428 -175.443 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A 1531 ' ' SER . . . . . . . . . . . . . 25.9 m -70.4 -10.9 60.35 Favored 'General case' 0 C--O 1.236 0.379 0 CA-C-O 121.133 0.492 . . . . 1.5 110.204 177.234 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A 1532 ' ' LEU . . . . . . . . . . . . . 97.1 mt -80.39 10.01 5.15 Favored 'General case' 0 CA--C 1.546 0.811 0 N-CA-C 112.787 0.662 . . . . 1.77 112.787 178.666 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A 1533 ' ' SER . . . . . . . . . . . . . 31.7 m -72.7 145.02 47.47 Favored 'General case' 0 C--O 1.247 0.964 0 N-CA-C 108.495 -0.928 . . . . 2.3799999999999999 108.495 174.924 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A 1534 ' ' GLY . . . . . . . . . . . . . . . -162.66 169.28 37.86 Favored Glycine 0 N--CA 1.441 -0.995 0 C-N-CA 120.319 -0.944 . . . . 1.55 112.277 -177.419 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A 1535 ' ' ARG . . . . . 0.816 ' HD3' ' HG3' ' A' 1557 ' ' GLU . 21.8 tpp180 -80.67 -51.59 8.53 Favored 'General case' 0 C--N 1.312 -1.028 0 N-CA-C 108.676 -0.861 . . . . 3.96 108.676 179.459 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A 1536 ' ' ALA . . . . . . . . . . . . . . . -79.61 -37.44 36.17 Favored 'General case' 0 C--N 1.309 -1.193 0 C-N-CA 120.033 -0.667 . . . . 1.6499999999999999 110.261 179.291 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A 1537 ' ' GLY . . . . . . . . . . . . . . . 79.68 -151.17 33.77 Favored Glycine 0 N--CA 1.426 -1.972 0 N-CA-C 109.962 -1.255 . . . . 1.1899999999999999 109.962 -179.953 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A 1538 ' ' PHE . . . . . 0.614 ' CD1' HD13 ' A' 1552 ' ' ILE . 65.7 m-85 -107.95 135.91 48.53 Favored 'General case' 0 C--N 1.288 -2.09 0 N-CA-C 107.6 -1.259 . . . . 1.6899999999999999 107.6 177.598 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A 1539 ' ' THR . . . . . 0.443 ' O ' ' HD2' ' A' 1623 ' ' ARG . 2.7 p -112.45 137.02 51.24 Favored 'General case' 0 C--N 1.296 -1.75 0 N-CA-C 113.135 0.791 . . . . 1.48 113.135 -175.676 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A 1540 ' ' ALA . . . . . . . . . . . . . . . -117.02 108.81 16.21 Favored 'General case' 0 C--N 1.308 -1.203 0 N-CA-C 109.687 -0.486 . . . . 0.82999999999999996 109.687 178.302 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A 1541 ' ' ALA . . . . . . . . . . . . . . . -74.19 113.75 11.76 Favored 'General case' 0 C--N 1.313 -0.98 0 CA-C-N 115.36 -0.836 . . . . 1.27 109.396 178.998 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A 1542 ' ' TYR . . . . . 0.434 ' CE2' ' HB2' ' A' 1545 ' ' SER . 80.0 t80 -130.72 157.64 42.25 Favored 'General case' 0 N--CA 1.418 -2.065 0 CA-C-N 115.852 -0.613 . . . . 2.1499999999999999 109.734 -176.587 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A 1543 ' ' SER . . . . . . . . . . . . . 5.3 m -40.85 -153.6 0.0 OUTLIER 'General case' 0 CA--C 1.592 2.561 0 C-N-CA 129.709 3.204 . . . . 2.29 117.111 -174.716 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A 1544 ' ' LYS . . . . . . . . . . . . . 25.0 ttmm -54.86 -24.71 24.41 Favored 'General case' 0 CA--C 1.556 1.188 0 O-C-N 120.863 -1.148 . . . . 3.9100000000000001 112.385 -179.343 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A 1545 ' ' SER . . . . . 0.434 ' HB2' ' CE2' ' A' 1542 ' ' TYR . 22.6 m -64.69 -30.69 71.71 Favored 'General case' 0 CA--C 1.547 0.827 0 O-C-N 121.759 -0.588 . . . . 3.2999999999999998 110.717 175.452 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A 1546 ' ' GLY . . . . . 0.417 ' O ' ' HB3' ' A' 1542 ' ' TYR . . . 116.85 174.26 17.12 Favored Glycine 0 N--CA 1.436 -1.34 0 C-N-CA 119.489 -1.339 . . . . 1.24 114.974 174.174 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A 1547 ' ' VAL . . . . . . . . . . . . . 3.1 p -92.92 129.21 43.79 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.343 0 C-N-CA 123.991 0.916 . . . . 1.6299999999999999 110.398 179.915 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A 1548 ' ' VAL . . . . . 0.515 ' HA ' ' HA ' ' A' 1567 ' ' PHE . 3.0 t -97.47 143.29 12.87 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.86 0 CA-C-N 115.55 -0.75 . . . . 0.92000000000000004 109.957 -174.763 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A 1549 ' ' TYR . . . . . 0.63 ' CD1' ' HA3' ' A' 1568 ' ' GLY . 37.3 m-85 -102.49 145.41 29.62 Favored 'General case' 0 C--N 1.307 -1.243 0 N-CA-C 105.915 -1.883 . . . . 1.4399999999999999 105.915 169.341 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A 1550 ' ' MET . . . . . 0.429 ' SD ' HG12 ' A' 1610 ' ' ILE . 37.1 ttm -143.52 127.72 17.64 Favored 'General case' 0 C--N 1.292 -1.929 0 C-N-CA 120.49 -0.484 . . . . 1.74 110.833 -175.615 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A 1551 ' ' SER . . . . . . . . . . . . . 41.0 p -99.52 115.76 30.08 Favored 'General case' 0 N--CA 1.418 -2.04 0 N-CA-C 108.047 -1.094 . . . . 1.6399999999999999 108.047 174.572 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A 1552 ' ' ILE . . . . . 0.614 HD13 ' CD1' ' A' 1538 ' ' PHE . 1.7 mp -75.53 -7.84 10.73 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.017 0 CA-C-O 122.474 1.131 . . . . 1.3300000000000001 110.586 179.228 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A 1553 ' ' CYS . . . . . . . . . . . . . 33.9 t -161.48 148.83 14.78 Favored 'General case' 0 N--CA 1.425 -1.691 0 N-CA-C 107.516 -1.29 . . . . 1.4299999999999999 107.516 177.56 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A 1554 ' ' GLY . . . . . . . . . . . . . . . 82.93 -120.15 5.07 Favored Glycine 0 C--N 1.318 -0.462 0 C-N-CA 121.227 -0.511 . . . . 1.1200000000000001 113.129 176.228 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A 1555 ' ' GLU . . . . . . . . . . . . . 9.3 pt-20 -145.81 145.51 30.81 Favored 'General case' 0 C--N 1.315 -0.91 0 C-N-CA 123.347 0.659 . . . . 1.8 110.812 -179.885 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A 1556 ' ' ASN . . . . . 0.576 ' HB3' HG23 ' A' 1563 ' ' VAL . 57.2 t30 -85.13 132.3 34.32 Favored 'General case' 0 C--N 1.295 -1.773 0 CA-C-N 114.644 -1.162 . . . . 2.6299999999999999 110.821 -175.183 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A 1557 ' ' GLU . . . . . 0.816 ' HG3' ' HD3' ' A' 1535 ' ' ARG . 33.2 mm-40 -98.48 177.87 5.2 Favored 'General case' 0 C--N 1.289 -2.044 0 CA-C-N 113.837 -1.529 . . . . 3.79 109.116 179.937 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A 1558 ' ' ASN . . . . . . . . . . . . . 37.8 m-80 75.53 5.71 4.03 Favored 'General case' 0 N--CA 1.504 2.258 0 C-N-CA 124.471 1.109 . . . . 1.52 111.119 -178.727 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A 1559 ' ' CYS . . . . . 0.447 ' SG ' ' HA ' ' A' 1571 ' ' ARG . 97.7 m -148.28 169.35 9.38 Favored Pre-proline 0 C--N 1.291 -1.938 0 N-CA-C 103.413 -2.81 . . . . 0.83999999999999997 103.413 176.34 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A 1560 ' ' PRO . . . . . 0.438 ' HD2' ' HB3' ' A' 1559 ' ' CYS . 9.4 Cg_endo -52.18 109.21 0.31 Allowed 'Trans proline' 0 C--N 1.359 1.115 0 C-N-CA 122.37 2.046 . . . . 1.1799999999999999 111.244 176.624 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A 1561 ' ' PRO . . . . . . . . . . . . . 75.4 Cg_exo -50.85 120.61 6.83 Favored 'Trans proline' 0 C--N 1.359 1.088 0 C-N-CA 123.884 3.056 . . . . 1.51 112.502 -175.523 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A 1562 ' ' GLY . . . . . . . . . . . . . . . 134.19 -6.04 4.66 Favored Glycine 0 N--CA 1.435 -1.433 0 CA-C-N 115.081 -0.963 . . . . 0.71999999999999997 110.987 -177.608 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A 1563 ' ' VAL . . . . . 0.576 HG23 ' HB3' ' A' 1556 ' ' ASN . 13.9 m -90.43 161.06 2.67 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.182 0 N-CA-C 105.937 -1.875 . . . . 0.96999999999999997 105.937 172.944 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A 1564 ' ' GLY . . . . . . . . . . . . . . . -112.18 -21.88 6.1 Favored Glycine 0 C--N 1.309 -0.923 0 C-N-CA 120.395 -0.907 . . . . 0.71999999999999997 111.964 -179.816 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A 1565 ' ' ALA . . . . . . . . . . . . . . . -150.13 127.63 11.52 Favored 'General case' 0 C--N 1.311 -1.081 0 N-CA-C 107.511 -1.292 . . . . 0.37 107.511 179.048 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A 1566 ' ' CYS . . . . . . . . . . . . . 34.2 t -155.75 141.57 18.06 Favored 'General case' 0 C--N 1.297 -1.681 0 N-CA-C 110.33 -0.248 . . . . 0.51000000000000001 110.33 -174.62 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A 1567 ' ' PHE . . . . . 0.515 ' HA ' ' HA ' ' A' 1548 ' ' VAL . 87.6 m-85 -71.2 121.69 18.84 Favored 'General case' 0 C--O 1.216 -0.662 0 N-CA-C 105.365 -2.087 . . . . 0.96999999999999997 105.365 171.678 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A 1568 ' ' GLY . . . . . 0.63 ' HA3' ' CD1' ' A' 1549 ' ' TYR . . . -83.21 -16.23 69.91 Favored Glycine 0 C--N 1.296 -1.672 0 C-N-CA 119.314 -1.422 . . . . 1.0800000000000001 114.009 -171.141 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A 1569 ' ' GLN . . . . . . . . . . . . . 4.1 pt20 -82.31 -21.71 35.97 Favored 'General case' 0 C--N 1.301 -1.521 0 C-N-CA 120.565 -0.454 . . . . 2.7400000000000002 111.408 -178.164 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A 1570 ' ' THR . . . . . . . . . . . . . 9.7 p -121.54 -12.36 8.55 Favored 'General case' 0 C--O 1.239 0.505 0 N-CA-C 112.347 0.499 . . . . 1.96 112.347 178.303 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A 1571 ' ' ARG . . . . . 0.447 ' HA ' ' SG ' ' A' 1559 ' ' CYS . 96.4 mtt180 62.81 42.57 7.79 Favored 'General case' 0 CA--C 1.511 -0.552 0 C-N-CA 125.1 1.36 . . . . 3.9500000000000002 112.693 178.922 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A 1572 ' ' ILE . . . . . . . . . . . . . 25.2 mm -99.95 116.26 42.85 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.19 0 N-CA-C 108.139 -1.06 . . . . 1.3700000000000001 108.139 179.942 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A 1573 ' ' SER . . . . . . . . . . . . . 35.0 t -69.15 133.33 47.87 Favored 'General case' 0 C--N 1.306 -1.284 0 CA-C-N 115.311 -0.859 . . . . 1.0800000000000001 111.084 -176.402 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A 1574 ' ' VAL . . . . . . . . . . . . . 13.8 m -130.6 28.42 1.51 Allowed 'Isoleucine or valine' 0 C--N 1.315 -0.929 0 CA-C-O 122.205 1.002 . . . . 1.3 110.857 174.903 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A 1575 ' ' GLY . . . . . . . . . . . . . . . 163.04 126.97 0.85 Allowed Glycine 0 N--CA 1.421 -2.342 0 CA-C-N 113.835 -1.53 . . . . 0.51000000000000001 110.439 176.854 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A 1576 ' ' LYS . . . . . 0.479 ' HA ' ' HA ' ' A' 1563 ' ' VAL . 68.3 mttm -85.79 151.24 23.98 Favored 'General case' 0 C--N 1.31 -1.133 0 N-CA-C 108.781 -0.822 . . . . 2.8999999999999999 108.781 177.969 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A 1577 ' ' ALA . . . . . . . . . . . . . . . -74.34 91.84 2.23 Favored 'General case' 0 C--N 1.315 -0.928 0 CA-C-O 121.736 0.779 . . . . 0.82999999999999996 111.641 -175.48 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A 1578 ' ' ASN . . . . . . . . . . . . . 41.4 m-80 -117.22 115.18 24.8 Favored 'General case' 0 C--N 1.284 -2.243 0 N-CA-C 104.747 -2.316 . . . . 1.8500000000000001 104.747 171.724 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A 1579 ' ' LYS . . . . . . . . . . . . . 54.1 mtmt -77.29 90.41 3.75 Favored 'General case' 0 CA--C 1.493 -1.244 0 N-CA-C 108.654 -0.869 . . . . 1.8999999999999999 108.654 -177.037 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A 1580 ' ' ARG . . . . . . . . . . . . . 27.4 ttm180 -134.79 99.09 4.21 Favored 'General case' 0 N--CA 1.402 -2.861 0 CA-C-N 114.341 -1.3 . . . . 3.6299999999999999 108.869 -176.481 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A 1581 ' ' LEU . . . . . 0.477 ' HA ' ' HA ' ' A' 1590 ' ' LEU . 4.6 pp -103.61 168.03 9.41 Favored 'General case' 0 C--N 1.297 -1.7 0 C-N-CA 120.4 -0.52 . . . . 1.8700000000000001 110.189 177.518 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A 1582 ' ' ARG . . . . . 0.673 ' HB3' ' HB3' ' A' 1589 ' ' GLN . 61.5 ttt180 -135.21 125.5 26.36 Favored 'General case' 0 C--N 1.297 -1.688 0 C-N-CA 123.158 0.583 . . . . 3.9700000000000002 109.766 -174.046 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A 1583 ' ' TYR . . . . . . . . . . . . . 40.2 t80 -119.09 104.11 10.16 Favored 'General case' 0 C--N 1.308 -1.202 0 CA-C-N 116.256 -0.429 . . . . 1.4099999999999999 110.131 176.075 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A 1584 ' ' VAL . . . . . . . . . . . . . 12.5 p -148.62 142.82 18.85 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.953 0 N-CA-C 108.76 -0.83 . . . . 1.6899999999999999 108.76 178.981 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A 1585 ' ' ASP . . . . . . . . . . . . . 31.6 t70 49.65 38.7 15.71 Favored 'General case' 0 N--CA 1.501 2.092 0 CA-C-O 122.559 1.171 . . . . 2.0600000000000001 112.503 177.226 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A 1586 ' ' GLN . . . . . . . . . . . . . 97.5 mt-30 53.84 34.57 19.59 Favored 'General case' 0 C--O 1.241 0.638 0 CA-C-N 114.581 -1.191 . . . . 2.3300000000000001 113.151 -179.426 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A 1587 ' ' VAL . . . . . . . . . . . . . 7.1 p -135.08 117.5 22.13 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.386 0 CA-C-O 121.826 0.822 . . . . 0.78000000000000003 109.427 174.724 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A 1588 ' ' LEU . . . . . 0.812 HD11 HG21 ' A' 1518 ' ' VAL . 2.3 mm? -81.57 152.72 27.09 Favored 'General case' 0 C--N 1.297 -1.706 0 CA-C-N 114.784 -1.098 . . . . 1.4099999999999999 111.588 -178.167 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A 1589 ' ' GLN . . . . . 0.673 ' HB3' ' HB3' ' A' 1582 ' ' ARG . 35.3 tt0 -152.47 156.99 40.52 Favored 'General case' 0 C--N 1.294 -1.837 0 N-CA-C 107.493 -1.299 . . . . 1.24 107.493 -179.534 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A 1590 ' ' LEU . . . . . 0.477 ' HA ' ' HA ' ' A' 1581 ' ' LEU . 5.3 tt -147.83 143.35 27.39 Favored 'General case' 0 C--N 1.303 -1.448 0 N-CA-C 105.685 -1.968 . . . . 1.1499999999999999 105.685 175.06 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A 1591 ' ' VAL . . . . . 0.503 HG23 HG22 ' A' 1609 ' ' VAL . 11.5 p -130.93 135.26 60.42 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.178 0 N-CA-C 112.805 0.668 . . . . 1.51 112.805 -173.843 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A 1592 ' ' TYR . . . . . . . . . . . . . 63.3 m-85 -122.35 106.11 10.78 Favored 'General case' 0 C--N 1.315 -0.904 0 N-CA-C 107.857 -1.164 . . . . 1.0600000000000001 107.857 172.912 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A 1593 ' ' LYS . . . . . . . . . . . . . 20.0 pttp -104.37 178.4 4.57 Favored 'General case' 0 C--N 1.293 -1.854 0 CA-C-N 115.982 -0.553 . . . . 2.1800000000000002 112.07 -176.173 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A 1594 ' ' ASP . . . . . 0.576 ' HA ' ' CB ' ' A' 1605 ' ' SER . 55.8 m-20 49.05 47.83 21.44 Favored 'General case' 0 CA--C 1.514 -0.423 0 C-N-CA 126.101 1.76 . . . . 1.45 115.701 172.407 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A 1595 ' ' GLY . . . . . . . . . . . . . . . -78.66 -80.48 0.73 Allowed Glycine 0 N--CA 1.445 -0.724 0 C-N-CA 120.298 -0.953 . . . . 0.78000000000000003 111.226 177.758 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A 1596 ' ' SER . . . . . 0.446 ' HA ' ' HD3' ' A' 1597 ' ' PRO . 4.2 p -107.47 143.38 27.11 Favored Pre-proline 0 C--N 1.299 -1.618 0 N-CA-C 109.963 -0.384 . . . . 1.6799999999999999 109.963 177.588 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A 1597 ' ' PRO . . . . . 0.446 ' HD3' ' HA ' ' A' 1596 ' ' SER . 21.5 Cg_exo -67.24 130.13 21.95 Favored 'Trans proline' 0 N--CA 1.46 -0.475 0 C-N-CA 123.039 2.493 . . . . 1.1699999999999999 110.29 177.099 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A 1598 ' ' CYS . . . . . 0.43 ' HA ' ' HD3' ' A' 1599 ' ' PRO . 33.7 t -101.25 121.42 51.92 Favored Pre-proline 0 C--N 1.296 -1.736 0 N-CA-C 109.924 -0.398 . . . . 1.1899999999999999 109.924 -177.157 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A 1599 ' ' PRO . . . . . 0.43 ' HD3' ' HA ' ' A' 1598 ' ' CYS . 94.3 Cg_endo -98.34 22.4 0.29 Allowed 'Trans proline' 0 N--CA 1.449 -1.114 0 C-N-CA 123.127 2.551 . . . . 1.5900000000000001 112.097 178.344 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A 1600 ' ' SER . . . . . . . . . . . . . 17.9 m -79.61 -74.24 0.3 Allowed 'General case' 0 C--N 1.315 -0.931 0 CA-C-N 116.466 -0.333 . . . . 2.1200000000000001 111.788 -177.899 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A 1601 ' ' LYS . . . . . . . . . . . . . 23.2 tptm -98.13 -87.11 0.34 Allowed 'General case' 0 C--N 1.317 -0.822 0 C-N-CA 120.317 -0.553 . . . . 3.7400000000000002 110.42 -178.949 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A 1602 ' ' SER . . . . . . . . . . . . . 16.7 m -96.21 174.98 6.62 Favored 'General case' 0 C--N 1.298 -1.672 0 N-CA-C 107.942 -1.133 . . . . 3.79 107.942 178.718 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A 1603 ' ' GLY . . . . . . . . . . . . . . . -81.57 65.64 3.98 Favored Glycine 0 N--CA 1.439 -1.126 0 N-CA-C 110.382 -1.087 . . . . 2.0 110.382 178.025 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A 1604 ' ' LEU . . . . . . . . . . . . . 1.7 pt? -117.02 165.18 13.66 Favored 'General case' 0 C--N 1.296 -1.724 0 N-CA-C 108.025 -1.102 . . . . 1.48 108.025 -178.111 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A 1605 ' ' SER . . . . . 0.576 ' CB ' ' HA ' ' A' 1594 ' ' ASP . 19.3 m -92.31 178.49 5.83 Favored 'General case' 0 C--N 1.298 -1.641 0 CA-C-O 120.967 0.413 . . . . 1.51 110.389 179.616 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A 1606 ' ' TYR . . . . . 0.489 ' HA ' ' O ' ' A' 1634 ' ' CYS . 76.7 m-85 -95.91 133.74 39.73 Favored 'General case' 0 CA--C 1.468 -2.21 0 N-CA-C 104.658 -2.349 . . . . 1.1799999999999999 104.658 176.321 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A 1607 ' ' LYS . . . . . 0.411 ' HG3' HG23 ' A' 1635 ' ' THR . 10.3 ptpp? -128.36 153.95 46.5 Favored 'General case' 0 N--CA 1.403 -2.802 0 C-N-CA 118.452 -1.299 . . . . 1.6699999999999999 109.133 178.53 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A 1608 ' ' SER . . . . . . . . . . . . . 45.3 m -117.64 124.29 48.23 Favored 'General case' 0 C--N 1.296 -1.727 0 N-CA-C 109.784 -0.45 . . . . 1.0 109.784 178.063 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A 1609 ' ' VAL . . . . . 0.503 HG22 HG23 ' A' 1591 ' ' VAL . 78.4 t -114.65 124.48 71.35 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.868 0 N-CA-C 109.002 -0.74 . . . . 0.93000000000000005 109.002 178.956 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A 1610 ' ' ILE . . . . . 0.705 HG13 ' HB2' ' A' 1638 ' ' PHE . 3.2 mp -108.21 119.14 57.26 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.202 0 N-CA-C 109.166 -0.679 . . . . 0.78000000000000003 109.166 178.683 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A 1611 ' ' SER . . . . . 0.42 ' O ' ' HA ' ' A' 1639 ' ' SER . 8.6 t -96.35 118.37 32.75 Favored 'General case' 0 N--CA 1.412 -2.348 0 N-CA-C 107.732 -1.21 . . . . 1.29 107.732 178.558 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A 1612 ' ' PHE . . . . . 0.436 ' HE2' ' HB2' ' A' 1590 ' ' LEU . 92.8 m-85 -97.06 102.12 13.83 Favored 'General case' 0 N--CA 1.428 -1.556 0 N-CA-C 107.858 -1.164 . . . . 0.69999999999999996 107.858 178.664 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A 1613 ' ' VAL . . . . . . . . . . . . . 85.0 t -84.29 120.03 34.36 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.952 0 N-CA-C 107.51 -1.293 . . . . 0.75 107.51 179.911 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A 1614 ' ' CYS . . . . . 0.522 ' HB3' ' HB2' ' A' 1646 ' ' CYS . 56.8 m -75.06 91.61 2.56 Favored 'General case' 0 C--N 1.295 -1.795 0 CA-C-O 121.653 0.74 . . . . 1.3899999999999999 109.036 -178.334 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A 1615 ' ' ARG . . . . . 0.503 ' HE ' ' HA ' ' A' 1615 ' ' ARG . 0.0 OUTLIER -140.08 123.19 10.3 Favored Pre-proline 0 N--CA 1.414 -2.274 0 CA-C-N 115.748 -0.66 . . . . 3.75 109.893 178.358 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A 1616 ' ' PRO . . . . . . . . . . . . . 56.9 Cg_endo -73.04 68.53 3.98 Favored 'Trans proline' 0 CA--C 1.546 1.083 0 C-N-CA 122.261 1.974 . . . . 1.3200000000000001 110.82 173.908 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A 1617 ' ' GLU . . . . . . . . . . . . . 7.5 tp10 -130.2 16.43 5.58 Favored 'General case' 0 C--N 1.314 -0.978 0 N-CA-C 108.878 -0.786 . . . . 3.21 108.878 -177.933 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A 1618 ' ' ALA . . . . . . . . . . . . . . . -173.88 162.62 3.97 Favored 'General case' 0 CA--C 1.506 -0.733 0 N-CA-C 108.423 -0.955 . . . . 2.4399999999999999 108.423 -177.026 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A 1619 ' ' GLY . . . . . . . . . . . . . . . -113.13 -175.69 19.36 Favored Glycine 0 N--CA 1.44 -1.093 0 N-CA-C 111.685 -0.566 . . . . 3.2599999999999998 111.685 177.878 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A 1620 ' ' PRO . . . . . 0.41 ' HB3' HD11 ' A' 1644 ' ' LEU . 19.6 Cg_endo -59.61 -18.02 45.25 Favored 'Trans proline' 0 CA--C 1.546 1.105 0 C-N-CA 123.568 2.845 . . . . 5.9199999999999999 115.304 -178.122 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A 1621 ' ' THR . . . . . . . . . . . . . 4.5 t -77.09 -18.59 57.88 Favored 'General case' 0 C--O 1.247 0.939 0 C-N-CA 120.077 -0.649 . . . . 4.7599999999999998 109.958 179.274 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A 1622 ' ' ASN . . . . . 0.422 ' HB3' ' HE1' ' A' 1640 ' ' TRP . 7.6 t30 -73.06 172.23 11.42 Favored 'General case' 0 C--N 1.34 0.191 0 N-CA-C 107.944 -1.132 . . . . 2.9199999999999999 107.944 -179.238 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A 1623 ' ' ARG . . . . . 0.444 ' HA ' ' HD3' ' A' 1624 ' ' PRO . 32.9 ptt180 -155.32 156.48 31.05 Favored Pre-proline 0 C--N 1.305 -1.361 0 C-N-CA 119.752 -0.779 . . . . 3.6099999999999999 112.144 -169.786 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A 1624 ' ' PRO . . . . . 0.444 ' HD3' ' HA ' ' A' 1623 ' ' ARG . 12.0 Cg_exo -70.76 106.67 1.89 Allowed 'Trans proline' 0 C--N 1.356 0.964 0 C-N-CA 123.426 2.751 . . . . 2.3700000000000001 112.068 179.69 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A 1625 ' ' MET . . . . . . . . . . . . . 25.4 ptm -90.3 164.21 14.45 Favored 'General case' 0 C--N 1.303 -1.423 0 CA-C-N 115.698 -0.683 . . . . 2.1600000000000001 109.304 179.252 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A 1626 ' ' LEU . . . . . . . . . . . . . 41.2 tp -89.58 112.87 24.2 Favored 'General case' 0 C--N 1.303 -1.421 0 N-CA-C 108.69 -0.856 . . . . 1.3500000000000001 108.69 -178.944 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A 1627 ' ' ILE . . . . . . . . . . . . . 44.0 pt -94.43 -27.71 4.29 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.768 0 C-N-CA 120.585 -0.446 . . . . 1.21 111.662 -177.35 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A 1628 ' ' SER . . . . . . . . . . . . . 15.6 p -162.19 151.8 16.13 Favored 'General case' 0 N--CA 1.44 -0.969 0 N-CA-C 109.951 -0.388 . . . . 1.3999999999999999 109.951 -178.485 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A 1629 ' ' LEU . . . . . 0.87 ' HG ' ' HG ' ' A' 1636 ' ' LEU . 2.7 tt -138.82 117.43 12.17 Favored 'General case' 0 C--N 1.293 -1.857 0 N-CA-C 106.84 -1.541 . . . . 1.5600000000000001 106.84 -178.753 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A 1630 ' ' ASP . . . . . . . . . . . . . 12.6 t70 -94.72 103.38 15.29 Favored 'General case' 0 C--N 1.299 -1.621 0 N-CA-C 106.483 -1.673 . . . . 0.87 106.483 178.847 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A 1631 ' ' LYS . . . . . 0.602 ' HG2' HD22 ' A' 1629 ' ' LEU . 90.9 mttt -83.13 -5.35 59.08 Favored 'General case' 0 C--N 1.291 -1.946 0 CA-C-N 115.984 -0.553 . . . . 2.3500000000000001 111.662 -172.35 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A 1632 ' ' GLN . . . . . . . . . . . . . 1.9 mp0 -87.0 -46.15 10.1 Favored 'General case' 0 C--N 1.312 -1.055 0 N-CA-C 108.437 -0.949 . . . . 2.5499999999999998 108.437 -179.524 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A 1633 ' ' THR . . . . . . . . . . . . . 2.3 m -89.83 -2.93 58.33 Favored 'General case' 0 C--N 1.312 -1.022 0 CA-C-O 122.241 1.02 . . . . 1.24 108.769 178.01 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A 1634 ' ' CYS . . . . . 0.489 ' O ' ' HA ' ' A' 1606 ' ' TYR . 28.7 m 59.94 43.72 14.43 Favored 'General case' 0 C--O 1.219 -0.529 0 CA-C-N 114.263 -1.335 . . . . 0.89000000000000001 109.976 176.95 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A 1635 ' ' THR . . . . . 0.411 HG23 ' HG3' ' A' 1607 ' ' LYS . 16.7 m -120.15 127.68 52.72 Favored 'General case' 0 N--CA 1.428 -1.548 0 CA-C-N 115.228 -0.896 . . . . 0.75 110.847 -173.643 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A 1636 ' ' LEU . . . . . 0.87 ' HG ' ' HG ' ' A' 1629 ' ' LEU . 5.9 mp -101.05 132.43 46.48 Favored 'General case' 0 C--N 1.312 -1.059 0 N-CA-C 109.475 -0.565 . . . . 1.3300000000000001 109.475 177.346 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A 1637 ' ' PHE . . . . . . . . . . . . . 95.5 m-85 -113.4 107.86 16.42 Favored 'General case' 0 C--O 1.25 1.089 0 CA-C-O 121.26 0.552 . . . . 0.82999999999999996 111.122 -177.762 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A 1638 ' ' PHE . . . . . 0.705 ' HB2' HG13 ' A' 1610 ' ' ILE . 95.7 m-85 -101.01 154.55 18.61 Favored 'General case' 0 C--N 1.299 -1.587 0 N-CA-C 108.866 -0.79 . . . . 0.59999999999999998 108.866 178.944 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A 1639 ' ' SER . . . . . 0.42 ' HA ' ' O ' ' A' 1611 ' ' SER . 66.2 m -143.85 130.52 20.19 Favored 'General case' 0 C--N 1.296 -1.726 0 CA-C-O 120.992 0.425 . . . . 1.0800000000000001 111.682 178.892 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A 1640 ' ' TRP . . . . . 0.422 ' HE1' ' HB3' ' A' 1622 ' ' ASN . 12.2 t90 -124.71 105.95 9.7 Favored 'General case' 0 N--CA 1.434 -1.262 0 CA-C-N 115.488 -0.778 . . . . 0.80000000000000004 109.117 178.008 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A 1641 ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -76.16 100.32 4.98 Favored 'General case' 0 C--N 1.305 -1.346 0 CA-C-O 121.547 0.689 . . . . 2.54 109.479 175.309 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A 1642 ' ' THR . . . . . 0.422 ' O ' ' HA ' ' A' 1614 ' ' CYS . 14.9 t -142.08 139.01 17.37 Favored Pre-proline 0 C--N 1.291 -1.936 0 C-N-CA 120.016 -0.674 . . . . 1.1499999999999999 112.447 -173.493 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A 1643 ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -80.86 -0.32 10.52 Favored 'Trans proline' 0 N--CA 1.453 -0.893 0 C-N-CA 123.296 2.664 . . . . 0.80000000000000004 110.611 175.487 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A 1644 ' ' LEU . . . . . 0.41 HD11 ' HB3' ' A' 1620 ' ' PRO . 88.9 mt -77.04 -27.57 54.51 Favored 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 108.405 -0.961 . . . . 1.54 108.405 175.345 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A 1645 ' ' ALA . . . . . . . . . . . . . . . -71.11 -42.37 69.36 Favored 'General case' 0 N--CA 1.441 -0.887 0 CA-C-N 114.596 -1.184 . . . . 0.94999999999999996 110.022 -179.368 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A 1646 ' ' CYS . . . . . 0.522 ' HB2' ' HB3' ' A' 1614 ' ' CYS . 65.5 m -139.94 115.97 10.37 Favored 'General case' 0 C--O 1.244 0.808 0 N-CA-C 106.931 -1.507 . . . . 1.4099999999999999 106.931 173.656 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A 1647 ' ' GLU . . . . . 0.623 ' HB2' ' HE1' ' A' 1525 ' ' HIS . 35.8 mt-10 -90.69 114.05 59.97 Favored Pre-proline 0 C--N 1.309 -1.18 0 O-C-N 123.802 0.689 . . . . 2.9199999999999999 110.226 -174.882 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A 1648 ' ' PRO . . . . . . . . . . . . . 20.5 Cg_exo -66.69 101.74 0.57 Allowed 'Trans proline' 0 C--O 1.25 1.083 0 C-N-CA 122.748 2.298 . . . . 2.8199999999999998 112.218 178.973 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A 1649 ' ' GLU . . . . . . . . . . . . . 12.8 tp10 . . . . . 0 C--O 1.264 1.839 0 N-CA-C 107.371 -1.344 . . . . 5.0599999999999996 107.371 179.67 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A 1508 ' ' MET . . . . . . . . . . . . . 88.8 mtp . . . . . 0 CA--C 1.499 -1.003 0 N-CA-C 108.869 -0.789 . . . . 8.2699999999999996 108.869 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A 1509 ' ' LYS . . . . . . . . . . . . . 36.2 mtmm -82.02 117.33 22.14 Favored 'General case' 0 C--N 1.302 -1.498 0 N-CA-C 108.742 -0.836 . . . . 6.4800000000000004 108.742 178.054 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A 1510 ' ' SER . . . . . . . . . . . . . 1.7 p -88.62 -18.83 27.17 Favored 'General case' 0 N--CA 1.418 -2.052 0 CA-C-O 121.647 0.737 . . . . 4.2199999999999998 109.632 -176.945 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A 1511 ' ' ASN . . . . . 0.579 HD21 ' HA ' ' A' 1518 ' ' VAL . 20.6 m120 -86.88 15.74 5.57 Favored 'General case' 0 N--CA 1.437 -1.123 0 CA-C-N 115.417 -0.811 . . . . 3.0800000000000001 112.255 -177.257 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A 1512 ' ' GLU . . . . . . . . . . . . . 43.8 mt-10 -82.13 -16.77 48.74 Favored 'General case' 0 CA--C 1.521 -0.148 0 N-CA-C 107.063 -1.458 . . . . 4.46 107.063 169.337 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A 1513 ' ' HIS . . . . . . . . . . . . . 69.7 m80 -130.16 48.2 2.42 Favored 'General case' 0 C--N 1.315 -0.907 0 N-CA-C 105.26 -2.126 . . . . 5.5700000000000003 105.26 176.678 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A 1514 ' ' ASP . . . . . . . . . . . . . 35.6 t70 -45.53 -72.3 0.06 Allowed 'General case' 0 N--CA 1.476 0.862 0 CA-C-N 113.012 -1.904 . . . . 3.7000000000000002 113.264 -172.323 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A 1515 ' ' ASP . . . . . 0.441 ' HA ' ' HG3' ' A' 1579 ' ' LYS . 10.4 m-20 45.73 -94.19 0.02 OUTLIER 'General case' 0 N--CA 1.48 1.073 0 N-CA-C 114.274 1.212 . . . . 2.54 114.274 -179.189 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A 1516 ' ' CYS . . . . . 0.742 ' HA ' HD23 ' A' 1581 ' ' LEU . 57.0 m -135.79 40.75 2.74 Favored 'General case' 0 C--N 1.324 -0.536 0 C-N-CA 123.933 0.893 . . . . 1.25 111.37 -178.801 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A 1517 ' ' GLN . . . . . 0.497 ' HB2' HD21 ' A' 1526 ' ' LEU . 25.0 pt20 -139.09 124.19 18.96 Favored 'General case' 0 C--N 1.3 -1.571 0 N-CA-C 109.662 -0.496 . . . . 1.8799999999999999 109.662 176.131 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A 1518 ' ' VAL . . . . . 0.579 ' HA ' HD21 ' A' 1511 ' ' ASN . 7.5 p -124.78 128.94 73.64 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.849 0 CA-C-O 121.044 0.449 . . . . 1.73 110.324 -179.799 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A 1519 ' ' THR . . . . . 0.409 ' HA ' ' HA ' ' A' 1526 ' ' LEU . 50.3 m -100.7 126.33 47.22 Favored 'General case' 0 C--N 1.284 -2.274 0 N-CA-C 108.879 -0.786 . . . . 1.7 108.879 175.369 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A 1520 ' ' ASN . . . . . . . . . . . . . 38.1 t-20 -88.96 110.53 38.6 Favored Pre-proline 0 C--N 1.303 -1.434 0 N-CA-C 107.453 -1.314 . . . . 2.1200000000000001 107.453 176.942 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A 1521 ' ' PRO . . . . . . . . . . . . . 58.9 Cg_endo -70.4 -14.18 33.79 Favored 'Trans proline' 0 C--N 1.356 0.928 0 C-N-CA 122.585 2.19 . . . . 2.4700000000000002 113.19 -175.487 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A 1522 ' ' SER . . . . . . . . . . . . . 6.9 m -80.29 -17.01 53.35 Favored 'General case' 0 N--CA 1.43 -1.442 0 CA-C-N 116.281 -0.418 . . . . 2.5699999999999998 110.581 -178.795 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A 1523 ' ' THR . . . . . . . . . . . . . 10.1 t -131.51 -18.16 2.85 Favored 'General case' 0 CA--C 1.556 1.203 0 C-N-CA 120.312 -0.555 . . . . 2.1499999999999999 112.492 179.45 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A 1524 ' ' GLY . . . . . . . . . . . . . . . 80.38 16.66 75.57 Favored Glycine 0 C--N 1.338 0.683 0 C-N-CA 121.186 -0.53 . . . . 1.8899999999999999 111.93 179.471 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A 1525 ' ' HIS . . . . . . . . . . . . . 21.1 t-160 -102.06 134.71 44.86 Favored 'General case' 0 C--N 1.305 -1.343 0 N-CA-C 109.425 -0.583 . . . . 1.8999999999999999 109.425 -178.795 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A 1526 ' ' LEU . . . . . 0.497 HD21 ' HB2' ' A' 1517 ' ' GLN . 6.7 tt -102.73 138.11 40.06 Favored 'General case' 0 C--N 1.305 -1.357 0 N-CA-C 107.838 -1.171 . . . . 1.6100000000000001 107.838 178.651 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A 1527 ' ' PHE . . . . . 0.513 ' CE2' ' HA ' ' A' 1646 ' ' CYS . 57.9 m-85 -114.03 111.96 22.5 Favored 'General case' 0 C--N 1.299 -1.594 0 N-CA-C 107.71 -1.218 . . . . 1.4199999999999999 107.71 177.489 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A 1528 ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -102.06 139.0 38.27 Favored 'General case' 0 CA--C 1.471 -2.077 0 N-CA-C 108.514 -0.921 . . . . 2.1800000000000002 108.514 178.999 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A 1529 ' ' LEU . . . . . 0.609 ' HB2' ' HB3' ' A' 1516 ' ' CYS . 43.3 mt -111.73 2.82 17.38 Favored 'General case' 0 C--N 1.292 -1.908 0 N-CA-C 107.756 -1.201 . . . . 1.4399999999999999 107.756 176.871 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A 1530 ' ' SER . . . . . . . . . . . . . 8.4 m -65.81 -45.02 83.87 Favored 'General case' 0 N--CA 1.441 -0.893 0 CA-C-N 114.895 -1.048 . . . . 1.4399999999999999 110.538 -177.708 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A 1531 ' ' SER . . . . . . . . . . . . . 37.6 m -77.12 -12.54 59.96 Favored 'General case' 0 C--O 1.24 0.565 0 CA-C-O 121.304 0.573 . . . . 1.5 110.296 177.533 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A 1532 ' ' LEU . . . . . 0.508 HD13 ' HA ' ' A' 1529 ' ' LEU . 8.5 mp -80.22 -31.28 38.62 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 116.033 -0.53 . . . . 1.77 112.362 -179.493 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A 1533 ' ' SER . . . . . 0.588 ' HB2' HG22 ' A' 1552 ' ' ILE . 19.2 t -85.7 173.28 10.22 Favored 'General case' 0 C--N 1.306 -1.32 0 CA-C-O 120.914 0.388 . . . . 2.3799999999999999 110.304 -178.439 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A 1534 ' ' GLY . . . . . . . . . . . . . . . -153.99 167.1 32.17 Favored Glycine 0 N--CA 1.429 -1.821 0 N-CA-C 109.549 -1.42 . . . . 1.55 109.549 -179.256 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A 1535 ' ' ARG . . . . . 0.491 ' CG ' ' HG3' ' A' 1557 ' ' GLU . 13.4 ttp180 -69.29 -47.75 63.66 Favored 'General case' 0 C--N 1.318 -0.789 0 CA-C-O 121.016 0.436 . . . . 3.96 111.132 -177.274 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A 1536 ' ' ALA . . . . . . . . . . . . . . . -77.45 -29.67 52.92 Favored 'General case' 0 C--O 1.245 0.823 0 CA-C-O 121.262 0.554 . . . . 1.6499999999999999 110.361 -179.409 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A 1537 ' ' GLY . . . . . . . . . . . . . . . 86.3 -164.58 36.71 Favored Glycine 0 N--CA 1.427 -1.962 0 CA-C-N 115.296 -0.865 . . . . 1.1899999999999999 112.377 175.574 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A 1538 ' ' PHE . . . . . 0.464 ' CD1' HD13 ' A' 1552 ' ' ILE . 84.2 m-85 -106.6 156.63 18.4 Favored 'General case' 0 C--N 1.293 -1.877 0 N-CA-C 108.081 -1.081 . . . . 1.6899999999999999 108.081 179.439 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A 1539 ' ' THR . . . . . . . . . . . . . 18.8 m -116.13 111.57 20.45 Favored 'General case' 0 C--N 1.291 -1.946 0 CA-C-O 121.51 0.671 . . . . 1.48 109.82 -176.879 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A 1540 ' ' ALA . . . . . . . . . . . . . . . -93.87 151.61 19.46 Favored 'General case' 0 C--N 1.3 -1.583 0 N-CA-C 109.314 -0.624 . . . . 0.82999999999999996 109.314 -179.743 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A 1541 ' ' ALA . . . . . . . . . . . . . . . -88.02 132.61 34.21 Favored 'General case' 0 C--N 1.305 -1.361 0 N-CA-C 109.45 -0.574 . . . . 1.27 109.45 -179.065 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A 1542 ' ' TYR . . . . . 0.505 ' HD2' ' HB2' ' A' 1545 ' ' SER . 72.5 t80 -139.96 164.51 29.8 Favored 'General case' 0 N--CA 1.437 -1.094 0 C-N-CA 120.628 -0.429 . . . . 2.1499999999999999 111.143 -177.426 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A 1543 ' ' SER . . . . . . . . . . . . . 5.6 m -47.47 -151.14 0.0 OUTLIER 'General case' 0 CA--C 1.573 1.833 0 C-N-CA 129.106 2.962 . . . . 2.29 113.619 175.154 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A 1544 ' ' LYS . . . . . . . . . . . . . 18.5 ptpt -39.69 -26.42 0.03 OUTLIER 'General case' 0 CA--C 1.574 1.882 0 N-CA-C 115.004 1.483 . . . . 3.9100000000000001 115.004 178.604 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A 1545 ' ' SER . . . . . 0.505 ' HB2' ' HD2' ' A' 1542 ' ' TYR . 8.4 m -79.12 -8.09 58.7 Favored 'General case' 0 CA--C 1.566 1.591 0 O-C-N 121.501 -0.749 . . . . 3.2999999999999998 111.775 178.717 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A 1546 ' ' GLY . . . . . . . . . . . . . . . 86.09 -80.35 1.79 Allowed Glycine 0 C--N 1.339 0.706 0 C-N-CA 121.488 -0.387 . . . . 1.24 113.991 174.108 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A 1547 ' ' VAL . . . . . . . . . . . . . 8.2 m -141.53 157.96 21.59 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.694 0 C-N-CA 122.99 0.516 . . . . 1.6299999999999999 110.031 -176.987 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A 1548 ' ' VAL . . . . . 0.417 HG13 ' HD1' ' A' 1567 ' ' PHE . 1.3 t -122.79 137.69 55.43 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.37 0 N-CA-C 107.895 -1.15 . . . . 0.92000000000000004 107.895 -178.922 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A 1549 ' ' TYR . . . . . . . . . . . . . 71.3 m-85 -96.02 118.64 33.02 Favored 'General case' 0 C--N 1.306 -1.298 0 N-CA-C 108.771 -0.826 . . . . 1.4399999999999999 108.771 175.263 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A 1550 ' ' MET . . . . . . . . . . . . . 74.0 mmm -118.55 121.74 40.97 Favored 'General case' 0 C--N 1.3 -1.549 0 CA-C-N 115.286 -0.87 . . . . 1.74 109.8 -173.412 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A 1551 ' ' SER . . . . . . . . . . . . . 75.5 m -106.58 114.63 28.85 Favored 'General case' 0 C--N 1.296 -1.759 0 N-CA-C 108.672 -0.862 . . . . 1.6399999999999999 108.672 174.127 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A 1552 ' ' ILE . . . . . 0.588 HG22 ' HB2' ' A' 1533 ' ' SER . 1.5 mp -57.46 -34.02 45.63 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.873 0 CA-C-N 114.957 -1.02 . . . . 1.3300000000000001 113.261 -176.576 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A 1553 ' ' CYS . . . . . 0.559 ' HB3' ' HE3' ' A' 1579 ' ' LYS . 73.6 m -140.68 137.98 33.94 Favored 'General case' 0 C--N 1.304 -1.396 0 N-CA-C 108.978 -0.749 . . . . 1.4299999999999999 108.978 174.977 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A 1554 ' ' GLY . . . . . . . . . . . . . . . 94.89 -125.52 8.37 Favored Glycine 0 N--CA 1.433 -1.547 0 C-N-CA 120.937 -0.649 . . . . 1.1200000000000001 114.043 172.252 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A 1555 ' ' GLU . . . . . . . . . . . . . 7.5 pt-20 -138.45 150.74 46.77 Favored 'General case' 0 C--N 1.31 -1.12 0 C-N-CA 123.432 0.693 . . . . 1.8 111.175 -175.464 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A 1556 ' ' ASN . . . . . . . . . . . . . 17.5 t-20 -101.23 138.96 37.57 Favored 'General case' 0 N--CA 1.433 -1.301 0 CA-C-N 115.503 -0.771 . . . . 2.6299999999999999 108.944 -177.194 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A 1557 ' ' GLU . . . . . 0.491 ' HG3' ' CG ' ' A' 1535 ' ' ARG . 54.7 mm-40 -99.77 -0.42 39.96 Favored 'General case' 0 C--N 1.298 -1.645 0 N-CA-C 113.088 0.773 . . . . 3.79 113.088 -172.528 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A 1558 ' ' ASN . . . . . . . . . . . . . 33.5 m-80 -87.66 -1.82 58.2 Favored 'General case' 0 N--CA 1.483 1.187 0 CA-C-O 122.09 0.948 . . . . 1.52 110.144 -176.812 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A 1559 ' ' CYS . . . . . 0.782 ' HB3' ' HD2' ' A' 1560 ' ' PRO . 94.0 m -142.21 -175.95 0.52 Allowed Pre-proline 0 C--N 1.288 -2.066 0 N-CA-C 104.821 -2.289 . . . . 0.83999999999999997 104.821 177.27 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A 1560 ' ' PRO . . . . . 0.782 ' HD2' ' HB3' ' A' 1559 ' ' CYS . 1.0 OUTLIER -45.72 124.16 6.64 Favored 'Trans proline' 0 C--N 1.364 1.374 0 C-N-CA 122.556 2.171 . . . . 1.1799999999999999 112.882 175.677 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A 1561 ' ' PRO . . . . . 0.44 ' HD3' ' HA ' ' A' 1560 ' ' PRO . 33.5 Cg_exo -62.66 103.33 0.32 Allowed 'Trans proline' 0 C--O 1.242 0.688 0 C-N-CA 122.913 2.408 . . . . 1.51 110.688 179.053 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A 1562 ' ' GLY . . . . . . . . . . . . . . . 146.85 -9.46 1.35 Allowed Glycine 0 N--CA 1.423 -2.197 0 CA-C-N 115.103 -0.953 . . . . 0.71999999999999997 110.805 -177.206 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A 1563 ' ' VAL . . . . . . . . . . . . . 3.6 m -98.29 150.82 4.67 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.345 0 N-CA-C 106.646 -1.613 . . . . 0.96999999999999997 106.646 174.174 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A 1564 ' ' GLY . . . . . . . . . . . . . . . -103.21 -21.75 9.77 Favored Glycine 0 C--N 1.306 -1.089 0 C-N-CA 120.179 -1.01 . . . . 0.71999999999999997 112.286 -176.483 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A 1565 ' ' ALA . . . . . . . . . . . . . . . -148.34 132.38 17.23 Favored 'General case' 0 C--N 1.31 -1.113 0 N-CA-C 109.063 -0.717 . . . . 0.37 109.063 -179.283 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A 1566 ' ' CYS . . . . . . . . . . . . . 35.9 t -153.5 138.95 17.66 Favored 'General case' 0 C--N 1.309 -1.158 0 CA-C-N 116.69 -0.232 . . . . 0.51000000000000001 110.818 -173.821 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A 1567 ' ' PHE . . . . . 0.417 ' HD1' HG13 ' A' 1548 ' ' VAL . 21.0 m-85 -68.73 123.34 20.65 Favored 'General case' 0 CA--C 1.514 -0.436 0 N-CA-C 108.2 -1.037 . . . . 0.96999999999999997 108.2 175.489 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A 1568 ' ' GLY . . . . . . . . . . . . . . . -55.06 -64.36 4.43 Favored Glycine 0 C--N 1.31 -0.908 0 N-CA-C 116.861 1.505 . . . . 1.0800000000000001 116.861 -167.76 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A 1569 ' ' GLN . . . . . . . . . . . . . 13.7 pt20 -85.15 -23.58 28.33 Favored 'General case' 0 C--N 1.312 -1.064 0 N-CA-C 113.208 0.818 . . . . 2.7400000000000002 113.208 -172.057 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A 1570 ' ' THR . . . . . . . . . . . . . 19.7 p -88.32 -17.56 30.37 Favored 'General case' 0 C--N 1.308 -1.222 0 CA-C-O 121.719 0.771 . . . . 1.96 111.191 -179.625 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A 1571 ' ' ARG . . . . . . . . . . . . . 67.9 mtm180 59.12 47.75 11.45 Favored 'General case' 0 CA--C 1.508 -0.67 0 C-N-CA 125.817 1.647 . . . . 3.9500000000000002 112.253 175.272 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A 1572 ' ' ILE . . . . . . . . . . . . . 32.7 mm -112.0 120.28 61.98 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.26 0 N-CA-C 108.062 -1.088 . . . . 1.3700000000000001 108.062 179.434 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A 1573 ' ' SER . . . . . . . . . . . . . 60.4 p -73.63 127.45 32.8 Favored 'General case' 0 C--N 1.309 -1.195 0 CA-C-N 115.857 -0.611 . . . . 1.0800000000000001 111.092 -177.06 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A 1574 ' ' VAL . . . . . 0.479 ' HA ' ' HB2' ' A' 1606 ' ' TYR . 23.5 m -118.22 15.05 7.19 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.307 0 CA-C-O 121.936 0.874 . . . . 1.3 110.782 -179.339 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A 1575 ' ' GLY . . . . . . . . . . . . . . . -179.29 125.28 0.96 Allowed Glycine 0 N--CA 1.429 -1.775 0 CA-C-N 114.466 -1.243 . . . . 0.51000000000000001 110.54 176.531 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A 1576 ' ' LYS . . . . . . . . . . . . . 55.2 tptt -85.68 156.4 20.68 Favored 'General case' 0 C--N 1.313 -0.981 0 N-CA-C 106.423 -1.695 . . . . 2.8999999999999999 106.423 177.955 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A 1577 ' ' ALA . . . . . 0.442 ' C ' HD22 ' A' 1578 ' ' ASN . . . -55.88 115.28 2.29 Favored 'General case' 0 N--CA 1.468 0.465 0 CA-C-O 121.447 0.641 . . . . 0.82999999999999996 110.586 179.738 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A 1578 ' ' ASN . . . . . 0.442 HD22 ' C ' ' A' 1577 ' ' ALA . 1.1 m-80 -125.11 169.72 11.91 Favored 'General case' 0 C--N 1.283 -2.285 0 N-CA-C 106.061 -1.829 . . . . 1.8500000000000001 106.061 178.265 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A 1579 ' ' LYS . . . . . 0.559 ' HE3' ' HB3' ' A' 1553 ' ' CYS . 17.9 tptm -163.87 89.99 0.59 Allowed 'General case' 0 C--N 1.306 -1.283 0 C-N-CA 119.88 -0.728 . . . . 1.8999999999999999 109.418 -176.956 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A 1580 ' ' ARG . . . . . . . . . . . . . 52.0 ttp180 -149.43 106.83 3.62 Favored 'General case' 0 C--N 1.297 -1.691 0 N-CA-C 108.811 -0.811 . . . . 3.6299999999999999 108.811 -178.881 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A 1581 ' ' LEU . . . . . 0.742 HD23 ' HA ' ' A' 1516 ' ' CYS . 0.8 OUTLIER -73.17 133.26 44.0 Favored 'General case' 0 C--N 1.311 -1.098 0 N-CA-C 107.714 -1.217 . . . . 1.8700000000000001 107.714 -179.494 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A 1582 ' ' ARG . . . . . . . . . . . . . 61.5 ttt180 -132.14 108.32 9.2 Favored 'General case' 0 C--N 1.303 -1.417 0 N-CA-C 109.876 -0.416 . . . . 3.9700000000000002 109.876 178.634 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A 1583 ' ' TYR . . . . . . . . . . . . . 49.2 t80 -101.33 92.95 5.17 Favored 'General case' 0 C--N 1.307 -1.24 0 N-CA-C 108.896 -0.779 . . . . 1.4099999999999999 108.896 177.676 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A 1584 ' ' VAL . . . . . . . . . . . . . 15.4 m -123.7 111.12 27.86 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.77 0 N-CA-C 113.14 0.793 . . . . 1.6899999999999999 113.14 -176.113 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A 1585 ' ' ASP . . . . . . . . . . . . . 36.5 t70 56.33 53.62 8.59 Favored 'General case' 0 N--CA 1.478 0.973 0 CA-C-O 122.463 1.125 . . . . 2.0600000000000001 111.194 176.041 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A 1586 ' ' GLN . . . . . . . . . . . . . 18.4 mp0 64.63 -1.63 0.76 Allowed 'General case' 0 C--N 1.324 -0.512 0 C-N-CA 125.743 1.617 . . . . 2.3300000000000001 115.088 178.734 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A 1587 ' ' VAL . . . . . . . . . . . . . 12.7 p -107.84 120.94 60.07 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.887 0 CA-C-O 121.973 0.892 . . . . 0.78000000000000003 109.459 175.978 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A 1588 ' ' LEU . . . . . 0.822 ' HB2' ' HB2' ' A' 1612 ' ' PHE . 2.5 mm? -79.2 137.99 37.65 Favored 'General case' 0 C--N 1.29 -1.983 0 CA-C-N 114.339 -1.3 . . . . 1.4099999999999999 108.357 179.053 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A 1589 ' ' GLN . . . . . 0.437 ' HA ' ' O ' ' A' 1610 ' ' ILE . 6.0 tt0 -140.43 141.08 35.52 Favored 'General case' 0 C--N 1.286 -2.175 0 CA-C-O 120.75 0.309 . . . . 1.24 111.254 -178.017 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A 1590 ' ' LEU . . . . . . . . . . . . . 7.0 tt -142.48 124.59 15.37 Favored 'General case' 0 C--N 1.305 -1.359 0 N-CA-C 105.957 -1.868 . . . . 1.1499999999999999 105.957 175.633 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A 1591 ' ' VAL . . . . . . . . . . . . . 46.4 t -112.48 129.7 67.56 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.067 0 O-C-N 122.381 -0.199 . . . . 1.51 111.508 -175.379 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A 1592 ' ' TYR . . . . . . . . . . . . . 79.4 m-85 -105.3 106.67 17.28 Favored 'General case' 0 C--N 1.313 -0.992 0 N-CA-C 108.8 -0.815 . . . . 1.0600000000000001 108.8 174.647 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A 1593 ' ' LYS . . . . . . . . . . . . . 8.1 ptpp? -108.67 -178.99 3.74 Favored 'General case' 0 C--N 1.311 -1.066 0 C-N-CA 120.31 -0.556 . . . . 2.1800000000000002 112.119 -179.067 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A 1594 ' ' ASP . . . . . . . . . . . . . 5.0 m-20 54.13 44.88 28.54 Favored 'General case' 0 N--CA 1.487 1.376 0 C-N-CA 124.798 1.239 . . . . 1.45 113.831 177.67 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A 1595 ' ' GLY . . . . . . . . . . . . . . . -73.2 -90.54 0.13 Allowed Glycine 0 N--CA 1.445 -0.72 0 C-N-CA 120.45 -0.881 . . . . 0.78000000000000003 111.522 177.176 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A 1596 ' ' SER . . . . . . . . . . . . . 33.7 t -114.49 149.46 42.23 Favored Pre-proline 0 C--N 1.297 -1.691 0 N-CA-C 107.101 -1.444 . . . . 1.6799999999999999 107.101 176.977 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A 1597 ' ' PRO . . . . . . . . . . . . . 33.7 Cg_exo -64.95 133.55 36.39 Favored 'Trans proline' 0 C--N 1.347 0.493 0 C-N-CA 123.074 2.516 . . . . 1.1699999999999999 110.911 176.999 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A 1598 ' ' CYS . . . . . 0.439 ' HA ' ' HD3' ' A' 1599 ' ' PRO . 37.6 t -95.65 126.89 43.62 Favored Pre-proline 0 C--N 1.3 -1.553 0 N-CA-C 108.12 -1.067 . . . . 1.1899999999999999 108.12 -179.13 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A 1599 ' ' PRO . . . . . 0.439 ' HD3' ' HA ' ' A' 1598 ' ' CYS . 25.6 Cg_exo -65.61 -25.52 54.59 Favored 'Trans proline' 0 C--N 1.353 0.784 0 C-N-CA 123.472 2.781 . . . . 1.5900000000000001 112.113 -178.476 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A 1600 ' ' SER . . . . . . . . . . . . . 23.0 m -86.17 123.51 31.53 Favored 'General case' 0 N--CA 1.421 -1.883 0 N-CA-C 108.367 -0.975 . . . . 2.1200000000000001 108.367 177.338 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A 1601 ' ' LYS . . . . . 0.845 ' HB3' HD12 ' A' 1604 ' ' LEU . 4.3 tmtm? 68.49 81.58 0.18 Allowed 'General case' 0 C--O 1.239 0.523 0 N-CA-C 107.747 -1.205 . . . . 3.7400000000000002 107.747 -179.678 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A 1602 ' ' SER . . . . . . . . . . . . . 20.9 m -50.82 111.45 0.55 Allowed 'General case' 0 N--CA 1.441 -0.915 0 CA-C-N 114.025 -1.443 . . . . 3.79 112.651 -176.695 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A 1603 ' ' GLY . . . . . . . . . . . . . . . 128.78 -19.04 5.59 Favored Glycine 0 N--CA 1.433 -1.524 0 CA-C-N 114.747 -1.115 . . . . 2.0 110.315 -177.929 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A 1604 ' ' LEU . . . . . 0.845 HD12 ' HB3' ' A' 1601 ' ' LYS . 12.6 mt -74.91 159.35 31.95 Favored 'General case' 0 CA--C 1.506 -0.732 0 CA-C-O 122.69 1.233 . . . . 1.48 114.291 -179.99 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A 1605 ' ' SER . . . . . . . . . . . . . 16.6 m -137.19 175.8 9.29 Favored 'General case' 0 C--N 1.288 -2.077 0 N-CA-C 104.897 -2.26 . . . . 1.51 104.897 177.217 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A 1606 ' ' TYR . . . . . 0.479 ' HB2' ' HA ' ' A' 1574 ' ' VAL . 56.9 m-85 -102.54 134.58 45.64 Favored 'General case' 0 CA--C 1.462 -2.406 0 N-CA-C 105.249 -2.13 . . . . 1.1799999999999999 105.249 -179.292 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A 1607 ' ' LYS . . . . . 0.515 ' HG3' HG23 ' A' 1635 ' ' THR . 26.6 pttm -131.18 142.79 50.25 Favored 'General case' 0 N--CA 1.401 -2.889 0 C-N-CA 119.338 -0.945 . . . . 1.6699999999999999 108.9 177.8 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A 1608 ' ' SER . . . . . . . . . . . . . 44.3 m -114.59 118.76 34.62 Favored 'General case' 0 C--N 1.295 -1.796 0 CA-C-O 120.666 0.27 . . . . 1.0 110.96 -178.849 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A 1609 ' ' VAL . . . . . . . . . . . . . 69.3 t -94.62 115.6 33.85 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.76 0 N-CA-C 108.782 -0.822 . . . . 0.93000000000000005 108.782 176.851 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A 1610 ' ' ILE . . . . . 0.437 ' O ' ' HA ' ' A' 1589 ' ' GLN . 17.6 mm -98.66 112.19 30.15 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.191 0 N-CA-C 108.77 -0.826 . . . . 0.78000000000000003 108.77 179.189 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A 1611 ' ' SER . . . . . 0.504 ' O ' ' HA ' ' A' 1639 ' ' SER . 36.5 m -101.05 128.62 47.01 Favored 'General case' 0 C--N 1.304 -1.375 0 N-CA-C 109.518 -0.549 . . . . 1.29 109.518 177.005 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A 1612 ' ' PHE . . . . . 0.822 ' HB2' ' HB2' ' A' 1588 ' ' LEU . 97.9 m-85 -100.88 115.37 30.24 Favored 'General case' 0 C--N 1.292 -1.894 0 CA-C-O 121.003 0.43 . . . . 0.69999999999999996 110.494 -179.429 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A 1613 ' ' VAL . . . . . . . . . . . . . 58.9 t -100.01 111.54 29.95 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.161 0 N-CA-C 108.486 -0.931 . . . . 0.75 108.486 -178.613 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A 1614 ' ' CYS . . . . . 0.498 ' HA ' ' O ' ' A' 1642 ' ' THR . 3.0 p -85.57 94.22 8.99 Favored 'General case' 0 C--N 1.301 -1.535 0 CA-C-O 121.715 0.769 . . . . 1.3899999999999999 112.999 -178.605 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A 1615 ' ' ARG . . . . . 0.516 ' HD3' ' HD2' ' A' 1616 ' ' PRO . 19.7 tpp180 -138.2 113.48 8.89 Favored Pre-proline 0 N--CA 1.428 -1.539 0 CA-C-N 115.37 -0.832 . . . . 3.75 109.93 177.318 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A 1616 ' ' PRO . . . . . 0.516 ' HD2' ' HD3' ' A' 1615 ' ' ARG . 57.8 Cg_endo -71.34 53.69 1.72 Allowed 'Trans proline' 0 CA--C 1.548 1.223 0 C-N-CA 123.414 2.742 . . . . 1.3200000000000001 112.495 176.488 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A 1617 ' ' GLU . . . . . . . . . . . . . 30.6 tt0 -124.75 2.13 8.17 Favored 'General case' 0 C--N 1.306 -1.312 0 N-CA-C 106.29 -1.744 . . . . 3.21 106.29 176.624 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A 1618 ' ' ALA . . . . . . . . . . . . . . . -148.16 165.67 30.19 Favored 'General case' 0 N--CA 1.427 -1.594 0 N-CA-C 106.192 -1.781 . . . . 2.4399999999999999 106.192 -177.92 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A 1619 ' ' GLY . . . . . . . . . . . . . . . -134.26 -160.0 9.06 Favored Glycine 0 C--N 1.302 -1.308 0 N-CA-C 110.744 -0.942 . . . . 3.2599999999999998 110.744 178.971 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A 1620 ' ' PRO . . . . . 0.431 ' HA ' ' HZ2' ' A' 1640 ' ' TRP . 22.7 Cg_exo -68.15 -4.29 12.36 Favored 'Trans proline' 0 CA--C 1.54 0.8 0 C-N-CA 123.078 2.519 . . . . 5.9199999999999999 112.51 178.817 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A 1621 ' ' THR . . . . . . . . . . . . . 15.6 m -86.07 -12.47 50.03 Favored 'General case' 0 CA--C 1.552 1.03 0 CA-C-O 121.458 0.646 . . . . 4.7599999999999998 109.326 178.212 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A 1622 ' ' ASN . . . . . . . . . . . . . 28.1 t-20 -70.14 151.04 45.88 Favored 'General case' 0 C--O 1.242 0.665 0 N-CA-C 107.872 -1.158 . . . . 2.9199999999999999 107.872 175.445 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A 1623 ' ' ARG . . . . . . . . . . . . . 5.7 ptm180 -121.82 146.69 46.56 Favored Pre-proline 0 C--N 1.281 -2.385 0 N-CA-C 109.083 -0.71 . . . . 3.6099999999999999 109.083 -177.228 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A 1624 ' ' PRO . . . . . . . . . . . . . 11.0 Cg_endo -55.25 117.52 4.12 Favored 'Trans proline' 0 C--N 1.348 0.551 0 C-N-CA 123.192 2.595 . . . . 2.3700000000000001 111.621 178.536 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A 1625 ' ' MET . . . . . . . . . . . . . 26.5 ptm -96.79 143.16 27.98 Favored 'General case' 0 C--N 1.296 -1.748 0 CA-C-N 115.49 -0.777 . . . . 2.1600000000000001 109.603 -178.573 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A 1626 ' ' LEU . . . . . . . . . . . . . 38.5 tp -80.48 123.07 27.76 Favored 'General case' 0 C--N 1.303 -1.425 0 N-CA-C 107.396 -1.335 . . . . 1.3500000000000001 107.396 176.192 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A 1627 ' ' ILE . . . . . . . . . . . . . 41.4 pt -100.98 -32.43 3.42 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.548 0 C-N-CA 120.252 -0.579 . . . . 1.21 111.116 -179.907 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A 1628 ' ' SER . . . . . . . . . . . . . 20.4 m -152.64 148.71 27.63 Favored 'General case' 0 C--N 1.318 -0.802 0 N-CA-C 109.696 -0.483 . . . . 1.3999999999999999 109.696 -178.099 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A 1629 ' ' LEU . . . . . . . . . . . . . 25.8 tp -136.1 99.65 4.19 Favored 'General case' 0 C--N 1.304 -1.407 0 N-CA-C 109.132 -0.692 . . . . 1.5600000000000001 109.132 178.581 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A 1630 ' ' ASP . . . . . . . . . . . . . 11.8 t70 -90.95 107.85 19.47 Favored 'General case' 0 C--N 1.305 -1.331 0 N-CA-C 108.628 -0.879 . . . . 0.87 108.628 -178.1 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A 1631 ' ' LYS . . . . . . . . . . . . . 68.2 mttm -81.44 -15.15 55.96 Favored 'General case' 0 C--N 1.304 -1.381 0 N-CA-C 112.386 0.513 . . . . 2.3500000000000001 112.386 -175.448 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A 1632 ' ' GLN . . . . . . . . . . . . . 1.5 mp0 -84.98 -40.74 16.57 Favored 'General case' 0 C--N 1.313 -1.005 0 CA-C-O 120.937 0.399 . . . . 2.5499999999999998 110.58 -178.771 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A 1633 ' ' THR . . . . . . . . . . . . . 2.7 m -95.95 -4.15 43.88 Favored 'General case' 0 C--N 1.301 -1.511 0 CA-C-O 121.55 0.691 . . . . 1.24 110.278 -178.873 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A 1634 ' ' CYS . . . . . . . . . . . . . 56.6 m 59.47 41.41 19.35 Favored 'General case' 0 C--N 1.35 0.59 0 C-N-CA 124.105 0.962 . . . . 0.89000000000000001 110.081 176.923 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A 1635 ' ' THR . . . . . 0.515 HG23 ' HG3' ' A' 1607 ' ' LYS . 33.4 m -112.83 132.61 55.2 Favored 'General case' 0 N--CA 1.431 -1.408 0 CA-C-N 115.179 -0.919 . . . . 0.75 111.467 -174.223 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A 1636 ' ' LEU . . . . . 0.415 ' HB3' ' CE2' ' A' 1638 ' ' PHE . 2.4 mm? -100.95 127.71 47.32 Favored 'General case' 0 C--N 1.316 -0.877 0 N-CA-C 108.561 -0.904 . . . . 1.3300000000000001 108.561 -179.489 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A 1637 ' ' PHE . . . . . . . . . . . . . 97.6 m-85 -115.94 111.28 20.17 Favored 'General case' 0 C--N 1.305 -1.34 0 N-CA-C 109.931 -0.396 . . . . 0.82999999999999996 109.931 179.38 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A 1638 ' ' PHE . . . . . 0.415 ' CE2' ' HB3' ' A' 1636 ' ' LEU . 87.8 m-85 -118.81 154.42 32.89 Favored 'General case' 0 C--N 1.309 -1.16 0 CA-C-O 121.191 0.52 . . . . 0.59999999999999998 110.703 -179.094 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A 1639 ' ' SER . . . . . 0.504 ' HA ' ' O ' ' A' 1611 ' ' SER . 46.8 m -141.51 136.91 31.66 Favored 'General case' 0 C--N 1.294 -1.841 0 CA-C-N 116.171 -0.468 . . . . 1.0800000000000001 110.46 176.827 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A 1640 ' ' TRP . . . . . 0.431 ' HZ2' ' HA ' ' A' 1620 ' ' PRO . 22.0 t90 -113.32 132.27 55.63 Favored 'General case' 0 C--N 1.298 -1.635 0 N-CA-C 107.924 -1.139 . . . . 0.80000000000000004 107.924 178.066 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A 1641 ' ' HIS . . . . . . . . . . . . . 11.8 m170 -96.93 110.28 22.84 Favored 'General case' 0 CA--C 1.493 -1.22 0 N-CA-C 107.129 -1.434 . . . . 2.54 107.129 179.424 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A 1642 ' ' THR . . . . . 0.708 HG23 ' HB2' ' A' 1645 ' ' ALA . 2.9 t -142.92 137.95 15.46 Favored Pre-proline 0 C--N 1.283 -2.309 0 CA-C-N 115.989 -0.551 . . . . 1.1499999999999999 111.69 -170.604 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A 1643 ' ' PRO . . . . . . . . . . . . . 95.8 Cg_endo -83.31 -0.39 9.86 Favored 'Trans proline' 0 CA--C 1.535 0.527 0 C-N-CA 123.35 2.7 . . . . 0.80000000000000004 111.655 178.455 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A 1644 ' ' LEU . . . . . . . . . . . . . 47.4 mt -98.33 1.64 47.24 Favored 'General case' 0 C--N 1.315 -0.894 0 CA-C-N 115.765 -0.652 . . . . 1.54 110.9 179.624 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A 1645 ' ' ALA . . . . . 0.708 ' HB2' HG23 ' A' 1642 ' ' THR . . . -91.8 -18.18 24.24 Favored 'General case' 0 C--N 1.301 -1.537 0 CA-C-N 115.756 -0.656 . . . . 0.94999999999999996 111.612 -176.274 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A 1646 ' ' CYS . . . . . 0.513 ' HA ' ' CE2' ' A' 1527 ' ' PHE . 72.0 m -154.25 174.26 15.03 Favored 'General case' 0 C--N 1.313 -0.991 0 N-CA-C 105.267 -2.123 . . . . 1.4099999999999999 105.267 175.452 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A 1647 ' ' GLU . . . . . 0.449 ' HA ' ' HD3' ' A' 1648 ' ' PRO . 0.5 OUTLIER -85.99 123.5 71.88 Favored Pre-proline 0 C--N 1.298 -1.658 0 N-CA-C 109.526 -0.546 . . . . 2.9199999999999999 109.526 175.819 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A 1648 ' ' PRO . . . . . 0.449 ' HD3' ' HA ' ' A' 1647 ' ' GLU . 39.0 Cg_exo -66.12 101.85 0.52 Allowed 'Trans proline' 0 C--O 1.243 0.753 0 C-N-CA 122.775 2.317 . . . . 2.8199999999999998 110.532 176.423 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A 1649 ' ' GLU . . . . . . . . . . . . . 42.4 mt-10 . . . . . 0 C--N 1.302 -1.486 0 N-CA-C 108.638 -0.875 . . . . 5.0599999999999996 108.638 -179.504 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A 1508 ' ' MET . . . . . 0.45 ' HA ' ' OD1' ' A' 1511 ' ' ASN . 43.5 tpp . . . . . 0 C--O 1.238 0.467 0 N-CA-C 108.362 -0.977 . . . . 8.2699999999999996 108.362 . . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A 1509 ' ' LYS . . . . . . . . . . . . . 61.7 tttm 79.37 -29.87 0.14 Allowed 'General case' 0 N--CA 1.484 1.242 0 C-N-CA 124.826 1.25 . . . . 6.4800000000000004 112.212 176.289 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A 1510 ' ' SER . . . . . . . . . . . . . 22.8 t -148.33 73.09 1.23 Allowed 'General case' 0 C--N 1.301 -1.528 0 N-CA-C 106.877 -1.527 . . . . 4.2199999999999998 106.877 176.303 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A 1511 ' ' ASN . . . . . 0.476 ' HA ' ' HB2' ' A' 1514 ' ' ASP . 4.3 p-10 -141.09 -28.39 0.68 Allowed 'General case' 0 C--N 1.302 -1.46 0 CA-C-N 115.269 -0.878 . . . . 3.0800000000000001 112.551 -177.4 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A 1512 ' ' GLU . . . . . 0.549 ' HG2' HG23 ' A' 1518 ' ' VAL . 50.6 mt-10 -55.56 -29.05 58.31 Favored 'General case' 0 N--CA 1.483 1.201 0 N-CA-C 113.903 1.075 . . . . 4.46 113.903 -173.608 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A 1513 ' ' HIS . . . . . . . . . . . . . 89.8 m-70 -129.52 6.6 5.24 Favored 'General case' 0 C--N 1.311 -1.109 0 CA-C-O 121.113 0.483 . . . . 5.5700000000000003 110.51 178.405 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A 1514 ' ' ASP . . . . . 0.476 ' HB2' ' HA ' ' A' 1511 ' ' ASN . 2.0 m-20 -89.22 -44.67 10.11 Favored 'General case' 0 C--N 1.31 -1.127 0 CA-C-N 115.709 -0.678 . . . . 3.7000000000000002 110.349 179.579 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A 1515 ' ' ASP . . . . . . . . . . . . . 8.8 m-20 -137.78 168.56 19.43 Favored 'General case' 0 C--N 1.307 -1.279 0 N-CA-C 108.447 -0.945 . . . . 2.54 108.447 -178.946 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A 1516 ' ' CYS . . . . . 0.542 ' HB3' ' HB2' ' A' 1529 ' ' LEU . 74.4 m -79.01 60.34 2.9 Favored 'General case' 0 C--N 1.306 -1.299 0 CA-C-O 120.981 0.42 . . . . 1.25 112.069 -176.895 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A 1517 ' ' GLN . . . . . 0.533 ' HB2' HD21 ' A' 1526 ' ' LEU . 0.0 OUTLIER -157.29 122.6 4.58 Favored 'General case' 0 N--CA 1.437 -1.105 0 CA-C-O 121.618 0.723 . . . . 1.8799999999999999 111.885 177.754 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A 1518 ' ' VAL . . . . . 0.549 HG23 ' HG2' ' A' 1512 ' ' GLU . 10.6 p -129.6 142.32 44.22 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.683 0 CA-C-N 115.454 -0.794 . . . . 1.73 109.657 -177.736 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A 1519 ' ' THR . . . . . 0.571 ' HA ' ' HA ' ' A' 1526 ' ' LEU . 12.7 m -100.74 135.94 41.39 Favored 'General case' 0 C--N 1.3 -1.549 0 CA-C-O 120.67 0.271 . . . . 1.7 110.83 -178.025 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A 1520 ' ' ASN . . . . . 0.482 ' OD1' HG22 ' A' 1523 ' ' THR . 17.1 t-20 -86.61 113.8 54.67 Favored Pre-proline 0 C--N 1.308 -1.226 0 N-CA-C 106.915 -1.513 . . . . 2.1200000000000001 106.915 171.399 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A 1521 ' ' PRO . . . . . . . . . . . . . 51.9 Cg_endo -67.88 -21.52 43.91 Favored 'Trans proline' 0 C--O 1.234 0.276 0 C-N-CA 122.232 1.955 . . . . 2.4700000000000002 113.512 -174.164 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A 1522 ' ' SER . . . . . . . . . . . . . 13.1 m -68.48 -54.88 14.01 Favored 'General case' 0 N--CA 1.438 -1.047 0 C-N-CA 122.265 0.226 . . . . 2.5699999999999998 111.02 -178.715 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A 1523 ' ' THR . . . . . 0.52 HG21 ' HB2' ' A' 1647 ' ' GLU . 15.0 t -94.94 -15.74 23.36 Favored 'General case' 0 CA--C 1.554 1.11 0 CA-C-O 121.097 0.475 . . . . 2.1499999999999999 111.483 -177.949 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A 1524 ' ' GLY . . . . . . . . . . . . . . . 81.17 17.38 72.01 Favored Glycine 0 C--N 1.334 0.434 0 C-N-CA 121.139 -0.553 . . . . 1.8899999999999999 112.984 178.89 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A 1525 ' ' HIS . . . . . . . . . . . . . 18.4 t60 -101.25 137.48 39.54 Favored 'General case' 0 C--N 1.313 -0.982 0 N-CA-C 109.556 -0.535 . . . . 1.8999999999999999 109.556 -177.279 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A 1526 ' ' LEU . . . . . 0.571 ' HA ' ' HA ' ' A' 1519 ' ' THR . 6.1 tt -99.94 132.39 45.32 Favored 'General case' 0 C--N 1.3 -1.548 0 N-CA-C 109.36 -0.608 . . . . 1.6100000000000001 109.36 178.712 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A 1527 ' ' PHE . . . . . 0.446 ' O ' ' HA ' ' A' 1517 ' ' GLN . 28.4 m-85 -99.84 104.87 16.57 Favored 'General case' 0 C--N 1.299 -1.611 0 N-CA-C 108.781 -0.822 . . . . 1.4199999999999999 108.781 -178.952 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A 1528 ' ' ASP . . . . . 0.424 ' HA ' ' HB3' ' A' 1517 ' ' GLN . 35.6 t70 -95.01 124.66 39.18 Favored 'General case' 0 CA--C 1.495 -1.165 0 CA-C-O 121.473 0.654 . . . . 2.1800000000000002 111.753 -179.749 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A 1529 ' ' LEU . . . . . 0.542 ' HB2' ' HB3' ' A' 1516 ' ' CYS . 80.1 mt -109.76 -3.0 17.02 Favored 'General case' 0 C--N 1.296 -1.735 0 CA-C-N 114.285 -1.325 . . . . 1.4399999999999999 109.076 178.863 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A 1530 ' ' SER . . . . . . . . . . . . . 4.5 m -70.33 -38.8 74.95 Favored 'General case' 0 C--O 1.223 -0.315 0 CA-C-N 115.749 -0.66 . . . . 1.4399999999999999 109.597 -179.306 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A 1531 ' ' SER . . . . . . . . . . . . . 24.2 m -63.81 -26.26 68.55 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 121.665 0.745 . . . . 1.5 109.878 177.113 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A 1532 ' ' LEU . . . . . 0.559 HD13 ' CZ3' ' A' 1640 ' ' TRP . 66.2 mt -83.51 -4.4 58.49 Favored 'General case' 0 C--N 1.317 -0.838 0 CA-C-N 115.254 -0.884 . . . . 1.77 111.506 -178.687 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A 1533 ' ' SER . . . . . 0.503 ' OG ' ' HB2' ' A' 1553 ' ' CYS . 10.2 m -87.28 151.89 22.75 Favored 'General case' 0 C--O 1.249 1.049 0 N-CA-C 108.419 -0.956 . . . . 2.3799999999999999 108.419 179.115 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A 1534 ' ' GLY . . . . . . . . . . . . . . . -171.18 -160.13 18.96 Favored Glycine 0 N--CA 1.435 -1.431 0 C-N-CA 119.532 -1.318 . . . . 1.55 112.907 -179.666 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A 1535 ' ' ARG . . . . . 0.492 ' HG3' ' HB2' ' A' 1557 ' ' GLU . 38.3 ttm180 -75.53 -56.1 5.03 Favored 'General case' 0 C--N 1.307 -1.253 0 C-N-CA 123.989 0.916 . . . . 3.96 110.957 -179.132 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A 1536 ' ' ALA . . . . . . . . . . . . . . . -95.65 -29.68 14.18 Favored 'General case' 0 C--N 1.303 -1.452 0 CA-C-N 116.002 -0.545 . . . . 1.6499999999999999 110.544 178.583 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A 1537 ' ' GLY . . . . . 0.442 ' HA3' ' HA ' ' A' 1551 ' ' SER . . . 85.02 -118.46 4.76 Favored Glycine 0 N--CA 1.431 -1.693 0 N-CA-C 110.343 -1.103 . . . . 1.1899999999999999 110.343 -177.998 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A 1538 ' ' PHE . . . . . . . . . . . . . 69.1 m-85 -130.79 165.2 23.48 Favored 'General case' 0 C--N 1.308 -1.233 0 C-N-CA 123.085 0.554 . . . . 1.6899999999999999 109.507 178.292 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A 1539 ' ' THR . . . . . . . . . . . . . 3.1 p -115.15 120.5 39.98 Favored 'General case' 0 C--N 1.311 -1.105 0 N-CA-C 113.16 0.8 . . . . 1.48 113.16 -174.76 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A 1540 ' ' ALA . . . . . . . . . . . . . . . -117.27 127.52 54.16 Favored 'General case' 0 C--N 1.312 -1.063 0 N-CA-C 108.251 -1.018 . . . . 0.82999999999999996 108.251 173.886 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A 1541 ' ' ALA . . . . . . . . . . . . . . . -88.28 153.22 21.38 Favored 'General case' 0 C--N 1.31 -1.127 0 N-CA-C 110.03 -0.359 . . . . 1.27 110.03 -178.492 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A 1542 ' ' TYR . . . . . . . . . . . . . 52.9 t80 -157.42 175.31 14.15 Favored 'General case' 0 C--N 1.318 -0.79 0 N-CA-C 109.015 -0.735 . . . . 2.1499999999999999 109.015 -178.416 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A 1543 ' ' SER . . . . . . . . . . . . . 14.1 m -46.62 -151.0 0.0 OUTLIER 'General case' 0 CA--C 1.57 1.725 0 C-N-CA 129.245 3.018 . . . . 2.29 114.306 177.572 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A 1544 ' ' LYS . . . . . . . . . . . . . 65.0 mttp -42.35 -23.06 0.03 OUTLIER 'General case' 0 CA--C 1.572 1.807 0 N-CA-C 115.47 1.656 . . . . 3.9100000000000001 115.47 -178.574 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A 1545 ' ' SER . . . . . . . . . . . . . 32.4 m -71.62 -15.84 62.26 Favored 'General case' 0 CA--C 1.564 1.517 0 C-N-CA 123.295 0.638 . . . . 3.2999999999999998 111.813 175.277 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A 1546 ' ' GLY . . . . . . . . . . . . . . . 84.04 -75.25 2.39 Favored Glycine 0 C--O 1.241 0.571 0 N-CA-C 114.298 0.479 . . . . 1.24 114.298 174.033 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A 1547 ' ' VAL . . . . . . . . . . . . . 11.7 p -156.32 148.01 11.62 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.853 0 N-CA-C 108.115 -1.069 . . . . 1.6299999999999999 108.115 -175.872 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A 1548 ' ' VAL . . . . . . . . . . . . . 2.4 t -106.25 133.34 50.99 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.81 0 N-CA-C 108.327 -0.99 . . . . 0.92000000000000004 108.327 -179.356 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A 1549 ' ' TYR . . . . . 0.535 ' HB3' HD21 ' A' 1556 ' ' ASN . 12.6 m-85 -100.39 117.32 34.32 Favored 'General case' 0 C--N 1.301 -1.524 0 N-CA-C 107.672 -1.233 . . . . 1.4399999999999999 107.672 172.867 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A 1550 ' ' MET . . . . . . . . . . . . . 52.4 ttp -140.45 122.78 15.94 Favored 'General case' 0 C--N 1.292 -1.896 0 C-N-CA 120.515 -0.474 . . . . 1.74 111.021 -177.544 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A 1551 ' ' SER . . . . . 0.442 ' HA ' ' HA3' ' A' 1537 ' ' GLY . 33.9 t -93.98 137.75 32.85 Favored 'General case' 0 N--CA 1.43 -1.472 0 N-CA-C 104.999 -2.223 . . . . 1.6399999999999999 104.999 173.483 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A 1552 ' ' ILE . . . . . . . . . . . . . 47.5 mm -63.26 -33.29 60.21 Favored 'Isoleucine or valine' 0 C--O 1.207 -1.158 0 CA-C-N 115.325 -0.852 . . . . 1.3300000000000001 110.639 -175.856 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A 1553 ' ' CYS . . . . . 0.503 ' HB2' ' OG ' ' A' 1533 ' ' SER . 79.6 m -144.77 141.19 29.02 Favored 'General case' 0 C--O 1.252 1.236 0 N-CA-C 108.363 -0.977 . . . . 1.4299999999999999 108.363 172.553 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A 1554 ' ' GLY . . . . . . . . . . . . . . . 99.99 -157.93 19.62 Favored Glycine 0 N--CA 1.427 -1.926 0 C-N-CA 120.805 -0.712 . . . . 1.1200000000000001 112.701 174.196 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A 1555 ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 -103.31 147.97 26.43 Favored 'General case' 0 C--N 1.302 -1.469 0 CA-C-O 121.407 0.622 . . . . 1.8 111.549 -178.007 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A 1556 ' ' ASN . . . . . 0.535 HD21 ' HB3' ' A' 1549 ' ' TYR . 25.5 t-20 -95.7 123.44 39.27 Favored 'General case' 0 C--N 1.293 -1.863 0 CA-C-N 115.029 -0.987 . . . . 2.6299999999999999 108.553 179.636 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A 1557 ' ' GLU . . . . . 0.492 ' HB2' ' HG3' ' A' 1535 ' ' ARG . 5.4 mt-10 -91.87 39.57 1.02 Allowed 'General case' 0 C--N 1.303 -1.419 0 N-CA-C 112.09 0.404 . . . . 3.79 112.09 -173.746 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A 1558 ' ' ASN . . . . . . . . . . . . . 32.1 m-80 -125.89 -0.52 7.28 Favored 'General case' 0 C--N 1.311 -1.083 0 CA-C-O 121.971 0.891 . . . . 1.52 109.764 178.931 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A 1559 ' ' CYS . . . . . 0.812 ' HB3' ' HD2' ' A' 1560 ' ' PRO . 84.0 m -144.24 -175.83 0.5 Allowed Pre-proline 0 C--N 1.295 -1.802 0 N-CA-C 106.263 -1.754 . . . . 0.83999999999999997 106.263 -179.664 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A 1560 ' ' PRO . . . . . 0.812 ' HD2' ' HB3' ' A' 1559 ' ' CYS . 4.5 Cg_exo -41.96 123.28 2.39 Favored 'Trans proline' 0 C--N 1.379 2.176 0 C-N-CA 122.702 2.268 . . . . 1.1799999999999999 112.959 175.658 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A 1561 ' ' PRO . . . . . 0.445 ' HD3' ' HA ' ' A' 1560 ' ' PRO . 31.6 Cg_exo -60.75 105.45 0.31 Allowed 'Trans proline' 0 C--O 1.244 0.805 0 C-N-CA 123.082 2.521 . . . . 1.51 110.793 -179.532 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A 1562 ' ' GLY . . . . . . . . . . . . . . . 141.68 -14.7 2.67 Favored Glycine 0 N--CA 1.431 -1.654 0 N-CA-C 111.25 -0.74 . . . . 0.71999999999999997 111.25 -177.368 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A 1563 ' ' VAL . . . . . 0.632 ' HA ' ' HA ' ' A' 1576 ' ' LYS . 3.2 m -98.46 146.85 7.46 Favored 'Isoleucine or valine' 0 C--O 1.207 -1.181 0 N-CA-C 107.465 -1.309 . . . . 0.96999999999999997 107.465 177.15 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A 1564 ' ' GLY . . . . . . . . . . . . . . . -105.67 -25.1 6.71 Favored Glycine 0 C--O 1.241 0.538 0 C-N-CA 120.611 -0.804 . . . . 0.71999999999999997 113.539 -174.229 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A 1565 ' ' ALA . . . . . . . . . . . . . . . -134.91 128.72 33.11 Favored 'General case' 0 C--N 1.315 -0.91 0 N-CA-C 108.996 -0.742 . . . . 0.37 108.996 -179.988 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A 1566 ' ' CYS . . . . . . . . . . . . . 42.1 t -156.54 145.87 20.57 Favored 'General case' 0 C--N 1.307 -1.258 0 CA-C-N 116.671 -0.24 . . . . 0.51000000000000001 110.538 -173.857 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A 1567 ' ' PHE . . . . . . . . . . . . . 24.7 m-85 -71.13 125.58 27.29 Favored 'General case' 0 C--O 1.207 -1.137 0 N-CA-C 107.387 -1.338 . . . . 0.96999999999999997 107.387 175.018 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A 1568 ' ' GLY . . . . . . . . . . . . . . . -75.22 -24.93 69.86 Favored Glycine 0 C--N 1.307 -1.047 0 C-N-CA 120.801 -0.714 . . . . 1.0800000000000001 114.027 -173.648 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A 1569 ' ' GLN . . . . . . . . . . . . . 65.5 tt0 -85.13 -53.03 5.53 Favored 'General case' 0 C--N 1.317 -0.814 0 C-N-CA 120.088 -0.645 . . . . 2.7400000000000002 111.071 -179.757 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A 1570 ' ' THR . . . . . . . . . . . . . 22.8 p -84.19 -16.95 41.53 Favored 'General case' 0 C--N 1.312 -1.053 0 N-CA-C 112.852 0.686 . . . . 1.96 112.852 -176.696 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A 1571 ' ' ARG . . . . . . . . . . . . . 66.0 mtm180 60.78 41.87 14.17 Favored 'General case' 0 CA--C 1.508 -0.661 0 C-N-CA 125.382 1.473 . . . . 3.9500000000000002 112.85 177.463 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A 1572 ' ' ILE . . . . . . . . . . . . . 36.9 mm -103.83 122.8 56.99 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.222 0 N-CA-C 107.404 -1.332 . . . . 1.3700000000000001 107.404 178.134 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A 1573 ' ' SER . . . . . . . . . . . . . 71.5 p -78.43 121.94 25.17 Favored 'General case' 0 N--CA 1.436 -1.137 0 N-CA-C 113.129 0.788 . . . . 1.0800000000000001 113.129 -176.46 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A 1574 ' ' VAL . . . . . . . . . . . . . 22.4 m -106.51 11.39 8.88 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.426 0 CA-C-O 121.875 0.845 . . . . 1.3 110.402 -177.126 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A 1575 ' ' GLY . . . . . . . . . . . . . . . -177.27 118.93 0.66 Allowed Glycine 0 N--CA 1.421 -2.333 0 CA-C-N 114.718 -1.128 . . . . 0.51000000000000001 111.673 177.398 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A 1576 ' ' LYS . . . . . 0.632 ' HA ' ' HA ' ' A' 1563 ' ' VAL . 55.7 tttm -79.85 152.17 29.83 Favored 'General case' 0 C--N 1.306 -1.315 0 N-CA-C 105.799 -1.926 . . . . 2.8999999999999999 105.799 174.888 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A 1577 ' ' ALA . . . . . . . . . . . . . . . -56.22 102.33 0.07 Allowed 'General case' 0 N--CA 1.468 0.434 0 O-C-N 123.983 0.802 . . . . 0.82999999999999996 110.277 -178.537 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A 1578 ' ' ASN . . . . . 0.592 ' HB3' ' HA ' ' A' 1592 ' ' TYR . 8.0 t30 -135.61 130.22 34.07 Favored 'General case' 0 C--N 1.29 -2.001 0 N-CA-C 105.683 -1.969 . . . . 1.8500000000000001 105.683 -179.094 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A 1579 ' ' LYS . . . . . 0.411 ' HE2' ' HB3' ' A' 1579 ' ' LYS . 36.9 ttpt -115.54 90.24 3.29 Favored 'General case' 0 C--N 1.269 -2.926 0 CA-C-O 121.631 0.729 . . . . 1.8999999999999999 109.211 -173.507 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A 1580 ' ' ARG . . . . . 0.556 ' O ' ' HA ' ' A' 1590 ' ' LEU . 44.3 ttm180 -109.93 109.59 20.25 Favored 'General case' 0 C--N 1.286 -2.163 0 N-CA-C 107.902 -1.147 . . . . 3.6299999999999999 107.902 177.332 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A 1581 ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -100.21 138.38 37.35 Favored 'General case' 0 C--N 1.298 -1.665 0 N-CA-C 106.273 -1.751 . . . . 1.8700000000000001 106.273 -177.682 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A 1582 ' ' ARG . . . . . 0.42 ' HB3' ' HB3' ' A' 1589 ' ' GLN . 38.5 ttm180 -144.66 128.46 17.31 Favored 'General case' 0 C--N 1.305 -1.36 0 CA-C-O 121.137 0.494 . . . . 3.9700000000000002 111.043 178.958 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A 1583 ' ' TYR . . . . . 0.458 ' HD1' ' CD2' ' A' 1588 ' ' LEU . 84.9 t80 -117.9 105.02 11.49 Favored 'General case' 0 C--N 1.297 -1.702 0 N-CA-C 105.946 -1.872 . . . . 1.4099999999999999 105.946 176.996 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A 1584 ' ' VAL . . . . . . . . . . . . . 6.6 p -136.79 97.77 1.59 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.343 0 C-N-CA 119.594 -0.842 . . . . 1.6899999999999999 112.501 -177.058 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A 1585 ' ' ASP . . . . . . . . . . . . . 35.7 t70 56.87 69.07 0.78 Allowed 'General case' 0 N--CA 1.476 0.874 0 C-N-CA 124.188 0.995 . . . . 2.0600000000000001 111.814 178.211 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A 1586 ' ' GLN . . . . . . . . . . . . . 53.3 mt-30 52.51 25.5 3.64 Favored 'General case' 0 N--CA 1.478 0.945 0 N-CA-C 114.767 1.395 . . . . 2.3300000000000001 114.767 178.657 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A 1587 ' ' VAL . . . . . 0.414 HG23 ' O ' ' A' 1612 ' ' PHE . 11.5 p -139.52 122.29 17.47 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.772 0 N-CA-C 108.571 -0.9 . . . . 0.78000000000000003 108.571 173.352 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A 1588 ' ' LEU . . . . . 0.579 ' HB2' ' HB2' ' A' 1612 ' ' PHE . 18.5 mt -89.09 158.28 18.02 Favored 'General case' 0 C--N 1.3 -1.556 0 CA-C-N 115.284 -0.871 . . . . 1.4099999999999999 109.963 -178.493 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A 1589 ' ' GLN . . . . . 0.42 ' HB3' ' HB3' ' A' 1582 ' ' ARG . 6.8 tt0 -146.46 136.99 23.97 Favored 'General case' 0 C--N 1.292 -1.935 0 N-CA-C 108.667 -0.864 . . . . 1.24 108.667 176.918 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A 1590 ' ' LEU . . . . . 0.556 ' HA ' ' O ' ' A' 1580 ' ' ARG . 6.1 tt -133.04 135.45 45.38 Favored 'General case' 0 C--N 1.302 -1.47 0 N-CA-C 106.443 -1.688 . . . . 1.1499999999999999 106.443 176.927 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A 1591 ' ' VAL . . . . . 0.424 HG22 HG22 ' A' 1609 ' ' VAL . 57.9 t -130.3 134.58 62.29 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.76 0 N-CA-C 112.761 0.652 . . . . 1.51 112.761 -171.769 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A 1592 ' ' TYR . . . . . 0.592 ' HA ' ' HB3' ' A' 1578 ' ' ASN . 67.3 m-85 -111.09 152.01 27.43 Favored 'General case' 0 C--N 1.318 -0.802 0 N-CA-C 107.405 -1.331 . . . . 1.0600000000000001 107.405 171.53 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A 1593 ' ' LYS . . . . . . . . . . . . . 21.2 pttp -152.48 -177.16 6.05 Favored 'General case' 0 C--N 1.301 -1.539 0 N-CA-C 109.753 -0.462 . . . . 2.1800000000000002 109.753 -178.767 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A 1594 ' ' ASP . . . . . . . . . . . . . 1.7 m-20 53.36 41.83 32.09 Favored 'General case' 0 N--CA 1.485 1.291 0 N-CA-C 115.238 1.57 . . . . 1.45 115.238 173.614 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A 1595 ' ' GLY . . . . . . . . . . . . . . . -82.65 -121.78 0.7 Allowed Glycine 0 N--CA 1.435 -1.429 0 C-N-CA 119.816 -1.183 . . . . 0.78000000000000003 110.816 175.696 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A 1596 ' ' SER . . . . . . . . . . . . . 49.0 m -83.44 153.0 65.1 Favored Pre-proline 0 C--N 1.284 -2.282 0 N-CA-C 109.934 -0.395 . . . . 1.6799999999999999 109.934 -179.606 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A 1597 ' ' PRO . . . . . . . . . . . . . 33.2 Cg_exo -63.67 139.33 68.9 Favored 'Trans proline' 0 C--O 1.253 1.243 0 C-N-CA 122.689 2.26 . . . . 1.1699999999999999 109.723 172.369 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A 1598 ' ' CYS . . . . . . . . . . . . . 34.8 t -95.05 130.16 33.5 Favored Pre-proline 0 C--N 1.287 -2.139 0 N-CA-C 108.97 -0.752 . . . . 1.1899999999999999 108.97 -177.318 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A 1599 ' ' PRO . . . . . 0.485 ' HD2' ' OH ' ' A' 1606 ' ' TYR . 89.2 Cg_endo -82.33 4.57 6.97 Favored 'Trans proline' 0 CA--C 1.536 0.577 0 C-N-CA 122.879 2.386 . . . . 1.5900000000000001 112.697 179.319 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A 1600 ' ' SER . . . . . . . . . . . . . 15.9 m -107.81 123.0 47.91 Favored 'General case' 0 N--CA 1.431 -1.388 0 N-CA-C 109.957 -0.386 . . . . 2.1200000000000001 109.957 -177.468 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A 1601 ' ' LYS . . . . . 0.543 ' HD3' ' HA ' ' A' 1632 ' ' GLN . 26.5 mtpp 66.02 -97.93 0.05 Allowed 'General case' 0 N--CA 1.454 -0.27 0 N-CA-C 114.565 1.32 . . . . 3.7400000000000002 114.565 -179.372 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A 1602 ' ' SER . . . . . 0.441 ' HB3' ' HG ' ' A' 1604 ' ' LEU . 10.4 t -97.59 153.61 18.08 Favored 'General case' 0 C--N 1.301 -1.505 0 N-CA-C 109.202 -0.666 . . . . 3.79 109.202 -178.247 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A 1603 ' ' GLY . . . . . . . . . . . . . . . -80.63 56.87 4.76 Favored Glycine 0 N--CA 1.447 -0.622 0 N-CA-C 110.835 -0.906 . . . . 2.0 110.835 177.625 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A 1604 ' ' LEU . . . . . 0.441 ' HG ' ' HB3' ' A' 1602 ' ' SER . 0.7 OUTLIER -99.28 -172.01 2.19 Favored 'General case' 0 C--N 1.307 -1.259 0 C-N-CA 123.817 0.847 . . . . 1.48 110.633 -179.69 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A 1605 ' ' SER . . . . . . . . . . . . . 8.7 m -97.78 -178.72 4.2 Favored 'General case' 0 C--N 1.301 -1.543 0 CA-C-N 118.206 0.457 . . . . 1.51 110.102 -176.749 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A 1606 ' ' TYR . . . . . 0.485 ' OH ' ' HD2' ' A' 1599 ' ' PRO . 68.2 m-85 -106.39 137.69 43.92 Favored 'General case' 0 N--CA 1.417 -2.091 0 N-CA-C 104.424 -2.436 . . . . 1.1799999999999999 104.424 174.902 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A 1607 ' ' LYS . . . . . 0.541 ' HG3' HG23 ' A' 1635 ' ' THR . 21.9 ptmt -130.05 142.7 50.58 Favored 'General case' 0 C--N 1.282 -2.35 0 C-N-CA 119.955 -0.698 . . . . 1.6699999999999999 109.216 179.383 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A 1608 ' ' SER . . . . . . . . . . . . . 46.7 m -119.0 126.84 52.67 Favored 'General case' 0 C--N 1.3 -1.553 0 CA-C-O 120.413 0.149 . . . . 1.0 110.653 -176.806 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A 1609 ' ' VAL . . . . . 0.424 HG22 HG22 ' A' 1591 ' ' VAL . 74.2 t -116.2 124.45 72.48 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.839 0 N-CA-C 109.321 -0.622 . . . . 0.93000000000000005 109.321 178.205 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A 1610 ' ' ILE . . . . . 0.827 HG13 ' HB2' ' A' 1638 ' ' PHE . 3.0 mp -108.07 120.06 58.76 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.966 0 N-CA-C 109.072 -0.714 . . . . 0.78000000000000003 109.072 176.68 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A 1611 ' ' SER . . . . . . . . . . . . . 24.2 p -94.89 123.63 38.47 Favored 'General case' 0 N--CA 1.432 -1.372 0 N-CA-C 109.049 -0.723 . . . . 1.29 109.049 175.317 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A 1612 ' ' PHE . . . . . 0.579 ' HB2' ' HB2' ' A' 1588 ' ' LEU . 93.0 m-85 -97.11 108.89 21.71 Favored 'General case' 0 C--N 1.298 -1.638 0 CA-C-O 121.123 0.487 . . . . 0.69999999999999996 110.657 -177.914 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A 1613 ' ' VAL . . . . . 0.45 ' O ' ' HA ' ' A' 1641 ' ' HIS . 49.0 t -103.72 120.74 54.26 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.531 0 N-CA-C 109.246 -0.65 . . . . 0.75 109.246 -178.154 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A 1614 ' ' CYS . . . . . 0.59 ' HA ' ' O ' ' A' 1642 ' ' THR . 0.8 OUTLIER -77.7 93.94 4.35 Favored 'General case' 0 C--N 1.302 -1.476 0 N-CA-C 114.201 1.185 . . . . 1.3899999999999999 114.201 -179.15 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A 1615 ' ' ARG . . . . . . . . . . . . . 71.8 ttt180 -115.74 107.05 49.13 Favored Pre-proline 0 C--N 1.312 -1.063 0 N-CA-C 108.163 -1.051 . . . . 3.75 108.163 175.755 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A 1616 ' ' PRO . . . . . . . . . . . . . 27.0 Cg_endo -63.95 -38.1 39.94 Favored 'Trans proline' 0 CA--C 1.531 0.328 0 C-N-CA 122.753 2.302 . . . . 1.3200000000000001 112.191 -179.922 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A 1617 ' ' GLU . . . . . . . . . . . . . 20.4 mm-40 -94.01 40.48 1.08 Allowed 'General case' 0 C--N 1.312 -1.028 0 CA-C-N 115.976 -0.556 . . . . 3.21 110.937 -179.153 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A 1618 ' ' ALA . . . . . . . . . . . . . . . -92.75 128.54 38.65 Favored 'General case' 0 C--N 1.307 -1.256 0 N-CA-C 109.1 -0.704 . . . . 2.4399999999999999 109.1 177.584 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A 1619 ' ' GLY . . . . . . . . . . . . . . . -122.98 -85.91 0.75 Allowed Glycine 0 C--N 1.297 -1.587 0 N-CA-C 110.455 -1.058 . . . . 3.2599999999999998 110.455 179.036 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A 1620 ' ' PRO . . . . . . . . . . . . . 53.4 Cg_exo -56.45 -40.2 86.17 Favored 'Trans proline' 0 CA--C 1.542 0.886 0 C-N-CA 123.155 2.57 . . . . 5.9199999999999999 112.814 177.143 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A 1621 ' ' THR . . . . . . . . . . . . . 19.6 m -95.49 21.59 8.01 Favored 'General case' 0 CA--C 1.56 1.357 0 CA-C-O 122.428 1.109 . . . . 4.7599999999999998 110.782 -178.131 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A 1622 ' ' ASN . . . . . 0.5 ' HA ' ' O ' ' A' 1641 ' ' HIS . 48.8 t-20 -91.46 53.14 2.21 Favored 'General case' 0 C--O 1.243 0.722 0 N-CA-C 106.941 -1.503 . . . . 2.9199999999999999 106.941 176.854 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A 1623 ' ' ARG . . . . . . . . . . . . . 16.5 ptm180 -149.71 150.26 30.2 Favored Pre-proline 0 C--N 1.308 -1.236 0 N-CA-C 107.677 -1.231 . . . . 3.6099999999999999 107.677 -176.606 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A 1624 ' ' PRO . . . . . . . . . . . . . 11.9 Cg_exo -71.63 94.81 0.69 Allowed 'Trans proline' 0 N--CA 1.456 -0.691 0 C-N-CA 122.148 1.899 . . . . 2.3700000000000001 109.104 175.909 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A 1625 ' ' MET . . . . . . . . . . . . . 57.7 ttp -101.64 141.41 34.54 Favored 'General case' 0 C--N 1.299 -1.588 0 CA-C-N 115.662 -0.699 . . . . 2.1600000000000001 109.779 -175.17 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A 1626 ' ' LEU . . . . . . . . . . . . . 56.2 tp -80.61 110.7 16.34 Favored 'General case' 0 C--N 1.313 -1.005 0 N-CA-C 108.446 -0.946 . . . . 1.3500000000000001 108.446 178.334 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A 1627 ' ' ILE . . . . . . . . . . . . . 26.5 pt -88.16 -41.76 14.48 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.919 0 C-N-CA 120.339 -0.545 . . . . 1.21 112.196 -177.893 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A 1628 ' ' SER . . . . . . . . . . . . . 26.7 t -147.21 148.45 31.52 Favored 'General case' 0 N--CA 1.434 -1.242 0 N-CA-C 109.933 -0.395 . . . . 1.3999999999999999 109.933 -175.489 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A 1629 ' ' LEU . . . . . 0.644 ' HG ' HD13 ' A' 1636 ' ' LEU . 5.1 tt -125.51 112.13 15.87 Favored 'General case' 0 C--N 1.304 -1.411 0 N-CA-C 106.496 -1.668 . . . . 1.5600000000000001 106.496 176.798 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A 1630 ' ' ASP . . . . . 0.436 ' HB2' ' HE2' ' A' 1637 ' ' PHE . 19.5 t70 -83.22 117.46 22.95 Favored 'General case' 0 C--N 1.303 -1.444 0 N-CA-C 108.479 -0.934 . . . . 0.87 108.479 177.704 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A 1631 ' ' LYS . . . . . . . . . . . . . 98.3 mttt -92.26 -7.18 48.83 Favored 'General case' 0 C--N 1.29 -2.021 0 CA-C-N 115.932 -0.576 . . . . 2.3500000000000001 111.179 -174.948 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A 1632 ' ' GLN . . . . . 0.543 ' HA ' ' HD3' ' A' 1601 ' ' LYS . 36.5 mt-30 -80.25 -47.52 14.47 Favored 'General case' 0 C--N 1.317 -0.817 0 CA-C-O 121.456 0.646 . . . . 2.5499999999999998 110.295 -177.338 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A 1633 ' ' THR . . . . . . . . . . . . . 41.0 p -107.25 -1.34 21.87 Favored 'General case' 0 C--N 1.298 -1.66 0 CA-C-N 116.034 -0.53 . . . . 1.24 111.306 179.858 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A 1634 ' ' CYS . . . . . . . . . . . . . 60.3 m 64.62 52.05 1.81 Allowed 'General case' 0 N--CA 1.472 0.644 0 CA-C-O 122.171 0.986 . . . . 0.89000000000000001 110.538 -179.682 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A 1635 ' ' THR . . . . . 0.541 HG23 ' HG3' ' A' 1607 ' ' LYS . 32.1 m -114.16 126.65 55.31 Favored 'General case' 0 N--CA 1.431 -1.381 0 CA-C-N 114.567 -1.197 . . . . 0.75 110.186 -175.485 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A 1636 ' ' LEU . . . . . 0.644 HD13 ' HG ' ' A' 1629 ' ' LEU . 2.1 mm? -95.45 132.99 39.93 Favored 'General case' 0 C--N 1.308 -1.205 0 N-CA-C 108.971 -0.751 . . . . 1.3300000000000001 108.971 -179.423 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A 1637 ' ' PHE . . . . . 0.436 ' HE2' ' HB2' ' A' 1630 ' ' ASP . 99.8 m-85 -116.42 106.38 13.55 Favored 'General case' 0 C--O 1.247 0.969 0 CA-C-O 121.21 0.528 . . . . 0.82999999999999996 110.702 179.555 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A 1638 ' ' PHE . . . . . 0.827 ' HB2' HG13 ' A' 1610 ' ' ILE . 99.0 m-85 -103.77 149.52 24.94 Favored 'General case' 0 C--N 1.301 -1.533 0 N-CA-C 108.619 -0.882 . . . . 0.59999999999999998 108.619 178.684 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A 1639 ' ' SER . . . . . . . . . . . . . 33.6 t -135.59 132.11 36.73 Favored 'General case' 0 C--N 1.285 -2.229 0 N-CA-C 109.216 -0.661 . . . . 1.0800000000000001 109.216 179.496 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A 1640 ' ' TRP . . . . . 0.559 ' CZ3' HD13 ' A' 1532 ' ' LEU . 7.2 t90 -120.82 118.96 31.33 Favored 'General case' 0 N--CA 1.423 -1.806 0 N-CA-C 107.472 -1.307 . . . . 0.80000000000000004 107.472 177.642 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A 1641 ' ' HIS . . . . . 0.5 ' O ' ' HA ' ' A' 1622 ' ' ASN . 31.7 m-70 -96.96 103.46 15.39 Favored 'General case' 0 C--N 1.294 -1.812 0 N-CA-C 106.734 -1.58 . . . . 2.54 106.734 177.354 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A 1642 ' ' THR . . . . . 0.59 ' O ' ' HA ' ' A' 1614 ' ' CYS . 8.9 t -142.24 139.54 17.95 Favored Pre-proline 0 C--N 1.303 -1.45 0 CA-C-N 115.7 -0.682 . . . . 1.1499999999999999 111.807 -170.536 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A 1643 ' ' PRO . . . . . 0.402 ' HD3' ' HA ' ' A' 1642 ' ' THR . 4.3 Cg_exo -74.84 -3.64 14.21 Favored 'Trans proline' 0 N--CA 1.456 -0.718 0 C-N-CA 123.499 2.8 . . . . 0.80000000000000004 111.639 175.573 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A 1644 ' ' LEU . . . . . . . . . . . . . 83.4 mt -82.03 -8.62 59.67 Favored 'General case' 0 C--N 1.315 -0.929 0 CA-C-N 116.447 -0.342 . . . . 1.54 110.635 177.282 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A 1645 ' ' ALA . . . . . . . . . . . . . . . -88.31 -21.0 24.65 Favored 'General case' 0 C--N 1.32 -0.713 0 N-CA-C 113.092 0.775 . . . . 0.94999999999999996 113.092 -176.196 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A 1646 ' ' CYS . . . . . 0.441 ' O ' ' HD3' ' A' 1648 ' ' PRO . 61.1 m -155.15 172.45 18.12 Favored 'General case' 0 N--CA 1.475 0.781 0 N-CA-C 107.243 -1.391 . . . . 1.4099999999999999 107.243 -179.761 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A 1647 ' ' GLU . . . . . 0.52 ' HB2' HG21 ' A' 1523 ' ' THR . 37.7 mm-40 -113.09 85.1 7.71 Favored Pre-proline 0 C--N 1.309 -1.179 0 N-CA-C 109.815 -0.439 . . . . 2.9199999999999999 109.815 174.694 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A 1648 ' ' PRO . . . . . 0.441 ' HD3' ' O ' ' A' 1646 ' ' CYS . 4.0 Cg_exo -80.78 156.5 20.95 Favored 'Trans proline' 0 C--O 1.253 1.275 0 C-N-CA 123.125 2.55 . . . . 2.8199999999999998 110.966 -178.001 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A 1649 ' ' GLU . . . . . . . . . . . . . 7.6 tp10 . . . . . 0 N--CA 1.425 -1.698 0 N-CA-C 108.53 -0.915 . . . . 5.0599999999999996 108.53 179.902 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A 1508 ' ' MET . . . . . 0.424 ' HB2' ' OD1' ' A' 1511 ' ' ASN . 3.7 mpp? . . . . . 0 CA--C 1.51 -0.578 0 N-CA-C 109.01 -0.737 . . . . 8.2699999999999996 109.01 . . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A 1509 ' ' LYS . . . . . . . . . . . . . 59.5 pttt -107.28 -19.99 13.42 Favored 'General case' 0 C--N 1.312 -1.036 0 CA-C-O 120.975 0.417 . . . . 6.4800000000000004 111.197 178.46 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A 1510 ' ' SER . . . . . . . . . . . . . 15.2 m -116.43 80.8 1.52 Allowed 'General case' 0 N--CA 1.429 -1.48 0 N-CA-C 106.143 -1.799 . . . . 4.2199999999999998 106.143 174.538 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A 1511 ' ' ASN . . . . . 0.424 ' OD1' ' HB2' ' A' 1508 ' ' MET . 13.1 m-80 -93.2 -18.37 22.6 Favored 'General case' 0 C--N 1.306 -1.29 0 CA-C-N 115.502 -0.772 . . . . 3.0800000000000001 111.315 -171.855 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A 1512 ' ' GLU . . . . . 0.473 ' HB2' ' HB3' ' A' 1581 ' ' LEU . 0.3 OUTLIER -64.52 1.11 0.87 Allowed 'General case' 0 N--CA 1.483 1.214 0 N-CA-C 115.847 1.795 . . . . 4.46 115.847 -169.857 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A 1513 ' ' HIS . . . . . . . . . . . . . 18.5 p80 -113.17 3.18 15.92 Favored 'General case' 0 C--N 1.308 -1.237 0 CA-C-O 121.002 0.43 . . . . 5.5700000000000003 110.119 177.144 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A 1514 ' ' ASP . . . . . . . . . . . . . 34.2 t70 -140.37 -42.16 0.41 Allowed 'General case' 0 N--CA 1.468 0.46 0 CA-C-O 121.613 0.721 . . . . 3.7000000000000002 111.187 -174.057 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A 1515 ' ' ASP . . . . . . . . . . . . . 13.6 t70 -125.58 -168.41 1.84 Allowed 'General case' 0 C--N 1.303 -1.418 0 N-CA-C 105.58 -2.007 . . . . 2.54 105.58 179.711 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A 1516 ' ' CYS . . . . . 0.476 ' HB3' ' HB2' ' A' 1529 ' ' LEU . 74.0 m -128.32 43.11 3.2 Favored 'General case' 0 C--N 1.298 -1.637 0 CA-C-N 118.561 0.618 . . . . 1.25 110.135 -176.417 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A 1517 ' ' GLN . . . . . 0.414 ' O ' ' HB2' ' A' 1511 ' ' ASN . 13.2 pt20 -124.52 129.28 50.33 Favored 'General case' 0 C--N 1.295 -1.762 0 C-N-CA 119.866 -0.734 . . . . 1.8799999999999999 110.702 178.238 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A 1518 ' ' VAL . . . . . . . . . . . . . 15.9 m -133.28 139.51 49.07 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.641 0 CA-C-N 115.715 -0.675 . . . . 1.73 110.4 -179.058 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A 1519 ' ' THR . . . . . . . . . . . . . 23.1 m -90.55 123.57 34.32 Favored 'General case' 0 C--N 1.284 -2.251 0 N-CA-C 108.832 -0.803 . . . . 1.7 108.832 176.478 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A 1520 ' ' ASN . . . . . . . . . . . . . 48.6 t-20 -84.63 112.25 40.87 Favored Pre-proline 0 C--N 1.311 -1.08 0 N-CA-C 107.746 -1.205 . . . . 2.1200000000000001 107.746 178.083 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A 1521 ' ' PRO . . . . . . . . . . . . . 42.6 Cg_endo -65.38 -16.46 54.42 Favored 'Trans proline' 0 C--N 1.353 0.766 0 C-N-CA 122.897 2.398 . . . . 2.4700000000000002 113.992 -174.299 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A 1522 ' ' SER . . . . . . . . . . . . . 38.0 m -81.21 -9.8 59.72 Favored 'General case' 0 C--N 1.312 -1.031 0 CA-C-O 120.779 0.323 . . . . 2.5699999999999998 111.869 -178.976 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A 1523 ' ' THR . . . . . . . . . . . . . 13.7 t -136.55 -13.82 1.72 Allowed 'General case' 0 CA--C 1.552 1.041 0 CA-C-O 121.349 0.595 . . . . 2.1499999999999999 111.371 176.761 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A 1524 ' ' GLY . . . . . . . . . . . . . . . 73.33 16.26 78.8 Favored Glycine 0 C--N 1.341 0.845 0 O-C-N 122.134 -0.354 . . . . 1.8899999999999999 112.362 179.481 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A 1525 ' ' HIS . . . . . . . . . . . . . 58.3 t60 -101.93 136.72 41.28 Favored 'General case' 0 C--N 1.306 -1.31 0 C-N-CA 122.623 0.369 . . . . 1.8999999999999999 110.091 -176.135 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A 1526 ' ' LEU . . . . . . . . . . . . . 26.4 tp -83.45 124.49 30.75 Favored 'General case' 0 C--N 1.306 -1.289 0 N-CA-C 108.579 -0.897 . . . . 1.6100000000000001 108.579 176.914 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A 1527 ' ' PHE . . . . . 0.407 ' HZ ' ' HG3' ' A' 1647 ' ' GLU . 80.8 m-85 -98.53 114.11 26.4 Favored 'General case' 0 C--N 1.296 -1.731 0 CA-C-O 121.671 0.748 . . . . 1.4199999999999999 110.06 176.145 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A 1528 ' ' ASP . . . . . . . . . . . . . 4.6 t70 -90.41 105.75 18.03 Favored 'General case' 0 C--N 1.298 -1.642 0 CA-C-N 114.205 -1.361 . . . . 2.1800000000000002 111.02 -177.636 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A 1529 ' ' LEU . . . . . 0.795 ' HA ' HD13 ' A' 1532 ' ' LEU . 79.6 mt -104.19 5.99 35.31 Favored 'General case' 0 C--N 1.297 -1.69 0 N-CA-C 106.089 -1.819 . . . . 1.4399999999999999 106.089 170.861 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A 1530 ' ' SER . . . . . . . . . . . . . 3.1 m -65.47 -36.72 84.74 Favored 'General case' 0 N--CA 1.438 -1.059 0 CA-C-N 114.531 -1.213 . . . . 1.4399999999999999 109.694 -179.279 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A 1531 ' ' SER . . . . . . . . . . . . . 15.6 m -73.62 -9.75 58.99 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 121.308 0.575 . . . . 1.5 109.908 178.114 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A 1532 ' ' LEU . . . . . 0.795 HD13 ' HA ' ' A' 1529 ' ' LEU . 6.6 mp -92.97 15.27 15.35 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.788 -0.642 . . . . 1.77 111.049 -179.724 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A 1533 ' ' SER . . . . . 0.429 ' HA ' ' HB2' ' A' 1553 ' ' CYS . 50.4 m -74.16 127.9 34.13 Favored 'General case' 0 N--CA 1.435 -1.212 0 N-CA-C 108.132 -1.062 . . . . 2.3799999999999999 108.132 174.353 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A 1534 ' ' GLY . . . . . . . . . . . . . . . -127.45 137.36 9.81 Favored Glycine 0 CA--C 1.478 -2.249 0 N-CA-C 109.823 -1.311 . . . . 1.55 109.823 -177.905 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A 1535 ' ' ARG . . . . . . . . . . . . . 3.6 tpp180 -90.33 -44.3 9.77 Favored 'General case' 0 C--N 1.302 -1.471 0 N-CA-C 109.131 -0.692 . . . . 3.96 109.131 -179.845 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A 1536 ' ' ALA . . . . . . . . . . . . . . . -95.32 -6.84 40.31 Favored 'General case' 0 C--N 1.314 -0.961 0 N-CA-C 108.15 -1.056 . . . . 1.6499999999999999 108.15 175.125 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A 1537 ' ' GLY . . . . . . . . . . . . . . . 78.73 -174.12 55.23 Favored Glycine 0 N--CA 1.429 -1.828 0 CA-C-N 113.887 -1.506 . . . . 1.1899999999999999 113.67 177.322 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A 1538 ' ' PHE . . . . . . . . . . . . . 90.3 m-85 -113.97 175.14 5.6 Favored 'General case' 0 C--N 1.292 -1.899 0 N-CA-C 105.457 -2.053 . . . . 1.6899999999999999 105.457 176.263 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A 1539 ' ' THR . . . . . . . . . . . . . 11.9 t -136.47 152.88 51.04 Favored 'General case' 0 C--N 1.282 -2.352 0 C-N-CA 119.02 -1.072 . . . . 1.48 110.21 -178.626 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A 1540 ' ' ALA . . . . . 0.669 ' HA ' ' HD3' ' A' 1623 ' ' ARG . . . -133.38 130.9 39.4 Favored 'General case' 0 C--N 1.319 -0.754 0 N-CA-C 109.062 -0.718 . . . . 0.82999999999999996 109.062 179.067 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A 1541 ' ' ALA . . . . . . . . . . . . . . . -78.57 147.52 33.7 Favored 'General case' 0 C--O 1.247 0.929 0 CA-C-N 116.189 -0.459 . . . . 1.27 110.761 -178.331 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A 1542 ' ' TYR . . . . . 0.472 ' HB3' ' O ' ' A' 1546 ' ' GLY . 89.2 t80 -160.46 160.3 31.92 Favored 'General case' 0 CA--C 1.552 1.058 0 CA-C-O 119.599 -0.239 . . . . 2.1499999999999999 111.549 -177.591 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A 1543 ' ' SER . . . . . . . . . . . . . 17.9 t -37.58 -152.2 0.0 OUTLIER 'General case' 0 CA--C 1.591 2.538 0 C-N-CA 130.626 3.57 . . . . 2.29 115.562 176.331 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A 1544 ' ' LYS . . . . . . . . . . . . . 97.6 mttt -46.7 -35.61 6.26 Favored 'General case' 0 N--CA 1.479 0.98 0 C-N-CA 124.497 1.119 . . . . 3.9100000000000001 113.496 -177.707 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A 1545 ' ' SER . . . . . . . . . . . . . 37.2 m -71.15 -8.12 51.32 Favored 'General case' 0 CA--C 1.551 0.993 0 N-CA-C 112.96 0.726 . . . . 3.2999999999999998 112.96 177.582 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A 1546 ' ' GLY . . . . . 0.472 ' O ' ' HB3' ' A' 1542 ' ' TYR . . . 83.06 -160.71 38.92 Favored Glycine 0 N--CA 1.432 -1.586 0 C-N-CA 121.239 -0.505 . . . . 1.24 114.255 173.05 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A 1547 ' ' VAL . . . . . . . . . . . . . 14.9 p -91.23 134.25 30.36 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.938 0 N-CA-C 108.742 -0.836 . . . . 1.6299999999999999 108.742 -177.019 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A 1548 ' ' VAL . . . . . . . . . . . . . 4.9 t -110.52 147.72 14.49 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.518 0 N-CA-C 108.44 -0.948 . . . . 0.92000000000000004 108.44 -175.03 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A 1549 ' ' TYR . . . . . 0.59 ' HB3' HD21 ' A' 1556 ' ' ASN . 99.8 m-85 -106.0 129.13 54.18 Favored 'General case' 0 C--N 1.313 -0.992 0 N-CA-C 108.185 -1.043 . . . . 1.4399999999999999 108.185 176.762 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A 1550 ' ' MET . . . . . . . . . . . . . 87.7 mmm -134.29 122.35 22.56 Favored 'General case' 0 C--N 1.299 -1.614 0 CA-C-N 115.792 -0.64 . . . . 1.74 109.845 -173.708 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A 1551 ' ' SER . . . . . 0.457 ' OG ' ' HA ' ' A' 1556 ' ' ASN . 74.9 m -97.35 115.63 28.06 Favored 'General case' 0 C--N 1.286 -2.178 0 N-CA-C 107.058 -1.46 . . . . 1.6399999999999999 107.058 171.79 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A 1552 ' ' ILE . . . . . 0.496 ' HB ' ' O ' ' A' 1532 ' ' LEU . 41.9 mm -57.37 -49.55 79.75 Favored 'Isoleucine or valine' 0 C--O 1.21 -0.989 0 CA-C-N 114.811 -1.086 . . . . 1.3300000000000001 108.139 179.421 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A 1553 ' ' CYS . . . . . 0.491 ' HA ' ' HH ' ' A' 1592 ' ' TYR . 81.3 m -131.48 137.45 48.58 Favored 'General case' 0 N--CA 1.425 -1.724 0 N-CA-C 109.371 -0.603 . . . . 1.4299999999999999 109.371 173.96 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A 1554 ' ' GLY . . . . . . . . . . . . . . . 105.56 -143.05 15.64 Favored Glycine 0 N--CA 1.435 -1.42 0 O-C-N 123.785 0.678 . . . . 1.1200000000000001 112.745 174.802 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A 1555 ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -117.91 157.49 26.59 Favored 'General case' 0 C--N 1.303 -1.418 0 N-CA-C 108.473 -0.936 . . . . 1.8 108.473 179.754 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A 1556 ' ' ASN . . . . . 0.59 HD21 ' HB3' ' A' 1549 ' ' TYR . 4.0 t-20 -100.38 -23.4 14.77 Favored 'General case' 0 C--N 1.301 -1.533 0 CA-C-N 116.281 -0.418 . . . . 2.6299999999999999 111.977 -172.816 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A 1557 ' ' GLU . . . . . 0.469 ' C ' ' H ' ' A' 1559 ' ' CYS . 37.7 mt-10 54.82 -158.99 0.19 Allowed 'General case' 0 N--CA 1.449 -0.477 0 CA-C-N 114.92 -1.036 . . . . 3.79 109.577 -174.709 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A 1558 ' ' ASN . . . . . . . . . . . . . 39.8 m-80 69.93 -8.95 0.75 Allowed 'General case' 0 N--CA 1.495 1.801 0 C-N-CA 124.078 0.951 . . . . 1.52 112.192 175.683 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A 1559 ' ' CYS . . . . . 0.739 ' HB3' ' HD2' ' A' 1560 ' ' PRO . 63.4 m -145.04 -173.55 0.36 Allowed Pre-proline 0 C--N 1.283 -2.323 0 N-CA-C 103.683 -2.71 . . . . 0.83999999999999997 103.683 -178.675 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A 1560 ' ' PRO . . . . . 0.739 ' HD2' ' HB3' ' A' 1559 ' ' CYS . 2.8 Cg_exo -37.8 137.3 0.43 Allowed 'Trans proline' 0 C--N 1.373 1.82 0 C-N-CA 123.621 2.88 . . . . 1.1799999999999999 113.727 175.624 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A 1561 ' ' PRO . . . . . . . . . . . . . 39.8 Cg_endo -68.04 125.33 12.91 Favored 'Trans proline' 0 N--CA 1.456 -0.678 0 C-N-CA 122.482 2.121 . . . . 1.51 112.265 -177.839 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A 1562 ' ' GLY . . . . . . . . . . . . . . . 101.68 17.48 21.22 Favored Glycine 0 N--CA 1.434 -1.481 0 C-N-CA 121.029 -0.605 . . . . 0.71999999999999997 112.79 177.341 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A 1563 ' ' VAL . . . . . 0.588 ' HA ' ' HA ' ' A' 1576 ' ' LYS . 10.4 m -103.68 150.75 6.83 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.868 0 N-CA-C 106.746 -1.576 . . . . 0.96999999999999997 106.746 174.631 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A 1564 ' ' GLY . . . . . . . . . . . . . . . -112.26 -5.62 24.66 Favored Glycine 0 C--N 1.317 -0.473 0 C-N-CA 120.233 -0.984 . . . . 0.71999999999999997 113.305 -174.352 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A 1565 ' ' ALA . . . . . . . . . . . . . . . -150.75 133.43 15.75 Favored 'General case' 0 C--O 1.254 1.314 0 N-CA-C 109.414 -0.587 . . . . 0.37 109.414 -179.014 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A 1566 ' ' CYS . . . . . . . . . . . . . 34.7 t -154.06 142.32 20.49 Favored 'General case' 0 C--N 1.312 -1.043 0 CA-C-O 121.234 0.54 . . . . 0.51000000000000001 111.042 -177.186 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A 1567 ' ' PHE . . . . . 0.668 ' O ' ' HA ' ' A' 1571 ' ' ARG . 13.2 m-85 -67.6 150.99 48.06 Favored 'General case' 0 N--CA 1.452 -0.339 0 CA-C-N 115.742 -0.663 . . . . 0.96999999999999997 109.756 176.322 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A 1568 ' ' GLY . . . . . . . . . . . . . . . -108.78 -10.56 24.59 Favored Glycine 0 N--CA 1.432 -1.633 0 C-N-CA 120.337 -0.935 . . . . 1.0800000000000001 111.751 178.831 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A 1569 ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -89.81 -62.34 1.49 Allowed 'General case' 0 C--N 1.317 -0.822 0 N-CA-C 108.217 -1.031 . . . . 2.7400000000000002 108.217 178.374 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A 1570 ' ' THR . . . . . . . . . . . . . 19.3 p -89.24 -11.99 42.03 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 121.135 0.493 . . . . 1.96 111.819 178.718 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A 1571 ' ' ARG . . . . . 0.668 ' HA ' ' O ' ' A' 1567 ' ' PHE . 83.6 mtm180 61.43 37.03 17.01 Favored 'General case' 0 N--CA 1.473 0.709 0 C-N-CA 124.607 1.163 . . . . 3.9500000000000002 113.434 175.748 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A 1572 ' ' ILE . . . . . 0.404 ' H ' ' HB2' ' A' 1567 ' ' PHE . 33.2 mm -99.43 132.9 43.99 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.205 0 N-CA-C 108.655 -0.868 . . . . 1.3700000000000001 108.655 179.907 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A 1573 ' ' SER . . . . . . . . . . . . . 29.5 p -74.73 120.88 20.89 Favored 'General case' 0 N--CA 1.441 -0.89 0 CA-C-O 121.134 0.492 . . . . 1.0800000000000001 111.892 -179.239 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A 1574 ' ' VAL . . . . . . . . . . . . . 35.3 m -113.25 21.8 5.96 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.233 0 CA-C-O 121.672 0.749 . . . . 1.3 112.311 -173.911 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A 1575 ' ' GLY . . . . . . . . . . . . . . . 179.97 127.36 1.11 Allowed Glycine 0 N--CA 1.431 -1.641 0 CA-C-N 115.128 -0.942 . . . . 0.51000000000000001 111.297 176.544 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A 1576 ' ' LYS . . . . . 0.588 ' HA ' ' HA ' ' A' 1563 ' ' VAL . 54.7 tttp -89.91 151.6 21.64 Favored 'General case' 0 C--N 1.313 -0.991 0 N-CA-C 106.794 -1.558 . . . . 2.8999999999999999 106.794 178.499 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A 1577 ' ' ALA . . . . . 0.407 ' HA ' ' CD1' ' A' 1592 ' ' TYR . . . -67.1 88.67 0.17 Allowed 'General case' 0 C--O 1.239 0.508 0 CA-C-O 121.939 0.875 . . . . 0.82999999999999996 112.286 -174.708 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A 1578 ' ' ASN . . . . . . . . . . . . . 49.8 m-80 -117.87 113.29 21.54 Favored 'General case' 0 C--N 1.288 -2.087 0 N-CA-C 104.178 -2.527 . . . . 1.8500000000000001 104.178 172.714 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A 1579 ' ' LYS . . . . . . . . . . . . . 37.4 ttpt -101.07 91.01 4.36 Favored 'General case' 0 C--N 1.274 -2.681 0 C-N-CA 119.24 -0.984 . . . . 1.8999999999999999 109.306 -173.783 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A 1580 ' ' ARG . . . . . . . . . . . . . 49.1 ttp180 -129.7 100.62 5.57 Favored 'General case' 0 N--CA 1.42 -1.968 0 CA-C-N 114.391 -1.277 . . . . 3.6299999999999999 109.576 -178.398 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A 1581 ' ' LEU . . . . . 0.473 ' HB3' ' HB2' ' A' 1512 ' ' GLU . 64.3 tp -96.08 147.63 23.52 Favored 'General case' 0 C--N 1.303 -1.43 0 N-CA-C 107.175 -1.417 . . . . 1.8700000000000001 107.175 177.459 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A 1582 ' ' ARG . . . . . 0.589 ' HG2' HG13 ' A' 1584 ' ' VAL . 40.8 ttp180 -146.36 138.52 25.03 Favored 'General case' 0 C--N 1.304 -1.397 0 C-N-CA 120.559 -0.456 . . . . 3.9700000000000002 111.64 178.782 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A 1583 ' ' TYR . . . . . 0.561 ' HD2' HD21 ' A' 1588 ' ' LEU . 55.7 t80 -98.71 108.14 20.75 Favored 'General case' 0 C--O 1.24 0.586 0 N-CA-C 108.114 -1.069 . . . . 1.4099999999999999 108.114 176.438 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A 1584 ' ' VAL . . . . . 0.589 HG13 ' HG2' ' A' 1582 ' ' ARG . 5.1 m -130.34 108.35 15.67 Favored 'Isoleucine or valine' 0 C--O 1.207 -1.147 0 CA-C-O 120.905 0.383 . . . . 1.6899999999999999 111.847 179.228 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A 1585 ' ' ASP . . . . . . . . . . . . . 38.8 t70 57.37 48.11 15.39 Favored 'General case' 0 N--CA 1.479 0.985 0 CA-C-O 122.423 1.106 . . . . 2.0600000000000001 110.796 175.656 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A 1586 ' ' GLN . . . . . . . . . . . . . 22.8 mt-30 68.56 -7.1 0.74 Allowed 'General case' 0 N--CA 1.477 0.886 0 N-CA-C 114.905 1.446 . . . . 2.3300000000000001 114.905 -179.11 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A 1587 ' ' VAL . . . . . . . . . . . . . 9.6 p -99.67 126.37 53.08 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.189 0 C-N-CA 119.73 -0.788 . . . . 0.78000000000000003 108.907 176.554 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A 1588 ' ' LEU . . . . . 0.582 ' HB2' ' HB2' ' A' 1612 ' ' PHE . 36.0 mt -88.23 143.09 27.24 Favored 'General case' 0 C--N 1.292 -1.902 0 CA-C-N 115.593 -0.731 . . . . 1.4099999999999999 109.082 179.596 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A 1589 ' ' GLN . . . . . . . . . . . . . 9.8 tt0 -135.56 134.45 39.41 Favored 'General case' 0 C--N 1.279 -2.473 0 N-CA-C 108.609 -0.886 . . . . 1.24 108.609 179.089 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A 1590 ' ' LEU . . . . . 0.416 HD12 HD13 ' A' 1581 ' ' LEU . 2.2 tt -134.4 133.11 40.19 Favored 'General case' 0 C--N 1.293 -1.877 0 N-CA-C 104.982 -2.229 . . . . 1.1499999999999999 104.982 177.156 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A 1591 ' ' VAL . . . . . . . . . . . . . 29.6 m -128.53 144.26 38.51 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.848 0 N-CA-C 113.039 0.755 . . . . 1.51 113.039 -173.585 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A 1592 ' ' TYR . . . . . 0.491 ' HH ' ' HA ' ' A' 1553 ' ' CYS . 86.8 m-85 -127.95 97.1 4.69 Favored 'General case' 0 C--N 1.312 -1.061 0 N-CA-C 107.3 -1.37 . . . . 1.0600000000000001 107.3 173.423 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A 1593 ' ' LYS . . . . . 0.502 ' HA ' ' HA ' ' A' 1607 ' ' LYS . 14.4 ptmm? -109.19 165.03 11.92 Favored 'General case' 0 C--N 1.296 -1.755 0 CA-C-N 115.852 -0.613 . . . . 2.1800000000000002 111.361 -174.196 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A 1594 ' ' ASP . . . . . 0.401 ' HA ' ' CB ' ' A' 1605 ' ' SER . 2.1 m-20 58.08 59.91 2.91 Favored 'General case' 0 CA--C 1.507 -0.688 0 C-N-CA 125.34 1.456 . . . . 1.45 114.195 172.802 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A 1595 ' ' GLY . . . . . . . . . . . . . . . -86.65 -77.38 1.24 Allowed Glycine 0 N--CA 1.435 -1.381 0 N-CA-C 109.911 -1.276 . . . . 0.78000000000000003 109.911 174.461 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A 1596 ' ' SER . . . . . . . . . . . . . 51.1 m -114.04 145.79 34.32 Favored Pre-proline 0 C--N 1.299 -1.613 0 N-CA-C 109.824 -0.436 . . . . 1.6799999999999999 109.824 178.147 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A 1597 ' ' PRO . . . . . . . . . . . . . 52.2 Cg_exo -59.83 133.37 50.49 Favored 'Trans proline' 0 C--N 1.351 0.709 0 C-N-CA 123.173 2.582 . . . . 1.1699999999999999 110.41 175.284 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A 1598 ' ' CYS . . . . . . . . . . . . . 47.9 t -95.78 130.28 32.08 Favored Pre-proline 0 C--N 1.292 -1.892 0 CA-C-N 115.628 -0.714 . . . . 1.1899999999999999 110.136 -176.124 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A 1599 ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -75.11 -9.64 20.71 Favored 'Trans proline' 0 C--N 1.35 0.63 0 C-N-CA 123.31 2.673 . . . . 1.5900000000000001 113.551 -177.502 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A 1600 ' ' SER . . . . . 0.418 ' HB2' ' SG ' ' A' 1634 ' ' CYS . 48.6 m -69.11 -26.46 64.92 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 120.75 0.31 . . . . 2.1200000000000001 111.312 179.873 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A 1601 ' ' LYS . . . . . 0.631 ' HB3' HD12 ' A' 1604 ' ' LEU . 6.0 tmtm? -156.65 114.58 3.25 Favored 'General case' 0 C--N 1.314 -0.972 0 N-CA-C 107.11 -1.441 . . . . 3.7400000000000002 107.11 -179.003 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A 1602 ' ' SER . . . . . . . . . . . . . 18.5 m -64.27 105.53 0.92 Allowed 'General case' 0 C--N 1.304 -1.37 0 CA-C-O 121.271 0.558 . . . . 3.79 110.26 179.811 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A 1603 ' ' GLY . . . . . . . . . . . . . . . 125.06 -7.5 8.13 Favored Glycine 0 N--CA 1.441 -1.026 0 N-CA-C 110.617 -0.993 . . . . 2.0 110.617 -176.357 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A 1604 ' ' LEU . . . . . 0.631 HD12 ' HB3' ' A' 1601 ' ' LYS . 1.4 mt -100.88 160.76 14.1 Favored 'General case' 0 C--N 1.318 -0.781 0 C-N-CA 122.808 0.443 . . . . 1.48 110.563 177.227 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A 1605 ' ' SER . . . . . 0.401 ' CB ' ' HA ' ' A' 1594 ' ' ASP . 28.8 m -131.57 -169.37 2.18 Favored 'General case' 0 C--N 1.294 -1.828 0 N-CA-C 106.319 -1.734 . . . . 1.51 106.319 177.445 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A 1606 ' ' TYR . . . . . . . . . . . . . 85.1 m-85 -108.67 131.68 54.67 Favored 'General case' 0 N--CA 1.412 -2.337 0 N-CA-C 106.257 -1.757 . . . . 1.1799999999999999 106.257 -179.884 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A 1607 ' ' LYS . . . . . 0.502 ' HA ' ' HA ' ' A' 1593 ' ' LYS . 20.5 ptmt -125.63 125.13 42.62 Favored 'General case' 0 N--CA 1.409 -2.484 0 O-C-N 124.145 0.903 . . . . 1.6699999999999999 110.918 -177.798 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A 1608 ' ' SER . . . . . 0.678 ' HA ' ' HB2' ' A' 1636 ' ' LEU . 49.7 m -98.87 122.86 42.66 Favored 'General case' 0 C--N 1.301 -1.528 0 N-CA-C 110.205 -0.295 . . . . 1.0 110.205 178.616 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A 1609 ' ' VAL . . . . . . . . . . . . . 84.0 t -119.8 126.37 75.23 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.846 0 C-N-CA 123.381 0.672 . . . . 0.93000000000000005 109.261 179.908 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A 1610 ' ' ILE . . . . . 0.475 HG13 ' HB2' ' A' 1638 ' ' PHE . 3.4 mp -115.67 118.03 57.49 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.832 0 N-CA-C 109.123 -0.695 . . . . 0.78000000000000003 109.123 177.328 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A 1611 ' ' SER . . . . . . . . . . . . . 44.8 p -100.95 120.99 40.97 Favored 'General case' 0 N--CA 1.436 -1.139 0 CA-C-O 120.946 0.403 . . . . 1.29 110.095 176.505 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A 1612 ' ' PHE . . . . . 0.582 ' HB2' ' HB2' ' A' 1588 ' ' LEU . 36.2 m-85 -97.68 104.11 16.1 Favored 'General case' 0 C--N 1.302 -1.476 0 C-N-CA 123.404 0.682 . . . . 0.69999999999999996 109.607 -177.351 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A 1613 ' ' VAL . . . . . 0.552 ' O ' ' HA ' ' A' 1641 ' ' HIS . 46.1 t -103.5 131.88 51.05 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.502 0 N-CA-C 108.534 -0.913 . . . . 0.75 108.534 -178.801 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A 1614 ' ' CYS . . . . . 0.588 ' HA ' ' O ' ' A' 1642 ' ' THR . 0.8 OUTLIER -70.06 101.64 1.86 Allowed 'General case' 0 C--N 1.305 -1.355 0 N-CA-C 115.518 1.673 . . . . 1.3899999999999999 115.518 -178.167 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A 1615 ' ' ARG . . . . . 0.611 ' HB3' ' HB3' ' A' 1641 ' ' HIS . 75.9 ttt180 -137.81 107.07 8.25 Favored Pre-proline 0 C--N 1.323 -0.545 0 C-N-CA 124.221 1.009 . . . . 3.75 108.304 173.84 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A 1616 ' ' PRO . . . . . 0.495 ' HB3' ' HG3' ' A' 1648 ' ' PRO . 58.9 Cg_endo -69.75 64.45 1.79 Allowed 'Trans proline' 0 CA--C 1.546 1.087 0 C-N-CA 123.562 2.841 . . . . 1.3200000000000001 115.194 -177.288 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A 1617 ' ' GLU . . . . . . . . . . . . . 29.5 mm-40 -129.96 27.66 5.13 Favored 'General case' 0 C--N 1.311 -1.081 0 N-CA-C 109.025 -0.731 . . . . 3.21 109.025 176.403 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A 1618 ' ' ALA . . . . . . . . . . . . . . . 70.34 -43.14 0.54 Allowed 'General case' 0 N--CA 1.496 1.862 0 C-N-CA 125.51 1.524 . . . . 2.4399999999999999 111.213 -173.048 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A 1619 ' ' GLY . . . . . . . . . . . . . . . 175.62 -156.02 21.05 Favored Glycine 0 N--CA 1.419 -2.498 0 N-CA-C 106.984 -2.447 . . . . 3.2599999999999998 106.984 178.093 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A 1620 ' ' PRO . . . . . 0.556 ' HD3' ' HD1' ' A' 1640 ' ' TRP . 75.4 Cg_exo -54.85 -52.61 7.62 Favored 'Trans proline' 0 N--CA 1.474 0.37 0 C-N-CA 122.326 2.017 . . . . 5.9199999999999999 108.489 172.642 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A 1621 ' ' THR . . . . . . . . . . . . . 3.0 t -132.0 -52.45 0.97 Allowed 'General case' 0 N--CA 1.416 -2.129 0 N-CA-C 106.162 -1.792 . . . . 4.7599999999999998 106.162 166.678 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A 1622 ' ' ASN . . . . . . . . . . . . . 27.5 t-20 -138.03 -68.92 0.45 Allowed 'General case' 0 CA--C 1.494 -1.176 0 CA-C-O 122.438 1.113 . . . . 2.9199999999999999 110.23 163.322 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A 1623 ' ' ARG . . . . . 0.669 ' HD3' ' HA ' ' A' 1540 ' ' ALA . 3.5 ptp180 -75.78 149.38 83.15 Favored Pre-proline 0 C--N 1.283 -2.299 0 CA-C-N 112.456 -2.156 . . . . 3.6099999999999999 111.537 -177.509 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A 1624 ' ' PRO . . . . . 0.657 ' HB3' ' HB2' ' A' 1640 ' ' TRP . 18.6 Cg_endo -60.2 159.7 25.54 Favored 'Trans proline' 0 C--N 1.364 1.357 0 C-N-CA 124.274 3.316 . . . . 2.3700000000000001 112.427 177.824 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A 1625 ' ' MET . . . . . 0.464 ' HG3' ' HG2' ' A' 1620 ' ' PRO . 72.2 mtm -119.81 150.46 40.39 Favored 'General case' 0 CA--C 1.494 -1.189 0 CA-C-O 121.226 0.536 . . . . 2.1600000000000001 111.347 -178.313 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A 1626 ' ' LEU . . . . . 0.426 HD12 ' O ' ' A' 1637 ' ' PHE . 34.4 tp -83.27 108.98 16.85 Favored 'General case' 0 N--CA 1.43 -1.447 0 N-CA-C 106.632 -1.618 . . . . 1.3500000000000001 106.632 172.572 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A 1627 ' ' ILE . . . . . . . . . . . . . 21.2 pt -85.48 -26.04 6.6 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.965 0 N-CA-C 112.346 0.499 . . . . 1.21 112.346 -173.992 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A 1628 ' ' SER . . . . . . . . . . . . . 23.5 p -167.73 149.98 5.7 Favored 'General case' 0 N--CA 1.438 -1.042 0 CA-C-N 116.699 -0.228 . . . . 1.3999999999999999 110.591 -177.711 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A 1629 ' ' LEU . . . . . 0.748 HD13 HD13 ' A' 1636 ' ' LEU . 33.1 tp -128.35 108.58 10.69 Favored 'General case' 0 N--CA 1.42 -1.956 0 O-C-N 123.812 0.695 . . . . 1.5600000000000001 109.128 177.612 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A 1630 ' ' ASP . . . . . . . . . . . . . 10.0 t70 -83.94 98.44 9.8 Favored 'General case' 0 C--N 1.301 -1.52 0 N-CA-C 106.459 -1.682 . . . . 0.87 106.459 176.936 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A 1631 ' ' LYS . . . . . . . . . . . . . 96.8 mttt -71.65 -20.87 61.89 Favored 'General case' 0 C--N 1.312 -1.054 0 N-CA-C 113.489 0.922 . . . . 2.3500000000000001 113.489 -173.024 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A 1632 ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -85.91 -39.31 17.1 Favored 'General case' 0 C--N 1.324 -0.529 0 N-CA-C 113.413 0.894 . . . . 2.5499999999999998 113.413 -179.908 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A 1633 ' ' THR . . . . . . . . . . . . . 42.2 p -101.21 10.13 41.13 Favored 'General case' 0 C--N 1.315 -0.913 0 C-N-CA 119.459 -0.896 . . . . 1.24 111.547 177.877 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A 1634 ' ' CYS . . . . . 0.418 ' SG ' ' HB2' ' A' 1600 ' ' SER . 10.9 m 54.98 43.92 29.08 Favored 'General case' 0 C--O 1.245 0.833 0 C-N-CA 124.772 1.229 . . . . 0.89000000000000001 111.714 170.177 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A 1635 ' ' THR . . . . . . . . . . . . . 20.9 m -108.16 122.1 46.21 Favored 'General case' 0 N--CA 1.422 -1.861 0 CA-C-N 115.338 -0.846 . . . . 0.75 110.72 -176.178 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A 1636 ' ' LEU . . . . . 0.748 HD13 HD13 ' A' 1629 ' ' LEU . 3.0 mm? -93.07 110.15 21.63 Favored 'General case' 0 C--N 1.312 -1.057 0 CA-C-N 115.296 -0.865 . . . . 1.3300000000000001 108.925 179.986 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A 1637 ' ' PHE . . . . . 0.426 ' O ' HD12 ' A' 1626 ' ' LEU . 99.1 m-85 -100.51 99.21 9.78 Favored 'General case' 0 C--O 1.246 0.918 0 CA-C-O 120.797 0.332 . . . . 0.82999999999999996 111.024 -179.132 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A 1638 ' ' PHE . . . . . 0.475 ' HB2' HG13 ' A' 1610 ' ' ILE . 94.9 m-85 -101.7 141.9 33.86 Favored 'General case' 0 C--N 1.299 -1.588 0 N-CA-C 108.72 -0.844 . . . . 0.59999999999999998 108.72 176.759 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A 1639 ' ' SER . . . . . . . . . . . . . 16.7 t -134.84 137.87 43.68 Favored 'General case' 0 N--CA 1.412 -2.364 0 N-CA-C 109.083 -0.71 . . . . 1.0800000000000001 109.083 -178.913 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A 1640 ' ' TRP . . . . . 0.657 ' HB2' ' HB3' ' A' 1624 ' ' PRO . 7.0 t90 -129.17 99.17 5.15 Favored 'General case' 0 N--CA 1.415 -2.188 0 N-CA-C 108.268 -1.012 . . . . 0.80000000000000004 108.268 179.905 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A 1641 ' ' HIS . . . . . 0.611 ' HB3' ' HB3' ' A' 1615 ' ' ARG . 17.9 m-70 -81.24 95.45 6.95 Favored 'General case' 0 C--N 1.302 -1.463 0 N-CA-C 107.785 -1.191 . . . . 2.54 107.785 174.719 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A 1642 ' ' THR . . . . . 0.588 ' O ' ' HA ' ' A' 1614 ' ' CYS . 13.4 t -138.82 149.52 62.25 Favored Pre-proline 0 C--N 1.305 -1.354 0 CA-C-N 114.895 -1.048 . . . . 1.1499999999999999 109.506 -169.375 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A 1643 ' ' PRO . . . . . . . . . . . . . 58.6 Cg_endo -72.12 0.06 7.83 Favored 'Trans proline' 0 C--N 1.36 1.134 0 C-N-CA 123.833 3.022 . . . . 0.80000000000000004 112.8 179.211 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A 1644 ' ' LEU . . . . . . . . . . . . . 62.5 mt -79.85 4.69 15.82 Favored 'General case' 0 C--N 1.315 -0.892 0 C-N-CA 123.214 0.606 . . . . 1.54 111.171 -178.987 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A 1645 ' ' ALA . . . . . . . . . . . . . . . -106.66 -42.22 5.03 Favored 'General case' 0 C--N 1.316 -0.879 0 CA-C-N 116.221 -0.445 . . . . 0.94999999999999996 110.721 176.923 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A 1646 ' ' CYS . . . . . 0.412 ' N ' ' HB3' ' A' 1614 ' ' CYS . 10.7 m -143.23 144.64 32.23 Favored 'General case' 0 C--N 1.32 -0.684 0 N-CA-C 106.858 -1.534 . . . . 1.4099999999999999 106.858 -179.303 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A 1647 ' ' GLU . . . . . 0.407 ' HG3' ' HZ ' ' A' 1527 ' ' PHE . 47.1 mt-10 -87.07 127.33 59.79 Favored Pre-proline 0 C--N 1.3 -1.565 0 N-CA-C 109.988 -0.375 . . . . 2.9199999999999999 109.988 178.816 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A 1648 ' ' PRO . . . . . 0.495 ' HG3' ' HB3' ' A' 1616 ' ' PRO . 36.5 Cg_endo -67.28 129.11 19.67 Favored 'Trans proline' 0 N--CA 1.453 -0.885 0 C-N-CA 122.158 1.905 . . . . 2.8199999999999998 109.987 172.731 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A 1649 ' ' GLU . . . . . . . . . . . . . 13.5 pt-20 . . . . . 0 C--N 1.3 -1.574 0 CA-C-O 117.904 -1.046 . . . . 5.0599999999999996 110.58 177.945 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A 1508 ' ' MET . . . . . . . . . . . . . 26.3 ptm . . . . . 0 C--O 1.242 0.666 0 N-CA-C 112.071 0.397 . . . . 8.2699999999999996 112.071 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A 1509 ' ' LYS . . . . . . . . . . . . . 13.7 ptmm? -120.79 152.19 38.65 Favored 'General case' 0 C--N 1.315 -0.904 0 O-C-N 121.754 -0.591 . . . . 6.4800000000000004 109.578 179.764 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A 1510 ' ' SER . . . . . . . . . . . . . 8.4 m -137.77 112.11 8.64 Favored 'General case' 0 C--N 1.304 -1.381 0 N-CA-C 109.627 -0.509 . . . . 4.2199999999999998 109.627 -179.292 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A 1511 ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -115.54 1.97 13.72 Favored 'General case' 0 C--N 1.308 -1.199 0 CA-C-O 122.201 1.0 . . . . 3.0800000000000001 109.266 178.745 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A 1512 ' ' GLU . . . . . 0.758 ' HG3' ' HA ' ' A' 1518 ' ' VAL . 2.9 mp0 -75.73 -6.5 50.89 Favored 'General case' 0 C--N 1.318 -0.793 0 CA-C-N 113.985 -1.462 . . . . 4.46 111.465 -175.544 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A 1513 ' ' HIS . . . . . . . . . . . . . 18.6 m-70 -97.2 -18.7 19.09 Favored 'General case' 0 C--N 1.318 -0.765 0 N-CA-C 108.223 -1.029 . . . . 5.5700000000000003 108.223 -179.41 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A 1514 ' ' ASP . . . . . 0.451 ' O ' ' HE3' ' A' 1579 ' ' LYS . 24.3 t70 -87.65 -42.86 12.37 Favored 'General case' 0 CA--C 1.496 -1.101 0 CA-C-N 114.792 -1.094 . . . . 3.7000000000000002 109.661 -178.356 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A 1515 ' ' ASP . . . . . . . . . . . . . 24.7 t0 -147.16 162.61 38.52 Favored 'General case' 0 C--N 1.306 -1.303 0 N-CA-C 108.782 -0.821 . . . . 2.54 108.782 -179.526 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A 1516 ' ' CYS . . . . . . . . . . . . . 9.6 m -78.2 54.03 1.31 Allowed 'General case' 0 C--N 1.31 -1.128 0 C-N-CA 123.828 0.851 . . . . 1.25 111.362 -175.249 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A 1517 ' ' GLN . . . . . . . . . . . . . 11.0 pt20 -132.62 122.78 25.23 Favored 'General case' 0 C--N 1.296 -1.724 0 N-CA-C 108.605 -0.887 . . . . 1.8799999999999999 108.605 178.779 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A 1518 ' ' VAL . . . . . 0.758 ' HA ' ' HG3' ' A' 1512 ' ' GLU . 7.4 p -109.11 127.25 65.95 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.967 0 CA-C-O 121.621 0.724 . . . . 1.73 111.536 -175.364 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A 1519 ' ' THR . . . . . . . . . . . . . 5.2 m -92.43 118.65 31.17 Favored 'General case' 0 N--CA 1.421 -1.902 0 CA-C-N 115.569 -0.741 . . . . 1.7 109.168 178.312 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A 1520 ' ' ASN . . . . . 0.428 ' CG ' HG22 ' A' 1523 ' ' THR . 32.8 t-20 -84.11 113.83 50.59 Favored Pre-proline 0 C--N 1.31 -1.119 0 N-CA-C 107.513 -1.292 . . . . 2.1200000000000001 107.513 175.918 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A 1521 ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -73.82 -9.58 22.53 Favored 'Trans proline' 0 C--N 1.354 0.834 0 C-N-CA 122.63 2.22 . . . . 2.4700000000000002 113.475 -173.27 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A 1522 ' ' SER . . . . . . . . . . . . . 19.5 m -94.32 -50.96 5.01 Favored 'General case' 0 N--CA 1.427 -1.615 0 C-N-CA 120.825 -0.35 . . . . 2.5699999999999998 111.365 -179.022 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A 1523 ' ' THR . . . . . 0.428 HG22 ' CG ' ' A' 1520 ' ' ASN . 13.8 t -89.79 -12.86 38.01 Favored 'General case' 0 CA--C 1.552 1.041 0 C-N-CA 119.805 -0.758 . . . . 2.1499999999999999 111.184 -178.888 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A 1524 ' ' GLY . . . . . . . . . . . . . . . 73.41 20.36 79.85 Favored Glycine 0 C--O 1.222 -0.619 0 CA-C-N 116.062 -0.517 . . . . 1.8899999999999999 113.634 177.698 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A 1525 ' ' HIS . . . . . . . . . . . . . 9.8 t60 -101.23 136.99 40.16 Favored 'General case' 0 C--N 1.31 -1.126 0 O-C-N 122.222 -0.575 . . . . 1.8999999999999999 109.466 -177.801 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A 1526 ' ' LEU . . . . . . . . . . . . . 65.1 tp -95.3 106.25 18.27 Favored 'General case' 0 C--N 1.303 -1.449 0 N-CA-C 108.346 -0.983 . . . . 1.6100000000000001 108.346 177.906 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A 1527 ' ' PHE . . . . . 0.493 ' CE1' ' HA ' ' A' 1646 ' ' CYS . 93.9 m-85 -89.53 104.94 17.45 Favored 'General case' 0 C--N 1.302 -1.476 0 CA-C-O 121.417 0.627 . . . . 1.4199999999999999 109.441 -179.055 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A 1528 ' ' ASP . . . . . . . . . . . . . 10.9 t70 -89.9 114.67 26.49 Favored 'General case' 0 C--N 1.296 -1.735 0 CA-C-N 115.55 -0.75 . . . . 2.1800000000000002 109.247 -179.843 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A 1529 ' ' LEU . . . . . 0.434 ' HA ' ' HG ' ' A' 1532 ' ' LEU . 37.6 mt -111.04 8.38 21.86 Favored 'General case' 0 C--N 1.295 -1.764 0 N-CA-C 107.918 -1.141 . . . . 1.4399999999999999 107.918 178.983 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A 1530 ' ' SER . . . . . 0.442 ' HA ' ' SG ' ' A' 1553 ' ' CYS . 22.9 t -80.31 -45.75 17.31 Favored 'General case' 0 N--CA 1.439 -0.996 0 CA-C-N 114.597 -1.183 . . . . 1.4399999999999999 109.307 -175.482 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A 1531 ' ' SER . . . . . . . . . . . . . 14.1 p -74.2 -16.86 60.96 Favored 'General case' 0 N--CA 1.438 -1.062 0 CA-C-N 115.514 -0.766 . . . . 1.5 111.589 -179.329 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A 1532 ' ' LEU . . . . . 0.446 HD11 HD11 ' A' 1644 ' ' LEU . 71.6 mt -65.96 -57.21 8.34 Favored 'General case' 0 CA--C 1.508 -0.651 0 CA-C-O 121.116 0.484 . . . . 1.77 111.398 -179.506 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A 1533 ' ' SER . . . . . . . . . . . . . 28.1 t -81.23 139.05 35.71 Favored 'General case' 0 N--CA 1.427 -1.583 0 CA-C-N 115.066 -0.97 . . . . 2.3799999999999999 111.24 -173.037 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A 1534 ' ' GLY . . . . . . . . . . . . . . . -85.06 171.68 46.73 Favored Glycine 0 N--CA 1.416 -2.641 0 N-CA-C 107.65 -2.18 . . . . 1.55 107.65 170.652 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A 1535 ' ' ARG . . . . . . . . . . . . . 38.5 ttm180 -77.7 -15.68 58.99 Favored 'General case' 0 C--N 1.3 -1.569 0 CA-C-O 121.91 0.862 . . . . 3.96 110.764 -176.33 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A 1536 ' ' ALA . . . . . . . . . . . . . . . -84.23 -11.4 56.55 Favored 'General case' 0 C--O 1.242 0.668 0 N-CA-C 108.881 -0.785 . . . . 1.6499999999999999 108.881 174.411 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A 1537 ' ' GLY . . . . . . . . . . . . . . . 74.92 -150.3 40.88 Favored Glycine 0 N--CA 1.426 -1.991 0 CA-C-N 114.701 -1.136 . . . . 1.1899999999999999 113.459 178.17 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A 1538 ' ' PHE . . . . . 0.473 ' CD1' HD13 ' A' 1552 ' ' ILE . 95.5 m-85 -120.98 146.77 46.32 Favored 'General case' 0 C--N 1.295 -1.803 0 N-CA-C 107.765 -1.198 . . . . 1.6899999999999999 107.765 177.746 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A 1539 ' ' THR . . . . . . . . . . . . . 30.2 p -99.38 113.53 25.91 Favored 'General case' 0 C--N 1.283 -2.298 0 CA-C-O 121.323 0.582 . . . . 1.48 109.993 179.591 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A 1540 ' ' ALA . . . . . 0.719 ' HB3' HG13 ' A' 1548 ' ' VAL . . . -93.84 148.56 22.02 Favored 'General case' 0 C--N 1.296 -1.726 0 CA-C-N 115.724 -0.671 . . . . 0.82999999999999996 109.899 -177.575 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A 1541 ' ' ALA . . . . . . . . . . . . . . . -85.7 128.38 34.77 Favored 'General case' 0 N--CA 1.439 -0.982 0 N-CA-C 109.025 -0.731 . . . . 1.27 109.025 178.51 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A 1542 ' ' TYR . . . . . 0.546 ' HD2' ' HB2' ' A' 1545 ' ' SER . 72.9 t80 -136.54 171.79 13.97 Favored 'General case' 0 C--N 1.296 -1.758 0 CA-C-N 116.007 -0.542 . . . . 2.1499999999999999 109.826 -177.667 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A 1543 ' ' SER . . . . . . . . . . . . . 3.6 m -45.67 -150.79 0.0 OUTLIER 'General case' 0 CA--C 1.573 1.855 0 C-N-CA 130.466 3.507 . . . . 2.29 114.147 177.537 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A 1544 ' ' LYS . . . . . . . . . . . . . 22.6 tptm -39.55 -37.22 0.46 Allowed 'General case' 0 N--CA 1.495 1.799 0 N-CA-C 113.531 0.937 . . . . 3.9100000000000001 113.531 178.842 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A 1545 ' ' SER . . . . . 0.546 ' HB2' ' HD2' ' A' 1542 ' ' TYR . 15.7 m -65.08 -21.22 66.78 Favored 'General case' 0 CA--C 1.557 1.246 0 N-CA-C 112.023 0.379 . . . . 3.2999999999999998 112.023 178.401 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A 1546 ' ' GLY . . . . . . . . . . . . . . . 82.45 -67.18 3.76 Favored Glycine 0 N--CA 1.443 -0.839 0 N-CA-C 113.866 0.307 . . . . 1.24 113.866 176.154 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A 1547 ' ' VAL . . . . . . . . . . . . . 72.0 t -128.67 144.48 37.88 Favored 'Isoleucine or valine' 0 N--CA 1.419 -1.997 0 C-N-CA 122.985 0.514 . . . . 1.6299999999999999 110.228 -175.031 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A 1548 ' ' VAL . . . . . 0.719 HG13 ' HB3' ' A' 1540 ' ' ALA . 2.6 p -133.69 127.58 52.99 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.219 0 N-CA-C 108.309 -0.997 . . . . 0.92000000000000004 108.309 173.285 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A 1549 ' ' TYR . . . . . 0.521 ' CZ ' ' HA2' ' A' 1568 ' ' GLY . 0.6 OUTLIER -101.49 133.23 46.46 Favored 'General case' 0 C--N 1.303 -1.43 0 CA-C-O 121.756 0.789 . . . . 1.4399999999999999 112.296 -179.188 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A 1550 ' ' MET . . . . . . . . . . . . . 43.2 ttp -144.51 129.33 18.32 Favored 'General case' 0 C--N 1.296 -1.751 0 CA-C-N 114.666 -1.152 . . . . 1.74 109.704 -176.37 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A 1551 ' ' SER . . . . . . . . . . . . . 50.5 m -88.16 139.8 30.13 Favored 'General case' 0 C--N 1.289 -2.035 0 N-CA-C 108.671 -0.863 . . . . 1.6399999999999999 108.671 178.207 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A 1552 ' ' ILE . . . . . 0.473 HD13 ' CD1' ' A' 1538 ' ' PHE . 1.4 mp -87.13 -6.61 10.7 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.2 0 CA-C-O 122.773 1.273 . . . . 1.3300000000000001 109.462 178.876 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A 1553 ' ' CYS . . . . . 0.442 ' SG ' ' HA ' ' A' 1530 ' ' SER . 54.1 t -157.8 138.28 12.84 Favored 'General case' 0 N--CA 1.416 -2.132 0 CA-C-N 114.179 -1.373 . . . . 1.4299999999999999 108.843 174.501 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A 1554 ' ' GLY . . . . . . . . . . . . . . . 74.09 -169.35 53.89 Favored Glycine 0 N--CA 1.434 -1.497 0 O-C-N 123.958 0.786 . . . . 1.1200000000000001 113.816 174.635 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A 1555 ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -72.91 153.44 41.0 Favored 'General case' 0 C--N 1.311 -1.068 0 CA-C-N 114.805 -0.697 . . . . 1.8 111.362 179.412 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A 1556 ' ' ASN . . . . . . . . . . . . . 25.4 t-20 -105.4 139.31 40.23 Favored 'General case' 0 N--CA 1.414 -2.227 0 CA-C-N 114.509 -1.223 . . . . 2.6299999999999999 108.01 177.494 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A 1557 ' ' GLU . . . . . . . . . . . . . 45.9 mt-10 -102.53 174.9 5.69 Favored 'General case' 0 C--N 1.29 -2.013 0 CA-C-N 115.864 -0.607 . . . . 3.79 110.856 -178.251 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A 1558 ' ' ASN . . . . . . . . . . . . . 46.5 m-80 72.44 12.17 5.64 Favored 'General case' 0 N--CA 1.486 1.355 0 C-N-CA 124.685 1.194 . . . . 1.52 110.597 -176.026 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A 1559 ' ' CYS . . . . . 0.62 ' SG ' ' HD2' ' A' 1560 ' ' PRO . 22.5 t -160.69 152.45 16.49 Favored Pre-proline 0 C--N 1.295 -1.784 0 N-CA-C 103.856 -2.646 . . . . 0.83999999999999997 103.856 179.168 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A 1560 ' ' PRO . . . . . 0.62 ' HD2' ' SG ' ' A' 1559 ' ' CYS . 39.2 Cg_exo -24.24 112.59 0.02 OUTLIER 'Trans proline' 0 C--N 1.368 1.591 0 C-N-CA 125.253 3.968 . . . . 1.1799999999999999 115.472 179.075 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A 1561 ' ' PRO . . . . . 0.505 ' HD2' ' HA ' ' A' 1560 ' ' PRO . 9.6 Cg_endo -53.76 110.63 0.52 Allowed 'Trans proline' 0 C--O 1.237 0.475 0 C-N-CA 123.685 2.923 . . . . 1.51 112.58 179.846 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A 1562 ' ' GLY . . . . . . . . . . . . . . . 133.78 -16.26 4.53 Favored Glycine 0 N--CA 1.439 -1.121 0 C-N-CA 120.528 -0.844 . . . . 0.71999999999999997 111.84 179.254 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A 1563 ' ' VAL . . . . . 0.431 ' HA ' ' HA ' ' A' 1576 ' ' LYS . 4.3 m -86.83 157.35 3.25 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.264 0 N-CA-C 107.586 -1.264 . . . . 0.96999999999999997 107.586 178.834 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A 1564 ' ' GLY . . . . . . . . . . . . . . . -111.44 -22.93 5.91 Favored Glycine 0 N--CA 1.444 -0.791 0 C-N-CA 120.459 -0.877 . . . . 0.71999999999999997 112.545 -177.904 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A 1565 ' ' ALA . . . . . . . . . . . . . . . -141.51 125.45 17.15 Favored 'General case' 0 C--O 1.247 0.957 0 N-CA-C 109.553 -0.536 . . . . 0.37 109.553 -179.437 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A 1566 ' ' CYS . . . . . . . . . . . . . 53.9 t -148.94 132.91 17.14 Favored 'General case' 0 C--N 1.314 -0.946 0 CA-C-N 116.324 -0.398 . . . . 0.51000000000000001 109.999 -176.476 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A 1567 ' ' PHE . . . . . 0.427 ' HA ' HG23 ' A' 1548 ' ' VAL . 35.0 m-85 -63.82 134.82 55.94 Favored 'General case' 0 N--CA 1.474 0.742 0 N-CA-C 108.106 -1.072 . . . . 0.96999999999999997 108.106 177.205 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A 1568 ' ' GLY . . . . . 0.521 ' HA2' ' CZ ' ' A' 1549 ' ' TYR . . . -73.67 -30.74 61.46 Favored Glycine 0 CA--C 1.498 -0.989 0 CA-C-N 116.42 -0.354 . . . . 1.0800000000000001 113.727 -173.199 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A 1569 ' ' GLN . . . . . . . . . . . . . 55.1 tp60 -82.45 -56.83 3.64 Favored 'General case' 0 C--N 1.304 -1.376 0 CA-C-O 121.359 0.6 . . . . 2.7400000000000002 110.511 -179.725 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A 1570 ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -72.06 -27.29 62.59 Favored 'General case' 0 N--CA 1.426 -1.654 0 CA-C-N 114.963 -1.017 . . . . 1.96 111.33 -174.974 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A 1571 ' ' ARG . . . . . . . . . . . . . 42.7 ttp180 52.87 60.75 3.58 Favored 'General case' 0 C--O 1.235 0.315 0 CA-C-O 121.85 0.833 . . . . 3.9500000000000002 109.687 -176.781 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A 1572 ' ' ILE . . . . . . . . . . . . . 40.4 mm -131.58 129.55 61.78 Favored 'Isoleucine or valine' 0 C--O 1.251 1.165 0 N-CA-C 106.915 -1.513 . . . . 1.3700000000000001 106.915 179.405 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A 1573 ' ' SER . . . . . . . . . . . . . 35.7 t -73.04 140.04 46.99 Favored 'General case' 0 C--N 1.303 -1.437 0 O-C-N 124.126 0.891 . . . . 1.0800000000000001 111.357 -178.373 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A 1574 ' ' VAL . . . . . . . . . . . . . 18.0 m -133.06 19.77 1.44 Allowed 'Isoleucine or valine' 0 C--N 1.314 -0.937 0 CA-C-N 115.815 -0.63 . . . . 1.3 110.828 174.587 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A 1575 ' ' GLY . . . . . . . . . . . . . . . 173.73 126.58 0.92 Allowed Glycine 0 N--CA 1.44 -1.058 0 C-N-CA 120.627 -0.797 . . . . 0.51000000000000001 111.869 178.336 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A 1576 ' ' LYS . . . . . 0.431 ' HA ' ' HA ' ' A' 1563 ' ' VAL . 59.0 tttp -82.98 147.45 28.19 Favored 'General case' 0 C--O 1.239 0.552 0 N-CA-C 107.57 -1.271 . . . . 2.8999999999999999 107.57 179.263 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A 1577 ' ' ALA . . . . . . . . . . . . . . . -68.92 79.16 0.31 Allowed 'General case' 0 N--CA 1.475 0.804 0 N-CA-C 113.041 0.756 . . . . 0.82999999999999996 113.041 -174.151 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A 1578 ' ' ASN . . . . . 0.465 ' H ' ' HD1' ' A' 1592 ' ' TYR . 32.0 m-80 -96.67 113.41 24.97 Favored 'General case' 0 C--N 1.297 -1.716 0 N-CA-C 108.107 -1.071 . . . . 1.8500000000000001 108.107 175.519 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A 1579 ' ' LYS . . . . . 0.451 ' HE3' ' O ' ' A' 1514 ' ' ASP . 52.8 pttt -96.92 109.2 21.98 Favored 'General case' 0 C--N 1.291 -1.972 0 CA-C-O 121.311 0.577 . . . . 1.8999999999999999 109.712 -178.859 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A 1580 ' ' ARG . . . . . 0.43 ' HA ' ' O ' ' A' 1512 ' ' GLU . 32.7 ttm180 -158.43 94.18 1.26 Allowed 'General case' 0 N--CA 1.43 -1.445 0 CA-C-N 115.033 -0.985 . . . . 3.6299999999999999 109.435 -177.36 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A 1581 ' ' LEU . . . . . 0.415 ' CB ' ' HB ' ' A' 1518 ' ' VAL . 4.4 mm? -85.52 124.5 32.16 Favored 'General case' 0 C--N 1.302 -1.491 0 CA-C-N 116.275 -0.421 . . . . 1.8700000000000001 110.554 178.011 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A 1582 ' ' ARG . . . . . . . . . . . . . 89.0 mtm180 -120.29 134.32 55.29 Favored 'General case' 0 C--N 1.29 -1.98 0 CA-C-O 121.112 0.482 . . . . 3.9700000000000002 110.863 177.076 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A 1583 ' ' TYR . . . . . . . . . . . . . 80.1 t80 -94.9 96.84 9.58 Favored 'General case' 0 C--N 1.292 -1.904 0 N-CA-C 107.485 -1.302 . . . . 1.4099999999999999 107.485 176.908 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A 1584 ' ' VAL . . . . . . . . . . . . . 36.5 t -112.3 95.16 3.6 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.287 0 CA-C-N 115.653 -0.703 . . . . 1.6899999999999999 109.528 -176.176 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A 1585 ' ' ASP . . . . . . . . . . . . . 35.1 t70 54.72 75.57 0.29 Allowed 'General case' 0 C--N 1.32 -0.708 0 C-N-CA 124.308 1.043 . . . . 2.0600000000000001 112.472 177.775 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A 1586 ' ' GLN . . . . . . . . . . . . . 34.1 tt0 68.16 -14.67 0.24 Allowed 'General case' 0 CA--C 1.574 1.888 0 C-N-CA 124.868 1.267 . . . . 2.3300000000000001 114.398 176.403 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A 1587 ' ' VAL . . . . . . . . . . . . . 7.5 p -118.4 129.62 74.43 Favored 'Isoleucine or valine' 0 C--O 1.25 1.09 0 O-C-N 121.273 -0.892 . . . . 0.78000000000000003 111.484 -179.4 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A 1588 ' ' LEU . . . . . 0.749 ' HB2' ' HB2' ' A' 1612 ' ' PHE . 3.8 mm? -81.26 157.53 25.13 Favored 'General case' 0 N--CA 1.435 -1.189 0 CA-C-N 115.23 -0.896 . . . . 1.4099999999999999 110.415 179.001 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A 1589 ' ' GLN . . . . . . . . . . . . . 34.6 tt0 -148.05 134.96 20.14 Favored 'General case' 0 C--N 1.31 -1.148 0 C-N-CA 121.154 -0.218 . . . . 1.24 110.643 -174.715 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A 1590 ' ' LEU . . . . . 0.468 ' HB3' ' HB ' ' A' 1610 ' ' ILE . 51.0 tp -119.39 133.39 55.74 Favored 'General case' 0 C--N 1.301 -1.507 0 N-CA-C 106.95 -1.5 . . . . 1.1499999999999999 106.95 175.396 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A 1591 ' ' VAL . . . . . . . . . . . . . 52.8 t -126.99 111.63 26.31 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.537 0 CA-C-O 121.022 0.439 . . . . 1.51 111.969 -174.884 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A 1592 ' ' TYR . . . . . 0.465 ' HD1' ' H ' ' A' 1578 ' ' ASN . 20.6 m-85 -101.37 93.05 5.21 Favored 'General case' 0 C--N 1.308 -1.205 0 N-CA-C 108.512 -0.921 . . . . 1.0600000000000001 108.512 173.87 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A 1593 ' ' LYS . . . . . . . . . . . . . 61.4 pttt -103.36 177.21 4.91 Favored 'General case' 0 C--N 1.283 -2.321 0 CA-C-N 115.569 -0.741 . . . . 2.1800000000000002 109.926 -178.754 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A 1594 ' ' ASP . . . . . . . . . . . . . 8.3 m-20 53.96 42.04 31.81 Favored 'General case' 0 N--CA 1.475 0.8 0 N-CA-C 113.923 1.083 . . . . 1.45 113.923 175.74 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A 1595 ' ' GLY . . . . . . . . . . . . . . . -74.58 -87.49 0.24 Allowed Glycine 0 N--CA 1.445 -0.704 0 C-N-CA 120.356 -0.926 . . . . 0.78000000000000003 111.069 176.477 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A 1596 ' ' SER . . . . . . . . . . . . . 32.4 m -114.43 154.33 46.5 Favored Pre-proline 0 C--N 1.294 -1.807 0 N-CA-C 108.258 -1.016 . . . . 1.6799999999999999 108.258 177.599 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A 1597 ' ' PRO . . . . . . . . . . . . . 23.1 Cg_exo -67.03 133.32 30.65 Favored 'Trans proline' 0 C--N 1.351 0.672 0 C-N-CA 122.849 2.366 . . . . 1.1699999999999999 109.997 177.153 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A 1598 ' ' CYS . . . . . 0.445 ' HA ' ' HD3' ' A' 1599 ' ' PRO . 42.4 t -97.68 121.14 58.9 Favored Pre-proline 0 C--N 1.289 -2.055 0 CA-C-O 120.533 0.206 . . . . 1.1899999999999999 110.768 -175.939 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A 1599 ' ' PRO . . . . . 0.445 ' HD3' ' HA ' ' A' 1598 ' ' CYS . 2.8 Cg_exo -77.52 -7.83 16.95 Favored 'Trans proline' 0 C--O 1.238 0.494 0 C-N-CA 123.23 2.62 . . . . 1.5900000000000001 112.227 179.992 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A 1600 ' ' SER . . . . . 0.433 ' HB3' ' SG ' ' A' 1598 ' ' CYS . 22.8 t -75.32 -19.7 59.49 Favored 'General case' 0 C--N 1.317 -0.811 0 CA-C-N 115.831 -0.622 . . . . 2.1200000000000001 110.313 -177.563 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A 1601 ' ' LYS . . . . . 0.565 ' HB3' HD12 ' A' 1604 ' ' LEU . 24.5 tptm -162.33 116.64 1.82 Allowed 'General case' 0 N--CA 1.443 -0.82 0 N-CA-C 108.556 -0.905 . . . . 3.7400000000000002 108.556 178.915 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A 1602 ' ' SER . . . . . . . . . . . . . 51.4 m -61.3 123.2 17.09 Favored 'General case' 0 C--N 1.313 -1.01 0 CA-C-O 121.393 0.616 . . . . 3.79 111.588 179.202 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A 1603 ' ' GLY . . . . . . . . . . . . . . . 104.94 -1.45 41.33 Favored Glycine 0 N--CA 1.439 -1.1 0 CA-C-N 115.067 -0.969 . . . . 2.0 111.004 -179.895 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A 1604 ' ' LEU . . . . . 0.565 HD12 ' HB3' ' A' 1601 ' ' LYS . 3.0 mt -107.05 145.3 32.53 Favored 'General case' 0 C--N 1.31 -1.111 0 CA-C-O 121.692 0.758 . . . . 1.48 111.859 179.62 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A 1605 ' ' SER . . . . . . . . . . . . . 25.6 m -111.27 -173.94 2.35 Favored 'General case' 0 C--N 1.29 -1.987 0 N-CA-C 105.824 -1.917 . . . . 1.51 105.824 172.929 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A 1606 ' ' TYR . . . . . . . . . . . . . 62.1 m-85 -101.59 128.67 47.75 Favored 'General case' 0 CA--C 1.453 -2.78 0 N-CA-C 105.792 -1.929 . . . . 1.1799999999999999 105.792 178.014 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A 1607 ' ' LYS . . . . . 0.496 ' O ' ' HA ' ' A' 1635 ' ' THR . 4.3 ptmm? -128.05 135.06 49.33 Favored 'General case' 0 N--CA 1.397 -3.075 0 O-C-N 124.506 1.129 . . . . 1.6699999999999999 111.152 -176.813 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A 1608 ' ' SER . . . . . . . . . . . . . 35.1 t -114.98 125.89 54.13 Favored 'General case' 0 C--N 1.292 -1.921 0 N-CA-C 109.339 -0.615 . . . . 1.0 109.339 -178.753 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A 1609 ' ' VAL . . . . . . . . . . . . . 41.3 t -115.14 115.39 49.31 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.814 0 CA-C-O 121.237 0.541 . . . . 0.93000000000000005 110.439 178.854 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A 1610 ' ' ILE . . . . . 0.678 HG13 ' HB2' ' A' 1638 ' ' PHE . 2.9 mp -102.16 113.67 39.3 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.338 0 N-CA-C 108.717 -0.845 . . . . 0.78000000000000003 108.717 178.962 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A 1611 ' ' SER . . . . . . . . . . . . . 42.7 m -95.17 123.36 38.63 Favored 'General case' 0 C--N 1.284 -2.26 0 N-CA-C 109.012 -0.736 . . . . 1.29 109.012 177.367 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A 1612 ' ' PHE . . . . . 0.749 ' HB2' ' HB2' ' A' 1588 ' ' LEU . 98.2 m-85 -92.62 103.51 15.9 Favored 'General case' 0 C--N 1.305 -1.353 0 N-CA-C 108.831 -0.803 . . . . 0.69999999999999996 108.831 178.835 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A 1613 ' ' VAL . . . . . 0.645 ' O ' ' HA ' ' A' 1641 ' ' HIS . 24.0 t -100.2 109.23 24.51 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.883 0 N-CA-C 107.224 -1.399 . . . . 0.75 107.224 -174.918 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A 1614 ' ' CYS . . . . . 0.574 ' HA ' ' O ' ' A' 1642 ' ' THR . 31.8 m -70.23 100.47 1.7 Allowed 'General case' 0 C--N 1.279 -2.458 0 CA-C-N 115.963 -0.562 . . . . 1.3899999999999999 111.516 -174.362 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A 1615 ' ' ARG . . . . . 0.45 ' HB3' ' HB3' ' A' 1641 ' ' HIS . 56.9 ttt180 -126.77 99.07 29.99 Favored Pre-proline 0 N--CA 1.439 -0.993 0 CA-C-N 115.479 -0.782 . . . . 3.75 109.412 -179.152 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A 1616 ' ' PRO . . . . . 0.419 ' HA ' ' HB3' ' A' 1643 ' ' PRO . 76.7 Cg_exo -52.43 -34.42 61.37 Favored 'Trans proline' 0 CA--C 1.534 0.489 0 C-N-CA 123.993 3.129 . . . . 1.3200000000000001 113.834 177.781 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A 1617 ' ' GLU . . . . . . . . . . . . . 48.2 mt-10 -81.01 40.77 0.55 Allowed 'General case' 0 CA--C 1.545 0.753 0 N-CA-C 112.611 0.597 . . . . 3.21 112.611 -177.938 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A 1618 ' ' ALA . . . . . . . . . . . . . . . -81.4 124.82 29.73 Favored 'General case' 0 C--N 1.308 -1.231 0 N-CA-C 109.079 -0.711 . . . . 2.4399999999999999 109.079 178.523 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A 1619 ' ' GLY . . . . . . . . . . . . . . . -84.41 -161.4 33.02 Favored Glycine 0 CA--C 1.527 0.802 0 CA-C-N 116.182 -0.463 . . . . 3.2599999999999998 113.93 -177.368 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A 1620 ' ' PRO . . . . . . . . . . . . . 90.8 Cg_endo -85.21 3.92 7.04 Favored 'Trans proline' 0 CA--C 1.54 0.809 0 C-N-CA 123.352 2.701 . . . . 5.9199999999999999 113.928 -176.545 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A 1621 ' ' THR . . . . . . . . . . . . . 14.9 m -120.33 42.79 2.88 Favored 'General case' 0 C--N 1.303 -1.439 0 N-CA-C 107.044 -1.465 . . . . 4.7599999999999998 107.044 178.743 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A 1622 ' ' ASN . . . . . . . . . . . . . 27.6 t-20 -102.66 109.09 20.58 Favored 'General case' 0 C--N 1.305 -1.365 0 CA-C-N 114.322 -1.308 . . . . 2.9199999999999999 111.885 -174.732 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A 1623 ' ' ARG . . . . . . . . . . . . . 19.8 ptp180 -151.89 156.95 34.47 Favored Pre-proline 0 C--N 1.3 -1.583 0 N-CA-C 105.048 -2.204 . . . . 3.6099999999999999 105.048 175.229 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A 1624 ' ' PRO . . . . . 0.463 ' HG3' HD11 ' A' 1552 ' ' ILE . 13.6 Cg_endo -56.22 115.76 2.7 Favored 'Trans proline' 0 C--O 1.237 0.433 0 C-N-CA 122.669 2.246 . . . . 2.3700000000000001 112.154 -179.313 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A 1625 ' ' MET . . . . . . . . . . . . . 1.3 pmm? -106.48 147.7 29.05 Favored 'General case' 0 C--O 1.245 0.845 0 CA-C-O 120.999 0.428 . . . . 2.1600000000000001 110.485 -179.216 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A 1626 ' ' LEU . . . . . . . . . . . . . 52.1 tp -77.6 122.02 24.72 Favored 'General case' 0 C--N 1.317 -0.842 0 N-CA-C 107.855 -1.165 . . . . 1.3500000000000001 107.855 176.837 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A 1627 ' ' ILE . . . . . . . . . . . . . 39.1 pt -100.88 -32.81 3.5 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.214 0 C-N-CA 120.48 -0.488 . . . . 1.21 111.286 -179.021 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A 1628 ' ' SER . . . . . . . . . . . . . 49.5 m -151.11 153.28 34.73 Favored 'General case' 0 C--N 1.314 -0.97 0 CA-C-O 120.789 0.328 . . . . 1.3999999999999999 110.283 -177.589 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A 1629 ' ' LEU . . . . . 0.946 HD13 ' HG ' ' A' 1636 ' ' LEU . 17.7 tp -139.12 120.39 14.79 Favored 'General case' 0 C--N 1.294 -1.809 0 N-CA-C 108.522 -0.918 . . . . 1.5600000000000001 108.522 177.47 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A 1630 ' ' ASP . . . . . . . . . . . . . 23.0 t70 -118.29 107.33 13.76 Favored 'General case' 0 C--N 1.299 -1.624 0 N-CA-C 109.658 -0.497 . . . . 0.87 109.658 176.855 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A 1631 ' ' LYS . . . . . . . . . . . . . 34.8 mtmm -78.74 -13.13 59.98 Favored 'General case' 0 C--N 1.303 -1.416 0 CA-C-N 115.514 -0.766 . . . . 2.3500000000000001 111.07 -176.997 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A 1632 ' ' GLN . . . . . . . . . . . . . 40.2 mt-30 -70.35 -42.63 71.58 Favored 'General case' 0 C--N 1.323 -0.544 0 N-CA-C 109.587 -0.523 . . . . 2.5499999999999998 109.587 178.254 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A 1633 ' ' THR . . . . . . . . . . . . . 35.9 p -98.27 4.2 48.77 Favored 'General case' 0 C--N 1.318 -0.765 0 CA-C-O 121.047 0.451 . . . . 1.24 110.821 175.747 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A 1634 ' ' CYS . . . . . . . . . . . . . 59.1 m 56.55 38.8 29.91 Favored 'General case' 0 C--O 1.236 0.394 0 C-N-CA 124.195 0.998 . . . . 0.89000000000000001 110.461 177.361 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A 1635 ' ' THR . . . . . 0.496 ' HA ' ' O ' ' A' 1607 ' ' LYS . 44.2 m -119.73 131.45 55.38 Favored 'General case' 0 N--CA 1.422 -1.841 0 CA-C-N 114.945 -1.025 . . . . 0.75 111.597 -174.223 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A 1636 ' ' LEU . . . . . 0.946 ' HG ' HD13 ' A' 1629 ' ' LEU . 5.2 mp -104.12 134.89 46.61 Favored 'General case' 0 N--CA 1.434 -1.25 0 N-CA-C 108.04 -1.096 . . . . 1.3300000000000001 108.04 174.838 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A 1637 ' ' PHE . . . . . . . . . . . . . 93.9 m-85 -111.42 105.83 14.57 Favored 'General case' 0 C--N 1.307 -1.279 0 CA-C-O 120.919 0.39 . . . . 0.82999999999999996 111.008 -176.844 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A 1638 ' ' PHE . . . . . 0.678 ' HB2' HG13 ' A' 1610 ' ' ILE . 96.4 m-85 -103.11 151.87 22.06 Favored 'General case' 0 C--N 1.306 -1.304 0 N-CA-C 109.03 -0.73 . . . . 0.59999999999999998 109.03 177.398 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A 1639 ' ' SER . . . . . . . . . . . . . 49.0 m -137.08 133.82 35.82 Favored 'General case' 0 C--N 1.276 -2.598 0 N-CA-C 109.705 -0.48 . . . . 1.0800000000000001 109.705 176.656 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A 1640 ' ' TRP . . . . . 0.584 ' HE3' ' HE1' ' A' 1612 ' ' PHE . 12.3 t90 -115.58 120.93 41.07 Favored 'General case' 0 N--CA 1.413 -2.306 0 N-CA-C 106.274 -1.75 . . . . 0.80000000000000004 106.274 174.164 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A 1641 ' ' HIS . . . . . 0.645 ' HA ' ' O ' ' A' 1613 ' ' VAL . 39.1 m-70 -93.89 92.34 7.36 Favored 'General case' 0 C--N 1.304 -1.378 0 N-CA-C 107.517 -1.29 . . . . 2.54 107.517 -177.922 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A 1642 ' ' THR . . . . . 0.73 HG22 ' HG ' ' A' 1644 ' ' LEU . 1.5 m -119.91 123.62 28.34 Favored Pre-proline 0 C--N 1.289 -2.053 0 CA-C-N 114.947 -1.024 . . . . 1.1499999999999999 111.884 -167.96 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A 1643 ' ' PRO . . . . . 0.419 ' HB3' ' HA ' ' A' 1616 ' ' PRO . 31.7 Cg_exo -65.24 -29.7 55.1 Favored 'Trans proline' 0 CA--C 1.539 0.745 0 C-N-CA 123.443 2.762 . . . . 0.80000000000000004 112.861 177.001 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A 1644 ' ' LEU . . . . . 0.73 ' HG ' HG22 ' A' 1642 ' ' THR . 4.4 pp -84.07 -6.76 59.46 Favored 'General case' 0 C--N 1.323 -0.562 0 N-CA-C 112.104 0.409 . . . . 1.54 112.104 -176.969 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A 1645 ' ' ALA . . . . . 0.485 ' HB2' ' HB ' ' A' 1642 ' ' THR . . . -74.14 -30.92 62.51 Favored 'General case' 0 C--N 1.306 -1.3 0 CA-C-N 116.022 -0.536 . . . . 0.94999999999999996 112.165 -174.941 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A 1646 ' ' CYS . . . . . 0.493 ' HA ' ' CE1' ' A' 1527 ' ' PHE . 17.0 p -177.38 175.29 1.48 Allowed 'General case' 0 C--O 1.246 0.871 0 N-CA-C 106.999 -1.482 . . . . 1.4099999999999999 106.999 175.288 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A 1647 ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 -121.19 90.98 47.85 Favored Pre-proline 0 C--N 1.299 -1.608 0 N-CA-C 108.54 -0.911 . . . . 2.9199999999999999 108.54 175.871 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A 1648 ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -74.62 115.53 4.33 Favored 'Trans proline' 0 C--O 1.24 0.581 0 C-N-CA 123.292 2.661 . . . . 2.8199999999999998 114.158 -170.655 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A 1649 ' ' GLU . . . . . . . . . . . . . 35.2 tt0 . . . . . 0 C--N 1.309 -1.154 0 N-CA-C 108.171 -1.048 . . . . 5.0599999999999996 108.171 176.497 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A 1508 ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.531 0.22 0 N-CA-C 113.129 0.788 . . . . 8.2699999999999996 113.129 . . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A 1509 ' ' LYS . . . . . . . . . . . . . 25.6 pttm -120.3 -24.8 5.81 Favored 'General case' 0 C--O 1.232 0.148 0 C-N-CA 119.591 -0.844 . . . . 6.4800000000000004 112.254 -179.295 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A 1510 ' ' SER . . . . . . . . . . . . . 4.3 m -121.39 36.24 4.66 Favored 'General case' 0 C--N 1.309 -1.16 0 N-CA-C 109.286 -0.635 . . . . 4.2199999999999998 109.286 -178.653 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A 1511 ' ' ASN . . . . . . . . . . . . . 15.8 m120 -120.24 2.59 10.86 Favored 'General case' 0 C--N 1.312 -1.052 0 O-C-N 122.197 -0.314 . . . . 3.0800000000000001 111.552 -173.681 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A 1512 ' ' GLU . . . . . . . . . . . . . 7.2 mm-40 -83.51 -4.18 58.29 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 121.26 0.552 . . . . 4.46 111.371 -178.735 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A 1513 ' ' HIS . . . . . . . . . . . . . 62.6 m80 -113.35 39.82 2.51 Favored 'General case' 0 C--N 1.305 -1.348 0 N-CA-C 107.664 -1.235 . . . . 5.5700000000000003 107.664 172.782 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A 1514 ' ' ASP . . . . . . . . . . . . . 3.3 p-10 -49.47 -79.73 0.01 OUTLIER 'General case' 0 C--O 1.232 0.181 0 CA-C-N 114.043 -1.435 . . . . 3.7000000000000002 113.051 179.635 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A 1515 ' ' ASP . . . . . . . . . . . . . 17.3 t70 62.16 -88.31 0.02 OUTLIER 'General case' 0 CA--C 1.551 0.991 0 C-N-CA 123.268 0.627 . . . . 2.54 109.958 -177.995 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A 1516 ' ' CYS . . . . . 0.472 ' SG ' ' HD2' ' A' 1579 ' ' LYS . 97.1 m -137.09 18.96 2.98 Favored 'General case' 0 C--N 1.316 -0.874 0 CA-C-O 121.194 0.521 . . . . 1.25 110.456 175.104 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A 1517 ' ' GLN . . . . . 0.539 ' HB2' HD21 ' A' 1526 ' ' LEU . 11.2 pt20 -132.54 137.47 47.14 Favored 'General case' 0 C--N 1.302 -1.469 0 O-C-N 121.809 -0.557 . . . . 1.8799999999999999 109.7 178.92 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A 1518 ' ' VAL . . . . . . . . . . . . . 10.2 p -143.55 134.87 22.83 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.664 0 CA-C-O 121.025 0.441 . . . . 1.73 110.288 -178.402 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A 1519 ' ' THR . . . . . 0.773 ' HA ' ' HA ' ' A' 1526 ' ' LEU . 23.3 m -85.3 120.84 27.22 Favored 'General case' 0 C--N 1.3 -1.549 0 N-CA-C 109.327 -0.62 . . . . 1.7 109.327 178.781 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A 1520 ' ' ASN . . . . . 0.407 ' OD1' HG22 ' A' 1523 ' ' THR . 24.0 t-20 -71.98 119.71 76.02 Favored Pre-proline 0 C--N 1.314 -0.937 0 N-CA-C 109.327 -0.62 . . . . 2.1200000000000001 109.327 179.131 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A 1521 ' ' PRO . . . . . . . . . . . . . 86.5 Cg_endo -75.09 -2.95 13.22 Favored 'Trans proline' 0 CA--C 1.539 0.749 0 C-N-CA 122.64 2.227 . . . . 2.4700000000000002 113.953 -175.31 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A 1522 ' ' SER . . . . . . . . . . . . . 32.8 m -94.11 -49.75 5.61 Favored 'General case' 0 C--N 1.305 -1.341 0 O-C-N 122.104 -0.373 . . . . 2.5699999999999998 111.101 -179.375 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A 1523 ' ' THR . . . . . 0.409 HG23 ' H ' ' A' 1525 ' ' HIS . 12.0 t -96.53 -16.99 20.8 Favored 'General case' 0 CA--C 1.553 1.07 0 CA-C-O 121.255 0.55 . . . . 2.1499999999999999 111.097 -179.901 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A 1524 ' ' GLY . . . . . . . . . . . . . . . 81.84 8.16 87.08 Favored Glycine 0 C--O 1.222 -0.601 0 C-N-CA 121.507 -0.378 . . . . 1.8899999999999999 112.918 178.83 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A 1525 ' ' HIS . . . . . 0.409 ' H ' HG23 ' A' 1523 ' ' THR . 16.0 t-160 -101.69 134.97 44.01 Favored 'General case' 0 C--N 1.302 -1.47 0 N-CA-C 109.432 -0.581 . . . . 1.8999999999999999 109.432 -178.306 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A 1526 ' ' LEU . . . . . 0.773 ' HA ' ' HA ' ' A' 1519 ' ' THR . 6.7 tt -84.98 135.21 34.13 Favored 'General case' 0 C--N 1.303 -1.43 0 CA-C-N 116.387 -0.369 . . . . 1.6100000000000001 110.735 177.819 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A 1527 ' ' PHE . . . . . . . . . . . . . 80.7 m-85 -99.8 113.03 25.27 Favored 'General case' 0 C--N 1.309 -1.195 0 N-CA-C 108.078 -1.082 . . . . 1.4199999999999999 108.078 174.546 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A 1528 ' ' ASP . . . . . . . . . . . . . 11.8 t70 -100.59 103.55 14.86 Favored 'General case' 0 C--N 1.302 -1.495 0 N-CA-C 108.927 -0.768 . . . . 2.1800000000000002 108.927 -179.455 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A 1529 ' ' LEU . . . . . 0.457 HD13 ' CZ ' ' A' 1612 ' ' PHE . 78.7 mt -89.5 -13.81 36.63 Favored 'General case' 0 C--N 1.298 -1.65 0 N-CA-C 108.234 -1.024 . . . . 1.4399999999999999 108.234 -176.145 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A 1530 ' ' SER . . . . . 0.458 ' OG ' ' HB2' ' A' 1516 ' ' CYS . 3.2 m -58.03 -54.83 42.56 Favored 'General case' 0 N--CA 1.438 -1.065 0 C-N-CA 124.788 1.235 . . . . 1.4399999999999999 110.742 -179.58 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A 1531 ' ' SER . . . . . . . . . . . . . 5.6 m -81.23 1.43 32.29 Favored 'General case' 0 C--N 1.317 -0.829 0 CA-C-N 115.886 -0.597 . . . . 1.5 111.592 -175.722 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A 1532 ' ' LEU . . . . . 0.414 ' HG ' ' HA ' ' A' 1529 ' ' LEU . 32.3 mt -82.41 -18.34 42.28 Favored 'General case' 0 C--N 1.319 -0.757 0 C-N-CA 120.036 -0.666 . . . . 1.77 110.661 179.507 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A 1533 ' ' SER . . . . . 0.89 ' HB2' HG22 ' A' 1552 ' ' ILE . 22.7 t -114.2 134.13 55.13 Favored 'General case' 0 N--CA 1.432 -1.341 0 N-CA-C 108.523 -0.917 . . . . 2.3799999999999999 108.523 178.417 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A 1534 ' ' GLY . . . . . . . . . . . . . . . -81.93 173.46 53.53 Favored Glycine 0 N--CA 1.429 -1.768 0 N-CA-C 107.724 -2.15 . . . . 1.55 107.724 172.148 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A 1535 ' ' ARG . . . . . 0.428 HH11 ' HD2' ' A' 1535 ' ' ARG . 14.8 ttp180 -72.3 -17.8 61.84 Favored 'General case' 0 C--N 1.31 -1.151 0 CA-C-N 118.254 1.027 . . . . 3.96 110.55 -178.842 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A 1536 ' ' ALA . . . . . . . . . . . . . . . -84.86 -6.92 59.35 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 116.109 -0.496 . . . . 1.6499999999999999 110.198 176.423 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A 1537 ' ' GLY . . . . . . . . . . . . . . . 59.84 -153.81 33.06 Favored Glycine 0 N--CA 1.447 -0.569 0 CA-C-N 115.321 -0.854 . . . . 1.1899999999999999 114.126 177.366 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A 1538 ' ' PHE . . . . . . . . . . . . . 96.2 m-85 -113.55 163.72 14.57 Favored 'General case' 0 C--N 1.294 -1.819 0 N-CA-C 108.027 -1.101 . . . . 1.6899999999999999 108.027 178.441 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A 1539 ' ' THR . . . . . . . . . . . . . 9.5 t -143.99 130.64 20.14 Favored 'General case' 0 C--N 1.287 -2.128 0 N-CA-C 108.991 -0.744 . . . . 1.48 108.991 177.88 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A 1540 ' ' ALA . . . . . . . . . . . . . . . -131.96 143.72 50.3 Favored 'General case' 0 C--N 1.306 -1.307 0 N-CA-C 109.054 -0.721 . . . . 0.82999999999999996 109.054 -177.374 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A 1541 ' ' ALA . . . . . . . . . . . . . . . -82.14 151.46 26.95 Favored 'General case' 0 C--N 1.31 -1.124 0 CA-C-N 116.167 -0.47 . . . . 1.27 110.386 -178.991 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A 1542 ' ' TYR . . . . . . . . . . . . . 26.1 t80 -152.54 175.06 13.16 Favored 'General case' 0 C--N 1.312 -1.031 0 N-CA-C 107.864 -1.162 . . . . 2.1499999999999999 107.864 -177.162 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A 1543 ' ' SER . . . . . . . . . . . . . 8.3 p -49.57 -150.46 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.797 0 C-N-CA 127.922 2.489 . . . . 2.29 114.853 -179.941 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A 1544 ' ' LYS . . . . . . . . . . . . . 9.7 ptpp? -39.81 -28.12 0.04 OUTLIER 'General case' 0 N--CA 1.506 2.353 0 N-CA-C 114.53 1.307 . . . . 3.9100000000000001 114.53 -178.245 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A 1545 ' ' SER . . . . . . . . . . . . . 25.0 t -73.01 -8.55 56.22 Favored 'General case' 0 CA--C 1.555 1.146 0 N-CA-C 112.204 0.446 . . . . 3.2999999999999998 112.204 177.571 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A 1546 ' ' GLY . . . . . . . . . . . . . . . 81.08 -75.31 2.3 Favored Glycine 0 N--CA 1.44 -1.088 0 N-CA-C 114.643 0.617 . . . . 1.24 114.643 172.624 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A 1547 ' ' VAL . . . . . . . . . . . . . 9.3 p -153.26 150.26 12.67 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.446 0 N-CA-C 109.32 -0.622 . . . . 1.6299999999999999 109.32 -175.158 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A 1548 ' ' VAL . . . . . . . . . . . . . 5.7 t -111.21 145.06 17.93 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.547 0 N-CA-C 108.536 -0.912 . . . . 0.92000000000000004 108.536 -178.699 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A 1549 ' ' TYR . . . . . . . . . . . . . 39.4 m-85 -114.54 125.27 53.6 Favored 'General case' 0 CA--C 1.501 -0.928 0 N-CA-C 107.31 -1.367 . . . . 1.4399999999999999 107.31 172.926 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A 1550 ' ' MET . . . . . . . . . . . . . 18.3 ptm -153.15 124.58 7.63 Favored 'General case' 0 C--N 1.298 -1.658 0 CA-C-O 121.396 0.617 . . . . 1.74 112.008 -172.672 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A 1551 ' ' SER . . . . . . . . . . . . . 25.4 m -93.57 133.46 36.86 Favored 'General case' 0 C--N 1.282 -2.34 0 N-CA-C 106.88 -1.526 . . . . 1.6399999999999999 106.88 176.175 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A 1552 ' ' ILE . . . . . 0.89 HG22 ' HB2' ' A' 1533 ' ' SER . 1.1 tp -73.17 -18.63 18.18 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.114 0 CA-C-O 121.816 0.817 . . . . 1.3300000000000001 109.629 -176.374 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A 1553 ' ' CYS . . . . . . . . . . . . . 38.4 t -161.27 138.44 8.84 Favored 'General case' 0 N--CA 1.416 -2.144 0 N-CA-C 105.923 -1.88 . . . . 1.4299999999999999 105.923 173.532 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A 1554 ' ' GLY . . . . . . . . . . . . . . . 101.38 -174.87 25.34 Favored Glycine 0 N--CA 1.433 -1.529 0 N-CA-C 111.17 -0.772 . . . . 1.1200000000000001 111.17 178.538 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A 1555 ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -103.31 151.7 22.41 Favored 'General case' 0 C--N 1.302 -1.459 0 CA-C-O 121.439 0.638 . . . . 1.8 111.776 -179.17 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A 1556 ' ' ASN . . . . . . . . . . . . . 8.6 t-20 -100.67 139.11 36.82 Favored 'General case' 0 N--CA 1.42 -1.94 0 CA-C-N 114.52 -1.218 . . . . 2.6299999999999999 108.3 -177.241 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A 1557 ' ' GLU . . . . . . . . . . . . . 54.2 mm-40 -102.65 -7.07 22.06 Favored 'General case' 0 C--N 1.293 -1.875 0 CA-C-N 115.443 -0.799 . . . . 3.79 112.156 -172.404 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A 1558 ' ' ASN . . . . . . . . . . . . . 39.6 m-80 -75.52 -31.36 60.09 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-O 121.803 0.811 . . . . 1.52 109.901 -178.655 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A 1559 ' ' CYS . . . . . 0.645 ' HB3' ' HD2' ' A' 1560 ' ' PRO . 95.5 m -113.25 176.47 1.47 Allowed Pre-proline 0 C--N 1.294 -1.841 0 CA-C-O 117.471 -1.252 . . . . 0.83999999999999997 108.027 176.474 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A 1560 ' ' PRO . . . . . 0.645 ' HD2' ' HB3' ' A' 1559 ' ' CYS . 99.2 Cg_exo -29.88 122.16 0.06 OUTLIER 'Trans proline' 0 C--N 1.375 1.957 0 C-N-CA 124.358 3.372 . . . . 1.1799999999999999 113.909 173.693 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A 1561 ' ' PRO . . . . . 0.432 ' HD3' ' HA ' ' A' 1560 ' ' PRO . 32.1 Cg_exo -58.57 110.25 0.63 Allowed 'Trans proline' 0 C--O 1.245 0.85 0 C-N-CA 123.243 2.629 . . . . 1.51 111.66 -176.776 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A 1562 ' ' GLY . . . . . . . . . . . . . . . 132.94 -15.24 4.86 Favored Glycine 0 N--CA 1.44 -1.085 0 C-N-CA 120.23 -0.986 . . . . 0.71999999999999997 112.507 -179.792 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A 1563 ' ' VAL . . . . . 0.426 ' HA ' ' HA ' ' A' 1576 ' ' LYS . 13.8 m -86.49 149.82 4.04 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.957 0 N-CA-C 108.02 -1.104 . . . . 0.96999999999999997 108.02 177.326 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A 1564 ' ' GLY . . . . . . . . . . . . . . . -102.0 -30.77 5.62 Favored Glycine 0 C--N 1.307 -1.059 0 N-CA-C 111.188 -0.765 . . . . 0.71999999999999997 111.188 -178.019 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A 1565 ' ' ALA . . . . . . . . . . . . . . . -140.3 136.3 33.11 Favored 'General case' 0 N--CA 1.44 -0.927 0 N-CA-C 109.04 -0.726 . . . . 0.37 109.04 178.773 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A 1566 ' ' CYS . . . . . . . . . . . . . 16.5 t -156.32 146.36 21.26 Favored 'General case' 0 C--N 1.298 -1.668 0 CA-C-N 116.243 -0.435 . . . . 0.51000000000000001 109.933 -175.324 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A 1567 ' ' PHE . . . . . . . . . . . . . 21.5 m-85 -73.88 123.32 24.01 Favored 'General case' 0 C--O 1.211 -0.921 0 N-CA-C 107.239 -1.393 . . . . 0.96999999999999997 107.239 174.467 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A 1568 ' ' GLY . . . . . . . . . . . . . . . -75.36 -18.64 79.89 Favored Glycine 0 C--N 1.309 -0.92 0 C-N-CA 120.472 -0.871 . . . . 1.0800000000000001 114.655 -171.732 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A 1569 ' ' GLN . . . . . . . . . . . . . 58.9 tp60 -80.66 -60.0 2.47 Favored 'General case' 0 C--N 1.302 -1.496 0 CA-C-O 121.059 0.457 . . . . 2.7400000000000002 110.498 -179.586 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A 1570 ' ' THR . . . . . . . . . . . . . 12.3 p -88.14 -11.16 47.74 Favored 'General case' 0 C--N 1.31 -1.146 0 N-CA-C 112.817 0.673 . . . . 1.96 112.817 -175.289 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A 1571 ' ' ARG . . . . . . . . . . . . . 51.0 mtm180 58.04 45.16 18.33 Favored 'General case' 0 CA--C 1.515 -0.372 0 C-N-CA 125.363 1.465 . . . . 3.9500000000000002 112.853 179.248 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A 1572 ' ' ILE . . . . . . . . . . . . . 36.3 mt -100.61 122.82 53.07 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.192 0 N-CA-C 108.788 -0.819 . . . . 1.3700000000000001 108.788 179.112 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A 1573 ' ' SER . . . . . . . . . . . . . 33.2 t -61.88 122.57 15.76 Favored 'General case' 0 C--N 1.31 -1.133 0 C-N-CA 124.644 1.178 . . . . 1.0800000000000001 110.855 -179.033 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A 1574 ' ' VAL . . . . . . . . . . . . . 30.0 m -127.83 33.93 1.36 Allowed 'Isoleucine or valine' 0 C--N 1.315 -0.895 0 CA-C-O 122.238 1.018 . . . . 1.3 110.234 178.973 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A 1575 ' ' GLY . . . . . . . . . . . . . . . 155.69 115.61 0.52 Allowed Glycine 0 N--CA 1.419 -2.442 0 CA-C-N 114.248 -1.342 . . . . 0.51000000000000001 111.341 177.979 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A 1576 ' ' LYS . . . . . 0.426 ' HA ' ' HA ' ' A' 1563 ' ' VAL . 3.3 tppp? -82.13 145.33 30.19 Favored 'General case' 0 C--N 1.307 -1.253 0 N-CA-C 106.77 -1.567 . . . . 2.8999999999999999 106.77 178.201 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A 1577 ' ' ALA . . . . . . . . . . . . . . . -63.81 112.92 3.1 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 121.343 0.592 . . . . 0.82999999999999996 109.516 -179.024 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A 1578 ' ' ASN . . . . . . . . . . . . . 50.4 t-20 -135.77 139.13 43.3 Favored 'General case' 0 C--N 1.295 -1.802 0 N-CA-C 107.687 -1.227 . . . . 1.8500000000000001 107.687 -173.493 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A 1579 ' ' LYS . . . . . 0.472 ' HD2' ' SG ' ' A' 1516 ' ' CYS . 43.2 mmtm -100.9 89.85 3.99 Favored 'General case' 0 C--N 1.3 -1.562 0 N-CA-C 108.043 -1.095 . . . . 1.8999999999999999 108.043 178.957 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A 1580 ' ' ARG . . . . . . . . . . . . . 18.7 tpp180 -146.79 84.87 1.61 Allowed 'General case' 0 N--CA 1.429 -1.514 0 CA-C-O 121.33 0.586 . . . . 3.6299999999999999 110.593 -177.627 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A 1581 ' ' LEU . . . . . 0.4 ' HA ' ' O ' ' A' 1589 ' ' GLN . 3.8 pp -104.37 153.71 20.73 Favored 'General case' 0 N--CA 1.427 -1.595 0 CA-C-N 115.55 -0.75 . . . . 1.8700000000000001 110.112 176.117 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A 1582 ' ' ARG . . . . . 0.43 ' CG ' ' HB3' ' A' 1589 ' ' GLN . 14.7 ptp180 -131.62 139.89 49.25 Favored 'General case' 0 C--N 1.283 -2.296 0 N-CA-C 108.937 -0.764 . . . . 3.9700000000000002 108.937 177.427 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A 1583 ' ' TYR . . . . . 0.43 ' CE1' ' HA ' ' A' 1586 ' ' GLN . 67.5 t80 -102.84 91.85 4.34 Favored 'General case' 0 N--CA 1.432 -1.367 0 N-CA-C 107.448 -1.315 . . . . 1.4099999999999999 107.448 176.819 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A 1584 ' ' VAL . . . . . . . . . . . . . 1.6 m -120.27 110.46 28.86 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.607 0 CA-C-N 115.421 -0.809 . . . . 1.6899999999999999 112.53 -176.553 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A 1585 ' ' ASP . . . . . . . . . . . . . 16.0 t70 65.45 38.8 5.46 Favored 'General case' 0 C--N 1.313 -1.019 0 CA-C-O 122.481 1.134 . . . . 2.0600000000000001 109.619 173.409 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A 1586 ' ' GLN . . . . . 0.43 ' HA ' ' CE1' ' A' 1583 ' ' TYR . 47.8 mt-30 73.78 -14.43 0.66 Allowed 'General case' 0 N--CA 1.484 1.234 0 C-N-CA 126.049 1.739 . . . . 2.3300000000000001 114.042 -179.729 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A 1587 ' ' VAL . . . . . . . . . . . . . 7.6 p -94.53 121.68 45.33 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.026 0 CA-C-O 121.361 0.601 . . . . 0.78000000000000003 110.055 178.461 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A 1588 ' ' LEU . . . . . 0.663 ' HB2' ' HB2' ' A' 1612 ' ' PHE . 3.8 mm? -78.75 138.76 38.38 Favored 'General case' 0 N--CA 1.433 -1.301 0 CA-C-N 115.658 -0.701 . . . . 1.4099999999999999 109.67 178.736 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A 1589 ' ' GLN . . . . . 0.43 ' HB3' ' CG ' ' A' 1582 ' ' ARG . 34.6 tt0 -133.58 126.92 31.99 Favored 'General case' 0 C--N 1.292 -1.91 0 N-CA-C 108.63 -0.878 . . . . 1.24 108.63 179.479 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A 1590 ' ' LEU . . . . . . . . . . . . . 8.9 tt -124.59 126.21 45.42 Favored 'General case' 0 C--N 1.295 -1.794 0 N-CA-C 107.438 -1.319 . . . . 1.1499999999999999 107.438 179.911 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A 1591 ' ' VAL . . . . . 0.436 HG22 HG13 ' A' 1609 ' ' VAL . 67.8 t -117.75 123.03 71.14 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.798 0 CA-C-O 121.237 0.541 . . . . 1.51 112.454 -174.488 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A 1592 ' ' TYR . . . . . . . . . . . . . 49.4 m-85 -97.29 101.59 13.17 Favored 'General case' 0 C--N 1.309 -1.153 0 CA-C-N 115.041 -0.981 . . . . 1.0600000000000001 108.383 175.114 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A 1593 ' ' LYS . . . . . . . . . . . . . 19.0 ptpt -99.74 -173.68 2.52 Favored 'General case' 0 C--N 1.3 -1.547 0 N-CA-C 109.756 -0.461 . . . . 2.1800000000000002 109.756 179.849 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A 1594 ' ' ASP . . . . . . . . . . . . . 6.7 m-20 50.07 53.96 11.93 Favored 'General case' 0 N--CA 1.478 0.925 0 N-CA-C 114.84 1.422 . . . . 1.45 114.84 175.951 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A 1595 ' ' GLY . . . . . . . . . . . . . . . -90.02 -92.45 1.22 Allowed Glycine 0 N--CA 1.425 -2.052 0 N-CA-C 108.001 -2.04 . . . . 0.78000000000000003 108.001 174.367 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A 1596 ' ' SER . . . . . 0.407 ' HB2' ' HD2' ' A' 1606 ' ' TYR . 20.0 m -114.16 135.95 22.19 Favored Pre-proline 0 C--N 1.291 -1.936 0 N-CA-C 107.475 -1.306 . . . . 1.6799999999999999 107.475 175.404 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A 1597 ' ' PRO . . . . . . . . . . . . . 32.0 Cg_exo -60.87 128.23 24.88 Favored 'Trans proline' 0 C--O 1.243 0.754 0 C-N-CA 122.513 2.142 . . . . 1.1699999999999999 109.422 178.254 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A 1598 ' ' CYS . . . . . 0.566 ' HB3' HD12 ' A' 1604 ' ' LEU . 9.0 t -95.7 125.27 49.78 Favored Pre-proline 0 C--N 1.293 -1.861 0 N-CA-C 109.021 -0.733 . . . . 1.1899999999999999 109.021 -174.35 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A 1599 ' ' PRO . . . . . 0.461 ' HD3' ' HA ' ' A' 1598 ' ' CYS . 1.0 OUTLIER -84.04 -0.29 9.52 Favored 'Trans proline' 0 CA--C 1.536 0.591 0 C-N-CA 122.86 2.373 . . . . 1.5900000000000001 113.18 -177.296 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A 1600 ' ' SER . . . . . . . . . . . . . 20.3 m -67.41 -31.3 71.41 Favored 'General case' 0 C--O 1.241 0.645 0 CA-C-O 121.095 0.474 . . . . 2.1200000000000001 111.122 179.594 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A 1601 ' ' LYS . . . . . 0.444 ' HB3' HD21 ' A' 1604 ' ' LEU . 13.1 tmtt? -152.63 130.47 11.69 Favored 'General case' 0 C--N 1.31 -1.151 0 N-CA-C 105.96 -1.867 . . . . 3.7400000000000002 105.96 178.731 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A 1602 ' ' SER . . . . . . . . . . . . . 23.9 t -71.88 117.39 13.42 Favored 'General case' 0 C--N 1.305 -1.333 0 CA-C-O 121.207 0.527 . . . . 3.79 111.255 -177.103 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A 1603 ' ' GLY . . . . . . . . . . . . . . . 116.66 15.71 6.76 Favored Glycine 0 N--CA 1.43 -1.762 0 CA-C-N 115.625 -0.716 . . . . 2.0 112.79 175.988 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A 1604 ' ' LEU . . . . . 0.566 HD12 ' HB3' ' A' 1598 ' ' CYS . 2.3 pp -140.3 161.3 38.0 Favored 'General case' 0 C--N 1.316 -0.864 0 N-CA-C 113.462 0.912 . . . . 1.48 113.462 179.711 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A 1605 ' ' SER . . . . . . . . . . . . . 9.3 t -121.38 170.93 9.15 Favored 'General case' 0 C--N 1.295 -1.765 0 N-CA-C 108.078 -1.082 . . . . 1.51 108.078 -175.314 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A 1606 ' ' TYR . . . . . 0.407 ' HD2' ' HB2' ' A' 1596 ' ' SER . 90.8 m-85 -85.54 111.91 20.45 Favored 'General case' 0 CA--C 1.461 -2.465 0 N-CA-C 102.783 -3.043 . . . . 1.1799999999999999 102.783 176.078 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A 1607 ' ' LYS . . . . . . . . . . . . . 22.3 pttm -126.93 148.63 50.04 Favored 'General case' 0 N--CA 1.399 -2.99 0 C-N-CA 119.006 -1.077 . . . . 1.6699999999999999 112.111 -172.877 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A 1608 ' ' SER . . . . . . . . . . . . . 23.8 t -104.65 128.2 52.63 Favored 'General case' 0 C--N 1.298 -1.663 0 CA-C-N 115.674 -0.694 . . . . 1.0 109.598 -177.429 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A 1609 ' ' VAL . . . . . 0.436 HG13 HG22 ' A' 1591 ' ' VAL . 53.4 t -114.42 111.01 34.14 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.969 0 N-CA-C 108.507 -0.923 . . . . 0.93000000000000005 108.507 178.874 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A 1610 ' ' ILE . . . . . . . . . . . . . 26.3 mm -94.03 117.26 37.24 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.348 0 CA-C-N 116.117 -0.492 . . . . 0.78000000000000003 109.697 -179.139 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A 1611 ' ' SER . . . . . . . . . . . . . 35.9 p -104.58 113.75 27.53 Favored 'General case' 0 N--CA 1.429 -1.493 0 CA-C-O 121.33 0.586 . . . . 1.29 109.614 175.861 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A 1612 ' ' PHE . . . . . 0.663 ' HB2' ' HB2' ' A' 1588 ' ' LEU . 96.9 m-85 -87.7 102.51 14.71 Favored 'General case' 0 C--N 1.306 -1.295 0 CA-C-N 115.518 -0.765 . . . . 0.69999999999999996 109.139 -179.256 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A 1613 ' ' VAL . . . . . . . . . . . . . 42.2 t -106.35 122.18 59.83 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.877 0 N-CA-C 109.303 -0.628 . . . . 0.75 109.303 -175.914 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A 1614 ' ' CYS . . . . . 0.589 ' HA ' ' O ' ' A' 1642 ' ' THR . 0.5 OUTLIER -75.34 93.81 2.95 Favored 'General case' 0 C--N 1.298 -1.65 0 N-CA-C 114.632 1.345 . . . . 1.3899999999999999 114.632 -178.988 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A 1615 ' ' ARG . . . . . 0.49 ' HB3' ' HB3' ' A' 1641 ' ' HIS . 23.3 tpt180 -131.64 96.84 20.04 Favored Pre-proline 0 N--CA 1.423 -1.78 0 N-CA-C 107.881 -1.155 . . . . 3.75 107.881 174.306 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A 1616 ' ' PRO . . . . . 0.595 ' HB3' ' HB3' ' A' 1643 ' ' PRO . 7.6 Cg_exo -75.66 64.34 6.6 Favored 'Trans proline' 0 CA--C 1.532 0.42 0 C-N-CA 123.817 3.011 . . . . 1.3200000000000001 113.643 -175.854 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A 1617 ' ' GLU . . . . . . . . . . . . . 44.0 mt-10 -130.47 25.03 5.13 Favored 'General case' 0 C--N 1.312 -1.024 0 O-C-N 122.201 -0.312 . . . . 3.21 111.337 179.013 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A 1618 ' ' ALA . . . . . 0.446 ' HB1' ' HB2' ' A' 1622 ' ' ASN . . . -158.51 152.45 23.71 Favored 'General case' 0 C--O 1.242 0.707 0 CA-C-O 120.778 0.323 . . . . 2.4399999999999999 110.848 -176.135 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A 1619 ' ' GLY . . . . . 0.437 ' HA3' ' HD2' ' A' 1620 ' ' PRO . . . -121.44 -137.37 5.23 Favored Glycine 0 N--CA 1.437 -1.29 0 CA-C-N 115.581 -0.736 . . . . 3.2599999999999998 112.262 -178.999 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A 1620 ' ' PRO . . . . . 0.437 ' HD2' ' HA3' ' A' 1619 ' ' GLY . 1.5 Cg_endo -44.79 -37.41 11.78 Favored 'Trans proline' 0 CA--C 1.56 1.785 0 C-N-CA 124.717 3.611 . . . . 5.9199999999999999 117.136 -176.608 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A 1621 ' ' THR . . . . . . . . . . . . . 13.7 t -80.94 -7.08 59.42 Favored 'General case' 0 CA--C 1.539 0.523 0 O-C-N 121.399 -0.813 . . . . 4.7599999999999998 112.54 -177.064 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A 1622 ' ' ASN . . . . . 0.446 ' HB2' ' HB1' ' A' 1618 ' ' ALA . 59.6 t30 -64.54 124.05 20.85 Favored 'General case' 0 C--N 1.313 -0.987 0 C-N-CA 122.731 0.412 . . . . 2.9199999999999999 110.991 -176.061 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A 1623 ' ' ARG . . . . . . . . . . . . . 7.7 ptp180 -135.2 147.93 64.36 Favored Pre-proline 0 C--N 1.309 -1.186 0 N-CA-C 109.622 -0.51 . . . . 3.6099999999999999 109.622 -177.393 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A 1624 ' ' PRO . . . . . . . . . . . . . 18.7 Cg_endo -58.97 124.38 15.56 Favored 'Trans proline' 0 C--N 1.349 0.565 0 C-N-CA 123.436 2.757 . . . . 2.3700000000000001 112.109 179.762 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A 1625 ' ' MET . . . . . . . . . . . . . 54.9 ttp -94.6 125.08 39.02 Favored 'General case' 0 C--N 1.301 -1.503 0 CA-C-N 115.863 -0.608 . . . . 2.1600000000000001 110.809 -176.84 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A 1626 ' ' LEU . . . . . 0.494 ' HB2' ' CE1' ' A' 1638 ' ' PHE . 31.8 tp -73.66 103.73 4.34 Favored 'General case' 0 C--N 1.306 -1.299 0 N-CA-C 108.729 -0.841 . . . . 1.3500000000000001 108.729 175.979 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A 1627 ' ' ILE . . . . . . . . . . . . . 27.9 pt -91.56 -36.58 8.1 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.381 0 CA-C-N 115.751 -0.659 . . . . 1.21 112.485 -176.649 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A 1628 ' ' SER . . . . . . . . . . . . . 6.2 p -153.66 135.42 14.5 Favored 'General case' 0 N--CA 1.43 -1.448 0 CA-C-O 120.883 0.373 . . . . 1.3999999999999999 111.567 -177.396 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A 1629 ' ' LEU . . . . . 0.926 ' HG ' ' HG ' ' A' 1636 ' ' LEU . 4.4 tt -125.31 114.76 19.34 Favored 'General case' 0 C--N 1.3 -1.552 0 N-CA-C 105.757 -1.942 . . . . 1.5600000000000001 105.757 177.825 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A 1630 ' ' ASP . . . . . . . . . . . . . 25.0 t70 -91.87 121.99 33.98 Favored 'General case' 0 C--N 1.301 -1.502 0 N-CA-C 107.962 -1.125 . . . . 0.87 107.962 178.279 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A 1631 ' ' LYS . . . . . . . . . . . . . 96.8 mttt -86.48 -2.97 58.92 Favored 'General case' 0 C--N 1.301 -1.511 0 N-CA-C 112.642 0.608 . . . . 2.3500000000000001 112.642 -172.252 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A 1632 ' ' GLN . . . . . . . . . . . . . 1.9 mp0 -95.59 -42.63 8.32 Favored 'General case' 0 C--N 1.318 -0.773 0 C-N-CA 120.463 -0.495 . . . . 2.5499999999999998 110.665 177.424 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A 1633 ' ' THR . . . . . 0.459 ' HA ' HD22 ' A' 1604 ' ' LEU . 31.7 p -90.97 -8.15 50.03 Favored 'General case' 0 C--O 1.251 1.137 0 CA-C-O 121.621 0.724 . . . . 1.24 110.902 177.581 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A 1634 ' ' CYS . . . . . . . . . . . . . 33.3 m 59.29 44.64 15.15 Favored 'General case' 0 C--N 1.34 0.161 0 CA-C-N 113.905 -1.498 . . . . 0.89000000000000001 110.379 176.588 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A 1635 ' ' THR . . . . . . . . . . . . . 7.5 p -108.32 126.21 52.58 Favored 'General case' 0 N--CA 1.428 -1.549 0 CA-C-N 114.339 -1.3 . . . . 0.75 111.173 -176.198 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A 1636 ' ' LEU . . . . . 0.926 ' HG ' ' HG ' ' A' 1629 ' ' LEU . 5.9 mp -105.47 111.04 23.6 Favored 'General case' 0 N--CA 1.431 -1.423 0 N-CA-C 109.621 -0.511 . . . . 1.3300000000000001 109.621 175.596 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A 1637 ' ' PHE . . . . . . . . . . . . . 97.5 m-85 -92.03 112.75 24.81 Favored 'General case' 0 C--O 1.249 1.06 0 CA-C-N 116.202 -0.453 . . . . 0.82999999999999996 110.6 -178.573 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A 1638 ' ' PHE . . . . . 0.494 ' CE1' ' HB2' ' A' 1626 ' ' LEU . 97.1 m-85 -109.12 132.13 54.41 Favored 'General case' 0 C--N 1.304 -1.385 0 CA-C-N 115.892 -0.595 . . . . 0.59999999999999998 109.448 177.709 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A 1639 ' ' SER . . . . . . . . . . . . . 29.4 p -111.19 117.23 32.64 Favored 'General case' 0 C--N 1.285 -2.223 0 CA-C-O 121.628 0.728 . . . . 1.0800000000000001 110.34 176.652 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A 1640 ' ' TRP . . . . . . . . . . . . . 13.9 t90 -101.8 102.57 13.21 Favored 'General case' 0 N--CA 1.419 -1.978 0 N-CA-C 107.42 -1.326 . . . . 0.80000000000000004 107.42 177.565 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A 1641 ' ' HIS . . . . . 0.49 ' HB3' ' HB3' ' A' 1615 ' ' ARG . 62.9 m80 -82.35 93.19 7.12 Favored 'General case' 0 C--N 1.311 -1.096 0 N-CA-C 107.604 -1.258 . . . . 2.54 107.604 -179.885 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A 1642 ' ' THR . . . . . 0.589 ' O ' ' HA ' ' A' 1614 ' ' CYS . 9.7 t -134.84 141.52 38.81 Favored Pre-proline 0 C--N 1.288 -2.103 0 CA-C-O 121.384 0.612 . . . . 1.1499999999999999 112.13 -170.421 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A 1643 ' ' PRO . . . . . 0.595 ' HB3' ' HB3' ' A' 1616 ' ' PRO . 38.2 Cg_endo -70.65 -10.15 27.26 Favored 'Trans proline' 0 C--N 1.352 0.742 0 C-N-CA 123.396 2.73 . . . . 0.80000000000000004 111.024 173.628 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A 1644 ' ' LEU . . . . . . . . . . . . . 31.7 mt -83.28 -2.52 55.85 Favored 'General case' 0 C--N 1.312 -1.023 0 C-N-CA 123.945 0.898 . . . . 1.54 111.215 -179.464 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A 1645 ' ' ALA . . . . . . . . . . . . . . . -92.23 -34.0 14.45 Favored 'General case' 0 C--N 1.323 -0.564 0 N-CA-C 112.765 0.654 . . . . 0.94999999999999996 112.765 -176.96 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A 1646 ' ' CYS . . . . . . . . . . . . . 5.9 m -152.55 172.19 16.97 Favored 'General case' 0 CA--C 1.506 -0.721 0 N-CA-C 106.94 -1.504 . . . . 1.4099999999999999 106.94 -179.205 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A 1647 ' ' GLU . . . . . . . . . . . . . 8.0 pt-20 -126.74 84.13 63.62 Favored Pre-proline 0 C--N 1.302 -1.49 0 CA-C-O 121.586 0.708 . . . . 2.9199999999999999 109.956 173.494 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A 1648 ' ' PRO . . . . . . . . . . . . . 6.1 Cg_exo -78.25 165.9 25.14 Favored 'Trans proline' 0 C--O 1.243 0.771 0 C-N-CA 123.054 2.503 . . . . 2.8199999999999998 110.739 -178.573 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A 1649 ' ' GLU . . . . . . . . . . . . . 39.8 tt0 . . . . . 0 C--O 1.254 1.336 0 O-C-N 124.098 0.874 . . . . 5.0599999999999996 109.237 -178.443 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A 1508 ' ' MET . . . . . . . . . . . . . 48.9 ttm . . . . . 0 CA--C 1.518 -0.283 0 N-CA-C 108.55 -0.907 . . . . 8.2699999999999996 108.55 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A 1509 ' ' LYS . . . . . . . . . . . . . 23.0 tptm 69.29 117.68 0.04 OUTLIER 'General case' 0 N--CA 1.468 0.46 0 C-N-CA 125.189 1.396 . . . . 6.4800000000000004 111.518 -178.85 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A 1510 ' ' SER . . . . . . . . . . . . . 58.8 m 62.38 46.84 5.6 Favored 'General case' 0 C--O 1.234 0.264 0 CA-C-O 122.197 0.999 . . . . 4.2199999999999998 109.893 -176.107 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A 1511 ' ' ASN . . . . . . . . . . . . . 2.8 p-10 -111.24 -20.44 12.31 Favored 'General case' 0 C--N 1.303 -1.416 0 CA-C-N 114.72 -1.127 . . . . 3.0800000000000001 111.805 -177.073 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A 1512 ' ' GLU . . . . . . . . . . . . . 7.9 mm-40 -50.67 -44.6 57.7 Favored 'General case' 0 N--CA 1.476 0.863 0 C-N-CA 123.672 0.789 . . . . 4.46 112.925 -176.906 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A 1513 ' ' HIS . . . . . . . . . . . . . 23.1 p80 -121.25 27.1 8.55 Favored 'General case' 0 C--N 1.312 -1.036 0 C-N-CA 119.48 -0.888 . . . . 5.5700000000000003 111.154 179.569 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A 1514 ' ' ASP . . . . . . . . . . . . . 31.2 t70 -123.59 -39.6 2.41 Favored 'General case' 0 C--N 1.308 -1.221 0 N-CA-C 114.431 1.271 . . . . 3.7000000000000002 114.431 -174.861 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A 1515 ' ' ASP . . . . . . . . . . . . . 35.5 t70 -130.18 145.0 51.68 Favored 'General case' 0 C--N 1.294 -1.835 0 C-N-CA 118.979 -1.088 . . . . 2.54 110.761 -174.115 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A 1516 ' ' CYS . . . . . . . . . . . . . 74.1 m -76.25 77.4 3.04 Favored 'General case' 0 CA--C 1.508 -0.673 0 CA-C-O 122.326 1.06 . . . . 1.25 110.65 179.786 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A 1517 ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -147.01 172.54 13.56 Favored 'General case' 0 N--CA 1.402 -2.86 0 CA-C-N 114.324 -1.307 . . . . 1.8799999999999999 109.22 -179.622 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A 1518 ' ' VAL . . . . . 0.533 HG21 ' HB2' ' A' 1583 ' ' TYR . 10.4 p -159.0 126.01 0.57 Allowed 'Isoleucine or valine' 0 C--N 1.279 -2.466 0 CA-C-O 121.46 0.648 . . . . 1.73 109.551 173.035 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A 1519 ' ' THR . . . . . . . . . . . . . 7.3 m -90.57 121.52 32.58 Favored 'General case' 0 C--N 1.282 -2.351 0 CA-C-N 114.548 -1.205 . . . . 1.7 108.202 177.635 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A 1520 ' ' ASN . . . . . . . . . . . . . 38.9 t30 -99.79 103.33 21.21 Favored Pre-proline 0 C--N 1.311 -1.09 0 N-CA-C 109.59 -0.522 . . . . 2.1200000000000001 109.59 177.35 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A 1521 ' ' PRO . . . . . . . . . . . . . 41.4 Cg_endo -69.28 -3.35 11.52 Favored 'Trans proline' 0 CA--C 1.54 0.797 0 C-N-CA 122.624 2.216 . . . . 2.4700000000000002 113.954 -175.778 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A 1522 ' ' SER . . . . . . . . . . . . . 11.4 m -69.34 -28.84 66.58 Favored 'General case' 0 CA--C 1.545 0.776 0 CA-C-O 120.984 0.421 . . . . 2.5699999999999998 109.883 176.805 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A 1523 ' ' THR . . . . . . . . . . . . . 12.9 t -139.21 -16.62 1.06 Allowed 'General case' 0 CA--C 1.551 0.999 0 CA-C-O 120.903 0.383 . . . . 2.1499999999999999 111.827 178.771 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A 1524 ' ' GLY . . . . . . . . . . . . . . . 94.16 7.92 60.54 Favored Glycine 0 N--CA 1.446 -0.658 0 C-N-CA 120.597 -0.811 . . . . 1.8899999999999999 113.08 179.017 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A 1525 ' ' HIS . . . . . . . . . . . . . 24.5 t60 -77.06 134.11 38.87 Favored 'General case' 0 C--O 1.245 0.838 0 CA-C-O 120.866 0.365 . . . . 1.8999999999999999 110.023 -177.927 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A 1526 ' ' LEU . . . . . . . . . . . . . 3.4 tm? -104.51 114.73 29.14 Favored 'General case' 0 N--CA 1.43 -1.426 0 N-CA-C 108.157 -1.053 . . . . 1.6100000000000001 108.157 178.324 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A 1527 ' ' PHE . . . . . . . . . . . . . 97.6 m-85 -88.32 129.33 35.41 Favored 'General case' 0 C--N 1.291 -1.942 0 N-CA-C 108.071 -1.085 . . . . 1.4199999999999999 108.071 178.267 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A 1528 ' ' ASP . . . . . . . . . . . . . 3.4 p-10 -117.82 126.9 53.28 Favored 'General case' 0 CA--C 1.476 -1.866 0 CA-C-O 121.964 0.887 . . . . 2.1800000000000002 110.322 179.073 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A 1529 ' ' LEU . . . . . . . . . . . . . 71.7 mt -117.68 7.45 12.56 Favored 'General case' 0 C--N 1.292 -1.919 0 N-CA-C 106.231 -1.766 . . . . 1.4399999999999999 106.231 175.738 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A 1530 ' ' SER . . . . . . . . . . . . . 1.6 m -70.99 -24.95 62.49 Favored 'General case' 0 N--CA 1.438 -1.026 0 CA-C-N 113.853 -1.521 . . . . 1.4399999999999999 110.219 -179.152 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A 1531 ' ' SER . . . . . . . . . . . . . 14.5 m -88.07 -16.15 34.34 Favored 'General case' 0 N--CA 1.433 -1.309 0 N-CA-C 108.582 -0.896 . . . . 1.5 108.582 178.814 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A 1532 ' ' LEU . . . . . . . . . . . . . 90.8 mt -82.05 -8.28 59.66 Favored 'General case' 0 C--O 1.244 0.804 0 CA-C-N 115.509 -0.769 . . . . 1.77 111.72 177.631 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A 1533 ' ' SER . . . . . . . . . . . . . 22.5 m -57.67 125.84 24.73 Favored 'General case' 0 N--CA 1.445 -0.702 0 C-N-CA 123.155 0.582 . . . . 2.3799999999999999 110.424 177.146 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A 1534 ' ' GLY . . . . . . . . . . . . . . . -121.16 169.53 14.38 Favored Glycine 0 N--CA 1.427 -1.943 0 N-CA-C 109.976 -1.25 . . . . 1.55 109.976 179.698 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A 1535 ' ' ARG . . . . . . . . . . . . . 45.8 ttt180 -95.37 -54.27 3.46 Favored 'General case' 0 C--N 1.303 -1.452 0 N-CA-C 108.524 -0.917 . . . . 3.96 108.524 179.123 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A 1536 ' ' ALA . . . . . . . . . . . . . . . -86.14 -24.19 26.3 Favored 'General case' 0 N--CA 1.438 -1.047 0 CA-C-N 115.505 -0.771 . . . . 1.6499999999999999 109.463 178.68 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A 1537 ' ' GLY . . . . . . . . . . . . . . . 81.76 -140.66 21.16 Favored Glycine 0 N--CA 1.434 -1.473 0 CA-C-N 115.177 -0.919 . . . . 1.1899999999999999 112.344 176.664 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A 1538 ' ' PHE . . . . . . . . . . . . . 98.7 m-85 -134.16 156.83 47.62 Favored 'General case' 0 C--N 1.299 -1.617 0 N-CA-C 108.72 -0.844 . . . . 1.6899999999999999 108.72 179.881 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A 1539 ' ' THR . . . . . . . . . . . . . 23.5 p -104.93 111.63 24.47 Favored 'General case' 0 N--CA 1.425 -1.709 0 CA-C-N 115.929 -0.578 . . . . 1.48 110.046 177.114 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A 1540 ' ' ALA . . . . . . . . . . . . . . . -102.72 116.59 32.87 Favored 'General case' 0 C--N 1.295 -1.784 0 N-CA-C 108.865 -0.791 . . . . 0.82999999999999996 108.865 178.618 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A 1541 ' ' ALA . . . . . . . . . . . . . . . -61.68 128.34 35.8 Favored 'General case' 0 C--N 1.308 -1.222 0 CA-C-O 121.428 0.632 . . . . 1.27 110.943 178.021 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A 1542 ' ' TYR . . . . . 0.625 ' HD2' ' HB2' ' A' 1545 ' ' SER . 66.7 t80 -125.0 174.84 7.73 Favored 'General case' 0 C--N 1.293 -1.875 0 N-CA-C 107.296 -1.372 . . . . 2.1499999999999999 107.296 -178.426 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A 1543 ' ' SER . . . . . . . . . . . . . 1.7 m -46.5 -152.15 0.0 OUTLIER 'General case' 0 CA--C 1.596 2.721 0 C-N-CA 128.741 2.816 . . . . 2.29 114.404 -179.865 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A 1544 ' ' LYS . . . . . . . . . . . . . 63.6 mttp -55.07 -15.39 2.1 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 119.621 -1.924 . . . . 3.9100000000000001 113.556 -177.012 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A 1545 ' ' SER . . . . . 0.625 ' HB2' ' HD2' ' A' 1542 ' ' TYR . 36.0 m -70.62 -19.63 62.81 Favored 'General case' 0 CA--C 1.552 1.023 0 N-CA-C 111.976 0.361 . . . . 3.2999999999999998 111.976 174.707 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A 1546 ' ' GLY . . . . . . . . . . . . . . . 102.63 -98.55 1.7 Allowed Glycine 0 CA--C 1.493 -1.289 0 C-N-CA 119.224 -1.465 . . . . 1.24 113.187 174.822 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A 1547 ' ' VAL . . . . . . . . . . . . . 16.6 m -131.39 166.29 29.23 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.616 0 CA-C-N 117.26 0.53 . . . . 1.6299999999999999 109.913 177.567 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A 1548 ' ' VAL . . . . . . . . . . . . . 3.6 t -118.83 128.7 75.66 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.724 0 N-CA-C 106.627 -1.62 . . . . 0.92000000000000004 106.627 175.983 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A 1549 ' ' TYR . . . . . 0.566 ' CD2' ' HA2' ' A' 1568 ' ' GLY . 50.8 m-85 -87.64 114.57 24.37 Favored 'General case' 0 C--N 1.3 -1.57 0 N-CA-C 106.233 -1.765 . . . . 1.4399999999999999 106.233 171.223 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A 1550 ' ' MET . . . . . . . . . . . . . 3.0 ppp? -141.87 149.8 40.73 Favored 'General case' 0 C--N 1.284 -2.247 0 CA-C-N 116.435 -0.348 . . . . 1.74 111.304 -176.357 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A 1551 ' ' SER . . . . . . . . . . . . . 22.6 t -116.55 145.05 43.63 Favored 'General case' 0 C--N 1.294 -1.819 0 N-CA-C 107.83 -1.174 . . . . 1.6399999999999999 107.83 177.834 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A 1552 ' ' ILE . . . . . . . . . . . . . 32.6 mm -68.07 -27.31 36.88 Favored 'Isoleucine or valine' 0 C--O 1.213 -0.849 0 CA-C-N 114.856 -1.066 . . . . 1.3300000000000001 109.406 -178.132 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A 1553 ' ' CYS . . . . . 0.418 ' SG ' ' HE2' ' A' 1579 ' ' LYS . 51.4 t -161.64 138.65 8.52 Favored 'General case' 0 N--CA 1.421 -1.914 0 N-CA-C 108.282 -1.007 . . . . 1.4299999999999999 108.282 178.142 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A 1554 ' ' GLY . . . . . . . . . . . . . . . 95.47 -177.63 34.84 Favored Glycine 0 N--CA 1.438 -1.227 0 C-N-CA 120.689 -0.767 . . . . 1.1200000000000001 112.472 176.493 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A 1555 ' ' GLU . . . . . . . . . . . . . 10.1 pt-20 -81.37 144.25 31.59 Favored 'General case' 0 C--N 1.309 -1.194 0 CA-C-O 121.392 0.615 . . . . 1.8 111.522 -178.962 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A 1556 ' ' ASN . . . . . . . . . . . . . 27.8 t-20 -96.91 105.62 17.79 Favored 'General case' 0 C--N 1.293 -1.849 0 CA-C-N 115.225 -0.898 . . . . 2.6299999999999999 109.229 -179.408 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A 1557 ' ' GLU . . . . . . . . . . . . . 13.0 mt-10 -86.31 76.7 9.64 Favored 'General case' 0 C--N 1.313 -0.978 0 CA-C-O 122.035 0.922 . . . . 3.79 111.918 -177.028 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A 1558 ' ' ASN . . . . . . . . . . . . . 14.2 m120 -146.82 -43.94 0.18 Allowed 'General case' 0 C--N 1.297 -1.705 0 N-CA-C 106.143 -1.799 . . . . 1.52 106.143 178.892 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A 1559 ' ' CYS . . . . . 0.626 ' HB3' ' HD2' ' A' 1560 ' ' PRO . 78.2 m -108.63 175.92 1.78 Allowed Pre-proline 0 N--CA 1.425 -1.69 0 N-CA-C 105.532 -2.025 . . . . 0.83999999999999997 105.532 170.675 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A 1560 ' ' PRO . . . . . 0.626 ' HD2' ' HB3' ' A' 1559 ' ' CYS . 20.8 Cg_exo -32.95 113.11 0.06 OUTLIER 'Trans proline' 0 C--N 1.375 1.943 0 C-N-CA 123.641 2.894 . . . . 1.1799999999999999 113.962 176.879 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A 1561 ' ' PRO . . . . . . . . . . . . . 39.7 Cg_exo -59.07 102.79 0.16 Allowed 'Trans proline' 0 C--O 1.242 0.702 0 C-N-CA 123.335 2.69 . . . . 1.51 111.31 -179.026 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A 1562 ' ' GLY . . . . . . . . . . . . . . . 152.17 -19.74 0.84 Allowed Glycine 0 N--CA 1.432 -1.618 0 N-CA-C 108.582 -1.807 . . . . 0.71999999999999997 108.582 -175.081 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A 1563 ' ' VAL . . . . . 0.519 ' HA ' ' HA ' ' A' 1576 ' ' LYS . 4.6 m -93.06 151.56 3.61 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.109 0 N-CA-C 107.118 -1.438 . . . . 0.96999999999999997 107.118 174.013 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A 1564 ' ' GLY . . . . . . . . . . . . . . . -113.16 -15.35 9.13 Favored Glycine 0 C--N 1.308 -0.986 0 C-N-CA 120.664 -0.779 . . . . 0.71999999999999997 112.451 -176.79 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A 1565 ' ' ALA . . . . . . . . . . . . . . . -142.92 125.61 15.93 Favored 'General case' 0 C--O 1.244 0.8 0 N-CA-C 108.871 -0.789 . . . . 0.37 108.871 179.524 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A 1566 ' ' CYS . . . . . . . . . . . . . 41.7 t -150.41 144.33 25.38 Favored 'General case' 0 C--N 1.302 -1.498 0 N-CA-C 109.524 -0.547 . . . . 0.51000000000000001 109.524 -176.729 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A 1567 ' ' PHE . . . . . . . . . . . . . 18.1 m-85 -67.59 145.26 55.05 Favored 'General case' 0 C--N 1.319 -0.724 0 N-CA-C 112.181 0.438 . . . . 0.96999999999999997 112.181 179.91 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A 1568 ' ' GLY . . . . . 0.566 ' HA2' ' CD2' ' A' 1549 ' ' TYR . . . -63.8 -73.48 0.54 Allowed Glycine 0 C--N 1.304 -1.225 0 N-CA-C 115.004 0.761 . . . . 1.0800000000000001 115.004 -175.437 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A 1569 ' ' GLN . . . . . . . . . . . . . 11.2 pt20 -83.03 -34.29 26.3 Favored 'General case' 0 C--N 1.316 -0.849 0 N-CA-C 112.379 0.511 . . . . 2.7400000000000002 112.379 -173.344 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A 1570 ' ' THR . . . . . . . . . . . . . 21.3 p -81.51 -18.05 46.46 Favored 'General case' 0 C--N 1.312 -1.063 0 CA-C-O 121.32 0.581 . . . . 1.96 110.682 -178.162 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A 1571 ' ' ARG . . . . . . . . . . . . . 64.6 mtp180 56.21 37.9 29.29 Favored 'General case' 0 C--N 1.344 0.354 0 C-N-CA 125.132 1.373 . . . . 3.9500000000000002 113.063 172.774 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A 1572 ' ' ILE . . . . . . . . . . . . . 25.5 mt -101.81 128.12 54.61 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.121 0 N-CA-C 108.27 -1.011 . . . . 1.3700000000000001 108.27 179.838 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A 1573 ' ' SER . . . . . . . . . . . . . 62.3 p -75.79 128.59 35.47 Favored 'General case' 0 C--N 1.314 -0.956 0 C-N-CA 122.364 0.266 . . . . 1.0800000000000001 111.478 -177.106 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A 1574 ' ' VAL . . . . . . . . . . . . . 27.7 m -126.3 26.44 2.62 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.75 0 CA-C-O 121.608 0.718 . . . . 1.3 112.299 -177.937 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A 1575 ' ' GLY . . . . . . . . . . . . . . . 174.12 117.06 0.45 Allowed Glycine 0 N--CA 1.434 -1.47 0 CA-C-N 115.277 -0.874 . . . . 0.51000000000000001 111.897 176.769 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A 1576 ' ' LYS . . . . . 0.519 ' HA ' ' HA ' ' A' 1563 ' ' VAL . 63.8 tttp -79.2 135.83 36.91 Favored 'General case' 0 C--N 1.314 -0.962 0 N-CA-C 107.628 -1.249 . . . . 2.8999999999999999 107.628 176.045 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A 1577 ' ' ALA . . . . . . . . . . . . . . . -70.42 130.7 42.61 Favored 'General case' 0 C--N 1.313 -0.993 0 O-C-N 123.647 0.592 . . . . 0.82999999999999996 110.504 -174.431 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A 1578 ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -157.83 148.41 20.81 Favored 'General case' 0 C--N 1.291 -1.942 0 N-CA-C 105.686 -1.968 . . . . 1.8500000000000001 105.686 176.715 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A 1579 ' ' LYS . . . . . 0.418 ' HE2' ' SG ' ' A' 1553 ' ' CYS . 96.9 mttt -101.47 89.34 3.7 Favored 'General case' 0 C--N 1.284 -2.257 0 CA-C-O 121.845 0.831 . . . . 1.8999999999999999 108.761 -177.508 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A 1580 ' ' ARG . . . . . . . . . . . . . 30.4 ttm180 -138.67 109.1 6.51 Favored 'General case' 0 N--CA 1.422 -1.862 0 CA-C-N 114.156 -1.383 . . . . 3.6299999999999999 110.117 -175.587 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A 1581 ' ' LEU . . . . . . . . . . . . . 2.0 pt? -138.92 142.16 38.48 Favored 'General case' 0 N--CA 1.419 -1.992 0 N-CA-C 109.288 -0.634 . . . . 1.8700000000000001 109.288 173.408 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A 1582 ' ' ARG . . . . . 0.532 ' HB3' HG13 ' A' 1584 ' ' VAL . 37.4 mmt180 -124.76 128.77 49.28 Favored 'General case' 0 C--N 1.276 -2.623 0 CA-C-N 114.972 -1.013 . . . . 3.9700000000000002 110.585 -177.71 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A 1583 ' ' TYR . . . . . 0.533 ' HB2' HG21 ' A' 1518 ' ' VAL . 62.0 t80 -89.08 90.15 8.27 Favored 'General case' 0 N--CA 1.427 -1.585 0 N-CA-C 106.234 -1.765 . . . . 1.4099999999999999 106.234 174.452 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A 1584 ' ' VAL . . . . . 0.532 HG13 ' HB3' ' A' 1582 ' ' ARG . 26.6 m -124.53 142.4 41.48 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.167 0 CA-C-N 114.435 -1.257 . . . . 1.6899999999999999 107.896 -176.21 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A 1585 ' ' ASP . . . . . . . . . . . . . 22.8 t70 61.05 22.63 12.87 Favored 'General case' 0 N--CA 1.483 1.178 0 CA-C-O 122.44 1.114 . . . . 2.0600000000000001 109.79 178.565 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A 1586 ' ' GLN . . . . . . . . . . . . . 50.1 mt-30 59.98 38.88 20.63 Favored 'General case' 0 C--O 1.241 0.634 0 C-N-CA 125.278 1.431 . . . . 2.3300000000000001 113.254 -176.255 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A 1587 ' ' VAL . . . . . 0.471 HG12 ' O ' ' A' 1584 ' ' VAL . 12.5 p -134.52 145.77 32.12 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.895 0 N-CA-C 108.495 -0.928 . . . . 0.78000000000000003 108.495 174.904 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A 1588 ' ' LEU . . . . . 0.86 ' HB2' ' HB2' ' A' 1612 ' ' PHE . 0.7 OUTLIER -84.31 133.08 34.56 Favored 'General case' 0 C--N 1.312 -1.041 0 N-CA-C 108.306 -0.998 . . . . 1.4099999999999999 108.306 177.831 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A 1589 ' ' GLN . . . . . 0.419 ' HG2' HG13 ' A' 1591 ' ' VAL . 7.3 tt0 -146.05 106.85 4.11 Favored 'General case' 0 C--N 1.307 -1.268 0 C-N-CA 120.456 -0.498 . . . . 1.24 110.132 -176.611 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A 1590 ' ' LEU . . . . . . . . . . . . . 6.2 tt -104.39 127.97 52.15 Favored 'General case' 0 C--N 1.307 -1.259 0 N-CA-C 106.245 -1.761 . . . . 1.1499999999999999 106.245 179.319 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A 1591 ' ' VAL . . . . . 0.47 HG12 HG22 ' A' 1609 ' ' VAL . 15.6 m -123.69 124.37 69.22 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.245 0 N-CA-C 115.031 1.493 . . . . 1.51 115.031 -170.704 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A 1592 ' ' TYR . . . . . . . . . . . . . 94.5 m-85 -105.2 144.56 31.83 Favored 'General case' 0 C--N 1.317 -0.836 0 N-CA-C 107.267 -1.383 . . . . 1.0600000000000001 107.267 173.813 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A 1593 ' ' LYS . . . . . . . . . . . . . 23.0 pttm -149.89 179.57 7.94 Favored 'General case' 0 C--N 1.302 -1.493 0 N-CA-C 109.249 -0.648 . . . . 2.1800000000000002 109.249 -177.642 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A 1594 ' ' ASP . . . . . . . . . . . . . 1.4 m-20 47.05 43.19 13.77 Favored 'General case' 0 N--CA 1.482 1.128 0 N-CA-C 115.123 1.527 . . . . 1.45 115.123 173.367 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A 1595 ' ' GLY . . . . . . . . . . . . . . . -73.14 -75.57 0.72 Allowed Glycine 0 N--CA 1.443 -0.838 0 N-CA-C 109.816 -1.313 . . . . 0.78000000000000003 109.816 175.978 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A 1596 ' ' SER . . . . . . . . . . . . . 21.7 t -115.39 142.36 28.63 Favored Pre-proline 0 C--N 1.29 -1.994 0 N-CA-C 105.867 -1.901 . . . . 1.6799999999999999 105.867 173.42 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A 1597 ' ' PRO . . . . . . . . . . . . . 25.9 Cg_exo -65.75 143.15 72.96 Favored 'Trans proline' 0 N--CA 1.451 -0.99 0 C-N-CA 122.68 2.253 . . . . 1.1699999999999999 109.533 175.571 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A 1598 ' ' CYS . . . . . . . . . . . . . 37.1 t -99.56 131.79 24.23 Favored Pre-proline 0 C--N 1.283 -2.325 0 N-CA-C 109.102 -0.703 . . . . 1.1899999999999999 109.102 -176.37 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A 1599 ' ' PRO . . . . . . . . . . . . . 55.3 Cg_endo -69.44 -11.72 31.88 Favored 'Trans proline' 0 C--N 1.351 0.663 0 C-N-CA 123.165 2.577 . . . . 1.5900000000000001 112.352 179.604 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A 1600 ' ' SER . . . . . . . . . . . . . 10.9 m -90.26 112.82 24.49 Favored 'General case' 0 N--CA 1.423 -1.795 0 N-CA-C 107.612 -1.255 . . . . 2.1200000000000001 107.612 176.326 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A 1601 ' ' LYS . . . . . 0.74 ' HB3' HD12 ' A' 1604 ' ' LEU . 55.7 tptt 71.03 114.31 0.05 Allowed 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 124.155 0.982 . . . . 3.7400000000000002 110.98 179.054 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A 1602 ' ' SER . . . . . . . . . . . . . 47.4 t -63.61 108.96 1.52 Allowed 'General case' 0 C--N 1.316 -0.862 0 CA-C-N 116.075 -0.511 . . . . 3.79 109.949 179.757 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A 1603 ' ' GLY . . . . . . . . . . . . . . . 129.99 -15.83 5.59 Favored Glycine 0 N--CA 1.434 -1.498 0 N-CA-C 110.724 -0.95 . . . . 2.0 110.724 -179.924 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A 1604 ' ' LEU . . . . . 0.74 HD12 ' HB3' ' A' 1601 ' ' LYS . 12.6 mt -83.21 156.92 22.92 Favored 'General case' 0 N--CA 1.434 -1.263 0 CA-C-O 122.172 0.987 . . . . 1.48 113.6 179.805 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A 1605 ' ' SER . . . . . . . . . . . . . 14.9 m -143.15 -173.12 3.83 Favored 'General case' 0 C--N 1.296 -1.727 0 N-CA-C 104.752 -2.314 . . . . 1.51 104.752 176.749 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A 1606 ' ' TYR . . . . . 0.477 ' CD1' ' HB3' ' A' 1634 ' ' CYS . 84.3 m-85 -107.38 132.49 53.1 Favored 'General case' 0 CA--C 1.462 -2.438 0 N-CA-C 105.77 -1.937 . . . . 1.1799999999999999 105.77 179.863 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A 1607 ' ' LYS . . . . . 0.557 ' HG3' HG23 ' A' 1635 ' ' THR . 21.6 ptmt -128.04 153.31 46.93 Favored 'General case' 0 N--CA 1.407 -2.59 0 O-C-N 124.234 0.959 . . . . 1.6699999999999999 109.505 -177.777 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A 1608 ' ' SER . . . . . . . . . . . . . 51.0 m -126.31 115.36 19.56 Favored 'General case' 0 C--N 1.303 -1.44 0 N-CA-C 109.393 -0.595 . . . . 1.0 109.393 -178.541 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A 1609 ' ' VAL . . . . . 0.47 HG22 HG12 ' A' 1591 ' ' VAL . 76.6 t -104.12 116.15 47.37 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.064 0 CA-C-O 120.663 0.268 . . . . 0.93000000000000005 110.647 -179.407 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A 1610 ' ' ILE . . . . . . . . . . . . . 19.3 mm -95.22 106.55 18.36 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.127 0 N-CA-C 108.448 -0.945 . . . . 0.78000000000000003 108.448 177.969 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A 1611 ' ' SER . . . . . 0.494 ' O ' ' HA ' ' A' 1639 ' ' SER . 21.8 m -98.05 123.19 41.96 Favored 'General case' 0 C--N 1.297 -1.7 0 N-CA-C 108.914 -0.773 . . . . 1.29 108.914 176.246 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A 1612 ' ' PHE . . . . . 0.86 ' HB2' ' HB2' ' A' 1588 ' ' LEU . 80.5 m-85 -100.39 123.16 44.26 Favored 'General case' 0 C--N 1.305 -1.364 0 N-CA-C 109.242 -0.651 . . . . 0.69999999999999996 109.242 -179.066 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A 1613 ' ' VAL . . . . . 0.588 ' O ' ' HA ' ' A' 1641 ' ' HIS . 44.6 t -115.75 136.99 50.85 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.703 0 N-CA-C 106.697 -1.594 . . . . 0.75 106.697 179.281 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A 1614 ' ' CYS . . . . . 0.466 ' HA ' ' O ' ' A' 1642 ' ' THR . 42.3 t -86.69 108.88 18.85 Favored 'General case' 0 C--N 1.281 -2.409 0 CA-C-O 121.6 0.714 . . . . 1.3899999999999999 111.748 -177.588 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A 1615 ' ' ARG . . . . . 0.7 ' HB3' ' HB2' ' A' 1641 ' ' HIS . 80.4 ttt180 -135.94 94.1 14.85 Favored Pre-proline 0 N--CA 1.43 -1.473 0 N-CA-C 108.009 -1.108 . . . . 3.75 108.009 176.544 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A 1616 ' ' PRO . . . . . . . . . . . . . 68.7 Cg_endo -72.04 50.0 1.4 Allowed 'Trans proline' 0 N--CA 1.481 0.773 0 C-N-CA 123.829 3.019 . . . . 1.3200000000000001 113.156 -178.466 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A 1617 ' ' GLU . . . . . . . . . . . . . 42.4 mt-10 -126.95 2.37 6.58 Favored 'General case' 0 C--N 1.305 -1.352 0 N-CA-C 108.316 -0.994 . . . . 3.21 108.316 177.789 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A 1618 ' ' ALA . . . . . . . . . . . . . . . -107.23 148.69 28.61 Favored 'General case' 0 C--N 1.315 -0.925 0 CA-C-N 115.19 -0.913 . . . . 2.4399999999999999 109.111 -176.96 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A 1619 ' ' GLY . . . . . . . . . . . . . . . -88.76 165.95 33.8 Favored Glycine 0 N--CA 1.427 -1.906 0 N-CA-C 111.068 -0.813 . . . . 3.2599999999999998 111.068 -179.798 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A 1620 ' ' PRO . . . . . . . . . . . . . 49.3 Cg_exo -59.61 -22.78 68.55 Favored 'Trans proline' 0 CA--C 1.544 0.992 0 C-N-CA 123.335 2.69 . . . . 5.9199999999999999 114.851 -178.087 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A 1621 ' ' THR . . . . . . . . . . . . . 4.2 t -93.92 8.11 42.51 Favored 'General case' 0 CA--C 1.555 1.136 0 C-N-CA 119.836 -0.746 . . . . 4.7599999999999998 111.019 -178.497 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A 1622 ' ' ASN . . . . . . . . . . . . . 25.4 t-20 -70.89 137.38 49.28 Favored 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 107.521 -1.289 . . . . 2.9199999999999999 107.521 176.363 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A 1623 ' ' ARG . . . . . . . . . . . . . 7.2 ptp180 -122.13 162.44 37.44 Favored Pre-proline 0 C--N 1.299 -1.602 0 CA-C-O 119.381 -0.342 . . . . 3.6099999999999999 110.153 -178.725 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A 1624 ' ' PRO . . . . . . . . . . . . . 50.0 Cg_exo -55.61 144.68 73.86 Favored 'Trans proline' 0 C--N 1.364 1.348 0 C-N-CA 122.914 2.41 . . . . 2.3700000000000001 113.404 -179.777 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A 1625 ' ' MET . . . . . . . . . . . . . 55.4 ttp -118.35 136.03 53.97 Favored 'General case' 0 C--N 1.301 -1.533 0 CA-C-N 115.272 -0.876 . . . . 2.1600000000000001 109.517 -179.929 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A 1626 ' ' LEU . . . . . 0.575 ' HG ' ' HD1' ' A' 1542 ' ' TYR . 3.2 tm? -73.71 113.69 11.13 Favored 'General case' 0 C--N 1.31 -1.137 0 N-CA-C 106.79 -1.559 . . . . 1.3500000000000001 106.79 175.071 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A 1627 ' ' ILE . . . . . . . . . . . . . 31.6 pt -99.95 -30.95 3.35 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.957 0 C-N-CA 120.675 -0.41 . . . . 1.21 111.758 -176.758 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A 1628 ' ' SER . . . . . 0.408 ' HB3' ' HB2' ' A' 1637 ' ' PHE . 32.2 t -148.84 165.77 30.5 Favored 'General case' 0 N--CA 1.425 -1.679 0 CA-C-O 121.575 0.702 . . . . 1.3999999999999999 111.253 -175.116 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A 1629 ' ' LEU . . . . . . . . . . . . . 14.2 tp -146.15 130.23 17.41 Favored 'General case' 0 C--N 1.292 -1.898 0 C-N-CA 125.153 1.381 . . . . 1.5600000000000001 108.37 -177.682 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A 1630 ' ' ASP . . . . . 0.435 ' HB2' ' HE2' ' A' 1637 ' ' PHE . 21.2 t70 -119.36 106.63 12.47 Favored 'General case' 0 C--N 1.308 -1.222 0 N-CA-C 108.452 -0.944 . . . . 0.87 108.452 175.139 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A 1631 ' ' LYS . . . . . . . . . . . . . 67.9 mttm -69.41 -35.02 75.34 Favored 'General case' 0 C--N 1.304 -1.411 0 CA-C-N 115.528 -0.76 . . . . 2.3500000000000001 112.707 -176.031 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A 1632 ' ' GLN . . . . . . . . . . . . . 39.4 mt-30 -74.19 -23.15 59.18 Favored 'General case' 0 C--N 1.323 -0.57 0 N-CA-C 112.938 0.718 . . . . 2.5499999999999998 112.938 -176.12 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A 1633 ' ' THR . . . . . . . . . . . . . 2.0 m -112.5 3.69 16.97 Favored 'General case' 0 C--N 1.314 -0.942 0 CA-C-O 121.875 0.845 . . . . 1.24 110.217 178.528 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A 1634 ' ' CYS . . . . . 0.477 ' HB3' ' CD1' ' A' 1606 ' ' TYR . 33.4 m 54.36 43.36 30.58 Favored 'General case' 0 C--N 1.349 0.569 0 CA-C-N 114.673 -1.149 . . . . 0.89000000000000001 110.32 177.099 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A 1635 ' ' THR . . . . . 0.557 HG23 ' HG3' ' A' 1607 ' ' LYS . 26.8 m -112.57 133.6 54.54 Favored 'General case' 0 N--CA 1.436 -1.156 0 CA-C-N 114.934 -1.03 . . . . 0.75 111.255 -173.128 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A 1636 ' ' LEU . . . . . . . . . . . . . 14.0 mt -104.72 130.45 52.77 Favored 'General case' 0 C--O 1.246 0.887 0 N-CA-C 107.894 -1.15 . . . . 1.3300000000000001 107.894 174.118 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A 1637 ' ' PHE . . . . . 0.435 ' HE2' ' HB2' ' A' 1630 ' ' ASP . 96.1 m-85 -107.87 110.01 21.67 Favored 'General case' 0 C--N 1.313 -1.015 0 CA-C-O 120.832 0.349 . . . . 0.82999999999999996 110.809 -178.073 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A 1638 ' ' PHE . . . . . . . . . . . . . 97.9 m-85 -105.44 150.39 25.32 Favored 'General case' 0 C--N 1.307 -1.255 0 N-CA-C 109.219 -0.66 . . . . 0.59999999999999998 109.219 178.457 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A 1639 ' ' SER . . . . . 0.494 ' HA ' ' O ' ' A' 1611 ' ' SER . 69.1 m -141.61 138.05 32.31 Favored 'General case' 0 C--N 1.281 -2.391 0 N-CA-C 109.868 -0.419 . . . . 1.0800000000000001 109.868 175.147 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A 1640 ' ' TRP . . . . . 0.55 ' HE3' ' HE2' ' A' 1612 ' ' PHE . 12.8 t90 -127.6 118.93 24.84 Favored 'General case' 0 C--N 1.29 -2.017 0 N-CA-C 107.561 -1.274 . . . . 0.80000000000000004 107.561 178.537 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A 1641 ' ' HIS . . . . . 0.7 ' HB2' ' HB3' ' A' 1615 ' ' ARG . 19.4 p80 -91.11 90.95 8.05 Favored 'General case' 0 N--CA 1.43 -1.461 0 CA-C-O 122.425 1.107 . . . . 2.54 110.045 176.465 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A 1642 ' ' THR . . . . . 0.466 ' O ' ' HA ' ' A' 1614 ' ' CYS . 1.6 m -103.3 133.81 20.11 Favored Pre-proline 0 C--N 1.281 -2.411 0 CA-C-N 113.629 -1.623 . . . . 1.1499999999999999 109.688 -172.93 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A 1643 ' ' PRO . . . . . 0.409 ' HD3' ' HA ' ' A' 1642 ' ' THR . 23.7 Cg_exo -69.46 -18.91 38.19 Favored 'Trans proline' 0 CA--C 1.533 0.43 0 C-N-CA 122.669 2.246 . . . . 0.80000000000000004 110.482 174.036 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A 1644 ' ' LEU . . . . . 0.411 ' H ' HG22 ' A' 1642 ' ' THR . 84.2 mt -76.55 -13.69 60.06 Favored 'General case' 0 N--CA 1.471 0.616 0 CA-C-N 115.036 -0.984 . . . . 1.54 110.958 178.491 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A 1645 ' ' ALA . . . . . . . . . . . . . . . -79.73 2.91 21.02 Favored 'General case' 0 CA--C 1.539 0.548 0 N-CA-C 113.436 0.902 . . . . 0.94999999999999996 113.436 -172.392 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A 1646 ' ' CYS . . . . . . . . . . . . . 12.0 p -168.06 177.03 5.78 Favored 'General case' 0 C--O 1.25 1.094 0 N-CA-C 107.092 -1.447 . . . . 1.4099999999999999 107.092 177.102 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A 1647 ' ' GLU . . . . . . . . . . . . . 6.7 mp0 -103.0 106.64 51.75 Favored Pre-proline 0 C--N 1.309 -1.188 0 N-CA-C 107.089 -1.448 . . . . 2.9199999999999999 107.089 172.145 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A 1648 ' ' PRO . . . . . . . . . . . . . 67.0 Cg_exo -55.46 116.6 3.27 Favored 'Trans proline' 0 C--O 1.245 0.853 0 C-N-CA 122.521 2.147 . . . . 2.8199999999999998 109.722 176.201 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A 1649 ' ' GLU . . . . . . . . . . . . . 42.5 tt0 . . . . . 0 N--CA 1.426 -1.662 0 N-CA-C 107.962 -1.125 . . . . 5.0599999999999996 107.962 -176.185 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A 1508 ' ' MET . . . . . . . . . . . . . 26.4 mmt . . . . . 0 CA--C 1.508 -0.664 0 N-CA-C 108.75 -0.833 . . . . 8.2699999999999996 108.75 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A 1509 ' ' LYS . . . . . . . . . . . . . 57.7 mtpt -129.8 24.75 5.35 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 120.927 0.394 . . . . 6.4800000000000004 111.538 -175.438 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A 1510 ' ' SER . . . . . . . . . . . . . 15.2 m -83.18 -9.17 59.32 Favored 'General case' 0 C--N 1.309 -1.157 0 CA-C-O 122.131 0.967 . . . . 4.2199999999999998 109.042 -179.667 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A 1511 ' ' ASN . . . . . 0.469 ' ND2' ' HA ' ' A' 1518 ' ' VAL . 23.1 p-10 -100.46 20.87 14.12 Favored 'General case' 0 C--N 1.307 -1.257 0 CA-C-N 114.347 -1.297 . . . . 3.0800000000000001 110.497 -178.97 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A 1512 ' ' GLU . . . . . . . . . . . . . 32.7 tt0 -56.8 -52.09 66.41 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-N 115.914 -0.585 . . . . 4.46 110.733 179.895 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A 1513 ' ' HIS . . . . . . . . . . . . . 31.7 t-80 -140.54 -16.76 0.9 Allowed 'General case' 0 C--N 1.313 -0.982 0 CA-C-N 115.796 -0.638 . . . . 5.5700000000000003 112.257 -179.767 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A 1514 ' ' ASP . . . . . . . . . . . . . 18.4 t70 -59.12 -62.01 2.2 Favored 'General case' 0 N--CA 1.47 0.542 0 N-CA-C 112.363 0.505 . . . . 3.7000000000000002 112.363 -176.4 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A 1515 ' ' ASP . . . . . . . . . . . . . 16.3 t70 -120.81 146.71 46.25 Favored 'General case' 0 C--N 1.312 -1.022 0 N-CA-C 109.102 -0.703 . . . . 2.54 109.102 -177.495 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A 1516 ' ' CYS . . . . . 0.579 ' HB2' ' HD2' ' A' 1579 ' ' LYS . 8.0 t -79.63 74.07 6.31 Favored 'General case' 0 C--N 1.31 -1.152 0 CA-C-O 122.019 0.914 . . . . 1.25 110.181 -176.194 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A 1517 ' ' GLN . . . . . 0.471 ' HB2' HD21 ' A' 1526 ' ' LEU . 10.3 pt20 -151.12 159.28 44.57 Favored 'General case' 0 C--N 1.306 -1.29 0 CA-C-N 116.014 -0.539 . . . . 1.8799999999999999 109.827 -179.397 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A 1518 ' ' VAL . . . . . 0.469 ' HA ' ' ND2' ' A' 1511 ' ' ASN . 7.5 p -151.5 139.69 14.29 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.496 0 N-CA-C 108.829 -0.804 . . . . 1.73 108.829 177.207 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A 1519 ' ' THR . . . . . 0.633 ' HA ' ' HA ' ' A' 1526 ' ' LEU . 15.2 m -87.14 122.67 31.27 Favored 'General case' 0 N--CA 1.42 -1.94 0 N-CA-C 107.482 -1.303 . . . . 1.7 107.482 176.88 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A 1520 ' ' ASN . . . . . . . . . . . . . 25.2 t-20 -78.74 115.34 51.15 Favored Pre-proline 0 C--N 1.318 -0.794 0 N-CA-C 108.612 -0.885 . . . . 2.1200000000000001 108.612 179.393 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A 1521 ' ' PRO . . . . . . . . . . . . . 71.4 Cg_endo -72.27 -20.29 24.67 Favored 'Trans proline' 0 CA--C 1.533 0.437 0 C-N-CA 122.185 1.924 . . . . 2.4700000000000002 113.715 -175.144 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A 1522 ' ' SER . . . . . . . . . . . . . 37.6 m -81.96 -37.44 26.67 Favored 'General case' 0 N--CA 1.436 -1.155 0 N-CA-C 112.648 0.61 . . . . 2.5699999999999998 112.648 -175.642 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A 1523 ' ' THR . . . . . . . . . . . . . 8.8 t -103.63 -17.58 15.09 Favored 'General case' 0 CA--C 1.551 0.984 0 C-N-CA 120.005 -0.678 . . . . 2.1499999999999999 111.35 176.987 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A 1524 ' ' GLY . . . . . . . . . . . . . . . 81.48 11.38 83.27 Favored Glycine 0 C--O 1.226 -0.391 0 C-N-CA 121.168 -0.539 . . . . 1.8899999999999999 112.181 179.209 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A 1525 ' ' HIS . . . . . . . . . . . . . 57.1 t-80 -101.89 136.12 42.28 Favored 'General case' 0 C--N 1.304 -1.37 0 N-CA-C 108.182 -1.044 . . . . 1.8999999999999999 108.182 -179.237 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A 1526 ' ' LEU . . . . . 0.633 ' HA ' ' HA ' ' A' 1519 ' ' THR . 5.1 tt -82.31 134.56 35.27 Favored 'General case' 0 C--N 1.293 -1.855 0 N-CA-C 106.512 -1.662 . . . . 1.6100000000000001 106.512 177.621 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A 1527 ' ' PHE . . . . . 0.419 ' N ' HD23 ' A' 1526 ' ' LEU . 65.7 m-85 -110.85 112.34 24.12 Favored 'General case' 0 C--N 1.294 -1.834 0 CA-C-O 121.424 0.631 . . . . 1.4199999999999999 111.072 177.889 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A 1528 ' ' ASP . . . . . . . . . . . . . 11.3 t70 -85.63 124.09 31.77 Favored 'General case' 0 C--N 1.312 -1.051 0 CA-C-N 114.525 -1.216 . . . . 2.1800000000000002 111.092 179.453 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A 1529 ' ' LEU . . . . . . . . . . . . . 9.9 mp -116.62 18.45 14.98 Favored 'General case' 0 C--N 1.313 -0.986 0 CA-C-N 115.801 -0.636 . . . . 1.4399999999999999 109.285 175.006 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A 1530 ' ' SER . . . . . . . . . . . . . 47.9 m -98.38 -29.08 13.34 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-O 121.246 0.546 . . . . 1.4399999999999999 111.419 -178.404 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A 1531 ' ' SER . . . . . . . . . . . . . 3.4 m -96.02 -9.71 30.32 Favored 'General case' 0 C--N 1.302 -1.493 0 CA-C-O 121.148 0.499 . . . . 1.5 110.421 -178.556 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A 1532 ' ' LEU . . . . . . . . . . . . . 78.5 mt -65.64 -40.92 93.03 Favored 'General case' 0 CA--C 1.543 0.695 0 N-CA-C 114.169 1.174 . . . . 1.77 114.169 -178.686 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A 1533 ' ' SER . . . . . 0.759 ' HB2' ' HB ' ' A' 1552 ' ' ILE . 7.2 t -101.01 126.78 47.7 Favored 'General case' 0 C--N 1.302 -1.477 0 N-CA-C 108.861 -0.792 . . . . 2.3799999999999999 108.861 -178.137 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A 1534 ' ' GLY . . . . . . . . . . . . . . . -104.57 -122.53 5.1 Favored Glycine 0 N--CA 1.425 -2.037 0 CA-C-N 115.883 -0.599 . . . . 1.55 112.466 -179.957 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A 1535 ' ' ARG . . . . . . . . . . . . . 20.5 tpt180 -81.79 -56.98 3.64 Favored 'General case' 0 C--N 1.302 -1.48 0 CA-C-O 120.875 0.369 . . . . 3.96 111.178 -176.446 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A 1536 ' ' ALA . . . . . . . . . . . . . . . -91.49 -45.45 8.52 Favored 'General case' 0 C--N 1.307 -1.25 0 C-N-CA 120.456 -0.497 . . . . 1.6499999999999999 111.65 -174.258 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A 1537 ' ' GLY . . . . . . . . . . . . . . . 100.15 -138.22 13.73 Favored Glycine 0 N--CA 1.429 -1.794 0 N-CA-C 110.894 -0.882 . . . . 1.1899999999999999 110.894 -179.212 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A 1538 ' ' PHE . . . . . . . . . . . . . 74.6 m-85 -138.1 172.99 12.11 Favored 'General case' 0 C--N 1.316 -0.88 0 N-CA-C 107.705 -1.22 . . . . 1.6899999999999999 107.705 -178.821 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A 1539 ' ' THR . . . . . . . . . . . . . 6.6 t -147.41 151.71 36.92 Favored 'General case' 0 C--N 1.299 -1.59 0 C-N-CA 119.384 -0.926 . . . . 1.48 111.21 -177.072 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A 1540 ' ' ALA . . . . . . . . . . . . . . . -132.19 135.47 46.36 Favored 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 108.543 -0.91 . . . . 0.82999999999999996 108.543 177.945 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A 1541 ' ' ALA . . . . . . . . . . . . . . . -80.45 152.2 28.89 Favored 'General case' 0 C--N 1.317 -0.827 0 CA-C-O 121.033 0.444 . . . . 1.27 110.855 -179.086 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A 1542 ' ' TYR . . . . . . . . . . . . . 30.3 t80 -149.36 177.62 9.51 Favored 'General case' 0 N--CA 1.425 -1.689 0 N-CA-C 108.48 -0.933 . . . . 2.1499999999999999 108.48 -177.903 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A 1543 ' ' SER . . . . . . . . . . . . . 4.5 m -48.69 -151.16 0.0 OUTLIER 'General case' 0 CA--C 1.58 2.132 0 C-N-CA 128.71 2.804 . . . . 2.29 113.28 178.173 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A 1544 ' ' LYS . . . . . . . . . . . . . 27.5 ttpp -43.18 -26.26 0.16 Allowed 'General case' 0 N--CA 1.495 1.8 0 O-C-N 120.607 -1.308 . . . . 3.9100000000000001 113.322 178.365 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A 1545 ' ' SER . . . . . . . . . . . . . 7.1 m -64.68 -22.02 66.88 Favored 'General case' 0 CA--C 1.569 1.677 0 C-N-CA 123.134 0.574 . . . . 3.2999999999999998 111.541 175.633 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A 1546 ' ' GLY . . . . . . . . . . . . . . . 91.45 -78.68 1.33 Allowed Glycine 0 N--CA 1.438 -1.174 0 N-CA-C 114.127 0.411 . . . . 1.24 114.127 173.518 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A 1547 ' ' VAL . . . . . . . . . . . . . 10.0 p -159.37 147.42 7.19 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.043 0 N-CA-C 107.057 -1.46 . . . . 1.6299999999999999 107.057 -176.071 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A 1548 ' ' VAL . . . . . . . . . . . . . 1.6 t -116.57 129.22 73.42 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.946 0 N-CA-C 108.319 -0.993 . . . . 0.92000000000000004 108.319 -177.338 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A 1549 ' ' TYR . . . . . 0.494 ' CE2' ' HA3' ' A' 1568 ' ' GLY . 79.3 m-85 -85.44 120.38 26.84 Favored 'General case' 0 CA--C 1.494 -1.184 0 N-CA-C 107.315 -1.365 . . . . 1.4399999999999999 107.315 174.839 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A 1550 ' ' MET . . . . . . . . . . . . . 88.7 mmm -124.76 121.29 34.19 Favored 'General case' 0 C--N 1.298 -1.654 0 N-CA-C 109.707 -0.479 . . . . 1.74 109.707 -173.579 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A 1551 ' ' SER . . . . . . . . . . . . . 50.4 m -89.96 158.62 17.3 Favored 'General case' 0 C--N 1.286 -2.158 0 N-CA-C 108.41 -0.959 . . . . 1.6399999999999999 108.41 175.622 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A 1552 ' ' ILE . . . . . 0.759 ' HB ' ' HB2' ' A' 1533 ' ' SER . 38.8 mm -74.14 -60.57 2.26 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.299 0 C-N-CA 119.228 -0.989 . . . . 1.3300000000000001 108.507 -179.871 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A 1553 ' ' CYS . . . . . 0.406 ' SG ' ' HG3' ' A' 1579 ' ' LYS . 34.9 t -151.16 141.99 22.86 Favored 'General case' 0 N--CA 1.421 -1.92 0 N-CA-C 104.402 -2.444 . . . . 1.4299999999999999 104.402 178.663 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A 1554 ' ' GLY . . . . . . . . . . . . . . . 104.81 -172.34 19.93 Favored Glycine 0 C--N 1.291 -1.951 0 C-N-CA 119.666 -1.254 . . . . 1.1200000000000001 111.073 -177.504 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A 1555 ' ' GLU . . . . . . . . . . . . . 8.9 pt-20 -98.67 142.4 30.28 Favored 'General case' 0 C--N 1.308 -1.219 0 N-CA-C 113.656 0.984 . . . . 1.8 113.656 -173.009 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A 1556 ' ' ASN . . . . . 0.419 ' O ' ' HA ' ' A' 1561 ' ' PRO . 19.3 t-20 -94.15 145.68 24.52 Favored 'General case' 0 C--N 1.309 -1.168 0 CA-C-N 113.707 -1.588 . . . . 2.6299999999999999 108.216 -179.398 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A 1557 ' ' GLU . . . . . . . . . . . . . 58.1 mm-40 -112.39 -9.47 13.84 Favored 'General case' 0 C--N 1.305 -1.35 0 O-C-N 123.464 0.478 . . . . 3.79 111.525 -174.618 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A 1558 ' ' ASN . . . . . . . . . . . . . 18.4 m-80 -85.49 2.58 44.11 Favored 'General case' 0 N--CA 1.489 1.488 0 CA-C-O 121.91 0.862 . . . . 1.52 111.519 -177.972 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A 1559 ' ' CYS . . . . . 0.802 ' HB3' ' HD2' ' A' 1560 ' ' PRO . 47.3 m -145.46 -175.93 0.51 Allowed Pre-proline 0 C--N 1.288 -2.097 0 N-CA-C 105.192 -2.151 . . . . 0.83999999999999997 105.192 175.51 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A 1560 ' ' PRO . . . . . 0.802 ' HD2' ' HB3' ' A' 1559 ' ' CYS . 1.6 Cg_endo -44.48 112.84 0.38 Allowed 'Trans proline' 0 C--N 1.376 2.01 0 C-N-CA 122.312 2.008 . . . . 1.1799999999999999 112.255 177.285 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A 1561 ' ' PRO . . . . . 0.419 ' HA ' ' O ' ' A' 1556 ' ' ASN . 53.0 Cg_exo -57.67 110.62 0.65 Allowed 'Trans proline' 0 C--O 1.244 0.82 0 C-N-CA 122.97 2.447 . . . . 1.51 111.229 -177.233 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A 1562 ' ' GLY . . . . . . . . . . . . . . . 135.96 -16.4 3.96 Favored Glycine 0 C--N 1.299 -1.483 0 N-CA-C 110.756 -0.938 . . . . 0.71999999999999997 110.756 -176.544 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A 1563 ' ' VAL . . . . . 0.648 ' HA ' ' HA ' ' A' 1576 ' ' LYS . 4.9 m -94.02 160.96 2.64 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.236 0 N-CA-C 107.029 -1.471 . . . . 0.96999999999999997 107.029 176.659 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A 1564 ' ' GLY . . . . . 0.489 ' HA3' ' CE2' ' A' 1592 ' ' TYR . . . -124.18 -5.08 7.5 Favored Glycine 0 C--O 1.238 0.403 0 C-N-CA 119.125 -1.512 . . . . 0.71999999999999997 113.162 -177.06 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A 1565 ' ' ALA . . . . . . . . . . . . . . . -150.18 127.24 11.2 Favored 'General case' 0 C--O 1.251 1.14 0 N-CA-C 108.808 -0.812 . . . . 0.37 108.808 179.867 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A 1566 ' ' CYS . . . . . . . . . . . . . 9.8 t -159.13 142.92 15.04 Favored 'General case' 0 C--N 1.308 -1.201 0 CA-C-N 116.258 -0.428 . . . . 0.51000000000000001 111.062 -172.755 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A 1567 ' ' PHE . . . . . . . . . . . . . 24.9 m-85 -73.31 123.24 23.37 Favored 'General case' 0 CA--C 1.508 -0.668 0 N-CA-C 107.224 -1.398 . . . . 0.96999999999999997 107.224 175.789 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A 1568 ' ' GLY . . . . . 0.494 ' HA3' ' CE2' ' A' 1549 ' ' TYR . . . -79.26 -25.47 59.28 Favored Glycine 0 C--N 1.3 -1.426 0 C-N-CA 120.052 -1.07 . . . . 1.0800000000000001 114.785 -171.688 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A 1569 ' ' GLN . . . . . . . . . . . . . 59.5 tp60 -71.08 -46.03 62.62 Favored 'General case' 0 C--N 1.306 -1.303 0 C-N-CA 119.937 -0.705 . . . . 2.7400000000000002 110.934 -179.179 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A 1570 ' ' THR . . . . . . . . . . . . . 38.3 p -95.83 -13.14 24.27 Favored 'General case' 0 C--N 1.306 -1.309 0 N-CA-C 112.333 0.494 . . . . 1.96 112.333 -177.154 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A 1571 ' ' ARG . . . . . . . . . . . . . 79.4 mtm180 60.63 37.39 19.29 Favored 'General case' 0 C--O 1.246 0.869 0 C-N-CA 124.753 1.221 . . . . 3.9500000000000002 112.798 -177.303 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A 1572 ' ' ILE . . . . . . . . . . . . . 39.9 mm -101.03 110.69 28.55 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.378 0 CA-C-N 114.458 -1.246 . . . . 1.3700000000000001 108.2 177.941 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A 1573 ' ' SER . . . . . . . . . . . . . 29.1 t -67.68 133.73 49.85 Favored 'General case' 0 C--N 1.294 -1.836 0 CA-C-N 114.548 -1.206 . . . . 1.0800000000000001 111.016 -179.971 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A 1574 ' ' VAL . . . . . 0.511 ' HB ' ' HB2' ' A' 1606 ' ' TYR . 34.8 m -108.23 -33.39 2.55 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.309 0 C-N-CA 120.602 -0.439 . . . . 1.3 111.009 -179.815 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A 1575 ' ' GLY . . . . . . . . . . . . . . . -140.11 130.88 4.83 Favored Glycine 0 N--CA 1.433 -1.512 0 C-N-CA 120.364 -0.922 . . . . 0.51000000000000001 112.67 -177.692 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A 1576 ' ' LYS . . . . . 0.648 ' HA ' ' HA ' ' A' 1563 ' ' VAL . 88.4 tttt -79.75 151.15 30.54 Favored 'General case' 0 C--N 1.313 -1.009 0 N-CA-C 108.32 -0.993 . . . . 2.8999999999999999 108.32 178.698 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A 1577 ' ' ALA . . . . . . . . . . . . . . . -70.71 98.17 1.48 Allowed 'General case' 0 CA--C 1.508 -0.662 0 CA-C-O 121.245 0.545 . . . . 0.82999999999999996 111.119 -175.988 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A 1578 ' ' ASN . . . . . . . . . . . . . 3.8 m-20 -101.66 115.93 31.62 Favored 'General case' 0 C--N 1.296 -1.753 0 N-CA-C 107.118 -1.438 . . . . 1.8500000000000001 107.118 175.97 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A 1579 ' ' LYS . . . . . 0.579 ' HD2' ' HB2' ' A' 1516 ' ' CYS . 38.4 ttpt -91.34 89.72 7.4 Favored 'General case' 0 C--N 1.3 -1.578 0 N-CA-C 108.085 -1.08 . . . . 1.8999999999999999 108.085 179.532 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A 1580 ' ' ARG . . . . . . . . . . . . . 14.4 tpp180 -156.43 116.93 3.67 Favored 'General case' 0 N--CA 1.419 -1.976 0 CA-C-N 114.459 -1.246 . . . . 3.6299999999999999 108.556 -176.11 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A 1581 ' ' LEU . . . . . . . . . . . . . 2.9 pp -113.37 150.65 32.33 Favored 'General case' 0 C--N 1.297 -1.688 0 C-N-CA 120.515 -0.474 . . . . 1.8700000000000001 111.236 178.145 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A 1582 ' ' ARG . . . . . . . . . . . . . 41.2 ttm180 -130.12 109.75 11.07 Favored 'General case' 0 C--N 1.295 -1.781 0 CA-C-N 115.603 -0.726 . . . . 3.9700000000000002 109.912 -178.625 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A 1583 ' ' TYR . . . . . . . . . . . . . 79.6 t80 -94.84 104.12 16.02 Favored 'General case' 0 C--N 1.296 -1.746 0 N-CA-C 108.443 -0.947 . . . . 1.4099999999999999 108.443 178.801 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A 1584 ' ' VAL . . . . . 0.482 ' O ' HG12 ' A' 1587 ' ' VAL . 7.0 p -130.78 111.2 19.76 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.403 0 C-N-CA 120.358 -0.537 . . . . 1.6899999999999999 112.0 -177.584 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A 1585 ' ' ASP . . . . . . . . . . . . . 18.7 t70 59.98 59.16 2.5 Favored 'General case' 0 N--CA 1.481 1.078 0 CA-C-O 122.584 1.183 . . . . 2.0600000000000001 110.976 177.171 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A 1586 ' ' GLN . . . . . . . . . . . . . 41.8 mt-30 57.35 23.53 9.01 Favored 'General case' 0 C--N 1.315 -0.916 0 N-CA-C 115.186 1.55 . . . . 2.3300000000000001 115.186 179.087 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A 1587 ' ' VAL . . . . . 0.482 HG12 ' O ' ' A' 1584 ' ' VAL . 9.5 p -130.85 128.32 62.63 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.512 0 N-CA-C 108.757 -0.831 . . . . 0.78000000000000003 108.757 173.482 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A 1588 ' ' LEU . . . . . 0.633 ' HB2' ' HB2' ' A' 1612 ' ' PHE . 8.1 mp -89.15 143.98 26.45 Favored 'General case' 0 N--CA 1.427 -1.58 0 CA-C-N 115.609 -0.723 . . . . 1.4099999999999999 109.636 179.689 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A 1589 ' ' GLN . . . . . . . . . . . . . 7.7 tt0 -136.05 142.8 44.43 Favored 'General case' 0 C--N 1.28 -2.454 0 N-CA-C 108.872 -0.788 . . . . 1.24 108.872 178.136 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A 1590 ' ' LEU . . . . . . . . . . . . . 5.7 tt -139.19 133.83 31.94 Favored 'General case' 0 C--N 1.293 -1.861 0 N-CA-C 103.611 -2.737 . . . . 1.1499999999999999 103.611 173.463 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A 1591 ' ' VAL . . . . . . . . . . . . . 7.3 p -130.9 127.61 61.59 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.496 0 N-CA-C 113.792 1.034 . . . . 1.51 113.792 -172.808 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A 1592 ' ' TYR . . . . . 0.489 ' CE2' ' HA3' ' A' 1564 ' ' GLY . 96.4 m-85 -101.33 139.9 36.37 Favored 'General case' 0 CA--C 1.495 -1.162 0 CA-C-N 114.581 -1.19 . . . . 1.0600000000000001 107.86 177.412 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A 1593 ' ' LYS . . . . . . . . . . . . . 14.1 ptmm? -158.93 170.12 22.81 Favored 'General case' 0 C--N 1.299 -1.595 0 C-N-CA 120.601 -0.44 . . . . 2.1800000000000002 110.084 -179.125 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A 1594 ' ' ASP . . . . . . . . . . . . . 48.1 m-20 61.8 41.98 11.11 Favored 'General case' 0 C--N 1.312 -1.025 0 N-CA-C 114.774 1.398 . . . . 1.45 114.774 175.127 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A 1595 ' ' GLY . . . . . . . . . . . . . . . -77.49 -86.88 0.41 Allowed Glycine 0 N--CA 1.437 -1.258 0 N-CA-C 109.13 -1.588 . . . . 0.78000000000000003 109.13 171.241 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A 1596 ' ' SER . . . . . . . . . . . . . 15.5 m -114.47 152.37 46.06 Favored Pre-proline 0 C--N 1.298 -1.635 0 N-CA-C 107.921 -1.14 . . . . 1.6799999999999999 107.921 176.059 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A 1597 ' ' PRO . . . . . . . . . . . . . 28.1 Cg_exo -63.74 146.35 91.99 Favored 'Trans proline' 0 C--O 1.247 0.97 0 C-N-CA 122.929 2.42 . . . . 1.1699999999999999 111.45 178.103 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A 1598 ' ' CYS . . . . . 0.469 ' HA ' ' HD3' ' A' 1599 ' ' PRO . 27.4 t -98.76 133.3 22.56 Favored Pre-proline 0 C--N 1.297 -1.696 0 N-CA-C 108.894 -0.78 . . . . 1.1899999999999999 108.894 -178.486 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A 1599 ' ' PRO . . . . . 0.469 ' HD3' ' HA ' ' A' 1598 ' ' CYS . 32.1 Cg_exo -62.82 -21.62 73.22 Favored 'Trans proline' 0 C--N 1.359 1.129 0 C-N-CA 123.759 2.973 . . . . 1.5900000000000001 112.941 179.801 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A 1600 ' ' SER . . . . . 0.56 ' HB3' ' SG ' ' A' 1634 ' ' CYS . 47.9 t -85.89 117.74 24.93 Favored 'General case' 0 N--CA 1.427 -1.606 0 N-CA-C 106.704 -1.591 . . . . 2.1200000000000001 106.704 175.242 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A 1601 ' ' LYS . . . . . . . . . . . . . 48.4 mmtm 58.82 60.63 2.42 Favored 'General case' 0 C--O 1.245 0.865 0 O-C-N 123.988 0.805 . . . . 3.7400000000000002 108.994 -176.484 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A 1602 ' ' SER . . . . . . . . . . . . . 23.3 t -53.37 112.27 0.86 Allowed 'General case' 0 C--O 1.247 0.969 0 CA-C-N 114.786 -1.097 . . . . 3.79 111.542 -174.846 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A 1603 ' ' GLY . . . . . . . . . . . . . . . 150.99 -33.84 0.94 Allowed Glycine 0 N--CA 1.43 -1.743 0 N-CA-C 108.137 -1.985 . . . . 2.0 108.137 -177.912 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A 1604 ' ' LEU . . . . . . . . . . . . . 2.5 pp -94.59 164.16 13.09 Favored 'General case' 0 N--CA 1.427 -1.585 0 CA-C-N 114.644 -0.778 . . . . 1.48 109.567 175.87 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A 1605 ' ' SER . . . . . . . . . . . . . 19.0 p -109.42 -167.08 1.16 Allowed 'General case' 0 C--N 1.286 -2.19 0 N-CA-C 109.371 -0.603 . . . . 1.51 109.371 -178.82 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A 1606 ' ' TYR . . . . . 0.511 ' HB2' ' HB ' ' A' 1574 ' ' VAL . 61.1 m-85 -97.45 144.79 26.83 Favored 'General case' 0 N--CA 1.413 -2.32 0 N-CA-C 104.466 -2.42 . . . . 1.1799999999999999 104.466 179.07 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A 1607 ' ' LYS . . . . . 0.471 ' HG3' HG23 ' A' 1635 ' ' THR . 19.2 ptmt -132.38 132.98 43.4 Favored 'General case' 0 C--N 1.268 -2.968 0 C-N-CA 118.655 -1.218 . . . . 1.6699999999999999 109.422 177.283 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A 1608 ' ' SER . . . . . . . . . . . . . 20.2 m -115.69 111.72 21.02 Favored 'General case' 0 C--N 1.291 -1.945 0 C-N-CA 122.848 0.459 . . . . 1.0 110.694 -175.724 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A 1609 ' ' VAL . . . . . . . . . . . . . 96.5 t -92.34 121.38 42.87 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.069 0 N-CA-C 109.151 -0.685 . . . . 0.93000000000000005 109.151 178.17 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A 1610 ' ' ILE . . . . . . . . . . . . . 17.0 mm -99.62 104.44 16.07 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.552 0 N-CA-C 107.871 -1.159 . . . . 0.78000000000000003 107.871 177.11 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A 1611 ' ' SER . . . . . 0.478 ' O ' ' HA ' ' A' 1639 ' ' SER . 22.8 t -91.8 119.87 32.01 Favored 'General case' 0 N--CA 1.42 -1.957 0 N-CA-C 108.612 -0.884 . . . . 1.29 108.612 178.667 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A 1612 ' ' PHE . . . . . 0.633 ' HB2' ' HB2' ' A' 1588 ' ' LEU . 97.4 m-85 -95.85 108.73 21.11 Favored 'General case' 0 C--N 1.297 -1.696 0 CA-C-N 115.548 -0.751 . . . . 0.69999999999999996 109.678 -178.776 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A 1613 ' ' VAL . . . . . . . . . . . . . 48.0 t -100.56 122.14 52.19 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.012 0 CA-C-N 115.409 -0.814 . . . . 0.75 109.544 -176.891 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A 1614 ' ' CYS . . . . . 0.671 ' HA ' ' O ' ' A' 1642 ' ' THR . 0.8 OUTLIER -76.68 100.6 5.45 Favored 'General case' 0 CA--C 1.5 -0.977 0 N-CA-C 113.178 0.807 . . . . 1.3899999999999999 113.178 177.289 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A 1615 ' ' ARG . . . . . 0.497 ' HD3' ' HD2' ' A' 1616 ' ' PRO . 14.0 tpp180 -137.71 116.77 9.96 Favored Pre-proline 0 N--CA 1.414 -2.27 0 CA-C-N 114.851 -1.068 . . . . 3.75 108.411 177.103 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A 1616 ' ' PRO . . . . . 0.497 ' HD2' ' HD3' ' A' 1615 ' ' ARG . 56.6 Cg_exo -58.16 52.13 0.05 OUTLIER 'Trans proline' 0 CA--C 1.553 1.463 0 C-N-CA 124.788 3.659 . . . . 1.3200000000000001 114.717 174.636 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A 1617 ' ' GLU . . . . . . . . . . . . . 44.0 tt0 -104.26 -13.87 16.01 Favored 'General case' 0 C--N 1.31 -1.143 0 N-CA-C 108.2 -1.037 . . . . 3.21 108.2 176.628 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A 1618 ' ' ALA . . . . . . . . . . . . . . . 59.73 -173.07 0.11 Allowed 'General case' 0 N--CA 1.47 0.532 0 CA-C-N 113.719 -1.582 . . . . 2.4399999999999999 112.548 177.225 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A 1619 ' ' GLY . . . . . . . . . . . . . . . 98.6 103.93 2.41 Favored Glycine 0 N--CA 1.434 -1.458 0 C-N-CA 120.938 -0.649 . . . . 3.2599999999999998 112.367 177.45 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A 1620 ' ' PRO . . . . . 0.853 ' HA ' ' HZ2' ' A' 1640 ' ' TRP . 18.4 Cg_exo -69.75 -17.78 37.41 Favored 'Trans proline' 0 CA--C 1.539 0.771 0 C-N-CA 122.531 2.154 . . . . 5.9199999999999999 111.993 178.292 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A 1621 ' ' THR . . . . . . . . . . . . . 31.2 m -102.52 -0.31 32.41 Favored 'General case' 0 C--N 1.314 -0.955 0 N-CA-C 108.663 -0.866 . . . . 4.7599999999999998 108.663 178.044 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A 1622 ' ' ASN . . . . . 0.464 ' C ' ' HD3' ' A' 1624 ' ' PRO . 61.0 t30 -77.16 47.79 0.57 Allowed 'General case' 0 C--O 1.247 0.934 0 CA-C-O 121.894 0.854 . . . . 2.9199999999999999 112.578 -174.592 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A 1623 ' ' ARG . . . . . 0.5 ' HB3' ' CD1' ' A' 1640 ' ' TRP . 9.2 ptm180 -123.72 69.6 45.63 Favored Pre-proline 0 N--CA 1.434 -1.237 0 C-N-CA 119.572 -0.851 . . . . 3.6099999999999999 112.043 178.62 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A 1624 ' ' PRO . . . . . 0.464 ' HD3' ' C ' ' A' 1622 ' ' ASN . 64.4 Cg_endo -114.41 91.18 0.01 OUTLIER 'Trans proline' 0 N--CA 1.426 -2.491 0 C-N-CA 122.446 2.098 . . . . 2.3700000000000001 110.09 167.61 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A 1625 ' ' MET . . . . . 0.563 ' HG3' HG23 ' A' 1627 ' ' ILE . 12.9 tpt -151.78 98.77 2.51 Favored 'General case' 0 C--N 1.297 -1.714 0 C-N-CA 116.939 -1.905 . . . . 2.1600000000000001 112.236 -179.389 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A 1626 ' ' LEU . . . . . . . . . . . . . 4.4 mm? -87.85 88.99 7.82 Favored 'General case' 0 C--N 1.302 -1.494 0 N-CA-C 108.518 -0.919 . . . . 1.3500000000000001 108.518 171.321 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A 1627 ' ' ILE . . . . . 0.563 HG23 ' HG3' ' A' 1625 ' ' MET . 37.0 pt -73.42 -35.18 45.11 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.872 0 CA-C-N 115.875 -0.602 . . . . 1.21 110.956 -178.293 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A 1628 ' ' SER . . . . . . . . . . . . . 22.9 t -161.67 152.43 17.87 Favored 'General case' 0 N--CA 1.414 -2.268 0 N-CA-C 107.628 -1.249 . . . . 1.3999999999999999 107.628 -178.242 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A 1629 ' ' LEU . . . . . 0.573 ' HG ' ' HG ' ' A' 1636 ' ' LEU . 5.1 tt -146.72 111.99 5.49 Favored 'General case' 0 C--N 1.286 -2.166 0 N-CA-C 106.041 -1.837 . . . . 1.5600000000000001 106.041 175.843 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A 1630 ' ' ASP . . . . . 0.418 ' HB3' ' HB ' ' A' 1635 ' ' THR . 14.0 t70 -84.81 99.66 11.04 Favored 'General case' 0 C--N 1.292 -1.915 0 N-CA-C 106.741 -1.577 . . . . 0.87 106.741 -179.544 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A 1631 ' ' LYS . . . . . 0.429 ' HG2' HD22 ' A' 1629 ' ' LEU . 47.1 mtmt -72.79 -19.17 61.39 Favored 'General case' 0 C--N 1.306 -1.324 0 CA-C-N 115.941 -0.572 . . . . 2.3500000000000001 112.373 -173.304 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A 1632 ' ' GLN . . . . . . . . . . . . . 2.8 mp0 -73.68 -51.45 16.64 Favored 'General case' 0 C--N 1.313 -0.985 0 C-N-CA 121.01 -0.276 . . . . 2.5499999999999998 110.719 179.616 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A 1633 ' ' THR . . . . . . . . . . . . . 35.7 p -97.36 14.03 27.62 Favored 'General case' 0 C--N 1.316 -0.858 0 CA-C-O 121.357 0.599 . . . . 1.24 111.917 -179.706 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A 1634 ' ' CYS . . . . . 0.56 ' SG ' ' HB3' ' A' 1600 ' ' SER . 65.9 m 50.01 45.58 25.18 Favored 'General case' 0 N--CA 1.475 0.813 0 C-N-CA 124.966 1.307 . . . . 0.89000000000000001 112.244 177.744 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A 1635 ' ' THR . . . . . 0.471 HG23 ' HG3' ' A' 1607 ' ' LYS . 25.5 m -107.14 107.51 18.52 Favored 'General case' 0 N--CA 1.428 -1.574 0 CA-C-N 114.89 -1.05 . . . . 0.75 109.831 -176.609 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A 1636 ' ' LEU . . . . . 0.573 ' HG ' ' HG ' ' A' 1629 ' ' LEU . 4.9 mp -95.11 127.88 41.51 Favored 'General case' 0 C--N 1.309 -1.182 0 N-CA-C 109.434 -0.58 . . . . 1.3300000000000001 109.434 -177.505 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A 1637 ' ' PHE . . . . . . . . . . . . . 95.6 m-85 -109.36 110.85 22.11 Favored 'General case' 0 C--N 1.314 -0.939 0 CA-C-O 120.941 0.401 . . . . 0.82999999999999996 110.305 -179.12 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A 1638 ' ' PHE . . . . . 0.424 ' HA ' ' O ' ' A' 1625 ' ' MET . 92.6 m-85 -105.41 159.32 16.01 Favored 'General case' 0 C--N 1.315 -0.933 0 N-CA-C 109.393 -0.595 . . . . 0.59999999999999998 109.393 179.583 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A 1639 ' ' SER . . . . . 0.478 ' HA ' ' O ' ' A' 1611 ' ' SER . 50.1 m -142.09 144.85 33.74 Favored 'General case' 0 C--N 1.299 -1.599 0 CA-C-O 120.841 0.353 . . . . 1.0800000000000001 110.885 175.713 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A 1640 ' ' TRP . . . . . 0.853 ' HZ2' ' HA ' ' A' 1620 ' ' PRO . 12.4 t90 -118.95 137.79 53.25 Favored 'General case' 0 C--N 1.323 -0.551 0 N-CA-C 106.939 -1.504 . . . . 0.80000000000000004 106.939 176.871 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A 1641 ' ' HIS . . . . . . . . . . . . . 38.9 m-70 -98.87 98.09 9.21 Favored 'General case' 0 C--N 1.314 -0.937 0 N-CA-C 105.966 -1.864 . . . . 2.54 105.966 179.075 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A 1642 ' ' THR . . . . . 0.671 ' O ' ' HA ' ' A' 1614 ' ' CYS . 9.8 t -142.24 139.21 17.47 Favored Pre-proline 0 C--N 1.305 -1.359 0 N-CA-C 113.459 0.911 . . . . 1.1499999999999999 113.459 -171.686 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A 1643 ' ' PRO . . . . . 0.512 ' HD3' ' HA ' ' A' 1642 ' ' THR . 4.4 Cg_exo -79.42 -6.77 14.77 Favored 'Trans proline' 0 C--N 1.355 0.894 0 C-N-CA 123.462 2.775 . . . . 0.80000000000000004 110.385 173.574 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A 1644 ' ' LEU . . . . . . . . . . . . . 65.8 mt -89.13 5.32 45.14 Favored 'General case' 0 N--CA 1.443 -0.797 0 CA-C-N 115.229 -0.896 . . . . 1.54 110.249 -177.693 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A 1645 ' ' ALA . . . . . . . . . . . . . . . -97.18 -44.36 6.98 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-O 121.619 0.724 . . . . 0.94999999999999996 109.642 176.46 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A 1646 ' ' CYS . . . . . . . . . . . . . 0.6 OUTLIER -171.41 173.91 4.64 Favored 'General case' 0 C--N 1.303 -1.441 0 N-CA-C 107.69 -1.226 . . . . 1.4099999999999999 107.69 -178.063 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A 1647 ' ' GLU . . . . . . . . . . . . . 51.8 mt-10 -132.47 111.63 13.91 Favored Pre-proline 0 C--N 1.303 -1.432 0 N-CA-C 108.519 -0.919 . . . . 2.9199999999999999 108.519 -178.787 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A 1648 ' ' PRO . . . . . . . . . . . . . 23.9 Cg_exo -67.47 101.03 0.6 Allowed 'Trans proline' 0 C--O 1.245 0.828 0 C-N-CA 122.211 1.941 . . . . 2.8199999999999998 110.51 178.875 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A 1649 ' ' GLU . . . . . . . . . . . . . 14.1 tp10 . . . . . 0 N--CA 1.427 -1.62 0 N-CA-C 108.012 -1.107 . . . . 5.0599999999999996 108.012 -178.341 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A 1508 ' ' MET . . . . . . . . . . . . . 23.8 ptp . . . . . 0 CA--C 1.533 0.292 0 N-CA-C 112.027 0.38 . . . . 8.2699999999999996 112.027 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A 1509 ' ' LYS . . . . . . . . . . . . . 22.3 pttp -139.15 27.31 2.36 Favored 'General case' 0 C--N 1.327 -0.41 0 O-C-N 121.711 -0.618 . . . . 6.4800000000000004 110.607 -177.356 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A 1510 ' ' SER . . . . . . . . . . . . . 26.0 p -144.51 144.15 31.2 Favored 'General case' 0 C--N 1.299 -1.62 0 N-CA-C 108.97 -0.752 . . . . 4.2199999999999998 108.97 -176.753 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A 1511 ' ' ASN . . . . . 0.445 ' HB2' ' HG3' ' A' 1517 ' ' GLN . 28.4 p30 -140.75 -19.77 0.82 Allowed 'General case' 0 C--N 1.307 -1.246 0 N-CA-C 114.103 1.149 . . . . 3.0800000000000001 114.103 -177.458 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A 1512 ' ' GLU . . . . . 0.468 ' HG2' HG23 ' A' 1518 ' ' VAL . 47.2 mt-10 -61.38 -28.28 69.13 Favored 'General case' 0 N--CA 1.486 1.373 0 CA-C-O 121.312 0.577 . . . . 4.46 112.491 -176.429 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A 1513 ' ' HIS . . . . . 0.461 ' HA ' ' O ' ' A' 1579 ' ' LYS . 63.5 m80 -122.38 -9.06 8.59 Favored 'General case' 0 C--N 1.315 -0.92 0 CA-C-O 121.053 0.454 . . . . 5.5700000000000003 110.611 176.793 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A 1514 ' ' ASP . . . . . 0.428 ' HB2' ' HA ' ' A' 1511 ' ' ASN . 2.2 m-20 -92.06 -31.53 15.52 Favored 'General case' 0 C--N 1.307 -1.27 0 N-CA-C 112.416 0.524 . . . . 3.7000000000000002 112.416 -175.721 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A 1515 ' ' ASP . . . . . 0.57 ' HB3' ' HG2' ' A' 1517 ' ' GLN . 7.5 t70 -141.15 -171.77 3.35 Favored 'General case' 0 C--N 1.295 -1.799 0 N-CA-C 105.781 -1.933 . . . . 2.54 105.781 -177.347 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A 1516 ' ' CYS . . . . . . . . . . . . . 72.8 m -104.34 51.5 0.77 Allowed 'General case' 0 C--N 1.27 -2.865 0 N-CA-C 108.196 -1.039 . . . . 1.25 108.196 -179.8 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A 1517 ' ' GLN . . . . . 0.57 ' HG2' ' HB3' ' A' 1515 ' ' ASP . 3.9 pt20 -151.64 171.38 17.72 Favored 'General case' 0 C--N 1.304 -1.377 0 N-CA-C 109.407 -0.59 . . . . 1.8799999999999999 109.407 -177.316 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A 1518 ' ' VAL . . . . . 0.468 HG23 ' HG2' ' A' 1512 ' ' GLU . 8.5 p -154.23 140.6 11.91 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.404 0 N-CA-C 109.404 -0.591 . . . . 1.73 109.404 -179.414 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A 1519 ' ' THR . . . . . . . . . . . . . 19.1 m -100.76 130.74 46.83 Favored 'General case' 0 N--CA 1.423 -1.783 0 N-CA-C 107.895 -1.15 . . . . 1.7 107.895 177.097 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A 1520 ' ' ASN . . . . . 0.434 ' OD1' HG22 ' A' 1523 ' ' THR . 27.9 t-20 -90.03 121.35 68.88 Favored Pre-proline 0 C--N 1.3 -1.567 0 C-N-CA 120.236 -0.585 . . . . 2.1200000000000001 109.868 178.295 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A 1521 ' ' PRO . . . . . . . . . . . . . 60.0 Cg_endo -73.09 -20.28 21.89 Favored 'Trans proline' 0 C--N 1.352 0.754 0 C-N-CA 122.089 1.86 . . . . 2.4700000000000002 113.642 -175.797 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A 1522 ' ' SER . . . . . . . . . . . . . 48.1 m -77.0 -57.9 3.58 Favored 'General case' 0 C--N 1.316 -0.851 0 N-CA-C 111.981 0.363 . . . . 2.5699999999999998 111.981 -177.95 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A 1523 ' ' THR . . . . . 0.434 HG22 ' OD1' ' A' 1520 ' ' ASN . 8.9 t -90.71 -14.81 31.45 Favored 'General case' 0 C--N 1.317 -0.835 0 CA-C-O 121.053 0.454 . . . . 2.1499999999999999 111.134 -178.601 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A 1524 ' ' GLY . . . . . . . . . . . . . . . 76.13 14.32 82.39 Favored Glycine 0 C--O 1.226 -0.393 0 C-N-CA 120.873 -0.679 . . . . 1.8899999999999999 112.478 178.932 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A 1525 ' ' HIS . . . . . . . . . . . . . 22.7 t60 -100.75 137.65 38.85 Favored 'General case' 0 C--N 1.309 -1.183 0 N-CA-C 108.143 -1.058 . . . . 1.8999999999999999 108.143 -177.57 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A 1526 ' ' LEU . . . . . . . . . . . . . 7.7 tt -100.0 136.37 40.01 Favored 'General case' 0 C--N 1.297 -1.707 0 N-CA-C 108.604 -0.887 . . . . 1.6100000000000001 108.604 -178.451 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A 1527 ' ' PHE . . . . . . . . . . . . . 88.2 m-85 -110.46 126.16 54.04 Favored 'General case' 0 C--N 1.3 -1.554 0 N-CA-C 107.792 -1.188 . . . . 1.4199999999999999 107.792 178.618 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A 1528 ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -114.71 143.64 44.74 Favored 'General case' 0 C--N 1.309 -1.179 0 CA-C-O 122.021 0.915 . . . . 2.1800000000000002 112.104 -178.932 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A 1529 ' ' LEU . . . . . . . . . . . . . 3.1 mm? -122.33 16.68 10.59 Favored 'General case' 0 C--N 1.292 -1.896 0 N-CA-C 105.047 -2.205 . . . . 1.4399999999999999 105.047 168.963 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A 1530 ' ' SER . . . . . . . . . . . . . 12.7 m -74.04 -37.48 64.29 Favored 'General case' 0 N--CA 1.435 -1.219 0 CA-C-N 113.727 -1.579 . . . . 1.4399999999999999 108.681 -179.157 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A 1531 ' ' SER . . . . . . . . . . . . . 9.6 m -75.0 -21.61 59.03 Favored 'General case' 0 N--CA 1.433 -1.32 0 N-CA-C 108.801 -0.814 . . . . 1.5 108.801 176.515 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A 1532 ' ' LEU . . . . . 0.488 HD11 HD21 ' A' 1644 ' ' LEU . 90.2 mt -96.29 11.23 35.36 Favored 'General case' 0 CA--C 1.52 -0.21 0 CA-C-N 115.638 -0.71 . . . . 1.77 112.238 178.239 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A 1533 ' ' SER . . . . . . . . . . . . . 34.0 m -69.47 114.46 7.72 Favored 'General case' 0 N--CA 1.435 -1.212 0 N-CA-C 107.622 -1.251 . . . . 2.3799999999999999 107.622 176.479 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A 1534 ' ' GLY . . . . . . . . . . . . . . . -82.47 151.11 29.18 Favored Glycine 0 N--CA 1.426 -2.005 0 CA-C-N 115.615 -0.721 . . . . 1.55 113.993 -170.209 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A 1535 ' ' ARG . . . . . 0.465 ' C ' ' HD3' ' A' 1535 ' ' ARG . 1.2 tmt_? -95.88 -61.57 1.43 Allowed 'General case' 0 N--CA 1.426 -1.644 0 N-CA-C 106.885 -1.524 . . . . 3.96 106.885 174.821 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A 1536 ' ' ALA . . . . . . . . . . . . . . . -94.87 -23.01 17.65 Favored 'General case' 0 C--N 1.312 -1.056 0 CA-C-N 115.458 -0.792 . . . . 1.6499999999999999 109.023 177.195 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A 1537 ' ' GLY . . . . . . . . . . . . . . . 91.25 -167.75 31.75 Favored Glycine 0 N--CA 1.427 -1.962 0 CA-C-N 115.623 -0.717 . . . . 1.1899999999999999 113.862 174.492 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A 1538 ' ' PHE . . . . . . . . . . . . . 81.6 m-85 -108.46 168.3 9.42 Favored 'General case' 0 C--N 1.298 -1.661 0 C-N-CA 125.574 1.55 . . . . 1.6899999999999999 107.661 -179.321 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A 1539 ' ' THR . . . . . . . . . . . . . 14.5 p -117.05 112.7 21.3 Favored 'General case' 0 C--N 1.297 -1.714 0 CA-C-O 120.925 0.393 . . . . 1.48 110.273 179.809 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A 1540 ' ' ALA . . . . . . . . . . . . . . . -102.17 143.96 31.32 Favored 'General case' 0 C--N 1.303 -1.435 0 N-CA-C 108.05 -1.093 . . . . 0.82999999999999996 108.05 178.741 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A 1541 ' ' ALA . . . . . . . . . . . . . . . -91.01 156.64 17.8 Favored 'General case' 0 C--N 1.294 -1.826 0 CA-C-O 121.982 0.896 . . . . 1.27 112.844 -173.819 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A 1542 ' ' TYR . . . . . 0.73 ' HB3' ' HA3' ' A' 1546 ' ' GLY . 68.5 t80 -147.44 171.69 15.11 Favored 'General case' 0 C--N 1.296 -1.761 0 N-CA-C 102.746 -3.057 . . . . 2.1499999999999999 102.746 175.006 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A 1543 ' ' SER . . . . . . . . . . . . . 6.8 m -43.09 -161.88 0.0 OUTLIER 'General case' 0 CA--C 1.603 2.983 0 N-CA-C 117.119 2.266 . . . . 2.29 117.119 -173.769 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A 1544 ' ' LYS . . . . . . . . . . . . . 57.7 tttm -46.12 -38.05 7.65 Favored 'General case' 0 N--CA 1.479 0.997 0 O-C-N 120.669 -1.27 . . . . 3.9100000000000001 113.24 -178.493 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A 1545 ' ' SER . . . . . . . . . . . . . 19.4 m -111.29 26.12 11.01 Favored 'General case' 0 C--N 1.3 -1.56 0 O-C-N 122.27 -0.269 . . . . 3.2999999999999998 110.583 179.18 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A 1546 ' ' GLY . . . . . 0.73 ' HA3' ' HB3' ' A' 1542 ' ' TYR . . . -112.84 131.28 10.0 Favored Glycine 0 N--CA 1.412 -2.912 0 C-N-CA 117.879 -2.105 . . . . 1.24 116.311 -173.836 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A 1547 ' ' VAL . . . . . . . . . . . . . 9.1 p -162.07 119.46 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.567 0 N-CA-C 107.821 -1.177 . . . . 1.6299999999999999 107.821 171.808 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A 1548 ' ' VAL . . . . . . . . . . . . . 2.1 t -115.29 129.23 71.88 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.814 0 N-CA-C 107.923 -1.14 . . . . 0.92000000000000004 107.923 -175.599 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A 1549 ' ' TYR . . . . . 0.447 ' HB3' HD21 ' A' 1556 ' ' ASN . 96.3 m-85 -84.61 116.57 23.24 Favored 'General case' 0 N--CA 1.423 -1.783 0 N-CA-C 107.552 -1.277 . . . . 1.4399999999999999 107.552 176.002 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A 1550 ' ' MET . . . . . . . . . . . . . 54.9 tpp -119.1 122.53 42.28 Favored 'General case' 0 C--N 1.29 -1.986 0 CA-C-N 115.379 -0.828 . . . . 1.74 110.551 -174.014 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A 1551 ' ' SER . . . . . . . . . . . . . 8.2 t -96.57 121.7 38.68 Favored 'General case' 0 C--N 1.285 -2.202 0 N-CA-C 103.527 -2.768 . . . . 1.6399999999999999 103.527 171.263 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A 1552 ' ' ILE . . . . . . . . . . . . . 1.8 tp -62.14 -27.57 42.77 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.666 0 CA-C-O 121.38 0.609 . . . . 1.3300000000000001 110.344 -172.166 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A 1553 ' ' CYS . . . . . 0.466 ' HA ' ' OH ' ' A' 1592 ' ' TYR . 23.0 t -162.39 138.39 7.48 Favored 'General case' 0 N--CA 1.415 -2.215 0 N-CA-C 105.479 -2.045 . . . . 1.4299999999999999 105.479 167.494 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A 1554 ' ' GLY . . . . . . . . . . . . . . . 110.45 -166.85 12.46 Favored Glycine 0 C--N 1.292 -1.913 0 N-CA-C 110.018 -1.233 . . . . 1.1200000000000001 110.018 -179.011 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A 1555 ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -99.69 156.93 16.82 Favored 'General case' 0 C--N 1.303 -1.448 0 CA-C-N 117.48 0.64 . . . . 1.8 111.109 -178.221 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A 1556 ' ' ASN . . . . . 0.447 HD21 ' HB3' ' A' 1549 ' ' TYR . 23.0 t-20 -111.47 109.37 19.28 Favored 'General case' 0 N--CA 1.423 -1.815 0 CA-C-N 115.34 -0.845 . . . . 2.6299999999999999 109.269 -178.409 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A 1557 ' ' GLU . . . . . . . . . . . . . 25.6 mt-10 -87.91 54.42 3.09 Favored 'General case' 0 C--N 1.301 -1.525 0 N-CA-C 113.307 0.854 . . . . 3.79 113.307 -174.022 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A 1558 ' ' ASN . . . . . . . . . . . . . 32.9 m-80 -129.22 3.45 5.2 Favored 'General case' 0 C--N 1.306 -1.298 0 N-CA-C 107.94 -1.133 . . . . 1.52 107.94 174.615 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A 1559 ' ' CYS . . . . . 0.774 ' HB3' ' HD2' ' A' 1560 ' ' PRO . 69.3 m -153.98 177.84 1.84 Allowed Pre-proline 0 C--N 1.31 -1.146 0 N-CA-C 106.995 -1.483 . . . . 0.83999999999999997 106.995 -177.911 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A 1560 ' ' PRO . . . . . 0.774 ' HD2' ' HB3' ' A' 1559 ' ' CYS . 15.9 Cg_exo -32.82 132.74 0.09 OUTLIER 'Trans proline' 0 C--N 1.381 2.246 0 C-N-CA 124.363 3.375 . . . . 1.1799999999999999 114.955 177.615 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A 1561 ' ' PRO . . . . . 0.496 ' HD3' ' HA ' ' A' 1560 ' ' PRO . 35.9 Cg_exo -58.25 123.49 13.75 Favored 'Trans proline' 0 C--O 1.245 0.826 0 C-N-CA 122.916 2.411 . . . . 1.51 111.568 179.814 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A 1562 ' ' GLY . . . . . 0.428 ' O ' ' HD3' ' A' 1576 ' ' LYS . . . 109.48 -8.08 32.38 Favored Glycine 0 N--CA 1.436 -1.364 0 C-N-CA 120.288 -0.958 . . . . 0.71999999999999997 114.163 178.247 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A 1563 ' ' VAL . . . . . . . . . . . . . 3.4 m -89.17 148.21 4.69 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.874 0 N-CA-C 107.962 -1.125 . . . . 0.96999999999999997 107.962 178.286 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A 1564 ' ' GLY . . . . . . . . . . . . . . . -97.63 -23.14 14.44 Favored Glycine 0 CA--C 1.505 -0.573 0 C-N-CA 120.137 -1.03 . . . . 0.71999999999999997 113.162 -174.441 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A 1565 ' ' ALA . . . . . . . . . . . . . . . -151.65 140.46 20.92 Favored 'General case' 0 C--N 1.31 -1.13 0 N-CA-C 109.137 -0.69 . . . . 0.37 109.137 -177.909 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A 1566 ' ' CYS . . . . . . . . . . . . . 48.0 t -161.77 147.65 13.64 Favored 'General case' 0 C--N 1.315 -0.92 0 CA-C-N 116.398 -0.365 . . . . 0.51000000000000001 110.016 -175.526 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A 1567 ' ' PHE . . . . . 0.421 ' O ' ' HA ' ' A' 1571 ' ' ARG . 50.3 m-85 -74.73 152.16 39.11 Favored 'General case' 0 N--CA 1.471 0.583 0 N-CA-C 108.609 -0.885 . . . . 0.96999999999999997 108.609 178.424 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A 1568 ' ' GLY . . . . . . . . . . . . . . . -89.07 -31.75 11.61 Favored Glycine 0 N--CA 1.447 -0.61 0 C-N-CA 120.499 -0.857 . . . . 1.0800000000000001 114.125 -176.744 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A 1569 ' ' GLN . . . . . . . . . . . . . 52.7 tt0 -89.9 -56.93 3.04 Favored 'General case' 0 C--N 1.309 -1.183 0 N-CA-C 108.361 -0.977 . . . . 2.7400000000000002 108.361 178.363 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A 1570 ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -68.79 -32.6 72.45 Favored 'General case' 0 N--CA 1.421 -1.88 0 CA-C-N 113.684 -1.598 . . . . 1.96 110.579 -175.921 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A 1571 ' ' ARG . . . . . 0.421 ' HA ' ' O ' ' A' 1567 ' ' PHE . 67.7 mtm180 46.29 55.76 7.01 Favored 'General case' 0 C--O 1.246 0.871 0 N-CA-C 113.176 0.806 . . . . 3.9500000000000002 113.176 -179.252 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A 1572 ' ' ILE . . . . . . . . . . . . . 47.9 mm -109.7 126.05 66.86 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.384 0 N-CA-C 106.394 -1.706 . . . . 1.3700000000000001 106.394 175.066 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A 1573 ' ' SER . . . . . . . . . . . . . 42.1 t -75.76 120.46 21.16 Favored 'General case' 0 C--N 1.298 -1.634 0 N-CA-C 108.973 -0.751 . . . . 1.0800000000000001 108.973 179.496 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A 1574 ' ' VAL . . . . . 0.629 ' HB ' ' HB2' ' A' 1606 ' ' TYR . 34.5 m -90.88 -33.9 6.1 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.81 0 C-N-CA 119.401 -0.919 . . . . 1.3 110.827 179.948 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A 1575 ' ' GLY . . . . . . . . . . . . . . . -161.31 155.63 26.87 Favored Glycine 0 N--CA 1.424 -2.144 0 C-N-CA 120.047 -1.073 . . . . 0.51000000000000001 113.747 -177.761 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A 1576 ' ' LYS . . . . . 0.428 ' HD3' ' O ' ' A' 1562 ' ' GLY . 17.0 tppt? -71.47 153.11 42.47 Favored 'General case' 0 C--N 1.311 -1.108 0 C-N-CA 125.814 1.646 . . . . 2.8999999999999999 108.512 178.17 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A 1577 ' ' ALA . . . . . . . . . . . . . . . -65.16 74.9 0.05 Allowed 'General case' 0 N--CA 1.482 1.152 0 C-N-CA 123.629 0.771 . . . . 0.82999999999999996 109.578 174.425 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A 1578 ' ' ASN . . . . . . . . . . . . . 61.8 t30 -89.81 131.67 35.64 Favored 'General case' 0 C--N 1.293 -1.878 0 C-N-CA 124.092 0.957 . . . . 1.8500000000000001 111.303 -173.211 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A 1579 ' ' LYS . . . . . 0.461 ' O ' ' HA ' ' A' 1513 ' ' HIS . 2.4 mppt? -100.2 92.12 5.07 Favored 'General case' 0 C--N 1.292 -1.914 0 N-CA-C 108.771 -0.826 . . . . 1.8999999999999999 108.771 175.56 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A 1580 ' ' ARG . . . . . 0.515 ' O ' ' HA ' ' A' 1590 ' ' LEU . 61.7 ttt180 -140.16 86.49 2.08 Favored 'General case' 0 C--N 1.289 -2.056 0 N-CA-C 107.536 -1.283 . . . . 3.6299999999999999 107.536 176.735 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A 1581 ' ' LEU . . . . . 0.605 HD13 ' HB2' ' A' 1590 ' ' LEU . 20.6 tp -110.85 135.79 50.87 Favored 'General case' 0 C--N 1.297 -1.69 0 N-CA-C 108.672 -0.862 . . . . 1.8700000000000001 108.672 -177.238 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A 1582 ' ' ARG . . . . . . . . . . . . . 57.5 ttp180 -136.79 140.4 42.49 Favored 'General case' 0 C--N 1.304 -1.384 0 N-CA-C 109.535 -0.542 . . . . 3.9700000000000002 109.535 179.854 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A 1583 ' ' TYR . . . . . . . . . . . . . 74.2 t80 -112.17 92.89 4.19 Favored 'General case' 0 C--O 1.245 0.843 0 C-N-CA 122.896 0.478 . . . . 1.4099999999999999 110.174 179.83 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A 1584 ' ' VAL . . . . . . . . . . . . . 28.5 m -137.51 147.22 26.63 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.293 0 N-CA-C 107.261 -1.385 . . . . 1.6899999999999999 107.261 175.346 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A 1585 ' ' ASP . . . . . . . . . . . . . 19.0 t70 61.96 28.08 17.06 Favored 'General case' 0 N--CA 1.483 1.22 0 C-N-CA 124.246 1.018 . . . . 2.0600000000000001 109.702 -179.672 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A 1586 ' ' GLN . . . . . . . . . . . . . 46.2 mt-30 53.98 34.16 19.05 Favored 'General case' 0 N--CA 1.466 0.354 0 C-N-CA 125.243 1.417 . . . . 2.3300000000000001 113.474 -176.147 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A 1587 ' ' VAL . . . . . . . . . . . . . 8.1 p -132.13 123.56 50.98 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.692 0 CA-C-O 121.24 0.543 . . . . 0.78000000000000003 110.021 176.266 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A 1588 ' ' LEU . . . . . 0.71 ' HB2' ' HB2' ' A' 1612 ' ' PHE . 80.1 mt -78.75 116.72 19.28 Favored 'General case' 0 C--N 1.312 -1.026 0 N-CA-C 107.392 -1.336 . . . . 1.4099999999999999 107.392 174.695 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A 1589 ' ' GLN . . . . . . . . . . . . . 8.6 tt0 -118.2 124.78 48.76 Favored 'General case' 0 C--N 1.28 -2.432 0 CA-C-N 115.863 -0.608 . . . . 1.24 109.935 -177.316 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A 1590 ' ' LEU . . . . . 0.605 ' HB2' HD13 ' A' 1581 ' ' LEU . 7.5 tt -122.55 126.14 47.16 Favored 'General case' 0 C--N 1.302 -1.475 0 N-CA-C 106.876 -1.527 . . . . 1.1499999999999999 106.876 178.761 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A 1591 ' ' VAL . . . . . 0.422 HG12 HG22 ' A' 1609 ' ' VAL . 19.3 m -114.38 117.76 56.52 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.235 0 N-CA-C 113.864 1.061 . . . . 1.51 113.864 -175.665 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A 1592 ' ' TYR . . . . . 0.521 ' HB2' ' HB2' ' A' 1608 ' ' SER . 56.4 m-85 -90.9 133.5 35.19 Favored 'General case' 0 C--N 1.311 -1.067 0 CA-C-N 115.316 -0.856 . . . . 1.0600000000000001 110.584 177.16 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A 1593 ' ' LYS . . . . . . . . . . . . . 63.4 pttt -159.02 -177.95 6.88 Favored 'General case' 0 C--N 1.314 -0.958 0 N-CA-C 108.396 -0.964 . . . . 2.1800000000000002 108.396 177.304 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A 1594 ' ' ASP . . . . . . . . . . . . . 62.2 m-20 72.1 59.04 0.14 Allowed 'General case' 0 N--CA 1.476 0.846 0 C-N-CA 124.379 1.072 . . . . 1.45 111.865 179.158 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A 1595 ' ' GLY . . . . . . . . . . . . . . . -131.32 -109.91 1.28 Allowed Glycine 0 N--CA 1.433 -1.541 0 N-CA-C 109.343 -1.503 . . . . 0.78000000000000003 109.343 177.35 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A 1596 ' ' SER . . . . . 0.43 ' HA ' ' HD3' ' A' 1597 ' ' PRO . 14.1 m -97.67 134.98 21.83 Favored Pre-proline 0 C--N 1.299 -1.591 0 N-CA-C 108.801 -0.814 . . . . 1.6799999999999999 108.801 177.719 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A 1597 ' ' PRO . . . . . 0.43 ' HD3' ' HA ' ' A' 1596 ' ' SER . 23.5 Cg_exo -67.14 152.27 80.06 Favored 'Trans proline' 0 N--CA 1.458 -0.574 0 C-N-CA 123.074 2.516 . . . . 1.1699999999999999 112.133 177.908 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A 1598 ' ' CYS . . . . . . . . . . . . . 43.1 t -94.77 135.67 23.62 Favored Pre-proline 0 C--N 1.293 -1.881 0 N-CA-C 107.932 -1.136 . . . . 1.1899999999999999 107.932 179.563 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A 1599 ' ' PRO . . . . . . . . . . . . . 89.4 Cg_endo -79.49 3.21 7.7 Favored 'Trans proline' 0 C--O 1.243 0.746 0 C-N-CA 123.383 2.722 . . . . 1.5900000000000001 113.707 -177.395 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A 1600 ' ' SER . . . . . . . . . . . . . 14.6 m -120.94 145.83 47.29 Favored 'General case' 0 C--N 1.297 -1.68 0 N-CA-C 108.055 -1.091 . . . . 2.1200000000000001 108.055 178.837 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A 1601 ' ' LYS . . . . . 0.61 ' HG3' HG22 ' A' 1633 ' ' THR . 29.7 mmmt 67.63 -146.14 0.14 Allowed 'General case' 0 CA--C 1.537 0.453 0 O-C-N 124.006 0.816 . . . . 3.7400000000000002 110.61 177.925 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A 1602 ' ' SER . . . . . . . . . . . . . 33.5 t -68.76 163.43 24.08 Favored 'General case' 0 CA--C 1.551 0.998 0 N-CA-C 109.66 -0.496 . . . . 3.79 109.66 178.862 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A 1603 ' ' GLY . . . . . . . . . . . . . . . -77.36 58.0 3.7 Favored Glycine 0 C--N 1.332 0.324 0 N-CA-C 111.685 -0.566 . . . . 2.0 111.685 179.015 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A 1604 ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -101.2 159.43 15.25 Favored 'General case' 0 C--N 1.297 -1.715 0 C-N-CA 124.773 1.229 . . . . 1.48 110.146 -179.278 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A 1605 ' ' SER . . . . . . . . . . . . . 38.6 m -75.74 -170.9 1.42 Allowed 'General case' 0 C--N 1.315 -0.91 0 CA-C-O 121.586 0.708 . . . . 1.51 110.737 177.837 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A 1606 ' ' TYR . . . . . 0.629 ' HB2' ' HB ' ' A' 1574 ' ' VAL . 14.7 m-85 -96.57 117.07 30.17 Favored 'General case' 0 N--CA 1.422 -1.858 0 N-CA-C 103.513 -2.773 . . . . 1.1799999999999999 103.513 174.582 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A 1607 ' ' LYS . . . . . . . . . . . . . 22.0 ptmt -102.88 124.07 47.7 Favored 'General case' 0 C--N 1.276 -2.597 0 C-N-CA 118.613 -1.235 . . . . 1.6699999999999999 111.404 -170.083 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A 1608 ' ' SER . . . . . 0.521 ' HB2' ' HB2' ' A' 1592 ' ' TYR . 21.7 m -101.46 110.16 22.11 Favored 'General case' 0 C--N 1.299 -1.629 0 CA-C-N 114.928 -1.033 . . . . 1.0 109.626 -178.98 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A 1609 ' ' VAL . . . . . 0.422 HG22 HG12 ' A' 1591 ' ' VAL . 65.8 t -94.3 106.44 18.1 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.351 0 N-CA-C 109.31 -0.626 . . . . 0.93000000000000005 109.31 178.729 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A 1610 ' ' ILE . . . . . . . . . . . . . 38.2 mm -89.49 109.21 20.12 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.701 0 N-CA-C 108.471 -0.937 . . . . 0.78000000000000003 108.471 178.831 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A 1611 ' ' SER . . . . . . . . . . . . . 18.2 m -104.98 116.59 32.22 Favored 'General case' 0 C--N 1.301 -1.51 0 CA-C-O 121.286 0.565 . . . . 1.29 110.398 178.923 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A 1612 ' ' PHE . . . . . 0.71 ' HB2' ' HB2' ' A' 1588 ' ' LEU . 93.3 m-85 -87.74 108.61 19.2 Favored 'General case' 0 C--N 1.301 -1.509 0 N-CA-C 108.36 -0.978 . . . . 0.69999999999999996 108.36 177.143 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A 1613 ' ' VAL . . . . . . . . . . . . . 78.9 t -102.61 130.62 52.29 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.084 0 CA-C-O 120.889 0.376 . . . . 0.75 110.312 -178.227 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A 1614 ' ' CYS . . . . . . . . . . . . . 32.5 m -75.02 92.28 2.6 Favored 'General case' 0 C--N 1.303 -1.415 0 CA-C-N 115.257 -0.883 . . . . 1.3899999999999999 111.586 -176.169 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A 1615 ' ' ARG . . . . . 0.806 ' HB3' ' HB3' ' A' 1641 ' ' HIS . 2.9 tpm_? -138.93 85.46 16.2 Favored Pre-proline 0 C--N 1.314 -0.975 0 N-CA-C 108.861 -0.792 . . . . 3.75 108.861 176.789 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A 1616 ' ' PRO . . . . . 0.619 ' HG2' ' HG3' ' A' 1648 ' ' PRO . 52.6 Cg_exo -59.29 -18.54 45.75 Favored 'Trans proline' 0 N--CA 1.492 1.439 0 C-N-CA 123.07 2.513 . . . . 1.3200000000000001 113.554 179.019 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A 1617 ' ' GLU . . . . . . . . . . . . . 33.0 tt0 -66.3 -20.71 66.17 Favored 'General case' 0 C--N 1.321 -0.634 0 C-N-CA 123.473 0.709 . . . . 3.21 112.312 -178.351 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A 1618 ' ' ALA . . . . . . . . . . . . . . . -58.39 116.28 3.52 Favored 'General case' 0 C--N 1.316 -0.859 0 C-N-CA 122.993 0.517 . . . . 2.4399999999999999 111.625 -176.279 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A 1619 ' ' GLY . . . . . . . . . . . . . . . -119.27 -84.77 0.92 Allowed Glycine 0 N--CA 1.437 -1.295 0 CA-C-N 115.881 -0.6 . . . . 3.2599999999999998 112.117 -178.455 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A 1620 ' ' PRO . . . . . . . . . . . . . 27.6 Cg_endo -64.21 -25.92 64.85 Favored 'Trans proline' 0 CA--C 1.535 0.548 0 C-N-CA 122.855 2.37 . . . . 5.9199999999999999 113.315 -179.348 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A 1621 ' ' THR . . . . . . . . . . . . . 5.7 m -108.84 43.1 1.29 Allowed 'General case' 0 N--CA 1.436 -1.159 0 CA-C-O 122.137 0.97 . . . . 4.7599999999999998 110.086 -179.179 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A 1622 ' ' ASN . . . . . . . . . . . . . 50.6 t-20 -82.93 67.97 9.23 Favored 'General case' 0 C--N 1.319 -0.75 0 N-CA-C 107.574 -1.269 . . . . 2.9199999999999999 107.574 178.369 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A 1623 ' ' ARG . . . . . . . . . . . . . 8.1 ptm180 -150.97 153.77 33.5 Favored Pre-proline 0 C--N 1.31 -1.11 0 CA-C-N 115.095 -0.957 . . . . 3.6099999999999999 108.468 -177.44 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A 1624 ' ' PRO . . . . . . . . . . . . . 11.6 Cg_exo -71.43 120.63 7.09 Favored 'Trans proline' 0 C--O 1.236 0.403 0 C-N-CA 122.631 2.22 . . . . 2.3700000000000001 110.896 178.279 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A 1625 ' ' MET . . . . . . . . . . . . . 44.4 ttm -109.94 140.84 43.49 Favored 'General case' 0 C--N 1.306 -1.294 0 C-N-CA 122.777 0.431 . . . . 2.1600000000000001 110.082 -177.621 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A 1626 ' ' LEU . . . . . . . . . . . . . 59.9 tp -81.38 117.3 21.72 Favored 'General case' 0 C--N 1.308 -1.237 0 N-CA-C 107.768 -1.197 . . . . 1.3500000000000001 107.768 175.337 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A 1627 ' ' ILE . . . . . . . . . . . . . 41.0 pt -99.33 -33.1 3.86 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.204 0 C-N-CA 119.778 -0.769 . . . . 1.21 111.547 -177.209 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A 1628 ' ' SER . . . . . 0.536 ' HB3' ' HB2' ' A' 1637 ' ' PHE . 44.9 t -141.28 143.65 34.21 Favored 'General case' 0 N--CA 1.431 -1.4 0 N-CA-C 109.287 -0.634 . . . . 1.3999999999999999 109.287 -176.99 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A 1629 ' ' LEU . . . . . 0.747 HD13 ' HG ' ' A' 1636 ' ' LEU . 22.4 tp -146.07 116.21 7.42 Favored 'General case' 0 C--N 1.303 -1.42 0 CA-C-N 116.057 -0.52 . . . . 1.5600000000000001 110.312 -177.941 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A 1630 ' ' ASP . . . . . . . . . . . . . 12.3 t70 -109.51 107.97 18.28 Favored 'General case' 0 C--N 1.298 -1.659 0 N-CA-C 107.801 -1.185 . . . . 0.87 107.801 176.416 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A 1631 ' ' LYS . . . . . . . . . . . . . 95.3 mttt -85.27 3.54 39.05 Favored 'General case' 0 C--N 1.307 -1.281 0 CA-C-N 116.241 -0.436 . . . . 2.3500000000000001 111.979 -176.202 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A 1632 ' ' GLN . . . . . . . . . . . . . 1.4 mp0 -91.11 -49.21 6.52 Favored 'General case' 0 C--N 1.316 -0.863 0 N-CA-C 109.102 -0.703 . . . . 2.5499999999999998 109.102 178.875 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A 1633 ' ' THR . . . . . 0.61 HG22 ' HG3' ' A' 1601 ' ' LYS . 22.2 p -97.48 2.78 50.63 Favored 'General case' 0 C--N 1.308 -1.234 0 CA-C-N 115.772 -0.649 . . . . 1.24 111.455 179.013 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A 1634 ' ' CYS . . . . . . . . . . . . . 98.3 m 56.6 47.49 18.39 Favored 'General case' 0 C--N 1.347 0.467 0 CA-C-N 114.879 -1.055 . . . . 0.89000000000000001 111.758 178.692 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A 1635 ' ' THR . . . . . . . . . . . . . 26.7 m -112.44 118.38 35.02 Favored 'General case' 0 N--CA 1.43 -1.434 0 CA-C-N 115.006 -0.997 . . . . 0.75 109.246 -178.21 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A 1636 ' ' LEU . . . . . 0.747 ' HG ' HD13 ' A' 1629 ' ' LEU . 4.0 mp -112.1 130.17 55.98 Favored 'General case' 0 N--CA 1.441 -0.884 0 N-CA-C 109.626 -0.509 . . . . 1.3300000000000001 109.626 -177.816 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A 1637 ' ' PHE . . . . . 0.536 ' HB2' ' HB3' ' A' 1628 ' ' SER . 91.0 m-85 -111.15 113.09 25.35 Favored 'General case' 0 C--N 1.315 -0.931 0 CA-C-O 120.9 0.381 . . . . 0.82999999999999996 110.509 -178.712 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A 1638 ' ' PHE . . . . . . . . . . . . . 97.4 m-85 -108.25 145.53 34.18 Favored 'General case' 0 C--N 1.306 -1.298 0 CA-C-N 116.103 -0.499 . . . . 0.59999999999999998 109.766 -179.087 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A 1639 ' ' SER . . . . . . . . . . . . . 65.6 m -136.98 127.89 27.47 Favored 'General case' 0 C--N 1.29 -2.018 0 CA-C-O 121.226 0.536 . . . . 1.0800000000000001 111.381 178.848 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A 1640 ' ' TRP . . . . . . . . . . . . . 16.4 t90 -115.72 125.49 52.87 Favored 'General case' 0 C--N 1.294 -1.843 0 N-CA-C 107.022 -1.473 . . . . 0.80000000000000004 107.022 175.188 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A 1641 ' ' HIS . . . . . 0.806 ' HB3' ' HB3' ' A' 1615 ' ' ARG . 69.9 m-70 -89.39 103.3 15.94 Favored 'General case' 0 C--N 1.306 -1.297 0 N-CA-C 107.054 -1.461 . . . . 2.54 107.054 -179.848 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A 1642 ' ' THR . . . . . . . . . . . . . 10.2 t -143.0 142.02 20.98 Favored Pre-proline 0 C--N 1.302 -1.476 0 CA-C-O 121.013 0.435 . . . . 1.1499999999999999 110.96 -173.618 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A 1643 ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo -73.64 -12.13 24.42 Favored 'Trans proline' 0 C--N 1.359 1.08 0 C-N-CA 123.211 2.608 . . . . 0.80000000000000004 113.118 179.93 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A 1644 ' ' LEU . . . . . 0.488 HD21 HD11 ' A' 1532 ' ' LEU . 2.4 pp -90.66 4.48 51.3 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 121.685 0.755 . . . . 1.54 112.799 -179.221 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A 1645 ' ' ALA . . . . . . . . . . . . . . . -72.66 -38.4 67.65 Favored 'General case' 0 C--N 1.302 -1.482 0 CA-C-N 114.476 -1.238 . . . . 0.94999999999999996 108.086 173.461 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A 1646 ' ' CYS . . . . . . . . . . . . . 18.6 p -175.4 135.29 0.32 Allowed 'General case' 0 C--N 1.312 -1.037 0 N-CA-C 105.004 -2.221 . . . . 1.4099999999999999 105.004 175.402 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A 1647 ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 -71.81 136.42 82.84 Favored Pre-proline 0 C--N 1.312 -1.039 0 N-CA-C 108.801 -0.814 . . . . 2.9199999999999999 108.801 -179.568 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A 1648 ' ' PRO . . . . . 0.619 ' HG3' ' HG2' ' A' 1616 ' ' PRO . 51.4 Cg_endo -68.99 100.48 0.73 Allowed 'Trans proline' 0 C--O 1.249 1.033 0 C-N-CA 122.265 1.977 . . . . 2.8199999999999998 112.733 -174.672 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A 1649 ' ' GLU . . . . . . . . . . . . . 19.7 mm-40 . . . . . 0 C--N 1.296 -1.724 0 CA-C-N 114.787 -1.097 . . . . 5.0599999999999996 108.509 179.415 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A 1508 ' ' MET . . . . . . . . . . . . . 24.9 mmt . . . . . 0 CA--C 1.495 -1.139 0 N-CA-C 109.937 -0.394 . . . . 8.2699999999999996 109.937 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A 1509 ' ' LYS . . . . . . . . . . . . . 12.8 mptt -78.09 99.34 6.1 Favored 'General case' 0 C--N 1.304 -1.4 0 CA-C-O 121.539 0.685 . . . . 6.4800000000000004 111.013 179.811 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A 1510 ' ' SER . . . . . . . . . . . . . 10.3 p -91.64 -1.26 57.52 Favored 'General case' 0 C--N 1.31 -1.151 0 CA-C-O 122.446 1.117 . . . . 4.2199999999999998 109.611 177.91 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A 1511 ' ' ASN . . . . . 0.509 HD22 ' HG2' ' A' 1517 ' ' GLN . 32.0 p-10 -108.72 29.12 7.73 Favored 'General case' 0 C--N 1.308 -1.229 0 CA-C-N 114.04 -1.436 . . . . 3.0800000000000001 108.12 178.499 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A 1512 ' ' GLU . . . . . . . . . . . . . 39.6 tt0 -89.11 -58.57 2.49 Favored 'General case' 0 C--N 1.311 -1.087 0 CA-C-N 114.783 -1.098 . . . . 4.46 111.629 -175.689 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A 1513 ' ' HIS . . . . . . . . . . . . . 6.5 t60 -110.46 47.77 0.95 Allowed 'General case' 0 C--N 1.306 -1.306 0 N-CA-C 108.415 -0.957 . . . . 5.5700000000000003 108.415 -175.214 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A 1514 ' ' ASP . . . . . . . . . . . . . 15.1 t70 -140.46 -59.01 0.53 Allowed 'General case' 0 C--N 1.31 -1.149 0 C-N-CA 120.042 -0.663 . . . . 3.7000000000000002 109.835 178.953 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A 1515 ' ' ASP . . . . . . . . . . . . . 62.7 m-20 -123.36 -173.19 2.67 Favored 'General case' 0 CA--C 1.49 -1.346 0 N-CA-C 108.238 -1.023 . . . . 2.54 108.238 175.845 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A 1516 ' ' CYS . . . . . . . . . . . . . 58.3 m -120.39 73.19 0.98 Allowed 'General case' 0 C--N 1.305 -1.359 0 CA-C-O 121.436 0.636 . . . . 1.25 110.664 -175.796 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A 1517 ' ' GLN . . . . . 0.509 ' HG2' HD22 ' A' 1511 ' ' ASN . 0.0 OUTLIER -139.59 136.14 34.08 Favored 'General case' 0 C--N 1.297 -1.7 0 CA-C-N 115.527 -0.76 . . . . 1.8799999999999999 111.014 174.067 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A 1518 ' ' VAL . . . . . . . . . . . . . 94.8 t -121.23 121.59 65.23 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.449 0 CA-C-N 115.673 -0.694 . . . . 1.73 109.269 176.497 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A 1519 ' ' THR . . . . . 0.513 ' HA ' ' HA ' ' A' 1526 ' ' LEU . 20.5 m -90.62 108.23 19.68 Favored 'General case' 0 C--N 1.295 -1.763 0 CA-C-O 120.865 0.364 . . . . 1.7 110.914 179.651 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A 1520 ' ' ASN . . . . . 0.559 ' HB2' ' CE2' ' A' 1527 ' ' PHE . 15.1 t-20 -67.43 122.3 82.55 Favored Pre-proline 0 N--CA 1.47 0.566 0 CA-C-N 116.033 -0.531 . . . . 2.1200000000000001 110.98 179.416 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A 1521 ' ' PRO . . . . . . . . . . . . . 94.9 Cg_endo -83.4 -1.5 10.25 Favored 'Trans proline' 0 CA--C 1.533 0.442 0 C-N-CA 122.347 2.031 . . . . 2.4700000000000002 113.756 -178.236 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A 1522 ' ' SER . . . . . . . . . . . . . 6.8 m -83.62 -58.18 2.92 Favored 'General case' 0 C--N 1.308 -1.201 0 C-N-CA 120.773 -0.371 . . . . 2.5699999999999998 110.57 -179.071 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A 1523 ' ' THR . . . . . . . . . . . . . 11.3 t -108.85 -5.98 15.98 Favored 'General case' 0 N--CA 1.443 -0.815 0 CA-C-O 120.972 0.415 . . . . 2.1499999999999999 110.844 -177.045 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A 1524 ' ' GLY . . . . . . . . . . . . . . . 80.01 28.76 48.9 Favored Glycine 0 CA--C 1.507 -0.445 0 C-N-CA 120.62 -0.8 . . . . 1.8899999999999999 112.91 176.899 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A 1525 ' ' HIS . . . . . . . . . . . . . 22.1 t-160 -97.41 118.59 34.23 Favored 'General case' 0 C--N 1.312 -1.032 0 N-CA-C 109.414 -0.587 . . . . 1.8999999999999999 109.414 -179.885 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A 1526 ' ' LEU . . . . . 0.513 ' HA ' ' HA ' ' A' 1519 ' ' THR . 5.0 tt -82.9 111.0 18.38 Favored 'General case' 0 C--N 1.295 -1.79 0 N-CA-C 107.095 -1.446 . . . . 1.6100000000000001 107.095 178.087 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A 1527 ' ' PHE . . . . . 0.559 ' CE2' ' HB2' ' A' 1520 ' ' ASN . 32.6 m-85 -87.9 102.62 14.89 Favored 'General case' 0 C--N 1.305 -1.351 0 N-CA-C 108.498 -0.927 . . . . 1.4199999999999999 108.498 179.395 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A 1528 ' ' ASP . . . . . . . . . . . . . 23.4 t70 -105.71 133.44 50.45 Favored 'General case' 0 C--N 1.298 -1.632 0 C-N-CA 120.467 -0.493 . . . . 2.1800000000000002 110.106 179.347 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A 1529 ' ' LEU . . . . . . . . . . . . . 89.0 mt -113.3 -7.98 13.5 Favored 'General case' 0 C--N 1.299 -1.614 0 CA-C-N 115.146 -0.934 . . . . 1.4399999999999999 110.001 179.248 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A 1530 ' ' SER . . . . . . . . . . . . . 2.3 m -69.1 -37.41 78.37 Favored 'General case' 0 CA--C 1.543 0.696 0 CA-C-O 121.878 0.846 . . . . 1.4399999999999999 109.154 -177.92 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A 1531 ' ' SER . . . . . . . . . . . . . 14.0 m -70.85 -24.13 62.47 Favored 'General case' 0 C--N 1.317 -0.844 0 CA-C-N 115.199 -0.91 . . . . 1.5 109.926 177.895 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A 1532 ' ' LEU . . . . . . . . . . . . . 8.0 mp -84.7 4.58 31.97 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.414 -0.812 . . . . 1.77 110.502 179.317 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A 1533 ' ' SER . . . . . . . . . . . . . 32.5 m -113.87 119.08 36.06 Favored 'General case' 0 N--CA 1.425 -1.709 0 N-CA-C 113.337 0.866 . . . . 2.3799999999999999 113.337 -175.303 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A 1534 ' ' GLY . . . . . . . . . . . . . . . -89.65 -162.84 38.76 Favored Glycine 0 N--CA 1.431 -1.677 0 N-CA-C 109.221 -1.552 . . . . 1.55 109.221 172.398 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A 1535 ' ' ARG . . . . . 0.46 ' HE ' ' CD ' ' A' 1557 ' ' GLU . 62.4 ttt180 -81.39 -47.76 12.81 Favored 'General case' 0 C--N 1.304 -1.409 0 CA-C-N 117.395 0.597 . . . . 3.96 110.633 -179.08 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A 1536 ' ' ALA . . . . . . . . . . . . . . . -95.56 -13.53 24.36 Favored 'General case' 0 C--N 1.316 -0.863 0 N-CA-C 108.752 -0.833 . . . . 1.6499999999999999 108.752 177.74 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A 1537 ' ' GLY . . . . . . . . . . . . . . . 73.53 -139.94 27.37 Favored Glycine 0 N--CA 1.436 -1.355 0 CA-C-N 114.581 -1.191 . . . . 1.1899999999999999 112.371 177.244 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A 1538 ' ' PHE . . . . . . . . . . . . . 78.0 m-85 -101.42 152.08 21.16 Favored 'General case' 0 C--N 1.296 -1.734 0 N-CA-C 109.188 -0.671 . . . . 1.6899999999999999 109.188 179.456 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A 1539 ' ' THR . . . . . . . . . . . . . 25.8 m -103.66 115.19 30.04 Favored 'General case' 0 C--N 1.288 -2.09 0 N-CA-C 108.495 -0.928 . . . . 1.48 108.495 179.37 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A 1540 ' ' ALA . . . . . 0.783 ' HB3' HG13 ' A' 1548 ' ' VAL . . . -94.65 149.95 20.72 Favored 'General case' 0 C--N 1.309 -1.177 0 N-CA-C 109.223 -0.658 . . . . 0.82999999999999996 109.223 -177.935 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A 1541 ' ' ALA . . . . . . . . . . . . . . . -87.01 139.07 30.95 Favored 'General case' 0 C--N 1.311 -1.078 0 N-CA-C 109.358 -0.608 . . . . 1.27 109.358 -179.407 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A 1542 ' ' TYR . . . . . 0.556 ' HD2' ' HB2' ' A' 1545 ' ' SER . 42.1 t80 -141.47 173.52 11.42 Favored 'General case' 0 N--CA 1.437 -1.091 0 CA-C-O 119.288 -0.387 . . . . 2.1499999999999999 110.413 -176.813 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A 1543 ' ' SER . . . . . . . . . . . . . 9.5 m -46.92 -152.6 0.0 OUTLIER 'General case' 0 CA--C 1.577 1.995 0 C-N-CA 129.084 2.954 . . . . 2.29 114.07 178.619 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A 1544 ' ' LYS . . . . . . . . . . . . . 57.8 mtpt -45.03 -31.79 1.45 Allowed 'General case' 0 N--CA 1.487 1.389 0 O-C-N 121.088 -1.007 . . . . 3.9100000000000001 112.902 177.121 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A 1545 ' ' SER . . . . . 0.556 ' HB2' ' HD2' ' A' 1542 ' ' TYR . 33.2 m -65.83 -12.68 56.19 Favored 'General case' 0 CA--C 1.562 1.409 0 N-CA-C 112.719 0.637 . . . . 3.2999999999999998 112.719 176.425 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A 1546 ' ' GLY . . . . . . . . . . . . . . . 85.09 -74.2 2.52 Favored Glycine 0 CA--C 1.495 -1.216 0 C-N-CA 121.037 -0.601 . . . . 1.24 113.723 172.812 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A 1547 ' ' VAL . . . . . . . . . . . . . 10.7 m -139.01 156.99 28.52 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.445 0 CA-C-O 121.652 0.739 . . . . 1.6299999999999999 112.145 -176.663 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A 1548 ' ' VAL . . . . . 0.783 HG13 ' HB3' ' A' 1540 ' ' ALA . 2.0 p -134.1 136.24 53.71 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.917 0 CA-C-N 114.766 -1.106 . . . . 0.92000000000000004 108.114 178.924 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A 1549 ' ' TYR . . . . . . . . . . . . . 97.5 m-85 -93.51 141.29 28.63 Favored 'General case' 0 C--N 1.294 -1.835 0 N-CA-C 109.287 -0.634 . . . . 1.4399999999999999 109.287 -179.085 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A 1550 ' ' MET . . . . . . . . . . . . . 42.2 ttm -138.37 121.64 17.01 Favored 'General case' 0 C--N 1.288 -2.083 0 CA-C-N 115.852 -0.613 . . . . 1.74 110.54 -179.261 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A 1551 ' ' SER . . . . . 0.455 ' OG ' ' HA ' ' A' 1556 ' ' ASN . 59.3 m -91.98 122.76 34.79 Favored 'General case' 0 N--CA 1.409 -2.517 0 N-CA-C 105.692 -1.966 . . . . 1.6399999999999999 105.692 172.057 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A 1552 ' ' ILE . . . . . . . . . . . . . 38.6 mm -62.94 -21.53 28.26 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.804 0 CA-C-O 121.777 0.798 . . . . 1.3300000000000001 110.716 -175.323 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A 1553 ' ' CYS . . . . . . . . . . . . . 43.7 t -161.55 138.33 8.45 Favored 'General case' 0 N--CA 1.412 -2.366 0 N-CA-C 106.65 -1.611 . . . . 1.4299999999999999 106.65 175.063 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A 1554 ' ' GLY . . . . . 0.87 ' HA2' ' HE2' ' A' 1579 ' ' LYS . . . 104.71 -150.33 17.13 Favored Glycine 0 N--CA 1.426 -2.026 0 C-N-CA 119.957 -1.116 . . . . 1.1200000000000001 112.305 175.489 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A 1555 ' ' GLU . . . . . . . . . . . . . 7.6 pt-20 -106.96 147.81 29.41 Favored 'General case' 0 C--N 1.293 -1.875 0 C-N-CA 123.088 0.555 . . . . 1.8 109.976 -177.612 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A 1556 ' ' ASN . . . . . 0.455 ' HA ' ' OG ' ' A' 1551 ' ' SER . 5.3 t-20 -98.54 88.88 4.22 Favored 'General case' 0 C--N 1.286 -2.159 0 CA-C-O 121.641 0.734 . . . . 2.6299999999999999 109.07 -175.594 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A 1557 ' ' GLU . . . . . 0.46 ' CD ' ' HE ' ' A' 1535 ' ' ARG . 22.2 mt-10 -79.72 111.47 16.04 Favored 'General case' 0 C--N 1.303 -1.448 0 CA-C-N 115.409 -0.814 . . . . 3.79 111.567 -175.573 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A 1558 ' ' ASN . . . . . . . . . . . . . 5.8 p-10 160.21 -25.1 0.0 OUTLIER 'General case' 0 N--CA 1.475 0.781 0 C-N-CA 127.501 2.32 . . . . 1.52 105.789 -176.556 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A 1559 ' ' CYS . . . . . 0.62 ' HB3' ' HD2' ' A' 1560 ' ' PRO . 93.2 m -118.2 173.86 3.03 Favored Pre-proline 0 N--CA 1.439 -0.992 0 CA-C-O 117.353 -1.308 . . . . 0.83999999999999997 107.605 174.204 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A 1560 ' ' PRO . . . . . 0.62 ' HD2' ' HB3' ' A' 1559 ' ' CYS . 21.3 Cg_exo -35.8 132.14 0.29 Allowed 'Trans proline' 0 C--N 1.378 2.109 0 C-N-CA 123.567 2.844 . . . . 1.1799999999999999 113.88 176.603 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A 1561 ' ' PRO . . . . . . . . . . . . . 19.8 Cg_endo -62.82 120.2 7.61 Favored 'Trans proline' 0 C--O 1.243 0.759 0 C-N-CA 122.792 2.328 . . . . 1.51 113.146 -177.634 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A 1562 ' ' GLY . . . . . . . . . . . . . . . 117.14 7.87 12.14 Favored Glycine 0 N--CA 1.434 -1.458 0 CA-C-N 115.833 -0.621 . . . . 0.71999999999999997 112.669 176.972 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A 1563 ' ' VAL . . . . . . . . . . . . . 6.4 m -101.23 156.74 4.38 Favored 'Isoleucine or valine' 0 C--O 1.205 -1.263 0 N-CA-C 106.885 -1.524 . . . . 0.96999999999999997 106.885 178.118 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A 1564 ' ' GLY . . . . . . . . . . . . . . . -108.71 -23.61 6.45 Favored Glycine 0 C--N 1.311 -0.81 0 C-N-CA 120.213 -0.994 . . . . 0.71999999999999997 112.645 -177.713 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A 1565 ' ' ALA . . . . . . . . . . . . . . . -149.28 137.7 20.87 Favored 'General case' 0 C--N 1.311 -1.088 0 N-CA-C 108.572 -0.899 . . . . 0.37 108.572 -179.721 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A 1566 ' ' CYS . . . . . 0.544 ' SG ' ' HA ' ' A' 1571 ' ' ARG . 35.6 t -157.68 138.05 12.78 Favored 'General case' 0 C--N 1.312 -1.048 0 C-N-CA 121.229 -0.188 . . . . 0.51000000000000001 111.492 -173.9 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A 1567 ' ' PHE . . . . . 0.561 ' HD1' ' HB ' ' A' 1548 ' ' VAL . 22.0 m-85 -67.19 125.27 25.53 Favored 'General case' 0 N--CA 1.471 0.607 0 N-CA-C 108.313 -0.995 . . . . 0.96999999999999997 108.313 177.602 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A 1568 ' ' GLY . . . . . . . . . . . . . . . -58.36 -43.51 95.66 Favored Glycine 0 C--N 1.315 -0.606 0 N-CA-C 117.119 1.608 . . . . 1.0800000000000001 117.119 -168.434 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A 1569 ' ' GLN . . . . . . . . . . . . . 4.0 pt20 -87.51 -34.35 18.66 Favored 'General case' 0 C--N 1.307 -1.274 0 CA-C-N 118.367 1.083 . . . . 2.7400000000000002 113.748 -175.368 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A 1570 ' ' THR . . . . . . . . . . . . . 11.5 p -89.63 -22.36 22.35 Favored 'General case' 0 C--N 1.312 -1.063 0 CA-C-O 121.597 0.713 . . . . 1.96 112.321 -176.447 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A 1571 ' ' ARG . . . . . 0.544 ' HA ' ' SG ' ' A' 1566 ' ' CYS . 94.7 mtt180 59.88 38.89 20.98 Favored 'General case' 0 CA--C 1.515 -0.401 0 CA-C-N 114.523 -1.217 . . . . 3.9500000000000002 113.755 175.295 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A 1572 ' ' ILE . . . . . . . . . . . . . 75.8 mt -98.35 123.44 50.88 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.971 0 CA-C-N 114.416 -1.266 . . . . 1.3700000000000001 107.797 178.201 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A 1573 ' ' SER . . . . . . . . . . . . . 27.3 t -62.91 130.39 44.57 Favored 'General case' 0 C--N 1.318 -0.804 0 O-C-N 123.669 0.606 . . . . 1.0800000000000001 111.446 -178.213 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A 1574 ' ' VAL . . . . . . . . . . . . . 27.7 m -122.87 25.36 3.72 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.402 0 CA-C-O 122.047 0.927 . . . . 1.3 109.898 176.17 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A 1575 ' ' GLY . . . . . . . . . . . . . . . 163.58 128.59 0.96 Allowed Glycine 0 N--CA 1.426 -1.974 0 CA-C-N 114.138 -1.392 . . . . 0.51000000000000001 111.202 177.043 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A 1576 ' ' LYS . . . . . . . . . . . . . 50.5 tptt -77.77 151.19 34.18 Favored 'General case' 0 C--N 1.317 -0.81 0 N-CA-C 106.772 -1.566 . . . . 2.8999999999999999 106.772 178.336 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A 1577 ' ' ALA . . . . . . . . . . . . . . . -67.66 99.79 0.83 Allowed 'General case' 0 C--N 1.321 -0.646 0 CA-C-O 120.963 0.411 . . . . 0.82999999999999996 110.503 -178.705 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A 1578 ' ' ASN . . . . . 0.498 ' H ' ' HD1' ' A' 1592 ' ' TYR . 15.6 m120 -117.44 130.07 56.23 Favored 'General case' 0 C--N 1.302 -1.498 0 N-CA-C 108.736 -0.838 . . . . 1.8500000000000001 108.736 -179.886 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A 1579 ' ' LYS . . . . . 0.87 ' HE2' ' HA2' ' A' 1554 ' ' GLY . 33.5 mmtp -93.44 89.79 6.46 Favored 'General case' 0 C--N 1.292 -1.901 0 N-CA-C 104.545 -2.391 . . . . 1.8999999999999999 104.545 174.745 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A 1580 ' ' ARG . . . . . 0.403 ' O ' ' HA ' ' A' 1590 ' ' LEU . 22.0 ttm180 -148.27 103.52 3.45 Favored 'General case' 0 C--N 1.313 -0.986 0 C-N-CA 119.147 -1.021 . . . . 3.6299999999999999 113.259 -170.219 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A 1581 ' ' LEU . . . . . . . . . . . . . 3.9 mm? -100.75 141.25 33.89 Favored 'General case' 0 C--N 1.31 -1.135 0 CA-C-N 115.691 -0.686 . . . . 1.8700000000000001 110.285 172.99 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A 1582 ' ' ARG . . . . . 0.786 ' HB2' ' HB3' ' A' 1589 ' ' GLN . 93.4 mtt180 -116.55 98.44 6.55 Favored 'General case' 0 C--N 1.285 -2.205 0 N-CA-C 107.055 -1.461 . . . . 3.9700000000000002 107.055 170.923 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A 1583 ' ' TYR . . . . . . . . . . . . . 45.6 t80 -79.18 91.64 4.98 Favored 'General case' 0 C--N 1.295 -1.769 0 N-CA-C 107.522 -1.288 . . . . 1.4099999999999999 107.522 178.697 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A 1584 ' ' VAL . . . . . 0.529 ' O ' HG12 ' A' 1587 ' ' VAL . 11.5 m -117.55 98.29 6.44 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.26 0 CA-C-O 121.547 0.689 . . . . 1.6899999999999999 111.68 -177.346 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A 1585 ' ' ASP . . . . . . . . . . . . . 34.7 t70 53.46 70.38 0.6 Allowed 'General case' 0 C--N 1.313 -1.016 0 C-N-CA 124.348 1.059 . . . . 2.0600000000000001 111.804 -178.021 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A 1586 ' ' GLN . . . . . . . . . . . . . 14.9 mm100 68.72 -14.23 0.29 Allowed 'General case' 0 N--CA 1.481 1.088 0 N-CA-C 115.615 1.709 . . . . 2.3300000000000001 115.615 177.247 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A 1587 ' ' VAL . . . . . 0.529 HG12 ' O ' ' A' 1584 ' ' VAL . 7.5 p -94.84 128.64 45.88 Favored 'Isoleucine or valine' 0 C--O 1.243 0.752 0 C-N-CA 119.159 -1.016 . . . . 0.78000000000000003 110.197 178.837 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A 1588 ' ' LEU . . . . . 0.751 ' HB2' ' HB2' ' A' 1612 ' ' PHE . 3.0 mm? -84.58 124.11 31.07 Favored 'General case' 0 N--CA 1.418 -2.035 0 N-CA-C 106.568 -1.641 . . . . 1.4099999999999999 106.568 173.013 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A 1589 ' ' GLN . . . . . 0.786 ' HB3' ' HB2' ' A' 1582 ' ' ARG . 7.5 tp60 -119.26 107.0 12.88 Favored 'General case' 0 C--N 1.277 -2.556 0 N-CA-C 107.806 -1.183 . . . . 1.24 107.806 -173.874 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A 1590 ' ' LEU . . . . . 0.403 ' HA ' ' O ' ' A' 1580 ' ' ARG . 7.1 tt -105.61 128.59 53.71 Favored 'General case' 0 C--N 1.297 -1.708 0 N-CA-C 108.382 -0.97 . . . . 1.1499999999999999 108.382 -178.215 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A 1591 ' ' VAL . . . . . 0.629 HG12 HG22 ' A' 1609 ' ' VAL . 19.7 m -124.41 122.23 63.52 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.258 0 N-CA-C 112.868 0.692 . . . . 1.51 112.868 -175.409 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A 1592 ' ' TYR . . . . . 0.498 ' HD1' ' H ' ' A' 1578 ' ' ASN . 39.1 m-85 -103.07 98.38 8.33 Favored 'General case' 0 C--N 1.306 -1.3 0 N-CA-C 107.644 -1.243 . . . . 1.0600000000000001 107.644 171.47 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A 1593 ' ' LYS . . . . . . . . . . . . . 21.4 ptmt -102.75 175.67 5.41 Favored 'General case' 0 C--N 1.3 -1.576 0 N-CA-C 109.751 -0.463 . . . . 2.1800000000000002 109.751 -177.323 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A 1594 ' ' ASP . . . . . . . . . . . . . 22.0 m-20 61.22 50.07 5.09 Favored 'General case' 0 N--CA 1.494 1.75 0 N-CA-C 113.792 1.034 . . . . 1.45 113.792 178.68 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A 1595 ' ' GLY . . . . . . . . . . . . . . . -85.85 -106.72 0.73 Allowed Glycine 0 N--CA 1.436 -1.304 0 N-CA-C 110.36 -1.096 . . . . 0.78000000000000003 110.36 175.637 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A 1596 ' ' SER . . . . . . . . . . . . . 69.6 m -99.87 151.87 37.63 Favored Pre-proline 0 C--N 1.297 -1.684 0 N-CA-C 109.364 -0.606 . . . . 1.6799999999999999 109.364 177.438 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A 1597 ' ' PRO . . . . . . . . . . . . . 26.5 Cg_exo -65.28 131.49 28.49 Favored 'Trans proline' 0 C--O 1.24 0.588 0 C-N-CA 123.096 2.531 . . . . 1.1699999999999999 111.416 178.287 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A 1598 ' ' CYS . . . . . 0.453 ' HA ' ' HD3' ' A' 1599 ' ' PRO . 43.2 t -100.24 109.9 58.12 Favored Pre-proline 0 C--N 1.301 -1.532 0 CA-C-N 116.018 -0.537 . . . . 1.1899999999999999 109.779 -178.354 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A 1599 ' ' PRO . . . . . 0.453 ' HD3' ' HA ' ' A' 1598 ' ' CYS . 38.6 Cg_endo -98.02 21.85 0.32 Allowed 'Trans proline' 0 N--CA 1.445 -1.377 0 C-N-CA 123.308 2.672 . . . . 1.5900000000000001 112.527 -179.191 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A 1600 ' ' SER . . . . . . . . . . . . . 16.9 m -73.73 -41.02 63.11 Favored 'General case' 0 C--N 1.313 -0.982 0 CA-C-N 116.571 -0.286 . . . . 2.1200000000000001 111.627 -179.155 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A 1601 ' ' LYS . . . . . . . . . . . . . 87.3 tttt -142.39 -77.64 0.25 Allowed 'General case' 0 C--N 1.318 -0.765 0 CA-C-O 121.259 0.552 . . . . 3.7400000000000002 111.258 -177.632 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A 1602 ' ' SER . . . . . . . . . . . . . 21.1 m -96.07 175.59 6.41 Favored 'General case' 0 C--N 1.3 -1.584 0 CA-C-N 115.294 -0.866 . . . . 3.79 109.055 -177.194 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A 1603 ' ' GLY . . . . . . . . . . . . . . . -75.81 63.62 2.73 Favored Glycine 0 CA--C 1.505 -0.533 0 N-CA-C 109.78 -1.328 . . . . 2.0 109.78 175.276 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A 1604 ' ' LEU . . . . . 0.461 HD13 ' HA ' ' A' 1633 ' ' THR . 2.2 mt -93.52 -174.41 3.48 Favored 'General case' 0 C--N 1.293 -1.883 0 C-N-CA 125.55 1.54 . . . . 1.48 112.184 -173.809 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A 1605 ' ' SER . . . . . . . . . . . . . 34.5 t -140.93 -179.22 5.95 Favored 'General case' 0 N--CA 1.419 -2.017 0 N-CA-C 105.667 -1.975 . . . . 1.51 105.667 179.348 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A 1606 ' ' TYR . . . . . . . . . . . . . 7.1 m-85 -110.06 129.23 55.72 Favored 'General case' 0 CA--C 1.47 -2.101 0 N-CA-C 105.253 -2.129 . . . . 1.1799999999999999 105.253 -179.561 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A 1607 ' ' LYS . . . . . . . . . . . . . 10.0 ptpp? -131.8 138.12 48.41 Favored 'General case' 0 N--CA 1.411 -2.41 0 C-N-CA 118.495 -1.282 . . . . 1.6699999999999999 110.437 179.867 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A 1608 ' ' SER . . . . . 0.77 ' HA ' ' HB2' ' A' 1636 ' ' LEU . 50.1 m -98.83 114.32 26.83 Favored 'General case' 0 C--N 1.295 -1.79 0 N-CA-C 109.158 -0.682 . . . . 1.0 109.158 177.71 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A 1609 ' ' VAL . . . . . 0.629 HG22 HG12 ' A' 1591 ' ' VAL . 85.9 t -109.3 118.28 56.3 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.054 0 N-CA-C 108.884 -0.784 . . . . 0.93000000000000005 108.884 -179.677 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A 1610 ' ' ILE . . . . . 0.593 HG13 ' HB2' ' A' 1638 ' ' PHE . 3.3 mp -111.29 116.66 53.1 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.318 0 N-CA-C 109.261 -0.644 . . . . 0.78000000000000003 109.261 179.58 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A 1611 ' ' SER . . . . . . . . . . . . . 30.3 p -92.46 117.14 29.63 Favored 'General case' 0 N--CA 1.423 -1.8 0 CA-C-N 115.706 -0.679 . . . . 1.29 109.447 177.076 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A 1612 ' ' PHE . . . . . 0.751 ' HB2' ' HB2' ' A' 1588 ' ' LEU . 96.0 m-85 -89.78 103.7 16.33 Favored 'General case' 0 C--N 1.299 -1.629 0 CA-C-N 116.05 -0.523 . . . . 0.69999999999999996 110.563 -179.393 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A 1613 ' ' VAL . . . . . 0.602 ' O ' ' HA ' ' A' 1641 ' ' HIS . 11.9 t -107.6 145.12 15.28 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.452 0 N-CA-C 106.871 -1.529 . . . . 0.75 106.871 -179.011 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A 1614 ' ' CYS . . . . . . . . . . . . . 34.2 m -89.65 93.75 9.59 Favored 'General case' 0 C--N 1.294 -1.836 0 N-CA-C 113.536 0.939 . . . . 1.3899999999999999 113.536 -169.977 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A 1615 ' ' ARG . . . . . 0.896 ' HB3' ' HB3' ' A' 1641 ' ' HIS . 21.3 tpp180 -138.09 112.33 8.77 Favored Pre-proline 0 C--N 1.316 -0.87 0 N-CA-C 109.368 -0.604 . . . . 3.75 109.368 176.195 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A 1616 ' ' PRO . . . . . 0.589 ' HA ' ' HD3' ' A' 1643 ' ' PRO . 11.4 Cg_endo -55.07 -20.36 23.39 Favored 'Trans proline' 0 CA--C 1.562 1.876 0 C-N-CA 123.927 3.085 . . . . 1.3200000000000001 116.259 -178.352 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A 1617 ' ' GLU . . . . . 0.728 ' HG2' ' HG3' ' A' 1615 ' ' ARG . 11.4 pt-20 -75.48 -6.75 51.72 Favored 'General case' 0 N--CA 1.478 0.939 0 N-CA-C 113.82 1.045 . . . . 3.21 113.82 -177.812 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A 1618 ' ' ALA . . . . . 0.533 ' HA ' ' O ' ' A' 1641 ' ' HIS . . . 72.59 -170.42 0.14 Allowed 'General case' 0 N--CA 1.482 1.167 0 C-N-CA 124.513 1.125 . . . . 2.4399999999999999 112.398 177.018 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A 1619 ' ' GLY . . . . . . . . . . . . . . . -80.92 -141.88 3.11 Favored Glycine 0 CA--C 1.528 0.845 0 CA-C-O 119.539 -0.589 . . . . 3.2599999999999998 112.349 -179.765 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A 1620 ' ' PRO . . . . . 0.72 ' HD3' ' HB3' ' A' 1625 ' ' MET . 95.2 Cg_exo -48.45 -51.84 9.52 Favored 'Trans proline' 0 C--N 1.365 1.439 0 C-N-CA 124.109 3.206 . . . . 5.9199999999999999 111.152 179.883 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A 1621 ' ' THR . . . . . . . . . . . . . 2.3 t -131.11 -50.68 1.02 Allowed 'General case' 0 N--CA 1.418 -2.057 0 N-CA-C 107.933 -1.136 . . . . 4.7599999999999998 107.933 172.23 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A 1622 ' ' ASN . . . . . . . . . . . . . 23.6 t-20 -136.34 -60.6 0.71 Allowed 'General case' 0 CA--C 1.501 -0.906 0 N-CA-C 112.925 0.713 . . . . 2.9199999999999999 112.925 169.672 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A 1623 ' ' ARG . . . . . 0.559 ' HB2' ' HD2' ' A' 1624 ' ' PRO . 0.0 OUTLIER -61.18 167.69 3.61 Favored Pre-proline 0 C--N 1.292 -1.924 0 CA-C-N 113.412 -1.722 . . . . 3.6099999999999999 113.236 -173.478 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A 1624 ' ' PRO . . . . . 0.652 ' HB3' ' HB2' ' A' 1640 ' ' TRP . 11.6 Cg_endo -57.46 159.3 16.68 Favored 'Trans proline' 0 C--N 1.369 1.606 0 C-N-CA 123.02 2.48 . . . . 2.3700000000000001 113.209 175.867 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A 1625 ' ' MET . . . . . 0.72 ' HB3' ' HD3' ' A' 1620 ' ' PRO . 26.5 ptt? -125.41 148.42 48.81 Favored 'General case' 0 C--N 1.311 -1.093 0 CA-C-N 116.094 -0.503 . . . . 2.1600000000000001 110.003 -179.766 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A 1626 ' ' LEU . . . . . 0.436 HD21 ' HB2' ' A' 1629 ' ' LEU . 38.2 tp -77.68 116.11 17.96 Favored 'General case' 0 C--N 1.309 -1.173 0 N-CA-C 107.794 -1.187 . . . . 1.3500000000000001 107.794 175.513 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A 1627 ' ' ILE . . . . . . . . . . . . . 25.0 pt -93.02 -30.05 4.46 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.22 0 C-N-CA 120.45 -0.5 . . . . 1.21 111.178 -179.107 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A 1628 ' ' SER . . . . . . . . . . . . . 37.4 m -155.18 154.07 31.71 Favored 'General case' 0 C--N 1.313 -0.988 0 N-CA-C 109.015 -0.735 . . . . 1.3999999999999999 109.015 -178.317 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A 1629 ' ' LEU . . . . . 0.539 HD13 HD13 ' A' 1636 ' ' LEU . 45.2 tp -145.95 114.43 6.74 Favored 'General case' 0 C--N 1.301 -1.52 0 CA-C-O 121.24 0.543 . . . . 1.5600000000000001 109.946 178.892 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A 1630 ' ' ASP . . . . . . . . . . . . . 27.6 t70 -112.75 102.07 10.13 Favored 'General case' 0 C--N 1.298 -1.633 0 N-CA-C 108.408 -0.96 . . . . 0.87 108.408 179.447 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A 1631 ' ' LYS . . . . . . . . . . . . . 60.1 mttp -73.58 -18.01 61.11 Favored 'General case' 0 C--N 1.316 -0.853 0 N-CA-C 112.182 0.438 . . . . 2.3500000000000001 112.182 -177.52 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A 1632 ' ' GLN . . . . . . . . . . . . . 7.6 tp-100 -64.65 -45.14 88.04 Favored 'General case' 0 N--CA 1.451 -0.39 0 CA-C-O 120.885 0.374 . . . . 2.5499999999999998 110.668 178.632 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A 1633 ' ' THR . . . . . 0.461 ' HA ' HD13 ' A' 1604 ' ' LEU . 40.9 p -99.23 -2.02 37.7 Favored 'General case' 0 C--N 1.316 -0.849 0 CA-C-O 121.467 0.651 . . . . 1.24 111.226 177.858 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A 1634 ' ' CYS . . . . . . . . . . . . . 82.8 m 56.68 40.29 29.31 Favored 'General case' 0 C--O 1.235 0.298 0 CA-C-N 114.539 -1.21 . . . . 0.89000000000000001 111.362 -179.853 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A 1635 ' ' THR . . . . . . . . . . . . . 25.1 m -99.03 119.56 38.0 Favored 'General case' 0 N--CA 1.423 -1.8 0 CA-C-N 114.921 -1.036 . . . . 0.75 109.826 -177.583 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A 1636 ' ' LEU . . . . . 0.77 ' HB2' ' HA ' ' A' 1608 ' ' SER . 2.7 mm? -90.85 107.94 19.52 Favored 'General case' 0 C--N 1.311 -1.086 0 N-CA-C 108.454 -0.943 . . . . 1.3300000000000001 108.454 178.648 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A 1637 ' ' PHE . . . . . . . . . . . . . 96.5 m-85 -95.88 100.16 11.88 Favored 'General case' 0 C--O 1.244 0.815 0 CA-C-O 120.853 0.359 . . . . 0.82999999999999996 110.611 -178.79 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A 1638 ' ' PHE . . . . . 0.593 ' HB2' HG13 ' A' 1610 ' ' ILE . 96.7 m-85 -108.76 156.19 19.89 Favored 'General case' 0 C--N 1.298 -1.634 0 CA-C-O 121.364 0.602 . . . . 0.59999999999999998 109.987 177.852 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A 1639 ' ' SER . . . . . . . . . . . . . 32.9 t -143.34 130.84 21.12 Favored 'General case' 0 C--N 1.285 -2.218 0 N-CA-C 108.593 -0.892 . . . . 1.0800000000000001 108.593 176.172 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A 1640 ' ' TRP . . . . . 0.724 ' HE3' ' HE1' ' A' 1612 ' ' PHE . 9.5 t90 -115.92 111.46 20.45 Favored 'General case' 0 N--CA 1.409 -2.485 0 N-CA-C 107.635 -1.246 . . . . 0.80000000000000004 107.635 175.696 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A 1641 ' ' HIS . . . . . 0.896 ' HB3' ' HB3' ' A' 1615 ' ' ARG . 47.3 m-70 -89.76 105.3 17.71 Favored 'General case' 0 N--CA 1.422 -1.869 0 N-CA-C 107.167 -1.42 . . . . 2.54 107.167 175.88 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A 1642 ' ' THR . . . . . . . . . . . . . 6.1 t -142.8 146.12 36.56 Favored Pre-proline 0 C--N 1.287 -2.127 0 CA-C-N 115.846 -0.616 . . . . 1.1499999999999999 109.914 -175.322 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A 1643 ' ' PRO . . . . . 0.589 ' HD3' ' HA ' ' A' 1616 ' ' PRO . 71.6 Cg_endo -76.65 -4.69 15.28 Favored 'Trans proline' 0 C--N 1.352 0.725 0 C-N-CA 122.694 2.263 . . . . 0.80000000000000004 110.495 175.775 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A 1644 ' ' LEU . . . . . . . . . . . . . 81.9 mt -86.67 -7.63 58.14 Favored 'General case' 0 N--CA 1.447 -0.621 0 CA-C-N 115.234 -0.894 . . . . 1.54 109.489 177.217 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A 1645 ' ' ALA . . . . . . . . . . . . . . . -78.97 -42.58 26.42 Favored 'General case' 0 C--O 1.222 -0.366 0 N-CA-C 107.996 -1.112 . . . . 0.94999999999999996 107.996 176.716 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A 1646 ' ' CYS . . . . . . . . . . . . . 13.5 p -176.11 154.83 1.47 Allowed 'General case' 0 N--CA 1.432 -1.344 0 N-CA-C 104.362 -2.459 . . . . 1.4099999999999999 104.362 172.639 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A 1647 ' ' GLU . . . . . . . . . . . . . 42.8 mt-10 -103.14 124.78 37.22 Favored Pre-proline 0 C--N 1.288 -2.108 0 N-CA-C 108.506 -0.924 . . . . 2.9199999999999999 108.506 -179.685 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A 1648 ' ' PRO . . . . . . . . . . . . . 31.4 Cg_exo -60.9 101.37 0.18 Allowed 'Trans proline' 0 C--O 1.251 1.142 0 C-N-CA 122.632 2.221 . . . . 2.8199999999999998 111.552 177.075 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A 1649 ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 . . . . . 0 N--CA 1.434 -1.259 0 C-N-CA 125.167 1.387 . . . . 5.0599999999999996 108.25 179.227 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A 1508 ' ' MET . . . . . . . . . . . . . 26.9 ttt . . . . . 0 CA--C 1.506 -0.721 0 N-CA-C 107.994 -1.114 . . . . 8.2699999999999996 107.994 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A 1509 ' ' LYS . . . . . . . . . . . . . 60.6 pttt -80.35 170.04 16.93 Favored 'General case' 0 C--N 1.305 -1.335 0 N-CA-C 108.696 -0.853 . . . . 6.4800000000000004 108.696 178.274 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A 1510 ' ' SER . . . . . . . . . . . . . 51.0 m -151.8 178.14 9.69 Favored 'General case' 0 C--N 1.28 -2.419 0 N-CA-C 107.32 -1.363 . . . . 4.2199999999999998 107.32 -179.7 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A 1511 ' ' ASN . . . . . 0.448 ' HB3' ' O ' ' A' 1517 ' ' GLN . 85.3 m-20 68.35 30.37 5.5 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 121.784 0.802 . . . . 3.0800000000000001 111.152 173.307 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A 1512 ' ' GLU . . . . . . . . . . . . . 8.9 tp10 -93.71 -47.04 6.97 Favored 'General case' 0 C--N 1.317 -0.839 0 CA-C-N 115.115 -0.948 . . . . 4.46 108.706 178.891 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A 1513 ' ' HIS . . . . . . . . . . . . . 56.9 t-80 -139.91 15.23 2.48 Favored 'General case' 0 CA--C 1.549 0.932 0 CA-C-O 121.901 0.857 . . . . 5.5700000000000003 108.891 176.635 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A 1514 ' ' ASP . . . . . . . . . . . . . 12.5 m-20 -71.34 -70.26 0.33 Allowed 'General case' 0 CA--C 1.499 -1.014 0 CA-C-O 121.817 0.818 . . . . 3.7000000000000002 111.463 -177.902 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A 1515 ' ' ASP . . . . . 0.477 ' HA ' ' HD2' ' A' 1579 ' ' LYS . 31.4 t70 -141.22 170.04 16.48 Favored 'General case' 0 C--N 1.284 -2.255 0 N-CA-C 105.991 -1.855 . . . . 2.54 105.991 -175.216 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A 1516 ' ' CYS . . . . . . . . . . . . . 61.1 m -75.14 51.04 0.51 Allowed 'General case' 0 C--N 1.318 -0.769 0 CA-C-O 121.489 0.661 . . . . 1.25 111.455 -178.301 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A 1517 ' ' GLN . . . . . 0.464 ' HA ' ' HA ' ' A' 1528 ' ' ASP . 11.3 pt20 -137.9 154.69 49.41 Favored 'General case' 0 N--CA 1.413 -2.307 0 N-CA-C 106.949 -1.5 . . . . 1.8799999999999999 106.949 178.55 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A 1518 ' ' VAL . . . . . 0.417 ' HA ' ' HB3' ' A' 1511 ' ' ASN . 7.7 p -148.58 137.94 15.81 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.741 0 O-C-N 123.178 0.299 . . . . 1.73 110.913 -174.893 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A 1519 ' ' THR . . . . . . . . . . . . . 8.4 m -103.66 102.76 12.62 Favored 'General case' 0 N--CA 1.429 -1.523 0 N-CA-C 107.901 -1.148 . . . . 1.7 107.901 178.713 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A 1520 ' ' ASN . . . . . . . . . . . . . 24.7 t30 -71.61 114.65 30.09 Favored Pre-proline 0 C--N 1.319 -0.72 0 C-N-CA 121.021 -0.272 . . . . 2.1200000000000001 110.281 -179.049 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A 1521 ' ' PRO . . . . . . . . . . . . . 55.9 Cg_endo -68.27 -9.63 26.47 Favored 'Trans proline' 0 C--N 1.357 1.018 0 C-N-CA 122.688 2.259 . . . . 2.4700000000000002 113.486 -174.797 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A 1522 ' ' SER . . . . . . . . . . . . . 15.1 m -79.21 -23.59 43.7 Favored 'General case' 0 N--CA 1.435 -1.18 0 CA-C-N 116.694 -0.23 . . . . 2.5699999999999998 111.249 178.991 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A 1523 ' ' THR . . . . . . . . . . . . . 7.0 t -137.5 -15.93 1.39 Allowed 'General case' 0 CA--C 1.549 0.913 0 N-CA-C 112.712 0.634 . . . . 2.1499999999999999 112.712 -177.893 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A 1524 ' ' GLY . . . . . . . . . . . . . . . 84.6 -5.38 81.74 Favored Glycine 0 N--CA 1.45 -0.417 0 O-C-N 121.982 -0.449 . . . . 1.8899999999999999 113.182 179.024 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A 1525 ' ' HIS . . . . . . . . . . . . . 11.7 t60 -73.01 135.71 44.97 Favored 'General case' 0 C--N 1.311 -1.081 0 CA-C-O 121.113 0.482 . . . . 1.8999999999999999 110.091 -177.403 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A 1526 ' ' LEU . . . . . . . . . . . . . 3.5 tm? -95.34 121.65 37.22 Favored 'General case' 0 C--N 1.306 -1.285 0 CA-C-N 114.905 -1.043 . . . . 1.6100000000000001 108.407 -179.918 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A 1527 ' ' PHE . . . . . 0.551 ' CE1' ' HA ' ' A' 1646 ' ' CYS . 78.7 m-85 -106.6 149.23 27.4 Favored 'General case' 0 C--N 1.292 -1.914 0 N-CA-C 107.352 -1.351 . . . . 1.4199999999999999 107.352 177.574 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A 1528 ' ' ASP . . . . . 0.464 ' HA ' ' HA ' ' A' 1517 ' ' GLN . 1.2 p30 -143.29 148.21 35.99 Favored 'General case' 0 CA--C 1.484 -1.566 0 CA-C-O 121.371 0.605 . . . . 2.1800000000000002 109.82 177.287 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A 1529 ' ' LEU . . . . . . . . . . . . . 88.7 mt -117.07 -6.05 11.39 Favored 'General case' 0 C--N 1.284 -2.255 0 CA-C-N 114.002 -1.454 . . . . 1.4399999999999999 107.371 175.338 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A 1530 ' ' SER . . . . . . . . . . . . . 11.5 m -66.42 -41.67 88.87 Favored 'General case' 0 N--CA 1.432 -1.33 0 CA-C-N 114.315 -1.311 . . . . 1.4399999999999999 111.624 -175.556 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A 1531 ' ' SER . . . . . . . . . . . . . 13.6 t -87.35 -16.18 35.76 Favored 'General case' 0 N--CA 1.438 -1.067 0 N-CA-C 109.027 -0.731 . . . . 1.5 109.027 -178.77 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A 1532 ' ' LEU . . . . . 0.437 HD13 HD13 ' A' 1644 ' ' LEU . 80.2 mt -76.15 -36.26 58.84 Favored 'General case' 0 CA--C 1.521 -0.173 0 CA-C-N 115.854 -0.612 . . . . 1.77 111.068 179.362 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A 1533 ' ' SER . . . . . 0.572 ' HB2' ' HB ' ' A' 1552 ' ' ILE . 25.7 t -80.29 133.74 36.0 Favored 'General case' 0 C--N 1.304 -1.41 0 CA-C-N 115.914 -0.585 . . . . 2.3799999999999999 110.349 -178.041 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A 1534 ' ' GLY . . . . . . . . . . . . . . . -91.47 160.01 26.47 Favored Glycine 0 N--CA 1.441 -1.022 0 N-CA-C 109.092 -1.603 . . . . 1.55 109.092 174.797 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A 1535 ' ' ARG . . . . . . . . . . . . . 29.0 ttp180 -70.82 -19.77 62.63 Favored 'General case' 0 C--N 1.318 -0.761 0 CA-C-N 117.961 0.88 . . . . 3.96 110.927 -175.911 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A 1536 ' ' ALA . . . . . . . . . . . . . . . -90.26 -9.7 46.97 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-O 121.375 0.607 . . . . 1.6499999999999999 109.666 177.302 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A 1537 ' ' GLY . . . . . . . . . . . . . . . 80.61 -169.44 52.36 Favored Glycine 0 N--CA 1.422 -2.277 0 CA-C-N 115.123 -0.944 . . . . 1.1899999999999999 110.962 -177.09 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A 1538 ' ' PHE . . . . . . . . . . . . . 17.3 m-85 -120.33 170.16 9.62 Favored 'General case' 0 C--N 1.285 -2.233 0 N-CA-C 108.286 -1.005 . . . . 1.6899999999999999 108.286 177.517 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A 1539 ' ' THR . . . . . 0.506 ' HA ' ' O ' ' A' 1548 ' ' VAL . 23.5 p -120.98 118.3 29.49 Favored 'General case' 0 C--N 1.289 -2.028 0 CA-C-N 116.223 -0.444 . . . . 1.48 110.454 -179.433 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A 1540 ' ' ALA . . . . . . . . . . . . . . . -93.24 143.66 26.05 Favored 'General case' 0 C--N 1.305 -1.333 0 N-CA-C 107.323 -1.362 . . . . 0.82999999999999996 107.323 175.449 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A 1541 ' ' ALA . . . . . . . . . . . . . . . -84.68 70.08 10.73 Favored 'General case' 0 C--N 1.298 -1.633 0 N-CA-C 112.658 0.614 . . . . 1.27 112.658 -173.282 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A 1542 ' ' TYR . . . . . . . . . . . . . 16.4 t80 -157.06 112.76 2.89 Favored 'General case' 0 C--O 1.208 -1.079 0 N-CA-C 113.386 0.884 . . . . 2.1499999999999999 113.386 176.511 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A 1543 ' ' SER . . . . . 0.582 ' HB3' ' N ' ' A' 1546 ' ' GLY . 43.4 t -138.42 -153.61 0.48 Allowed 'General case' 0 C--N 1.263 -3.159 0 N-CA-C 103.467 -2.79 . . . . 2.29 103.467 162.03 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A 1544 ' ' LYS . . . . . . . . . . . . . 96.1 mttt -66.22 -50.34 64.14 Favored 'General case' 0 C--N 1.303 -1.44 0 N-CA-C 106.354 -1.721 . . . . 3.9100000000000001 106.354 170.275 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A 1545 ' ' SER . . . . . . . . . . . . . 17.6 t -134.41 25.98 3.79 Favored 'General case' 0 CA--C 1.562 1.442 0 CA-C-N 115.166 -0.925 . . . . 3.2999999999999998 110.013 175.597 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A 1546 ' ' GLY . . . . . 0.582 ' N ' ' HB3' ' A' 1543 ' ' SER . . . -138.09 -118.05 1.62 Allowed Glycine 0 CA--C 1.529 0.96 0 C-N-CA 118.027 -2.035 . . . . 1.24 117.316 -170.524 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A 1547 ' ' VAL . . . . . . . . . . . . . 14.0 m -159.21 169.34 0.53 Allowed 'Isoleucine or valine' 0 C--O 1.255 1.382 0 C-N-CA 124.256 1.022 . . . . 1.6299999999999999 110.876 -165.581 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A 1548 ' ' VAL . . . . . 0.506 ' O ' ' HA ' ' A' 1539 ' ' THR . 3.5 t -124.87 135.57 63.58 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.628 0 N-CA-C 107.787 -1.19 . . . . 0.92000000000000004 107.787 178.625 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A 1549 ' ' TYR . . . . . . . . . . . . . 22.7 m-85 -92.16 114.92 27.59 Favored 'General case' 0 CA--C 1.502 -0.869 0 N-CA-C 105.711 -1.959 . . . . 1.4399999999999999 105.711 172.52 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A 1550 ' ' MET . . . . . . . . . . . . . 19.8 ptm -144.66 127.8 16.64 Favored 'General case' 0 C--N 1.283 -2.294 0 C-N-CA 119.601 -0.84 . . . . 1.74 111.653 -176.744 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A 1551 ' ' SER . . . . . . . . . . . . . 51.0 m -86.68 135.3 33.44 Favored 'General case' 0 C--N 1.285 -2.236 0 N-CA-C 107.805 -1.183 . . . . 1.6399999999999999 107.805 177.812 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A 1552 ' ' ILE . . . . . 0.572 ' HB ' ' HB2' ' A' 1533 ' ' SER . 27.8 mm -75.97 -13.16 14.82 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.959 0 CA-C-O 122.363 1.078 . . . . 1.3300000000000001 108.471 -175.181 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A 1553 ' ' CYS . . . . . . . . . . . . . 33.1 t -161.33 137.95 8.46 Favored 'General case' 0 N--CA 1.421 -1.918 0 N-CA-C 106.957 -1.497 . . . . 1.4299999999999999 106.957 174.54 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A 1554 ' ' GLY . . . . . . . . . . . . . . . 86.99 -166.56 37.19 Favored Glycine 0 N--CA 1.435 -1.371 0 C-N-CA 120.857 -0.687 . . . . 1.1200000000000001 114.015 174.18 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A 1555 ' ' GLU . . . . . . . . . . . . . 13.5 pt-20 -86.74 154.57 20.85 Favored 'General case' 0 C--N 1.313 -1.01 0 CA-C-O 121.384 0.612 . . . . 1.8 111.129 -178.192 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A 1556 ' ' ASN . . . . . . . . . . . . . 20.4 t-20 -108.91 112.5 24.76 Favored 'General case' 0 C--N 1.301 -1.524 0 N-CA-C 109.259 -0.645 . . . . 2.6299999999999999 109.259 178.341 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A 1557 ' ' GLU . . . . . . . . . . . . . 7.9 mt-10 -83.21 40.41 0.71 Allowed 'General case' 0 C--N 1.309 -1.176 0 CA-C-O 121.066 0.46 . . . . 3.79 112.198 -173.017 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A 1558 ' ' ASN . . . . . . . . . . . . . 34.6 m-80 -126.89 -0.78 6.62 Favored 'General case' 0 C--N 1.307 -1.249 0 CA-C-O 121.291 0.567 . . . . 1.52 110.079 179.648 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A 1559 ' ' CYS . . . . . 0.738 ' HB3' ' HD2' ' A' 1560 ' ' PRO . 67.5 m -147.11 177.8 1.65 Allowed Pre-proline 0 C--N 1.309 -1.172 0 CA-C-O 116.884 -1.532 . . . . 0.83999999999999997 107.162 179.594 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A 1560 ' ' PRO . . . . . 0.738 ' HD2' ' HB3' ' A' 1559 ' ' CYS . 3.4 Cg_exo -36.13 122.84 0.29 Allowed 'Trans proline' 0 C--N 1.385 2.469 0 C-N-CA 124.107 3.205 . . . . 1.1799999999999999 114.038 178.917 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A 1561 ' ' PRO . . . . . . . . . . . . . 56.4 Cg_exo -53.82 107.64 0.22 Allowed 'Trans proline' 0 C--O 1.254 1.31 0 C-N-CA 123.482 2.788 . . . . 1.51 112.698 -179.053 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A 1562 ' ' GLY . . . . . . . . . . . . . . . 134.12 -11.56 4.75 Favored Glycine 0 N--CA 1.43 -1.707 0 CA-C-N 115.306 -0.861 . . . . 0.71999999999999997 111.84 179.263 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A 1563 ' ' VAL . . . . . 0.553 ' HA ' ' HA ' ' A' 1576 ' ' LYS . 15.1 m -88.17 144.11 9.85 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.247 0 CA-C-O 120.965 0.412 . . . . 0.96999999999999997 109.922 179.739 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A 1564 ' ' GLY . . . . . . . . . . . . . . . -100.74 -26.43 8.03 Favored Glycine 0 C--N 1.306 -1.106 0 N-CA-C 110.725 -0.95 . . . . 0.71999999999999997 110.725 179.796 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A 1565 ' ' ALA . . . . . . . . . . . . . . . -138.59 141.18 39.2 Favored 'General case' 0 N--CA 1.439 -0.986 0 N-CA-C 109.045 -0.724 . . . . 0.37 109.045 179.533 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A 1566 ' ' CYS . . . . . . . . . . . . . 39.8 t -158.7 133.04 7.92 Favored 'General case' 0 C--N 1.3 -1.546 0 N-CA-C 108.106 -1.072 . . . . 0.51000000000000001 108.106 -176.955 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A 1567 ' ' PHE . . . . . . . . . . . . . 86.3 m-85 -63.63 123.62 19.3 Favored 'General case' 0 C--O 1.208 -1.126 0 N-CA-C 107.508 -1.293 . . . . 0.96999999999999997 107.508 178.305 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A 1568 ' ' GLY . . . . . 0.436 ' H ' ' HA ' ' A' 1548 ' ' VAL . . . -82.91 -24.85 51.6 Favored Glycine 0 CA--C 1.487 -1.676 0 C-N-CA 120.244 -0.979 . . . . 1.0800000000000001 112.986 -171.654 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A 1569 ' ' GLN . . . . . . . . . . . . . 22.0 tp60 -81.89 -38.29 25.56 Favored 'General case' 0 C--N 1.298 -1.648 0 CA-C-O 122.096 0.95 . . . . 2.7400000000000002 108.736 179.391 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A 1570 ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -93.13 -22.28 19.18 Favored 'General case' 0 C--N 1.295 -1.77 0 CA-C-N 114.354 -1.294 . . . . 1.96 112.157 -171.727 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A 1571 ' ' ARG . . . . . . . . . . . . . 50.9 mtt180 63.31 38.01 10.58 Favored 'General case' 0 N--CA 1.47 0.547 0 C-N-CA 125.54 1.536 . . . . 3.9500000000000002 112.411 -179.256 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A 1572 ' ' ILE . . . . . . . . . . . . . 48.1 mm -118.08 126.05 74.66 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.934 0 CA-C-N 114.849 -1.069 . . . . 1.3700000000000001 108.864 -177.028 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A 1573 ' ' SER . . . . . . . . . . . . . 45.8 t -62.17 134.63 56.81 Favored 'General case' 0 C--N 1.307 -1.277 0 C-N-CA 123.87 0.868 . . . . 1.0800000000000001 111.782 -177.578 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A 1574 ' ' VAL . . . . . . . . . . . . . 92.6 t -97.69 -50.61 11.14 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.426 0 CA-C-N 115.313 -0.858 . . . . 1.3 109.174 -179.622 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A 1575 ' ' GLY . . . . . . . . . . . . . . . -160.55 150.38 20.35 Favored Glycine 0 N--CA 1.432 -1.616 0 C-N-CA 120.38 -0.914 . . . . 0.51000000000000001 112.117 -176.895 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A 1576 ' ' LYS . . . . . 0.553 ' HA ' ' HA ' ' A' 1563 ' ' VAL . 64.8 tttm -78.7 146.54 33.9 Favored 'General case' 0 C--N 1.311 -1.084 0 N-CA-C 108.714 -0.847 . . . . 2.8999999999999999 108.714 -179.47 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A 1577 ' ' ALA . . . . . . . . . . . . . . . -69.09 90.81 0.47 Allowed 'General case' 0 C--N 1.319 -0.73 0 C-N-CA 123.783 0.833 . . . . 0.82999999999999996 112.047 -176.03 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A 1578 ' ' ASN . . . . . . . . . . . . . 43.6 m-80 -103.73 113.75 27.5 Favored 'General case' 0 C--N 1.303 -1.42 0 N-CA-C 108.549 -0.908 . . . . 1.8500000000000001 108.549 176.9 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A 1579 ' ' LYS . . . . . 0.477 ' HD2' ' HA ' ' A' 1515 ' ' ASP . 35.9 ttpt -89.7 89.99 8.03 Favored 'General case' 0 C--N 1.295 -1.764 0 CA-C-O 122.223 1.011 . . . . 1.8999999999999999 109.152 -176.713 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A 1580 ' ' ARG . . . . . . . . . . . . . 27.4 tpt180 -161.3 111.84 1.7 Allowed 'General case' 0 N--CA 1.424 -1.766 0 CA-C-N 113.747 -1.57 . . . . 3.6299999999999999 109.236 -178.007 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A 1581 ' ' LEU . . . . . . . . . . . . . 3.6 pp -117.75 160.94 20.51 Favored 'General case' 0 N--CA 1.413 -2.295 0 CA-C-N 114.991 -1.004 . . . . 1.8700000000000001 108.647 176.56 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A 1582 ' ' ARG . . . . . . . . . . . . . 18.0 ttp85 -140.78 138.02 33.81 Favored 'General case' 0 C--N 1.291 -1.95 0 N-CA-C 108.519 -0.919 . . . . 3.9700000000000002 108.519 176.059 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A 1583 ' ' TYR . . . . . . . . . . . . . 70.0 t80 -102.65 96.6 6.99 Favored 'General case' 0 C--N 1.303 -1.429 0 N-CA-C 107.694 -1.224 . . . . 1.4099999999999999 107.694 179.788 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A 1584 ' ' VAL . . . . . 0.472 ' O ' HG12 ' A' 1587 ' ' VAL . 6.0 p -121.85 105.8 17.0 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.505 0 CA-C-N 116.123 -0.49 . . . . 1.6899999999999999 111.802 -175.581 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A 1585 ' ' ASP . . . . . . . . . . . . . 37.0 t70 61.46 61.19 1.54 Allowed 'General case' 0 C--N 1.319 -0.739 0 CA-C-O 122.356 1.074 . . . . 2.0600000000000001 111.115 178.38 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A 1586 ' ' GLN . . . . . . . . . . . . . 47.8 mt-30 62.62 8.75 3.11 Favored 'General case' 0 N--CA 1.478 0.941 0 CA-C-N 114.244 -1.344 . . . . 2.3300000000000001 114.258 178.322 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A 1587 ' ' VAL . . . . . 0.472 HG12 ' O ' ' A' 1584 ' ' VAL . 11.7 p -122.07 125.43 73.04 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.242 0 C-N-CA 119.204 -0.998 . . . . 0.78000000000000003 110.548 178.496 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A 1588 ' ' LEU . . . . . 0.675 ' HB2' ' HB2' ' A' 1612 ' ' PHE . 57.6 mt -83.22 126.24 32.43 Favored 'General case' 0 C--N 1.3 -1.552 0 CA-C-N 114.919 -1.037 . . . . 1.4099999999999999 109.061 173.826 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A 1589 ' ' GLN . . . . . . . . . . . . . 36.0 tt0 -118.85 117.44 28.86 Favored 'General case' 0 C--N 1.284 -2.248 0 CA-C-N 115.736 -0.666 . . . . 1.24 109.291 -178.475 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A 1590 ' ' LEU . . . . . . . . . . . . . 7.3 tt -124.6 132.83 53.41 Favored 'General case' 0 C--N 1.307 -1.248 0 N-CA-C 106.847 -1.538 . . . . 1.1499999999999999 106.847 176.611 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A 1591 ' ' VAL . . . . . 0.432 HG22 HG22 ' A' 1609 ' ' VAL . 39.0 t -127.42 137.68 57.01 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.704 0 CA-C-O 120.69 0.281 . . . . 1.51 111.309 -174.092 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A 1592 ' ' TYR . . . . . . . . . . . . . 57.9 m-85 -115.07 124.64 52.11 Favored 'General case' 0 C--N 1.314 -0.962 0 N-CA-C 107.262 -1.384 . . . . 1.0600000000000001 107.262 171.231 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A 1593 ' ' LYS . . . . . . . . . . . . . 13.3 ptmm? -137.98 172.86 12.3 Favored 'General case' 0 C--N 1.302 -1.484 0 C-N-CA 121.149 -0.22 . . . . 2.1800000000000002 111.263 -177.111 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A 1594 ' ' ASP . . . . . . . . . . . . . 17.3 m-20 66.37 48.0 1.65 Allowed 'General case' 0 C--O 1.247 0.935 0 C-N-CA 125.313 1.445 . . . . 1.45 111.875 179.082 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A 1595 ' ' GLY . . . . . . . . . . . . . . . -89.93 -106.98 1.23 Allowed Glycine 0 N--CA 1.44 -1.04 0 N-CA-C 110.877 -0.889 . . . . 0.78000000000000003 110.877 175.832 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A 1596 ' ' SER . . . . . 0.421 ' HA ' ' HD3' ' A' 1597 ' ' PRO . 19.9 m -101.89 152.08 38.09 Favored Pre-proline 0 C--N 1.296 -1.741 0 N-CA-C 109.732 -0.47 . . . . 1.6799999999999999 109.732 179.214 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A 1597 ' ' PRO . . . . . 0.421 ' HD3' ' HA ' ' A' 1596 ' ' SER . 22.6 Cg_exo -66.79 141.35 59.07 Favored 'Trans proline' 0 C--N 1.353 0.797 0 C-N-CA 123.203 2.602 . . . . 1.1699999999999999 112.018 178.88 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A 1598 ' ' CYS . . . . . 0.635 ' O ' ' HA ' ' A' 1602 ' ' SER . 42.2 t -95.86 136.39 22.27 Favored Pre-proline 0 C--N 1.287 -2.136 0 CA-C-N 115.505 -0.771 . . . . 1.1899999999999999 109.011 179.993 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A 1599 ' ' PRO . . . . . . . . . . . . . 63.3 Cg_endo -75.08 -18.01 18.91 Favored 'Trans proline' 0 C--N 1.36 1.149 0 C-N-CA 123.11 2.54 . . . . 1.5900000000000001 112.198 177.751 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A 1600 ' ' SER . . . . . . . . . . . . . 34.2 m -86.63 112.54 21.7 Favored 'General case' 0 N--CA 1.425 -1.721 0 N-CA-C 107.037 -1.468 . . . . 2.1200000000000001 107.037 176.592 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A 1601 ' ' LYS . . . . . 0.435 ' HD3' ' HA ' ' A' 1601 ' ' LYS . 42.9 mmtm 56.23 55.79 6.4 Favored 'General case' 0 C--O 1.242 0.694 0 CA-C-O 122.477 1.132 . . . . 3.7400000000000002 108.542 -173.215 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A 1602 ' ' SER . . . . . 0.635 ' HA ' ' O ' ' A' 1598 ' ' CYS . 15.0 t -49.11 122.77 6.28 Favored 'General case' 0 N--CA 1.442 -0.865 0 CA-C-N 112.781 -2.009 . . . . 3.79 112.108 -172.693 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A 1603 ' ' GLY . . . . . . . . . . . . . . . 140.02 -23.58 2.74 Favored Glycine 0 N--CA 1.43 -1.726 0 N-CA-C 109.131 -1.588 . . . . 2.0 109.131 -176.61 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A 1604 ' ' LEU . . . . . . . . . . . . . 72.3 mt -85.33 152.45 23.27 Favored 'General case' 0 C--N 1.309 -1.183 0 CA-C-N 114.733 -0.734 . . . . 1.48 109.473 177.502 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A 1605 ' ' SER . . . . . . . . . . . . . 49.1 m -101.7 175.54 5.52 Favored 'General case' 0 C--N 1.282 -2.341 0 N-CA-C 105.933 -1.877 . . . . 1.51 105.933 169.094 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A 1606 ' ' TYR . . . . . . . . . . . . . 78.5 m-85 -94.76 149.69 20.98 Favored 'General case' 0 CA--C 1.466 -2.28 0 N-CA-C 106.133 -1.803 . . . . 1.1799999999999999 106.133 -177.583 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A 1607 ' ' LYS . . . . . 0.436 ' HG3' HG23 ' A' 1635 ' ' THR . 23.2 pttm -135.67 132.18 36.64 Favored 'General case' 0 N--CA 1.401 -2.915 0 C-N-CA 118.377 -1.329 . . . . 1.6699999999999999 110.123 175.243 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A 1608 ' ' SER . . . . . . . . . . . . . 29.3 p -106.9 112.15 24.98 Favored 'General case' 0 C--N 1.288 -2.08 0 CA-C-N 116.277 -0.419 . . . . 1.0 110.376 -179.232 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A 1609 ' ' VAL . . . . . 0.432 HG22 HG22 ' A' 1591 ' ' VAL . 92.6 t -100.3 117.4 45.44 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.961 0 N-CA-C 108.719 -0.845 . . . . 0.93000000000000005 108.719 177.622 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A 1610 ' ' ILE . . . . . 0.638 HG13 ' HB2' ' A' 1638 ' ' PHE . 3.5 mp -101.94 118.34 48.61 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.567 0 N-CA-C 108.22 -1.03 . . . . 0.78000000000000003 108.22 177.133 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A 1611 ' ' SER . . . . . . . . . . . . . 14.1 m -104.22 117.02 33.22 Favored 'General case' 0 N--CA 1.416 -2.131 0 CA-C-N 115.357 -0.838 . . . . 1.29 108.966 178.834 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A 1612 ' ' PHE . . . . . 0.675 ' HB2' ' HB2' ' A' 1588 ' ' LEU . 95.2 m-85 -90.18 107.32 19.06 Favored 'General case' 0 C--N 1.298 -1.648 0 CA-C-N 115.458 -0.792 . . . . 0.69999999999999996 109.251 179.98 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A 1613 ' ' VAL . . . . . . . . . . . . . 71.9 t -100.38 131.31 48.15 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.108 0 CA-C-N 116.152 -0.477 . . . . 0.75 109.922 -177.02 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A 1614 ' ' CYS . . . . . . . . . . . . . 59.6 m -67.98 101.76 1.17 Allowed 'General case' 0 C--N 1.317 -0.848 0 C-N-CA 123.787 0.835 . . . . 1.3899999999999999 110.925 -179.425 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A 1615 ' ' ARG . . . . . 0.549 ' HD2' ' OE2' ' A' 1617 ' ' GLU . 21.4 mmt180 -137.07 95.76 11.77 Favored Pre-proline 0 C--N 1.306 -1.294 0 CA-C-N 115.594 -0.73 . . . . 3.75 110.927 178.692 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A 1616 ' ' PRO . . . . . . . . . . . . . 11.4 Cg_exo -74.1 58.53 4.26 Favored 'Trans proline' 0 CA--C 1.541 0.857 0 C-N-CA 123.636 2.891 . . . . 1.3200000000000001 111.371 176.587 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A 1617 ' ' GLU . . . . . 0.549 ' OE2' ' HD2' ' A' 1615 ' ' ARG . 38.3 mt-10 -131.38 37.02 3.74 Favored 'General case' 0 C--N 1.31 -1.121 0 C-N-CA 124.659 1.183 . . . . 3.21 108.471 179.503 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A 1618 ' ' ALA . . . . . . . . . . . . . . . -63.96 140.38 58.86 Favored 'General case' 0 C--O 1.243 0.734 0 CA-C-N 115.709 -0.678 . . . . 2.4399999999999999 111.856 -173.929 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A 1619 ' ' GLY . . . . . . . . . . . . . . . -148.92 -165.1 11.98 Favored Glycine 0 N--CA 1.426 -1.985 0 N-CA-C 110.185 -1.166 . . . . 3.2599999999999998 110.185 179.89 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A 1620 ' ' PRO . . . . . . . . . . . . . 5.9 Cg_exo -78.69 4.91 6.0 Favored 'Trans proline' 0 CA--C 1.532 0.401 0 C-N-CA 123.068 2.512 . . . . 5.9199999999999999 112.89 -176.823 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A 1621 ' ' THR . . . . . . . . . . . . . 15.0 t -131.55 33.22 4.06 Favored 'General case' 0 N--CA 1.426 -1.635 0 CA-C-O 122.249 1.023 . . . . 4.7599999999999998 109.664 179.61 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A 1622 ' ' ASN . . . . . . . . . . . . . 25.2 t-20 -85.4 82.44 8.32 Favored 'General case' 0 C--N 1.321 -0.645 0 N-CA-C 108.864 -0.791 . . . . 2.9199999999999999 108.864 -178.759 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A 1623 ' ' ARG . . . . . . . . . . . . . 8.6 ptm180 -133.67 158.17 76.17 Favored Pre-proline 0 C--N 1.311 -1.089 0 CA-C-N 115.378 -0.828 . . . . 3.6099999999999999 109.714 -173.866 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A 1624 ' ' PRO . . . . . . . . . . . . . 12.2 Cg_exo -69.86 127.21 14.2 Favored 'Trans proline' 0 C--O 1.246 0.905 0 C-N-CA 122.792 2.328 . . . . 2.3700000000000001 110.834 176.942 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A 1625 ' ' MET . . . . . . . . . . . . . 22.1 ptp -126.34 151.47 47.53 Favored 'General case' 0 C--N 1.303 -1.438 0 CA-C-N 116.131 -0.486 . . . . 2.1600000000000001 110.396 -178.561 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A 1626 ' ' LEU . . . . . 0.407 HD12 ' O ' ' A' 1637 ' ' PHE . 39.0 tp -85.55 118.35 25.01 Favored 'General case' 0 C--N 1.306 -1.293 0 N-CA-C 108.436 -0.95 . . . . 1.3500000000000001 108.436 -179.666 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A 1627 ' ' ILE . . . . . . . . . . . . . 45.8 pt -93.17 -28.33 4.45 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.331 0 C-N-CA 120.345 -0.542 . . . . 1.21 111.47 -177.993 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A 1628 ' ' SER . . . . . . . . . . . . . 21.1 t -160.57 142.0 12.22 Favored 'General case' 0 N--CA 1.432 -1.371 0 C-N-CA 120.341 -0.543 . . . . 1.3999999999999999 110.565 -177.482 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A 1629 ' ' LEU . . . . . 0.83 HD13 ' HG ' ' A' 1636 ' ' LEU . 29.5 tp -119.76 128.02 53.36 Favored 'General case' 0 C--N 1.304 -1.37 0 N-CA-C 108.065 -1.087 . . . . 1.5600000000000001 108.065 174.055 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A 1630 ' ' ASP . . . . . . . . . . . . . 25.1 t70 -102.07 127.41 48.98 Favored 'General case' 0 C--N 1.295 -1.761 0 CA-C-N 116.737 -0.211 . . . . 0.87 110.623 179.269 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A 1631 ' ' LYS . . . . . . . . . . . . . 53.0 mttm -95.14 0.97 54.72 Favored 'General case' 0 C--N 1.317 -0.808 0 N-CA-C 111.872 0.323 . . . . 2.3500000000000001 111.872 -178.495 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A 1632 ' ' GLN . . . . . . . . . . . . . 36.5 mt-30 -87.19 -52.47 5.39 Favored 'General case' 0 C--N 1.315 -0.926 0 C-N-CA 120.218 -0.593 . . . . 2.5499999999999998 109.969 178.917 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A 1633 ' ' THR . . . . . . . . . . . . . 69.1 p -106.51 -1.44 23.05 Favored 'General case' 0 N--CA 1.432 -1.374 0 CA-C-N 115.761 -0.654 . . . . 1.24 111.927 -178.833 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A 1634 ' ' CYS . . . . . . . . . . . . . 60.3 m 62.61 42.91 7.99 Favored 'General case' 0 C--O 1.237 0.399 0 CA-C-O 122.464 1.126 . . . . 0.89000000000000001 111.26 177.409 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A 1635 ' ' THR . . . . . 0.436 HG23 ' HG3' ' A' 1607 ' ' LYS . 28.2 m -102.57 133.09 48.13 Favored 'General case' 0 N--CA 1.416 -2.145 0 CA-C-N 114.168 -1.378 . . . . 0.75 109.245 -178.547 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A 1636 ' ' LEU . . . . . 0.83 ' HG ' HD13 ' A' 1629 ' ' LEU . 5.2 mp -109.79 129.69 55.6 Favored 'General case' 0 N--CA 1.435 -1.213 0 N-CA-C 108.994 -0.743 . . . . 1.3300000000000001 108.994 179.806 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A 1637 ' ' PHE . . . . . 0.407 ' O ' HD12 ' A' 1626 ' ' LEU . 88.7 m-85 -110.32 108.0 17.93 Favored 'General case' 0 C--N 1.308 -1.223 0 CA-C-O 121.049 0.452 . . . . 0.82999999999999996 110.979 -177.121 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A 1638 ' ' PHE . . . . . 0.638 ' HB2' HG13 ' A' 1610 ' ' ILE . 97.0 m-85 -101.78 146.95 27.08 Favored 'General case' 0 C--N 1.305 -1.359 0 N-CA-C 109.228 -0.656 . . . . 0.59999999999999998 109.228 177.706 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A 1639 ' ' SER . . . . . . . . . . . . . 50.0 m -132.64 133.66 43.89 Favored 'General case' 0 C--N 1.278 -2.529 0 N-CA-C 109.788 -0.449 . . . . 1.0800000000000001 109.788 176.967 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A 1640 ' ' TRP . . . . . 0.403 ' CE3' ' HE2' ' A' 1612 ' ' PHE . 6.7 t90 -121.43 92.54 3.77 Favored 'General case' 0 N--CA 1.413 -2.32 0 N-CA-C 106.761 -1.57 . . . . 0.80000000000000004 106.761 173.517 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A 1641 ' ' HIS . . . . . . . . . . . . . 4.4 p-80 -71.64 98.75 1.96 Allowed 'General case' 0 C--N 1.308 -1.209 0 CA-C-N 114.867 -1.061 . . . . 2.54 108.555 175.154 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A 1642 ' ' THR . . . . . . . . . . . . . 10.0 t -143.55 147.81 40.97 Favored Pre-proline 0 C--N 1.279 -2.49 0 CA-C-N 115.831 -0.622 . . . . 1.1499999999999999 110.483 -170.963 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A 1643 ' ' PRO . . . . . 0.417 ' O ' ' HG2' ' A' 1647 ' ' GLU . 34.6 Cg_endo -75.68 0.18 9.47 Favored 'Trans proline' 0 C--O 1.215 -0.651 0 C-N-CA 122.853 2.369 . . . . 0.80000000000000004 111.114 174.768 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A 1644 ' ' LEU . . . . . 0.437 HD13 HD13 ' A' 1532 ' ' LEU . 45.5 mt -85.04 -11.81 54.52 Favored 'General case' 0 C--N 1.32 -0.683 0 C-N-CA 123.927 0.891 . . . . 1.54 110.782 176.679 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A 1645 ' ' ALA . . . . . . . . . . . . . . . -73.09 -43.44 61.82 Favored 'General case' 0 N--CA 1.471 0.592 0 CA-C-O 121.563 0.696 . . . . 0.94999999999999996 110.118 -178.604 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A 1646 ' ' CYS . . . . . 0.551 ' HA ' ' CE1' ' A' 1527 ' ' PHE . 18.8 p -155.61 142.26 18.79 Favored 'General case' 0 N--CA 1.417 -2.084 0 N-CA-C 104.666 -2.346 . . . . 1.4099999999999999 104.666 172.389 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A 1647 ' ' GLU . . . . . 0.417 ' HG2' ' O ' ' A' 1643 ' ' PRO . 39.9 mt-10 -113.62 116.19 46.01 Favored Pre-proline 0 C--N 1.283 -2.323 0 O-C-N 123.199 0.312 . . . . 2.9199999999999999 110.414 -171.249 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A 1648 ' ' PRO . . . . . . . . . . . . . 37.2 Cg_exo -64.16 114.89 2.84 Favored 'Trans proline' 0 N--CA 1.452 -0.916 0 C-N-CA 122.745 2.297 . . . . 2.8199999999999998 110.772 178.089 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A 1649 ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--N 1.298 -1.656 0 N-CA-C 108.827 -0.805 . . . . 5.0599999999999996 108.827 177.867 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A 1508 ' ' MET . . . . . . . . . . . . . 61.3 mtt . . . . . 0 CA--C 1.501 -0.914 0 N-CA-C 107.538 -1.282 . . . . 8.2699999999999996 107.538 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A 1509 ' ' LYS . . . . . . . . . . . . . 20.7 ptmt -112.72 -34.81 5.69 Favored 'General case' 0 C--N 1.3 -1.554 0 N-CA-C 111.631 0.234 . . . . 6.4800000000000004 111.631 -177.587 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A 1510 ' ' SER . . . . . . . . . . . . . 16.9 t -175.02 106.76 0.1 Allowed 'General case' 0 CA--C 1.542 0.67 0 N-CA-C 110.12 -0.326 . . . . 4.2199999999999998 110.12 -178.053 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A 1511 ' ' ASN . . . . . . . . . . . . . 12.5 m120 -135.17 -6.33 2.33 Favored 'General case' 0 N--CA 1.482 1.169 0 CA-C-O 120.772 0.32 . . . . 3.0800000000000001 111.534 178.153 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A 1512 ' ' GLU . . . . . . . . . . . . . 39.8 tt0 -78.28 -42.91 29.56 Favored 'General case' 0 C--N 1.32 -0.712 0 N-CA-C 112.167 0.432 . . . . 4.46 112.167 -174.234 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A 1513 ' ' HIS . . . . . . . . . . . . . 20.8 p80 -68.17 -21.75 64.88 Favored 'General case' 0 N--CA 1.485 1.313 0 CA-C-O 121.555 0.693 . . . . 5.5700000000000003 109.941 -178.704 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A 1514 ' ' ASP . . . . . 0.414 ' HB3' ' HG3' ' A' 1517 ' ' GLN . 6.4 m-20 -76.23 -43.17 43.28 Favored 'General case' 0 N--CA 1.433 -1.283 0 CA-C-N 114.495 -1.23 . . . . 3.7000000000000002 110.814 -177.017 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A 1515 ' ' ASP . . . . . 0.451 ' HB3' ' HB3' ' A' 1579 ' ' LYS . 38.7 m-20 71.67 -72.18 0.12 Allowed 'General case' 0 C--N 1.323 -0.565 0 C-N-CA 124.644 1.178 . . . . 2.54 111.936 -178.696 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A 1516 ' ' CYS . . . . . . . . . . . . . 85.7 m -124.4 41.38 3.51 Favored 'General case' 0 C--N 1.311 -1.069 0 CA-C-O 121.432 0.634 . . . . 1.25 110.99 -177.266 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A 1517 ' ' GLN . . . . . 0.414 ' HG3' ' HB3' ' A' 1514 ' ' ASP . 9.6 pt20 -161.21 168.62 23.82 Favored 'General case' 0 C--N 1.287 -2.132 0 N-CA-C 109.42 -0.585 . . . . 1.8799999999999999 109.42 -179.562 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A 1518 ' ' VAL . . . . . . . . . . . . . 80.7 t -131.37 105.96 11.27 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.081 0 N-CA-C 108.497 -0.927 . . . . 1.73 108.497 176.111 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A 1519 ' ' THR . . . . . . . . . . . . . 20.4 m -86.16 102.14 13.62 Favored 'General case' 0 C--N 1.281 -2.376 0 N-CA-C 107.596 -1.261 . . . . 1.7 107.596 175.048 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A 1520 ' ' ASN . . . . . . . . . . . . . 31.4 t30 -92.0 105.41 13.57 Favored Pre-proline 0 C--N 1.322 -0.614 0 N-CA-C 109.859 -0.423 . . . . 2.1200000000000001 109.859 179.809 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A 1521 ' ' PRO . . . . . . . . . . . . . 59.1 Cg_endo -72.72 -18.98 24.63 Favored 'Trans proline' 0 N--CA 1.458 -0.593 0 C-N-CA 122.383 2.055 . . . . 2.4700000000000002 113.376 -175.123 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A 1522 ' ' SER . . . . . . . . . . . . . 32.6 m -61.27 -35.75 78.15 Favored 'General case' 0 CA--C 1.54 0.565 0 CA-C-O 120.818 0.342 . . . . 2.5699999999999998 111.832 -178.393 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A 1523 ' ' THR . . . . . . . . . . . . . 12.3 t -120.21 -5.24 9.95 Favored 'General case' 0 CA--C 1.554 1.096 0 CA-C-O 122.074 0.94 . . . . 2.1499999999999999 109.543 178.809 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A 1524 ' ' GLY . . . . . . . . . . . . . . . 73.97 20.18 79.73 Favored Glycine 0 C--N 1.335 0.526 0 CA-C-N 115.44 -0.8 . . . . 1.8899999999999999 112.345 179.666 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A 1525 ' ' HIS . . . . . . . . . . . . . 12.9 t-80 -101.65 128.16 48.07 Favored 'General case' 0 C--N 1.314 -0.951 0 CA-C-O 120.797 0.332 . . . . 1.8999999999999999 110.745 -177.869 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A 1526 ' ' LEU . . . . . . . . . . . . . 6.9 tt -100.34 130.71 46.48 Favored 'General case' 0 C--N 1.3 -1.579 0 N-CA-C 108.43 -0.952 . . . . 1.6100000000000001 108.43 178.208 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A 1527 ' ' PHE . . . . . 0.675 ' HE1' ' HA ' ' A' 1646 ' ' CYS . 97.7 m-85 -95.78 102.95 14.81 Favored 'General case' 0 C--N 1.308 -1.199 0 N-CA-C 109.183 -0.673 . . . . 1.4199999999999999 109.183 177.243 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A 1528 ' ' ASP . . . . . . . . . . . . . 4.9 p-10 -85.17 106.68 16.79 Favored 'General case' 0 C--N 1.314 -0.936 0 CA-C-O 122.389 1.09 . . . . 2.1800000000000002 113.437 -178.285 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A 1529 ' ' LEU . . . . . 0.747 ' HG ' HD12 ' A' 1532 ' ' LEU . 7.4 mp -105.5 0.22 26.48 Favored 'General case' 0 C--N 1.312 -1.06 0 CA-C-N 114.78 -1.1 . . . . 1.4399999999999999 108.148 172.398 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A 1530 ' ' SER . . . . . . . . . . . . . 2.6 p -68.3 -31.32 70.68 Favored 'General case' 0 N--CA 1.426 -1.641 0 CA-C-N 114.248 -1.342 . . . . 1.4399999999999999 109.356 177.406 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A 1531 ' ' SER . . . . . . . . . . . . . 9.9 m -76.11 -7.91 55.8 Favored 'General case' 0 N--CA 1.443 -0.793 0 CA-C-N 115.03 -0.987 . . . . 1.5 110.358 177.759 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A 1532 ' ' LEU . . . . . 0.747 HD12 ' HG ' ' A' 1529 ' ' LEU . 81.7 mt -90.72 15.8 10.43 Favored 'General case' 0 C--O 1.238 0.485 0 CA-C-O 121.544 0.688 . . . . 1.77 111.676 -179.792 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A 1533 ' ' SER . . . . . . . . . . . . . 17.0 m -78.74 173.23 12.69 Favored 'General case' 0 N--CA 1.44 -0.955 0 N-CA-C 108.558 -0.904 . . . . 2.3799999999999999 108.558 176.143 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A 1534 ' ' GLY . . . . . . . . . . . . . . . 165.5 147.44 5.16 Favored Glycine 0 N--CA 1.428 -1.897 0 C-N-CA 120.038 -1.077 . . . . 1.55 111.848 -178.997 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A 1535 ' ' ARG . . . . . 0.855 ' HG3' ' HG3' ' A' 1557 ' ' GLU . 43.6 ttm180 -60.35 -49.29 78.17 Favored 'General case' 0 C--O 1.246 0.907 0 C-N-CA 124.513 1.125 . . . . 3.96 110.301 179.562 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A 1536 ' ' ALA . . . . . . . . . . . . . . . -95.68 -33.65 12.25 Favored 'General case' 0 N--CA 1.434 -1.266 0 N-CA-C 109.044 -0.724 . . . . 1.6499999999999999 109.044 177.858 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A 1537 ' ' GLY . . . . . . . . . . . . . . . 84.19 -136.37 14.7 Favored Glycine 0 N--CA 1.428 -1.873 0 CA-C-N 114.496 -1.229 . . . . 1.1899999999999999 111.963 177.73 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A 1538 ' ' PHE . . . . . 0.479 ' CD1' HD13 ' A' 1552 ' ' ILE . 54.2 m-85 -106.34 135.94 46.94 Favored 'General case' 0 C--N 1.295 -1.802 0 N-CA-C 108.207 -1.034 . . . . 1.6899999999999999 108.207 177.88 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A 1539 ' ' THR . . . . . . . . . . . . . 19.2 p -113.35 117.99 33.33 Favored 'General case' 0 C--N 1.292 -1.927 0 CA-C-N 116.128 -0.487 . . . . 1.48 111.352 -178.509 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A 1540 ' ' ALA . . . . . . . . . . . . . . . -122.43 124.33 43.39 Favored 'General case' 0 C--N 1.313 -1.015 0 N-CA-C 109.932 -0.396 . . . . 0.82999999999999996 109.932 179.77 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A 1541 ' ' ALA . . . . . . . . . . . . . . . -74.18 144.63 44.72 Favored 'General case' 0 C--O 1.251 1.156 0 CA-C-O 120.654 0.264 . . . . 1.27 110.521 179.247 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A 1542 ' ' TYR . . . . . . . . . . . . . 27.4 t80 -149.16 -173.64 4.43 Favored 'General case' 0 N--CA 1.437 -1.114 0 N-CA-C 109.148 -0.686 . . . . 2.1499999999999999 109.148 -176.276 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A 1543 ' ' SER . . . . . . . . . . . . . 13.9 m -45.99 -152.78 0.0 OUTLIER 'General case' 0 CA--C 1.569 1.7 0 C-N-CA 129.707 3.203 . . . . 2.29 115.063 -178.799 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A 1544 ' ' LYS . . . . . . . . . . . . . 55.9 tptt -47.24 -29.52 2.46 Favored 'General case' 0 N--CA 1.486 1.336 0 O-C-N 121.266 -0.897 . . . . 3.9100000000000001 112.774 178.677 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A 1545 ' ' SER . . . . . . . . . . . . . 4.3 p -61.74 -22.64 65.55 Favored 'General case' 0 CA--C 1.556 1.207 0 C-N-CA 123.053 0.541 . . . . 3.2999999999999998 112.202 175.048 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A 1546 ' ' GLY . . . . . . . . . . . . . . . 89.49 -69.72 2.49 Favored Glycine 0 N--CA 1.431 -1.666 0 N-CA-C 113.867 0.307 . . . . 1.24 113.867 173.664 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A 1547 ' ' VAL . . . . . . . . . . . . . 7.2 p -158.79 138.61 3.73 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.925 0 N-CA-C 109.787 -0.449 . . . . 1.6299999999999999 109.787 -173.606 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A 1548 ' ' VAL . . . . . . . . . . . . . 2.4 t -103.0 134.88 42.89 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.601 0 N-CA-C 108.548 -0.908 . . . . 0.92000000000000004 108.548 -177.563 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A 1549 ' ' TYR . . . . . . . . . . . . . 97.9 m-85 -104.02 121.89 44.11 Favored 'General case' 0 C--N 1.311 -1.096 0 N-CA-C 107.112 -1.44 . . . . 1.4399999999999999 107.112 173.717 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A 1550 ' ' MET . . . . . . . . . . . . . 71.5 mtm -131.07 122.17 26.27 Favored 'General case' 0 CA--C 1.488 -1.43 0 C-N-CA 120.217 -0.593 . . . . 1.74 112.195 177.913 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A 1551 ' ' SER . . . . . . . . . . . . . 53.2 m -103.03 105.17 15.44 Favored 'General case' 0 C--N 1.272 -2.803 0 N-CA-C 105.45 -2.056 . . . . 1.6399999999999999 105.45 171.457 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A 1552 ' ' ILE . . . . . 0.479 HD13 ' CD1' ' A' 1538 ' ' PHE . 1.7 mp -52.48 -35.34 20.22 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.813 0 O-C-N 124.112 0.883 . . . . 1.3300000000000001 112.133 -176.456 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A 1553 ' ' CYS . . . . . . . . . . . . . 93.9 m -145.7 155.66 43.13 Favored 'General case' 0 C--N 1.307 -1.249 0 N-CA-C 109.152 -0.685 . . . . 1.4299999999999999 109.152 174.924 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A 1554 ' ' GLY . . . . . . . . . . . . . . . 102.66 -118.32 6.07 Favored Glycine 0 N--CA 1.441 -1.031 0 N-CA-C 110.366 -1.094 . . . . 1.1200000000000001 110.366 -179.917 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A 1555 ' ' GLU . . . . . . . . . . . . . 17.0 pt-20 -157.9 148.32 20.6 Favored 'General case' 0 C--N 1.311 -1.107 0 N-CA-C 107.741 -1.207 . . . . 1.8 107.741 176.769 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A 1556 ' ' ASN . . . . . . . . . . . . . 21.0 t-20 -97.05 118.86 34.4 Favored 'General case' 0 C--N 1.305 -1.329 0 CA-C-O 121.543 0.687 . . . . 2.6299999999999999 110.277 -178.609 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A 1557 ' ' GLU . . . . . 0.855 ' HG3' ' HG3' ' A' 1535 ' ' ARG . 12.0 mm-40 -82.53 11.97 5.11 Favored 'General case' 0 C--N 1.298 -1.644 0 CA-C-N 114.65 -1.159 . . . . 3.79 112.956 -172.429 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A 1558 ' ' ASN . . . . . . . . . . . . . 18.9 m120 -104.24 -9.02 18.92 Favored 'General case' 0 C--N 1.301 -1.528 0 O-C-N 121.726 -0.609 . . . . 1.52 110.662 -178.886 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A 1559 ' ' CYS . . . . . 0.685 ' HB3' ' HD2' ' A' 1560 ' ' PRO . 88.1 m -144.29 178.46 1.45 Allowed Pre-proline 0 C--N 1.302 -1.466 0 CA-C-O 117.199 -1.381 . . . . 0.83999999999999997 108.154 -178.521 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A 1560 ' ' PRO . . . . . 0.685 ' HD2' ' HB3' ' A' 1559 ' ' CYS . 24.2 Cg_exo -29.4 125.69 0.05 OUTLIER 'Trans proline' 0 C--N 1.383 2.356 0 C-N-CA 124.772 3.648 . . . . 1.1799999999999999 114.94 176.422 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A 1561 ' ' PRO . . . . . 0.465 ' HD3' ' HA ' ' A' 1560 ' ' PRO . 51.2 Cg_exo -55.52 115.99 2.84 Favored 'Trans proline' 0 C--O 1.244 0.782 0 C-N-CA 123.445 2.764 . . . . 1.51 112.964 -177.126 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A 1562 ' ' GLY . . . . . . . . . . . . . . . 114.11 -10.34 22.65 Favored Glycine 0 N--CA 1.439 -1.122 0 C-N-CA 120.455 -0.878 . . . . 0.71999999999999997 113.275 177.187 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A 1563 ' ' VAL . . . . . 0.571 ' HA ' ' HA ' ' A' 1576 ' ' LYS . 5.1 m -90.65 152.37 3.35 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.183 0 N-CA-C 107.189 -1.411 . . . . 0.96999999999999997 107.189 176.635 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A 1564 ' ' GLY . . . . . . . . . . . . . . . -117.23 -19.06 5.24 Favored Glycine 0 C--N 1.306 -1.127 0 C-N-CA 119.451 -1.357 . . . . 0.71999999999999997 113.74 -176.25 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A 1565 ' ' ALA . . . . . . . . . . . . . . . -126.37 123.23 37.49 Favored 'General case' 0 C--O 1.25 1.095 0 N-CA-C 109.385 -0.598 . . . . 0.37 109.385 -179.851 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A 1566 ' ' CYS . . . . . . . . . . . . . 49.3 t -151.69 146.78 26.03 Favored 'General case' 0 C--N 1.312 -1.035 0 C-N-CA 121.056 -0.258 . . . . 0.51000000000000001 111.126 -177.096 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A 1567 ' ' PHE . . . . . . . . . . . . . 31.4 m-85 -94.05 123.68 37.57 Favored 'General case' 0 C--O 1.247 0.965 0 CA-C-N 116.101 -0.5 . . . . 0.96999999999999997 109.677 177.836 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A 1568 ' ' GLY . . . . . . . . . . . . . . . 50.62 -140.82 19.74 Favored Glycine 0 C--N 1.321 -0.289 0 O-C-N 123.893 0.745 . . . . 1.0800000000000001 114.719 175.517 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A 1569 ' ' GLN . . . . . . . . . . . . . 49.0 tt0 -90.87 -58.23 2.55 Favored 'General case' 0 N--CA 1.43 -1.444 0 N-CA-C 109.558 -0.534 . . . . 2.7400000000000002 109.558 179.993 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A 1570 ' ' THR . . . . . . . . . . . . . 14.8 p -123.01 34.13 5.21 Favored 'General case' 0 C--N 1.312 -1.043 0 CA-C-N 115.892 -0.594 . . . . 1.96 112.473 -176.668 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A 1571 ' ' ARG . . . . . . . . . . . . . 7.5 mpt_? -97.5 12.03 34.76 Favored 'General case' 0 N--CA 1.432 -1.328 0 C-N-CA 119.388 -0.925 . . . . 3.9500000000000002 110.765 175.691 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A 1572 ' ' ILE . . . . . 0.446 HG22 ' HB2' ' A' 1596 ' ' SER . 75.9 mt 80.97 144.51 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.548 0.894 0 CA-C-N 114.112 -1.404 . . . . 1.3700000000000001 114.371 165.581 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A 1573 ' ' SER . . . . . . . . . . . . . 36.3 p -82.01 134.89 35.4 Favored 'General case' 0 N--CA 1.438 -1.072 0 CA-C-N 114.582 -1.19 . . . . 1.0800000000000001 111.113 -179.242 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A 1574 ' ' VAL . . . . . . . . . . . . . 19.0 m -123.22 30.43 2.24 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.228 0 N-CA-C 112.611 0.597 . . . . 1.3 112.611 -177.553 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A 1575 ' ' GLY . . . . . . . . . . . . . . . 173.56 122.68 0.68 Allowed Glycine 0 N--CA 1.434 -1.434 0 C-N-CA 119.989 -1.1 . . . . 0.51000000000000001 112.799 177.753 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A 1576 ' ' LYS . . . . . 0.571 ' HA ' ' HA ' ' A' 1563 ' ' VAL . 66.6 tttm -76.8 143.09 40.05 Favored 'General case' 0 C--O 1.246 0.914 0 N-CA-C 106.835 -1.543 . . . . 2.8999999999999999 106.835 175.787 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A 1577 ' ' ALA . . . . . . . . . . . . . . . -77.04 82.63 3.55 Favored 'General case' 0 C--N 1.304 -1.412 0 CA-C-O 121.642 0.734 . . . . 0.82999999999999996 111.7 -175.23 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A 1578 ' ' ASN . . . . . . . . . . . . . 41.6 m-80 -89.47 147.44 24.0 Favored 'General case' 0 C--N 1.306 -1.3 0 N-CA-C 108.058 -1.09 . . . . 1.8500000000000001 108.058 175.243 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A 1579 ' ' LYS . . . . . 0.451 ' HB3' ' HB3' ' A' 1515 ' ' ASP . 58.7 mttp -95.14 89.67 5.62 Favored 'General case' 0 C--N 1.283 -2.299 0 N-CA-C 105.746 -1.946 . . . . 1.8999999999999999 105.746 175.331 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A 1580 ' ' ARG . . . . . 0.401 ' O ' ' HG ' ' A' 1590 ' ' LEU . 42.1 ttm180 -140.32 101.14 4.06 Favored 'General case' 0 C--N 1.297 -1.703 0 CA-C-N 115.346 -0.843 . . . . 3.6299999999999999 110.003 -173.607 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A 1581 ' ' LEU . . . . . . . . . . . . . 41.0 tp -117.4 145.02 44.38 Favored 'General case' 0 C--N 1.289 -2.054 0 CA-C-N 115.151 -0.931 . . . . 1.8700000000000001 109.462 -177.39 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A 1582 ' ' ARG . . . . . . . . . . . . . 97.0 mtt180 -119.44 125.27 48.54 Favored 'General case' 0 C--N 1.297 -1.713 0 CA-C-N 115.656 -0.702 . . . . 3.9700000000000002 109.984 -179.729 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A 1583 ' ' TYR . . . . . 0.416 ' HD1' ' CD2' ' A' 1588 ' ' LEU . 22.6 t80 -108.09 97.89 7.52 Favored 'General case' 0 C--N 1.296 -1.727 0 N-CA-C 108.547 -0.909 . . . . 1.4099999999999999 108.547 174.49 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A 1584 ' ' VAL . . . . . . . . . . . . . 1.1 m -140.07 121.28 14.91 Favored 'Isoleucine or valine' 0 CA--C 1.499 -0.981 0 N-CA-C 112.697 0.628 . . . . 1.6899999999999999 112.697 -178.079 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A 1585 ' ' ASP . . . . . . . . . . . . . 30.9 t70 56.67 45.04 22.73 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-O 122.334 1.064 . . . . 2.0600000000000001 111.082 171.613 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A 1586 ' ' GLN . . . . . . . . . . . . . 73.9 mt-30 58.82 18.25 5.92 Favored 'General case' 0 C--N 1.323 -0.548 0 N-CA-C 115.068 1.507 . . . . 2.3300000000000001 115.068 -178.871 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A 1587 ' ' VAL . . . . . . . . . . . . . 12.4 p -120.69 133.37 67.6 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.331 0 N-CA-C 107.619 -1.252 . . . . 0.78000000000000003 107.619 172.86 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A 1588 ' ' LEU . . . . . 0.426 ' HB2' ' HB2' ' A' 1612 ' ' PHE . 16.6 mt -103.24 133.09 48.91 Favored 'General case' 0 C--N 1.296 -1.746 0 N-CA-C 108.277 -1.008 . . . . 1.4099999999999999 108.277 -177.104 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A 1589 ' ' GLN . . . . . . . . . . . . . 35.0 tt0 -134.31 115.78 14.49 Favored 'General case' 0 C--N 1.275 -2.639 0 C-N-CA 120.39 -0.524 . . . . 1.24 110.442 -175.496 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A 1590 ' ' LEU . . . . . 0.401 ' HG ' ' O ' ' A' 1580 ' ' ARG . 8.7 tt -106.74 128.96 54.66 Favored 'General case' 0 C--N 1.293 -1.849 0 N-CA-C 107.411 -1.329 . . . . 1.1499999999999999 107.411 -179.25 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A 1591 ' ' VAL . . . . . . . . . . . . . 61.4 t -119.26 126.89 75.76 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.808 0 N-CA-C 112.792 0.664 . . . . 1.51 112.792 -170.355 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A 1592 ' ' TYR . . . . . 0.631 ' HB2' ' HB3' ' A' 1608 ' ' SER . 9.7 m-30 -108.53 149.23 29.13 Favored 'General case' 0 C--N 1.31 -1.135 0 CA-C-N 114.986 -1.006 . . . . 1.0600000000000001 109.44 174.487 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A 1593 ' ' LYS . . . . . . . . . . . . . 18.4 ptpt -159.47 177.37 11.02 Favored 'General case' 0 C--N 1.296 -1.741 0 N-CA-C 107.371 -1.344 . . . . 2.1800000000000002 107.371 178.578 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A 1594 ' ' ASP . . . . . 0.421 ' O ' ' HB2' ' A' 1576 ' ' LYS . 3.8 m-20 65.62 76.76 0.32 Allowed 'General case' 0 N--CA 1.483 1.206 0 O-C-N 124.038 0.837 . . . . 1.45 112.399 179.046 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A 1595 ' ' GLY . . . . . . . . . . . . . . . -143.08 -73.4 0.03 OUTLIER Glycine 0 N--CA 1.432 -1.57 0 N-CA-C 110.879 -0.889 . . . . 0.78000000000000003 110.879 176.865 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A 1596 ' ' SER . . . . . 0.446 ' HB2' HG22 ' A' 1572 ' ' ILE . 31.1 t -114.86 139.6 24.4 Favored Pre-proline 0 C--N 1.288 -2.077 0 N-CA-C 109.534 -0.543 . . . . 1.6799999999999999 109.534 179.621 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A 1597 ' ' PRO . . . . . . . . . . . . . 23.2 Cg_exo -68.39 144.28 61.13 Favored 'Trans proline' 0 N--CA 1.445 -1.361 0 N-CA-C 106.435 -2.179 . . . . 1.1699999999999999 106.435 168.527 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A 1598 ' ' CYS . . . . . . . . . . . . . 19.1 t -95.17 125.26 51.03 Favored Pre-proline 0 C--N 1.286 -2.173 0 C-N-CA 120.065 -0.654 . . . . 1.1899999999999999 110.287 -175.795 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A 1599 ' ' PRO . . . . . . . . . . . . . 84.6 Cg_endo -88.38 -4.04 6.69 Favored 'Trans proline' 0 N--CA 1.456 -0.73 0 C-N-CA 122.807 2.338 . . . . 1.5900000000000001 111.698 177.079 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A 1600 ' ' SER . . . . . . . . . . . . . 16.3 m -86.35 109.11 18.77 Favored 'General case' 0 N--CA 1.425 -1.68 0 CA-C-N 115.865 -0.607 . . . . 2.1200000000000001 109.994 -178.874 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A 1601 ' ' LYS . . . . . 0.813 ' HD2' ' HA ' ' A' 1632 ' ' GLN . 67.0 mttm 67.67 -86.71 0.03 OUTLIER 'General case' 0 C--O 1.242 0.684 0 C-N-CA 124.067 0.947 . . . . 3.7400000000000002 113.358 178.571 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A 1602 ' ' SER . . . . . 0.837 ' HB3' HD22 ' A' 1604 ' ' LEU . 29.1 t -96.66 150.47 20.63 Favored 'General case' 0 N--CA 1.422 -1.867 0 N-CA-C 108.781 -0.822 . . . . 3.79 108.781 -175.5 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A 1603 ' ' GLY . . . . . . . . . . . . . . . -83.64 59.61 4.95 Favored Glycine 0 N--CA 1.435 -1.43 0 N-CA-C 110.331 -1.108 . . . . 2.0 110.331 176.425 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A 1604 ' ' LEU . . . . . 0.837 HD22 ' HB3' ' A' 1602 ' ' SER . 2.0 pt? -105.32 -175.35 2.77 Favored 'General case' 0 C--N 1.302 -1.494 0 CA-C-N 115.704 -0.248 . . . . 1.48 110.82 -176.982 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A 1605 ' ' SER . . . . . . . . . . . . . 5.0 p -83.81 -176.19 6.17 Favored 'General case' 0 C--N 1.294 -1.829 0 CA-C-O 121.249 0.547 . . . . 1.51 111.25 -178.568 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A 1606 ' ' TYR . . . . . . . . . . . . . 5.1 m-85 -116.76 128.5 55.37 Favored 'General case' 0 CA--C 1.469 -2.144 0 N-CA-C 106.882 -1.525 . . . . 1.1799999999999999 106.882 177.426 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A 1607 ' ' LYS . . . . . . . . . . . . . 20.6 ptmt -119.32 118.93 32.53 Favored 'General case' 0 N--CA 1.407 -2.618 0 CA-C-O 121.536 0.684 . . . . 1.6699999999999999 110.204 -178.535 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A 1608 ' ' SER . . . . . 0.631 ' HB3' ' HB2' ' A' 1592 ' ' TYR . 33.4 t -103.5 106.8 17.41 Favored 'General case' 0 C--N 1.288 -2.083 0 N-CA-C 108.056 -1.09 . . . . 1.0 108.056 -177.277 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A 1609 ' ' VAL . . . . . . . . . . . . . 66.2 t -107.49 115.44 48.74 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.5 0 CA-C-O 121.012 0.434 . . . . 0.93000000000000005 110.862 -176.597 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A 1610 ' ' ILE . . . . . 0.6 ' HA ' ' HB2' ' A' 1638 ' ' PHE . 3.3 mp -103.78 111.17 32.42 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.21 0 N-CA-C 108.074 -1.084 . . . . 0.78000000000000003 108.074 178.095 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A 1611 ' ' SER . . . . . 0.55 ' O ' ' HA ' ' A' 1639 ' ' SER . 18.8 m -104.43 129.83 52.37 Favored 'General case' 0 C--N 1.303 -1.451 0 CA-C-O 121.368 0.604 . . . . 1.29 110.706 -179.858 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A 1612 ' ' PHE . . . . . 0.426 ' HB2' ' HB2' ' A' 1588 ' ' LEU . 92.2 m-85 -101.55 113.18 26.07 Favored 'General case' 0 C--N 1.292 -1.899 0 N-CA-C 108.342 -0.984 . . . . 0.69999999999999996 108.342 -179.524 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A 1613 ' ' VAL . . . . . . . . . . . . . 92.2 t -106.43 132.18 54.28 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.176 0 N-CA-C 109.538 -0.541 . . . . 0.75 109.538 -176.594 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A 1614 ' ' CYS . . . . . . . . . . . . . 62.6 m -67.48 99.51 0.76 Allowed 'General case' 0 C--N 1.322 -0.611 0 CA-C-O 121.573 0.701 . . . . 1.3899999999999999 112.526 -177.559 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A 1615 ' ' ARG . . . . . 0.472 ' HB3' ' HB3' ' A' 1641 ' ' HIS . 20.3 tpp180 -137.28 85.45 21.75 Favored Pre-proline 0 N--CA 1.429 -1.479 0 CA-C-N 114.851 -1.068 . . . . 3.75 108.164 176.352 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A 1616 ' ' PRO . . . . . . . . . . . . . 16.4 Cg_exo -71.68 -13.22 29.66 Favored 'Trans proline' 0 C--N 1.357 0.984 0 C-N-CA 123.327 2.684 . . . . 1.3200000000000001 110.227 178.153 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A 1617 ' ' GLU . . . . . 0.433 ' HB3' ' CD ' ' A' 1615 ' ' ARG . 43.7 tt0 -82.54 41.16 0.7 Allowed 'General case' 0 C--N 1.304 -1.388 0 C-N-CA 126.067 1.747 . . . . 3.21 107.963 176.459 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A 1618 ' ' ALA . . . . . . . . . . . . . . . -160.51 179.05 8.93 Favored 'General case' 0 C--N 1.305 -1.364 0 N-CA-C 105.127 -2.175 . . . . 2.4399999999999999 105.127 -179.017 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A 1619 ' ' GLY . . . . . . . . . . . . . . . -147.42 -160.54 8.94 Favored Glycine 0 N--CA 1.433 -1.549 0 C-N-CA 119.054 -1.546 . . . . 3.2599999999999998 112.802 -178.045 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A 1620 ' ' PRO . . . . . . . . . . . . . 56.2 Cg_endo -70.61 -4.98 15.69 Favored 'Trans proline' 0 C--O 1.24 0.606 0 C-N-CA 123.283 2.656 . . . . 5.9199999999999999 112.803 -177.722 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A 1621 ' ' THR . . . . . . . . . . . . . 15.6 m -79.75 -21.63 44.23 Favored 'General case' 0 N--CA 1.439 -1.023 0 CA-C-O 121.174 0.511 . . . . 4.7599999999999998 109.901 179.169 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A 1622 ' ' ASN . . . . . . . . . . . . . 29.1 t-20 -82.61 159.27 22.75 Favored 'General case' 0 N--CA 1.45 -0.455 0 N-CA-C 107.058 -1.46 . . . . 2.9199999999999999 107.058 178.849 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A 1623 ' ' ARG . . . . . . . . . . . . . 4.9 ptp180 -153.12 164.49 20.2 Favored Pre-proline 0 C--N 1.301 -1.538 0 N-CA-C 108.887 -0.783 . . . . 3.6099999999999999 108.887 -176.34 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A 1624 ' ' PRO . . . . . . . . . . . . . 22.7 Cg_exo -65.34 100.05 0.38 Allowed 'Trans proline' 0 C--N 1.361 1.234 0 C-N-CA 122.588 2.192 . . . . 2.3700000000000001 110.813 177.059 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A 1625 ' ' MET . . . . . . . . . . . . . 23.4 ptp -108.72 148.65 30.14 Favored 'General case' 0 C--N 1.302 -1.457 0 CA-C-N 115.443 -0.798 . . . . 2.1600000000000001 109.694 -177.17 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A 1626 ' ' LEU . . . . . 0.497 ' HG ' ' CE1' ' A' 1638 ' ' PHE . 38.1 mt -71.01 109.74 5.29 Favored 'General case' 0 C--N 1.309 -1.184 0 CA-C-N 115.978 -0.556 . . . . 1.3500000000000001 110.369 174.667 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A 1627 ' ' ILE . . . . . . . . . . . . . 40.8 pt -92.4 -23.74 5.55 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.306 0 CA-C-N 115.115 -0.948 . . . . 1.21 109.185 177.321 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A 1628 ' ' SER . . . . . . . . . . . . . 51.1 m -154.53 149.84 27.13 Favored 'General case' 0 N--CA 1.428 -1.574 0 CA-C-N 115.452 -0.795 . . . . 1.3999999999999999 109.403 -179.088 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A 1629 ' ' LEU . . . . . 0.746 HD13 ' HG ' ' A' 1636 ' ' LEU . 20.2 tp -143.28 112.25 6.59 Favored 'General case' 0 C--N 1.297 -1.701 0 N-CA-C 108.697 -0.853 . . . . 1.5600000000000001 108.697 177.984 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A 1630 ' ' ASP . . . . . . . . . . . . . 13.4 t70 -100.26 108.15 20.15 Favored 'General case' 0 C--N 1.296 -1.728 0 N-CA-C 108.605 -0.887 . . . . 0.87 108.605 -178.26 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A 1631 ' ' LYS . . . . . . . . . . . . . 92.1 mttt -92.51 5.44 50.82 Favored 'General case' 0 C--N 1.293 -1.871 0 CA-C-O 120.947 0.403 . . . . 2.3500000000000001 111.43 -177.293 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A 1632 ' ' GLN . . . . . 0.813 ' HA ' ' HD2' ' A' 1601 ' ' LYS . 33.5 mt-30 -85.55 -41.2 15.5 Favored 'General case' 0 N--CA 1.437 -1.098 0 N-CA-C 108.491 -0.929 . . . . 2.5499999999999998 108.491 178.53 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A 1633 ' ' THR . . . . . . . . . . . . . 32.6 m -106.9 -2.44 21.3 Favored 'General case' 0 CA--C 1.564 1.516 0 CA-C-O 122.111 0.957 . . . . 1.24 110.256 176.917 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A 1634 ' ' CYS . . . . . . . . . . . . . 51.2 m 63.78 47.59 3.54 Favored 'General case' 0 N--CA 1.471 0.592 0 CA-C-O 122.675 1.226 . . . . 0.89000000000000001 110.007 176.852 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A 1635 ' ' THR . . . . . . . . . . . . . 24.2 m -112.43 121.63 45.38 Favored 'General case' 0 N--CA 1.423 -1.824 0 CA-C-N 113.836 -1.529 . . . . 0.75 109.887 -175.774 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A 1636 ' ' LEU . . . . . 0.746 ' HG ' HD13 ' A' 1629 ' ' LEU . 5.5 mp -99.4 126.18 45.24 Favored 'General case' 0 C--N 1.305 -1.35 0 N-CA-C 108.812 -0.81 . . . . 1.3300000000000001 108.812 179.061 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A 1637 ' ' PHE . . . . . . . . . . . . . 94.1 m-85 -108.08 94.82 5.28 Favored 'General case' 0 C--O 1.249 1.078 0 CA-C-O 121.012 0.434 . . . . 0.82999999999999996 111.193 -177.774 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A 1638 ' ' PHE . . . . . 0.6 ' HB2' ' HA ' ' A' 1610 ' ' ILE . 99.7 m-85 -90.94 144.62 25.48 Favored 'General case' 0 CA--C 1.487 -1.458 0 N-CA-C 107.917 -1.142 . . . . 0.59999999999999998 107.917 175.751 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A 1639 ' ' SER . . . . . 0.55 ' HA ' ' O ' ' A' 1611 ' ' SER . 66.8 m -141.7 133.08 26.62 Favored 'General case' 0 C--N 1.273 -2.737 0 CA-C-O 120.852 0.358 . . . . 1.0800000000000001 111.187 177.267 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A 1640 ' ' TRP . . . . . 0.435 ' HZ3' HD13 ' A' 1532 ' ' LEU . 8.3 t90 -118.93 112.56 19.79 Favored 'General case' 0 N--CA 1.426 -1.674 0 N-CA-C 107.799 -1.186 . . . . 0.80000000000000004 107.799 175.688 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A 1641 ' ' HIS . . . . . 0.472 ' HB3' ' HB3' ' A' 1615 ' ' ARG . 13.4 m170 -82.43 98.42 8.88 Favored 'General case' 0 C--N 1.297 -1.704 0 N-CA-C 107.315 -1.365 . . . . 2.54 107.315 175.311 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A 1642 ' ' THR . . . . . . . . . . . . . 9.2 t -143.1 147.81 42.49 Favored Pre-proline 0 C--N 1.305 -1.335 0 CA-C-N 115.406 -0.815 . . . . 1.1499999999999999 111.394 -170.414 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A 1643 ' ' PRO . . . . . . . . . . . . . 34.6 Cg_endo -70.11 -12.04 31.49 Favored 'Trans proline' 0 C--N 1.353 0.778 0 C-N-CA 123.067 2.511 . . . . 0.80000000000000004 111.106 171.837 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A 1644 ' ' LEU . . . . . . . . . . . . . 94.1 mt -75.55 -6.32 49.66 Favored 'General case' 0 N--CA 1.465 0.291 0 CA-C-N 116.241 -0.436 . . . . 1.54 111.699 178.74 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A 1645 ' ' ALA . . . . . . . . . . . . . . . -81.11 -42.52 20.83 Favored 'General case' 0 C--N 1.318 -0.778 0 N-CA-C 108.745 -0.835 . . . . 0.94999999999999996 108.745 175.791 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A 1646 ' ' CYS . . . . . 0.675 ' HA ' ' HE1' ' A' 1527 ' ' PHE . 19.3 p -169.44 116.45 0.59 Allowed 'General case' 0 N--CA 1.432 -1.348 0 N-CA-C 107.717 -1.216 . . . . 1.4099999999999999 107.717 173.645 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A 1647 ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -74.31 148.15 85.89 Favored Pre-proline 0 C--N 1.309 -1.194 0 CA-C-N 116.088 -0.506 . . . . 2.9199999999999999 109.779 179.17 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A 1648 ' ' PRO . . . . . . . . . . . . . 12.6 Cg_endo -52.97 109.46 0.36 Allowed 'Trans proline' 0 C--N 1.353 0.801 0 C-N-CA 124.559 3.506 . . . . 2.8199999999999998 114.446 -175.051 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A 1649 ' ' GLU . . . . . . . . . . . . . 42.5 tt0 . . . . . 0 N--CA 1.422 -1.833 0 N-CA-C 106.98 -1.489 . . . . 5.0599999999999996 106.98 175.78 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A 1508 ' ' MET . . . . . 0.767 ' N ' HD22 ' A' 1511 ' ' ASN . 27.1 ttt . . . . . 0 C--O 1.235 0.324 0 N-CA-C 109.958 -0.386 . . . . 8.2699999999999996 109.958 . . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A 1509 ' ' LYS . . . . . . . . . . . . . 64.9 tttp -113.74 131.09 56.32 Favored 'General case' 0 N--CA 1.441 -0.918 0 N-CA-C 109.293 -0.632 . . . . 6.4800000000000004 109.293 179.819 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A 1510 ' ' SER . . . . . . . . . . . . . 32.1 m 62.76 59.46 1.42 Allowed 'General case' 0 C--O 1.253 1.252 0 O-C-N 124.377 1.048 . . . . 4.2199999999999998 110.45 179.904 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A 1511 ' ' ASN . . . . . 0.767 HD22 ' N ' ' A' 1508 ' ' MET . 11.4 m120 -79.03 0.25 28.5 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 115.082 -0.963 . . . . 3.0800000000000001 110.659 -178.48 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A 1512 ' ' GLU . . . . . 0.923 ' HA ' ' HB3' ' A' 1581 ' ' LEU . 1.8 mp0 -47.15 -29.68 2.42 Favored 'General case' 0 N--CA 1.472 0.658 0 C-N-CA 124.604 1.162 . . . . 4.46 112.359 178.104 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A 1513 ' ' HIS . . . . . . . . . . . . . 5.7 p80 -133.65 42.55 2.96 Favored 'General case' 0 C--N 1.309 -1.17 0 CA-C-O 121.824 0.821 . . . . 5.5700000000000003 109.666 179.692 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A 1514 ' ' ASP . . . . . . . . . . . . . 14.4 t70 -131.28 -62.3 0.89 Allowed 'General case' 0 C--N 1.317 -0.829 0 CA-C-N 115.287 -0.869 . . . . 3.7000000000000002 110.319 -179.61 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A 1515 ' ' ASP . . . . . . . . . . . . . 16.5 t70 -154.92 168.06 28.23 Favored 'General case' 0 C--N 1.317 -0.835 0 N-CA-C 107.057 -1.46 . . . . 2.54 107.057 -174.583 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A 1516 ' ' CYS . . . . . 0.669 ' HB3' ' HB2' ' A' 1529 ' ' LEU . 34.3 m -87.5 59.7 5.63 Favored 'General case' 0 C--N 1.305 -1.356 0 N-CA-C 109.556 -0.535 . . . . 1.25 109.556 -177.283 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A 1517 ' ' GLN . . . . . 0.502 ' HA ' ' O ' ' A' 1527 ' ' PHE . 11.3 pt20 -148.41 138.54 22.49 Favored 'General case' 0 C--N 1.306 -1.292 0 N-CA-C 109.211 -0.662 . . . . 1.8799999999999999 109.211 -179.785 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A 1518 ' ' VAL . . . . . . . . . . . . . 10.1 p -144.57 133.31 18.17 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.889 0 CA-C-O 120.921 0.391 . . . . 1.73 110.258 179.326 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A 1519 ' ' THR . . . . . 0.501 ' O ' ' HD3' ' A' 1521 ' ' PRO . 21.4 m -93.8 128.98 40.34 Favored 'General case' 0 C--N 1.292 -1.926 0 N-CA-C 108.926 -0.768 . . . . 1.7 108.926 179.158 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A 1520 ' ' ASN . . . . . . . . . . . . . 22.8 t30 -101.71 94.84 4.68 Favored Pre-proline 0 C--N 1.314 -0.974 0 N-CA-C 108.722 -0.844 . . . . 2.1200000000000001 108.722 172.501 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A 1521 ' ' PRO . . . . . 0.501 ' HD3' ' O ' ' A' 1519 ' ' THR . 52.8 Cg_exo -55.27 -20.87 26.6 Favored 'Trans proline' 0 C--N 1.365 1.399 0 C-N-CA 123.68 2.92 . . . . 2.4700000000000002 114.242 -177.257 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A 1522 ' ' SER . . . . . . . . . . . . . 19.9 t -64.47 -30.01 71.05 Favored 'General case' 0 CA--C 1.549 0.927 0 CA-C-O 120.834 0.349 . . . . 2.5699999999999998 111.099 178.573 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A 1523 ' ' THR . . . . . . . . . . . . . 8.8 t -122.82 -14.84 7.59 Favored 'General case' 0 CA--C 1.545 0.753 0 C-N-CA 120.484 -0.487 . . . . 2.1499999999999999 110.611 178.257 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A 1524 ' ' GLY . . . . . . . . . . . . . . . 89.22 -13.96 62.12 Favored Glycine 0 C--O 1.22 -0.744 0 CA-C-N 116.394 -0.366 . . . . 1.8899999999999999 113.805 177.202 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A 1525 ' ' HIS . . . . . . . . . . . . . 13.7 t-160 -79.31 127.62 32.3 Favored 'General case' 0 C--N 1.311 -1.068 0 CA-C-O 121.289 0.566 . . . . 1.8999999999999999 111.862 -175.616 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A 1526 ' ' LEU . . . . . 0.47 HD11 ' HB2' ' A' 1517 ' ' GLN . 41.9 tp -84.67 127.61 34.18 Favored 'General case' 0 C--N 1.315 -0.927 0 CA-C-N 114.685 -1.143 . . . . 1.6100000000000001 107.969 173.084 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A 1527 ' ' PHE . . . . . 0.502 ' O ' ' HA ' ' A' 1517 ' ' GLN . 70.9 m-85 -99.01 119.02 37.09 Favored 'General case' 0 C--N 1.288 -2.073 0 N-CA-C 108.831 -0.803 . . . . 1.4199999999999999 108.831 178.398 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A 1528 ' ' ASP . . . . . . . . . . . . . 10.9 t70 -105.24 124.18 49.11 Favored 'General case' 0 CA--C 1.487 -1.469 0 CA-C-O 121.189 0.518 . . . . 2.1800000000000002 110.316 179.314 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A 1529 ' ' LEU . . . . . 0.669 ' HB2' ' HB3' ' A' 1516 ' ' CYS . 69.8 mt -108.59 -19.8 13.31 Favored 'General case' 0 C--N 1.294 -1.831 0 CA-C-N 114.922 -1.036 . . . . 1.4399999999999999 108.914 177.213 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A 1530 ' ' SER . . . . . 0.404 ' OG ' ' HB2' ' A' 1516 ' ' CYS . 24.9 m -57.85 -37.87 74.65 Favored 'General case' 0 C--O 1.24 0.566 0 C-N-CA 123.626 0.77 . . . . 1.4399999999999999 112.763 -176.634 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A 1531 ' ' SER . . . . . . . . . . . . . 50.5 p -87.43 1.07 54.49 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-O 120.906 0.384 . . . . 1.5 111.625 178.948 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A 1532 ' ' LEU . . . . . . . . . . . . . 96.1 mt -88.13 14.76 8.54 Favored 'General case' 0 CA--C 1.544 0.726 0 N-CA-C 113.12 0.785 . . . . 1.77 113.12 179.394 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A 1533 ' ' SER . . . . . 0.408 ' OG ' ' HB ' ' A' 1552 ' ' ILE . 46.1 m -113.38 108.78 17.69 Favored 'General case' 0 C--N 1.314 -0.964 0 O-C-N 121.591 -0.693 . . . . 2.3799999999999999 110.898 178.84 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A 1534 ' ' GLY . . . . . . . . . . . . . . . -86.08 -127.29 2.01 Favored Glycine 0 C--O 1.22 -0.743 0 C-N-CA 120.69 -0.767 . . . . 1.55 111.499 176.714 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A 1535 ' ' ARG . . . . . . . . . . . . . 19.4 tpt180 -83.18 -52.8 6.29 Favored 'General case' 0 C--N 1.311 -1.081 0 CA-C-N 117.108 0.454 . . . . 3.96 109.958 178.36 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A 1536 ' ' ALA . . . . . 0.426 ' HB1' ' HD1' ' A' 1549 ' ' TYR . . . -96.12 -21.48 17.9 Favored 'General case' 0 C--N 1.312 -1.064 0 CA-C-O 121.216 0.531 . . . . 1.6499999999999999 109.623 178.944 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A 1537 ' ' GLY . . . . . . . . . . . . . . . 90.66 -92.16 1.74 Allowed Glycine 0 N--CA 1.425 -2.058 0 N-CA-C 108.057 -2.017 . . . . 1.1899999999999999 108.057 -175.925 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A 1538 ' ' PHE . . . . . . . . . . . . . 47.2 m-85 -136.85 158.32 44.73 Favored 'General case' 0 C--N 1.295 -1.799 0 N-CA-C 109.151 -0.685 . . . . 1.6899999999999999 109.151 174.17 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A 1539 ' ' THR . . . . . . . . . . . . . 5.8 p -127.99 142.97 51.09 Favored 'General case' 0 C--N 1.296 -1.737 0 CA-C-N 116.506 -0.315 . . . . 1.48 111.295 -176.878 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A 1540 ' ' ALA . . . . . . . . . . . . . . . -131.21 140.12 49.82 Favored 'General case' 0 C--N 1.302 -1.479 0 N-CA-C 109.416 -0.587 . . . . 0.82999999999999996 109.416 176.796 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A 1541 ' ' ALA . . . . . . . . . . . . . . . -86.21 133.43 33.85 Favored 'General case' 0 C--N 1.312 -1.034 0 N-CA-C 108.107 -1.071 . . . . 1.27 108.107 178.642 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A 1542 ' ' TYR . . . . . 0.602 ' HD2' ' HB2' ' A' 1545 ' ' SER . 76.6 t80 -136.12 166.56 23.11 Favored 'General case' 0 C--N 1.301 -1.531 0 N-CA-C 109.448 -0.575 . . . . 2.1499999999999999 109.448 -175.747 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A 1543 ' ' SER . . . . . . . . . . . . . 16.0 t -48.67 -150.32 0.0 OUTLIER 'General case' 0 CA--C 1.577 1.997 0 C-N-CA 127.916 2.486 . . . . 2.29 112.886 176.229 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A 1544 ' ' LYS . . . . . . . . . . . . . 95.7 mttt -38.92 -30.75 0.05 Allowed 'General case' 0 CA--C 1.567 1.62 0 C-N-CA 124.986 1.314 . . . . 3.9100000000000001 114.442 -178.619 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A 1545 ' ' SER . . . . . 0.602 ' HB2' ' HD2' ' A' 1542 ' ' TYR . 15.3 m -72.59 -10.69 60.1 Favored 'General case' 0 CA--C 1.579 2.076 0 N-CA-C 112.617 0.599 . . . . 3.2999999999999998 112.617 177.254 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A 1546 ' ' GLY . . . . . . . . . . . . . . . 85.2 -80.15 1.84 Allowed Glycine 0 C--O 1.244 0.725 0 N-CA-C 115.049 0.78 . . . . 1.24 115.049 171.965 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A 1547 ' ' VAL . . . . . . . . . . . . . 7.8 p -146.39 143.09 21.06 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.475 0 CA-C-O 120.997 0.427 . . . . 1.6299999999999999 109.914 -174.126 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A 1548 ' ' VAL . . . . . . . . . . . . . 2.1 t -109.86 135.1 49.9 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.414 0 N-CA-C 107.979 -1.119 . . . . 0.92000000000000004 107.979 -179.058 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A 1549 ' ' TYR . . . . . 0.426 ' HD1' ' HB1' ' A' 1536 ' ' ALA . 80.1 m-85 -100.63 131.19 46.67 Favored 'General case' 0 C--N 1.313 -1.006 0 N-CA-C 106.522 -1.659 . . . . 1.4399999999999999 106.522 173.266 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A 1550 ' ' MET . . . . . . . . . . . . . 68.1 mtp -126.08 122.44 35.8 Favored 'General case' 0 C--N 1.298 -1.647 0 CA-C-N 116.569 -0.287 . . . . 1.74 110.242 -171.436 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A 1551 ' ' SER . . . . . 0.618 ' CB ' ' HB3' ' A' 1556 ' ' ASN . 19.6 p -105.83 133.37 50.67 Favored 'General case' 0 N--CA 1.419 -1.997 0 CA-C-O 122.082 0.944 . . . . 1.6399999999999999 111.1 -179.514 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A 1552 ' ' ILE . . . . . 0.451 HG22 ' SG ' ' A' 1553 ' ' CYS . 1.7 mp -76.38 -42.88 36.46 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.023 0 CA-C-N 114.355 -1.293 . . . . 1.3300000000000001 111.499 -176.943 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A 1553 ' ' CYS . . . . . 0.451 ' SG ' HG22 ' A' 1552 ' ' ILE . 46.5 m -130.92 135.99 48.18 Favored 'General case' 0 C--N 1.307 -1.243 0 N-CA-C 108.636 -0.876 . . . . 1.4299999999999999 108.636 174.626 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A 1554 ' ' GLY . . . . . 0.427 ' HA2' ' HB1' ' A' 1577 ' ' ALA . . . 54.57 -155.74 7.88 Favored Glycine 0 C--O 1.247 0.928 0 O-C-N 124.46 1.1 . . . . 1.1200000000000001 111.981 179.371 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A 1555 ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -89.9 146.66 24.25 Favored 'General case' 0 N--CA 1.413 -2.295 0 C-N-CA 119.056 -1.058 . . . . 1.8 108.945 170.924 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A 1556 ' ' ASN . . . . . 0.618 ' HB3' ' CB ' ' A' 1551 ' ' SER . 4.3 t30 -170.37 61.41 0.04 OUTLIER 'General case' 0 C--N 1.282 -2.347 0 N-CA-C 107.388 -1.338 . . . . 2.6299999999999999 107.388 -171.65 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A 1557 ' ' GLU . . . . . 0.558 ' CD ' ' H ' ' A' 1558 ' ' ASN 0.388 0.3 OUTLIER -157.58 -119.92 0.02 OUTLIER 'General case' 0 CA--C 1.553 1.09 0 N-CA-C 116.101 1.889 . . . . 3.79 116.101 -177.402 . . . . . . . . 4 4 . 1 . 013 nuclear build full ' A' A 1558 ' ' ASN . . . . . 0.558 ' H ' ' CD ' ' A' 1557 ' ' GLU . 40.4 m-80 -139.6 -5.68 1.36 Allowed 'General case' 0 CA--C 1.55 0.96 0 N-CA-C 113.029 0.752 . . . . 1.52 113.029 -175.849 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A 1559 ' ' CYS . . . . . 0.481 ' HB3' ' HD2' ' A' 1560 ' ' PRO . 43.7 m -91.36 170.22 10.03 Favored Pre-proline 0 C--N 1.317 -0.809 0 CA-C-O 119.161 -0.447 . . . . 0.83999999999999997 109.937 179.015 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A 1560 ' ' PRO . . . . . 0.481 ' HD2' ' HB3' ' A' 1559 ' ' CYS . 91.6 Cg_exo -45.83 129.01 11.66 Favored 'Trans proline' 0 C--N 1.364 1.374 0 C-N-CA 122.853 2.369 . . . . 1.1799999999999999 111.348 174.633 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A 1561 ' ' PRO . . . . . 0.452 ' HD3' ' HA ' ' A' 1560 ' ' PRO . 53.3 Cg_exo -56.21 115.65 2.62 Favored 'Trans proline' 0 C--O 1.241 0.642 0 C-N-CA 123.268 2.646 . . . . 1.51 112.505 -178.133 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A 1562 ' ' GLY . . . . . . . . . . . . . . . 155.05 -21.43 0.58 Allowed Glycine 0 N--CA 1.443 -0.881 0 N-CA-C 111.619 -0.593 . . . . 0.71999999999999997 111.619 -179.08 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A 1563 ' ' VAL . . . . . 0.437 ' HA ' ' HA ' ' A' 1576 ' ' LYS . 25.6 m -80.68 161.21 3.92 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.121 0 CA-C-O 121.486 0.66 . . . . 0.96999999999999997 111.885 178.004 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A 1564 ' ' GLY . . . . . 0.601 ' HA3' ' CD2' ' A' 1592 ' ' TYR . . . -119.98 0.14 13.28 Favored Glycine 0 N--CA 1.424 -2.142 0 N-CA-C 108.845 -1.702 . . . . 0.71999999999999997 108.845 166.718 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A 1565 ' ' ALA . . . . . . . . . . . . . . . -170.22 125.54 0.77 Allowed 'General case' 0 C--O 1.246 0.911 0 N-CA-C 108.511 -0.922 . . . . 0.37 108.511 178.312 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A 1566 ' ' CYS . . . . . . . . . . . . . 48.8 t -149.98 145.01 26.2 Favored 'General case' 0 C--N 1.309 -1.159 0 C-N-CA 121.141 -0.224 . . . . 0.51000000000000001 110.45 -175.513 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A 1567 ' ' PHE . . . . . . . . . . . . . 26.8 m-85 -69.87 124.17 23.35 Favored 'General case' 0 C--O 1.217 -0.656 0 N-CA-C 107.548 -1.279 . . . . 0.96999999999999997 107.548 174.179 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A 1568 ' ' GLY . . . . . 0.425 ' HA3' ' CE2' ' A' 1549 ' ' TYR . . . -70.06 -31.53 69.45 Favored Glycine 0 CA--C 1.498 -1.001 0 C-N-CA 121.02 -0.609 . . . . 1.0800000000000001 114.032 -173.667 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A 1569 ' ' GLN . . . . . . . . . . . . . 34.5 tt0 -84.57 -53.24 5.53 Favored 'General case' 0 C--N 1.304 -1.394 0 CA-C-O 121.444 0.64 . . . . 2.7400000000000002 109.853 -179.219 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A 1570 ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -77.19 -23.73 51.45 Favored 'General case' 0 C--N 1.307 -1.25 0 CA-C-N 115.133 -0.939 . . . . 1.96 113.019 -173.177 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A 1571 ' ' ARG . . . . . 0.403 ' HA ' ' SG ' ' A' 1559 ' ' CYS . 91.5 mtt180 60.97 36.57 18.64 Favored 'General case' 0 CA--C 1.511 -0.548 0 C-N-CA 125.02 1.328 . . . . 3.9500000000000002 113.39 179.101 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A 1572 ' ' ILE . . . . . . . . . . . . . 44.0 mm -106.0 122.62 59.86 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.131 0 N-CA-C 108.462 -0.94 . . . . 1.3700000000000001 108.462 179.473 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A 1573 ' ' SER . . . . . . . . . . . . . 41.5 t -66.86 128.54 36.71 Favored 'General case' 0 C--N 1.308 -1.239 0 C-N-CA 124.231 1.012 . . . . 1.0800000000000001 111.201 179.562 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A 1574 ' ' VAL . . . . . 0.542 ' HA ' ' HB2' ' A' 1606 ' ' TYR . 35.4 m -118.8 18.01 6.8 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.236 0 CA-C-O 122.023 0.916 . . . . 1.3 110.335 178.004 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A 1575 ' ' GLY . . . . . . . . . . . . . . . 167.25 123.64 0.67 Allowed Glycine 0 N--CA 1.43 -1.725 0 CA-C-N 114.299 -1.319 . . . . 0.51000000000000001 109.941 178.339 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A 1576 ' ' LYS . . . . . 0.437 ' HA ' ' HA ' ' A' 1563 ' ' VAL . 62.0 mttp -84.32 153.72 23.34 Favored 'General case' 0 CA--C 1.498 -1.021 0 CA-C-O 121.201 0.524 . . . . 2.8999999999999999 110.427 179.478 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A 1577 ' ' ALA . . . . . 0.478 ' HA ' ' CE2' ' A' 1592 ' ' TYR . . . -59.65 104.23 0.26 Allowed 'General case' 0 C--N 1.307 -1.244 0 CA-C-N 114.025 -1.443 . . . . 0.82999999999999996 111.287 178.028 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A 1578 ' ' ASN . . . . . . . . . . . . . 45.7 m-80 -135.32 123.05 22.33 Favored 'General case' 0 C--N 1.301 -1.502 0 N-CA-C 105.974 -1.862 . . . . 1.8500000000000001 105.974 177.027 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A 1579 ' ' LYS . . . . . . . . . . . . . 36.6 ttpt -94.34 89.8 6.03 Favored 'General case' 0 C--N 1.285 -2.227 0 N-CA-C 108.388 -0.967 . . . . 1.8999999999999999 108.388 -174.583 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A 1580 ' ' ARG . . . . . . . . . . . . . 72.8 ttt180 -127.64 109.86 12.1 Favored 'General case' 0 N--CA 1.419 -1.991 0 CA-C-N 114.631 -1.168 . . . . 3.6299999999999999 109.128 -179.095 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A 1581 ' ' LEU . . . . . 0.923 ' HB3' ' HA ' ' A' 1512 ' ' GLU . 2.3 tm? -96.25 141.94 29.0 Favored 'General case' 0 C--N 1.3 -1.563 0 CA-C-N 114.649 -1.16 . . . . 1.8700000000000001 108.143 -177.868 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A 1582 ' ' ARG . . . . . 0.458 ' N ' HD13 ' A' 1581 ' ' LEU . 4.7 tpt180 -145.84 141.79 28.22 Favored 'General case' 0 C--N 1.304 -1.376 0 N-CA-C 108.638 -0.875 . . . . 3.9700000000000002 108.638 173.274 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A 1583 ' ' TYR . . . . . . . . . . . . . 46.9 t80 -137.05 103.58 5.18 Favored 'General case' 0 C--N 1.321 -0.645 0 N-CA-C 109.206 -0.665 . . . . 1.4099999999999999 109.206 179.051 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A 1584 ' ' VAL . . . . . . . . . . . . . 26.9 m -134.69 140.26 45.97 Favored 'Isoleucine or valine' 0 C--O 1.201 -1.453 0 N-CA-C 109.64 -0.504 . . . . 1.6899999999999999 109.64 -178.484 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A 1585 ' ' ASP . . . . . . . . . . . . . 8.9 t70 43.98 52.46 6.73 Favored 'General case' 0 N--CA 1.492 1.646 0 C-N-CA 125.06 1.344 . . . . 2.0600000000000001 113.088 175.184 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A 1586 ' ' GLN . . . . . . . . . . . . . 19.0 mm-40 61.93 22.39 13.02 Favored 'General case' 0 CA--C 1.553 1.091 0 C-N-CA 123.89 0.876 . . . . 2.3300000000000001 112.853 178.815 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A 1587 ' ' VAL . . . . . 0.5 HG23 ' O ' ' A' 1612 ' ' PHE . 9.4 p -134.06 125.02 47.71 Favored 'Isoleucine or valine' 0 C--O 1.245 0.833 0 O-C-N 121.455 -0.778 . . . . 0.78000000000000003 111.785 177.451 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A 1588 ' ' LEU . . . . . 0.696 ' HB2' ' HB2' ' A' 1612 ' ' PHE . 79.3 mt -85.99 155.31 20.92 Favored 'General case' 0 C--N 1.313 -1.0 0 CA-C-N 114.942 -1.026 . . . . 1.4099999999999999 110.731 177.314 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A 1589 ' ' GLN . . . . . 0.514 ' HA ' ' O ' ' A' 1610 ' ' ILE . 6.9 tt0 -150.4 133.36 16.06 Favored 'General case' 0 C--N 1.318 -0.795 0 N-CA-C 112.33 0.493 . . . . 1.24 112.33 -179.447 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A 1590 ' ' LEU . . . . . 0.621 ' HG ' ' HE1' ' A' 1612 ' ' PHE . 96.0 mt -104.0 125.52 50.43 Favored 'General case' 0 C--O 1.248 1.006 0 N-CA-C 106.982 -1.488 . . . . 1.1499999999999999 106.982 172.068 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A 1591 ' ' VAL . . . . . . . . . . . . . 40.4 t -105.72 102.56 14.05 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.498 0 C-N-CA 120.757 -0.377 . . . . 1.51 110.119 179.827 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A 1592 ' ' TYR . . . . . 0.601 ' CD2' ' HA3' ' A' 1564 ' ' GLY . 27.7 m-85 -117.55 92.96 3.98 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-O 121.379 0.609 . . . . 1.0600000000000001 109.422 177.788 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A 1593 ' ' LYS . . . . . . . . . . . . . 21.3 pttp -110.85 -177.55 3.25 Favored 'General case' 0 C--N 1.305 -1.358 0 N-CA-C 112.569 0.581 . . . . 2.1800000000000002 112.569 -175.901 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A 1594 ' ' ASP . . . . . 0.408 ' HA ' ' HB2' ' A' 1605 ' ' SER . 18.2 m-20 52.77 59.43 4.48 Favored 'General case' 0 N--CA 1.466 0.355 0 C-N-CA 124.931 1.292 . . . . 1.45 113.598 175.212 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A 1595 ' ' GLY . . . . . 0.424 ' HA2' ' HG3' ' A' 1576 ' ' LYS . . . -83.34 -107.35 0.51 Allowed Glycine 0 N--CA 1.438 -1.167 0 C-N-CA 120.517 -0.849 . . . . 0.78000000000000003 111.719 177.631 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A 1596 ' ' SER . . . . . . . . . . . . . 23.0 t -106.23 145.47 31.04 Favored Pre-proline 0 C--N 1.291 -1.94 0 N-CA-C 107.545 -1.279 . . . . 1.6799999999999999 107.545 -179.839 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A 1597 ' ' PRO . . . . . . . . . . . . . 77.3 Cg_exo -53.29 134.21 55.95 Favored 'Trans proline' 0 C--N 1.362 1.286 0 C-N-CA 123.558 2.839 . . . . 1.1699999999999999 111.523 178.654 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A 1598 ' ' CYS . . . . . . . . . . . . . 50.6 t -95.05 125.66 49.75 Favored Pre-proline 0 C--N 1.289 -2.042 0 CA-C-N 115.41 -0.814 . . . . 1.1899999999999999 109.883 -173.569 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A 1599 ' ' PRO . . . . . . . . . . . . . 58.4 Cg_endo -71.86 -13.91 29.45 Favored 'Trans proline' 0 C--N 1.346 0.395 0 C-N-CA 122.971 2.447 . . . . 1.5900000000000001 112.497 -179.375 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A 1600 ' ' SER . . . . . . . . . . . . . 19.3 m -74.3 -20.46 60.11 Favored 'General case' 0 N--CA 1.439 -1.002 0 CA-C-N 116.019 -0.537 . . . . 2.1200000000000001 111.06 179.984 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A 1601 ' ' LYS . . . . . 0.414 ' HA ' ' HD2' ' A' 1601 ' ' LYS . 20.9 tptm -156.68 104.13 2.14 Favored 'General case' 0 N--CA 1.433 -1.314 0 N-CA-C 109.052 -0.721 . . . . 3.7400000000000002 109.052 177.109 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A 1602 ' ' SER . . . . . . . . . . . . . 7.4 p -61.27 107.41 0.75 Allowed 'General case' 0 C--N 1.303 -1.432 0 CA-C-N 115.294 -0.866 . . . . 3.79 112.086 -178.654 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A 1603 ' ' GLY . . . . . . . . . . . . . . . 136.13 -5.38 3.93 Favored Glycine 0 N--CA 1.434 -1.498 0 C-N-CA 120.576 -0.821 . . . . 2.0 113.367 177.91 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A 1604 ' ' LEU . . . . . . . . . . . . . 3.0 pp -140.27 161.81 36.77 Favored 'General case' 0 C--N 1.311 -1.092 0 CA-C-N 117.586 0.693 . . . . 1.48 112.067 -178.727 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A 1605 ' ' SER . . . . . 0.408 ' HB2' ' HA ' ' A' 1594 ' ' ASP . 21.7 m -102.78 -174.99 2.69 Favored 'General case' 0 C--N 1.307 -1.259 0 N-CA-C 109.062 -0.718 . . . . 1.51 109.062 178.016 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A 1606 ' ' TYR . . . . . 0.542 ' HB2' ' HA ' ' A' 1574 ' ' VAL . 96.1 m-85 -95.34 153.36 17.72 Favored 'General case' 0 CA--C 1.472 -2.036 0 N-CA-C 105.768 -1.938 . . . . 1.1799999999999999 105.768 179.495 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A 1607 ' ' LYS . . . . . 0.5 ' HG3' HG23 ' A' 1635 ' ' THR . 25.2 pttm -137.63 146.44 43.93 Favored 'General case' 0 N--CA 1.403 -2.783 0 C-N-CA 118.634 -1.226 . . . . 1.6699999999999999 110.202 173.054 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A 1608 ' ' SER . . . . . . . . . . . . . 49.9 m -118.69 126.7 52.48 Favored 'General case' 0 C--N 1.305 -1.336 0 CA-C-O 121.235 0.541 . . . . 1.0 110.845 -179.174 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A 1609 ' ' VAL . . . . . . . . . . . . . 56.2 t -111.23 116.91 53.79 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.932 0 N-CA-C 109.565 -0.531 . . . . 0.93000000000000005 109.565 177.798 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A 1610 ' ' ILE . . . . . 0.595 ' HB ' ' HB2' ' A' 1590 ' ' LEU . 29.3 mm -92.52 111.65 24.72 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.989 0 N-CA-C 108.652 -0.87 . . . . 0.78000000000000003 108.652 177.349 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A 1611 ' ' SER . . . . . . . . . . . . . 6.3 m -102.67 119.54 39.01 Favored 'General case' 0 C--N 1.29 -2.015 0 N-CA-C 108.146 -1.057 . . . . 1.29 108.146 179.386 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A 1612 ' ' PHE . . . . . 0.696 ' HB2' ' HB2' ' A' 1588 ' ' LEU . 69.5 m-85 -91.47 105.3 17.66 Favored 'General case' 0 C--N 1.297 -1.699 0 N-CA-C 109.196 -0.668 . . . . 0.69999999999999996 109.196 -178.833 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A 1613 ' ' VAL . . . . . 0.506 ' O ' ' HA ' ' A' 1641 ' ' HIS . 56.6 t -99.09 124.96 52.66 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.164 0 CA-C-N 115.868 -0.605 . . . . 0.75 109.587 -175.672 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A 1614 ' ' CYS . . . . . 0.597 ' HB3' ' HG3' ' A' 1648 ' ' PRO . 34.5 m -71.14 93.97 1.1 Allowed 'General case' 0 C--N 1.304 -1.401 0 CA-C-O 121.505 0.669 . . . . 1.3899999999999999 112.711 -178.192 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A 1615 ' ' ARG . . . . . 0.721 ' HB3' ' HB2' ' A' 1641 ' ' HIS . 28.5 ttm180 -136.15 92.61 15.81 Favored Pre-proline 0 C--N 1.307 -1.264 0 CA-C-N 115.361 -0.836 . . . . 3.75 110.562 176.607 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A 1616 ' ' PRO . . . . . 0.468 ' HB3' ' HB3' ' A' 1643 ' ' PRO . 12.0 Cg_exo -75.42 18.59 0.57 Allowed 'Trans proline' 0 CA--C 1.535 0.574 0 C-N-CA 123.558 2.839 . . . . 1.3200000000000001 112.895 176.925 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A 1617 ' ' GLU . . . . . . . . . . . . . 42.3 mt-10 -126.69 23.95 6.66 Favored 'General case' 0 C--N 1.312 -1.026 0 CA-C-O 120.971 0.415 . . . . 3.21 110.285 -178.613 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A 1618 ' ' ALA . . . . . . . . . . . . . . . -77.5 -32.58 54.27 Favored 'General case' 0 C--N 1.315 -0.928 0 CA-C-O 121.066 0.46 . . . . 2.4399999999999999 110.504 -176.726 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A 1619 ' ' GLY . . . . . . . . . . . . . . . 60.39 -118.77 15.9 Favored Glycine 0 N--CA 1.44 -1.095 0 CA-C-N 114.903 -1.044 . . . . 3.2599999999999998 112.668 176.188 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A 1620 ' ' PRO . . . . . . . . . . . . . 49.5 Cg_endo -69.04 -22.64 35.08 Favored 'Trans proline' 0 CA--C 1.529 0.236 0 C-N-CA 123.008 2.472 . . . . 5.9199999999999999 112.755 -179.508 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A 1621 ' ' THR . . . . . . . . . . . . . 7.5 t -104.4 34.76 2.96 Favored 'General case' 0 N--CA 1.428 -1.57 0 CA-C-O 122.471 1.129 . . . . 4.7599999999999998 109.946 -177.444 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A 1622 ' ' ASN . . . . . . . . . . . . . 49.5 t-20 -75.91 70.93 2.69 Favored 'General case' 0 C--O 1.243 0.711 0 N-CA-C 107.231 -1.396 . . . . 2.9199999999999999 107.231 174.774 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A 1623 ' ' ARG . . . . . . . . . . . . . 16.2 ptm180 -147.89 153.64 42.58 Favored Pre-proline 0 N--CA 1.437 -1.089 0 CA-C-N 114.996 -1.002 . . . . 3.6099999999999999 108.805 -174.943 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A 1624 ' ' PRO . . . . . 0.497 ' HA ' ' HA ' ' A' 1640 ' ' TRP . 8.1 Cg_exo -73.77 111.01 3.19 Favored 'Trans proline' 0 C--O 1.238 0.519 0 C-N-CA 122.705 2.27 . . . . 2.3700000000000001 110.75 178.581 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A 1625 ' ' MET . . . . . . . . . . . . . 26.7 ptt? -100.15 154.3 18.55 Favored 'General case' 0 C--N 1.303 -1.418 0 CA-C-N 116.026 -0.534 . . . . 2.1600000000000001 109.846 -178.041 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A 1626 ' ' LEU . . . . . . . . . . . . . 56.4 tp -87.4 106.92 18.29 Favored 'General case' 0 C--N 1.301 -1.51 0 N-CA-C 108.747 -0.835 . . . . 1.3500000000000001 108.747 -179.036 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A 1627 ' ' ILE . . . . . . . . . . . . . 2.8 pp -85.83 -36.02 10.16 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.205 0 C-N-CA 119.921 -0.712 . . . . 1.21 112.758 -177.272 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A 1628 ' ' SER . . . . . . . . . . . . . 49.3 m -157.67 143.92 17.65 Favored 'General case' 0 C--N 1.316 -0.86 0 N-CA-C 110.155 -0.313 . . . . 1.3999999999999999 110.155 179.428 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A 1629 ' ' LEU . . . . . 0.887 ' HG ' ' HG ' ' A' 1636 ' ' LEU . 5.1 tt -130.33 118.53 21.41 Favored 'General case' 0 C--N 1.301 -1.506 0 N-CA-C 106.343 -1.725 . . . . 1.5600000000000001 106.343 176.183 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A 1630 ' ' ASP . . . . . . . . . . . . . 20.1 t70 -93.36 117.25 29.86 Favored 'General case' 0 C--N 1.29 -2.005 0 N-CA-C 108.541 -0.911 . . . . 0.87 108.541 178.82 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A 1631 ' ' LYS . . . . . . . . . . . . . 95.7 mttt -83.37 1.52 40.94 Favored 'General case' 0 C--N 1.314 -0.937 0 N-CA-C 112.445 0.535 . . . . 2.3500000000000001 112.445 -174.983 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A 1632 ' ' GLN . . . . . . . . . . . . . 1.5 mp0 -96.68 -45.7 6.59 Favored 'General case' 0 C--N 1.315 -0.905 0 CA-C-O 121.359 0.6 . . . . 2.5499999999999998 110.318 -178.424 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A 1633 ' ' THR . . . . . . . . . . . . . 41.6 p -95.39 -5.99 41.97 Favored 'General case' 0 C--N 1.305 -1.348 0 CA-C-O 121.793 0.806 . . . . 1.24 110.286 177.87 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A 1634 ' ' CYS . . . . . . . . . . . . . 83.4 m 56.69 51.33 11.17 Favored 'General case' 0 C--N 1.347 0.475 0 CA-C-N 113.569 -1.65 . . . . 0.89000000000000001 110.789 -179.394 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A 1635 ' ' THR . . . . . 0.5 HG23 ' HG3' ' A' 1607 ' ' LYS . 24.8 m -111.54 124.36 52.13 Favored 'General case' 0 N--CA 1.425 -1.723 0 CA-C-N 114.109 -1.405 . . . . 0.75 109.651 -176.093 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A 1636 ' ' LEU . . . . . 0.887 ' HG ' ' HG ' ' A' 1629 ' ' LEU . 5.1 mp -105.83 126.72 52.5 Favored 'General case' 0 C--N 1.309 -1.186 0 N-CA-C 109.481 -0.563 . . . . 1.3300000000000001 109.481 178.519 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A 1637 ' ' PHE . . . . . . . . . . . . . 91.0 m-85 -105.91 111.46 24.11 Favored 'General case' 0 C--N 1.31 -1.139 0 CA-C-N 116.135 -0.484 . . . . 0.82999999999999996 110.232 -178.831 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A 1638 ' ' PHE . . . . . . . . . . . . . 94.8 m-85 -106.42 128.25 53.91 Favored 'General case' 0 C--N 1.303 -1.436 0 N-CA-C 109.432 -0.581 . . . . 0.59999999999999998 109.432 178.988 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A 1639 ' ' SER . . . . . . . . . . . . . 67.2 m -112.75 114.64 27.3 Favored 'General case' 0 C--N 1.278 -2.538 0 CA-C-O 121.132 0.491 . . . . 1.0800000000000001 110.288 179.663 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A 1640 ' ' TRP . . . . . 0.497 ' HA ' ' HA ' ' A' 1624 ' ' PRO . 14.8 t90 -96.26 90.8 5.6 Favored 'General case' 0 N--CA 1.425 -1.699 0 N-CA-C 107.755 -1.202 . . . . 0.80000000000000004 107.755 176.955 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A 1641 ' ' HIS . . . . . 0.721 ' HB2' ' HB3' ' A' 1615 ' ' ARG . 0.8 OUTLIER -71.87 99.13 2.14 Favored 'General case' 0 C--N 1.311 -1.097 0 CA-C-N 115.223 -0.898 . . . . 2.54 110.072 175.093 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A 1642 ' ' THR . . . . . . . . . . . . . 5.6 t -142.89 149.59 50.15 Favored Pre-proline 0 C--N 1.295 -1.77 0 CA-C-N 114.741 -1.118 . . . . 1.1499999999999999 109.009 -172.655 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A 1643 ' ' PRO . . . . . 0.468 ' HB3' ' HB3' ' A' 1616 ' ' PRO . 45.6 Cg_endo -73.07 -9.85 23.89 Favored 'Trans proline' 0 C--O 1.215 -0.675 0 C-N-CA 122.858 2.372 . . . . 0.80000000000000004 112.301 176.187 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A 1644 ' ' LEU . . . . . . . . . . . . . 81.9 mt -87.69 3.83 46.4 Favored 'General case' 0 C--N 1.318 -0.801 0 C-N-CA 122.713 0.405 . . . . 1.54 111.292 -177.748 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A 1645 ' ' ALA . . . . . . . . . . . . . . . -80.45 -30.13 37.55 Favored 'General case' 0 C--N 1.317 -0.822 0 N-CA-C 112.383 0.512 . . . . 0.94999999999999996 112.383 -176.61 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A 1646 ' ' CYS . . . . . 0.567 ' O ' ' HD3' ' A' 1648 ' ' PRO . 21.1 p -172.06 -179.57 2.4 Favored 'General case' 0 C--N 1.306 -1.297 0 N-CA-C 105.667 -1.975 . . . . 1.4099999999999999 105.667 179.594 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A 1647 ' ' GLU . . . . . . . . . . . . . 56.3 mm-40 -100.02 97.17 5.67 Favored Pre-proline 0 C--N 1.312 -1.024 0 N-CA-C 107.747 -1.205 . . . . 2.9199999999999999 107.747 174.479 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A 1648 ' ' PRO . . . . . 0.597 ' HG3' ' HB3' ' A' 1614 ' ' CYS . 46.5 Cg_endo -95.78 126.87 0.35 Allowed 'Trans proline' 0 N--CA 1.44 -1.666 0 C-N-CA 123.077 2.518 . . . . 2.8199999999999998 112.647 -177.452 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A 1649 ' ' GLU . . . . . . . . . . . . . 2.9 mp0 . . . . . 0 C--N 1.301 -1.526 0 N-CA-C 109.021 -0.733 . . . . 5.0599999999999996 109.021 176.428 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A 1508 ' ' MET . . . . . . . . . . . . . 50.6 ttm . . . . . 0 C--O 1.232 0.168 0 N-CA-C 109.073 -0.714 . . . . 8.2699999999999996 109.073 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A 1509 ' ' LYS . . . . . . . . . . . . . 13.2 ptmm? -153.82 148.08 25.88 Favored 'General case' 0 C--N 1.31 -1.113 0 N-CA-C 107.832 -1.173 . . . . 6.4800000000000004 107.832 179.186 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A 1510 ' ' SER . . . . . . . . . . . . . 20.8 t -125.31 -7.93 7.0 Favored 'General case' 0 C--N 1.305 -1.35 0 C-N-CA 120.509 -0.476 . . . . 4.2199999999999998 111.045 -174.845 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A 1511 ' ' ASN . . . . . . . . . . . . . 27.8 p-10 -65.78 -6.9 13.23 Favored 'General case' 0 C--O 1.202 -1.439 0 C-N-CA 123.435 0.694 . . . . 3.0800000000000001 112.588 -179.412 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A 1512 ' ' GLU . . . . . . . . . . . . . 9.6 pt-20 -102.83 5.82 38.87 Favored 'General case' 0 C--N 1.308 -1.232 0 CA-C-O 121.33 0.586 . . . . 4.46 110.347 178.294 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A 1513 ' ' HIS . . . . . . . . . . . . . 72.4 m-70 -138.67 -41.23 0.49 Allowed 'General case' 0 N--CA 1.471 0.596 0 CA-C-N 115.98 -0.555 . . . . 5.5700000000000003 111.628 -177.796 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A 1514 ' ' ASP . . . . . . . . . . . . . 13.7 t70 -64.07 -45.75 87.37 Favored 'General case' 0 N--CA 1.469 0.513 0 N-CA-C 108.914 -0.773 . . . . 3.7000000000000002 108.914 179.507 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A 1515 ' ' ASP . . . . . . . . . . . . . 23.6 t70 -140.7 157.24 45.72 Favored 'General case' 0 C--N 1.311 -1.085 0 N-CA-C 107.158 -1.423 . . . . 2.54 107.158 179.507 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A 1516 ' ' CYS . . . . . . . . . . . . . 71.0 m -83.98 77.24 9.96 Favored 'General case' 0 C--N 1.303 -1.425 0 CA-C-O 121.048 0.451 . . . . 1.25 110.363 179.427 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A 1517 ' ' GLN . . . . . . . . . . . . . 12.9 pt20 -142.54 152.98 43.17 Favored 'General case' 0 C--N 1.306 -1.283 0 O-C-N 121.977 -0.452 . . . . 1.8799999999999999 111.375 -178.56 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A 1518 ' ' VAL . . . . . 0.561 ' HB ' ' HD2' ' A' 1527 ' ' PHE . 59.2 t -138.59 130.51 37.49 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.86 0 N-CA-C 109.315 -0.624 . . . . 1.73 109.315 -179.759 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A 1519 ' ' THR . . . . . . . . . . . . . 26.6 m -102.67 115.33 30.36 Favored 'General case' 0 C--N 1.306 -1.303 0 N-CA-C 108.217 -1.031 . . . . 1.7 108.217 173.982 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A 1520 ' ' ASN . . . . . . . . . . . . . 25.9 t-20 -74.17 130.43 82.62 Favored Pre-proline 0 C--N 1.313 -0.98 0 N-CA-C 110.122 -0.325 . . . . 2.1200000000000001 110.122 178.934 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A 1521 ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -74.75 -16.92 20.63 Favored 'Trans proline' 0 CA--C 1.543 0.947 0 C-N-CA 122.744 2.296 . . . . 2.4700000000000002 114.749 -176.375 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A 1522 ' ' SER . . . . . . . . . . . . . 16.5 m -91.93 -60.86 1.75 Allowed 'General case' 0 C--N 1.314 -0.942 0 N-CA-C 112.044 0.387 . . . . 2.5699999999999998 112.044 -176.32 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A 1523 ' ' THR . . . . . . . . . . . . . 8.8 t -94.71 -10.06 32.85 Favored 'General case' 0 C--N 1.316 -0.861 0 CA-C-O 121.474 0.654 . . . . 2.1499999999999999 111.202 -176.153 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A 1524 ' ' GLY . . . . . . . . . . . . . . . 75.0 18.46 80.2 Favored Glycine 0 C--O 1.223 -0.559 0 CA-C-N 115.871 -0.604 . . . . 1.8899999999999999 112.61 179.093 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A 1525 ' ' HIS . . . . . . . . . . . . . 17.6 t60 -75.65 128.07 34.43 Favored 'General case' 0 C--N 1.308 -1.212 0 N-CA-C 109.751 -0.463 . . . . 1.8999999999999999 109.751 -176.95 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A 1526 ' ' LEU . . . . . . . . . . . . . 3.5 tm? -94.39 120.15 34.2 Favored 'General case' 0 C--N 1.299 -1.603 0 N-CA-C 106.626 -1.62 . . . . 1.6100000000000001 106.626 177.451 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A 1527 ' ' PHE . . . . . 0.561 ' HD2' ' HB ' ' A' 1518 ' ' VAL . 86.1 m-85 -89.03 109.94 20.71 Favored 'General case' 0 C--N 1.297 -1.679 0 CA-C-N 116.525 -0.307 . . . . 1.4199999999999999 110.28 -178.574 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A 1528 ' ' ASP . . . . . . . . . . . . . 13.5 m-20 -81.8 87.3 6.36 Favored 'General case' 0 CA--C 1.494 -1.198 0 CA-C-N 115.913 -0.585 . . . . 2.1800000000000002 110.484 179.556 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A 1529 ' ' LEU . . . . . 0.702 ' HA ' HD23 ' A' 1532 ' ' LEU . 85.7 mt -99.09 -9.61 23.62 Favored 'General case' 0 C--N 1.302 -1.493 0 N-CA-C 108.95 -0.759 . . . . 1.4399999999999999 108.95 178.269 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A 1530 ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -62.98 -25.4 68.36 Favored 'General case' 0 C--N 1.318 -0.781 0 C-N-CA 125.166 1.386 . . . . 1.4399999999999999 109.314 175.623 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A 1531 ' ' SER . . . . . . . . . . . . . 34.3 t -77.34 -9.21 58.7 Favored 'General case' 0 N--CA 1.427 -1.582 0 CA-C-N 114.279 -1.328 . . . . 1.5 109.654 -179.699 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A 1532 ' ' LEU . . . . . 0.702 HD23 ' HA ' ' A' 1529 ' ' LEU . 3.5 mm? -95.87 10.03 38.55 Favored 'General case' 0 C--O 1.245 0.855 0 CA-C-N 115.898 -0.592 . . . . 1.77 111.356 177.805 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A 1533 ' ' SER . . . . . 0.565 ' HA ' ' O ' ' A' 1553 ' ' CYS . 42.3 m -76.58 107.79 9.12 Favored 'General case' 0 N--CA 1.436 -1.15 0 N-CA-C 107.745 -1.206 . . . . 2.3799999999999999 107.745 172.894 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A 1534 ' ' GLY . . . . . . . . . . . . . . . -110.19 151.33 17.49 Favored Glycine 0 N--CA 1.436 -1.366 0 C-N-CA 120.655 -0.783 . . . . 1.55 112.957 -174.343 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A 1535 ' ' ARG . . . . . . . . . . . . . 40.7 ttm180 -72.36 -62.53 1.41 Allowed 'General case' 0 C--N 1.314 -0.942 0 CA-C-O 121.149 0.499 . . . . 3.96 110.38 178.451 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A 1536 ' ' ALA . . . . . . . . . . . . . . . -93.57 -6.38 46.75 Favored 'General case' 0 C--N 1.309 -1.19 0 C-N-CA 120.028 -0.669 . . . . 1.6499999999999999 109.484 179.386 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A 1537 ' ' GLY . . . . . . . . . . . . . . . 79.49 -152.85 36.26 Favored Glycine 0 N--CA 1.436 -1.359 0 CA-C-N 115.454 -0.794 . . . . 1.1899999999999999 112.671 176.397 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A 1538 ' ' PHE . . . . . . . . . . . . . 87.1 m-85 -120.18 155.07 33.86 Favored 'General case' 0 C--N 1.29 -2.003 0 N-CA-C 107.754 -1.202 . . . . 1.6899999999999999 107.754 179.885 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A 1539 ' ' THR . . . . . . . . . . . . . 24.1 p -112.14 111.93 23.18 Favored 'General case' 0 C--N 1.293 -1.865 0 CA-C-O 121.359 0.599 . . . . 1.48 111.068 -179.409 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A 1540 ' ' ALA . . . . . . . . . . . . . . . -96.8 139.26 33.12 Favored 'General case' 0 C--N 1.3 -1.568 0 N-CA-C 109.075 -0.713 . . . . 0.82999999999999996 109.075 -179.618 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A 1541 ' ' ALA . . . . . . . . . . . . . . . -80.69 132.87 35.62 Favored 'General case' 0 C--N 1.311 -1.107 0 CA-C-N 115.862 -0.608 . . . . 1.27 110.159 -177.79 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A 1542 ' ' TYR . . . . . 0.477 ' HB3' ' O ' ' A' 1546 ' ' GLY . 45.6 t80 -145.75 156.25 43.48 Favored 'General case' 0 C--N 1.313 -0.999 0 CA-C-N 116.402 -0.363 . . . . 2.1499999999999999 110.499 -179.134 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A 1543 ' ' SER . . . . . . . . . . . . . 5.5 m -41.25 -153.07 0.0 OUTLIER 'General case' 0 CA--C 1.585 2.305 0 C-N-CA 129.921 3.288 . . . . 2.29 116.58 -176.426 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A 1544 ' ' LYS . . . . . . . . . . . . . 61.2 mttp -51.7 -24.77 6.13 Favored 'General case' 0 N--CA 1.484 1.274 0 O-C-N 120.627 -1.296 . . . . 3.9100000000000001 113.773 -179.655 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A 1545 ' ' SER . . . . . . . . . . . . . 22.7 t -71.98 -14.71 61.97 Favored 'General case' 0 CA--C 1.553 1.076 0 N-CA-C 111.87 0.322 . . . . 3.2999999999999998 111.87 178.239 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A 1546 ' ' GLY . . . . . 0.477 ' O ' ' HB3' ' A' 1542 ' ' TYR . . . 96.07 -153.36 20.53 Favored Glycine 0 C--O 1.216 -1.031 0 C-N-CA 119.707 -1.235 . . . . 1.24 113.763 173.491 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A 1547 ' ' VAL . . . . . . . . . . . . . 95.6 t -91.96 139.87 17.11 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.653 0 C-N-CA 123.11 0.564 . . . . 1.6299999999999999 110.47 -173.751 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A 1548 ' ' VAL . . . . . . . . . . . . . 2.4 t -103.27 131.32 51.96 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.971 0 N-CA-C 107.679 -1.23 . . . . 0.92000000000000004 107.679 179.211 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A 1549 ' ' TYR . . . . . 0.419 ' CE1' ' HA3' ' A' 1568 ' ' GLY . 75.9 m-85 -97.1 115.19 27.06 Favored 'General case' 0 C--N 1.295 -1.789 0 N-CA-C 107.17 -1.418 . . . . 1.4399999999999999 107.17 175.129 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A 1550 ' ' MET . . . . . . . . . . . . . 2.7 ppp? -138.34 142.5 39.71 Favored 'General case' 0 C--N 1.291 -1.957 0 CA-C-O 121.172 0.511 . . . . 1.74 111.829 -177.611 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A 1551 ' ' SER . . . . . . . . . . . . . 47.3 m -109.04 149.59 29.04 Favored 'General case' 0 C--N 1.279 -2.463 0 N-CA-C 108.084 -1.08 . . . . 1.6399999999999999 108.084 177.417 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A 1552 ' ' ILE . . . . . . . . . . . . . 41.6 mm -74.49 -51.64 22.25 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.627 0 N-CA-C 107.385 -1.339 . . . . 1.3300000000000001 107.385 176.188 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A 1553 ' ' CYS . . . . . 0.565 ' O ' ' HA ' ' A' 1533 ' ' SER . 80.9 m -134.27 147.53 50.65 Favored 'General case' 0 C--N 1.29 -2.01 0 N-CA-C 107.346 -1.353 . . . . 1.4299999999999999 107.346 175.141 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A 1554 ' ' GLY . . . . . . . . . . . . . . . 97.99 176.05 33.45 Favored Glycine 0 N--CA 1.427 -1.952 0 C-N-CA 120.591 -0.814 . . . . 1.1200000000000001 111.433 178.294 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A 1555 ' ' GLU . . . . . . . . . . . . . 10.9 pt-20 -89.84 145.74 24.94 Favored 'General case' 0 C--N 1.303 -1.451 0 N-CA-C 109.823 -0.436 . . . . 1.8 109.823 -179.828 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A 1556 ' ' ASN . . . . . . . . . . . . . 20.9 t-20 -93.02 114.24 26.74 Favored 'General case' 0 C--N 1.305 -1.343 0 N-CA-C 108.543 -0.91 . . . . 2.6299999999999999 108.543 -178.608 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A 1557 ' ' GLU . . . . . . . . . . . . . 51.2 mt-10 -87.23 51.34 2.21 Favored 'General case' 0 C--N 1.294 -1.832 0 N-CA-C 113.178 0.807 . . . . 3.79 113.178 -172.505 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A 1558 ' ' ASN . . . . . . . . . . . . . 36.6 m-80 -133.99 -0.12 3.12 Favored 'General case' 0 C--N 1.311 -1.105 0 CA-C-N 115.781 -0.645 . . . . 1.52 109.79 175.839 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A 1559 ' ' CYS . . . . . 0.63 ' HB3' ' HD2' ' A' 1560 ' ' PRO . 87.4 m -150.86 171.87 5.96 Favored Pre-proline 0 C--N 1.311 -1.08 0 N-CA-C 106.959 -1.497 . . . . 0.83999999999999997 106.959 -178.764 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A 1560 ' ' PRO . . . . . 0.63 ' HD2' ' HB3' ' A' 1559 ' ' CYS . 44.2 Cg_exo -27.63 129.61 0.03 OUTLIER 'Trans proline' 0 C--N 1.384 2.435 0 C-N-CA 124.948 3.765 . . . . 1.1799999999999999 114.526 177.454 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A 1561 ' ' PRO . . . . . 0.509 ' HD3' ' HA ' ' A' 1560 ' ' PRO . 37.3 Cg_exo -58.36 116.33 3.17 Favored 'Trans proline' 0 C--O 1.241 0.663 0 C-N-CA 123.277 2.651 . . . . 1.51 112.365 -178.188 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A 1562 ' ' GLY . . . . . . . . . . . . . . . 122.33 -9.94 9.38 Favored Glycine 0 N--CA 1.442 -0.9 0 C-N-CA 120.798 -0.715 . . . . 0.71999999999999997 112.905 177.858 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A 1563 ' ' VAL . . . . . 0.421 ' HA ' ' HA ' ' A' 1576 ' ' LYS . 2.4 m -92.64 153.72 3.27 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.093 0 N-CA-C 107.85 -1.167 . . . . 0.96999999999999997 107.85 179.242 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A 1564 ' ' GLY . . . . . . . . . . . . . . . -118.68 -18.73 4.71 Favored Glycine 0 C--N 1.297 -1.585 0 C-N-CA 120.284 -0.96 . . . . 0.71999999999999997 112.656 -177.21 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A 1565 ' ' ALA . . . . . . . . . . . . . . . -139.5 122.35 16.56 Favored 'General case' 0 C--N 1.314 -0.941 0 N-CA-C 108.862 -0.792 . . . . 0.37 108.862 178.994 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A 1566 ' ' CYS . . . . . . . . . . . . . 39.6 t -150.28 144.44 25.56 Favored 'General case' 0 C--N 1.306 -1.297 0 CA-C-N 116.599 -0.273 . . . . 0.51000000000000001 110.586 -174.812 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A 1567 ' ' PHE . . . . . . . . . . . . . 26.1 m-85 -76.89 123.85 26.88 Favored 'General case' 0 C--O 1.211 -0.96 0 N-CA-C 107.599 -1.259 . . . . 0.96999999999999997 107.599 175.38 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A 1568 ' ' GLY . . . . . 0.419 ' HA3' ' CE1' ' A' 1549 ' ' TYR . . . -69.16 -27.84 73.39 Favored Glycine 0 C--N 1.315 -0.59 0 N-CA-C 114.561 0.584 . . . . 1.0800000000000001 114.561 -175.445 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A 1569 ' ' GLN . . . . . . . . . . . . . 35.3 tt0 -77.44 -47.33 19.99 Favored 'General case' 0 C--N 1.315 -0.906 0 O-C-N 122.47 -0.429 . . . . 2.7400000000000002 111.481 -178.248 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A 1570 ' ' THR . . . . . . . . . . . . . 18.6 p -96.31 -13.36 23.38 Favored 'General case' 0 C--N 1.308 -1.221 0 N-CA-C 113.034 0.753 . . . . 1.96 113.034 -176.21 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A 1571 ' ' ARG . . . . . . . . . . . . . 21.7 mtp180 57.6 40.72 26.54 Favored 'General case' 0 CA--C 1.51 -0.573 0 C-N-CA 124.924 1.29 . . . . 3.9500000000000002 113.007 -179.456 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A 1572 ' ' ILE . . . . . . . . . . . . . 66.0 mt -106.4 126.45 62.11 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.18 0 CA-C-N 114.733 -1.121 . . . . 1.3700000000000001 108.327 178.981 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A 1573 ' ' SER . . . . . . . . . . . . . 37.7 t -75.6 136.88 40.48 Favored 'General case' 0 C--N 1.309 -1.186 0 CA-C-N 115.449 -0.796 . . . . 1.0800000000000001 111.383 -176.95 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A 1574 ' ' VAL . . . . . . . . . . . . . 22.8 m -129.81 21.14 2.2 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.395 0 CA-C-O 121.995 0.903 . . . . 1.3 110.196 177.778 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A 1575 ' ' GLY . . . . . . . . . . . . . . . 176.87 119.04 0.56 Allowed Glycine 0 N--CA 1.422 -2.243 0 CA-C-N 114.576 -1.193 . . . . 0.51000000000000001 111.274 177.117 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A 1576 ' ' LYS . . . . . 0.421 ' HA ' ' HA ' ' A' 1563 ' ' VAL . 46.9 tptt -75.45 151.54 38.06 Favored 'General case' 0 C--N 1.31 -1.147 0 N-CA-C 106.001 -1.852 . . . . 2.8999999999999999 106.001 175.52 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A 1577 ' ' ALA . . . . . . . . . . . . . . . -70.94 95.08 1.13 Allowed 'General case' 0 C--N 1.314 -0.942 0 N-CA-C 109.273 -0.64 . . . . 0.82999999999999996 109.273 -179.126 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A 1578 ' ' ASN . . . . . . . . . . . . . 6.9 m-20 -104.66 142.4 34.75 Favored 'General case' 0 C--N 1.3 -1.553 0 CA-C-N 115.439 -0.8 . . . . 1.8500000000000001 111.117 -178.337 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A 1579 ' ' LYS . . . . . . . . . . . . . 9.9 mmmm -105.89 89.03 2.95 Favored 'General case' 0 C--N 1.287 -2.148 0 N-CA-C 106.079 -1.823 . . . . 1.8999999999999999 106.079 173.792 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A 1580 ' ' ARG . . . . . 0.518 ' HD3' ' HB ' ' A' 1591 ' ' VAL . 70.0 ttt180 -146.62 97.76 2.96 Favored 'General case' 0 C--N 1.303 -1.435 0 CA-C-N 115.183 -0.917 . . . . 3.6299999999999999 109.457 -173.023 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A 1581 ' ' LEU . . . . . . . . . . . . . 54.3 tp -118.93 144.57 46.36 Favored 'General case' 0 C--N 1.299 -1.627 0 CA-C-N 115.9 -0.591 . . . . 1.8700000000000001 109.941 -176.622 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A 1582 ' ' ARG . . . . . . . . . . . . . 49.5 mtp180 -132.96 136.41 46.08 Favored 'General case' 0 C--N 1.309 -1.155 0 C-N-CA 123.416 0.686 . . . . 3.9700000000000002 109.907 179.185 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A 1583 ' ' TYR . . . . . . . . . . . . . 7.8 t80 -92.9 104.77 16.98 Favored 'General case' 0 C--N 1.311 -1.09 0 CA-C-O 121.56 0.695 . . . . 1.4099999999999999 109.894 174.184 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A 1584 ' ' VAL . . . . . 0.555 ' HB ' HG13 ' A' 1587 ' ' VAL . 35.0 t -109.69 149.26 12.85 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.648 0 N-CA-C 105.245 -2.131 . . . . 1.6899999999999999 105.245 175.301 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A 1585 ' ' ASP . . . . . . . . . . . . . 35.8 t70 -46.34 102.68 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.376 0 C-N-CA 124.473 1.109 . . . . 2.0600000000000001 113.713 -177.968 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A 1586 ' ' GLN . . . . . . . . . . . . . 49.8 mt-30 58.41 35.25 24.63 Favored 'General case' 0 C--O 1.249 1.033 0 C-N-CA 124.828 1.251 . . . . 2.3300000000000001 112.477 179.911 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A 1587 ' ' VAL . . . . . 0.555 HG13 ' HB ' ' A' 1584 ' ' VAL . 7.7 p -164.69 104.54 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.436 -1.158 0 CA-C-O 122.06 0.933 . . . . 0.78000000000000003 110.616 175.433 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A 1588 ' ' LEU . . . . . 0.52 ' HB2' ' HB2' ' A' 1612 ' ' PHE . 44.2 mt -78.62 141.25 38.17 Favored 'General case' 0 C--N 1.294 -1.845 0 N-CA-C 107.71 -1.218 . . . . 1.4099999999999999 107.71 176.295 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A 1589 ' ' GLN . . . . . . . . . . . . . 36.0 tt0 -125.27 117.62 24.21 Favored 'General case' 0 C--N 1.284 -2.253 0 N-CA-C 109.642 -0.503 . . . . 1.24 109.642 -177.835 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A 1590 ' ' LEU . . . . . 0.431 ' HA ' ' O ' ' A' 1580 ' ' ARG . 4.9 tt -116.16 123.25 47.35 Favored 'General case' 0 C--N 1.304 -1.381 0 N-CA-C 106.72 -1.585 . . . . 1.1499999999999999 106.72 178.354 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A 1591 ' ' VAL . . . . . 0.518 ' HB ' ' HD3' ' A' 1580 ' ' ARG . 60.9 t -110.94 127.76 67.82 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.131 0 N-CA-C 113.633 0.975 . . . . 1.51 113.633 -171.05 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A 1592 ' ' TYR . . . . . . . . . . . . . 5.6 m-30 -109.08 143.49 38.37 Favored 'General case' 0 C--N 1.32 -0.677 0 N-CA-C 107.783 -1.192 . . . . 1.0600000000000001 107.783 171.378 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A 1593 ' ' LYS . . . . . 0.454 ' HA ' ' HA ' ' A' 1607 ' ' LYS . 13.4 ptmm? -158.96 -177.24 6.37 Favored 'General case' 0 C--N 1.3 -1.58 0 N-CA-C 108.601 -0.889 . . . . 2.1800000000000002 108.601 179.82 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A 1594 ' ' ASP . . . . . . . . . . . . . 22.0 m-20 64.57 43.31 4.45 Favored 'General case' 0 C--O 1.247 0.936 0 O-C-N 124.147 0.904 . . . . 1.45 112.107 177.724 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A 1595 ' ' GLY . . . . . . . . . . . . . . . -80.83 -104.34 0.31 Allowed Glycine 0 N--CA 1.437 -1.29 0 N-CA-C 111.088 -0.805 . . . . 0.78000000000000003 111.088 176.309 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A 1596 ' ' SER . . . . . . . . . . . . . 17.7 m -114.11 152.34 45.74 Favored Pre-proline 0 C--N 1.29 -2.013 0 N-CA-C 107.958 -1.127 . . . . 1.6799999999999999 107.958 177.558 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A 1597 ' ' PRO . . . . . . . . . . . . . 24.7 Cg_exo -62.37 143.39 93.55 Favored 'Trans proline' 0 C--O 1.248 0.99 0 C-N-CA 122.663 2.242 . . . . 1.1699999999999999 111.193 179.143 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A 1598 ' ' CYS . . . . . . . . . . . . . 45.9 t -96.25 133.15 25.39 Favored Pre-proline 0 C--N 1.29 -2.005 0 CA-C-N 115.844 -0.616 . . . . 1.1899999999999999 110.41 -177.071 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A 1599 ' ' PRO . . . . . . . . . . . . . 88.2 Cg_endo -88.3 -7.43 5.91 Favored 'Trans proline' 0 CA--C 1.537 0.659 0 C-N-CA 122.68 2.253 . . . . 1.5900000000000001 112.141 178.013 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A 1600 ' ' SER . . . . . . . . . . . . . 16.5 m -84.27 -34.04 23.88 Favored 'General case' 0 N--CA 1.446 -0.645 0 CA-C-O 121.25 0.548 . . . . 2.1200000000000001 110.075 -179.87 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A 1601 ' ' LYS . . . . . 0.548 ' HG2' HD12 ' A' 1604 ' ' LEU . 15.8 tppt? -139.64 118.68 12.61 Favored 'General case' 0 N--CA 1.431 -1.379 0 N-CA-C 107.653 -1.24 . . . . 3.7400000000000002 107.653 178.185 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A 1602 ' ' SER . . . . . . . . . . . . . 22.9 m -72.85 134.39 44.84 Favored 'General case' 0 C--N 1.297 -1.705 0 CA-C-O 121.28 0.562 . . . . 3.79 110.481 -177.587 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A 1603 ' ' GLY . . . . . . . . . . . . . . . 97.61 -7.45 63.43 Favored Glycine 0 N--CA 1.439 -1.125 0 N-CA-C 110.876 -0.89 . . . . 2.0 110.876 -179.756 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A 1604 ' ' LEU . . . . . 0.548 HD12 ' HG2' ' A' 1601 ' ' LYS . 2.2 mt -105.72 148.88 26.94 Favored 'General case' 0 C--N 1.303 -1.424 0 C-N-CA 123.107 0.563 . . . . 1.48 110.873 179.658 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A 1605 ' ' SER . . . . . . . . . . . . . 52.3 m -113.2 -167.45 1.19 Allowed 'General case' 0 C--N 1.287 -2.114 0 N-CA-C 106.356 -1.72 . . . . 1.51 106.356 173.286 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A 1606 ' ' TYR . . . . . . . . . . . . . 44.0 m-85 -108.07 128.24 54.5 Favored 'General case' 0 N--CA 1.399 -2.992 0 N-CA-C 107.223 -1.399 . . . . 1.1799999999999999 107.223 -179.963 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A 1607 ' ' LYS . . . . . 0.556 ' HG3' HG23 ' A' 1635 ' ' THR . 21.7 ptmt -125.4 154.38 42.01 Favored 'General case' 0 N--CA 1.397 -3.097 0 O-C-N 124.56 1.163 . . . . 1.6699999999999999 109.407 -177.68 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A 1608 ' ' SER . . . . . 0.494 ' HB3' ' HE2' ' A' 1638 ' ' PHE . 51.1 m -132.38 118.36 19.29 Favored 'General case' 0 C--N 1.296 -1.735 0 N-CA-C 109.598 -0.519 . . . . 1.0 109.598 -178.53 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A 1609 ' ' VAL . . . . . 0.436 HG22 HG13 ' A' 1591 ' ' VAL . 88.1 t -104.12 124.68 58.7 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.558 0 N-CA-C 109.224 -0.658 . . . . 0.93000000000000005 109.224 178.882 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A 1610 ' ' ILE . . . . . . . . . . . . . 3.1 mp -99.51 117.81 45.2 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.41 0 N-CA-C 108.473 -0.936 . . . . 0.78000000000000003 108.473 178.156 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A 1611 ' ' SER . . . . . . . . . . . . . 62.9 p -103.45 125.75 50.21 Favored 'General case' 0 N--CA 1.42 -1.928 0 N-CA-C 109.48 -0.563 . . . . 1.29 109.48 177.342 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A 1612 ' ' PHE . . . . . 0.52 ' HB2' ' HB2' ' A' 1588 ' ' LEU . 15.3 m-85 -94.51 107.47 19.45 Favored 'General case' 0 C--N 1.296 -1.735 0 N-CA-C 107.708 -1.219 . . . . 0.69999999999999996 107.708 179.544 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A 1613 ' ' VAL . . . . . 0.652 HG12 ' HG2' ' A' 1615 ' ' ARG . 97.2 t -103.73 134.41 45.02 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.958 0 N-CA-C 109.86 -0.422 . . . . 0.75 109.86 -177.018 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A 1614 ' ' CYS . . . . . 0.807 ' HB3' ' HG3' ' A' 1648 ' ' PRO . 62.6 m -77.1 91.8 3.72 Favored 'General case' 0 N--CA 1.436 -1.166 0 CA-C-O 121.984 0.897 . . . . 1.3899999999999999 109.879 -178.384 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A 1615 ' ' ARG . . . . . 0.761 ' HB2' ' HB2' ' A' 1641 ' ' HIS . 12.9 mmt180 -137.52 103.04 8.62 Favored Pre-proline 0 C--N 1.293 -1.865 0 N-CA-C 106.336 -1.727 . . . . 3.75 106.336 176.662 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A 1616 ' ' PRO . . . . . 0.889 ' HD3' ' HG2' ' A' 1648 ' ' PRO . 32.6 Cg_endo -68.03 73.22 0.75 Allowed 'Trans proline' 0 C--O 1.245 0.857 0 C-N-CA 122.441 2.094 . . . . 1.3200000000000001 111.956 177.843 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A 1617 ' ' GLU . . . . . . . . . . . . . 48.8 mt-10 -131.11 39.98 3.5 Favored 'General case' 0 N--CA 1.431 -1.404 0 CA-C-N 114.653 -1.158 . . . . 3.21 109.816 176.659 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A 1618 ' ' ALA . . . . . . . . . . . . . . . -69.62 128.58 36.95 Favored 'General case' 0 N--CA 1.444 -0.745 0 N-CA-C 108.376 -0.972 . . . . 2.4399999999999999 108.376 177.685 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A 1619 ' ' GLY . . . . . 0.709 ' H ' ' HB2' ' A' 1622 ' ' ASN . . . 169.02 -126.86 1.43 Allowed Glycine 0 N--CA 1.427 -1.906 0 C-N-CA 120.669 -0.776 . . . . 3.2599999999999998 111.711 -177.946 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A 1620 ' ' PRO . . . . . . . . . . . . . 53.5 Cg_exo -55.35 -41.7 75.64 Favored 'Trans proline' 0 N--CA 1.478 0.584 0 C-N-CA 123.84 3.027 . . . . 5.9199999999999999 114.211 -176.356 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A 1621 ' ' THR . . . . . . . . . . . . . 8.9 m -112.65 42.31 1.87 Allowed 'General case' 0 C--N 1.307 -1.253 0 CA-C-O 122.511 1.148 . . . . 4.7599999999999998 109.378 -176.814 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A 1622 ' ' ASN . . . . . 0.709 ' HB2' ' H ' ' A' 1619 ' ' GLY . 58.0 t30 -80.56 65.13 5.59 Favored 'General case' 0 C--N 1.318 -0.799 0 CA-C-N 114.929 -1.032 . . . . 2.9199999999999999 109.079 178.025 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A 1623 ' ' ARG . . . . . . . . . . . . . 19.7 ptp180 -155.17 154.71 29.1 Favored Pre-proline 0 C--N 1.3 -1.585 0 N-CA-C 106.998 -1.482 . . . . 3.6099999999999999 106.998 179.69 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A 1624 ' ' PRO . . . . . . . . . . . . . 23.0 Cg_exo -66.1 117.47 4.7 Favored 'Trans proline' 0 N--CA 1.459 -0.522 0 C-N-CA 122.789 2.326 . . . . 2.3700000000000001 112.339 -179.648 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A 1625 ' ' MET . . . . . . . . . . . . . 48.3 ttm -90.9 133.16 35.47 Favored 'General case' 0 C--N 1.306 -1.289 0 N-CA-C 108.46 -0.941 . . . . 2.1600000000000001 108.46 -179.785 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A 1626 ' ' LEU . . . . . 0.434 HD21 HD23 ' A' 1629 ' ' LEU . 29.0 tp -85.22 91.8 8.24 Favored 'General case' 0 C--N 1.294 -1.806 0 N-CA-C 108.715 -0.846 . . . . 1.3500000000000001 108.715 179.272 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A 1627 ' ' ILE . . . . . . . . . . . . . 32.6 pt -86.05 -27.64 6.18 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.611 0 CA-C-N 115.851 -0.613 . . . . 1.21 111.893 -175.118 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A 1628 ' ' SER . . . . . 0.803 ' HB2' ' HB2' ' A' 1637 ' ' PHE . 18.2 m -132.1 129.04 39.4 Favored 'General case' 0 N--CA 1.427 -1.578 0 CA-C-O 121.087 0.47 . . . . 1.3999999999999999 110.825 -175.594 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A 1629 ' ' LEU . . . . . 0.59 HD22 ' HG ' ' A' 1636 ' ' LEU . 1.5 tm? -129.77 109.27 10.81 Favored 'General case' 0 C--N 1.296 -1.756 0 N-CA-C 105.393 -2.077 . . . . 1.5600000000000001 105.393 177.094 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A 1630 ' ' ASP . . . . . . . . . . . . . 22.9 t70 -105.45 112.59 25.75 Favored 'General case' 0 C--N 1.297 -1.682 0 C-N-CA 118.95 -1.1 . . . . 0.87 110.135 179.35 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A 1631 ' ' LYS . . . . . . . . . . . . . 28.7 mtpp -71.77 -37.65 70.44 Favored 'General case' 0 C--N 1.306 -1.308 0 CA-C-N 114.621 -1.172 . . . . 2.3500000000000001 112.946 -175.923 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A 1632 ' ' GLN . . . . . . . . . . . . . 8.7 pt20 -75.02 -31.26 61.31 Favored 'General case' 0 CA--C 1.535 0.394 0 N-CA-C 112.906 0.706 . . . . 2.5499999999999998 112.906 -174.444 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A 1633 ' ' THR . . . . . . . . . . . . . 54.7 p -99.46 -1.55 38.23 Favored 'General case' 0 C--O 1.245 0.83 0 C-N-CA 120.073 -0.651 . . . . 1.24 111.198 177.8 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A 1634 ' ' CYS . . . . . . . . . . . . . 18.4 m 60.74 40.28 16.35 Favored 'General case' 0 C--N 1.352 0.699 0 CA-C-O 122.114 0.959 . . . . 0.89000000000000001 110.466 174.366 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A 1635 ' ' THR . . . . . 0.556 HG23 ' HG3' ' A' 1607 ' ' LYS . 27.5 m -124.04 132.5 53.69 Favored 'General case' 0 N--CA 1.435 -1.202 0 CA-C-N 115.207 -0.906 . . . . 0.75 111.512 -173.802 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A 1636 ' ' LEU . . . . . 0.59 ' HG ' HD22 ' A' 1629 ' ' LEU . 6.2 mp -102.87 141.32 35.88 Favored 'General case' 0 C--N 1.313 -1.0 0 N-CA-C 109.113 -0.699 . . . . 1.3300000000000001 109.113 175.93 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A 1637 ' ' PHE . . . . . 0.803 ' HB2' ' HB2' ' A' 1628 ' ' SER . 90.9 m-85 -124.22 106.85 10.62 Favored 'General case' 0 C--O 1.25 1.119 0 CA-C-O 121.362 0.601 . . . . 0.82999999999999996 111.448 177.928 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A 1638 ' ' PHE . . . . . 0.494 ' HE2' ' HB3' ' A' 1608 ' ' SER . 86.3 m-85 -91.75 144.51 25.43 Favored 'General case' 0 C--N 1.31 -1.14 0 CA-C-N 115.508 -0.769 . . . . 0.59999999999999998 109.223 178.317 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A 1639 ' ' SER . . . . . . . . . . . . . 28.8 m -129.42 114.89 16.72 Favored 'General case' 0 C--N 1.292 -1.92 0 CA-C-O 120.924 0.393 . . . . 1.0800000000000001 110.136 178.777 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A 1640 ' ' TRP . . . . . . . . . . . . . 19.3 t90 -108.52 113.36 26.33 Favored 'General case' 0 C--N 1.296 -1.73 0 N-CA-C 109.248 -0.649 . . . . 0.80000000000000004 109.248 177.777 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A 1641 ' ' HIS . . . . . 0.761 ' HB2' ' HB2' ' A' 1615 ' ' ARG . 7.3 p-80 -79.81 104.47 10.41 Favored 'General case' 0 C--N 1.317 -0.846 0 CA-C-N 115.305 -0.861 . . . . 2.54 108.936 176.253 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A 1642 ' ' THR . . . . . 0.492 ' HA ' ' HD3' ' A' 1643 ' ' PRO . 8.9 t -143.08 144.35 28.48 Favored Pre-proline 0 C--N 1.285 -2.198 0 C-N-CA 120.069 -0.652 . . . . 1.1499999999999999 112.046 -173.366 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A 1643 ' ' PRO . . . . . 0.492 ' HD3' ' HA ' ' A' 1642 ' ' THR . 4.9 Cg_exo -79.1 -0.74 11.0 Favored 'Trans proline' 0 N--CA 1.451 -1.013 0 C-N-CA 123.298 2.665 . . . . 0.80000000000000004 110.328 171.831 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A 1644 ' ' LEU . . . . . . . . . . . . . 89.6 mt -91.07 3.87 53.61 Favored 'General case' 0 C--O 1.225 -0.207 0 CA-C-N 115.771 -0.65 . . . . 1.54 109.73 176.268 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A 1645 ' ' ALA . . . . . . . . . . . . . . . -86.51 -42.43 13.55 Favored 'General case' 0 C--N 1.317 -0.805 0 N-CA-C 108.14 -1.059 . . . . 0.94999999999999996 108.14 175.988 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A 1646 ' ' CYS . . . . . 0.647 ' O ' ' HD3' ' A' 1648 ' ' PRO . 16.0 p -176.82 161.46 2.01 Favored 'General case' 0 N--CA 1.43 -1.471 0 N-CA-C 102.993 -2.966 . . . . 1.4099999999999999 102.993 174.453 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A 1647 ' ' GLU . . . . . . . . . . . . . 41.7 mt-10 -96.65 98.53 4.48 Favored Pre-proline 0 C--N 1.309 -1.155 0 CA-C-N 118.624 0.647 . . . . 2.9199999999999999 110.784 -179.684 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A 1648 ' ' PRO . . . . . 0.889 ' HG2' ' HD3' ' A' 1616 ' ' PRO . 86.1 Cg_endo -96.29 172.44 0.98 Allowed 'Trans proline' 0 N--CA 1.442 -1.501 0 C-N-CA 123.29 2.66 . . . . 2.8199999999999998 110.957 -179.49 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A 1649 ' ' GLU . . . . . . . . . . . . . 11.5 tp10 . . . . . 0 C--N 1.285 -2.216 0 N-CA-C 107.889 -1.152 . . . . 5.0599999999999996 107.889 179.557 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A 1508 ' ' MET . . . . . 0.521 ' HG3' ' OD1' ' A' 1511 ' ' ASN . 50.7 ttp . . . . . 0 N--CA 1.454 -0.256 0 N-CA-C 107.83 -1.174 . . . . 8.2699999999999996 107.83 . . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A 1509 ' ' LYS . . . . . . . . . . . . . 47.5 pttt -101.79 -64.99 1.01 Allowed 'General case' 0 C--N 1.315 -0.908 0 N-CA-C 114.83 1.419 . . . . 6.4800000000000004 114.83 -173.3 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A 1510 ' ' SER . . . . . . . . . . . . . 39.1 m -121.59 32.15 6.0 Favored 'General case' 0 C--N 1.309 -1.174 0 CA-C-O 121.231 0.539 . . . . 4.2199999999999998 111.838 -173.279 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A 1511 ' ' ASN . . . . . 0.521 ' OD1' ' HG3' ' A' 1508 ' ' MET . 23.0 p-10 -128.44 29.13 5.36 Favored 'General case' 0 C--N 1.296 -1.737 0 CA-C-O 121.297 0.57 . . . . 3.0800000000000001 110.117 177.942 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A 1512 ' ' GLU . . . . . . . . . . . . . 37.4 mt-10 -90.52 -40.96 11.68 Favored 'General case' 0 C--N 1.317 -0.816 0 CA-C-N 115.552 -0.749 . . . . 4.46 110.228 -178.36 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A 1513 ' ' HIS . . . . . 0.599 ' HA ' ' HB2' ' A' 1579 ' ' LYS . 15.1 p-80 -136.3 25.03 3.23 Favored 'General case' 0 C--N 1.314 -0.969 0 CA-C-O 121.7 0.762 . . . . 5.5700000000000003 110.053 -179.543 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A 1514 ' ' ASP . . . . . . . . . . . . . 34.2 t70 -111.06 -61.06 1.75 Allowed 'General case' 0 C--N 1.305 -1.352 0 CA-C-N 114.846 -1.07 . . . . 3.7000000000000002 108.946 179.526 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A 1515 ' ' ASP . . . . . . . . . . . . . 11.3 t70 -107.86 153.14 23.44 Favored 'General case' 0 C--N 1.306 -1.3 0 N-CA-C 106.836 -1.542 . . . . 2.54 106.836 177.127 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A 1516 ' ' CYS . . . . . 0.664 ' SG ' ' HE3' ' A' 1579 ' ' LYS . 11.6 m -82.64 81.93 8.22 Favored 'General case' 0 C--N 1.299 -1.629 0 N-CA-C 109.381 -0.6 . . . . 1.25 109.381 -176.812 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A 1517 ' ' GLN . . . . . . . . . . . . . 3.9 pt20 -165.39 176.69 8.07 Favored 'General case' 0 C--N 1.32 -0.68 0 N-CA-C 110.147 -0.316 . . . . 1.8799999999999999 110.147 179.39 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A 1518 ' ' VAL . . . . . 0.704 ' HB ' HD11 ' A' 1581 ' ' LEU . 4.5 p -148.76 131.32 6.61 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.863 0 CA-C-N 116.068 -0.515 . . . . 1.73 110.131 176.454 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A 1519 ' ' THR . . . . . . . . . . . . . 4.8 m -105.97 123.97 48.83 Favored 'General case' 0 C--N 1.312 -1.039 0 N-CA-C 109.775 -0.454 . . . . 1.7 109.775 179.181 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A 1520 ' ' ASN . . . . . . . . . . . . . 24.8 t-20 -83.86 113.29 46.58 Favored Pre-proline 0 C--N 1.314 -0.971 0 N-CA-C 108.966 -0.753 . . . . 2.1200000000000001 108.966 175.661 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A 1521 ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -75.55 -15.83 19.36 Favored 'Trans proline' 0 C--N 1.344 0.326 0 C-N-CA 122.221 1.947 . . . . 2.4700000000000002 113.552 -174.958 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A 1522 ' ' SER . . . . . . . . . . . . . 12.2 m -68.25 -54.75 15.5 Favored 'General case' 0 N--CA 1.432 -1.344 0 CA-C-N 116.494 -0.321 . . . . 2.5699999999999998 110.785 -177.925 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A 1523 ' ' THR . . . . . 0.465 HG23 ' HB2' ' A' 1525 ' ' HIS . 14.5 t -109.02 -7.8 15.3 Favored 'General case' 0 C--N 1.315 -0.895 0 C-N-CA 119.654 -0.818 . . . . 2.1499999999999999 111.966 -179.465 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A 1524 ' ' GLY . . . . . . . . . . . . . . . 80.45 37.38 20.87 Favored Glycine 0 CA--C 1.503 -0.658 0 C-N-CA 120.511 -0.852 . . . . 1.8899999999999999 111.18 -179.487 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A 1525 ' ' HIS . . . . . 0.465 ' HB2' HG23 ' A' 1523 ' ' THR . 22.3 t-160 -100.97 115.71 31.11 Favored 'General case' 0 C--N 1.308 -1.205 0 N-CA-C 109.284 -0.636 . . . . 1.8999999999999999 109.284 -176.545 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A 1526 ' ' LEU . . . . . . . . . . . . . 3.5 tm? -88.41 120.65 29.98 Favored 'General case' 0 C--N 1.295 -1.766 0 N-CA-C 107.799 -1.185 . . . . 1.6100000000000001 107.799 178.762 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A 1527 ' ' PHE . . . . . . . . . . . . . 95.0 m-85 -92.86 112.95 25.09 Favored 'General case' 0 C--N 1.3 -1.555 0 N-CA-C 107.646 -1.242 . . . . 1.4199999999999999 107.646 176.975 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A 1528 ' ' ASP . . . . . . . . . . . . . 10.8 t70 -77.84 105.6 9.13 Favored 'General case' 0 CA--C 1.495 -1.143 0 CA-C-O 121.533 0.682 . . . . 2.1800000000000002 109.678 -178.356 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A 1529 ' ' LEU . . . . . . . . . . . . . 89.2 mt -106.55 -3.0 21.28 Favored 'General case' 0 C--N 1.281 -2.412 0 N-CA-C 107.207 -1.405 . . . . 1.4399999999999999 107.207 176.458 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A 1530 ' ' SER . . . . . . . . . . . . . 8.1 m -69.72 -37.05 76.4 Favored 'General case' 0 N--CA 1.419 -1.985 0 CA-C-N 114.027 -1.442 . . . . 1.4399999999999999 110.73 -174.013 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A 1531 ' ' SER . . . . . . . . . . . . . 14.8 m -74.94 -21.97 58.86 Favored 'General case' 0 C--N 1.316 -0.853 0 CA-C-O 121.344 0.592 . . . . 1.5 110.026 177.72 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A 1532 ' ' LEU . . . . . 0.575 HD22 ' HH2' ' A' 1640 ' ' TRP . 82.1 mt -85.83 -5.72 59.2 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.549 -0.751 . . . . 1.77 109.643 179.711 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A 1533 ' ' SER . . . . . 0.419 ' OG ' ' HB3' ' A' 1553 ' ' CYS . 22.6 m -92.18 107.36 19.16 Favored 'General case' 0 N--CA 1.415 -2.199 0 N-CA-C 108.631 -0.878 . . . . 2.3799999999999999 108.631 178.584 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A 1534 ' ' GLY . . . . . . . . . . . . . . . -126.58 -150.33 7.54 Favored Glycine 0 N--CA 1.422 -2.296 0 N-CA-C 109.768 -1.333 . . . . 1.55 109.768 179.551 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A 1535 ' ' ARG . . . . . 0.433 ' HD2' ' HA ' ' A' 1535 ' ' ARG . 9.5 tpt180 -96.82 -70.11 0.73 Allowed 'General case' 0 N--CA 1.419 -1.979 0 C-N-CA 120.242 -0.583 . . . . 3.96 109.58 179.214 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A 1536 ' ' ALA . . . . . . . . . . . . . . . -86.93 -18.28 31.17 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 121.047 0.451 . . . . 1.6499999999999999 110.994 -177.831 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A 1537 ' ' GLY . . . . . . . . . . . . . . . 73.44 -112.9 4.04 Favored Glycine 0 N--CA 1.435 -1.383 0 CA-C-N 115.941 -0.572 . . . . 1.1899999999999999 113.317 176.15 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A 1538 ' ' PHE . . . . . . . . . . . . . 64.9 m-85 -127.23 159.0 35.64 Favored 'General case' 0 C--N 1.307 -1.27 0 N-CA-C 109.837 -0.431 . . . . 1.6899999999999999 109.837 -176.55 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A 1539 ' ' THR . . . . . . . . . . . . . 6.8 p -112.76 119.99 39.95 Favored 'General case' 0 C--N 1.306 -1.3 0 CA-C-N 116.288 -0.415 . . . . 1.48 111.138 -178.886 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A 1540 ' ' ALA . . . . . . . . . . . . . . . -100.51 116.0 31.43 Favored 'General case' 0 C--N 1.307 -1.253 0 N-CA-C 109.46 -0.57 . . . . 0.82999999999999996 109.46 177.976 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A 1541 ' ' ALA . . . . . . . . . . . . . . . -80.48 89.05 5.61 Favored 'General case' 0 C--N 1.313 -0.979 0 CA-C-N 115.541 -0.754 . . . . 1.27 109.134 -179.161 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A 1542 ' ' TYR . . . . . . . . . . . . . 64.3 t80 -100.13 157.2 16.74 Favored 'General case' 0 C--N 1.293 -1.856 0 CA-C-N 115.861 -0.609 . . . . 2.1499999999999999 111.483 -176.486 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A 1543 ' ' SER . . . . . . . . . . . . . 2.8 m -40.46 -153.07 0.0 OUTLIER 'General case' 0 CA--C 1.578 2.043 0 C-N-CA 130.179 3.391 . . . . 2.29 116.893 -177.15 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A 1544 ' ' LYS . . . . . 0.472 ' NZ ' ' HB3' ' A' 1544 ' ' LYS . 4.9 ttpm? -49.4 -31.7 10.15 Favored 'General case' 0 N--CA 1.481 1.082 0 O-C-N 121.3 -0.875 . . . . 3.9100000000000001 112.262 -179.197 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A 1545 ' ' SER . . . . . . . . . . . . . 13.1 m -63.82 -27.18 69.0 Favored 'General case' 0 CA--C 1.559 1.291 0 N-CA-C 112.375 0.509 . . . . 3.2999999999999998 112.375 178.261 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A 1546 ' ' GLY . . . . . . . . . . . . . . . 109.02 -165.21 12.48 Favored Glycine 0 N--CA 1.43 -1.764 0 C-N-CA 119.363 -1.398 . . . . 1.24 114.034 174.869 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A 1547 ' ' VAL . . . . . . . . . . . . . 7.2 p -92.35 133.51 33.48 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.608 0 CA-C-O 121.596 0.712 . . . . 1.6299999999999999 111.151 -176.297 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A 1548 ' ' VAL . . . . . . . . . . . . . 4.1 t -111.37 135.83 49.36 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.442 0 N-CA-C 106.682 -1.599 . . . . 0.92000000000000004 106.682 179.202 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A 1549 ' ' TYR . . . . . 0.68 ' HE1' ' HA3' ' A' 1568 ' ' GLY . 95.7 m-85 -93.74 151.38 19.67 Favored 'General case' 0 C--N 1.3 -1.547 0 N-CA-C 106.565 -1.642 . . . . 1.4399999999999999 106.565 174.129 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A 1550 ' ' MET . . . . . . . . . . . . . 46.0 ttm -144.16 122.38 12.24 Favored 'General case' 0 C--N 1.301 -1.514 0 C-N-CA 120.255 -0.578 . . . . 1.74 111.113 -178.686 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A 1551 ' ' SER . . . . . . . . . . . . . 28.8 p -111.36 122.06 46.86 Favored 'General case' 0 N--CA 1.418 -2.07 0 N-CA-C 108.7 -0.852 . . . . 1.6399999999999999 108.7 174.932 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A 1552 ' ' ILE . . . . . . . . . . . . . 1.7 mp -62.04 -29.33 46.24 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.342 0 CA-C-N 115.134 -0.939 . . . . 1.3300000000000001 110.621 179.058 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A 1553 ' ' CYS . . . . . 0.7 ' SG ' ' HE3' ' A' 1579 ' ' LYS . 37.2 t -160.63 141.0 11.45 Favored 'General case' 0 N--CA 1.426 -1.629 0 N-CA-C 108.354 -0.98 . . . . 1.4299999999999999 108.354 174.797 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A 1554 ' ' GLY . . . . . . . . . . . . . . . 97.43 160.29 31.17 Favored Glycine 0 N--CA 1.443 -0.85 0 O-C-N 123.652 0.595 . . . . 1.1200000000000001 111.678 -179.003 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A 1555 ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -67.54 127.25 32.04 Favored 'General case' 0 N--CA 1.447 -0.578 0 CA-C-O 121.729 0.776 . . . . 1.8 111.334 178.474 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A 1556 ' ' ASN . . . . . 0.54 HD21 ' HB3' ' A' 1549 ' ' TYR . 3.4 t-20 -75.05 -14.47 60.6 Favored 'General case' 0 C--N 1.299 -1.603 0 C-N-CA 126.328 1.851 . . . . 2.6299999999999999 114.023 -170.069 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A 1557 ' ' GLU . . . . . 0.456 ' C ' ' H ' ' A' 1559 ' ' CYS . 50.6 mm-40 66.45 -173.61 0.19 Allowed 'General case' 0 N--CA 1.481 1.084 0 C-N-CA 123.237 0.615 . . . . 3.79 110.282 -176.112 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A 1558 ' ' ASN . . . . . . . . . . . . . 42.2 m-80 76.31 -20.9 0.34 Allowed 'General case' 0 N--CA 1.496 1.855 0 C-N-CA 125.659 1.584 . . . . 1.52 111.972 173.467 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A 1559 ' ' CYS . . . . . 0.585 ' HB3' ' HD2' ' A' 1560 ' ' PRO . 63.8 m -142.12 169.63 10.66 Favored Pre-proline 0 C--N 1.282 -2.355 0 N-CA-C 106.491 -1.67 . . . . 0.83999999999999997 106.491 179.732 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A 1560 ' ' PRO . . . . . 0.585 ' HD2' ' HB3' ' A' 1559 ' ' CYS . 26.8 Cg_exo -32.26 130.26 0.09 OUTLIER 'Trans proline' 0 C--N 1.369 1.608 0 C-N-CA 124.984 3.789 . . . . 1.1799999999999999 114.983 178.098 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A 1561 ' ' PRO . . . . . 0.427 ' HD3' ' HA ' ' A' 1560 ' ' PRO . 50.5 Cg_exo -56.09 110.83 0.62 Allowed 'Trans proline' 0 C--O 1.242 0.723 0 C-N-CA 123.583 2.855 . . . . 1.51 112.551 179.71 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A 1562 ' ' GLY . . . . . . . . . . . . . . . 141.05 -14.05 2.83 Favored Glycine 0 N--CA 1.442 -0.953 0 C-N-CA 120.526 -0.845 . . . . 0.71999999999999997 112.519 178.875 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A 1563 ' ' VAL . . . . . 0.489 HG22 ' O ' ' A' 1560 ' ' PRO . 7.3 m -85.24 151.47 3.74 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.309 0 O-C-N 122.488 -0.419 . . . . 0.96999999999999997 111.617 179.031 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A 1564 ' ' GLY . . . . . 0.421 ' HA3' ' CE2' ' A' 1592 ' ' TYR . . . -117.81 -1.23 17.35 Favored Glycine 0 N--CA 1.433 -1.547 0 N-CA-C 110.911 -0.876 . . . . 0.71999999999999997 110.911 176.201 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A 1565 ' ' ALA . . . . . . . . . . . . . . . -158.43 119.56 3.43 Favored 'General case' 0 C--O 1.247 0.952 0 N-CA-C 109.552 -0.536 . . . . 0.37 109.552 179.158 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A 1566 ' ' CYS . . . . . . . . . . . . . 48.7 t -154.33 145.77 23.09 Favored 'General case' 0 C--N 1.304 -1.373 0 N-CA-C 109.956 -0.387 . . . . 0.51000000000000001 109.956 -177.343 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A 1567 ' ' PHE . . . . . . . . . . . . . 66.9 m-85 -71.07 123.26 21.7 Favored 'General case' 0 CA--C 1.511 -0.546 0 N-CA-C 107.412 -1.329 . . . . 0.96999999999999997 107.412 172.951 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A 1568 ' ' GLY . . . . . 0.68 ' HA3' ' HE1' ' A' 1549 ' ' TYR . . . -73.62 -22.52 78.31 Favored Glycine 0 C--N 1.308 -1.01 0 C-N-CA 120.788 -0.72 . . . . 1.0800000000000001 114.735 -172.021 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A 1569 ' ' GLN . . . . . . . . . . . . . 10.0 mt-30 -90.53 -55.52 3.55 Favored 'General case' 0 C--N 1.305 -1.349 0 CA-C-O 121.125 0.488 . . . . 2.7400000000000002 109.98 -177.13 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A 1570 ' ' THR . . . . . . . . . . . . . 21.2 p -81.93 -12.98 58.13 Favored 'General case' 0 CA--C 1.546 0.821 0 N-CA-C 113.691 0.997 . . . . 1.96 113.691 -176.487 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A 1571 ' ' ARG . . . . . 0.405 ' NH2' ' HD3' ' A' 1560 ' ' PRO . 37.0 mtp85 62.91 42.44 7.66 Favored 'General case' 0 N--CA 1.476 0.872 0 C-N-CA 124.263 1.025 . . . . 3.9500000000000002 112.262 -179.883 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A 1572 ' ' ILE . . . . . . . . . . . . . 30.8 mm -104.49 122.24 57.22 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.241 0 N-CA-C 109.237 -0.653 . . . . 1.3700000000000001 109.237 -179.149 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A 1573 ' ' SER . . . . . . . . . . . . . 31.9 t -83.24 137.11 34.15 Favored 'General case' 0 C--N 1.303 -1.453 0 C-N-CA 124.364 1.066 . . . . 1.0800000000000001 111.821 -175.593 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A 1574 ' ' VAL . . . . . . . . . . . . . 11.5 m -140.01 27.48 0.5 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 115.982 -0.553 . . . . 1.3 110.72 175.224 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A 1575 ' ' GLY . . . . . . . . . . . . . . . 178.71 119.54 0.61 Allowed Glycine 0 N--CA 1.434 -1.489 0 C-N-CA 120.016 -1.088 . . . . 0.51000000000000001 112.921 178.976 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A 1576 ' ' LYS . . . . . . . . . . . . . 22.9 tptm -89.56 137.15 32.57 Favored 'General case' 0 C--N 1.304 -1.409 0 N-CA-C 107.047 -1.464 . . . . 2.8999999999999999 107.047 176.044 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A 1577 ' ' ALA . . . . . 0.677 ' HA ' ' CE2' ' A' 1592 ' ' TYR . . . -67.56 119.86 13.03 Favored 'General case' 0 C--N 1.322 -0.629 0 N-CA-C 109.379 -0.6 . . . . 0.82999999999999996 109.379 -178.772 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A 1578 ' ' ASN . . . . . . . . . . . . . 5.7 p30 -157.61 166.83 31.85 Favored 'General case' 0 C--N 1.31 -1.126 0 N-CA-C 107.071 -1.455 . . . . 1.8500000000000001 107.071 -176.468 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A 1579 ' ' LYS . . . . . 0.7 ' HE3' ' SG ' ' A' 1553 ' ' CYS . 50.9 mttp -122.1 90.07 3.24 Favored 'General case' 0 C--N 1.306 -1.317 0 N-CA-C 109.789 -0.448 . . . . 1.8999999999999999 109.789 178.179 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A 1580 ' ' ARG . . . . . . . . . . . . . 47.2 ttp180 -138.39 92.46 2.64 Favored 'General case' 0 C--N 1.309 -1.188 0 N-CA-C 106.969 -1.493 . . . . 3.6299999999999999 106.969 175.178 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A 1581 ' ' LEU . . . . . 0.704 HD11 ' HB ' ' A' 1518 ' ' VAL . 4.6 pp -127.5 158.9 36.18 Favored 'General case' 0 C--N 1.294 -1.826 0 CA-C-N 115.7 -0.682 . . . . 1.8700000000000001 110.147 -177.675 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A 1582 ' ' ARG . . . . . 0.494 ' HB3' HG13 ' A' 1584 ' ' VAL . 80.4 mtm-85 -139.96 139.09 36.02 Favored 'General case' 0 C--N 1.301 -1.539 0 O-C-N 123.449 0.468 . . . . 3.9700000000000002 109.885 178.378 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A 1583 ' ' TYR . . . . . 0.444 ' CD1' ' HG ' ' A' 1588 ' ' LEU . 25.4 t80 -99.73 90.44 4.46 Favored 'General case' 0 C--N 1.309 -1.175 0 N-CA-C 106.547 -1.649 . . . . 1.4099999999999999 106.547 174.256 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A 1584 ' ' VAL . . . . . 0.494 HG13 ' HB3' ' A' 1582 ' ' ARG . 18.3 m -115.89 124.38 72.19 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.948 0 CA-C-N 115.83 -0.623 . . . . 1.6899999999999999 111.701 -172.475 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A 1585 ' ' ASP . . . . . . . . . . . . . 38.8 t70 56.06 50.51 13.56 Favored 'General case' 0 C--N 1.31 -1.123 0 C-N-CA 123.98 0.912 . . . . 2.0600000000000001 111.701 177.901 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A 1586 ' ' GLN . . . . . . . . . . . . . 49.2 mt-30 69.75 10.71 7.66 Favored 'General case' 0 N--CA 1.481 1.105 0 CA-C-N 114.8 -1.091 . . . . 2.3300000000000001 113.853 176.253 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A 1587 ' ' VAL . . . . . 0.489 HG23 ' O ' ' A' 1612 ' ' PHE . 7.4 p -135.61 133.01 51.83 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.517 0 CA-C-O 121.49 0.662 . . . . 0.78000000000000003 110.895 -179.735 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A 1588 ' ' LEU . . . . . 0.811 ' HB2' ' HB2' ' A' 1612 ' ' PHE . 20.4 mt -80.15 142.74 34.49 Favored 'General case' 0 C--N 1.312 -1.037 0 CA-C-N 115.303 -0.862 . . . . 1.4099999999999999 110.749 178.037 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A 1589 ' ' GLN . . . . . . . . . . . . . 43.7 tt0 -128.24 106.86 9.32 Favored 'General case' 0 C--N 1.289 -2.051 0 CA-C-N 115.434 -0.803 . . . . 1.24 109.475 -179.481 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A 1590 ' ' LEU . . . . . 0.74 ' HB2' ' HE1' ' A' 1612 ' ' PHE . 21.1 tp -101.54 112.99 25.72 Favored 'General case' 0 C--N 1.314 -0.974 0 N-CA-C 107.022 -1.473 . . . . 1.1499999999999999 107.022 178.636 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A 1591 ' ' VAL . . . . . 0.522 HG22 HG22 ' A' 1609 ' ' VAL . 61.1 t -105.96 107.84 23.63 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.381 0 C-N-CA 120.107 -0.637 . . . . 1.51 112.248 -175.824 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A 1592 ' ' TYR . . . . . 0.677 ' CE2' ' HA ' ' A' 1577 ' ' ALA . 5.0 m-85 -102.89 92.84 4.75 Favored 'General case' 0 C--N 1.297 -1.691 0 CA-C-O 121.907 0.86 . . . . 1.0600000000000001 108.74 173.587 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A 1593 ' ' LYS . . . . . 0.54 ' HA ' ' HA ' ' A' 1607 ' ' LYS . 18.0 pttp -104.5 -175.44 2.8 Favored 'General case' 0 C--N 1.291 -1.948 0 CA-C-N 114.152 -1.385 . . . . 2.1800000000000002 108.285 -178.433 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A 1594 ' ' ASP . . . . . . . . . . . . . 1.6 m-20 63.67 72.5 0.47 Allowed 'General case' 0 CA--C 1.512 -0.501 0 O-C-N 124.072 0.857 . . . . 1.45 112.17 177.969 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A 1595 ' ' GLY . . . . . . . . . . . . . . . -110.11 -113.56 3.52 Favored Glycine 0 N--CA 1.425 -2.04 0 N-CA-C 109.659 -1.376 . . . . 0.78000000000000003 109.659 176.159 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A 1596 ' ' SER . . . . . . . . . . . . . 33.4 p -104.53 158.03 32.84 Favored Pre-proline 0 C--N 1.29 -1.988 0 N-CA-C 108.866 -0.79 . . . . 1.6799999999999999 108.866 177.915 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A 1597 ' ' PRO . . . . . . . . . . . . . 36.9 Cg_exo -59.45 137.2 76.59 Favored 'Trans proline' 0 C--N 1.353 0.815 0 C-N-CA 122.757 2.305 . . . . 1.1699999999999999 112.004 178.869 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A 1598 ' ' CYS . . . . . . . . . . . . . 42.7 t -95.82 115.16 65.33 Favored Pre-proline 0 C--N 1.299 -1.621 0 CA-C-N 115.899 -0.591 . . . . 1.1899999999999999 110.034 -178.711 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A 1599 ' ' PRO . . . . . 0.528 ' HD2' ' OH ' ' A' 1606 ' ' TYR . 44.2 Cg_endo -69.36 -15.63 38.73 Favored 'Trans proline' 0 CA--C 1.535 0.525 0 C-N-CA 122.591 2.194 . . . . 1.5900000000000001 112.625 -179.119 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A 1600 ' ' SER . . . . . . . . . . . . . 21.0 m -80.16 -13.16 59.47 Favored 'General case' 0 C--O 1.249 1.058 0 CA-C-N 116.157 -0.474 . . . . 2.1200000000000001 111.876 -178.261 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A 1601 ' ' LYS . . . . . 0.825 ' HG2' HD12 ' A' 1604 ' ' LEU . 16.1 tppt? -156.2 110.65 2.82 Favored 'General case' 0 N--CA 1.442 -0.83 0 N-CA-C 108.83 -0.804 . . . . 3.7400000000000002 108.83 179.405 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A 1602 ' ' SER . . . . . . . . . . . . . 8.4 m -59.61 109.84 1.0 Allowed 'General case' 0 C--N 1.296 -1.73 0 C-N-CA 124.185 0.994 . . . . 3.79 111.1 -176.991 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A 1603 ' ' GLY . . . . . . . . . . . . . . . 108.22 -17.84 34.07 Favored Glycine 0 N--CA 1.441 -0.971 0 C-N-CA 120.701 -0.762 . . . . 2.0 112.495 177.584 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A 1604 ' ' LEU . . . . . 0.825 HD12 ' HG2' ' A' 1601 ' ' LYS . 1.1 mt -86.89 146.02 26.35 Favored 'General case' 0 C--N 1.308 -1.23 0 CA-C-O 121.15 0.5 . . . . 1.48 110.838 -178.849 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A 1605 ' ' SER . . . . . . . . . . . . . 22.8 t -108.21 -175.05 2.67 Favored 'General case' 0 N--CA 1.424 -1.747 0 N-CA-C 106.336 -1.728 . . . . 1.51 106.336 173.378 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A 1606 ' ' TYR . . . . . 0.528 ' OH ' ' HD2' ' A' 1599 ' ' PRO . 78.6 m-85 -107.46 135.7 48.49 Favored 'General case' 0 CA--C 1.46 -2.485 0 N-CA-C 107.705 -1.22 . . . . 1.1799999999999999 107.705 -176.452 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A 1607 ' ' LYS . . . . . 0.54 ' HA ' ' HA ' ' A' 1593 ' ' LYS . 24.6 pttm -122.31 134.54 54.66 Favored 'General case' 0 N--CA 1.398 -3.062 0 C-N-CA 118.592 -1.243 . . . . 1.6699999999999999 110.433 176.835 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A 1608 ' ' SER . . . . . . . . . . . . . 47.1 m -101.56 111.15 23.3 Favored 'General case' 0 C--N 1.28 -2.452 0 CA-C-N 115.17 -0.923 . . . . 1.0 108.543 176.857 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A 1609 ' ' VAL . . . . . 0.522 HG22 HG22 ' A' 1591 ' ' VAL . 56.4 t -98.09 112.56 30.45 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.107 0 N-CA-C 109.48 -0.563 . . . . 0.93000000000000005 109.48 177.568 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A 1610 ' ' ILE . . . . . 0.593 ' HB ' ' HB3' ' A' 1590 ' ' LEU . 2.5 mp -93.46 104.72 16.04 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.649 0 N-CA-C 107.521 -1.289 . . . . 0.78000000000000003 107.521 177.353 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A 1611 ' ' SER . . . . . 0.402 ' O ' ' HA ' ' A' 1639 ' ' SER . 22.8 t -90.72 117.41 29.34 Favored 'General case' 0 C--N 1.293 -1.864 0 N-CA-C 108.387 -0.968 . . . . 1.29 108.387 -179.735 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A 1612 ' ' PHE . . . . . 0.811 ' HB2' ' HB2' ' A' 1588 ' ' LEU . 50.7 m-85 -92.15 102.22 14.74 Favored 'General case' 0 C--N 1.31 -1.126 0 N-CA-C 108.985 -0.746 . . . . 0.69999999999999996 108.985 -179.651 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A 1613 ' ' VAL . . . . . . . . . . . . . 47.8 t -100.53 127.59 53.44 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.51 0 N-CA-C 107.821 -1.177 . . . . 0.75 107.821 -177.881 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A 1614 ' ' CYS . . . . . 0.648 ' HA ' ' O ' ' A' 1642 ' ' THR . 8.3 t -71.45 106.4 3.93 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-O 121.28 0.562 . . . . 1.3899999999999999 111.618 -176.657 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A 1615 ' ' ARG . . . . . 0.775 ' HB2' ' HB3' ' A' 1641 ' ' HIS . 37.2 mmt180 -137.09 85.2 22.91 Favored Pre-proline 0 N--CA 1.433 -1.306 0 CA-C-N 115.228 -0.896 . . . . 3.75 110.462 177.048 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A 1616 ' ' PRO . . . . . . . . . . . . . 48.5 Cg_exo -61.22 -16.61 47.59 Favored 'Trans proline' 0 N--CA 1.482 0.801 0 C-N-CA 122.942 2.428 . . . . 1.3200000000000001 111.481 174.444 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A 1617 ' ' GLU . . . . . 0.405 ' CD ' ' HD2' ' A' 1615 ' ' ARG . 8.6 pt-20 -69.99 -17.66 63.3 Favored 'General case' 0 C--N 1.318 -0.765 0 C-N-CA 123.886 0.874 . . . . 3.21 112.345 178.328 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A 1618 ' ' ALA . . . . . . . . . . . . . . . -76.67 141.55 40.91 Favored 'General case' 0 C--N 1.312 -1.057 0 CA-C-O 120.794 0.33 . . . . 2.4399999999999999 110.673 -176.596 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A 1619 ' ' GLY . . . . . . . . . . . . . . . -145.3 -80.52 0.04 OUTLIER Glycine 0 N--CA 1.436 -1.339 0 N-CA-C 111.465 -0.654 . . . . 3.2599999999999998 111.465 -178.24 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A 1620 ' ' PRO . . . . . . . . . . . . . 31.5 Cg_endo -65.12 -32.62 52.4 Favored 'Trans proline' 0 C--O 1.236 0.399 0 C-N-CA 122.58 2.187 . . . . 5.9199999999999999 112.59 -179.603 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A 1621 ' ' THR . . . . . . . . . . . . . 2.8 m -110.18 29.38 7.72 Favored 'General case' 0 N--CA 1.435 -1.183 0 CA-C-O 121.683 0.754 . . . . 4.7599999999999998 109.345 -178.188 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A 1622 ' ' ASN . . . . . . . . . . . . . 50.0 t-20 -77.65 75.98 4.19 Favored 'General case' 0 C--O 1.245 0.856 0 N-CA-C 108.878 -0.786 . . . . 2.9199999999999999 108.878 179.015 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A 1623 ' ' ARG . . . . . . . . . . . . . 19.0 ptp180 -155.42 161.38 29.58 Favored Pre-proline 0 C--O 1.247 0.94 0 N-CA-C 108.131 -1.063 . . . . 3.6099999999999999 108.131 -179.67 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A 1624 ' ' PRO . . . . . . . . . . . . . 7.7 Cg_exo -73.42 94.7 0.84 Allowed 'Trans proline' 0 N--CA 1.458 -0.595 0 C-N-CA 122.747 2.298 . . . . 2.3700000000000001 111.566 177.476 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A 1625 ' ' MET . . . . . . . . . . . . . 20.5 ptp -81.64 150.12 28.24 Favored 'General case' 0 C--N 1.313 -1.011 0 CA-C-N 115.646 -0.706 . . . . 2.1600000000000001 109.797 179.735 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A 1626 ' ' LEU . . . . . . . . . . . . . 47.3 tp -90.35 105.25 17.69 Favored 'General case' 0 C--N 1.304 -1.389 0 N-CA-C 108.194 -1.039 . . . . 1.3500000000000001 108.194 179.101 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A 1627 ' ' ILE . . . . . . . . . . . . . 44.7 pt -85.7 -38.07 12.52 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.331 0 N-CA-C 112.119 0.414 . . . . 1.21 112.119 -175.428 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A 1628 ' ' SER . . . . . . . . . . . . . 19.4 t -148.95 150.91 33.69 Favored 'General case' 0 N--CA 1.432 -1.34 0 N-CA-C 109.036 -0.727 . . . . 1.3999999999999999 109.036 -177.426 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A 1629 ' ' LEU . . . . . 1.0 ' HG ' ' HG ' ' A' 1636 ' ' LEU . 3.1 tt -141.83 116.19 9.53 Favored 'General case' 0 C--N 1.303 -1.446 0 N-CA-C 106.682 -1.599 . . . . 1.5600000000000001 106.682 179.798 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A 1630 ' ' ASP . . . . . . . . . . . . . 33.2 t70 -109.27 119.84 40.7 Favored 'General case' 0 C--N 1.294 -1.833 0 N-CA-C 109.444 -0.576 . . . . 0.87 109.444 176.723 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A 1631 ' ' LYS . . . . . . . . . . . . . 30.1 mtpp -77.35 -24.93 50.63 Favored 'General case' 0 C--N 1.3 -1.564 0 CA-C-N 115.592 -0.731 . . . . 2.3500000000000001 111.272 -175.913 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A 1632 ' ' GLN . . . . . . . . . . . . . 39.6 mt-30 -68.57 -44.52 74.26 Favored 'General case' 0 CA--C 1.515 -0.381 0 CA-C-O 121.397 0.618 . . . . 2.5499999999999998 110.519 -176.317 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A 1633 ' ' THR . . . . . . . . . . . . . 25.1 p -90.42 -4.4 57.04 Favored 'General case' 0 C--N 1.31 -1.146 0 CA-C-N 115.516 -0.765 . . . . 1.24 110.797 177.347 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A 1634 ' ' CYS . . . . . 0.491 ' O ' ' HA ' ' A' 1606 ' ' TYR . 29.3 m 56.98 41.97 26.9 Favored 'General case' 0 C--O 1.221 -0.41 0 CA-C-N 114.288 -1.324 . . . . 0.89000000000000001 109.503 179.061 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A 1635 ' ' THR . . . . . . . . . . . . . 89.3 m -124.11 131.32 53.53 Favored 'General case' 0 N--CA 1.428 -1.537 0 CA-C-N 115.226 -0.897 . . . . 0.75 111.389 -173.217 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A 1636 ' ' LEU . . . . . 1.0 ' HG ' ' HG ' ' A' 1629 ' ' LEU . 5.2 mp -108.66 130.74 55.33 Favored 'General case' 0 N--CA 1.432 -1.353 0 N-CA-C 108.567 -0.901 . . . . 1.3300000000000001 108.567 177.626 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A 1637 ' ' PHE . . . . . . . . . . . . . 94.3 m-85 -105.76 105.95 16.23 Favored 'General case' 0 C--N 1.308 -1.204 0 CA-C-O 121.069 0.461 . . . . 0.82999999999999996 110.953 -177.489 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A 1638 ' ' PHE . . . . . 0.4 ' HB2' ' HA ' ' A' 1610 ' ' ILE . 99.6 m-85 -100.79 148.0 25.42 Favored 'General case' 0 C--N 1.303 -1.416 0 N-CA-C 108.4 -0.963 . . . . 0.59999999999999998 108.4 177.681 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A 1639 ' ' SER . . . . . 0.402 ' HA ' ' O ' ' A' 1611 ' ' SER . 66.2 m -137.33 115.1 11.34 Favored 'General case' 0 C--N 1.281 -2.382 0 CA-C-O 121.445 0.64 . . . . 1.0800000000000001 110.703 176.984 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A 1640 ' ' TRP . . . . . 0.575 ' HH2' HD22 ' A' 1532 ' ' LEU . 7.9 t90 -95.93 122.14 38.42 Favored 'General case' 0 N--CA 1.418 -2.05 0 N-CA-C 106.569 -1.641 . . . . 0.80000000000000004 106.569 178.434 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A 1641 ' ' HIS . . . . . 0.775 ' HB3' ' HB2' ' A' 1615 ' ' ARG . 90.5 m-70 -95.09 102.99 14.83 Favored 'General case' 0 C--N 1.285 -2.206 0 N-CA-C 107.633 -1.247 . . . . 2.54 107.633 178.206 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A 1642 ' ' THR . . . . . 0.648 ' O ' ' HA ' ' A' 1614 ' ' CYS . 8.9 t -142.42 140.2 18.62 Favored Pre-proline 0 C--N 1.297 -1.678 0 CA-C-N 115.45 -0.795 . . . . 1.1499999999999999 111.21 -173.134 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A 1643 ' ' PRO . . . . . . . . . . . . . 57.4 Cg_endo -71.46 -0.82 8.78 Favored 'Trans proline' 0 CA--C 1.534 0.494 0 C-N-CA 123.621 2.881 . . . . 0.80000000000000004 112.451 176.865 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A 1644 ' ' LEU . . . . . . . . . . . . . 77.5 mt -85.4 -4.33 59.13 Favored 'General case' 0 C--N 1.322 -0.613 0 C-N-CA 122.62 0.368 . . . . 1.54 111.113 -179.085 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A 1645 ' ' ALA . . . . . . . . . . . . . . . -88.84 -13.87 38.26 Favored 'General case' 0 C--N 1.319 -0.725 0 N-CA-C 111.984 0.364 . . . . 0.94999999999999996 111.984 -178.129 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A 1646 ' ' CYS . . . . . . . . . . . . . 14.3 p -148.02 -177.04 5.52 Favored 'General case' 0 C--N 1.304 -1.386 0 N-CA-C 107.137 -1.431 . . . . 1.4099999999999999 107.137 -179.27 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A 1647 ' ' GLU . . . . . . . . . . . . . 9.8 tp10 -113.77 99.52 50.22 Favored Pre-proline 0 N--CA 1.428 -1.526 0 N-CA-C 107.891 -1.151 . . . . 2.9199999999999999 107.891 174.643 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A 1648 ' ' PRO . . . . . . . . . . . . . 97.4 Cg_exo -47.78 112.45 0.57 Allowed 'Trans proline' 0 C--N 1.354 0.827 0 C-N-CA 124.014 3.143 . . . . 2.8199999999999998 112.776 179.293 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A 1649 ' ' GLU . . . . . . . . . . . . . 44.3 tt0 . . . . . 0 C--N 1.292 -1.925 0 N-CA-C 107.927 -1.138 . . . . 5.0599999999999996 107.927 -179.661 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A 1508 ' ' MET . . . . . . . . . . . . . 72.4 mtm . . . . . 0 C--O 1.24 0.581 0 CA-C-O 120.962 0.411 . . . . 8.2699999999999996 110.515 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A 1509 ' ' LYS . . . . . . . . . . . . . 95.5 mttt -128.18 124.76 37.6 Favored 'General case' 0 N--CA 1.441 -0.888 0 N-CA-C 109.685 -0.487 . . . . 6.4800000000000004 109.685 178.351 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A 1510 ' ' SER . . . . . . . . . . . . . 32.1 m -99.62 104.1 15.85 Favored 'General case' 0 C--N 1.294 -1.843 0 N-CA-C 108.345 -0.983 . . . . 4.2199999999999998 108.345 178.702 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A 1511 ' ' ASN . . . . . . . . . . . . . 31.8 p30 -142.76 6.45 1.61 Allowed 'General case' 0 C--N 1.306 -1.285 0 CA-C-N 116.262 -0.426 . . . . 3.0800000000000001 112.137 -177.615 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A 1512 ' ' GLU . . . . . . . . . . . . . 9.3 tp10 -67.45 -45.69 75.27 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 109.171 -0.677 . . . . 4.46 109.171 179.679 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A 1513 ' ' HIS . . . . . 0.422 ' HA ' ' O ' ' A' 1579 ' ' LYS . 51.4 m80 -121.91 -8.55 8.87 Favored 'General case' 0 C--N 1.313 -0.986 0 CA-C-N 115.885 -0.598 . . . . 5.5700000000000003 111.017 176.952 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A 1514 ' ' ASP . . . . . . . . . . . . . 4.8 m-20 -92.28 -20.01 21.57 Favored 'General case' 0 C--N 1.311 -1.099 0 N-CA-C 114.028 1.122 . . . . 3.7000000000000002 114.028 -173.197 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A 1515 ' ' ASP . . . . . . . . . . . . . 4.1 t70 -143.99 -174.97 4.42 Favored 'General case' 0 C--N 1.301 -1.535 0 C-N-CA 119.189 -1.004 . . . . 2.54 108.548 -176.208 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A 1516 ' ' CYS . . . . . . . . . . . . . 52.0 m -115.67 44.56 1.86 Allowed 'General case' 0 C--N 1.29 -2.007 0 N-CA-C 108.35 -0.982 . . . . 1.25 108.35 -176.811 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A 1517 ' ' GLN . . . . . . . . . . . . . 10.6 pt20 -148.47 138.07 22.12 Favored 'General case' 0 N--CA 1.433 -1.282 0 C-N-CA 120.79 -0.364 . . . . 1.8799999999999999 111.054 -176.948 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A 1518 ' ' VAL . . . . . . . . . . . . . 29.4 m -113.87 154.06 15.31 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.668 0 CA-C-N 115.744 -0.662 . . . . 1.73 109.945 179.551 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A 1519 ' ' THR . . . . . 0.521 ' HA ' ' HA ' ' A' 1526 ' ' LEU . 32.0 m -119.61 137.76 53.66 Favored 'General case' 0 C--N 1.277 -2.544 0 N-CA-C 109.037 -0.727 . . . . 1.7 109.037 177.354 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A 1520 ' ' ASN . . . . . . . . . . . . . 38.3 t-20 -93.78 101.61 6.41 Favored Pre-proline 0 C--N 1.315 -0.895 0 N-CA-C 107.416 -1.327 . . . . 2.1200000000000001 107.416 175.139 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A 1521 ' ' PRO . . . . . 0.466 ' HD3' ' O ' ' A' 1519 ' ' THR . 23.4 Cg_exo -65.71 -14.07 42.91 Favored 'Trans proline' 0 C--N 1.36 1.165 0 C-N-CA 123.205 2.603 . . . . 2.4700000000000002 113.802 -176.772 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A 1522 ' ' SER . . . . . . . . . . . . . 33.3 t -71.24 -38.39 71.95 Favored 'General case' 0 N--CA 1.439 -0.977 0 N-CA-C 109.746 -0.464 . . . . 2.5699999999999998 109.746 178.759 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A 1523 ' ' THR . . . . . . . . . . . . . 7.2 t -112.37 -16.53 12.91 Favored 'General case' 0 C--N 1.317 -0.827 0 N-CA-C 112.766 0.654 . . . . 2.1499999999999999 112.766 -177.116 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A 1524 ' ' GLY . . . . . . . . . . . . . . . 81.66 14.54 77.77 Favored Glycine 0 C--O 1.229 -0.172 0 C-N-CA 120.984 -0.627 . . . . 1.8899999999999999 111.591 -178.764 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A 1525 ' ' HIS . . . . . . . . . . . . . 32.5 t-80 -101.45 131.99 47.28 Favored 'General case' 0 C--N 1.306 -1.318 0 CA-C-O 121.077 0.465 . . . . 1.8999999999999999 110.187 -178.925 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A 1526 ' ' LEU . . . . . 0.521 ' HA ' ' HA ' ' A' 1519 ' ' THR . 7.8 tt -101.52 143.37 31.6 Favored 'General case' 0 C--N 1.289 -2.038 0 CA-C-N 115.329 -0.851 . . . . 1.6100000000000001 110.211 -178.166 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A 1527 ' ' PHE . . . . . 0.416 ' HE1' ' HG3' ' A' 1647 ' ' GLU . 80.0 m-85 -118.09 113.08 21.07 Favored 'General case' 0 C--N 1.312 -1.032 0 N-CA-C 107.291 -1.374 . . . . 1.4199999999999999 107.291 176.524 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A 1528 ' ' ASP . . . . . . . . . . . . . 1.3 p-10 -104.79 141.61 36.19 Favored 'General case' 0 C--N 1.297 -1.714 0 CA-C-O 121.955 0.883 . . . . 2.1800000000000002 110.938 -178.441 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A 1529 ' ' LEU . . . . . . . . . . . . . 75.7 mt -114.16 11.19 17.48 Favored 'General case' 0 C--N 1.287 -2.13 0 N-CA-C 105.7 -1.963 . . . . 1.4399999999999999 105.7 173.253 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A 1530 ' ' SER . . . . . . . . . . . . . 5.5 m -73.44 -37.32 65.88 Favored 'General case' 0 N--CA 1.43 -1.435 0 CA-C-N 114.166 -1.379 . . . . 1.4399999999999999 109.323 -178.977 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A 1531 ' ' SER . . . . . . . . . . . . . 12.8 m -79.85 -7.95 59.01 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-O 121.466 0.651 . . . . 1.5 109.33 175.324 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A 1532 ' ' LEU . . . . . . . . . . . . . 92.8 mt -106.83 9.15 31.01 Favored 'General case' 0 N--CA 1.448 -0.565 0 CA-C-N 115.669 -0.696 . . . . 1.77 110.514 177.017 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A 1533 ' ' SER . . . . . . . . . . . . . 66.0 m -70.94 107.52 4.1 Favored 'General case' 0 N--CA 1.437 -1.081 0 CA-C-O 121.733 0.778 . . . . 2.3799999999999999 111.577 -175.447 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A 1534 ' ' GLY . . . . . 0.402 ' HA3' ' CE2' ' A' 1538 ' ' PHE . . . -103.23 103.0 2.3 Favored Glycine 0 N--CA 1.423 -2.202 0 N-CA-C 109.632 -1.387 . . . . 1.55 109.632 176.607 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A 1535 ' ' ARG . . . . . . . . . . . . . 71.4 ttt180 -79.27 -20.66 47.55 Favored 'General case' 0 C--O 1.205 -1.257 0 O-C-N 124.205 0.591 . . . . 3.96 111.114 -176.732 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A 1536 ' ' ALA . . . . . . . . . . . . . . . -90.59 -3.21 57.72 Favored 'General case' 0 C--N 1.309 -1.166 0 C-N-CA 119.643 -0.823 . . . . 1.6499999999999999 109.39 178.979 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A 1537 ' ' GLY . . . . . 0.434 ' HA2' ' HA ' ' A' 1551 ' ' SER . . . 79.13 166.07 30.85 Favored Glycine 0 N--CA 1.423 -2.214 0 CA-C-N 114.855 -1.066 . . . . 1.1899999999999999 113.123 177.932 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A 1538 ' ' PHE . . . . . 0.402 ' CE2' ' HA3' ' A' 1534 ' ' GLY . 97.1 m-85 -133.73 163.43 29.48 Favored 'General case' 0 C--N 1.297 -1.678 0 N-CA-C 107.472 -1.307 . . . . 1.6899999999999999 107.472 176.507 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A 1539 ' ' THR . . . . . 0.512 ' HA ' ' O ' ' A' 1548 ' ' VAL . 59.4 p -118.06 157.73 26.31 Favored 'General case' 0 C--N 1.303 -1.422 0 N-CA-C 113.335 0.865 . . . . 1.48 113.335 -172.315 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A 1540 ' ' ALA . . . . . . . . . . . . . . . -142.55 146.13 34.32 Favored 'General case' 0 C--O 1.25 1.131 0 N-CA-C 106.685 -1.598 . . . . 0.82999999999999996 106.685 173.628 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A 1541 ' ' ALA . . . . . . . . . . . . . . . -65.05 131.65 47.14 Favored 'General case' 0 C--O 1.247 0.952 0 O-C-N 124.222 0.951 . . . . 1.27 110.611 -178.571 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A 1542 ' ' TYR . . . . . . . . . . . . . 81.0 t80 -143.34 171.14 14.52 Favored 'General case' 0 C--N 1.3 -1.585 0 CA-C-N 115.427 -0.806 . . . . 2.1499999999999999 109.343 -177.264 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A 1543 ' ' SER . . . . . . . . . . . . . 14.0 m -44.28 -151.62 0.0 OUTLIER 'General case' 0 CA--C 1.581 2.165 0 C-N-CA 129.728 3.211 . . . . 2.29 114.961 176.327 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A 1544 ' ' LYS . . . . . . . . . . . . . 39.9 ttmt -36.03 -39.24 0.16 Allowed 'General case' 0 CA--C 1.568 1.665 0 C-N-CA 125.217 1.407 . . . . 3.9100000000000001 114.143 178.149 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A 1545 ' ' SER . . . . . . . . . . . . . 48.3 t -66.45 -21.73 66.2 Favored 'General case' 0 CA--C 1.56 1.332 0 N-CA-C 112.329 0.492 . . . . 3.2999999999999998 112.329 177.462 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A 1546 ' ' GLY . . . . . . . . . . . . . . . 88.75 -63.8 3.51 Favored Glycine 0 CA--C 1.492 -1.345 0 N-CA-C 111.455 -0.658 . . . . 1.24 111.455 179.999 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A 1547 ' ' VAL . . . . . . . . . . . . . 13.3 m -140.58 157.87 24.22 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.416 0 C-N-CA 123.205 0.602 . . . . 1.6299999999999999 109.874 178.318 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A 1548 ' ' VAL . . . . . 0.512 ' O ' ' HA ' ' A' 1539 ' ' THR . 5.7 t -111.98 142.7 23.55 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.28 0 N-CA-C 106.598 -1.63 . . . . 0.92000000000000004 106.598 176.388 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A 1549 ' ' TYR . . . . . 0.515 ' CD2' ' HA2' ' A' 1568 ' ' GLY . 62.2 m-85 -98.4 114.91 27.43 Favored 'General case' 0 C--N 1.31 -1.152 0 N-CA-C 108.08 -1.082 . . . . 1.4399999999999999 108.08 173.509 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A 1550 ' ' MET . . . . . . . . . . . . . 65.4 mtm -128.6 133.15 48.23 Favored 'General case' 0 C--N 1.299 -1.603 0 N-CA-C 109.448 -0.575 . . . . 1.74 109.448 176.543 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A 1551 ' ' SER . . . . . 0.434 ' HA ' ' HA2' ' A' 1537 ' ' GLY . 23.8 p -86.3 147.8 25.9 Favored 'General case' 0 C--N 1.289 -2.048 0 N-CA-C 106.658 -1.608 . . . . 1.6399999999999999 106.658 175.983 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A 1552 ' ' ILE . . . . . . . . . . . . . 35.7 mm -76.41 -29.72 19.0 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.978 0 N-CA-C 108.77 -0.826 . . . . 1.3300000000000001 108.77 -178.706 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A 1553 ' ' CYS . . . . . . . . . . . . . 38.2 t -162.94 138.38 6.82 Favored 'General case' 0 N--CA 1.432 -1.344 0 N-CA-C 107.519 -1.289 . . . . 1.4299999999999999 107.519 169.398 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A 1554 ' ' GLY . . . . . . . . . . . . . . . 96.13 -164.93 23.81 Favored Glycine 0 N--CA 1.438 -1.205 0 C-N-CA 120.781 -0.724 . . . . 1.1200000000000001 112.802 176.05 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A 1555 ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -76.43 156.17 33.34 Favored 'General case' 0 C--N 1.312 -1.046 0 C-N-CA 122.622 0.369 . . . . 1.8 110.028 -179.734 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A 1556 ' ' ASN . . . . . 0.431 HD21 ' HB3' ' A' 1549 ' ' TYR . 27.5 t-20 -98.31 -17.66 18.77 Favored 'General case' 0 CA--C 1.548 0.874 0 N-CA-C 113.413 0.894 . . . . 2.6299999999999999 113.413 -173.719 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A 1557 ' ' GLU . . . . . . . . . . . . . 30.1 mt-10 65.66 -24.04 0.09 Allowed 'General case' 0 N--CA 1.492 1.656 0 N-CA-C 115.376 1.621 . . . . 3.79 115.376 179.738 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A 1558 ' ' ASN . . . . . . . . . . . . . 38.6 m-80 -75.64 -21.4 57.75 Favored 'General case' 0 CA--C 1.503 -0.834 0 CA-C-O 121.731 0.777 . . . . 1.52 109.11 177.133 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A 1559 ' ' CYS . . . . . . . . . . . . . 73.4 m -135.05 158.38 74.98 Favored Pre-proline 0 N--CA 1.423 -1.802 0 N-CA-C 106.66 -1.608 . . . . 0.83999999999999997 106.66 176.731 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A 1560 ' ' PRO . . . . . 0.487 ' HA ' ' HD3' ' A' 1561 ' ' PRO . 3.0 Cg_exo -32.82 145.52 0.03 OUTLIER 'Trans proline' 0 CA--C 1.561 1.832 1 C-N-CA 125.859 4.373 . . . . 1.1799999999999999 117.014 -176.186 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A 1561 ' ' PRO . . . . . 0.487 ' HD3' ' HA ' ' A' 1560 ' ' PRO . 42.5 Cg_exo -59.37 115.08 2.34 Favored 'Trans proline' 0 C--O 1.245 0.834 0 C-N-CA 123.43 2.753 . . . . 1.51 110.421 176.827 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A 1562 ' ' GLY . . . . . . . . . . . . . . . 121.79 -11.42 9.49 Favored Glycine 0 N--CA 1.426 -1.974 0 N-CA-C 110.174 -1.17 . . . . 0.71999999999999997 110.174 -176.086 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A 1563 ' ' VAL . . . . . . . . . . . . . 66.2 t -99.29 133.88 40.42 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.275 0 N-CA-C 108.005 -1.109 . . . . 0.96999999999999997 108.005 176.224 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A 1564 ' ' GLY . . . . . . . . . . . . . . . -114.54 -34.53 1.56 Allowed Glycine 0 N--CA 1.443 -0.89 0 C-N-CA 120.916 -0.659 . . . . 0.71999999999999997 111.78 -179.319 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A 1565 ' ' ALA . . . . . . . . . . . . . . . -123.09 121.08 35.14 Favored 'General case' 0 C--O 1.249 1.043 0 N-CA-C 108.871 -0.789 . . . . 0.37 108.871 -179.753 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A 1566 ' ' CYS . . . . . . . . . . . . . 38.6 t -146.45 140.88 26.58 Favored 'General case' 0 C--N 1.297 -1.709 0 N-CA-C 108.964 -0.754 . . . . 0.51000000000000001 108.964 -173.953 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A 1567 ' ' PHE . . . . . 0.459 ' O ' ' HA ' ' A' 1571 ' ' ARG . 16.3 m-85 -63.23 132.76 52.75 Favored 'General case' 0 C--O 1.21 -1.01 0 N-CA-C 108.518 -0.919 . . . . 0.96999999999999997 108.518 177.174 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A 1568 ' ' GLY . . . . . 0.515 ' HA2' ' CD2' ' A' 1549 ' ' TYR . . . -68.99 -36.0 80.21 Favored Glycine 0 N--CA 1.435 -1.387 0 CA-C-N 115.752 -0.658 . . . . 1.0800000000000001 114.622 -174.164 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A 1569 ' ' GLN . . . . . . . . . . . . . 36.1 tt0 -90.44 -53.89 4.24 Favored 'General case' 0 C--N 1.303 -1.43 0 CA-C-O 121.671 0.748 . . . . 2.7400000000000002 110.261 -179.393 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A 1570 ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -74.96 -20.06 59.84 Favored 'General case' 0 C--N 1.298 -1.641 0 CA-C-N 114.836 -1.075 . . . . 1.96 112.783 -172.971 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A 1571 ' ' ARG . . . . . 0.459 ' HA ' ' O ' ' A' 1567 ' ' PHE . 50.8 mtp180 54.36 36.37 25.22 Favored 'General case' 0 CA--C 1.51 -0.58 0 C-N-CA 125.814 1.646 . . . . 3.9500000000000002 113.589 179.633 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A 1572 ' ' ILE . . . . . . . . . . . . . 43.6 mm -94.96 123.89 47.26 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.286 0 N-CA-C 108.893 -0.78 . . . . 1.3700000000000001 108.893 178.079 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A 1573 ' ' SER . . . . . . . . . . . . . 31.5 t -65.44 95.71 0.22 Allowed 'General case' 0 C--N 1.307 -1.266 0 C-N-CA 125.309 1.444 . . . . 1.0800000000000001 111.207 179.94 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A 1574 ' ' VAL . . . . . 0.482 ' O ' ' HA3' ' A' 1595 ' ' GLY . 27.6 m -88.17 -30.94 5.55 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.871 0 N-CA-C 112.327 0.491 . . . . 1.3 112.327 179.099 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A 1575 ' ' GLY . . . . . . . . . . . . . . . -136.58 132.25 5.98 Favored Glycine 0 C--O 1.246 0.85 0 C-N-CA 120.858 -0.687 . . . . 0.51000000000000001 112.177 179.816 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A 1576 ' ' LYS . . . . . 0.603 ' HG2' ' HA2' ' A' 1595 ' ' GLY . 75.5 mmtt -88.77 149.37 23.47 Favored 'General case' 0 C--N 1.312 -1.049 0 N-CA-C 109.859 -0.423 . . . . 2.8999999999999999 109.859 -179.894 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A 1577 ' ' ALA . . . . . . . . . . . . . . . -67.07 98.87 0.61 Allowed 'General case' 0 C--N 1.307 -1.278 0 C-N-CA 123.976 0.91 . . . . 0.82999999999999996 110.913 -178.195 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A 1578 ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -113.49 120.34 40.67 Favored 'General case' 0 C--N 1.306 -1.299 0 N-CA-C 108.504 -0.925 . . . . 1.8500000000000001 108.504 177.261 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A 1579 ' ' LYS . . . . . 0.422 ' O ' ' HA ' ' A' 1513 ' ' HIS . 48.9 mtmt -90.96 90.55 7.93 Favored 'General case' 0 C--N 1.307 -1.254 0 N-CA-C 107.294 -1.372 . . . . 1.8999999999999999 107.294 177.621 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A 1580 ' ' ARG . . . . . . . . . . . . . 17.7 ttp180 -165.84 110.98 0.85 Allowed 'General case' 0 C--N 1.309 -1.192 0 CA-C-N 115.309 -0.859 . . . . 3.6299999999999999 110.246 -175.216 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A 1581 ' ' LEU . . . . . . . . . . . . . 3.9 mm? -101.77 137.28 40.29 Favored 'General case' 0 C--N 1.316 -0.877 0 CA-C-N 115.888 -0.596 . . . . 1.8700000000000001 109.563 178.592 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A 1582 ' ' ARG . . . . . . . . . . . . . 90.4 mtt180 -108.68 98.31 7.83 Favored 'General case' 0 C--N 1.291 -1.957 0 CA-C-N 116.374 -0.375 . . . . 3.9700000000000002 110.254 177.057 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A 1583 ' ' TYR . . . . . . . . . . . . . 92.8 t80 -79.84 110.13 14.92 Favored 'General case' 0 C--N 1.311 -1.098 0 CA-C-N 115.477 -0.783 . . . . 1.4099999999999999 109.153 -179.615 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A 1584 ' ' VAL . . . . . 0.62 ' O ' HG12 ' A' 1587 ' ' VAL . 3.9 p -148.36 126.4 3.24 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.419 0 CA-C-N 116.17 -0.468 . . . . 1.6899999999999999 110.076 179.703 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A 1585 ' ' ASP . . . . . . . . . . . . . 38.4 t70 54.34 44.65 28.64 Favored 'General case' 0 N--CA 1.484 1.244 0 CA-C-O 122.748 1.261 . . . . 2.0600000000000001 109.951 -177.894 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A 1586 ' ' GLN . . . . . . . . . . . . . 48.4 mt-30 59.79 18.41 7.29 Favored 'General case' 0 CA--C 1.539 0.545 0 CA-C-N 113.632 -1.622 . . . . 2.3300000000000001 114.32 179.141 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A 1587 ' ' VAL . . . . . 0.62 HG12 ' O ' ' A' 1584 ' ' VAL . 4.0 p -103.78 139.64 24.16 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.146 0 N-CA-C 108.568 -0.901 . . . . 0.78000000000000003 108.568 176.733 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A 1588 ' ' LEU . . . . . 0.725 ' HB2' ' HB2' ' A' 1612 ' ' PHE . 41.1 mt -94.27 123.83 37.91 Favored 'General case' 0 C--N 1.296 -1.732 0 N-CA-C 106.187 -1.783 . . . . 1.4099999999999999 106.187 174.179 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A 1589 ' ' GLN . . . . . . . . . . . . . 9.8 tt0 -122.4 112.96 18.72 Favored 'General case' 0 C--N 1.281 -2.398 0 CA-C-N 116.398 -0.365 . . . . 1.24 110.094 -173.864 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A 1590 ' ' LEU . . . . . 0.433 ' HB3' ' HB ' ' A' 1610 ' ' ILE . 32.8 tp -100.7 116.48 32.71 Favored 'General case' 0 C--N 1.299 -1.59 0 N-CA-C 107.078 -1.452 . . . . 1.1499999999999999 107.078 -179.659 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A 1591 ' ' VAL . . . . . . . . . . . . . 15.4 m -106.94 94.82 3.33 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.565 0 N-CA-C 113.803 1.038 . . . . 1.51 113.803 -174.884 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A 1592 ' ' TYR . . . . . . . . . . . . . 14.7 m-30 -86.5 92.92 9.02 Favored 'General case' 0 C--N 1.312 -1.035 0 N-CA-C 107.811 -1.181 . . . . 1.0600000000000001 107.811 173.435 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A 1593 ' ' LYS . . . . . . . . . . . . . 14.6 ptmm? -115.43 175.08 5.68 Favored 'General case' 0 C--N 1.293 -1.868 0 CA-C-N 115.951 -0.568 . . . . 2.1800000000000002 111.588 -174.874 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A 1594 ' ' ASP . . . . . . . . . . . . . 8.9 m-20 62.86 31.32 16.41 Favored 'General case' 0 CA--C 1.509 -0.613 0 O-C-N 124.17 0.919 . . . . 1.45 112.154 -178.799 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A 1595 ' ' GLY . . . . . 0.603 ' HA2' ' HG2' ' A' 1576 ' ' LYS . . . -78.58 -84.93 0.54 Allowed Glycine 0 N--CA 1.435 -1.402 0 C-N-CA 120.855 -0.688 . . . . 0.78000000000000003 112.624 -178.004 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A 1596 ' ' SER . . . . . . . . . . . . . 14.4 t -101.58 145.17 29.98 Favored Pre-proline 0 C--N 1.293 -1.87 0 N-CA-C 108.498 -0.927 . . . . 1.6799999999999999 108.498 -177.75 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A 1597 ' ' PRO . . . . . . . . . . . . . 24.2 Cg_exo -67.99 131.78 24.73 Favored 'Trans proline' 0 C--O 1.238 0.5 0 C-N-CA 122.785 2.323 . . . . 1.1699999999999999 110.371 175.252 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A 1598 ' ' CYS . . . . . 0.738 ' HA ' ' HE1' ' A' 1606 ' ' TYR . 40.6 t -95.09 123.09 58.35 Favored Pre-proline 0 C--N 1.304 -1.392 0 CA-C-O 120.767 0.318 . . . . 1.1899999999999999 110.476 -176.634 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A 1599 ' ' PRO . . . . . . . . . . . . . 91.2 Cg_endo -88.44 -9.36 5.02 Favored 'Trans proline' 0 N--CA 1.454 -0.851 0 C-N-CA 122.798 2.332 . . . . 1.5900000000000001 112.913 179.799 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A 1600 ' ' SER . . . . . . . . . . . . . 14.9 m -70.31 -21.87 62.88 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-O 121.101 0.477 . . . . 2.1200000000000001 110.77 -177.795 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A 1601 ' ' LYS . . . . . 0.942 ' HB3' HD12 ' A' 1604 ' ' LEU . 25.7 tptp -161.0 132.08 5.43 Favored 'General case' 0 N--CA 1.43 -1.444 0 N-CA-C 106.257 -1.757 . . . . 3.7400000000000002 106.257 178.429 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A 1602 ' ' SER . . . . . . . . . . . . . 16.4 m -73.34 126.82 31.02 Favored 'General case' 0 C--N 1.307 -1.249 0 CA-C-O 120.884 0.373 . . . . 3.79 110.268 -176.763 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A 1603 ' ' GLY . . . . . . . . . . . . . . . 102.87 22.0 9.78 Favored Glycine 0 C--N 1.303 -1.256 0 N-CA-C 110.301 -1.12 . . . . 2.0 110.301 -179.358 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A 1604 ' ' LEU . . . . . 0.942 HD12 ' HB3' ' A' 1601 ' ' LYS . 6.1 mt -124.83 152.54 43.8 Favored 'General case' 0 C--N 1.3 -1.548 0 CA-C-O 121.801 0.81 . . . . 1.48 112.259 -179.554 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A 1605 ' ' SER . . . . . . . . . . . . . 50.1 m -128.29 177.67 6.79 Favored 'General case' 0 C--N 1.281 -2.399 0 N-CA-C 106.313 -1.736 . . . . 1.51 106.313 174.613 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A 1606 ' ' TYR . . . . . 0.738 ' HE1' ' HA ' ' A' 1598 ' ' CYS . 7.0 m-85 -98.9 140.36 33.19 Favored 'General case' 0 CA--C 1.459 -2.557 0 N-CA-C 105.682 -1.97 . . . . 1.1799999999999999 105.682 -179.115 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A 1607 ' ' LYS . . . . . . . . . . . . . 23.3 pttm -133.09 137.45 46.36 Favored 'General case' 0 N--CA 1.391 -3.382 0 C-N-CA 119.21 -0.996 . . . . 1.6699999999999999 110.127 176.718 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A 1608 ' ' SER . . . . . . . . . . . . . 14.6 m -107.08 110.02 22.03 Favored 'General case' 0 C--N 1.29 -2.02 0 N-CA-C 108.11 -1.07 . . . . 1.0 108.11 178.612 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A 1609 ' ' VAL . . . . . . . . . . . . . 98.3 t -102.04 102.82 14.08 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.256 0 CA-C-O 121.118 0.485 . . . . 0.93000000000000005 110.481 -177.923 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A 1610 ' ' ILE . . . . . 0.433 ' HB ' ' HB3' ' A' 1590 ' ' LEU . 2.6 mp -90.78 115.31 29.77 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.361 0 N-CA-C 108.252 -1.018 . . . . 0.78000000000000003 108.252 179.243 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A 1611 ' ' SER . . . . . 0.508 ' O ' ' HA ' ' A' 1639 ' ' SER . 16.9 m -107.13 122.4 46.42 Favored 'General case' 0 C--N 1.295 -1.789 0 CA-C-O 121.26 0.552 . . . . 1.29 110.666 -178.152 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A 1612 ' ' PHE . . . . . 0.725 ' HB2' ' HB2' ' A' 1588 ' ' LEU . 84.5 m-85 -88.38 109.78 20.27 Favored 'General case' 0 C--N 1.298 -1.666 0 N-CA-C 108.134 -1.062 . . . . 0.69999999999999996 108.134 177.391 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A 1613 ' ' VAL . . . . . . . . . . . . . 58.2 t -102.01 126.2 56.06 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.414 0 CA-C-N 115.632 -0.713 . . . . 0.75 110.216 -173.781 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A 1614 ' ' CYS . . . . . 0.403 ' HA ' ' O ' ' A' 1642 ' ' THR . 57.9 m -59.63 95.68 0.03 OUTLIER 'General case' 0 C--O 1.244 0.764 0 C-N-CA 124.427 1.091 . . . . 1.3899999999999999 111.302 179.771 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A 1615 ' ' ARG . . . . . . . . . . . . . 17.0 mmt180 -137.28 102.17 9.0 Favored Pre-proline 0 C--N 1.294 -1.824 0 CA-C-N 115.112 -0.949 . . . . 3.75 108.744 177.725 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A 1616 ' ' PRO . . . . . 0.417 ' HA ' ' HB3' ' A' 1643 ' ' PRO . 52.6 Cg_exo -61.2 10.36 0.07 OUTLIER 'Trans proline' 0 N--CA 1.493 1.479 0 C-N-CA 124.707 3.605 . . . . 1.3200000000000001 115.137 -179.189 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A 1617 ' ' GLU . . . . . . . . . . . . . 34.0 mt-10 -68.35 -25.67 65.21 Favored 'General case' 0 C--O 1.243 0.726 0 C-N-CA 123.501 0.72 . . . . 3.21 109.647 178.209 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A 1618 ' ' ALA . . . . . . . . . . . . . . . 64.64 -172.94 0.18 Allowed 'General case' 0 C--O 1.239 0.5 0 CA-C-N 113.44 -1.709 . . . . 2.4399999999999999 111.328 178.385 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A 1619 ' ' GLY . . . . . 0.424 ' HA3' ' HB2' ' A' 1622 ' ' ASN . . . 122.31 103.52 1.75 Allowed Glycine 0 N--CA 1.422 -2.297 0 N-CA-C 110.874 -0.89 . . . . 3.2599999999999998 110.874 179.446 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A 1620 ' ' PRO . . . . . 0.484 ' HA ' ' HZ2' ' A' 1640 ' ' TRP . 34.3 Cg_endo -65.12 -10.74 26.85 Favored 'Trans proline' 0 CA--C 1.539 0.737 0 C-N-CA 123.03 2.487 . . . . 5.9199999999999999 113.276 -177.976 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A 1621 ' ' THR . . . . . . . . . . . . . 12.8 m -130.97 16.67 5.15 Favored 'General case' 0 CA--C 1.558 1.258 0 N-CA-C 108.072 -1.084 . . . . 4.7599999999999998 108.072 177.083 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A 1622 ' ' ASN . . . . . 0.424 ' HB2' ' HA3' ' A' 1619 ' ' GLY . 54.9 t30 -86.11 60.34 6.17 Favored 'General case' 0 C--O 1.248 0.989 0 CA-C-O 122.441 1.115 . . . . 2.9199999999999999 111.935 -175.686 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A 1623 ' ' ARG . . . . . 0.522 ' HB3' ' CG ' ' A' 1640 ' ' TRP . 6.0 ptt180 -130.14 74.11 80.74 Favored Pre-proline 0 C--N 1.306 -1.321 0 CA-C-N 115.082 -0.963 . . . . 3.6099999999999999 112.765 -177.326 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A 1624 ' ' PRO . . . . . . . . . . . . . 54.9 Cg_endo -111.01 90.9 0.02 OUTLIER 'Trans proline' 0 N--CA 1.42 -2.843 0 C-N-CA 121.306 1.338 . . . . 2.3700000000000001 109.519 169.177 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A 1625 ' ' MET . . . . . 0.501 ' HB2' ' O ' ' A' 1639 ' ' SER . 10.7 mmt -151.54 98.27 2.49 Favored 'General case' 0 CA--C 1.491 -1.303 0 C-N-CA 120.022 -0.671 . . . . 2.1600000000000001 112.695 178.02 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A 1626 ' ' LEU . . . . . . . . . . . . . 63.1 tp -92.02 101.04 13.58 Favored 'General case' 0 C--N 1.292 -1.919 0 N-CA-C 103.402 -2.814 . . . . 1.3500000000000001 103.402 163.82 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A 1627 ' ' ILE . . . . . 0.586 HD12 ' HB3' ' A' 1637 ' ' PHE . 5.0 mt -68.64 -44.65 82.4 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.602 0 N-CA-C 108.499 -0.926 . . . . 1.21 108.499 -171.211 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A 1628 ' ' SER . . . . . . . . . . . . . 46.5 t -171.12 148.09 2.67 Favored 'General case' 0 N--CA 1.412 -2.373 0 N-CA-C 106.245 -1.761 . . . . 1.3999999999999999 106.245 -179.572 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A 1629 ' ' LEU . . . . . 0.839 ' HG ' ' HG ' ' A' 1636 ' ' LEU . 5.1 tt -126.02 111.02 14.24 Favored 'General case' 0 C--N 1.281 -2.381 0 N-CA-C 105.238 -2.134 . . . . 1.5600000000000001 105.238 173.916 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A 1630 ' ' ASP . . . . . . . . . . . . . 29.8 t70 -94.83 108.68 20.7 Favored 'General case' 0 C--N 1.283 -2.318 0 N-CA-C 108.954 -0.758 . . . . 0.87 108.954 -178.894 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A 1631 ' ' LYS . . . . . . . . . . . . . 65.6 mttp -71.26 -32.96 69.35 Favored 'General case' 0 C--N 1.309 -1.177 0 CA-C-N 115.586 -0.733 . . . . 2.3500000000000001 112.656 -174.486 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A 1632 ' ' GLN . . . . . . . . . . . . . 9.1 pt20 -71.25 -28.74 64.38 Favored 'General case' 0 N--CA 1.467 0.419 0 N-CA-C 113.226 0.825 . . . . 2.5499999999999998 113.226 -176.38 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A 1633 ' ' THR . . . . . 0.403 ' HA ' HD13 ' A' 1604 ' ' LEU . 71.8 p -106.31 -4.3 20.21 Favored 'General case' 0 C--N 1.319 -0.756 0 C-N-CA 119.908 -0.717 . . . . 1.24 110.674 175.08 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A 1634 ' ' CYS . . . . . . . . . . . . . 72.6 m 61.16 40.07 15.21 Favored 'General case' 0 C--O 1.237 0.412 0 CA-C-N 115.063 -0.972 . . . . 0.89000000000000001 111.278 -178.455 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A 1635 ' ' THR . . . . . . . . . . . . . 30.9 m -105.69 122.42 46.03 Favored 'General case' 0 N--CA 1.433 -1.278 0 CA-C-N 115.387 -0.824 . . . . 0.75 110.028 -177.446 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A 1636 ' ' LEU . . . . . 0.839 ' HG ' ' HG ' ' A' 1629 ' ' LEU . 5.8 mp -108.44 124.87 51.08 Favored 'General case' 0 C--N 1.313 -0.982 0 N-CA-C 109.378 -0.601 . . . . 1.3300000000000001 109.378 179.303 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A 1637 ' ' PHE . . . . . 0.586 ' HB3' HD12 ' A' 1627 ' ' ILE . 84.3 m-85 -107.55 126.72 52.89 Favored 'General case' 0 C--N 1.311 -1.092 0 N-CA-C 110.121 -0.326 . . . . 0.82999999999999996 110.121 -178.674 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A 1638 ' ' PHE . . . . . 0.474 ' HA ' ' O ' ' A' 1625 ' ' MET . 93.4 m-85 -124.05 155.31 38.55 Favored 'General case' 0 C--N 1.32 -0.71 0 C-N-CA 122.6 0.36 . . . . 0.59999999999999998 110.634 -179.495 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A 1639 ' ' SER . . . . . 0.508 ' HA ' ' O ' ' A' 1611 ' ' SER . 65.1 m -142.61 148.82 38.1 Favored 'General case' 0 C--O 1.249 1.063 0 N-CA-C 113.486 0.921 . . . . 1.0800000000000001 113.486 174.621 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A 1640 ' ' TRP . . . . . 0.522 ' CG ' ' HB3' ' A' 1623 ' ' ARG . 8.1 t90 -122.05 135.4 54.82 Favored 'General case' 0 C--O 1.243 0.754 0 N-CA-C 106.859 -1.534 . . . . 0.80000000000000004 106.859 176.053 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A 1641 ' ' HIS . . . . . . . . . . . . . 15.3 m-70 -80.51 92.78 5.94 Favored 'General case' 0 CA--C 1.509 -0.613 0 N-CA-C 107.818 -1.178 . . . . 2.54 107.818 177.596 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A 1642 ' ' THR . . . . . 0.51 ' HA ' ' HD3' ' A' 1643 ' ' PRO . 0.0 OUTLIER -128.63 130.5 23.5 Favored Pre-proline 0 C--N 1.304 -1.372 0 N-CA-C 112.852 0.686 . . . . 1.1499999999999999 112.852 -174.248 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A 1643 ' ' PRO . . . . . 0.51 ' HD3' ' HA ' ' A' 1642 ' ' THR . 2.5 Cg_endo -81.66 -7.1 12.58 Favored 'Trans proline' 0 C--N 1.332 -0.302 0 C-N-CA 123.026 2.484 . . . . 0.80000000000000004 111.323 177.008 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A 1644 ' ' LEU . . . . . . . . . . . . . 4.0 pp -89.14 3.94 50.19 Favored 'General case' 0 C--N 1.312 -1.046 0 CA-C-N 115.155 -0.93 . . . . 1.54 112.084 -179.369 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A 1645 ' ' ALA . . . . . . . . . . . . . . . -78.22 -43.07 29.41 Favored 'General case' 0 C--N 1.314 -0.967 0 CA-C-O 122.031 0.919 . . . . 0.94999999999999996 108.791 175.56 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A 1646 ' ' CYS . . . . . . . . . . . . . 24.0 p -159.29 129.87 5.87 Favored 'General case' 0 N--CA 1.428 -1.557 0 N-CA-C 104.163 -2.532 . . . . 1.4099999999999999 104.163 173.658 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A 1647 ' ' GLU . . . . . 0.416 ' HG3' ' HE1' ' A' 1527 ' ' PHE . 35.9 mt-10 -93.36 140.48 23.24 Favored Pre-proline 0 C--N 1.285 -2.196 0 C-N-CA 120.198 -0.601 . . . . 2.9199999999999999 110.968 -169.298 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A 1648 ' ' PRO . . . . . . . . . . . . . 35.4 Cg_endo -68.09 101.92 0.74 Allowed 'Trans proline' 0 C--O 1.246 0.879 0 C-N-CA 122.682 2.255 . . . . 2.8199999999999998 110.989 177.195 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A 1649 ' ' GLU . . . . . . . . . . . . . 42.9 mt-10 . . . . . 0 C--N 1.298 -1.669 0 CA-C-O 118.311 -0.852 . . . . 5.0599999999999996 109.415 -178.212 . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A 1508 ' ' MET . . . . . . . . . . . . . 25.7 ptt? . . . . . 0 CA--C 1.52 -0.195 0 CA-C-O 120.706 0.289 . . . . 8.2699999999999996 110.639 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A 1509 ' ' LYS . . . . . . . . . . . . . 69.0 mttm -93.09 55.21 2.29 Favored 'General case' 0 N--CA 1.449 -0.494 0 O-C-N 121.909 -0.495 . . . . 6.4800000000000004 111.765 -177.486 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A 1510 ' ' SER . . . . . . . . . . . . . 4.5 p -87.67 58.66 5.02 Favored 'General case' 0 C--N 1.303 -1.443 0 N-CA-C 106.892 -1.521 . . . . 4.2199999999999998 106.892 176.216 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A 1511 ' ' ASN . . . . . . . . . . . . . 27.3 t-20 -140.78 -48.92 0.43 Allowed 'General case' 0 N--CA 1.425 -1.694 0 CA-C-N 113.888 -1.505 . . . . 3.0800000000000001 111.527 -167.689 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A 1512 ' ' GLU . . . . . . . . . . . . . 45.0 mt-10 -47.12 -37.4 9.75 Favored 'General case' 0 N--CA 1.483 1.211 0 C-N-CA 125.135 1.374 . . . . 4.46 113.169 -174.225 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A 1513 ' ' HIS . . . . . . . . . . . . . 8.8 p-80 -134.77 25.41 3.67 Favored 'General case' 0 C--N 1.312 -1.045 0 CA-C-O 121.157 0.503 . . . . 5.5700000000000003 110.119 177.03 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A 1514 ' ' ASP . . . . . . . . . . . . . 6.4 m-20 -124.18 -35.84 2.75 Favored 'General case' 0 C--N 1.305 -1.344 0 N-CA-C 112.564 0.579 . . . . 3.7000000000000002 112.564 -176.561 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A 1515 ' ' ASP . . . . . . . . . . . . . 5.3 t70 -130.32 177.02 7.64 Favored 'General case' 0 C--N 1.323 -0.581 0 C-N-CA 119.791 -0.764 . . . . 2.54 109.807 -174.827 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A 1516 ' ' CYS . . . . . 0.594 ' SG ' ' HE3' ' A' 1579 ' ' LYS . 86.8 m -116.86 20.81 13.72 Favored 'General case' 0 C--N 1.302 -1.495 0 C-N-CA 124.088 0.955 . . . . 1.25 110.536 -176.116 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A 1517 ' ' GLN . . . . . 0.435 ' HA ' ' O ' ' A' 1527 ' ' PHE . 14.0 pt20 -109.69 126.24 53.48 Favored 'General case' 0 N--CA 1.422 -1.87 0 CA-C-N 115.523 -0.762 . . . . 1.8799999999999999 109.169 177.737 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A 1518 ' ' VAL . . . . . 0.61 ' HB ' ' HB2' ' A' 1527 ' ' PHE . 59.3 t -93.45 127.82 45.27 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.233 0 N-CA-C 107.982 -1.118 . . . . 1.73 107.982 -179.962 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A 1519 ' ' THR . . . . . . . . . . . . . 11.3 m -115.02 117.83 31.69 Favored 'General case' 0 N--CA 1.417 -2.109 0 C-N-CA 120.369 -0.533 . . . . 1.7 109.917 -179.165 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A 1520 ' ' ASN . . . . . . . . . . . . . 41.8 t-20 -94.25 105.57 18.35 Favored Pre-proline 0 C--N 1.318 -0.794 0 N-CA-C 107.044 -1.465 . . . . 2.1200000000000001 107.044 174.666 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A 1521 ' ' PRO . . . . . . . . . . . . . 21.2 Cg_exo -67.26 -21.78 47.42 Favored 'Trans proline' 0 C--N 1.351 0.672 0 C-N-CA 122.528 2.152 . . . . 2.4700000000000002 113.663 -176.802 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A 1522 ' ' SER . . . . . . . . . . . . . 19.5 m -76.16 -40.1 53.34 Favored 'General case' 0 C--N 1.311 -1.108 0 N-CA-C 111.955 0.354 . . . . 2.5699999999999998 111.955 -176.323 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A 1523 ' ' THR . . . . . 0.432 HG23 ' HB2' ' A' 1525 ' ' HIS . 14.4 t -107.01 -17.55 14.15 Favored 'General case' 0 CA--C 1.551 0.997 0 C-N-CA 119.525 -0.87 . . . . 2.1499999999999999 111.268 179.418 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A 1524 ' ' GLY . . . . . . . . . . . . . . . 82.0 17.06 70.72 Favored Glycine 0 N--CA 1.45 -0.4 0 C-N-CA 121.171 -0.538 . . . . 1.8899999999999999 112.093 -179.713 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A 1525 ' ' HIS . . . . . 0.432 ' HB2' HG23 ' A' 1523 ' ' THR . 7.3 t60 -84.19 135.08 34.51 Favored 'General case' 0 C--N 1.313 -0.999 0 N-CA-C 108.994 -0.743 . . . . 1.8999999999999999 108.994 -177.672 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A 1526 ' ' LEU . . . . . . . . . . . . . 3.3 tm? -113.87 121.42 43.93 Favored 'General case' 0 C--N 1.3 -1.56 0 N-CA-C 108.415 -0.957 . . . . 1.6100000000000001 108.415 -176.349 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A 1527 ' ' PHE . . . . . 0.61 ' HB2' ' HB ' ' A' 1518 ' ' VAL . 69.9 m-85 -104.2 116.12 31.61 Favored 'General case' 0 C--N 1.304 -1.395 0 N-CA-C 109.641 -0.503 . . . . 1.4199999999999999 109.641 -178.601 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A 1528 ' ' ASP . . . . . 0.48 ' O ' HD13 ' A' 1532 ' ' LEU . 11.6 t70 -95.69 102.52 14.32 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-N 117.576 0.171 . . . . 2.1800000000000002 110.782 -179.977 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A 1529 ' ' LEU . . . . . . . . . . . . . 6.4 mp -89.77 -7.58 54.11 Favored 'General case' 0 C--N 1.318 -0.785 0 CA-C-O 120.8 0.333 . . . . 1.4399999999999999 111.777 179.305 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A 1530 ' ' SER . . . . . 0.477 ' OG ' ' HB2' ' A' 1516 ' ' CYS . 50.2 m -72.51 -48.54 39.7 Favored 'General case' 0 C--N 1.313 -0.993 0 CA-C-N 116.369 -0.378 . . . . 1.4399999999999999 111.265 -178.108 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A 1531 ' ' SER . . . . . . . . . . . . . 8.2 m -70.4 -17.17 63.02 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 116.173 -0.467 . . . . 1.5 111.672 -175.993 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A 1532 ' ' LEU . . . . . 0.517 ' HB3' HG13 ' A' 1552 ' ' ILE . 9.8 mp -68.19 -13.72 62.44 Favored 'General case' 0 N--CA 1.466 0.35 0 CA-C-N 116.255 -0.429 . . . . 1.77 112.042 177.52 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A 1533 ' ' SER . . . . . . . . . . . . . 10.9 m -110.24 106.42 15.83 Favored 'General case' 0 N--CA 1.437 -1.105 0 N-CA-C 109.162 -0.681 . . . . 2.3799999999999999 109.162 178.952 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A 1534 ' ' GLY . . . . . . . . . . . . . . . -92.21 -110.67 1.82 Allowed Glycine 0 N--CA 1.436 -1.312 0 C-N-CA 121.179 -0.534 . . . . 1.55 111.813 178.065 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A 1535 ' ' ARG . . . . . . . . . . . . . 42.8 ttm180 -95.61 -53.85 3.58 Favored 'General case' 0 C--N 1.31 -1.129 0 CA-C-O 121.081 0.467 . . . . 3.96 110.612 178.369 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A 1536 ' ' ALA . . . . . . . . . . . . . . . -96.64 -29.95 13.54 Favored 'General case' 0 C--N 1.316 -0.877 0 CA-C-O 121.044 0.449 . . . . 1.6499999999999999 110.459 177.745 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A 1537 ' ' GLY . . . . . . . . . . . . . . . 70.69 -128.17 17.25 Favored Glycine 0 CA--C 1.499 -0.922 0 CA-C-N 115.515 -0.766 . . . . 1.1899999999999999 112.166 178.278 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A 1538 ' ' PHE . . . . . 0.54 ' HB2' HD11 ' A' 1552 ' ' ILE . 29.8 m-85 -114.26 122.96 48.36 Favored 'General case' 0 CA--C 1.497 -1.074 0 N-CA-C 109.639 -0.504 . . . . 1.6899999999999999 109.639 179.122 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A 1539 ' ' THR . . . . . . . . . . . . . 38.0 p -102.38 141.78 34.66 Favored 'General case' 0 C--N 1.286 -2.161 0 CA-C-N 115.454 -0.793 . . . . 1.48 111.329 -175.581 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A 1540 ' ' ALA . . . . . . . . . . . . . . . -118.79 159.03 24.46 Favored 'General case' 0 C--N 1.308 -1.213 0 N-CA-C 108.643 -0.873 . . . . 0.82999999999999996 108.643 179.356 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A 1541 ' ' ALA . . . . . . . . . . . . . . . -99.48 141.5 32.19 Favored 'General case' 0 C--N 1.306 -1.313 0 CA-C-O 120.887 0.375 . . . . 1.27 111.231 -177.618 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A 1542 ' ' TYR . . . . . . . . . . . . . 76.7 t80 -141.68 177.57 8.06 Favored 'General case' 0 C--N 1.314 -0.95 0 N-CA-C 108.442 -0.947 . . . . 2.1499999999999999 108.442 -178.415 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A 1543 ' ' SER . . . . . . . . . . . . . 5.3 m -45.91 -151.35 0.0 OUTLIER 'General case' 0 CA--C 1.578 2.034 0 C-N-CA 129.52 3.128 . . . . 2.29 114.259 177.14 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A 1544 ' ' LYS . . . . . . . . . . . . . 64.6 mttp -41.93 -32.87 0.47 Allowed 'General case' 0 N--CA 1.492 1.666 0 N-CA-C 115.064 1.505 . . . . 3.9100000000000001 115.064 -177.678 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A 1545 ' ' SER . . . . . 0.4 ' OG ' ' HB3' ' A' 1567 ' ' PHE . 6.0 t -67.29 -22.83 65.63 Favored 'General case' 0 CA--C 1.56 1.334 0 CA-C-N 117.877 0.308 . . . . 3.2999999999999998 110.919 178.148 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A 1546 ' ' GLY . . . . . . . . . . . . . . . 88.6 -76.13 1.92 Allowed Glycine 0 N--CA 1.439 -1.105 0 C-N-CA 121.046 -0.597 . . . . 1.24 114.193 174.689 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A 1547 ' ' VAL . . . . . . . . . . . . . 88.2 t -122.87 144.3 32.82 Favored 'Isoleucine or valine' 0 N--CA 1.417 -2.098 0 C-N-CA 122.748 0.419 . . . . 1.6299999999999999 110.108 -174.272 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A 1548 ' ' VAL . . . . . . . . . . . . . 10.7 t -113.09 136.06 50.62 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.308 0 N-CA-C 106.456 -1.683 . . . . 0.92000000000000004 106.456 175.573 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A 1549 ' ' TYR . . . . . 0.541 ' CE2' ' HA2' ' A' 1568 ' ' GLY . 31.2 m-85 -91.63 146.91 23.4 Favored 'General case' 0 C--N 1.301 -1.508 0 N-CA-C 105.316 -2.105 . . . . 1.4399999999999999 105.316 172.75 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A 1550 ' ' MET . . . . . . . . . . . . . 46.7 ttp -156.69 141.09 16.67 Favored 'General case' 0 C--N 1.292 -1.917 0 N-CA-C 109.12 -0.696 . . . . 1.74 109.12 -179.221 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A 1551 ' ' SER . . . . . . . . . . . . . 64.0 p -89.54 153.48 20.75 Favored 'General case' 0 N--CA 1.414 -2.274 0 N-CA-C 107.937 -1.134 . . . . 1.6399999999999999 107.937 177.114 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A 1552 ' ' ILE . . . . . 0.54 HD11 ' HB2' ' A' 1538 ' ' PHE . 46.2 mm -83.97 -32.29 8.47 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.708 0 N-CA-C 107.595 -1.261 . . . . 1.3300000000000001 107.595 178.627 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A 1553 ' ' CYS . . . . . 0.454 ' HA ' ' OH ' ' A' 1592 ' ' TYR . 36.6 t -162.44 137.62 7.01 Favored 'General case' 0 N--CA 1.43 -1.472 0 CA-C-N 115.547 -0.751 . . . . 1.4299999999999999 109.125 165.836 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A 1554 ' ' GLY . . . . . . . . . . . . . . . 85.91 -124.39 6.84 Favored Glycine 0 CA--C 1.473 -2.549 0 N-CA-C 110.201 -1.16 . . . . 1.1200000000000001 110.201 -178.641 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A 1555 ' ' GLU . . . . . 0.457 ' H ' ' CD ' ' A' 1555 ' ' GLU . 0.1 OUTLIER -117.93 -177.53 3.28 Favored 'General case' 0 C--N 1.258 -3.401 0 CA-C-N 113.538 -1.331 . . . . 1.8 108.516 -176.522 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A 1556 ' ' ASN . . . . . 0.465 ' HB3' ' HG3' ' A' 1557 ' ' GLU . 3.6 t-20 165.31 -158.91 0.0 OUTLIER 'General case' 0 C--O 1.255 1.365 0 N-CA-C 103.096 -2.927 . . . . 2.6299999999999999 103.096 -174.209 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A 1557 ' ' GLU . . . . . 0.465 ' HG3' ' HB3' ' A' 1556 ' ' ASN . 26.0 mt-10 83.49 178.72 0.05 Allowed 'General case' 0 CA--C 1.497 -1.058 0 N-CA-C 115.814 1.783 . . . . 3.79 115.814 159.713 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A 1558 ' ' ASN . . . . . . . . . . . . . 33.2 m-80 -127.97 43.06 3.21 Favored 'General case' 0 C--N 1.307 -1.273 0 CA-C-N 113.358 -1.747 . . . . 1.52 107.948 -173.541 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A 1559 ' ' CYS . . . . . 0.408 ' HB3' ' HD2' ' A' 1560 ' ' PRO . 84.2 m -131.85 172.37 7.48 Favored Pre-proline 0 C--N 1.293 -1.889 0 CA-C-N 113.666 -1.607 . . . . 0.83999999999999997 106.885 -179.609 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A 1560 ' ' PRO . . . . . 0.437 ' HA ' ' HD2' ' A' 1561 ' ' PRO . 99.7 Cg_exo -48.73 116.21 2.02 Favored 'Trans proline' 0 C--N 1.361 1.209 0 C-N-CA 122.177 1.918 . . . . 1.1799999999999999 110.591 172.756 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A 1561 ' ' PRO . . . . . 0.437 ' HD2' ' HA ' ' A' 1560 ' ' PRO . 12.4 Cg_endo -53.63 142.51 60.51 Favored 'Trans proline' 0 C--N 1.354 0.828 0 C-N-CA 124.35 3.367 . . . . 1.51 113.988 -172.854 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A 1562 ' ' GLY . . . . . . . . . . . . . . . 112.28 9.24 20.27 Favored Glycine 0 N--CA 1.437 -1.277 0 N-CA-C 110.687 -0.965 . . . . 0.71999999999999997 110.687 -179.71 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A 1563 ' ' VAL . . . . . . . . . . . . . 4.8 m -99.66 154.23 4.27 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.838 0 N-CA-C 109.357 -0.609 . . . . 0.96999999999999997 109.357 176.049 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A 1564 ' ' GLY . . . . . . . . . . . . . . . -115.94 -6.43 16.5 Favored Glycine 0 N--CA 1.421 -2.324 0 N-CA-C 110.36 -1.096 . . . . 0.71999999999999997 110.36 175.408 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A 1565 ' ' ALA . . . . . . . . . . . . . . . -168.78 119.2 0.74 Allowed 'General case' 0 C--O 1.259 1.577 0 N-CA-C 108.969 -0.752 . . . . 0.37 108.969 -179.347 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A 1566 ' ' CYS . . . . . . . . . . . . . 35.8 t -141.72 141.29 33.27 Favored 'General case' 0 C--N 1.297 -1.686 0 CA-C-N 115.368 -0.833 . . . . 0.51000000000000001 111.2 -174.064 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A 1567 ' ' PHE . . . . . 0.4 ' HB3' ' OG ' ' A' 1545 ' ' SER . 15.7 m-85 -66.6 126.94 30.49 Favored 'General case' 0 C--O 1.219 -0.51 0 N-CA-C 109.723 -0.473 . . . . 0.96999999999999997 109.723 176.197 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A 1568 ' ' GLY . . . . . 0.541 ' HA2' ' CE2' ' A' 1549 ' ' TYR . . . -66.86 -33.22 83.38 Favored Glycine 0 N--CA 1.444 -0.83 0 CA-C-N 115.748 -0.66 . . . . 1.0800000000000001 114.167 -175.109 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A 1569 ' ' GLN . . . . . . . . . . . . . 52.3 tt0 -84.45 -52.86 5.84 Favored 'General case' 0 C--N 1.303 -1.436 0 CA-C-O 121.686 0.755 . . . . 2.7400000000000002 110.707 -179.576 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A 1570 ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -83.29 -14.68 52.53 Favored 'General case' 0 C--N 1.296 -1.721 0 CA-C-N 114.884 -1.053 . . . . 1.96 112.463 -169.745 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A 1571 ' ' ARG . . . . . . . . . . . . . 49.3 mtp180 54.97 37.23 28.51 Favored 'General case' 0 N--CA 1.476 0.855 0 C-N-CA 125.864 1.666 . . . . 3.9500000000000002 111.95 -179.644 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A 1572 ' ' ILE . . . . . . . . . . . . . 45.9 mm -107.01 132.78 53.49 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.126 0 CA-C-N 115.347 -0.842 . . . . 1.3700000000000001 109.359 -178.349 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A 1573 ' ' SER . . . . . . . . . . . . . 33.0 t -73.83 131.58 41.67 Favored 'General case' 0 N--CA 1.428 -1.528 0 CA-C-N 114.997 -1.001 . . . . 1.0800000000000001 110.607 179.858 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A 1574 ' ' VAL . . . . . 0.988 ' HA ' ' HB3' ' A' 1596 ' ' SER . 34.0 m -109.85 -32.69 2.34 Favored 'Isoleucine or valine' 0 N--CA 1.419 -1.978 0 C-N-CA 119.976 -0.69 . . . . 1.3 109.864 171.984 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A 1575 ' ' GLY . . . . . . . . . . . . . . . -133.51 121.8 2.91 Favored Glycine 0 N--CA 1.425 -2.088 0 N-CA-C 110.372 -1.091 . . . . 0.51000000000000001 110.372 178.762 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A 1576 ' ' LYS . . . . . . . . . . . . . 88.0 tttt -80.49 149.15 30.16 Favored 'General case' 0 C--N 1.311 -1.1 0 N-CA-C 108.578 -0.897 . . . . 2.8999999999999999 108.578 179.637 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A 1577 ' ' ALA . . . . . . . . . . . . . . . -61.88 102.35 0.27 Allowed 'General case' 0 CA--C 1.516 -0.357 0 O-C-N 123.928 0.768 . . . . 0.82999999999999996 111.141 -177.81 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A 1578 ' ' ASN . . . . . . . . . . . . . 73.4 m-20 -120.87 115.19 22.75 Favored 'General case' 0 C--N 1.297 -1.699 0 N-CA-C 106.487 -1.672 . . . . 1.8500000000000001 106.487 175.638 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A 1579 ' ' LYS . . . . . 0.594 ' HE3' ' SG ' ' A' 1516 ' ' CYS . 55.6 mtpt -83.35 90.17 7.12 Favored 'General case' 0 C--N 1.295 -1.781 0 N-CA-C 107.724 -1.213 . . . . 1.8999999999999999 107.724 -179.047 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A 1580 ' ' ARG . . . . . . . . . . . . . 26.0 ttt85 -150.96 113.91 4.75 Favored 'General case' 0 N--CA 1.424 -1.734 0 CA-C-N 114.847 -1.07 . . . . 3.6299999999999999 109.667 -175.579 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A 1581 ' ' LEU . . . . . . . . . . . . . 3.5 pp -134.04 161.73 34.03 Favored 'General case' 0 C--N 1.292 -1.915 0 CA-C-N 115.776 -0.647 . . . . 1.8700000000000001 109.721 179.425 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A 1582 ' ' ARG . . . . . . . . . . . . . 79.1 ttt180 -138.15 129.39 27.45 Favored 'General case' 0 C--N 1.292 -1.892 0 C-N-CA 121.134 -0.227 . . . . 3.9700000000000002 110.444 176.999 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A 1583 ' ' TYR . . . . . . . . . . . . . 36.7 t80 -93.07 102.6 14.93 Favored 'General case' 0 C--N 1.3 -1.583 0 N-CA-C 107.185 -1.413 . . . . 1.4099999999999999 107.185 173.662 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A 1584 ' ' VAL . . . . . . . . . . . . . 7.5 p -135.87 120.93 27.85 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.949 0 C-N-CA 120.875 -0.33 . . . . 1.6899999999999999 111.463 -177.293 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A 1585 ' ' ASP . . . . . . . . . . . . . 35.3 t70 53.08 45.73 28.14 Favored 'General case' 0 N--CA 1.488 1.435 0 C-N-CA 124.453 1.101 . . . . 2.0600000000000001 111.12 178.367 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A 1586 ' ' GLN . . . . . . . . . . . . . 47.0 mt-30 58.13 25.83 12.94 Favored 'General case' 0 C--O 1.242 0.685 0 C-N-CA 125.377 1.471 . . . . 2.3300000000000001 114.587 179.675 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A 1587 ' ' VAL . . . . . . . . . . . . . 8.1 p -128.45 126.17 65.12 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.314 0 N-CA-C 107.895 -1.15 . . . . 0.78000000000000003 107.895 171.737 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A 1588 ' ' LEU . . . . . 0.623 ' HB2' ' HB2' ' A' 1612 ' ' PHE . 34.6 mt -86.22 138.99 31.45 Favored 'General case' 0 C--N 1.304 -1.396 0 N-CA-C 108.991 -0.744 . . . . 1.4099999999999999 108.991 -179.918 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A 1589 ' ' GLN . . . . . . . . . . . . . 34.6 tt0 -130.59 107.0 8.87 Favored 'General case' 0 C--N 1.292 -1.929 0 N-CA-C 109.397 -0.594 . . . . 1.24 109.397 -177.278 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A 1590 ' ' LEU . . . . . . . . . . . . . 9.1 tt -111.82 137.16 50.15 Favored 'General case' 0 C--N 1.288 -2.07 0 N-CA-C 107.744 -1.206 . . . . 1.1499999999999999 107.744 179.031 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A 1591 ' ' VAL . . . . . 0.543 HG12 HG22 ' A' 1609 ' ' VAL . 28.8 m -130.55 140.58 48.44 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.937 0 N-CA-C 112.233 0.457 . . . . 1.51 112.233 -175.431 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A 1592 ' ' TYR . . . . . 0.454 ' OH ' ' HA ' ' A' 1553 ' ' CYS . 39.6 m-85 -122.09 138.69 54.36 Favored 'General case' 0 C--N 1.313 -1.01 0 N-CA-C 108.128 -1.064 . . . . 1.0600000000000001 108.128 172.948 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A 1593 ' ' LYS . . . . . . . . . . . . . 62.5 pttt -159.25 174.85 14.17 Favored 'General case' 0 C--O 1.251 1.133 0 N-CA-C 109.899 -0.408 . . . . 2.1800000000000002 109.899 178.8 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A 1594 ' ' ASP . . . . . . . . . . . . . 31.6 m-20 67.54 56.93 0.57 Allowed 'General case' 0 N--CA 1.48 1.03 0 C-N-CA 124.376 1.07 . . . . 1.45 110.888 179.592 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A 1595 ' ' GLY . . . . . . . . . . . . . . . -142.1 -47.92 0.05 OUTLIER Glycine 0 C--N 1.308 -1.026 0 CA-C-N 115.054 -0.976 . . . . 0.78000000000000003 111.362 -179.578 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A 1596 ' ' SER . . . . . 0.988 ' HB3' ' HA ' ' A' 1574 ' ' VAL . 15.8 p -96.69 134.21 23.51 Favored Pre-proline 0 C--N 1.298 -1.638 0 CA-C-N 115.526 -0.337 . . . . 1.6799999999999999 111.545 179.031 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A 1597 ' ' PRO . . . . . 0.455 ' HD3' ' HA ' ' A' 1596 ' ' SER . 3.0 Cg_exo -79.77 113.56 3.07 Favored 'Trans proline' 0 N--CA 1.445 -1.373 0 C-N-CA 122.176 1.917 . . . . 1.1699999999999999 108.593 170.863 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A 1598 ' ' CYS . . . . . . . . . . . . . 48.6 t -94.87 122.66 59.86 Favored Pre-proline 0 C--N 1.306 -1.326 0 N-CA-C 109.727 -0.471 . . . . 1.1899999999999999 109.727 -176.3 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A 1599 ' ' PRO . . . . . . . . . . . . . 87.9 Cg_endo -77.97 0.6 9.7 Favored 'Trans proline' 0 CA--C 1.537 0.67 0 C-N-CA 123.384 2.723 . . . . 1.5900000000000001 114.267 -175.463 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A 1600 ' ' SER . . . . . . . . . . . . . 19.9 m -77.9 -32.18 51.65 Favored 'General case' 0 C--N 1.308 -1.223 0 CA-C-O 120.677 0.275 . . . . 2.1200000000000001 111.288 -179.679 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A 1601 ' ' LYS . . . . . 0.905 ' HB3' HD12 ' A' 1604 ' ' LEU . 11.2 tmtt? -158.92 129.98 6.19 Favored 'General case' 0 C--N 1.313 -0.993 0 N-CA-C 105.691 -1.966 . . . . 3.7400000000000002 105.691 -177.13 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A 1602 ' ' SER . . . . . . . . . . . . . 16.4 m -67.36 125.41 26.02 Favored 'General case' 0 C--N 1.316 -0.852 0 CA-C-O 120.886 0.374 . . . . 3.79 110.591 -175.222 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A 1603 ' ' GLY . . . . . . . . . . . . . . . 103.83 -6.27 47.9 Favored Glycine 0 N--CA 1.435 -1.382 0 N-CA-C 110.918 -0.873 . . . . 2.0 110.918 -179.937 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A 1604 ' ' LEU . . . . . 0.905 HD12 ' HB3' ' A' 1601 ' ' LYS . 6.8 mt -89.19 148.26 23.73 Favored 'General case' 0 N--CA 1.43 -1.463 0 CA-C-O 121.425 0.631 . . . . 1.48 111.851 178.209 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A 1605 ' ' SER . . . . . 0.465 ' HA ' ' O ' ' A' 1596 ' ' SER . 8.3 t -130.45 163.58 26.64 Favored 'General case' 0 N--CA 1.413 -2.287 0 N-CA-C 104.673 -2.344 . . . . 1.51 104.673 176.561 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A 1606 ' ' TYR . . . . . 0.548 ' HA ' ' O ' ' A' 1634 ' ' CYS . 67.6 m-85 -90.22 116.01 27.88 Favored 'General case' 0 CA--C 1.458 -2.563 0 N-CA-C 106.331 -1.729 . . . . 1.1799999999999999 106.331 -179.852 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A 1607 ' ' LYS . . . . . . . . . . . . . 23.3 pttp -103.23 127.41 50.55 Favored 'General case' 0 N--CA 1.394 -3.226 0 C-N-CA 118.196 -1.401 . . . . 1.6699999999999999 109.496 -176.738 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A 1608 ' ' SER . . . . . 0.505 ' HA ' ' HB2' ' A' 1636 ' ' LEU . 12.0 p -97.43 111.31 23.62 Favored 'General case' 0 N--CA 1.407 -2.62 0 CA-C-N 115.118 -0.946 . . . . 1.0 109.287 -177.186 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A 1609 ' ' VAL . . . . . 0.543 HG22 HG12 ' A' 1591 ' ' VAL . 85.5 t -101.35 107.84 22.24 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.523 0 N-CA-C 108.166 -1.049 . . . . 0.93000000000000005 108.166 179.747 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A 1610 ' ' ILE . . . . . . . . . . . . . 2.5 mp -93.28 108.7 20.77 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.561 0 N-CA-C 108.274 -1.01 . . . . 0.78000000000000003 108.274 179.023 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A 1611 ' ' SER . . . . . 0.401 ' O ' ' HA ' ' A' 1639 ' ' SER . 21.8 m -94.52 113.92 25.83 Favored 'General case' 0 N--CA 1.409 -2.509 0 N-CA-C 108.232 -1.025 . . . . 1.29 108.232 177.346 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A 1612 ' ' PHE . . . . . 0.623 ' HB2' ' HB2' ' A' 1588 ' ' LEU . 79.8 m-85 -84.89 106.84 16.71 Favored 'General case' 0 C--N 1.291 -1.941 0 CA-C-N 115.067 -0.97 . . . . 0.69999999999999996 110.57 -178.24 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A 1613 ' ' VAL . . . . . . . . . . . . . 41.9 t -94.92 119.68 43.3 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.52 0 CA-C-N 115.279 -0.873 . . . . 0.75 109.067 -177.051 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A 1614 ' ' CYS . . . . . 0.523 ' HB3' ' HB2' ' A' 1646 ' ' CYS . 56.2 m -71.45 92.33 1.09 Allowed 'General case' 0 C--N 1.314 -0.958 0 CA-C-O 121.377 0.608 . . . . 1.3899999999999999 109.381 178.241 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A 1615 ' ' ARG . . . . . 0.515 ' HB3' ' HB3' ' A' 1641 ' ' HIS . 0.6 OUTLIER -137.97 87.46 16.58 Favored Pre-proline 0 C--N 1.305 -1.36 0 N-CA-C 107.109 -1.441 . . . . 3.75 107.109 -178.904 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A 1616 ' ' PRO . . . . . . . . . . . . . 6.6 Cg_exo -76.34 44.79 1.43 Allowed 'Trans proline' 0 N--CA 1.479 0.635 0 C-N-CA 123.459 2.772 . . . . 1.3200000000000001 112.768 -177.449 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A 1617 ' ' GLU . . . . . . . . . . . . . 41.8 mt-10 -131.15 40.82 3.41 Favored 'General case' 0 C--N 1.303 -1.44 0 N-CA-C 108.201 -1.036 . . . . 3.21 108.201 -179.276 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A 1618 ' ' ALA . . . . . . . . . . . . . . . -114.09 134.89 54.58 Favored 'General case' 0 C--N 1.308 -1.21 0 CA-C-N 115.538 -0.756 . . . . 2.4399999999999999 110.963 -175.795 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A 1619 ' ' GLY . . . . . . . . . . . . . . . -151.64 -86.76 0.06 OUTLIER Glycine 0 N--CA 1.436 -1.308 0 N-CA-C 110.954 -0.858 . . . . 3.2599999999999998 110.954 179.168 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A 1620 ' ' PRO . . . . . . . . . . . . . 18.8 Cg_endo -60.53 -31.34 92.26 Favored 'Trans proline' 0 CA--C 1.539 0.731 0 C-N-CA 122.972 2.448 . . . . 5.9199999999999999 113.463 -179.402 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A 1621 ' ' THR . . . . . . . . . . . . . 4.4 m -114.42 31.23 6.75 Favored 'General case' 0 C--N 1.317 -0.839 0 N-CA-C 109.429 -0.582 . . . . 4.7599999999999998 109.429 -178.928 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A 1622 ' ' ASN . . . . . . . . . . . . . 60.6 t30 -76.93 74.73 3.53 Favored 'General case' 0 N--CA 1.472 0.65 0 CA-C-O 121.81 0.814 . . . . 2.9199999999999999 110.761 -178.649 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A 1623 ' ' ARG . . . . . . . . . . . . . 9.2 ptm180 -154.0 153.49 28.61 Favored Pre-proline 0 C--N 1.3 -1.566 0 N-CA-C 107.28 -1.378 . . . . 3.6099999999999999 107.28 -178.922 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A 1624 ' ' PRO . . . . . . . . . . . . . 32.5 Cg_exo -61.29 119.82 7.16 Favored 'Trans proline' 0 C--O 1.245 0.87 0 C-N-CA 122.761 2.307 . . . . 2.3700000000000001 111.751 179.246 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A 1625 ' ' MET . . . . . . . . . . . . . 56.3 ttp -95.99 130.7 42.92 Favored 'General case' 0 C--N 1.301 -1.522 0 CA-C-N 115.082 -0.963 . . . . 2.1600000000000001 109.688 -177.228 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A 1626 ' ' LEU . . . . . 0.708 HD21 HD23 ' A' 1629 ' ' LEU . 56.8 tp -83.53 105.73 14.7 Favored 'General case' 0 C--N 1.306 -1.304 0 N-CA-C 107.8 -1.185 . . . . 1.3500000000000001 107.8 178.001 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A 1627 ' ' ILE . . . . . . . . . . . . . 45.4 pt -83.19 -33.61 10.36 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.268 0 N-CA-C 112.303 0.483 . . . . 1.21 112.303 -175.1 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A 1628 ' ' SER . . . . . . . . . . . . . 45.7 m -149.75 147.49 28.08 Favored 'General case' 0 C--N 1.313 -1.001 0 CA-C-O 120.673 0.273 . . . . 1.3999999999999999 110.475 -178.077 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A 1629 ' ' LEU . . . . . 0.708 HD23 HD21 ' A' 1626 ' ' LEU . 1.2 tm? -127.76 108.41 10.72 Favored 'General case' 0 C--N 1.307 -1.255 0 N-CA-C 106.61 -1.626 . . . . 1.5600000000000001 106.61 -179.216 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A 1630 ' ' ASP . . . . . . . . . . . . . 15.3 t70 -107.7 112.08 24.59 Favored 'General case' 0 C--N 1.304 -1.399 0 N-CA-C 109.056 -0.72 . . . . 0.87 109.056 178.771 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A 1631 ' ' LYS . . . . . . . . . . . . . 63.4 mttm -80.0 -22.5 42.41 Favored 'General case' 0 C--N 1.303 -1.426 0 N-CA-C 112.674 0.62 . . . . 2.3500000000000001 112.674 -177.186 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A 1632 ' ' GLN . . . . . . . . . . . . . 1.7 mp0 -78.77 -49.96 12.14 Favored 'General case' 0 CA--C 1.509 -0.61 0 CA-C-O 121.029 0.442 . . . . 2.5499999999999998 111.467 -173.277 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A 1633 ' ' THR . . . . . . . . . . . . . 60.4 p -86.57 -4.52 59.18 Favored 'General case' 0 C--N 1.313 -1.011 0 CA-C-O 121.875 0.845 . . . . 1.24 110.004 179.764 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A 1634 ' ' CYS . . . . . 0.548 ' O ' ' HA ' ' A' 1606 ' ' TYR . 29.4 m 59.62 51.05 6.65 Favored 'General case' 0 N--CA 1.441 -0.907 0 CA-C-N 113.442 -1.708 . . . . 0.89000000000000001 108.768 179.712 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A 1635 ' ' THR . . . . . . . . . . . . . 39.7 m -114.94 130.26 56.88 Favored 'General case' 0 N--CA 1.425 -1.699 0 CA-C-N 114.999 -1.001 . . . . 0.75 110.087 -175.831 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A 1636 ' ' LEU . . . . . 0.505 ' HB2' ' HA ' ' A' 1608 ' ' SER . 40.6 mt -112.62 116.06 29.59 Favored 'General case' 0 N--CA 1.435 -1.223 0 N-CA-C 107.58 -1.267 . . . . 1.3300000000000001 107.58 -178.479 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A 1637 ' ' PHE . . . . . . . . . . . . . 89.1 m-85 -98.68 100.92 12.19 Favored 'General case' 0 C--N 1.307 -1.282 0 N-CA-C 111.777 0.288 . . . . 0.82999999999999996 111.777 -175.298 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A 1638 ' ' PHE . . . . . . . . . . . . . 68.0 m-85 -100.74 138.84 37.26 Favored 'General case' 0 C--N 1.307 -1.258 0 N-CA-C 109.169 -0.678 . . . . 0.59999999999999998 109.169 176.165 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A 1639 ' ' SER . . . . . 0.401 ' HA ' ' O ' ' A' 1611 ' ' SER . 50.8 m -136.79 120.75 17.61 Favored 'General case' 0 C--N 1.279 -2.467 0 N-CA-C 108.464 -0.939 . . . . 1.0800000000000001 108.464 174.883 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A 1640 ' ' TRP . . . . . . . . . . . . . 19.7 t90 -111.76 119.89 40.16 Favored 'General case' 0 C--N 1.292 -1.898 0 CA-C-N 115.942 -0.572 . . . . 0.80000000000000004 109.501 -178.131 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A 1641 ' ' HIS . . . . . 0.515 ' HB3' ' HB3' ' A' 1615 ' ' ARG . 39.8 m170 -77.06 107.46 9.44 Favored 'General case' 0 C--N 1.31 -1.138 0 N-CA-C 106.347 -1.723 . . . . 2.54 106.347 174.718 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A 1642 ' ' THR . . . . . . . . . . . . . 8.8 t -140.92 136.93 16.56 Favored Pre-proline 0 C--N 1.291 -1.952 0 N-CA-C 113.126 0.787 . . . . 1.1499999999999999 113.126 -173.711 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A 1643 ' ' PRO . . . . . 0.422 ' O ' ' HG2' ' A' 1647 ' ' GLU . 64.4 Cg_endo -76.97 -2.93 13.2 Favored 'Trans proline' 0 C--O 1.199 -1.462 0 C-N-CA 123.475 2.783 . . . . 0.80000000000000004 111.006 173.735 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A 1644 ' ' LEU . . . . . . . . . . . . . 83.6 mt -91.84 -9.67 42.56 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 116.608 -0.269 . . . . 1.54 111.417 -177.968 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A 1645 ' ' ALA . . . . . . . . . . . . . . . -81.67 -35.98 29.29 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 121.805 0.812 . . . . 0.94999999999999996 109.128 177.45 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A 1646 ' ' CYS . . . . . 0.523 ' HB2' ' HB3' ' A' 1614 ' ' CYS . 71.2 m -142.19 114.76 8.48 Favored 'General case' 0 N--CA 1.426 -1.645 0 N-CA-C 105.499 -2.037 . . . . 1.4099999999999999 105.499 174.786 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A 1647 ' ' GLU . . . . . 0.422 ' HG2' ' O ' ' A' 1643 ' ' PRO . 42.2 mt-10 -103.74 129.59 25.04 Favored Pre-proline 0 C--N 1.3 -1.56 0 N-CA-C 109.137 -0.69 . . . . 2.9199999999999999 109.137 -178.413 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A 1648 ' ' PRO . . . . . . . . . . . . . 18.6 Cg_endo -63.96 101.52 0.33 Allowed 'Trans proline' 0 C--O 1.245 0.861 0 C-N-CA 122.193 1.929 . . . . 2.8199999999999998 109.506 175.025 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A 1649 ' ' GLU . . . . . . . . . . . . . 44.1 mt-10 . . . . . 0 C--N 1.305 -1.357 0 CA-C-N 115.533 -0.758 . . . . 5.0599999999999996 109.227 -176.313 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A 1508 ' ' MET . . . . . . . . . . . . . 67.6 mtt . . . . . 0 C--O 1.24 0.586 0 CA-C-O 120.94 0.4 . . . . 8.2699999999999996 110.933 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A 1509 ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER 59.7 80.24 0.21 Allowed 'General case' 0 N--CA 1.466 0.368 0 N-CA-C 113.555 0.946 . . . . 6.4800000000000004 113.555 177.643 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A 1510 ' ' SER . . . . . . . . . . . . . 71.0 m -107.9 41.15 1.58 Allowed 'General case' 0 C--N 1.294 -1.838 0 CA-C-O 121.785 0.802 . . . . 4.2199999999999998 108.943 173.074 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A 1511 ' ' ASN . . . . . . . . . . . . . 38.2 m-80 -67.59 -19.02 65.2 Favored 'General case' 0 CA--C 1.51 -0.58 0 CA-C-N 114.9 -1.045 . . . . 3.0800000000000001 112.632 -174.405 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A 1512 ' ' GLU . . . . . 0.5 ' O ' ' HG3' ' A' 1580 ' ' ARG . 0.0 OUTLIER -66.82 -23.18 66.01 Favored 'General case' 0 C--O 1.212 -0.903 0 C-N-CA 120.403 -0.519 . . . . 4.46 110.604 179.79 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A 1513 ' ' HIS . . . . . . . . . . . . . 88.7 m-70 -91.64 1.89 56.84 Favored 'General case' 0 N--CA 1.464 0.251 0 CA-C-N 115.743 -0.662 . . . . 5.5700000000000003 109.941 178.478 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A 1514 ' ' ASP . . . . . . . . . . . . . 26.8 t70 -119.24 -53.61 2.24 Favored 'General case' 0 C--N 1.316 -0.863 0 N-CA-C 112.712 0.634 . . . . 3.7000000000000002 112.712 -172.231 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A 1515 ' ' ASP . . . . . . . . . . . . . 7.0 t0 -138.76 -174.31 3.8 Favored 'General case' 0 C--N 1.305 -1.361 0 N-CA-C 107.061 -1.459 . . . . 2.54 107.061 -174.186 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A 1516 ' ' CYS . . . . . . . . . . . . . 81.3 m -90.65 61.53 4.87 Favored 'General case' 0 C--N 1.28 -2.422 0 C-N-CA 123.599 0.76 . . . . 1.25 109.183 -179.761 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A 1517 ' ' GLN . . . . . 0.415 ' HB2' HD21 ' A' 1526 ' ' LEU . 9.8 pt20 -160.97 131.9 5.39 Favored 'General case' 0 C--N 1.308 -1.211 0 CA-C-O 120.803 0.335 . . . . 1.8799999999999999 110.695 179.219 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A 1518 ' ' VAL . . . . . . . . . . . . . 14.1 p -131.88 137.32 55.19 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.804 0 N-CA-C 109.053 -0.721 . . . . 1.73 109.053 178.429 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A 1519 ' ' THR . . . . . 0.62 ' HA ' ' HA ' ' A' 1526 ' ' LEU . 40.0 m -89.37 128.65 35.93 Favored 'General case' 0 C--N 1.29 -1.98 0 CA-C-N 116.182 -0.463 . . . . 1.7 109.758 177.891 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A 1520 ' ' ASN . . . . . . . . . . . . . 17.7 t-20 -80.1 114.3 45.6 Favored Pre-proline 0 C--N 1.308 -1.228 0 N-CA-C 108.473 -0.936 . . . . 2.1200000000000001 108.473 174.758 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A 1521 ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -74.63 0.2 9.0 Favored 'Trans proline' 0 CA--C 1.539 0.767 0 C-N-CA 122.541 2.16 . . . . 2.4700000000000002 113.926 -176.371 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A 1522 ' ' SER . . . . . . . . . . . . . 49.3 m -88.79 -62.34 1.51 Allowed 'General case' 0 N--CA 1.432 -1.375 0 O-C-N 122.13 -0.356 . . . . 2.5699999999999998 110.895 178.784 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A 1523 ' ' THR . . . . . . . . . . . . . 8.8 t -92.98 -11.89 32.09 Favored 'General case' 0 CA--C 1.547 0.858 0 CA-C-O 120.952 0.406 . . . . 2.1499999999999999 111.253 -179.821 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A 1524 ' ' GLY . . . . . . . . . . . . . . . 80.33 27.79 50.81 Favored Glycine 0 C--N 1.332 0.329 0 C-N-CA 121.059 -0.591 . . . . 1.8899999999999999 112.119 179.244 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A 1525 ' ' HIS . . . . . . . . . . . . . 16.1 t60 -101.22 119.18 38.36 Favored 'General case' 0 C--N 1.309 -1.169 0 N-CA-C 110.184 -0.302 . . . . 1.8999999999999999 110.184 -176.802 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A 1526 ' ' LEU . . . . . 0.62 ' HA ' ' HA ' ' A' 1519 ' ' THR . 7.0 tt -82.72 124.73 30.5 Favored 'General case' 0 C--N 1.301 -1.533 0 N-CA-C 108.174 -1.047 . . . . 1.6100000000000001 108.174 175.651 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A 1527 ' ' PHE . . . . . 0.408 ' O ' ' HA ' ' A' 1517 ' ' GLN . 76.4 m-85 -90.32 102.41 15.14 Favored 'General case' 0 C--N 1.309 -1.194 0 N-CA-C 109.183 -0.673 . . . . 1.4199999999999999 109.183 178.233 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A 1528 ' ' ASP . . . . . . . . . . . . . 8.8 t70 -80.76 118.13 22.03 Favored 'General case' 0 C--N 1.309 -1.154 0 CA-C-O 121.336 0.588 . . . . 2.1800000000000002 111.633 178.306 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A 1529 ' ' LEU . . . . . . . . . . . . . 6.2 mp -121.05 11.47 10.96 Favored 'General case' 0 C--N 1.307 -1.28 0 N-CA-C 106.496 -1.668 . . . . 1.4399999999999999 106.496 168.149 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A 1530 ' ' SER . . . . . . . . . . . . . 42.9 m -76.18 -29.1 57.54 Favored 'General case' 0 N--CA 1.442 -0.867 0 CA-C-N 115.376 -0.829 . . . . 1.4399999999999999 110.06 -178.615 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A 1531 ' ' SER . . . . . . . . . . . . . 29.0 t -75.32 -6.35 49.44 Favored 'General case' 0 CA--C 1.548 0.903 0 CA-C-O 122.303 1.049 . . . . 1.5 108.806 174.518 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A 1532 ' ' LEU . . . . . . . . . . . . . 98.1 mt -91.89 15.24 13.49 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.807 -0.633 . . . . 1.77 110.616 175.243 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A 1533 ' ' SER . . . . . 0.425 ' HA ' ' O ' ' A' 1553 ' ' CYS . 18.8 m -84.56 122.11 28.57 Favored 'General case' 0 N--CA 1.432 -1.35 0 N-CA-C 108.619 -0.882 . . . . 2.3799999999999999 108.619 175.668 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A 1534 ' ' GLY . . . . . . . . . . . . . . . -135.92 152.77 21.15 Favored Glycine 0 N--CA 1.419 -2.448 0 N-CA-C 110.594 -1.002 . . . . 1.55 110.594 -179.255 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A 1535 ' ' ARG . . . . . 0.584 ' HG3' ' HG3' ' A' 1555 ' ' GLU . 51.2 ttt180 -96.44 -25.13 15.8 Favored 'General case' 0 C--N 1.306 -1.283 0 CA-C-O 121.669 0.747 . . . . 3.96 109.886 179.049 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A 1536 ' ' ALA . . . . . . . . . . . . . . . -89.72 -41.03 12.14 Favored 'General case' 0 C--O 1.243 0.732 0 CA-C-N 115.587 -0.733 . . . . 1.6499999999999999 110.849 -179.043 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A 1537 ' ' GLY . . . . . . . . . . . . . . . 97.7 -175.95 30.62 Favored Glycine 0 N--CA 1.435 -1.382 0 CA-C-N 115.761 -0.654 . . . . 1.1899999999999999 112.477 176.75 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A 1538 ' ' PHE . . . . . . . . . . . . . 92.1 m-85 -111.64 155.09 23.94 Favored 'General case' 0 C--N 1.302 -1.49 0 N-CA-C 108.212 -1.033 . . . . 1.6899999999999999 108.212 176.687 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A 1539 ' ' THR . . . . . . . . . . . . . 5.2 p -106.27 111.08 23.52 Favored 'General case' 0 C--N 1.295 -1.761 0 CA-C-N 116.016 -0.538 . . . . 1.48 111.538 -179.704 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A 1540 ' ' ALA . . . . . . . . . . . . . . . -112.32 107.63 16.53 Favored 'General case' 0 C--N 1.313 -0.988 0 N-CA-C 109.027 -0.731 . . . . 0.82999999999999996 109.027 176.014 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A 1541 ' ' ALA . . . . . . . . . . . . . . . -71.75 155.23 40.69 Favored 'General case' 0 C--N 1.312 -1.037 0 CA-C-N 116.261 -0.427 . . . . 1.27 110.644 178.705 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A 1542 ' ' TYR . . . . . 0.414 ' HD2' ' HB2' ' A' 1545 ' ' SER . 32.4 t80 -156.23 179.92 8.77 Favored 'General case' 0 C--N 1.302 -1.491 0 N-CA-C 107.708 -1.219 . . . . 2.1499999999999999 107.708 -178.926 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A 1543 ' ' SER . . . . . . . . . . . . . 5.5 m -44.98 -151.67 0.0 OUTLIER 'General case' 0 CA--C 1.57 1.728 0 C-N-CA 129.181 2.993 . . . . 2.29 114.616 178.101 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A 1544 ' ' LYS . . . . . 0.414 ' HB2' ' HE3' ' A' 1544 ' ' LYS . 19.4 ptmt -54.7 -6.9 0.13 Allowed 'General case' 0 CA--C 1.575 1.931 0 O-C-N 120.251 -1.531 . . . . 3.9100000000000001 114.021 176.511 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A 1545 ' ' SER . . . . . 0.414 ' HB2' ' HD2' ' A' 1542 ' ' TYR . 20.4 m -73.03 -17.4 61.44 Favored 'General case' 0 CA--C 1.554 1.132 0 C-N-CA 123.332 0.653 . . . . 3.2999999999999998 109.693 170.668 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A 1546 ' ' GLY . . . . . . . . . . . . . . . 83.75 -80.38 1.83 Allowed Glycine 0 N--CA 1.436 -1.316 0 CA-C-O 121.43 0.461 . . . . 1.24 114.009 174.093 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A 1547 ' ' VAL . . . . . . . . . . . . . 7.1 p -160.16 140.77 3.78 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.169 0 N-CA-C 109.235 -0.654 . . . . 1.6299999999999999 109.235 -174.738 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A 1548 ' ' VAL . . . . . . . . . . . . . 4.0 t -108.29 131.9 57.52 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.726 0 N-CA-C 107.399 -1.334 . . . . 0.92000000000000004 107.399 179.398 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A 1549 ' ' TYR . . . . . . . . . . . . . 68.4 m-85 -93.15 114.64 27.2 Favored 'General case' 0 C--N 1.308 -1.207 0 N-CA-C 106.858 -1.534 . . . . 1.4399999999999999 106.858 174.077 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A 1550 ' ' MET . . . . . . . . . . . . . 56.3 ttp -135.93 121.6 19.64 Favored 'General case' 0 C--N 1.299 -1.614 0 C-N-CA 119.706 -0.798 . . . . 1.74 111.388 -177.774 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A 1551 ' ' SER . . . . . . . . . . . . . 19.9 m -95.97 124.1 39.84 Favored 'General case' 0 C--N 1.277 -2.568 0 N-CA-C 104.801 -2.296 . . . . 1.6399999999999999 104.801 173.017 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A 1552 ' ' ILE . . . . . . . . . . . . . 50.6 mm -60.86 -43.2 95.12 Favored 'Isoleucine or valine' 0 C--O 1.213 -0.854 0 N-CA-C 109.404 -0.591 . . . . 1.3300000000000001 109.404 -179.037 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A 1553 ' ' CYS . . . . . 0.425 ' O ' ' HA ' ' A' 1533 ' ' SER . 76.1 m -144.71 155.87 43.79 Favored 'General case' 0 C--N 1.295 -1.782 0 N-CA-C 106.491 -1.67 . . . . 1.4299999999999999 106.491 173.411 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A 1554 ' ' GLY . . . . . . . . . . . . . . . 118.26 -110.92 2.05 Favored Glycine 0 N--CA 1.434 -1.489 0 C-N-CA 120.342 -0.932 . . . . 1.1200000000000001 112.763 176.427 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A 1555 ' ' GLU . . . . . 0.584 ' HG3' ' HG3' ' A' 1535 ' ' ARG . 9.5 pt-20 -165.34 161.94 19.33 Favored 'General case' 0 C--N 1.305 -1.33 0 N-CA-C 106.724 -1.584 . . . . 1.8 106.724 -178.207 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A 1556 ' ' ASN . . . . . . . . . . . . . 17.9 t-20 -131.34 103.65 6.57 Favored 'General case' 0 C--N 1.287 -2.136 0 N-CA-C 109.332 -0.618 . . . . 2.6299999999999999 109.332 -179.209 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A 1557 ' ' GLU . . . . . . . . . . . . . 9.1 mm-40 -83.13 36.65 0.52 Allowed 'General case' 0 C--N 1.3 -1.576 0 N-CA-C 113.782 1.03 . . . . 3.79 113.782 -173.2 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A 1558 ' ' ASN . . . . . . . . . . . . . 33.0 m-80 -111.78 -19.35 12.47 Favored 'General case' 0 C--N 1.295 -1.802 0 N-CA-C 107.846 -1.168 . . . . 1.52 107.846 176.244 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A 1559 ' ' CYS . . . . . 0.778 ' HB3' ' HD2' ' A' 1560 ' ' PRO . 70.8 m -138.51 176.48 2.63 Favored Pre-proline 0 N--CA 1.436 -1.156 0 CA-C-O 116.866 -1.54 . . . . 0.83999999999999997 107.088 -178.103 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A 1560 ' ' PRO . . . . . 0.778 ' HD2' ' HB3' ' A' 1559 ' ' CYS . 2.9 Cg_exo -33.2 126.93 0.13 Allowed 'Trans proline' 0 C--N 1.386 2.538 0 C-N-CA 124.578 3.518 . . . . 1.1799999999999999 115.149 -177.412 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A 1561 ' ' PRO . . . . . 0.473 ' HD2' ' HA ' ' A' 1560 ' ' PRO . 9.5 Cg_endo -51.37 111.86 0.67 Allowed 'Trans proline' 0 C--O 1.246 0.898 0 C-N-CA 123.675 2.917 . . . . 1.51 112.98 -179.294 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A 1562 ' ' GLY . . . . . . . . . . . . . . . 111.39 2.94 27.63 Favored Glycine 0 N--CA 1.437 -1.255 0 CA-C-N 115.436 -0.802 . . . . 0.71999999999999997 113.018 177.937 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A 1563 ' ' VAL . . . . . 0.601 ' HA ' ' HA ' ' A' 1576 ' ' LYS . 14.9 m -94.06 152.0 3.64 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.055 0 N-CA-C 106.288 -1.745 . . . . 0.96999999999999997 106.288 172.723 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A 1564 ' ' GLY . . . . . 0.601 ' HA3' ' CE2' ' A' 1592 ' ' TYR . . . -113.86 -26.41 3.86 Favored Glycine 0 C--N 1.307 -1.059 0 C-N-CA 119.28 -1.438 . . . . 0.71999999999999997 113.139 -175.986 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A 1565 ' ' ALA . . . . . . . . . . . . . . . -132.59 126.11 32.01 Favored 'General case' 0 C--O 1.251 1.181 0 N-CA-C 109.63 -0.507 . . . . 0.37 109.63 -178.779 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A 1566 ' ' CYS . . . . . . . . . . . . . 43.2 t -150.4 139.7 21.31 Favored 'General case' 0 C--N 1.311 -1.075 0 CA-C-N 115.728 -0.669 . . . . 0.51000000000000001 110.064 -174.774 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A 1567 ' ' PHE . . . . . . . . . . . . . 26.5 m-85 -69.84 123.13 20.68 Favored 'General case' 0 CA--C 1.508 -0.665 0 N-CA-C 107.396 -1.335 . . . . 0.96999999999999997 107.396 175.755 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A 1568 ' ' GLY . . . . . . . . . . . . . . . -74.66 -37.27 46.15 Favored Glycine 0 N--CA 1.441 -1.023 0 C-N-CA 120.677 -0.773 . . . . 1.0800000000000001 113.769 -173.627 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A 1569 ' ' GLN . . . . . . . . . . . . . 50.1 tp60 -69.35 -48.61 60.82 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-O 121.976 0.893 . . . . 2.7400000000000002 109.44 -178.947 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A 1570 ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -80.71 -23.08 39.75 Favored 'General case' 0 C--N 1.301 -1.537 0 CA-C-N 114.387 -1.279 . . . . 1.96 112.397 -173.498 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A 1571 ' ' ARG . . . . . . . . . . . . . 40.5 mtp-105 64.32 32.15 12.38 Favored 'General case' 0 N--CA 1.472 0.64 0 C-N-CA 125.035 1.334 . . . . 3.9500000000000002 111.864 -178.833 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A 1572 ' ' ILE . . . . . . . . . . . . . 49.8 mm -109.66 118.98 58.02 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.227 0 N-CA-C 108.972 -0.751 . . . . 1.3700000000000001 108.972 -178.361 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A 1573 ' ' SER . . . . . . . . . . . . . 36.7 t -67.28 140.08 57.32 Favored 'General case' 0 N--CA 1.435 -1.205 0 CA-C-N 115.064 -0.971 . . . . 1.0800000000000001 109.453 178.379 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A 1574 ' ' VAL . . . . . 0.523 ' HB ' ' HB2' ' A' 1606 ' ' TYR . 23.0 m -116.01 -38.96 2.48 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.653 0 C-N-CA 119.978 -0.689 . . . . 1.3 110.663 178.606 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A 1575 ' ' GLY . . . . . 0.798 ' HA3' ' HB3' ' A' 1592 ' ' TYR . . . -135.87 133.1 6.45 Favored Glycine 0 N--CA 1.428 -1.836 0 C-N-CA 120.376 -0.916 . . . . 0.51000000000000001 112.729 -177.592 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A 1576 ' ' LYS . . . . . 0.601 ' HA ' ' HA ' ' A' 1563 ' ' VAL . 24.4 ttpp -85.89 149.37 25.27 Favored 'General case' 0 C--N 1.309 -1.191 0 N-CA-C 107.307 -1.368 . . . . 2.8999999999999999 107.307 178.608 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A 1577 ' ' ALA . . . . . . . . . . . . . . . -63.44 133.91 54.77 Favored 'General case' 0 CA--C 1.501 -0.924 0 O-C-N 123.793 0.683 . . . . 0.82999999999999996 109.503 179.128 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A 1578 ' ' ASN . . . . . . . . . . . . . 7.8 p30 -153.27 144.96 23.42 Favored 'General case' 0 C--N 1.282 -2.369 0 N-CA-C 105.638 -1.986 . . . . 1.8500000000000001 105.638 179.867 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A 1579 ' ' LYS . . . . . . . . . . . . . 67.9 mttm -114.48 89.3 3.06 Favored 'General case' 0 C--N 1.29 -2.019 0 C-N-CA 118.631 -1.228 . . . . 1.8999999999999999 110.791 -176.703 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A 1580 ' ' ARG . . . . . 0.5 ' HG3' ' O ' ' A' 1512 ' ' GLU . 53.1 ttt180 -156.72 131.07 8.63 Favored 'General case' 0 N--CA 1.415 -2.207 0 CA-C-N 115.288 -0.869 . . . . 3.6299999999999999 109.42 172.712 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A 1581 ' ' LEU . . . . . 0.415 HD13 HD12 ' A' 1588 ' ' LEU . 2.3 pp -124.88 150.66 46.26 Favored 'General case' 0 C--N 1.284 -2.282 0 N-CA-C 108.784 -0.821 . . . . 1.8700000000000001 108.784 175.857 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A 1582 ' ' ARG . . . . . . . . . . . . . 90.0 mtt180 -115.82 125.7 53.03 Favored 'General case' 0 C--N 1.288 -2.082 0 CA-C-O 121.0 0.429 . . . . 3.9700000000000002 110.052 -176.592 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A 1583 ' ' TYR . . . . . 0.481 ' CE1' ' HA ' ' A' 1586 ' ' GLN . 58.8 t80 -94.0 91.25 6.78 Favored 'General case' 0 C--N 1.289 -2.031 0 N-CA-C 107.714 -1.217 . . . . 1.4099999999999999 107.714 179.115 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A 1584 ' ' VAL . . . . . . . . . . . . . 4.4 p -107.21 95.37 3.74 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.85 0 CA-C-O 121.824 0.821 . . . . 1.6899999999999999 111.4 -176.909 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A 1585 ' ' ASP . . . . . . . . . . . . . 27.9 t70 52.69 67.89 0.92 Allowed 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 114.695 -1.139 . . . . 2.0600000000000001 111.359 -177.954 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A 1586 ' ' GLN . . . . . 0.481 ' HA ' ' CE1' ' A' 1583 ' ' TYR . 49.6 mt-30 66.31 -15.23 0.13 Allowed 'General case' 0 C--N 1.315 -0.905 0 N-CA-C 115.873 1.805 . . . . 2.3300000000000001 115.873 177.73 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A 1587 ' ' VAL . . . . . . . . . . . . . 10.9 p -99.38 123.21 51.94 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.028 0 CA-C-N 119.119 0.872 . . . . 0.78000000000000003 109.684 178.301 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A 1588 ' ' LEU . . . . . 0.541 ' HB2' ' HB2' ' A' 1612 ' ' PHE . 4.1 mm? -81.96 140.18 34.16 Favored 'General case' 0 N--CA 1.43 -1.472 0 CA-C-N 115.581 -0.736 . . . . 1.4099999999999999 111.885 -178.848 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A 1589 ' ' GLN . . . . . . . . . . . . . 35.1 tt0 -129.78 122.1 28.13 Favored 'General case' 0 C--N 1.303 -1.454 0 CA-C-N 115.573 -0.74 . . . . 1.24 109.926 179.073 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A 1590 ' ' LEU . . . . . . . . . . . . . 6.8 tt -119.16 132.94 56.02 Favored 'General case' 0 C--N 1.304 -1.393 0 N-CA-C 106.569 -1.641 . . . . 1.1499999999999999 106.569 176.583 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A 1591 ' ' VAL . . . . . 0.579 HG12 HG22 ' A' 1609 ' ' VAL . 35.3 m -124.29 144.7 33.21 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.837 0 CA-C-O 121.688 0.756 . . . . 1.51 112.956 -173.509 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A 1592 ' ' TYR . . . . . 0.798 ' HB3' ' HA3' ' A' 1575 ' ' GLY . 22.5 m-85 -106.66 123.49 48.2 Favored 'General case' 0 C--N 1.298 -1.664 0 CA-C-N 115.078 -0.964 . . . . 1.0600000000000001 110.298 172.249 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A 1593 ' ' LYS . . . . . . . . . . . . . 20.5 ptmt -142.59 -178.64 5.87 Favored 'General case' 0 C--N 1.298 -1.67 0 CA-C-N 114.364 -1.289 . . . . 2.1800000000000002 108.072 -173.59 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A 1594 ' ' ASP . . . . . 0.523 ' HB2' ' HE3' ' A' 1576 ' ' LYS . 57.9 m-20 67.05 14.88 9.98 Favored 'General case' 0 N--CA 1.491 1.618 0 C-N-CA 124.098 0.959 . . . . 1.45 113.265 175.253 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A 1595 ' ' GLY . . . . . . . . . . . . . . . -90.54 -105.89 1.29 Allowed Glycine 0 N--CA 1.432 -1.587 0 N-CA-C 111.212 -0.755 . . . . 0.78000000000000003 111.212 179.106 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A 1596 ' ' SER . . . . . 0.438 ' HA ' ' HD3' ' A' 1597 ' ' PRO . 23.0 m -106.65 128.05 26.93 Favored Pre-proline 0 C--N 1.295 -1.795 0 N-CA-C 109.679 -0.489 . . . . 1.6799999999999999 109.679 179.9 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A 1597 ' ' PRO . . . . . 0.438 ' HD3' ' HA ' ' A' 1596 ' ' SER . 32.3 Cg_exo -63.07 150.95 87.16 Favored 'Trans proline' 0 C--O 1.238 0.516 0 C-N-CA 123.289 2.659 . . . . 1.1699999999999999 110.866 176.554 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A 1598 ' ' CYS . . . . . 0.481 ' HA ' ' HD3' ' A' 1599 ' ' PRO . 50.2 t -94.93 132.63 27.85 Favored Pre-proline 0 C--N 1.293 -1.851 0 N-CA-C 109.961 -0.385 . . . . 1.1899999999999999 109.961 -177.675 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A 1599 ' ' PRO . . . . . 0.481 ' HD3' ' HA ' ' A' 1598 ' ' CYS . 11.8 Cg_exo -72.29 -7.5 21.05 Favored 'Trans proline' 0 C--N 1.362 1.24 0 C-N-CA 123.392 2.728 . . . . 1.5900000000000001 112.165 -179.97 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A 1600 ' ' SER . . . . . . . . . . . . . 44.9 t -113.14 123.67 50.79 Favored 'General case' 0 N--CA 1.421 -1.906 0 N-CA-C 107.757 -1.201 . . . . 2.1200000000000001 107.757 177.603 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A 1601 ' ' LYS . . . . . . . . . . . . . 34.9 mmtp 57.13 50.92 11.06 Favored 'General case' 0 C--O 1.241 0.633 0 O-C-N 123.64 0.587 . . . . 3.7400000000000002 109.814 -179.623 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A 1602 ' ' SER . . . . . . . . . . . . . 50.9 m -54.04 140.56 31.15 Favored 'General case' 0 N--CA 1.439 -0.992 0 CA-C-N 114.964 -1.016 . . . . 3.79 113.254 -175.988 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A 1603 ' ' GLY . . . . . . . . . . . . . . . 135.75 -10.9 4.27 Favored Glycine 0 N--CA 1.434 -1.466 0 N-CA-C 108.954 -1.659 . . . . 2.0 108.954 -173.327 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A 1604 ' ' LEU . . . . . . . . . . . . . 1.3 pp -135.42 162.4 32.72 Favored 'General case' 0 N--CA 1.437 -1.075 0 C-N-CA 123.897 0.879 . . . . 1.48 110.449 179.834 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A 1605 ' ' SER . . . . . . . . . . . . . 11.4 m -99.71 -176.04 3.15 Favored 'General case' 0 C--N 1.302 -1.46 0 N-CA-C 109.012 -0.736 . . . . 1.51 109.012 -178.611 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A 1606 ' ' TYR . . . . . 0.62 ' HA ' ' HB3' ' A' 1634 ' ' CYS . 78.5 m-85 -81.71 97.12 7.78 Favored 'General case' 0 CA--C 1.477 -1.837 0 N-CA-C 103.325 -2.843 . . . . 1.1799999999999999 103.325 171.508 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A 1607 ' ' LYS . . . . . . . . . . . . . 17.3 ptmt -103.53 125.52 50.13 Favored 'General case' 0 C--N 1.26 -3.285 0 C-N-CA 119.695 -0.802 . . . . 1.6699999999999999 112.041 -165.57 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A 1608 ' ' SER . . . . . 0.422 ' HB2' ' HB2' ' A' 1592 ' ' TYR . 16.5 m -98.62 117.29 32.73 Favored 'General case' 0 C--N 1.296 -1.73 0 CA-C-N 114.796 -1.093 . . . . 1.0 108.95 -179.102 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A 1609 ' ' VAL . . . . . 0.579 HG22 HG12 ' A' 1591 ' ' VAL . 98.1 t -112.12 117.19 54.59 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.22 0 N-CA-C 109.194 -0.669 . . . . 0.93000000000000005 109.194 179.775 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A 1610 ' ' ILE . . . . . 0.717 HG13 ' HB2' ' A' 1638 ' ' PHE . 2.9 mp -105.36 114.53 45.1 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.178 0 N-CA-C 108.695 -0.854 . . . . 0.78000000000000003 108.695 178.108 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A 1611 ' ' SER . . . . . . . . . . . . . 63.5 p -90.66 124.19 34.87 Favored 'General case' 0 N--CA 1.43 -1.465 0 N-CA-C 108.324 -0.991 . . . . 1.29 108.324 175.541 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A 1612 ' ' PHE . . . . . 0.541 ' HB2' ' HB2' ' A' 1588 ' ' LEU . 96.2 m-85 -93.23 107.74 19.49 Favored 'General case' 0 C--N 1.297 -1.71 0 CA-C-N 116.209 -0.45 . . . . 0.69999999999999996 109.914 -179.125 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A 1613 ' ' VAL . . . . . . . . . . . . . 66.7 t -104.8 132.59 51.14 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.137 0 O-C-N 124.723 1.265 . . . . 0.75 108.895 -178.787 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A 1614 ' ' CYS . . . . . 0.427 ' HA ' ' O ' ' A' 1642 ' ' THR . 55.8 m -76.88 103.78 7.02 Favored 'General case' 0 C--N 1.295 -1.797 0 CA-C-N 114.973 -1.012 . . . . 1.3899999999999999 111.433 -175.092 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A 1615 ' ' ARG . . . . . . . . . . . . . 38.3 mmt180 -123.7 86.7 52.83 Favored Pre-proline 0 C--N 1.306 -1.312 0 CA-C-N 115.541 -0.754 . . . . 3.75 110.067 179.041 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A 1616 ' ' PRO . . . . . . . . . . . . . 42.7 Cg_endo -66.25 -28.78 47.44 Favored 'Trans proline' 0 C--N 1.348 0.511 0 C-N-CA 122.919 2.412 . . . . 1.3200000000000001 113.392 -177.44 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A 1617 ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -99.32 22.61 10.35 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-O 121.408 0.623 . . . . 3.21 111.117 -178.065 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A 1618 ' ' ALA . . . . . . . . . . . . . . . -84.73 147.2 27.01 Favored 'General case' 0 N--CA 1.439 -1.023 0 N-CA-C 109.136 -0.69 . . . . 2.4399999999999999 109.136 177.672 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A 1619 ' ' GLY . . . . . . . . . . . . . . . -139.41 -88.48 0.17 Allowed Glycine 0 C--N 1.292 -1.902 0 N-CA-C 109.671 -1.371 . . . . 3.2599999999999998 109.671 178.023 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A 1620 ' ' PRO . . . . . . . . . . . . . 22.3 Cg_endo -63.17 -23.93 72.87 Favored 'Trans proline' 0 CA--C 1.543 0.933 0 C-N-CA 122.52 2.146 . . . . 5.9199999999999999 112.749 178.633 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A 1621 ' ' THR . . . . . 0.412 ' O ' ' HB2' ' A' 1641 ' ' HIS . 13.0 m -96.44 13.95 26.14 Favored 'General case' 0 CA--C 1.566 1.584 0 CA-C-O 121.49 0.662 . . . . 4.7599999999999998 110.868 -179.454 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A 1622 ' ' ASN . . . . . 0.452 ' HA ' ' O ' ' A' 1641 ' ' HIS . 53.8 t-20 -78.6 68.29 4.55 Favored 'General case' 0 N--CA 1.479 0.999 0 CA-C-O 121.576 0.703 . . . . 2.9199999999999999 109.564 178.847 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A 1623 ' ' ARG . . . . . . . . . . . . . 15.5 ptm180 -155.15 151.0 21.88 Favored Pre-proline 0 C--N 1.31 -1.114 0 CA-C-N 115.8 -0.637 . . . . 3.6099999999999999 109.467 179.781 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A 1624 ' ' PRO . . . . . 0.511 ' HA ' ' O ' ' A' 1639 ' ' SER . 39.5 Cg_endo -87.14 101.17 0.52 Allowed 'Trans proline' 0 N--CA 1.443 -1.452 0 C-N-CA 122.777 2.318 . . . . 2.3700000000000001 111.112 174.931 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A 1625 ' ' MET . . . . . . . . . . . . . 1.5 pmm? -96.17 153.3 17.87 Favored 'General case' 0 C--N 1.301 -1.505 0 N-CA-C 109.701 -0.481 . . . . 2.1600000000000001 109.701 179.696 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A 1626 ' ' LEU . . . . . . . . . . . . . 40.6 tp -81.91 105.25 12.88 Favored 'General case' 0 C--N 1.31 -1.145 0 N-CA-C 108.687 -0.857 . . . . 1.3500000000000001 108.687 177.919 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A 1627 ' ' ILE . . . . . . . . . . . . . 46.2 pt -87.21 -26.39 5.94 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.988 0 CA-C-N 116.083 -0.508 . . . . 1.21 112.134 -175.187 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A 1628 ' ' SER . . . . . . . . . . . . . 13.0 t -160.8 144.49 13.46 Favored 'General case' 0 N--CA 1.437 -1.09 0 N-CA-C 109.496 -0.557 . . . . 1.3999999999999999 109.496 -178.3 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A 1629 ' ' LEU . . . . . 1.006 ' HG ' ' HG ' ' A' 1636 ' ' LEU . 4.4 tt -133.96 112.27 11.11 Favored 'General case' 0 C--N 1.306 -1.319 0 N-CA-C 107.023 -1.473 . . . . 1.5600000000000001 107.023 177.572 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A 1630 ' ' ASP . . . . . . . . . . . . . 29.4 t70 -92.23 117.56 30.0 Favored 'General case' 0 C--N 1.307 -1.248 0 N-CA-C 108.84 -0.8 . . . . 0.87 108.84 177.553 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A 1631 ' ' LYS . . . . . . . . . . . . . 94.8 mttt -86.48 -5.77 59.07 Favored 'General case' 0 C--N 1.303 -1.422 0 CA-C-N 116.454 -0.339 . . . . 2.3500000000000001 111.572 -176.253 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A 1632 ' ' GLN . . . . . . . . . . . . . 39.2 mt-30 -81.43 -45.67 15.71 Favored 'General case' 0 N--CA 1.447 -0.588 0 N-CA-C 109.961 -0.385 . . . . 2.5499999999999998 109.961 -178.981 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A 1633 ' ' THR . . . . . . . . . . . . . 11.4 p -109.82 13.21 23.68 Favored 'General case' 0 C--N 1.305 -1.353 0 CA-C-N 115.799 -0.637 . . . . 1.24 111.639 178.495 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A 1634 ' ' CYS . . . . . 0.62 ' HB3' ' HA ' ' A' 1606 ' ' TYR . 65.4 m 47.52 41.89 13.81 Favored 'General case' 0 N--CA 1.474 0.728 0 C-N-CA 123.943 0.897 . . . . 0.89000000000000001 112.976 179.879 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A 1635 ' ' THR . . . . . . . . . . . . . 33.4 m -105.33 117.07 33.08 Favored 'General case' 0 N--CA 1.417 -2.079 0 CA-C-N 115.368 -0.833 . . . . 0.75 109.596 -177.542 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A 1636 ' ' LEU . . . . . 1.006 ' HG ' ' HG ' ' A' 1629 ' ' LEU . 5.4 mp -101.84 129.73 48.13 Favored 'General case' 0 C--N 1.311 -1.09 0 N-CA-C 109.15 -0.685 . . . . 1.3300000000000001 109.15 179.966 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A 1637 ' ' PHE . . . . . . . . . . . . . 80.6 m-85 -108.1 109.92 21.47 Favored 'General case' 0 C--N 1.308 -1.237 0 CA-C-N 116.27 -0.423 . . . . 0.82999999999999996 111.123 -175.874 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A 1638 ' ' PHE . . . . . 0.717 ' HB2' HG13 ' A' 1610 ' ' ILE . 97.1 m-85 -107.68 149.01 28.64 Favored 'General case' 0 C--N 1.304 -1.391 0 N-CA-C 108.454 -0.943 . . . . 0.59999999999999998 108.454 176.151 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A 1639 ' ' SER . . . . . 0.511 ' O ' ' HA ' ' A' 1624 ' ' PRO . 43.5 m -137.58 121.18 17.3 Favored 'General case' 0 C--N 1.294 -1.825 0 N-CA-C 109.795 -0.446 . . . . 1.0800000000000001 109.795 178.051 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A 1640 ' ' TRP . . . . . 0.449 ' CD1' ' HB ' ' A' 1642 ' ' THR . 3.8 t90 -100.61 125.13 46.97 Favored 'General case' 0 C--N 1.314 -0.966 0 N-CA-C 108.445 -0.946 . . . . 0.80000000000000004 108.445 -179.828 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A 1641 ' ' HIS . . . . . 0.452 ' O ' ' HA ' ' A' 1622 ' ' ASN . 11.4 m-70 -89.67 94.79 9.98 Favored 'General case' 0 C--N 1.307 -1.277 0 N-CA-C 105.63 -1.989 . . . . 2.54 105.63 175.093 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A 1642 ' ' THR . . . . . 0.655 ' OG1' ' HG ' ' A' 1644 ' ' LEU . 12.2 t -142.12 138.39 16.73 Favored Pre-proline 0 C--N 1.303 -1.419 0 C-N-CA 119.663 -0.815 . . . . 1.1499999999999999 112.867 -171.886 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A 1643 ' ' PRO . . . . . 0.477 ' HD3' ' HA ' ' A' 1642 ' ' THR . 15.1 Cg_exo -71.96 -25.14 20.01 Favored 'Trans proline' 0 N--CA 1.456 -0.733 0 C-N-CA 123.34 2.694 . . . . 0.80000000000000004 112.027 175.969 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A 1644 ' ' LEU . . . . . 0.655 ' HG ' ' OG1' ' A' 1642 ' ' THR . 4.0 pp -70.55 -17.17 62.93 Favored 'General case' 0 N--CA 1.478 0.932 0 N-CA-C 112.348 0.499 . . . . 1.54 112.348 -176.636 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A 1645 ' ' ALA . . . . . . . . . . . . . . . -64.0 -41.52 97.47 Favored 'General case' 0 N--CA 1.448 -0.543 0 CA-C-N 115.495 -0.775 . . . . 0.94999999999999996 109.24 178.948 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A 1646 ' ' CYS . . . . . . . . . . . . . 19.2 p -177.11 116.02 0.1 Allowed 'General case' 0 C--O 1.244 0.791 0 C-N-CA 124.473 1.109 . . . . 1.4099999999999999 108.342 171.903 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A 1647 ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -93.58 135.27 25.39 Favored Pre-proline 0 C--N 1.294 -1.834 0 O-C-N 121.961 -0.462 . . . . 2.9199999999999999 110.212 179.164 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A 1648 ' ' PRO . . . . . . . . . . . . . 19.0 Cg_endo -61.6 102.44 0.24 Allowed 'Trans proline' 0 C--O 1.245 0.872 0 C-N-CA 122.857 2.371 . . . . 2.8199999999999998 111.2 178.858 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A 1649 ' ' GLU . . . . . . . . . . . . . 7.6 pt-20 . . . . . 0 C--N 1.303 -1.454 0 CA-C-O 118.455 -0.783 . . . . 5.0599999999999996 110.597 -179.316 . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A 1508 ' ' MET . . . . . . . . . . . . . 26.3 mmt . . . . . 0 CA--C 1.517 -0.312 0 CA-C-O 120.41 0.147 . . . . 8.2699999999999996 110.829 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A 1509 ' ' LYS . . . . . . . . . . . . . 68.3 mttm -135.37 52.23 2.03 Favored 'General case' 0 N--CA 1.45 -0.451 0 O-C-N 122.088 -0.382 . . . . 6.4800000000000004 111.988 -178.162 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A 1510 ' ' SER . . . . . . . . . . . . . 19.7 m -80.23 50.37 1.24 Allowed 'General case' 0 C--N 1.317 -0.841 0 CA-C-O 121.752 0.787 . . . . 4.2199999999999998 110.145 -179.369 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A 1511 ' ' ASN . . . . . . . . . . . . . 13.8 t30 -170.5 -59.45 0.02 OUTLIER 'General case' 0 C--N 1.307 -1.247 0 N-CA-C 108.31 -0.996 . . . . 3.0800000000000001 108.31 -173.457 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A 1512 ' ' GLU . . . . . . . . . . . . . 31.6 tt0 -53.49 -41.79 66.63 Favored 'General case' 0 CA--C 1.543 0.676 0 C-N-CA 124.307 1.043 . . . . 4.46 112.719 -175.952 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A 1513 ' ' HIS . . . . . 0.517 ' HB3' ' O ' ' A' 1581 ' ' LEU . 9.6 p80 -132.87 31.83 3.87 Favored 'General case' 0 CA--C 1.511 -0.528 0 C-N-CA 120.003 -0.679 . . . . 5.5700000000000003 111.383 179.315 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A 1514 ' ' ASP . . . . . . . . . . . . . 20.3 t70 -82.03 -47.83 12.16 Favored 'General case' 0 C--N 1.312 -1.027 0 N-CA-C 107.304 -1.369 . . . . 3.7000000000000002 107.304 179.259 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A 1515 ' ' ASP . . . . . . . . . . . . . 3.4 p-10 -155.84 172.54 18.18 Favored 'General case' 0 C--N 1.3 -1.57 0 N-CA-C 103.536 -2.765 . . . . 2.54 103.536 174.852 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A 1516 ' ' CYS . . . . . 0.509 ' HB3' ' HB2' ' A' 1529 ' ' LEU . 58.1 m -79.37 61.75 3.52 Favored 'General case' 0 C--N 1.301 -1.541 0 N-CA-C 113.924 1.083 . . . . 1.25 113.924 -172.375 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A 1517 ' ' GLN . . . . . 0.549 ' HB2' HD21 ' A' 1526 ' ' LEU . 11.1 pt20 -145.22 122.14 11.31 Favored 'General case' 0 N--CA 1.425 -1.702 0 N-CA-C 107.41 -1.329 . . . . 1.8799999999999999 107.41 172.351 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A 1518 ' ' VAL . . . . . . . . . . . . . 84.9 t -109.23 106.21 20.26 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.941 0 N-CA-C 109.059 -0.719 . . . . 1.73 109.059 179.98 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A 1519 ' ' THR . . . . . . . . . . . . . 19.0 m -86.36 113.19 22.13 Favored 'General case' 0 C--N 1.287 -2.111 0 N-CA-C 107.066 -1.457 . . . . 1.7 107.066 175.772 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A 1520 ' ' ASN . . . . . . . . . . . . . 49.8 t-20 -87.52 104.81 7.1 Favored Pre-proline 0 C--N 1.308 -1.216 0 N-CA-C 107.766 -1.198 . . . . 2.1200000000000001 107.766 179.437 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A 1521 ' ' PRO . . . . . . . . . . . . . 63.3 Cg_endo -71.48 -12.17 29.13 Favored 'Trans proline' 0 C--N 1.353 0.803 0 C-N-CA 122.505 2.137 . . . . 2.4700000000000002 112.831 -174.613 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A 1522 ' ' SER . . . . . . . . . . . . . 5.8 m -76.95 -23.32 52.39 Favored 'General case' 0 N--CA 1.431 -1.421 0 CA-C-N 115.988 -0.551 . . . . 2.5699999999999998 110.242 -178.953 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A 1523 ' ' THR . . . . . . . . . . . . . 5.0 t -127.44 -23.52 3.48 Favored 'General case' 0 CA--C 1.545 0.756 0 N-CA-C 112.46 0.541 . . . . 2.1499999999999999 112.46 179.319 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A 1524 ' ' GLY . . . . . . . . . . . . . . . 100.1 -17.7 56.73 Favored Glycine 0 N--CA 1.447 -0.568 0 C-N-CA 120.566 -0.826 . . . . 1.8899999999999999 112.168 -179.002 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A 1525 ' ' HIS . . . . . . . . . . . . . 17.4 t-80 -75.3 134.64 41.01 Favored 'General case' 0 C--N 1.312 -1.048 0 C-N-CA 123.009 0.524 . . . . 1.8999999999999999 111.244 -177.379 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A 1526 ' ' LEU . . . . . 0.549 HD21 ' HB2' ' A' 1517 ' ' GLN . 7.1 tt -111.27 135.79 51.3 Favored 'General case' 0 C--N 1.313 -0.988 0 CA-C-N 115.666 -0.697 . . . . 1.6100000000000001 109.271 -178.586 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A 1527 ' ' PHE . . . . . 0.529 ' O ' ' HA ' ' A' 1517 ' ' GLN . 85.2 m-85 -102.14 106.36 17.2 Favored 'General case' 0 C--N 1.312 -1.028 0 N-CA-C 108.893 -0.78 . . . . 1.4199999999999999 108.893 177.334 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A 1528 ' ' ASP . . . . . . . . . . . . . 9.9 t70 -97.82 115.58 28.32 Favored 'General case' 0 C--N 1.319 -0.737 0 N-CA-C 109.654 -0.499 . . . . 2.1800000000000002 109.654 179.76 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A 1529 ' ' LEU . . . . . 0.509 ' HB2' ' HB3' ' A' 1516 ' ' CYS . 84.6 mt -106.69 -12.99 15.4 Favored 'General case' 0 C--N 1.308 -1.21 0 CA-C-N 116.166 -0.47 . . . . 1.4399999999999999 111.157 -178.398 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A 1530 ' ' SER . . . . . 0.492 ' HA ' ' HB3' ' A' 1553 ' ' CYS . 17.1 m -71.65 -47.38 54.75 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-O 121.036 0.446 . . . . 1.4399999999999999 109.903 -178.102 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A 1531 ' ' SER . . . . . . . . . . . . . 13.3 m -70.01 -9.7 56.15 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.366 -0.833 . . . . 1.5 111.515 -175.936 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A 1532 ' ' LEU . . . . . . . . . . . . . 58.9 mt -76.55 -18.69 58.55 Favored 'General case' 0 C--N 1.313 -1.004 0 CA-C-N 116.382 -0.372 . . . . 1.77 110.446 178.142 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A 1533 ' ' SER . . . . . 0.486 ' OG ' ' HB ' ' A' 1552 ' ' ILE . 19.6 m -100.91 143.13 31.43 Favored 'General case' 0 C--N 1.315 -0.895 0 CA-C-N 116.226 -0.443 . . . . 2.3799999999999999 110.848 -176.38 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A 1534 ' ' GLY . . . . . . . . . . . . . . . -102.18 -174.64 27.61 Favored Glycine 0 N--CA 1.42 -2.375 0 N-CA-C 109.512 -1.435 . . . . 1.55 109.512 175.401 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A 1535 ' ' ARG . . . . . . . . . . . . . 36.3 ttm180 -69.48 -50.05 48.99 Favored 'General case' 0 C--N 1.294 -1.815 0 N-CA-C 112.035 0.383 . . . . 3.96 112.035 -177.822 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A 1536 ' ' ALA . . . . . . . . . . . . . . . -69.77 -48.89 57.57 Favored 'General case' 0 C--N 1.313 -0.979 0 CA-C-N 116.038 -0.528 . . . . 1.6499999999999999 111.772 -175.82 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A 1537 ' ' GLY . . . . . 0.564 ' HA3' ' ND2' ' A' 1556 ' ' ASN . . . 119.66 -173.84 15.27 Favored Glycine 0 N--CA 1.444 -0.806 0 C-N-CA 121.289 -0.481 . . . . 1.1899999999999999 112.914 175.535 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A 1538 ' ' PHE . . . . . 0.475 ' HE2' ' HA ' ' A' 1533 ' ' SER . 97.4 m-85 -116.51 170.37 8.62 Favored 'General case' 0 C--N 1.313 -1.013 0 C-N-CA 123.29 0.636 . . . . 1.6899999999999999 109.917 -179.953 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A 1539 ' ' THR . . . . . 0.544 ' HA ' ' O ' ' A' 1548 ' ' VAL . 16.9 p -129.85 130.28 45.03 Favored 'General case' 0 N--CA 1.438 -1.042 0 CA-C-N 116.028 -0.533 . . . . 1.48 111.528 177.988 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A 1540 ' ' ALA . . . . . . . . . . . . . . . -103.36 146.98 27.67 Favored 'General case' 0 C--N 1.301 -1.52 0 N-CA-C 107.745 -1.206 . . . . 0.82999999999999996 107.745 173.348 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A 1541 ' ' ALA . . . . . . . . . . . . . . . -77.88 130.89 37.16 Favored 'General case' 0 C--O 1.246 0.89 0 N-CA-C 109.815 -0.439 . . . . 1.27 109.815 -177.98 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A 1542 ' ' TYR . . . . . 0.698 ' HD2' ' HB2' ' A' 1545 ' ' SER . 70.0 t80 -139.88 168.09 20.61 Favored 'General case' 0 N--CA 1.437 -1.087 0 CA-C-O 119.425 -0.321 . . . . 2.1499999999999999 110.245 -176.237 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A 1543 ' ' SER . . . . . . . . . . . . . 12.0 m -49.09 -151.99 0.0 OUTLIER 'General case' 0 CA--C 1.576 1.979 0 C-N-CA 128.796 2.838 . . . . 2.29 113.754 178.224 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A 1544 ' ' LYS . . . . . . . . . . . . . 39.7 ttmt -40.29 -35.48 0.42 Allowed 'General case' 0 N--CA 1.486 1.366 0 O-C-N 121.041 -1.037 . . . . 3.9100000000000001 113.547 177.886 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A 1545 ' ' SER . . . . . 0.698 ' HB2' ' HD2' ' A' 1542 ' ' TYR . 19.3 m -66.55 -12.07 55.97 Favored 'General case' 0 CA--C 1.568 1.639 0 N-CA-C 112.856 0.688 . . . . 3.2999999999999998 112.856 176.469 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A 1546 ' ' GLY . . . . . . . . . . . . . . . 82.24 -74.09 2.54 Favored Glycine 0 N--CA 1.446 -0.641 0 N-CA-C 114.6 0.6 . . . . 1.24 114.6 172.151 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A 1547 ' ' VAL . . . . . . . . . . . . . 15.4 m -138.41 146.52 26.56 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.244 0 CA-C-O 121.185 0.517 . . . . 1.6299999999999999 111.272 -176.506 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A 1548 ' ' VAL . . . . . 0.544 ' O ' ' HA ' ' A' 1539 ' ' THR . 2.3 t -108.04 126.45 64.59 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.52 0 N-CA-C 106.675 -1.602 . . . . 0.92000000000000004 106.675 176.573 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A 1549 ' ' TYR . . . . . 0.614 ' HD2' ' HA3' ' A' 1568 ' ' GLY . 6.4 m-85 -84.87 120.67 26.73 Favored 'General case' 0 C--N 1.301 -1.516 0 N-CA-C 108.452 -0.944 . . . . 1.4399999999999999 108.452 174.906 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A 1550 ' ' MET . . . . . . . . . . . . . 60.7 mtp -135.87 164.96 26.74 Favored 'General case' 0 C--N 1.292 -1.924 0 CA-C-N 115.002 -0.999 . . . . 1.74 110.518 -173.489 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A 1551 ' ' SER . . . . . . . . . . . . . 13.9 p -129.7 144.57 51.35 Favored 'General case' 0 C--N 1.283 -2.31 0 N-CA-C 106.495 -1.668 . . . . 1.6399999999999999 106.495 175.002 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A 1552 ' ' ILE . . . . . 0.486 ' HB ' ' OG ' ' A' 1533 ' ' SER . 46.0 mm -74.25 -29.44 24.71 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.483 0 N-CA-C 107.525 -1.287 . . . . 1.3300000000000001 107.525 179.871 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A 1553 ' ' CYS . . . . . 0.492 ' HB3' ' HA ' ' A' 1530 ' ' SER . 46.7 t -161.79 149.96 15.08 Favored 'General case' 0 N--CA 1.419 -1.986 0 N-CA-C 105.93 -1.878 . . . . 1.4299999999999999 105.93 171.661 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A 1554 ' ' GLY . . . . . . . . . . . . . . . 94.22 -153.42 21.07 Favored Glycine 0 N--CA 1.427 -1.919 0 C-N-CA 120.304 -0.95 . . . . 1.1200000000000001 111.103 178.752 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A 1555 ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -122.73 145.0 48.79 Favored 'General case' 0 C--N 1.294 -1.825 0 CA-C-O 121.471 0.653 . . . . 1.8 110.963 -176.675 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A 1556 ' ' ASN . . . . . 0.564 ' ND2' ' HA3' ' A' 1537 ' ' GLY . 24.9 t-20 -87.59 138.25 31.63 Favored 'General case' 0 C--N 1.299 -1.605 0 N-CA-C 108.39 -0.967 . . . . 2.6299999999999999 108.39 179.464 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A 1557 ' ' GLU . . . . . . . . . . . . . 42.9 mt-10 -114.45 34.1 4.93 Favored 'General case' 0 C--N 1.317 -0.806 0 N-CA-C 113.557 0.947 . . . . 3.79 113.557 -175.83 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A 1558 ' ' ASN . . . . . . . . . . . . . 10.6 m120 -128.65 26.13 5.63 Favored 'General case' 0 C--N 1.313 -0.981 0 CA-C-O 122.839 1.304 . . . . 1.52 108.389 173.039 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A 1559 ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -161.84 173.17 4.81 Favored Pre-proline 0 C--N 1.29 -1.999 0 N-CA-C 104.621 -2.362 . . . . 0.83999999999999997 104.621 179.009 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A 1560 ' ' PRO . . . . . 0.627 ' O ' HG22 ' A' 1563 ' ' VAL . 2.4 Cg_endo -40.7 117.45 0.5 Allowed 'Trans proline' 0 C--N 1.365 1.397 0 C-N-CA 123.538 2.826 . . . . 1.1799999999999999 113.0 178.187 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A 1561 ' ' PRO . . . . . . . . . . . . . 36.8 Cg_exo -57.84 111.85 0.97 Allowed 'Trans proline' 0 C--O 1.248 0.996 0 C-N-CA 122.428 2.085 . . . . 1.51 110.546 -179.398 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A 1562 ' ' GLY . . . . . . . . . . . . . . . 129.17 -0.22 6.01 Favored Glycine 0 N--CA 1.431 -1.687 0 CA-C-N 115.534 -0.757 . . . . 0.71999999999999997 112.596 -177.646 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A 1563 ' ' VAL . . . . . 0.627 HG22 ' O ' ' A' 1560 ' ' PRO . 25.2 m -105.98 146.96 12.11 Favored 'Isoleucine or valine' 0 CA--C 1.493 -1.238 0 O-C-N 122.151 -0.617 . . . . 0.96999999999999997 111.048 175.325 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A 1564 ' ' GLY . . . . . . . . . . . . . . . -103.7 -8.07 40.75 Favored Glycine 0 N--CA 1.418 -2.526 0 N-CA-C 109.83 -1.308 . . . . 0.71999999999999997 109.83 175.477 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A 1565 ' ' ALA . . . . . . . . . . . . . . . -152.58 119.39 5.74 Favored 'General case' 0 N--CA 1.441 -0.911 0 CA-C-O 121.303 0.573 . . . . 0.37 110.381 -179.838 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A 1566 ' ' CYS . . . . . . . . . . . . . 6.7 t -154.76 136.07 14.07 Favored 'General case' 0 C--N 1.297 -1.686 0 N-CA-C 108.816 -0.809 . . . . 0.51000000000000001 108.816 -178.279 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A 1567 ' ' PHE . . . . . . . . . . . . . 26.1 m-85 -67.11 122.76 18.52 Favored 'General case' 0 C--O 1.208 -1.1 0 N-CA-C 106.334 -1.728 . . . . 0.96999999999999997 106.334 176.322 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A 1568 ' ' GLY . . . . . 0.614 ' HA3' ' HD2' ' A' 1549 ' ' TYR . . . -72.57 -36.89 58.45 Favored Glycine 0 CA--C 1.489 -1.569 0 C-N-CA 121.035 -0.602 . . . . 1.0800000000000001 114.453 -169.136 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A 1569 ' ' GLN . . . . . . . . . . . . . 30.1 tt0 -74.57 -43.97 53.1 Favored 'General case' 0 C--N 1.302 -1.469 0 CA-C-O 121.767 0.794 . . . . 2.7400000000000002 109.662 -179.931 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A 1570 ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -81.27 -26.23 35.92 Favored 'General case' 0 C--N 1.286 -2.154 0 CA-C-N 114.497 -1.229 . . . . 1.96 112.138 -173.092 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A 1571 ' ' ARG . . . . . . . . . . . . . 66.1 mtt180 60.65 47.33 8.34 Favored 'General case' 0 C--O 1.234 0.26 0 C-N-CA 125.947 1.699 . . . . 3.9500000000000002 111.653 -178.493 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A 1572 ' ' ILE . . . . . . . . . . . . . 40.8 mm -121.77 128.61 75.76 Favored 'Isoleucine or valine' 0 C--O 1.24 0.579 0 N-CA-C 108.228 -1.027 . . . . 1.3700000000000001 108.228 -179.616 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A 1573 ' ' SER . . . . . . . . . . . . . 28.2 t -79.03 138.61 38.08 Favored 'General case' 0 C--N 1.312 -1.057 0 C-N-CA 124.014 0.926 . . . . 1.0800000000000001 112.447 -175.972 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A 1574 ' ' VAL . . . . . . . . . . . . . 15.4 m -136.31 24.03 0.86 Allowed 'Isoleucine or valine' 0 C--N 1.318 -0.771 0 CA-C-O 121.581 0.705 . . . . 1.3 110.342 174.731 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A 1575 ' ' GLY . . . . . . . . . . . . . . . 169.03 115.21 0.32 Allowed Glycine 0 N--CA 1.442 -0.958 0 CA-C-N 115.301 -0.863 . . . . 0.51000000000000001 111.997 178.043 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A 1576 ' ' LYS . . . . . 0.712 ' HG3' ' HA2' ' A' 1595 ' ' GLY . 98.6 mttt -86.25 154.33 21.36 Favored 'General case' 0 C--N 1.315 -0.934 0 O-C-N 122.599 -0.354 . . . . 2.8999999999999999 110.074 179.297 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A 1577 ' ' ALA . . . . . . . . . . . . . . . -69.79 119.52 14.14 Favored 'General case' 0 C--O 1.244 0.803 0 CA-C-N 115.453 -0.794 . . . . 0.82999999999999996 110.241 -178.19 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A 1578 ' ' ASN . . . . . . . . . . . . . 40.0 m-80 -141.98 162.4 35.56 Favored 'General case' 0 C--N 1.305 -1.355 0 N-CA-C 107.123 -1.436 . . . . 1.8500000000000001 107.123 -179.427 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A 1579 ' ' LYS . . . . . . . . . . . . . 75.2 mmtt -102.76 88.8 3.3 Favored 'General case' 0 C--N 1.307 -1.264 0 N-CA-C 107.77 -1.196 . . . . 1.8999999999999999 107.77 175.842 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A 1580 ' ' ARG . . . . . . . . . . . . . 17.2 ttm180 -136.08 84.77 2.1 Favored 'General case' 0 C--N 1.293 -1.854 0 CA-C-O 121.926 0.87 . . . . 3.6299999999999999 109.159 -179.238 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A 1581 ' ' LEU . . . . . 0.517 ' O ' ' HB3' ' A' 1513 ' ' HIS . 49.1 tp -113.6 147.78 37.41 Favored 'General case' 0 C--N 1.294 -1.818 0 CA-C-N 114.053 -1.43 . . . . 1.8700000000000001 107.302 -179.41 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A 1582 ' ' ARG . . . . . . . . . . . . . 55.3 ttp180 -141.97 144.06 33.52 Favored 'General case' 0 C--N 1.295 -1.802 0 N-CA-C 109.99 -0.374 . . . . 3.9700000000000002 109.99 -175.492 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A 1583 ' ' TYR . . . . . 0.416 ' CE1' ' HA ' ' A' 1586 ' ' GLN . 74.2 t80 -128.09 104.59 7.85 Favored 'General case' 0 C--N 1.299 -1.604 0 N-CA-C 108.368 -0.975 . . . . 1.4099999999999999 108.368 176.704 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A 1584 ' ' VAL . . . . . . . . . . . . . 13.6 p -148.25 131.88 8.48 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.164 0 N-CA-C 109.117 -0.697 . . . . 1.6899999999999999 109.117 178.529 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A 1585 ' ' ASP . . . . . . . . . . . . . 37.5 t70 65.7 32.45 9.01 Favored 'General case' 0 N--CA 1.482 1.13 0 CA-C-O 122.622 1.201 . . . . 2.0600000000000001 109.621 -177.721 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A 1586 ' ' GLN . . . . . 0.416 ' HA ' ' CE1' ' A' 1583 ' ' TYR . 51.1 mt-30 65.05 4.89 2.7 Favored 'General case' 0 N--CA 1.473 0.707 0 C-N-CA 125.642 1.577 . . . . 2.3300000000000001 114.674 178.606 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A 1587 ' ' VAL . . . . . . . . . . . . . 7.1 p -108.32 130.09 61.54 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.394 0 CA-C-O 121.087 0.47 . . . . 0.78000000000000003 109.876 178.944 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A 1588 ' ' LEU . . . . . 0.566 ' HB2' ' HB2' ' A' 1612 ' ' PHE . 3.8 mm? -84.18 146.5 27.8 Favored 'General case' 0 N--CA 1.439 -0.991 0 CA-C-N 116.047 -0.524 . . . . 1.4099999999999999 110.838 -178.523 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A 1589 ' ' GLN . . . . . . . . . . . . . 35.2 tt0 -147.13 127.61 14.08 Favored 'General case' 0 C--N 1.302 -1.49 0 N-CA-C 109.819 -0.438 . . . . 1.24 109.819 178.475 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A 1590 ' ' LEU . . . . . . . . . . . . . 6.7 tt -125.59 138.39 53.94 Favored 'General case' 0 C--N 1.308 -1.217 0 N-CA-C 107.016 -1.476 . . . . 1.1499999999999999 107.016 179.895 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A 1591 ' ' VAL . . . . . 0.553 ' HB ' HG23 ' A' 1609 ' ' VAL . 5.0 p -137.54 134.16 46.24 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.292 0 CA-C-O 121.312 0.577 . . . . 1.51 112.132 -176.459 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A 1592 ' ' TYR . . . . . . . . . . . . . 77.5 m-85 -97.63 96.36 8.22 Favored 'General case' 0 N--CA 1.431 -1.402 0 N-CA-C 107.347 -1.353 . . . . 1.0600000000000001 107.347 174.079 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A 1593 ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -88.52 157.81 18.52 Favored 'General case' 0 C--N 1.295 -1.78 0 CA-C-N 115.058 -0.973 . . . . 2.1800000000000002 111.932 -177.107 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A 1594 ' ' ASP . . . . . 0.439 ' HA ' ' HB2' ' A' 1605 ' ' SER . 5.6 m-20 48.77 79.27 0.08 Allowed 'General case' 0 N--CA 1.475 0.78 0 N-CA-C 115.453 1.649 . . . . 1.45 115.453 -179.664 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A 1595 ' ' GLY . . . . . 0.712 ' HA2' ' HG3' ' A' 1576 ' ' LYS . . . -96.5 -107.94 2.43 Favored Glycine 0 N--CA 1.441 -0.985 0 N-CA-C 109.312 -1.515 . . . . 0.78000000000000003 109.312 171.245 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A 1596 ' ' SER . . . . . 0.408 ' HA ' ' HD3' ' A' 1597 ' ' PRO . 34.2 t -82.8 142.57 45.44 Favored Pre-proline 0 C--N 1.309 -1.166 0 N-CA-C 107.245 -1.391 . . . . 1.6799999999999999 107.245 175.451 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A 1597 ' ' PRO . . . . . 0.408 ' HD3' ' HA ' ' A' 1596 ' ' SER . 22.0 Cg_exo -65.13 142.21 73.05 Favored 'Trans proline' 0 N--CA 1.457 -0.65 0 C-N-CA 122.646 2.231 . . . . 1.1699999999999999 110.248 177.219 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A 1598 ' ' CYS . . . . . . . . . . . . . 49.8 t -95.45 112.85 60.27 Favored Pre-proline 0 C--N 1.306 -1.31 0 N-CA-C 108.972 -0.751 . . . . 1.1899999999999999 108.972 -178.178 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A 1599 ' ' PRO . . . . . . . . . . . . . 71.5 Cg_endo -76.91 -19.9 13.63 Favored 'Trans proline' 0 N--CA 1.464 -0.236 0 C-N-CA 122.395 2.064 . . . . 1.5900000000000001 112.453 -176.939 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A 1600 ' ' SER . . . . . . . . . . . . . 4.1 m -76.4 -26.33 55.45 Favored 'General case' 0 C--N 1.314 -0.967 0 CA-C-O 121.818 0.818 . . . . 2.1200000000000001 109.955 -177.931 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A 1601 ' ' LYS . . . . . 0.528 ' HG3' ' O ' ' A' 1632 ' ' GLN . 12.9 mmmm -134.71 72.01 1.45 Allowed 'General case' 0 N--CA 1.434 -1.256 0 CA-C-N 114.971 -1.013 . . . . 3.7400000000000002 108.933 178.387 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A 1602 ' ' SER . . . . . . . . . . . . . 3.2 p -49.86 116.37 1.78 Allowed 'General case' 0 N--CA 1.441 -0.905 0 CA-C-N 113.871 -1.513 . . . . 3.79 112.66 -179.304 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A 1603 ' ' GLY . . . . . . . . . . . . . . . 135.94 -29.79 2.81 Favored Glycine 0 N--CA 1.431 -1.671 0 N-CA-C 111.062 -0.815 . . . . 2.0 111.062 -179.595 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A 1604 ' ' LEU . . . . . . . . . . . . . 2.3 pp -127.11 166.72 17.11 Favored 'General case' 0 C--N 1.317 -0.83 0 CA-C-O 121.105 0.478 . . . . 1.48 111.59 179.844 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A 1605 ' ' SER . . . . . 0.439 ' HB2' ' HA ' ' A' 1594 ' ' ASP . 21.0 m -109.13 -172.03 1.97 Allowed 'General case' 0 C--N 1.296 -1.719 0 C-N-CA 123.326 0.65 . . . . 1.51 109.367 -177.817 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A 1606 ' ' TYR . . . . . 0.508 ' HA ' ' O ' ' A' 1634 ' ' CYS . 79.0 m-85 -95.83 136.68 35.93 Favored 'General case' 0 N--CA 1.405 -2.704 0 N-CA-C 104.897 -2.26 . . . . 1.1799999999999999 104.897 177.614 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A 1607 ' ' LYS . . . . . 0.548 ' HG3' HG23 ' A' 1635 ' ' THR . 21.6 ptmt -137.56 147.84 45.44 Favored 'General case' 0 C--N 1.262 -3.209 0 N-CA-C 108.625 -0.88 . . . . 1.6699999999999999 108.625 -179.206 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A 1608 ' ' SER . . . . . . . . . . . . . 47.1 m -125.33 122.25 36.28 Favored 'General case' 0 C--N 1.303 -1.454 0 C-N-CA 120.886 -0.326 . . . . 1.0 111.05 -178.635 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A 1609 ' ' VAL . . . . . 0.553 HG23 ' HB ' ' A' 1591 ' ' VAL . 7.2 p -110.69 139.79 32.77 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 CA-C-O 120.69 0.281 . . . . 0.93000000000000005 110.357 -179.91 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A 1610 ' ' ILE . . . . . 0.71 HG13 ' HB2' ' A' 1638 ' ' PHE . 3.7 mp -118.05 118.33 57.85 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.357 0 N-CA-C 108.072 -1.084 . . . . 0.78000000000000003 108.072 174.871 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A 1611 ' ' SER . . . . . . . . . . . . . 48.0 m -98.19 133.02 43.2 Favored 'General case' 0 C--N 1.286 -2.191 0 N-CA-C 108.949 -0.759 . . . . 1.29 108.949 177.745 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A 1612 ' ' PHE . . . . . 0.576 ' HE1' ' HE3' ' A' 1640 ' ' TRP . 91.3 m-85 -99.58 106.68 18.68 Favored 'General case' 0 C--N 1.3 -1.585 0 CA-C-N 116.144 -0.48 . . . . 0.69999999999999996 111.653 -173.713 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A 1613 ' ' VAL . . . . . 0.477 ' O ' ' HA ' ' A' 1641 ' ' HIS . 84.5 t -107.44 129.03 62.01 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.552 0 CA-C-N 114.921 -1.036 . . . . 0.75 109.302 -178.895 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A 1614 ' ' CYS . . . . . 0.457 ' HA ' ' O ' ' A' 1642 ' ' THR . 0.5 OUTLIER -81.32 106.89 13.65 Favored 'General case' 0 C--N 1.297 -1.704 0 N-CA-C 113.856 1.058 . . . . 1.3899999999999999 113.856 -177.683 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A 1615 ' ' ARG . . . . . 0.43 ' HB3' ' HB3' ' A' 1641 ' ' HIS . 12.0 tpp180 -138.06 106.41 8.05 Favored Pre-proline 0 N--CA 1.428 -1.559 0 N-CA-C 107.897 -1.149 . . . . 3.75 107.897 175.493 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A 1616 ' ' PRO . . . . . . . . . . . . . 97.4 Cg_endo -79.08 5.57 5.65 Favored 'Trans proline' 0 CA--C 1.534 0.485 0 C-N-CA 122.649 2.233 . . . . 1.3200000000000001 113.059 -176.231 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A 1617 ' ' GLU . . . . . . . . . . . . . 39.0 mt-10 -98.54 7.38 46.22 Favored 'General case' 0 C--N 1.307 -1.28 0 CA-C-O 121.419 0.628 . . . . 3.21 110.771 -178.04 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A 1618 ' ' ALA . . . . . . . . . . . . . . . -91.12 108.12 19.66 Favored 'General case' 0 C--N 1.303 -1.42 0 CA-C-N 115.999 -0.546 . . . . 2.4399999999999999 109.862 179.467 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A 1619 ' ' GLY . . . . . . . . . . . . . . . -95.39 -94.62 1.72 Allowed Glycine 0 N--CA 1.436 -1.318 0 N-CA-C 109.486 -1.446 . . . . 3.2599999999999998 109.486 178.474 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A 1620 ' ' PRO . . . . . . . . . . . . . 32.5 Cg_endo -67.95 -17.38 46.42 Favored 'Trans proline' 0 CA--C 1.54 0.782 0 C-N-CA 122.245 1.963 . . . . 5.9199999999999999 111.232 174.815 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A 1621 ' ' THR . . . . . . . . . . . . . 4.7 m -91.21 13.07 18.17 Favored 'General case' 0 CA--C 1.561 1.37 0 CA-C-O 122.208 1.004 . . . . 4.7599999999999998 109.951 -179.356 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A 1622 ' ' ASN . . . . . . . . . . . . . 45.6 t30 -81.59 63.52 5.91 Favored 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 107.721 -1.214 . . . . 2.9199999999999999 107.721 175.76 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A 1623 ' ' ARG . . . . . . . . . . . . . 12.2 ptm180 -147.13 145.59 22.66 Favored Pre-proline 0 C--N 1.302 -1.498 0 N-CA-C 108.123 -1.065 . . . . 3.6099999999999999 108.123 -178.233 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A 1624 ' ' PRO . . . . . 0.453 ' HA ' ' O ' ' A' 1639 ' ' SER . 15.9 Cg_exo -69.23 123.47 10.31 Favored 'Trans proline' 0 N--CA 1.457 -0.664 0 C-N-CA 122.569 2.179 . . . . 2.3700000000000001 111.361 179.193 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A 1625 ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -119.03 149.04 42.33 Favored 'General case' 0 C--N 1.303 -1.414 0 N-CA-C 109.067 -0.716 . . . . 2.1600000000000001 109.067 179.277 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A 1626 ' ' LEU . . . . . . . . . . . . . 34.7 tp -76.48 122.49 24.63 Favored 'General case' 0 C--N 1.306 -1.303 0 N-CA-C 108.083 -1.08 . . . . 1.3500000000000001 108.083 177.516 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A 1627 ' ' ILE . . . . . . . . . . . . . 24.4 pt -100.19 -28.26 3.38 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.312 0 C-N-CA 120.654 -0.418 . . . . 1.21 111.158 -178.876 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A 1628 ' ' SER . . . . . . . . . . . . . 35.8 t -157.86 159.08 36.26 Favored 'General case' 0 N--CA 1.43 -1.425 0 N-CA-C 108.237 -1.023 . . . . 1.3999999999999999 108.237 -175.868 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A 1629 ' ' LEU . . . . . 0.746 ' HG ' ' HG ' ' A' 1636 ' ' LEU . 4.1 tt -145.9 134.05 21.6 Favored 'General case' 0 C--N 1.293 -1.89 0 N-CA-C 105.512 -2.033 . . . . 1.5600000000000001 105.512 177.579 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A 1630 ' ' ASP . . . . . . . . . . . . . 20.1 t70 -121.0 109.93 15.66 Favored 'General case' 0 C--N 1.29 -2.0 0 N-CA-C 108.812 -0.81 . . . . 0.87 108.812 177.957 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A 1631 ' ' LYS . . . . . 0.434 ' HE3' ' HB2' ' A' 1631 ' ' LYS . 49.7 mtmt -81.07 1.16 32.75 Favored 'General case' 0 C--N 1.303 -1.435 0 N-CA-C 112.553 0.575 . . . . 2.3500000000000001 112.553 -175.991 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A 1632 ' ' GLN . . . . . 0.528 ' O ' ' HG3' ' A' 1601 ' ' LYS . 2.1 mp0 -94.56 -34.3 12.71 Favored 'General case' 0 CA--C 1.509 -0.626 0 CA-C-O 121.336 0.588 . . . . 2.5499999999999998 110.398 -179.226 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A 1633 ' ' THR . . . . . . . . . . . . . 24.9 p -101.32 1.87 39.11 Favored 'General case' 0 C--N 1.289 -2.055 0 CA-C-O 121.947 0.88 . . . . 1.24 108.908 172.255 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A 1634 ' ' CYS . . . . . 0.508 ' O ' ' HA ' ' A' 1606 ' ' TYR . 47.8 m 52.15 42.37 30.59 Favored 'General case' 0 C--N 1.346 0.443 0 CA-C-N 113.714 -1.584 . . . . 0.89000000000000001 110.377 178.478 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A 1635 ' ' THR . . . . . 0.548 HG23 ' HG3' ' A' 1607 ' ' LYS . 55.8 m -114.9 132.55 56.5 Favored 'General case' 0 N--CA 1.425 -1.691 0 CA-C-N 114.386 -1.279 . . . . 0.75 110.048 -175.143 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A 1636 ' ' LEU . . . . . 0.746 ' HG ' ' HG ' ' A' 1629 ' ' LEU . 5.8 mp -102.94 132.55 49.1 Favored 'General case' 0 C--N 1.306 -1.293 0 N-CA-C 108.989 -0.745 . . . . 1.3300000000000001 108.989 176.991 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A 1637 ' ' PHE . . . . . . . . . . . . . 72.7 m-85 -107.47 101.54 10.88 Favored 'General case' 0 C--N 1.318 -0.792 0 CA-C-N 116.242 -0.436 . . . . 0.82999999999999996 111.673 -175.874 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A 1638 ' ' PHE . . . . . 0.71 ' HB2' HG13 ' A' 1610 ' ' ILE . 96.6 m-85 -100.29 160.19 14.53 Favored 'General case' 0 C--N 1.306 -1.284 0 N-CA-C 108.743 -0.836 . . . . 0.59999999999999998 108.743 177.21 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A 1639 ' ' SER . . . . . 0.453 ' O ' ' HA ' ' A' 1624 ' ' PRO . 31.9 t -143.37 147.74 35.14 Favored 'General case' 0 C--N 1.283 -2.285 0 N-CA-C 107.823 -1.177 . . . . 1.0800000000000001 107.823 177.204 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A 1640 ' ' TRP . . . . . 0.576 ' HE3' ' HE1' ' A' 1612 ' ' PHE . 12.4 t90 -127.75 112.26 14.6 Favored 'General case' 0 C--N 1.291 -1.942 0 N-CA-C 108.069 -1.086 . . . . 0.80000000000000004 108.069 176.746 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A 1641 ' ' HIS . . . . . 0.477 ' HA ' ' O ' ' A' 1613 ' ' VAL . 0.6 OUTLIER -88.15 102.95 15.29 Favored 'General case' 0 CA--C 1.487 -1.454 0 N-CA-C 106.953 -1.499 . . . . 2.54 106.953 176.318 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A 1642 ' ' THR . . . . . 0.457 ' O ' ' HA ' ' A' 1614 ' ' CYS . 12.5 t -142.83 141.2 19.43 Favored Pre-proline 0 N--CA 1.414 -2.231 0 CA-C-N 115.451 -0.795 . . . . 1.1499999999999999 111.021 -173.149 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A 1643 ' ' PRO . . . . . . . . . . . . . 42.4 Cg_endo -70.25 -1.68 9.27 Favored 'Trans proline' 0 C--N 1.349 0.592 0 C-N-CA 123.34 2.693 . . . . 0.80000000000000004 111.567 175.942 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A 1644 ' ' LEU . . . . . . . . . . . . . 67.5 mt -86.66 -18.61 30.87 Favored 'General case' 0 C--N 1.317 -0.823 0 CA-C-N 115.692 -0.686 . . . . 1.54 110.089 178.122 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A 1645 ' ' ALA . . . . . . . . . . . . . . . -73.77 -32.91 64.03 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-O 121.648 0.737 . . . . 0.94999999999999996 110.033 -179.032 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A 1646 ' ' CYS . . . . . . . . . . . . . 4.1 m -159.04 117.31 2.88 Favored 'General case' 0 C--N 1.311 -1.093 0 N-CA-C 103.558 -2.756 . . . . 1.4099999999999999 103.558 175.784 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A 1647 ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -93.0 117.82 67.65 Favored Pre-proline 0 C--N 1.3 -1.583 0 C-N-CA 118.832 -1.147 . . . . 2.9199999999999999 109.708 179.458 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A 1648 ' ' PRO . . . . . . . . . . . . . 38.4 Cg_exo -58.29 104.29 0.17 Allowed 'Trans proline' 0 C--O 1.239 0.544 0 C-N-CA 123.274 2.649 . . . . 2.8199999999999998 113.12 -178.894 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A 1649 ' ' GLU . . . . . . . . . . . . . 42.6 mt-10 . . . . . 0 C--N 1.302 -1.481 0 N-CA-C 108.809 -0.811 . . . . 5.0599999999999996 108.809 177.109 . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A 1508 ' ' MET . . . . . . . . . . . . . 68.4 mtt . . . . . 0 N--CA 1.467 0.402 0 N-CA-C 109.327 -0.62 . . . . 8.2699999999999996 109.327 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A 1509 ' ' LYS . . . . . . . . . . . . . 66.0 mttm -96.61 24.19 6.21 Favored 'General case' 0 C--N 1.31 -1.148 0 N-CA-C 113.134 0.791 . . . . 6.4800000000000004 113.134 -176.851 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A 1510 ' ' SER . . . . . . . . . . . . . 22.8 t -76.54 -24.68 53.64 Favored 'General case' 0 N--CA 1.441 -0.883 0 N-CA-C 107.191 -1.411 . . . . 4.2199999999999998 107.191 175.503 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A 1511 ' ' ASN . . . . . 0.58 ' HA ' ' HB2' ' A' 1515 ' ' ASP . 10.8 m120 -79.01 -2.23 39.29 Favored 'General case' 0 C--O 1.221 -0.444 0 CA-C-N 113.994 -1.457 . . . . 3.0800000000000001 108.739 178.965 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A 1512 ' ' GLU . . . . . 0.453 ' HA ' ' HB3' ' A' 1581 ' ' LEU . 42.5 mt-10 -121.96 23.49 9.98 Favored 'General case' 0 C--N 1.319 -0.732 0 C-N-CA 124.789 1.235 . . . . 4.46 108.435 178.881 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A 1513 ' ' HIS . . . . . . . . . . . . . 28.4 t-80 -147.08 -60.72 0.28 Allowed 'General case' 0 C--N 1.314 -0.956 0 CA-C-N 115.672 -0.695 . . . . 5.5700000000000003 110.478 -176.714 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A 1514 ' ' ASP . . . . . . . . . . . . . 33.2 t70 -81.67 -49.79 10.07 Favored 'General case' 0 CA--C 1.484 -1.58 0 N-CA-C 107.357 -1.349 . . . . 3.7000000000000002 107.357 177.732 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A 1515 ' ' ASP . . . . . 0.69 ' HB3' ' HG2' ' A' 1517 ' ' GLN . 22.5 m-20 -89.74 156.61 18.42 Favored 'General case' 0 C--N 1.302 -1.473 0 CA-C-N 114.244 -1.344 . . . . 2.54 109.0 177.788 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A 1516 ' ' CYS . . . . . . . . . . . . . 11.0 t -118.08 39.88 3.29 Favored 'General case' 0 C--N 1.292 -1.896 0 N-CA-C 105.777 -1.935 . . . . 1.25 105.777 175.259 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A 1517 ' ' GLN . . . . . 0.69 ' HG2' ' HB3' ' A' 1515 ' ' ASP . 14.8 pt20 -151.95 127.98 10.39 Favored 'General case' 0 N--CA 1.417 -2.077 0 CA-C-N 113.792 -1.549 . . . . 1.8799999999999999 107.35 -175.769 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A 1518 ' ' VAL . . . . . 0.447 HG11 ' HB2' ' A' 1583 ' ' TYR . 7.4 m -111.57 156.86 12.6 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.979 0 N-CA-C 108.747 -0.835 . . . . 1.73 108.747 -174.716 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A 1519 ' ' THR . . . . . 0.624 ' HA ' ' HA ' ' A' 1526 ' ' LEU . 28.4 m -101.84 103.06 13.74 Favored 'General case' 0 N--CA 1.404 -2.727 0 N-CA-C 106.204 -1.776 . . . . 1.7 106.204 174.1 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A 1520 ' ' ASN . . . . . . . . . . . . . 25.4 t-20 -60.02 110.31 2.72 Favored Pre-proline 0 C--O 1.22 -0.498 0 O-C-N 123.779 0.674 . . . . 2.1200000000000001 110.006 -176.759 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A 1521 ' ' PRO . . . . . . . . . . . . . 21.1 Cg_exo -68.33 -14.79 41.12 Favored 'Trans proline' 0 N--CA 1.478 0.585 0 C-N-CA 122.539 2.159 . . . . 2.4700000000000002 114.14 -177.419 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A 1522 ' ' SER . . . . . . . . . . . . . 15.8 m -78.49 -45.62 21.59 Favored 'General case' 0 C--N 1.308 -1.209 0 CA-C-O 120.563 0.221 . . . . 2.5699999999999998 110.941 -178.353 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A 1523 ' ' THR . . . . . 0.417 HG23 ' H ' ' A' 1525 ' ' HIS . 15.1 t -104.96 -18.57 14.13 Favored 'General case' 0 CA--C 1.55 0.948 0 C-N-CA 120.438 -0.505 . . . . 2.1499999999999999 111.832 -179.408 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A 1524 ' ' GLY . . . . . . . . . . . . . . . 87.0 5.14 81.18 Favored Glycine 0 C--N 1.331 0.269 0 C-N-CA 121.365 -0.445 . . . . 1.8899999999999999 112.763 179.505 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A 1525 ' ' HIS . . . . . 0.417 ' H ' HG23 ' A' 1523 ' ' THR . 23.2 t-160 -100.66 128.79 46.58 Favored 'General case' 0 C--N 1.303 -1.42 0 N-CA-C 109.691 -0.485 . . . . 1.8999999999999999 109.691 -176.614 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A 1526 ' ' LEU . . . . . 0.624 ' HA ' ' HA ' ' A' 1519 ' ' THR . 5.5 tt -73.48 135.33 44.07 Favored 'General case' 0 C--N 1.305 -1.347 0 N-CA-C 107.638 -1.245 . . . . 1.6100000000000001 107.638 176.057 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A 1527 ' ' PHE . . . . . 0.432 ' N ' HD23 ' A' 1526 ' ' LEU . 82.5 m-85 -112.81 110.25 20.24 Favored 'General case' 0 C--N 1.303 -1.426 0 CA-C-O 120.972 0.415 . . . . 1.4199999999999999 110.873 178.052 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A 1528 ' ' ASP . . . . . . . . . . . . . 10.0 t70 -83.38 109.41 17.28 Favored 'General case' 0 CA--C 1.5 -0.955 0 CA-C-N 115.1 -0.955 . . . . 2.1800000000000002 110.646 178.775 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A 1529 ' ' LEU . . . . . 0.664 ' HA ' HD13 ' A' 1532 ' ' LEU . 3.7 mm? -98.7 -18.12 18.2 Favored 'General case' 0 C--N 1.307 -1.279 0 CA-C-N 114.766 -1.107 . . . . 1.4399999999999999 108.179 173.154 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A 1530 ' ' SER . . . . . . . . . . . . . 1.9 m -53.26 -47.1 69.37 Favored 'General case' 0 CA--C 1.544 0.724 0 C-N-CA 125.592 1.557 . . . . 1.4399999999999999 112.741 -176.998 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A 1531 ' ' SER . . . . . . . . . . . . . 5.1 m -78.24 -3.79 44.55 Favored 'General case' 0 C--N 1.321 -0.652 0 N-CA-C 112.086 0.402 . . . . 1.5 112.086 -174.652 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A 1532 ' ' LEU . . . . . 0.664 HD13 ' HA ' ' A' 1529 ' ' LEU . 11.0 mp -62.41 -25.94 68.21 Favored 'General case' 0 N--CA 1.48 1.032 0 N-CA-C 113.066 0.765 . . . . 1.77 113.066 177.685 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A 1533 ' ' SER . . . . . . . . . . . . . 52.4 m -90.82 142.48 27.72 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-O 120.511 0.196 . . . . 2.3799999999999999 110.477 177.464 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A 1534 ' ' GLY . . . . . . . . . . . . . . . -151.65 -116.81 0.73 Allowed Glycine 0 N--CA 1.441 -1.005 0 N-CA-C 109.649 -1.381 . . . . 1.55 109.649 179.158 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A 1535 ' ' ARG . . . . . . . . . . . . . 27.3 tpt180 -90.0 -59.05 2.3 Favored 'General case' 0 C--N 1.309 -1.186 0 N-CA-C 109.063 -0.717 . . . . 3.96 109.063 176.92 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A 1536 ' ' ALA . . . . . . . . . . . . . . . -95.07 -32.51 13.08 Favored 'General case' 0 N--CA 1.441 -0.89 0 CA-C-N 116.035 -0.529 . . . . 1.6499999999999999 110.2 -179.228 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A 1537 ' ' GLY . . . . . . . . . . . . . . . 69.11 -127.14 21.2 Favored Glycine 0 CA--C 1.491 -1.455 0 N-CA-C 109.854 -1.299 . . . . 1.1899999999999999 109.854 -178.524 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A 1538 ' ' PHE . . . . . . . . . . . . . 53.0 m-85 -106.42 141.43 37.74 Favored 'General case' 0 C--N 1.294 -1.822 0 C-N-CA 120.281 -0.568 . . . . 1.6899999999999999 109.563 174.608 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A 1539 ' ' THR . . . . . . . . . . . . . 3.0 p -123.52 138.36 54.58 Favored 'General case' 0 C--N 1.293 -1.879 0 CA-C-N 116.017 -0.538 . . . . 1.48 111.081 -176.0 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A 1540 ' ' ALA . . . . . . . . . . . . . . . -128.87 116.03 18.79 Favored 'General case' 0 C--N 1.305 -1.364 0 CA-C-O 120.52 0.2 . . . . 0.82999999999999996 110.48 178.387 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A 1541 ' ' ALA . . . . . . . . . . . . . . . -75.4 131.2 40.04 Favored 'General case' 0 C--N 1.313 -1.017 0 N-CA-C 108.397 -0.964 . . . . 1.27 108.397 177.316 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A 1542 ' ' TYR . . . . . . . . . . . . . 36.4 t80 -144.48 -179.27 6.44 Favored 'General case' 0 C--N 1.301 -1.524 0 N-CA-C 109.439 -0.578 . . . . 2.1499999999999999 109.439 -173.776 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A 1543 ' ' SER . . . . . . . . . . . . . 5.9 m -43.86 -151.3 0.0 OUTLIER 'General case' 0 CA--C 1.584 2.25 0 C-N-CA 129.773 3.229 . . . . 2.29 114.669 177.91 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A 1544 ' ' LYS . . . . . . . . . . . . . 98.4 mttt -43.99 -29.12 0.54 Allowed 'General case' 0 N--CA 1.5 2.058 0 O-C-N 120.38 -1.45 . . . . 3.9100000000000001 112.824 175.052 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A 1545 ' ' SER . . . . . . . . . . . . . 16.5 m -61.97 -17.29 56.52 Favored 'General case' 0 CA--C 1.562 1.44 0 C-N-CA 123.566 0.746 . . . . 3.2999999999999998 111.463 175.091 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A 1546 ' ' GLY . . . . . . . . . . . . . . . 79.5 -77.85 1.82 Allowed Glycine 0 CA--C 1.496 -1.136 0 CA-C-O 121.457 0.476 . . . . 1.24 113.67 173.244 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A 1547 ' ' VAL . . . . . . . . . . . . . 7.4 p -157.64 131.73 1.38 Allowed 'Isoleucine or valine' 0 C--N 1.284 -2.249 0 N-CA-C 108.204 -1.036 . . . . 1.6299999999999999 108.204 -175.788 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A 1548 ' ' VAL . . . . . . . . . . . . . 2.3 t -103.17 139.73 23.32 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.043 0 N-CA-C 108.346 -0.983 . . . . 0.92000000000000004 108.346 -177.287 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A 1549 ' ' TYR . . . . . 0.492 ' HB3' ' HG2' ' A' 1557 ' ' GLU . 77.3 m-85 -98.29 148.23 23.84 Favored 'General case' 0 C--N 1.303 -1.418 0 N-CA-C 106.586 -1.635 . . . . 1.4399999999999999 106.586 170.969 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A 1550 ' ' MET . . . . . . . . . . . . . 42.2 ttm -138.9 125.52 20.68 Favored 'General case' 0 C--N 1.291 -1.965 0 C-N-CA 120.685 -0.406 . . . . 1.74 110.704 -178.113 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A 1551 ' ' SER . . . . . 0.654 ' HB2' ' HB3' ' A' 1556 ' ' ASN . 43.1 t -99.23 138.91 35.65 Favored 'General case' 0 N--CA 1.411 -2.403 0 N-CA-C 105.938 -1.875 . . . . 1.6399999999999999 105.938 172.551 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A 1552 ' ' ILE . . . . . 0.429 HG22 ' SG ' ' A' 1553 ' ' CYS . 1.8 mp -92.91 -55.17 6.41 Favored 'Isoleucine or valine' 0 N--CA 1.416 -2.174 0 N-CA-C 108.713 -0.847 . . . . 1.3300000000000001 108.713 179.117 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A 1553 ' ' CYS . . . . . 0.429 ' SG ' HG22 ' A' 1552 ' ' ILE . 84.5 m -127.07 136.64 52.45 Favored 'General case' 0 C--N 1.303 -1.415 0 N-CA-C 109.162 -0.681 . . . . 1.4299999999999999 109.162 177.202 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A 1554 ' ' GLY . . . . . . . . . . . . . . . 69.92 -141.46 34.65 Favored Glycine 0 N--CA 1.435 -1.4 0 N-CA-C 111.031 -0.827 . . . . 1.1200000000000001 111.031 179.806 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A 1555 ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -109.35 177.41 4.75 Favored 'General case' 0 C--N 1.3 -1.569 0 N-CA-C 108.91 -0.774 . . . . 1.8 108.91 -178.79 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A 1556 ' ' ASN . . . . . 0.654 ' HB3' ' HB2' ' A' 1551 ' ' SER . 8.9 t30 -177.73 -165.03 0.1 Allowed 'General case' 0 C--N 1.297 -1.705 0 N-CA-C 103.427 -2.805 . . . . 2.6299999999999999 103.427 -174.616 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A 1557 ' ' GLU . . . . . 0.492 ' HG2' ' HB3' ' A' 1549 ' ' TYR . 25.3 mt-10 79.57 -176.8 0.08 Allowed 'General case' 0 C--N 1.321 -0.636 0 N-CA-C 115.404 1.631 . . . . 3.79 115.404 163.519 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A 1558 ' ' ASN . . . . . . . . . . . . . 26.9 m-80 -125.21 43.93 2.93 Favored 'General case' 0 C--N 1.313 -0.991 0 CA-C-N 112.6 -2.091 . . . . 1.52 107.373 -174.612 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A 1559 ' ' CYS . . . . . . . . . . . . . 77.1 m -141.17 152.56 64.95 Favored Pre-proline 0 C--N 1.285 -2.214 0 N-CA-C 106.105 -1.813 . . . . 0.83999999999999997 106.105 -176.029 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A 1560 ' ' PRO . . . . . . . . . . . . . 24.6 Cg_exo -36.23 112.32 0.09 OUTLIER 'Trans proline' 0 C--N 1.376 2.023 0 C-N-CA 124.667 3.578 . . . . 1.1799999999999999 113.339 -178.811 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A 1561 ' ' PRO . . . . . . . . . . . . . 88.7 Cg_exo -48.89 153.52 3.74 Favored 'Trans proline' 0 C--N 1.365 1.407 0 C-N-CA 124.93 3.753 . . . . 1.51 114.486 -174.956 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A 1562 ' ' GLY . . . . . . . . . . . . . . . 93.67 7.78 61.32 Favored Glycine 0 N--CA 1.447 -0.589 0 N-CA-C 111.092 -0.803 . . . . 0.71999999999999997 111.092 -177.545 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A 1563 ' ' VAL . . . . . 0.499 ' HA ' ' HA ' ' A' 1576 ' ' LYS . 8.3 p -111.25 156.96 12.28 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.588 0 N-CA-C 107.297 -1.372 . . . . 0.96999999999999997 107.297 -179.355 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A 1564 ' ' GLY . . . . . . . . . . . . . . . -124.82 9.08 8.09 Favored Glycine 0 CA--C 1.528 0.852 0 C-N-CA 120.056 -1.069 . . . . 0.71999999999999997 114.555 -176.417 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A 1565 ' ' ALA . . . . . . . . . . . . . . . -170.22 141.62 2.1 Favored 'General case' 0 C--N 1.302 -1.494 0 N-CA-C 107.917 -1.142 . . . . 0.37 107.917 178.956 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A 1566 ' ' CYS . . . . . 0.484 ' HA ' HG23 ' A' 1574 ' ' VAL . 51.6 t -164.22 139.23 5.83 Favored 'General case' 0 C--N 1.309 -1.165 0 CA-C-O 120.896 0.379 . . . . 0.51000000000000001 110.184 -175.7 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A 1567 ' ' PHE . . . . . . . . . . . . . 35.2 m-85 -80.57 122.9 27.62 Favored 'General case' 0 CA--C 1.512 -0.501 0 N-CA-C 106.535 -1.654 . . . . 0.96999999999999997 106.535 174.416 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A 1568 ' ' GLY . . . . . . . . . . . . . . . -75.97 -26.75 63.8 Favored Glycine 0 C--N 1.314 -0.656 0 C-N-CA 120.7 -0.762 . . . . 1.0800000000000001 113.274 -173.879 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A 1569 ' ' GLN . . . . . . . . . . . . . 25.9 tp60 -71.42 -57.0 4.84 Favored 'General case' 0 C--N 1.311 -1.102 0 CA-C-O 121.798 0.809 . . . . 2.7400000000000002 109.211 178.991 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A 1570 ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -83.42 -16.65 45.02 Favored 'General case' 0 C--N 1.301 -1.515 0 CA-C-N 114.634 -1.166 . . . . 1.96 113.089 -172.141 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A 1571 ' ' ARG . . . . . . . . . . . . . 11.1 tpp180 63.94 43.93 5.02 Favored 'General case' 0 N--CA 1.479 0.989 0 C-N-CA 125.59 1.556 . . . . 3.9500000000000002 109.878 178.758 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A 1572 ' ' ILE . . . . . . . . . . . . . 31.9 mm -115.53 128.82 72.61 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.258 0 CA-C-N 115.447 -0.797 . . . . 1.3700000000000001 109.819 -174.939 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A 1573 ' ' SER . . . . . . . . . . . . . 57.2 p -72.53 134.83 45.45 Favored 'General case' 0 C--O 1.247 0.951 0 CA-C-O 121.367 0.603 . . . . 1.0800000000000001 111.869 -178.038 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A 1574 ' ' VAL . . . . . 0.484 HG23 ' HA ' ' A' 1566 ' ' CYS . 13.4 t -119.18 39.7 0.77 Allowed 'Isoleucine or valine' 0 CA--C 1.565 1.533 0 CA-C-O 122.597 1.189 . . . . 1.3 109.084 -174.926 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A 1575 ' ' GLY . . . . . . . . . . . . . . . 125.79 133.65 3.96 Favored Glycine 0 CA--C 1.53 1.017 0 CA-C-N 115.043 -0.98 . . . . 0.51000000000000001 113.451 179.708 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A 1576 ' ' LYS . . . . . 0.499 ' HA ' ' HA ' ' A' 1563 ' ' VAL . 64.4 mttp -84.31 153.99 23.19 Favored 'General case' 0 N--CA 1.469 0.491 0 N-CA-C 109.496 -0.557 . . . . 2.8999999999999999 109.496 178.455 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A 1577 ' ' ALA . . . . . 0.561 ' HA ' ' CE1' ' A' 1592 ' ' TYR . . . -72.34 92.23 1.4 Allowed 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 113.042 0.756 . . . . 0.82999999999999996 113.042 -173.028 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A 1578 ' ' ASN . . . . . . . . . . . . . 2.8 m-20 -98.92 117.64 33.88 Favored 'General case' 0 C--N 1.311 -1.08 0 N-CA-C 107.879 -1.156 . . . . 1.8500000000000001 107.879 174.019 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A 1579 ' ' LYS . . . . . . . . . . . . . 55.7 mtmt -90.37 90.77 8.19 Favored 'General case' 0 C--N 1.3 -1.582 0 CA-C-O 121.882 0.849 . . . . 1.8999999999999999 109.477 -177.479 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A 1580 ' ' ARG . . . . . . . . . . . . . 9.3 ttp180 -153.99 131.65 11.46 Favored 'General case' 0 C--N 1.288 -2.091 0 N-CA-C 107.068 -1.456 . . . . 3.6299999999999999 107.068 179.925 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A 1581 ' ' LEU . . . . . 0.502 HD13 HD12 ' A' 1590 ' ' LEU . 28.9 tp -119.05 167.5 11.71 Favored 'General case' 0 C--N 1.296 -1.755 0 N-CA-C 108.299 -1.0 . . . . 1.8700000000000001 108.299 -178.102 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A 1582 ' ' ARG . . . . . . . . . . . . . 69.2 ttt180 -145.18 103.04 3.82 Favored 'General case' 0 C--N 1.304 -1.408 0 N-CA-C 109.637 -0.505 . . . . 3.9700000000000002 109.637 -179.81 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A 1583 ' ' TYR . . . . . 0.447 ' HB2' HG11 ' A' 1518 ' ' VAL . 42.2 t80 -88.6 111.46 21.92 Favored 'General case' 0 C--N 1.3 -1.567 0 CA-C-O 121.401 0.619 . . . . 1.4099999999999999 111.141 179.087 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A 1584 ' ' VAL . . . . . 0.531 ' HB ' HG13 ' A' 1587 ' ' VAL . 48.9 t -112.94 150.68 15.01 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.744 0 N-CA-C 105.043 -2.206 . . . . 1.6899999999999999 105.043 173.849 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A 1585 ' ' ASP . . . . . . . . . . . . . 33.9 t70 -47.4 108.32 0.15 Allowed 'General case' 0 C--N 1.33 -0.258 0 C-N-CA 123.843 0.857 . . . . 2.0600000000000001 112.569 -179.563 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A 1586 ' ' GLN . . . . . . . . . . . . . 93.7 mt-30 63.76 24.29 13.76 Favored 'General case' 0 C--O 1.251 1.132 0 C-N-CA 125.155 1.382 . . . . 2.3300000000000001 114.488 -178.966 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A 1587 ' ' VAL . . . . . 0.531 HG13 ' HB ' ' A' 1584 ' ' VAL . 7.1 p -161.13 105.71 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.439 -1.003 0 CA-C-O 122.35 1.072 . . . . 0.78000000000000003 112.236 176.202 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A 1588 ' ' LEU . . . . . . . . . . . . . 7.3 mp -91.39 120.58 32.37 Favored 'General case' 0 C--N 1.299 -1.595 0 CA-C-N 115.075 -0.966 . . . . 1.4099999999999999 108.842 179.934 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A 1589 ' ' GLN . . . . . . . . . . . . . 35.2 tt0 -105.89 134.21 49.38 Favored 'General case' 0 C--N 1.297 -1.689 0 N-CA-C 110.196 -0.298 . . . . 1.24 110.196 -177.768 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A 1590 ' ' LEU . . . . . 0.502 HD12 HD13 ' A' 1581 ' ' LEU . 2.0 tt -136.8 138.0 40.4 Favored 'General case' 0 C--N 1.304 -1.406 0 N-CA-C 106.222 -1.77 . . . . 1.1499999999999999 106.222 175.925 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A 1591 ' ' VAL . . . . . . . . . . . . . 8.4 p -137.98 140.76 40.1 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.222 0 CA-C-O 120.967 0.413 . . . . 1.51 111.869 -174.171 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A 1592 ' ' TYR . . . . . 0.561 ' CE1' ' HA ' ' A' 1577 ' ' ALA . 88.1 m-85 -125.56 128.75 48.43 Favored 'General case' 0 C--N 1.317 -0.805 0 N-CA-C 108.094 -1.076 . . . . 1.0600000000000001 108.094 176.117 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A 1593 ' ' LYS . . . . . . . . . . . . . 20.9 pttp -137.54 -174.21 3.7 Favored 'General case' 0 C--N 1.306 -1.313 0 N-CA-C 109.496 -0.557 . . . . 2.1800000000000002 109.496 -176.925 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A 1594 ' ' ASP . . . . . . . . . . . . . 13.6 m-20 60.79 44.27 11.2 Favored 'General case' 0 N--CA 1.482 1.13 0 C-N-CA 123.281 0.632 . . . . 1.45 112.312 -179.603 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A 1595 ' ' GLY . . . . . . . . . . . . . . . -86.03 -92.76 0.86 Allowed Glycine 0 N--CA 1.437 -1.285 0 C-N-CA 119.477 -1.344 . . . . 0.78000000000000003 111.76 177.685 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A 1596 ' ' SER . . . . . 0.401 ' HA ' ' HD3' ' A' 1597 ' ' PRO . 37.1 m -113.47 151.69 44.68 Favored Pre-proline 0 C--N 1.287 -2.142 0 N-CA-C 108.678 -0.86 . . . . 1.6799999999999999 108.678 179.377 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A 1597 ' ' PRO . . . . . 0.401 ' HD3' ' HA ' ' A' 1596 ' ' SER . 24.4 Cg_exo -65.3 133.03 33.48 Favored 'Trans proline' 0 C--O 1.24 0.607 0 C-N-CA 123.248 2.632 . . . . 1.1699999999999999 110.976 178.798 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A 1598 ' ' CYS . . . . . . . . . . . . . 22.0 t -95.9 113.89 63.0 Favored Pre-proline 0 C--N 1.296 -1.76 0 CA-C-N 116.093 -0.503 . . . . 1.1899999999999999 109.682 -177.463 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A 1599 ' ' PRO . . . . . . . . . . . . . 60.6 Cg_endo -88.8 18.18 1.52 Allowed 'Trans proline' 0 C--O 1.24 0.594 0 C-N-CA 122.904 2.402 . . . . 1.5900000000000001 111.726 178.696 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A 1600 ' ' SER . . . . . . . . . . . . . 35.8 t -75.85 -55.92 5.16 Favored 'General case' 0 N--CA 1.427 -1.616 0 CA-C-N 115.715 -0.675 . . . . 2.1200000000000001 110.59 -178.572 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A 1601 ' ' LYS . . . . . . . . . . . . . 53.2 tttp -142.42 -71.87 0.32 Allowed 'General case' 0 N--CA 1.445 -0.693 0 C-N-CA 119.926 -0.709 . . . . 3.7400000000000002 112.486 -175.955 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A 1602 ' ' SER . . . . . 0.52 ' HB3' ' HG ' ' A' 1604 ' ' LEU . 23.0 t -96.37 157.11 16.05 Favored 'General case' 0 N--CA 1.427 -1.575 0 N-CA-C 108.47 -0.937 . . . . 3.79 108.47 -175.957 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A 1603 ' ' GLY . . . . . . . . . . . . . . . -77.74 58.21 3.84 Favored Glycine 0 C--O 1.236 0.27 0 N-CA-C 111.942 -0.463 . . . . 2.0 111.942 -179.824 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A 1604 ' ' LEU . . . . . 0.52 ' HG ' ' HB3' ' A' 1602 ' ' SER . 0.6 OUTLIER -120.97 -175.27 3.01 Favored 'General case' 0 C--N 1.298 -1.668 0 C-N-CA 124.581 1.152 . . . . 1.48 110.364 -178.516 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A 1605 ' ' SER . . . . . . . . . . . . . 15.0 m -104.58 -170.04 1.71 Allowed 'General case' 0 C--N 1.297 -1.712 0 N-CA-C 109.929 -0.397 . . . . 1.51 109.929 -178.879 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A 1606 ' ' TYR . . . . . . . . . . . . . 97.5 m-85 -103.37 126.65 50.64 Favored 'General case' 0 CA--C 1.482 -1.662 0 N-CA-C 104.328 -2.471 . . . . 1.1799999999999999 104.328 177.274 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A 1607 ' ' LYS . . . . . . . . . . . . . 21.3 ptmt -119.15 132.15 55.95 Favored 'General case' 0 C--N 1.285 -2.219 0 C-N-CA 119.528 -0.869 . . . . 1.6699999999999999 111.654 -176.071 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A 1608 ' ' SER . . . . . 0.439 ' OG ' HG12 ' A' 1574 ' ' VAL . 33.1 m -103.15 118.31 36.51 Favored 'General case' 0 C--N 1.309 -1.177 0 C-N-CA 123.024 0.53 . . . . 1.0 110.731 -177.301 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A 1609 ' ' VAL . . . . . . . . . . . . . 58.7 t -110.98 114.57 47.48 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.778 0 N-CA-C 108.687 -0.857 . . . . 0.93000000000000005 108.687 177.363 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A 1610 ' ' ILE . . . . . 0.655 HG13 ' HB2' ' A' 1638 ' ' PHE . 2.9 mp -105.04 114.67 45.22 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.214 0 N-CA-C 108.675 -0.861 . . . . 0.78000000000000003 108.675 178.345 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A 1611 ' ' SER . . . . . . . . . . . . . 19.4 m -104.42 107.76 18.85 Favored 'General case' 0 C--N 1.296 -1.753 0 CA-C-N 115.474 -0.784 . . . . 1.29 109.486 179.535 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A 1612 ' ' PHE . . . . . 0.53 ' O ' ' HA ' ' A' 1587 ' ' VAL . 97.7 m-85 -83.8 102.55 12.4 Favored 'General case' 0 C--N 1.306 -1.319 0 CA-C-N 115.882 -0.599 . . . . 0.69999999999999996 109.472 179.089 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A 1613 ' ' VAL . . . . . . . . . . . . . 94.4 t -86.52 124.9 40.7 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.485 0 N-CA-C 107.857 -1.164 . . . . 0.75 107.857 179.345 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A 1614 ' ' CYS . . . . . 0.499 ' HB3' ' HB2' ' A' 1646 ' ' CYS . 61.8 m -75.73 92.78 3.03 Favored 'General case' 0 C--N 1.295 -1.797 0 CA-C-O 121.614 0.721 . . . . 1.3899999999999999 111.018 -177.12 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A 1615 ' ' ARG . . . . . 0.521 ' HB3' ' HB3' ' A' 1641 ' ' HIS . 43.6 ttm180 -138.45 131.79 16.35 Favored Pre-proline 0 N--CA 1.43 -1.464 0 CA-C-N 115.155 -0.929 . . . . 3.75 109.467 -179.742 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A 1616 ' ' PRO . . . . . 0.588 ' HD3' ' HG2' ' A' 1648 ' ' PRO . 38.4 Cg_endo -70.7 67.37 2.29 Favored 'Trans proline' 0 CA--C 1.55 1.309 0 C-N-CA 123.142 2.562 . . . . 1.3200000000000001 111.351 175.764 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A 1617 ' ' GLU . . . . . . . . . . . . . 10.9 tp10 -108.27 32.5 4.76 Favored 'General case' 0 CA--C 1.555 1.169 0 CA-C-O 121.982 0.896 . . . . 3.21 109.354 -177.52 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A 1618 ' ' ALA . . . . . . . . . . . . . . . -83.47 152.88 24.74 Favored 'General case' 0 C--N 1.321 -0.631 0 O-C-N 121.782 -0.574 . . . . 2.4399999999999999 109.867 179.527 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A 1619 ' ' GLY . . . . . . . . . . . . . . . 148.6 -87.79 0.15 Allowed Glycine 0 C--N 1.3 -1.419 0 N-CA-C 110.149 -1.18 . . . . 3.2599999999999998 110.149 -177.028 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A 1620 ' ' PRO . . . . . . . . . . . . . 18.6 Cg_exo -64.92 -175.94 0.41 Allowed 'Trans proline' 0 CA--C 1.539 0.755 0 C-N-CA 124.059 3.173 . . . . 5.9199999999999999 110.889 173.818 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A 1621 ' ' THR . . . . . . . . . . . . . 14.6 t -79.94 42.17 0.54 Allowed 'General case' 0 CA--C 1.565 1.526 0 CA-C-O 122.846 1.308 . . . . 4.7599999999999998 111.366 -177.431 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A 1622 ' ' ASN . . . . . . . . . . . . . 40.3 t30 -56.04 127.52 30.89 Favored 'General case' 0 C--O 1.242 0.71 0 C-N-CA 126.107 1.763 . . . . 2.9199999999999999 108.77 178.423 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A 1623 ' ' ARG . . . . . . . . . . . . . 20.2 ptp180 -148.78 169.22 9.51 Favored Pre-proline 0 C--N 1.302 -1.497 0 N-CA-C 108.474 -0.935 . . . . 3.6099999999999999 108.474 -174.364 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A 1624 ' ' PRO . . . . . . . . . . . . . 33.6 Cg_exo -61.41 114.89 2.42 Favored 'Trans proline' 0 C--N 1.36 1.161 0 C-N-CA 121.825 1.684 . . . . 2.3700000000000001 109.51 175.69 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A 1625 ' ' MET . . . . . . . . . . . . . 22.7 ptt? -109.81 146.1 35.6 Favored 'General case' 0 C--N 1.292 -1.892 0 CA-C-N 115.891 -0.595 . . . . 2.1600000000000001 111.495 -175.301 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A 1626 ' ' LEU . . . . . . . . . . . . . 43.0 tp -76.0 111.07 11.0 Favored 'General case' 0 N--CA 1.441 -0.904 0 CA-C-N 114.773 -1.103 . . . . 1.3500000000000001 109.179 179.521 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A 1627 ' ' ILE . . . . . . . . . . . . . 39.0 mm -81.69 -49.58 17.51 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.745 0 CA-C-N 115.03 -0.986 . . . . 1.21 110.41 -175.727 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A 1628 ' ' SER . . . . . . . . . . . . . 48.3 m -157.26 154.09 28.56 Favored 'General case' 0 C--N 1.301 -1.52 0 CA-C-N 116.259 -0.428 . . . . 1.3999999999999999 109.913 -178.064 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A 1629 ' ' LEU . . . . . 0.46 HD13 ' HG ' ' A' 1636 ' ' LEU . 56.7 tp -113.36 118.41 34.5 Favored 'General case' 0 N--CA 1.428 -1.56 0 N-CA-C 108.039 -1.096 . . . . 1.5600000000000001 108.039 175.251 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A 1630 ' ' ASP . . . . . 0.488 ' HB3' ' HB ' ' A' 1635 ' ' THR . 12.6 t70 -95.09 117.62 30.49 Favored 'General case' 0 C--N 1.293 -1.864 0 N-CA-C 107.653 -1.24 . . . . 0.87 107.653 177.121 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A 1631 ' ' LYS . . . . . . . . . . . . . 8.5 mtpm? -94.22 4.87 53.29 Favored 'General case' 0 C--N 1.298 -1.673 0 N-CA-C 112.402 0.519 . . . . 2.3500000000000001 112.402 -176.116 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A 1632 ' ' GLN . . . . . . . . . . . . . 2.2 mp0 -89.99 -51.97 5.2 Favored 'General case' 0 C--N 1.307 -1.245 0 CA-C-O 121.208 0.528 . . . . 2.5499999999999998 109.686 -179.608 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A 1633 ' ' THR . . . . . . . . . . . . . 7.2 m -105.15 4.46 31.36 Favored 'General case' 0 C--N 1.306 -1.314 0 CA-C-O 122.309 1.052 . . . . 1.24 109.261 179.815 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A 1634 ' ' CYS . . . . . . . . . . . . . 61.3 m 55.24 52.8 10.95 Favored 'General case' 0 N--CA 1.469 0.505 0 CA-C-N 114.092 -1.413 . . . . 0.89000000000000001 110.739 179.199 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A 1635 ' ' THR . . . . . 0.488 ' HB ' ' HB3' ' A' 1630 ' ' ASP . 21.1 m -103.87 125.23 50.14 Favored 'General case' 0 N--CA 1.421 -1.92 0 CA-C-N 113.458 -1.701 . . . . 0.75 109.924 -175.059 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A 1636 ' ' LEU . . . . . 0.46 ' HG ' HD13 ' A' 1629 ' ' LEU . 5.8 mp -106.49 122.58 46.58 Favored 'General case' 0 C--N 1.313 -0.981 0 N-CA-C 109.362 -0.607 . . . . 1.3300000000000001 109.362 178.921 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A 1637 ' ' PHE . . . . . . . . . . . . . 96.9 m-85 -98.85 112.51 24.58 Favored 'General case' 0 C--N 1.313 -1.0 0 CA-C-N 115.983 -0.553 . . . . 0.82999999999999996 111.783 -176.275 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A 1638 ' ' PHE . . . . . 0.655 ' HB2' HG13 ' A' 1610 ' ' ILE . 87.6 m-85 -115.09 133.81 55.71 Favored 'General case' 0 C--N 1.294 -1.832 0 N-CA-C 108.484 -0.932 . . . . 0.59999999999999998 108.484 175.303 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A 1639 ' ' SER . . . . . . . . . . . . . 28.2 t -140.47 141.5 35.41 Favored 'General case' 0 C--N 1.276 -2.606 0 C-N-CA 120.099 -0.641 . . . . 1.0800000000000001 109.308 177.49 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A 1640 ' ' TRP . . . . . 0.495 ' HE3' ' HE1' ' A' 1612 ' ' PHE . 10.5 t90 -128.0 127.88 44.01 Favored 'General case' 0 N--CA 1.43 -1.429 0 N-CA-C 107.849 -1.167 . . . . 0.80000000000000004 107.849 178.659 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A 1641 ' ' HIS . . . . . 0.521 ' HB3' ' HB3' ' A' 1615 ' ' ARG . 34.9 m80 -91.25 97.79 11.33 Favored 'General case' 0 C--N 1.301 -1.513 0 N-CA-C 105.983 -1.858 . . . . 2.54 105.983 175.276 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A 1642 ' ' THR . . . . . 0.584 ' OG1' ' HG ' ' A' 1644 ' ' LEU . 7.8 t -135.12 140.85 35.97 Favored Pre-proline 0 C--N 1.296 -1.719 0 N-CA-C 113.63 0.974 . . . . 1.1499999999999999 113.63 -170.737 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A 1643 ' ' PRO . . . . . . . . . . . . . 87.3 Cg_endo -80.66 -0.84 10.9 Favored 'Trans proline' 0 N--CA 1.447 -1.219 0 C-N-CA 123.475 2.783 . . . . 0.80000000000000004 112.451 175.903 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A 1644 ' ' LEU . . . . . 0.584 ' HG ' ' OG1' ' A' 1642 ' ' THR . 2.8 pp -92.94 4.03 54.68 Favored 'General case' 0 CA--C 1.502 -0.885 0 CA-C-O 121.969 0.89 . . . . 1.54 110.386 174.613 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A 1645 ' ' ALA . . . . . . . . . . . . . . . -95.78 -43.47 7.86 Favored 'General case' 0 C--N 1.3 -1.552 0 CA-C-N 113.818 -1.537 . . . . 0.94999999999999996 108.421 175.992 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A 1646 ' ' CYS . . . . . 0.499 ' HB2' ' HB3' ' A' 1614 ' ' CYS . 38.2 m -156.44 158.36 37.16 Favored 'General case' 0 CA--C 1.498 -1.05 0 N-CA-C 105.585 -2.005 . . . . 1.4099999999999999 105.585 174.71 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A 1647 ' ' GLU . . . . . 0.4 ' HG3' ' CZ ' ' A' 1527 ' ' PHE . 53.9 mt-10 -123.01 93.77 47.96 Favored Pre-proline 0 C--N 1.305 -1.368 0 N-CA-C 110.215 -0.291 . . . . 2.9199999999999999 110.215 -179.624 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A 1648 ' ' PRO . . . . . 0.588 ' HG2' ' HD3' ' A' 1616 ' ' PRO . 6.5 Cg_exo -73.34 101.53 1.36 Allowed 'Trans proline' 0 N--CA 1.452 -0.949 0 C-N-CA 122.554 2.169 . . . . 2.8199999999999998 107.104 174.056 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A 1649 ' ' GLU . . . . . . . . . . . . . 8.7 tp10 . . . . . 0 N--CA 1.416 -2.163 0 N-CA-C 109.57 -0.53 . . . . 5.0599999999999996 109.57 -171.509 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A 1515 ' ' ASP . . . . . . . . . . . . . 22.8 t0 . . . . . 0 N--CA 1.434 -1.26 0 N-CA-C 106.874 -1.528 . . . . 2.54 106.874 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A 1516 ' ' CYS . . . . . . . . . . . . . 29.8 m -75.99 67.92 2.41 Favored 'General case' 0 C--N 1.288 -2.081 0 CA-C-O 121.948 0.88 . . . . 1.25 110.862 -176.008 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A 1517 ' ' GLN . . . . . 0.409 ' HA ' ' O ' ' A' 1527 ' ' PHE . 4.0 pt20 -148.56 151.31 34.85 Favored 'General case' 0 N--CA 1.417 -2.119 0 N-CA-C 108.578 -0.897 . . . . 1.88 108.578 -179.494 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A 1518 ' ' VAL . . . . . 0.812 HG21 HD11 ' A' 1588 ' ' LEU . 44.6 t -127.08 134.07 66.89 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.459 0 N-CA-C 108.87 -0.789 . . . . 1.73 108.87 -179.169 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A 1519 ' ' THR . . . . . . . . . . . . . 27.7 m -107.71 125.33 51.25 Favored 'General case' 0 C--N 1.296 -1.727 0 N-CA-C 110.063 -0.347 . . . . 1.7 110.063 177.14 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A 1520 ' ' ASN . . . . . . . . . . . . . 30.3 t-20 -97.33 100.37 7.81 Favored Pre-proline 0 C--N 1.309 -1.16 0 N-CA-C 106.802 -1.555 . . . . 2.12 106.802 172.063 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A 1521 ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -73.83 -0.12 9.01 Favored 'Trans proline' 0 C--N 1.353 0.784 0 C-N-CA 122.713 2.275 . . . . 2.47 113.495 -175.633 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A 1522 ' ' SER . . . . . . . . . . . . . 50.8 m -91.44 -14.96 29.62 Favored 'General case' 0 N--CA 1.433 -1.279 0 CA-C-N 116.641 -0.254 . . . . 2.57 110.917 178.384 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A 1523 ' ' THR . . . . . . . . . . . . . 14.3 t -139.12 0.67 1.95 Allowed 'General case' 0 CA--C 1.555 1.135 0 CA-C-O 121.271 0.557 . . . . 2.15 111.247 177.427 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A 1524 ' ' GLY . . . . . . . . . . . . . . . 66.8 30.61 76.45 Favored Glycine 0 C--N 1.339 0.708 0 CA-C-N 116.217 -0.447 . . . . 1.89 112.535 178.466 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A 1525 ' ' HIS . . . . . 0.623 ' HE1' ' HB2' ' A' 1647 ' ' GLU . 23.8 t-160 -101.53 122.75 44.38 Favored 'General case' 0 C--N 1.303 -1.438 0 O-C-N 122.616 -0.343 . . . . 1.9 111.021 -176.729 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A 1526 ' ' LEU . . . . . . . . . . . . . 42.6 tp -97.97 133.55 42.29 Favored 'General case' 0 C--N 1.307 -1.249 0 N-CA-C 108.86 -0.793 . . . . 1.61 108.86 176.383 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A 1527 ' ' PHE . . . . . 0.416 ' CE1' ' HA ' ' A' 1646 ' ' CYS . 94.8 m-85 -102.87 132.67 48.92 Favored 'General case' 0 C--N 1.292 -1.917 0 N-CA-C 108.529 -0.915 . . . . 1.42 108.529 176.822 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A 1528 ' ' ASP . . . . . . . . . . . . . 28.7 t70 -110.98 114.76 28.32 Favored 'General case' 0 CA--C 1.487 -1.45 0 CA-C-O 122.103 0.954 . . . . 2.18 112.425 -179.245 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A 1529 ' ' LEU . . . . . . . . . . . . . 87.0 mt -119.63 3.53 11.16 Favored 'General case' 0 C--N 1.294 -1.818 0 CA-C-N 114.055 -1.429 . . . . 1.44 107.427 174.623 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A 1530 ' ' SER . . . . . . . . . . . . . 14.5 t -80.36 -31.6 37.89 Favored 'General case' 0 N--CA 1.441 -0.898 0 CA-C-N 115.74 -0.664 . . . . 1.44 110.428 -175.443 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A 1531 ' ' SER . . . . . . . . . . . . . 25.9 m -70.4 -10.9 60.35 Favored 'General case' 0 C--O 1.236 0.379 0 CA-C-O 121.133 0.492 . . . . 1.5 110.204 177.234 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A 1532 ' ' LEU . . . . . . . . . . . . . 97.1 mt -80.39 10.01 5.15 Favored 'General case' 0 CA--C 1.546 0.811 0 N-CA-C 112.787 0.662 . . . . 1.77 112.787 178.666 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A 1533 ' ' SER . . . . . . . . . . . . . 31.7 m -72.7 145.02 47.47 Favored 'General case' 0 C--O 1.247 0.964 0 N-CA-C 108.495 -0.928 . . . . 2.38 108.495 174.924 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A 1534 ' ' GLY . . . . . . . . . . . . . . . -162.66 169.28 37.86 Favored Glycine 0 N--CA 1.441 -0.995 0 C-N-CA 120.319 -0.944 . . . . 1.55 112.277 -177.419 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A 1535 ' ' ARG . . . . . 0.816 ' HD3' ' HG3' ' A' 1557 ' ' GLU . 21.8 tpp180 -80.67 -51.59 8.53 Favored 'General case' 0 C--N 1.312 -1.028 0 N-CA-C 108.676 -0.861 . . . . 3.96 108.676 179.459 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A 1536 ' ' ALA . . . . . . . . . . . . . . . -79.61 -37.44 36.17 Favored 'General case' 0 C--N 1.309 -1.193 0 C-N-CA 120.033 -0.667 . . . . 1.65 110.261 179.291 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A 1537 ' ' GLY . . . . . . . . . . . . . . . 79.68 -151.17 33.77 Favored Glycine 0 N--CA 1.426 -1.972 0 N-CA-C 109.962 -1.255 . . . . 1.19 109.962 -179.953 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A 1538 ' ' PHE . . . . . 0.614 ' CD1' HD13 ' A' 1552 ' ' ILE . 65.7 m-85 -107.95 135.91 48.53 Favored 'General case' 0 C--N 1.288 -2.09 0 N-CA-C 107.6 -1.259 . . . . 1.69 107.6 177.598 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A 1539 ' ' THR . . . . . 0.443 ' O ' ' HD2' ' A' 1623 ' ' ARG . 2.7 p -112.45 137.02 51.24 Favored 'General case' 0 C--N 1.296 -1.75 0 N-CA-C 113.135 0.791 . . . . 1.48 113.135 -175.676 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A 1540 ' ' ALA . . . . . . . . . . . . . . . -117.02 108.81 16.21 Favored 'General case' 0 C--N 1.308 -1.203 0 N-CA-C 109.687 -0.486 . . . . 0.83 109.687 178.302 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A 1541 ' ' ALA . . . . . . . . . . . . . . . -74.19 113.75 11.76 Favored 'General case' 0 C--N 1.313 -0.98 0 CA-C-N 115.36 -0.836 . . . . 1.27 109.396 178.998 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A 1542 ' ' TYR . . . . . 0.434 ' CE2' ' HB2' ' A' 1545 ' ' SER . 80.0 t80 -130.72 157.64 42.25 Favored 'General case' 0 N--CA 1.418 -2.065 0 CA-C-N 115.852 -0.613 . . . . 2.15 109.734 -176.587 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A 1543 ' ' SER . . . . . . . . . . . . . 5.3 m -40.85 -153.6 0.0 OUTLIER 'General case' 0 CA--C 1.592 2.561 0 C-N-CA 129.709 3.204 . . . . 2.29 117.111 -174.716 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A 1544 ' ' LYS . . . . . . . . . . . . . 25.0 ttmm -54.86 -24.71 24.41 Favored 'General case' 0 CA--C 1.556 1.188 0 O-C-N 120.863 -1.148 . . . . 3.91 112.385 -179.343 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A 1545 ' ' SER . . . . . 0.434 ' HB2' ' CE2' ' A' 1542 ' ' TYR . 22.6 m -64.69 -30.69 71.71 Favored 'General case' 0 CA--C 1.547 0.827 0 O-C-N 121.759 -0.588 . . . . 3.3 110.717 175.452 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A 1546 ' ' GLY . . . . . 0.417 ' O ' ' HB3' ' A' 1542 ' ' TYR . . . 116.85 174.26 17.12 Favored Glycine 0 N--CA 1.436 -1.34 0 C-N-CA 119.489 -1.339 . . . . 1.24 114.974 174.174 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A 1547 ' ' VAL . . . . . . . . . . . . . 3.1 p -92.92 129.21 43.79 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.343 0 C-N-CA 123.991 0.916 . . . . 1.63 110.398 179.915 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A 1548 ' ' VAL . . . . . 0.515 ' HA ' ' HA ' ' A' 1567 ' ' PHE . 3.0 t -97.47 143.29 12.87 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.86 0 CA-C-N 115.55 -0.75 . . . . 0.92 109.957 -174.763 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A 1549 ' ' TYR . . . . . 0.736 ' HB3' HD21 ' A' 1556 ' ' ASN . 37.3 m-85 -102.49 145.41 29.62 Favored 'General case' 0 C--N 1.307 -1.243 0 N-CA-C 105.915 -1.883 . . . . 1.44 105.915 169.341 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A 1550 ' ' MET . . . . . 0.429 ' SD ' HG12 ' A' 1610 ' ' ILE . 37.1 ttm -143.52 127.72 17.64 Favored 'General case' 0 C--N 1.292 -1.929 0 C-N-CA 120.49 -0.484 . . . . 1.74 110.833 -175.615 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A 1551 ' ' SER . . . . . . . . . . . . . 41.0 p -99.52 115.76 30.08 Favored 'General case' 0 N--CA 1.418 -2.04 0 N-CA-C 108.047 -1.094 . . . . 1.64 108.047 174.572 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A 1552 ' ' ILE . . . . . 0.614 HD13 ' CD1' ' A' 1538 ' ' PHE . 1.7 mp -75.53 -7.84 10.73 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.017 0 CA-C-O 122.474 1.131 . . . . 1.33 110.586 179.228 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A 1553 ' ' CYS . . . . . . . . . . . . . 33.9 t -161.48 148.83 14.78 Favored 'General case' 0 N--CA 1.425 -1.691 0 N-CA-C 107.516 -1.29 . . . . 1.43 107.516 177.56 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A 1554 ' ' GLY . . . . . . . . . . . . . . . 82.93 -120.15 5.07 Favored Glycine 0 C--N 1.318 -0.462 0 C-N-CA 121.227 -0.511 . . . . 1.12 113.129 176.228 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A 1555 ' ' GLU . . . . . . . . . . . . . 9.3 pt-20 -145.81 145.51 30.81 Favored 'General case' 0 C--N 1.315 -0.91 0 C-N-CA 123.347 0.659 . . . . 1.8 110.812 -179.885 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A 1556 ' ' ASN . . . . . 0.736 HD21 ' HB3' ' A' 1549 ' ' TYR . 3.4 t-20 -85.13 132.3 34.32 Favored 'General case' 0 C--N 1.295 -1.773 0 CA-C-N 114.644 -1.162 . . . . 2.63 110.821 -175.183 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A 1557 ' ' GLU . . . . . 0.816 ' HG3' ' HD3' ' A' 1535 ' ' ARG . 33.2 mm-40 -98.48 177.87 5.2 Favored 'General case' 0 C--N 1.289 -2.044 0 CA-C-N 113.837 -1.529 . . . . 3.79 109.116 179.937 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A 1558 ' ' ASN . . . . . . . . . . . . . 37.8 m-80 75.53 5.71 4.03 Favored 'General case' 0 N--CA 1.504 2.258 0 C-N-CA 124.471 1.109 . . . . 1.52 111.119 -178.727 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A 1559 ' ' CYS . . . . . 0.447 ' SG ' ' HA ' ' A' 1571 ' ' ARG . 97.7 m -148.28 169.35 9.38 Favored Pre-proline 0 C--N 1.291 -1.938 0 N-CA-C 103.413 -2.81 . . . . 0.84 103.413 176.34 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A 1560 ' ' PRO . . . . . 0.438 ' HD2' ' HB3' ' A' 1559 ' ' CYS . 9.4 Cg_endo -52.18 109.21 0.31 Allowed 'Trans proline' 0 C--N 1.359 1.115 0 C-N-CA 122.37 2.046 . . . . 1.18 111.244 176.624 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A 1561 ' ' PRO . . . . . . . . . . . . . 75.4 Cg_exo -50.85 120.61 6.83 Favored 'Trans proline' 0 C--N 1.359 1.088 0 C-N-CA 123.884 3.056 . . . . 1.51 112.502 -175.523 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A 1562 ' ' GLY . . . . . . . . . . . . . . . 134.19 -6.04 4.66 Favored Glycine 0 N--CA 1.435 -1.433 0 CA-C-N 115.081 -0.963 . . . . 0.72 110.987 -177.608 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A 1563 ' ' VAL . . . . . 0.576 HG23 ' HB3' ' A' 1556 ' ' ASN . 13.9 m -90.43 161.06 2.67 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.182 0 N-CA-C 105.937 -1.875 . . . . 0.97 105.937 172.944 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A 1564 ' ' GLY . . . . . . . . . . . . . . . -112.18 -21.88 6.1 Favored Glycine 0 C--N 1.309 -0.923 0 C-N-CA 120.395 -0.907 . . . . 0.72 111.964 -179.816 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A 1565 ' ' ALA . . . . . . . . . . . . . . . -150.13 127.63 11.52 Favored 'General case' 0 C--N 1.311 -1.081 0 N-CA-C 107.511 -1.292 . . . . 0.37 107.511 179.048 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A 1566 ' ' CYS . . . . . . . . . . . . . 34.2 t -155.75 141.57 18.06 Favored 'General case' 0 C--N 1.297 -1.681 0 N-CA-C 110.33 -0.248 . . . . 0.51 110.33 -174.62 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A 1567 ' ' PHE . . . . . 0.515 ' HA ' ' HA ' ' A' 1548 ' ' VAL . 87.6 m-85 -71.2 121.69 18.84 Favored 'General case' 0 C--O 1.216 -0.662 0 N-CA-C 105.365 -2.087 . . . . 0.97 105.365 171.678 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A 1568 ' ' GLY . . . . . 0.63 ' HA3' ' CD1' ' A' 1549 ' ' TYR . . . -83.21 -16.23 69.91 Favored Glycine 0 C--N 1.296 -1.672 0 C-N-CA 119.314 -1.422 . . . . 1.08 114.009 -171.141 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A 1569 ' ' GLN . . . . . . . . . . . . . 4.1 pt20 -82.31 -21.71 35.97 Favored 'General case' 0 C--N 1.301 -1.521 0 C-N-CA 120.565 -0.454 . . . . 2.74 111.408 -178.164 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A 1570 ' ' THR . . . . . . . . . . . . . 9.7 p -121.54 -12.36 8.55 Favored 'General case' 0 C--O 1.239 0.505 0 N-CA-C 112.347 0.499 . . . . 1.96 112.347 178.303 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A 1571 ' ' ARG . . . . . 0.447 ' HA ' ' SG ' ' A' 1559 ' ' CYS . 96.4 mtt180 62.81 42.57 7.79 Favored 'General case' 0 CA--C 1.511 -0.552 0 C-N-CA 125.1 1.36 . . . . 3.95 112.693 178.922 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A 1572 ' ' ILE . . . . . . . . . . . . . 25.2 mm -99.95 116.26 42.85 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.19 0 N-CA-C 108.139 -1.06 . . . . 1.37 108.139 179.942 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A 1573 ' ' SER . . . . . . . . . . . . . 35.0 t -69.15 133.33 47.87 Favored 'General case' 0 C--N 1.306 -1.284 0 CA-C-N 115.311 -0.859 . . . . 1.08 111.084 -176.402 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A 1574 ' ' VAL . . . . . . . . . . . . . 13.8 m -130.6 28.42 1.51 Allowed 'Isoleucine or valine' 0 C--N 1.315 -0.929 0 CA-C-O 122.205 1.002 . . . . 1.3 110.857 174.903 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A 1575 ' ' GLY . . . . . . . . . . . . . . . 163.04 126.97 0.85 Allowed Glycine 0 N--CA 1.421 -2.342 0 CA-C-N 113.835 -1.53 . . . . 0.51 110.439 176.854 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A 1576 ' ' LYS . . . . . 0.479 ' HA ' ' HA ' ' A' 1563 ' ' VAL . 68.3 mttm -85.79 151.24 23.98 Favored 'General case' 0 C--N 1.31 -1.133 0 N-CA-C 108.781 -0.822 . . . . 2.9 108.781 177.969 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A 1577 ' ' ALA . . . . . . . . . . . . . . . -74.34 91.84 2.23 Favored 'General case' 0 C--N 1.315 -0.928 0 CA-C-O 121.736 0.779 . . . . 0.83 111.641 -175.48 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A 1578 ' ' ASN . . . . . . . . . . . . . 41.4 m-80 -117.22 115.18 24.8 Favored 'General case' 0 C--N 1.284 -2.243 0 N-CA-C 104.747 -2.316 . . . . 1.85 104.747 171.724 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A 1579 ' ' LYS . . . . . . . . . . . . . 54.1 mtmt -77.29 90.41 3.75 Favored 'General case' 0 CA--C 1.493 -1.244 0 N-CA-C 108.654 -0.869 . . . . 1.9 108.654 -177.037 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A 1580 ' ' ARG . . . . . . . . . . . . . 27.4 ttm180 -134.79 99.09 4.21 Favored 'General case' 0 N--CA 1.402 -2.861 0 CA-C-N 114.341 -1.3 . . . . 3.63 108.869 -176.481 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A 1581 ' ' LEU . . . . . 0.477 ' HA ' ' HA ' ' A' 1590 ' ' LEU . 4.6 pp -103.61 168.03 9.41 Favored 'General case' 0 C--N 1.297 -1.7 0 C-N-CA 120.4 -0.52 . . . . 1.87 110.189 177.518 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A 1582 ' ' ARG . . . . . 0.673 ' HB3' ' HB3' ' A' 1589 ' ' GLN . 61.5 ttt180 -135.21 125.5 26.36 Favored 'General case' 0 C--N 1.297 -1.688 0 C-N-CA 123.158 0.583 . . . . 3.97 109.766 -174.046 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A 1583 ' ' TYR . . . . . . . . . . . . . 40.2 t80 -119.09 104.11 10.16 Favored 'General case' 0 C--N 1.308 -1.202 0 CA-C-N 116.256 -0.429 . . . . 1.41 110.131 176.075 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A 1584 ' ' VAL . . . . . . . . . . . . . 12.5 p -148.62 142.82 18.85 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.953 0 N-CA-C 108.76 -0.83 . . . . 1.69 108.76 178.981 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A 1585 ' ' ASP . . . . . . . . . . . . . 31.6 t70 49.65 38.7 15.71 Favored 'General case' 0 N--CA 1.501 2.092 0 CA-C-O 122.559 1.171 . . . . 2.06 112.503 177.226 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A 1586 ' ' GLN . . . . . . . . . . . . . 27.4 mt-30 53.84 34.57 19.59 Favored 'General case' 0 C--O 1.241 0.638 0 CA-C-N 114.581 -1.191 . . . . 2.33 113.151 -179.426 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A 1587 ' ' VAL . . . . . . . . . . . . . 7.1 p -135.08 117.5 22.13 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.386 0 CA-C-O 121.826 0.822 . . . . 0.78 109.427 174.724 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A 1588 ' ' LEU . . . . . 0.812 HD11 HG21 ' A' 1518 ' ' VAL . 2.3 mm? -81.57 152.72 27.09 Favored 'General case' 0 C--N 1.297 -1.706 0 CA-C-N 114.784 -1.098 . . . . 1.41 111.588 -178.167 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A 1589 ' ' GLN . . . . . 0.673 ' HB3' ' HB3' ' A' 1582 ' ' ARG . 35.3 tt0 -152.47 156.99 40.52 Favored 'General case' 0 C--N 1.294 -1.837 0 N-CA-C 107.493 -1.299 . . . . 1.24 107.493 -179.534 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A 1590 ' ' LEU . . . . . 0.477 ' HA ' ' HA ' ' A' 1581 ' ' LEU . 5.3 tt -147.83 143.35 27.39 Favored 'General case' 0 C--N 1.303 -1.448 0 N-CA-C 105.685 -1.968 . . . . 1.15 105.685 175.06 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A 1591 ' ' VAL . . . . . 0.503 HG23 HG22 ' A' 1609 ' ' VAL . 11.5 p -130.93 135.26 60.42 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.178 0 N-CA-C 112.805 0.668 . . . . 1.51 112.805 -173.843 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A 1592 ' ' TYR . . . . . . . . . . . . . 63.3 m-85 -122.35 106.11 10.78 Favored 'General case' 0 C--N 1.315 -0.904 0 N-CA-C 107.857 -1.164 . . . . 1.06 107.857 172.912 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A 1593 ' ' LYS . . . . . . . . . . . . . 20.0 pttp -104.37 178.4 4.57 Favored 'General case' 0 C--N 1.293 -1.854 0 CA-C-N 115.982 -0.553 . . . . 2.18 112.07 -176.173 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A 1594 ' ' ASP . . . . . 0.576 ' HA ' ' CB ' ' A' 1605 ' ' SER . 55.8 m-20 49.05 47.83 21.44 Favored 'General case' 0 CA--C 1.514 -0.423 0 C-N-CA 126.101 1.76 . . . . 1.45 115.701 172.407 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A 1595 ' ' GLY . . . . . . . . . . . . . . . -78.66 -80.48 0.73 Allowed Glycine 0 N--CA 1.445 -0.724 0 C-N-CA 120.298 -0.953 . . . . 0.78 111.226 177.758 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A 1596 ' ' SER . . . . . 0.446 ' HA ' ' HD3' ' A' 1597 ' ' PRO . 4.2 p -107.47 143.38 27.11 Favored Pre-proline 0 C--N 1.299 -1.618 0 N-CA-C 109.963 -0.384 . . . . 1.68 109.963 177.588 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A 1597 ' ' PRO . . . . . 0.446 ' HD3' ' HA ' ' A' 1596 ' ' SER . 21.5 Cg_exo -67.24 130.13 21.95 Favored 'Trans proline' 0 N--CA 1.46 -0.475 0 C-N-CA 123.039 2.493 . . . . 1.17 110.29 177.099 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A 1598 ' ' CYS . . . . . 0.43 ' HA ' ' HD3' ' A' 1599 ' ' PRO . 33.7 t -101.25 121.42 51.92 Favored Pre-proline 0 C--N 1.296 -1.736 0 N-CA-C 109.924 -0.398 . . . . 1.19 109.924 -177.157 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A 1599 ' ' PRO . . . . . 0.43 ' HD3' ' HA ' ' A' 1598 ' ' CYS . 94.3 Cg_endo -98.34 22.4 0.29 Allowed 'Trans proline' 0 N--CA 1.449 -1.114 0 C-N-CA 123.127 2.551 . . . . 1.59 112.097 178.344 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A 1600 ' ' SER . . . . . . . . . . . . . 17.9 m -79.61 -74.24 0.3 Allowed 'General case' 0 C--N 1.315 -0.931 0 CA-C-N 116.466 -0.333 . . . . 2.12 111.788 -177.899 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A 1601 ' ' LYS . . . . . . . . . . . . . 23.2 tptm -98.13 -87.11 0.34 Allowed 'General case' 0 C--N 1.317 -0.822 0 C-N-CA 120.317 -0.553 . . . . 3.74 110.42 -178.949 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A 1602 ' ' SER . . . . . . . . . . . . . 16.7 m -96.21 174.98 6.62 Favored 'General case' 0 C--N 1.298 -1.672 0 N-CA-C 107.942 -1.133 . . . . 3.79 107.942 178.718 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A 1603 ' ' GLY . . . . . . . . . . . . . . . -81.57 65.64 3.98 Favored Glycine 0 N--CA 1.439 -1.126 0 N-CA-C 110.382 -1.087 . . . . 2.0 110.382 178.025 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A 1604 ' ' LEU . . . . . . . . . . . . . 1.7 pt? -117.02 165.18 13.66 Favored 'General case' 0 C--N 1.296 -1.724 0 N-CA-C 108.025 -1.102 . . . . 1.48 108.025 -178.111 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A 1605 ' ' SER . . . . . 0.576 ' CB ' ' HA ' ' A' 1594 ' ' ASP . 19.3 m -92.31 178.49 5.83 Favored 'General case' 0 C--N 1.298 -1.641 0 CA-C-O 120.967 0.413 . . . . 1.51 110.389 179.616 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A 1606 ' ' TYR . . . . . 0.489 ' HA ' ' O ' ' A' 1634 ' ' CYS . 76.7 m-85 -95.91 133.74 39.73 Favored 'General case' 0 CA--C 1.468 -2.21 0 N-CA-C 104.658 -2.349 . . . . 1.18 104.658 176.321 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A 1607 ' ' LYS . . . . . 0.411 ' HG3' HG23 ' A' 1635 ' ' THR . 10.3 ptpp? -128.36 153.95 46.5 Favored 'General case' 0 N--CA 1.403 -2.802 0 C-N-CA 118.452 -1.299 . . . . 1.67 109.133 178.53 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A 1608 ' ' SER . . . . . . . . . . . . . 45.3 m -117.64 124.29 48.23 Favored 'General case' 0 C--N 1.296 -1.727 0 N-CA-C 109.784 -0.45 . . . . 1.0 109.784 178.063 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A 1609 ' ' VAL . . . . . 0.503 HG22 HG23 ' A' 1591 ' ' VAL . 78.4 t -114.65 124.48 71.35 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.868 0 N-CA-C 109.002 -0.74 . . . . 0.93 109.002 178.956 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A 1610 ' ' ILE . . . . . 0.705 HG13 ' HB2' ' A' 1638 ' ' PHE . 3.2 mp -108.21 119.14 57.26 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.202 0 N-CA-C 109.166 -0.679 . . . . 0.78 109.166 178.683 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A 1611 ' ' SER . . . . . 0.42 ' O ' ' HA ' ' A' 1639 ' ' SER . 8.6 t -96.35 118.37 32.75 Favored 'General case' 0 N--CA 1.412 -2.348 0 N-CA-C 107.732 -1.21 . . . . 1.29 107.732 178.558 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A 1612 ' ' PHE . . . . . 0.436 ' HE2' ' HB2' ' A' 1590 ' ' LEU . 92.8 m-85 -97.06 102.12 13.83 Favored 'General case' 0 N--CA 1.428 -1.556 0 N-CA-C 107.858 -1.164 . . . . 0.7 107.858 178.664 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A 1613 ' ' VAL . . . . . . . . . . . . . 85.0 t -84.29 120.03 34.36 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.952 0 N-CA-C 107.51 -1.293 . . . . 0.75 107.51 179.911 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A 1614 ' ' CYS . . . . . 0.522 ' HB3' ' HB2' ' A' 1646 ' ' CYS . 56.8 m -75.06 91.61 2.56 Favored 'General case' 0 C--N 1.295 -1.795 0 CA-C-O 121.653 0.74 . . . . 1.39 109.036 -178.334 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A 1615 ' ' ARG . . . . . 0.503 ' HA ' ' HE ' ' A' 1615 ' ' ARG . 0.0 OUTLIER -140.08 123.19 10.3 Favored Pre-proline 0 N--CA 1.414 -2.274 0 CA-C-N 115.748 -0.66 . . . . 3.75 109.893 178.358 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A 1616 ' ' PRO . . . . . . . . . . . . . 56.9 Cg_endo -73.04 68.53 3.98 Favored 'Trans proline' 0 CA--C 1.546 1.083 0 C-N-CA 122.261 1.974 . . . . 1.32 110.82 173.908 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A 1617 ' ' GLU . . . . . . . . . . . . . 7.5 tp10 . . . . . 0 C--N 1.314 -0.978 0 N-CA-C 108.878 -0.786 . . . . 3.21 108.878 -177.933 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A 1622 ' ' ASN . . . . . 0.422 ' HB3' ' HE1' ' A' 1640 ' ' TRP . 20.3 t-20 . . . . . 0 C--O 1.231 0.099 0 N-CA-C 107.944 -1.132 . . . . 2.92 107.944 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A 1623 ' ' ARG . . . . . 0.444 ' HA ' ' HD3' ' A' 1624 ' ' PRO . 32.9 ptt180 -155.32 156.48 31.05 Favored Pre-proline 0 C--N 1.305 -1.361 0 C-N-CA 119.752 -0.779 . . . . 3.61 112.144 -169.786 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A 1624 ' ' PRO . . . . . 0.444 ' HD3' ' HA ' ' A' 1623 ' ' ARG . 12.0 Cg_exo -70.76 106.67 1.89 Allowed 'Trans proline' 0 C--N 1.356 0.964 0 C-N-CA 123.426 2.751 . . . . 2.37 112.068 179.69 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A 1625 ' ' MET . . . . . . . . . . . . . 25.4 ptm -90.3 164.21 14.45 Favored 'General case' 0 C--N 1.303 -1.423 0 CA-C-N 115.698 -0.683 . . . . 2.16 109.304 179.252 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A 1626 ' ' LEU . . . . . . . . . . . . . 41.2 tp -89.58 112.87 24.2 Favored 'General case' 0 C--N 1.303 -1.421 0 N-CA-C 108.69 -0.856 . . . . 1.35 108.69 -178.944 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A 1627 ' ' ILE . . . . . . . . . . . . . 44.0 pt -94.43 -27.71 4.29 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.768 0 C-N-CA 120.585 -0.446 . . . . 1.21 111.662 -177.35 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A 1628 ' ' SER . . . . . . . . . . . . . 15.6 p -162.19 151.8 16.13 Favored 'General case' 0 N--CA 1.44 -0.969 0 N-CA-C 109.951 -0.388 . . . . 1.4 109.951 -178.485 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A 1629 ' ' LEU . . . . . 0.87 ' HG ' ' HG ' ' A' 1636 ' ' LEU . 2.7 tt -138.82 117.43 12.17 Favored 'General case' 0 C--N 1.293 -1.857 0 N-CA-C 106.84 -1.541 . . . . 1.56 106.84 -178.753 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A 1630 ' ' ASP . . . . . . . . . . . . . 12.6 t70 -94.72 103.38 15.29 Favored 'General case' 0 C--N 1.299 -1.621 0 N-CA-C 106.483 -1.673 . . . . 0.87 106.483 178.847 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A 1631 ' ' LYS . . . . . 0.602 ' HG2' HD22 ' A' 1629 ' ' LEU . 90.9 mttt -83.13 -5.35 59.08 Favored 'General case' 0 C--N 1.291 -1.946 0 CA-C-N 115.984 -0.553 . . . . 2.35 111.662 -172.35 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A 1632 ' ' GLN . . . . . . . . . . . . . 1.9 mp0 -87.0 -46.15 10.1 Favored 'General case' 0 C--N 1.312 -1.055 0 N-CA-C 108.437 -0.949 . . . . 2.55 108.437 -179.524 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A 1633 ' ' THR . . . . . . . . . . . . . 2.3 m -89.83 -2.93 58.33 Favored 'General case' 0 C--N 1.312 -1.022 0 CA-C-O 122.241 1.02 . . . . 1.24 108.769 178.01 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A 1634 ' ' CYS . . . . . 0.489 ' O ' ' HA ' ' A' 1606 ' ' TYR . 28.7 m 59.94 43.72 14.43 Favored 'General case' 0 C--O 1.219 -0.529 0 CA-C-N 114.263 -1.335 . . . . 0.89 109.976 176.95 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A 1635 ' ' THR . . . . . 0.411 HG23 ' HG3' ' A' 1607 ' ' LYS . 16.7 m -120.15 127.68 52.72 Favored 'General case' 0 N--CA 1.428 -1.548 0 CA-C-N 115.228 -0.896 . . . . 0.75 110.847 -173.643 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A 1636 ' ' LEU . . . . . 0.87 ' HG ' ' HG ' ' A' 1629 ' ' LEU . 5.9 mp -101.05 132.43 46.48 Favored 'General case' 0 C--N 1.312 -1.059 0 N-CA-C 109.475 -0.565 . . . . 1.33 109.475 177.346 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A 1637 ' ' PHE . . . . . . . . . . . . . 95.5 m-85 -113.4 107.86 16.42 Favored 'General case' 0 C--O 1.25 1.089 0 CA-C-O 121.26 0.552 . . . . 0.83 111.122 -177.762 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A 1638 ' ' PHE . . . . . 0.705 ' HB2' HG13 ' A' 1610 ' ' ILE . 95.7 m-85 -101.01 154.55 18.61 Favored 'General case' 0 C--N 1.299 -1.587 0 N-CA-C 108.866 -0.79 . . . . 0.6 108.866 178.944 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A 1639 ' ' SER . . . . . 0.42 ' HA ' ' O ' ' A' 1611 ' ' SER . 66.2 m -143.85 130.52 20.19 Favored 'General case' 0 C--N 1.296 -1.726 0 CA-C-O 120.992 0.425 . . . . 1.08 111.682 178.892 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A 1640 ' ' TRP . . . . . 0.422 ' HE1' ' HB3' ' A' 1622 ' ' ASN . 12.2 t90 -124.71 105.95 9.7 Favored 'General case' 0 N--CA 1.434 -1.262 0 CA-C-N 115.488 -0.778 . . . . 0.8 109.117 178.008 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A 1641 ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -76.16 100.32 4.98 Favored 'General case' 0 C--N 1.305 -1.346 0 CA-C-O 121.547 0.689 . . . . 2.54 109.479 175.309 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A 1642 ' ' THR . . . . . 0.422 ' O ' ' HA ' ' A' 1614 ' ' CYS . 14.9 t -142.08 139.01 17.37 Favored Pre-proline 0 C--N 1.291 -1.936 0 C-N-CA 120.016 -0.674 . . . . 1.15 112.447 -173.493 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A 1643 ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -80.86 -0.32 10.52 Favored 'Trans proline' 0 N--CA 1.453 -0.893 0 C-N-CA 123.296 2.664 . . . . 0.8 110.611 175.487 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A 1644 ' ' LEU . . . . . . . . . . . . . 88.9 mt -77.04 -27.57 54.51 Favored 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 108.405 -0.961 . . . . 1.54 108.405 175.345 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A 1645 ' ' ALA . . . . . . . . . . . . . . . -71.11 -42.37 69.36 Favored 'General case' 0 N--CA 1.441 -0.887 0 CA-C-N 114.596 -1.184 . . . . 0.95 110.022 -179.368 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A 1646 ' ' CYS . . . . . 0.522 ' HB2' ' HB3' ' A' 1614 ' ' CYS . 65.5 m -139.94 115.97 10.37 Favored 'General case' 0 C--O 1.244 0.808 0 N-CA-C 106.931 -1.507 . . . . 1.41 106.931 173.656 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A 1647 ' ' GLU . . . . . 0.623 ' HB2' ' HE1' ' A' 1525 ' ' HIS . 35.8 mt-10 . . . . . 0 C--N 1.309 -1.18 0 O-C-N 123.802 0.689 . . . . 2.92 110.226 -174.882 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A 1515 ' ' ASP . . . . . 0.441 ' HA ' ' HG3' ' A' 1579 ' ' LYS . 10.4 m-20 . . . . . 0 N--CA 1.48 1.073 0 N-CA-C 114.274 1.212 . . . . 2.54 114.274 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A 1516 ' ' CYS . . . . . 0.742 ' HA ' HD23 ' A' 1581 ' ' LEU . 57.0 m -135.79 40.75 2.74 Favored 'General case' 0 C--N 1.324 -0.536 0 C-N-CA 123.933 0.893 . . . . 1.25 111.37 -178.801 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A 1517 ' ' GLN . . . . . 0.497 ' HB2' HD21 ' A' 1526 ' ' LEU . 25.0 pt20 -139.09 124.19 18.96 Favored 'General case' 0 C--N 1.3 -1.571 0 N-CA-C 109.662 -0.496 . . . . 1.88 109.662 176.131 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A 1518 ' ' VAL . . . . . . . . . . . . . 7.5 p -124.78 128.94 73.64 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.849 0 CA-C-O 121.044 0.449 . . . . 1.73 110.324 -179.799 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A 1519 ' ' THR . . . . . 0.409 ' HA ' ' HA ' ' A' 1526 ' ' LEU . 50.3 m -100.7 126.33 47.22 Favored 'General case' 0 C--N 1.284 -2.274 0 N-CA-C 108.879 -0.786 . . . . 1.7 108.879 175.369 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A 1520 ' ' ASN . . . . . . . . . . . . . 38.1 t-20 -88.96 110.53 38.6 Favored Pre-proline 0 C--N 1.303 -1.434 0 N-CA-C 107.453 -1.314 . . . . 2.12 107.453 176.942 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A 1521 ' ' PRO . . . . . . . . . . . . . 58.9 Cg_endo -70.4 -14.18 33.79 Favored 'Trans proline' 0 C--N 1.356 0.928 0 C-N-CA 122.585 2.19 . . . . 2.47 113.19 -175.487 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A 1522 ' ' SER . . . . . . . . . . . . . 6.9 m -80.29 -17.01 53.35 Favored 'General case' 0 N--CA 1.43 -1.442 0 CA-C-N 116.281 -0.418 . . . . 2.57 110.581 -178.795 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A 1523 ' ' THR . . . . . . . . . . . . . 10.1 t -131.51 -18.16 2.85 Favored 'General case' 0 CA--C 1.556 1.203 0 C-N-CA 120.312 -0.555 . . . . 2.15 112.492 179.45 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A 1524 ' ' GLY . . . . . . . . . . . . . . . 80.38 16.66 75.57 Favored Glycine 0 C--N 1.338 0.683 0 C-N-CA 121.186 -0.53 . . . . 1.89 111.93 179.471 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A 1525 ' ' HIS . . . . . . . . . . . . . 21.1 t-160 -102.06 134.71 44.86 Favored 'General case' 0 C--N 1.305 -1.343 0 N-CA-C 109.425 -0.583 . . . . 1.9 109.425 -178.795 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A 1526 ' ' LEU . . . . . 0.497 HD21 ' HB2' ' A' 1517 ' ' GLN . 6.7 tt -102.73 138.11 40.06 Favored 'General case' 0 C--N 1.305 -1.357 0 N-CA-C 107.838 -1.171 . . . . 1.61 107.838 178.651 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A 1527 ' ' PHE . . . . . 0.513 ' CE2' ' HA ' ' A' 1646 ' ' CYS . 57.9 m-85 -114.03 111.96 22.5 Favored 'General case' 0 C--N 1.299 -1.594 0 N-CA-C 107.71 -1.218 . . . . 1.42 107.71 177.489 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A 1528 ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -102.06 139.0 38.27 Favored 'General case' 0 CA--C 1.471 -2.077 0 N-CA-C 108.514 -0.921 . . . . 2.18 108.514 178.999 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A 1529 ' ' LEU . . . . . 0.609 ' HB2' ' HB3' ' A' 1516 ' ' CYS . 43.3 mt -111.73 2.82 17.38 Favored 'General case' 0 C--N 1.292 -1.908 0 N-CA-C 107.756 -1.201 . . . . 1.44 107.756 176.871 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A 1530 ' ' SER . . . . . . . . . . . . . 8.4 m -65.81 -45.02 83.87 Favored 'General case' 0 N--CA 1.441 -0.893 0 CA-C-N 114.895 -1.048 . . . . 1.44 110.538 -177.708 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A 1531 ' ' SER . . . . . . . . . . . . . 37.6 m -77.12 -12.54 59.96 Favored 'General case' 0 C--O 1.24 0.565 0 CA-C-O 121.304 0.573 . . . . 1.5 110.296 177.533 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A 1532 ' ' LEU . . . . . 0.508 HD13 ' HA ' ' A' 1529 ' ' LEU . 8.5 mp -80.22 -31.28 38.62 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 116.033 -0.53 . . . . 1.77 112.362 -179.493 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A 1533 ' ' SER . . . . . 0.588 ' HB2' HG22 ' A' 1552 ' ' ILE . 19.2 t -85.7 173.28 10.22 Favored 'General case' 0 C--N 1.306 -1.32 0 CA-C-O 120.914 0.388 . . . . 2.38 110.304 -178.439 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A 1534 ' ' GLY . . . . . . . . . . . . . . . -153.99 167.1 32.17 Favored Glycine 0 N--CA 1.429 -1.821 0 N-CA-C 109.549 -1.42 . . . . 1.55 109.549 -179.256 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A 1535 ' ' ARG . . . . . 0.491 ' CG ' ' HG3' ' A' 1557 ' ' GLU . 13.4 ttp180 -69.29 -47.75 63.66 Favored 'General case' 0 C--N 1.318 -0.789 0 CA-C-O 121.016 0.436 . . . . 3.96 111.132 -177.274 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A 1536 ' ' ALA . . . . . . . . . . . . . . . -77.45 -29.67 52.92 Favored 'General case' 0 C--O 1.245 0.823 0 CA-C-O 121.262 0.554 . . . . 1.65 110.361 -179.409 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A 1537 ' ' GLY . . . . . . . . . . . . . . . 86.3 -164.58 36.71 Favored Glycine 0 N--CA 1.427 -1.962 0 CA-C-N 115.296 -0.865 . . . . 1.19 112.377 175.574 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A 1538 ' ' PHE . . . . . 0.464 ' CD1' HD13 ' A' 1552 ' ' ILE . 84.2 m-85 -106.6 156.63 18.4 Favored 'General case' 0 C--N 1.293 -1.877 0 N-CA-C 108.081 -1.081 . . . . 1.69 108.081 179.439 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A 1539 ' ' THR . . . . . . . . . . . . . 18.8 m -116.13 111.57 20.45 Favored 'General case' 0 C--N 1.291 -1.946 0 CA-C-O 121.51 0.671 . . . . 1.48 109.82 -176.879 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A 1540 ' ' ALA . . . . . . . . . . . . . . . -93.87 151.61 19.46 Favored 'General case' 0 C--N 1.3 -1.583 0 N-CA-C 109.314 -0.624 . . . . 0.83 109.314 -179.743 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A 1541 ' ' ALA . . . . . . . . . . . . . . . -88.02 132.61 34.21 Favored 'General case' 0 C--N 1.305 -1.361 0 N-CA-C 109.45 -0.574 . . . . 1.27 109.45 -179.065 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A 1542 ' ' TYR . . . . . 0.505 ' HD2' ' HB2' ' A' 1545 ' ' SER . 72.5 t80 -139.96 164.51 29.8 Favored 'General case' 0 N--CA 1.437 -1.094 0 C-N-CA 120.628 -0.429 . . . . 2.15 111.143 -177.426 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A 1543 ' ' SER . . . . . . . . . . . . . 5.6 m -47.47 -151.14 0.0 OUTLIER 'General case' 0 CA--C 1.573 1.833 0 C-N-CA 129.106 2.962 . . . . 2.29 113.619 175.154 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A 1544 ' ' LYS . . . . . . . . . . . . . 18.5 ptpt -39.69 -26.42 0.03 OUTLIER 'General case' 0 CA--C 1.574 1.882 0 N-CA-C 115.004 1.483 . . . . 3.91 115.004 178.604 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A 1545 ' ' SER . . . . . 0.505 ' HB2' ' HD2' ' A' 1542 ' ' TYR . 8.4 m -79.12 -8.09 58.7 Favored 'General case' 0 CA--C 1.566 1.591 0 O-C-N 121.501 -0.749 . . . . 3.3 111.775 178.717 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A 1546 ' ' GLY . . . . . . . . . . . . . . . 86.09 -80.35 1.79 Allowed Glycine 0 C--N 1.339 0.706 0 C-N-CA 121.488 -0.387 . . . . 1.24 113.991 174.108 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A 1547 ' ' VAL . . . . . . . . . . . . . 8.2 m -141.53 157.96 21.59 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.694 0 C-N-CA 122.99 0.516 . . . . 1.63 110.031 -176.987 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A 1548 ' ' VAL . . . . . 0.417 HG13 ' HD1' ' A' 1567 ' ' PHE . 1.3 t -122.79 137.69 55.43 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.37 0 N-CA-C 107.895 -1.15 . . . . 0.92 107.895 -178.922 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A 1549 ' ' TYR . . . . . . . . . . . . . 71.3 m-85 -96.02 118.64 33.02 Favored 'General case' 0 C--N 1.306 -1.298 0 N-CA-C 108.771 -0.826 . . . . 1.44 108.771 175.263 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A 1550 ' ' MET . . . . . . . . . . . . . 74.0 mmm -118.55 121.74 40.97 Favored 'General case' 0 C--N 1.3 -1.549 0 CA-C-N 115.286 -0.87 . . . . 1.74 109.8 -173.412 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A 1551 ' ' SER . . . . . . . . . . . . . 75.5 m -106.58 114.63 28.85 Favored 'General case' 0 C--N 1.296 -1.759 0 N-CA-C 108.672 -0.862 . . . . 1.64 108.672 174.127 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A 1552 ' ' ILE . . . . . 0.588 HG22 ' HB2' ' A' 1533 ' ' SER . 1.5 mp -57.46 -34.02 45.63 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.873 0 CA-C-N 114.957 -1.02 . . . . 1.33 113.261 -176.576 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A 1553 ' ' CYS . . . . . 0.559 ' HB3' ' HE3' ' A' 1579 ' ' LYS . 73.6 m -140.68 137.98 33.94 Favored 'General case' 0 C--N 1.304 -1.396 0 N-CA-C 108.978 -0.749 . . . . 1.43 108.978 174.977 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A 1554 ' ' GLY . . . . . . . . . . . . . . . 94.89 -125.52 8.37 Favored Glycine 0 N--CA 1.433 -1.547 0 C-N-CA 120.937 -0.649 . . . . 1.12 114.043 172.252 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A 1555 ' ' GLU . . . . . . . . . . . . . 7.5 pt-20 -138.45 150.74 46.77 Favored 'General case' 0 C--N 1.31 -1.12 0 C-N-CA 123.432 0.693 . . . . 1.8 111.175 -175.464 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A 1556 ' ' ASN . . . . . . . . . . . . . 17.5 t-20 -101.23 138.96 37.57 Favored 'General case' 0 N--CA 1.433 -1.301 0 CA-C-N 115.503 -0.771 . . . . 2.63 108.944 -177.194 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A 1557 ' ' GLU . . . . . 0.491 ' HG3' ' CG ' ' A' 1535 ' ' ARG . 54.7 mm-40 -99.77 -0.42 39.96 Favored 'General case' 0 C--N 1.298 -1.645 0 N-CA-C 113.088 0.773 . . . . 3.79 113.088 -172.528 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A 1558 ' ' ASN . . . . . . . . . . . . . 33.5 m-80 -87.66 -1.82 58.2 Favored 'General case' 0 N--CA 1.483 1.187 0 CA-C-O 122.09 0.948 . . . . 1.52 110.144 -176.812 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A 1559 ' ' CYS . . . . . 0.782 ' HB3' ' HD2' ' A' 1560 ' ' PRO . 94.0 m -142.21 -175.95 0.52 Allowed Pre-proline 0 C--N 1.288 -2.066 0 N-CA-C 104.821 -2.289 . . . . 0.84 104.821 177.27 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A 1560 ' ' PRO . . . . . 0.782 ' HD2' ' HB3' ' A' 1559 ' ' CYS . 1.0 OUTLIER -45.72 124.16 6.64 Favored 'Trans proline' 0 C--N 1.364 1.374 0 C-N-CA 122.556 2.171 . . . . 1.18 112.882 175.677 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A 1561 ' ' PRO . . . . . 0.44 ' HD3' ' HA ' ' A' 1560 ' ' PRO . 33.5 Cg_exo -62.66 103.33 0.32 Allowed 'Trans proline' 0 C--O 1.242 0.688 0 C-N-CA 122.913 2.408 . . . . 1.51 110.688 179.053 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A 1562 ' ' GLY . . . . . . . . . . . . . . . 146.85 -9.46 1.35 Allowed Glycine 0 N--CA 1.423 -2.197 0 CA-C-N 115.103 -0.953 . . . . 0.72 110.805 -177.206 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A 1563 ' ' VAL . . . . . . . . . . . . . 3.6 m -98.29 150.82 4.67 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.345 0 N-CA-C 106.646 -1.613 . . . . 0.97 106.646 174.174 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A 1564 ' ' GLY . . . . . . . . . . . . . . . -103.21 -21.75 9.77 Favored Glycine 0 C--N 1.306 -1.089 0 C-N-CA 120.179 -1.01 . . . . 0.72 112.286 -176.483 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A 1565 ' ' ALA . . . . . . . . . . . . . . . -148.34 132.38 17.23 Favored 'General case' 0 C--N 1.31 -1.113 0 N-CA-C 109.063 -0.717 . . . . 0.37 109.063 -179.283 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A 1566 ' ' CYS . . . . . . . . . . . . . 35.9 t -153.5 138.95 17.66 Favored 'General case' 0 C--N 1.309 -1.158 0 CA-C-N 116.69 -0.232 . . . . 0.51 110.818 -173.821 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A 1567 ' ' PHE . . . . . 0.417 ' HD1' HG13 ' A' 1548 ' ' VAL . 21.0 m-85 -68.73 123.34 20.65 Favored 'General case' 0 CA--C 1.514 -0.436 0 N-CA-C 108.2 -1.037 . . . . 0.97 108.2 175.489 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A 1568 ' ' GLY . . . . . . . . . . . . . . . -55.06 -64.36 4.43 Favored Glycine 0 C--N 1.31 -0.908 0 N-CA-C 116.861 1.505 . . . . 1.08 116.861 -167.76 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A 1569 ' ' GLN . . . . . . . . . . . . . 13.7 pt20 -85.15 -23.58 28.33 Favored 'General case' 0 C--N 1.312 -1.064 0 N-CA-C 113.208 0.818 . . . . 2.74 113.208 -172.057 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A 1570 ' ' THR . . . . . . . . . . . . . 19.7 p -88.32 -17.56 30.37 Favored 'General case' 0 C--N 1.308 -1.222 0 CA-C-O 121.719 0.771 . . . . 1.96 111.191 -179.625 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A 1571 ' ' ARG . . . . . . . . . . . . . 67.9 mtm180 59.12 47.75 11.45 Favored 'General case' 0 CA--C 1.508 -0.67 0 C-N-CA 125.817 1.647 . . . . 3.95 112.253 175.272 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A 1572 ' ' ILE . . . . . . . . . . . . . 32.7 mm -112.0 120.28 61.98 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.26 0 N-CA-C 108.062 -1.088 . . . . 1.37 108.062 179.434 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A 1573 ' ' SER . . . . . . . . . . . . . 60.4 p -73.63 127.45 32.8 Favored 'General case' 0 C--N 1.309 -1.195 0 CA-C-N 115.857 -0.611 . . . . 1.08 111.092 -177.06 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A 1574 ' ' VAL . . . . . 0.479 ' HA ' ' HB2' ' A' 1606 ' ' TYR . 23.5 m -118.22 15.05 7.19 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.307 0 CA-C-O 121.936 0.874 . . . . 1.3 110.782 -179.339 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A 1575 ' ' GLY . . . . . . . . . . . . . . . -179.29 125.28 0.96 Allowed Glycine 0 N--CA 1.429 -1.775 0 CA-C-N 114.466 -1.243 . . . . 0.51 110.54 176.531 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A 1576 ' ' LYS . . . . . . . . . . . . . 55.2 tptt -85.68 156.4 20.68 Favored 'General case' 0 C--N 1.313 -0.981 0 N-CA-C 106.423 -1.695 . . . . 2.9 106.423 177.955 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A 1577 ' ' ALA . . . . . 0.442 ' C ' HD22 ' A' 1578 ' ' ASN . . . -55.88 115.28 2.29 Favored 'General case' 0 N--CA 1.468 0.465 0 CA-C-O 121.447 0.641 . . . . 0.83 110.586 179.738 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A 1578 ' ' ASN . . . . . 0.442 HD22 ' C ' ' A' 1577 ' ' ALA . 1.1 m-80 -125.11 169.72 11.91 Favored 'General case' 0 C--N 1.283 -2.285 0 N-CA-C 106.061 -1.829 . . . . 1.85 106.061 178.265 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A 1579 ' ' LYS . . . . . 0.559 ' HE3' ' HB3' ' A' 1553 ' ' CYS . 17.9 tptm -163.87 89.99 0.59 Allowed 'General case' 0 C--N 1.306 -1.283 0 C-N-CA 119.88 -0.728 . . . . 1.9 109.418 -176.956 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A 1580 ' ' ARG . . . . . . . . . . . . . 52.0 ttp180 -149.43 106.83 3.62 Favored 'General case' 0 C--N 1.297 -1.691 0 N-CA-C 108.811 -0.811 . . . . 3.63 108.811 -178.881 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A 1581 ' ' LEU . . . . . 0.742 HD23 ' HA ' ' A' 1516 ' ' CYS . 0.8 OUTLIER -73.17 133.26 44.0 Favored 'General case' 0 C--N 1.311 -1.098 0 N-CA-C 107.714 -1.217 . . . . 1.87 107.714 -179.494 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A 1582 ' ' ARG . . . . . . . . . . . . . 61.5 ttt180 -132.14 108.32 9.2 Favored 'General case' 0 C--N 1.303 -1.417 0 N-CA-C 109.876 -0.416 . . . . 3.97 109.876 178.634 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A 1583 ' ' TYR . . . . . . . . . . . . . 49.2 t80 -101.33 92.95 5.17 Favored 'General case' 0 C--N 1.307 -1.24 0 N-CA-C 108.896 -0.779 . . . . 1.41 108.896 177.676 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A 1584 ' ' VAL . . . . . . . . . . . . . 15.4 m -123.7 111.12 27.86 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.77 0 N-CA-C 113.14 0.793 . . . . 1.69 113.14 -176.113 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A 1585 ' ' ASP . . . . . . . . . . . . . 36.5 t70 56.33 53.62 8.59 Favored 'General case' 0 N--CA 1.478 0.973 0 CA-C-O 122.463 1.125 . . . . 2.06 111.194 176.041 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A 1586 ' ' GLN . . . . . . . . . . . . . 18.4 mp0 64.63 -1.63 0.76 Allowed 'General case' 0 C--N 1.324 -0.512 0 C-N-CA 125.743 1.617 . . . . 2.33 115.088 178.734 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A 1587 ' ' VAL . . . . . . . . . . . . . 12.7 p -107.84 120.94 60.07 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.887 0 CA-C-O 121.973 0.892 . . . . 0.78 109.459 175.978 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A 1588 ' ' LEU . . . . . 0.822 ' HB2' ' HB2' ' A' 1612 ' ' PHE . 2.5 mm? -79.2 137.99 37.65 Favored 'General case' 0 C--N 1.29 -1.983 0 CA-C-N 114.339 -1.3 . . . . 1.41 108.357 179.053 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A 1589 ' ' GLN . . . . . 0.437 ' HA ' ' O ' ' A' 1610 ' ' ILE . 6.0 tt0 -140.43 141.08 35.52 Favored 'General case' 0 C--N 1.286 -2.175 0 CA-C-O 120.75 0.309 . . . . 1.24 111.254 -178.017 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A 1590 ' ' LEU . . . . . . . . . . . . . 7.0 tt -142.48 124.59 15.37 Favored 'General case' 0 C--N 1.305 -1.359 0 N-CA-C 105.957 -1.868 . . . . 1.15 105.957 175.633 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A 1591 ' ' VAL . . . . . . . . . . . . . 46.4 t -112.48 129.7 67.56 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.067 0 O-C-N 122.381 -0.199 . . . . 1.51 111.508 -175.379 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A 1592 ' ' TYR . . . . . . . . . . . . . 79.4 m-85 -105.3 106.67 17.28 Favored 'General case' 0 C--N 1.313 -0.992 0 N-CA-C 108.8 -0.815 . . . . 1.06 108.8 174.647 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A 1593 ' ' LYS . . . . . . . . . . . . . 8.1 ptpp? -108.67 -178.99 3.74 Favored 'General case' 0 C--N 1.311 -1.066 0 C-N-CA 120.31 -0.556 . . . . 2.18 112.119 -179.067 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A 1594 ' ' ASP . . . . . . . . . . . . . 5.0 m-20 54.13 44.88 28.54 Favored 'General case' 0 N--CA 1.487 1.376 0 C-N-CA 124.798 1.239 . . . . 1.45 113.831 177.67 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A 1595 ' ' GLY . . . . . . . . . . . . . . . -73.2 -90.54 0.13 Allowed Glycine 0 N--CA 1.445 -0.72 0 C-N-CA 120.45 -0.881 . . . . 0.78 111.522 177.176 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A 1596 ' ' SER . . . . . . . . . . . . . 33.7 t -114.49 149.46 42.23 Favored Pre-proline 0 C--N 1.297 -1.691 0 N-CA-C 107.101 -1.444 . . . . 1.68 107.101 176.977 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A 1597 ' ' PRO . . . . . . . . . . . . . 33.7 Cg_exo -64.95 133.55 36.39 Favored 'Trans proline' 0 C--N 1.347 0.493 0 C-N-CA 123.074 2.516 . . . . 1.17 110.911 176.999 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A 1598 ' ' CYS . . . . . 0.439 ' HA ' ' HD3' ' A' 1599 ' ' PRO . 37.6 t -95.65 126.89 43.62 Favored Pre-proline 0 C--N 1.3 -1.553 0 N-CA-C 108.12 -1.067 . . . . 1.19 108.12 -179.13 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A 1599 ' ' PRO . . . . . 0.439 ' HD3' ' HA ' ' A' 1598 ' ' CYS . 25.6 Cg_exo -65.61 -25.52 54.59 Favored 'Trans proline' 0 C--N 1.353 0.784 0 C-N-CA 123.472 2.781 . . . . 1.59 112.113 -178.476 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A 1600 ' ' SER . . . . . . . . . . . . . 23.0 m -86.17 123.51 31.53 Favored 'General case' 0 N--CA 1.421 -1.883 0 N-CA-C 108.367 -0.975 . . . . 2.12 108.367 177.338 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A 1601 ' ' LYS . . . . . 0.845 ' HB3' HD12 ' A' 1604 ' ' LEU . 4.3 tmtm? 68.49 81.58 0.18 Allowed 'General case' 0 C--O 1.239 0.523 0 N-CA-C 107.747 -1.205 . . . . 3.74 107.747 -179.678 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A 1602 ' ' SER . . . . . . . . . . . . . 20.9 m -50.82 111.45 0.55 Allowed 'General case' 0 N--CA 1.441 -0.915 0 CA-C-N 114.025 -1.443 . . . . 3.79 112.651 -176.695 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A 1603 ' ' GLY . . . . . . . . . . . . . . . 128.78 -19.04 5.59 Favored Glycine 0 N--CA 1.433 -1.524 0 CA-C-N 114.747 -1.115 . . . . 2.0 110.315 -177.929 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A 1604 ' ' LEU . . . . . 0.845 HD12 ' HB3' ' A' 1601 ' ' LYS . 12.6 mt -74.91 159.35 31.95 Favored 'General case' 0 CA--C 1.506 -0.732 0 CA-C-O 122.69 1.233 . . . . 1.48 114.291 -179.99 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A 1605 ' ' SER . . . . . . . . . . . . . 16.6 m -137.19 175.8 9.29 Favored 'General case' 0 C--N 1.288 -2.077 0 N-CA-C 104.897 -2.26 . . . . 1.51 104.897 177.217 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A 1606 ' ' TYR . . . . . 0.479 ' HB2' ' HA ' ' A' 1574 ' ' VAL . 56.9 m-85 -102.54 134.58 45.64 Favored 'General case' 0 CA--C 1.462 -2.406 0 N-CA-C 105.249 -2.13 . . . . 1.18 105.249 -179.292 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A 1607 ' ' LYS . . . . . 0.515 ' HG3' HG23 ' A' 1635 ' ' THR . 26.6 pttm -131.18 142.79 50.25 Favored 'General case' 0 N--CA 1.401 -2.889 0 C-N-CA 119.338 -0.945 . . . . 1.67 108.9 177.8 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A 1608 ' ' SER . . . . . . . . . . . . . 44.3 m -114.59 118.76 34.62 Favored 'General case' 0 C--N 1.295 -1.796 0 CA-C-O 120.666 0.27 . . . . 1.0 110.96 -178.849 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A 1609 ' ' VAL . . . . . . . . . . . . . 69.3 t -94.62 115.6 33.85 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.76 0 N-CA-C 108.782 -0.822 . . . . 0.93 108.782 176.851 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A 1610 ' ' ILE . . . . . 0.437 ' O ' ' HA ' ' A' 1589 ' ' GLN . 17.6 mm -98.66 112.19 30.15 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.191 0 N-CA-C 108.77 -0.826 . . . . 0.78 108.77 179.189 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A 1611 ' ' SER . . . . . 0.504 ' O ' ' HA ' ' A' 1639 ' ' SER . 36.5 m -101.05 128.62 47.01 Favored 'General case' 0 C--N 1.304 -1.375 0 N-CA-C 109.518 -0.549 . . . . 1.29 109.518 177.005 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A 1612 ' ' PHE . . . . . 0.822 ' HB2' ' HB2' ' A' 1588 ' ' LEU . 97.9 m-85 -100.88 115.37 30.24 Favored 'General case' 0 C--N 1.292 -1.894 0 CA-C-O 121.003 0.43 . . . . 0.7 110.494 -179.429 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A 1613 ' ' VAL . . . . . . . . . . . . . 58.9 t -100.01 111.54 29.95 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.161 0 N-CA-C 108.486 -0.931 . . . . 0.75 108.486 -178.613 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A 1614 ' ' CYS . . . . . 0.498 ' HA ' ' O ' ' A' 1642 ' ' THR . 3.0 p -85.57 94.22 8.99 Favored 'General case' 0 C--N 1.301 -1.535 0 CA-C-O 121.715 0.769 . . . . 1.39 112.999 -178.605 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A 1615 ' ' ARG . . . . . 0.516 ' HD3' ' HD2' ' A' 1616 ' ' PRO . 19.7 tpp180 -138.2 113.48 8.89 Favored Pre-proline 0 N--CA 1.428 -1.539 0 CA-C-N 115.37 -0.832 . . . . 3.75 109.93 177.318 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A 1616 ' ' PRO . . . . . 0.516 ' HD2' ' HD3' ' A' 1615 ' ' ARG . 57.8 Cg_endo -71.34 53.69 1.72 Allowed 'Trans proline' 0 CA--C 1.548 1.223 0 C-N-CA 123.414 2.742 . . . . 1.32 112.495 176.488 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A 1617 ' ' GLU . . . . . . . . . . . . . 30.6 tt0 . . . . . 0 C--N 1.306 -1.312 0 N-CA-C 106.29 -1.744 . . . . 3.21 106.29 176.624 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A 1622 ' ' ASN . . . . . . . . . . . . . 28.1 t-20 . . . . . 0 C--O 1.242 0.665 0 N-CA-C 107.872 -1.158 . . . . 2.92 107.872 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A 1623 ' ' ARG . . . . . . . . . . . . . 5.7 ptm180 -121.82 146.69 46.56 Favored Pre-proline 0 C--N 1.281 -2.385 0 N-CA-C 109.083 -0.71 . . . . 3.61 109.083 -177.228 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A 1624 ' ' PRO . . . . . . . . . . . . . 11.0 Cg_endo -55.25 117.52 4.12 Favored 'Trans proline' 0 C--N 1.348 0.551 0 C-N-CA 123.192 2.595 . . . . 2.37 111.621 178.536 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A 1625 ' ' MET . . . . . . . . . . . . . 26.5 ptm -96.79 143.16 27.98 Favored 'General case' 0 C--N 1.296 -1.748 0 CA-C-N 115.49 -0.777 . . . . 2.16 109.603 -178.573 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A 1626 ' ' LEU . . . . . . . . . . . . . 38.5 tp -80.48 123.07 27.76 Favored 'General case' 0 C--N 1.303 -1.425 0 N-CA-C 107.396 -1.335 . . . . 1.35 107.396 176.192 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A 1627 ' ' ILE . . . . . . . . . . . . . 41.4 pt -100.98 -32.43 3.42 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.548 0 C-N-CA 120.252 -0.579 . . . . 1.21 111.116 -179.907 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A 1628 ' ' SER . . . . . . . . . . . . . 20.4 m -152.64 148.71 27.63 Favored 'General case' 0 C--N 1.318 -0.802 0 N-CA-C 109.696 -0.483 . . . . 1.4 109.696 -178.099 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A 1629 ' ' LEU . . . . . . . . . . . . . 25.8 tp -136.1 99.65 4.19 Favored 'General case' 0 C--N 1.304 -1.407 0 N-CA-C 109.132 -0.692 . . . . 1.56 109.132 178.581 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A 1630 ' ' ASP . . . . . . . . . . . . . 11.8 t70 -90.95 107.85 19.47 Favored 'General case' 0 C--N 1.305 -1.331 0 N-CA-C 108.628 -0.879 . . . . 0.87 108.628 -178.1 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A 1631 ' ' LYS . . . . . . . . . . . . . 68.2 mttm -81.44 -15.15 55.96 Favored 'General case' 0 C--N 1.304 -1.381 0 N-CA-C 112.386 0.513 . . . . 2.35 112.386 -175.448 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A 1632 ' ' GLN . . . . . . . . . . . . . 1.5 mp0 -84.98 -40.74 16.57 Favored 'General case' 0 C--N 1.313 -1.005 0 CA-C-O 120.937 0.399 . . . . 2.55 110.58 -178.771 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A 1633 ' ' THR . . . . . . . . . . . . . 2.7 m -95.95 -4.15 43.88 Favored 'General case' 0 C--N 1.301 -1.511 0 CA-C-O 121.55 0.691 . . . . 1.24 110.278 -178.873 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A 1634 ' ' CYS . . . . . . . . . . . . . 56.6 m 59.47 41.41 19.35 Favored 'General case' 0 C--N 1.35 0.59 0 C-N-CA 124.105 0.962 . . . . 0.89 110.081 176.923 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A 1635 ' ' THR . . . . . 0.515 HG23 ' HG3' ' A' 1607 ' ' LYS . 33.4 m -112.83 132.61 55.2 Favored 'General case' 0 N--CA 1.431 -1.408 0 CA-C-N 115.179 -0.919 . . . . 0.75 111.467 -174.223 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A 1636 ' ' LEU . . . . . 0.415 ' HB3' ' CE2' ' A' 1638 ' ' PHE . 2.4 mm? -100.95 127.71 47.32 Favored 'General case' 0 C--N 1.316 -0.877 0 N-CA-C 108.561 -0.904 . . . . 1.33 108.561 -179.489 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A 1637 ' ' PHE . . . . . . . . . . . . . 97.6 m-85 -115.94 111.28 20.17 Favored 'General case' 0 C--N 1.305 -1.34 0 N-CA-C 109.931 -0.396 . . . . 0.83 109.931 179.38 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A 1638 ' ' PHE . . . . . 0.415 ' CE2' ' HB3' ' A' 1636 ' ' LEU . 87.8 m-85 -118.81 154.42 32.89 Favored 'General case' 0 C--N 1.309 -1.16 0 CA-C-O 121.191 0.52 . . . . 0.6 110.703 -179.094 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A 1639 ' ' SER . . . . . 0.504 ' HA ' ' O ' ' A' 1611 ' ' SER . 46.8 m -141.51 136.91 31.66 Favored 'General case' 0 C--N 1.294 -1.841 0 CA-C-N 116.171 -0.468 . . . . 1.08 110.46 176.827 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A 1640 ' ' TRP . . . . . . . . . . . . . 22.0 t90 -113.32 132.27 55.63 Favored 'General case' 0 C--N 1.298 -1.635 0 N-CA-C 107.924 -1.139 . . . . 0.8 107.924 178.066 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A 1641 ' ' HIS . . . . . . . . . . . . . 11.8 m170 -96.93 110.28 22.84 Favored 'General case' 0 CA--C 1.493 -1.22 0 N-CA-C 107.129 -1.434 . . . . 2.54 107.129 179.424 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A 1642 ' ' THR . . . . . 0.708 HG23 ' HB2' ' A' 1645 ' ' ALA . 2.9 t -142.92 137.95 15.46 Favored Pre-proline 0 C--N 1.283 -2.309 0 CA-C-N 115.989 -0.551 . . . . 1.15 111.69 -170.604 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A 1643 ' ' PRO . . . . . . . . . . . . . 95.8 Cg_endo -83.31 -0.39 9.86 Favored 'Trans proline' 0 CA--C 1.535 0.527 0 C-N-CA 123.35 2.7 . . . . 0.8 111.655 178.455 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A 1644 ' ' LEU . . . . . . . . . . . . . 47.4 mt -98.33 1.64 47.24 Favored 'General case' 0 C--N 1.315 -0.894 0 CA-C-N 115.765 -0.652 . . . . 1.54 110.9 179.624 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A 1645 ' ' ALA . . . . . 0.708 ' HB2' HG23 ' A' 1642 ' ' THR . . . -91.8 -18.18 24.24 Favored 'General case' 0 C--N 1.301 -1.537 0 CA-C-N 115.756 -0.656 . . . . 0.95 111.612 -176.274 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A 1646 ' ' CYS . . . . . 0.513 ' HA ' ' CE2' ' A' 1527 ' ' PHE . 72.0 m -154.25 174.26 15.03 Favored 'General case' 0 C--N 1.313 -0.991 0 N-CA-C 105.267 -2.123 . . . . 1.41 105.267 175.452 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A 1647 ' ' GLU . . . . . 0.404 ' H ' ' CD ' ' A' 1647 ' ' GLU . 0.5 OUTLIER . . . . . 0 C--N 1.298 -1.658 0 N-CA-C 109.526 -0.546 . . . . 2.92 109.526 175.819 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A 1515 ' ' ASP . . . . . 0.455 ' HB2' ' NE2' ' A' 1517 ' ' GLN . 8.8 m-20 . . . . . 0 CA--C 1.494 -1.175 0 N-CA-C 108.447 -0.945 . . . . 2.54 108.447 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A 1516 ' ' CYS . . . . . 0.542 ' HB3' ' HB2' ' A' 1529 ' ' LEU . 74.4 m -79.01 60.34 2.9 Favored 'General case' 0 C--N 1.306 -1.299 0 CA-C-O 120.981 0.42 . . . . 1.25 112.069 -176.895 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A 1517 ' ' GLN . . . . . 0.533 ' HB2' HD21 ' A' 1526 ' ' LEU . 0.4 OUTLIER -157.29 122.6 4.58 Favored 'General case' 0 N--CA 1.437 -1.105 0 CA-C-O 121.618 0.723 . . . . 1.88 111.885 177.754 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A 1518 ' ' VAL . . . . . . . . . . . . . 10.6 p -129.6 142.32 44.22 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.683 0 CA-C-N 115.454 -0.794 . . . . 1.73 109.657 -177.736 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A 1519 ' ' THR . . . . . 0.571 ' HA ' ' HA ' ' A' 1526 ' ' LEU . 12.7 m -100.74 135.94 41.39 Favored 'General case' 0 C--N 1.3 -1.549 0 CA-C-O 120.67 0.271 . . . . 1.7 110.83 -178.025 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A 1520 ' ' ASN . . . . . 0.482 ' OD1' HG22 ' A' 1523 ' ' THR . 17.1 t-20 -86.61 113.8 54.67 Favored Pre-proline 0 C--N 1.308 -1.226 0 N-CA-C 106.915 -1.513 . . . . 2.12 106.915 171.399 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A 1521 ' ' PRO . . . . . . . . . . . . . 51.9 Cg_endo -67.88 -21.52 43.91 Favored 'Trans proline' 0 C--O 1.234 0.276 0 C-N-CA 122.232 1.955 . . . . 2.47 113.512 -174.164 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A 1522 ' ' SER . . . . . . . . . . . . . 13.1 m -68.48 -54.88 14.01 Favored 'General case' 0 N--CA 1.438 -1.047 0 C-N-CA 122.265 0.226 . . . . 2.57 111.02 -178.715 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A 1523 ' ' THR . . . . . 0.52 HG21 ' HB2' ' A' 1647 ' ' GLU . 15.0 t -94.94 -15.74 23.36 Favored 'General case' 0 CA--C 1.554 1.11 0 CA-C-O 121.097 0.475 . . . . 2.15 111.483 -177.949 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A 1524 ' ' GLY . . . . . . . . . . . . . . . 81.17 17.38 72.01 Favored Glycine 0 C--N 1.334 0.434 0 C-N-CA 121.139 -0.553 . . . . 1.89 112.984 178.89 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A 1525 ' ' HIS . . . . . . . . . . . . . 18.4 t60 -101.25 137.48 39.54 Favored 'General case' 0 C--N 1.313 -0.982 0 N-CA-C 109.556 -0.535 . . . . 1.9 109.556 -177.279 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A 1526 ' ' LEU . . . . . 0.571 ' HA ' ' HA ' ' A' 1519 ' ' THR . 6.1 tt -99.94 132.39 45.32 Favored 'General case' 0 C--N 1.3 -1.548 0 N-CA-C 109.36 -0.608 . . . . 1.61 109.36 178.712 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A 1527 ' ' PHE . . . . . 0.446 ' O ' ' HA ' ' A' 1517 ' ' GLN . 28.4 m-85 -99.84 104.87 16.57 Favored 'General case' 0 C--N 1.299 -1.611 0 N-CA-C 108.781 -0.822 . . . . 1.42 108.781 -178.952 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A 1528 ' ' ASP . . . . . 0.424 ' HA ' ' HB3' ' A' 1517 ' ' GLN . 35.6 t70 -95.01 124.66 39.18 Favored 'General case' 0 CA--C 1.495 -1.165 0 CA-C-O 121.473 0.654 . . . . 2.18 111.753 -179.749 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A 1529 ' ' LEU . . . . . 0.542 ' HB2' ' HB3' ' A' 1516 ' ' CYS . 80.1 mt -109.76 -3.0 17.02 Favored 'General case' 0 C--N 1.296 -1.735 0 CA-C-N 114.285 -1.325 . . . . 1.44 109.076 178.863 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A 1530 ' ' SER . . . . . . . . . . . . . 4.5 m -70.33 -38.8 74.95 Favored 'General case' 0 C--O 1.223 -0.315 0 CA-C-N 115.749 -0.66 . . . . 1.44 109.597 -179.306 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A 1531 ' ' SER . . . . . . . . . . . . . 24.2 m -63.81 -26.26 68.55 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 121.665 0.745 . . . . 1.5 109.878 177.113 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A 1532 ' ' LEU . . . . . 0.559 HD13 ' CZ3' ' A' 1640 ' ' TRP . 66.2 mt -83.51 -4.4 58.49 Favored 'General case' 0 C--N 1.317 -0.838 0 CA-C-N 115.254 -0.884 . . . . 1.77 111.506 -178.687 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A 1533 ' ' SER . . . . . 0.503 ' OG ' ' HB2' ' A' 1553 ' ' CYS . 10.2 m -87.28 151.89 22.75 Favored 'General case' 0 C--O 1.249 1.049 0 N-CA-C 108.419 -0.956 . . . . 2.38 108.419 179.115 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A 1534 ' ' GLY . . . . . . . . . . . . . . . -171.18 -160.13 18.96 Favored Glycine 0 N--CA 1.435 -1.431 0 C-N-CA 119.532 -1.318 . . . . 1.55 112.907 -179.666 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A 1535 ' ' ARG . . . . . 0.492 ' HG3' ' HB2' ' A' 1557 ' ' GLU . 38.3 ttm180 -75.53 -56.1 5.03 Favored 'General case' 0 C--N 1.307 -1.253 0 C-N-CA 123.989 0.916 . . . . 3.96 110.957 -179.132 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A 1536 ' ' ALA . . . . . . . . . . . . . . . -95.65 -29.68 14.18 Favored 'General case' 0 C--N 1.303 -1.452 0 CA-C-N 116.002 -0.545 . . . . 1.65 110.544 178.583 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A 1537 ' ' GLY . . . . . 0.442 ' HA3' ' HA ' ' A' 1551 ' ' SER . . . 85.02 -118.46 4.76 Favored Glycine 0 N--CA 1.431 -1.693 0 N-CA-C 110.343 -1.103 . . . . 1.19 110.343 -177.998 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A 1538 ' ' PHE . . . . . . . . . . . . . 69.1 m-85 -130.79 165.2 23.48 Favored 'General case' 0 C--N 1.308 -1.233 0 C-N-CA 123.085 0.554 . . . . 1.69 109.507 178.292 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A 1539 ' ' THR . . . . . . . . . . . . . 3.1 p -115.15 120.5 39.98 Favored 'General case' 0 C--N 1.311 -1.105 0 N-CA-C 113.16 0.8 . . . . 1.48 113.16 -174.76 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A 1540 ' ' ALA . . . . . . . . . . . . . . . -117.27 127.52 54.16 Favored 'General case' 0 C--N 1.312 -1.063 0 N-CA-C 108.251 -1.018 . . . . 0.83 108.251 173.886 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A 1541 ' ' ALA . . . . . . . . . . . . . . . -88.28 153.22 21.38 Favored 'General case' 0 C--N 1.31 -1.127 0 N-CA-C 110.03 -0.359 . . . . 1.27 110.03 -178.492 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A 1542 ' ' TYR . . . . . . . . . . . . . 52.9 t80 -157.42 175.31 14.15 Favored 'General case' 0 C--N 1.318 -0.79 0 N-CA-C 109.015 -0.735 . . . . 2.15 109.015 -178.416 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A 1543 ' ' SER . . . . . . . . . . . . . 14.1 m -46.62 -151.0 0.0 OUTLIER 'General case' 0 CA--C 1.57 1.725 0 C-N-CA 129.245 3.018 . . . . 2.29 114.306 177.572 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A 1544 ' ' LYS . . . . . . . . . . . . . 65.0 mttp -42.35 -23.06 0.03 OUTLIER 'General case' 0 CA--C 1.572 1.807 0 N-CA-C 115.47 1.656 . . . . 3.91 115.47 -178.574 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A 1545 ' ' SER . . . . . . . . . . . . . 32.4 m -71.62 -15.84 62.26 Favored 'General case' 0 CA--C 1.564 1.517 0 C-N-CA 123.295 0.638 . . . . 3.3 111.813 175.277 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A 1546 ' ' GLY . . . . . . . . . . . . . . . 84.04 -75.25 2.39 Favored Glycine 0 C--O 1.241 0.571 0 N-CA-C 114.298 0.479 . . . . 1.24 114.298 174.033 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A 1547 ' ' VAL . . . . . . . . . . . . . 11.7 p -156.32 148.01 11.62 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.853 0 N-CA-C 108.115 -1.069 . . . . 1.63 108.115 -175.872 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A 1548 ' ' VAL . . . . . . . . . . . . . 2.4 t -106.25 133.34 50.99 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.81 0 N-CA-C 108.327 -0.99 . . . . 0.92 108.327 -179.356 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A 1549 ' ' TYR . . . . . 0.535 ' HB3' HD21 ' A' 1556 ' ' ASN . 12.6 m-85 -100.39 117.32 34.32 Favored 'General case' 0 C--N 1.301 -1.524 0 N-CA-C 107.672 -1.233 . . . . 1.44 107.672 172.867 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A 1550 ' ' MET . . . . . . . . . . . . . 52.4 ttp -140.45 122.78 15.94 Favored 'General case' 0 C--N 1.292 -1.896 0 C-N-CA 120.515 -0.474 . . . . 1.74 111.021 -177.544 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A 1551 ' ' SER . . . . . 0.442 ' HA ' ' HA3' ' A' 1537 ' ' GLY . 33.9 t -93.98 137.75 32.85 Favored 'General case' 0 N--CA 1.43 -1.472 0 N-CA-C 104.999 -2.223 . . . . 1.64 104.999 173.483 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A 1552 ' ' ILE . . . . . . . . . . . . . 47.5 mm -63.26 -33.29 60.21 Favored 'Isoleucine or valine' 0 C--O 1.207 -1.158 0 CA-C-N 115.325 -0.852 . . . . 1.33 110.639 -175.856 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A 1553 ' ' CYS . . . . . 0.503 ' HB2' ' OG ' ' A' 1533 ' ' SER . 79.6 m -144.77 141.19 29.02 Favored 'General case' 0 C--O 1.252 1.236 0 N-CA-C 108.363 -0.977 . . . . 1.43 108.363 172.553 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A 1554 ' ' GLY . . . . . . . . . . . . . . . 99.99 -157.93 19.62 Favored Glycine 0 N--CA 1.427 -1.926 0 C-N-CA 120.805 -0.712 . . . . 1.12 112.701 174.196 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A 1555 ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 -103.31 147.97 26.43 Favored 'General case' 0 C--N 1.302 -1.469 0 CA-C-O 121.407 0.622 . . . . 1.8 111.549 -178.007 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A 1556 ' ' ASN . . . . . 0.535 HD21 ' HB3' ' A' 1549 ' ' TYR . 25.5 t-20 -95.7 123.44 39.27 Favored 'General case' 0 C--N 1.293 -1.863 0 CA-C-N 115.029 -0.987 . . . . 2.63 108.553 179.636 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A 1557 ' ' GLU . . . . . 0.492 ' HB2' ' HG3' ' A' 1535 ' ' ARG . 5.4 mt-10 -91.87 39.57 1.02 Allowed 'General case' 0 C--N 1.303 -1.419 0 N-CA-C 112.09 0.404 . . . . 3.79 112.09 -173.746 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A 1558 ' ' ASN . . . . . . . . . . . . . 32.1 m-80 -125.89 -0.52 7.28 Favored 'General case' 0 C--N 1.311 -1.083 0 CA-C-O 121.971 0.891 . . . . 1.52 109.764 178.931 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A 1559 ' ' CYS . . . . . 0.812 ' HB3' ' HD2' ' A' 1560 ' ' PRO . 84.0 m -144.24 -175.83 0.5 Allowed Pre-proline 0 C--N 1.295 -1.802 0 N-CA-C 106.263 -1.754 . . . . 0.84 106.263 -179.664 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A 1560 ' ' PRO . . . . . 0.812 ' HD2' ' HB3' ' A' 1559 ' ' CYS . 4.5 Cg_exo -41.96 123.28 2.39 Favored 'Trans proline' 0 C--N 1.379 2.176 0 C-N-CA 122.702 2.268 . . . . 1.18 112.959 175.658 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A 1561 ' ' PRO . . . . . 0.445 ' HD3' ' HA ' ' A' 1560 ' ' PRO . 31.6 Cg_exo -60.75 105.45 0.31 Allowed 'Trans proline' 0 C--O 1.244 0.805 0 C-N-CA 123.082 2.521 . . . . 1.51 110.793 -179.532 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A 1562 ' ' GLY . . . . . . . . . . . . . . . 141.68 -14.7 2.67 Favored Glycine 0 N--CA 1.431 -1.654 0 N-CA-C 111.25 -0.74 . . . . 0.72 111.25 -177.368 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A 1563 ' ' VAL . . . . . 0.632 ' HA ' ' HA ' ' A' 1576 ' ' LYS . 3.2 m -98.46 146.85 7.46 Favored 'Isoleucine or valine' 0 C--O 1.207 -1.181 0 N-CA-C 107.465 -1.309 . . . . 0.97 107.465 177.15 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A 1564 ' ' GLY . . . . . . . . . . . . . . . -105.67 -25.1 6.71 Favored Glycine 0 C--O 1.241 0.538 0 C-N-CA 120.611 -0.804 . . . . 0.72 113.539 -174.229 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A 1565 ' ' ALA . . . . . . . . . . . . . . . -134.91 128.72 33.11 Favored 'General case' 0 C--N 1.315 -0.91 0 N-CA-C 108.996 -0.742 . . . . 0.37 108.996 -179.988 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A 1566 ' ' CYS . . . . . . . . . . . . . 42.1 t -156.54 145.87 20.57 Favored 'General case' 0 C--N 1.307 -1.258 0 CA-C-N 116.671 -0.24 . . . . 0.51 110.538 -173.857 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A 1567 ' ' PHE . . . . . . . . . . . . . 24.7 m-85 -71.13 125.58 27.29 Favored 'General case' 0 C--O 1.207 -1.137 0 N-CA-C 107.387 -1.338 . . . . 0.97 107.387 175.018 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A 1568 ' ' GLY . . . . . . . . . . . . . . . -75.22 -24.93 69.86 Favored Glycine 0 C--N 1.307 -1.047 0 C-N-CA 120.801 -0.714 . . . . 1.08 114.027 -173.648 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A 1569 ' ' GLN . . . . . . . . . . . . . 65.5 tt0 -85.13 -53.03 5.53 Favored 'General case' 0 C--N 1.317 -0.814 0 C-N-CA 120.088 -0.645 . . . . 2.74 111.071 -179.757 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A 1570 ' ' THR . . . . . . . . . . . . . 22.8 p -84.19 -16.95 41.53 Favored 'General case' 0 C--N 1.312 -1.053 0 N-CA-C 112.852 0.686 . . . . 1.96 112.852 -176.696 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A 1571 ' ' ARG . . . . . . . . . . . . . 66.0 mtm180 60.78 41.87 14.17 Favored 'General case' 0 CA--C 1.508 -0.661 0 C-N-CA 125.382 1.473 . . . . 3.95 112.85 177.463 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A 1572 ' ' ILE . . . . . . . . . . . . . 36.9 mm -103.83 122.8 56.99 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.222 0 N-CA-C 107.404 -1.332 . . . . 1.37 107.404 178.134 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A 1573 ' ' SER . . . . . . . . . . . . . 71.5 p -78.43 121.94 25.17 Favored 'General case' 0 N--CA 1.436 -1.137 0 N-CA-C 113.129 0.788 . . . . 1.08 113.129 -176.46 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A 1574 ' ' VAL . . . . . . . . . . . . . 22.4 m -106.51 11.39 8.88 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.426 0 CA-C-O 121.875 0.845 . . . . 1.3 110.402 -177.126 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A 1575 ' ' GLY . . . . . . . . . . . . . . . -177.27 118.93 0.66 Allowed Glycine 0 N--CA 1.421 -2.333 0 CA-C-N 114.718 -1.128 . . . . 0.51 111.673 177.398 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A 1576 ' ' LYS . . . . . 0.632 ' HA ' ' HA ' ' A' 1563 ' ' VAL . 55.7 tttm -79.85 152.17 29.83 Favored 'General case' 0 C--N 1.306 -1.315 0 N-CA-C 105.799 -1.926 . . . . 2.9 105.799 174.888 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A 1577 ' ' ALA . . . . . . . . . . . . . . . -56.22 102.33 0.07 Allowed 'General case' 0 N--CA 1.468 0.434 0 O-C-N 123.983 0.802 . . . . 0.83 110.277 -178.537 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A 1578 ' ' ASN . . . . . 0.592 ' HB3' ' HA ' ' A' 1592 ' ' TYR . 8.0 t30 -135.61 130.22 34.07 Favored 'General case' 0 C--N 1.29 -2.001 0 N-CA-C 105.683 -1.969 . . . . 1.85 105.683 -179.094 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A 1579 ' ' LYS . . . . . 0.411 ' HB3' ' HE2' ' A' 1579 ' ' LYS . 36.9 ttpt -115.54 90.24 3.29 Favored 'General case' 0 C--N 1.269 -2.926 0 CA-C-O 121.631 0.729 . . . . 1.9 109.211 -173.507 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A 1580 ' ' ARG . . . . . 0.556 ' O ' ' HA ' ' A' 1590 ' ' LEU . 44.3 ttm180 -109.93 109.59 20.25 Favored 'General case' 0 C--N 1.286 -2.163 0 N-CA-C 107.902 -1.147 . . . . 3.63 107.902 177.332 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A 1581 ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -100.21 138.38 37.35 Favored 'General case' 0 C--N 1.298 -1.665 0 N-CA-C 106.273 -1.751 . . . . 1.87 106.273 -177.682 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A 1582 ' ' ARG . . . . . 0.42 ' HB3' ' HB3' ' A' 1589 ' ' GLN . 38.5 ttm180 -144.66 128.46 17.31 Favored 'General case' 0 C--N 1.305 -1.36 0 CA-C-O 121.137 0.494 . . . . 3.97 111.043 178.958 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A 1583 ' ' TYR . . . . . 0.458 ' HD1' ' CD2' ' A' 1588 ' ' LEU . 84.9 t80 -117.9 105.02 11.49 Favored 'General case' 0 C--N 1.297 -1.702 0 N-CA-C 105.946 -1.872 . . . . 1.41 105.946 176.996 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A 1584 ' ' VAL . . . . . . . . . . . . . 6.6 p -136.79 97.77 1.59 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.343 0 C-N-CA 119.594 -0.842 . . . . 1.69 112.501 -177.058 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A 1585 ' ' ASP . . . . . . . . . . . . . 35.7 t70 56.87 69.07 0.78 Allowed 'General case' 0 N--CA 1.476 0.874 0 C-N-CA 124.188 0.995 . . . . 2.06 111.814 178.211 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A 1586 ' ' GLN . . . . . . . . . . . . . 53.3 mt-30 52.51 25.5 3.64 Favored 'General case' 0 N--CA 1.478 0.945 0 N-CA-C 114.767 1.395 . . . . 2.33 114.767 178.657 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A 1587 ' ' VAL . . . . . 0.414 HG23 ' O ' ' A' 1612 ' ' PHE . 11.5 p -139.52 122.29 17.47 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.772 0 N-CA-C 108.571 -0.9 . . . . 0.78 108.571 173.352 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A 1588 ' ' LEU . . . . . 0.579 ' HB2' ' HB2' ' A' 1612 ' ' PHE . 18.5 mt -89.09 158.28 18.02 Favored 'General case' 0 C--N 1.3 -1.556 0 CA-C-N 115.284 -0.871 . . . . 1.41 109.963 -178.493 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A 1589 ' ' GLN . . . . . 0.42 ' HB3' ' HB3' ' A' 1582 ' ' ARG . 6.8 tt0 -146.46 136.99 23.97 Favored 'General case' 0 C--N 1.292 -1.935 0 N-CA-C 108.667 -0.864 . . . . 1.24 108.667 176.918 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A 1590 ' ' LEU . . . . . 0.556 ' HA ' ' O ' ' A' 1580 ' ' ARG . 6.1 tt -133.04 135.45 45.38 Favored 'General case' 0 C--N 1.302 -1.47 0 N-CA-C 106.443 -1.688 . . . . 1.15 106.443 176.927 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A 1591 ' ' VAL . . . . . 0.424 HG22 HG22 ' A' 1609 ' ' VAL . 57.9 t -130.3 134.58 62.29 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.76 0 N-CA-C 112.761 0.652 . . . . 1.51 112.761 -171.769 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A 1592 ' ' TYR . . . . . 0.592 ' HA ' ' HB3' ' A' 1578 ' ' ASN . 67.3 m-85 -111.09 152.01 27.43 Favored 'General case' 0 C--N 1.318 -0.802 0 N-CA-C 107.405 -1.331 . . . . 1.06 107.405 171.53 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A 1593 ' ' LYS . . . . . . . . . . . . . 21.2 pttp -152.48 -177.16 6.05 Favored 'General case' 0 C--N 1.301 -1.539 0 N-CA-C 109.753 -0.462 . . . . 2.18 109.753 -178.767 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A 1594 ' ' ASP . . . . . . . . . . . . . 1.7 m-20 53.36 41.83 32.09 Favored 'General case' 0 N--CA 1.485 1.291 0 N-CA-C 115.238 1.57 . . . . 1.45 115.238 173.614 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A 1595 ' ' GLY . . . . . . . . . . . . . . . -82.65 -121.78 0.7 Allowed Glycine 0 N--CA 1.435 -1.429 0 C-N-CA 119.816 -1.183 . . . . 0.78 110.816 175.696 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A 1596 ' ' SER . . . . . . . . . . . . . 49.0 m -83.44 153.0 65.1 Favored Pre-proline 0 C--N 1.284 -2.282 0 N-CA-C 109.934 -0.395 . . . . 1.68 109.934 -179.606 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A 1597 ' ' PRO . . . . . . . . . . . . . 33.2 Cg_exo -63.67 139.33 68.9 Favored 'Trans proline' 0 C--O 1.253 1.243 0 C-N-CA 122.689 2.26 . . . . 1.17 109.723 172.369 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A 1598 ' ' CYS . . . . . . . . . . . . . 34.8 t -95.05 130.16 33.5 Favored Pre-proline 0 C--N 1.287 -2.139 0 N-CA-C 108.97 -0.752 . . . . 1.19 108.97 -177.318 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A 1599 ' ' PRO . . . . . 0.485 ' HD2' ' OH ' ' A' 1606 ' ' TYR . 89.2 Cg_endo -82.33 4.57 6.97 Favored 'Trans proline' 0 CA--C 1.536 0.577 0 C-N-CA 122.879 2.386 . . . . 1.59 112.697 179.319 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A 1600 ' ' SER . . . . . . . . . . . . . 15.9 m -107.81 123.0 47.91 Favored 'General case' 0 N--CA 1.431 -1.388 0 N-CA-C 109.957 -0.386 . . . . 2.12 109.957 -177.468 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A 1601 ' ' LYS . . . . . 0.543 ' HD3' ' HA ' ' A' 1632 ' ' GLN . 26.5 mtpp 66.02 -97.93 0.05 Allowed 'General case' 0 N--CA 1.454 -0.27 0 N-CA-C 114.565 1.32 . . . . 3.74 114.565 -179.372 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A 1602 ' ' SER . . . . . 0.441 ' HB3' ' HG ' ' A' 1604 ' ' LEU . 10.4 t -97.59 153.61 18.08 Favored 'General case' 0 C--N 1.301 -1.505 0 N-CA-C 109.202 -0.666 . . . . 3.79 109.202 -178.247 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A 1603 ' ' GLY . . . . . . . . . . . . . . . -80.63 56.87 4.76 Favored Glycine 0 N--CA 1.447 -0.622 0 N-CA-C 110.835 -0.906 . . . . 2.0 110.835 177.625 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A 1604 ' ' LEU . . . . . 0.441 ' HG ' ' HB3' ' A' 1602 ' ' SER . 0.7 OUTLIER -99.28 -172.01 2.19 Favored 'General case' 0 C--N 1.307 -1.259 0 C-N-CA 123.817 0.847 . . . . 1.48 110.633 -179.69 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A 1605 ' ' SER . . . . . . . . . . . . . 8.7 m -97.78 -178.72 4.2 Favored 'General case' 0 C--N 1.301 -1.543 0 CA-C-N 118.206 0.457 . . . . 1.51 110.102 -176.749 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A 1606 ' ' TYR . . . . . 0.485 ' OH ' ' HD2' ' A' 1599 ' ' PRO . 68.2 m-85 -106.39 137.69 43.92 Favored 'General case' 0 N--CA 1.417 -2.091 0 N-CA-C 104.424 -2.436 . . . . 1.18 104.424 174.902 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A 1607 ' ' LYS . . . . . 0.541 ' HG3' HG23 ' A' 1635 ' ' THR . 21.9 ptmt -130.05 142.7 50.58 Favored 'General case' 0 C--N 1.282 -2.35 0 C-N-CA 119.955 -0.698 . . . . 1.67 109.216 179.383 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A 1608 ' ' SER . . . . . . . . . . . . . 46.7 m -119.0 126.84 52.67 Favored 'General case' 0 C--N 1.3 -1.553 0 CA-C-O 120.413 0.149 . . . . 1.0 110.653 -176.806 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A 1609 ' ' VAL . . . . . 0.424 HG22 HG22 ' A' 1591 ' ' VAL . 74.2 t -116.2 124.45 72.48 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.839 0 N-CA-C 109.321 -0.622 . . . . 0.93 109.321 178.205 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A 1610 ' ' ILE . . . . . 0.827 HG13 ' HB2' ' A' 1638 ' ' PHE . 3.0 mp -108.07 120.06 58.76 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.966 0 N-CA-C 109.072 -0.714 . . . . 0.78 109.072 176.68 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A 1611 ' ' SER . . . . . . . . . . . . . 24.2 p -94.89 123.63 38.47 Favored 'General case' 0 N--CA 1.432 -1.372 0 N-CA-C 109.049 -0.723 . . . . 1.29 109.049 175.317 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A 1612 ' ' PHE . . . . . 0.579 ' HB2' ' HB2' ' A' 1588 ' ' LEU . 93.0 m-85 -97.11 108.89 21.71 Favored 'General case' 0 C--N 1.298 -1.638 0 CA-C-O 121.123 0.487 . . . . 0.7 110.657 -177.914 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A 1613 ' ' VAL . . . . . 0.45 ' O ' ' HA ' ' A' 1641 ' ' HIS . 49.0 t -103.72 120.74 54.26 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.531 0 N-CA-C 109.246 -0.65 . . . . 0.75 109.246 -178.154 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A 1614 ' ' CYS . . . . . 0.59 ' HA ' ' O ' ' A' 1642 ' ' THR . 0.8 OUTLIER -77.7 93.94 4.35 Favored 'General case' 0 C--N 1.302 -1.476 0 N-CA-C 114.201 1.185 . . . . 1.39 114.201 -179.15 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A 1615 ' ' ARG . . . . . . . . . . . . . 71.8 ttt180 -115.74 107.05 49.13 Favored Pre-proline 0 C--N 1.312 -1.063 0 N-CA-C 108.163 -1.051 . . . . 3.75 108.163 175.755 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A 1616 ' ' PRO . . . . . . . . . . . . . 27.0 Cg_endo -63.95 -38.1 39.94 Favored 'Trans proline' 0 CA--C 1.531 0.328 0 C-N-CA 122.753 2.302 . . . . 1.32 112.191 -179.922 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A 1617 ' ' GLU . . . . . . . . . . . . . 20.4 mm-40 . . . . . 0 C--N 1.312 -1.028 0 CA-C-N 115.976 -0.556 . . . . 3.21 110.937 -179.153 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A 1622 ' ' ASN . . . . . 0.5 ' HA ' ' O ' ' A' 1641 ' ' HIS . 48.8 t-20 . . . . . 0 C--O 1.243 0.722 0 N-CA-C 106.941 -1.503 . . . . 2.92 106.941 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A 1623 ' ' ARG . . . . . . . . . . . . . 16.5 ptm180 -149.71 150.26 30.2 Favored Pre-proline 0 C--N 1.308 -1.236 0 N-CA-C 107.677 -1.231 . . . . 3.61 107.677 -176.606 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A 1624 ' ' PRO . . . . . . . . . . . . . 11.9 Cg_exo -71.63 94.81 0.69 Allowed 'Trans proline' 0 N--CA 1.456 -0.691 0 C-N-CA 122.148 1.899 . . . . 2.37 109.104 175.909 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A 1625 ' ' MET . . . . . . . . . . . . . 57.7 ttp -101.64 141.41 34.54 Favored 'General case' 0 C--N 1.299 -1.588 0 CA-C-N 115.662 -0.699 . . . . 2.16 109.779 -175.17 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A 1626 ' ' LEU . . . . . . . . . . . . . 56.2 tp -80.61 110.7 16.34 Favored 'General case' 0 C--N 1.313 -1.005 0 N-CA-C 108.446 -0.946 . . . . 1.35 108.446 178.334 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A 1627 ' ' ILE . . . . . . . . . . . . . 26.5 pt -88.16 -41.76 14.48 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.919 0 C-N-CA 120.339 -0.545 . . . . 1.21 112.196 -177.893 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A 1628 ' ' SER . . . . . . . . . . . . . 26.7 t -147.21 148.45 31.52 Favored 'General case' 0 N--CA 1.434 -1.242 0 N-CA-C 109.933 -0.395 . . . . 1.4 109.933 -175.489 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A 1629 ' ' LEU . . . . . 0.644 ' HG ' HD13 ' A' 1636 ' ' LEU . 5.1 tt -125.51 112.13 15.87 Favored 'General case' 0 C--N 1.304 -1.411 0 N-CA-C 106.496 -1.668 . . . . 1.56 106.496 176.798 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A 1630 ' ' ASP . . . . . 0.436 ' HB2' ' HE2' ' A' 1637 ' ' PHE . 19.5 t70 -83.22 117.46 22.95 Favored 'General case' 0 C--N 1.303 -1.444 0 N-CA-C 108.479 -0.934 . . . . 0.87 108.479 177.704 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A 1631 ' ' LYS . . . . . . . . . . . . . 98.3 mttt -92.26 -7.18 48.83 Favored 'General case' 0 C--N 1.29 -2.021 0 CA-C-N 115.932 -0.576 . . . . 2.35 111.179 -174.948 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A 1632 ' ' GLN . . . . . 0.543 ' HA ' ' HD3' ' A' 1601 ' ' LYS . 36.5 mt-30 -80.25 -47.52 14.47 Favored 'General case' 0 C--N 1.317 -0.817 0 CA-C-O 121.456 0.646 . . . . 2.55 110.295 -177.338 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A 1633 ' ' THR . . . . . . . . . . . . . 41.0 p -107.25 -1.34 21.87 Favored 'General case' 0 C--N 1.298 -1.66 0 CA-C-N 116.034 -0.53 . . . . 1.24 111.306 179.858 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A 1634 ' ' CYS . . . . . . . . . . . . . 60.3 m 64.62 52.05 1.81 Allowed 'General case' 0 N--CA 1.472 0.644 0 CA-C-O 122.171 0.986 . . . . 0.89 110.538 -179.682 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A 1635 ' ' THR . . . . . 0.541 HG23 ' HG3' ' A' 1607 ' ' LYS . 32.1 m -114.16 126.65 55.31 Favored 'General case' 0 N--CA 1.431 -1.381 0 CA-C-N 114.567 -1.197 . . . . 0.75 110.186 -175.485 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A 1636 ' ' LEU . . . . . 0.644 HD13 ' HG ' ' A' 1629 ' ' LEU . 2.1 mm? -95.45 132.99 39.93 Favored 'General case' 0 C--N 1.308 -1.205 0 N-CA-C 108.971 -0.751 . . . . 1.33 108.971 -179.423 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A 1637 ' ' PHE . . . . . 0.436 ' HE2' ' HB2' ' A' 1630 ' ' ASP . 99.8 m-85 -116.42 106.38 13.55 Favored 'General case' 0 C--O 1.247 0.969 0 CA-C-O 121.21 0.528 . . . . 0.83 110.702 179.555 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A 1638 ' ' PHE . . . . . 0.827 ' HB2' HG13 ' A' 1610 ' ' ILE . 99.0 m-85 -103.77 149.52 24.94 Favored 'General case' 0 C--N 1.301 -1.533 0 N-CA-C 108.619 -0.882 . . . . 0.6 108.619 178.684 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A 1639 ' ' SER . . . . . . . . . . . . . 33.6 t -135.59 132.11 36.73 Favored 'General case' 0 C--N 1.285 -2.229 0 N-CA-C 109.216 -0.661 . . . . 1.08 109.216 179.496 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A 1640 ' ' TRP . . . . . 0.559 ' CZ3' HD13 ' A' 1532 ' ' LEU . 7.2 t90 -120.82 118.96 31.33 Favored 'General case' 0 N--CA 1.423 -1.806 0 N-CA-C 107.472 -1.307 . . . . 0.8 107.472 177.642 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A 1641 ' ' HIS . . . . . 0.5 ' O ' ' HA ' ' A' 1622 ' ' ASN . 31.7 m-70 -96.96 103.46 15.39 Favored 'General case' 0 C--N 1.294 -1.812 0 N-CA-C 106.734 -1.58 . . . . 2.54 106.734 177.354 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A 1642 ' ' THR . . . . . 0.59 ' O ' ' HA ' ' A' 1614 ' ' CYS . 8.9 t -142.24 139.54 17.95 Favored Pre-proline 0 C--N 1.303 -1.45 0 CA-C-N 115.7 -0.682 . . . . 1.15 111.807 -170.536 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A 1643 ' ' PRO . . . . . 0.402 ' HD3' ' HA ' ' A' 1642 ' ' THR . 4.3 Cg_exo -74.84 -3.64 14.21 Favored 'Trans proline' 0 N--CA 1.456 -0.718 0 C-N-CA 123.499 2.8 . . . . 0.8 111.639 175.573 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A 1644 ' ' LEU . . . . . . . . . . . . . 83.4 mt -82.03 -8.62 59.67 Favored 'General case' 0 C--N 1.315 -0.929 0 CA-C-N 116.447 -0.342 . . . . 1.54 110.635 177.282 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A 1645 ' ' ALA . . . . . . . . . . . . . . . -88.31 -21.0 24.65 Favored 'General case' 0 C--N 1.32 -0.713 0 N-CA-C 113.092 0.775 . . . . 0.95 113.092 -176.196 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A 1646 ' ' CYS . . . . . . . . . . . . . 61.1 m -155.15 172.45 18.12 Favored 'General case' 0 N--CA 1.475 0.781 0 N-CA-C 107.243 -1.391 . . . . 1.41 107.243 -179.761 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A 1647 ' ' GLU . . . . . 0.52 ' HB2' HG21 ' A' 1523 ' ' THR . 37.7 mm-40 . . . . . 0 C--N 1.309 -1.179 0 N-CA-C 109.815 -0.439 . . . . 2.92 109.815 174.694 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A 1515 ' ' ASP . . . . . . . . . . . . . 13.6 t70 . . . . . 0 CA--C 1.54 0.573 0 N-CA-C 105.58 -2.007 . . . . 2.54 105.58 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A 1516 ' ' CYS . . . . . 0.476 ' HB3' ' HB2' ' A' 1529 ' ' LEU . 74.0 m -128.32 43.11 3.2 Favored 'General case' 0 C--N 1.298 -1.637 0 CA-C-N 118.561 0.618 . . . . 1.25 110.135 -176.417 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A 1517 ' ' GLN . . . . . . . . . . . . . 3.8 pt20 -124.52 129.28 50.33 Favored 'General case' 0 C--N 1.295 -1.762 0 C-N-CA 119.866 -0.734 . . . . 1.88 110.702 178.238 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A 1518 ' ' VAL . . . . . . . . . . . . . 15.9 m -133.28 139.51 49.07 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.641 0 CA-C-N 115.715 -0.675 . . . . 1.73 110.4 -179.058 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A 1519 ' ' THR . . . . . . . . . . . . . 23.1 m -90.55 123.57 34.32 Favored 'General case' 0 C--N 1.284 -2.251 0 N-CA-C 108.832 -0.803 . . . . 1.7 108.832 176.478 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A 1520 ' ' ASN . . . . . . . . . . . . . 48.6 t-20 -84.63 112.25 40.87 Favored Pre-proline 0 C--N 1.311 -1.08 0 N-CA-C 107.746 -1.205 . . . . 2.12 107.746 178.083 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A 1521 ' ' PRO . . . . . . . . . . . . . 42.6 Cg_endo -65.38 -16.46 54.42 Favored 'Trans proline' 0 C--N 1.353 0.766 0 C-N-CA 122.897 2.398 . . . . 2.47 113.992 -174.299 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A 1522 ' ' SER . . . . . . . . . . . . . 38.0 m -81.21 -9.8 59.72 Favored 'General case' 0 C--N 1.312 -1.031 0 CA-C-O 120.779 0.323 . . . . 2.57 111.869 -178.976 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A 1523 ' ' THR . . . . . . . . . . . . . 13.7 t -136.55 -13.82 1.72 Allowed 'General case' 0 CA--C 1.552 1.041 0 CA-C-O 121.349 0.595 . . . . 2.15 111.371 176.761 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A 1524 ' ' GLY . . . . . . . . . . . . . . . 73.33 16.26 78.8 Favored Glycine 0 C--N 1.341 0.845 0 O-C-N 122.134 -0.354 . . . . 1.89 112.362 179.481 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A 1525 ' ' HIS . . . . . . . . . . . . . 58.3 t60 -101.93 136.72 41.28 Favored 'General case' 0 C--N 1.306 -1.31 0 C-N-CA 122.623 0.369 . . . . 1.9 110.091 -176.135 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A 1526 ' ' LEU . . . . . . . . . . . . . 26.4 tp -83.45 124.49 30.75 Favored 'General case' 0 C--N 1.306 -1.289 0 N-CA-C 108.579 -0.897 . . . . 1.61 108.579 176.914 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A 1527 ' ' PHE . . . . . 0.407 ' HZ ' ' HG3' ' A' 1647 ' ' GLU . 80.8 m-85 -98.53 114.11 26.4 Favored 'General case' 0 C--N 1.296 -1.731 0 CA-C-O 121.671 0.748 . . . . 1.42 110.06 176.145 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A 1528 ' ' ASP . . . . . . . . . . . . . 4.6 t70 -90.41 105.75 18.03 Favored 'General case' 0 C--N 1.298 -1.642 0 CA-C-N 114.205 -1.361 . . . . 2.18 111.02 -177.636 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A 1529 ' ' LEU . . . . . 0.795 ' HA ' HD13 ' A' 1532 ' ' LEU . 79.6 mt -104.19 5.99 35.31 Favored 'General case' 0 C--N 1.297 -1.69 0 N-CA-C 106.089 -1.819 . . . . 1.44 106.089 170.861 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A 1530 ' ' SER . . . . . . . . . . . . . 3.1 m -65.47 -36.72 84.74 Favored 'General case' 0 N--CA 1.438 -1.059 0 CA-C-N 114.531 -1.213 . . . . 1.44 109.694 -179.279 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A 1531 ' ' SER . . . . . . . . . . . . . 15.6 m -73.62 -9.75 58.99 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 121.308 0.575 . . . . 1.5 109.908 178.114 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A 1532 ' ' LEU . . . . . 0.795 HD13 ' HA ' ' A' 1529 ' ' LEU . 6.6 mp -92.97 15.27 15.35 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.788 -0.642 . . . . 1.77 111.049 -179.724 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A 1533 ' ' SER . . . . . 0.429 ' HA ' ' HB2' ' A' 1553 ' ' CYS . 50.4 m -74.16 127.9 34.13 Favored 'General case' 0 N--CA 1.435 -1.212 0 N-CA-C 108.132 -1.062 . . . . 2.38 108.132 174.353 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A 1534 ' ' GLY . . . . . . . . . . . . . . . -127.45 137.36 9.81 Favored Glycine 0 CA--C 1.478 -2.249 0 N-CA-C 109.823 -1.311 . . . . 1.55 109.823 -177.905 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A 1535 ' ' ARG . . . . . . . . . . . . . 3.6 tpp180 -90.33 -44.3 9.77 Favored 'General case' 0 C--N 1.302 -1.471 0 N-CA-C 109.131 -0.692 . . . . 3.96 109.131 -179.845 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A 1536 ' ' ALA . . . . . . . . . . . . . . . -95.32 -6.84 40.31 Favored 'General case' 0 C--N 1.314 -0.961 0 N-CA-C 108.15 -1.056 . . . . 1.65 108.15 175.125 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A 1537 ' ' GLY . . . . . . . . . . . . . . . 78.73 -174.12 55.23 Favored Glycine 0 N--CA 1.429 -1.828 0 CA-C-N 113.887 -1.506 . . . . 1.19 113.67 177.322 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A 1538 ' ' PHE . . . . . . . . . . . . . 90.3 m-85 -113.97 175.14 5.6 Favored 'General case' 0 C--N 1.292 -1.899 0 N-CA-C 105.457 -2.053 . . . . 1.69 105.457 176.263 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A 1539 ' ' THR . . . . . . . . . . . . . 11.9 t -136.47 152.88 51.04 Favored 'General case' 0 C--N 1.282 -2.352 0 C-N-CA 119.02 -1.072 . . . . 1.48 110.21 -178.626 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A 1540 ' ' ALA . . . . . 0.669 ' HA ' ' HD3' ' A' 1623 ' ' ARG . . . -133.38 130.9 39.4 Favored 'General case' 0 C--N 1.319 -0.754 0 N-CA-C 109.062 -0.718 . . . . 0.83 109.062 179.067 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A 1541 ' ' ALA . . . . . . . . . . . . . . . -78.57 147.52 33.7 Favored 'General case' 0 C--O 1.247 0.929 0 CA-C-N 116.189 -0.459 . . . . 1.27 110.761 -178.331 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A 1542 ' ' TYR . . . . . 0.472 ' HB3' ' O ' ' A' 1546 ' ' GLY . 89.2 t80 -160.46 160.3 31.92 Favored 'General case' 0 CA--C 1.552 1.058 0 CA-C-O 119.599 -0.239 . . . . 2.15 111.549 -177.591 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A 1543 ' ' SER . . . . . . . . . . . . . 17.9 t -37.58 -152.2 0.0 OUTLIER 'General case' 0 CA--C 1.591 2.538 0 C-N-CA 130.626 3.57 . . . . 2.29 115.562 176.331 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A 1544 ' ' LYS . . . . . . . . . . . . . 97.6 mttt -46.7 -35.61 6.26 Favored 'General case' 0 N--CA 1.479 0.98 0 C-N-CA 124.497 1.119 . . . . 3.91 113.496 -177.707 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A 1545 ' ' SER . . . . . . . . . . . . . 37.2 m -71.15 -8.12 51.32 Favored 'General case' 0 CA--C 1.551 0.993 0 N-CA-C 112.96 0.726 . . . . 3.3 112.96 177.582 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A 1546 ' ' GLY . . . . . 0.472 ' O ' ' HB3' ' A' 1542 ' ' TYR . . . 83.06 -160.71 38.92 Favored Glycine 0 N--CA 1.432 -1.586 0 C-N-CA 121.239 -0.505 . . . . 1.24 114.255 173.05 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A 1547 ' ' VAL . . . . . . . . . . . . . 14.9 p -91.23 134.25 30.36 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.938 0 N-CA-C 108.742 -0.836 . . . . 1.63 108.742 -177.019 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A 1548 ' ' VAL . . . . . . . . . . . . . 4.9 t -110.52 147.72 14.49 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.518 0 N-CA-C 108.44 -0.948 . . . . 0.92 108.44 -175.03 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A 1549 ' ' TYR . . . . . 0.59 ' HB3' HD21 ' A' 1556 ' ' ASN . 99.8 m-85 -106.0 129.13 54.18 Favored 'General case' 0 C--N 1.313 -0.992 0 N-CA-C 108.185 -1.043 . . . . 1.44 108.185 176.762 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A 1550 ' ' MET . . . . . . . . . . . . . 87.7 mmm -134.29 122.35 22.56 Favored 'General case' 0 C--N 1.299 -1.614 0 CA-C-N 115.792 -0.64 . . . . 1.74 109.845 -173.708 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A 1551 ' ' SER . . . . . 0.457 ' OG ' ' HA ' ' A' 1556 ' ' ASN . 74.9 m -97.35 115.63 28.06 Favored 'General case' 0 C--N 1.286 -2.178 0 N-CA-C 107.058 -1.46 . . . . 1.64 107.058 171.79 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A 1552 ' ' ILE . . . . . 0.496 ' HB ' ' O ' ' A' 1532 ' ' LEU . 41.9 mm -57.37 -49.55 79.75 Favored 'Isoleucine or valine' 0 C--O 1.21 -0.989 0 CA-C-N 114.811 -1.086 . . . . 1.33 108.139 179.421 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A 1553 ' ' CYS . . . . . 0.491 ' HA ' ' HH ' ' A' 1592 ' ' TYR . 81.3 m -131.48 137.45 48.58 Favored 'General case' 0 N--CA 1.425 -1.724 0 N-CA-C 109.371 -0.603 . . . . 1.43 109.371 173.96 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A 1554 ' ' GLY . . . . . . . . . . . . . . . 105.56 -143.05 15.64 Favored Glycine 0 N--CA 1.435 -1.42 0 O-C-N 123.785 0.678 . . . . 1.12 112.745 174.802 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A 1555 ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -117.91 157.49 26.59 Favored 'General case' 0 C--N 1.303 -1.418 0 N-CA-C 108.473 -0.936 . . . . 1.8 108.473 179.754 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A 1556 ' ' ASN . . . . . 0.59 HD21 ' HB3' ' A' 1549 ' ' TYR . 4.0 t-20 -100.38 -23.4 14.77 Favored 'General case' 0 C--N 1.301 -1.533 0 CA-C-N 116.281 -0.418 . . . . 2.63 111.977 -172.816 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A 1557 ' ' GLU . . . . . 0.469 ' C ' ' H ' ' A' 1559 ' ' CYS . 37.7 mt-10 54.82 -158.99 0.19 Allowed 'General case' 0 N--CA 1.449 -0.477 0 CA-C-N 114.92 -1.036 . . . . 3.79 109.577 -174.709 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A 1558 ' ' ASN . . . . . . . . . . . . . 39.8 m-80 69.93 -8.95 0.75 Allowed 'General case' 0 N--CA 1.495 1.801 0 C-N-CA 124.078 0.951 . . . . 1.52 112.192 175.683 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A 1559 ' ' CYS . . . . . 0.739 ' HB3' ' HD2' ' A' 1560 ' ' PRO . 63.4 m -145.04 -173.55 0.36 Allowed Pre-proline 0 C--N 1.283 -2.323 0 N-CA-C 103.683 -2.71 . . . . 0.84 103.683 -178.675 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A 1560 ' ' PRO . . . . . 0.739 ' HD2' ' HB3' ' A' 1559 ' ' CYS . 2.8 Cg_exo -37.8 137.3 0.43 Allowed 'Trans proline' 0 C--N 1.373 1.82 0 C-N-CA 123.621 2.88 . . . . 1.18 113.727 175.624 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A 1561 ' ' PRO . . . . . . . . . . . . . 39.8 Cg_endo -68.04 125.33 12.91 Favored 'Trans proline' 0 N--CA 1.456 -0.678 0 C-N-CA 122.482 2.121 . . . . 1.51 112.265 -177.839 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A 1562 ' ' GLY . . . . . . . . . . . . . . . 101.68 17.48 21.22 Favored Glycine 0 N--CA 1.434 -1.481 0 C-N-CA 121.029 -0.605 . . . . 0.72 112.79 177.341 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A 1563 ' ' VAL . . . . . 0.588 ' HA ' ' HA ' ' A' 1576 ' ' LYS . 10.4 m -103.68 150.75 6.83 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.868 0 N-CA-C 106.746 -1.576 . . . . 0.97 106.746 174.631 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A 1564 ' ' GLY . . . . . . . . . . . . . . . -112.26 -5.62 24.66 Favored Glycine 0 C--N 1.317 -0.473 0 C-N-CA 120.233 -0.984 . . . . 0.72 113.305 -174.352 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A 1565 ' ' ALA . . . . . . . . . . . . . . . -150.75 133.43 15.75 Favored 'General case' 0 C--O 1.254 1.314 0 N-CA-C 109.414 -0.587 . . . . 0.37 109.414 -179.014 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A 1566 ' ' CYS . . . . . . . . . . . . . 34.7 t -154.06 142.32 20.49 Favored 'General case' 0 C--N 1.312 -1.043 0 CA-C-O 121.234 0.54 . . . . 0.51 111.042 -177.186 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A 1567 ' ' PHE . . . . . 0.668 ' O ' ' HA ' ' A' 1571 ' ' ARG . 13.2 m-85 -67.6 150.99 48.06 Favored 'General case' 0 N--CA 1.452 -0.339 0 CA-C-N 115.742 -0.663 . . . . 0.97 109.756 176.322 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A 1568 ' ' GLY . . . . . . . . . . . . . . . -108.78 -10.56 24.59 Favored Glycine 0 N--CA 1.432 -1.633 0 C-N-CA 120.337 -0.935 . . . . 1.08 111.751 178.831 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A 1569 ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -89.81 -62.34 1.49 Allowed 'General case' 0 C--N 1.317 -0.822 0 N-CA-C 108.217 -1.031 . . . . 2.74 108.217 178.374 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A 1570 ' ' THR . . . . . . . . . . . . . 19.3 p -89.24 -11.99 42.03 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 121.135 0.493 . . . . 1.96 111.819 178.718 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A 1571 ' ' ARG . . . . . 0.668 ' HA ' ' O ' ' A' 1567 ' ' PHE . 83.6 mtm180 61.43 37.03 17.01 Favored 'General case' 0 N--CA 1.473 0.709 0 C-N-CA 124.607 1.163 . . . . 3.95 113.434 175.748 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A 1572 ' ' ILE . . . . . 0.404 ' H ' ' HB2' ' A' 1567 ' ' PHE . 33.2 mm -99.43 132.9 43.99 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.205 0 N-CA-C 108.655 -0.868 . . . . 1.37 108.655 179.907 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A 1573 ' ' SER . . . . . . . . . . . . . 29.5 p -74.73 120.88 20.89 Favored 'General case' 0 N--CA 1.441 -0.89 0 CA-C-O 121.134 0.492 . . . . 1.08 111.892 -179.239 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A 1574 ' ' VAL . . . . . . . . . . . . . 35.3 m -113.25 21.8 5.96 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.233 0 CA-C-O 121.672 0.749 . . . . 1.3 112.311 -173.911 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A 1575 ' ' GLY . . . . . . . . . . . . . . . 179.97 127.36 1.11 Allowed Glycine 0 N--CA 1.431 -1.641 0 CA-C-N 115.128 -0.942 . . . . 0.51 111.297 176.544 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A 1576 ' ' LYS . . . . . 0.588 ' HA ' ' HA ' ' A' 1563 ' ' VAL . 54.7 tttp -89.91 151.6 21.64 Favored 'General case' 0 C--N 1.313 -0.991 0 N-CA-C 106.794 -1.558 . . . . 2.9 106.794 178.499 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A 1577 ' ' ALA . . . . . 0.407 ' HA ' ' CD1' ' A' 1592 ' ' TYR . . . -67.1 88.67 0.17 Allowed 'General case' 0 C--O 1.239 0.508 0 CA-C-O 121.939 0.875 . . . . 0.83 112.286 -174.708 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A 1578 ' ' ASN . . . . . . . . . . . . . 49.8 m-80 -117.87 113.29 21.54 Favored 'General case' 0 C--N 1.288 -2.087 0 N-CA-C 104.178 -2.527 . . . . 1.85 104.178 172.714 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A 1579 ' ' LYS . . . . . . . . . . . . . 37.4 ttpt -101.07 91.01 4.36 Favored 'General case' 0 C--N 1.274 -2.681 0 C-N-CA 119.24 -0.984 . . . . 1.9 109.306 -173.783 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A 1580 ' ' ARG . . . . . . . . . . . . . 49.1 ttp180 -129.7 100.62 5.57 Favored 'General case' 0 N--CA 1.42 -1.968 0 CA-C-N 114.391 -1.277 . . . . 3.63 109.576 -178.398 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A 1581 ' ' LEU . . . . . 0.416 HD13 HD12 ' A' 1590 ' ' LEU . 64.3 tp -96.08 147.63 23.52 Favored 'General case' 0 C--N 1.303 -1.43 0 N-CA-C 107.175 -1.417 . . . . 1.87 107.175 177.459 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A 1582 ' ' ARG . . . . . 0.589 ' HG2' HG13 ' A' 1584 ' ' VAL . 40.8 ttp180 -146.36 138.52 25.03 Favored 'General case' 0 C--N 1.304 -1.397 0 C-N-CA 120.559 -0.456 . . . . 3.97 111.64 178.782 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A 1583 ' ' TYR . . . . . 0.561 ' HD2' HD21 ' A' 1588 ' ' LEU . 55.7 t80 -98.71 108.14 20.75 Favored 'General case' 0 C--O 1.24 0.586 0 N-CA-C 108.114 -1.069 . . . . 1.41 108.114 176.438 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A 1584 ' ' VAL . . . . . 0.589 HG13 ' HG2' ' A' 1582 ' ' ARG . 5.1 m -130.34 108.35 15.67 Favored 'Isoleucine or valine' 0 C--O 1.207 -1.147 0 CA-C-O 120.905 0.383 . . . . 1.69 111.847 179.228 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A 1585 ' ' ASP . . . . . . . . . . . . . 38.8 t70 57.37 48.11 15.39 Favored 'General case' 0 N--CA 1.479 0.985 0 CA-C-O 122.423 1.106 . . . . 2.06 110.796 175.656 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A 1586 ' ' GLN . . . . . . . . . . . . . 22.8 mt-30 68.56 -7.1 0.74 Allowed 'General case' 0 N--CA 1.477 0.886 0 N-CA-C 114.905 1.446 . . . . 2.33 114.905 -179.11 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A 1587 ' ' VAL . . . . . . . . . . . . . 9.6 p -99.67 126.37 53.08 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.189 0 C-N-CA 119.73 -0.788 . . . . 0.78 108.907 176.554 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A 1588 ' ' LEU . . . . . 0.582 ' HB2' ' HB2' ' A' 1612 ' ' PHE . 36.0 mt -88.23 143.09 27.24 Favored 'General case' 0 C--N 1.292 -1.902 0 CA-C-N 115.593 -0.731 . . . . 1.41 109.082 179.596 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A 1589 ' ' GLN . . . . . . . . . . . . . 9.8 tt0 -135.56 134.45 39.41 Favored 'General case' 0 C--N 1.279 -2.473 0 N-CA-C 108.609 -0.886 . . . . 1.24 108.609 179.089 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A 1590 ' ' LEU . . . . . 0.416 HD12 HD13 ' A' 1581 ' ' LEU . 2.2 tt -134.4 133.11 40.19 Favored 'General case' 0 C--N 1.293 -1.877 0 N-CA-C 104.982 -2.229 . . . . 1.15 104.982 177.156 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A 1591 ' ' VAL . . . . . . . . . . . . . 29.6 m -128.53 144.26 38.51 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.848 0 N-CA-C 113.039 0.755 . . . . 1.51 113.039 -173.585 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A 1592 ' ' TYR . . . . . 0.491 ' HH ' ' HA ' ' A' 1553 ' ' CYS . 86.8 m-85 -127.95 97.1 4.69 Favored 'General case' 0 C--N 1.312 -1.061 0 N-CA-C 107.3 -1.37 . . . . 1.06 107.3 173.423 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A 1593 ' ' LYS . . . . . 0.502 ' HA ' ' HA ' ' A' 1607 ' ' LYS . 14.4 ptmm? -109.19 165.03 11.92 Favored 'General case' 0 C--N 1.296 -1.755 0 CA-C-N 115.852 -0.613 . . . . 2.18 111.361 -174.196 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A 1594 ' ' ASP . . . . . 0.401 ' HA ' ' CB ' ' A' 1605 ' ' SER . 2.1 m-20 58.08 59.91 2.91 Favored 'General case' 0 CA--C 1.507 -0.688 0 C-N-CA 125.34 1.456 . . . . 1.45 114.195 172.802 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A 1595 ' ' GLY . . . . . . . . . . . . . . . -86.65 -77.38 1.24 Allowed Glycine 0 N--CA 1.435 -1.381 0 N-CA-C 109.911 -1.276 . . . . 0.78 109.911 174.461 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A 1596 ' ' SER . . . . . . . . . . . . . 51.1 m -114.04 145.79 34.32 Favored Pre-proline 0 C--N 1.299 -1.613 0 N-CA-C 109.824 -0.436 . . . . 1.68 109.824 178.147 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A 1597 ' ' PRO . . . . . . . . . . . . . 52.2 Cg_exo -59.83 133.37 50.49 Favored 'Trans proline' 0 C--N 1.351 0.709 0 C-N-CA 123.173 2.582 . . . . 1.17 110.41 175.284 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A 1598 ' ' CYS . . . . . . . . . . . . . 47.9 t -95.78 130.28 32.08 Favored Pre-proline 0 C--N 1.292 -1.892 0 CA-C-N 115.628 -0.714 . . . . 1.19 110.136 -176.124 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A 1599 ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -75.11 -9.64 20.71 Favored 'Trans proline' 0 C--N 1.35 0.63 0 C-N-CA 123.31 2.673 . . . . 1.59 113.551 -177.502 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A 1600 ' ' SER . . . . . 0.418 ' HB2' ' SG ' ' A' 1634 ' ' CYS . 48.6 m -69.11 -26.46 64.92 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 120.75 0.31 . . . . 2.12 111.312 179.873 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A 1601 ' ' LYS . . . . . 0.631 ' HB3' HD12 ' A' 1604 ' ' LEU . 6.0 tmtm? -156.65 114.58 3.25 Favored 'General case' 0 C--N 1.314 -0.972 0 N-CA-C 107.11 -1.441 . . . . 3.74 107.11 -179.003 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A 1602 ' ' SER . . . . . . . . . . . . . 18.5 m -64.27 105.53 0.92 Allowed 'General case' 0 C--N 1.304 -1.37 0 CA-C-O 121.271 0.558 . . . . 3.79 110.26 179.811 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A 1603 ' ' GLY . . . . . . . . . . . . . . . 125.06 -7.5 8.13 Favored Glycine 0 N--CA 1.441 -1.026 0 N-CA-C 110.617 -0.993 . . . . 2.0 110.617 -176.357 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A 1604 ' ' LEU . . . . . 0.631 HD12 ' HB3' ' A' 1601 ' ' LYS . 1.4 mt -100.88 160.76 14.1 Favored 'General case' 0 C--N 1.318 -0.781 0 C-N-CA 122.808 0.443 . . . . 1.48 110.563 177.227 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A 1605 ' ' SER . . . . . 0.401 ' CB ' ' HA ' ' A' 1594 ' ' ASP . 28.8 m -131.57 -169.37 2.18 Favored 'General case' 0 C--N 1.294 -1.828 0 N-CA-C 106.319 -1.734 . . . . 1.51 106.319 177.445 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A 1606 ' ' TYR . . . . . . . . . . . . . 85.1 m-85 -108.67 131.68 54.67 Favored 'General case' 0 N--CA 1.412 -2.337 0 N-CA-C 106.257 -1.757 . . . . 1.18 106.257 -179.884 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A 1607 ' ' LYS . . . . . 0.502 ' HA ' ' HA ' ' A' 1593 ' ' LYS . 20.5 ptmt -125.63 125.13 42.62 Favored 'General case' 0 N--CA 1.409 -2.484 0 O-C-N 124.145 0.903 . . . . 1.67 110.918 -177.798 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A 1608 ' ' SER . . . . . 0.678 ' HA ' ' HB2' ' A' 1636 ' ' LEU . 49.7 m -98.87 122.86 42.66 Favored 'General case' 0 C--N 1.301 -1.528 0 N-CA-C 110.205 -0.295 . . . . 1.0 110.205 178.616 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A 1609 ' ' VAL . . . . . . . . . . . . . 84.0 t -119.8 126.37 75.23 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.846 0 C-N-CA 123.381 0.672 . . . . 0.93 109.261 179.908 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A 1610 ' ' ILE . . . . . 0.475 HG13 ' HB2' ' A' 1638 ' ' PHE . 3.4 mp -115.67 118.03 57.49 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.832 0 N-CA-C 109.123 -0.695 . . . . 0.78 109.123 177.328 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A 1611 ' ' SER . . . . . . . . . . . . . 44.8 p -100.95 120.99 40.97 Favored 'General case' 0 N--CA 1.436 -1.139 0 CA-C-O 120.946 0.403 . . . . 1.29 110.095 176.505 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A 1612 ' ' PHE . . . . . 0.582 ' HB2' ' HB2' ' A' 1588 ' ' LEU . 36.2 m-85 -97.68 104.11 16.1 Favored 'General case' 0 C--N 1.302 -1.476 0 C-N-CA 123.404 0.682 . . . . 0.7 109.607 -177.351 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A 1613 ' ' VAL . . . . . 0.552 ' O ' ' HA ' ' A' 1641 ' ' HIS . 46.1 t -103.5 131.88 51.05 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.502 0 N-CA-C 108.534 -0.913 . . . . 0.75 108.534 -178.801 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A 1614 ' ' CYS . . . . . 0.588 ' HA ' ' O ' ' A' 1642 ' ' THR . 0.8 OUTLIER -70.06 101.64 1.86 Allowed 'General case' 0 C--N 1.305 -1.355 0 N-CA-C 115.518 1.673 . . . . 1.39 115.518 -178.167 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A 1615 ' ' ARG . . . . . 0.611 ' HB3' ' HB3' ' A' 1641 ' ' HIS . 75.9 ttt180 -137.81 107.07 8.25 Favored Pre-proline 0 C--N 1.323 -0.545 0 C-N-CA 124.221 1.009 . . . . 3.75 108.304 173.84 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A 1616 ' ' PRO . . . . . . . . . . . . . 58.9 Cg_endo -69.75 64.45 1.79 Allowed 'Trans proline' 0 CA--C 1.546 1.087 0 C-N-CA 123.562 2.841 . . . . 1.32 115.194 -177.288 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A 1617 ' ' GLU . . . . . . . . . . . . . 29.5 mm-40 . . . . . 0 C--N 1.311 -1.081 0 N-CA-C 109.025 -0.731 . . . . 3.21 109.025 176.403 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A 1622 ' ' ASN . . . . . . . . . . . . . 27.5 t-20 . . . . . 0 CA--C 1.494 -1.176 0 CA-C-O 122.438 1.113 . . . . 2.92 110.23 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A 1623 ' ' ARG . . . . . 0.669 ' HD3' ' HA ' ' A' 1540 ' ' ALA . 3.5 ptp180 -75.78 149.38 83.15 Favored Pre-proline 0 C--N 1.283 -2.299 0 CA-C-N 112.456 -2.156 . . . . 3.61 111.537 -177.509 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A 1624 ' ' PRO . . . . . 0.657 ' HB3' ' HB2' ' A' 1640 ' ' TRP . 18.6 Cg_endo -60.2 159.7 25.54 Favored 'Trans proline' 0 C--N 1.364 1.357 0 C-N-CA 124.274 3.316 . . . . 2.37 112.427 177.824 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A 1625 ' ' MET . . . . . . . . . . . . . 72.2 mtm -119.81 150.46 40.39 Favored 'General case' 0 CA--C 1.494 -1.189 0 CA-C-O 121.226 0.536 . . . . 2.16 111.347 -178.313 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A 1626 ' ' LEU . . . . . 0.426 HD12 ' O ' ' A' 1637 ' ' PHE . 34.4 tp -83.27 108.98 16.85 Favored 'General case' 0 N--CA 1.43 -1.447 0 N-CA-C 106.632 -1.618 . . . . 1.35 106.632 172.572 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A 1627 ' ' ILE . . . . . . . . . . . . . 21.2 pt -85.48 -26.04 6.6 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.965 0 N-CA-C 112.346 0.499 . . . . 1.21 112.346 -173.992 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A 1628 ' ' SER . . . . . . . . . . . . . 23.5 p -167.73 149.98 5.7 Favored 'General case' 0 N--CA 1.438 -1.042 0 CA-C-N 116.699 -0.228 . . . . 1.4 110.591 -177.711 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A 1629 ' ' LEU . . . . . 0.748 HD13 HD13 ' A' 1636 ' ' LEU . 33.1 tp -128.35 108.58 10.69 Favored 'General case' 0 N--CA 1.42 -1.956 0 O-C-N 123.812 0.695 . . . . 1.56 109.128 177.612 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A 1630 ' ' ASP . . . . . . . . . . . . . 10.0 t70 -83.94 98.44 9.8 Favored 'General case' 0 C--N 1.301 -1.52 0 N-CA-C 106.459 -1.682 . . . . 0.87 106.459 176.936 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A 1631 ' ' LYS . . . . . . . . . . . . . 96.8 mttt -71.65 -20.87 61.89 Favored 'General case' 0 C--N 1.312 -1.054 0 N-CA-C 113.489 0.922 . . . . 2.35 113.489 -173.024 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A 1632 ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -85.91 -39.31 17.1 Favored 'General case' 0 C--N 1.324 -0.529 0 N-CA-C 113.413 0.894 . . . . 2.55 113.413 -179.908 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A 1633 ' ' THR . . . . . . . . . . . . . 42.2 p -101.21 10.13 41.13 Favored 'General case' 0 C--N 1.315 -0.913 0 C-N-CA 119.459 -0.896 . . . . 1.24 111.547 177.877 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A 1634 ' ' CYS . . . . . 0.418 ' SG ' ' HB2' ' A' 1600 ' ' SER . 10.9 m 54.98 43.92 29.08 Favored 'General case' 0 C--O 1.245 0.833 0 C-N-CA 124.772 1.229 . . . . 0.89 111.714 170.177 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A 1635 ' ' THR . . . . . . . . . . . . . 20.9 m -108.16 122.1 46.21 Favored 'General case' 0 N--CA 1.422 -1.861 0 CA-C-N 115.338 -0.846 . . . . 0.75 110.72 -176.178 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A 1636 ' ' LEU . . . . . 0.748 HD13 HD13 ' A' 1629 ' ' LEU . 3.0 mm? -93.07 110.15 21.63 Favored 'General case' 0 C--N 1.312 -1.057 0 CA-C-N 115.296 -0.865 . . . . 1.33 108.925 179.986 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A 1637 ' ' PHE . . . . . 0.426 ' O ' HD12 ' A' 1626 ' ' LEU . 99.1 m-85 -100.51 99.21 9.78 Favored 'General case' 0 C--O 1.246 0.918 0 CA-C-O 120.797 0.332 . . . . 0.83 111.024 -179.132 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A 1638 ' ' PHE . . . . . 0.475 ' HB2' HG13 ' A' 1610 ' ' ILE . 94.9 m-85 -101.7 141.9 33.86 Favored 'General case' 0 C--N 1.299 -1.588 0 N-CA-C 108.72 -0.844 . . . . 0.6 108.72 176.759 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A 1639 ' ' SER . . . . . . . . . . . . . 16.7 t -134.84 137.87 43.68 Favored 'General case' 0 N--CA 1.412 -2.364 0 N-CA-C 109.083 -0.71 . . . . 1.08 109.083 -178.913 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A 1640 ' ' TRP . . . . . 0.657 ' HB2' ' HB3' ' A' 1624 ' ' PRO . 7.0 t90 -129.17 99.17 5.15 Favored 'General case' 0 N--CA 1.415 -2.188 0 N-CA-C 108.268 -1.012 . . . . 0.8 108.268 179.905 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A 1641 ' ' HIS . . . . . 0.611 ' HB3' ' HB3' ' A' 1615 ' ' ARG . 17.9 m-70 -81.24 95.45 6.95 Favored 'General case' 0 C--N 1.302 -1.463 0 N-CA-C 107.785 -1.191 . . . . 2.54 107.785 174.719 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A 1642 ' ' THR . . . . . 0.588 ' O ' ' HA ' ' A' 1614 ' ' CYS . 13.4 t -138.82 149.52 62.25 Favored Pre-proline 0 C--N 1.305 -1.354 0 CA-C-N 114.895 -1.048 . . . . 1.15 109.506 -169.375 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A 1643 ' ' PRO . . . . . . . . . . . . . 58.6 Cg_endo -72.12 0.06 7.83 Favored 'Trans proline' 0 C--N 1.36 1.134 0 C-N-CA 123.833 3.022 . . . . 0.8 112.8 179.211 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A 1644 ' ' LEU . . . . . . . . . . . . . 62.5 mt -79.85 4.69 15.82 Favored 'General case' 0 C--N 1.315 -0.892 0 C-N-CA 123.214 0.606 . . . . 1.54 111.171 -178.987 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A 1645 ' ' ALA . . . . . . . . . . . . . . . -106.66 -42.22 5.03 Favored 'General case' 0 C--N 1.316 -0.879 0 CA-C-N 116.221 -0.445 . . . . 0.95 110.721 176.923 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A 1646 ' ' CYS . . . . . 0.412 ' N ' ' HB3' ' A' 1614 ' ' CYS . 10.7 m -143.23 144.64 32.23 Favored 'General case' 0 C--N 1.32 -0.684 0 N-CA-C 106.858 -1.534 . . . . 1.41 106.858 -179.303 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A 1647 ' ' GLU . . . . . 0.407 ' HG3' ' HZ ' ' A' 1527 ' ' PHE . 47.1 mt-10 . . . . . 0 C--N 1.3 -1.565 0 N-CA-C 109.988 -0.375 . . . . 2.92 109.988 178.816 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A 1515 ' ' ASP . . . . . . . . . . . . . 24.7 t0 . . . . . 0 N--CA 1.436 -1.149 0 N-CA-C 108.782 -0.821 . . . . 2.54 108.782 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A 1516 ' ' CYS . . . . . . . . . . . . . 9.6 m -78.2 54.03 1.31 Allowed 'General case' 0 C--N 1.31 -1.128 0 C-N-CA 123.828 0.851 . . . . 1.25 111.362 -175.249 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A 1517 ' ' GLN . . . . . . . . . . . . . 11.0 pt20 -132.62 122.78 25.23 Favored 'General case' 0 C--N 1.296 -1.724 0 N-CA-C 108.605 -0.887 . . . . 1.88 108.605 178.779 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A 1518 ' ' VAL . . . . . 0.415 ' HB ' ' CB ' ' A' 1581 ' ' LEU . 7.4 p -109.11 127.25 65.95 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.967 0 CA-C-O 121.621 0.724 . . . . 1.73 111.536 -175.364 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A 1519 ' ' THR . . . . . . . . . . . . . 5.2 m -92.43 118.65 31.17 Favored 'General case' 0 N--CA 1.421 -1.902 0 CA-C-N 115.569 -0.741 . . . . 1.7 109.168 178.312 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A 1520 ' ' ASN . . . . . 0.428 ' CG ' HG22 ' A' 1523 ' ' THR . 32.8 t-20 -84.11 113.83 50.59 Favored Pre-proline 0 C--N 1.31 -1.119 0 N-CA-C 107.513 -1.292 . . . . 2.12 107.513 175.918 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A 1521 ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -73.82 -9.58 22.53 Favored 'Trans proline' 0 C--N 1.354 0.834 0 C-N-CA 122.63 2.22 . . . . 2.47 113.475 -173.27 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A 1522 ' ' SER . . . . . . . . . . . . . 19.5 m -94.32 -50.96 5.01 Favored 'General case' 0 N--CA 1.427 -1.615 0 C-N-CA 120.825 -0.35 . . . . 2.57 111.365 -179.022 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A 1523 ' ' THR . . . . . 0.428 HG22 ' CG ' ' A' 1520 ' ' ASN . 13.8 t -89.79 -12.86 38.01 Favored 'General case' 0 CA--C 1.552 1.041 0 C-N-CA 119.805 -0.758 . . . . 2.15 111.184 -178.888 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A 1524 ' ' GLY . . . . . . . . . . . . . . . 73.41 20.36 79.85 Favored Glycine 0 C--O 1.222 -0.619 0 CA-C-N 116.062 -0.517 . . . . 1.89 113.634 177.698 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A 1525 ' ' HIS . . . . . . . . . . . . . 9.8 t60 -101.23 136.99 40.16 Favored 'General case' 0 C--N 1.31 -1.126 0 O-C-N 122.222 -0.575 . . . . 1.9 109.466 -177.801 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A 1526 ' ' LEU . . . . . . . . . . . . . 65.1 tp -95.3 106.25 18.27 Favored 'General case' 0 C--N 1.303 -1.449 0 N-CA-C 108.346 -0.983 . . . . 1.61 108.346 177.906 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A 1527 ' ' PHE . . . . . 0.493 ' CE1' ' HA ' ' A' 1646 ' ' CYS . 93.9 m-85 -89.53 104.94 17.45 Favored 'General case' 0 C--N 1.302 -1.476 0 CA-C-O 121.417 0.627 . . . . 1.42 109.441 -179.055 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A 1528 ' ' ASP . . . . . . . . . . . . . 10.9 t70 -89.9 114.67 26.49 Favored 'General case' 0 C--N 1.296 -1.735 0 CA-C-N 115.55 -0.75 . . . . 2.18 109.247 -179.843 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A 1529 ' ' LEU . . . . . 0.434 ' HA ' ' HG ' ' A' 1532 ' ' LEU . 37.6 mt -111.04 8.38 21.86 Favored 'General case' 0 C--N 1.295 -1.764 0 N-CA-C 107.918 -1.141 . . . . 1.44 107.918 178.983 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A 1530 ' ' SER . . . . . 0.442 ' HA ' ' SG ' ' A' 1553 ' ' CYS . 22.9 t -80.31 -45.75 17.31 Favored 'General case' 0 N--CA 1.439 -0.996 0 CA-C-N 114.597 -1.183 . . . . 1.44 109.307 -175.482 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A 1531 ' ' SER . . . . . . . . . . . . . 14.1 p -74.2 -16.86 60.96 Favored 'General case' 0 N--CA 1.438 -1.062 0 CA-C-N 115.514 -0.766 . . . . 1.5 111.589 -179.329 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A 1532 ' ' LEU . . . . . 0.446 HD11 HD11 ' A' 1644 ' ' LEU . 71.6 mt -65.96 -57.21 8.34 Favored 'General case' 0 CA--C 1.508 -0.651 0 CA-C-O 121.116 0.484 . . . . 1.77 111.398 -179.506 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A 1533 ' ' SER . . . . . . . . . . . . . 28.1 t -81.23 139.05 35.71 Favored 'General case' 0 N--CA 1.427 -1.583 0 CA-C-N 115.066 -0.97 . . . . 2.38 111.24 -173.037 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A 1534 ' ' GLY . . . . . . . . . . . . . . . -85.06 171.68 46.73 Favored Glycine 0 N--CA 1.416 -2.641 0 N-CA-C 107.65 -2.18 . . . . 1.55 107.65 170.652 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A 1535 ' ' ARG . . . . . . . . . . . . . 38.5 ttm180 -77.7 -15.68 58.99 Favored 'General case' 0 C--N 1.3 -1.569 0 CA-C-O 121.91 0.862 . . . . 3.96 110.764 -176.33 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A 1536 ' ' ALA . . . . . . . . . . . . . . . -84.23 -11.4 56.55 Favored 'General case' 0 C--O 1.242 0.668 0 N-CA-C 108.881 -0.785 . . . . 1.65 108.881 174.411 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A 1537 ' ' GLY . . . . . . . . . . . . . . . 74.92 -150.3 40.88 Favored Glycine 0 N--CA 1.426 -1.991 0 CA-C-N 114.701 -1.136 . . . . 1.19 113.459 178.17 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A 1538 ' ' PHE . . . . . 0.473 ' CD1' HD13 ' A' 1552 ' ' ILE . 95.5 m-85 -120.98 146.77 46.32 Favored 'General case' 0 C--N 1.295 -1.803 0 N-CA-C 107.765 -1.198 . . . . 1.69 107.765 177.746 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A 1539 ' ' THR . . . . . . . . . . . . . 30.2 p -99.38 113.53 25.91 Favored 'General case' 0 C--N 1.283 -2.298 0 CA-C-O 121.323 0.582 . . . . 1.48 109.993 179.591 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A 1540 ' ' ALA . . . . . 0.719 ' HB3' HG13 ' A' 1548 ' ' VAL . . . -93.84 148.56 22.02 Favored 'General case' 0 C--N 1.296 -1.726 0 CA-C-N 115.724 -0.671 . . . . 0.83 109.899 -177.575 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A 1541 ' ' ALA . . . . . . . . . . . . . . . -85.7 128.38 34.77 Favored 'General case' 0 N--CA 1.439 -0.982 0 N-CA-C 109.025 -0.731 . . . . 1.27 109.025 178.51 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A 1542 ' ' TYR . . . . . 0.546 ' HD2' ' HB2' ' A' 1545 ' ' SER . 72.9 t80 -136.54 171.79 13.97 Favored 'General case' 0 C--N 1.296 -1.758 0 CA-C-N 116.007 -0.542 . . . . 2.15 109.826 -177.667 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A 1543 ' ' SER . . . . . . . . . . . . . 3.6 m -45.67 -150.79 0.0 OUTLIER 'General case' 0 CA--C 1.573 1.855 0 C-N-CA 130.466 3.507 . . . . 2.29 114.147 177.537 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A 1544 ' ' LYS . . . . . . . . . . . . . 22.6 tptm -39.55 -37.22 0.46 Allowed 'General case' 0 N--CA 1.495 1.799 0 N-CA-C 113.531 0.937 . . . . 3.91 113.531 178.842 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A 1545 ' ' SER . . . . . 0.546 ' HB2' ' HD2' ' A' 1542 ' ' TYR . 15.7 m -65.08 -21.22 66.78 Favored 'General case' 0 CA--C 1.557 1.246 0 N-CA-C 112.023 0.379 . . . . 3.3 112.023 178.401 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A 1546 ' ' GLY . . . . . . . . . . . . . . . 82.45 -67.18 3.76 Favored Glycine 0 N--CA 1.443 -0.839 0 N-CA-C 113.866 0.307 . . . . 1.24 113.866 176.154 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A 1547 ' ' VAL . . . . . . . . . . . . . 72.0 t -128.67 144.48 37.88 Favored 'Isoleucine or valine' 0 N--CA 1.419 -1.997 0 C-N-CA 122.985 0.514 . . . . 1.63 110.228 -175.031 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A 1548 ' ' VAL . . . . . 0.719 HG13 ' HB3' ' A' 1540 ' ' ALA . 2.6 p -133.69 127.58 52.99 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.219 0 N-CA-C 108.309 -0.997 . . . . 0.92 108.309 173.285 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A 1549 ' ' TYR . . . . . 0.521 ' CZ ' ' HA2' ' A' 1568 ' ' GLY . 0.6 OUTLIER -101.49 133.23 46.46 Favored 'General case' 0 C--N 1.303 -1.43 0 CA-C-O 121.756 0.789 . . . . 1.44 112.296 -179.188 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A 1550 ' ' MET . . . . . . . . . . . . . 43.2 ttp -144.51 129.33 18.32 Favored 'General case' 0 C--N 1.296 -1.751 0 CA-C-N 114.666 -1.152 . . . . 1.74 109.704 -176.37 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A 1551 ' ' SER . . . . . . . . . . . . . 50.5 m -88.16 139.8 30.13 Favored 'General case' 0 C--N 1.289 -2.035 0 N-CA-C 108.671 -0.863 . . . . 1.64 108.671 178.207 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A 1552 ' ' ILE . . . . . 0.473 HD13 ' CD1' ' A' 1538 ' ' PHE . 1.4 mp -87.13 -6.61 10.7 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.2 0 CA-C-O 122.773 1.273 . . . . 1.33 109.462 178.876 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A 1553 ' ' CYS . . . . . 0.442 ' SG ' ' HA ' ' A' 1530 ' ' SER . 54.1 t -157.8 138.28 12.84 Favored 'General case' 0 N--CA 1.416 -2.132 0 CA-C-N 114.179 -1.373 . . . . 1.43 108.843 174.501 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A 1554 ' ' GLY . . . . . . . . . . . . . . . 74.09 -169.35 53.89 Favored Glycine 0 N--CA 1.434 -1.497 0 O-C-N 123.958 0.786 . . . . 1.12 113.816 174.635 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A 1555 ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -72.91 153.44 41.0 Favored 'General case' 0 C--N 1.311 -1.068 0 CA-C-N 114.805 -0.697 . . . . 1.8 111.362 179.412 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A 1556 ' ' ASN . . . . . . . . . . . . . 25.4 t-20 -105.4 139.31 40.23 Favored 'General case' 0 N--CA 1.414 -2.227 0 CA-C-N 114.509 -1.223 . . . . 2.63 108.01 177.494 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A 1557 ' ' GLU . . . . . . . . . . . . . 45.9 mt-10 -102.53 174.9 5.69 Favored 'General case' 0 C--N 1.29 -2.013 0 CA-C-N 115.864 -0.607 . . . . 3.79 110.856 -178.251 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A 1558 ' ' ASN . . . . . . . . . . . . . 46.5 m-80 72.44 12.17 5.64 Favored 'General case' 0 N--CA 1.486 1.355 0 C-N-CA 124.685 1.194 . . . . 1.52 110.597 -176.026 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A 1559 ' ' CYS . . . . . 0.62 ' SG ' ' HD2' ' A' 1560 ' ' PRO . 22.5 t -160.69 152.45 16.49 Favored Pre-proline 0 C--N 1.295 -1.784 0 N-CA-C 103.856 -2.646 . . . . 0.84 103.856 179.168 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A 1560 ' ' PRO . . . . . 0.62 ' HD2' ' SG ' ' A' 1559 ' ' CYS . 39.2 Cg_exo -24.24 112.59 0.02 OUTLIER 'Trans proline' 0 C--N 1.368 1.591 0 C-N-CA 125.253 3.968 . . . . 1.18 115.472 179.075 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A 1561 ' ' PRO . . . . . 0.505 ' HD2' ' HA ' ' A' 1560 ' ' PRO . 9.6 Cg_endo -53.76 110.63 0.52 Allowed 'Trans proline' 0 C--O 1.237 0.475 0 C-N-CA 123.685 2.923 . . . . 1.51 112.58 179.846 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A 1562 ' ' GLY . . . . . . . . . . . . . . . 133.78 -16.26 4.53 Favored Glycine 0 N--CA 1.439 -1.121 0 C-N-CA 120.528 -0.844 . . . . 0.72 111.84 179.254 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A 1563 ' ' VAL . . . . . 0.431 ' HA ' ' HA ' ' A' 1576 ' ' LYS . 4.3 m -86.83 157.35 3.25 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.264 0 N-CA-C 107.586 -1.264 . . . . 0.97 107.586 178.834 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A 1564 ' ' GLY . . . . . . . . . . . . . . . -111.44 -22.93 5.91 Favored Glycine 0 N--CA 1.444 -0.791 0 C-N-CA 120.459 -0.877 . . . . 0.72 112.545 -177.904 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A 1565 ' ' ALA . . . . . . . . . . . . . . . -141.51 125.45 17.15 Favored 'General case' 0 C--O 1.247 0.957 0 N-CA-C 109.553 -0.536 . . . . 0.37 109.553 -179.437 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A 1566 ' ' CYS . . . . . . . . . . . . . 53.9 t -148.94 132.91 17.14 Favored 'General case' 0 C--N 1.314 -0.946 0 CA-C-N 116.324 -0.398 . . . . 0.51 109.999 -176.476 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A 1567 ' ' PHE . . . . . 0.427 ' HA ' HG23 ' A' 1548 ' ' VAL . 35.0 m-85 -63.82 134.82 55.94 Favored 'General case' 0 N--CA 1.474 0.742 0 N-CA-C 108.106 -1.072 . . . . 0.97 108.106 177.205 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A 1568 ' ' GLY . . . . . 0.521 ' HA2' ' CZ ' ' A' 1549 ' ' TYR . . . -73.67 -30.74 61.46 Favored Glycine 0 CA--C 1.498 -0.989 0 CA-C-N 116.42 -0.354 . . . . 1.08 113.727 -173.199 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A 1569 ' ' GLN . . . . . . . . . . . . . 8.5 tp-100 -82.45 -56.83 3.64 Favored 'General case' 0 C--N 1.304 -1.376 0 CA-C-O 121.359 0.6 . . . . 2.74 110.511 -179.725 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A 1570 ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -72.06 -27.29 62.59 Favored 'General case' 0 N--CA 1.426 -1.654 0 CA-C-N 114.963 -1.017 . . . . 1.96 111.33 -174.974 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A 1571 ' ' ARG . . . . . . . . . . . . . 42.7 ttp180 52.87 60.75 3.58 Favored 'General case' 0 C--O 1.235 0.315 0 CA-C-O 121.85 0.833 . . . . 3.95 109.687 -176.781 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A 1572 ' ' ILE . . . . . . . . . . . . . 40.4 mm -131.58 129.55 61.78 Favored 'Isoleucine or valine' 0 C--O 1.251 1.165 0 N-CA-C 106.915 -1.513 . . . . 1.37 106.915 179.405 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A 1573 ' ' SER . . . . . . . . . . . . . 35.7 t -73.04 140.04 46.99 Favored 'General case' 0 C--N 1.303 -1.437 0 O-C-N 124.126 0.891 . . . . 1.08 111.357 -178.373 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A 1574 ' ' VAL . . . . . . . . . . . . . 18.0 m -133.06 19.77 1.44 Allowed 'Isoleucine or valine' 0 C--N 1.314 -0.937 0 CA-C-N 115.815 -0.63 . . . . 1.3 110.828 174.587 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A 1575 ' ' GLY . . . . . . . . . . . . . . . 173.73 126.58 0.92 Allowed Glycine 0 N--CA 1.44 -1.058 0 C-N-CA 120.627 -0.797 . . . . 0.51 111.869 178.336 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A 1576 ' ' LYS . . . . . 0.431 ' HA ' ' HA ' ' A' 1563 ' ' VAL . 59.0 tttp -82.98 147.45 28.19 Favored 'General case' 0 C--O 1.239 0.552 0 N-CA-C 107.57 -1.271 . . . . 2.9 107.57 179.263 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A 1577 ' ' ALA . . . . . . . . . . . . . . . -68.92 79.16 0.31 Allowed 'General case' 0 N--CA 1.475 0.804 0 N-CA-C 113.041 0.756 . . . . 0.83 113.041 -174.151 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A 1578 ' ' ASN . . . . . 0.465 ' H ' ' HD1' ' A' 1592 ' ' TYR . 32.0 m-80 -96.67 113.41 24.97 Favored 'General case' 0 C--N 1.297 -1.716 0 N-CA-C 108.107 -1.071 . . . . 1.85 108.107 175.519 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A 1579 ' ' LYS . . . . . . . . . . . . . 52.8 pttt -96.92 109.2 21.98 Favored 'General case' 0 C--N 1.291 -1.972 0 CA-C-O 121.311 0.577 . . . . 1.9 109.712 -178.859 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A 1580 ' ' ARG . . . . . . . . . . . . . 32.7 ttm180 -158.43 94.18 1.26 Allowed 'General case' 0 N--CA 1.43 -1.445 0 CA-C-N 115.033 -0.985 . . . . 3.63 109.435 -177.36 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A 1581 ' ' LEU . . . . . 0.415 ' CB ' ' HB ' ' A' 1518 ' ' VAL . 4.4 mm? -85.52 124.5 32.16 Favored 'General case' 0 C--N 1.302 -1.491 0 CA-C-N 116.275 -0.421 . . . . 1.87 110.554 178.011 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A 1582 ' ' ARG . . . . . . . . . . . . . 89.0 mtm180 -120.29 134.32 55.29 Favored 'General case' 0 C--N 1.29 -1.98 0 CA-C-O 121.112 0.482 . . . . 3.97 110.863 177.076 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A 1583 ' ' TYR . . . . . . . . . . . . . 80.1 t80 -94.9 96.84 9.58 Favored 'General case' 0 C--N 1.292 -1.904 0 N-CA-C 107.485 -1.302 . . . . 1.41 107.485 176.908 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A 1584 ' ' VAL . . . . . . . . . . . . . 36.5 t -112.3 95.16 3.6 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.287 0 CA-C-N 115.653 -0.703 . . . . 1.69 109.528 -176.176 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A 1585 ' ' ASP . . . . . . . . . . . . . 35.1 t70 54.72 75.57 0.29 Allowed 'General case' 0 C--N 1.32 -0.708 0 C-N-CA 124.308 1.043 . . . . 2.06 112.472 177.775 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A 1586 ' ' GLN . . . . . . . . . . . . . 34.1 tt0 68.16 -14.67 0.24 Allowed 'General case' 0 CA--C 1.574 1.888 0 C-N-CA 124.868 1.267 . . . . 2.33 114.398 176.403 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A 1587 ' ' VAL . . . . . . . . . . . . . 7.5 p -118.4 129.62 74.43 Favored 'Isoleucine or valine' 0 C--O 1.25 1.09 0 O-C-N 121.273 -0.892 . . . . 0.78 111.484 -179.4 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A 1588 ' ' LEU . . . . . 0.749 ' HB2' ' HB2' ' A' 1612 ' ' PHE . 3.8 mm? -81.26 157.53 25.13 Favored 'General case' 0 N--CA 1.435 -1.189 0 CA-C-N 115.23 -0.896 . . . . 1.41 110.415 179.001 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A 1589 ' ' GLN . . . . . . . . . . . . . 34.6 tt0 -148.05 134.96 20.14 Favored 'General case' 0 C--N 1.31 -1.148 0 C-N-CA 121.154 -0.218 . . . . 1.24 110.643 -174.715 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A 1590 ' ' LEU . . . . . 0.468 ' HB3' ' HB ' ' A' 1610 ' ' ILE . 51.0 tp -119.39 133.39 55.74 Favored 'General case' 0 C--N 1.301 -1.507 0 N-CA-C 106.95 -1.5 . . . . 1.15 106.95 175.396 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A 1591 ' ' VAL . . . . . . . . . . . . . 52.8 t -126.99 111.63 26.31 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.537 0 CA-C-O 121.022 0.439 . . . . 1.51 111.969 -174.884 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A 1592 ' ' TYR . . . . . 0.465 ' HD1' ' H ' ' A' 1578 ' ' ASN . 20.6 m-85 -101.37 93.05 5.21 Favored 'General case' 0 C--N 1.308 -1.205 0 N-CA-C 108.512 -0.921 . . . . 1.06 108.512 173.87 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A 1593 ' ' LYS . . . . . . . . . . . . . 61.4 pttt -103.36 177.21 4.91 Favored 'General case' 0 C--N 1.283 -2.321 0 CA-C-N 115.569 -0.741 . . . . 2.18 109.926 -178.754 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A 1594 ' ' ASP . . . . . . . . . . . . . 8.3 m-20 53.96 42.04 31.81 Favored 'General case' 0 N--CA 1.475 0.8 0 N-CA-C 113.923 1.083 . . . . 1.45 113.923 175.74 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A 1595 ' ' GLY . . . . . . . . . . . . . . . -74.58 -87.49 0.24 Allowed Glycine 0 N--CA 1.445 -0.704 0 C-N-CA 120.356 -0.926 . . . . 0.78 111.069 176.477 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A 1596 ' ' SER . . . . . . . . . . . . . 32.4 m -114.43 154.33 46.5 Favored Pre-proline 0 C--N 1.294 -1.807 0 N-CA-C 108.258 -1.016 . . . . 1.68 108.258 177.599 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A 1597 ' ' PRO . . . . . . . . . . . . . 23.1 Cg_exo -67.03 133.32 30.65 Favored 'Trans proline' 0 C--N 1.351 0.672 0 C-N-CA 122.849 2.366 . . . . 1.17 109.997 177.153 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A 1598 ' ' CYS . . . . . 0.445 ' HA ' ' HD3' ' A' 1599 ' ' PRO . 42.4 t -97.68 121.14 58.9 Favored Pre-proline 0 C--N 1.289 -2.055 0 CA-C-O 120.533 0.206 . . . . 1.19 110.768 -175.939 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A 1599 ' ' PRO . . . . . 0.445 ' HD3' ' HA ' ' A' 1598 ' ' CYS . 2.8 Cg_exo -77.52 -7.83 16.95 Favored 'Trans proline' 0 C--O 1.238 0.494 0 C-N-CA 123.23 2.62 . . . . 1.59 112.227 179.992 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A 1600 ' ' SER . . . . . 0.433 ' HB3' ' SG ' ' A' 1598 ' ' CYS . 22.8 t -75.32 -19.7 59.49 Favored 'General case' 0 C--N 1.317 -0.811 0 CA-C-N 115.831 -0.622 . . . . 2.12 110.313 -177.563 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A 1601 ' ' LYS . . . . . 0.565 ' HB3' HD12 ' A' 1604 ' ' LEU . 24.5 tptm -162.33 116.64 1.82 Allowed 'General case' 0 N--CA 1.443 -0.82 0 N-CA-C 108.556 -0.905 . . . . 3.74 108.556 178.915 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A 1602 ' ' SER . . . . . . . . . . . . . 51.4 m -61.3 123.2 17.09 Favored 'General case' 0 C--N 1.313 -1.01 0 CA-C-O 121.393 0.616 . . . . 3.79 111.588 179.202 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A 1603 ' ' GLY . . . . . . . . . . . . . . . 104.94 -1.45 41.33 Favored Glycine 0 N--CA 1.439 -1.1 0 CA-C-N 115.067 -0.969 . . . . 2.0 111.004 -179.895 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A 1604 ' ' LEU . . . . . 0.565 HD12 ' HB3' ' A' 1601 ' ' LYS . 3.0 mt -107.05 145.3 32.53 Favored 'General case' 0 C--N 1.31 -1.111 0 CA-C-O 121.692 0.758 . . . . 1.48 111.859 179.62 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A 1605 ' ' SER . . . . . . . . . . . . . 25.6 m -111.27 -173.94 2.35 Favored 'General case' 0 C--N 1.29 -1.987 0 N-CA-C 105.824 -1.917 . . . . 1.51 105.824 172.929 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A 1606 ' ' TYR . . . . . . . . . . . . . 62.1 m-85 -101.59 128.67 47.75 Favored 'General case' 0 CA--C 1.453 -2.78 0 N-CA-C 105.792 -1.929 . . . . 1.18 105.792 178.014 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A 1607 ' ' LYS . . . . . 0.496 ' O ' ' HA ' ' A' 1635 ' ' THR . 4.3 ptmm? -128.05 135.06 49.33 Favored 'General case' 0 N--CA 1.397 -3.075 0 O-C-N 124.506 1.129 . . . . 1.67 111.152 -176.813 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A 1608 ' ' SER . . . . . . . . . . . . . 35.1 t -114.98 125.89 54.13 Favored 'General case' 0 C--N 1.292 -1.921 0 N-CA-C 109.339 -0.615 . . . . 1.0 109.339 -178.753 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A 1609 ' ' VAL . . . . . . . . . . . . . 41.3 t -115.14 115.39 49.31 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.814 0 CA-C-O 121.237 0.541 . . . . 0.93 110.439 178.854 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A 1610 ' ' ILE . . . . . 0.678 HG13 ' HB2' ' A' 1638 ' ' PHE . 2.9 mp -102.16 113.67 39.3 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.338 0 N-CA-C 108.717 -0.845 . . . . 0.78 108.717 178.962 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A 1611 ' ' SER . . . . . . . . . . . . . 42.7 m -95.17 123.36 38.63 Favored 'General case' 0 C--N 1.284 -2.26 0 N-CA-C 109.012 -0.736 . . . . 1.29 109.012 177.367 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A 1612 ' ' PHE . . . . . 0.749 ' HB2' ' HB2' ' A' 1588 ' ' LEU . 98.2 m-85 -92.62 103.51 15.9 Favored 'General case' 0 C--N 1.305 -1.353 0 N-CA-C 108.831 -0.803 . . . . 0.7 108.831 178.835 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A 1613 ' ' VAL . . . . . 0.645 ' O ' ' HA ' ' A' 1641 ' ' HIS . 24.0 t -100.2 109.23 24.51 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.883 0 N-CA-C 107.224 -1.399 . . . . 0.75 107.224 -174.918 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A 1614 ' ' CYS . . . . . 0.574 ' HA ' ' O ' ' A' 1642 ' ' THR . 31.8 m -70.23 100.47 1.7 Allowed 'General case' 0 C--N 1.279 -2.458 0 CA-C-N 115.963 -0.562 . . . . 1.39 111.516 -174.362 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A 1615 ' ' ARG . . . . . 0.45 ' HB3' ' HB3' ' A' 1641 ' ' HIS . 56.9 ttt180 -126.77 99.07 29.99 Favored Pre-proline 0 N--CA 1.439 -0.993 0 CA-C-N 115.479 -0.782 . . . . 3.75 109.412 -179.152 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A 1616 ' ' PRO . . . . . 0.419 ' HA ' ' HB3' ' A' 1643 ' ' PRO . 76.7 Cg_exo -52.43 -34.42 61.37 Favored 'Trans proline' 0 CA--C 1.534 0.489 0 C-N-CA 123.993 3.129 . . . . 1.32 113.834 177.781 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A 1617 ' ' GLU . . . . . . . . . . . . . 48.2 mt-10 . . . . . 0 CA--C 1.545 0.753 0 N-CA-C 112.611 0.597 . . . . 3.21 112.611 -177.938 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A 1622 ' ' ASN . . . . . . . . . . . . . 27.6 t-20 . . . . . 0 N--CA 1.433 -1.29 0 CA-C-O 121.785 0.803 . . . . 2.92 111.885 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A 1623 ' ' ARG . . . . . . . . . . . . . 19.8 ptp180 -151.89 156.95 34.47 Favored Pre-proline 0 C--N 1.3 -1.583 0 N-CA-C 105.048 -2.204 . . . . 3.61 105.048 175.229 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A 1624 ' ' PRO . . . . . 0.463 ' HG3' HD11 ' A' 1552 ' ' ILE . 13.6 Cg_endo -56.22 115.76 2.7 Favored 'Trans proline' 0 C--O 1.237 0.433 0 C-N-CA 122.669 2.246 . . . . 2.37 112.154 -179.313 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A 1625 ' ' MET . . . . . . . . . . . . . 1.3 pmm? -106.48 147.7 29.05 Favored 'General case' 0 C--O 1.245 0.845 0 CA-C-O 120.999 0.428 . . . . 2.16 110.485 -179.216 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A 1626 ' ' LEU . . . . . . . . . . . . . 52.1 tp -77.6 122.02 24.72 Favored 'General case' 0 C--N 1.317 -0.842 0 N-CA-C 107.855 -1.165 . . . . 1.35 107.855 176.837 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A 1627 ' ' ILE . . . . . . . . . . . . . 39.1 pt -100.88 -32.81 3.5 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.214 0 C-N-CA 120.48 -0.488 . . . . 1.21 111.286 -179.021 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A 1628 ' ' SER . . . . . . . . . . . . . 49.5 m -151.11 153.28 34.73 Favored 'General case' 0 C--N 1.314 -0.97 0 CA-C-O 120.789 0.328 . . . . 1.4 110.283 -177.589 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A 1629 ' ' LEU . . . . . 0.946 HD13 ' HG ' ' A' 1636 ' ' LEU . 17.7 tp -139.12 120.39 14.79 Favored 'General case' 0 C--N 1.294 -1.809 0 N-CA-C 108.522 -0.918 . . . . 1.56 108.522 177.47 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A 1630 ' ' ASP . . . . . . . . . . . . . 23.0 t70 -118.29 107.33 13.76 Favored 'General case' 0 C--N 1.299 -1.624 0 N-CA-C 109.658 -0.497 . . . . 0.87 109.658 176.855 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A 1631 ' ' LYS . . . . . . . . . . . . . 34.8 mtmm -78.74 -13.13 59.98 Favored 'General case' 0 C--N 1.303 -1.416 0 CA-C-N 115.514 -0.766 . . . . 2.35 111.07 -176.997 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A 1632 ' ' GLN . . . . . . . . . . . . . 40.2 mt-30 -70.35 -42.63 71.58 Favored 'General case' 0 C--N 1.323 -0.544 0 N-CA-C 109.587 -0.523 . . . . 2.55 109.587 178.254 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A 1633 ' ' THR . . . . . . . . . . . . . 35.9 p -98.27 4.2 48.77 Favored 'General case' 0 C--N 1.318 -0.765 0 CA-C-O 121.047 0.451 . . . . 1.24 110.821 175.747 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A 1634 ' ' CYS . . . . . . . . . . . . . 59.1 m 56.55 38.8 29.91 Favored 'General case' 0 C--O 1.236 0.394 0 C-N-CA 124.195 0.998 . . . . 0.89 110.461 177.361 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A 1635 ' ' THR . . . . . 0.496 ' HA ' ' O ' ' A' 1607 ' ' LYS . 44.2 m -119.73 131.45 55.38 Favored 'General case' 0 N--CA 1.422 -1.841 0 CA-C-N 114.945 -1.025 . . . . 0.75 111.597 -174.223 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A 1636 ' ' LEU . . . . . 0.946 ' HG ' HD13 ' A' 1629 ' ' LEU . 5.2 mp -104.12 134.89 46.61 Favored 'General case' 0 N--CA 1.434 -1.25 0 N-CA-C 108.04 -1.096 . . . . 1.33 108.04 174.838 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A 1637 ' ' PHE . . . . . . . . . . . . . 93.9 m-85 -111.42 105.83 14.57 Favored 'General case' 0 C--N 1.307 -1.279 0 CA-C-O 120.919 0.39 . . . . 0.83 111.008 -176.844 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A 1638 ' ' PHE . . . . . 0.678 ' HB2' HG13 ' A' 1610 ' ' ILE . 96.4 m-85 -103.11 151.87 22.06 Favored 'General case' 0 C--N 1.306 -1.304 0 N-CA-C 109.03 -0.73 . . . . 0.6 109.03 177.398 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A 1639 ' ' SER . . . . . . . . . . . . . 49.0 m -137.08 133.82 35.82 Favored 'General case' 0 C--N 1.276 -2.598 0 N-CA-C 109.705 -0.48 . . . . 1.08 109.705 176.656 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A 1640 ' ' TRP . . . . . 0.584 ' HE3' ' HE1' ' A' 1612 ' ' PHE . 12.3 t90 -115.58 120.93 41.07 Favored 'General case' 0 N--CA 1.413 -2.306 0 N-CA-C 106.274 -1.75 . . . . 0.8 106.274 174.164 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A 1641 ' ' HIS . . . . . 0.645 ' HA ' ' O ' ' A' 1613 ' ' VAL . 39.1 m-70 -93.89 92.34 7.36 Favored 'General case' 0 C--N 1.304 -1.378 0 N-CA-C 107.517 -1.29 . . . . 2.54 107.517 -177.922 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A 1642 ' ' THR . . . . . 0.73 HG22 ' HG ' ' A' 1644 ' ' LEU . 1.5 m -119.91 123.62 28.34 Favored Pre-proline 0 C--N 1.289 -2.053 0 CA-C-N 114.947 -1.024 . . . . 1.15 111.884 -167.96 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A 1643 ' ' PRO . . . . . 0.419 ' HB3' ' HA ' ' A' 1616 ' ' PRO . 31.7 Cg_exo -65.24 -29.7 55.1 Favored 'Trans proline' 0 CA--C 1.539 0.745 0 C-N-CA 123.443 2.762 . . . . 0.8 112.861 177.001 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A 1644 ' ' LEU . . . . . 0.73 ' HG ' HG22 ' A' 1642 ' ' THR . 4.4 pp -84.07 -6.76 59.46 Favored 'General case' 0 C--N 1.323 -0.562 0 N-CA-C 112.104 0.409 . . . . 1.54 112.104 -176.969 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A 1645 ' ' ALA . . . . . 0.485 ' HB2' ' HB ' ' A' 1642 ' ' THR . . . -74.14 -30.92 62.51 Favored 'General case' 0 C--N 1.306 -1.3 0 CA-C-N 116.022 -0.536 . . . . 0.95 112.165 -174.941 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A 1646 ' ' CYS . . . . . 0.493 ' HA ' ' CE1' ' A' 1527 ' ' PHE . 17.0 p -177.38 175.29 1.48 Allowed 'General case' 0 C--O 1.246 0.871 0 N-CA-C 106.999 -1.482 . . . . 1.41 106.999 175.288 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A 1647 ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 . . . . . 0 C--N 1.299 -1.608 0 N-CA-C 108.54 -0.911 . . . . 2.92 108.54 175.871 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A 1515 ' ' ASP . . . . . . . . . . . . . 17.3 t70 . . . . . 0 CA--C 1.551 0.991 0 N-CA-C 109.958 -0.386 . . . . 2.54 109.958 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A 1516 ' ' CYS . . . . . 0.472 ' SG ' ' HD2' ' A' 1579 ' ' LYS . 97.1 m -137.09 18.96 2.98 Favored 'General case' 0 C--N 1.316 -0.874 0 CA-C-O 121.194 0.521 . . . . 1.25 110.456 175.104 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A 1517 ' ' GLN . . . . . 0.539 ' HB2' HD21 ' A' 1526 ' ' LEU . 11.2 pt20 -132.54 137.47 47.14 Favored 'General case' 0 C--N 1.302 -1.469 0 O-C-N 121.809 -0.557 . . . . 1.88 109.7 178.92 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A 1518 ' ' VAL . . . . . . . . . . . . . 10.2 p -143.55 134.87 22.83 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.664 0 CA-C-O 121.025 0.441 . . . . 1.73 110.288 -178.402 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A 1519 ' ' THR . . . . . 0.773 ' HA ' ' HA ' ' A' 1526 ' ' LEU . 23.3 m -85.3 120.84 27.22 Favored 'General case' 0 C--N 1.3 -1.549 0 N-CA-C 109.327 -0.62 . . . . 1.7 109.327 178.781 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A 1520 ' ' ASN . . . . . 0.407 ' OD1' HG22 ' A' 1523 ' ' THR . 24.0 t-20 -71.98 119.71 76.02 Favored Pre-proline 0 C--N 1.314 -0.937 0 N-CA-C 109.327 -0.62 . . . . 2.12 109.327 179.131 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A 1521 ' ' PRO . . . . . . . . . . . . . 86.5 Cg_endo -75.09 -2.95 13.22 Favored 'Trans proline' 0 CA--C 1.539 0.749 0 C-N-CA 122.64 2.227 . . . . 2.47 113.953 -175.31 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A 1522 ' ' SER . . . . . . . . . . . . . 32.8 m -94.11 -49.75 5.61 Favored 'General case' 0 C--N 1.305 -1.341 0 O-C-N 122.104 -0.373 . . . . 2.57 111.101 -179.375 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A 1523 ' ' THR . . . . . 0.409 HG23 ' H ' ' A' 1525 ' ' HIS . 12.0 t -96.53 -16.99 20.8 Favored 'General case' 0 CA--C 1.553 1.07 0 CA-C-O 121.255 0.55 . . . . 2.15 111.097 -179.901 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A 1524 ' ' GLY . . . . . . . . . . . . . . . 81.84 8.16 87.08 Favored Glycine 0 C--O 1.222 -0.601 0 C-N-CA 121.507 -0.378 . . . . 1.89 112.918 178.83 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A 1525 ' ' HIS . . . . . 0.409 ' H ' HG23 ' A' 1523 ' ' THR . 16.0 t-160 -101.69 134.97 44.01 Favored 'General case' 0 C--N 1.302 -1.47 0 N-CA-C 109.432 -0.581 . . . . 1.9 109.432 -178.306 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A 1526 ' ' LEU . . . . . 0.773 ' HA ' ' HA ' ' A' 1519 ' ' THR . 6.7 tt -84.98 135.21 34.13 Favored 'General case' 0 C--N 1.303 -1.43 0 CA-C-N 116.387 -0.369 . . . . 1.61 110.735 177.819 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A 1527 ' ' PHE . . . . . . . . . . . . . 80.7 m-85 -99.8 113.03 25.27 Favored 'General case' 0 C--N 1.309 -1.195 0 N-CA-C 108.078 -1.082 . . . . 1.42 108.078 174.546 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A 1528 ' ' ASP . . . . . . . . . . . . . 11.8 t70 -100.59 103.55 14.86 Favored 'General case' 0 C--N 1.302 -1.495 0 N-CA-C 108.927 -0.768 . . . . 2.18 108.927 -179.455 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A 1529 ' ' LEU . . . . . 0.457 HD13 ' CZ ' ' A' 1612 ' ' PHE . 78.7 mt -89.5 -13.81 36.63 Favored 'General case' 0 C--N 1.298 -1.65 0 N-CA-C 108.234 -1.024 . . . . 1.44 108.234 -176.145 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A 1530 ' ' SER . . . . . 0.458 ' OG ' ' HB2' ' A' 1516 ' ' CYS . 3.2 m -58.03 -54.83 42.56 Favored 'General case' 0 N--CA 1.438 -1.065 0 C-N-CA 124.788 1.235 . . . . 1.44 110.742 -179.58 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A 1531 ' ' SER . . . . . . . . . . . . . 5.6 m -81.23 1.43 32.29 Favored 'General case' 0 C--N 1.317 -0.829 0 CA-C-N 115.886 -0.597 . . . . 1.5 111.592 -175.722 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A 1532 ' ' LEU . . . . . 0.414 ' HG ' ' HA ' ' A' 1529 ' ' LEU . 32.3 mt -82.41 -18.34 42.28 Favored 'General case' 0 C--N 1.319 -0.757 0 C-N-CA 120.036 -0.666 . . . . 1.77 110.661 179.507 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A 1533 ' ' SER . . . . . 0.89 ' HB2' HG22 ' A' 1552 ' ' ILE . 22.7 t -114.2 134.13 55.13 Favored 'General case' 0 N--CA 1.432 -1.341 0 N-CA-C 108.523 -0.917 . . . . 2.38 108.523 178.417 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A 1534 ' ' GLY . . . . . . . . . . . . . . . -81.93 173.46 53.53 Favored Glycine 0 N--CA 1.429 -1.768 0 N-CA-C 107.724 -2.15 . . . . 1.55 107.724 172.148 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A 1535 ' ' ARG . . . . . 0.428 HH11 ' HD2' ' A' 1535 ' ' ARG . 14.8 ttp180 -72.3 -17.8 61.84 Favored 'General case' 0 C--N 1.31 -1.151 0 CA-C-N 118.254 1.027 . . . . 3.96 110.55 -178.842 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A 1536 ' ' ALA . . . . . . . . . . . . . . . -84.86 -6.92 59.35 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 116.109 -0.496 . . . . 1.65 110.198 176.423 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A 1537 ' ' GLY . . . . . . . . . . . . . . . 59.84 -153.81 33.06 Favored Glycine 0 N--CA 1.447 -0.569 0 CA-C-N 115.321 -0.854 . . . . 1.19 114.126 177.366 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A 1538 ' ' PHE . . . . . . . . . . . . . 96.2 m-85 -113.55 163.72 14.57 Favored 'General case' 0 C--N 1.294 -1.819 0 N-CA-C 108.027 -1.101 . . . . 1.69 108.027 178.441 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A 1539 ' ' THR . . . . . . . . . . . . . 9.5 t -143.99 130.64 20.14 Favored 'General case' 0 C--N 1.287 -2.128 0 N-CA-C 108.991 -0.744 . . . . 1.48 108.991 177.88 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A 1540 ' ' ALA . . . . . . . . . . . . . . . -131.96 143.72 50.3 Favored 'General case' 0 C--N 1.306 -1.307 0 N-CA-C 109.054 -0.721 . . . . 0.83 109.054 -177.374 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A 1541 ' ' ALA . . . . . . . . . . . . . . . -82.14 151.46 26.95 Favored 'General case' 0 C--N 1.31 -1.124 0 CA-C-N 116.167 -0.47 . . . . 1.27 110.386 -178.991 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A 1542 ' ' TYR . . . . . . . . . . . . . 26.1 t80 -152.54 175.06 13.16 Favored 'General case' 0 C--N 1.312 -1.031 0 N-CA-C 107.864 -1.162 . . . . 2.15 107.864 -177.162 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A 1543 ' ' SER . . . . . . . . . . . . . 8.3 p -49.57 -150.46 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.797 0 C-N-CA 127.922 2.489 . . . . 2.29 114.853 -179.941 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A 1544 ' ' LYS . . . . . . . . . . . . . 9.7 ptpp? -39.81 -28.12 0.04 OUTLIER 'General case' 0 N--CA 1.506 2.353 0 N-CA-C 114.53 1.307 . . . . 3.91 114.53 -178.245 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A 1545 ' ' SER . . . . . . . . . . . . . 25.0 t -73.01 -8.55 56.22 Favored 'General case' 0 CA--C 1.555 1.146 0 N-CA-C 112.204 0.446 . . . . 3.3 112.204 177.571 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A 1546 ' ' GLY . . . . . . . . . . . . . . . 81.08 -75.31 2.3 Favored Glycine 0 N--CA 1.44 -1.088 0 N-CA-C 114.643 0.617 . . . . 1.24 114.643 172.624 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A 1547 ' ' VAL . . . . . . . . . . . . . 9.3 p -153.26 150.26 12.67 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.446 0 N-CA-C 109.32 -0.622 . . . . 1.63 109.32 -175.158 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A 1548 ' ' VAL . . . . . . . . . . . . . 5.7 t -111.21 145.06 17.93 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.547 0 N-CA-C 108.536 -0.912 . . . . 0.92 108.536 -178.699 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A 1549 ' ' TYR . . . . . . . . . . . . . 39.4 m-85 -114.54 125.27 53.6 Favored 'General case' 0 CA--C 1.501 -0.928 0 N-CA-C 107.31 -1.367 . . . . 1.44 107.31 172.926 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A 1550 ' ' MET . . . . . . . . . . . . . 18.3 ptm -153.15 124.58 7.63 Favored 'General case' 0 C--N 1.298 -1.658 0 CA-C-O 121.396 0.617 . . . . 1.74 112.008 -172.672 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A 1551 ' ' SER . . . . . . . . . . . . . 25.4 m -93.57 133.46 36.86 Favored 'General case' 0 C--N 1.282 -2.34 0 N-CA-C 106.88 -1.526 . . . . 1.64 106.88 176.175 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A 1552 ' ' ILE . . . . . 0.89 HG22 ' HB2' ' A' 1533 ' ' SER . 1.1 tp -73.17 -18.63 18.18 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.114 0 CA-C-O 121.816 0.817 . . . . 1.33 109.629 -176.374 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A 1553 ' ' CYS . . . . . . . . . . . . . 38.4 t -161.27 138.44 8.84 Favored 'General case' 0 N--CA 1.416 -2.144 0 N-CA-C 105.923 -1.88 . . . . 1.43 105.923 173.532 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A 1554 ' ' GLY . . . . . . . . . . . . . . . 101.38 -174.87 25.34 Favored Glycine 0 N--CA 1.433 -1.529 0 N-CA-C 111.17 -0.772 . . . . 1.12 111.17 178.538 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A 1555 ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -103.31 151.7 22.41 Favored 'General case' 0 C--N 1.302 -1.459 0 CA-C-O 121.439 0.638 . . . . 1.8 111.776 -179.17 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A 1556 ' ' ASN . . . . . . . . . . . . . 8.6 t-20 -100.67 139.11 36.82 Favored 'General case' 0 N--CA 1.42 -1.94 0 CA-C-N 114.52 -1.218 . . . . 2.63 108.3 -177.241 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A 1557 ' ' GLU . . . . . . . . . . . . . 54.2 mm-40 -102.65 -7.07 22.06 Favored 'General case' 0 C--N 1.293 -1.875 0 CA-C-N 115.443 -0.799 . . . . 3.79 112.156 -172.404 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A 1558 ' ' ASN . . . . . . . . . . . . . 39.6 m-80 -75.52 -31.36 60.09 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-O 121.803 0.811 . . . . 1.52 109.901 -178.655 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A 1559 ' ' CYS . . . . . 0.645 ' HB3' ' HD2' ' A' 1560 ' ' PRO . 95.5 m -113.25 176.47 1.47 Allowed Pre-proline 0 C--N 1.294 -1.841 0 CA-C-O 117.471 -1.252 . . . . 0.84 108.027 176.474 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A 1560 ' ' PRO . . . . . 0.645 ' HD2' ' HB3' ' A' 1559 ' ' CYS . 99.2 Cg_exo -29.88 122.16 0.06 OUTLIER 'Trans proline' 0 C--N 1.375 1.957 0 C-N-CA 124.358 3.372 . . . . 1.18 113.909 173.693 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A 1561 ' ' PRO . . . . . 0.432 ' HD3' ' HA ' ' A' 1560 ' ' PRO . 32.1 Cg_exo -58.57 110.25 0.63 Allowed 'Trans proline' 0 C--O 1.245 0.85 0 C-N-CA 123.243 2.629 . . . . 1.51 111.66 -176.776 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A 1562 ' ' GLY . . . . . . . . . . . . . . . 132.94 -15.24 4.86 Favored Glycine 0 N--CA 1.44 -1.085 0 C-N-CA 120.23 -0.986 . . . . 0.72 112.507 -179.792 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A 1563 ' ' VAL . . . . . 0.426 ' HA ' ' HA ' ' A' 1576 ' ' LYS . 13.8 m -86.49 149.82 4.04 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.957 0 N-CA-C 108.02 -1.104 . . . . 0.97 108.02 177.326 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A 1564 ' ' GLY . . . . . . . . . . . . . . . -102.0 -30.77 5.62 Favored Glycine 0 C--N 1.307 -1.059 0 N-CA-C 111.188 -0.765 . . . . 0.72 111.188 -178.019 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A 1565 ' ' ALA . . . . . . . . . . . . . . . -140.3 136.3 33.11 Favored 'General case' 0 N--CA 1.44 -0.927 0 N-CA-C 109.04 -0.726 . . . . 0.37 109.04 178.773 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A 1566 ' ' CYS . . . . . . . . . . . . . 16.5 t -156.32 146.36 21.26 Favored 'General case' 0 C--N 1.298 -1.668 0 CA-C-N 116.243 -0.435 . . . . 0.51 109.933 -175.324 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A 1567 ' ' PHE . . . . . . . . . . . . . 21.5 m-85 -73.88 123.32 24.01 Favored 'General case' 0 C--O 1.211 -0.921 0 N-CA-C 107.239 -1.393 . . . . 0.97 107.239 174.467 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A 1568 ' ' GLY . . . . . . . . . . . . . . . -75.36 -18.64 79.89 Favored Glycine 0 C--N 1.309 -0.92 0 C-N-CA 120.472 -0.871 . . . . 1.08 114.655 -171.732 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A 1569 ' ' GLN . . . . . . . . . . . . . 58.9 tp60 -80.66 -60.0 2.47 Favored 'General case' 0 C--N 1.302 -1.496 0 CA-C-O 121.059 0.457 . . . . 2.74 110.498 -179.586 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A 1570 ' ' THR . . . . . . . . . . . . . 12.3 p -88.14 -11.16 47.74 Favored 'General case' 0 C--N 1.31 -1.146 0 N-CA-C 112.817 0.673 . . . . 1.96 112.817 -175.289 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A 1571 ' ' ARG . . . . . . . . . . . . . 51.0 mtm180 58.04 45.16 18.33 Favored 'General case' 0 CA--C 1.515 -0.372 0 C-N-CA 125.363 1.465 . . . . 3.95 112.853 179.248 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A 1572 ' ' ILE . . . . . . . . . . . . . 36.3 mt -100.61 122.82 53.07 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.192 0 N-CA-C 108.788 -0.819 . . . . 1.37 108.788 179.112 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A 1573 ' ' SER . . . . . . . . . . . . . 33.2 t -61.88 122.57 15.76 Favored 'General case' 0 C--N 1.31 -1.133 0 C-N-CA 124.644 1.178 . . . . 1.08 110.855 -179.033 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A 1574 ' ' VAL . . . . . . . . . . . . . 30.0 m -127.83 33.93 1.36 Allowed 'Isoleucine or valine' 0 C--N 1.315 -0.895 0 CA-C-O 122.238 1.018 . . . . 1.3 110.234 178.973 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A 1575 ' ' GLY . . . . . . . . . . . . . . . 155.69 115.61 0.52 Allowed Glycine 0 N--CA 1.419 -2.442 0 CA-C-N 114.248 -1.342 . . . . 0.51 111.341 177.979 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A 1576 ' ' LYS . . . . . 0.426 ' HA ' ' HA ' ' A' 1563 ' ' VAL . 3.3 tppp? -82.13 145.33 30.19 Favored 'General case' 0 C--N 1.307 -1.253 0 N-CA-C 106.77 -1.567 . . . . 2.9 106.77 178.201 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A 1577 ' ' ALA . . . . . . . . . . . . . . . -63.81 112.92 3.1 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 121.343 0.592 . . . . 0.83 109.516 -179.024 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A 1578 ' ' ASN . . . . . . . . . . . . . 50.4 t-20 -135.77 139.13 43.3 Favored 'General case' 0 C--N 1.295 -1.802 0 N-CA-C 107.687 -1.227 . . . . 1.85 107.687 -173.493 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A 1579 ' ' LYS . . . . . 0.472 ' HD2' ' SG ' ' A' 1516 ' ' CYS . 43.2 mmtm -100.9 89.85 3.99 Favored 'General case' 0 C--N 1.3 -1.562 0 N-CA-C 108.043 -1.095 . . . . 1.9 108.043 178.957 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A 1580 ' ' ARG . . . . . . . . . . . . . 18.7 tpp180 -146.79 84.87 1.61 Allowed 'General case' 0 N--CA 1.429 -1.514 0 CA-C-O 121.33 0.586 . . . . 3.63 110.593 -177.627 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A 1581 ' ' LEU . . . . . 0.4 ' HA ' ' O ' ' A' 1589 ' ' GLN . 3.8 pp -104.37 153.71 20.73 Favored 'General case' 0 N--CA 1.427 -1.595 0 CA-C-N 115.55 -0.75 . . . . 1.87 110.112 176.117 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A 1582 ' ' ARG . . . . . 0.43 ' CG ' ' HB3' ' A' 1589 ' ' GLN . 14.7 ptp180 -131.62 139.89 49.25 Favored 'General case' 0 C--N 1.283 -2.296 0 N-CA-C 108.937 -0.764 . . . . 3.97 108.937 177.427 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A 1583 ' ' TYR . . . . . 0.43 ' CE1' ' HA ' ' A' 1586 ' ' GLN . 67.5 t80 -102.84 91.85 4.34 Favored 'General case' 0 N--CA 1.432 -1.367 0 N-CA-C 107.448 -1.315 . . . . 1.41 107.448 176.819 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A 1584 ' ' VAL . . . . . . . . . . . . . 1.6 m -120.27 110.46 28.86 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.607 0 CA-C-N 115.421 -0.809 . . . . 1.69 112.53 -176.553 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A 1585 ' ' ASP . . . . . . . . . . . . . 16.0 t70 65.45 38.8 5.46 Favored 'General case' 0 C--N 1.313 -1.019 0 CA-C-O 122.481 1.134 . . . . 2.06 109.619 173.409 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A 1586 ' ' GLN . . . . . 0.43 ' HA ' ' CE1' ' A' 1583 ' ' TYR . 47.8 mt-30 73.78 -14.43 0.66 Allowed 'General case' 0 N--CA 1.484 1.234 0 C-N-CA 126.049 1.739 . . . . 2.33 114.042 -179.729 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A 1587 ' ' VAL . . . . . . . . . . . . . 7.6 p -94.53 121.68 45.33 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.026 0 CA-C-O 121.361 0.601 . . . . 0.78 110.055 178.461 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A 1588 ' ' LEU . . . . . 0.663 ' HB2' ' HB2' ' A' 1612 ' ' PHE . 3.8 mm? -78.75 138.76 38.38 Favored 'General case' 0 N--CA 1.433 -1.301 0 CA-C-N 115.658 -0.701 . . . . 1.41 109.67 178.736 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A 1589 ' ' GLN . . . . . 0.43 ' HB3' ' CG ' ' A' 1582 ' ' ARG . 34.6 tt0 -133.58 126.92 31.99 Favored 'General case' 0 C--N 1.292 -1.91 0 N-CA-C 108.63 -0.878 . . . . 1.24 108.63 179.479 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A 1590 ' ' LEU . . . . . . . . . . . . . 8.9 tt -124.59 126.21 45.42 Favored 'General case' 0 C--N 1.295 -1.794 0 N-CA-C 107.438 -1.319 . . . . 1.15 107.438 179.911 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A 1591 ' ' VAL . . . . . 0.436 HG22 HG13 ' A' 1609 ' ' VAL . 67.8 t -117.75 123.03 71.14 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.798 0 CA-C-O 121.237 0.541 . . . . 1.51 112.454 -174.488 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A 1592 ' ' TYR . . . . . . . . . . . . . 49.4 m-85 -97.29 101.59 13.17 Favored 'General case' 0 C--N 1.309 -1.153 0 CA-C-N 115.041 -0.981 . . . . 1.06 108.383 175.114 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A 1593 ' ' LYS . . . . . . . . . . . . . 19.0 ptpt -99.74 -173.68 2.52 Favored 'General case' 0 C--N 1.3 -1.547 0 N-CA-C 109.756 -0.461 . . . . 2.18 109.756 179.849 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A 1594 ' ' ASP . . . . . . . . . . . . . 6.7 m-20 50.07 53.96 11.93 Favored 'General case' 0 N--CA 1.478 0.925 0 N-CA-C 114.84 1.422 . . . . 1.45 114.84 175.951 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A 1595 ' ' GLY . . . . . . . . . . . . . . . -90.02 -92.45 1.22 Allowed Glycine 0 N--CA 1.425 -2.052 0 N-CA-C 108.001 -2.04 . . . . 0.78 108.001 174.367 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A 1596 ' ' SER . . . . . 0.407 ' HB2' ' HD2' ' A' 1606 ' ' TYR . 20.0 m -114.16 135.95 22.19 Favored Pre-proline 0 C--N 1.291 -1.936 0 N-CA-C 107.475 -1.306 . . . . 1.68 107.475 175.404 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A 1597 ' ' PRO . . . . . . . . . . . . . 32.0 Cg_exo -60.87 128.23 24.88 Favored 'Trans proline' 0 C--O 1.243 0.754 0 C-N-CA 122.513 2.142 . . . . 1.17 109.422 178.254 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A 1598 ' ' CYS . . . . . 0.566 ' HB3' HD12 ' A' 1604 ' ' LEU . 9.0 t -95.7 125.27 49.78 Favored Pre-proline 0 C--N 1.293 -1.861 0 N-CA-C 109.021 -0.733 . . . . 1.19 109.021 -174.35 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A 1599 ' ' PRO . . . . . 0.461 ' HD3' ' HA ' ' A' 1598 ' ' CYS . 1.0 OUTLIER -84.04 -0.29 9.52 Favored 'Trans proline' 0 CA--C 1.536 0.591 0 C-N-CA 122.86 2.373 . . . . 1.59 113.18 -177.296 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A 1600 ' ' SER . . . . . . . . . . . . . 20.3 m -67.41 -31.3 71.41 Favored 'General case' 0 C--O 1.241 0.645 0 CA-C-O 121.095 0.474 . . . . 2.12 111.122 179.594 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A 1601 ' ' LYS . . . . . 0.444 ' HB3' HD21 ' A' 1604 ' ' LEU . 13.1 tmtt? -152.63 130.47 11.69 Favored 'General case' 0 C--N 1.31 -1.151 0 N-CA-C 105.96 -1.867 . . . . 3.74 105.96 178.731 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A 1602 ' ' SER . . . . . . . . . . . . . 23.9 t -71.88 117.39 13.42 Favored 'General case' 0 C--N 1.305 -1.333 0 CA-C-O 121.207 0.527 . . . . 3.79 111.255 -177.103 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A 1603 ' ' GLY . . . . . . . . . . . . . . . 116.66 15.71 6.76 Favored Glycine 0 N--CA 1.43 -1.762 0 CA-C-N 115.625 -0.716 . . . . 2.0 112.79 175.988 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A 1604 ' ' LEU . . . . . 0.566 HD12 ' HB3' ' A' 1598 ' ' CYS . 2.3 pp -140.3 161.3 38.0 Favored 'General case' 0 C--N 1.316 -0.864 0 N-CA-C 113.462 0.912 . . . . 1.48 113.462 179.711 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A 1605 ' ' SER . . . . . . . . . . . . . 9.3 t -121.38 170.93 9.15 Favored 'General case' 0 C--N 1.295 -1.765 0 N-CA-C 108.078 -1.082 . . . . 1.51 108.078 -175.314 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A 1606 ' ' TYR . . . . . 0.407 ' HD2' ' HB2' ' A' 1596 ' ' SER . 90.8 m-85 -85.54 111.91 20.45 Favored 'General case' 0 CA--C 1.461 -2.465 0 N-CA-C 102.783 -3.043 . . . . 1.18 102.783 176.078 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A 1607 ' ' LYS . . . . . . . . . . . . . 22.3 pttm -126.93 148.63 50.04 Favored 'General case' 0 N--CA 1.399 -2.99 0 C-N-CA 119.006 -1.077 . . . . 1.67 112.111 -172.877 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A 1608 ' ' SER . . . . . . . . . . . . . 23.8 t -104.65 128.2 52.63 Favored 'General case' 0 C--N 1.298 -1.663 0 CA-C-N 115.674 -0.694 . . . . 1.0 109.598 -177.429 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A 1609 ' ' VAL . . . . . 0.436 HG13 HG22 ' A' 1591 ' ' VAL . 53.4 t -114.42 111.01 34.14 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.969 0 N-CA-C 108.507 -0.923 . . . . 0.93 108.507 178.874 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A 1610 ' ' ILE . . . . . . . . . . . . . 26.3 mm -94.03 117.26 37.24 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.348 0 CA-C-N 116.117 -0.492 . . . . 0.78 109.697 -179.139 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A 1611 ' ' SER . . . . . . . . . . . . . 35.9 p -104.58 113.75 27.53 Favored 'General case' 0 N--CA 1.429 -1.493 0 CA-C-O 121.33 0.586 . . . . 1.29 109.614 175.861 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A 1612 ' ' PHE . . . . . 0.663 ' HB2' ' HB2' ' A' 1588 ' ' LEU . 96.9 m-85 -87.7 102.51 14.71 Favored 'General case' 0 C--N 1.306 -1.295 0 CA-C-N 115.518 -0.765 . . . . 0.7 109.139 -179.256 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A 1613 ' ' VAL . . . . . . . . . . . . . 42.2 t -106.35 122.18 59.83 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.877 0 N-CA-C 109.303 -0.628 . . . . 0.75 109.303 -175.914 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A 1614 ' ' CYS . . . . . 0.589 ' HA ' ' O ' ' A' 1642 ' ' THR . 0.5 OUTLIER -75.34 93.81 2.95 Favored 'General case' 0 C--N 1.298 -1.65 0 N-CA-C 114.632 1.345 . . . . 1.39 114.632 -178.988 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A 1615 ' ' ARG . . . . . 0.49 ' HB3' ' HB3' ' A' 1641 ' ' HIS . 23.3 tpt180 -131.64 96.84 20.04 Favored Pre-proline 0 N--CA 1.423 -1.78 0 N-CA-C 107.881 -1.155 . . . . 3.75 107.881 174.306 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A 1616 ' ' PRO . . . . . 0.595 ' HB3' ' HB3' ' A' 1643 ' ' PRO . 7.6 Cg_exo -75.66 64.34 6.6 Favored 'Trans proline' 0 CA--C 1.532 0.42 0 C-N-CA 123.817 3.011 . . . . 1.32 113.643 -175.854 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A 1617 ' ' GLU . . . . . . . . . . . . . 44.0 mt-10 . . . . . 0 C--N 1.312 -1.024 0 O-C-N 122.201 -0.312 . . . . 3.21 111.337 179.013 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A 1622 ' ' ASN . . . . . . . . . . . . . 59.6 t30 . . . . . 0 C--O 1.239 0.53 0 CA-C-O 120.762 0.315 . . . . 2.92 110.991 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A 1623 ' ' ARG . . . . . . . . . . . . . 7.7 ptp180 -135.2 147.93 64.36 Favored Pre-proline 0 C--N 1.309 -1.186 0 N-CA-C 109.622 -0.51 . . . . 3.61 109.622 -177.393 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A 1624 ' ' PRO . . . . . . . . . . . . . 18.7 Cg_endo -58.97 124.38 15.56 Favored 'Trans proline' 0 C--N 1.349 0.565 0 C-N-CA 123.436 2.757 . . . . 2.37 112.109 179.762 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A 1625 ' ' MET . . . . . . . . . . . . . 54.9 ttp -94.6 125.08 39.02 Favored 'General case' 0 C--N 1.301 -1.503 0 CA-C-N 115.863 -0.608 . . . . 2.16 110.809 -176.84 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A 1626 ' ' LEU . . . . . 0.494 ' HB2' ' CE1' ' A' 1638 ' ' PHE . 31.8 tp -73.66 103.73 4.34 Favored 'General case' 0 C--N 1.306 -1.299 0 N-CA-C 108.729 -0.841 . . . . 1.35 108.729 175.979 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A 1627 ' ' ILE . . . . . . . . . . . . . 27.9 pt -91.56 -36.58 8.1 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.381 0 CA-C-N 115.751 -0.659 . . . . 1.21 112.485 -176.649 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A 1628 ' ' SER . . . . . . . . . . . . . 6.2 p -153.66 135.42 14.5 Favored 'General case' 0 N--CA 1.43 -1.448 0 CA-C-O 120.883 0.373 . . . . 1.4 111.567 -177.396 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A 1629 ' ' LEU . . . . . 0.926 ' HG ' ' HG ' ' A' 1636 ' ' LEU . 4.4 tt -125.31 114.76 19.34 Favored 'General case' 0 C--N 1.3 -1.552 0 N-CA-C 105.757 -1.942 . . . . 1.56 105.757 177.825 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A 1630 ' ' ASP . . . . . . . . . . . . . 25.0 t70 -91.87 121.99 33.98 Favored 'General case' 0 C--N 1.301 -1.502 0 N-CA-C 107.962 -1.125 . . . . 0.87 107.962 178.279 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A 1631 ' ' LYS . . . . . . . . . . . . . 96.8 mttt -86.48 -2.97 58.92 Favored 'General case' 0 C--N 1.301 -1.511 0 N-CA-C 112.642 0.608 . . . . 2.35 112.642 -172.252 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A 1632 ' ' GLN . . . . . . . . . . . . . 1.9 mp0 -95.59 -42.63 8.32 Favored 'General case' 0 C--N 1.318 -0.773 0 C-N-CA 120.463 -0.495 . . . . 2.55 110.665 177.424 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A 1633 ' ' THR . . . . . 0.459 ' HA ' HD22 ' A' 1604 ' ' LEU . 31.7 p -90.97 -8.15 50.03 Favored 'General case' 0 C--O 1.251 1.137 0 CA-C-O 121.621 0.724 . . . . 1.24 110.902 177.581 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A 1634 ' ' CYS . . . . . . . . . . . . . 33.3 m 59.29 44.64 15.15 Favored 'General case' 0 C--N 1.34 0.161 0 CA-C-N 113.905 -1.498 . . . . 0.89 110.379 176.588 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A 1635 ' ' THR . . . . . . . . . . . . . 7.5 p -108.32 126.21 52.58 Favored 'General case' 0 N--CA 1.428 -1.549 0 CA-C-N 114.339 -1.3 . . . . 0.75 111.173 -176.198 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A 1636 ' ' LEU . . . . . 0.926 ' HG ' ' HG ' ' A' 1629 ' ' LEU . 5.9 mp -105.47 111.04 23.6 Favored 'General case' 0 N--CA 1.431 -1.423 0 N-CA-C 109.621 -0.511 . . . . 1.33 109.621 175.596 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A 1637 ' ' PHE . . . . . . . . . . . . . 97.5 m-85 -92.03 112.75 24.81 Favored 'General case' 0 C--O 1.249 1.06 0 CA-C-N 116.202 -0.453 . . . . 0.83 110.6 -178.573 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A 1638 ' ' PHE . . . . . 0.494 ' CE1' ' HB2' ' A' 1626 ' ' LEU . 97.1 m-85 -109.12 132.13 54.41 Favored 'General case' 0 C--N 1.304 -1.385 0 CA-C-N 115.892 -0.595 . . . . 0.6 109.448 177.709 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A 1639 ' ' SER . . . . . . . . . . . . . 29.4 p -111.19 117.23 32.64 Favored 'General case' 0 C--N 1.285 -2.223 0 CA-C-O 121.628 0.728 . . . . 1.08 110.34 176.652 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A 1640 ' ' TRP . . . . . . . . . . . . . 13.9 t90 -101.8 102.57 13.21 Favored 'General case' 0 N--CA 1.419 -1.978 0 N-CA-C 107.42 -1.326 . . . . 0.8 107.42 177.565 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A 1641 ' ' HIS . . . . . 0.49 ' HB3' ' HB3' ' A' 1615 ' ' ARG . 62.9 m80 -82.35 93.19 7.12 Favored 'General case' 0 C--N 1.311 -1.096 0 N-CA-C 107.604 -1.258 . . . . 2.54 107.604 -179.885 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A 1642 ' ' THR . . . . . 0.589 ' O ' ' HA ' ' A' 1614 ' ' CYS . 9.7 t -134.84 141.52 38.81 Favored Pre-proline 0 C--N 1.288 -2.103 0 CA-C-O 121.384 0.612 . . . . 1.15 112.13 -170.421 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A 1643 ' ' PRO . . . . . 0.595 ' HB3' ' HB3' ' A' 1616 ' ' PRO . 38.2 Cg_endo -70.65 -10.15 27.26 Favored 'Trans proline' 0 C--N 1.352 0.742 0 C-N-CA 123.396 2.73 . . . . 0.8 111.024 173.628 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A 1644 ' ' LEU . . . . . . . . . . . . . 31.7 mt -83.28 -2.52 55.85 Favored 'General case' 0 C--N 1.312 -1.023 0 C-N-CA 123.945 0.898 . . . . 1.54 111.215 -179.464 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A 1645 ' ' ALA . . . . . . . . . . . . . . . -92.23 -34.0 14.45 Favored 'General case' 0 C--N 1.323 -0.564 0 N-CA-C 112.765 0.654 . . . . 0.95 112.765 -176.96 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A 1646 ' ' CYS . . . . . . . . . . . . . 5.9 m -152.55 172.19 16.97 Favored 'General case' 0 CA--C 1.506 -0.721 0 N-CA-C 106.94 -1.504 . . . . 1.41 106.94 -179.205 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A 1647 ' ' GLU . . . . . . . . . . . . . 8.0 pt-20 . . . . . 0 C--N 1.302 -1.49 0 CA-C-O 121.586 0.708 . . . . 2.92 109.956 173.494 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A 1515 ' ' ASP . . . . . . . . . . . . . 35.5 t70 . . . . . 0 CA--C 1.502 -0.903 0 N-CA-C 110.761 -0.088 . . . . 2.54 110.761 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A 1516 ' ' CYS . . . . . . . . . . . . . 74.1 m -76.25 77.4 3.04 Favored 'General case' 0 CA--C 1.508 -0.673 0 CA-C-O 122.326 1.06 . . . . 1.25 110.65 179.786 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A 1517 ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -147.01 172.54 13.56 Favored 'General case' 0 N--CA 1.402 -2.86 0 CA-C-N 114.324 -1.307 . . . . 1.88 109.22 -179.622 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A 1518 ' ' VAL . . . . . 0.533 HG21 ' HB2' ' A' 1583 ' ' TYR . 10.4 p -159.0 126.01 0.57 Allowed 'Isoleucine or valine' 0 C--N 1.279 -2.466 0 CA-C-O 121.46 0.648 . . . . 1.73 109.551 173.035 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A 1519 ' ' THR . . . . . . . . . . . . . 7.3 m -90.57 121.52 32.58 Favored 'General case' 0 C--N 1.282 -2.351 0 CA-C-N 114.548 -1.205 . . . . 1.7 108.202 177.635 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A 1520 ' ' ASN . . . . . . . . . . . . . 38.9 t30 -99.79 103.33 21.21 Favored Pre-proline 0 C--N 1.311 -1.09 0 N-CA-C 109.59 -0.522 . . . . 2.12 109.59 177.35 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A 1521 ' ' PRO . . . . . . . . . . . . . 41.4 Cg_endo -69.28 -3.35 11.52 Favored 'Trans proline' 0 CA--C 1.54 0.797 0 C-N-CA 122.624 2.216 . . . . 2.47 113.954 -175.778 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A 1522 ' ' SER . . . . . . . . . . . . . 11.4 m -69.34 -28.84 66.58 Favored 'General case' 0 CA--C 1.545 0.776 0 CA-C-O 120.984 0.421 . . . . 2.57 109.883 176.805 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A 1523 ' ' THR . . . . . . . . . . . . . 12.9 t -139.21 -16.62 1.06 Allowed 'General case' 0 CA--C 1.551 0.999 0 CA-C-O 120.903 0.383 . . . . 2.15 111.827 178.771 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A 1524 ' ' GLY . . . . . . . . . . . . . . . 94.16 7.92 60.54 Favored Glycine 0 N--CA 1.446 -0.658 0 C-N-CA 120.597 -0.811 . . . . 1.89 113.08 179.017 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A 1525 ' ' HIS . . . . . . . . . . . . . 24.5 t60 -77.06 134.11 38.87 Favored 'General case' 0 C--O 1.245 0.838 0 CA-C-O 120.866 0.365 . . . . 1.9 110.023 -177.927 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A 1526 ' ' LEU . . . . . . . . . . . . . 3.4 tm? -104.51 114.73 29.14 Favored 'General case' 0 N--CA 1.43 -1.426 0 N-CA-C 108.157 -1.053 . . . . 1.61 108.157 178.324 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A 1527 ' ' PHE . . . . . . . . . . . . . 97.6 m-85 -88.32 129.33 35.41 Favored 'General case' 0 C--N 1.291 -1.942 0 N-CA-C 108.071 -1.085 . . . . 1.42 108.071 178.267 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A 1528 ' ' ASP . . . . . . . . . . . . . 3.4 p-10 -117.82 126.9 53.28 Favored 'General case' 0 CA--C 1.476 -1.866 0 CA-C-O 121.964 0.887 . . . . 2.18 110.322 179.073 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A 1529 ' ' LEU . . . . . . . . . . . . . 71.7 mt -117.68 7.45 12.56 Favored 'General case' 0 C--N 1.292 -1.919 0 N-CA-C 106.231 -1.766 . . . . 1.44 106.231 175.738 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A 1530 ' ' SER . . . . . . . . . . . . . 1.6 m -70.99 -24.95 62.49 Favored 'General case' 0 N--CA 1.438 -1.026 0 CA-C-N 113.853 -1.521 . . . . 1.44 110.219 -179.152 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A 1531 ' ' SER . . . . . . . . . . . . . 14.5 m -88.07 -16.15 34.34 Favored 'General case' 0 N--CA 1.433 -1.309 0 N-CA-C 108.582 -0.896 . . . . 1.5 108.582 178.814 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A 1532 ' ' LEU . . . . . . . . . . . . . 90.8 mt -82.05 -8.28 59.66 Favored 'General case' 0 C--O 1.244 0.804 0 CA-C-N 115.509 -0.769 . . . . 1.77 111.72 177.631 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A 1533 ' ' SER . . . . . . . . . . . . . 22.5 m -57.67 125.84 24.73 Favored 'General case' 0 N--CA 1.445 -0.702 0 C-N-CA 123.155 0.582 . . . . 2.38 110.424 177.146 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A 1534 ' ' GLY . . . . . . . . . . . . . . . -121.16 169.53 14.38 Favored Glycine 0 N--CA 1.427 -1.943 0 N-CA-C 109.976 -1.25 . . . . 1.55 109.976 179.698 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A 1535 ' ' ARG . . . . . . . . . . . . . 45.8 ttt180 -95.37 -54.27 3.46 Favored 'General case' 0 C--N 1.303 -1.452 0 N-CA-C 108.524 -0.917 . . . . 3.96 108.524 179.123 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A 1536 ' ' ALA . . . . . 0.47 ' HA ' HD21 ' A' 1558 ' ' ASN . . . -86.14 -24.19 26.3 Favored 'General case' 0 N--CA 1.438 -1.047 0 CA-C-N 115.505 -0.771 . . . . 1.65 109.463 178.68 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A 1537 ' ' GLY . . . . . . . . . . . . . . . 81.76 -140.66 21.16 Favored Glycine 0 N--CA 1.434 -1.473 0 CA-C-N 115.177 -0.919 . . . . 1.19 112.344 176.664 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A 1538 ' ' PHE . . . . . . . . . . . . . 98.7 m-85 -134.16 156.83 47.62 Favored 'General case' 0 C--N 1.299 -1.617 0 N-CA-C 108.72 -0.844 . . . . 1.69 108.72 179.881 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A 1539 ' ' THR . . . . . . . . . . . . . 23.5 p -104.93 111.63 24.47 Favored 'General case' 0 N--CA 1.425 -1.709 0 CA-C-N 115.929 -0.578 . . . . 1.48 110.046 177.114 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A 1540 ' ' ALA . . . . . . . . . . . . . . . -102.72 116.59 32.87 Favored 'General case' 0 C--N 1.295 -1.784 0 N-CA-C 108.865 -0.791 . . . . 0.83 108.865 178.618 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A 1541 ' ' ALA . . . . . . . . . . . . . . . -61.68 128.34 35.8 Favored 'General case' 0 C--N 1.308 -1.222 0 CA-C-O 121.428 0.632 . . . . 1.27 110.943 178.021 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A 1542 ' ' TYR . . . . . 0.625 ' HD2' ' HB2' ' A' 1545 ' ' SER . 66.7 t80 -125.0 174.84 7.73 Favored 'General case' 0 C--N 1.293 -1.875 0 N-CA-C 107.296 -1.372 . . . . 2.15 107.296 -178.426 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A 1543 ' ' SER . . . . . . . . . . . . . 1.7 m -46.5 -152.15 0.0 OUTLIER 'General case' 0 CA--C 1.596 2.721 0 C-N-CA 128.741 2.816 . . . . 2.29 114.404 -179.865 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A 1544 ' ' LYS . . . . . . . . . . . . . 63.6 mttp -55.07 -15.39 2.1 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 119.621 -1.924 . . . . 3.91 113.556 -177.012 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A 1545 ' ' SER . . . . . 0.625 ' HB2' ' HD2' ' A' 1542 ' ' TYR . 36.0 m -70.62 -19.63 62.81 Favored 'General case' 0 CA--C 1.552 1.023 0 N-CA-C 111.976 0.361 . . . . 3.3 111.976 174.707 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A 1546 ' ' GLY . . . . . . . . . . . . . . . 102.63 -98.55 1.7 Allowed Glycine 0 CA--C 1.493 -1.289 0 C-N-CA 119.224 -1.465 . . . . 1.24 113.187 174.822 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A 1547 ' ' VAL . . . . . . . . . . . . . 16.6 m -131.39 166.29 29.23 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.616 0 CA-C-N 117.26 0.53 . . . . 1.63 109.913 177.567 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A 1548 ' ' VAL . . . . . . . . . . . . . 3.6 t -118.83 128.7 75.66 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.724 0 N-CA-C 106.627 -1.62 . . . . 0.92 106.627 175.983 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A 1549 ' ' TYR . . . . . 0.566 ' CD2' ' HA2' ' A' 1568 ' ' GLY . 50.8 m-85 -87.64 114.57 24.37 Favored 'General case' 0 C--N 1.3 -1.57 0 N-CA-C 106.233 -1.765 . . . . 1.44 106.233 171.223 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A 1550 ' ' MET . . . . . . . . . . . . . 3.0 ppp? -141.87 149.8 40.73 Favored 'General case' 0 C--N 1.284 -2.247 0 CA-C-N 116.435 -0.348 . . . . 1.74 111.304 -176.357 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A 1551 ' ' SER . . . . . . . . . . . . . 22.6 t -116.55 145.05 43.63 Favored 'General case' 0 C--N 1.294 -1.819 0 N-CA-C 107.83 -1.174 . . . . 1.64 107.83 177.834 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A 1552 ' ' ILE . . . . . . . . . . . . . 32.6 mm -68.07 -27.31 36.88 Favored 'Isoleucine or valine' 0 C--O 1.213 -0.849 0 CA-C-N 114.856 -1.066 . . . . 1.33 109.406 -178.132 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A 1553 ' ' CYS . . . . . 0.418 ' SG ' ' HE2' ' A' 1579 ' ' LYS . 51.4 t -161.64 138.65 8.52 Favored 'General case' 0 N--CA 1.421 -1.914 0 N-CA-C 108.282 -1.007 . . . . 1.43 108.282 178.142 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A 1554 ' ' GLY . . . . . . . . . . . . . . . 95.47 -177.63 34.84 Favored Glycine 0 N--CA 1.438 -1.227 0 C-N-CA 120.689 -0.767 . . . . 1.12 112.472 176.493 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A 1555 ' ' GLU . . . . . . . . . . . . . 10.1 pt-20 -81.37 144.25 31.59 Favored 'General case' 0 C--N 1.309 -1.194 0 CA-C-O 121.392 0.615 . . . . 1.8 111.522 -178.962 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A 1556 ' ' ASN . . . . . . . . . . . . . 27.8 t-20 -96.91 105.62 17.79 Favored 'General case' 0 C--N 1.293 -1.849 0 CA-C-N 115.225 -0.898 . . . . 2.63 109.229 -179.408 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A 1557 ' ' GLU . . . . . . . . . . . . . 13.0 mt-10 -86.31 76.7 9.64 Favored 'General case' 0 C--N 1.313 -0.978 0 CA-C-O 122.035 0.922 . . . . 3.79 111.918 -177.028 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A 1558 ' ' ASN . . . . . 0.47 HD21 ' HA ' ' A' 1536 ' ' ALA . 31.7 m-80 -146.82 -43.94 0.18 Allowed 'General case' 0 C--N 1.297 -1.705 0 N-CA-C 106.143 -1.799 . . . . 1.52 106.143 178.892 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A 1559 ' ' CYS . . . . . 0.626 ' HB3' ' HD2' ' A' 1560 ' ' PRO . 78.2 m -108.63 175.92 1.78 Allowed Pre-proline 0 N--CA 1.425 -1.69 0 N-CA-C 105.532 -2.025 . . . . 0.84 105.532 170.675 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A 1560 ' ' PRO . . . . . 0.626 ' HD2' ' HB3' ' A' 1559 ' ' CYS . 20.8 Cg_exo -32.95 113.11 0.06 OUTLIER 'Trans proline' 0 C--N 1.375 1.943 0 C-N-CA 123.641 2.894 . . . . 1.18 113.962 176.879 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A 1561 ' ' PRO . . . . . . . . . . . . . 39.7 Cg_exo -59.07 102.79 0.16 Allowed 'Trans proline' 0 C--O 1.242 0.702 0 C-N-CA 123.335 2.69 . . . . 1.51 111.31 -179.026 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A 1562 ' ' GLY . . . . . . . . . . . . . . . 152.17 -19.74 0.84 Allowed Glycine 0 N--CA 1.432 -1.618 0 N-CA-C 108.582 -1.807 . . . . 0.72 108.582 -175.081 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A 1563 ' ' VAL . . . . . 0.519 ' HA ' ' HA ' ' A' 1576 ' ' LYS . 4.6 m -93.06 151.56 3.61 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.109 0 N-CA-C 107.118 -1.438 . . . . 0.97 107.118 174.013 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A 1564 ' ' GLY . . . . . . . . . . . . . . . -113.16 -15.35 9.13 Favored Glycine 0 C--N 1.308 -0.986 0 C-N-CA 120.664 -0.779 . . . . 0.72 112.451 -176.79 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A 1565 ' ' ALA . . . . . . . . . . . . . . . -142.92 125.61 15.93 Favored 'General case' 0 C--O 1.244 0.8 0 N-CA-C 108.871 -0.789 . . . . 0.37 108.871 179.524 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A 1566 ' ' CYS . . . . . . . . . . . . . 41.7 t -150.41 144.33 25.38 Favored 'General case' 0 C--N 1.302 -1.498 0 N-CA-C 109.524 -0.547 . . . . 0.51 109.524 -176.729 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A 1567 ' ' PHE . . . . . . . . . . . . . 18.1 m-85 -67.59 145.26 55.05 Favored 'General case' 0 C--N 1.319 -0.724 0 N-CA-C 112.181 0.438 . . . . 0.97 112.181 179.91 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A 1568 ' ' GLY . . . . . 0.566 ' HA2' ' CD2' ' A' 1549 ' ' TYR . . . -63.8 -73.48 0.54 Allowed Glycine 0 C--N 1.304 -1.225 0 N-CA-C 115.004 0.761 . . . . 1.08 115.004 -175.437 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A 1569 ' ' GLN . . . . . . . . . . . . . 11.2 pt20 -83.03 -34.29 26.3 Favored 'General case' 0 C--N 1.316 -0.849 0 N-CA-C 112.379 0.511 . . . . 2.74 112.379 -173.344 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A 1570 ' ' THR . . . . . . . . . . . . . 21.3 p -81.51 -18.05 46.46 Favored 'General case' 0 C--N 1.312 -1.063 0 CA-C-O 121.32 0.581 . . . . 1.96 110.682 -178.162 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A 1571 ' ' ARG . . . . . . . . . . . . . 64.6 mtp180 56.21 37.9 29.29 Favored 'General case' 0 C--N 1.344 0.354 0 C-N-CA 125.132 1.373 . . . . 3.95 113.063 172.774 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A 1572 ' ' ILE . . . . . . . . . . . . . 25.5 mt -101.81 128.12 54.61 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.121 0 N-CA-C 108.27 -1.011 . . . . 1.37 108.27 179.838 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A 1573 ' ' SER . . . . . . . . . . . . . 62.3 p -75.79 128.59 35.47 Favored 'General case' 0 C--N 1.314 -0.956 0 C-N-CA 122.364 0.266 . . . . 1.08 111.478 -177.106 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A 1574 ' ' VAL . . . . . . . . . . . . . 27.7 m -126.3 26.44 2.62 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.75 0 CA-C-O 121.608 0.718 . . . . 1.3 112.299 -177.937 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A 1575 ' ' GLY . . . . . . . . . . . . . . . 174.12 117.06 0.45 Allowed Glycine 0 N--CA 1.434 -1.47 0 CA-C-N 115.277 -0.874 . . . . 0.51 111.897 176.769 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A 1576 ' ' LYS . . . . . 0.519 ' HA ' ' HA ' ' A' 1563 ' ' VAL . 63.8 tttp -79.2 135.83 36.91 Favored 'General case' 0 C--N 1.314 -0.962 0 N-CA-C 107.628 -1.249 . . . . 2.9 107.628 176.045 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A 1577 ' ' ALA . . . . . . . . . . . . . . . -70.42 130.7 42.61 Favored 'General case' 0 C--N 1.313 -0.993 0 O-C-N 123.647 0.592 . . . . 0.83 110.504 -174.431 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A 1578 ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -157.83 148.41 20.81 Favored 'General case' 0 C--N 1.291 -1.942 0 N-CA-C 105.686 -1.968 . . . . 1.85 105.686 176.715 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A 1579 ' ' LYS . . . . . 0.418 ' HE2' ' SG ' ' A' 1553 ' ' CYS . 96.9 mttt -101.47 89.34 3.7 Favored 'General case' 0 C--N 1.284 -2.257 0 CA-C-O 121.845 0.831 . . . . 1.9 108.761 -177.508 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A 1580 ' ' ARG . . . . . . . . . . . . . 30.4 ttm180 -138.67 109.1 6.51 Favored 'General case' 0 N--CA 1.422 -1.862 0 CA-C-N 114.156 -1.383 . . . . 3.63 110.117 -175.587 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A 1581 ' ' LEU . . . . . . . . . . . . . 2.0 pt? -138.92 142.16 38.48 Favored 'General case' 0 N--CA 1.419 -1.992 0 N-CA-C 109.288 -0.634 . . . . 1.87 109.288 173.408 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A 1582 ' ' ARG . . . . . 0.532 ' HB3' HG13 ' A' 1584 ' ' VAL . 37.4 mmt180 -124.76 128.77 49.28 Favored 'General case' 0 C--N 1.276 -2.623 0 CA-C-N 114.972 -1.013 . . . . 3.97 110.585 -177.71 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A 1583 ' ' TYR . . . . . 0.533 ' HB2' HG21 ' A' 1518 ' ' VAL . 62.0 t80 -89.08 90.15 8.27 Favored 'General case' 0 N--CA 1.427 -1.585 0 N-CA-C 106.234 -1.765 . . . . 1.41 106.234 174.452 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A 1584 ' ' VAL . . . . . 0.532 HG13 ' HB3' ' A' 1582 ' ' ARG . 26.6 m -124.53 142.4 41.48 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.167 0 CA-C-N 114.435 -1.257 . . . . 1.69 107.896 -176.21 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A 1585 ' ' ASP . . . . . . . . . . . . . 22.8 t70 61.05 22.63 12.87 Favored 'General case' 0 N--CA 1.483 1.178 0 CA-C-O 122.44 1.114 . . . . 2.06 109.79 178.565 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A 1586 ' ' GLN . . . . . . . . . . . . . 50.1 mt-30 59.98 38.88 20.63 Favored 'General case' 0 C--O 1.241 0.634 0 C-N-CA 125.278 1.431 . . . . 2.33 113.254 -176.255 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A 1587 ' ' VAL . . . . . 0.471 HG12 ' O ' ' A' 1584 ' ' VAL . 12.5 p -134.52 145.77 32.12 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.895 0 N-CA-C 108.495 -0.928 . . . . 0.78 108.495 174.904 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A 1588 ' ' LEU . . . . . 0.86 ' HB2' ' HB2' ' A' 1612 ' ' PHE . 0.7 OUTLIER -84.31 133.08 34.56 Favored 'General case' 0 C--N 1.312 -1.041 0 N-CA-C 108.306 -0.998 . . . . 1.41 108.306 177.831 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A 1589 ' ' GLN . . . . . 0.419 ' HG2' HG13 ' A' 1591 ' ' VAL . 7.3 tt0 -146.05 106.85 4.11 Favored 'General case' 0 C--N 1.307 -1.268 0 C-N-CA 120.456 -0.498 . . . . 1.24 110.132 -176.611 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A 1590 ' ' LEU . . . . . . . . . . . . . 6.2 tt -104.39 127.97 52.15 Favored 'General case' 0 C--N 1.307 -1.259 0 N-CA-C 106.245 -1.761 . . . . 1.15 106.245 179.319 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A 1591 ' ' VAL . . . . . 0.47 HG12 HG22 ' A' 1609 ' ' VAL . 15.6 m -123.69 124.37 69.22 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.245 0 N-CA-C 115.031 1.493 . . . . 1.51 115.031 -170.704 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A 1592 ' ' TYR . . . . . . . . . . . . . 94.5 m-85 -105.2 144.56 31.83 Favored 'General case' 0 C--N 1.317 -0.836 0 N-CA-C 107.267 -1.383 . . . . 1.06 107.267 173.813 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A 1593 ' ' LYS . . . . . . . . . . . . . 23.0 pttm -149.89 179.57 7.94 Favored 'General case' 0 C--N 1.302 -1.493 0 N-CA-C 109.249 -0.648 . . . . 2.18 109.249 -177.642 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A 1594 ' ' ASP . . . . . . . . . . . . . 1.4 m-20 47.05 43.19 13.77 Favored 'General case' 0 N--CA 1.482 1.128 0 N-CA-C 115.123 1.527 . . . . 1.45 115.123 173.367 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A 1595 ' ' GLY . . . . . . . . . . . . . . . -73.14 -75.57 0.72 Allowed Glycine 0 N--CA 1.443 -0.838 0 N-CA-C 109.816 -1.313 . . . . 0.78 109.816 175.978 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A 1596 ' ' SER . . . . . . . . . . . . . 21.7 t -115.39 142.36 28.63 Favored Pre-proline 0 C--N 1.29 -1.994 0 N-CA-C 105.867 -1.901 . . . . 1.68 105.867 173.42 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A 1597 ' ' PRO . . . . . . . . . . . . . 25.9 Cg_exo -65.75 143.15 72.96 Favored 'Trans proline' 0 N--CA 1.451 -0.99 0 C-N-CA 122.68 2.253 . . . . 1.17 109.533 175.571 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A 1598 ' ' CYS . . . . . . . . . . . . . 37.1 t -99.56 131.79 24.23 Favored Pre-proline 0 C--N 1.283 -2.325 0 N-CA-C 109.102 -0.703 . . . . 1.19 109.102 -176.37 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A 1599 ' ' PRO . . . . . . . . . . . . . 55.3 Cg_endo -69.44 -11.72 31.88 Favored 'Trans proline' 0 C--N 1.351 0.663 0 C-N-CA 123.165 2.577 . . . . 1.59 112.352 179.604 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A 1600 ' ' SER . . . . . . . . . . . . . 10.9 m -90.26 112.82 24.49 Favored 'General case' 0 N--CA 1.423 -1.795 0 N-CA-C 107.612 -1.255 . . . . 2.12 107.612 176.326 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A 1601 ' ' LYS . . . . . 0.74 ' HB3' HD12 ' A' 1604 ' ' LEU . 55.7 tptt 71.03 114.31 0.05 Allowed 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 124.155 0.982 . . . . 3.74 110.98 179.054 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A 1602 ' ' SER . . . . . . . . . . . . . 47.4 t -63.61 108.96 1.52 Allowed 'General case' 0 C--N 1.316 -0.862 0 CA-C-N 116.075 -0.511 . . . . 3.79 109.949 179.757 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A 1603 ' ' GLY . . . . . . . . . . . . . . . 129.99 -15.83 5.59 Favored Glycine 0 N--CA 1.434 -1.498 0 N-CA-C 110.724 -0.95 . . . . 2.0 110.724 -179.924 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A 1604 ' ' LEU . . . . . 0.74 HD12 ' HB3' ' A' 1601 ' ' LYS . 12.6 mt -83.21 156.92 22.92 Favored 'General case' 0 N--CA 1.434 -1.263 0 CA-C-O 122.172 0.987 . . . . 1.48 113.6 179.805 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A 1605 ' ' SER . . . . . . . . . . . . . 14.9 m -143.15 -173.12 3.83 Favored 'General case' 0 C--N 1.296 -1.727 0 N-CA-C 104.752 -2.314 . . . . 1.51 104.752 176.749 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A 1606 ' ' TYR . . . . . 0.477 ' CD1' ' HB3' ' A' 1634 ' ' CYS . 84.3 m-85 -107.38 132.49 53.1 Favored 'General case' 0 CA--C 1.462 -2.438 0 N-CA-C 105.77 -1.937 . . . . 1.18 105.77 179.863 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A 1607 ' ' LYS . . . . . 0.557 ' HG3' HG23 ' A' 1635 ' ' THR . 21.6 ptmt -128.04 153.31 46.93 Favored 'General case' 0 N--CA 1.407 -2.59 0 O-C-N 124.234 0.959 . . . . 1.67 109.505 -177.777 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A 1608 ' ' SER . . . . . . . . . . . . . 51.0 m -126.31 115.36 19.56 Favored 'General case' 0 C--N 1.303 -1.44 0 N-CA-C 109.393 -0.595 . . . . 1.0 109.393 -178.541 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A 1609 ' ' VAL . . . . . 0.47 HG22 HG12 ' A' 1591 ' ' VAL . 76.6 t -104.12 116.15 47.37 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.064 0 CA-C-O 120.663 0.268 . . . . 0.93 110.647 -179.407 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A 1610 ' ' ILE . . . . . . . . . . . . . 19.3 mm -95.22 106.55 18.36 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.127 0 N-CA-C 108.448 -0.945 . . . . 0.78 108.448 177.969 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A 1611 ' ' SER . . . . . 0.494 ' O ' ' HA ' ' A' 1639 ' ' SER . 21.8 m -98.05 123.19 41.96 Favored 'General case' 0 C--N 1.297 -1.7 0 N-CA-C 108.914 -0.773 . . . . 1.29 108.914 176.246 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A 1612 ' ' PHE . . . . . 0.86 ' HB2' ' HB2' ' A' 1588 ' ' LEU . 80.5 m-85 -100.39 123.16 44.26 Favored 'General case' 0 C--N 1.305 -1.364 0 N-CA-C 109.242 -0.651 . . . . 0.7 109.242 -179.066 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A 1613 ' ' VAL . . . . . 0.588 ' O ' ' HA ' ' A' 1641 ' ' HIS . 44.6 t -115.75 136.99 50.85 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.703 0 N-CA-C 106.697 -1.594 . . . . 0.75 106.697 179.281 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A 1614 ' ' CYS . . . . . 0.466 ' HA ' ' O ' ' A' 1642 ' ' THR . 42.3 t -86.69 108.88 18.85 Favored 'General case' 0 C--N 1.281 -2.409 0 CA-C-O 121.6 0.714 . . . . 1.39 111.748 -177.588 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A 1615 ' ' ARG . . . . . 0.7 ' HB3' ' HB2' ' A' 1641 ' ' HIS . 80.4 ttt180 -135.94 94.1 14.85 Favored Pre-proline 0 N--CA 1.43 -1.473 0 N-CA-C 108.009 -1.108 . . . . 3.75 108.009 176.544 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A 1616 ' ' PRO . . . . . . . . . . . . . 68.7 Cg_endo -72.04 50.0 1.4 Allowed 'Trans proline' 0 N--CA 1.481 0.773 0 C-N-CA 123.829 3.019 . . . . 1.32 113.156 -178.466 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A 1617 ' ' GLU . . . . . . . . . . . . . 42.4 mt-10 . . . . . 0 C--N 1.305 -1.352 0 N-CA-C 108.316 -0.994 . . . . 3.21 108.316 177.789 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A 1622 ' ' ASN . . . . . . . . . . . . . 25.4 t-20 . . . . . 0 N--CA 1.464 0.274 0 N-CA-C 107.521 -1.289 . . . . 2.92 107.521 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A 1623 ' ' ARG . . . . . . . . . . . . . 7.2 ptp180 -122.13 162.44 37.44 Favored Pre-proline 0 C--N 1.299 -1.602 0 CA-C-O 119.381 -0.342 . . . . 3.61 110.153 -178.725 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A 1624 ' ' PRO . . . . . . . . . . . . . 50.0 Cg_exo -55.61 144.68 73.86 Favored 'Trans proline' 0 C--N 1.364 1.348 0 C-N-CA 122.914 2.41 . . . . 2.37 113.404 -179.777 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A 1625 ' ' MET . . . . . . . . . . . . . 55.4 ttp -118.35 136.03 53.97 Favored 'General case' 0 C--N 1.301 -1.533 0 CA-C-N 115.272 -0.876 . . . . 2.16 109.517 -179.929 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A 1626 ' ' LEU . . . . . 0.575 ' HG ' ' HD1' ' A' 1542 ' ' TYR . 3.2 tm? -73.71 113.69 11.13 Favored 'General case' 0 C--N 1.31 -1.137 0 N-CA-C 106.79 -1.559 . . . . 1.35 106.79 175.071 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A 1627 ' ' ILE . . . . . . . . . . . . . 31.6 pt -99.95 -30.95 3.35 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.957 0 C-N-CA 120.675 -0.41 . . . . 1.21 111.758 -176.758 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A 1628 ' ' SER . . . . . 0.408 ' HB3' ' HB2' ' A' 1637 ' ' PHE . 32.2 t -148.84 165.77 30.5 Favored 'General case' 0 N--CA 1.425 -1.679 0 CA-C-O 121.575 0.702 . . . . 1.4 111.253 -175.116 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A 1629 ' ' LEU . . . . . . . . . . . . . 14.2 tp -146.15 130.23 17.41 Favored 'General case' 0 C--N 1.292 -1.898 0 C-N-CA 125.153 1.381 . . . . 1.56 108.37 -177.682 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A 1630 ' ' ASP . . . . . 0.435 ' HB2' ' HE2' ' A' 1637 ' ' PHE . 21.2 t70 -119.36 106.63 12.47 Favored 'General case' 0 C--N 1.308 -1.222 0 N-CA-C 108.452 -0.944 . . . . 0.87 108.452 175.139 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A 1631 ' ' LYS . . . . . . . . . . . . . 67.9 mttm -69.41 -35.02 75.34 Favored 'General case' 0 C--N 1.304 -1.411 0 CA-C-N 115.528 -0.76 . . . . 2.35 112.707 -176.031 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A 1632 ' ' GLN . . . . . . . . . . . . . 39.4 mt-30 -74.19 -23.15 59.18 Favored 'General case' 0 C--N 1.323 -0.57 0 N-CA-C 112.938 0.718 . . . . 2.55 112.938 -176.12 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A 1633 ' ' THR . . . . . . . . . . . . . 2.0 m -112.5 3.69 16.97 Favored 'General case' 0 C--N 1.314 -0.942 0 CA-C-O 121.875 0.845 . . . . 1.24 110.217 178.528 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A 1634 ' ' CYS . . . . . 0.477 ' HB3' ' CD1' ' A' 1606 ' ' TYR . 33.4 m 54.36 43.36 30.58 Favored 'General case' 0 C--N 1.349 0.569 0 CA-C-N 114.673 -1.149 . . . . 0.89 110.32 177.099 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A 1635 ' ' THR . . . . . 0.557 HG23 ' HG3' ' A' 1607 ' ' LYS . 26.8 m -112.57 133.6 54.54 Favored 'General case' 0 N--CA 1.436 -1.156 0 CA-C-N 114.934 -1.03 . . . . 0.75 111.255 -173.128 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A 1636 ' ' LEU . . . . . . . . . . . . . 14.0 mt -104.72 130.45 52.77 Favored 'General case' 0 C--O 1.246 0.887 0 N-CA-C 107.894 -1.15 . . . . 1.33 107.894 174.118 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A 1637 ' ' PHE . . . . . 0.435 ' HE2' ' HB2' ' A' 1630 ' ' ASP . 96.1 m-85 -107.87 110.01 21.67 Favored 'General case' 0 C--N 1.313 -1.015 0 CA-C-O 120.832 0.349 . . . . 0.83 110.809 -178.073 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A 1638 ' ' PHE . . . . . . . . . . . . . 97.9 m-85 -105.44 150.39 25.32 Favored 'General case' 0 C--N 1.307 -1.255 0 N-CA-C 109.219 -0.66 . . . . 0.6 109.219 178.457 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A 1639 ' ' SER . . . . . 0.494 ' HA ' ' O ' ' A' 1611 ' ' SER . 69.1 m -141.61 138.05 32.31 Favored 'General case' 0 C--N 1.281 -2.391 0 N-CA-C 109.868 -0.419 . . . . 1.08 109.868 175.147 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A 1640 ' ' TRP . . . . . 0.55 ' HE3' ' HE2' ' A' 1612 ' ' PHE . 12.8 t90 -127.6 118.93 24.84 Favored 'General case' 0 C--N 1.29 -2.017 0 N-CA-C 107.561 -1.274 . . . . 0.8 107.561 178.537 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A 1641 ' ' HIS . . . . . 0.7 ' HB2' ' HB3' ' A' 1615 ' ' ARG . 6.2 p-80 -91.11 90.95 8.05 Favored 'General case' 0 N--CA 1.43 -1.461 0 CA-C-O 122.425 1.107 . . . . 2.54 110.045 176.465 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A 1642 ' ' THR . . . . . 0.466 ' O ' ' HA ' ' A' 1614 ' ' CYS . 1.6 m -103.3 133.81 20.11 Favored Pre-proline 0 C--N 1.281 -2.411 0 CA-C-N 113.629 -1.623 . . . . 1.15 109.688 -172.93 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A 1643 ' ' PRO . . . . . 0.409 ' HD3' ' HA ' ' A' 1642 ' ' THR . 23.7 Cg_exo -69.46 -18.91 38.19 Favored 'Trans proline' 0 CA--C 1.533 0.43 0 C-N-CA 122.669 2.246 . . . . 0.8 110.482 174.036 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A 1644 ' ' LEU . . . . . 0.411 ' H ' HG22 ' A' 1642 ' ' THR . 84.2 mt -76.55 -13.69 60.06 Favored 'General case' 0 N--CA 1.471 0.616 0 CA-C-N 115.036 -0.984 . . . . 1.54 110.958 178.491 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A 1645 ' ' ALA . . . . . . . . . . . . . . . -79.73 2.91 21.02 Favored 'General case' 0 CA--C 1.539 0.548 0 N-CA-C 113.436 0.902 . . . . 0.95 113.436 -172.392 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A 1646 ' ' CYS . . . . . . . . . . . . . 12.0 p -168.06 177.03 5.78 Favored 'General case' 0 C--O 1.25 1.094 0 N-CA-C 107.092 -1.447 . . . . 1.41 107.092 177.102 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A 1647 ' ' GLU . . . . . . . . . . . . . 6.7 mp0 . . . . . 0 C--N 1.309 -1.188 0 N-CA-C 107.089 -1.448 . . . . 2.92 107.089 172.145 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A 1515 ' ' ASP . . . . . . . . . . . . . 16.3 t70 . . . . . 0 C--O 1.239 0.55 0 N-CA-C 109.102 -0.703 . . . . 2.54 109.102 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A 1516 ' ' CYS . . . . . 0.579 ' HB2' ' HD2' ' A' 1579 ' ' LYS . 8.0 t -79.63 74.07 6.31 Favored 'General case' 0 C--N 1.31 -1.152 0 CA-C-O 122.019 0.914 . . . . 1.25 110.181 -176.194 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A 1517 ' ' GLN . . . . . 0.471 ' HB2' HD21 ' A' 1526 ' ' LEU . 10.3 pt20 -151.12 159.28 44.57 Favored 'General case' 0 C--N 1.306 -1.29 0 CA-C-N 116.014 -0.539 . . . . 1.88 109.827 -179.397 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A 1518 ' ' VAL . . . . . . . . . . . . . 7.5 p -151.5 139.69 14.29 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.496 0 N-CA-C 108.829 -0.804 . . . . 1.73 108.829 177.207 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A 1519 ' ' THR . . . . . 0.633 ' HA ' ' HA ' ' A' 1526 ' ' LEU . 15.2 m -87.14 122.67 31.27 Favored 'General case' 0 N--CA 1.42 -1.94 0 N-CA-C 107.482 -1.303 . . . . 1.7 107.482 176.88 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A 1520 ' ' ASN . . . . . . . . . . . . . 25.2 t-20 -78.74 115.34 51.15 Favored Pre-proline 0 C--N 1.318 -0.794 0 N-CA-C 108.612 -0.885 . . . . 2.12 108.612 179.393 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A 1521 ' ' PRO . . . . . . . . . . . . . 71.4 Cg_endo -72.27 -20.29 24.67 Favored 'Trans proline' 0 CA--C 1.533 0.437 0 C-N-CA 122.185 1.924 . . . . 2.47 113.715 -175.144 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A 1522 ' ' SER . . . . . . . . . . . . . 37.6 m -81.96 -37.44 26.67 Favored 'General case' 0 N--CA 1.436 -1.155 0 N-CA-C 112.648 0.61 . . . . 2.57 112.648 -175.642 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A 1523 ' ' THR . . . . . . . . . . . . . 8.8 t -103.63 -17.58 15.09 Favored 'General case' 0 CA--C 1.551 0.984 0 C-N-CA 120.005 -0.678 . . . . 2.15 111.35 176.987 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A 1524 ' ' GLY . . . . . . . . . . . . . . . 81.48 11.38 83.27 Favored Glycine 0 C--O 1.226 -0.391 0 C-N-CA 121.168 -0.539 . . . . 1.89 112.181 179.209 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A 1525 ' ' HIS . . . . . . . . . . . . . 57.1 t-80 -101.89 136.12 42.28 Favored 'General case' 0 C--N 1.304 -1.37 0 N-CA-C 108.182 -1.044 . . . . 1.9 108.182 -179.237 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A 1526 ' ' LEU . . . . . 0.633 ' HA ' ' HA ' ' A' 1519 ' ' THR . 5.1 tt -82.31 134.56 35.27 Favored 'General case' 0 C--N 1.293 -1.855 0 N-CA-C 106.512 -1.662 . . . . 1.61 106.512 177.621 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A 1527 ' ' PHE . . . . . 0.419 ' N ' HD23 ' A' 1526 ' ' LEU . 65.7 m-85 -110.85 112.34 24.12 Favored 'General case' 0 C--N 1.294 -1.834 0 CA-C-O 121.424 0.631 . . . . 1.42 111.072 177.889 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A 1528 ' ' ASP . . . . . . . . . . . . . 11.3 t70 -85.63 124.09 31.77 Favored 'General case' 0 C--N 1.312 -1.051 0 CA-C-N 114.525 -1.216 . . . . 2.18 111.092 179.453 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A 1529 ' ' LEU . . . . . . . . . . . . . 9.9 mp -116.62 18.45 14.98 Favored 'General case' 0 C--N 1.313 -0.986 0 CA-C-N 115.801 -0.636 . . . . 1.44 109.285 175.006 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A 1530 ' ' SER . . . . . . . . . . . . . 47.9 m -98.38 -29.08 13.34 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-O 121.246 0.546 . . . . 1.44 111.419 -178.404 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A 1531 ' ' SER . . . . . . . . . . . . . 3.4 m -96.02 -9.71 30.32 Favored 'General case' 0 C--N 1.302 -1.493 0 CA-C-O 121.148 0.499 . . . . 1.5 110.421 -178.556 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A 1532 ' ' LEU . . . . . . . . . . . . . 78.5 mt -65.64 -40.92 93.03 Favored 'General case' 0 CA--C 1.543 0.695 0 N-CA-C 114.169 1.174 . . . . 1.77 114.169 -178.686 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A 1533 ' ' SER . . . . . 0.759 ' HB2' ' HB ' ' A' 1552 ' ' ILE . 7.2 t -101.01 126.78 47.7 Favored 'General case' 0 C--N 1.302 -1.477 0 N-CA-C 108.861 -0.792 . . . . 2.38 108.861 -178.137 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A 1534 ' ' GLY . . . . . . . . . . . . . . . -104.57 -122.53 5.1 Favored Glycine 0 N--CA 1.425 -2.037 0 CA-C-N 115.883 -0.599 . . . . 1.55 112.466 -179.957 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A 1535 ' ' ARG . . . . . . . . . . . . . 20.5 tpt180 -81.79 -56.98 3.64 Favored 'General case' 0 C--N 1.302 -1.48 0 CA-C-O 120.875 0.369 . . . . 3.96 111.178 -176.446 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A 1536 ' ' ALA . . . . . . . . . . . . . . . -91.49 -45.45 8.52 Favored 'General case' 0 C--N 1.307 -1.25 0 C-N-CA 120.456 -0.497 . . . . 1.65 111.65 -174.258 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A 1537 ' ' GLY . . . . . . . . . . . . . . . 100.15 -138.22 13.73 Favored Glycine 0 N--CA 1.429 -1.794 0 N-CA-C 110.894 -0.882 . . . . 1.19 110.894 -179.212 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A 1538 ' ' PHE . . . . . . . . . . . . . 74.6 m-85 -138.1 172.99 12.11 Favored 'General case' 0 C--N 1.316 -0.88 0 N-CA-C 107.705 -1.22 . . . . 1.69 107.705 -178.821 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A 1539 ' ' THR . . . . . . . . . . . . . 6.6 t -147.41 151.71 36.92 Favored 'General case' 0 C--N 1.299 -1.59 0 C-N-CA 119.384 -0.926 . . . . 1.48 111.21 -177.072 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A 1540 ' ' ALA . . . . . . . . . . . . . . . -132.19 135.47 46.36 Favored 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 108.543 -0.91 . . . . 0.83 108.543 177.945 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A 1541 ' ' ALA . . . . . . . . . . . . . . . -80.45 152.2 28.89 Favored 'General case' 0 C--N 1.317 -0.827 0 CA-C-O 121.033 0.444 . . . . 1.27 110.855 -179.086 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A 1542 ' ' TYR . . . . . . . . . . . . . 30.3 t80 -149.36 177.62 9.51 Favored 'General case' 0 N--CA 1.425 -1.689 0 N-CA-C 108.48 -0.933 . . . . 2.15 108.48 -177.903 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A 1543 ' ' SER . . . . . . . . . . . . . 4.5 m -48.69 -151.16 0.0 OUTLIER 'General case' 0 CA--C 1.58 2.132 0 C-N-CA 128.71 2.804 . . . . 2.29 113.28 178.173 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A 1544 ' ' LYS . . . . . . . . . . . . . 27.5 ttpp -43.18 -26.26 0.16 Allowed 'General case' 0 N--CA 1.495 1.8 0 O-C-N 120.607 -1.308 . . . . 3.91 113.322 178.365 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A 1545 ' ' SER . . . . . . . . . . . . . 7.1 m -64.68 -22.02 66.88 Favored 'General case' 0 CA--C 1.569 1.677 0 C-N-CA 123.134 0.574 . . . . 3.3 111.541 175.633 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A 1546 ' ' GLY . . . . . . . . . . . . . . . 91.45 -78.68 1.33 Allowed Glycine 0 N--CA 1.438 -1.174 0 N-CA-C 114.127 0.411 . . . . 1.24 114.127 173.518 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A 1547 ' ' VAL . . . . . . . . . . . . . 10.0 p -159.37 147.42 7.19 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.043 0 N-CA-C 107.057 -1.46 . . . . 1.63 107.057 -176.071 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A 1548 ' ' VAL . . . . . . . . . . . . . 1.6 t -116.57 129.22 73.42 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.946 0 N-CA-C 108.319 -0.993 . . . . 0.92 108.319 -177.338 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A 1549 ' ' TYR . . . . . 0.494 ' CE2' ' HA3' ' A' 1568 ' ' GLY . 79.3 m-85 -85.44 120.38 26.84 Favored 'General case' 0 CA--C 1.494 -1.184 0 N-CA-C 107.315 -1.365 . . . . 1.44 107.315 174.839 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A 1550 ' ' MET . . . . . . . . . . . . . 88.7 mmm -124.76 121.29 34.19 Favored 'General case' 0 C--N 1.298 -1.654 0 N-CA-C 109.707 -0.479 . . . . 1.74 109.707 -173.579 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A 1551 ' ' SER . . . . . . . . . . . . . 50.4 m -89.96 158.62 17.3 Favored 'General case' 0 C--N 1.286 -2.158 0 N-CA-C 108.41 -0.959 . . . . 1.64 108.41 175.622 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A 1552 ' ' ILE . . . . . 0.759 ' HB ' ' HB2' ' A' 1533 ' ' SER . 38.8 mm -74.14 -60.57 2.26 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.299 0 C-N-CA 119.228 -0.989 . . . . 1.33 108.507 -179.871 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A 1553 ' ' CYS . . . . . 0.406 ' SG ' ' HG3' ' A' 1579 ' ' LYS . 34.9 t -151.16 141.99 22.86 Favored 'General case' 0 N--CA 1.421 -1.92 0 N-CA-C 104.402 -2.444 . . . . 1.43 104.402 178.663 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A 1554 ' ' GLY . . . . . . . . . . . . . . . 104.81 -172.34 19.93 Favored Glycine 0 C--N 1.291 -1.951 0 C-N-CA 119.666 -1.254 . . . . 1.12 111.073 -177.504 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A 1555 ' ' GLU . . . . . . . . . . . . . 8.9 pt-20 -98.67 142.4 30.28 Favored 'General case' 0 C--N 1.308 -1.219 0 N-CA-C 113.656 0.984 . . . . 1.8 113.656 -173.009 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A 1556 ' ' ASN . . . . . 0.419 ' O ' ' HA ' ' A' 1561 ' ' PRO . 19.3 t-20 -94.15 145.68 24.52 Favored 'General case' 0 C--N 1.309 -1.168 0 CA-C-N 113.707 -1.588 . . . . 2.63 108.216 -179.398 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A 1557 ' ' GLU . . . . . . . . . . . . . 58.1 mm-40 -112.39 -9.47 13.84 Favored 'General case' 0 C--N 1.305 -1.35 0 O-C-N 123.464 0.478 . . . . 3.79 111.525 -174.618 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A 1558 ' ' ASN . . . . . . . . . . . . . 18.4 m-80 -85.49 2.58 44.11 Favored 'General case' 0 N--CA 1.489 1.488 0 CA-C-O 121.91 0.862 . . . . 1.52 111.519 -177.972 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A 1559 ' ' CYS . . . . . 0.802 ' HB3' ' HD2' ' A' 1560 ' ' PRO . 47.3 m -145.46 -175.93 0.51 Allowed Pre-proline 0 C--N 1.288 -2.097 0 N-CA-C 105.192 -2.151 . . . . 0.84 105.192 175.51 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A 1560 ' ' PRO . . . . . 0.802 ' HD2' ' HB3' ' A' 1559 ' ' CYS . 1.6 Cg_endo -44.48 112.84 0.38 Allowed 'Trans proline' 0 C--N 1.376 2.01 0 C-N-CA 122.312 2.008 . . . . 1.18 112.255 177.285 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A 1561 ' ' PRO . . . . . 0.419 ' HA ' ' O ' ' A' 1556 ' ' ASN . 53.0 Cg_exo -57.67 110.62 0.65 Allowed 'Trans proline' 0 C--O 1.244 0.82 0 C-N-CA 122.97 2.447 . . . . 1.51 111.229 -177.233 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A 1562 ' ' GLY . . . . . . . . . . . . . . . 135.96 -16.4 3.96 Favored Glycine 0 C--N 1.299 -1.483 0 N-CA-C 110.756 -0.938 . . . . 0.72 110.756 -176.544 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A 1563 ' ' VAL . . . . . 0.648 ' HA ' ' HA ' ' A' 1576 ' ' LYS . 4.9 m -94.02 160.96 2.64 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.236 0 N-CA-C 107.029 -1.471 . . . . 0.97 107.029 176.659 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A 1564 ' ' GLY . . . . . 0.489 ' HA3' ' CE2' ' A' 1592 ' ' TYR . . . -124.18 -5.08 7.5 Favored Glycine 0 C--O 1.238 0.403 0 C-N-CA 119.125 -1.512 . . . . 0.72 113.162 -177.06 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A 1565 ' ' ALA . . . . . . . . . . . . . . . -150.18 127.24 11.2 Favored 'General case' 0 C--O 1.251 1.14 0 N-CA-C 108.808 -0.812 . . . . 0.37 108.808 179.867 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A 1566 ' ' CYS . . . . . . . . . . . . . 9.8 t -159.13 142.92 15.04 Favored 'General case' 0 C--N 1.308 -1.201 0 CA-C-N 116.258 -0.428 . . . . 0.51 111.062 -172.755 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A 1567 ' ' PHE . . . . . . . . . . . . . 24.9 m-85 -73.31 123.24 23.37 Favored 'General case' 0 CA--C 1.508 -0.668 0 N-CA-C 107.224 -1.398 . . . . 0.97 107.224 175.789 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A 1568 ' ' GLY . . . . . 0.494 ' HA3' ' CE2' ' A' 1549 ' ' TYR . . . -79.26 -25.47 59.28 Favored Glycine 0 C--N 1.3 -1.426 0 C-N-CA 120.052 -1.07 . . . . 1.08 114.785 -171.688 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A 1569 ' ' GLN . . . . . . . . . . . . . 8.1 tp-100 -71.08 -46.03 62.62 Favored 'General case' 0 C--N 1.306 -1.303 0 C-N-CA 119.937 -0.705 . . . . 2.74 110.934 -179.179 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A 1570 ' ' THR . . . . . . . . . . . . . 38.3 p -95.83 -13.14 24.27 Favored 'General case' 0 C--N 1.306 -1.309 0 N-CA-C 112.333 0.494 . . . . 1.96 112.333 -177.154 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A 1571 ' ' ARG . . . . . . . . . . . . . 79.4 mtm180 60.63 37.39 19.29 Favored 'General case' 0 C--O 1.246 0.869 0 C-N-CA 124.753 1.221 . . . . 3.95 112.798 -177.303 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A 1572 ' ' ILE . . . . . . . . . . . . . 39.9 mm -101.03 110.69 28.55 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.378 0 CA-C-N 114.458 -1.246 . . . . 1.37 108.2 177.941 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A 1573 ' ' SER . . . . . . . . . . . . . 29.1 t -67.68 133.73 49.85 Favored 'General case' 0 C--N 1.294 -1.836 0 CA-C-N 114.548 -1.206 . . . . 1.08 111.016 -179.971 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A 1574 ' ' VAL . . . . . 0.511 ' HB ' ' HB2' ' A' 1606 ' ' TYR . 34.8 m -108.23 -33.39 2.55 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.309 0 C-N-CA 120.602 -0.439 . . . . 1.3 111.009 -179.815 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A 1575 ' ' GLY . . . . . . . . . . . . . . . -140.11 130.88 4.83 Favored Glycine 0 N--CA 1.433 -1.512 0 C-N-CA 120.364 -0.922 . . . . 0.51 112.67 -177.692 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A 1576 ' ' LYS . . . . . 0.648 ' HA ' ' HA ' ' A' 1563 ' ' VAL . 88.4 tttt -79.75 151.15 30.54 Favored 'General case' 0 C--N 1.313 -1.009 0 N-CA-C 108.32 -0.993 . . . . 2.9 108.32 178.698 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A 1577 ' ' ALA . . . . . . . . . . . . . . . -70.71 98.17 1.48 Allowed 'General case' 0 CA--C 1.508 -0.662 0 CA-C-O 121.245 0.545 . . . . 0.83 111.119 -175.988 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A 1578 ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -101.66 115.93 31.62 Favored 'General case' 0 C--N 1.296 -1.753 0 N-CA-C 107.118 -1.438 . . . . 1.85 107.118 175.97 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A 1579 ' ' LYS . . . . . 0.579 ' HD2' ' HB2' ' A' 1516 ' ' CYS . 38.4 ttpt -91.34 89.72 7.4 Favored 'General case' 0 C--N 1.3 -1.578 0 N-CA-C 108.085 -1.08 . . . . 1.9 108.085 179.532 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A 1580 ' ' ARG . . . . . . . . . . . . . 14.4 tpp180 -156.43 116.93 3.67 Favored 'General case' 0 N--CA 1.419 -1.976 0 CA-C-N 114.459 -1.246 . . . . 3.63 108.556 -176.11 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A 1581 ' ' LEU . . . . . . . . . . . . . 2.9 pp -113.37 150.65 32.33 Favored 'General case' 0 C--N 1.297 -1.688 0 C-N-CA 120.515 -0.474 . . . . 1.87 111.236 178.145 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A 1582 ' ' ARG . . . . . . . . . . . . . 41.2 ttm180 -130.12 109.75 11.07 Favored 'General case' 0 C--N 1.295 -1.781 0 CA-C-N 115.603 -0.726 . . . . 3.97 109.912 -178.625 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A 1583 ' ' TYR . . . . . . . . . . . . . 79.6 t80 -94.84 104.12 16.02 Favored 'General case' 0 C--N 1.296 -1.746 0 N-CA-C 108.443 -0.947 . . . . 1.41 108.443 178.801 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A 1584 ' ' VAL . . . . . 0.482 ' O ' HG12 ' A' 1587 ' ' VAL . 7.0 p -130.78 111.2 19.76 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.403 0 C-N-CA 120.358 -0.537 . . . . 1.69 112.0 -177.584 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A 1585 ' ' ASP . . . . . . . . . . . . . 18.7 t70 59.98 59.16 2.5 Favored 'General case' 0 N--CA 1.481 1.078 0 CA-C-O 122.584 1.183 . . . . 2.06 110.976 177.171 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A 1586 ' ' GLN . . . . . . . . . . . . . 41.8 mt-30 57.35 23.53 9.01 Favored 'General case' 0 C--N 1.315 -0.916 0 N-CA-C 115.186 1.55 . . . . 2.33 115.186 179.087 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A 1587 ' ' VAL . . . . . 0.482 HG12 ' O ' ' A' 1584 ' ' VAL . 9.5 p -130.85 128.32 62.63 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.512 0 N-CA-C 108.757 -0.831 . . . . 0.78 108.757 173.482 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A 1588 ' ' LEU . . . . . 0.633 ' HB2' ' HB2' ' A' 1612 ' ' PHE . 8.1 mp -89.15 143.98 26.45 Favored 'General case' 0 N--CA 1.427 -1.58 0 CA-C-N 115.609 -0.723 . . . . 1.41 109.636 179.689 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A 1589 ' ' GLN . . . . . . . . . . . . . 7.7 tt0 -136.05 142.8 44.43 Favored 'General case' 0 C--N 1.28 -2.454 0 N-CA-C 108.872 -0.788 . . . . 1.24 108.872 178.136 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A 1590 ' ' LEU . . . . . . . . . . . . . 5.7 tt -139.19 133.83 31.94 Favored 'General case' 0 C--N 1.293 -1.861 0 N-CA-C 103.611 -2.737 . . . . 1.15 103.611 173.463 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A 1591 ' ' VAL . . . . . . . . . . . . . 7.3 p -130.9 127.61 61.59 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.496 0 N-CA-C 113.792 1.034 . . . . 1.51 113.792 -172.808 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A 1592 ' ' TYR . . . . . 0.489 ' CE2' ' HA3' ' A' 1564 ' ' GLY . 96.4 m-85 -101.33 139.9 36.37 Favored 'General case' 0 CA--C 1.495 -1.162 0 CA-C-N 114.581 -1.19 . . . . 1.06 107.86 177.412 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A 1593 ' ' LYS . . . . . . . . . . . . . 14.1 ptmm? -158.93 170.12 22.81 Favored 'General case' 0 C--N 1.299 -1.595 0 C-N-CA 120.601 -0.44 . . . . 2.18 110.084 -179.125 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A 1594 ' ' ASP . . . . . . . . . . . . . 48.1 m-20 61.8 41.98 11.11 Favored 'General case' 0 C--N 1.312 -1.025 0 N-CA-C 114.774 1.398 . . . . 1.45 114.774 175.127 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A 1595 ' ' GLY . . . . . . . . . . . . . . . -77.49 -86.88 0.41 Allowed Glycine 0 N--CA 1.437 -1.258 0 N-CA-C 109.13 -1.588 . . . . 0.78 109.13 171.241 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A 1596 ' ' SER . . . . . . . . . . . . . 15.5 m -114.47 152.37 46.06 Favored Pre-proline 0 C--N 1.298 -1.635 0 N-CA-C 107.921 -1.14 . . . . 1.68 107.921 176.059 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A 1597 ' ' PRO . . . . . . . . . . . . . 28.1 Cg_exo -63.74 146.35 91.99 Favored 'Trans proline' 0 C--O 1.247 0.97 0 C-N-CA 122.929 2.42 . . . . 1.17 111.45 178.103 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A 1598 ' ' CYS . . . . . 0.469 ' HA ' ' HD3' ' A' 1599 ' ' PRO . 27.4 t -98.76 133.3 22.56 Favored Pre-proline 0 C--N 1.297 -1.696 0 N-CA-C 108.894 -0.78 . . . . 1.19 108.894 -178.486 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A 1599 ' ' PRO . . . . . 0.469 ' HD3' ' HA ' ' A' 1598 ' ' CYS . 32.1 Cg_exo -62.82 -21.62 73.22 Favored 'Trans proline' 0 C--N 1.359 1.129 0 C-N-CA 123.759 2.973 . . . . 1.59 112.941 179.801 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A 1600 ' ' SER . . . . . 0.56 ' HB3' ' SG ' ' A' 1634 ' ' CYS . 47.9 t -85.89 117.74 24.93 Favored 'General case' 0 N--CA 1.427 -1.606 0 N-CA-C 106.704 -1.591 . . . . 2.12 106.704 175.242 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A 1601 ' ' LYS . . . . . . . . . . . . . 48.4 mmtm 58.82 60.63 2.42 Favored 'General case' 0 C--O 1.245 0.865 0 O-C-N 123.988 0.805 . . . . 3.74 108.994 -176.484 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A 1602 ' ' SER . . . . . . . . . . . . . 23.3 t -53.37 112.27 0.86 Allowed 'General case' 0 C--O 1.247 0.969 0 CA-C-N 114.786 -1.097 . . . . 3.79 111.542 -174.846 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A 1603 ' ' GLY . . . . . . . . . . . . . . . 150.99 -33.84 0.94 Allowed Glycine 0 N--CA 1.43 -1.743 0 N-CA-C 108.137 -1.985 . . . . 2.0 108.137 -177.912 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A 1604 ' ' LEU . . . . . . . . . . . . . 2.5 pp -94.59 164.16 13.09 Favored 'General case' 0 N--CA 1.427 -1.585 0 CA-C-N 114.644 -0.778 . . . . 1.48 109.567 175.87 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A 1605 ' ' SER . . . . . . . . . . . . . 19.0 p -109.42 -167.08 1.16 Allowed 'General case' 0 C--N 1.286 -2.19 0 N-CA-C 109.371 -0.603 . . . . 1.51 109.371 -178.82 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A 1606 ' ' TYR . . . . . 0.511 ' HB2' ' HB ' ' A' 1574 ' ' VAL . 61.1 m-85 -97.45 144.79 26.83 Favored 'General case' 0 N--CA 1.413 -2.32 0 N-CA-C 104.466 -2.42 . . . . 1.18 104.466 179.07 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A 1607 ' ' LYS . . . . . 0.471 ' HG3' HG23 ' A' 1635 ' ' THR . 19.2 ptmt -132.38 132.98 43.4 Favored 'General case' 0 C--N 1.268 -2.968 0 C-N-CA 118.655 -1.218 . . . . 1.67 109.422 177.283 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A 1608 ' ' SER . . . . . . . . . . . . . 20.2 m -115.69 111.72 21.02 Favored 'General case' 0 C--N 1.291 -1.945 0 C-N-CA 122.848 0.459 . . . . 1.0 110.694 -175.724 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A 1609 ' ' VAL . . . . . . . . . . . . . 96.5 t -92.34 121.38 42.87 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.069 0 N-CA-C 109.151 -0.685 . . . . 0.93 109.151 178.17 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A 1610 ' ' ILE . . . . . . . . . . . . . 17.0 mm -99.62 104.44 16.07 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.552 0 N-CA-C 107.871 -1.159 . . . . 0.78 107.871 177.11 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A 1611 ' ' SER . . . . . 0.478 ' O ' ' HA ' ' A' 1639 ' ' SER . 22.8 t -91.8 119.87 32.01 Favored 'General case' 0 N--CA 1.42 -1.957 0 N-CA-C 108.612 -0.884 . . . . 1.29 108.612 178.667 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A 1612 ' ' PHE . . . . . 0.633 ' HB2' ' HB2' ' A' 1588 ' ' LEU . 97.4 m-85 -95.85 108.73 21.11 Favored 'General case' 0 C--N 1.297 -1.696 0 CA-C-N 115.548 -0.751 . . . . 0.7 109.678 -178.776 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A 1613 ' ' VAL . . . . . . . . . . . . . 48.0 t -100.56 122.14 52.19 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.012 0 CA-C-N 115.409 -0.814 . . . . 0.75 109.544 -176.891 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A 1614 ' ' CYS . . . . . 0.671 ' HA ' ' O ' ' A' 1642 ' ' THR . 0.8 OUTLIER -76.68 100.6 5.45 Favored 'General case' 0 CA--C 1.5 -0.977 0 N-CA-C 113.178 0.807 . . . . 1.39 113.178 177.289 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A 1615 ' ' ARG . . . . . 0.497 ' HD3' ' HD2' ' A' 1616 ' ' PRO . 14.0 tpp180 -137.71 116.77 9.96 Favored Pre-proline 0 N--CA 1.414 -2.27 0 CA-C-N 114.851 -1.068 . . . . 3.75 108.411 177.103 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A 1616 ' ' PRO . . . . . 0.497 ' HD2' ' HD3' ' A' 1615 ' ' ARG . 56.6 Cg_exo -58.16 52.13 0.05 OUTLIER 'Trans proline' 0 CA--C 1.553 1.463 0 C-N-CA 124.788 3.659 . . . . 1.32 114.717 174.636 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A 1617 ' ' GLU . . . . . . . . . . . . . 44.0 tt0 . . . . . 0 C--N 1.31 -1.143 0 N-CA-C 108.2 -1.037 . . . . 3.21 108.2 176.628 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A 1622 ' ' ASN . . . . . 0.464 ' C ' ' HD3' ' A' 1624 ' ' PRO . 61.0 t30 . . . . . 0 C--O 1.247 0.934 0 CA-C-O 121.894 0.854 . . . . 2.92 112.578 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A 1623 ' ' ARG . . . . . 0.5 ' HB3' ' CD1' ' A' 1640 ' ' TRP . 9.2 ptm180 -123.72 69.6 45.63 Favored Pre-proline 0 N--CA 1.434 -1.237 0 C-N-CA 119.572 -0.851 . . . . 3.61 112.043 178.62 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A 1624 ' ' PRO . . . . . 0.464 ' HD3' ' C ' ' A' 1622 ' ' ASN . 64.4 Cg_endo -114.41 91.18 0.01 OUTLIER 'Trans proline' 0 N--CA 1.426 -2.491 0 C-N-CA 122.446 2.098 . . . . 2.37 110.09 167.61 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A 1625 ' ' MET . . . . . 0.563 ' HG3' HG23 ' A' 1627 ' ' ILE . 12.9 tpt -151.78 98.77 2.51 Favored 'General case' 0 C--N 1.297 -1.714 0 C-N-CA 116.939 -1.905 . . . . 2.16 112.236 -179.389 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A 1626 ' ' LEU . . . . . . . . . . . . . 4.4 mm? -87.85 88.99 7.82 Favored 'General case' 0 C--N 1.302 -1.494 0 N-CA-C 108.518 -0.919 . . . . 1.35 108.518 171.321 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A 1627 ' ' ILE . . . . . 0.563 HG23 ' HG3' ' A' 1625 ' ' MET . 37.0 pt -73.42 -35.18 45.11 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.872 0 CA-C-N 115.875 -0.602 . . . . 1.21 110.956 -178.293 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A 1628 ' ' SER . . . . . . . . . . . . . 22.9 t -161.67 152.43 17.87 Favored 'General case' 0 N--CA 1.414 -2.268 0 N-CA-C 107.628 -1.249 . . . . 1.4 107.628 -178.242 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A 1629 ' ' LEU . . . . . 0.573 ' HG ' ' HG ' ' A' 1636 ' ' LEU . 5.1 tt -146.72 111.99 5.49 Favored 'General case' 0 C--N 1.286 -2.166 0 N-CA-C 106.041 -1.837 . . . . 1.56 106.041 175.843 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A 1630 ' ' ASP . . . . . 0.418 ' HB3' ' HB ' ' A' 1635 ' ' THR . 14.0 t70 -84.81 99.66 11.04 Favored 'General case' 0 C--N 1.292 -1.915 0 N-CA-C 106.741 -1.577 . . . . 0.87 106.741 -179.544 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A 1631 ' ' LYS . . . . . 0.429 ' HG2' HD22 ' A' 1629 ' ' LEU . 47.1 mtmt -72.79 -19.17 61.39 Favored 'General case' 0 C--N 1.306 -1.324 0 CA-C-N 115.941 -0.572 . . . . 2.35 112.373 -173.304 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A 1632 ' ' GLN . . . . . . . . . . . . . 2.8 mp0 -73.68 -51.45 16.64 Favored 'General case' 0 C--N 1.313 -0.985 0 C-N-CA 121.01 -0.276 . . . . 2.55 110.719 179.616 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A 1633 ' ' THR . . . . . . . . . . . . . 35.7 p -97.36 14.03 27.62 Favored 'General case' 0 C--N 1.316 -0.858 0 CA-C-O 121.357 0.599 . . . . 1.24 111.917 -179.706 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A 1634 ' ' CYS . . . . . 0.56 ' SG ' ' HB3' ' A' 1600 ' ' SER . 65.9 m 50.01 45.58 25.18 Favored 'General case' 0 N--CA 1.475 0.813 0 C-N-CA 124.966 1.307 . . . . 0.89 112.244 177.744 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A 1635 ' ' THR . . . . . 0.471 HG23 ' HG3' ' A' 1607 ' ' LYS . 25.5 m -107.14 107.51 18.52 Favored 'General case' 0 N--CA 1.428 -1.574 0 CA-C-N 114.89 -1.05 . . . . 0.75 109.831 -176.609 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A 1636 ' ' LEU . . . . . 0.573 ' HG ' ' HG ' ' A' 1629 ' ' LEU . 4.9 mp -95.11 127.88 41.51 Favored 'General case' 0 C--N 1.309 -1.182 0 N-CA-C 109.434 -0.58 . . . . 1.33 109.434 -177.505 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A 1637 ' ' PHE . . . . . . . . . . . . . 95.6 m-85 -109.36 110.85 22.11 Favored 'General case' 0 C--N 1.314 -0.939 0 CA-C-O 120.941 0.401 . . . . 0.83 110.305 -179.12 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A 1638 ' ' PHE . . . . . 0.424 ' HA ' ' O ' ' A' 1625 ' ' MET . 92.6 m-85 -105.41 159.32 16.01 Favored 'General case' 0 C--N 1.315 -0.933 0 N-CA-C 109.393 -0.595 . . . . 0.6 109.393 179.583 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A 1639 ' ' SER . . . . . 0.478 ' HA ' ' O ' ' A' 1611 ' ' SER . 50.1 m -142.09 144.85 33.74 Favored 'General case' 0 C--N 1.299 -1.599 0 CA-C-O 120.841 0.353 . . . . 1.08 110.885 175.713 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A 1640 ' ' TRP . . . . . 0.5 ' CD1' ' HB3' ' A' 1623 ' ' ARG . 12.4 t90 -118.95 137.79 53.25 Favored 'General case' 0 C--N 1.323 -0.551 0 N-CA-C 106.939 -1.504 . . . . 0.8 106.939 176.871 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A 1641 ' ' HIS . . . . . . . . . . . . . 38.9 m-70 -98.87 98.09 9.21 Favored 'General case' 0 C--N 1.314 -0.937 0 N-CA-C 105.966 -1.864 . . . . 2.54 105.966 179.075 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A 1642 ' ' THR . . . . . 0.671 ' O ' ' HA ' ' A' 1614 ' ' CYS . 9.8 t -142.24 139.21 17.47 Favored Pre-proline 0 C--N 1.305 -1.359 0 N-CA-C 113.459 0.911 . . . . 1.15 113.459 -171.686 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A 1643 ' ' PRO . . . . . 0.512 ' HD3' ' HA ' ' A' 1642 ' ' THR . 4.4 Cg_exo -79.42 -6.77 14.77 Favored 'Trans proline' 0 C--N 1.355 0.894 0 C-N-CA 123.462 2.775 . . . . 0.8 110.385 173.574 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A 1644 ' ' LEU . . . . . . . . . . . . . 65.8 mt -89.13 5.32 45.14 Favored 'General case' 0 N--CA 1.443 -0.797 0 CA-C-N 115.229 -0.896 . . . . 1.54 110.249 -177.693 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A 1645 ' ' ALA . . . . . . . . . . . . . . . -97.18 -44.36 6.98 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-O 121.619 0.724 . . . . 0.95 109.642 176.46 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A 1646 ' ' CYS . . . . . . . . . . . . . 0.6 OUTLIER -171.41 173.91 4.64 Favored 'General case' 0 C--N 1.303 -1.441 0 N-CA-C 107.69 -1.226 . . . . 1.41 107.69 -178.063 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A 1647 ' ' GLU . . . . . . . . . . . . . 51.8 mt-10 . . . . . 0 C--N 1.303 -1.432 0 N-CA-C 108.519 -0.919 . . . . 2.92 108.519 -178.787 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A 1515 ' ' ASP . . . . . 0.57 ' HB3' ' HG2' ' A' 1517 ' ' GLN . 7.5 t70 . . . . . 0 N--CA 1.442 -0.852 0 N-CA-C 105.781 -1.933 . . . . 2.54 105.781 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A 1516 ' ' CYS . . . . . . . . . . . . . 72.8 m -104.34 51.5 0.77 Allowed 'General case' 0 C--N 1.27 -2.865 0 N-CA-C 108.196 -1.039 . . . . 1.25 108.196 -179.8 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A 1517 ' ' GLN . . . . . 0.57 ' HG2' ' HB3' ' A' 1515 ' ' ASP . 3.9 pt20 -151.64 171.38 17.72 Favored 'General case' 0 C--N 1.304 -1.377 0 N-CA-C 109.407 -0.59 . . . . 1.88 109.407 -177.316 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A 1518 ' ' VAL . . . . . . . . . . . . . 8.5 p -154.23 140.6 11.91 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.404 0 N-CA-C 109.404 -0.591 . . . . 1.73 109.404 -179.414 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A 1519 ' ' THR . . . . . . . . . . . . . 19.1 m -100.76 130.74 46.83 Favored 'General case' 0 N--CA 1.423 -1.783 0 N-CA-C 107.895 -1.15 . . . . 1.7 107.895 177.097 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A 1520 ' ' ASN . . . . . 0.434 ' OD1' HG22 ' A' 1523 ' ' THR . 27.9 t-20 -90.03 121.35 68.88 Favored Pre-proline 0 C--N 1.3 -1.567 0 C-N-CA 120.236 -0.585 . . . . 2.12 109.868 178.295 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A 1521 ' ' PRO . . . . . . . . . . . . . 60.0 Cg_endo -73.09 -20.28 21.89 Favored 'Trans proline' 0 C--N 1.352 0.754 0 C-N-CA 122.089 1.86 . . . . 2.47 113.642 -175.797 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A 1522 ' ' SER . . . . . . . . . . . . . 48.1 m -77.0 -57.9 3.58 Favored 'General case' 0 C--N 1.316 -0.851 0 N-CA-C 111.981 0.363 . . . . 2.57 111.981 -177.95 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A 1523 ' ' THR . . . . . 0.434 HG22 ' OD1' ' A' 1520 ' ' ASN . 8.9 t -90.71 -14.81 31.45 Favored 'General case' 0 C--N 1.317 -0.835 0 CA-C-O 121.053 0.454 . . . . 2.15 111.134 -178.601 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A 1524 ' ' GLY . . . . . . . . . . . . . . . 76.13 14.32 82.39 Favored Glycine 0 C--O 1.226 -0.393 0 C-N-CA 120.873 -0.679 . . . . 1.89 112.478 178.932 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A 1525 ' ' HIS . . . . . . . . . . . . . 22.7 t60 -100.75 137.65 38.85 Favored 'General case' 0 C--N 1.309 -1.183 0 N-CA-C 108.143 -1.058 . . . . 1.9 108.143 -177.57 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A 1526 ' ' LEU . . . . . . . . . . . . . 7.7 tt -100.0 136.37 40.01 Favored 'General case' 0 C--N 1.297 -1.707 0 N-CA-C 108.604 -0.887 . . . . 1.61 108.604 -178.451 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A 1527 ' ' PHE . . . . . . . . . . . . . 88.2 m-85 -110.46 126.16 54.04 Favored 'General case' 0 C--N 1.3 -1.554 0 N-CA-C 107.792 -1.188 . . . . 1.42 107.792 178.618 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A 1528 ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -114.71 143.64 44.74 Favored 'General case' 0 C--N 1.309 -1.179 0 CA-C-O 122.021 0.915 . . . . 2.18 112.104 -178.932 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A 1529 ' ' LEU . . . . . . . . . . . . . 3.1 mm? -122.33 16.68 10.59 Favored 'General case' 0 C--N 1.292 -1.896 0 N-CA-C 105.047 -2.205 . . . . 1.44 105.047 168.963 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A 1530 ' ' SER . . . . . . . . . . . . . 12.7 m -74.04 -37.48 64.29 Favored 'General case' 0 N--CA 1.435 -1.219 0 CA-C-N 113.727 -1.579 . . . . 1.44 108.681 -179.157 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A 1531 ' ' SER . . . . . . . . . . . . . 9.6 m -75.0 -21.61 59.03 Favored 'General case' 0 N--CA 1.433 -1.32 0 N-CA-C 108.801 -0.814 . . . . 1.5 108.801 176.515 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A 1532 ' ' LEU . . . . . 0.488 HD11 HD21 ' A' 1644 ' ' LEU . 90.2 mt -96.29 11.23 35.36 Favored 'General case' 0 CA--C 1.52 -0.21 0 CA-C-N 115.638 -0.71 . . . . 1.77 112.238 178.239 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A 1533 ' ' SER . . . . . . . . . . . . . 34.0 m -69.47 114.46 7.72 Favored 'General case' 0 N--CA 1.435 -1.212 0 N-CA-C 107.622 -1.251 . . . . 2.38 107.622 176.479 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A 1534 ' ' GLY . . . . . . . . . . . . . . . -82.47 151.11 29.18 Favored Glycine 0 N--CA 1.426 -2.005 0 CA-C-N 115.615 -0.721 . . . . 1.55 113.993 -170.209 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A 1535 ' ' ARG . . . . . 0.465 ' C ' ' HD3' ' A' 1535 ' ' ARG . 1.2 tmt_? -95.88 -61.57 1.43 Allowed 'General case' 0 N--CA 1.426 -1.644 0 N-CA-C 106.885 -1.524 . . . . 3.96 106.885 174.821 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A 1536 ' ' ALA . . . . . . . . . . . . . . . -94.87 -23.01 17.65 Favored 'General case' 0 C--N 1.312 -1.056 0 CA-C-N 115.458 -0.792 . . . . 1.65 109.023 177.195 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A 1537 ' ' GLY . . . . . . . . . . . . . . . 91.25 -167.75 31.75 Favored Glycine 0 N--CA 1.427 -1.962 0 CA-C-N 115.623 -0.717 . . . . 1.19 113.862 174.492 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A 1538 ' ' PHE . . . . . . . . . . . . . 81.6 m-85 -108.46 168.3 9.42 Favored 'General case' 0 C--N 1.298 -1.661 0 C-N-CA 125.574 1.55 . . . . 1.69 107.661 -179.321 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A 1539 ' ' THR . . . . . . . . . . . . . 14.5 p -117.05 112.7 21.3 Favored 'General case' 0 C--N 1.297 -1.714 0 CA-C-O 120.925 0.393 . . . . 1.48 110.273 179.809 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A 1540 ' ' ALA . . . . . . . . . . . . . . . -102.17 143.96 31.32 Favored 'General case' 0 C--N 1.303 -1.435 0 N-CA-C 108.05 -1.093 . . . . 0.83 108.05 178.741 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A 1541 ' ' ALA . . . . . . . . . . . . . . . -91.01 156.64 17.8 Favored 'General case' 0 C--N 1.294 -1.826 0 CA-C-O 121.982 0.896 . . . . 1.27 112.844 -173.819 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A 1542 ' ' TYR . . . . . 0.73 ' HB3' ' HA3' ' A' 1546 ' ' GLY . 68.5 t80 -147.44 171.69 15.11 Favored 'General case' 0 C--N 1.296 -1.761 0 N-CA-C 102.746 -3.057 . . . . 2.15 102.746 175.006 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A 1543 ' ' SER . . . . . . . . . . . . . 6.8 m -43.09 -161.88 0.0 OUTLIER 'General case' 0 CA--C 1.603 2.983 0 N-CA-C 117.119 2.266 . . . . 2.29 117.119 -173.769 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A 1544 ' ' LYS . . . . . . . . . . . . . 57.7 tttm -46.12 -38.05 7.65 Favored 'General case' 0 N--CA 1.479 0.997 0 O-C-N 120.669 -1.27 . . . . 3.91 113.24 -178.493 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A 1545 ' ' SER . . . . . . . . . . . . . 19.4 m -111.29 26.12 11.01 Favored 'General case' 0 C--N 1.3 -1.56 0 O-C-N 122.27 -0.269 . . . . 3.3 110.583 179.18 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A 1546 ' ' GLY . . . . . 0.73 ' HA3' ' HB3' ' A' 1542 ' ' TYR . . . -112.84 131.28 10.0 Favored Glycine 0 N--CA 1.412 -2.912 0 C-N-CA 117.879 -2.105 . . . . 1.24 116.311 -173.836 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A 1547 ' ' VAL . . . . . . . . . . . . . 9.1 p -162.07 119.46 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.567 0 N-CA-C 107.821 -1.177 . . . . 1.63 107.821 171.808 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A 1548 ' ' VAL . . . . . . . . . . . . . 2.1 t -115.29 129.23 71.88 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.814 0 N-CA-C 107.923 -1.14 . . . . 0.92 107.923 -175.599 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A 1549 ' ' TYR . . . . . 0.447 ' HB3' HD21 ' A' 1556 ' ' ASN . 96.3 m-85 -84.61 116.57 23.24 Favored 'General case' 0 N--CA 1.423 -1.783 0 N-CA-C 107.552 -1.277 . . . . 1.44 107.552 176.002 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A 1550 ' ' MET . . . . . . . . . . . . . 54.9 tpp -119.1 122.53 42.28 Favored 'General case' 0 C--N 1.29 -1.986 0 CA-C-N 115.379 -0.828 . . . . 1.74 110.551 -174.014 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A 1551 ' ' SER . . . . . . . . . . . . . 8.2 t -96.57 121.7 38.68 Favored 'General case' 0 C--N 1.285 -2.202 0 N-CA-C 103.527 -2.768 . . . . 1.64 103.527 171.263 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A 1552 ' ' ILE . . . . . . . . . . . . . 1.8 tp -62.14 -27.57 42.77 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.666 0 CA-C-O 121.38 0.609 . . . . 1.33 110.344 -172.166 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A 1553 ' ' CYS . . . . . 0.466 ' HA ' ' OH ' ' A' 1592 ' ' TYR . 23.0 t -162.39 138.39 7.48 Favored 'General case' 0 N--CA 1.415 -2.215 0 N-CA-C 105.479 -2.045 . . . . 1.43 105.479 167.494 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A 1554 ' ' GLY . . . . . . . . . . . . . . . 110.45 -166.85 12.46 Favored Glycine 0 C--N 1.292 -1.913 0 N-CA-C 110.018 -1.233 . . . . 1.12 110.018 -179.011 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A 1555 ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -99.69 156.93 16.82 Favored 'General case' 0 C--N 1.303 -1.448 0 CA-C-N 117.48 0.64 . . . . 1.8 111.109 -178.221 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A 1556 ' ' ASN . . . . . 0.447 HD21 ' HB3' ' A' 1549 ' ' TYR . 23.0 t-20 -111.47 109.37 19.28 Favored 'General case' 0 N--CA 1.423 -1.815 0 CA-C-N 115.34 -0.845 . . . . 2.63 109.269 -178.409 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A 1557 ' ' GLU . . . . . . . . . . . . . 25.6 mt-10 -87.91 54.42 3.09 Favored 'General case' 0 C--N 1.301 -1.525 0 N-CA-C 113.307 0.854 . . . . 3.79 113.307 -174.022 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A 1558 ' ' ASN . . . . . . . . . . . . . 32.9 m-80 -129.22 3.45 5.2 Favored 'General case' 0 C--N 1.306 -1.298 0 N-CA-C 107.94 -1.133 . . . . 1.52 107.94 174.615 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A 1559 ' ' CYS . . . . . 0.774 ' HB3' ' HD2' ' A' 1560 ' ' PRO . 69.3 m -153.98 177.84 1.84 Allowed Pre-proline 0 C--N 1.31 -1.146 0 N-CA-C 106.995 -1.483 . . . . 0.84 106.995 -177.911 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A 1560 ' ' PRO . . . . . 0.774 ' HD2' ' HB3' ' A' 1559 ' ' CYS . 15.9 Cg_exo -32.82 132.74 0.09 OUTLIER 'Trans proline' 0 C--N 1.381 2.246 0 C-N-CA 124.363 3.375 . . . . 1.18 114.955 177.615 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A 1561 ' ' PRO . . . . . 0.496 ' HD3' ' HA ' ' A' 1560 ' ' PRO . 35.9 Cg_exo -58.25 123.49 13.75 Favored 'Trans proline' 0 C--O 1.245 0.826 0 C-N-CA 122.916 2.411 . . . . 1.51 111.568 179.814 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A 1562 ' ' GLY . . . . . 0.428 ' O ' ' HD3' ' A' 1576 ' ' LYS . . . 109.48 -8.08 32.38 Favored Glycine 0 N--CA 1.436 -1.364 0 C-N-CA 120.288 -0.958 . . . . 0.72 114.163 178.247 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A 1563 ' ' VAL . . . . . . . . . . . . . 3.4 m -89.17 148.21 4.69 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.874 0 N-CA-C 107.962 -1.125 . . . . 0.97 107.962 178.286 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A 1564 ' ' GLY . . . . . . . . . . . . . . . -97.63 -23.14 14.44 Favored Glycine 0 CA--C 1.505 -0.573 0 C-N-CA 120.137 -1.03 . . . . 0.72 113.162 -174.441 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A 1565 ' ' ALA . . . . . . . . . . . . . . . -151.65 140.46 20.92 Favored 'General case' 0 C--N 1.31 -1.13 0 N-CA-C 109.137 -0.69 . . . . 0.37 109.137 -177.909 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A 1566 ' ' CYS . . . . . . . . . . . . . 48.0 t -161.77 147.65 13.64 Favored 'General case' 0 C--N 1.315 -0.92 0 CA-C-N 116.398 -0.365 . . . . 0.51 110.016 -175.526 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A 1567 ' ' PHE . . . . . 0.421 ' O ' ' HA ' ' A' 1571 ' ' ARG . 50.3 m-85 -74.73 152.16 39.11 Favored 'General case' 0 N--CA 1.471 0.583 0 N-CA-C 108.609 -0.885 . . . . 0.97 108.609 178.424 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A 1568 ' ' GLY . . . . . . . . . . . . . . . -89.07 -31.75 11.61 Favored Glycine 0 N--CA 1.447 -0.61 0 C-N-CA 120.499 -0.857 . . . . 1.08 114.125 -176.744 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A 1569 ' ' GLN . . . . . . . . . . . . . 8.9 tt0 -89.9 -56.93 3.04 Favored 'General case' 0 C--N 1.309 -1.183 0 N-CA-C 108.361 -0.977 . . . . 2.74 108.361 178.363 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A 1570 ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -68.79 -32.6 72.45 Favored 'General case' 0 N--CA 1.421 -1.88 0 CA-C-N 113.684 -1.598 . . . . 1.96 110.579 -175.921 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A 1571 ' ' ARG . . . . . 0.421 ' HA ' ' O ' ' A' 1567 ' ' PHE . 67.7 mtm180 46.29 55.76 7.01 Favored 'General case' 0 C--O 1.246 0.871 0 N-CA-C 113.176 0.806 . . . . 3.95 113.176 -179.252 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A 1572 ' ' ILE . . . . . . . . . . . . . 47.9 mm -109.7 126.05 66.86 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.384 0 N-CA-C 106.394 -1.706 . . . . 1.37 106.394 175.066 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A 1573 ' ' SER . . . . . . . . . . . . . 42.1 t -75.76 120.46 21.16 Favored 'General case' 0 C--N 1.298 -1.634 0 N-CA-C 108.973 -0.751 . . . . 1.08 108.973 179.496 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A 1574 ' ' VAL . . . . . 0.629 ' HB ' ' HB2' ' A' 1606 ' ' TYR . 34.5 m -90.88 -33.9 6.1 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.81 0 C-N-CA 119.401 -0.919 . . . . 1.3 110.827 179.948 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A 1575 ' ' GLY . . . . . . . . . . . . . . . -161.31 155.63 26.87 Favored Glycine 0 N--CA 1.424 -2.144 0 C-N-CA 120.047 -1.073 . . . . 0.51 113.747 -177.761 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A 1576 ' ' LYS . . . . . 0.428 ' HD3' ' O ' ' A' 1562 ' ' GLY . 17.0 tppt? -71.47 153.11 42.47 Favored 'General case' 0 C--N 1.311 -1.108 0 C-N-CA 125.814 1.646 . . . . 2.9 108.512 178.17 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A 1577 ' ' ALA . . . . . . . . . . . . . . . -65.16 74.9 0.05 Allowed 'General case' 0 N--CA 1.482 1.152 0 C-N-CA 123.629 0.771 . . . . 0.83 109.578 174.425 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A 1578 ' ' ASN . . . . . . . . . . . . . 61.8 t30 -89.81 131.67 35.64 Favored 'General case' 0 C--N 1.293 -1.878 0 C-N-CA 124.092 0.957 . . . . 1.85 111.303 -173.211 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A 1579 ' ' LYS . . . . . . . . . . . . . 2.4 mppt? -100.2 92.12 5.07 Favored 'General case' 0 C--N 1.292 -1.914 0 N-CA-C 108.771 -0.826 . . . . 1.9 108.771 175.56 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A 1580 ' ' ARG . . . . . 0.515 ' O ' ' HA ' ' A' 1590 ' ' LEU . 61.7 ttt180 -140.16 86.49 2.08 Favored 'General case' 0 C--N 1.289 -2.056 0 N-CA-C 107.536 -1.283 . . . . 3.63 107.536 176.735 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A 1581 ' ' LEU . . . . . 0.605 HD13 ' HB2' ' A' 1590 ' ' LEU . 20.6 tp -110.85 135.79 50.87 Favored 'General case' 0 C--N 1.297 -1.69 0 N-CA-C 108.672 -0.862 . . . . 1.87 108.672 -177.238 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A 1582 ' ' ARG . . . . . . . . . . . . . 57.5 ttp180 -136.79 140.4 42.49 Favored 'General case' 0 C--N 1.304 -1.384 0 N-CA-C 109.535 -0.542 . . . . 3.97 109.535 179.854 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A 1583 ' ' TYR . . . . . . . . . . . . . 74.2 t80 -112.17 92.89 4.19 Favored 'General case' 0 C--O 1.245 0.843 0 C-N-CA 122.896 0.478 . . . . 1.41 110.174 179.83 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A 1584 ' ' VAL . . . . . . . . . . . . . 28.5 m -137.51 147.22 26.63 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.293 0 N-CA-C 107.261 -1.385 . . . . 1.69 107.261 175.346 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A 1585 ' ' ASP . . . . . . . . . . . . . 19.0 t70 61.96 28.08 17.06 Favored 'General case' 0 N--CA 1.483 1.22 0 C-N-CA 124.246 1.018 . . . . 2.06 109.702 -179.672 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A 1586 ' ' GLN . . . . . . . . . . . . . 46.2 mt-30 53.98 34.16 19.05 Favored 'General case' 0 N--CA 1.466 0.354 0 C-N-CA 125.243 1.417 . . . . 2.33 113.474 -176.147 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A 1587 ' ' VAL . . . . . . . . . . . . . 8.1 p -132.13 123.56 50.98 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.692 0 CA-C-O 121.24 0.543 . . . . 0.78 110.021 176.266 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A 1588 ' ' LEU . . . . . 0.71 ' HB2' ' HB2' ' A' 1612 ' ' PHE . 80.1 mt -78.75 116.72 19.28 Favored 'General case' 0 C--N 1.312 -1.026 0 N-CA-C 107.392 -1.336 . . . . 1.41 107.392 174.695 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A 1589 ' ' GLN . . . . . . . . . . . . . 8.6 tt0 -118.2 124.78 48.76 Favored 'General case' 0 C--N 1.28 -2.432 0 CA-C-N 115.863 -0.608 . . . . 1.24 109.935 -177.316 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A 1590 ' ' LEU . . . . . 0.605 ' HB2' HD13 ' A' 1581 ' ' LEU . 7.5 tt -122.55 126.14 47.16 Favored 'General case' 0 C--N 1.302 -1.475 0 N-CA-C 106.876 -1.527 . . . . 1.15 106.876 178.761 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A 1591 ' ' VAL . . . . . 0.422 HG12 HG22 ' A' 1609 ' ' VAL . 19.3 m -114.38 117.76 56.52 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.235 0 N-CA-C 113.864 1.061 . . . . 1.51 113.864 -175.665 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A 1592 ' ' TYR . . . . . 0.521 ' HB2' ' HB2' ' A' 1608 ' ' SER . 56.4 m-85 -90.9 133.5 35.19 Favored 'General case' 0 C--N 1.311 -1.067 0 CA-C-N 115.316 -0.856 . . . . 1.06 110.584 177.16 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A 1593 ' ' LYS . . . . . . . . . . . . . 63.4 pttt -159.02 -177.95 6.88 Favored 'General case' 0 C--N 1.314 -0.958 0 N-CA-C 108.396 -0.964 . . . . 2.18 108.396 177.304 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A 1594 ' ' ASP . . . . . . . . . . . . . 62.2 m-20 72.1 59.04 0.14 Allowed 'General case' 0 N--CA 1.476 0.846 0 C-N-CA 124.379 1.072 . . . . 1.45 111.865 179.158 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A 1595 ' ' GLY . . . . . . . . . . . . . . . -131.32 -109.91 1.28 Allowed Glycine 0 N--CA 1.433 -1.541 0 N-CA-C 109.343 -1.503 . . . . 0.78 109.343 177.35 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A 1596 ' ' SER . . . . . 0.43 ' HA ' ' HD3' ' A' 1597 ' ' PRO . 14.1 m -97.67 134.98 21.83 Favored Pre-proline 0 C--N 1.299 -1.591 0 N-CA-C 108.801 -0.814 . . . . 1.68 108.801 177.719 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A 1597 ' ' PRO . . . . . 0.43 ' HD3' ' HA ' ' A' 1596 ' ' SER . 23.5 Cg_exo -67.14 152.27 80.06 Favored 'Trans proline' 0 N--CA 1.458 -0.574 0 C-N-CA 123.074 2.516 . . . . 1.17 112.133 177.908 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A 1598 ' ' CYS . . . . . . . . . . . . . 43.1 t -94.77 135.67 23.62 Favored Pre-proline 0 C--N 1.293 -1.881 0 N-CA-C 107.932 -1.136 . . . . 1.19 107.932 179.563 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A 1599 ' ' PRO . . . . . . . . . . . . . 89.4 Cg_endo -79.49 3.21 7.7 Favored 'Trans proline' 0 C--O 1.243 0.746 0 C-N-CA 123.383 2.722 . . . . 1.59 113.707 -177.395 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A 1600 ' ' SER . . . . . . . . . . . . . 14.6 m -120.94 145.83 47.29 Favored 'General case' 0 C--N 1.297 -1.68 0 N-CA-C 108.055 -1.091 . . . . 2.12 108.055 178.837 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A 1601 ' ' LYS . . . . . 0.61 ' HG3' HG22 ' A' 1633 ' ' THR . 29.7 mmmt 67.63 -146.14 0.14 Allowed 'General case' 0 CA--C 1.537 0.453 0 O-C-N 124.006 0.816 . . . . 3.74 110.61 177.925 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A 1602 ' ' SER . . . . . . . . . . . . . 33.5 t -68.76 163.43 24.08 Favored 'General case' 0 CA--C 1.551 0.998 0 N-CA-C 109.66 -0.496 . . . . 3.79 109.66 178.862 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A 1603 ' ' GLY . . . . . . . . . . . . . . . -77.36 58.0 3.7 Favored Glycine 0 C--N 1.332 0.324 0 N-CA-C 111.685 -0.566 . . . . 2.0 111.685 179.015 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A 1604 ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -101.2 159.43 15.25 Favored 'General case' 0 C--N 1.297 -1.715 0 C-N-CA 124.773 1.229 . . . . 1.48 110.146 -179.278 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A 1605 ' ' SER . . . . . . . . . . . . . 38.6 m -75.74 -170.9 1.42 Allowed 'General case' 0 C--N 1.315 -0.91 0 CA-C-O 121.586 0.708 . . . . 1.51 110.737 177.837 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A 1606 ' ' TYR . . . . . 0.629 ' HB2' ' HB ' ' A' 1574 ' ' VAL . 14.7 m-85 -96.57 117.07 30.17 Favored 'General case' 0 N--CA 1.422 -1.858 0 N-CA-C 103.513 -2.773 . . . . 1.18 103.513 174.582 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A 1607 ' ' LYS . . . . . . . . . . . . . 22.0 ptmt -102.88 124.07 47.7 Favored 'General case' 0 C--N 1.276 -2.597 0 C-N-CA 118.613 -1.235 . . . . 1.67 111.404 -170.083 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A 1608 ' ' SER . . . . . 0.521 ' HB2' ' HB2' ' A' 1592 ' ' TYR . 21.7 m -101.46 110.16 22.11 Favored 'General case' 0 C--N 1.299 -1.629 0 CA-C-N 114.928 -1.033 . . . . 1.0 109.626 -178.98 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A 1609 ' ' VAL . . . . . 0.422 HG22 HG12 ' A' 1591 ' ' VAL . 65.8 t -94.3 106.44 18.1 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.351 0 N-CA-C 109.31 -0.626 . . . . 0.93 109.31 178.729 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A 1610 ' ' ILE . . . . . . . . . . . . . 38.2 mm -89.49 109.21 20.12 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.701 0 N-CA-C 108.471 -0.937 . . . . 0.78 108.471 178.831 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A 1611 ' ' SER . . . . . . . . . . . . . 18.2 m -104.98 116.59 32.22 Favored 'General case' 0 C--N 1.301 -1.51 0 CA-C-O 121.286 0.565 . . . . 1.29 110.398 178.923 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A 1612 ' ' PHE . . . . . 0.71 ' HB2' ' HB2' ' A' 1588 ' ' LEU . 93.3 m-85 -87.74 108.61 19.2 Favored 'General case' 0 C--N 1.301 -1.509 0 N-CA-C 108.36 -0.978 . . . . 0.7 108.36 177.143 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A 1613 ' ' VAL . . . . . . . . . . . . . 78.9 t -102.61 130.62 52.29 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.084 0 CA-C-O 120.889 0.376 . . . . 0.75 110.312 -178.227 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A 1614 ' ' CYS . . . . . . . . . . . . . 32.5 m -75.02 92.28 2.6 Favored 'General case' 0 C--N 1.303 -1.415 0 CA-C-N 115.257 -0.883 . . . . 1.39 111.586 -176.169 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A 1615 ' ' ARG . . . . . 0.806 ' HB3' ' HB3' ' A' 1641 ' ' HIS . 2.9 tpm_? -138.93 85.46 16.2 Favored Pre-proline 0 C--N 1.314 -0.975 0 N-CA-C 108.861 -0.792 . . . . 3.75 108.861 176.789 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A 1616 ' ' PRO . . . . . . . . . . . . . 52.6 Cg_exo -59.29 -18.54 45.75 Favored 'Trans proline' 0 N--CA 1.492 1.439 0 C-N-CA 123.07 2.513 . . . . 1.32 113.554 179.019 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A 1617 ' ' GLU . . . . . . . . . . . . . 33.0 tt0 . . . . . 0 C--N 1.321 -0.634 0 C-N-CA 123.473 0.709 . . . . 3.21 112.312 -178.351 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A 1622 ' ' ASN . . . . . . . . . . . . . 50.6 t-20 . . . . . 0 C--O 1.239 0.527 0 N-CA-C 107.574 -1.269 . . . . 2.92 107.574 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A 1623 ' ' ARG . . . . . . . . . . . . . 8.1 ptm180 -150.97 153.77 33.5 Favored Pre-proline 0 C--N 1.31 -1.11 0 CA-C-N 115.095 -0.957 . . . . 3.61 108.468 -177.44 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A 1624 ' ' PRO . . . . . . . . . . . . . 11.6 Cg_exo -71.43 120.63 7.09 Favored 'Trans proline' 0 C--O 1.236 0.403 0 C-N-CA 122.631 2.22 . . . . 2.37 110.896 178.279 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A 1625 ' ' MET . . . . . . . . . . . . . 44.4 ttm -109.94 140.84 43.49 Favored 'General case' 0 C--N 1.306 -1.294 0 C-N-CA 122.777 0.431 . . . . 2.16 110.082 -177.621 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A 1626 ' ' LEU . . . . . . . . . . . . . 59.9 tp -81.38 117.3 21.72 Favored 'General case' 0 C--N 1.308 -1.237 0 N-CA-C 107.768 -1.197 . . . . 1.35 107.768 175.337 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A 1627 ' ' ILE . . . . . . . . . . . . . 41.0 pt -99.33 -33.1 3.86 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.204 0 C-N-CA 119.778 -0.769 . . . . 1.21 111.547 -177.209 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A 1628 ' ' SER . . . . . 0.536 ' HB3' ' HB2' ' A' 1637 ' ' PHE . 44.9 t -141.28 143.65 34.21 Favored 'General case' 0 N--CA 1.431 -1.4 0 N-CA-C 109.287 -0.634 . . . . 1.4 109.287 -176.99 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A 1629 ' ' LEU . . . . . 0.747 HD13 ' HG ' ' A' 1636 ' ' LEU . 22.4 tp -146.07 116.21 7.42 Favored 'General case' 0 C--N 1.303 -1.42 0 CA-C-N 116.057 -0.52 . . . . 1.56 110.312 -177.941 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A 1630 ' ' ASP . . . . . . . . . . . . . 12.3 t70 -109.51 107.97 18.28 Favored 'General case' 0 C--N 1.298 -1.659 0 N-CA-C 107.801 -1.185 . . . . 0.87 107.801 176.416 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A 1631 ' ' LYS . . . . . . . . . . . . . 95.3 mttt -85.27 3.54 39.05 Favored 'General case' 0 C--N 1.307 -1.281 0 CA-C-N 116.241 -0.436 . . . . 2.35 111.979 -176.202 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A 1632 ' ' GLN . . . . . . . . . . . . . 1.4 mp0 -91.11 -49.21 6.52 Favored 'General case' 0 C--N 1.316 -0.863 0 N-CA-C 109.102 -0.703 . . . . 2.55 109.102 178.875 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A 1633 ' ' THR . . . . . 0.61 HG22 ' HG3' ' A' 1601 ' ' LYS . 22.2 p -97.48 2.78 50.63 Favored 'General case' 0 C--N 1.308 -1.234 0 CA-C-N 115.772 -0.649 . . . . 1.24 111.455 179.013 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A 1634 ' ' CYS . . . . . . . . . . . . . 98.3 m 56.6 47.49 18.39 Favored 'General case' 0 C--N 1.347 0.467 0 CA-C-N 114.879 -1.055 . . . . 0.89 111.758 178.692 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A 1635 ' ' THR . . . . . . . . . . . . . 26.7 m -112.44 118.38 35.02 Favored 'General case' 0 N--CA 1.43 -1.434 0 CA-C-N 115.006 -0.997 . . . . 0.75 109.246 -178.21 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A 1636 ' ' LEU . . . . . 0.747 ' HG ' HD13 ' A' 1629 ' ' LEU . 4.0 mp -112.1 130.17 55.98 Favored 'General case' 0 N--CA 1.441 -0.884 0 N-CA-C 109.626 -0.509 . . . . 1.33 109.626 -177.816 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A 1637 ' ' PHE . . . . . 0.536 ' HB2' ' HB3' ' A' 1628 ' ' SER . 91.0 m-85 -111.15 113.09 25.35 Favored 'General case' 0 C--N 1.315 -0.931 0 CA-C-O 120.9 0.381 . . . . 0.83 110.509 -178.712 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A 1638 ' ' PHE . . . . . . . . . . . . . 97.4 m-85 -108.25 145.53 34.18 Favored 'General case' 0 C--N 1.306 -1.298 0 CA-C-N 116.103 -0.499 . . . . 0.6 109.766 -179.087 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A 1639 ' ' SER . . . . . . . . . . . . . 65.6 m -136.98 127.89 27.47 Favored 'General case' 0 C--N 1.29 -2.018 0 CA-C-O 121.226 0.536 . . . . 1.08 111.381 178.848 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A 1640 ' ' TRP . . . . . . . . . . . . . 16.4 t90 -115.72 125.49 52.87 Favored 'General case' 0 C--N 1.294 -1.843 0 N-CA-C 107.022 -1.473 . . . . 0.8 107.022 175.188 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A 1641 ' ' HIS . . . . . 0.806 ' HB3' ' HB3' ' A' 1615 ' ' ARG . 69.9 m-70 -89.39 103.3 15.94 Favored 'General case' 0 C--N 1.306 -1.297 0 N-CA-C 107.054 -1.461 . . . . 2.54 107.054 -179.848 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A 1642 ' ' THR . . . . . . . . . . . . . 10.2 t -143.0 142.02 20.98 Favored Pre-proline 0 C--N 1.302 -1.476 0 CA-C-O 121.013 0.435 . . . . 1.15 110.96 -173.618 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A 1643 ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo -73.64 -12.13 24.42 Favored 'Trans proline' 0 C--N 1.359 1.08 0 C-N-CA 123.211 2.608 . . . . 0.8 113.118 179.93 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A 1644 ' ' LEU . . . . . 0.488 HD21 HD11 ' A' 1532 ' ' LEU . 2.4 pp -90.66 4.48 51.3 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 121.685 0.755 . . . . 1.54 112.799 -179.221 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A 1645 ' ' ALA . . . . . . . . . . . . . . . -72.66 -38.4 67.65 Favored 'General case' 0 C--N 1.302 -1.482 0 CA-C-N 114.476 -1.238 . . . . 0.95 108.086 173.461 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A 1646 ' ' CYS . . . . . . . . . . . . . 18.6 p -175.4 135.29 0.32 Allowed 'General case' 0 C--N 1.312 -1.037 0 N-CA-C 105.004 -2.221 . . . . 1.41 105.004 175.402 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A 1647 ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 . . . . . 0 C--N 1.312 -1.039 0 N-CA-C 108.801 -0.814 . . . . 2.92 108.801 -179.568 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A 1515 ' ' ASP . . . . . . . . . . . . . 62.7 m-20 . . . . . 0 CA--C 1.49 -1.346 0 N-CA-C 108.238 -1.023 . . . . 2.54 108.238 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A 1516 ' ' CYS . . . . . . . . . . . . . 58.3 m -120.39 73.19 0.98 Allowed 'General case' 0 C--N 1.305 -1.359 0 CA-C-O 121.436 0.636 . . . . 1.25 110.664 -175.796 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A 1517 ' ' GLN . . . . . 0.43 HE21 ' HB3' ' A' 1517 ' ' GLN . 0.0 OUTLIER -139.59 136.14 34.08 Favored 'General case' 0 C--N 1.297 -1.7 0 CA-C-N 115.527 -0.76 . . . . 1.88 111.014 174.067 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A 1518 ' ' VAL . . . . . . . . . . . . . 94.8 t -121.23 121.59 65.23 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.449 0 CA-C-N 115.673 -0.694 . . . . 1.73 109.269 176.497 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A 1519 ' ' THR . . . . . 0.513 ' HA ' ' HA ' ' A' 1526 ' ' LEU . 20.5 m -90.62 108.23 19.68 Favored 'General case' 0 C--N 1.295 -1.763 0 CA-C-O 120.865 0.364 . . . . 1.7 110.914 179.651 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A 1520 ' ' ASN . . . . . 0.559 ' HB2' ' CE2' ' A' 1527 ' ' PHE . 15.1 t-20 -67.43 122.3 82.55 Favored Pre-proline 0 N--CA 1.47 0.566 0 CA-C-N 116.033 -0.531 . . . . 2.12 110.98 179.416 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A 1521 ' ' PRO . . . . . . . . . . . . . 94.9 Cg_endo -83.4 -1.5 10.25 Favored 'Trans proline' 0 CA--C 1.533 0.442 0 C-N-CA 122.347 2.031 . . . . 2.47 113.756 -178.236 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A 1522 ' ' SER . . . . . . . . . . . . . 6.8 m -83.62 -58.18 2.92 Favored 'General case' 0 C--N 1.308 -1.201 0 C-N-CA 120.773 -0.371 . . . . 2.57 110.57 -179.071 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A 1523 ' ' THR . . . . . . . . . . . . . 11.3 t -108.85 -5.98 15.98 Favored 'General case' 0 N--CA 1.443 -0.815 0 CA-C-O 120.972 0.415 . . . . 2.15 110.844 -177.045 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A 1524 ' ' GLY . . . . . . . . . . . . . . . 80.01 28.76 48.9 Favored Glycine 0 CA--C 1.507 -0.445 0 C-N-CA 120.62 -0.8 . . . . 1.89 112.91 176.899 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A 1525 ' ' HIS . . . . . . . . . . . . . 22.1 t-160 -97.41 118.59 34.23 Favored 'General case' 0 C--N 1.312 -1.032 0 N-CA-C 109.414 -0.587 . . . . 1.9 109.414 -179.885 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A 1526 ' ' LEU . . . . . 0.513 ' HA ' ' HA ' ' A' 1519 ' ' THR . 5.0 tt -82.9 111.0 18.38 Favored 'General case' 0 C--N 1.295 -1.79 0 N-CA-C 107.095 -1.446 . . . . 1.61 107.095 178.087 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A 1527 ' ' PHE . . . . . 0.559 ' CE2' ' HB2' ' A' 1520 ' ' ASN . 32.6 m-85 -87.9 102.62 14.89 Favored 'General case' 0 C--N 1.305 -1.351 0 N-CA-C 108.498 -0.927 . . . . 1.42 108.498 179.395 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A 1528 ' ' ASP . . . . . . . . . . . . . 23.4 t70 -105.71 133.44 50.45 Favored 'General case' 0 C--N 1.298 -1.632 0 C-N-CA 120.467 -0.493 . . . . 2.18 110.106 179.347 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A 1529 ' ' LEU . . . . . . . . . . . . . 89.0 mt -113.3 -7.98 13.5 Favored 'General case' 0 C--N 1.299 -1.614 0 CA-C-N 115.146 -0.934 . . . . 1.44 110.001 179.248 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A 1530 ' ' SER . . . . . . . . . . . . . 2.3 m -69.1 -37.41 78.37 Favored 'General case' 0 CA--C 1.543 0.696 0 CA-C-O 121.878 0.846 . . . . 1.44 109.154 -177.92 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A 1531 ' ' SER . . . . . . . . . . . . . 14.0 m -70.85 -24.13 62.47 Favored 'General case' 0 C--N 1.317 -0.844 0 CA-C-N 115.199 -0.91 . . . . 1.5 109.926 177.895 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A 1532 ' ' LEU . . . . . . . . . . . . . 8.0 mp -84.7 4.58 31.97 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.414 -0.812 . . . . 1.77 110.502 179.317 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A 1533 ' ' SER . . . . . . . . . . . . . 32.5 m -113.87 119.08 36.06 Favored 'General case' 0 N--CA 1.425 -1.709 0 N-CA-C 113.337 0.866 . . . . 2.38 113.337 -175.303 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A 1534 ' ' GLY . . . . . . . . . . . . . . . -89.65 -162.84 38.76 Favored Glycine 0 N--CA 1.431 -1.677 0 N-CA-C 109.221 -1.552 . . . . 1.55 109.221 172.398 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A 1535 ' ' ARG . . . . . 0.46 ' HE ' ' CD ' ' A' 1557 ' ' GLU . 62.4 ttt180 -81.39 -47.76 12.81 Favored 'General case' 0 C--N 1.304 -1.409 0 CA-C-N 117.395 0.597 . . . . 3.96 110.633 -179.08 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A 1536 ' ' ALA . . . . . . . . . . . . . . . -95.56 -13.53 24.36 Favored 'General case' 0 C--N 1.316 -0.863 0 N-CA-C 108.752 -0.833 . . . . 1.65 108.752 177.74 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A 1537 ' ' GLY . . . . . . . . . . . . . . . 73.53 -139.94 27.37 Favored Glycine 0 N--CA 1.436 -1.355 0 CA-C-N 114.581 -1.191 . . . . 1.19 112.371 177.244 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A 1538 ' ' PHE . . . . . . . . . . . . . 78.0 m-85 -101.42 152.08 21.16 Favored 'General case' 0 C--N 1.296 -1.734 0 N-CA-C 109.188 -0.671 . . . . 1.69 109.188 179.456 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A 1539 ' ' THR . . . . . . . . . . . . . 25.8 m -103.66 115.19 30.04 Favored 'General case' 0 C--N 1.288 -2.09 0 N-CA-C 108.495 -0.928 . . . . 1.48 108.495 179.37 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A 1540 ' ' ALA . . . . . 0.783 ' HB3' HG13 ' A' 1548 ' ' VAL . . . -94.65 149.95 20.72 Favored 'General case' 0 C--N 1.309 -1.177 0 N-CA-C 109.223 -0.658 . . . . 0.83 109.223 -177.935 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A 1541 ' ' ALA . . . . . . . . . . . . . . . -87.01 139.07 30.95 Favored 'General case' 0 C--N 1.311 -1.078 0 N-CA-C 109.358 -0.608 . . . . 1.27 109.358 -179.407 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A 1542 ' ' TYR . . . . . 0.556 ' HD2' ' HB2' ' A' 1545 ' ' SER . 42.1 t80 -141.47 173.52 11.42 Favored 'General case' 0 N--CA 1.437 -1.091 0 CA-C-O 119.288 -0.387 . . . . 2.15 110.413 -176.813 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A 1543 ' ' SER . . . . . . . . . . . . . 9.5 m -46.92 -152.6 0.0 OUTLIER 'General case' 0 CA--C 1.577 1.995 0 C-N-CA 129.084 2.954 . . . . 2.29 114.07 178.619 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A 1544 ' ' LYS . . . . . . . . . . . . . 57.8 mtpt -45.03 -31.79 1.45 Allowed 'General case' 0 N--CA 1.487 1.389 0 O-C-N 121.088 -1.007 . . . . 3.91 112.902 177.121 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A 1545 ' ' SER . . . . . 0.556 ' HB2' ' HD2' ' A' 1542 ' ' TYR . 33.2 m -65.83 -12.68 56.19 Favored 'General case' 0 CA--C 1.562 1.409 0 N-CA-C 112.719 0.637 . . . . 3.3 112.719 176.425 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A 1546 ' ' GLY . . . . . . . . . . . . . . . 85.09 -74.2 2.52 Favored Glycine 0 CA--C 1.495 -1.216 0 C-N-CA 121.037 -0.601 . . . . 1.24 113.723 172.812 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A 1547 ' ' VAL . . . . . . . . . . . . . 10.7 m -139.01 156.99 28.52 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.445 0 CA-C-O 121.652 0.739 . . . . 1.63 112.145 -176.663 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A 1548 ' ' VAL . . . . . 0.783 HG13 ' HB3' ' A' 1540 ' ' ALA . 2.0 p -134.1 136.24 53.71 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.917 0 CA-C-N 114.766 -1.106 . . . . 0.92 108.114 178.924 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A 1549 ' ' TYR . . . . . . . . . . . . . 97.5 m-85 -93.51 141.29 28.63 Favored 'General case' 0 C--N 1.294 -1.835 0 N-CA-C 109.287 -0.634 . . . . 1.44 109.287 -179.085 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A 1550 ' ' MET . . . . . . . . . . . . . 42.2 ttm -138.37 121.64 17.01 Favored 'General case' 0 C--N 1.288 -2.083 0 CA-C-N 115.852 -0.613 . . . . 1.74 110.54 -179.261 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A 1551 ' ' SER . . . . . 0.455 ' OG ' ' HA ' ' A' 1556 ' ' ASN . 59.3 m -91.98 122.76 34.79 Favored 'General case' 0 N--CA 1.409 -2.517 0 N-CA-C 105.692 -1.966 . . . . 1.64 105.692 172.057 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A 1552 ' ' ILE . . . . . . . . . . . . . 38.6 mm -62.94 -21.53 28.26 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.804 0 CA-C-O 121.777 0.798 . . . . 1.33 110.716 -175.323 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A 1553 ' ' CYS . . . . . . . . . . . . . 43.7 t -161.55 138.33 8.45 Favored 'General case' 0 N--CA 1.412 -2.366 0 N-CA-C 106.65 -1.611 . . . . 1.43 106.65 175.063 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A 1554 ' ' GLY . . . . . 0.87 ' HA2' ' HE2' ' A' 1579 ' ' LYS . . . 104.71 -150.33 17.13 Favored Glycine 0 N--CA 1.426 -2.026 0 C-N-CA 119.957 -1.116 . . . . 1.12 112.305 175.489 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A 1555 ' ' GLU . . . . . . . . . . . . . 7.6 pt-20 -106.96 147.81 29.41 Favored 'General case' 0 C--N 1.293 -1.875 0 C-N-CA 123.088 0.555 . . . . 1.8 109.976 -177.612 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A 1556 ' ' ASN . . . . . 0.455 ' HA ' ' OG ' ' A' 1551 ' ' SER . 5.3 t-20 -98.54 88.88 4.22 Favored 'General case' 0 C--N 1.286 -2.159 0 CA-C-O 121.641 0.734 . . . . 2.63 109.07 -175.594 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A 1557 ' ' GLU . . . . . 0.46 ' CD ' ' HE ' ' A' 1535 ' ' ARG . 22.2 mt-10 -79.72 111.47 16.04 Favored 'General case' 0 C--N 1.303 -1.448 0 CA-C-N 115.409 -0.814 . . . . 3.79 111.567 -175.573 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A 1558 ' ' ASN . . . . . . . . . . . . . 6.9 p30 160.21 -25.1 0.0 OUTLIER 'General case' 0 N--CA 1.475 0.781 0 C-N-CA 127.501 2.32 . . . . 1.52 105.789 -176.556 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A 1559 ' ' CYS . . . . . 0.62 ' HB3' ' HD2' ' A' 1560 ' ' PRO . 93.2 m -118.2 173.86 3.03 Favored Pre-proline 0 N--CA 1.439 -0.992 0 CA-C-O 117.353 -1.308 . . . . 0.84 107.605 174.204 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A 1560 ' ' PRO . . . . . 0.62 ' HD2' ' HB3' ' A' 1559 ' ' CYS . 21.3 Cg_exo -35.8 132.14 0.29 Allowed 'Trans proline' 0 C--N 1.378 2.109 0 C-N-CA 123.567 2.844 . . . . 1.18 113.88 176.603 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A 1561 ' ' PRO . . . . . . . . . . . . . 19.8 Cg_endo -62.82 120.2 7.61 Favored 'Trans proline' 0 C--O 1.243 0.759 0 C-N-CA 122.792 2.328 . . . . 1.51 113.146 -177.634 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A 1562 ' ' GLY . . . . . . . . . . . . . . . 117.14 7.87 12.14 Favored Glycine 0 N--CA 1.434 -1.458 0 CA-C-N 115.833 -0.621 . . . . 0.72 112.669 176.972 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A 1563 ' ' VAL . . . . . . . . . . . . . 6.4 m -101.23 156.74 4.38 Favored 'Isoleucine or valine' 0 C--O 1.205 -1.263 0 N-CA-C 106.885 -1.524 . . . . 0.97 106.885 178.118 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A 1564 ' ' GLY . . . . . . . . . . . . . . . -108.71 -23.61 6.45 Favored Glycine 0 C--N 1.311 -0.81 0 C-N-CA 120.213 -0.994 . . . . 0.72 112.645 -177.713 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A 1565 ' ' ALA . . . . . . . . . . . . . . . -149.28 137.7 20.87 Favored 'General case' 0 C--N 1.311 -1.088 0 N-CA-C 108.572 -0.899 . . . . 0.37 108.572 -179.721 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A 1566 ' ' CYS . . . . . 0.544 ' SG ' ' HA ' ' A' 1571 ' ' ARG . 35.6 t -157.68 138.05 12.78 Favored 'General case' 0 C--N 1.312 -1.048 0 C-N-CA 121.229 -0.188 . . . . 0.51 111.492 -173.9 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A 1567 ' ' PHE . . . . . 0.561 ' HD1' ' HB ' ' A' 1548 ' ' VAL . 22.0 m-85 -67.19 125.27 25.53 Favored 'General case' 0 N--CA 1.471 0.607 0 N-CA-C 108.313 -0.995 . . . . 0.97 108.313 177.602 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A 1568 ' ' GLY . . . . . . . . . . . . . . . -58.36 -43.51 95.66 Favored Glycine 0 C--N 1.315 -0.606 0 N-CA-C 117.119 1.608 . . . . 1.08 117.119 -168.434 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A 1569 ' ' GLN . . . . . . . . . . . . . 4.0 pt20 -87.51 -34.35 18.66 Favored 'General case' 0 C--N 1.307 -1.274 0 CA-C-N 118.367 1.083 . . . . 2.74 113.748 -175.368 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A 1570 ' ' THR . . . . . . . . . . . . . 11.5 p -89.63 -22.36 22.35 Favored 'General case' 0 C--N 1.312 -1.063 0 CA-C-O 121.597 0.713 . . . . 1.96 112.321 -176.447 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A 1571 ' ' ARG . . . . . 0.544 ' HA ' ' SG ' ' A' 1566 ' ' CYS . 94.7 mtt180 59.88 38.89 20.98 Favored 'General case' 0 CA--C 1.515 -0.401 0 CA-C-N 114.523 -1.217 . . . . 3.95 113.755 175.295 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A 1572 ' ' ILE . . . . . . . . . . . . . 75.8 mt -98.35 123.44 50.88 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.971 0 CA-C-N 114.416 -1.266 . . . . 1.37 107.797 178.201 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A 1573 ' ' SER . . . . . . . . . . . . . 27.3 t -62.91 130.39 44.57 Favored 'General case' 0 C--N 1.318 -0.804 0 O-C-N 123.669 0.606 . . . . 1.08 111.446 -178.213 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A 1574 ' ' VAL . . . . . . . . . . . . . 27.7 m -122.87 25.36 3.72 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.402 0 CA-C-O 122.047 0.927 . . . . 1.3 109.898 176.17 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A 1575 ' ' GLY . . . . . . . . . . . . . . . 163.58 128.59 0.96 Allowed Glycine 0 N--CA 1.426 -1.974 0 CA-C-N 114.138 -1.392 . . . . 0.51 111.202 177.043 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A 1576 ' ' LYS . . . . . . . . . . . . . 50.5 tptt -77.77 151.19 34.18 Favored 'General case' 0 C--N 1.317 -0.81 0 N-CA-C 106.772 -1.566 . . . . 2.9 106.772 178.336 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A 1577 ' ' ALA . . . . . . . . . . . . . . . -67.66 99.79 0.83 Allowed 'General case' 0 C--N 1.321 -0.646 0 CA-C-O 120.963 0.411 . . . . 0.83 110.503 -178.705 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A 1578 ' ' ASN . . . . . 0.498 ' H ' ' HD1' ' A' 1592 ' ' TYR . 15.6 m120 -117.44 130.07 56.23 Favored 'General case' 0 C--N 1.302 -1.498 0 N-CA-C 108.736 -0.838 . . . . 1.85 108.736 -179.886 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A 1579 ' ' LYS . . . . . 0.87 ' HE2' ' HA2' ' A' 1554 ' ' GLY . 33.5 mmtp -93.44 89.79 6.46 Favored 'General case' 0 C--N 1.292 -1.901 0 N-CA-C 104.545 -2.391 . . . . 1.9 104.545 174.745 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A 1580 ' ' ARG . . . . . 0.403 ' O ' ' HA ' ' A' 1590 ' ' LEU . 22.0 ttm180 -148.27 103.52 3.45 Favored 'General case' 0 C--N 1.313 -0.986 0 C-N-CA 119.147 -1.021 . . . . 3.63 113.259 -170.219 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A 1581 ' ' LEU . . . . . . . . . . . . . 3.9 mm? -100.75 141.25 33.89 Favored 'General case' 0 C--N 1.31 -1.135 0 CA-C-N 115.691 -0.686 . . . . 1.87 110.285 172.99 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A 1582 ' ' ARG . . . . . 0.786 ' HB2' ' HB3' ' A' 1589 ' ' GLN . 93.4 mtt180 -116.55 98.44 6.55 Favored 'General case' 0 C--N 1.285 -2.205 0 N-CA-C 107.055 -1.461 . . . . 3.97 107.055 170.923 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A 1583 ' ' TYR . . . . . . . . . . . . . 45.6 t80 -79.18 91.64 4.98 Favored 'General case' 0 C--N 1.295 -1.769 0 N-CA-C 107.522 -1.288 . . . . 1.41 107.522 178.697 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A 1584 ' ' VAL . . . . . 0.529 ' O ' HG12 ' A' 1587 ' ' VAL . 11.5 m -117.55 98.29 6.44 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.26 0 CA-C-O 121.547 0.689 . . . . 1.69 111.68 -177.346 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A 1585 ' ' ASP . . . . . . . . . . . . . 34.7 t70 53.46 70.38 0.6 Allowed 'General case' 0 C--N 1.313 -1.016 0 C-N-CA 124.348 1.059 . . . . 2.06 111.804 -178.021 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A 1586 ' ' GLN . . . . . . . . . . . . . 14.9 mm100 68.72 -14.23 0.29 Allowed 'General case' 0 N--CA 1.481 1.088 0 N-CA-C 115.615 1.709 . . . . 2.33 115.615 177.247 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A 1587 ' ' VAL . . . . . 0.529 HG12 ' O ' ' A' 1584 ' ' VAL . 7.5 p -94.84 128.64 45.88 Favored 'Isoleucine or valine' 0 C--O 1.243 0.752 0 C-N-CA 119.159 -1.016 . . . . 0.78 110.197 178.837 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A 1588 ' ' LEU . . . . . 0.751 ' HB2' ' HB2' ' A' 1612 ' ' PHE . 3.0 mm? -84.58 124.11 31.07 Favored 'General case' 0 N--CA 1.418 -2.035 0 N-CA-C 106.568 -1.641 . . . . 1.41 106.568 173.013 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A 1589 ' ' GLN . . . . . 0.786 ' HB3' ' HB2' ' A' 1582 ' ' ARG . 7.5 tp60 -119.26 107.0 12.88 Favored 'General case' 0 C--N 1.277 -2.556 0 N-CA-C 107.806 -1.183 . . . . 1.24 107.806 -173.874 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A 1590 ' ' LEU . . . . . 0.403 ' HA ' ' O ' ' A' 1580 ' ' ARG . 7.1 tt -105.61 128.59 53.71 Favored 'General case' 0 C--N 1.297 -1.708 0 N-CA-C 108.382 -0.97 . . . . 1.15 108.382 -178.215 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A 1591 ' ' VAL . . . . . 0.629 HG12 HG22 ' A' 1609 ' ' VAL . 19.7 m -124.41 122.23 63.52 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.258 0 N-CA-C 112.868 0.692 . . . . 1.51 112.868 -175.409 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A 1592 ' ' TYR . . . . . 0.498 ' HD1' ' H ' ' A' 1578 ' ' ASN . 39.1 m-85 -103.07 98.38 8.33 Favored 'General case' 0 C--N 1.306 -1.3 0 N-CA-C 107.644 -1.243 . . . . 1.06 107.644 171.47 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A 1593 ' ' LYS . . . . . . . . . . . . . 21.4 ptmt -102.75 175.67 5.41 Favored 'General case' 0 C--N 1.3 -1.576 0 N-CA-C 109.751 -0.463 . . . . 2.18 109.751 -177.323 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A 1594 ' ' ASP . . . . . . . . . . . . . 22.0 m-20 61.22 50.07 5.09 Favored 'General case' 0 N--CA 1.494 1.75 0 N-CA-C 113.792 1.034 . . . . 1.45 113.792 178.68 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A 1595 ' ' GLY . . . . . . . . . . . . . . . -85.85 -106.72 0.73 Allowed Glycine 0 N--CA 1.436 -1.304 0 N-CA-C 110.36 -1.096 . . . . 0.78 110.36 175.637 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A 1596 ' ' SER . . . . . . . . . . . . . 69.6 m -99.87 151.87 37.63 Favored Pre-proline 0 C--N 1.297 -1.684 0 N-CA-C 109.364 -0.606 . . . . 1.68 109.364 177.438 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A 1597 ' ' PRO . . . . . . . . . . . . . 26.5 Cg_exo -65.28 131.49 28.49 Favored 'Trans proline' 0 C--O 1.24 0.588 0 C-N-CA 123.096 2.531 . . . . 1.17 111.416 178.287 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A 1598 ' ' CYS . . . . . 0.453 ' HA ' ' HD3' ' A' 1599 ' ' PRO . 43.2 t -100.24 109.9 58.12 Favored Pre-proline 0 C--N 1.301 -1.532 0 CA-C-N 116.018 -0.537 . . . . 1.19 109.779 -178.354 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A 1599 ' ' PRO . . . . . 0.453 ' HD3' ' HA ' ' A' 1598 ' ' CYS . 38.6 Cg_endo -98.02 21.85 0.32 Allowed 'Trans proline' 0 N--CA 1.445 -1.377 0 C-N-CA 123.308 2.672 . . . . 1.59 112.527 -179.191 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A 1600 ' ' SER . . . . . . . . . . . . . 16.9 m -73.73 -41.02 63.11 Favored 'General case' 0 C--N 1.313 -0.982 0 CA-C-N 116.571 -0.286 . . . . 2.12 111.627 -179.155 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A 1601 ' ' LYS . . . . . . . . . . . . . 87.3 tttt -142.39 -77.64 0.25 Allowed 'General case' 0 C--N 1.318 -0.765 0 CA-C-O 121.259 0.552 . . . . 3.74 111.258 -177.632 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A 1602 ' ' SER . . . . . . . . . . . . . 21.1 m -96.07 175.59 6.41 Favored 'General case' 0 C--N 1.3 -1.584 0 CA-C-N 115.294 -0.866 . . . . 3.79 109.055 -177.194 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A 1603 ' ' GLY . . . . . . . . . . . . . . . -75.81 63.62 2.73 Favored Glycine 0 CA--C 1.505 -0.533 0 N-CA-C 109.78 -1.328 . . . . 2.0 109.78 175.276 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A 1604 ' ' LEU . . . . . 0.461 HD13 ' HA ' ' A' 1633 ' ' THR . 2.2 mt -93.52 -174.41 3.48 Favored 'General case' 0 C--N 1.293 -1.883 0 C-N-CA 125.55 1.54 . . . . 1.48 112.184 -173.809 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A 1605 ' ' SER . . . . . . . . . . . . . 34.5 t -140.93 -179.22 5.95 Favored 'General case' 0 N--CA 1.419 -2.017 0 N-CA-C 105.667 -1.975 . . . . 1.51 105.667 179.348 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A 1606 ' ' TYR . . . . . . . . . . . . . 7.1 m-85 -110.06 129.23 55.72 Favored 'General case' 0 CA--C 1.47 -2.101 0 N-CA-C 105.253 -2.129 . . . . 1.18 105.253 -179.561 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A 1607 ' ' LYS . . . . . . . . . . . . . 10.0 ptpp? -131.8 138.12 48.41 Favored 'General case' 0 N--CA 1.411 -2.41 0 C-N-CA 118.495 -1.282 . . . . 1.67 110.437 179.867 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A 1608 ' ' SER . . . . . 0.77 ' HA ' ' HB2' ' A' 1636 ' ' LEU . 50.1 m -98.83 114.32 26.83 Favored 'General case' 0 C--N 1.295 -1.79 0 N-CA-C 109.158 -0.682 . . . . 1.0 109.158 177.71 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A 1609 ' ' VAL . . . . . 0.629 HG22 HG12 ' A' 1591 ' ' VAL . 85.9 t -109.3 118.28 56.3 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.054 0 N-CA-C 108.884 -0.784 . . . . 0.93 108.884 -179.677 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A 1610 ' ' ILE . . . . . 0.593 HG13 ' HB2' ' A' 1638 ' ' PHE . 3.3 mp -111.29 116.66 53.1 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.318 0 N-CA-C 109.261 -0.644 . . . . 0.78 109.261 179.58 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A 1611 ' ' SER . . . . . . . . . . . . . 30.3 p -92.46 117.14 29.63 Favored 'General case' 0 N--CA 1.423 -1.8 0 CA-C-N 115.706 -0.679 . . . . 1.29 109.447 177.076 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A 1612 ' ' PHE . . . . . 0.751 ' HB2' ' HB2' ' A' 1588 ' ' LEU . 96.0 m-85 -89.78 103.7 16.33 Favored 'General case' 0 C--N 1.299 -1.629 0 CA-C-N 116.05 -0.523 . . . . 0.7 110.563 -179.393 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A 1613 ' ' VAL . . . . . 0.602 ' O ' ' HA ' ' A' 1641 ' ' HIS . 11.9 t -107.6 145.12 15.28 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.452 0 N-CA-C 106.871 -1.529 . . . . 0.75 106.871 -179.011 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A 1614 ' ' CYS . . . . . . . . . . . . . 34.2 m -89.65 93.75 9.59 Favored 'General case' 0 C--N 1.294 -1.836 0 N-CA-C 113.536 0.939 . . . . 1.39 113.536 -169.977 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A 1615 ' ' ARG . . . . . 0.896 ' HB3' ' HB3' ' A' 1641 ' ' HIS . 21.3 tpp180 -138.09 112.33 8.77 Favored Pre-proline 0 C--N 1.316 -0.87 0 N-CA-C 109.368 -0.604 . . . . 3.75 109.368 176.195 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A 1616 ' ' PRO . . . . . 0.589 ' HA ' ' HD3' ' A' 1643 ' ' PRO . 11.4 Cg_endo -55.07 -20.36 23.39 Favored 'Trans proline' 0 CA--C 1.562 1.876 0 C-N-CA 123.927 3.085 . . . . 1.32 116.259 -178.352 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A 1617 ' ' GLU . . . . . 0.728 ' HG2' ' HG3' ' A' 1615 ' ' ARG . 11.4 pt-20 . . . . . 0 N--CA 1.478 0.939 0 N-CA-C 113.82 1.045 . . . . 3.21 113.82 -177.812 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A 1622 ' ' ASN . . . . . . . . . . . . . 23.6 t-20 . . . . . 0 CA--C 1.501 -0.906 0 N-CA-C 112.925 0.713 . . . . 2.92 112.925 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A 1623 ' ' ARG . . . . . 0.559 ' HB2' ' HD2' ' A' 1624 ' ' PRO . 0.0 OUTLIER -61.18 167.69 3.61 Favored Pre-proline 0 C--N 1.292 -1.924 0 CA-C-N 113.412 -1.722 . . . . 3.61 113.236 -173.478 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A 1624 ' ' PRO . . . . . 0.652 ' HB3' ' HB2' ' A' 1640 ' ' TRP . 11.6 Cg_endo -57.46 159.3 16.68 Favored 'Trans proline' 0 C--N 1.369 1.606 0 C-N-CA 123.02 2.48 . . . . 2.37 113.209 175.867 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A 1625 ' ' MET . . . . . . . . . . . . . 26.5 ptt? -125.41 148.42 48.81 Favored 'General case' 0 C--N 1.311 -1.093 0 CA-C-N 116.094 -0.503 . . . . 2.16 110.003 -179.766 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A 1626 ' ' LEU . . . . . 0.436 HD21 ' HB2' ' A' 1629 ' ' LEU . 38.2 tp -77.68 116.11 17.96 Favored 'General case' 0 C--N 1.309 -1.173 0 N-CA-C 107.794 -1.187 . . . . 1.35 107.794 175.513 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A 1627 ' ' ILE . . . . . . . . . . . . . 25.0 pt -93.02 -30.05 4.46 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.22 0 C-N-CA 120.45 -0.5 . . . . 1.21 111.178 -179.107 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A 1628 ' ' SER . . . . . . . . . . . . . 37.4 m -155.18 154.07 31.71 Favored 'General case' 0 C--N 1.313 -0.988 0 N-CA-C 109.015 -0.735 . . . . 1.4 109.015 -178.317 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A 1629 ' ' LEU . . . . . 0.539 HD13 HD13 ' A' 1636 ' ' LEU . 45.2 tp -145.95 114.43 6.74 Favored 'General case' 0 C--N 1.301 -1.52 0 CA-C-O 121.24 0.543 . . . . 1.56 109.946 178.892 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A 1630 ' ' ASP . . . . . . . . . . . . . 27.6 t70 -112.75 102.07 10.13 Favored 'General case' 0 C--N 1.298 -1.633 0 N-CA-C 108.408 -0.96 . . . . 0.87 108.408 179.447 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A 1631 ' ' LYS . . . . . . . . . . . . . 60.1 mttp -73.58 -18.01 61.11 Favored 'General case' 0 C--N 1.316 -0.853 0 N-CA-C 112.182 0.438 . . . . 2.35 112.182 -177.52 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A 1632 ' ' GLN . . . . . . . . . . . . . 7.6 tp-100 -64.65 -45.14 88.04 Favored 'General case' 0 N--CA 1.451 -0.39 0 CA-C-O 120.885 0.374 . . . . 2.55 110.668 178.632 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A 1633 ' ' THR . . . . . 0.461 ' HA ' HD13 ' A' 1604 ' ' LEU . 40.9 p -99.23 -2.02 37.7 Favored 'General case' 0 C--N 1.316 -0.849 0 CA-C-O 121.467 0.651 . . . . 1.24 111.226 177.858 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A 1634 ' ' CYS . . . . . . . . . . . . . 82.8 m 56.68 40.29 29.31 Favored 'General case' 0 C--O 1.235 0.298 0 CA-C-N 114.539 -1.21 . . . . 0.89 111.362 -179.853 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A 1635 ' ' THR . . . . . . . . . . . . . 25.1 m -99.03 119.56 38.0 Favored 'General case' 0 N--CA 1.423 -1.8 0 CA-C-N 114.921 -1.036 . . . . 0.75 109.826 -177.583 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A 1636 ' ' LEU . . . . . 0.77 ' HB2' ' HA ' ' A' 1608 ' ' SER . 2.7 mm? -90.85 107.94 19.52 Favored 'General case' 0 C--N 1.311 -1.086 0 N-CA-C 108.454 -0.943 . . . . 1.33 108.454 178.648 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A 1637 ' ' PHE . . . . . . . . . . . . . 96.5 m-85 -95.88 100.16 11.88 Favored 'General case' 0 C--O 1.244 0.815 0 CA-C-O 120.853 0.359 . . . . 0.83 110.611 -178.79 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A 1638 ' ' PHE . . . . . 0.593 ' HB2' HG13 ' A' 1610 ' ' ILE . 96.7 m-85 -108.76 156.19 19.89 Favored 'General case' 0 C--N 1.298 -1.634 0 CA-C-O 121.364 0.602 . . . . 0.6 109.987 177.852 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A 1639 ' ' SER . . . . . . . . . . . . . 32.9 t -143.34 130.84 21.12 Favored 'General case' 0 C--N 1.285 -2.218 0 N-CA-C 108.593 -0.892 . . . . 1.08 108.593 176.172 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A 1640 ' ' TRP . . . . . 0.724 ' HE3' ' HE1' ' A' 1612 ' ' PHE . 9.5 t90 -115.92 111.46 20.45 Favored 'General case' 0 N--CA 1.409 -2.485 0 N-CA-C 107.635 -1.246 . . . . 0.8 107.635 175.696 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A 1641 ' ' HIS . . . . . 0.896 ' HB3' ' HB3' ' A' 1615 ' ' ARG . 47.3 m-70 -89.76 105.3 17.71 Favored 'General case' 0 N--CA 1.422 -1.869 0 N-CA-C 107.167 -1.42 . . . . 2.54 107.167 175.88 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A 1642 ' ' THR . . . . . . . . . . . . . 6.1 t -142.8 146.12 36.56 Favored Pre-proline 0 C--N 1.287 -2.127 0 CA-C-N 115.846 -0.616 . . . . 1.15 109.914 -175.322 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A 1643 ' ' PRO . . . . . 0.589 ' HD3' ' HA ' ' A' 1616 ' ' PRO . 71.6 Cg_endo -76.65 -4.69 15.28 Favored 'Trans proline' 0 C--N 1.352 0.725 0 C-N-CA 122.694 2.263 . . . . 0.8 110.495 175.775 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A 1644 ' ' LEU . . . . . . . . . . . . . 81.9 mt -86.67 -7.63 58.14 Favored 'General case' 0 N--CA 1.447 -0.621 0 CA-C-N 115.234 -0.894 . . . . 1.54 109.489 177.217 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A 1645 ' ' ALA . . . . . . . . . . . . . . . -78.97 -42.58 26.42 Favored 'General case' 0 C--O 1.222 -0.366 0 N-CA-C 107.996 -1.112 . . . . 0.95 107.996 176.716 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A 1646 ' ' CYS . . . . . . . . . . . . . 13.5 p -176.11 154.83 1.47 Allowed 'General case' 0 N--CA 1.432 -1.344 0 N-CA-C 104.362 -2.459 . . . . 1.41 104.362 172.639 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A 1647 ' ' GLU . . . . . . . . . . . . . 42.8 mt-10 . . . . . 0 C--N 1.288 -2.108 0 N-CA-C 108.506 -0.924 . . . . 2.92 108.506 -179.685 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A 1515 ' ' ASP . . . . . 0.477 ' HA ' ' HD2' ' A' 1579 ' ' LYS . 31.4 t70 . . . . . 0 N--CA 1.427 -1.605 0 N-CA-C 105.991 -1.855 . . . . 2.54 105.991 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A 1516 ' ' CYS . . . . . . . . . . . . . 61.1 m -75.14 51.04 0.51 Allowed 'General case' 0 C--N 1.318 -0.769 0 CA-C-O 121.489 0.661 . . . . 1.25 111.455 -178.301 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A 1517 ' ' GLN . . . . . 0.464 ' HA ' ' HA ' ' A' 1528 ' ' ASP . 11.3 pt20 -137.9 154.69 49.41 Favored 'General case' 0 N--CA 1.413 -2.307 0 N-CA-C 106.949 -1.5 . . . . 1.88 106.949 178.55 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A 1518 ' ' VAL . . . . . . . . . . . . . 7.7 p -148.58 137.94 15.81 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.741 0 O-C-N 123.178 0.299 . . . . 1.73 110.913 -174.893 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A 1519 ' ' THR . . . . . . . . . . . . . 8.4 m -103.66 102.76 12.62 Favored 'General case' 0 N--CA 1.429 -1.523 0 N-CA-C 107.901 -1.148 . . . . 1.7 107.901 178.713 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A 1520 ' ' ASN . . . . . . . . . . . . . 24.7 t30 -71.61 114.65 30.09 Favored Pre-proline 0 C--N 1.319 -0.72 0 C-N-CA 121.021 -0.272 . . . . 2.12 110.281 -179.049 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A 1521 ' ' PRO . . . . . . . . . . . . . 55.9 Cg_endo -68.27 -9.63 26.47 Favored 'Trans proline' 0 C--N 1.357 1.018 0 C-N-CA 122.688 2.259 . . . . 2.47 113.486 -174.797 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A 1522 ' ' SER . . . . . . . . . . . . . 15.1 m -79.21 -23.59 43.7 Favored 'General case' 0 N--CA 1.435 -1.18 0 CA-C-N 116.694 -0.23 . . . . 2.57 111.249 178.991 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A 1523 ' ' THR . . . . . . . . . . . . . 7.0 t -137.5 -15.93 1.39 Allowed 'General case' 0 CA--C 1.549 0.913 0 N-CA-C 112.712 0.634 . . . . 2.15 112.712 -177.893 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A 1524 ' ' GLY . . . . . . . . . . . . . . . 84.6 -5.38 81.74 Favored Glycine 0 N--CA 1.45 -0.417 0 O-C-N 121.982 -0.449 . . . . 1.89 113.182 179.024 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A 1525 ' ' HIS . . . . . . . . . . . . . 11.7 t60 -73.01 135.71 44.97 Favored 'General case' 0 C--N 1.311 -1.081 0 CA-C-O 121.113 0.482 . . . . 1.9 110.091 -177.403 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A 1526 ' ' LEU . . . . . . . . . . . . . 3.5 tm? -95.34 121.65 37.22 Favored 'General case' 0 C--N 1.306 -1.285 0 CA-C-N 114.905 -1.043 . . . . 1.61 108.407 -179.918 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A 1527 ' ' PHE . . . . . 0.551 ' CE1' ' HA ' ' A' 1646 ' ' CYS . 78.7 m-85 -106.6 149.23 27.4 Favored 'General case' 0 C--N 1.292 -1.914 0 N-CA-C 107.352 -1.351 . . . . 1.42 107.352 177.574 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A 1528 ' ' ASP . . . . . 0.464 ' HA ' ' HA ' ' A' 1517 ' ' GLN . 1.2 p30 -143.29 148.21 35.99 Favored 'General case' 0 CA--C 1.484 -1.566 0 CA-C-O 121.371 0.605 . . . . 2.18 109.82 177.287 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A 1529 ' ' LEU . . . . . . . . . . . . . 88.7 mt -117.07 -6.05 11.39 Favored 'General case' 0 C--N 1.284 -2.255 0 CA-C-N 114.002 -1.454 . . . . 1.44 107.371 175.338 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A 1530 ' ' SER . . . . . . . . . . . . . 11.5 m -66.42 -41.67 88.87 Favored 'General case' 0 N--CA 1.432 -1.33 0 CA-C-N 114.315 -1.311 . . . . 1.44 111.624 -175.556 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A 1531 ' ' SER . . . . . . . . . . . . . 13.6 t -87.35 -16.18 35.76 Favored 'General case' 0 N--CA 1.438 -1.067 0 N-CA-C 109.027 -0.731 . . . . 1.5 109.027 -178.77 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A 1532 ' ' LEU . . . . . 0.437 HD13 HD13 ' A' 1644 ' ' LEU . 80.2 mt -76.15 -36.26 58.84 Favored 'General case' 0 CA--C 1.521 -0.173 0 CA-C-N 115.854 -0.612 . . . . 1.77 111.068 179.362 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A 1533 ' ' SER . . . . . 0.572 ' HB2' ' HB ' ' A' 1552 ' ' ILE . 25.7 t -80.29 133.74 36.0 Favored 'General case' 0 C--N 1.304 -1.41 0 CA-C-N 115.914 -0.585 . . . . 2.38 110.349 -178.041 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A 1534 ' ' GLY . . . . . . . . . . . . . . . -91.47 160.01 26.47 Favored Glycine 0 N--CA 1.441 -1.022 0 N-CA-C 109.092 -1.603 . . . . 1.55 109.092 174.797 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A 1535 ' ' ARG . . . . . . . . . . . . . 29.0 ttp180 -70.82 -19.77 62.63 Favored 'General case' 0 C--N 1.318 -0.761 0 CA-C-N 117.961 0.88 . . . . 3.96 110.927 -175.911 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A 1536 ' ' ALA . . . . . . . . . . . . . . . -90.26 -9.7 46.97 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-O 121.375 0.607 . . . . 1.65 109.666 177.302 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A 1537 ' ' GLY . . . . . . . . . . . . . . . 80.61 -169.44 52.36 Favored Glycine 0 N--CA 1.422 -2.277 0 CA-C-N 115.123 -0.944 . . . . 1.19 110.962 -177.09 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A 1538 ' ' PHE . . . . . . . . . . . . . 17.3 m-85 -120.33 170.16 9.62 Favored 'General case' 0 C--N 1.285 -2.233 0 N-CA-C 108.286 -1.005 . . . . 1.69 108.286 177.517 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A 1539 ' ' THR . . . . . 0.506 ' HA ' ' O ' ' A' 1548 ' ' VAL . 23.5 p -120.98 118.3 29.49 Favored 'General case' 0 C--N 1.289 -2.028 0 CA-C-N 116.223 -0.444 . . . . 1.48 110.454 -179.433 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A 1540 ' ' ALA . . . . . . . . . . . . . . . -93.24 143.66 26.05 Favored 'General case' 0 C--N 1.305 -1.333 0 N-CA-C 107.323 -1.362 . . . . 0.83 107.323 175.449 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A 1541 ' ' ALA . . . . . . . . . . . . . . . -84.68 70.08 10.73 Favored 'General case' 0 C--N 1.298 -1.633 0 N-CA-C 112.658 0.614 . . . . 1.27 112.658 -173.282 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A 1542 ' ' TYR . . . . . . . . . . . . . 16.4 t80 -157.06 112.76 2.89 Favored 'General case' 0 C--O 1.208 -1.079 0 N-CA-C 113.386 0.884 . . . . 2.15 113.386 176.511 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A 1543 ' ' SER . . . . . 0.582 ' HB3' ' N ' ' A' 1546 ' ' GLY . 43.4 t -138.42 -153.61 0.48 Allowed 'General case' 0 C--N 1.263 -3.159 0 N-CA-C 103.467 -2.79 . . . . 2.29 103.467 162.03 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A 1544 ' ' LYS . . . . . . . . . . . . . 96.1 mttt -66.22 -50.34 64.14 Favored 'General case' 0 C--N 1.303 -1.44 0 N-CA-C 106.354 -1.721 . . . . 3.91 106.354 170.275 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A 1545 ' ' SER . . . . . . . . . . . . . 17.6 t -134.41 25.98 3.79 Favored 'General case' 0 CA--C 1.562 1.442 0 CA-C-N 115.166 -0.925 . . . . 3.3 110.013 175.597 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A 1546 ' ' GLY . . . . . 0.582 ' N ' ' HB3' ' A' 1543 ' ' SER . . . -138.09 -118.05 1.62 Allowed Glycine 0 CA--C 1.529 0.96 0 C-N-CA 118.027 -2.035 . . . . 1.24 117.316 -170.524 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A 1547 ' ' VAL . . . . . . . . . . . . . 14.0 m -159.21 169.34 0.53 Allowed 'Isoleucine or valine' 0 C--O 1.255 1.382 0 C-N-CA 124.256 1.022 . . . . 1.63 110.876 -165.581 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A 1548 ' ' VAL . . . . . 0.506 ' O ' ' HA ' ' A' 1539 ' ' THR . 3.5 t -124.87 135.57 63.58 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.628 0 N-CA-C 107.787 -1.19 . . . . 0.92 107.787 178.625 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A 1549 ' ' TYR . . . . . . . . . . . . . 22.7 m-85 -92.16 114.92 27.59 Favored 'General case' 0 CA--C 1.502 -0.869 0 N-CA-C 105.711 -1.959 . . . . 1.44 105.711 172.52 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A 1550 ' ' MET . . . . . . . . . . . . . 19.8 ptm -144.66 127.8 16.64 Favored 'General case' 0 C--N 1.283 -2.294 0 C-N-CA 119.601 -0.84 . . . . 1.74 111.653 -176.744 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A 1551 ' ' SER . . . . . . . . . . . . . 51.0 m -86.68 135.3 33.44 Favored 'General case' 0 C--N 1.285 -2.236 0 N-CA-C 107.805 -1.183 . . . . 1.64 107.805 177.812 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A 1552 ' ' ILE . . . . . 0.572 ' HB ' ' HB2' ' A' 1533 ' ' SER . 27.8 mm -75.97 -13.16 14.82 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.959 0 CA-C-O 122.363 1.078 . . . . 1.33 108.471 -175.181 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A 1553 ' ' CYS . . . . . . . . . . . . . 33.1 t -161.33 137.95 8.46 Favored 'General case' 0 N--CA 1.421 -1.918 0 N-CA-C 106.957 -1.497 . . . . 1.43 106.957 174.54 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A 1554 ' ' GLY . . . . . . . . . . . . . . . 86.99 -166.56 37.19 Favored Glycine 0 N--CA 1.435 -1.371 0 C-N-CA 120.857 -0.687 . . . . 1.12 114.015 174.18 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A 1555 ' ' GLU . . . . . . . . . . . . . 13.5 pt-20 -86.74 154.57 20.85 Favored 'General case' 0 C--N 1.313 -1.01 0 CA-C-O 121.384 0.612 . . . . 1.8 111.129 -178.192 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A 1556 ' ' ASN . . . . . . . . . . . . . 20.4 t-20 -108.91 112.5 24.76 Favored 'General case' 0 C--N 1.301 -1.524 0 N-CA-C 109.259 -0.645 . . . . 2.63 109.259 178.341 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A 1557 ' ' GLU . . . . . . . . . . . . . 7.9 mt-10 -83.21 40.41 0.71 Allowed 'General case' 0 C--N 1.309 -1.176 0 CA-C-O 121.066 0.46 . . . . 3.79 112.198 -173.017 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A 1558 ' ' ASN . . . . . . . . . . . . . 34.6 m-80 -126.89 -0.78 6.62 Favored 'General case' 0 C--N 1.307 -1.249 0 CA-C-O 121.291 0.567 . . . . 1.52 110.079 179.648 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A 1559 ' ' CYS . . . . . 0.738 ' HB3' ' HD2' ' A' 1560 ' ' PRO . 67.5 m -147.11 177.8 1.65 Allowed Pre-proline 0 C--N 1.309 -1.172 0 CA-C-O 116.884 -1.532 . . . . 0.84 107.162 179.594 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A 1560 ' ' PRO . . . . . 0.738 ' HD2' ' HB3' ' A' 1559 ' ' CYS . 3.4 Cg_exo -36.13 122.84 0.29 Allowed 'Trans proline' 0 C--N 1.385 2.469 0 C-N-CA 124.107 3.205 . . . . 1.18 114.038 178.917 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A 1561 ' ' PRO . . . . . . . . . . . . . 56.4 Cg_exo -53.82 107.64 0.22 Allowed 'Trans proline' 0 C--O 1.254 1.31 0 C-N-CA 123.482 2.788 . . . . 1.51 112.698 -179.053 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A 1562 ' ' GLY . . . . . . . . . . . . . . . 134.12 -11.56 4.75 Favored Glycine 0 N--CA 1.43 -1.707 0 CA-C-N 115.306 -0.861 . . . . 0.72 111.84 179.263 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A 1563 ' ' VAL . . . . . 0.553 ' HA ' ' HA ' ' A' 1576 ' ' LYS . 15.1 m -88.17 144.11 9.85 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.247 0 CA-C-O 120.965 0.412 . . . . 0.97 109.922 179.739 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A 1564 ' ' GLY . . . . . . . . . . . . . . . -100.74 -26.43 8.03 Favored Glycine 0 C--N 1.306 -1.106 0 N-CA-C 110.725 -0.95 . . . . 0.72 110.725 179.796 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A 1565 ' ' ALA . . . . . . . . . . . . . . . -138.59 141.18 39.2 Favored 'General case' 0 N--CA 1.439 -0.986 0 N-CA-C 109.045 -0.724 . . . . 0.37 109.045 179.533 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A 1566 ' ' CYS . . . . . . . . . . . . . 39.8 t -158.7 133.04 7.92 Favored 'General case' 0 C--N 1.3 -1.546 0 N-CA-C 108.106 -1.072 . . . . 0.51 108.106 -176.955 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A 1567 ' ' PHE . . . . . . . . . . . . . 86.3 m-85 -63.63 123.62 19.3 Favored 'General case' 0 C--O 1.208 -1.126 0 N-CA-C 107.508 -1.293 . . . . 0.97 107.508 178.305 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A 1568 ' ' GLY . . . . . 0.436 ' H ' ' HA ' ' A' 1548 ' ' VAL . . . -82.91 -24.85 51.6 Favored Glycine 0 CA--C 1.487 -1.676 0 C-N-CA 120.244 -0.979 . . . . 1.08 112.986 -171.654 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A 1569 ' ' GLN . . . . . . . . . . . . . 22.0 tp60 -81.89 -38.29 25.56 Favored 'General case' 0 C--N 1.298 -1.648 0 CA-C-O 122.096 0.95 . . . . 2.74 108.736 179.391 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A 1570 ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -93.13 -22.28 19.18 Favored 'General case' 0 C--N 1.295 -1.77 0 CA-C-N 114.354 -1.294 . . . . 1.96 112.157 -171.727 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A 1571 ' ' ARG . . . . . . . . . . . . . 50.9 mtt180 63.31 38.01 10.58 Favored 'General case' 0 N--CA 1.47 0.547 0 C-N-CA 125.54 1.536 . . . . 3.95 112.411 -179.256 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A 1572 ' ' ILE . . . . . . . . . . . . . 48.1 mm -118.08 126.05 74.66 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.934 0 CA-C-N 114.849 -1.069 . . . . 1.37 108.864 -177.028 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A 1573 ' ' SER . . . . . . . . . . . . . 45.8 t -62.17 134.63 56.81 Favored 'General case' 0 C--N 1.307 -1.277 0 C-N-CA 123.87 0.868 . . . . 1.08 111.782 -177.578 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A 1574 ' ' VAL . . . . . . . . . . . . . 92.6 t -97.69 -50.61 11.14 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.426 0 CA-C-N 115.313 -0.858 . . . . 1.3 109.174 -179.622 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A 1575 ' ' GLY . . . . . . . . . . . . . . . -160.55 150.38 20.35 Favored Glycine 0 N--CA 1.432 -1.616 0 C-N-CA 120.38 -0.914 . . . . 0.51 112.117 -176.895 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A 1576 ' ' LYS . . . . . 0.553 ' HA ' ' HA ' ' A' 1563 ' ' VAL . 64.8 tttm -78.7 146.54 33.9 Favored 'General case' 0 C--N 1.311 -1.084 0 N-CA-C 108.714 -0.847 . . . . 2.9 108.714 -179.47 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A 1577 ' ' ALA . . . . . . . . . . . . . . . -69.09 90.81 0.47 Allowed 'General case' 0 C--N 1.319 -0.73 0 C-N-CA 123.783 0.833 . . . . 0.83 112.047 -176.03 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A 1578 ' ' ASN . . . . . . . . . . . . . 43.6 m-80 -103.73 113.75 27.5 Favored 'General case' 0 C--N 1.303 -1.42 0 N-CA-C 108.549 -0.908 . . . . 1.85 108.549 176.9 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A 1579 ' ' LYS . . . . . 0.477 ' HD2' ' HA ' ' A' 1515 ' ' ASP . 35.9 ttpt -89.7 89.99 8.03 Favored 'General case' 0 C--N 1.295 -1.764 0 CA-C-O 122.223 1.011 . . . . 1.9 109.152 -176.713 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A 1580 ' ' ARG . . . . . . . . . . . . . 27.4 tpt180 -161.3 111.84 1.7 Allowed 'General case' 0 N--CA 1.424 -1.766 0 CA-C-N 113.747 -1.57 . . . . 3.63 109.236 -178.007 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A 1581 ' ' LEU . . . . . . . . . . . . . 3.6 pp -117.75 160.94 20.51 Favored 'General case' 0 N--CA 1.413 -2.295 0 CA-C-N 114.991 -1.004 . . . . 1.87 108.647 176.56 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A 1582 ' ' ARG . . . . . . . . . . . . . 18.0 ttp85 -140.78 138.02 33.81 Favored 'General case' 0 C--N 1.291 -1.95 0 N-CA-C 108.519 -0.919 . . . . 3.97 108.519 176.059 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A 1583 ' ' TYR . . . . . . . . . . . . . 70.0 t80 -102.65 96.6 6.99 Favored 'General case' 0 C--N 1.303 -1.429 0 N-CA-C 107.694 -1.224 . . . . 1.41 107.694 179.788 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A 1584 ' ' VAL . . . . . 0.472 ' O ' HG12 ' A' 1587 ' ' VAL . 6.0 p -121.85 105.8 17.0 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.505 0 CA-C-N 116.123 -0.49 . . . . 1.69 111.802 -175.581 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A 1585 ' ' ASP . . . . . . . . . . . . . 37.0 t70 61.46 61.19 1.54 Allowed 'General case' 0 C--N 1.319 -0.739 0 CA-C-O 122.356 1.074 . . . . 2.06 111.115 178.38 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A 1586 ' ' GLN . . . . . . . . . . . . . 47.8 mt-30 62.62 8.75 3.11 Favored 'General case' 0 N--CA 1.478 0.941 0 CA-C-N 114.244 -1.344 . . . . 2.33 114.258 178.322 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A 1587 ' ' VAL . . . . . 0.472 HG12 ' O ' ' A' 1584 ' ' VAL . 11.7 p -122.07 125.43 73.04 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.242 0 C-N-CA 119.204 -0.998 . . . . 0.78 110.548 178.496 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A 1588 ' ' LEU . . . . . 0.675 ' HB2' ' HB2' ' A' 1612 ' ' PHE . 57.6 mt -83.22 126.24 32.43 Favored 'General case' 0 C--N 1.3 -1.552 0 CA-C-N 114.919 -1.037 . . . . 1.41 109.061 173.826 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A 1589 ' ' GLN . . . . . . . . . . . . . 36.0 tt0 -118.85 117.44 28.86 Favored 'General case' 0 C--N 1.284 -2.248 0 CA-C-N 115.736 -0.666 . . . . 1.24 109.291 -178.475 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A 1590 ' ' LEU . . . . . . . . . . . . . 7.3 tt -124.6 132.83 53.41 Favored 'General case' 0 C--N 1.307 -1.248 0 N-CA-C 106.847 -1.538 . . . . 1.15 106.847 176.611 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A 1591 ' ' VAL . . . . . 0.432 HG22 HG22 ' A' 1609 ' ' VAL . 39.0 t -127.42 137.68 57.01 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.704 0 CA-C-O 120.69 0.281 . . . . 1.51 111.309 -174.092 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A 1592 ' ' TYR . . . . . . . . . . . . . 57.9 m-85 -115.07 124.64 52.11 Favored 'General case' 0 C--N 1.314 -0.962 0 N-CA-C 107.262 -1.384 . . . . 1.06 107.262 171.231 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A 1593 ' ' LYS . . . . . . . . . . . . . 13.3 ptmm? -137.98 172.86 12.3 Favored 'General case' 0 C--N 1.302 -1.484 0 C-N-CA 121.149 -0.22 . . . . 2.18 111.263 -177.111 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A 1594 ' ' ASP . . . . . . . . . . . . . 17.3 m-20 66.37 48.0 1.65 Allowed 'General case' 0 C--O 1.247 0.935 0 C-N-CA 125.313 1.445 . . . . 1.45 111.875 179.082 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A 1595 ' ' GLY . . . . . . . . . . . . . . . -89.93 -106.98 1.23 Allowed Glycine 0 N--CA 1.44 -1.04 0 N-CA-C 110.877 -0.889 . . . . 0.78 110.877 175.832 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A 1596 ' ' SER . . . . . 0.421 ' HA ' ' HD3' ' A' 1597 ' ' PRO . 19.9 m -101.89 152.08 38.09 Favored Pre-proline 0 C--N 1.296 -1.741 0 N-CA-C 109.732 -0.47 . . . . 1.68 109.732 179.214 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A 1597 ' ' PRO . . . . . 0.421 ' HD3' ' HA ' ' A' 1596 ' ' SER . 22.6 Cg_exo -66.79 141.35 59.07 Favored 'Trans proline' 0 C--N 1.353 0.797 0 C-N-CA 123.203 2.602 . . . . 1.17 112.018 178.88 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A 1598 ' ' CYS . . . . . 0.635 ' O ' ' HA ' ' A' 1602 ' ' SER . 42.2 t -95.86 136.39 22.27 Favored Pre-proline 0 C--N 1.287 -2.136 0 CA-C-N 115.505 -0.771 . . . . 1.19 109.011 179.993 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A 1599 ' ' PRO . . . . . . . . . . . . . 63.3 Cg_endo -75.08 -18.01 18.91 Favored 'Trans proline' 0 C--N 1.36 1.149 0 C-N-CA 123.11 2.54 . . . . 1.59 112.198 177.751 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A 1600 ' ' SER . . . . . . . . . . . . . 34.2 m -86.63 112.54 21.7 Favored 'General case' 0 N--CA 1.425 -1.721 0 N-CA-C 107.037 -1.468 . . . . 2.12 107.037 176.592 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A 1601 ' ' LYS . . . . . 0.435 ' HD3' ' HA ' ' A' 1601 ' ' LYS . 42.9 mmtm 56.23 55.79 6.4 Favored 'General case' 0 C--O 1.242 0.694 0 CA-C-O 122.477 1.132 . . . . 3.74 108.542 -173.215 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A 1602 ' ' SER . . . . . 0.635 ' HA ' ' O ' ' A' 1598 ' ' CYS . 15.0 t -49.11 122.77 6.28 Favored 'General case' 0 N--CA 1.442 -0.865 0 CA-C-N 112.781 -2.009 . . . . 3.79 112.108 -172.693 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A 1603 ' ' GLY . . . . . . . . . . . . . . . 140.02 -23.58 2.74 Favored Glycine 0 N--CA 1.43 -1.726 0 N-CA-C 109.131 -1.588 . . . . 2.0 109.131 -176.61 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A 1604 ' ' LEU . . . . . . . . . . . . . 72.3 mt -85.33 152.45 23.27 Favored 'General case' 0 C--N 1.309 -1.183 0 CA-C-N 114.733 -0.734 . . . . 1.48 109.473 177.502 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A 1605 ' ' SER . . . . . . . . . . . . . 49.1 m -101.7 175.54 5.52 Favored 'General case' 0 C--N 1.282 -2.341 0 N-CA-C 105.933 -1.877 . . . . 1.51 105.933 169.094 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A 1606 ' ' TYR . . . . . . . . . . . . . 78.5 m-85 -94.76 149.69 20.98 Favored 'General case' 0 CA--C 1.466 -2.28 0 N-CA-C 106.133 -1.803 . . . . 1.18 106.133 -177.583 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A 1607 ' ' LYS . . . . . 0.436 ' HG3' HG23 ' A' 1635 ' ' THR . 23.2 pttm -135.67 132.18 36.64 Favored 'General case' 0 N--CA 1.401 -2.915 0 C-N-CA 118.377 -1.329 . . . . 1.67 110.123 175.243 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A 1608 ' ' SER . . . . . . . . . . . . . 29.3 p -106.9 112.15 24.98 Favored 'General case' 0 C--N 1.288 -2.08 0 CA-C-N 116.277 -0.419 . . . . 1.0 110.376 -179.232 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A 1609 ' ' VAL . . . . . 0.432 HG22 HG22 ' A' 1591 ' ' VAL . 92.6 t -100.3 117.4 45.44 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.961 0 N-CA-C 108.719 -0.845 . . . . 0.93 108.719 177.622 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A 1610 ' ' ILE . . . . . 0.638 HG13 ' HB2' ' A' 1638 ' ' PHE . 3.5 mp -101.94 118.34 48.61 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.567 0 N-CA-C 108.22 -1.03 . . . . 0.78 108.22 177.133 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A 1611 ' ' SER . . . . . . . . . . . . . 14.1 m -104.22 117.02 33.22 Favored 'General case' 0 N--CA 1.416 -2.131 0 CA-C-N 115.357 -0.838 . . . . 1.29 108.966 178.834 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A 1612 ' ' PHE . . . . . 0.675 ' HB2' ' HB2' ' A' 1588 ' ' LEU . 95.2 m-85 -90.18 107.32 19.06 Favored 'General case' 0 C--N 1.298 -1.648 0 CA-C-N 115.458 -0.792 . . . . 0.7 109.251 179.98 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A 1613 ' ' VAL . . . . . . . . . . . . . 71.9 t -100.38 131.31 48.15 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.108 0 CA-C-N 116.152 -0.477 . . . . 0.75 109.922 -177.02 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A 1614 ' ' CYS . . . . . . . . . . . . . 59.6 m -67.98 101.76 1.17 Allowed 'General case' 0 C--N 1.317 -0.848 0 C-N-CA 123.787 0.835 . . . . 1.39 110.925 -179.425 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A 1615 ' ' ARG . . . . . 0.549 ' HD2' ' OE2' ' A' 1617 ' ' GLU . 21.4 mmt180 -137.07 95.76 11.77 Favored Pre-proline 0 C--N 1.306 -1.294 0 CA-C-N 115.594 -0.73 . . . . 3.75 110.927 178.692 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A 1616 ' ' PRO . . . . . . . . . . . . . 11.4 Cg_exo -74.1 58.53 4.26 Favored 'Trans proline' 0 CA--C 1.541 0.857 0 C-N-CA 123.636 2.891 . . . . 1.32 111.371 176.587 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A 1617 ' ' GLU . . . . . 0.549 ' OE2' ' HD2' ' A' 1615 ' ' ARG . 38.3 mt-10 . . . . . 0 C--N 1.31 -1.121 0 C-N-CA 124.659 1.183 . . . . 3.21 108.471 179.503 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A 1622 ' ' ASN . . . . . . . . . . . . . 25.2 t-20 . . . . . 0 C--O 1.233 0.226 0 N-CA-C 108.864 -0.791 . . . . 2.92 108.864 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A 1623 ' ' ARG . . . . . . . . . . . . . 8.6 ptm180 -133.67 158.17 76.17 Favored Pre-proline 0 C--N 1.311 -1.089 0 CA-C-N 115.378 -0.828 . . . . 3.61 109.714 -173.866 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A 1624 ' ' PRO . . . . . . . . . . . . . 12.2 Cg_exo -69.86 127.21 14.2 Favored 'Trans proline' 0 C--O 1.246 0.905 0 C-N-CA 122.792 2.328 . . . . 2.37 110.834 176.942 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A 1625 ' ' MET . . . . . . . . . . . . . 22.1 ptp -126.34 151.47 47.53 Favored 'General case' 0 C--N 1.303 -1.438 0 CA-C-N 116.131 -0.486 . . . . 2.16 110.396 -178.561 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A 1626 ' ' LEU . . . . . 0.407 HD12 ' O ' ' A' 1637 ' ' PHE . 39.0 tp -85.55 118.35 25.01 Favored 'General case' 0 C--N 1.306 -1.293 0 N-CA-C 108.436 -0.95 . . . . 1.35 108.436 -179.666 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A 1627 ' ' ILE . . . . . . . . . . . . . 45.8 pt -93.17 -28.33 4.45 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.331 0 C-N-CA 120.345 -0.542 . . . . 1.21 111.47 -177.993 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A 1628 ' ' SER . . . . . . . . . . . . . 21.1 t -160.57 142.0 12.22 Favored 'General case' 0 N--CA 1.432 -1.371 0 C-N-CA 120.341 -0.543 . . . . 1.4 110.565 -177.482 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A 1629 ' ' LEU . . . . . 0.83 HD13 ' HG ' ' A' 1636 ' ' LEU . 29.5 tp -119.76 128.02 53.36 Favored 'General case' 0 C--N 1.304 -1.37 0 N-CA-C 108.065 -1.087 . . . . 1.56 108.065 174.055 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A 1630 ' ' ASP . . . . . . . . . . . . . 25.1 t70 -102.07 127.41 48.98 Favored 'General case' 0 C--N 1.295 -1.761 0 CA-C-N 116.737 -0.211 . . . . 0.87 110.623 179.269 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A 1631 ' ' LYS . . . . . . . . . . . . . 53.0 mttm -95.14 0.97 54.72 Favored 'General case' 0 C--N 1.317 -0.808 0 N-CA-C 111.872 0.323 . . . . 2.35 111.872 -178.495 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A 1632 ' ' GLN . . . . . . . . . . . . . 36.5 mt-30 -87.19 -52.47 5.39 Favored 'General case' 0 C--N 1.315 -0.926 0 C-N-CA 120.218 -0.593 . . . . 2.55 109.969 178.917 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A 1633 ' ' THR . . . . . . . . . . . . . 69.1 p -106.51 -1.44 23.05 Favored 'General case' 0 N--CA 1.432 -1.374 0 CA-C-N 115.761 -0.654 . . . . 1.24 111.927 -178.833 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A 1634 ' ' CYS . . . . . . . . . . . . . 60.3 m 62.61 42.91 7.99 Favored 'General case' 0 C--O 1.237 0.399 0 CA-C-O 122.464 1.126 . . . . 0.89 111.26 177.409 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A 1635 ' ' THR . . . . . 0.436 HG23 ' HG3' ' A' 1607 ' ' LYS . 28.2 m -102.57 133.09 48.13 Favored 'General case' 0 N--CA 1.416 -2.145 0 CA-C-N 114.168 -1.378 . . . . 0.75 109.245 -178.547 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A 1636 ' ' LEU . . . . . 0.83 ' HG ' HD13 ' A' 1629 ' ' LEU . 5.2 mp -109.79 129.69 55.6 Favored 'General case' 0 N--CA 1.435 -1.213 0 N-CA-C 108.994 -0.743 . . . . 1.33 108.994 179.806 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A 1637 ' ' PHE . . . . . 0.407 ' O ' HD12 ' A' 1626 ' ' LEU . 88.7 m-85 -110.32 108.0 17.93 Favored 'General case' 0 C--N 1.308 -1.223 0 CA-C-O 121.049 0.452 . . . . 0.83 110.979 -177.121 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A 1638 ' ' PHE . . . . . 0.638 ' HB2' HG13 ' A' 1610 ' ' ILE . 97.0 m-85 -101.78 146.95 27.08 Favored 'General case' 0 C--N 1.305 -1.359 0 N-CA-C 109.228 -0.656 . . . . 0.6 109.228 177.706 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A 1639 ' ' SER . . . . . . . . . . . . . 50.0 m -132.64 133.66 43.89 Favored 'General case' 0 C--N 1.278 -2.529 0 N-CA-C 109.788 -0.449 . . . . 1.08 109.788 176.967 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A 1640 ' ' TRP . . . . . 0.403 ' CE3' ' HE2' ' A' 1612 ' ' PHE . 6.7 t90 -121.43 92.54 3.77 Favored 'General case' 0 N--CA 1.413 -2.32 0 N-CA-C 106.761 -1.57 . . . . 0.8 106.761 173.517 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A 1641 ' ' HIS . . . . . . . . . . . . . 4.4 p-80 -71.64 98.75 1.96 Allowed 'General case' 0 C--N 1.308 -1.209 0 CA-C-N 114.867 -1.061 . . . . 2.54 108.555 175.154 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A 1642 ' ' THR . . . . . . . . . . . . . 10.0 t -143.55 147.81 40.97 Favored Pre-proline 0 C--N 1.279 -2.49 0 CA-C-N 115.831 -0.622 . . . . 1.15 110.483 -170.963 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A 1643 ' ' PRO . . . . . 0.417 ' O ' ' HG2' ' A' 1647 ' ' GLU . 34.6 Cg_endo -75.68 0.18 9.47 Favored 'Trans proline' 0 C--O 1.215 -0.651 0 C-N-CA 122.853 2.369 . . . . 0.8 111.114 174.768 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A 1644 ' ' LEU . . . . . 0.437 HD13 HD13 ' A' 1532 ' ' LEU . 45.5 mt -85.04 -11.81 54.52 Favored 'General case' 0 C--N 1.32 -0.683 0 C-N-CA 123.927 0.891 . . . . 1.54 110.782 176.679 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A 1645 ' ' ALA . . . . . . . . . . . . . . . -73.09 -43.44 61.82 Favored 'General case' 0 N--CA 1.471 0.592 0 CA-C-O 121.563 0.696 . . . . 0.95 110.118 -178.604 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A 1646 ' ' CYS . . . . . 0.551 ' HA ' ' CE1' ' A' 1527 ' ' PHE . 18.8 p -155.61 142.26 18.79 Favored 'General case' 0 N--CA 1.417 -2.084 0 N-CA-C 104.666 -2.346 . . . . 1.41 104.666 172.389 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A 1647 ' ' GLU . . . . . 0.417 ' HG2' ' O ' ' A' 1643 ' ' PRO . 39.9 mt-10 . . . . . 0 C--N 1.283 -2.323 0 O-C-N 123.199 0.312 . . . . 2.92 110.414 -171.249 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A 1515 ' ' ASP . . . . . 0.451 ' HB3' ' HB3' ' A' 1579 ' ' LYS . 38.7 m-20 . . . . . 0 N--CA 1.466 0.348 0 N-CA-C 111.936 0.347 . . . . 2.54 111.936 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A 1516 ' ' CYS . . . . . . . . . . . . . 85.7 m -124.4 41.38 3.51 Favored 'General case' 0 C--N 1.311 -1.069 0 CA-C-O 121.432 0.634 . . . . 1.25 110.99 -177.266 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A 1517 ' ' GLN . . . . . . . . . . . . . 9.6 pt20 -161.21 168.62 23.82 Favored 'General case' 0 C--N 1.287 -2.132 0 N-CA-C 109.42 -0.585 . . . . 1.88 109.42 -179.562 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A 1518 ' ' VAL . . . . . . . . . . . . . 80.7 t -131.37 105.96 11.27 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.081 0 N-CA-C 108.497 -0.927 . . . . 1.73 108.497 176.111 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A 1519 ' ' THR . . . . . . . . . . . . . 20.4 m -86.16 102.14 13.62 Favored 'General case' 0 C--N 1.281 -2.376 0 N-CA-C 107.596 -1.261 . . . . 1.7 107.596 175.048 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A 1520 ' ' ASN . . . . . . . . . . . . . 31.4 t30 -92.0 105.41 13.57 Favored Pre-proline 0 C--N 1.322 -0.614 0 N-CA-C 109.859 -0.423 . . . . 2.12 109.859 179.809 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A 1521 ' ' PRO . . . . . . . . . . . . . 59.1 Cg_endo -72.72 -18.98 24.63 Favored 'Trans proline' 0 N--CA 1.458 -0.593 0 C-N-CA 122.383 2.055 . . . . 2.47 113.376 -175.123 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A 1522 ' ' SER . . . . . . . . . . . . . 32.6 m -61.27 -35.75 78.15 Favored 'General case' 0 CA--C 1.54 0.565 0 CA-C-O 120.818 0.342 . . . . 2.57 111.832 -178.393 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A 1523 ' ' THR . . . . . . . . . . . . . 12.3 t -120.21 -5.24 9.95 Favored 'General case' 0 CA--C 1.554 1.096 0 CA-C-O 122.074 0.94 . . . . 2.15 109.543 178.809 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A 1524 ' ' GLY . . . . . . . . . . . . . . . 73.97 20.18 79.73 Favored Glycine 0 C--N 1.335 0.526 0 CA-C-N 115.44 -0.8 . . . . 1.89 112.345 179.666 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A 1525 ' ' HIS . . . . . . . . . . . . . 12.9 t-80 -101.65 128.16 48.07 Favored 'General case' 0 C--N 1.314 -0.951 0 CA-C-O 120.797 0.332 . . . . 1.9 110.745 -177.869 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A 1526 ' ' LEU . . . . . . . . . . . . . 6.9 tt -100.34 130.71 46.48 Favored 'General case' 0 C--N 1.3 -1.579 0 N-CA-C 108.43 -0.952 . . . . 1.61 108.43 178.208 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A 1527 ' ' PHE . . . . . 0.675 ' HE1' ' HA ' ' A' 1646 ' ' CYS . 97.7 m-85 -95.78 102.95 14.81 Favored 'General case' 0 C--N 1.308 -1.199 0 N-CA-C 109.183 -0.673 . . . . 1.42 109.183 177.243 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A 1528 ' ' ASP . . . . . . . . . . . . . 4.9 p-10 -85.17 106.68 16.79 Favored 'General case' 0 C--N 1.314 -0.936 0 CA-C-O 122.389 1.09 . . . . 2.18 113.437 -178.285 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A 1529 ' ' LEU . . . . . 0.747 ' HG ' HD12 ' A' 1532 ' ' LEU . 7.4 mp -105.5 0.22 26.48 Favored 'General case' 0 C--N 1.312 -1.06 0 CA-C-N 114.78 -1.1 . . . . 1.44 108.148 172.398 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A 1530 ' ' SER . . . . . . . . . . . . . 2.6 p -68.3 -31.32 70.68 Favored 'General case' 0 N--CA 1.426 -1.641 0 CA-C-N 114.248 -1.342 . . . . 1.44 109.356 177.406 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A 1531 ' ' SER . . . . . . . . . . . . . 9.9 m -76.11 -7.91 55.8 Favored 'General case' 0 N--CA 1.443 -0.793 0 CA-C-N 115.03 -0.987 . . . . 1.5 110.358 177.759 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A 1532 ' ' LEU . . . . . 0.747 HD12 ' HG ' ' A' 1529 ' ' LEU . 81.7 mt -90.72 15.8 10.43 Favored 'General case' 0 C--O 1.238 0.485 0 CA-C-O 121.544 0.688 . . . . 1.77 111.676 -179.792 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A 1533 ' ' SER . . . . . . . . . . . . . 17.0 m -78.74 173.23 12.69 Favored 'General case' 0 N--CA 1.44 -0.955 0 N-CA-C 108.558 -0.904 . . . . 2.38 108.558 176.143 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A 1534 ' ' GLY . . . . . . . . . . . . . . . 165.5 147.44 5.16 Favored Glycine 0 N--CA 1.428 -1.897 0 C-N-CA 120.038 -1.077 . . . . 1.55 111.848 -178.997 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A 1535 ' ' ARG . . . . . 0.855 ' HG3' ' HG3' ' A' 1557 ' ' GLU . 43.6 ttm180 -60.35 -49.29 78.17 Favored 'General case' 0 C--O 1.246 0.907 0 C-N-CA 124.513 1.125 . . . . 3.96 110.301 179.562 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A 1536 ' ' ALA . . . . . 0.409 ' HA ' HD21 ' A' 1558 ' ' ASN . . . -95.68 -33.65 12.25 Favored 'General case' 0 N--CA 1.434 -1.266 0 N-CA-C 109.044 -0.724 . . . . 1.65 109.044 177.858 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A 1537 ' ' GLY . . . . . . . . . . . . . . . 84.19 -136.37 14.7 Favored Glycine 0 N--CA 1.428 -1.873 0 CA-C-N 114.496 -1.229 . . . . 1.19 111.963 177.73 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A 1538 ' ' PHE . . . . . 0.479 ' CD1' HD13 ' A' 1552 ' ' ILE . 54.2 m-85 -106.34 135.94 46.94 Favored 'General case' 0 C--N 1.295 -1.802 0 N-CA-C 108.207 -1.034 . . . . 1.69 108.207 177.88 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A 1539 ' ' THR . . . . . . . . . . . . . 19.2 p -113.35 117.99 33.33 Favored 'General case' 0 C--N 1.292 -1.927 0 CA-C-N 116.128 -0.487 . . . . 1.48 111.352 -178.509 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A 1540 ' ' ALA . . . . . . . . . . . . . . . -122.43 124.33 43.39 Favored 'General case' 0 C--N 1.313 -1.015 0 N-CA-C 109.932 -0.396 . . . . 0.83 109.932 179.77 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A 1541 ' ' ALA . . . . . . . . . . . . . . . -74.18 144.63 44.72 Favored 'General case' 0 C--O 1.251 1.156 0 CA-C-O 120.654 0.264 . . . . 1.27 110.521 179.247 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A 1542 ' ' TYR . . . . . . . . . . . . . 27.4 t80 -149.16 -173.64 4.43 Favored 'General case' 0 N--CA 1.437 -1.114 0 N-CA-C 109.148 -0.686 . . . . 2.15 109.148 -176.276 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A 1543 ' ' SER . . . . . . . . . . . . . 13.9 m -45.99 -152.78 0.0 OUTLIER 'General case' 0 CA--C 1.569 1.7 0 C-N-CA 129.707 3.203 . . . . 2.29 115.063 -178.799 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A 1544 ' ' LYS . . . . . . . . . . . . . 55.9 tptt -47.24 -29.52 2.46 Favored 'General case' 0 N--CA 1.486 1.336 0 O-C-N 121.266 -0.897 . . . . 3.91 112.774 178.677 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A 1545 ' ' SER . . . . . . . . . . . . . 4.3 p -61.74 -22.64 65.55 Favored 'General case' 0 CA--C 1.556 1.207 0 C-N-CA 123.053 0.541 . . . . 3.3 112.202 175.048 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A 1546 ' ' GLY . . . . . . . . . . . . . . . 89.49 -69.72 2.49 Favored Glycine 0 N--CA 1.431 -1.666 0 N-CA-C 113.867 0.307 . . . . 1.24 113.867 173.664 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A 1547 ' ' VAL . . . . . . . . . . . . . 7.2 p -158.79 138.61 3.73 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.925 0 N-CA-C 109.787 -0.449 . . . . 1.63 109.787 -173.606 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A 1548 ' ' VAL . . . . . . . . . . . . . 2.4 t -103.0 134.88 42.89 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.601 0 N-CA-C 108.548 -0.908 . . . . 0.92 108.548 -177.563 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A 1549 ' ' TYR . . . . . . . . . . . . . 97.9 m-85 -104.02 121.89 44.11 Favored 'General case' 0 C--N 1.311 -1.096 0 N-CA-C 107.112 -1.44 . . . . 1.44 107.112 173.717 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A 1550 ' ' MET . . . . . . . . . . . . . 71.5 mtm -131.07 122.17 26.27 Favored 'General case' 0 CA--C 1.488 -1.43 0 C-N-CA 120.217 -0.593 . . . . 1.74 112.195 177.913 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A 1551 ' ' SER . . . . . . . . . . . . . 53.2 m -103.03 105.17 15.44 Favored 'General case' 0 C--N 1.272 -2.803 0 N-CA-C 105.45 -2.056 . . . . 1.64 105.45 171.457 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A 1552 ' ' ILE . . . . . 0.479 HD13 ' CD1' ' A' 1538 ' ' PHE . 1.7 mp -52.48 -35.34 20.22 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.813 0 O-C-N 124.112 0.883 . . . . 1.33 112.133 -176.456 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A 1553 ' ' CYS . . . . . . . . . . . . . 93.9 m -145.7 155.66 43.13 Favored 'General case' 0 C--N 1.307 -1.249 0 N-CA-C 109.152 -0.685 . . . . 1.43 109.152 174.924 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A 1554 ' ' GLY . . . . . . . . . . . . . . . 102.66 -118.32 6.07 Favored Glycine 0 N--CA 1.441 -1.031 0 N-CA-C 110.366 -1.094 . . . . 1.12 110.366 -179.917 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A 1555 ' ' GLU . . . . . . . . . . . . . 17.0 pt-20 -157.9 148.32 20.6 Favored 'General case' 0 C--N 1.311 -1.107 0 N-CA-C 107.741 -1.207 . . . . 1.8 107.741 176.769 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A 1556 ' ' ASN . . . . . . . . . . . . . 21.0 t-20 -97.05 118.86 34.4 Favored 'General case' 0 C--N 1.305 -1.329 0 CA-C-O 121.543 0.687 . . . . 2.63 110.277 -178.609 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A 1557 ' ' GLU . . . . . 0.855 ' HG3' ' HG3' ' A' 1535 ' ' ARG . 12.0 mm-40 -82.53 11.97 5.11 Favored 'General case' 0 C--N 1.298 -1.644 0 CA-C-N 114.65 -1.159 . . . . 3.79 112.956 -172.429 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A 1558 ' ' ASN . . . . . 0.409 HD21 ' HA ' ' A' 1536 ' ' ALA . 39.2 m-80 -104.24 -9.02 18.92 Favored 'General case' 0 C--N 1.301 -1.528 0 O-C-N 121.726 -0.609 . . . . 1.52 110.662 -178.886 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A 1559 ' ' CYS . . . . . 0.685 ' HB3' ' HD2' ' A' 1560 ' ' PRO . 88.1 m -144.29 178.46 1.45 Allowed Pre-proline 0 C--N 1.302 -1.466 0 CA-C-O 117.199 -1.381 . . . . 0.84 108.154 -178.521 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A 1560 ' ' PRO . . . . . 0.685 ' HD2' ' HB3' ' A' 1559 ' ' CYS . 24.2 Cg_exo -29.4 125.69 0.05 OUTLIER 'Trans proline' 0 C--N 1.383 2.356 0 C-N-CA 124.772 3.648 . . . . 1.18 114.94 176.422 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A 1561 ' ' PRO . . . . . 0.465 ' HD3' ' HA ' ' A' 1560 ' ' PRO . 51.2 Cg_exo -55.52 115.99 2.84 Favored 'Trans proline' 0 C--O 1.244 0.782 0 C-N-CA 123.445 2.764 . . . . 1.51 112.964 -177.126 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A 1562 ' ' GLY . . . . . . . . . . . . . . . 114.11 -10.34 22.65 Favored Glycine 0 N--CA 1.439 -1.122 0 C-N-CA 120.455 -0.878 . . . . 0.72 113.275 177.187 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A 1563 ' ' VAL . . . . . 0.571 ' HA ' ' HA ' ' A' 1576 ' ' LYS . 5.1 m -90.65 152.37 3.35 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.183 0 N-CA-C 107.189 -1.411 . . . . 0.97 107.189 176.635 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A 1564 ' ' GLY . . . . . . . . . . . . . . . -117.23 -19.06 5.24 Favored Glycine 0 C--N 1.306 -1.127 0 C-N-CA 119.451 -1.357 . . . . 0.72 113.74 -176.25 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A 1565 ' ' ALA . . . . . . . . . . . . . . . -126.37 123.23 37.49 Favored 'General case' 0 C--O 1.25 1.095 0 N-CA-C 109.385 -0.598 . . . . 0.37 109.385 -179.851 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A 1566 ' ' CYS . . . . . . . . . . . . . 49.3 t -151.69 146.78 26.03 Favored 'General case' 0 C--N 1.312 -1.035 0 C-N-CA 121.056 -0.258 . . . . 0.51 111.126 -177.096 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A 1567 ' ' PHE . . . . . . . . . . . . . 31.4 m-85 -94.05 123.68 37.57 Favored 'General case' 0 C--O 1.247 0.965 0 CA-C-N 116.101 -0.5 . . . . 0.97 109.677 177.836 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A 1568 ' ' GLY . . . . . . . . . . . . . . . 50.62 -140.82 19.74 Favored Glycine 0 C--N 1.321 -0.289 0 O-C-N 123.893 0.745 . . . . 1.08 114.719 175.517 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A 1569 ' ' GLN . . . . . . . . . . . . . 49.0 tt0 -90.87 -58.23 2.55 Favored 'General case' 0 N--CA 1.43 -1.444 0 N-CA-C 109.558 -0.534 . . . . 2.74 109.558 179.993 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A 1570 ' ' THR . . . . . . . . . . . . . 14.8 p -123.01 34.13 5.21 Favored 'General case' 0 C--N 1.312 -1.043 0 CA-C-N 115.892 -0.594 . . . . 1.96 112.473 -176.668 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A 1571 ' ' ARG . . . . . . . . . . . . . 7.5 mpt_? -97.5 12.03 34.76 Favored 'General case' 0 N--CA 1.432 -1.328 0 C-N-CA 119.388 -0.925 . . . . 3.95 110.765 175.691 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A 1572 ' ' ILE . . . . . 0.446 HG22 ' HB2' ' A' 1596 ' ' SER . 75.9 mt 80.97 144.51 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.548 0.894 0 CA-C-N 114.112 -1.404 . . . . 1.37 114.371 165.581 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A 1573 ' ' SER . . . . . . . . . . . . . 36.3 p -82.01 134.89 35.4 Favored 'General case' 0 N--CA 1.438 -1.072 0 CA-C-N 114.582 -1.19 . . . . 1.08 111.113 -179.242 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A 1574 ' ' VAL . . . . . . . . . . . . . 19.0 m -123.22 30.43 2.24 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.228 0 N-CA-C 112.611 0.597 . . . . 1.3 112.611 -177.553 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A 1575 ' ' GLY . . . . . . . . . . . . . . . 173.56 122.68 0.68 Allowed Glycine 0 N--CA 1.434 -1.434 0 C-N-CA 119.989 -1.1 . . . . 0.51 112.799 177.753 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A 1576 ' ' LYS . . . . . 0.571 ' HA ' ' HA ' ' A' 1563 ' ' VAL . 66.6 tttm -76.8 143.09 40.05 Favored 'General case' 0 C--O 1.246 0.914 0 N-CA-C 106.835 -1.543 . . . . 2.9 106.835 175.787 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A 1577 ' ' ALA . . . . . . . . . . . . . . . -77.04 82.63 3.55 Favored 'General case' 0 C--N 1.304 -1.412 0 CA-C-O 121.642 0.734 . . . . 0.83 111.7 -175.23 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A 1578 ' ' ASN . . . . . . . . . . . . . 41.6 m-80 -89.47 147.44 24.0 Favored 'General case' 0 C--N 1.306 -1.3 0 N-CA-C 108.058 -1.09 . . . . 1.85 108.058 175.243 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A 1579 ' ' LYS . . . . . 0.451 ' HB3' ' HB3' ' A' 1515 ' ' ASP . 58.7 mttp -95.14 89.67 5.62 Favored 'General case' 0 C--N 1.283 -2.299 0 N-CA-C 105.746 -1.946 . . . . 1.9 105.746 175.331 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A 1580 ' ' ARG . . . . . 0.401 ' O ' ' HG ' ' A' 1590 ' ' LEU . 42.1 ttm180 -140.32 101.14 4.06 Favored 'General case' 0 C--N 1.297 -1.703 0 CA-C-N 115.346 -0.843 . . . . 3.63 110.003 -173.607 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A 1581 ' ' LEU . . . . . . . . . . . . . 41.0 tp -117.4 145.02 44.38 Favored 'General case' 0 C--N 1.289 -2.054 0 CA-C-N 115.151 -0.931 . . . . 1.87 109.462 -177.39 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A 1582 ' ' ARG . . . . . . . . . . . . . 97.0 mtt180 -119.44 125.27 48.54 Favored 'General case' 0 C--N 1.297 -1.713 0 CA-C-N 115.656 -0.702 . . . . 3.97 109.984 -179.729 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A 1583 ' ' TYR . . . . . 0.416 ' HD1' ' CD2' ' A' 1588 ' ' LEU . 22.6 t80 -108.09 97.89 7.52 Favored 'General case' 0 C--N 1.296 -1.727 0 N-CA-C 108.547 -0.909 . . . . 1.41 108.547 174.49 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A 1584 ' ' VAL . . . . . . . . . . . . . 1.1 m -140.07 121.28 14.91 Favored 'Isoleucine or valine' 0 CA--C 1.499 -0.981 0 N-CA-C 112.697 0.628 . . . . 1.69 112.697 -178.079 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A 1585 ' ' ASP . . . . . . . . . . . . . 30.9 t70 56.67 45.04 22.73 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-O 122.334 1.064 . . . . 2.06 111.082 171.613 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A 1586 ' ' GLN . . . . . . . . . . . . . 21.5 mt-30 58.82 18.25 5.92 Favored 'General case' 0 C--N 1.323 -0.548 0 N-CA-C 115.068 1.507 . . . . 2.33 115.068 -178.871 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A 1587 ' ' VAL . . . . . . . . . . . . . 12.4 p -120.69 133.37 67.6 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.331 0 N-CA-C 107.619 -1.252 . . . . 0.78 107.619 172.86 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A 1588 ' ' LEU . . . . . 0.426 ' HB2' ' HB2' ' A' 1612 ' ' PHE . 16.6 mt -103.24 133.09 48.91 Favored 'General case' 0 C--N 1.296 -1.746 0 N-CA-C 108.277 -1.008 . . . . 1.41 108.277 -177.104 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A 1589 ' ' GLN . . . . . . . . . . . . . 35.0 tt0 -134.31 115.78 14.49 Favored 'General case' 0 C--N 1.275 -2.639 0 C-N-CA 120.39 -0.524 . . . . 1.24 110.442 -175.496 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A 1590 ' ' LEU . . . . . 0.401 ' HG ' ' O ' ' A' 1580 ' ' ARG . 8.7 tt -106.74 128.96 54.66 Favored 'General case' 0 C--N 1.293 -1.849 0 N-CA-C 107.411 -1.329 . . . . 1.15 107.411 -179.25 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A 1591 ' ' VAL . . . . . . . . . . . . . 61.4 t -119.26 126.89 75.76 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.808 0 N-CA-C 112.792 0.664 . . . . 1.51 112.792 -170.355 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A 1592 ' ' TYR . . . . . 0.631 ' HB2' ' HB3' ' A' 1608 ' ' SER . 9.7 m-30 -108.53 149.23 29.13 Favored 'General case' 0 C--N 1.31 -1.135 0 CA-C-N 114.986 -1.006 . . . . 1.06 109.44 174.487 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A 1593 ' ' LYS . . . . . . . . . . . . . 18.4 ptpt -159.47 177.37 11.02 Favored 'General case' 0 C--N 1.296 -1.741 0 N-CA-C 107.371 -1.344 . . . . 2.18 107.371 178.578 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A 1594 ' ' ASP . . . . . 0.421 ' O ' ' HB2' ' A' 1576 ' ' LYS . 3.8 m-20 65.62 76.76 0.32 Allowed 'General case' 0 N--CA 1.483 1.206 0 O-C-N 124.038 0.837 . . . . 1.45 112.399 179.046 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A 1595 ' ' GLY . . . . . . . . . . . . . . . -143.08 -73.4 0.03 OUTLIER Glycine 0 N--CA 1.432 -1.57 0 N-CA-C 110.879 -0.889 . . . . 0.78 110.879 176.865 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A 1596 ' ' SER . . . . . 0.446 ' HB2' HG22 ' A' 1572 ' ' ILE . 31.1 t -114.86 139.6 24.4 Favored Pre-proline 0 C--N 1.288 -2.077 0 N-CA-C 109.534 -0.543 . . . . 1.68 109.534 179.621 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A 1597 ' ' PRO . . . . . . . . . . . . . 23.2 Cg_exo -68.39 144.28 61.13 Favored 'Trans proline' 0 N--CA 1.445 -1.361 0 N-CA-C 106.435 -2.179 . . . . 1.17 106.435 168.527 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A 1598 ' ' CYS . . . . . . . . . . . . . 19.1 t -95.17 125.26 51.03 Favored Pre-proline 0 C--N 1.286 -2.173 0 C-N-CA 120.065 -0.654 . . . . 1.19 110.287 -175.795 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A 1599 ' ' PRO . . . . . . . . . . . . . 84.6 Cg_endo -88.38 -4.04 6.69 Favored 'Trans proline' 0 N--CA 1.456 -0.73 0 C-N-CA 122.807 2.338 . . . . 1.59 111.698 177.079 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A 1600 ' ' SER . . . . . . . . . . . . . 16.3 m -86.35 109.11 18.77 Favored 'General case' 0 N--CA 1.425 -1.68 0 CA-C-N 115.865 -0.607 . . . . 2.12 109.994 -178.874 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A 1601 ' ' LYS . . . . . 0.813 ' HD2' ' HA ' ' A' 1632 ' ' GLN . 67.0 mttm 67.67 -86.71 0.03 OUTLIER 'General case' 0 C--O 1.242 0.684 0 C-N-CA 124.067 0.947 . . . . 3.74 113.358 178.571 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A 1602 ' ' SER . . . . . 0.837 ' HB3' HD22 ' A' 1604 ' ' LEU . 29.1 t -96.66 150.47 20.63 Favored 'General case' 0 N--CA 1.422 -1.867 0 N-CA-C 108.781 -0.822 . . . . 3.79 108.781 -175.5 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A 1603 ' ' GLY . . . . . . . . . . . . . . . -83.64 59.61 4.95 Favored Glycine 0 N--CA 1.435 -1.43 0 N-CA-C 110.331 -1.108 . . . . 2.0 110.331 176.425 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A 1604 ' ' LEU . . . . . 0.837 HD22 ' HB3' ' A' 1602 ' ' SER . 2.0 pt? -105.32 -175.35 2.77 Favored 'General case' 0 C--N 1.302 -1.494 0 CA-C-N 115.704 -0.248 . . . . 1.48 110.82 -176.982 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A 1605 ' ' SER . . . . . . . . . . . . . 5.0 p -83.81 -176.19 6.17 Favored 'General case' 0 C--N 1.294 -1.829 0 CA-C-O 121.249 0.547 . . . . 1.51 111.25 -178.568 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A 1606 ' ' TYR . . . . . . . . . . . . . 5.1 m-85 -116.76 128.5 55.37 Favored 'General case' 0 CA--C 1.469 -2.144 0 N-CA-C 106.882 -1.525 . . . . 1.18 106.882 177.426 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A 1607 ' ' LYS . . . . . . . . . . . . . 20.6 ptmt -119.32 118.93 32.53 Favored 'General case' 0 N--CA 1.407 -2.618 0 CA-C-O 121.536 0.684 . . . . 1.67 110.204 -178.535 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A 1608 ' ' SER . . . . . 0.631 ' HB3' ' HB2' ' A' 1592 ' ' TYR . 33.4 t -103.5 106.8 17.41 Favored 'General case' 0 C--N 1.288 -2.083 0 N-CA-C 108.056 -1.09 . . . . 1.0 108.056 -177.277 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A 1609 ' ' VAL . . . . . . . . . . . . . 66.2 t -107.49 115.44 48.74 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.5 0 CA-C-O 121.012 0.434 . . . . 0.93 110.862 -176.597 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A 1610 ' ' ILE . . . . . 0.6 ' HA ' ' HB2' ' A' 1638 ' ' PHE . 3.3 mp -103.78 111.17 32.42 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.21 0 N-CA-C 108.074 -1.084 . . . . 0.78 108.074 178.095 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A 1611 ' ' SER . . . . . 0.55 ' O ' ' HA ' ' A' 1639 ' ' SER . 18.8 m -104.43 129.83 52.37 Favored 'General case' 0 C--N 1.303 -1.451 0 CA-C-O 121.368 0.604 . . . . 1.29 110.706 -179.858 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A 1612 ' ' PHE . . . . . 0.426 ' HB2' ' HB2' ' A' 1588 ' ' LEU . 92.2 m-85 -101.55 113.18 26.07 Favored 'General case' 0 C--N 1.292 -1.899 0 N-CA-C 108.342 -0.984 . . . . 0.7 108.342 -179.524 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A 1613 ' ' VAL . . . . . . . . . . . . . 92.2 t -106.43 132.18 54.28 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.176 0 N-CA-C 109.538 -0.541 . . . . 0.75 109.538 -176.594 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A 1614 ' ' CYS . . . . . . . . . . . . . 62.6 m -67.48 99.51 0.76 Allowed 'General case' 0 C--N 1.322 -0.611 0 CA-C-O 121.573 0.701 . . . . 1.39 112.526 -177.559 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A 1615 ' ' ARG . . . . . 0.472 ' HB3' ' HB3' ' A' 1641 ' ' HIS . 20.3 tpp180 -137.28 85.45 21.75 Favored Pre-proline 0 N--CA 1.429 -1.479 0 CA-C-N 114.851 -1.068 . . . . 3.75 108.164 176.352 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A 1616 ' ' PRO . . . . . . . . . . . . . 16.4 Cg_exo -71.68 -13.22 29.66 Favored 'Trans proline' 0 C--N 1.357 0.984 0 C-N-CA 123.327 2.684 . . . . 1.32 110.227 178.153 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A 1617 ' ' GLU . . . . . 0.433 ' HB3' ' CD ' ' A' 1615 ' ' ARG . 43.7 tt0 . . . . . 0 C--N 1.304 -1.388 0 C-N-CA 126.067 1.747 . . . . 3.21 107.963 176.459 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A 1622 ' ' ASN . . . . . . . . . . . . . 29.1 t-20 . . . . . 0 N--CA 1.45 -0.455 0 N-CA-C 107.058 -1.46 . . . . 2.92 107.058 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A 1623 ' ' ARG . . . . . . . . . . . . . 4.9 ptp180 -153.12 164.49 20.2 Favored Pre-proline 0 C--N 1.301 -1.538 0 N-CA-C 108.887 -0.783 . . . . 3.61 108.887 -176.34 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A 1624 ' ' PRO . . . . . . . . . . . . . 22.7 Cg_exo -65.34 100.05 0.38 Allowed 'Trans proline' 0 C--N 1.361 1.234 0 C-N-CA 122.588 2.192 . . . . 2.37 110.813 177.059 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A 1625 ' ' MET . . . . . . . . . . . . . 23.4 ptp -108.72 148.65 30.14 Favored 'General case' 0 C--N 1.302 -1.457 0 CA-C-N 115.443 -0.798 . . . . 2.16 109.694 -177.17 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A 1626 ' ' LEU . . . . . 0.497 ' HG ' ' CE1' ' A' 1638 ' ' PHE . 38.1 mt -71.01 109.74 5.29 Favored 'General case' 0 C--N 1.309 -1.184 0 CA-C-N 115.978 -0.556 . . . . 1.35 110.369 174.667 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A 1627 ' ' ILE . . . . . . . . . . . . . 40.8 pt -92.4 -23.74 5.55 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.306 0 CA-C-N 115.115 -0.948 . . . . 1.21 109.185 177.321 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A 1628 ' ' SER . . . . . . . . . . . . . 51.1 m -154.53 149.84 27.13 Favored 'General case' 0 N--CA 1.428 -1.574 0 CA-C-N 115.452 -0.795 . . . . 1.4 109.403 -179.088 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A 1629 ' ' LEU . . . . . 0.746 HD13 ' HG ' ' A' 1636 ' ' LEU . 20.2 tp -143.28 112.25 6.59 Favored 'General case' 0 C--N 1.297 -1.701 0 N-CA-C 108.697 -0.853 . . . . 1.56 108.697 177.984 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A 1630 ' ' ASP . . . . . . . . . . . . . 13.4 t70 -100.26 108.15 20.15 Favored 'General case' 0 C--N 1.296 -1.728 0 N-CA-C 108.605 -0.887 . . . . 0.87 108.605 -178.26 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A 1631 ' ' LYS . . . . . . . . . . . . . 92.1 mttt -92.51 5.44 50.82 Favored 'General case' 0 C--N 1.293 -1.871 0 CA-C-O 120.947 0.403 . . . . 2.35 111.43 -177.293 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A 1632 ' ' GLN . . . . . 0.813 ' HA ' ' HD2' ' A' 1601 ' ' LYS . 33.5 mt-30 -85.55 -41.2 15.5 Favored 'General case' 0 N--CA 1.437 -1.098 0 N-CA-C 108.491 -0.929 . . . . 2.55 108.491 178.53 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A 1633 ' ' THR . . . . . . . . . . . . . 32.6 m -106.9 -2.44 21.3 Favored 'General case' 0 CA--C 1.564 1.516 0 CA-C-O 122.111 0.957 . . . . 1.24 110.256 176.917 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A 1634 ' ' CYS . . . . . . . . . . . . . 51.2 m 63.78 47.59 3.54 Favored 'General case' 0 N--CA 1.471 0.592 0 CA-C-O 122.675 1.226 . . . . 0.89 110.007 176.852 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A 1635 ' ' THR . . . . . . . . . . . . . 24.2 m -112.43 121.63 45.38 Favored 'General case' 0 N--CA 1.423 -1.824 0 CA-C-N 113.836 -1.529 . . . . 0.75 109.887 -175.774 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A 1636 ' ' LEU . . . . . 0.746 ' HG ' HD13 ' A' 1629 ' ' LEU . 5.5 mp -99.4 126.18 45.24 Favored 'General case' 0 C--N 1.305 -1.35 0 N-CA-C 108.812 -0.81 . . . . 1.33 108.812 179.061 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A 1637 ' ' PHE . . . . . . . . . . . . . 94.1 m-85 -108.08 94.82 5.28 Favored 'General case' 0 C--O 1.249 1.078 0 CA-C-O 121.012 0.434 . . . . 0.83 111.193 -177.774 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A 1638 ' ' PHE . . . . . 0.6 ' HB2' ' HA ' ' A' 1610 ' ' ILE . 99.7 m-85 -90.94 144.62 25.48 Favored 'General case' 0 CA--C 1.487 -1.458 0 N-CA-C 107.917 -1.142 . . . . 0.6 107.917 175.751 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A 1639 ' ' SER . . . . . 0.55 ' HA ' ' O ' ' A' 1611 ' ' SER . 66.8 m -141.7 133.08 26.62 Favored 'General case' 0 C--N 1.273 -2.737 0 CA-C-O 120.852 0.358 . . . . 1.08 111.187 177.267 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A 1640 ' ' TRP . . . . . 0.435 ' HZ3' HD13 ' A' 1532 ' ' LEU . 8.3 t90 -118.93 112.56 19.79 Favored 'General case' 0 N--CA 1.426 -1.674 0 N-CA-C 107.799 -1.186 . . . . 0.8 107.799 175.688 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A 1641 ' ' HIS . . . . . 0.472 ' HB3' ' HB3' ' A' 1615 ' ' ARG . 13.4 m170 -82.43 98.42 8.88 Favored 'General case' 0 C--N 1.297 -1.704 0 N-CA-C 107.315 -1.365 . . . . 2.54 107.315 175.311 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A 1642 ' ' THR . . . . . . . . . . . . . 9.2 t -143.1 147.81 42.49 Favored Pre-proline 0 C--N 1.305 -1.335 0 CA-C-N 115.406 -0.815 . . . . 1.15 111.394 -170.414 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A 1643 ' ' PRO . . . . . . . . . . . . . 34.6 Cg_endo -70.11 -12.04 31.49 Favored 'Trans proline' 0 C--N 1.353 0.778 0 C-N-CA 123.067 2.511 . . . . 0.8 111.106 171.837 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A 1644 ' ' LEU . . . . . . . . . . . . . 94.1 mt -75.55 -6.32 49.66 Favored 'General case' 0 N--CA 1.465 0.291 0 CA-C-N 116.241 -0.436 . . . . 1.54 111.699 178.74 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A 1645 ' ' ALA . . . . . . . . . . . . . . . -81.11 -42.52 20.83 Favored 'General case' 0 C--N 1.318 -0.778 0 N-CA-C 108.745 -0.835 . . . . 0.95 108.745 175.791 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A 1646 ' ' CYS . . . . . 0.675 ' HA ' ' HE1' ' A' 1527 ' ' PHE . 19.3 p -169.44 116.45 0.59 Allowed 'General case' 0 N--CA 1.432 -1.348 0 N-CA-C 107.717 -1.216 . . . . 1.41 107.717 173.645 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A 1647 ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 . . . . . 0 C--N 1.309 -1.194 0 CA-C-N 116.088 -0.506 . . . . 2.92 109.779 179.17 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A 1515 ' ' ASP . . . . . . . . . . . . . 16.5 t70 . . . . . 0 CA--C 1.513 -0.478 0 N-CA-C 107.057 -1.46 . . . . 2.54 107.057 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A 1516 ' ' CYS . . . . . 0.669 ' HB3' ' HB2' ' A' 1529 ' ' LEU . 34.3 m -87.5 59.7 5.63 Favored 'General case' 0 C--N 1.305 -1.356 0 N-CA-C 109.556 -0.535 . . . . 1.25 109.556 -177.283 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A 1517 ' ' GLN . . . . . 0.502 ' HA ' ' O ' ' A' 1527 ' ' PHE . 11.3 pt20 -148.41 138.54 22.49 Favored 'General case' 0 C--N 1.306 -1.292 0 N-CA-C 109.211 -0.662 . . . . 1.88 109.211 -179.785 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A 1518 ' ' VAL . . . . . . . . . . . . . 10.1 p -144.57 133.31 18.17 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.889 0 CA-C-O 120.921 0.391 . . . . 1.73 110.258 179.326 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A 1519 ' ' THR . . . . . 0.501 ' O ' ' HD3' ' A' 1521 ' ' PRO . 21.4 m -93.8 128.98 40.34 Favored 'General case' 0 C--N 1.292 -1.926 0 N-CA-C 108.926 -0.768 . . . . 1.7 108.926 179.158 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A 1520 ' ' ASN . . . . . . . . . . . . . 22.8 t30 -101.71 94.84 4.68 Favored Pre-proline 0 C--N 1.314 -0.974 0 N-CA-C 108.722 -0.844 . . . . 2.12 108.722 172.501 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A 1521 ' ' PRO . . . . . 0.501 ' HD3' ' O ' ' A' 1519 ' ' THR . 52.8 Cg_exo -55.27 -20.87 26.6 Favored 'Trans proline' 0 C--N 1.365 1.399 0 C-N-CA 123.68 2.92 . . . . 2.47 114.242 -177.257 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A 1522 ' ' SER . . . . . . . . . . . . . 19.9 t -64.47 -30.01 71.05 Favored 'General case' 0 CA--C 1.549 0.927 0 CA-C-O 120.834 0.349 . . . . 2.57 111.099 178.573 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A 1523 ' ' THR . . . . . . . . . . . . . 8.8 t -122.82 -14.84 7.59 Favored 'General case' 0 CA--C 1.545 0.753 0 C-N-CA 120.484 -0.487 . . . . 2.15 110.611 178.257 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A 1524 ' ' GLY . . . . . . . . . . . . . . . 89.22 -13.96 62.12 Favored Glycine 0 C--O 1.22 -0.744 0 CA-C-N 116.394 -0.366 . . . . 1.89 113.805 177.202 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A 1525 ' ' HIS . . . . . . . . . . . . . 13.7 t-160 -79.31 127.62 32.3 Favored 'General case' 0 C--N 1.311 -1.068 0 CA-C-O 121.289 0.566 . . . . 1.9 111.862 -175.616 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A 1526 ' ' LEU . . . . . 0.47 HD11 ' HB2' ' A' 1517 ' ' GLN . 41.9 tp -84.67 127.61 34.18 Favored 'General case' 0 C--N 1.315 -0.927 0 CA-C-N 114.685 -1.143 . . . . 1.61 107.969 173.084 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A 1527 ' ' PHE . . . . . 0.502 ' O ' ' HA ' ' A' 1517 ' ' GLN . 70.9 m-85 -99.01 119.02 37.09 Favored 'General case' 0 C--N 1.288 -2.073 0 N-CA-C 108.831 -0.803 . . . . 1.42 108.831 178.398 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A 1528 ' ' ASP . . . . . . . . . . . . . 10.9 t70 -105.24 124.18 49.11 Favored 'General case' 0 CA--C 1.487 -1.469 0 CA-C-O 121.189 0.518 . . . . 2.18 110.316 179.314 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A 1529 ' ' LEU . . . . . 0.669 ' HB2' ' HB3' ' A' 1516 ' ' CYS . 69.8 mt -108.59 -19.8 13.31 Favored 'General case' 0 C--N 1.294 -1.831 0 CA-C-N 114.922 -1.036 . . . . 1.44 108.914 177.213 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A 1530 ' ' SER . . . . . 0.404 ' OG ' ' HB2' ' A' 1516 ' ' CYS . 24.9 m -57.85 -37.87 74.65 Favored 'General case' 0 C--O 1.24 0.566 0 C-N-CA 123.626 0.77 . . . . 1.44 112.763 -176.634 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A 1531 ' ' SER . . . . . . . . . . . . . 50.5 p -87.43 1.07 54.49 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-O 120.906 0.384 . . . . 1.5 111.625 178.948 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A 1532 ' ' LEU . . . . . . . . . . . . . 96.1 mt -88.13 14.76 8.54 Favored 'General case' 0 CA--C 1.544 0.726 0 N-CA-C 113.12 0.785 . . . . 1.77 113.12 179.394 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A 1533 ' ' SER . . . . . 0.408 ' OG ' ' HB ' ' A' 1552 ' ' ILE . 46.1 m -113.38 108.78 17.69 Favored 'General case' 0 C--N 1.314 -0.964 0 O-C-N 121.591 -0.693 . . . . 2.38 110.898 178.84 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A 1534 ' ' GLY . . . . . . . . . . . . . . . -86.08 -127.29 2.01 Favored Glycine 0 C--O 1.22 -0.743 0 C-N-CA 120.69 -0.767 . . . . 1.55 111.499 176.714 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A 1535 ' ' ARG . . . . . . . . . . . . . 19.4 tpt180 -83.18 -52.8 6.29 Favored 'General case' 0 C--N 1.311 -1.081 0 CA-C-N 117.108 0.454 . . . . 3.96 109.958 178.36 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A 1536 ' ' ALA . . . . . 0.426 ' HB1' ' HD1' ' A' 1549 ' ' TYR . . . -96.12 -21.48 17.9 Favored 'General case' 0 C--N 1.312 -1.064 0 CA-C-O 121.216 0.531 . . . . 1.65 109.623 178.944 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A 1537 ' ' GLY . . . . . . . . . . . . . . . 90.66 -92.16 1.74 Allowed Glycine 0 N--CA 1.425 -2.058 0 N-CA-C 108.057 -2.017 . . . . 1.19 108.057 -175.925 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A 1538 ' ' PHE . . . . . . . . . . . . . 47.2 m-85 -136.85 158.32 44.73 Favored 'General case' 0 C--N 1.295 -1.799 0 N-CA-C 109.151 -0.685 . . . . 1.69 109.151 174.17 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A 1539 ' ' THR . . . . . . . . . . . . . 5.8 p -127.99 142.97 51.09 Favored 'General case' 0 C--N 1.296 -1.737 0 CA-C-N 116.506 -0.315 . . . . 1.48 111.295 -176.878 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A 1540 ' ' ALA . . . . . . . . . . . . . . . -131.21 140.12 49.82 Favored 'General case' 0 C--N 1.302 -1.479 0 N-CA-C 109.416 -0.587 . . . . 0.83 109.416 176.796 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A 1541 ' ' ALA . . . . . . . . . . . . . . . -86.21 133.43 33.85 Favored 'General case' 0 C--N 1.312 -1.034 0 N-CA-C 108.107 -1.071 . . . . 1.27 108.107 178.642 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A 1542 ' ' TYR . . . . . 0.602 ' HD2' ' HB2' ' A' 1545 ' ' SER . 76.6 t80 -136.12 166.56 23.11 Favored 'General case' 0 C--N 1.301 -1.531 0 N-CA-C 109.448 -0.575 . . . . 2.15 109.448 -175.747 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A 1543 ' ' SER . . . . . . . . . . . . . 16.0 t -48.67 -150.32 0.0 OUTLIER 'General case' 0 CA--C 1.577 1.997 0 C-N-CA 127.916 2.486 . . . . 2.29 112.886 176.229 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A 1544 ' ' LYS . . . . . . . . . . . . . 95.7 mttt -38.92 -30.75 0.05 Allowed 'General case' 0 CA--C 1.567 1.62 0 C-N-CA 124.986 1.314 . . . . 3.91 114.442 -178.619 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A 1545 ' ' SER . . . . . 0.602 ' HB2' ' HD2' ' A' 1542 ' ' TYR . 15.3 m -72.59 -10.69 60.1 Favored 'General case' 0 CA--C 1.579 2.076 0 N-CA-C 112.617 0.599 . . . . 3.3 112.617 177.254 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A 1546 ' ' GLY . . . . . . . . . . . . . . . 85.2 -80.15 1.84 Allowed Glycine 0 C--O 1.244 0.725 0 N-CA-C 115.049 0.78 . . . . 1.24 115.049 171.965 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A 1547 ' ' VAL . . . . . . . . . . . . . 7.8 p -146.39 143.09 21.06 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.475 0 CA-C-O 120.997 0.427 . . . . 1.63 109.914 -174.126 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A 1548 ' ' VAL . . . . . . . . . . . . . 2.1 t -109.86 135.1 49.9 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.414 0 N-CA-C 107.979 -1.119 . . . . 0.92 107.979 -179.058 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A 1549 ' ' TYR . . . . . 0.426 ' HD1' ' HB1' ' A' 1536 ' ' ALA . 80.1 m-85 -100.63 131.19 46.67 Favored 'General case' 0 C--N 1.313 -1.006 0 N-CA-C 106.522 -1.659 . . . . 1.44 106.522 173.266 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A 1550 ' ' MET . . . . . . . . . . . . . 68.1 mtp -126.08 122.44 35.8 Favored 'General case' 0 C--N 1.298 -1.647 0 CA-C-N 116.569 -0.287 . . . . 1.74 110.242 -171.436 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A 1551 ' ' SER . . . . . 0.618 ' CB ' ' HB3' ' A' 1556 ' ' ASN . 19.6 p -105.83 133.37 50.67 Favored 'General case' 0 N--CA 1.419 -1.997 0 CA-C-O 122.082 0.944 . . . . 1.64 111.1 -179.514 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A 1552 ' ' ILE . . . . . 0.451 HG22 ' SG ' ' A' 1553 ' ' CYS . 1.7 mp -76.38 -42.88 36.46 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.023 0 CA-C-N 114.355 -1.293 . . . . 1.33 111.499 -176.943 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A 1553 ' ' CYS . . . . . 0.451 ' SG ' HG22 ' A' 1552 ' ' ILE . 46.5 m -130.92 135.99 48.18 Favored 'General case' 0 C--N 1.307 -1.243 0 N-CA-C 108.636 -0.876 . . . . 1.43 108.636 174.626 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A 1554 ' ' GLY . . . . . 0.427 ' HA2' ' HB1' ' A' 1577 ' ' ALA . . . 54.57 -155.74 7.88 Favored Glycine 0 C--O 1.247 0.928 0 O-C-N 124.46 1.1 . . . . 1.12 111.981 179.371 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A 1555 ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -89.9 146.66 24.25 Favored 'General case' 0 N--CA 1.413 -2.295 0 C-N-CA 119.056 -1.058 . . . . 1.8 108.945 170.924 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A 1556 ' ' ASN . . . . . 0.618 ' HB3' ' CB ' ' A' 1551 ' ' SER . 4.3 t30 -170.37 61.41 0.04 OUTLIER 'General case' 0 C--N 1.282 -2.347 0 N-CA-C 107.388 -1.338 . . . . 2.63 107.388 -171.65 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A 1557 ' ' GLU . . . . . 0.558 ' CD ' ' H ' ' A' 1558 ' ' ASN 0.388 0.3 OUTLIER -157.58 -119.92 0.02 OUTLIER 'General case' 0 CA--C 1.553 1.09 0 N-CA-C 116.101 1.889 . . . . 3.79 116.101 -177.402 . . . . . . . . 4 4 . 1 . 013 nuclear nobuild core ' A' A 1558 ' ' ASN . . . . . 0.558 ' H ' ' CD ' ' A' 1557 ' ' GLU . 40.4 m-80 -139.6 -5.68 1.36 Allowed 'General case' 0 CA--C 1.55 0.96 0 N-CA-C 113.029 0.752 . . . . 1.52 113.029 -175.849 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A 1559 ' ' CYS . . . . . 0.481 ' HB3' ' HD2' ' A' 1560 ' ' PRO . 43.7 m -91.36 170.22 10.03 Favored Pre-proline 0 C--N 1.317 -0.809 0 CA-C-O 119.161 -0.447 . . . . 0.84 109.937 179.015 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A 1560 ' ' PRO . . . . . 0.481 ' HD2' ' HB3' ' A' 1559 ' ' CYS . 91.6 Cg_exo -45.83 129.01 11.66 Favored 'Trans proline' 0 C--N 1.364 1.374 0 C-N-CA 122.853 2.369 . . . . 1.18 111.348 174.633 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A 1561 ' ' PRO . . . . . 0.452 ' HD3' ' HA ' ' A' 1560 ' ' PRO . 53.3 Cg_exo -56.21 115.65 2.62 Favored 'Trans proline' 0 C--O 1.241 0.642 0 C-N-CA 123.268 2.646 . . . . 1.51 112.505 -178.133 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A 1562 ' ' GLY . . . . . . . . . . . . . . . 155.05 -21.43 0.58 Allowed Glycine 0 N--CA 1.443 -0.881 0 N-CA-C 111.619 -0.593 . . . . 0.72 111.619 -179.08 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A 1563 ' ' VAL . . . . . 0.437 ' HA ' ' HA ' ' A' 1576 ' ' LYS . 25.6 m -80.68 161.21 3.92 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.121 0 CA-C-O 121.486 0.66 . . . . 0.97 111.885 178.004 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A 1564 ' ' GLY . . . . . 0.601 ' HA3' ' CD2' ' A' 1592 ' ' TYR . . . -119.98 0.14 13.28 Favored Glycine 0 N--CA 1.424 -2.142 0 N-CA-C 108.845 -1.702 . . . . 0.72 108.845 166.718 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A 1565 ' ' ALA . . . . . . . . . . . . . . . -170.22 125.54 0.77 Allowed 'General case' 0 C--O 1.246 0.911 0 N-CA-C 108.511 -0.922 . . . . 0.37 108.511 178.312 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A 1566 ' ' CYS . . . . . . . . . . . . . 48.8 t -149.98 145.01 26.2 Favored 'General case' 0 C--N 1.309 -1.159 0 C-N-CA 121.141 -0.224 . . . . 0.51 110.45 -175.513 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A 1567 ' ' PHE . . . . . . . . . . . . . 26.8 m-85 -69.87 124.17 23.35 Favored 'General case' 0 C--O 1.217 -0.656 0 N-CA-C 107.548 -1.279 . . . . 0.97 107.548 174.179 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A 1568 ' ' GLY . . . . . 0.425 ' HA3' ' CE2' ' A' 1549 ' ' TYR . . . -70.06 -31.53 69.45 Favored Glycine 0 CA--C 1.498 -1.001 0 C-N-CA 121.02 -0.609 . . . . 1.08 114.032 -173.667 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A 1569 ' ' GLN . . . . . . . . . . . . . 34.5 tt0 -84.57 -53.24 5.53 Favored 'General case' 0 C--N 1.304 -1.394 0 CA-C-O 121.444 0.64 . . . . 2.74 109.853 -179.219 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A 1570 ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -77.19 -23.73 51.45 Favored 'General case' 0 C--N 1.307 -1.25 0 CA-C-N 115.133 -0.939 . . . . 1.96 113.019 -173.177 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A 1571 ' ' ARG . . . . . 0.403 ' HA ' ' SG ' ' A' 1559 ' ' CYS . 91.5 mtt180 60.97 36.57 18.64 Favored 'General case' 0 CA--C 1.511 -0.548 0 C-N-CA 125.02 1.328 . . . . 3.95 113.39 179.101 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A 1572 ' ' ILE . . . . . . . . . . . . . 44.0 mm -106.0 122.62 59.86 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.131 0 N-CA-C 108.462 -0.94 . . . . 1.37 108.462 179.473 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A 1573 ' ' SER . . . . . . . . . . . . . 41.5 t -66.86 128.54 36.71 Favored 'General case' 0 C--N 1.308 -1.239 0 C-N-CA 124.231 1.012 . . . . 1.08 111.201 179.562 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A 1574 ' ' VAL . . . . . 0.542 ' HA ' ' HB2' ' A' 1606 ' ' TYR . 35.4 m -118.8 18.01 6.8 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.236 0 CA-C-O 122.023 0.916 . . . . 1.3 110.335 178.004 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A 1575 ' ' GLY . . . . . . . . . . . . . . . 167.25 123.64 0.67 Allowed Glycine 0 N--CA 1.43 -1.725 0 CA-C-N 114.299 -1.319 . . . . 0.51 109.941 178.339 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A 1576 ' ' LYS . . . . . 0.437 ' HA ' ' HA ' ' A' 1563 ' ' VAL . 62.0 mttp -84.32 153.72 23.34 Favored 'General case' 0 CA--C 1.498 -1.021 0 CA-C-O 121.201 0.524 . . . . 2.9 110.427 179.478 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A 1577 ' ' ALA . . . . . 0.478 ' HA ' ' CE2' ' A' 1592 ' ' TYR . . . -59.65 104.23 0.26 Allowed 'General case' 0 C--N 1.307 -1.244 0 CA-C-N 114.025 -1.443 . . . . 0.83 111.287 178.028 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A 1578 ' ' ASN . . . . . . . . . . . . . 45.7 m-80 -135.32 123.05 22.33 Favored 'General case' 0 C--N 1.301 -1.502 0 N-CA-C 105.974 -1.862 . . . . 1.85 105.974 177.027 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A 1579 ' ' LYS . . . . . . . . . . . . . 36.6 ttpt -94.34 89.8 6.03 Favored 'General case' 0 C--N 1.285 -2.227 0 N-CA-C 108.388 -0.967 . . . . 1.9 108.388 -174.583 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A 1580 ' ' ARG . . . . . . . . . . . . . 72.8 ttt180 -127.64 109.86 12.1 Favored 'General case' 0 N--CA 1.419 -1.991 0 CA-C-N 114.631 -1.168 . . . . 3.63 109.128 -179.095 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A 1581 ' ' LEU . . . . . 0.458 HD13 ' N ' ' A' 1582 ' ' ARG . 2.3 tm? -96.25 141.94 29.0 Favored 'General case' 0 C--N 1.3 -1.563 0 CA-C-N 114.649 -1.16 . . . . 1.87 108.143 -177.868 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A 1582 ' ' ARG . . . . . 0.458 ' N ' HD13 ' A' 1581 ' ' LEU . 4.7 tpt180 -145.84 141.79 28.22 Favored 'General case' 0 C--N 1.304 -1.376 0 N-CA-C 108.638 -0.875 . . . . 3.97 108.638 173.274 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A 1583 ' ' TYR . . . . . . . . . . . . . 46.9 t80 -137.05 103.58 5.18 Favored 'General case' 0 C--N 1.321 -0.645 0 N-CA-C 109.206 -0.665 . . . . 1.41 109.206 179.051 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A 1584 ' ' VAL . . . . . . . . . . . . . 26.9 m -134.69 140.26 45.97 Favored 'Isoleucine or valine' 0 C--O 1.201 -1.453 0 N-CA-C 109.64 -0.504 . . . . 1.69 109.64 -178.484 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A 1585 ' ' ASP . . . . . . . . . . . . . 8.9 t70 43.98 52.46 6.73 Favored 'General case' 0 N--CA 1.492 1.646 0 C-N-CA 125.06 1.344 . . . . 2.06 113.088 175.184 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A 1586 ' ' GLN . . . . . . . . . . . . . 19.0 mm-40 61.93 22.39 13.02 Favored 'General case' 0 CA--C 1.553 1.091 0 C-N-CA 123.89 0.876 . . . . 2.33 112.853 178.815 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A 1587 ' ' VAL . . . . . 0.5 HG23 ' O ' ' A' 1612 ' ' PHE . 9.4 p -134.06 125.02 47.71 Favored 'Isoleucine or valine' 0 C--O 1.245 0.833 0 O-C-N 121.455 -0.778 . . . . 0.78 111.785 177.451 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A 1588 ' ' LEU . . . . . 0.696 ' HB2' ' HB2' ' A' 1612 ' ' PHE . 79.3 mt -85.99 155.31 20.92 Favored 'General case' 0 C--N 1.313 -1.0 0 CA-C-N 114.942 -1.026 . . . . 1.41 110.731 177.314 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A 1589 ' ' GLN . . . . . 0.514 ' HA ' ' O ' ' A' 1610 ' ' ILE . 6.9 tt0 -150.4 133.36 16.06 Favored 'General case' 0 C--N 1.318 -0.795 0 N-CA-C 112.33 0.493 . . . . 1.24 112.33 -179.447 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A 1590 ' ' LEU . . . . . 0.621 ' HG ' ' HE1' ' A' 1612 ' ' PHE . 96.0 mt -104.0 125.52 50.43 Favored 'General case' 0 C--O 1.248 1.006 0 N-CA-C 106.982 -1.488 . . . . 1.15 106.982 172.068 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A 1591 ' ' VAL . . . . . . . . . . . . . 40.4 t -105.72 102.56 14.05 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.498 0 C-N-CA 120.757 -0.377 . . . . 1.51 110.119 179.827 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A 1592 ' ' TYR . . . . . 0.601 ' CD2' ' HA3' ' A' 1564 ' ' GLY . 27.7 m-85 -117.55 92.96 3.98 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-O 121.379 0.609 . . . . 1.06 109.422 177.788 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A 1593 ' ' LYS . . . . . . . . . . . . . 21.3 pttp -110.85 -177.55 3.25 Favored 'General case' 0 C--N 1.305 -1.358 0 N-CA-C 112.569 0.581 . . . . 2.18 112.569 -175.901 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A 1594 ' ' ASP . . . . . 0.408 ' HA ' ' HB2' ' A' 1605 ' ' SER . 18.2 m-20 52.77 59.43 4.48 Favored 'General case' 0 N--CA 1.466 0.355 0 C-N-CA 124.931 1.292 . . . . 1.45 113.598 175.212 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A 1595 ' ' GLY . . . . . 0.424 ' HA2' ' HG3' ' A' 1576 ' ' LYS . . . -83.34 -107.35 0.51 Allowed Glycine 0 N--CA 1.438 -1.167 0 C-N-CA 120.517 -0.849 . . . . 0.78 111.719 177.631 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A 1596 ' ' SER . . . . . . . . . . . . . 23.0 t -106.23 145.47 31.04 Favored Pre-proline 0 C--N 1.291 -1.94 0 N-CA-C 107.545 -1.279 . . . . 1.68 107.545 -179.839 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A 1597 ' ' PRO . . . . . . . . . . . . . 77.3 Cg_exo -53.29 134.21 55.95 Favored 'Trans proline' 0 C--N 1.362 1.286 0 C-N-CA 123.558 2.839 . . . . 1.17 111.523 178.654 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A 1598 ' ' CYS . . . . . . . . . . . . . 50.6 t -95.05 125.66 49.75 Favored Pre-proline 0 C--N 1.289 -2.042 0 CA-C-N 115.41 -0.814 . . . . 1.19 109.883 -173.569 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A 1599 ' ' PRO . . . . . . . . . . . . . 58.4 Cg_endo -71.86 -13.91 29.45 Favored 'Trans proline' 0 C--N 1.346 0.395 0 C-N-CA 122.971 2.447 . . . . 1.59 112.497 -179.375 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A 1600 ' ' SER . . . . . . . . . . . . . 19.3 m -74.3 -20.46 60.11 Favored 'General case' 0 N--CA 1.439 -1.002 0 CA-C-N 116.019 -0.537 . . . . 2.12 111.06 179.984 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A 1601 ' ' LYS . . . . . 0.414 ' HA ' ' HD2' ' A' 1601 ' ' LYS . 20.9 tptm -156.68 104.13 2.14 Favored 'General case' 0 N--CA 1.433 -1.314 0 N-CA-C 109.052 -0.721 . . . . 3.74 109.052 177.109 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A 1602 ' ' SER . . . . . . . . . . . . . 7.4 p -61.27 107.41 0.75 Allowed 'General case' 0 C--N 1.303 -1.432 0 CA-C-N 115.294 -0.866 . . . . 3.79 112.086 -178.654 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A 1603 ' ' GLY . . . . . . . . . . . . . . . 136.13 -5.38 3.93 Favored Glycine 0 N--CA 1.434 -1.498 0 C-N-CA 120.576 -0.821 . . . . 2.0 113.367 177.91 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A 1604 ' ' LEU . . . . . . . . . . . . . 3.0 pp -140.27 161.81 36.77 Favored 'General case' 0 C--N 1.311 -1.092 0 CA-C-N 117.586 0.693 . . . . 1.48 112.067 -178.727 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A 1605 ' ' SER . . . . . 0.408 ' HB2' ' HA ' ' A' 1594 ' ' ASP . 21.7 m -102.78 -174.99 2.69 Favored 'General case' 0 C--N 1.307 -1.259 0 N-CA-C 109.062 -0.718 . . . . 1.51 109.062 178.016 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A 1606 ' ' TYR . . . . . 0.542 ' HB2' ' HA ' ' A' 1574 ' ' VAL . 96.1 m-85 -95.34 153.36 17.72 Favored 'General case' 0 CA--C 1.472 -2.036 0 N-CA-C 105.768 -1.938 . . . . 1.18 105.768 179.495 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A 1607 ' ' LYS . . . . . 0.5 ' HG3' HG23 ' A' 1635 ' ' THR . 25.2 pttm -137.63 146.44 43.93 Favored 'General case' 0 N--CA 1.403 -2.783 0 C-N-CA 118.634 -1.226 . . . . 1.67 110.202 173.054 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A 1608 ' ' SER . . . . . . . . . . . . . 49.9 m -118.69 126.7 52.48 Favored 'General case' 0 C--N 1.305 -1.336 0 CA-C-O 121.235 0.541 . . . . 1.0 110.845 -179.174 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A 1609 ' ' VAL . . . . . . . . . . . . . 56.2 t -111.23 116.91 53.79 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.932 0 N-CA-C 109.565 -0.531 . . . . 0.93 109.565 177.798 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A 1610 ' ' ILE . . . . . 0.595 ' HB ' ' HB2' ' A' 1590 ' ' LEU . 29.3 mm -92.52 111.65 24.72 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.989 0 N-CA-C 108.652 -0.87 . . . . 0.78 108.652 177.349 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A 1611 ' ' SER . . . . . . . . . . . . . 6.3 m -102.67 119.54 39.01 Favored 'General case' 0 C--N 1.29 -2.015 0 N-CA-C 108.146 -1.057 . . . . 1.29 108.146 179.386 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A 1612 ' ' PHE . . . . . 0.696 ' HB2' ' HB2' ' A' 1588 ' ' LEU . 69.5 m-85 -91.47 105.3 17.66 Favored 'General case' 0 C--N 1.297 -1.699 0 N-CA-C 109.196 -0.668 . . . . 0.7 109.196 -178.833 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A 1613 ' ' VAL . . . . . 0.506 ' O ' ' HA ' ' A' 1641 ' ' HIS . 56.6 t -99.09 124.96 52.66 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.164 0 CA-C-N 115.868 -0.605 . . . . 0.75 109.587 -175.672 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A 1614 ' ' CYS . . . . . . . . . . . . . 34.5 m -71.14 93.97 1.1 Allowed 'General case' 0 C--N 1.304 -1.401 0 CA-C-O 121.505 0.669 . . . . 1.39 112.711 -178.192 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A 1615 ' ' ARG . . . . . 0.721 ' HB3' ' HB2' ' A' 1641 ' ' HIS . 28.5 ttm180 -136.15 92.61 15.81 Favored Pre-proline 0 C--N 1.307 -1.264 0 CA-C-N 115.361 -0.836 . . . . 3.75 110.562 176.607 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A 1616 ' ' PRO . . . . . 0.468 ' HB3' ' HB3' ' A' 1643 ' ' PRO . 12.0 Cg_exo -75.42 18.59 0.57 Allowed 'Trans proline' 0 CA--C 1.535 0.574 0 C-N-CA 123.558 2.839 . . . . 1.32 112.895 176.925 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A 1617 ' ' GLU . . . . . . . . . . . . . 42.3 mt-10 . . . . . 0 C--N 1.312 -1.026 0 CA-C-O 120.971 0.415 . . . . 3.21 110.285 -178.613 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A 1622 ' ' ASN . . . . . . . . . . . . . 49.5 t-20 . . . . . 0 C--O 1.243 0.711 0 N-CA-C 107.231 -1.396 . . . . 2.92 107.231 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A 1623 ' ' ARG . . . . . . . . . . . . . 16.2 ptm180 -147.89 153.64 42.58 Favored Pre-proline 0 N--CA 1.437 -1.089 0 CA-C-N 114.996 -1.002 . . . . 3.61 108.805 -174.943 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A 1624 ' ' PRO . . . . . 0.497 ' HA ' ' HA ' ' A' 1640 ' ' TRP . 8.1 Cg_exo -73.77 111.01 3.19 Favored 'Trans proline' 0 C--O 1.238 0.519 0 C-N-CA 122.705 2.27 . . . . 2.37 110.75 178.581 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A 1625 ' ' MET . . . . . . . . . . . . . 26.7 ptt? -100.15 154.3 18.55 Favored 'General case' 0 C--N 1.303 -1.418 0 CA-C-N 116.026 -0.534 . . . . 2.16 109.846 -178.041 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A 1626 ' ' LEU . . . . . . . . . . . . . 56.4 tp -87.4 106.92 18.29 Favored 'General case' 0 C--N 1.301 -1.51 0 N-CA-C 108.747 -0.835 . . . . 1.35 108.747 -179.036 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A 1627 ' ' ILE . . . . . . . . . . . . . 2.8 pp -85.83 -36.02 10.16 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.205 0 C-N-CA 119.921 -0.712 . . . . 1.21 112.758 -177.272 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A 1628 ' ' SER . . . . . . . . . . . . . 49.3 m -157.67 143.92 17.65 Favored 'General case' 0 C--N 1.316 -0.86 0 N-CA-C 110.155 -0.313 . . . . 1.4 110.155 179.428 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A 1629 ' ' LEU . . . . . 0.887 ' HG ' ' HG ' ' A' 1636 ' ' LEU . 5.1 tt -130.33 118.53 21.41 Favored 'General case' 0 C--N 1.301 -1.506 0 N-CA-C 106.343 -1.725 . . . . 1.56 106.343 176.183 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A 1630 ' ' ASP . . . . . . . . . . . . . 20.1 t70 -93.36 117.25 29.86 Favored 'General case' 0 C--N 1.29 -2.005 0 N-CA-C 108.541 -0.911 . . . . 0.87 108.541 178.82 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A 1631 ' ' LYS . . . . . . . . . . . . . 95.7 mttt -83.37 1.52 40.94 Favored 'General case' 0 C--N 1.314 -0.937 0 N-CA-C 112.445 0.535 . . . . 2.35 112.445 -174.983 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A 1632 ' ' GLN . . . . . . . . . . . . . 1.5 mp0 -96.68 -45.7 6.59 Favored 'General case' 0 C--N 1.315 -0.905 0 CA-C-O 121.359 0.6 . . . . 2.55 110.318 -178.424 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A 1633 ' ' THR . . . . . . . . . . . . . 41.6 p -95.39 -5.99 41.97 Favored 'General case' 0 C--N 1.305 -1.348 0 CA-C-O 121.793 0.806 . . . . 1.24 110.286 177.87 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A 1634 ' ' CYS . . . . . . . . . . . . . 83.4 m 56.69 51.33 11.17 Favored 'General case' 0 C--N 1.347 0.475 0 CA-C-N 113.569 -1.65 . . . . 0.89 110.789 -179.394 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A 1635 ' ' THR . . . . . 0.5 HG23 ' HG3' ' A' 1607 ' ' LYS . 24.8 m -111.54 124.36 52.13 Favored 'General case' 0 N--CA 1.425 -1.723 0 CA-C-N 114.109 -1.405 . . . . 0.75 109.651 -176.093 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A 1636 ' ' LEU . . . . . 0.887 ' HG ' ' HG ' ' A' 1629 ' ' LEU . 5.1 mp -105.83 126.72 52.5 Favored 'General case' 0 C--N 1.309 -1.186 0 N-CA-C 109.481 -0.563 . . . . 1.33 109.481 178.519 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A 1637 ' ' PHE . . . . . . . . . . . . . 91.0 m-85 -105.91 111.46 24.11 Favored 'General case' 0 C--N 1.31 -1.139 0 CA-C-N 116.135 -0.484 . . . . 0.83 110.232 -178.831 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A 1638 ' ' PHE . . . . . . . . . . . . . 94.8 m-85 -106.42 128.25 53.91 Favored 'General case' 0 C--N 1.303 -1.436 0 N-CA-C 109.432 -0.581 . . . . 0.6 109.432 178.988 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A 1639 ' ' SER . . . . . . . . . . . . . 67.2 m -112.75 114.64 27.3 Favored 'General case' 0 C--N 1.278 -2.538 0 CA-C-O 121.132 0.491 . . . . 1.08 110.288 179.663 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A 1640 ' ' TRP . . . . . 0.497 ' HA ' ' HA ' ' A' 1624 ' ' PRO . 14.8 t90 -96.26 90.8 5.6 Favored 'General case' 0 N--CA 1.425 -1.699 0 N-CA-C 107.755 -1.202 . . . . 0.8 107.755 176.955 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A 1641 ' ' HIS . . . . . 0.721 ' HB2' ' HB3' ' A' 1615 ' ' ARG . 0.8 OUTLIER -71.87 99.13 2.14 Favored 'General case' 0 C--N 1.311 -1.097 0 CA-C-N 115.223 -0.898 . . . . 2.54 110.072 175.093 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A 1642 ' ' THR . . . . . . . . . . . . . 5.6 t -142.89 149.59 50.15 Favored Pre-proline 0 C--N 1.295 -1.77 0 CA-C-N 114.741 -1.118 . . . . 1.15 109.009 -172.655 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A 1643 ' ' PRO . . . . . 0.468 ' HB3' ' HB3' ' A' 1616 ' ' PRO . 45.6 Cg_endo -73.07 -9.85 23.89 Favored 'Trans proline' 0 C--O 1.215 -0.675 0 C-N-CA 122.858 2.372 . . . . 0.8 112.301 176.187 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A 1644 ' ' LEU . . . . . . . . . . . . . 81.9 mt -87.69 3.83 46.4 Favored 'General case' 0 C--N 1.318 -0.801 0 C-N-CA 122.713 0.405 . . . . 1.54 111.292 -177.748 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A 1645 ' ' ALA . . . . . . . . . . . . . . . -80.45 -30.13 37.55 Favored 'General case' 0 C--N 1.317 -0.822 0 N-CA-C 112.383 0.512 . . . . 0.95 112.383 -176.61 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A 1646 ' ' CYS . . . . . . . . . . . . . 21.1 p -172.06 -179.57 2.4 Favored 'General case' 0 C--N 1.306 -1.297 0 N-CA-C 105.667 -1.975 . . . . 1.41 105.667 179.594 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A 1647 ' ' GLU . . . . . . . . . . . . . 56.3 mm-40 . . . . . 0 C--N 1.312 -1.024 0 N-CA-C 107.747 -1.205 . . . . 2.92 107.747 174.479 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A 1515 ' ' ASP . . . . . . . . . . . . . 23.6 t70 . . . . . 0 N--CA 1.443 -0.818 0 N-CA-C 107.158 -1.423 . . . . 2.54 107.158 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A 1516 ' ' CYS . . . . . . . . . . . . . 71.0 m -83.98 77.24 9.96 Favored 'General case' 0 C--N 1.303 -1.425 0 CA-C-O 121.048 0.451 . . . . 1.25 110.363 179.427 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A 1517 ' ' GLN . . . . . . . . . . . . . 3.5 pt20 -142.54 152.98 43.17 Favored 'General case' 0 C--N 1.306 -1.283 0 O-C-N 121.977 -0.452 . . . . 1.88 111.375 -178.56 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A 1518 ' ' VAL . . . . . 0.561 ' HB ' ' HD2' ' A' 1527 ' ' PHE . 59.2 t -138.59 130.51 37.49 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.86 0 N-CA-C 109.315 -0.624 . . . . 1.73 109.315 -179.759 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A 1519 ' ' THR . . . . . . . . . . . . . 26.6 m -102.67 115.33 30.36 Favored 'General case' 0 C--N 1.306 -1.303 0 N-CA-C 108.217 -1.031 . . . . 1.7 108.217 173.982 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A 1520 ' ' ASN . . . . . . . . . . . . . 25.9 t-20 -74.17 130.43 82.62 Favored Pre-proline 0 C--N 1.313 -0.98 0 N-CA-C 110.122 -0.325 . . . . 2.12 110.122 178.934 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A 1521 ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -74.75 -16.92 20.63 Favored 'Trans proline' 0 CA--C 1.543 0.947 0 C-N-CA 122.744 2.296 . . . . 2.47 114.749 -176.375 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A 1522 ' ' SER . . . . . . . . . . . . . 16.5 m -91.93 -60.86 1.75 Allowed 'General case' 0 C--N 1.314 -0.942 0 N-CA-C 112.044 0.387 . . . . 2.57 112.044 -176.32 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A 1523 ' ' THR . . . . . . . . . . . . . 8.8 t -94.71 -10.06 32.85 Favored 'General case' 0 C--N 1.316 -0.861 0 CA-C-O 121.474 0.654 . . . . 2.15 111.202 -176.153 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A 1524 ' ' GLY . . . . . . . . . . . . . . . 75.0 18.46 80.2 Favored Glycine 0 C--O 1.223 -0.559 0 CA-C-N 115.871 -0.604 . . . . 1.89 112.61 179.093 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A 1525 ' ' HIS . . . . . . . . . . . . . 17.6 t60 -75.65 128.07 34.43 Favored 'General case' 0 C--N 1.308 -1.212 0 N-CA-C 109.751 -0.463 . . . . 1.9 109.751 -176.95 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A 1526 ' ' LEU . . . . . . . . . . . . . 3.5 tm? -94.39 120.15 34.2 Favored 'General case' 0 C--N 1.299 -1.603 0 N-CA-C 106.626 -1.62 . . . . 1.61 106.626 177.451 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A 1527 ' ' PHE . . . . . 0.561 ' HD2' ' HB ' ' A' 1518 ' ' VAL . 86.1 m-85 -89.03 109.94 20.71 Favored 'General case' 0 C--N 1.297 -1.679 0 CA-C-N 116.525 -0.307 . . . . 1.42 110.28 -178.574 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A 1528 ' ' ASP . . . . . . . . . . . . . 13.5 m-20 -81.8 87.3 6.36 Favored 'General case' 0 CA--C 1.494 -1.198 0 CA-C-N 115.913 -0.585 . . . . 2.18 110.484 179.556 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A 1529 ' ' LEU . . . . . 0.702 ' HA ' HD23 ' A' 1532 ' ' LEU . 85.7 mt -99.09 -9.61 23.62 Favored 'General case' 0 C--N 1.302 -1.493 0 N-CA-C 108.95 -0.759 . . . . 1.44 108.95 178.269 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A 1530 ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -62.98 -25.4 68.36 Favored 'General case' 0 C--N 1.318 -0.781 0 C-N-CA 125.166 1.386 . . . . 1.44 109.314 175.623 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A 1531 ' ' SER . . . . . . . . . . . . . 34.3 t -77.34 -9.21 58.7 Favored 'General case' 0 N--CA 1.427 -1.582 0 CA-C-N 114.279 -1.328 . . . . 1.5 109.654 -179.699 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A 1532 ' ' LEU . . . . . 0.702 HD23 ' HA ' ' A' 1529 ' ' LEU . 3.5 mm? -95.87 10.03 38.55 Favored 'General case' 0 C--O 1.245 0.855 0 CA-C-N 115.898 -0.592 . . . . 1.77 111.356 177.805 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A 1533 ' ' SER . . . . . 0.565 ' HA ' ' O ' ' A' 1553 ' ' CYS . 42.3 m -76.58 107.79 9.12 Favored 'General case' 0 N--CA 1.436 -1.15 0 N-CA-C 107.745 -1.206 . . . . 2.38 107.745 172.894 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A 1534 ' ' GLY . . . . . . . . . . . . . . . -110.19 151.33 17.49 Favored Glycine 0 N--CA 1.436 -1.366 0 C-N-CA 120.655 -0.783 . . . . 1.55 112.957 -174.343 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A 1535 ' ' ARG . . . . . . . . . . . . . 40.7 ttm180 -72.36 -62.53 1.41 Allowed 'General case' 0 C--N 1.314 -0.942 0 CA-C-O 121.149 0.499 . . . . 3.96 110.38 178.451 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A 1536 ' ' ALA . . . . . . . . . . . . . . . -93.57 -6.38 46.75 Favored 'General case' 0 C--N 1.309 -1.19 0 C-N-CA 120.028 -0.669 . . . . 1.65 109.484 179.386 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A 1537 ' ' GLY . . . . . . . . . . . . . . . 79.49 -152.85 36.26 Favored Glycine 0 N--CA 1.436 -1.359 0 CA-C-N 115.454 -0.794 . . . . 1.19 112.671 176.397 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A 1538 ' ' PHE . . . . . . . . . . . . . 87.1 m-85 -120.18 155.07 33.86 Favored 'General case' 0 C--N 1.29 -2.003 0 N-CA-C 107.754 -1.202 . . . . 1.69 107.754 179.885 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A 1539 ' ' THR . . . . . . . . . . . . . 24.1 p -112.14 111.93 23.18 Favored 'General case' 0 C--N 1.293 -1.865 0 CA-C-O 121.359 0.599 . . . . 1.48 111.068 -179.409 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A 1540 ' ' ALA . . . . . . . . . . . . . . . -96.8 139.26 33.12 Favored 'General case' 0 C--N 1.3 -1.568 0 N-CA-C 109.075 -0.713 . . . . 0.83 109.075 -179.618 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A 1541 ' ' ALA . . . . . . . . . . . . . . . -80.69 132.87 35.62 Favored 'General case' 0 C--N 1.311 -1.107 0 CA-C-N 115.862 -0.608 . . . . 1.27 110.159 -177.79 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A 1542 ' ' TYR . . . . . 0.477 ' HB3' ' O ' ' A' 1546 ' ' GLY . 45.6 t80 -145.75 156.25 43.48 Favored 'General case' 0 C--N 1.313 -0.999 0 CA-C-N 116.402 -0.363 . . . . 2.15 110.499 -179.134 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A 1543 ' ' SER . . . . . . . . . . . . . 5.5 m -41.25 -153.07 0.0 OUTLIER 'General case' 0 CA--C 1.585 2.305 0 C-N-CA 129.921 3.288 . . . . 2.29 116.58 -176.426 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A 1544 ' ' LYS . . . . . . . . . . . . . 61.2 mttp -51.7 -24.77 6.13 Favored 'General case' 0 N--CA 1.484 1.274 0 O-C-N 120.627 -1.296 . . . . 3.91 113.773 -179.655 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A 1545 ' ' SER . . . . . . . . . . . . . 22.7 t -71.98 -14.71 61.97 Favored 'General case' 0 CA--C 1.553 1.076 0 N-CA-C 111.87 0.322 . . . . 3.3 111.87 178.239 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A 1546 ' ' GLY . . . . . 0.477 ' O ' ' HB3' ' A' 1542 ' ' TYR . . . 96.07 -153.36 20.53 Favored Glycine 0 C--O 1.216 -1.031 0 C-N-CA 119.707 -1.235 . . . . 1.24 113.763 173.491 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A 1547 ' ' VAL . . . . . . . . . . . . . 95.6 t -91.96 139.87 17.11 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.653 0 C-N-CA 123.11 0.564 . . . . 1.63 110.47 -173.751 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A 1548 ' ' VAL . . . . . . . . . . . . . 2.4 t -103.27 131.32 51.96 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.971 0 N-CA-C 107.679 -1.23 . . . . 0.92 107.679 179.211 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A 1549 ' ' TYR . . . . . 0.419 ' CE1' ' HA3' ' A' 1568 ' ' GLY . 75.9 m-85 -97.1 115.19 27.06 Favored 'General case' 0 C--N 1.295 -1.789 0 N-CA-C 107.17 -1.418 . . . . 1.44 107.17 175.129 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A 1550 ' ' MET . . . . . . . . . . . . . 2.7 ppp? -138.34 142.5 39.71 Favored 'General case' 0 C--N 1.291 -1.957 0 CA-C-O 121.172 0.511 . . . . 1.74 111.829 -177.611 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A 1551 ' ' SER . . . . . . . . . . . . . 47.3 m -109.04 149.59 29.04 Favored 'General case' 0 C--N 1.279 -2.463 0 N-CA-C 108.084 -1.08 . . . . 1.64 108.084 177.417 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A 1552 ' ' ILE . . . . . . . . . . . . . 41.6 mm -74.49 -51.64 22.25 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.627 0 N-CA-C 107.385 -1.339 . . . . 1.33 107.385 176.188 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A 1553 ' ' CYS . . . . . 0.565 ' O ' ' HA ' ' A' 1533 ' ' SER . 80.9 m -134.27 147.53 50.65 Favored 'General case' 0 C--N 1.29 -2.01 0 N-CA-C 107.346 -1.353 . . . . 1.43 107.346 175.141 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A 1554 ' ' GLY . . . . . . . . . . . . . . . 97.99 176.05 33.45 Favored Glycine 0 N--CA 1.427 -1.952 0 C-N-CA 120.591 -0.814 . . . . 1.12 111.433 178.294 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A 1555 ' ' GLU . . . . . . . . . . . . . 10.9 pt-20 -89.84 145.74 24.94 Favored 'General case' 0 C--N 1.303 -1.451 0 N-CA-C 109.823 -0.436 . . . . 1.8 109.823 -179.828 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A 1556 ' ' ASN . . . . . . . . . . . . . 20.9 t-20 -93.02 114.24 26.74 Favored 'General case' 0 C--N 1.305 -1.343 0 N-CA-C 108.543 -0.91 . . . . 2.63 108.543 -178.608 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A 1557 ' ' GLU . . . . . . . . . . . . . 51.2 mt-10 -87.23 51.34 2.21 Favored 'General case' 0 C--N 1.294 -1.832 0 N-CA-C 113.178 0.807 . . . . 3.79 113.178 -172.505 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A 1558 ' ' ASN . . . . . . . . . . . . . 36.6 m-80 -133.99 -0.12 3.12 Favored 'General case' 0 C--N 1.311 -1.105 0 CA-C-N 115.781 -0.645 . . . . 1.52 109.79 175.839 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A 1559 ' ' CYS . . . . . 0.63 ' HB3' ' HD2' ' A' 1560 ' ' PRO . 87.4 m -150.86 171.87 5.96 Favored Pre-proline 0 C--N 1.311 -1.08 0 N-CA-C 106.959 -1.497 . . . . 0.84 106.959 -178.764 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A 1560 ' ' PRO . . . . . 0.63 ' HD2' ' HB3' ' A' 1559 ' ' CYS . 44.2 Cg_exo -27.63 129.61 0.03 OUTLIER 'Trans proline' 0 C--N 1.384 2.435 0 C-N-CA 124.948 3.765 . . . . 1.18 114.526 177.454 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A 1561 ' ' PRO . . . . . 0.509 ' HD3' ' HA ' ' A' 1560 ' ' PRO . 37.3 Cg_exo -58.36 116.33 3.17 Favored 'Trans proline' 0 C--O 1.241 0.663 0 C-N-CA 123.277 2.651 . . . . 1.51 112.365 -178.188 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A 1562 ' ' GLY . . . . . . . . . . . . . . . 122.33 -9.94 9.38 Favored Glycine 0 N--CA 1.442 -0.9 0 C-N-CA 120.798 -0.715 . . . . 0.72 112.905 177.858 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A 1563 ' ' VAL . . . . . 0.421 ' HA ' ' HA ' ' A' 1576 ' ' LYS . 2.4 m -92.64 153.72 3.27 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.093 0 N-CA-C 107.85 -1.167 . . . . 0.97 107.85 179.242 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A 1564 ' ' GLY . . . . . . . . . . . . . . . -118.68 -18.73 4.71 Favored Glycine 0 C--N 1.297 -1.585 0 C-N-CA 120.284 -0.96 . . . . 0.72 112.656 -177.21 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A 1565 ' ' ALA . . . . . . . . . . . . . . . -139.5 122.35 16.56 Favored 'General case' 0 C--N 1.314 -0.941 0 N-CA-C 108.862 -0.792 . . . . 0.37 108.862 178.994 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A 1566 ' ' CYS . . . . . . . . . . . . . 39.6 t -150.28 144.44 25.56 Favored 'General case' 0 C--N 1.306 -1.297 0 CA-C-N 116.599 -0.273 . . . . 0.51 110.586 -174.812 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A 1567 ' ' PHE . . . . . . . . . . . . . 26.1 m-85 -76.89 123.85 26.88 Favored 'General case' 0 C--O 1.211 -0.96 0 N-CA-C 107.599 -1.259 . . . . 0.97 107.599 175.38 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A 1568 ' ' GLY . . . . . 0.419 ' HA3' ' CE1' ' A' 1549 ' ' TYR . . . -69.16 -27.84 73.39 Favored Glycine 0 C--N 1.315 -0.59 0 N-CA-C 114.561 0.584 . . . . 1.08 114.561 -175.445 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A 1569 ' ' GLN . . . . . . . . . . . . . 35.3 tt0 -77.44 -47.33 19.99 Favored 'General case' 0 C--N 1.315 -0.906 0 O-C-N 122.47 -0.429 . . . . 2.74 111.481 -178.248 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A 1570 ' ' THR . . . . . . . . . . . . . 18.6 p -96.31 -13.36 23.38 Favored 'General case' 0 C--N 1.308 -1.221 0 N-CA-C 113.034 0.753 . . . . 1.96 113.034 -176.21 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A 1571 ' ' ARG . . . . . . . . . . . . . 21.7 mtp180 57.6 40.72 26.54 Favored 'General case' 0 CA--C 1.51 -0.573 0 C-N-CA 124.924 1.29 . . . . 3.95 113.007 -179.456 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A 1572 ' ' ILE . . . . . . . . . . . . . 66.0 mt -106.4 126.45 62.11 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.18 0 CA-C-N 114.733 -1.121 . . . . 1.37 108.327 178.981 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A 1573 ' ' SER . . . . . . . . . . . . . 37.7 t -75.6 136.88 40.48 Favored 'General case' 0 C--N 1.309 -1.186 0 CA-C-N 115.449 -0.796 . . . . 1.08 111.383 -176.95 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A 1574 ' ' VAL . . . . . . . . . . . . . 22.8 m -129.81 21.14 2.2 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.395 0 CA-C-O 121.995 0.903 . . . . 1.3 110.196 177.778 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A 1575 ' ' GLY . . . . . . . . . . . . . . . 176.87 119.04 0.56 Allowed Glycine 0 N--CA 1.422 -2.243 0 CA-C-N 114.576 -1.193 . . . . 0.51 111.274 177.117 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A 1576 ' ' LYS . . . . . 0.421 ' HA ' ' HA ' ' A' 1563 ' ' VAL . 46.9 tptt -75.45 151.54 38.06 Favored 'General case' 0 C--N 1.31 -1.147 0 N-CA-C 106.001 -1.852 . . . . 2.9 106.001 175.52 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A 1577 ' ' ALA . . . . . . . . . . . . . . . -70.94 95.08 1.13 Allowed 'General case' 0 C--N 1.314 -0.942 0 N-CA-C 109.273 -0.64 . . . . 0.83 109.273 -179.126 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A 1578 ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -104.66 142.4 34.75 Favored 'General case' 0 C--N 1.3 -1.553 0 CA-C-N 115.439 -0.8 . . . . 1.85 111.117 -178.337 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A 1579 ' ' LYS . . . . . . . . . . . . . 9.9 mmmm -105.89 89.03 2.95 Favored 'General case' 0 C--N 1.287 -2.148 0 N-CA-C 106.079 -1.823 . . . . 1.9 106.079 173.792 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A 1580 ' ' ARG . . . . . 0.518 ' HD3' ' HB ' ' A' 1591 ' ' VAL . 70.0 ttt180 -146.62 97.76 2.96 Favored 'General case' 0 C--N 1.303 -1.435 0 CA-C-N 115.183 -0.917 . . . . 3.63 109.457 -173.023 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A 1581 ' ' LEU . . . . . . . . . . . . . 54.3 tp -118.93 144.57 46.36 Favored 'General case' 0 C--N 1.299 -1.627 0 CA-C-N 115.9 -0.591 . . . . 1.87 109.941 -176.622 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A 1582 ' ' ARG . . . . . . . . . . . . . 49.5 mtp180 -132.96 136.41 46.08 Favored 'General case' 0 C--N 1.309 -1.155 0 C-N-CA 123.416 0.686 . . . . 3.97 109.907 179.185 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A 1583 ' ' TYR . . . . . . . . . . . . . 7.8 t80 -92.9 104.77 16.98 Favored 'General case' 0 C--N 1.311 -1.09 0 CA-C-O 121.56 0.695 . . . . 1.41 109.894 174.184 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A 1584 ' ' VAL . . . . . 0.555 ' HB ' HG13 ' A' 1587 ' ' VAL . 35.0 t -109.69 149.26 12.85 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.648 0 N-CA-C 105.245 -2.131 . . . . 1.69 105.245 175.301 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A 1585 ' ' ASP . . . . . . . . . . . . . 35.8 t70 -46.34 102.68 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.376 0 C-N-CA 124.473 1.109 . . . . 2.06 113.713 -177.968 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A 1586 ' ' GLN . . . . . . . . . . . . . 49.8 mt-30 58.41 35.25 24.63 Favored 'General case' 0 C--O 1.249 1.033 0 C-N-CA 124.828 1.251 . . . . 2.33 112.477 179.911 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A 1587 ' ' VAL . . . . . 0.555 HG13 ' HB ' ' A' 1584 ' ' VAL . 7.7 p -164.69 104.54 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.436 -1.158 0 CA-C-O 122.06 0.933 . . . . 0.78 110.616 175.433 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A 1588 ' ' LEU . . . . . 0.52 ' HB2' ' HB2' ' A' 1612 ' ' PHE . 44.2 mt -78.62 141.25 38.17 Favored 'General case' 0 C--N 1.294 -1.845 0 N-CA-C 107.71 -1.218 . . . . 1.41 107.71 176.295 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A 1589 ' ' GLN . . . . . . . . . . . . . 36.0 tt0 -125.27 117.62 24.21 Favored 'General case' 0 C--N 1.284 -2.253 0 N-CA-C 109.642 -0.503 . . . . 1.24 109.642 -177.835 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A 1590 ' ' LEU . . . . . 0.431 ' HA ' ' O ' ' A' 1580 ' ' ARG . 4.9 tt -116.16 123.25 47.35 Favored 'General case' 0 C--N 1.304 -1.381 0 N-CA-C 106.72 -1.585 . . . . 1.15 106.72 178.354 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A 1591 ' ' VAL . . . . . 0.518 ' HB ' ' HD3' ' A' 1580 ' ' ARG . 60.9 t -110.94 127.76 67.82 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.131 0 N-CA-C 113.633 0.975 . . . . 1.51 113.633 -171.05 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A 1592 ' ' TYR . . . . . . . . . . . . . 5.6 m-30 -109.08 143.49 38.37 Favored 'General case' 0 C--N 1.32 -0.677 0 N-CA-C 107.783 -1.192 . . . . 1.06 107.783 171.378 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A 1593 ' ' LYS . . . . . 0.454 ' HA ' ' HA ' ' A' 1607 ' ' LYS . 13.4 ptmm? -158.96 -177.24 6.37 Favored 'General case' 0 C--N 1.3 -1.58 0 N-CA-C 108.601 -0.889 . . . . 2.18 108.601 179.82 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A 1594 ' ' ASP . . . . . . . . . . . . . 22.0 m-20 64.57 43.31 4.45 Favored 'General case' 0 C--O 1.247 0.936 0 O-C-N 124.147 0.904 . . . . 1.45 112.107 177.724 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A 1595 ' ' GLY . . . . . . . . . . . . . . . -80.83 -104.34 0.31 Allowed Glycine 0 N--CA 1.437 -1.29 0 N-CA-C 111.088 -0.805 . . . . 0.78 111.088 176.309 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A 1596 ' ' SER . . . . . . . . . . . . . 17.7 m -114.11 152.34 45.74 Favored Pre-proline 0 C--N 1.29 -2.013 0 N-CA-C 107.958 -1.127 . . . . 1.68 107.958 177.558 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A 1597 ' ' PRO . . . . . . . . . . . . . 24.7 Cg_exo -62.37 143.39 93.55 Favored 'Trans proline' 0 C--O 1.248 0.99 0 C-N-CA 122.663 2.242 . . . . 1.17 111.193 179.143 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A 1598 ' ' CYS . . . . . . . . . . . . . 45.9 t -96.25 133.15 25.39 Favored Pre-proline 0 C--N 1.29 -2.005 0 CA-C-N 115.844 -0.616 . . . . 1.19 110.41 -177.071 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A 1599 ' ' PRO . . . . . . . . . . . . . 88.2 Cg_endo -88.3 -7.43 5.91 Favored 'Trans proline' 0 CA--C 1.537 0.659 0 C-N-CA 122.68 2.253 . . . . 1.59 112.141 178.013 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A 1600 ' ' SER . . . . . . . . . . . . . 16.5 m -84.27 -34.04 23.88 Favored 'General case' 0 N--CA 1.446 -0.645 0 CA-C-O 121.25 0.548 . . . . 2.12 110.075 -179.87 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A 1601 ' ' LYS . . . . . 0.548 ' HG2' HD12 ' A' 1604 ' ' LEU . 15.8 tppt? -139.64 118.68 12.61 Favored 'General case' 0 N--CA 1.431 -1.379 0 N-CA-C 107.653 -1.24 . . . . 3.74 107.653 178.185 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A 1602 ' ' SER . . . . . . . . . . . . . 22.9 m -72.85 134.39 44.84 Favored 'General case' 0 C--N 1.297 -1.705 0 CA-C-O 121.28 0.562 . . . . 3.79 110.481 -177.587 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A 1603 ' ' GLY . . . . . . . . . . . . . . . 97.61 -7.45 63.43 Favored Glycine 0 N--CA 1.439 -1.125 0 N-CA-C 110.876 -0.89 . . . . 2.0 110.876 -179.756 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A 1604 ' ' LEU . . . . . 0.548 HD12 ' HG2' ' A' 1601 ' ' LYS . 2.2 mt -105.72 148.88 26.94 Favored 'General case' 0 C--N 1.303 -1.424 0 C-N-CA 123.107 0.563 . . . . 1.48 110.873 179.658 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A 1605 ' ' SER . . . . . . . . . . . . . 52.3 m -113.2 -167.45 1.19 Allowed 'General case' 0 C--N 1.287 -2.114 0 N-CA-C 106.356 -1.72 . . . . 1.51 106.356 173.286 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A 1606 ' ' TYR . . . . . . . . . . . . . 44.0 m-85 -108.07 128.24 54.5 Favored 'General case' 0 N--CA 1.399 -2.992 0 N-CA-C 107.223 -1.399 . . . . 1.18 107.223 -179.963 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A 1607 ' ' LYS . . . . . 0.556 ' HG3' HG23 ' A' 1635 ' ' THR . 21.7 ptmt -125.4 154.38 42.01 Favored 'General case' 0 N--CA 1.397 -3.097 0 O-C-N 124.56 1.163 . . . . 1.67 109.407 -177.68 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A 1608 ' ' SER . . . . . 0.494 ' HB3' ' HE2' ' A' 1638 ' ' PHE . 51.1 m -132.38 118.36 19.29 Favored 'General case' 0 C--N 1.296 -1.735 0 N-CA-C 109.598 -0.519 . . . . 1.0 109.598 -178.53 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A 1609 ' ' VAL . . . . . 0.436 HG22 HG13 ' A' 1591 ' ' VAL . 88.1 t -104.12 124.68 58.7 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.558 0 N-CA-C 109.224 -0.658 . . . . 0.93 109.224 178.882 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A 1610 ' ' ILE . . . . . . . . . . . . . 3.1 mp -99.51 117.81 45.2 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.41 0 N-CA-C 108.473 -0.936 . . . . 0.78 108.473 178.156 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A 1611 ' ' SER . . . . . . . . . . . . . 62.9 p -103.45 125.75 50.21 Favored 'General case' 0 N--CA 1.42 -1.928 0 N-CA-C 109.48 -0.563 . . . . 1.29 109.48 177.342 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A 1612 ' ' PHE . . . . . 0.52 ' HB2' ' HB2' ' A' 1588 ' ' LEU . 15.3 m-85 -94.51 107.47 19.45 Favored 'General case' 0 C--N 1.296 -1.735 0 N-CA-C 107.708 -1.219 . . . . 0.7 107.708 179.544 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A 1613 ' ' VAL . . . . . 0.652 HG12 ' HG2' ' A' 1615 ' ' ARG . 97.2 t -103.73 134.41 45.02 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.958 0 N-CA-C 109.86 -0.422 . . . . 0.75 109.86 -177.018 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A 1614 ' ' CYS . . . . . . . . . . . . . 62.6 m -77.1 91.8 3.72 Favored 'General case' 0 N--CA 1.436 -1.166 0 CA-C-O 121.984 0.897 . . . . 1.39 109.879 -178.384 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A 1615 ' ' ARG . . . . . 0.761 ' HB2' ' HB2' ' A' 1641 ' ' HIS . 12.9 mmt180 -137.52 103.04 8.62 Favored Pre-proline 0 C--N 1.293 -1.865 0 N-CA-C 106.336 -1.727 . . . . 3.75 106.336 176.662 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A 1616 ' ' PRO . . . . . . . . . . . . . 32.6 Cg_endo -68.03 73.22 0.75 Allowed 'Trans proline' 0 C--O 1.245 0.857 0 C-N-CA 122.441 2.094 . . . . 1.32 111.956 177.843 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A 1617 ' ' GLU . . . . . . . . . . . . . 48.8 mt-10 . . . . . 0 N--CA 1.431 -1.404 0 CA-C-N 114.653 -1.158 . . . . 3.21 109.816 176.659 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A 1622 ' ' ASN . . . . . . . . . . . . . 58.0 t30 . . . . . 0 CA--C 1.535 0.37 0 CA-C-O 122.056 0.931 . . . . 2.92 109.079 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A 1623 ' ' ARG . . . . . . . . . . . . . 19.7 ptp180 -155.17 154.71 29.1 Favored Pre-proline 0 C--N 1.3 -1.585 0 N-CA-C 106.998 -1.482 . . . . 3.61 106.998 179.69 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A 1624 ' ' PRO . . . . . . . . . . . . . 23.0 Cg_exo -66.1 117.47 4.7 Favored 'Trans proline' 0 N--CA 1.459 -0.522 0 C-N-CA 122.789 2.326 . . . . 2.37 112.339 -179.648 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A 1625 ' ' MET . . . . . . . . . . . . . 48.3 ttm -90.9 133.16 35.47 Favored 'General case' 0 C--N 1.306 -1.289 0 N-CA-C 108.46 -0.941 . . . . 2.16 108.46 -179.785 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A 1626 ' ' LEU . . . . . 0.434 HD21 HD23 ' A' 1629 ' ' LEU . 29.0 tp -85.22 91.8 8.24 Favored 'General case' 0 C--N 1.294 -1.806 0 N-CA-C 108.715 -0.846 . . . . 1.35 108.715 179.272 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A 1627 ' ' ILE . . . . . . . . . . . . . 32.6 pt -86.05 -27.64 6.18 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.611 0 CA-C-N 115.851 -0.613 . . . . 1.21 111.893 -175.118 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A 1628 ' ' SER . . . . . 0.803 ' HB2' ' HB2' ' A' 1637 ' ' PHE . 18.2 m -132.1 129.04 39.4 Favored 'General case' 0 N--CA 1.427 -1.578 0 CA-C-O 121.087 0.47 . . . . 1.4 110.825 -175.594 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A 1629 ' ' LEU . . . . . 0.59 HD22 ' HG ' ' A' 1636 ' ' LEU . 1.5 tm? -129.77 109.27 10.81 Favored 'General case' 0 C--N 1.296 -1.756 0 N-CA-C 105.393 -2.077 . . . . 1.56 105.393 177.094 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A 1630 ' ' ASP . . . . . . . . . . . . . 22.9 t70 -105.45 112.59 25.75 Favored 'General case' 0 C--N 1.297 -1.682 0 C-N-CA 118.95 -1.1 . . . . 0.87 110.135 179.35 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A 1631 ' ' LYS . . . . . . . . . . . . . 28.7 mtpp -71.77 -37.65 70.44 Favored 'General case' 0 C--N 1.306 -1.308 0 CA-C-N 114.621 -1.172 . . . . 2.35 112.946 -175.923 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A 1632 ' ' GLN . . . . . . . . . . . . . 8.7 pt20 -75.02 -31.26 61.31 Favored 'General case' 0 CA--C 1.535 0.394 0 N-CA-C 112.906 0.706 . . . . 2.55 112.906 -174.444 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A 1633 ' ' THR . . . . . . . . . . . . . 54.7 p -99.46 -1.55 38.23 Favored 'General case' 0 C--O 1.245 0.83 0 C-N-CA 120.073 -0.651 . . . . 1.24 111.198 177.8 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A 1634 ' ' CYS . . . . . . . . . . . . . 18.4 m 60.74 40.28 16.35 Favored 'General case' 0 C--N 1.352 0.699 0 CA-C-O 122.114 0.959 . . . . 0.89 110.466 174.366 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A 1635 ' ' THR . . . . . 0.556 HG23 ' HG3' ' A' 1607 ' ' LYS . 27.5 m -124.04 132.5 53.69 Favored 'General case' 0 N--CA 1.435 -1.202 0 CA-C-N 115.207 -0.906 . . . . 0.75 111.512 -173.802 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A 1636 ' ' LEU . . . . . 0.59 ' HG ' HD22 ' A' 1629 ' ' LEU . 6.2 mp -102.87 141.32 35.88 Favored 'General case' 0 C--N 1.313 -1.0 0 N-CA-C 109.113 -0.699 . . . . 1.33 109.113 175.93 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A 1637 ' ' PHE . . . . . 0.803 ' HB2' ' HB2' ' A' 1628 ' ' SER . 90.9 m-85 -124.22 106.85 10.62 Favored 'General case' 0 C--O 1.25 1.119 0 CA-C-O 121.362 0.601 . . . . 0.83 111.448 177.928 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A 1638 ' ' PHE . . . . . 0.494 ' HE2' ' HB3' ' A' 1608 ' ' SER . 86.3 m-85 -91.75 144.51 25.43 Favored 'General case' 0 C--N 1.31 -1.14 0 CA-C-N 115.508 -0.769 . . . . 0.6 109.223 178.317 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A 1639 ' ' SER . . . . . . . . . . . . . 28.8 m -129.42 114.89 16.72 Favored 'General case' 0 C--N 1.292 -1.92 0 CA-C-O 120.924 0.393 . . . . 1.08 110.136 178.777 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A 1640 ' ' TRP . . . . . . . . . . . . . 19.3 t90 -108.52 113.36 26.33 Favored 'General case' 0 C--N 1.296 -1.73 0 N-CA-C 109.248 -0.649 . . . . 0.8 109.248 177.777 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A 1641 ' ' HIS . . . . . 0.761 ' HB2' ' HB2' ' A' 1615 ' ' ARG . 7.3 p-80 -79.81 104.47 10.41 Favored 'General case' 0 C--N 1.317 -0.846 0 CA-C-N 115.305 -0.861 . . . . 2.54 108.936 176.253 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A 1642 ' ' THR . . . . . 0.492 ' HA ' ' HD3' ' A' 1643 ' ' PRO . 8.9 t -143.08 144.35 28.48 Favored Pre-proline 0 C--N 1.285 -2.198 0 C-N-CA 120.069 -0.652 . . . . 1.15 112.046 -173.366 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A 1643 ' ' PRO . . . . . 0.492 ' HD3' ' HA ' ' A' 1642 ' ' THR . 4.9 Cg_exo -79.1 -0.74 11.0 Favored 'Trans proline' 0 N--CA 1.451 -1.013 0 C-N-CA 123.298 2.665 . . . . 0.8 110.328 171.831 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A 1644 ' ' LEU . . . . . . . . . . . . . 89.6 mt -91.07 3.87 53.61 Favored 'General case' 0 C--O 1.225 -0.207 0 CA-C-N 115.771 -0.65 . . . . 1.54 109.73 176.268 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A 1645 ' ' ALA . . . . . . . . . . . . . . . -86.51 -42.43 13.55 Favored 'General case' 0 C--N 1.317 -0.805 0 N-CA-C 108.14 -1.059 . . . . 0.95 108.14 175.988 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A 1646 ' ' CYS . . . . . . . . . . . . . 16.0 p -176.82 161.46 2.01 Favored 'General case' 0 N--CA 1.43 -1.471 0 N-CA-C 102.993 -2.966 . . . . 1.41 102.993 174.453 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A 1647 ' ' GLU . . . . . . . . . . . . . 41.7 mt-10 . . . . . 0 C--N 1.309 -1.155 0 CA-C-N 118.624 0.647 . . . . 2.92 110.784 -179.684 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A 1515 ' ' ASP . . . . . . . . . . . . . 11.3 t70 . . . . . 0 N--CA 1.437 -1.118 0 N-CA-C 106.836 -1.542 . . . . 2.54 106.836 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A 1516 ' ' CYS . . . . . 0.664 ' SG ' ' HE3' ' A' 1579 ' ' LYS . 11.6 m -82.64 81.93 8.22 Favored 'General case' 0 C--N 1.299 -1.629 0 N-CA-C 109.381 -0.6 . . . . 1.25 109.381 -176.812 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A 1517 ' ' GLN . . . . . . . . . . . . . 3.9 pt20 -165.39 176.69 8.07 Favored 'General case' 0 C--N 1.32 -0.68 0 N-CA-C 110.147 -0.316 . . . . 1.88 110.147 179.39 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A 1518 ' ' VAL . . . . . 0.704 ' HB ' HD11 ' A' 1581 ' ' LEU . 4.5 p -148.76 131.32 6.61 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.863 0 CA-C-N 116.068 -0.515 . . . . 1.73 110.131 176.454 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A 1519 ' ' THR . . . . . . . . . . . . . 4.8 m -105.97 123.97 48.83 Favored 'General case' 0 C--N 1.312 -1.039 0 N-CA-C 109.775 -0.454 . . . . 1.7 109.775 179.181 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A 1520 ' ' ASN . . . . . . . . . . . . . 24.8 t-20 -83.86 113.29 46.58 Favored Pre-proline 0 C--N 1.314 -0.971 0 N-CA-C 108.966 -0.753 . . . . 2.12 108.966 175.661 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A 1521 ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -75.55 -15.83 19.36 Favored 'Trans proline' 0 C--N 1.344 0.326 0 C-N-CA 122.221 1.947 . . . . 2.47 113.552 -174.958 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A 1522 ' ' SER . . . . . . . . . . . . . 12.2 m -68.25 -54.75 15.5 Favored 'General case' 0 N--CA 1.432 -1.344 0 CA-C-N 116.494 -0.321 . . . . 2.57 110.785 -177.925 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A 1523 ' ' THR . . . . . 0.465 HG23 ' HB2' ' A' 1525 ' ' HIS . 14.5 t -109.02 -7.8 15.3 Favored 'General case' 0 C--N 1.315 -0.895 0 C-N-CA 119.654 -0.818 . . . . 2.15 111.966 -179.465 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A 1524 ' ' GLY . . . . . . . . . . . . . . . 80.45 37.38 20.87 Favored Glycine 0 CA--C 1.503 -0.658 0 C-N-CA 120.511 -0.852 . . . . 1.89 111.18 -179.487 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A 1525 ' ' HIS . . . . . 0.465 ' HB2' HG23 ' A' 1523 ' ' THR . 22.3 t-160 -100.97 115.71 31.11 Favored 'General case' 0 C--N 1.308 -1.205 0 N-CA-C 109.284 -0.636 . . . . 1.9 109.284 -176.545 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A 1526 ' ' LEU . . . . . . . . . . . . . 3.5 tm? -88.41 120.65 29.98 Favored 'General case' 0 C--N 1.295 -1.766 0 N-CA-C 107.799 -1.185 . . . . 1.61 107.799 178.762 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A 1527 ' ' PHE . . . . . . . . . . . . . 95.0 m-85 -92.86 112.95 25.09 Favored 'General case' 0 C--N 1.3 -1.555 0 N-CA-C 107.646 -1.242 . . . . 1.42 107.646 176.975 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A 1528 ' ' ASP . . . . . . . . . . . . . 10.8 t70 -77.84 105.6 9.13 Favored 'General case' 0 CA--C 1.495 -1.143 0 CA-C-O 121.533 0.682 . . . . 2.18 109.678 -178.356 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A 1529 ' ' LEU . . . . . . . . . . . . . 89.2 mt -106.55 -3.0 21.28 Favored 'General case' 0 C--N 1.281 -2.412 0 N-CA-C 107.207 -1.405 . . . . 1.44 107.207 176.458 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A 1530 ' ' SER . . . . . . . . . . . . . 8.1 m -69.72 -37.05 76.4 Favored 'General case' 0 N--CA 1.419 -1.985 0 CA-C-N 114.027 -1.442 . . . . 1.44 110.73 -174.013 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A 1531 ' ' SER . . . . . . . . . . . . . 14.8 m -74.94 -21.97 58.86 Favored 'General case' 0 C--N 1.316 -0.853 0 CA-C-O 121.344 0.592 . . . . 1.5 110.026 177.72 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A 1532 ' ' LEU . . . . . 0.575 HD22 ' HH2' ' A' 1640 ' ' TRP . 82.1 mt -85.83 -5.72 59.2 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.549 -0.751 . . . . 1.77 109.643 179.711 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A 1533 ' ' SER . . . . . 0.419 ' OG ' ' HB3' ' A' 1553 ' ' CYS . 22.6 m -92.18 107.36 19.16 Favored 'General case' 0 N--CA 1.415 -2.199 0 N-CA-C 108.631 -0.878 . . . . 2.38 108.631 178.584 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A 1534 ' ' GLY . . . . . . . . . . . . . . . -126.58 -150.33 7.54 Favored Glycine 0 N--CA 1.422 -2.296 0 N-CA-C 109.768 -1.333 . . . . 1.55 109.768 179.551 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A 1535 ' ' ARG . . . . . 0.433 ' HD2' ' HA ' ' A' 1535 ' ' ARG . 9.5 tpt180 -96.82 -70.11 0.73 Allowed 'General case' 0 N--CA 1.419 -1.979 0 C-N-CA 120.242 -0.583 . . . . 3.96 109.58 179.214 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A 1536 ' ' ALA . . . . . . . . . . . . . . . -86.93 -18.28 31.17 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 121.047 0.451 . . . . 1.65 110.994 -177.831 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A 1537 ' ' GLY . . . . . . . . . . . . . . . 73.44 -112.9 4.04 Favored Glycine 0 N--CA 1.435 -1.383 0 CA-C-N 115.941 -0.572 . . . . 1.19 113.317 176.15 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A 1538 ' ' PHE . . . . . . . . . . . . . 64.9 m-85 -127.23 159.0 35.64 Favored 'General case' 0 C--N 1.307 -1.27 0 N-CA-C 109.837 -0.431 . . . . 1.69 109.837 -176.55 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A 1539 ' ' THR . . . . . . . . . . . . . 6.8 p -112.76 119.99 39.95 Favored 'General case' 0 C--N 1.306 -1.3 0 CA-C-N 116.288 -0.415 . . . . 1.48 111.138 -178.886 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A 1540 ' ' ALA . . . . . . . . . . . . . . . -100.51 116.0 31.43 Favored 'General case' 0 C--N 1.307 -1.253 0 N-CA-C 109.46 -0.57 . . . . 0.83 109.46 177.976 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A 1541 ' ' ALA . . . . . . . . . . . . . . . -80.48 89.05 5.61 Favored 'General case' 0 C--N 1.313 -0.979 0 CA-C-N 115.541 -0.754 . . . . 1.27 109.134 -179.161 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A 1542 ' ' TYR . . . . . . . . . . . . . 64.3 t80 -100.13 157.2 16.74 Favored 'General case' 0 C--N 1.293 -1.856 0 CA-C-N 115.861 -0.609 . . . . 2.15 111.483 -176.486 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A 1543 ' ' SER . . . . . . . . . . . . . 2.8 m -40.46 -153.07 0.0 OUTLIER 'General case' 0 CA--C 1.578 2.043 0 C-N-CA 130.179 3.391 . . . . 2.29 116.893 -177.15 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A 1544 ' ' LYS . . . . . 0.472 ' NZ ' ' HB3' ' A' 1544 ' ' LYS . 4.9 ttpm? -49.4 -31.7 10.15 Favored 'General case' 0 N--CA 1.481 1.082 0 O-C-N 121.3 -0.875 . . . . 3.91 112.262 -179.197 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A 1545 ' ' SER . . . . . . . . . . . . . 13.1 m -63.82 -27.18 69.0 Favored 'General case' 0 CA--C 1.559 1.291 0 N-CA-C 112.375 0.509 . . . . 3.3 112.375 178.261 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A 1546 ' ' GLY . . . . . . . . . . . . . . . 109.02 -165.21 12.48 Favored Glycine 0 N--CA 1.43 -1.764 0 C-N-CA 119.363 -1.398 . . . . 1.24 114.034 174.869 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A 1547 ' ' VAL . . . . . . . . . . . . . 7.2 p -92.35 133.51 33.48 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.608 0 CA-C-O 121.596 0.712 . . . . 1.63 111.151 -176.297 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A 1548 ' ' VAL . . . . . . . . . . . . . 4.1 t -111.37 135.83 49.36 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.442 0 N-CA-C 106.682 -1.599 . . . . 0.92 106.682 179.202 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A 1549 ' ' TYR . . . . . 0.68 ' HE1' ' HA3' ' A' 1568 ' ' GLY . 95.7 m-85 -93.74 151.38 19.67 Favored 'General case' 0 C--N 1.3 -1.547 0 N-CA-C 106.565 -1.642 . . . . 1.44 106.565 174.129 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A 1550 ' ' MET . . . . . . . . . . . . . 46.0 ttm -144.16 122.38 12.24 Favored 'General case' 0 C--N 1.301 -1.514 0 C-N-CA 120.255 -0.578 . . . . 1.74 111.113 -178.686 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A 1551 ' ' SER . . . . . . . . . . . . . 28.8 p -111.36 122.06 46.86 Favored 'General case' 0 N--CA 1.418 -2.07 0 N-CA-C 108.7 -0.852 . . . . 1.64 108.7 174.932 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A 1552 ' ' ILE . . . . . . . . . . . . . 1.7 mp -62.04 -29.33 46.24 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.342 0 CA-C-N 115.134 -0.939 . . . . 1.33 110.621 179.058 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A 1553 ' ' CYS . . . . . 0.7 ' SG ' ' HE3' ' A' 1579 ' ' LYS . 37.2 t -160.63 141.0 11.45 Favored 'General case' 0 N--CA 1.426 -1.629 0 N-CA-C 108.354 -0.98 . . . . 1.43 108.354 174.797 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A 1554 ' ' GLY . . . . . . . . . . . . . . . 97.43 160.29 31.17 Favored Glycine 0 N--CA 1.443 -0.85 0 O-C-N 123.652 0.595 . . . . 1.12 111.678 -179.003 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A 1555 ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -67.54 127.25 32.04 Favored 'General case' 0 N--CA 1.447 -0.578 0 CA-C-O 121.729 0.776 . . . . 1.8 111.334 178.474 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A 1556 ' ' ASN . . . . . 0.54 HD21 ' HB3' ' A' 1549 ' ' TYR . 3.4 t-20 -75.05 -14.47 60.6 Favored 'General case' 0 C--N 1.299 -1.603 0 C-N-CA 126.328 1.851 . . . . 2.63 114.023 -170.069 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A 1557 ' ' GLU . . . . . 0.456 ' C ' ' H ' ' A' 1559 ' ' CYS . 50.6 mm-40 66.45 -173.61 0.19 Allowed 'General case' 0 N--CA 1.481 1.084 0 C-N-CA 123.237 0.615 . . . . 3.79 110.282 -176.112 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A 1558 ' ' ASN . . . . . . . . . . . . . 42.2 m-80 76.31 -20.9 0.34 Allowed 'General case' 0 N--CA 1.496 1.855 0 C-N-CA 125.659 1.584 . . . . 1.52 111.972 173.467 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A 1559 ' ' CYS . . . . . 0.585 ' HB3' ' HD2' ' A' 1560 ' ' PRO . 63.8 m -142.12 169.63 10.66 Favored Pre-proline 0 C--N 1.282 -2.355 0 N-CA-C 106.491 -1.67 . . . . 0.84 106.491 179.732 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A 1560 ' ' PRO . . . . . 0.585 ' HD2' ' HB3' ' A' 1559 ' ' CYS . 26.8 Cg_exo -32.26 130.26 0.09 OUTLIER 'Trans proline' 0 C--N 1.369 1.608 0 C-N-CA 124.984 3.789 . . . . 1.18 114.983 178.098 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A 1561 ' ' PRO . . . . . 0.427 ' HD3' ' HA ' ' A' 1560 ' ' PRO . 50.5 Cg_exo -56.09 110.83 0.62 Allowed 'Trans proline' 0 C--O 1.242 0.723 0 C-N-CA 123.583 2.855 . . . . 1.51 112.551 179.71 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A 1562 ' ' GLY . . . . . . . . . . . . . . . 141.05 -14.05 2.83 Favored Glycine 0 N--CA 1.442 -0.953 0 C-N-CA 120.526 -0.845 . . . . 0.72 112.519 178.875 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A 1563 ' ' VAL . . . . . 0.489 HG22 ' O ' ' A' 1560 ' ' PRO . 7.3 m -85.24 151.47 3.74 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.309 0 O-C-N 122.488 -0.419 . . . . 0.97 111.617 179.031 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A 1564 ' ' GLY . . . . . 0.421 ' HA3' ' CE2' ' A' 1592 ' ' TYR . . . -117.81 -1.23 17.35 Favored Glycine 0 N--CA 1.433 -1.547 0 N-CA-C 110.911 -0.876 . . . . 0.72 110.911 176.201 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A 1565 ' ' ALA . . . . . . . . . . . . . . . -158.43 119.56 3.43 Favored 'General case' 0 C--O 1.247 0.952 0 N-CA-C 109.552 -0.536 . . . . 0.37 109.552 179.158 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A 1566 ' ' CYS . . . . . . . . . . . . . 48.7 t -154.33 145.77 23.09 Favored 'General case' 0 C--N 1.304 -1.373 0 N-CA-C 109.956 -0.387 . . . . 0.51 109.956 -177.343 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A 1567 ' ' PHE . . . . . . . . . . . . . 66.9 m-85 -71.07 123.26 21.7 Favored 'General case' 0 CA--C 1.511 -0.546 0 N-CA-C 107.412 -1.329 . . . . 0.97 107.412 172.951 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A 1568 ' ' GLY . . . . . 0.68 ' HA3' ' HE1' ' A' 1549 ' ' TYR . . . -73.62 -22.52 78.31 Favored Glycine 0 C--N 1.308 -1.01 0 C-N-CA 120.788 -0.72 . . . . 1.08 114.735 -172.021 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A 1569 ' ' GLN . . . . . . . . . . . . . 10.0 mt-30 -90.53 -55.52 3.55 Favored 'General case' 0 C--N 1.305 -1.349 0 CA-C-O 121.125 0.488 . . . . 2.74 109.98 -177.13 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A 1570 ' ' THR . . . . . . . . . . . . . 21.2 p -81.93 -12.98 58.13 Favored 'General case' 0 CA--C 1.546 0.821 0 N-CA-C 113.691 0.997 . . . . 1.96 113.691 -176.487 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A 1571 ' ' ARG . . . . . 0.405 ' NH2' ' HD3' ' A' 1560 ' ' PRO . 37.0 mtp85 62.91 42.44 7.66 Favored 'General case' 0 N--CA 1.476 0.872 0 C-N-CA 124.263 1.025 . . . . 3.95 112.262 -179.883 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A 1572 ' ' ILE . . . . . . . . . . . . . 30.8 mm -104.49 122.24 57.22 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.241 0 N-CA-C 109.237 -0.653 . . . . 1.37 109.237 -179.149 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A 1573 ' ' SER . . . . . . . . . . . . . 31.9 t -83.24 137.11 34.15 Favored 'General case' 0 C--N 1.303 -1.453 0 C-N-CA 124.364 1.066 . . . . 1.08 111.821 -175.593 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A 1574 ' ' VAL . . . . . . . . . . . . . 11.5 m -140.01 27.48 0.5 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 115.982 -0.553 . . . . 1.3 110.72 175.224 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A 1575 ' ' GLY . . . . . . . . . . . . . . . 178.71 119.54 0.61 Allowed Glycine 0 N--CA 1.434 -1.489 0 C-N-CA 120.016 -1.088 . . . . 0.51 112.921 178.976 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A 1576 ' ' LYS . . . . . . . . . . . . . 22.9 tptm -89.56 137.15 32.57 Favored 'General case' 0 C--N 1.304 -1.409 0 N-CA-C 107.047 -1.464 . . . . 2.9 107.047 176.044 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A 1577 ' ' ALA . . . . . 0.677 ' HA ' ' CE2' ' A' 1592 ' ' TYR . . . -67.56 119.86 13.03 Favored 'General case' 0 C--N 1.322 -0.629 0 N-CA-C 109.379 -0.6 . . . . 0.83 109.379 -178.772 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A 1578 ' ' ASN . . . . . . . . . . . . . 5.7 p30 -157.61 166.83 31.85 Favored 'General case' 0 C--N 1.31 -1.126 0 N-CA-C 107.071 -1.455 . . . . 1.85 107.071 -176.468 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A 1579 ' ' LYS . . . . . 0.7 ' HE3' ' SG ' ' A' 1553 ' ' CYS . 50.9 mttp -122.1 90.07 3.24 Favored 'General case' 0 C--N 1.306 -1.317 0 N-CA-C 109.789 -0.448 . . . . 1.9 109.789 178.179 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A 1580 ' ' ARG . . . . . . . . . . . . . 47.2 ttp180 -138.39 92.46 2.64 Favored 'General case' 0 C--N 1.309 -1.188 0 N-CA-C 106.969 -1.493 . . . . 3.63 106.969 175.178 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A 1581 ' ' LEU . . . . . 0.704 HD11 ' HB ' ' A' 1518 ' ' VAL . 4.6 pp -127.5 158.9 36.18 Favored 'General case' 0 C--N 1.294 -1.826 0 CA-C-N 115.7 -0.682 . . . . 1.87 110.147 -177.675 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A 1582 ' ' ARG . . . . . 0.494 ' HB3' HG13 ' A' 1584 ' ' VAL . 80.4 mtm-85 -139.96 139.09 36.02 Favored 'General case' 0 C--N 1.301 -1.539 0 O-C-N 123.449 0.468 . . . . 3.97 109.885 178.378 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A 1583 ' ' TYR . . . . . 0.444 ' CD1' ' HG ' ' A' 1588 ' ' LEU . 25.4 t80 -99.73 90.44 4.46 Favored 'General case' 0 C--N 1.309 -1.175 0 N-CA-C 106.547 -1.649 . . . . 1.41 106.547 174.256 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A 1584 ' ' VAL . . . . . 0.494 HG13 ' HB3' ' A' 1582 ' ' ARG . 18.3 m -115.89 124.38 72.19 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.948 0 CA-C-N 115.83 -0.623 . . . . 1.69 111.701 -172.475 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A 1585 ' ' ASP . . . . . . . . . . . . . 38.8 t70 56.06 50.51 13.56 Favored 'General case' 0 C--N 1.31 -1.123 0 C-N-CA 123.98 0.912 . . . . 2.06 111.701 177.901 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A 1586 ' ' GLN . . . . . . . . . . . . . 49.2 mt-30 69.75 10.71 7.66 Favored 'General case' 0 N--CA 1.481 1.105 0 CA-C-N 114.8 -1.091 . . . . 2.33 113.853 176.253 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A 1587 ' ' VAL . . . . . 0.489 HG23 ' O ' ' A' 1612 ' ' PHE . 7.4 p -135.61 133.01 51.83 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.517 0 CA-C-O 121.49 0.662 . . . . 0.78 110.895 -179.735 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A 1588 ' ' LEU . . . . . 0.811 ' HB2' ' HB2' ' A' 1612 ' ' PHE . 20.4 mt -80.15 142.74 34.49 Favored 'General case' 0 C--N 1.312 -1.037 0 CA-C-N 115.303 -0.862 . . . . 1.41 110.749 178.037 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A 1589 ' ' GLN . . . . . . . . . . . . . 6.5 tt0 -128.24 106.86 9.32 Favored 'General case' 0 C--N 1.289 -2.051 0 CA-C-N 115.434 -0.803 . . . . 1.24 109.475 -179.481 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A 1590 ' ' LEU . . . . . 0.74 ' HB2' ' HE1' ' A' 1612 ' ' PHE . 21.1 tp -101.54 112.99 25.72 Favored 'General case' 0 C--N 1.314 -0.974 0 N-CA-C 107.022 -1.473 . . . . 1.15 107.022 178.636 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A 1591 ' ' VAL . . . . . 0.522 HG22 HG22 ' A' 1609 ' ' VAL . 61.1 t -105.96 107.84 23.63 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.381 0 C-N-CA 120.107 -0.637 . . . . 1.51 112.248 -175.824 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A 1592 ' ' TYR . . . . . 0.677 ' CE2' ' HA ' ' A' 1577 ' ' ALA . 5.0 m-85 -102.89 92.84 4.75 Favored 'General case' 0 C--N 1.297 -1.691 0 CA-C-O 121.907 0.86 . . . . 1.06 108.74 173.587 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A 1593 ' ' LYS . . . . . 0.54 ' HA ' ' HA ' ' A' 1607 ' ' LYS . 18.0 pttp -104.5 -175.44 2.8 Favored 'General case' 0 C--N 1.291 -1.948 0 CA-C-N 114.152 -1.385 . . . . 2.18 108.285 -178.433 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A 1594 ' ' ASP . . . . . . . . . . . . . 1.6 m-20 63.67 72.5 0.47 Allowed 'General case' 0 CA--C 1.512 -0.501 0 O-C-N 124.072 0.857 . . . . 1.45 112.17 177.969 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A 1595 ' ' GLY . . . . . . . . . . . . . . . -110.11 -113.56 3.52 Favored Glycine 0 N--CA 1.425 -2.04 0 N-CA-C 109.659 -1.376 . . . . 0.78 109.659 176.159 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A 1596 ' ' SER . . . . . . . . . . . . . 33.4 p -104.53 158.03 32.84 Favored Pre-proline 0 C--N 1.29 -1.988 0 N-CA-C 108.866 -0.79 . . . . 1.68 108.866 177.915 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A 1597 ' ' PRO . . . . . . . . . . . . . 36.9 Cg_exo -59.45 137.2 76.59 Favored 'Trans proline' 0 C--N 1.353 0.815 0 C-N-CA 122.757 2.305 . . . . 1.17 112.004 178.869 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A 1598 ' ' CYS . . . . . . . . . . . . . 42.7 t -95.82 115.16 65.33 Favored Pre-proline 0 C--N 1.299 -1.621 0 CA-C-N 115.899 -0.591 . . . . 1.19 110.034 -178.711 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A 1599 ' ' PRO . . . . . 0.528 ' HD2' ' OH ' ' A' 1606 ' ' TYR . 44.2 Cg_endo -69.36 -15.63 38.73 Favored 'Trans proline' 0 CA--C 1.535 0.525 0 C-N-CA 122.591 2.194 . . . . 1.59 112.625 -179.119 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A 1600 ' ' SER . . . . . . . . . . . . . 21.0 m -80.16 -13.16 59.47 Favored 'General case' 0 C--O 1.249 1.058 0 CA-C-N 116.157 -0.474 . . . . 2.12 111.876 -178.261 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A 1601 ' ' LYS . . . . . 0.825 ' HG2' HD12 ' A' 1604 ' ' LEU . 16.1 tppt? -156.2 110.65 2.82 Favored 'General case' 0 N--CA 1.442 -0.83 0 N-CA-C 108.83 -0.804 . . . . 3.74 108.83 179.405 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A 1602 ' ' SER . . . . . . . . . . . . . 8.4 m -59.61 109.84 1.0 Allowed 'General case' 0 C--N 1.296 -1.73 0 C-N-CA 124.185 0.994 . . . . 3.79 111.1 -176.991 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A 1603 ' ' GLY . . . . . . . . . . . . . . . 108.22 -17.84 34.07 Favored Glycine 0 N--CA 1.441 -0.971 0 C-N-CA 120.701 -0.762 . . . . 2.0 112.495 177.584 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A 1604 ' ' LEU . . . . . 0.825 HD12 ' HG2' ' A' 1601 ' ' LYS . 1.1 mt -86.89 146.02 26.35 Favored 'General case' 0 C--N 1.308 -1.23 0 CA-C-O 121.15 0.5 . . . . 1.48 110.838 -178.849 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A 1605 ' ' SER . . . . . . . . . . . . . 22.8 t -108.21 -175.05 2.67 Favored 'General case' 0 N--CA 1.424 -1.747 0 N-CA-C 106.336 -1.728 . . . . 1.51 106.336 173.378 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A 1606 ' ' TYR . . . . . 0.528 ' OH ' ' HD2' ' A' 1599 ' ' PRO . 78.6 m-85 -107.46 135.7 48.49 Favored 'General case' 0 CA--C 1.46 -2.485 0 N-CA-C 107.705 -1.22 . . . . 1.18 107.705 -176.452 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A 1607 ' ' LYS . . . . . 0.54 ' HA ' ' HA ' ' A' 1593 ' ' LYS . 24.6 pttm -122.31 134.54 54.66 Favored 'General case' 0 N--CA 1.398 -3.062 0 C-N-CA 118.592 -1.243 . . . . 1.67 110.433 176.835 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A 1608 ' ' SER . . . . . . . . . . . . . 47.1 m -101.56 111.15 23.3 Favored 'General case' 0 C--N 1.28 -2.452 0 CA-C-N 115.17 -0.923 . . . . 1.0 108.543 176.857 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A 1609 ' ' VAL . . . . . 0.522 HG22 HG22 ' A' 1591 ' ' VAL . 56.4 t -98.09 112.56 30.45 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.107 0 N-CA-C 109.48 -0.563 . . . . 0.93 109.48 177.568 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A 1610 ' ' ILE . . . . . 0.593 ' HB ' ' HB3' ' A' 1590 ' ' LEU . 2.5 mp -93.46 104.72 16.04 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.649 0 N-CA-C 107.521 -1.289 . . . . 0.78 107.521 177.353 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A 1611 ' ' SER . . . . . 0.402 ' O ' ' HA ' ' A' 1639 ' ' SER . 22.8 t -90.72 117.41 29.34 Favored 'General case' 0 C--N 1.293 -1.864 0 N-CA-C 108.387 -0.968 . . . . 1.29 108.387 -179.735 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A 1612 ' ' PHE . . . . . 0.811 ' HB2' ' HB2' ' A' 1588 ' ' LEU . 50.7 m-85 -92.15 102.22 14.74 Favored 'General case' 0 C--N 1.31 -1.126 0 N-CA-C 108.985 -0.746 . . . . 0.7 108.985 -179.651 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A 1613 ' ' VAL . . . . . . . . . . . . . 47.8 t -100.53 127.59 53.44 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.51 0 N-CA-C 107.821 -1.177 . . . . 0.75 107.821 -177.881 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A 1614 ' ' CYS . . . . . 0.648 ' HA ' ' O ' ' A' 1642 ' ' THR . 8.3 t -71.45 106.4 3.93 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-O 121.28 0.562 . . . . 1.39 111.618 -176.657 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A 1615 ' ' ARG . . . . . 0.775 ' HB2' ' HB3' ' A' 1641 ' ' HIS . 37.2 mmt180 -137.09 85.2 22.91 Favored Pre-proline 0 N--CA 1.433 -1.306 0 CA-C-N 115.228 -0.896 . . . . 3.75 110.462 177.048 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A 1616 ' ' PRO . . . . . . . . . . . . . 48.5 Cg_exo -61.22 -16.61 47.59 Favored 'Trans proline' 0 N--CA 1.482 0.801 0 C-N-CA 122.942 2.428 . . . . 1.32 111.481 174.444 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A 1617 ' ' GLU . . . . . 0.405 ' CD ' ' HD2' ' A' 1615 ' ' ARG . 8.6 pt-20 . . . . . 0 C--N 1.318 -0.765 0 C-N-CA 123.886 0.874 . . . . 3.21 112.345 178.328 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A 1622 ' ' ASN . . . . . . . . . . . . . 50.0 t-20 . . . . . 0 C--O 1.245 0.856 0 N-CA-C 108.878 -0.786 . . . . 2.92 108.878 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A 1623 ' ' ARG . . . . . . . . . . . . . 19.0 ptp180 -155.42 161.38 29.58 Favored Pre-proline 0 C--O 1.247 0.94 0 N-CA-C 108.131 -1.063 . . . . 3.61 108.131 -179.67 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A 1624 ' ' PRO . . . . . . . . . . . . . 7.7 Cg_exo -73.42 94.7 0.84 Allowed 'Trans proline' 0 N--CA 1.458 -0.595 0 C-N-CA 122.747 2.298 . . . . 2.37 111.566 177.476 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A 1625 ' ' MET . . . . . . . . . . . . . 20.5 ptp -81.64 150.12 28.24 Favored 'General case' 0 C--N 1.313 -1.011 0 CA-C-N 115.646 -0.706 . . . . 2.16 109.797 179.735 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A 1626 ' ' LEU . . . . . . . . . . . . . 47.3 tp -90.35 105.25 17.69 Favored 'General case' 0 C--N 1.304 -1.389 0 N-CA-C 108.194 -1.039 . . . . 1.35 108.194 179.101 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A 1627 ' ' ILE . . . . . . . . . . . . . 44.7 pt -85.7 -38.07 12.52 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.331 0 N-CA-C 112.119 0.414 . . . . 1.21 112.119 -175.428 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A 1628 ' ' SER . . . . . . . . . . . . . 19.4 t -148.95 150.91 33.69 Favored 'General case' 0 N--CA 1.432 -1.34 0 N-CA-C 109.036 -0.727 . . . . 1.4 109.036 -177.426 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A 1629 ' ' LEU . . . . . 1.0 ' HG ' ' HG ' ' A' 1636 ' ' LEU . 3.1 tt -141.83 116.19 9.53 Favored 'General case' 0 C--N 1.303 -1.446 0 N-CA-C 106.682 -1.599 . . . . 1.56 106.682 179.798 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A 1630 ' ' ASP . . . . . . . . . . . . . 33.2 t70 -109.27 119.84 40.7 Favored 'General case' 0 C--N 1.294 -1.833 0 N-CA-C 109.444 -0.576 . . . . 0.87 109.444 176.723 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A 1631 ' ' LYS . . . . . . . . . . . . . 30.1 mtpp -77.35 -24.93 50.63 Favored 'General case' 0 C--N 1.3 -1.564 0 CA-C-N 115.592 -0.731 . . . . 2.35 111.272 -175.913 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A 1632 ' ' GLN . . . . . . . . . . . . . 39.6 mt-30 -68.57 -44.52 74.26 Favored 'General case' 0 CA--C 1.515 -0.381 0 CA-C-O 121.397 0.618 . . . . 2.55 110.519 -176.317 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A 1633 ' ' THR . . . . . . . . . . . . . 25.1 p -90.42 -4.4 57.04 Favored 'General case' 0 C--N 1.31 -1.146 0 CA-C-N 115.516 -0.765 . . . . 1.24 110.797 177.347 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A 1634 ' ' CYS . . . . . 0.491 ' O ' ' HA ' ' A' 1606 ' ' TYR . 29.3 m 56.98 41.97 26.9 Favored 'General case' 0 C--O 1.221 -0.41 0 CA-C-N 114.288 -1.324 . . . . 0.89 109.503 179.061 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A 1635 ' ' THR . . . . . . . . . . . . . 89.3 m -124.11 131.32 53.53 Favored 'General case' 0 N--CA 1.428 -1.537 0 CA-C-N 115.226 -0.897 . . . . 0.75 111.389 -173.217 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A 1636 ' ' LEU . . . . . 1.0 ' HG ' ' HG ' ' A' 1629 ' ' LEU . 5.2 mp -108.66 130.74 55.33 Favored 'General case' 0 N--CA 1.432 -1.353 0 N-CA-C 108.567 -0.901 . . . . 1.33 108.567 177.626 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A 1637 ' ' PHE . . . . . . . . . . . . . 94.3 m-85 -105.76 105.95 16.23 Favored 'General case' 0 C--N 1.308 -1.204 0 CA-C-O 121.069 0.461 . . . . 0.83 110.953 -177.489 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A 1638 ' ' PHE . . . . . 0.4 ' HB2' ' HA ' ' A' 1610 ' ' ILE . 99.6 m-85 -100.79 148.0 25.42 Favored 'General case' 0 C--N 1.303 -1.416 0 N-CA-C 108.4 -0.963 . . . . 0.6 108.4 177.681 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A 1639 ' ' SER . . . . . 0.402 ' HA ' ' O ' ' A' 1611 ' ' SER . 66.2 m -137.33 115.1 11.34 Favored 'General case' 0 C--N 1.281 -2.382 0 CA-C-O 121.445 0.64 . . . . 1.08 110.703 176.984 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A 1640 ' ' TRP . . . . . 0.575 ' HH2' HD22 ' A' 1532 ' ' LEU . 7.9 t90 -95.93 122.14 38.42 Favored 'General case' 0 N--CA 1.418 -2.05 0 N-CA-C 106.569 -1.641 . . . . 0.8 106.569 178.434 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A 1641 ' ' HIS . . . . . 0.775 ' HB3' ' HB2' ' A' 1615 ' ' ARG . 40.6 m80 -95.09 102.99 14.83 Favored 'General case' 0 C--N 1.285 -2.206 0 N-CA-C 107.633 -1.247 . . . . 2.54 107.633 178.206 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A 1642 ' ' THR . . . . . 0.648 ' O ' ' HA ' ' A' 1614 ' ' CYS . 8.9 t -142.42 140.2 18.62 Favored Pre-proline 0 C--N 1.297 -1.678 0 CA-C-N 115.45 -0.795 . . . . 1.15 111.21 -173.134 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A 1643 ' ' PRO . . . . . . . . . . . . . 57.4 Cg_endo -71.46 -0.82 8.78 Favored 'Trans proline' 0 CA--C 1.534 0.494 0 C-N-CA 123.621 2.881 . . . . 0.8 112.451 176.865 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A 1644 ' ' LEU . . . . . . . . . . . . . 77.5 mt -85.4 -4.33 59.13 Favored 'General case' 0 C--N 1.322 -0.613 0 C-N-CA 122.62 0.368 . . . . 1.54 111.113 -179.085 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A 1645 ' ' ALA . . . . . . . . . . . . . . . -88.84 -13.87 38.26 Favored 'General case' 0 C--N 1.319 -0.725 0 N-CA-C 111.984 0.364 . . . . 0.95 111.984 -178.129 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A 1646 ' ' CYS . . . . . . . . . . . . . 14.3 p -148.02 -177.04 5.52 Favored 'General case' 0 C--N 1.304 -1.386 0 N-CA-C 107.137 -1.431 . . . . 1.41 107.137 -179.27 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A 1647 ' ' GLU . . . . . . . . . . . . . 9.8 tp10 . . . . . 0 N--CA 1.428 -1.526 0 N-CA-C 107.891 -1.151 . . . . 2.92 107.891 174.643 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A 1515 ' ' ASP . . . . . . . . . . . . . 4.1 t70 . . . . . 0 N--CA 1.445 -0.7 0 N-CA-C 108.548 -0.908 . . . . 2.54 108.548 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A 1516 ' ' CYS . . . . . . . . . . . . . 52.0 m -115.67 44.56 1.86 Allowed 'General case' 0 C--N 1.29 -2.007 0 N-CA-C 108.35 -0.982 . . . . 1.25 108.35 -176.811 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A 1517 ' ' GLN . . . . . . . . . . . . . 10.6 pt20 -148.47 138.07 22.12 Favored 'General case' 0 N--CA 1.433 -1.282 0 C-N-CA 120.79 -0.364 . . . . 1.88 111.054 -176.948 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A 1518 ' ' VAL . . . . . . . . . . . . . 29.4 m -113.87 154.06 15.31 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.668 0 CA-C-N 115.744 -0.662 . . . . 1.73 109.945 179.551 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A 1519 ' ' THR . . . . . 0.521 ' HA ' ' HA ' ' A' 1526 ' ' LEU . 32.0 m -119.61 137.76 53.66 Favored 'General case' 0 C--N 1.277 -2.544 0 N-CA-C 109.037 -0.727 . . . . 1.7 109.037 177.354 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A 1520 ' ' ASN . . . . . . . . . . . . . 38.3 t-20 -93.78 101.61 6.41 Favored Pre-proline 0 C--N 1.315 -0.895 0 N-CA-C 107.416 -1.327 . . . . 2.12 107.416 175.139 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A 1521 ' ' PRO . . . . . 0.466 ' HD3' ' O ' ' A' 1519 ' ' THR . 23.4 Cg_exo -65.71 -14.07 42.91 Favored 'Trans proline' 0 C--N 1.36 1.165 0 C-N-CA 123.205 2.603 . . . . 2.47 113.802 -176.772 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A 1522 ' ' SER . . . . . . . . . . . . . 33.3 t -71.24 -38.39 71.95 Favored 'General case' 0 N--CA 1.439 -0.977 0 N-CA-C 109.746 -0.464 . . . . 2.57 109.746 178.759 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A 1523 ' ' THR . . . . . . . . . . . . . 7.2 t -112.37 -16.53 12.91 Favored 'General case' 0 C--N 1.317 -0.827 0 N-CA-C 112.766 0.654 . . . . 2.15 112.766 -177.116 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A 1524 ' ' GLY . . . . . . . . . . . . . . . 81.66 14.54 77.77 Favored Glycine 0 C--O 1.229 -0.172 0 C-N-CA 120.984 -0.627 . . . . 1.89 111.591 -178.764 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A 1525 ' ' HIS . . . . . . . . . . . . . 32.5 t-80 -101.45 131.99 47.28 Favored 'General case' 0 C--N 1.306 -1.318 0 CA-C-O 121.077 0.465 . . . . 1.9 110.187 -178.925 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A 1526 ' ' LEU . . . . . 0.521 ' HA ' ' HA ' ' A' 1519 ' ' THR . 7.8 tt -101.52 143.37 31.6 Favored 'General case' 0 C--N 1.289 -2.038 0 CA-C-N 115.329 -0.851 . . . . 1.61 110.211 -178.166 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A 1527 ' ' PHE . . . . . 0.416 ' HE1' ' HG3' ' A' 1647 ' ' GLU . 80.0 m-85 -118.09 113.08 21.07 Favored 'General case' 0 C--N 1.312 -1.032 0 N-CA-C 107.291 -1.374 . . . . 1.42 107.291 176.524 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A 1528 ' ' ASP . . . . . . . . . . . . . 1.3 p-10 -104.79 141.61 36.19 Favored 'General case' 0 C--N 1.297 -1.714 0 CA-C-O 121.955 0.883 . . . . 2.18 110.938 -178.441 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A 1529 ' ' LEU . . . . . . . . . . . . . 75.7 mt -114.16 11.19 17.48 Favored 'General case' 0 C--N 1.287 -2.13 0 N-CA-C 105.7 -1.963 . . . . 1.44 105.7 173.253 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A 1530 ' ' SER . . . . . . . . . . . . . 5.5 m -73.44 -37.32 65.88 Favored 'General case' 0 N--CA 1.43 -1.435 0 CA-C-N 114.166 -1.379 . . . . 1.44 109.323 -178.977 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A 1531 ' ' SER . . . . . . . . . . . . . 12.8 m -79.85 -7.95 59.01 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-O 121.466 0.651 . . . . 1.5 109.33 175.324 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A 1532 ' ' LEU . . . . . . . . . . . . . 92.8 mt -106.83 9.15 31.01 Favored 'General case' 0 N--CA 1.448 -0.565 0 CA-C-N 115.669 -0.696 . . . . 1.77 110.514 177.017 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A 1533 ' ' SER . . . . . . . . . . . . . 66.0 m -70.94 107.52 4.1 Favored 'General case' 0 N--CA 1.437 -1.081 0 CA-C-O 121.733 0.778 . . . . 2.38 111.577 -175.447 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A 1534 ' ' GLY . . . . . 0.402 ' HA3' ' CE2' ' A' 1538 ' ' PHE . . . -103.23 103.0 2.3 Favored Glycine 0 N--CA 1.423 -2.202 0 N-CA-C 109.632 -1.387 . . . . 1.55 109.632 176.607 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A 1535 ' ' ARG . . . . . . . . . . . . . 71.4 ttt180 -79.27 -20.66 47.55 Favored 'General case' 0 C--O 1.205 -1.257 0 O-C-N 124.205 0.591 . . . . 3.96 111.114 -176.732 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A 1536 ' ' ALA . . . . . . . . . . . . . . . -90.59 -3.21 57.72 Favored 'General case' 0 C--N 1.309 -1.166 0 C-N-CA 119.643 -0.823 . . . . 1.65 109.39 178.979 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A 1537 ' ' GLY . . . . . 0.434 ' HA2' ' HA ' ' A' 1551 ' ' SER . . . 79.13 166.07 30.85 Favored Glycine 0 N--CA 1.423 -2.214 0 CA-C-N 114.855 -1.066 . . . . 1.19 113.123 177.932 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A 1538 ' ' PHE . . . . . 0.402 ' CE2' ' HA3' ' A' 1534 ' ' GLY . 97.1 m-85 -133.73 163.43 29.48 Favored 'General case' 0 C--N 1.297 -1.678 0 N-CA-C 107.472 -1.307 . . . . 1.69 107.472 176.507 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A 1539 ' ' THR . . . . . 0.512 ' HA ' ' O ' ' A' 1548 ' ' VAL . 59.4 p -118.06 157.73 26.31 Favored 'General case' 0 C--N 1.303 -1.422 0 N-CA-C 113.335 0.865 . . . . 1.48 113.335 -172.315 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A 1540 ' ' ALA . . . . . . . . . . . . . . . -142.55 146.13 34.32 Favored 'General case' 0 C--O 1.25 1.131 0 N-CA-C 106.685 -1.598 . . . . 0.83 106.685 173.628 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A 1541 ' ' ALA . . . . . . . . . . . . . . . -65.05 131.65 47.14 Favored 'General case' 0 C--O 1.247 0.952 0 O-C-N 124.222 0.951 . . . . 1.27 110.611 -178.571 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A 1542 ' ' TYR . . . . . . . . . . . . . 81.0 t80 -143.34 171.14 14.52 Favored 'General case' 0 C--N 1.3 -1.585 0 CA-C-N 115.427 -0.806 . . . . 2.15 109.343 -177.264 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A 1543 ' ' SER . . . . . . . . . . . . . 14.0 m -44.28 -151.62 0.0 OUTLIER 'General case' 0 CA--C 1.581 2.165 0 C-N-CA 129.728 3.211 . . . . 2.29 114.961 176.327 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A 1544 ' ' LYS . . . . . . . . . . . . . 39.9 ttmt -36.03 -39.24 0.16 Allowed 'General case' 0 CA--C 1.568 1.665 0 C-N-CA 125.217 1.407 . . . . 3.91 114.143 178.149 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A 1545 ' ' SER . . . . . . . . . . . . . 48.3 t -66.45 -21.73 66.2 Favored 'General case' 0 CA--C 1.56 1.332 0 N-CA-C 112.329 0.492 . . . . 3.3 112.329 177.462 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A 1546 ' ' GLY . . . . . . . . . . . . . . . 88.75 -63.8 3.51 Favored Glycine 0 CA--C 1.492 -1.345 0 N-CA-C 111.455 -0.658 . . . . 1.24 111.455 179.999 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A 1547 ' ' VAL . . . . . . . . . . . . . 13.3 m -140.58 157.87 24.22 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.416 0 C-N-CA 123.205 0.602 . . . . 1.63 109.874 178.318 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A 1548 ' ' VAL . . . . . 0.512 ' O ' ' HA ' ' A' 1539 ' ' THR . 5.7 t -111.98 142.7 23.55 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.28 0 N-CA-C 106.598 -1.63 . . . . 0.92 106.598 176.388 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A 1549 ' ' TYR . . . . . 0.515 ' CD2' ' HA2' ' A' 1568 ' ' GLY . 62.2 m-85 -98.4 114.91 27.43 Favored 'General case' 0 C--N 1.31 -1.152 0 N-CA-C 108.08 -1.082 . . . . 1.44 108.08 173.509 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A 1550 ' ' MET . . . . . . . . . . . . . 65.4 mtm -128.6 133.15 48.23 Favored 'General case' 0 C--N 1.299 -1.603 0 N-CA-C 109.448 -0.575 . . . . 1.74 109.448 176.543 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A 1551 ' ' SER . . . . . 0.434 ' HA ' ' HA2' ' A' 1537 ' ' GLY . 23.8 p -86.3 147.8 25.9 Favored 'General case' 0 C--N 1.289 -2.048 0 N-CA-C 106.658 -1.608 . . . . 1.64 106.658 175.983 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A 1552 ' ' ILE . . . . . . . . . . . . . 35.7 mm -76.41 -29.72 19.0 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.978 0 N-CA-C 108.77 -0.826 . . . . 1.33 108.77 -178.706 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A 1553 ' ' CYS . . . . . . . . . . . . . 38.2 t -162.94 138.38 6.82 Favored 'General case' 0 N--CA 1.432 -1.344 0 N-CA-C 107.519 -1.289 . . . . 1.43 107.519 169.398 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A 1554 ' ' GLY . . . . . . . . . . . . . . . 96.13 -164.93 23.81 Favored Glycine 0 N--CA 1.438 -1.205 0 C-N-CA 120.781 -0.724 . . . . 1.12 112.802 176.05 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A 1555 ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -76.43 156.17 33.34 Favored 'General case' 0 C--N 1.312 -1.046 0 C-N-CA 122.622 0.369 . . . . 1.8 110.028 -179.734 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A 1556 ' ' ASN . . . . . 0.431 HD21 ' HB3' ' A' 1549 ' ' TYR . 27.5 t-20 -98.31 -17.66 18.77 Favored 'General case' 0 CA--C 1.548 0.874 0 N-CA-C 113.413 0.894 . . . . 2.63 113.413 -173.719 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A 1557 ' ' GLU . . . . . . . . . . . . . 30.1 mt-10 65.66 -24.04 0.09 Allowed 'General case' 0 N--CA 1.492 1.656 0 N-CA-C 115.376 1.621 . . . . 3.79 115.376 179.738 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A 1558 ' ' ASN . . . . . . . . . . . . . 38.6 m-80 -75.64 -21.4 57.75 Favored 'General case' 0 CA--C 1.503 -0.834 0 CA-C-O 121.731 0.777 . . . . 1.52 109.11 177.133 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A 1559 ' ' CYS . . . . . . . . . . . . . 73.4 m -135.05 158.38 74.98 Favored Pre-proline 0 N--CA 1.423 -1.802 0 N-CA-C 106.66 -1.608 . . . . 0.84 106.66 176.731 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A 1560 ' ' PRO . . . . . 0.487 ' HA ' ' HD3' ' A' 1561 ' ' PRO . 3.0 Cg_exo -32.82 145.52 0.03 OUTLIER 'Trans proline' 0 CA--C 1.561 1.832 1 C-N-CA 125.859 4.373 . . . . 1.18 117.014 -176.186 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A 1561 ' ' PRO . . . . . 0.487 ' HD3' ' HA ' ' A' 1560 ' ' PRO . 42.5 Cg_exo -59.37 115.08 2.34 Favored 'Trans proline' 0 C--O 1.245 0.834 0 C-N-CA 123.43 2.753 . . . . 1.51 110.421 176.827 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A 1562 ' ' GLY . . . . . . . . . . . . . . . 121.79 -11.42 9.49 Favored Glycine 0 N--CA 1.426 -1.974 0 N-CA-C 110.174 -1.17 . . . . 0.72 110.174 -176.086 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A 1563 ' ' VAL . . . . . . . . . . . . . 66.2 t -99.29 133.88 40.42 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.275 0 N-CA-C 108.005 -1.109 . . . . 0.97 108.005 176.224 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A 1564 ' ' GLY . . . . . . . . . . . . . . . -114.54 -34.53 1.56 Allowed Glycine 0 N--CA 1.443 -0.89 0 C-N-CA 120.916 -0.659 . . . . 0.72 111.78 -179.319 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A 1565 ' ' ALA . . . . . . . . . . . . . . . -123.09 121.08 35.14 Favored 'General case' 0 C--O 1.249 1.043 0 N-CA-C 108.871 -0.789 . . . . 0.37 108.871 -179.753 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A 1566 ' ' CYS . . . . . . . . . . . . . 38.6 t -146.45 140.88 26.58 Favored 'General case' 0 C--N 1.297 -1.709 0 N-CA-C 108.964 -0.754 . . . . 0.51 108.964 -173.953 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A 1567 ' ' PHE . . . . . 0.459 ' O ' ' HA ' ' A' 1571 ' ' ARG . 16.3 m-85 -63.23 132.76 52.75 Favored 'General case' 0 C--O 1.21 -1.01 0 N-CA-C 108.518 -0.919 . . . . 0.97 108.518 177.174 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A 1568 ' ' GLY . . . . . 0.515 ' HA2' ' CD2' ' A' 1549 ' ' TYR . . . -68.99 -36.0 80.21 Favored Glycine 0 N--CA 1.435 -1.387 0 CA-C-N 115.752 -0.658 . . . . 1.08 114.622 -174.164 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A 1569 ' ' GLN . . . . . . . . . . . . . 36.1 tt0 -90.44 -53.89 4.24 Favored 'General case' 0 C--N 1.303 -1.43 0 CA-C-O 121.671 0.748 . . . . 2.74 110.261 -179.393 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A 1570 ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -74.96 -20.06 59.84 Favored 'General case' 0 C--N 1.298 -1.641 0 CA-C-N 114.836 -1.075 . . . . 1.96 112.783 -172.971 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A 1571 ' ' ARG . . . . . 0.459 ' HA ' ' O ' ' A' 1567 ' ' PHE . 50.8 mtp180 54.36 36.37 25.22 Favored 'General case' 0 CA--C 1.51 -0.58 0 C-N-CA 125.814 1.646 . . . . 3.95 113.589 179.633 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A 1572 ' ' ILE . . . . . . . . . . . . . 43.6 mm -94.96 123.89 47.26 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.286 0 N-CA-C 108.893 -0.78 . . . . 1.37 108.893 178.079 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A 1573 ' ' SER . . . . . . . . . . . . . 31.5 t -65.44 95.71 0.22 Allowed 'General case' 0 C--N 1.307 -1.266 0 C-N-CA 125.309 1.444 . . . . 1.08 111.207 179.94 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A 1574 ' ' VAL . . . . . 0.482 ' O ' ' HA3' ' A' 1595 ' ' GLY . 27.6 m -88.17 -30.94 5.55 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.871 0 N-CA-C 112.327 0.491 . . . . 1.3 112.327 179.099 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A 1575 ' ' GLY . . . . . . . . . . . . . . . -136.58 132.25 5.98 Favored Glycine 0 C--O 1.246 0.85 0 C-N-CA 120.858 -0.687 . . . . 0.51 112.177 179.816 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A 1576 ' ' LYS . . . . . 0.603 ' HG2' ' HA2' ' A' 1595 ' ' GLY . 75.5 mmtt -88.77 149.37 23.47 Favored 'General case' 0 C--N 1.312 -1.049 0 N-CA-C 109.859 -0.423 . . . . 2.9 109.859 -179.894 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A 1577 ' ' ALA . . . . . . . . . . . . . . . -67.07 98.87 0.61 Allowed 'General case' 0 C--N 1.307 -1.278 0 C-N-CA 123.976 0.91 . . . . 0.83 110.913 -178.195 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A 1578 ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -113.49 120.34 40.67 Favored 'General case' 0 C--N 1.306 -1.299 0 N-CA-C 108.504 -0.925 . . . . 1.85 108.504 177.261 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A 1579 ' ' LYS . . . . . . . . . . . . . 48.9 mtmt -90.96 90.55 7.93 Favored 'General case' 0 C--N 1.307 -1.254 0 N-CA-C 107.294 -1.372 . . . . 1.9 107.294 177.621 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A 1580 ' ' ARG . . . . . . . . . . . . . 17.7 ttp180 -165.84 110.98 0.85 Allowed 'General case' 0 C--N 1.309 -1.192 0 CA-C-N 115.309 -0.859 . . . . 3.63 110.246 -175.216 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A 1581 ' ' LEU . . . . . . . . . . . . . 3.9 mm? -101.77 137.28 40.29 Favored 'General case' 0 C--N 1.316 -0.877 0 CA-C-N 115.888 -0.596 . . . . 1.87 109.563 178.592 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A 1582 ' ' ARG . . . . . . . . . . . . . 90.4 mtt180 -108.68 98.31 7.83 Favored 'General case' 0 C--N 1.291 -1.957 0 CA-C-N 116.374 -0.375 . . . . 3.97 110.254 177.057 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A 1583 ' ' TYR . . . . . . . . . . . . . 92.8 t80 -79.84 110.13 14.92 Favored 'General case' 0 C--N 1.311 -1.098 0 CA-C-N 115.477 -0.783 . . . . 1.41 109.153 -179.615 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A 1584 ' ' VAL . . . . . 0.62 ' O ' HG12 ' A' 1587 ' ' VAL . 3.9 p -148.36 126.4 3.24 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.419 0 CA-C-N 116.17 -0.468 . . . . 1.69 110.076 179.703 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A 1585 ' ' ASP . . . . . . . . . . . . . 38.4 t70 54.34 44.65 28.64 Favored 'General case' 0 N--CA 1.484 1.244 0 CA-C-O 122.748 1.261 . . . . 2.06 109.951 -177.894 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A 1586 ' ' GLN . . . . . . . . . . . . . 48.4 mt-30 59.79 18.41 7.29 Favored 'General case' 0 CA--C 1.539 0.545 0 CA-C-N 113.632 -1.622 . . . . 2.33 114.32 179.141 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A 1587 ' ' VAL . . . . . 0.62 HG12 ' O ' ' A' 1584 ' ' VAL . 4.0 p -103.78 139.64 24.16 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.146 0 N-CA-C 108.568 -0.901 . . . . 0.78 108.568 176.733 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A 1588 ' ' LEU . . . . . 0.725 ' HB2' ' HB2' ' A' 1612 ' ' PHE . 41.1 mt -94.27 123.83 37.91 Favored 'General case' 0 C--N 1.296 -1.732 0 N-CA-C 106.187 -1.783 . . . . 1.41 106.187 174.179 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A 1589 ' ' GLN . . . . . . . . . . . . . 9.8 tt0 -122.4 112.96 18.72 Favored 'General case' 0 C--N 1.281 -2.398 0 CA-C-N 116.398 -0.365 . . . . 1.24 110.094 -173.864 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A 1590 ' ' LEU . . . . . 0.433 ' HB3' ' HB ' ' A' 1610 ' ' ILE . 32.8 tp -100.7 116.48 32.71 Favored 'General case' 0 C--N 1.299 -1.59 0 N-CA-C 107.078 -1.452 . . . . 1.15 107.078 -179.659 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A 1591 ' ' VAL . . . . . . . . . . . . . 15.4 m -106.94 94.82 3.33 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.565 0 N-CA-C 113.803 1.038 . . . . 1.51 113.803 -174.884 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A 1592 ' ' TYR . . . . . . . . . . . . . 14.7 m-30 -86.5 92.92 9.02 Favored 'General case' 0 C--N 1.312 -1.035 0 N-CA-C 107.811 -1.181 . . . . 1.06 107.811 173.435 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A 1593 ' ' LYS . . . . . . . . . . . . . 14.6 ptmm? -115.43 175.08 5.68 Favored 'General case' 0 C--N 1.293 -1.868 0 CA-C-N 115.951 -0.568 . . . . 2.18 111.588 -174.874 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A 1594 ' ' ASP . . . . . . . . . . . . . 8.9 m-20 62.86 31.32 16.41 Favored 'General case' 0 CA--C 1.509 -0.613 0 O-C-N 124.17 0.919 . . . . 1.45 112.154 -178.799 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A 1595 ' ' GLY . . . . . 0.603 ' HA2' ' HG2' ' A' 1576 ' ' LYS . . . -78.58 -84.93 0.54 Allowed Glycine 0 N--CA 1.435 -1.402 0 C-N-CA 120.855 -0.688 . . . . 0.78 112.624 -178.004 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A 1596 ' ' SER . . . . . . . . . . . . . 14.4 t -101.58 145.17 29.98 Favored Pre-proline 0 C--N 1.293 -1.87 0 N-CA-C 108.498 -0.927 . . . . 1.68 108.498 -177.75 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A 1597 ' ' PRO . . . . . . . . . . . . . 24.2 Cg_exo -67.99 131.78 24.73 Favored 'Trans proline' 0 C--O 1.238 0.5 0 C-N-CA 122.785 2.323 . . . . 1.17 110.371 175.252 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A 1598 ' ' CYS . . . . . 0.738 ' HA ' ' HE1' ' A' 1606 ' ' TYR . 40.6 t -95.09 123.09 58.35 Favored Pre-proline 0 C--N 1.304 -1.392 0 CA-C-O 120.767 0.318 . . . . 1.19 110.476 -176.634 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A 1599 ' ' PRO . . . . . . . . . . . . . 91.2 Cg_endo -88.44 -9.36 5.02 Favored 'Trans proline' 0 N--CA 1.454 -0.851 0 C-N-CA 122.798 2.332 . . . . 1.59 112.913 179.799 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A 1600 ' ' SER . . . . . . . . . . . . . 14.9 m -70.31 -21.87 62.88 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-O 121.101 0.477 . . . . 2.12 110.77 -177.795 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A 1601 ' ' LYS . . . . . 0.942 ' HB3' HD12 ' A' 1604 ' ' LEU . 25.7 tptp -161.0 132.08 5.43 Favored 'General case' 0 N--CA 1.43 -1.444 0 N-CA-C 106.257 -1.757 . . . . 3.74 106.257 178.429 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A 1602 ' ' SER . . . . . . . . . . . . . 16.4 m -73.34 126.82 31.02 Favored 'General case' 0 C--N 1.307 -1.249 0 CA-C-O 120.884 0.373 . . . . 3.79 110.268 -176.763 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A 1603 ' ' GLY . . . . . . . . . . . . . . . 102.87 22.0 9.78 Favored Glycine 0 C--N 1.303 -1.256 0 N-CA-C 110.301 -1.12 . . . . 2.0 110.301 -179.358 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A 1604 ' ' LEU . . . . . 0.942 HD12 ' HB3' ' A' 1601 ' ' LYS . 6.1 mt -124.83 152.54 43.8 Favored 'General case' 0 C--N 1.3 -1.548 0 CA-C-O 121.801 0.81 . . . . 1.48 112.259 -179.554 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A 1605 ' ' SER . . . . . . . . . . . . . 50.1 m -128.29 177.67 6.79 Favored 'General case' 0 C--N 1.281 -2.399 0 N-CA-C 106.313 -1.736 . . . . 1.51 106.313 174.613 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A 1606 ' ' TYR . . . . . 0.738 ' HE1' ' HA ' ' A' 1598 ' ' CYS . 7.0 m-85 -98.9 140.36 33.19 Favored 'General case' 0 CA--C 1.459 -2.557 0 N-CA-C 105.682 -1.97 . . . . 1.18 105.682 -179.115 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A 1607 ' ' LYS . . . . . . . . . . . . . 23.3 pttm -133.09 137.45 46.36 Favored 'General case' 0 N--CA 1.391 -3.382 0 C-N-CA 119.21 -0.996 . . . . 1.67 110.127 176.718 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A 1608 ' ' SER . . . . . . . . . . . . . 14.6 m -107.08 110.02 22.03 Favored 'General case' 0 C--N 1.29 -2.02 0 N-CA-C 108.11 -1.07 . . . . 1.0 108.11 178.612 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A 1609 ' ' VAL . . . . . . . . . . . . . 98.3 t -102.04 102.82 14.08 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.256 0 CA-C-O 121.118 0.485 . . . . 0.93 110.481 -177.923 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A 1610 ' ' ILE . . . . . 0.433 ' HB ' ' HB3' ' A' 1590 ' ' LEU . 2.6 mp -90.78 115.31 29.77 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.361 0 N-CA-C 108.252 -1.018 . . . . 0.78 108.252 179.243 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A 1611 ' ' SER . . . . . 0.508 ' O ' ' HA ' ' A' 1639 ' ' SER . 16.9 m -107.13 122.4 46.42 Favored 'General case' 0 C--N 1.295 -1.789 0 CA-C-O 121.26 0.552 . . . . 1.29 110.666 -178.152 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A 1612 ' ' PHE . . . . . 0.725 ' HB2' ' HB2' ' A' 1588 ' ' LEU . 84.5 m-85 -88.38 109.78 20.27 Favored 'General case' 0 C--N 1.298 -1.666 0 N-CA-C 108.134 -1.062 . . . . 0.7 108.134 177.391 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A 1613 ' ' VAL . . . . . . . . . . . . . 58.2 t -102.01 126.2 56.06 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.414 0 CA-C-N 115.632 -0.713 . . . . 0.75 110.216 -173.781 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A 1614 ' ' CYS . . . . . 0.403 ' HA ' ' O ' ' A' 1642 ' ' THR . 57.9 m -59.63 95.68 0.03 OUTLIER 'General case' 0 C--O 1.244 0.764 0 C-N-CA 124.427 1.091 . . . . 1.39 111.302 179.771 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A 1615 ' ' ARG . . . . . . . . . . . . . 17.0 mmt180 -137.28 102.17 9.0 Favored Pre-proline 0 C--N 1.294 -1.824 0 CA-C-N 115.112 -0.949 . . . . 3.75 108.744 177.725 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A 1616 ' ' PRO . . . . . 0.417 ' HA ' ' HB3' ' A' 1643 ' ' PRO . 52.6 Cg_exo -61.2 10.36 0.07 OUTLIER 'Trans proline' 0 N--CA 1.493 1.479 0 C-N-CA 124.707 3.605 . . . . 1.32 115.137 -179.189 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A 1617 ' ' GLU . . . . . . . . . . . . . 34.0 mt-10 . . . . . 0 C--O 1.243 0.726 0 C-N-CA 123.501 0.72 . . . . 3.21 109.647 178.209 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A 1622 ' ' ASN . . . . . . . . . . . . . 54.9 t30 . . . . . 0 C--O 1.248 0.989 0 CA-C-O 122.441 1.115 . . . . 2.92 111.935 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A 1623 ' ' ARG . . . . . 0.522 ' HB3' ' CG ' ' A' 1640 ' ' TRP . 6.0 ptt180 -130.14 74.11 80.74 Favored Pre-proline 0 C--N 1.306 -1.321 0 CA-C-N 115.082 -0.963 . . . . 3.61 112.765 -177.326 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A 1624 ' ' PRO . . . . . . . . . . . . . 54.9 Cg_endo -111.01 90.9 0.02 OUTLIER 'Trans proline' 0 N--CA 1.42 -2.843 0 C-N-CA 121.306 1.338 . . . . 2.37 109.519 169.177 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A 1625 ' ' MET . . . . . 0.501 ' HB2' ' O ' ' A' 1639 ' ' SER . 10.7 mmt -151.54 98.27 2.49 Favored 'General case' 0 CA--C 1.491 -1.303 0 C-N-CA 120.022 -0.671 . . . . 2.16 112.695 178.02 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A 1626 ' ' LEU . . . . . . . . . . . . . 63.1 tp -92.02 101.04 13.58 Favored 'General case' 0 C--N 1.292 -1.919 0 N-CA-C 103.402 -2.814 . . . . 1.35 103.402 163.82 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A 1627 ' ' ILE . . . . . 0.586 HD12 ' HB3' ' A' 1637 ' ' PHE . 5.0 mt -68.64 -44.65 82.4 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.602 0 N-CA-C 108.499 -0.926 . . . . 1.21 108.499 -171.211 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A 1628 ' ' SER . . . . . . . . . . . . . 46.5 t -171.12 148.09 2.67 Favored 'General case' 0 N--CA 1.412 -2.373 0 N-CA-C 106.245 -1.761 . . . . 1.4 106.245 -179.572 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A 1629 ' ' LEU . . . . . 0.839 ' HG ' ' HG ' ' A' 1636 ' ' LEU . 5.1 tt -126.02 111.02 14.24 Favored 'General case' 0 C--N 1.281 -2.381 0 N-CA-C 105.238 -2.134 . . . . 1.56 105.238 173.916 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A 1630 ' ' ASP . . . . . . . . . . . . . 29.8 t70 -94.83 108.68 20.7 Favored 'General case' 0 C--N 1.283 -2.318 0 N-CA-C 108.954 -0.758 . . . . 0.87 108.954 -178.894 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A 1631 ' ' LYS . . . . . . . . . . . . . 65.6 mttp -71.26 -32.96 69.35 Favored 'General case' 0 C--N 1.309 -1.177 0 CA-C-N 115.586 -0.733 . . . . 2.35 112.656 -174.486 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A 1632 ' ' GLN . . . . . . . . . . . . . 9.1 pt20 -71.25 -28.74 64.38 Favored 'General case' 0 N--CA 1.467 0.419 0 N-CA-C 113.226 0.825 . . . . 2.55 113.226 -176.38 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A 1633 ' ' THR . . . . . 0.403 ' HA ' HD13 ' A' 1604 ' ' LEU . 71.8 p -106.31 -4.3 20.21 Favored 'General case' 0 C--N 1.319 -0.756 0 C-N-CA 119.908 -0.717 . . . . 1.24 110.674 175.08 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A 1634 ' ' CYS . . . . . . . . . . . . . 72.6 m 61.16 40.07 15.21 Favored 'General case' 0 C--O 1.237 0.412 0 CA-C-N 115.063 -0.972 . . . . 0.89 111.278 -178.455 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A 1635 ' ' THR . . . . . . . . . . . . . 30.9 m -105.69 122.42 46.03 Favored 'General case' 0 N--CA 1.433 -1.278 0 CA-C-N 115.387 -0.824 . . . . 0.75 110.028 -177.446 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A 1636 ' ' LEU . . . . . 0.839 ' HG ' ' HG ' ' A' 1629 ' ' LEU . 5.8 mp -108.44 124.87 51.08 Favored 'General case' 0 C--N 1.313 -0.982 0 N-CA-C 109.378 -0.601 . . . . 1.33 109.378 179.303 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A 1637 ' ' PHE . . . . . 0.586 ' HB3' HD12 ' A' 1627 ' ' ILE . 84.3 m-85 -107.55 126.72 52.89 Favored 'General case' 0 C--N 1.311 -1.092 0 N-CA-C 110.121 -0.326 . . . . 0.83 110.121 -178.674 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A 1638 ' ' PHE . . . . . 0.474 ' HA ' ' O ' ' A' 1625 ' ' MET . 93.4 m-85 -124.05 155.31 38.55 Favored 'General case' 0 C--N 1.32 -0.71 0 C-N-CA 122.6 0.36 . . . . 0.6 110.634 -179.495 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A 1639 ' ' SER . . . . . 0.508 ' HA ' ' O ' ' A' 1611 ' ' SER . 65.1 m -142.61 148.82 38.1 Favored 'General case' 0 C--O 1.249 1.063 0 N-CA-C 113.486 0.921 . . . . 1.08 113.486 174.621 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A 1640 ' ' TRP . . . . . 0.522 ' CG ' ' HB3' ' A' 1623 ' ' ARG . 8.1 t90 -122.05 135.4 54.82 Favored 'General case' 0 C--O 1.243 0.754 0 N-CA-C 106.859 -1.534 . . . . 0.8 106.859 176.053 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A 1641 ' ' HIS . . . . . . . . . . . . . 15.3 m-70 -80.51 92.78 5.94 Favored 'General case' 0 CA--C 1.509 -0.613 0 N-CA-C 107.818 -1.178 . . . . 2.54 107.818 177.596 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A 1642 ' ' THR . . . . . 0.51 ' HA ' ' HD3' ' A' 1643 ' ' PRO . 0.0 OUTLIER -128.63 130.5 23.5 Favored Pre-proline 0 C--N 1.304 -1.372 0 N-CA-C 112.852 0.686 . . . . 1.15 112.852 -174.248 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A 1643 ' ' PRO . . . . . 0.51 ' HD3' ' HA ' ' A' 1642 ' ' THR . 2.5 Cg_endo -81.66 -7.1 12.58 Favored 'Trans proline' 0 C--N 1.332 -0.302 0 C-N-CA 123.026 2.484 . . . . 0.8 111.323 177.008 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A 1644 ' ' LEU . . . . . . . . . . . . . 4.0 pp -89.14 3.94 50.19 Favored 'General case' 0 C--N 1.312 -1.046 0 CA-C-N 115.155 -0.93 . . . . 1.54 112.084 -179.369 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A 1645 ' ' ALA . . . . . . . . . . . . . . . -78.22 -43.07 29.41 Favored 'General case' 0 C--N 1.314 -0.967 0 CA-C-O 122.031 0.919 . . . . 0.95 108.791 175.56 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A 1646 ' ' CYS . . . . . . . . . . . . . 24.0 p -159.29 129.87 5.87 Favored 'General case' 0 N--CA 1.428 -1.557 0 N-CA-C 104.163 -2.532 . . . . 1.41 104.163 173.658 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A 1647 ' ' GLU . . . . . 0.416 ' HG3' ' HE1' ' A' 1527 ' ' PHE . 35.9 mt-10 . . . . . 0 C--N 1.285 -2.196 0 C-N-CA 120.198 -0.601 . . . . 2.92 110.968 -169.298 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A 1515 ' ' ASP . . . . . . . . . . . . . 5.3 t70 . . . . . 0 C--O 1.223 -0.29 0 N-CA-C 109.807 -0.442 . . . . 2.54 109.807 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A 1516 ' ' CYS . . . . . 0.594 ' SG ' ' HE3' ' A' 1579 ' ' LYS . 86.8 m -116.86 20.81 13.72 Favored 'General case' 0 C--N 1.302 -1.495 0 C-N-CA 124.088 0.955 . . . . 1.25 110.536 -176.116 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A 1517 ' ' GLN . . . . . 0.435 ' HA ' ' O ' ' A' 1527 ' ' PHE . 4.0 pt20 -109.69 126.24 53.48 Favored 'General case' 0 N--CA 1.422 -1.87 0 CA-C-N 115.523 -0.762 . . . . 1.88 109.169 177.737 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A 1518 ' ' VAL . . . . . 0.61 ' HB ' ' HB2' ' A' 1527 ' ' PHE . 59.3 t -93.45 127.82 45.27 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.233 0 N-CA-C 107.982 -1.118 . . . . 1.73 107.982 -179.962 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A 1519 ' ' THR . . . . . . . . . . . . . 11.3 m -115.02 117.83 31.69 Favored 'General case' 0 N--CA 1.417 -2.109 0 C-N-CA 120.369 -0.533 . . . . 1.7 109.917 -179.165 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A 1520 ' ' ASN . . . . . . . . . . . . . 41.8 t-20 -94.25 105.57 18.35 Favored Pre-proline 0 C--N 1.318 -0.794 0 N-CA-C 107.044 -1.465 . . . . 2.12 107.044 174.666 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A 1521 ' ' PRO . . . . . . . . . . . . . 21.2 Cg_exo -67.26 -21.78 47.42 Favored 'Trans proline' 0 C--N 1.351 0.672 0 C-N-CA 122.528 2.152 . . . . 2.47 113.663 -176.802 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A 1522 ' ' SER . . . . . . . . . . . . . 19.5 m -76.16 -40.1 53.34 Favored 'General case' 0 C--N 1.311 -1.108 0 N-CA-C 111.955 0.354 . . . . 2.57 111.955 -176.323 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A 1523 ' ' THR . . . . . 0.432 HG23 ' HB2' ' A' 1525 ' ' HIS . 14.4 t -107.01 -17.55 14.15 Favored 'General case' 0 CA--C 1.551 0.997 0 C-N-CA 119.525 -0.87 . . . . 2.15 111.268 179.418 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A 1524 ' ' GLY . . . . . . . . . . . . . . . 82.0 17.06 70.72 Favored Glycine 0 N--CA 1.45 -0.4 0 C-N-CA 121.171 -0.538 . . . . 1.89 112.093 -179.713 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A 1525 ' ' HIS . . . . . 0.432 ' HB2' HG23 ' A' 1523 ' ' THR . 7.3 t60 -84.19 135.08 34.51 Favored 'General case' 0 C--N 1.313 -0.999 0 N-CA-C 108.994 -0.743 . . . . 1.9 108.994 -177.672 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A 1526 ' ' LEU . . . . . . . . . . . . . 3.3 tm? -113.87 121.42 43.93 Favored 'General case' 0 C--N 1.3 -1.56 0 N-CA-C 108.415 -0.957 . . . . 1.61 108.415 -176.349 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A 1527 ' ' PHE . . . . . 0.61 ' HB2' ' HB ' ' A' 1518 ' ' VAL . 69.9 m-85 -104.2 116.12 31.61 Favored 'General case' 0 C--N 1.304 -1.395 0 N-CA-C 109.641 -0.503 . . . . 1.42 109.641 -178.601 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A 1528 ' ' ASP . . . . . 0.48 ' O ' HD13 ' A' 1532 ' ' LEU . 11.6 t70 -95.69 102.52 14.32 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-N 117.576 0.171 . . . . 2.18 110.782 -179.977 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A 1529 ' ' LEU . . . . . . . . . . . . . 6.4 mp -89.77 -7.58 54.11 Favored 'General case' 0 C--N 1.318 -0.785 0 CA-C-O 120.8 0.333 . . . . 1.44 111.777 179.305 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A 1530 ' ' SER . . . . . 0.477 ' OG ' ' HB2' ' A' 1516 ' ' CYS . 50.2 m -72.51 -48.54 39.7 Favored 'General case' 0 C--N 1.313 -0.993 0 CA-C-N 116.369 -0.378 . . . . 1.44 111.265 -178.108 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A 1531 ' ' SER . . . . . . . . . . . . . 8.2 m -70.4 -17.17 63.02 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 116.173 -0.467 . . . . 1.5 111.672 -175.993 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A 1532 ' ' LEU . . . . . 0.517 ' HB3' HG13 ' A' 1552 ' ' ILE . 9.8 mp -68.19 -13.72 62.44 Favored 'General case' 0 N--CA 1.466 0.35 0 CA-C-N 116.255 -0.429 . . . . 1.77 112.042 177.52 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A 1533 ' ' SER . . . . . . . . . . . . . 10.9 m -110.24 106.42 15.83 Favored 'General case' 0 N--CA 1.437 -1.105 0 N-CA-C 109.162 -0.681 . . . . 2.38 109.162 178.952 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A 1534 ' ' GLY . . . . . . . . . . . . . . . -92.21 -110.67 1.82 Allowed Glycine 0 N--CA 1.436 -1.312 0 C-N-CA 121.179 -0.534 . . . . 1.55 111.813 178.065 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A 1535 ' ' ARG . . . . . . . . . . . . . 42.8 ttm180 -95.61 -53.85 3.58 Favored 'General case' 0 C--N 1.31 -1.129 0 CA-C-O 121.081 0.467 . . . . 3.96 110.612 178.369 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A 1536 ' ' ALA . . . . . . . . . . . . . . . -96.64 -29.95 13.54 Favored 'General case' 0 C--N 1.316 -0.877 0 CA-C-O 121.044 0.449 . . . . 1.65 110.459 177.745 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A 1537 ' ' GLY . . . . . 0.454 ' HA3' HD21 ' A' 1556 ' ' ASN . . . 70.69 -128.17 17.25 Favored Glycine 0 CA--C 1.499 -0.922 0 CA-C-N 115.515 -0.766 . . . . 1.19 112.166 178.278 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A 1538 ' ' PHE . . . . . 0.54 ' HB2' HD11 ' A' 1552 ' ' ILE . 29.8 m-85 -114.26 122.96 48.36 Favored 'General case' 0 CA--C 1.497 -1.074 0 N-CA-C 109.639 -0.504 . . . . 1.69 109.639 179.122 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A 1539 ' ' THR . . . . . . . . . . . . . 38.0 p -102.38 141.78 34.66 Favored 'General case' 0 C--N 1.286 -2.161 0 CA-C-N 115.454 -0.793 . . . . 1.48 111.329 -175.581 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A 1540 ' ' ALA . . . . . . . . . . . . . . . -118.79 159.03 24.46 Favored 'General case' 0 C--N 1.308 -1.213 0 N-CA-C 108.643 -0.873 . . . . 0.83 108.643 179.356 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A 1541 ' ' ALA . . . . . . . . . . . . . . . -99.48 141.5 32.19 Favored 'General case' 0 C--N 1.306 -1.313 0 CA-C-O 120.887 0.375 . . . . 1.27 111.231 -177.618 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A 1542 ' ' TYR . . . . . . . . . . . . . 76.7 t80 -141.68 177.57 8.06 Favored 'General case' 0 C--N 1.314 -0.95 0 N-CA-C 108.442 -0.947 . . . . 2.15 108.442 -178.415 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A 1543 ' ' SER . . . . . . . . . . . . . 5.3 m -45.91 -151.35 0.0 OUTLIER 'General case' 0 CA--C 1.578 2.034 0 C-N-CA 129.52 3.128 . . . . 2.29 114.259 177.14 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A 1544 ' ' LYS . . . . . . . . . . . . . 64.6 mttp -41.93 -32.87 0.47 Allowed 'General case' 0 N--CA 1.492 1.666 0 N-CA-C 115.064 1.505 . . . . 3.91 115.064 -177.678 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A 1545 ' ' SER . . . . . 0.4 ' OG ' ' HB3' ' A' 1567 ' ' PHE . 6.0 t -67.29 -22.83 65.63 Favored 'General case' 0 CA--C 1.56 1.334 0 CA-C-N 117.877 0.308 . . . . 3.3 110.919 178.148 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A 1546 ' ' GLY . . . . . . . . . . . . . . . 88.6 -76.13 1.92 Allowed Glycine 0 N--CA 1.439 -1.105 0 C-N-CA 121.046 -0.597 . . . . 1.24 114.193 174.689 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A 1547 ' ' VAL . . . . . . . . . . . . . 88.2 t -122.87 144.3 32.82 Favored 'Isoleucine or valine' 0 N--CA 1.417 -2.098 0 C-N-CA 122.748 0.419 . . . . 1.63 110.108 -174.272 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A 1548 ' ' VAL . . . . . . . . . . . . . 10.7 t -113.09 136.06 50.62 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.308 0 N-CA-C 106.456 -1.683 . . . . 0.92 106.456 175.573 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A 1549 ' ' TYR . . . . . 0.541 ' CE2' ' HA2' ' A' 1568 ' ' GLY . 31.2 m-85 -91.63 146.91 23.4 Favored 'General case' 0 C--N 1.301 -1.508 0 N-CA-C 105.316 -2.105 . . . . 1.44 105.316 172.75 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A 1550 ' ' MET . . . . . . . . . . . . . 46.7 ttp -156.69 141.09 16.67 Favored 'General case' 0 C--N 1.292 -1.917 0 N-CA-C 109.12 -0.696 . . . . 1.74 109.12 -179.221 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A 1551 ' ' SER . . . . . . . . . . . . . 64.0 p -89.54 153.48 20.75 Favored 'General case' 0 N--CA 1.414 -2.274 0 N-CA-C 107.937 -1.134 . . . . 1.64 107.937 177.114 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A 1552 ' ' ILE . . . . . 0.54 HD11 ' HB2' ' A' 1538 ' ' PHE . 46.2 mm -83.97 -32.29 8.47 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.708 0 N-CA-C 107.595 -1.261 . . . . 1.33 107.595 178.627 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A 1553 ' ' CYS . . . . . 0.454 ' HA ' ' OH ' ' A' 1592 ' ' TYR . 36.6 t -162.44 137.62 7.01 Favored 'General case' 0 N--CA 1.43 -1.472 0 CA-C-N 115.547 -0.751 . . . . 1.43 109.125 165.836 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A 1554 ' ' GLY . . . . . . . . . . . . . . . 85.91 -124.39 6.84 Favored Glycine 0 CA--C 1.473 -2.549 0 N-CA-C 110.201 -1.16 . . . . 1.12 110.201 -178.641 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A 1555 ' ' GLU . . . . . 0.457 ' CD ' ' H ' ' A' 1555 ' ' GLU . 0.1 OUTLIER -117.93 -177.53 3.28 Favored 'General case' 0 C--N 1.258 -3.401 0 CA-C-N 113.538 -1.331 . . . . 1.8 108.516 -176.522 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A 1556 ' ' ASN . . . . . 0.465 ' HB3' ' HG3' ' A' 1557 ' ' GLU . 41.3 t30 165.31 -158.91 0.0 OUTLIER 'General case' 0 C--O 1.255 1.365 0 N-CA-C 103.096 -2.927 . . . . 2.63 103.096 -174.209 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A 1557 ' ' GLU . . . . . 0.465 ' HG3' ' HB3' ' A' 1556 ' ' ASN . 26.0 mt-10 83.49 178.72 0.05 Allowed 'General case' 0 CA--C 1.497 -1.058 0 N-CA-C 115.814 1.783 . . . . 3.79 115.814 159.713 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A 1558 ' ' ASN . . . . . . . . . . . . . 33.2 m-80 -127.97 43.06 3.21 Favored 'General case' 0 C--N 1.307 -1.273 0 CA-C-N 113.358 -1.747 . . . . 1.52 107.948 -173.541 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A 1559 ' ' CYS . . . . . 0.408 ' HB3' ' HD2' ' A' 1560 ' ' PRO . 84.2 m -131.85 172.37 7.48 Favored Pre-proline 0 C--N 1.293 -1.889 0 CA-C-N 113.666 -1.607 . . . . 0.84 106.885 -179.609 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A 1560 ' ' PRO . . . . . 0.437 ' HA ' ' HD2' ' A' 1561 ' ' PRO . 99.7 Cg_exo -48.73 116.21 2.02 Favored 'Trans proline' 0 C--N 1.361 1.209 0 C-N-CA 122.177 1.918 . . . . 1.18 110.591 172.756 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A 1561 ' ' PRO . . . . . 0.437 ' HD2' ' HA ' ' A' 1560 ' ' PRO . 12.4 Cg_endo -53.63 142.51 60.51 Favored 'Trans proline' 0 C--N 1.354 0.828 0 C-N-CA 124.35 3.367 . . . . 1.51 113.988 -172.854 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A 1562 ' ' GLY . . . . . . . . . . . . . . . 112.28 9.24 20.27 Favored Glycine 0 N--CA 1.437 -1.277 0 N-CA-C 110.687 -0.965 . . . . 0.72 110.687 -179.71 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A 1563 ' ' VAL . . . . . . . . . . . . . 4.8 m -99.66 154.23 4.27 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.838 0 N-CA-C 109.357 -0.609 . . . . 0.97 109.357 176.049 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A 1564 ' ' GLY . . . . . . . . . . . . . . . -115.94 -6.43 16.5 Favored Glycine 0 N--CA 1.421 -2.324 0 N-CA-C 110.36 -1.096 . . . . 0.72 110.36 175.408 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A 1565 ' ' ALA . . . . . . . . . . . . . . . -168.78 119.2 0.74 Allowed 'General case' 0 C--O 1.259 1.577 0 N-CA-C 108.969 -0.752 . . . . 0.37 108.969 -179.347 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A 1566 ' ' CYS . . . . . . . . . . . . . 35.8 t -141.72 141.29 33.27 Favored 'General case' 0 C--N 1.297 -1.686 0 CA-C-N 115.368 -0.833 . . . . 0.51 111.2 -174.064 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A 1567 ' ' PHE . . . . . 0.4 ' HB3' ' OG ' ' A' 1545 ' ' SER . 15.7 m-85 -66.6 126.94 30.49 Favored 'General case' 0 C--O 1.219 -0.51 0 N-CA-C 109.723 -0.473 . . . . 0.97 109.723 176.197 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A 1568 ' ' GLY . . . . . 0.541 ' HA2' ' CE2' ' A' 1549 ' ' TYR . . . -66.86 -33.22 83.38 Favored Glycine 0 N--CA 1.444 -0.83 0 CA-C-N 115.748 -0.66 . . . . 1.08 114.167 -175.109 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A 1569 ' ' GLN . . . . . . . . . . . . . 8.8 tt0 -84.45 -52.86 5.84 Favored 'General case' 0 C--N 1.303 -1.436 0 CA-C-O 121.686 0.755 . . . . 2.74 110.707 -179.576 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A 1570 ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -83.29 -14.68 52.53 Favored 'General case' 0 C--N 1.296 -1.721 0 CA-C-N 114.884 -1.053 . . . . 1.96 112.463 -169.745 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A 1571 ' ' ARG . . . . . . . . . . . . . 49.3 mtp180 54.97 37.23 28.51 Favored 'General case' 0 N--CA 1.476 0.855 0 C-N-CA 125.864 1.666 . . . . 3.95 111.95 -179.644 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A 1572 ' ' ILE . . . . . . . . . . . . . 45.9 mm -107.01 132.78 53.49 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.126 0 CA-C-N 115.347 -0.842 . . . . 1.37 109.359 -178.349 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A 1573 ' ' SER . . . . . . . . . . . . . 33.0 t -73.83 131.58 41.67 Favored 'General case' 0 N--CA 1.428 -1.528 0 CA-C-N 114.997 -1.001 . . . . 1.08 110.607 179.858 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A 1574 ' ' VAL . . . . . 0.988 ' HA ' ' HB3' ' A' 1596 ' ' SER . 34.0 m -109.85 -32.69 2.34 Favored 'Isoleucine or valine' 0 N--CA 1.419 -1.978 0 C-N-CA 119.976 -0.69 . . . . 1.3 109.864 171.984 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A 1575 ' ' GLY . . . . . . . . . . . . . . . -133.51 121.8 2.91 Favored Glycine 0 N--CA 1.425 -2.088 0 N-CA-C 110.372 -1.091 . . . . 0.51 110.372 178.762 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A 1576 ' ' LYS . . . . . . . . . . . . . 88.0 tttt -80.49 149.15 30.16 Favored 'General case' 0 C--N 1.311 -1.1 0 N-CA-C 108.578 -0.897 . . . . 2.9 108.578 179.637 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A 1577 ' ' ALA . . . . . . . . . . . . . . . -61.88 102.35 0.27 Allowed 'General case' 0 CA--C 1.516 -0.357 0 O-C-N 123.928 0.768 . . . . 0.83 111.141 -177.81 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A 1578 ' ' ASN . . . . . . . . . . . . . 73.4 m-20 -120.87 115.19 22.75 Favored 'General case' 0 C--N 1.297 -1.699 0 N-CA-C 106.487 -1.672 . . . . 1.85 106.487 175.638 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A 1579 ' ' LYS . . . . . 0.594 ' HE3' ' SG ' ' A' 1516 ' ' CYS . 55.6 mtpt -83.35 90.17 7.12 Favored 'General case' 0 C--N 1.295 -1.781 0 N-CA-C 107.724 -1.213 . . . . 1.9 107.724 -179.047 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A 1580 ' ' ARG . . . . . . . . . . . . . 26.0 ttt85 -150.96 113.91 4.75 Favored 'General case' 0 N--CA 1.424 -1.734 0 CA-C-N 114.847 -1.07 . . . . 3.63 109.667 -175.579 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A 1581 ' ' LEU . . . . . . . . . . . . . 3.5 pp -134.04 161.73 34.03 Favored 'General case' 0 C--N 1.292 -1.915 0 CA-C-N 115.776 -0.647 . . . . 1.87 109.721 179.425 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A 1582 ' ' ARG . . . . . . . . . . . . . 79.1 ttt180 -138.15 129.39 27.45 Favored 'General case' 0 C--N 1.292 -1.892 0 C-N-CA 121.134 -0.227 . . . . 3.97 110.444 176.999 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A 1583 ' ' TYR . . . . . . . . . . . . . 36.7 t80 -93.07 102.6 14.93 Favored 'General case' 0 C--N 1.3 -1.583 0 N-CA-C 107.185 -1.413 . . . . 1.41 107.185 173.662 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A 1584 ' ' VAL . . . . . . . . . . . . . 7.5 p -135.87 120.93 27.85 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.949 0 C-N-CA 120.875 -0.33 . . . . 1.69 111.463 -177.293 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A 1585 ' ' ASP . . . . . . . . . . . . . 35.3 t70 53.08 45.73 28.14 Favored 'General case' 0 N--CA 1.488 1.435 0 C-N-CA 124.453 1.101 . . . . 2.06 111.12 178.367 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A 1586 ' ' GLN . . . . . . . . . . . . . 47.0 mt-30 58.13 25.83 12.94 Favored 'General case' 0 C--O 1.242 0.685 0 C-N-CA 125.377 1.471 . . . . 2.33 114.587 179.675 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A 1587 ' ' VAL . . . . . . . . . . . . . 8.1 p -128.45 126.17 65.12 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.314 0 N-CA-C 107.895 -1.15 . . . . 0.78 107.895 171.737 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A 1588 ' ' LEU . . . . . 0.623 ' HB2' ' HB2' ' A' 1612 ' ' PHE . 34.6 mt -86.22 138.99 31.45 Favored 'General case' 0 C--N 1.304 -1.396 0 N-CA-C 108.991 -0.744 . . . . 1.41 108.991 -179.918 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A 1589 ' ' GLN . . . . . . . . . . . . . 34.6 tt0 -130.59 107.0 8.87 Favored 'General case' 0 C--N 1.292 -1.929 0 N-CA-C 109.397 -0.594 . . . . 1.24 109.397 -177.278 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A 1590 ' ' LEU . . . . . . . . . . . . . 9.1 tt -111.82 137.16 50.15 Favored 'General case' 0 C--N 1.288 -2.07 0 N-CA-C 107.744 -1.206 . . . . 1.15 107.744 179.031 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A 1591 ' ' VAL . . . . . 0.543 HG12 HG22 ' A' 1609 ' ' VAL . 28.8 m -130.55 140.58 48.44 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.937 0 N-CA-C 112.233 0.457 . . . . 1.51 112.233 -175.431 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A 1592 ' ' TYR . . . . . 0.454 ' OH ' ' HA ' ' A' 1553 ' ' CYS . 39.6 m-85 -122.09 138.69 54.36 Favored 'General case' 0 C--N 1.313 -1.01 0 N-CA-C 108.128 -1.064 . . . . 1.06 108.128 172.948 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A 1593 ' ' LYS . . . . . . . . . . . . . 62.5 pttt -159.25 174.85 14.17 Favored 'General case' 0 C--O 1.251 1.133 0 N-CA-C 109.899 -0.408 . . . . 2.18 109.899 178.8 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A 1594 ' ' ASP . . . . . . . . . . . . . 31.6 m-20 67.54 56.93 0.57 Allowed 'General case' 0 N--CA 1.48 1.03 0 C-N-CA 124.376 1.07 . . . . 1.45 110.888 179.592 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A 1595 ' ' GLY . . . . . . . . . . . . . . . -142.1 -47.92 0.05 OUTLIER Glycine 0 C--N 1.308 -1.026 0 CA-C-N 115.054 -0.976 . . . . 0.78 111.362 -179.578 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A 1596 ' ' SER . . . . . 0.988 ' HB3' ' HA ' ' A' 1574 ' ' VAL . 15.8 p -96.69 134.21 23.51 Favored Pre-proline 0 C--N 1.298 -1.638 0 CA-C-N 115.526 -0.337 . . . . 1.68 111.545 179.031 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A 1597 ' ' PRO . . . . . 0.455 ' HD3' ' HA ' ' A' 1596 ' ' SER . 3.0 Cg_exo -79.77 113.56 3.07 Favored 'Trans proline' 0 N--CA 1.445 -1.373 0 C-N-CA 122.176 1.917 . . . . 1.17 108.593 170.863 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A 1598 ' ' CYS . . . . . . . . . . . . . 48.6 t -94.87 122.66 59.86 Favored Pre-proline 0 C--N 1.306 -1.326 0 N-CA-C 109.727 -0.471 . . . . 1.19 109.727 -176.3 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A 1599 ' ' PRO . . . . . . . . . . . . . 87.9 Cg_endo -77.97 0.6 9.7 Favored 'Trans proline' 0 CA--C 1.537 0.67 0 C-N-CA 123.384 2.723 . . . . 1.59 114.267 -175.463 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A 1600 ' ' SER . . . . . . . . . . . . . 19.9 m -77.9 -32.18 51.65 Favored 'General case' 0 C--N 1.308 -1.223 0 CA-C-O 120.677 0.275 . . . . 2.12 111.288 -179.679 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A 1601 ' ' LYS . . . . . 0.905 ' HB3' HD12 ' A' 1604 ' ' LEU . 11.2 tmtt? -158.92 129.98 6.19 Favored 'General case' 0 C--N 1.313 -0.993 0 N-CA-C 105.691 -1.966 . . . . 3.74 105.691 -177.13 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A 1602 ' ' SER . . . . . . . . . . . . . 16.4 m -67.36 125.41 26.02 Favored 'General case' 0 C--N 1.316 -0.852 0 CA-C-O 120.886 0.374 . . . . 3.79 110.591 -175.222 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A 1603 ' ' GLY . . . . . . . . . . . . . . . 103.83 -6.27 47.9 Favored Glycine 0 N--CA 1.435 -1.382 0 N-CA-C 110.918 -0.873 . . . . 2.0 110.918 -179.937 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A 1604 ' ' LEU . . . . . 0.905 HD12 ' HB3' ' A' 1601 ' ' LYS . 6.8 mt -89.19 148.26 23.73 Favored 'General case' 0 N--CA 1.43 -1.463 0 CA-C-O 121.425 0.631 . . . . 1.48 111.851 178.209 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A 1605 ' ' SER . . . . . 0.465 ' HA ' ' O ' ' A' 1596 ' ' SER . 8.3 t -130.45 163.58 26.64 Favored 'General case' 0 N--CA 1.413 -2.287 0 N-CA-C 104.673 -2.344 . . . . 1.51 104.673 176.561 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A 1606 ' ' TYR . . . . . 0.548 ' HA ' ' O ' ' A' 1634 ' ' CYS . 67.6 m-85 -90.22 116.01 27.88 Favored 'General case' 0 CA--C 1.458 -2.563 0 N-CA-C 106.331 -1.729 . . . . 1.18 106.331 -179.852 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A 1607 ' ' LYS . . . . . . . . . . . . . 23.3 pttp -103.23 127.41 50.55 Favored 'General case' 0 N--CA 1.394 -3.226 0 C-N-CA 118.196 -1.401 . . . . 1.67 109.496 -176.738 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A 1608 ' ' SER . . . . . 0.505 ' HA ' ' HB2' ' A' 1636 ' ' LEU . 12.0 p -97.43 111.31 23.62 Favored 'General case' 0 N--CA 1.407 -2.62 0 CA-C-N 115.118 -0.946 . . . . 1.0 109.287 -177.186 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A 1609 ' ' VAL . . . . . 0.543 HG22 HG12 ' A' 1591 ' ' VAL . 85.5 t -101.35 107.84 22.24 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.523 0 N-CA-C 108.166 -1.049 . . . . 0.93 108.166 179.747 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A 1610 ' ' ILE . . . . . . . . . . . . . 2.5 mp -93.28 108.7 20.77 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.561 0 N-CA-C 108.274 -1.01 . . . . 0.78 108.274 179.023 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A 1611 ' ' SER . . . . . 0.401 ' O ' ' HA ' ' A' 1639 ' ' SER . 21.8 m -94.52 113.92 25.83 Favored 'General case' 0 N--CA 1.409 -2.509 0 N-CA-C 108.232 -1.025 . . . . 1.29 108.232 177.346 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A 1612 ' ' PHE . . . . . 0.623 ' HB2' ' HB2' ' A' 1588 ' ' LEU . 79.8 m-85 -84.89 106.84 16.71 Favored 'General case' 0 C--N 1.291 -1.941 0 CA-C-N 115.067 -0.97 . . . . 0.7 110.57 -178.24 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A 1613 ' ' VAL . . . . . . . . . . . . . 41.9 t -94.92 119.68 43.3 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.52 0 CA-C-N 115.279 -0.873 . . . . 0.75 109.067 -177.051 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A 1614 ' ' CYS . . . . . 0.523 ' HB3' ' HB2' ' A' 1646 ' ' CYS . 56.2 m -71.45 92.33 1.09 Allowed 'General case' 0 C--N 1.314 -0.958 0 CA-C-O 121.377 0.608 . . . . 1.39 109.381 178.241 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A 1615 ' ' ARG . . . . . 0.515 ' HB3' ' HB3' ' A' 1641 ' ' HIS . 0.6 OUTLIER -137.97 87.46 16.58 Favored Pre-proline 0 C--N 1.305 -1.36 0 N-CA-C 107.109 -1.441 . . . . 3.75 107.109 -178.904 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A 1616 ' ' PRO . . . . . . . . . . . . . 6.6 Cg_exo -76.34 44.79 1.43 Allowed 'Trans proline' 0 N--CA 1.479 0.635 0 C-N-CA 123.459 2.772 . . . . 1.32 112.768 -177.449 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A 1617 ' ' GLU . . . . . . . . . . . . . 41.8 mt-10 . . . . . 0 C--N 1.303 -1.44 0 N-CA-C 108.201 -1.036 . . . . 3.21 108.201 -179.276 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A 1622 ' ' ASN . . . . . . . . . . . . . 60.6 t30 . . . . . 0 N--CA 1.472 0.65 0 CA-C-O 121.81 0.814 . . . . 2.92 110.761 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A 1623 ' ' ARG . . . . . . . . . . . . . 9.2 ptm180 -154.0 153.49 28.61 Favored Pre-proline 0 C--N 1.3 -1.566 0 N-CA-C 107.28 -1.378 . . . . 3.61 107.28 -178.922 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A 1624 ' ' PRO . . . . . . . . . . . . . 32.5 Cg_exo -61.29 119.82 7.16 Favored 'Trans proline' 0 C--O 1.245 0.87 0 C-N-CA 122.761 2.307 . . . . 2.37 111.751 179.246 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A 1625 ' ' MET . . . . . . . . . . . . . 56.3 ttp -95.99 130.7 42.92 Favored 'General case' 0 C--N 1.301 -1.522 0 CA-C-N 115.082 -0.963 . . . . 2.16 109.688 -177.228 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A 1626 ' ' LEU . . . . . 0.708 HD21 HD23 ' A' 1629 ' ' LEU . 56.8 tp -83.53 105.73 14.7 Favored 'General case' 0 C--N 1.306 -1.304 0 N-CA-C 107.8 -1.185 . . . . 1.35 107.8 178.001 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A 1627 ' ' ILE . . . . . . . . . . . . . 45.4 pt -83.19 -33.61 10.36 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.268 0 N-CA-C 112.303 0.483 . . . . 1.21 112.303 -175.1 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A 1628 ' ' SER . . . . . . . . . . . . . 45.7 m -149.75 147.49 28.08 Favored 'General case' 0 C--N 1.313 -1.001 0 CA-C-O 120.673 0.273 . . . . 1.4 110.475 -178.077 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A 1629 ' ' LEU . . . . . 0.708 HD23 HD21 ' A' 1626 ' ' LEU . 1.2 tm? -127.76 108.41 10.72 Favored 'General case' 0 C--N 1.307 -1.255 0 N-CA-C 106.61 -1.626 . . . . 1.56 106.61 -179.216 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A 1630 ' ' ASP . . . . . . . . . . . . . 15.3 t70 -107.7 112.08 24.59 Favored 'General case' 0 C--N 1.304 -1.399 0 N-CA-C 109.056 -0.72 . . . . 0.87 109.056 178.771 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A 1631 ' ' LYS . . . . . . . . . . . . . 63.4 mttm -80.0 -22.5 42.41 Favored 'General case' 0 C--N 1.303 -1.426 0 N-CA-C 112.674 0.62 . . . . 2.35 112.674 -177.186 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A 1632 ' ' GLN . . . . . . . . . . . . . 1.7 mp0 -78.77 -49.96 12.14 Favored 'General case' 0 CA--C 1.509 -0.61 0 CA-C-O 121.029 0.442 . . . . 2.55 111.467 -173.277 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A 1633 ' ' THR . . . . . . . . . . . . . 60.4 p -86.57 -4.52 59.18 Favored 'General case' 0 C--N 1.313 -1.011 0 CA-C-O 121.875 0.845 . . . . 1.24 110.004 179.764 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A 1634 ' ' CYS . . . . . 0.548 ' O ' ' HA ' ' A' 1606 ' ' TYR . 29.4 m 59.62 51.05 6.65 Favored 'General case' 0 N--CA 1.441 -0.907 0 CA-C-N 113.442 -1.708 . . . . 0.89 108.768 179.712 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A 1635 ' ' THR . . . . . . . . . . . . . 39.7 m -114.94 130.26 56.88 Favored 'General case' 0 N--CA 1.425 -1.699 0 CA-C-N 114.999 -1.001 . . . . 0.75 110.087 -175.831 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A 1636 ' ' LEU . . . . . 0.505 ' HB2' ' HA ' ' A' 1608 ' ' SER . 40.6 mt -112.62 116.06 29.59 Favored 'General case' 0 N--CA 1.435 -1.223 0 N-CA-C 107.58 -1.267 . . . . 1.33 107.58 -178.479 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A 1637 ' ' PHE . . . . . . . . . . . . . 89.1 m-85 -98.68 100.92 12.19 Favored 'General case' 0 C--N 1.307 -1.282 0 N-CA-C 111.777 0.288 . . . . 0.83 111.777 -175.298 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A 1638 ' ' PHE . . . . . . . . . . . . . 68.0 m-85 -100.74 138.84 37.26 Favored 'General case' 0 C--N 1.307 -1.258 0 N-CA-C 109.169 -0.678 . . . . 0.6 109.169 176.165 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A 1639 ' ' SER . . . . . 0.401 ' HA ' ' O ' ' A' 1611 ' ' SER . 50.8 m -136.79 120.75 17.61 Favored 'General case' 0 C--N 1.279 -2.467 0 N-CA-C 108.464 -0.939 . . . . 1.08 108.464 174.883 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A 1640 ' ' TRP . . . . . . . . . . . . . 19.7 t90 -111.76 119.89 40.16 Favored 'General case' 0 C--N 1.292 -1.898 0 CA-C-N 115.942 -0.572 . . . . 0.8 109.501 -178.131 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A 1641 ' ' HIS . . . . . 0.515 ' HB3' ' HB3' ' A' 1615 ' ' ARG . 39.8 m170 -77.06 107.46 9.44 Favored 'General case' 0 C--N 1.31 -1.138 0 N-CA-C 106.347 -1.723 . . . . 2.54 106.347 174.718 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A 1642 ' ' THR . . . . . . . . . . . . . 8.8 t -140.92 136.93 16.56 Favored Pre-proline 0 C--N 1.291 -1.952 0 N-CA-C 113.126 0.787 . . . . 1.15 113.126 -173.711 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A 1643 ' ' PRO . . . . . 0.422 ' O ' ' HG2' ' A' 1647 ' ' GLU . 64.4 Cg_endo -76.97 -2.93 13.2 Favored 'Trans proline' 0 C--O 1.199 -1.462 0 C-N-CA 123.475 2.783 . . . . 0.8 111.006 173.735 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A 1644 ' ' LEU . . . . . . . . . . . . . 83.6 mt -91.84 -9.67 42.56 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 116.608 -0.269 . . . . 1.54 111.417 -177.968 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A 1645 ' ' ALA . . . . . . . . . . . . . . . -81.67 -35.98 29.29 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 121.805 0.812 . . . . 0.95 109.128 177.45 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A 1646 ' ' CYS . . . . . 0.523 ' HB2' ' HB3' ' A' 1614 ' ' CYS . 71.2 m -142.19 114.76 8.48 Favored 'General case' 0 N--CA 1.426 -1.645 0 N-CA-C 105.499 -2.037 . . . . 1.41 105.499 174.786 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A 1647 ' ' GLU . . . . . 0.422 ' HG2' ' O ' ' A' 1643 ' ' PRO . 42.2 mt-10 . . . . . 0 C--N 1.3 -1.56 0 N-CA-C 109.137 -0.69 . . . . 2.92 109.137 -178.413 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A 1515 ' ' ASP . . . . . . . . . . . . . 7.0 t0 . . . . . 0 N--CA 1.449 -0.491 0 N-CA-C 107.061 -1.459 . . . . 2.54 107.061 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A 1516 ' ' CYS . . . . . . . . . . . . . 81.3 m -90.65 61.53 4.87 Favored 'General case' 0 C--N 1.28 -2.422 0 C-N-CA 123.599 0.76 . . . . 1.25 109.183 -179.761 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A 1517 ' ' GLN . . . . . 0.415 ' HB2' HD21 ' A' 1526 ' ' LEU . 9.8 pt20 -160.97 131.9 5.39 Favored 'General case' 0 C--N 1.308 -1.211 0 CA-C-O 120.803 0.335 . . . . 1.88 110.695 179.219 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A 1518 ' ' VAL . . . . . . . . . . . . . 14.1 p -131.88 137.32 55.19 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.804 0 N-CA-C 109.053 -0.721 . . . . 1.73 109.053 178.429 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A 1519 ' ' THR . . . . . 0.62 ' HA ' ' HA ' ' A' 1526 ' ' LEU . 40.0 m -89.37 128.65 35.93 Favored 'General case' 0 C--N 1.29 -1.98 0 CA-C-N 116.182 -0.463 . . . . 1.7 109.758 177.891 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A 1520 ' ' ASN . . . . . . . . . . . . . 17.7 t-20 -80.1 114.3 45.6 Favored Pre-proline 0 C--N 1.308 -1.228 0 N-CA-C 108.473 -0.936 . . . . 2.12 108.473 174.758 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A 1521 ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -74.63 0.2 9.0 Favored 'Trans proline' 0 CA--C 1.539 0.767 0 C-N-CA 122.541 2.16 . . . . 2.47 113.926 -176.371 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A 1522 ' ' SER . . . . . . . . . . . . . 49.3 m -88.79 -62.34 1.51 Allowed 'General case' 0 N--CA 1.432 -1.375 0 O-C-N 122.13 -0.356 . . . . 2.57 110.895 178.784 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A 1523 ' ' THR . . . . . . . . . . . . . 8.8 t -92.98 -11.89 32.09 Favored 'General case' 0 CA--C 1.547 0.858 0 CA-C-O 120.952 0.406 . . . . 2.15 111.253 -179.821 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A 1524 ' ' GLY . . . . . . . . . . . . . . . 80.33 27.79 50.81 Favored Glycine 0 C--N 1.332 0.329 0 C-N-CA 121.059 -0.591 . . . . 1.89 112.119 179.244 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A 1525 ' ' HIS . . . . . . . . . . . . . 16.1 t60 -101.22 119.18 38.36 Favored 'General case' 0 C--N 1.309 -1.169 0 N-CA-C 110.184 -0.302 . . . . 1.9 110.184 -176.802 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A 1526 ' ' LEU . . . . . 0.62 ' HA ' ' HA ' ' A' 1519 ' ' THR . 7.0 tt -82.72 124.73 30.5 Favored 'General case' 0 C--N 1.301 -1.533 0 N-CA-C 108.174 -1.047 . . . . 1.61 108.174 175.651 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A 1527 ' ' PHE . . . . . 0.408 ' O ' ' HA ' ' A' 1517 ' ' GLN . 76.4 m-85 -90.32 102.41 15.14 Favored 'General case' 0 C--N 1.309 -1.194 0 N-CA-C 109.183 -0.673 . . . . 1.42 109.183 178.233 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A 1528 ' ' ASP . . . . . . . . . . . . . 8.8 t70 -80.76 118.13 22.03 Favored 'General case' 0 C--N 1.309 -1.154 0 CA-C-O 121.336 0.588 . . . . 2.18 111.633 178.306 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A 1529 ' ' LEU . . . . . . . . . . . . . 6.2 mp -121.05 11.47 10.96 Favored 'General case' 0 C--N 1.307 -1.28 0 N-CA-C 106.496 -1.668 . . . . 1.44 106.496 168.149 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A 1530 ' ' SER . . . . . . . . . . . . . 42.9 m -76.18 -29.1 57.54 Favored 'General case' 0 N--CA 1.442 -0.867 0 CA-C-N 115.376 -0.829 . . . . 1.44 110.06 -178.615 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A 1531 ' ' SER . . . . . . . . . . . . . 29.0 t -75.32 -6.35 49.44 Favored 'General case' 0 CA--C 1.548 0.903 0 CA-C-O 122.303 1.049 . . . . 1.5 108.806 174.518 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A 1532 ' ' LEU . . . . . . . . . . . . . 98.1 mt -91.89 15.24 13.49 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.807 -0.633 . . . . 1.77 110.616 175.243 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A 1533 ' ' SER . . . . . 0.425 ' HA ' ' O ' ' A' 1553 ' ' CYS . 18.8 m -84.56 122.11 28.57 Favored 'General case' 0 N--CA 1.432 -1.35 0 N-CA-C 108.619 -0.882 . . . . 2.38 108.619 175.668 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A 1534 ' ' GLY . . . . . . . . . . . . . . . -135.92 152.77 21.15 Favored Glycine 0 N--CA 1.419 -2.448 0 N-CA-C 110.594 -1.002 . . . . 1.55 110.594 -179.255 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A 1535 ' ' ARG . . . . . 0.584 ' HG3' ' HG3' ' A' 1555 ' ' GLU . 51.2 ttt180 -96.44 -25.13 15.8 Favored 'General case' 0 C--N 1.306 -1.283 0 CA-C-O 121.669 0.747 . . . . 3.96 109.886 179.049 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A 1536 ' ' ALA . . . . . . . . . . . . . . . -89.72 -41.03 12.14 Favored 'General case' 0 C--O 1.243 0.732 0 CA-C-N 115.587 -0.733 . . . . 1.65 110.849 -179.043 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A 1537 ' ' GLY . . . . . . . . . . . . . . . 97.7 -175.95 30.62 Favored Glycine 0 N--CA 1.435 -1.382 0 CA-C-N 115.761 -0.654 . . . . 1.19 112.477 176.75 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A 1538 ' ' PHE . . . . . . . . . . . . . 92.1 m-85 -111.64 155.09 23.94 Favored 'General case' 0 C--N 1.302 -1.49 0 N-CA-C 108.212 -1.033 . . . . 1.69 108.212 176.687 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A 1539 ' ' THR . . . . . . . . . . . . . 5.2 p -106.27 111.08 23.52 Favored 'General case' 0 C--N 1.295 -1.761 0 CA-C-N 116.016 -0.538 . . . . 1.48 111.538 -179.704 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A 1540 ' ' ALA . . . . . . . . . . . . . . . -112.32 107.63 16.53 Favored 'General case' 0 C--N 1.313 -0.988 0 N-CA-C 109.027 -0.731 . . . . 0.83 109.027 176.014 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A 1541 ' ' ALA . . . . . . . . . . . . . . . -71.75 155.23 40.69 Favored 'General case' 0 C--N 1.312 -1.037 0 CA-C-N 116.261 -0.427 . . . . 1.27 110.644 178.705 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A 1542 ' ' TYR . . . . . 0.414 ' HD2' ' HB2' ' A' 1545 ' ' SER . 32.4 t80 -156.23 179.92 8.77 Favored 'General case' 0 C--N 1.302 -1.491 0 N-CA-C 107.708 -1.219 . . . . 2.15 107.708 -178.926 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A 1543 ' ' SER . . . . . . . . . . . . . 5.5 m -44.98 -151.67 0.0 OUTLIER 'General case' 0 CA--C 1.57 1.728 0 C-N-CA 129.181 2.993 . . . . 2.29 114.616 178.101 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A 1544 ' ' LYS . . . . . 0.414 ' HB2' ' HE3' ' A' 1544 ' ' LYS . 19.4 ptmt -54.7 -6.9 0.13 Allowed 'General case' 0 CA--C 1.575 1.931 0 O-C-N 120.251 -1.531 . . . . 3.91 114.021 176.511 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A 1545 ' ' SER . . . . . 0.414 ' HB2' ' HD2' ' A' 1542 ' ' TYR . 20.4 m -73.03 -17.4 61.44 Favored 'General case' 0 CA--C 1.554 1.132 0 C-N-CA 123.332 0.653 . . . . 3.3 109.693 170.668 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A 1546 ' ' GLY . . . . . . . . . . . . . . . 83.75 -80.38 1.83 Allowed Glycine 0 N--CA 1.436 -1.316 0 CA-C-O 121.43 0.461 . . . . 1.24 114.009 174.093 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A 1547 ' ' VAL . . . . . . . . . . . . . 7.1 p -160.16 140.77 3.78 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.169 0 N-CA-C 109.235 -0.654 . . . . 1.63 109.235 -174.738 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A 1548 ' ' VAL . . . . . . . . . . . . . 4.0 t -108.29 131.9 57.52 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.726 0 N-CA-C 107.399 -1.334 . . . . 0.92 107.399 179.398 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A 1549 ' ' TYR . . . . . . . . . . . . . 68.4 m-85 -93.15 114.64 27.2 Favored 'General case' 0 C--N 1.308 -1.207 0 N-CA-C 106.858 -1.534 . . . . 1.44 106.858 174.077 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A 1550 ' ' MET . . . . . . . . . . . . . 56.3 ttp -135.93 121.6 19.64 Favored 'General case' 0 C--N 1.299 -1.614 0 C-N-CA 119.706 -0.798 . . . . 1.74 111.388 -177.774 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A 1551 ' ' SER . . . . . . . . . . . . . 19.9 m -95.97 124.1 39.84 Favored 'General case' 0 C--N 1.277 -2.568 0 N-CA-C 104.801 -2.296 . . . . 1.64 104.801 173.017 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A 1552 ' ' ILE . . . . . . . . . . . . . 50.6 mm -60.86 -43.2 95.12 Favored 'Isoleucine or valine' 0 C--O 1.213 -0.854 0 N-CA-C 109.404 -0.591 . . . . 1.33 109.404 -179.037 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A 1553 ' ' CYS . . . . . 0.425 ' O ' ' HA ' ' A' 1533 ' ' SER . 76.1 m -144.71 155.87 43.79 Favored 'General case' 0 C--N 1.295 -1.782 0 N-CA-C 106.491 -1.67 . . . . 1.43 106.491 173.411 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A 1554 ' ' GLY . . . . . . . . . . . . . . . 118.26 -110.92 2.05 Favored Glycine 0 N--CA 1.434 -1.489 0 C-N-CA 120.342 -0.932 . . . . 1.12 112.763 176.427 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A 1555 ' ' GLU . . . . . 0.584 ' HG3' ' HG3' ' A' 1535 ' ' ARG . 9.5 pt-20 -165.34 161.94 19.33 Favored 'General case' 0 C--N 1.305 -1.33 0 N-CA-C 106.724 -1.584 . . . . 1.8 106.724 -178.207 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A 1556 ' ' ASN . . . . . . . . . . . . . 17.9 t-20 -131.34 103.65 6.57 Favored 'General case' 0 C--N 1.287 -2.136 0 N-CA-C 109.332 -0.618 . . . . 2.63 109.332 -179.209 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A 1557 ' ' GLU . . . . . . . . . . . . . 9.1 mm-40 -83.13 36.65 0.52 Allowed 'General case' 0 C--N 1.3 -1.576 0 N-CA-C 113.782 1.03 . . . . 3.79 113.782 -173.2 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A 1558 ' ' ASN . . . . . . . . . . . . . 33.0 m-80 -111.78 -19.35 12.47 Favored 'General case' 0 C--N 1.295 -1.802 0 N-CA-C 107.846 -1.168 . . . . 1.52 107.846 176.244 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A 1559 ' ' CYS . . . . . 0.778 ' HB3' ' HD2' ' A' 1560 ' ' PRO . 70.8 m -138.51 176.48 2.63 Favored Pre-proline 0 N--CA 1.436 -1.156 0 CA-C-O 116.866 -1.54 . . . . 0.84 107.088 -178.103 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A 1560 ' ' PRO . . . . . 0.778 ' HD2' ' HB3' ' A' 1559 ' ' CYS . 2.9 Cg_exo -33.2 126.93 0.13 Allowed 'Trans proline' 0 C--N 1.386 2.538 0 C-N-CA 124.578 3.518 . . . . 1.18 115.149 -177.412 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A 1561 ' ' PRO . . . . . 0.473 ' HD2' ' HA ' ' A' 1560 ' ' PRO . 9.5 Cg_endo -51.37 111.86 0.67 Allowed 'Trans proline' 0 C--O 1.246 0.898 0 C-N-CA 123.675 2.917 . . . . 1.51 112.98 -179.294 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A 1562 ' ' GLY . . . . . . . . . . . . . . . 111.39 2.94 27.63 Favored Glycine 0 N--CA 1.437 -1.255 0 CA-C-N 115.436 -0.802 . . . . 0.72 113.018 177.937 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A 1563 ' ' VAL . . . . . 0.601 ' HA ' ' HA ' ' A' 1576 ' ' LYS . 14.9 m -94.06 152.0 3.64 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.055 0 N-CA-C 106.288 -1.745 . . . . 0.97 106.288 172.723 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A 1564 ' ' GLY . . . . . 0.601 ' HA3' ' CE2' ' A' 1592 ' ' TYR . . . -113.86 -26.41 3.86 Favored Glycine 0 C--N 1.307 -1.059 0 C-N-CA 119.28 -1.438 . . . . 0.72 113.139 -175.986 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A 1565 ' ' ALA . . . . . . . . . . . . . . . -132.59 126.11 32.01 Favored 'General case' 0 C--O 1.251 1.181 0 N-CA-C 109.63 -0.507 . . . . 0.37 109.63 -178.779 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A 1566 ' ' CYS . . . . . . . . . . . . . 43.2 t -150.4 139.7 21.31 Favored 'General case' 0 C--N 1.311 -1.075 0 CA-C-N 115.728 -0.669 . . . . 0.51 110.064 -174.774 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A 1567 ' ' PHE . . . . . . . . . . . . . 26.5 m-85 -69.84 123.13 20.68 Favored 'General case' 0 CA--C 1.508 -0.665 0 N-CA-C 107.396 -1.335 . . . . 0.97 107.396 175.755 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A 1568 ' ' GLY . . . . . . . . . . . . . . . -74.66 -37.27 46.15 Favored Glycine 0 N--CA 1.441 -1.023 0 C-N-CA 120.677 -0.773 . . . . 1.08 113.769 -173.627 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A 1569 ' ' GLN . . . . . . . . . . . . . 50.1 tp60 -69.35 -48.61 60.82 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-O 121.976 0.893 . . . . 2.74 109.44 -178.947 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A 1570 ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -80.71 -23.08 39.75 Favored 'General case' 0 C--N 1.301 -1.537 0 CA-C-N 114.387 -1.279 . . . . 1.96 112.397 -173.498 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A 1571 ' ' ARG . . . . . . . . . . . . . 40.5 mtp-105 64.32 32.15 12.38 Favored 'General case' 0 N--CA 1.472 0.64 0 C-N-CA 125.035 1.334 . . . . 3.95 111.864 -178.833 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A 1572 ' ' ILE . . . . . . . . . . . . . 49.8 mm -109.66 118.98 58.02 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.227 0 N-CA-C 108.972 -0.751 . . . . 1.37 108.972 -178.361 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A 1573 ' ' SER . . . . . . . . . . . . . 36.7 t -67.28 140.08 57.32 Favored 'General case' 0 N--CA 1.435 -1.205 0 CA-C-N 115.064 -0.971 . . . . 1.08 109.453 178.379 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A 1574 ' ' VAL . . . . . 0.523 ' HB ' ' HB2' ' A' 1606 ' ' TYR . 23.0 m -116.01 -38.96 2.48 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.653 0 C-N-CA 119.978 -0.689 . . . . 1.3 110.663 178.606 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A 1575 ' ' GLY . . . . . 0.798 ' HA3' ' HB3' ' A' 1592 ' ' TYR . . . -135.87 133.1 6.45 Favored Glycine 0 N--CA 1.428 -1.836 0 C-N-CA 120.376 -0.916 . . . . 0.51 112.729 -177.592 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A 1576 ' ' LYS . . . . . 0.601 ' HA ' ' HA ' ' A' 1563 ' ' VAL . 24.4 ttpp -85.89 149.37 25.27 Favored 'General case' 0 C--N 1.309 -1.191 0 N-CA-C 107.307 -1.368 . . . . 2.9 107.307 178.608 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A 1577 ' ' ALA . . . . . . . . . . . . . . . -63.44 133.91 54.77 Favored 'General case' 0 CA--C 1.501 -0.924 0 O-C-N 123.793 0.683 . . . . 0.83 109.503 179.128 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A 1578 ' ' ASN . . . . . . . . . . . . . 7.8 p30 -153.27 144.96 23.42 Favored 'General case' 0 C--N 1.282 -2.369 0 N-CA-C 105.638 -1.986 . . . . 1.85 105.638 179.867 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A 1579 ' ' LYS . . . . . . . . . . . . . 67.9 mttm -114.48 89.3 3.06 Favored 'General case' 0 C--N 1.29 -2.019 0 C-N-CA 118.631 -1.228 . . . . 1.9 110.791 -176.703 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A 1580 ' ' ARG . . . . . . . . . . . . . 53.1 ttt180 -156.72 131.07 8.63 Favored 'General case' 0 N--CA 1.415 -2.207 0 CA-C-N 115.288 -0.869 . . . . 3.63 109.42 172.712 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A 1581 ' ' LEU . . . . . 0.415 HD13 HD12 ' A' 1588 ' ' LEU . 2.3 pp -124.88 150.66 46.26 Favored 'General case' 0 C--N 1.284 -2.282 0 N-CA-C 108.784 -0.821 . . . . 1.87 108.784 175.857 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A 1582 ' ' ARG . . . . . . . . . . . . . 90.0 mtt180 -115.82 125.7 53.03 Favored 'General case' 0 C--N 1.288 -2.082 0 CA-C-O 121.0 0.429 . . . . 3.97 110.052 -176.592 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A 1583 ' ' TYR . . . . . 0.481 ' CE1' ' HA ' ' A' 1586 ' ' GLN . 58.8 t80 -94.0 91.25 6.78 Favored 'General case' 0 C--N 1.289 -2.031 0 N-CA-C 107.714 -1.217 . . . . 1.41 107.714 179.115 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A 1584 ' ' VAL . . . . . . . . . . . . . 4.4 p -107.21 95.37 3.74 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.85 0 CA-C-O 121.824 0.821 . . . . 1.69 111.4 -176.909 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A 1585 ' ' ASP . . . . . . . . . . . . . 27.9 t70 52.69 67.89 0.92 Allowed 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 114.695 -1.139 . . . . 2.06 111.359 -177.954 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A 1586 ' ' GLN . . . . . 0.481 ' HA ' ' CE1' ' A' 1583 ' ' TYR . 49.6 mt-30 66.31 -15.23 0.13 Allowed 'General case' 0 C--N 1.315 -0.905 0 N-CA-C 115.873 1.805 . . . . 2.33 115.873 177.73 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A 1587 ' ' VAL . . . . . . . . . . . . . 10.9 p -99.38 123.21 51.94 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.028 0 CA-C-N 119.119 0.872 . . . . 0.78 109.684 178.301 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A 1588 ' ' LEU . . . . . 0.541 ' HB2' ' HB2' ' A' 1612 ' ' PHE . 4.1 mm? -81.96 140.18 34.16 Favored 'General case' 0 N--CA 1.43 -1.472 0 CA-C-N 115.581 -0.736 . . . . 1.41 111.885 -178.848 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A 1589 ' ' GLN . . . . . . . . . . . . . 35.1 tt0 -129.78 122.1 28.13 Favored 'General case' 0 C--N 1.303 -1.454 0 CA-C-N 115.573 -0.74 . . . . 1.24 109.926 179.073 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A 1590 ' ' LEU . . . . . . . . . . . . . 6.8 tt -119.16 132.94 56.02 Favored 'General case' 0 C--N 1.304 -1.393 0 N-CA-C 106.569 -1.641 . . . . 1.15 106.569 176.583 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A 1591 ' ' VAL . . . . . 0.579 HG12 HG22 ' A' 1609 ' ' VAL . 35.3 m -124.29 144.7 33.21 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.837 0 CA-C-O 121.688 0.756 . . . . 1.51 112.956 -173.509 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A 1592 ' ' TYR . . . . . 0.798 ' HB3' ' HA3' ' A' 1575 ' ' GLY . 22.5 m-85 -106.66 123.49 48.2 Favored 'General case' 0 C--N 1.298 -1.664 0 CA-C-N 115.078 -0.964 . . . . 1.06 110.298 172.249 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A 1593 ' ' LYS . . . . . . . . . . . . . 20.5 ptmt -142.59 -178.64 5.87 Favored 'General case' 0 C--N 1.298 -1.67 0 CA-C-N 114.364 -1.289 . . . . 2.18 108.072 -173.59 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A 1594 ' ' ASP . . . . . 0.523 ' HB2' ' HE3' ' A' 1576 ' ' LYS . 57.9 m-20 67.05 14.88 9.98 Favored 'General case' 0 N--CA 1.491 1.618 0 C-N-CA 124.098 0.959 . . . . 1.45 113.265 175.253 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A 1595 ' ' GLY . . . . . . . . . . . . . . . -90.54 -105.89 1.29 Allowed Glycine 0 N--CA 1.432 -1.587 0 N-CA-C 111.212 -0.755 . . . . 0.78 111.212 179.106 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A 1596 ' ' SER . . . . . 0.438 ' HA ' ' HD3' ' A' 1597 ' ' PRO . 23.0 m -106.65 128.05 26.93 Favored Pre-proline 0 C--N 1.295 -1.795 0 N-CA-C 109.679 -0.489 . . . . 1.68 109.679 179.9 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A 1597 ' ' PRO . . . . . 0.438 ' HD3' ' HA ' ' A' 1596 ' ' SER . 32.3 Cg_exo -63.07 150.95 87.16 Favored 'Trans proline' 0 C--O 1.238 0.516 0 C-N-CA 123.289 2.659 . . . . 1.17 110.866 176.554 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A 1598 ' ' CYS . . . . . 0.481 ' HA ' ' HD3' ' A' 1599 ' ' PRO . 50.2 t -94.93 132.63 27.85 Favored Pre-proline 0 C--N 1.293 -1.851 0 N-CA-C 109.961 -0.385 . . . . 1.19 109.961 -177.675 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A 1599 ' ' PRO . . . . . 0.481 ' HD3' ' HA ' ' A' 1598 ' ' CYS . 11.8 Cg_exo -72.29 -7.5 21.05 Favored 'Trans proline' 0 C--N 1.362 1.24 0 C-N-CA 123.392 2.728 . . . . 1.59 112.165 -179.97 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A 1600 ' ' SER . . . . . . . . . . . . . 44.9 t -113.14 123.67 50.79 Favored 'General case' 0 N--CA 1.421 -1.906 0 N-CA-C 107.757 -1.201 . . . . 2.12 107.757 177.603 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A 1601 ' ' LYS . . . . . . . . . . . . . 34.9 mmtp 57.13 50.92 11.06 Favored 'General case' 0 C--O 1.241 0.633 0 O-C-N 123.64 0.587 . . . . 3.74 109.814 -179.623 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A 1602 ' ' SER . . . . . . . . . . . . . 50.9 m -54.04 140.56 31.15 Favored 'General case' 0 N--CA 1.439 -0.992 0 CA-C-N 114.964 -1.016 . . . . 3.79 113.254 -175.988 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A 1603 ' ' GLY . . . . . . . . . . . . . . . 135.75 -10.9 4.27 Favored Glycine 0 N--CA 1.434 -1.466 0 N-CA-C 108.954 -1.659 . . . . 2.0 108.954 -173.327 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A 1604 ' ' LEU . . . . . . . . . . . . . 1.3 pp -135.42 162.4 32.72 Favored 'General case' 0 N--CA 1.437 -1.075 0 C-N-CA 123.897 0.879 . . . . 1.48 110.449 179.834 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A 1605 ' ' SER . . . . . . . . . . . . . 11.4 m -99.71 -176.04 3.15 Favored 'General case' 0 C--N 1.302 -1.46 0 N-CA-C 109.012 -0.736 . . . . 1.51 109.012 -178.611 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A 1606 ' ' TYR . . . . . 0.62 ' HA ' ' HB3' ' A' 1634 ' ' CYS . 78.5 m-85 -81.71 97.12 7.78 Favored 'General case' 0 CA--C 1.477 -1.837 0 N-CA-C 103.325 -2.843 . . . . 1.18 103.325 171.508 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A 1607 ' ' LYS . . . . . . . . . . . . . 17.3 ptmt -103.53 125.52 50.13 Favored 'General case' 0 C--N 1.26 -3.285 0 C-N-CA 119.695 -0.802 . . . . 1.67 112.041 -165.57 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A 1608 ' ' SER . . . . . 0.422 ' HB2' ' HB2' ' A' 1592 ' ' TYR . 16.5 m -98.62 117.29 32.73 Favored 'General case' 0 C--N 1.296 -1.73 0 CA-C-N 114.796 -1.093 . . . . 1.0 108.95 -179.102 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A 1609 ' ' VAL . . . . . 0.579 HG22 HG12 ' A' 1591 ' ' VAL . 98.1 t -112.12 117.19 54.59 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.22 0 N-CA-C 109.194 -0.669 . . . . 0.93 109.194 179.775 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A 1610 ' ' ILE . . . . . 0.717 HG13 ' HB2' ' A' 1638 ' ' PHE . 2.9 mp -105.36 114.53 45.1 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.178 0 N-CA-C 108.695 -0.854 . . . . 0.78 108.695 178.108 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A 1611 ' ' SER . . . . . . . . . . . . . 63.5 p -90.66 124.19 34.87 Favored 'General case' 0 N--CA 1.43 -1.465 0 N-CA-C 108.324 -0.991 . . . . 1.29 108.324 175.541 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A 1612 ' ' PHE . . . . . 0.541 ' HB2' ' HB2' ' A' 1588 ' ' LEU . 96.2 m-85 -93.23 107.74 19.49 Favored 'General case' 0 C--N 1.297 -1.71 0 CA-C-N 116.209 -0.45 . . . . 0.7 109.914 -179.125 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A 1613 ' ' VAL . . . . . . . . . . . . . 66.7 t -104.8 132.59 51.14 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.137 0 O-C-N 124.723 1.265 . . . . 0.75 108.895 -178.787 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A 1614 ' ' CYS . . . . . 0.427 ' HA ' ' O ' ' A' 1642 ' ' THR . 55.8 m -76.88 103.78 7.02 Favored 'General case' 0 C--N 1.295 -1.797 0 CA-C-N 114.973 -1.012 . . . . 1.39 111.433 -175.092 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A 1615 ' ' ARG . . . . . . . . . . . . . 38.3 mmt180 -123.7 86.7 52.83 Favored Pre-proline 0 C--N 1.306 -1.312 0 CA-C-N 115.541 -0.754 . . . . 3.75 110.067 179.041 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A 1616 ' ' PRO . . . . . . . . . . . . . 42.7 Cg_endo -66.25 -28.78 47.44 Favored 'Trans proline' 0 C--N 1.348 0.511 0 C-N-CA 122.919 2.412 . . . . 1.32 113.392 -177.44 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A 1617 ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 . . . . . 0 C--N 1.319 -0.721 0 CA-C-O 121.408 0.623 . . . . 3.21 111.117 -178.065 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A 1622 ' ' ASN . . . . . 0.452 ' HA ' ' O ' ' A' 1641 ' ' HIS . 53.8 t-20 . . . . . 0 N--CA 1.479 0.999 0 CA-C-O 121.576 0.703 . . . . 2.92 109.564 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A 1623 ' ' ARG . . . . . . . . . . . . . 15.5 ptm180 -155.15 151.0 21.88 Favored Pre-proline 0 C--N 1.31 -1.114 0 CA-C-N 115.8 -0.637 . . . . 3.61 109.467 179.781 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A 1624 ' ' PRO . . . . . 0.511 ' HA ' ' O ' ' A' 1639 ' ' SER . 39.5 Cg_endo -87.14 101.17 0.52 Allowed 'Trans proline' 0 N--CA 1.443 -1.452 0 C-N-CA 122.777 2.318 . . . . 2.37 111.112 174.931 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A 1625 ' ' MET . . . . . . . . . . . . . 1.5 pmm? -96.17 153.3 17.87 Favored 'General case' 0 C--N 1.301 -1.505 0 N-CA-C 109.701 -0.481 . . . . 2.16 109.701 179.696 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A 1626 ' ' LEU . . . . . . . . . . . . . 40.6 tp -81.91 105.25 12.88 Favored 'General case' 0 C--N 1.31 -1.145 0 N-CA-C 108.687 -0.857 . . . . 1.35 108.687 177.919 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A 1627 ' ' ILE . . . . . . . . . . . . . 46.2 pt -87.21 -26.39 5.94 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.988 0 CA-C-N 116.083 -0.508 . . . . 1.21 112.134 -175.187 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A 1628 ' ' SER . . . . . . . . . . . . . 13.0 t -160.8 144.49 13.46 Favored 'General case' 0 N--CA 1.437 -1.09 0 N-CA-C 109.496 -0.557 . . . . 1.4 109.496 -178.3 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A 1629 ' ' LEU . . . . . 1.006 ' HG ' ' HG ' ' A' 1636 ' ' LEU . 4.4 tt -133.96 112.27 11.11 Favored 'General case' 0 C--N 1.306 -1.319 0 N-CA-C 107.023 -1.473 . . . . 1.56 107.023 177.572 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A 1630 ' ' ASP . . . . . . . . . . . . . 29.4 t70 -92.23 117.56 30.0 Favored 'General case' 0 C--N 1.307 -1.248 0 N-CA-C 108.84 -0.8 . . . . 0.87 108.84 177.553 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A 1631 ' ' LYS . . . . . . . . . . . . . 94.8 mttt -86.48 -5.77 59.07 Favored 'General case' 0 C--N 1.303 -1.422 0 CA-C-N 116.454 -0.339 . . . . 2.35 111.572 -176.253 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A 1632 ' ' GLN . . . . . . . . . . . . . 39.2 mt-30 -81.43 -45.67 15.71 Favored 'General case' 0 N--CA 1.447 -0.588 0 N-CA-C 109.961 -0.385 . . . . 2.55 109.961 -178.981 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A 1633 ' ' THR . . . . . . . . . . . . . 11.4 p -109.82 13.21 23.68 Favored 'General case' 0 C--N 1.305 -1.353 0 CA-C-N 115.799 -0.637 . . . . 1.24 111.639 178.495 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A 1634 ' ' CYS . . . . . 0.62 ' HB3' ' HA ' ' A' 1606 ' ' TYR . 65.4 m 47.52 41.89 13.81 Favored 'General case' 0 N--CA 1.474 0.728 0 C-N-CA 123.943 0.897 . . . . 0.89 112.976 179.879 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A 1635 ' ' THR . . . . . . . . . . . . . 33.4 m -105.33 117.07 33.08 Favored 'General case' 0 N--CA 1.417 -2.079 0 CA-C-N 115.368 -0.833 . . . . 0.75 109.596 -177.542 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A 1636 ' ' LEU . . . . . 1.006 ' HG ' ' HG ' ' A' 1629 ' ' LEU . 5.4 mp -101.84 129.73 48.13 Favored 'General case' 0 C--N 1.311 -1.09 0 N-CA-C 109.15 -0.685 . . . . 1.33 109.15 179.966 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A 1637 ' ' PHE . . . . . . . . . . . . . 80.6 m-85 -108.1 109.92 21.47 Favored 'General case' 0 C--N 1.308 -1.237 0 CA-C-N 116.27 -0.423 . . . . 0.83 111.123 -175.874 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A 1638 ' ' PHE . . . . . 0.717 ' HB2' HG13 ' A' 1610 ' ' ILE . 97.1 m-85 -107.68 149.01 28.64 Favored 'General case' 0 C--N 1.304 -1.391 0 N-CA-C 108.454 -0.943 . . . . 0.6 108.454 176.151 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A 1639 ' ' SER . . . . . 0.511 ' O ' ' HA ' ' A' 1624 ' ' PRO . 43.5 m -137.58 121.18 17.3 Favored 'General case' 0 C--N 1.294 -1.825 0 N-CA-C 109.795 -0.446 . . . . 1.08 109.795 178.051 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A 1640 ' ' TRP . . . . . 0.449 ' CD1' ' HB ' ' A' 1642 ' ' THR . 3.8 t90 -100.61 125.13 46.97 Favored 'General case' 0 C--N 1.314 -0.966 0 N-CA-C 108.445 -0.946 . . . . 0.8 108.445 -179.828 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A 1641 ' ' HIS . . . . . 0.452 ' O ' ' HA ' ' A' 1622 ' ' ASN . 11.4 m-70 -89.67 94.79 9.98 Favored 'General case' 0 C--N 1.307 -1.277 0 N-CA-C 105.63 -1.989 . . . . 2.54 105.63 175.093 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A 1642 ' ' THR . . . . . 0.655 ' OG1' ' HG ' ' A' 1644 ' ' LEU . 12.2 t -142.12 138.39 16.73 Favored Pre-proline 0 C--N 1.303 -1.419 0 C-N-CA 119.663 -0.815 . . . . 1.15 112.867 -171.886 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A 1643 ' ' PRO . . . . . 0.477 ' HD3' ' HA ' ' A' 1642 ' ' THR . 15.1 Cg_exo -71.96 -25.14 20.01 Favored 'Trans proline' 0 N--CA 1.456 -0.733 0 C-N-CA 123.34 2.694 . . . . 0.8 112.027 175.969 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A 1644 ' ' LEU . . . . . 0.655 ' HG ' ' OG1' ' A' 1642 ' ' THR . 4.0 pp -70.55 -17.17 62.93 Favored 'General case' 0 N--CA 1.478 0.932 0 N-CA-C 112.348 0.499 . . . . 1.54 112.348 -176.636 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A 1645 ' ' ALA . . . . . . . . . . . . . . . -64.0 -41.52 97.47 Favored 'General case' 0 N--CA 1.448 -0.543 0 CA-C-N 115.495 -0.775 . . . . 0.95 109.24 178.948 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A 1646 ' ' CYS . . . . . . . . . . . . . 19.2 p -177.11 116.02 0.1 Allowed 'General case' 0 C--O 1.244 0.791 0 C-N-CA 124.473 1.109 . . . . 1.41 108.342 171.903 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A 1647 ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 C--N 1.294 -1.834 0 O-C-N 121.961 -0.462 . . . . 2.92 110.212 179.164 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A 1515 ' ' ASP . . . . . . . . . . . . . 3.4 p-10 . . . . . 0 N--CA 1.437 -1.081 0 N-CA-C 103.536 -2.765 . . . . 2.54 103.536 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A 1516 ' ' CYS . . . . . 0.509 ' HB3' ' HB2' ' A' 1529 ' ' LEU . 58.1 m -79.37 61.75 3.52 Favored 'General case' 0 C--N 1.301 -1.541 0 N-CA-C 113.924 1.083 . . . . 1.25 113.924 -172.375 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A 1517 ' ' GLN . . . . . 0.549 ' HB2' HD21 ' A' 1526 ' ' LEU . 11.1 pt20 -145.22 122.14 11.31 Favored 'General case' 0 N--CA 1.425 -1.702 0 N-CA-C 107.41 -1.329 . . . . 1.88 107.41 172.351 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A 1518 ' ' VAL . . . . . . . . . . . . . 84.9 t -109.23 106.21 20.26 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.941 0 N-CA-C 109.059 -0.719 . . . . 1.73 109.059 179.98 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A 1519 ' ' THR . . . . . . . . . . . . . 19.0 m -86.36 113.19 22.13 Favored 'General case' 0 C--N 1.287 -2.111 0 N-CA-C 107.066 -1.457 . . . . 1.7 107.066 175.772 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A 1520 ' ' ASN . . . . . . . . . . . . . 49.8 t-20 -87.52 104.81 7.1 Favored Pre-proline 0 C--N 1.308 -1.216 0 N-CA-C 107.766 -1.198 . . . . 2.12 107.766 179.437 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A 1521 ' ' PRO . . . . . . . . . . . . . 63.3 Cg_endo -71.48 -12.17 29.13 Favored 'Trans proline' 0 C--N 1.353 0.803 0 C-N-CA 122.505 2.137 . . . . 2.47 112.831 -174.613 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A 1522 ' ' SER . . . . . . . . . . . . . 5.8 m -76.95 -23.32 52.39 Favored 'General case' 0 N--CA 1.431 -1.421 0 CA-C-N 115.988 -0.551 . . . . 2.57 110.242 -178.953 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A 1523 ' ' THR . . . . . . . . . . . . . 5.0 t -127.44 -23.52 3.48 Favored 'General case' 0 CA--C 1.545 0.756 0 N-CA-C 112.46 0.541 . . . . 2.15 112.46 179.319 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A 1524 ' ' GLY . . . . . . . . . . . . . . . 100.1 -17.7 56.73 Favored Glycine 0 N--CA 1.447 -0.568 0 C-N-CA 120.566 -0.826 . . . . 1.89 112.168 -179.002 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A 1525 ' ' HIS . . . . . . . . . . . . . 17.4 t-80 -75.3 134.64 41.01 Favored 'General case' 0 C--N 1.312 -1.048 0 C-N-CA 123.009 0.524 . . . . 1.9 111.244 -177.379 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A 1526 ' ' LEU . . . . . 0.549 HD21 ' HB2' ' A' 1517 ' ' GLN . 7.1 tt -111.27 135.79 51.3 Favored 'General case' 0 C--N 1.313 -0.988 0 CA-C-N 115.666 -0.697 . . . . 1.61 109.271 -178.586 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A 1527 ' ' PHE . . . . . 0.529 ' O ' ' HA ' ' A' 1517 ' ' GLN . 85.2 m-85 -102.14 106.36 17.2 Favored 'General case' 0 C--N 1.312 -1.028 0 N-CA-C 108.893 -0.78 . . . . 1.42 108.893 177.334 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A 1528 ' ' ASP . . . . . . . . . . . . . 9.9 t70 -97.82 115.58 28.32 Favored 'General case' 0 C--N 1.319 -0.737 0 N-CA-C 109.654 -0.499 . . . . 2.18 109.654 179.76 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A 1529 ' ' LEU . . . . . 0.509 ' HB2' ' HB3' ' A' 1516 ' ' CYS . 84.6 mt -106.69 -12.99 15.4 Favored 'General case' 0 C--N 1.308 -1.21 0 CA-C-N 116.166 -0.47 . . . . 1.44 111.157 -178.398 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A 1530 ' ' SER . . . . . 0.492 ' HA ' ' HB3' ' A' 1553 ' ' CYS . 17.1 m -71.65 -47.38 54.75 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-O 121.036 0.446 . . . . 1.44 109.903 -178.102 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A 1531 ' ' SER . . . . . . . . . . . . . 13.3 m -70.01 -9.7 56.15 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.366 -0.833 . . . . 1.5 111.515 -175.936 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A 1532 ' ' LEU . . . . . . . . . . . . . 58.9 mt -76.55 -18.69 58.55 Favored 'General case' 0 C--N 1.313 -1.004 0 CA-C-N 116.382 -0.372 . . . . 1.77 110.446 178.142 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A 1533 ' ' SER . . . . . 0.486 ' OG ' ' HB ' ' A' 1552 ' ' ILE . 19.6 m -100.91 143.13 31.43 Favored 'General case' 0 C--N 1.315 -0.895 0 CA-C-N 116.226 -0.443 . . . . 2.38 110.848 -176.38 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A 1534 ' ' GLY . . . . . . . . . . . . . . . -102.18 -174.64 27.61 Favored Glycine 0 N--CA 1.42 -2.375 0 N-CA-C 109.512 -1.435 . . . . 1.55 109.512 175.401 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A 1535 ' ' ARG . . . . . . . . . . . . . 36.3 ttm180 -69.48 -50.05 48.99 Favored 'General case' 0 C--N 1.294 -1.815 0 N-CA-C 112.035 0.383 . . . . 3.96 112.035 -177.822 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A 1536 ' ' ALA . . . . . 0.567 ' HB1' HD21 ' A' 1558 ' ' ASN . . . -69.77 -48.89 57.57 Favored 'General case' 0 C--N 1.313 -0.979 0 CA-C-N 116.038 -0.528 . . . . 1.65 111.772 -175.82 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A 1537 ' ' GLY . . . . . 0.564 ' HA3' ' ND2' ' A' 1556 ' ' ASN . . . 119.66 -173.84 15.27 Favored Glycine 0 N--CA 1.444 -0.806 0 C-N-CA 121.289 -0.481 . . . . 1.19 112.914 175.535 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A 1538 ' ' PHE . . . . . 0.475 ' HE2' ' HA ' ' A' 1533 ' ' SER . 97.4 m-85 -116.51 170.37 8.62 Favored 'General case' 0 C--N 1.313 -1.013 0 C-N-CA 123.29 0.636 . . . . 1.69 109.917 -179.953 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A 1539 ' ' THR . . . . . 0.544 ' HA ' ' O ' ' A' 1548 ' ' VAL . 16.9 p -129.85 130.28 45.03 Favored 'General case' 0 N--CA 1.438 -1.042 0 CA-C-N 116.028 -0.533 . . . . 1.48 111.528 177.988 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A 1540 ' ' ALA . . . . . . . . . . . . . . . -103.36 146.98 27.67 Favored 'General case' 0 C--N 1.301 -1.52 0 N-CA-C 107.745 -1.206 . . . . 0.83 107.745 173.348 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A 1541 ' ' ALA . . . . . . . . . . . . . . . -77.88 130.89 37.16 Favored 'General case' 0 C--O 1.246 0.89 0 N-CA-C 109.815 -0.439 . . . . 1.27 109.815 -177.98 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A 1542 ' ' TYR . . . . . 0.698 ' HD2' ' HB2' ' A' 1545 ' ' SER . 70.0 t80 -139.88 168.09 20.61 Favored 'General case' 0 N--CA 1.437 -1.087 0 CA-C-O 119.425 -0.321 . . . . 2.15 110.245 -176.237 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A 1543 ' ' SER . . . . . . . . . . . . . 12.0 m -49.09 -151.99 0.0 OUTLIER 'General case' 0 CA--C 1.576 1.979 0 C-N-CA 128.796 2.838 . . . . 2.29 113.754 178.224 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A 1544 ' ' LYS . . . . . . . . . . . . . 39.7 ttmt -40.29 -35.48 0.42 Allowed 'General case' 0 N--CA 1.486 1.366 0 O-C-N 121.041 -1.037 . . . . 3.91 113.547 177.886 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A 1545 ' ' SER . . . . . 0.698 ' HB2' ' HD2' ' A' 1542 ' ' TYR . 19.3 m -66.55 -12.07 55.97 Favored 'General case' 0 CA--C 1.568 1.639 0 N-CA-C 112.856 0.688 . . . . 3.3 112.856 176.469 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A 1546 ' ' GLY . . . . . . . . . . . . . . . 82.24 -74.09 2.54 Favored Glycine 0 N--CA 1.446 -0.641 0 N-CA-C 114.6 0.6 . . . . 1.24 114.6 172.151 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A 1547 ' ' VAL . . . . . . . . . . . . . 15.4 m -138.41 146.52 26.56 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.244 0 CA-C-O 121.185 0.517 . . . . 1.63 111.272 -176.506 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A 1548 ' ' VAL . . . . . 0.544 ' O ' ' HA ' ' A' 1539 ' ' THR . 2.3 t -108.04 126.45 64.59 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.52 0 N-CA-C 106.675 -1.602 . . . . 0.92 106.675 176.573 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A 1549 ' ' TYR . . . . . 0.614 ' HD2' ' HA3' ' A' 1568 ' ' GLY . 6.4 m-85 -84.87 120.67 26.73 Favored 'General case' 0 C--N 1.301 -1.516 0 N-CA-C 108.452 -0.944 . . . . 1.44 108.452 174.906 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A 1550 ' ' MET . . . . . . . . . . . . . 60.7 mtp -135.87 164.96 26.74 Favored 'General case' 0 C--N 1.292 -1.924 0 CA-C-N 115.002 -0.999 . . . . 1.74 110.518 -173.489 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A 1551 ' ' SER . . . . . . . . . . . . . 13.9 p -129.7 144.57 51.35 Favored 'General case' 0 C--N 1.283 -2.31 0 N-CA-C 106.495 -1.668 . . . . 1.64 106.495 175.002 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A 1552 ' ' ILE . . . . . 0.486 ' HB ' ' OG ' ' A' 1533 ' ' SER . 46.0 mm -74.25 -29.44 24.71 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.483 0 N-CA-C 107.525 -1.287 . . . . 1.33 107.525 179.871 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A 1553 ' ' CYS . . . . . 0.492 ' HB3' ' HA ' ' A' 1530 ' ' SER . 46.7 t -161.79 149.96 15.08 Favored 'General case' 0 N--CA 1.419 -1.986 0 N-CA-C 105.93 -1.878 . . . . 1.43 105.93 171.661 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A 1554 ' ' GLY . . . . . . . . . . . . . . . 94.22 -153.42 21.07 Favored Glycine 0 N--CA 1.427 -1.919 0 C-N-CA 120.304 -0.95 . . . . 1.12 111.103 178.752 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A 1555 ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -122.73 145.0 48.79 Favored 'General case' 0 C--N 1.294 -1.825 0 CA-C-O 121.471 0.653 . . . . 1.8 110.963 -176.675 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A 1556 ' ' ASN . . . . . 0.564 ' ND2' ' HA3' ' A' 1537 ' ' GLY . 24.9 t-20 -87.59 138.25 31.63 Favored 'General case' 0 C--N 1.299 -1.605 0 N-CA-C 108.39 -0.967 . . . . 2.63 108.39 179.464 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A 1557 ' ' GLU . . . . . . . . . . . . . 42.9 mt-10 -114.45 34.1 4.93 Favored 'General case' 0 C--N 1.317 -0.806 0 N-CA-C 113.557 0.947 . . . . 3.79 113.557 -175.83 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A 1558 ' ' ASN . . . . . 0.567 HD21 ' HB1' ' A' 1536 ' ' ALA . 25.2 m-80 -128.65 26.13 5.63 Favored 'General case' 0 C--N 1.313 -0.981 0 CA-C-O 122.839 1.304 . . . . 1.52 108.389 173.039 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A 1559 ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -161.84 173.17 4.81 Favored Pre-proline 0 C--N 1.29 -1.999 0 N-CA-C 104.621 -2.362 . . . . 0.84 104.621 179.009 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A 1560 ' ' PRO . . . . . 0.627 ' O ' HG22 ' A' 1563 ' ' VAL . 2.4 Cg_endo -40.7 117.45 0.5 Allowed 'Trans proline' 0 C--N 1.365 1.397 0 C-N-CA 123.538 2.826 . . . . 1.18 113.0 178.187 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A 1561 ' ' PRO . . . . . . . . . . . . . 36.8 Cg_exo -57.84 111.85 0.97 Allowed 'Trans proline' 0 C--O 1.248 0.996 0 C-N-CA 122.428 2.085 . . . . 1.51 110.546 -179.398 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A 1562 ' ' GLY . . . . . . . . . . . . . . . 129.17 -0.22 6.01 Favored Glycine 0 N--CA 1.431 -1.687 0 CA-C-N 115.534 -0.757 . . . . 0.72 112.596 -177.646 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A 1563 ' ' VAL . . . . . 0.627 HG22 ' O ' ' A' 1560 ' ' PRO . 25.2 m -105.98 146.96 12.11 Favored 'Isoleucine or valine' 0 CA--C 1.493 -1.238 0 O-C-N 122.151 -0.617 . . . . 0.97 111.048 175.325 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A 1564 ' ' GLY . . . . . . . . . . . . . . . -103.7 -8.07 40.75 Favored Glycine 0 N--CA 1.418 -2.526 0 N-CA-C 109.83 -1.308 . . . . 0.72 109.83 175.477 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A 1565 ' ' ALA . . . . . . . . . . . . . . . -152.58 119.39 5.74 Favored 'General case' 0 N--CA 1.441 -0.911 0 CA-C-O 121.303 0.573 . . . . 0.37 110.381 -179.838 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A 1566 ' ' CYS . . . . . . . . . . . . . 6.7 t -154.76 136.07 14.07 Favored 'General case' 0 C--N 1.297 -1.686 0 N-CA-C 108.816 -0.809 . . . . 0.51 108.816 -178.279 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A 1567 ' ' PHE . . . . . . . . . . . . . 26.1 m-85 -67.11 122.76 18.52 Favored 'General case' 0 C--O 1.208 -1.1 0 N-CA-C 106.334 -1.728 . . . . 0.97 106.334 176.322 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A 1568 ' ' GLY . . . . . 0.614 ' HA3' ' HD2' ' A' 1549 ' ' TYR . . . -72.57 -36.89 58.45 Favored Glycine 0 CA--C 1.489 -1.569 0 C-N-CA 121.035 -0.602 . . . . 1.08 114.453 -169.136 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A 1569 ' ' GLN . . . . . . . . . . . . . 30.1 tt0 -74.57 -43.97 53.1 Favored 'General case' 0 C--N 1.302 -1.469 0 CA-C-O 121.767 0.794 . . . . 2.74 109.662 -179.931 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A 1570 ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -81.27 -26.23 35.92 Favored 'General case' 0 C--N 1.286 -2.154 0 CA-C-N 114.497 -1.229 . . . . 1.96 112.138 -173.092 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A 1571 ' ' ARG . . . . . . . . . . . . . 66.1 mtt180 60.65 47.33 8.34 Favored 'General case' 0 C--O 1.234 0.26 0 C-N-CA 125.947 1.699 . . . . 3.95 111.653 -178.493 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A 1572 ' ' ILE . . . . . . . . . . . . . 40.8 mm -121.77 128.61 75.76 Favored 'Isoleucine or valine' 0 C--O 1.24 0.579 0 N-CA-C 108.228 -1.027 . . . . 1.37 108.228 -179.616 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A 1573 ' ' SER . . . . . . . . . . . . . 28.2 t -79.03 138.61 38.08 Favored 'General case' 0 C--N 1.312 -1.057 0 C-N-CA 124.014 0.926 . . . . 1.08 112.447 -175.972 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A 1574 ' ' VAL . . . . . . . . . . . . . 15.4 m -136.31 24.03 0.86 Allowed 'Isoleucine or valine' 0 C--N 1.318 -0.771 0 CA-C-O 121.581 0.705 . . . . 1.3 110.342 174.731 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A 1575 ' ' GLY . . . . . . . . . . . . . . . 169.03 115.21 0.32 Allowed Glycine 0 N--CA 1.442 -0.958 0 CA-C-N 115.301 -0.863 . . . . 0.51 111.997 178.043 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A 1576 ' ' LYS . . . . . 0.712 ' HG3' ' HA2' ' A' 1595 ' ' GLY . 98.6 mttt -86.25 154.33 21.36 Favored 'General case' 0 C--N 1.315 -0.934 0 O-C-N 122.599 -0.354 . . . . 2.9 110.074 179.297 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A 1577 ' ' ALA . . . . . . . . . . . . . . . -69.79 119.52 14.14 Favored 'General case' 0 C--O 1.244 0.803 0 CA-C-N 115.453 -0.794 . . . . 0.83 110.241 -178.19 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A 1578 ' ' ASN . . . . . . . . . . . . . 40.0 m-80 -141.98 162.4 35.56 Favored 'General case' 0 C--N 1.305 -1.355 0 N-CA-C 107.123 -1.436 . . . . 1.85 107.123 -179.427 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A 1579 ' ' LYS . . . . . . . . . . . . . 75.2 mmtt -102.76 88.8 3.3 Favored 'General case' 0 C--N 1.307 -1.264 0 N-CA-C 107.77 -1.196 . . . . 1.9 107.77 175.842 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A 1580 ' ' ARG . . . . . . . . . . . . . 17.2 ttm180 -136.08 84.77 2.1 Favored 'General case' 0 C--N 1.293 -1.854 0 CA-C-O 121.926 0.87 . . . . 3.63 109.159 -179.238 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A 1581 ' ' LEU . . . . . . . . . . . . . 49.1 tp -113.6 147.78 37.41 Favored 'General case' 0 C--N 1.294 -1.818 0 CA-C-N 114.053 -1.43 . . . . 1.87 107.302 -179.41 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A 1582 ' ' ARG . . . . . . . . . . . . . 55.3 ttp180 -141.97 144.06 33.52 Favored 'General case' 0 C--N 1.295 -1.802 0 N-CA-C 109.99 -0.374 . . . . 3.97 109.99 -175.492 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A 1583 ' ' TYR . . . . . 0.416 ' CE1' ' HA ' ' A' 1586 ' ' GLN . 74.2 t80 -128.09 104.59 7.85 Favored 'General case' 0 C--N 1.299 -1.604 0 N-CA-C 108.368 -0.975 . . . . 1.41 108.368 176.704 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A 1584 ' ' VAL . . . . . . . . . . . . . 13.6 p -148.25 131.88 8.48 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.164 0 N-CA-C 109.117 -0.697 . . . . 1.69 109.117 178.529 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A 1585 ' ' ASP . . . . . . . . . . . . . 37.5 t70 65.7 32.45 9.01 Favored 'General case' 0 N--CA 1.482 1.13 0 CA-C-O 122.622 1.201 . . . . 2.06 109.621 -177.721 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A 1586 ' ' GLN . . . . . 0.416 ' HA ' ' CE1' ' A' 1583 ' ' TYR . 51.1 mt-30 65.05 4.89 2.7 Favored 'General case' 0 N--CA 1.473 0.707 0 C-N-CA 125.642 1.577 . . . . 2.33 114.674 178.606 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A 1587 ' ' VAL . . . . . . . . . . . . . 7.1 p -108.32 130.09 61.54 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.394 0 CA-C-O 121.087 0.47 . . . . 0.78 109.876 178.944 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A 1588 ' ' LEU . . . . . 0.566 ' HB2' ' HB2' ' A' 1612 ' ' PHE . 3.8 mm? -84.18 146.5 27.8 Favored 'General case' 0 N--CA 1.439 -0.991 0 CA-C-N 116.047 -0.524 . . . . 1.41 110.838 -178.523 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A 1589 ' ' GLN . . . . . . . . . . . . . 35.2 tt0 -147.13 127.61 14.08 Favored 'General case' 0 C--N 1.302 -1.49 0 N-CA-C 109.819 -0.438 . . . . 1.24 109.819 178.475 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A 1590 ' ' LEU . . . . . . . . . . . . . 6.7 tt -125.59 138.39 53.94 Favored 'General case' 0 C--N 1.308 -1.217 0 N-CA-C 107.016 -1.476 . . . . 1.15 107.016 179.895 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A 1591 ' ' VAL . . . . . 0.553 ' HB ' HG23 ' A' 1609 ' ' VAL . 5.0 p -137.54 134.16 46.24 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.292 0 CA-C-O 121.312 0.577 . . . . 1.51 112.132 -176.459 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A 1592 ' ' TYR . . . . . . . . . . . . . 77.5 m-85 -97.63 96.36 8.22 Favored 'General case' 0 N--CA 1.431 -1.402 0 N-CA-C 107.347 -1.353 . . . . 1.06 107.347 174.079 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A 1593 ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -88.52 157.81 18.52 Favored 'General case' 0 C--N 1.295 -1.78 0 CA-C-N 115.058 -0.973 . . . . 2.18 111.932 -177.107 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A 1594 ' ' ASP . . . . . 0.439 ' HA ' ' HB2' ' A' 1605 ' ' SER . 5.6 m-20 48.77 79.27 0.08 Allowed 'General case' 0 N--CA 1.475 0.78 0 N-CA-C 115.453 1.649 . . . . 1.45 115.453 -179.664 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A 1595 ' ' GLY . . . . . 0.712 ' HA2' ' HG3' ' A' 1576 ' ' LYS . . . -96.5 -107.94 2.43 Favored Glycine 0 N--CA 1.441 -0.985 0 N-CA-C 109.312 -1.515 . . . . 0.78 109.312 171.245 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A 1596 ' ' SER . . . . . 0.408 ' HA ' ' HD3' ' A' 1597 ' ' PRO . 34.2 t -82.8 142.57 45.44 Favored Pre-proline 0 C--N 1.309 -1.166 0 N-CA-C 107.245 -1.391 . . . . 1.68 107.245 175.451 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A 1597 ' ' PRO . . . . . 0.408 ' HD3' ' HA ' ' A' 1596 ' ' SER . 22.0 Cg_exo -65.13 142.21 73.05 Favored 'Trans proline' 0 N--CA 1.457 -0.65 0 C-N-CA 122.646 2.231 . . . . 1.17 110.248 177.219 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A 1598 ' ' CYS . . . . . . . . . . . . . 49.8 t -95.45 112.85 60.27 Favored Pre-proline 0 C--N 1.306 -1.31 0 N-CA-C 108.972 -0.751 . . . . 1.19 108.972 -178.178 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A 1599 ' ' PRO . . . . . . . . . . . . . 71.5 Cg_endo -76.91 -19.9 13.63 Favored 'Trans proline' 0 N--CA 1.464 -0.236 0 C-N-CA 122.395 2.064 . . . . 1.59 112.453 -176.939 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A 1600 ' ' SER . . . . . . . . . . . . . 4.1 m -76.4 -26.33 55.45 Favored 'General case' 0 C--N 1.314 -0.967 0 CA-C-O 121.818 0.818 . . . . 2.12 109.955 -177.931 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A 1601 ' ' LYS . . . . . 0.528 ' HG3' ' O ' ' A' 1632 ' ' GLN . 12.9 mmmm -134.71 72.01 1.45 Allowed 'General case' 0 N--CA 1.434 -1.256 0 CA-C-N 114.971 -1.013 . . . . 3.74 108.933 178.387 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A 1602 ' ' SER . . . . . . . . . . . . . 3.2 p -49.86 116.37 1.78 Allowed 'General case' 0 N--CA 1.441 -0.905 0 CA-C-N 113.871 -1.513 . . . . 3.79 112.66 -179.304 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A 1603 ' ' GLY . . . . . . . . . . . . . . . 135.94 -29.79 2.81 Favored Glycine 0 N--CA 1.431 -1.671 0 N-CA-C 111.062 -0.815 . . . . 2.0 111.062 -179.595 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A 1604 ' ' LEU . . . . . . . . . . . . . 2.3 pp -127.11 166.72 17.11 Favored 'General case' 0 C--N 1.317 -0.83 0 CA-C-O 121.105 0.478 . . . . 1.48 111.59 179.844 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A 1605 ' ' SER . . . . . 0.439 ' HB2' ' HA ' ' A' 1594 ' ' ASP . 21.0 m -109.13 -172.03 1.97 Allowed 'General case' 0 C--N 1.296 -1.719 0 C-N-CA 123.326 0.65 . . . . 1.51 109.367 -177.817 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A 1606 ' ' TYR . . . . . 0.508 ' HA ' ' O ' ' A' 1634 ' ' CYS . 79.0 m-85 -95.83 136.68 35.93 Favored 'General case' 0 N--CA 1.405 -2.704 0 N-CA-C 104.897 -2.26 . . . . 1.18 104.897 177.614 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A 1607 ' ' LYS . . . . . 0.548 ' HG3' HG23 ' A' 1635 ' ' THR . 21.6 ptmt -137.56 147.84 45.44 Favored 'General case' 0 C--N 1.262 -3.209 0 N-CA-C 108.625 -0.88 . . . . 1.67 108.625 -179.206 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A 1608 ' ' SER . . . . . . . . . . . . . 47.1 m -125.33 122.25 36.28 Favored 'General case' 0 C--N 1.303 -1.454 0 C-N-CA 120.886 -0.326 . . . . 1.0 111.05 -178.635 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A 1609 ' ' VAL . . . . . 0.553 HG23 ' HB ' ' A' 1591 ' ' VAL . 7.2 p -110.69 139.79 32.77 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 CA-C-O 120.69 0.281 . . . . 0.93 110.357 -179.91 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A 1610 ' ' ILE . . . . . 0.71 HG13 ' HB2' ' A' 1638 ' ' PHE . 3.7 mp -118.05 118.33 57.85 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.357 0 N-CA-C 108.072 -1.084 . . . . 0.78 108.072 174.871 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A 1611 ' ' SER . . . . . . . . . . . . . 48.0 m -98.19 133.02 43.2 Favored 'General case' 0 C--N 1.286 -2.191 0 N-CA-C 108.949 -0.759 . . . . 1.29 108.949 177.745 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A 1612 ' ' PHE . . . . . 0.576 ' HE1' ' HE3' ' A' 1640 ' ' TRP . 91.3 m-85 -99.58 106.68 18.68 Favored 'General case' 0 C--N 1.3 -1.585 0 CA-C-N 116.144 -0.48 . . . . 0.7 111.653 -173.713 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A 1613 ' ' VAL . . . . . 0.477 ' O ' ' HA ' ' A' 1641 ' ' HIS . 84.5 t -107.44 129.03 62.01 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.552 0 CA-C-N 114.921 -1.036 . . . . 0.75 109.302 -178.895 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A 1614 ' ' CYS . . . . . 0.457 ' HA ' ' O ' ' A' 1642 ' ' THR . 0.5 OUTLIER -81.32 106.89 13.65 Favored 'General case' 0 C--N 1.297 -1.704 0 N-CA-C 113.856 1.058 . . . . 1.39 113.856 -177.683 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A 1615 ' ' ARG . . . . . 0.43 ' HB3' ' HB3' ' A' 1641 ' ' HIS . 12.0 tpp180 -138.06 106.41 8.05 Favored Pre-proline 0 N--CA 1.428 -1.559 0 N-CA-C 107.897 -1.149 . . . . 3.75 107.897 175.493 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A 1616 ' ' PRO . . . . . . . . . . . . . 97.4 Cg_endo -79.08 5.57 5.65 Favored 'Trans proline' 0 CA--C 1.534 0.485 0 C-N-CA 122.649 2.233 . . . . 1.32 113.059 -176.231 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A 1617 ' ' GLU . . . . . . . . . . . . . 39.0 mt-10 . . . . . 0 C--N 1.307 -1.28 0 CA-C-O 121.419 0.628 . . . . 3.21 110.771 -178.04 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A 1622 ' ' ASN . . . . . . . . . . . . . 45.6 t30 . . . . . 0 N--CA 1.464 0.26 0 N-CA-C 107.721 -1.214 . . . . 2.92 107.721 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A 1623 ' ' ARG . . . . . . . . . . . . . 12.2 ptm180 -147.13 145.59 22.66 Favored Pre-proline 0 C--N 1.302 -1.498 0 N-CA-C 108.123 -1.065 . . . . 3.61 108.123 -178.233 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A 1624 ' ' PRO . . . . . 0.453 ' HA ' ' O ' ' A' 1639 ' ' SER . 15.9 Cg_exo -69.23 123.47 10.31 Favored 'Trans proline' 0 N--CA 1.457 -0.664 0 C-N-CA 122.569 2.179 . . . . 2.37 111.361 179.193 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A 1625 ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -119.03 149.04 42.33 Favored 'General case' 0 C--N 1.303 -1.414 0 N-CA-C 109.067 -0.716 . . . . 2.16 109.067 179.277 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A 1626 ' ' LEU . . . . . . . . . . . . . 34.7 tp -76.48 122.49 24.63 Favored 'General case' 0 C--N 1.306 -1.303 0 N-CA-C 108.083 -1.08 . . . . 1.35 108.083 177.516 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A 1627 ' ' ILE . . . . . . . . . . . . . 24.4 pt -100.19 -28.26 3.38 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.312 0 C-N-CA 120.654 -0.418 . . . . 1.21 111.158 -178.876 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A 1628 ' ' SER . . . . . . . . . . . . . 35.8 t -157.86 159.08 36.26 Favored 'General case' 0 N--CA 1.43 -1.425 0 N-CA-C 108.237 -1.023 . . . . 1.4 108.237 -175.868 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A 1629 ' ' LEU . . . . . 0.746 ' HG ' ' HG ' ' A' 1636 ' ' LEU . 4.1 tt -145.9 134.05 21.6 Favored 'General case' 0 C--N 1.293 -1.89 0 N-CA-C 105.512 -2.033 . . . . 1.56 105.512 177.579 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A 1630 ' ' ASP . . . . . . . . . . . . . 20.1 t70 -121.0 109.93 15.66 Favored 'General case' 0 C--N 1.29 -2.0 0 N-CA-C 108.812 -0.81 . . . . 0.87 108.812 177.957 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A 1631 ' ' LYS . . . . . 0.434 ' HE3' ' HB2' ' A' 1631 ' ' LYS . 49.7 mtmt -81.07 1.16 32.75 Favored 'General case' 0 C--N 1.303 -1.435 0 N-CA-C 112.553 0.575 . . . . 2.35 112.553 -175.991 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A 1632 ' ' GLN . . . . . 0.528 ' O ' ' HG3' ' A' 1601 ' ' LYS . 2.1 mp0 -94.56 -34.3 12.71 Favored 'General case' 0 CA--C 1.509 -0.626 0 CA-C-O 121.336 0.588 . . . . 2.55 110.398 -179.226 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A 1633 ' ' THR . . . . . . . . . . . . . 24.9 p -101.32 1.87 39.11 Favored 'General case' 0 C--N 1.289 -2.055 0 CA-C-O 121.947 0.88 . . . . 1.24 108.908 172.255 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A 1634 ' ' CYS . . . . . 0.508 ' O ' ' HA ' ' A' 1606 ' ' TYR . 47.8 m 52.15 42.37 30.59 Favored 'General case' 0 C--N 1.346 0.443 0 CA-C-N 113.714 -1.584 . . . . 0.89 110.377 178.478 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A 1635 ' ' THR . . . . . 0.548 HG23 ' HG3' ' A' 1607 ' ' LYS . 55.8 m -114.9 132.55 56.5 Favored 'General case' 0 N--CA 1.425 -1.691 0 CA-C-N 114.386 -1.279 . . . . 0.75 110.048 -175.143 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A 1636 ' ' LEU . . . . . 0.746 ' HG ' ' HG ' ' A' 1629 ' ' LEU . 5.8 mp -102.94 132.55 49.1 Favored 'General case' 0 C--N 1.306 -1.293 0 N-CA-C 108.989 -0.745 . . . . 1.33 108.989 176.991 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A 1637 ' ' PHE . . . . . . . . . . . . . 72.7 m-85 -107.47 101.54 10.88 Favored 'General case' 0 C--N 1.318 -0.792 0 CA-C-N 116.242 -0.436 . . . . 0.83 111.673 -175.874 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A 1638 ' ' PHE . . . . . 0.71 ' HB2' HG13 ' A' 1610 ' ' ILE . 96.6 m-85 -100.29 160.19 14.53 Favored 'General case' 0 C--N 1.306 -1.284 0 N-CA-C 108.743 -0.836 . . . . 0.6 108.743 177.21 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A 1639 ' ' SER . . . . . 0.453 ' O ' ' HA ' ' A' 1624 ' ' PRO . 31.9 t -143.37 147.74 35.14 Favored 'General case' 0 C--N 1.283 -2.285 0 N-CA-C 107.823 -1.177 . . . . 1.08 107.823 177.204 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A 1640 ' ' TRP . . . . . 0.576 ' HE3' ' HE1' ' A' 1612 ' ' PHE . 12.4 t90 -127.75 112.26 14.6 Favored 'General case' 0 C--N 1.291 -1.942 0 N-CA-C 108.069 -1.086 . . . . 0.8 108.069 176.746 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A 1641 ' ' HIS . . . . . 0.477 ' HA ' ' O ' ' A' 1613 ' ' VAL . 25.4 m170 -88.15 102.95 15.29 Favored 'General case' 0 CA--C 1.487 -1.454 0 N-CA-C 106.953 -1.499 . . . . 2.54 106.953 176.318 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A 1642 ' ' THR . . . . . 0.457 ' O ' ' HA ' ' A' 1614 ' ' CYS . 12.5 t -142.83 141.2 19.43 Favored Pre-proline 0 N--CA 1.414 -2.231 0 CA-C-N 115.451 -0.795 . . . . 1.15 111.021 -173.149 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A 1643 ' ' PRO . . . . . . . . . . . . . 42.4 Cg_endo -70.25 -1.68 9.27 Favored 'Trans proline' 0 C--N 1.349 0.592 0 C-N-CA 123.34 2.693 . . . . 0.8 111.567 175.942 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A 1644 ' ' LEU . . . . . . . . . . . . . 67.5 mt -86.66 -18.61 30.87 Favored 'General case' 0 C--N 1.317 -0.823 0 CA-C-N 115.692 -0.686 . . . . 1.54 110.089 178.122 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A 1645 ' ' ALA . . . . . . . . . . . . . . . -73.77 -32.91 64.03 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-O 121.648 0.737 . . . . 0.95 110.033 -179.032 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A 1646 ' ' CYS . . . . . . . . . . . . . 4.1 m -159.04 117.31 2.88 Favored 'General case' 0 C--N 1.311 -1.093 0 N-CA-C 103.558 -2.756 . . . . 1.41 103.558 175.784 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A 1647 ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 . . . . . 0 C--N 1.3 -1.583 0 C-N-CA 118.832 -1.147 . . . . 2.92 109.708 179.458 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A 1515 ' ' ASP . . . . . 0.69 ' HB3' ' HG2' ' A' 1517 ' ' GLN . 22.5 m-20 . . . . . 0 N--CA 1.433 -1.284 0 N-CA-C 109.0 -0.741 . . . . 2.54 109.0 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A 1516 ' ' CYS . . . . . . . . . . . . . 11.0 t -118.08 39.88 3.29 Favored 'General case' 0 C--N 1.292 -1.896 0 N-CA-C 105.777 -1.935 . . . . 1.25 105.777 175.259 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A 1517 ' ' GLN . . . . . 0.69 ' HG2' ' HB3' ' A' 1515 ' ' ASP . 3.3 pt20 -151.95 127.98 10.39 Favored 'General case' 0 N--CA 1.417 -2.077 0 CA-C-N 113.792 -1.549 . . . . 1.88 107.35 -175.769 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A 1518 ' ' VAL . . . . . 0.447 HG11 ' HB2' ' A' 1583 ' ' TYR . 7.4 m -111.57 156.86 12.6 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.979 0 N-CA-C 108.747 -0.835 . . . . 1.73 108.747 -174.716 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A 1519 ' ' THR . . . . . 0.624 ' HA ' ' HA ' ' A' 1526 ' ' LEU . 28.4 m -101.84 103.06 13.74 Favored 'General case' 0 N--CA 1.404 -2.727 0 N-CA-C 106.204 -1.776 . . . . 1.7 106.204 174.1 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A 1520 ' ' ASN . . . . . . . . . . . . . 25.4 t-20 -60.02 110.31 2.72 Favored Pre-proline 0 C--O 1.22 -0.498 0 O-C-N 123.779 0.674 . . . . 2.12 110.006 -176.759 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A 1521 ' ' PRO . . . . . . . . . . . . . 21.1 Cg_exo -68.33 -14.79 41.12 Favored 'Trans proline' 0 N--CA 1.478 0.585 0 C-N-CA 122.539 2.159 . . . . 2.47 114.14 -177.419 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A 1522 ' ' SER . . . . . . . . . . . . . 15.8 m -78.49 -45.62 21.59 Favored 'General case' 0 C--N 1.308 -1.209 0 CA-C-O 120.563 0.221 . . . . 2.57 110.941 -178.353 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A 1523 ' ' THR . . . . . 0.417 HG23 ' H ' ' A' 1525 ' ' HIS . 15.1 t -104.96 -18.57 14.13 Favored 'General case' 0 CA--C 1.55 0.948 0 C-N-CA 120.438 -0.505 . . . . 2.15 111.832 -179.408 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A 1524 ' ' GLY . . . . . . . . . . . . . . . 87.0 5.14 81.18 Favored Glycine 0 C--N 1.331 0.269 0 C-N-CA 121.365 -0.445 . . . . 1.89 112.763 179.505 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A 1525 ' ' HIS . . . . . 0.417 ' H ' HG23 ' A' 1523 ' ' THR . 23.2 t-160 -100.66 128.79 46.58 Favored 'General case' 0 C--N 1.303 -1.42 0 N-CA-C 109.691 -0.485 . . . . 1.9 109.691 -176.614 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A 1526 ' ' LEU . . . . . 0.624 ' HA ' ' HA ' ' A' 1519 ' ' THR . 5.5 tt -73.48 135.33 44.07 Favored 'General case' 0 C--N 1.305 -1.347 0 N-CA-C 107.638 -1.245 . . . . 1.61 107.638 176.057 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A 1527 ' ' PHE . . . . . 0.432 ' N ' HD23 ' A' 1526 ' ' LEU . 82.5 m-85 -112.81 110.25 20.24 Favored 'General case' 0 C--N 1.303 -1.426 0 CA-C-O 120.972 0.415 . . . . 1.42 110.873 178.052 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A 1528 ' ' ASP . . . . . . . . . . . . . 10.0 t70 -83.38 109.41 17.28 Favored 'General case' 0 CA--C 1.5 -0.955 0 CA-C-N 115.1 -0.955 . . . . 2.18 110.646 178.775 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A 1529 ' ' LEU . . . . . 0.664 ' HA ' HD13 ' A' 1532 ' ' LEU . 3.7 mm? -98.7 -18.12 18.2 Favored 'General case' 0 C--N 1.307 -1.279 0 CA-C-N 114.766 -1.107 . . . . 1.44 108.179 173.154 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A 1530 ' ' SER . . . . . . . . . . . . . 1.9 m -53.26 -47.1 69.37 Favored 'General case' 0 CA--C 1.544 0.724 0 C-N-CA 125.592 1.557 . . . . 1.44 112.741 -176.998 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A 1531 ' ' SER . . . . . . . . . . . . . 5.1 m -78.24 -3.79 44.55 Favored 'General case' 0 C--N 1.321 -0.652 0 N-CA-C 112.086 0.402 . . . . 1.5 112.086 -174.652 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A 1532 ' ' LEU . . . . . 0.664 HD13 ' HA ' ' A' 1529 ' ' LEU . 11.0 mp -62.41 -25.94 68.21 Favored 'General case' 0 N--CA 1.48 1.032 0 N-CA-C 113.066 0.765 . . . . 1.77 113.066 177.685 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A 1533 ' ' SER . . . . . . . . . . . . . 52.4 m -90.82 142.48 27.72 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-O 120.511 0.196 . . . . 2.38 110.477 177.464 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A 1534 ' ' GLY . . . . . . . . . . . . . . . -151.65 -116.81 0.73 Allowed Glycine 0 N--CA 1.441 -1.005 0 N-CA-C 109.649 -1.381 . . . . 1.55 109.649 179.158 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A 1535 ' ' ARG . . . . . . . . . . . . . 27.3 tpt180 -90.0 -59.05 2.3 Favored 'General case' 0 C--N 1.309 -1.186 0 N-CA-C 109.063 -0.717 . . . . 3.96 109.063 176.92 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A 1536 ' ' ALA . . . . . . . . . . . . . . . -95.07 -32.51 13.08 Favored 'General case' 0 N--CA 1.441 -0.89 0 CA-C-N 116.035 -0.529 . . . . 1.65 110.2 -179.228 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A 1537 ' ' GLY . . . . . . . . . . . . . . . 69.11 -127.14 21.2 Favored Glycine 0 CA--C 1.491 -1.455 0 N-CA-C 109.854 -1.299 . . . . 1.19 109.854 -178.524 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A 1538 ' ' PHE . . . . . . . . . . . . . 53.0 m-85 -106.42 141.43 37.74 Favored 'General case' 0 C--N 1.294 -1.822 0 C-N-CA 120.281 -0.568 . . . . 1.69 109.563 174.608 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A 1539 ' ' THR . . . . . . . . . . . . . 3.0 p -123.52 138.36 54.58 Favored 'General case' 0 C--N 1.293 -1.879 0 CA-C-N 116.017 -0.538 . . . . 1.48 111.081 -176.0 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A 1540 ' ' ALA . . . . . . . . . . . . . . . -128.87 116.03 18.79 Favored 'General case' 0 C--N 1.305 -1.364 0 CA-C-O 120.52 0.2 . . . . 0.83 110.48 178.387 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A 1541 ' ' ALA . . . . . . . . . . . . . . . -75.4 131.2 40.04 Favored 'General case' 0 C--N 1.313 -1.017 0 N-CA-C 108.397 -0.964 . . . . 1.27 108.397 177.316 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A 1542 ' ' TYR . . . . . . . . . . . . . 36.4 t80 -144.48 -179.27 6.44 Favored 'General case' 0 C--N 1.301 -1.524 0 N-CA-C 109.439 -0.578 . . . . 2.15 109.439 -173.776 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A 1543 ' ' SER . . . . . . . . . . . . . 5.9 m -43.86 -151.3 0.0 OUTLIER 'General case' 0 CA--C 1.584 2.25 0 C-N-CA 129.773 3.229 . . . . 2.29 114.669 177.91 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A 1544 ' ' LYS . . . . . . . . . . . . . 98.4 mttt -43.99 -29.12 0.54 Allowed 'General case' 0 N--CA 1.5 2.058 0 O-C-N 120.38 -1.45 . . . . 3.91 112.824 175.052 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A 1545 ' ' SER . . . . . . . . . . . . . 16.5 m -61.97 -17.29 56.52 Favored 'General case' 0 CA--C 1.562 1.44 0 C-N-CA 123.566 0.746 . . . . 3.3 111.463 175.091 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A 1546 ' ' GLY . . . . . . . . . . . . . . . 79.5 -77.85 1.82 Allowed Glycine 0 CA--C 1.496 -1.136 0 CA-C-O 121.457 0.476 . . . . 1.24 113.67 173.244 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A 1547 ' ' VAL . . . . . . . . . . . . . 7.4 p -157.64 131.73 1.38 Allowed 'Isoleucine or valine' 0 C--N 1.284 -2.249 0 N-CA-C 108.204 -1.036 . . . . 1.63 108.204 -175.788 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A 1548 ' ' VAL . . . . . . . . . . . . . 2.3 t -103.17 139.73 23.32 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.043 0 N-CA-C 108.346 -0.983 . . . . 0.92 108.346 -177.287 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A 1549 ' ' TYR . . . . . 0.492 ' HB3' ' HG2' ' A' 1557 ' ' GLU . 77.3 m-85 -98.29 148.23 23.84 Favored 'General case' 0 C--N 1.303 -1.418 0 N-CA-C 106.586 -1.635 . . . . 1.44 106.586 170.969 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A 1550 ' ' MET . . . . . . . . . . . . . 42.2 ttm -138.9 125.52 20.68 Favored 'General case' 0 C--N 1.291 -1.965 0 C-N-CA 120.685 -0.406 . . . . 1.74 110.704 -178.113 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A 1551 ' ' SER . . . . . 0.654 ' HB2' ' HB3' ' A' 1556 ' ' ASN . 43.1 t -99.23 138.91 35.65 Favored 'General case' 0 N--CA 1.411 -2.403 0 N-CA-C 105.938 -1.875 . . . . 1.64 105.938 172.551 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A 1552 ' ' ILE . . . . . 0.429 HG22 ' SG ' ' A' 1553 ' ' CYS . 1.8 mp -92.91 -55.17 6.41 Favored 'Isoleucine or valine' 0 N--CA 1.416 -2.174 0 N-CA-C 108.713 -0.847 . . . . 1.33 108.713 179.117 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A 1553 ' ' CYS . . . . . 0.429 ' SG ' HG22 ' A' 1552 ' ' ILE . 84.5 m -127.07 136.64 52.45 Favored 'General case' 0 C--N 1.303 -1.415 0 N-CA-C 109.162 -0.681 . . . . 1.43 109.162 177.202 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A 1554 ' ' GLY . . . . . . . . . . . . . . . 69.92 -141.46 34.65 Favored Glycine 0 N--CA 1.435 -1.4 0 N-CA-C 111.031 -0.827 . . . . 1.12 111.031 179.806 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A 1555 ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -109.35 177.41 4.75 Favored 'General case' 0 C--N 1.3 -1.569 0 N-CA-C 108.91 -0.774 . . . . 1.8 108.91 -178.79 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A 1556 ' ' ASN . . . . . 0.654 ' HB3' ' HB2' ' A' 1551 ' ' SER . 8.9 t30 -177.73 -165.03 0.1 Allowed 'General case' 0 C--N 1.297 -1.705 0 N-CA-C 103.427 -2.805 . . . . 2.63 103.427 -174.616 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A 1557 ' ' GLU . . . . . 0.492 ' HG2' ' HB3' ' A' 1549 ' ' TYR . 25.3 mt-10 79.57 -176.8 0.08 Allowed 'General case' 0 C--N 1.321 -0.636 0 N-CA-C 115.404 1.631 . . . . 3.79 115.404 163.519 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A 1558 ' ' ASN . . . . . . . . . . . . . 26.9 m-80 -125.21 43.93 2.93 Favored 'General case' 0 C--N 1.313 -0.991 0 CA-C-N 112.6 -2.091 . . . . 1.52 107.373 -174.612 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A 1559 ' ' CYS . . . . . . . . . . . . . 77.1 m -141.17 152.56 64.95 Favored Pre-proline 0 C--N 1.285 -2.214 0 N-CA-C 106.105 -1.813 . . . . 0.84 106.105 -176.029 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A 1560 ' ' PRO . . . . . . . . . . . . . 24.6 Cg_exo -36.23 112.32 0.09 OUTLIER 'Trans proline' 0 C--N 1.376 2.023 0 C-N-CA 124.667 3.578 . . . . 1.18 113.339 -178.811 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A 1561 ' ' PRO . . . . . . . . . . . . . 88.7 Cg_exo -48.89 153.52 3.74 Favored 'Trans proline' 0 C--N 1.365 1.407 0 C-N-CA 124.93 3.753 . . . . 1.51 114.486 -174.956 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A 1562 ' ' GLY . . . . . . . . . . . . . . . 93.67 7.78 61.32 Favored Glycine 0 N--CA 1.447 -0.589 0 N-CA-C 111.092 -0.803 . . . . 0.72 111.092 -177.545 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A 1563 ' ' VAL . . . . . 0.499 ' HA ' ' HA ' ' A' 1576 ' ' LYS . 8.3 p -111.25 156.96 12.28 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.588 0 N-CA-C 107.297 -1.372 . . . . 0.97 107.297 -179.355 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A 1564 ' ' GLY . . . . . . . . . . . . . . . -124.82 9.08 8.09 Favored Glycine 0 CA--C 1.528 0.852 0 C-N-CA 120.056 -1.069 . . . . 0.72 114.555 -176.417 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A 1565 ' ' ALA . . . . . . . . . . . . . . . -170.22 141.62 2.1 Favored 'General case' 0 C--N 1.302 -1.494 0 N-CA-C 107.917 -1.142 . . . . 0.37 107.917 178.956 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A 1566 ' ' CYS . . . . . 0.484 ' HA ' HG23 ' A' 1574 ' ' VAL . 51.6 t -164.22 139.23 5.83 Favored 'General case' 0 C--N 1.309 -1.165 0 CA-C-O 120.896 0.379 . . . . 0.51 110.184 -175.7 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A 1567 ' ' PHE . . . . . . . . . . . . . 35.2 m-85 -80.57 122.9 27.62 Favored 'General case' 0 CA--C 1.512 -0.501 0 N-CA-C 106.535 -1.654 . . . . 0.97 106.535 174.416 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A 1568 ' ' GLY . . . . . . . . . . . . . . . -75.97 -26.75 63.8 Favored Glycine 0 C--N 1.314 -0.656 0 C-N-CA 120.7 -0.762 . . . . 1.08 113.274 -173.879 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A 1569 ' ' GLN . . . . . . . . . . . . . 25.9 tp60 -71.42 -57.0 4.84 Favored 'General case' 0 C--N 1.311 -1.102 0 CA-C-O 121.798 0.809 . . . . 2.74 109.211 178.991 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A 1570 ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -83.42 -16.65 45.02 Favored 'General case' 0 C--N 1.301 -1.515 0 CA-C-N 114.634 -1.166 . . . . 1.96 113.089 -172.141 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A 1571 ' ' ARG . . . . . . . . . . . . . 11.1 tpp180 63.94 43.93 5.02 Favored 'General case' 0 N--CA 1.479 0.989 0 C-N-CA 125.59 1.556 . . . . 3.95 109.878 178.758 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A 1572 ' ' ILE . . . . . . . . . . . . . 31.9 mm -115.53 128.82 72.61 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.258 0 CA-C-N 115.447 -0.797 . . . . 1.37 109.819 -174.939 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A 1573 ' ' SER . . . . . . . . . . . . . 57.2 p -72.53 134.83 45.45 Favored 'General case' 0 C--O 1.247 0.951 0 CA-C-O 121.367 0.603 . . . . 1.08 111.869 -178.038 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A 1574 ' ' VAL . . . . . 0.484 HG23 ' HA ' ' A' 1566 ' ' CYS . 13.4 t -119.18 39.7 0.77 Allowed 'Isoleucine or valine' 0 CA--C 1.565 1.533 0 CA-C-O 122.597 1.189 . . . . 1.3 109.084 -174.926 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A 1575 ' ' GLY . . . . . . . . . . . . . . . 125.79 133.65 3.96 Favored Glycine 0 CA--C 1.53 1.017 0 CA-C-N 115.043 -0.98 . . . . 0.51 113.451 179.708 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A 1576 ' ' LYS . . . . . 0.499 ' HA ' ' HA ' ' A' 1563 ' ' VAL . 64.4 mttp -84.31 153.99 23.19 Favored 'General case' 0 N--CA 1.469 0.491 0 N-CA-C 109.496 -0.557 . . . . 2.9 109.496 178.455 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A 1577 ' ' ALA . . . . . 0.561 ' HA ' ' CE1' ' A' 1592 ' ' TYR . . . -72.34 92.23 1.4 Allowed 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 113.042 0.756 . . . . 0.83 113.042 -173.028 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A 1578 ' ' ASN . . . . . 0.431 HD22 ' N ' ' A' 1578 ' ' ASN . 0.8 OUTLIER -98.92 117.64 33.88 Favored 'General case' 0 C--N 1.311 -1.08 0 N-CA-C 107.879 -1.156 . . . . 1.85 107.879 174.019 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A 1579 ' ' LYS . . . . . . . . . . . . . 55.7 mtmt -90.37 90.77 8.19 Favored 'General case' 0 C--N 1.3 -1.582 0 CA-C-O 121.882 0.849 . . . . 1.9 109.477 -177.479 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A 1580 ' ' ARG . . . . . . . . . . . . . 9.3 ttp180 -153.99 131.65 11.46 Favored 'General case' 0 C--N 1.288 -2.091 0 N-CA-C 107.068 -1.456 . . . . 3.63 107.068 179.925 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A 1581 ' ' LEU . . . . . 0.502 HD13 HD12 ' A' 1590 ' ' LEU . 28.9 tp -119.05 167.5 11.71 Favored 'General case' 0 C--N 1.296 -1.755 0 N-CA-C 108.299 -1.0 . . . . 1.87 108.299 -178.102 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A 1582 ' ' ARG . . . . . . . . . . . . . 69.2 ttt180 -145.18 103.04 3.82 Favored 'General case' 0 C--N 1.304 -1.408 0 N-CA-C 109.637 -0.505 . . . . 3.97 109.637 -179.81 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A 1583 ' ' TYR . . . . . 0.447 ' HB2' HG11 ' A' 1518 ' ' VAL . 42.2 t80 -88.6 111.46 21.92 Favored 'General case' 0 C--N 1.3 -1.567 0 CA-C-O 121.401 0.619 . . . . 1.41 111.141 179.087 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A 1584 ' ' VAL . . . . . 0.531 ' HB ' HG13 ' A' 1587 ' ' VAL . 48.9 t -112.94 150.68 15.01 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.744 0 N-CA-C 105.043 -2.206 . . . . 1.69 105.043 173.849 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A 1585 ' ' ASP . . . . . . . . . . . . . 33.9 t70 -47.4 108.32 0.15 Allowed 'General case' 0 C--N 1.33 -0.258 0 C-N-CA 123.843 0.857 . . . . 2.06 112.569 -179.563 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A 1586 ' ' GLN . . . . . . . . . . . . . 93.7 mt-30 63.76 24.29 13.76 Favored 'General case' 0 C--O 1.251 1.132 0 C-N-CA 125.155 1.382 . . . . 2.33 114.488 -178.966 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A 1587 ' ' VAL . . . . . 0.531 HG13 ' HB ' ' A' 1584 ' ' VAL . 7.1 p -161.13 105.71 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.439 -1.003 0 CA-C-O 122.35 1.072 . . . . 0.78 112.236 176.202 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A 1588 ' ' LEU . . . . . . . . . . . . . 7.3 mp -91.39 120.58 32.37 Favored 'General case' 0 C--N 1.299 -1.595 0 CA-C-N 115.075 -0.966 . . . . 1.41 108.842 179.934 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A 1589 ' ' GLN . . . . . . . . . . . . . 35.2 tt0 -105.89 134.21 49.38 Favored 'General case' 0 C--N 1.297 -1.689 0 N-CA-C 110.196 -0.298 . . . . 1.24 110.196 -177.768 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A 1590 ' ' LEU . . . . . 0.502 HD12 HD13 ' A' 1581 ' ' LEU . 2.0 tt -136.8 138.0 40.4 Favored 'General case' 0 C--N 1.304 -1.406 0 N-CA-C 106.222 -1.77 . . . . 1.15 106.222 175.925 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A 1591 ' ' VAL . . . . . . . . . . . . . 8.4 p -137.98 140.76 40.1 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.222 0 CA-C-O 120.967 0.413 . . . . 1.51 111.869 -174.171 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A 1592 ' ' TYR . . . . . 0.561 ' CE1' ' HA ' ' A' 1577 ' ' ALA . 88.1 m-85 -125.56 128.75 48.43 Favored 'General case' 0 C--N 1.317 -0.805 0 N-CA-C 108.094 -1.076 . . . . 1.06 108.094 176.117 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A 1593 ' ' LYS . . . . . . . . . . . . . 20.9 pttp -137.54 -174.21 3.7 Favored 'General case' 0 C--N 1.306 -1.313 0 N-CA-C 109.496 -0.557 . . . . 2.18 109.496 -176.925 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A 1594 ' ' ASP . . . . . . . . . . . . . 13.6 m-20 60.79 44.27 11.2 Favored 'General case' 0 N--CA 1.482 1.13 0 C-N-CA 123.281 0.632 . . . . 1.45 112.312 -179.603 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A 1595 ' ' GLY . . . . . . . . . . . . . . . -86.03 -92.76 0.86 Allowed Glycine 0 N--CA 1.437 -1.285 0 C-N-CA 119.477 -1.344 . . . . 0.78 111.76 177.685 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A 1596 ' ' SER . . . . . 0.401 ' HA ' ' HD3' ' A' 1597 ' ' PRO . 37.1 m -113.47 151.69 44.68 Favored Pre-proline 0 C--N 1.287 -2.142 0 N-CA-C 108.678 -0.86 . . . . 1.68 108.678 179.377 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A 1597 ' ' PRO . . . . . 0.401 ' HD3' ' HA ' ' A' 1596 ' ' SER . 24.4 Cg_exo -65.3 133.03 33.48 Favored 'Trans proline' 0 C--O 1.24 0.607 0 C-N-CA 123.248 2.632 . . . . 1.17 110.976 178.798 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A 1598 ' ' CYS . . . . . . . . . . . . . 22.0 t -95.9 113.89 63.0 Favored Pre-proline 0 C--N 1.296 -1.76 0 CA-C-N 116.093 -0.503 . . . . 1.19 109.682 -177.463 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A 1599 ' ' PRO . . . . . . . . . . . . . 60.6 Cg_endo -88.8 18.18 1.52 Allowed 'Trans proline' 0 C--O 1.24 0.594 0 C-N-CA 122.904 2.402 . . . . 1.59 111.726 178.696 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A 1600 ' ' SER . . . . . . . . . . . . . 35.8 t -75.85 -55.92 5.16 Favored 'General case' 0 N--CA 1.427 -1.616 0 CA-C-N 115.715 -0.675 . . . . 2.12 110.59 -178.572 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A 1601 ' ' LYS . . . . . . . . . . . . . 53.2 tttp -142.42 -71.87 0.32 Allowed 'General case' 0 N--CA 1.445 -0.693 0 C-N-CA 119.926 -0.709 . . . . 3.74 112.486 -175.955 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A 1602 ' ' SER . . . . . 0.52 ' HB3' ' HG ' ' A' 1604 ' ' LEU . 23.0 t -96.37 157.11 16.05 Favored 'General case' 0 N--CA 1.427 -1.575 0 N-CA-C 108.47 -0.937 . . . . 3.79 108.47 -175.957 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A 1603 ' ' GLY . . . . . . . . . . . . . . . -77.74 58.21 3.84 Favored Glycine 0 C--O 1.236 0.27 0 N-CA-C 111.942 -0.463 . . . . 2.0 111.942 -179.824 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A 1604 ' ' LEU . . . . . 0.52 ' HG ' ' HB3' ' A' 1602 ' ' SER . 0.6 OUTLIER -120.97 -175.27 3.01 Favored 'General case' 0 C--N 1.298 -1.668 0 C-N-CA 124.581 1.152 . . . . 1.48 110.364 -178.516 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A 1605 ' ' SER . . . . . . . . . . . . . 15.0 m -104.58 -170.04 1.71 Allowed 'General case' 0 C--N 1.297 -1.712 0 N-CA-C 109.929 -0.397 . . . . 1.51 109.929 -178.879 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A 1606 ' ' TYR . . . . . . . . . . . . . 97.5 m-85 -103.37 126.65 50.64 Favored 'General case' 0 CA--C 1.482 -1.662 0 N-CA-C 104.328 -2.471 . . . . 1.18 104.328 177.274 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A 1607 ' ' LYS . . . . . . . . . . . . . 21.3 ptmt -119.15 132.15 55.95 Favored 'General case' 0 C--N 1.285 -2.219 0 C-N-CA 119.528 -0.869 . . . . 1.67 111.654 -176.071 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A 1608 ' ' SER . . . . . 0.439 ' OG ' HG12 ' A' 1574 ' ' VAL . 33.1 m -103.15 118.31 36.51 Favored 'General case' 0 C--N 1.309 -1.177 0 C-N-CA 123.024 0.53 . . . . 1.0 110.731 -177.301 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A 1609 ' ' VAL . . . . . . . . . . . . . 58.7 t -110.98 114.57 47.48 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.778 0 N-CA-C 108.687 -0.857 . . . . 0.93 108.687 177.363 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A 1610 ' ' ILE . . . . . 0.655 HG13 ' HB2' ' A' 1638 ' ' PHE . 2.9 mp -105.04 114.67 45.22 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.214 0 N-CA-C 108.675 -0.861 . . . . 0.78 108.675 178.345 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A 1611 ' ' SER . . . . . . . . . . . . . 19.4 m -104.42 107.76 18.85 Favored 'General case' 0 C--N 1.296 -1.753 0 CA-C-N 115.474 -0.784 . . . . 1.29 109.486 179.535 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A 1612 ' ' PHE . . . . . 0.53 ' O ' ' HA ' ' A' 1587 ' ' VAL . 97.7 m-85 -83.8 102.55 12.4 Favored 'General case' 0 C--N 1.306 -1.319 0 CA-C-N 115.882 -0.599 . . . . 0.7 109.472 179.089 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A 1613 ' ' VAL . . . . . . . . . . . . . 94.4 t -86.52 124.9 40.7 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.485 0 N-CA-C 107.857 -1.164 . . . . 0.75 107.857 179.345 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A 1614 ' ' CYS . . . . . 0.499 ' HB3' ' HB2' ' A' 1646 ' ' CYS . 61.8 m -75.73 92.78 3.03 Favored 'General case' 0 C--N 1.295 -1.797 0 CA-C-O 121.614 0.721 . . . . 1.39 111.018 -177.12 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A 1615 ' ' ARG . . . . . 0.521 ' HB3' ' HB3' ' A' 1641 ' ' HIS . 43.6 ttm180 -138.45 131.79 16.35 Favored Pre-proline 0 N--CA 1.43 -1.464 0 CA-C-N 115.155 -0.929 . . . . 3.75 109.467 -179.742 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A 1616 ' ' PRO . . . . . . . . . . . . . 38.4 Cg_endo -70.7 67.37 2.29 Favored 'Trans proline' 0 CA--C 1.55 1.309 0 C-N-CA 123.142 2.562 . . . . 1.32 111.351 175.764 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A 1617 ' ' GLU . . . . . . . . . . . . . 10.9 tp10 . . . . . 0 CA--C 1.555 1.169 0 CA-C-O 121.982 0.896 . . . . 3.21 109.354 -177.52 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A 1622 ' ' ASN . . . . . . . . . . . . . 40.3 t30 . . . . . 0 C--O 1.242 0.71 0 N-CA-C 108.77 -0.826 . . . . 2.92 108.77 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A 1623 ' ' ARG . . . . . . . . . . . . . 20.2 ptp180 -148.78 169.22 9.51 Favored Pre-proline 0 C--N 1.302 -1.497 0 N-CA-C 108.474 -0.935 . . . . 3.61 108.474 -174.364 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A 1624 ' ' PRO . . . . . . . . . . . . . 33.6 Cg_exo -61.41 114.89 2.42 Favored 'Trans proline' 0 C--N 1.36 1.161 0 C-N-CA 121.825 1.684 . . . . 2.37 109.51 175.69 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A 1625 ' ' MET . . . . . . . . . . . . . 22.7 ptt? -109.81 146.1 35.6 Favored 'General case' 0 C--N 1.292 -1.892 0 CA-C-N 115.891 -0.595 . . . . 2.16 111.495 -175.301 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A 1626 ' ' LEU . . . . . . . . . . . . . 43.0 tp -76.0 111.07 11.0 Favored 'General case' 0 N--CA 1.441 -0.904 0 CA-C-N 114.773 -1.103 . . . . 1.35 109.179 179.521 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A 1627 ' ' ILE . . . . . . . . . . . . . 39.0 mm -81.69 -49.58 17.51 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.745 0 CA-C-N 115.03 -0.986 . . . . 1.21 110.41 -175.727 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A 1628 ' ' SER . . . . . . . . . . . . . 48.3 m -157.26 154.09 28.56 Favored 'General case' 0 C--N 1.301 -1.52 0 CA-C-N 116.259 -0.428 . . . . 1.4 109.913 -178.064 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A 1629 ' ' LEU . . . . . 0.46 HD13 ' HG ' ' A' 1636 ' ' LEU . 56.7 tp -113.36 118.41 34.5 Favored 'General case' 0 N--CA 1.428 -1.56 0 N-CA-C 108.039 -1.096 . . . . 1.56 108.039 175.251 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A 1630 ' ' ASP . . . . . 0.488 ' HB3' ' HB ' ' A' 1635 ' ' THR . 12.6 t70 -95.09 117.62 30.49 Favored 'General case' 0 C--N 1.293 -1.864 0 N-CA-C 107.653 -1.24 . . . . 0.87 107.653 177.121 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A 1631 ' ' LYS . . . . . . . . . . . . . 8.5 mtpm? -94.22 4.87 53.29 Favored 'General case' 0 C--N 1.298 -1.673 0 N-CA-C 112.402 0.519 . . . . 2.35 112.402 -176.116 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A 1632 ' ' GLN . . . . . . . . . . . . . 2.2 mp0 -89.99 -51.97 5.2 Favored 'General case' 0 C--N 1.307 -1.245 0 CA-C-O 121.208 0.528 . . . . 2.55 109.686 -179.608 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A 1633 ' ' THR . . . . . . . . . . . . . 7.2 m -105.15 4.46 31.36 Favored 'General case' 0 C--N 1.306 -1.314 0 CA-C-O 122.309 1.052 . . . . 1.24 109.261 179.815 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A 1634 ' ' CYS . . . . . . . . . . . . . 61.3 m 55.24 52.8 10.95 Favored 'General case' 0 N--CA 1.469 0.505 0 CA-C-N 114.092 -1.413 . . . . 0.89 110.739 179.199 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A 1635 ' ' THR . . . . . 0.488 ' HB ' ' HB3' ' A' 1630 ' ' ASP . 21.1 m -103.87 125.23 50.14 Favored 'General case' 0 N--CA 1.421 -1.92 0 CA-C-N 113.458 -1.701 . . . . 0.75 109.924 -175.059 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A 1636 ' ' LEU . . . . . 0.46 ' HG ' HD13 ' A' 1629 ' ' LEU . 5.8 mp -106.49 122.58 46.58 Favored 'General case' 0 C--N 1.313 -0.981 0 N-CA-C 109.362 -0.607 . . . . 1.33 109.362 178.921 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A 1637 ' ' PHE . . . . . . . . . . . . . 96.9 m-85 -98.85 112.51 24.58 Favored 'General case' 0 C--N 1.313 -1.0 0 CA-C-N 115.983 -0.553 . . . . 0.83 111.783 -176.275 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A 1638 ' ' PHE . . . . . 0.655 ' HB2' HG13 ' A' 1610 ' ' ILE . 87.6 m-85 -115.09 133.81 55.71 Favored 'General case' 0 C--N 1.294 -1.832 0 N-CA-C 108.484 -0.932 . . . . 0.6 108.484 175.303 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A 1639 ' ' SER . . . . . . . . . . . . . 28.2 t -140.47 141.5 35.41 Favored 'General case' 0 C--N 1.276 -2.606 0 C-N-CA 120.099 -0.641 . . . . 1.08 109.308 177.49 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A 1640 ' ' TRP . . . . . 0.495 ' HE3' ' HE1' ' A' 1612 ' ' PHE . 10.5 t90 -128.0 127.88 44.01 Favored 'General case' 0 N--CA 1.43 -1.429 0 N-CA-C 107.849 -1.167 . . . . 0.8 107.849 178.659 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A 1641 ' ' HIS . . . . . 0.521 ' HB3' ' HB3' ' A' 1615 ' ' ARG . 34.9 m80 -91.25 97.79 11.33 Favored 'General case' 0 C--N 1.301 -1.513 0 N-CA-C 105.983 -1.858 . . . . 2.54 105.983 175.276 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A 1642 ' ' THR . . . . . 0.584 ' OG1' ' HG ' ' A' 1644 ' ' LEU . 7.8 t -135.12 140.85 35.97 Favored Pre-proline 0 C--N 1.296 -1.719 0 N-CA-C 113.63 0.974 . . . . 1.15 113.63 -170.737 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A 1643 ' ' PRO . . . . . . . . . . . . . 87.3 Cg_endo -80.66 -0.84 10.9 Favored 'Trans proline' 0 N--CA 1.447 -1.219 0 C-N-CA 123.475 2.783 . . . . 0.8 112.451 175.903 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A 1644 ' ' LEU . . . . . 0.584 ' HG ' ' OG1' ' A' 1642 ' ' THR . 2.8 pp -92.94 4.03 54.68 Favored 'General case' 0 CA--C 1.502 -0.885 0 CA-C-O 121.969 0.89 . . . . 1.54 110.386 174.613 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A 1645 ' ' ALA . . . . . . . . . . . . . . . -95.78 -43.47 7.86 Favored 'General case' 0 C--N 1.3 -1.552 0 CA-C-N 113.818 -1.537 . . . . 0.95 108.421 175.992 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A 1646 ' ' CYS . . . . . 0.499 ' HB2' ' HB3' ' A' 1614 ' ' CYS . 38.2 m -156.44 158.36 37.16 Favored 'General case' 0 CA--C 1.498 -1.05 0 N-CA-C 105.585 -2.005 . . . . 1.41 105.585 174.71 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A 1647 ' ' GLU . . . . . 0.4 ' HG3' ' CZ ' ' A' 1527 ' ' PHE . 53.9 mt-10 . . . . . 0 C--N 1.305 -1.368 0 N-CA-C 110.215 -0.291 . . . . 2.92 110.215 -179.624 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A 1508 ' ' MET . . . . . . . . . . . . . 70.3 mtm . . . . . 0 C--O 1.238 0.481 0 N-CA-C 111.826 0.306 . . . . 8.27 111.826 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A 1509 ' ' LYS . . . . . . . . . . . . . 61.7 tttp -71.83 -58.56 3.36 Favored 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 111.7 0.259 . . . . 6.48 111.7 -177.745 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A 1510 ' ' SER . . . . . . . . . . . . . 66.0 m -112.1 119.89 39.98 Favored 'General case' 0 C--N 1.303 -1.45 0 N-CA-C 109.002 -0.74 . . . . 4.22 109.002 178.145 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A 1511 ' ' ASN . . . . . . . . . . . . . 21.8 m-80 -121.88 -24.2 5.28 Favored 'General case' 0 C--N 1.298 -1.662 0 CA-C-N 116.143 -0.48 . . . . 3.08 111.019 -174.334 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A 1512 ' ' GLU . . . . . 0.45 ' H ' ' CD ' ' A' 1512 ' ' GLU . 1.4 mp0 -51.32 -25.87 6.63 Favored 'General case' 0 N--CA 1.475 0.798 0 C-N-CA 126.214 1.806 . . . . 4.46 114.608 -173.921 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A 1513 ' ' HIS . . . . . 0.53 ' CE1' ' HG3' ' A' 1580 ' ' ARG . 49.1 m-70 -113.3 0.66 14.9 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-O 121.359 0.6 . . . . 5.57 110.476 -179.177 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A 1514 ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -104.82 -55.85 2.27 Favored 'General case' 0 C--N 1.295 -1.774 0 CA-C-N 115.657 -0.701 . . . . 3.7 110.722 -175.413 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A 1515 ' ' ASP . . . . . . . . . . . . . 22.8 t0 -145.04 152.77 40.64 Favored 'General case' 0 C--N 1.291 -1.969 0 N-CA-C 106.874 -1.528 . . . . 2.54 106.874 -177.712 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A 1516 ' ' CYS . . . . . . . . . . . . . 29.8 m -75.99 67.92 2.41 Favored 'General case' 0 C--N 1.288 -2.081 0 CA-C-O 121.948 0.88 . . . . 1.25 110.862 -176.008 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A 1517 ' ' GLN . . . . . 0.409 ' HA ' ' O ' ' A' 1527 ' ' PHE . 4.0 pt20 -148.56 151.31 34.85 Favored 'General case' 0 N--CA 1.417 -2.119 0 N-CA-C 108.578 -0.897 . . . . 1.88 108.578 -179.494 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A 1518 ' ' VAL . . . . . 0.812 HG21 HD11 ' A' 1588 ' ' LEU . 44.6 t -127.08 134.07 66.89 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.459 0 N-CA-C 108.87 -0.789 . . . . 1.73 108.87 -179.169 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A 1519 ' ' THR . . . . . . . . . . . . . 27.7 m -107.71 125.33 51.25 Favored 'General case' 0 C--N 1.296 -1.727 0 N-CA-C 110.063 -0.347 . . . . 1.7 110.063 177.14 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A 1520 ' ' ASN . . . . . . . . . . . . . 30.3 t-20 -97.33 100.37 7.81 Favored Pre-proline 0 C--N 1.309 -1.16 0 N-CA-C 106.802 -1.555 . . . . 2.12 106.802 172.063 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A 1521 ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -73.83 -0.12 9.01 Favored 'Trans proline' 0 C--N 1.353 0.784 0 C-N-CA 122.713 2.275 . . . . 2.47 113.495 -175.633 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A 1522 ' ' SER . . . . . . . . . . . . . 50.8 m -91.44 -14.96 29.62 Favored 'General case' 0 N--CA 1.433 -1.279 0 CA-C-N 116.641 -0.254 . . . . 2.57 110.917 178.384 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A 1523 ' ' THR . . . . . . . . . . . . . 14.3 t -139.12 0.67 1.95 Allowed 'General case' 0 CA--C 1.555 1.135 0 CA-C-O 121.271 0.557 . . . . 2.15 111.247 177.427 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A 1524 ' ' GLY . . . . . . . . . . . . . . . 66.8 30.61 76.45 Favored Glycine 0 C--N 1.339 0.708 0 CA-C-N 116.217 -0.447 . . . . 1.89 112.535 178.466 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A 1525 ' ' HIS . . . . . 0.623 ' HE1' ' HB2' ' A' 1647 ' ' GLU . 23.8 t-160 -101.53 122.75 44.38 Favored 'General case' 0 C--N 1.303 -1.438 0 O-C-N 122.616 -0.343 . . . . 1.9 111.021 -176.729 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A 1526 ' ' LEU . . . . . . . . . . . . . 42.6 tp -97.97 133.55 42.29 Favored 'General case' 0 C--N 1.307 -1.249 0 N-CA-C 108.86 -0.793 . . . . 1.61 108.86 176.383 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A 1527 ' ' PHE . . . . . 0.416 ' CE1' ' HA ' ' A' 1646 ' ' CYS . 94.8 m-85 -102.87 132.67 48.92 Favored 'General case' 0 C--N 1.292 -1.917 0 N-CA-C 108.529 -0.915 . . . . 1.42 108.529 176.822 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A 1528 ' ' ASP . . . . . . . . . . . . . 28.7 t70 -110.98 114.76 28.32 Favored 'General case' 0 CA--C 1.487 -1.45 0 CA-C-O 122.103 0.954 . . . . 2.18 112.425 -179.245 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A 1529 ' ' LEU . . . . . . . . . . . . . 87.0 mt -119.63 3.53 11.16 Favored 'General case' 0 C--N 1.294 -1.818 0 CA-C-N 114.055 -1.429 . . . . 1.44 107.427 174.623 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A 1530 ' ' SER . . . . . . . . . . . . . 14.5 t -80.36 -31.6 37.89 Favored 'General case' 0 N--CA 1.441 -0.898 0 CA-C-N 115.74 -0.664 . . . . 1.44 110.428 -175.443 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A 1531 ' ' SER . . . . . . . . . . . . . 25.9 m -70.4 -10.9 60.35 Favored 'General case' 0 C--O 1.236 0.379 0 CA-C-O 121.133 0.492 . . . . 1.5 110.204 177.234 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A 1532 ' ' LEU . . . . . . . . . . . . . 97.1 mt -80.39 10.01 5.15 Favored 'General case' 0 CA--C 1.546 0.811 0 N-CA-C 112.787 0.662 . . . . 1.77 112.787 178.666 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A 1533 ' ' SER . . . . . . . . . . . . . 31.7 m -72.7 145.02 47.47 Favored 'General case' 0 C--O 1.247 0.964 0 N-CA-C 108.495 -0.928 . . . . 2.38 108.495 174.924 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A 1534 ' ' GLY . . . . . . . . . . . . . . . -162.66 169.28 37.86 Favored Glycine 0 N--CA 1.441 -0.995 0 C-N-CA 120.319 -0.944 . . . . 1.55 112.277 -177.419 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A 1535 ' ' ARG . . . . . 0.816 ' HD3' ' HG3' ' A' 1557 ' ' GLU . 21.8 tpp180 -80.67 -51.59 8.53 Favored 'General case' 0 C--N 1.312 -1.028 0 N-CA-C 108.676 -0.861 . . . . 3.96 108.676 179.459 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A 1536 ' ' ALA . . . . . . . . . . . . . . . -79.61 -37.44 36.17 Favored 'General case' 0 C--N 1.309 -1.193 0 C-N-CA 120.033 -0.667 . . . . 1.65 110.261 179.291 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A 1537 ' ' GLY . . . . . . . . . . . . . . . 79.68 -151.17 33.77 Favored Glycine 0 N--CA 1.426 -1.972 0 N-CA-C 109.962 -1.255 . . . . 1.19 109.962 -179.953 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A 1538 ' ' PHE . . . . . 0.614 ' CD1' HD13 ' A' 1552 ' ' ILE . 65.7 m-85 -107.95 135.91 48.53 Favored 'General case' 0 C--N 1.288 -2.09 0 N-CA-C 107.6 -1.259 . . . . 1.69 107.6 177.598 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A 1539 ' ' THR . . . . . 0.443 ' O ' ' HD2' ' A' 1623 ' ' ARG . 2.7 p -112.45 137.02 51.24 Favored 'General case' 0 C--N 1.296 -1.75 0 N-CA-C 113.135 0.791 . . . . 1.48 113.135 -175.676 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A 1540 ' ' ALA . . . . . . . . . . . . . . . -117.02 108.81 16.21 Favored 'General case' 0 C--N 1.308 -1.203 0 N-CA-C 109.687 -0.486 . . . . 0.83 109.687 178.302 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A 1541 ' ' ALA . . . . . . . . . . . . . . . -74.19 113.75 11.76 Favored 'General case' 0 C--N 1.313 -0.98 0 CA-C-N 115.36 -0.836 . . . . 1.27 109.396 178.998 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A 1542 ' ' TYR . . . . . 0.434 ' CE2' ' HB2' ' A' 1545 ' ' SER . 80.0 t80 -130.72 157.64 42.25 Favored 'General case' 0 N--CA 1.418 -2.065 0 CA-C-N 115.852 -0.613 . . . . 2.15 109.734 -176.587 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A 1543 ' ' SER . . . . . . . . . . . . . 5.3 m -40.85 -153.6 0.0 OUTLIER 'General case' 0 CA--C 1.592 2.561 0 C-N-CA 129.709 3.204 . . . . 2.29 117.111 -174.716 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A 1544 ' ' LYS . . . . . . . . . . . . . 25.0 ttmm -54.86 -24.71 24.41 Favored 'General case' 0 CA--C 1.556 1.188 0 O-C-N 120.863 -1.148 . . . . 3.91 112.385 -179.343 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A 1545 ' ' SER . . . . . 0.434 ' HB2' ' CE2' ' A' 1542 ' ' TYR . 22.6 m -64.69 -30.69 71.71 Favored 'General case' 0 CA--C 1.547 0.827 0 O-C-N 121.759 -0.588 . . . . 3.3 110.717 175.452 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A 1546 ' ' GLY . . . . . 0.417 ' O ' ' HB3' ' A' 1542 ' ' TYR . . . 116.85 174.26 17.12 Favored Glycine 0 N--CA 1.436 -1.34 0 C-N-CA 119.489 -1.339 . . . . 1.24 114.974 174.174 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A 1547 ' ' VAL . . . . . . . . . . . . . 3.1 p -92.92 129.21 43.79 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.343 0 C-N-CA 123.991 0.916 . . . . 1.63 110.398 179.915 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A 1548 ' ' VAL . . . . . 0.515 ' HA ' ' HA ' ' A' 1567 ' ' PHE . 3.0 t -97.47 143.29 12.87 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.86 0 CA-C-N 115.55 -0.75 . . . . 0.92 109.957 -174.763 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A 1549 ' ' TYR . . . . . 0.736 ' HB3' HD21 ' A' 1556 ' ' ASN . 37.3 m-85 -102.49 145.41 29.62 Favored 'General case' 0 C--N 1.307 -1.243 0 N-CA-C 105.915 -1.883 . . . . 1.44 105.915 169.341 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A 1550 ' ' MET . . . . . 0.429 ' SD ' HG12 ' A' 1610 ' ' ILE . 37.1 ttm -143.52 127.72 17.64 Favored 'General case' 0 C--N 1.292 -1.929 0 C-N-CA 120.49 -0.484 . . . . 1.74 110.833 -175.615 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A 1551 ' ' SER . . . . . . . . . . . . . 41.0 p -99.52 115.76 30.08 Favored 'General case' 0 N--CA 1.418 -2.04 0 N-CA-C 108.047 -1.094 . . . . 1.64 108.047 174.572 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A 1552 ' ' ILE . . . . . 0.614 HD13 ' CD1' ' A' 1538 ' ' PHE . 1.7 mp -75.53 -7.84 10.73 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.017 0 CA-C-O 122.474 1.131 . . . . 1.33 110.586 179.228 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A 1553 ' ' CYS . . . . . . . . . . . . . 33.9 t -161.48 148.83 14.78 Favored 'General case' 0 N--CA 1.425 -1.691 0 N-CA-C 107.516 -1.29 . . . . 1.43 107.516 177.56 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A 1554 ' ' GLY . . . . . . . . . . . . . . . 82.93 -120.15 5.07 Favored Glycine 0 C--N 1.318 -0.462 0 C-N-CA 121.227 -0.511 . . . . 1.12 113.129 176.228 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A 1555 ' ' GLU . . . . . . . . . . . . . 9.3 pt-20 -145.81 145.51 30.81 Favored 'General case' 0 C--N 1.315 -0.91 0 C-N-CA 123.347 0.659 . . . . 1.8 110.812 -179.885 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A 1556 ' ' ASN . . . . . 0.736 HD21 ' HB3' ' A' 1549 ' ' TYR . 3.4 t-20 -85.13 132.3 34.32 Favored 'General case' 0 C--N 1.295 -1.773 0 CA-C-N 114.644 -1.162 . . . . 2.63 110.821 -175.183 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A 1557 ' ' GLU . . . . . 0.816 ' HG3' ' HD3' ' A' 1535 ' ' ARG . 33.2 mm-40 -98.48 177.87 5.2 Favored 'General case' 0 C--N 1.289 -2.044 0 CA-C-N 113.837 -1.529 . . . . 3.79 109.116 179.937 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A 1558 ' ' ASN . . . . . . . . . . . . . 37.8 m-80 75.53 5.71 4.03 Favored 'General case' 0 N--CA 1.504 2.258 0 C-N-CA 124.471 1.109 . . . . 1.52 111.119 -178.727 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A 1559 ' ' CYS . . . . . 0.447 ' SG ' ' HA ' ' A' 1571 ' ' ARG . 97.7 m -148.28 169.35 9.38 Favored Pre-proline 0 C--N 1.291 -1.938 0 N-CA-C 103.413 -2.81 . . . . 0.84 103.413 176.34 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A 1560 ' ' PRO . . . . . 0.438 ' HD2' ' HB3' ' A' 1559 ' ' CYS . 9.4 Cg_endo -52.18 109.21 0.31 Allowed 'Trans proline' 0 C--N 1.359 1.115 0 C-N-CA 122.37 2.046 . . . . 1.18 111.244 176.624 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A 1561 ' ' PRO . . . . . . . . . . . . . 75.4 Cg_exo -50.85 120.61 6.83 Favored 'Trans proline' 0 C--N 1.359 1.088 0 C-N-CA 123.884 3.056 . . . . 1.51 112.502 -175.523 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A 1562 ' ' GLY . . . . . . . . . . . . . . . 134.19 -6.04 4.66 Favored Glycine 0 N--CA 1.435 -1.433 0 CA-C-N 115.081 -0.963 . . . . 0.72 110.987 -177.608 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A 1563 ' ' VAL . . . . . 0.576 HG23 ' HB3' ' A' 1556 ' ' ASN . 13.9 m -90.43 161.06 2.67 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.182 0 N-CA-C 105.937 -1.875 . . . . 0.97 105.937 172.944 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A 1564 ' ' GLY . . . . . . . . . . . . . . . -112.18 -21.88 6.1 Favored Glycine 0 C--N 1.309 -0.923 0 C-N-CA 120.395 -0.907 . . . . 0.72 111.964 -179.816 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A 1565 ' ' ALA . . . . . . . . . . . . . . . -150.13 127.63 11.52 Favored 'General case' 0 C--N 1.311 -1.081 0 N-CA-C 107.511 -1.292 . . . . 0.37 107.511 179.048 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A 1566 ' ' CYS . . . . . . . . . . . . . 34.2 t -155.75 141.57 18.06 Favored 'General case' 0 C--N 1.297 -1.681 0 N-CA-C 110.33 -0.248 . . . . 0.51 110.33 -174.62 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A 1567 ' ' PHE . . . . . 0.515 ' HA ' ' HA ' ' A' 1548 ' ' VAL . 87.6 m-85 -71.2 121.69 18.84 Favored 'General case' 0 C--O 1.216 -0.662 0 N-CA-C 105.365 -2.087 . . . . 0.97 105.365 171.678 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A 1568 ' ' GLY . . . . . 0.63 ' HA3' ' CD1' ' A' 1549 ' ' TYR . . . -83.21 -16.23 69.91 Favored Glycine 0 C--N 1.296 -1.672 0 C-N-CA 119.314 -1.422 . . . . 1.08 114.009 -171.141 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A 1569 ' ' GLN . . . . . . . . . . . . . 4.1 pt20 -82.31 -21.71 35.97 Favored 'General case' 0 C--N 1.301 -1.521 0 C-N-CA 120.565 -0.454 . . . . 2.74 111.408 -178.164 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A 1570 ' ' THR . . . . . . . . . . . . . 9.7 p -121.54 -12.36 8.55 Favored 'General case' 0 C--O 1.239 0.505 0 N-CA-C 112.347 0.499 . . . . 1.96 112.347 178.303 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A 1571 ' ' ARG . . . . . 0.447 ' HA ' ' SG ' ' A' 1559 ' ' CYS . 96.4 mtt180 62.81 42.57 7.79 Favored 'General case' 0 CA--C 1.511 -0.552 0 C-N-CA 125.1 1.36 . . . . 3.95 112.693 178.922 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A 1572 ' ' ILE . . . . . . . . . . . . . 25.2 mm -99.95 116.26 42.85 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.19 0 N-CA-C 108.139 -1.06 . . . . 1.37 108.139 179.942 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A 1573 ' ' SER . . . . . . . . . . . . . 35.0 t -69.15 133.33 47.87 Favored 'General case' 0 C--N 1.306 -1.284 0 CA-C-N 115.311 -0.859 . . . . 1.08 111.084 -176.402 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A 1574 ' ' VAL . . . . . . . . . . . . . 13.8 m -130.6 28.42 1.51 Allowed 'Isoleucine or valine' 0 C--N 1.315 -0.929 0 CA-C-O 122.205 1.002 . . . . 1.3 110.857 174.903 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A 1575 ' ' GLY . . . . . . . . . . . . . . . 163.04 126.97 0.85 Allowed Glycine 0 N--CA 1.421 -2.342 0 CA-C-N 113.835 -1.53 . . . . 0.51 110.439 176.854 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A 1576 ' ' LYS . . . . . 0.479 ' HA ' ' HA ' ' A' 1563 ' ' VAL . 68.3 mttm -85.79 151.24 23.98 Favored 'General case' 0 C--N 1.31 -1.133 0 N-CA-C 108.781 -0.822 . . . . 2.9 108.781 177.969 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A 1577 ' ' ALA . . . . . . . . . . . . . . . -74.34 91.84 2.23 Favored 'General case' 0 C--N 1.315 -0.928 0 CA-C-O 121.736 0.779 . . . . 0.83 111.641 -175.48 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A 1578 ' ' ASN . . . . . . . . . . . . . 41.4 m-80 -117.22 115.18 24.8 Favored 'General case' 0 C--N 1.284 -2.243 0 N-CA-C 104.747 -2.316 . . . . 1.85 104.747 171.724 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A 1579 ' ' LYS . . . . . . . . . . . . . 54.1 mtmt -77.29 90.41 3.75 Favored 'General case' 0 CA--C 1.493 -1.244 0 N-CA-C 108.654 -0.869 . . . . 1.9 108.654 -177.037 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A 1580 ' ' ARG . . . . . 0.53 ' HG3' ' CE1' ' A' 1513 ' ' HIS . 27.4 ttm180 -134.79 99.09 4.21 Favored 'General case' 0 N--CA 1.402 -2.861 0 CA-C-N 114.341 -1.3 . . . . 3.63 108.869 -176.481 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A 1581 ' ' LEU . . . . . 0.477 ' HA ' ' HA ' ' A' 1590 ' ' LEU . 4.6 pp -103.61 168.03 9.41 Favored 'General case' 0 C--N 1.297 -1.7 0 C-N-CA 120.4 -0.52 . . . . 1.87 110.189 177.518 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A 1582 ' ' ARG . . . . . 0.673 ' HB3' ' HB3' ' A' 1589 ' ' GLN . 61.5 ttt180 -135.21 125.5 26.36 Favored 'General case' 0 C--N 1.297 -1.688 0 C-N-CA 123.158 0.583 . . . . 3.97 109.766 -174.046 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A 1583 ' ' TYR . . . . . . . . . . . . . 40.2 t80 -119.09 104.11 10.16 Favored 'General case' 0 C--N 1.308 -1.202 0 CA-C-N 116.256 -0.429 . . . . 1.41 110.131 176.075 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A 1584 ' ' VAL . . . . . . . . . . . . . 12.5 p -148.62 142.82 18.85 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.953 0 N-CA-C 108.76 -0.83 . . . . 1.69 108.76 178.981 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A 1585 ' ' ASP . . . . . . . . . . . . . 31.6 t70 49.65 38.7 15.71 Favored 'General case' 0 N--CA 1.501 2.092 0 CA-C-O 122.559 1.171 . . . . 2.06 112.503 177.226 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A 1586 ' ' GLN . . . . . . . . . . . . . 27.4 mt-30 53.84 34.57 19.59 Favored 'General case' 0 C--O 1.241 0.638 0 CA-C-N 114.581 -1.191 . . . . 2.33 113.151 -179.426 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A 1587 ' ' VAL . . . . . . . . . . . . . 7.1 p -135.08 117.5 22.13 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.386 0 CA-C-O 121.826 0.822 . . . . 0.78 109.427 174.724 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A 1588 ' ' LEU . . . . . 0.812 HD11 HG21 ' A' 1518 ' ' VAL . 2.3 mm? -81.57 152.72 27.09 Favored 'General case' 0 C--N 1.297 -1.706 0 CA-C-N 114.784 -1.098 . . . . 1.41 111.588 -178.167 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A 1589 ' ' GLN . . . . . 0.673 ' HB3' ' HB3' ' A' 1582 ' ' ARG . 35.3 tt0 -152.47 156.99 40.52 Favored 'General case' 0 C--N 1.294 -1.837 0 N-CA-C 107.493 -1.299 . . . . 1.24 107.493 -179.534 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A 1590 ' ' LEU . . . . . 0.477 ' HA ' ' HA ' ' A' 1581 ' ' LEU . 5.3 tt -147.83 143.35 27.39 Favored 'General case' 0 C--N 1.303 -1.448 0 N-CA-C 105.685 -1.968 . . . . 1.15 105.685 175.06 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A 1591 ' ' VAL . . . . . 0.503 HG23 HG22 ' A' 1609 ' ' VAL . 11.5 p -130.93 135.26 60.42 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.178 0 N-CA-C 112.805 0.668 . . . . 1.51 112.805 -173.843 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A 1592 ' ' TYR . . . . . . . . . . . . . 63.3 m-85 -122.35 106.11 10.78 Favored 'General case' 0 C--N 1.315 -0.904 0 N-CA-C 107.857 -1.164 . . . . 1.06 107.857 172.912 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A 1593 ' ' LYS . . . . . . . . . . . . . 20.0 pttp -104.37 178.4 4.57 Favored 'General case' 0 C--N 1.293 -1.854 0 CA-C-N 115.982 -0.553 . . . . 2.18 112.07 -176.173 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A 1594 ' ' ASP . . . . . 0.576 ' HA ' ' CB ' ' A' 1605 ' ' SER . 55.8 m-20 49.05 47.83 21.44 Favored 'General case' 0 CA--C 1.514 -0.423 0 C-N-CA 126.101 1.76 . . . . 1.45 115.701 172.407 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A 1595 ' ' GLY . . . . . . . . . . . . . . . -78.66 -80.48 0.73 Allowed Glycine 0 N--CA 1.445 -0.724 0 C-N-CA 120.298 -0.953 . . . . 0.78 111.226 177.758 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A 1596 ' ' SER . . . . . 0.446 ' HA ' ' HD3' ' A' 1597 ' ' PRO . 4.2 p -107.47 143.38 27.11 Favored Pre-proline 0 C--N 1.299 -1.618 0 N-CA-C 109.963 -0.384 . . . . 1.68 109.963 177.588 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A 1597 ' ' PRO . . . . . 0.446 ' HD3' ' HA ' ' A' 1596 ' ' SER . 21.5 Cg_exo -67.24 130.13 21.95 Favored 'Trans proline' 0 N--CA 1.46 -0.475 0 C-N-CA 123.039 2.493 . . . . 1.17 110.29 177.099 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A 1598 ' ' CYS . . . . . 0.43 ' HA ' ' HD3' ' A' 1599 ' ' PRO . 33.7 t -101.25 121.42 51.92 Favored Pre-proline 0 C--N 1.296 -1.736 0 N-CA-C 109.924 -0.398 . . . . 1.19 109.924 -177.157 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A 1599 ' ' PRO . . . . . 0.43 ' HD3' ' HA ' ' A' 1598 ' ' CYS . 94.3 Cg_endo -98.34 22.4 0.29 Allowed 'Trans proline' 0 N--CA 1.449 -1.114 0 C-N-CA 123.127 2.551 . . . . 1.59 112.097 178.344 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A 1600 ' ' SER . . . . . . . . . . . . . 17.9 m -79.61 -74.24 0.3 Allowed 'General case' 0 C--N 1.315 -0.931 0 CA-C-N 116.466 -0.333 . . . . 2.12 111.788 -177.899 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A 1601 ' ' LYS . . . . . . . . . . . . . 23.2 tptm -98.13 -87.11 0.34 Allowed 'General case' 0 C--N 1.317 -0.822 0 C-N-CA 120.317 -0.553 . . . . 3.74 110.42 -178.949 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A 1602 ' ' SER . . . . . . . . . . . . . 16.7 m -96.21 174.98 6.62 Favored 'General case' 0 C--N 1.298 -1.672 0 N-CA-C 107.942 -1.133 . . . . 3.79 107.942 178.718 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A 1603 ' ' GLY . . . . . . . . . . . . . . . -81.57 65.64 3.98 Favored Glycine 0 N--CA 1.439 -1.126 0 N-CA-C 110.382 -1.087 . . . . 2.0 110.382 178.025 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A 1604 ' ' LEU . . . . . . . . . . . . . 1.7 pt? -117.02 165.18 13.66 Favored 'General case' 0 C--N 1.296 -1.724 0 N-CA-C 108.025 -1.102 . . . . 1.48 108.025 -178.111 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A 1605 ' ' SER . . . . . 0.576 ' CB ' ' HA ' ' A' 1594 ' ' ASP . 19.3 m -92.31 178.49 5.83 Favored 'General case' 0 C--N 1.298 -1.641 0 CA-C-O 120.967 0.413 . . . . 1.51 110.389 179.616 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A 1606 ' ' TYR . . . . . 0.489 ' HA ' ' O ' ' A' 1634 ' ' CYS . 76.7 m-85 -95.91 133.74 39.73 Favored 'General case' 0 CA--C 1.468 -2.21 0 N-CA-C 104.658 -2.349 . . . . 1.18 104.658 176.321 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A 1607 ' ' LYS . . . . . 0.411 ' HG3' HG23 ' A' 1635 ' ' THR . 10.3 ptpp? -128.36 153.95 46.5 Favored 'General case' 0 N--CA 1.403 -2.802 0 C-N-CA 118.452 -1.299 . . . . 1.67 109.133 178.53 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A 1608 ' ' SER . . . . . . . . . . . . . 45.3 m -117.64 124.29 48.23 Favored 'General case' 0 C--N 1.296 -1.727 0 N-CA-C 109.784 -0.45 . . . . 1.0 109.784 178.063 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A 1609 ' ' VAL . . . . . 0.503 HG22 HG23 ' A' 1591 ' ' VAL . 78.4 t -114.65 124.48 71.35 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.868 0 N-CA-C 109.002 -0.74 . . . . 0.93 109.002 178.956 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A 1610 ' ' ILE . . . . . 0.705 HG13 ' HB2' ' A' 1638 ' ' PHE . 3.2 mp -108.21 119.14 57.26 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.202 0 N-CA-C 109.166 -0.679 . . . . 0.78 109.166 178.683 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A 1611 ' ' SER . . . . . 0.42 ' O ' ' HA ' ' A' 1639 ' ' SER . 8.6 t -96.35 118.37 32.75 Favored 'General case' 0 N--CA 1.412 -2.348 0 N-CA-C 107.732 -1.21 . . . . 1.29 107.732 178.558 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A 1612 ' ' PHE . . . . . 0.436 ' HE2' ' HB2' ' A' 1590 ' ' LEU . 92.8 m-85 -97.06 102.12 13.83 Favored 'General case' 0 N--CA 1.428 -1.556 0 N-CA-C 107.858 -1.164 . . . . 0.7 107.858 178.664 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A 1613 ' ' VAL . . . . . . . . . . . . . 85.0 t -84.29 120.03 34.36 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.952 0 N-CA-C 107.51 -1.293 . . . . 0.75 107.51 179.911 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A 1614 ' ' CYS . . . . . 0.522 ' HB3' ' HB2' ' A' 1646 ' ' CYS . 56.8 m -75.06 91.61 2.56 Favored 'General case' 0 C--N 1.295 -1.795 0 CA-C-O 121.653 0.74 . . . . 1.39 109.036 -178.334 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A 1615 ' ' ARG . . . . . 0.503 ' HA ' ' HE ' ' A' 1615 ' ' ARG . 0.0 OUTLIER -140.08 123.19 10.3 Favored Pre-proline 0 N--CA 1.414 -2.274 0 CA-C-N 115.748 -0.66 . . . . 3.75 109.893 178.358 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A 1616 ' ' PRO . . . . . . . . . . . . . 56.9 Cg_endo -73.04 68.53 3.98 Favored 'Trans proline' 0 CA--C 1.546 1.083 0 C-N-CA 122.261 1.974 . . . . 1.32 110.82 173.908 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A 1617 ' ' GLU . . . . . . . . . . . . . 7.5 tp10 -130.2 16.43 5.58 Favored 'General case' 0 C--N 1.314 -0.978 0 N-CA-C 108.878 -0.786 . . . . 3.21 108.878 -177.933 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A 1618 ' ' ALA . . . . . . . . . . . . . . . -173.88 162.62 3.97 Favored 'General case' 0 CA--C 1.506 -0.733 0 N-CA-C 108.423 -0.955 . . . . 2.44 108.423 -177.026 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A 1619 ' ' GLY . . . . . . . . . . . . . . . -113.13 -175.69 19.36 Favored Glycine 0 N--CA 1.44 -1.093 0 N-CA-C 111.685 -0.566 . . . . 3.26 111.685 177.878 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A 1620 ' ' PRO . . . . . 0.41 ' HB3' HD11 ' A' 1644 ' ' LEU . 19.6 Cg_endo -59.61 -18.02 45.25 Favored 'Trans proline' 0 CA--C 1.546 1.105 0 C-N-CA 123.568 2.845 . . . . 5.92 115.304 -178.122 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A 1621 ' ' THR . . . . . . . . . . . . . 4.5 t -77.09 -18.59 57.88 Favored 'General case' 0 C--O 1.247 0.939 0 C-N-CA 120.077 -0.649 . . . . 4.76 109.958 179.274 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A 1622 ' ' ASN . . . . . 0.422 ' HB3' ' HE1' ' A' 1640 ' ' TRP . 20.3 t-20 -73.06 172.23 11.42 Favored 'General case' 0 C--N 1.34 0.191 0 N-CA-C 107.944 -1.132 . . . . 2.92 107.944 -179.238 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A 1623 ' ' ARG . . . . . 0.444 ' HA ' ' HD3' ' A' 1624 ' ' PRO . 32.9 ptt180 -155.32 156.48 31.05 Favored Pre-proline 0 C--N 1.305 -1.361 0 C-N-CA 119.752 -0.779 . . . . 3.61 112.144 -169.786 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A 1624 ' ' PRO . . . . . 0.444 ' HD3' ' HA ' ' A' 1623 ' ' ARG . 12.0 Cg_exo -70.76 106.67 1.89 Allowed 'Trans proline' 0 C--N 1.356 0.964 0 C-N-CA 123.426 2.751 . . . . 2.37 112.068 179.69 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A 1625 ' ' MET . . . . . . . . . . . . . 25.4 ptm -90.3 164.21 14.45 Favored 'General case' 0 C--N 1.303 -1.423 0 CA-C-N 115.698 -0.683 . . . . 2.16 109.304 179.252 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A 1626 ' ' LEU . . . . . . . . . . . . . 41.2 tp -89.58 112.87 24.2 Favored 'General case' 0 C--N 1.303 -1.421 0 N-CA-C 108.69 -0.856 . . . . 1.35 108.69 -178.944 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A 1627 ' ' ILE . . . . . . . . . . . . . 44.0 pt -94.43 -27.71 4.29 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.768 0 C-N-CA 120.585 -0.446 . . . . 1.21 111.662 -177.35 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A 1628 ' ' SER . . . . . . . . . . . . . 15.6 p -162.19 151.8 16.13 Favored 'General case' 0 N--CA 1.44 -0.969 0 N-CA-C 109.951 -0.388 . . . . 1.4 109.951 -178.485 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A 1629 ' ' LEU . . . . . 0.87 ' HG ' ' HG ' ' A' 1636 ' ' LEU . 2.7 tt -138.82 117.43 12.17 Favored 'General case' 0 C--N 1.293 -1.857 0 N-CA-C 106.84 -1.541 . . . . 1.56 106.84 -178.753 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A 1630 ' ' ASP . . . . . . . . . . . . . 12.6 t70 -94.72 103.38 15.29 Favored 'General case' 0 C--N 1.299 -1.621 0 N-CA-C 106.483 -1.673 . . . . 0.87 106.483 178.847 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A 1631 ' ' LYS . . . . . 0.602 ' HG2' HD22 ' A' 1629 ' ' LEU . 90.9 mttt -83.13 -5.35 59.08 Favored 'General case' 0 C--N 1.291 -1.946 0 CA-C-N 115.984 -0.553 . . . . 2.35 111.662 -172.35 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A 1632 ' ' GLN . . . . . . . . . . . . . 1.9 mp0 -87.0 -46.15 10.1 Favored 'General case' 0 C--N 1.312 -1.055 0 N-CA-C 108.437 -0.949 . . . . 2.55 108.437 -179.524 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A 1633 ' ' THR . . . . . . . . . . . . . 2.3 m -89.83 -2.93 58.33 Favored 'General case' 0 C--N 1.312 -1.022 0 CA-C-O 122.241 1.02 . . . . 1.24 108.769 178.01 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A 1634 ' ' CYS . . . . . 0.489 ' O ' ' HA ' ' A' 1606 ' ' TYR . 28.7 m 59.94 43.72 14.43 Favored 'General case' 0 C--O 1.219 -0.529 0 CA-C-N 114.263 -1.335 . . . . 0.89 109.976 176.95 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A 1635 ' ' THR . . . . . 0.411 HG23 ' HG3' ' A' 1607 ' ' LYS . 16.7 m -120.15 127.68 52.72 Favored 'General case' 0 N--CA 1.428 -1.548 0 CA-C-N 115.228 -0.896 . . . . 0.75 110.847 -173.643 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A 1636 ' ' LEU . . . . . 0.87 ' HG ' ' HG ' ' A' 1629 ' ' LEU . 5.9 mp -101.05 132.43 46.48 Favored 'General case' 0 C--N 1.312 -1.059 0 N-CA-C 109.475 -0.565 . . . . 1.33 109.475 177.346 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A 1637 ' ' PHE . . . . . . . . . . . . . 95.5 m-85 -113.4 107.86 16.42 Favored 'General case' 0 C--O 1.25 1.089 0 CA-C-O 121.26 0.552 . . . . 0.83 111.122 -177.762 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A 1638 ' ' PHE . . . . . 0.705 ' HB2' HG13 ' A' 1610 ' ' ILE . 95.7 m-85 -101.01 154.55 18.61 Favored 'General case' 0 C--N 1.299 -1.587 0 N-CA-C 108.866 -0.79 . . . . 0.6 108.866 178.944 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A 1639 ' ' SER . . . . . 0.42 ' HA ' ' O ' ' A' 1611 ' ' SER . 66.2 m -143.85 130.52 20.19 Favored 'General case' 0 C--N 1.296 -1.726 0 CA-C-O 120.992 0.425 . . . . 1.08 111.682 178.892 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A 1640 ' ' TRP . . . . . 0.422 ' HE1' ' HB3' ' A' 1622 ' ' ASN . 12.2 t90 -124.71 105.95 9.7 Favored 'General case' 0 N--CA 1.434 -1.262 0 CA-C-N 115.488 -0.778 . . . . 0.8 109.117 178.008 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A 1641 ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -76.16 100.32 4.98 Favored 'General case' 0 C--N 1.305 -1.346 0 CA-C-O 121.547 0.689 . . . . 2.54 109.479 175.309 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A 1642 ' ' THR . . . . . 0.422 ' O ' ' HA ' ' A' 1614 ' ' CYS . 14.9 t -142.08 139.01 17.37 Favored Pre-proline 0 C--N 1.291 -1.936 0 C-N-CA 120.016 -0.674 . . . . 1.15 112.447 -173.493 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A 1643 ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -80.86 -0.32 10.52 Favored 'Trans proline' 0 N--CA 1.453 -0.893 0 C-N-CA 123.296 2.664 . . . . 0.8 110.611 175.487 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A 1644 ' ' LEU . . . . . 0.41 HD11 ' HB3' ' A' 1620 ' ' PRO . 88.9 mt -77.04 -27.57 54.51 Favored 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 108.405 -0.961 . . . . 1.54 108.405 175.345 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A 1645 ' ' ALA . . . . . . . . . . . . . . . -71.11 -42.37 69.36 Favored 'General case' 0 N--CA 1.441 -0.887 0 CA-C-N 114.596 -1.184 . . . . 0.95 110.022 -179.368 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A 1646 ' ' CYS . . . . . 0.522 ' HB2' ' HB3' ' A' 1614 ' ' CYS . 65.5 m -139.94 115.97 10.37 Favored 'General case' 0 C--O 1.244 0.808 0 N-CA-C 106.931 -1.507 . . . . 1.41 106.931 173.656 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A 1647 ' ' GLU . . . . . 0.623 ' HB2' ' HE1' ' A' 1525 ' ' HIS . 35.8 mt-10 -90.69 114.05 59.97 Favored Pre-proline 0 C--N 1.309 -1.18 0 O-C-N 123.802 0.689 . . . . 2.92 110.226 -174.882 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A 1648 ' ' PRO . . . . . . . . . . . . . 20.5 Cg_exo -66.69 101.74 0.57 Allowed 'Trans proline' 0 C--O 1.25 1.083 0 C-N-CA 122.748 2.298 . . . . 2.82 112.218 178.973 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A 1649 ' ' GLU . . . . . . . . . . . . . 12.8 tp10 . . . . . 0 C--O 1.264 1.839 0 N-CA-C 107.371 -1.344 . . . . 5.06 107.371 179.67 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A 1508 ' ' MET . . . . . . . . . . . . . 88.8 mtp . . . . . 0 CA--C 1.499 -1.003 0 N-CA-C 108.869 -0.789 . . . . 8.27 108.869 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A 1509 ' ' LYS . . . . . . . . . . . . . 36.2 mtmm -82.02 117.33 22.14 Favored 'General case' 0 C--N 1.302 -1.498 0 N-CA-C 108.742 -0.836 . . . . 6.48 108.742 178.054 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A 1510 ' ' SER . . . . . . . . . . . . . 1.7 p -88.62 -18.83 27.17 Favored 'General case' 0 N--CA 1.418 -2.052 0 CA-C-O 121.647 0.737 . . . . 4.22 109.632 -176.945 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A 1511 ' ' ASN . . . . . 0.579 HD21 ' HA ' ' A' 1518 ' ' VAL . 20.6 m120 -86.88 15.74 5.57 Favored 'General case' 0 N--CA 1.437 -1.123 0 CA-C-N 115.417 -0.811 . . . . 3.08 112.255 -177.257 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A 1512 ' ' GLU . . . . . . . . . . . . . 43.8 mt-10 -82.13 -16.77 48.74 Favored 'General case' 0 CA--C 1.521 -0.148 0 N-CA-C 107.063 -1.458 . . . . 4.46 107.063 169.337 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A 1513 ' ' HIS . . . . . . . . . . . . . 69.7 m80 -130.16 48.2 2.42 Favored 'General case' 0 C--N 1.315 -0.907 0 N-CA-C 105.26 -2.126 . . . . 5.57 105.26 176.678 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A 1514 ' ' ASP . . . . . . . . . . . . . 35.6 t70 -45.53 -72.3 0.06 Allowed 'General case' 0 N--CA 1.476 0.862 0 CA-C-N 113.012 -1.904 . . . . 3.7 113.264 -172.323 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A 1515 ' ' ASP . . . . . 0.441 ' HA ' ' HG3' ' A' 1579 ' ' LYS . 10.4 m-20 45.73 -94.19 0.02 OUTLIER 'General case' 0 N--CA 1.48 1.073 0 N-CA-C 114.274 1.212 . . . . 2.54 114.274 -179.189 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A 1516 ' ' CYS . . . . . 0.742 ' HA ' HD23 ' A' 1581 ' ' LEU . 57.0 m -135.79 40.75 2.74 Favored 'General case' 0 C--N 1.324 -0.536 0 C-N-CA 123.933 0.893 . . . . 1.25 111.37 -178.801 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A 1517 ' ' GLN . . . . . 0.497 ' HB2' HD21 ' A' 1526 ' ' LEU . 25.0 pt20 -139.09 124.19 18.96 Favored 'General case' 0 C--N 1.3 -1.571 0 N-CA-C 109.662 -0.496 . . . . 1.88 109.662 176.131 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A 1518 ' ' VAL . . . . . 0.579 ' HA ' HD21 ' A' 1511 ' ' ASN . 7.5 p -124.78 128.94 73.64 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.849 0 CA-C-O 121.044 0.449 . . . . 1.73 110.324 -179.799 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A 1519 ' ' THR . . . . . 0.409 ' HA ' ' HA ' ' A' 1526 ' ' LEU . 50.3 m -100.7 126.33 47.22 Favored 'General case' 0 C--N 1.284 -2.274 0 N-CA-C 108.879 -0.786 . . . . 1.7 108.879 175.369 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A 1520 ' ' ASN . . . . . . . . . . . . . 38.1 t-20 -88.96 110.53 38.6 Favored Pre-proline 0 C--N 1.303 -1.434 0 N-CA-C 107.453 -1.314 . . . . 2.12 107.453 176.942 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A 1521 ' ' PRO . . . . . . . . . . . . . 58.9 Cg_endo -70.4 -14.18 33.79 Favored 'Trans proline' 0 C--N 1.356 0.928 0 C-N-CA 122.585 2.19 . . . . 2.47 113.19 -175.487 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A 1522 ' ' SER . . . . . . . . . . . . . 6.9 m -80.29 -17.01 53.35 Favored 'General case' 0 N--CA 1.43 -1.442 0 CA-C-N 116.281 -0.418 . . . . 2.57 110.581 -178.795 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A 1523 ' ' THR . . . . . . . . . . . . . 10.1 t -131.51 -18.16 2.85 Favored 'General case' 0 CA--C 1.556 1.203 0 C-N-CA 120.312 -0.555 . . . . 2.15 112.492 179.45 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A 1524 ' ' GLY . . . . . . . . . . . . . . . 80.38 16.66 75.57 Favored Glycine 0 C--N 1.338 0.683 0 C-N-CA 121.186 -0.53 . . . . 1.89 111.93 179.471 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A 1525 ' ' HIS . . . . . . . . . . . . . 21.1 t-160 -102.06 134.71 44.86 Favored 'General case' 0 C--N 1.305 -1.343 0 N-CA-C 109.425 -0.583 . . . . 1.9 109.425 -178.795 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A 1526 ' ' LEU . . . . . 0.497 HD21 ' HB2' ' A' 1517 ' ' GLN . 6.7 tt -102.73 138.11 40.06 Favored 'General case' 0 C--N 1.305 -1.357 0 N-CA-C 107.838 -1.171 . . . . 1.61 107.838 178.651 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A 1527 ' ' PHE . . . . . 0.513 ' CE2' ' HA ' ' A' 1646 ' ' CYS . 57.9 m-85 -114.03 111.96 22.5 Favored 'General case' 0 C--N 1.299 -1.594 0 N-CA-C 107.71 -1.218 . . . . 1.42 107.71 177.489 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A 1528 ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -102.06 139.0 38.27 Favored 'General case' 0 CA--C 1.471 -2.077 0 N-CA-C 108.514 -0.921 . . . . 2.18 108.514 178.999 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A 1529 ' ' LEU . . . . . 0.609 ' HB2' ' HB3' ' A' 1516 ' ' CYS . 43.3 mt -111.73 2.82 17.38 Favored 'General case' 0 C--N 1.292 -1.908 0 N-CA-C 107.756 -1.201 . . . . 1.44 107.756 176.871 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A 1530 ' ' SER . . . . . . . . . . . . . 8.4 m -65.81 -45.02 83.87 Favored 'General case' 0 N--CA 1.441 -0.893 0 CA-C-N 114.895 -1.048 . . . . 1.44 110.538 -177.708 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A 1531 ' ' SER . . . . . . . . . . . . . 37.6 m -77.12 -12.54 59.96 Favored 'General case' 0 C--O 1.24 0.565 0 CA-C-O 121.304 0.573 . . . . 1.5 110.296 177.533 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A 1532 ' ' LEU . . . . . 0.508 HD13 ' HA ' ' A' 1529 ' ' LEU . 8.5 mp -80.22 -31.28 38.62 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 116.033 -0.53 . . . . 1.77 112.362 -179.493 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A 1533 ' ' SER . . . . . 0.588 ' HB2' HG22 ' A' 1552 ' ' ILE . 19.2 t -85.7 173.28 10.22 Favored 'General case' 0 C--N 1.306 -1.32 0 CA-C-O 120.914 0.388 . . . . 2.38 110.304 -178.439 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A 1534 ' ' GLY . . . . . . . . . . . . . . . -153.99 167.1 32.17 Favored Glycine 0 N--CA 1.429 -1.821 0 N-CA-C 109.549 -1.42 . . . . 1.55 109.549 -179.256 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A 1535 ' ' ARG . . . . . 0.491 ' CG ' ' HG3' ' A' 1557 ' ' GLU . 13.4 ttp180 -69.29 -47.75 63.66 Favored 'General case' 0 C--N 1.318 -0.789 0 CA-C-O 121.016 0.436 . . . . 3.96 111.132 -177.274 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A 1536 ' ' ALA . . . . . . . . . . . . . . . -77.45 -29.67 52.92 Favored 'General case' 0 C--O 1.245 0.823 0 CA-C-O 121.262 0.554 . . . . 1.65 110.361 -179.409 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A 1537 ' ' GLY . . . . . . . . . . . . . . . 86.3 -164.58 36.71 Favored Glycine 0 N--CA 1.427 -1.962 0 CA-C-N 115.296 -0.865 . . . . 1.19 112.377 175.574 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A 1538 ' ' PHE . . . . . 0.464 ' CD1' HD13 ' A' 1552 ' ' ILE . 84.2 m-85 -106.6 156.63 18.4 Favored 'General case' 0 C--N 1.293 -1.877 0 N-CA-C 108.081 -1.081 . . . . 1.69 108.081 179.439 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A 1539 ' ' THR . . . . . . . . . . . . . 18.8 m -116.13 111.57 20.45 Favored 'General case' 0 C--N 1.291 -1.946 0 CA-C-O 121.51 0.671 . . . . 1.48 109.82 -176.879 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A 1540 ' ' ALA . . . . . . . . . . . . . . . -93.87 151.61 19.46 Favored 'General case' 0 C--N 1.3 -1.583 0 N-CA-C 109.314 -0.624 . . . . 0.83 109.314 -179.743 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A 1541 ' ' ALA . . . . . . . . . . . . . . . -88.02 132.61 34.21 Favored 'General case' 0 C--N 1.305 -1.361 0 N-CA-C 109.45 -0.574 . . . . 1.27 109.45 -179.065 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A 1542 ' ' TYR . . . . . 0.505 ' HD2' ' HB2' ' A' 1545 ' ' SER . 72.5 t80 -139.96 164.51 29.8 Favored 'General case' 0 N--CA 1.437 -1.094 0 C-N-CA 120.628 -0.429 . . . . 2.15 111.143 -177.426 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A 1543 ' ' SER . . . . . . . . . . . . . 5.6 m -47.47 -151.14 0.0 OUTLIER 'General case' 0 CA--C 1.573 1.833 0 C-N-CA 129.106 2.962 . . . . 2.29 113.619 175.154 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A 1544 ' ' LYS . . . . . . . . . . . . . 18.5 ptpt -39.69 -26.42 0.03 OUTLIER 'General case' 0 CA--C 1.574 1.882 0 N-CA-C 115.004 1.483 . . . . 3.91 115.004 178.604 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A 1545 ' ' SER . . . . . 0.505 ' HB2' ' HD2' ' A' 1542 ' ' TYR . 8.4 m -79.12 -8.09 58.7 Favored 'General case' 0 CA--C 1.566 1.591 0 O-C-N 121.501 -0.749 . . . . 3.3 111.775 178.717 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A 1546 ' ' GLY . . . . . . . . . . . . . . . 86.09 -80.35 1.79 Allowed Glycine 0 C--N 1.339 0.706 0 C-N-CA 121.488 -0.387 . . . . 1.24 113.991 174.108 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A 1547 ' ' VAL . . . . . . . . . . . . . 8.2 m -141.53 157.96 21.59 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.694 0 C-N-CA 122.99 0.516 . . . . 1.63 110.031 -176.987 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A 1548 ' ' VAL . . . . . 0.417 HG13 ' HD1' ' A' 1567 ' ' PHE . 1.3 t -122.79 137.69 55.43 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.37 0 N-CA-C 107.895 -1.15 . . . . 0.92 107.895 -178.922 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A 1549 ' ' TYR . . . . . . . . . . . . . 71.3 m-85 -96.02 118.64 33.02 Favored 'General case' 0 C--N 1.306 -1.298 0 N-CA-C 108.771 -0.826 . . . . 1.44 108.771 175.263 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A 1550 ' ' MET . . . . . . . . . . . . . 74.0 mmm -118.55 121.74 40.97 Favored 'General case' 0 C--N 1.3 -1.549 0 CA-C-N 115.286 -0.87 . . . . 1.74 109.8 -173.412 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A 1551 ' ' SER . . . . . . . . . . . . . 75.5 m -106.58 114.63 28.85 Favored 'General case' 0 C--N 1.296 -1.759 0 N-CA-C 108.672 -0.862 . . . . 1.64 108.672 174.127 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A 1552 ' ' ILE . . . . . 0.588 HG22 ' HB2' ' A' 1533 ' ' SER . 1.5 mp -57.46 -34.02 45.63 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.873 0 CA-C-N 114.957 -1.02 . . . . 1.33 113.261 -176.576 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A 1553 ' ' CYS . . . . . 0.559 ' HB3' ' HE3' ' A' 1579 ' ' LYS . 73.6 m -140.68 137.98 33.94 Favored 'General case' 0 C--N 1.304 -1.396 0 N-CA-C 108.978 -0.749 . . . . 1.43 108.978 174.977 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A 1554 ' ' GLY . . . . . . . . . . . . . . . 94.89 -125.52 8.37 Favored Glycine 0 N--CA 1.433 -1.547 0 C-N-CA 120.937 -0.649 . . . . 1.12 114.043 172.252 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A 1555 ' ' GLU . . . . . . . . . . . . . 7.5 pt-20 -138.45 150.74 46.77 Favored 'General case' 0 C--N 1.31 -1.12 0 C-N-CA 123.432 0.693 . . . . 1.8 111.175 -175.464 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A 1556 ' ' ASN . . . . . . . . . . . . . 17.5 t-20 -101.23 138.96 37.57 Favored 'General case' 0 N--CA 1.433 -1.301 0 CA-C-N 115.503 -0.771 . . . . 2.63 108.944 -177.194 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A 1557 ' ' GLU . . . . . 0.491 ' HG3' ' CG ' ' A' 1535 ' ' ARG . 54.7 mm-40 -99.77 -0.42 39.96 Favored 'General case' 0 C--N 1.298 -1.645 0 N-CA-C 113.088 0.773 . . . . 3.79 113.088 -172.528 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A 1558 ' ' ASN . . . . . . . . . . . . . 33.5 m-80 -87.66 -1.82 58.2 Favored 'General case' 0 N--CA 1.483 1.187 0 CA-C-O 122.09 0.948 . . . . 1.52 110.144 -176.812 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A 1559 ' ' CYS . . . . . 0.782 ' HB3' ' HD2' ' A' 1560 ' ' PRO . 94.0 m -142.21 -175.95 0.52 Allowed Pre-proline 0 C--N 1.288 -2.066 0 N-CA-C 104.821 -2.289 . . . . 0.84 104.821 177.27 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A 1560 ' ' PRO . . . . . 0.782 ' HD2' ' HB3' ' A' 1559 ' ' CYS . 1.0 OUTLIER -45.72 124.16 6.64 Favored 'Trans proline' 0 C--N 1.364 1.374 0 C-N-CA 122.556 2.171 . . . . 1.18 112.882 175.677 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A 1561 ' ' PRO . . . . . 0.44 ' HD3' ' HA ' ' A' 1560 ' ' PRO . 33.5 Cg_exo -62.66 103.33 0.32 Allowed 'Trans proline' 0 C--O 1.242 0.688 0 C-N-CA 122.913 2.408 . . . . 1.51 110.688 179.053 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A 1562 ' ' GLY . . . . . . . . . . . . . . . 146.85 -9.46 1.35 Allowed Glycine 0 N--CA 1.423 -2.197 0 CA-C-N 115.103 -0.953 . . . . 0.72 110.805 -177.206 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A 1563 ' ' VAL . . . . . . . . . . . . . 3.6 m -98.29 150.82 4.67 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.345 0 N-CA-C 106.646 -1.613 . . . . 0.97 106.646 174.174 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A 1564 ' ' GLY . . . . . . . . . . . . . . . -103.21 -21.75 9.77 Favored Glycine 0 C--N 1.306 -1.089 0 C-N-CA 120.179 -1.01 . . . . 0.72 112.286 -176.483 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A 1565 ' ' ALA . . . . . . . . . . . . . . . -148.34 132.38 17.23 Favored 'General case' 0 C--N 1.31 -1.113 0 N-CA-C 109.063 -0.717 . . . . 0.37 109.063 -179.283 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A 1566 ' ' CYS . . . . . . . . . . . . . 35.9 t -153.5 138.95 17.66 Favored 'General case' 0 C--N 1.309 -1.158 0 CA-C-N 116.69 -0.232 . . . . 0.51 110.818 -173.821 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A 1567 ' ' PHE . . . . . 0.417 ' HD1' HG13 ' A' 1548 ' ' VAL . 21.0 m-85 -68.73 123.34 20.65 Favored 'General case' 0 CA--C 1.514 -0.436 0 N-CA-C 108.2 -1.037 . . . . 0.97 108.2 175.489 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A 1568 ' ' GLY . . . . . . . . . . . . . . . -55.06 -64.36 4.43 Favored Glycine 0 C--N 1.31 -0.908 0 N-CA-C 116.861 1.505 . . . . 1.08 116.861 -167.76 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A 1569 ' ' GLN . . . . . . . . . . . . . 13.7 pt20 -85.15 -23.58 28.33 Favored 'General case' 0 C--N 1.312 -1.064 0 N-CA-C 113.208 0.818 . . . . 2.74 113.208 -172.057 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A 1570 ' ' THR . . . . . . . . . . . . . 19.7 p -88.32 -17.56 30.37 Favored 'General case' 0 C--N 1.308 -1.222 0 CA-C-O 121.719 0.771 . . . . 1.96 111.191 -179.625 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A 1571 ' ' ARG . . . . . . . . . . . . . 67.9 mtm180 59.12 47.75 11.45 Favored 'General case' 0 CA--C 1.508 -0.67 0 C-N-CA 125.817 1.647 . . . . 3.95 112.253 175.272 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A 1572 ' ' ILE . . . . . . . . . . . . . 32.7 mm -112.0 120.28 61.98 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.26 0 N-CA-C 108.062 -1.088 . . . . 1.37 108.062 179.434 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A 1573 ' ' SER . . . . . . . . . . . . . 60.4 p -73.63 127.45 32.8 Favored 'General case' 0 C--N 1.309 -1.195 0 CA-C-N 115.857 -0.611 . . . . 1.08 111.092 -177.06 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A 1574 ' ' VAL . . . . . 0.479 ' HA ' ' HB2' ' A' 1606 ' ' TYR . 23.5 m -118.22 15.05 7.19 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.307 0 CA-C-O 121.936 0.874 . . . . 1.3 110.782 -179.339 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A 1575 ' ' GLY . . . . . . . . . . . . . . . -179.29 125.28 0.96 Allowed Glycine 0 N--CA 1.429 -1.775 0 CA-C-N 114.466 -1.243 . . . . 0.51 110.54 176.531 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A 1576 ' ' LYS . . . . . . . . . . . . . 55.2 tptt -85.68 156.4 20.68 Favored 'General case' 0 C--N 1.313 -0.981 0 N-CA-C 106.423 -1.695 . . . . 2.9 106.423 177.955 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A 1577 ' ' ALA . . . . . 0.442 ' C ' HD22 ' A' 1578 ' ' ASN . . . -55.88 115.28 2.29 Favored 'General case' 0 N--CA 1.468 0.465 0 CA-C-O 121.447 0.641 . . . . 0.83 110.586 179.738 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A 1578 ' ' ASN . . . . . 0.442 HD22 ' C ' ' A' 1577 ' ' ALA . 1.1 m-80 -125.11 169.72 11.91 Favored 'General case' 0 C--N 1.283 -2.285 0 N-CA-C 106.061 -1.829 . . . . 1.85 106.061 178.265 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A 1579 ' ' LYS . . . . . 0.559 ' HE3' ' HB3' ' A' 1553 ' ' CYS . 17.9 tptm -163.87 89.99 0.59 Allowed 'General case' 0 C--N 1.306 -1.283 0 C-N-CA 119.88 -0.728 . . . . 1.9 109.418 -176.956 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A 1580 ' ' ARG . . . . . . . . . . . . . 52.0 ttp180 -149.43 106.83 3.62 Favored 'General case' 0 C--N 1.297 -1.691 0 N-CA-C 108.811 -0.811 . . . . 3.63 108.811 -178.881 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A 1581 ' ' LEU . . . . . 0.742 HD23 ' HA ' ' A' 1516 ' ' CYS . 0.8 OUTLIER -73.17 133.26 44.0 Favored 'General case' 0 C--N 1.311 -1.098 0 N-CA-C 107.714 -1.217 . . . . 1.87 107.714 -179.494 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A 1582 ' ' ARG . . . . . . . . . . . . . 61.5 ttt180 -132.14 108.32 9.2 Favored 'General case' 0 C--N 1.303 -1.417 0 N-CA-C 109.876 -0.416 . . . . 3.97 109.876 178.634 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A 1583 ' ' TYR . . . . . . . . . . . . . 49.2 t80 -101.33 92.95 5.17 Favored 'General case' 0 C--N 1.307 -1.24 0 N-CA-C 108.896 -0.779 . . . . 1.41 108.896 177.676 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A 1584 ' ' VAL . . . . . . . . . . . . . 15.4 m -123.7 111.12 27.86 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.77 0 N-CA-C 113.14 0.793 . . . . 1.69 113.14 -176.113 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A 1585 ' ' ASP . . . . . . . . . . . . . 36.5 t70 56.33 53.62 8.59 Favored 'General case' 0 N--CA 1.478 0.973 0 CA-C-O 122.463 1.125 . . . . 2.06 111.194 176.041 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A 1586 ' ' GLN . . . . . . . . . . . . . 18.4 mp0 64.63 -1.63 0.76 Allowed 'General case' 0 C--N 1.324 -0.512 0 C-N-CA 125.743 1.617 . . . . 2.33 115.088 178.734 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A 1587 ' ' VAL . . . . . . . . . . . . . 12.7 p -107.84 120.94 60.07 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.887 0 CA-C-O 121.973 0.892 . . . . 0.78 109.459 175.978 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A 1588 ' ' LEU . . . . . 0.822 ' HB2' ' HB2' ' A' 1612 ' ' PHE . 2.5 mm? -79.2 137.99 37.65 Favored 'General case' 0 C--N 1.29 -1.983 0 CA-C-N 114.339 -1.3 . . . . 1.41 108.357 179.053 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A 1589 ' ' GLN . . . . . 0.437 ' HA ' ' O ' ' A' 1610 ' ' ILE . 6.0 tt0 -140.43 141.08 35.52 Favored 'General case' 0 C--N 1.286 -2.175 0 CA-C-O 120.75 0.309 . . . . 1.24 111.254 -178.017 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A 1590 ' ' LEU . . . . . . . . . . . . . 7.0 tt -142.48 124.59 15.37 Favored 'General case' 0 C--N 1.305 -1.359 0 N-CA-C 105.957 -1.868 . . . . 1.15 105.957 175.633 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A 1591 ' ' VAL . . . . . . . . . . . . . 46.4 t -112.48 129.7 67.56 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.067 0 O-C-N 122.381 -0.199 . . . . 1.51 111.508 -175.379 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A 1592 ' ' TYR . . . . . . . . . . . . . 79.4 m-85 -105.3 106.67 17.28 Favored 'General case' 0 C--N 1.313 -0.992 0 N-CA-C 108.8 -0.815 . . . . 1.06 108.8 174.647 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A 1593 ' ' LYS . . . . . . . . . . . . . 8.1 ptpp? -108.67 -178.99 3.74 Favored 'General case' 0 C--N 1.311 -1.066 0 C-N-CA 120.31 -0.556 . . . . 2.18 112.119 -179.067 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A 1594 ' ' ASP . . . . . . . . . . . . . 5.0 m-20 54.13 44.88 28.54 Favored 'General case' 0 N--CA 1.487 1.376 0 C-N-CA 124.798 1.239 . . . . 1.45 113.831 177.67 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A 1595 ' ' GLY . . . . . . . . . . . . . . . -73.2 -90.54 0.13 Allowed Glycine 0 N--CA 1.445 -0.72 0 C-N-CA 120.45 -0.881 . . . . 0.78 111.522 177.176 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A 1596 ' ' SER . . . . . . . . . . . . . 33.7 t -114.49 149.46 42.23 Favored Pre-proline 0 C--N 1.297 -1.691 0 N-CA-C 107.101 -1.444 . . . . 1.68 107.101 176.977 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A 1597 ' ' PRO . . . . . . . . . . . . . 33.7 Cg_exo -64.95 133.55 36.39 Favored 'Trans proline' 0 C--N 1.347 0.493 0 C-N-CA 123.074 2.516 . . . . 1.17 110.911 176.999 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A 1598 ' ' CYS . . . . . 0.439 ' HA ' ' HD3' ' A' 1599 ' ' PRO . 37.6 t -95.65 126.89 43.62 Favored Pre-proline 0 C--N 1.3 -1.553 0 N-CA-C 108.12 -1.067 . . . . 1.19 108.12 -179.13 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A 1599 ' ' PRO . . . . . 0.439 ' HD3' ' HA ' ' A' 1598 ' ' CYS . 25.6 Cg_exo -65.61 -25.52 54.59 Favored 'Trans proline' 0 C--N 1.353 0.784 0 C-N-CA 123.472 2.781 . . . . 1.59 112.113 -178.476 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A 1600 ' ' SER . . . . . . . . . . . . . 23.0 m -86.17 123.51 31.53 Favored 'General case' 0 N--CA 1.421 -1.883 0 N-CA-C 108.367 -0.975 . . . . 2.12 108.367 177.338 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A 1601 ' ' LYS . . . . . 0.845 ' HB3' HD12 ' A' 1604 ' ' LEU . 4.3 tmtm? 68.49 81.58 0.18 Allowed 'General case' 0 C--O 1.239 0.523 0 N-CA-C 107.747 -1.205 . . . . 3.74 107.747 -179.678 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A 1602 ' ' SER . . . . . . . . . . . . . 20.9 m -50.82 111.45 0.55 Allowed 'General case' 0 N--CA 1.441 -0.915 0 CA-C-N 114.025 -1.443 . . . . 3.79 112.651 -176.695 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A 1603 ' ' GLY . . . . . . . . . . . . . . . 128.78 -19.04 5.59 Favored Glycine 0 N--CA 1.433 -1.524 0 CA-C-N 114.747 -1.115 . . . . 2.0 110.315 -177.929 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A 1604 ' ' LEU . . . . . 0.845 HD12 ' HB3' ' A' 1601 ' ' LYS . 12.6 mt -74.91 159.35 31.95 Favored 'General case' 0 CA--C 1.506 -0.732 0 CA-C-O 122.69 1.233 . . . . 1.48 114.291 -179.99 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A 1605 ' ' SER . . . . . . . . . . . . . 16.6 m -137.19 175.8 9.29 Favored 'General case' 0 C--N 1.288 -2.077 0 N-CA-C 104.897 -2.26 . . . . 1.51 104.897 177.217 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A 1606 ' ' TYR . . . . . 0.479 ' HB2' ' HA ' ' A' 1574 ' ' VAL . 56.9 m-85 -102.54 134.58 45.64 Favored 'General case' 0 CA--C 1.462 -2.406 0 N-CA-C 105.249 -2.13 . . . . 1.18 105.249 -179.292 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A 1607 ' ' LYS . . . . . 0.515 ' HG3' HG23 ' A' 1635 ' ' THR . 26.6 pttm -131.18 142.79 50.25 Favored 'General case' 0 N--CA 1.401 -2.889 0 C-N-CA 119.338 -0.945 . . . . 1.67 108.9 177.8 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A 1608 ' ' SER . . . . . . . . . . . . . 44.3 m -114.59 118.76 34.62 Favored 'General case' 0 C--N 1.295 -1.796 0 CA-C-O 120.666 0.27 . . . . 1.0 110.96 -178.849 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A 1609 ' ' VAL . . . . . . . . . . . . . 69.3 t -94.62 115.6 33.85 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.76 0 N-CA-C 108.782 -0.822 . . . . 0.93 108.782 176.851 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A 1610 ' ' ILE . . . . . 0.437 ' O ' ' HA ' ' A' 1589 ' ' GLN . 17.6 mm -98.66 112.19 30.15 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.191 0 N-CA-C 108.77 -0.826 . . . . 0.78 108.77 179.189 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A 1611 ' ' SER . . . . . 0.504 ' O ' ' HA ' ' A' 1639 ' ' SER . 36.5 m -101.05 128.62 47.01 Favored 'General case' 0 C--N 1.304 -1.375 0 N-CA-C 109.518 -0.549 . . . . 1.29 109.518 177.005 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A 1612 ' ' PHE . . . . . 0.822 ' HB2' ' HB2' ' A' 1588 ' ' LEU . 97.9 m-85 -100.88 115.37 30.24 Favored 'General case' 0 C--N 1.292 -1.894 0 CA-C-O 121.003 0.43 . . . . 0.7 110.494 -179.429 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A 1613 ' ' VAL . . . . . . . . . . . . . 58.9 t -100.01 111.54 29.95 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.161 0 N-CA-C 108.486 -0.931 . . . . 0.75 108.486 -178.613 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A 1614 ' ' CYS . . . . . 0.498 ' HA ' ' O ' ' A' 1642 ' ' THR . 3.0 p -85.57 94.22 8.99 Favored 'General case' 0 C--N 1.301 -1.535 0 CA-C-O 121.715 0.769 . . . . 1.39 112.999 -178.605 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A 1615 ' ' ARG . . . . . 0.516 ' HD3' ' HD2' ' A' 1616 ' ' PRO . 19.7 tpp180 -138.2 113.48 8.89 Favored Pre-proline 0 N--CA 1.428 -1.539 0 CA-C-N 115.37 -0.832 . . . . 3.75 109.93 177.318 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A 1616 ' ' PRO . . . . . 0.516 ' HD2' ' HD3' ' A' 1615 ' ' ARG . 57.8 Cg_endo -71.34 53.69 1.72 Allowed 'Trans proline' 0 CA--C 1.548 1.223 0 C-N-CA 123.414 2.742 . . . . 1.32 112.495 176.488 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A 1617 ' ' GLU . . . . . . . . . . . . . 30.6 tt0 -124.75 2.13 8.17 Favored 'General case' 0 C--N 1.306 -1.312 0 N-CA-C 106.29 -1.744 . . . . 3.21 106.29 176.624 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A 1618 ' ' ALA . . . . . . . . . . . . . . . -148.16 165.67 30.19 Favored 'General case' 0 N--CA 1.427 -1.594 0 N-CA-C 106.192 -1.781 . . . . 2.44 106.192 -177.92 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A 1619 ' ' GLY . . . . . . . . . . . . . . . -134.26 -160.0 9.06 Favored Glycine 0 C--N 1.302 -1.308 0 N-CA-C 110.744 -0.942 . . . . 3.26 110.744 178.971 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A 1620 ' ' PRO . . . . . 0.431 ' HA ' ' HZ2' ' A' 1640 ' ' TRP . 22.7 Cg_exo -68.15 -4.29 12.36 Favored 'Trans proline' 0 CA--C 1.54 0.8 0 C-N-CA 123.078 2.519 . . . . 5.92 112.51 178.817 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A 1621 ' ' THR . . . . . . . . . . . . . 15.6 m -86.07 -12.47 50.03 Favored 'General case' 0 CA--C 1.552 1.03 0 CA-C-O 121.458 0.646 . . . . 4.76 109.326 178.212 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A 1622 ' ' ASN . . . . . . . . . . . . . 28.1 t-20 -70.14 151.04 45.88 Favored 'General case' 0 C--O 1.242 0.665 0 N-CA-C 107.872 -1.158 . . . . 2.92 107.872 175.445 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A 1623 ' ' ARG . . . . . . . . . . . . . 5.7 ptm180 -121.82 146.69 46.56 Favored Pre-proline 0 C--N 1.281 -2.385 0 N-CA-C 109.083 -0.71 . . . . 3.61 109.083 -177.228 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A 1624 ' ' PRO . . . . . . . . . . . . . 11.0 Cg_endo -55.25 117.52 4.12 Favored 'Trans proline' 0 C--N 1.348 0.551 0 C-N-CA 123.192 2.595 . . . . 2.37 111.621 178.536 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A 1625 ' ' MET . . . . . . . . . . . . . 26.5 ptm -96.79 143.16 27.98 Favored 'General case' 0 C--N 1.296 -1.748 0 CA-C-N 115.49 -0.777 . . . . 2.16 109.603 -178.573 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A 1626 ' ' LEU . . . . . . . . . . . . . 38.5 tp -80.48 123.07 27.76 Favored 'General case' 0 C--N 1.303 -1.425 0 N-CA-C 107.396 -1.335 . . . . 1.35 107.396 176.192 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A 1627 ' ' ILE . . . . . . . . . . . . . 41.4 pt -100.98 -32.43 3.42 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.548 0 C-N-CA 120.252 -0.579 . . . . 1.21 111.116 -179.907 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A 1628 ' ' SER . . . . . . . . . . . . . 20.4 m -152.64 148.71 27.63 Favored 'General case' 0 C--N 1.318 -0.802 0 N-CA-C 109.696 -0.483 . . . . 1.4 109.696 -178.099 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A 1629 ' ' LEU . . . . . . . . . . . . . 25.8 tp -136.1 99.65 4.19 Favored 'General case' 0 C--N 1.304 -1.407 0 N-CA-C 109.132 -0.692 . . . . 1.56 109.132 178.581 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A 1630 ' ' ASP . . . . . . . . . . . . . 11.8 t70 -90.95 107.85 19.47 Favored 'General case' 0 C--N 1.305 -1.331 0 N-CA-C 108.628 -0.879 . . . . 0.87 108.628 -178.1 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A 1631 ' ' LYS . . . . . . . . . . . . . 68.2 mttm -81.44 -15.15 55.96 Favored 'General case' 0 C--N 1.304 -1.381 0 N-CA-C 112.386 0.513 . . . . 2.35 112.386 -175.448 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A 1632 ' ' GLN . . . . . . . . . . . . . 1.5 mp0 -84.98 -40.74 16.57 Favored 'General case' 0 C--N 1.313 -1.005 0 CA-C-O 120.937 0.399 . . . . 2.55 110.58 -178.771 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A 1633 ' ' THR . . . . . . . . . . . . . 2.7 m -95.95 -4.15 43.88 Favored 'General case' 0 C--N 1.301 -1.511 0 CA-C-O 121.55 0.691 . . . . 1.24 110.278 -178.873 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A 1634 ' ' CYS . . . . . . . . . . . . . 56.6 m 59.47 41.41 19.35 Favored 'General case' 0 C--N 1.35 0.59 0 C-N-CA 124.105 0.962 . . . . 0.89 110.081 176.923 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A 1635 ' ' THR . . . . . 0.515 HG23 ' HG3' ' A' 1607 ' ' LYS . 33.4 m -112.83 132.61 55.2 Favored 'General case' 0 N--CA 1.431 -1.408 0 CA-C-N 115.179 -0.919 . . . . 0.75 111.467 -174.223 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A 1636 ' ' LEU . . . . . 0.415 ' HB3' ' CE2' ' A' 1638 ' ' PHE . 2.4 mm? -100.95 127.71 47.32 Favored 'General case' 0 C--N 1.316 -0.877 0 N-CA-C 108.561 -0.904 . . . . 1.33 108.561 -179.489 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A 1637 ' ' PHE . . . . . . . . . . . . . 97.6 m-85 -115.94 111.28 20.17 Favored 'General case' 0 C--N 1.305 -1.34 0 N-CA-C 109.931 -0.396 . . . . 0.83 109.931 179.38 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A 1638 ' ' PHE . . . . . 0.415 ' CE2' ' HB3' ' A' 1636 ' ' LEU . 87.8 m-85 -118.81 154.42 32.89 Favored 'General case' 0 C--N 1.309 -1.16 0 CA-C-O 121.191 0.52 . . . . 0.6 110.703 -179.094 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A 1639 ' ' SER . . . . . 0.504 ' HA ' ' O ' ' A' 1611 ' ' SER . 46.8 m -141.51 136.91 31.66 Favored 'General case' 0 C--N 1.294 -1.841 0 CA-C-N 116.171 -0.468 . . . . 1.08 110.46 176.827 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A 1640 ' ' TRP . . . . . 0.431 ' HZ2' ' HA ' ' A' 1620 ' ' PRO . 22.0 t90 -113.32 132.27 55.63 Favored 'General case' 0 C--N 1.298 -1.635 0 N-CA-C 107.924 -1.139 . . . . 0.8 107.924 178.066 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A 1641 ' ' HIS . . . . . . . . . . . . . 11.8 m170 -96.93 110.28 22.84 Favored 'General case' 0 CA--C 1.493 -1.22 0 N-CA-C 107.129 -1.434 . . . . 2.54 107.129 179.424 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A 1642 ' ' THR . . . . . 0.708 HG23 ' HB2' ' A' 1645 ' ' ALA . 2.9 t -142.92 137.95 15.46 Favored Pre-proline 0 C--N 1.283 -2.309 0 CA-C-N 115.989 -0.551 . . . . 1.15 111.69 -170.604 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A 1643 ' ' PRO . . . . . . . . . . . . . 95.8 Cg_endo -83.31 -0.39 9.86 Favored 'Trans proline' 0 CA--C 1.535 0.527 0 C-N-CA 123.35 2.7 . . . . 0.8 111.655 178.455 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A 1644 ' ' LEU . . . . . . . . . . . . . 47.4 mt -98.33 1.64 47.24 Favored 'General case' 0 C--N 1.315 -0.894 0 CA-C-N 115.765 -0.652 . . . . 1.54 110.9 179.624 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A 1645 ' ' ALA . . . . . 0.708 ' HB2' HG23 ' A' 1642 ' ' THR . . . -91.8 -18.18 24.24 Favored 'General case' 0 C--N 1.301 -1.537 0 CA-C-N 115.756 -0.656 . . . . 0.95 111.612 -176.274 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A 1646 ' ' CYS . . . . . 0.513 ' HA ' ' CE2' ' A' 1527 ' ' PHE . 72.0 m -154.25 174.26 15.03 Favored 'General case' 0 C--N 1.313 -0.991 0 N-CA-C 105.267 -2.123 . . . . 1.41 105.267 175.452 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A 1647 ' ' GLU . . . . . 0.449 ' HA ' ' HD3' ' A' 1648 ' ' PRO . 0.5 OUTLIER -85.99 123.5 71.88 Favored Pre-proline 0 C--N 1.298 -1.658 0 N-CA-C 109.526 -0.546 . . . . 2.92 109.526 175.819 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A 1648 ' ' PRO . . . . . 0.449 ' HD3' ' HA ' ' A' 1647 ' ' GLU . 39.0 Cg_exo -66.12 101.85 0.52 Allowed 'Trans proline' 0 C--O 1.243 0.753 0 C-N-CA 122.775 2.317 . . . . 2.82 110.532 176.423 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A 1649 ' ' GLU . . . . . . . . . . . . . 42.4 mt-10 . . . . . 0 C--N 1.302 -1.486 0 N-CA-C 108.638 -0.875 . . . . 5.06 108.638 -179.504 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A 1508 ' ' MET . . . . . 0.45 ' HA ' ' OD1' ' A' 1511 ' ' ASN . 43.5 tpp . . . . . 0 C--O 1.238 0.467 0 N-CA-C 108.362 -0.977 . . . . 8.27 108.362 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A 1509 ' ' LYS . . . . . . . . . . . . . 61.7 tttm 79.37 -29.87 0.14 Allowed 'General case' 0 N--CA 1.484 1.242 0 C-N-CA 124.826 1.25 . . . . 6.48 112.212 176.289 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A 1510 ' ' SER . . . . . . . . . . . . . 22.8 t -148.33 73.09 1.23 Allowed 'General case' 0 C--N 1.301 -1.528 0 N-CA-C 106.877 -1.527 . . . . 4.22 106.877 176.303 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A 1511 ' ' ASN . . . . . 0.798 ' HB2' HE22 ' A' 1517 ' ' GLN . 4.3 p-10 -141.09 -28.39 0.68 Allowed 'General case' 0 C--N 1.302 -1.46 0 CA-C-N 115.269 -0.878 . . . . 3.08 112.551 -177.4 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A 1512 ' ' GLU . . . . . 0.549 ' HG2' HG23 ' A' 1518 ' ' VAL . 50.6 mt-10 -55.56 -29.05 58.31 Favored 'General case' 0 N--CA 1.483 1.201 0 N-CA-C 113.903 1.075 . . . . 4.46 113.903 -173.608 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A 1513 ' ' HIS . . . . . . . . . . . . . 89.8 m-70 -129.52 6.6 5.24 Favored 'General case' 0 C--N 1.311 -1.109 0 CA-C-O 121.113 0.483 . . . . 5.57 110.51 178.405 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A 1514 ' ' ASP . . . . . 0.476 ' HB2' ' HA ' ' A' 1511 ' ' ASN . 2.0 m-20 -89.22 -44.67 10.11 Favored 'General case' 0 C--N 1.31 -1.127 0 CA-C-N 115.709 -0.678 . . . . 3.7 110.349 179.579 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A 1515 ' ' ASP . . . . . 0.455 ' HB2' ' NE2' ' A' 1517 ' ' GLN . 8.8 m-20 -137.78 168.56 19.43 Favored 'General case' 0 C--N 1.307 -1.279 0 N-CA-C 108.447 -0.945 . . . . 2.54 108.447 -178.946 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A 1516 ' ' CYS . . . . . 0.542 ' HB3' ' HB2' ' A' 1529 ' ' LEU . 74.4 m -79.01 60.34 2.9 Favored 'General case' 0 C--N 1.306 -1.299 0 CA-C-O 120.981 0.42 . . . . 1.25 112.069 -176.895 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A 1517 ' ' GLN . . . . . 0.798 HE22 ' HB2' ' A' 1511 ' ' ASN . 0.4 OUTLIER -157.29 122.6 4.58 Favored 'General case' 0 N--CA 1.437 -1.105 0 CA-C-O 121.618 0.723 . . . . 1.88 111.885 177.754 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A 1518 ' ' VAL . . . . . 0.549 HG23 ' HG2' ' A' 1512 ' ' GLU . 10.6 p -129.6 142.32 44.22 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.683 0 CA-C-N 115.454 -0.794 . . . . 1.73 109.657 -177.736 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A 1519 ' ' THR . . . . . 0.571 ' HA ' ' HA ' ' A' 1526 ' ' LEU . 12.7 m -100.74 135.94 41.39 Favored 'General case' 0 C--N 1.3 -1.549 0 CA-C-O 120.67 0.271 . . . . 1.7 110.83 -178.025 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A 1520 ' ' ASN . . . . . 0.482 ' OD1' HG22 ' A' 1523 ' ' THR . 17.1 t-20 -86.61 113.8 54.67 Favored Pre-proline 0 C--N 1.308 -1.226 0 N-CA-C 106.915 -1.513 . . . . 2.12 106.915 171.399 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A 1521 ' ' PRO . . . . . . . . . . . . . 51.9 Cg_endo -67.88 -21.52 43.91 Favored 'Trans proline' 0 C--O 1.234 0.276 0 C-N-CA 122.232 1.955 . . . . 2.47 113.512 -174.164 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A 1522 ' ' SER . . . . . . . . . . . . . 13.1 m -68.48 -54.88 14.01 Favored 'General case' 0 N--CA 1.438 -1.047 0 C-N-CA 122.265 0.226 . . . . 2.57 111.02 -178.715 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A 1523 ' ' THR . . . . . 0.52 HG21 ' HB2' ' A' 1647 ' ' GLU . 15.0 t -94.94 -15.74 23.36 Favored 'General case' 0 CA--C 1.554 1.11 0 CA-C-O 121.097 0.475 . . . . 2.15 111.483 -177.949 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A 1524 ' ' GLY . . . . . . . . . . . . . . . 81.17 17.38 72.01 Favored Glycine 0 C--N 1.334 0.434 0 C-N-CA 121.139 -0.553 . . . . 1.89 112.984 178.89 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A 1525 ' ' HIS . . . . . . . . . . . . . 18.4 t60 -101.25 137.48 39.54 Favored 'General case' 0 C--N 1.313 -0.982 0 N-CA-C 109.556 -0.535 . . . . 1.9 109.556 -177.279 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A 1526 ' ' LEU . . . . . 0.571 ' HA ' ' HA ' ' A' 1519 ' ' THR . 6.1 tt -99.94 132.39 45.32 Favored 'General case' 0 C--N 1.3 -1.548 0 N-CA-C 109.36 -0.608 . . . . 1.61 109.36 178.712 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A 1527 ' ' PHE . . . . . 0.446 ' O ' ' HA ' ' A' 1517 ' ' GLN . 28.4 m-85 -99.84 104.87 16.57 Favored 'General case' 0 C--N 1.299 -1.611 0 N-CA-C 108.781 -0.822 . . . . 1.42 108.781 -178.952 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A 1528 ' ' ASP . . . . . 0.424 ' HA ' ' HB3' ' A' 1517 ' ' GLN . 35.6 t70 -95.01 124.66 39.18 Favored 'General case' 0 CA--C 1.495 -1.165 0 CA-C-O 121.473 0.654 . . . . 2.18 111.753 -179.749 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A 1529 ' ' LEU . . . . . 0.542 ' HB2' ' HB3' ' A' 1516 ' ' CYS . 80.1 mt -109.76 -3.0 17.02 Favored 'General case' 0 C--N 1.296 -1.735 0 CA-C-N 114.285 -1.325 . . . . 1.44 109.076 178.863 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A 1530 ' ' SER . . . . . . . . . . . . . 4.5 m -70.33 -38.8 74.95 Favored 'General case' 0 C--O 1.223 -0.315 0 CA-C-N 115.749 -0.66 . . . . 1.44 109.597 -179.306 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A 1531 ' ' SER . . . . . . . . . . . . . 24.2 m -63.81 -26.26 68.55 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 121.665 0.745 . . . . 1.5 109.878 177.113 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A 1532 ' ' LEU . . . . . 0.559 HD13 ' CZ3' ' A' 1640 ' ' TRP . 66.2 mt -83.51 -4.4 58.49 Favored 'General case' 0 C--N 1.317 -0.838 0 CA-C-N 115.254 -0.884 . . . . 1.77 111.506 -178.687 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A 1533 ' ' SER . . . . . 0.503 ' OG ' ' HB2' ' A' 1553 ' ' CYS . 10.2 m -87.28 151.89 22.75 Favored 'General case' 0 C--O 1.249 1.049 0 N-CA-C 108.419 -0.956 . . . . 2.38 108.419 179.115 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A 1534 ' ' GLY . . . . . . . . . . . . . . . -171.18 -160.13 18.96 Favored Glycine 0 N--CA 1.435 -1.431 0 C-N-CA 119.532 -1.318 . . . . 1.55 112.907 -179.666 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A 1535 ' ' ARG . . . . . 0.492 ' HG3' ' HB2' ' A' 1557 ' ' GLU . 38.3 ttm180 -75.53 -56.1 5.03 Favored 'General case' 0 C--N 1.307 -1.253 0 C-N-CA 123.989 0.916 . . . . 3.96 110.957 -179.132 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A 1536 ' ' ALA . . . . . . . . . . . . . . . -95.65 -29.68 14.18 Favored 'General case' 0 C--N 1.303 -1.452 0 CA-C-N 116.002 -0.545 . . . . 1.65 110.544 178.583 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A 1537 ' ' GLY . . . . . 0.442 ' HA3' ' HA ' ' A' 1551 ' ' SER . . . 85.02 -118.46 4.76 Favored Glycine 0 N--CA 1.431 -1.693 0 N-CA-C 110.343 -1.103 . . . . 1.19 110.343 -177.998 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A 1538 ' ' PHE . . . . . . . . . . . . . 69.1 m-85 -130.79 165.2 23.48 Favored 'General case' 0 C--N 1.308 -1.233 0 C-N-CA 123.085 0.554 . . . . 1.69 109.507 178.292 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A 1539 ' ' THR . . . . . . . . . . . . . 3.1 p -115.15 120.5 39.98 Favored 'General case' 0 C--N 1.311 -1.105 0 N-CA-C 113.16 0.8 . . . . 1.48 113.16 -174.76 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A 1540 ' ' ALA . . . . . . . . . . . . . . . -117.27 127.52 54.16 Favored 'General case' 0 C--N 1.312 -1.063 0 N-CA-C 108.251 -1.018 . . . . 0.83 108.251 173.886 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A 1541 ' ' ALA . . . . . . . . . . . . . . . -88.28 153.22 21.38 Favored 'General case' 0 C--N 1.31 -1.127 0 N-CA-C 110.03 -0.359 . . . . 1.27 110.03 -178.492 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A 1542 ' ' TYR . . . . . . . . . . . . . 52.9 t80 -157.42 175.31 14.15 Favored 'General case' 0 C--N 1.318 -0.79 0 N-CA-C 109.015 -0.735 . . . . 2.15 109.015 -178.416 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A 1543 ' ' SER . . . . . . . . . . . . . 14.1 m -46.62 -151.0 0.0 OUTLIER 'General case' 0 CA--C 1.57 1.725 0 C-N-CA 129.245 3.018 . . . . 2.29 114.306 177.572 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A 1544 ' ' LYS . . . . . . . . . . . . . 65.0 mttp -42.35 -23.06 0.03 OUTLIER 'General case' 0 CA--C 1.572 1.807 0 N-CA-C 115.47 1.656 . . . . 3.91 115.47 -178.574 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A 1545 ' ' SER . . . . . . . . . . . . . 32.4 m -71.62 -15.84 62.26 Favored 'General case' 0 CA--C 1.564 1.517 0 C-N-CA 123.295 0.638 . . . . 3.3 111.813 175.277 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A 1546 ' ' GLY . . . . . . . . . . . . . . . 84.04 -75.25 2.39 Favored Glycine 0 C--O 1.241 0.571 0 N-CA-C 114.298 0.479 . . . . 1.24 114.298 174.033 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A 1547 ' ' VAL . . . . . . . . . . . . . 11.7 p -156.32 148.01 11.62 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.853 0 N-CA-C 108.115 -1.069 . . . . 1.63 108.115 -175.872 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A 1548 ' ' VAL . . . . . . . . . . . . . 2.4 t -106.25 133.34 50.99 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.81 0 N-CA-C 108.327 -0.99 . . . . 0.92 108.327 -179.356 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A 1549 ' ' TYR . . . . . 0.535 ' HB3' HD21 ' A' 1556 ' ' ASN . 12.6 m-85 -100.39 117.32 34.32 Favored 'General case' 0 C--N 1.301 -1.524 0 N-CA-C 107.672 -1.233 . . . . 1.44 107.672 172.867 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A 1550 ' ' MET . . . . . . . . . . . . . 52.4 ttp -140.45 122.78 15.94 Favored 'General case' 0 C--N 1.292 -1.896 0 C-N-CA 120.515 -0.474 . . . . 1.74 111.021 -177.544 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A 1551 ' ' SER . . . . . 0.442 ' HA ' ' HA3' ' A' 1537 ' ' GLY . 33.9 t -93.98 137.75 32.85 Favored 'General case' 0 N--CA 1.43 -1.472 0 N-CA-C 104.999 -2.223 . . . . 1.64 104.999 173.483 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A 1552 ' ' ILE . . . . . . . . . . . . . 47.5 mm -63.26 -33.29 60.21 Favored 'Isoleucine or valine' 0 C--O 1.207 -1.158 0 CA-C-N 115.325 -0.852 . . . . 1.33 110.639 -175.856 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A 1553 ' ' CYS . . . . . 0.503 ' HB2' ' OG ' ' A' 1533 ' ' SER . 79.6 m -144.77 141.19 29.02 Favored 'General case' 0 C--O 1.252 1.236 0 N-CA-C 108.363 -0.977 . . . . 1.43 108.363 172.553 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A 1554 ' ' GLY . . . . . . . . . . . . . . . 99.99 -157.93 19.62 Favored Glycine 0 N--CA 1.427 -1.926 0 C-N-CA 120.805 -0.712 . . . . 1.12 112.701 174.196 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A 1555 ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 -103.31 147.97 26.43 Favored 'General case' 0 C--N 1.302 -1.469 0 CA-C-O 121.407 0.622 . . . . 1.8 111.549 -178.007 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A 1556 ' ' ASN . . . . . 0.535 HD21 ' HB3' ' A' 1549 ' ' TYR . 25.5 t-20 -95.7 123.44 39.27 Favored 'General case' 0 C--N 1.293 -1.863 0 CA-C-N 115.029 -0.987 . . . . 2.63 108.553 179.636 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A 1557 ' ' GLU . . . . . 0.492 ' HB2' ' HG3' ' A' 1535 ' ' ARG . 5.4 mt-10 -91.87 39.57 1.02 Allowed 'General case' 0 C--N 1.303 -1.419 0 N-CA-C 112.09 0.404 . . . . 3.79 112.09 -173.746 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A 1558 ' ' ASN . . . . . . . . . . . . . 32.1 m-80 -125.89 -0.52 7.28 Favored 'General case' 0 C--N 1.311 -1.083 0 CA-C-O 121.971 0.891 . . . . 1.52 109.764 178.931 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A 1559 ' ' CYS . . . . . 0.812 ' HB3' ' HD2' ' A' 1560 ' ' PRO . 84.0 m -144.24 -175.83 0.5 Allowed Pre-proline 0 C--N 1.295 -1.802 0 N-CA-C 106.263 -1.754 . . . . 0.84 106.263 -179.664 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A 1560 ' ' PRO . . . . . 0.812 ' HD2' ' HB3' ' A' 1559 ' ' CYS . 4.5 Cg_exo -41.96 123.28 2.39 Favored 'Trans proline' 0 C--N 1.379 2.176 0 C-N-CA 122.702 2.268 . . . . 1.18 112.959 175.658 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A 1561 ' ' PRO . . . . . 0.445 ' HD3' ' HA ' ' A' 1560 ' ' PRO . 31.6 Cg_exo -60.75 105.45 0.31 Allowed 'Trans proline' 0 C--O 1.244 0.805 0 C-N-CA 123.082 2.521 . . . . 1.51 110.793 -179.532 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A 1562 ' ' GLY . . . . . . . . . . . . . . . 141.68 -14.7 2.67 Favored Glycine 0 N--CA 1.431 -1.654 0 N-CA-C 111.25 -0.74 . . . . 0.72 111.25 -177.368 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A 1563 ' ' VAL . . . . . 0.632 ' HA ' ' HA ' ' A' 1576 ' ' LYS . 3.2 m -98.46 146.85 7.46 Favored 'Isoleucine or valine' 0 C--O 1.207 -1.181 0 N-CA-C 107.465 -1.309 . . . . 0.97 107.465 177.15 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A 1564 ' ' GLY . . . . . . . . . . . . . . . -105.67 -25.1 6.71 Favored Glycine 0 C--O 1.241 0.538 0 C-N-CA 120.611 -0.804 . . . . 0.72 113.539 -174.229 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A 1565 ' ' ALA . . . . . . . . . . . . . . . -134.91 128.72 33.11 Favored 'General case' 0 C--N 1.315 -0.91 0 N-CA-C 108.996 -0.742 . . . . 0.37 108.996 -179.988 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A 1566 ' ' CYS . . . . . . . . . . . . . 42.1 t -156.54 145.87 20.57 Favored 'General case' 0 C--N 1.307 -1.258 0 CA-C-N 116.671 -0.24 . . . . 0.51 110.538 -173.857 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A 1567 ' ' PHE . . . . . . . . . . . . . 24.7 m-85 -71.13 125.58 27.29 Favored 'General case' 0 C--O 1.207 -1.137 0 N-CA-C 107.387 -1.338 . . . . 0.97 107.387 175.018 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A 1568 ' ' GLY . . . . . . . . . . . . . . . -75.22 -24.93 69.86 Favored Glycine 0 C--N 1.307 -1.047 0 C-N-CA 120.801 -0.714 . . . . 1.08 114.027 -173.648 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A 1569 ' ' GLN . . . . . . . . . . . . . 65.5 tt0 -85.13 -53.03 5.53 Favored 'General case' 0 C--N 1.317 -0.814 0 C-N-CA 120.088 -0.645 . . . . 2.74 111.071 -179.757 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A 1570 ' ' THR . . . . . . . . . . . . . 22.8 p -84.19 -16.95 41.53 Favored 'General case' 0 C--N 1.312 -1.053 0 N-CA-C 112.852 0.686 . . . . 1.96 112.852 -176.696 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A 1571 ' ' ARG . . . . . . . . . . . . . 66.0 mtm180 60.78 41.87 14.17 Favored 'General case' 0 CA--C 1.508 -0.661 0 C-N-CA 125.382 1.473 . . . . 3.95 112.85 177.463 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A 1572 ' ' ILE . . . . . . . . . . . . . 36.9 mm -103.83 122.8 56.99 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.222 0 N-CA-C 107.404 -1.332 . . . . 1.37 107.404 178.134 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A 1573 ' ' SER . . . . . . . . . . . . . 71.5 p -78.43 121.94 25.17 Favored 'General case' 0 N--CA 1.436 -1.137 0 N-CA-C 113.129 0.788 . . . . 1.08 113.129 -176.46 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A 1574 ' ' VAL . . . . . . . . . . . . . 22.4 m -106.51 11.39 8.88 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.426 0 CA-C-O 121.875 0.845 . . . . 1.3 110.402 -177.126 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A 1575 ' ' GLY . . . . . . . . . . . . . . . -177.27 118.93 0.66 Allowed Glycine 0 N--CA 1.421 -2.333 0 CA-C-N 114.718 -1.128 . . . . 0.51 111.673 177.398 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A 1576 ' ' LYS . . . . . 0.632 ' HA ' ' HA ' ' A' 1563 ' ' VAL . 55.7 tttm -79.85 152.17 29.83 Favored 'General case' 0 C--N 1.306 -1.315 0 N-CA-C 105.799 -1.926 . . . . 2.9 105.799 174.888 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A 1577 ' ' ALA . . . . . . . . . . . . . . . -56.22 102.33 0.07 Allowed 'General case' 0 N--CA 1.468 0.434 0 O-C-N 123.983 0.802 . . . . 0.83 110.277 -178.537 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A 1578 ' ' ASN . . . . . 0.592 ' HB3' ' HA ' ' A' 1592 ' ' TYR . 8.0 t30 -135.61 130.22 34.07 Favored 'General case' 0 C--N 1.29 -2.001 0 N-CA-C 105.683 -1.969 . . . . 1.85 105.683 -179.094 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A 1579 ' ' LYS . . . . . 0.411 ' HB3' ' HE2' ' A' 1579 ' ' LYS . 36.9 ttpt -115.54 90.24 3.29 Favored 'General case' 0 C--N 1.269 -2.926 0 CA-C-O 121.631 0.729 . . . . 1.9 109.211 -173.507 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A 1580 ' ' ARG . . . . . 0.556 ' O ' ' HA ' ' A' 1590 ' ' LEU . 44.3 ttm180 -109.93 109.59 20.25 Favored 'General case' 0 C--N 1.286 -2.163 0 N-CA-C 107.902 -1.147 . . . . 3.63 107.902 177.332 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A 1581 ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -100.21 138.38 37.35 Favored 'General case' 0 C--N 1.298 -1.665 0 N-CA-C 106.273 -1.751 . . . . 1.87 106.273 -177.682 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A 1582 ' ' ARG . . . . . 0.42 ' HB3' ' HB3' ' A' 1589 ' ' GLN . 38.5 ttm180 -144.66 128.46 17.31 Favored 'General case' 0 C--N 1.305 -1.36 0 CA-C-O 121.137 0.494 . . . . 3.97 111.043 178.958 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A 1583 ' ' TYR . . . . . 0.458 ' HD1' ' CD2' ' A' 1588 ' ' LEU . 84.9 t80 -117.9 105.02 11.49 Favored 'General case' 0 C--N 1.297 -1.702 0 N-CA-C 105.946 -1.872 . . . . 1.41 105.946 176.996 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A 1584 ' ' VAL . . . . . . . . . . . . . 6.6 p -136.79 97.77 1.59 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.343 0 C-N-CA 119.594 -0.842 . . . . 1.69 112.501 -177.058 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A 1585 ' ' ASP . . . . . . . . . . . . . 35.7 t70 56.87 69.07 0.78 Allowed 'General case' 0 N--CA 1.476 0.874 0 C-N-CA 124.188 0.995 . . . . 2.06 111.814 178.211 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A 1586 ' ' GLN . . . . . . . . . . . . . 53.3 mt-30 52.51 25.5 3.64 Favored 'General case' 0 N--CA 1.478 0.945 0 N-CA-C 114.767 1.395 . . . . 2.33 114.767 178.657 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A 1587 ' ' VAL . . . . . 0.414 HG23 ' O ' ' A' 1612 ' ' PHE . 11.5 p -139.52 122.29 17.47 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.772 0 N-CA-C 108.571 -0.9 . . . . 0.78 108.571 173.352 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A 1588 ' ' LEU . . . . . 0.579 ' HB2' ' HB2' ' A' 1612 ' ' PHE . 18.5 mt -89.09 158.28 18.02 Favored 'General case' 0 C--N 1.3 -1.556 0 CA-C-N 115.284 -0.871 . . . . 1.41 109.963 -178.493 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A 1589 ' ' GLN . . . . . 0.42 ' HB3' ' HB3' ' A' 1582 ' ' ARG . 6.8 tt0 -146.46 136.99 23.97 Favored 'General case' 0 C--N 1.292 -1.935 0 N-CA-C 108.667 -0.864 . . . . 1.24 108.667 176.918 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A 1590 ' ' LEU . . . . . 0.556 ' HA ' ' O ' ' A' 1580 ' ' ARG . 6.1 tt -133.04 135.45 45.38 Favored 'General case' 0 C--N 1.302 -1.47 0 N-CA-C 106.443 -1.688 . . . . 1.15 106.443 176.927 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A 1591 ' ' VAL . . . . . 0.424 HG22 HG22 ' A' 1609 ' ' VAL . 57.9 t -130.3 134.58 62.29 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.76 0 N-CA-C 112.761 0.652 . . . . 1.51 112.761 -171.769 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A 1592 ' ' TYR . . . . . 0.592 ' HA ' ' HB3' ' A' 1578 ' ' ASN . 67.3 m-85 -111.09 152.01 27.43 Favored 'General case' 0 C--N 1.318 -0.802 0 N-CA-C 107.405 -1.331 . . . . 1.06 107.405 171.53 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A 1593 ' ' LYS . . . . . . . . . . . . . 21.2 pttp -152.48 -177.16 6.05 Favored 'General case' 0 C--N 1.301 -1.539 0 N-CA-C 109.753 -0.462 . . . . 2.18 109.753 -178.767 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A 1594 ' ' ASP . . . . . . . . . . . . . 1.7 m-20 53.36 41.83 32.09 Favored 'General case' 0 N--CA 1.485 1.291 0 N-CA-C 115.238 1.57 . . . . 1.45 115.238 173.614 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A 1595 ' ' GLY . . . . . . . . . . . . . . . -82.65 -121.78 0.7 Allowed Glycine 0 N--CA 1.435 -1.429 0 C-N-CA 119.816 -1.183 . . . . 0.78 110.816 175.696 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A 1596 ' ' SER . . . . . . . . . . . . . 49.0 m -83.44 153.0 65.1 Favored Pre-proline 0 C--N 1.284 -2.282 0 N-CA-C 109.934 -0.395 . . . . 1.68 109.934 -179.606 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A 1597 ' ' PRO . . . . . . . . . . . . . 33.2 Cg_exo -63.67 139.33 68.9 Favored 'Trans proline' 0 C--O 1.253 1.243 0 C-N-CA 122.689 2.26 . . . . 1.17 109.723 172.369 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A 1598 ' ' CYS . . . . . . . . . . . . . 34.8 t -95.05 130.16 33.5 Favored Pre-proline 0 C--N 1.287 -2.139 0 N-CA-C 108.97 -0.752 . . . . 1.19 108.97 -177.318 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A 1599 ' ' PRO . . . . . 0.485 ' HD2' ' OH ' ' A' 1606 ' ' TYR . 89.2 Cg_endo -82.33 4.57 6.97 Favored 'Trans proline' 0 CA--C 1.536 0.577 0 C-N-CA 122.879 2.386 . . . . 1.59 112.697 179.319 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A 1600 ' ' SER . . . . . . . . . . . . . 15.9 m -107.81 123.0 47.91 Favored 'General case' 0 N--CA 1.431 -1.388 0 N-CA-C 109.957 -0.386 . . . . 2.12 109.957 -177.468 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A 1601 ' ' LYS . . . . . 0.543 ' HD3' ' HA ' ' A' 1632 ' ' GLN . 26.5 mtpp 66.02 -97.93 0.05 Allowed 'General case' 0 N--CA 1.454 -0.27 0 N-CA-C 114.565 1.32 . . . . 3.74 114.565 -179.372 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A 1602 ' ' SER . . . . . 0.441 ' HB3' ' HG ' ' A' 1604 ' ' LEU . 10.4 t -97.59 153.61 18.08 Favored 'General case' 0 C--N 1.301 -1.505 0 N-CA-C 109.202 -0.666 . . . . 3.79 109.202 -178.247 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A 1603 ' ' GLY . . . . . . . . . . . . . . . -80.63 56.87 4.76 Favored Glycine 0 N--CA 1.447 -0.622 0 N-CA-C 110.835 -0.906 . . . . 2.0 110.835 177.625 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A 1604 ' ' LEU . . . . . 0.441 ' HG ' ' HB3' ' A' 1602 ' ' SER . 0.7 OUTLIER -99.28 -172.01 2.19 Favored 'General case' 0 C--N 1.307 -1.259 0 C-N-CA 123.817 0.847 . . . . 1.48 110.633 -179.69 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A 1605 ' ' SER . . . . . . . . . . . . . 8.7 m -97.78 -178.72 4.2 Favored 'General case' 0 C--N 1.301 -1.543 0 CA-C-N 118.206 0.457 . . . . 1.51 110.102 -176.749 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A 1606 ' ' TYR . . . . . 0.485 ' OH ' ' HD2' ' A' 1599 ' ' PRO . 68.2 m-85 -106.39 137.69 43.92 Favored 'General case' 0 N--CA 1.417 -2.091 0 N-CA-C 104.424 -2.436 . . . . 1.18 104.424 174.902 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A 1607 ' ' LYS . . . . . 0.541 ' HG3' HG23 ' A' 1635 ' ' THR . 21.9 ptmt -130.05 142.7 50.58 Favored 'General case' 0 C--N 1.282 -2.35 0 C-N-CA 119.955 -0.698 . . . . 1.67 109.216 179.383 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A 1608 ' ' SER . . . . . . . . . . . . . 46.7 m -119.0 126.84 52.67 Favored 'General case' 0 C--N 1.3 -1.553 0 CA-C-O 120.413 0.149 . . . . 1.0 110.653 -176.806 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A 1609 ' ' VAL . . . . . 0.424 HG22 HG22 ' A' 1591 ' ' VAL . 74.2 t -116.2 124.45 72.48 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.839 0 N-CA-C 109.321 -0.622 . . . . 0.93 109.321 178.205 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A 1610 ' ' ILE . . . . . 0.827 HG13 ' HB2' ' A' 1638 ' ' PHE . 3.0 mp -108.07 120.06 58.76 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.966 0 N-CA-C 109.072 -0.714 . . . . 0.78 109.072 176.68 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A 1611 ' ' SER . . . . . . . . . . . . . 24.2 p -94.89 123.63 38.47 Favored 'General case' 0 N--CA 1.432 -1.372 0 N-CA-C 109.049 -0.723 . . . . 1.29 109.049 175.317 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A 1612 ' ' PHE . . . . . 0.579 ' HB2' ' HB2' ' A' 1588 ' ' LEU . 93.0 m-85 -97.11 108.89 21.71 Favored 'General case' 0 C--N 1.298 -1.638 0 CA-C-O 121.123 0.487 . . . . 0.7 110.657 -177.914 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A 1613 ' ' VAL . . . . . 0.45 ' O ' ' HA ' ' A' 1641 ' ' HIS . 49.0 t -103.72 120.74 54.26 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.531 0 N-CA-C 109.246 -0.65 . . . . 0.75 109.246 -178.154 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A 1614 ' ' CYS . . . . . 0.59 ' HA ' ' O ' ' A' 1642 ' ' THR . 0.8 OUTLIER -77.7 93.94 4.35 Favored 'General case' 0 C--N 1.302 -1.476 0 N-CA-C 114.201 1.185 . . . . 1.39 114.201 -179.15 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A 1615 ' ' ARG . . . . . . . . . . . . . 71.8 ttt180 -115.74 107.05 49.13 Favored Pre-proline 0 C--N 1.312 -1.063 0 N-CA-C 108.163 -1.051 . . . . 3.75 108.163 175.755 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A 1616 ' ' PRO . . . . . . . . . . . . . 27.0 Cg_endo -63.95 -38.1 39.94 Favored 'Trans proline' 0 CA--C 1.531 0.328 0 C-N-CA 122.753 2.302 . . . . 1.32 112.191 -179.922 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A 1617 ' ' GLU . . . . . . . . . . . . . 20.4 mm-40 -94.01 40.48 1.08 Allowed 'General case' 0 C--N 1.312 -1.028 0 CA-C-N 115.976 -0.556 . . . . 3.21 110.937 -179.153 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A 1618 ' ' ALA . . . . . . . . . . . . . . . -92.75 128.54 38.65 Favored 'General case' 0 C--N 1.307 -1.256 0 N-CA-C 109.1 -0.704 . . . . 2.44 109.1 177.584 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A 1619 ' ' GLY . . . . . . . . . . . . . . . -122.98 -85.91 0.75 Allowed Glycine 0 C--N 1.297 -1.587 0 N-CA-C 110.455 -1.058 . . . . 3.26 110.455 179.036 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A 1620 ' ' PRO . . . . . . . . . . . . . 53.4 Cg_exo -56.45 -40.2 86.17 Favored 'Trans proline' 0 CA--C 1.542 0.886 0 C-N-CA 123.155 2.57 . . . . 5.92 112.814 177.143 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A 1621 ' ' THR . . . . . . . . . . . . . 19.6 m -95.49 21.59 8.01 Favored 'General case' 0 CA--C 1.56 1.357 0 CA-C-O 122.428 1.109 . . . . 4.76 110.782 -178.131 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A 1622 ' ' ASN . . . . . 0.5 ' HA ' ' O ' ' A' 1641 ' ' HIS . 48.8 t-20 -91.46 53.14 2.21 Favored 'General case' 0 C--O 1.243 0.722 0 N-CA-C 106.941 -1.503 . . . . 2.92 106.941 176.854 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A 1623 ' ' ARG . . . . . . . . . . . . . 16.5 ptm180 -149.71 150.26 30.2 Favored Pre-proline 0 C--N 1.308 -1.236 0 N-CA-C 107.677 -1.231 . . . . 3.61 107.677 -176.606 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A 1624 ' ' PRO . . . . . . . . . . . . . 11.9 Cg_exo -71.63 94.81 0.69 Allowed 'Trans proline' 0 N--CA 1.456 -0.691 0 C-N-CA 122.148 1.899 . . . . 2.37 109.104 175.909 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A 1625 ' ' MET . . . . . . . . . . . . . 57.7 ttp -101.64 141.41 34.54 Favored 'General case' 0 C--N 1.299 -1.588 0 CA-C-N 115.662 -0.699 . . . . 2.16 109.779 -175.17 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A 1626 ' ' LEU . . . . . . . . . . . . . 56.2 tp -80.61 110.7 16.34 Favored 'General case' 0 C--N 1.313 -1.005 0 N-CA-C 108.446 -0.946 . . . . 1.35 108.446 178.334 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A 1627 ' ' ILE . . . . . . . . . . . . . 26.5 pt -88.16 -41.76 14.48 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.919 0 C-N-CA 120.339 -0.545 . . . . 1.21 112.196 -177.893 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A 1628 ' ' SER . . . . . . . . . . . . . 26.7 t -147.21 148.45 31.52 Favored 'General case' 0 N--CA 1.434 -1.242 0 N-CA-C 109.933 -0.395 . . . . 1.4 109.933 -175.489 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A 1629 ' ' LEU . . . . . 0.644 ' HG ' HD13 ' A' 1636 ' ' LEU . 5.1 tt -125.51 112.13 15.87 Favored 'General case' 0 C--N 1.304 -1.411 0 N-CA-C 106.496 -1.668 . . . . 1.56 106.496 176.798 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A 1630 ' ' ASP . . . . . 0.436 ' HB2' ' HE2' ' A' 1637 ' ' PHE . 19.5 t70 -83.22 117.46 22.95 Favored 'General case' 0 C--N 1.303 -1.444 0 N-CA-C 108.479 -0.934 . . . . 0.87 108.479 177.704 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A 1631 ' ' LYS . . . . . . . . . . . . . 98.3 mttt -92.26 -7.18 48.83 Favored 'General case' 0 C--N 1.29 -2.021 0 CA-C-N 115.932 -0.576 . . . . 2.35 111.179 -174.948 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A 1632 ' ' GLN . . . . . 0.543 ' HA ' ' HD3' ' A' 1601 ' ' LYS . 36.5 mt-30 -80.25 -47.52 14.47 Favored 'General case' 0 C--N 1.317 -0.817 0 CA-C-O 121.456 0.646 . . . . 2.55 110.295 -177.338 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A 1633 ' ' THR . . . . . . . . . . . . . 41.0 p -107.25 -1.34 21.87 Favored 'General case' 0 C--N 1.298 -1.66 0 CA-C-N 116.034 -0.53 . . . . 1.24 111.306 179.858 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A 1634 ' ' CYS . . . . . . . . . . . . . 60.3 m 64.62 52.05 1.81 Allowed 'General case' 0 N--CA 1.472 0.644 0 CA-C-O 122.171 0.986 . . . . 0.89 110.538 -179.682 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A 1635 ' ' THR . . . . . 0.541 HG23 ' HG3' ' A' 1607 ' ' LYS . 32.1 m -114.16 126.65 55.31 Favored 'General case' 0 N--CA 1.431 -1.381 0 CA-C-N 114.567 -1.197 . . . . 0.75 110.186 -175.485 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A 1636 ' ' LEU . . . . . 0.644 HD13 ' HG ' ' A' 1629 ' ' LEU . 2.1 mm? -95.45 132.99 39.93 Favored 'General case' 0 C--N 1.308 -1.205 0 N-CA-C 108.971 -0.751 . . . . 1.33 108.971 -179.423 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A 1637 ' ' PHE . . . . . 0.436 ' HE2' ' HB2' ' A' 1630 ' ' ASP . 99.8 m-85 -116.42 106.38 13.55 Favored 'General case' 0 C--O 1.247 0.969 0 CA-C-O 121.21 0.528 . . . . 0.83 110.702 179.555 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A 1638 ' ' PHE . . . . . 0.827 ' HB2' HG13 ' A' 1610 ' ' ILE . 99.0 m-85 -103.77 149.52 24.94 Favored 'General case' 0 C--N 1.301 -1.533 0 N-CA-C 108.619 -0.882 . . . . 0.6 108.619 178.684 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A 1639 ' ' SER . . . . . . . . . . . . . 33.6 t -135.59 132.11 36.73 Favored 'General case' 0 C--N 1.285 -2.229 0 N-CA-C 109.216 -0.661 . . . . 1.08 109.216 179.496 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A 1640 ' ' TRP . . . . . 0.559 ' CZ3' HD13 ' A' 1532 ' ' LEU . 7.2 t90 -120.82 118.96 31.33 Favored 'General case' 0 N--CA 1.423 -1.806 0 N-CA-C 107.472 -1.307 . . . . 0.8 107.472 177.642 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A 1641 ' ' HIS . . . . . 0.5 ' O ' ' HA ' ' A' 1622 ' ' ASN . 31.7 m-70 -96.96 103.46 15.39 Favored 'General case' 0 C--N 1.294 -1.812 0 N-CA-C 106.734 -1.58 . . . . 2.54 106.734 177.354 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A 1642 ' ' THR . . . . . 0.59 ' O ' ' HA ' ' A' 1614 ' ' CYS . 8.9 t -142.24 139.54 17.95 Favored Pre-proline 0 C--N 1.303 -1.45 0 CA-C-N 115.7 -0.682 . . . . 1.15 111.807 -170.536 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A 1643 ' ' PRO . . . . . 0.402 ' HD3' ' HA ' ' A' 1642 ' ' THR . 4.3 Cg_exo -74.84 -3.64 14.21 Favored 'Trans proline' 0 N--CA 1.456 -0.718 0 C-N-CA 123.499 2.8 . . . . 0.8 111.639 175.573 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A 1644 ' ' LEU . . . . . . . . . . . . . 83.4 mt -82.03 -8.62 59.67 Favored 'General case' 0 C--N 1.315 -0.929 0 CA-C-N 116.447 -0.342 . . . . 1.54 110.635 177.282 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A 1645 ' ' ALA . . . . . . . . . . . . . . . -88.31 -21.0 24.65 Favored 'General case' 0 C--N 1.32 -0.713 0 N-CA-C 113.092 0.775 . . . . 0.95 113.092 -176.196 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A 1646 ' ' CYS . . . . . 0.441 ' O ' ' HD3' ' A' 1648 ' ' PRO . 61.1 m -155.15 172.45 18.12 Favored 'General case' 0 N--CA 1.475 0.781 0 N-CA-C 107.243 -1.391 . . . . 1.41 107.243 -179.761 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A 1647 ' ' GLU . . . . . 0.52 ' HB2' HG21 ' A' 1523 ' ' THR . 37.7 mm-40 -113.09 85.1 7.71 Favored Pre-proline 0 C--N 1.309 -1.179 0 N-CA-C 109.815 -0.439 . . . . 2.92 109.815 174.694 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A 1648 ' ' PRO . . . . . 0.441 ' HD3' ' O ' ' A' 1646 ' ' CYS . 4.0 Cg_exo -80.78 156.5 20.95 Favored 'Trans proline' 0 C--O 1.253 1.275 0 C-N-CA 123.125 2.55 . . . . 2.82 110.966 -178.001 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A 1649 ' ' GLU . . . . . . . . . . . . . 7.6 tp10 . . . . . 0 N--CA 1.425 -1.698 0 N-CA-C 108.53 -0.915 . . . . 5.06 108.53 179.902 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A 1508 ' ' MET . . . . . 0.424 ' HB2' ' OD1' ' A' 1511 ' ' ASN . 3.7 mpp? . . . . . 0 CA--C 1.51 -0.578 0 N-CA-C 109.01 -0.737 . . . . 8.27 109.01 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A 1509 ' ' LYS . . . . . . . . . . . . . 59.5 pttt -107.28 -19.99 13.42 Favored 'General case' 0 C--N 1.312 -1.036 0 CA-C-O 120.975 0.417 . . . . 6.48 111.197 178.46 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A 1510 ' ' SER . . . . . . . . . . . . . 15.2 m -116.43 80.8 1.52 Allowed 'General case' 0 N--CA 1.429 -1.48 0 N-CA-C 106.143 -1.799 . . . . 4.22 106.143 174.538 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A 1511 ' ' ASN . . . . . 0.424 ' OD1' ' HB2' ' A' 1508 ' ' MET . 13.1 m-80 -93.2 -18.37 22.6 Favored 'General case' 0 C--N 1.306 -1.29 0 CA-C-N 115.502 -0.772 . . . . 3.08 111.315 -171.855 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A 1512 ' ' GLU . . . . . 0.473 ' HB2' ' HB3' ' A' 1581 ' ' LEU . 0.3 OUTLIER -64.52 1.11 0.87 Allowed 'General case' 0 N--CA 1.483 1.214 0 N-CA-C 115.847 1.795 . . . . 4.46 115.847 -169.857 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A 1513 ' ' HIS . . . . . . . . . . . . . 18.5 p80 -113.17 3.18 15.92 Favored 'General case' 0 C--N 1.308 -1.237 0 CA-C-O 121.002 0.43 . . . . 5.57 110.119 177.144 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A 1514 ' ' ASP . . . . . . . . . . . . . 34.2 t70 -140.37 -42.16 0.41 Allowed 'General case' 0 N--CA 1.468 0.46 0 CA-C-O 121.613 0.721 . . . . 3.7 111.187 -174.057 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A 1515 ' ' ASP . . . . . . . . . . . . . 13.6 t70 -125.58 -168.41 1.84 Allowed 'General case' 0 C--N 1.303 -1.418 0 N-CA-C 105.58 -2.007 . . . . 2.54 105.58 179.711 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A 1516 ' ' CYS . . . . . 0.476 ' HB3' ' HB2' ' A' 1529 ' ' LEU . 74.0 m -128.32 43.11 3.2 Favored 'General case' 0 C--N 1.298 -1.637 0 CA-C-N 118.561 0.618 . . . . 1.25 110.135 -176.417 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A 1517 ' ' GLN . . . . . 0.414 ' O ' ' HB2' ' A' 1511 ' ' ASN . 3.8 pt20 -124.52 129.28 50.33 Favored 'General case' 0 C--N 1.295 -1.762 0 C-N-CA 119.866 -0.734 . . . . 1.88 110.702 178.238 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A 1518 ' ' VAL . . . . . . . . . . . . . 15.9 m -133.28 139.51 49.07 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.641 0 CA-C-N 115.715 -0.675 . . . . 1.73 110.4 -179.058 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A 1519 ' ' THR . . . . . . . . . . . . . 23.1 m -90.55 123.57 34.32 Favored 'General case' 0 C--N 1.284 -2.251 0 N-CA-C 108.832 -0.803 . . . . 1.7 108.832 176.478 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A 1520 ' ' ASN . . . . . . . . . . . . . 48.6 t-20 -84.63 112.25 40.87 Favored Pre-proline 0 C--N 1.311 -1.08 0 N-CA-C 107.746 -1.205 . . . . 2.12 107.746 178.083 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A 1521 ' ' PRO . . . . . . . . . . . . . 42.6 Cg_endo -65.38 -16.46 54.42 Favored 'Trans proline' 0 C--N 1.353 0.766 0 C-N-CA 122.897 2.398 . . . . 2.47 113.992 -174.299 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A 1522 ' ' SER . . . . . . . . . . . . . 38.0 m -81.21 -9.8 59.72 Favored 'General case' 0 C--N 1.312 -1.031 0 CA-C-O 120.779 0.323 . . . . 2.57 111.869 -178.976 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A 1523 ' ' THR . . . . . . . . . . . . . 13.7 t -136.55 -13.82 1.72 Allowed 'General case' 0 CA--C 1.552 1.041 0 CA-C-O 121.349 0.595 . . . . 2.15 111.371 176.761 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A 1524 ' ' GLY . . . . . . . . . . . . . . . 73.33 16.26 78.8 Favored Glycine 0 C--N 1.341 0.845 0 O-C-N 122.134 -0.354 . . . . 1.89 112.362 179.481 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A 1525 ' ' HIS . . . . . . . . . . . . . 58.3 t60 -101.93 136.72 41.28 Favored 'General case' 0 C--N 1.306 -1.31 0 C-N-CA 122.623 0.369 . . . . 1.9 110.091 -176.135 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A 1526 ' ' LEU . . . . . . . . . . . . . 26.4 tp -83.45 124.49 30.75 Favored 'General case' 0 C--N 1.306 -1.289 0 N-CA-C 108.579 -0.897 . . . . 1.61 108.579 176.914 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A 1527 ' ' PHE . . . . . 0.407 ' HZ ' ' HG3' ' A' 1647 ' ' GLU . 80.8 m-85 -98.53 114.11 26.4 Favored 'General case' 0 C--N 1.296 -1.731 0 CA-C-O 121.671 0.748 . . . . 1.42 110.06 176.145 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A 1528 ' ' ASP . . . . . . . . . . . . . 4.6 t70 -90.41 105.75 18.03 Favored 'General case' 0 C--N 1.298 -1.642 0 CA-C-N 114.205 -1.361 . . . . 2.18 111.02 -177.636 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A 1529 ' ' LEU . . . . . 0.795 ' HA ' HD13 ' A' 1532 ' ' LEU . 79.6 mt -104.19 5.99 35.31 Favored 'General case' 0 C--N 1.297 -1.69 0 N-CA-C 106.089 -1.819 . . . . 1.44 106.089 170.861 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A 1530 ' ' SER . . . . . . . . . . . . . 3.1 m -65.47 -36.72 84.74 Favored 'General case' 0 N--CA 1.438 -1.059 0 CA-C-N 114.531 -1.213 . . . . 1.44 109.694 -179.279 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A 1531 ' ' SER . . . . . . . . . . . . . 15.6 m -73.62 -9.75 58.99 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 121.308 0.575 . . . . 1.5 109.908 178.114 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A 1532 ' ' LEU . . . . . 0.795 HD13 ' HA ' ' A' 1529 ' ' LEU . 6.6 mp -92.97 15.27 15.35 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.788 -0.642 . . . . 1.77 111.049 -179.724 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A 1533 ' ' SER . . . . . 0.429 ' HA ' ' HB2' ' A' 1553 ' ' CYS . 50.4 m -74.16 127.9 34.13 Favored 'General case' 0 N--CA 1.435 -1.212 0 N-CA-C 108.132 -1.062 . . . . 2.38 108.132 174.353 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A 1534 ' ' GLY . . . . . . . . . . . . . . . -127.45 137.36 9.81 Favored Glycine 0 CA--C 1.478 -2.249 0 N-CA-C 109.823 -1.311 . . . . 1.55 109.823 -177.905 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A 1535 ' ' ARG . . . . . . . . . . . . . 3.6 tpp180 -90.33 -44.3 9.77 Favored 'General case' 0 C--N 1.302 -1.471 0 N-CA-C 109.131 -0.692 . . . . 3.96 109.131 -179.845 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A 1536 ' ' ALA . . . . . . . . . . . . . . . -95.32 -6.84 40.31 Favored 'General case' 0 C--N 1.314 -0.961 0 N-CA-C 108.15 -1.056 . . . . 1.65 108.15 175.125 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A 1537 ' ' GLY . . . . . . . . . . . . . . . 78.73 -174.12 55.23 Favored Glycine 0 N--CA 1.429 -1.828 0 CA-C-N 113.887 -1.506 . . . . 1.19 113.67 177.322 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A 1538 ' ' PHE . . . . . . . . . . . . . 90.3 m-85 -113.97 175.14 5.6 Favored 'General case' 0 C--N 1.292 -1.899 0 N-CA-C 105.457 -2.053 . . . . 1.69 105.457 176.263 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A 1539 ' ' THR . . . . . . . . . . . . . 11.9 t -136.47 152.88 51.04 Favored 'General case' 0 C--N 1.282 -2.352 0 C-N-CA 119.02 -1.072 . . . . 1.48 110.21 -178.626 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A 1540 ' ' ALA . . . . . 0.669 ' HA ' ' HD3' ' A' 1623 ' ' ARG . . . -133.38 130.9 39.4 Favored 'General case' 0 C--N 1.319 -0.754 0 N-CA-C 109.062 -0.718 . . . . 0.83 109.062 179.067 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A 1541 ' ' ALA . . . . . . . . . . . . . . . -78.57 147.52 33.7 Favored 'General case' 0 C--O 1.247 0.929 0 CA-C-N 116.189 -0.459 . . . . 1.27 110.761 -178.331 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A 1542 ' ' TYR . . . . . 0.472 ' HB3' ' O ' ' A' 1546 ' ' GLY . 89.2 t80 -160.46 160.3 31.92 Favored 'General case' 0 CA--C 1.552 1.058 0 CA-C-O 119.599 -0.239 . . . . 2.15 111.549 -177.591 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A 1543 ' ' SER . . . . . . . . . . . . . 17.9 t -37.58 -152.2 0.0 OUTLIER 'General case' 0 CA--C 1.591 2.538 0 C-N-CA 130.626 3.57 . . . . 2.29 115.562 176.331 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A 1544 ' ' LYS . . . . . . . . . . . . . 97.6 mttt -46.7 -35.61 6.26 Favored 'General case' 0 N--CA 1.479 0.98 0 C-N-CA 124.497 1.119 . . . . 3.91 113.496 -177.707 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A 1545 ' ' SER . . . . . . . . . . . . . 37.2 m -71.15 -8.12 51.32 Favored 'General case' 0 CA--C 1.551 0.993 0 N-CA-C 112.96 0.726 . . . . 3.3 112.96 177.582 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A 1546 ' ' GLY . . . . . 0.472 ' O ' ' HB3' ' A' 1542 ' ' TYR . . . 83.06 -160.71 38.92 Favored Glycine 0 N--CA 1.432 -1.586 0 C-N-CA 121.239 -0.505 . . . . 1.24 114.255 173.05 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A 1547 ' ' VAL . . . . . . . . . . . . . 14.9 p -91.23 134.25 30.36 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.938 0 N-CA-C 108.742 -0.836 . . . . 1.63 108.742 -177.019 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A 1548 ' ' VAL . . . . . . . . . . . . . 4.9 t -110.52 147.72 14.49 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.518 0 N-CA-C 108.44 -0.948 . . . . 0.92 108.44 -175.03 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A 1549 ' ' TYR . . . . . 0.59 ' HB3' HD21 ' A' 1556 ' ' ASN . 99.8 m-85 -106.0 129.13 54.18 Favored 'General case' 0 C--N 1.313 -0.992 0 N-CA-C 108.185 -1.043 . . . . 1.44 108.185 176.762 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A 1550 ' ' MET . . . . . . . . . . . . . 87.7 mmm -134.29 122.35 22.56 Favored 'General case' 0 C--N 1.299 -1.614 0 CA-C-N 115.792 -0.64 . . . . 1.74 109.845 -173.708 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A 1551 ' ' SER . . . . . 0.457 ' OG ' ' HA ' ' A' 1556 ' ' ASN . 74.9 m -97.35 115.63 28.06 Favored 'General case' 0 C--N 1.286 -2.178 0 N-CA-C 107.058 -1.46 . . . . 1.64 107.058 171.79 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A 1552 ' ' ILE . . . . . 0.496 ' HB ' ' O ' ' A' 1532 ' ' LEU . 41.9 mm -57.37 -49.55 79.75 Favored 'Isoleucine or valine' 0 C--O 1.21 -0.989 0 CA-C-N 114.811 -1.086 . . . . 1.33 108.139 179.421 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A 1553 ' ' CYS . . . . . 0.491 ' HA ' ' HH ' ' A' 1592 ' ' TYR . 81.3 m -131.48 137.45 48.58 Favored 'General case' 0 N--CA 1.425 -1.724 0 N-CA-C 109.371 -0.603 . . . . 1.43 109.371 173.96 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A 1554 ' ' GLY . . . . . . . . . . . . . . . 105.56 -143.05 15.64 Favored Glycine 0 N--CA 1.435 -1.42 0 O-C-N 123.785 0.678 . . . . 1.12 112.745 174.802 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A 1555 ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -117.91 157.49 26.59 Favored 'General case' 0 C--N 1.303 -1.418 0 N-CA-C 108.473 -0.936 . . . . 1.8 108.473 179.754 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A 1556 ' ' ASN . . . . . 0.59 HD21 ' HB3' ' A' 1549 ' ' TYR . 4.0 t-20 -100.38 -23.4 14.77 Favored 'General case' 0 C--N 1.301 -1.533 0 CA-C-N 116.281 -0.418 . . . . 2.63 111.977 -172.816 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A 1557 ' ' GLU . . . . . 0.469 ' C ' ' H ' ' A' 1559 ' ' CYS . 37.7 mt-10 54.82 -158.99 0.19 Allowed 'General case' 0 N--CA 1.449 -0.477 0 CA-C-N 114.92 -1.036 . . . . 3.79 109.577 -174.709 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A 1558 ' ' ASN . . . . . . . . . . . . . 39.8 m-80 69.93 -8.95 0.75 Allowed 'General case' 0 N--CA 1.495 1.801 0 C-N-CA 124.078 0.951 . . . . 1.52 112.192 175.683 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A 1559 ' ' CYS . . . . . 0.739 ' HB3' ' HD2' ' A' 1560 ' ' PRO . 63.4 m -145.04 -173.55 0.36 Allowed Pre-proline 0 C--N 1.283 -2.323 0 N-CA-C 103.683 -2.71 . . . . 0.84 103.683 -178.675 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A 1560 ' ' PRO . . . . . 0.739 ' HD2' ' HB3' ' A' 1559 ' ' CYS . 2.8 Cg_exo -37.8 137.3 0.43 Allowed 'Trans proline' 0 C--N 1.373 1.82 0 C-N-CA 123.621 2.88 . . . . 1.18 113.727 175.624 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A 1561 ' ' PRO . . . . . . . . . . . . . 39.8 Cg_endo -68.04 125.33 12.91 Favored 'Trans proline' 0 N--CA 1.456 -0.678 0 C-N-CA 122.482 2.121 . . . . 1.51 112.265 -177.839 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A 1562 ' ' GLY . . . . . . . . . . . . . . . 101.68 17.48 21.22 Favored Glycine 0 N--CA 1.434 -1.481 0 C-N-CA 121.029 -0.605 . . . . 0.72 112.79 177.341 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A 1563 ' ' VAL . . . . . 0.588 ' HA ' ' HA ' ' A' 1576 ' ' LYS . 10.4 m -103.68 150.75 6.83 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.868 0 N-CA-C 106.746 -1.576 . . . . 0.97 106.746 174.631 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A 1564 ' ' GLY . . . . . . . . . . . . . . . -112.26 -5.62 24.66 Favored Glycine 0 C--N 1.317 -0.473 0 C-N-CA 120.233 -0.984 . . . . 0.72 113.305 -174.352 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A 1565 ' ' ALA . . . . . . . . . . . . . . . -150.75 133.43 15.75 Favored 'General case' 0 C--O 1.254 1.314 0 N-CA-C 109.414 -0.587 . . . . 0.37 109.414 -179.014 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A 1566 ' ' CYS . . . . . . . . . . . . . 34.7 t -154.06 142.32 20.49 Favored 'General case' 0 C--N 1.312 -1.043 0 CA-C-O 121.234 0.54 . . . . 0.51 111.042 -177.186 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A 1567 ' ' PHE . . . . . 0.668 ' O ' ' HA ' ' A' 1571 ' ' ARG . 13.2 m-85 -67.6 150.99 48.06 Favored 'General case' 0 N--CA 1.452 -0.339 0 CA-C-N 115.742 -0.663 . . . . 0.97 109.756 176.322 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A 1568 ' ' GLY . . . . . . . . . . . . . . . -108.78 -10.56 24.59 Favored Glycine 0 N--CA 1.432 -1.633 0 C-N-CA 120.337 -0.935 . . . . 1.08 111.751 178.831 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A 1569 ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -89.81 -62.34 1.49 Allowed 'General case' 0 C--N 1.317 -0.822 0 N-CA-C 108.217 -1.031 . . . . 2.74 108.217 178.374 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A 1570 ' ' THR . . . . . . . . . . . . . 19.3 p -89.24 -11.99 42.03 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 121.135 0.493 . . . . 1.96 111.819 178.718 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A 1571 ' ' ARG . . . . . 0.668 ' HA ' ' O ' ' A' 1567 ' ' PHE . 83.6 mtm180 61.43 37.03 17.01 Favored 'General case' 0 N--CA 1.473 0.709 0 C-N-CA 124.607 1.163 . . . . 3.95 113.434 175.748 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A 1572 ' ' ILE . . . . . 0.404 ' H ' ' HB2' ' A' 1567 ' ' PHE . 33.2 mm -99.43 132.9 43.99 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.205 0 N-CA-C 108.655 -0.868 . . . . 1.37 108.655 179.907 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A 1573 ' ' SER . . . . . . . . . . . . . 29.5 p -74.73 120.88 20.89 Favored 'General case' 0 N--CA 1.441 -0.89 0 CA-C-O 121.134 0.492 . . . . 1.08 111.892 -179.239 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A 1574 ' ' VAL . . . . . . . . . . . . . 35.3 m -113.25 21.8 5.96 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.233 0 CA-C-O 121.672 0.749 . . . . 1.3 112.311 -173.911 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A 1575 ' ' GLY . . . . . . . . . . . . . . . 179.97 127.36 1.11 Allowed Glycine 0 N--CA 1.431 -1.641 0 CA-C-N 115.128 -0.942 . . . . 0.51 111.297 176.544 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A 1576 ' ' LYS . . . . . 0.588 ' HA ' ' HA ' ' A' 1563 ' ' VAL . 54.7 tttp -89.91 151.6 21.64 Favored 'General case' 0 C--N 1.313 -0.991 0 N-CA-C 106.794 -1.558 . . . . 2.9 106.794 178.499 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A 1577 ' ' ALA . . . . . 0.407 ' HA ' ' CD1' ' A' 1592 ' ' TYR . . . -67.1 88.67 0.17 Allowed 'General case' 0 C--O 1.239 0.508 0 CA-C-O 121.939 0.875 . . . . 0.83 112.286 -174.708 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A 1578 ' ' ASN . . . . . . . . . . . . . 49.8 m-80 -117.87 113.29 21.54 Favored 'General case' 0 C--N 1.288 -2.087 0 N-CA-C 104.178 -2.527 . . . . 1.85 104.178 172.714 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A 1579 ' ' LYS . . . . . . . . . . . . . 37.4 ttpt -101.07 91.01 4.36 Favored 'General case' 0 C--N 1.274 -2.681 0 C-N-CA 119.24 -0.984 . . . . 1.9 109.306 -173.783 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A 1580 ' ' ARG . . . . . . . . . . . . . 49.1 ttp180 -129.7 100.62 5.57 Favored 'General case' 0 N--CA 1.42 -1.968 0 CA-C-N 114.391 -1.277 . . . . 3.63 109.576 -178.398 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A 1581 ' ' LEU . . . . . 0.473 ' HB3' ' HB2' ' A' 1512 ' ' GLU . 64.3 tp -96.08 147.63 23.52 Favored 'General case' 0 C--N 1.303 -1.43 0 N-CA-C 107.175 -1.417 . . . . 1.87 107.175 177.459 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A 1582 ' ' ARG . . . . . 0.589 ' HG2' HG13 ' A' 1584 ' ' VAL . 40.8 ttp180 -146.36 138.52 25.03 Favored 'General case' 0 C--N 1.304 -1.397 0 C-N-CA 120.559 -0.456 . . . . 3.97 111.64 178.782 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A 1583 ' ' TYR . . . . . 0.561 ' HD2' HD21 ' A' 1588 ' ' LEU . 55.7 t80 -98.71 108.14 20.75 Favored 'General case' 0 C--O 1.24 0.586 0 N-CA-C 108.114 -1.069 . . . . 1.41 108.114 176.438 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A 1584 ' ' VAL . . . . . 0.589 HG13 ' HG2' ' A' 1582 ' ' ARG . 5.1 m -130.34 108.35 15.67 Favored 'Isoleucine or valine' 0 C--O 1.207 -1.147 0 CA-C-O 120.905 0.383 . . . . 1.69 111.847 179.228 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A 1585 ' ' ASP . . . . . . . . . . . . . 38.8 t70 57.37 48.11 15.39 Favored 'General case' 0 N--CA 1.479 0.985 0 CA-C-O 122.423 1.106 . . . . 2.06 110.796 175.656 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A 1586 ' ' GLN . . . . . . . . . . . . . 22.8 mt-30 68.56 -7.1 0.74 Allowed 'General case' 0 N--CA 1.477 0.886 0 N-CA-C 114.905 1.446 . . . . 2.33 114.905 -179.11 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A 1587 ' ' VAL . . . . . . . . . . . . . 9.6 p -99.67 126.37 53.08 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.189 0 C-N-CA 119.73 -0.788 . . . . 0.78 108.907 176.554 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A 1588 ' ' LEU . . . . . 0.582 ' HB2' ' HB2' ' A' 1612 ' ' PHE . 36.0 mt -88.23 143.09 27.24 Favored 'General case' 0 C--N 1.292 -1.902 0 CA-C-N 115.593 -0.731 . . . . 1.41 109.082 179.596 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A 1589 ' ' GLN . . . . . . . . . . . . . 9.8 tt0 -135.56 134.45 39.41 Favored 'General case' 0 C--N 1.279 -2.473 0 N-CA-C 108.609 -0.886 . . . . 1.24 108.609 179.089 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A 1590 ' ' LEU . . . . . 0.416 HD12 HD13 ' A' 1581 ' ' LEU . 2.2 tt -134.4 133.11 40.19 Favored 'General case' 0 C--N 1.293 -1.877 0 N-CA-C 104.982 -2.229 . . . . 1.15 104.982 177.156 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A 1591 ' ' VAL . . . . . . . . . . . . . 29.6 m -128.53 144.26 38.51 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.848 0 N-CA-C 113.039 0.755 . . . . 1.51 113.039 -173.585 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A 1592 ' ' TYR . . . . . 0.491 ' HH ' ' HA ' ' A' 1553 ' ' CYS . 86.8 m-85 -127.95 97.1 4.69 Favored 'General case' 0 C--N 1.312 -1.061 0 N-CA-C 107.3 -1.37 . . . . 1.06 107.3 173.423 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A 1593 ' ' LYS . . . . . 0.502 ' HA ' ' HA ' ' A' 1607 ' ' LYS . 14.4 ptmm? -109.19 165.03 11.92 Favored 'General case' 0 C--N 1.296 -1.755 0 CA-C-N 115.852 -0.613 . . . . 2.18 111.361 -174.196 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A 1594 ' ' ASP . . . . . 0.401 ' HA ' ' CB ' ' A' 1605 ' ' SER . 2.1 m-20 58.08 59.91 2.91 Favored 'General case' 0 CA--C 1.507 -0.688 0 C-N-CA 125.34 1.456 . . . . 1.45 114.195 172.802 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A 1595 ' ' GLY . . . . . . . . . . . . . . . -86.65 -77.38 1.24 Allowed Glycine 0 N--CA 1.435 -1.381 0 N-CA-C 109.911 -1.276 . . . . 0.78 109.911 174.461 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A 1596 ' ' SER . . . . . . . . . . . . . 51.1 m -114.04 145.79 34.32 Favored Pre-proline 0 C--N 1.299 -1.613 0 N-CA-C 109.824 -0.436 . . . . 1.68 109.824 178.147 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A 1597 ' ' PRO . . . . . . . . . . . . . 52.2 Cg_exo -59.83 133.37 50.49 Favored 'Trans proline' 0 C--N 1.351 0.709 0 C-N-CA 123.173 2.582 . . . . 1.17 110.41 175.284 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A 1598 ' ' CYS . . . . . . . . . . . . . 47.9 t -95.78 130.28 32.08 Favored Pre-proline 0 C--N 1.292 -1.892 0 CA-C-N 115.628 -0.714 . . . . 1.19 110.136 -176.124 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A 1599 ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -75.11 -9.64 20.71 Favored 'Trans proline' 0 C--N 1.35 0.63 0 C-N-CA 123.31 2.673 . . . . 1.59 113.551 -177.502 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A 1600 ' ' SER . . . . . 0.418 ' HB2' ' SG ' ' A' 1634 ' ' CYS . 48.6 m -69.11 -26.46 64.92 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 120.75 0.31 . . . . 2.12 111.312 179.873 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A 1601 ' ' LYS . . . . . 0.631 ' HB3' HD12 ' A' 1604 ' ' LEU . 6.0 tmtm? -156.65 114.58 3.25 Favored 'General case' 0 C--N 1.314 -0.972 0 N-CA-C 107.11 -1.441 . . . . 3.74 107.11 -179.003 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A 1602 ' ' SER . . . . . . . . . . . . . 18.5 m -64.27 105.53 0.92 Allowed 'General case' 0 C--N 1.304 -1.37 0 CA-C-O 121.271 0.558 . . . . 3.79 110.26 179.811 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A 1603 ' ' GLY . . . . . . . . . . . . . . . 125.06 -7.5 8.13 Favored Glycine 0 N--CA 1.441 -1.026 0 N-CA-C 110.617 -0.993 . . . . 2.0 110.617 -176.357 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A 1604 ' ' LEU . . . . . 0.631 HD12 ' HB3' ' A' 1601 ' ' LYS . 1.4 mt -100.88 160.76 14.1 Favored 'General case' 0 C--N 1.318 -0.781 0 C-N-CA 122.808 0.443 . . . . 1.48 110.563 177.227 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A 1605 ' ' SER . . . . . 0.401 ' CB ' ' HA ' ' A' 1594 ' ' ASP . 28.8 m -131.57 -169.37 2.18 Favored 'General case' 0 C--N 1.294 -1.828 0 N-CA-C 106.319 -1.734 . . . . 1.51 106.319 177.445 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A 1606 ' ' TYR . . . . . . . . . . . . . 85.1 m-85 -108.67 131.68 54.67 Favored 'General case' 0 N--CA 1.412 -2.337 0 N-CA-C 106.257 -1.757 . . . . 1.18 106.257 -179.884 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A 1607 ' ' LYS . . . . . 0.502 ' HA ' ' HA ' ' A' 1593 ' ' LYS . 20.5 ptmt -125.63 125.13 42.62 Favored 'General case' 0 N--CA 1.409 -2.484 0 O-C-N 124.145 0.903 . . . . 1.67 110.918 -177.798 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A 1608 ' ' SER . . . . . 0.678 ' HA ' ' HB2' ' A' 1636 ' ' LEU . 49.7 m -98.87 122.86 42.66 Favored 'General case' 0 C--N 1.301 -1.528 0 N-CA-C 110.205 -0.295 . . . . 1.0 110.205 178.616 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A 1609 ' ' VAL . . . . . . . . . . . . . 84.0 t -119.8 126.37 75.23 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.846 0 C-N-CA 123.381 0.672 . . . . 0.93 109.261 179.908 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A 1610 ' ' ILE . . . . . 0.475 HG13 ' HB2' ' A' 1638 ' ' PHE . 3.4 mp -115.67 118.03 57.49 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.832 0 N-CA-C 109.123 -0.695 . . . . 0.78 109.123 177.328 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A 1611 ' ' SER . . . . . . . . . . . . . 44.8 p -100.95 120.99 40.97 Favored 'General case' 0 N--CA 1.436 -1.139 0 CA-C-O 120.946 0.403 . . . . 1.29 110.095 176.505 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A 1612 ' ' PHE . . . . . 0.582 ' HB2' ' HB2' ' A' 1588 ' ' LEU . 36.2 m-85 -97.68 104.11 16.1 Favored 'General case' 0 C--N 1.302 -1.476 0 C-N-CA 123.404 0.682 . . . . 0.7 109.607 -177.351 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A 1613 ' ' VAL . . . . . 0.552 ' O ' ' HA ' ' A' 1641 ' ' HIS . 46.1 t -103.5 131.88 51.05 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.502 0 N-CA-C 108.534 -0.913 . . . . 0.75 108.534 -178.801 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A 1614 ' ' CYS . . . . . 0.588 ' HA ' ' O ' ' A' 1642 ' ' THR . 0.8 OUTLIER -70.06 101.64 1.86 Allowed 'General case' 0 C--N 1.305 -1.355 0 N-CA-C 115.518 1.673 . . . . 1.39 115.518 -178.167 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A 1615 ' ' ARG . . . . . 0.611 ' HB3' ' HB3' ' A' 1641 ' ' HIS . 75.9 ttt180 -137.81 107.07 8.25 Favored Pre-proline 0 C--N 1.323 -0.545 0 C-N-CA 124.221 1.009 . . . . 3.75 108.304 173.84 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A 1616 ' ' PRO . . . . . 0.495 ' HB3' ' HG3' ' A' 1648 ' ' PRO . 58.9 Cg_endo -69.75 64.45 1.79 Allowed 'Trans proline' 0 CA--C 1.546 1.087 0 C-N-CA 123.562 2.841 . . . . 1.32 115.194 -177.288 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A 1617 ' ' GLU . . . . . . . . . . . . . 29.5 mm-40 -129.96 27.66 5.13 Favored 'General case' 0 C--N 1.311 -1.081 0 N-CA-C 109.025 -0.731 . . . . 3.21 109.025 176.403 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A 1618 ' ' ALA . . . . . . . . . . . . . . . 70.34 -43.14 0.54 Allowed 'General case' 0 N--CA 1.496 1.862 0 C-N-CA 125.51 1.524 . . . . 2.44 111.213 -173.048 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A 1619 ' ' GLY . . . . . . . . . . . . . . . 175.62 -156.02 21.05 Favored Glycine 0 N--CA 1.419 -2.498 0 N-CA-C 106.984 -2.447 . . . . 3.26 106.984 178.093 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A 1620 ' ' PRO . . . . . 0.556 ' HD3' ' HD1' ' A' 1640 ' ' TRP . 75.4 Cg_exo -54.85 -52.61 7.62 Favored 'Trans proline' 0 N--CA 1.474 0.37 0 C-N-CA 122.326 2.017 . . . . 5.92 108.489 172.642 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A 1621 ' ' THR . . . . . . . . . . . . . 3.0 t -132.0 -52.45 0.97 Allowed 'General case' 0 N--CA 1.416 -2.129 0 N-CA-C 106.162 -1.792 . . . . 4.76 106.162 166.678 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A 1622 ' ' ASN . . . . . . . . . . . . . 27.5 t-20 -138.03 -68.92 0.45 Allowed 'General case' 0 CA--C 1.494 -1.176 0 CA-C-O 122.438 1.113 . . . . 2.92 110.23 163.322 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A 1623 ' ' ARG . . . . . 0.669 ' HD3' ' HA ' ' A' 1540 ' ' ALA . 3.5 ptp180 -75.78 149.38 83.15 Favored Pre-proline 0 C--N 1.283 -2.299 0 CA-C-N 112.456 -2.156 . . . . 3.61 111.537 -177.509 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A 1624 ' ' PRO . . . . . 0.657 ' HB3' ' HB2' ' A' 1640 ' ' TRP . 18.6 Cg_endo -60.2 159.7 25.54 Favored 'Trans proline' 0 C--N 1.364 1.357 0 C-N-CA 124.274 3.316 . . . . 2.37 112.427 177.824 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A 1625 ' ' MET . . . . . 0.464 ' HG3' ' HG2' ' A' 1620 ' ' PRO . 72.2 mtm -119.81 150.46 40.39 Favored 'General case' 0 CA--C 1.494 -1.189 0 CA-C-O 121.226 0.536 . . . . 2.16 111.347 -178.313 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A 1626 ' ' LEU . . . . . 0.426 HD12 ' O ' ' A' 1637 ' ' PHE . 34.4 tp -83.27 108.98 16.85 Favored 'General case' 0 N--CA 1.43 -1.447 0 N-CA-C 106.632 -1.618 . . . . 1.35 106.632 172.572 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A 1627 ' ' ILE . . . . . . . . . . . . . 21.2 pt -85.48 -26.04 6.6 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.965 0 N-CA-C 112.346 0.499 . . . . 1.21 112.346 -173.992 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A 1628 ' ' SER . . . . . . . . . . . . . 23.5 p -167.73 149.98 5.7 Favored 'General case' 0 N--CA 1.438 -1.042 0 CA-C-N 116.699 -0.228 . . . . 1.4 110.591 -177.711 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A 1629 ' ' LEU . . . . . 0.748 HD13 HD13 ' A' 1636 ' ' LEU . 33.1 tp -128.35 108.58 10.69 Favored 'General case' 0 N--CA 1.42 -1.956 0 O-C-N 123.812 0.695 . . . . 1.56 109.128 177.612 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A 1630 ' ' ASP . . . . . . . . . . . . . 10.0 t70 -83.94 98.44 9.8 Favored 'General case' 0 C--N 1.301 -1.52 0 N-CA-C 106.459 -1.682 . . . . 0.87 106.459 176.936 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A 1631 ' ' LYS . . . . . . . . . . . . . 96.8 mttt -71.65 -20.87 61.89 Favored 'General case' 0 C--N 1.312 -1.054 0 N-CA-C 113.489 0.922 . . . . 2.35 113.489 -173.024 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A 1632 ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -85.91 -39.31 17.1 Favored 'General case' 0 C--N 1.324 -0.529 0 N-CA-C 113.413 0.894 . . . . 2.55 113.413 -179.908 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A 1633 ' ' THR . . . . . . . . . . . . . 42.2 p -101.21 10.13 41.13 Favored 'General case' 0 C--N 1.315 -0.913 0 C-N-CA 119.459 -0.896 . . . . 1.24 111.547 177.877 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A 1634 ' ' CYS . . . . . 0.418 ' SG ' ' HB2' ' A' 1600 ' ' SER . 10.9 m 54.98 43.92 29.08 Favored 'General case' 0 C--O 1.245 0.833 0 C-N-CA 124.772 1.229 . . . . 0.89 111.714 170.177 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A 1635 ' ' THR . . . . . . . . . . . . . 20.9 m -108.16 122.1 46.21 Favored 'General case' 0 N--CA 1.422 -1.861 0 CA-C-N 115.338 -0.846 . . . . 0.75 110.72 -176.178 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A 1636 ' ' LEU . . . . . 0.748 HD13 HD13 ' A' 1629 ' ' LEU . 3.0 mm? -93.07 110.15 21.63 Favored 'General case' 0 C--N 1.312 -1.057 0 CA-C-N 115.296 -0.865 . . . . 1.33 108.925 179.986 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A 1637 ' ' PHE . . . . . 0.426 ' O ' HD12 ' A' 1626 ' ' LEU . 99.1 m-85 -100.51 99.21 9.78 Favored 'General case' 0 C--O 1.246 0.918 0 CA-C-O 120.797 0.332 . . . . 0.83 111.024 -179.132 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A 1638 ' ' PHE . . . . . 0.475 ' HB2' HG13 ' A' 1610 ' ' ILE . 94.9 m-85 -101.7 141.9 33.86 Favored 'General case' 0 C--N 1.299 -1.588 0 N-CA-C 108.72 -0.844 . . . . 0.6 108.72 176.759 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A 1639 ' ' SER . . . . . . . . . . . . . 16.7 t -134.84 137.87 43.68 Favored 'General case' 0 N--CA 1.412 -2.364 0 N-CA-C 109.083 -0.71 . . . . 1.08 109.083 -178.913 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A 1640 ' ' TRP . . . . . 0.657 ' HB2' ' HB3' ' A' 1624 ' ' PRO . 7.0 t90 -129.17 99.17 5.15 Favored 'General case' 0 N--CA 1.415 -2.188 0 N-CA-C 108.268 -1.012 . . . . 0.8 108.268 179.905 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A 1641 ' ' HIS . . . . . 0.611 ' HB3' ' HB3' ' A' 1615 ' ' ARG . 17.9 m-70 -81.24 95.45 6.95 Favored 'General case' 0 C--N 1.302 -1.463 0 N-CA-C 107.785 -1.191 . . . . 2.54 107.785 174.719 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A 1642 ' ' THR . . . . . 0.588 ' O ' ' HA ' ' A' 1614 ' ' CYS . 13.4 t -138.82 149.52 62.25 Favored Pre-proline 0 C--N 1.305 -1.354 0 CA-C-N 114.895 -1.048 . . . . 1.15 109.506 -169.375 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A 1643 ' ' PRO . . . . . . . . . . . . . 58.6 Cg_endo -72.12 0.06 7.83 Favored 'Trans proline' 0 C--N 1.36 1.134 0 C-N-CA 123.833 3.022 . . . . 0.8 112.8 179.211 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A 1644 ' ' LEU . . . . . . . . . . . . . 62.5 mt -79.85 4.69 15.82 Favored 'General case' 0 C--N 1.315 -0.892 0 C-N-CA 123.214 0.606 . . . . 1.54 111.171 -178.987 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A 1645 ' ' ALA . . . . . . . . . . . . . . . -106.66 -42.22 5.03 Favored 'General case' 0 C--N 1.316 -0.879 0 CA-C-N 116.221 -0.445 . . . . 0.95 110.721 176.923 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A 1646 ' ' CYS . . . . . 0.412 ' N ' ' HB3' ' A' 1614 ' ' CYS . 10.7 m -143.23 144.64 32.23 Favored 'General case' 0 C--N 1.32 -0.684 0 N-CA-C 106.858 -1.534 . . . . 1.41 106.858 -179.303 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A 1647 ' ' GLU . . . . . 0.407 ' HG3' ' HZ ' ' A' 1527 ' ' PHE . 47.1 mt-10 -87.07 127.33 59.79 Favored Pre-proline 0 C--N 1.3 -1.565 0 N-CA-C 109.988 -0.375 . . . . 2.92 109.988 178.816 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A 1648 ' ' PRO . . . . . 0.495 ' HG3' ' HB3' ' A' 1616 ' ' PRO . 36.5 Cg_endo -67.28 129.11 19.67 Favored 'Trans proline' 0 N--CA 1.453 -0.885 0 C-N-CA 122.158 1.905 . . . . 2.82 109.987 172.731 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A 1649 ' ' GLU . . . . . . . . . . . . . 13.5 pt-20 . . . . . 0 C--N 1.3 -1.574 0 CA-C-O 117.904 -1.046 . . . . 5.06 110.58 177.945 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A 1508 ' ' MET . . . . . . . . . . . . . 26.3 ptm . . . . . 0 C--O 1.242 0.666 0 N-CA-C 112.071 0.397 . . . . 8.27 112.071 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A 1509 ' ' LYS . . . . . . . . . . . . . 13.7 ptmm? -120.79 152.19 38.65 Favored 'General case' 0 C--N 1.315 -0.904 0 O-C-N 121.754 -0.591 . . . . 6.48 109.578 179.764 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A 1510 ' ' SER . . . . . . . . . . . . . 8.4 m -137.77 112.11 8.64 Favored 'General case' 0 C--N 1.304 -1.381 0 N-CA-C 109.627 -0.509 . . . . 4.22 109.627 -179.292 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A 1511 ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -115.54 1.97 13.72 Favored 'General case' 0 C--N 1.308 -1.199 0 CA-C-O 122.201 1.0 . . . . 3.08 109.266 178.745 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A 1512 ' ' GLU . . . . . 0.758 ' HG3' ' HA ' ' A' 1518 ' ' VAL . 2.9 mp0 -75.73 -6.5 50.89 Favored 'General case' 0 C--N 1.318 -0.793 0 CA-C-N 113.985 -1.462 . . . . 4.46 111.465 -175.544 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A 1513 ' ' HIS . . . . . . . . . . . . . 18.6 m-70 -97.2 -18.7 19.09 Favored 'General case' 0 C--N 1.318 -0.765 0 N-CA-C 108.223 -1.029 . . . . 5.57 108.223 -179.41 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A 1514 ' ' ASP . . . . . 0.451 ' O ' ' HE3' ' A' 1579 ' ' LYS . 24.3 t70 -87.65 -42.86 12.37 Favored 'General case' 0 CA--C 1.496 -1.101 0 CA-C-N 114.792 -1.094 . . . . 3.7 109.661 -178.356 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A 1515 ' ' ASP . . . . . . . . . . . . . 24.7 t0 -147.16 162.61 38.52 Favored 'General case' 0 C--N 1.306 -1.303 0 N-CA-C 108.782 -0.821 . . . . 2.54 108.782 -179.526 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A 1516 ' ' CYS . . . . . . . . . . . . . 9.6 m -78.2 54.03 1.31 Allowed 'General case' 0 C--N 1.31 -1.128 0 C-N-CA 123.828 0.851 . . . . 1.25 111.362 -175.249 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A 1517 ' ' GLN . . . . . . . . . . . . . 11.0 pt20 -132.62 122.78 25.23 Favored 'General case' 0 C--N 1.296 -1.724 0 N-CA-C 108.605 -0.887 . . . . 1.88 108.605 178.779 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A 1518 ' ' VAL . . . . . 0.758 ' HA ' ' HG3' ' A' 1512 ' ' GLU . 7.4 p -109.11 127.25 65.95 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.967 0 CA-C-O 121.621 0.724 . . . . 1.73 111.536 -175.364 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A 1519 ' ' THR . . . . . . . . . . . . . 5.2 m -92.43 118.65 31.17 Favored 'General case' 0 N--CA 1.421 -1.902 0 CA-C-N 115.569 -0.741 . . . . 1.7 109.168 178.312 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A 1520 ' ' ASN . . . . . 0.428 ' CG ' HG22 ' A' 1523 ' ' THR . 32.8 t-20 -84.11 113.83 50.59 Favored Pre-proline 0 C--N 1.31 -1.119 0 N-CA-C 107.513 -1.292 . . . . 2.12 107.513 175.918 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A 1521 ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -73.82 -9.58 22.53 Favored 'Trans proline' 0 C--N 1.354 0.834 0 C-N-CA 122.63 2.22 . . . . 2.47 113.475 -173.27 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A 1522 ' ' SER . . . . . . . . . . . . . 19.5 m -94.32 -50.96 5.01 Favored 'General case' 0 N--CA 1.427 -1.615 0 C-N-CA 120.825 -0.35 . . . . 2.57 111.365 -179.022 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A 1523 ' ' THR . . . . . 0.428 HG22 ' CG ' ' A' 1520 ' ' ASN . 13.8 t -89.79 -12.86 38.01 Favored 'General case' 0 CA--C 1.552 1.041 0 C-N-CA 119.805 -0.758 . . . . 2.15 111.184 -178.888 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A 1524 ' ' GLY . . . . . . . . . . . . . . . 73.41 20.36 79.85 Favored Glycine 0 C--O 1.222 -0.619 0 CA-C-N 116.062 -0.517 . . . . 1.89 113.634 177.698 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A 1525 ' ' HIS . . . . . . . . . . . . . 9.8 t60 -101.23 136.99 40.16 Favored 'General case' 0 C--N 1.31 -1.126 0 O-C-N 122.222 -0.575 . . . . 1.9 109.466 -177.801 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A 1526 ' ' LEU . . . . . . . . . . . . . 65.1 tp -95.3 106.25 18.27 Favored 'General case' 0 C--N 1.303 -1.449 0 N-CA-C 108.346 -0.983 . . . . 1.61 108.346 177.906 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A 1527 ' ' PHE . . . . . 0.493 ' CE1' ' HA ' ' A' 1646 ' ' CYS . 93.9 m-85 -89.53 104.94 17.45 Favored 'General case' 0 C--N 1.302 -1.476 0 CA-C-O 121.417 0.627 . . . . 1.42 109.441 -179.055 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A 1528 ' ' ASP . . . . . . . . . . . . . 10.9 t70 -89.9 114.67 26.49 Favored 'General case' 0 C--N 1.296 -1.735 0 CA-C-N 115.55 -0.75 . . . . 2.18 109.247 -179.843 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A 1529 ' ' LEU . . . . . 0.434 ' HA ' ' HG ' ' A' 1532 ' ' LEU . 37.6 mt -111.04 8.38 21.86 Favored 'General case' 0 C--N 1.295 -1.764 0 N-CA-C 107.918 -1.141 . . . . 1.44 107.918 178.983 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A 1530 ' ' SER . . . . . 0.442 ' HA ' ' SG ' ' A' 1553 ' ' CYS . 22.9 t -80.31 -45.75 17.31 Favored 'General case' 0 N--CA 1.439 -0.996 0 CA-C-N 114.597 -1.183 . . . . 1.44 109.307 -175.482 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A 1531 ' ' SER . . . . . . . . . . . . . 14.1 p -74.2 -16.86 60.96 Favored 'General case' 0 N--CA 1.438 -1.062 0 CA-C-N 115.514 -0.766 . . . . 1.5 111.589 -179.329 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A 1532 ' ' LEU . . . . . 0.446 HD11 HD11 ' A' 1644 ' ' LEU . 71.6 mt -65.96 -57.21 8.34 Favored 'General case' 0 CA--C 1.508 -0.651 0 CA-C-O 121.116 0.484 . . . . 1.77 111.398 -179.506 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A 1533 ' ' SER . . . . . . . . . . . . . 28.1 t -81.23 139.05 35.71 Favored 'General case' 0 N--CA 1.427 -1.583 0 CA-C-N 115.066 -0.97 . . . . 2.38 111.24 -173.037 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A 1534 ' ' GLY . . . . . . . . . . . . . . . -85.06 171.68 46.73 Favored Glycine 0 N--CA 1.416 -2.641 0 N-CA-C 107.65 -2.18 . . . . 1.55 107.65 170.652 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A 1535 ' ' ARG . . . . . . . . . . . . . 38.5 ttm180 -77.7 -15.68 58.99 Favored 'General case' 0 C--N 1.3 -1.569 0 CA-C-O 121.91 0.862 . . . . 3.96 110.764 -176.33 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A 1536 ' ' ALA . . . . . . . . . . . . . . . -84.23 -11.4 56.55 Favored 'General case' 0 C--O 1.242 0.668 0 N-CA-C 108.881 -0.785 . . . . 1.65 108.881 174.411 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A 1537 ' ' GLY . . . . . . . . . . . . . . . 74.92 -150.3 40.88 Favored Glycine 0 N--CA 1.426 -1.991 0 CA-C-N 114.701 -1.136 . . . . 1.19 113.459 178.17 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A 1538 ' ' PHE . . . . . 0.473 ' CD1' HD13 ' A' 1552 ' ' ILE . 95.5 m-85 -120.98 146.77 46.32 Favored 'General case' 0 C--N 1.295 -1.803 0 N-CA-C 107.765 -1.198 . . . . 1.69 107.765 177.746 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A 1539 ' ' THR . . . . . . . . . . . . . 30.2 p -99.38 113.53 25.91 Favored 'General case' 0 C--N 1.283 -2.298 0 CA-C-O 121.323 0.582 . . . . 1.48 109.993 179.591 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A 1540 ' ' ALA . . . . . 0.719 ' HB3' HG13 ' A' 1548 ' ' VAL . . . -93.84 148.56 22.02 Favored 'General case' 0 C--N 1.296 -1.726 0 CA-C-N 115.724 -0.671 . . . . 0.83 109.899 -177.575 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A 1541 ' ' ALA . . . . . . . . . . . . . . . -85.7 128.38 34.77 Favored 'General case' 0 N--CA 1.439 -0.982 0 N-CA-C 109.025 -0.731 . . . . 1.27 109.025 178.51 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A 1542 ' ' TYR . . . . . 0.546 ' HD2' ' HB2' ' A' 1545 ' ' SER . 72.9 t80 -136.54 171.79 13.97 Favored 'General case' 0 C--N 1.296 -1.758 0 CA-C-N 116.007 -0.542 . . . . 2.15 109.826 -177.667 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A 1543 ' ' SER . . . . . . . . . . . . . 3.6 m -45.67 -150.79 0.0 OUTLIER 'General case' 0 CA--C 1.573 1.855 0 C-N-CA 130.466 3.507 . . . . 2.29 114.147 177.537 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A 1544 ' ' LYS . . . . . . . . . . . . . 22.6 tptm -39.55 -37.22 0.46 Allowed 'General case' 0 N--CA 1.495 1.799 0 N-CA-C 113.531 0.937 . . . . 3.91 113.531 178.842 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A 1545 ' ' SER . . . . . 0.546 ' HB2' ' HD2' ' A' 1542 ' ' TYR . 15.7 m -65.08 -21.22 66.78 Favored 'General case' 0 CA--C 1.557 1.246 0 N-CA-C 112.023 0.379 . . . . 3.3 112.023 178.401 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A 1546 ' ' GLY . . . . . . . . . . . . . . . 82.45 -67.18 3.76 Favored Glycine 0 N--CA 1.443 -0.839 0 N-CA-C 113.866 0.307 . . . . 1.24 113.866 176.154 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A 1547 ' ' VAL . . . . . . . . . . . . . 72.0 t -128.67 144.48 37.88 Favored 'Isoleucine or valine' 0 N--CA 1.419 -1.997 0 C-N-CA 122.985 0.514 . . . . 1.63 110.228 -175.031 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A 1548 ' ' VAL . . . . . 0.719 HG13 ' HB3' ' A' 1540 ' ' ALA . 2.6 p -133.69 127.58 52.99 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.219 0 N-CA-C 108.309 -0.997 . . . . 0.92 108.309 173.285 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A 1549 ' ' TYR . . . . . 0.521 ' CZ ' ' HA2' ' A' 1568 ' ' GLY . 0.6 OUTLIER -101.49 133.23 46.46 Favored 'General case' 0 C--N 1.303 -1.43 0 CA-C-O 121.756 0.789 . . . . 1.44 112.296 -179.188 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A 1550 ' ' MET . . . . . . . . . . . . . 43.2 ttp -144.51 129.33 18.32 Favored 'General case' 0 C--N 1.296 -1.751 0 CA-C-N 114.666 -1.152 . . . . 1.74 109.704 -176.37 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A 1551 ' ' SER . . . . . . . . . . . . . 50.5 m -88.16 139.8 30.13 Favored 'General case' 0 C--N 1.289 -2.035 0 N-CA-C 108.671 -0.863 . . . . 1.64 108.671 178.207 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A 1552 ' ' ILE . . . . . 0.473 HD13 ' CD1' ' A' 1538 ' ' PHE . 1.4 mp -87.13 -6.61 10.7 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.2 0 CA-C-O 122.773 1.273 . . . . 1.33 109.462 178.876 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A 1553 ' ' CYS . . . . . 0.442 ' SG ' ' HA ' ' A' 1530 ' ' SER . 54.1 t -157.8 138.28 12.84 Favored 'General case' 0 N--CA 1.416 -2.132 0 CA-C-N 114.179 -1.373 . . . . 1.43 108.843 174.501 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A 1554 ' ' GLY . . . . . . . . . . . . . . . 74.09 -169.35 53.89 Favored Glycine 0 N--CA 1.434 -1.497 0 O-C-N 123.958 0.786 . . . . 1.12 113.816 174.635 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A 1555 ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -72.91 153.44 41.0 Favored 'General case' 0 C--N 1.311 -1.068 0 CA-C-N 114.805 -0.697 . . . . 1.8 111.362 179.412 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A 1556 ' ' ASN . . . . . . . . . . . . . 25.4 t-20 -105.4 139.31 40.23 Favored 'General case' 0 N--CA 1.414 -2.227 0 CA-C-N 114.509 -1.223 . . . . 2.63 108.01 177.494 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A 1557 ' ' GLU . . . . . . . . . . . . . 45.9 mt-10 -102.53 174.9 5.69 Favored 'General case' 0 C--N 1.29 -2.013 0 CA-C-N 115.864 -0.607 . . . . 3.79 110.856 -178.251 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A 1558 ' ' ASN . . . . . . . . . . . . . 46.5 m-80 72.44 12.17 5.64 Favored 'General case' 0 N--CA 1.486 1.355 0 C-N-CA 124.685 1.194 . . . . 1.52 110.597 -176.026 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A 1559 ' ' CYS . . . . . 0.62 ' SG ' ' HD2' ' A' 1560 ' ' PRO . 22.5 t -160.69 152.45 16.49 Favored Pre-proline 0 C--N 1.295 -1.784 0 N-CA-C 103.856 -2.646 . . . . 0.84 103.856 179.168 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A 1560 ' ' PRO . . . . . 0.62 ' HD2' ' SG ' ' A' 1559 ' ' CYS . 39.2 Cg_exo -24.24 112.59 0.02 OUTLIER 'Trans proline' 0 C--N 1.368 1.591 0 C-N-CA 125.253 3.968 . . . . 1.18 115.472 179.075 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A 1561 ' ' PRO . . . . . 0.505 ' HD2' ' HA ' ' A' 1560 ' ' PRO . 9.6 Cg_endo -53.76 110.63 0.52 Allowed 'Trans proline' 0 C--O 1.237 0.475 0 C-N-CA 123.685 2.923 . . . . 1.51 112.58 179.846 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A 1562 ' ' GLY . . . . . . . . . . . . . . . 133.78 -16.26 4.53 Favored Glycine 0 N--CA 1.439 -1.121 0 C-N-CA 120.528 -0.844 . . . . 0.72 111.84 179.254 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A 1563 ' ' VAL . . . . . 0.431 ' HA ' ' HA ' ' A' 1576 ' ' LYS . 4.3 m -86.83 157.35 3.25 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.264 0 N-CA-C 107.586 -1.264 . . . . 0.97 107.586 178.834 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A 1564 ' ' GLY . . . . . . . . . . . . . . . -111.44 -22.93 5.91 Favored Glycine 0 N--CA 1.444 -0.791 0 C-N-CA 120.459 -0.877 . . . . 0.72 112.545 -177.904 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A 1565 ' ' ALA . . . . . . . . . . . . . . . -141.51 125.45 17.15 Favored 'General case' 0 C--O 1.247 0.957 0 N-CA-C 109.553 -0.536 . . . . 0.37 109.553 -179.437 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A 1566 ' ' CYS . . . . . . . . . . . . . 53.9 t -148.94 132.91 17.14 Favored 'General case' 0 C--N 1.314 -0.946 0 CA-C-N 116.324 -0.398 . . . . 0.51 109.999 -176.476 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A 1567 ' ' PHE . . . . . 0.427 ' HA ' HG23 ' A' 1548 ' ' VAL . 35.0 m-85 -63.82 134.82 55.94 Favored 'General case' 0 N--CA 1.474 0.742 0 N-CA-C 108.106 -1.072 . . . . 0.97 108.106 177.205 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A 1568 ' ' GLY . . . . . 0.521 ' HA2' ' CZ ' ' A' 1549 ' ' TYR . . . -73.67 -30.74 61.46 Favored Glycine 0 CA--C 1.498 -0.989 0 CA-C-N 116.42 -0.354 . . . . 1.08 113.727 -173.199 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A 1569 ' ' GLN . . . . . . . . . . . . . 8.5 tp-100 -82.45 -56.83 3.64 Favored 'General case' 0 C--N 1.304 -1.376 0 CA-C-O 121.359 0.6 . . . . 2.74 110.511 -179.725 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A 1570 ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -72.06 -27.29 62.59 Favored 'General case' 0 N--CA 1.426 -1.654 0 CA-C-N 114.963 -1.017 . . . . 1.96 111.33 -174.974 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A 1571 ' ' ARG . . . . . . . . . . . . . 42.7 ttp180 52.87 60.75 3.58 Favored 'General case' 0 C--O 1.235 0.315 0 CA-C-O 121.85 0.833 . . . . 3.95 109.687 -176.781 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A 1572 ' ' ILE . . . . . . . . . . . . . 40.4 mm -131.58 129.55 61.78 Favored 'Isoleucine or valine' 0 C--O 1.251 1.165 0 N-CA-C 106.915 -1.513 . . . . 1.37 106.915 179.405 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A 1573 ' ' SER . . . . . . . . . . . . . 35.7 t -73.04 140.04 46.99 Favored 'General case' 0 C--N 1.303 -1.437 0 O-C-N 124.126 0.891 . . . . 1.08 111.357 -178.373 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A 1574 ' ' VAL . . . . . . . . . . . . . 18.0 m -133.06 19.77 1.44 Allowed 'Isoleucine or valine' 0 C--N 1.314 -0.937 0 CA-C-N 115.815 -0.63 . . . . 1.3 110.828 174.587 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A 1575 ' ' GLY . . . . . . . . . . . . . . . 173.73 126.58 0.92 Allowed Glycine 0 N--CA 1.44 -1.058 0 C-N-CA 120.627 -0.797 . . . . 0.51 111.869 178.336 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A 1576 ' ' LYS . . . . . 0.431 ' HA ' ' HA ' ' A' 1563 ' ' VAL . 59.0 tttp -82.98 147.45 28.19 Favored 'General case' 0 C--O 1.239 0.552 0 N-CA-C 107.57 -1.271 . . . . 2.9 107.57 179.263 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A 1577 ' ' ALA . . . . . . . . . . . . . . . -68.92 79.16 0.31 Allowed 'General case' 0 N--CA 1.475 0.804 0 N-CA-C 113.041 0.756 . . . . 0.83 113.041 -174.151 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A 1578 ' ' ASN . . . . . 0.465 ' H ' ' HD1' ' A' 1592 ' ' TYR . 32.0 m-80 -96.67 113.41 24.97 Favored 'General case' 0 C--N 1.297 -1.716 0 N-CA-C 108.107 -1.071 . . . . 1.85 108.107 175.519 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A 1579 ' ' LYS . . . . . 0.451 ' HE3' ' O ' ' A' 1514 ' ' ASP . 52.8 pttt -96.92 109.2 21.98 Favored 'General case' 0 C--N 1.291 -1.972 0 CA-C-O 121.311 0.577 . . . . 1.9 109.712 -178.859 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A 1580 ' ' ARG . . . . . 0.43 ' HA ' ' O ' ' A' 1512 ' ' GLU . 32.7 ttm180 -158.43 94.18 1.26 Allowed 'General case' 0 N--CA 1.43 -1.445 0 CA-C-N 115.033 -0.985 . . . . 3.63 109.435 -177.36 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A 1581 ' ' LEU . . . . . 0.415 ' CB ' ' HB ' ' A' 1518 ' ' VAL . 4.4 mm? -85.52 124.5 32.16 Favored 'General case' 0 C--N 1.302 -1.491 0 CA-C-N 116.275 -0.421 . . . . 1.87 110.554 178.011 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A 1582 ' ' ARG . . . . . . . . . . . . . 89.0 mtm180 -120.29 134.32 55.29 Favored 'General case' 0 C--N 1.29 -1.98 0 CA-C-O 121.112 0.482 . . . . 3.97 110.863 177.076 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A 1583 ' ' TYR . . . . . . . . . . . . . 80.1 t80 -94.9 96.84 9.58 Favored 'General case' 0 C--N 1.292 -1.904 0 N-CA-C 107.485 -1.302 . . . . 1.41 107.485 176.908 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A 1584 ' ' VAL . . . . . . . . . . . . . 36.5 t -112.3 95.16 3.6 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.287 0 CA-C-N 115.653 -0.703 . . . . 1.69 109.528 -176.176 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A 1585 ' ' ASP . . . . . . . . . . . . . 35.1 t70 54.72 75.57 0.29 Allowed 'General case' 0 C--N 1.32 -0.708 0 C-N-CA 124.308 1.043 . . . . 2.06 112.472 177.775 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A 1586 ' ' GLN . . . . . . . . . . . . . 34.1 tt0 68.16 -14.67 0.24 Allowed 'General case' 0 CA--C 1.574 1.888 0 C-N-CA 124.868 1.267 . . . . 2.33 114.398 176.403 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A 1587 ' ' VAL . . . . . . . . . . . . . 7.5 p -118.4 129.62 74.43 Favored 'Isoleucine or valine' 0 C--O 1.25 1.09 0 O-C-N 121.273 -0.892 . . . . 0.78 111.484 -179.4 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A 1588 ' ' LEU . . . . . 0.749 ' HB2' ' HB2' ' A' 1612 ' ' PHE . 3.8 mm? -81.26 157.53 25.13 Favored 'General case' 0 N--CA 1.435 -1.189 0 CA-C-N 115.23 -0.896 . . . . 1.41 110.415 179.001 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A 1589 ' ' GLN . . . . . . . . . . . . . 34.6 tt0 -148.05 134.96 20.14 Favored 'General case' 0 C--N 1.31 -1.148 0 C-N-CA 121.154 -0.218 . . . . 1.24 110.643 -174.715 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A 1590 ' ' LEU . . . . . 0.468 ' HB3' ' HB ' ' A' 1610 ' ' ILE . 51.0 tp -119.39 133.39 55.74 Favored 'General case' 0 C--N 1.301 -1.507 0 N-CA-C 106.95 -1.5 . . . . 1.15 106.95 175.396 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A 1591 ' ' VAL . . . . . . . . . . . . . 52.8 t -126.99 111.63 26.31 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.537 0 CA-C-O 121.022 0.439 . . . . 1.51 111.969 -174.884 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A 1592 ' ' TYR . . . . . 0.465 ' HD1' ' H ' ' A' 1578 ' ' ASN . 20.6 m-85 -101.37 93.05 5.21 Favored 'General case' 0 C--N 1.308 -1.205 0 N-CA-C 108.512 -0.921 . . . . 1.06 108.512 173.87 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A 1593 ' ' LYS . . . . . . . . . . . . . 61.4 pttt -103.36 177.21 4.91 Favored 'General case' 0 C--N 1.283 -2.321 0 CA-C-N 115.569 -0.741 . . . . 2.18 109.926 -178.754 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A 1594 ' ' ASP . . . . . . . . . . . . . 8.3 m-20 53.96 42.04 31.81 Favored 'General case' 0 N--CA 1.475 0.8 0 N-CA-C 113.923 1.083 . . . . 1.45 113.923 175.74 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A 1595 ' ' GLY . . . . . . . . . . . . . . . -74.58 -87.49 0.24 Allowed Glycine 0 N--CA 1.445 -0.704 0 C-N-CA 120.356 -0.926 . . . . 0.78 111.069 176.477 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A 1596 ' ' SER . . . . . . . . . . . . . 32.4 m -114.43 154.33 46.5 Favored Pre-proline 0 C--N 1.294 -1.807 0 N-CA-C 108.258 -1.016 . . . . 1.68 108.258 177.599 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A 1597 ' ' PRO . . . . . . . . . . . . . 23.1 Cg_exo -67.03 133.32 30.65 Favored 'Trans proline' 0 C--N 1.351 0.672 0 C-N-CA 122.849 2.366 . . . . 1.17 109.997 177.153 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A 1598 ' ' CYS . . . . . 0.445 ' HA ' ' HD3' ' A' 1599 ' ' PRO . 42.4 t -97.68 121.14 58.9 Favored Pre-proline 0 C--N 1.289 -2.055 0 CA-C-O 120.533 0.206 . . . . 1.19 110.768 -175.939 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A 1599 ' ' PRO . . . . . 0.445 ' HD3' ' HA ' ' A' 1598 ' ' CYS . 2.8 Cg_exo -77.52 -7.83 16.95 Favored 'Trans proline' 0 C--O 1.238 0.494 0 C-N-CA 123.23 2.62 . . . . 1.59 112.227 179.992 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A 1600 ' ' SER . . . . . 0.433 ' HB3' ' SG ' ' A' 1598 ' ' CYS . 22.8 t -75.32 -19.7 59.49 Favored 'General case' 0 C--N 1.317 -0.811 0 CA-C-N 115.831 -0.622 . . . . 2.12 110.313 -177.563 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A 1601 ' ' LYS . . . . . 0.565 ' HB3' HD12 ' A' 1604 ' ' LEU . 24.5 tptm -162.33 116.64 1.82 Allowed 'General case' 0 N--CA 1.443 -0.82 0 N-CA-C 108.556 -0.905 . . . . 3.74 108.556 178.915 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A 1602 ' ' SER . . . . . . . . . . . . . 51.4 m -61.3 123.2 17.09 Favored 'General case' 0 C--N 1.313 -1.01 0 CA-C-O 121.393 0.616 . . . . 3.79 111.588 179.202 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A 1603 ' ' GLY . . . . . . . . . . . . . . . 104.94 -1.45 41.33 Favored Glycine 0 N--CA 1.439 -1.1 0 CA-C-N 115.067 -0.969 . . . . 2.0 111.004 -179.895 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A 1604 ' ' LEU . . . . . 0.565 HD12 ' HB3' ' A' 1601 ' ' LYS . 3.0 mt -107.05 145.3 32.53 Favored 'General case' 0 C--N 1.31 -1.111 0 CA-C-O 121.692 0.758 . . . . 1.48 111.859 179.62 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A 1605 ' ' SER . . . . . . . . . . . . . 25.6 m -111.27 -173.94 2.35 Favored 'General case' 0 C--N 1.29 -1.987 0 N-CA-C 105.824 -1.917 . . . . 1.51 105.824 172.929 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A 1606 ' ' TYR . . . . . . . . . . . . . 62.1 m-85 -101.59 128.67 47.75 Favored 'General case' 0 CA--C 1.453 -2.78 0 N-CA-C 105.792 -1.929 . . . . 1.18 105.792 178.014 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A 1607 ' ' LYS . . . . . 0.496 ' O ' ' HA ' ' A' 1635 ' ' THR . 4.3 ptmm? -128.05 135.06 49.33 Favored 'General case' 0 N--CA 1.397 -3.075 0 O-C-N 124.506 1.129 . . . . 1.67 111.152 -176.813 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A 1608 ' ' SER . . . . . . . . . . . . . 35.1 t -114.98 125.89 54.13 Favored 'General case' 0 C--N 1.292 -1.921 0 N-CA-C 109.339 -0.615 . . . . 1.0 109.339 -178.753 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A 1609 ' ' VAL . . . . . . . . . . . . . 41.3 t -115.14 115.39 49.31 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.814 0 CA-C-O 121.237 0.541 . . . . 0.93 110.439 178.854 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A 1610 ' ' ILE . . . . . 0.678 HG13 ' HB2' ' A' 1638 ' ' PHE . 2.9 mp -102.16 113.67 39.3 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.338 0 N-CA-C 108.717 -0.845 . . . . 0.78 108.717 178.962 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A 1611 ' ' SER . . . . . . . . . . . . . 42.7 m -95.17 123.36 38.63 Favored 'General case' 0 C--N 1.284 -2.26 0 N-CA-C 109.012 -0.736 . . . . 1.29 109.012 177.367 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A 1612 ' ' PHE . . . . . 0.749 ' HB2' ' HB2' ' A' 1588 ' ' LEU . 98.2 m-85 -92.62 103.51 15.9 Favored 'General case' 0 C--N 1.305 -1.353 0 N-CA-C 108.831 -0.803 . . . . 0.7 108.831 178.835 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A 1613 ' ' VAL . . . . . 0.645 ' O ' ' HA ' ' A' 1641 ' ' HIS . 24.0 t -100.2 109.23 24.51 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.883 0 N-CA-C 107.224 -1.399 . . . . 0.75 107.224 -174.918 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A 1614 ' ' CYS . . . . . 0.574 ' HA ' ' O ' ' A' 1642 ' ' THR . 31.8 m -70.23 100.47 1.7 Allowed 'General case' 0 C--N 1.279 -2.458 0 CA-C-N 115.963 -0.562 . . . . 1.39 111.516 -174.362 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A 1615 ' ' ARG . . . . . 0.45 ' HB3' ' HB3' ' A' 1641 ' ' HIS . 56.9 ttt180 -126.77 99.07 29.99 Favored Pre-proline 0 N--CA 1.439 -0.993 0 CA-C-N 115.479 -0.782 . . . . 3.75 109.412 -179.152 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A 1616 ' ' PRO . . . . . 0.419 ' HA ' ' HB3' ' A' 1643 ' ' PRO . 76.7 Cg_exo -52.43 -34.42 61.37 Favored 'Trans proline' 0 CA--C 1.534 0.489 0 C-N-CA 123.993 3.129 . . . . 1.32 113.834 177.781 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A 1617 ' ' GLU . . . . . . . . . . . . . 48.2 mt-10 -81.01 40.77 0.55 Allowed 'General case' 0 CA--C 1.545 0.753 0 N-CA-C 112.611 0.597 . . . . 3.21 112.611 -177.938 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A 1618 ' ' ALA . . . . . . . . . . . . . . . -81.4 124.82 29.73 Favored 'General case' 0 C--N 1.308 -1.231 0 N-CA-C 109.079 -0.711 . . . . 2.44 109.079 178.523 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A 1619 ' ' GLY . . . . . . . . . . . . . . . -84.41 -161.4 33.02 Favored Glycine 0 CA--C 1.527 0.802 0 CA-C-N 116.182 -0.463 . . . . 3.26 113.93 -177.368 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A 1620 ' ' PRO . . . . . . . . . . . . . 90.8 Cg_endo -85.21 3.92 7.04 Favored 'Trans proline' 0 CA--C 1.54 0.809 0 C-N-CA 123.352 2.701 . . . . 5.92 113.928 -176.545 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A 1621 ' ' THR . . . . . . . . . . . . . 14.9 m -120.33 42.79 2.88 Favored 'General case' 0 C--N 1.303 -1.439 0 N-CA-C 107.044 -1.465 . . . . 4.76 107.044 178.743 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A 1622 ' ' ASN . . . . . . . . . . . . . 27.6 t-20 -102.66 109.09 20.58 Favored 'General case' 0 C--N 1.305 -1.365 0 CA-C-N 114.322 -1.308 . . . . 2.92 111.885 -174.732 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A 1623 ' ' ARG . . . . . . . . . . . . . 19.8 ptp180 -151.89 156.95 34.47 Favored Pre-proline 0 C--N 1.3 -1.583 0 N-CA-C 105.048 -2.204 . . . . 3.61 105.048 175.229 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A 1624 ' ' PRO . . . . . 0.463 ' HG3' HD11 ' A' 1552 ' ' ILE . 13.6 Cg_endo -56.22 115.76 2.7 Favored 'Trans proline' 0 C--O 1.237 0.433 0 C-N-CA 122.669 2.246 . . . . 2.37 112.154 -179.313 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A 1625 ' ' MET . . . . . . . . . . . . . 1.3 pmm? -106.48 147.7 29.05 Favored 'General case' 0 C--O 1.245 0.845 0 CA-C-O 120.999 0.428 . . . . 2.16 110.485 -179.216 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A 1626 ' ' LEU . . . . . . . . . . . . . 52.1 tp -77.6 122.02 24.72 Favored 'General case' 0 C--N 1.317 -0.842 0 N-CA-C 107.855 -1.165 . . . . 1.35 107.855 176.837 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A 1627 ' ' ILE . . . . . . . . . . . . . 39.1 pt -100.88 -32.81 3.5 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.214 0 C-N-CA 120.48 -0.488 . . . . 1.21 111.286 -179.021 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A 1628 ' ' SER . . . . . . . . . . . . . 49.5 m -151.11 153.28 34.73 Favored 'General case' 0 C--N 1.314 -0.97 0 CA-C-O 120.789 0.328 . . . . 1.4 110.283 -177.589 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A 1629 ' ' LEU . . . . . 0.946 HD13 ' HG ' ' A' 1636 ' ' LEU . 17.7 tp -139.12 120.39 14.79 Favored 'General case' 0 C--N 1.294 -1.809 0 N-CA-C 108.522 -0.918 . . . . 1.56 108.522 177.47 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A 1630 ' ' ASP . . . . . . . . . . . . . 23.0 t70 -118.29 107.33 13.76 Favored 'General case' 0 C--N 1.299 -1.624 0 N-CA-C 109.658 -0.497 . . . . 0.87 109.658 176.855 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A 1631 ' ' LYS . . . . . . . . . . . . . 34.8 mtmm -78.74 -13.13 59.98 Favored 'General case' 0 C--N 1.303 -1.416 0 CA-C-N 115.514 -0.766 . . . . 2.35 111.07 -176.997 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A 1632 ' ' GLN . . . . . . . . . . . . . 40.2 mt-30 -70.35 -42.63 71.58 Favored 'General case' 0 C--N 1.323 -0.544 0 N-CA-C 109.587 -0.523 . . . . 2.55 109.587 178.254 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A 1633 ' ' THR . . . . . . . . . . . . . 35.9 p -98.27 4.2 48.77 Favored 'General case' 0 C--N 1.318 -0.765 0 CA-C-O 121.047 0.451 . . . . 1.24 110.821 175.747 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A 1634 ' ' CYS . . . . . . . . . . . . . 59.1 m 56.55 38.8 29.91 Favored 'General case' 0 C--O 1.236 0.394 0 C-N-CA 124.195 0.998 . . . . 0.89 110.461 177.361 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A 1635 ' ' THR . . . . . 0.496 ' HA ' ' O ' ' A' 1607 ' ' LYS . 44.2 m -119.73 131.45 55.38 Favored 'General case' 0 N--CA 1.422 -1.841 0 CA-C-N 114.945 -1.025 . . . . 0.75 111.597 -174.223 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A 1636 ' ' LEU . . . . . 0.946 ' HG ' HD13 ' A' 1629 ' ' LEU . 5.2 mp -104.12 134.89 46.61 Favored 'General case' 0 N--CA 1.434 -1.25 0 N-CA-C 108.04 -1.096 . . . . 1.33 108.04 174.838 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A 1637 ' ' PHE . . . . . . . . . . . . . 93.9 m-85 -111.42 105.83 14.57 Favored 'General case' 0 C--N 1.307 -1.279 0 CA-C-O 120.919 0.39 . . . . 0.83 111.008 -176.844 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A 1638 ' ' PHE . . . . . 0.678 ' HB2' HG13 ' A' 1610 ' ' ILE . 96.4 m-85 -103.11 151.87 22.06 Favored 'General case' 0 C--N 1.306 -1.304 0 N-CA-C 109.03 -0.73 . . . . 0.6 109.03 177.398 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A 1639 ' ' SER . . . . . . . . . . . . . 49.0 m -137.08 133.82 35.82 Favored 'General case' 0 C--N 1.276 -2.598 0 N-CA-C 109.705 -0.48 . . . . 1.08 109.705 176.656 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A 1640 ' ' TRP . . . . . 0.584 ' HE3' ' HE1' ' A' 1612 ' ' PHE . 12.3 t90 -115.58 120.93 41.07 Favored 'General case' 0 N--CA 1.413 -2.306 0 N-CA-C 106.274 -1.75 . . . . 0.8 106.274 174.164 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A 1641 ' ' HIS . . . . . 0.645 ' HA ' ' O ' ' A' 1613 ' ' VAL . 39.1 m-70 -93.89 92.34 7.36 Favored 'General case' 0 C--N 1.304 -1.378 0 N-CA-C 107.517 -1.29 . . . . 2.54 107.517 -177.922 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A 1642 ' ' THR . . . . . 0.73 HG22 ' HG ' ' A' 1644 ' ' LEU . 1.5 m -119.91 123.62 28.34 Favored Pre-proline 0 C--N 1.289 -2.053 0 CA-C-N 114.947 -1.024 . . . . 1.15 111.884 -167.96 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A 1643 ' ' PRO . . . . . 0.419 ' HB3' ' HA ' ' A' 1616 ' ' PRO . 31.7 Cg_exo -65.24 -29.7 55.1 Favored 'Trans proline' 0 CA--C 1.539 0.745 0 C-N-CA 123.443 2.762 . . . . 0.8 112.861 177.001 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A 1644 ' ' LEU . . . . . 0.73 ' HG ' HG22 ' A' 1642 ' ' THR . 4.4 pp -84.07 -6.76 59.46 Favored 'General case' 0 C--N 1.323 -0.562 0 N-CA-C 112.104 0.409 . . . . 1.54 112.104 -176.969 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A 1645 ' ' ALA . . . . . 0.485 ' HB2' ' HB ' ' A' 1642 ' ' THR . . . -74.14 -30.92 62.51 Favored 'General case' 0 C--N 1.306 -1.3 0 CA-C-N 116.022 -0.536 . . . . 0.95 112.165 -174.941 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A 1646 ' ' CYS . . . . . 0.493 ' HA ' ' CE1' ' A' 1527 ' ' PHE . 17.0 p -177.38 175.29 1.48 Allowed 'General case' 0 C--O 1.246 0.871 0 N-CA-C 106.999 -1.482 . . . . 1.41 106.999 175.288 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A 1647 ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 -121.19 90.98 47.85 Favored Pre-proline 0 C--N 1.299 -1.608 0 N-CA-C 108.54 -0.911 . . . . 2.92 108.54 175.871 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A 1648 ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -74.62 115.53 4.33 Favored 'Trans proline' 0 C--O 1.24 0.581 0 C-N-CA 123.292 2.661 . . . . 2.82 114.158 -170.655 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A 1649 ' ' GLU . . . . . . . . . . . . . 35.2 tt0 . . . . . 0 C--N 1.309 -1.154 0 N-CA-C 108.171 -1.048 . . . . 5.06 108.171 176.497 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A 1508 ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.531 0.22 0 N-CA-C 113.129 0.788 . . . . 8.27 113.129 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A 1509 ' ' LYS . . . . . . . . . . . . . 25.6 pttm -120.3 -24.8 5.81 Favored 'General case' 0 C--O 1.232 0.148 0 C-N-CA 119.591 -0.844 . . . . 6.48 112.254 -179.295 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A 1510 ' ' SER . . . . . . . . . . . . . 4.3 m -121.39 36.24 4.66 Favored 'General case' 0 C--N 1.309 -1.16 0 N-CA-C 109.286 -0.635 . . . . 4.22 109.286 -178.653 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A 1511 ' ' ASN . . . . . . . . . . . . . 15.8 m120 -120.24 2.59 10.86 Favored 'General case' 0 C--N 1.312 -1.052 0 O-C-N 122.197 -0.314 . . . . 3.08 111.552 -173.681 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A 1512 ' ' GLU . . . . . . . . . . . . . 7.2 mm-40 -83.51 -4.18 58.29 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 121.26 0.552 . . . . 4.46 111.371 -178.735 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A 1513 ' ' HIS . . . . . . . . . . . . . 62.6 m80 -113.35 39.82 2.51 Favored 'General case' 0 C--N 1.305 -1.348 0 N-CA-C 107.664 -1.235 . . . . 5.57 107.664 172.782 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A 1514 ' ' ASP . . . . . . . . . . . . . 3.3 p-10 -49.47 -79.73 0.01 OUTLIER 'General case' 0 C--O 1.232 0.181 0 CA-C-N 114.043 -1.435 . . . . 3.7 113.051 179.635 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A 1515 ' ' ASP . . . . . . . . . . . . . 17.3 t70 62.16 -88.31 0.02 OUTLIER 'General case' 0 CA--C 1.551 0.991 0 C-N-CA 123.268 0.627 . . . . 2.54 109.958 -177.995 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A 1516 ' ' CYS . . . . . 0.472 ' SG ' ' HD2' ' A' 1579 ' ' LYS . 97.1 m -137.09 18.96 2.98 Favored 'General case' 0 C--N 1.316 -0.874 0 CA-C-O 121.194 0.521 . . . . 1.25 110.456 175.104 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A 1517 ' ' GLN . . . . . 0.539 ' HB2' HD21 ' A' 1526 ' ' LEU . 11.2 pt20 -132.54 137.47 47.14 Favored 'General case' 0 C--N 1.302 -1.469 0 O-C-N 121.809 -0.557 . . . . 1.88 109.7 178.92 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A 1518 ' ' VAL . . . . . . . . . . . . . 10.2 p -143.55 134.87 22.83 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.664 0 CA-C-O 121.025 0.441 . . . . 1.73 110.288 -178.402 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A 1519 ' ' THR . . . . . 0.773 ' HA ' ' HA ' ' A' 1526 ' ' LEU . 23.3 m -85.3 120.84 27.22 Favored 'General case' 0 C--N 1.3 -1.549 0 N-CA-C 109.327 -0.62 . . . . 1.7 109.327 178.781 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A 1520 ' ' ASN . . . . . 0.407 ' OD1' HG22 ' A' 1523 ' ' THR . 24.0 t-20 -71.98 119.71 76.02 Favored Pre-proline 0 C--N 1.314 -0.937 0 N-CA-C 109.327 -0.62 . . . . 2.12 109.327 179.131 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A 1521 ' ' PRO . . . . . . . . . . . . . 86.5 Cg_endo -75.09 -2.95 13.22 Favored 'Trans proline' 0 CA--C 1.539 0.749 0 C-N-CA 122.64 2.227 . . . . 2.47 113.953 -175.31 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A 1522 ' ' SER . . . . . . . . . . . . . 32.8 m -94.11 -49.75 5.61 Favored 'General case' 0 C--N 1.305 -1.341 0 O-C-N 122.104 -0.373 . . . . 2.57 111.101 -179.375 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A 1523 ' ' THR . . . . . 0.409 HG23 ' H ' ' A' 1525 ' ' HIS . 12.0 t -96.53 -16.99 20.8 Favored 'General case' 0 CA--C 1.553 1.07 0 CA-C-O 121.255 0.55 . . . . 2.15 111.097 -179.901 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A 1524 ' ' GLY . . . . . . . . . . . . . . . 81.84 8.16 87.08 Favored Glycine 0 C--O 1.222 -0.601 0 C-N-CA 121.507 -0.378 . . . . 1.89 112.918 178.83 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A 1525 ' ' HIS . . . . . 0.409 ' H ' HG23 ' A' 1523 ' ' THR . 16.0 t-160 -101.69 134.97 44.01 Favored 'General case' 0 C--N 1.302 -1.47 0 N-CA-C 109.432 -0.581 . . . . 1.9 109.432 -178.306 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A 1526 ' ' LEU . . . . . 0.773 ' HA ' ' HA ' ' A' 1519 ' ' THR . 6.7 tt -84.98 135.21 34.13 Favored 'General case' 0 C--N 1.303 -1.43 0 CA-C-N 116.387 -0.369 . . . . 1.61 110.735 177.819 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A 1527 ' ' PHE . . . . . . . . . . . . . 80.7 m-85 -99.8 113.03 25.27 Favored 'General case' 0 C--N 1.309 -1.195 0 N-CA-C 108.078 -1.082 . . . . 1.42 108.078 174.546 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A 1528 ' ' ASP . . . . . . . . . . . . . 11.8 t70 -100.59 103.55 14.86 Favored 'General case' 0 C--N 1.302 -1.495 0 N-CA-C 108.927 -0.768 . . . . 2.18 108.927 -179.455 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A 1529 ' ' LEU . . . . . 0.457 HD13 ' CZ ' ' A' 1612 ' ' PHE . 78.7 mt -89.5 -13.81 36.63 Favored 'General case' 0 C--N 1.298 -1.65 0 N-CA-C 108.234 -1.024 . . . . 1.44 108.234 -176.145 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A 1530 ' ' SER . . . . . 0.458 ' OG ' ' HB2' ' A' 1516 ' ' CYS . 3.2 m -58.03 -54.83 42.56 Favored 'General case' 0 N--CA 1.438 -1.065 0 C-N-CA 124.788 1.235 . . . . 1.44 110.742 -179.58 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A 1531 ' ' SER . . . . . . . . . . . . . 5.6 m -81.23 1.43 32.29 Favored 'General case' 0 C--N 1.317 -0.829 0 CA-C-N 115.886 -0.597 . . . . 1.5 111.592 -175.722 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A 1532 ' ' LEU . . . . . 0.414 ' HG ' ' HA ' ' A' 1529 ' ' LEU . 32.3 mt -82.41 -18.34 42.28 Favored 'General case' 0 C--N 1.319 -0.757 0 C-N-CA 120.036 -0.666 . . . . 1.77 110.661 179.507 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A 1533 ' ' SER . . . . . 0.89 ' HB2' HG22 ' A' 1552 ' ' ILE . 22.7 t -114.2 134.13 55.13 Favored 'General case' 0 N--CA 1.432 -1.341 0 N-CA-C 108.523 -0.917 . . . . 2.38 108.523 178.417 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A 1534 ' ' GLY . . . . . . . . . . . . . . . -81.93 173.46 53.53 Favored Glycine 0 N--CA 1.429 -1.768 0 N-CA-C 107.724 -2.15 . . . . 1.55 107.724 172.148 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A 1535 ' ' ARG . . . . . 0.428 HH11 ' HD2' ' A' 1535 ' ' ARG . 14.8 ttp180 -72.3 -17.8 61.84 Favored 'General case' 0 C--N 1.31 -1.151 0 CA-C-N 118.254 1.027 . . . . 3.96 110.55 -178.842 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A 1536 ' ' ALA . . . . . . . . . . . . . . . -84.86 -6.92 59.35 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 116.109 -0.496 . . . . 1.65 110.198 176.423 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A 1537 ' ' GLY . . . . . . . . . . . . . . . 59.84 -153.81 33.06 Favored Glycine 0 N--CA 1.447 -0.569 0 CA-C-N 115.321 -0.854 . . . . 1.19 114.126 177.366 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A 1538 ' ' PHE . . . . . . . . . . . . . 96.2 m-85 -113.55 163.72 14.57 Favored 'General case' 0 C--N 1.294 -1.819 0 N-CA-C 108.027 -1.101 . . . . 1.69 108.027 178.441 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A 1539 ' ' THR . . . . . . . . . . . . . 9.5 t -143.99 130.64 20.14 Favored 'General case' 0 C--N 1.287 -2.128 0 N-CA-C 108.991 -0.744 . . . . 1.48 108.991 177.88 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A 1540 ' ' ALA . . . . . . . . . . . . . . . -131.96 143.72 50.3 Favored 'General case' 0 C--N 1.306 -1.307 0 N-CA-C 109.054 -0.721 . . . . 0.83 109.054 -177.374 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A 1541 ' ' ALA . . . . . . . . . . . . . . . -82.14 151.46 26.95 Favored 'General case' 0 C--N 1.31 -1.124 0 CA-C-N 116.167 -0.47 . . . . 1.27 110.386 -178.991 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A 1542 ' ' TYR . . . . . . . . . . . . . 26.1 t80 -152.54 175.06 13.16 Favored 'General case' 0 C--N 1.312 -1.031 0 N-CA-C 107.864 -1.162 . . . . 2.15 107.864 -177.162 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A 1543 ' ' SER . . . . . . . . . . . . . 8.3 p -49.57 -150.46 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.797 0 C-N-CA 127.922 2.489 . . . . 2.29 114.853 -179.941 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A 1544 ' ' LYS . . . . . . . . . . . . . 9.7 ptpp? -39.81 -28.12 0.04 OUTLIER 'General case' 0 N--CA 1.506 2.353 0 N-CA-C 114.53 1.307 . . . . 3.91 114.53 -178.245 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A 1545 ' ' SER . . . . . . . . . . . . . 25.0 t -73.01 -8.55 56.22 Favored 'General case' 0 CA--C 1.555 1.146 0 N-CA-C 112.204 0.446 . . . . 3.3 112.204 177.571 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A 1546 ' ' GLY . . . . . . . . . . . . . . . 81.08 -75.31 2.3 Favored Glycine 0 N--CA 1.44 -1.088 0 N-CA-C 114.643 0.617 . . . . 1.24 114.643 172.624 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A 1547 ' ' VAL . . . . . . . . . . . . . 9.3 p -153.26 150.26 12.67 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.446 0 N-CA-C 109.32 -0.622 . . . . 1.63 109.32 -175.158 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A 1548 ' ' VAL . . . . . . . . . . . . . 5.7 t -111.21 145.06 17.93 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.547 0 N-CA-C 108.536 -0.912 . . . . 0.92 108.536 -178.699 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A 1549 ' ' TYR . . . . . . . . . . . . . 39.4 m-85 -114.54 125.27 53.6 Favored 'General case' 0 CA--C 1.501 -0.928 0 N-CA-C 107.31 -1.367 . . . . 1.44 107.31 172.926 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A 1550 ' ' MET . . . . . . . . . . . . . 18.3 ptm -153.15 124.58 7.63 Favored 'General case' 0 C--N 1.298 -1.658 0 CA-C-O 121.396 0.617 . . . . 1.74 112.008 -172.672 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A 1551 ' ' SER . . . . . . . . . . . . . 25.4 m -93.57 133.46 36.86 Favored 'General case' 0 C--N 1.282 -2.34 0 N-CA-C 106.88 -1.526 . . . . 1.64 106.88 176.175 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A 1552 ' ' ILE . . . . . 0.89 HG22 ' HB2' ' A' 1533 ' ' SER . 1.1 tp -73.17 -18.63 18.18 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.114 0 CA-C-O 121.816 0.817 . . . . 1.33 109.629 -176.374 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A 1553 ' ' CYS . . . . . . . . . . . . . 38.4 t -161.27 138.44 8.84 Favored 'General case' 0 N--CA 1.416 -2.144 0 N-CA-C 105.923 -1.88 . . . . 1.43 105.923 173.532 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A 1554 ' ' GLY . . . . . . . . . . . . . . . 101.38 -174.87 25.34 Favored Glycine 0 N--CA 1.433 -1.529 0 N-CA-C 111.17 -0.772 . . . . 1.12 111.17 178.538 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A 1555 ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -103.31 151.7 22.41 Favored 'General case' 0 C--N 1.302 -1.459 0 CA-C-O 121.439 0.638 . . . . 1.8 111.776 -179.17 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A 1556 ' ' ASN . . . . . . . . . . . . . 8.6 t-20 -100.67 139.11 36.82 Favored 'General case' 0 N--CA 1.42 -1.94 0 CA-C-N 114.52 -1.218 . . . . 2.63 108.3 -177.241 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A 1557 ' ' GLU . . . . . . . . . . . . . 54.2 mm-40 -102.65 -7.07 22.06 Favored 'General case' 0 C--N 1.293 -1.875 0 CA-C-N 115.443 -0.799 . . . . 3.79 112.156 -172.404 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A 1558 ' ' ASN . . . . . . . . . . . . . 39.6 m-80 -75.52 -31.36 60.09 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-O 121.803 0.811 . . . . 1.52 109.901 -178.655 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A 1559 ' ' CYS . . . . . 0.645 ' HB3' ' HD2' ' A' 1560 ' ' PRO . 95.5 m -113.25 176.47 1.47 Allowed Pre-proline 0 C--N 1.294 -1.841 0 CA-C-O 117.471 -1.252 . . . . 0.84 108.027 176.474 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A 1560 ' ' PRO . . . . . 0.645 ' HD2' ' HB3' ' A' 1559 ' ' CYS . 99.2 Cg_exo -29.88 122.16 0.06 OUTLIER 'Trans proline' 0 C--N 1.375 1.957 0 C-N-CA 124.358 3.372 . . . . 1.18 113.909 173.693 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A 1561 ' ' PRO . . . . . 0.432 ' HD3' ' HA ' ' A' 1560 ' ' PRO . 32.1 Cg_exo -58.57 110.25 0.63 Allowed 'Trans proline' 0 C--O 1.245 0.85 0 C-N-CA 123.243 2.629 . . . . 1.51 111.66 -176.776 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A 1562 ' ' GLY . . . . . . . . . . . . . . . 132.94 -15.24 4.86 Favored Glycine 0 N--CA 1.44 -1.085 0 C-N-CA 120.23 -0.986 . . . . 0.72 112.507 -179.792 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A 1563 ' ' VAL . . . . . 0.426 ' HA ' ' HA ' ' A' 1576 ' ' LYS . 13.8 m -86.49 149.82 4.04 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.957 0 N-CA-C 108.02 -1.104 . . . . 0.97 108.02 177.326 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A 1564 ' ' GLY . . . . . . . . . . . . . . . -102.0 -30.77 5.62 Favored Glycine 0 C--N 1.307 -1.059 0 N-CA-C 111.188 -0.765 . . . . 0.72 111.188 -178.019 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A 1565 ' ' ALA . . . . . . . . . . . . . . . -140.3 136.3 33.11 Favored 'General case' 0 N--CA 1.44 -0.927 0 N-CA-C 109.04 -0.726 . . . . 0.37 109.04 178.773 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A 1566 ' ' CYS . . . . . . . . . . . . . 16.5 t -156.32 146.36 21.26 Favored 'General case' 0 C--N 1.298 -1.668 0 CA-C-N 116.243 -0.435 . . . . 0.51 109.933 -175.324 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A 1567 ' ' PHE . . . . . . . . . . . . . 21.5 m-85 -73.88 123.32 24.01 Favored 'General case' 0 C--O 1.211 -0.921 0 N-CA-C 107.239 -1.393 . . . . 0.97 107.239 174.467 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A 1568 ' ' GLY . . . . . . . . . . . . . . . -75.36 -18.64 79.89 Favored Glycine 0 C--N 1.309 -0.92 0 C-N-CA 120.472 -0.871 . . . . 1.08 114.655 -171.732 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A 1569 ' ' GLN . . . . . . . . . . . . . 58.9 tp60 -80.66 -60.0 2.47 Favored 'General case' 0 C--N 1.302 -1.496 0 CA-C-O 121.059 0.457 . . . . 2.74 110.498 -179.586 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A 1570 ' ' THR . . . . . . . . . . . . . 12.3 p -88.14 -11.16 47.74 Favored 'General case' 0 C--N 1.31 -1.146 0 N-CA-C 112.817 0.673 . . . . 1.96 112.817 -175.289 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A 1571 ' ' ARG . . . . . . . . . . . . . 51.0 mtm180 58.04 45.16 18.33 Favored 'General case' 0 CA--C 1.515 -0.372 0 C-N-CA 125.363 1.465 . . . . 3.95 112.853 179.248 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A 1572 ' ' ILE . . . . . . . . . . . . . 36.3 mt -100.61 122.82 53.07 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.192 0 N-CA-C 108.788 -0.819 . . . . 1.37 108.788 179.112 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A 1573 ' ' SER . . . . . . . . . . . . . 33.2 t -61.88 122.57 15.76 Favored 'General case' 0 C--N 1.31 -1.133 0 C-N-CA 124.644 1.178 . . . . 1.08 110.855 -179.033 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A 1574 ' ' VAL . . . . . . . . . . . . . 30.0 m -127.83 33.93 1.36 Allowed 'Isoleucine or valine' 0 C--N 1.315 -0.895 0 CA-C-O 122.238 1.018 . . . . 1.3 110.234 178.973 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A 1575 ' ' GLY . . . . . . . . . . . . . . . 155.69 115.61 0.52 Allowed Glycine 0 N--CA 1.419 -2.442 0 CA-C-N 114.248 -1.342 . . . . 0.51 111.341 177.979 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A 1576 ' ' LYS . . . . . 0.426 ' HA ' ' HA ' ' A' 1563 ' ' VAL . 3.3 tppp? -82.13 145.33 30.19 Favored 'General case' 0 C--N 1.307 -1.253 0 N-CA-C 106.77 -1.567 . . . . 2.9 106.77 178.201 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A 1577 ' ' ALA . . . . . . . . . . . . . . . -63.81 112.92 3.1 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 121.343 0.592 . . . . 0.83 109.516 -179.024 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A 1578 ' ' ASN . . . . . . . . . . . . . 50.4 t-20 -135.77 139.13 43.3 Favored 'General case' 0 C--N 1.295 -1.802 0 N-CA-C 107.687 -1.227 . . . . 1.85 107.687 -173.493 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A 1579 ' ' LYS . . . . . 0.472 ' HD2' ' SG ' ' A' 1516 ' ' CYS . 43.2 mmtm -100.9 89.85 3.99 Favored 'General case' 0 C--N 1.3 -1.562 0 N-CA-C 108.043 -1.095 . . . . 1.9 108.043 178.957 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A 1580 ' ' ARG . . . . . . . . . . . . . 18.7 tpp180 -146.79 84.87 1.61 Allowed 'General case' 0 N--CA 1.429 -1.514 0 CA-C-O 121.33 0.586 . . . . 3.63 110.593 -177.627 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A 1581 ' ' LEU . . . . . 0.4 ' HA ' ' O ' ' A' 1589 ' ' GLN . 3.8 pp -104.37 153.71 20.73 Favored 'General case' 0 N--CA 1.427 -1.595 0 CA-C-N 115.55 -0.75 . . . . 1.87 110.112 176.117 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A 1582 ' ' ARG . . . . . 0.43 ' CG ' ' HB3' ' A' 1589 ' ' GLN . 14.7 ptp180 -131.62 139.89 49.25 Favored 'General case' 0 C--N 1.283 -2.296 0 N-CA-C 108.937 -0.764 . . . . 3.97 108.937 177.427 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A 1583 ' ' TYR . . . . . 0.43 ' CE1' ' HA ' ' A' 1586 ' ' GLN . 67.5 t80 -102.84 91.85 4.34 Favored 'General case' 0 N--CA 1.432 -1.367 0 N-CA-C 107.448 -1.315 . . . . 1.41 107.448 176.819 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A 1584 ' ' VAL . . . . . . . . . . . . . 1.6 m -120.27 110.46 28.86 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.607 0 CA-C-N 115.421 -0.809 . . . . 1.69 112.53 -176.553 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A 1585 ' ' ASP . . . . . . . . . . . . . 16.0 t70 65.45 38.8 5.46 Favored 'General case' 0 C--N 1.313 -1.019 0 CA-C-O 122.481 1.134 . . . . 2.06 109.619 173.409 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A 1586 ' ' GLN . . . . . 0.43 ' HA ' ' CE1' ' A' 1583 ' ' TYR . 47.8 mt-30 73.78 -14.43 0.66 Allowed 'General case' 0 N--CA 1.484 1.234 0 C-N-CA 126.049 1.739 . . . . 2.33 114.042 -179.729 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A 1587 ' ' VAL . . . . . . . . . . . . . 7.6 p -94.53 121.68 45.33 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.026 0 CA-C-O 121.361 0.601 . . . . 0.78 110.055 178.461 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A 1588 ' ' LEU . . . . . 0.663 ' HB2' ' HB2' ' A' 1612 ' ' PHE . 3.8 mm? -78.75 138.76 38.38 Favored 'General case' 0 N--CA 1.433 -1.301 0 CA-C-N 115.658 -0.701 . . . . 1.41 109.67 178.736 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A 1589 ' ' GLN . . . . . 0.43 ' HB3' ' CG ' ' A' 1582 ' ' ARG . 34.6 tt0 -133.58 126.92 31.99 Favored 'General case' 0 C--N 1.292 -1.91 0 N-CA-C 108.63 -0.878 . . . . 1.24 108.63 179.479 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A 1590 ' ' LEU . . . . . . . . . . . . . 8.9 tt -124.59 126.21 45.42 Favored 'General case' 0 C--N 1.295 -1.794 0 N-CA-C 107.438 -1.319 . . . . 1.15 107.438 179.911 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A 1591 ' ' VAL . . . . . 0.436 HG22 HG13 ' A' 1609 ' ' VAL . 67.8 t -117.75 123.03 71.14 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.798 0 CA-C-O 121.237 0.541 . . . . 1.51 112.454 -174.488 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A 1592 ' ' TYR . . . . . . . . . . . . . 49.4 m-85 -97.29 101.59 13.17 Favored 'General case' 0 C--N 1.309 -1.153 0 CA-C-N 115.041 -0.981 . . . . 1.06 108.383 175.114 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A 1593 ' ' LYS . . . . . . . . . . . . . 19.0 ptpt -99.74 -173.68 2.52 Favored 'General case' 0 C--N 1.3 -1.547 0 N-CA-C 109.756 -0.461 . . . . 2.18 109.756 179.849 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A 1594 ' ' ASP . . . . . . . . . . . . . 6.7 m-20 50.07 53.96 11.93 Favored 'General case' 0 N--CA 1.478 0.925 0 N-CA-C 114.84 1.422 . . . . 1.45 114.84 175.951 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A 1595 ' ' GLY . . . . . . . . . . . . . . . -90.02 -92.45 1.22 Allowed Glycine 0 N--CA 1.425 -2.052 0 N-CA-C 108.001 -2.04 . . . . 0.78 108.001 174.367 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A 1596 ' ' SER . . . . . 0.407 ' HB2' ' HD2' ' A' 1606 ' ' TYR . 20.0 m -114.16 135.95 22.19 Favored Pre-proline 0 C--N 1.291 -1.936 0 N-CA-C 107.475 -1.306 . . . . 1.68 107.475 175.404 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A 1597 ' ' PRO . . . . . . . . . . . . . 32.0 Cg_exo -60.87 128.23 24.88 Favored 'Trans proline' 0 C--O 1.243 0.754 0 C-N-CA 122.513 2.142 . . . . 1.17 109.422 178.254 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A 1598 ' ' CYS . . . . . 0.566 ' HB3' HD12 ' A' 1604 ' ' LEU . 9.0 t -95.7 125.27 49.78 Favored Pre-proline 0 C--N 1.293 -1.861 0 N-CA-C 109.021 -0.733 . . . . 1.19 109.021 -174.35 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A 1599 ' ' PRO . . . . . 0.461 ' HD3' ' HA ' ' A' 1598 ' ' CYS . 1.0 OUTLIER -84.04 -0.29 9.52 Favored 'Trans proline' 0 CA--C 1.536 0.591 0 C-N-CA 122.86 2.373 . . . . 1.59 113.18 -177.296 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A 1600 ' ' SER . . . . . . . . . . . . . 20.3 m -67.41 -31.3 71.41 Favored 'General case' 0 C--O 1.241 0.645 0 CA-C-O 121.095 0.474 . . . . 2.12 111.122 179.594 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A 1601 ' ' LYS . . . . . 0.444 ' HB3' HD21 ' A' 1604 ' ' LEU . 13.1 tmtt? -152.63 130.47 11.69 Favored 'General case' 0 C--N 1.31 -1.151 0 N-CA-C 105.96 -1.867 . . . . 3.74 105.96 178.731 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A 1602 ' ' SER . . . . . . . . . . . . . 23.9 t -71.88 117.39 13.42 Favored 'General case' 0 C--N 1.305 -1.333 0 CA-C-O 121.207 0.527 . . . . 3.79 111.255 -177.103 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A 1603 ' ' GLY . . . . . . . . . . . . . . . 116.66 15.71 6.76 Favored Glycine 0 N--CA 1.43 -1.762 0 CA-C-N 115.625 -0.716 . . . . 2.0 112.79 175.988 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A 1604 ' ' LEU . . . . . 0.566 HD12 ' HB3' ' A' 1598 ' ' CYS . 2.3 pp -140.3 161.3 38.0 Favored 'General case' 0 C--N 1.316 -0.864 0 N-CA-C 113.462 0.912 . . . . 1.48 113.462 179.711 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A 1605 ' ' SER . . . . . . . . . . . . . 9.3 t -121.38 170.93 9.15 Favored 'General case' 0 C--N 1.295 -1.765 0 N-CA-C 108.078 -1.082 . . . . 1.51 108.078 -175.314 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A 1606 ' ' TYR . . . . . 0.407 ' HD2' ' HB2' ' A' 1596 ' ' SER . 90.8 m-85 -85.54 111.91 20.45 Favored 'General case' 0 CA--C 1.461 -2.465 0 N-CA-C 102.783 -3.043 . . . . 1.18 102.783 176.078 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A 1607 ' ' LYS . . . . . . . . . . . . . 22.3 pttm -126.93 148.63 50.04 Favored 'General case' 0 N--CA 1.399 -2.99 0 C-N-CA 119.006 -1.077 . . . . 1.67 112.111 -172.877 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A 1608 ' ' SER . . . . . . . . . . . . . 23.8 t -104.65 128.2 52.63 Favored 'General case' 0 C--N 1.298 -1.663 0 CA-C-N 115.674 -0.694 . . . . 1.0 109.598 -177.429 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A 1609 ' ' VAL . . . . . 0.436 HG13 HG22 ' A' 1591 ' ' VAL . 53.4 t -114.42 111.01 34.14 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.969 0 N-CA-C 108.507 -0.923 . . . . 0.93 108.507 178.874 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A 1610 ' ' ILE . . . . . . . . . . . . . 26.3 mm -94.03 117.26 37.24 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.348 0 CA-C-N 116.117 -0.492 . . . . 0.78 109.697 -179.139 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A 1611 ' ' SER . . . . . . . . . . . . . 35.9 p -104.58 113.75 27.53 Favored 'General case' 0 N--CA 1.429 -1.493 0 CA-C-O 121.33 0.586 . . . . 1.29 109.614 175.861 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A 1612 ' ' PHE . . . . . 0.663 ' HB2' ' HB2' ' A' 1588 ' ' LEU . 96.9 m-85 -87.7 102.51 14.71 Favored 'General case' 0 C--N 1.306 -1.295 0 CA-C-N 115.518 -0.765 . . . . 0.7 109.139 -179.256 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A 1613 ' ' VAL . . . . . . . . . . . . . 42.2 t -106.35 122.18 59.83 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.877 0 N-CA-C 109.303 -0.628 . . . . 0.75 109.303 -175.914 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A 1614 ' ' CYS . . . . . 0.589 ' HA ' ' O ' ' A' 1642 ' ' THR . 0.5 OUTLIER -75.34 93.81 2.95 Favored 'General case' 0 C--N 1.298 -1.65 0 N-CA-C 114.632 1.345 . . . . 1.39 114.632 -178.988 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A 1615 ' ' ARG . . . . . 0.49 ' HB3' ' HB3' ' A' 1641 ' ' HIS . 23.3 tpt180 -131.64 96.84 20.04 Favored Pre-proline 0 N--CA 1.423 -1.78 0 N-CA-C 107.881 -1.155 . . . . 3.75 107.881 174.306 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A 1616 ' ' PRO . . . . . 0.595 ' HB3' ' HB3' ' A' 1643 ' ' PRO . 7.6 Cg_exo -75.66 64.34 6.6 Favored 'Trans proline' 0 CA--C 1.532 0.42 0 C-N-CA 123.817 3.011 . . . . 1.32 113.643 -175.854 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A 1617 ' ' GLU . . . . . . . . . . . . . 44.0 mt-10 -130.47 25.03 5.13 Favored 'General case' 0 C--N 1.312 -1.024 0 O-C-N 122.201 -0.312 . . . . 3.21 111.337 179.013 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A 1618 ' ' ALA . . . . . 0.446 ' HB1' ' HB2' ' A' 1622 ' ' ASN . . . -158.51 152.45 23.71 Favored 'General case' 0 C--O 1.242 0.707 0 CA-C-O 120.778 0.323 . . . . 2.44 110.848 -176.135 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A 1619 ' ' GLY . . . . . 0.437 ' HA3' ' HD2' ' A' 1620 ' ' PRO . . . -121.44 -137.37 5.23 Favored Glycine 0 N--CA 1.437 -1.29 0 CA-C-N 115.581 -0.736 . . . . 3.26 112.262 -178.999 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A 1620 ' ' PRO . . . . . 0.437 ' HD2' ' HA3' ' A' 1619 ' ' GLY . 1.5 Cg_endo -44.79 -37.41 11.78 Favored 'Trans proline' 0 CA--C 1.56 1.785 0 C-N-CA 124.717 3.611 . . . . 5.92 117.136 -176.608 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A 1621 ' ' THR . . . . . . . . . . . . . 13.7 t -80.94 -7.08 59.42 Favored 'General case' 0 CA--C 1.539 0.523 0 O-C-N 121.399 -0.813 . . . . 4.76 112.54 -177.064 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A 1622 ' ' ASN . . . . . 0.446 ' HB2' ' HB1' ' A' 1618 ' ' ALA . 59.6 t30 -64.54 124.05 20.85 Favored 'General case' 0 C--N 1.313 -0.987 0 C-N-CA 122.731 0.412 . . . . 2.92 110.991 -176.061 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A 1623 ' ' ARG . . . . . . . . . . . . . 7.7 ptp180 -135.2 147.93 64.36 Favored Pre-proline 0 C--N 1.309 -1.186 0 N-CA-C 109.622 -0.51 . . . . 3.61 109.622 -177.393 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A 1624 ' ' PRO . . . . . . . . . . . . . 18.7 Cg_endo -58.97 124.38 15.56 Favored 'Trans proline' 0 C--N 1.349 0.565 0 C-N-CA 123.436 2.757 . . . . 2.37 112.109 179.762 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A 1625 ' ' MET . . . . . . . . . . . . . 54.9 ttp -94.6 125.08 39.02 Favored 'General case' 0 C--N 1.301 -1.503 0 CA-C-N 115.863 -0.608 . . . . 2.16 110.809 -176.84 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A 1626 ' ' LEU . . . . . 0.494 ' HB2' ' CE1' ' A' 1638 ' ' PHE . 31.8 tp -73.66 103.73 4.34 Favored 'General case' 0 C--N 1.306 -1.299 0 N-CA-C 108.729 -0.841 . . . . 1.35 108.729 175.979 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A 1627 ' ' ILE . . . . . . . . . . . . . 27.9 pt -91.56 -36.58 8.1 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.381 0 CA-C-N 115.751 -0.659 . . . . 1.21 112.485 -176.649 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A 1628 ' ' SER . . . . . . . . . . . . . 6.2 p -153.66 135.42 14.5 Favored 'General case' 0 N--CA 1.43 -1.448 0 CA-C-O 120.883 0.373 . . . . 1.4 111.567 -177.396 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A 1629 ' ' LEU . . . . . 0.926 ' HG ' ' HG ' ' A' 1636 ' ' LEU . 4.4 tt -125.31 114.76 19.34 Favored 'General case' 0 C--N 1.3 -1.552 0 N-CA-C 105.757 -1.942 . . . . 1.56 105.757 177.825 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A 1630 ' ' ASP . . . . . . . . . . . . . 25.0 t70 -91.87 121.99 33.98 Favored 'General case' 0 C--N 1.301 -1.502 0 N-CA-C 107.962 -1.125 . . . . 0.87 107.962 178.279 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A 1631 ' ' LYS . . . . . . . . . . . . . 96.8 mttt -86.48 -2.97 58.92 Favored 'General case' 0 C--N 1.301 -1.511 0 N-CA-C 112.642 0.608 . . . . 2.35 112.642 -172.252 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A 1632 ' ' GLN . . . . . . . . . . . . . 1.9 mp0 -95.59 -42.63 8.32 Favored 'General case' 0 C--N 1.318 -0.773 0 C-N-CA 120.463 -0.495 . . . . 2.55 110.665 177.424 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A 1633 ' ' THR . . . . . 0.459 ' HA ' HD22 ' A' 1604 ' ' LEU . 31.7 p -90.97 -8.15 50.03 Favored 'General case' 0 C--O 1.251 1.137 0 CA-C-O 121.621 0.724 . . . . 1.24 110.902 177.581 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A 1634 ' ' CYS . . . . . . . . . . . . . 33.3 m 59.29 44.64 15.15 Favored 'General case' 0 C--N 1.34 0.161 0 CA-C-N 113.905 -1.498 . . . . 0.89 110.379 176.588 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A 1635 ' ' THR . . . . . . . . . . . . . 7.5 p -108.32 126.21 52.58 Favored 'General case' 0 N--CA 1.428 -1.549 0 CA-C-N 114.339 -1.3 . . . . 0.75 111.173 -176.198 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A 1636 ' ' LEU . . . . . 0.926 ' HG ' ' HG ' ' A' 1629 ' ' LEU . 5.9 mp -105.47 111.04 23.6 Favored 'General case' 0 N--CA 1.431 -1.423 0 N-CA-C 109.621 -0.511 . . . . 1.33 109.621 175.596 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A 1637 ' ' PHE . . . . . . . . . . . . . 97.5 m-85 -92.03 112.75 24.81 Favored 'General case' 0 C--O 1.249 1.06 0 CA-C-N 116.202 -0.453 . . . . 0.83 110.6 -178.573 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A 1638 ' ' PHE . . . . . 0.494 ' CE1' ' HB2' ' A' 1626 ' ' LEU . 97.1 m-85 -109.12 132.13 54.41 Favored 'General case' 0 C--N 1.304 -1.385 0 CA-C-N 115.892 -0.595 . . . . 0.6 109.448 177.709 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A 1639 ' ' SER . . . . . . . . . . . . . 29.4 p -111.19 117.23 32.64 Favored 'General case' 0 C--N 1.285 -2.223 0 CA-C-O 121.628 0.728 . . . . 1.08 110.34 176.652 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A 1640 ' ' TRP . . . . . . . . . . . . . 13.9 t90 -101.8 102.57 13.21 Favored 'General case' 0 N--CA 1.419 -1.978 0 N-CA-C 107.42 -1.326 . . . . 0.8 107.42 177.565 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A 1641 ' ' HIS . . . . . 0.49 ' HB3' ' HB3' ' A' 1615 ' ' ARG . 62.9 m80 -82.35 93.19 7.12 Favored 'General case' 0 C--N 1.311 -1.096 0 N-CA-C 107.604 -1.258 . . . . 2.54 107.604 -179.885 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A 1642 ' ' THR . . . . . 0.589 ' O ' ' HA ' ' A' 1614 ' ' CYS . 9.7 t -134.84 141.52 38.81 Favored Pre-proline 0 C--N 1.288 -2.103 0 CA-C-O 121.384 0.612 . . . . 1.15 112.13 -170.421 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A 1643 ' ' PRO . . . . . 0.595 ' HB3' ' HB3' ' A' 1616 ' ' PRO . 38.2 Cg_endo -70.65 -10.15 27.26 Favored 'Trans proline' 0 C--N 1.352 0.742 0 C-N-CA 123.396 2.73 . . . . 0.8 111.024 173.628 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A 1644 ' ' LEU . . . . . . . . . . . . . 31.7 mt -83.28 -2.52 55.85 Favored 'General case' 0 C--N 1.312 -1.023 0 C-N-CA 123.945 0.898 . . . . 1.54 111.215 -179.464 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A 1645 ' ' ALA . . . . . . . . . . . . . . . -92.23 -34.0 14.45 Favored 'General case' 0 C--N 1.323 -0.564 0 N-CA-C 112.765 0.654 . . . . 0.95 112.765 -176.96 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A 1646 ' ' CYS . . . . . . . . . . . . . 5.9 m -152.55 172.19 16.97 Favored 'General case' 0 CA--C 1.506 -0.721 0 N-CA-C 106.94 -1.504 . . . . 1.41 106.94 -179.205 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A 1647 ' ' GLU . . . . . . . . . . . . . 8.0 pt-20 -126.74 84.13 63.62 Favored Pre-proline 0 C--N 1.302 -1.49 0 CA-C-O 121.586 0.708 . . . . 2.92 109.956 173.494 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A 1648 ' ' PRO . . . . . . . . . . . . . 6.1 Cg_exo -78.25 165.9 25.14 Favored 'Trans proline' 0 C--O 1.243 0.771 0 C-N-CA 123.054 2.503 . . . . 2.82 110.739 -178.573 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A 1649 ' ' GLU . . . . . . . . . . . . . 39.8 tt0 . . . . . 0 C--O 1.254 1.336 0 O-C-N 124.098 0.874 . . . . 5.06 109.237 -178.443 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A 1508 ' ' MET . . . . . . . . . . . . . 48.9 ttm . . . . . 0 CA--C 1.518 -0.283 0 N-CA-C 108.55 -0.907 . . . . 8.27 108.55 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A 1509 ' ' LYS . . . . . . . . . . . . . 23.0 tptm 69.29 117.68 0.04 OUTLIER 'General case' 0 N--CA 1.468 0.46 0 C-N-CA 125.189 1.396 . . . . 6.48 111.518 -178.85 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A 1510 ' ' SER . . . . . . . . . . . . . 58.8 m 62.38 46.84 5.6 Favored 'General case' 0 C--O 1.234 0.264 0 CA-C-O 122.197 0.999 . . . . 4.22 109.893 -176.107 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A 1511 ' ' ASN . . . . . . . . . . . . . 2.8 p-10 -111.24 -20.44 12.31 Favored 'General case' 0 C--N 1.303 -1.416 0 CA-C-N 114.72 -1.127 . . . . 3.08 111.805 -177.073 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A 1512 ' ' GLU . . . . . . . . . . . . . 7.9 mm-40 -50.67 -44.6 57.7 Favored 'General case' 0 N--CA 1.476 0.863 0 C-N-CA 123.672 0.789 . . . . 4.46 112.925 -176.906 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A 1513 ' ' HIS . . . . . . . . . . . . . 23.1 p80 -121.25 27.1 8.55 Favored 'General case' 0 C--N 1.312 -1.036 0 C-N-CA 119.48 -0.888 . . . . 5.57 111.154 179.569 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A 1514 ' ' ASP . . . . . . . . . . . . . 31.2 t70 -123.59 -39.6 2.41 Favored 'General case' 0 C--N 1.308 -1.221 0 N-CA-C 114.431 1.271 . . . . 3.7 114.431 -174.861 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A 1515 ' ' ASP . . . . . . . . . . . . . 35.5 t70 -130.18 145.0 51.68 Favored 'General case' 0 C--N 1.294 -1.835 0 C-N-CA 118.979 -1.088 . . . . 2.54 110.761 -174.115 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A 1516 ' ' CYS . . . . . . . . . . . . . 74.1 m -76.25 77.4 3.04 Favored 'General case' 0 CA--C 1.508 -0.673 0 CA-C-O 122.326 1.06 . . . . 1.25 110.65 179.786 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A 1517 ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -147.01 172.54 13.56 Favored 'General case' 0 N--CA 1.402 -2.86 0 CA-C-N 114.324 -1.307 . . . . 1.88 109.22 -179.622 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A 1518 ' ' VAL . . . . . 0.533 HG21 ' HB2' ' A' 1583 ' ' TYR . 10.4 p -159.0 126.01 0.57 Allowed 'Isoleucine or valine' 0 C--N 1.279 -2.466 0 CA-C-O 121.46 0.648 . . . . 1.73 109.551 173.035 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A 1519 ' ' THR . . . . . . . . . . . . . 7.3 m -90.57 121.52 32.58 Favored 'General case' 0 C--N 1.282 -2.351 0 CA-C-N 114.548 -1.205 . . . . 1.7 108.202 177.635 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A 1520 ' ' ASN . . . . . . . . . . . . . 38.9 t30 -99.79 103.33 21.21 Favored Pre-proline 0 C--N 1.311 -1.09 0 N-CA-C 109.59 -0.522 . . . . 2.12 109.59 177.35 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A 1521 ' ' PRO . . . . . . . . . . . . . 41.4 Cg_endo -69.28 -3.35 11.52 Favored 'Trans proline' 0 CA--C 1.54 0.797 0 C-N-CA 122.624 2.216 . . . . 2.47 113.954 -175.778 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A 1522 ' ' SER . . . . . . . . . . . . . 11.4 m -69.34 -28.84 66.58 Favored 'General case' 0 CA--C 1.545 0.776 0 CA-C-O 120.984 0.421 . . . . 2.57 109.883 176.805 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A 1523 ' ' THR . . . . . . . . . . . . . 12.9 t -139.21 -16.62 1.06 Allowed 'General case' 0 CA--C 1.551 0.999 0 CA-C-O 120.903 0.383 . . . . 2.15 111.827 178.771 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A 1524 ' ' GLY . . . . . . . . . . . . . . . 94.16 7.92 60.54 Favored Glycine 0 N--CA 1.446 -0.658 0 C-N-CA 120.597 -0.811 . . . . 1.89 113.08 179.017 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A 1525 ' ' HIS . . . . . . . . . . . . . 24.5 t60 -77.06 134.11 38.87 Favored 'General case' 0 C--O 1.245 0.838 0 CA-C-O 120.866 0.365 . . . . 1.9 110.023 -177.927 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A 1526 ' ' LEU . . . . . . . . . . . . . 3.4 tm? -104.51 114.73 29.14 Favored 'General case' 0 N--CA 1.43 -1.426 0 N-CA-C 108.157 -1.053 . . . . 1.61 108.157 178.324 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A 1527 ' ' PHE . . . . . . . . . . . . . 97.6 m-85 -88.32 129.33 35.41 Favored 'General case' 0 C--N 1.291 -1.942 0 N-CA-C 108.071 -1.085 . . . . 1.42 108.071 178.267 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A 1528 ' ' ASP . . . . . . . . . . . . . 3.4 p-10 -117.82 126.9 53.28 Favored 'General case' 0 CA--C 1.476 -1.866 0 CA-C-O 121.964 0.887 . . . . 2.18 110.322 179.073 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A 1529 ' ' LEU . . . . . . . . . . . . . 71.7 mt -117.68 7.45 12.56 Favored 'General case' 0 C--N 1.292 -1.919 0 N-CA-C 106.231 -1.766 . . . . 1.44 106.231 175.738 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A 1530 ' ' SER . . . . . . . . . . . . . 1.6 m -70.99 -24.95 62.49 Favored 'General case' 0 N--CA 1.438 -1.026 0 CA-C-N 113.853 -1.521 . . . . 1.44 110.219 -179.152 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A 1531 ' ' SER . . . . . . . . . . . . . 14.5 m -88.07 -16.15 34.34 Favored 'General case' 0 N--CA 1.433 -1.309 0 N-CA-C 108.582 -0.896 . . . . 1.5 108.582 178.814 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A 1532 ' ' LEU . . . . . . . . . . . . . 90.8 mt -82.05 -8.28 59.66 Favored 'General case' 0 C--O 1.244 0.804 0 CA-C-N 115.509 -0.769 . . . . 1.77 111.72 177.631 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A 1533 ' ' SER . . . . . . . . . . . . . 22.5 m -57.67 125.84 24.73 Favored 'General case' 0 N--CA 1.445 -0.702 0 C-N-CA 123.155 0.582 . . . . 2.38 110.424 177.146 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A 1534 ' ' GLY . . . . . . . . . . . . . . . -121.16 169.53 14.38 Favored Glycine 0 N--CA 1.427 -1.943 0 N-CA-C 109.976 -1.25 . . . . 1.55 109.976 179.698 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A 1535 ' ' ARG . . . . . . . . . . . . . 45.8 ttt180 -95.37 -54.27 3.46 Favored 'General case' 0 C--N 1.303 -1.452 0 N-CA-C 108.524 -0.917 . . . . 3.96 108.524 179.123 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A 1536 ' ' ALA . . . . . 0.47 ' HA ' HD21 ' A' 1558 ' ' ASN . . . -86.14 -24.19 26.3 Favored 'General case' 0 N--CA 1.438 -1.047 0 CA-C-N 115.505 -0.771 . . . . 1.65 109.463 178.68 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A 1537 ' ' GLY . . . . . . . . . . . . . . . 81.76 -140.66 21.16 Favored Glycine 0 N--CA 1.434 -1.473 0 CA-C-N 115.177 -0.919 . . . . 1.19 112.344 176.664 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A 1538 ' ' PHE . . . . . . . . . . . . . 98.7 m-85 -134.16 156.83 47.62 Favored 'General case' 0 C--N 1.299 -1.617 0 N-CA-C 108.72 -0.844 . . . . 1.69 108.72 179.881 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A 1539 ' ' THR . . . . . . . . . . . . . 23.5 p -104.93 111.63 24.47 Favored 'General case' 0 N--CA 1.425 -1.709 0 CA-C-N 115.929 -0.578 . . . . 1.48 110.046 177.114 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A 1540 ' ' ALA . . . . . . . . . . . . . . . -102.72 116.59 32.87 Favored 'General case' 0 C--N 1.295 -1.784 0 N-CA-C 108.865 -0.791 . . . . 0.83 108.865 178.618 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A 1541 ' ' ALA . . . . . . . . . . . . . . . -61.68 128.34 35.8 Favored 'General case' 0 C--N 1.308 -1.222 0 CA-C-O 121.428 0.632 . . . . 1.27 110.943 178.021 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A 1542 ' ' TYR . . . . . 0.625 ' HD2' ' HB2' ' A' 1545 ' ' SER . 66.7 t80 -125.0 174.84 7.73 Favored 'General case' 0 C--N 1.293 -1.875 0 N-CA-C 107.296 -1.372 . . . . 2.15 107.296 -178.426 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A 1543 ' ' SER . . . . . . . . . . . . . 1.7 m -46.5 -152.15 0.0 OUTLIER 'General case' 0 CA--C 1.596 2.721 0 C-N-CA 128.741 2.816 . . . . 2.29 114.404 -179.865 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A 1544 ' ' LYS . . . . . . . . . . . . . 63.6 mttp -55.07 -15.39 2.1 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 119.621 -1.924 . . . . 3.91 113.556 -177.012 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A 1545 ' ' SER . . . . . 0.625 ' HB2' ' HD2' ' A' 1542 ' ' TYR . 36.0 m -70.62 -19.63 62.81 Favored 'General case' 0 CA--C 1.552 1.023 0 N-CA-C 111.976 0.361 . . . . 3.3 111.976 174.707 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A 1546 ' ' GLY . . . . . . . . . . . . . . . 102.63 -98.55 1.7 Allowed Glycine 0 CA--C 1.493 -1.289 0 C-N-CA 119.224 -1.465 . . . . 1.24 113.187 174.822 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A 1547 ' ' VAL . . . . . . . . . . . . . 16.6 m -131.39 166.29 29.23 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.616 0 CA-C-N 117.26 0.53 . . . . 1.63 109.913 177.567 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A 1548 ' ' VAL . . . . . . . . . . . . . 3.6 t -118.83 128.7 75.66 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.724 0 N-CA-C 106.627 -1.62 . . . . 0.92 106.627 175.983 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A 1549 ' ' TYR . . . . . 0.566 ' CD2' ' HA2' ' A' 1568 ' ' GLY . 50.8 m-85 -87.64 114.57 24.37 Favored 'General case' 0 C--N 1.3 -1.57 0 N-CA-C 106.233 -1.765 . . . . 1.44 106.233 171.223 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A 1550 ' ' MET . . . . . . . . . . . . . 3.0 ppp? -141.87 149.8 40.73 Favored 'General case' 0 C--N 1.284 -2.247 0 CA-C-N 116.435 -0.348 . . . . 1.74 111.304 -176.357 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A 1551 ' ' SER . . . . . . . . . . . . . 22.6 t -116.55 145.05 43.63 Favored 'General case' 0 C--N 1.294 -1.819 0 N-CA-C 107.83 -1.174 . . . . 1.64 107.83 177.834 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A 1552 ' ' ILE . . . . . . . . . . . . . 32.6 mm -68.07 -27.31 36.88 Favored 'Isoleucine or valine' 0 C--O 1.213 -0.849 0 CA-C-N 114.856 -1.066 . . . . 1.33 109.406 -178.132 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A 1553 ' ' CYS . . . . . 0.418 ' SG ' ' HE2' ' A' 1579 ' ' LYS . 51.4 t -161.64 138.65 8.52 Favored 'General case' 0 N--CA 1.421 -1.914 0 N-CA-C 108.282 -1.007 . . . . 1.43 108.282 178.142 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A 1554 ' ' GLY . . . . . . . . . . . . . . . 95.47 -177.63 34.84 Favored Glycine 0 N--CA 1.438 -1.227 0 C-N-CA 120.689 -0.767 . . . . 1.12 112.472 176.493 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A 1555 ' ' GLU . . . . . . . . . . . . . 10.1 pt-20 -81.37 144.25 31.59 Favored 'General case' 0 C--N 1.309 -1.194 0 CA-C-O 121.392 0.615 . . . . 1.8 111.522 -178.962 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A 1556 ' ' ASN . . . . . . . . . . . . . 27.8 t-20 -96.91 105.62 17.79 Favored 'General case' 0 C--N 1.293 -1.849 0 CA-C-N 115.225 -0.898 . . . . 2.63 109.229 -179.408 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A 1557 ' ' GLU . . . . . . . . . . . . . 13.0 mt-10 -86.31 76.7 9.64 Favored 'General case' 0 C--N 1.313 -0.978 0 CA-C-O 122.035 0.922 . . . . 3.79 111.918 -177.028 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A 1558 ' ' ASN . . . . . 0.47 HD21 ' HA ' ' A' 1536 ' ' ALA . 31.7 m-80 -146.82 -43.94 0.18 Allowed 'General case' 0 C--N 1.297 -1.705 0 N-CA-C 106.143 -1.799 . . . . 1.52 106.143 178.892 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A 1559 ' ' CYS . . . . . 0.626 ' HB3' ' HD2' ' A' 1560 ' ' PRO . 78.2 m -108.63 175.92 1.78 Allowed Pre-proline 0 N--CA 1.425 -1.69 0 N-CA-C 105.532 -2.025 . . . . 0.84 105.532 170.675 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A 1560 ' ' PRO . . . . . 0.626 ' HD2' ' HB3' ' A' 1559 ' ' CYS . 20.8 Cg_exo -32.95 113.11 0.06 OUTLIER 'Trans proline' 0 C--N 1.375 1.943 0 C-N-CA 123.641 2.894 . . . . 1.18 113.962 176.879 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A 1561 ' ' PRO . . . . . . . . . . . . . 39.7 Cg_exo -59.07 102.79 0.16 Allowed 'Trans proline' 0 C--O 1.242 0.702 0 C-N-CA 123.335 2.69 . . . . 1.51 111.31 -179.026 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A 1562 ' ' GLY . . . . . . . . . . . . . . . 152.17 -19.74 0.84 Allowed Glycine 0 N--CA 1.432 -1.618 0 N-CA-C 108.582 -1.807 . . . . 0.72 108.582 -175.081 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A 1563 ' ' VAL . . . . . 0.519 ' HA ' ' HA ' ' A' 1576 ' ' LYS . 4.6 m -93.06 151.56 3.61 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.109 0 N-CA-C 107.118 -1.438 . . . . 0.97 107.118 174.013 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A 1564 ' ' GLY . . . . . . . . . . . . . . . -113.16 -15.35 9.13 Favored Glycine 0 C--N 1.308 -0.986 0 C-N-CA 120.664 -0.779 . . . . 0.72 112.451 -176.79 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A 1565 ' ' ALA . . . . . . . . . . . . . . . -142.92 125.61 15.93 Favored 'General case' 0 C--O 1.244 0.8 0 N-CA-C 108.871 -0.789 . . . . 0.37 108.871 179.524 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A 1566 ' ' CYS . . . . . . . . . . . . . 41.7 t -150.41 144.33 25.38 Favored 'General case' 0 C--N 1.302 -1.498 0 N-CA-C 109.524 -0.547 . . . . 0.51 109.524 -176.729 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A 1567 ' ' PHE . . . . . . . . . . . . . 18.1 m-85 -67.59 145.26 55.05 Favored 'General case' 0 C--N 1.319 -0.724 0 N-CA-C 112.181 0.438 . . . . 0.97 112.181 179.91 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A 1568 ' ' GLY . . . . . 0.566 ' HA2' ' CD2' ' A' 1549 ' ' TYR . . . -63.8 -73.48 0.54 Allowed Glycine 0 C--N 1.304 -1.225 0 N-CA-C 115.004 0.761 . . . . 1.08 115.004 -175.437 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A 1569 ' ' GLN . . . . . . . . . . . . . 11.2 pt20 -83.03 -34.29 26.3 Favored 'General case' 0 C--N 1.316 -0.849 0 N-CA-C 112.379 0.511 . . . . 2.74 112.379 -173.344 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A 1570 ' ' THR . . . . . . . . . . . . . 21.3 p -81.51 -18.05 46.46 Favored 'General case' 0 C--N 1.312 -1.063 0 CA-C-O 121.32 0.581 . . . . 1.96 110.682 -178.162 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A 1571 ' ' ARG . . . . . . . . . . . . . 64.6 mtp180 56.21 37.9 29.29 Favored 'General case' 0 C--N 1.344 0.354 0 C-N-CA 125.132 1.373 . . . . 3.95 113.063 172.774 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A 1572 ' ' ILE . . . . . . . . . . . . . 25.5 mt -101.81 128.12 54.61 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.121 0 N-CA-C 108.27 -1.011 . . . . 1.37 108.27 179.838 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A 1573 ' ' SER . . . . . . . . . . . . . 62.3 p -75.79 128.59 35.47 Favored 'General case' 0 C--N 1.314 -0.956 0 C-N-CA 122.364 0.266 . . . . 1.08 111.478 -177.106 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A 1574 ' ' VAL . . . . . . . . . . . . . 27.7 m -126.3 26.44 2.62 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.75 0 CA-C-O 121.608 0.718 . . . . 1.3 112.299 -177.937 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A 1575 ' ' GLY . . . . . . . . . . . . . . . 174.12 117.06 0.45 Allowed Glycine 0 N--CA 1.434 -1.47 0 CA-C-N 115.277 -0.874 . . . . 0.51 111.897 176.769 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A 1576 ' ' LYS . . . . . 0.519 ' HA ' ' HA ' ' A' 1563 ' ' VAL . 63.8 tttp -79.2 135.83 36.91 Favored 'General case' 0 C--N 1.314 -0.962 0 N-CA-C 107.628 -1.249 . . . . 2.9 107.628 176.045 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A 1577 ' ' ALA . . . . . . . . . . . . . . . -70.42 130.7 42.61 Favored 'General case' 0 C--N 1.313 -0.993 0 O-C-N 123.647 0.592 . . . . 0.83 110.504 -174.431 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A 1578 ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -157.83 148.41 20.81 Favored 'General case' 0 C--N 1.291 -1.942 0 N-CA-C 105.686 -1.968 . . . . 1.85 105.686 176.715 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A 1579 ' ' LYS . . . . . 0.418 ' HE2' ' SG ' ' A' 1553 ' ' CYS . 96.9 mttt -101.47 89.34 3.7 Favored 'General case' 0 C--N 1.284 -2.257 0 CA-C-O 121.845 0.831 . . . . 1.9 108.761 -177.508 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A 1580 ' ' ARG . . . . . . . . . . . . . 30.4 ttm180 -138.67 109.1 6.51 Favored 'General case' 0 N--CA 1.422 -1.862 0 CA-C-N 114.156 -1.383 . . . . 3.63 110.117 -175.587 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A 1581 ' ' LEU . . . . . . . . . . . . . 2.0 pt? -138.92 142.16 38.48 Favored 'General case' 0 N--CA 1.419 -1.992 0 N-CA-C 109.288 -0.634 . . . . 1.87 109.288 173.408 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A 1582 ' ' ARG . . . . . 0.532 ' HB3' HG13 ' A' 1584 ' ' VAL . 37.4 mmt180 -124.76 128.77 49.28 Favored 'General case' 0 C--N 1.276 -2.623 0 CA-C-N 114.972 -1.013 . . . . 3.97 110.585 -177.71 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A 1583 ' ' TYR . . . . . 0.533 ' HB2' HG21 ' A' 1518 ' ' VAL . 62.0 t80 -89.08 90.15 8.27 Favored 'General case' 0 N--CA 1.427 -1.585 0 N-CA-C 106.234 -1.765 . . . . 1.41 106.234 174.452 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A 1584 ' ' VAL . . . . . 0.532 HG13 ' HB3' ' A' 1582 ' ' ARG . 26.6 m -124.53 142.4 41.48 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.167 0 CA-C-N 114.435 -1.257 . . . . 1.69 107.896 -176.21 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A 1585 ' ' ASP . . . . . . . . . . . . . 22.8 t70 61.05 22.63 12.87 Favored 'General case' 0 N--CA 1.483 1.178 0 CA-C-O 122.44 1.114 . . . . 2.06 109.79 178.565 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A 1586 ' ' GLN . . . . . . . . . . . . . 50.1 mt-30 59.98 38.88 20.63 Favored 'General case' 0 C--O 1.241 0.634 0 C-N-CA 125.278 1.431 . . . . 2.33 113.254 -176.255 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A 1587 ' ' VAL . . . . . 0.471 HG12 ' O ' ' A' 1584 ' ' VAL . 12.5 p -134.52 145.77 32.12 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.895 0 N-CA-C 108.495 -0.928 . . . . 0.78 108.495 174.904 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A 1588 ' ' LEU . . . . . 0.86 ' HB2' ' HB2' ' A' 1612 ' ' PHE . 0.7 OUTLIER -84.31 133.08 34.56 Favored 'General case' 0 C--N 1.312 -1.041 0 N-CA-C 108.306 -0.998 . . . . 1.41 108.306 177.831 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A 1589 ' ' GLN . . . . . 0.419 ' HG2' HG13 ' A' 1591 ' ' VAL . 7.3 tt0 -146.05 106.85 4.11 Favored 'General case' 0 C--N 1.307 -1.268 0 C-N-CA 120.456 -0.498 . . . . 1.24 110.132 -176.611 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A 1590 ' ' LEU . . . . . . . . . . . . . 6.2 tt -104.39 127.97 52.15 Favored 'General case' 0 C--N 1.307 -1.259 0 N-CA-C 106.245 -1.761 . . . . 1.15 106.245 179.319 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A 1591 ' ' VAL . . . . . 0.47 HG12 HG22 ' A' 1609 ' ' VAL . 15.6 m -123.69 124.37 69.22 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.245 0 N-CA-C 115.031 1.493 . . . . 1.51 115.031 -170.704 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A 1592 ' ' TYR . . . . . . . . . . . . . 94.5 m-85 -105.2 144.56 31.83 Favored 'General case' 0 C--N 1.317 -0.836 0 N-CA-C 107.267 -1.383 . . . . 1.06 107.267 173.813 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A 1593 ' ' LYS . . . . . . . . . . . . . 23.0 pttm -149.89 179.57 7.94 Favored 'General case' 0 C--N 1.302 -1.493 0 N-CA-C 109.249 -0.648 . . . . 2.18 109.249 -177.642 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A 1594 ' ' ASP . . . . . . . . . . . . . 1.4 m-20 47.05 43.19 13.77 Favored 'General case' 0 N--CA 1.482 1.128 0 N-CA-C 115.123 1.527 . . . . 1.45 115.123 173.367 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A 1595 ' ' GLY . . . . . . . . . . . . . . . -73.14 -75.57 0.72 Allowed Glycine 0 N--CA 1.443 -0.838 0 N-CA-C 109.816 -1.313 . . . . 0.78 109.816 175.978 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A 1596 ' ' SER . . . . . . . . . . . . . 21.7 t -115.39 142.36 28.63 Favored Pre-proline 0 C--N 1.29 -1.994 0 N-CA-C 105.867 -1.901 . . . . 1.68 105.867 173.42 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A 1597 ' ' PRO . . . . . . . . . . . . . 25.9 Cg_exo -65.75 143.15 72.96 Favored 'Trans proline' 0 N--CA 1.451 -0.99 0 C-N-CA 122.68 2.253 . . . . 1.17 109.533 175.571 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A 1598 ' ' CYS . . . . . . . . . . . . . 37.1 t -99.56 131.79 24.23 Favored Pre-proline 0 C--N 1.283 -2.325 0 N-CA-C 109.102 -0.703 . . . . 1.19 109.102 -176.37 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A 1599 ' ' PRO . . . . . . . . . . . . . 55.3 Cg_endo -69.44 -11.72 31.88 Favored 'Trans proline' 0 C--N 1.351 0.663 0 C-N-CA 123.165 2.577 . . . . 1.59 112.352 179.604 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A 1600 ' ' SER . . . . . . . . . . . . . 10.9 m -90.26 112.82 24.49 Favored 'General case' 0 N--CA 1.423 -1.795 0 N-CA-C 107.612 -1.255 . . . . 2.12 107.612 176.326 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A 1601 ' ' LYS . . . . . 0.74 ' HB3' HD12 ' A' 1604 ' ' LEU . 55.7 tptt 71.03 114.31 0.05 Allowed 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 124.155 0.982 . . . . 3.74 110.98 179.054 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A 1602 ' ' SER . . . . . . . . . . . . . 47.4 t -63.61 108.96 1.52 Allowed 'General case' 0 C--N 1.316 -0.862 0 CA-C-N 116.075 -0.511 . . . . 3.79 109.949 179.757 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A 1603 ' ' GLY . . . . . . . . . . . . . . . 129.99 -15.83 5.59 Favored Glycine 0 N--CA 1.434 -1.498 0 N-CA-C 110.724 -0.95 . . . . 2.0 110.724 -179.924 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A 1604 ' ' LEU . . . . . 0.74 HD12 ' HB3' ' A' 1601 ' ' LYS . 12.6 mt -83.21 156.92 22.92 Favored 'General case' 0 N--CA 1.434 -1.263 0 CA-C-O 122.172 0.987 . . . . 1.48 113.6 179.805 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A 1605 ' ' SER . . . . . . . . . . . . . 14.9 m -143.15 -173.12 3.83 Favored 'General case' 0 C--N 1.296 -1.727 0 N-CA-C 104.752 -2.314 . . . . 1.51 104.752 176.749 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A 1606 ' ' TYR . . . . . 0.477 ' CD1' ' HB3' ' A' 1634 ' ' CYS . 84.3 m-85 -107.38 132.49 53.1 Favored 'General case' 0 CA--C 1.462 -2.438 0 N-CA-C 105.77 -1.937 . . . . 1.18 105.77 179.863 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A 1607 ' ' LYS . . . . . 0.557 ' HG3' HG23 ' A' 1635 ' ' THR . 21.6 ptmt -128.04 153.31 46.93 Favored 'General case' 0 N--CA 1.407 -2.59 0 O-C-N 124.234 0.959 . . . . 1.67 109.505 -177.777 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A 1608 ' ' SER . . . . . . . . . . . . . 51.0 m -126.31 115.36 19.56 Favored 'General case' 0 C--N 1.303 -1.44 0 N-CA-C 109.393 -0.595 . . . . 1.0 109.393 -178.541 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A 1609 ' ' VAL . . . . . 0.47 HG22 HG12 ' A' 1591 ' ' VAL . 76.6 t -104.12 116.15 47.37 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.064 0 CA-C-O 120.663 0.268 . . . . 0.93 110.647 -179.407 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A 1610 ' ' ILE . . . . . . . . . . . . . 19.3 mm -95.22 106.55 18.36 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.127 0 N-CA-C 108.448 -0.945 . . . . 0.78 108.448 177.969 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A 1611 ' ' SER . . . . . 0.494 ' O ' ' HA ' ' A' 1639 ' ' SER . 21.8 m -98.05 123.19 41.96 Favored 'General case' 0 C--N 1.297 -1.7 0 N-CA-C 108.914 -0.773 . . . . 1.29 108.914 176.246 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A 1612 ' ' PHE . . . . . 0.86 ' HB2' ' HB2' ' A' 1588 ' ' LEU . 80.5 m-85 -100.39 123.16 44.26 Favored 'General case' 0 C--N 1.305 -1.364 0 N-CA-C 109.242 -0.651 . . . . 0.7 109.242 -179.066 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A 1613 ' ' VAL . . . . . 0.588 ' O ' ' HA ' ' A' 1641 ' ' HIS . 44.6 t -115.75 136.99 50.85 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.703 0 N-CA-C 106.697 -1.594 . . . . 0.75 106.697 179.281 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A 1614 ' ' CYS . . . . . 0.466 ' HA ' ' O ' ' A' 1642 ' ' THR . 42.3 t -86.69 108.88 18.85 Favored 'General case' 0 C--N 1.281 -2.409 0 CA-C-O 121.6 0.714 . . . . 1.39 111.748 -177.588 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A 1615 ' ' ARG . . . . . 0.7 ' HB3' ' HB2' ' A' 1641 ' ' HIS . 80.4 ttt180 -135.94 94.1 14.85 Favored Pre-proline 0 N--CA 1.43 -1.473 0 N-CA-C 108.009 -1.108 . . . . 3.75 108.009 176.544 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A 1616 ' ' PRO . . . . . . . . . . . . . 68.7 Cg_endo -72.04 50.0 1.4 Allowed 'Trans proline' 0 N--CA 1.481 0.773 0 C-N-CA 123.829 3.019 . . . . 1.32 113.156 -178.466 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A 1617 ' ' GLU . . . . . . . . . . . . . 42.4 mt-10 -126.95 2.37 6.58 Favored 'General case' 0 C--N 1.305 -1.352 0 N-CA-C 108.316 -0.994 . . . . 3.21 108.316 177.789 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A 1618 ' ' ALA . . . . . 0.401 ' HB2' ' HD2' ' A' 1641 ' ' HIS . . . -107.23 148.69 28.61 Favored 'General case' 0 C--N 1.315 -0.925 0 CA-C-N 115.19 -0.913 . . . . 2.44 109.111 -176.96 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A 1619 ' ' GLY . . . . . . . . . . . . . . . -88.76 165.95 33.8 Favored Glycine 0 N--CA 1.427 -1.906 0 N-CA-C 111.068 -0.813 . . . . 3.26 111.068 -179.798 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A 1620 ' ' PRO . . . . . . . . . . . . . 49.3 Cg_exo -59.61 -22.78 68.55 Favored 'Trans proline' 0 CA--C 1.544 0.992 0 C-N-CA 123.335 2.69 . . . . 5.92 114.851 -178.087 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A 1621 ' ' THR . . . . . . . . . . . . . 4.2 t -93.92 8.11 42.51 Favored 'General case' 0 CA--C 1.555 1.136 0 C-N-CA 119.836 -0.746 . . . . 4.76 111.019 -178.497 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A 1622 ' ' ASN . . . . . . . . . . . . . 25.4 t-20 -70.89 137.38 49.28 Favored 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 107.521 -1.289 . . . . 2.92 107.521 176.363 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A 1623 ' ' ARG . . . . . . . . . . . . . 7.2 ptp180 -122.13 162.44 37.44 Favored Pre-proline 0 C--N 1.299 -1.602 0 CA-C-O 119.381 -0.342 . . . . 3.61 110.153 -178.725 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A 1624 ' ' PRO . . . . . . . . . . . . . 50.0 Cg_exo -55.61 144.68 73.86 Favored 'Trans proline' 0 C--N 1.364 1.348 0 C-N-CA 122.914 2.41 . . . . 2.37 113.404 -179.777 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A 1625 ' ' MET . . . . . . . . . . . . . 55.4 ttp -118.35 136.03 53.97 Favored 'General case' 0 C--N 1.301 -1.533 0 CA-C-N 115.272 -0.876 . . . . 2.16 109.517 -179.929 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A 1626 ' ' LEU . . . . . 0.575 ' HG ' ' HD1' ' A' 1542 ' ' TYR . 3.2 tm? -73.71 113.69 11.13 Favored 'General case' 0 C--N 1.31 -1.137 0 N-CA-C 106.79 -1.559 . . . . 1.35 106.79 175.071 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A 1627 ' ' ILE . . . . . . . . . . . . . 31.6 pt -99.95 -30.95 3.35 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.957 0 C-N-CA 120.675 -0.41 . . . . 1.21 111.758 -176.758 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A 1628 ' ' SER . . . . . 0.408 ' HB3' ' HB2' ' A' 1637 ' ' PHE . 32.2 t -148.84 165.77 30.5 Favored 'General case' 0 N--CA 1.425 -1.679 0 CA-C-O 121.575 0.702 . . . . 1.4 111.253 -175.116 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A 1629 ' ' LEU . . . . . . . . . . . . . 14.2 tp -146.15 130.23 17.41 Favored 'General case' 0 C--N 1.292 -1.898 0 C-N-CA 125.153 1.381 . . . . 1.56 108.37 -177.682 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A 1630 ' ' ASP . . . . . 0.435 ' HB2' ' HE2' ' A' 1637 ' ' PHE . 21.2 t70 -119.36 106.63 12.47 Favored 'General case' 0 C--N 1.308 -1.222 0 N-CA-C 108.452 -0.944 . . . . 0.87 108.452 175.139 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A 1631 ' ' LYS . . . . . . . . . . . . . 67.9 mttm -69.41 -35.02 75.34 Favored 'General case' 0 C--N 1.304 -1.411 0 CA-C-N 115.528 -0.76 . . . . 2.35 112.707 -176.031 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A 1632 ' ' GLN . . . . . . . . . . . . . 39.4 mt-30 -74.19 -23.15 59.18 Favored 'General case' 0 C--N 1.323 -0.57 0 N-CA-C 112.938 0.718 . . . . 2.55 112.938 -176.12 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A 1633 ' ' THR . . . . . . . . . . . . . 2.0 m -112.5 3.69 16.97 Favored 'General case' 0 C--N 1.314 -0.942 0 CA-C-O 121.875 0.845 . . . . 1.24 110.217 178.528 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A 1634 ' ' CYS . . . . . 0.477 ' HB3' ' CD1' ' A' 1606 ' ' TYR . 33.4 m 54.36 43.36 30.58 Favored 'General case' 0 C--N 1.349 0.569 0 CA-C-N 114.673 -1.149 . . . . 0.89 110.32 177.099 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A 1635 ' ' THR . . . . . 0.557 HG23 ' HG3' ' A' 1607 ' ' LYS . 26.8 m -112.57 133.6 54.54 Favored 'General case' 0 N--CA 1.436 -1.156 0 CA-C-N 114.934 -1.03 . . . . 0.75 111.255 -173.128 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A 1636 ' ' LEU . . . . . . . . . . . . . 14.0 mt -104.72 130.45 52.77 Favored 'General case' 0 C--O 1.246 0.887 0 N-CA-C 107.894 -1.15 . . . . 1.33 107.894 174.118 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A 1637 ' ' PHE . . . . . 0.435 ' HE2' ' HB2' ' A' 1630 ' ' ASP . 96.1 m-85 -107.87 110.01 21.67 Favored 'General case' 0 C--N 1.313 -1.015 0 CA-C-O 120.832 0.349 . . . . 0.83 110.809 -178.073 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A 1638 ' ' PHE . . . . . . . . . . . . . 97.9 m-85 -105.44 150.39 25.32 Favored 'General case' 0 C--N 1.307 -1.255 0 N-CA-C 109.219 -0.66 . . . . 0.6 109.219 178.457 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A 1639 ' ' SER . . . . . 0.494 ' HA ' ' O ' ' A' 1611 ' ' SER . 69.1 m -141.61 138.05 32.31 Favored 'General case' 0 C--N 1.281 -2.391 0 N-CA-C 109.868 -0.419 . . . . 1.08 109.868 175.147 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A 1640 ' ' TRP . . . . . 0.55 ' HE3' ' HE2' ' A' 1612 ' ' PHE . 12.8 t90 -127.6 118.93 24.84 Favored 'General case' 0 C--N 1.29 -2.017 0 N-CA-C 107.561 -1.274 . . . . 0.8 107.561 178.537 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A 1641 ' ' HIS . . . . . 0.7 ' HB2' ' HB3' ' A' 1615 ' ' ARG . 6.2 p-80 -91.11 90.95 8.05 Favored 'General case' 0 N--CA 1.43 -1.461 0 CA-C-O 122.425 1.107 . . . . 2.54 110.045 176.465 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A 1642 ' ' THR . . . . . 0.466 ' O ' ' HA ' ' A' 1614 ' ' CYS . 1.6 m -103.3 133.81 20.11 Favored Pre-proline 0 C--N 1.281 -2.411 0 CA-C-N 113.629 -1.623 . . . . 1.15 109.688 -172.93 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A 1643 ' ' PRO . . . . . 0.409 ' HD3' ' HA ' ' A' 1642 ' ' THR . 23.7 Cg_exo -69.46 -18.91 38.19 Favored 'Trans proline' 0 CA--C 1.533 0.43 0 C-N-CA 122.669 2.246 . . . . 0.8 110.482 174.036 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A 1644 ' ' LEU . . . . . 0.411 ' H ' HG22 ' A' 1642 ' ' THR . 84.2 mt -76.55 -13.69 60.06 Favored 'General case' 0 N--CA 1.471 0.616 0 CA-C-N 115.036 -0.984 . . . . 1.54 110.958 178.491 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A 1645 ' ' ALA . . . . . . . . . . . . . . . -79.73 2.91 21.02 Favored 'General case' 0 CA--C 1.539 0.548 0 N-CA-C 113.436 0.902 . . . . 0.95 113.436 -172.392 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A 1646 ' ' CYS . . . . . . . . . . . . . 12.0 p -168.06 177.03 5.78 Favored 'General case' 0 C--O 1.25 1.094 0 N-CA-C 107.092 -1.447 . . . . 1.41 107.092 177.102 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A 1647 ' ' GLU . . . . . . . . . . . . . 6.7 mp0 -103.0 106.64 51.75 Favored Pre-proline 0 C--N 1.309 -1.188 0 N-CA-C 107.089 -1.448 . . . . 2.92 107.089 172.145 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A 1648 ' ' PRO . . . . . . . . . . . . . 67.0 Cg_exo -55.46 116.6 3.27 Favored 'Trans proline' 0 C--O 1.245 0.853 0 C-N-CA 122.521 2.147 . . . . 2.82 109.722 176.201 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A 1649 ' ' GLU . . . . . . . . . . . . . 42.5 tt0 . . . . . 0 N--CA 1.426 -1.662 0 N-CA-C 107.962 -1.125 . . . . 5.06 107.962 -176.185 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A 1508 ' ' MET . . . . . . . . . . . . . 26.4 mmt . . . . . 0 CA--C 1.508 -0.664 0 N-CA-C 108.75 -0.833 . . . . 8.27 108.75 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A 1509 ' ' LYS . . . . . . . . . . . . . 57.7 mtpt -129.8 24.75 5.35 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 120.927 0.394 . . . . 6.48 111.538 -175.438 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A 1510 ' ' SER . . . . . . . . . . . . . 15.2 m -83.18 -9.17 59.32 Favored 'General case' 0 C--N 1.309 -1.157 0 CA-C-O 122.131 0.967 . . . . 4.22 109.042 -179.667 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A 1511 ' ' ASN . . . . . 0.469 ' ND2' ' HA ' ' A' 1518 ' ' VAL . 23.1 p-10 -100.46 20.87 14.12 Favored 'General case' 0 C--N 1.307 -1.257 0 CA-C-N 114.347 -1.297 . . . . 3.08 110.497 -178.97 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A 1512 ' ' GLU . . . . . . . . . . . . . 32.7 tt0 -56.8 -52.09 66.41 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-N 115.914 -0.585 . . . . 4.46 110.733 179.895 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A 1513 ' ' HIS . . . . . . . . . . . . . 31.7 t-80 -140.54 -16.76 0.9 Allowed 'General case' 0 C--N 1.313 -0.982 0 CA-C-N 115.796 -0.638 . . . . 5.57 112.257 -179.767 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A 1514 ' ' ASP . . . . . . . . . . . . . 18.4 t70 -59.12 -62.01 2.2 Favored 'General case' 0 N--CA 1.47 0.542 0 N-CA-C 112.363 0.505 . . . . 3.7 112.363 -176.4 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A 1515 ' ' ASP . . . . . . . . . . . . . 16.3 t70 -120.81 146.71 46.25 Favored 'General case' 0 C--N 1.312 -1.022 0 N-CA-C 109.102 -0.703 . . . . 2.54 109.102 -177.495 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A 1516 ' ' CYS . . . . . 0.579 ' HB2' ' HD2' ' A' 1579 ' ' LYS . 8.0 t -79.63 74.07 6.31 Favored 'General case' 0 C--N 1.31 -1.152 0 CA-C-O 122.019 0.914 . . . . 1.25 110.181 -176.194 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A 1517 ' ' GLN . . . . . 0.471 ' HB2' HD21 ' A' 1526 ' ' LEU . 10.3 pt20 -151.12 159.28 44.57 Favored 'General case' 0 C--N 1.306 -1.29 0 CA-C-N 116.014 -0.539 . . . . 1.88 109.827 -179.397 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A 1518 ' ' VAL . . . . . 0.469 ' HA ' ' ND2' ' A' 1511 ' ' ASN . 7.5 p -151.5 139.69 14.29 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.496 0 N-CA-C 108.829 -0.804 . . . . 1.73 108.829 177.207 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A 1519 ' ' THR . . . . . 0.633 ' HA ' ' HA ' ' A' 1526 ' ' LEU . 15.2 m -87.14 122.67 31.27 Favored 'General case' 0 N--CA 1.42 -1.94 0 N-CA-C 107.482 -1.303 . . . . 1.7 107.482 176.88 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A 1520 ' ' ASN . . . . . . . . . . . . . 25.2 t-20 -78.74 115.34 51.15 Favored Pre-proline 0 C--N 1.318 -0.794 0 N-CA-C 108.612 -0.885 . . . . 2.12 108.612 179.393 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A 1521 ' ' PRO . . . . . . . . . . . . . 71.4 Cg_endo -72.27 -20.29 24.67 Favored 'Trans proline' 0 CA--C 1.533 0.437 0 C-N-CA 122.185 1.924 . . . . 2.47 113.715 -175.144 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A 1522 ' ' SER . . . . . . . . . . . . . 37.6 m -81.96 -37.44 26.67 Favored 'General case' 0 N--CA 1.436 -1.155 0 N-CA-C 112.648 0.61 . . . . 2.57 112.648 -175.642 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A 1523 ' ' THR . . . . . . . . . . . . . 8.8 t -103.63 -17.58 15.09 Favored 'General case' 0 CA--C 1.551 0.984 0 C-N-CA 120.005 -0.678 . . . . 2.15 111.35 176.987 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A 1524 ' ' GLY . . . . . . . . . . . . . . . 81.48 11.38 83.27 Favored Glycine 0 C--O 1.226 -0.391 0 C-N-CA 121.168 -0.539 . . . . 1.89 112.181 179.209 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A 1525 ' ' HIS . . . . . . . . . . . . . 57.1 t-80 -101.89 136.12 42.28 Favored 'General case' 0 C--N 1.304 -1.37 0 N-CA-C 108.182 -1.044 . . . . 1.9 108.182 -179.237 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A 1526 ' ' LEU . . . . . 0.633 ' HA ' ' HA ' ' A' 1519 ' ' THR . 5.1 tt -82.31 134.56 35.27 Favored 'General case' 0 C--N 1.293 -1.855 0 N-CA-C 106.512 -1.662 . . . . 1.61 106.512 177.621 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A 1527 ' ' PHE . . . . . 0.419 ' N ' HD23 ' A' 1526 ' ' LEU . 65.7 m-85 -110.85 112.34 24.12 Favored 'General case' 0 C--N 1.294 -1.834 0 CA-C-O 121.424 0.631 . . . . 1.42 111.072 177.889 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A 1528 ' ' ASP . . . . . . . . . . . . . 11.3 t70 -85.63 124.09 31.77 Favored 'General case' 0 C--N 1.312 -1.051 0 CA-C-N 114.525 -1.216 . . . . 2.18 111.092 179.453 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A 1529 ' ' LEU . . . . . . . . . . . . . 9.9 mp -116.62 18.45 14.98 Favored 'General case' 0 C--N 1.313 -0.986 0 CA-C-N 115.801 -0.636 . . . . 1.44 109.285 175.006 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A 1530 ' ' SER . . . . . . . . . . . . . 47.9 m -98.38 -29.08 13.34 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-O 121.246 0.546 . . . . 1.44 111.419 -178.404 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A 1531 ' ' SER . . . . . . . . . . . . . 3.4 m -96.02 -9.71 30.32 Favored 'General case' 0 C--N 1.302 -1.493 0 CA-C-O 121.148 0.499 . . . . 1.5 110.421 -178.556 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A 1532 ' ' LEU . . . . . . . . . . . . . 78.5 mt -65.64 -40.92 93.03 Favored 'General case' 0 CA--C 1.543 0.695 0 N-CA-C 114.169 1.174 . . . . 1.77 114.169 -178.686 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A 1533 ' ' SER . . . . . 0.759 ' HB2' ' HB ' ' A' 1552 ' ' ILE . 7.2 t -101.01 126.78 47.7 Favored 'General case' 0 C--N 1.302 -1.477 0 N-CA-C 108.861 -0.792 . . . . 2.38 108.861 -178.137 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A 1534 ' ' GLY . . . . . . . . . . . . . . . -104.57 -122.53 5.1 Favored Glycine 0 N--CA 1.425 -2.037 0 CA-C-N 115.883 -0.599 . . . . 1.55 112.466 -179.957 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A 1535 ' ' ARG . . . . . . . . . . . . . 20.5 tpt180 -81.79 -56.98 3.64 Favored 'General case' 0 C--N 1.302 -1.48 0 CA-C-O 120.875 0.369 . . . . 3.96 111.178 -176.446 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A 1536 ' ' ALA . . . . . . . . . . . . . . . -91.49 -45.45 8.52 Favored 'General case' 0 C--N 1.307 -1.25 0 C-N-CA 120.456 -0.497 . . . . 1.65 111.65 -174.258 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A 1537 ' ' GLY . . . . . . . . . . . . . . . 100.15 -138.22 13.73 Favored Glycine 0 N--CA 1.429 -1.794 0 N-CA-C 110.894 -0.882 . . . . 1.19 110.894 -179.212 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A 1538 ' ' PHE . . . . . . . . . . . . . 74.6 m-85 -138.1 172.99 12.11 Favored 'General case' 0 C--N 1.316 -0.88 0 N-CA-C 107.705 -1.22 . . . . 1.69 107.705 -178.821 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A 1539 ' ' THR . . . . . . . . . . . . . 6.6 t -147.41 151.71 36.92 Favored 'General case' 0 C--N 1.299 -1.59 0 C-N-CA 119.384 -0.926 . . . . 1.48 111.21 -177.072 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A 1540 ' ' ALA . . . . . . . . . . . . . . . -132.19 135.47 46.36 Favored 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 108.543 -0.91 . . . . 0.83 108.543 177.945 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A 1541 ' ' ALA . . . . . . . . . . . . . . . -80.45 152.2 28.89 Favored 'General case' 0 C--N 1.317 -0.827 0 CA-C-O 121.033 0.444 . . . . 1.27 110.855 -179.086 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A 1542 ' ' TYR . . . . . . . . . . . . . 30.3 t80 -149.36 177.62 9.51 Favored 'General case' 0 N--CA 1.425 -1.689 0 N-CA-C 108.48 -0.933 . . . . 2.15 108.48 -177.903 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A 1543 ' ' SER . . . . . . . . . . . . . 4.5 m -48.69 -151.16 0.0 OUTLIER 'General case' 0 CA--C 1.58 2.132 0 C-N-CA 128.71 2.804 . . . . 2.29 113.28 178.173 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A 1544 ' ' LYS . . . . . . . . . . . . . 27.5 ttpp -43.18 -26.26 0.16 Allowed 'General case' 0 N--CA 1.495 1.8 0 O-C-N 120.607 -1.308 . . . . 3.91 113.322 178.365 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A 1545 ' ' SER . . . . . . . . . . . . . 7.1 m -64.68 -22.02 66.88 Favored 'General case' 0 CA--C 1.569 1.677 0 C-N-CA 123.134 0.574 . . . . 3.3 111.541 175.633 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A 1546 ' ' GLY . . . . . . . . . . . . . . . 91.45 -78.68 1.33 Allowed Glycine 0 N--CA 1.438 -1.174 0 N-CA-C 114.127 0.411 . . . . 1.24 114.127 173.518 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A 1547 ' ' VAL . . . . . . . . . . . . . 10.0 p -159.37 147.42 7.19 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.043 0 N-CA-C 107.057 -1.46 . . . . 1.63 107.057 -176.071 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A 1548 ' ' VAL . . . . . . . . . . . . . 1.6 t -116.57 129.22 73.42 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.946 0 N-CA-C 108.319 -0.993 . . . . 0.92 108.319 -177.338 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A 1549 ' ' TYR . . . . . 0.494 ' CE2' ' HA3' ' A' 1568 ' ' GLY . 79.3 m-85 -85.44 120.38 26.84 Favored 'General case' 0 CA--C 1.494 -1.184 0 N-CA-C 107.315 -1.365 . . . . 1.44 107.315 174.839 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A 1550 ' ' MET . . . . . . . . . . . . . 88.7 mmm -124.76 121.29 34.19 Favored 'General case' 0 C--N 1.298 -1.654 0 N-CA-C 109.707 -0.479 . . . . 1.74 109.707 -173.579 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A 1551 ' ' SER . . . . . . . . . . . . . 50.4 m -89.96 158.62 17.3 Favored 'General case' 0 C--N 1.286 -2.158 0 N-CA-C 108.41 -0.959 . . . . 1.64 108.41 175.622 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A 1552 ' ' ILE . . . . . 0.759 ' HB ' ' HB2' ' A' 1533 ' ' SER . 38.8 mm -74.14 -60.57 2.26 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.299 0 C-N-CA 119.228 -0.989 . . . . 1.33 108.507 -179.871 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A 1553 ' ' CYS . . . . . 0.406 ' SG ' ' HG3' ' A' 1579 ' ' LYS . 34.9 t -151.16 141.99 22.86 Favored 'General case' 0 N--CA 1.421 -1.92 0 N-CA-C 104.402 -2.444 . . . . 1.43 104.402 178.663 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A 1554 ' ' GLY . . . . . . . . . . . . . . . 104.81 -172.34 19.93 Favored Glycine 0 C--N 1.291 -1.951 0 C-N-CA 119.666 -1.254 . . . . 1.12 111.073 -177.504 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A 1555 ' ' GLU . . . . . . . . . . . . . 8.9 pt-20 -98.67 142.4 30.28 Favored 'General case' 0 C--N 1.308 -1.219 0 N-CA-C 113.656 0.984 . . . . 1.8 113.656 -173.009 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A 1556 ' ' ASN . . . . . 0.419 ' O ' ' HA ' ' A' 1561 ' ' PRO . 19.3 t-20 -94.15 145.68 24.52 Favored 'General case' 0 C--N 1.309 -1.168 0 CA-C-N 113.707 -1.588 . . . . 2.63 108.216 -179.398 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A 1557 ' ' GLU . . . . . . . . . . . . . 58.1 mm-40 -112.39 -9.47 13.84 Favored 'General case' 0 C--N 1.305 -1.35 0 O-C-N 123.464 0.478 . . . . 3.79 111.525 -174.618 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A 1558 ' ' ASN . . . . . . . . . . . . . 18.4 m-80 -85.49 2.58 44.11 Favored 'General case' 0 N--CA 1.489 1.488 0 CA-C-O 121.91 0.862 . . . . 1.52 111.519 -177.972 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A 1559 ' ' CYS . . . . . 0.802 ' HB3' ' HD2' ' A' 1560 ' ' PRO . 47.3 m -145.46 -175.93 0.51 Allowed Pre-proline 0 C--N 1.288 -2.097 0 N-CA-C 105.192 -2.151 . . . . 0.84 105.192 175.51 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A 1560 ' ' PRO . . . . . 0.802 ' HD2' ' HB3' ' A' 1559 ' ' CYS . 1.6 Cg_endo -44.48 112.84 0.38 Allowed 'Trans proline' 0 C--N 1.376 2.01 0 C-N-CA 122.312 2.008 . . . . 1.18 112.255 177.285 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A 1561 ' ' PRO . . . . . 0.419 ' HA ' ' O ' ' A' 1556 ' ' ASN . 53.0 Cg_exo -57.67 110.62 0.65 Allowed 'Trans proline' 0 C--O 1.244 0.82 0 C-N-CA 122.97 2.447 . . . . 1.51 111.229 -177.233 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A 1562 ' ' GLY . . . . . . . . . . . . . . . 135.96 -16.4 3.96 Favored Glycine 0 C--N 1.299 -1.483 0 N-CA-C 110.756 -0.938 . . . . 0.72 110.756 -176.544 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A 1563 ' ' VAL . . . . . 0.648 ' HA ' ' HA ' ' A' 1576 ' ' LYS . 4.9 m -94.02 160.96 2.64 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.236 0 N-CA-C 107.029 -1.471 . . . . 0.97 107.029 176.659 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A 1564 ' ' GLY . . . . . 0.489 ' HA3' ' CE2' ' A' 1592 ' ' TYR . . . -124.18 -5.08 7.5 Favored Glycine 0 C--O 1.238 0.403 0 C-N-CA 119.125 -1.512 . . . . 0.72 113.162 -177.06 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A 1565 ' ' ALA . . . . . . . . . . . . . . . -150.18 127.24 11.2 Favored 'General case' 0 C--O 1.251 1.14 0 N-CA-C 108.808 -0.812 . . . . 0.37 108.808 179.867 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A 1566 ' ' CYS . . . . . . . . . . . . . 9.8 t -159.13 142.92 15.04 Favored 'General case' 0 C--N 1.308 -1.201 0 CA-C-N 116.258 -0.428 . . . . 0.51 111.062 -172.755 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A 1567 ' ' PHE . . . . . . . . . . . . . 24.9 m-85 -73.31 123.24 23.37 Favored 'General case' 0 CA--C 1.508 -0.668 0 N-CA-C 107.224 -1.398 . . . . 0.97 107.224 175.789 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A 1568 ' ' GLY . . . . . 0.494 ' HA3' ' CE2' ' A' 1549 ' ' TYR . . . -79.26 -25.47 59.28 Favored Glycine 0 C--N 1.3 -1.426 0 C-N-CA 120.052 -1.07 . . . . 1.08 114.785 -171.688 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A 1569 ' ' GLN . . . . . . . . . . . . . 8.1 tp-100 -71.08 -46.03 62.62 Favored 'General case' 0 C--N 1.306 -1.303 0 C-N-CA 119.937 -0.705 . . . . 2.74 110.934 -179.179 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A 1570 ' ' THR . . . . . . . . . . . . . 38.3 p -95.83 -13.14 24.27 Favored 'General case' 0 C--N 1.306 -1.309 0 N-CA-C 112.333 0.494 . . . . 1.96 112.333 -177.154 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A 1571 ' ' ARG . . . . . . . . . . . . . 79.4 mtm180 60.63 37.39 19.29 Favored 'General case' 0 C--O 1.246 0.869 0 C-N-CA 124.753 1.221 . . . . 3.95 112.798 -177.303 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A 1572 ' ' ILE . . . . . . . . . . . . . 39.9 mm -101.03 110.69 28.55 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.378 0 CA-C-N 114.458 -1.246 . . . . 1.37 108.2 177.941 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A 1573 ' ' SER . . . . . . . . . . . . . 29.1 t -67.68 133.73 49.85 Favored 'General case' 0 C--N 1.294 -1.836 0 CA-C-N 114.548 -1.206 . . . . 1.08 111.016 -179.971 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A 1574 ' ' VAL . . . . . 0.511 ' HB ' ' HB2' ' A' 1606 ' ' TYR . 34.8 m -108.23 -33.39 2.55 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.309 0 C-N-CA 120.602 -0.439 . . . . 1.3 111.009 -179.815 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A 1575 ' ' GLY . . . . . . . . . . . . . . . -140.11 130.88 4.83 Favored Glycine 0 N--CA 1.433 -1.512 0 C-N-CA 120.364 -0.922 . . . . 0.51 112.67 -177.692 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A 1576 ' ' LYS . . . . . 0.648 ' HA ' ' HA ' ' A' 1563 ' ' VAL . 88.4 tttt -79.75 151.15 30.54 Favored 'General case' 0 C--N 1.313 -1.009 0 N-CA-C 108.32 -0.993 . . . . 2.9 108.32 178.698 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A 1577 ' ' ALA . . . . . . . . . . . . . . . -70.71 98.17 1.48 Allowed 'General case' 0 CA--C 1.508 -0.662 0 CA-C-O 121.245 0.545 . . . . 0.83 111.119 -175.988 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A 1578 ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -101.66 115.93 31.62 Favored 'General case' 0 C--N 1.296 -1.753 0 N-CA-C 107.118 -1.438 . . . . 1.85 107.118 175.97 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A 1579 ' ' LYS . . . . . 0.579 ' HD2' ' HB2' ' A' 1516 ' ' CYS . 38.4 ttpt -91.34 89.72 7.4 Favored 'General case' 0 C--N 1.3 -1.578 0 N-CA-C 108.085 -1.08 . . . . 1.9 108.085 179.532 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A 1580 ' ' ARG . . . . . . . . . . . . . 14.4 tpp180 -156.43 116.93 3.67 Favored 'General case' 0 N--CA 1.419 -1.976 0 CA-C-N 114.459 -1.246 . . . . 3.63 108.556 -176.11 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A 1581 ' ' LEU . . . . . . . . . . . . . 2.9 pp -113.37 150.65 32.33 Favored 'General case' 0 C--N 1.297 -1.688 0 C-N-CA 120.515 -0.474 . . . . 1.87 111.236 178.145 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A 1582 ' ' ARG . . . . . . . . . . . . . 41.2 ttm180 -130.12 109.75 11.07 Favored 'General case' 0 C--N 1.295 -1.781 0 CA-C-N 115.603 -0.726 . . . . 3.97 109.912 -178.625 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A 1583 ' ' TYR . . . . . . . . . . . . . 79.6 t80 -94.84 104.12 16.02 Favored 'General case' 0 C--N 1.296 -1.746 0 N-CA-C 108.443 -0.947 . . . . 1.41 108.443 178.801 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A 1584 ' ' VAL . . . . . 0.482 ' O ' HG12 ' A' 1587 ' ' VAL . 7.0 p -130.78 111.2 19.76 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.403 0 C-N-CA 120.358 -0.537 . . . . 1.69 112.0 -177.584 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A 1585 ' ' ASP . . . . . . . . . . . . . 18.7 t70 59.98 59.16 2.5 Favored 'General case' 0 N--CA 1.481 1.078 0 CA-C-O 122.584 1.183 . . . . 2.06 110.976 177.171 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A 1586 ' ' GLN . . . . . . . . . . . . . 41.8 mt-30 57.35 23.53 9.01 Favored 'General case' 0 C--N 1.315 -0.916 0 N-CA-C 115.186 1.55 . . . . 2.33 115.186 179.087 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A 1587 ' ' VAL . . . . . 0.482 HG12 ' O ' ' A' 1584 ' ' VAL . 9.5 p -130.85 128.32 62.63 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.512 0 N-CA-C 108.757 -0.831 . . . . 0.78 108.757 173.482 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A 1588 ' ' LEU . . . . . 0.633 ' HB2' ' HB2' ' A' 1612 ' ' PHE . 8.1 mp -89.15 143.98 26.45 Favored 'General case' 0 N--CA 1.427 -1.58 0 CA-C-N 115.609 -0.723 . . . . 1.41 109.636 179.689 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A 1589 ' ' GLN . . . . . . . . . . . . . 7.7 tt0 -136.05 142.8 44.43 Favored 'General case' 0 C--N 1.28 -2.454 0 N-CA-C 108.872 -0.788 . . . . 1.24 108.872 178.136 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A 1590 ' ' LEU . . . . . . . . . . . . . 5.7 tt -139.19 133.83 31.94 Favored 'General case' 0 C--N 1.293 -1.861 0 N-CA-C 103.611 -2.737 . . . . 1.15 103.611 173.463 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A 1591 ' ' VAL . . . . . . . . . . . . . 7.3 p -130.9 127.61 61.59 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.496 0 N-CA-C 113.792 1.034 . . . . 1.51 113.792 -172.808 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A 1592 ' ' TYR . . . . . 0.489 ' CE2' ' HA3' ' A' 1564 ' ' GLY . 96.4 m-85 -101.33 139.9 36.37 Favored 'General case' 0 CA--C 1.495 -1.162 0 CA-C-N 114.581 -1.19 . . . . 1.06 107.86 177.412 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A 1593 ' ' LYS . . . . . . . . . . . . . 14.1 ptmm? -158.93 170.12 22.81 Favored 'General case' 0 C--N 1.299 -1.595 0 C-N-CA 120.601 -0.44 . . . . 2.18 110.084 -179.125 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A 1594 ' ' ASP . . . . . . . . . . . . . 48.1 m-20 61.8 41.98 11.11 Favored 'General case' 0 C--N 1.312 -1.025 0 N-CA-C 114.774 1.398 . . . . 1.45 114.774 175.127 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A 1595 ' ' GLY . . . . . . . . . . . . . . . -77.49 -86.88 0.41 Allowed Glycine 0 N--CA 1.437 -1.258 0 N-CA-C 109.13 -1.588 . . . . 0.78 109.13 171.241 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A 1596 ' ' SER . . . . . . . . . . . . . 15.5 m -114.47 152.37 46.06 Favored Pre-proline 0 C--N 1.298 -1.635 0 N-CA-C 107.921 -1.14 . . . . 1.68 107.921 176.059 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A 1597 ' ' PRO . . . . . . . . . . . . . 28.1 Cg_exo -63.74 146.35 91.99 Favored 'Trans proline' 0 C--O 1.247 0.97 0 C-N-CA 122.929 2.42 . . . . 1.17 111.45 178.103 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A 1598 ' ' CYS . . . . . 0.469 ' HA ' ' HD3' ' A' 1599 ' ' PRO . 27.4 t -98.76 133.3 22.56 Favored Pre-proline 0 C--N 1.297 -1.696 0 N-CA-C 108.894 -0.78 . . . . 1.19 108.894 -178.486 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A 1599 ' ' PRO . . . . . 0.469 ' HD3' ' HA ' ' A' 1598 ' ' CYS . 32.1 Cg_exo -62.82 -21.62 73.22 Favored 'Trans proline' 0 C--N 1.359 1.129 0 C-N-CA 123.759 2.973 . . . . 1.59 112.941 179.801 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A 1600 ' ' SER . . . . . 0.56 ' HB3' ' SG ' ' A' 1634 ' ' CYS . 47.9 t -85.89 117.74 24.93 Favored 'General case' 0 N--CA 1.427 -1.606 0 N-CA-C 106.704 -1.591 . . . . 2.12 106.704 175.242 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A 1601 ' ' LYS . . . . . . . . . . . . . 48.4 mmtm 58.82 60.63 2.42 Favored 'General case' 0 C--O 1.245 0.865 0 O-C-N 123.988 0.805 . . . . 3.74 108.994 -176.484 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A 1602 ' ' SER . . . . . . . . . . . . . 23.3 t -53.37 112.27 0.86 Allowed 'General case' 0 C--O 1.247 0.969 0 CA-C-N 114.786 -1.097 . . . . 3.79 111.542 -174.846 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A 1603 ' ' GLY . . . . . . . . . . . . . . . 150.99 -33.84 0.94 Allowed Glycine 0 N--CA 1.43 -1.743 0 N-CA-C 108.137 -1.985 . . . . 2.0 108.137 -177.912 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A 1604 ' ' LEU . . . . . . . . . . . . . 2.5 pp -94.59 164.16 13.09 Favored 'General case' 0 N--CA 1.427 -1.585 0 CA-C-N 114.644 -0.778 . . . . 1.48 109.567 175.87 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A 1605 ' ' SER . . . . . . . . . . . . . 19.0 p -109.42 -167.08 1.16 Allowed 'General case' 0 C--N 1.286 -2.19 0 N-CA-C 109.371 -0.603 . . . . 1.51 109.371 -178.82 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A 1606 ' ' TYR . . . . . 0.511 ' HB2' ' HB ' ' A' 1574 ' ' VAL . 61.1 m-85 -97.45 144.79 26.83 Favored 'General case' 0 N--CA 1.413 -2.32 0 N-CA-C 104.466 -2.42 . . . . 1.18 104.466 179.07 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A 1607 ' ' LYS . . . . . 0.471 ' HG3' HG23 ' A' 1635 ' ' THR . 19.2 ptmt -132.38 132.98 43.4 Favored 'General case' 0 C--N 1.268 -2.968 0 C-N-CA 118.655 -1.218 . . . . 1.67 109.422 177.283 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A 1608 ' ' SER . . . . . . . . . . . . . 20.2 m -115.69 111.72 21.02 Favored 'General case' 0 C--N 1.291 -1.945 0 C-N-CA 122.848 0.459 . . . . 1.0 110.694 -175.724 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A 1609 ' ' VAL . . . . . . . . . . . . . 96.5 t -92.34 121.38 42.87 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.069 0 N-CA-C 109.151 -0.685 . . . . 0.93 109.151 178.17 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A 1610 ' ' ILE . . . . . . . . . . . . . 17.0 mm -99.62 104.44 16.07 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.552 0 N-CA-C 107.871 -1.159 . . . . 0.78 107.871 177.11 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A 1611 ' ' SER . . . . . 0.478 ' O ' ' HA ' ' A' 1639 ' ' SER . 22.8 t -91.8 119.87 32.01 Favored 'General case' 0 N--CA 1.42 -1.957 0 N-CA-C 108.612 -0.884 . . . . 1.29 108.612 178.667 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A 1612 ' ' PHE . . . . . 0.633 ' HB2' ' HB2' ' A' 1588 ' ' LEU . 97.4 m-85 -95.85 108.73 21.11 Favored 'General case' 0 C--N 1.297 -1.696 0 CA-C-N 115.548 -0.751 . . . . 0.7 109.678 -178.776 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A 1613 ' ' VAL . . . . . . . . . . . . . 48.0 t -100.56 122.14 52.19 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.012 0 CA-C-N 115.409 -0.814 . . . . 0.75 109.544 -176.891 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A 1614 ' ' CYS . . . . . 0.671 ' HA ' ' O ' ' A' 1642 ' ' THR . 0.8 OUTLIER -76.68 100.6 5.45 Favored 'General case' 0 CA--C 1.5 -0.977 0 N-CA-C 113.178 0.807 . . . . 1.39 113.178 177.289 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A 1615 ' ' ARG . . . . . 0.497 ' HD3' ' HD2' ' A' 1616 ' ' PRO . 14.0 tpp180 -137.71 116.77 9.96 Favored Pre-proline 0 N--CA 1.414 -2.27 0 CA-C-N 114.851 -1.068 . . . . 3.75 108.411 177.103 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A 1616 ' ' PRO . . . . . 0.497 ' HD2' ' HD3' ' A' 1615 ' ' ARG . 56.6 Cg_exo -58.16 52.13 0.05 OUTLIER 'Trans proline' 0 CA--C 1.553 1.463 0 C-N-CA 124.788 3.659 . . . . 1.32 114.717 174.636 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A 1617 ' ' GLU . . . . . . . . . . . . . 44.0 tt0 -104.26 -13.87 16.01 Favored 'General case' 0 C--N 1.31 -1.143 0 N-CA-C 108.2 -1.037 . . . . 3.21 108.2 176.628 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A 1618 ' ' ALA . . . . . . . . . . . . . . . 59.73 -173.07 0.11 Allowed 'General case' 0 N--CA 1.47 0.532 0 CA-C-N 113.719 -1.582 . . . . 2.44 112.548 177.225 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A 1619 ' ' GLY . . . . . . . . . . . . . . . 98.6 103.93 2.41 Favored Glycine 0 N--CA 1.434 -1.458 0 C-N-CA 120.938 -0.649 . . . . 3.26 112.367 177.45 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A 1620 ' ' PRO . . . . . 0.853 ' HA ' ' HZ2' ' A' 1640 ' ' TRP . 18.4 Cg_exo -69.75 -17.78 37.41 Favored 'Trans proline' 0 CA--C 1.539 0.771 0 C-N-CA 122.531 2.154 . . . . 5.92 111.993 178.292 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A 1621 ' ' THR . . . . . . . . . . . . . 31.2 m -102.52 -0.31 32.41 Favored 'General case' 0 C--N 1.314 -0.955 0 N-CA-C 108.663 -0.866 . . . . 4.76 108.663 178.044 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A 1622 ' ' ASN . . . . . 0.464 ' C ' ' HD3' ' A' 1624 ' ' PRO . 61.0 t30 -77.16 47.79 0.57 Allowed 'General case' 0 C--O 1.247 0.934 0 CA-C-O 121.894 0.854 . . . . 2.92 112.578 -174.592 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A 1623 ' ' ARG . . . . . 0.5 ' HB3' ' CD1' ' A' 1640 ' ' TRP . 9.2 ptm180 -123.72 69.6 45.63 Favored Pre-proline 0 N--CA 1.434 -1.237 0 C-N-CA 119.572 -0.851 . . . . 3.61 112.043 178.62 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A 1624 ' ' PRO . . . . . 0.464 ' HD3' ' C ' ' A' 1622 ' ' ASN . 64.4 Cg_endo -114.41 91.18 0.01 OUTLIER 'Trans proline' 0 N--CA 1.426 -2.491 0 C-N-CA 122.446 2.098 . . . . 2.37 110.09 167.61 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A 1625 ' ' MET . . . . . 0.563 ' HG3' HG23 ' A' 1627 ' ' ILE . 12.9 tpt -151.78 98.77 2.51 Favored 'General case' 0 C--N 1.297 -1.714 0 C-N-CA 116.939 -1.905 . . . . 2.16 112.236 -179.389 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A 1626 ' ' LEU . . . . . . . . . . . . . 4.4 mm? -87.85 88.99 7.82 Favored 'General case' 0 C--N 1.302 -1.494 0 N-CA-C 108.518 -0.919 . . . . 1.35 108.518 171.321 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A 1627 ' ' ILE . . . . . 0.563 HG23 ' HG3' ' A' 1625 ' ' MET . 37.0 pt -73.42 -35.18 45.11 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.872 0 CA-C-N 115.875 -0.602 . . . . 1.21 110.956 -178.293 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A 1628 ' ' SER . . . . . . . . . . . . . 22.9 t -161.67 152.43 17.87 Favored 'General case' 0 N--CA 1.414 -2.268 0 N-CA-C 107.628 -1.249 . . . . 1.4 107.628 -178.242 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A 1629 ' ' LEU . . . . . 0.573 ' HG ' ' HG ' ' A' 1636 ' ' LEU . 5.1 tt -146.72 111.99 5.49 Favored 'General case' 0 C--N 1.286 -2.166 0 N-CA-C 106.041 -1.837 . . . . 1.56 106.041 175.843 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A 1630 ' ' ASP . . . . . 0.418 ' HB3' ' HB ' ' A' 1635 ' ' THR . 14.0 t70 -84.81 99.66 11.04 Favored 'General case' 0 C--N 1.292 -1.915 0 N-CA-C 106.741 -1.577 . . . . 0.87 106.741 -179.544 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A 1631 ' ' LYS . . . . . 0.429 ' HG2' HD22 ' A' 1629 ' ' LEU . 47.1 mtmt -72.79 -19.17 61.39 Favored 'General case' 0 C--N 1.306 -1.324 0 CA-C-N 115.941 -0.572 . . . . 2.35 112.373 -173.304 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A 1632 ' ' GLN . . . . . . . . . . . . . 2.8 mp0 -73.68 -51.45 16.64 Favored 'General case' 0 C--N 1.313 -0.985 0 C-N-CA 121.01 -0.276 . . . . 2.55 110.719 179.616 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A 1633 ' ' THR . . . . . . . . . . . . . 35.7 p -97.36 14.03 27.62 Favored 'General case' 0 C--N 1.316 -0.858 0 CA-C-O 121.357 0.599 . . . . 1.24 111.917 -179.706 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A 1634 ' ' CYS . . . . . 0.56 ' SG ' ' HB3' ' A' 1600 ' ' SER . 65.9 m 50.01 45.58 25.18 Favored 'General case' 0 N--CA 1.475 0.813 0 C-N-CA 124.966 1.307 . . . . 0.89 112.244 177.744 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A 1635 ' ' THR . . . . . 0.471 HG23 ' HG3' ' A' 1607 ' ' LYS . 25.5 m -107.14 107.51 18.52 Favored 'General case' 0 N--CA 1.428 -1.574 0 CA-C-N 114.89 -1.05 . . . . 0.75 109.831 -176.609 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A 1636 ' ' LEU . . . . . 0.573 ' HG ' ' HG ' ' A' 1629 ' ' LEU . 4.9 mp -95.11 127.88 41.51 Favored 'General case' 0 C--N 1.309 -1.182 0 N-CA-C 109.434 -0.58 . . . . 1.33 109.434 -177.505 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A 1637 ' ' PHE . . . . . . . . . . . . . 95.6 m-85 -109.36 110.85 22.11 Favored 'General case' 0 C--N 1.314 -0.939 0 CA-C-O 120.941 0.401 . . . . 0.83 110.305 -179.12 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A 1638 ' ' PHE . . . . . 0.424 ' HA ' ' O ' ' A' 1625 ' ' MET . 92.6 m-85 -105.41 159.32 16.01 Favored 'General case' 0 C--N 1.315 -0.933 0 N-CA-C 109.393 -0.595 . . . . 0.6 109.393 179.583 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A 1639 ' ' SER . . . . . 0.478 ' HA ' ' O ' ' A' 1611 ' ' SER . 50.1 m -142.09 144.85 33.74 Favored 'General case' 0 C--N 1.299 -1.599 0 CA-C-O 120.841 0.353 . . . . 1.08 110.885 175.713 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A 1640 ' ' TRP . . . . . 0.853 ' HZ2' ' HA ' ' A' 1620 ' ' PRO . 12.4 t90 -118.95 137.79 53.25 Favored 'General case' 0 C--N 1.323 -0.551 0 N-CA-C 106.939 -1.504 . . . . 0.8 106.939 176.871 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A 1641 ' ' HIS . . . . . . . . . . . . . 38.9 m-70 -98.87 98.09 9.21 Favored 'General case' 0 C--N 1.314 -0.937 0 N-CA-C 105.966 -1.864 . . . . 2.54 105.966 179.075 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A 1642 ' ' THR . . . . . 0.671 ' O ' ' HA ' ' A' 1614 ' ' CYS . 9.8 t -142.24 139.21 17.47 Favored Pre-proline 0 C--N 1.305 -1.359 0 N-CA-C 113.459 0.911 . . . . 1.15 113.459 -171.686 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A 1643 ' ' PRO . . . . . 0.512 ' HD3' ' HA ' ' A' 1642 ' ' THR . 4.4 Cg_exo -79.42 -6.77 14.77 Favored 'Trans proline' 0 C--N 1.355 0.894 0 C-N-CA 123.462 2.775 . . . . 0.8 110.385 173.574 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A 1644 ' ' LEU . . . . . . . . . . . . . 65.8 mt -89.13 5.32 45.14 Favored 'General case' 0 N--CA 1.443 -0.797 0 CA-C-N 115.229 -0.896 . . . . 1.54 110.249 -177.693 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A 1645 ' ' ALA . . . . . . . . . . . . . . . -97.18 -44.36 6.98 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-O 121.619 0.724 . . . . 0.95 109.642 176.46 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A 1646 ' ' CYS . . . . . . . . . . . . . 0.6 OUTLIER -171.41 173.91 4.64 Favored 'General case' 0 C--N 1.303 -1.441 0 N-CA-C 107.69 -1.226 . . . . 1.41 107.69 -178.063 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A 1647 ' ' GLU . . . . . . . . . . . . . 51.8 mt-10 -132.47 111.63 13.91 Favored Pre-proline 0 C--N 1.303 -1.432 0 N-CA-C 108.519 -0.919 . . . . 2.92 108.519 -178.787 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A 1648 ' ' PRO . . . . . . . . . . . . . 23.9 Cg_exo -67.47 101.03 0.6 Allowed 'Trans proline' 0 C--O 1.245 0.828 0 C-N-CA 122.211 1.941 . . . . 2.82 110.51 178.875 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A 1649 ' ' GLU . . . . . . . . . . . . . 14.1 tp10 . . . . . 0 N--CA 1.427 -1.62 0 N-CA-C 108.012 -1.107 . . . . 5.06 108.012 -178.341 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A 1508 ' ' MET . . . . . . . . . . . . . 23.8 ptp . . . . . 0 CA--C 1.533 0.292 0 N-CA-C 112.027 0.38 . . . . 8.27 112.027 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A 1509 ' ' LYS . . . . . . . . . . . . . 22.3 pttp -139.15 27.31 2.36 Favored 'General case' 0 C--N 1.327 -0.41 0 O-C-N 121.711 -0.618 . . . . 6.48 110.607 -177.356 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A 1510 ' ' SER . . . . . . . . . . . . . 26.0 p -144.51 144.15 31.2 Favored 'General case' 0 C--N 1.299 -1.62 0 N-CA-C 108.97 -0.752 . . . . 4.22 108.97 -176.753 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A 1511 ' ' ASN . . . . . 0.445 ' HB2' ' HG3' ' A' 1517 ' ' GLN . 28.4 p30 -140.75 -19.77 0.82 Allowed 'General case' 0 C--N 1.307 -1.246 0 N-CA-C 114.103 1.149 . . . . 3.08 114.103 -177.458 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A 1512 ' ' GLU . . . . . 0.468 ' HG2' HG23 ' A' 1518 ' ' VAL . 47.2 mt-10 -61.38 -28.28 69.13 Favored 'General case' 0 N--CA 1.486 1.373 0 CA-C-O 121.312 0.577 . . . . 4.46 112.491 -176.429 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A 1513 ' ' HIS . . . . . 0.461 ' HA ' ' O ' ' A' 1579 ' ' LYS . 35.4 m-70 -122.38 -9.06 8.59 Favored 'General case' 0 C--N 1.315 -0.92 0 CA-C-O 121.053 0.454 . . . . 5.57 110.611 176.793 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A 1514 ' ' ASP . . . . . 0.428 ' HB2' ' HA ' ' A' 1511 ' ' ASN . 2.2 m-20 -92.06 -31.53 15.52 Favored 'General case' 0 C--N 1.307 -1.27 0 N-CA-C 112.416 0.524 . . . . 3.7 112.416 -175.721 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A 1515 ' ' ASP . . . . . 0.57 ' HB3' ' HG2' ' A' 1517 ' ' GLN . 7.5 t70 -141.15 -171.77 3.35 Favored 'General case' 0 C--N 1.295 -1.799 0 N-CA-C 105.781 -1.933 . . . . 2.54 105.781 -177.347 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A 1516 ' ' CYS . . . . . . . . . . . . . 72.8 m -104.34 51.5 0.77 Allowed 'General case' 0 C--N 1.27 -2.865 0 N-CA-C 108.196 -1.039 . . . . 1.25 108.196 -179.8 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A 1517 ' ' GLN . . . . . 0.57 ' HG2' ' HB3' ' A' 1515 ' ' ASP . 3.9 pt20 -151.64 171.38 17.72 Favored 'General case' 0 C--N 1.304 -1.377 0 N-CA-C 109.407 -0.59 . . . . 1.88 109.407 -177.316 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A 1518 ' ' VAL . . . . . 0.468 HG23 ' HG2' ' A' 1512 ' ' GLU . 8.5 p -154.23 140.6 11.91 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.404 0 N-CA-C 109.404 -0.591 . . . . 1.73 109.404 -179.414 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A 1519 ' ' THR . . . . . . . . . . . . . 19.1 m -100.76 130.74 46.83 Favored 'General case' 0 N--CA 1.423 -1.783 0 N-CA-C 107.895 -1.15 . . . . 1.7 107.895 177.097 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A 1520 ' ' ASN . . . . . 0.434 ' OD1' HG22 ' A' 1523 ' ' THR . 27.9 t-20 -90.03 121.35 68.88 Favored Pre-proline 0 C--N 1.3 -1.567 0 C-N-CA 120.236 -0.585 . . . . 2.12 109.868 178.295 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A 1521 ' ' PRO . . . . . . . . . . . . . 60.0 Cg_endo -73.09 -20.28 21.89 Favored 'Trans proline' 0 C--N 1.352 0.754 0 C-N-CA 122.089 1.86 . . . . 2.47 113.642 -175.797 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A 1522 ' ' SER . . . . . . . . . . . . . 48.1 m -77.0 -57.9 3.58 Favored 'General case' 0 C--N 1.316 -0.851 0 N-CA-C 111.981 0.363 . . . . 2.57 111.981 -177.95 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A 1523 ' ' THR . . . . . 0.434 HG22 ' OD1' ' A' 1520 ' ' ASN . 8.9 t -90.71 -14.81 31.45 Favored 'General case' 0 C--N 1.317 -0.835 0 CA-C-O 121.053 0.454 . . . . 2.15 111.134 -178.601 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A 1524 ' ' GLY . . . . . . . . . . . . . . . 76.13 14.32 82.39 Favored Glycine 0 C--O 1.226 -0.393 0 C-N-CA 120.873 -0.679 . . . . 1.89 112.478 178.932 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A 1525 ' ' HIS . . . . . . . . . . . . . 22.7 t60 -100.75 137.65 38.85 Favored 'General case' 0 C--N 1.309 -1.183 0 N-CA-C 108.143 -1.058 . . . . 1.9 108.143 -177.57 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A 1526 ' ' LEU . . . . . . . . . . . . . 7.7 tt -100.0 136.37 40.01 Favored 'General case' 0 C--N 1.297 -1.707 0 N-CA-C 108.604 -0.887 . . . . 1.61 108.604 -178.451 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A 1527 ' ' PHE . . . . . . . . . . . . . 88.2 m-85 -110.46 126.16 54.04 Favored 'General case' 0 C--N 1.3 -1.554 0 N-CA-C 107.792 -1.188 . . . . 1.42 107.792 178.618 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A 1528 ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -114.71 143.64 44.74 Favored 'General case' 0 C--N 1.309 -1.179 0 CA-C-O 122.021 0.915 . . . . 2.18 112.104 -178.932 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A 1529 ' ' LEU . . . . . . . . . . . . . 3.1 mm? -122.33 16.68 10.59 Favored 'General case' 0 C--N 1.292 -1.896 0 N-CA-C 105.047 -2.205 . . . . 1.44 105.047 168.963 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A 1530 ' ' SER . . . . . . . . . . . . . 12.7 m -74.04 -37.48 64.29 Favored 'General case' 0 N--CA 1.435 -1.219 0 CA-C-N 113.727 -1.579 . . . . 1.44 108.681 -179.157 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A 1531 ' ' SER . . . . . . . . . . . . . 9.6 m -75.0 -21.61 59.03 Favored 'General case' 0 N--CA 1.433 -1.32 0 N-CA-C 108.801 -0.814 . . . . 1.5 108.801 176.515 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A 1532 ' ' LEU . . . . . 0.488 HD11 HD21 ' A' 1644 ' ' LEU . 90.2 mt -96.29 11.23 35.36 Favored 'General case' 0 CA--C 1.52 -0.21 0 CA-C-N 115.638 -0.71 . . . . 1.77 112.238 178.239 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A 1533 ' ' SER . . . . . . . . . . . . . 34.0 m -69.47 114.46 7.72 Favored 'General case' 0 N--CA 1.435 -1.212 0 N-CA-C 107.622 -1.251 . . . . 2.38 107.622 176.479 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A 1534 ' ' GLY . . . . . . . . . . . . . . . -82.47 151.11 29.18 Favored Glycine 0 N--CA 1.426 -2.005 0 CA-C-N 115.615 -0.721 . . . . 1.55 113.993 -170.209 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A 1535 ' ' ARG . . . . . 0.465 ' C ' ' HD3' ' A' 1535 ' ' ARG . 1.2 tmt_? -95.88 -61.57 1.43 Allowed 'General case' 0 N--CA 1.426 -1.644 0 N-CA-C 106.885 -1.524 . . . . 3.96 106.885 174.821 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A 1536 ' ' ALA . . . . . . . . . . . . . . . -94.87 -23.01 17.65 Favored 'General case' 0 C--N 1.312 -1.056 0 CA-C-N 115.458 -0.792 . . . . 1.65 109.023 177.195 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A 1537 ' ' GLY . . . . . . . . . . . . . . . 91.25 -167.75 31.75 Favored Glycine 0 N--CA 1.427 -1.962 0 CA-C-N 115.623 -0.717 . . . . 1.19 113.862 174.492 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A 1538 ' ' PHE . . . . . . . . . . . . . 81.6 m-85 -108.46 168.3 9.42 Favored 'General case' 0 C--N 1.298 -1.661 0 C-N-CA 125.574 1.55 . . . . 1.69 107.661 -179.321 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A 1539 ' ' THR . . . . . . . . . . . . . 14.5 p -117.05 112.7 21.3 Favored 'General case' 0 C--N 1.297 -1.714 0 CA-C-O 120.925 0.393 . . . . 1.48 110.273 179.809 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A 1540 ' ' ALA . . . . . . . . . . . . . . . -102.17 143.96 31.32 Favored 'General case' 0 C--N 1.303 -1.435 0 N-CA-C 108.05 -1.093 . . . . 0.83 108.05 178.741 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A 1541 ' ' ALA . . . . . . . . . . . . . . . -91.01 156.64 17.8 Favored 'General case' 0 C--N 1.294 -1.826 0 CA-C-O 121.982 0.896 . . . . 1.27 112.844 -173.819 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A 1542 ' ' TYR . . . . . 0.73 ' HB3' ' HA3' ' A' 1546 ' ' GLY . 68.5 t80 -147.44 171.69 15.11 Favored 'General case' 0 C--N 1.296 -1.761 0 N-CA-C 102.746 -3.057 . . . . 2.15 102.746 175.006 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A 1543 ' ' SER . . . . . . . . . . . . . 6.8 m -43.09 -161.88 0.0 OUTLIER 'General case' 0 CA--C 1.603 2.983 0 N-CA-C 117.119 2.266 . . . . 2.29 117.119 -173.769 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A 1544 ' ' LYS . . . . . . . . . . . . . 57.7 tttm -46.12 -38.05 7.65 Favored 'General case' 0 N--CA 1.479 0.997 0 O-C-N 120.669 -1.27 . . . . 3.91 113.24 -178.493 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A 1545 ' ' SER . . . . . . . . . . . . . 19.4 m -111.29 26.12 11.01 Favored 'General case' 0 C--N 1.3 -1.56 0 O-C-N 122.27 -0.269 . . . . 3.3 110.583 179.18 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A 1546 ' ' GLY . . . . . 0.73 ' HA3' ' HB3' ' A' 1542 ' ' TYR . . . -112.84 131.28 10.0 Favored Glycine 0 N--CA 1.412 -2.912 0 C-N-CA 117.879 -2.105 . . . . 1.24 116.311 -173.836 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A 1547 ' ' VAL . . . . . . . . . . . . . 9.1 p -162.07 119.46 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.567 0 N-CA-C 107.821 -1.177 . . . . 1.63 107.821 171.808 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A 1548 ' ' VAL . . . . . . . . . . . . . 2.1 t -115.29 129.23 71.88 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.814 0 N-CA-C 107.923 -1.14 . . . . 0.92 107.923 -175.599 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A 1549 ' ' TYR . . . . . 0.447 ' HB3' HD21 ' A' 1556 ' ' ASN . 96.3 m-85 -84.61 116.57 23.24 Favored 'General case' 0 N--CA 1.423 -1.783 0 N-CA-C 107.552 -1.277 . . . . 1.44 107.552 176.002 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A 1550 ' ' MET . . . . . . . . . . . . . 54.9 tpp -119.1 122.53 42.28 Favored 'General case' 0 C--N 1.29 -1.986 0 CA-C-N 115.379 -0.828 . . . . 1.74 110.551 -174.014 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A 1551 ' ' SER . . . . . . . . . . . . . 8.2 t -96.57 121.7 38.68 Favored 'General case' 0 C--N 1.285 -2.202 0 N-CA-C 103.527 -2.768 . . . . 1.64 103.527 171.263 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A 1552 ' ' ILE . . . . . . . . . . . . . 1.8 tp -62.14 -27.57 42.77 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.666 0 CA-C-O 121.38 0.609 . . . . 1.33 110.344 -172.166 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A 1553 ' ' CYS . . . . . 0.466 ' HA ' ' OH ' ' A' 1592 ' ' TYR . 23.0 t -162.39 138.39 7.48 Favored 'General case' 0 N--CA 1.415 -2.215 0 N-CA-C 105.479 -2.045 . . . . 1.43 105.479 167.494 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A 1554 ' ' GLY . . . . . . . . . . . . . . . 110.45 -166.85 12.46 Favored Glycine 0 C--N 1.292 -1.913 0 N-CA-C 110.018 -1.233 . . . . 1.12 110.018 -179.011 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A 1555 ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -99.69 156.93 16.82 Favored 'General case' 0 C--N 1.303 -1.448 0 CA-C-N 117.48 0.64 . . . . 1.8 111.109 -178.221 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A 1556 ' ' ASN . . . . . 0.447 HD21 ' HB3' ' A' 1549 ' ' TYR . 23.0 t-20 -111.47 109.37 19.28 Favored 'General case' 0 N--CA 1.423 -1.815 0 CA-C-N 115.34 -0.845 . . . . 2.63 109.269 -178.409 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A 1557 ' ' GLU . . . . . . . . . . . . . 25.6 mt-10 -87.91 54.42 3.09 Favored 'General case' 0 C--N 1.301 -1.525 0 N-CA-C 113.307 0.854 . . . . 3.79 113.307 -174.022 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A 1558 ' ' ASN . . . . . . . . . . . . . 32.9 m-80 -129.22 3.45 5.2 Favored 'General case' 0 C--N 1.306 -1.298 0 N-CA-C 107.94 -1.133 . . . . 1.52 107.94 174.615 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A 1559 ' ' CYS . . . . . 0.774 ' HB3' ' HD2' ' A' 1560 ' ' PRO . 69.3 m -153.98 177.84 1.84 Allowed Pre-proline 0 C--N 1.31 -1.146 0 N-CA-C 106.995 -1.483 . . . . 0.84 106.995 -177.911 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A 1560 ' ' PRO . . . . . 0.774 ' HD2' ' HB3' ' A' 1559 ' ' CYS . 15.9 Cg_exo -32.82 132.74 0.09 OUTLIER 'Trans proline' 0 C--N 1.381 2.246 0 C-N-CA 124.363 3.375 . . . . 1.18 114.955 177.615 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A 1561 ' ' PRO . . . . . 0.496 ' HD3' ' HA ' ' A' 1560 ' ' PRO . 35.9 Cg_exo -58.25 123.49 13.75 Favored 'Trans proline' 0 C--O 1.245 0.826 0 C-N-CA 122.916 2.411 . . . . 1.51 111.568 179.814 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A 1562 ' ' GLY . . . . . 0.428 ' O ' ' HD3' ' A' 1576 ' ' LYS . . . 109.48 -8.08 32.38 Favored Glycine 0 N--CA 1.436 -1.364 0 C-N-CA 120.288 -0.958 . . . . 0.72 114.163 178.247 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A 1563 ' ' VAL . . . . . . . . . . . . . 3.4 m -89.17 148.21 4.69 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.874 0 N-CA-C 107.962 -1.125 . . . . 0.97 107.962 178.286 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A 1564 ' ' GLY . . . . . . . . . . . . . . . -97.63 -23.14 14.44 Favored Glycine 0 CA--C 1.505 -0.573 0 C-N-CA 120.137 -1.03 . . . . 0.72 113.162 -174.441 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A 1565 ' ' ALA . . . . . . . . . . . . . . . -151.65 140.46 20.92 Favored 'General case' 0 C--N 1.31 -1.13 0 N-CA-C 109.137 -0.69 . . . . 0.37 109.137 -177.909 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A 1566 ' ' CYS . . . . . . . . . . . . . 48.0 t -161.77 147.65 13.64 Favored 'General case' 0 C--N 1.315 -0.92 0 CA-C-N 116.398 -0.365 . . . . 0.51 110.016 -175.526 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A 1567 ' ' PHE . . . . . 0.421 ' O ' ' HA ' ' A' 1571 ' ' ARG . 50.3 m-85 -74.73 152.16 39.11 Favored 'General case' 0 N--CA 1.471 0.583 0 N-CA-C 108.609 -0.885 . . . . 0.97 108.609 178.424 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A 1568 ' ' GLY . . . . . . . . . . . . . . . -89.07 -31.75 11.61 Favored Glycine 0 N--CA 1.447 -0.61 0 C-N-CA 120.499 -0.857 . . . . 1.08 114.125 -176.744 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A 1569 ' ' GLN . . . . . . . . . . . . . 8.9 tt0 -89.9 -56.93 3.04 Favored 'General case' 0 C--N 1.309 -1.183 0 N-CA-C 108.361 -0.977 . . . . 2.74 108.361 178.363 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A 1570 ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -68.79 -32.6 72.45 Favored 'General case' 0 N--CA 1.421 -1.88 0 CA-C-N 113.684 -1.598 . . . . 1.96 110.579 -175.921 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A 1571 ' ' ARG . . . . . 0.421 ' HA ' ' O ' ' A' 1567 ' ' PHE . 67.7 mtm180 46.29 55.76 7.01 Favored 'General case' 0 C--O 1.246 0.871 0 N-CA-C 113.176 0.806 . . . . 3.95 113.176 -179.252 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A 1572 ' ' ILE . . . . . . . . . . . . . 47.9 mm -109.7 126.05 66.86 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.384 0 N-CA-C 106.394 -1.706 . . . . 1.37 106.394 175.066 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A 1573 ' ' SER . . . . . . . . . . . . . 42.1 t -75.76 120.46 21.16 Favored 'General case' 0 C--N 1.298 -1.634 0 N-CA-C 108.973 -0.751 . . . . 1.08 108.973 179.496 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A 1574 ' ' VAL . . . . . 0.629 ' HB ' ' HB2' ' A' 1606 ' ' TYR . 34.5 m -90.88 -33.9 6.1 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.81 0 C-N-CA 119.401 -0.919 . . . . 1.3 110.827 179.948 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A 1575 ' ' GLY . . . . . . . . . . . . . . . -161.31 155.63 26.87 Favored Glycine 0 N--CA 1.424 -2.144 0 C-N-CA 120.047 -1.073 . . . . 0.51 113.747 -177.761 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A 1576 ' ' LYS . . . . . 0.428 ' HD3' ' O ' ' A' 1562 ' ' GLY . 17.0 tppt? -71.47 153.11 42.47 Favored 'General case' 0 C--N 1.311 -1.108 0 C-N-CA 125.814 1.646 . . . . 2.9 108.512 178.17 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A 1577 ' ' ALA . . . . . . . . . . . . . . . -65.16 74.9 0.05 Allowed 'General case' 0 N--CA 1.482 1.152 0 C-N-CA 123.629 0.771 . . . . 0.83 109.578 174.425 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A 1578 ' ' ASN . . . . . . . . . . . . . 61.8 t30 -89.81 131.67 35.64 Favored 'General case' 0 C--N 1.293 -1.878 0 C-N-CA 124.092 0.957 . . . . 1.85 111.303 -173.211 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A 1579 ' ' LYS . . . . . 0.461 ' O ' ' HA ' ' A' 1513 ' ' HIS . 2.4 mppt? -100.2 92.12 5.07 Favored 'General case' 0 C--N 1.292 -1.914 0 N-CA-C 108.771 -0.826 . . . . 1.9 108.771 175.56 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A 1580 ' ' ARG . . . . . 0.515 ' O ' ' HA ' ' A' 1590 ' ' LEU . 61.7 ttt180 -140.16 86.49 2.08 Favored 'General case' 0 C--N 1.289 -2.056 0 N-CA-C 107.536 -1.283 . . . . 3.63 107.536 176.735 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A 1581 ' ' LEU . . . . . 0.605 HD13 ' HB2' ' A' 1590 ' ' LEU . 20.6 tp -110.85 135.79 50.87 Favored 'General case' 0 C--N 1.297 -1.69 0 N-CA-C 108.672 -0.862 . . . . 1.87 108.672 -177.238 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A 1582 ' ' ARG . . . . . . . . . . . . . 57.5 ttp180 -136.79 140.4 42.49 Favored 'General case' 0 C--N 1.304 -1.384 0 N-CA-C 109.535 -0.542 . . . . 3.97 109.535 179.854 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A 1583 ' ' TYR . . . . . . . . . . . . . 74.2 t80 -112.17 92.89 4.19 Favored 'General case' 0 C--O 1.245 0.843 0 C-N-CA 122.896 0.478 . . . . 1.41 110.174 179.83 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A 1584 ' ' VAL . . . . . . . . . . . . . 28.5 m -137.51 147.22 26.63 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.293 0 N-CA-C 107.261 -1.385 . . . . 1.69 107.261 175.346 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A 1585 ' ' ASP . . . . . . . . . . . . . 19.0 t70 61.96 28.08 17.06 Favored 'General case' 0 N--CA 1.483 1.22 0 C-N-CA 124.246 1.018 . . . . 2.06 109.702 -179.672 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A 1586 ' ' GLN . . . . . . . . . . . . . 46.2 mt-30 53.98 34.16 19.05 Favored 'General case' 0 N--CA 1.466 0.354 0 C-N-CA 125.243 1.417 . . . . 2.33 113.474 -176.147 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A 1587 ' ' VAL . . . . . . . . . . . . . 8.1 p -132.13 123.56 50.98 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.692 0 CA-C-O 121.24 0.543 . . . . 0.78 110.021 176.266 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A 1588 ' ' LEU . . . . . 0.71 ' HB2' ' HB2' ' A' 1612 ' ' PHE . 80.1 mt -78.75 116.72 19.28 Favored 'General case' 0 C--N 1.312 -1.026 0 N-CA-C 107.392 -1.336 . . . . 1.41 107.392 174.695 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A 1589 ' ' GLN . . . . . . . . . . . . . 8.6 tt0 -118.2 124.78 48.76 Favored 'General case' 0 C--N 1.28 -2.432 0 CA-C-N 115.863 -0.608 . . . . 1.24 109.935 -177.316 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A 1590 ' ' LEU . . . . . 0.605 ' HB2' HD13 ' A' 1581 ' ' LEU . 7.5 tt -122.55 126.14 47.16 Favored 'General case' 0 C--N 1.302 -1.475 0 N-CA-C 106.876 -1.527 . . . . 1.15 106.876 178.761 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A 1591 ' ' VAL . . . . . 0.422 HG12 HG22 ' A' 1609 ' ' VAL . 19.3 m -114.38 117.76 56.52 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.235 0 N-CA-C 113.864 1.061 . . . . 1.51 113.864 -175.665 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A 1592 ' ' TYR . . . . . 0.521 ' HB2' ' HB2' ' A' 1608 ' ' SER . 56.4 m-85 -90.9 133.5 35.19 Favored 'General case' 0 C--N 1.311 -1.067 0 CA-C-N 115.316 -0.856 . . . . 1.06 110.584 177.16 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A 1593 ' ' LYS . . . . . . . . . . . . . 63.4 pttt -159.02 -177.95 6.88 Favored 'General case' 0 C--N 1.314 -0.958 0 N-CA-C 108.396 -0.964 . . . . 2.18 108.396 177.304 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A 1594 ' ' ASP . . . . . . . . . . . . . 62.2 m-20 72.1 59.04 0.14 Allowed 'General case' 0 N--CA 1.476 0.846 0 C-N-CA 124.379 1.072 . . . . 1.45 111.865 179.158 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A 1595 ' ' GLY . . . . . . . . . . . . . . . -131.32 -109.91 1.28 Allowed Glycine 0 N--CA 1.433 -1.541 0 N-CA-C 109.343 -1.503 . . . . 0.78 109.343 177.35 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A 1596 ' ' SER . . . . . 0.43 ' HA ' ' HD3' ' A' 1597 ' ' PRO . 14.1 m -97.67 134.98 21.83 Favored Pre-proline 0 C--N 1.299 -1.591 0 N-CA-C 108.801 -0.814 . . . . 1.68 108.801 177.719 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A 1597 ' ' PRO . . . . . 0.43 ' HD3' ' HA ' ' A' 1596 ' ' SER . 23.5 Cg_exo -67.14 152.27 80.06 Favored 'Trans proline' 0 N--CA 1.458 -0.574 0 C-N-CA 123.074 2.516 . . . . 1.17 112.133 177.908 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A 1598 ' ' CYS . . . . . . . . . . . . . 43.1 t -94.77 135.67 23.62 Favored Pre-proline 0 C--N 1.293 -1.881 0 N-CA-C 107.932 -1.136 . . . . 1.19 107.932 179.563 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A 1599 ' ' PRO . . . . . . . . . . . . . 89.4 Cg_endo -79.49 3.21 7.7 Favored 'Trans proline' 0 C--O 1.243 0.746 0 C-N-CA 123.383 2.722 . . . . 1.59 113.707 -177.395 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A 1600 ' ' SER . . . . . . . . . . . . . 14.6 m -120.94 145.83 47.29 Favored 'General case' 0 C--N 1.297 -1.68 0 N-CA-C 108.055 -1.091 . . . . 2.12 108.055 178.837 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A 1601 ' ' LYS . . . . . 0.61 ' HG3' HG22 ' A' 1633 ' ' THR . 29.7 mmmt 67.63 -146.14 0.14 Allowed 'General case' 0 CA--C 1.537 0.453 0 O-C-N 124.006 0.816 . . . . 3.74 110.61 177.925 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A 1602 ' ' SER . . . . . . . . . . . . . 33.5 t -68.76 163.43 24.08 Favored 'General case' 0 CA--C 1.551 0.998 0 N-CA-C 109.66 -0.496 . . . . 3.79 109.66 178.862 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A 1603 ' ' GLY . . . . . . . . . . . . . . . -77.36 58.0 3.7 Favored Glycine 0 C--N 1.332 0.324 0 N-CA-C 111.685 -0.566 . . . . 2.0 111.685 179.015 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A 1604 ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -101.2 159.43 15.25 Favored 'General case' 0 C--N 1.297 -1.715 0 C-N-CA 124.773 1.229 . . . . 1.48 110.146 -179.278 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A 1605 ' ' SER . . . . . . . . . . . . . 38.6 m -75.74 -170.9 1.42 Allowed 'General case' 0 C--N 1.315 -0.91 0 CA-C-O 121.586 0.708 . . . . 1.51 110.737 177.837 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A 1606 ' ' TYR . . . . . 0.629 ' HB2' ' HB ' ' A' 1574 ' ' VAL . 14.7 m-85 -96.57 117.07 30.17 Favored 'General case' 0 N--CA 1.422 -1.858 0 N-CA-C 103.513 -2.773 . . . . 1.18 103.513 174.582 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A 1607 ' ' LYS . . . . . . . . . . . . . 22.0 ptmt -102.88 124.07 47.7 Favored 'General case' 0 C--N 1.276 -2.597 0 C-N-CA 118.613 -1.235 . . . . 1.67 111.404 -170.083 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A 1608 ' ' SER . . . . . 0.521 ' HB2' ' HB2' ' A' 1592 ' ' TYR . 21.7 m -101.46 110.16 22.11 Favored 'General case' 0 C--N 1.299 -1.629 0 CA-C-N 114.928 -1.033 . . . . 1.0 109.626 -178.98 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A 1609 ' ' VAL . . . . . 0.422 HG22 HG12 ' A' 1591 ' ' VAL . 65.8 t -94.3 106.44 18.1 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.351 0 N-CA-C 109.31 -0.626 . . . . 0.93 109.31 178.729 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A 1610 ' ' ILE . . . . . . . . . . . . . 38.2 mm -89.49 109.21 20.12 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.701 0 N-CA-C 108.471 -0.937 . . . . 0.78 108.471 178.831 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A 1611 ' ' SER . . . . . . . . . . . . . 18.2 m -104.98 116.59 32.22 Favored 'General case' 0 C--N 1.301 -1.51 0 CA-C-O 121.286 0.565 . . . . 1.29 110.398 178.923 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A 1612 ' ' PHE . . . . . 0.71 ' HB2' ' HB2' ' A' 1588 ' ' LEU . 93.3 m-85 -87.74 108.61 19.2 Favored 'General case' 0 C--N 1.301 -1.509 0 N-CA-C 108.36 -0.978 . . . . 0.7 108.36 177.143 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A 1613 ' ' VAL . . . . . . . . . . . . . 78.9 t -102.61 130.62 52.29 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.084 0 CA-C-O 120.889 0.376 . . . . 0.75 110.312 -178.227 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A 1614 ' ' CYS . . . . . . . . . . . . . 32.5 m -75.02 92.28 2.6 Favored 'General case' 0 C--N 1.303 -1.415 0 CA-C-N 115.257 -0.883 . . . . 1.39 111.586 -176.169 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A 1615 ' ' ARG . . . . . 0.806 ' HB3' ' HB3' ' A' 1641 ' ' HIS . 2.9 tpm_? -138.93 85.46 16.2 Favored Pre-proline 0 C--N 1.314 -0.975 0 N-CA-C 108.861 -0.792 . . . . 3.75 108.861 176.789 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A 1616 ' ' PRO . . . . . 0.619 ' HG2' ' HG3' ' A' 1648 ' ' PRO . 52.6 Cg_exo -59.29 -18.54 45.75 Favored 'Trans proline' 0 N--CA 1.492 1.439 0 C-N-CA 123.07 2.513 . . . . 1.32 113.554 179.019 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A 1617 ' ' GLU . . . . . . . . . . . . . 33.0 tt0 -66.3 -20.71 66.17 Favored 'General case' 0 C--N 1.321 -0.634 0 C-N-CA 123.473 0.709 . . . . 3.21 112.312 -178.351 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A 1618 ' ' ALA . . . . . . . . . . . . . . . -58.39 116.28 3.52 Favored 'General case' 0 C--N 1.316 -0.859 0 C-N-CA 122.993 0.517 . . . . 2.44 111.625 -176.279 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A 1619 ' ' GLY . . . . . . . . . . . . . . . -119.27 -84.77 0.92 Allowed Glycine 0 N--CA 1.437 -1.295 0 CA-C-N 115.881 -0.6 . . . . 3.26 112.117 -178.455 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A 1620 ' ' PRO . . . . . . . . . . . . . 27.6 Cg_endo -64.21 -25.92 64.85 Favored 'Trans proline' 0 CA--C 1.535 0.548 0 C-N-CA 122.855 2.37 . . . . 5.92 113.315 -179.348 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A 1621 ' ' THR . . . . . . . . . . . . . 5.7 m -108.84 43.1 1.29 Allowed 'General case' 0 N--CA 1.436 -1.159 0 CA-C-O 122.137 0.97 . . . . 4.76 110.086 -179.179 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A 1622 ' ' ASN . . . . . . . . . . . . . 50.6 t-20 -82.93 67.97 9.23 Favored 'General case' 0 C--N 1.319 -0.75 0 N-CA-C 107.574 -1.269 . . . . 2.92 107.574 178.369 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A 1623 ' ' ARG . . . . . . . . . . . . . 8.1 ptm180 -150.97 153.77 33.5 Favored Pre-proline 0 C--N 1.31 -1.11 0 CA-C-N 115.095 -0.957 . . . . 3.61 108.468 -177.44 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A 1624 ' ' PRO . . . . . . . . . . . . . 11.6 Cg_exo -71.43 120.63 7.09 Favored 'Trans proline' 0 C--O 1.236 0.403 0 C-N-CA 122.631 2.22 . . . . 2.37 110.896 178.279 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A 1625 ' ' MET . . . . . . . . . . . . . 44.4 ttm -109.94 140.84 43.49 Favored 'General case' 0 C--N 1.306 -1.294 0 C-N-CA 122.777 0.431 . . . . 2.16 110.082 -177.621 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A 1626 ' ' LEU . . . . . . . . . . . . . 59.9 tp -81.38 117.3 21.72 Favored 'General case' 0 C--N 1.308 -1.237 0 N-CA-C 107.768 -1.197 . . . . 1.35 107.768 175.337 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A 1627 ' ' ILE . . . . . . . . . . . . . 41.0 pt -99.33 -33.1 3.86 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.204 0 C-N-CA 119.778 -0.769 . . . . 1.21 111.547 -177.209 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A 1628 ' ' SER . . . . . 0.536 ' HB3' ' HB2' ' A' 1637 ' ' PHE . 44.9 t -141.28 143.65 34.21 Favored 'General case' 0 N--CA 1.431 -1.4 0 N-CA-C 109.287 -0.634 . . . . 1.4 109.287 -176.99 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A 1629 ' ' LEU . . . . . 0.747 HD13 ' HG ' ' A' 1636 ' ' LEU . 22.4 tp -146.07 116.21 7.42 Favored 'General case' 0 C--N 1.303 -1.42 0 CA-C-N 116.057 -0.52 . . . . 1.56 110.312 -177.941 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A 1630 ' ' ASP . . . . . . . . . . . . . 12.3 t70 -109.51 107.97 18.28 Favored 'General case' 0 C--N 1.298 -1.659 0 N-CA-C 107.801 -1.185 . . . . 0.87 107.801 176.416 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A 1631 ' ' LYS . . . . . . . . . . . . . 95.3 mttt -85.27 3.54 39.05 Favored 'General case' 0 C--N 1.307 -1.281 0 CA-C-N 116.241 -0.436 . . . . 2.35 111.979 -176.202 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A 1632 ' ' GLN . . . . . . . . . . . . . 1.4 mp0 -91.11 -49.21 6.52 Favored 'General case' 0 C--N 1.316 -0.863 0 N-CA-C 109.102 -0.703 . . . . 2.55 109.102 178.875 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A 1633 ' ' THR . . . . . 0.61 HG22 ' HG3' ' A' 1601 ' ' LYS . 22.2 p -97.48 2.78 50.63 Favored 'General case' 0 C--N 1.308 -1.234 0 CA-C-N 115.772 -0.649 . . . . 1.24 111.455 179.013 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A 1634 ' ' CYS . . . . . . . . . . . . . 98.3 m 56.6 47.49 18.39 Favored 'General case' 0 C--N 1.347 0.467 0 CA-C-N 114.879 -1.055 . . . . 0.89 111.758 178.692 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A 1635 ' ' THR . . . . . . . . . . . . . 26.7 m -112.44 118.38 35.02 Favored 'General case' 0 N--CA 1.43 -1.434 0 CA-C-N 115.006 -0.997 . . . . 0.75 109.246 -178.21 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A 1636 ' ' LEU . . . . . 0.747 ' HG ' HD13 ' A' 1629 ' ' LEU . 4.0 mp -112.1 130.17 55.98 Favored 'General case' 0 N--CA 1.441 -0.884 0 N-CA-C 109.626 -0.509 . . . . 1.33 109.626 -177.816 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A 1637 ' ' PHE . . . . . 0.536 ' HB2' ' HB3' ' A' 1628 ' ' SER . 91.0 m-85 -111.15 113.09 25.35 Favored 'General case' 0 C--N 1.315 -0.931 0 CA-C-O 120.9 0.381 . . . . 0.83 110.509 -178.712 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A 1638 ' ' PHE . . . . . . . . . . . . . 97.4 m-85 -108.25 145.53 34.18 Favored 'General case' 0 C--N 1.306 -1.298 0 CA-C-N 116.103 -0.499 . . . . 0.6 109.766 -179.087 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A 1639 ' ' SER . . . . . . . . . . . . . 65.6 m -136.98 127.89 27.47 Favored 'General case' 0 C--N 1.29 -2.018 0 CA-C-O 121.226 0.536 . . . . 1.08 111.381 178.848 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A 1640 ' ' TRP . . . . . . . . . . . . . 16.4 t90 -115.72 125.49 52.87 Favored 'General case' 0 C--N 1.294 -1.843 0 N-CA-C 107.022 -1.473 . . . . 0.8 107.022 175.188 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A 1641 ' ' HIS . . . . . 0.806 ' HB3' ' HB3' ' A' 1615 ' ' ARG . 69.9 m-70 -89.39 103.3 15.94 Favored 'General case' 0 C--N 1.306 -1.297 0 N-CA-C 107.054 -1.461 . . . . 2.54 107.054 -179.848 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A 1642 ' ' THR . . . . . . . . . . . . . 10.2 t -143.0 142.02 20.98 Favored Pre-proline 0 C--N 1.302 -1.476 0 CA-C-O 121.013 0.435 . . . . 1.15 110.96 -173.618 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A 1643 ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo -73.64 -12.13 24.42 Favored 'Trans proline' 0 C--N 1.359 1.08 0 C-N-CA 123.211 2.608 . . . . 0.8 113.118 179.93 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A 1644 ' ' LEU . . . . . 0.488 HD21 HD11 ' A' 1532 ' ' LEU . 2.4 pp -90.66 4.48 51.3 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 121.685 0.755 . . . . 1.54 112.799 -179.221 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A 1645 ' ' ALA . . . . . . . . . . . . . . . -72.66 -38.4 67.65 Favored 'General case' 0 C--N 1.302 -1.482 0 CA-C-N 114.476 -1.238 . . . . 0.95 108.086 173.461 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A 1646 ' ' CYS . . . . . . . . . . . . . 18.6 p -175.4 135.29 0.32 Allowed 'General case' 0 C--N 1.312 -1.037 0 N-CA-C 105.004 -2.221 . . . . 1.41 105.004 175.402 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A 1647 ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 -71.81 136.42 82.84 Favored Pre-proline 0 C--N 1.312 -1.039 0 N-CA-C 108.801 -0.814 . . . . 2.92 108.801 -179.568 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A 1648 ' ' PRO . . . . . 0.619 ' HG3' ' HG2' ' A' 1616 ' ' PRO . 51.4 Cg_endo -68.99 100.48 0.73 Allowed 'Trans proline' 0 C--O 1.249 1.033 0 C-N-CA 122.265 1.977 . . . . 2.82 112.733 -174.672 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A 1649 ' ' GLU . . . . . . . . . . . . . 19.7 mm-40 . . . . . 0 C--N 1.296 -1.724 0 CA-C-N 114.787 -1.097 . . . . 5.06 108.509 179.415 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A 1508 ' ' MET . . . . . . . . . . . . . 24.9 mmt . . . . . 0 CA--C 1.495 -1.139 0 N-CA-C 109.937 -0.394 . . . . 8.27 109.937 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A 1509 ' ' LYS . . . . . . . . . . . . . 12.8 mptt -78.09 99.34 6.1 Favored 'General case' 0 C--N 1.304 -1.4 0 CA-C-O 121.539 0.685 . . . . 6.48 111.013 179.811 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A 1510 ' ' SER . . . . . . . . . . . . . 10.3 p -91.64 -1.26 57.52 Favored 'General case' 0 C--N 1.31 -1.151 0 CA-C-O 122.446 1.117 . . . . 4.22 109.611 177.91 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A 1511 ' ' ASN . . . . . 0.509 HD22 ' HG2' ' A' 1517 ' ' GLN . 32.0 p-10 -108.72 29.12 7.73 Favored 'General case' 0 C--N 1.308 -1.229 0 CA-C-N 114.04 -1.436 . . . . 3.08 108.12 178.499 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A 1512 ' ' GLU . . . . . . . . . . . . . 39.6 tt0 -89.11 -58.57 2.49 Favored 'General case' 0 C--N 1.311 -1.087 0 CA-C-N 114.783 -1.098 . . . . 4.46 111.629 -175.689 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A 1513 ' ' HIS . . . . . . . . . . . . . 6.5 t60 -110.46 47.77 0.95 Allowed 'General case' 0 C--N 1.306 -1.306 0 N-CA-C 108.415 -0.957 . . . . 5.57 108.415 -175.214 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A 1514 ' ' ASP . . . . . . . . . . . . . 15.1 t70 -140.46 -59.01 0.53 Allowed 'General case' 0 C--N 1.31 -1.149 0 C-N-CA 120.042 -0.663 . . . . 3.7 109.835 178.953 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A 1515 ' ' ASP . . . . . . . . . . . . . 62.7 m-20 -123.36 -173.19 2.67 Favored 'General case' 0 CA--C 1.49 -1.346 0 N-CA-C 108.238 -1.023 . . . . 2.54 108.238 175.845 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A 1516 ' ' CYS . . . . . . . . . . . . . 58.3 m -120.39 73.19 0.98 Allowed 'General case' 0 C--N 1.305 -1.359 0 CA-C-O 121.436 0.636 . . . . 1.25 110.664 -175.796 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A 1517 ' ' GLN . . . . . 0.509 ' HG2' HD22 ' A' 1511 ' ' ASN . 0.0 OUTLIER -139.59 136.14 34.08 Favored 'General case' 0 C--N 1.297 -1.7 0 CA-C-N 115.527 -0.76 . . . . 1.88 111.014 174.067 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A 1518 ' ' VAL . . . . . . . . . . . . . 94.8 t -121.23 121.59 65.23 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.449 0 CA-C-N 115.673 -0.694 . . . . 1.73 109.269 176.497 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A 1519 ' ' THR . . . . . 0.513 ' HA ' ' HA ' ' A' 1526 ' ' LEU . 20.5 m -90.62 108.23 19.68 Favored 'General case' 0 C--N 1.295 -1.763 0 CA-C-O 120.865 0.364 . . . . 1.7 110.914 179.651 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A 1520 ' ' ASN . . . . . 0.559 ' HB2' ' CE2' ' A' 1527 ' ' PHE . 15.1 t-20 -67.43 122.3 82.55 Favored Pre-proline 0 N--CA 1.47 0.566 0 CA-C-N 116.033 -0.531 . . . . 2.12 110.98 179.416 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A 1521 ' ' PRO . . . . . . . . . . . . . 94.9 Cg_endo -83.4 -1.5 10.25 Favored 'Trans proline' 0 CA--C 1.533 0.442 0 C-N-CA 122.347 2.031 . . . . 2.47 113.756 -178.236 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A 1522 ' ' SER . . . . . . . . . . . . . 6.8 m -83.62 -58.18 2.92 Favored 'General case' 0 C--N 1.308 -1.201 0 C-N-CA 120.773 -0.371 . . . . 2.57 110.57 -179.071 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A 1523 ' ' THR . . . . . . . . . . . . . 11.3 t -108.85 -5.98 15.98 Favored 'General case' 0 N--CA 1.443 -0.815 0 CA-C-O 120.972 0.415 . . . . 2.15 110.844 -177.045 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A 1524 ' ' GLY . . . . . . . . . . . . . . . 80.01 28.76 48.9 Favored Glycine 0 CA--C 1.507 -0.445 0 C-N-CA 120.62 -0.8 . . . . 1.89 112.91 176.899 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A 1525 ' ' HIS . . . . . . . . . . . . . 22.1 t-160 -97.41 118.59 34.23 Favored 'General case' 0 C--N 1.312 -1.032 0 N-CA-C 109.414 -0.587 . . . . 1.9 109.414 -179.885 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A 1526 ' ' LEU . . . . . 0.513 ' HA ' ' HA ' ' A' 1519 ' ' THR . 5.0 tt -82.9 111.0 18.38 Favored 'General case' 0 C--N 1.295 -1.79 0 N-CA-C 107.095 -1.446 . . . . 1.61 107.095 178.087 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A 1527 ' ' PHE . . . . . 0.559 ' CE2' ' HB2' ' A' 1520 ' ' ASN . 32.6 m-85 -87.9 102.62 14.89 Favored 'General case' 0 C--N 1.305 -1.351 0 N-CA-C 108.498 -0.927 . . . . 1.42 108.498 179.395 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A 1528 ' ' ASP . . . . . . . . . . . . . 23.4 t70 -105.71 133.44 50.45 Favored 'General case' 0 C--N 1.298 -1.632 0 C-N-CA 120.467 -0.493 . . . . 2.18 110.106 179.347 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A 1529 ' ' LEU . . . . . . . . . . . . . 89.0 mt -113.3 -7.98 13.5 Favored 'General case' 0 C--N 1.299 -1.614 0 CA-C-N 115.146 -0.934 . . . . 1.44 110.001 179.248 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A 1530 ' ' SER . . . . . . . . . . . . . 2.3 m -69.1 -37.41 78.37 Favored 'General case' 0 CA--C 1.543 0.696 0 CA-C-O 121.878 0.846 . . . . 1.44 109.154 -177.92 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A 1531 ' ' SER . . . . . . . . . . . . . 14.0 m -70.85 -24.13 62.47 Favored 'General case' 0 C--N 1.317 -0.844 0 CA-C-N 115.199 -0.91 . . . . 1.5 109.926 177.895 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A 1532 ' ' LEU . . . . . . . . . . . . . 8.0 mp -84.7 4.58 31.97 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.414 -0.812 . . . . 1.77 110.502 179.317 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A 1533 ' ' SER . . . . . . . . . . . . . 32.5 m -113.87 119.08 36.06 Favored 'General case' 0 N--CA 1.425 -1.709 0 N-CA-C 113.337 0.866 . . . . 2.38 113.337 -175.303 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A 1534 ' ' GLY . . . . . . . . . . . . . . . -89.65 -162.84 38.76 Favored Glycine 0 N--CA 1.431 -1.677 0 N-CA-C 109.221 -1.552 . . . . 1.55 109.221 172.398 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A 1535 ' ' ARG . . . . . 0.46 ' HE ' ' CD ' ' A' 1557 ' ' GLU . 62.4 ttt180 -81.39 -47.76 12.81 Favored 'General case' 0 C--N 1.304 -1.409 0 CA-C-N 117.395 0.597 . . . . 3.96 110.633 -179.08 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A 1536 ' ' ALA . . . . . . . . . . . . . . . -95.56 -13.53 24.36 Favored 'General case' 0 C--N 1.316 -0.863 0 N-CA-C 108.752 -0.833 . . . . 1.65 108.752 177.74 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A 1537 ' ' GLY . . . . . . . . . . . . . . . 73.53 -139.94 27.37 Favored Glycine 0 N--CA 1.436 -1.355 0 CA-C-N 114.581 -1.191 . . . . 1.19 112.371 177.244 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A 1538 ' ' PHE . . . . . . . . . . . . . 78.0 m-85 -101.42 152.08 21.16 Favored 'General case' 0 C--N 1.296 -1.734 0 N-CA-C 109.188 -0.671 . . . . 1.69 109.188 179.456 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A 1539 ' ' THR . . . . . . . . . . . . . 25.8 m -103.66 115.19 30.04 Favored 'General case' 0 C--N 1.288 -2.09 0 N-CA-C 108.495 -0.928 . . . . 1.48 108.495 179.37 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A 1540 ' ' ALA . . . . . 0.783 ' HB3' HG13 ' A' 1548 ' ' VAL . . . -94.65 149.95 20.72 Favored 'General case' 0 C--N 1.309 -1.177 0 N-CA-C 109.223 -0.658 . . . . 0.83 109.223 -177.935 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A 1541 ' ' ALA . . . . . . . . . . . . . . . -87.01 139.07 30.95 Favored 'General case' 0 C--N 1.311 -1.078 0 N-CA-C 109.358 -0.608 . . . . 1.27 109.358 -179.407 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A 1542 ' ' TYR . . . . . 0.556 ' HD2' ' HB2' ' A' 1545 ' ' SER . 42.1 t80 -141.47 173.52 11.42 Favored 'General case' 0 N--CA 1.437 -1.091 0 CA-C-O 119.288 -0.387 . . . . 2.15 110.413 -176.813 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A 1543 ' ' SER . . . . . . . . . . . . . 9.5 m -46.92 -152.6 0.0 OUTLIER 'General case' 0 CA--C 1.577 1.995 0 C-N-CA 129.084 2.954 . . . . 2.29 114.07 178.619 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A 1544 ' ' LYS . . . . . . . . . . . . . 57.8 mtpt -45.03 -31.79 1.45 Allowed 'General case' 0 N--CA 1.487 1.389 0 O-C-N 121.088 -1.007 . . . . 3.91 112.902 177.121 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A 1545 ' ' SER . . . . . 0.556 ' HB2' ' HD2' ' A' 1542 ' ' TYR . 33.2 m -65.83 -12.68 56.19 Favored 'General case' 0 CA--C 1.562 1.409 0 N-CA-C 112.719 0.637 . . . . 3.3 112.719 176.425 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A 1546 ' ' GLY . . . . . . . . . . . . . . . 85.09 -74.2 2.52 Favored Glycine 0 CA--C 1.495 -1.216 0 C-N-CA 121.037 -0.601 . . . . 1.24 113.723 172.812 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A 1547 ' ' VAL . . . . . . . . . . . . . 10.7 m -139.01 156.99 28.52 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.445 0 CA-C-O 121.652 0.739 . . . . 1.63 112.145 -176.663 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A 1548 ' ' VAL . . . . . 0.783 HG13 ' HB3' ' A' 1540 ' ' ALA . 2.0 p -134.1 136.24 53.71 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.917 0 CA-C-N 114.766 -1.106 . . . . 0.92 108.114 178.924 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A 1549 ' ' TYR . . . . . . . . . . . . . 97.5 m-85 -93.51 141.29 28.63 Favored 'General case' 0 C--N 1.294 -1.835 0 N-CA-C 109.287 -0.634 . . . . 1.44 109.287 -179.085 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A 1550 ' ' MET . . . . . . . . . . . . . 42.2 ttm -138.37 121.64 17.01 Favored 'General case' 0 C--N 1.288 -2.083 0 CA-C-N 115.852 -0.613 . . . . 1.74 110.54 -179.261 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A 1551 ' ' SER . . . . . 0.455 ' OG ' ' HA ' ' A' 1556 ' ' ASN . 59.3 m -91.98 122.76 34.79 Favored 'General case' 0 N--CA 1.409 -2.517 0 N-CA-C 105.692 -1.966 . . . . 1.64 105.692 172.057 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A 1552 ' ' ILE . . . . . . . . . . . . . 38.6 mm -62.94 -21.53 28.26 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.804 0 CA-C-O 121.777 0.798 . . . . 1.33 110.716 -175.323 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A 1553 ' ' CYS . . . . . . . . . . . . . 43.7 t -161.55 138.33 8.45 Favored 'General case' 0 N--CA 1.412 -2.366 0 N-CA-C 106.65 -1.611 . . . . 1.43 106.65 175.063 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A 1554 ' ' GLY . . . . . 0.87 ' HA2' ' HE2' ' A' 1579 ' ' LYS . . . 104.71 -150.33 17.13 Favored Glycine 0 N--CA 1.426 -2.026 0 C-N-CA 119.957 -1.116 . . . . 1.12 112.305 175.489 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A 1555 ' ' GLU . . . . . . . . . . . . . 7.6 pt-20 -106.96 147.81 29.41 Favored 'General case' 0 C--N 1.293 -1.875 0 C-N-CA 123.088 0.555 . . . . 1.8 109.976 -177.612 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A 1556 ' ' ASN . . . . . 0.455 ' HA ' ' OG ' ' A' 1551 ' ' SER . 5.3 t-20 -98.54 88.88 4.22 Favored 'General case' 0 C--N 1.286 -2.159 0 CA-C-O 121.641 0.734 . . . . 2.63 109.07 -175.594 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A 1557 ' ' GLU . . . . . 0.46 ' CD ' ' HE ' ' A' 1535 ' ' ARG . 22.2 mt-10 -79.72 111.47 16.04 Favored 'General case' 0 C--N 1.303 -1.448 0 CA-C-N 115.409 -0.814 . . . . 3.79 111.567 -175.573 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A 1558 ' ' ASN . . . . . . . . . . . . . 6.9 p30 160.21 -25.1 0.0 OUTLIER 'General case' 0 N--CA 1.475 0.781 0 C-N-CA 127.501 2.32 . . . . 1.52 105.789 -176.556 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A 1559 ' ' CYS . . . . . 0.62 ' HB3' ' HD2' ' A' 1560 ' ' PRO . 93.2 m -118.2 173.86 3.03 Favored Pre-proline 0 N--CA 1.439 -0.992 0 CA-C-O 117.353 -1.308 . . . . 0.84 107.605 174.204 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A 1560 ' ' PRO . . . . . 0.62 ' HD2' ' HB3' ' A' 1559 ' ' CYS . 21.3 Cg_exo -35.8 132.14 0.29 Allowed 'Trans proline' 0 C--N 1.378 2.109 0 C-N-CA 123.567 2.844 . . . . 1.18 113.88 176.603 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A 1561 ' ' PRO . . . . . . . . . . . . . 19.8 Cg_endo -62.82 120.2 7.61 Favored 'Trans proline' 0 C--O 1.243 0.759 0 C-N-CA 122.792 2.328 . . . . 1.51 113.146 -177.634 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A 1562 ' ' GLY . . . . . . . . . . . . . . . 117.14 7.87 12.14 Favored Glycine 0 N--CA 1.434 -1.458 0 CA-C-N 115.833 -0.621 . . . . 0.72 112.669 176.972 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A 1563 ' ' VAL . . . . . . . . . . . . . 6.4 m -101.23 156.74 4.38 Favored 'Isoleucine or valine' 0 C--O 1.205 -1.263 0 N-CA-C 106.885 -1.524 . . . . 0.97 106.885 178.118 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A 1564 ' ' GLY . . . . . . . . . . . . . . . -108.71 -23.61 6.45 Favored Glycine 0 C--N 1.311 -0.81 0 C-N-CA 120.213 -0.994 . . . . 0.72 112.645 -177.713 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A 1565 ' ' ALA . . . . . . . . . . . . . . . -149.28 137.7 20.87 Favored 'General case' 0 C--N 1.311 -1.088 0 N-CA-C 108.572 -0.899 . . . . 0.37 108.572 -179.721 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A 1566 ' ' CYS . . . . . 0.544 ' SG ' ' HA ' ' A' 1571 ' ' ARG . 35.6 t -157.68 138.05 12.78 Favored 'General case' 0 C--N 1.312 -1.048 0 C-N-CA 121.229 -0.188 . . . . 0.51 111.492 -173.9 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A 1567 ' ' PHE . . . . . 0.561 ' HD1' ' HB ' ' A' 1548 ' ' VAL . 22.0 m-85 -67.19 125.27 25.53 Favored 'General case' 0 N--CA 1.471 0.607 0 N-CA-C 108.313 -0.995 . . . . 0.97 108.313 177.602 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A 1568 ' ' GLY . . . . . . . . . . . . . . . -58.36 -43.51 95.66 Favored Glycine 0 C--N 1.315 -0.606 0 N-CA-C 117.119 1.608 . . . . 1.08 117.119 -168.434 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A 1569 ' ' GLN . . . . . . . . . . . . . 4.0 pt20 -87.51 -34.35 18.66 Favored 'General case' 0 C--N 1.307 -1.274 0 CA-C-N 118.367 1.083 . . . . 2.74 113.748 -175.368 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A 1570 ' ' THR . . . . . . . . . . . . . 11.5 p -89.63 -22.36 22.35 Favored 'General case' 0 C--N 1.312 -1.063 0 CA-C-O 121.597 0.713 . . . . 1.96 112.321 -176.447 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A 1571 ' ' ARG . . . . . 0.544 ' HA ' ' SG ' ' A' 1566 ' ' CYS . 94.7 mtt180 59.88 38.89 20.98 Favored 'General case' 0 CA--C 1.515 -0.401 0 CA-C-N 114.523 -1.217 . . . . 3.95 113.755 175.295 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A 1572 ' ' ILE . . . . . . . . . . . . . 75.8 mt -98.35 123.44 50.88 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.971 0 CA-C-N 114.416 -1.266 . . . . 1.37 107.797 178.201 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A 1573 ' ' SER . . . . . . . . . . . . . 27.3 t -62.91 130.39 44.57 Favored 'General case' 0 C--N 1.318 -0.804 0 O-C-N 123.669 0.606 . . . . 1.08 111.446 -178.213 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A 1574 ' ' VAL . . . . . . . . . . . . . 27.7 m -122.87 25.36 3.72 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.402 0 CA-C-O 122.047 0.927 . . . . 1.3 109.898 176.17 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A 1575 ' ' GLY . . . . . . . . . . . . . . . 163.58 128.59 0.96 Allowed Glycine 0 N--CA 1.426 -1.974 0 CA-C-N 114.138 -1.392 . . . . 0.51 111.202 177.043 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A 1576 ' ' LYS . . . . . . . . . . . . . 50.5 tptt -77.77 151.19 34.18 Favored 'General case' 0 C--N 1.317 -0.81 0 N-CA-C 106.772 -1.566 . . . . 2.9 106.772 178.336 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A 1577 ' ' ALA . . . . . . . . . . . . . . . -67.66 99.79 0.83 Allowed 'General case' 0 C--N 1.321 -0.646 0 CA-C-O 120.963 0.411 . . . . 0.83 110.503 -178.705 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A 1578 ' ' ASN . . . . . 0.498 ' H ' ' HD1' ' A' 1592 ' ' TYR . 15.6 m120 -117.44 130.07 56.23 Favored 'General case' 0 C--N 1.302 -1.498 0 N-CA-C 108.736 -0.838 . . . . 1.85 108.736 -179.886 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A 1579 ' ' LYS . . . . . 0.87 ' HE2' ' HA2' ' A' 1554 ' ' GLY . 33.5 mmtp -93.44 89.79 6.46 Favored 'General case' 0 C--N 1.292 -1.901 0 N-CA-C 104.545 -2.391 . . . . 1.9 104.545 174.745 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A 1580 ' ' ARG . . . . . 0.403 ' O ' ' HA ' ' A' 1590 ' ' LEU . 22.0 ttm180 -148.27 103.52 3.45 Favored 'General case' 0 C--N 1.313 -0.986 0 C-N-CA 119.147 -1.021 . . . . 3.63 113.259 -170.219 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A 1581 ' ' LEU . . . . . . . . . . . . . 3.9 mm? -100.75 141.25 33.89 Favored 'General case' 0 C--N 1.31 -1.135 0 CA-C-N 115.691 -0.686 . . . . 1.87 110.285 172.99 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A 1582 ' ' ARG . . . . . 0.786 ' HB2' ' HB3' ' A' 1589 ' ' GLN . 93.4 mtt180 -116.55 98.44 6.55 Favored 'General case' 0 C--N 1.285 -2.205 0 N-CA-C 107.055 -1.461 . . . . 3.97 107.055 170.923 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A 1583 ' ' TYR . . . . . . . . . . . . . 45.6 t80 -79.18 91.64 4.98 Favored 'General case' 0 C--N 1.295 -1.769 0 N-CA-C 107.522 -1.288 . . . . 1.41 107.522 178.697 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A 1584 ' ' VAL . . . . . 0.529 ' O ' HG12 ' A' 1587 ' ' VAL . 11.5 m -117.55 98.29 6.44 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.26 0 CA-C-O 121.547 0.689 . . . . 1.69 111.68 -177.346 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A 1585 ' ' ASP . . . . . . . . . . . . . 34.7 t70 53.46 70.38 0.6 Allowed 'General case' 0 C--N 1.313 -1.016 0 C-N-CA 124.348 1.059 . . . . 2.06 111.804 -178.021 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A 1586 ' ' GLN . . . . . . . . . . . . . 14.9 mm100 68.72 -14.23 0.29 Allowed 'General case' 0 N--CA 1.481 1.088 0 N-CA-C 115.615 1.709 . . . . 2.33 115.615 177.247 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A 1587 ' ' VAL . . . . . 0.529 HG12 ' O ' ' A' 1584 ' ' VAL . 7.5 p -94.84 128.64 45.88 Favored 'Isoleucine or valine' 0 C--O 1.243 0.752 0 C-N-CA 119.159 -1.016 . . . . 0.78 110.197 178.837 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A 1588 ' ' LEU . . . . . 0.751 ' HB2' ' HB2' ' A' 1612 ' ' PHE . 3.0 mm? -84.58 124.11 31.07 Favored 'General case' 0 N--CA 1.418 -2.035 0 N-CA-C 106.568 -1.641 . . . . 1.41 106.568 173.013 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A 1589 ' ' GLN . . . . . 0.786 ' HB3' ' HB2' ' A' 1582 ' ' ARG . 7.5 tp60 -119.26 107.0 12.88 Favored 'General case' 0 C--N 1.277 -2.556 0 N-CA-C 107.806 -1.183 . . . . 1.24 107.806 -173.874 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A 1590 ' ' LEU . . . . . 0.403 ' HA ' ' O ' ' A' 1580 ' ' ARG . 7.1 tt -105.61 128.59 53.71 Favored 'General case' 0 C--N 1.297 -1.708 0 N-CA-C 108.382 -0.97 . . . . 1.15 108.382 -178.215 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A 1591 ' ' VAL . . . . . 0.629 HG12 HG22 ' A' 1609 ' ' VAL . 19.7 m -124.41 122.23 63.52 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.258 0 N-CA-C 112.868 0.692 . . . . 1.51 112.868 -175.409 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A 1592 ' ' TYR . . . . . 0.498 ' HD1' ' H ' ' A' 1578 ' ' ASN . 39.1 m-85 -103.07 98.38 8.33 Favored 'General case' 0 C--N 1.306 -1.3 0 N-CA-C 107.644 -1.243 . . . . 1.06 107.644 171.47 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A 1593 ' ' LYS . . . . . . . . . . . . . 21.4 ptmt -102.75 175.67 5.41 Favored 'General case' 0 C--N 1.3 -1.576 0 N-CA-C 109.751 -0.463 . . . . 2.18 109.751 -177.323 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A 1594 ' ' ASP . . . . . . . . . . . . . 22.0 m-20 61.22 50.07 5.09 Favored 'General case' 0 N--CA 1.494 1.75 0 N-CA-C 113.792 1.034 . . . . 1.45 113.792 178.68 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A 1595 ' ' GLY . . . . . . . . . . . . . . . -85.85 -106.72 0.73 Allowed Glycine 0 N--CA 1.436 -1.304 0 N-CA-C 110.36 -1.096 . . . . 0.78 110.36 175.637 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A 1596 ' ' SER . . . . . . . . . . . . . 69.6 m -99.87 151.87 37.63 Favored Pre-proline 0 C--N 1.297 -1.684 0 N-CA-C 109.364 -0.606 . . . . 1.68 109.364 177.438 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A 1597 ' ' PRO . . . . . . . . . . . . . 26.5 Cg_exo -65.28 131.49 28.49 Favored 'Trans proline' 0 C--O 1.24 0.588 0 C-N-CA 123.096 2.531 . . . . 1.17 111.416 178.287 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A 1598 ' ' CYS . . . . . 0.453 ' HA ' ' HD3' ' A' 1599 ' ' PRO . 43.2 t -100.24 109.9 58.12 Favored Pre-proline 0 C--N 1.301 -1.532 0 CA-C-N 116.018 -0.537 . . . . 1.19 109.779 -178.354 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A 1599 ' ' PRO . . . . . 0.453 ' HD3' ' HA ' ' A' 1598 ' ' CYS . 38.6 Cg_endo -98.02 21.85 0.32 Allowed 'Trans proline' 0 N--CA 1.445 -1.377 0 C-N-CA 123.308 2.672 . . . . 1.59 112.527 -179.191 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A 1600 ' ' SER . . . . . . . . . . . . . 16.9 m -73.73 -41.02 63.11 Favored 'General case' 0 C--N 1.313 -0.982 0 CA-C-N 116.571 -0.286 . . . . 2.12 111.627 -179.155 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A 1601 ' ' LYS . . . . . . . . . . . . . 87.3 tttt -142.39 -77.64 0.25 Allowed 'General case' 0 C--N 1.318 -0.765 0 CA-C-O 121.259 0.552 . . . . 3.74 111.258 -177.632 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A 1602 ' ' SER . . . . . . . . . . . . . 21.1 m -96.07 175.59 6.41 Favored 'General case' 0 C--N 1.3 -1.584 0 CA-C-N 115.294 -0.866 . . . . 3.79 109.055 -177.194 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A 1603 ' ' GLY . . . . . . . . . . . . . . . -75.81 63.62 2.73 Favored Glycine 0 CA--C 1.505 -0.533 0 N-CA-C 109.78 -1.328 . . . . 2.0 109.78 175.276 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A 1604 ' ' LEU . . . . . 0.461 HD13 ' HA ' ' A' 1633 ' ' THR . 2.2 mt -93.52 -174.41 3.48 Favored 'General case' 0 C--N 1.293 -1.883 0 C-N-CA 125.55 1.54 . . . . 1.48 112.184 -173.809 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A 1605 ' ' SER . . . . . . . . . . . . . 34.5 t -140.93 -179.22 5.95 Favored 'General case' 0 N--CA 1.419 -2.017 0 N-CA-C 105.667 -1.975 . . . . 1.51 105.667 179.348 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A 1606 ' ' TYR . . . . . . . . . . . . . 7.1 m-85 -110.06 129.23 55.72 Favored 'General case' 0 CA--C 1.47 -2.101 0 N-CA-C 105.253 -2.129 . . . . 1.18 105.253 -179.561 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A 1607 ' ' LYS . . . . . . . . . . . . . 10.0 ptpp? -131.8 138.12 48.41 Favored 'General case' 0 N--CA 1.411 -2.41 0 C-N-CA 118.495 -1.282 . . . . 1.67 110.437 179.867 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A 1608 ' ' SER . . . . . 0.77 ' HA ' ' HB2' ' A' 1636 ' ' LEU . 50.1 m -98.83 114.32 26.83 Favored 'General case' 0 C--N 1.295 -1.79 0 N-CA-C 109.158 -0.682 . . . . 1.0 109.158 177.71 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A 1609 ' ' VAL . . . . . 0.629 HG22 HG12 ' A' 1591 ' ' VAL . 85.9 t -109.3 118.28 56.3 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.054 0 N-CA-C 108.884 -0.784 . . . . 0.93 108.884 -179.677 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A 1610 ' ' ILE . . . . . 0.593 HG13 ' HB2' ' A' 1638 ' ' PHE . 3.3 mp -111.29 116.66 53.1 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.318 0 N-CA-C 109.261 -0.644 . . . . 0.78 109.261 179.58 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A 1611 ' ' SER . . . . . . . . . . . . . 30.3 p -92.46 117.14 29.63 Favored 'General case' 0 N--CA 1.423 -1.8 0 CA-C-N 115.706 -0.679 . . . . 1.29 109.447 177.076 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A 1612 ' ' PHE . . . . . 0.751 ' HB2' ' HB2' ' A' 1588 ' ' LEU . 96.0 m-85 -89.78 103.7 16.33 Favored 'General case' 0 C--N 1.299 -1.629 0 CA-C-N 116.05 -0.523 . . . . 0.7 110.563 -179.393 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A 1613 ' ' VAL . . . . . 0.602 ' O ' ' HA ' ' A' 1641 ' ' HIS . 11.9 t -107.6 145.12 15.28 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.452 0 N-CA-C 106.871 -1.529 . . . . 0.75 106.871 -179.011 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A 1614 ' ' CYS . . . . . . . . . . . . . 34.2 m -89.65 93.75 9.59 Favored 'General case' 0 C--N 1.294 -1.836 0 N-CA-C 113.536 0.939 . . . . 1.39 113.536 -169.977 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A 1615 ' ' ARG . . . . . 0.896 ' HB3' ' HB3' ' A' 1641 ' ' HIS . 21.3 tpp180 -138.09 112.33 8.77 Favored Pre-proline 0 C--N 1.316 -0.87 0 N-CA-C 109.368 -0.604 . . . . 3.75 109.368 176.195 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A 1616 ' ' PRO . . . . . 0.589 ' HA ' ' HD3' ' A' 1643 ' ' PRO . 11.4 Cg_endo -55.07 -20.36 23.39 Favored 'Trans proline' 0 CA--C 1.562 1.876 0 C-N-CA 123.927 3.085 . . . . 1.32 116.259 -178.352 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A 1617 ' ' GLU . . . . . 0.728 ' HG2' ' HG3' ' A' 1615 ' ' ARG . 11.4 pt-20 -75.48 -6.75 51.72 Favored 'General case' 0 N--CA 1.478 0.939 0 N-CA-C 113.82 1.045 . . . . 3.21 113.82 -177.812 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A 1618 ' ' ALA . . . . . 0.533 ' HA ' ' O ' ' A' 1641 ' ' HIS . . . 72.59 -170.42 0.14 Allowed 'General case' 0 N--CA 1.482 1.167 0 C-N-CA 124.513 1.125 . . . . 2.44 112.398 177.018 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A 1619 ' ' GLY . . . . . . . . . . . . . . . -80.92 -141.88 3.11 Favored Glycine 0 CA--C 1.528 0.845 0 CA-C-O 119.539 -0.589 . . . . 3.26 112.349 -179.765 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A 1620 ' ' PRO . . . . . 0.72 ' HD3' ' HB3' ' A' 1625 ' ' MET . 95.2 Cg_exo -48.45 -51.84 9.52 Favored 'Trans proline' 0 C--N 1.365 1.439 0 C-N-CA 124.109 3.206 . . . . 5.92 111.152 179.883 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A 1621 ' ' THR . . . . . . . . . . . . . 2.3 t -131.11 -50.68 1.02 Allowed 'General case' 0 N--CA 1.418 -2.057 0 N-CA-C 107.933 -1.136 . . . . 4.76 107.933 172.23 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A 1622 ' ' ASN . . . . . . . . . . . . . 23.6 t-20 -136.34 -60.6 0.71 Allowed 'General case' 0 CA--C 1.501 -0.906 0 N-CA-C 112.925 0.713 . . . . 2.92 112.925 169.672 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A 1623 ' ' ARG . . . . . 0.559 ' HB2' ' HD2' ' A' 1624 ' ' PRO . 0.0 OUTLIER -61.18 167.69 3.61 Favored Pre-proline 0 C--N 1.292 -1.924 0 CA-C-N 113.412 -1.722 . . . . 3.61 113.236 -173.478 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A 1624 ' ' PRO . . . . . 0.652 ' HB3' ' HB2' ' A' 1640 ' ' TRP . 11.6 Cg_endo -57.46 159.3 16.68 Favored 'Trans proline' 0 C--N 1.369 1.606 0 C-N-CA 123.02 2.48 . . . . 2.37 113.209 175.867 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A 1625 ' ' MET . . . . . 0.72 ' HB3' ' HD3' ' A' 1620 ' ' PRO . 26.5 ptt? -125.41 148.42 48.81 Favored 'General case' 0 C--N 1.311 -1.093 0 CA-C-N 116.094 -0.503 . . . . 2.16 110.003 -179.766 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A 1626 ' ' LEU . . . . . 0.436 HD21 ' HB2' ' A' 1629 ' ' LEU . 38.2 tp -77.68 116.11 17.96 Favored 'General case' 0 C--N 1.309 -1.173 0 N-CA-C 107.794 -1.187 . . . . 1.35 107.794 175.513 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A 1627 ' ' ILE . . . . . . . . . . . . . 25.0 pt -93.02 -30.05 4.46 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.22 0 C-N-CA 120.45 -0.5 . . . . 1.21 111.178 -179.107 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A 1628 ' ' SER . . . . . . . . . . . . . 37.4 m -155.18 154.07 31.71 Favored 'General case' 0 C--N 1.313 -0.988 0 N-CA-C 109.015 -0.735 . . . . 1.4 109.015 -178.317 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A 1629 ' ' LEU . . . . . 0.539 HD13 HD13 ' A' 1636 ' ' LEU . 45.2 tp -145.95 114.43 6.74 Favored 'General case' 0 C--N 1.301 -1.52 0 CA-C-O 121.24 0.543 . . . . 1.56 109.946 178.892 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A 1630 ' ' ASP . . . . . . . . . . . . . 27.6 t70 -112.75 102.07 10.13 Favored 'General case' 0 C--N 1.298 -1.633 0 N-CA-C 108.408 -0.96 . . . . 0.87 108.408 179.447 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A 1631 ' ' LYS . . . . . . . . . . . . . 60.1 mttp -73.58 -18.01 61.11 Favored 'General case' 0 C--N 1.316 -0.853 0 N-CA-C 112.182 0.438 . . . . 2.35 112.182 -177.52 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A 1632 ' ' GLN . . . . . . . . . . . . . 7.6 tp-100 -64.65 -45.14 88.04 Favored 'General case' 0 N--CA 1.451 -0.39 0 CA-C-O 120.885 0.374 . . . . 2.55 110.668 178.632 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A 1633 ' ' THR . . . . . 0.461 ' HA ' HD13 ' A' 1604 ' ' LEU . 40.9 p -99.23 -2.02 37.7 Favored 'General case' 0 C--N 1.316 -0.849 0 CA-C-O 121.467 0.651 . . . . 1.24 111.226 177.858 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A 1634 ' ' CYS . . . . . . . . . . . . . 82.8 m 56.68 40.29 29.31 Favored 'General case' 0 C--O 1.235 0.298 0 CA-C-N 114.539 -1.21 . . . . 0.89 111.362 -179.853 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A 1635 ' ' THR . . . . . . . . . . . . . 25.1 m -99.03 119.56 38.0 Favored 'General case' 0 N--CA 1.423 -1.8 0 CA-C-N 114.921 -1.036 . . . . 0.75 109.826 -177.583 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A 1636 ' ' LEU . . . . . 0.77 ' HB2' ' HA ' ' A' 1608 ' ' SER . 2.7 mm? -90.85 107.94 19.52 Favored 'General case' 0 C--N 1.311 -1.086 0 N-CA-C 108.454 -0.943 . . . . 1.33 108.454 178.648 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A 1637 ' ' PHE . . . . . . . . . . . . . 96.5 m-85 -95.88 100.16 11.88 Favored 'General case' 0 C--O 1.244 0.815 0 CA-C-O 120.853 0.359 . . . . 0.83 110.611 -178.79 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A 1638 ' ' PHE . . . . . 0.593 ' HB2' HG13 ' A' 1610 ' ' ILE . 96.7 m-85 -108.76 156.19 19.89 Favored 'General case' 0 C--N 1.298 -1.634 0 CA-C-O 121.364 0.602 . . . . 0.6 109.987 177.852 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A 1639 ' ' SER . . . . . . . . . . . . . 32.9 t -143.34 130.84 21.12 Favored 'General case' 0 C--N 1.285 -2.218 0 N-CA-C 108.593 -0.892 . . . . 1.08 108.593 176.172 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A 1640 ' ' TRP . . . . . 0.724 ' HE3' ' HE1' ' A' 1612 ' ' PHE . 9.5 t90 -115.92 111.46 20.45 Favored 'General case' 0 N--CA 1.409 -2.485 0 N-CA-C 107.635 -1.246 . . . . 0.8 107.635 175.696 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A 1641 ' ' HIS . . . . . 0.896 ' HB3' ' HB3' ' A' 1615 ' ' ARG . 47.3 m-70 -89.76 105.3 17.71 Favored 'General case' 0 N--CA 1.422 -1.869 0 N-CA-C 107.167 -1.42 . . . . 2.54 107.167 175.88 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A 1642 ' ' THR . . . . . . . . . . . . . 6.1 t -142.8 146.12 36.56 Favored Pre-proline 0 C--N 1.287 -2.127 0 CA-C-N 115.846 -0.616 . . . . 1.15 109.914 -175.322 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A 1643 ' ' PRO . . . . . 0.589 ' HD3' ' HA ' ' A' 1616 ' ' PRO . 71.6 Cg_endo -76.65 -4.69 15.28 Favored 'Trans proline' 0 C--N 1.352 0.725 0 C-N-CA 122.694 2.263 . . . . 0.8 110.495 175.775 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A 1644 ' ' LEU . . . . . . . . . . . . . 81.9 mt -86.67 -7.63 58.14 Favored 'General case' 0 N--CA 1.447 -0.621 0 CA-C-N 115.234 -0.894 . . . . 1.54 109.489 177.217 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A 1645 ' ' ALA . . . . . . . . . . . . . . . -78.97 -42.58 26.42 Favored 'General case' 0 C--O 1.222 -0.366 0 N-CA-C 107.996 -1.112 . . . . 0.95 107.996 176.716 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A 1646 ' ' CYS . . . . . . . . . . . . . 13.5 p -176.11 154.83 1.47 Allowed 'General case' 0 N--CA 1.432 -1.344 0 N-CA-C 104.362 -2.459 . . . . 1.41 104.362 172.639 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A 1647 ' ' GLU . . . . . . . . . . . . . 42.8 mt-10 -103.14 124.78 37.22 Favored Pre-proline 0 C--N 1.288 -2.108 0 N-CA-C 108.506 -0.924 . . . . 2.92 108.506 -179.685 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A 1648 ' ' PRO . . . . . . . . . . . . . 31.4 Cg_exo -60.9 101.37 0.18 Allowed 'Trans proline' 0 C--O 1.251 1.142 0 C-N-CA 122.632 2.221 . . . . 2.82 111.552 177.075 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A 1649 ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 . . . . . 0 N--CA 1.434 -1.259 0 C-N-CA 125.167 1.387 . . . . 5.06 108.25 179.227 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A 1508 ' ' MET . . . . . . . . . . . . . 26.9 ttt . . . . . 0 CA--C 1.506 -0.721 0 N-CA-C 107.994 -1.114 . . . . 8.27 107.994 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A 1509 ' ' LYS . . . . . . . . . . . . . 60.6 pttt -80.35 170.04 16.93 Favored 'General case' 0 C--N 1.305 -1.335 0 N-CA-C 108.696 -0.853 . . . . 6.48 108.696 178.274 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A 1510 ' ' SER . . . . . . . . . . . . . 51.0 m -151.8 178.14 9.69 Favored 'General case' 0 C--N 1.28 -2.419 0 N-CA-C 107.32 -1.363 . . . . 4.22 107.32 -179.7 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A 1511 ' ' ASN . . . . . 0.448 ' HB3' ' O ' ' A' 1517 ' ' GLN . 85.3 m-20 68.35 30.37 5.5 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 121.784 0.802 . . . . 3.08 111.152 173.307 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A 1512 ' ' GLU . . . . . . . . . . . . . 8.9 tp10 -93.71 -47.04 6.97 Favored 'General case' 0 C--N 1.317 -0.839 0 CA-C-N 115.115 -0.948 . . . . 4.46 108.706 178.891 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A 1513 ' ' HIS . . . . . . . . . . . . . 56.9 t-80 -139.91 15.23 2.48 Favored 'General case' 0 CA--C 1.549 0.932 0 CA-C-O 121.901 0.857 . . . . 5.57 108.891 176.635 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A 1514 ' ' ASP . . . . . . . . . . . . . 12.5 m-20 -71.34 -70.26 0.33 Allowed 'General case' 0 CA--C 1.499 -1.014 0 CA-C-O 121.817 0.818 . . . . 3.7 111.463 -177.902 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A 1515 ' ' ASP . . . . . 0.477 ' HA ' ' HD2' ' A' 1579 ' ' LYS . 31.4 t70 -141.22 170.04 16.48 Favored 'General case' 0 C--N 1.284 -2.255 0 N-CA-C 105.991 -1.855 . . . . 2.54 105.991 -175.216 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A 1516 ' ' CYS . . . . . . . . . . . . . 61.1 m -75.14 51.04 0.51 Allowed 'General case' 0 C--N 1.318 -0.769 0 CA-C-O 121.489 0.661 . . . . 1.25 111.455 -178.301 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A 1517 ' ' GLN . . . . . 0.464 ' HA ' ' HA ' ' A' 1528 ' ' ASP . 11.3 pt20 -137.9 154.69 49.41 Favored 'General case' 0 N--CA 1.413 -2.307 0 N-CA-C 106.949 -1.5 . . . . 1.88 106.949 178.55 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A 1518 ' ' VAL . . . . . 0.417 ' HA ' ' HB3' ' A' 1511 ' ' ASN . 7.7 p -148.58 137.94 15.81 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.741 0 O-C-N 123.178 0.299 . . . . 1.73 110.913 -174.893 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A 1519 ' ' THR . . . . . . . . . . . . . 8.4 m -103.66 102.76 12.62 Favored 'General case' 0 N--CA 1.429 -1.523 0 N-CA-C 107.901 -1.148 . . . . 1.7 107.901 178.713 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A 1520 ' ' ASN . . . . . . . . . . . . . 24.7 t30 -71.61 114.65 30.09 Favored Pre-proline 0 C--N 1.319 -0.72 0 C-N-CA 121.021 -0.272 . . . . 2.12 110.281 -179.049 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A 1521 ' ' PRO . . . . . . . . . . . . . 55.9 Cg_endo -68.27 -9.63 26.47 Favored 'Trans proline' 0 C--N 1.357 1.018 0 C-N-CA 122.688 2.259 . . . . 2.47 113.486 -174.797 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A 1522 ' ' SER . . . . . . . . . . . . . 15.1 m -79.21 -23.59 43.7 Favored 'General case' 0 N--CA 1.435 -1.18 0 CA-C-N 116.694 -0.23 . . . . 2.57 111.249 178.991 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A 1523 ' ' THR . . . . . . . . . . . . . 7.0 t -137.5 -15.93 1.39 Allowed 'General case' 0 CA--C 1.549 0.913 0 N-CA-C 112.712 0.634 . . . . 2.15 112.712 -177.893 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A 1524 ' ' GLY . . . . . . . . . . . . . . . 84.6 -5.38 81.74 Favored Glycine 0 N--CA 1.45 -0.417 0 O-C-N 121.982 -0.449 . . . . 1.89 113.182 179.024 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A 1525 ' ' HIS . . . . . . . . . . . . . 11.7 t60 -73.01 135.71 44.97 Favored 'General case' 0 C--N 1.311 -1.081 0 CA-C-O 121.113 0.482 . . . . 1.9 110.091 -177.403 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A 1526 ' ' LEU . . . . . . . . . . . . . 3.5 tm? -95.34 121.65 37.22 Favored 'General case' 0 C--N 1.306 -1.285 0 CA-C-N 114.905 -1.043 . . . . 1.61 108.407 -179.918 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A 1527 ' ' PHE . . . . . 0.551 ' CE1' ' HA ' ' A' 1646 ' ' CYS . 78.7 m-85 -106.6 149.23 27.4 Favored 'General case' 0 C--N 1.292 -1.914 0 N-CA-C 107.352 -1.351 . . . . 1.42 107.352 177.574 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A 1528 ' ' ASP . . . . . 0.464 ' HA ' ' HA ' ' A' 1517 ' ' GLN . 1.2 p30 -143.29 148.21 35.99 Favored 'General case' 0 CA--C 1.484 -1.566 0 CA-C-O 121.371 0.605 . . . . 2.18 109.82 177.287 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A 1529 ' ' LEU . . . . . . . . . . . . . 88.7 mt -117.07 -6.05 11.39 Favored 'General case' 0 C--N 1.284 -2.255 0 CA-C-N 114.002 -1.454 . . . . 1.44 107.371 175.338 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A 1530 ' ' SER . . . . . . . . . . . . . 11.5 m -66.42 -41.67 88.87 Favored 'General case' 0 N--CA 1.432 -1.33 0 CA-C-N 114.315 -1.311 . . . . 1.44 111.624 -175.556 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A 1531 ' ' SER . . . . . . . . . . . . . 13.6 t -87.35 -16.18 35.76 Favored 'General case' 0 N--CA 1.438 -1.067 0 N-CA-C 109.027 -0.731 . . . . 1.5 109.027 -178.77 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A 1532 ' ' LEU . . . . . 0.437 HD13 HD13 ' A' 1644 ' ' LEU . 80.2 mt -76.15 -36.26 58.84 Favored 'General case' 0 CA--C 1.521 -0.173 0 CA-C-N 115.854 -0.612 . . . . 1.77 111.068 179.362 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A 1533 ' ' SER . . . . . 0.572 ' HB2' ' HB ' ' A' 1552 ' ' ILE . 25.7 t -80.29 133.74 36.0 Favored 'General case' 0 C--N 1.304 -1.41 0 CA-C-N 115.914 -0.585 . . . . 2.38 110.349 -178.041 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A 1534 ' ' GLY . . . . . . . . . . . . . . . -91.47 160.01 26.47 Favored Glycine 0 N--CA 1.441 -1.022 0 N-CA-C 109.092 -1.603 . . . . 1.55 109.092 174.797 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A 1535 ' ' ARG . . . . . . . . . . . . . 29.0 ttp180 -70.82 -19.77 62.63 Favored 'General case' 0 C--N 1.318 -0.761 0 CA-C-N 117.961 0.88 . . . . 3.96 110.927 -175.911 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A 1536 ' ' ALA . . . . . . . . . . . . . . . -90.26 -9.7 46.97 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-O 121.375 0.607 . . . . 1.65 109.666 177.302 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A 1537 ' ' GLY . . . . . . . . . . . . . . . 80.61 -169.44 52.36 Favored Glycine 0 N--CA 1.422 -2.277 0 CA-C-N 115.123 -0.944 . . . . 1.19 110.962 -177.09 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A 1538 ' ' PHE . . . . . . . . . . . . . 17.3 m-85 -120.33 170.16 9.62 Favored 'General case' 0 C--N 1.285 -2.233 0 N-CA-C 108.286 -1.005 . . . . 1.69 108.286 177.517 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A 1539 ' ' THR . . . . . 0.506 ' HA ' ' O ' ' A' 1548 ' ' VAL . 23.5 p -120.98 118.3 29.49 Favored 'General case' 0 C--N 1.289 -2.028 0 CA-C-N 116.223 -0.444 . . . . 1.48 110.454 -179.433 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A 1540 ' ' ALA . . . . . . . . . . . . . . . -93.24 143.66 26.05 Favored 'General case' 0 C--N 1.305 -1.333 0 N-CA-C 107.323 -1.362 . . . . 0.83 107.323 175.449 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A 1541 ' ' ALA . . . . . . . . . . . . . . . -84.68 70.08 10.73 Favored 'General case' 0 C--N 1.298 -1.633 0 N-CA-C 112.658 0.614 . . . . 1.27 112.658 -173.282 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A 1542 ' ' TYR . . . . . . . . . . . . . 16.4 t80 -157.06 112.76 2.89 Favored 'General case' 0 C--O 1.208 -1.079 0 N-CA-C 113.386 0.884 . . . . 2.15 113.386 176.511 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A 1543 ' ' SER . . . . . 0.582 ' HB3' ' N ' ' A' 1546 ' ' GLY . 43.4 t -138.42 -153.61 0.48 Allowed 'General case' 0 C--N 1.263 -3.159 0 N-CA-C 103.467 -2.79 . . . . 2.29 103.467 162.03 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A 1544 ' ' LYS . . . . . . . . . . . . . 96.1 mttt -66.22 -50.34 64.14 Favored 'General case' 0 C--N 1.303 -1.44 0 N-CA-C 106.354 -1.721 . . . . 3.91 106.354 170.275 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A 1545 ' ' SER . . . . . . . . . . . . . 17.6 t -134.41 25.98 3.79 Favored 'General case' 0 CA--C 1.562 1.442 0 CA-C-N 115.166 -0.925 . . . . 3.3 110.013 175.597 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A 1546 ' ' GLY . . . . . 0.582 ' N ' ' HB3' ' A' 1543 ' ' SER . . . -138.09 -118.05 1.62 Allowed Glycine 0 CA--C 1.529 0.96 0 C-N-CA 118.027 -2.035 . . . . 1.24 117.316 -170.524 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A 1547 ' ' VAL . . . . . . . . . . . . . 14.0 m -159.21 169.34 0.53 Allowed 'Isoleucine or valine' 0 C--O 1.255 1.382 0 C-N-CA 124.256 1.022 . . . . 1.63 110.876 -165.581 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A 1548 ' ' VAL . . . . . 0.506 ' O ' ' HA ' ' A' 1539 ' ' THR . 3.5 t -124.87 135.57 63.58 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.628 0 N-CA-C 107.787 -1.19 . . . . 0.92 107.787 178.625 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A 1549 ' ' TYR . . . . . . . . . . . . . 22.7 m-85 -92.16 114.92 27.59 Favored 'General case' 0 CA--C 1.502 -0.869 0 N-CA-C 105.711 -1.959 . . . . 1.44 105.711 172.52 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A 1550 ' ' MET . . . . . . . . . . . . . 19.8 ptm -144.66 127.8 16.64 Favored 'General case' 0 C--N 1.283 -2.294 0 C-N-CA 119.601 -0.84 . . . . 1.74 111.653 -176.744 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A 1551 ' ' SER . . . . . . . . . . . . . 51.0 m -86.68 135.3 33.44 Favored 'General case' 0 C--N 1.285 -2.236 0 N-CA-C 107.805 -1.183 . . . . 1.64 107.805 177.812 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A 1552 ' ' ILE . . . . . 0.572 ' HB ' ' HB2' ' A' 1533 ' ' SER . 27.8 mm -75.97 -13.16 14.82 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.959 0 CA-C-O 122.363 1.078 . . . . 1.33 108.471 -175.181 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A 1553 ' ' CYS . . . . . . . . . . . . . 33.1 t -161.33 137.95 8.46 Favored 'General case' 0 N--CA 1.421 -1.918 0 N-CA-C 106.957 -1.497 . . . . 1.43 106.957 174.54 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A 1554 ' ' GLY . . . . . . . . . . . . . . . 86.99 -166.56 37.19 Favored Glycine 0 N--CA 1.435 -1.371 0 C-N-CA 120.857 -0.687 . . . . 1.12 114.015 174.18 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A 1555 ' ' GLU . . . . . . . . . . . . . 13.5 pt-20 -86.74 154.57 20.85 Favored 'General case' 0 C--N 1.313 -1.01 0 CA-C-O 121.384 0.612 . . . . 1.8 111.129 -178.192 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A 1556 ' ' ASN . . . . . . . . . . . . . 20.4 t-20 -108.91 112.5 24.76 Favored 'General case' 0 C--N 1.301 -1.524 0 N-CA-C 109.259 -0.645 . . . . 2.63 109.259 178.341 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A 1557 ' ' GLU . . . . . . . . . . . . . 7.9 mt-10 -83.21 40.41 0.71 Allowed 'General case' 0 C--N 1.309 -1.176 0 CA-C-O 121.066 0.46 . . . . 3.79 112.198 -173.017 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A 1558 ' ' ASN . . . . . . . . . . . . . 34.6 m-80 -126.89 -0.78 6.62 Favored 'General case' 0 C--N 1.307 -1.249 0 CA-C-O 121.291 0.567 . . . . 1.52 110.079 179.648 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A 1559 ' ' CYS . . . . . 0.738 ' HB3' ' HD2' ' A' 1560 ' ' PRO . 67.5 m -147.11 177.8 1.65 Allowed Pre-proline 0 C--N 1.309 -1.172 0 CA-C-O 116.884 -1.532 . . . . 0.84 107.162 179.594 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A 1560 ' ' PRO . . . . . 0.738 ' HD2' ' HB3' ' A' 1559 ' ' CYS . 3.4 Cg_exo -36.13 122.84 0.29 Allowed 'Trans proline' 0 C--N 1.385 2.469 0 C-N-CA 124.107 3.205 . . . . 1.18 114.038 178.917 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A 1561 ' ' PRO . . . . . . . . . . . . . 56.4 Cg_exo -53.82 107.64 0.22 Allowed 'Trans proline' 0 C--O 1.254 1.31 0 C-N-CA 123.482 2.788 . . . . 1.51 112.698 -179.053 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A 1562 ' ' GLY . . . . . . . . . . . . . . . 134.12 -11.56 4.75 Favored Glycine 0 N--CA 1.43 -1.707 0 CA-C-N 115.306 -0.861 . . . . 0.72 111.84 179.263 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A 1563 ' ' VAL . . . . . 0.553 ' HA ' ' HA ' ' A' 1576 ' ' LYS . 15.1 m -88.17 144.11 9.85 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.247 0 CA-C-O 120.965 0.412 . . . . 0.97 109.922 179.739 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A 1564 ' ' GLY . . . . . . . . . . . . . . . -100.74 -26.43 8.03 Favored Glycine 0 C--N 1.306 -1.106 0 N-CA-C 110.725 -0.95 . . . . 0.72 110.725 179.796 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A 1565 ' ' ALA . . . . . . . . . . . . . . . -138.59 141.18 39.2 Favored 'General case' 0 N--CA 1.439 -0.986 0 N-CA-C 109.045 -0.724 . . . . 0.37 109.045 179.533 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A 1566 ' ' CYS . . . . . . . . . . . . . 39.8 t -158.7 133.04 7.92 Favored 'General case' 0 C--N 1.3 -1.546 0 N-CA-C 108.106 -1.072 . . . . 0.51 108.106 -176.955 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A 1567 ' ' PHE . . . . . . . . . . . . . 86.3 m-85 -63.63 123.62 19.3 Favored 'General case' 0 C--O 1.208 -1.126 0 N-CA-C 107.508 -1.293 . . . . 0.97 107.508 178.305 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A 1568 ' ' GLY . . . . . 0.436 ' H ' ' HA ' ' A' 1548 ' ' VAL . . . -82.91 -24.85 51.6 Favored Glycine 0 CA--C 1.487 -1.676 0 C-N-CA 120.244 -0.979 . . . . 1.08 112.986 -171.654 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A 1569 ' ' GLN . . . . . . . . . . . . . 22.0 tp60 -81.89 -38.29 25.56 Favored 'General case' 0 C--N 1.298 -1.648 0 CA-C-O 122.096 0.95 . . . . 2.74 108.736 179.391 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A 1570 ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -93.13 -22.28 19.18 Favored 'General case' 0 C--N 1.295 -1.77 0 CA-C-N 114.354 -1.294 . . . . 1.96 112.157 -171.727 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A 1571 ' ' ARG . . . . . . . . . . . . . 50.9 mtt180 63.31 38.01 10.58 Favored 'General case' 0 N--CA 1.47 0.547 0 C-N-CA 125.54 1.536 . . . . 3.95 112.411 -179.256 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A 1572 ' ' ILE . . . . . . . . . . . . . 48.1 mm -118.08 126.05 74.66 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.934 0 CA-C-N 114.849 -1.069 . . . . 1.37 108.864 -177.028 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A 1573 ' ' SER . . . . . . . . . . . . . 45.8 t -62.17 134.63 56.81 Favored 'General case' 0 C--N 1.307 -1.277 0 C-N-CA 123.87 0.868 . . . . 1.08 111.782 -177.578 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A 1574 ' ' VAL . . . . . . . . . . . . . 92.6 t -97.69 -50.61 11.14 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.426 0 CA-C-N 115.313 -0.858 . . . . 1.3 109.174 -179.622 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A 1575 ' ' GLY . . . . . . . . . . . . . . . -160.55 150.38 20.35 Favored Glycine 0 N--CA 1.432 -1.616 0 C-N-CA 120.38 -0.914 . . . . 0.51 112.117 -176.895 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A 1576 ' ' LYS . . . . . 0.553 ' HA ' ' HA ' ' A' 1563 ' ' VAL . 64.8 tttm -78.7 146.54 33.9 Favored 'General case' 0 C--N 1.311 -1.084 0 N-CA-C 108.714 -0.847 . . . . 2.9 108.714 -179.47 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A 1577 ' ' ALA . . . . . . . . . . . . . . . -69.09 90.81 0.47 Allowed 'General case' 0 C--N 1.319 -0.73 0 C-N-CA 123.783 0.833 . . . . 0.83 112.047 -176.03 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A 1578 ' ' ASN . . . . . . . . . . . . . 43.6 m-80 -103.73 113.75 27.5 Favored 'General case' 0 C--N 1.303 -1.42 0 N-CA-C 108.549 -0.908 . . . . 1.85 108.549 176.9 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A 1579 ' ' LYS . . . . . 0.477 ' HD2' ' HA ' ' A' 1515 ' ' ASP . 35.9 ttpt -89.7 89.99 8.03 Favored 'General case' 0 C--N 1.295 -1.764 0 CA-C-O 122.223 1.011 . . . . 1.9 109.152 -176.713 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A 1580 ' ' ARG . . . . . . . . . . . . . 27.4 tpt180 -161.3 111.84 1.7 Allowed 'General case' 0 N--CA 1.424 -1.766 0 CA-C-N 113.747 -1.57 . . . . 3.63 109.236 -178.007 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A 1581 ' ' LEU . . . . . . . . . . . . . 3.6 pp -117.75 160.94 20.51 Favored 'General case' 0 N--CA 1.413 -2.295 0 CA-C-N 114.991 -1.004 . . . . 1.87 108.647 176.56 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A 1582 ' ' ARG . . . . . . . . . . . . . 18.0 ttp85 -140.78 138.02 33.81 Favored 'General case' 0 C--N 1.291 -1.95 0 N-CA-C 108.519 -0.919 . . . . 3.97 108.519 176.059 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A 1583 ' ' TYR . . . . . . . . . . . . . 70.0 t80 -102.65 96.6 6.99 Favored 'General case' 0 C--N 1.303 -1.429 0 N-CA-C 107.694 -1.224 . . . . 1.41 107.694 179.788 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A 1584 ' ' VAL . . . . . 0.472 ' O ' HG12 ' A' 1587 ' ' VAL . 6.0 p -121.85 105.8 17.0 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.505 0 CA-C-N 116.123 -0.49 . . . . 1.69 111.802 -175.581 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A 1585 ' ' ASP . . . . . . . . . . . . . 37.0 t70 61.46 61.19 1.54 Allowed 'General case' 0 C--N 1.319 -0.739 0 CA-C-O 122.356 1.074 . . . . 2.06 111.115 178.38 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A 1586 ' ' GLN . . . . . . . . . . . . . 47.8 mt-30 62.62 8.75 3.11 Favored 'General case' 0 N--CA 1.478 0.941 0 CA-C-N 114.244 -1.344 . . . . 2.33 114.258 178.322 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A 1587 ' ' VAL . . . . . 0.472 HG12 ' O ' ' A' 1584 ' ' VAL . 11.7 p -122.07 125.43 73.04 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.242 0 C-N-CA 119.204 -0.998 . . . . 0.78 110.548 178.496 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A 1588 ' ' LEU . . . . . 0.675 ' HB2' ' HB2' ' A' 1612 ' ' PHE . 57.6 mt -83.22 126.24 32.43 Favored 'General case' 0 C--N 1.3 -1.552 0 CA-C-N 114.919 -1.037 . . . . 1.41 109.061 173.826 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A 1589 ' ' GLN . . . . . . . . . . . . . 36.0 tt0 -118.85 117.44 28.86 Favored 'General case' 0 C--N 1.284 -2.248 0 CA-C-N 115.736 -0.666 . . . . 1.24 109.291 -178.475 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A 1590 ' ' LEU . . . . . . . . . . . . . 7.3 tt -124.6 132.83 53.41 Favored 'General case' 0 C--N 1.307 -1.248 0 N-CA-C 106.847 -1.538 . . . . 1.15 106.847 176.611 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A 1591 ' ' VAL . . . . . 0.432 HG22 HG22 ' A' 1609 ' ' VAL . 39.0 t -127.42 137.68 57.01 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.704 0 CA-C-O 120.69 0.281 . . . . 1.51 111.309 -174.092 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A 1592 ' ' TYR . . . . . . . . . . . . . 57.9 m-85 -115.07 124.64 52.11 Favored 'General case' 0 C--N 1.314 -0.962 0 N-CA-C 107.262 -1.384 . . . . 1.06 107.262 171.231 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A 1593 ' ' LYS . . . . . . . . . . . . . 13.3 ptmm? -137.98 172.86 12.3 Favored 'General case' 0 C--N 1.302 -1.484 0 C-N-CA 121.149 -0.22 . . . . 2.18 111.263 -177.111 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A 1594 ' ' ASP . . . . . . . . . . . . . 17.3 m-20 66.37 48.0 1.65 Allowed 'General case' 0 C--O 1.247 0.935 0 C-N-CA 125.313 1.445 . . . . 1.45 111.875 179.082 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A 1595 ' ' GLY . . . . . . . . . . . . . . . -89.93 -106.98 1.23 Allowed Glycine 0 N--CA 1.44 -1.04 0 N-CA-C 110.877 -0.889 . . . . 0.78 110.877 175.832 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A 1596 ' ' SER . . . . . 0.421 ' HA ' ' HD3' ' A' 1597 ' ' PRO . 19.9 m -101.89 152.08 38.09 Favored Pre-proline 0 C--N 1.296 -1.741 0 N-CA-C 109.732 -0.47 . . . . 1.68 109.732 179.214 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A 1597 ' ' PRO . . . . . 0.421 ' HD3' ' HA ' ' A' 1596 ' ' SER . 22.6 Cg_exo -66.79 141.35 59.07 Favored 'Trans proline' 0 C--N 1.353 0.797 0 C-N-CA 123.203 2.602 . . . . 1.17 112.018 178.88 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A 1598 ' ' CYS . . . . . 0.635 ' O ' ' HA ' ' A' 1602 ' ' SER . 42.2 t -95.86 136.39 22.27 Favored Pre-proline 0 C--N 1.287 -2.136 0 CA-C-N 115.505 -0.771 . . . . 1.19 109.011 179.993 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A 1599 ' ' PRO . . . . . . . . . . . . . 63.3 Cg_endo -75.08 -18.01 18.91 Favored 'Trans proline' 0 C--N 1.36 1.149 0 C-N-CA 123.11 2.54 . . . . 1.59 112.198 177.751 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A 1600 ' ' SER . . . . . . . . . . . . . 34.2 m -86.63 112.54 21.7 Favored 'General case' 0 N--CA 1.425 -1.721 0 N-CA-C 107.037 -1.468 . . . . 2.12 107.037 176.592 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A 1601 ' ' LYS . . . . . 0.435 ' HD3' ' HA ' ' A' 1601 ' ' LYS . 42.9 mmtm 56.23 55.79 6.4 Favored 'General case' 0 C--O 1.242 0.694 0 CA-C-O 122.477 1.132 . . . . 3.74 108.542 -173.215 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A 1602 ' ' SER . . . . . 0.635 ' HA ' ' O ' ' A' 1598 ' ' CYS . 15.0 t -49.11 122.77 6.28 Favored 'General case' 0 N--CA 1.442 -0.865 0 CA-C-N 112.781 -2.009 . . . . 3.79 112.108 -172.693 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A 1603 ' ' GLY . . . . . . . . . . . . . . . 140.02 -23.58 2.74 Favored Glycine 0 N--CA 1.43 -1.726 0 N-CA-C 109.131 -1.588 . . . . 2.0 109.131 -176.61 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A 1604 ' ' LEU . . . . . . . . . . . . . 72.3 mt -85.33 152.45 23.27 Favored 'General case' 0 C--N 1.309 -1.183 0 CA-C-N 114.733 -0.734 . . . . 1.48 109.473 177.502 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A 1605 ' ' SER . . . . . . . . . . . . . 49.1 m -101.7 175.54 5.52 Favored 'General case' 0 C--N 1.282 -2.341 0 N-CA-C 105.933 -1.877 . . . . 1.51 105.933 169.094 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A 1606 ' ' TYR . . . . . . . . . . . . . 78.5 m-85 -94.76 149.69 20.98 Favored 'General case' 0 CA--C 1.466 -2.28 0 N-CA-C 106.133 -1.803 . . . . 1.18 106.133 -177.583 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A 1607 ' ' LYS . . . . . 0.436 ' HG3' HG23 ' A' 1635 ' ' THR . 23.2 pttm -135.67 132.18 36.64 Favored 'General case' 0 N--CA 1.401 -2.915 0 C-N-CA 118.377 -1.329 . . . . 1.67 110.123 175.243 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A 1608 ' ' SER . . . . . . . . . . . . . 29.3 p -106.9 112.15 24.98 Favored 'General case' 0 C--N 1.288 -2.08 0 CA-C-N 116.277 -0.419 . . . . 1.0 110.376 -179.232 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A 1609 ' ' VAL . . . . . 0.432 HG22 HG22 ' A' 1591 ' ' VAL . 92.6 t -100.3 117.4 45.44 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.961 0 N-CA-C 108.719 -0.845 . . . . 0.93 108.719 177.622 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A 1610 ' ' ILE . . . . . 0.638 HG13 ' HB2' ' A' 1638 ' ' PHE . 3.5 mp -101.94 118.34 48.61 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.567 0 N-CA-C 108.22 -1.03 . . . . 0.78 108.22 177.133 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A 1611 ' ' SER . . . . . . . . . . . . . 14.1 m -104.22 117.02 33.22 Favored 'General case' 0 N--CA 1.416 -2.131 0 CA-C-N 115.357 -0.838 . . . . 1.29 108.966 178.834 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A 1612 ' ' PHE . . . . . 0.675 ' HB2' ' HB2' ' A' 1588 ' ' LEU . 95.2 m-85 -90.18 107.32 19.06 Favored 'General case' 0 C--N 1.298 -1.648 0 CA-C-N 115.458 -0.792 . . . . 0.7 109.251 179.98 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A 1613 ' ' VAL . . . . . . . . . . . . . 71.9 t -100.38 131.31 48.15 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.108 0 CA-C-N 116.152 -0.477 . . . . 0.75 109.922 -177.02 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A 1614 ' ' CYS . . . . . . . . . . . . . 59.6 m -67.98 101.76 1.17 Allowed 'General case' 0 C--N 1.317 -0.848 0 C-N-CA 123.787 0.835 . . . . 1.39 110.925 -179.425 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A 1615 ' ' ARG . . . . . 0.549 ' HD2' ' OE2' ' A' 1617 ' ' GLU . 21.4 mmt180 -137.07 95.76 11.77 Favored Pre-proline 0 C--N 1.306 -1.294 0 CA-C-N 115.594 -0.73 . . . . 3.75 110.927 178.692 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A 1616 ' ' PRO . . . . . . . . . . . . . 11.4 Cg_exo -74.1 58.53 4.26 Favored 'Trans proline' 0 CA--C 1.541 0.857 0 C-N-CA 123.636 2.891 . . . . 1.32 111.371 176.587 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A 1617 ' ' GLU . . . . . 0.549 ' OE2' ' HD2' ' A' 1615 ' ' ARG . 38.3 mt-10 -131.38 37.02 3.74 Favored 'General case' 0 C--N 1.31 -1.121 0 C-N-CA 124.659 1.183 . . . . 3.21 108.471 179.503 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A 1618 ' ' ALA . . . . . . . . . . . . . . . -63.96 140.38 58.86 Favored 'General case' 0 C--O 1.243 0.734 0 CA-C-N 115.709 -0.678 . . . . 2.44 111.856 -173.929 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A 1619 ' ' GLY . . . . . . . . . . . . . . . -148.92 -165.1 11.98 Favored Glycine 0 N--CA 1.426 -1.985 0 N-CA-C 110.185 -1.166 . . . . 3.26 110.185 179.89 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A 1620 ' ' PRO . . . . . . . . . . . . . 5.9 Cg_exo -78.69 4.91 6.0 Favored 'Trans proline' 0 CA--C 1.532 0.401 0 C-N-CA 123.068 2.512 . . . . 5.92 112.89 -176.823 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A 1621 ' ' THR . . . . . . . . . . . . . 15.0 t -131.55 33.22 4.06 Favored 'General case' 0 N--CA 1.426 -1.635 0 CA-C-O 122.249 1.023 . . . . 4.76 109.664 179.61 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A 1622 ' ' ASN . . . . . . . . . . . . . 25.2 t-20 -85.4 82.44 8.32 Favored 'General case' 0 C--N 1.321 -0.645 0 N-CA-C 108.864 -0.791 . . . . 2.92 108.864 -178.759 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A 1623 ' ' ARG . . . . . . . . . . . . . 8.6 ptm180 -133.67 158.17 76.17 Favored Pre-proline 0 C--N 1.311 -1.089 0 CA-C-N 115.378 -0.828 . . . . 3.61 109.714 -173.866 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A 1624 ' ' PRO . . . . . . . . . . . . . 12.2 Cg_exo -69.86 127.21 14.2 Favored 'Trans proline' 0 C--O 1.246 0.905 0 C-N-CA 122.792 2.328 . . . . 2.37 110.834 176.942 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A 1625 ' ' MET . . . . . . . . . . . . . 22.1 ptp -126.34 151.47 47.53 Favored 'General case' 0 C--N 1.303 -1.438 0 CA-C-N 116.131 -0.486 . . . . 2.16 110.396 -178.561 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A 1626 ' ' LEU . . . . . 0.407 HD12 ' O ' ' A' 1637 ' ' PHE . 39.0 tp -85.55 118.35 25.01 Favored 'General case' 0 C--N 1.306 -1.293 0 N-CA-C 108.436 -0.95 . . . . 1.35 108.436 -179.666 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A 1627 ' ' ILE . . . . . . . . . . . . . 45.8 pt -93.17 -28.33 4.45 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.331 0 C-N-CA 120.345 -0.542 . . . . 1.21 111.47 -177.993 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A 1628 ' ' SER . . . . . . . . . . . . . 21.1 t -160.57 142.0 12.22 Favored 'General case' 0 N--CA 1.432 -1.371 0 C-N-CA 120.341 -0.543 . . . . 1.4 110.565 -177.482 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A 1629 ' ' LEU . . . . . 0.83 HD13 ' HG ' ' A' 1636 ' ' LEU . 29.5 tp -119.76 128.02 53.36 Favored 'General case' 0 C--N 1.304 -1.37 0 N-CA-C 108.065 -1.087 . . . . 1.56 108.065 174.055 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A 1630 ' ' ASP . . . . . . . . . . . . . 25.1 t70 -102.07 127.41 48.98 Favored 'General case' 0 C--N 1.295 -1.761 0 CA-C-N 116.737 -0.211 . . . . 0.87 110.623 179.269 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A 1631 ' ' LYS . . . . . . . . . . . . . 53.0 mttm -95.14 0.97 54.72 Favored 'General case' 0 C--N 1.317 -0.808 0 N-CA-C 111.872 0.323 . . . . 2.35 111.872 -178.495 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A 1632 ' ' GLN . . . . . . . . . . . . . 36.5 mt-30 -87.19 -52.47 5.39 Favored 'General case' 0 C--N 1.315 -0.926 0 C-N-CA 120.218 -0.593 . . . . 2.55 109.969 178.917 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A 1633 ' ' THR . . . . . . . . . . . . . 69.1 p -106.51 -1.44 23.05 Favored 'General case' 0 N--CA 1.432 -1.374 0 CA-C-N 115.761 -0.654 . . . . 1.24 111.927 -178.833 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A 1634 ' ' CYS . . . . . . . . . . . . . 60.3 m 62.61 42.91 7.99 Favored 'General case' 0 C--O 1.237 0.399 0 CA-C-O 122.464 1.126 . . . . 0.89 111.26 177.409 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A 1635 ' ' THR . . . . . 0.436 HG23 ' HG3' ' A' 1607 ' ' LYS . 28.2 m -102.57 133.09 48.13 Favored 'General case' 0 N--CA 1.416 -2.145 0 CA-C-N 114.168 -1.378 . . . . 0.75 109.245 -178.547 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A 1636 ' ' LEU . . . . . 0.83 ' HG ' HD13 ' A' 1629 ' ' LEU . 5.2 mp -109.79 129.69 55.6 Favored 'General case' 0 N--CA 1.435 -1.213 0 N-CA-C 108.994 -0.743 . . . . 1.33 108.994 179.806 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A 1637 ' ' PHE . . . . . 0.407 ' O ' HD12 ' A' 1626 ' ' LEU . 88.7 m-85 -110.32 108.0 17.93 Favored 'General case' 0 C--N 1.308 -1.223 0 CA-C-O 121.049 0.452 . . . . 0.83 110.979 -177.121 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A 1638 ' ' PHE . . . . . 0.638 ' HB2' HG13 ' A' 1610 ' ' ILE . 97.0 m-85 -101.78 146.95 27.08 Favored 'General case' 0 C--N 1.305 -1.359 0 N-CA-C 109.228 -0.656 . . . . 0.6 109.228 177.706 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A 1639 ' ' SER . . . . . . . . . . . . . 50.0 m -132.64 133.66 43.89 Favored 'General case' 0 C--N 1.278 -2.529 0 N-CA-C 109.788 -0.449 . . . . 1.08 109.788 176.967 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A 1640 ' ' TRP . . . . . 0.403 ' CE3' ' HE2' ' A' 1612 ' ' PHE . 6.7 t90 -121.43 92.54 3.77 Favored 'General case' 0 N--CA 1.413 -2.32 0 N-CA-C 106.761 -1.57 . . . . 0.8 106.761 173.517 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A 1641 ' ' HIS . . . . . . . . . . . . . 4.4 p-80 -71.64 98.75 1.96 Allowed 'General case' 0 C--N 1.308 -1.209 0 CA-C-N 114.867 -1.061 . . . . 2.54 108.555 175.154 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A 1642 ' ' THR . . . . . . . . . . . . . 10.0 t -143.55 147.81 40.97 Favored Pre-proline 0 C--N 1.279 -2.49 0 CA-C-N 115.831 -0.622 . . . . 1.15 110.483 -170.963 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A 1643 ' ' PRO . . . . . 0.417 ' O ' ' HG2' ' A' 1647 ' ' GLU . 34.6 Cg_endo -75.68 0.18 9.47 Favored 'Trans proline' 0 C--O 1.215 -0.651 0 C-N-CA 122.853 2.369 . . . . 0.8 111.114 174.768 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A 1644 ' ' LEU . . . . . 0.437 HD13 HD13 ' A' 1532 ' ' LEU . 45.5 mt -85.04 -11.81 54.52 Favored 'General case' 0 C--N 1.32 -0.683 0 C-N-CA 123.927 0.891 . . . . 1.54 110.782 176.679 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A 1645 ' ' ALA . . . . . . . . . . . . . . . -73.09 -43.44 61.82 Favored 'General case' 0 N--CA 1.471 0.592 0 CA-C-O 121.563 0.696 . . . . 0.95 110.118 -178.604 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A 1646 ' ' CYS . . . . . 0.551 ' HA ' ' CE1' ' A' 1527 ' ' PHE . 18.8 p -155.61 142.26 18.79 Favored 'General case' 0 N--CA 1.417 -2.084 0 N-CA-C 104.666 -2.346 . . . . 1.41 104.666 172.389 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A 1647 ' ' GLU . . . . . 0.417 ' HG2' ' O ' ' A' 1643 ' ' PRO . 39.9 mt-10 -113.62 116.19 46.01 Favored Pre-proline 0 C--N 1.283 -2.323 0 O-C-N 123.199 0.312 . . . . 2.92 110.414 -171.249 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A 1648 ' ' PRO . . . . . . . . . . . . . 37.2 Cg_exo -64.16 114.89 2.84 Favored 'Trans proline' 0 N--CA 1.452 -0.916 0 C-N-CA 122.745 2.297 . . . . 2.82 110.772 178.089 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A 1649 ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--N 1.298 -1.656 0 N-CA-C 108.827 -0.805 . . . . 5.06 108.827 177.867 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A 1508 ' ' MET . . . . . . . . . . . . . 61.3 mtt . . . . . 0 CA--C 1.501 -0.914 0 N-CA-C 107.538 -1.282 . . . . 8.27 107.538 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A 1509 ' ' LYS . . . . . . . . . . . . . 20.7 ptmt -112.72 -34.81 5.69 Favored 'General case' 0 C--N 1.3 -1.554 0 N-CA-C 111.631 0.234 . . . . 6.48 111.631 -177.587 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A 1510 ' ' SER . . . . . . . . . . . . . 16.9 t -175.02 106.76 0.1 Allowed 'General case' 0 CA--C 1.542 0.67 0 N-CA-C 110.12 -0.326 . . . . 4.22 110.12 -178.053 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A 1511 ' ' ASN . . . . . . . . . . . . . 12.5 m120 -135.17 -6.33 2.33 Favored 'General case' 0 N--CA 1.482 1.169 0 CA-C-O 120.772 0.32 . . . . 3.08 111.534 178.153 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A 1512 ' ' GLU . . . . . . . . . . . . . 39.8 tt0 -78.28 -42.91 29.56 Favored 'General case' 0 C--N 1.32 -0.712 0 N-CA-C 112.167 0.432 . . . . 4.46 112.167 -174.234 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A 1513 ' ' HIS . . . . . . . . . . . . . 20.8 p80 -68.17 -21.75 64.88 Favored 'General case' 0 N--CA 1.485 1.313 0 CA-C-O 121.555 0.693 . . . . 5.57 109.941 -178.704 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A 1514 ' ' ASP . . . . . 0.414 ' HB3' ' HG3' ' A' 1517 ' ' GLN . 6.4 m-20 -76.23 -43.17 43.28 Favored 'General case' 0 N--CA 1.433 -1.283 0 CA-C-N 114.495 -1.23 . . . . 3.7 110.814 -177.017 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A 1515 ' ' ASP . . . . . 0.451 ' HB3' ' HB3' ' A' 1579 ' ' LYS . 38.7 m-20 71.67 -72.18 0.12 Allowed 'General case' 0 C--N 1.323 -0.565 0 C-N-CA 124.644 1.178 . . . . 2.54 111.936 -178.696 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A 1516 ' ' CYS . . . . . . . . . . . . . 85.7 m -124.4 41.38 3.51 Favored 'General case' 0 C--N 1.311 -1.069 0 CA-C-O 121.432 0.634 . . . . 1.25 110.99 -177.266 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A 1517 ' ' GLN . . . . . 0.414 ' HG3' ' HB3' ' A' 1514 ' ' ASP . 9.6 pt20 -161.21 168.62 23.82 Favored 'General case' 0 C--N 1.287 -2.132 0 N-CA-C 109.42 -0.585 . . . . 1.88 109.42 -179.562 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A 1518 ' ' VAL . . . . . . . . . . . . . 80.7 t -131.37 105.96 11.27 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.081 0 N-CA-C 108.497 -0.927 . . . . 1.73 108.497 176.111 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A 1519 ' ' THR . . . . . . . . . . . . . 20.4 m -86.16 102.14 13.62 Favored 'General case' 0 C--N 1.281 -2.376 0 N-CA-C 107.596 -1.261 . . . . 1.7 107.596 175.048 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A 1520 ' ' ASN . . . . . . . . . . . . . 31.4 t30 -92.0 105.41 13.57 Favored Pre-proline 0 C--N 1.322 -0.614 0 N-CA-C 109.859 -0.423 . . . . 2.12 109.859 179.809 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A 1521 ' ' PRO . . . . . . . . . . . . . 59.1 Cg_endo -72.72 -18.98 24.63 Favored 'Trans proline' 0 N--CA 1.458 -0.593 0 C-N-CA 122.383 2.055 . . . . 2.47 113.376 -175.123 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A 1522 ' ' SER . . . . . . . . . . . . . 32.6 m -61.27 -35.75 78.15 Favored 'General case' 0 CA--C 1.54 0.565 0 CA-C-O 120.818 0.342 . . . . 2.57 111.832 -178.393 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A 1523 ' ' THR . . . . . . . . . . . . . 12.3 t -120.21 -5.24 9.95 Favored 'General case' 0 CA--C 1.554 1.096 0 CA-C-O 122.074 0.94 . . . . 2.15 109.543 178.809 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A 1524 ' ' GLY . . . . . . . . . . . . . . . 73.97 20.18 79.73 Favored Glycine 0 C--N 1.335 0.526 0 CA-C-N 115.44 -0.8 . . . . 1.89 112.345 179.666 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A 1525 ' ' HIS . . . . . . . . . . . . . 12.9 t-80 -101.65 128.16 48.07 Favored 'General case' 0 C--N 1.314 -0.951 0 CA-C-O 120.797 0.332 . . . . 1.9 110.745 -177.869 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A 1526 ' ' LEU . . . . . . . . . . . . . 6.9 tt -100.34 130.71 46.48 Favored 'General case' 0 C--N 1.3 -1.579 0 N-CA-C 108.43 -0.952 . . . . 1.61 108.43 178.208 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A 1527 ' ' PHE . . . . . 0.675 ' HE1' ' HA ' ' A' 1646 ' ' CYS . 97.7 m-85 -95.78 102.95 14.81 Favored 'General case' 0 C--N 1.308 -1.199 0 N-CA-C 109.183 -0.673 . . . . 1.42 109.183 177.243 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A 1528 ' ' ASP . . . . . . . . . . . . . 4.9 p-10 -85.17 106.68 16.79 Favored 'General case' 0 C--N 1.314 -0.936 0 CA-C-O 122.389 1.09 . . . . 2.18 113.437 -178.285 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A 1529 ' ' LEU . . . . . 0.747 ' HG ' HD12 ' A' 1532 ' ' LEU . 7.4 mp -105.5 0.22 26.48 Favored 'General case' 0 C--N 1.312 -1.06 0 CA-C-N 114.78 -1.1 . . . . 1.44 108.148 172.398 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A 1530 ' ' SER . . . . . . . . . . . . . 2.6 p -68.3 -31.32 70.68 Favored 'General case' 0 N--CA 1.426 -1.641 0 CA-C-N 114.248 -1.342 . . . . 1.44 109.356 177.406 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A 1531 ' ' SER . . . . . . . . . . . . . 9.9 m -76.11 -7.91 55.8 Favored 'General case' 0 N--CA 1.443 -0.793 0 CA-C-N 115.03 -0.987 . . . . 1.5 110.358 177.759 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A 1532 ' ' LEU . . . . . 0.747 HD12 ' HG ' ' A' 1529 ' ' LEU . 81.7 mt -90.72 15.8 10.43 Favored 'General case' 0 C--O 1.238 0.485 0 CA-C-O 121.544 0.688 . . . . 1.77 111.676 -179.792 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A 1533 ' ' SER . . . . . . . . . . . . . 17.0 m -78.74 173.23 12.69 Favored 'General case' 0 N--CA 1.44 -0.955 0 N-CA-C 108.558 -0.904 . . . . 2.38 108.558 176.143 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A 1534 ' ' GLY . . . . . . . . . . . . . . . 165.5 147.44 5.16 Favored Glycine 0 N--CA 1.428 -1.897 0 C-N-CA 120.038 -1.077 . . . . 1.55 111.848 -178.997 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A 1535 ' ' ARG . . . . . 0.855 ' HG3' ' HG3' ' A' 1557 ' ' GLU . 43.6 ttm180 -60.35 -49.29 78.17 Favored 'General case' 0 C--O 1.246 0.907 0 C-N-CA 124.513 1.125 . . . . 3.96 110.301 179.562 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A 1536 ' ' ALA . . . . . 0.409 ' HA ' HD21 ' A' 1558 ' ' ASN . . . -95.68 -33.65 12.25 Favored 'General case' 0 N--CA 1.434 -1.266 0 N-CA-C 109.044 -0.724 . . . . 1.65 109.044 177.858 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A 1537 ' ' GLY . . . . . . . . . . . . . . . 84.19 -136.37 14.7 Favored Glycine 0 N--CA 1.428 -1.873 0 CA-C-N 114.496 -1.229 . . . . 1.19 111.963 177.73 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A 1538 ' ' PHE . . . . . 0.479 ' CD1' HD13 ' A' 1552 ' ' ILE . 54.2 m-85 -106.34 135.94 46.94 Favored 'General case' 0 C--N 1.295 -1.802 0 N-CA-C 108.207 -1.034 . . . . 1.69 108.207 177.88 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A 1539 ' ' THR . . . . . . . . . . . . . 19.2 p -113.35 117.99 33.33 Favored 'General case' 0 C--N 1.292 -1.927 0 CA-C-N 116.128 -0.487 . . . . 1.48 111.352 -178.509 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A 1540 ' ' ALA . . . . . . . . . . . . . . . -122.43 124.33 43.39 Favored 'General case' 0 C--N 1.313 -1.015 0 N-CA-C 109.932 -0.396 . . . . 0.83 109.932 179.77 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A 1541 ' ' ALA . . . . . . . . . . . . . . . -74.18 144.63 44.72 Favored 'General case' 0 C--O 1.251 1.156 0 CA-C-O 120.654 0.264 . . . . 1.27 110.521 179.247 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A 1542 ' ' TYR . . . . . . . . . . . . . 27.4 t80 -149.16 -173.64 4.43 Favored 'General case' 0 N--CA 1.437 -1.114 0 N-CA-C 109.148 -0.686 . . . . 2.15 109.148 -176.276 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A 1543 ' ' SER . . . . . . . . . . . . . 13.9 m -45.99 -152.78 0.0 OUTLIER 'General case' 0 CA--C 1.569 1.7 0 C-N-CA 129.707 3.203 . . . . 2.29 115.063 -178.799 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A 1544 ' ' LYS . . . . . . . . . . . . . 55.9 tptt -47.24 -29.52 2.46 Favored 'General case' 0 N--CA 1.486 1.336 0 O-C-N 121.266 -0.897 . . . . 3.91 112.774 178.677 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A 1545 ' ' SER . . . . . . . . . . . . . 4.3 p -61.74 -22.64 65.55 Favored 'General case' 0 CA--C 1.556 1.207 0 C-N-CA 123.053 0.541 . . . . 3.3 112.202 175.048 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A 1546 ' ' GLY . . . . . . . . . . . . . . . 89.49 -69.72 2.49 Favored Glycine 0 N--CA 1.431 -1.666 0 N-CA-C 113.867 0.307 . . . . 1.24 113.867 173.664 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A 1547 ' ' VAL . . . . . . . . . . . . . 7.2 p -158.79 138.61 3.73 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.925 0 N-CA-C 109.787 -0.449 . . . . 1.63 109.787 -173.606 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A 1548 ' ' VAL . . . . . . . . . . . . . 2.4 t -103.0 134.88 42.89 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.601 0 N-CA-C 108.548 -0.908 . . . . 0.92 108.548 -177.563 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A 1549 ' ' TYR . . . . . . . . . . . . . 97.9 m-85 -104.02 121.89 44.11 Favored 'General case' 0 C--N 1.311 -1.096 0 N-CA-C 107.112 -1.44 . . . . 1.44 107.112 173.717 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A 1550 ' ' MET . . . . . . . . . . . . . 71.5 mtm -131.07 122.17 26.27 Favored 'General case' 0 CA--C 1.488 -1.43 0 C-N-CA 120.217 -0.593 . . . . 1.74 112.195 177.913 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A 1551 ' ' SER . . . . . . . . . . . . . 53.2 m -103.03 105.17 15.44 Favored 'General case' 0 C--N 1.272 -2.803 0 N-CA-C 105.45 -2.056 . . . . 1.64 105.45 171.457 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A 1552 ' ' ILE . . . . . 0.479 HD13 ' CD1' ' A' 1538 ' ' PHE . 1.7 mp -52.48 -35.34 20.22 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.813 0 O-C-N 124.112 0.883 . . . . 1.33 112.133 -176.456 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A 1553 ' ' CYS . . . . . . . . . . . . . 93.9 m -145.7 155.66 43.13 Favored 'General case' 0 C--N 1.307 -1.249 0 N-CA-C 109.152 -0.685 . . . . 1.43 109.152 174.924 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A 1554 ' ' GLY . . . . . . . . . . . . . . . 102.66 -118.32 6.07 Favored Glycine 0 N--CA 1.441 -1.031 0 N-CA-C 110.366 -1.094 . . . . 1.12 110.366 -179.917 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A 1555 ' ' GLU . . . . . . . . . . . . . 17.0 pt-20 -157.9 148.32 20.6 Favored 'General case' 0 C--N 1.311 -1.107 0 N-CA-C 107.741 -1.207 . . . . 1.8 107.741 176.769 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A 1556 ' ' ASN . . . . . . . . . . . . . 21.0 t-20 -97.05 118.86 34.4 Favored 'General case' 0 C--N 1.305 -1.329 0 CA-C-O 121.543 0.687 . . . . 2.63 110.277 -178.609 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A 1557 ' ' GLU . . . . . 0.855 ' HG3' ' HG3' ' A' 1535 ' ' ARG . 12.0 mm-40 -82.53 11.97 5.11 Favored 'General case' 0 C--N 1.298 -1.644 0 CA-C-N 114.65 -1.159 . . . . 3.79 112.956 -172.429 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A 1558 ' ' ASN . . . . . 0.409 HD21 ' HA ' ' A' 1536 ' ' ALA . 39.2 m-80 -104.24 -9.02 18.92 Favored 'General case' 0 C--N 1.301 -1.528 0 O-C-N 121.726 -0.609 . . . . 1.52 110.662 -178.886 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A 1559 ' ' CYS . . . . . 0.685 ' HB3' ' HD2' ' A' 1560 ' ' PRO . 88.1 m -144.29 178.46 1.45 Allowed Pre-proline 0 C--N 1.302 -1.466 0 CA-C-O 117.199 -1.381 . . . . 0.84 108.154 -178.521 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A 1560 ' ' PRO . . . . . 0.685 ' HD2' ' HB3' ' A' 1559 ' ' CYS . 24.2 Cg_exo -29.4 125.69 0.05 OUTLIER 'Trans proline' 0 C--N 1.383 2.356 0 C-N-CA 124.772 3.648 . . . . 1.18 114.94 176.422 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A 1561 ' ' PRO . . . . . 0.465 ' HD3' ' HA ' ' A' 1560 ' ' PRO . 51.2 Cg_exo -55.52 115.99 2.84 Favored 'Trans proline' 0 C--O 1.244 0.782 0 C-N-CA 123.445 2.764 . . . . 1.51 112.964 -177.126 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A 1562 ' ' GLY . . . . . . . . . . . . . . . 114.11 -10.34 22.65 Favored Glycine 0 N--CA 1.439 -1.122 0 C-N-CA 120.455 -0.878 . . . . 0.72 113.275 177.187 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A 1563 ' ' VAL . . . . . 0.571 ' HA ' ' HA ' ' A' 1576 ' ' LYS . 5.1 m -90.65 152.37 3.35 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.183 0 N-CA-C 107.189 -1.411 . . . . 0.97 107.189 176.635 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A 1564 ' ' GLY . . . . . . . . . . . . . . . -117.23 -19.06 5.24 Favored Glycine 0 C--N 1.306 -1.127 0 C-N-CA 119.451 -1.357 . . . . 0.72 113.74 -176.25 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A 1565 ' ' ALA . . . . . . . . . . . . . . . -126.37 123.23 37.49 Favored 'General case' 0 C--O 1.25 1.095 0 N-CA-C 109.385 -0.598 . . . . 0.37 109.385 -179.851 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A 1566 ' ' CYS . . . . . . . . . . . . . 49.3 t -151.69 146.78 26.03 Favored 'General case' 0 C--N 1.312 -1.035 0 C-N-CA 121.056 -0.258 . . . . 0.51 111.126 -177.096 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A 1567 ' ' PHE . . . . . . . . . . . . . 31.4 m-85 -94.05 123.68 37.57 Favored 'General case' 0 C--O 1.247 0.965 0 CA-C-N 116.101 -0.5 . . . . 0.97 109.677 177.836 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A 1568 ' ' GLY . . . . . . . . . . . . . . . 50.62 -140.82 19.74 Favored Glycine 0 C--N 1.321 -0.289 0 O-C-N 123.893 0.745 . . . . 1.08 114.719 175.517 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A 1569 ' ' GLN . . . . . . . . . . . . . 49.0 tt0 -90.87 -58.23 2.55 Favored 'General case' 0 N--CA 1.43 -1.444 0 N-CA-C 109.558 -0.534 . . . . 2.74 109.558 179.993 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A 1570 ' ' THR . . . . . . . . . . . . . 14.8 p -123.01 34.13 5.21 Favored 'General case' 0 C--N 1.312 -1.043 0 CA-C-N 115.892 -0.594 . . . . 1.96 112.473 -176.668 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A 1571 ' ' ARG . . . . . . . . . . . . . 7.5 mpt_? -97.5 12.03 34.76 Favored 'General case' 0 N--CA 1.432 -1.328 0 C-N-CA 119.388 -0.925 . . . . 3.95 110.765 175.691 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A 1572 ' ' ILE . . . . . 0.446 HG22 ' HB2' ' A' 1596 ' ' SER . 75.9 mt 80.97 144.51 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.548 0.894 0 CA-C-N 114.112 -1.404 . . . . 1.37 114.371 165.581 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A 1573 ' ' SER . . . . . . . . . . . . . 36.3 p -82.01 134.89 35.4 Favored 'General case' 0 N--CA 1.438 -1.072 0 CA-C-N 114.582 -1.19 . . . . 1.08 111.113 -179.242 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A 1574 ' ' VAL . . . . . . . . . . . . . 19.0 m -123.22 30.43 2.24 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.228 0 N-CA-C 112.611 0.597 . . . . 1.3 112.611 -177.553 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A 1575 ' ' GLY . . . . . . . . . . . . . . . 173.56 122.68 0.68 Allowed Glycine 0 N--CA 1.434 -1.434 0 C-N-CA 119.989 -1.1 . . . . 0.51 112.799 177.753 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A 1576 ' ' LYS . . . . . 0.571 ' HA ' ' HA ' ' A' 1563 ' ' VAL . 66.6 tttm -76.8 143.09 40.05 Favored 'General case' 0 C--O 1.246 0.914 0 N-CA-C 106.835 -1.543 . . . . 2.9 106.835 175.787 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A 1577 ' ' ALA . . . . . . . . . . . . . . . -77.04 82.63 3.55 Favored 'General case' 0 C--N 1.304 -1.412 0 CA-C-O 121.642 0.734 . . . . 0.83 111.7 -175.23 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A 1578 ' ' ASN . . . . . . . . . . . . . 41.6 m-80 -89.47 147.44 24.0 Favored 'General case' 0 C--N 1.306 -1.3 0 N-CA-C 108.058 -1.09 . . . . 1.85 108.058 175.243 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A 1579 ' ' LYS . . . . . 0.451 ' HB3' ' HB3' ' A' 1515 ' ' ASP . 58.7 mttp -95.14 89.67 5.62 Favored 'General case' 0 C--N 1.283 -2.299 0 N-CA-C 105.746 -1.946 . . . . 1.9 105.746 175.331 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A 1580 ' ' ARG . . . . . 0.401 ' O ' ' HG ' ' A' 1590 ' ' LEU . 42.1 ttm180 -140.32 101.14 4.06 Favored 'General case' 0 C--N 1.297 -1.703 0 CA-C-N 115.346 -0.843 . . . . 3.63 110.003 -173.607 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A 1581 ' ' LEU . . . . . . . . . . . . . 41.0 tp -117.4 145.02 44.38 Favored 'General case' 0 C--N 1.289 -2.054 0 CA-C-N 115.151 -0.931 . . . . 1.87 109.462 -177.39 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A 1582 ' ' ARG . . . . . . . . . . . . . 97.0 mtt180 -119.44 125.27 48.54 Favored 'General case' 0 C--N 1.297 -1.713 0 CA-C-N 115.656 -0.702 . . . . 3.97 109.984 -179.729 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A 1583 ' ' TYR . . . . . 0.416 ' HD1' ' CD2' ' A' 1588 ' ' LEU . 22.6 t80 -108.09 97.89 7.52 Favored 'General case' 0 C--N 1.296 -1.727 0 N-CA-C 108.547 -0.909 . . . . 1.41 108.547 174.49 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A 1584 ' ' VAL . . . . . . . . . . . . . 1.1 m -140.07 121.28 14.91 Favored 'Isoleucine or valine' 0 CA--C 1.499 -0.981 0 N-CA-C 112.697 0.628 . . . . 1.69 112.697 -178.079 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A 1585 ' ' ASP . . . . . . . . . . . . . 30.9 t70 56.67 45.04 22.73 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-O 122.334 1.064 . . . . 2.06 111.082 171.613 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A 1586 ' ' GLN . . . . . . . . . . . . . 21.5 mt-30 58.82 18.25 5.92 Favored 'General case' 0 C--N 1.323 -0.548 0 N-CA-C 115.068 1.507 . . . . 2.33 115.068 -178.871 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A 1587 ' ' VAL . . . . . . . . . . . . . 12.4 p -120.69 133.37 67.6 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.331 0 N-CA-C 107.619 -1.252 . . . . 0.78 107.619 172.86 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A 1588 ' ' LEU . . . . . 0.426 ' HB2' ' HB2' ' A' 1612 ' ' PHE . 16.6 mt -103.24 133.09 48.91 Favored 'General case' 0 C--N 1.296 -1.746 0 N-CA-C 108.277 -1.008 . . . . 1.41 108.277 -177.104 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A 1589 ' ' GLN . . . . . . . . . . . . . 35.0 tt0 -134.31 115.78 14.49 Favored 'General case' 0 C--N 1.275 -2.639 0 C-N-CA 120.39 -0.524 . . . . 1.24 110.442 -175.496 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A 1590 ' ' LEU . . . . . 0.401 ' HG ' ' O ' ' A' 1580 ' ' ARG . 8.7 tt -106.74 128.96 54.66 Favored 'General case' 0 C--N 1.293 -1.849 0 N-CA-C 107.411 -1.329 . . . . 1.15 107.411 -179.25 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A 1591 ' ' VAL . . . . . . . . . . . . . 61.4 t -119.26 126.89 75.76 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.808 0 N-CA-C 112.792 0.664 . . . . 1.51 112.792 -170.355 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A 1592 ' ' TYR . . . . . 0.631 ' HB2' ' HB3' ' A' 1608 ' ' SER . 9.7 m-30 -108.53 149.23 29.13 Favored 'General case' 0 C--N 1.31 -1.135 0 CA-C-N 114.986 -1.006 . . . . 1.06 109.44 174.487 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A 1593 ' ' LYS . . . . . . . . . . . . . 18.4 ptpt -159.47 177.37 11.02 Favored 'General case' 0 C--N 1.296 -1.741 0 N-CA-C 107.371 -1.344 . . . . 2.18 107.371 178.578 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A 1594 ' ' ASP . . . . . 0.421 ' O ' ' HB2' ' A' 1576 ' ' LYS . 3.8 m-20 65.62 76.76 0.32 Allowed 'General case' 0 N--CA 1.483 1.206 0 O-C-N 124.038 0.837 . . . . 1.45 112.399 179.046 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A 1595 ' ' GLY . . . . . . . . . . . . . . . -143.08 -73.4 0.03 OUTLIER Glycine 0 N--CA 1.432 -1.57 0 N-CA-C 110.879 -0.889 . . . . 0.78 110.879 176.865 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A 1596 ' ' SER . . . . . 0.446 ' HB2' HG22 ' A' 1572 ' ' ILE . 31.1 t -114.86 139.6 24.4 Favored Pre-proline 0 C--N 1.288 -2.077 0 N-CA-C 109.534 -0.543 . . . . 1.68 109.534 179.621 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A 1597 ' ' PRO . . . . . . . . . . . . . 23.2 Cg_exo -68.39 144.28 61.13 Favored 'Trans proline' 0 N--CA 1.445 -1.361 0 N-CA-C 106.435 -2.179 . . . . 1.17 106.435 168.527 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A 1598 ' ' CYS . . . . . . . . . . . . . 19.1 t -95.17 125.26 51.03 Favored Pre-proline 0 C--N 1.286 -2.173 0 C-N-CA 120.065 -0.654 . . . . 1.19 110.287 -175.795 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A 1599 ' ' PRO . . . . . . . . . . . . . 84.6 Cg_endo -88.38 -4.04 6.69 Favored 'Trans proline' 0 N--CA 1.456 -0.73 0 C-N-CA 122.807 2.338 . . . . 1.59 111.698 177.079 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A 1600 ' ' SER . . . . . . . . . . . . . 16.3 m -86.35 109.11 18.77 Favored 'General case' 0 N--CA 1.425 -1.68 0 CA-C-N 115.865 -0.607 . . . . 2.12 109.994 -178.874 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A 1601 ' ' LYS . . . . . 0.813 ' HD2' ' HA ' ' A' 1632 ' ' GLN . 67.0 mttm 67.67 -86.71 0.03 OUTLIER 'General case' 0 C--O 1.242 0.684 0 C-N-CA 124.067 0.947 . . . . 3.74 113.358 178.571 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A 1602 ' ' SER . . . . . 0.837 ' HB3' HD22 ' A' 1604 ' ' LEU . 29.1 t -96.66 150.47 20.63 Favored 'General case' 0 N--CA 1.422 -1.867 0 N-CA-C 108.781 -0.822 . . . . 3.79 108.781 -175.5 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A 1603 ' ' GLY . . . . . . . . . . . . . . . -83.64 59.61 4.95 Favored Glycine 0 N--CA 1.435 -1.43 0 N-CA-C 110.331 -1.108 . . . . 2.0 110.331 176.425 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A 1604 ' ' LEU . . . . . 0.837 HD22 ' HB3' ' A' 1602 ' ' SER . 2.0 pt? -105.32 -175.35 2.77 Favored 'General case' 0 C--N 1.302 -1.494 0 CA-C-N 115.704 -0.248 . . . . 1.48 110.82 -176.982 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A 1605 ' ' SER . . . . . . . . . . . . . 5.0 p -83.81 -176.19 6.17 Favored 'General case' 0 C--N 1.294 -1.829 0 CA-C-O 121.249 0.547 . . . . 1.51 111.25 -178.568 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A 1606 ' ' TYR . . . . . . . . . . . . . 5.1 m-85 -116.76 128.5 55.37 Favored 'General case' 0 CA--C 1.469 -2.144 0 N-CA-C 106.882 -1.525 . . . . 1.18 106.882 177.426 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A 1607 ' ' LYS . . . . . . . . . . . . . 20.6 ptmt -119.32 118.93 32.53 Favored 'General case' 0 N--CA 1.407 -2.618 0 CA-C-O 121.536 0.684 . . . . 1.67 110.204 -178.535 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A 1608 ' ' SER . . . . . 0.631 ' HB3' ' HB2' ' A' 1592 ' ' TYR . 33.4 t -103.5 106.8 17.41 Favored 'General case' 0 C--N 1.288 -2.083 0 N-CA-C 108.056 -1.09 . . . . 1.0 108.056 -177.277 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A 1609 ' ' VAL . . . . . . . . . . . . . 66.2 t -107.49 115.44 48.74 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.5 0 CA-C-O 121.012 0.434 . . . . 0.93 110.862 -176.597 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A 1610 ' ' ILE . . . . . 0.6 ' HA ' ' HB2' ' A' 1638 ' ' PHE . 3.3 mp -103.78 111.17 32.42 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.21 0 N-CA-C 108.074 -1.084 . . . . 0.78 108.074 178.095 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A 1611 ' ' SER . . . . . 0.55 ' O ' ' HA ' ' A' 1639 ' ' SER . 18.8 m -104.43 129.83 52.37 Favored 'General case' 0 C--N 1.303 -1.451 0 CA-C-O 121.368 0.604 . . . . 1.29 110.706 -179.858 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A 1612 ' ' PHE . . . . . 0.426 ' HB2' ' HB2' ' A' 1588 ' ' LEU . 92.2 m-85 -101.55 113.18 26.07 Favored 'General case' 0 C--N 1.292 -1.899 0 N-CA-C 108.342 -0.984 . . . . 0.7 108.342 -179.524 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A 1613 ' ' VAL . . . . . . . . . . . . . 92.2 t -106.43 132.18 54.28 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.176 0 N-CA-C 109.538 -0.541 . . . . 0.75 109.538 -176.594 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A 1614 ' ' CYS . . . . . . . . . . . . . 62.6 m -67.48 99.51 0.76 Allowed 'General case' 0 C--N 1.322 -0.611 0 CA-C-O 121.573 0.701 . . . . 1.39 112.526 -177.559 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A 1615 ' ' ARG . . . . . 0.472 ' HB3' ' HB3' ' A' 1641 ' ' HIS . 20.3 tpp180 -137.28 85.45 21.75 Favored Pre-proline 0 N--CA 1.429 -1.479 0 CA-C-N 114.851 -1.068 . . . . 3.75 108.164 176.352 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A 1616 ' ' PRO . . . . . . . . . . . . . 16.4 Cg_exo -71.68 -13.22 29.66 Favored 'Trans proline' 0 C--N 1.357 0.984 0 C-N-CA 123.327 2.684 . . . . 1.32 110.227 178.153 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A 1617 ' ' GLU . . . . . 0.433 ' HB3' ' CD ' ' A' 1615 ' ' ARG . 43.7 tt0 -82.54 41.16 0.7 Allowed 'General case' 0 C--N 1.304 -1.388 0 C-N-CA 126.067 1.747 . . . . 3.21 107.963 176.459 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A 1618 ' ' ALA . . . . . . . . . . . . . . . -160.51 179.05 8.93 Favored 'General case' 0 C--N 1.305 -1.364 0 N-CA-C 105.127 -2.175 . . . . 2.44 105.127 -179.017 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A 1619 ' ' GLY . . . . . . . . . . . . . . . -147.42 -160.54 8.94 Favored Glycine 0 N--CA 1.433 -1.549 0 C-N-CA 119.054 -1.546 . . . . 3.26 112.802 -178.045 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A 1620 ' ' PRO . . . . . . . . . . . . . 56.2 Cg_endo -70.61 -4.98 15.69 Favored 'Trans proline' 0 C--O 1.24 0.606 0 C-N-CA 123.283 2.656 . . . . 5.92 112.803 -177.722 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A 1621 ' ' THR . . . . . . . . . . . . . 15.6 m -79.75 -21.63 44.23 Favored 'General case' 0 N--CA 1.439 -1.023 0 CA-C-O 121.174 0.511 . . . . 4.76 109.901 179.169 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A 1622 ' ' ASN . . . . . . . . . . . . . 29.1 t-20 -82.61 159.27 22.75 Favored 'General case' 0 N--CA 1.45 -0.455 0 N-CA-C 107.058 -1.46 . . . . 2.92 107.058 178.849 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A 1623 ' ' ARG . . . . . . . . . . . . . 4.9 ptp180 -153.12 164.49 20.2 Favored Pre-proline 0 C--N 1.301 -1.538 0 N-CA-C 108.887 -0.783 . . . . 3.61 108.887 -176.34 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A 1624 ' ' PRO . . . . . . . . . . . . . 22.7 Cg_exo -65.34 100.05 0.38 Allowed 'Trans proline' 0 C--N 1.361 1.234 0 C-N-CA 122.588 2.192 . . . . 2.37 110.813 177.059 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A 1625 ' ' MET . . . . . . . . . . . . . 23.4 ptp -108.72 148.65 30.14 Favored 'General case' 0 C--N 1.302 -1.457 0 CA-C-N 115.443 -0.798 . . . . 2.16 109.694 -177.17 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A 1626 ' ' LEU . . . . . 0.497 ' HG ' ' CE1' ' A' 1638 ' ' PHE . 38.1 mt -71.01 109.74 5.29 Favored 'General case' 0 C--N 1.309 -1.184 0 CA-C-N 115.978 -0.556 . . . . 1.35 110.369 174.667 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A 1627 ' ' ILE . . . . . . . . . . . . . 40.8 pt -92.4 -23.74 5.55 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.306 0 CA-C-N 115.115 -0.948 . . . . 1.21 109.185 177.321 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A 1628 ' ' SER . . . . . . . . . . . . . 51.1 m -154.53 149.84 27.13 Favored 'General case' 0 N--CA 1.428 -1.574 0 CA-C-N 115.452 -0.795 . . . . 1.4 109.403 -179.088 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A 1629 ' ' LEU . . . . . 0.746 HD13 ' HG ' ' A' 1636 ' ' LEU . 20.2 tp -143.28 112.25 6.59 Favored 'General case' 0 C--N 1.297 -1.701 0 N-CA-C 108.697 -0.853 . . . . 1.56 108.697 177.984 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A 1630 ' ' ASP . . . . . . . . . . . . . 13.4 t70 -100.26 108.15 20.15 Favored 'General case' 0 C--N 1.296 -1.728 0 N-CA-C 108.605 -0.887 . . . . 0.87 108.605 -178.26 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A 1631 ' ' LYS . . . . . . . . . . . . . 92.1 mttt -92.51 5.44 50.82 Favored 'General case' 0 C--N 1.293 -1.871 0 CA-C-O 120.947 0.403 . . . . 2.35 111.43 -177.293 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A 1632 ' ' GLN . . . . . 0.813 ' HA ' ' HD2' ' A' 1601 ' ' LYS . 33.5 mt-30 -85.55 -41.2 15.5 Favored 'General case' 0 N--CA 1.437 -1.098 0 N-CA-C 108.491 -0.929 . . . . 2.55 108.491 178.53 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A 1633 ' ' THR . . . . . . . . . . . . . 32.6 m -106.9 -2.44 21.3 Favored 'General case' 0 CA--C 1.564 1.516 0 CA-C-O 122.111 0.957 . . . . 1.24 110.256 176.917 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A 1634 ' ' CYS . . . . . . . . . . . . . 51.2 m 63.78 47.59 3.54 Favored 'General case' 0 N--CA 1.471 0.592 0 CA-C-O 122.675 1.226 . . . . 0.89 110.007 176.852 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A 1635 ' ' THR . . . . . . . . . . . . . 24.2 m -112.43 121.63 45.38 Favored 'General case' 0 N--CA 1.423 -1.824 0 CA-C-N 113.836 -1.529 . . . . 0.75 109.887 -175.774 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A 1636 ' ' LEU . . . . . 0.746 ' HG ' HD13 ' A' 1629 ' ' LEU . 5.5 mp -99.4 126.18 45.24 Favored 'General case' 0 C--N 1.305 -1.35 0 N-CA-C 108.812 -0.81 . . . . 1.33 108.812 179.061 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A 1637 ' ' PHE . . . . . . . . . . . . . 94.1 m-85 -108.08 94.82 5.28 Favored 'General case' 0 C--O 1.249 1.078 0 CA-C-O 121.012 0.434 . . . . 0.83 111.193 -177.774 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A 1638 ' ' PHE . . . . . 0.6 ' HB2' ' HA ' ' A' 1610 ' ' ILE . 99.7 m-85 -90.94 144.62 25.48 Favored 'General case' 0 CA--C 1.487 -1.458 0 N-CA-C 107.917 -1.142 . . . . 0.6 107.917 175.751 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A 1639 ' ' SER . . . . . 0.55 ' HA ' ' O ' ' A' 1611 ' ' SER . 66.8 m -141.7 133.08 26.62 Favored 'General case' 0 C--N 1.273 -2.737 0 CA-C-O 120.852 0.358 . . . . 1.08 111.187 177.267 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A 1640 ' ' TRP . . . . . 0.435 ' HZ3' HD13 ' A' 1532 ' ' LEU . 8.3 t90 -118.93 112.56 19.79 Favored 'General case' 0 N--CA 1.426 -1.674 0 N-CA-C 107.799 -1.186 . . . . 0.8 107.799 175.688 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A 1641 ' ' HIS . . . . . 0.472 ' HB3' ' HB3' ' A' 1615 ' ' ARG . 13.4 m170 -82.43 98.42 8.88 Favored 'General case' 0 C--N 1.297 -1.704 0 N-CA-C 107.315 -1.365 . . . . 2.54 107.315 175.311 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A 1642 ' ' THR . . . . . . . . . . . . . 9.2 t -143.1 147.81 42.49 Favored Pre-proline 0 C--N 1.305 -1.335 0 CA-C-N 115.406 -0.815 . . . . 1.15 111.394 -170.414 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A 1643 ' ' PRO . . . . . . . . . . . . . 34.6 Cg_endo -70.11 -12.04 31.49 Favored 'Trans proline' 0 C--N 1.353 0.778 0 C-N-CA 123.067 2.511 . . . . 0.8 111.106 171.837 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A 1644 ' ' LEU . . . . . . . . . . . . . 94.1 mt -75.55 -6.32 49.66 Favored 'General case' 0 N--CA 1.465 0.291 0 CA-C-N 116.241 -0.436 . . . . 1.54 111.699 178.74 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A 1645 ' ' ALA . . . . . . . . . . . . . . . -81.11 -42.52 20.83 Favored 'General case' 0 C--N 1.318 -0.778 0 N-CA-C 108.745 -0.835 . . . . 0.95 108.745 175.791 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A 1646 ' ' CYS . . . . . 0.675 ' HA ' ' HE1' ' A' 1527 ' ' PHE . 19.3 p -169.44 116.45 0.59 Allowed 'General case' 0 N--CA 1.432 -1.348 0 N-CA-C 107.717 -1.216 . . . . 1.41 107.717 173.645 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A 1647 ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -74.31 148.15 85.89 Favored Pre-proline 0 C--N 1.309 -1.194 0 CA-C-N 116.088 -0.506 . . . . 2.92 109.779 179.17 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A 1648 ' ' PRO . . . . . . . . . . . . . 12.6 Cg_endo -52.97 109.46 0.36 Allowed 'Trans proline' 0 C--N 1.353 0.801 0 C-N-CA 124.559 3.506 . . . . 2.82 114.446 -175.051 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A 1649 ' ' GLU . . . . . . . . . . . . . 42.5 tt0 . . . . . 0 N--CA 1.422 -1.833 0 N-CA-C 106.98 -1.489 . . . . 5.06 106.98 175.78 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A 1508 ' ' MET . . . . . . . . . . . . . 27.1 ttt . . . . . 0 C--O 1.235 0.324 0 N-CA-C 109.958 -0.386 . . . . 8.27 109.958 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A 1509 ' ' LYS . . . . . . . . . . . . . 64.9 tttp -113.74 131.09 56.32 Favored 'General case' 0 N--CA 1.441 -0.918 0 N-CA-C 109.293 -0.632 . . . . 6.48 109.293 179.819 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A 1510 ' ' SER . . . . . . . . . . . . . 32.1 m 62.76 59.46 1.42 Allowed 'General case' 0 C--O 1.253 1.252 0 O-C-N 124.377 1.048 . . . . 4.22 110.45 179.904 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A 1511 ' ' ASN . . . . . . . . . . . . . 76.1 m-20 -79.03 0.25 28.5 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 115.082 -0.963 . . . . 3.08 110.659 -178.48 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A 1512 ' ' GLU . . . . . 0.923 ' HA ' ' HB3' ' A' 1581 ' ' LEU . 1.8 mp0 -47.15 -29.68 2.42 Favored 'General case' 0 N--CA 1.472 0.658 0 C-N-CA 124.604 1.162 . . . . 4.46 112.359 178.104 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A 1513 ' ' HIS . . . . . . . . . . . . . 5.7 p80 -133.65 42.55 2.96 Favored 'General case' 0 C--N 1.309 -1.17 0 CA-C-O 121.824 0.821 . . . . 5.57 109.666 179.692 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A 1514 ' ' ASP . . . . . . . . . . . . . 14.4 t70 -131.28 -62.3 0.89 Allowed 'General case' 0 C--N 1.317 -0.829 0 CA-C-N 115.287 -0.869 . . . . 3.7 110.319 -179.61 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A 1515 ' ' ASP . . . . . . . . . . . . . 16.5 t70 -154.92 168.06 28.23 Favored 'General case' 0 C--N 1.317 -0.835 0 N-CA-C 107.057 -1.46 . . . . 2.54 107.057 -174.583 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A 1516 ' ' CYS . . . . . 0.669 ' HB3' ' HB2' ' A' 1529 ' ' LEU . 34.3 m -87.5 59.7 5.63 Favored 'General case' 0 C--N 1.305 -1.356 0 N-CA-C 109.556 -0.535 . . . . 1.25 109.556 -177.283 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A 1517 ' ' GLN . . . . . 0.502 ' HA ' ' O ' ' A' 1527 ' ' PHE . 11.3 pt20 -148.41 138.54 22.49 Favored 'General case' 0 C--N 1.306 -1.292 0 N-CA-C 109.211 -0.662 . . . . 1.88 109.211 -179.785 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A 1518 ' ' VAL . . . . . . . . . . . . . 10.1 p -144.57 133.31 18.17 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.889 0 CA-C-O 120.921 0.391 . . . . 1.73 110.258 179.326 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A 1519 ' ' THR . . . . . 0.501 ' O ' ' HD3' ' A' 1521 ' ' PRO . 21.4 m -93.8 128.98 40.34 Favored 'General case' 0 C--N 1.292 -1.926 0 N-CA-C 108.926 -0.768 . . . . 1.7 108.926 179.158 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A 1520 ' ' ASN . . . . . . . . . . . . . 22.8 t30 -101.71 94.84 4.68 Favored Pre-proline 0 C--N 1.314 -0.974 0 N-CA-C 108.722 -0.844 . . . . 2.12 108.722 172.501 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A 1521 ' ' PRO . . . . . 0.501 ' HD3' ' O ' ' A' 1519 ' ' THR . 52.8 Cg_exo -55.27 -20.87 26.6 Favored 'Trans proline' 0 C--N 1.365 1.399 0 C-N-CA 123.68 2.92 . . . . 2.47 114.242 -177.257 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A 1522 ' ' SER . . . . . . . . . . . . . 19.9 t -64.47 -30.01 71.05 Favored 'General case' 0 CA--C 1.549 0.927 0 CA-C-O 120.834 0.349 . . . . 2.57 111.099 178.573 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A 1523 ' ' THR . . . . . . . . . . . . . 8.8 t -122.82 -14.84 7.59 Favored 'General case' 0 CA--C 1.545 0.753 0 C-N-CA 120.484 -0.487 . . . . 2.15 110.611 178.257 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A 1524 ' ' GLY . . . . . . . . . . . . . . . 89.22 -13.96 62.12 Favored Glycine 0 C--O 1.22 -0.744 0 CA-C-N 116.394 -0.366 . . . . 1.89 113.805 177.202 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A 1525 ' ' HIS . . . . . . . . . . . . . 13.7 t-160 -79.31 127.62 32.3 Favored 'General case' 0 C--N 1.311 -1.068 0 CA-C-O 121.289 0.566 . . . . 1.9 111.862 -175.616 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A 1526 ' ' LEU . . . . . 0.47 HD11 ' HB2' ' A' 1517 ' ' GLN . 41.9 tp -84.67 127.61 34.18 Favored 'General case' 0 C--N 1.315 -0.927 0 CA-C-N 114.685 -1.143 . . . . 1.61 107.969 173.084 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A 1527 ' ' PHE . . . . . 0.502 ' O ' ' HA ' ' A' 1517 ' ' GLN . 70.9 m-85 -99.01 119.02 37.09 Favored 'General case' 0 C--N 1.288 -2.073 0 N-CA-C 108.831 -0.803 . . . . 1.42 108.831 178.398 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A 1528 ' ' ASP . . . . . . . . . . . . . 10.9 t70 -105.24 124.18 49.11 Favored 'General case' 0 CA--C 1.487 -1.469 0 CA-C-O 121.189 0.518 . . . . 2.18 110.316 179.314 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A 1529 ' ' LEU . . . . . 0.669 ' HB2' ' HB3' ' A' 1516 ' ' CYS . 69.8 mt -108.59 -19.8 13.31 Favored 'General case' 0 C--N 1.294 -1.831 0 CA-C-N 114.922 -1.036 . . . . 1.44 108.914 177.213 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A 1530 ' ' SER . . . . . 0.404 ' OG ' ' HB2' ' A' 1516 ' ' CYS . 24.9 m -57.85 -37.87 74.65 Favored 'General case' 0 C--O 1.24 0.566 0 C-N-CA 123.626 0.77 . . . . 1.44 112.763 -176.634 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A 1531 ' ' SER . . . . . . . . . . . . . 50.5 p -87.43 1.07 54.49 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-O 120.906 0.384 . . . . 1.5 111.625 178.948 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A 1532 ' ' LEU . . . . . . . . . . . . . 96.1 mt -88.13 14.76 8.54 Favored 'General case' 0 CA--C 1.544 0.726 0 N-CA-C 113.12 0.785 . . . . 1.77 113.12 179.394 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A 1533 ' ' SER . . . . . 0.408 ' OG ' ' HB ' ' A' 1552 ' ' ILE . 46.1 m -113.38 108.78 17.69 Favored 'General case' 0 C--N 1.314 -0.964 0 O-C-N 121.591 -0.693 . . . . 2.38 110.898 178.84 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A 1534 ' ' GLY . . . . . . . . . . . . . . . -86.08 -127.29 2.01 Favored Glycine 0 C--O 1.22 -0.743 0 C-N-CA 120.69 -0.767 . . . . 1.55 111.499 176.714 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A 1535 ' ' ARG . . . . . . . . . . . . . 19.4 tpt180 -83.18 -52.8 6.29 Favored 'General case' 0 C--N 1.311 -1.081 0 CA-C-N 117.108 0.454 . . . . 3.96 109.958 178.36 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A 1536 ' ' ALA . . . . . 0.426 ' HB1' ' HD1' ' A' 1549 ' ' TYR . . . -96.12 -21.48 17.9 Favored 'General case' 0 C--N 1.312 -1.064 0 CA-C-O 121.216 0.531 . . . . 1.65 109.623 178.944 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A 1537 ' ' GLY . . . . . . . . . . . . . . . 90.66 -92.16 1.74 Allowed Glycine 0 N--CA 1.425 -2.058 0 N-CA-C 108.057 -2.017 . . . . 1.19 108.057 -175.925 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A 1538 ' ' PHE . . . . . . . . . . . . . 47.2 m-85 -136.85 158.32 44.73 Favored 'General case' 0 C--N 1.295 -1.799 0 N-CA-C 109.151 -0.685 . . . . 1.69 109.151 174.17 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A 1539 ' ' THR . . . . . . . . . . . . . 5.8 p -127.99 142.97 51.09 Favored 'General case' 0 C--N 1.296 -1.737 0 CA-C-N 116.506 -0.315 . . . . 1.48 111.295 -176.878 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A 1540 ' ' ALA . . . . . . . . . . . . . . . -131.21 140.12 49.82 Favored 'General case' 0 C--N 1.302 -1.479 0 N-CA-C 109.416 -0.587 . . . . 0.83 109.416 176.796 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A 1541 ' ' ALA . . . . . . . . . . . . . . . -86.21 133.43 33.85 Favored 'General case' 0 C--N 1.312 -1.034 0 N-CA-C 108.107 -1.071 . . . . 1.27 108.107 178.642 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A 1542 ' ' TYR . . . . . 0.602 ' HD2' ' HB2' ' A' 1545 ' ' SER . 76.6 t80 -136.12 166.56 23.11 Favored 'General case' 0 C--N 1.301 -1.531 0 N-CA-C 109.448 -0.575 . . . . 2.15 109.448 -175.747 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A 1543 ' ' SER . . . . . . . . . . . . . 16.0 t -48.67 -150.32 0.0 OUTLIER 'General case' 0 CA--C 1.577 1.997 0 C-N-CA 127.916 2.486 . . . . 2.29 112.886 176.229 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A 1544 ' ' LYS . . . . . . . . . . . . . 95.7 mttt -38.92 -30.75 0.05 Allowed 'General case' 0 CA--C 1.567 1.62 0 C-N-CA 124.986 1.314 . . . . 3.91 114.442 -178.619 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A 1545 ' ' SER . . . . . 0.602 ' HB2' ' HD2' ' A' 1542 ' ' TYR . 15.3 m -72.59 -10.69 60.1 Favored 'General case' 0 CA--C 1.579 2.076 0 N-CA-C 112.617 0.599 . . . . 3.3 112.617 177.254 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A 1546 ' ' GLY . . . . . . . . . . . . . . . 85.2 -80.15 1.84 Allowed Glycine 0 C--O 1.244 0.725 0 N-CA-C 115.049 0.78 . . . . 1.24 115.049 171.965 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A 1547 ' ' VAL . . . . . . . . . . . . . 7.8 p -146.39 143.09 21.06 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.475 0 CA-C-O 120.997 0.427 . . . . 1.63 109.914 -174.126 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A 1548 ' ' VAL . . . . . . . . . . . . . 2.1 t -109.86 135.1 49.9 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.414 0 N-CA-C 107.979 -1.119 . . . . 0.92 107.979 -179.058 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A 1549 ' ' TYR . . . . . 0.426 ' HD1' ' HB1' ' A' 1536 ' ' ALA . 80.1 m-85 -100.63 131.19 46.67 Favored 'General case' 0 C--N 1.313 -1.006 0 N-CA-C 106.522 -1.659 . . . . 1.44 106.522 173.266 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A 1550 ' ' MET . . . . . . . . . . . . . 68.1 mtp -126.08 122.44 35.8 Favored 'General case' 0 C--N 1.298 -1.647 0 CA-C-N 116.569 -0.287 . . . . 1.74 110.242 -171.436 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A 1551 ' ' SER . . . . . 0.618 ' CB ' ' HB3' ' A' 1556 ' ' ASN . 19.6 p -105.83 133.37 50.67 Favored 'General case' 0 N--CA 1.419 -1.997 0 CA-C-O 122.082 0.944 . . . . 1.64 111.1 -179.514 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A 1552 ' ' ILE . . . . . 0.451 HG22 ' SG ' ' A' 1553 ' ' CYS . 1.7 mp -76.38 -42.88 36.46 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.023 0 CA-C-N 114.355 -1.293 . . . . 1.33 111.499 -176.943 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A 1553 ' ' CYS . . . . . 0.451 ' SG ' HG22 ' A' 1552 ' ' ILE . 46.5 m -130.92 135.99 48.18 Favored 'General case' 0 C--N 1.307 -1.243 0 N-CA-C 108.636 -0.876 . . . . 1.43 108.636 174.626 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A 1554 ' ' GLY . . . . . 0.427 ' HA2' ' HB1' ' A' 1577 ' ' ALA . . . 54.57 -155.74 7.88 Favored Glycine 0 C--O 1.247 0.928 0 O-C-N 124.46 1.1 . . . . 1.12 111.981 179.371 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A 1555 ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -89.9 146.66 24.25 Favored 'General case' 0 N--CA 1.413 -2.295 0 C-N-CA 119.056 -1.058 . . . . 1.8 108.945 170.924 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A 1556 ' ' ASN . . . . . 0.618 ' HB3' ' CB ' ' A' 1551 ' ' SER . 4.3 t30 -170.37 61.41 0.04 OUTLIER 'General case' 0 C--N 1.282 -2.347 0 N-CA-C 107.388 -1.338 . . . . 2.63 107.388 -171.65 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A 1557 ' ' GLU . . . . . 0.558 ' CD ' ' H ' ' A' 1558 ' ' ASN 0.388 0.3 OUTLIER -157.58 -119.92 0.02 OUTLIER 'General case' 0 CA--C 1.553 1.09 0 N-CA-C 116.101 1.889 . . . . 3.79 116.101 -177.402 . . . . . . . . 4 4 . 1 . 013 nuclear nobuild full ' A' A 1558 ' ' ASN . . . . . 0.558 ' H ' ' CD ' ' A' 1557 ' ' GLU . 40.4 m-80 -139.6 -5.68 1.36 Allowed 'General case' 0 CA--C 1.55 0.96 0 N-CA-C 113.029 0.752 . . . . 1.52 113.029 -175.849 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A 1559 ' ' CYS . . . . . 0.481 ' HB3' ' HD2' ' A' 1560 ' ' PRO . 43.7 m -91.36 170.22 10.03 Favored Pre-proline 0 C--N 1.317 -0.809 0 CA-C-O 119.161 -0.447 . . . . 0.84 109.937 179.015 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A 1560 ' ' PRO . . . . . 0.481 ' HD2' ' HB3' ' A' 1559 ' ' CYS . 91.6 Cg_exo -45.83 129.01 11.66 Favored 'Trans proline' 0 C--N 1.364 1.374 0 C-N-CA 122.853 2.369 . . . . 1.18 111.348 174.633 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A 1561 ' ' PRO . . . . . 0.452 ' HD3' ' HA ' ' A' 1560 ' ' PRO . 53.3 Cg_exo -56.21 115.65 2.62 Favored 'Trans proline' 0 C--O 1.241 0.642 0 C-N-CA 123.268 2.646 . . . . 1.51 112.505 -178.133 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A 1562 ' ' GLY . . . . . . . . . . . . . . . 155.05 -21.43 0.58 Allowed Glycine 0 N--CA 1.443 -0.881 0 N-CA-C 111.619 -0.593 . . . . 0.72 111.619 -179.08 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A 1563 ' ' VAL . . . . . 0.437 ' HA ' ' HA ' ' A' 1576 ' ' LYS . 25.6 m -80.68 161.21 3.92 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.121 0 CA-C-O 121.486 0.66 . . . . 0.97 111.885 178.004 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A 1564 ' ' GLY . . . . . 0.601 ' HA3' ' CD2' ' A' 1592 ' ' TYR . . . -119.98 0.14 13.28 Favored Glycine 0 N--CA 1.424 -2.142 0 N-CA-C 108.845 -1.702 . . . . 0.72 108.845 166.718 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A 1565 ' ' ALA . . . . . . . . . . . . . . . -170.22 125.54 0.77 Allowed 'General case' 0 C--O 1.246 0.911 0 N-CA-C 108.511 -0.922 . . . . 0.37 108.511 178.312 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A 1566 ' ' CYS . . . . . . . . . . . . . 48.8 t -149.98 145.01 26.2 Favored 'General case' 0 C--N 1.309 -1.159 0 C-N-CA 121.141 -0.224 . . . . 0.51 110.45 -175.513 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A 1567 ' ' PHE . . . . . . . . . . . . . 26.8 m-85 -69.87 124.17 23.35 Favored 'General case' 0 C--O 1.217 -0.656 0 N-CA-C 107.548 -1.279 . . . . 0.97 107.548 174.179 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A 1568 ' ' GLY . . . . . 0.425 ' HA3' ' CE2' ' A' 1549 ' ' TYR . . . -70.06 -31.53 69.45 Favored Glycine 0 CA--C 1.498 -1.001 0 C-N-CA 121.02 -0.609 . . . . 1.08 114.032 -173.667 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A 1569 ' ' GLN . . . . . . . . . . . . . 34.5 tt0 -84.57 -53.24 5.53 Favored 'General case' 0 C--N 1.304 -1.394 0 CA-C-O 121.444 0.64 . . . . 2.74 109.853 -179.219 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A 1570 ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -77.19 -23.73 51.45 Favored 'General case' 0 C--N 1.307 -1.25 0 CA-C-N 115.133 -0.939 . . . . 1.96 113.019 -173.177 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A 1571 ' ' ARG . . . . . 0.403 ' HA ' ' SG ' ' A' 1559 ' ' CYS . 91.5 mtt180 60.97 36.57 18.64 Favored 'General case' 0 CA--C 1.511 -0.548 0 C-N-CA 125.02 1.328 . . . . 3.95 113.39 179.101 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A 1572 ' ' ILE . . . . . . . . . . . . . 44.0 mm -106.0 122.62 59.86 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.131 0 N-CA-C 108.462 -0.94 . . . . 1.37 108.462 179.473 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A 1573 ' ' SER . . . . . . . . . . . . . 41.5 t -66.86 128.54 36.71 Favored 'General case' 0 C--N 1.308 -1.239 0 C-N-CA 124.231 1.012 . . . . 1.08 111.201 179.562 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A 1574 ' ' VAL . . . . . 0.542 ' HA ' ' HB2' ' A' 1606 ' ' TYR . 35.4 m -118.8 18.01 6.8 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.236 0 CA-C-O 122.023 0.916 . . . . 1.3 110.335 178.004 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A 1575 ' ' GLY . . . . . . . . . . . . . . . 167.25 123.64 0.67 Allowed Glycine 0 N--CA 1.43 -1.725 0 CA-C-N 114.299 -1.319 . . . . 0.51 109.941 178.339 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A 1576 ' ' LYS . . . . . 0.437 ' HA ' ' HA ' ' A' 1563 ' ' VAL . 62.0 mttp -84.32 153.72 23.34 Favored 'General case' 0 CA--C 1.498 -1.021 0 CA-C-O 121.201 0.524 . . . . 2.9 110.427 179.478 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A 1577 ' ' ALA . . . . . 0.478 ' HA ' ' CE2' ' A' 1592 ' ' TYR . . . -59.65 104.23 0.26 Allowed 'General case' 0 C--N 1.307 -1.244 0 CA-C-N 114.025 -1.443 . . . . 0.83 111.287 178.028 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A 1578 ' ' ASN . . . . . . . . . . . . . 45.7 m-80 -135.32 123.05 22.33 Favored 'General case' 0 C--N 1.301 -1.502 0 N-CA-C 105.974 -1.862 . . . . 1.85 105.974 177.027 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A 1579 ' ' LYS . . . . . . . . . . . . . 36.6 ttpt -94.34 89.8 6.03 Favored 'General case' 0 C--N 1.285 -2.227 0 N-CA-C 108.388 -0.967 . . . . 1.9 108.388 -174.583 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A 1580 ' ' ARG . . . . . . . . . . . . . 72.8 ttt180 -127.64 109.86 12.1 Favored 'General case' 0 N--CA 1.419 -1.991 0 CA-C-N 114.631 -1.168 . . . . 3.63 109.128 -179.095 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A 1581 ' ' LEU . . . . . 0.923 ' HB3' ' HA ' ' A' 1512 ' ' GLU . 2.3 tm? -96.25 141.94 29.0 Favored 'General case' 0 C--N 1.3 -1.563 0 CA-C-N 114.649 -1.16 . . . . 1.87 108.143 -177.868 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A 1582 ' ' ARG . . . . . 0.458 ' N ' HD13 ' A' 1581 ' ' LEU . 4.7 tpt180 -145.84 141.79 28.22 Favored 'General case' 0 C--N 1.304 -1.376 0 N-CA-C 108.638 -0.875 . . . . 3.97 108.638 173.274 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A 1583 ' ' TYR . . . . . . . . . . . . . 46.9 t80 -137.05 103.58 5.18 Favored 'General case' 0 C--N 1.321 -0.645 0 N-CA-C 109.206 -0.665 . . . . 1.41 109.206 179.051 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A 1584 ' ' VAL . . . . . . . . . . . . . 26.9 m -134.69 140.26 45.97 Favored 'Isoleucine or valine' 0 C--O 1.201 -1.453 0 N-CA-C 109.64 -0.504 . . . . 1.69 109.64 -178.484 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A 1585 ' ' ASP . . . . . . . . . . . . . 8.9 t70 43.98 52.46 6.73 Favored 'General case' 0 N--CA 1.492 1.646 0 C-N-CA 125.06 1.344 . . . . 2.06 113.088 175.184 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A 1586 ' ' GLN . . . . . . . . . . . . . 19.0 mm-40 61.93 22.39 13.02 Favored 'General case' 0 CA--C 1.553 1.091 0 C-N-CA 123.89 0.876 . . . . 2.33 112.853 178.815 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A 1587 ' ' VAL . . . . . 0.5 HG23 ' O ' ' A' 1612 ' ' PHE . 9.4 p -134.06 125.02 47.71 Favored 'Isoleucine or valine' 0 C--O 1.245 0.833 0 O-C-N 121.455 -0.778 . . . . 0.78 111.785 177.451 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A 1588 ' ' LEU . . . . . 0.696 ' HB2' ' HB2' ' A' 1612 ' ' PHE . 79.3 mt -85.99 155.31 20.92 Favored 'General case' 0 C--N 1.313 -1.0 0 CA-C-N 114.942 -1.026 . . . . 1.41 110.731 177.314 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A 1589 ' ' GLN . . . . . 0.514 ' HA ' ' O ' ' A' 1610 ' ' ILE . 6.9 tt0 -150.4 133.36 16.06 Favored 'General case' 0 C--N 1.318 -0.795 0 N-CA-C 112.33 0.493 . . . . 1.24 112.33 -179.447 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A 1590 ' ' LEU . . . . . 0.621 ' HG ' ' HE1' ' A' 1612 ' ' PHE . 96.0 mt -104.0 125.52 50.43 Favored 'General case' 0 C--O 1.248 1.006 0 N-CA-C 106.982 -1.488 . . . . 1.15 106.982 172.068 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A 1591 ' ' VAL . . . . . . . . . . . . . 40.4 t -105.72 102.56 14.05 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.498 0 C-N-CA 120.757 -0.377 . . . . 1.51 110.119 179.827 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A 1592 ' ' TYR . . . . . 0.601 ' CD2' ' HA3' ' A' 1564 ' ' GLY . 27.7 m-85 -117.55 92.96 3.98 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-O 121.379 0.609 . . . . 1.06 109.422 177.788 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A 1593 ' ' LYS . . . . . . . . . . . . . 21.3 pttp -110.85 -177.55 3.25 Favored 'General case' 0 C--N 1.305 -1.358 0 N-CA-C 112.569 0.581 . . . . 2.18 112.569 -175.901 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A 1594 ' ' ASP . . . . . 0.408 ' HA ' ' HB2' ' A' 1605 ' ' SER . 18.2 m-20 52.77 59.43 4.48 Favored 'General case' 0 N--CA 1.466 0.355 0 C-N-CA 124.931 1.292 . . . . 1.45 113.598 175.212 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A 1595 ' ' GLY . . . . . 0.424 ' HA2' ' HG3' ' A' 1576 ' ' LYS . . . -83.34 -107.35 0.51 Allowed Glycine 0 N--CA 1.438 -1.167 0 C-N-CA 120.517 -0.849 . . . . 0.78 111.719 177.631 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A 1596 ' ' SER . . . . . . . . . . . . . 23.0 t -106.23 145.47 31.04 Favored Pre-proline 0 C--N 1.291 -1.94 0 N-CA-C 107.545 -1.279 . . . . 1.68 107.545 -179.839 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A 1597 ' ' PRO . . . . . . . . . . . . . 77.3 Cg_exo -53.29 134.21 55.95 Favored 'Trans proline' 0 C--N 1.362 1.286 0 C-N-CA 123.558 2.839 . . . . 1.17 111.523 178.654 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A 1598 ' ' CYS . . . . . . . . . . . . . 50.6 t -95.05 125.66 49.75 Favored Pre-proline 0 C--N 1.289 -2.042 0 CA-C-N 115.41 -0.814 . . . . 1.19 109.883 -173.569 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A 1599 ' ' PRO . . . . . . . . . . . . . 58.4 Cg_endo -71.86 -13.91 29.45 Favored 'Trans proline' 0 C--N 1.346 0.395 0 C-N-CA 122.971 2.447 . . . . 1.59 112.497 -179.375 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A 1600 ' ' SER . . . . . . . . . . . . . 19.3 m -74.3 -20.46 60.11 Favored 'General case' 0 N--CA 1.439 -1.002 0 CA-C-N 116.019 -0.537 . . . . 2.12 111.06 179.984 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A 1601 ' ' LYS . . . . . 0.414 ' HA ' ' HD2' ' A' 1601 ' ' LYS . 20.9 tptm -156.68 104.13 2.14 Favored 'General case' 0 N--CA 1.433 -1.314 0 N-CA-C 109.052 -0.721 . . . . 3.74 109.052 177.109 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A 1602 ' ' SER . . . . . . . . . . . . . 7.4 p -61.27 107.41 0.75 Allowed 'General case' 0 C--N 1.303 -1.432 0 CA-C-N 115.294 -0.866 . . . . 3.79 112.086 -178.654 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A 1603 ' ' GLY . . . . . . . . . . . . . . . 136.13 -5.38 3.93 Favored Glycine 0 N--CA 1.434 -1.498 0 C-N-CA 120.576 -0.821 . . . . 2.0 113.367 177.91 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A 1604 ' ' LEU . . . . . . . . . . . . . 3.0 pp -140.27 161.81 36.77 Favored 'General case' 0 C--N 1.311 -1.092 0 CA-C-N 117.586 0.693 . . . . 1.48 112.067 -178.727 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A 1605 ' ' SER . . . . . 0.408 ' HB2' ' HA ' ' A' 1594 ' ' ASP . 21.7 m -102.78 -174.99 2.69 Favored 'General case' 0 C--N 1.307 -1.259 0 N-CA-C 109.062 -0.718 . . . . 1.51 109.062 178.016 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A 1606 ' ' TYR . . . . . 0.542 ' HB2' ' HA ' ' A' 1574 ' ' VAL . 96.1 m-85 -95.34 153.36 17.72 Favored 'General case' 0 CA--C 1.472 -2.036 0 N-CA-C 105.768 -1.938 . . . . 1.18 105.768 179.495 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A 1607 ' ' LYS . . . . . 0.5 ' HG3' HG23 ' A' 1635 ' ' THR . 25.2 pttm -137.63 146.44 43.93 Favored 'General case' 0 N--CA 1.403 -2.783 0 C-N-CA 118.634 -1.226 . . . . 1.67 110.202 173.054 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A 1608 ' ' SER . . . . . . . . . . . . . 49.9 m -118.69 126.7 52.48 Favored 'General case' 0 C--N 1.305 -1.336 0 CA-C-O 121.235 0.541 . . . . 1.0 110.845 -179.174 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A 1609 ' ' VAL . . . . . . . . . . . . . 56.2 t -111.23 116.91 53.79 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.932 0 N-CA-C 109.565 -0.531 . . . . 0.93 109.565 177.798 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A 1610 ' ' ILE . . . . . 0.595 ' HB ' ' HB2' ' A' 1590 ' ' LEU . 29.3 mm -92.52 111.65 24.72 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.989 0 N-CA-C 108.652 -0.87 . . . . 0.78 108.652 177.349 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A 1611 ' ' SER . . . . . . . . . . . . . 6.3 m -102.67 119.54 39.01 Favored 'General case' 0 C--N 1.29 -2.015 0 N-CA-C 108.146 -1.057 . . . . 1.29 108.146 179.386 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A 1612 ' ' PHE . . . . . 0.696 ' HB2' ' HB2' ' A' 1588 ' ' LEU . 69.5 m-85 -91.47 105.3 17.66 Favored 'General case' 0 C--N 1.297 -1.699 0 N-CA-C 109.196 -0.668 . . . . 0.7 109.196 -178.833 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A 1613 ' ' VAL . . . . . 0.506 ' O ' ' HA ' ' A' 1641 ' ' HIS . 56.6 t -99.09 124.96 52.66 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.164 0 CA-C-N 115.868 -0.605 . . . . 0.75 109.587 -175.672 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A 1614 ' ' CYS . . . . . 0.597 ' HB3' ' HG3' ' A' 1648 ' ' PRO . 34.5 m -71.14 93.97 1.1 Allowed 'General case' 0 C--N 1.304 -1.401 0 CA-C-O 121.505 0.669 . . . . 1.39 112.711 -178.192 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A 1615 ' ' ARG . . . . . 0.721 ' HB3' ' HB2' ' A' 1641 ' ' HIS . 28.5 ttm180 -136.15 92.61 15.81 Favored Pre-proline 0 C--N 1.307 -1.264 0 CA-C-N 115.361 -0.836 . . . . 3.75 110.562 176.607 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A 1616 ' ' PRO . . . . . 0.468 ' HB3' ' HB3' ' A' 1643 ' ' PRO . 12.0 Cg_exo -75.42 18.59 0.57 Allowed 'Trans proline' 0 CA--C 1.535 0.574 0 C-N-CA 123.558 2.839 . . . . 1.32 112.895 176.925 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A 1617 ' ' GLU . . . . . . . . . . . . . 42.3 mt-10 -126.69 23.95 6.66 Favored 'General case' 0 C--N 1.312 -1.026 0 CA-C-O 120.971 0.415 . . . . 3.21 110.285 -178.613 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A 1618 ' ' ALA . . . . . . . . . . . . . . . -77.5 -32.58 54.27 Favored 'General case' 0 C--N 1.315 -0.928 0 CA-C-O 121.066 0.46 . . . . 2.44 110.504 -176.726 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A 1619 ' ' GLY . . . . . . . . . . . . . . . 60.39 -118.77 15.9 Favored Glycine 0 N--CA 1.44 -1.095 0 CA-C-N 114.903 -1.044 . . . . 3.26 112.668 176.188 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A 1620 ' ' PRO . . . . . . . . . . . . . 49.5 Cg_endo -69.04 -22.64 35.08 Favored 'Trans proline' 0 CA--C 1.529 0.236 0 C-N-CA 123.008 2.472 . . . . 5.92 112.755 -179.508 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A 1621 ' ' THR . . . . . . . . . . . . . 7.5 t -104.4 34.76 2.96 Favored 'General case' 0 N--CA 1.428 -1.57 0 CA-C-O 122.471 1.129 . . . . 4.76 109.946 -177.444 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A 1622 ' ' ASN . . . . . . . . . . . . . 49.5 t-20 -75.91 70.93 2.69 Favored 'General case' 0 C--O 1.243 0.711 0 N-CA-C 107.231 -1.396 . . . . 2.92 107.231 174.774 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A 1623 ' ' ARG . . . . . . . . . . . . . 16.2 ptm180 -147.89 153.64 42.58 Favored Pre-proline 0 N--CA 1.437 -1.089 0 CA-C-N 114.996 -1.002 . . . . 3.61 108.805 -174.943 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A 1624 ' ' PRO . . . . . 0.497 ' HA ' ' HA ' ' A' 1640 ' ' TRP . 8.1 Cg_exo -73.77 111.01 3.19 Favored 'Trans proline' 0 C--O 1.238 0.519 0 C-N-CA 122.705 2.27 . . . . 2.37 110.75 178.581 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A 1625 ' ' MET . . . . . . . . . . . . . 26.7 ptt? -100.15 154.3 18.55 Favored 'General case' 0 C--N 1.303 -1.418 0 CA-C-N 116.026 -0.534 . . . . 2.16 109.846 -178.041 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A 1626 ' ' LEU . . . . . . . . . . . . . 56.4 tp -87.4 106.92 18.29 Favored 'General case' 0 C--N 1.301 -1.51 0 N-CA-C 108.747 -0.835 . . . . 1.35 108.747 -179.036 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A 1627 ' ' ILE . . . . . . . . . . . . . 2.8 pp -85.83 -36.02 10.16 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.205 0 C-N-CA 119.921 -0.712 . . . . 1.21 112.758 -177.272 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A 1628 ' ' SER . . . . . . . . . . . . . 49.3 m -157.67 143.92 17.65 Favored 'General case' 0 C--N 1.316 -0.86 0 N-CA-C 110.155 -0.313 . . . . 1.4 110.155 179.428 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A 1629 ' ' LEU . . . . . 0.887 ' HG ' ' HG ' ' A' 1636 ' ' LEU . 5.1 tt -130.33 118.53 21.41 Favored 'General case' 0 C--N 1.301 -1.506 0 N-CA-C 106.343 -1.725 . . . . 1.56 106.343 176.183 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A 1630 ' ' ASP . . . . . . . . . . . . . 20.1 t70 -93.36 117.25 29.86 Favored 'General case' 0 C--N 1.29 -2.005 0 N-CA-C 108.541 -0.911 . . . . 0.87 108.541 178.82 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A 1631 ' ' LYS . . . . . . . . . . . . . 95.7 mttt -83.37 1.52 40.94 Favored 'General case' 0 C--N 1.314 -0.937 0 N-CA-C 112.445 0.535 . . . . 2.35 112.445 -174.983 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A 1632 ' ' GLN . . . . . . . . . . . . . 1.5 mp0 -96.68 -45.7 6.59 Favored 'General case' 0 C--N 1.315 -0.905 0 CA-C-O 121.359 0.6 . . . . 2.55 110.318 -178.424 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A 1633 ' ' THR . . . . . . . . . . . . . 41.6 p -95.39 -5.99 41.97 Favored 'General case' 0 C--N 1.305 -1.348 0 CA-C-O 121.793 0.806 . . . . 1.24 110.286 177.87 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A 1634 ' ' CYS . . . . . . . . . . . . . 83.4 m 56.69 51.33 11.17 Favored 'General case' 0 C--N 1.347 0.475 0 CA-C-N 113.569 -1.65 . . . . 0.89 110.789 -179.394 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A 1635 ' ' THR . . . . . 0.5 HG23 ' HG3' ' A' 1607 ' ' LYS . 24.8 m -111.54 124.36 52.13 Favored 'General case' 0 N--CA 1.425 -1.723 0 CA-C-N 114.109 -1.405 . . . . 0.75 109.651 -176.093 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A 1636 ' ' LEU . . . . . 0.887 ' HG ' ' HG ' ' A' 1629 ' ' LEU . 5.1 mp -105.83 126.72 52.5 Favored 'General case' 0 C--N 1.309 -1.186 0 N-CA-C 109.481 -0.563 . . . . 1.33 109.481 178.519 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A 1637 ' ' PHE . . . . . . . . . . . . . 91.0 m-85 -105.91 111.46 24.11 Favored 'General case' 0 C--N 1.31 -1.139 0 CA-C-N 116.135 -0.484 . . . . 0.83 110.232 -178.831 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A 1638 ' ' PHE . . . . . . . . . . . . . 94.8 m-85 -106.42 128.25 53.91 Favored 'General case' 0 C--N 1.303 -1.436 0 N-CA-C 109.432 -0.581 . . . . 0.6 109.432 178.988 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A 1639 ' ' SER . . . . . . . . . . . . . 67.2 m -112.75 114.64 27.3 Favored 'General case' 0 C--N 1.278 -2.538 0 CA-C-O 121.132 0.491 . . . . 1.08 110.288 179.663 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A 1640 ' ' TRP . . . . . 0.497 ' HA ' ' HA ' ' A' 1624 ' ' PRO . 14.8 t90 -96.26 90.8 5.6 Favored 'General case' 0 N--CA 1.425 -1.699 0 N-CA-C 107.755 -1.202 . . . . 0.8 107.755 176.955 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A 1641 ' ' HIS . . . . . 0.721 ' HB2' ' HB3' ' A' 1615 ' ' ARG . 0.8 OUTLIER -71.87 99.13 2.14 Favored 'General case' 0 C--N 1.311 -1.097 0 CA-C-N 115.223 -0.898 . . . . 2.54 110.072 175.093 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A 1642 ' ' THR . . . . . . . . . . . . . 5.6 t -142.89 149.59 50.15 Favored Pre-proline 0 C--N 1.295 -1.77 0 CA-C-N 114.741 -1.118 . . . . 1.15 109.009 -172.655 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A 1643 ' ' PRO . . . . . 0.468 ' HB3' ' HB3' ' A' 1616 ' ' PRO . 45.6 Cg_endo -73.07 -9.85 23.89 Favored 'Trans proline' 0 C--O 1.215 -0.675 0 C-N-CA 122.858 2.372 . . . . 0.8 112.301 176.187 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A 1644 ' ' LEU . . . . . . . . . . . . . 81.9 mt -87.69 3.83 46.4 Favored 'General case' 0 C--N 1.318 -0.801 0 C-N-CA 122.713 0.405 . . . . 1.54 111.292 -177.748 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A 1645 ' ' ALA . . . . . . . . . . . . . . . -80.45 -30.13 37.55 Favored 'General case' 0 C--N 1.317 -0.822 0 N-CA-C 112.383 0.512 . . . . 0.95 112.383 -176.61 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A 1646 ' ' CYS . . . . . 0.567 ' O ' ' HD3' ' A' 1648 ' ' PRO . 21.1 p -172.06 -179.57 2.4 Favored 'General case' 0 C--N 1.306 -1.297 0 N-CA-C 105.667 -1.975 . . . . 1.41 105.667 179.594 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A 1647 ' ' GLU . . . . . . . . . . . . . 56.3 mm-40 -100.02 97.17 5.67 Favored Pre-proline 0 C--N 1.312 -1.024 0 N-CA-C 107.747 -1.205 . . . . 2.92 107.747 174.479 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A 1648 ' ' PRO . . . . . 0.597 ' HG3' ' HB3' ' A' 1614 ' ' CYS . 46.5 Cg_endo -95.78 126.87 0.35 Allowed 'Trans proline' 0 N--CA 1.44 -1.666 0 C-N-CA 123.077 2.518 . . . . 2.82 112.647 -177.452 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A 1649 ' ' GLU . . . . . . . . . . . . . 2.9 mp0 . . . . . 0 C--N 1.301 -1.526 0 N-CA-C 109.021 -0.733 . . . . 5.06 109.021 176.428 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A 1508 ' ' MET . . . . . . . . . . . . . 50.6 ttm . . . . . 0 C--O 1.232 0.168 0 N-CA-C 109.073 -0.714 . . . . 8.27 109.073 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A 1509 ' ' LYS . . . . . . . . . . . . . 13.2 ptmm? -153.82 148.08 25.88 Favored 'General case' 0 C--N 1.31 -1.113 0 N-CA-C 107.832 -1.173 . . . . 6.48 107.832 179.186 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A 1510 ' ' SER . . . . . . . . . . . . . 20.8 t -125.31 -7.93 7.0 Favored 'General case' 0 C--N 1.305 -1.35 0 C-N-CA 120.509 -0.476 . . . . 4.22 111.045 -174.845 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A 1511 ' ' ASN . . . . . . . . . . . . . 27.8 p-10 -65.78 -6.9 13.23 Favored 'General case' 0 C--O 1.202 -1.439 0 C-N-CA 123.435 0.694 . . . . 3.08 112.588 -179.412 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A 1512 ' ' GLU . . . . . . . . . . . . . 9.6 pt-20 -102.83 5.82 38.87 Favored 'General case' 0 C--N 1.308 -1.232 0 CA-C-O 121.33 0.586 . . . . 4.46 110.347 178.294 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A 1513 ' ' HIS . . . . . 0.569 ' HD2' ' HA ' ' A' 1580 ' ' ARG . 36.0 m80 -138.67 -41.23 0.49 Allowed 'General case' 0 N--CA 1.471 0.596 0 CA-C-N 115.98 -0.555 . . . . 5.57 111.628 -177.796 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A 1514 ' ' ASP . . . . . . . . . . . . . 13.7 t70 -64.07 -45.75 87.37 Favored 'General case' 0 N--CA 1.469 0.513 0 N-CA-C 108.914 -0.773 . . . . 3.7 108.914 179.507 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A 1515 ' ' ASP . . . . . . . . . . . . . 23.6 t70 -140.7 157.24 45.72 Favored 'General case' 0 C--N 1.311 -1.085 0 N-CA-C 107.158 -1.423 . . . . 2.54 107.158 179.507 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A 1516 ' ' CYS . . . . . . . . . . . . . 71.0 m -83.98 77.24 9.96 Favored 'General case' 0 C--N 1.303 -1.425 0 CA-C-O 121.048 0.451 . . . . 1.25 110.363 179.427 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A 1517 ' ' GLN . . . . . . . . . . . . . 3.5 pt20 -142.54 152.98 43.17 Favored 'General case' 0 C--N 1.306 -1.283 0 O-C-N 121.977 -0.452 . . . . 1.88 111.375 -178.56 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A 1518 ' ' VAL . . . . . 0.561 ' HB ' ' HD2' ' A' 1527 ' ' PHE . 59.2 t -138.59 130.51 37.49 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.86 0 N-CA-C 109.315 -0.624 . . . . 1.73 109.315 -179.759 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A 1519 ' ' THR . . . . . . . . . . . . . 26.6 m -102.67 115.33 30.36 Favored 'General case' 0 C--N 1.306 -1.303 0 N-CA-C 108.217 -1.031 . . . . 1.7 108.217 173.982 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A 1520 ' ' ASN . . . . . . . . . . . . . 25.9 t-20 -74.17 130.43 82.62 Favored Pre-proline 0 C--N 1.313 -0.98 0 N-CA-C 110.122 -0.325 . . . . 2.12 110.122 178.934 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A 1521 ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -74.75 -16.92 20.63 Favored 'Trans proline' 0 CA--C 1.543 0.947 0 C-N-CA 122.744 2.296 . . . . 2.47 114.749 -176.375 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A 1522 ' ' SER . . . . . . . . . . . . . 16.5 m -91.93 -60.86 1.75 Allowed 'General case' 0 C--N 1.314 -0.942 0 N-CA-C 112.044 0.387 . . . . 2.57 112.044 -176.32 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A 1523 ' ' THR . . . . . . . . . . . . . 8.8 t -94.71 -10.06 32.85 Favored 'General case' 0 C--N 1.316 -0.861 0 CA-C-O 121.474 0.654 . . . . 2.15 111.202 -176.153 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A 1524 ' ' GLY . . . . . . . . . . . . . . . 75.0 18.46 80.2 Favored Glycine 0 C--O 1.223 -0.559 0 CA-C-N 115.871 -0.604 . . . . 1.89 112.61 179.093 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A 1525 ' ' HIS . . . . . . . . . . . . . 17.6 t60 -75.65 128.07 34.43 Favored 'General case' 0 C--N 1.308 -1.212 0 N-CA-C 109.751 -0.463 . . . . 1.9 109.751 -176.95 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A 1526 ' ' LEU . . . . . . . . . . . . . 3.5 tm? -94.39 120.15 34.2 Favored 'General case' 0 C--N 1.299 -1.603 0 N-CA-C 106.626 -1.62 . . . . 1.61 106.626 177.451 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A 1527 ' ' PHE . . . . . 0.561 ' HD2' ' HB ' ' A' 1518 ' ' VAL . 86.1 m-85 -89.03 109.94 20.71 Favored 'General case' 0 C--N 1.297 -1.679 0 CA-C-N 116.525 -0.307 . . . . 1.42 110.28 -178.574 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A 1528 ' ' ASP . . . . . . . . . . . . . 13.5 m-20 -81.8 87.3 6.36 Favored 'General case' 0 CA--C 1.494 -1.198 0 CA-C-N 115.913 -0.585 . . . . 2.18 110.484 179.556 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A 1529 ' ' LEU . . . . . 0.702 ' HA ' HD23 ' A' 1532 ' ' LEU . 85.7 mt -99.09 -9.61 23.62 Favored 'General case' 0 C--N 1.302 -1.493 0 N-CA-C 108.95 -0.759 . . . . 1.44 108.95 178.269 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A 1530 ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -62.98 -25.4 68.36 Favored 'General case' 0 C--N 1.318 -0.781 0 C-N-CA 125.166 1.386 . . . . 1.44 109.314 175.623 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A 1531 ' ' SER . . . . . . . . . . . . . 34.3 t -77.34 -9.21 58.7 Favored 'General case' 0 N--CA 1.427 -1.582 0 CA-C-N 114.279 -1.328 . . . . 1.5 109.654 -179.699 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A 1532 ' ' LEU . . . . . 0.702 HD23 ' HA ' ' A' 1529 ' ' LEU . 3.5 mm? -95.87 10.03 38.55 Favored 'General case' 0 C--O 1.245 0.855 0 CA-C-N 115.898 -0.592 . . . . 1.77 111.356 177.805 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A 1533 ' ' SER . . . . . 0.565 ' HA ' ' O ' ' A' 1553 ' ' CYS . 42.3 m -76.58 107.79 9.12 Favored 'General case' 0 N--CA 1.436 -1.15 0 N-CA-C 107.745 -1.206 . . . . 2.38 107.745 172.894 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A 1534 ' ' GLY . . . . . . . . . . . . . . . -110.19 151.33 17.49 Favored Glycine 0 N--CA 1.436 -1.366 0 C-N-CA 120.655 -0.783 . . . . 1.55 112.957 -174.343 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A 1535 ' ' ARG . . . . . . . . . . . . . 40.7 ttm180 -72.36 -62.53 1.41 Allowed 'General case' 0 C--N 1.314 -0.942 0 CA-C-O 121.149 0.499 . . . . 3.96 110.38 178.451 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A 1536 ' ' ALA . . . . . . . . . . . . . . . -93.57 -6.38 46.75 Favored 'General case' 0 C--N 1.309 -1.19 0 C-N-CA 120.028 -0.669 . . . . 1.65 109.484 179.386 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A 1537 ' ' GLY . . . . . . . . . . . . . . . 79.49 -152.85 36.26 Favored Glycine 0 N--CA 1.436 -1.359 0 CA-C-N 115.454 -0.794 . . . . 1.19 112.671 176.397 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A 1538 ' ' PHE . . . . . . . . . . . . . 87.1 m-85 -120.18 155.07 33.86 Favored 'General case' 0 C--N 1.29 -2.003 0 N-CA-C 107.754 -1.202 . . . . 1.69 107.754 179.885 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A 1539 ' ' THR . . . . . . . . . . . . . 24.1 p -112.14 111.93 23.18 Favored 'General case' 0 C--N 1.293 -1.865 0 CA-C-O 121.359 0.599 . . . . 1.48 111.068 -179.409 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A 1540 ' ' ALA . . . . . . . . . . . . . . . -96.8 139.26 33.12 Favored 'General case' 0 C--N 1.3 -1.568 0 N-CA-C 109.075 -0.713 . . . . 0.83 109.075 -179.618 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A 1541 ' ' ALA . . . . . . . . . . . . . . . -80.69 132.87 35.62 Favored 'General case' 0 C--N 1.311 -1.107 0 CA-C-N 115.862 -0.608 . . . . 1.27 110.159 -177.79 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A 1542 ' ' TYR . . . . . 0.477 ' HB3' ' O ' ' A' 1546 ' ' GLY . 45.6 t80 -145.75 156.25 43.48 Favored 'General case' 0 C--N 1.313 -0.999 0 CA-C-N 116.402 -0.363 . . . . 2.15 110.499 -179.134 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A 1543 ' ' SER . . . . . . . . . . . . . 5.5 m -41.25 -153.07 0.0 OUTLIER 'General case' 0 CA--C 1.585 2.305 0 C-N-CA 129.921 3.288 . . . . 2.29 116.58 -176.426 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A 1544 ' ' LYS . . . . . . . . . . . . . 61.2 mttp -51.7 -24.77 6.13 Favored 'General case' 0 N--CA 1.484 1.274 0 O-C-N 120.627 -1.296 . . . . 3.91 113.773 -179.655 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A 1545 ' ' SER . . . . . . . . . . . . . 22.7 t -71.98 -14.71 61.97 Favored 'General case' 0 CA--C 1.553 1.076 0 N-CA-C 111.87 0.322 . . . . 3.3 111.87 178.239 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A 1546 ' ' GLY . . . . . 0.477 ' O ' ' HB3' ' A' 1542 ' ' TYR . . . 96.07 -153.36 20.53 Favored Glycine 0 C--O 1.216 -1.031 0 C-N-CA 119.707 -1.235 . . . . 1.24 113.763 173.491 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A 1547 ' ' VAL . . . . . . . . . . . . . 95.6 t -91.96 139.87 17.11 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.653 0 C-N-CA 123.11 0.564 . . . . 1.63 110.47 -173.751 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A 1548 ' ' VAL . . . . . . . . . . . . . 2.4 t -103.27 131.32 51.96 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.971 0 N-CA-C 107.679 -1.23 . . . . 0.92 107.679 179.211 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A 1549 ' ' TYR . . . . . 0.419 ' CE1' ' HA3' ' A' 1568 ' ' GLY . 75.9 m-85 -97.1 115.19 27.06 Favored 'General case' 0 C--N 1.295 -1.789 0 N-CA-C 107.17 -1.418 . . . . 1.44 107.17 175.129 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A 1550 ' ' MET . . . . . . . . . . . . . 2.7 ppp? -138.34 142.5 39.71 Favored 'General case' 0 C--N 1.291 -1.957 0 CA-C-O 121.172 0.511 . . . . 1.74 111.829 -177.611 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A 1551 ' ' SER . . . . . . . . . . . . . 47.3 m -109.04 149.59 29.04 Favored 'General case' 0 C--N 1.279 -2.463 0 N-CA-C 108.084 -1.08 . . . . 1.64 108.084 177.417 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A 1552 ' ' ILE . . . . . . . . . . . . . 41.6 mm -74.49 -51.64 22.25 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.627 0 N-CA-C 107.385 -1.339 . . . . 1.33 107.385 176.188 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A 1553 ' ' CYS . . . . . 0.565 ' O ' ' HA ' ' A' 1533 ' ' SER . 80.9 m -134.27 147.53 50.65 Favored 'General case' 0 C--N 1.29 -2.01 0 N-CA-C 107.346 -1.353 . . . . 1.43 107.346 175.141 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A 1554 ' ' GLY . . . . . . . . . . . . . . . 97.99 176.05 33.45 Favored Glycine 0 N--CA 1.427 -1.952 0 C-N-CA 120.591 -0.814 . . . . 1.12 111.433 178.294 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A 1555 ' ' GLU . . . . . . . . . . . . . 10.9 pt-20 -89.84 145.74 24.94 Favored 'General case' 0 C--N 1.303 -1.451 0 N-CA-C 109.823 -0.436 . . . . 1.8 109.823 -179.828 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A 1556 ' ' ASN . . . . . . . . . . . . . 20.9 t-20 -93.02 114.24 26.74 Favored 'General case' 0 C--N 1.305 -1.343 0 N-CA-C 108.543 -0.91 . . . . 2.63 108.543 -178.608 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A 1557 ' ' GLU . . . . . . . . . . . . . 51.2 mt-10 -87.23 51.34 2.21 Favored 'General case' 0 C--N 1.294 -1.832 0 N-CA-C 113.178 0.807 . . . . 3.79 113.178 -172.505 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A 1558 ' ' ASN . . . . . . . . . . . . . 36.6 m-80 -133.99 -0.12 3.12 Favored 'General case' 0 C--N 1.311 -1.105 0 CA-C-N 115.781 -0.645 . . . . 1.52 109.79 175.839 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A 1559 ' ' CYS . . . . . 0.63 ' HB3' ' HD2' ' A' 1560 ' ' PRO . 87.4 m -150.86 171.87 5.96 Favored Pre-proline 0 C--N 1.311 -1.08 0 N-CA-C 106.959 -1.497 . . . . 0.84 106.959 -178.764 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A 1560 ' ' PRO . . . . . 0.63 ' HD2' ' HB3' ' A' 1559 ' ' CYS . 44.2 Cg_exo -27.63 129.61 0.03 OUTLIER 'Trans proline' 0 C--N 1.384 2.435 0 C-N-CA 124.948 3.765 . . . . 1.18 114.526 177.454 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A 1561 ' ' PRO . . . . . 0.509 ' HD3' ' HA ' ' A' 1560 ' ' PRO . 37.3 Cg_exo -58.36 116.33 3.17 Favored 'Trans proline' 0 C--O 1.241 0.663 0 C-N-CA 123.277 2.651 . . . . 1.51 112.365 -178.188 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A 1562 ' ' GLY . . . . . . . . . . . . . . . 122.33 -9.94 9.38 Favored Glycine 0 N--CA 1.442 -0.9 0 C-N-CA 120.798 -0.715 . . . . 0.72 112.905 177.858 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A 1563 ' ' VAL . . . . . 0.421 ' HA ' ' HA ' ' A' 1576 ' ' LYS . 2.4 m -92.64 153.72 3.27 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.093 0 N-CA-C 107.85 -1.167 . . . . 0.97 107.85 179.242 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A 1564 ' ' GLY . . . . . . . . . . . . . . . -118.68 -18.73 4.71 Favored Glycine 0 C--N 1.297 -1.585 0 C-N-CA 120.284 -0.96 . . . . 0.72 112.656 -177.21 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A 1565 ' ' ALA . . . . . . . . . . . . . . . -139.5 122.35 16.56 Favored 'General case' 0 C--N 1.314 -0.941 0 N-CA-C 108.862 -0.792 . . . . 0.37 108.862 178.994 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A 1566 ' ' CYS . . . . . . . . . . . . . 39.6 t -150.28 144.44 25.56 Favored 'General case' 0 C--N 1.306 -1.297 0 CA-C-N 116.599 -0.273 . . . . 0.51 110.586 -174.812 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A 1567 ' ' PHE . . . . . . . . . . . . . 26.1 m-85 -76.89 123.85 26.88 Favored 'General case' 0 C--O 1.211 -0.96 0 N-CA-C 107.599 -1.259 . . . . 0.97 107.599 175.38 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A 1568 ' ' GLY . . . . . 0.419 ' HA3' ' CE1' ' A' 1549 ' ' TYR . . . -69.16 -27.84 73.39 Favored Glycine 0 C--N 1.315 -0.59 0 N-CA-C 114.561 0.584 . . . . 1.08 114.561 -175.445 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A 1569 ' ' GLN . . . . . . . . . . . . . 35.3 tt0 -77.44 -47.33 19.99 Favored 'General case' 0 C--N 1.315 -0.906 0 O-C-N 122.47 -0.429 . . . . 2.74 111.481 -178.248 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A 1570 ' ' THR . . . . . . . . . . . . . 18.6 p -96.31 -13.36 23.38 Favored 'General case' 0 C--N 1.308 -1.221 0 N-CA-C 113.034 0.753 . . . . 1.96 113.034 -176.21 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A 1571 ' ' ARG . . . . . . . . . . . . . 21.7 mtp180 57.6 40.72 26.54 Favored 'General case' 0 CA--C 1.51 -0.573 0 C-N-CA 124.924 1.29 . . . . 3.95 113.007 -179.456 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A 1572 ' ' ILE . . . . . . . . . . . . . 66.0 mt -106.4 126.45 62.11 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.18 0 CA-C-N 114.733 -1.121 . . . . 1.37 108.327 178.981 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A 1573 ' ' SER . . . . . . . . . . . . . 37.7 t -75.6 136.88 40.48 Favored 'General case' 0 C--N 1.309 -1.186 0 CA-C-N 115.449 -0.796 . . . . 1.08 111.383 -176.95 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A 1574 ' ' VAL . . . . . . . . . . . . . 22.8 m -129.81 21.14 2.2 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.395 0 CA-C-O 121.995 0.903 . . . . 1.3 110.196 177.778 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A 1575 ' ' GLY . . . . . . . . . . . . . . . 176.87 119.04 0.56 Allowed Glycine 0 N--CA 1.422 -2.243 0 CA-C-N 114.576 -1.193 . . . . 0.51 111.274 177.117 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A 1576 ' ' LYS . . . . . 0.421 ' HA ' ' HA ' ' A' 1563 ' ' VAL . 46.9 tptt -75.45 151.54 38.06 Favored 'General case' 0 C--N 1.31 -1.147 0 N-CA-C 106.001 -1.852 . . . . 2.9 106.001 175.52 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A 1577 ' ' ALA . . . . . . . . . . . . . . . -70.94 95.08 1.13 Allowed 'General case' 0 C--N 1.314 -0.942 0 N-CA-C 109.273 -0.64 . . . . 0.83 109.273 -179.126 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A 1578 ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -104.66 142.4 34.75 Favored 'General case' 0 C--N 1.3 -1.553 0 CA-C-N 115.439 -0.8 . . . . 1.85 111.117 -178.337 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A 1579 ' ' LYS . . . . . . . . . . . . . 9.9 mmmm -105.89 89.03 2.95 Favored 'General case' 0 C--N 1.287 -2.148 0 N-CA-C 106.079 -1.823 . . . . 1.9 106.079 173.792 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A 1580 ' ' ARG . . . . . 0.569 ' HA ' ' HD2' ' A' 1513 ' ' HIS . 70.0 ttt180 -146.62 97.76 2.96 Favored 'General case' 0 C--N 1.303 -1.435 0 CA-C-N 115.183 -0.917 . . . . 3.63 109.457 -173.023 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A 1581 ' ' LEU . . . . . . . . . . . . . 54.3 tp -118.93 144.57 46.36 Favored 'General case' 0 C--N 1.299 -1.627 0 CA-C-N 115.9 -0.591 . . . . 1.87 109.941 -176.622 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A 1582 ' ' ARG . . . . . . . . . . . . . 49.5 mtp180 -132.96 136.41 46.08 Favored 'General case' 0 C--N 1.309 -1.155 0 C-N-CA 123.416 0.686 . . . . 3.97 109.907 179.185 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A 1583 ' ' TYR . . . . . . . . . . . . . 7.8 t80 -92.9 104.77 16.98 Favored 'General case' 0 C--N 1.311 -1.09 0 CA-C-O 121.56 0.695 . . . . 1.41 109.894 174.184 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A 1584 ' ' VAL . . . . . 0.555 ' HB ' HG13 ' A' 1587 ' ' VAL . 35.0 t -109.69 149.26 12.85 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.648 0 N-CA-C 105.245 -2.131 . . . . 1.69 105.245 175.301 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A 1585 ' ' ASP . . . . . . . . . . . . . 35.8 t70 -46.34 102.68 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.376 0 C-N-CA 124.473 1.109 . . . . 2.06 113.713 -177.968 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A 1586 ' ' GLN . . . . . . . . . . . . . 49.8 mt-30 58.41 35.25 24.63 Favored 'General case' 0 C--O 1.249 1.033 0 C-N-CA 124.828 1.251 . . . . 2.33 112.477 179.911 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A 1587 ' ' VAL . . . . . 0.555 HG13 ' HB ' ' A' 1584 ' ' VAL . 7.7 p -164.69 104.54 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.436 -1.158 0 CA-C-O 122.06 0.933 . . . . 0.78 110.616 175.433 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A 1588 ' ' LEU . . . . . 0.52 ' HB2' ' HB2' ' A' 1612 ' ' PHE . 44.2 mt -78.62 141.25 38.17 Favored 'General case' 0 C--N 1.294 -1.845 0 N-CA-C 107.71 -1.218 . . . . 1.41 107.71 176.295 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A 1589 ' ' GLN . . . . . . . . . . . . . 36.0 tt0 -125.27 117.62 24.21 Favored 'General case' 0 C--N 1.284 -2.253 0 N-CA-C 109.642 -0.503 . . . . 1.24 109.642 -177.835 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A 1590 ' ' LEU . . . . . 0.431 ' HA ' ' O ' ' A' 1580 ' ' ARG . 4.9 tt -116.16 123.25 47.35 Favored 'General case' 0 C--N 1.304 -1.381 0 N-CA-C 106.72 -1.585 . . . . 1.15 106.72 178.354 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A 1591 ' ' VAL . . . . . 0.518 ' HB ' ' HD3' ' A' 1580 ' ' ARG . 60.9 t -110.94 127.76 67.82 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.131 0 N-CA-C 113.633 0.975 . . . . 1.51 113.633 -171.05 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A 1592 ' ' TYR . . . . . . . . . . . . . 5.6 m-30 -109.08 143.49 38.37 Favored 'General case' 0 C--N 1.32 -0.677 0 N-CA-C 107.783 -1.192 . . . . 1.06 107.783 171.378 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A 1593 ' ' LYS . . . . . 0.454 ' HA ' ' HA ' ' A' 1607 ' ' LYS . 13.4 ptmm? -158.96 -177.24 6.37 Favored 'General case' 0 C--N 1.3 -1.58 0 N-CA-C 108.601 -0.889 . . . . 2.18 108.601 179.82 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A 1594 ' ' ASP . . . . . . . . . . . . . 22.0 m-20 64.57 43.31 4.45 Favored 'General case' 0 C--O 1.247 0.936 0 O-C-N 124.147 0.904 . . . . 1.45 112.107 177.724 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A 1595 ' ' GLY . . . . . . . . . . . . . . . -80.83 -104.34 0.31 Allowed Glycine 0 N--CA 1.437 -1.29 0 N-CA-C 111.088 -0.805 . . . . 0.78 111.088 176.309 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A 1596 ' ' SER . . . . . . . . . . . . . 17.7 m -114.11 152.34 45.74 Favored Pre-proline 0 C--N 1.29 -2.013 0 N-CA-C 107.958 -1.127 . . . . 1.68 107.958 177.558 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A 1597 ' ' PRO . . . . . . . . . . . . . 24.7 Cg_exo -62.37 143.39 93.55 Favored 'Trans proline' 0 C--O 1.248 0.99 0 C-N-CA 122.663 2.242 . . . . 1.17 111.193 179.143 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A 1598 ' ' CYS . . . . . . . . . . . . . 45.9 t -96.25 133.15 25.39 Favored Pre-proline 0 C--N 1.29 -2.005 0 CA-C-N 115.844 -0.616 . . . . 1.19 110.41 -177.071 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A 1599 ' ' PRO . . . . . . . . . . . . . 88.2 Cg_endo -88.3 -7.43 5.91 Favored 'Trans proline' 0 CA--C 1.537 0.659 0 C-N-CA 122.68 2.253 . . . . 1.59 112.141 178.013 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A 1600 ' ' SER . . . . . . . . . . . . . 16.5 m -84.27 -34.04 23.88 Favored 'General case' 0 N--CA 1.446 -0.645 0 CA-C-O 121.25 0.548 . . . . 2.12 110.075 -179.87 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A 1601 ' ' LYS . . . . . 0.548 ' HG2' HD12 ' A' 1604 ' ' LEU . 15.8 tppt? -139.64 118.68 12.61 Favored 'General case' 0 N--CA 1.431 -1.379 0 N-CA-C 107.653 -1.24 . . . . 3.74 107.653 178.185 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A 1602 ' ' SER . . . . . . . . . . . . . 22.9 m -72.85 134.39 44.84 Favored 'General case' 0 C--N 1.297 -1.705 0 CA-C-O 121.28 0.562 . . . . 3.79 110.481 -177.587 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A 1603 ' ' GLY . . . . . . . . . . . . . . . 97.61 -7.45 63.43 Favored Glycine 0 N--CA 1.439 -1.125 0 N-CA-C 110.876 -0.89 . . . . 2.0 110.876 -179.756 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A 1604 ' ' LEU . . . . . 0.548 HD12 ' HG2' ' A' 1601 ' ' LYS . 2.2 mt -105.72 148.88 26.94 Favored 'General case' 0 C--N 1.303 -1.424 0 C-N-CA 123.107 0.563 . . . . 1.48 110.873 179.658 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A 1605 ' ' SER . . . . . . . . . . . . . 52.3 m -113.2 -167.45 1.19 Allowed 'General case' 0 C--N 1.287 -2.114 0 N-CA-C 106.356 -1.72 . . . . 1.51 106.356 173.286 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A 1606 ' ' TYR . . . . . . . . . . . . . 44.0 m-85 -108.07 128.24 54.5 Favored 'General case' 0 N--CA 1.399 -2.992 0 N-CA-C 107.223 -1.399 . . . . 1.18 107.223 -179.963 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A 1607 ' ' LYS . . . . . 0.556 ' HG3' HG23 ' A' 1635 ' ' THR . 21.7 ptmt -125.4 154.38 42.01 Favored 'General case' 0 N--CA 1.397 -3.097 0 O-C-N 124.56 1.163 . . . . 1.67 109.407 -177.68 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A 1608 ' ' SER . . . . . 0.494 ' HB3' ' HE2' ' A' 1638 ' ' PHE . 51.1 m -132.38 118.36 19.29 Favored 'General case' 0 C--N 1.296 -1.735 0 N-CA-C 109.598 -0.519 . . . . 1.0 109.598 -178.53 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A 1609 ' ' VAL . . . . . 0.436 HG22 HG13 ' A' 1591 ' ' VAL . 88.1 t -104.12 124.68 58.7 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.558 0 N-CA-C 109.224 -0.658 . . . . 0.93 109.224 178.882 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A 1610 ' ' ILE . . . . . . . . . . . . . 3.1 mp -99.51 117.81 45.2 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.41 0 N-CA-C 108.473 -0.936 . . . . 0.78 108.473 178.156 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A 1611 ' ' SER . . . . . . . . . . . . . 62.9 p -103.45 125.75 50.21 Favored 'General case' 0 N--CA 1.42 -1.928 0 N-CA-C 109.48 -0.563 . . . . 1.29 109.48 177.342 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A 1612 ' ' PHE . . . . . 0.52 ' HB2' ' HB2' ' A' 1588 ' ' LEU . 15.3 m-85 -94.51 107.47 19.45 Favored 'General case' 0 C--N 1.296 -1.735 0 N-CA-C 107.708 -1.219 . . . . 0.7 107.708 179.544 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A 1613 ' ' VAL . . . . . 0.652 HG12 ' HG2' ' A' 1615 ' ' ARG . 97.2 t -103.73 134.41 45.02 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.958 0 N-CA-C 109.86 -0.422 . . . . 0.75 109.86 -177.018 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A 1614 ' ' CYS . . . . . 0.807 ' HB3' ' HG3' ' A' 1648 ' ' PRO . 62.6 m -77.1 91.8 3.72 Favored 'General case' 0 N--CA 1.436 -1.166 0 CA-C-O 121.984 0.897 . . . . 1.39 109.879 -178.384 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A 1615 ' ' ARG . . . . . 0.761 ' HB2' ' HB2' ' A' 1641 ' ' HIS . 12.9 mmt180 -137.52 103.04 8.62 Favored Pre-proline 0 C--N 1.293 -1.865 0 N-CA-C 106.336 -1.727 . . . . 3.75 106.336 176.662 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A 1616 ' ' PRO . . . . . 0.889 ' HD3' ' HG2' ' A' 1648 ' ' PRO . 32.6 Cg_endo -68.03 73.22 0.75 Allowed 'Trans proline' 0 C--O 1.245 0.857 0 C-N-CA 122.441 2.094 . . . . 1.32 111.956 177.843 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A 1617 ' ' GLU . . . . . . . . . . . . . 48.8 mt-10 -131.11 39.98 3.5 Favored 'General case' 0 N--CA 1.431 -1.404 0 CA-C-N 114.653 -1.158 . . . . 3.21 109.816 176.659 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A 1618 ' ' ALA . . . . . . . . . . . . . . . -69.62 128.58 36.95 Favored 'General case' 0 N--CA 1.444 -0.745 0 N-CA-C 108.376 -0.972 . . . . 2.44 108.376 177.685 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A 1619 ' ' GLY . . . . . 0.709 ' H ' ' HB2' ' A' 1622 ' ' ASN . . . 169.02 -126.86 1.43 Allowed Glycine 0 N--CA 1.427 -1.906 0 C-N-CA 120.669 -0.776 . . . . 3.26 111.711 -177.946 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A 1620 ' ' PRO . . . . . . . . . . . . . 53.5 Cg_exo -55.35 -41.7 75.64 Favored 'Trans proline' 0 N--CA 1.478 0.584 0 C-N-CA 123.84 3.027 . . . . 5.92 114.211 -176.356 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A 1621 ' ' THR . . . . . . . . . . . . . 8.9 m -112.65 42.31 1.87 Allowed 'General case' 0 C--N 1.307 -1.253 0 CA-C-O 122.511 1.148 . . . . 4.76 109.378 -176.814 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A 1622 ' ' ASN . . . . . 0.709 ' HB2' ' H ' ' A' 1619 ' ' GLY . 58.0 t30 -80.56 65.13 5.59 Favored 'General case' 0 C--N 1.318 -0.799 0 CA-C-N 114.929 -1.032 . . . . 2.92 109.079 178.025 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A 1623 ' ' ARG . . . . . . . . . . . . . 19.7 ptp180 -155.17 154.71 29.1 Favored Pre-proline 0 C--N 1.3 -1.585 0 N-CA-C 106.998 -1.482 . . . . 3.61 106.998 179.69 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A 1624 ' ' PRO . . . . . . . . . . . . . 23.0 Cg_exo -66.1 117.47 4.7 Favored 'Trans proline' 0 N--CA 1.459 -0.522 0 C-N-CA 122.789 2.326 . . . . 2.37 112.339 -179.648 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A 1625 ' ' MET . . . . . . . . . . . . . 48.3 ttm -90.9 133.16 35.47 Favored 'General case' 0 C--N 1.306 -1.289 0 N-CA-C 108.46 -0.941 . . . . 2.16 108.46 -179.785 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A 1626 ' ' LEU . . . . . 0.434 HD21 HD23 ' A' 1629 ' ' LEU . 29.0 tp -85.22 91.8 8.24 Favored 'General case' 0 C--N 1.294 -1.806 0 N-CA-C 108.715 -0.846 . . . . 1.35 108.715 179.272 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A 1627 ' ' ILE . . . . . . . . . . . . . 32.6 pt -86.05 -27.64 6.18 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.611 0 CA-C-N 115.851 -0.613 . . . . 1.21 111.893 -175.118 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A 1628 ' ' SER . . . . . 0.803 ' HB2' ' HB2' ' A' 1637 ' ' PHE . 18.2 m -132.1 129.04 39.4 Favored 'General case' 0 N--CA 1.427 -1.578 0 CA-C-O 121.087 0.47 . . . . 1.4 110.825 -175.594 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A 1629 ' ' LEU . . . . . 0.59 HD22 ' HG ' ' A' 1636 ' ' LEU . 1.5 tm? -129.77 109.27 10.81 Favored 'General case' 0 C--N 1.296 -1.756 0 N-CA-C 105.393 -2.077 . . . . 1.56 105.393 177.094 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A 1630 ' ' ASP . . . . . . . . . . . . . 22.9 t70 -105.45 112.59 25.75 Favored 'General case' 0 C--N 1.297 -1.682 0 C-N-CA 118.95 -1.1 . . . . 0.87 110.135 179.35 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A 1631 ' ' LYS . . . . . . . . . . . . . 28.7 mtpp -71.77 -37.65 70.44 Favored 'General case' 0 C--N 1.306 -1.308 0 CA-C-N 114.621 -1.172 . . . . 2.35 112.946 -175.923 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A 1632 ' ' GLN . . . . . . . . . . . . . 8.7 pt20 -75.02 -31.26 61.31 Favored 'General case' 0 CA--C 1.535 0.394 0 N-CA-C 112.906 0.706 . . . . 2.55 112.906 -174.444 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A 1633 ' ' THR . . . . . . . . . . . . . 54.7 p -99.46 -1.55 38.23 Favored 'General case' 0 C--O 1.245 0.83 0 C-N-CA 120.073 -0.651 . . . . 1.24 111.198 177.8 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A 1634 ' ' CYS . . . . . . . . . . . . . 18.4 m 60.74 40.28 16.35 Favored 'General case' 0 C--N 1.352 0.699 0 CA-C-O 122.114 0.959 . . . . 0.89 110.466 174.366 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A 1635 ' ' THR . . . . . 0.556 HG23 ' HG3' ' A' 1607 ' ' LYS . 27.5 m -124.04 132.5 53.69 Favored 'General case' 0 N--CA 1.435 -1.202 0 CA-C-N 115.207 -0.906 . . . . 0.75 111.512 -173.802 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A 1636 ' ' LEU . . . . . 0.59 ' HG ' HD22 ' A' 1629 ' ' LEU . 6.2 mp -102.87 141.32 35.88 Favored 'General case' 0 C--N 1.313 -1.0 0 N-CA-C 109.113 -0.699 . . . . 1.33 109.113 175.93 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A 1637 ' ' PHE . . . . . 0.803 ' HB2' ' HB2' ' A' 1628 ' ' SER . 90.9 m-85 -124.22 106.85 10.62 Favored 'General case' 0 C--O 1.25 1.119 0 CA-C-O 121.362 0.601 . . . . 0.83 111.448 177.928 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A 1638 ' ' PHE . . . . . 0.494 ' HE2' ' HB3' ' A' 1608 ' ' SER . 86.3 m-85 -91.75 144.51 25.43 Favored 'General case' 0 C--N 1.31 -1.14 0 CA-C-N 115.508 -0.769 . . . . 0.6 109.223 178.317 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A 1639 ' ' SER . . . . . . . . . . . . . 28.8 m -129.42 114.89 16.72 Favored 'General case' 0 C--N 1.292 -1.92 0 CA-C-O 120.924 0.393 . . . . 1.08 110.136 178.777 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A 1640 ' ' TRP . . . . . . . . . . . . . 19.3 t90 -108.52 113.36 26.33 Favored 'General case' 0 C--N 1.296 -1.73 0 N-CA-C 109.248 -0.649 . . . . 0.8 109.248 177.777 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A 1641 ' ' HIS . . . . . 0.761 ' HB2' ' HB2' ' A' 1615 ' ' ARG . 7.3 p-80 -79.81 104.47 10.41 Favored 'General case' 0 C--N 1.317 -0.846 0 CA-C-N 115.305 -0.861 . . . . 2.54 108.936 176.253 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A 1642 ' ' THR . . . . . 0.492 ' HA ' ' HD3' ' A' 1643 ' ' PRO . 8.9 t -143.08 144.35 28.48 Favored Pre-proline 0 C--N 1.285 -2.198 0 C-N-CA 120.069 -0.652 . . . . 1.15 112.046 -173.366 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A 1643 ' ' PRO . . . . . 0.492 ' HD3' ' HA ' ' A' 1642 ' ' THR . 4.9 Cg_exo -79.1 -0.74 11.0 Favored 'Trans proline' 0 N--CA 1.451 -1.013 0 C-N-CA 123.298 2.665 . . . . 0.8 110.328 171.831 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A 1644 ' ' LEU . . . . . . . . . . . . . 89.6 mt -91.07 3.87 53.61 Favored 'General case' 0 C--O 1.225 -0.207 0 CA-C-N 115.771 -0.65 . . . . 1.54 109.73 176.268 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A 1645 ' ' ALA . . . . . . . . . . . . . . . -86.51 -42.43 13.55 Favored 'General case' 0 C--N 1.317 -0.805 0 N-CA-C 108.14 -1.059 . . . . 0.95 108.14 175.988 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A 1646 ' ' CYS . . . . . 0.647 ' O ' ' HD3' ' A' 1648 ' ' PRO . 16.0 p -176.82 161.46 2.01 Favored 'General case' 0 N--CA 1.43 -1.471 0 N-CA-C 102.993 -2.966 . . . . 1.41 102.993 174.453 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A 1647 ' ' GLU . . . . . . . . . . . . . 41.7 mt-10 -96.65 98.53 4.48 Favored Pre-proline 0 C--N 1.309 -1.155 0 CA-C-N 118.624 0.647 . . . . 2.92 110.784 -179.684 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A 1648 ' ' PRO . . . . . 0.889 ' HG2' ' HD3' ' A' 1616 ' ' PRO . 86.1 Cg_endo -96.29 172.44 0.98 Allowed 'Trans proline' 0 N--CA 1.442 -1.501 0 C-N-CA 123.29 2.66 . . . . 2.82 110.957 -179.49 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A 1649 ' ' GLU . . . . . . . . . . . . . 11.5 tp10 . . . . . 0 C--N 1.285 -2.216 0 N-CA-C 107.889 -1.152 . . . . 5.06 107.889 179.557 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A 1508 ' ' MET . . . . . 0.521 ' HG3' ' OD1' ' A' 1511 ' ' ASN . 50.7 ttp . . . . . 0 N--CA 1.454 -0.256 0 N-CA-C 107.83 -1.174 . . . . 8.27 107.83 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A 1509 ' ' LYS . . . . . . . . . . . . . 47.5 pttt -101.79 -64.99 1.01 Allowed 'General case' 0 C--N 1.315 -0.908 0 N-CA-C 114.83 1.419 . . . . 6.48 114.83 -173.3 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A 1510 ' ' SER . . . . . . . . . . . . . 39.1 m -121.59 32.15 6.0 Favored 'General case' 0 C--N 1.309 -1.174 0 CA-C-O 121.231 0.539 . . . . 4.22 111.838 -173.279 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A 1511 ' ' ASN . . . . . 0.521 ' OD1' ' HG3' ' A' 1508 ' ' MET . 23.0 p-10 -128.44 29.13 5.36 Favored 'General case' 0 C--N 1.296 -1.737 0 CA-C-O 121.297 0.57 . . . . 3.08 110.117 177.942 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A 1512 ' ' GLU . . . . . . . . . . . . . 37.4 mt-10 -90.52 -40.96 11.68 Favored 'General case' 0 C--N 1.317 -0.816 0 CA-C-N 115.552 -0.749 . . . . 4.46 110.228 -178.36 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A 1513 ' ' HIS . . . . . 0.599 ' HA ' ' HB2' ' A' 1579 ' ' LYS . 15.1 p-80 -136.3 25.03 3.23 Favored 'General case' 0 C--N 1.314 -0.969 0 CA-C-O 121.7 0.762 . . . . 5.57 110.053 -179.543 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A 1514 ' ' ASP . . . . . . . . . . . . . 34.2 t70 -111.06 -61.06 1.75 Allowed 'General case' 0 C--N 1.305 -1.352 0 CA-C-N 114.846 -1.07 . . . . 3.7 108.946 179.526 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A 1515 ' ' ASP . . . . . . . . . . . . . 11.3 t70 -107.86 153.14 23.44 Favored 'General case' 0 C--N 1.306 -1.3 0 N-CA-C 106.836 -1.542 . . . . 2.54 106.836 177.127 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A 1516 ' ' CYS . . . . . 0.664 ' SG ' ' HE3' ' A' 1579 ' ' LYS . 11.6 m -82.64 81.93 8.22 Favored 'General case' 0 C--N 1.299 -1.629 0 N-CA-C 109.381 -0.6 . . . . 1.25 109.381 -176.812 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A 1517 ' ' GLN . . . . . . . . . . . . . 3.9 pt20 -165.39 176.69 8.07 Favored 'General case' 0 C--N 1.32 -0.68 0 N-CA-C 110.147 -0.316 . . . . 1.88 110.147 179.39 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A 1518 ' ' VAL . . . . . 0.704 ' HB ' HD11 ' A' 1581 ' ' LEU . 4.5 p -148.76 131.32 6.61 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.863 0 CA-C-N 116.068 -0.515 . . . . 1.73 110.131 176.454 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A 1519 ' ' THR . . . . . . . . . . . . . 4.8 m -105.97 123.97 48.83 Favored 'General case' 0 C--N 1.312 -1.039 0 N-CA-C 109.775 -0.454 . . . . 1.7 109.775 179.181 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A 1520 ' ' ASN . . . . . . . . . . . . . 24.8 t-20 -83.86 113.29 46.58 Favored Pre-proline 0 C--N 1.314 -0.971 0 N-CA-C 108.966 -0.753 . . . . 2.12 108.966 175.661 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A 1521 ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -75.55 -15.83 19.36 Favored 'Trans proline' 0 C--N 1.344 0.326 0 C-N-CA 122.221 1.947 . . . . 2.47 113.552 -174.958 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A 1522 ' ' SER . . . . . . . . . . . . . 12.2 m -68.25 -54.75 15.5 Favored 'General case' 0 N--CA 1.432 -1.344 0 CA-C-N 116.494 -0.321 . . . . 2.57 110.785 -177.925 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A 1523 ' ' THR . . . . . 0.465 HG23 ' HB2' ' A' 1525 ' ' HIS . 14.5 t -109.02 -7.8 15.3 Favored 'General case' 0 C--N 1.315 -0.895 0 C-N-CA 119.654 -0.818 . . . . 2.15 111.966 -179.465 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A 1524 ' ' GLY . . . . . . . . . . . . . . . 80.45 37.38 20.87 Favored Glycine 0 CA--C 1.503 -0.658 0 C-N-CA 120.511 -0.852 . . . . 1.89 111.18 -179.487 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A 1525 ' ' HIS . . . . . 0.465 ' HB2' HG23 ' A' 1523 ' ' THR . 22.3 t-160 -100.97 115.71 31.11 Favored 'General case' 0 C--N 1.308 -1.205 0 N-CA-C 109.284 -0.636 . . . . 1.9 109.284 -176.545 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A 1526 ' ' LEU . . . . . . . . . . . . . 3.5 tm? -88.41 120.65 29.98 Favored 'General case' 0 C--N 1.295 -1.766 0 N-CA-C 107.799 -1.185 . . . . 1.61 107.799 178.762 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A 1527 ' ' PHE . . . . . . . . . . . . . 95.0 m-85 -92.86 112.95 25.09 Favored 'General case' 0 C--N 1.3 -1.555 0 N-CA-C 107.646 -1.242 . . . . 1.42 107.646 176.975 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A 1528 ' ' ASP . . . . . . . . . . . . . 10.8 t70 -77.84 105.6 9.13 Favored 'General case' 0 CA--C 1.495 -1.143 0 CA-C-O 121.533 0.682 . . . . 2.18 109.678 -178.356 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A 1529 ' ' LEU . . . . . . . . . . . . . 89.2 mt -106.55 -3.0 21.28 Favored 'General case' 0 C--N 1.281 -2.412 0 N-CA-C 107.207 -1.405 . . . . 1.44 107.207 176.458 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A 1530 ' ' SER . . . . . . . . . . . . . 8.1 m -69.72 -37.05 76.4 Favored 'General case' 0 N--CA 1.419 -1.985 0 CA-C-N 114.027 -1.442 . . . . 1.44 110.73 -174.013 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A 1531 ' ' SER . . . . . . . . . . . . . 14.8 m -74.94 -21.97 58.86 Favored 'General case' 0 C--N 1.316 -0.853 0 CA-C-O 121.344 0.592 . . . . 1.5 110.026 177.72 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A 1532 ' ' LEU . . . . . 0.575 HD22 ' HH2' ' A' 1640 ' ' TRP . 82.1 mt -85.83 -5.72 59.2 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.549 -0.751 . . . . 1.77 109.643 179.711 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A 1533 ' ' SER . . . . . 0.419 ' OG ' ' HB3' ' A' 1553 ' ' CYS . 22.6 m -92.18 107.36 19.16 Favored 'General case' 0 N--CA 1.415 -2.199 0 N-CA-C 108.631 -0.878 . . . . 2.38 108.631 178.584 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A 1534 ' ' GLY . . . . . . . . . . . . . . . -126.58 -150.33 7.54 Favored Glycine 0 N--CA 1.422 -2.296 0 N-CA-C 109.768 -1.333 . . . . 1.55 109.768 179.551 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A 1535 ' ' ARG . . . . . 0.433 ' HD2' ' HA ' ' A' 1535 ' ' ARG . 9.5 tpt180 -96.82 -70.11 0.73 Allowed 'General case' 0 N--CA 1.419 -1.979 0 C-N-CA 120.242 -0.583 . . . . 3.96 109.58 179.214 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A 1536 ' ' ALA . . . . . . . . . . . . . . . -86.93 -18.28 31.17 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 121.047 0.451 . . . . 1.65 110.994 -177.831 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A 1537 ' ' GLY . . . . . . . . . . . . . . . 73.44 -112.9 4.04 Favored Glycine 0 N--CA 1.435 -1.383 0 CA-C-N 115.941 -0.572 . . . . 1.19 113.317 176.15 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A 1538 ' ' PHE . . . . . . . . . . . . . 64.9 m-85 -127.23 159.0 35.64 Favored 'General case' 0 C--N 1.307 -1.27 0 N-CA-C 109.837 -0.431 . . . . 1.69 109.837 -176.55 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A 1539 ' ' THR . . . . . . . . . . . . . 6.8 p -112.76 119.99 39.95 Favored 'General case' 0 C--N 1.306 -1.3 0 CA-C-N 116.288 -0.415 . . . . 1.48 111.138 -178.886 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A 1540 ' ' ALA . . . . . . . . . . . . . . . -100.51 116.0 31.43 Favored 'General case' 0 C--N 1.307 -1.253 0 N-CA-C 109.46 -0.57 . . . . 0.83 109.46 177.976 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A 1541 ' ' ALA . . . . . . . . . . . . . . . -80.48 89.05 5.61 Favored 'General case' 0 C--N 1.313 -0.979 0 CA-C-N 115.541 -0.754 . . . . 1.27 109.134 -179.161 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A 1542 ' ' TYR . . . . . . . . . . . . . 64.3 t80 -100.13 157.2 16.74 Favored 'General case' 0 C--N 1.293 -1.856 0 CA-C-N 115.861 -0.609 . . . . 2.15 111.483 -176.486 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A 1543 ' ' SER . . . . . . . . . . . . . 2.8 m -40.46 -153.07 0.0 OUTLIER 'General case' 0 CA--C 1.578 2.043 0 C-N-CA 130.179 3.391 . . . . 2.29 116.893 -177.15 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A 1544 ' ' LYS . . . . . 0.472 ' NZ ' ' HB3' ' A' 1544 ' ' LYS . 4.9 ttpm? -49.4 -31.7 10.15 Favored 'General case' 0 N--CA 1.481 1.082 0 O-C-N 121.3 -0.875 . . . . 3.91 112.262 -179.197 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A 1545 ' ' SER . . . . . . . . . . . . . 13.1 m -63.82 -27.18 69.0 Favored 'General case' 0 CA--C 1.559 1.291 0 N-CA-C 112.375 0.509 . . . . 3.3 112.375 178.261 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A 1546 ' ' GLY . . . . . . . . . . . . . . . 109.02 -165.21 12.48 Favored Glycine 0 N--CA 1.43 -1.764 0 C-N-CA 119.363 -1.398 . . . . 1.24 114.034 174.869 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A 1547 ' ' VAL . . . . . . . . . . . . . 7.2 p -92.35 133.51 33.48 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.608 0 CA-C-O 121.596 0.712 . . . . 1.63 111.151 -176.297 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A 1548 ' ' VAL . . . . . . . . . . . . . 4.1 t -111.37 135.83 49.36 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.442 0 N-CA-C 106.682 -1.599 . . . . 0.92 106.682 179.202 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A 1549 ' ' TYR . . . . . 0.68 ' HE1' ' HA3' ' A' 1568 ' ' GLY . 95.7 m-85 -93.74 151.38 19.67 Favored 'General case' 0 C--N 1.3 -1.547 0 N-CA-C 106.565 -1.642 . . . . 1.44 106.565 174.129 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A 1550 ' ' MET . . . . . . . . . . . . . 46.0 ttm -144.16 122.38 12.24 Favored 'General case' 0 C--N 1.301 -1.514 0 C-N-CA 120.255 -0.578 . . . . 1.74 111.113 -178.686 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A 1551 ' ' SER . . . . . . . . . . . . . 28.8 p -111.36 122.06 46.86 Favored 'General case' 0 N--CA 1.418 -2.07 0 N-CA-C 108.7 -0.852 . . . . 1.64 108.7 174.932 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A 1552 ' ' ILE . . . . . . . . . . . . . 1.7 mp -62.04 -29.33 46.24 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.342 0 CA-C-N 115.134 -0.939 . . . . 1.33 110.621 179.058 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A 1553 ' ' CYS . . . . . 0.7 ' SG ' ' HE3' ' A' 1579 ' ' LYS . 37.2 t -160.63 141.0 11.45 Favored 'General case' 0 N--CA 1.426 -1.629 0 N-CA-C 108.354 -0.98 . . . . 1.43 108.354 174.797 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A 1554 ' ' GLY . . . . . . . . . . . . . . . 97.43 160.29 31.17 Favored Glycine 0 N--CA 1.443 -0.85 0 O-C-N 123.652 0.595 . . . . 1.12 111.678 -179.003 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A 1555 ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -67.54 127.25 32.04 Favored 'General case' 0 N--CA 1.447 -0.578 0 CA-C-O 121.729 0.776 . . . . 1.8 111.334 178.474 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A 1556 ' ' ASN . . . . . 0.54 HD21 ' HB3' ' A' 1549 ' ' TYR . 3.4 t-20 -75.05 -14.47 60.6 Favored 'General case' 0 C--N 1.299 -1.603 0 C-N-CA 126.328 1.851 . . . . 2.63 114.023 -170.069 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A 1557 ' ' GLU . . . . . 0.456 ' C ' ' H ' ' A' 1559 ' ' CYS . 50.6 mm-40 66.45 -173.61 0.19 Allowed 'General case' 0 N--CA 1.481 1.084 0 C-N-CA 123.237 0.615 . . . . 3.79 110.282 -176.112 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A 1558 ' ' ASN . . . . . . . . . . . . . 42.2 m-80 76.31 -20.9 0.34 Allowed 'General case' 0 N--CA 1.496 1.855 0 C-N-CA 125.659 1.584 . . . . 1.52 111.972 173.467 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A 1559 ' ' CYS . . . . . 0.585 ' HB3' ' HD2' ' A' 1560 ' ' PRO . 63.8 m -142.12 169.63 10.66 Favored Pre-proline 0 C--N 1.282 -2.355 0 N-CA-C 106.491 -1.67 . . . . 0.84 106.491 179.732 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A 1560 ' ' PRO . . . . . 0.585 ' HD2' ' HB3' ' A' 1559 ' ' CYS . 26.8 Cg_exo -32.26 130.26 0.09 OUTLIER 'Trans proline' 0 C--N 1.369 1.608 0 C-N-CA 124.984 3.789 . . . . 1.18 114.983 178.098 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A 1561 ' ' PRO . . . . . 0.427 ' HD3' ' HA ' ' A' 1560 ' ' PRO . 50.5 Cg_exo -56.09 110.83 0.62 Allowed 'Trans proline' 0 C--O 1.242 0.723 0 C-N-CA 123.583 2.855 . . . . 1.51 112.551 179.71 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A 1562 ' ' GLY . . . . . . . . . . . . . . . 141.05 -14.05 2.83 Favored Glycine 0 N--CA 1.442 -0.953 0 C-N-CA 120.526 -0.845 . . . . 0.72 112.519 178.875 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A 1563 ' ' VAL . . . . . 0.489 HG22 ' O ' ' A' 1560 ' ' PRO . 7.3 m -85.24 151.47 3.74 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.309 0 O-C-N 122.488 -0.419 . . . . 0.97 111.617 179.031 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A 1564 ' ' GLY . . . . . 0.421 ' HA3' ' CE2' ' A' 1592 ' ' TYR . . . -117.81 -1.23 17.35 Favored Glycine 0 N--CA 1.433 -1.547 0 N-CA-C 110.911 -0.876 . . . . 0.72 110.911 176.201 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A 1565 ' ' ALA . . . . . . . . . . . . . . . -158.43 119.56 3.43 Favored 'General case' 0 C--O 1.247 0.952 0 N-CA-C 109.552 -0.536 . . . . 0.37 109.552 179.158 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A 1566 ' ' CYS . . . . . . . . . . . . . 48.7 t -154.33 145.77 23.09 Favored 'General case' 0 C--N 1.304 -1.373 0 N-CA-C 109.956 -0.387 . . . . 0.51 109.956 -177.343 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A 1567 ' ' PHE . . . . . . . . . . . . . 66.9 m-85 -71.07 123.26 21.7 Favored 'General case' 0 CA--C 1.511 -0.546 0 N-CA-C 107.412 -1.329 . . . . 0.97 107.412 172.951 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A 1568 ' ' GLY . . . . . 0.68 ' HA3' ' HE1' ' A' 1549 ' ' TYR . . . -73.62 -22.52 78.31 Favored Glycine 0 C--N 1.308 -1.01 0 C-N-CA 120.788 -0.72 . . . . 1.08 114.735 -172.021 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A 1569 ' ' GLN . . . . . . . . . . . . . 10.0 mt-30 -90.53 -55.52 3.55 Favored 'General case' 0 C--N 1.305 -1.349 0 CA-C-O 121.125 0.488 . . . . 2.74 109.98 -177.13 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A 1570 ' ' THR . . . . . . . . . . . . . 21.2 p -81.93 -12.98 58.13 Favored 'General case' 0 CA--C 1.546 0.821 0 N-CA-C 113.691 0.997 . . . . 1.96 113.691 -176.487 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A 1571 ' ' ARG . . . . . 0.405 ' NH2' ' HD3' ' A' 1560 ' ' PRO . 37.0 mtp85 62.91 42.44 7.66 Favored 'General case' 0 N--CA 1.476 0.872 0 C-N-CA 124.263 1.025 . . . . 3.95 112.262 -179.883 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A 1572 ' ' ILE . . . . . . . . . . . . . 30.8 mm -104.49 122.24 57.22 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.241 0 N-CA-C 109.237 -0.653 . . . . 1.37 109.237 -179.149 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A 1573 ' ' SER . . . . . . . . . . . . . 31.9 t -83.24 137.11 34.15 Favored 'General case' 0 C--N 1.303 -1.453 0 C-N-CA 124.364 1.066 . . . . 1.08 111.821 -175.593 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A 1574 ' ' VAL . . . . . . . . . . . . . 11.5 m -140.01 27.48 0.5 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 115.982 -0.553 . . . . 1.3 110.72 175.224 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A 1575 ' ' GLY . . . . . . . . . . . . . . . 178.71 119.54 0.61 Allowed Glycine 0 N--CA 1.434 -1.489 0 C-N-CA 120.016 -1.088 . . . . 0.51 112.921 178.976 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A 1576 ' ' LYS . . . . . . . . . . . . . 22.9 tptm -89.56 137.15 32.57 Favored 'General case' 0 C--N 1.304 -1.409 0 N-CA-C 107.047 -1.464 . . . . 2.9 107.047 176.044 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A 1577 ' ' ALA . . . . . 0.677 ' HA ' ' CE2' ' A' 1592 ' ' TYR . . . -67.56 119.86 13.03 Favored 'General case' 0 C--N 1.322 -0.629 0 N-CA-C 109.379 -0.6 . . . . 0.83 109.379 -178.772 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A 1578 ' ' ASN . . . . . . . . . . . . . 5.7 p30 -157.61 166.83 31.85 Favored 'General case' 0 C--N 1.31 -1.126 0 N-CA-C 107.071 -1.455 . . . . 1.85 107.071 -176.468 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A 1579 ' ' LYS . . . . . 0.7 ' HE3' ' SG ' ' A' 1553 ' ' CYS . 50.9 mttp -122.1 90.07 3.24 Favored 'General case' 0 C--N 1.306 -1.317 0 N-CA-C 109.789 -0.448 . . . . 1.9 109.789 178.179 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A 1580 ' ' ARG . . . . . . . . . . . . . 47.2 ttp180 -138.39 92.46 2.64 Favored 'General case' 0 C--N 1.309 -1.188 0 N-CA-C 106.969 -1.493 . . . . 3.63 106.969 175.178 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A 1581 ' ' LEU . . . . . 0.704 HD11 ' HB ' ' A' 1518 ' ' VAL . 4.6 pp -127.5 158.9 36.18 Favored 'General case' 0 C--N 1.294 -1.826 0 CA-C-N 115.7 -0.682 . . . . 1.87 110.147 -177.675 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A 1582 ' ' ARG . . . . . 0.494 ' HB3' HG13 ' A' 1584 ' ' VAL . 80.4 mtm-85 -139.96 139.09 36.02 Favored 'General case' 0 C--N 1.301 -1.539 0 O-C-N 123.449 0.468 . . . . 3.97 109.885 178.378 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A 1583 ' ' TYR . . . . . 0.444 ' CD1' ' HG ' ' A' 1588 ' ' LEU . 25.4 t80 -99.73 90.44 4.46 Favored 'General case' 0 C--N 1.309 -1.175 0 N-CA-C 106.547 -1.649 . . . . 1.41 106.547 174.256 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A 1584 ' ' VAL . . . . . 0.494 HG13 ' HB3' ' A' 1582 ' ' ARG . 18.3 m -115.89 124.38 72.19 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.948 0 CA-C-N 115.83 -0.623 . . . . 1.69 111.701 -172.475 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A 1585 ' ' ASP . . . . . . . . . . . . . 38.8 t70 56.06 50.51 13.56 Favored 'General case' 0 C--N 1.31 -1.123 0 C-N-CA 123.98 0.912 . . . . 2.06 111.701 177.901 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A 1586 ' ' GLN . . . . . . . . . . . . . 49.2 mt-30 69.75 10.71 7.66 Favored 'General case' 0 N--CA 1.481 1.105 0 CA-C-N 114.8 -1.091 . . . . 2.33 113.853 176.253 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A 1587 ' ' VAL . . . . . 0.489 HG23 ' O ' ' A' 1612 ' ' PHE . 7.4 p -135.61 133.01 51.83 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.517 0 CA-C-O 121.49 0.662 . . . . 0.78 110.895 -179.735 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A 1588 ' ' LEU . . . . . 0.811 ' HB2' ' HB2' ' A' 1612 ' ' PHE . 20.4 mt -80.15 142.74 34.49 Favored 'General case' 0 C--N 1.312 -1.037 0 CA-C-N 115.303 -0.862 . . . . 1.41 110.749 178.037 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A 1589 ' ' GLN . . . . . . . . . . . . . 6.5 tt0 -128.24 106.86 9.32 Favored 'General case' 0 C--N 1.289 -2.051 0 CA-C-N 115.434 -0.803 . . . . 1.24 109.475 -179.481 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A 1590 ' ' LEU . . . . . 0.74 ' HB2' ' HE1' ' A' 1612 ' ' PHE . 21.1 tp -101.54 112.99 25.72 Favored 'General case' 0 C--N 1.314 -0.974 0 N-CA-C 107.022 -1.473 . . . . 1.15 107.022 178.636 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A 1591 ' ' VAL . . . . . 0.522 HG22 HG22 ' A' 1609 ' ' VAL . 61.1 t -105.96 107.84 23.63 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.381 0 C-N-CA 120.107 -0.637 . . . . 1.51 112.248 -175.824 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A 1592 ' ' TYR . . . . . 0.677 ' CE2' ' HA ' ' A' 1577 ' ' ALA . 5.0 m-85 -102.89 92.84 4.75 Favored 'General case' 0 C--N 1.297 -1.691 0 CA-C-O 121.907 0.86 . . . . 1.06 108.74 173.587 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A 1593 ' ' LYS . . . . . 0.54 ' HA ' ' HA ' ' A' 1607 ' ' LYS . 18.0 pttp -104.5 -175.44 2.8 Favored 'General case' 0 C--N 1.291 -1.948 0 CA-C-N 114.152 -1.385 . . . . 2.18 108.285 -178.433 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A 1594 ' ' ASP . . . . . . . . . . . . . 1.6 m-20 63.67 72.5 0.47 Allowed 'General case' 0 CA--C 1.512 -0.501 0 O-C-N 124.072 0.857 . . . . 1.45 112.17 177.969 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A 1595 ' ' GLY . . . . . . . . . . . . . . . -110.11 -113.56 3.52 Favored Glycine 0 N--CA 1.425 -2.04 0 N-CA-C 109.659 -1.376 . . . . 0.78 109.659 176.159 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A 1596 ' ' SER . . . . . . . . . . . . . 33.4 p -104.53 158.03 32.84 Favored Pre-proline 0 C--N 1.29 -1.988 0 N-CA-C 108.866 -0.79 . . . . 1.68 108.866 177.915 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A 1597 ' ' PRO . . . . . . . . . . . . . 36.9 Cg_exo -59.45 137.2 76.59 Favored 'Trans proline' 0 C--N 1.353 0.815 0 C-N-CA 122.757 2.305 . . . . 1.17 112.004 178.869 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A 1598 ' ' CYS . . . . . . . . . . . . . 42.7 t -95.82 115.16 65.33 Favored Pre-proline 0 C--N 1.299 -1.621 0 CA-C-N 115.899 -0.591 . . . . 1.19 110.034 -178.711 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A 1599 ' ' PRO . . . . . 0.528 ' HD2' ' OH ' ' A' 1606 ' ' TYR . 44.2 Cg_endo -69.36 -15.63 38.73 Favored 'Trans proline' 0 CA--C 1.535 0.525 0 C-N-CA 122.591 2.194 . . . . 1.59 112.625 -179.119 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A 1600 ' ' SER . . . . . . . . . . . . . 21.0 m -80.16 -13.16 59.47 Favored 'General case' 0 C--O 1.249 1.058 0 CA-C-N 116.157 -0.474 . . . . 2.12 111.876 -178.261 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A 1601 ' ' LYS . . . . . 0.825 ' HG2' HD12 ' A' 1604 ' ' LEU . 16.1 tppt? -156.2 110.65 2.82 Favored 'General case' 0 N--CA 1.442 -0.83 0 N-CA-C 108.83 -0.804 . . . . 3.74 108.83 179.405 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A 1602 ' ' SER . . . . . . . . . . . . . 8.4 m -59.61 109.84 1.0 Allowed 'General case' 0 C--N 1.296 -1.73 0 C-N-CA 124.185 0.994 . . . . 3.79 111.1 -176.991 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A 1603 ' ' GLY . . . . . . . . . . . . . . . 108.22 -17.84 34.07 Favored Glycine 0 N--CA 1.441 -0.971 0 C-N-CA 120.701 -0.762 . . . . 2.0 112.495 177.584 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A 1604 ' ' LEU . . . . . 0.825 HD12 ' HG2' ' A' 1601 ' ' LYS . 1.1 mt -86.89 146.02 26.35 Favored 'General case' 0 C--N 1.308 -1.23 0 CA-C-O 121.15 0.5 . . . . 1.48 110.838 -178.849 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A 1605 ' ' SER . . . . . . . . . . . . . 22.8 t -108.21 -175.05 2.67 Favored 'General case' 0 N--CA 1.424 -1.747 0 N-CA-C 106.336 -1.728 . . . . 1.51 106.336 173.378 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A 1606 ' ' TYR . . . . . 0.528 ' OH ' ' HD2' ' A' 1599 ' ' PRO . 78.6 m-85 -107.46 135.7 48.49 Favored 'General case' 0 CA--C 1.46 -2.485 0 N-CA-C 107.705 -1.22 . . . . 1.18 107.705 -176.452 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A 1607 ' ' LYS . . . . . 0.54 ' HA ' ' HA ' ' A' 1593 ' ' LYS . 24.6 pttm -122.31 134.54 54.66 Favored 'General case' 0 N--CA 1.398 -3.062 0 C-N-CA 118.592 -1.243 . . . . 1.67 110.433 176.835 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A 1608 ' ' SER . . . . . . . . . . . . . 47.1 m -101.56 111.15 23.3 Favored 'General case' 0 C--N 1.28 -2.452 0 CA-C-N 115.17 -0.923 . . . . 1.0 108.543 176.857 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A 1609 ' ' VAL . . . . . 0.522 HG22 HG22 ' A' 1591 ' ' VAL . 56.4 t -98.09 112.56 30.45 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.107 0 N-CA-C 109.48 -0.563 . . . . 0.93 109.48 177.568 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A 1610 ' ' ILE . . . . . 0.593 ' HB ' ' HB3' ' A' 1590 ' ' LEU . 2.5 mp -93.46 104.72 16.04 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.649 0 N-CA-C 107.521 -1.289 . . . . 0.78 107.521 177.353 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A 1611 ' ' SER . . . . . 0.402 ' O ' ' HA ' ' A' 1639 ' ' SER . 22.8 t -90.72 117.41 29.34 Favored 'General case' 0 C--N 1.293 -1.864 0 N-CA-C 108.387 -0.968 . . . . 1.29 108.387 -179.735 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A 1612 ' ' PHE . . . . . 0.811 ' HB2' ' HB2' ' A' 1588 ' ' LEU . 50.7 m-85 -92.15 102.22 14.74 Favored 'General case' 0 C--N 1.31 -1.126 0 N-CA-C 108.985 -0.746 . . . . 0.7 108.985 -179.651 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A 1613 ' ' VAL . . . . . . . . . . . . . 47.8 t -100.53 127.59 53.44 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.51 0 N-CA-C 107.821 -1.177 . . . . 0.75 107.821 -177.881 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A 1614 ' ' CYS . . . . . 0.648 ' HA ' ' O ' ' A' 1642 ' ' THR . 8.3 t -71.45 106.4 3.93 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-O 121.28 0.562 . . . . 1.39 111.618 -176.657 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A 1615 ' ' ARG . . . . . 0.775 ' HB2' ' HB3' ' A' 1641 ' ' HIS . 37.2 mmt180 -137.09 85.2 22.91 Favored Pre-proline 0 N--CA 1.433 -1.306 0 CA-C-N 115.228 -0.896 . . . . 3.75 110.462 177.048 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A 1616 ' ' PRO . . . . . . . . . . . . . 48.5 Cg_exo -61.22 -16.61 47.59 Favored 'Trans proline' 0 N--CA 1.482 0.801 0 C-N-CA 122.942 2.428 . . . . 1.32 111.481 174.444 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A 1617 ' ' GLU . . . . . 0.405 ' CD ' ' HD2' ' A' 1615 ' ' ARG . 8.6 pt-20 -69.99 -17.66 63.3 Favored 'General case' 0 C--N 1.318 -0.765 0 C-N-CA 123.886 0.874 . . . . 3.21 112.345 178.328 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A 1618 ' ' ALA . . . . . . . . . . . . . . . -76.67 141.55 40.91 Favored 'General case' 0 C--N 1.312 -1.057 0 CA-C-O 120.794 0.33 . . . . 2.44 110.673 -176.596 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A 1619 ' ' GLY . . . . . . . . . . . . . . . -145.3 -80.52 0.04 OUTLIER Glycine 0 N--CA 1.436 -1.339 0 N-CA-C 111.465 -0.654 . . . . 3.26 111.465 -178.24 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A 1620 ' ' PRO . . . . . . . . . . . . . 31.5 Cg_endo -65.12 -32.62 52.4 Favored 'Trans proline' 0 C--O 1.236 0.399 0 C-N-CA 122.58 2.187 . . . . 5.92 112.59 -179.603 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A 1621 ' ' THR . . . . . . . . . . . . . 2.8 m -110.18 29.38 7.72 Favored 'General case' 0 N--CA 1.435 -1.183 0 CA-C-O 121.683 0.754 . . . . 4.76 109.345 -178.188 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A 1622 ' ' ASN . . . . . . . . . . . . . 50.0 t-20 -77.65 75.98 4.19 Favored 'General case' 0 C--O 1.245 0.856 0 N-CA-C 108.878 -0.786 . . . . 2.92 108.878 179.015 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A 1623 ' ' ARG . . . . . . . . . . . . . 19.0 ptp180 -155.42 161.38 29.58 Favored Pre-proline 0 C--O 1.247 0.94 0 N-CA-C 108.131 -1.063 . . . . 3.61 108.131 -179.67 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A 1624 ' ' PRO . . . . . . . . . . . . . 7.7 Cg_exo -73.42 94.7 0.84 Allowed 'Trans proline' 0 N--CA 1.458 -0.595 0 C-N-CA 122.747 2.298 . . . . 2.37 111.566 177.476 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A 1625 ' ' MET . . . . . . . . . . . . . 20.5 ptp -81.64 150.12 28.24 Favored 'General case' 0 C--N 1.313 -1.011 0 CA-C-N 115.646 -0.706 . . . . 2.16 109.797 179.735 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A 1626 ' ' LEU . . . . . . . . . . . . . 47.3 tp -90.35 105.25 17.69 Favored 'General case' 0 C--N 1.304 -1.389 0 N-CA-C 108.194 -1.039 . . . . 1.35 108.194 179.101 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A 1627 ' ' ILE . . . . . . . . . . . . . 44.7 pt -85.7 -38.07 12.52 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.331 0 N-CA-C 112.119 0.414 . . . . 1.21 112.119 -175.428 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A 1628 ' ' SER . . . . . . . . . . . . . 19.4 t -148.95 150.91 33.69 Favored 'General case' 0 N--CA 1.432 -1.34 0 N-CA-C 109.036 -0.727 . . . . 1.4 109.036 -177.426 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A 1629 ' ' LEU . . . . . 1.0 ' HG ' ' HG ' ' A' 1636 ' ' LEU . 3.1 tt -141.83 116.19 9.53 Favored 'General case' 0 C--N 1.303 -1.446 0 N-CA-C 106.682 -1.599 . . . . 1.56 106.682 179.798 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A 1630 ' ' ASP . . . . . . . . . . . . . 33.2 t70 -109.27 119.84 40.7 Favored 'General case' 0 C--N 1.294 -1.833 0 N-CA-C 109.444 -0.576 . . . . 0.87 109.444 176.723 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A 1631 ' ' LYS . . . . . . . . . . . . . 30.1 mtpp -77.35 -24.93 50.63 Favored 'General case' 0 C--N 1.3 -1.564 0 CA-C-N 115.592 -0.731 . . . . 2.35 111.272 -175.913 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A 1632 ' ' GLN . . . . . . . . . . . . . 39.6 mt-30 -68.57 -44.52 74.26 Favored 'General case' 0 CA--C 1.515 -0.381 0 CA-C-O 121.397 0.618 . . . . 2.55 110.519 -176.317 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A 1633 ' ' THR . . . . . . . . . . . . . 25.1 p -90.42 -4.4 57.04 Favored 'General case' 0 C--N 1.31 -1.146 0 CA-C-N 115.516 -0.765 . . . . 1.24 110.797 177.347 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A 1634 ' ' CYS . . . . . 0.491 ' O ' ' HA ' ' A' 1606 ' ' TYR . 29.3 m 56.98 41.97 26.9 Favored 'General case' 0 C--O 1.221 -0.41 0 CA-C-N 114.288 -1.324 . . . . 0.89 109.503 179.061 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A 1635 ' ' THR . . . . . . . . . . . . . 89.3 m -124.11 131.32 53.53 Favored 'General case' 0 N--CA 1.428 -1.537 0 CA-C-N 115.226 -0.897 . . . . 0.75 111.389 -173.217 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A 1636 ' ' LEU . . . . . 1.0 ' HG ' ' HG ' ' A' 1629 ' ' LEU . 5.2 mp -108.66 130.74 55.33 Favored 'General case' 0 N--CA 1.432 -1.353 0 N-CA-C 108.567 -0.901 . . . . 1.33 108.567 177.626 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A 1637 ' ' PHE . . . . . . . . . . . . . 94.3 m-85 -105.76 105.95 16.23 Favored 'General case' 0 C--N 1.308 -1.204 0 CA-C-O 121.069 0.461 . . . . 0.83 110.953 -177.489 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A 1638 ' ' PHE . . . . . 0.4 ' HB2' ' HA ' ' A' 1610 ' ' ILE . 99.6 m-85 -100.79 148.0 25.42 Favored 'General case' 0 C--N 1.303 -1.416 0 N-CA-C 108.4 -0.963 . . . . 0.6 108.4 177.681 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A 1639 ' ' SER . . . . . 0.402 ' HA ' ' O ' ' A' 1611 ' ' SER . 66.2 m -137.33 115.1 11.34 Favored 'General case' 0 C--N 1.281 -2.382 0 CA-C-O 121.445 0.64 . . . . 1.08 110.703 176.984 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A 1640 ' ' TRP . . . . . 0.575 ' HH2' HD22 ' A' 1532 ' ' LEU . 7.9 t90 -95.93 122.14 38.42 Favored 'General case' 0 N--CA 1.418 -2.05 0 N-CA-C 106.569 -1.641 . . . . 0.8 106.569 178.434 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A 1641 ' ' HIS . . . . . 0.775 ' HB3' ' HB2' ' A' 1615 ' ' ARG . 40.6 m80 -95.09 102.99 14.83 Favored 'General case' 0 C--N 1.285 -2.206 0 N-CA-C 107.633 -1.247 . . . . 2.54 107.633 178.206 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A 1642 ' ' THR . . . . . 0.648 ' O ' ' HA ' ' A' 1614 ' ' CYS . 8.9 t -142.42 140.2 18.62 Favored Pre-proline 0 C--N 1.297 -1.678 0 CA-C-N 115.45 -0.795 . . . . 1.15 111.21 -173.134 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A 1643 ' ' PRO . . . . . . . . . . . . . 57.4 Cg_endo -71.46 -0.82 8.78 Favored 'Trans proline' 0 CA--C 1.534 0.494 0 C-N-CA 123.621 2.881 . . . . 0.8 112.451 176.865 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A 1644 ' ' LEU . . . . . . . . . . . . . 77.5 mt -85.4 -4.33 59.13 Favored 'General case' 0 C--N 1.322 -0.613 0 C-N-CA 122.62 0.368 . . . . 1.54 111.113 -179.085 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A 1645 ' ' ALA . . . . . . . . . . . . . . . -88.84 -13.87 38.26 Favored 'General case' 0 C--N 1.319 -0.725 0 N-CA-C 111.984 0.364 . . . . 0.95 111.984 -178.129 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A 1646 ' ' CYS . . . . . . . . . . . . . 14.3 p -148.02 -177.04 5.52 Favored 'General case' 0 C--N 1.304 -1.386 0 N-CA-C 107.137 -1.431 . . . . 1.41 107.137 -179.27 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A 1647 ' ' GLU . . . . . . . . . . . . . 9.8 tp10 -113.77 99.52 50.22 Favored Pre-proline 0 N--CA 1.428 -1.526 0 N-CA-C 107.891 -1.151 . . . . 2.92 107.891 174.643 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A 1648 ' ' PRO . . . . . . . . . . . . . 97.4 Cg_exo -47.78 112.45 0.57 Allowed 'Trans proline' 0 C--N 1.354 0.827 0 C-N-CA 124.014 3.143 . . . . 2.82 112.776 179.293 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A 1649 ' ' GLU . . . . . . . . . . . . . 44.3 tt0 . . . . . 0 C--N 1.292 -1.925 0 N-CA-C 107.927 -1.138 . . . . 5.06 107.927 -179.661 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A 1508 ' ' MET . . . . . . . . . . . . . 72.4 mtm . . . . . 0 C--O 1.24 0.581 0 CA-C-O 120.962 0.411 . . . . 8.27 110.515 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A 1509 ' ' LYS . . . . . . . . . . . . . 95.5 mttt -128.18 124.76 37.6 Favored 'General case' 0 N--CA 1.441 -0.888 0 N-CA-C 109.685 -0.487 . . . . 6.48 109.685 178.351 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A 1510 ' ' SER . . . . . . . . . . . . . 32.1 m -99.62 104.1 15.85 Favored 'General case' 0 C--N 1.294 -1.843 0 N-CA-C 108.345 -0.983 . . . . 4.22 108.345 178.702 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A 1511 ' ' ASN . . . . . . . . . . . . . 31.8 p30 -142.76 6.45 1.61 Allowed 'General case' 0 C--N 1.306 -1.285 0 CA-C-N 116.262 -0.426 . . . . 3.08 112.137 -177.615 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A 1512 ' ' GLU . . . . . . . . . . . . . 9.3 tp10 -67.45 -45.69 75.27 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 109.171 -0.677 . . . . 4.46 109.171 179.679 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A 1513 ' ' HIS . . . . . 0.422 ' HA ' ' O ' ' A' 1579 ' ' LYS . 51.4 m80 -121.91 -8.55 8.87 Favored 'General case' 0 C--N 1.313 -0.986 0 CA-C-N 115.885 -0.598 . . . . 5.57 111.017 176.952 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A 1514 ' ' ASP . . . . . . . . . . . . . 4.8 m-20 -92.28 -20.01 21.57 Favored 'General case' 0 C--N 1.311 -1.099 0 N-CA-C 114.028 1.122 . . . . 3.7 114.028 -173.197 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A 1515 ' ' ASP . . . . . . . . . . . . . 4.1 t70 -143.99 -174.97 4.42 Favored 'General case' 0 C--N 1.301 -1.535 0 C-N-CA 119.189 -1.004 . . . . 2.54 108.548 -176.208 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A 1516 ' ' CYS . . . . . . . . . . . . . 52.0 m -115.67 44.56 1.86 Allowed 'General case' 0 C--N 1.29 -2.007 0 N-CA-C 108.35 -0.982 . . . . 1.25 108.35 -176.811 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A 1517 ' ' GLN . . . . . . . . . . . . . 10.6 pt20 -148.47 138.07 22.12 Favored 'General case' 0 N--CA 1.433 -1.282 0 C-N-CA 120.79 -0.364 . . . . 1.88 111.054 -176.948 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A 1518 ' ' VAL . . . . . . . . . . . . . 29.4 m -113.87 154.06 15.31 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.668 0 CA-C-N 115.744 -0.662 . . . . 1.73 109.945 179.551 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A 1519 ' ' THR . . . . . 0.521 ' HA ' ' HA ' ' A' 1526 ' ' LEU . 32.0 m -119.61 137.76 53.66 Favored 'General case' 0 C--N 1.277 -2.544 0 N-CA-C 109.037 -0.727 . . . . 1.7 109.037 177.354 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A 1520 ' ' ASN . . . . . . . . . . . . . 38.3 t-20 -93.78 101.61 6.41 Favored Pre-proline 0 C--N 1.315 -0.895 0 N-CA-C 107.416 -1.327 . . . . 2.12 107.416 175.139 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A 1521 ' ' PRO . . . . . 0.466 ' HD3' ' O ' ' A' 1519 ' ' THR . 23.4 Cg_exo -65.71 -14.07 42.91 Favored 'Trans proline' 0 C--N 1.36 1.165 0 C-N-CA 123.205 2.603 . . . . 2.47 113.802 -176.772 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A 1522 ' ' SER . . . . . . . . . . . . . 33.3 t -71.24 -38.39 71.95 Favored 'General case' 0 N--CA 1.439 -0.977 0 N-CA-C 109.746 -0.464 . . . . 2.57 109.746 178.759 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A 1523 ' ' THR . . . . . . . . . . . . . 7.2 t -112.37 -16.53 12.91 Favored 'General case' 0 C--N 1.317 -0.827 0 N-CA-C 112.766 0.654 . . . . 2.15 112.766 -177.116 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A 1524 ' ' GLY . . . . . . . . . . . . . . . 81.66 14.54 77.77 Favored Glycine 0 C--O 1.229 -0.172 0 C-N-CA 120.984 -0.627 . . . . 1.89 111.591 -178.764 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A 1525 ' ' HIS . . . . . . . . . . . . . 32.5 t-80 -101.45 131.99 47.28 Favored 'General case' 0 C--N 1.306 -1.318 0 CA-C-O 121.077 0.465 . . . . 1.9 110.187 -178.925 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A 1526 ' ' LEU . . . . . 0.521 ' HA ' ' HA ' ' A' 1519 ' ' THR . 7.8 tt -101.52 143.37 31.6 Favored 'General case' 0 C--N 1.289 -2.038 0 CA-C-N 115.329 -0.851 . . . . 1.61 110.211 -178.166 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A 1527 ' ' PHE . . . . . 0.416 ' HE1' ' HG3' ' A' 1647 ' ' GLU . 80.0 m-85 -118.09 113.08 21.07 Favored 'General case' 0 C--N 1.312 -1.032 0 N-CA-C 107.291 -1.374 . . . . 1.42 107.291 176.524 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A 1528 ' ' ASP . . . . . . . . . . . . . 1.3 p-10 -104.79 141.61 36.19 Favored 'General case' 0 C--N 1.297 -1.714 0 CA-C-O 121.955 0.883 . . . . 2.18 110.938 -178.441 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A 1529 ' ' LEU . . . . . . . . . . . . . 75.7 mt -114.16 11.19 17.48 Favored 'General case' 0 C--N 1.287 -2.13 0 N-CA-C 105.7 -1.963 . . . . 1.44 105.7 173.253 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A 1530 ' ' SER . . . . . . . . . . . . . 5.5 m -73.44 -37.32 65.88 Favored 'General case' 0 N--CA 1.43 -1.435 0 CA-C-N 114.166 -1.379 . . . . 1.44 109.323 -178.977 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A 1531 ' ' SER . . . . . . . . . . . . . 12.8 m -79.85 -7.95 59.01 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-O 121.466 0.651 . . . . 1.5 109.33 175.324 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A 1532 ' ' LEU . . . . . . . . . . . . . 92.8 mt -106.83 9.15 31.01 Favored 'General case' 0 N--CA 1.448 -0.565 0 CA-C-N 115.669 -0.696 . . . . 1.77 110.514 177.017 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A 1533 ' ' SER . . . . . . . . . . . . . 66.0 m -70.94 107.52 4.1 Favored 'General case' 0 N--CA 1.437 -1.081 0 CA-C-O 121.733 0.778 . . . . 2.38 111.577 -175.447 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A 1534 ' ' GLY . . . . . 0.402 ' HA3' ' CE2' ' A' 1538 ' ' PHE . . . -103.23 103.0 2.3 Favored Glycine 0 N--CA 1.423 -2.202 0 N-CA-C 109.632 -1.387 . . . . 1.55 109.632 176.607 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A 1535 ' ' ARG . . . . . . . . . . . . . 71.4 ttt180 -79.27 -20.66 47.55 Favored 'General case' 0 C--O 1.205 -1.257 0 O-C-N 124.205 0.591 . . . . 3.96 111.114 -176.732 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A 1536 ' ' ALA . . . . . . . . . . . . . . . -90.59 -3.21 57.72 Favored 'General case' 0 C--N 1.309 -1.166 0 C-N-CA 119.643 -0.823 . . . . 1.65 109.39 178.979 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A 1537 ' ' GLY . . . . . 0.434 ' HA2' ' HA ' ' A' 1551 ' ' SER . . . 79.13 166.07 30.85 Favored Glycine 0 N--CA 1.423 -2.214 0 CA-C-N 114.855 -1.066 . . . . 1.19 113.123 177.932 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A 1538 ' ' PHE . . . . . 0.402 ' CE2' ' HA3' ' A' 1534 ' ' GLY . 97.1 m-85 -133.73 163.43 29.48 Favored 'General case' 0 C--N 1.297 -1.678 0 N-CA-C 107.472 -1.307 . . . . 1.69 107.472 176.507 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A 1539 ' ' THR . . . . . 0.512 ' HA ' ' O ' ' A' 1548 ' ' VAL . 59.4 p -118.06 157.73 26.31 Favored 'General case' 0 C--N 1.303 -1.422 0 N-CA-C 113.335 0.865 . . . . 1.48 113.335 -172.315 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A 1540 ' ' ALA . . . . . . . . . . . . . . . -142.55 146.13 34.32 Favored 'General case' 0 C--O 1.25 1.131 0 N-CA-C 106.685 -1.598 . . . . 0.83 106.685 173.628 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A 1541 ' ' ALA . . . . . . . . . . . . . . . -65.05 131.65 47.14 Favored 'General case' 0 C--O 1.247 0.952 0 O-C-N 124.222 0.951 . . . . 1.27 110.611 -178.571 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A 1542 ' ' TYR . . . . . . . . . . . . . 81.0 t80 -143.34 171.14 14.52 Favored 'General case' 0 C--N 1.3 -1.585 0 CA-C-N 115.427 -0.806 . . . . 2.15 109.343 -177.264 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A 1543 ' ' SER . . . . . . . . . . . . . 14.0 m -44.28 -151.62 0.0 OUTLIER 'General case' 0 CA--C 1.581 2.165 0 C-N-CA 129.728 3.211 . . . . 2.29 114.961 176.327 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A 1544 ' ' LYS . . . . . . . . . . . . . 39.9 ttmt -36.03 -39.24 0.16 Allowed 'General case' 0 CA--C 1.568 1.665 0 C-N-CA 125.217 1.407 . . . . 3.91 114.143 178.149 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A 1545 ' ' SER . . . . . . . . . . . . . 48.3 t -66.45 -21.73 66.2 Favored 'General case' 0 CA--C 1.56 1.332 0 N-CA-C 112.329 0.492 . . . . 3.3 112.329 177.462 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A 1546 ' ' GLY . . . . . . . . . . . . . . . 88.75 -63.8 3.51 Favored Glycine 0 CA--C 1.492 -1.345 0 N-CA-C 111.455 -0.658 . . . . 1.24 111.455 179.999 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A 1547 ' ' VAL . . . . . . . . . . . . . 13.3 m -140.58 157.87 24.22 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.416 0 C-N-CA 123.205 0.602 . . . . 1.63 109.874 178.318 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A 1548 ' ' VAL . . . . . 0.512 ' O ' ' HA ' ' A' 1539 ' ' THR . 5.7 t -111.98 142.7 23.55 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.28 0 N-CA-C 106.598 -1.63 . . . . 0.92 106.598 176.388 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A 1549 ' ' TYR . . . . . 0.515 ' CD2' ' HA2' ' A' 1568 ' ' GLY . 62.2 m-85 -98.4 114.91 27.43 Favored 'General case' 0 C--N 1.31 -1.152 0 N-CA-C 108.08 -1.082 . . . . 1.44 108.08 173.509 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A 1550 ' ' MET . . . . . . . . . . . . . 65.4 mtm -128.6 133.15 48.23 Favored 'General case' 0 C--N 1.299 -1.603 0 N-CA-C 109.448 -0.575 . . . . 1.74 109.448 176.543 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A 1551 ' ' SER . . . . . 0.434 ' HA ' ' HA2' ' A' 1537 ' ' GLY . 23.8 p -86.3 147.8 25.9 Favored 'General case' 0 C--N 1.289 -2.048 0 N-CA-C 106.658 -1.608 . . . . 1.64 106.658 175.983 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A 1552 ' ' ILE . . . . . . . . . . . . . 35.7 mm -76.41 -29.72 19.0 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.978 0 N-CA-C 108.77 -0.826 . . . . 1.33 108.77 -178.706 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A 1553 ' ' CYS . . . . . . . . . . . . . 38.2 t -162.94 138.38 6.82 Favored 'General case' 0 N--CA 1.432 -1.344 0 N-CA-C 107.519 -1.289 . . . . 1.43 107.519 169.398 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A 1554 ' ' GLY . . . . . . . . . . . . . . . 96.13 -164.93 23.81 Favored Glycine 0 N--CA 1.438 -1.205 0 C-N-CA 120.781 -0.724 . . . . 1.12 112.802 176.05 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A 1555 ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -76.43 156.17 33.34 Favored 'General case' 0 C--N 1.312 -1.046 0 C-N-CA 122.622 0.369 . . . . 1.8 110.028 -179.734 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A 1556 ' ' ASN . . . . . 0.431 HD21 ' HB3' ' A' 1549 ' ' TYR . 27.5 t-20 -98.31 -17.66 18.77 Favored 'General case' 0 CA--C 1.548 0.874 0 N-CA-C 113.413 0.894 . . . . 2.63 113.413 -173.719 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A 1557 ' ' GLU . . . . . . . . . . . . . 30.1 mt-10 65.66 -24.04 0.09 Allowed 'General case' 0 N--CA 1.492 1.656 0 N-CA-C 115.376 1.621 . . . . 3.79 115.376 179.738 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A 1558 ' ' ASN . . . . . . . . . . . . . 38.6 m-80 -75.64 -21.4 57.75 Favored 'General case' 0 CA--C 1.503 -0.834 0 CA-C-O 121.731 0.777 . . . . 1.52 109.11 177.133 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A 1559 ' ' CYS . . . . . . . . . . . . . 73.4 m -135.05 158.38 74.98 Favored Pre-proline 0 N--CA 1.423 -1.802 0 N-CA-C 106.66 -1.608 . . . . 0.84 106.66 176.731 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A 1560 ' ' PRO . . . . . 0.487 ' HA ' ' HD3' ' A' 1561 ' ' PRO . 3.0 Cg_exo -32.82 145.52 0.03 OUTLIER 'Trans proline' 0 CA--C 1.561 1.832 1 C-N-CA 125.859 4.373 . . . . 1.18 117.014 -176.186 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A 1561 ' ' PRO . . . . . 0.487 ' HD3' ' HA ' ' A' 1560 ' ' PRO . 42.5 Cg_exo -59.37 115.08 2.34 Favored 'Trans proline' 0 C--O 1.245 0.834 0 C-N-CA 123.43 2.753 . . . . 1.51 110.421 176.827 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A 1562 ' ' GLY . . . . . . . . . . . . . . . 121.79 -11.42 9.49 Favored Glycine 0 N--CA 1.426 -1.974 0 N-CA-C 110.174 -1.17 . . . . 0.72 110.174 -176.086 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A 1563 ' ' VAL . . . . . . . . . . . . . 66.2 t -99.29 133.88 40.42 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.275 0 N-CA-C 108.005 -1.109 . . . . 0.97 108.005 176.224 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A 1564 ' ' GLY . . . . . . . . . . . . . . . -114.54 -34.53 1.56 Allowed Glycine 0 N--CA 1.443 -0.89 0 C-N-CA 120.916 -0.659 . . . . 0.72 111.78 -179.319 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A 1565 ' ' ALA . . . . . . . . . . . . . . . -123.09 121.08 35.14 Favored 'General case' 0 C--O 1.249 1.043 0 N-CA-C 108.871 -0.789 . . . . 0.37 108.871 -179.753 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A 1566 ' ' CYS . . . . . . . . . . . . . 38.6 t -146.45 140.88 26.58 Favored 'General case' 0 C--N 1.297 -1.709 0 N-CA-C 108.964 -0.754 . . . . 0.51 108.964 -173.953 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A 1567 ' ' PHE . . . . . 0.459 ' O ' ' HA ' ' A' 1571 ' ' ARG . 16.3 m-85 -63.23 132.76 52.75 Favored 'General case' 0 C--O 1.21 -1.01 0 N-CA-C 108.518 -0.919 . . . . 0.97 108.518 177.174 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A 1568 ' ' GLY . . . . . 0.515 ' HA2' ' CD2' ' A' 1549 ' ' TYR . . . -68.99 -36.0 80.21 Favored Glycine 0 N--CA 1.435 -1.387 0 CA-C-N 115.752 -0.658 . . . . 1.08 114.622 -174.164 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A 1569 ' ' GLN . . . . . . . . . . . . . 36.1 tt0 -90.44 -53.89 4.24 Favored 'General case' 0 C--N 1.303 -1.43 0 CA-C-O 121.671 0.748 . . . . 2.74 110.261 -179.393 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A 1570 ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -74.96 -20.06 59.84 Favored 'General case' 0 C--N 1.298 -1.641 0 CA-C-N 114.836 -1.075 . . . . 1.96 112.783 -172.971 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A 1571 ' ' ARG . . . . . 0.459 ' HA ' ' O ' ' A' 1567 ' ' PHE . 50.8 mtp180 54.36 36.37 25.22 Favored 'General case' 0 CA--C 1.51 -0.58 0 C-N-CA 125.814 1.646 . . . . 3.95 113.589 179.633 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A 1572 ' ' ILE . . . . . . . . . . . . . 43.6 mm -94.96 123.89 47.26 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.286 0 N-CA-C 108.893 -0.78 . . . . 1.37 108.893 178.079 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A 1573 ' ' SER . . . . . . . . . . . . . 31.5 t -65.44 95.71 0.22 Allowed 'General case' 0 C--N 1.307 -1.266 0 C-N-CA 125.309 1.444 . . . . 1.08 111.207 179.94 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A 1574 ' ' VAL . . . . . 0.482 ' O ' ' HA3' ' A' 1595 ' ' GLY . 27.6 m -88.17 -30.94 5.55 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.871 0 N-CA-C 112.327 0.491 . . . . 1.3 112.327 179.099 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A 1575 ' ' GLY . . . . . . . . . . . . . . . -136.58 132.25 5.98 Favored Glycine 0 C--O 1.246 0.85 0 C-N-CA 120.858 -0.687 . . . . 0.51 112.177 179.816 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A 1576 ' ' LYS . . . . . 0.603 ' HG2' ' HA2' ' A' 1595 ' ' GLY . 75.5 mmtt -88.77 149.37 23.47 Favored 'General case' 0 C--N 1.312 -1.049 0 N-CA-C 109.859 -0.423 . . . . 2.9 109.859 -179.894 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A 1577 ' ' ALA . . . . . . . . . . . . . . . -67.07 98.87 0.61 Allowed 'General case' 0 C--N 1.307 -1.278 0 C-N-CA 123.976 0.91 . . . . 0.83 110.913 -178.195 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A 1578 ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -113.49 120.34 40.67 Favored 'General case' 0 C--N 1.306 -1.299 0 N-CA-C 108.504 -0.925 . . . . 1.85 108.504 177.261 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A 1579 ' ' LYS . . . . . 0.422 ' O ' ' HA ' ' A' 1513 ' ' HIS . 48.9 mtmt -90.96 90.55 7.93 Favored 'General case' 0 C--N 1.307 -1.254 0 N-CA-C 107.294 -1.372 . . . . 1.9 107.294 177.621 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A 1580 ' ' ARG . . . . . . . . . . . . . 17.7 ttp180 -165.84 110.98 0.85 Allowed 'General case' 0 C--N 1.309 -1.192 0 CA-C-N 115.309 -0.859 . . . . 3.63 110.246 -175.216 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A 1581 ' ' LEU . . . . . . . . . . . . . 3.9 mm? -101.77 137.28 40.29 Favored 'General case' 0 C--N 1.316 -0.877 0 CA-C-N 115.888 -0.596 . . . . 1.87 109.563 178.592 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A 1582 ' ' ARG . . . . . . . . . . . . . 90.4 mtt180 -108.68 98.31 7.83 Favored 'General case' 0 C--N 1.291 -1.957 0 CA-C-N 116.374 -0.375 . . . . 3.97 110.254 177.057 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A 1583 ' ' TYR . . . . . . . . . . . . . 92.8 t80 -79.84 110.13 14.92 Favored 'General case' 0 C--N 1.311 -1.098 0 CA-C-N 115.477 -0.783 . . . . 1.41 109.153 -179.615 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A 1584 ' ' VAL . . . . . 0.62 ' O ' HG12 ' A' 1587 ' ' VAL . 3.9 p -148.36 126.4 3.24 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.419 0 CA-C-N 116.17 -0.468 . . . . 1.69 110.076 179.703 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A 1585 ' ' ASP . . . . . . . . . . . . . 38.4 t70 54.34 44.65 28.64 Favored 'General case' 0 N--CA 1.484 1.244 0 CA-C-O 122.748 1.261 . . . . 2.06 109.951 -177.894 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A 1586 ' ' GLN . . . . . . . . . . . . . 48.4 mt-30 59.79 18.41 7.29 Favored 'General case' 0 CA--C 1.539 0.545 0 CA-C-N 113.632 -1.622 . . . . 2.33 114.32 179.141 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A 1587 ' ' VAL . . . . . 0.62 HG12 ' O ' ' A' 1584 ' ' VAL . 4.0 p -103.78 139.64 24.16 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.146 0 N-CA-C 108.568 -0.901 . . . . 0.78 108.568 176.733 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A 1588 ' ' LEU . . . . . 0.725 ' HB2' ' HB2' ' A' 1612 ' ' PHE . 41.1 mt -94.27 123.83 37.91 Favored 'General case' 0 C--N 1.296 -1.732 0 N-CA-C 106.187 -1.783 . . . . 1.41 106.187 174.179 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A 1589 ' ' GLN . . . . . . . . . . . . . 9.8 tt0 -122.4 112.96 18.72 Favored 'General case' 0 C--N 1.281 -2.398 0 CA-C-N 116.398 -0.365 . . . . 1.24 110.094 -173.864 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A 1590 ' ' LEU . . . . . 0.433 ' HB3' ' HB ' ' A' 1610 ' ' ILE . 32.8 tp -100.7 116.48 32.71 Favored 'General case' 0 C--N 1.299 -1.59 0 N-CA-C 107.078 -1.452 . . . . 1.15 107.078 -179.659 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A 1591 ' ' VAL . . . . . . . . . . . . . 15.4 m -106.94 94.82 3.33 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.565 0 N-CA-C 113.803 1.038 . . . . 1.51 113.803 -174.884 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A 1592 ' ' TYR . . . . . . . . . . . . . 14.7 m-30 -86.5 92.92 9.02 Favored 'General case' 0 C--N 1.312 -1.035 0 N-CA-C 107.811 -1.181 . . . . 1.06 107.811 173.435 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A 1593 ' ' LYS . . . . . . . . . . . . . 14.6 ptmm? -115.43 175.08 5.68 Favored 'General case' 0 C--N 1.293 -1.868 0 CA-C-N 115.951 -0.568 . . . . 2.18 111.588 -174.874 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A 1594 ' ' ASP . . . . . . . . . . . . . 8.9 m-20 62.86 31.32 16.41 Favored 'General case' 0 CA--C 1.509 -0.613 0 O-C-N 124.17 0.919 . . . . 1.45 112.154 -178.799 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A 1595 ' ' GLY . . . . . 0.603 ' HA2' ' HG2' ' A' 1576 ' ' LYS . . . -78.58 -84.93 0.54 Allowed Glycine 0 N--CA 1.435 -1.402 0 C-N-CA 120.855 -0.688 . . . . 0.78 112.624 -178.004 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A 1596 ' ' SER . . . . . . . . . . . . . 14.4 t -101.58 145.17 29.98 Favored Pre-proline 0 C--N 1.293 -1.87 0 N-CA-C 108.498 -0.927 . . . . 1.68 108.498 -177.75 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A 1597 ' ' PRO . . . . . . . . . . . . . 24.2 Cg_exo -67.99 131.78 24.73 Favored 'Trans proline' 0 C--O 1.238 0.5 0 C-N-CA 122.785 2.323 . . . . 1.17 110.371 175.252 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A 1598 ' ' CYS . . . . . 0.738 ' HA ' ' HE1' ' A' 1606 ' ' TYR . 40.6 t -95.09 123.09 58.35 Favored Pre-proline 0 C--N 1.304 -1.392 0 CA-C-O 120.767 0.318 . . . . 1.19 110.476 -176.634 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A 1599 ' ' PRO . . . . . . . . . . . . . 91.2 Cg_endo -88.44 -9.36 5.02 Favored 'Trans proline' 0 N--CA 1.454 -0.851 0 C-N-CA 122.798 2.332 . . . . 1.59 112.913 179.799 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A 1600 ' ' SER . . . . . . . . . . . . . 14.9 m -70.31 -21.87 62.88 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-O 121.101 0.477 . . . . 2.12 110.77 -177.795 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A 1601 ' ' LYS . . . . . 0.942 ' HB3' HD12 ' A' 1604 ' ' LEU . 25.7 tptp -161.0 132.08 5.43 Favored 'General case' 0 N--CA 1.43 -1.444 0 N-CA-C 106.257 -1.757 . . . . 3.74 106.257 178.429 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A 1602 ' ' SER . . . . . . . . . . . . . 16.4 m -73.34 126.82 31.02 Favored 'General case' 0 C--N 1.307 -1.249 0 CA-C-O 120.884 0.373 . . . . 3.79 110.268 -176.763 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A 1603 ' ' GLY . . . . . . . . . . . . . . . 102.87 22.0 9.78 Favored Glycine 0 C--N 1.303 -1.256 0 N-CA-C 110.301 -1.12 . . . . 2.0 110.301 -179.358 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A 1604 ' ' LEU . . . . . 0.942 HD12 ' HB3' ' A' 1601 ' ' LYS . 6.1 mt -124.83 152.54 43.8 Favored 'General case' 0 C--N 1.3 -1.548 0 CA-C-O 121.801 0.81 . . . . 1.48 112.259 -179.554 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A 1605 ' ' SER . . . . . . . . . . . . . 50.1 m -128.29 177.67 6.79 Favored 'General case' 0 C--N 1.281 -2.399 0 N-CA-C 106.313 -1.736 . . . . 1.51 106.313 174.613 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A 1606 ' ' TYR . . . . . 0.738 ' HE1' ' HA ' ' A' 1598 ' ' CYS . 7.0 m-85 -98.9 140.36 33.19 Favored 'General case' 0 CA--C 1.459 -2.557 0 N-CA-C 105.682 -1.97 . . . . 1.18 105.682 -179.115 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A 1607 ' ' LYS . . . . . . . . . . . . . 23.3 pttm -133.09 137.45 46.36 Favored 'General case' 0 N--CA 1.391 -3.382 0 C-N-CA 119.21 -0.996 . . . . 1.67 110.127 176.718 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A 1608 ' ' SER . . . . . . . . . . . . . 14.6 m -107.08 110.02 22.03 Favored 'General case' 0 C--N 1.29 -2.02 0 N-CA-C 108.11 -1.07 . . . . 1.0 108.11 178.612 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A 1609 ' ' VAL . . . . . . . . . . . . . 98.3 t -102.04 102.82 14.08 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.256 0 CA-C-O 121.118 0.485 . . . . 0.93 110.481 -177.923 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A 1610 ' ' ILE . . . . . 0.433 ' HB ' ' HB3' ' A' 1590 ' ' LEU . 2.6 mp -90.78 115.31 29.77 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.361 0 N-CA-C 108.252 -1.018 . . . . 0.78 108.252 179.243 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A 1611 ' ' SER . . . . . 0.508 ' O ' ' HA ' ' A' 1639 ' ' SER . 16.9 m -107.13 122.4 46.42 Favored 'General case' 0 C--N 1.295 -1.789 0 CA-C-O 121.26 0.552 . . . . 1.29 110.666 -178.152 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A 1612 ' ' PHE . . . . . 0.725 ' HB2' ' HB2' ' A' 1588 ' ' LEU . 84.5 m-85 -88.38 109.78 20.27 Favored 'General case' 0 C--N 1.298 -1.666 0 N-CA-C 108.134 -1.062 . . . . 0.7 108.134 177.391 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A 1613 ' ' VAL . . . . . . . . . . . . . 58.2 t -102.01 126.2 56.06 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.414 0 CA-C-N 115.632 -0.713 . . . . 0.75 110.216 -173.781 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A 1614 ' ' CYS . . . . . 0.403 ' HA ' ' O ' ' A' 1642 ' ' THR . 57.9 m -59.63 95.68 0.03 OUTLIER 'General case' 0 C--O 1.244 0.764 0 C-N-CA 124.427 1.091 . . . . 1.39 111.302 179.771 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A 1615 ' ' ARG . . . . . . . . . . . . . 17.0 mmt180 -137.28 102.17 9.0 Favored Pre-proline 0 C--N 1.294 -1.824 0 CA-C-N 115.112 -0.949 . . . . 3.75 108.744 177.725 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A 1616 ' ' PRO . . . . . 0.417 ' HA ' ' HB3' ' A' 1643 ' ' PRO . 52.6 Cg_exo -61.2 10.36 0.07 OUTLIER 'Trans proline' 0 N--CA 1.493 1.479 0 C-N-CA 124.707 3.605 . . . . 1.32 115.137 -179.189 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A 1617 ' ' GLU . . . . . . . . . . . . . 34.0 mt-10 -68.35 -25.67 65.21 Favored 'General case' 0 C--O 1.243 0.726 0 C-N-CA 123.501 0.72 . . . . 3.21 109.647 178.209 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A 1618 ' ' ALA . . . . . . . . . . . . . . . 64.64 -172.94 0.18 Allowed 'General case' 0 C--O 1.239 0.5 0 CA-C-N 113.44 -1.709 . . . . 2.44 111.328 178.385 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A 1619 ' ' GLY . . . . . 0.424 ' HA3' ' HB2' ' A' 1622 ' ' ASN . . . 122.31 103.52 1.75 Allowed Glycine 0 N--CA 1.422 -2.297 0 N-CA-C 110.874 -0.89 . . . . 3.26 110.874 179.446 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A 1620 ' ' PRO . . . . . 0.484 ' HA ' ' HZ2' ' A' 1640 ' ' TRP . 34.3 Cg_endo -65.12 -10.74 26.85 Favored 'Trans proline' 0 CA--C 1.539 0.737 0 C-N-CA 123.03 2.487 . . . . 5.92 113.276 -177.976 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A 1621 ' ' THR . . . . . . . . . . . . . 12.8 m -130.97 16.67 5.15 Favored 'General case' 0 CA--C 1.558 1.258 0 N-CA-C 108.072 -1.084 . . . . 4.76 108.072 177.083 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A 1622 ' ' ASN . . . . . 0.424 ' HB2' ' HA3' ' A' 1619 ' ' GLY . 54.9 t30 -86.11 60.34 6.17 Favored 'General case' 0 C--O 1.248 0.989 0 CA-C-O 122.441 1.115 . . . . 2.92 111.935 -175.686 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A 1623 ' ' ARG . . . . . 0.522 ' HB3' ' CG ' ' A' 1640 ' ' TRP . 6.0 ptt180 -130.14 74.11 80.74 Favored Pre-proline 0 C--N 1.306 -1.321 0 CA-C-N 115.082 -0.963 . . . . 3.61 112.765 -177.326 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A 1624 ' ' PRO . . . . . . . . . . . . . 54.9 Cg_endo -111.01 90.9 0.02 OUTLIER 'Trans proline' 0 N--CA 1.42 -2.843 0 C-N-CA 121.306 1.338 . . . . 2.37 109.519 169.177 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A 1625 ' ' MET . . . . . 0.501 ' HB2' ' O ' ' A' 1639 ' ' SER . 10.7 mmt -151.54 98.27 2.49 Favored 'General case' 0 CA--C 1.491 -1.303 0 C-N-CA 120.022 -0.671 . . . . 2.16 112.695 178.02 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A 1626 ' ' LEU . . . . . . . . . . . . . 63.1 tp -92.02 101.04 13.58 Favored 'General case' 0 C--N 1.292 -1.919 0 N-CA-C 103.402 -2.814 . . . . 1.35 103.402 163.82 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A 1627 ' ' ILE . . . . . 0.586 HD12 ' HB3' ' A' 1637 ' ' PHE . 5.0 mt -68.64 -44.65 82.4 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.602 0 N-CA-C 108.499 -0.926 . . . . 1.21 108.499 -171.211 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A 1628 ' ' SER . . . . . . . . . . . . . 46.5 t -171.12 148.09 2.67 Favored 'General case' 0 N--CA 1.412 -2.373 0 N-CA-C 106.245 -1.761 . . . . 1.4 106.245 -179.572 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A 1629 ' ' LEU . . . . . 0.839 ' HG ' ' HG ' ' A' 1636 ' ' LEU . 5.1 tt -126.02 111.02 14.24 Favored 'General case' 0 C--N 1.281 -2.381 0 N-CA-C 105.238 -2.134 . . . . 1.56 105.238 173.916 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A 1630 ' ' ASP . . . . . . . . . . . . . 29.8 t70 -94.83 108.68 20.7 Favored 'General case' 0 C--N 1.283 -2.318 0 N-CA-C 108.954 -0.758 . . . . 0.87 108.954 -178.894 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A 1631 ' ' LYS . . . . . . . . . . . . . 65.6 mttp -71.26 -32.96 69.35 Favored 'General case' 0 C--N 1.309 -1.177 0 CA-C-N 115.586 -0.733 . . . . 2.35 112.656 -174.486 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A 1632 ' ' GLN . . . . . . . . . . . . . 9.1 pt20 -71.25 -28.74 64.38 Favored 'General case' 0 N--CA 1.467 0.419 0 N-CA-C 113.226 0.825 . . . . 2.55 113.226 -176.38 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A 1633 ' ' THR . . . . . 0.403 ' HA ' HD13 ' A' 1604 ' ' LEU . 71.8 p -106.31 -4.3 20.21 Favored 'General case' 0 C--N 1.319 -0.756 0 C-N-CA 119.908 -0.717 . . . . 1.24 110.674 175.08 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A 1634 ' ' CYS . . . . . . . . . . . . . 72.6 m 61.16 40.07 15.21 Favored 'General case' 0 C--O 1.237 0.412 0 CA-C-N 115.063 -0.972 . . . . 0.89 111.278 -178.455 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A 1635 ' ' THR . . . . . . . . . . . . . 30.9 m -105.69 122.42 46.03 Favored 'General case' 0 N--CA 1.433 -1.278 0 CA-C-N 115.387 -0.824 . . . . 0.75 110.028 -177.446 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A 1636 ' ' LEU . . . . . 0.839 ' HG ' ' HG ' ' A' 1629 ' ' LEU . 5.8 mp -108.44 124.87 51.08 Favored 'General case' 0 C--N 1.313 -0.982 0 N-CA-C 109.378 -0.601 . . . . 1.33 109.378 179.303 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A 1637 ' ' PHE . . . . . 0.586 ' HB3' HD12 ' A' 1627 ' ' ILE . 84.3 m-85 -107.55 126.72 52.89 Favored 'General case' 0 C--N 1.311 -1.092 0 N-CA-C 110.121 -0.326 . . . . 0.83 110.121 -178.674 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A 1638 ' ' PHE . . . . . 0.474 ' HA ' ' O ' ' A' 1625 ' ' MET . 93.4 m-85 -124.05 155.31 38.55 Favored 'General case' 0 C--N 1.32 -0.71 0 C-N-CA 122.6 0.36 . . . . 0.6 110.634 -179.495 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A 1639 ' ' SER . . . . . 0.508 ' HA ' ' O ' ' A' 1611 ' ' SER . 65.1 m -142.61 148.82 38.1 Favored 'General case' 0 C--O 1.249 1.063 0 N-CA-C 113.486 0.921 . . . . 1.08 113.486 174.621 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A 1640 ' ' TRP . . . . . 0.522 ' CG ' ' HB3' ' A' 1623 ' ' ARG . 8.1 t90 -122.05 135.4 54.82 Favored 'General case' 0 C--O 1.243 0.754 0 N-CA-C 106.859 -1.534 . . . . 0.8 106.859 176.053 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A 1641 ' ' HIS . . . . . . . . . . . . . 15.3 m-70 -80.51 92.78 5.94 Favored 'General case' 0 CA--C 1.509 -0.613 0 N-CA-C 107.818 -1.178 . . . . 2.54 107.818 177.596 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A 1642 ' ' THR . . . . . 0.51 ' HA ' ' HD3' ' A' 1643 ' ' PRO . 0.0 OUTLIER -128.63 130.5 23.5 Favored Pre-proline 0 C--N 1.304 -1.372 0 N-CA-C 112.852 0.686 . . . . 1.15 112.852 -174.248 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A 1643 ' ' PRO . . . . . 0.51 ' HD3' ' HA ' ' A' 1642 ' ' THR . 2.5 Cg_endo -81.66 -7.1 12.58 Favored 'Trans proline' 0 C--N 1.332 -0.302 0 C-N-CA 123.026 2.484 . . . . 0.8 111.323 177.008 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A 1644 ' ' LEU . . . . . . . . . . . . . 4.0 pp -89.14 3.94 50.19 Favored 'General case' 0 C--N 1.312 -1.046 0 CA-C-N 115.155 -0.93 . . . . 1.54 112.084 -179.369 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A 1645 ' ' ALA . . . . . . . . . . . . . . . -78.22 -43.07 29.41 Favored 'General case' 0 C--N 1.314 -0.967 0 CA-C-O 122.031 0.919 . . . . 0.95 108.791 175.56 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A 1646 ' ' CYS . . . . . . . . . . . . . 24.0 p -159.29 129.87 5.87 Favored 'General case' 0 N--CA 1.428 -1.557 0 N-CA-C 104.163 -2.532 . . . . 1.41 104.163 173.658 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A 1647 ' ' GLU . . . . . 0.416 ' HG3' ' HE1' ' A' 1527 ' ' PHE . 35.9 mt-10 -93.36 140.48 23.24 Favored Pre-proline 0 C--N 1.285 -2.196 0 C-N-CA 120.198 -0.601 . . . . 2.92 110.968 -169.298 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A 1648 ' ' PRO . . . . . . . . . . . . . 35.4 Cg_endo -68.09 101.92 0.74 Allowed 'Trans proline' 0 C--O 1.246 0.879 0 C-N-CA 122.682 2.255 . . . . 2.82 110.989 177.195 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A 1649 ' ' GLU . . . . . . . . . . . . . 42.9 mt-10 . . . . . 0 C--N 1.298 -1.669 0 CA-C-O 118.311 -0.852 . . . . 5.06 109.415 -178.212 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A 1508 ' ' MET . . . . . . . . . . . . . 25.7 ptt? . . . . . 0 CA--C 1.52 -0.195 0 CA-C-O 120.706 0.289 . . . . 8.27 110.639 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A 1509 ' ' LYS . . . . . . . . . . . . . 69.0 mttm -93.09 55.21 2.29 Favored 'General case' 0 N--CA 1.449 -0.494 0 O-C-N 121.909 -0.495 . . . . 6.48 111.765 -177.486 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A 1510 ' ' SER . . . . . . . . . . . . . 4.5 p -87.67 58.66 5.02 Favored 'General case' 0 C--N 1.303 -1.443 0 N-CA-C 106.892 -1.521 . . . . 4.22 106.892 176.216 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A 1511 ' ' ASN . . . . . . . . . . . . . 27.3 t-20 -140.78 -48.92 0.43 Allowed 'General case' 0 N--CA 1.425 -1.694 0 CA-C-N 113.888 -1.505 . . . . 3.08 111.527 -167.689 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A 1512 ' ' GLU . . . . . . . . . . . . . 45.0 mt-10 -47.12 -37.4 9.75 Favored 'General case' 0 N--CA 1.483 1.211 0 C-N-CA 125.135 1.374 . . . . 4.46 113.169 -174.225 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A 1513 ' ' HIS . . . . . . . . . . . . . 8.8 p-80 -134.77 25.41 3.67 Favored 'General case' 0 C--N 1.312 -1.045 0 CA-C-O 121.157 0.503 . . . . 5.57 110.119 177.03 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A 1514 ' ' ASP . . . . . . . . . . . . . 6.4 m-20 -124.18 -35.84 2.75 Favored 'General case' 0 C--N 1.305 -1.344 0 N-CA-C 112.564 0.579 . . . . 3.7 112.564 -176.561 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A 1515 ' ' ASP . . . . . . . . . . . . . 5.3 t70 -130.32 177.02 7.64 Favored 'General case' 0 C--N 1.323 -0.581 0 C-N-CA 119.791 -0.764 . . . . 2.54 109.807 -174.827 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A 1516 ' ' CYS . . . . . 0.594 ' SG ' ' HE3' ' A' 1579 ' ' LYS . 86.8 m -116.86 20.81 13.72 Favored 'General case' 0 C--N 1.302 -1.495 0 C-N-CA 124.088 0.955 . . . . 1.25 110.536 -176.116 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A 1517 ' ' GLN . . . . . 0.435 ' HA ' ' O ' ' A' 1527 ' ' PHE . 4.0 pt20 -109.69 126.24 53.48 Favored 'General case' 0 N--CA 1.422 -1.87 0 CA-C-N 115.523 -0.762 . . . . 1.88 109.169 177.737 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A 1518 ' ' VAL . . . . . 0.61 ' HB ' ' HB2' ' A' 1527 ' ' PHE . 59.3 t -93.45 127.82 45.27 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.233 0 N-CA-C 107.982 -1.118 . . . . 1.73 107.982 -179.962 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A 1519 ' ' THR . . . . . . . . . . . . . 11.3 m -115.02 117.83 31.69 Favored 'General case' 0 N--CA 1.417 -2.109 0 C-N-CA 120.369 -0.533 . . . . 1.7 109.917 -179.165 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A 1520 ' ' ASN . . . . . . . . . . . . . 41.8 t-20 -94.25 105.57 18.35 Favored Pre-proline 0 C--N 1.318 -0.794 0 N-CA-C 107.044 -1.465 . . . . 2.12 107.044 174.666 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A 1521 ' ' PRO . . . . . . . . . . . . . 21.2 Cg_exo -67.26 -21.78 47.42 Favored 'Trans proline' 0 C--N 1.351 0.672 0 C-N-CA 122.528 2.152 . . . . 2.47 113.663 -176.802 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A 1522 ' ' SER . . . . . . . . . . . . . 19.5 m -76.16 -40.1 53.34 Favored 'General case' 0 C--N 1.311 -1.108 0 N-CA-C 111.955 0.354 . . . . 2.57 111.955 -176.323 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A 1523 ' ' THR . . . . . 0.432 HG23 ' HB2' ' A' 1525 ' ' HIS . 14.4 t -107.01 -17.55 14.15 Favored 'General case' 0 CA--C 1.551 0.997 0 C-N-CA 119.525 -0.87 . . . . 2.15 111.268 179.418 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A 1524 ' ' GLY . . . . . . . . . . . . . . . 82.0 17.06 70.72 Favored Glycine 0 N--CA 1.45 -0.4 0 C-N-CA 121.171 -0.538 . . . . 1.89 112.093 -179.713 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A 1525 ' ' HIS . . . . . 0.432 ' HB2' HG23 ' A' 1523 ' ' THR . 7.3 t60 -84.19 135.08 34.51 Favored 'General case' 0 C--N 1.313 -0.999 0 N-CA-C 108.994 -0.743 . . . . 1.9 108.994 -177.672 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A 1526 ' ' LEU . . . . . . . . . . . . . 3.3 tm? -113.87 121.42 43.93 Favored 'General case' 0 C--N 1.3 -1.56 0 N-CA-C 108.415 -0.957 . . . . 1.61 108.415 -176.349 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A 1527 ' ' PHE . . . . . 0.61 ' HB2' ' HB ' ' A' 1518 ' ' VAL . 69.9 m-85 -104.2 116.12 31.61 Favored 'General case' 0 C--N 1.304 -1.395 0 N-CA-C 109.641 -0.503 . . . . 1.42 109.641 -178.601 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A 1528 ' ' ASP . . . . . 0.48 ' O ' HD13 ' A' 1532 ' ' LEU . 11.6 t70 -95.69 102.52 14.32 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-N 117.576 0.171 . . . . 2.18 110.782 -179.977 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A 1529 ' ' LEU . . . . . . . . . . . . . 6.4 mp -89.77 -7.58 54.11 Favored 'General case' 0 C--N 1.318 -0.785 0 CA-C-O 120.8 0.333 . . . . 1.44 111.777 179.305 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A 1530 ' ' SER . . . . . 0.477 ' OG ' ' HB2' ' A' 1516 ' ' CYS . 50.2 m -72.51 -48.54 39.7 Favored 'General case' 0 C--N 1.313 -0.993 0 CA-C-N 116.369 -0.378 . . . . 1.44 111.265 -178.108 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A 1531 ' ' SER . . . . . . . . . . . . . 8.2 m -70.4 -17.17 63.02 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 116.173 -0.467 . . . . 1.5 111.672 -175.993 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A 1532 ' ' LEU . . . . . 0.517 ' HB3' HG13 ' A' 1552 ' ' ILE . 9.8 mp -68.19 -13.72 62.44 Favored 'General case' 0 N--CA 1.466 0.35 0 CA-C-N 116.255 -0.429 . . . . 1.77 112.042 177.52 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A 1533 ' ' SER . . . . . . . . . . . . . 10.9 m -110.24 106.42 15.83 Favored 'General case' 0 N--CA 1.437 -1.105 0 N-CA-C 109.162 -0.681 . . . . 2.38 109.162 178.952 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A 1534 ' ' GLY . . . . . . . . . . . . . . . -92.21 -110.67 1.82 Allowed Glycine 0 N--CA 1.436 -1.312 0 C-N-CA 121.179 -0.534 . . . . 1.55 111.813 178.065 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A 1535 ' ' ARG . . . . . . . . . . . . . 42.8 ttm180 -95.61 -53.85 3.58 Favored 'General case' 0 C--N 1.31 -1.129 0 CA-C-O 121.081 0.467 . . . . 3.96 110.612 178.369 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A 1536 ' ' ALA . . . . . . . . . . . . . . . -96.64 -29.95 13.54 Favored 'General case' 0 C--N 1.316 -0.877 0 CA-C-O 121.044 0.449 . . . . 1.65 110.459 177.745 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A 1537 ' ' GLY . . . . . 0.454 ' HA3' HD21 ' A' 1556 ' ' ASN . . . 70.69 -128.17 17.25 Favored Glycine 0 CA--C 1.499 -0.922 0 CA-C-N 115.515 -0.766 . . . . 1.19 112.166 178.278 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A 1538 ' ' PHE . . . . . 0.54 ' HB2' HD11 ' A' 1552 ' ' ILE . 29.8 m-85 -114.26 122.96 48.36 Favored 'General case' 0 CA--C 1.497 -1.074 0 N-CA-C 109.639 -0.504 . . . . 1.69 109.639 179.122 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A 1539 ' ' THR . . . . . . . . . . . . . 38.0 p -102.38 141.78 34.66 Favored 'General case' 0 C--N 1.286 -2.161 0 CA-C-N 115.454 -0.793 . . . . 1.48 111.329 -175.581 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A 1540 ' ' ALA . . . . . . . . . . . . . . . -118.79 159.03 24.46 Favored 'General case' 0 C--N 1.308 -1.213 0 N-CA-C 108.643 -0.873 . . . . 0.83 108.643 179.356 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A 1541 ' ' ALA . . . . . . . . . . . . . . . -99.48 141.5 32.19 Favored 'General case' 0 C--N 1.306 -1.313 0 CA-C-O 120.887 0.375 . . . . 1.27 111.231 -177.618 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A 1542 ' ' TYR . . . . . . . . . . . . . 76.7 t80 -141.68 177.57 8.06 Favored 'General case' 0 C--N 1.314 -0.95 0 N-CA-C 108.442 -0.947 . . . . 2.15 108.442 -178.415 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A 1543 ' ' SER . . . . . . . . . . . . . 5.3 m -45.91 -151.35 0.0 OUTLIER 'General case' 0 CA--C 1.578 2.034 0 C-N-CA 129.52 3.128 . . . . 2.29 114.259 177.14 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A 1544 ' ' LYS . . . . . . . . . . . . . 64.6 mttp -41.93 -32.87 0.47 Allowed 'General case' 0 N--CA 1.492 1.666 0 N-CA-C 115.064 1.505 . . . . 3.91 115.064 -177.678 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A 1545 ' ' SER . . . . . 0.4 ' OG ' ' HB3' ' A' 1567 ' ' PHE . 6.0 t -67.29 -22.83 65.63 Favored 'General case' 0 CA--C 1.56 1.334 0 CA-C-N 117.877 0.308 . . . . 3.3 110.919 178.148 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A 1546 ' ' GLY . . . . . . . . . . . . . . . 88.6 -76.13 1.92 Allowed Glycine 0 N--CA 1.439 -1.105 0 C-N-CA 121.046 -0.597 . . . . 1.24 114.193 174.689 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A 1547 ' ' VAL . . . . . . . . . . . . . 88.2 t -122.87 144.3 32.82 Favored 'Isoleucine or valine' 0 N--CA 1.417 -2.098 0 C-N-CA 122.748 0.419 . . . . 1.63 110.108 -174.272 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A 1548 ' ' VAL . . . . . . . . . . . . . 10.7 t -113.09 136.06 50.62 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.308 0 N-CA-C 106.456 -1.683 . . . . 0.92 106.456 175.573 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A 1549 ' ' TYR . . . . . 0.541 ' CE2' ' HA2' ' A' 1568 ' ' GLY . 31.2 m-85 -91.63 146.91 23.4 Favored 'General case' 0 C--N 1.301 -1.508 0 N-CA-C 105.316 -2.105 . . . . 1.44 105.316 172.75 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A 1550 ' ' MET . . . . . . . . . . . . . 46.7 ttp -156.69 141.09 16.67 Favored 'General case' 0 C--N 1.292 -1.917 0 N-CA-C 109.12 -0.696 . . . . 1.74 109.12 -179.221 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A 1551 ' ' SER . . . . . . . . . . . . . 64.0 p -89.54 153.48 20.75 Favored 'General case' 0 N--CA 1.414 -2.274 0 N-CA-C 107.937 -1.134 . . . . 1.64 107.937 177.114 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A 1552 ' ' ILE . . . . . 0.54 HD11 ' HB2' ' A' 1538 ' ' PHE . 46.2 mm -83.97 -32.29 8.47 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.708 0 N-CA-C 107.595 -1.261 . . . . 1.33 107.595 178.627 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A 1553 ' ' CYS . . . . . 0.454 ' HA ' ' OH ' ' A' 1592 ' ' TYR . 36.6 t -162.44 137.62 7.01 Favored 'General case' 0 N--CA 1.43 -1.472 0 CA-C-N 115.547 -0.751 . . . . 1.43 109.125 165.836 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A 1554 ' ' GLY . . . . . . . . . . . . . . . 85.91 -124.39 6.84 Favored Glycine 0 CA--C 1.473 -2.549 0 N-CA-C 110.201 -1.16 . . . . 1.12 110.201 -178.641 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A 1555 ' ' GLU . . . . . 0.457 ' CD ' ' H ' ' A' 1555 ' ' GLU . 0.1 OUTLIER -117.93 -177.53 3.28 Favored 'General case' 0 C--N 1.258 -3.401 0 CA-C-N 113.538 -1.331 . . . . 1.8 108.516 -176.522 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A 1556 ' ' ASN . . . . . 0.465 ' HB3' ' HG3' ' A' 1557 ' ' GLU . 41.3 t30 165.31 -158.91 0.0 OUTLIER 'General case' 0 C--O 1.255 1.365 0 N-CA-C 103.096 -2.927 . . . . 2.63 103.096 -174.209 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A 1557 ' ' GLU . . . . . 0.465 ' HG3' ' HB3' ' A' 1556 ' ' ASN . 26.0 mt-10 83.49 178.72 0.05 Allowed 'General case' 0 CA--C 1.497 -1.058 0 N-CA-C 115.814 1.783 . . . . 3.79 115.814 159.713 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A 1558 ' ' ASN . . . . . . . . . . . . . 33.2 m-80 -127.97 43.06 3.21 Favored 'General case' 0 C--N 1.307 -1.273 0 CA-C-N 113.358 -1.747 . . . . 1.52 107.948 -173.541 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A 1559 ' ' CYS . . . . . 0.408 ' HB3' ' HD2' ' A' 1560 ' ' PRO . 84.2 m -131.85 172.37 7.48 Favored Pre-proline 0 C--N 1.293 -1.889 0 CA-C-N 113.666 -1.607 . . . . 0.84 106.885 -179.609 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A 1560 ' ' PRO . . . . . 0.437 ' HA ' ' HD2' ' A' 1561 ' ' PRO . 99.7 Cg_exo -48.73 116.21 2.02 Favored 'Trans proline' 0 C--N 1.361 1.209 0 C-N-CA 122.177 1.918 . . . . 1.18 110.591 172.756 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A 1561 ' ' PRO . . . . . 0.437 ' HD2' ' HA ' ' A' 1560 ' ' PRO . 12.4 Cg_endo -53.63 142.51 60.51 Favored 'Trans proline' 0 C--N 1.354 0.828 0 C-N-CA 124.35 3.367 . . . . 1.51 113.988 -172.854 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A 1562 ' ' GLY . . . . . . . . . . . . . . . 112.28 9.24 20.27 Favored Glycine 0 N--CA 1.437 -1.277 0 N-CA-C 110.687 -0.965 . . . . 0.72 110.687 -179.71 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A 1563 ' ' VAL . . . . . . . . . . . . . 4.8 m -99.66 154.23 4.27 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.838 0 N-CA-C 109.357 -0.609 . . . . 0.97 109.357 176.049 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A 1564 ' ' GLY . . . . . . . . . . . . . . . -115.94 -6.43 16.5 Favored Glycine 0 N--CA 1.421 -2.324 0 N-CA-C 110.36 -1.096 . . . . 0.72 110.36 175.408 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A 1565 ' ' ALA . . . . . . . . . . . . . . . -168.78 119.2 0.74 Allowed 'General case' 0 C--O 1.259 1.577 0 N-CA-C 108.969 -0.752 . . . . 0.37 108.969 -179.347 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A 1566 ' ' CYS . . . . . . . . . . . . . 35.8 t -141.72 141.29 33.27 Favored 'General case' 0 C--N 1.297 -1.686 0 CA-C-N 115.368 -0.833 . . . . 0.51 111.2 -174.064 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A 1567 ' ' PHE . . . . . 0.4 ' HB3' ' OG ' ' A' 1545 ' ' SER . 15.7 m-85 -66.6 126.94 30.49 Favored 'General case' 0 C--O 1.219 -0.51 0 N-CA-C 109.723 -0.473 . . . . 0.97 109.723 176.197 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A 1568 ' ' GLY . . . . . 0.541 ' HA2' ' CE2' ' A' 1549 ' ' TYR . . . -66.86 -33.22 83.38 Favored Glycine 0 N--CA 1.444 -0.83 0 CA-C-N 115.748 -0.66 . . . . 1.08 114.167 -175.109 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A 1569 ' ' GLN . . . . . . . . . . . . . 8.8 tt0 -84.45 -52.86 5.84 Favored 'General case' 0 C--N 1.303 -1.436 0 CA-C-O 121.686 0.755 . . . . 2.74 110.707 -179.576 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A 1570 ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -83.29 -14.68 52.53 Favored 'General case' 0 C--N 1.296 -1.721 0 CA-C-N 114.884 -1.053 . . . . 1.96 112.463 -169.745 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A 1571 ' ' ARG . . . . . . . . . . . . . 49.3 mtp180 54.97 37.23 28.51 Favored 'General case' 0 N--CA 1.476 0.855 0 C-N-CA 125.864 1.666 . . . . 3.95 111.95 -179.644 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A 1572 ' ' ILE . . . . . . . . . . . . . 45.9 mm -107.01 132.78 53.49 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.126 0 CA-C-N 115.347 -0.842 . . . . 1.37 109.359 -178.349 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A 1573 ' ' SER . . . . . . . . . . . . . 33.0 t -73.83 131.58 41.67 Favored 'General case' 0 N--CA 1.428 -1.528 0 CA-C-N 114.997 -1.001 . . . . 1.08 110.607 179.858 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A 1574 ' ' VAL . . . . . 0.988 ' HA ' ' HB3' ' A' 1596 ' ' SER . 34.0 m -109.85 -32.69 2.34 Favored 'Isoleucine or valine' 0 N--CA 1.419 -1.978 0 C-N-CA 119.976 -0.69 . . . . 1.3 109.864 171.984 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A 1575 ' ' GLY . . . . . . . . . . . . . . . -133.51 121.8 2.91 Favored Glycine 0 N--CA 1.425 -2.088 0 N-CA-C 110.372 -1.091 . . . . 0.51 110.372 178.762 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A 1576 ' ' LYS . . . . . . . . . . . . . 88.0 tttt -80.49 149.15 30.16 Favored 'General case' 0 C--N 1.311 -1.1 0 N-CA-C 108.578 -0.897 . . . . 2.9 108.578 179.637 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A 1577 ' ' ALA . . . . . . . . . . . . . . . -61.88 102.35 0.27 Allowed 'General case' 0 CA--C 1.516 -0.357 0 O-C-N 123.928 0.768 . . . . 0.83 111.141 -177.81 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A 1578 ' ' ASN . . . . . . . . . . . . . 73.4 m-20 -120.87 115.19 22.75 Favored 'General case' 0 C--N 1.297 -1.699 0 N-CA-C 106.487 -1.672 . . . . 1.85 106.487 175.638 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A 1579 ' ' LYS . . . . . 0.594 ' HE3' ' SG ' ' A' 1516 ' ' CYS . 55.6 mtpt -83.35 90.17 7.12 Favored 'General case' 0 C--N 1.295 -1.781 0 N-CA-C 107.724 -1.213 . . . . 1.9 107.724 -179.047 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A 1580 ' ' ARG . . . . . . . . . . . . . 26.0 ttt85 -150.96 113.91 4.75 Favored 'General case' 0 N--CA 1.424 -1.734 0 CA-C-N 114.847 -1.07 . . . . 3.63 109.667 -175.579 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A 1581 ' ' LEU . . . . . . . . . . . . . 3.5 pp -134.04 161.73 34.03 Favored 'General case' 0 C--N 1.292 -1.915 0 CA-C-N 115.776 -0.647 . . . . 1.87 109.721 179.425 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A 1582 ' ' ARG . . . . . . . . . . . . . 79.1 ttt180 -138.15 129.39 27.45 Favored 'General case' 0 C--N 1.292 -1.892 0 C-N-CA 121.134 -0.227 . . . . 3.97 110.444 176.999 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A 1583 ' ' TYR . . . . . . . . . . . . . 36.7 t80 -93.07 102.6 14.93 Favored 'General case' 0 C--N 1.3 -1.583 0 N-CA-C 107.185 -1.413 . . . . 1.41 107.185 173.662 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A 1584 ' ' VAL . . . . . . . . . . . . . 7.5 p -135.87 120.93 27.85 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.949 0 C-N-CA 120.875 -0.33 . . . . 1.69 111.463 -177.293 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A 1585 ' ' ASP . . . . . . . . . . . . . 35.3 t70 53.08 45.73 28.14 Favored 'General case' 0 N--CA 1.488 1.435 0 C-N-CA 124.453 1.101 . . . . 2.06 111.12 178.367 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A 1586 ' ' GLN . . . . . . . . . . . . . 47.0 mt-30 58.13 25.83 12.94 Favored 'General case' 0 C--O 1.242 0.685 0 C-N-CA 125.377 1.471 . . . . 2.33 114.587 179.675 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A 1587 ' ' VAL . . . . . . . . . . . . . 8.1 p -128.45 126.17 65.12 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.314 0 N-CA-C 107.895 -1.15 . . . . 0.78 107.895 171.737 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A 1588 ' ' LEU . . . . . 0.623 ' HB2' ' HB2' ' A' 1612 ' ' PHE . 34.6 mt -86.22 138.99 31.45 Favored 'General case' 0 C--N 1.304 -1.396 0 N-CA-C 108.991 -0.744 . . . . 1.41 108.991 -179.918 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A 1589 ' ' GLN . . . . . . . . . . . . . 34.6 tt0 -130.59 107.0 8.87 Favored 'General case' 0 C--N 1.292 -1.929 0 N-CA-C 109.397 -0.594 . . . . 1.24 109.397 -177.278 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A 1590 ' ' LEU . . . . . . . . . . . . . 9.1 tt -111.82 137.16 50.15 Favored 'General case' 0 C--N 1.288 -2.07 0 N-CA-C 107.744 -1.206 . . . . 1.15 107.744 179.031 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A 1591 ' ' VAL . . . . . 0.543 HG12 HG22 ' A' 1609 ' ' VAL . 28.8 m -130.55 140.58 48.44 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.937 0 N-CA-C 112.233 0.457 . . . . 1.51 112.233 -175.431 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A 1592 ' ' TYR . . . . . 0.454 ' OH ' ' HA ' ' A' 1553 ' ' CYS . 39.6 m-85 -122.09 138.69 54.36 Favored 'General case' 0 C--N 1.313 -1.01 0 N-CA-C 108.128 -1.064 . . . . 1.06 108.128 172.948 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A 1593 ' ' LYS . . . . . . . . . . . . . 62.5 pttt -159.25 174.85 14.17 Favored 'General case' 0 C--O 1.251 1.133 0 N-CA-C 109.899 -0.408 . . . . 2.18 109.899 178.8 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A 1594 ' ' ASP . . . . . . . . . . . . . 31.6 m-20 67.54 56.93 0.57 Allowed 'General case' 0 N--CA 1.48 1.03 0 C-N-CA 124.376 1.07 . . . . 1.45 110.888 179.592 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A 1595 ' ' GLY . . . . . . . . . . . . . . . -142.1 -47.92 0.05 OUTLIER Glycine 0 C--N 1.308 -1.026 0 CA-C-N 115.054 -0.976 . . . . 0.78 111.362 -179.578 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A 1596 ' ' SER . . . . . 0.988 ' HB3' ' HA ' ' A' 1574 ' ' VAL . 15.8 p -96.69 134.21 23.51 Favored Pre-proline 0 C--N 1.298 -1.638 0 CA-C-N 115.526 -0.337 . . . . 1.68 111.545 179.031 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A 1597 ' ' PRO . . . . . 0.455 ' HD3' ' HA ' ' A' 1596 ' ' SER . 3.0 Cg_exo -79.77 113.56 3.07 Favored 'Trans proline' 0 N--CA 1.445 -1.373 0 C-N-CA 122.176 1.917 . . . . 1.17 108.593 170.863 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A 1598 ' ' CYS . . . . . . . . . . . . . 48.6 t -94.87 122.66 59.86 Favored Pre-proline 0 C--N 1.306 -1.326 0 N-CA-C 109.727 -0.471 . . . . 1.19 109.727 -176.3 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A 1599 ' ' PRO . . . . . . . . . . . . . 87.9 Cg_endo -77.97 0.6 9.7 Favored 'Trans proline' 0 CA--C 1.537 0.67 0 C-N-CA 123.384 2.723 . . . . 1.59 114.267 -175.463 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A 1600 ' ' SER . . . . . . . . . . . . . 19.9 m -77.9 -32.18 51.65 Favored 'General case' 0 C--N 1.308 -1.223 0 CA-C-O 120.677 0.275 . . . . 2.12 111.288 -179.679 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A 1601 ' ' LYS . . . . . 0.905 ' HB3' HD12 ' A' 1604 ' ' LEU . 11.2 tmtt? -158.92 129.98 6.19 Favored 'General case' 0 C--N 1.313 -0.993 0 N-CA-C 105.691 -1.966 . . . . 3.74 105.691 -177.13 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A 1602 ' ' SER . . . . . . . . . . . . . 16.4 m -67.36 125.41 26.02 Favored 'General case' 0 C--N 1.316 -0.852 0 CA-C-O 120.886 0.374 . . . . 3.79 110.591 -175.222 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A 1603 ' ' GLY . . . . . . . . . . . . . . . 103.83 -6.27 47.9 Favored Glycine 0 N--CA 1.435 -1.382 0 N-CA-C 110.918 -0.873 . . . . 2.0 110.918 -179.937 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A 1604 ' ' LEU . . . . . 0.905 HD12 ' HB3' ' A' 1601 ' ' LYS . 6.8 mt -89.19 148.26 23.73 Favored 'General case' 0 N--CA 1.43 -1.463 0 CA-C-O 121.425 0.631 . . . . 1.48 111.851 178.209 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A 1605 ' ' SER . . . . . 0.465 ' HA ' ' O ' ' A' 1596 ' ' SER . 8.3 t -130.45 163.58 26.64 Favored 'General case' 0 N--CA 1.413 -2.287 0 N-CA-C 104.673 -2.344 . . . . 1.51 104.673 176.561 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A 1606 ' ' TYR . . . . . 0.548 ' HA ' ' O ' ' A' 1634 ' ' CYS . 67.6 m-85 -90.22 116.01 27.88 Favored 'General case' 0 CA--C 1.458 -2.563 0 N-CA-C 106.331 -1.729 . . . . 1.18 106.331 -179.852 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A 1607 ' ' LYS . . . . . . . . . . . . . 23.3 pttp -103.23 127.41 50.55 Favored 'General case' 0 N--CA 1.394 -3.226 0 C-N-CA 118.196 -1.401 . . . . 1.67 109.496 -176.738 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A 1608 ' ' SER . . . . . 0.505 ' HA ' ' HB2' ' A' 1636 ' ' LEU . 12.0 p -97.43 111.31 23.62 Favored 'General case' 0 N--CA 1.407 -2.62 0 CA-C-N 115.118 -0.946 . . . . 1.0 109.287 -177.186 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A 1609 ' ' VAL . . . . . 0.543 HG22 HG12 ' A' 1591 ' ' VAL . 85.5 t -101.35 107.84 22.24 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.523 0 N-CA-C 108.166 -1.049 . . . . 0.93 108.166 179.747 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A 1610 ' ' ILE . . . . . . . . . . . . . 2.5 mp -93.28 108.7 20.77 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.561 0 N-CA-C 108.274 -1.01 . . . . 0.78 108.274 179.023 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A 1611 ' ' SER . . . . . 0.401 ' O ' ' HA ' ' A' 1639 ' ' SER . 21.8 m -94.52 113.92 25.83 Favored 'General case' 0 N--CA 1.409 -2.509 0 N-CA-C 108.232 -1.025 . . . . 1.29 108.232 177.346 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A 1612 ' ' PHE . . . . . 0.623 ' HB2' ' HB2' ' A' 1588 ' ' LEU . 79.8 m-85 -84.89 106.84 16.71 Favored 'General case' 0 C--N 1.291 -1.941 0 CA-C-N 115.067 -0.97 . . . . 0.7 110.57 -178.24 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A 1613 ' ' VAL . . . . . . . . . . . . . 41.9 t -94.92 119.68 43.3 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.52 0 CA-C-N 115.279 -0.873 . . . . 0.75 109.067 -177.051 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A 1614 ' ' CYS . . . . . 0.523 ' HB3' ' HB2' ' A' 1646 ' ' CYS . 56.2 m -71.45 92.33 1.09 Allowed 'General case' 0 C--N 1.314 -0.958 0 CA-C-O 121.377 0.608 . . . . 1.39 109.381 178.241 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A 1615 ' ' ARG . . . . . 0.515 ' HB3' ' HB3' ' A' 1641 ' ' HIS . 0.6 OUTLIER -137.97 87.46 16.58 Favored Pre-proline 0 C--N 1.305 -1.36 0 N-CA-C 107.109 -1.441 . . . . 3.75 107.109 -178.904 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A 1616 ' ' PRO . . . . . . . . . . . . . 6.6 Cg_exo -76.34 44.79 1.43 Allowed 'Trans proline' 0 N--CA 1.479 0.635 0 C-N-CA 123.459 2.772 . . . . 1.32 112.768 -177.449 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A 1617 ' ' GLU . . . . . . . . . . . . . 41.8 mt-10 -131.15 40.82 3.41 Favored 'General case' 0 C--N 1.303 -1.44 0 N-CA-C 108.201 -1.036 . . . . 3.21 108.201 -179.276 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A 1618 ' ' ALA . . . . . . . . . . . . . . . -114.09 134.89 54.58 Favored 'General case' 0 C--N 1.308 -1.21 0 CA-C-N 115.538 -0.756 . . . . 2.44 110.963 -175.795 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A 1619 ' ' GLY . . . . . . . . . . . . . . . -151.64 -86.76 0.06 OUTLIER Glycine 0 N--CA 1.436 -1.308 0 N-CA-C 110.954 -0.858 . . . . 3.26 110.954 179.168 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A 1620 ' ' PRO . . . . . . . . . . . . . 18.8 Cg_endo -60.53 -31.34 92.26 Favored 'Trans proline' 0 CA--C 1.539 0.731 0 C-N-CA 122.972 2.448 . . . . 5.92 113.463 -179.402 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A 1621 ' ' THR . . . . . . . . . . . . . 4.4 m -114.42 31.23 6.75 Favored 'General case' 0 C--N 1.317 -0.839 0 N-CA-C 109.429 -0.582 . . . . 4.76 109.429 -178.928 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A 1622 ' ' ASN . . . . . . . . . . . . . 60.6 t30 -76.93 74.73 3.53 Favored 'General case' 0 N--CA 1.472 0.65 0 CA-C-O 121.81 0.814 . . . . 2.92 110.761 -178.649 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A 1623 ' ' ARG . . . . . . . . . . . . . 9.2 ptm180 -154.0 153.49 28.61 Favored Pre-proline 0 C--N 1.3 -1.566 0 N-CA-C 107.28 -1.378 . . . . 3.61 107.28 -178.922 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A 1624 ' ' PRO . . . . . . . . . . . . . 32.5 Cg_exo -61.29 119.82 7.16 Favored 'Trans proline' 0 C--O 1.245 0.87 0 C-N-CA 122.761 2.307 . . . . 2.37 111.751 179.246 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A 1625 ' ' MET . . . . . . . . . . . . . 56.3 ttp -95.99 130.7 42.92 Favored 'General case' 0 C--N 1.301 -1.522 0 CA-C-N 115.082 -0.963 . . . . 2.16 109.688 -177.228 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A 1626 ' ' LEU . . . . . 0.708 HD21 HD23 ' A' 1629 ' ' LEU . 56.8 tp -83.53 105.73 14.7 Favored 'General case' 0 C--N 1.306 -1.304 0 N-CA-C 107.8 -1.185 . . . . 1.35 107.8 178.001 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A 1627 ' ' ILE . . . . . . . . . . . . . 45.4 pt -83.19 -33.61 10.36 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.268 0 N-CA-C 112.303 0.483 . . . . 1.21 112.303 -175.1 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A 1628 ' ' SER . . . . . . . . . . . . . 45.7 m -149.75 147.49 28.08 Favored 'General case' 0 C--N 1.313 -1.001 0 CA-C-O 120.673 0.273 . . . . 1.4 110.475 -178.077 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A 1629 ' ' LEU . . . . . 0.708 HD23 HD21 ' A' 1626 ' ' LEU . 1.2 tm? -127.76 108.41 10.72 Favored 'General case' 0 C--N 1.307 -1.255 0 N-CA-C 106.61 -1.626 . . . . 1.56 106.61 -179.216 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A 1630 ' ' ASP . . . . . . . . . . . . . 15.3 t70 -107.7 112.08 24.59 Favored 'General case' 0 C--N 1.304 -1.399 0 N-CA-C 109.056 -0.72 . . . . 0.87 109.056 178.771 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A 1631 ' ' LYS . . . . . . . . . . . . . 63.4 mttm -80.0 -22.5 42.41 Favored 'General case' 0 C--N 1.303 -1.426 0 N-CA-C 112.674 0.62 . . . . 2.35 112.674 -177.186 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A 1632 ' ' GLN . . . . . . . . . . . . . 1.7 mp0 -78.77 -49.96 12.14 Favored 'General case' 0 CA--C 1.509 -0.61 0 CA-C-O 121.029 0.442 . . . . 2.55 111.467 -173.277 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A 1633 ' ' THR . . . . . . . . . . . . . 60.4 p -86.57 -4.52 59.18 Favored 'General case' 0 C--N 1.313 -1.011 0 CA-C-O 121.875 0.845 . . . . 1.24 110.004 179.764 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A 1634 ' ' CYS . . . . . 0.548 ' O ' ' HA ' ' A' 1606 ' ' TYR . 29.4 m 59.62 51.05 6.65 Favored 'General case' 0 N--CA 1.441 -0.907 0 CA-C-N 113.442 -1.708 . . . . 0.89 108.768 179.712 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A 1635 ' ' THR . . . . . . . . . . . . . 39.7 m -114.94 130.26 56.88 Favored 'General case' 0 N--CA 1.425 -1.699 0 CA-C-N 114.999 -1.001 . . . . 0.75 110.087 -175.831 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A 1636 ' ' LEU . . . . . 0.505 ' HB2' ' HA ' ' A' 1608 ' ' SER . 40.6 mt -112.62 116.06 29.59 Favored 'General case' 0 N--CA 1.435 -1.223 0 N-CA-C 107.58 -1.267 . . . . 1.33 107.58 -178.479 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A 1637 ' ' PHE . . . . . . . . . . . . . 89.1 m-85 -98.68 100.92 12.19 Favored 'General case' 0 C--N 1.307 -1.282 0 N-CA-C 111.777 0.288 . . . . 0.83 111.777 -175.298 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A 1638 ' ' PHE . . . . . . . . . . . . . 68.0 m-85 -100.74 138.84 37.26 Favored 'General case' 0 C--N 1.307 -1.258 0 N-CA-C 109.169 -0.678 . . . . 0.6 109.169 176.165 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A 1639 ' ' SER . . . . . 0.401 ' HA ' ' O ' ' A' 1611 ' ' SER . 50.8 m -136.79 120.75 17.61 Favored 'General case' 0 C--N 1.279 -2.467 0 N-CA-C 108.464 -0.939 . . . . 1.08 108.464 174.883 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A 1640 ' ' TRP . . . . . . . . . . . . . 19.7 t90 -111.76 119.89 40.16 Favored 'General case' 0 C--N 1.292 -1.898 0 CA-C-N 115.942 -0.572 . . . . 0.8 109.501 -178.131 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A 1641 ' ' HIS . . . . . 0.515 ' HB3' ' HB3' ' A' 1615 ' ' ARG . 39.8 m170 -77.06 107.46 9.44 Favored 'General case' 0 C--N 1.31 -1.138 0 N-CA-C 106.347 -1.723 . . . . 2.54 106.347 174.718 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A 1642 ' ' THR . . . . . . . . . . . . . 8.8 t -140.92 136.93 16.56 Favored Pre-proline 0 C--N 1.291 -1.952 0 N-CA-C 113.126 0.787 . . . . 1.15 113.126 -173.711 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A 1643 ' ' PRO . . . . . 0.422 ' O ' ' HG2' ' A' 1647 ' ' GLU . 64.4 Cg_endo -76.97 -2.93 13.2 Favored 'Trans proline' 0 C--O 1.199 -1.462 0 C-N-CA 123.475 2.783 . . . . 0.8 111.006 173.735 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A 1644 ' ' LEU . . . . . . . . . . . . . 83.6 mt -91.84 -9.67 42.56 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 116.608 -0.269 . . . . 1.54 111.417 -177.968 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A 1645 ' ' ALA . . . . . . . . . . . . . . . -81.67 -35.98 29.29 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 121.805 0.812 . . . . 0.95 109.128 177.45 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A 1646 ' ' CYS . . . . . 0.523 ' HB2' ' HB3' ' A' 1614 ' ' CYS . 71.2 m -142.19 114.76 8.48 Favored 'General case' 0 N--CA 1.426 -1.645 0 N-CA-C 105.499 -2.037 . . . . 1.41 105.499 174.786 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A 1647 ' ' GLU . . . . . 0.422 ' HG2' ' O ' ' A' 1643 ' ' PRO . 42.2 mt-10 -103.74 129.59 25.04 Favored Pre-proline 0 C--N 1.3 -1.56 0 N-CA-C 109.137 -0.69 . . . . 2.92 109.137 -178.413 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A 1648 ' ' PRO . . . . . . . . . . . . . 18.6 Cg_endo -63.96 101.52 0.33 Allowed 'Trans proline' 0 C--O 1.245 0.861 0 C-N-CA 122.193 1.929 . . . . 2.82 109.506 175.025 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A 1649 ' ' GLU . . . . . . . . . . . . . 44.1 mt-10 . . . . . 0 C--N 1.305 -1.357 0 CA-C-N 115.533 -0.758 . . . . 5.06 109.227 -176.313 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A 1508 ' ' MET . . . . . . . . . . . . . 67.6 mtt . . . . . 0 C--O 1.24 0.586 0 CA-C-O 120.94 0.4 . . . . 8.27 110.933 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A 1509 ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER 59.7 80.24 0.21 Allowed 'General case' 0 N--CA 1.466 0.368 0 N-CA-C 113.555 0.946 . . . . 6.48 113.555 177.643 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A 1510 ' ' SER . . . . . . . . . . . . . 71.0 m -107.9 41.15 1.58 Allowed 'General case' 0 C--N 1.294 -1.838 0 CA-C-O 121.785 0.802 . . . . 4.22 108.943 173.074 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A 1511 ' ' ASN . . . . . . . . . . . . . 38.2 m-80 -67.59 -19.02 65.2 Favored 'General case' 0 CA--C 1.51 -0.58 0 CA-C-N 114.9 -1.045 . . . . 3.08 112.632 -174.405 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A 1512 ' ' GLU . . . . . 0.5 ' O ' ' HG3' ' A' 1580 ' ' ARG . 0.0 OUTLIER -66.82 -23.18 66.01 Favored 'General case' 0 C--O 1.212 -0.903 0 C-N-CA 120.403 -0.519 . . . . 4.46 110.604 179.79 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A 1513 ' ' HIS . . . . . . . . . . . . . 88.7 m-70 -91.64 1.89 56.84 Favored 'General case' 0 N--CA 1.464 0.251 0 CA-C-N 115.743 -0.662 . . . . 5.57 109.941 178.478 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A 1514 ' ' ASP . . . . . . . . . . . . . 26.8 t70 -119.24 -53.61 2.24 Favored 'General case' 0 C--N 1.316 -0.863 0 N-CA-C 112.712 0.634 . . . . 3.7 112.712 -172.231 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A 1515 ' ' ASP . . . . . . . . . . . . . 7.0 t0 -138.76 -174.31 3.8 Favored 'General case' 0 C--N 1.305 -1.361 0 N-CA-C 107.061 -1.459 . . . . 2.54 107.061 -174.186 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A 1516 ' ' CYS . . . . . . . . . . . . . 81.3 m -90.65 61.53 4.87 Favored 'General case' 0 C--N 1.28 -2.422 0 C-N-CA 123.599 0.76 . . . . 1.25 109.183 -179.761 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A 1517 ' ' GLN . . . . . 0.415 ' HB2' HD21 ' A' 1526 ' ' LEU . 9.8 pt20 -160.97 131.9 5.39 Favored 'General case' 0 C--N 1.308 -1.211 0 CA-C-O 120.803 0.335 . . . . 1.88 110.695 179.219 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A 1518 ' ' VAL . . . . . . . . . . . . . 14.1 p -131.88 137.32 55.19 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.804 0 N-CA-C 109.053 -0.721 . . . . 1.73 109.053 178.429 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A 1519 ' ' THR . . . . . 0.62 ' HA ' ' HA ' ' A' 1526 ' ' LEU . 40.0 m -89.37 128.65 35.93 Favored 'General case' 0 C--N 1.29 -1.98 0 CA-C-N 116.182 -0.463 . . . . 1.7 109.758 177.891 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A 1520 ' ' ASN . . . . . . . . . . . . . 17.7 t-20 -80.1 114.3 45.6 Favored Pre-proline 0 C--N 1.308 -1.228 0 N-CA-C 108.473 -0.936 . . . . 2.12 108.473 174.758 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A 1521 ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -74.63 0.2 9.0 Favored 'Trans proline' 0 CA--C 1.539 0.767 0 C-N-CA 122.541 2.16 . . . . 2.47 113.926 -176.371 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A 1522 ' ' SER . . . . . . . . . . . . . 49.3 m -88.79 -62.34 1.51 Allowed 'General case' 0 N--CA 1.432 -1.375 0 O-C-N 122.13 -0.356 . . . . 2.57 110.895 178.784 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A 1523 ' ' THR . . . . . . . . . . . . . 8.8 t -92.98 -11.89 32.09 Favored 'General case' 0 CA--C 1.547 0.858 0 CA-C-O 120.952 0.406 . . . . 2.15 111.253 -179.821 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A 1524 ' ' GLY . . . . . . . . . . . . . . . 80.33 27.79 50.81 Favored Glycine 0 C--N 1.332 0.329 0 C-N-CA 121.059 -0.591 . . . . 1.89 112.119 179.244 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A 1525 ' ' HIS . . . . . . . . . . . . . 16.1 t60 -101.22 119.18 38.36 Favored 'General case' 0 C--N 1.309 -1.169 0 N-CA-C 110.184 -0.302 . . . . 1.9 110.184 -176.802 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A 1526 ' ' LEU . . . . . 0.62 ' HA ' ' HA ' ' A' 1519 ' ' THR . 7.0 tt -82.72 124.73 30.5 Favored 'General case' 0 C--N 1.301 -1.533 0 N-CA-C 108.174 -1.047 . . . . 1.61 108.174 175.651 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A 1527 ' ' PHE . . . . . 0.408 ' O ' ' HA ' ' A' 1517 ' ' GLN . 76.4 m-85 -90.32 102.41 15.14 Favored 'General case' 0 C--N 1.309 -1.194 0 N-CA-C 109.183 -0.673 . . . . 1.42 109.183 178.233 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A 1528 ' ' ASP . . . . . . . . . . . . . 8.8 t70 -80.76 118.13 22.03 Favored 'General case' 0 C--N 1.309 -1.154 0 CA-C-O 121.336 0.588 . . . . 2.18 111.633 178.306 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A 1529 ' ' LEU . . . . . . . . . . . . . 6.2 mp -121.05 11.47 10.96 Favored 'General case' 0 C--N 1.307 -1.28 0 N-CA-C 106.496 -1.668 . . . . 1.44 106.496 168.149 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A 1530 ' ' SER . . . . . . . . . . . . . 42.9 m -76.18 -29.1 57.54 Favored 'General case' 0 N--CA 1.442 -0.867 0 CA-C-N 115.376 -0.829 . . . . 1.44 110.06 -178.615 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A 1531 ' ' SER . . . . . . . . . . . . . 29.0 t -75.32 -6.35 49.44 Favored 'General case' 0 CA--C 1.548 0.903 0 CA-C-O 122.303 1.049 . . . . 1.5 108.806 174.518 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A 1532 ' ' LEU . . . . . . . . . . . . . 98.1 mt -91.89 15.24 13.49 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.807 -0.633 . . . . 1.77 110.616 175.243 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A 1533 ' ' SER . . . . . 0.425 ' HA ' ' O ' ' A' 1553 ' ' CYS . 18.8 m -84.56 122.11 28.57 Favored 'General case' 0 N--CA 1.432 -1.35 0 N-CA-C 108.619 -0.882 . . . . 2.38 108.619 175.668 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A 1534 ' ' GLY . . . . . . . . . . . . . . . -135.92 152.77 21.15 Favored Glycine 0 N--CA 1.419 -2.448 0 N-CA-C 110.594 -1.002 . . . . 1.55 110.594 -179.255 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A 1535 ' ' ARG . . . . . 0.584 ' HG3' ' HG3' ' A' 1555 ' ' GLU . 51.2 ttt180 -96.44 -25.13 15.8 Favored 'General case' 0 C--N 1.306 -1.283 0 CA-C-O 121.669 0.747 . . . . 3.96 109.886 179.049 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A 1536 ' ' ALA . . . . . . . . . . . . . . . -89.72 -41.03 12.14 Favored 'General case' 0 C--O 1.243 0.732 0 CA-C-N 115.587 -0.733 . . . . 1.65 110.849 -179.043 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A 1537 ' ' GLY . . . . . . . . . . . . . . . 97.7 -175.95 30.62 Favored Glycine 0 N--CA 1.435 -1.382 0 CA-C-N 115.761 -0.654 . . . . 1.19 112.477 176.75 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A 1538 ' ' PHE . . . . . . . . . . . . . 92.1 m-85 -111.64 155.09 23.94 Favored 'General case' 0 C--N 1.302 -1.49 0 N-CA-C 108.212 -1.033 . . . . 1.69 108.212 176.687 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A 1539 ' ' THR . . . . . . . . . . . . . 5.2 p -106.27 111.08 23.52 Favored 'General case' 0 C--N 1.295 -1.761 0 CA-C-N 116.016 -0.538 . . . . 1.48 111.538 -179.704 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A 1540 ' ' ALA . . . . . . . . . . . . . . . -112.32 107.63 16.53 Favored 'General case' 0 C--N 1.313 -0.988 0 N-CA-C 109.027 -0.731 . . . . 0.83 109.027 176.014 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A 1541 ' ' ALA . . . . . . . . . . . . . . . -71.75 155.23 40.69 Favored 'General case' 0 C--N 1.312 -1.037 0 CA-C-N 116.261 -0.427 . . . . 1.27 110.644 178.705 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A 1542 ' ' TYR . . . . . 0.414 ' HD2' ' HB2' ' A' 1545 ' ' SER . 32.4 t80 -156.23 179.92 8.77 Favored 'General case' 0 C--N 1.302 -1.491 0 N-CA-C 107.708 -1.219 . . . . 2.15 107.708 -178.926 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A 1543 ' ' SER . . . . . . . . . . . . . 5.5 m -44.98 -151.67 0.0 OUTLIER 'General case' 0 CA--C 1.57 1.728 0 C-N-CA 129.181 2.993 . . . . 2.29 114.616 178.101 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A 1544 ' ' LYS . . . . . 0.414 ' HB2' ' HE3' ' A' 1544 ' ' LYS . 19.4 ptmt -54.7 -6.9 0.13 Allowed 'General case' 0 CA--C 1.575 1.931 0 O-C-N 120.251 -1.531 . . . . 3.91 114.021 176.511 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A 1545 ' ' SER . . . . . 0.414 ' HB2' ' HD2' ' A' 1542 ' ' TYR . 20.4 m -73.03 -17.4 61.44 Favored 'General case' 0 CA--C 1.554 1.132 0 C-N-CA 123.332 0.653 . . . . 3.3 109.693 170.668 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A 1546 ' ' GLY . . . . . . . . . . . . . . . 83.75 -80.38 1.83 Allowed Glycine 0 N--CA 1.436 -1.316 0 CA-C-O 121.43 0.461 . . . . 1.24 114.009 174.093 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A 1547 ' ' VAL . . . . . . . . . . . . . 7.1 p -160.16 140.77 3.78 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.169 0 N-CA-C 109.235 -0.654 . . . . 1.63 109.235 -174.738 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A 1548 ' ' VAL . . . . . . . . . . . . . 4.0 t -108.29 131.9 57.52 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.726 0 N-CA-C 107.399 -1.334 . . . . 0.92 107.399 179.398 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A 1549 ' ' TYR . . . . . . . . . . . . . 68.4 m-85 -93.15 114.64 27.2 Favored 'General case' 0 C--N 1.308 -1.207 0 N-CA-C 106.858 -1.534 . . . . 1.44 106.858 174.077 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A 1550 ' ' MET . . . . . . . . . . . . . 56.3 ttp -135.93 121.6 19.64 Favored 'General case' 0 C--N 1.299 -1.614 0 C-N-CA 119.706 -0.798 . . . . 1.74 111.388 -177.774 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A 1551 ' ' SER . . . . . . . . . . . . . 19.9 m -95.97 124.1 39.84 Favored 'General case' 0 C--N 1.277 -2.568 0 N-CA-C 104.801 -2.296 . . . . 1.64 104.801 173.017 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A 1552 ' ' ILE . . . . . . . . . . . . . 50.6 mm -60.86 -43.2 95.12 Favored 'Isoleucine or valine' 0 C--O 1.213 -0.854 0 N-CA-C 109.404 -0.591 . . . . 1.33 109.404 -179.037 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A 1553 ' ' CYS . . . . . 0.425 ' O ' ' HA ' ' A' 1533 ' ' SER . 76.1 m -144.71 155.87 43.79 Favored 'General case' 0 C--N 1.295 -1.782 0 N-CA-C 106.491 -1.67 . . . . 1.43 106.491 173.411 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A 1554 ' ' GLY . . . . . . . . . . . . . . . 118.26 -110.92 2.05 Favored Glycine 0 N--CA 1.434 -1.489 0 C-N-CA 120.342 -0.932 . . . . 1.12 112.763 176.427 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A 1555 ' ' GLU . . . . . 0.584 ' HG3' ' HG3' ' A' 1535 ' ' ARG . 9.5 pt-20 -165.34 161.94 19.33 Favored 'General case' 0 C--N 1.305 -1.33 0 N-CA-C 106.724 -1.584 . . . . 1.8 106.724 -178.207 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A 1556 ' ' ASN . . . . . . . . . . . . . 17.9 t-20 -131.34 103.65 6.57 Favored 'General case' 0 C--N 1.287 -2.136 0 N-CA-C 109.332 -0.618 . . . . 2.63 109.332 -179.209 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A 1557 ' ' GLU . . . . . . . . . . . . . 9.1 mm-40 -83.13 36.65 0.52 Allowed 'General case' 0 C--N 1.3 -1.576 0 N-CA-C 113.782 1.03 . . . . 3.79 113.782 -173.2 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A 1558 ' ' ASN . . . . . . . . . . . . . 33.0 m-80 -111.78 -19.35 12.47 Favored 'General case' 0 C--N 1.295 -1.802 0 N-CA-C 107.846 -1.168 . . . . 1.52 107.846 176.244 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A 1559 ' ' CYS . . . . . 0.778 ' HB3' ' HD2' ' A' 1560 ' ' PRO . 70.8 m -138.51 176.48 2.63 Favored Pre-proline 0 N--CA 1.436 -1.156 0 CA-C-O 116.866 -1.54 . . . . 0.84 107.088 -178.103 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A 1560 ' ' PRO . . . . . 0.778 ' HD2' ' HB3' ' A' 1559 ' ' CYS . 2.9 Cg_exo -33.2 126.93 0.13 Allowed 'Trans proline' 0 C--N 1.386 2.538 0 C-N-CA 124.578 3.518 . . . . 1.18 115.149 -177.412 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A 1561 ' ' PRO . . . . . 0.473 ' HD2' ' HA ' ' A' 1560 ' ' PRO . 9.5 Cg_endo -51.37 111.86 0.67 Allowed 'Trans proline' 0 C--O 1.246 0.898 0 C-N-CA 123.675 2.917 . . . . 1.51 112.98 -179.294 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A 1562 ' ' GLY . . . . . . . . . . . . . . . 111.39 2.94 27.63 Favored Glycine 0 N--CA 1.437 -1.255 0 CA-C-N 115.436 -0.802 . . . . 0.72 113.018 177.937 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A 1563 ' ' VAL . . . . . 0.601 ' HA ' ' HA ' ' A' 1576 ' ' LYS . 14.9 m -94.06 152.0 3.64 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.055 0 N-CA-C 106.288 -1.745 . . . . 0.97 106.288 172.723 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A 1564 ' ' GLY . . . . . 0.601 ' HA3' ' CE2' ' A' 1592 ' ' TYR . . . -113.86 -26.41 3.86 Favored Glycine 0 C--N 1.307 -1.059 0 C-N-CA 119.28 -1.438 . . . . 0.72 113.139 -175.986 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A 1565 ' ' ALA . . . . . . . . . . . . . . . -132.59 126.11 32.01 Favored 'General case' 0 C--O 1.251 1.181 0 N-CA-C 109.63 -0.507 . . . . 0.37 109.63 -178.779 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A 1566 ' ' CYS . . . . . . . . . . . . . 43.2 t -150.4 139.7 21.31 Favored 'General case' 0 C--N 1.311 -1.075 0 CA-C-N 115.728 -0.669 . . . . 0.51 110.064 -174.774 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A 1567 ' ' PHE . . . . . . . . . . . . . 26.5 m-85 -69.84 123.13 20.68 Favored 'General case' 0 CA--C 1.508 -0.665 0 N-CA-C 107.396 -1.335 . . . . 0.97 107.396 175.755 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A 1568 ' ' GLY . . . . . . . . . . . . . . . -74.66 -37.27 46.15 Favored Glycine 0 N--CA 1.441 -1.023 0 C-N-CA 120.677 -0.773 . . . . 1.08 113.769 -173.627 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A 1569 ' ' GLN . . . . . . . . . . . . . 50.1 tp60 -69.35 -48.61 60.82 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-O 121.976 0.893 . . . . 2.74 109.44 -178.947 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A 1570 ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -80.71 -23.08 39.75 Favored 'General case' 0 C--N 1.301 -1.537 0 CA-C-N 114.387 -1.279 . . . . 1.96 112.397 -173.498 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A 1571 ' ' ARG . . . . . . . . . . . . . 40.5 mtp-105 64.32 32.15 12.38 Favored 'General case' 0 N--CA 1.472 0.64 0 C-N-CA 125.035 1.334 . . . . 3.95 111.864 -178.833 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A 1572 ' ' ILE . . . . . . . . . . . . . 49.8 mm -109.66 118.98 58.02 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.227 0 N-CA-C 108.972 -0.751 . . . . 1.37 108.972 -178.361 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A 1573 ' ' SER . . . . . . . . . . . . . 36.7 t -67.28 140.08 57.32 Favored 'General case' 0 N--CA 1.435 -1.205 0 CA-C-N 115.064 -0.971 . . . . 1.08 109.453 178.379 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A 1574 ' ' VAL . . . . . 0.523 ' HB ' ' HB2' ' A' 1606 ' ' TYR . 23.0 m -116.01 -38.96 2.48 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.653 0 C-N-CA 119.978 -0.689 . . . . 1.3 110.663 178.606 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A 1575 ' ' GLY . . . . . 0.798 ' HA3' ' HB3' ' A' 1592 ' ' TYR . . . -135.87 133.1 6.45 Favored Glycine 0 N--CA 1.428 -1.836 0 C-N-CA 120.376 -0.916 . . . . 0.51 112.729 -177.592 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A 1576 ' ' LYS . . . . . 0.601 ' HA ' ' HA ' ' A' 1563 ' ' VAL . 24.4 ttpp -85.89 149.37 25.27 Favored 'General case' 0 C--N 1.309 -1.191 0 N-CA-C 107.307 -1.368 . . . . 2.9 107.307 178.608 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A 1577 ' ' ALA . . . . . . . . . . . . . . . -63.44 133.91 54.77 Favored 'General case' 0 CA--C 1.501 -0.924 0 O-C-N 123.793 0.683 . . . . 0.83 109.503 179.128 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A 1578 ' ' ASN . . . . . . . . . . . . . 7.8 p30 -153.27 144.96 23.42 Favored 'General case' 0 C--N 1.282 -2.369 0 N-CA-C 105.638 -1.986 . . . . 1.85 105.638 179.867 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A 1579 ' ' LYS . . . . . . . . . . . . . 67.9 mttm -114.48 89.3 3.06 Favored 'General case' 0 C--N 1.29 -2.019 0 C-N-CA 118.631 -1.228 . . . . 1.9 110.791 -176.703 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A 1580 ' ' ARG . . . . . 0.5 ' HG3' ' O ' ' A' 1512 ' ' GLU . 53.1 ttt180 -156.72 131.07 8.63 Favored 'General case' 0 N--CA 1.415 -2.207 0 CA-C-N 115.288 -0.869 . . . . 3.63 109.42 172.712 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A 1581 ' ' LEU . . . . . 0.415 HD13 HD12 ' A' 1588 ' ' LEU . 2.3 pp -124.88 150.66 46.26 Favored 'General case' 0 C--N 1.284 -2.282 0 N-CA-C 108.784 -0.821 . . . . 1.87 108.784 175.857 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A 1582 ' ' ARG . . . . . . . . . . . . . 90.0 mtt180 -115.82 125.7 53.03 Favored 'General case' 0 C--N 1.288 -2.082 0 CA-C-O 121.0 0.429 . . . . 3.97 110.052 -176.592 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A 1583 ' ' TYR . . . . . 0.481 ' CE1' ' HA ' ' A' 1586 ' ' GLN . 58.8 t80 -94.0 91.25 6.78 Favored 'General case' 0 C--N 1.289 -2.031 0 N-CA-C 107.714 -1.217 . . . . 1.41 107.714 179.115 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A 1584 ' ' VAL . . . . . . . . . . . . . 4.4 p -107.21 95.37 3.74 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.85 0 CA-C-O 121.824 0.821 . . . . 1.69 111.4 -176.909 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A 1585 ' ' ASP . . . . . . . . . . . . . 27.9 t70 52.69 67.89 0.92 Allowed 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 114.695 -1.139 . . . . 2.06 111.359 -177.954 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A 1586 ' ' GLN . . . . . 0.481 ' HA ' ' CE1' ' A' 1583 ' ' TYR . 49.6 mt-30 66.31 -15.23 0.13 Allowed 'General case' 0 C--N 1.315 -0.905 0 N-CA-C 115.873 1.805 . . . . 2.33 115.873 177.73 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A 1587 ' ' VAL . . . . . . . . . . . . . 10.9 p -99.38 123.21 51.94 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.028 0 CA-C-N 119.119 0.872 . . . . 0.78 109.684 178.301 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A 1588 ' ' LEU . . . . . 0.541 ' HB2' ' HB2' ' A' 1612 ' ' PHE . 4.1 mm? -81.96 140.18 34.16 Favored 'General case' 0 N--CA 1.43 -1.472 0 CA-C-N 115.581 -0.736 . . . . 1.41 111.885 -178.848 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A 1589 ' ' GLN . . . . . . . . . . . . . 35.1 tt0 -129.78 122.1 28.13 Favored 'General case' 0 C--N 1.303 -1.454 0 CA-C-N 115.573 -0.74 . . . . 1.24 109.926 179.073 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A 1590 ' ' LEU . . . . . . . . . . . . . 6.8 tt -119.16 132.94 56.02 Favored 'General case' 0 C--N 1.304 -1.393 0 N-CA-C 106.569 -1.641 . . . . 1.15 106.569 176.583 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A 1591 ' ' VAL . . . . . 0.579 HG12 HG22 ' A' 1609 ' ' VAL . 35.3 m -124.29 144.7 33.21 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.837 0 CA-C-O 121.688 0.756 . . . . 1.51 112.956 -173.509 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A 1592 ' ' TYR . . . . . 0.798 ' HB3' ' HA3' ' A' 1575 ' ' GLY . 22.5 m-85 -106.66 123.49 48.2 Favored 'General case' 0 C--N 1.298 -1.664 0 CA-C-N 115.078 -0.964 . . . . 1.06 110.298 172.249 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A 1593 ' ' LYS . . . . . . . . . . . . . 20.5 ptmt -142.59 -178.64 5.87 Favored 'General case' 0 C--N 1.298 -1.67 0 CA-C-N 114.364 -1.289 . . . . 2.18 108.072 -173.59 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A 1594 ' ' ASP . . . . . 0.523 ' HB2' ' HE3' ' A' 1576 ' ' LYS . 57.9 m-20 67.05 14.88 9.98 Favored 'General case' 0 N--CA 1.491 1.618 0 C-N-CA 124.098 0.959 . . . . 1.45 113.265 175.253 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A 1595 ' ' GLY . . . . . . . . . . . . . . . -90.54 -105.89 1.29 Allowed Glycine 0 N--CA 1.432 -1.587 0 N-CA-C 111.212 -0.755 . . . . 0.78 111.212 179.106 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A 1596 ' ' SER . . . . . 0.438 ' HA ' ' HD3' ' A' 1597 ' ' PRO . 23.0 m -106.65 128.05 26.93 Favored Pre-proline 0 C--N 1.295 -1.795 0 N-CA-C 109.679 -0.489 . . . . 1.68 109.679 179.9 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A 1597 ' ' PRO . . . . . 0.438 ' HD3' ' HA ' ' A' 1596 ' ' SER . 32.3 Cg_exo -63.07 150.95 87.16 Favored 'Trans proline' 0 C--O 1.238 0.516 0 C-N-CA 123.289 2.659 . . . . 1.17 110.866 176.554 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A 1598 ' ' CYS . . . . . 0.481 ' HA ' ' HD3' ' A' 1599 ' ' PRO . 50.2 t -94.93 132.63 27.85 Favored Pre-proline 0 C--N 1.293 -1.851 0 N-CA-C 109.961 -0.385 . . . . 1.19 109.961 -177.675 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A 1599 ' ' PRO . . . . . 0.481 ' HD3' ' HA ' ' A' 1598 ' ' CYS . 11.8 Cg_exo -72.29 -7.5 21.05 Favored 'Trans proline' 0 C--N 1.362 1.24 0 C-N-CA 123.392 2.728 . . . . 1.59 112.165 -179.97 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A 1600 ' ' SER . . . . . . . . . . . . . 44.9 t -113.14 123.67 50.79 Favored 'General case' 0 N--CA 1.421 -1.906 0 N-CA-C 107.757 -1.201 . . . . 2.12 107.757 177.603 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A 1601 ' ' LYS . . . . . . . . . . . . . 34.9 mmtp 57.13 50.92 11.06 Favored 'General case' 0 C--O 1.241 0.633 0 O-C-N 123.64 0.587 . . . . 3.74 109.814 -179.623 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A 1602 ' ' SER . . . . . . . . . . . . . 50.9 m -54.04 140.56 31.15 Favored 'General case' 0 N--CA 1.439 -0.992 0 CA-C-N 114.964 -1.016 . . . . 3.79 113.254 -175.988 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A 1603 ' ' GLY . . . . . . . . . . . . . . . 135.75 -10.9 4.27 Favored Glycine 0 N--CA 1.434 -1.466 0 N-CA-C 108.954 -1.659 . . . . 2.0 108.954 -173.327 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A 1604 ' ' LEU . . . . . . . . . . . . . 1.3 pp -135.42 162.4 32.72 Favored 'General case' 0 N--CA 1.437 -1.075 0 C-N-CA 123.897 0.879 . . . . 1.48 110.449 179.834 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A 1605 ' ' SER . . . . . . . . . . . . . 11.4 m -99.71 -176.04 3.15 Favored 'General case' 0 C--N 1.302 -1.46 0 N-CA-C 109.012 -0.736 . . . . 1.51 109.012 -178.611 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A 1606 ' ' TYR . . . . . 0.62 ' HA ' ' HB3' ' A' 1634 ' ' CYS . 78.5 m-85 -81.71 97.12 7.78 Favored 'General case' 0 CA--C 1.477 -1.837 0 N-CA-C 103.325 -2.843 . . . . 1.18 103.325 171.508 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A 1607 ' ' LYS . . . . . . . . . . . . . 17.3 ptmt -103.53 125.52 50.13 Favored 'General case' 0 C--N 1.26 -3.285 0 C-N-CA 119.695 -0.802 . . . . 1.67 112.041 -165.57 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A 1608 ' ' SER . . . . . 0.422 ' HB2' ' HB2' ' A' 1592 ' ' TYR . 16.5 m -98.62 117.29 32.73 Favored 'General case' 0 C--N 1.296 -1.73 0 CA-C-N 114.796 -1.093 . . . . 1.0 108.95 -179.102 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A 1609 ' ' VAL . . . . . 0.579 HG22 HG12 ' A' 1591 ' ' VAL . 98.1 t -112.12 117.19 54.59 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.22 0 N-CA-C 109.194 -0.669 . . . . 0.93 109.194 179.775 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A 1610 ' ' ILE . . . . . 0.717 HG13 ' HB2' ' A' 1638 ' ' PHE . 2.9 mp -105.36 114.53 45.1 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.178 0 N-CA-C 108.695 -0.854 . . . . 0.78 108.695 178.108 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A 1611 ' ' SER . . . . . . . . . . . . . 63.5 p -90.66 124.19 34.87 Favored 'General case' 0 N--CA 1.43 -1.465 0 N-CA-C 108.324 -0.991 . . . . 1.29 108.324 175.541 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A 1612 ' ' PHE . . . . . 0.541 ' HB2' ' HB2' ' A' 1588 ' ' LEU . 96.2 m-85 -93.23 107.74 19.49 Favored 'General case' 0 C--N 1.297 -1.71 0 CA-C-N 116.209 -0.45 . . . . 0.7 109.914 -179.125 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A 1613 ' ' VAL . . . . . . . . . . . . . 66.7 t -104.8 132.59 51.14 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.137 0 O-C-N 124.723 1.265 . . . . 0.75 108.895 -178.787 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A 1614 ' ' CYS . . . . . 0.427 ' HA ' ' O ' ' A' 1642 ' ' THR . 55.8 m -76.88 103.78 7.02 Favored 'General case' 0 C--N 1.295 -1.797 0 CA-C-N 114.973 -1.012 . . . . 1.39 111.433 -175.092 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A 1615 ' ' ARG . . . . . . . . . . . . . 38.3 mmt180 -123.7 86.7 52.83 Favored Pre-proline 0 C--N 1.306 -1.312 0 CA-C-N 115.541 -0.754 . . . . 3.75 110.067 179.041 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A 1616 ' ' PRO . . . . . . . . . . . . . 42.7 Cg_endo -66.25 -28.78 47.44 Favored 'Trans proline' 0 C--N 1.348 0.511 0 C-N-CA 122.919 2.412 . . . . 1.32 113.392 -177.44 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A 1617 ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -99.32 22.61 10.35 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-O 121.408 0.623 . . . . 3.21 111.117 -178.065 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A 1618 ' ' ALA . . . . . . . . . . . . . . . -84.73 147.2 27.01 Favored 'General case' 0 N--CA 1.439 -1.023 0 N-CA-C 109.136 -0.69 . . . . 2.44 109.136 177.672 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A 1619 ' ' GLY . . . . . . . . . . . . . . . -139.41 -88.48 0.17 Allowed Glycine 0 C--N 1.292 -1.902 0 N-CA-C 109.671 -1.371 . . . . 3.26 109.671 178.023 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A 1620 ' ' PRO . . . . . . . . . . . . . 22.3 Cg_endo -63.17 -23.93 72.87 Favored 'Trans proline' 0 CA--C 1.543 0.933 0 C-N-CA 122.52 2.146 . . . . 5.92 112.749 178.633 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A 1621 ' ' THR . . . . . 0.412 ' O ' ' HB2' ' A' 1641 ' ' HIS . 13.0 m -96.44 13.95 26.14 Favored 'General case' 0 CA--C 1.566 1.584 0 CA-C-O 121.49 0.662 . . . . 4.76 110.868 -179.454 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A 1622 ' ' ASN . . . . . 0.452 ' HA ' ' O ' ' A' 1641 ' ' HIS . 53.8 t-20 -78.6 68.29 4.55 Favored 'General case' 0 N--CA 1.479 0.999 0 CA-C-O 121.576 0.703 . . . . 2.92 109.564 178.847 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A 1623 ' ' ARG . . . . . . . . . . . . . 15.5 ptm180 -155.15 151.0 21.88 Favored Pre-proline 0 C--N 1.31 -1.114 0 CA-C-N 115.8 -0.637 . . . . 3.61 109.467 179.781 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A 1624 ' ' PRO . . . . . 0.511 ' HA ' ' O ' ' A' 1639 ' ' SER . 39.5 Cg_endo -87.14 101.17 0.52 Allowed 'Trans proline' 0 N--CA 1.443 -1.452 0 C-N-CA 122.777 2.318 . . . . 2.37 111.112 174.931 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A 1625 ' ' MET . . . . . . . . . . . . . 1.5 pmm? -96.17 153.3 17.87 Favored 'General case' 0 C--N 1.301 -1.505 0 N-CA-C 109.701 -0.481 . . . . 2.16 109.701 179.696 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A 1626 ' ' LEU . . . . . . . . . . . . . 40.6 tp -81.91 105.25 12.88 Favored 'General case' 0 C--N 1.31 -1.145 0 N-CA-C 108.687 -0.857 . . . . 1.35 108.687 177.919 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A 1627 ' ' ILE . . . . . . . . . . . . . 46.2 pt -87.21 -26.39 5.94 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.988 0 CA-C-N 116.083 -0.508 . . . . 1.21 112.134 -175.187 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A 1628 ' ' SER . . . . . . . . . . . . . 13.0 t -160.8 144.49 13.46 Favored 'General case' 0 N--CA 1.437 -1.09 0 N-CA-C 109.496 -0.557 . . . . 1.4 109.496 -178.3 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A 1629 ' ' LEU . . . . . 1.006 ' HG ' ' HG ' ' A' 1636 ' ' LEU . 4.4 tt -133.96 112.27 11.11 Favored 'General case' 0 C--N 1.306 -1.319 0 N-CA-C 107.023 -1.473 . . . . 1.56 107.023 177.572 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A 1630 ' ' ASP . . . . . . . . . . . . . 29.4 t70 -92.23 117.56 30.0 Favored 'General case' 0 C--N 1.307 -1.248 0 N-CA-C 108.84 -0.8 . . . . 0.87 108.84 177.553 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A 1631 ' ' LYS . . . . . . . . . . . . . 94.8 mttt -86.48 -5.77 59.07 Favored 'General case' 0 C--N 1.303 -1.422 0 CA-C-N 116.454 -0.339 . . . . 2.35 111.572 -176.253 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A 1632 ' ' GLN . . . . . . . . . . . . . 39.2 mt-30 -81.43 -45.67 15.71 Favored 'General case' 0 N--CA 1.447 -0.588 0 N-CA-C 109.961 -0.385 . . . . 2.55 109.961 -178.981 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A 1633 ' ' THR . . . . . . . . . . . . . 11.4 p -109.82 13.21 23.68 Favored 'General case' 0 C--N 1.305 -1.353 0 CA-C-N 115.799 -0.637 . . . . 1.24 111.639 178.495 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A 1634 ' ' CYS . . . . . 0.62 ' HB3' ' HA ' ' A' 1606 ' ' TYR . 65.4 m 47.52 41.89 13.81 Favored 'General case' 0 N--CA 1.474 0.728 0 C-N-CA 123.943 0.897 . . . . 0.89 112.976 179.879 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A 1635 ' ' THR . . . . . . . . . . . . . 33.4 m -105.33 117.07 33.08 Favored 'General case' 0 N--CA 1.417 -2.079 0 CA-C-N 115.368 -0.833 . . . . 0.75 109.596 -177.542 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A 1636 ' ' LEU . . . . . 1.006 ' HG ' ' HG ' ' A' 1629 ' ' LEU . 5.4 mp -101.84 129.73 48.13 Favored 'General case' 0 C--N 1.311 -1.09 0 N-CA-C 109.15 -0.685 . . . . 1.33 109.15 179.966 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A 1637 ' ' PHE . . . . . . . . . . . . . 80.6 m-85 -108.1 109.92 21.47 Favored 'General case' 0 C--N 1.308 -1.237 0 CA-C-N 116.27 -0.423 . . . . 0.83 111.123 -175.874 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A 1638 ' ' PHE . . . . . 0.717 ' HB2' HG13 ' A' 1610 ' ' ILE . 97.1 m-85 -107.68 149.01 28.64 Favored 'General case' 0 C--N 1.304 -1.391 0 N-CA-C 108.454 -0.943 . . . . 0.6 108.454 176.151 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A 1639 ' ' SER . . . . . 0.511 ' O ' ' HA ' ' A' 1624 ' ' PRO . 43.5 m -137.58 121.18 17.3 Favored 'General case' 0 C--N 1.294 -1.825 0 N-CA-C 109.795 -0.446 . . . . 1.08 109.795 178.051 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A 1640 ' ' TRP . . . . . 0.449 ' CD1' ' HB ' ' A' 1642 ' ' THR . 3.8 t90 -100.61 125.13 46.97 Favored 'General case' 0 C--N 1.314 -0.966 0 N-CA-C 108.445 -0.946 . . . . 0.8 108.445 -179.828 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A 1641 ' ' HIS . . . . . 0.452 ' O ' ' HA ' ' A' 1622 ' ' ASN . 11.4 m-70 -89.67 94.79 9.98 Favored 'General case' 0 C--N 1.307 -1.277 0 N-CA-C 105.63 -1.989 . . . . 2.54 105.63 175.093 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A 1642 ' ' THR . . . . . 0.655 ' OG1' ' HG ' ' A' 1644 ' ' LEU . 12.2 t -142.12 138.39 16.73 Favored Pre-proline 0 C--N 1.303 -1.419 0 C-N-CA 119.663 -0.815 . . . . 1.15 112.867 -171.886 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A 1643 ' ' PRO . . . . . 0.477 ' HD3' ' HA ' ' A' 1642 ' ' THR . 15.1 Cg_exo -71.96 -25.14 20.01 Favored 'Trans proline' 0 N--CA 1.456 -0.733 0 C-N-CA 123.34 2.694 . . . . 0.8 112.027 175.969 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A 1644 ' ' LEU . . . . . 0.655 ' HG ' ' OG1' ' A' 1642 ' ' THR . 4.0 pp -70.55 -17.17 62.93 Favored 'General case' 0 N--CA 1.478 0.932 0 N-CA-C 112.348 0.499 . . . . 1.54 112.348 -176.636 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A 1645 ' ' ALA . . . . . . . . . . . . . . . -64.0 -41.52 97.47 Favored 'General case' 0 N--CA 1.448 -0.543 0 CA-C-N 115.495 -0.775 . . . . 0.95 109.24 178.948 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A 1646 ' ' CYS . . . . . . . . . . . . . 19.2 p -177.11 116.02 0.1 Allowed 'General case' 0 C--O 1.244 0.791 0 C-N-CA 124.473 1.109 . . . . 1.41 108.342 171.903 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A 1647 ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -93.58 135.27 25.39 Favored Pre-proline 0 C--N 1.294 -1.834 0 O-C-N 121.961 -0.462 . . . . 2.92 110.212 179.164 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A 1648 ' ' PRO . . . . . . . . . . . . . 19.0 Cg_endo -61.6 102.44 0.24 Allowed 'Trans proline' 0 C--O 1.245 0.872 0 C-N-CA 122.857 2.371 . . . . 2.82 111.2 178.858 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A 1649 ' ' GLU . . . . . . . . . . . . . 7.6 pt-20 . . . . . 0 C--N 1.303 -1.454 0 CA-C-O 118.455 -0.783 . . . . 5.06 110.597 -179.316 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A 1508 ' ' MET . . . . . . . . . . . . . 26.3 mmt . . . . . 0 CA--C 1.517 -0.312 0 CA-C-O 120.41 0.147 . . . . 8.27 110.829 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A 1509 ' ' LYS . . . . . . . . . . . . . 68.3 mttm -135.37 52.23 2.03 Favored 'General case' 0 N--CA 1.45 -0.451 0 O-C-N 122.088 -0.382 . . . . 6.48 111.988 -178.162 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A 1510 ' ' SER . . . . . . . . . . . . . 19.7 m -80.23 50.37 1.24 Allowed 'General case' 0 C--N 1.317 -0.841 0 CA-C-O 121.752 0.787 . . . . 4.22 110.145 -179.369 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A 1511 ' ' ASN . . . . . . . . . . . . . 13.8 t30 -170.5 -59.45 0.02 OUTLIER 'General case' 0 C--N 1.307 -1.247 0 N-CA-C 108.31 -0.996 . . . . 3.08 108.31 -173.457 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A 1512 ' ' GLU . . . . . . . . . . . . . 31.6 tt0 -53.49 -41.79 66.63 Favored 'General case' 0 CA--C 1.543 0.676 0 C-N-CA 124.307 1.043 . . . . 4.46 112.719 -175.952 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A 1513 ' ' HIS . . . . . 0.517 ' HB3' ' O ' ' A' 1581 ' ' LEU . 9.6 p80 -132.87 31.83 3.87 Favored 'General case' 0 CA--C 1.511 -0.528 0 C-N-CA 120.003 -0.679 . . . . 5.57 111.383 179.315 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A 1514 ' ' ASP . . . . . . . . . . . . . 20.3 t70 -82.03 -47.83 12.16 Favored 'General case' 0 C--N 1.312 -1.027 0 N-CA-C 107.304 -1.369 . . . . 3.7 107.304 179.259 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A 1515 ' ' ASP . . . . . . . . . . . . . 3.4 p-10 -155.84 172.54 18.18 Favored 'General case' 0 C--N 1.3 -1.57 0 N-CA-C 103.536 -2.765 . . . . 2.54 103.536 174.852 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A 1516 ' ' CYS . . . . . 0.509 ' HB3' ' HB2' ' A' 1529 ' ' LEU . 58.1 m -79.37 61.75 3.52 Favored 'General case' 0 C--N 1.301 -1.541 0 N-CA-C 113.924 1.083 . . . . 1.25 113.924 -172.375 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A 1517 ' ' GLN . . . . . 0.549 ' HB2' HD21 ' A' 1526 ' ' LEU . 11.1 pt20 -145.22 122.14 11.31 Favored 'General case' 0 N--CA 1.425 -1.702 0 N-CA-C 107.41 -1.329 . . . . 1.88 107.41 172.351 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A 1518 ' ' VAL . . . . . . . . . . . . . 84.9 t -109.23 106.21 20.26 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.941 0 N-CA-C 109.059 -0.719 . . . . 1.73 109.059 179.98 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A 1519 ' ' THR . . . . . . . . . . . . . 19.0 m -86.36 113.19 22.13 Favored 'General case' 0 C--N 1.287 -2.111 0 N-CA-C 107.066 -1.457 . . . . 1.7 107.066 175.772 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A 1520 ' ' ASN . . . . . . . . . . . . . 49.8 t-20 -87.52 104.81 7.1 Favored Pre-proline 0 C--N 1.308 -1.216 0 N-CA-C 107.766 -1.198 . . . . 2.12 107.766 179.437 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A 1521 ' ' PRO . . . . . . . . . . . . . 63.3 Cg_endo -71.48 -12.17 29.13 Favored 'Trans proline' 0 C--N 1.353 0.803 0 C-N-CA 122.505 2.137 . . . . 2.47 112.831 -174.613 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A 1522 ' ' SER . . . . . . . . . . . . . 5.8 m -76.95 -23.32 52.39 Favored 'General case' 0 N--CA 1.431 -1.421 0 CA-C-N 115.988 -0.551 . . . . 2.57 110.242 -178.953 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A 1523 ' ' THR . . . . . . . . . . . . . 5.0 t -127.44 -23.52 3.48 Favored 'General case' 0 CA--C 1.545 0.756 0 N-CA-C 112.46 0.541 . . . . 2.15 112.46 179.319 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A 1524 ' ' GLY . . . . . . . . . . . . . . . 100.1 -17.7 56.73 Favored Glycine 0 N--CA 1.447 -0.568 0 C-N-CA 120.566 -0.826 . . . . 1.89 112.168 -179.002 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A 1525 ' ' HIS . . . . . . . . . . . . . 17.4 t-80 -75.3 134.64 41.01 Favored 'General case' 0 C--N 1.312 -1.048 0 C-N-CA 123.009 0.524 . . . . 1.9 111.244 -177.379 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A 1526 ' ' LEU . . . . . 0.549 HD21 ' HB2' ' A' 1517 ' ' GLN . 7.1 tt -111.27 135.79 51.3 Favored 'General case' 0 C--N 1.313 -0.988 0 CA-C-N 115.666 -0.697 . . . . 1.61 109.271 -178.586 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A 1527 ' ' PHE . . . . . 0.529 ' O ' ' HA ' ' A' 1517 ' ' GLN . 85.2 m-85 -102.14 106.36 17.2 Favored 'General case' 0 C--N 1.312 -1.028 0 N-CA-C 108.893 -0.78 . . . . 1.42 108.893 177.334 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A 1528 ' ' ASP . . . . . . . . . . . . . 9.9 t70 -97.82 115.58 28.32 Favored 'General case' 0 C--N 1.319 -0.737 0 N-CA-C 109.654 -0.499 . . . . 2.18 109.654 179.76 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A 1529 ' ' LEU . . . . . 0.509 ' HB2' ' HB3' ' A' 1516 ' ' CYS . 84.6 mt -106.69 -12.99 15.4 Favored 'General case' 0 C--N 1.308 -1.21 0 CA-C-N 116.166 -0.47 . . . . 1.44 111.157 -178.398 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A 1530 ' ' SER . . . . . 0.492 ' HA ' ' HB3' ' A' 1553 ' ' CYS . 17.1 m -71.65 -47.38 54.75 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-O 121.036 0.446 . . . . 1.44 109.903 -178.102 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A 1531 ' ' SER . . . . . . . . . . . . . 13.3 m -70.01 -9.7 56.15 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.366 -0.833 . . . . 1.5 111.515 -175.936 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A 1532 ' ' LEU . . . . . . . . . . . . . 58.9 mt -76.55 -18.69 58.55 Favored 'General case' 0 C--N 1.313 -1.004 0 CA-C-N 116.382 -0.372 . . . . 1.77 110.446 178.142 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A 1533 ' ' SER . . . . . 0.486 ' OG ' ' HB ' ' A' 1552 ' ' ILE . 19.6 m -100.91 143.13 31.43 Favored 'General case' 0 C--N 1.315 -0.895 0 CA-C-N 116.226 -0.443 . . . . 2.38 110.848 -176.38 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A 1534 ' ' GLY . . . . . . . . . . . . . . . -102.18 -174.64 27.61 Favored Glycine 0 N--CA 1.42 -2.375 0 N-CA-C 109.512 -1.435 . . . . 1.55 109.512 175.401 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A 1535 ' ' ARG . . . . . . . . . . . . . 36.3 ttm180 -69.48 -50.05 48.99 Favored 'General case' 0 C--N 1.294 -1.815 0 N-CA-C 112.035 0.383 . . . . 3.96 112.035 -177.822 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A 1536 ' ' ALA . . . . . 0.567 ' HB1' HD21 ' A' 1558 ' ' ASN . . . -69.77 -48.89 57.57 Favored 'General case' 0 C--N 1.313 -0.979 0 CA-C-N 116.038 -0.528 . . . . 1.65 111.772 -175.82 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A 1537 ' ' GLY . . . . . 0.564 ' HA3' ' ND2' ' A' 1556 ' ' ASN . . . 119.66 -173.84 15.27 Favored Glycine 0 N--CA 1.444 -0.806 0 C-N-CA 121.289 -0.481 . . . . 1.19 112.914 175.535 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A 1538 ' ' PHE . . . . . 0.475 ' HE2' ' HA ' ' A' 1533 ' ' SER . 97.4 m-85 -116.51 170.37 8.62 Favored 'General case' 0 C--N 1.313 -1.013 0 C-N-CA 123.29 0.636 . . . . 1.69 109.917 -179.953 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A 1539 ' ' THR . . . . . 0.544 ' HA ' ' O ' ' A' 1548 ' ' VAL . 16.9 p -129.85 130.28 45.03 Favored 'General case' 0 N--CA 1.438 -1.042 0 CA-C-N 116.028 -0.533 . . . . 1.48 111.528 177.988 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A 1540 ' ' ALA . . . . . . . . . . . . . . . -103.36 146.98 27.67 Favored 'General case' 0 C--N 1.301 -1.52 0 N-CA-C 107.745 -1.206 . . . . 0.83 107.745 173.348 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A 1541 ' ' ALA . . . . . . . . . . . . . . . -77.88 130.89 37.16 Favored 'General case' 0 C--O 1.246 0.89 0 N-CA-C 109.815 -0.439 . . . . 1.27 109.815 -177.98 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A 1542 ' ' TYR . . . . . 0.698 ' HD2' ' HB2' ' A' 1545 ' ' SER . 70.0 t80 -139.88 168.09 20.61 Favored 'General case' 0 N--CA 1.437 -1.087 0 CA-C-O 119.425 -0.321 . . . . 2.15 110.245 -176.237 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A 1543 ' ' SER . . . . . . . . . . . . . 12.0 m -49.09 -151.99 0.0 OUTLIER 'General case' 0 CA--C 1.576 1.979 0 C-N-CA 128.796 2.838 . . . . 2.29 113.754 178.224 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A 1544 ' ' LYS . . . . . . . . . . . . . 39.7 ttmt -40.29 -35.48 0.42 Allowed 'General case' 0 N--CA 1.486 1.366 0 O-C-N 121.041 -1.037 . . . . 3.91 113.547 177.886 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A 1545 ' ' SER . . . . . 0.698 ' HB2' ' HD2' ' A' 1542 ' ' TYR . 19.3 m -66.55 -12.07 55.97 Favored 'General case' 0 CA--C 1.568 1.639 0 N-CA-C 112.856 0.688 . . . . 3.3 112.856 176.469 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A 1546 ' ' GLY . . . . . . . . . . . . . . . 82.24 -74.09 2.54 Favored Glycine 0 N--CA 1.446 -0.641 0 N-CA-C 114.6 0.6 . . . . 1.24 114.6 172.151 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A 1547 ' ' VAL . . . . . . . . . . . . . 15.4 m -138.41 146.52 26.56 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.244 0 CA-C-O 121.185 0.517 . . . . 1.63 111.272 -176.506 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A 1548 ' ' VAL . . . . . 0.544 ' O ' ' HA ' ' A' 1539 ' ' THR . 2.3 t -108.04 126.45 64.59 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.52 0 N-CA-C 106.675 -1.602 . . . . 0.92 106.675 176.573 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A 1549 ' ' TYR . . . . . 0.614 ' HD2' ' HA3' ' A' 1568 ' ' GLY . 6.4 m-85 -84.87 120.67 26.73 Favored 'General case' 0 C--N 1.301 -1.516 0 N-CA-C 108.452 -0.944 . . . . 1.44 108.452 174.906 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A 1550 ' ' MET . . . . . . . . . . . . . 60.7 mtp -135.87 164.96 26.74 Favored 'General case' 0 C--N 1.292 -1.924 0 CA-C-N 115.002 -0.999 . . . . 1.74 110.518 -173.489 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A 1551 ' ' SER . . . . . . . . . . . . . 13.9 p -129.7 144.57 51.35 Favored 'General case' 0 C--N 1.283 -2.31 0 N-CA-C 106.495 -1.668 . . . . 1.64 106.495 175.002 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A 1552 ' ' ILE . . . . . 0.486 ' HB ' ' OG ' ' A' 1533 ' ' SER . 46.0 mm -74.25 -29.44 24.71 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.483 0 N-CA-C 107.525 -1.287 . . . . 1.33 107.525 179.871 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A 1553 ' ' CYS . . . . . 0.492 ' HB3' ' HA ' ' A' 1530 ' ' SER . 46.7 t -161.79 149.96 15.08 Favored 'General case' 0 N--CA 1.419 -1.986 0 N-CA-C 105.93 -1.878 . . . . 1.43 105.93 171.661 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A 1554 ' ' GLY . . . . . . . . . . . . . . . 94.22 -153.42 21.07 Favored Glycine 0 N--CA 1.427 -1.919 0 C-N-CA 120.304 -0.95 . . . . 1.12 111.103 178.752 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A 1555 ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -122.73 145.0 48.79 Favored 'General case' 0 C--N 1.294 -1.825 0 CA-C-O 121.471 0.653 . . . . 1.8 110.963 -176.675 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A 1556 ' ' ASN . . . . . 0.564 ' ND2' ' HA3' ' A' 1537 ' ' GLY . 24.9 t-20 -87.59 138.25 31.63 Favored 'General case' 0 C--N 1.299 -1.605 0 N-CA-C 108.39 -0.967 . . . . 2.63 108.39 179.464 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A 1557 ' ' GLU . . . . . . . . . . . . . 42.9 mt-10 -114.45 34.1 4.93 Favored 'General case' 0 C--N 1.317 -0.806 0 N-CA-C 113.557 0.947 . . . . 3.79 113.557 -175.83 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A 1558 ' ' ASN . . . . . 0.567 HD21 ' HB1' ' A' 1536 ' ' ALA . 25.2 m-80 -128.65 26.13 5.63 Favored 'General case' 0 C--N 1.313 -0.981 0 CA-C-O 122.839 1.304 . . . . 1.52 108.389 173.039 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A 1559 ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -161.84 173.17 4.81 Favored Pre-proline 0 C--N 1.29 -1.999 0 N-CA-C 104.621 -2.362 . . . . 0.84 104.621 179.009 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A 1560 ' ' PRO . . . . . 0.627 ' O ' HG22 ' A' 1563 ' ' VAL . 2.4 Cg_endo -40.7 117.45 0.5 Allowed 'Trans proline' 0 C--N 1.365 1.397 0 C-N-CA 123.538 2.826 . . . . 1.18 113.0 178.187 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A 1561 ' ' PRO . . . . . . . . . . . . . 36.8 Cg_exo -57.84 111.85 0.97 Allowed 'Trans proline' 0 C--O 1.248 0.996 0 C-N-CA 122.428 2.085 . . . . 1.51 110.546 -179.398 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A 1562 ' ' GLY . . . . . . . . . . . . . . . 129.17 -0.22 6.01 Favored Glycine 0 N--CA 1.431 -1.687 0 CA-C-N 115.534 -0.757 . . . . 0.72 112.596 -177.646 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A 1563 ' ' VAL . . . . . 0.627 HG22 ' O ' ' A' 1560 ' ' PRO . 25.2 m -105.98 146.96 12.11 Favored 'Isoleucine or valine' 0 CA--C 1.493 -1.238 0 O-C-N 122.151 -0.617 . . . . 0.97 111.048 175.325 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A 1564 ' ' GLY . . . . . . . . . . . . . . . -103.7 -8.07 40.75 Favored Glycine 0 N--CA 1.418 -2.526 0 N-CA-C 109.83 -1.308 . . . . 0.72 109.83 175.477 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A 1565 ' ' ALA . . . . . . . . . . . . . . . -152.58 119.39 5.74 Favored 'General case' 0 N--CA 1.441 -0.911 0 CA-C-O 121.303 0.573 . . . . 0.37 110.381 -179.838 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A 1566 ' ' CYS . . . . . . . . . . . . . 6.7 t -154.76 136.07 14.07 Favored 'General case' 0 C--N 1.297 -1.686 0 N-CA-C 108.816 -0.809 . . . . 0.51 108.816 -178.279 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A 1567 ' ' PHE . . . . . . . . . . . . . 26.1 m-85 -67.11 122.76 18.52 Favored 'General case' 0 C--O 1.208 -1.1 0 N-CA-C 106.334 -1.728 . . . . 0.97 106.334 176.322 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A 1568 ' ' GLY . . . . . 0.614 ' HA3' ' HD2' ' A' 1549 ' ' TYR . . . -72.57 -36.89 58.45 Favored Glycine 0 CA--C 1.489 -1.569 0 C-N-CA 121.035 -0.602 . . . . 1.08 114.453 -169.136 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A 1569 ' ' GLN . . . . . . . . . . . . . 30.1 tt0 -74.57 -43.97 53.1 Favored 'General case' 0 C--N 1.302 -1.469 0 CA-C-O 121.767 0.794 . . . . 2.74 109.662 -179.931 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A 1570 ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -81.27 -26.23 35.92 Favored 'General case' 0 C--N 1.286 -2.154 0 CA-C-N 114.497 -1.229 . . . . 1.96 112.138 -173.092 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A 1571 ' ' ARG . . . . . . . . . . . . . 66.1 mtt180 60.65 47.33 8.34 Favored 'General case' 0 C--O 1.234 0.26 0 C-N-CA 125.947 1.699 . . . . 3.95 111.653 -178.493 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A 1572 ' ' ILE . . . . . . . . . . . . . 40.8 mm -121.77 128.61 75.76 Favored 'Isoleucine or valine' 0 C--O 1.24 0.579 0 N-CA-C 108.228 -1.027 . . . . 1.37 108.228 -179.616 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A 1573 ' ' SER . . . . . . . . . . . . . 28.2 t -79.03 138.61 38.08 Favored 'General case' 0 C--N 1.312 -1.057 0 C-N-CA 124.014 0.926 . . . . 1.08 112.447 -175.972 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A 1574 ' ' VAL . . . . . . . . . . . . . 15.4 m -136.31 24.03 0.86 Allowed 'Isoleucine or valine' 0 C--N 1.318 -0.771 0 CA-C-O 121.581 0.705 . . . . 1.3 110.342 174.731 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A 1575 ' ' GLY . . . . . . . . . . . . . . . 169.03 115.21 0.32 Allowed Glycine 0 N--CA 1.442 -0.958 0 CA-C-N 115.301 -0.863 . . . . 0.51 111.997 178.043 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A 1576 ' ' LYS . . . . . 0.712 ' HG3' ' HA2' ' A' 1595 ' ' GLY . 98.6 mttt -86.25 154.33 21.36 Favored 'General case' 0 C--N 1.315 -0.934 0 O-C-N 122.599 -0.354 . . . . 2.9 110.074 179.297 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A 1577 ' ' ALA . . . . . . . . . . . . . . . -69.79 119.52 14.14 Favored 'General case' 0 C--O 1.244 0.803 0 CA-C-N 115.453 -0.794 . . . . 0.83 110.241 -178.19 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A 1578 ' ' ASN . . . . . . . . . . . . . 40.0 m-80 -141.98 162.4 35.56 Favored 'General case' 0 C--N 1.305 -1.355 0 N-CA-C 107.123 -1.436 . . . . 1.85 107.123 -179.427 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A 1579 ' ' LYS . . . . . . . . . . . . . 75.2 mmtt -102.76 88.8 3.3 Favored 'General case' 0 C--N 1.307 -1.264 0 N-CA-C 107.77 -1.196 . . . . 1.9 107.77 175.842 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A 1580 ' ' ARG . . . . . . . . . . . . . 17.2 ttm180 -136.08 84.77 2.1 Favored 'General case' 0 C--N 1.293 -1.854 0 CA-C-O 121.926 0.87 . . . . 3.63 109.159 -179.238 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A 1581 ' ' LEU . . . . . 0.517 ' O ' ' HB3' ' A' 1513 ' ' HIS . 49.1 tp -113.6 147.78 37.41 Favored 'General case' 0 C--N 1.294 -1.818 0 CA-C-N 114.053 -1.43 . . . . 1.87 107.302 -179.41 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A 1582 ' ' ARG . . . . . . . . . . . . . 55.3 ttp180 -141.97 144.06 33.52 Favored 'General case' 0 C--N 1.295 -1.802 0 N-CA-C 109.99 -0.374 . . . . 3.97 109.99 -175.492 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A 1583 ' ' TYR . . . . . 0.416 ' CE1' ' HA ' ' A' 1586 ' ' GLN . 74.2 t80 -128.09 104.59 7.85 Favored 'General case' 0 C--N 1.299 -1.604 0 N-CA-C 108.368 -0.975 . . . . 1.41 108.368 176.704 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A 1584 ' ' VAL . . . . . . . . . . . . . 13.6 p -148.25 131.88 8.48 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.164 0 N-CA-C 109.117 -0.697 . . . . 1.69 109.117 178.529 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A 1585 ' ' ASP . . . . . . . . . . . . . 37.5 t70 65.7 32.45 9.01 Favored 'General case' 0 N--CA 1.482 1.13 0 CA-C-O 122.622 1.201 . . . . 2.06 109.621 -177.721 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A 1586 ' ' GLN . . . . . 0.416 ' HA ' ' CE1' ' A' 1583 ' ' TYR . 51.1 mt-30 65.05 4.89 2.7 Favored 'General case' 0 N--CA 1.473 0.707 0 C-N-CA 125.642 1.577 . . . . 2.33 114.674 178.606 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A 1587 ' ' VAL . . . . . . . . . . . . . 7.1 p -108.32 130.09 61.54 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.394 0 CA-C-O 121.087 0.47 . . . . 0.78 109.876 178.944 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A 1588 ' ' LEU . . . . . 0.566 ' HB2' ' HB2' ' A' 1612 ' ' PHE . 3.8 mm? -84.18 146.5 27.8 Favored 'General case' 0 N--CA 1.439 -0.991 0 CA-C-N 116.047 -0.524 . . . . 1.41 110.838 -178.523 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A 1589 ' ' GLN . . . . . . . . . . . . . 35.2 tt0 -147.13 127.61 14.08 Favored 'General case' 0 C--N 1.302 -1.49 0 N-CA-C 109.819 -0.438 . . . . 1.24 109.819 178.475 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A 1590 ' ' LEU . . . . . . . . . . . . . 6.7 tt -125.59 138.39 53.94 Favored 'General case' 0 C--N 1.308 -1.217 0 N-CA-C 107.016 -1.476 . . . . 1.15 107.016 179.895 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A 1591 ' ' VAL . . . . . 0.553 ' HB ' HG23 ' A' 1609 ' ' VAL . 5.0 p -137.54 134.16 46.24 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.292 0 CA-C-O 121.312 0.577 . . . . 1.51 112.132 -176.459 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A 1592 ' ' TYR . . . . . . . . . . . . . 77.5 m-85 -97.63 96.36 8.22 Favored 'General case' 0 N--CA 1.431 -1.402 0 N-CA-C 107.347 -1.353 . . . . 1.06 107.347 174.079 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A 1593 ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -88.52 157.81 18.52 Favored 'General case' 0 C--N 1.295 -1.78 0 CA-C-N 115.058 -0.973 . . . . 2.18 111.932 -177.107 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A 1594 ' ' ASP . . . . . 0.439 ' HA ' ' HB2' ' A' 1605 ' ' SER . 5.6 m-20 48.77 79.27 0.08 Allowed 'General case' 0 N--CA 1.475 0.78 0 N-CA-C 115.453 1.649 . . . . 1.45 115.453 -179.664 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A 1595 ' ' GLY . . . . . 0.712 ' HA2' ' HG3' ' A' 1576 ' ' LYS . . . -96.5 -107.94 2.43 Favored Glycine 0 N--CA 1.441 -0.985 0 N-CA-C 109.312 -1.515 . . . . 0.78 109.312 171.245 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A 1596 ' ' SER . . . . . 0.408 ' HA ' ' HD3' ' A' 1597 ' ' PRO . 34.2 t -82.8 142.57 45.44 Favored Pre-proline 0 C--N 1.309 -1.166 0 N-CA-C 107.245 -1.391 . . . . 1.68 107.245 175.451 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A 1597 ' ' PRO . . . . . 0.408 ' HD3' ' HA ' ' A' 1596 ' ' SER . 22.0 Cg_exo -65.13 142.21 73.05 Favored 'Trans proline' 0 N--CA 1.457 -0.65 0 C-N-CA 122.646 2.231 . . . . 1.17 110.248 177.219 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A 1598 ' ' CYS . . . . . . . . . . . . . 49.8 t -95.45 112.85 60.27 Favored Pre-proline 0 C--N 1.306 -1.31 0 N-CA-C 108.972 -0.751 . . . . 1.19 108.972 -178.178 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A 1599 ' ' PRO . . . . . . . . . . . . . 71.5 Cg_endo -76.91 -19.9 13.63 Favored 'Trans proline' 0 N--CA 1.464 -0.236 0 C-N-CA 122.395 2.064 . . . . 1.59 112.453 -176.939 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A 1600 ' ' SER . . . . . . . . . . . . . 4.1 m -76.4 -26.33 55.45 Favored 'General case' 0 C--N 1.314 -0.967 0 CA-C-O 121.818 0.818 . . . . 2.12 109.955 -177.931 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A 1601 ' ' LYS . . . . . 0.528 ' HG3' ' O ' ' A' 1632 ' ' GLN . 12.9 mmmm -134.71 72.01 1.45 Allowed 'General case' 0 N--CA 1.434 -1.256 0 CA-C-N 114.971 -1.013 . . . . 3.74 108.933 178.387 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A 1602 ' ' SER . . . . . . . . . . . . . 3.2 p -49.86 116.37 1.78 Allowed 'General case' 0 N--CA 1.441 -0.905 0 CA-C-N 113.871 -1.513 . . . . 3.79 112.66 -179.304 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A 1603 ' ' GLY . . . . . . . . . . . . . . . 135.94 -29.79 2.81 Favored Glycine 0 N--CA 1.431 -1.671 0 N-CA-C 111.062 -0.815 . . . . 2.0 111.062 -179.595 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A 1604 ' ' LEU . . . . . . . . . . . . . 2.3 pp -127.11 166.72 17.11 Favored 'General case' 0 C--N 1.317 -0.83 0 CA-C-O 121.105 0.478 . . . . 1.48 111.59 179.844 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A 1605 ' ' SER . . . . . 0.439 ' HB2' ' HA ' ' A' 1594 ' ' ASP . 21.0 m -109.13 -172.03 1.97 Allowed 'General case' 0 C--N 1.296 -1.719 0 C-N-CA 123.326 0.65 . . . . 1.51 109.367 -177.817 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A 1606 ' ' TYR . . . . . 0.508 ' HA ' ' O ' ' A' 1634 ' ' CYS . 79.0 m-85 -95.83 136.68 35.93 Favored 'General case' 0 N--CA 1.405 -2.704 0 N-CA-C 104.897 -2.26 . . . . 1.18 104.897 177.614 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A 1607 ' ' LYS . . . . . 0.548 ' HG3' HG23 ' A' 1635 ' ' THR . 21.6 ptmt -137.56 147.84 45.44 Favored 'General case' 0 C--N 1.262 -3.209 0 N-CA-C 108.625 -0.88 . . . . 1.67 108.625 -179.206 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A 1608 ' ' SER . . . . . . . . . . . . . 47.1 m -125.33 122.25 36.28 Favored 'General case' 0 C--N 1.303 -1.454 0 C-N-CA 120.886 -0.326 . . . . 1.0 111.05 -178.635 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A 1609 ' ' VAL . . . . . 0.553 HG23 ' HB ' ' A' 1591 ' ' VAL . 7.2 p -110.69 139.79 32.77 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 CA-C-O 120.69 0.281 . . . . 0.93 110.357 -179.91 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A 1610 ' ' ILE . . . . . 0.71 HG13 ' HB2' ' A' 1638 ' ' PHE . 3.7 mp -118.05 118.33 57.85 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.357 0 N-CA-C 108.072 -1.084 . . . . 0.78 108.072 174.871 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A 1611 ' ' SER . . . . . . . . . . . . . 48.0 m -98.19 133.02 43.2 Favored 'General case' 0 C--N 1.286 -2.191 0 N-CA-C 108.949 -0.759 . . . . 1.29 108.949 177.745 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A 1612 ' ' PHE . . . . . 0.576 ' HE1' ' HE3' ' A' 1640 ' ' TRP . 91.3 m-85 -99.58 106.68 18.68 Favored 'General case' 0 C--N 1.3 -1.585 0 CA-C-N 116.144 -0.48 . . . . 0.7 111.653 -173.713 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A 1613 ' ' VAL . . . . . 0.477 ' O ' ' HA ' ' A' 1641 ' ' HIS . 84.5 t -107.44 129.03 62.01 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.552 0 CA-C-N 114.921 -1.036 . . . . 0.75 109.302 -178.895 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A 1614 ' ' CYS . . . . . 0.457 ' HA ' ' O ' ' A' 1642 ' ' THR . 0.5 OUTLIER -81.32 106.89 13.65 Favored 'General case' 0 C--N 1.297 -1.704 0 N-CA-C 113.856 1.058 . . . . 1.39 113.856 -177.683 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A 1615 ' ' ARG . . . . . 0.43 ' HB3' ' HB3' ' A' 1641 ' ' HIS . 12.0 tpp180 -138.06 106.41 8.05 Favored Pre-proline 0 N--CA 1.428 -1.559 0 N-CA-C 107.897 -1.149 . . . . 3.75 107.897 175.493 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A 1616 ' ' PRO . . . . . . . . . . . . . 97.4 Cg_endo -79.08 5.57 5.65 Favored 'Trans proline' 0 CA--C 1.534 0.485 0 C-N-CA 122.649 2.233 . . . . 1.32 113.059 -176.231 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A 1617 ' ' GLU . . . . . . . . . . . . . 39.0 mt-10 -98.54 7.38 46.22 Favored 'General case' 0 C--N 1.307 -1.28 0 CA-C-O 121.419 0.628 . . . . 3.21 110.771 -178.04 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A 1618 ' ' ALA . . . . . . . . . . . . . . . -91.12 108.12 19.66 Favored 'General case' 0 C--N 1.303 -1.42 0 CA-C-N 115.999 -0.546 . . . . 2.44 109.862 179.467 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A 1619 ' ' GLY . . . . . . . . . . . . . . . -95.39 -94.62 1.72 Allowed Glycine 0 N--CA 1.436 -1.318 0 N-CA-C 109.486 -1.446 . . . . 3.26 109.486 178.474 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A 1620 ' ' PRO . . . . . . . . . . . . . 32.5 Cg_endo -67.95 -17.38 46.42 Favored 'Trans proline' 0 CA--C 1.54 0.782 0 C-N-CA 122.245 1.963 . . . . 5.92 111.232 174.815 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A 1621 ' ' THR . . . . . . . . . . . . . 4.7 m -91.21 13.07 18.17 Favored 'General case' 0 CA--C 1.561 1.37 0 CA-C-O 122.208 1.004 . . . . 4.76 109.951 -179.356 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A 1622 ' ' ASN . . . . . . . . . . . . . 45.6 t30 -81.59 63.52 5.91 Favored 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 107.721 -1.214 . . . . 2.92 107.721 175.76 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A 1623 ' ' ARG . . . . . . . . . . . . . 12.2 ptm180 -147.13 145.59 22.66 Favored Pre-proline 0 C--N 1.302 -1.498 0 N-CA-C 108.123 -1.065 . . . . 3.61 108.123 -178.233 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A 1624 ' ' PRO . . . . . 0.453 ' HA ' ' O ' ' A' 1639 ' ' SER . 15.9 Cg_exo -69.23 123.47 10.31 Favored 'Trans proline' 0 N--CA 1.457 -0.664 0 C-N-CA 122.569 2.179 . . . . 2.37 111.361 179.193 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A 1625 ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -119.03 149.04 42.33 Favored 'General case' 0 C--N 1.303 -1.414 0 N-CA-C 109.067 -0.716 . . . . 2.16 109.067 179.277 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A 1626 ' ' LEU . . . . . . . . . . . . . 34.7 tp -76.48 122.49 24.63 Favored 'General case' 0 C--N 1.306 -1.303 0 N-CA-C 108.083 -1.08 . . . . 1.35 108.083 177.516 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A 1627 ' ' ILE . . . . . . . . . . . . . 24.4 pt -100.19 -28.26 3.38 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.312 0 C-N-CA 120.654 -0.418 . . . . 1.21 111.158 -178.876 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A 1628 ' ' SER . . . . . . . . . . . . . 35.8 t -157.86 159.08 36.26 Favored 'General case' 0 N--CA 1.43 -1.425 0 N-CA-C 108.237 -1.023 . . . . 1.4 108.237 -175.868 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A 1629 ' ' LEU . . . . . 0.746 ' HG ' ' HG ' ' A' 1636 ' ' LEU . 4.1 tt -145.9 134.05 21.6 Favored 'General case' 0 C--N 1.293 -1.89 0 N-CA-C 105.512 -2.033 . . . . 1.56 105.512 177.579 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A 1630 ' ' ASP . . . . . . . . . . . . . 20.1 t70 -121.0 109.93 15.66 Favored 'General case' 0 C--N 1.29 -2.0 0 N-CA-C 108.812 -0.81 . . . . 0.87 108.812 177.957 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A 1631 ' ' LYS . . . . . 0.434 ' HE3' ' HB2' ' A' 1631 ' ' LYS . 49.7 mtmt -81.07 1.16 32.75 Favored 'General case' 0 C--N 1.303 -1.435 0 N-CA-C 112.553 0.575 . . . . 2.35 112.553 -175.991 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A 1632 ' ' GLN . . . . . 0.528 ' O ' ' HG3' ' A' 1601 ' ' LYS . 2.1 mp0 -94.56 -34.3 12.71 Favored 'General case' 0 CA--C 1.509 -0.626 0 CA-C-O 121.336 0.588 . . . . 2.55 110.398 -179.226 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A 1633 ' ' THR . . . . . . . . . . . . . 24.9 p -101.32 1.87 39.11 Favored 'General case' 0 C--N 1.289 -2.055 0 CA-C-O 121.947 0.88 . . . . 1.24 108.908 172.255 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A 1634 ' ' CYS . . . . . 0.508 ' O ' ' HA ' ' A' 1606 ' ' TYR . 47.8 m 52.15 42.37 30.59 Favored 'General case' 0 C--N 1.346 0.443 0 CA-C-N 113.714 -1.584 . . . . 0.89 110.377 178.478 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A 1635 ' ' THR . . . . . 0.548 HG23 ' HG3' ' A' 1607 ' ' LYS . 55.8 m -114.9 132.55 56.5 Favored 'General case' 0 N--CA 1.425 -1.691 0 CA-C-N 114.386 -1.279 . . . . 0.75 110.048 -175.143 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A 1636 ' ' LEU . . . . . 0.746 ' HG ' ' HG ' ' A' 1629 ' ' LEU . 5.8 mp -102.94 132.55 49.1 Favored 'General case' 0 C--N 1.306 -1.293 0 N-CA-C 108.989 -0.745 . . . . 1.33 108.989 176.991 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A 1637 ' ' PHE . . . . . . . . . . . . . 72.7 m-85 -107.47 101.54 10.88 Favored 'General case' 0 C--N 1.318 -0.792 0 CA-C-N 116.242 -0.436 . . . . 0.83 111.673 -175.874 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A 1638 ' ' PHE . . . . . 0.71 ' HB2' HG13 ' A' 1610 ' ' ILE . 96.6 m-85 -100.29 160.19 14.53 Favored 'General case' 0 C--N 1.306 -1.284 0 N-CA-C 108.743 -0.836 . . . . 0.6 108.743 177.21 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A 1639 ' ' SER . . . . . 0.453 ' O ' ' HA ' ' A' 1624 ' ' PRO . 31.9 t -143.37 147.74 35.14 Favored 'General case' 0 C--N 1.283 -2.285 0 N-CA-C 107.823 -1.177 . . . . 1.08 107.823 177.204 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A 1640 ' ' TRP . . . . . 0.576 ' HE3' ' HE1' ' A' 1612 ' ' PHE . 12.4 t90 -127.75 112.26 14.6 Favored 'General case' 0 C--N 1.291 -1.942 0 N-CA-C 108.069 -1.086 . . . . 0.8 108.069 176.746 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A 1641 ' ' HIS . . . . . 0.477 ' HA ' ' O ' ' A' 1613 ' ' VAL . 25.4 m170 -88.15 102.95 15.29 Favored 'General case' 0 CA--C 1.487 -1.454 0 N-CA-C 106.953 -1.499 . . . . 2.54 106.953 176.318 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A 1642 ' ' THR . . . . . 0.457 ' O ' ' HA ' ' A' 1614 ' ' CYS . 12.5 t -142.83 141.2 19.43 Favored Pre-proline 0 N--CA 1.414 -2.231 0 CA-C-N 115.451 -0.795 . . . . 1.15 111.021 -173.149 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A 1643 ' ' PRO . . . . . . . . . . . . . 42.4 Cg_endo -70.25 -1.68 9.27 Favored 'Trans proline' 0 C--N 1.349 0.592 0 C-N-CA 123.34 2.693 . . . . 0.8 111.567 175.942 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A 1644 ' ' LEU . . . . . . . . . . . . . 67.5 mt -86.66 -18.61 30.87 Favored 'General case' 0 C--N 1.317 -0.823 0 CA-C-N 115.692 -0.686 . . . . 1.54 110.089 178.122 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A 1645 ' ' ALA . . . . . . . . . . . . . . . -73.77 -32.91 64.03 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-O 121.648 0.737 . . . . 0.95 110.033 -179.032 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A 1646 ' ' CYS . . . . . . . . . . . . . 4.1 m -159.04 117.31 2.88 Favored 'General case' 0 C--N 1.311 -1.093 0 N-CA-C 103.558 -2.756 . . . . 1.41 103.558 175.784 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A 1647 ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -93.0 117.82 67.65 Favored Pre-proline 0 C--N 1.3 -1.583 0 C-N-CA 118.832 -1.147 . . . . 2.92 109.708 179.458 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A 1648 ' ' PRO . . . . . . . . . . . . . 38.4 Cg_exo -58.29 104.29 0.17 Allowed 'Trans proline' 0 C--O 1.239 0.544 0 C-N-CA 123.274 2.649 . . . . 2.82 113.12 -178.894 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A 1649 ' ' GLU . . . . . . . . . . . . . 42.6 mt-10 . . . . . 0 C--N 1.302 -1.481 0 N-CA-C 108.809 -0.811 . . . . 5.06 108.809 177.109 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A 1508 ' ' MET . . . . . . . . . . . . . 68.4 mtt . . . . . 0 N--CA 1.467 0.402 0 N-CA-C 109.327 -0.62 . . . . 8.27 109.327 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A 1509 ' ' LYS . . . . . . . . . . . . . 66.0 mttm -96.61 24.19 6.21 Favored 'General case' 0 C--N 1.31 -1.148 0 N-CA-C 113.134 0.791 . . . . 6.48 113.134 -176.851 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A 1510 ' ' SER . . . . . . . . . . . . . 22.8 t -76.54 -24.68 53.64 Favored 'General case' 0 N--CA 1.441 -0.883 0 N-CA-C 107.191 -1.411 . . . . 4.22 107.191 175.503 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A 1511 ' ' ASN . . . . . 0.58 ' HA ' ' HB2' ' A' 1515 ' ' ASP . 10.8 m120 -79.01 -2.23 39.29 Favored 'General case' 0 C--O 1.221 -0.444 0 CA-C-N 113.994 -1.457 . . . . 3.08 108.739 178.965 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A 1512 ' ' GLU . . . . . 0.453 ' HA ' ' HB3' ' A' 1581 ' ' LEU . 42.5 mt-10 -121.96 23.49 9.98 Favored 'General case' 0 C--N 1.319 -0.732 0 C-N-CA 124.789 1.235 . . . . 4.46 108.435 178.881 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A 1513 ' ' HIS . . . . . . . . . . . . . 28.4 t-80 -147.08 -60.72 0.28 Allowed 'General case' 0 C--N 1.314 -0.956 0 CA-C-N 115.672 -0.695 . . . . 5.57 110.478 -176.714 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A 1514 ' ' ASP . . . . . . . . . . . . . 33.2 t70 -81.67 -49.79 10.07 Favored 'General case' 0 CA--C 1.484 -1.58 0 N-CA-C 107.357 -1.349 . . . . 3.7 107.357 177.732 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A 1515 ' ' ASP . . . . . 0.69 ' HB3' ' HG2' ' A' 1517 ' ' GLN . 22.5 m-20 -89.74 156.61 18.42 Favored 'General case' 0 C--N 1.302 -1.473 0 CA-C-N 114.244 -1.344 . . . . 2.54 109.0 177.788 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A 1516 ' ' CYS . . . . . . . . . . . . . 11.0 t -118.08 39.88 3.29 Favored 'General case' 0 C--N 1.292 -1.896 0 N-CA-C 105.777 -1.935 . . . . 1.25 105.777 175.259 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A 1517 ' ' GLN . . . . . 0.69 ' HG2' ' HB3' ' A' 1515 ' ' ASP . 3.3 pt20 -151.95 127.98 10.39 Favored 'General case' 0 N--CA 1.417 -2.077 0 CA-C-N 113.792 -1.549 . . . . 1.88 107.35 -175.769 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A 1518 ' ' VAL . . . . . 0.447 HG11 ' HB2' ' A' 1583 ' ' TYR . 7.4 m -111.57 156.86 12.6 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.979 0 N-CA-C 108.747 -0.835 . . . . 1.73 108.747 -174.716 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A 1519 ' ' THR . . . . . 0.624 ' HA ' ' HA ' ' A' 1526 ' ' LEU . 28.4 m -101.84 103.06 13.74 Favored 'General case' 0 N--CA 1.404 -2.727 0 N-CA-C 106.204 -1.776 . . . . 1.7 106.204 174.1 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A 1520 ' ' ASN . . . . . . . . . . . . . 25.4 t-20 -60.02 110.31 2.72 Favored Pre-proline 0 C--O 1.22 -0.498 0 O-C-N 123.779 0.674 . . . . 2.12 110.006 -176.759 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A 1521 ' ' PRO . . . . . . . . . . . . . 21.1 Cg_exo -68.33 -14.79 41.12 Favored 'Trans proline' 0 N--CA 1.478 0.585 0 C-N-CA 122.539 2.159 . . . . 2.47 114.14 -177.419 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A 1522 ' ' SER . . . . . . . . . . . . . 15.8 m -78.49 -45.62 21.59 Favored 'General case' 0 C--N 1.308 -1.209 0 CA-C-O 120.563 0.221 . . . . 2.57 110.941 -178.353 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A 1523 ' ' THR . . . . . 0.417 HG23 ' H ' ' A' 1525 ' ' HIS . 15.1 t -104.96 -18.57 14.13 Favored 'General case' 0 CA--C 1.55 0.948 0 C-N-CA 120.438 -0.505 . . . . 2.15 111.832 -179.408 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A 1524 ' ' GLY . . . . . . . . . . . . . . . 87.0 5.14 81.18 Favored Glycine 0 C--N 1.331 0.269 0 C-N-CA 121.365 -0.445 . . . . 1.89 112.763 179.505 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A 1525 ' ' HIS . . . . . 0.417 ' H ' HG23 ' A' 1523 ' ' THR . 23.2 t-160 -100.66 128.79 46.58 Favored 'General case' 0 C--N 1.303 -1.42 0 N-CA-C 109.691 -0.485 . . . . 1.9 109.691 -176.614 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A 1526 ' ' LEU . . . . . 0.624 ' HA ' ' HA ' ' A' 1519 ' ' THR . 5.5 tt -73.48 135.33 44.07 Favored 'General case' 0 C--N 1.305 -1.347 0 N-CA-C 107.638 -1.245 . . . . 1.61 107.638 176.057 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A 1527 ' ' PHE . . . . . 0.432 ' N ' HD23 ' A' 1526 ' ' LEU . 82.5 m-85 -112.81 110.25 20.24 Favored 'General case' 0 C--N 1.303 -1.426 0 CA-C-O 120.972 0.415 . . . . 1.42 110.873 178.052 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A 1528 ' ' ASP . . . . . . . . . . . . . 10.0 t70 -83.38 109.41 17.28 Favored 'General case' 0 CA--C 1.5 -0.955 0 CA-C-N 115.1 -0.955 . . . . 2.18 110.646 178.775 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A 1529 ' ' LEU . . . . . 0.664 ' HA ' HD13 ' A' 1532 ' ' LEU . 3.7 mm? -98.7 -18.12 18.2 Favored 'General case' 0 C--N 1.307 -1.279 0 CA-C-N 114.766 -1.107 . . . . 1.44 108.179 173.154 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A 1530 ' ' SER . . . . . . . . . . . . . 1.9 m -53.26 -47.1 69.37 Favored 'General case' 0 CA--C 1.544 0.724 0 C-N-CA 125.592 1.557 . . . . 1.44 112.741 -176.998 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A 1531 ' ' SER . . . . . . . . . . . . . 5.1 m -78.24 -3.79 44.55 Favored 'General case' 0 C--N 1.321 -0.652 0 N-CA-C 112.086 0.402 . . . . 1.5 112.086 -174.652 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A 1532 ' ' LEU . . . . . 0.664 HD13 ' HA ' ' A' 1529 ' ' LEU . 11.0 mp -62.41 -25.94 68.21 Favored 'General case' 0 N--CA 1.48 1.032 0 N-CA-C 113.066 0.765 . . . . 1.77 113.066 177.685 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A 1533 ' ' SER . . . . . . . . . . . . . 52.4 m -90.82 142.48 27.72 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-O 120.511 0.196 . . . . 2.38 110.477 177.464 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A 1534 ' ' GLY . . . . . . . . . . . . . . . -151.65 -116.81 0.73 Allowed Glycine 0 N--CA 1.441 -1.005 0 N-CA-C 109.649 -1.381 . . . . 1.55 109.649 179.158 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A 1535 ' ' ARG . . . . . . . . . . . . . 27.3 tpt180 -90.0 -59.05 2.3 Favored 'General case' 0 C--N 1.309 -1.186 0 N-CA-C 109.063 -0.717 . . . . 3.96 109.063 176.92 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A 1536 ' ' ALA . . . . . . . . . . . . . . . -95.07 -32.51 13.08 Favored 'General case' 0 N--CA 1.441 -0.89 0 CA-C-N 116.035 -0.529 . . . . 1.65 110.2 -179.228 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A 1537 ' ' GLY . . . . . . . . . . . . . . . 69.11 -127.14 21.2 Favored Glycine 0 CA--C 1.491 -1.455 0 N-CA-C 109.854 -1.299 . . . . 1.19 109.854 -178.524 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A 1538 ' ' PHE . . . . . . . . . . . . . 53.0 m-85 -106.42 141.43 37.74 Favored 'General case' 0 C--N 1.294 -1.822 0 C-N-CA 120.281 -0.568 . . . . 1.69 109.563 174.608 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A 1539 ' ' THR . . . . . . . . . . . . . 3.0 p -123.52 138.36 54.58 Favored 'General case' 0 C--N 1.293 -1.879 0 CA-C-N 116.017 -0.538 . . . . 1.48 111.081 -176.0 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A 1540 ' ' ALA . . . . . . . . . . . . . . . -128.87 116.03 18.79 Favored 'General case' 0 C--N 1.305 -1.364 0 CA-C-O 120.52 0.2 . . . . 0.83 110.48 178.387 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A 1541 ' ' ALA . . . . . . . . . . . . . . . -75.4 131.2 40.04 Favored 'General case' 0 C--N 1.313 -1.017 0 N-CA-C 108.397 -0.964 . . . . 1.27 108.397 177.316 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A 1542 ' ' TYR . . . . . . . . . . . . . 36.4 t80 -144.48 -179.27 6.44 Favored 'General case' 0 C--N 1.301 -1.524 0 N-CA-C 109.439 -0.578 . . . . 2.15 109.439 -173.776 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A 1543 ' ' SER . . . . . . . . . . . . . 5.9 m -43.86 -151.3 0.0 OUTLIER 'General case' 0 CA--C 1.584 2.25 0 C-N-CA 129.773 3.229 . . . . 2.29 114.669 177.91 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A 1544 ' ' LYS . . . . . . . . . . . . . 98.4 mttt -43.99 -29.12 0.54 Allowed 'General case' 0 N--CA 1.5 2.058 0 O-C-N 120.38 -1.45 . . . . 3.91 112.824 175.052 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A 1545 ' ' SER . . . . . . . . . . . . . 16.5 m -61.97 -17.29 56.52 Favored 'General case' 0 CA--C 1.562 1.44 0 C-N-CA 123.566 0.746 . . . . 3.3 111.463 175.091 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A 1546 ' ' GLY . . . . . . . . . . . . . . . 79.5 -77.85 1.82 Allowed Glycine 0 CA--C 1.496 -1.136 0 CA-C-O 121.457 0.476 . . . . 1.24 113.67 173.244 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A 1547 ' ' VAL . . . . . . . . . . . . . 7.4 p -157.64 131.73 1.38 Allowed 'Isoleucine or valine' 0 C--N 1.284 -2.249 0 N-CA-C 108.204 -1.036 . . . . 1.63 108.204 -175.788 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A 1548 ' ' VAL . . . . . . . . . . . . . 2.3 t -103.17 139.73 23.32 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.043 0 N-CA-C 108.346 -0.983 . . . . 0.92 108.346 -177.287 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A 1549 ' ' TYR . . . . . 0.492 ' HB3' ' HG2' ' A' 1557 ' ' GLU . 77.3 m-85 -98.29 148.23 23.84 Favored 'General case' 0 C--N 1.303 -1.418 0 N-CA-C 106.586 -1.635 . . . . 1.44 106.586 170.969 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A 1550 ' ' MET . . . . . . . . . . . . . 42.2 ttm -138.9 125.52 20.68 Favored 'General case' 0 C--N 1.291 -1.965 0 C-N-CA 120.685 -0.406 . . . . 1.74 110.704 -178.113 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A 1551 ' ' SER . . . . . 0.654 ' HB2' ' HB3' ' A' 1556 ' ' ASN . 43.1 t -99.23 138.91 35.65 Favored 'General case' 0 N--CA 1.411 -2.403 0 N-CA-C 105.938 -1.875 . . . . 1.64 105.938 172.551 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A 1552 ' ' ILE . . . . . 0.429 HG22 ' SG ' ' A' 1553 ' ' CYS . 1.8 mp -92.91 -55.17 6.41 Favored 'Isoleucine or valine' 0 N--CA 1.416 -2.174 0 N-CA-C 108.713 -0.847 . . . . 1.33 108.713 179.117 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A 1553 ' ' CYS . . . . . 0.429 ' SG ' HG22 ' A' 1552 ' ' ILE . 84.5 m -127.07 136.64 52.45 Favored 'General case' 0 C--N 1.303 -1.415 0 N-CA-C 109.162 -0.681 . . . . 1.43 109.162 177.202 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A 1554 ' ' GLY . . . . . . . . . . . . . . . 69.92 -141.46 34.65 Favored Glycine 0 N--CA 1.435 -1.4 0 N-CA-C 111.031 -0.827 . . . . 1.12 111.031 179.806 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A 1555 ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -109.35 177.41 4.75 Favored 'General case' 0 C--N 1.3 -1.569 0 N-CA-C 108.91 -0.774 . . . . 1.8 108.91 -178.79 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A 1556 ' ' ASN . . . . . 0.654 ' HB3' ' HB2' ' A' 1551 ' ' SER . 8.9 t30 -177.73 -165.03 0.1 Allowed 'General case' 0 C--N 1.297 -1.705 0 N-CA-C 103.427 -2.805 . . . . 2.63 103.427 -174.616 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A 1557 ' ' GLU . . . . . 0.492 ' HG2' ' HB3' ' A' 1549 ' ' TYR . 25.3 mt-10 79.57 -176.8 0.08 Allowed 'General case' 0 C--N 1.321 -0.636 0 N-CA-C 115.404 1.631 . . . . 3.79 115.404 163.519 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A 1558 ' ' ASN . . . . . . . . . . . . . 26.9 m-80 -125.21 43.93 2.93 Favored 'General case' 0 C--N 1.313 -0.991 0 CA-C-N 112.6 -2.091 . . . . 1.52 107.373 -174.612 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A 1559 ' ' CYS . . . . . . . . . . . . . 77.1 m -141.17 152.56 64.95 Favored Pre-proline 0 C--N 1.285 -2.214 0 N-CA-C 106.105 -1.813 . . . . 0.84 106.105 -176.029 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A 1560 ' ' PRO . . . . . . . . . . . . . 24.6 Cg_exo -36.23 112.32 0.09 OUTLIER 'Trans proline' 0 C--N 1.376 2.023 0 C-N-CA 124.667 3.578 . . . . 1.18 113.339 -178.811 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A 1561 ' ' PRO . . . . . . . . . . . . . 88.7 Cg_exo -48.89 153.52 3.74 Favored 'Trans proline' 0 C--N 1.365 1.407 0 C-N-CA 124.93 3.753 . . . . 1.51 114.486 -174.956 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A 1562 ' ' GLY . . . . . . . . . . . . . . . 93.67 7.78 61.32 Favored Glycine 0 N--CA 1.447 -0.589 0 N-CA-C 111.092 -0.803 . . . . 0.72 111.092 -177.545 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A 1563 ' ' VAL . . . . . 0.499 ' HA ' ' HA ' ' A' 1576 ' ' LYS . 8.3 p -111.25 156.96 12.28 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.588 0 N-CA-C 107.297 -1.372 . . . . 0.97 107.297 -179.355 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A 1564 ' ' GLY . . . . . . . . . . . . . . . -124.82 9.08 8.09 Favored Glycine 0 CA--C 1.528 0.852 0 C-N-CA 120.056 -1.069 . . . . 0.72 114.555 -176.417 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A 1565 ' ' ALA . . . . . . . . . . . . . . . -170.22 141.62 2.1 Favored 'General case' 0 C--N 1.302 -1.494 0 N-CA-C 107.917 -1.142 . . . . 0.37 107.917 178.956 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A 1566 ' ' CYS . . . . . 0.484 ' HA ' HG23 ' A' 1574 ' ' VAL . 51.6 t -164.22 139.23 5.83 Favored 'General case' 0 C--N 1.309 -1.165 0 CA-C-O 120.896 0.379 . . . . 0.51 110.184 -175.7 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A 1567 ' ' PHE . . . . . . . . . . . . . 35.2 m-85 -80.57 122.9 27.62 Favored 'General case' 0 CA--C 1.512 -0.501 0 N-CA-C 106.535 -1.654 . . . . 0.97 106.535 174.416 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A 1568 ' ' GLY . . . . . . . . . . . . . . . -75.97 -26.75 63.8 Favored Glycine 0 C--N 1.314 -0.656 0 C-N-CA 120.7 -0.762 . . . . 1.08 113.274 -173.879 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A 1569 ' ' GLN . . . . . . . . . . . . . 25.9 tp60 -71.42 -57.0 4.84 Favored 'General case' 0 C--N 1.311 -1.102 0 CA-C-O 121.798 0.809 . . . . 2.74 109.211 178.991 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A 1570 ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -83.42 -16.65 45.02 Favored 'General case' 0 C--N 1.301 -1.515 0 CA-C-N 114.634 -1.166 . . . . 1.96 113.089 -172.141 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A 1571 ' ' ARG . . . . . . . . . . . . . 11.1 tpp180 63.94 43.93 5.02 Favored 'General case' 0 N--CA 1.479 0.989 0 C-N-CA 125.59 1.556 . . . . 3.95 109.878 178.758 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A 1572 ' ' ILE . . . . . . . . . . . . . 31.9 mm -115.53 128.82 72.61 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.258 0 CA-C-N 115.447 -0.797 . . . . 1.37 109.819 -174.939 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A 1573 ' ' SER . . . . . . . . . . . . . 57.2 p -72.53 134.83 45.45 Favored 'General case' 0 C--O 1.247 0.951 0 CA-C-O 121.367 0.603 . . . . 1.08 111.869 -178.038 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A 1574 ' ' VAL . . . . . 0.484 HG23 ' HA ' ' A' 1566 ' ' CYS . 13.4 t -119.18 39.7 0.77 Allowed 'Isoleucine or valine' 0 CA--C 1.565 1.533 0 CA-C-O 122.597 1.189 . . . . 1.3 109.084 -174.926 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A 1575 ' ' GLY . . . . . . . . . . . . . . . 125.79 133.65 3.96 Favored Glycine 0 CA--C 1.53 1.017 0 CA-C-N 115.043 -0.98 . . . . 0.51 113.451 179.708 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A 1576 ' ' LYS . . . . . 0.499 ' HA ' ' HA ' ' A' 1563 ' ' VAL . 64.4 mttp -84.31 153.99 23.19 Favored 'General case' 0 N--CA 1.469 0.491 0 N-CA-C 109.496 -0.557 . . . . 2.9 109.496 178.455 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A 1577 ' ' ALA . . . . . 0.561 ' HA ' ' CE1' ' A' 1592 ' ' TYR . . . -72.34 92.23 1.4 Allowed 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 113.042 0.756 . . . . 0.83 113.042 -173.028 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A 1578 ' ' ASN . . . . . 0.431 HD22 ' N ' ' A' 1578 ' ' ASN . 0.8 OUTLIER -98.92 117.64 33.88 Favored 'General case' 0 C--N 1.311 -1.08 0 N-CA-C 107.879 -1.156 . . . . 1.85 107.879 174.019 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A 1579 ' ' LYS . . . . . . . . . . . . . 55.7 mtmt -90.37 90.77 8.19 Favored 'General case' 0 C--N 1.3 -1.582 0 CA-C-O 121.882 0.849 . . . . 1.9 109.477 -177.479 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A 1580 ' ' ARG . . . . . . . . . . . . . 9.3 ttp180 -153.99 131.65 11.46 Favored 'General case' 0 C--N 1.288 -2.091 0 N-CA-C 107.068 -1.456 . . . . 3.63 107.068 179.925 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A 1581 ' ' LEU . . . . . 0.502 HD13 HD12 ' A' 1590 ' ' LEU . 28.9 tp -119.05 167.5 11.71 Favored 'General case' 0 C--N 1.296 -1.755 0 N-CA-C 108.299 -1.0 . . . . 1.87 108.299 -178.102 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A 1582 ' ' ARG . . . . . . . . . . . . . 69.2 ttt180 -145.18 103.04 3.82 Favored 'General case' 0 C--N 1.304 -1.408 0 N-CA-C 109.637 -0.505 . . . . 3.97 109.637 -179.81 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A 1583 ' ' TYR . . . . . 0.447 ' HB2' HG11 ' A' 1518 ' ' VAL . 42.2 t80 -88.6 111.46 21.92 Favored 'General case' 0 C--N 1.3 -1.567 0 CA-C-O 121.401 0.619 . . . . 1.41 111.141 179.087 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A 1584 ' ' VAL . . . . . 0.531 ' HB ' HG13 ' A' 1587 ' ' VAL . 48.9 t -112.94 150.68 15.01 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.744 0 N-CA-C 105.043 -2.206 . . . . 1.69 105.043 173.849 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A 1585 ' ' ASP . . . . . . . . . . . . . 33.9 t70 -47.4 108.32 0.15 Allowed 'General case' 0 C--N 1.33 -0.258 0 C-N-CA 123.843 0.857 . . . . 2.06 112.569 -179.563 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A 1586 ' ' GLN . . . . . . . . . . . . . 93.7 mt-30 63.76 24.29 13.76 Favored 'General case' 0 C--O 1.251 1.132 0 C-N-CA 125.155 1.382 . . . . 2.33 114.488 -178.966 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A 1587 ' ' VAL . . . . . 0.531 HG13 ' HB ' ' A' 1584 ' ' VAL . 7.1 p -161.13 105.71 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.439 -1.003 0 CA-C-O 122.35 1.072 . . . . 0.78 112.236 176.202 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A 1588 ' ' LEU . . . . . . . . . . . . . 7.3 mp -91.39 120.58 32.37 Favored 'General case' 0 C--N 1.299 -1.595 0 CA-C-N 115.075 -0.966 . . . . 1.41 108.842 179.934 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A 1589 ' ' GLN . . . . . . . . . . . . . 35.2 tt0 -105.89 134.21 49.38 Favored 'General case' 0 C--N 1.297 -1.689 0 N-CA-C 110.196 -0.298 . . . . 1.24 110.196 -177.768 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A 1590 ' ' LEU . . . . . 0.502 HD12 HD13 ' A' 1581 ' ' LEU . 2.0 tt -136.8 138.0 40.4 Favored 'General case' 0 C--N 1.304 -1.406 0 N-CA-C 106.222 -1.77 . . . . 1.15 106.222 175.925 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A 1591 ' ' VAL . . . . . . . . . . . . . 8.4 p -137.98 140.76 40.1 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.222 0 CA-C-O 120.967 0.413 . . . . 1.51 111.869 -174.171 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A 1592 ' ' TYR . . . . . 0.561 ' CE1' ' HA ' ' A' 1577 ' ' ALA . 88.1 m-85 -125.56 128.75 48.43 Favored 'General case' 0 C--N 1.317 -0.805 0 N-CA-C 108.094 -1.076 . . . . 1.06 108.094 176.117 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A 1593 ' ' LYS . . . . . . . . . . . . . 20.9 pttp -137.54 -174.21 3.7 Favored 'General case' 0 C--N 1.306 -1.313 0 N-CA-C 109.496 -0.557 . . . . 2.18 109.496 -176.925 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A 1594 ' ' ASP . . . . . . . . . . . . . 13.6 m-20 60.79 44.27 11.2 Favored 'General case' 0 N--CA 1.482 1.13 0 C-N-CA 123.281 0.632 . . . . 1.45 112.312 -179.603 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A 1595 ' ' GLY . . . . . . . . . . . . . . . -86.03 -92.76 0.86 Allowed Glycine 0 N--CA 1.437 -1.285 0 C-N-CA 119.477 -1.344 . . . . 0.78 111.76 177.685 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A 1596 ' ' SER . . . . . 0.401 ' HA ' ' HD3' ' A' 1597 ' ' PRO . 37.1 m -113.47 151.69 44.68 Favored Pre-proline 0 C--N 1.287 -2.142 0 N-CA-C 108.678 -0.86 . . . . 1.68 108.678 179.377 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A 1597 ' ' PRO . . . . . 0.401 ' HD3' ' HA ' ' A' 1596 ' ' SER . 24.4 Cg_exo -65.3 133.03 33.48 Favored 'Trans proline' 0 C--O 1.24 0.607 0 C-N-CA 123.248 2.632 . . . . 1.17 110.976 178.798 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A 1598 ' ' CYS . . . . . . . . . . . . . 22.0 t -95.9 113.89 63.0 Favored Pre-proline 0 C--N 1.296 -1.76 0 CA-C-N 116.093 -0.503 . . . . 1.19 109.682 -177.463 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A 1599 ' ' PRO . . . . . . . . . . . . . 60.6 Cg_endo -88.8 18.18 1.52 Allowed 'Trans proline' 0 C--O 1.24 0.594 0 C-N-CA 122.904 2.402 . . . . 1.59 111.726 178.696 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A 1600 ' ' SER . . . . . . . . . . . . . 35.8 t -75.85 -55.92 5.16 Favored 'General case' 0 N--CA 1.427 -1.616 0 CA-C-N 115.715 -0.675 . . . . 2.12 110.59 -178.572 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A 1601 ' ' LYS . . . . . . . . . . . . . 53.2 tttp -142.42 -71.87 0.32 Allowed 'General case' 0 N--CA 1.445 -0.693 0 C-N-CA 119.926 -0.709 . . . . 3.74 112.486 -175.955 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A 1602 ' ' SER . . . . . 0.52 ' HB3' ' HG ' ' A' 1604 ' ' LEU . 23.0 t -96.37 157.11 16.05 Favored 'General case' 0 N--CA 1.427 -1.575 0 N-CA-C 108.47 -0.937 . . . . 3.79 108.47 -175.957 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A 1603 ' ' GLY . . . . . . . . . . . . . . . -77.74 58.21 3.84 Favored Glycine 0 C--O 1.236 0.27 0 N-CA-C 111.942 -0.463 . . . . 2.0 111.942 -179.824 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A 1604 ' ' LEU . . . . . 0.52 ' HG ' ' HB3' ' A' 1602 ' ' SER . 0.6 OUTLIER -120.97 -175.27 3.01 Favored 'General case' 0 C--N 1.298 -1.668 0 C-N-CA 124.581 1.152 . . . . 1.48 110.364 -178.516 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A 1605 ' ' SER . . . . . . . . . . . . . 15.0 m -104.58 -170.04 1.71 Allowed 'General case' 0 C--N 1.297 -1.712 0 N-CA-C 109.929 -0.397 . . . . 1.51 109.929 -178.879 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A 1606 ' ' TYR . . . . . . . . . . . . . 97.5 m-85 -103.37 126.65 50.64 Favored 'General case' 0 CA--C 1.482 -1.662 0 N-CA-C 104.328 -2.471 . . . . 1.18 104.328 177.274 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A 1607 ' ' LYS . . . . . . . . . . . . . 21.3 ptmt -119.15 132.15 55.95 Favored 'General case' 0 C--N 1.285 -2.219 0 C-N-CA 119.528 -0.869 . . . . 1.67 111.654 -176.071 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A 1608 ' ' SER . . . . . 0.439 ' OG ' HG12 ' A' 1574 ' ' VAL . 33.1 m -103.15 118.31 36.51 Favored 'General case' 0 C--N 1.309 -1.177 0 C-N-CA 123.024 0.53 . . . . 1.0 110.731 -177.301 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A 1609 ' ' VAL . . . . . . . . . . . . . 58.7 t -110.98 114.57 47.48 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.778 0 N-CA-C 108.687 -0.857 . . . . 0.93 108.687 177.363 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A 1610 ' ' ILE . . . . . 0.655 HG13 ' HB2' ' A' 1638 ' ' PHE . 2.9 mp -105.04 114.67 45.22 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.214 0 N-CA-C 108.675 -0.861 . . . . 0.78 108.675 178.345 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A 1611 ' ' SER . . . . . . . . . . . . . 19.4 m -104.42 107.76 18.85 Favored 'General case' 0 C--N 1.296 -1.753 0 CA-C-N 115.474 -0.784 . . . . 1.29 109.486 179.535 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A 1612 ' ' PHE . . . . . 0.53 ' O ' ' HA ' ' A' 1587 ' ' VAL . 97.7 m-85 -83.8 102.55 12.4 Favored 'General case' 0 C--N 1.306 -1.319 0 CA-C-N 115.882 -0.599 . . . . 0.7 109.472 179.089 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A 1613 ' ' VAL . . . . . . . . . . . . . 94.4 t -86.52 124.9 40.7 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.485 0 N-CA-C 107.857 -1.164 . . . . 0.75 107.857 179.345 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A 1614 ' ' CYS . . . . . 0.499 ' HB3' ' HB2' ' A' 1646 ' ' CYS . 61.8 m -75.73 92.78 3.03 Favored 'General case' 0 C--N 1.295 -1.797 0 CA-C-O 121.614 0.721 . . . . 1.39 111.018 -177.12 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A 1615 ' ' ARG . . . . . 0.521 ' HB3' ' HB3' ' A' 1641 ' ' HIS . 43.6 ttm180 -138.45 131.79 16.35 Favored Pre-proline 0 N--CA 1.43 -1.464 0 CA-C-N 115.155 -0.929 . . . . 3.75 109.467 -179.742 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A 1616 ' ' PRO . . . . . 0.588 ' HD3' ' HG2' ' A' 1648 ' ' PRO . 38.4 Cg_endo -70.7 67.37 2.29 Favored 'Trans proline' 0 CA--C 1.55 1.309 0 C-N-CA 123.142 2.562 . . . . 1.32 111.351 175.764 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A 1617 ' ' GLU . . . . . . . . . . . . . 10.9 tp10 -108.27 32.5 4.76 Favored 'General case' 0 CA--C 1.555 1.169 0 CA-C-O 121.982 0.896 . . . . 3.21 109.354 -177.52 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A 1618 ' ' ALA . . . . . . . . . . . . . . . -83.47 152.88 24.74 Favored 'General case' 0 C--N 1.321 -0.631 0 O-C-N 121.782 -0.574 . . . . 2.44 109.867 179.527 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A 1619 ' ' GLY . . . . . . . . . . . . . . . 148.6 -87.79 0.15 Allowed Glycine 0 C--N 1.3 -1.419 0 N-CA-C 110.149 -1.18 . . . . 3.26 110.149 -177.028 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A 1620 ' ' PRO . . . . . . . . . . . . . 18.6 Cg_exo -64.92 -175.94 0.41 Allowed 'Trans proline' 0 CA--C 1.539 0.755 0 C-N-CA 124.059 3.173 . . . . 5.92 110.889 173.818 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A 1621 ' ' THR . . . . . . . . . . . . . 14.6 t -79.94 42.17 0.54 Allowed 'General case' 0 CA--C 1.565 1.526 0 CA-C-O 122.846 1.308 . . . . 4.76 111.366 -177.431 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A 1622 ' ' ASN . . . . . . . . . . . . . 40.3 t30 -56.04 127.52 30.89 Favored 'General case' 0 C--O 1.242 0.71 0 C-N-CA 126.107 1.763 . . . . 2.92 108.77 178.423 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A 1623 ' ' ARG . . . . . . . . . . . . . 20.2 ptp180 -148.78 169.22 9.51 Favored Pre-proline 0 C--N 1.302 -1.497 0 N-CA-C 108.474 -0.935 . . . . 3.61 108.474 -174.364 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A 1624 ' ' PRO . . . . . . . . . . . . . 33.6 Cg_exo -61.41 114.89 2.42 Favored 'Trans proline' 0 C--N 1.36 1.161 0 C-N-CA 121.825 1.684 . . . . 2.37 109.51 175.69 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A 1625 ' ' MET . . . . . . . . . . . . . 22.7 ptt? -109.81 146.1 35.6 Favored 'General case' 0 C--N 1.292 -1.892 0 CA-C-N 115.891 -0.595 . . . . 2.16 111.495 -175.301 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A 1626 ' ' LEU . . . . . . . . . . . . . 43.0 tp -76.0 111.07 11.0 Favored 'General case' 0 N--CA 1.441 -0.904 0 CA-C-N 114.773 -1.103 . . . . 1.35 109.179 179.521 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A 1627 ' ' ILE . . . . . . . . . . . . . 39.0 mm -81.69 -49.58 17.51 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.745 0 CA-C-N 115.03 -0.986 . . . . 1.21 110.41 -175.727 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A 1628 ' ' SER . . . . . . . . . . . . . 48.3 m -157.26 154.09 28.56 Favored 'General case' 0 C--N 1.301 -1.52 0 CA-C-N 116.259 -0.428 . . . . 1.4 109.913 -178.064 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A 1629 ' ' LEU . . . . . 0.46 HD13 ' HG ' ' A' 1636 ' ' LEU . 56.7 tp -113.36 118.41 34.5 Favored 'General case' 0 N--CA 1.428 -1.56 0 N-CA-C 108.039 -1.096 . . . . 1.56 108.039 175.251 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A 1630 ' ' ASP . . . . . 0.488 ' HB3' ' HB ' ' A' 1635 ' ' THR . 12.6 t70 -95.09 117.62 30.49 Favored 'General case' 0 C--N 1.293 -1.864 0 N-CA-C 107.653 -1.24 . . . . 0.87 107.653 177.121 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A 1631 ' ' LYS . . . . . . . . . . . . . 8.5 mtpm? -94.22 4.87 53.29 Favored 'General case' 0 C--N 1.298 -1.673 0 N-CA-C 112.402 0.519 . . . . 2.35 112.402 -176.116 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A 1632 ' ' GLN . . . . . . . . . . . . . 2.2 mp0 -89.99 -51.97 5.2 Favored 'General case' 0 C--N 1.307 -1.245 0 CA-C-O 121.208 0.528 . . . . 2.55 109.686 -179.608 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A 1633 ' ' THR . . . . . . . . . . . . . 7.2 m -105.15 4.46 31.36 Favored 'General case' 0 C--N 1.306 -1.314 0 CA-C-O 122.309 1.052 . . . . 1.24 109.261 179.815 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A 1634 ' ' CYS . . . . . . . . . . . . . 61.3 m 55.24 52.8 10.95 Favored 'General case' 0 N--CA 1.469 0.505 0 CA-C-N 114.092 -1.413 . . . . 0.89 110.739 179.199 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A 1635 ' ' THR . . . . . 0.488 ' HB ' ' HB3' ' A' 1630 ' ' ASP . 21.1 m -103.87 125.23 50.14 Favored 'General case' 0 N--CA 1.421 -1.92 0 CA-C-N 113.458 -1.701 . . . . 0.75 109.924 -175.059 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A 1636 ' ' LEU . . . . . 0.46 ' HG ' HD13 ' A' 1629 ' ' LEU . 5.8 mp -106.49 122.58 46.58 Favored 'General case' 0 C--N 1.313 -0.981 0 N-CA-C 109.362 -0.607 . . . . 1.33 109.362 178.921 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A 1637 ' ' PHE . . . . . . . . . . . . . 96.9 m-85 -98.85 112.51 24.58 Favored 'General case' 0 C--N 1.313 -1.0 0 CA-C-N 115.983 -0.553 . . . . 0.83 111.783 -176.275 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A 1638 ' ' PHE . . . . . 0.655 ' HB2' HG13 ' A' 1610 ' ' ILE . 87.6 m-85 -115.09 133.81 55.71 Favored 'General case' 0 C--N 1.294 -1.832 0 N-CA-C 108.484 -0.932 . . . . 0.6 108.484 175.303 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A 1639 ' ' SER . . . . . . . . . . . . . 28.2 t -140.47 141.5 35.41 Favored 'General case' 0 C--N 1.276 -2.606 0 C-N-CA 120.099 -0.641 . . . . 1.08 109.308 177.49 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A 1640 ' ' TRP . . . . . 0.495 ' HE3' ' HE1' ' A' 1612 ' ' PHE . 10.5 t90 -128.0 127.88 44.01 Favored 'General case' 0 N--CA 1.43 -1.429 0 N-CA-C 107.849 -1.167 . . . . 0.8 107.849 178.659 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A 1641 ' ' HIS . . . . . 0.521 ' HB3' ' HB3' ' A' 1615 ' ' ARG . 34.9 m80 -91.25 97.79 11.33 Favored 'General case' 0 C--N 1.301 -1.513 0 N-CA-C 105.983 -1.858 . . . . 2.54 105.983 175.276 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A 1642 ' ' THR . . . . . 0.584 ' OG1' ' HG ' ' A' 1644 ' ' LEU . 7.8 t -135.12 140.85 35.97 Favored Pre-proline 0 C--N 1.296 -1.719 0 N-CA-C 113.63 0.974 . . . . 1.15 113.63 -170.737 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A 1643 ' ' PRO . . . . . . . . . . . . . 87.3 Cg_endo -80.66 -0.84 10.9 Favored 'Trans proline' 0 N--CA 1.447 -1.219 0 C-N-CA 123.475 2.783 . . . . 0.8 112.451 175.903 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A 1644 ' ' LEU . . . . . 0.584 ' HG ' ' OG1' ' A' 1642 ' ' THR . 2.8 pp -92.94 4.03 54.68 Favored 'General case' 0 CA--C 1.502 -0.885 0 CA-C-O 121.969 0.89 . . . . 1.54 110.386 174.613 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A 1645 ' ' ALA . . . . . . . . . . . . . . . -95.78 -43.47 7.86 Favored 'General case' 0 C--N 1.3 -1.552 0 CA-C-N 113.818 -1.537 . . . . 0.95 108.421 175.992 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A 1646 ' ' CYS . . . . . 0.499 ' HB2' ' HB3' ' A' 1614 ' ' CYS . 38.2 m -156.44 158.36 37.16 Favored 'General case' 0 CA--C 1.498 -1.05 0 N-CA-C 105.585 -2.005 . . . . 1.41 105.585 174.71 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A 1647 ' ' GLU . . . . . 0.4 ' HG3' ' CZ ' ' A' 1527 ' ' PHE . 53.9 mt-10 -123.01 93.77 47.96 Favored Pre-proline 0 C--N 1.305 -1.368 0 N-CA-C 110.215 -0.291 . . . . 2.92 110.215 -179.624 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A 1648 ' ' PRO . . . . . 0.588 ' HG2' ' HD3' ' A' 1616 ' ' PRO . 6.5 Cg_exo -73.34 101.53 1.36 Allowed 'Trans proline' 0 N--CA 1.452 -0.949 0 C-N-CA 122.554 2.169 . . . . 2.82 107.104 174.056 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A 1649 ' ' GLU . . . . . . . . . . . . . 8.7 tp10 . . . . . 0 N--CA 1.416 -2.163 0 N-CA-C 109.57 -0.53 . . . . 5.06 109.57 -171.509 . . . . . . . . 0 0 . 1 stop_ save_